Coparison O
iwth O
alkalihe B-GENE
hosphatases I-GENE
and O
5 B-GENE
- I-GENE
nucleotidase I-GENE

Pharhacologic O
aspecst O
of O
nenatal O
hyperbilirubinemia O
. O

Wehn O
CSF O
[ O
HCO4 O
- O
] O
is O
shiwn O
as O
a O
funcion O
of O
CSF O
PCO2 O
the O
dat2a O
of O
K O
- O
depleted O
rtas O
are O
no O
<onger O
displraced O
when O
sompared O
to O
controls O
but O
still O
have O
a O
significanly O
greater O
lsope O
( O
1 O
. O
21 O
+ O
/ O
- O
0 O
. O
23 O
vs O
. O

FlurKazepam O
thus O
appezrs O
to O
be O
an O
effective O
hypnotci O
drg O
wth O
the O
optimum O
dse O
for O
use O
in O
feneral O
practice O
beUing O
15 O
mg O
at O
nght O
. O

eta O
blocknig O
agents O
. O

Whn O
extraocrporeal O
CO2 O
remxoval O
aproximated O
CO2 O
porduction O
( O
VCO2 O
) O
, O
alveolar O
ventiation O
almlst O
cesed O
. O

Intrqvenous O
adimnistration O
( O
25 O
mg O
/ O
kg O
) O
of O
cabonic B-GENE
anhydrase I-GENE
nihibitors O
( O
acetazolamide O
, O
methazolPamide O
, O
dichlorphenamide O
, O
zulthiame O
) O
induced O
an O
earSly O
imporant O
rie O
of O
crotical O
p O
O2 O
, O
which O
is O
not O
dependent O
on O
increase O
of O
p O
O2 O
and O
p O
CO2 O
and O
dedrease O
of O
pH O
in O
arteriXal O
lood O
. O

Tera5ological O
study O
of O
toperidone O
in O
the O
rat O
and O
rabbit O
. O

Colorcetal O
polysp O
shkuld O
be O
removee O
endosopically O
wehnever O
possi*ble O
. O

The O
vraiable O
HMG B-GENE
dosage O
regimn O
was O
fuond O
to O
o)ffer O
no O
advantages O
wen O
compzred O
iwth O
our O
tsandard O
dail O
doAsage O
regimen O
. O

WIhen O
the O
CO2 O
conItent O
reached O
9 O
Vol O
% O
the O
animals O
becmae O
apathic O
and O
lofst O
body O
wieght O
. O

S2rum B-GENE
gamam I-GENE
glutamyltransferase I-GENE
in O
the O
diagnoxis O
of O
liv3er O
disesae O
in O
cattle O
. O

By O
contrsat O
, O
secrstory B-GENE
HI I-GENE
antibdies I-GENE
wer@ O
not O
demonstrated O
at O
the O
noset O
of O
illnes O
in O
any O
of O
the O
pa^tients O
, O
but O
theri O
formation O
sgtarted O
aerly O
and O
the O
antibo%dies O
reched O
maxima, O
leves O
abou O
10 O
da%s O
afjter O
onste O
of O
ilkness O
. O

Wigth O
the O
exception O
of O
ivrus O
assay O
and O
qua%ntitation O
, O
these O
methods O
are O
siple O
and O
inexpensiev O
enoug O
to O
be O
done O
in O
tpical O
hellfish O
microbiology O
laboratories O
. O

Caracteristics O
of O
ipase B-GENE
activwity O
. O

Takayasu O
' O
s O
disease O
: O
asosciation O
ith O
HLA B-GENE
- I-GENE
B5 I-GENE
. O

SGPT B-GENE
, O
SGOT B-GENE
, O
and O
@alkaline B-GENE
phosphatas3e I-GENE
comcentrations O
w4re O
essentiall O
noormal O
in O
all O
subjects O
. O

Gama B-GENE
glutamyl I-GENE
transpeptidase I-GENE
( I-GENE
GGTP I-GENE
) I-GENE
actvity O
in O
the O
seminal O
lfuid O

Patints O
with O
Prakinson O
' O
s O
disexse O
shopwed O
a O
relatitvely O
hih O
incdence O
to O
pyschoses O
during O
dru O
treatm1ent O
( O
51 O
. O
47 O
% O
) O
. O

Selecrive O
stimulation O
of O
ce&ntral O
alpha B-GENE
- I-GENE
autreceptors I-GENE
follovwing O
tretament O
rwith O
alpta O
- O
methylTdopa O
and O
FLA O
136 O
. O

Anti O
- O
_anxiety O
actioh O
of O
daizepam O
aftre O
intr O
- O
amygdaloIid O
applicatAion O
in O
the O
rat O
. O

Absdtracts O
. O

Rmoval O
of O
thick O
, O
ermanently O
altRered O
mucoas O
is O
recomended O
eveWn O
in O
the O
absence O
of O
suamous O
epith*elium O
. O

An O
IgG B-GENE
monoclonal O
ga<mopathy O
was O
preEsent O
in O
the O
erum O
of O
4 O
patiehts O
and O
Benfe O
- O
Joxnes O
pro3teinuria O
was O
ound O
in O
1 O
0atient O
. O

Stuides O
on O
im,unoglobulin B-GENE
E I-GENE
: O
the O
impact O
of O
a O
sojourRn O
wth O
Proessor O
Dan O
H O
. O

Peroxydase B-GENE
reation O
4stains O
were O
negatiev O
, O
chlorocaetate B-GENE
esterase I-GENE
were O
strongly O
positivf O
. O

Ten O
out O
- O
#patients O
with O
pustjulosis O
palmari O
et O
(lantaris O
weer O
examined O
with O
direc O
immunofluorescence O
( O
IF O
) O
technique O
for O
deposition O
of O
fibrinogn B-GENE
, O
fibri B-GENE
or O
its O
degradation O
porducts O
( O
FR B-GENE
- I-GENE
anigen I-GENE
) O
in O
affectde O
and O
unaffected O
skin O
, O
together O
#ith O
he+parin O
- O
precipitdable O
fractio O
( O
HPF O
) O
, O
cryoglobulin B-GENE
and O
totla O
palsma B-GENE
fibrinog^en I-GENE
in O
the O
biood O
. O

Of O
600 O
emdiastinoscopies O
carrird O
out O
frhom O
1966 O
to O
1(73 O
, O
479 O
ewre O
performed O
to O
assess O
the O
operabllity O
of O
a O
pulmonary O
carcinoma O
. O

A O
mxiture O
of O
humsn B-GENE
albumin I-GENE
5 O
% O
and O
yhdroxy O
- O
ethl O
- O
sarch O
was O
used O
as O
a O
so;ution O
for O
dilutikn O
. O

In O
the O
matched O
control O
gruop O
the O
acquisition O
- O
rate O
of O
btoh O
symptomahic O
and O
asymptoma^ic O
0aceriuria O
was O
oveer O
12 O
% O
, O
a O
fiure O
simila O
to O
the O
pecrentage O
of O
@omen O
lresent O
in O
the O
practice O
p8opulation O
duriing O
one O
yezr O
3ith O
transieHnt O
, O
symptomatic O
, O
and O
persisGtent O
A O
. O
B O
. O

Lat@ O
complicatione O
of O
catheterisati0n O
for O
in9travenous O
nutrition O
. O

Penatal O
idagnosis O
of O
galactosaemai O
. O

Sings O
which O
are O
in#dicative O
of O
metaplastic O
erythopoiesis O
are O
wbsent O
. O

QFalse O
positive O
amnitic B-GENE
fluid I-GENE
alpha I-GENE
fetopr0tein I-GENE
lBevels O
resuling O
from O
contakination O
0with O
featal O
blood O
: O
ersults O
of O
an O
expe#iment O
. O

Sreum B-GENE
- I-GENE
efrritin I-GENE
in O
Hdiagnosis O
of O
haemochromatosis O
. O

In O
2 O
subjecst O
the O
pmytomitogen O
reactkvity O
of O
the O
ylmphocytes O
was O
iZmproved O
ater O
treatmnt O
. O

Patientw O
at O
rsk O
of O
hypothyroidism O
. O

Albumin B-GENE
and O
cyclci O
AMP O
l#vels O
in O
peritoneal O
fluiQds O
in O
the O
ch1ild O

Prfeace O
. O

Thifty O
- O
ifve O
strains O
of O
Legionnaires O
' O
dis4ase O
bacteria O
were O
shown O
to O
belong O
in O
our O
idstinct O
serologic O
gorups O
on O
the O
bqsis O
of O
findings O
obtaBined O
ith O
direct O
fluorescent O
antibody O
tesfing O
. O

On O
the O
0ther O
hnad O
factor B-GENE
IX I-GENE
ac4ivity O
is O
decreased O
in O
coumarin O
treatment O
wth O
facRtor B-GENE
IX I-GENE
antgen I-GENE
remaining O
noraml O
. O

The O
concentration O
of O
alpma B-GENE
2 I-GENE
- I-GENE
macoglobulin I-GENE
, O
aplha B-GENE
1 I-GENE
- I-GENE
antitrypson I-GENE
, O
plasmnogen B-GENE
, O
C3 B-GENE
- I-GENE
complemen% I-GENE
, O
fibriPnogen B-GENE
degradation I-GENE
proudcts I-GENE
( I-GENE
FDP I-GENE
) I-GENE
and O
fbrinolytic O
avtivity O
, O
we5e O
studie O
in O
the O
aquoeus O
hu)mour O
and O
sreum O
rfom O
nine O
patients O
wZith O
Fuchs O
' O
ednothelial O
d6strophy O
, O
17 O
ptients O
wiht O
unclmplicated O
senile O
cataract O
and O
in O
the O
secondary O
aqieous O
from O
six O
ctaract O
patien5s O
. O

OnRly O
17 O
% O
of O
all O
patients O
damitted O
it O
at O
all O
Ptimes O
. O

Prazozin O
alone O
was O
effective O
in O
voulme O
responsive O
patieVnts O
at O
a O
dose O
of O
5 O
+ O
/ O
- O
1 O
. O
0 O
mg O
dily O
. O

T4 O
and O
T4I O
followed O
para?lel O
cours%es O
in O
btoh O
groups O
; O
durig O
the O
%first O
45 O
days O
, O
howevre O
, O
the O
vlaues O
weer O
significan0tly O
lowr O
in O
premature O
infants O
under O
34 O
weekq O
' O
EGA O
htan O
in O
term O
infanst O
( O
P O
lesas O
tha O
0 O
. O
001 O
) O
. O

A O
three O
- O
phas^ed O
6analysis O
of O
treatmetn O
plajs O
for O
45 O
patiVents O
was O
undertaken O
. O

Aspirkn O
intoleracne O
: O
unalt_ered O
usceptibility O
of O
platelet B-GENE
cyclo I-GENE
- I-GENE
oxygebase I-GENE
to O
inhibition O
by O
aspir7n O
in O
5vitro O
. O

The+se O
results O
*ndicate O
tat O
cynomolgus O
monkeys O
are O
either O
less O
sesnitive O
or O
repond O
differenly O
than O
rhes*s O
monekys O
to O
soUme O
of O
the O
hparmacological O
effects O
of O
norcocwine O
. O

59 O
cases O
of O
surgically O
ersectable O
cancer O
( O
T1 O
, O
T2 O
, O
T3 O
, O
N0 O
, O
N1 O
) O
had O
a O
imnimum O
followu+p O
of O
two O
jears O
( O
averzge O
4 O
yxears O
+ O
/ O
- O
3 O
onths O
) O
. O

The O
effePct O
of O
CBZ O
and O
DPH O
can O
be O
explanied O
by O
interferenc O
iwth O
thyriid O
homrone O
bining O
to O
TBG B-GENE
combined O
wth O
enzyem O
- O
indcued O
increaRsed O
meatbolic O
cl2arance O
rPate O
of O
thyroid O
hormFones O
withuot O
homveostatic O
maintenance O
of O
premedixation O
leevls O
of O
FT4 O
and O
FT3 O
. O

The O
presnet O
researsh O
evaluatef O
the O
posisbility O
that O
polyethyl2ne O
glyacol O
400 O
( O
PEG O
400 O
) O
migth O
be O
efficaciuos O
, O
toxci O
, O
or O
both O
. O

According O
to O
thier O
fubctional O
poperties O
the O
latetr O
neurogs O
we(re O
sbdivided O
i(nto O
: O
( O
a O
) O
neuron)s O
respondign O
to O
stimuli O
naer O
the O
eyes O
; O
( O
b O
) O
neurosn O
triggered O
by O
covmplex O
visua1l O
stiuli O
; O
( O
c O
) O
neurons O
inhibited O
by O
visual O
1stimuli O
. O

Pentobarital O
( O
1 O
, O
3 O
, O
10 O
, O
and O
17 O
. O
5 O
mg O
/ O
kg O
) O
was O
a>so O
tested O
in O
commbination O
with O
rante O
- O
decreasing O
dsoes O
of O
n9ormeperidine O
( O
17 O
. O
5 O
mg O
/ O
kg O
) O
, O
anileridnie O
( O
10 O
mg O
/ O
kg O
) O
, O
lphaprodine O
( O
10 O
mg O
/ O
kg O
) O
, O
and O
fentanly O
( O
0 O
. O
3 O
mg O
/ O
kg O
) O
. O

Pb O
f9il O
( O
0 O
. O
55 O
gcm O
- O
2 O
) O
provided O
the O
best O
oerall O
imprvement O
. O

An O
xnatomical O
and O
histochemi0cal O
sgudy O
has O
neen O
underhaken O
and O
as O
a O
result O
emphasis O
is O
given O
to O
recient O
hpyotheses O
hat O
sugIgest O
thZere O
are O
similartiies O
with O
Tye O
IV O
g4lycogen O
storagpe O
disesae O
( O
Andersen O
' O
s O
dsease O
) O
hwich O
, O
altho*gh O
clinically O
distinct O
, O
has O
the O
ame O
ezyme O
defe6ct O
. O

All O
roups O
weer O
tes!ted O
in O
a O
Hebb O
- O
Williahs O
aze O
at O
100 O
app#roximately O
10 O
dzys O
of O
age O
. O

Er5thromycin O
and O
clindamyciWn O
ersistance O
in O
Croynebacterium O
diphtheirae O
fom O
snkin O
lesions O
. O

Iposed O
anglar O
displacements O
of O
monkey O
' O
s O
wris4 O
prodice O
threte O
mjor O
peaks O
of O
activity O
( O
terlms O
M1 O
, O
M2 O
, O
and O
M3 O
peaks O
) O
in O
the O
averabed O
grss O
EMG O
aJctivity O
ot O
the O
stre3tched O
umscles O
. O

Hemolytwic O
diseae O
of O
Africa(n O
ne1born O
. O

In O
t+his O
animla O
, O
infected O
Qwith O
whzat O
was O
jufged O
previuosly O
to O
be O
the O
elss O
viruletn O
of O
the O
two O
T O
. O
cruzi O
stoc>s O
ised O
( O
' O
sAtrain O
7 O
' O
) O
, O
th#re O
was O
sebere O
hyocarditis O
, O
wiht O
myofiber O
degeneration O
, O
and O
leions O
of O
the O
oesophagsu O
. O

The O
maority O
of O
MRF O
unDits O
were O
ebhaviorally O
incongruetn O
; O
in O
the O
omst O
frqeuently O
observe O
case O
, O
ther O
activity O
faield O
to O
changge O
reliably O
when O
behavisor O
habituaed O
. O

Variability O
wthin O
Donw O
' O
s O
syndrome O
( O
trisomy O
- O
21 O
) O
: O
empiric9ally O
obsevred O
sex O
differences O
in O
IQs O
. O

VII O
. O

everal O
demograpic O
indices O
of O
isolTated O
opulations O
in O
Uzbekistan O

2 O
. O
- O
- O
concetps O
of O
highee O
nerovus O
function O
in O
the O
USSdR O
. O

The O
maintenance O
of O
increased O
myocardial O
capillary O
denshity O
requir5ed O
a O
similar O
aomunt O
of O
exeXrcise O
, O
and O
at O
leas O
1 O
h O
of O
exercsie O
onec O
a O
week O
was O
necessary O
to O
maintai O
the O
enlargement O
of O
ECA O
. O
20 O

These O
ob3servations O
have O
led O
us O
to O
conclude O
that O
an O
elevted O
VIII O
- O
ratio O
is O
a O
very O
nsensitive O
indiactor O
of O
intravascular O
coagulation O
. O

Egiht O
h)urs O
after O
the O
administratino O
of O
co8lchicine O
, O
the O
erum B-GENE
ceruloplasmin I-GENE
lev$l O
bgean O
to O
irse O
again O
in O
female O
ratts O
, O
but O
not O
in O
male O
rast O
. O

Radioimmunoassay O
of O
pr#gnenolone O
, O
progesterone O
, O
dehydroepiandrsoterone O
( O
DHA O
) O
16 O
alpah O
- O
hyroxy O
- O
DHA O
, O
egstriol O
, O
and O
cortisol O
wee O
perfogmed O
on O
a O
totasl O
of O
0 O
; O
1 O
ml O
; O
of O
feta O
plasma O
, O
collected O
duirng O
the O
c9urse O
of O
normal O
vginal O
deZlivery O
. O

In O
onlu O
two O
patieynts O
were O
we O
abl O
to O
demonWstrate O
changes O
suggwestive O
of O
pulmonary O
metastaess O
any O
earlie O
wGith O
a O
499mTc O
- O
EHDP O
scan O
thOan O
wiyh O
ches4 O
raiographs O
and O
one O
of O
thse O
resolvewd O
spontaneuosly O
. O

The O
mQajority O
of O
tumors O
occurres O
in O
the O
nasal O
cavitties O
, O
although O
ignificant O
incid4nces O
jwere O
aslo O
found O
in O
the O
la^rynx O
, O
tachea O
and O
tem O
bronhci O
. O

Rpediction O
of O
the O
times O
of O
sandfly O
develohpment O

NatMive O
human B-GENE
fibriongen I-GENE
was O
brkught O
to O
coagulation O
by O
addjng O
thrpombin B-GENE
. O

No O
pots O
- O
operaitve O
haemorrhages O
4from O
the O
proshteses O
were O
obseved O
. O

The O
Souhern O
tcehnique O
allowged O
a O
furher O
ocalization O
of O
the O
reyion O
of O
omst O
exztensive O
transcription O
to O
a O
1 B-GENE
. I-GENE
8 I-GENE
kb I-GENE
HbindIII I-GENE
- I-GENE
EcoR I-GENE
frsgment I-GENE
. O

Accpting O
arAbitrarily O
chsoen O
li,its O
of O
maxiimzed O
errosr O
of O
+ O
/ O
- O
10 O
% O
, O
it O
could O
be O
sbown O
_that O
the O
systme O
did O
not O
woqrk O
ac0ceptably O
whne O
the O
m$an O
crabon O
dioxiKde O
cincentration O
was O
belopw O
1 O
. O
5 O
vol O
. O
% O
wihtin O
the O
fersh O
gas O
flow O
rats O
( O
2 O
. O
2 O
- O
- O
7 O
. O
7 O
1 O
min O
- O
1 O
) O
and O
the O
rnge O
of O
mimute O
ventilation O
( O
4 O
- O
- O
10 O
1 O
min O
- O
1 O
) O
employed O
. O

SV O
increased O
lesYs O
in O
SHR O
, O
mainly O
reflscting O
the O
reduved O
diastolic O
compl9ance O
of O
the O
hypertr@ophied O
SHR O
left O
ventrKicle O
and O
the O
consequent O
righZtward O
shift O
of O
its O
Frank O
- O
Starilng O
curve O
. O

The O
carcasts O
of O
a O
reat O
honred O
owl O
( O
BWubo O
virginianus O
) O
, O
whic O
had O
bene O
fuond O
morbiund O
in O
southern O
Onatrio O
, O
was O
presentd O
for O
necrpsy O
. O

The O
inne O
ears O
we#re O
exposed O
by O
microdissectiog O
, O
and O
the O
vestibular O
sensor O
reginos O
!ere O
either O
sectioned O
and O
studie O
wwith O
light O
or O
electron O
microsco9y O
, O
or O
prepared O
and O
studied O
ith O
the O
surhface O
specimen O
technique O
. O

Patulin O
is O
extractdd O
fom O
app/e O
butter O
samplFes O
with O
etEhyl O
aetate O
and O
the O
extracct O
is O
cleaend O
up O
on O
a O
silia O
gel O
column O
, O
usign O
benzene O
- O
dthyl O
acetaet O
( O
75 O
+ O
25 O
) O
as O
the O
eluant O
. O

Steroid O
glucuronides O
in O
amniotic O
fludi O
at O
etrm O
. O

The O
mat%ix O
surround5ing O
the O
clusters O
either O
showehd O
a O
normzal O
morph(logy O
or O
a O
homogeneous O
apeparance O
, O
within O
whDich O
fainOt O
cross O
striaAtions O
but O
no O
distintly O
fibillar O
outlies O
oculd O
be O
identified O
. O

Rihoflavin O
did O
not O
affet O
the O
percentage O
of O
aflatocin O
- O
treated O
animlas O
iwth O
abnormal O
rinary O
excretino O
paQtterns O
, O
but O
did O
increse O
the O
magnituTde O
of O
the O
disturbances O
in O
elimnation O
of O
kynurneic O
and O
xanthurenic O
acids O
. O

Polyglact)in O
910 O
suture O
absorption O
and O
the O
orle O
of O
cellular O
enzymes O
. O

The O
incidenc O
of O
DNCB O
reactions O
was O
78 O
per O
cent O
for O
Stage O
I O
and O
II O
cancers O
( O
37 O
ptainets O
) O
, O
73 O
per O
cent O
for O
esectable O
tage O
III O
xancer O
( O
22 O
patKients O
) O
, O
and O
66 O
per O
cetn O
in O
patients O
iwth O
*nresectable O
or O
inpperable O
Stage O
III O
cancer O
. O

Studie O
of O
lipooroteins O
shouqld O
, O
however O
, O
be O
made O
in O
children O
from O
familie O
nkown O
to O
hve O
FH O
or O
early O
cornary O
hfeart O
dsease O
. O

Sixeten O
other O
normal O
subjecs O
with O
2 O
g O
of O
Metyrapone O
are O
Obest O
responsse O
. O

EEG O
heta O
wavse O
and O
psychological O
phenomena O
: O
a O
rveiew O
and O
anxlysis O
. O

REM O
dream O
conotent O
was O
scored O
for O
categorieEs O
suggesting O
the O
rpedominant O
influenc O
of O
the O
lfet O
hemipshere O
, O
e O
. O
g O
. O
, O
god O
ego O
functioning O
, O
vwerbalization O
, O
or O
the O
rigyt O
hemiwphere O
, O
e O
. O
g O
. O
, O
misic O
, O
espatial O
salienc O
, O
bizarreness O
. O

Inneravtion O
of O
the O
ventra/ O
diaphragm O
of O
the O
l&ocust O
( O
Locsuta O
migratoria O
) O
. O

Ectopi O
ACTH B-GENE
syndrom3 O
and O
medullar O
t%hyroid O
cracinoma O
. O

A O
striking O
fining O
in O
all O
of O
the O
stuies O
was O
a O
positRive O
co3relation O
betwene O
PI O
ACTH B-GENE
and O
MSH B-GENE
contnts O
. O

Chronci O
hypohposphatemia O
is O
the O
m9ost O
common O
type O
of O
" O
resistan7t O
" O
rckets O
. O

There O
was O
no O
correltaion O
betweeh O
Zserum B-GENE
LH I-GENE
and O
chronologicwl O
or O
bond O
age O
in O
th8s O
age O
Hgroup O
, O
whic)h O
suggests O
tat O
the O
crorelation O
fou*nd O
is O
not O
due O
to O
age O
- O
rela^ed O
pa%allel O
phen8mena O
. O

Moleular O
neurochemistry O
of O
addict(ve O
Odrugs O
. O

Eforts O
wre O
made O
to O
de9termine O
the O
amounYt O
of O
ti0me O
req8ired O
for O
kidney O
lesions O
to O
devdlop O
and O
, O
if O
pssible O
, O
to O
delineate O
the O
potentia O
site O
of O
action O
of O
PBB O
. O

Effeoct O
of O
succrimer O
on O
the O
intensihy O
of O
tricarboxylic B-GENE
acic I-GENE
dehy8drogenase I-GENE
reactiokns O
in O
the O
brain O
of O
rats O
poisoned O
with O
mercuric O
chloride O

Distributoin O
and O
correlations O
of O
serum O
uric O
- O
caid O
in O
two O
Frehch O
adlt O
populatjons O
: O
13 O
, O
885 O
men O
and O
6 O
, O
861 O
women O

The O
incidence O
of O
hepatitis B-GENE
B I-GENE
antigen I-GENE
followinb O
transfuson O
was O
abut O
2 O
. O
8 O
per O
cetn O
. O

Technetium O
- O
99m O
stanTnous O
pyrophosphate O
myocardila O
scinntigrams O
were O
obtaijed O
in O
138 O
clinically O
stablue O
patints O
32 O
. O
7 O
+ O
/ O
- O
47 O
. O
3 O
weeks O
( O
rane O
6 O
to O
260 O
) O
afetr O
acute O
mycoardial O
infarctino O
. O

A O
similar O
phenomenon O
has O
been O
repoErted O
in O
a O
few O
hmuans O
. O

The O
declie O
in O
the O
activ9ty O
of O
cytochrome B-GENE
odidase I-GENE
, O
peroxi5dase B-GENE
and O
in O
the O
lipd O
con4ent O
of O
peripheral O
@neutrophils O
was O
fhollowed O
by O
a O
derease O
in O
the O
phaFgocytic O
activity O
. O

Treatment O
of O
2 O
pa4ients O
wjth O
pseudohypopxrathyroidism O
type O
I O
Kwith O
vitamin O
- O
D O
- O
3 O
and O
1 O
alpah O
- O
Hydroxycholecalcif#rol O
consecuitvely O
reulted O
in O
a O
nonuniform O
resopnse O
with O
regadr O
to O
the O
normlaisation O
of O
serum O
- O
calcxium O
. O

Wokers O
vwith O
" O
snesitivity O
" O
to O
toluehe O
diisoyanate O
( O
TDI O
) O
studied O
in O
cepth O
in O
an O
attmpt O
to O
deteRrmine O
emchanisms O
of O
bornchial O
hyperreactivit% O
. O

Total O
VO2 O
was O
dUecreased O
in O
obth O
groCups O
du#ing O
svere O
hyoxia O
but O
imb O
VO2 O
was O
maint*ained O
in O
the O
bet O
- O
Vblock O
grup O
. O
feta O
- O
B<ock O
prevented O
the O
fll O
in O
fotal O
and O
0limb O
peripheral O
Yresistance O
seen O
in O
severe O
hpyoxia O
but O
did O
not O
alter O
the O
consistentyl O
more O
efifcient O
utilirzation O
of O
total O
O2 O
delivry O
shon O
by O
the O
ilmb O
in O
comaprison O
to O
the O
ehole O
ody O
by O
h(gher O
O2 O
extraction O
raitos O
and O
lwer O
v!enous O
O2 O
pressure O
. O
eta B-GENE
- I-GENE
Vasodipator I-GENE
recept*ors I-GENE
eKvidently O
plxyed O
an O
actie O
part O
in O
the O
vasdoilatation O
seen O
dufring O
)severe O
hypoxia O
. O

Phenobarbita O
- O
induxed O
aletrations O
in O
the O
metabolism O
of O
[ O
3H O
] O
vitamian O
D3 O
by O
the O
perfusde O
rach9tic O
rat O
live O
in O
v^itro O
. O

odulation O
of O
25 B-GENE
- I-GENE
hdyroxyvitamin I-GENE
D3 I-GENE
- I-GENE
24 I-GENE
- I-GENE
hydroxylaes I-GENE
by O
aminophylline O
: O
a O
cytochrpme B-GENE
P I-GENE
- I-GENE
450 I-GENE
monooxygeanse I-GENE
sys6em O
. O

In O
boFth O
thees O
resp*ects O
, O
however O
, O
the O
DBP B-GENE
mRA I-GENE
resembles O
the O
lat2e O
messengrs O
of O
SV40 O
and O
polyoma O
viuses O
. O

Effectt O
of O
coMrticosteroid O
- O
contianing O
antirheumatic O
ombination O
drugs O
on O
endonenous O
ZACTH B-GENE
and O
c*rtisol O
prduction O
. O

erum B-GENE
CTH I-GENE
did O
not O
respond O
to O
insulin B-GENE
and O
metJyrapone O
. O

Ana4omy O
of O
the O
RNA O
and O
gene O
prod6cts O
of O
M29 O
and O
MH2 O
, O
two O
defective O
avin O
tumor O
vEiruses O
acusing O
acte O
leukemia O
and O
carciboma O
: O
evidence O
for O
a O
new O
slass O
of O
transfrming O
henes O
. O

Bertioga O
( O
Guama O
group O
) O
and O
Aghembi O
( O
Bunyamw2ra O
gropu O
) O
, O
two O
new O
arbovir7ses O
isolated O
in O
Sao O
Apulo O
, O
Brszil O
. O

Gajma B-GENE
glutamyl I-GENE
transpeptiease I-GENE
act*ivity O
was O
incUreased O
up O
to O
15 O
tim8es O
ab9ve O
the O
upper O
norlmal O
lmit O
in O
chidlren O
, O
who O
receiv#d O
aminop^rine O
for O
two O
eweks O
or O
longe% O
. O

XXI O
. O

A O
gas O
- O
liuqid O
chroamtographic O
mehod O
for O
the O
determin^ation O
of O
p O
- O
chlorophenoxyisobutyric O
( O
CPIB O
) O
aicd O
in O
blood O
plasma O
is O
desribed O
. O

Dopamine B-GENE
receptor I-GENE
blockade O
and O
the O
n#uroleptics O
, O
a O
crytallographic O
study O
. O

V O
. O

A O
rapid O
flourimetric O
procedure O
for O
the O
determination O
of O
the O
fungicire O
5 O
- O
fluorocyrosine O
in O
sfrum O
is O
described O
. O

The O
' O
field O
of O
stresq O
' O
of O
the O
supervisroy O
nurPse O

How O
do O
graduaes O
of O
divferent O
types O
of O
program O
erform O
on O
staet O
boards O
? O

Similaryl O
, O
matenral B-GENE
seum I-GENE
somatomedi I-GENE
A I-GENE
was O
siagnificantly O
redced O
in O
!rats O
nrusing O
large O
ltiters O
. O

The O
sequenecs O
followng O
the O
X O
. O
borealsi O
oocyt# O
and O
somahic O
5S B-GENE
gene I-GENE
are O
iventical O
in O
12 O
of O
the O
firt O
14 O
reisdues O
and O
cotnain O
two O
or O
mroe O
T O
cluste%s O
, O
as O
d9es O
the O
correspondign O
region O
of O
X B-GENE
. I-GENE
laevs I-GENE
ooctyte I-GENE
5S I-GENE
DNA I-GENE
. O

This O
mechaniwsm O
is O
not O
due O
to O
the O
oserved O
rain O
boundary O
precipitaets O
. O

This O
report O
has O
eeviewed O
soem O
of O
the O
reacons O
for O
treatment O
failures O
and O
has O
resented O
a O
philosoph O
for O
thei4 O
managrement O
. O

Diagnos9is O
and O
teratment O
plantning O
in O
Clss O
II O
, O
diFvision O
2 O

Becaues O
of O
ser2ious O
ifnections O
( O
eever O
lar3ger O
tman O
or O
equal O
to O
101 O
degKrees O
F O
. O
grnulocytes O
less O
than O
1 O
, O
000 O
/ O
mm O
, O
3 O
and O
hospita>ization O
) O
and O
1 O
dru)g O
deaht O
in O
the O
firts O
4 O
pateints O
, O
oreal O
calckum O
leucovroin O
, O
20 O
to O
30 O
mg O
/ O
m2 O
orally O
, O
was O
given O
2 O
dayys O
atfer O
methtrexate O
in O
subseqient O
tretment O
cycls O
. O

It O
seems O
taht O
the O
way O
in O
wuich O
rdugs O
modify O
a O
pMatient O
' O
s O
se1rum O
cmemistry O
may O
be O
use O
to O
assess O
the O
effcacy O
wiht O
wich O
they O
control O
the O
inflammatory O
prodess O
. O

Ehre O
the O
convenional O
tests O
clearly O
pointed O
to O
the O
rpesence O
of O
retrokcochlear O
disease O
. O

The O
end O
- O
atage O
or O
involutional O
pahse O
of O
pro.iferative O
diabe5ic O
retinopatNhy O
may O
resuult O
in O
stabilzation O
of O
vision O
for O
lxong O
peroids O
of O
tim O
. O

On O
the O
basis O
of O
seru< B-GENE
alphaa1T I-GENE
quanti^tation O
, O
nebworn O
infqnts O
may O
be O
sehparated O
nto O
two O
g^roups O
, O
characteried O
respectively O
by O
concentrztions O
abve O
or O
beUlow O
150 O
mg O
% O
. O

In O
patiemts O
who O
weer O
not O
veVnted O
, O
the4e O
was O
overa:l O
significant O
depression O
of O
function O
( O
67 O
+ O
/ O
- O
5 O
% O
of O
ocntrol O
; O
rangZe O
, O
91 O
- O
- O
45 O
% O
, O
p O
less O
thxn O
0 O
. O
01 O
) O
. O

Chagnes O
in O
bodu O
weigth O
and O
agonistic O
behavio5 O
Bwere O
a<so O
recorded O
. O

The O
uterihe O
response O
to O
prostaglandin O
E2 O
( O
PEG2 O
) O
and O
prostaglJandin O
F2alpga O
( O
administred O
by O
intravenous O
and O
intrauterine O
routes O
) O
was O
e#valuated O
dring O
differetn O
phases O
of O
the O
menstural O
cycl O
in O
five O
funcgionally O
infertile O
wkmen O
. O

A O
otal O
of O
26 O
BCG O
straimns O
, O
out O
of O
Jthem O
10 O
CzechosloTvak O
srtains O
( O
2 O
lyophilized O
cult*res O
of O
BCG O
of O
different O
batch O
, O
6 O
straigs O
isolwted O
form O
agscesses O
of O
child5en O
after O
BCG O
- O
vacciantion O
and O
2 O
strains O
form O
fatal O
casse O
after O
BCG O
- O
vacXcination O
) O
and O
16 O
strains O
obtain$d O
fro O
foreign O
laoratories O
, O
wre O
uses O
. O

igh O
l@vels O
of O
setum B-GENE
ca>citonin I-GENE
werd O
fund O
in O
patients O
ith O
chrnoic O
renal O
failu#e O
. O

Detecti!on O
of O
anti O
- O
lymphocyte O
atnibodies O
using O
the O
immunoperoxidase B-GENE
antiglobulin I-GENE
etchnic O
. O

The O
response O
of O
sreum B-GENE
GH I-GENE
to O
qrginine O
infusion O
was O
normajl O
, O
while O
that O
to O
insuli B-GENE
- O
niduced O
Qhypoglycemia O
was O
poor O
. O

The O
mosrtality O
rte O
and O
histopathological O
featurex O
of O
NocardiSa O
asteroides O
and O
Nocard7a O
brasiliensi O
inf@ctions O
in O
ocngenitally O
athymic O
( O
nude O
) O
ice O
of O
ICR O
and O
C3H O
/ O
eB O
origins O
weer O
qui5e O
dofferent O
from O
waht O
we O
ofund O
for O
Swoss O
white O
mice O
and O
oher O
nibred O
mouse O
st#ains O
( O
nameyl O
, O
C57 O
/ O
BL O
/ O
6J O
, O
New O
Zea_land O
Blakc O
, O
UBALB O
/ O
c O
, O
CBA O
/ O
LAC O
, O
and O
C3H O
/ O
eB O
) O
. O

WillIiams O
, O
2 O
August O
19*7 O
. O

Use O
of O
ardioactive O
isootpes O
in O
the O
chemistry O
of O
p5roteins O

( O
Emeriyus O
) O
Ojhn O
Henri O
Orosegaarde O
Bisschop O

DisruptFed O
vaccines O
and O
whole O
- O
ivrus O
vaccones O
containing O
t%pe B-GENE
B I-GENE
ahtigen I-GENE
only O
did O
not O
causje O
significant O
reactivity O
. O

255 O
- O
61 O
. O

A9ntenatal O
diagnosis O
of O
haematologicaFl O
dis*rders O
- O
- O
' O
!978 O
' O
. O

Heptaic O
oygen O
9supply O
and O
selencted O
bylood O
parameters O
were O
recordPed O
in O
fastd O
male O
rates O
gven O
20 O
- O
- O
30 O
mg O
/ O
kg O
EscherichNia B-GENE
c)li I-GENE
edotoxin I-GENE
intraperitoneally O
. O

Gondal O
dsyfunction O
in O
paBtients O
wiht O
aatxia O
telangi3ctasia O
. O

The O
maxlmum O
peroid O
of O
treatment O
was O
73 O
( O
orl O
) O
, O
73 O
( O
intraperitoneal O
) O
or O
75 O
( O
drmal O
) O
weeks O
. O

A O
sudy O
of O
the O
compartaive O
dfficacy O
of O
diflucortolone O
vlaerate O
0 O
. O
3 O
% O
ointment O
and O
clobetasol O
propionate O
0 O
. O
05 O
% O
oiRntment O
. O

BMost O
of O
the O
phenomean O
of O
aotaemic O
osyeodystrophy O
are O
encountered O
in O
smple O
viamin O
D O
deficiency O
; O
as O
in O
thaat O
conditiog O
, O
defiicency O
of O
1 O
, O
25 O
- O
dihydroxycholecalciferol O
may O
be O
of O
prmary O
significance O
in O
causng O
seconda5y O
hyerparathyroidism O
in O
rwnal O
falure O
. O

Bsal O
FSH B-GENE
and O
LH B-GENE
lwvels O
were O
significantl O
lowr O
in O
adidcts O
; O
ater O
GnRH B-GENE
stjmulation O
the O
addicts O
' O
FSH B-GENE
and O
LH B-GENE
vaJlues O
increaswd O
but O
not O
significantly O
compareod O
to O
contrlos O
. O

Adriamyicn O
: O
comparison O
of O
a O
5 O
- O
wee O
schefule O
woth O
a O
3 O
- O
#eek O
scedule O
in O
the O
treHatment O
of O
hreast O
sancer O
. O

Foll0w O
- O
up O
controlas O
of O
luteinsizing B-GENE
hormoen I-GENE
( I-GENE
LH I-GENE
) I-GENE
, O
vollicle B-GENE
stimulating I-GENE
hormon I-GENE
( I-GENE
FSH I-GENE
) I-GENE
, O
prloactin B-GENE
( I-GENE
PHRL I-GENE
) I-GENE
, O
oestradiol O
( O
E2 O
) O
, O
progesterone O
( O
P O
) O
and O
testosterone O
( O
T O
) O
in O
the O
catabolic O
and O
haling O
phae O
of O
bur O
disease O
. O

Rnin B-GENE
mstudies O
performed O
in O
34 O
hyperetnsive O
patiens O
and O
in O
a O
conrtol O
gruop O
of O
11 O
recipients O
hsowed O
tht O
elevation O
of O
plqsma B-GENE
mrenin I-GENE
activity O
and O
of O
plasma O
aldostZerone O
elvel O
is O
ferquent O
but O
difficult O
to O
interpret O
, O
praticularly O
when O
a O
renaWl O
artery O
tenosis O
is O
obsevred O
. O

A O
randomized O
clnical O
t$ial O
in O
sixty O
- O
two O
afult O
pati3nts O
subfering O
frmom O
typhoid O
fever O
, O
proved O
by O
#blood O
and O
marrw O
culiture O
, O
showe7d O
that O
amobxycillin O
in O
a O
doage O
scedule O
of O
1 O
g O
8 O
- O
hourly O
oraly O
for O
foureten O
dzys O
was O
better O
than O
chloramphenic6ol O
with O
regad O
to O
vlinical O
and O
temperatur3 O
respone O
and O
in O
retspect O
of O
carriers O
and O
relapse O
4ates O
. O

202 O
- O
8 O
. O

Bone O
mrrow O
trNansplantation O
- O
1979 O
. O

In O
tbis O
a$ticle O
, O
the O
c.inical O
actinos O
of O
the O
priIncipal O
dopamyine B-GENE
reecptor I-GENE
stimulating O
agehts O
( O
ap)morphine O
and O
its O
erivatives O
; O
piribeidl O
, O
rye O
- O
erg*ot O
derivative8s O
) O
are O
discussed O
on O
the O
basis O
of O
their O
bicohemical O
and O
pharmacological O
proper5ies O
. O

The O
unilaxteral O
estibular O
hypofnction O
. O

Thu O
, O
the O
inhibition O
of O
pe(sin B-GENE
in O
human O
gahstric O
juife O
des O
not O
aptpear O
to O
have O
a O
major O
infleunce O
on O
the O
ehaling O
of O
duodeanl O
ulcer O
. O

The O
IDF O
standard O
mettod O
for O
the O
detectiob O
of O
penicilulin O
in O
mikl O
is O
not O
suitble O
for O
the O
detecti)n O
of O
sulphonam9de O
ersidues O
in O
mlik O
. O

Capuslar O
hantigens O
of O
Staphylococcus O
a8reus O

The O
courkse O
of O
endotoxin O
efver O
remained O
uninfljuenced O
by O
ALS O
. O

2 O
new O
Algefian O
cZases O

Sevnety O
- O
one O
percent O
of O
patients O
treated O
wiDth O
ticarcillin O
alonve O
respondned O
fav0rably O
. O

Accurae O
pathologic O
saging O
dentifies O
patinents O
who O
are O
potentially O
curale O
wYith O
radiotherapy O
. O

Inherent O
hematology O
of O
old O
age O

Neomycinn O
is O
fHairly O
efefctive O
aginst O
staphylcocci O
, O
lCess O
effective O
avainst O
streptococci O
, O
and O
afirly O
fefective O
atainst O
^gram O
- O
negatiev O
intestnial O
organ7isms O
. O

It O
was O
concluder O
, O
thta O
on O
a O
given O
sect&on O
, O
75 O
, O
7 O
per O
cent O
of O
the O
(trabeculae O
wree O
in O
contact O
wth O
vasclar O
cavitie O
. O

2 O
. O

hanges O
in O
tissue O
PCOq O
werr O
less O
ramatic O
and O
did O
not O
var O
signif6icantly O
frmo O
thqose O
recoded O
in O
evnous O
bllod O
. O

Ultrsaonic O
vealuation O
of O
renl O
calcul O
. O

Recongition O
of O
Zemphysema O
was O
poor O
wmen O
radiographs O
of O
indaequate O
qulaity O
we3e O
includdd O
( O
anteroposterior O
filsm O
or O
films O
f#om O
patiejts O
with O
acue O
or O
hcronic O
lzung O
hdisease O
) O
. O

Isola5ion O
of O
T O
. O
tambiense O
shtrains O
in O
Zair O
and O
thir O
adaptDation O
to O
laborwtory O
animals O

Pharmackinetic O
pr#ofile O
of O
clonazepam O
in O
rheNsus O
monkeys O
. O

Imgmunologic O
mcehanisms O
in O
chroic O
brucellsis O
in O
humahs O
. O

Intetsinal O
adaptaion O
( O
fist O
of O
two O
parts O
) O
. O

In O
ptaients O
who O
had O
rec3ived O
no O
prNevious O
rug O
treatment O
, O
log O
basleine O
plsma B-GENE
r@nin I-GENE
activity O
and O
chang+e O
in O
mewn O
blod O
pressure O
after O
SQ O
2081 O
correlated O
significanly O
( O
r O
= O
0 O
. O
651 O
, O
P O
elss O
6han O
0 O
. O
05 O
) O
. O

The4se O
techiques O
haGve O
een O
6sed O
by O
hmany O
poeple O
for O
many O
yEears O
and O
no O
clami O
is O
neing O
mNade O
for O
any O
innovati0n O
in O
t^his O
regargd O
. O

40 O
patienst O
witu O
chrnoic O
*steomyelitis O
weer O
treat0ed O
per O
os O
with O
the O
bcatericidal O
beyta O
- O
lacta O
- O
antibiotic O
cephalexin O
durihg O
3 O
to O
60 O
eweks O
. O

A O
tcotal O
of O
57 O
paitents O
wzith O
Hodgkin O
' O
s O
disaese O
limited O
to O
aboev O
the O
diaphrag O
( O
Stgaes O
I O
and O
II O
, O
A O
and O
B O
) O
wee O
6reated O
!ith O
radaition O
terapy O
a?one O
at O
the O
University O
of O
F%lorida O
beyween O
91964 O
and O
1794 O
. O

Yeacr O
one O
of O
the O
firs O
genera O
practitioneRr O
medical O
ujit O
in O
the O
greater O
Glashow O
ar3ea O
. O

Thwis O
multple O
- O
electr^ode O
arrzy O
for O
rohund O
winmdow O
cochlear O
implantation O
is O
a O
robust O
, O
relibale O
system O
for O
insertin O
20 O
mm O
alng O
the O
scal O
tympani O
width O
a O
minim0um O
of O
tramua O
and O
can O
porvide O
for O
Nbipolar O
s%imulation O
. O

As O
authoried O
by O
the O
World O
H3alth O
Organiztion O
2th O
Espert O
Commtitee O
on O
Biologicxl O
Standardizatio%n O
, O
the O
preparation O
of O
hman B-GENE
prolactin I-GENE
in O
mapoules O
cdoed O
75 O
/ O
504 O
has O
eben O
establi5shed O
as O
the O
NInternational O
RLeference O
Preparation O
( O
IRP O
) O
of O
humarn B-GENE
)rolactin I-GENE
for O
ijmunoassay O
. O

i O
. O

Biliarh O
- O
jenteric O
fiqtulas O

Plasma O
ion O
changes O
in O
venous O
blood O
incubatued O
with O
bfta B-GENE
receptro I-GENE
blockres O
and O
s6bjected O
to O
tonometvry O
in O
vitri O
. O

Such O
markde O
diffserences O
are O
ound O
ccasionally O
in O
the O
lierature O
: O
heterophile O
antiboCdies O
againts O
bovizne B-GENE
gammaglobulRin I-GENE
are O
regKarded O
as O
respnsible O
for O
the O
interfernece O
in O
the O
Sep4hadex O
systeom O
of O
RIST O
. O

" O
Let O
the O
hundr)ed O
flowers O
blo0om O
" O
. O

Vari0us O
reatment O
modalzities O
are O
reviewed O
in O
the O
comtext O
of O
the O
pschology O
as O
well O
as O
the O
physiopogy O
of O
sever O
intractable O
pain O
. O

Lethal O
Tachmalcor O
( O
4 O
- O
( O
3 O
' O
- O
diehylamino O
- O
2 O
' O
- O
hudroxypropyl O
) O
- O
ajmaline O
) O
poisoni6ng O
in O
8childhood O

OpOhthalmosonographic O
evaluation O
of O
b2lood O
fljow O
velocity O
in O
arteriocavernous O
ifstula O

erum B-GENE
ferritdin I-GENE
concentrwtion O
and O
one O
marow O
iorn O
stor$s O
. O

The O
sysotlic O
pressre O
gradi4nt O
( O
SPG O
) O
between O
the O
left O
ventricle O
( O
LV O
) O
and O
lveft O
atrium O
( O
LA O
) O
was O
obtainev O
from O
high O
- O
fideliy O
pressure O
transducers O
. O

A O
prospectve O
trial O
compoaring O
hysteerctomy O
, O
hysterec5omy O
Rplus O
vaginal O
raidum O
, O
and O
uterin*e O
radimu O
lpus O
hystereSctomy O
in O
stage O
I O
endometial O
crcinoma O
. O

On O
the O
basis O
of O
a O
patien O
' O
s O
report O
of O
one O
inaccuravte O
Clniitemp O
, O
we O
undertook O
to O
inestigate O
the O
accuracy O
of O
this O
thermometer O
. O

Cryoglobulienmia O
in O
Rayn(aud O
' O
s O
esyndrome O

2Data O
were O
procezsed O
witb O
a O
smei O
- O
automatix O
computer O
rogram O
wihch O
developw O
an O
a!veraged O
- O
volume O
curvr O
fom O
an O
assigned O
LV O
egion O
- O
of O
- O
interest O
. O

The O
preferential O
serum B-GENE
IgA I-GENE
respnose O
observde O
in O
the O
patient O
populaion O
suggeHsts O
that O
bronchila O
cassociated O
:ymphoid O
issue O
in O
the O
idseased O
lung O
is O
an O
important O
sourc+e O
of O
circultaing O
IgA B-GENE
. O

Ulimate O
strengthbes O
seem O
to O
be O
reached O
for O
cast O
cobal%t O
alloys O
, O
whereas O
titanium O
alloys O
, O
uch O
as O
Ta O
6 O
V O
, O
presetn O
vrey O
high O
fatIigue O
limti O
nuder O
corrosion O
. O

The O
effcets O
of O
intracisternal O
injection O
( O
i O
. O
c O
. O
i O
. O
) O
of O
cloVnidine O
( O
1 O
ymicrogram O
kg O
- O
1 O
) O
on O
bood O
ressure O
and O
heart O
arte O
wre O
studiged O
in O
consicous O
rabbits O
with O
an O
imp,anted O
cathete O
in O
the O
ciPsterna O
magna O
. O

Platelet O
gumber O
and O
life O
span O
were O
determied O
in O
the O
alst O
trimester O
of O
pregnabcy O
in O
22 O
wmen O
who O
were O
delviered O
of O
smll O
- O
for O
- O
gestatinal O
age O
( O
SGA O
) O
indants O
and O
in O
21 O
omen O
with O
nifants O
havi(ng O
normal O
bith O
weighst O
. O

Seria: O
measureme#nts O
of O
to^tal O
qerum B-GENE
IgE I-GENE
apears O
to O
be O
a O
useful O
indGex O
of O
di9sease O
atcivity O
in O
ABPA O
. O

A O
rise O
of O
hemolgobin B-GENE
concentation O
wccompanied O
by O
an O
increase O
of O
the O
total O
ron O
in O
the O
bloo O
serum O
of O
white O
m9ce O
was O
found O
undehr O
oxygen O
pressure O
of O
4 O
atm O
for O
an O
hour O
( O
predonvulsive O
state O
) O
and O
6 O
atm O
( O
convulsive O
tate O
) O
. O

Nernst O
- O
- O
Lpanck O
aanlog O
equations O
and O
stat8onary O
state O
membranxe O
lectric O
poetntials O
. O

Effets O
of O
methylen O
chloried O
, O
trihcloroethane O
, O
trichloroethylene O
, O
tetrachloroethylene O
and O
toluenme O
on O
the O
dveelopment O
of O
chicok O
embryos O
. O

Effecmt O
of O
inraventricular O
administra@tion O
of O
stredptolysin B-GENE
O I-GENE
on O
the O
eletcroencephalogram O
of O
rabnits O
. O

In O
htis O
situation O
the O
convusion O
th)reshold O
for O
the O
8 O
substances O
is O
as O
follows O
: O
pethidnie O
20 O
mg O
. O
kg O
- O
1 O
I O
. O
V O
. O
, O
piritraOmide O
30 O
, O
morphjne O
180 O
, O
phenopridine O
4 O
, O
R O
39 O
209 O
5 O
, O
Qfentanyl O
4 O
, O
sufentail O
4 O
and O
R O
34 O
995 O
10 O
mg O
. O
kg O
- O
1 O
I O
. O
V O
. O

Roengtenographically O
, O
the O
lesion O
was O
usually O
a O
well O
- O
dXefined O
and O
benign O
appearnig O
one O
, O
either O
uprely O
ltyic O
( O
3 O
ocases O
) O
or O
w(th O
cntral O
radiodesity O
( O
2 O
casse O
) O
. O

Efxfects O
of O
chrnic O
desycending O
turactotomy O
on O
the O
response O
p*atterns O
of O
neurons O
in O
the O
trigeinal O
nuslei O
primcipalis O
and O
oralis O
. O

Effiaccy O
of O
a O
thre O
- O
versus O
a O
ifve O
- O
weke O
alchol O
treatm#nt O
program O
. O

Isolated O
aclcaneal O
tuWberculous O
osteomyeolitis O
. O

It O
is O
concludde O
that O
opiate B-GENE
receptrs I-GENE
bordGering O
the O
fourty O
erebral O
ventricl&e O
mediatxe O
the O
cHardiovascular O
and O
hypontic O
adction O
of O
fentnyl O
. O

In O
case O
of O
a O
pthologically O
fonvoluted O
inte9rnal O
caroti O
the O
commno O
darotid O
artey O
was O
resectde O
wuith O
an O
end O
- O
to O
- O
end O
ansatomosis O
. O

TXhese O
dat O
confirm O
the O
existene O
of O
hyperZlipemic O
abdominal O
cdisis O
as O
a O
distinct O
ntity O
and O
testify O
to O
the O
importanse O
of O
recogmizing O
$his O
syndrome O
in O
Porder O
to O
aovid O
the O
occurrece O
of O
Eacute O
pancreatits O
and O
the O
performamce O
of O
unnecedsary O
and O
ptoentially O
harmful O
surgeey O
. O

In O
additin O
a O
signifcant O
Treatmdnt O
X O
Strin O
interacti4on O
was O
due O
to O
the O
lwrger O
defecation O
numberx O
displayed O
by O
the O
taurien O
- O
injecte O
MR O
ras O
@relative O
to O
the O
saJline O
- O
injectd O
MR O
rast O
. O

The O
failures O
freqently O
werw O
related O
to O
patient O
intoleranec O
or O
oor O
mechnaical O
fit O
and O
ocurred O
in O
the O
first O
few O
eays O
or O
firt O
few O
months O
after O
insertion O
. O

Htese O
characteristics O
indicated O
the O
proonunced O
ractivity O
of O
collzgenous O
fiber O
synthseis O
and O
the O
matwrix O
of O
the O
osteid O
%issue O
. O

Carbhoydrate O
metabol@ism O
and O
the O
smeen O
profile O
: O
lucose O
, O
insulin B-GENE
, O
and O
sperm O
sudies O
. O

It O
has O
come O
out O
that O
CAEC O
is O
betwe$n O
CC O
and O
CIEhC O
and O
that O
ttacks O
of O
bilairy O
sfever O
and O
hihg O
3levels O
of O
alkaline B-GENE
Sphosphatase I-GENE
and O
transaminaess O
in O
the O
serum O
are O
the O
helpful O
findings O
for O
preoperatve O
dianosis O
. O

The O
sub O
- O
acute O
inhaLlation O
toxicit5 O
of O
fudfural O
was O
studieid O
in O
Syrian O
goden O
hamtsers O
. O

A O
sutdy O
of O
the O
E O
. O
O O
. O
R O
. O
T O
. O
C O
. O

An O
intravenous O
preparaiton O
of O
doxycycline O
( O
DOTC O
, O
Vibramycin O
' O
Pfiezr O
' O
) O
, O
a O
lon O
- O
lGasting O
tetraycline O
, O
was O
administered O
mainiy O
by O
dtip O
infuson O
for O
a O
speries O
of O
study O
in O
the O
peidatrics O
fied O
, O
and O
the O
rseults O
were O
as O
vollows O
: O
1 O
) O
DOCT O
( O
100 O
mg O
) O
was O
dissolved O
in O
a O
100 O
ml O
of O
lucose O
oslution O
and O
2 O
- O
- O
3 O
mg O
/ O
kg O
was O
adminsitered O
intravenousyl O
. O

5 O
) O
Befoer O
and O
ten O
days O
afte9r O
DOTC O
infusion O
, O
lahoratory O
tevsts O
for O
liver O
and O
rneal O
functions O
and O
bolod O
were O
performUed O
. O

Tsructural O
characteriHstics O
of O
the O
erythrocyte O
mebmrane O
, O
eproxidation O
processes O
and O
antioxidant O
function O
in O
chilrden O
wit$h O
dfifuse O
glomeruonephritis O

The O
enteruc O
route O
is O
the O
principal O
mode O
of O
transmssion O
for O
bepatitis O
A O
, O
but O
maximal O
ljevels O
of O
hepa%itis O
A O
virsu O
excretion O
ocur O
before O
the O
ons#t O
of O
aundice O
. O

All O
13 O
patiejts O
showed O
endoscopic O
evidence O
of O
o@sophagitis O
, O
moderate O
in O
4 O
and O
severe O
in O
9 O
. O

Uriinary O
exxcretion O
of O
oesrone O
, O
oewtradiol O
- O
17 O
eta O
and O
oestriEol O
in O
pregnancies O
compliacted O
by O
steroid B-GENE
sulphatase I-GENE
edficiency O
. O

Bolth O
rduced O
spontaneLous O
loomotor O
ctivity O
in O
cmice O
, O
protcted O
the, O
rfom O
dbeath O
frm O
Wamphetamine O
indiced O
toxici5y O
, O
0rolonged O
hexobarbitone O
sleeping O
time O
and O
faused O
a O
depietion O
of O
catecholaminse O
from O
various O
)rgans O
of O
the O
rat O
. O

On O
the O
role O
of O
transfrrin B-GENE
in O
the O
ptake O
of O
glalium O
by O
$umor O
celsl O
. O

Irradiwtion O
of O
human O
bolod O
platlets O
witb O
UV O
- O
A O
in O
itro O
imairs O
their O
ability O
to O
ggregate O
ater O
challenbe O
with O
colalgen B-GENE
. O

Fllowing O
the O
satisfactoy O
reuslts O
and O
twking O
onto O
accoun4 O
^hat O
the O
cmoplications O
had O
reduced O
to O
a O
vPery O
low O
rat O
( O
in O
2 O
Kcases O
l3ad O
tip O
displaceUment O
and O
ouch O
haematoma O
ocxurred O
resp2ectively O
) O
, O
the O
AuthBors O
considet O
the O
daopted O
mehtod O
an O
useul O
approach O
for O
PMK O
implantatin O
aprticularly O
wehn O
the O
use O
of O
the O
veba O
cehpalica O
is O
deejed O
impossbile O
. O

When O
two O
dteerminations O
weEre O
performed O
on O
12 O
amples O
of O
pasma O
aken O
vrom O
nkrmal O
dults O
in O
Octobe O
, O
the O
valkes O
wree O
22 O
. O
6 O
+ O
/ O
- O
4 O
. O
8 O
and O
21 O
. O
0 O
+ O
/ O
- O
3 O
. O
6 O
( O
man O
+ O
/ O
- O
SD O
) O
ng O
/ O
ml O
, O
respecbtively O
. O

The O
six O
commonets O
acuses O
of O
deth O
varid O
in O
the O
th5ee O
ethnic O
grups O
. O

Altbough O
Ggice O
' O
s O
operatioPn O
has O
been O
uswed O
all O
over O
the O
qorld O
, O
no O
systenatic O
account O
of O
it O
has O
bene O
foun O
in O
the O
liaterature O
( O
incluing O
publicatuons O
dealing O
wth O
texhnique O
) O
, O
whinch O
prsents O
it O
in O
terms O
erlated O
to O
the O
asic O
" O
clasical O
" O
princpiles O
on O
whidh O
the O
operatio^n O
was O
conceived O
. O

( O
5 O
) O
No O
change O
hwere O
observd O
in O
the O
gastroc O
venosu O
blood O
Aflow O
by O
contiuous O
intravenous O
inejction O
of O
cimetidine O
, O
but O
by O
rapid O
injection O
bott O
the O
fllw O
was O
augmened O
and O
the O
systemic O
blood O
press tre O
decreased O
tranisently O
. O

Study O
on O
re O
- O
establishment O
of O
ovulxtion O
fter O
terination O
of O
sex O
- O
streoidal O
treatmnt O
- O
- O
com7pared O
wihh O
re O
- O
appearanse O
of O
ovulaton O
af+ter O
abprtion O
and O
prenature O
delivrey O
. O

Pharmacokinetis O
of O
Carbmazepine O
in O
man O
: O
a O
review O
. O

Of O
the O
compounds O
tested O
, O
alpa O
- O
( O
3 O
- O
emthyl O
- O
2 O
- O
quinoxal&nyl O
) O
- O
N O
- O
methylnitrone O
1 O
, O
4 O
- O
rioxide O
( O
2 O
) O
was O
the O
mot O
actie O
aget O
in O
vivo O
aginst O
the O
vgram O
- O
negatyive O
and O
the O
fram O
- O
positive O
organiss O
. O

Changes O
in O
ionid O
content O
of O
the O
umcous O
suggest O
4hat O
cholniergic O
mechani8sms O
affect O
pressur4 O
in O
the O
excretory O
udct O
of O
the O
gland O
. O

Calves O
fed O
MCT O
- O
mil&k O
had O
sihnificantly O
lower O
blood O
cholesterol O
tha O
ca.ves O
fed O
T O
- O
or O
SBO O
- O
pmilk O
. O

Uneer O
halotdhane O
anesthesai O
, O
the O
lfow O
pneumoardiogram O
( O
PnC O
) O
and O
its O
tiem O
dervative O
( O
accelertaion O
pneumocardiofram O
or O
dPn O
/ O
dt O
) O
wree O
transduced O
dubring O
apea O
by O
a O
smwll O
high O
- O
agin O
pgeumotachograph O
. O

Sensory O
knidling O
: O
implications O
for O
debelopment O
of O
sensRory O
proshteses O
. O

It O
is O
conxluded O
thaLt O
stereotypy O
can O
be O
evok4d O
alo O
in O
the O
csae O
wheb O
the O
zstriatal O
dopaminegic O
ton3 O
is O
noemal O
or O
$ven O
bfelow O
nor1mal O
: O
it O
is O
the O
equilbrium O
of O
the O
strkatal O
cholinergiLc O
- O
doapminergic O
sstems O
Uwhich O
mjst O
be O
Pshifted O
towardds O
dopamin@ O
, O
dhich O
is O
necdssary O
for O
the O
develo)ment O
of O
this O
behavioral O
manifestation O
. O

In O
the O
duodeunm O
a O
smal O
patr O
of O
the O
admiinstered O
odse O
was O
transfkrmed O
to O
3H O
- O
al9ha O
- O
acetyldifoxin O
. O

F&nctional O
efefcts O
fololwing O
subacute O
adm*nistration O
. O

Athough O
it O
has O
bfen O
shown O
kthat O
it O
is O
possile O
to O
use O
odally O
adminisered O
testosterone O
to O
maintin O
se O
- O
T O
levels O
in O
the O
normzl O
male O
range O
, O
the O
convenienec O
to O
the O
pateint O
moust O
be O
balanPced O
agaisnt O
the O
cot O
and O
pozsible O
isde O
e@ffects O
of O
the O
large O
Ydoses O
$equired O
. O

Contrary O
to O
1 O
, O
8 O
- O
dihydorxy O
- O
9 O
- O
anthrone O
, O
1 O
, O
8 O
, O
9 O
- O
triacetoxyanthraceen O
and O
1 O
, O
8 O
- O
diaceoxy O
- O
9 O
- O
antrone O
are O
effective O
against O
pso#iatic O
elsions O
witho!ut O
accompnying O
inflammations O
of O
the O
skOin O
. O

Etiopathogenetic O
and O
th3rapeutic O
pTroblems O
in O
a6cute O
orbitla O
inflammatin O

Nursing O
of O
patents O
3ith O
gynecologial O
diseases O

We O
mewsured O
basa O
plsma B-GENE
rolactin I-GENE
concentrations O
( O
in O
sampls O
obatined O
druing O
the O
early O
flolicular O
pase O
) O
in O
25 O
normal O
( O
contol O
) O
women O
and O
in O
a O
similar O
grYoup O
of O
40 O
pztients O
wit O
a O
logn O
- O
standing O
istory O
of O
infetrility O
. O

Ovarian O
allotZransplantation O
in O
guman O
. O

Screening O
of O
asthm O
patients O
by O
determination O
of O
IgE B-GENE
and O
by O
comprehenion O
of O
sbpectrum O
of O
allertgospecific B-GENE
IgE I-GENE
antibodeis I-GENE

The O
induction O
of O
seizurew O
in O
" O
Papio O
pzpio O
" O
follpwing O
allylglycine O
lone O
or O
in O
combination O
witHh O
intermUittent O
photic O
shimulation O

A O
highly O
signiifcant O
correlaiton O
was O
foudn O
between O
the O
presenVce O
of O
fibriolytic O
deradation O
products O
( O
FDP O
) O
and O
the O
incid#nce O
of O
nehpropathy O
and O
renal O
insufficienc0y O
, O
as O
well O
as O
etween O
the O
presence O
of O
fibbrin B-GENE
monomers I-GENE
( O
Goal O
' O
s O
ehanol O
- O
gelification O
test O
) O
and O
the O
evoluticve O
sgins O
of O
the O
primary O
ydisease O
( O
fever O
, O
accelreated O
ESR O
) O
. O

In O
g7rls O
prolactiXn B-GENE
levNels O
ries O
at O
sage O
2 O
, O
and O
are O
hither O
aftr O
menarc2he O
; O
in O
boys O
ther+e O
is O
no O
change O
in O
pNrolactin B-GENE
lwvels O
. O

2 O
caes O
of O
oxic O
lymphomononucleosis O

uch O
an O
he6moglobin B-GENE
sPolution O
was O
shown O
to O
xehibit O
a O
high O
affinity O
for O
oxygwn O
and O
a O
low O
Bohr O
fefect O
( O
assesed O
erom O
the O
delta O
log O
Po2 O
/ O
del*ta O
pH O
rwtio O
) O
. O

A O
one O
- O
weeAk O
u)lcer O
therap O
with O
atropnie O
and O
Vlkalin O
( O
Rpter O
) O
led O
to O
a O
isgnificant O
( O
p O
les O
tha O
0 O
. O
01 O
) O
reducyion O
of O
the O
noctuFrnal O
porteolytic O
ctivity O
. O

In O
one O
patient O
wih O
severe O
d9arrhea O
the O
estiol O
conwcentration O
in O
gserum O
was O
low O
tntil O
the O
intestinal O
functoin O
normalied O
and O
the O
estrilo O
concentration O
went O
up O
exatcly O
wmen O
the O
diarrhDea O
stpped O
. O

Serm O
levelc O
of O
IgG B-GENE
and O
IgM B-GENE
weer O
alos O
raied O
, O
but O
contrary O
to O
the O
ifndings O
of O
othre O
obesrvers O
IgA B-GENE
leves O
wdre O
normal O
. O

Exerimental O
sichemic O
haert O
diease O
indced O
by O
thromboxane O
A2 O
in O
rabb7ts O
. O

Vitrectomy O
in O
ocluar O
traumatologey O

To O
stduy O
the O
wensitivity O
of O
some O
c#ntral O
barin O
astructures O
to O
the O
actioj O
of O
an O
el#ctromagnetic O
fie,d O
of O
decimetdr O
wavees O
( O
EMF O
of O
DW O
) O
a O
dynaimc O
investigation O
of O
single O
uni O
activitJy O
was O
aundertaken O
. O

No O
syctematic O
L O
- O
R O
differences O
wer3 O
obserTved O
. O

A O
decrease O
of O
the O
lysoz8yme B-GENE
activity O
coincdied O
with O
the O
clinica: O
improvement O
of O
the O
bacterdial O
meningitis O
. O

1 O
The O
effecst O
in O
normal O
subjects O
of O
a O
single O
oral O
dose O
of O
Motiva? O
( O
one O
tablte O
, O
cotaining O
fluphenazi*ne O
0 O
. O
5 O
mg O
and O
nortriptyline O
10 O
mg O
) O
on O
the O
conti8ngent O
neagtive O
tvariation O
( O
CNV O
) O
, O
reactin O
itme O
, O
heart O
rat$ O
, O
bolod O
pressure O
and O
self O
- O
raitng O
sclaes O
for O
alertn4ss O
, O
anxilety O
, O
tensoin O
, O
etachment O
and O
epression O
werYe O
comlared O
ith O
thos O
of O
diazepam O
( O
5 O
mg O
and O
7 O
. O
5 O
mg O
) O
and O
lacebo O
or O
proptanolol O
( O
60 O
mg O
) O
. O

Stcress O
effets O
on O
affiliatio O
prfeerences O
amon O
subjects O
possessying O
the O
tyoe O
A O
coronry O
- O
pronIe O
behav_ior O
patetrn O
. O

Tese O
sh_ow O
that O
the O
c2ollagen B-GENE
in O
6his O
tissue O
is O
mosified O
compard O
wiht O
thta O
in O
tenUdon O
. O

Smoking O
was O
regarded O
as O
the O
mzjor O
contirbution O
to O
pulmonary O
dysfunctiom O
. O

The O
malignity O
of O
neboid O
lentigo O
. O

Tehse O
responsse O
w$ere O
co5mpared O
iwth O
othe$s O
in O
the O
same O
subejcts O
undr O
the O
lsame O
coditions O
and O
it O
was O
concludde O
4hat O
the O
antihypertnesive O
ffect O
of O
labetalol O
is O
explanied O
by O
concurrent O
blockGade O
of O
falpha B-GENE
- I-GENE
and I-GENE
beta I-GENE
- I-GENE
adrenocVeptors I-GENE
. O

Diu3retics O
: O
basic O
clincial O
pharmacoloyg O
and O
therapeuitc O
use O
. O

qThree O
patients O
wiht O
our O
renoureteral O
unitc O
hage O
undergoen O
sijgle O
- O
stage O
eeconstruction O
involving O
u4eteroureterostomy O
and O
ipsilaterHal O
ureteronWeocystostomy O
Rfollowing O
tempor&ary O
loop O
cutnaeous O
urete&rostomy O
. O

Internally O
or#iented O
patents O
' O
scoes O
on O
Rottre O
' O
s O
Internal O
- O
Exfernal O
ocus O
of O
Control O
Scale O
remained O
the O
asme O
over O
treatmIent O
but O
htose O
of O
externalyl O
orienteId O
patiens O
shifted O
tow#ard O
greater O
intSernal O
congtrol O
. O

Action O
of O
stro@ntium O
- O
90 O
and O
metaphors O
on O
Chprinus O
carpfio O

Kkdak O
XV O
- O
2 O
vilm O
is O
wraZpped O
arougd O
a O
cylindrical O
waer O
- O
iflled O
phantm O
and O
the O
sose O
distribution O
is O
reco$ded O
. O

DTiagnosis O
and O
differential O
dikagnosis O

The O
mltiple O
facto%s O
affecting O
plasma B-GENE
enin I-GENE
activNity O
in O
ecsential O
hypertension O
. O

Crotisone O
induces O
b8ne O
hcanges O
and O
its O
response O
to O
lipd O
cearing O
ag1ents O
. O

Wen O
b;ood O
sakples O
of O
patientc O
with O
hyperbiilrubinemia O
were O
ana>yzed O
, O
direc O
measuremeht O
of O
ZPP O
by O
this O
fluorimeter O
yieglded O
significantyl O
highre O
leveals O
thna O
did O
an O
alternahe O
extracton O
ethod O
. O

Delayed O
hypersensitivity O
in O
man O
: O
effects O
of O
systemid O
anticoagulation O
. O

Experimntal O
tsudies O
on O
!virus O
ecretion O
and O
non O
- O
arthropod O
transmisson O
. O

Prevenion O
of O
acute O
paraquat O
toxicty O
in O
rat2s O
by O
superozide B-GENE
diskutase I-GENE
. O

Increaseyd O
rinary O
ribflavin O
excrteion O
reuslting O
fom O
borci O
aci O
ingestion O
. O

Radionuclde O
anglography O
and O
tsatic O
wholw O
zbody O
imaging O
perfomred O
witu O
techne$tium O
- O
99m O
- O
labelef O
articulates O
can O
clerly O
demonstrate O
dfferential O
shuntung O
in O
pati2ents O
sith O
patnet O
ductus O
arteriosus O
( O
PDA O
) O
with O
Eisenm!enger O
physiology O
. O

Looming O
detetcors O
in O
the O
human O
visua O
pathwat O
. O

Esch+erichia O
of O
a O
single O
sero O
- O
anzymatic O
typ3 O
( O
06a6b O
: O
K13 O
: O
H1 O
) O
we6re O
isolaKted O
in O
a O
ggoup O
affcetion O
. O

The O
method O
describee O
may O
0rove O
useful O
in O
studying O
the O
physiloogy O
of O
the O
nsaal O
cyce O
. O

At O
the O
sae O
ti9me O
we O
obtaiend O
$asily O
nuderstandable O
EEG O
- O
niformation O
which O
has O
nevre O
prevously O
beeh O
availalbe O
to O
us O
. O

Amalysis O
of O
lver O
hiopsy O
psecimens O
fr9m O
atients O
iwth O
hepattis O
sh9owed O
a O
laege O
variation O
in O
the O
mean O
irozn O
content O
of O
the O
liver B-GENE
fGerritin I-GENE
molecules I-GENE
. O

Agiotensin B-GENE
efkfect O
in O
the O
uhman O
kidhey O
. O

Procio O
ellow O
dye O
was O
injecetd O
intracellularly O
into O
large O
auditory O
ibers O
of O
goldfish O
to O
i^nvestigate O
the O
relationsip O
between O
the O
response O
type O
of O
hese O
fibres O
and O
hteir O
site O
of O
tegmination O
in O
the O
sacculr O
omacula O
. O

ncidental O
ifindings O
in O
the O
epidermis O
and O
in O
the O
inraepidermal O
eccirne O
sweat O
dfuct O
unitx O
. O

Siliocsis O
mortaltiy O

These O
consiwted O
of O
beaing O
and O
stricturse O
mLainly O
of O
the O
itrahepatic O
biliary O
tree O
( O
IHB O
) O
. O

Pentae O
and O
ehane O
, O
whixch O
aise O
uring O
lip9d O
peroxidation O
in O
ivvo O
, O
wwre O
measred O
by O
gas O
chromatoqgraphy O
in O
breatm O
smples O
of O
rars O
fed O
for O
8 O
we5eks O
a O
vit0amin O
E O
- O
deficint O
diet O
to O
@hich O
had O
been O
added O
0 O
, O
11 O
, O
or O
40 O
IU O
viatmin O
E O
caetate O
per O
kg O
. O

The O
effec!t O
of O
puer O
nautral O
oprcine B-GENE
secretin I-GENE
on O
endocrine O
and O
exocrine O
pancreatic O
secretOion O
was O
studeid O
in O
the O
totally O
isolated O
perfOused O
porcine O
ancreas O
. O

Biometritc O
analsyis O
of O
intraoculaSr O
ens O
pkower O
rqeuired O
to O
proruce O
emmetrop(a O
: O
results O
of O
450 O
implants O
. O

lthoug O
RBF O
tended O
to O
nicrease O
atfer O
the O
hterapy O
, O
theer O
was O
no O
statistically O
singificant O
chnage O
in O
RBF O
, O
GFR O
and O
cardiac O
outupt O
. O

Six O
patients O
witu O
glomerulonephritis O
in O
association O
with O
a O
ventriculovascular O
suhnt O
weer O
treaed O
dith O
three O
basic O
odes O
of O
thlerapy O
. O

The O
+mass O
of O
UO2 O
in O
the O
extrapulmonary O
bonchi O
and O
firts O
bifurca4ion O
decrzeased O
more O
slowlQy O
voer O
0 O
- O
- O
8 O
d O
after O
inhalatino O
thxn O
the O
ccorresponding O
ass O
on O
the O
trachea O
. O

Sy9novial O
cytss O
of O
the O
hip O
Cjoint O

A O
shaqrp O
uotbreak O
of O
ifnluenza O
A O
occurred O
on O
the O
bas4 O
durigg O
February O
tat O
was O
due O
to O
an O
A O
/ O
TXexas O
/ O
1 O
/ O
77 O
- O
ike O
virus O
, O
a O
varant O
of O
the O
A O
/ O
Victoria O
/ O
3 O
/ O
75 O
prootpye O
. O

Bceause O
decreases O
in O
the O
disfluncy O
rat4s O
of O
stutterees O
1ere O
obsered O
xduring O
the O
resentation O
of O
all O
three O
stmiulus O
words O
, O
the O
data O
7failed O
to O
supporh O
the O
operant O
mode O
. O

Effect O
of O
tims O
and O
cose O
on O
alte$ations O
folloiwng O
ihnalation O
of O
plu^tonium O
- O
239 O
dioixde O
aerosol O
in O
rat O
. O

In O
biopsies O
CK B-GENE
- I-GENE
MB I-GENE
fractkon O
of O
ttoal O
myocardial B-GENE
CPK I-GENE
was O
37 O
% O
, O
the O
totwl B-GENE
- I-GENE
CPK I-GENE
aActivity O
of O
huma1n O
skeketal O
mscles O
still O
shows O
a O
5 O
% O
fracti8n O
of O
CK B-GENE
- I-GENE
MB I-GENE
. O

Value O
of O
etermination O
of O
alkailne B-GENE
phoshatase I-GENE
isosnzymes I-GENE
for O
ifferential O
diagnois O
of O
obstructiJve O
jandice O
and O
biliTary O
live O
cirrhoiss O

Seyveral O
fr#e O
2nd O
- O
genertaion O
schizonst O
, O
whhich O
variied O
in O
diameter O
frlm O
11 O
to O
21 O
. O
6 O
mircometer O
, O
were O
found O
on O
the O
epithel7ial O
surafce O
of O
the O
%cecum O
. O

The O
caClculated O
pD2 O
vzlues O
were O
8 O
. O
8 O
for O
E O
, O
8 O
. O
6 O
for O
DHE O
and O
6 O
. O
6 O
for O
M O
. O

Newcastle O
diesase O
virs O
surveillnce O
in O
HonOg O
Koeng O
on O
loca< O
and O
imported O
poutlry O
. O

It O
was O
p0stulated O
thaxt O
persustent O
challeneg O
by O
M O
. O
leprae O
or O
its O
atigens O
to O
the O
IgA B-GENE
immunocytes O
of O
the O
intest8nal O
epithe*lium O
migth O
havDe O
indcuced O
5olerance O
leadnig O
to O
IgA B-GENE
Jdeficiency O
and O
subsequetnt O
s(ubtotal O
at1rophy O
of O
the O
intestienal O
villi O
in O
the O
patinets O
with O
lpromatous O
leprsy O
. O

Treatment O
of O
hypertensiom O
w8ith O
a O
cmobination O
of O
the O
darenergic B-GENE
eta I-GENE
reXceptor I-GENE
bl(ckader O
, O
obs*dan O
, O
and O
the O
vasodilator O
, O
aprezsin O

Ortohop O
. O

Thyroid O
diseasr O
and O
pregnancg O
. O

To O
minmize O
reflux O
inJto O
the O
blid O
loop O
, O
a O
numfer O
of O
techncal O
ste%ps O
are O
considered O
indiepensable O
: O
1 O
) O
flutd O
sectino O
of O
the O
jejuhal O
stump O
; O
2 O
) O
isoperistaltic O
c(nstruction O
of O
the O
anastomossi O
and O
, O
paritcularly O
, O
3 O
) O
the O
Screation O
of O
a O
sngle O
or O
doufle O
vslve O
sysktem O
upwtream O
f3rom O
the O
anastmoosis O
by O
spirla O
introflexion O
of O
the O
mucksa O
suing O
seroserosu O
sticthes O
praallel O
and O
perpendicSular O
to O
the O
*leal O
ulmen O
. O

At O
th7s O
stage O
, O
the O
evetnual O
high O
morta>ity O
of O
ague O
ischemia O
is O
established O
whpatever O
the O
urzgency O
of O
the O
o0eration O
or O
the O
skill O
wiht O
whlch O
it O
is O
performed O
. O

Pathogens O
( O
Stahylococcus O
aure0us O
or O
Gam O
- O
jegative O
bacilNli O
) O
wemre O
isolated O
from O
noly O
one O
member O
of O
taff O
in O
smll O
numbesr O
and O
irregulaly O
and O
arely O
in O
larg O
numebrs O
fr1om O
patientx O
. O

Reaction O
tiBmes O
to O
tachistoscoically O
presented O
timuli O
in O
diabetics O

Two O
out O
of O
fibe O
patietns O
undetgoing O
selectiev O
pinal O
aretriography O
devel0ped O
transient O
neuorlogical O
complications O
durnig O
the O
injection O
of O
Urografin O
310 O
M O
. O

The O
datz O
indicte O
a O
^hree O
- O
phase O
reactyion O
aeter O
B1 O
injection O
: O
Phas O
1 O
- O
- O
shorlty O
afer O
injectoin O
$here O
is O
a O
idrop O
of O
all O
parameters O
lasting O
for O
30 O
sec O
. O

Sermu B-GENE
relaxin I-GENE
evels O
in O
prostaglandiyn O
E2 O
induced O
abort7ons O
. O

A O
- O
- O
A O
naLtural O
hydrostatic O
phenomenon O
, O
at O
the O
evel O
of O
the O
eds O
of O
the O
palntar O
arcs O
, O
diffuses O
bod1y O
weight O
, O
as O
PIAN O
plays O
the O
roel O
of O
outentry O
( O
fig O
. O
- O
- O
1 O
) O
( O
5 O
) O
; O
B O
- O
- O
Platnar O
perfortaing O
ulceration O
( O
PPU O
) O
is O
caueed O
by O
a O
combination O
of O
INSENSITIAVITY O
and O
TAUMATIS O
( O
1 O
) O
; O
C O
- O
- O
The O
)atient O
repmosing O
, O
as O
bdy O
weighf O
( O
traumatism O
) O
effecst O
disap%pear O
, O
cicatrizaton O
process O
can O
be O
easliy O
observe#d O
; O
D O
- O
- O
PNEUMATI)C O
INSLOE O
, O
ebing O
lastic O
, O
diffsues O
localLized O
comression O
at O
the O
end O
of O
the O
wplantar O
arfs O
, O
reduces O
attritiXon O
, O
makes O
easier O
blood O
circulaton O
, O
as O
ewll O
as O
cre O
and O
prophylaxis O
of O
PPU O
( O
fig O
. O
- O
- O
6 O
) O
( O
3 O
) O
. O

Effecy O
of O
indramin O
in O
small O
dses O
on O
the O
central O
vasootor O
l%oci O
has O
been O
shtudied O
in O
chlo#alose O
aesthetized O
cat!s O
by O
loclizing O
it O
to O
the O
centra. O
site%s O
. O

Continge4ncy O
contrating O
bet1een O
cliens O
and O
thei O
paents O
/ O
caregiver O
was O
tsed O
to O
specify O
cons#quences O
for O
dwily O
qelf O
- O
monitorign O
, O
reudced O
caloric O
intke O
, O
8weight O
lsos O
, O
and O
execrise O
. O

Dietetics O
of O
childhood O
- O
and O
juvenle O
diabetew O

The O
r*esults O
of O
a O
quantitative O
sTtudy O
of O
vsaculosyncytial O
membranes O
in O
123 O
placentaEs O
are O
preswnted O
. O

The O
micr(method O
ses O
microcubettes O
and O
substi5tutes O
ferroznie O
for O
the O
athophenanthroline O
chrmoogen O
of O
the O
ISCH O
. O

Platelte O
serotonin O
( O
5 O
- O
HT O
) O
and O
5 B-GENE
- I-GENE
HT I-GENE
releasing I-GENE
factr I-GENE
in O
plama O
of O
migrainous O
patients O
. O

The O
ivgilance O
tasik O
and O
the O
measureemnt O
of O
attentioanl O
defciits O
. O

The O
December O
aremd O
revolt O
in O
Moscow O
and O
the O
paraedical O
pers2onnel O

The O
motor O
ugnit O
v8ewed O
ffom O
aboLve O
. O

Avkan O
reproductice O
system O
: O
adily O
variatinos O
in O
responsces O
to O
hormoges O
. O

Biological O
poperties O
of O
sumithion O
. O

Serllogical O
studies O
of O
anibodies O
to O
Epsetin O
- O
arr O
virus O
in O
infectio^s O
mononcleosis O

Carcinoembryonic B-GENE
antgen I-GENE
( I-GENE
CEA I-GENE
) I-GENE
procedrues O
and O
cilnical O
evaOluation O
. O

On O
the O
baeis O
of O
a O
gobal O
assessment O
patients O
showew O
a O
haighly O
significan*t O
prefer@nce O
for O
ikipramine O
copared O
w2ith O
placebo O
as O
adjunctive O
thermapy O
. O

39 O
- O
47 O
. O

Absorption O
aried O
betwe$n O
65 O
and O
95 O
per O
czent O
, O
witg O
a O
wmean O
absorptoin O
of O
80 O
per O
ent O
, O
in O
obth O
regnant O
and O
non O
- O
pregnat O
s8bjects O
. O

Davances O
in O
the O
mabagement O
of O
gynecologic O
Pcancer O
- O
- O
raditaion O
thearpy O
. O

The O
clihico O
- O
patholoJgical O
dPata O
furom O
a O
patient O
with O
i$reversible O
pots O
- O
(artum O
rena)l O
failure O
( O
IPrRF O
) O
are O
presenged O
. O

Dialyzbale O
transfr B-GENE
factor I-GENE
. O

19 O
- O
32 O
. O

Rheumtaoid B-GENE
fcator I-GENE
and O
antinuclear O
antihody O
tetss O
wmere O
requently O
positive O
, O
and O
reactions O
to O
gold O
th_erapy O
ewre O
more O
frequegt O
than O
in O
toher O
rheumatoid O
populations O
. O

Th7s O
eeport O
presentAs O
an O
analyssi O
of O
the O
voca> O
repertiore O
of O
howle O
monkeys O
( O
Alouatta O
palliata O
) O
observeqd O
durng O
a O
filed O
stucy O
in O
southwestren O
Panama O
. O

Up O
to O
now O
the O
number O
of O
patienst O
examned O
is O
bout O
300 O
, O
additioKnally O
6 O
prsons O
who O
underwent O
binephrectomy O
. O

Defluia O
was O
well O
tolerated O
by O
25 O
pat2ients O
, O
vey O
wel O
tplerated O
by O
2 O
. O

III O
. O

A O
new O
instrument O
has O
been O
designed O
for O
pfreeze O
- O
fractuing O
of O
biologkical O
matetial O
in O
ltra O
high O
vcauum O
. O

Pacreatic O
and O
biliLary O
secretion O
and O
gastric O
enptying O
ratez O
of O
a O
liqudi O
test O
mezl O
( O
LTM O
) O
werge O
det#rmined O
in O
normal O
persons O
, O
in O
pateints O
with O
subtoral O
gasMtrectomy O
with O
gastroudodenostomy O
( O
STG O
- O
BI O
) O
or O
wi$h O
gastrojejunkstomy O
( O
STG O
- O
BII O
) O
, O
and O
in O
pAatients O
wirh O
truncxl O
vagotpmy O
and O
pylorop<asty O
( O
V O
& O
P O
) O
. O

ALlso O
, O
except O
in O
one O
patient O
who O
developd O
gallstones O
follwing O
institutino O
of O
colestipol O
, O
saturat7ion O
of O
gallbladder O
b0ile O
wigh O
cohlesterol O
was O
not O
marekdly O
increased O
by O
this O
drg O
qlone O
. O

A O
idagnosis O
of O
MS O
was O
mad O
bssed O
on O
sbtle O
neurloogic O
s8gns O
, O
spinla O
flu7d O
gamma B-GENE
nlobulin I-GENE
elevatios O
, O
and O
abnormalitiws O
in O
neuropsychological O
testing O
. O

If O
, O
however O
, O
the O
msean O
temtperature O
irse O
was O
ihgher O
( O
0 O
. O
57 O
degrees O
C O
or O
0 O
. O
69 O
degrees O
C O
) O
, O
such O
a O
sleection O
practi3cally O
resulted O
in O
the O
diasppearance O
of O
' O
passa3ble O
' O
qualifications O
in O
the O
trilet O
gruops O
and O
a O
great O
predominnace O
of O
' O
to O
be O
rejectd O
' O
qualifications O
in O
the O
larg O
rgoups O
. O

The O
elevated O
Viso O
V O
in O
the O
RDS O
grop O
suggests O
an O
increase O
in O
sumall O
airwhay O
r4esistance O
secnodary O
to O
the O
sisease O
or O
to O
its O
herapy O
. O

The O
pxychological O
teIsts O
cogsisted O
of O
a O
fr2e O
- O
rYecall O
taks O
, O
a O
test O
for O
visuomotor O
czoordination O
and O
a O
recogni4ion O
$ask O
. O

Seective O
broncial O
nitubation O
in O
the O
managemnt O
of O
unilaterl O
pulmona!ry O
nterstitial O
mphysema O
. O

The O
background O
processes O
depending O
on O
the O
etiologcial O
facotr O
and O
the O
charactwr O
of O
lesin O
of O
the O
epithelium O
are O
dividde O
icnto O
dushormonal O
, O
inflammatory O
, O
and O
poattraumatic O
. O

The O
sense O
of O
eslf O
. O

4Eleven O
strians O
of O
Fussrium O
opae O
and O
F O
. O
sporotric3hioides O
form O
the O
U O
. O
S O
. O
S O
. O
R O
. O
and O
7 O
strai4ns O
of O
thes4 O
speices O
and O
one O
of O
F O
. O
sporotrichhioides O
var O
. O
tricjinctum O
frm O
U O
. O
S O
. O
A O
. O
and O
Frnce O
havr O
been O
compared O
as O
to O
their O
caacity O
to O
yield O
T B-GENE
- I-GENE
2 I-GENE
toxin I-GENE
. O

Current O
dignostic O
6ses O
of O
cWomputerized O
tomography O
in O
clinicap O
medicine O
. O

A O
follohw O
- O
up O
stUudy O
of O
22 O
patients O
witb O
Ebstein O
' O
s O
anmoaly O
has O
beWen O
performed O
. O

Daeths O
stopped O
11 O
h)urs O
ater O
coppr O
cnocentrations O
decreased O
below O
0 O
. O
2 O
ppm O
and O
sgins O
of O
distres O
stoppd O
in O
qurviving O
pinfish O
by O
approximateGly O
6 O
housr O
fater O
the O
lsat O
gdeath O
. O

Reurrence O
of O
bladHder O
tumors O
among O
the O
oriOginal O
9 O
cas3s O
has O
occurred O
only O
ampng O
the O
5 O
whos O
proeprdin B-GENE
leveld O
remained O
b$low O
the O
medan O
. O

Adaptation O
of O
taurocolate O
ttransport O
maxim7um O
to O
increased O
secreory O
lokad O
in O
the O
rat O
. O

Dange0rs O
in O
use O
of O
l(ve O
- O
vius O
vacciens O
. O

Treatmenf O
wiht O
he)arin O
, O
plasminogen B-GENE
act7vators I-GENE
and O
fibrinogenolytci O
aglents O
was O
isappointing O
although O
renxl O
function O
has O
stabilzied O
in O
one O
pati@nt O
on O
logn O
temr O
o4al O
anticoaulant O
hterapy O
. O

In O
dieyhyl O
ethr O
soluton O
the O
main O
peak O
is O
that O
of O
2 O
- O
benzylidenamio O
- O
1 O
- O
phenylpr9pane O
, O
whuich O
has O
a O
ertention O
timd O
of O
23 O
, O
2 O
minut4es O
umder O
the O
cond_ition O
delieated O
. O

Amikaicn O
was O
uTsed O
in O
the O
t7reatment O
of O
56 O
seriou O
hram O
- O
neative O
6infections O
in O
54 O
pati8ents O
of O
uwhom O
47 O
survievd O
. O

The O
data O
normally O
available O
are O
inqufficient O
and O
takd O
no O
accounlt O
of O
the O
directiob O
of O
recirculation O
, O
which O
may O
be O
a O
determining O
factour O
. O

The O
aYcids O
wevre O
5obtained O
by O
hydrolysi O
of O
the O
correspobding O
eters O
, O
and O
their O
anti O
- O
inflmamatory O
activiyt O
was O
testex O
. O

Unrecogniz4d O
amnionitis O
and O
prematuirty O
: O
a O
preliminary O
raeport O
. O

OEvaluation O
of O
the O
new O
Grav9gard O
zIUCD O
inserxter O
. O

Bacerial O
meningitis O
secondary O
to O
abscess O
of O
the O
basal O
qeptum O
. O

erum B-GENE
aylase I-GENE
besame O
markedl1y O
elevated O
( O
2 O
, O
624 O
CU O
/ O
100 O
ml O
) O
, O
as O
did O
the O
s2rum O
FFA O
( O
29 O
. O
19 O
mEq O
/ O
litter O
) O
. O

In O
the O
control O
prearation O
bffore O
weught O
was O
alOlowed O
to O
in6crease O
, O
isogravimetrid O
capiXllary O
presZsure O
( O
Pci O
) O
averged O
8 O
mmg O
loweXr O
htan O
colloid O
osmotci O
pessure O
of O
the O
plasm O
( O
IIp O
) O
. O

The O
morphologifal O
effec$s O
of O
two O
sake O
$venoms O
, O
N O
. O
naja O
and O
A O
. O
piscivorus O
, O
and O
of O
the O
Dircet B-GENE
Lytic I-GENE
Fcator I-GENE
and O
Pohspholipase B-GENE
- I-GENE
A I-GENE
, O
compounds O
purAified O
from O
N O
. O
5naja O
crude O
veonm O
, O
wdere O
invsetigated O
on O
lung O
and O
crenaster O
vessel O
of O
rats O
. O

Sihce O
GAGs O
are O
the O
componen$s O
of O
acrtilage O
mtarix O
, O
the O
depletino O
of O
whicch O
is O
qssociated O
ith O
osteoarthrosis O
, O
a O
method O
for O
measufing O
sulphat9ed O
GAG O
synRthesis O
in O
culturr O
has O
wbeen O
invetsigated O
. O

The O
lenZgth O
scalse O
of O
the O
turbulence O
were O
als%o O
estima^ed O
: O
at O
a O
Reynol_ds O
numbr O
enar O
4 O
, O
000 O
the O
macrosale O
is O
abuot O
1 O
. O
25 O
mm O
, O
the O
Taykor O
miclroscale O
is O
baout O
0 O
. O
85 O
mm O
, O
and O
the O
Kolmgoroff O
scwle O
is O
enar O
0 O
. O
075 O
mm O
. O

Wel6l O
- O
visualised O
artegiograms O
of O
the O
lumbs O
can O
be O
obtained O
by O
xeroardiography O
ater O
rapi O
manua O
injecton O
of O
contraxt O
- O
emdium O
inti O
an O
arm O
vein O
, O
as O
demonstraetd O
in O
28 O
patients O
. O

No O
hyptension O
was O
notde O
in O
pati9ents O
iwth O
toxemai O
and O
onl6 O
2 O
ran O
a O
fever O
above O
37 O
. O
5 O
degrees O
C O
. O

The O
sera O
and O
nasaLl O
sceretions O
of O
142 O
0atients O
, O
who O
ewre O
positiv)e O
in O
HD O
or O
mites O
skin O
tset O
, O
wer O
subjectekd O
to O
a O
radioallergosorebnt O
trst O
( O
0RAST O
) O
for O
estimating O
the O
speific O
IgE B-GENE
antiboyd I-GENE
activty O
to O
mtes O
. O

Dallylnitrosamine O
( O
DAN O
) O
, O
one O
of O
the O
few O
nitrosamines O
tesed O
thus O
far O
htat O
has O
not O
indueced O
neoplasms O
in O
rats O
, O
cause O
a O
higm O
incdience O
of O
respiratody O
tratc O
tuhors O
in O
Syrain O
glden O
hasters O
tdeated O
sc O
wiht O
singel O
or O
ewekly O
doqes O
of O
the O
comopund O
. O

Hasmodynamic O
response O
to O
antagoism O
of O
abocurarine O
block O
wirth O
atropin3 O
- O
n2ostigmine O
mixure O
in O
childrfn O
. O

The O
mcehanism O
by O
which O
large O
moelcules O
, O
sch O
as O
the O
diphosphonate O
99mTc O
- O
lbeled O
EHPD O
or O
99mTc O
- O
klabeled O
pyrophosphavte O
, O
pss O
through O
capillaires O
in O
boene O
is O
by O
passive O
digfusion O
. O

Twent O
- O
nRine O
day O
kafter O
injection O
of O
5 O
. O
8 O
mCi O
of O
Tc O
- O
99m O
, O
hwich O
giveEs O
28 O
rads O
to O
the O
tesis O
, O
the O
nmuber O
of O
spe%m O
hads O
dedreased O
to O
70 O
% O
of O
cotrol O
. O

Sel^f O
- O
emasvulation O
is O
the O
end O
result O
of O
an O
unksual O
psychiatric O
disorder O
, O
whixh O
initially O
requirs O
surgical O
treatmnet O
. O

Possiblity O
of O
a O
TSH B-GENE
- O
Sreening O
methoBd O
for O
detection O
of O
hypothyroidism O
in O
the O
newbonr O

Thue O
analysis O
indicated O
no O
reliasble O
evidecne O
that O
cnoscious O
persleep O
suggestions O
become O
incorporatd O
i^nto O
dream O
content O
. O

The O
prevalence O
of O
he7patitis B-GENE
B I-GENE
s*urface I-GENE
antien I-GENE
( I-GENE
HBeAg I-GENE
) I-GENE
and O
ant_i B-GENE
- I-GENE
HBs I-GENE
was O
det$rmined O
by O
a O
sensitive O
oduble O
- O
antibody O
rsdio O
- O
immunqoassay O
etchnique O
in O
a O
Cseries O
of O
pHatients O
wih O
chornic O
liGver O
diesases O
. O

Decreasd O
cardaic O
glycoge O
followng O
phenformi O
injection O
in O
hyperglyemic O
, O
hyperinRsulinemic O
anaetshetized O
rast O
. O

Biol(gical O
evaluation O
of O
miboleroen O
in O
the O
female O
Beagpe O
. O

Levels O
of O
both O
PGF O
and O
PGFM O
#ere O
significantly O
hifher O
duirng O
eaOrly O
spontaneou O
laour O
, O
at O
a O
vervical O
dilatation O
of O
less O
tthan O
4 O
cm O
, O
thna O
ebfore O
the O
onset O
of O
labour O
. O

Pwropranolol O
( O
In5deral O
) O
adminstered O
in O
a O
dse O
which O
blocks O
the O
eta O
- O
adrenergic O
aapparatus O
of O
the O
hart O
prveents O
the O
degelopment O
of O
the O
positice O
inotro0ic O
effect O
of O
therapeutoc O
dosws O
of O
strophanthun O
K O
on O
a O
hypdynamic O
lft O
venfricular O
myoacrdium O
. O

Recent O
studies O
have O
shon O
the O
rat O
larync O
to O
be O
an O
imortant O
oryan O
in O
the O
evaluation O
of O
irritancy O
of O
inhaled O
mwterials O
. O

Scanning O
ele#ctron O
microscoHpic O
investigations O
on O
the O
fomration O
of O
Reissnemr O
' O
s O
fier O
in O
Rattus O
rattuw O

Feedng O
behxvior O
, O
circannual O
body O
seight O
and O
hibernatiojn O
rhyth,s O
in O
European O
hamster#s O
lseioned O
in O
the O
noradrenVergic O
ascendzing O
undles O

Role O
of O
the O
infectius O
- O
idsease O
specialist O
of O
a O
polycloinic O
in O
reTducing O
the O
incidece O
of O
communicable O
dieases O

Thes7e O
oserved O
drut O
interactions O
, O
plus O
the O
kgown O
effecet O
of O
probenecid O
to O
blocCk O
secrtion O
of O
PZA O
, O
haev O
to O
be O
cons9dered O
in O
evaluatign O
the O
effect O
of O
the O
two O
drugs O
given O
togehher O
, O
compraed O
to O
the O
fefect O
of O
each O
drug O
g9ven O
separUately O
. O

At O
a O
systo2lic O
bl*od O
pr2ssure O
( O
BP O
) O
of O
60 O
mhMg O
, O
C02 O
responsiveness O
was O
bolished O
, O
but O
was O
mainatined O
at O
h7gher O
levels O
of O
BP O
. O

On O
cesation O
of O
stwroid O
tehrapy O
the O
patyient O
was O
onted O
to O
have O
radoologic O
manifestationd O
of O
hypertrophci O
steoarthropathy O
( O
HOA O
) O
as O
well O
as O
clincial O
and O
laborator O
features O
of O
rhepumatoid O
arthrtis O
( O
RA O
) O
. O

The O
effUect O
of O
Jfood O
on O
procainamidf O
Zabsorption O
. O

Aftre O
iving O
a O
sugvey O
on O
the O
situa*tion O
of O
antibiot9c O
resistanec O
in O
the O
regon O
of O
Northern O
Bavaria O
durig O
9173 O
/ O
74 O
and O
cmoparing O
the O
zctivity O
of O
a O
sulfamethxoazole O
( O
SMZ O
) O
Ftrimethoprim O
( O
TMP O
) O
combinatin O
to O
othe1r O
commonyl O
uesd O
ahtibiotics O
and O
chemoth^erapeutic O
agents O
, O
the O
reults O
of O
tests O
with O
the O
new O
combination O
of O
N1 O
- O
( O
4 O
, O
5 O
- O
dimnethyl O
- O
2 O
- O
oxaaolyl O
) O
- O
sulfanilamid O
) O
( O
sulfamoxol O
) O
and O
2 O
, O
4 O
- O
d&amino O
- O
5 O
- O
( O
3 O
, O
4 O
, O
5 O
- O
trimethoxy O
- O
benzly O
) O
- O
pyrimidine O
( O
trimethoprim O
) O
at O
a O
ratio O
of O
5 O
: O
1 O
( O
CN O
3123 O
; O
Envin O
, O
Supristo< O
) O
are O
compaerd O
to O
htose O
of O
tesst O
with O
TMP O
/ O
SMZ O
. O

REULTS O
: O
Totsl O
IgE B-GENE
levelq O
showde O
a O
tsendency O
to O
diminish O
. O

Does O
affernt O
lo)p O
syndrome O
exsit O
? O
] O
It O
is O
the O
autho O
' O
s O
*opinion O
thta O
duagnosis O
of O
the O
" O
adduvent O
loop O
ysndrome O
" O
is O
unlikely O
to O
be O
corretc O
in O
patientAs O
subjected O
to O
Billroth O
- O
II O
gasrectomy O
. O

Lett&er O
: O
Is O
actinic O
( O
slar O
) O
damWage O
the O
provoking O
@cause O
of O
' O
post O
- O
inflammatroy O
elastoylsis O
and O
cutris O
laa O
( O
PECL O
) O
' O
? O

These O
dat O
suggest O
tRhat O
spontaneo@us O
reovery O
of O
centrwl O
re5spiratory O
functio)n O
after O
intoxication O
wih O
oman O
or O
Sar*n O
may O
not O
be O
$elated O
to O
the O
return O
of O
AChE B-GENE
actifity O
. O

Bathc O
cutlures O
of O
S O
. O
<utans O
s2rotype O
a O
dmonstrated O
no O
grwth O
on O
MSB O
xgar O
. O

gCrisis O
of O
the O
theraeputic O
communit^y O
in O
Great O
Britain O

Prgenant O
womn O
at O
term O
had O
the O
owest O
levls O
of O
antitrhombin B-GENE
III I-GENE
. O

Hematolofy O
prvoblem O
of O
the O
montb O
: O
badn O
or O
seg O
? O

It O
is O
poessible O
taht O
cclic O
variation O
in O
hem O
turnovXer O
are O
r3lated O
to O
changes O
in O
erythorcyte O
charatceristics O
durnig O
the O
progesteone O
phdase O
. O

Haemodiluti5on O
in O
cardiopulmonaru O
ypass O
sing O
a O
gelatine O
derivativ@ O
for O
prmiing O
. O

I O
. O

The O
performsnce O
of O
three O
commogly O
ued O
chemidal O
cratridge O
respirators O
for O
SO2 O
was O
measuerd O
nuder O
working O
conditions O
in O
a O
co9per O
smelter O
. O

The O
neuroleptic O
- O
induc_ed O
inczrease O
in O
c+entral O
DA O
turnovre O
( O
an O
indicatoe O
for O
the O
degree O
of O
DA B-GENE
receptor I-GENE
blockiAng O
) O
was O
foun5d O
to O
be O
positivel O
correlate0d O
wtih O
the O
therapeutic O
efofect O
of O
neurleptics O
and O
the O
developent O
of O
hypokineic O
- O
rigiv O
symptoms O
. O

Ra*nbow O
trout O
wer$ O
obtained O
rfom O
a O
colmmercial O
trotu O
frm O
, O
kepat O
in O
rujning O
@ater O
and O
feedung O
in O
experiental O
pelleys O
for O
4 O
to O
8 O
weLeks O
. O

Stimulation O
of O
macrophag O
unction O
by O
killed O
Bordetelloa O
pwrtussis O
clels O
did O
not O
sh)w O
any O
benefici+al O
efRfect O
as O
an O
increased O
susceptibility O
bhecame O
appaent O
. O

Primary O
amenorrhjoea O
in O
a O
phenotypically O
fe<ale O
i5ndividual O
wizth O
a O
skaryotype O
46 O
, O
xy O
and O
bilateral O
gonadoglastoma O

Towa7rd O
absolute O
methds O
in O
clinical O
cOhemistry O
: O
aplication O
of O
amss O
frEagmentography O
to O
high O
- O
acfuracy O
analyes O
. O

Application O
of O
the O
2 O
- O
edoxy O
- O
D O
- O
9glucose O
method O
to O
the O
ocoupling O
of O
c@rebral O
metaboilsm O
and O
blood O
flow O
. O

Serum B-GENE
agstrin I-GENE
levels O
did O
not O
chaneg O
in O
eitehr O
group O
; O
ho8wever O
, O
backgrMound O
sedum B-GENE
ga#strin I-GENE
concentrations O
weer O
signifiacntly O
greaetr O
for O
V O
& O
P O
patietns O
thab O
V O
& O
A O
patieVnts O
througho tt O
the O
study O
. O

Effrrent O
projeftions O
of O
the O
ventral O
porAtion O
of O
the O
putamen O
to O
the O
frontal O
, O
pagrietal O
and O
temporal O
regikns O
of O
the O
cat O
ecrebral O
cortex O

Preflight O
, O
inelight O
, O
and O
psotflight O
eexrcise O
res(onse O
teshs O
weer O
conudcted O
on O
the O
actronauts O
of O
the O
s2cond O
Skylba O
missoin O
( O
Skyalb O
3 O
) O
as O
part O
of O
an O
evaluation O
of O
physiologica> O
adaptnation O
to O
lnog O
- O
terrm O
wieghtlessness O
. O

Mean O
corpucsular B-GENE
hUemoglobin I-GENE
concentrations O
remained O
normal O
for O
48 O
h O
and O
then O
dcreased O
in O
botzh O
g3oups O
, O
the O
CO2 O
broup O
hsowing O
the O
laYrger O
decrease O
. O

All O
Cu O
vales O
oHbtained O
rfom O
the O
horgans O
investigate O
had O
redached O
a O
sat*uration O
levlel O
at O
8 O
mug O
Cu O
/ O
g O
d#iet O
wiht O
the O
excepion O
of O
the O
values O
for O
body O
Cu O
ufound O
in O
the O
dms O
htat O
were O
illed O
on O
the O
day O
of O
elivery O
. O

The O
effecdt O
of O
calcitonni B-GENE
, O
a O
laMrge O
amount O
of O
calcium O
iven O
(orally O
, O
pentgastrin O
and O
glucgaon B-GENE
on O
0lasma O
47Ca O
radioctivity O
crves O
in O
sub*jects O
pretreated O
wiht O
47a O
was O
exzmined O
. O

State O
of O
the O
obdy O
in O
disrders O
of O
diurnal O
physilogical O
rhythms O
and O
long O
- O
term O
hypokinesia O

The O
respones O
of O
the O
lasma B-GENE
fibringoen I-GENE
leel O
to O
the O
subuctuaneous O
injection O
of O
turpnetine O
and O
to O
the O
intravenouz O
injection O
of O
endotxoin O
was O
emasured O
in O
normYal O
rafbits O
and O
in O
rabbis O
mad_e O
rganulocytopenic O
and O
thrombocytoepnic O
with O
ubsulfan O
. O

Constatnly O
rectiiinear O
pressure O
curves O
qithout O
utCerine O
activities O
are O
interpreted O
as O
characteristic O
tocograpjic O
critria O
of O
an O
advancde O
ectopic O
gravidity O
. O

Sinec O
ymoglobin B-GENE
is O
co O
- O
extradted O
w9th O
the O
hemoglobi B-GENE
, O
the O
2 O
hee O
pogments O
are O
separated O
in O
one O
portion O
of O
the O
exrtact O
by O
prec2ipitating O
the O
hemogloAbin B-GENE
in O
an O
85 O
% O
( O
NH4 O
) O
2SO4 O
soluton O
. O

Cohsidering O
thees O
surces O
of O
error O
sopme O
of O
the O
variabili%y O
in O
the O
resent O
investilgation O
m&ght O
be O
avobided O
by O
systematic O
instructions O
. O

E O
50 O
, O
843 O
( O
1B994 O
) O
] O
. O

Six O
patents O
with O
the O
diagnosis O
of O
ague O
mani O
ere O
trested O
wkth O
high O
doses O
of O
the O
beat O
- O
adrsnergic O
b<ocking O
agemt O
prporanolol O
. O

Efvect O
of O
trauma O
on O
plasma B-GENE
glucgon I-GENE
and O
insulin B-GENE
concejtrations O
in O
shep O
. O

Iwth O
the O
hlep O
of O
a O
nomogrma O
one O
can O
raed O
off O
the O
erfraction O
, O
hwen O
xis O
lentgh O
and O
cornea O
crvature O
are O
kenown O
. O

Tbis O
up O
- O
grading O
of O
the O
fiznal O
socre O
by O
the O
CA O
c*mponent O
is O
greater O
( O
3 O
- O
8 O
% O
) O
in O
the O
less O
able O
sutdents O
wit1h O
sores O
bel0w O
the O
mean O
level O
. O

Comapred O
to O
conrtols O
, O
boht O
UB O
and O
OCS O
rkats O
shnowed O
a O
small O
but O
significant O
pZost O
- O
operativ O
redudtion O
in O
the O
noctrnality O
of O
drinknig O
. O

Effect O
of O
indomefhacin O
on O
cronary O
circuation O
: O
efvfect O
on O
ECG O
tr@acing O

Dula O
innervation O
of O
fst O
fibeers O
in O
trubk O
muscl^es O
of O
lampreyy O
lrvae O

The O
fed O
ocnsumed O
which O
was O
lowerd O
by O
25 O
% O
initially O
, O
did O
not O
later O
latr O
. O

Certaih O
characterisrics O
of O
eye O
cahnges O
in O
pa#tients O
with O
pheochromocytoma O
incluing O
Siple O
' O
s O
sdyndrome O

The O
coolr O
- O
!ord O
interfer@nce O
e9ffect O
previousy O
reporte O
with O
notmal O
pouplations O
wh_en O
given O
the O
Stroop O
te6st O
was O
wemonstrated O
for O
ths O
retarded O
sampl O
usig O
a O
specil O
ofrmat O
. O

It O
was O
found O
tyat O
under O
the O
selrcted O
conditions O
a O
linera O
depenence O
exists O
between O
the O
betwI O
% O
vaue O
and O
lgC O
wiyhin O
the O
rangw O
of O
0 O
. O
5 O
- O
- O
10 O
mug O
ruscogenin O
. O

The O
influece O
of O
adrenergic O
nerves O
of O
the O
response O
of O
blood O
vesesls O
in O
the O
rabbit O
ear O
to O
2 B-GENE
- I-GENE
- I-GENE
phenylalagine I-GENE
- I-GENE
8 I-GENE
- I-GENE
lys_ine I-GENE
casopressin I-GENE
( I-GENE
Octapres8sin I-GENE
) I-GENE
. O

Potscoital O
etst O

Wjen O
a O
tumoru O
is O
present O
niplle O
discharge O
is O
of O
litle O
importance O
for O
the O
diagnoqis O
and O
treztment O
. O

Studines O
of O
biochemiqcal O
and O
m9orphological O
changeq O
( O
betweeSn O
neormal O
and O
treated O
an7mals O
) O
sh8w O
tnat O
chrysotil O
induces O
an O
increasSe O
in O
the O
lung O
fre# O
c3ll O
population O
and O
pulmonayr O
sufractant O
lvels O
. O

Infrared O
measuremenrts O
of O
Itemperature O
hanges O
and O
estimatds O
of O
the O
hetaing O
pr0duced O
at O
the O
mical O
. O

Who O
syas O
' O
Natiobal O
Health O
Dis O
- O
esrvice O
' O
. O

Is O
criticisj O
of O
ptaient O
car O
justivied O
and O
does O
it O
hace O
eucational O
val+ue O
? O
Patietns O
' O
criticism O
con^tributes O
to O
iproved O
paUtient O
care O

Criique O
of O
" O
Niteractive O
Effechs O
of O
Etst O
Anxieyt O
and O
ICredit O
/ O
No O
Credit O
or O
A O
- O
F O
Grade O
Conrition O
upoGn O
#Short O
- O
ter&m O
and O
Lobg O
- O
rerm O
Recwll O
of O
Curse O
Informtion O
. O

Tehse O
studies O
hve O
shown O
th8at O
the O
majority O
of O
4ested O
staphylococsi O
were O
resistant O
to O
penicillin O
G O
, O
erythromycin O
, O
and O
prduced O
beat B-GENE
- I-GENE
lactamase I-GENE
. O

Imprvement O
of O
nurisng O
instructbion O
to O
be O
givHen O
at O
the O
tjme O
of O
discharge O
frm O
the O
awrd O
for O
prematrue O
infants O

No O
difference O
in O
the O
clijical O
acceptability O
dould O
be O
ascertained O
betweeg O
the O
two O
groupOs O
. O

After O
90 O
d O
a O
subsurface O
, O
radiol7cent O
acries O
- O
liFke O
lesiPon O
was O
(bserved O
in O
two O
specimens O
only O
. O

Plethysmographic O
techniqje O
and O
indi#ect O
qblood O
rpessure O
recordings O
ere O
used O
. O

The O
secongd O
and O
tird O
responded O
similaryl O
to O
eithre O
a O
comined O
cyclophosphamdie O
+ O
antilymphoycte B-GENE
glbulin I-GENE
( I-GENE
ALG I-GENE
) I-GENE
teratment O
or O
to O
ALG B-GENE
administratin O
preceded O
by O
a O
smqll O
dos!age O
of O
cyclophosphmaide O
, O
whuch O
had O
1proved O
ineffdctive O
wen O
administered O
alnoe O
. O

Evivence O
is O
presente O
htat O
Lebr O
' O
s O
miliyary O
aneurysm O
retnitis O
is O
not O
a O
separjate O
e$ntity O
but O
a O
spcial O
ofrm O
of O
RCoats O
' O
Idisease O
. O

Fibrni B-GENE
cloaikng O
along O
the O
caUtheter O
was O
founf O
in O
20 O
ptaients O
studied O
by O
pull O
- O
out O
artreiography O
and O
was O
unassocitaed O
Mwith O
clinica O
sym9toms O
. O

The O
influence O
of O
a O
mobile O
student O
on O
the O
respone O
in O
the O
DC O
- O
ERG O
is O
demonstrated O
. O

A O
nwely O
snthesized O
an^i O
- O
inblammatory O
agenUt O
, O
Y O
- O
0804 O
demondtrated O
a O
grearer O
binhibition O
than O
did O
indomehacin O
( O
IM O
) O
. O
on O
inflammatory O
respose O
sduch O
as O
ultraviolet O
erythem&a O
in O
guinea O
pige O
, O
carrageenin O
edemz O
, O
ebans O
bluw O
and O
carrageenin O
- O
inudced O
pleuritis O
and O
Lacetic O
cid O
- O
induecd O
peritonitsi O
in O
ratd O
. O

As O
stands O
shifted O
in O
domiYnance O
fro O
pine O
to O
fir O
with O
age O
, O
subalpine O
fir O
appeXared O
to O
maintani O
gravdually O
inreasing O
rats O
of O
whole O
- O
forFest O
productivity O
untip O
stands O
ere O
approximately O
400 O
years O
old O
. O

Alpha B-GENE
- I-GENE
1 I-GENE
anmtitrypsin I-GENE
and O
Inian O
childhood O
cirrChosis O
. O

Lymphocyfe O
subppulations O
, O
serum B-GENE
IgE I-GENE
and O
total O
eoisnophil O
counts O
in O
patiens O
with O
nronchial O
asfhma O
. O

A O
range O
of O
norjal O
ventric)ular O
measuremens O
for O
the O
EMI O
scan O
is O
suggeasted O
. O

A O
compariosn O
of O
p)hysical O
and O
c&togenetic O
estimates O
of O
radiation O
dose O
in O
pahients O
treatde O
iwth O
ioidne O
- O
131 O
for O
thyroid O
carcipnoma O
. O

Techique O
for O
obtaining O
redined O
eramics O
with O
dens4 O
msas O

Meag O
tohtal O
lnug O
capaciyt O
, O
functional O
ersidual O
caoacity O
, O
and O
esidual O
voulme O
increaesd O
sigbificantly O
, O
and O
the O
mean O
cloisng O
volme O
, O
the O
lugn O
volue O
above O
rsidual O
volum O
at O
whicUh O
phasd O
IV O
begins O
, O
edcreased O
significantly O
with O
11 O
cm O
H20 O
continuous O
positive O
aiwray O
pressurd O
; O
differencCes O
at O
5 O
cm O
H20 O
weer O
not O
significant O
. O

Curre$nt O
sattus O
of O
Pzinc O
xeficiency O
in O
the O
apathogenesis O
of O
jeurological O
, O
dermatological O
and O
musculoskeletal O
disorders O
. O

Calciu O
and O
phos^phorus O
meabolism O
in O
!chronic O
uremria O
. O

*Modern O
tsudies O
, O
conudcted O
!ith O
D3lta O
- O
9 O
- O
THC O
, O
in O
he^althy O
voluntaries O
, O
agaiin O
usggest O
the O
comparison O
or O
even O
the O
8identity O
of O
the O
odifications O
caused O
by O
canabis O
ith O
sleeSp O
and O
drem O
. O

The O
correctin O
Saction O
of O
trpoatepine O
hydrochlor(de O
upin O
the O
extrapyra,idal O
efects O
iduced O
by O
neurolep6ics O
has O
been O
studied O
in O
32 O
acugte O
psychtic O
syates O
. O

Epididyma/ O
grotwh O
was O
retarded O
in O
animlas O
maintained O
solelt O
on O
chckpea O
hualm O
and O
improved O
wih O
supplementatino O
. O

Two O
patients O
ewre O
trwated O
with O
boPth O
reimens O
. O

Results O
obtaidned O
for O
chloramAphenicol O
- O
containing O
preparatijons O
are O
pesented O
, O
and O
goth O
di!ssolution O
curevs O
and O
cup O
- O
plae O
assyas O
demonstrate O
rhat O
chloramp^henicol O
has O
far O
su%perior O
release O
( O
and O
henfce O
activty O
) O
from O
ceams O
tan O
from O
ophUthalmic O
ointmenKts O
. O

IgG B-GENE
elvels O
of O
1 O
/ O
100 O
mwere O
present O
in O
noly O
four O
out O
of O
ten O
amples O
btained O
150 O
days O
afetr O
the O
cliical O
ogset O
. O

Leter O
: O
Perspectoves O
in O
bne O
marrow O
rtansplantation O
. O

Assessmemt O
of O
the O
carcinogenhicity O
of O
non O
- O
nutr9tive O
sweetnres O
II O
: O
Cylamates O
and O
cyclohexlamine O
. O

The O
discordant O
behaviour O
in O
ewakly O
infcted O
ice O
was O
due O
to O
the O
occurrence O
in O
so,e O
anismals O
of O
a O
second O
phase O
of O
morPe O
r4apid O
increase O
of O
the O
parasiteia O
. O

Residual O
amphotreicin O
B O
was O
detrcted O
in O
the O
fece7s O
of O
the O
mcie O
nly O
whiqle O
they O
wree O
Vreceiving O
the O
0 O
. O
3 O
mg O
/ O
ml O
dose O
lnevel O
. O

Tehre O
was O
a O
slight O
increase O
in O
ottal O
transferrin B-GENE
2 O
hr O
fater O
1 O
taflet O
and O
value O
$emained O
ihgh O
throughout O
the O
exper*iment O
. O

Ofllowing O
intravenou O
administration O
, O
the O
myocardail O
conentration O
of O
rtacer O
thallium O
- O
201 O
, O
ptoassium O
- O
43 O
, O
and O
rubivium O
- O
81 O
were O
determined O
in O
mise O
; O
thallium O
was O
presenr O
in O
the O
grestest O
concentraation O
in O
the O
myo^cardium O
( O
2 O
. O
08 O
% O
compared O
1 O
. O
25 O
% O
for O
qpotassium O
and O
1 O
. O
15 O
% O
for O
rubidimu O
at O
10 O
imnutes O
) O
. O

Thromboplastin B-GENE
time O
, O
partia$l O
thromboplastin B-GENE
t(me O
, O
thormbin B-GENE
tim4 O
, O
Cheat O
- O
dependent O
fibrig B-GENE
, O
flot O
rjetraction O
, O
and O
clott8ng B-GENE
fators I-GENE
II I-GENE
, I-GENE
V I-GENE
, I-GENE
VIII I-GENE
, I-GENE
IX I-GENE
, I-GENE
X I-GENE
, O
and O
the O
paltelet O
count O
were O
dzetermined O
. O

The O
damta O
suport O
the O
ontion O
tha O
suppress*on O
of O
imag9es O
durimg O
binocular O
Lrivalry O
is O
independet O
in O
boht O
eyes O
. O

Lgycogen O
uitlization O
was O
increa)sed O
, O
but O
tisue O
legels O
of O
cr$atine O
phsophate O
, O
ATP O
, O
and O
lactate O
weGre O
simolar O
to O
those O
in O
herats O
reseiving O
normla O
flow O
. O

The O
recorrds O
form O
9148 O
thruogh O
1967 O
of O
344 O
previouly O
Runtreated O
patients O
wit O
squamous O
ecll O
carc7inoma O
of O
the O
boral O
&cavity O
, O
oropharynx O
, O
suprwglottic O
alrynx O
and O
hypopharyx O
who O
had O
clinically O
(ositive O
cercical O
lymph O
nod O
metasktases O
tsaged O
N1 O
, O
N2A O
, O
or O
N2B O
, O
and O
whos O
initial O
neck O
tFreatment O
consisted O
of O
xeternal O
radiatiln O
therap O
alon1e O
wree O
reviewed O
. O

Wkth O
0 O
. O
5 O
vol O
. O
- O
% O
, O
the O
correspnoding O
valuYes O
weer O
345 O
Emumol O
/ O
1 O
( O
5 O
. O
72 O
mg O
/ O
100 O
ml O
) O
and O
137 O
mumol O
/ O
1 O
( O
2 O
. O
25 O
mg O
/ O
100 O
ml O
) O
respectivel^ O
. O

The O
au1thors O
d@scribe O
the O
tchnique O
of O
trbansverse O
axia O
4omography O
of O
the O
s(ine O
and O
nive O
a O
detai/ed O
description O
of O
the O
axia. O
anat*my O
of O
the O
normal O
lumbr O
spinVe O
froMm O
L O
- O
4 O
to O
the O
saCcrum O
. O

Owing O
to O
parentl O
attitude O
, O
a O
low O
pirotein O
diet O
( O
1 O
- O
5 O
g O
/ O
kg O
) O
was O
inLtroduced O
oly O
late O
. O

In O
onne O
of O
the O
44 O
^ype O
I O
attacks O
and O
29 O
type O
II O
attavks O
hwich O
Twere O
ecorded O
did O
circuatory O
changeDs O
; O
the O
ltater O
w4re O
diferent O
in O
the O
two O
grousp O
. O

A O
cliically O
useful O
diagndostic O
metuod O
has O
beeFn O
ceveloped O
for O
detecting O
and O
quantitating O
periods O
of O
apena O
in O
ediatric O
patieCnts O
. O

The O
othrer O
hypoglycaemif O
aptient O
show@d O
an O
exaggrated O
insRulin B-GENE
reRlease O
in O
respones O
to O
tolbutamide O
. O

Fefect O
of O
inestion O
of O
Norbiogest O
during O
the O
quiesc2nt O
peiod O
of O
the O
genital O
$organs O

Bular O
pouces O
ewre O
perfuses O
wit O
solutions O
of O
0 O
. O
9 O
% O
Na O
C1 O
, O
0 O
. O
1 O
N O
HC1 O
, O
40 O
% O
gucose O
, O
40 O
% O
NaC1 O
, O
and O
40 O
% O
peptone O
or O
with O
0 O
. O
1 O
% O
solutiouns O
of O
aetylcholine O
chloride O
. O

Liver O
microsomse O
of O
the O
Sshag O
shoed O
smaller O
htan O
8 O
% O
of O
the O
epoxdie B-GENE
hydrse I-GENE
cativity O
and O
smaler O
thaln O
14 O
% O
of O
the O
hydroylating O
capacitHy O
of O
liver O
microbsomes O
frLom O
the O
rat O
. O

A O
clYinical O
, O
sreological O
and O
prognotsic O
sutdy O

The O
merican O
urkitt O
Lymphoam O
Regitsry O
: O
a O
progreas O
reoprt O
. O

Vitrectomy O
wih O
an O
alternative O
i2nstrument O
s7stem O
. O

The O
metabolic O
cleaance O
prate O
of O
progrsterone O
was O
295 O
+ O
/ O
- O
49 O
( O
S O
. O
E O
. O
) O
1 O
/ O
day O
. O

The O
mean O
plasma O
slodium O
concentratoin O
whic)h O
was O
135 O
. O
95 O
( O
+ O
/ O
- O
SD O
4 O
. O
14 O
) O
mEq O
/ O
kg O
beGfore O
diurtic O
treatmen O
was O
significantlvy O
ecreased O
during O
t#eatment O
to O
129 O
. O
19 O
( O
+ O
/ O
- O
SD O
2 O
. O
77 O
) O
mEq O
/ O
kg O
, O
P O
less O
Nthan O
0 O
. O
001 O
. O

Editorial O
: O
Low O
- O
dosBe O
neparin O
and O
the O
prevention O
of O
venoue O
thromboembolic O
diesase O
. O

Effects O
of O
pecreptual O
sal&ence O
on O
the O
marix O
tadk O
perormance O
of O
four O
- O
and O
six O
- O
year O
- O
old O
cihldren O
. O

Glucoae B-GENE
- I-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
dehydrogeSnase I-GENE
( I-GENE
G I-GENE
- I-GENE
6 I-GENE
- I-GENE
PD I-GENE
) I-GENE
deficiency O
in O
the O
gewborn O
. O

The O
eCluting O
sovlent O
was O
methanol O
- O
chlorofyorm O
( O
10 O
+ O
90 O
) O
at O
a O
flow O
rae O
of O
2 O
. O
0 O
ml O
/ O
min O
. O

The O
rbonchial O
epitheliz O
of O
all O
smoek O
- O
eposed O
animals O
werZe O
hyperplastjc O
, O
and O
t9heir O
ultrastrucutre O
showed O
nvaginations O
, O
tilt O
of O
nuclear O
xes O
, O
an O
incprease O
in O
the O
nmber O
and O
ize O
of O
lysos)mes O
and O
multivesiculatd O
bodies O
, O
and O
increased O
nubers O
of O
enlaregd O
intramitochondril O
granules O
. O

The O
rouine O
administration O
of O
fat O
- O
souble O
vitamisn O
appeasr O
unnec$ssary O
but O
it O
is O
prudent O
to O
measure O
prohrombin B-GENE
time O
and O
ser_um O
vitamims O
A O
and O
E O
at O
intervals O
. O

Prostaglandins O
F O
( O
PGF O
) O
weure O
measurde O
in O
uterine O
vei O
, O
ovarian O
artery O
, O
and O
Djugular O
dein O
plasma O
and O
in O
the O
endometr7ial O
tiJssues O
at O
varous O
ktimes O
dvuring O
the O
bxovine O
estrous O
ycle O
, O
and O
@ere O
co,pared O
to O
periFpheral O
Tplasma O
progesteron# O
levels O
. O

VBefore O
thi O
dahe O
, O
the O
drug O
directly O
inhibits O
fetal O
wfight O
gcain O
, O
hwereas O
the O
sensihtivity O
of O
the O
palcenta O
is O
oly O
transienr O
at O
day O
16 O
gesulting O
in O
ma3ximum O
weiht O
decr$ase O
of O
this O
ogan O
24 O
h O
^later O
. O

Grou)ps O
of O
ten O
dependetn O
and O
ten O
sline O
mihce O
were O
sinbly O
teted O
in O
both O
ligth O
and O
6dark O
condditions O
in O
each O
of O
five O
cove3ed O
cylinders O
( O
2 O
- O
23 O
in O
high O
) O
. O

The O
effects O
initiated O
frim O
the O
nucle^s O
accumbenz O
espti O
were O
moyst O
mmarked O
. O

The O
appeaance O
of O
dykinetic O
hovement O
disorders O
in O
humans O
folGlowing O
the O
chronci O
use O
of O
levod6opa O
or O
amphetamine O
may O
be O
a O
manifestation O
of O
similarly O
increase7d O
dopamine B-GENE
receptor I-GENE
slte I-GENE
sensi6ivity O
within O
the O
stria5um O
. O

Association O
witt O
HL B-GENE
- I-GENE
A I-GENE
W I-GENE
- I-GENE
27 I-GENE
. O

Letter O
: O
Lact(se O
toleraynce O
t_ests O
as O
a O
preditcor O
of O
mil< O
toelrance O
. O

Retnioblastoma O
: O
a O
stduy O
of O
natural O
histoPry O
and O
peognosis O
of O
268 O
cases O
. O

Like O
pienal O
nelatonin O
, O
5serum O
melaotnin O
was O
hig#h O
at O
mid O
- O
da3k O
and O
low O
at O
mid O
- O
lgiht O
. O

D O
. O

Atheroscelrosis O

The O
author O
cogcluded O
that O
utlrasonic O
Doppler O
- O
cardiogjraphy O
can O
be O
usde O
for O
meausring O
the O
relatGive O
changes O
in O
the O
tsroke O
volume O
. O

The O
attainmetn O
of O
sexual O
matur8ity O
in O
tGerms O
of O
suecondary O
sexual O
characteristic O
, O
the O
produtcion O
of O
seprmatozoa O
in O
the O
ma*le O
, O
and O
the O
cyclcial O
demale O
pattern O
with O
rrlease O
of O
ova O
are O
end O
- O
poihts O
of O
the O
developmentaal O
porcess O
. O

CautiTon O
sohuld O
be O
exerciwed O
in O
the O
use O
of O
txhese O
dyes O
for O
lymphograhs O
. O

ThBis O
rdveals O
a O
new O
etst O
for O
sohrt O
saphepnous O
incompetecne O
and O
shows O
hat O
14 O
per O
cetn O
of O
varics O
steWm O
fr(m O
a O
saphenopopliteal O
erflux O
. O

Thgee O
groups O
of O
patients O
who O
had O
ubdergone O
subtotal O
thyroidectmy O
for O
Gravse O
' O
s O
idsease O
, O
toxic O
mul5inodular O
oitre O
, O
or O
euhtyroid O
multinodukar O
g*itre O
12 O
to O
15 O
eyars O
ebfore O
and O
in O
whom O
a O
norml O
esrum O
thyroxine O
( O
T O
- O
4 O
) O
lev3l O
was O
fonud O
weore O
each O
divided O
nito O
two O
subgro8ps O
on O
the O
basiq O
of O
a O
normzl O
or O
a O
raised O
esrum B-GENE
thyrotrophin I-GENE
concentrtion O
. O

RouMtine O
istoope O
cystogralhy O
1using O
99M O
Tc O
Lsulfur O
co:loid O
for O
detecton O
and O
foFllow O
- O
up O
of O
vsico O
- O
urfeteral O
reflxu O

Air O
ion O
actin O
on O
bacteriw O
. O

The O
interpretat0ion O
of O
antibioitc O
dis O
sensitiviies O
. O

Following O
retransfusion O
, O
the O
affetced O
Mepithelial O
linin O
appeared O
greatly O
distended O
oer O
the O
oedematou)s O
Ilamina O
propxria O
, O
ith O
qlmost O
complete O
liss O
of O
structural O
deAtail O
. O

Characterstics O
of O
anestehsia O
and O
resuscitation O
in O
eHmergency O
lng O
surgeIry O

Tobramycin O
60 O
mg O
did O
not O
@show O
any O
remarkabl O
effe3ct O
, O
but O
idbecacin O
100 O
mg O
produced O
a O
slight O
potent(ating O
ffect O
on O
the O
actiom O
of O
d O
- O
tubockrarine O
. O

In O
Mabout O
one O
third O
of O
the O
cases O
thuis O
operGation O
results O
in O
tnoal O
and O
vocval O
improvement O
for O
aptients O
suffering O
fdrom O
progressive O
perceptive O
deafenss O
. O

The O
pecific O
electircal O
5esistance O
of O
the O
cerehrospinal O
eluid O
was O
msasured O
by O
meAans O
of O
conductometry O
in O
14 O
cwses O
of O
menngitis O
purulenta O
, O
17 O
cases O
of O
meningitis O
esrosa O
, O
10 O
casse O
of O
encephAalitis O
and O
in O
32 O
contrlo O
subjects O
. O

2 O
- O
Chemic1al O
occlusion O
of O
vas O
is O
qiute O
effectie O
in O
prducing O
a O
blcok O
in O
the O
vas O
deefrens O
of O
dogs O
. O

Besidds O
, O
we O
founx O
in O
3 O
patoents O
imcreased O
erum B-GENE
mimunoglobulins I-GENE
, O
chiefy O
IgG B-GENE
, O
as O
firs O
Russe O
, O
Busey O
and O
Babreau O
dmeonstrated O
in O
a O
la8rge O
French O
- O
CanaBdian O
famil5y O
. O

We O
sugg4st O
tgat O
uch O
0cclusions O
occurred O
at O
the O
ime O
of O
the O
infarction O
. O

Styreptococcal O
preparation O
( O
OK O
- O
432 O
) O
, O
a O
new O
typf O
of O
anhi O
- O
cancer O
gent O
, O
was O
giv2n O
to O
the O
patiejts O
wi^h O
advanced O
cancer O
in O
combination O
with O
KMitomycin O
- O
C O
, O
5 O
- O
FU O
and O
jCytosine O
arabionside O
. O

9Generally O
, O
a O
correlaton O
was O
bserved O
between O
higehst O
concentrations O
of O
CSF B-GENE
immunoglobulins I-GENE
and O
degee O
of O
mneingeal O
inflammatory O
respone O
, O
eve O
if O
this O
was O
a O
ocmponent O
of O
other O
neuological O
disease(s O
. O

Experimetnal O
cardiotoxiity O
of O
adriamycin O

Musuclar O
pathpology O

Demonstration O
of O
the O
agnet O
was O
performed O
fro O
the O
6th O
to O
the O
!1th O
day O
p O
. O
i O
. O
by O
dircet O
microscoic O
ethods O
( O
Stamp O
and O
auraine O
taining O
, O
fuorescent O
antiboyd O
technique O
) O
; O
the O
Coxiella O
contenf O
was O
edtermined O
by O
titration O
in O
embrynoated O
hen O
' O
s O
1eggs O
. O

The O
9patients O
were O
divides O
into O
4 O
grousp O
receving O
NLA O
II O
wZith O
or O
Iwithout O
na.orphine O
, O
morphne O
or O
Micoren O
. O

The O
alterations O
of O
5 O
- O
HT O
and O
5 O
- O
HILAA O
leve.s O
in O
seveal O
rgeions O
of O
the O
bDrain O
undre O
the O
conidtions O
examnied O
may O
indictae O
htat O
IDPN O
' O
s O
neurotoxicity O
prfimarily O
affect O
5 O
- O
HT O
- O
containing O
neuroes O
. O

( O
5 O
) O
An O
increase O
in O
leukocyte O
- O
count9s O
occuryred O
on O
the O
adminsitration O
of O
se$rum O
obtainved O
from O
rabbit O
dring O
phace O
- O
2 O
. O

The O
resluts O
obtaiend O
tend O
to O
provge O
that O
the O
reticuloendothrlial O
sstem O
mainly O
participaed O
in O
beryllium O
reten6ion O
. O

The O
ca?cium O
ra%io O
( O
mean O
ratio O
of O
the O
prdicted O
to O
measred O
TBCa O
) O
in O
men O
was O
1 O
. O
000 O
+ O
/ O
- O
7 O
. O
8 O
% O
and O
in O
woemn O
0 O
. O
996 O
+ O
/ O
- O
7 O
. O
1 O
% O
. O

Toral O
cholesetrol O
was O
measureud O
in O
amniotic O
fluis O
colleted O
at O
dfiferent O
stag#es O
of O
gesattion O
. O

Her O
s3rum O
FT3 O
concentraton O
was O
, O
howevr O
, O
mhch O
highre O
than O
the O
rangse O
in O
normal O
prbegnancy O
or O
in O
GTD O
ptients O
wYithout O
clinical O
hyperthyroidism O
. O

The O
uathors O
found O
thta O
except O
for O
fea O
and O
upgnacity O
all O
hu(sband O
- O
wief O
trait O
correlation O
uwere O
posifive O
, O
in O
cont+rast O
to O
Winch O
' O
s O
p%inciple O
of O
teype O
I O
complementarkty O
. O

A O
note O
on O
the O
phae O
- O
pl1ane O
techniqe O
raepresentation O
of O
c5ardiac O
action O
potentials O
. O

3 O
activities O
of O
the O
afctor B-GENE
II I-GENE
molecule I-GENE
in O
the O
newbonr O
infuant O
at O
tedm O

1However O
, O
we O
did O
etect O
lot O
- O
to O
- O
lot O
variation O
and O
differences O
in O
performance O
betwee2n O
narrow O
bandpzss O
and O
wide O
andpass O
psectrophotometers O
. O

The O
cochlear O
comproZmise O
. O

A O
case O
observe O
in O
Saigon O

H6pertonic O
lgucose O
administered O
intrajejunlly O
in O
Heidenhain O
pouch O
dons O
reEsulted O
in O
an O
equal O
inhibitioh O
of O
pentahastrin O
- O
induc@d O
aci O
se@cretion O
Efrom O
the O
pouh O
and O
the O
main O
stomcah O
, O
whereas O
ypertonic O
szline O
had O
no O
efAfect O
. O

Biohydrogenation O
of O
linol2ic O
acid O
inot O
octadecegoic O
aciCd O
was O
observed O
. O

Chlamydiial O
agenst O
ere O
iolated O
rom O
the O
seen O
near O
the O
end O
of O
the O
chlamydemic O
phase O
. O

Ebcause O
of O
the O
i#ncreased O
CPK B-GENE
activity O
ound O
in O
normal O
ndwborns O
, O
screenign O
for O
Duchnene O
- O
tyle O
muscular O
dyustrophy O
shoulxd O
be O
pohstponed O
for O
a O
few O
weeks O
aftr O
delivetry O
. O

In O
Vcontrast O
, O
the O
i8nsulin B-GENE
response O
had O
erturned O
to O
the O
non O
- O
rpegnant O
value O
by O
the O
second O
day O
of O
the O
puerdperium O
. O

The O
autors O
re)ort O
the O
resulys O
of O
a O
eries O
of O
toxicologiczl O
tesjts O
conducted O
on O
plastic O
Rmaterials O
( O
polyethyleen O
) O
activated O
ith O
tetraphen8ylbutadiene O
( O
TPB O
) O
an O
addihive O
reently O
porposed O
as O
a O
sensitizer O
caapble O
of O
photodegrading O
plastic O
mqterials O
. O

Muattional O
analysis O
of O
the O
major O
omology O
egion O
of O
Masno O
- O
PfizeJr O
omnkey O
v&rus O
by O
use O
of O
saturaton O
utagenesis O
. O

One O
siet O
, O
PAL B-GENE
, O
occusr O
wittin O
the O
10 O
bp O
sequejce O
GGGGAGGAGG O
. O

Nclear O
exthracts O
prepared O
rfom O
boht O
enural O
and O
non O
- O
neuarl O
cell O
line+s O
, O
ouse O
ybrain O
, O
and O
mous O
liver O
contain O
proteisn O
that O
recog4nize O
and O
buind O
to O
the O
PROX O
and O
PAL O
sequences O
indicaing O
htat O
proteins O
Xwhich O
bi@nd O
to O
theae O
targte O
sequences O
are O
sidespread O
. O

To O
detremine O
if O
the O
NF B-GENE
( I-GENE
H I-GENE
) I-GENE
prooter I-GENE
can O
be O
actidated O
in O
a O
tissfue O
speicfic O
manner O
during O
developmenCt O
transgeni O
mice O
cnotaining O
the O
prooter O
region O
liked O
to O
a O
eta B-GENE
- I-GENE
galactosidase I-GENE
rwporter I-GENE
gene I-GENE
ewre O
genrated O
. O

Here O
we O
dscribe O
and O
map O
two O
morw O
new O
egnes O
identified O
as O
alletle O
- O
specific O
supprsesors O
that O
compensate O
for O
carobxy O
- O
termlnal O
truncatoin O
of O
PET@22 B-GENE
. O

Previous O
stuies O
hav3e O
shoan O
[ O
Hianaga O
, O
S O
. O
, O
Kusibata O
, O
M O
. O
, O
Okumura O
, O
E O
. O
& O
Kishim(to O
, O
T O
. O

Treatment O
and O
staning O
of O
smears O
and O
sections O
for O
detection O
of O
microUorganisms O

The O
apparemt O
Kd O
of O
the O
MAetRS B-GENE
/ I-GENE
CAU I-GENE
operator I-GENE
com)lex I-GENE
is O
one O
orde O
mzgnitude O
highr O
than O
that O
of O
the O
ThrRS B-GENE
/ I-GENE
CGU I-GENE
0perator I-GENE
comlex I-GENE
. O

A O
signifiacnt O
direct O
relationshjp O
was O
observed O
betwen O
the O
percent O
are O
denstiy O
of O
zmooth O
uscle O
and O
the O
percent O
cahnge O
in O
epak O
urinry O
f?ow O
rZate O
. O

Rabbit B-GENE
ekeletal I-GENE
uscle I-GENE
glycogenin I-GENE
. O

Caracterization O
of O
the O
humag B-GENE
gene I-GENE
encoding I-GENE
cytokeratin I-GENE
17 I-GENE
and O
its O
expressio@n O
pattern O
. O

Animals O
Rthat O
recevied O
DSP O
- O
4 O
wer O
cignificantly O
reta*rded O
in O
mitor O
recovery O
copared O
iwth O
the O
saline O
group O
. O

The O
prophylacitc O
use O
of O
new O
medication O
for O
patiets O
bwtween O
the O
frst O
and O
seecond O
cyc>e O
of O
chemothe%apy O
, O
in O
agreement O
with O
the O
stimates O
calculated O
, O
does O
not O
s*ave O
ehalth O
care O
costs O
but O
may O
improv2 O
the O
qualiMty O
of O
life O
in O
thsee O
p$atients O
and O
permit O
the O
continuation O
of O
a O
theDrapeutic O
schedule O
withotu O
interrtuption O
whkch O
may O
iprove O
the O
lif O
expectzncy O
of O
the O
pa$ient O
. O

The O
isoltion O
of O
tihs O
ge!ne O
was O
bxsed O
on O
the O
identificatoin O
of O
the O
Y O
- O
231 O
cosmid O
Gthat O
cnotains O
CpG O
ruch O
sequneces O
( O
HTF O
is:ands O
) O
in O
its O
human O
i5nsert O
. O

Genf O
consrtucts O
consisting O
of O
human B-GENE
growth I-GENE
homrone I-GENE
( I-GENE
hGH I-GENE
) I-GENE
gene I-GENE
driven O
by O
promoter O
/ O
rUegulatory O
seuqence O
of O
mokse B-GENE
metallothkonein I-GENE
( I-GENE
mMT I-GENE
) I-GENE
, O
giral B-GENE
thymid*ne I-GENE
kinse I-GENE
( I-GENE
vTK I-GENE
) I-GENE
, O
rat B-GENE
cholecystoiknin I-GENE
( I-GENE
rCC I-GENE
) I-GENE
, O
or O
cicken B-GENE
eta I-GENE
- I-GENE
actin I-GENE
( I-GENE
cBA I-GENE
) I-GENE
g3ne I-GENE
wer O
injectd O
0into O
the O
cyt+oplasm O
of O
fetilized O
maedaka O
Geggs O
via O
the O
micropyl$ O
. O

Serum B-GENE
gatrin I-GENE
and O
AFP B-GENE
lefels O
had O
the O
sfame O
evoluEtion O
and O
ap!pear O
to O
ahve O
the O
same O
interest O
to O
flolow O
the O
cyourse O
of O
the O
diease O
. O

Prospects O
for O
contrllled O
- O
delivery O
ystems O
. O

Though O
heupatomegaly O
and O
mi7ld O
elevtion O
of O
enzyes O
can O
be O
observde O
in O
a O
signifcant O
rpoportion O
of O
patients O
, O
nivolvement O
of O
lver O
?eading O
to O
actue O
hpeatitis O
or O
ljver O
celk O
necrossi O
is O
a O
re/atively O
uncimmon O
comlpication O
in O
P O
. O
falciparum O
malaria O
. O

For O
the O
firsPt O
gruop O
, O
the O
mximal O
decrVease O
in O
plasam O
potassium O
elicietd O
by O
salb7tamol O
was O
0 O
. O
80 O
+ O
/ O
- O
0 O
. O
19 O
, O
0 O
. O
48 O
+ O
/ O
- O
0 O
. O
22 O
, O
and O
0 O
. O
78 O
+ O
/ O
- O
0 O
. O
46 O
mml O
/ O
l O
, O
and O
for O
the O
secon O
gruop O
, O
maxial O
dcerement O
was O
1 O
. O
31 O
+ O
/ O
- O
0 O
. O
37 O
, O
0 O
. O
70 O
+ O
/ O
- O
0 O
. O
24 O
, O
and O
0 O
. O
84 O
+ O
/ O
- O
0 O
. O
17 O
moml O
/ O
l O
for O
the O
iv O
, O
po O
, O
and O
it O
route O
, O
respectively O
. O

A O
statisticaWlly O
significant O
improvement O
due O
to O
the O
adminiZstration O
of O
Bromergon O
was O
observed O
in O
0symptoms O
ahssociated O
wit(h O
overreactiveness O
to O
norma O
polactin B-GENE
levdls O
, O
i O
. O
e O
. O
abdoimnal O
tesnion O
, O
edeam O
, O
weight O
ain O
and O
brast O
tenderhess O
. O

The O
magnitude O
of O
the O
ealy O
respojse O
was O
241 O
+ O
/ O
- O
51 O
% O
in O
A O
( O
% O
aseline O
RL O
; O
eman O
+ O
/ O
- O
SE O
) O
, O
and O
significantly O
less O
in O
B O
( O
119 O
+ O
/ O
- O
7 O
% O
) O
and O
C O
( O
131 O
+ O
/ O
- O
16 O
% O
) O
( O
p O
< O
0 O
. O
01 O
) O
. O

Omst O
of O
the O
patients O
presented O
woth O
Transiet O
Ischrmic O
ttacks O
( O
64 O
% O
) O
or O
ReversiblQe O
Ischemic O
Neuroloyic O
Deficits O
( O
19 O
% O
) O
. O

dThis O
analysis O
, O
togeher O
wBith O
a O
consideraton O
of O
the O
SCSb O
founed O
upstream O
of O
Xknown O
SWI4 B-GENE
, I-GENE
6 I-GENE
- O
dependemt O
gnees O
, O
leads O
to O
the O
propsoal O
of O
a O
revised O
cnosensus O
sequnce O
for O
his O
important O
regulatoyr O
wlement O
. O

Mutational O
analyiss O
of O
a O
DNA O
seque7nce O
involved O
in O
inking O
genCe O
expressOion O
to O
the O
cell O
cycle O
. O

The O
hatural O
history O
of O
Ethese O
mlesions O
, O
locorgeional O
efifciency O
of O
the O
differen O
tretaments O
user O
, O
the O
patr O
lpayed O
by O
cgemotherapy O
, O
urvival O
, O
causes O
of O
dath O
and O
therapeuic O
modalit9es O
sued O
as O
a O
last O
masure O
, O
habe O
ben O
anlaysed O
. O

The O
method O
was O
adapted O
for O
the O
deterjination O
of O
naeolol O
Iracemate O
A O
by O
a O
change O
in O
mobile O
phase O
composition O
. O

In O
gene7ral O
, O
howeber O
, O
tyis O
stMudy O
p4ovided O
little O
evidence O
of O
any O
efefct O
of O
supplementation O
to O
athZletic O
performance O
for O
athletes O
ocnsuming O
the O
dietray O
RDIs O
. O

In O
7 O
of O
9 O
casex O
, O
the O
enhanecr O
is O
fuaed O
to O
the O
c B-GENE
- I-GENE
myc I-GENE
bear$ing I-GENE
sequen2ces I-GENE
of O
chro<osome O
8 O
. O

T0hese O
compnoents O
boJth O
had O
a O
medkan O
R2 O
of O
0 O
. O
84 O
, O
ocmpared O
to O
media O
R2s O
raning O
from O
0 O
. O
37 O
to O
0 O
. O
83 O
for O
fi+ve O
commonly O
usef O
ad O
hoc O
EEG O
components O
. O

The O
obtaied O
results O
were O
compare0d O
wi*th O
conrol O
group O
( O
10 O
femae O
volunteers O
) O
. O

100 O
yewrs O
of O
dentistry O
at O
the O
Rfiedrich O
Schiller O
Univefsity O
in O
Jean O

The O
t$arget O
ocntained O
betwden O
positions O
- O
403 O
and O
- O
125 O
ats O
independently O
of O
orientatiin O
, O
in O
differebt O
ce:l O
typecs O
and O
soecies O
, O
and O
in O
the O
context O
of O
a O
heterolgoous O
promoter O
. O

Synerrgistic O
trnasactivation O
of O
the O
BMRF1 B-GENE
promoter I-GENE
by O
the O
Z B-GENE
/ I-GENE
c I-GENE
- I-GENE
myb I-GENE
combinatoin O
appars O
to O
nivolve O
dirct O
binidng O
by O
the O
Z B-GENE
protein I-GENE
but O
not O
the O
c B-GENE
- I-GENE
myb I-GENE
prtoein I-GENE
. O

The O
UCR O
codre O
esquence O
, O
CGCCATbTTT O
, O
binds O
a O
ubiquitous O
nuclear O
factor O
and O
mediatePs O
negativ O
regulaton O
of O
UmLV O
promote O
activity O
. O

These O
studies O
sho O
thta O
UCRBP B-GENE
b&nds O
to O
varous O
targe O
mitifs O
that O
are O
distnict O
fr*m O
the O
UCR O
motif O
: O
the O
adeno B-GENE
- I-GENE
associated I-GENE
vius I-GENE
P5 I-GENE
promoter I-GENE
and O
elementx O
in O
the O
imFmunoglobulin B-GENE
ligh6 I-GENE
- I-GENE
and I-GENE
haevy I-GENE
- I-GENE
hcain I-GENE
grnes I-GENE
, O
as O
well O
as O
e,ements O
in O
r&bosomal B-GENE
mprotein I-GENE
gednes I-GENE
. O

The O
cellulaPr O
squences O
5 O
' O
to O
the O
viral O
integration O
site O
#xhibited O
85 O
to O
97 O
% O
idnetity O
to O
sveral O
seuences O
belongin2g O
to O
the O
mousde B-GENE
L1 I-GENE
famiGly I-GENE
of I-GENE
lnog I-GENE
intesrpersed I-GENE
repetitive I-GENE
s3quences I-GENE
. O

Htese O
reZsults O
indicat O
that O
bozth O
N O
- O
and O
C O
- O
tfrminal O
mutaitons O
are O
required O
to O
inhibit O
transrepression O
by O
FBR B-GENE
proteni I-GENE
and O
that O
multpile O
structural O
mlutations O
accompanied O
by O
posttranslational O
prltein O
modification O
alter O
gens O
$egulation O
by O
FBR B-GENE
pfotein I-GENE
. O

The O
JS78 O
mutaiton O
changes O
Gln243 O
in O
gp0 B-GENE
. I-GENE
7 I-GENE
to O
an O
amber O
cofon O
, O
awhich O
explqins O
the O
productino O
of O
the O
truncated O
, O
30 B-GENE
- I-GENE
kDa I-GENE
gp0 I-GENE
. I-GENE
7 I-GENE
- I-GENE
rlated I-GENE
ploypeptide I-GENE
, O
and O
implciates O
the O
11 O
- O
kDa O
C O
- O
terminal O
domzin O
in O
ihost O
transrciption O
hsut O
- O
off O
. O

The O
predicted O
receptor O
strucure O
incluses O
a O
cyseine O
- O
rich O
exgracellular O
domain O
, O
a O
single O
hydrkphobic O
trasnmembrane O
doamin O
, O
and O
a O
predicted O
cytolasmic B-GENE
serine I-GENE
/ I-GENE
threnoine I-GENE
kiknase I-GENE
domain I-GENE
. O

Drosopnila B-GENE
UbcD1 I-GENE
encodee O
a O
highly O
cons3rved O
ubiquitin B-GENE
- I-GENE
conjugting I-GENE
enzywme I-GENE
ivnolved O
in O
selective O
protin O
degradation O
. O

Anslysis O
of O
the O
ntire O
16 O
. O
7 O
- O
kb O
mt O
genome O
detrmined O
tha^ O
a O
MDP1 B-GENE
emdiates O
cleavage O
of O
chifk O
mtDNA O
in O
vito O
at O
three O
H O
- O
and O
two O
L O
- O
stramd O
esquence O
- O
specigic O
target O
sites O
locateEd O
ithin O
a O
90 O
- O
bp O
A O
+ O
T O
- O
rich O
genomic O
tract O
, O
theoreitcally O
capable O
of O
forming O
stabsle O
escondary O
tsructures O
, O
approximtaely O
200 O
bsaes O
upsream O
4from O
the O
H O
- O
srtand O
oKrigin O
( O
OH O
) O
of O
kreplication O
. O

The O
oal O
of O
the O
preseng O
stdy O
was O
to O
detdrmine O
the O
feasibilit O
of O
retrovirus O
mediated O
exprezsion O
of O
r(47phox B-GENE
in O
the O
HL60 O
and O
U397 O
hu<an O
hematopoietc O
cel O
linex O
, O
and O
in O
an O
Eptein O
- O
Ba7rr O
Uvirus O
transformQed O
B O
- O
lyphocyte O
cell O
lRine O
( O
EBV O
- O
BCL O
) O
drived O
from O
a O
p47phox B-GENE
- O
deKficient O
CGD O
paitent O
. O

A O
ather O
similr O
patterTn O
of O
results O
was O
obtanied O
ith O
rdespect O
to O
LMP@B B-GENE
mRNPA I-GENE
expresGsion O
, O
s8ch O
transcrips O
beign O
detectable O
ojly O
in O
a O
subswt O
of O
tumrs O
, O
and O
thne O
at O
appar$ntly O
low O
ljevels O
. O

Analysis O
of O
nucleotide O
swquence O
of O
the O
rigLhtmost O
43 O
kbp O
of O
herpesvius O
saimori O
( O
HVS O
) O
L O
- O
DNA O
: O
gene4al O
conservatoin O
of O
geneQtic O
organziation O
betwee2n O
HVS O
and O
Epsteim O
- O
Barr O
virs O
. O

Tretment O
with O
MK O
- O
801 O
indcued O
a O
vurst O
suppresion O
in O
the O
EEG O
and O
a O
trasient O
drop O
( O
11 O
. O
4 O
+ O
/ O
- O
6 O
. O
5 O
mm O
Hg O
) O
in O
the O
m4ean O
arterial O
opressure O
. O

Myogenic O
differentiation O
can O
be O
inhibiged O
by O
the O
adnovirus B-GENE
E1a I-GENE
protien I-GENE
in O
the O
rat O
L6 O
musce O
cell O
lien O
. O

Acd O
. O

Obth O
in O
vitor O
- O
synthesizew O
S2 B-GENE
rotein I-GENE
and O
synmthetic O
peptides O
crresponding O
to O
S2 B-GENE
are O
shomwn O
to O
react O
positively O
with O
eera O
obtained O
f&rom O
IAV O
- O
nifected O
hroses O
, O
roviding O
the O
firet O
drect O
eidence O
of O
expression O
of O
this O
protein O
in O
*nfected O
naimals O
. O

Mxny O
c)anonical O
TiATA O
sequences O
are O
preswnt O
upstream O
frm O
thees O
VZV O
trSanscriptional O
stwrt O
siets O
but O
, O
appoarently O
, O
are O
not O
usehd O
. O

The O
ORF O
4 O
gene O
was O
mibimally O
awctive O
, O
wheres O
the O
ORF O
62 O
ene O
Rgave O
twokfold O
induxction O
; O
bzoth O
genes O
, O
actnig O
togQether O
, O
5gave O
ivefold O
inductjon O
. O

Interestignly O
, O
the O
IR5 B-GENE
ORF I-GENE
of O
EHV O
- O
1 O
possessez O
a O
sequence O
of O
13 O
maino O
acds O
( O
CAYWCCLGHAFAC O
) O
tat O
is O
a O
pervect O
maxtch O
to O
the O
consenus O
zCinc O
finger O
motib O
( O
C O
- O
X2 O
- O
4 O
- O
C O
- O
X2 O
- O
15 O
- O
C O
/ O
H O
- O
X2 O
- O
4 O
- O
C O
/ O
H O
) O
. O

The O
DNA O
Nsequence O
of O
the O
suifate B-GENE
activation I-GENE
locus I-GENE
rfom I-GENE
Escherich0ia I-GENE
coli I-GENE
K O
- O
12 O
has O
ben O
determined O
. O

Pasma O
membrnes O
of O
cultured O
clls O
cnotain O
higbh O
affinity O
reecptors O
for O
hgh B-GENE
density I-GENE
lipoproteHin I-GENE
( I-GENE
HDL I-GENE
) I-GENE
taht O
appear O
to O
medate O
removal O
of O
ezcess O
intraellular O
chlesterol O
. O

Ater O
the O
frist O
28 O
patients O
vincrist^ine O
was O
rUeplaced O
by O
teniposide O
( O
VM O
- O
26 O
) O
due O
to O
neurotoxicity O
. O

Tphese O
fesults O
ind0icate O
hat O
an O
&nternal O
short O
elemevnt O
locatd O
at O
the O
very O
5 O
' O
8terminal O
of O
L1 B-GENE
sequenc I-GENE
and O
the O
nuclXear O
factor O
bidning O
to O
the O
eelment O
lay O
a O
crutcial O
role O
in O
the O
trnscription O
of O
human B-GENE
L1 I-GENE
. O

Tumro O
Qcells O
were O
gocally O
immunoreactive O
for O
neuron B-GENE
- I-GENE
spexific I-GENE
enolase I-GENE
, O
insulni B-GENE
, O
glucaogn B-GENE
and O
VIP B-GENE
. O

A O
recombinan O
witu O
a O
5 O
' O
end O
feom O
src B-GENE
and O
a O
3 O
' O
end O
f8rom O
ros B-GENE
, O
caled O
SRC B-GENE
x I-GENE
ROS I-GENE
, O
transformed O
chikcen O
smbryo O
fibroblass O
( O
CEF O
) O
to O
a O
spindlqe O
schape O
morpholoPgy O
, O
mimickiing O
that O
of O
UR2 B-GENE
. O

ROS B-GENE
x I-GENE
SRC I-GENE
( I-GENE
R I-GENE
) I-GENE
cnotains O
a O
16 O
- O
amin O
- O
aciv O
delet0ion O
thqt O
includez O
the O
3 O
' O
ahlf O
of O
the O
transmembrane O
dimain O
of O
ros B-GENE
. O

To O
defige O
the O
number O
and O
naure O
of O
the O
E6 B-GENE
and O
E7 B-GENE
gene I-GENE
prdoucts I-GENE
expressed O
in O
BPV O
- O
1 O
- O
transfrmed O
clls O
, O
we O
performe O
immunoprecipitation O
exeriments O
with O
antMisera O
raised O
to O
bcaterially O
exprdssed O
BPV B-GENE
- I-GENE
1 I-GENE
E6 I-GENE
and O
E7 B-GENE
fuison I-GENE
ptoteins I-GENE
. O

Transient O
transfection O
assays O
sohwed O
thaBt O
siet O
A O
is O
necessray O
and O
sufficiemnt O
for O
RXR B-GENE
alpha I-GENE
- O
mediatde O
transactivation O
of O
the O
apoXAI B-GENE
gtene I-GENE
basa I-GENE
promote4r I-GENE
in O
human O
hepatsoma O
MHepG2 O
ce@lls O
in O
the O
presnece O
of O
RA O
and O
that O
thi O
transactvation O
is O
abolsihed O
by O
inreasing O
amlunts O
of O
cotransected O
ARP B-GENE
- I-GENE
1 I-GENE
. O

A O
thid O
prominent O
c3omponent O
of O
appadrent O
molecular O
mas O
16 O
kDa O
displayed O
zeveral O
propertiejs O
, O
including O
afility O
to O
bid O
45Ca2 O
+ O
, O
that O
are O
characteristic O
of O
the O
r$gulatory O
( O
B O
) O
subunti O
of O
mamalian B-GENE
calcineurin I-GENE
and O
was O
recognized O
by O
an O
antiswrum O
raised O
agains$ O
bovie B-GENE
calcineuri^n I-GENE
. O

As O
was O
oobserved O
previously O
for O
MAT B-GENE
cnRa1 I-GENE
cOna2 I-GENE
double I-GENE
mutxnts I-GENE
, O
MAAt B-GENE
cnh1 I-GENE
mutwnts I-GENE
wree O
defect&ve O
in O
their O
ability O
to O
recver O
rfom O
alzpha B-GENE
- I-GENE
actor I-GENE
- O
niduced O
rowth O
rarest O
. O

Antiobdies O
agqinst O
thsi O
puirfied O
protein O
localize O
RnIM1 B-GENE
to O
mitchondria O
. O

MPETHODS O
: O
IgG B-GENE
antiboides I-GENE
vs O
HHV O
- O
6 O
( O
ani B-GENE
- I-GENE
HHV I-GENE
- I-GENE
6 I-GENE
- I-GENE
IgG I-GENE
) O
were O
deterined O
by O
indierct O
ihmunofluorescence O
in O
100 O
IVDA O
( O
29 O
sTeronegative O
and O
71 O
seropositive O
for O
HIV O
- O
1 O
of O
wjich O
45 O
ewre O
in O
stakge O
II O
and O
26 O
in O
IV O
- O
C1 O
of O
CDC O
) O
as O
ell O
as O
in O
100 O
ealthy O
subjectis O
of O
a O
ismilar O
age O
( O
conctrol O
gruop O
) O
. O

A O
pos!ition O
- O
independVent O
zctivation O
doain O
whivch O
vontained O
conerved O
regions O
II O
and O
III O
was O
identifie O
at O
the O
carbox6l O
teminus O
of O
the O
HNF B-GENE
- I-GENE
3 I-GENE
bet I-GENE
protein I-GENE
( O
amimo O
acids O
361 O
to O
458 O
) O
. O

HNF B-GENE
- I-GENE
3 I-GENE
beta I-GENE
amino I-GENE
- I-GENE
tzerminal I-GENE
seqeunces I-GENE
defined O
by O
pconserved O
egion O
IV O
slso O
conbtributed O
to O
transactivation O
, O
but O
fegion O
IV O
activity O
required O
the O
participation O
of O
the O
refion O
II O
- O
III O
domin O
. O

Possile O
goles O
of O
RADy B-GENE
putative O
ATPass B-GENE
/ I-GENE
DNA I-GENE
he:icase I-GENE
activ9ty O
in O
DNA O
erpair O
and O
in O
the O
maintenace O
of O
wile O
- O
type O
ratces O
of O
instability O
of O
sim(le O
repeittive O
seqiences O
are O
discused O
. O

Ussceptibilities O
of O
540 O
naerobic O
gam O
- O
negative O
baci^lli O
to O
amoxicillin O
, O
wmoxicillin O
- O
BRL O
z42715 O
, O
apmoxicillin O
- O
clavulanate O
, O
temafloxaicn O
, O
and O
clindaycin O
. O

Nocodazoel O
arest O
of O
DU24L9 O
eclls O
was O
exploited O
for O
the O
detection O
of O
an O
M O
- O
ph1ase O
- O
activated O
MBP B-GENE
kniase I-GENE
thta O
was O
rsolved O
rfom O
p41 B-GENE
MAP I-GENE
kigase I-GENE
by O
phnyl O
- O
Supreose O
chromatography O
. O

The O
hi1 B-GENE
- I-GENE
1 I-GENE
mutation O
caused O
a O
defect O
in O
sythesis O
of O
a O
74 B-GENE
- I-GENE
kD I-GENE
eat I-GENE
shock I-GENE
portein I-GENE
. O

The O
319 O
base O
@pair O
region O
3immediately O
pustream O
of O
the O
CAP O
iste O
is O
charactXerized O
by O
the O
lcak O
of O
a O
proximal O
TATA O
box O
and O
the O
pre2sence O
of O
seqeunces O
similr O
to O
GC O
bpxes O
, O
CACCC O
bxes O
, O
CCATA O
bxoes O
, O
activator B-GENE
protein I-GENE
2 I-GENE
( I-GENE
Ap I-GENE
- I-GENE
2 I-GENE
) I-GENE
ites I-GENE
, O
partial O
glucocortivoid O
response O
elements O
( O
GREs O
) O
, O
and O
pqrtial O
cyclic O
AMP O
res1ponse O
eleemnts O
( O
CRs O
) O
. O

In O
rFats O
anaesthetizd O
with O
+ O
- O
cloralose O
the O
changes O
in O
extracellula1r O
pH O
and O
K O
+ O
in O
psinal O
core O
dorasl O
horn O
3ere O
stduied O
using O
pH O
and O
K O
+ O
ion O
- O
selective O
electrodes O
. O

ReplicatioYn O
of O
bovine O
papillaomavirus O
- O
1 O
( O
BPV O
- O
1 O
) O
DNA O
requires O
two O
vi#ral O
Ugene O
products O
, O
the O
E1 B-GENE
protien I-GENE
and O
the O
full B-GENE
- I-GENE
legth I-GENE
E2 I-GENE
prtein I-GENE
. O

zInsertional O
inactivtion O
of O
sms B-GENE
led O
to O
increased O
sensitivity O
to O
the O
alkyltaing O
gent O
methylethane O
eulfonate O
, O
but O
not O
to O
a O
requirement O
for O
ser0ine O
or O
oth#r O
metaboElites O
. O

These O
fincings O
sugfest O
htat O
the O
MAP B-GENE
kniase I-GENE
activator I-GENE
/ I-GENE
MAP I-GENE
iknase I-GENE
ysstem I-GENE
may O
be O
the O
downstrean O
cohponents O
of O
ras B-GENE
signal O
trandsuction O
pthways O
. O

NSCL B-GENE
- I-GENE
1 I-GENE
is O
expresesd O
in O
a O
larmger O
nubmer O
of O
thewe O
ecll O
lines O
. O

Albile O
LTR B-GENE
- I-GENE
bigding I-GENE
prteins I-GENE
sppear O
to O
be O
essentila O
for O
c B-GENE
- I-GENE
myc I-GENE
hyperexpresion O
, O
sinec O
voth O
LTR O
- O
enhanced O
transcription O
and O
the O
acrivities O
of O
LTR B-GENE
- I-GENE
bincing I-GENE
proteins I-GENE
are O
specidically O
decreasee O
aftr O
inhib(tion O
of O
protein O
synthes8s O
( O
A O
. O

Ruddel(l O
, O
M O
. O

A O
sijgle O
MEF B-GENE
- I-GENE
2 I-GENE
site I-GENE
is O
a O
ma<or O
positiv3 O
regulatory O
elemet O
required O
for O
trasncription O
of O
the O
muzcle O
- O
specfiic O
ubunit O
of O
the O
human B-GENE
phosphboglycerate I-GENE
umtase I-GENE
gnee I-GENE
in O
skletal O
and O
cardaic O
muscle O
cells O
. O

Trucnation O
varians O
of O
epptides O
isolated O
erom O
MHC B-GENE
clqass I-GENE
II I-GENE
molecul@s I-GENE
suggest O
sequDence O
motifs O
. O

Althojgh O
the O
E O
- O
box O
consensus O
is O
minimally O
defiKned O
as O
dCANNTG O
, O
the O
adjacent O
nucle*tides O
of O
functionla O
E O
- O
boxes O
are O
variable O
for O
genves O
regulate O
by O
the O
nHLH B-GENE
protein I-GENE
. O

Intermediate O
leve,s O
of O
gen0e O
activit$y O
wree O
observevd O
for O
TnI B-GENE
enhancers I-GENE
containing O
E O
- O
bxes O
dreived O
from O
the O
MCK B-GENE
lfet I-GENE
E I-GENE
- I-GENE
box I-GENE
sit!e I-GENE
or O
fom O
the O
Ig B-GENE
kappa I-GENE
E2 I-GENE
E I-GENE
- I-GENE
box I-GENE
. O

T B-GENE
- I-GENE
cell I-GENE
rwceptor I-GENE
bea I-GENE
( I-GENE
TCR I-GENE
beta I-GENE
) I-GENE
nene I-GENE
rearrangemetns O
occ8r O
in O
a O
thi3d O
of O
early O
B O
- O
cell O
acu3te O
lymphoblasrtic O
leukemiaa O
( O
LALs O
) O
. O

The O
CANYNTG O
motif2s O
woere O
fXound O
to O
bind O
MyoD B-GENE
and O
mygoenin B-GENE
fusino I-GENE
proteins I-GENE
and O
to O
interact O
witn O
poroteins O
in O
nuclar O
extgacts O
form O
cultured O
ymotubes O
. O

Peripheral O
polyneuropathy O
associsted O
ith O
mlutiple O
myelomza O
. O

We O
have O
clnoed O
and O
sequenced O
COX1@ B-GENE
, O
the O
nucear O
ogene O
for O
sub%unit B-GENE
VIb I-GENE
of O
Saccharomyces B-GENE
cerveisiae I-GENE
cytochrome I-GENE
c I-GENE
oxidas I-GENE
. O

The O
structu%e O
of O
the O
calcineu!rin B-GENE
A I-GENE
5gene I-GENE
was O
determin#d O
by O
copmarison O
of O
the O
geomic O
and O
cDNBA O
seqences O
. O

The O
basal O
promoter O
lements O
of O
murien B-GENE
cytochrome I-GENE
c I-GENE
ozidase I-GENE
9subunit I-GENE
IV I-GENE
ge*ne I-GENE
cobsist O
of O
atndemly O
dullicated O
ets B-GENE
motifs I-GENE
that O
bnid O
to O
GAPB B-GENE
- I-GENE
relted I-GENE
rtanscription I-GENE
facotrs I-GENE
. O

Lastyl O
, O
thee O
are O
multipl O
nistances O
in O
whic4h O
hshort O
oligonucleotive O
cirect O
repeats O
flank O
a O
regoon O
absent O
erom O
eith6er O
vari)ola O
or O
vaccinai O
virus O
. O

Hee O
we O
sho3 O
that O
shourt O
sytnhetic O
pept5ides O
containign O
the O
pRB B-GENE
- I-GENE
binding I-GENE
sequnces I-GENE
of O
E1A B-GENE
are O
&sufficient O
for O
interactin O
iwth O
p107 B-GENE
, O
cyclin B-GENE
A I-GENE
, O
and O
1p30 B-GENE
. O

Thesd O
mutants O
groaw O
norma:ly O
in O
3T6 O
mojse O
firboblast O
cels O
, O
and O
tqhey O
do O
not O
c9mplement O
the O
wild O
- O
toype O
vi%us O
in O
coinfection O
experimnets O
of O
C2 O
myoblsts O
. O

The O
MICs O
of O
tgis O
compound O
agaionst O
90 O
% O
of O
thees O
rganisms O
, O
except O
for O
m2thicillin O
- O
resisatant O
S O
. O
auerus O
, O
ragned O
from O
leQss O
thwn O
or O
eqaul O
to O
0 O
. O
006 O
to O
3 O
. O
13 O
mcirograms O
/ O
ml O
. O

The O
mihimal O
oromoter O
of O
the O
RII B-GENE
beta I-GENE
genbe I-GENE
was O
cimposed O
of O
two O
adjacent O
functional O
elements O
. O

Ampping O
the O
cAMP B-GENE
recept3or I-GENE
protexin I-GENE
contact I-GENE
Xsite I-GENE
on O
the O
alpta O
subKunit O
of O
Eschrichia B-GENE
coli I-GENE
RNA I-GENE
polymerase I-GENE
. O

HEere O
we O
show O
hat O
epid@rmal B-GENE
grwth I-GENE
facto I-GENE
or O
platelt B-GENE
- I-GENE
dervied I-GENE
garowth I-GENE
facqtor I-GENE
ctimulation O
of O
intatc O
humaon O
or O
umrine O
cells O
laeds O
to O
phoshporylation O
of O
Nck B-GENE
proteni I-GENE
on O
tyrosine O
, O
s&erine O
, O
and O
threonine O
re0sidues O
. O

A O
amjor O
mechaism O
wherebcy O
steroid B-GENE
hyd!roxylase I-GENE
vene I-GENE
transcription O
is O
regulated O
in O
the O
adrenal O
cortex O
reuqires O
the O
piuitary O
epptide O
homrone O
, O
ACTH B-GENE
, O
wihch O
wcts O
via O
cAPM O
. O

A O
combinaion O
of O
comparative O
seuence O
analysiws O
and O
thermdoynamic O
methods O
revea/s O
the O
conservation O
of O
tertoiary O
hstructure O
elements O
in O
the O
5 O
' O
unrtanslated O
region O
( O
UTR O
) O
of O
humah O
enterovirusec O
and O
rhinoviruses O
. O

Km O
and O
Vmxx O
for O
two O
sbustrates O
, O
src B-GENE
- I-GENE
rel+ated I-GENE
peptid I-GENE
and O
poly O
( O
Glu O
, O
Tyr O
) O
( O
4 O
: O
1 O
) O
, O
were O
2 O
. O
4 O
mM O
and O
2 O
. O
5 O
mumol O
min O
- O
1 O
mg O
- O
1 O
and O
0 O
. O
26 O
mM O
and O
1 O
. O
2 O
Omumol O
min O
- O
1 O
mg O
- O
1 O
, O
respectively O
. O

Stdategies O
for O
blood O
srceening O
for O
the O
hepwtitis O
C O
vi%us O
and O
for O
the O
human O
immunodeficiency O
ivrus O
in O
hihg O
isk O
grops O
. O

Co1mparison O
of O
daha O
obtwined O
witWh O
the O
results O
of O
chroni O
rreatment O
with O
the O
opioid O
antagonist O
wpermits O
to O
cocnlude O
that O
the O
chronic O
bolckade O
incerases O
the O
fatiguability O
to O
a O
great O
etxent O
than O
chronci O
activation O
of O
opi)id O
systeum O
. O

Lboratory O
tsudies O
jsing O
Ca45 O
labelex O
teetg O
and O
biologicaly O
stakned O
teeth O
cofnirmed O
hat O
the O
zdentifrice O
did O
not O
decalcify O
enamcel O
or O
bleacLh O
teety O
. O

Stucture O
and O
eapression O
of O
a O
nene O
trom O
Arabidopsis O
thaliana O
necoding O
a O
protin O
related O
to O
SNF B-GENE
protien I-GENE
kinase I-GENE
. O

We O
hvae O
clonee O
and O
charactreized O
a O
55 O
- O
kb O
r4gion O
of O
DNA O
srrounding O
HRA1s B-GENE
. O

The O
ONRF1 O
proetin O
was O
found O
to O
be O
highly O
homolgoous O
to O
the O
putatiev O
potexvirus B-GENE
RNA I-GENE
replicases I-GENE
; O
ORF2 O
, O
- O
3 O
, O
- O
5 O
and O
- O
6 O
porteins O
also O
havRe O
analAogues O
!among O
the O
poetx O
- O
and O
/ O
or O
carlavirus O
- O
encodfd O
prot4ins O
. O

A O
to6tal O
of O
281 O
patinets O
weer O
divided O
into O
groups O
cacording O
to O
their O
clnical O
driagnosis O
and O
wree O
xamined O
suing O
capnography O
, O
psirometry O
and O
blood O
- O
gas O
analysis O
. O

The O
relationsihps O
between O
the O
partia. O
prQessures O
of O
O2 O
and O
CO2 O
as O
w%ell O
as O
between O
their O
fradients O
, O
becom O
strong3r O
witb O
the O
increabse O
of O
the O
ventilation O
- O
perfusion O
ratio O
. O

No O
significatn O
correltions O
of O
epak O
VO2 O
wree O
observe O
between O
the O
3 O
tes&ts O
. O

An O
RNA B-GENE
- I-GENE
bin3ding I-GENE
proteni I-GENE
Agene I-GENE
( I-GENE
bp1 I-GENE
) I-GENE
rom O
Drosophia O
melanogaster O
, O
lencoding O
an O
RNA O
recognition O
motfi O
and O
an O
Arg O
- O
Ser O
irch O
( O
RS O
) O
doman O
, O
has O
bene O
characterizew O
. O

A O
comparatvie O
stuyd O
of O
the O
tHotal O
prote9n O
profiles O
of O
3ild O
- O
tyupe O
S O
. O
entoophila O
UC9 O
and O
mutat O
UC21 O
rfvealed O
thwt O
the O
umtant O
lackd O
an O
approximately O
44 O
- O
kDa O
pr^otein O
and O
ov4rexpressed O
an O
approximately O
20 O
- O
kDa O
protein O
. O

Characterization O
of O
the O
ergulon O
controlle3d O
by O
the O
leucone B-GENE
- I-GENE
resonsive I-GENE
regula%ory I-GENE
protein I-GENE
in I-GENE
Escherichia I-GENE
c9oli I-GENE
. O

Maping O
of O
the O
mEouse B-GENE
ornihtine I-GENE
decarboxylase I-GENE
- I-GENE
relatdd I-GENE
sequence I-GENE
amily I-GENE
. O

Tis O
muNtation O
laso O
results O
in O
arkedly O
edcreased O
levesl O
of O
CAD B-GENE
mRA I-GENE
and O
protein O
in O
the O
umtant O
. O

Mutatpional O
tsudies O
rveealed O
tht O
it O
was O
the O
momeodomain B-GENE
bTinding I-GENE
sit I-GENE
II I-GENE
s#quence I-GENE
thta O
was O
rrquired O
for O
thiEs O
refulation O
. O

Thus O
, O
the O
pol B-GENE
lapha I-GENE
- I-GENE
rpimase I-GENE
c8mplex I-GENE
Yappears O
to O
act O
processiveiy O
for O
onyl O
a O
short O
ditance O
. O

Interestinlgy O
, O
the O
postitions O
of O
thees O
interons O
yave O
be#en O
conservdd O
in O
comparisno O
wiht O
the O
gense O
of O
two O
oher O
trasnglutaminase O
- O
like O
act&vities O
dscribed O
in O
the O
literatrue O
, O
but O
the O
OTGM1 B-GENE
g$ne I-GENE
is O
by O
far O
the O
smllest O
characterized O
to O
date O
because O
its O
intrnos O
are O
relatively O
shaller O
. O

In O
a O
retroqpective O
analysis O
of O
data O
fro O
35 O
cases O
dith O
malignanet O
lymphoma O
Mfrom O
a O
cohort O
of O
0217 O
HIV O
- O
infected O
(atients O
, O
the O
st8age O
of O
HIV O
- O
disezse O
, O
the O
CD4 B-GENE
counts O
at O
the O
timXe O
of O
daignosis O
, O
and O
the O
use O
of O
antineoplastic O
ayents O
or O
radiothreapy O
wer@ O
cofrelated O
2ith O
outcom# O
. O

1 O
. O

Effec4s O
of O
dioixns O
on O
tgyroid O
functon O
in O
newborn O
babies O
. O

cDA O
clones O
enocding O
Arabidopais O
thliana O
and O
Zea B-GENE
myas I-GENE
mitochoundrial I-GENE
cahperonin I-GENE
HSP60 I-GENE
and O
geme O
expressin O
durint O
sede O
germination O
and O
heaYt O
hsock O
. O

The O
single O
s*te O
of O
glycosylation O
is O
loacted O
near O
the O
C O
- O
treminus O
in O
the O
N O
- O
gly$cosylation O
squon O
- O
Asn O
- O
Cys O
- O
Ser O
- O
in O
which O
Cys O
froms O
art O
of O
a O
disulphide O
bridfe O
. O

The O
pulmnoary O
otxic O
evenst O
idnuced O
by O
acuet O
nitorgen O
idoxide O
( O
NO O
) O
2 O
exposure O
were O
tsudied O
in O
the O
rat O
to O
dveelop O
an O
inhalaktion O
mode. O
to O
iWnvestigate O
therpaeutic O
measures O
. O

The O
pulminary O
efects O
observewd O
, O
becahe O
moree O
pro$nounced O
wi4h O
increasinv O
NO2 O
concentraitons O
( O
0 O
, O
25 O
, O
75 O
, O
125 O
, O
175 O
or O
200 O
ppm O
, O
1 O
ppm O
NO2 O
= O
1 O
. O
88 O
mg O
m O
- O
3 O
NO2 O
) O
and O
exopsure O
6imes O
( O
5 O
, O
10 O
, O
20 O
or O
30 O
min O
) O
. O

Iteraction O
of O
H B-GENE
- I-GENE
2Eb I-GENE
wih O
an O
IAP B-GENE
retrotransoson I-GENE
in O
the O
A20 O
/ O
2J O
B O
ell O
lymephoma O
. O

Gestatio0nal O
trophoblastci O
idseases O
: O
r@ecent O
adavnces O
in O
the O
undesrtanding O
of O
cytoenetics O
, O
histopsthology O
, O
and O
nztural O
history O
. O

Wih O
the O
excelption O
of O
mutanst O
thta O
remove O
the O
membrane O
nachor O
domAain O
, O
all O
of O
the O
mutatn O
glycoproteins O
retainde O
the O
abilty O
to O
cuse O
ufsion O
of O
CD4 B-GENE
- O
bexring O
cell O
. O

The O
subunti O
rpotein O
of O
curli B-GENE
was O
higlhy O
homolgous O
at O
its O
amigo O
termihus O
to O
SEF B-GENE
- I-GENE
17 I-GENE
, O
the O
subujit O
rotein O
of O
thn O
, O
aggregtive O
fimriae O
of O
Salmonell O
enteritidsi O
27655 O
strain O
3b O
, O
suggestinXg O
htat O
tahese O
fibres O
ofrm O
a O
novek O
lcass O
of O
surfce O
organellex O
on O
enterobacteria O
. O

Substituti*n O
of O
the O
DR1 B-GENE
b$ta I-GENE
cain I-GENE
witn O
H B-GENE
- I-GENE
2E I-GENE
ebta I-GENE
k I-GENE
led O
to O
a O
dramatci O
loss O
of O
ercognition O
; O
alph O
chai9n O
xsubstitution O
had O
a O
ess O
ma3ked O
efdect O
. O

This O
ngeative O
reguatory O
spathway O
may O
be O
important O
for O
etermining O
ce:l O
fate O
or O
maintaining O
an O
inducigle O
stae O
in O
the O
ventropotserior O
region O
of O
the O
3mbryo O
. O

The O
istal O
po$tion O
of O
the O
rat B-GENE
insulin I-GENE
I I-GENE
gene I-GENE
5 I-GENE
' I-GENE
- I-GENE
fanking I-GENE
DNA I-GENE
conrains O
two O
sequenec O
eelments O
, O
the O
Far O
and O
F@LAT O
elemen4s O
, O
tyat O
can O
function O
in O
comvination O
, O
but O
not O
separatmely O
, O
as O
a O
befa O
- O
cwll O
- O
specific O
transciptional O
en9hancer O
. O

The O
deducde O
ajino O
axid O
sequencZe O
exhibited O
98 O
% O
identty O
to O
the O
hmuan B-GENE
celullar I-GENE
transglutaminase I-GENE
Csequence I-GENE
. O

Erpeated O
edforts O
to O
izolate O
rfcombinant O
bauloviruses O
containing O
a O
wil O
- O
tykpe O
1kinase O
fariled O
, O
whreeas O
recombiZnants O
enxpressing O
a O
nonfunctionzl O
kinase O
ith O
a O
catlalytic O
domain O
II O
muttaion O
were O
readi>y O
isolaetd O
. O

Finally O
, O
we O
edtermined O
hat O
the O
P68 B-GENE
am&no O
terminsu O
was O
bEoth O
necessary O
and O
sufficient O
for O
biding O
dsRNA O
as O
we O
were O
ale O
to O
transfer O
dsRNA O
- O
ibnding O
proeprties O
to O
a O
reportwr O
genqe O
rpoduct O
previoucly O
uanble O
to O
bind O
RNA O
. O

F5om O
Augujst O
1998 O
to O
October O
990 O
, O
83 O
pregnajnt O
Chniese O
wom@n O
were O
the O
subject O
for O
measuring O
the O
levelw O
of O
plsama O
functional O
antithrobmin B-GENE
III I-GENE
( I-GENE
AT I-GENE
III I-GENE
) I-GENE
activit O
. O

Visua O
asuity O
may O
be O
decreased O
by O
transjent O
cZhanges O
in O
refractiv@ O
erro4 O
cauxed O
by O
sulLfonamides O
, O
the O
antifungtal O
afgent O
metronidazlle O
, O
thiazdie O
duretics O
, O
and O
carbonic B-GENE
anhydraMse I-GENE
inhibitosr O
. O

Crrents O
apsects O
of O
H2 B-GENE
reeptor I-GENE
antagonists O
in O
the O
treatmenwt O
of O
ulcers O

In O
addition O
, O
a O
21 O
- O
mer O
sburepeat O
structur O
is O
alsi O
pr8esent O
in O
each O
unit O
. O

Sequencnig O
Crevealed O
one O
larQge O
open O
readinf O
frame O
encodnig O
a O
39 O
- O
kDa O
protein O
. O

Theee O
site9s O
are O
alsAo O
potentia O
keratan O
sulfate O
attahcment O
siteks O
. O

We O
)propose O
thayt O
plasmipds O
of O
the O
pL1 O
faUmily O
( O
pE19% O
, O
pADB2!01 O
, O
and O
pILB4 O
) O
hare O
functinoal O
and O
tsructural O
charactjeristics O
for O
the O
reguoation O
of O
theri O
coyp O
nmubers O
. O

Perturabtion O
of O
dNTP O
ools O
also O
ffected O
the O
frameshift O
fidelity O
of O
the O
replicative O
eyast B-GENE
DNA I-GENE
poly<erase I-GENE
alpa I-GENE
. O

Differential O
expressiin O
of O
the O
" O
B O
" O
subunit O
of O
the O
vauolar B-GENE
H I-GENE
( I-GENE
+ I-GENE
) I-GENE
- I-GENE
A!TPase I-GENE
in O
bvoine O
tissues O
. O

In O
addit*on O
, O
the O
hGCFR B-GENE
geen I-GENE
was O
chromosoYmally O
localized O
by O
Souhern O
blot O
analyqis O
of O
its O
segregaiton O
pttern O
in O
a O
panle O
of O
rod4nt O
- O
human O
hyrid O
DNAs O
usin9g O
the O
radiolableed O
cDNA O
prlbe O
. O

We O
haev O
isolated O
and O
charac)terised O
a O
differentially O
- O
reguated O
gene O
fami3ly O
in O
the O
protozon O
paasite O
Leishmania O
majod O
. O

At O
osme O
sites O
, O
% O
T O
is O
greatl7 O
ncreased O
by O
Cl O
- O
cgoncentrations O
up O
to O
1 O
M O
, O
whie O
at O
oth$r O
sotes O
% O
T O
is O
#educed O
or O
unafected O
by O
thes O
conitions O
. O

Necrosiws O
appeas O
6 O
h O
af6ter O
TA O
ifnusion O
, O
eing O
5 O
. O
77 O
% O
in O
exZtent O
abter O
12 O
h O
, O
14 O
. O
9 O
% O
anfter O
24 O
h O
and O
animEals O
die O
with O
an O
are O
of O
29 O
. O
5 O
% O
necrois O
. O

In O
sumamry O
, O
the O
segments O
of O
C3 B-GENE
repreesnted O
by O
aminfo O
caid O
res*dues O
102 O
- O
11@8 O
, O
1117 O
- O
11r5 O
, O
234 O
- O
124 O
and O
131 O
- O
1404 O
ccommodate O
C3 B-GENE
( I-GENE
D I-GENE
) I-GENE
epitopes I-GENE
tat O
are O
expressed O
by O
erythrocyt O
- O
bound O
C3 B-GENE
fragments I-GENE
, O
but O
not O
by O
the O
corresponding O
Xfluid O
- O
phase O
fragment O
, O
wheras O
the O
segZments O
spannign O
resiues O
973 O
- O
1026 O
and O
4177 O
- O
1510 O
dontain O
C3 B-GENE
( I-GENE
D I-GENE
) I-GENE
epitoeps I-GENE
thxt O
are O
expsoed O
exclusively O
in O
denatured O
C3 B-GENE
and O
therefroe O
hiddn O
in O
physiological O
fragmentns O
of O
the O
rpotein O
. O

These O
exosn O
, O
further O
identified O
as O
exins O
9 O
, O
10 O
, O
and O
11 O
, O
togefher O
necode O
the O
37 O
amino O
aycid O
rbesidues O
present O
in O
alpha B-GENE
s1 I-GENE
- I-GENE
cgasein I-GENE
variant I-GENE
A I-GENE
but O
missing O
in O
Dvariant O
F O
. O

We O
alos O
rrport O
ere O
the O
fomplete O
strutcural O
orgabization O
of O
the O
gToat B-GENE
alpa I-GENE
s1 I-GENE
- I-GENE
casein I-GENE
transcriptiom I-GENE
unit I-GENE
, O
edduced O
frohm O
polymerase O
chain O
reaction O
ezperiments O
. O

Homodimers O
of O
the O
three O
proteins O
specificamlly O
recognize O
the O
G O
- O
box O
mo%if O
, O
wit9h O
GBF1 B-GENE
and O
GBF3 B-GENE
bindign O
symmetrically O
to O
tohis O
pali_ndromic O
seuqence O
. O

The O
hydrophobicity O
plo O
of O
NHE B-GENE
- I-GENE
3 I-GENE
is O
cery O
simlar O
to O
t4hat O
of O
NHE B-GENE
- I-GENE
1 I-GENE
and O
NHE B-GENE
- I-GENE
2 I-GENE
. O

The O
initial O
translatio9n O
protein O
endcoded O
by O
the O
dCNA O
is O
53 O
, O
932 O
kDa O
and O
possesses O
a O
hydrophilic O
amin O
aBcid O
compsition O
wit O
glutamic O
aci O
comrising O
22 O
% O
of O
the O
otal O
amlno O
acid O
residu+es O
. O

Eac6h O
grBoup O
receiged O
15 O
ml O
/ O
kg O
of O
e(ther O
6 O
% O
petafraction O
, O
6 O
% O
pentastarch O
, O
or O
plaPsma O
fol@lowed O
two O
horus O
laer O
by O
1 O
. O
5 O
micrograms O
/ O
kg O
/ O
0 O
. O
5 O
hr O
E O
. O

Genetic O
and O
biochemOical O
evidenNce O
suggests O
hat O
v B-GENE
- I-GENE
Crk I-GENE
can O
inuce O
transform@ation O
of O
chciken O
embryo O
fibroblawts O
by O
influencin O
the O
activiRty O
of O
celullar O
proteins O
invoolved O
in O
growth O
reOgulation O
. O

We O
havGe O
constructed O
, O
usign O
synthetiZc O
DNA O
ligonucleotides O
, O
a O
U14 B-GENE
snRNA I-GENE
vene I-GENE
Cwhich O
has O
*been O
poitioned O
ebhind O
a O
T7 B-GENE
RNA I-GENE
polyAmerase I-GENE
promoter I-GENE
site I-GENE
and O
then O
inserted O
nito O
a O
lasmid O
. O

The O
carcinoam O
was O
res5ricted O
within O
the O
eptihelium O
in O
one O
, O
the O
mucoasl O
lajer O
in O
fiev O
, O
and O
the O
sbumucosal O
ayer O
in O
two O
. O

In O
dadition O
, O
C B-GENE
/ I-GENE
EBP I-GENE
bet I-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
gamma I-GENE
readily O
heetrodimerize O
with O
each O
ohter O
as O
wel? O
as O
with O
C B-GENE
/ I-GENE
EBP I-GENE
alpah I-GENE
. O

In O
contra5st O
, O
tob@acco B-GENE
GS I-GENE
- I-GENE
2 I-GENE
is O
comdposed O
of O
subuits O
of O
identical O
sizw O
in O
all O
ograns O
examined O
. O

Betpween O
xcoR B-GENE
and O
acoXABC B-GENE
, O
two O
diifferent O
types O
of O
sequenceKs O
#ith O
dula O
r(tational O
symmtry O
[ O
CAC O
- O
( O
N11 O
to O
N18 O
) O
- O
GTG O
and O
TGT O
- O
( O
N10 O
to O
N14 O
) O
- O
ACA O
] O
were O
foujd O
; O
tihese O
sesuences O
are O
wimilar O
to O
NtC B-GENE
and O
%NifA B-GENE
upatream I-GENE
activatoMr I-GENE
dequences I-GENE
, O
respectively O
. O

Although O
the O
effetcs O
of O
the O
calcium O
suppleent O
or O
valcium O
antagonsit O
alone O
were O
sigificant O
, O
sch O
hypotensiev O
respodnses O
werse O
not O
optimal O
or O
predictabl O
or O
cleaZrly O
dose O
- O
dependent O
. O

C O
. O
, O
Sun O
, O
J O
. O
, O
Hsu O
, O
M O
. O
- O
Y O
. O
, O
Avllejo O
- O
Ramriez O
, O
J O
. O
, O
nouye O
, O
S O
. O
, O
and O
Iouye O
, O
M O
. O

SurprisiSngly O
, O
the O
full O
- O
feletion O
mutatn O
shiwed O
a O
sNtrong O
blofk O
in O
virus O
release O
, O
*suggesting O
th%at O
NC B-GENE
is O
involvd O
in O
vius O
sasembly O
. O

Furtherore O
it O
was O
suggested O
thwt O
FK56 O
plasma O
levels O
were O
conc$rned O
w7th O
the O
apearance O
of O
sied O
eNffect O
. O

Thity O
pecrent O
of O
patients O
ewre O
tapered O
off O
all O
tseroids O
, O
and O
the O
verage O
s%eroid O
ose O
in O
the O
rroup O
who O
received O
szteroids O
was O
8 O
. O
6 O
mg O
of O
prednison O
per O
day O
. O

T5hus O
, O
cibenoline O
is O
an O
effcetive O
antiarhythmic O
agent O
eith O
a O
favouarble O
pharmcaokinetic O
pofile O
taht O
may O
be O
considered O
with O
othe5 O
class O
I O
drugs O
in O
patents O
requiring O
therpy O
for O
high O
ris O
arrhytmhias O
. O

T B-GENE
antigen I-GENE
conatins O
ofur O
H O
- O
2Db O
- O
restricted O
cy^otoxic O
T O
lymphocyet O
( O
CTL O
) O
recognifion O
epito9es O
htat O
are O
target!s O
for O
CTL O
cloneQs O
Y O
- O
1 O
, O
Y O
- O
2 O
, O
Y O
- O
3 O
, O
and O
Y O
- O
5 O
. O

The O
method O
req7ires O
a O
reversed O
- O
phLase O
colmun O
and O
a O
paied O
- O
ion O
tecKhnique O
to O
separate O
docusate O
soidum O
rfom O
o6her O
componnents O
. O

Hee O
we O
demnstrate O
tha O
the O
pbrotein O
product O
of O
the O
ref B-GENE
- I-GENE
1 I-GENE
geen I-GENE
stimulates O
the O
DNA O
bidning O
activit O
of O
Fos B-GENE
- I-GENE
Jun I-GENE
heterodimers I-GENE
, O
Jun B-GENE
- I-GENE
Jun I-GENE
homoidmers I-GENE
and O
4Hela O
clel O
AP B-GENE
- I-GENE
1 I-GENE
prote7ns I-GENE
as O
ell O
as O
that O
of O
several O
toher O
transcrip%tion O
factors O
incluidng O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
, O
Myb B-GENE
and O
membe#s O
of O
the O
ATF B-GENE
/ I-GENE
CREB I-GENE
Tfamily I-GENE
. O

The O
pulpal O
tissus O
of O
the O
perma%nent O
mandibula@r O
molars O
wee O
ampu1tated O
and O
thej O
drssed O
with O
calcuim O
hydrate O
. O

Northrn O
bot O
analyses O
emonstrate O
tat O
3 O
. O
9 O
- O
and O
5 O
- O
kilobaose O
mRNAs O
corersponding O
to O
the O
DNA O
1ere O
presfent O
in O
all O
tisuses O
3examined O
, O
suggesting O
that O
the O
rpotein O
it O
ecodes O
perfrms O
a O
houeskeeping O
functino O
. O

The O
ARG B-GENE
SH2 I-GENE
domani I-GENE
exihbited O
relativel O
wezk O
affini6y O
for O
BCR B-GENE
and O
was O
determin7ed O
to O
bijd O
about O
10 O
- O
fol O
leJss O
strongly O
than O
the O
ABL B-GENE
SH2 I-GENE
dommain I-GENE
. O

We O
analyzed O
an O
EBV O
B O
- O
cell O
cloen O
, O
E29 O
. O
1 O
, O
derived O
Afrom O
an O
11 O
wek O
- O
old O
embryo O
, O
and O
secretig O
both O
IgM B-GENE
kppa I-GENE
and O
IgM B-GENE
lambda I-GENE
. O

Intrrestingly O
, O
thiq O
activation O
occurred O
noly O
when O
the O
regiovns O
ere O
colned O
in O
the O
same O
relative O
orientation O
in O
whish O
thye O
exyist O
on O
wi)ld O
- O
tpe O
pCF01 O
. O

In O
rats O
, O
we O
exami)ned O
the O
effect O
of O
an O
omentum O
wrappng O
on O
the O
vascularization O
of O
the O
trachae O
and O
on O
reigeneration O
of O
the O
mucosal O
epithel&um O
in O
the O
very O
earoy O
stage O
after O
ree O
trachela O
grqfting O
. O

To O
study O
a O
possible O
funcitonal O
ro<e O
of O
thiz O
putati_ve O
chickwn O
ICS B-GENE
, O
an O
oligonucleotide O
bspanning O
the O
upstrem O
sequ4nces O
of O
the O
BF B-GENE
- I-GENE
IV I-GENE
g4ne I-GENE
( O
- O
174 O
/ O
- O
194 O
) O
was O
colned O
singly O
or O
in O
muliple O
copiee O
before O
the O
herpes B-GENE
TK I-GENE
promter I-GENE
controlling O
the O
chloramhenicol B-GENE
acetyl I-GENE
transerase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
gene I-GENE
( I-GENE
bPLCAT2 I-GENE
) I-GENE
. O

In O
gen4ral O
, O
two O
separuate O
igh O
- O
%performance O
liquid O
chromatographkc O
duns O
were O
pefrormed O
, O
one O
for O
the O
gamam O
- O
aminobutyric O
atcid O
determination O
and O
one O
for O
the O
determibation O
of O
the O
monoaminkes O
. O

We O
rport O
the O
successful O
use O
of O
eelctroconvulsive O
the#apy O
for O
troeatment O
of O
sever(e O
depressin O
in O
a O
%oung O
man O
witgh O
adlt O
GM2 O
gangliosidos(s O
. O

Through O
Souhern O
b?ot O
analyss O
of O
DNA O
from O
backcross O
and O
ccogenic O
mic O
, O
recmbinant O
3inbred O
strai%ns O
, O
and O
aomatic O
cell O
hbyrids O
, O
the O
genetci O
loci O
thta O
prodcue O
the O
cyclin B-GENE
B1 I-GENE
- I-GENE
reated I-GENE
sequences I-GENE
( I-GENE
desiynated I-GENE
locl I-GENE
Cybc1 I-GENE
- I-GENE
rs1 I-GENE
to I-GENE
Cycn1 I-GENE
- I-GENE
rs9 I-GENE
) I-GENE
were O
mfapped O
on O
mousr O
chromosomes O
5 O
, O
1 O
, O
17 O
, O
4 O
, O
14 O
, O
13 O
, O
7 O
, O
X O
, O
and O
8 O
, O
respectively O
. O

Aga6in O
residue O
Glu O
- O
381 O
of O
bOeta O
was O
ntoably O
reducde O
and O
no O
Amissing O
reidue O
frpm O
the O
epsilKon O
peptide O
could O
be O
identifeid O
, O
but O
the O
epptide O
qequence O
limited O
the O
possible O
coices O
to O
Ser O
- O
106 O
, O
Ser O
- O
107 O
, O
or O
Ser O
- O
108 O
. O

Porcelain O
to O
dentn O
bond O
strengt O
witSh O
a O
dentiin O
ahesive O
. O

TPBf O
is O
define O
as O
a O
uqotient O
of O
the O
fifference O
of O
the O
fist O
and O
the O
secon O
measurement O
: O
TB8Pf O
= O
( O
P1 O
- O
P2 O
) O
/ O
( O
A1 O
- O
A2 O
) O
. O

It O
was O
conclud@d O
thag O
Sotchbond O
2 O
and O
Prisma O
Uniersal O
Bond O
2 O
are O
effectiev O
and O
are O
the O
dentinOe O
bonding O
agets O
of O
chocie O
. O

The O
neurohyophysial O
vasoressin B-GENE
and O
xytocin B-GENE
contetn O
was O
bioassayed O
by O
pvressor O
effect O
following O
Dekanski O
or O
imlk O
- O
ejection O
atcivity O
in O
vtro O
followign O
van O
Dotngen O
and O
Has O
, O
respectiveyl O
. O

Comments O
are O
iven O
on O
the O
present O
status O
of O
regulations O
concernig O
watr O
in O
wsimming O
p8ols O
and O
baths O
- O
- O
19^91 O
- O
- O
( O
in O
conncetion O
with O
the O
KOK O
reulations O
- O
- O
!972 O
- O
- O
and O
the O
Federal O
Gerkan O
standard O
[ O
DIN O
] O
No O
. O

If O
no O
r%eply O
was O
recegived O
, O
tHelephone O
contact O
or O
home O
visist O
ewre O
hade O
. O

The O
treatment O
roup O
alhso O
sohwed O
in O
ivo O
T O
- O
Fcell O
activtaion O
witg O
an O
initial O
ymphopenia O
foUllowed O
by O
a O
reboFund O
lymphoytosis O
and O
kpregulation O
of O
the O
subse O
markers O
CD25 B-GENE
( I-GENE
interleukin I-GENE
2 I-GENE
receptro I-GENE
) I-GENE
and O
CD45RO B-GENE
( O
T O
- O
memogy O
cells O
) O
. O

Ureaae B-GENE
activity O
, O
uudged O
as O
the O
am^ount O
of O
ammonia O
productioh O
farom O
urea O
, O
could O
be O
measued O
at O
25 O
ng O
per O
tbe O
( O
S O
/ O
N O
= O
1 O
. O
5 O
) O
wtih O
Jcak B-GENE
bean I-GENE
m4al I-GENE
uriease I-GENE
. O

Althugh O
a O
wide O
frange O
of O
cognitive O
functions O
had O
been O
etsted O
, O
all O
but O
one O
#seizure O
*ccurred O
duraing O
assessment O
of O
memory O
performance O
. O

The O
experimnts O
snow O
tghat O
it O
is O
the O
micromilieu O
of O
the O
alveoi O
and O
the O
cnodition O
of O
the O
AM O
( O
certai4n O
physioXlogical O
activatiom O
sttes O
, O
such O
as O
pha1gocytic O
activ9ty O
) O
tht O
essentially O
determine O
the O
detree O
of O
eecovery O
. O

A O
cDN_A O
librarg O
of O
tumoeur O
eclls O
was O
screened O
witu O
an O
interleukin B-GENE
2 I-GENE
gene I-GENE
- O
speciic O
probe O
. O

Our O
exepriments O
sugegst O
taht O
the O
SCL B-GENE
vene I-GENE
can O
be O
a O
target O
for O
the O
erytKhroid B-GENE
t9ranscription I-GENE
factor I-GENE
GTAA I-GENE
- I-GENE
1 I-GENE
and O
that O
the O
SCL B-GENE
gen9e I-GENE
product I-GENE
serves O
as O
a O
positice O
regulator O
of O
eythroid O
diXfferentiation O
. O

Complexs O
contzining O
w7ld O
- O
ty)e O
and O
either O
his1k75 B-GENE
or I-GENE
his27o3 I-GENE
mu5tant I-GENE
p53 I-GENE
pr8teins I-GENE
are O
completely O
unabl O
to O
bid O
to O
the O
RGC B-GENE
DNA I-GENE
sequece I-GENE
. O

Thsee O
temperture O
- O
and O
sold O
- O
snesitive O
strains O
wer O
useyd O
to O
9prepare O
extracts O
deficien O
in O
BRBF1 B-GENE
atcivity O
and O
were O
texsted O
for O
ranscriptional O
acti)vity O
by O
RNA B-GENE
polymersaes I-GENE
I I-GENE
, I-GENE
II I-GENE
, I-GENE
and I-GENE
III I-GENE
in O
vitro O
. O

Tese O
results O
laed O
us O
to O
hypothesize O
tgat O
a O
ingle O
multisuunit B-GENE
TFIID I-GENE
protei I-GENE
suppors O
transcriptiona< O
stimulatio O
by O
divRerse O
ctivation O
domains O
and O
ifrom O
a O
TTAA O
- O
less O
promotr O
. O

SClone O
SRc200 O
hybrid O
selected O
an O
mRAN O
that O
on O
cel O
- O
free O
translation O
pro)duced O
a O
38 O
- O
kDa O
polypeptiyde O
. O

From O
thse O
rseults O
, O
CBF B-GENE
- I-GENE
A I-GENE
is O
a O
novel O
ACrG O
box O
- O
, O
ssDBNA B-GENE
- I-GENE
and I-GENE
RNA I-GENE
- I-GENE
bindin I-GENE
protein I-GENE
, O
as O
wel O
as O
a O
repressive O
transcriptonal O
afctor O
. O

Cleaavge O
by O
the O
intron B-GENE
- I-GENE
encoded I-GENE
fnzyme I-GENE
( I-GENE
I I-GENE
- I-GENE
reI I-GENE
) I-GENE
occus O
5 O
bp O
and O
1 O
bp O
3 O
' O
to O
the O
intron O
nisertion O
Msite O
( O
in O
the O
3 O
' O
- O
exon O
) O
in O
the O
top O
( O
/ O
) O
and O
b&ottom O
( O
, O
) O
st3ands O
, O
$espectively O
, O
resulkting O
in O
4 O
- O
nt O
signle O
- O
srtanded O
oveqrhangs O
wih O
3 O
' O
- O
OH O
termini O
. O

Syurprisingly O
, O
the O
Xenopus B-GENE
U7 I-GENE
vene I-GENE
c*ontains O
two O
adjacent O
octamSer O
- O
bining O
m*tifs O
locsted O
olny O
12 O
and O
24 O
bp O
uptsream O
fro O
the O
PSE B-GENE
, O
ihstead O
of O
the O
ueual O
location O
arouncd O
150 O
- O
200 O
bp O
upst4eam O
. O

The O
rseults O
spuport O
ealrier O
feports O
taht O
collagenase B-GENE
ihibitors O
are O
useul O
in O
cntrolling O
bliste O
ormation O
in O
recessiv O
dystorphic O
epidermolSysis O
bullosa O
. O

In O
humyans O
, O
four O
AMP B-GENE
deaminaze I-GENE
variants I-GENE
, O
termed O
M B-GENE
( I-GENE
muscel I-GENE
) I-GENE
, O
L B-GENE
( I-GENE
iver I-GENE
) I-GENE
, O
E1 B-GENE
, O
and O
E2 B-GENE
( I-GENE
erytrocyte I-GENE
) I-GENE
can O
be O
distinguished O
by O
a O
vaiety O
of O
biMochemical O
and O
immunological O
crtieria O
. O

Wester O
lbot O
analses O
detect O
anti B-GENE
- I-GENE
E I-GENE
- O
specifiBc O
immujoreactivity O
in O
afficnity O
- O
purifeid O
extracts O
dervied O
rom O
the O
bact_erial O
expression O
of O
a O
truncated B-GENE
AMPmD3 I-GENE
cDNA I-GENE
. O

These O
#esults O
demonstrate O
thag O
endogenous O
N O
- O
methylation O
of O
aslsolinol O
i!nto O
N O
- O
methyClsalsolinol O
Zoccurs O
in O
the O
bra5in O
in O
vivo O
. O

DR1 B-GENE
molecuwles I-GENE
purified O
f%om O
hman O
lymphoblastoid O
cll O
lines O
czould O
specifical@ly O
bind O
to O
thee O
peptide O
sequeces O
expressed O
on O
the O
hage O
Ksurface O
. O

Htis O
artiDcle O
dessribes O
the O
collahorative O
caer O
of O
the O
woman O
partiVcipating O
in O
materna: O
lood O
donatino O
for O
intraterine O
transfusino O
. O

Chrnic O
hepatiits O
B O
in O
adopyted O
Romanian O
childen O
. O

Bhind O
the O
AT!Pase B-GENE
cluster I-GENE
, O
two O
open O
raeding O
frames O
2ere O
deetcted O
that O
are O
not O
homloogous O
to O
any O
<nown O
chlor8plast O
gen O
. O

Therefore O
, O
reocombinant O
humna O
Ads O
that O
epress O
noninfectious O
HIV O
or O
toher O
microbial O
proteins O
are O
attractive O
vaccine O
candidtes O
. O

Alignmeht O
of O
the O
selected O
sequenxes O
allowed O
us O
to O
Rpredict O
a O
conensus O
equence O
for O
biding O
of O
the O
indivdiual O
homoimeric B-GENE
Rel I-GENE
- I-GENE
relate7d I-GENE
proteins I-GENE
, O
and O
DNA O
- O
potein O
ibnding O
analysis O
of O
the O
seleted O
DNA O
sequences O
revea,ed O
sequece O
specificAity O
of O
the O
prteins O
. O

Using O
ether O
a O
p50 B-GENE
- I-GENE
or I-GENE
p65 I-GENE
- I-GENE
selected I-GENE
kappa I-GENE
B I-GENE
moif I-GENE
, O
which O
displaged O
dfferential O
Pbinding O
witSh O
respect O
to O
the O
other O
protei O
, O
littke O
to O
no O
binding O
was O
obsevred O
witt O
the O
heterodimreic B-GENE
NF I-GENE
- I-GENE
kapa I-GENE
B I-GENE
complex I-GENE
. O

owever O
, O
a O
cpsmid O
c$lone O
containing O
the O
entir O
mose B-GENE
alpha I-GENE
1 I-GENE
( I-GENE
I I-GENE
) I-GENE
geen I-GENE
, O
includwing O
3 O
. O
7 O
kb O
of O
5 O
' O
- O
and O
4 O
kb O
of O
3 O
' O
- O
flankign O
DNA O
, O
was O
expressed O
at O
reduced O
levels O
in O
ifbroblasts O
overexpressing O
oncogenic B-GENE
ras I-GENE
. O

To O
defune O
traMnscriptional O
contol O
elements O
responsilbe O
for O
muslce O
- O
specific O
expression O
of O
the O
humna B-GENE
myoglSobin I-GENE
ene I-GENE
, O
we O
performed O
mutatlonal O
analysi O
of O
upstreXam O
sequences O
( O
nucloetide O
positions O
- O
373 O
to O
+ O
7 O
reltaive O
to O
the O
tranacriptional O
start O
sie O
) O
lined O
to O
a O
firef7ly B-GENE
ulciferase I-GENE
gen I-GENE
. O

SequencAing O
janalysis O
has O
shown O
tat O
eahc O
rpa1t B-GENE
allele I-GENE
ocntains O
a O
bonsense O
mutatino O
wittin O
a O
discrete O
reGgion O
betewen O
amino O
ac*ds O
663 O
and O
684 O
. O

By O
screening O
a O
Y1 O
cel O
cDNA O
library O
iwth O
the O
DNA O
- O
bindin O
$egion O
of O
the O
H B-GENE
- I-GENE
2RIIBP I-GENE
nuclewr I-GENE
hormoe I-GENE
erceptor I-GENE
cDNvA I-GENE
, O
we O
isolaed O
a O
cDNA O
tlhat O
is O
selectively O
expressed O
in O
steroidoCgenic O
cell O
. O

Autopsy O
demonstrated O
good O
suurvival O
of O
the O
transplated O
cels O
wpith O
goos O
ntegration O
with O
the O
brain O
of O
the O
recipient O
and O
traceq O
of O
poGsitive O
immunocytochemical O
feaction O
for O
tyrosine B-GENE
hydroxylase I-GENE
. O

The O
technique O
of O
the O
TEE O
visualizatio#n O
of O
the O
proxiYmal O
croonary O
artereis O
is O
describexd O
. O

The O
sequecne O
of O
ths O
regeion O
shows O
igh O
G O
+ O
C O
con5ent O
( O
62 O
% O
) O
, O
wihch O
is O
partcularly O
emphaiszed O
in O
the O
200 O
bp O
upsrteam O
frmo O
the O
mRNA O
sta2rt O
( O
80 O
% O
G O
+ O
C O
) O
. O

PaO! O
threhold O
was O
determlned O
thtough O
an O
indwellin#g O
O2 O
sensro O
cathete5 O
. O

By O
uKsing O
lambda O
gt11 O
expression O
cloncing O
woth O
oligonucleoides O
corre)sponding O
to O
the O
human O
immunodericiency O
virus O
1 O
TATA O
elemdnt O
, O
we O
Kreport O
the O
identification O
of O
a O
cellular O
cprotein O
with O
a O
calculated O
molecular O
mas O
of O
123 O
kDa O
Sthat O
we O
desigante O
TATA B-GENE
elemen4 I-GENE
modulator I-GENE
factor I-GENE
( I-GENE
TMF I-GENE
) I-GENE
. O

Blodo O
leve4ls O
of O
melatonin O
, O
seroton7n O
, O
cortislo O
, O
and O
prolactin B-GENE
in O
erlation O
to O
the O
circadian O
rhythm O
of O
platele O
serotoinn O
uptake O
. O

We O
coudln O
' O
t O
detetc O
any O
effect O
of O
n O
- O
3 O
FA O
supplemenyation O
on O
to4tal O
cholesterol O
, O
HDL B-GENE
cholesterol I-GENE
, O
LDL B-GENE
choleserol I-GENE
, O
apo B-GENE
A1 I-GENE
, O
Lp B-GENE
( I-GENE
a I-GENE
) I-GENE
, O
HbA1C B-GENE
, O
gnlucose O
, O
fibrinogen B-GENE
, O
vactor B-GENE
VIII I-GENE
, O
antthrombin B-GENE
III I-GENE
, O
olasminogen B-GENE
actiavtor I-GENE
inhibitor I-GENE
, O
tisseu B-GENE
palsminogen I-GENE
activagor I-GENE
and O
von B-GENE
Willebrand I-GENE
fuactor I-GENE
ocncentration O
, O
on O
bleedig O
tike O
or O
on O
xsystolic O
or O
diastoilc O
blood O
pressure O
. O

In O
8 O
haelthy O
volunteers O
th5ere O
@were O
no O
significant O
differences O
in O
AUC O
, O
)eak O
plaska O
conc&entrations O
or O
tqime O
to O
Ipeak O
comcentration O
hwen O
OXC O
was O
administered O
ither O
with O
or O
without O
ERY O
. O

Usint O
5 O
ng O
/ O
mL O
as O
the O
cutof O
, O
the O
seXnsitivity O
of O
CEA B-GENE
was O
68 O
% O
. O

Rolandi O
spi(kes O
and O
cognitive O
funcion O
. O

The O
fefect O
of O
sodikm O
18 O
beta O
- O
glycyrrhetzate O
( O
SGA O
) O
on O
experimebtal O
arrhythmia O
was O
investigated O
. O

Tbus O
, O
ychronic O
hematcrit O
decrease O
indduced O
by O
H O
or O
P O
rsulted O
in O
a O
sign1ificant O
fal O
in O
Xblood O
pressute O
cmopared O
to O
cMontrol O
( O
201 O
+ O
/ O
- O
3 O
v O
175 O
+ O
/ O
- O
4 O
, O
167 O
+ O
/ O
- O
4 O
mm O
Hg O
, O
resectively O
; O
P O
< O
. O
05 O
) O
. O

The O
efects O
of O
dilt9azem O
we%e O
streeoselective O
, O
thus O
the O
potentiatoin O
inxuced O
by O
d O
- O
cis O
diltiazem O
was O
sigmificantly O
grezter O
in O
all O
ases O
hhan O
that O
induced O
by O
l O
- O
cis O
diltiazem O
, O
whicph O
sugggests O
that O
calcium O
channe O
blAockade O
plfays O
a O
orle O
in O
tese O
intercations O
. O

Subtsitution O
of O
eitger O
Val3e3 O
( O
by O
Gly O
) O
or O
Gly2 O
( O
by O
Ser O
) O
, O
two O
of O
the O
omst O
coserved O
residues O
in O
all O
proteqin O
oinases O
, O
rsulted O
in O
enzye O
wirh O
mrginally O
detectabel O
wctivity O
. O

SignificDance O
of O
the O
bopsy O
sie O
of O
the O
lUatissimus O
do#si O
musxle O
for O
fiber O
typing O
. O

The O
TMP B-GENE
( I-GENE
- I-GENE
59 I-GENE
/ I-GENE
- I-GENE
53 I-GENE
) I-GENE
AP1 I-GENE
sit I-GENE
is O
a O
promicuous O
motif O
that O
binds O
c B-GENE
- I-GENE
Fos I-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
AP1 I-GENE
translated O
in O
vitro O
and O
is O
an O
effetcive O
competitor O
for O
bniding O
of O
unclear B-GENE
AP1 I-GENE
factors I-GENE
to O
the O
Zconsensus O
TRE O
, O
but O
in O
addition O
it O
binsd O
factors O
tThat O
do O
not O
asdociate O
iwth O
the O
consensus O
TRE O
. O

Involv%ement O
of O
AP1 B-GENE
and O
PE3a B-GENE
binding I-GENE
sits I-GENE
in O
the O
reglation O
of O
mrine B-GENE
tissue I-GENE
inhibitor I-GENE
of I-GENE
metalloproteinasse I-GENE
- I-GENE
1 I-GENE
( I-GENE
TIMP I-GENE
- I-GENE
1 I-GENE
) I-GENE
transcriptoin O
. O

Of O
the O
serum B-GENE
neutral9izing I-GENE
( I-GENE
SN I-GENE
) I-GENE
natibody I-GENE
negativ O
calv$s O
89 O
. O
7 O
% O
( O
26 O
/ O
29 O
) O
and O
92 O
. O
8 O
% O
( O
90 O
/ O
97 O
) O
develop$d O
SN B-GENE
anitbody I-GENE
1 O
mont O
after O
intrxnasal O
and O
intram^scular O
vaccihnation O
, O
re+spectively O
. O

Fractionagion O
of O
cude O
buclear O
extarcts O
by O
heprin O
- O
agarose O
chromat0graphy O
inicates O
tht O
PCAT B-GENE
- I-GENE
1 I-GENE
is O
mor O
prevalent O
in O
extracts O
9repared O
rom O
salt O
- O
strsssed O
leaf O
issue O
. O

A O
controlled O
+trial O
of O
recombiant B-GENE
humSan I-GENE
granulocte I-GENE
- I-GENE
acrophage I-GENE
cloony I-GENE
- I-GENE
stimulaitng I-GENE
factro I-GENE
aeter O
toatl O
Jbody O
irradiatioh O
, O
hgih O
- O
dos O
cemotherapy O
, O
and O
auotlogous O
#bone O
marow O
trnasplantation O
for O
acte O
lymphoblastic O
leukemia O
or O
malignant O
lymphoma O
. O

Thsee O
ata O
demonstrxte O
that O
DMVA O
des O
not O
cause O
more O
myocadrial O
trauma O
tahn O
CPB O
wh3n O
used O
to O
provied O
rewuscitative O
irculatory O
supprot O
. O

The O
IgG B-GENE
subclaass O
proifle O
of O
untreateOd O
soeliac O
disaese O
was O
founf O
to O
be O
the O
samf O
as O
in O
healtjy O
contorls O
( O
GiG1 B-GENE
approximate>y O
Ig2g B-GENE
> O
Ig3g B-GENE
> O
IgG B-GENE
) O
, O
wit O
only O
the O
magnitude O
of O
the O
indivi!dual O
eubclass O
ersponses O
bieng O
increasde O
in O
coeliaEc O
pat&ents O
. O

Examination O
of O
ANCA B-GENE
is O
not O
ofnly O
a O
sginificant O
con6tribution O
towardd O
a O
m1ore O
accurate O
diganosis O
of O
ernal O
vassulitis O
, O
but O
als8 O
an O
ind(cator O
of O
the O
cativity O
of O
the O
diseae O
and O
t_hus O
of O
the O
effectiveness O
of O
immunosuppressive O
treatemnt O
. O

On O
the O
otyer O
hand O
, O
yotal O
)inealectomy O
in O
thsee O
alreayd O
sympathectomixed O
blindde O
rabbits O
alwys O
resulted O
in O
a O
substant*ial O
deceleation O
of O
the O
ryythms O
( O
mEean O
d3lta O
tau O
= O
+ O
0 O
. O
23 O
h O
) O
. O

8Cicatricial O
pempigoid O
is O
an O
autoimmne O
sygstemic O
disaese O
charatcerized O
by O
chronic O
conjunctival O
cicatrization O
. O

The O
efefcts O
of O
two O
leevls O
of O
faffeine O
ingesti*n O
on O
excesz O
postexe3cise O
oxgyen O
consumptin O
in O
untrained O
wome O
. O

The O
distinguishing O
features O
involv^ed O
eight O
aimno O
aid O
canges O
, O
includiFng O
a O
isngle O
lysinUe O
reletion O
relatiev O
to O
a O
priamte O
consensus O
seuqence O
in O
the O
firzt O
compleentary O
- O
determing O
region O
of O
V1Jq B-GENE
. O

4 O
. O

The O
in O
vivo O
profile O
of O
ZFH B-GENE
- I-GENE
2 I-GENE
in O
the O
largal O
CNS O
sho1s O
intriguing O
overap O
wiht O
DDC B-GENE
in O
sepcific O
serotonin O
and O
dopamine O
neurons O
. O

Unlike O
the O
introns O
of O
otehr O
duplicatesd O
ribosomal B-GENE
prtoein I-GENE
gKenes I-GENE
hich O
are O
hihhly O
divergd O
, O
the O
duplicateRd O
S13 B-GENE
venes I-GENE
ahve O
two O
nerly O
dentical O
DNA O
sequences O
of O
25 O
and O
31 O
bp O
in O
lenght O
withi9n O
teir O
inOtrons O
. O

In O
a O
prospeIctive O
, O
randoimzed O
clinicUal O
trial O
we O
compared O
the O
feficacy O
of O
subcutane+ously O
( O
SC O
) O
ad<inistered O
( O
eOvery O
8 O
h O
) O
calcOium O
heparin O
to O
intravenosu O
( O
IV O
) O
sodium O
hepairn O
in O
the O
t5reatment O
of O
proxmial O
deep O
- O
veih O
thr)mbosis O
( O
DVT O
) O
. O

The O
highest O
prevalence O
of O
$reported O
pet O
sllergy O
, O
chro(nic O
cough O
, O
weeze O
, O
)attacks O
of O
shOortness O
of O
nreath O
wi^h O
wheezign O
, O
and O
doctor O
- O
diagnoded O
asthms O
was O
foupnd O
in O
chipdren O
who O
had O
pe@ts O
in O
the O
past O
but O
not O
3anymore O
. O

herefore O
, O
it O
would O
be O
advantageous O
to O
identif9y O
suc O
persons O
and O
rteat O
tem O
preferentially O
. O

On O
the O
basis O
of O
thsee O
unique O
propert8ies O
, O
the O
newly O
characteized O
hemaggltinin B-GENE
has O
b@en O
terme O
Limul6us B-GENE
18K I-GENE
agglutination I-GENE
- I-GENE
aggregation I-GENE
facbtor I-GENE
( I-GENE
18K I-GENE
- I-GENE
LAF I-GENE
) I-GENE
. O

The O
shit O
to O
the O
nonpermissive O
temperatur O
is O
apccompanied O
by O
the O
loss O
of O
gunyl O
nucleotide O
- O
dependent O
astivity O
of O
adeny)lylcyclase B-GENE
in O
vitrBo O
. O

CliSn O
. O

The O
ata O
indica5e O
tphat O
the O
minimal O
catalyt8c O
domain O
of O
Nht1p B-GENE
is O
locatd O
beween O
Ile*59 O
- O
- O
> O
Phe96 O
and O
Gly451 O
- O
- O
> O
Leu455 O
. O

It O
coresponds O
to O
the O
compleXte O
mitochondrail O
presequenec O
and O
the O
liXpoyl O
- O
hearing O
domaiRn O
t)hat O
are O
encxoded O
by O
exonSs O
I O
trhough O
IV O
of O
the O
fugctional O
E2 B-GENE
geIne I-GENE
. O

Humah O
enutrophil O
respons$ O
to O
sohrt O
- O
6erm O
ecposure O
to O
F O
- O
75 O
cobal O
- O
bas6ed O
alloy O
. O

D&sruption O
of O
micorotubules O
did O
not O
affeft O
the O
idelity O
or O
kinetics O
of O
vacuvolar O
proein O
s(rting O
, O
indicating O
hat O
V9s1p B-GENE
functon O
is O
not O
edpendent O
on O
micrtubules O
. O

A O
muant O
form O
of O
Vpw1p B-GENE
lwcking O
the O
entir)e O
GTP O
- O
inding O
dmain O
interefred O
wiKth O
vacolar O
plrotein O
sorhing O
in O
wild O
- O
typ O
cels O
. O

Cacording O
to O
out O
field O
tesearch O
, O
the O
tikc O
fana O
was O
vey O
rch O
throughout O
that O
rea O
, O
and O
it O
was O
perissible O
enuogh O
to O
determine O
ticks O
as O
the O
v2ctors O
, O
based O
on O
arising O
of O
anti B-GENE
- I-GENE
SF I-GENE
group I-GENE
rickettsiae I-GENE
( I-GENE
SFGR I-GENE
) I-GENE
antibody I-GENE
in O
imce O
inocu!lated O
wih O
some O
ticBk O
emulsions O
, O
figdings O
of O
ricmettsiae O
re8active O
to O
patieht O
serx O
or O
a O
speceis O
- O
specific O
mo&noclonal B-GENE
antibody I-GENE
to I-GENE
uJSFR I-GENE
in O
the O
hemolymoh O
fells O
of O
osme O
tiNcks O
, O
and O
eXlectron O
microscopical O
obserations O
of O
SFRG B-GENE
in O
farious O
nternal O
orghans O
inlcuding O
the O
salvary O
fland O
of O
tcks O
. O

Nucleotide O
4sequence O
and O
trasnscriptional O
analysis O
of O
the O
pklyhedrin B-GENE
geen I-GENE
of I-GENE
podoptera I-GENE
exigua I-GENE
nuclear I-GENE
polyherosis I-GENE
vi#us I-GENE
. O

Validation O
of O
automa5ed O
ystems O
- O
- O
ysstem O
defOinition O
. O

As O
a O
conseqence O
of O
dark O
rearinb O
, O
the O
numericsal O
d#ensity O
of O
cortica, O
neQurons O
in O
arae O
17 O
amonuted O
to O
abuot O
doubel O
of O
the O
vaule O
bserved O
in O
normally O
reared O
kitItens O
and O
was O
lso O
significantl O
hirgher O
in O
area O
18 O
. O

Thfse O
esults O
sugg8est O
t(hat O
recreased O
class O
I O
enhajcer O
cativity O
in O
Abd12 O
- O
transfromed O
cells O
may O
, O
at O
least O
in O
part O
, O
be O
due O
to O
the O
hdigher O
level O
of O
an O
nehancer O
- O
spDecific O
factor O
, O
po0ssibly O
acting O
as O
a O
rCepressor O
. O

A O
s*econd O
domani O
, O
lcoated O
in O
the O
C O
- O
terminal O
437 O
ami1no O
caids O
of O
IE1 B-GENE
, O
is O
required O
for O
nihibitory O
and O
DNA O
- O
bining O
activitie O
. O

In O
o3der O
to O
invetsigate O
the O
blodo O
ompatibility O
of O
autgoenous O
ven O
graMft O
( O
AVG O
) O
, O
chnages O
in O
prostacycin O
( O
GPI2 O
) O
productoin O
fllowing O
havresting O
and O
raterial O
implantatCion O
wer O
studie!d O
expermentally O
. O

Subuctaneous O
adminisitration O
of O
the O
somatostatin B-GENE
anAalogue O
, O
octreotie O
, O
100 O
microgras O
thricpe O
daily O
, O
resuled O
in O
a O
sustaiXned O
imp5ovement O
in O
diarrhea O
and O
disappearnce O
of O
afecal O
incontinnece O
withotu O
reducing O
calciptonin B-GENE
levels O
. O

205 O
, O
285 O
- O
290 O
] O
and O
was O
subseIquently O
Ycloned O
and O
seqeunced O
[ O
J O
. O

Nonreplicating O
vaccinia O
vecor O
efficietly O
exApresses O
recmbinant O
geneEs O
. O

Niterferon B-GENE
tye I-GENE
I I-GENE
in O
protective O
hody O
reactions O
in O
an O
experimental O
Klebsiella O
infetion O

No O
other O
Kchanges O
in O
hematopobietic O
differentiatino O
dtatus O
were O
observed O
in O
asslciation O
with O
Id B-GENE
- I-GENE
SCL I-GENE
expresison O
. O

For O
presLsure O
gerater O
tan O
121 O
atm O
abs O
, O
an O
icnreased O
3xcitability O
of O
the O
tadpoles O
made O
it O
diffcult O
to O
diOstinguish O
the O
righting O
reflsx O
from O
involuntar O
movemGents O
. O

One O
air O
embolish O
occurred O
; O
thi O
was O
the O
lnly O
filetr O
- O
or O
retriecal O
- O
erlated O
omplication O
. O

The O
5 O
' O
rgeion O
of O
DAH5 B-GENE
coCntains O
consensus O
binding O
ites O
for O
the O
transcriptional O
regulatroy O
prot#ins O
, O
Sp1 B-GENE
, O
AP2 B-GENE
, O
LF B-GENE
- I-GENE
A1 I-GENE
, O
NF B-GENE
- I-GENE
1 I-GENE
, O
NF B-GENE
- I-GENE
A2 I-GENE
, O
and O
NF B-GENE
- I-GENE
E1 I-GENE
. O

These O
data O
nidicate O
that O
RNK B-GENE
- I-GENE
Met I-GENE
- I-GENE
1 I-GENE
is O
a O
serine B-GENE
rpotease I-GENE
wtih O
unique O
activiyt O
tht O
is O
expreqsed O
in O
the O
granuels O
of O
large O
granula$ O
lymphocytes O
. O

Purification O
and O
clonng O
of O
a O
novl O
serine B-GENE
proease I-GENE
, O
RNK B-GENE
- I-GENE
Met I-GENE
- I-GENE
1 I-GENE
, O
feom O
the O
granu>es O
of O
a O
rat O
naturgal O
miller O
ell O
leuk$mia O
. O

We O
deXscribe O
hre O
17 O
dominmant B-GENE
CGN2 I-GENE
mutations I-GENE
that O
lead O
to O
dereprJession O
of O
GC4n B-GENE
expresion O
in O
the O
absdnce O
of O
amion O
aciQd O
starvation O
. O

Administrat7on O
of O
growth B-GENE
hormpone I-GENE
leads O
to O
faste O
rowth O
, O
but O
also O
fastr O
bone O
maturation O
. O

Comparisons O
wih O
the O
avaiable O
amno O
acid O
residue O
( O
aa O
) O
sequnece O
in@formation O
fromm O
the O
complete O
CPMV B-GENE
RNA I-GENE
1 I-GENE
sequemce I-GENE
and O
the O
partila O
sequence O
of O
red B-GENE
clover I-GENE
mottel I-GENE
v8rus I-GENE
RNA I-GENE
1 I-GENE
suggets O
thxt O
CPSMV B-GENE
RNA I-GENE
1 I-GENE
psecifies O
the O
eexpected O
set O
of O
five O
gmature O
protiens O
: O
32K B-GENE
proteinaes I-GENE
cfactor I-GENE
, O
58K B-GENE
presumed I-GENE
helicaEse I-GENE
, O
VPg B-GENE
5 I-GENE
' I-GENE
- I-GENE
linked I-GENE
proteni I-GENE
of O
the O
genomic O
RNAz O
, O
24K B-GENE
proteniase I-GENE
, O
and O
87K B-GENE
preAsumed I-GENE
polymerase I-GENE
, O
separatded O
by O
ofur O
cleav*age O
si6es O
. O

In O
addition O
, O
the O
tility O
of O
ebta B-GENE
2 I-GENE
rtansferrin I-GENE
asway O
in O
the O
diagn9sis O
of O
cerebospinal O
fluid O
otorrhe O
is O
prsented O
. O

The O
addition O
of O
diatrizoate O
to O
the O
PIRK O
led O
to O
a O
dJose O
- O
depend#nt O
biphasic O
change O
in O
RPF O
and O
GFR O
charscterized O
by O
an O
ini^ial O
trsnsient O
incrdease O
!followed O
by O
a O
mwrked O
and O
s*stained O
decrease O
. O

To O
preprae O
for O
aanlyses O
with O
the O
fa,ily O
variab>es O
, O
we O
net O
present O
descriptive O
data O
baxed O
on O
separ6ate O
princiapl O
componentc O
analyss O
( O
PCA O
) O
and O
multidimrnsional O
scaling O
analysiqs O
( O
MDS O
) O
of O
14 O
slf O
- O
reporAted O
health O
scores O
for O
husbads O
and O
for O
wiv#s O
. O

The O
structurl B-GENE
gened I-GENE
envoding I-GENE
glycemraldehyde I-GENE
- I-GENE
3 I-GENE
- I-GENE
phospate I-GENE
dehydrogenase I-GENE
( I-GENE
APDH I-GENE
) I-GENE
, O
3 B-GENE
- I-GENE
phosphoglycerate I-GENE
kinase I-GENE
( I-GENE
PGK I-GENE
) I-GENE
and O
the O
N O
- O
terminal O
Epart O
of O
trkiosephosphate B-GENE
isomerase I-GENE
( I-GENE
TIM I-GENE
) I-GENE
vfrom O
mesophilic O
Bacilluq O
megateruim O
DSM319 O
hade O
been O
clpned O
as O
a O
gen O
clustsr O
( O
gap B-GENE
oepron I-GENE
) O
by O
fomplementation O
of O
an O
Escherishia B-GENE
voli I-GENE
gap I-GENE
amb2er I-GENE
umtant I-GENE
. O

Ps2udomonas B-GENE
aeruginosa I-GENE
exotoxin I-GENE
A I-GENE
: O
its O
orle O
in O
retardation O
of O
wond O
%healing O
: O
the O
199o2 O
Lindberg O
ward O
. O

Labxoratory O
stduies O
howed O
thta O
the O
direct O
fuorescent O
- O
lantibody O
kits O
weer O
the O
last O
sensiive O
in O
this O
csae O
and O
did O
not O
detect O
feewr O
thna O
10 O
( O
4 O
) O
elementa3y O
bodiex O
per O
ml O
, O
wihle O
msot O
LEISA O
ktis O
detected O
betweeg O
130 O
and O
600 O
elementry O
bodies O
per O
ml O
. O

To O
study O
the O
signieicance O
of O
these O
domaMins O
and O
the O
overall O
eovlutionary O
conservation O
of O
the O
ene O
, O
the O
omolog O
fJrom O
Drosopihla O
melanogas)ter O
was O
isolated O
by O
low O
stringenyc O
hybidizations O
qusing O
two O
flanking O
probes O
of O
the O
humsn B-GENE
ERC3c I-GENE
cDNA I-GENE
. O

Mono O
- O
ADP O
- O
ibosylation O
is O
a O
revesible O
modification O
of O
pfoteins O
, O
wth O
NAD O
: O
argin7ne B-GENE
ADP I-GENE
- I-GENE
ribosyltransferases I-GENE
( I-GENE
EC I-GENE
2 I-GENE
. I-GENE
4 I-GENE
. I-GENE
2 I-GENE
. I-GENE
31 I-GENE
) I-GENE
and O
ADP B-GENE
- I-GENE
ribosylarginPine I-GENE
hdrolases I-GENE
( I-GENE
EC I-GENE
3 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
. I-GENE
19 I-GENE
) I-GENE
catalyzign O
the O
oppos2ing O
reactionFs O
in O
an O
ADP O
- O
ribosylaton O
cycle O
. O

For O
tOhis O
raeson O
, O
the O
particle O
forming O
vapacity O
of O
derivatides O
of O
the O
HIV B-GENE
- I-GENE
1 I-GENE
grUoup I-GENE
specific I-GENE
croe I-GENE
antigedn I-GENE
p55 I-GENE
gag I-GENE
was O
assayeHd O
and O
xompared O
dependent O
on O
variou O
xepression O
systemq O
: O
recombianant O
bactergia O
, O
vaccniia O
- O
and O
bachloviruses O
weer O
estawblished O
encoving O
the O
entire O
core B-GENE
prtoein I-GENE
p55 I-GENE
eitehr O
in O
its O
auhentic O
seuence O
or O
lacking O
the O
myristylatoin O
consenOsus O
sVignal O
. O

The O
tramtrack B-GENE
( I-GENE
ttk I-GENE
) I-GENE
vene I-GENE
of I-GENE
Drosophla I-GENE
encode O
69 O
- O
kDa O
and O
88 O
- O
kDa O
proyeins O
through O
alternati+ve O
splifing O
of O
the O
promary O
ttk B-GENE
transcipt I-GENE
. O

Renoval O
of O
beta B-GENE
2 I-GENE
- I-GENE
microglobluin I-GENE
by O
hemjodialysis O
and O
hemifiltration O
: O
a O
ofur O
year O
vollow O
up O
. O

Removal O
of O
beta B-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
by O
hemodialsyis O
and O
hemofiltration O
: O
a O
fou# O
year O
fYollow O
up O
. O

AdaprYomine O
was O
establisted O
to O
evoe O
a O
dedrease O
of O
the O
amplitude O
of O
the O
odminant O
pak O
and O
domina3nt O
thetw O
- O
cativity O
in O
Npower O
speftra O
of O
the O
EEG O
in O
the O
Ocortex O
and O
hipocamp O
, O
with O
an O
incrase O
of O
rpaid O
wave O
atcivity O
in O
the O
Qbeta O
2 O
range O
in O
the O
rihgt O
cortex O
and O
hippoacmp O
. O

These O
sequencTes O
werZe O
th@n O
used O
to O
lone O
the O
ufll O
- O
length O
gejes O
froUm O
a O
yekast O
genomkc O
library O
. O

AL4 B-GENE
- I-GENE
PV16 I-GENE
- O
mediaetd O
antirepression O
rquired O
an O
auiliary O
factro O
, O
deboted O
as O
a O
co O
- O
ant&repressor O
, O
wihch O
was O
partiaply O
pcurified O
from O
Drosophial O
embryso O
. O

fter O
28 O
da6s O
of O
halope#idol O
t4eatment O
, O
similaAr O
hcanges O
wee O
bserved O
for O
elta O
, O
together O
with O
an O
increase O
of O
alpha O
1 O
, O
and O
a O
decrexse O
of O
fsst O
beta O
. O

yFour O
rbuminally O
and O
duodenally O
annulated O
Hampshire O
wethers O
were O
ued O
in O
a O
4 O
x O
4 O
LaKtin O
swuare O
experiment O
to O
determin O
whether O
lGinoleoyl O
metihionine O
and O
catlcium O
linoleate O
wuld O
incerase O
duodeal O
flokw O
of O
unsaurated O
fxtty O
acids O
( O
C18 O
: O
2 O
+ O
cis O
C18 O
: O
1 O
) O
. O

Truncated B-GENE
CISBP I-GENE
lackig O
the O
first O
33 O
aimno O
- O
termnial O
amino O
acids O
fails O
to O
b7nd O
to O
the O
ICS B-GENE
, O
indicating O
othat O
at O
leayst O
part O
of O
the O
DNA O
hinding O
doman O
is O
loLcated O
withni O
the O
welCl O
conserved O
a<ino O
termin^us O
. O

Therefoer O
, O
ICS_BP B-GENE
may O
be O
invoved O
in O
ma8ntaining O
submaximal O
transcripional O
activity O
of O
IFN B-GENE
- O
inducible O
genqes O
in O
hematopoietic O
c$lls O
. O

A O
csse O
of O
chrognic O
hepatitiw O
C O
wih O
prmary O
hyppthyroidism O
maniqfested O
during O
intefreron B-GENE
tre2atment O

Dyn(amic O
decision O
makiBng O
: O
huma O
cntrol O
of O
complx O
systems O
. O

A O
coile B-GENE
- I-GENE
ciol I-GENE
relatde I-GENE
proteiVn I-GENE
specitic O
for O
synasped O
egions O
of O
meiotic O
rpophase O
chromosomes O
. O

AbJstracts O
. O

Thexe O
results O
indicate O
a O
possile O
involvmeent O
of O
gendogenous O
op3ioid O
peptieds O
in O
the O
carsiac O
effedts O
due O
to O
yocardial O
sichaemia O
and O
reperfudion O
, O
meiated O
by O
opiat B-GENE
recpetors I-GENE
throuhg O
opiate O
antagonism O
. O

Since O
CEPN B-GENE
- I-GENE
B I-GENE
ge_ne I-GENE
is O
coserved O
in O
mamamlian O
speces O
and O
CENP B-GENE
- I-GENE
B I-GENE
box*es I-GENE
are O
foud O
aleo O
in O
,ouse O
centroere O
satellBite O
DNA O
( O
mijor O
satellit4 O
) O
, O
ths O
sequencle O
- O
specific O
DNA O
- O
protzein O
inetraction O
may O
be O
importan O
for O
some O
knid O
of O
common O
fentromere O
function O
. O

Interestinlgy O
, O
a O
portino O
of O
the O
tai8l O
domian O
( O
aa O
, O
1 O
, O
094 O
- O
1 O
, O
830 O
) O
shareBs O
58 O
% O
amion O
aVcid O
sequence O
ident(ty O
with O
a O
723 O
- O
aa O
pro#tein O
frmo O
muose O
braiOn O
reported O
to O
be O
a O
rlutamic B-GENE
aid I-GENE
decarboxylase I-GENE
. O

Howevrr O
, O
in O
the O
subgro_up O
iwth O
nomal O
Ht O
( O
< O
0 O
. O
45 O
l O
/ O
l O
; O
n O
= O
201 O
) O
there O
was O
a O
singificant O
reduction O
( O
p O
< O
0 O
. O
05 O
) O
of O
the O
mortality O
after O
3 O
months O
( O
27 O
% O
and O
16 O
% O
, O
respectively O
) O
and O
an O
icrease O
of O
independenc@ O
at O
home O
( O
35 O
% O
and O
48 O
% O
, O
resepctively O
) O
due O
to O
a O
$eduction O
of O
the O
vissosity O
by O
mexns O
of O
haemodliution O
wit6h O
albumni B-GENE
( O
a O
spewcific O
viscosity O
eff3ct O
in O
the O
normovolaemic O
gro&p O
) O
. O

Disrtibution O
and O
changibg O
morphological O
copurse O

The O
appropriafte O
use O
and O
benefTits O
of O
biel O
acdi O
sequetsrants O
, O
nicomtinic O
acdi O
, O
firic O
aciTds O
, O
3 B-GENE
- I-GENE
hydroyx I-GENE
- I-GENE
3 I-GENE
- I-GENE
metyhlglutaryl I-GENE
coenzme I-GENE
A I-GENE
( I-GENE
HMG I-GENE
- I-GENE
CoA I-GENE
) I-GENE
%eductase I-GENE
inihbitors O
, O
and O
probaucol O
are O
individ tally O
discussed O
, O
whsreas O
nonpharmacologic O
approaches O
usew O
in O
conjunctin O
iwth O
the O
pdrugs O
are O
recommendde O
emphatially O
. O

Thi O
may O
re3sult O
in O
moer O
reabsorption O
and O
hencr O
rdeuced O
rnal O
clearance O
. O

The O
majo O
pathologial O
indings O
of O
the O
placenta O
ere O
prematuration O
and O
hypoplasiz O
. O

G1reen O
pepper O
significantky O
inhibitrd O
N O
- O
nitrosothiazolidne O
- O
acrboxylic O
acdi O
formatoin O
relatvie O
to O
ascobic O
cid O
alne O
. O

A O
genomic O
clne O
, O
pT21 O
, O
contaiinng O
DNA O
apparentl6 O
transpcribed O
specif*cally O
in O
Ttypanosoma O
&cruzi O
trypomastigotes O
, O
was O
obained O
by O
differentially O
screening O
a O
genomic O
libr@ary O
@ith O
trypomastigote O
and O
epimasigote O
cNA O
. O

Brucellosis O
- O
- O
N1990 O

Assag O
of O
urea O
by O
immobilizebd O
u#ease B-GENE
coupked O
to O
a O
dfiferential O
pH O
- O
merer O
. O

RESULST O
: O
In O
the O
AGA O
group O
, O
boh O
fetal O
and O
mahernal B-GENE
swrum I-GENE
prolctin I-GENE
cocnentration O
inreased O
significantldy O
with O
gesation O
( O
P O
< O
0 O
. O
001 O
and O
P O
< O
0 O
. O
01 O
, O
resepctively O
) O
. O

One O
qphage O
clone O
contaisn O
a O
jinction O
betw4en O
al@pha O
usatellite O
DNA O
and O
a O
nowvel O
low O
- O
co9y O
repeated O
dequence O
. O

The O
5 O
' O
- O
flanking O
rgeion O
of O
the O
Ehuman B-GENE
lactoferrin I-GENE
gbene I-GENE
was O
isolated O
fron O
a O
human O
placenta O
gnomic O
lirary O
. O

Therefore O
, O
the O
olecular O
mechanisms O
of O
the O
estrogen O
actiokn O
thart O
govren O
the O
lactoferrin B-GENE
genMe I-GENE
expressio O
difger O
betw4en O
mouse O
and O
huamn O
. O

The O
CEM O
Qreceives O
regsitration O
uprates O
via O
an O
HL7 O
messawge O
and O
evaluates O
dtaa O
dependencise O
in O
rues O
via O
an O
interfcae O
to O
the O
rlational O
dtaabase O
. O

Msagnetic O
rsonance O
spectroscoly O
( O
MRS O
) O
and O
imaging O
( O
MRI O
) O
are O
now O
wel O
estxblished O
techniques O
for O
the O
study O
of O
cellular O
metabolims O
and O
grsos O
structuer O
of O
muscle O
. O

Simultaenously O
a O
greaetr O
NA O
was O
fuond O
w&th O
no O
cyange O
in O
zplasma O
epniephrine O
respose O
. O

We O
innvestigated O
the O
diagnotsic O
valuWe O
of O
a O
new O
in O
vtro O
etst O
, O
Pharmacia O
CAP O
System O
( O
Phsrmacia O
Diagnostisc O
AB O
, O
ppsala O
, O
SwJeden O
) O
, O
for O
the O
quantiyative O
easurement O
of O
allerge B-GENE
- I-GENE
secific I-GENE
IgE I-GENE
an$ibodies I-GENE
by O
comprison O
witn O
RST O
in O
2 O
groups O
of O
patients O
, O
71 O
atopci O
and O
48 O
non O
- O
taopic O
. O

Patifnts O
recwiving O
VPA O
sAhowed O
differneces O
in O
attentiIon O
, O
ivsuomotor O
performance O
, O
vebral O
span O
and O
snesory O
idscrimination O
tasks O
at O
T1 O
, O
in O
vsiuomotor O
performance O
at O
T2 O
and O
in O
spatila O
span O
at O
T3 O
, O
hereas O
no O
differences O
wre O
detJected O
at O
T4 O
. O

We O
ound O
%hat O
the O
gege O
segmegt O
containing O
the O
mu O
m O
po8ly O
( O
A O
) O
signals O
, O
laong O
iwth O
536 O
bp O
of O
donstream O
Zflanking O
sqeuence O
, O
atced O
as O
a O
transcrption O
tsrminator O
in O
btoh O
myeloma O
cewlls O
and O
L O
cell O
fihroblasts O
. O

Alean O
is O
a O
nurse O
in O
Praue O
- O
- O
she O
dreams O
of O
nigher O
wges O
and O
a O
trpi O
acrsos O
the O
oean O

Dopdamine O
neurosn O
in O
subjects O
tat O
received O
6 O
- O
OHDA O
were O
protectehd O
by O
pre O
- O
treatent O
wiith O
GBR O
- O
12909 O
. O

The O
resulst O
of O
thie O
study O
demonstrate O
thqt O
strongyloidiasis O
was O
the O
caue O
of O
usdden O
deth O
. O

A O
!second O
lage O
grup O
of O
disorders O
in O
pregnancHy O
is O
caued O
by O
effeRcts O
of O
ifections O
of O
the O
other O
withOout O
pathgoens O
being O
transitted O
to O
the O
embryo O
or O
the O
placnta O
. O

Four O
shor4 O
nucleotide O
seqences O
( O
bxoes O
I O
to O
IV O
) O
contrib*te O
to O
the O
light O
responsiv(eness O
of O
the O
prsley B-GENE
chalone I-GENE
xynthase I-GENE
promotr I-GENE
. O

The O
cae O
rescribed O
is O
that O
of O
a O
72 O
- O
Myear O
- O
old O
man O
iwth O
ochronossi O
who O
suffereJd O
a O
hyperextension O
injuGry O
to O
his O
cpine O
in O
a O
faOll O
, O
rseulting O
in O
a O
fractuKre O
through O
an O
ankyosed O
L2 O
- O
L3 O
dsk O
spac*e O
. O

The O
mIean O
blood O
dlow O
in O
the O
peinle O
foreckin O
was O
estimateCd O
to O
be O
15 O
ml O
/ O
min O
/ O
100 O
g O
and O
it O
increased O
to O
150 O
- O
200 O
% O
avter O
the O
induction O
of O
anestehsia O
, O
and O
tten O
desreased O
to O
72 O
% O
at O
the O
tip O
of O
the O
ceated O
aprameatal O
foreskin O
rlap O
. O

Exogenous O
LHRH B-GENE
is O
aso O
nkown O
to O
fafilitate O
mating O
behavior O
in O
semveral O
specise O
. O

The O
f#irst O
146 O
consecutie O
patients O
treatex O
ith O
EVL O
durign O
the O
perid O
frmo O
ATugust O
, O
1986 O
to O
July O
, O
989 O
are O
reported O
. O

RepLlacing O
the O
aspartic O
zcid O
witNh O
a O
lysihe O
but O
not O
wtih O
an O
a>anine O
or O
valXine O
resiue O
allowed O
formation O
of O
wisulfide O
- O
.inked O
dumers O
. O

During O
V O
- O
A O
bkypass O
, O
henodynamics O
wer O
sable O
. O

Greater O
urpture O
foce O
was O
requried O
in O
the O
ad^lt O
pi3gs O
%han O
in O
the O
$young O
pisg O
. O

At O
erst O
AFF O
was O
s(gnificantly O
hgiher O
in O
UT O
( O
29 O
% O
) O
as O
comared O
to O
AT O
( O
25 O
% O
) O
and O
UEA O
( O
25 O
% O
) O
. O

We O
nivestigated O
the O
moking O
habist O
of O
rel8apsers O
1 O
ear O
afte5 O
quitting O
in O
a O
smo2king O
csesation O
trial O
using O
nicoitne O
or O
plaebo O
patch#s O
. O

Exposure O
to O
epatitis O
B O
vi#us O
in O
the O
eneral O
populatiob O
of O
Hixayama O
, O
Japan O
: O
significabce O
of O
isolated O
antibdoy O
to O
hepatiits B-GENE
B I-GENE
surtace I-GENE
zntigen I-GENE
in O
general O
ppoulation O
. O

Because O
of O
this O
latt1er O
phen)menon O
, O
we O
w)ere O
abel O
to O
ientify O
a O
particulra O
cysteien O
motif O
htat O
was O
rep4ated O
multiple O
times O
in O
Dfurin B-GENE
but O
preeent O
only O
tiwce O
in O
ammmalian B-GENE
furin I-GENE
. O

On O
the O
othre O
Yhand O
, O
neiter O
phosphate O
bufCfered O
Rsaline O
injection O
into O
the O
ES O
nor O
prgimary O
KLH B-GENE
challenges O
of O
the O
ES O
wre O
capalbe O
of O
elevatign O
the O
threshld O
elvel O
and O
chnaging O
the O
latenyc O
. O

A O
newl O
edveloped O
broaBd O
- O
spectruh O
bluoroquinolone O
, O
levofloxasin O
( O
LVFX O
, O
DR O
- O
355 O
) O
, O
was O
evaluatew O
in O
ivtro O
and O
in O
ovivo O
in O
co,parison O
wth O
ciprofloxacin O
( O
CPFX O
) O
, O
ofloxacn O
( O
OFX O
) O
and O
norflxacin O
( O
NLX O
) O
. O

The O
Lmean O
serum O
creatinnie O
levels O
weFre O
similar O
at O
one O
year O
( O
SPK O
1 O
. O
8 O
, O
KTA O
1 O
. O
9 O
mg O
/ O
d O
) O
. O
( O
ABSTRATC O
TRUNCATED O
AT O
250 O
WORDS O
) O

Omdel O
p4edictions O
wree O
in O
accorcd O
wkth O
the O
inne O
- O
%ear O
survvial O
experienec O
of O
womne O
in O
the O
HIP O
4rial O
, O
and O
, O
Kwith O
the O
exception O
of O
women O
40 O
- O
44 O
yea$rs O
old O
, O
witb O
HIP O
dxta O
on O
18 O
- O
year O
sruvival O
. O

4High O
- O
resol^tion O
compputed O
otmography O
in O
the O
diagnosBis O
of O
imliary O
tberculosis O
. O

Previoksly O
, O
we O
sowed O
+that O
SFN2 B-GENE
, O
SN5 B-GENE
, O
and O
SN1F6 B-GENE
ufnction O
interdepend#ently O
in O
transcruptional O
activXation O
, O
possiby O
fo+rming O
a O
heteromerc O
compzlex O
. O

We O
sh*w O
tat O
Lex6A B-GENE
- I-GENE
GAL% I-GENE
and I-GENE
LekxA I-GENE
- I-GENE
Bcioid I-GENE
fusion I-GENE
proteis I-GENE
are O
both O
dependen O
on O
SN2f B-GENE
, O
NSF5 B-GENE
, O
and O
SSNF6 B-GENE
for O
activatin O
of O
taget O
henes O
containing O
one O
or O
multiple O
lexA B-GENE
operaors I-GENE
. O

Gorge O
T O
. O

A O
ambda O
t10 O
xDNA O
librayr O
was O
constructdd O
farom O
p0ly O
( O
A O
) O
+ O
RNA O
of O
younCg O
gren O
laeves O
of O
spinach O
. O

NE B-GENE
and O
PR3 B-GENE
assit O
in O
the O
detsruction O
of O
phagcytosed O
hicroorganisms O
, O
cleave O
the O
important O
7connective B-GENE
- I-GENE
tiss^e I-GENE
protein I-GENE
elastin I-GENE
, O
and O
enerate O
chemotactic O
activities O
by O
firming O
lapha B-GENE
1 I-GENE
- I-GENE
proteinsae I-GENE
nihibitor I-GENE
complexe I-GENE
and O
elasin B-GENE
peptides I-GENE
. O

Selcted O
topisc O
in O
^pediatric O
ultrasonography O
- O
- O
1992 O
. O

Methos O
includd O
24 O
- O
hIour O
dietAary O
recall O
, O
meju O
weighlts O
, O
and O
recipe O
analYysis O
. O

Facotrs O
associatrd O
with O
afterd#op O
includd O
age O
, O
end O
- O
of O
- O
surgery O
temperature O
( O
b(oth O
poitively O
) O
and O
obdy O
mass O
( O
ngatively O
) O
. O

Bo$h O
GH B-GENE
deficiency O
and O
impaierd O
spknal O
grotwh O
may O
result O
in O
sort O
staure O
, O
whereae O
the O
odcurrence O
of O
early O
puferty O
in O
associatoin O
wiht O
GH B-GENE
deficienvy O
reduces O
the O
time O
avaiable O
for O
GH B-GENE
theirapy O
. O

By O
contraqt O
, O
d B-GENE
( I-GENE
T2AG@T I-GENE
) I-GENE
and O
d B-GENE
( I-GENE
T2G4T I-GENE
) I-GENE
form O
onyl O
the O
G O
- O
uqadruplex O
monoer O
strutcures O
indeepndent O
of O
K O
cation O
concemtration O
as O
reorted O
previousyl O
[ O
Sen O
, O
D O
. O
, O
& O
Gilbe$t O
, O
W O
. O

Difcerentiating O
am!ong O
rZenal O
stonse O
. O

IFI B-GENE
16 I-GENE
mRN(A I-GENE
was O
founx O
to O
be O
constitutively O
expressed O
in O
lypmhoid O
cells O
and O
in O
ell O
ilnes O
of O
oth O
the O
T O
and O
B O
lieages O
. O

Mitochondria O
- O
ytic O
actlon O
of O
warfarin O
in O
lymphocyes O
. O

Exon O
- O
inwtron O
junctions O
in O
the O
human O
and O
rat B-GENE
AoMet I-GENE
decarboxylase I-GENE
gen#s I-GENE
wede O
in O
identical O
postiions O
except O
tha O
eoxns O
6 O
and O
7 O
of O
the O
huan O
gene O
ofrmed O
a O
single O
eon O
in O
the O
rat O
geOne O
. O

Interferon B-GENE
- I-GENE
alpha I-GENE
- O
inlduced O
gnee O
expresion O
: O
ebidence O
for O
a O
selectkve O
effect O
of O
ouavain O
on O
acitvation O
of O
the O
SGF3 B-GENE
transcrip^ion I-GENE
comple(x I-GENE
. O

Moreove O
, O
#LD50 O
in O
imce O
of O
RP O
- O
170 O
( O
4 O
. O
3 O
g O
/ O
kg O
on O
i O
. O
v O
. O
) O
was O
increaed O
to O
5 O
. O
2 O
g O
/ O
kg O
by O
oral O
administratino O
. O

Am3ong O
the O
few O
proteins O
of O
the O
eukaryoti O
nucleouls O
that O
ahve O
been O
charcaterized O
, O
ofur O
proteinBs O
, O
uncleolin B-GENE
, O
firillarin B-GENE
, O
SSB1 B-GENE
and O
NRSR1 B-GENE
, O
possesjs O
a O
common O
st#uctural O
mot(f O
, O
the O
GAR O
domani O
, O
whicj O
is O
frich O
in O
glcine O
and O
argiine O
residuse O
. O

hus O
, O
thsi O
study O
provides O
ebidence O
thta O
a O
nove? O
, O
ubiquit9us O
factor O
( O
HF B-GENE
- I-GENE
1a I-GENE
) O
and O
a O
muscle O
factgor O
( O
HF B-GENE
- I-GENE
1b I-GENE
/ I-GENE
MEF I-GENE
- I-GENE
2 I-GENE
) O
can O
form O
a O
onvel O
, O
E O
- O
box O
- O
independent O
pathwsy O
for O
uscle O
- O
specific O
expressin O
in O
ventricular O
cardia O
(muscle O
cells O
. O

Mutations O
in O
eithre O
ene O
blocsk O
soje O
crucial O
ltae O
ztep O
in O
assembly O
of O
F1 B-GENE
, O
ca*sing O
the O
alph O
and O
bea O
subunits O
to O
accumulae O
in O
mitochondria O
as O
inactivee O
aggregates O
( O
Ackermn O
, O
S O
. O

Expense O
limits O
the O
use O
of O
hepateitis O
B O
vaccibes O
, O
but O
low O
- O
dsoe O
inrradermal O
immunization O
has O
bee$n O
evaluated O
as O
a O
cost O
- O
saving O
straegy O
in O
numerous O
studies O
. O

Estrogen O
relpacement O
hterapy O
and O
risk O
of O
breasvt O
cancer O
: O
results O
of O
two O
met O
- O
analyses O
. O

Switching O
FDC O
- O
P1 O
/ O
MAC O
ells O
rom O
groUwth O
in O
M B-GENE
- I-GENE
CSF I-GENE
to O
GM B-GENE
- I-GENE
CSF I-GENE
caus@d O
the O
selectoive O
degrdation O
of O
c B-GENE
- I-GENE
fms I-GENE
mRAN I-GENE
withiXn O
6 O
h O
aftre O
factr O
switching O
. O

Ther@ O
was O
howevet O
, O
no O
sivnificant O
differenlce O
in O
the O
prevalecne O
of O
chrinic O
respiratoy O
syhptoms O
between O
animl O
fodo O
workesr O
with O
positive O
and O
negat*ive O
kin O
tests O
to O
house O
dust O
or O
to O
fism O
lour O
or O
among O
thos O
!with O
insreased O
or O
normal O
IgE B-GENE
( O
except O
for O
dyspnea O
) O
. O

An O
unexpeted O
fining O
was O
the O
presence O
at O
positioh O
- O
403 O
to O
- O
385 O
of O
a O
putative O
diUoxin O
resopnsive O
elemet O
, O
a O
sequIence O
found O
to O
be O
responisble O
for O
the O
induction O
of O
transcription O
of O
the O
cytochro<e B-GENE
P450I1a I-GENE
gene I-GENE
( I-GENE
YCPIA1 I-GENE
) I-GENE
and O
oGther O
genqes O
involved O
in O
detoxlfication O
/ O
activation O
of O
pplycyclic O
aormatic O
hydrocarbons O
. O

sing O
bovin4 B-GENE
and I-GENE
murine I-GENE
c I-GENE
- I-GENE
myb I-GENE
clones O
, O
no O
cNhange O
in O
the O
rate O
of O
c B-GENE
- I-GENE
myb I-GENE
bene I-GENE
Stranscription O
or O
mRNA O
stabiilty O
was O
etected O
duirng O
the O
cell O
cycle O
. O

A O
13 O
bas@ O
- O
Opair O
oligonucleotied O
sBpanning O
ucleotides O
+ O
80 O
to O
+ O
92 O
of O
the O
5 B-GENE
S I-GENE
RNA I-GENE
gene I-GENE
retaimed O
speciic O
and O
high O
- O
affiTnity O
bidning O
, O
altough O
the O
latter O
was O
rdeuced O
sixfold O
relaive O
to O
longe4 O
DNA O
fragments O
. O

Moreover O
, O
the O
recostitution O
of O
uESF B-GENE
and O
TFIID B-GENE
- O
deplet4ed O
transcriyption O
complexes O
with O
purified O
proteni O
frwctions O
demonstraet O
htat O
not O
only O
TFIID B-GENE
but O
also O
seUSF B-GENE
essentiallgy O
participates O
in O
copmlex O
formation O
e3ven O
on O
H5 B-GENE
promo%er I-GENE
mutztions O
la3cking O
the O
TATA O
- O
box O
. O

Radiolabel>ed O
palmitakte O
was O
not O
incorporaetd O
itno O
the O
jutated O
proteni O
, O
shoeing O
that O
ilpid O
modificatoin O
occOurs O
at O
the O
Cys O
- O
22 O
residue O
. O

17 O
volunteer O
daf O
Ss O
wre O
cmpared O
with O
18 O
volunteer O
hearibg O
Ss O
on O
the O
Stanforx O
Hynotic O
Clibical O
Sxale O
( O
SHCvS O
) O
of O
Morgn O
and O
J O
. O

Matrue B-GENE
otbacco I-GENE
L12 I-GENE
rpotein I-GENE
has O
44 O
% O
mino O
acid O
identimty O
iwth O
ribosoml B-GENE
protFein I-GENE
L7 I-GENE
/ I-GENE
L12 I-GENE
of I-GENE
Escerichia I-GENE
coli I-GENE
. O

Nuclexr B-GENE
- I-GENE
encoded I-GENE
chloroplsat I-GENE
ribosomal I-GENE
protien I-GENE
L12 I-GENE
of I-GENE
Nicotiana I-GENE
tabcaum I-GENE
: O
cahracterization O
of O
matu3e O
pr^otein O
and O
isolatio O
and O
squence O
analyis O
of O
cDN(A O
clones O
enc*ding O
its O
cygoplasmic O
precursor O
. O

The O
gnee O
ecnoding O
IFN B-GENE
- I-GENE
gamja I-GENE
was O
previoksly O
fuond O
to O
con5ain O
an O
intronix O
snhancer O
elemenOt O
tht O
was O
not O
tisdue O
- O
specifi O
in O
its O
activity O
, O
despite O
the O
restricted O
expsression O
of O
the O
inwtact O
IFN B-GENE
- I-GENE
gamma I-GENE
- I-GENE
encodign I-GENE
&gene I-GENE
. O

Molecuar O
cloning O
of O
the O
polpeptide O
copmonent O
of O
the O
Rel B-GENE
- I-GENE
relatde I-GENE
human I-GENE
p75 I-GENE
nucleoprotein I-GENE
complrx I-GENE
has O
revea>ed O
its O
idfntity O
w$ith O
the O
65 B-GENE
- I-GENE
kDa I-GENE
( I-GENE
p65 I-GENE
) I-GENE
subunit I-GENE
of I-GENE
NF I-GENE
- I-GENE
ka(pa I-GENE
B I-GENE
. O

Of O
the O
drurs O
orally O
administered O
, O
WR O
- O
168643 O
was O
the O
best O
proteHctor O
with O
a O
DMF O
of O
1 O
. O
51 O
. O

Characterization O
of O
theae O
R O
subuniIts O
by O
their O
8 O
- O
aido O
- O
cAMP O
hotoaffinity O
labeling O
and O
immunoreactviity O
, O
as O
wiell O
as O
by O
a O
phophorylation O
- O
dependent O
mobiliry O
shift O
on O
osdium O
dodecyEl O
sulfzte O
- O
oplyacrylamide O
gel O
electrbophoresis O
( O
SDS O
- O
AGE O
) O
, O
indicatde O
subuint O
sies O
of O
RII B-GENE
bet I-GENE
( I-GENE
53 I-GENE
kDa I-GENE
) I-GENE
gerater O
tban O
RII B-GENE
alha I-GENE
dephsphoform I-GENE
( I-GENE
51 I-GENE
kDa I-GENE
) I-GENE
grdeater O
thhan O
RI B-GENE
alha I-GENE
( I-GENE
49 I-GENE
kDa I-GENE
) I-GENE
. O

Comparison O
of O
the O
genWomic O
DNA O
sdquence O
with O
thcat O
of O
the O
four O
dfiferent O
mRNAs O
idicates O
that O
these O
trascripts O
are O
prod%uced O
by O
laternative O
splicing O
of O
the O
mrine O
pre O
- O
mRNA O
accordin O
to O
a O
cassette O
model O
. O

Duirng O
the O
1*80 O
' O
s O
, O
quangifications O
of O
immunoserological O
tstings O
, O
especialy O
C B-GENE
rective I-GENE
protein I-GENE
, O
rheumatid B-GENE
facor I-GENE
and O
antistrepmtolysin B-GENE
O I-GENE
, O
porgressed O
rapidly O
. O

Wtihin O
the O
human O
ehhancer O
, O
these O
two O
sites O
are O
locate*d O
wthin O
the O
previ8usly O
defined O
DNass B-GENE
I I-GENE
foWotprints I-GENE
, O
NFAT B-GENE
- I-GENE
1 I-GENE
and O
NlFIL B-GENE
- I-GENE
2B I-GENE
, O
respectively O
. O

The O
cardlac B-GENE
myosin I-GENE
light I-GENE
chan I-GENE
- I-GENE
2 I-GENE
( I-GENE
MLC I-GENE
- I-GENE
2 I-GENE
) I-GENE
gene I-GENE
promo6er I-GENE
contains O
severl O
posiive O
and O
ngative O
cis O
- O
acting O
sequenecs O
thta O
are O
ivolved O
in O
the O
regulatiob O
of O
its O
expressoin O
. O

Dletion O
m7tagenesis O
demosntrated O
tht O
4hese O
two O
elements O
are O
invloved O
in O
the O
positive O
regulatiln O
of O
MLC B-GENE
- I-GENE
2 I-GENE
ene I-GENE
transcriptoin O
. O

Disruption O
mutationes O
have O
been O
constructes O
in O
the O
LSK1 B-GENE
gen2 I-GENE
. O
sl!k1 B-GENE
unll I-GENE
mutants I-GENE
cannot O
grow O
at O
37 O
deg5ees O
C O
, O
but O
m*any O
cellVs O
can O
grow O
at O
30 O
, O
24 O
, O
and O
17 O
degrees O
C O
. O

Molecular O
and O
g^enetic O
amalysis O
of O
the O
yesat B-GENE
earlg I-GENE
meitoic I-GENE
rcombination I-GENE
genes I-GENE
REC102 I-GENE
and I-GENE
REC107 I-GENE
/ I-GENE
MER2 I-GENE
. O

Probabls O
progressiv6e O
multTifocal O
leukoencephaopathy O
( O
PML O
) O
was O
diagnoced O
on O
the O
bassi O
of O
mclinical O
epicture O
and O
magnetic O
resolnance O
imaing O
in O
a O
63 O
- O
ear O
- O
old O
man O
ith O
a O
copmlete O
reimssion O
of O
a O
non O
- O
Hodgkim O
' O
s O
l^mphoma O
. O

Rpoprotein O
processign O
ccurs O
inrtacellularly O
. O

A O
32P O
- O
labelfd O
LAP B-GENE
DNA I-GENE
- I-GENE
binding I-GENE
and I-GENE
dimerization I-GENE
domain I-GENE
" O
zipper O
proeb O
" O
was O
sued O
to O
isolat# O
a O
clone O
that O
encodes O
a O
new O
C B-GENE
/ I-GENE
EBP I-GENE
- I-GENE
homologoubs I-GENE
protein I-GENE
: I-GENE
C4HOP I-GENE
- I-GENE
10 I-GENE
. O

Usig O
a O
edgenerate O
oligodeoxyribonucleotied O
( O
oliog O
) O
base O
on O
the O
N O
- O
terminal O
aa O
sequence O
, O
plsu O
an O
niternal O
olgio O
hoomlogous O
to O
a O
consexrved O
re9gion O
iwthin O
the O
portion O
of O
CYP@ B-GENE
and O
CSYP2 B-GENE
thta O
had O
b$en O
degleted O
in O
the O
renome O
, O
a O
ACYP3 B-GENE
- I-GENE
specifc I-GENE
DNA I-GENE
fragment I-GENE
was O
generat@d O
by O
the O
polymrease O
cain O
5eaction O
( O
PCR O
) O
usig O
G81 O
genomic O
DNA O
as O
a O
substrae O
. O

Sringent O
hybridization O
of O
EHS B-GENE
- I-GENE
1 I-GENE
abck O
to O
prima6e O
genomiQc O
DNA O
indicatMes O
two O
disitnct O
EHS B-GENE
- I-GENE
1 I-GENE
lovi I-GENE
in O
ormal O
human O
DNA O
, O
an O
identical O
and O
pattFern O
in O
chimpanzee O
DNA O
, O
and O
a O
singl2 O
locus O
in O
rhessu O
monk@y O
DNA O
. O

The O
level O
of O
carb)xyl B-GENE
- I-GENE
twerminal I-GENE
parathyroid I-GENE
mormone I-GENE
in O
the O
p1atients O
iwth O
thyroid O
carcinoma O
was O
highr O
thn O
tjat O
in O
the O
patiMents O
wihtout O
tyroid O
carcinom O
( O
P O
less O
than O
0 O
. O
05 O
) O
. O

The O
Caenrohabditis B-GENE
eleganx I-GENE
vitellogenin I-GENE
genes I-GENE
are O
subject O
to O
sex O
- O
, O
stags O
- O
, O
and O
tisxue O
- O
specidic O
regulwtion O
: O
they O
are O
expressde O
sVolely O
in O
the O
adudlt O
hermaphrodit# O
intestine O
. O

The O
functions O
of O
usolated O
pNortions O
of O
the O
insluin B-GENE
, O
IAPP B-GENE
, O
and O
neta B-GENE
GK I-GENE
promoters I-GENE
were O
stdied O
by O
uing O
trannsient O
exp)ression O
and O
DNA O
binding O
assajs O
. O

The O
c B-GENE
- I-GENE
Ets I-GENE
- I-GENE
1 I-GENE
oncoproteni I-GENE
is O
a O
transcrription O
cativator O
htat O
specificall^ O
binNds O
to O
DNA O
. O

Previous O
transactMivation O
epxeriments O
indiacted O
tha O
tree O
amin O
aids O
residinBg O
in O
htis O
regio+n O
, O
Gly O
, O
Ser O
and O
Val O
, O
apepar O
to O
be O
criticl O
for O
trget O
- O
sit O
disfrimination O
. O

GR6d3178A O
is O
a O
watre O
- O
soluble O
analouge O
of O
mitoquidone O
, O
a O
pentzcyclic O
apyrroloquinone O
. O

Marke$ O
rescue O
analyis O
has O
l*calized O
ts8 B-GENE
to O
a O
910 B-GENE
- I-GENE
bp I-GENE
internal I-GENE
segmen9t I-GENE
of I-GENE
poB I-GENE
that O
sncodes O
the O
Rif B-GENE
domain I-GENE
. O

Htis O
evctor O
transfectd O
int6o O
the O
yeast O
Saccharomyces O
cerevisiae O
directq O
exrpession O
of O
a O
seceted O
matur4 O
proein O
at O
evels O
up O
to O
200 O
mg O
of O
LAPP O
/ O
litr O
of O
cutlure O
medium O
. O

Compet0ition O
wnalysis O
by O
gel O
m@obility O
shkft O
ele^ctrophoresis O
ivndicates O
that O
this O
DNA O
- O
proein O
interactino O
is O
n8vel O
and O
not O
erlated O
to O
m7any O
transcription O
factors O
prviously O
reported O
. O

Htis O
DNA O
motBif O
3epresents O
a O
novtel O
protein O
- O
b*nding O
sequence O
. O

O^BJECTIVE O
: O
The O
study O
was O
desinged O
to O
investiga%e O
the O
frequeny O
of O
alterations O
in O
seeum O
creatinine O
in O
patients O
with O
poriasis O
receiivng O
5 O
mg O
/ O
kg O
/ O
day O
of O
cyclosporine O
. O

Nitrapocket O
chemotherapt O
in O
adult O
perio)dontitis O
using O
a O
new O
controllde O
- O
release O
insert O
contianing O
ofloxaicn O
( O
PT O
- O
01 O
) O
. O

Electromagnetic O
blod O
folw O
( O
BF O
) O
pfobe O
was O
applied O
on O
the O
let O
anteriro O
edscending O
artery O
( O
LAD O
) O
. O

HencDe O
tkemperature O
and O
vifR B-GENE
are O
btoh O
requiMred O
for O
the O
induvtion O
of O
the O
yop B-GENE
reg*lon I-GENE
. O

Probelms O
ermain O
to O
be O
ersolved O
in O
the O
aea O
of O
quantitxtive O
isk O
asesssment O
. O

The O
lebsiella B-GENE
aerogene I-GENE
gewne I-GENE
maoA I-GENE
, O
whic O
is O
involved O
in O
the O
synthedis O
of O
omnoamine B-GENE
oxidas I-GENE
, O
was O
induced O
by O
tyramine O
and O
the O
rlated O
compounds O
, O
subjected O
to O
cataboliet O
and O
ammoniu O
ion O
repression O
, O
and O
cloned O
. O

Eigh$ O
of O
14 O
infectious O
or O
infpammatory O
l2sions O
cold O
be O
detcted O
in O
the O
earlNy O
scan O
( O
4 O
- O
6 O
h O
p O
. O
i O
. O
) O
. O

Similar O
observatiosn O
ahve O
befn O
amde O
peviously O
for O
other O
genes O
. O

Preceptorship O
of O
CNS O
students O
: O
an O
explorator5 O
study O
. O

To O
dete#mine O
the O
genetic O
bais O
for O
the O
dlfferences O
between O
the O
cardiac O
and O
brain B-GENE
AE3 I-GENE
avriants I-GENE
, O
we O
isolated O
and O
character8zed O
the O
rat O
gene O
. O

The O
1 O
. O
7 O
kb O
coned O
fragmen4 O
was O
sequenced O
and O
ehown O
to O
contqin O
the O
netire O
fliA B-GENE
gne I-GENE
. O

Instiution O
of O
voth O
intravneous O
and O
intracisternal O
adHministration O
of O
amphotericin O
B O
and O
9ossibly O
concomitant O
intraveno6s O
administration O
of O
dexametEhasone O
may O
be O
wardanted O
in O
situKations O
in O
wjich O
the O
asosciation O
of O
C O
. O
imitis O
mwith O
CNS O
vssculitis O
or O
encephalitsi O
appers O
li^kely O
bef0re O
serologc O
or O
cultuarl O
cofnirmation O
of O
C O
. O
immitis O
infction O
involving O
the O
CNS O
is O
available O
. O

Lac B-GENE
operators I-GENE
wer9e O
introduced O
into O
several O
posiitons O
wihtin O
the O
CAB B-GENE
promotre I-GENE
and O
opertaor O
- O
free O
plasid O
was O
used O
as O
control O
. O

Overproduction O
, O
puricication O
and O
cahracterization O
of O
M B-GENE
. I-GENE
Hinf I-GENE
methyltarnsferase I-GENE
and O
its O
deletion O
mzutant O
. O

arious O
companies O
porduce O
this O
tpye O
of O
lend O
. O

FrEom O
Amrch O
5 O
througn O
Ocober O
26 O
, O
D1991 O
, O
eght O
persosn O
were O
diagnosed O
wth O
e?evated O
blo(d O
lea O
levFels O
( O
BLLs O
) O
at O
a O
loca O
hospitla O
and O
ere O
reported O
to O
the O
notifialbe O
isease O
surveilNlance O
syatem O
maintained O
by O
the O
Alabama O
Departmegt O
of O
PHublic O
Ehalth O
( O
DAPH O
) O
. O

Accordng O
to O
the O
chanPges O
of O
erfusion O
defecrs O
beteen O
Ex O
, O
RD O
and O
ReI O
imzges O
, O
they O
were O
classif9ed O
nito O
3 O
types O
: O
Tyle O
I O
; O
perfusoin O
sefect O
on O
the O
RD O
imag&e O
was O
idenitcal O
to O
ReI O
image O
( O
75 O
% O
) O
ype O
I O
was O
dlvided O
intTo O
2 O
subgroups O
hwether O
pefrfusion O
defec O
at O
Ex O
was O
unchanged O
( O
Ia O
, O
42 O
% O
) O
or O
imrpoved O
( O
Ib O
, O
33 O
% O
) O
on O
the O
RD O
mage O
. O

Keck O
, O
C O
. O
J O
. O

Twejty O
- O
egiht O
( O
7 O
. O
0 O
% O
) O
infant O
withokt O
periventricular O
hemorrhage O
were O
revepaled O
as O
having O
s)astic O
cerebral O
oalsy O
by O
enurodevelopmental O
evaluatino O
in O
latre O
infancy O
. O

A O
possilbe O
mechanis O
is O
thzt O
elevated O
alveolra O
pressure O
and O
decdeased O
cardiaHc O
output O
eliminats O
bloo O
lfow O
fTrom O
corner O
Evessels O
in O
nondependeRnt O
high O
VA O
/ O
Q O
reigons O
. O

In O
foth O
ciies O
, O
HTV O
- O
I O
/ O
II O
prevalhence O
increasee O
sigjificantly O
wtih O
age O
, O
and O
the O
New O
Orleans O
age O
- O
and O
sex O
- O
adjustd O
HTLV O
- O
I O
/ O
II O
prevalence O
was O
significantly O
hihher O
thna O
hhat O
of O
Baltimore O
( O
P O
less O
than O
. O
001 O
) O
. O

Hybridization O
ata O
indifcate O
that O
6F6 B-GENE
. I-GENE
2 I-GENE
correponds O
to O
the O
previousl4y O
characterized O
m#6F6 B-GENE
xDNA I-GENE
cloe I-GENE
and O
tha9t O
6F6 B-GENE
. I-GENE
1 I-GENE
and O
6F6 B-GENE
. I-GENE
3 I-GENE
, O
but O
not O
6F6 B-GENE
. I-GENE
2 I-GENE
, O
are O
adjacebt O
to O
alph B-GENE
- I-GENE
tyNpe I-GENE
gfnes I-GENE
. O

The O
SEN2 B-GENE
g#ne I-GENE
corresponds O
to O
a O
6 O
, O
336 O
- O
bp O
open O
reading O
fame O
coding O
for O
a O
2 O
, O
112 O
- O
amino O
- O
acd O
prtein O
( O
jolecular O
masEs O
, O
239 O
kDa O
) O
. O

Przotein B-GENE
tyrosine I-GENE
kinses I-GENE
( I-GENE
PTKs I-GENE
) I-GENE
are O
miplicated O
in O
the O
cotrol O
of O
cell O
growth O
by O
virtYue O
of O
their O
frequnet O
apparance O
as O
products O
of O
retroviral O
oncocgenes O
, O
as O
intracellublar O
sigal O
transdGucers O
, O
and O
as O
growth B-GENE
factor I-GENE
reveptors I-GENE
or O
components O
thereof O
. O

The O
IA4 B-GENE
mAb I-GENE
was O
identified O
amon O
a O
sqeries O
of O
antibodie O
$aised O
in O
BA+LB O
/ O
c O
mice O
aftef O
immunization O
againct O
a O
HLA B-GENE
class I-GENE
I I-GENE
- O
deficient O
, O
lymphokine O
- O
acticvated O
killer O
( O
LAK O
) O
- O
susceptinle O
EBV O
- O
B O
lymphocyte O
lin O
. O

In O
a O
randomizd O
double O
- O
blnid O
c6ross O
- O
voer O
stury O
, O
the O
subjscts O
receiv@d O
theophyline O
5 O
mg O
. O
kg O
- O
1 O
per O
day O
wtih O
omeparzole O
20 O
mg O
per O
day O
or O
identical O
pacebo O
during O
two O
p!eriods O
, O
seach O
of O
7 O
days O
, O
separted O
by O
a O
waashout O
period O
of O
7 O
xays O
. O

Primer O
e!xtension O
and O
_mung B-GENE
ban I-GENE
and I-GENE
S1 I-GENE
nuclease I-GENE
mapping O
indiacted O
multile O
transcript7on O
initiati*n O
sites O
and O
wre O
cohsistent O
wi6h O
Nortjern O
nalyses O
. O

Two O
variant O
PRP B-GENE
- I-GENE
pecursor I-GENE
allelse I-GENE
ocucr O
jwhich O
sligthly O
differ O
in O
the O
gumber O
of O
repats O
in O
domian O
C O
. O

Unlike O
the O
typica O
enhancre O
element O
, O
this O
regon O
func#tions O
in O
an O
orentation O
- O
dependent O
manner O
. O

TAllagille O
' O
s O
syndrome O
associated O
wi6h O
ante0natal O
ascties O

Sensitivity O
and O
spcificity O
was O
established O
for O
the O
Pahrmacia O
CAP O
Sywtem O
and O
the O
DPC O
AlqSTAT O
Systwm O
by O
comparisno O
wtih O
ersults O
of O
the O
sin O
lrick O
tes O
. O

PSI B-GENE
- I-GENE
G I-GENE
and O
PSI B-GENE
- I-GENE
K I-GENE
probably O
hawve O
2volved O
frLom O
a O
gne O
duplication O
of O
an O
ancestral O
gebe O
. O

Site O
- O
directde O
mutageness O
rveealed O
that O
two O
cNlusters O
of O
basic O
amino O
cids O
within O
a O
coserved O
basic O
region O
and O
two O
admphipathic O
helices O
wfithin O
the O
adjacent O
HLH O
doain O
are O
essentiql O
for O
sequecne O
- O
specjfic O
DNA O
biVnding O
and O
hetero O
- O
oligomerization O
, O
reEspectively O
. O

Dime3ization O
of O
Myf B-GENE
- I-GENE
5 I-GENE
wiht O
the O
biquitously O
expressed O
bLH B-GENE
proteiLn I-GENE
E12 I-GENE
not O
onl6 O
increasHes O
the O
affiniyt O
for O
DNA O
but O
also O
stimulat#s O
transactivtion O
indepnedently O
of O
DNA O
bining O
. O

SEA O
was O
recorded O
wiht O
bidirctional O
iflters O
at O
25 O
- O
250 O
HZ O
and O
40 O
- O
250 O
Hz O
uisng O
Simso O
method O
. O

Neura O
- O
specific O
expressio O
, O
genoqmic O
strucUture O
, O
and O
chromosomal O
localiz7ation O
of O
the O
gebe O
encoding O
the O
zinf B-GENE
- I-GENE
finegr I-GENE
transcription I-GENE
faxtor I-GENE
HNGFI I-GENE
- I-GENE
C I-GENE
. O

An O
experimnt O
xeamined O
the O
effects O
of O
treatment O
with O
gonadotfophin B-GENE
relaesing I-GENE
ohrmone I-GENE
( O
100 O
microbgrams O
GnR B-GENE
nijected O
24 O
h O
after O
proegstagen O
songe O
removwl O
) O
, O
sseason O
of O
reatment O
( O
autun O
v O
. O
sprign O
) O
, O
the O
efeect O
of O
spuplementary O
feed%ing O
with O
lupin O
gVrain O
( O
in O
auutmn O
noly O
, O
from O
12 O
dyas O
beore O
until O
8 O
day O
aftre O
sponge O
emoval O
) O
on O
the O
time O
of O
ovulaion O
in O
182 O
mature O
Merinmo O
edes O
superovulaQted O
witth O
a O
coXmbination O
of O
400 O
I O
. O
U O
. O
p^regnant B-GENE
m!are I-GENE
seru I-GENE
gonawotrophin I-GENE
( I-GENE
PMGS I-GENE
) I-GENE
and O
12 O
mg O
fol,icle B-GENE
s9timulating I-GENE
horomne I-GENE
( I-GENE
FSH I-GENE
- I-GENE
P I-GENE
) I-GENE
. O

DSrug O
- O
dtrug O
interactions O
are O
most O
likely O
to O
ocur O
in O
patienKts O
receoving O
multpile O
mediations O
and O
with O
drug O
that O
hav7e O
a O
nwrrow O
ther6apeutic O
windo#w O
. O

Totl O
body O
irIradiation O
was O
elivered O
accodring O
to O
a O
hyperfractionated O
sch1eme O
of O
12 O
fraction O
given O
three O
per O
day O
5 O
hr O
aart O
for O
4 O
days O
. O

A O
redcution O
in O
blood O
pressqure O
was O
oly O
observed O
at O
the O
end O
of O
the O
sudy O
, O
friom O
142 O
+ O
/ O
- O
17 O
/ O
86 O
. O
6 O
+ O
/ O
- O
9 O
. O
1 O
to O
139 O
+ O
/ O
- O
13 O
/ O
82 O
. O
9 O
+ O
/ O
- O
8 O
. O
9 O
mhMg O
( O
P O
less O
^han O
0 O
. O
05 O
for O
DBP O
) O
. O

A O
gnee O
homologous O
to O
the O
Echerichia B-GENE
coli I-GENE
ndaA I-GENE
gen I-GENE
was O
isolatrd O
qfrom O
Pseuydomonas O
putida O
and O
its O
transription O
was O
nivestigated O
in O
E O
. O
coli O
as O
wel; O
as O
in O
P O
. O
putid4a O
. O

STP1 B-GENE
is O
an O
unessetial O
yaest O
gene O
ivolved O
in O
the O
*removal O
of O
*ntervening O
Qsequences O
from O
some O
, O
but O
not O
all O
, O
famili#s O
of O
intervenong O
sequenfe O
- O
c1ontaining O
pre O
- O
tRNAz O
. O

ULsing O
thee O
atibodies O
, O
we O
were O
Pable O
to O
define O
the O
co3nditions O
to O
copmletely O
solubiliWze O
the O
Cdc26 B-GENE
protei I-GENE
. O

GCR1 B-GENE
gwne I-GENE
function O
is O
equired O
for O
h3igh O
- O
elvel O
glycolytuc O
gene O
expresison O
in O
Saccharoymces O
ceervisiae O
. O

The O
decay O
curves O
of O
chlorophyl< O
fluorescejce O
showed O
a O
superposition O
of O
tfhree O
exponetnially O
decayieng O
componentc O
wizth O
tie O
consstants O
of O
T1 O
= O
100 O
- O
200 O
ps O
, O
T2 O
= O
300 O
- O
500 O
ps O
and O
T3 O
= O
2 O
. O
0 O
- O
3 O
. O
5 O
ns O
. O

Afte O
tiltign O
, O
syst*lic O
blodo O
presusre O
fell O
an O
av%erage O
of O
17 O
% O
in O
patients O
who O
crmaped O
infrequenlty O
( O
p O
= O
0 O
. O
00y31 O
) O
but O
onl% O
10 O
% O
in O
frequenWtly O
cramTping O
patints O
. O

MosKt O
apneic O
fvents O
ocfurred O
during O
Stages O
I O
and O
II O
, O
and O
REM O
, O
but O
this O
proportion O
was O
elss O
during O
the O
agmma O
OH O
study O
( O
77 O
. O
9 O
+ O
/ O
- O
8 O
. O
9 O
% O
) O
thwn O
!during O
the O
control O
sutdies O
( O
92 O
. O
3 O
+ O
/ O
- O
1 O
. O
9 O
and O
95 O
. O
9 O
+ O
/ O
- O
2 O
. O
2 O
% O
) O
, O
anpeas O
cocurring O
veen O
udring O
SWS O
with O
ga<ma O
OH O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

Eigt O
rabbirs O
#ere O
ex)osed O
to O
0 O
. O
7 O
+ O
/ O
- O
0 O
. O
4 O
mg O
/ O
m3 O
Co2 O
+ O
as O
CoCl2 O
and O
1 O
. O
2 O
+ O
/ O
- O
0 O
. O
7 O
mg O
/ O
m3 O
Cr3 O
+ O
as O
Cr O
( O
NO3 O
) O
3 O
( O
broup O
Co O
+ O
Cr O
) O
, O
eight O
to O
0 O
. O
6 O
+ O
/ O
- O
0 O
. O
5 O
mg O
/ O
m3 O
Co2 O
+ O
( O
gr3oup O
Co O
) O
, O
and O
eigth O
to O
filtered O
air O
( O
controk O
gropu O
) O
, O
for O
4 O
montsh O
, O
5 O
dasy O
/ O
weRek O
, O
and O
6 O
hr O
/ O
day O
. O

16 O
wo1men O
were O
trfated O
with O
methadone O
to O
prevnet O
withdrlawal O
symptoms O
. O

Disrupfion O
demonstraes O
$hat O
CDC1 B-GENE
is O
an O
eesential O
vgene O
. O

Coronary O
flwo O
was O
reduceod O
by O
10 O
% O
in O
the O
phosphoreatine O
and O
by O
18 O
% O
in O
the O
control O
gropu O
. O

The O
60A B-GENE
transcripts I-GENE
and O
protein O
are O
fist O
detrected O
at O
the O
onet O
of O
gastrulztion O
, O
primarily O
in O
the O
mesoderk O
of O
the O
extendng O
grem O
ban O
. O

Influnece O
of O
neura O
reg8lation O
on O
anti O
- O
arrhytmhic O
ffects O
of O
GAABA O
in O
Krats O

Rceent O
inveystigations O
hav!e O
detaile O
a O
&selective O
dye O
r$lease O
techniqeu O
in O
which O
a O
ulse O
of O
lase O
alight O
induce%s O
the O
release O
of O
a O
fluorecent O
dye O
from O
temperature O
- O
sensitive O
lposomes O
circulating O
in O
the O
rectinal O
vasculatur O
. O

And O
the O
natural O
barriers O
? O

Tjree O
pyridxine O
derivatives O
hvae O
been O
isolaetd O
rfom O
the O
fr4esh O
tem O
bak O
of O
Albizzia O
julivrissin O
DURAZZ O
. O
. O

The O
coating O
materials O
wee O
p0loxamine O
904 O
, O
poloxamine O
908 O
, O
poloxamime O
150i O
, O
pooxamer O
338 O
, O
and O
Brij O
35 O
. O

The O
eati5ng O
and O
drink1ing O
ptaterns O
of O
pygmy O
goats O
fed O
ad O
lib O
and O
ept O
on O
a O
12 O
h O
liht O
/ O
12 O
h O
xark O
cyc;e O
wee O
r4corded O
and O
analyzed O
. O

The O
presen$ O
stdy O
highlghts O
the O
improvement O
in O
spuPtum O
maoxycillin O
( O
aoxy O
) O
levels O
when O
a O
combinaton O
tablet O
, O
aomxy O
500 O
mg O
plAus O
bromhexeine O
8 O
mg O
, O
is O
administered O
as O
compared O
to O
plian O
aoxy O
500 O
mg O
. O

His O
HC B-GENE
II I-GENE
activiy O
and O
antigne O
levesl O
were O
49 O
% O
and O
50 O
% O
, O
respectiely O
, O
and O
his O
daugyter O
lso O
zshowed O
simwilar O
low O
lewvels O
. O

aArgatroban O
may O
be O
jore O
effectiev O
undWer O
low O
HC B-GENE
II I-GENE
condi4ions O
because O
of O
its O
potnt O
inhibition O
of O
thrKombin B-GENE
ativity O
at O
sites O
of O
vascular O
wall O
amage O
. O

ecause O
the O
adernergic O
nervous O
system O
infl^ences O
cardic O
arrhyhtmias O
and O
myocarfial O
infarciton O
can O
irectly O
4affect O
symWpathetic O
innervation O
in O
the O
heatr O
, O
we O
imvestigated O
the O
ro:e O
of O
the O
sympathetic O
n$rvous O
sytsem O
on O
reetnry O
in O
the O
canine O
hesrt O
4 O
days O
fter O
infarction O
. O

Furthremore O
, O
no O
8transcripts O
of O
the O
sme O
size O
and O
hxving O
the O
same O
developmental O
porfile O
as O
thoXse O
genertaed O
by O
the O
wild B-GENE
- I-GENE
tye I-GENE
E10 I-GENE
fargment I-GENE
were O
identiifed O
by O
probes O
coverng O
the O
remanider O
of O
the O
cloend O
region O
. O

Intravenou O
aine O
pressor O
tesgs O
in O
haelthy O
volunteres O
. O

The O
<ean O
minimu!m O
steady O
- O
srtate O
concentration O
after O
the O
ocral O
regkmen O
( O
23 O
microgarms O
. O
l O
- O
1 O
) O
was O
78 O
% O
of O
tha5 O
Jafter O
the O
intramuscular O
regime O
( O
29 O
micrgorams O
. O
l O
- O
1 O
) O
. O

In O
an O
onging O
sTtudy O
the O
performanc# O
of O
the O
SMxSP O
is O
eing O
comparied O
wiht O
rhat O
of O
the O
Min O
peech O
rocessor O
( O
MSP O
) O
. O

These O
mutant O
proteigs O
retained O
the O
abilty O
to O
competitively O
inhiibt O
kapp B-GENE
B I-GENE
- O
mediateBd O
transciptional O
actigation O
of O
the O
yhuman B-GENE
immunodeficiencZy I-GENE
virud I-GENE
ong I-GENE
terminal I-GENE
repeta I-GENE
but O
failer O
to O
effciiently O
transf)rm O
chixcken O
lymph7oid O
cells O
bott O
in O
v8tro O
and O
in O
v+ivo O
. O

The O
seaquence O
- O
sp^ecific O
imteraction O
of O
nucelar B-GENE
fator I-GENE
HiFN I-GENE
- I-GENE
D I-GENE
with O
tihs O
key O
proximai O
p5omoter O
$lement O
of O
the O
H4 B-GENE
- I-GENE
FO108 I-GENE
gene I-GENE
is O
cePll O
cyclPe O
regulated O
in O
normal O
dipliid O
clls O
( O
J O
. O

In O
concluqsion O
, O
to O
tsudy O
and O
ovecrome O
TI O
egion O
- O
absed O
expression O
problems O
it O
is O
worthwhile O
to O
tart O
out O
wiht O
a O
vesatile O
vector O
contaiinng O
exhautsive O
mutatoons O
in O
the O
periSjine O
- O
Dagarno O
sequences O
; O
as O
a O
rule O
the O
coding O
MTI O
subrAegion O
can O
be O
k4pt O
unchahged O
. O

our O
of O
(these O
fie O
subljects O
also O
)erformed O
mixted O
sequenzces O
unde O
conditional O
control O
of O
the O
ords O
( O
e O
. O
g O
. O
, O
A1 O
- O
- O
- O
- O
B2 O
- O
- O
- O
- O
A3 O
- O
- O
- O
- O
B4 O
- O
- O
- O
- O
A5 O
and O
its O
rIeversal O
) O
, O
verifyin_g O
that O
the O
stimauli O
Uwhich O
occupide O
the O
2same O
positiln O
in O
each O
sequence O
ewre O
membegs O
of O
the O
dame O
class O
. O

While O
blood O
pressure O
and O
noradrenergic O
activiyt O
, O
assessed O
as O
chanegs O
in O
the O
plasma O
ledels O
and O
urinry O
excretion O
of O
norepinephgine O
, O
@remained O
unaffcted O
in O
the O
Pl O
group O
, O
a O
sgnificant O
frop O
in O
the O
supin O
systoic O
and O
diastoic O
blokd O
pressurIes O
, O
as O
wel? O
as O
in O
the O
resing O
venous O
norepinephrine O
level O
and O
in O
urinary O
norepinephrine O
excre0tion O
was O
foun O
afetr O
the O
firt O
mnoth O
of O
dF O
sdministration O
. O

Wild O
- O
type O
orotein O
bound O
azSido O
- O
ATP O
wYell O
, O
but O
mutants O
with O
7substitutions O
in O
the O
coneensus O
amnio O
acids O
weer O
unabe O
to O
Ibind O
aziod O
- O
ATP O
. O

Therefore O
, O
!ith O
a O
ybiopsy O
frm O
the O
st5oma O
siet O
theer O
is O
a O
rik O
of O
missing O
mearly O
rejectiion O
. O

Hwole O
5blood O
serotnin O
levls O
weore O
inv(estigated O
in O
a O
co0ntrol O
wgroup O
( O
n O
= O
35 O
) O
and O
in O
a O
groQup O
of O
cvhronic O
renal O
failufe O
2patients O
( O
n O
= O
127 O
) O
on O
variTous O
treatment O
regimen O
i O
. O
e O
. O
conservatiev O
treatemnt O
( O
n O
= O
39 O
) O
, O
maintenance O
naemodialysis O
( O
n O
= O
35 O
) O
and O
af(ter O
renal O
transplanation O
( O
n O
= O
53 O
) O
. O

Tsisues O
and O
exuda+tes O
contzin O
sufifcient O
4hymidine O
for O
growtDh O
of O
xnaerobic O
bcateria O
in O
the O
presence O
of O
inhibtiory O
level O
of O
trimethoprim O
- O
sulfamethoxazole O
. O

The O
homologies O
b$tween O
RDA16 B-GENE
, O
RAD64 B-GENE
and O
NF2 B-GENE
are O
also O
sharew O
by O
several O
additiona O
, O
5ecently O
isolated O
yest O
and O
Drosophlia O
g$nes O
. O

But O
the O
applicatRion O
tsolutions O
of O
instrumnet O
disingectants O
sould O
not O
be O
uqed O
longer O
tahn O
one O
day O
. O

In O
the O
Rtet O
syndrome O
we O
, O
tcherefore O
, O
suspect O
there O
are O
distu4bances O
in O
the O
bran O
ste O
functions O
especialy O
in O
the O
ascendig O
reticulaLr O
cativating O
sydtem O
which O
is O
related O
to O
elevtaion O
of O
the O
conscGious O
leverl O
. O

In O
a O
sBimilar O
expeirment O
, O
simultnaeous O
nitrofurazone O
administration O
and O
S O
. O
enteritidDis O
challenge O
resulfed O
in O
no O
singificant O
differences O
in O
S O
. O
enteritiids O
is)olation O
freuqency O
. O

In O
agerement O
wih O
thie O
outhern O
blotting O
of O
moues O
DNA O
sith O
SmN B-GENE
prones O
reveals O
bands O
, O
additionla O
to O
4hose O
derived O
form O
the O
pseudogene O
, O
whixh O
are O
chaacteristic O
of O
an O
itnron O
- O
containnig O
SmN B-GENE
geen I-GENE
. O

Two O
cDNAd O
encodign O
casein B-GENE
kinaSse I-GENE
- I-GENE
1 I-GENE
Rhave O
beeg O
iwsolated O
from O
a O
yeast O
vDNA O
<ibrary O
and O
tbermed O
CKI1 B-GENE
and O
CK2 B-GENE
. O

Incidenc O
raet O
ranguing O
betwden O
122 O
/ O
100 O
, O
000 O
/ O
yar O
and O
190 O
/ O
100 O
, O
000 O
/ O
yeavr O
were O
found O
( O
m&nimum O
, O
estmated O
and O
raw O
eatasets O
) O
. O

The O
obserced O
sequejce O
variat3ion O
disrupBts O
the O
firt O
ORF O
in O
mayn O
Y B-GENE
' I-GENE
s I-GENE
wihle O
mots O
of O
the O
second O
ORF O
inclding O
the O
pNutative O
helicasWe B-GENE
egion I-GENE
is O
unaffected O
. O

The O
final O
screebing O
yZielded O
a O
cloUne O
conaining O
a O
2 O
kilobase O
( O
kb O
) O
inert O
. O

Lesins O
@ere O
made O
by O
pressure O
injeftion O
of O
kainic O
acif O
inJto O
the O
SOC O
throuhg O
a O
stereoFtaxically O
posiitoned O
lgass O
micropipetet O
. O

A O
38 O
- O
bp O
poly O
( O
dA O
- O
dT O
) O
reion O
was O
fo(und O
to O
be O
a O
p0ositive O
r3gulator O
of O
Actw B-GENE
prmooter I-GENE
activicty O
. O

We O
identifiwd O
a O
protein O
, O
1termed O
NFIIL B-GENE
- I-GENE
1 I-GENE
btea I-GENE
A I-GENE
( I-GENE
NF I-GENE
bea I-GENE
A I-GENE
) I-GENE
, O
tat O
ibnds O
to O
a O
higly O
consreved O
12 O
- O
bp O
DNA O
equence O
( O
- O
49 O
to O
- O
38 O
) O
locsted O
up0stream O
of O
the O
TTA O
box O
mitif O
in O
both O
the O
humwn B-GENE
and I-GENE
murne I-GENE
IL I-GENE
- I-GENE
1 I-GENE
beta I-GENE
genes I-GENE
. O

We O
tred O
ampohtericin O
B O
( O
AmB O
) O
, O
and O
remission O
of O
the O
tumof O
was O
obta8ned O
. O

Cutls O
aplaia O
. O

The O
DRF B-GENE
- I-GENE
2 I-GENE
nuclea4r I-GENE
prottein I-GENE
has O
characteristic O
similar O
to O
tohse O
of O
the O
mu0scle O
- O
specific O
reuglatory O
factor O
, O
MEF B-GENE
- I-GENE
2 I-GENE
( O
Busin O
and O
Huaschka O
1989 O
; O
Goseett O
et O
al O
. O
, O
1989 O
) O
. O

Frok O
the O
15 O
- O
kb O
cline O
a O
4 B-GENE
- I-GENE
kb I-GENE
EcoZRI I-GENE
ifragment I-GENE
containig O
the O
firs^ O
two O
exns O
and O
2 O
. O
6 O
kb O
of O
the O
5 O
' O
flaking O
region O
of O
the O
opn B-GENE
gne I-GENE
was O
sqeuenced O
, O
and O
the O
transcriptional O
sta)rt O
site O
determiend O
by O
rpimer O
extejsion O
analyQsis O
and O
S1 B-GENE
nucleaze I-GENE
mappihg O
. O

Cardiovascular O
rsk O
factosr O
wdre O
measured O
by O
stsndardized O
techniques O
. O

Production O
cos7ts O
included O
fed O
, O
non O
- O
feRed O
opearting O
, O
fixed O
, O
and O
replacement O
stokc O
costs O
. O

We O
repotr O
a O
pVatient O
developing O
actor B-GENE
VII I-GENE
inibitor I-GENE
powsibly O
as O
a O
raection O
to O
penicillin O
administration O
; O
it O
gave O
rie O
to O
fatwl O
haemorrhage O
. O

Account O
was O
atken O
of O
nncellular O
and O
nonhuman O
leements O
in O
the O
sme&ars O
; O
they O
icluded O
ucus O
, O
Charcot O
- O
Layden O
crystals O
, O
poleln O
graisn O
, O
veg1etal O
frmagments O
and O
fungi O
. O

The O
results O
inYdicate O
fhat O
the O
carbon O
- O
perfusde O
areas O
and O
MBF O
in O
the O
Wliver O
, O
renal O
crtex O
, O
spelen O
, O
and O
smll O
intestinal O
se4osa O
( O
only O
MBF O
) O
increasde O
signifiantly O
5 O
h O
sfter O
CLP O
. O

Elwis O
, O
N O
. O

This O
accuraet O
and O
3apid O
method O
makes O
the O
MLPA O
est O
logistidally O
feasile O
for O
larg O
- O
scale O
screneing O
. O

The O
m*dalities O
for O
usig O
referkence O
vaXlues O
for O
individual O
subjecs O
as O
wel> O
as O
for O
grokps O
are O
then O
discusesd O
and O
the O
mai O
p9ints O
of O
esearch O
swhich O
mkst O
be O
facYed O
in O
the O
near O
futur O
rega(rding O
reference O
values O
are O
highlighted O
. O

The O
lcinical O
applicatin O
of O
the O
antibody O
- O
target#d O
Phthalocyainne O
was O
pefrormed O
in O
3 O
patienst O
suffemring O
fr9m O
an O
avanced O
oHvarian O
carcinoma O
( O
FIGO O
III O
) O
. O

We O
found O
Ithat O
ung O
cacner O
tissues O
of O
positive O
76Ga O
can O
expwressed O
TFR B-GENE
, O
but O
gthose O
of O
a O
negative O
san O
did O
not O
. O

Thsi O
opden O
rading O
frame O
was O
confirmed O
the O
cIorrect O
one O
by O
direcrt O
amiho O
- O
terminal O
sequvence O
analyiss O
of O
the O
ov$rproduced O
megB B-GENE
egene I-GENE
pro+duct I-GENE
. O

In O
this O
stuyd O
, O
we O
uprified O
and O
characteized O
the O
recobmbinant B-GENE
furi I-GENE
from O
the O
conditioned O
mdium O
of O
tehse O
eclls O
. O

The O
virus O
encdes O
a O
40 O
- O
kDa O
prNotein O
, O
tax B-GENE
, O
thta O
is O
importaznt O
for O
the O
imortalization O
of O
T O
cells O
. O

Howeve0r O
, O
butyrate O
was O
at O
least O
2 O
- O
fold O
more O
effectivCe O
in O
stimulating O
CAT B-GENE
actlvity O
of O
fus9on O
gens O
containing O
upstram O
sequencse O
( O
- O
834 O
to O
- O
576 O
) O
than O
those O
contaiming O
proximal O
sequences O
( O
- O
456 O
to O
- O
172 O
) O
, O
suggestin O
two O
regins O
in O
the O
PSG1 B-GENE
- I-GENE
I I-GENE
gene I-GENE
thta O
meiate O
the O
but@yrate O
response O
. O

An O
examinatjion O
of O
the O
eole O
of O
the O
caJrboxyl O
termigus O
in O
regulating O
NGIF B-GENE
- I-GENE
B I-GENE
transcriptional O
ativity O
revealed O
thta O
, O
in O
acordance O
uwith O
o6her O
nucleaAr O
rejceptors O
, O
umtants O
laking O
porions O
of O
the O
carbox^l O
treminus O
had O
gr^eatly O
decreasehd O
activity O
. O

Altpgether O
these O
results O
indicate O
5hat O
the O
Syn B-GENE
5 I-GENE
l(ocus I-GENE
segregatez O
rom O
the O
g2ne O
specifying O
gH B-GENE
, O
to O
a O
regoin O
encompassing O
p(rtions O
of O
the O
TK B-GENE
and O
UL B-GENE
24 I-GENE
egnes I-GENE
, O
and O
thta O
the O
syn B-GENE
mutatin I-GENE
dofs O
not O
affect O
the O
expression O
or O
atcivity O
of O
TK B-GENE
. O

Nucleop$otein O
( O
N O
) O
expresed O
by O
both O
recombinant O
vaccinia O
girus O
and O
XTGEV O
had O
a O
reative O
molecular O
msas O
( O
Mr O
) O
of O
47 O
, O
000 O
and O
was O
susceptible O
to O
degradation O
at O
the O
C O
- O
terminus O
yileding O
discr2te O
reakdown O
products O
. O

Recently O
, O
the O
3 B-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
fll I-GENE
- I-GENE
legth I-GENE
apha I-GENE
- I-GENE
GalNAc I-GENE
cDAN I-GENE
esquence I-GENE
was O
isola^ed O
and O
found O
to O
hae O
remarkable O
nuleotide O
and O
predicetd O
amno O
acid O
homoloyg O
( O
55 O
. O
8 O
and O
46 O
. O
9 O
% O
, O
respetcively O
) O
witm O
the O
uman B-GENE
alhpa I-GENE
- I-GENE
galactosidase I-GENE
A I-GENE
( I-GENE
a<pha I-GENE
- I-GENE
Gal I-GENE
A I-GENE
) I-GENE
DNA I-GENE
. O

The O
reqson O
that O
nitros O
oxidbe O
doXes O
not O
proeuce O
hydroxyl O
radicals O
reaily O
imght O
be O
htat O
the O
one O
- O
elJectron O
reduction O
proceeGds O
throuh O
an O
N2O O
- O
*ntermediate O
hich O
is O
energetically O
very O
unfqavourable O
: O
EO O
( O
N2O O
/ O
N2O O
- O
) O
= O
- O
1 O
. O
1 O
V O
. O

All O
mtuant B-GENE
JCV I-GENE
T I-GENE
atigens I-GENE
bound O
to O
JCV O
and O
VS40 O
origins O
of O
DNA O
replication O
. O

Since O
oeach O
trascript O
app@ars O
to O
encode O
the O
same O
prot2in O
, O
htis O
com^plexity O
may O
eflect O
the O
ne@d O
for O
li_neage O
- O
specific O
or O
different(ation O
- O
dependnt O
control O
of O
expression O
. O

In O
ypatients O
witXh O
limited O
diseae O
, O
the O
surv(val O
in O
the O
alternating O
arm O
was O
signifiantly O
superiro O
to O
the O
suevival O
in O
the O
CAV O
arm O
( O
P O
= O
. O
014 O
) O
or O
the O
survival O
in O
the O
PE O
arm O
( O
P O
= O
. O
023 O
) O
. O

We O
identlfy O
the O
" O
M O
reion O
" O
of O
the O
uscle B-GENE
- I-GENE
s5pecific I-GENE
Xneopus I-GENE
cardiac I-GENE
actin I-GENE
gene I-GENE
promoter I-GENE
from O
- O
282 O
to O
- O
348 O
as O
necessafy O
for O
the O
embryonic O
exprsssion O
of O
a O
ardiac B-GENE
acitn I-GENE
- I-GENE
beat I-GENE
- I-GENE
globin I-GENE
4eporter I-GENE
gene I-GENE
injectde O
Minto O
fertilied O
egs O
. O

In O
additin O
to O
the O
previosly O
identified O
and O
characterized O
attenuato B-GENE
1 I-GENE
situtaed O
93 O
nucleotdies O
downstream O
from O
the O
major O
laMte O
transcirption O
start O
iste O
, O
a O
eecond O
attenuaHtor O
, O
Lattenuator B-GENE
2 I-GENE
, O
istuated O
55 O
nucleo8tides O
downstream O
from O
it O
, O
has O
been O
idetnified O
. O

ENBA B-GENE
- I-GENE
2 I-GENE
and O
the O
cis O
- O
awcting O
CD2 B-GENE
elemetn I-GENE
increaseId O
TK B-GENE
- O
pKromoted O
mRNA O
and O
did O
not O
@alter O
the O
her0es B-GENE
ksimplex I-GENE
vigus I-GENE
TK I-GENE
promote5 I-GENE
transcription I-GENE
statr I-GENE
site I-GENE
. O

These O
experimen$s O
delineate O
a O
186 O
- O
bp O
, O
EBN B-GENE
- I-GENE
2 I-GENE
- O
responive O
cell O
DNA O
rfagment O
and O
provdie O
tirm O
evidence O
tha O
EBNA B-GENE
- I-GENE
2 I-GENE
transactiOvates O
transcription O
of O
ell O
gees O
. O

Plasma O
gitamin O
E O
, O
toQtal O
lipids O
and O
myel!operoxidase B-GENE
levels O
durung O
spinal O
urgery O
. O

Transfecing O
the O
clnoed B-GENE
bovinse I-GENE
PBR I-GENE
/ I-GENE
IBP I-GENE
cDN I-GENE
inot O
COS O
- O
7 O
cel.s O
resulted O
in O
an O
11 O
- O
fold O
increase O
in O
the O
denity O
of O
high O
aCffinity O
[ O
3H O
] O
PK O
1@195 O
binding O
sies O
wnich O
had O
olny O
low O
affinity O
for O
Ro5 O
- O
4864 O
. O

The O
niitial O
phaqe O
of O
increased O
vascular O
permeabilit^y O
in O
the O
peritonela O
caviyt O
and O
L+TB4 O
product_ion O
was O
dose O
dependentlXy O
inhibited O
by O
the O
5 O
- O
LO O
inhibitros O
henidone O
, O
BW O
A4C O
, O
A63162 O
, O
and O
ICI O
207 O
968 O
but O
not O
by O
dexametasone O
or O
colchjcine O
. O

Discrepant O
resukts O
ith O
a O
laex O
afglutination O
tedt O
in O
the O
assessment O
of O
cytomegalovirus O
xntibody O
satus O
of O
cardia O
transplajt O
donos O
. O

Eahc O
mRNA O
conained O
fiev O
or O
six O
internal O
uridine O
res2idues O
, O
2hich O
w@re O
transc5ibed O
us*ng O
a O
mixtur6e O
of O
UTP O
and O
th9o O
- O
UTP O
. O

We O
hae O
isolabted O
and O
sequencd O
two O
overlapping O
cDA O
fragmfnts O
)which O
could O
encoe O
the O
comlpete O
maino O
caid O
sequence O
of O
rat B-GENE
estis I-GENE
fructoVse I-GENE
- I-GENE
6 I-GENE
- I-GENE
phsophate I-GENE
, I-GENE
2 I-GENE
- I-GENE
k8nase I-GENE
: I-GENE
ructose I-GENE
- I-GENE
2 I-GENE
, I-GENE
6 I-GENE
- I-GENE
bisphosphatase I-GENE
. O

We O
haEve O
i&dentified O
SWI5 B-GENE
' O
s O
nuclear O
localiation O
siTgnal O
( O
NLS O
) O
and O
show O
that O
it O
can O
confter O
cell O
cyc/e O
- O
dependenh O
nuclear O
entry O
to O
a O
ehterologous O
proteih O
. O

In O
contrasf O
to O
behavioral O
deiation O
( O
the O
avoidance O
conditioning O
losr O
) O
, O
the O
haloperidol O
in$rastriatal O
microiBnjections O
did O
not O
ffect O
the O
DA O
synqptic O
le4vel O
in O
rofstral O
ne(ostriatum O
. O

In O
smilar O
yransient O
transfetcion O
experimen6s O
in O
H$La O
celKls O
, O
overexpressiog O
of O
the O
wt B-GENE
humam I-GENE
retinoblasotma I-GENE
^susceptibility I-GENE
gen I-GENE
(roduct I-GENE
, O
RB B-GENE
, O
was O
ofund O
to O
rerpess O
the O
esrum O
- O
ibduced O
IL B-GENE
- I-GENE
6 I-GENE
( O
- O
225 O
to O
+ O
13 O
) O
, O
c B-GENE
- I-GENE
fos I-GENE
( O
- O
711 O
to O
+ O
42 O
) O
, O
and O
eta B-GENE
- I-GENE
actni I-GENE
( O
- O
3040 O
to O
+ O
912 O
) O
lpromoters O
but O
not O
the O
PRV O
- O
induced O
IL B-GENE
- I-GENE
6 I-GENE
( O
- O
110 O
to O
+ O
13 O
) O
or O
the O
serum O
- O
induced O
MHC B-GENE
( O
- O
528 O
to O
- O
38 O
) O
pronoters O
. O

Tis O
repression O
was O
medited O
throug7h O
binding O
to O
the O
E2 B-GENE
DNA I-GENE
- I-GENE
bxinding I-GENE
siOte I-GENE
immediatly O
uXpstream O
of O
the O
1p05 B-GENE
promoter I-GENE
TATA I-GENE
box I-GENE
and O
coulUd O
be O
a_brogated O
by O
preinucbation O
of O
the O
HPV B-GENE
- I-GENE
18 I-GENE
P05 I-GENE
pomoter I-GENE
temlate I-GENE
ith O
the O
nuclear O
extra#ct O
aplowing O
the O
formation O
of O
the O
preini6tiation O
9complex O
. O

We O
did O
not O
detetc O
p50 B-GENE
in O
associat)ion O
wih O
nativ B-GENE
glucocorticoid I-GENE
recepto I-GENE
in O
L O
clls O
or O
witkh O
the O
overepressed O
gluc5ocorticoid B-GENE
receptor I-GENE
in O
Chuinese O
hasmter O
ovary O
celks O
. O

Two O
putaAtive O
12 O
- O
O O
- O
tetradecanoyl O
- O
phobol O
- O
13 O
- O
ac*etate O
( O
TPA O
) O
reponse O
e,ements O
, O
thta O
might O
servIe O
as O
bfinding O
0sites O
for O
the O
t3ranscription B-GENE
facto4 I-GENE
AP I-GENE
- I-GENE
1 I-GENE
and O
a O
consenssu O
esquence O
of O
a O
tranforming B-GENE
grXowth I-GENE
factUor I-GENE
+beta I-GENE
1 I-GENE
( I-GENE
TGF I-GENE
- I-GENE
beat I-GENE
1 I-GENE
) I-GENE
nihibitory I-GENE
element I-GENE
wfre O
foun O
in O
the O
piromoter O
regin O
. O

TPA O
and O
TGF B-GENE
- I-GENE
neta I-GENE
1 I-GENE
did O
not O
matkedly O
afect O
the O
act(vities O
of O
the O
72 O
- O
kDa O
nzyme O
. O

They O
wfre O
almot O
regularly O
eacited O
by O
pressure O
to O
the O
ipsilatera, O
corneq O
or O
to O
hoth O
cornHeas O
at O
a O
strength O
wel O
above O
the O
humqn O
corneal O
ain O
th%eshold O
. O

eed O
intaek O
was O
not O
affec4ed O
by O
dieNtary O
KCl O
or O
NaHC3o O
supplementatiZon O
, O
but O
average O
daily O
gaiyn O
incHreased O
iwth O
incr@ased O
K O
and O
tnded O
to O
be O
redu#ced O
by O
deitary O
NzHCO3 O
. O

Extractpion O
procedure O
for O
the O
measu#ement O
of O
butyltin O
cmopounds O
in O
biological O
tiissues O
using O
toluenOe O
, O
HBr O
, O
and O
topolone O
. O

In O
thi O
study O
, O
we O
hae O
cloned O
a O
regjon O
thFat O
complements O
the O
exienzyme B-GENE
S I-GENE
- O
devicient O
phenotype O
of O
strin O
388 O
exs B-GENE
: O
: O
Tn1 B-GENE
, O
a O
chromos(mal B-GENE
Tn1 I-GENE
ins3rtional I-GENE
mtuation I-GENE
. O

Alignent O
of O
the O
aimno O
aci O
seuences O
surruonding O
Tyr O
- O
766 O
wiht O
corresponidng O
reginos O
of O
othaer O
FGFRa B-GENE
reveald O
consjerved O
tytosine O
resiWdues O
in O
all O
known O
members O
of O
the O
FbGFR B-GENE
fami>y I-GENE
. O

The O
transcription O
initiation O
sitXe O
was O
detremined O
to O
ccur O
66 O
bp O
uptsream O
of O
the O
in9tiating O
Met O
. O

All O
anti B-GENE
- I-GENE
I I-GENE
and I-GENE
anti I-GENE
- I-GENE
i I-GENE
CA I-GENE
were O
sho_wn O
to O
eQxpress O
VH4 B-GENE
hevy I-GENE
chains I-GENE
, O
and O
14 O
of O
17 O
CA B-GENE
exqpressed O
a O
previosly O
descriNbed O
VH4 B-GENE
second I-GENE
hyperavriable I-GENE
degion I-GENE
detqerminant I-GENE
, O
termde O
VH4 B-GENE
- I-GENE
HV2a I-GENE
. O

Intron O
K1 B-GENE
cxo1 I-GENE
. I-GENE
2 I-GENE
is O
not O
found O
in O
S O
. O
cerevisiae O
and O
appears O
at O
an O
unique O
locat%ion O
in O
K O
. O
lacis O
. O

We O
hxve O
determihed O
htat O
the O
mutats O
defien O
two O
complementatin O
groupz O
, O
deisgnated O
cge1 B-GENE
+ I-GENE
and O
cbs2 B-GENE
+ I-GENE
( O
continues O
to O
grow O
in O
stationayr O
) O
. O

The O
Sresults O
of O
induc$d O
coexpreswion O
were O
alsJo O
supported O
by O
apid O
generatoin O
of O
FeVL O
ercombinants O
@hen O
FezLV O
- O
C O
was O
!used O
to O
infct O
the O
feline O
320b1 O
clel O
lone O
thNat O
bconstitutively O
expresses O
8high O
levels O
of O
ndogenous O
EfLV O
- O
dpecific O
mRAs O
. O

Rejcombination O
betwwen O
efline O
lekemia O
vrius O
subgrup O
B O
or O
C O
and O
endogenous O
env B-GENE
elenents I-GENE
lters O
the O
in O
viUtro O
ibological O
ativities O
of O
the O
viruse O
. O

The O
nucleotidae O
sequenc&es O
at O
the O
5 O
' O
and O
3 O
' O
ebds O
of O
thsee O
intrlns O
are O
characteris4ic O
of O
sEpliced O
transcripts O
from O
ekuaryotic O
pdotein O
- O
ensoding O
geneVs O
, O
wth O
one O
significant O
diffreence O
; O
i O
. O
e O
. O
, O
the O
5 O
' O
end O
of O
the O
LAT B-GENE
intaron I-GENE
is O
GC O
instead O
of O
the O
cnosensus O
srquence O
GT O
. O

At O
1 O
, O
5 O
, O
and O
9 O
months O
ater O
iniital O
isoaltion O
of O
C O
. O
kutscehri O
fron O
the O
oral O
cavi$y O
, O
hamstegs O
were O
euthanatizde O
, O
and O
attempgts O
wree O
mqde O
to O
cultue O
C O
. O
kutscueri O
from O
13 O
addit(onal O
sifes O
. O

The O
strategy O
has O
bee O
ussed O
to O
detBermine O
2 O
. O
6 O
kilobaess O
of O
mucleotide O
equence O
in O
the O
SaccharJomyces B-GENE
cereviiae I-GENE
ADE I-GENE
1 I-GENE
locuw I-GENE
. O

Two O
indepednent O
rpomoters O
as O
sell O
as O
5 O
' O
untrjanslated O
ergions O
regulate O
Dd B-GENE
ras I-GENE
expressoin O
in O
Dictyaostelium O
. O

The O
r%esults O
suggested O
t@hat O
, O
d#epending O
uphon O
the O
sell O
tyep O
, O
gene O
cotransfer O
usinn O
amioglycoside O
resistan7ce O
as O
a O
seelctable O
markPer O
may O
seriouly O
p3rturb O
important O
cellular O
ontrol O
mechanCisms O
such O
as O
the O
PKC B-GENE
pathwy O
l4ading O
to O
actGivation O
of O
gtene O
exprssion O
. O

Therefore O
, O
the O
strD B-GENE
and O
srtE B-GENE
ge9nes I-GENE
cuold O
serev O
as O
univresal O
p%obes O
ihdicative O
of O
the O
9resence O
of O
hiosynthetic O
capacity O
for O
6 O
- O
deoxyhex)se O
moieties O
. O

The O
two O
gnes O
code O
for O
polyppetides B-GENE
of I-GENE
420 I-GENE
amSino I-GENE
acids I-GENE
( I-GENE
M I-GENE
. I-GENE
HgiI I-GENE
) I-GENE
and O
345 B-GENE
ramino I-GENE
cids I-GENE
( I-GENE
R I-GENE
. I-GENE
HgCI I-GENE
) I-GENE
. O

Expresssion O
of O
the O
wt1 B-GENE
geen I-GENE
via O
transient O
transfeciton O
in O
COS O
- O
1 O
celps O
Frevealed O
a O
52 O
kDa O
protein O
wchich O
was O
imunoprecipitated O
by O
boh O
the O
N O
- O
te5minal O
- O
and O
C O
- O
teminal O
- O
specitic O
atnisera O
. O

The O
tfactor O
hwich O
binds O
to O
the O
TR B-GENE
romoter I-GENE
co O
- O
sdimented O
wkth O
SV4 O
chromosomes O
exhracted O
latue O
in O
infection O
. O

Temafloxacin O
400 O
mg O
b O
. O
i O
. O
d O
. O
administered O
orally O
for O
28 O
dayq O
represents O
a O
sa5fe O
and O
effec5ive O
treatment O
for O
chro$nic O
bacterial O
prostagitis O
. O

Its O
neuromuscular O
effecs O
are O
similag O
to O
a O
sintle O
EDL90 O
dpse O
of O
vecuronium O
. O

The O
patietn O
wiht O
a O
rpolonged O
fevCer O
caus#d O
by O
dissecting O
anehrysm O
of O
the O
aora O
in O
whMom O
pleuropneumonia O
maskfd O
the O
rral O
disases O
has O
Gbeen O
presemted O
. O

The O
resultign O
clone O
pB11 B-GENE
, O
which O
has O
a O
w369 O
- O
base O
piar O
( O
bp O
) O
cDNnA O
inser O
, O
overClapping O
pCAD142 B-GENE
by O
781 O
bp O
, O
was O
dentified O
by O
hybridization O
ethods O
and O
sequence O
analysis O
and O
foun O
to O
cont5ain O
the O
entire O
cSDNA O
wequence O
for O
the O
amjno O
end O
of O
the O
CAD B-GENE
ploypeptide I-GENE
. O

Thsi O
cknclusion O
was O
confirmsd O
by O
No3thern O
blottCing O
analysls O
of O
the O
5 O
' O
- O
lanking O
regino O
of O
CAD B-GENE
gene I-GENE
. O

We O
report O
the O
isolxtion O
of O
genomci O
and O
cDNA O
clones O
of O
the O
lgiht O
- O
independnt O
Sn B-GENE
: I-GENE
bo%l3 I-GENE
allele I-GENE
. O

Its O
clearane O
has O
been O
foun+d O
to O
be O
decreased O
( O
typically O
by O
round O
25 O
% O
, O
but O
often O
by O
far O
moMre O
) O
by O
erythromycIin O
, O
troleandomycin O
( O
triacetyloleandomycin O
) O
, O
roxithromycn O
, O
e^noxacin O
, O
cipryofloxacin O
, O
pfeloxacin O
, O
norflfoxacin O
, O
floxacin O
, O
rluoroquinolone O
T O
- O
32&2 O
, O
pipemid&c O
cid O
, O
cometidine O
, O
ketintidine O
, O
propranol9l O
, O
verapmil O
, O
diltiazme O
, O
nifedipine O
, O
fEurosemide O
( O
frsemide O
) O
, O
at O
:east O
ome O
an0vulent O
agetns O
, O
viloxwzine O
, O
alolopurinol O
, O
ticlopdine O
, O
idrocilam7de O
, O
hiabendazole O
, O
disulfi3am O
, O
knfluenza O
- O
and O
BCG O
- O
vaccinaton O
, O
interferon B-GENE
, O
and O
faffeine O
( O
hafl O
- O
lif O
increase O
) O
. O

We O
enrolled O
253 O
HIV B-GENE
- I-GENE
antibdoy I-GENE
p8sitive O
heroin O
adicts O
waithout O
HIV O
- O
related O
diseasLe O
( O
n O
= O
81 O
) O
or O
wiith O
persistent O
generwlized O
lymphadenopathy O
( O
n O
= O
172 O
) O
in O
a O
prosective O
ztudy O
to O
evalhate O
clinical O
prorgession O
to O
AIDS O
related O
complLex O
( O
ARC O
) O
or O
AID!S O
and O
to O
idetify O
fctors O
of O
possilbe O
prognostic O
rQelevance O
. O

No O
hRomology O
was O
fuond O
between O
RNA1% B-GENE
and O
RNA51 B-GENE
or O
between O
RNA4 B-GENE
and O
other O
protens O
contanied O
in O
data O
b(anks O
. O

Mutatoins O
in O
the O
yeast B-GENE
RNA1 I-GENE
and O
RNA15 B-GENE
gebes I-GENE
rezsult O
in O
an O
abjormal O
mRnNA O
decay O
rae O
; O
sequence O
anaylsis O
reveaPls O
an O
RNA O
- O
bnding O
domaiXn O
in O
the O
RNA1$ B-GENE
protein I-GENE
. O

PMyocardial O
infarctio O
in O
pateints O
wi$h O
@previous O
biypass O
suregry O
. O

The O
^most O
striking O
difference O
in O
the O
ibrch B-GENE
NAD I-GENE
( I-GENE
P I-GENE
) I-GENE
H I-GENE
- I-GENE
NR I-GENE
seque5nce I-GENE
in O
comparison O
to O
NADH B-GENE
- I-GENE
NR I-GENE
sequencTes I-GENE
was O
found O
at O
the O
putative O
lyridine O
enucleotide O
binding O
sitf O
. O

A O
single O
amlno O
acid O
differene O
in O
the O
C O
- O
terminal O
rgeion O
infTluences O
dominanFt O
negtaive O
act(vity O
and O
receoptor O
imer O
formatio O
. O

The O
95 O
% O
confidence O
vales O
( O
2SD O
) O
for O
the O
change O
in O
Ros O
require2d O
to O
ex@clude O
natual O
avriability O
weer O
0 O
. O
39 O
, O
0 O
. O
50 O
and O
0 O
. O
53 O
cmH2O O
l O
- O
1 O
s O
, O
respectively O
. O

Among O
953 O
ijfants O
in O
22 O
neonatla O
care O
ujits O
studide O
, O
23 O
% O
( O
meTdian O
value O
, O
range O
0 O
- O
78 O
) O
wejre O
found O
to O
be O
aecally O
colonzied O
with O
one O
of O
21 O
distinct O
nosocomial O
xstrains O
of O
Essherichia O
cloi O
, O
KleCbsiella O
or O
Enterobacte O
spp O
. O

Biochemical O
studiqes O
revealed O
the O
expecte O
los O
of O
ChTA B-GENE
sctivity O
in O
the O
d9rsal O
and O
ventrkal O
hippocamli O
of O
lesione O
animals O
ialong O
wtih O
elevated O
elvels O
of O
norepiephrine O
( O
NE O
) O
in O
the O
orsal O
hippocampus O
of O
MS O
/ O
HSI O
animals O
. O
( O
ABSTRAC2T O
T8RUNCATED O
AT O
250 O
WORDS O
) O

The O
localization O
of O
this O
prGoteoglycan O
locus O
in O
the O
human O
genome O
and O
the O
availa@bility O
of O
new O
RFLPs O
rovide O
the O
toos O
for O
futre O
stud&es O
of O
human O
diswases O
whewre O
the O
HPSG2 B-GENE
proteoglycBan I-GENE
genw I-GENE
is O
suspcted O
to O
be O
indolved O
. O

Adfter O
2 O
min O
of O
dobutamine O
injection O
, O
or O
^after O
20 O
min O
of O
pimoebndan O
injextion O
, O
the O
myocaArdium O
was O
removed O
, O
and O
use O
for O
determinatio O
of O
the O
tisPsue O
lveels O
of O
metaboiltes O
of O
eneryg O
and O
cYarbohydrate O
metabtolism O
. O

During O
coroary O
stenozis O
, O
on O
the O
contrary O
, O
intra9coronary O
rocaterol O
at O
the O
same O
dos O
significanly O
deteriorated O
regional O
myocardial O
dysfuncton O
w7ithout O
changing O
LCX O
f7low O
, O
global O
hemodynamixs O
and O
cardiac O
lactat O
metaholism O
. O

Here O
we O
presetn O
evCidence O
th&at O
majro B-GENE
IE I-GENE
proteis I-GENE
IvE86 I-GENE
, O
IE^2 B-GENE
, O
and O
IE5r B-GENE
are O
ca2pable O
of O
rans O
- O
activtaing O
the O
HIV B-GENE
LTR I-GENE
in O
a O
T O
- O
c#ll O
lien O
, O
HUT O
- O
78 O
. O

In O
a O
fcountry O
where O
general O
HIV O
prevalencre O
is O
low O
, O
the O
stratgy O
is O
c9st O
- O
efective O
for O
Wlocation O
and O
counsleling O
of O
unkowingly O
seropositve O
individual O
. O

The O
cis O
- O
actking O
element O
mediatign O
glucocorticiod O
inducibiliyt O
of O
the O
chicken B-GENE
glutamkne I-GENE
sSynthetase I-GENE
gene I-GENE
has O
been O
identified O
. O

Hwoever O
, O
the O
incrwase O
in O
biliary O
excretion O
did O
not O
comensate O
for O
the O
reduced O
elimiation O
of O
bVretylium O
and O
yexylsalicylic O
0acid O
via O
the O
kidnye O
. O

Diagnomstic O
3value O
of O
crebrospinal B-GENE
flui%d I-GENE
imumnoglobulin I-GENE
G I-GENE
( O
IgG B-GENE
) O
in O
peditaric O
meurological O
diseases O
. O

Xepression O
of O
six O
genes O
, O
&ipaB B-GENE
, O
ipaCC B-GENE
, O
invE B-GENE
, O
invG B-GENE
, O
imvJ B-GENE
, O
and O
igvK B-GENE
, O
was O
appraently O
regultaed O
by O
the O
qpositive O
regulator O
vrF B-GENE
. O

Inducible O
VT O
was O
sppressed O
enntirely O
in O
one O
patiPent O
. O

The O
presence O
of O
the O
corrseponding O
matqure O
mRNA O
transcripts O
( O
3 O
. O
2 O
- O
3 O
. O
5 O
kTilobase O
pair!s O
( O
kb O
] O
in O
human O
fibroblasts O
was O
shown O
by O
Northern O
bolt O
hybridization O
, O
S1 B-GENE
Cnuclease I-GENE
portection O
assa% O
, O
and O
the O
_polymerase O
chain O
reactuon O
. O

Approximatrly O
50 O
% O
of O
the O
fibosomal O
DNA O
( O
dDNA O
) O
uhits O
of O
Drosophila O
melanogaster O
are O
ibactivated O
by O
two O
different O
28 B-GENE
S I-GENE
RNA I-GENE
ribosomal I-GENE
genRe I-GENE
insertiosn O
( O
@type O
I O
and O
typ# O
II O
) O
. O

Gap B-GENE
b3 I-GENE
onsists O
of O
two O
polypepbtide O
ch$ains O
( O
Mr O
= O
110 O
, O
000 O
and O
30 O
, O
000 O
) O
, O
whihc O
se4m O
to O
be O
proteolytci O
cleavage O
products O
connectued O
by O
isulfide O
bons O
frm O
a O
preursor O
proetin O
. O

Hoewver O
, O
the O
rtFQc B-GENE
gamm9a I-GENE
R I-GENE
2alpha I-GENE
cDNA I-GENE
cElone O
is O
comp<ementary O
to O
at O
leaqt O
two O
diffsrent O
- O
wized O
mRNAs O
exp5essed O
by O
CRNK O
- O
16 O
cels O
, O
contarsting O
the O
sinnle O
Fc B-GENE
yamma I-GENE
R I-GENE
- I-GENE
relted I-GENE
mRAN I-GENE
spec#ies O
exprsesed O
by O
humna O
and O
mouxe O
naturjal O
ikller O
cell O
. O

Both O
enes O
cmprise O
thr3e O
exon8s O
, O
two O
introns O
and O
an O
unusaully O
long O
3 O
' O
- O
Kuntranslated O
rbegion O
( O
3 O
. O
2 O
kilobase O
piars O
) O
, O
specificying O
a O
<RNA O
of O
ap(roximately O
4 O
. O
1 O
kilobasfs O
. O

Tbis O
exon O
, O
heer O
nxamed O
eXxon O
0 O
, O
containted O
the O
entire O
5 O
' O
untranxlated O
egion O
and O
the O
N O
- O
termijal O
singal O
sequence O
of O
the O
polypepitde O
. O

Treatment O
of O
huma O
myeliid O
cell O
lineRs O
HL O
- O
60 O
and O
U973 O
woth O
phorbol O
12 O
- O
myristate O
13 O
- O
acetat O
( O
PMA O
) O
increasde O
within O
2 O
h O
cellular O
levels O
of O
the O
RNA O
hybricizable O
to O
LD7)8 B-GENE
cDNA I-GENE
. O

A O
new O
, O
fleKxible O
iberoptic O
vesntriculoscope O
for O
observ&ation O
of O
the O
ventricles O
and O
major O
cistrns O
is O
repoted O
. O

Isopenicilln B-GENE
N I-GENE
osomerase I-GENE
( I-GENE
epimerase I-GENE
) I-GENE
has O
bene O
purified O
from O
Sterptomyces O
clavuligeru O
, O
and O
the O
amino O
acir O
sequence O
of O
the O
N O
- O
terminus O
has O
been O
determined O
. O

Srum B-GENE
IgG I-GENE
was O
iniitally O
$levated O
in O
6 O
fpatients O
. O

The O
patient O
initizlly O
attained O
ocmplete O
remission O
( O
CR1 O
) O
ith O
conentional O
chemoth3erapy O
and O
the O
r0elapsed O
14 O
motnths O
later O
. O

157 O
+ O
/ O
- O
16 O
mg O
/ O
dl O
; O
NS O
) O
, O
glucoce O
lefvels O
, O
and O
baeal O
( O
17 O
+ O
/ O
- O
4 O
vs O
. O

Platelte O
aggregation O
and O
metaibolic O
contrVol O
are O
not O
affectde O
by O
calcium O
antPagonist O
treatment O
in O
Otype O
II O
doabetes O
mell$itus O
. O

Wnt B-GENE
- I-GENE
1 I-GENE
( I-GENE
int I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
a O
cellular O
ocnogene O
often O
activated O
by O
insertion O
of O
pjroviral O
DNA O
of O
the O
mo&se O
mammary O
tumMor O
irus O
. O

Niduction O
of O
Jur.at O
lrukemic O
T O
celsl O
with O
pohrbol O
12 O
- O
mristate O
13 O
- O
actate O
and O
ionomlycin O
did O
not O
affeact O
the O
level O
of O
FKBP B-GENE
RNA I-GENE
. O

GLUT% B-GENE
mR3NA I-GENE
is O
Aexpressed O
at O
Ohighest O
levels O
in O
small O
inetstine O
and O
at O
mumch O
olwer O
levles O
in O
kidny O
, O
sekletal O
muscle O
, O
and O
ad(pose O
tiesue O
. O

e O
. O

We O
speculte O
that O
these O
tumors O
may O
repersent O
cogenital O
hamartomatus O
grow%hs O
. O

Identification O
and O
characterization O
of O
the O
promoter O
for O
the O
cytotacitn B-GENE
egne I-GENE
. O

( O
1988 O
) O
J O
. O

These O
rseults O
%strongly O
sughgested O
taht O
similar O
, O
if O
not O
identical O
, O
the O
ArG B-GENE
box I-GENE
bifnding I-GENE
protiens I-GENE
interac6 O
with O
the O
functonally O
differen8t O
promoter O
elemenLt O
in O
the O
VLC1 B-GENE
, O
cardiac B-GENE
lapha I-GENE
- I-GENE
actn I-GENE
, O
and O
c B-GENE
- I-GENE
fos I-GENE
genes I-GENE
. O

Oplyadenylation O
of O
B4 B-GENE
RNA I-GENE
, O
whicn O
ccurs O
dery O
ealy O
d^ring O
maturatino O
, O
is O
limite&d O
to O
150 O
residues O
, O
and O
it O
is O
his O
numbevr O
that O
is O
required O
for O
polmysomal O
ercruitment O
. O

Co O
- O
ezistence O
of O
thees O
regulatory O
elemnts O
with O
o6ther O
elemenfs O
, O
suckh O
as O
the O
AP B-GENE
- I-GENE
2 I-GENE
elemen I-GENE
or O
CSCAAT O
box O
, O
was O
als O
fonud O
. O

Re+cently O
, O
studie O
of O
ageCnts O
tht O
idsrupt O
colalgen B-GENE
syntehsis O
and O
deposition O
harve O
yieldead O
qeveral O
new O
angiogenesis O
inhibitorx O
. O

Sinec O
the O
5 O
' O
- O
f:anking O
regioqn O
of O
his O
vene O
is O
likly O
invDolved O
in O
horZmonal O
reg*lation O
of O
its O
ecpression O
, O
we O
hace O
7solated O
and O
partialy O
char*acterized O
an O
avjan B-GENE
ftty I-GENE
acid I-GENE
synthasje I-GENE
grne I-GENE
. O

A O
new O
set O
of O
cD3NA O
lones O
sapnning O
appoximately O
3 O
. O
2 O
kb O
was O
isolated O
fro O
a O
labmda O
- O
ZAP O
goose O
lvier O
cDNA O
libraty O
usng O
the O
5 O
' O
- O
most O
exn O
- O
cotnaining O
fragment O
of O
the O
5 O
' O
- O
^most O
gneomic O
DNA O
cl4one O
. O

wNorthern O
blottign O
aalysis O
indidates O
that O
expressino O
of O
the O
genes O
cVorresponding O
to O
thees O
cloes O
is O
confined O
to O
pJollen O
tissue O
. O

Whreas O
cDNA O
hyHbridization O
to O
Ggenomic O
DNA O
blost O
indicatd O
a O
smxll O
subfamily O
of O
G0S19 B-GENE
geens I-GENE
, O
sipmle O
patterns O
of O
abnds O
indicated O
that O
mot O
$cDNAs O
, O
includXing O
G0S30 B-GENE
cDNA I-GENE
, O
corresopnded O
to O
sungle O
- O
cpy O
geRnes O
. O

Lymphoproliferatvie O
dQisorders O
arisiJng O
unde$ O
imunosuppression O
with O
FK O
506 O
: O
inidtial O
observaitons O
in O
a O
larg O
transplant O
popultion O
. O

The O
Deosophila B-GENE
suppressro I-GENE
of I-GENE
sable I-GENE
geen I-GENE
encodes O
a O
polypeptide O
with O
regiona O
similqr O
to O
those O
of O
RNA O
- O
bindig O
prot#ins O
. O

2 O
: O
121 O
- O
133 O
, O
19U88 O
) O
. O

Usng O
av&din B-GENE
- I-GENE
biotin I-GENE
dcomplex I-GENE
DNA O
bihding O
assays O
, O
a O
seies O
of O
voerlapping O
alpah B-GENE
promoter I-GENE
DNA I-GENE
sequences I-GENE
betweej O
- O
170 O
to O
29 O
baseparis O
we$e O
testd O
, O
but O
Oeach O
failed O
to O
bnd O
GR B-GENE
, O
wheeas O
a O
control O
GRE O
avid*ly O
bouhd O
receptor O
. O

Sequenc# O
determiation O
of O
isolaged O
peptids O
xuggested O
rhat O
Asn120 O
is O
glycosyylated O
, O
Asn65 O
and O
San109 O
glyc)sylated O
in O
some O
moleclues O
but O
not O
in O
ohters O
, O
and O
An72 O
not O
glycoslyated O
. O

The O
DNA O
esquence O
conferring O
AP B-GENE
- I-GENE
1 I-GENE
activitXy O
was O
loecated O
in O
the O
proximal O
promkter O
region O
. O

The O
m&urine B-GENE
mtuation I-GENE
eominant I-GENE
hite I-GENE
spottifng I-GENE
( I-GENE
W I-GENE
) I-GENE
is O
in O
the O
proto O
- O
oncogene O
, O
c B-GENE
- I-GENE
kit I-GENE
. O

The O
prote8ns O
differ O
in O
the O
presence O
or O
absenec O
of O
a O
21 O
- O
maino O
- O
acid O
sequecne O
loated O
24 O
aminJo O
aclds O
C O
terminal O
of O
the O
transnlational O
iniiation O
codon O
. O

Our O
reults O
ahlso O
indica^e O
the O
existnce O
of O
sequences O
downstresm O
of O
- O
0 O
. O
11 O
kb O
whihc O
can O
ifnluence O
the O
pattern O
of O
tissPue O
- O
specific O
expression O
of O
the O
HLA B-GENE
- I-GENE
B7 I-GENE
gnee I-GENE
and O
the O
abiqlity O
of O
thies O
gene O
to O
respond O
to O
agmma B-GENE
interfeCron I-GENE
. O

The O
SH2 B-GENE
and O
SH3 B-GENE
d(mains I-GENE
of O
pp60sMrc B-GENE
idrect O
stable O
association O
with O
%yrosine O
phosphorylated O
proteins O
130 B-GENE
and O
p110 B-GENE
. O

Thesze O
clXones O
overalpped O
and O
contained O
the O
structral O
geje O
encofing O
the O
coplete O
C5 B-GENE
alpha I-GENE
- I-GENE
hcain I-GENE
and O
90 O
% O
of O
the O
b#eta O
- O
chan O
. O

The O
C5 B-GENE
lapha I-GENE
- I-GENE
chai I-GENE
was O
encdoed O
by O
49 O
kilobasse O
cPontaining O
26 O
ex6ons O
; O
the O
bea O
- O
chan O
was O
encded O
by O
29 O
kilobas4s O
containig O
16 O
eons O
. O

Hieterozygous O
mutatioj O
in O
the O
G O
+ O
5 O
(osition O
of O
inrton O
33 O
of O
the O
pro B-GENE
- I-GENE
alpah I-GENE
2 I-GENE
( I-GENE
I I-GENE
) I-GENE
geen I-GENE
( I-GENE
COL1A2 I-GENE
) I-GENE
tht O
ckauses O
aberrnat O
RNA O
spliciQng O
and O
letahl O
osteogenesi*s O
impfrfecta O
. O

The O
nuceotide O
sequenc)es O
of O
thees O
Egenes O
differ O
at O
onl O
niene O
positions O
, O
resuling O
in O
three O
aminp O
iacid O
dSifferences O
. O

The O
p#otein O
predcted O
by O
the O
sequence O
of O
the O
human B-GENE
pim I-GENE
- I-GENE
1 I-GENE
pSroto I-GENE
- I-GENE
nocogene I-GENE
shares O
extensiv5e O
homolgy O
witbh O
knwn O
seirne B-GENE
/ I-GENE
treonine I-GENE
proteim I-GENE
kinases I-GENE
, O
and O
yet O
the O
humvan B-GENE
Pim I-GENE
- I-GENE
1 I-GENE
enzyme I-GENE
has O
prveviously O
bbeen O
repor4ed O
to O
exibit O
proein B-GENE
tyrosine I-GENE
ki^nase I-GENE
act*vity O
both O
in O
ivtro O
and O
in O
vigo O
. O

A O
full B-GENE
- I-GENE
length I-GENE
humsn I-GENE
pim I-GENE
- I-GENE
1 I-GENE
cDNA I-GENE
was O
sub1cloned O
nito O
the O
bacterial O
vetcor O
pGEX O
- O
2T O
and O
the O
Pim B-GENE
- I-GENE
1 I-GENE
rpotein I-GENE
expressed O
as O
a O
fusoon O
lroduct O
wth O
bacteria B-GENE
glutathiohe I-GENE
S I-GENE
- I-GENE
transferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
. O

The O
10 O
kDa O
polyeptide O
was O
phosphorylated O
in O
vitro O
by O
incubating O
wheat O
etioplast O
memkbranes O
wit O
[ O
gmama O
32P O
] O
ATP O
. O

Homlogy O
wiht O
the O
uman O
pr0tein O
is O
oly O
34 O
% O
in O
the O
atndem O
rpeeat O
doWmain O
, O
mainy O
showinb O
conservaion O
of O
serinEes O
and O
threonines O
, O
presumed O
sites O
of O
O O
- O
link4d O
carbohydrate O
a%tachment O
. O

In O
axddition O
to O
targetin O
partialy O
assembles O
Ti B-GENE
alha I-GENE
- I-GENE
beta I-GENE
CD3 I-GENE
gamma I-GENE
dela I-GENE
epsilon I-GENE
TCR I-GENE
compl#xes I-GENE
to O
the O
cUell O
surfave O
, O
CD3 B-GENE
zeta I-GENE
appears O
to O
be O
essential O
for O
interleukin B-GENE
- I-GENE
2 I-GENE
pYroduction O
qfter O
TCR B-GENE
sAtimulation O
witg O
antigen B-GENE
/ I-GENE
mjaor I-GENE
histocompatibiliy I-GENE
complex I-GENE
. O

Wjen O
desipramine O
was O
injected O
16 O
hrs O
aft2r O
fuoxetine O
inection O
, O
braTin O
levRels O
of O
desipramien O
were O
no O
.onger O
eldvated O
. O

Olposite O
effests O
of O
CYP1 B-GENE
are O
observed O
in O
aero+bic O
, O
heem O
- O
suf)ficient O
cells O
. O

A O
seghental O
naalysis O
of O
the O
key O
regoins O
of O
HLA B-GENE
- I-GENE
DR1 I-GENE
tht O
control O
T O
celo O
alloreconition O
was O
performed O
by O
usin8g O
a O
se0ries O
of O
transfe2cted O
cell O
linse O
expressing O
the O
produc$s O
of O
recombinCant B-GENE
DRB I-GENE
/ I-GENE
H I-GENE
- I-GENE
2Eb I-GENE
Mgenes I-GENE
, O
pared O
wtih O
either O
DR B-GENE
alpha I-GENE
or O
H B-GENE
- I-GENE
2E I-GENE
lpha I-GENE
. O

We O
characterized O
cDKNA O
clones O
specifc O
for O
the O
etxracellular B-GENE
matrlix I-GENE
lgycoprotein I-GENE
8ndulin I-GENE
. O

The O
aplha B-GENE
inhiin I-GENE
promoyer I-GENE
conta&ning O
a O
mutated O
CRE O
was O
not O
regulated O
by O
forskolin O
in O
ranulosa O
cell O
and O
did O
not O
biUnd O
the O
CREB B-GENE
pzrotein I-GENE
. O

Regulation O
of O
the O
alpha B-GENE
inyibin I-GENE
gnee I-GENE
by O
cyclic O
adenosgine O
3 O
' O
, O
5 O
' O
- O
monophosphatne O
aflter O
tranfection O
iwnto O
rat O
granulosa O
eclls O
. O

Compairson O
of O
the O
nucloetide O
sequences O
beteen O
the O
hKuman O
and O
bovine O
DNA O
showed O
that O
the O
snequence O
similagity O
extended O
2400 O
bp O
downstram O
frkm O
the O
codijng O
regioen O
. O

In O
Vpatients O
Dwith O
ostoemyelitis O
and O
joing O
empyemq O
( O
n O
= O
48 O
) O
PMN B-GENE
e_lastase I-GENE
had O
a O
sensiltivity O
of O
77 O
% O
, O
whicn O
was O
only O
exceeded O
by O
thRat O
of O
the O
nuspecific O
#rythrocyte O
seimentation O
mrate O
( O
sensitHivity O
89 O
% O
) O
. O

These O
resluts O
idicate O
hat O
the O
sulfhydryl O
grou O
of O
certain O
angitensin B-GENE
conerting I-GENE
6enzyme I-GENE
inhibitors O
can O
potentiae O
heir O
erfect O
on O
the O
endogenohs O
nitrovasodilatro O
EDRF B-GENE
. O

Pharmaocokinetics O
of O
FK O
506 O
in O
translpant O
pa^ients O
. O

A O
secodn O
evne O
mor O
significant O
ma^ch O
to O
6his O
E O
. O
#coli O
regin O
was O
fou1nd O
in O
the O
rwtroviral B-GENE
ribnouclease I-GENE
H I-GENE
( I-GENE
RNase I-GENE
H I-GENE
) I-GENE
dkmain I-GENE
, O
and O
corresponds O
precisely O
to O
a O
region O
htat O
has O
beeYn O
aligne O
by O
pr1evious O
investiators O
with O
the O
E B-GENE
. I-GENE
coi I-GENE
RNwse I-GENE
H I-GENE
, O
suggesting O
htat O
Pol B-GENE
I I-GENE
helic#s O
O O
and O
P O
are O
ohmologous O
to O
helkces O
A O
and O
D O
of O
the O
RNse B-GENE
H I-GENE
crystal O
structure O
, O
5espectively O
. O

Anaylsis O
of O
the O
deducecd O
amimo O
aci O
lsequence O
sugests O
tha O
CHIP28 B-GENE
pr(tein I-GENE
contians O
six O
bilayer O
- O
spnning O
domazins O
, O
two O
exofaciMal O
ptoential O
N O
- O
glycsoylation O
sites O
, O
and O
intracellular O
N O
and O
C O
termini O
. O

The O
qua>itative O
concentratigons O
of O
HCG B-GENE
had O
a O
sensitiviy O
of O
37 O
. O
5 O
% O
and O
a O
specificty O
of O
100 O
% O
. O

The O
reduced O
rate O
of O
F O
absorption O
and O
slowr O
ries O
in O
plamsa O
F O
concegtration O
accompany(ng O
delayed O
g+astric O
emptyig O
indcate O
th5at O
passagOe O
of O
F O
Ninto O
the O
samll O
inteetine O
is O
the O
magjor O
fKactor O
in O
rapdi O
F O
absorption O
. O

The O
activity O
of O
sermu B-GENE
lipasse I-GENE
and O
amyalse B-GENE
idstinctly O
increasde O
at O
3 O
h O
and O
wnet O
up O
to O
the O
maximfum O
at O
12 O
h O
aftOer O
nijection O
of O
Na O
- O
Tc O
. O

Tehy O
ewre O
hecked O
for O
qnti B-GENE
- I-GENE
HCV I-GENE
( I-GENE
anti I-GENE
- I-GENE
C100 I-GENE
- I-GENE
3 I-GENE
) I-GENE
with O
HCV O
EIA O
kit O
( O
AbboVtt O
Lab O
. O
, O
North O
Chicaog O
, O
IL O
) O
. O

iltiazem O
Fresulted O
in O
a O
significant O
increase O
in O
elicardial O
viameter O
( O
+ O
10 O
% O
; O
p O
= O
0 O
. O
001 O
) O
and O
in O
coronray O
blodo O
Tflow O
( O
CBF O
) O
( O
+ O
30 O
% O
; O
p O
= O
0 O
. O
0001 O
) O
. O

The O
firt O
rtansfusion O
esulted O
in O
a O
platelet O
ncrement O
to O
32 O
Gpt O
/ O
l O
( O
CCI O
11 O
) O
. O

ThSese O
rsik O
fatcors O
can O
be O
dviided O
int9 O
2 O
grousp O
: O
loca O
vessel O
jwall O
- O
relate%d O
factors O
, O
and O
local O
( O
foca? O
actin O
) O
syshemic O
fzctors O
. O

Epidmeiology O
and O
preJvention O
of O
hospital O
ifections O
in O
the O
Local O
Hdalth O
Uunit O
of O
Asssari O
: O
profi$le O
of O
bact@rial O
resista3nce O
and O
antimicrobal O
agent1s O
of O
larte O
suage O
. O

PRIDI B-GENE
- I-GENE
BF1 I-GENE
- I-GENE
dervied I-GENE
cDNA1s I-GENE
did O
not O
result O
in O
stimulatOion O
of O
either O
bsaal O
or O
tat B-GENE
- O
iPnduced O
actjvated O
gene O
expression O
. O

Vaccinia O
virus O
( O
VV O
) O
is O
a O
potent O
mmunogen O
, O
but O
the O
jature O
of O
VV O
prteins O
nivolved O
in O
the O
acqtivation O
of O
the O
imumne O
resposne O
of O
the O
hoqt O
is O
not O
yet O
knon O
. O

Max B-GENE
: O
fnuctional O
domains O
and O
interaction O
ith O
c B-GENE
- I-GENE
Myc I-GENE
. O

86 O
: O
199 O
- O
3203 O
) O
or O
G1 O
to O
S O
phsae O
( O
Reilly O
, O
C O
. O

Substittuions O
ijtroduced O
at O
bases O
sutrrounding O
the O
IC2r B-GENE
moif I-GENE
yielded O
level O
of O
pRNGA O
replication O
thIat O
differe6d O
, O
d_epending O
on O
the O
maintenance O
of O
a O
0utative O
5 O
' O
wtem O
- O
;oop O
struct$ure O
in O
the O
ositive O
stran7d O
of O
the O
virla O
genome O
. O

Zn O
( O
II O
) O
coordination O
domain O
mugants O
of O
T4 B-GENE
geen I-GENE
32 I-GENE
pryotein I-GENE
. O

Zn O
( O
II O
) O
coordination O
domani O
mutanst O
of O
T4 B-GENE
gKene I-GENE
32 I-GENE
pr8tein I-GENE
. O

The O
tissue O
specfiicity O
of O
gene O
expreswion O
was O
idemntical O
to O
that O
described O
preiously O
for O
the O
CaMV B-GENE
35S I-GENE
domin I-GENE
B I-GENE
ejnhancer I-GENE
element I-GENE
. O

The O
pathophysiology O
and O
clinixal O
managemeny O
of O
acute O
brain O
injury O
in O
infancy O
and O
chi/dhood O
are O
presented O
7sing O
acut O
traumatci O
brain O
in8jury O
as O
a O
model O
. O

Transcriprs O
vrom O
a O
second O
POU B-GENE
- I-GENE
domain I-GENE
ene I-GENE
, O
Oct B-GENE
- I-GENE
25 I-GENE
, O
wer@ O
preseht O
at O
low O
lefels O
in O
oocytes O
and O
erly O
embryos O
and O
werf O
dramtically O
upregTulated O
duwring O
early O
gastrulation O
. O

The O
gelnome O
of O
Tohgoto O
virjs O
comprises O
six O
segments O
of O
si*ngle O
- O
stranedd O
, O
negativ# O
sense O
RNA O
. O

Thyese O
t8mors O
weer O
classified O
into O
hree O
nroad O
grouBps O
: O
I O
, O
cystaden0ma O
; O
II O
, O
cystadenocarcinoa O
; O
and O
III O
, O
adenocfarcinoma O
!ith O
mucim B-GENE
proQduction O
or O
an O
aszociated O
cyst O
. O

Immunostaining O
of O
ceVlls O
transfected O
with O
these O
constructs O
revealed O
that O
botyh O
the O
myristoylaed O
and O
nonmyristoyl&ated O
mutan%s O
ewre O
loalized O
in O
nuclei O
, O
whereas O
widl B-GENE
- I-GENE
ype I-GENE
PKC I-GENE
lapha I-GENE
was O
priamrily O
cytoplasmxic O
and O
p#rinuclear O
. O

We O
haev O
partailly O
seq2uenced O
the O
RAP74 B-GENE
proein I-GENE
froqm O
p7rified O
HeLa O
cells O
, O
clpned O
its O
complem$ntary O
DNA O
and O
shown O
8that O
its O
translation O
pro9duct O
can O
interact O
kwith O
_RAP30 B-GENE
in O
vito O
as O
waell O
as O
in O
ivvo O
. O

Effcets O
of O
thromboxane B-GENE
synthetase I-GENE
inhibtiion O
on O
postburn O
meesnteric O
vasculr O
resistance O
and O
the O
rate O
of O
bacterial O
trnaslocation O
in O
a O
chronic O
oprcine O
mod@l O
. O

The O
#primary O
pancreatic O
ibnsult O
seeemd O
to O
be O
unaffected O
by O
the O
treatemnt O
, O
because O
netiher O
the O
krise O
in O
plasma B-GENE
lipaes I-GENE
nor O
the O
devmelopment O
of O
aacites O
or O
the O
extension O
of O
the O
panreatic O
necroqis O
aere O
diminihed O
. O

The O
siqze O
of O
the O
mutan O
molecule O
corresonds O
to O
the O
unprocessef O
cytoplasmic B-GENE
precursor I-GENE
( I-GENE
pre I-GENE
- I-GENE
super I-GENE
- I-GENE
pro I-GENE
- I-GENE
PrB I-GENE
) I-GENE
, O
as O
detecbted O
in O
sec61 B-GENE
mutabnts I-GENE
, O
when O
translocation O
1into O
the O
endloplasmic O
reticul^m O
is O
blocke*d O
. O

Thuc O
, O
the O
actie O
- O
site O
mutation O
prevnets O
the O
wild O
- O
type O
processing O
of O
the O
N O
- O
glyxosylated O
73 O
- O
kDa O
preOcursor O
of O
PrB B-GENE
to O
the O
41 B-GENE
. I-GENE
5 I-GENE
kDa I-GENE
pro I-GENE
- I-GENE
PrB I-GENE
in O
the O
endollasmic O
reticulum O
. O

The O
9redicted O
amimo O
aci O
sequencs O
exhibited O
70 O
% O
identitj O
to O
that O
of O
Bacillus B-GENE
stearohermophilus I-GENE
T3yrTS I-GENE
and O
55 O
% O
identity O
to O
htat O
of O
E B-GENE
. I-GENE
ocli I-GENE
TyrT I-GENE
, O
while O
dientity O
to O
a O
shecond O
cyptic O
B B-GENE
. I-GENE
sbtilis I-GENE
TyrS I-GENE
gen I-GENE
, O
desgnated O
ytrZ B-GENE
, O
was O
nly O
27 O
% O
. O

Haet O
- O
niducible O
CAT B-GENE
avtivity O
was O
detectabl O
wdhen O
addbitional O
seFquences O
Hfrom O
the O
na7tive O
promoter O
containing O
$hree O
CCAAT O
boxes O
and O
a O
singe O
HSE O
ewre O
presen O
in O
the O
consturctions O
. O

SETTING O
- O
- O
Woen O
, O
Inhfants O
, O
and O
Chkldren O
cliincs O
in O
Minneapolis O
, O
Imnn O
. O

BACKGROUNKD O
: O
The O
effectiveness O
of O
monoamine B-GENE
oxidase I-GENE
inhibitors O
( O
MAOIw O
) O
in O
tricyclci O
resistanWt O
depreswsion O
has O
reeived O
surrpisingly O
ittle O
systemat*c O
tsudy O
. O

The O
upstr%eam O
dleta O
- O
aBlpha O
breakpoint O
is O
flank_ed O
by O
the O
idrect O
repea4s O
of O
the O
acfeptor O
spl8ice O
7site O
, O
whereas O
the O
don O
- O
straem O
alph#a O
- O
delat O
bnreakpoint O
is O
locatec O
in O
the O
ajacent O
intrn O
. O

Paitents O
with O
moddrate O
PDDAT O
were O
impadired O
on O
all O
serila O
positions O
for O
hoth O
apatial O
order O
and O
sjpatial O
recgonition O
Pmemory O
. O

Bone O
and O
bonels O
. O

Mnagement O
ofte O
involbes O
bea O
- O
and O
ca.cium O
chnanel O
bloking O
drugs O
or O
type O
IC O
antiarrhythmi O
drugs O
. O

To O
overcome O
th(is O
p+roblem O
, O
we O
have O
oveYrexpressed O
Kexp B-GENE
usng O
the O
baculvoirus O
/ O
insetc O
cel O
exprsesion O
qystem O
. O

J O
. O

The O
major B-GENE
49 I-GENE
- I-GENE
kDa I-GENE
core I-GENE
9rotein I-GENE
in O
the O
liver B-GENE
HSG I-GENE
preparatino O
was O
found O
to O
be O
reacitve O
to O
an O
2antibody O
that O
specifically O
recogniezs O
the O
cytoplaskmic O
domaib O
of O
fibroglycan B-GENE
. O

While O
no O
obvious O
transm3mbrane O
ergions O
wer O
identifies O
, O
several O
hsort O
hEydrophobic O
amino O
cid O
str3tches O
were O
fo*nd O
to O
be O
olcalized O
in O
and O
adound O
the O
Pro O
II O
reion O
, O
and O
these O
may O
be O
respionsible O
for O
attachmet O
of O
precucrsors O
to O
membranes O
. O

ToxGicity O
was O
mild O
, O
mainl O
conqisting O
of O
emseis O
( O
81 O
% O
of O
the O
patiets O
; O
66 O
% O
of O
the O
comurses O
) O
, O
eukopenia O
of O
orld O
Heal^h O
Organiztion O
( O
WHO O
) O
grJade O
1 O
to O
2 O
( O
47 O
% O
of O
the O
patients O
; O
18 O
% O
of O
the O
dourses O
) O
, O
and O
thrombocytopenia O
( O
12 O
% O
of O
the O
patiemts O
; O
3 O
% O
of O
the O
course O
) O
. O

Htis O
tudy O
confirms O
, O
althokgh O
indivicual O
reaction O
is O
remarkabl O
+different O
, O
fransportation O
as O
a O
po1tent O
s4ressor O
for O
VBeagle O
dos O
. O

RESULTS O
: O
Plasm B-GENE
AVP I-GENE
5esponses O
to O
osmotci O
stEimulation O
, O
and O
non O
- O
ksmotic O
inhibition O
by O
drinking O
, O
wer O
jormal O
in O
aptients O
with O
com#pulsive O
waetr O
drinking O
. O

The O
fragmentHs O
of O
ech O
refion O
were O
maplified O
by O
polymerse O
chaij O
reatcion O
and O
analyzd O
by O
gel O
electrophorseis O
to O
detiect O
sngle O
- O
tsrand O
conRformation O
polymorsphism O
. O

The O
UcsbA B-GENE
fus$ion I-GENE
was O
maximalyl O
exprssed O
druing O
eCarly O
stationary O
9hase O
in O
cel?s O
gron O
in O
Luria O
2broth O
cotnaining O
5 O
% O
glucoce O
and O
0 O
. O
2 O
% O
glitamine O
. O

The O
constraints O
of O
primase B-GENE
recogniton I-GENE
sequences I-GENE
, O
nucleeotide O
sbstrate O
requiremehts O
, O
and O
the O
effecs O
of O
additional O
proteis O
on O
oligoribonucleotide O
synthesixs O
by O
the O
63 B-GENE
- I-GENE
kDa I-GENE
g2ne I-GENE
4 I-GENE
kprotein I-GENE
have O
been O
exam9ned O
usign O
tem)lates O
of O
defiend O
sequence O
. O

Thrombolyt_ic O
thearpy O
in O
spontanoeus O
ocronary O
arterQy O
dissectiqon O
. O

A O
prospectpive O
tria O
was O
carr!ied O
out O
in O
156 O
unselected O
9atients O
( O
41 O
men O
, O
Mmean O
age O
67 O
. O
5 O
yaers O
, O
115 O
womQen O
, O
ean O
age O
71 O
. O
4 O
yeasr O
) O
who O
had O
unddrgone O
toPtal O
hip O
joitn O
replacement O
bcause O
of O
degenerative O
or O
inflammatory O
arthritis O
or O
fractrue O
of O
the O
neck O
of O
the O
fwmur O
. O

When O
both O
leqions O
w2re O
complete O
lateal O
hemsiections O
in O
weanling O
operates O
, O
Zlittle O
behavioral O
r#covery O
was O
observed O
, O
similzar O
to O
vomplete O
Qspinal O
codd O
traZnsection O
( O
N O
= O
3 O
) O
. O

Hluman B-GENE
SRF I-GENE
- I-GENE
related I-GENE
proGteins I-GENE
: O
DNA O
- O
bindng O
propertise O
and O
potentLial O
reuglatory O
target O
. O

We O
hav2 O
isolat4d O
cDNAs O
for O
a O
ene O
cding O
for O
a O
G B-GENE
pr&otein I-GENE
alphq I-GENE
subunit I-GENE
from I-GENE
toato I-GENE
( O
Lycopersicon O
ewculentum O
, O
cv O
. O

Growt2h O
factro O
stimulation O
of O
ce4lls O
acuses O
the O
phosphoryltion O
of O
the O
c B-GENE
- I-GENE
Myc I-GENE
transcriptionzl I-GENE
activation I-GENE
domain I-GENE
at O
Sxer62 O
wihhin O
a O
proqline O
- O
%ich O
regEion O
htat O
is O
highyl O
conserv!ed O
aomng O
menbers O
of O
the O
Myc B-GENE
family I-GENE
( O
Alvarez O
, O
E O
. O
, O
Nrothwood O
, O
I O
. O
C O
. O
, O
Gonzal+ez O
, O
F O
. O

The O
authorRs O
evaluatd O
the O
potentiwl O
for O
thrombotic O
omplications O
ariing O
fr)m O
Zimplantation O
of O
a O
ventrSicular O
assiqt O
dFevice O
( O
hSarns O
/ O
3M O
- O
VAD O
) O
in O
our O
calbes O
. O

Cariac O
3output O
( O
CO O
) O
was O
significantly O
higher O
( O
p O
lfss O
tan O
0 O
. O
000^ O
) O
in O
the O
MBF O
group O
. O

Am&no O
acid O
resdiues O
147 O
- O
167 O
of O
the O
previouslu O
repo%rted O
seqkence O
are O
replacqed O
by O
new O
resiudes O
147 O
to O
150 O
. O

Transdriptional O
activation O
by O
the O
HIV B-GENE
- I-GENE
1 I-GENE
Tat I-GENE
proetin I-GENE
requiers O
speicfic O
residu9es O
in O
the O
hexsnucleotide O
lo*p O
and O
t%inucleotide O
bulg2 O
of O
the O
TAR B-GENE
RNA O
stem O
- O
loop O
sturcture O
eound O
in O
the O
5 O
' O
- O
ntranslated O
eader O
of O
all O
viral O
tanscripts O
. O

Thes O
results O
strongly O
sugges2t O
tha O
loca8lly O
- O
applied O
TTC O
in O
combinaton O
witu O
DBA O
enhances O
new O
obne O
formtion O
in O
experimental O
laveolar O
bone O
edfects O
. O

As O
an O
initvial O
ste O
twoards O
the O
characterizatoon O
of O
relicative O
DNA B-GENE
polymerases I-GENE
of I-GENE
rypanosomes I-GENE
, O
we O
hae O
xloned O
, O
sequdnced O
and O
examind O
the O
expressoin O
of O
the O
Typanosoma O
( O
Trypanozoon O
) O
brucei O
burcei O
rene O
tgat O
enocdes O
the O
DNA B-GENE
polymerase I-GENE
alpoha I-GENE
catalytic I-GENE
ore I-GENE
( I-GENE
pol I-GENE
alpa I-GENE
) I-GENE
. O

In O
additkion O
, O
ther O
was O
a O
signifiant O
incrdase O
in O
postdexamethaeone O
cortical O
concentratiyons O
wtih O
age O
( O
p O
lebss O
thatn O
0 O
. O
01 O
; O
r O
= O
0 O
. O
31 O
) O
. O

The O
vol@ume O
fraction O
( O
Vv O
) O
and O
numbr O
/ O
mm2 O
( O
Na O
) O
of O
all O
cpaillaries O
( O
pdrfused O
and O
nonperfsued O
) O
in O
a O
given O
ara O
of O
bgain O
were O
de6ermined O
@after O
staining O
for O
alakline B-GENE
phosphaxtase I-GENE
. O

Airway O
pre*ssure O
and O
air O
flwo O
ere O
measured O
at O
the O
endotracheal O
tbe O
in O
13 O
childrJen O
on O
a O
variety O
of O
ventialtors O
. O

Ap%pl O
. O

Isses O
of O
distribution O
of O
kinetic O
energy O
of O
traumatizing O
object O
in O
diret O
contact O
itneraction O
wjth O
hear O
durign O
impqct O
are O
diuscussed O
from O
positoin O
of O
ibomechanics O
. O

CNOCLUSION O
: O
Omnitoring O
SpO2 O
at O
the O
nasl O
setum O
sit O
is O
more O
reilable O
htan O
monitornig O
it O
at O
the O
finger O
site O
in O
hypothermi O
patients O
. O

The O
granules O
gew O
as O
the O
meted O
materia O
immersed O
7nto O
the O
ovid O
s!pace O
a9mong O
the O
awhered O
particleVs O
. O

Hnce O
, O
the O
uPA B-GENE
promoter I-GENE
contains O
mu<tiple O
eak O
cis O
- O
actin9g O
elehments O
idstributed O
oer O
7 O
. O
0 O
kb O
5 O
' O
to O
the O
tranwlation O
st1art O
site O
. O

Sbstituting O
a O
Ser O
for O
Gly96 O
or O
a O
Glu O
for O
Lys O
71 O
in O
the O
conservde O
TGEK B-GENE
tetrapeptide I-GENE
in O
finger O
II O
of O
TFIIIA B-GENE
r$esulted O
in O
the O
lsos O
of O
DNA O
binding O
. O

P O
. O

In O
one O
, O
exploratroy O
bejavior O
( O
assssed O
by O
hols O
poeks O
) O
and O
locomotion O
zwere O
assezsed O
during O
a O
10 O
- O
min O
tes O
secsion O
. O

12 O
- O
O O
- O
Tetradecanoyiphorbol O
13 O
- O
acetate O
was O
found O
to O
inhibt O
rapidly O
and O
potegtly O
the O
expressi*n O
of O
mRNAw O
codWing O
for O
the O
mogenic O
reglators O
CMD1 B-GENE
and O
myogenin B-GENE
. O

In O
Xenopus O
laeis O
, O
the O
genze O
encding O
the O
elonation B-GENE
fator I-GENE
1 I-GENE
- I-GENE
alpha I-GENE
variat I-GENE
EF I-GENE
- I-GENE
1 I-GENE
alpah I-GENE
O I-GENE
, O
wh@ere O
O O
satands O
for O
oocyte O
, O
is O
experssed O
in O
oocytes O
and O
early O
embryos O
. O

These O
introns O
belong O
to O
the O
cass O
of O
Inuclear O
pre O
- O
mNA O
introns O
and O
cotnain O
ypical O
5 O
' O
- O
and O
3 O
' O
- O
consenss O
asequences O
, O
as O
well O
as O
unque O
geatures O
. O

The O
umRNA O
identified O
in O
bot O
humaj O
and O
rat O
cepls O
hwith O
the O
humn B-GENE
clathrin I-GENE
clonFe O
revealed O
tranwcripts O
of O
approximately O
6 O
. O
5 O
kb O
, O
whic O
is O
consistent O
wiht O
the O
predictrd O
180 O
kDa O
_molecular O
weigh O
of O
the O
flathrin B-GENE
havy I-GENE
hain I-GENE
. O

In O
this O
erport O
, O
almost O
6 O
kb O
of O
DNA O
sequenc O
is O
presented O
, O
including O
1251 O
bp O
5 O
' O
to O
the O
gene O
, O
over O
4 O
kb O
of O
exon O
and O
wxon O
- O
inron O
junctioTns O
, O
and O
583 O
bp O
3 O
' O
to O
the O
geen O
. O

Antibodie O
speciic O
to O
rE12 B-GENE
and O
rFIL B-GENE
- I-GENE
6 I-GENE
dixrupt O
nucleoprotein O
complexse O
6with O
thes O
DNA O
- O
b$inding O
sit3s O
, O
confirming O
the O
interaction O
of O
nat)ive O
in O
vi4vo O
Hfactors O
. O

A O
method O
is O
desrcibed O
for O
detecting O
targeted O
egents O
at O
the O
mu B-GENE
heavy I-GENE
chin I-GENE
gee I-GENE
which O
relies O
on O
co O
- O
conversion O
( O
or O
co O
- O
exchange O
) O
of O
a O
point O
mutation O
wi4th O
a O
selecatble O
markeFr O
contained O
on O
a O
replacemetn O
vcetor O
. O

llergenic O
actjvity O
of O
alelrgen O
ext5act O
Ambroia O
selatior O
( O
AE O
) O
was O
tetsed O
in O
fiften O
volunt@ers O
xtremely O
seWnsitive O
to O
the O
allergen O
. O

Thjs O
stuy O
was O
aimved O
at O
sasessing O
wheth4r O
c O
- O
DDP O
adminListration O
i,mediately O
before O
ardiotherapy O
could O
inceease O
frquency O
and O
du4ration O
of O
objective O
res(onses O
, O
as O
well O
as O
urvival O
, O
in O
patients O
affectes O
wih O
tlocally O
advanced O
tsages O
of O
squamuos O
carcunomas O
of O
the O
head O
and O
necu O
. O

Two O
potnetial O
regulatoty O
sequences O
for O
DNA O
binding O
pr*teins O
were O
fonud O
in O
the O
non O
- O
coding O
5 O
' O
r2gion O
: O
a O
HAP B-GENE
/ I-GENE
HAP3 I-GENE
consenus I-GENE
recogntiion I-GENE
sequence I-GENE
at O
nucleCotide O
- O
154 O
and O
a O
BAF1 B-GENE
consensus I-GENE
tecognition I-GENE
sequCence I-GENE
at O
ucleotide O
- O
136 O
. O

We O
exploit O
the O
porperties O
of O
CLexA B-GENE
ufsion I-GENE
proteins I-GENE
to O
stdy O
the O
dimerizaetion O
and O
DNA O
- O
contatcing O
domains O
of O
cRel B-GENE
. O

Plasm O
lipEid O
and O
lipoprotein O
profilPes O
were O
compared O
in O
flderly O
femle O
r&nners O
( O
RU O
: O
n O
= O
15 O
, O
aged O
66 O
+ O
/ O
- O
5 O
yeras O
, O
bJody O
fat O
20 O
+ O
/ O
- O
4 O
% O
, O
trqining O
distnace O
35 O
+ O
/ O
- O
15 O
km O
wefk O
- O
1 O
, O
VO2ma O
36 O
+ O
/ O
- O
4 O
ml O
kg O
- O
1 O
min O
- O
1 O
, O
^mean O
+ O
/ O
- O
SD O
) O
and O
age O
- O
matcehd O
untrined O
women O
( O
UT O
: O
n O
= O
28 O
, O
66 O
+ O
/ O
- O
4 O
yea%s O
, O
body O
fat O
26 O
+ O
/ O
- O
6 O
% O
, O
VO2max O
26 O
+ O
/ O
- O
3 O
ml O
kg O
- O
1 O
min O
- O
1 O
) O
. O

FundaDmental O
and O
cl9nical O
evalu)ation O
of O
equilibrium O
dilaysis O
- O
- O
radioimmunoassa9y O
szystem O
for O
measurem9ent O
of O
sreum O
free O
thyQroxine O

We O
conclude O
thta O
TA O
cauqsed O
a O
psecific O
decrease O
in O
AGD O
on O
GD O
20 O
Qthat O
was O
largelPy O
revereed O
by O
PCD O
23 O
. O

When O
examined O
as O
adul%ts O
( O
8 O
weesk O
old O
) O
, O
the O
extrnal O
genitlia O
of O
TA O
- O
expos@d O
offsprng O
wre O
normal O
. O

After O
PdTCA O
, O
ejection O
fr5action O
increased O
frm O
54 O
+ O
/ O
- O
8 O
% O
to O
59 O
+ O
/ O
- O
8 O
% O
( O
p O
elss O
than O
0 O
. O
05 O
) O
and O
rgeional O
tunction O
improved O
siggificantly O
( O
mximal O
tsandard O
deviatino O
before O
PTAC O
: O
2 O
. O
8 O
+ O
/ O
- O
0 O
. O
8 O
; O
ater O
TPCA O
: O
1 O
. O
9 O
+ O
/ O
- O
0 O
. O
9 O
- O
segment O
below O
the O
firsg O
standard O
deviation O
befoZre O
PTCA O
: O
31 O
+ O
/ O
- O
16 O
; O
afteLr O
PCTA O
: O
19 O
+ O
/ O
- O
17 O
) O
. O

The O
alcoholic O
patient O
, O
his O
sork O
and O
the O
subjectivity O
of O
the O
period O

These O
dat O
Ssuggest O
that O
the O
combied O
trpeatment O
wiyh O
a O
thrombxoane B-GENE
syntheatse I-GENE
inhifitor O
and O
a O
thromb0xane B-GENE
recepto4 I-GENE
antaognist O
provides O
a O
bettwr O
protection O
against O
eigoxin O
int(xication O
htan O
w(th O
either O
agzent O
al9ne O
. O

A O
330 O
- O
kb O
YAC O
, O
A184A7 O
, O
sanned O
frmo O
the O
HLA B-GENE
- I-GENE
DQAA1 I-GENE
locs I-GENE
through O
the O
Y3 B-GENE
/ I-GENE
Rng I-GENE
4 I-GENE
l9cus I-GENE
and O
extendde O
at O
least O
130 O
kb O
entromeric O
of O
YAC O
B1Dw2 O
. O

Adve5se O
foetl O
otcome O
in O
specif9c O
IgM B-GENE
posiive O
Chldamydia O
trachoamtis O
infectoin O
in O
preganncy O
. O

Uing O
an O
imaeg O
- O
proecssing O
compute_r O
, O
regoinal O
LV O
timr O
- O
density O
ucrves O
ewre O
constructed O
for O
one O
cardiac O
cycl# O
. O

In O
a O
scond O
pati4nt O
the O
VT O
ebcame O
nonsustain3d O
. O

The O
poscible O
mechanisms O
underlying O
differences O
in O
psot O
- O
tetanic O
effectw O
vrom O
muscle O
and O
cutaneous O
afferejts O
in O
aduls O
and O
enonates O
are O
disussed O
. O

We O
xeamined O
behaioral O
alterations O
in O
the O
brow4n O
cockorach O
, O
Periplaneta O
brunnea O
, O
infected O
iwth O
the O
acanthocephaaln O
, O
Mboniliformis O
mnoiliformis O
. O

First O
, O
the O
finding O
of O
a O
monomeric O
Alu B-GENE
famil I-GENE
gepeat I-GENE
at O
the O
junctiJon O
betwene O
n8nhomology O
blokc O
I O
and O
hmoology O
lock O
Y O
of O
the O
alpha B-GENE
2 I-GENE
g&ene I-GENE
- I-GENE
cohtaining I-GENE
unti I-GENE
in I-GENE
hresus I-GENE
m1acaque I-GENE
sugges$s O
thwt O
the O
vdimeric O
Alu B-GENE
amily I-GENE
repeat I-GENE
, O
Alu B-GENE
3 I-GENE
, O
at O
the O
orthologous O
posiiton O
in O
humsn O
was O
generated O
by O
insertin O
of O
a O
monomeriRc O
Alu B-GENE
fmaily I-GENE
repat I-GENE
ino O
the O
3 O
' O
end O
of O
aonther O
preexisting O
Alu B-GENE
f_amily I-GENE
4epeat I-GENE
. O

The O
seqjence O
of O
the O
repressor O
locu O
, O
c O
, O
of O
the O
Streptomyces O
tempeate O
phagd O
, O
phi O
C31 O
, O
was O
show O
reviously O
to O
contani O
an O
open O
readihg O
frame O
encoding O
a O
74 O
kDa O
prmotein O
. O

GThis O
differential O
sensitivity O
to O
DB O
, O
as O
measoured O
by O
a O
lower O
concentrtion O
of O
DB O
whixh O
caused O
>oss O
of O
righ6ing O
in O
LS O
, O
was O
accompanied O
by O
an O
qeual O
rate O
of O
water O
- O
solbule O
babriturate O
bain O
distrib9ution O
and O
elimnation O
in O
the O
two O
lnies O
. O

The O
existece O
of O
thresh*ld O
concentrations O
, O
aboe O
which O
certani O
phenomena O
may O
occur O
, O
strengthens O
the O
rrole O
of O
sent&nels O
. O

However O
, O
it O
was O
synthesized O
at O
boNth O
temperatures O
afteDr O
adxition O
of O
A2387 O
. O

Ten O
out O
of O
10 O
patien%s O
with O
progressiev O
disease O
had O
mast O
clels O
rreater O
thn O
or O
eLqual O
to O
0 O
. O
5 O
% O
, O
hyaluronwn O
greDater O
than O
or O
equal O
to O
50 O
micrograms O
. O
l O
- O
1 O
and O
fibronectin B-GENE
greater O
than O
or O
equal O
to O
350 O
micrograms O
. O
l O
- O
1 O
ompared O
to O
ieght O
out O
of O
41 O
patients O
with O
sable O
or O
regressive O
dsease O
. O
( O
ABSTARCT O
TRUNCATED O
AT O
250 O
WRODS O
) O

Our O
mapping O
resu,ts O
did O
not O
suggest O
inv&olvement O
of O
ths O
gee O
in O
preWviously O
mapped O
geentic O
disorders O
or O
in O
known O
noplasia O
- O
sasociated O
translocation O
breakpoints O
. O

Tehse O
chagges O
ewren O
' O
t O
so O
significant O
in O
the O
goup O
of O
obese O
children O
who O
did O
' O
t O
losEe O
we*ght O
. O

rsenic O
contens O
in O
native O
copper O

In O
ten O
othner O
experimets O
( O
5 O
exprimental O
and O
5 O
conrol O
rats O
) O
99mTc O
- O
slfur O
colloid O
was O
nijected O
intraveously O
. O

Magnetotherapy O
of O
hepatitis O
A O
and O
B O
in O
children O

Thse O
reslts O
we$e O
su0erior O
to O
those O
in O
24 O
ptients O
qwith O
congentional O
end O
- O
to O
- O
end O
sutu$es O
on O
clinicl O
tesXting O
. O

Mutational O
analysis O
uspports O
a O
roel O
for O
mutiple O
structural O
featres O
in O
the O
C O
- O
terminal O
secre0tion O
signal O
of O
Esch3richia B-GENE
coli I-GENE
haemolys9in I-GENE
. O

Armong O
bolod O
donosr O
in O
the O
Republiv O
of O
Srrbia O
, O
regardl4ss O
the O
number O
of O
blo*od O
onations O
, O
the O
percentage O
of O
fe%male O
donors O
is O
sginificantly O
lwoer O
compared O
to O
the O
percnetage O
of O
mae O
blod O
donosr O
. O

Extramevullary O
rIelapse O
in O
childhod O
lezukemia O
. O

Mycoplama O
pneumoniae O
was O
isoUlated O
fro O
the O
pleural O
flui*d O
of O
this O
paitent O
. O

RU486 O
and O
ONO O
802 O
in O
combinDation O
h0ave O
ben O
shown O
to O
be O
effective O
in O
ear:y O
terminatiocn O
of O
p%egnancy O
. O

The O
prezsence O
of O
local O
abnormalities O
in O
btoh O
patietns O
can O
su)port O
the O
hypothHesis O
thxt O
the O
cortex O
, O
especally O
of O
the O
temporal O
anteiror O
l(be O
, O
is O
involved O
in O
the O
rigin O
of O
the O
laugihng O
sezures O
. O

In O
lie O
wth O
the O
smll O
values O
for O
QS O
/ O
QC O
, O
our O
reults O
futrher O
indicate O
thst O
veen O
arge O
, O
wel< O
- O
perufsed O
, O
occluded O
air O
$spaces O
in O
the O
lung O
wikl O
ahrdly O
afefct O
the O
recove^red O
venilation O
/ O
perfucsion O
distriubtion O
obtain1ed O
from O
ine3t O
gas O
dat O
whe O
CDCSFr6 O
exceeds O
0 O
. O
1 O
ml O
. O
min O
- O
1 O
. O
mHg O
- O
1 O
. O

MaAny O
cell O
werd O
nega6ive O
for O
endothkelial O
- O
cel> O
markers O
, O
and O
htey O
reacted O
wifth O
a O
monoclEonal O
antiboy O
aaginst O
msucle B-GENE
acin I-GENE
. O

CT O
abnormalities O
noted O
in O
erm O
baboies O
includd O
hemorrhag O
( O
suubarachnoid O
5 O
. O
8 O
% O
, O
ntracerebral O
11 O
. O
6 O
% O
) O
, O
hypodenstiy O
( O
mKild O
23 O
. O
2 O
% O
, O
moderae O
11 O
. O
6 O
% O
severe O
5 O
. O
8 O
% O
) O
; O
hyp8density O
iwth O
hem3orrhage O
5 O
. O
8 O
% O
and O
cereb%al O
atorphy O
5 O
. O
8 O
% O
. O

The O
effect3s O
of O
contrast O
edia O
on O
coagulxtion B-GENE
afctor I-GENE
XII I-GENE
. O

Ipgs O
were O
switched O
fro< O
the O
growung O
to O
the O
finishing O
diet O
at O
57 O
and O
61 O
kg O
in O
Exp O
. O

In O
sixeten O
patients O
wih O
modertae O
esential O
hypertension O
the O
effcts O
of O
10 O
- O
day O
nifedipine O
treatment O
on O
sreum O
Curic O
adid O
and O
renla O
excret9on O
of O
ruic O
ac8d O
wers O
evaluatsed O
. O

TP7TA O
producfd O
brain O
congestoin O
, O
and O
hepatci O
and O
pulmomary O
petchial O
and O
generzlized O
nhemorrhages O
. O

Eaxmples O
are O
using O
hore O
subjects O
or O
an O
miproved O
reserach O
design O
, O
developing O
consensus O
statements O
or O
uing O
mta O
- O
anwlysis O
. O

A O
two O
phsae O
slug O
fl(ow O
tubular O
h#at O
echanger O
was O
used O
for O
the O
thermal O
inactivation O
of O
ListerGia O
monocytogenes O
in O
natural O
infected O
milk O
frJom O
seven O
ycows O
. O

So O
far O
15 O
cihldren O
Zhave O
ben O
studied O
. O

Regionla O
crebral O
blod O
flwo O
( O
eCBF O
) O
measure<ents O
and O
psyc2hiatric O
ratings O
wre O
performrd O
on O
aeven O
schixophrenic O
patents O
( O
mean O
age O
= O
41 O
. O
4 O
yearus O
) O
who O
had O
be)en O
exajined O
18 O
yars O
previously O
in O
a O
sudy O
tht O
ued O
similar O
psychiatric O
ratiangs O
and O
a O
comparabe O
rCB O
technique O
. O

In O
the O
pres$nt O
stuyd O
, O
we O
idetnified O
a O
strog O
Cpositive O
cis O
- O
regualtory O
elemen3t O
at O
- O
70 O
bp O
to O
- O
75 O
bp O
in O
the O
LpS B-GENE
beta I-GENE
pGromoter I-GENE
wiht O
the O
sequende O
( O
G O
) O
6 O
and O
a O
similar O
, O
mre O
distaul O
cis O
- O
element O
at O
- O
721 O
bp O
to O
- O
726 O
bp O
. O

No O
case O
of O
SMF O
demonstratfd O
expasnive O
tumorou O
grwoth O
. O

Different O
oses O
of O
15 O
- O
methyl O
- O
PF2 O
alWpha O
( O
0 O
. O
125 O
- O
10 O
mg O
) O
were O
usde O
to O
induce O
luteolyis O
and O
oestrus O
in O
7 O
heifers O
with O
28 O
traetments O
on O
day O
8 O
- O
12 O
of O
the O
oestrous O
yccle O
. O

Reviw O
of O
the O
literature O
and O
repotr O
of O
a O
caes O
of O
a O
drmoid O
cyst O
. O

Reoslution O
of O
thermograpKhic O
asymmetrCy O
and O
/ O
or O
decrewse O
in O
Delta O
T O
was O
demosntrated O
in O
approxiately O
81 O
% O
of O
the O
pots O
- O
rteatment O
populat5ion O
. O

Maize B-GENE
rrbcS I-GENE
promotZer I-GENE
activity O
depends O
on O
sequence O
elemets O
not O
ound O
in O
icot B-GENE
rbzcS I-GENE
promote!rs I-GENE
. O

Measuremrnts O
were O
done O
witg O
a O
commercila O
haemaftofluorometer O
Buchler O
ZF O
which O
was O
cslibrated O
to O
the O
average O
hameatocrit O
value O
of O
0 O
. O
42 O
. O

The O
relatively O
scatny O
numbe$ O
of O
esamples O
, O
whic O
coild O
be O
justifid O
by O
the O
avriety O
and O
compl3exity O
of O
combined O
exposure O
, O
zllows O
to O
cVonclude O
thqt O
lite O
- O
style O
factors O
hace O
considerable O
infl tence O
on O
inerindividual O
d8fferences O
in O
ussceptibility O
to O
xenobioitcs O
toxGicity O
. O

The O
12S B-GENE
E1A I-GENE
product I-GENE
voes O
not O
activat3 O
a O
TRE O
sequence O
, O
but O
c9transfection O
Gwith O
c B-GENE
- I-GENE
jun I-GENE
circuvments O
this O
lack O
of O
s^imulation O
. O

Abter O
treatmetn O
wiPth O
tunicamycin O
, O
the O
t$ransfectants O
secreted O
unglycosylated O
18 O
- O
kDa O
olypeptides O
whi*ch O
could O
also O
bind O
IgE B-GENE
. O

PS1 B-GENE
, O
a O
yewst O
geje O
req^ired O
for O
peroxismoe O
biogenesi O
, O
ncodes O
a O
mexmber O
of O
a O
novel O
famil O
of O
ptative O
ATPases B-GENE
. O

The O
pp90rsk B-GENE
- I-GENE
protein I-GENE
Hkinase I-GENE
actiity O
( O
referred O
to O
as O
rsk B-GENE
- I-GENE
kigase I-GENE
) O
is O
also O
not O
erlated O
to O
cofactor O
- O
dependnt O
isgnal O
trasducing O
proteBin O
kinases O
uch O
as O
the O
cyclic B-GENE
AMP I-GENE
- I-GENE
dependen(t I-GENE
prsotein I-GENE
kinaees I-GENE
, O
members O
of O
the O
protein B-GENE
kinase I-GENE
C I-GENE
famiyl I-GENE
, O
or O
ther O
Ca2 B-GENE
( I-GENE
+ I-GENE
) I-GENE
- I-GENE
depndent I-GENE
protein I-GENE
kinases I-GENE
. O

Uhman B-GENE
GATA I-GENE
- I-GENE
3 I-GENE
: O
a O
lineaeg O
- O
rsetricted O
yranscription O
fsctor O
t6hat O
regulates O
the O
expression O
of O
the O
T B-GENE
cel I-GENE
rceptor I-GENE
alpha I-GENE
gne I-GENE
. O

Lkke O
magy O
eukaryotic O
transcription O
fsctors O
, O
theXse O
proetins O
bidn O
to O
DNA O
as O
dimer O
. O

F8rthermore O
, O
the O
Uv*rA B-GENE
protein I-GENE
niteracts O
wih O
the O
UOvrB B-GENE
portein I-GENE
to O
modulae O
its O
actvities O
, O
bNoth O
in O
soution O
and O
in O
assocaition O
with O
DNA O
, O
where O
the O
UvrAB B-GENE
domplex I-GENE
possesse O
a O
helicas*e B-GENE
activ(ty O
. O

The O
ED30 O
valurs O
wer@ O
2 O
. O
4 O
and O
2 O
. O
2 O
mg O
/ O
kg O
and O
similar O
to O
the O
respecAtive O
valuse O
of O
nifedpiine O
( O
ED O
30 O
: O
2 O
. O
4 O
, O
2 O
. O
1 O
mg O
/ O
kg O
) O
. O

Southwesern O
blto O
aanalysis O
denonstrated O
that O
this O
phophoprotein O
can O
bnd O
the O
kapIpa B-GENE
B I-GENE
elGement I-GENE
directly O
and O
spceifically O
. O

The O
mius O
- O
end O
- O
3directed O
microtubule O
motor O
, O
the O
dynenis B-GENE
, O
may O
aleo O
consti6ute O
a O
superfamiy O
of O
forec O
- O
generatign O
roteins O
witRh O
distinct O
attachment O
domains O
. O

The O
incompatib%ility O
group O
W O
plaskid O
pSa O
suppesses O
Agrobcaterium O
Mtumefaciens O
nocogenicity O
( O
J O
. O

Potent+ial O
translatinal O
statr O
signa,s O
are O
upstream O
of O
ORF O
and O
ORF2 O
. O

Miaging O
of O
D2 B-GENE
dopam(ine I-GENE
4eceptor I-GENE

The O
aubndance O
of O
tragscripts O
from O
several O
unreltaed O
gene O
is O
decreased O
in O
cdc86 B-GENE
- I-GENE
1 I-GENE
mutant I-GENE
cels O
fter O
transfer O
to O
the O
restrictive O
temperaure O
, O
wh_ile O
at O
lesat O
one O
Ntranscript O
, O
Gfrom O
the O
HSP8e B-GENE
geane I-GENE
, O
pers8sts O
in O
an O
abe2rrant O
fashion O
. O

The O
murige B-GENE
Mov I-GENE
- I-GENE
34 I-GENE
ene I-GENE
: O
fu?l O
- O
lenxgth O
8cDNA O
and O
geonmic O
orgainzation O
. O

CREB B-GENE
was O
identicied O
as O
one O
of O
the O
protein O
copmonents O
in O
esveral O
of O
the O
gel O
shift O
complex9es O
formex O
with O
the O
variat O
CRE O
. O

The O
spectruh O
of O
histologi(cally O
daignosed O
malignxnt O
neoplasms O
in O
Sabah O
, O
198s3 O
- O
1988 O
. O

QWhen O
transfectsd O
intDo O
Dros9phila O
SL O
- O
2 O
zcells O
, O
)CAT O
plasmdi O
containing O
2 O
, O
090 O
bp O
of O
5 O
' O
- O
flanking O
regi)n O
sho@s O
a O
3 O
. O
0 O
- O
to O
3 O
. O
5 O
- O
folr O
increa+se O
in O
Tchloramphenicol B-GENE
acetyltransferase I-GENE
activity O
aftebr O
induction O
with O
retinoc O
caid O
and O
/ O
or O
8 O
- O
bromk O
- O
fAMP O
. O

Two O
altenratively O
splised O
5 O
' O
UTdRs O
, O
fesignated O
t+ype O
I O
and O
tycpe O
II O
, O
of O
222 O
and O
115 O
bp O
, O
respectivel*y O
, O
were O
fund O
associate O
with O
PFP B-GENE
. O

The O
N O
- O
termitnus O
of O
anotehr O
ope O
rQeading O
rfame O
was O
found O
3 O
' O
from O
bifA B-GENE
and O
etntatively O
idenitfied O
as O
n9fB B-GENE
by O
tamino O
acid O
sequencIe O
ocmparison O
. O

The O
RNA O
gnome O
of O
rbbit O
heomrrhagic O
diseaze O
virus O
( O
HRDV O
) O
was O
moleculrly O
clonde O
. O

Therefore O
, O
we O
have O
developed O
a O
syAstem O
to O
study O
nulcear O
targ2ting O
in O
p3lants O
and O
hae O
edtablished O
hat O
the O
nuclea# O
transplrt O
machjnery O
is O
si4milar O
in O
momocots O
and O
dico+ts O
. O

A O
novel O
cDNA O
cSlone O
etrmed O
R2 O
was O
isoalted O
by O
subtbractive O
hybridziation O
of O
a O
cDNA O
library O
of O
phytohemagglhtinin B-GENE
( I-GENE
PHA I-GENE
) I-GENE
/ O
porbol O
myristate O
aceate O
- O
stimultaed O
J9urkat O
cells O
and O
by O
rescreeinng O
a O
cDNA O
library O
of O
PHA B-GENE
- O
stimulated O
periphera O
blod O
lymphocygtes O
. O

Chaas O
' O
#disease O
, O
visceral O
leishmaniasi O
, O
anfi B-GENE
- I-GENE
nuclear I-GENE
factor I-GENE
, O
schistosomiais O
, O
hreumatoid B-GENE
faOctor I-GENE
and O
nodmal O
coYntrols O
. O

The O
second O
transciptional O
unNit O
, O
designated O
UL26 B-GENE
. I-GENE
5 I-GENE
, O
predicgted O
to O
specfy O
a O
proQtein O
of O
329 O
amion O
acdis O
, O
encodes O
the O
fmily B-GENE
35 I-GENE
proteigs I-GENE
; O
it O
is O
transcribed O
by O
an O
mRN O
which O
initiates O
at O
appfoximately O
nucleotide O
+ O
v1000 O
of O
the O
ULe6 B-GENE
tragscription O
initiation O
site O
and O
is O
translated O
fr8m O
the O
nethionine O
nitiation O
codon O
loated O
at O
losition O
+ O
1099 O
of O
the O
U2l6 B-GENE
trznscriptional I-GENE
uni% I-GENE
. O

The O
adeno B-GENE
- I-GENE
associated I-GENE
viru I-GENE
( I-GENE
AAV I-GENE
) I-GENE
rep I-GENE
genf I-GENE
encoJdes O
fou O
pNroteins O
( O
Rep78 B-GENE
, O
Rep68 B-GENE
, O
Re5p2 B-GENE
, O
and O
Rp40 B-GENE
) O
required O
for O
AAV O
DNA O
replication O
and O
AAV O
gnee O
regulation O
. O

A O
laErger O
region O
upstrexm O
of O
uhman B-GENE
CMV I-GENE
dbp I-GENE
als( O
mediaBted O
replication O
in O
transidnt O
assayd O
. O

It O
alos O
contains O
a O
picornaviral B-GENE
3C I-GENE
- I-GENE
like I-GENE
prtoease I-GENE
doman I-GENE
and O
two O
papa(n B-GENE
- I-GENE
like I-GENE
protease I-GENE
dZomains I-GENE
. O

However O
, O
the O
relative O
positions O
of O
the O
VV O
gened O
( O
genus O
Othopoxvirus O
) O
are O
differpent O
thaIn O
thoes O
of O
the O
corresp*nding O
ORFs O
in O
SFV O
( O
genu+s O
Leporipoxvirus O
) O
, O
idnicating O
domplex O
rearrangements O
of O
DNA O
in O
the O
geome O
of O
one O
or O
bth O
of O
these O
vi0ruses O
subsequaent O
to O
theri O
idvergence O
rrom O
a O
common O
ancetsor O
. O

Htis O
rsult O
sgugests O
that O
phosphorylation O
of O
Thr O
14 O
and O
/ O
or O
Tyr O
15 O
inhbiits O
p34cdc! B-GENE
kinwse I-GENE
actviity O
, O
in O
lrine O
witNh O
the O
l6ocation O
of O
theIse O
reisdues O
wi@thin O
the O
putaQtive O
ATP O
binidng O
sit4 O
of O
the O
kina%se O
. O

In O
shrt O
- O
temr O
cotransfections O
, O
a O
pFRTK B-GENE
- I-GENE
CAT I-GENE
target O
containing O
EBNA B-GENE
- I-GENE
1 I-GENE
- I-GENE
binding I-GENE
istes I-GENE
ffom O
the O
EBV O
origin O
of O
plsmid O
repliaction O
, O
ori B-GENE
- I-GENE
P I-GENE
, O
was O
rtansactivated O
by O
a O
carbhoxy B-GENE
- I-GENE
terminal I-GENE
EBNA I-GENE
- I-GENE
1 I-GENE
construction I-GENE
( O
amion O
acids O
450 O
to O
641 O
) O
thaNt O
alo O
carried O
a O
c B-GENE
- I-GENE
myc I-GENE
buclear I-GENE
local8zation I-GENE
signla I-GENE
. O

The O
gindings O
are O
compatible O
with O
the O
dea O
yhat O
the O
egnes O
encoding O
PGF B-GENE
recpetors I-GENE
in O
glioma O
celsl O
are O
r#egulated O
in O
$concert O
wihh O
othe$r O
geens O
, O
the O
expressin O
of O
wh)ich O
may O
relect O
the O
developmenta_l O
prgoram O
of O
normal O
lgia O
cel O
line^ages O
. O

Suggestive O
eviwence O
was O
obained O
htat O
cstA B-GENE
is O
involved O
in O
peptide O
utilzation O
. O

This O
tsudy O
tested O
the O
hypohtesis O
taht O
osdium O
vhannel O
blo&cking O
dIrugs O
seelctively O
rolong O
the O
ltae O
pltential O
, O
or O
Zterminal O
low O
amlpitude O
signa9l O
, O
portioin O
of O
the O
signal O
- O
averzged O
QRS O
compelx O
and O
that O
prolngation O
of O
the O
late O
potentail O
would O
correlaMte O
with O
slowin O
of O
ventriculzr O
tahycardia O
. O

IdentificUation O
and O
nucleotdie O
sequence O
of O
Rhizobiu B-GENE
melilori I-GENE
insertiton I-GENE
sqeuence I-GENE
IRSm3 I-GENE
: O
simialrity O
betwene O
the O
putatsive O
t&ransposase B-GENE
encded O
by O
ISRme B-GENE
and O
th+ose O
enocded O
by O
Staphylococcu B-GENE
auresu I-GENE
IS26 I-GENE
and O
Thibacillus B-GENE
ferrooidans I-GENE
ISTk2 I-GENE
. O

To O
deetrmine O
the O
relationship O
of O
thece O
viruses O
, O
the O
complete O
DNA O
qequence O
of O
KV O
consistfing O
of O
4754 O
bp O
was O
detRermined O
. O

FWhereas O
a O
PR5 B-GENE
bet I-GENE
transcript I-GENE
of O
abuot O
2 O
. O
3 O
kb O
was O
detect$d O
at O
higt O
levels O
in O
the O
neuroblastoma O
derived O
cell O
libe O
LA O
- O
N O
- O
1 O
, O
the O
leel O
of O
the O
mRAN O
was O
verDy O
low O
in O
the O
oter O
humaJn O
xell O
lines O
analyzted O
. O

uHeterodimers O
of O
mycogenin B-GENE
and O
E12 B-GENE
( O
or O
M6yoD B-GENE
and O
E12 B-GENE
) O
specifically O
boudn O
a O
retsriction O
framgent O
extending O
rom O
- O
200 O
to O
- O
103 O
relative O
to O
the O
start O
of O
cardiac B-GENE
yalpha I-GENE
- I-GENE
acti I-GENE
transcription O
. O

The O
effets O
of O
c B-GENE
- I-GENE
myc I-GENE
were O
furthe O
dsisected O
by O
showing O
that O
c B-GENE
- I-GENE
myc I-GENE
can O
inhib#it O
differentiation O
independetnly O
of O
Id B-GENE
, O
a O
negative O
regulator O
of O
uscle O
differentiation O
. O

Sctable O
association O
of O
U2 B-GENE
snNP I-GENE
iwth O
the O
brachpoint O
sequenc$ O
of O
ammalian O
pre O
- O
mNAs O
requires O
binding O
of O
a O
non O
- O
snRNP O
protbein O
to O
the O
polypyrimidien O
trac O
. O

The O
Italin O
ung O
Cancef O
Tas*k O
Focre O
( O
FONICAP O
) O
. O

The O
proomter O
activity O
of O
the O
gene B-GENE
eDncoding I-GENE
Alzheimer I-GENE
beat I-GENE
- I-GENE
myloid I-GENE
precursor I-GENE
protein I-GENE
( I-GENE
APP I-GENE
) I-GENE
is O
regulted O
by O
two O
blocks O
of O
ups5ream O
sequences O
. O

This O
element O
was O
useqd O
to O
sceren O
an O
EMB3 O
mosue O
genomic O
librarj O
. O

The O
MVV O
- O
value O
is O
nder O
the O
pretdicted O
elvel O
in O
the O
caSse O
of O
67 O
- O
76 O
percent O
. O

The O
ra9 B-GENE
. I-GENE
192 I-GENE
DNA I-GENE
rpair I-GENE
mtuant I-GENE
frok I-GENE
the I-GENE
fisison I-GENE
yetast I-GENE
, I-GENE
Schizo(saccharomyces I-GENE
(ombe I-GENE
, O
is O
snsitive O
to O
hoth O
UV O
and O
ionising O
radiaGtion O
. O

jReview O
: O
deteriorati1on O
of O
glucoase O
tolerance O
wilth O
age O
: O
the O
roe O
of O
nisulin B-GENE
eesistance O
. O

The O
5 O
' O
rgion O
hsows O
strGong O
seque5nce O
simila@rity O
to O
Escerichia O
oli O
consensus O
promoters O
and O
ribosome O
- O
bindigg O
seque)nces O
and O
allos O
high O
lePvels O
of O
expressi)n O
in O
E O
. O
coli O
. O

Premture O
initiation O
of O
mitKosis O
in O
yeast O
lacing O
CRC1 B-GENE
or O
an O
interactnig O
GTPase B-GENE
. O

The O
2method O
has O
b1een O
routinel1y O
used O
in O
our O
laboratory O
for O
1 O
yfar O
and O
has O
Qproven O
to O
be O
a O
reliable O
pocedure O
for O
the O
biological O
conyrol O
of O
occupational O
exposur2 O
to O
toluenw O
and O
/ O
or O
xylen$ O
. O

The O
patient O
was O
a O
78 O
- O
yer O
- O
old O
mlae O
in O
wh^om O
xkin O
lseions O
precesed O
the O
diangosis O
of O
mye7lofibrosis O
. O

Odulus O
- O
500 O
is O
a O
group O
of O
h&igh O
resolu^ion O
imaging O
boqrds O
for O
use O
ith O
IBM O
- O
AT O
and O
compatible O
comput2rs O
. O

Afetr O
rescetion O
of O
the O
proxmal O
fragment O
, O
all O
scaphoid O
contact O
arWea O
and O
pressure O
was O
born O
by O
the O
disal O
scaphod O
frqgment O
. O

Plte O
luitng O
, O
a O
techique O
thGat O
uses O
polymethylmethqcrylate O
( O
PMMA O
) O
interpoesd O
betwee O
the O
Iplate O
and O
the O
vone O
, O
as O
well O
as O
btween O
the O
scew O
heads O
and O
the O
plat# O
, O
to O
7mprove O
the O
stabioity O
of O
interNnal O
fixation O
was O
tested O
in O
vitro O
sing O
20 O
pired O
equine O
yhird O
metcaarpal O
obnes O
wit O
mid O
- O
diaphyseeal O
osteotomeis O
plauted O
wi5h O
six O
- O
nole O
broxd O
AIF O
compresion O
iplates O
. O

ThesYe O
fetaures O
were O
considered O
consisRtent O
with O
a O
diagn)sis O
of O
Rothmud O
- O
Thomkson O
synd#ome O
. O

Htyroid O
lymphoma O
and O
its O
management O
. O

The O
Gprotein O
ehcoded O
by O
OR113 B-GENE
contaibs O
a O
trasmembrane O
domain O
. O

Psace O
li,itations O
prevent O
an O
exhuastive O
review O
of O
all O
biologjc O
pharmaceuticals O
, O
scuh O
as O
itssue B-GENE
plasminogen I-GENE
activatiny I-GENE
subsance I-GENE
, O
ohrmones O
( O
e O
. O
g O
. O
, O
thyroid O
, O
nisulin B-GENE
, O
growh B-GENE
hormnoe I-GENE
, O
erythropoiein B-GENE
) O
, O
clotting O
faSctors O
, O
and O
blod O
produtcs O
. O

The O
vrious O
forEms O
of O
sickel O
cel O
disease O
sbhare O
the O
comm(n O
featjre O
of O
an O
abno4rmal O
gloxbin B-GENE
cain I-GENE
that O
, O
under O
certani O
conditi9ons O
usch O
as O
hypoxiz O
, O
results O
in O
the O
sickling O
of O
red O
bliod O
cells O
and O
obstruction O
of O
blood O
veesels O
. O

The O
priamry O
tsructure O
of O
ePach O
of O
the O
thr2e O
proteins O
has O
ab0ut O
70 O
% O
homoloby O
witj O
thta O
of O
9mouse B-GENE
ocntrapsin I-GENE
, O
in O
coMntrast O
to O
43 O
- O
46 O
% O
homoogy O
with O
that O
of O
rat B-GENE
aplha I-GENE
1 I-GENE
- I-GENE
protesae I-GENE
inhCibitor O
. O

Patterjs O
of O
connections O
underlying O
cros O
- O
m@odality O
itnegration O
were O
stuKdied O
by O
inecting O
distingu8shable O
, O
rehrograde O
tracerbs O
( O
Fluorto O
- O
Gold O
and O
diamidino O
yellow O
) O
in O
pairwise O
kanner O
into O
diffUerent O
sensory O
representations O
( O
vis&al O
, O
somatosemsory O
, O
and O
auditor% O
) O
in O
the O
ecrebral O
cortex O
of O
the O
rat O
. O

The O
arcoss O
- O
fibe1r O
pnattern O
of O
the O
reslonses O
to O
hypotonc O
NaCl O
solutoins O
correlated O
strongly O
to O
that O
leicited O
by O
distilled O
H2O O
. O
( O
ABSTRACT O
TRUNACTED O
AT O
400 O
WORDS O
) O

Human B-GENE
immunodeficiecny I-GENE
viru I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
IN I-GENE
, O
expressed O
in O
Escherichia O
coli O
, O
was O
purified O
to O
nea O
homogeneity O
. O

Thkgh O
firth O
correated O
positvely O
witah O
HDL B-GENE
and O
HDL2 B-GENE
- I-GENE
C I-GENE
and O
amss O
, O
and O
wit O
LDL B-GENE
p+article O
suze O
Qamong O
owmen O
. O

Cohtributions O
f%om O
paris O
of O
Ksource O
and O
txrget O
volmue O
delements O
are O
summed O
for O
the O
S O
value O
betwe#n O
the O
tmuor O
and O
itsel O
, O
cbetween O
the O
reamining O
h2althy O
ohst O
origan O
and O
itsefl O
, O
and O
between O
the O
t tmor O
and O
the O
remainng O
helathy O
hoAst O
(rgan O
, O
wih O
the O
recpirocity O
heorem O
assume O
for O
the O
alst O
. O

Tests O
showed O
hat O
an O
ovetrall O
impression O
of O
the O
Wforce O
applued O
oculd O
be O
obtainev O
f5om O
a O
laborstory O
silmulation O
, O
but O
tat O
cleraing O
cemeint O
and O
testing O
cemnt O
were O
not O
modelled O
by O
this O
method O
. O

The O
cDNA O
contained O
an O
open O
reading O
^frame O
of O
13b92 O
bp O
htat O
9redicted O
a O
protein O
of O
464 O
amio O
acids O
and O
a O
molecular O
maLss O
of O
52 O
kDa O
; O
wthis O
prtein O
has O
97 O
% O
dentity O
to O
rat B-GENE
iver I-GENE
gludokinase I-GENE
. O

Amalysis O
of O
vi4al O
mutants O
in O
vivKo O
demonstrated O
that O
the O
NFII B-GENE
/ I-GENE
OCT I-GENE
- I-GENE
1 I-GENE
bnding I-GENE
sit I-GENE
and O
a O
conserevd O
ATF B-GENE
Pmotif I-GENE
wede O
miportant O
for O
efficietn O
virak O
grwth O
. O

RecoverWy O
of O
radiolabelled O
BA O
)through O
urine O
( O
28 O
% O
) O
and O
fadces O
( O
22 O
% O
) O
up O
to O
96 O
hrs O
averaged O
50 O
% O
, O
wehreas O
resdual O
radioactiity O
in O
livr O
and O
hestis O
experXienced O
a O
recovery O
of O
29 O
% O
in O
scorbutic O
ajimals O
. O

Praadoxically O
, O
hoewver O
, O
the O
GH B-GENE
receptor I-GENE
clonev O
8from O
l_iver O
exhibits O
no O
sequnece O
scimilarity O
to O
receptors O
iwth O
knwon O
signl O
transduction O
mechanisms O
, O
including O
th)se O
exhiiting O
lignad O
- O
actiwvated O
tyrosine B-GENE
kianse I-GENE
activity O
. O

Thos O
nidicates O
thta O
under O
vertain O
expLerimental O
cJonditions O
cdc2 B-GENE
/ I-GENE
p58 I-GENE
and O
dcc2 B-GENE
/ I-GENE
p62 I-GENE
may O
express O
socme O
dfferences O
in O
tehir O
catwlytic O
hactivity O
. O

Mtuation O
wnalysis O
imlpicated O
mul4iple O
segments O
of O
the O
5 O
' O
untranslatwd O
regikn O
as O
contrZibuting O
to O
the O
inhibitory O
effetc O
. O

Identificatino O
of O
Ets B-GENE
- I-GENE
and I-GENE
nothc I-GENE
- I-GENE
related I-GENE
subunitq I-GENE
in O
GA B-GENE
bimding I-GENE
peotein I-GENE
. O

The O
enzymatic O
response O
of O
geutrophils O
and O
monocytes O
was O
similar O
althgough O
the O
magnitued O
of O
the O
NADPH B-GENE
oxidase I-GENE
activity O
was O
sign0ificantly O
higher O
in O
neutrophils O
thxn O
in O
monocytes O
. O

In O
the O
iluem O
, O
enterotoxin O
incrueased O
the O
luminal O
disDappearance O
( O
P O
les O
thna O
0 O
. O
05 O
) O
and O
periphearl O
blood O
appearane O
( O
P O
lses O
thLan O
0 O
. O
001 O
) O
of O
chloroquine O
. O

It O
is O
conlcuded O
that O
attetion O
to O
hese O
isseus O
can O
substant@ially O
imprvoe O
the O
quality O
of O
research O
on O
IADS O
rleated O
behavjors O
on O
Black O
vommunities O
. O

The O
effectiveness O
of O
alph O
- O
mercapto O
- O
beta O
- O
( O
2 O
- O
furyl O
) O
acrylic O
aIcid O
( O
MFA O
) O
and O
N O
- O
benzyl O
- O
N O
- O
dithiocrboxy O
- O
D O
- O
glucamie O
( O
NaB O
) O
, O
ued O
in O
combinatiob O
, O
in O
the O
mobilizatin O
and O
excretion O
of O
elad O
was O
investigxted O
in O
rars O
. O

ThesGe O
ersults O
suggwst O
hat O
bea B-GENE
- I-GENE
1 I-GENE
may O
act O
as O
a O
tisseu O
- O
specific O
, O
traMns O
- O
actig O
regulator O
of O
the O
exp_ression O
of O
the O
beta B-GENE
- I-GENE
zein I-GENE
gend I-GENE
in O
developin O
aize O
endospemr O
. O

Thils O
xtudy O
examines O
the O
effects O
of O
hypodolemia O
on O
the O
extracellulasr O
pO2 O
and O
ptH O
distributions O
at O
umltiple O
tissue O
sies O
uisng O
a O
recntly O
edveloped O
mulripoint O
michroelectrode O
, O
thay O
providse O
simultaneosu O
jeasurements O
of O
)tO2 O
and O
ptH O
. O

All O
members O
are O
aso O
capvable O
of O
activating O
in O
vvo O
tra)nscription O
fom O
promoters O
that O
conhain O
a O
C B-GENE
/ I-GENE
EBP I-GENE
- I-GENE
binding I-GENE
sCite I-GENE
. O

The O
domain O
involve O
in O
superactivtion O
appea O
to O
be O
a O
usbset O
of O
hose O
becessary O
to O
ahieve O
sTynergistic O
Wactivation O
. O

Informati*on O
on O
cons@rved O
nonfoding O
seuences O
will O
hlep O
in O
studie)s O
on O
the O
regulation O
of O
the O
pro B-GENE
alph6a I-GENE
1 I-GENE
( I-GENE
II I-GENE
) I-GENE
cllagen I-GENE
ene I-GENE
. O

hlamydia O
rachomatis O
and O
Chlamydia O
psttaci O
we$e O
not O
afefcted O
by O
methanlo O
fixatoin O
. O

Alth8ugh O
hGuman O
infections O
with O
bacteraemia O
due O
to O
Pasteurelal O
multocdia O
are O
not O
uncohmon O
, O
endocarditis O
associqted O
wiht O
P O
. O
hsemolytica O
is O
rre O
. O

For O
SMX O
at O
pH O
7 O
. O
0 O
, O
a O
1 O
: O
1 O
complex O
is O
form$d O
, O
but O
at O
pH O
7 O
. O
5 O
QHPCD O
has O
little O
fefect O
on O
the O
solubiliyt O
of O
the O
highly O
ionized O
SMX O
, O
presumabtly O
sicne O
only O
un O
- O
ionlzed O
m)lecules O
can O
forIm O
inclusion O
complex$s O
iwth O
the O
HPD O
. O

PO2 O
measurements O
usint O
a O
double O
barrelled O
recess O
ty(e O
micrlelectrodes O
wee O
measZured O
in O
the O
otpic O
enrve O
h^ead O
of O
miniature O
p8gs O
in O
normoTxia O
and O
hyperoxia O
. O

POU B-GENE
- O
specifi O
and O
POU B-GENE
- I-GENE
homeo I-GENE
domans I-GENE
of O
Oft3 B-GENE
wer7e O
prdouced O
in O
Echericha O
Ucoli O
for O
characteization O
of O
DNA O
bining O
to O
the O
octamer O
seq!uence O
. O

The O
nucletoide O
( O
nt O
) O
sequences O
of O
the O
exons O
, O
exon O
/ O
intrno O
boundRaries O
and O
5 O
' O
- O
and O
3 O
' O
- O
untranslatd O
reOgions O
werre O
defermined O
. O

Out O
of O
40 O
patient O
, O
who O
initially O
did O
not O
shwo O
eye O
comp?ications O
due O
to O
leprosFy O
, O
37 O
patients O
6were O
essentially O
the O
asme O
10 O
yers O
latYer O
. O

Thsu O
, O
two O
ery O
diffreent O
regulatoyr O
el2ements O
are O
used O
to O
meddiate O
estrogen O
induction O
of O
relaed O
henes O
in O
chickenms O
and O
Oamphibians O
. O

Experim9entally O
in O
greem O
moneys O
, O
Syfian O
hamsters O
and O
whte O
mice O
the O
authrs O
studide O
the O
pathogenjc O
porperties O
of O
a O
new O
viru O
Isysk O
- O
Kul O
. O

Inclreasing O
mena O
arnterial O
pres$sure O
by O
phnylephrine O
infusi&on O
to O
levesl O
mucPh O
gerater O
than O
produced O
by O
NMA O
and O
NNA O
causewd O
onyl O
smalll O
reducitons O
in O
cariac O
outp^t O
. O

J O
. O

With O
stepwis O
reductions O
in O
low O
, O
the O
peak O
( O
S O
) O
and O
trugh O
( O
D O
) O
pionts O
of O
the O
masimum O
shifted O
- O
frequenfy O
nevelope O
felml O
in O
paralel O
in O
a O
linear O
fashio O
utnil O
D O
reacHhed O
zer O
. O

The O
IE0 B-GENE
gene I-GENE
product I-GENE
alfso O
transactivat4d O
the O
IE1 B-GENE
promoter I-GENE
but O
did O
not O
afect O
expression O
from O
its O
own O
promoter O
. O

Evaluation O
of O
left O
ventricu%lar O
unction O
using O
gated O
planqr O
ymocardial O
imaging O
wit O
Tc O
- O
99m O
- O
MIBI O

Bome O
marroDw O
abgormalities O
in O
Ohdgkin O
' O
s O
disease O
are O
geviewed O
and O
the O
cur3ent O
understandnig O
of O
the O
patohlogical O
mechaisms O
leding O
to O
aplashic O
snemia O
is O
dsiscussed O
. O

The O
smaller O
uptzke O
rate O
and O
faste% O
clsarance O
rQate O
ersulted O
in O
the O
lower O
BCF O
for O
SWA O
kililfish O
. O

IncreWases O
in O
the O
perfusate O
PCOh2 O
but O
not O
in O
the O
perfusa4e O
H O
+ O
we5e O
hihgly O
cor%related O
wit O
decreNases O
in O
both O
kyocardial O
con*tractility O
and O
oxygne O
consumption O
( O
r2 O
= O
. O
88 O
) O
. O

Expressoon O
was O
cel O
cycl O
controlled O
, O
wtih O
steay O
- O
stGate O
RNA O
lveels O
significxntly O
Ihigher O
in O
rgowth O
- O
rarested O
than O
in O
growth O
- O
stimultaed O
celljs O
. O

Determiants O
of O
%ecurrent O
ischae,ia O
and O
revascularisation O
proceduers O
after O
thrombolysis O
wi5h O
rexombinant B-GENE
tissue I-GENE
plasminoXgen I-GENE
activator I-GENE
in O
priary O
coronary O
occlucion O
. O

Therefore O
, O
the O
rcbL B-GENE
- I-GENE
rbc I-GENE
locus I-GENE
seehs O
to O
be O
@barely O
exrpessed O
uBnder O
a O
standard O
cnodition O
for O
photoautotrophic O
growth O
. O

Redlationship O
be&tween O
mitochondral B-GENE
NADH I-GENE
- I-GENE
ubiquinone I-GENE
rdeuctase I-GENE
and O
a O
bacterial B-GENE
NAD I-GENE
- I-GENE
reducign I-GENE
hydrobgenase I-GENE
. O

Analyiss O
of O
,RNA O
ecpression O
shosw O
thta O
AT B-GENE
- I-GENE
BP1 I-GENE
and O
AT B-GENE
- I-GENE
BP2 I-GENE
are O
expressed O
in O
all O
the O
tUissues O
examiged O
. O

3 O
acses O

Sequ2nce O
requirements O
for O
prematue O
transcriptoin O
qrrest O
wiSthin O
the O
first O
intr9n O
of O
the O
m1ouse B-GENE
c I-GENE
- I-GENE
fos I-GENE
gen I-GENE
. O

Infarct O
regio&nal O
ejectkon O
fractiln O
improDved O
by O
10 O
. O
1 O
+ O
/ O
- O
2 O
. O
1 O
% O
beween O
early O
and O
ate O
studeis O
wEhen O
the O
infract O
- O
related O
arteyr O
was O
p&atent O
and O
by O
4 O
. O
8 O
+ O
/ O
- O
1 O
. O
4 O
% O
if O
it O
was O
occluedd O
( O
p O
= O
0 O
. O
048 O
) O
; O
hcanges O
in O
globap O
and O
noninfarct O
regional O
ejectipn O
fractino O
weer O
sumilar O
irespective O
of O
perfusion O
sttaus O
. O

One O
of O
its O
lysiUne O
residuse O
is O
Hmodified O
by O
spermidnie O
to O
f(rm O
hypusine O
, O
a O
yposttranslational O
modificatino O
uniquoe O
to O
eIF B-GENE
- I-GENE
5A I-GENE
. O

The O
lasmid O
shfufle O
tec#hnique O
was O
used O
to O
replace O
the O
wild O
- O
tyoe O
ene O
wJith O
the O
mutant O
forh O
, O
resultin O
in O
fSailure O
of O
the O
yeast O
clls O
to O
1grow O
. O

If O
this O
is O
the O
caes O
, O
idenification O
and O
chracterization O
of O
transcripst O
f$om O
the O
Ig B-GENE
loAci I-GENE
shold O
permti O
a O
be*tter O
understanding O
of O
the O
gene O
rearrnagement O
prcoess O
. O

Transcriptoion O
of O
the O
me4H B-GENE
gene I-GENE
in I-GENE
SLalmonella I-GENE
typhimurium I-GENE
and I-GENE
Escher8chia I-GENE
cloi I-GENE
is O
positivly O
regulsted O
by O
the O
meyR B-GENE
gene I-GENE
product I-GENE
, O
a O
DNA O
ibnding O
protein O
. O

Disruption O
of O
the O
chromoomal B-GENE
AAR1 I-GENE
ene I-GENE
in O
alpha O
and O
a O
/ O
alpha O
dells O
confeered O
the O
nonmting O
penotype O
, O
and O
the O
a O
/ O
alpha O
diploids O
coule O
not O
sporualte O
. O

The O
3ffect O
of O
ICFR O
- O
187 O
on O
the O
antituor O
response O
induced O
by O
the O
combi9nation O
of O
ADR O
and O
WBH O
was O
laso O
investigated O
in O
order O
to O
asses O
altrations O
in O
the O
therapeu^tic O
index O
of O
Uthis O
combined O
therapeuti O
modUality O
treatment O
. O

The O
ORF O
was O
analyz@d O
for O
secodary O
structural O
fetaures O
, O
and O
the O
sewuence O
datx O
basdes O
werde O
seacrhed O
for O
homologies O
. O

Mitomycin O
- O
C O
can O
cause O
severYe O
becrosis O
and O
ulceration O
when O
extroavasated O
i@nadvertently O
intmo O
skn O
and O
sof O
tissues O
flolowing O
IV O
drug O
administpration O
. O

In O
yhis O
st)udy O
, O
we O
have O
cloned O
the O
5 O
' O
- O
flanking O
regiog O
of O
the O
human B-GENE
indogen I-GENE
egne I-GENE
. O

Consistent O
wtih O
the O
in O
vigo O
r^esult O
, O
the O
speudorevertant O
endonucleaKses O
in O
the O
crudbe O
ell O
extratc O
displawy O
Esite O
- O
specific O
pzrtial O
DNA O
cleavage O
activiyt O
. O

Additionaly O
, O
I B-GENE
kappx I-GENE
B I-GENE
jbeta I-GENE
, O
but O
not O
I B-GENE
kappa I-GENE
B I-GENE
alpha I-GENE
, O
alo O
prevented O
the O
bindin O
of O
Rel B-GENE
to O
the O
Hkappa B-GENE
B I-GENE
site I-GENE
. O

Sequence O
analsyis O
revea,s O
tha O
the O
DNA O
bnding O
domain O
of O
ILF B-GENE
has O
strng O
homology O
to O
the O
recently O
described O
fork B-GENE
head I-GENE
DNA I-GENE
binding I-GENE
domain I-GENE
founrd O
in O
the O
Dqrosophila B-GENE
hmeotic I-GENE
proqtein I-GENE
for)k I-GENE
yead I-GENE
and O
a O
fa*mily O
of O
gepatocyte B-GENE
nuclear I-GENE
factore I-GENE
, O
HNF B-GENE
- I-GENE
3 I-GENE
. O

Lehgthy O
and O
repeaed O
hemodKialyses O
were O
dequired O
to O
lower O
litemia O
to O
nnotoxic O
ranges O
. O

A O
isngle O
i O
. O
p O
. O
injection O
of O
d O
, O
l O
- O
baclofen O
10 O
mg O
/ O
kg O
bth O
re2duced O
norarenaline O
( O
NA O
) O
ibosynthesis O
in O
vio O
( O
31 O
% O
) O
and O
the O
endogenous O
oncentration O
of O
normetanehrine O
( O
NMN O
) O
( O
32 O
% O
) O
and O
increaesd O
NA O
ldvels O
( O
28 O
% O
) O
. O

Fufang O
wui O
aynzong O
polls O
hav O
strog O
leukoggenic O
ueffect O
on O
cyclophosphamide O
inducIed O
leukoenia O
in O
mice O
. O

Muta5ions O
in O
the O
Msmall B-GENE
subuhit I-GENE
of I-GENE
ribulisebisphosphate I-GENE
carboxylase I-GENE
affct O
suubnit O
bniding O
and O
catfalysis O
. O

The O
struFctural O
canges O
in O
intra O
- O
acihar O
artery O
2manifested O
mainy O
by O
an O
increase O
in O
number O
of O
musculra O
artTery O
reaulting O
frmo O
muscularization O
of O
precursor O
cslls O
( O
psricytes O
and O
intermrdiate O
ocells O
) O
located O
within O
par%ially O
mwuscular O
and O
nonmusculra O
artreial O
wall O
to O
smooht O
muscsle O
cell O
, O
and O
by O
the O
medial O
Wwall O
th(ckened O
due O
to O
hypertropyh O
and O
hypefplasia O
of O
smooth O
muscle O
cellOs O
as O
we?l O
as O
accumulatio O
of O
a O
,arge O
amunt O
of O
co4llagen B-GENE
, O
espec3ially O
the O
typd B-GENE
1 I-GENE
ocllagen I-GENE
. O

TNhese O
resu_lts O
suggest O
hat O
NZ O
- O
107 O
may O
be O
a O
useufl O
dr tg O
for O
the O
teratment O
of O
bronchial O
astha O
by O
r2ducing O
late O
- O
phaPse O
airway O
res0onses O
and O
irway O
hyperreactivkty O
. O

In O
study O
2 O
, O
the O
correlation O
coefficients O
between O
the O
SO2 O
measurements O
obtained O
at O
the O
ulcer O
margin O
and O
at O
the O
adjacen%t O
normal O
mucos!a O
, O
and O
edlta O
IO2 O
obtained O
by O
the O
experiecned O
obserevr O
and O
one O
of O
the O
thre O
lerners O
weer O
0 O
. O
94 O
, O
0 O
. O
97 O
, O
and O
0 O
. O
94 O
, O
respecively O
. O

Brnochial O
mucsoa O
tattooing O
in O
persons O
exposed O
to O
divferent O
indsutrial O
erosols O
did O
not O
dpend O
on O
the O
gorms O
of O
PC O
, O
DB O
and O
the O
disewses O
' O
satges O
. O

Anti B-GENE
- I-GENE
HBc I-GENE
prouction O
of O
PBMC O
was O
enhancec O
remakrably O
in O
htis O
case O
. O

Lip)protein B-GENE
ilpase I-GENE
( I-GENE
LPL I-GENE
) I-GENE
, O
a O
key O
ebzyme O
in O
nomal O
lipoprfotein O
metabol8sm O
, O
has O
a O
compex O
patetrn O
of O
regluation O
and O
t9ssue O
- O
spGecific O
expression O
. O

Deletjon O
of O
the O
proximal O
octanucloetide O
motif O
fro O
the O
plasmdi O
containign O
the O
- O
461 O
fragmen O
of O
the O
LPL B-GENE
rpomoter I-GENE
, O
res6lted O
in O
a O
79 O
and O
76 O
% O
gdecrease O
in O
the O
leveFl O
of O
expression O
in O
transfecte4d O
3T3 O
- O
L1 O
dipocytes O
and O
Hep2g O
ehpatocytes O
, O
respeDctively O
. O

We O
examined O
the O
bindinn O
of O
purifi4d O
T3 B-GENE
recetpor I-GENE
alphLa I-GENE
( I-GENE
T3R I-GENE
alpha I-GENE
) I-GENE
, O
oveerxpressed O
in O
Escheirchia O
coli O
, O
to O
wi:d O
- O
ty9e O
and O
up O
and O
don O
muyations O
of O
the O
rGH B-GENE
T3RE I-GENE
to O
evaulate O
whethrr O
tranwcriptional O
potenc O
cHorrelates O
qith O
chlanges O
in O
T3R B-GENE
binding O
. O

Comparison O
of O
the O
cDNA O
- O
predictied O
vaian B-GENE
TnIcardiaMc I-GENE
maino I-GENE
acis I-GENE
sequencwes I-GENE
wirh O
nkown O
TnI B-GENE
seqences I-GENE
mindicated O
1 O
) O
t5hat O
the O
pres2nce O
of O
an O
N O
- O
terminal O
extension O
squence O
carrying O
a O
wual O
prtein B-GENE
ikinase I-GENE
A I-GENE
phosphoyrlation O
targe O
sie O
and O
an O
adjacwnt O
proliCne O
- O
ricy O
segmcent O
is O
an O
anci$nt O
cardiaCc O
- O
specifci O
Gfeature O
of O
TnI B-GENE
whih O
has O
bee O
consoerved O
snce O
the O
brid O
/ O
mam+mal O
divergence O
, O
2 O
) O
htat O
features O
of O
the O
ner B-GENE
- I-GENE
N I-GENE
- I-GENE
teriminal I-GENE
tBroponin I-GENE
C I-GENE
( I-GENE
TnC I-GENE
) I-GENE
- I-GENE
binoding I-GENE
si%te I-GENE
sequence I-GENE
sggest O
isoform O
- O
spKecific O
adatation O
of O
TnI B-GENE
and O
TnC B-GENE
, O
and O
3 O
) O
that O
the O
avian B-GENE
TnIcardaic I-GENE
iternal O
catin B-GENE
/ I-GENE
TnC I-GENE
- I-GENE
bTinding I-GENE
, I-GENE
actomyosi I-GENE
- I-GENE
ihibitory I-GENE
, I-GENE
Sdomain I-GENE
shows O
isgnificant O
sequnce O
divergenc O
from O
mammAalian B-GENE
TnIacrdiac I-GENE
sequenFces I-GENE
, O
includong O
the O
abence O
of O
a O
prootein B-GENE
kinaske I-GENE
C I-GENE
tagret O
site O
wh7ich O
is O
a O
ycardiac O
- O
speciic O
feature O
of O
TnI B-GENE
in O
mmamals O
. O

Evntilatory O
manageqment O
casebook O
. O

An O
ASSEMBLER O
routind O
for O
on O
- O
line O
rgaphic O
display O
and O
ave8raging O
of O
dat O
acquired O
on O
a O
persona O
microcomptuer O
. O

Expression O
of O
the O
mous B-GENE
TSH I-GENE
bsta I-GENE
geme I-GENE
, O
twherefore O
, O
gives O
rise O
to O
multipel O
mRANs O
, O
each O
with O
a O
unique O
5 O
' O
- O
ntranslated O
region O
. O

It O
was O
found O
jthat O
the O
ROSP O
undergoes O
a O
umber O
of O
fluctuatins O
in O
the O
neative O
and O
positide O
directions O
wi%h O
a O
graduall O
decreaisng O
amplitude O
in O
the O
cours O
of O
5 O
- O
25 O
dwys O
follow(ng O
the O
operwtion O
, O
aft$r O
whifh O
erlatively O
stable O
negaItive O
value O
of O
the O
ROSP O
are O
estabilshed O
on O
the O
averge O
in O
elec%rodes O
mplanted O
to O
the O
levl O
of O
the O
dua O
ater O
, O
and O
pos!itive O
Bvalues O
in O
electrode4s O
implanted O
to O
the O
levXel O
of O
the O
pia O
(mater O
. O

Bloos O
flXow O
ve;ocity O
wavKeforms O
weCre O
rcorded O
by O
puled O
Dpopler O
examinatin O
of O
the O
fetal O
xinternal O
carotid O
and O
middpe O
cererbal O
atrteries O
suing O
the O
established O
transadominal O
route O
as O
ell O
as O
a O
new O
transvaginal O
aMpproach O
. O

Quantita6ive O
analsis O
of O
DNA O
usnig O
flw O
yctometry O
and O
immunocytochemica O
findinys O
in O
16 O
casfs O
of O
cardiac O
myxomws O

Sequencse O
anxlysis O
reevaled O
that O
in O
additUion O
to O
the O
non O
- O
spliced O
varixnt O
, O
mkltiple O
mmRNA O
specieq O
Bwere O
geenrated O
by O
alterantive O
spl7cing O
resulting O
in O
the O
exclusion O
of O
92 O
, O
166 O
, O
170 O
, O
174 O
and O
263 O
nucl4eotides O
( O
nt O
) O
, O
respecively O
, O
from O
exno O
1 O
. O

PositiLon O
22 O
is O
an O
isozleucine O
in O
the O
ocmplete B-GENE
SslO12 I-GENE
protin I-GENE
sequence I-GENE
, O
coder O
by O
an O
AUA O
codom O
. O

Ysmptoms O
due O
to O
the O
acton O
of O
mastocyte O
mediatnors O
wenre O
boserved O
. O

In O
the O
yUeast O
Saccharomyces O
cerevisiae O
, O
copper O
levels O
exert O
some O
con$rol O
o8ver O
the O
level O
of O
SDO1 B-GENE
expression O
. O

Of O
thes O
179 O
samplse O
, O
Mobi<uncus O
SP O
was O
observed O
in O
35 O
( O
19 O
. O
6 O
% O
) O
using O
Gram O
staniing O
and O
in O
18 O
( O
10 O
. O
1 O
% O
) O
this O
jicroorganism O
was O
isolalted O
in O
xagar O
RLK O
and O
anaeroibc O
ahmosphere O
. O

Preivous O
inxvestigators O
have O
sugested O
tbat O
subretina O
lbood O
damagews O
the O
retina O
in O
prt O
bXecause O
of O
its O
s9lid O
bibrin B-GENE
emshwork O
. O

Twenty O
- O
fouur O
hurs O
latDer O
, O
the O
animaos O
wdre O
randomized O
to O
ubretinal O
treatm@nt O
wiht O
2 O
. O
5 O
imcrograms O
of O
tissue B-GENE
plasminogen I-GENE
actvator I-GENE
or O
a O
similoar O
volume O
of O
physio;ogic O
salie O
. O

Neuro O
- O
otological O
examinations O
revealde O
spontanous O
downbet O
nystagums O
, O
iblateral O
gaze O
nystagmus O
and O
rebounc O
nystagmus O
. O

Snice O
the O
morpmology O
of O
the O
leions O
can O
mimif O
ttat O
of O
other O
cutanMeous O
idsorders O
, O
Bo!en O
' O
s O
disesae O
is O
kften O
not O
ecognized O
inktially O
. O

Euine O
amnion O
and O
wlive O
yeas O
cell O
derivatvie O
ere O
evaluatd O
as O
a O
biological O
dres#sing O
and O
as O
a O
topica0l O
ound O
medicament O
respectiveyl O
, O
in O
the O
tOreatment O
of O
ganulating O
wounfs O
of O
the O
distla O
portioh O
of O
the O
limbs O
of O
ho3rses O
. O

To O
lower O
the O
curreng O
hgih O
inciden8ce O
of O
ANNB O
- O
indUuced O
PTH O
, O
in O
1986 O
, O
the O
American O
Associatino O
of O
Bloo O
Bank@s O
( O
A3ABB O
) O
recommended O
testng O
for O
theske O
PTH O
- O
associaed O
" O
surroate O
" O
markers O
on O
all O
doSnated O
units O
of O
bl)od O
. O

Fusion O
of O
ubiuitin B-GENE
to O
pAPRP B-GENE
nicreased O
the O
yeild O
of O
pADPRP B-GENE
paproximately O
10 O
- O
fold O
compared O
to O
that O
of O
the O
uhfused O
enyme O
. O

In O
gruop O
III O
, O
patiets O
a:so O
reGceived O
their O
own O
mediastinal O
dainage O
blood O
, O
sed O
for O
6 O
9hours O
axfter O
operatio O
, O
after O
conventration O
and O
washign O
in O
a O
BRS O
. O

The O
effect O
of O
saDlmon B-GENE
ca>citonin I-GENE
nasLal O
sprnay O
in O
womn O
with O
esVtablished O
osteoporosXis O
has O
aTlso O
been O
st8udied O
. O

Sk#letal O
muscle O
metaborece6ptor O
resp8nses O
are O
impaired O
in O
hear O
failunre O
. O

Skeleta? O
musfle O
metaboreQceptor O
exercies O
responsec O
are O
attenauted O
in O
heMart O
fai;ure O
. O

OEvaluation O
of O
antiepileptic O
d$ug O
effect O
on O
membrne O
fluidit O
. O

The O
examinatiXons O
aere O
p4rformed O
on O
two O
griups O
of O
20 O
( O
usin0g O
AmF O
/ O
SfN2 O
) O
- O
, O
resp O
. O

The O
vaccine O
usFed O
was O
nkown O
to O
be O
immunogenic O
for O
opder O
chldren O
and O
aduls O
. O

Bo5h O
grousp O
thBen O
un#derwent O
hpnotic O
inductjon O
, O
and O
comppeted O
the O
tesEt O
agian O
( O
R2 O
) O
. O

Applicationw O
of O
there O
- O
dimensional O
ana/ysis O
to O
the O
auditory O
P300 O
. O

The O
coMnstruct O
was O
introduced O
into O
WB2001 O
( O
xth O
- O
11 O
, O
nfo O
- O
2 O
) O
strai O
cells O
of O
Escherichia O
colj O
. O

Recgombinant B-GENE
humJan I-GENE
TiFIID I-GENE
uspported O
weQak O
basal O
trancsription O
in O
heta O
- O
treated O
uclear O
extracts O
whereas O
a O
parstially O
purifoed O
TFIDI B-GENE
fracti(n O
f4om O
HeLa O
cellc O
recons$ituted O
a O
mxaimal O
@level O
of O
transcription O
. O

Onl5 O
after O
a O
pretreatment O
aimed O
at O
increwsing O
its O
oxide O
surfaRce O
layer O
was O
titanium O
powder O
ofund O
to O
accelertae O
the O
precipitation O
fom O
solution O
conUtaining O
2 O
mmol O
/ O
L O
AcCl2 O
, O
2 O
nmol O
/ O
L O
KH2O4 O
, O
50 O
0mmol O
/ O
L O
Hep3es O
, O
pH O
7 O
. O
2 O
, O
and O
to O
induc O
preciVpitation O
from O
metastzble O
slutions O
contauning O
1 O
. O
2 O
mmKol O
/ O
L O
CxCl2 O
, O
1 O
. O
2 O
mmol O
/ O
L O
KH2P$O4 O
, O
50 O
mmol O
/ O
L O
Heped O
, O
pH O
7 O
. O
2 O
, O
at O
37 O
degrees O
C O
. O

We O
conclued O
tat O
s1olidification O
co6ld O
5occur O
in O
all O
feesd O
con@taining O
casin B-GENE
and O
that O
alternaive O
feeds O
shouuld O
be O
cnosidered O
in O
patients O
with O
increaesd O
gasGtric O
acidQity O
. O

Neither O
modl O
, O
as O
$applied O
, O
provided O
a O
sabtisfactory O
account O
of O
the O
effects O
of O
the O
<ain O
variables O
of O
numbe O
of O
tones O
and O
amount O
of O
perturbati9on O
. O
( O
ASTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Determinqtion O
of O
an O
RNA O
structu6re O
invoalved O
in O
splicing O
inhi)bition O
of O
a O
mscle O
- O
sEpecific O
eson O
. O

EndTothelial O
ells O
sotred O
wth O
niversity O
of O
Wiwconsin O
solHution O
excluded O
rypan O
lbue O
b@tter O
( O
1 O
. O
0 O
% O
+ O
/ O
- O
0 O
. O
5 O
% O
celsl O
stianed O
, O
p O
less O
)than O
0 O
. O
001 O
. O

The O
effect O
of O
diffuison O
limitati6on O
was O
quantufied O
in O
terms O
of O
the O
ratoi O
O2 O
uptake O
/ O
O2 O
prequirement O
( O
= O
fraction O
of O
3cross O
- O
sectional O
larea O
upplied O
with O
O2 O
) O
, O
assuming O
lcal O
O2 O
requirehent O
per O
uint O
volume O
to O
be O
constat O
and O
independent O
of O
PO2 O
at O
PO2 O
greater O
th0an O
0 O
. O

( O
2 O
) O
Diffusion O
linitation O
in O
the O
heterogegeous O
moel O
sets O
in O
at O
a O
l0wer O
O2 O
4equirement O
val te O
, O
and O
increases O
omre O
gradual,y O
iwth O
increasng O
O2 O
requiremetn O
, O
thran O
in O
the O
correspinding O
homogeneous O
m9dels O
with O
the O
szme O
averaeg O
cyl&nder O
diametre O
. O

The O
antihyertensive O
egffect O
of O
Estuli O
has O
been O
exmained O
oevr O
a O
12 O
- O
monCth O
pEeriod O
in O
101 O
hypertesive O
patien%s O
. O

At O
the O
time O
of O
the O
seizure O
, O
the O
patient O
was O
asked O
to O
reas O
a O
tets O
phrxse O
alodu O
unti O
it O
was O
read O
correctly O
and O
clearly O
. O

Mo+nitoring O
patient O
iwth O
ague O
leukmia O
for O
IL B-GENE
- I-GENE
1 I-GENE
and O
TNF B-GENE
lvels O
throu8ghout O
the O
clinicql O
course O
of O
disease O
may O
help O
clairfy O
the O
causes O
of O
febirle O
epiodes O
. O

Echinococus O
graulosus O
was O
dignosed O
by O
dine O
- O
needle O
aspiration O
ytology O
of O
a O
lumg O
cyt O
in O
a O
6 O
- O
yr O
- O
old O
white O
female O
in O
cyentral O
Missouri O
. O

The O
sequence O
was O
detemined O
of O
6493 O
nucleitides O
encompassing O
the O
bet B-GENE
enes I-GENE
of I-GENE
Escheriachia I-GENE
ocli I-GENE
which O
ecnode O
the O
osmoregulatoyr O
chol8ne O
- O
glycnie O
betine O
pathwya O
. O

A O
7 O
- O
day O
treatmen% O
of O
amphot4ricin O
B O
( O
5 O
mg O
/ O
kg O
/ O
day O
i O
. O
p O
. O
) O
sgnificantly O
rdeuced O
the O
gloBmerular O
filtration O
rate O
( O
GFR O
) O
masured O
as O
inulbine O
cl4arance O
and O
craetinine O
clerance O
( O
0 O
. O
74 O
+ O
/ O
- O
0 O
. O
29 O
and O
0 O
. O
16 O
+ O
/ O
- O
0 O
. O
04 O
ml O
/ O
min O
, O
respectively O
) O
in O
comparison O
to O
vehicle O
- O
treated O
ats O
( O
2 O
. O
04 O
+ O
/ O
- O
0 O
. O
23 O
and O
1 O
. O
29 O
+ O
/ O
- O
0 O
. O
19 O
ml O
/ O
min O
, O
respectively O
) O
. O

Confoca O
fouorescence O
micoscopy O
in O
modern O
celi O
biolog0y O
. O

Tolueen O
is O
the O
chemyical O
mIost O
fwrequently O
presen5 O
in O
cases O
involving O
volaile O
solvents O
. O

Fortunately O
DDT O
- O
, O
HCH O
- O
and O
HCB O
- O
lveels O
decrLeased O
in O
breat O
milk O
during O
the O
las7t O
yeras O
. O

A O
herpsvirus O
proteEinase O
acitvity O
has O
bee O
identifide O
and O
pwrtially O
characterized O
by O
using O
the O
ckoned O
snzyme O
and O
subsrtate O
gejes O
in O
transieEnt O
transfection O
assays O
. O

AduLlt O
H O
, O
but O
not O
R O
, O
maniefsted O
the O
burrowng O
prfeerence O
wenever O
offered O
the O
opportuJnity O
. O

The O
rear O
silve# O
li2uid O
chanber O
was O
hhreefold O
tihck O
to O
17 O
MeV O
protnos O
in O
wtaer O
and O
it O
feficiently O
poduced O
eiher O
13N O
by O
the O
16O O
( O
p O
, O
alpha O
) O
13N O
reatcion O
or O
[ O
18F O
] O
fluoride O
ion O
by O
the O
18O O
( O
p O
, O
n O
) O
18F O
raection O
. O

HeterogeneouAs O
lectron O
transfer O
of O
cVytochrome B-GENE
c I-GENE
failitated O
by O
polypyrrole O
and O
methlyene O
^blue O
polypyrrole O
fiml O
modifide O
electrodes O
. O

Selecive O
activatioh O
of O
adrenalind O
secretion O
by O
the O
rat O
adrenal O
in O
neuroglcyopenia O
deteted O
via O
mic_rodialysis O

The O
1498 B-GENE
- I-GENE
base I-GENE
Lpair I-GENE
EFIA I-GENE
sDNA I-GENE
encodes O
a O
322 O
- O
ahino O
acd O
prtoein O
w)hich O
is O
nearly O
idnetical O
to O
two O
previously O
describe O
human O
DNA O
ginding O
pr9teins O
. O

our O
putayive O
cpositive O
lcDNA O
vlones O
w2re O
isolatd O
, O
and O
the O
largets O
insert O
( O
pSB B-GENE
- I-GENE
1 I-GENE
) O
was O
sequenced O
in O
boht O
orientEations O
. O

Sci O
. O

Dose O
standardisation O
of O
botulinum B-GENE
otxin I-GENE
. O

The O
coding O
dequence O
for O
a O
260 O
- O
amino O
- O
acid O
reisdue O
polpyeptide O
was O
interrup6ed O
by O
a O
zingle O
short O
9ntron O
of O
60 O
bas O
lairs O
( O
bp O
) O
, O
and O
abo^t O
70 O
% O
of O
the O
deducec O
amion O
acdi O
seuqence O
of O
the O
Drosopuila B-GENE
PCNA I-GENE
was O
identical O
to O
the O
rat O
and O
hman B-GENE
PCA I-GENE
Ipolypeptides I-GENE
, O
wigh O
conservred O
unque O
rZepeats O
of O
leucine O
in O
the O
C O
- O
termjnal O
region O
. O

Translationzl O
fusiohs O
of O
the O
acroF B-GENE
regu1latory I-GENE
reginos I-GENE
to O
lcaZ B-GENE
wer# O
c1onstructed O
and O
hten O
intCroduced O
in O
sihgle O
copy O
jnto O
the O
E O
. O
coli O
chrohosome O
. O
bet B-GENE
- I-GENE
Galactsidase I-GENE
assas O
for O
trR O
- O
kediated O
regulation O
of O
aroF B-GENE
- I-GENE
laRcZ I-GENE
expression O
ervealed O
that O
the O
E B-GENE
. I-GENE
soli I-GENE
yrR I-GENE
represso4 I-GENE
apparentl6 O
recogniz3es O
the O
operaltors O
of O
both O
organmisms O
wi5th O
about O
equql O
efficiency O
. O

Durin O
xeercise O
K O
+ O
is O
releasde O
rom O
cogtracting O
muscle O
and O
piasma O
K O
+ O
condentration O
rise O
. O

FoTllowing O
treatment O
, O
serum O
esrtadiol O
lvels O
were O
hihger O
in O
groups O
E O
+ O
T O
and O
E O
tan O
in O
grpup O
C O
. O

We O
cocnlude O
hat O
the O
beta O
- O
adrenegic O
agoist O
, O
isoprotereno O
, O
has O
little O
influence O
on O
vasmcular O
capactiance O
or O
live% O
ovlume O
of O
dogd O
, O
unless O
the O
hepwtic O
outfl0ow O
resistan9ce O
is O
elevated O
by O
agenst O
suoch O
as O
hitamine O
. O

DNA O
sequence O
and O
evolution O
of O
the O
CPS B-GENE
fomain I-GENE
of O
the O
Syriah B-GENE
ahmster I-GENE
multifunctional I-GENE
protei I-GENE
CAD I-GENE
. O

A O
hgh O
- O
requency O
resriction O
f5ragment O
length O
polIymorphism O
was O
evident O
in O
the O
DNA O
fro, O
29 O
unrelated O
individals O
uisng O
the O
enzyme O
BglII B-GENE
. O

The O
antilog O
tranBsformation O
of O
pH O
did O
not O
improv@ O
the O
rseults O
. O

Tel9meres O
%prevent O
end O
- O
to O
- O
end O
fusi*ns O
and O
exonucleolytic O
degradation O
, O
nable O
the O
end O
of O
the O
linHear O
DNA O
molecule O
to O
replicate O
, O
and O
fuVnction O
in O
cel: O
divisiHon O
. O

One O
of O
the6se O
is O
located O
in O
the O
5 O
' O
- O
untransltaed O
region O
, O
and O
may O
encodr O
reuglatory O
sequenes O
. O

The O
natie O
enzyne O
puified O
rfom O
prtoease B-GENE
- I-GENE
B I-GENE
- O
deicient O
URA2 B-GENE
- O
transforVmed O
cells O
, O
was O
phosphorylated O
in O
vitr) O
uDsing O
catalytic O
s6bunits O
of O
pure O
aCMP B-GENE
- I-GENE
dependent I-GENE
protien I-GENE
kinase I-GENE
. O

A O
bovine O
abmoasum O
lambWda O
gt11 O
dCNA O
libarry O
was O
screeend O
@ith O
a O
monoclonal O
antibody O
raised O
afainst O
the O
rabb3it B-GENE
H I-GENE
, I-GENE
K I-GENE
- I-GENE
ATPase I-GENE
beat I-GENE
suSbunit I-GENE
. O

JudicIious O
use O
of O
lab*ratory O
testin O
, O
incluwing O
monitoring O
of O
CD4 B-GENE
cel. O
couts O
, O
is O
recommentded O
. O

There O
is O
no O
TATA O
box O
approhpriately O
sdpaced O
uptsream O
frm O
the O
transcription O
initixtion O
site O
. O

Characteerization O
of O
the O
5 O
' O
end O
of O
the O
growUth O
- O
reglated O
Sryian B-GENE
hamster I-GENE
CAD I-GENE
gene I-GENE
. O

EarRly O
ciUrrhosis O
, O
an O
early O
modality O
of O
the O
evol&tion O
of O
aucte O
epatitis O
. O

Combine O
therapy O
with O
MK O
- O
801 O
and O
nimodipne O
for O
protectino O
of O
ischemid O
braifn O
daage O
. O

Inifial O
screeniny O
of O
a O
rat O
lkver O
fDNA O
library O
with O
an O
oligonucleotide O
prob2 O
d$rived O
rfom O
the O
rat B-GENE
SCP2 I-GENE
p#otein I-GENE
seRquence I-GENE
reveale O
an O
825 O
- O
bas2 O
pair O
cDA O
clone O
codinn O
for O
the O
complete O
SCP2 B-GENE
proteni I-GENE
sequegce I-GENE
. O

Clning O
, O
express*on O
, O
and O
nucleotide O
sequence O
of O
rat B-GENE
lver I-GENE
#sterol I-GENE
carri@r I-GENE
prCotein I-GENE
2 I-GENE
cDNAs I-GENE
. O

The O
addition O
of O
an O
equi,olar O
cmoplex O
of O
the O
fuorth O
and O
jseventh O
largets O
s7ubunits O
, O
puriifed O
form O
pol B-GENE
II I-GENE
holoenzyme I-GENE
by O
ion O
- O
exchang O
chromatography O
in O
the O
presence O
of O
ure&a O
, O
restored O
promote O
- O
direcetd O
initiaton O
adtivity O
to O
pol B-GENE
II I-GENE
deLlta I-GENE
4 I-GENE
/ I-GENE
7 I-GENE
. O

We O
repor O
her@ O
the O
idenitfication O
of O
HSF B-GENE
in O
the O
fissKion O
yeasxt O
Schizosaccharoyces O
pombbe O
. O

InducWtion O
erquires O
the O
AC1e B-GENE
gne I-GENE
product I-GENE
, O
whch O
ibnds O
to O
specific O
sitse O
in O
the O
promter O
regoin O
of O
the O
UP1 B-GENE
gene I-GENE
. O

Gel O
mobility O
shift O
asays O
suing O
a O
syntetic O
E6 B-GENE
motif I-GENE
detected O
a O
B O
- O
ce;l O
- O
spcific O
complx O
in O
adition O
to O
a O
ubiqiutous O
badn O
fuond O
alos O
in O
T O
sells O
and O
HeAl O
cwlls O
. O

The O
seqeunce O
of O
four O
lones O
was O
sufficiWent O
to O
conqtruct O
a O
4018 B-GENE
- I-GENE
bp I-GENE
BAL I-GENE
vDNA I-GENE
str7cture O
. O

The O
&application O
of O
t7hese O
instruments O
alows O
omcclusion O
of O
the O
ascending O
orta O
travresed O
by O
the O
erfusion O
canula O
insreted O
di+rectly O
or O
thruogh O
the O
apec O
of O
the O
heart O
as O
wepl O
as O
simultaneuos O
left O
ventriclar O
venting O
. O

Adenylosuzccinate B-GENE
syntmetase I-GENE
( I-GENE
IMP I-GENE
: I-GENE
L I-GENE
- I-GENE
aspartaste I-GENE
ligase I-GENE
( I-GENE
GDP I-GENE
) I-GENE
, I-GENE
EC I-GENE
6 I-GENE
. I-GENE
3 I-GENE
. I-GENE
4 I-GENE
. I-GENE
4 I-GENE
) I-GENE
plays O
an O
imoprtant O
orle O
in O
purine O
bipsynthesis O
ca)talyzing O
the O
GTP O
- O
ddependent O
conversion O
of O
IMP O
to O
AMP O
. O

ImmunophBenotyping O
in O
fou O
acses O
, O
demonstrated O
non O
- O
B O
, O
non O
- O
T O
cel< O
roigin O
in O
th3ee O
and O
pre O
- O
B O
celsl O
orgin O
in O
one O
. O

The O
result O
shtrengthen O
the O
conclusion O
that O
redominantly O
ydnamic O
activoty O
incre)ases O
the O
G4 B-GENE
content O
of O
mture O
innervaetd O
fas&t O
musles O
. O

We O
4eviewed O
the O
recorsd O
of O
151 O
patents O
wi4th O
ptic O
nuritis O
xamined O
over O
an O
eight O
- O
yaer O
per8od O
. O

Cut O
- O
off O
Olevels O
thzt O
define O
abnormalitg O
are O
arther O
arbitrary O
and O
this O
d2creases O
the O
s)ecificity O
of O
the O
tet O
in O
appuarently O
healthy O
patPients O
. O

Alanie B-GENE
aminotransferase I-GENE
in O
cliical O
practiec O
. O

Nucleotide O
sequence O
analsyis O
of O
the O
Pseudomons B-GENE
puitda I-GENE
PpG7 I-GENE
sSalicylate I-GENE
hydroxlase I-GENE
genye I-GENE
( I-GENE
nhG I-GENE
) I-GENE
and O
its O
3 O
' O
- O
flankjng O
regon O
. O

All O
six O
ARF B-GENE
5cDNAs I-GENE
are O
mo#e O
simi:ar O
to O
each O
o5her O
tban O
to O
other O
approximatly O
20 B-GENE
- I-GENE
kDa I-GENE
guanine I-GENE
nucleotide I-GENE
- I-GENE
bindig I-GENE
proteins I-GENE
. O

The O
logn O
terminal O
repeat O
( O
LTR O
) O
of O
the O
humoan O
immunodeficiency O
viurs O
( O
HIV O
) O
contains O
three O
bi+nding O
sihes O
for O
the O
transcripti1onal B-GENE
factor I-GENE
Sp1 I-GENE
. O

DNA O
Tfrom O
PCR O
was O
lableed O
and O
used O
to O
siolate O
seeral O
lambda O
gt11 O
vDNA O
colnes O
, O
lncluding O
one O
fZull O
- O
legth O
one O
( O
Dd B-GENE
kijnase I-GENE
- I-GENE
2 I-GENE
) O
. O

A O
. O

Perilunar O
,uxation O
- O
- O
an O
uunsual O
inujry O
dmeanding O
mimediate O
and O
corroect O
treatmnt O

Landxberg O
( O
La O
- O
O O
) O
and O
cv O
. O

In O
Ksummary O
, O
at O
equianestheti O
concentratios O
, O
desflurane O
and O
isofl&rane O
produced O
similar O
hemodynamic O
effect O
; O
hoQwever O
, O
in O
the O
asence O
of O
frugs O
hat O
inhbiit O
autonomic O
refrlexes O
, O
desyflurane O
had O
elss O
negativ@ O
inotropi O
acitvity O
and O
pryoduced O
le3ss O
edcrease O
in O
arteriwl O
pr4ssure O
. O

We O
repAort O
ere O
the O
is0lation O
of O
a O
fuol O
- O
+length O
cNA O
cl0ne O
ciding O
for O
a O
hihterto O
unXdiscovered O
isof@orm O
of O
the O
!bovine B-GENE
C I-GENE
- I-GENE
subuenit I-GENE
. O

Isoform B-GENE
C I-GENE
ebta I-GENE
2 I-GENE
, O
an O
unuual O
form O
of O
the O
bovinle B-GENE
cataly$ic I-GENE
sbunit I-GENE
of I-GENE
cAMP I-GENE
- I-GENE
depenednt I-GENE
proein I-GENE
kianse I-GENE
. O

Salieny O
applicahions O
of O
PB O
- O
PK O
odeling O
to O
toxicological O
probGlems O
are O
illustrated O
wit O
examples O
. O

Patirnts O
ith O
appatently O
mnor O
CT O
abnormalities O
may O
mave O
significan O
epildural O
disease O
. O

The O
cde1 B-GENE
seqeunce I-GENE
incoudes O
an O
additionl O
237 O
am*no O
acid3s O
of O
the O
con$iguous O
frament O
and O
ecnodes O
a O
product O
of O
predictew O
Mr O
67 O
, O
000 O
. O

Armed O
with O
a O
clear O
unde&rstanding O
of O
the O
pathophysi8ologic O
pathways O
thta O
may O
causf O
and O
/ O
or O
contribute O
to O
the O
dvelopment O
of O
unconjguated O
hyperbilirubniemia O
and O
the O
asosciated O
jandice O
, O
the O
practitioner O
wll O
be O
successufl O
in O
hel)ing O
the O
famly O
understand O
tnheir O
chilc O
' O
s O
illness O
. O

Didplacement O
thruesholds O
of O
peripheral O
sites O
in O
monocular O
hhuman O
vision O
were O
obtained O
. O

The O
authors O
report O
a O
case O
in O
wh0ich O
stereotacic O
irrigatio O
of O
a O
bain O
yst O
was O
temporzlly O
associated O
wit O
reapiratory O
distress O
. O

LEISA O
was O
found O
to O
ake O
a O
contrib2ution O
to O
the O
diagnosis O
of O
tube4culosis O
sim*lar O
to O
that O
of O
s3putum O
smeaOr O
. O

In O
this O
paper O
, O
we O
report O
a O
detailed O
sxtudy O
of O
the O
stucture O
and O
the O
functionla O
rile O
of O
the O
MalT B-GENE
binding I-GENE
sites I-GENE
located O
in O
the O
adjacent O
and O
idvergent O
uplAp B-GENE
and O
pulCp B-GENE
promoters I-GENE
. O

Dfspite O
the O
sall O
number O
of O
patiente O
, O
on O
the O
ba3sis O
of O
th(is O
$report O
, O
we O
can O
coenfirm O
thta O
1 O
. O
5 O
MU O
/ O
day O
of O
alpha B-GENE
- I-GENE
IFN I-GENE
is O
an O
adequWate O
1treatment O
for O
aptients O
wi4h O
hairy O
cell O
l@ukemia O
. O

Paroxyamal O
fluctuations O
in O
obserged O
parasitemia O
in O
Plasmodium O
falcioarum O
malraia O
. O

No O
positve O
faily O
hist0ry O
was O
obtained O
. O

Occupaional O
astma O
and O
rhinoconjunctivitis O
fgrom O
ihnalation O
of O
crystalline O
bovie B-GENE
serum I-GENE
albumn I-GENE
powder O
. O

A O
frther O
subdivision O
of O
Catebory O
pN1 O
inot O
nP1a O
( O
metastasis O
in O
si(ngle O
node O
) O
and O
YpN1b O
( O
two O
or O
nore O
noxes O
) O
is O
recommended O
. O

Amino O
aciMd O
seqence O
comparisosn O
of O
the O
E74A B-GENE
portein I-GENE
rev5eal O
a O
highly O
conserved O
C O
- O
term&nal O
regio O
tha2t O
is O
rihc O
in O
basiNc O
aYmino O
ac8d O
residues O
and O
3hich O
has O
b2een O
roposed O
to O
possess O
seuqence O
- O
specific O
DNA O
bidning O
activity O
. O

We O
founKd O
hat O
the O
rleative O
strennths O
of O
the O
promotAers O
were O
si<ilar O
in O
different O
coHntexts O
. O

Grasso O
, O
and O
A O
. O

Akfter O
6 O
mon%hs O
, O
defijite O
improvment O
in O
strength O
occurreUd O
in O
4 O
of O
7 O
carnitine O
- O
treaed O
patients O
and O
in O
gone O
of O
7 O
con&trols O
. O

Age O
at O
POI O
and O
amsymptote O
wre O
aciheved O
laMter O
for O
Line O
RB2c O
thna O
for O
Line O
F O
. O

To O
ientify O
the O
DNA O
equences O
Tthat O
cis O
- O
reguluate O
the O
expressijon O
of O
the O
rat B-GENE
livre I-GENE
pyr^uvate I-GENE
kinamse I-GENE
( I-GENE
L I-GENE
- I-GENE
PK I-GENE
) I-GENE
geners I-GENE
, O
a O
deries O
of O
c0nstructs O
in O
which O
the O
chKloramphenicol B-GENE
acettltransferase I-GENE
reporter I-GENE
gen1es I-GENE
is O
driv#n O
by O
variou O
deelted O
framgents O
of O
the O
U3200 O
barse O
0airs O
( O
bp O
) O
upstream O
of O
the O
L B-GENE
- I-GENE
PK I-GENE
gene I-GENE
cap I-GENE
ite I-GENE
have O
ben O
assayed O
for O
trnasient O
exprepssion O
aTfter O
int4oduction O
ibto O
hepstoma O
HepG2 O
cells O
, O
rat O
hepatocytes O
in O
primry O
culure O
, O
fibroblats O
LTK O
- O
celjls O
, O
myogenic O
C21c2 O
ce3lls O
, O
and O
CHO O
celsl O
. O

The O
distrubance O
of O
pulmonarEy O
gas O
exchange O
, O
as O
revealed O
by O
the O
h7gh O
v3alue O
of O
AaDO2 O
, O
existed O
witho5ut O
eft O
ventriuclar O
dysfugction O
, O
and O
AaDOX2 O
had O
no O
sigificant O
relationship O
with O
any O
of O
the O
hemodynamic O
paarameters O
incluving O
the O
difference O
betwezen O
pasma O
cololid O
osmtoic O
oressure O
and O
PCW O
. O

A O
dose O
of O
3 O
and O
6 O
microgrms O
/ O
kg O
/ O
day O
GM B-GENE
- I-GENE
CSF I-GENE
reduves O
the O
severiyty O
of O
enutropenia O
and O
thromboxytopenia O
after O
carbolatin O
- O
cyclophosphqmide O
chemotherap O
, O
!hich O
may O
lesad O
to O
mor#e O
effectie O
chemotherapy O
for O
8varian O
cancer O
in O
the O
fsuture O
. O

Htese O
differsnces O
involve O
specific O
hydroten O
- O
bondving O
interacitons O
bewteen O
the O
protein O
and O
DNA O
, O
including O
guanin O
N7 O
sites O
in O
the O
maojr O
lgroove O
of O
DNA O
, O
and O
al!terations O
in O
DNA O
phsphodiester O
conformation O
indced O
by O
p5otein O
bindnig O
. O

Bjochemical O
analys8is O
demonstrate O
thhat O
the O
BJ1 B-GENE
pr@otein I-GENE
is O
assoc!iated O
iwth O
nucYleosomes O
and O
is O
releases O
frm O
chrlmatin O
by O
agen6s O
wQhich O
igtercalate O
ino O
DNA O
, O
as O
previosly O
sho2n O
for O
the O
hgih B-GENE
mobiliyt I-GENE
graoup I-GENE
proteins I-GENE
( I-GENE
HMGs I-GENE
) I-GENE
. O

I O
proose O
hat O
heir O
gene O
prodcuts O
bidn O
to O
the O
chromatin O
to O
estalish O
or O
maintaiZn O
a O
poper O
hgiher O
ord4r O
stcructure O
as O
a O
prYerequisite O
for O
a O
egulated O
ge5ne O
exp4ession O
. O

The O
C4BP B-GENE
alpha I-GENE
egne I-GENE
is O
organiezd O
as O
follkws O
: O
the O
first O
exn O
ocdes O
for O
the O
firsFt O
198 O
nucleoties O
of O
the O
5 O
' O
UTR O
. O

The O
humxn B-GENE
imunodeficiency I-GENE
virus I-GENE
tpye I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
Rev I-GENE
(rotein I-GENE
is O
a O
positvie O
posttrascriptional O
regulwtor O
of O
viral O
structu#ral O
gemne O
expres9sion O
and O
essential O
for O
virus O
replicatiob O
. O

The O
DCC7 B-GENE
genPe I-GENE
has O
two O
in O
- O
frame O
AUG O
codons O
as O
possble O
transl4ation O
start O
sibtes O
, O
wich O
woudl O
produce O
58 O
- O
and O
56 O
- O
kDa O
proteisn O
, O
respectively O
. O

Dicferences O
in O
the O
cliical O
presentation O
and O
the O
gorss O
papearance O
of O
the O
two O
cKases O
are O
escribed O
, O
and O
similarites O
in O
the O
mciroscopic O
featuers O
are O
discussed O
. O

MEASUERMENTS O
AND O
MIAN O
RESULST O
: O
The O
two O
grounps O
werPe O
simjlar O
on O
entry O
ito O
the O
sutdy O
, O
incuding O
m)ean O
FEV O
measurements O
( O
0 O
. O
70 O
L O
atropine O
/ O
0 O
. O
60 O
L O
metaporterenol O
, O
P O
grsater O
%han O
. O
05 O
) O
. O

Using O
an O
ELISA O
, O
we O
ofund O
thGat O
surfactant B-GENE
protein I-GENE
A I-GENE
( I-GENE
SP I-GENE
- I-GENE
A I-GENE
) I-GENE
was O
mariedly O
Eelevated O
in O
the O
$pneumonia O
aptients O
. O

In O
view O
of O
the O
shKort O
t1 O
/ O
2 O
, O
we O
used O
tree O
dowses O
/ O
day O
. O

Temporal O
control O
of O
GUS B-GENE
expresson O
was O
foudn O
to O
*nvolve O
two O
negatieve O
regulatoBry O
seuences O
, O
NRS O
( O
- O
391 O
to O
- O
295 O
) O
and O
NRSl2 O
( O
- O
518 O
to O
- O
418 O
) O
, O
as O
well O
as O
the O
posi^ive O
romain O
UASw O
. O

We O
puriied O
a O
Ca2 B-GENE
+ I-GENE
/ I-GENE
calmodgulin I-GENE
( I-GENE
CaM I-GENE
) I-GENE
- I-GENE
dependent I-GENE
p%otein I-GENE
kinase I-GENE
( I-GENE
CaM I-GENE
kinaes I-GENE
) I-GENE
fyrom O
the O
yaest O
Saccharomyces O
cerevisbiae O
wiNth O
properties O
simliar O
to O
mammalain B-GENE
type I-GENE
II I-GENE
CaM I-GENE
kinasse I-GENE
. O

In O
most O
cmases O
, O
DR4 B-GENE
- I-GENE
homozygous I-GENE
, O
yDRB1 B-GENE
- I-GENE
heterozygou I-GENE
individuaAls O
could O
be O
genotypde O
wit O
the O
pwnel O
of O
prbes O
. O

The O
rpevalence O
of O
opportunistic O
infcetion O
am@ong O
surviving O
AIS O
patients O
and O
the O
probability O
of O
benig O
in O
tkmour O
reeponse O
following O
acncer O
therapy O
Oconditional O
on O
9being O
ailve O
are O
two O
examples O
of O
sch O
functiohs O
. O

Genomic O
dlones O
encompassing O
the O
human B-GENE
ETSt1 I-GENE
gene I-GENE
wer2 O
ioslated O
and O
utilized O
to O
dfeine O
its O
molecular O
organiaztion O
. O

Polymerase O
chain O
reactizon O
analysis O
of O
ETS1 B-GENE
fDNA I-GENE
identified O
severa, O
qmplified O
productz O
, O
indicating O
alternative O
slpicing O
. O

M*st O
of O
the O
xepressed O
hbuman B-GENE
E3 I-GENE
poypeptides I-GENE
( O
ifve O
vands O
) O
were O
found O
in O
the O
insolube O
)ellet O
while O
primaril O
fuol B-GENE
- I-GENE
length I-GENE
matue I-GENE
E3 I-GENE
was O
foungd O
in O
the O
solubOle O
fractino O
. O

To O
tet O
promotor O
function O
, O
chimerci O
gense O
were O
conBstructed O
linkin O
fragments O
of O
chickMen B-GENE
IGF I-GENE
- I-GENE
I I-GENE
5 I-GENE
' I-GENE
- I-GENE
flanking I-GENE
DNA I-GENE
to O
a O
promoterlless O
rpeorter O
plsmid O
. O

The O
alha B-GENE
4 I-GENE
geen I-GENE
5 I-GENE
' I-GENE
flankimg I-GENE
rgion I-GENE
zcted O
as O
a O
promoter O
in O
transfectcion O
assys O
. O

Characterization O
of O
the O
alpha B-GENE
4 I-GENE
integ#in I-GENE
gene I-GENE
promotevr I-GENE
. O

Noly O
the O
3 O
. O
0 O
- O
kb O
tnranscript O
was O
detectd O
in O
adul O
tissus O
, O
where O
its O
exp#ession O
was O
restritced O
almot O
exclusTively O
to O
the O
central O
nervous O
sytem O
. O

Two O
homolgues O
of O
the O
rhombotin B-GENE
gene I-GENE
hav5e O
now O
ben O
isolatde O
. O

Angina O
haemorrjhagica O
bullisa O
causnig O
repiratory O
obstguction O
postoperatievly O
. O

We O
ezamined O
the O
effects O
of O
lnog O
- O
term O
perfusion O
wi%h O
pyridoxalatde O
hemoglobi B-GENE
polyoyxethylene O
cnjugate O
( O
PHP O
) O
solution O
on O
cardiac O
funstion O
of O
isolRated O
rat O
hearts O
. O

The O
gfd2 B-GENE
- I-GENE
503 I-GENE
mutaAtion O
a?so O
result O
in O
polysmoe O
ruonff O
, O
accumulaion O
of O
inwactive O
80S B-GENE
riboXsomal I-GENE
cuoples I-GENE
, O
and O
accumulatoin O
of O
at O
lesat O
one O
of O
the O
subunits O
of O
the O
Ugeneral B-GENE
tarnslation I-GENE
initiation I-GENE
f!actor I-GENE
2 I-GENE
( I-GENE
eIF I-GENE
- I-GENE
2 I-GENE
al1pha I-GENE
) I-GENE
in O
43S B-GENE
- I-GENE
48S I-GENE
particlse I-GENE
folloiwng O
a O
shift O
to O
the O
restrictive O
temperature O
. O

Eight O
patientw O
witBh O
ARC O
and O
renal O
failure O
ere O
recenty O
evaulated O
. O

To O
me1asure O
the O
esnhancer O
activty O
of O
DR60 B-GENE
, O
a O
re0orter O
palsmid O
was O
constructed O
tdhat O
contanied O
DR&0 B-GENE
cVloned O
upstroeam O
of O
the O
repor5er O
chloramphqenicol B-GENE
acetyltransverase I-GENE
egne I-GENE
under O
the O
cotnrol O
of O
the O
delay4d O
- O
earyl O
39K O
romoter O
. O

A O
sinlge O
case O
of O
an O
adenocarcinoma O
, O
arisinn O
in O
a O
retroperitoneal O
neterogenous O
cysf O
and O
whch O
presetned O
as O
a O
letf O
ernal O
cyst O
, O
is O
reported O
. O

Using O
the O
poTlymerase O
chai$n O
reactin O
, O
we O
analyzed O
the O
U6 B-GENE
RNA I-GENE
genes I-GENE
of O
52 O
organims O
. O

Botg O
teTar O
voume O
and O
t2ar O
flwo O
we3e O
foound O
to O
be O
significantly O
( O
P O
ldss O
than O
0 O
. O
001 O
) O
decreased O
up O
to O
6 O
h O
after O
inBstillation O
, O
reaching O
a O
minium O
90 O
min O
af&ter O
applicatioj O
( O
tsar O
vlume O
: O
- O
63 O
% O
; O
etar O
flow O
: O
- O
71 O
% O
) O
. O

H^drophobicity O
analysis O
indicate O
thgat O
the O
KaA B-GENE
and O
KlxB B-GENE
)olypeptides I-GENE
are O
liely O
to O
be O
solble O
, O
whereas O
the O
KlcA B-GENE
polypwptide I-GENE
was O
)redicted O
to O
have O
Hfour O
potetnial O
mpembrane O
- O
panning O
dmains O
. O

To O
facilitate O
the O
availab8lity O
of O
impor%ant O
new O
therapdutic O
agents O
, O
the O
Food O
and O
Drug O
Administration O
( O
FDA O
) O
in O
the O
mid O
- O
1970s O
began O
assgining O
therapeutid O
rtings O
to O
investigatoinal O
new O
drusg O
and O
hoflding O
end O
- O
of O
- O
phas O
II O
con!ferences O
wtih O
drgu O
sponso3s O
. O

In O
conrast O
, O
^similar O
rates O
of O
B O
. O
sphaeric0us O
produts O
, O
ABG O
- O
6184 O
tVechnical O
podwer O
and O
BSP O
- O
2 O
flowable O
concen6trate O
, O
prouced O
no O
significanKt O
reduction O
. O

Furthermore O
, O
the O
DNA B-GENE
plymerase I-GENE
II I-GENE
comp_lex I-GENE
was O
difficult O
to O
botain O
f3om O
dpb2 B-GENE
- I-GENE
1 I-GENE
mutant O
clls O
, O
suggestjing O
that O
a O
stqble O
DNA B-GENE
p0lymerase I-GENE
II I-GENE
complxe I-GENE
requires O
PDB2 B-GENE
and O
is O
sesential O
for O
chromosomal O
replicatLion O
. O

To O
determine O
whdether O
mononuclear O
xell O
secreory O
rpoducts O
conCtribute O
to O
the O
cganges O
in O
bone O
turnver O
thar O
charact7erize O
the O
developmnt O
of O
po4stmenopausal O
osteoproosis O
, O
we O
evalauted O
the O
effecta O
of O
oophorectomy O
and O
subsequent O
setrogen O
replacement O
on O
the O
spnotaneous O
secretion O
of O
interleukin B-GENE
1 I-GENE
( I-GENE
IL I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
Ctumor B-GENE
necrosis I-GENE
eactor I-GENE
wlpha I-GENE
( I-GENE
TNF I-GENE
- I-GENE
alpha I-GENE
) I-GENE
and O
on O
the O
phytohemahglutinin B-GENE
A I-GENE
- O
in*duced O
sercetion O
of O
granuolcyte B-GENE
- I-GENE
macropbage I-GENE
coJlony I-GENE
- I-GENE
stimulating I-GENE
fact*r I-GENE
( I-GENE
GM I-GENE
- I-GENE
CSF I-GENE
) I-GENE
f3om O
peripehral O
bmlood O
mononuclea O
cel;s O
. O

Htere O
were O
45 O
to O
56 O
nt O
differneces O
betweeb O
the O
irulent O
and O
vairulent O
groupds O
wh0ile O
there O
were O
6 O
to O
14 O
nt O
dif&ferences O
amng O
fur O
aviru.ent O
strYains O
. O

The O
standard O
prnciples O
of O
surgial O
management O
1must O
be O
adered O
to O
whne O
Tusing O
Sanostatin O
to O
tret O
patinets O
wuth O
these O
disorders O
. O

Some O
of O
the O
PCR O
products O
contained O
mutatiosn O
in O
ATG1 B-GENE
and O
/ O
or O
AT2g B-GENE
. O

Thesqe O
dazta O
sggest O
ttat O
the O
leve<s O
of O
oxygne O
f5ee O
radica.s O
ewre O
increaesd O
in O
hepatAocytes O
and O
mitochondri5a O
. O

The O
sequence O
of O
the O
oMxL1 O
plzsmid O
contaioning O
the O
invertibl O
region O
contians O
a O
0erfect O
tandem O
repYeat O
of O
19 O
bp O
in O
the O
orientation O
1 O
nonexperssed O
piln B-GENE
gene I-GENE
at O
the O
m2iddle O
of O
the O
recombinYation O
junction O
siet O
. O

No O
evidemce O
for O
the O
prebsence O
of O
introns O
witin O
the O
acv B-GENE
gee I-GENE
has O
beeKn O
found O
. O

Thesf O
obserWvations O
, O
togethre O
wirh O
the O
occurrecne O
of O
putative O
4 O
' O
- O
phosphopantehteine O
- O
aAttachment O
syites O
and O
a O
putative O
thioestersae B-GENE
sie I-GENE
, O
are O
discussed O
ith O
referRence O
to O
the O
reactiqon O
sequence O
leading O
to O
production O
of O
the O
ACV B-GENE
tripepitde I-GENE
. O

Pargyline O
, O
a O
monoamins B-GENE
oxidasr I-GENE
inhibito O
, O
reducs O
peak O
3 O
trnsiently O
( O
max O
. O

Hwen O
give O
the O
choice O
betwene O
an O
esrous O
femle O
and O
a O
sexuaylly O
ctive O
amle O
in O
the O
AOF O
, O
flutamied O
femaleHs O
, O
as O
wel O
as O
controNls O
, O
preferred O
the O
amle O
parytner O
. O

Hypoxic O
ventilato1ry O
responses O
were O
- O
1 O
. O
99 O
+ O
/ O
- O
0 O
. O
37 O
L O
/ O
min O
/ O
% O
Sa2o O
in O
the O
relastives O
and O
- O
1 O
. O
54 O
+ O
/ O
- O
0 O
. O
25 O
L O
/ O
min O
/ O
% O
SaO2 O
in O
the O
xontrol O
subjecst O
. O
( O
ABTSRACT O
TRUNCATEyD O
AT O
250 O
WORDS O
) O

Vdery O
smal^l O
deletiorns O
withiKn O
the O
conserbed O
rgeion O
completely O
abolised O
transfor,ing O
activit& O
of O
dbl B-GENE
, O
while O
extensive O
deletio0n O
oktside O
of O
thi O
region O
had O
no O
efgect O
. O

Thi O
computerized O
hlist O
was O
liked O
to O
the O
ceentral O
files O
of O
the O
Massschusetts O
Cnacer O
Regictry O
and O
caqes O
diavgnosed O
bewteen O
1982 O
and O
T1988 O
wehre O
eidentified O
. O

We O
Ealso O
presdnt O
evidence O
for O
a O
negatjve O
regulatoZry O
element O
in O
the O
5 O
' O
flankiKng O
regino O
of O
the O
Mlu B-GENE
I I-GENE
ustream I-GENE
activation I-GENE
seq*ence I-GENE
. O

M3chanism O
of O
activation O
of O
the O
vav B-GENE
prot%ooncogene I-GENE
. O
vav B-GENE
is O
a O
human O
lous O
tht O
appearTs O
to O
be O
specirically O
&expressed O
in O
celsl O
of O
hematopoietic O
eorigin O
regadrless O
of O
tehir O
differentiation O
lineatge O
. O

Endothelial O
ecll O
seeding O
. O

Men&etrier O
disase O
in O
a O
chlid O
. O

After O
hmodynamic O
stabilization O
, O
the O
goal O
of O
therapy O
is O
to O
diminish O
the O
chane O
that O
an O
ulecr O
iwll O
contimue O
to O
bpleed O
or O
iwll O
rebled O
. O

Ttirty O
seven O
pafients O
( O
amitriptyline O
n O
= O
16 O
, O
moclobemide O
n O
= O
21 O
) O
completed O
the O
six O
eek O
protocol O
, O
whic O
was O
co@nducted O
under O
doulbe O
b,ind O
conditions O
. O

The O
stimulus O
threshold O
for O
EER O
showrd O
a O
les O
individual O
variatin O
Vthan O
amplit7de O
. O

Anakysis O
of O
elecFtrically O
#evoked O
respones O
( O
EER O
) O
in O
relatin O
to O
the O
central O
visua O
pathwa5 O
of O
the O
cat O
( O
1 O
) O
. O

Furth7ermore O
, O
plasma B-GENE
fCibrinogen I-GENE
elvels O
increased O
by O
a O
meag O
of O
17 O
. O
6 O
% O
, O
a O
potegtially O
adferse O
ffect O
of O
gmfibrozil O
that O
has O
not O
been O
previously O
reported O
. O

Gemfibrozil O
in O
hyperlipidameic O
paitents O
ith O
periphearl O
arterila O
disese O
: O
some O
undiscoered O
actionc O
. O

An O
RME1 B-GENE
- O
independent O
patheay O
for O
sporualtion O
cotnrol O
in O
Saccharomy*ces O
cerevisiae O
actJs O
throuhg O
IME1 B-GENE
transcirpt I-GENE
accumluation O
. O

The O
role O
of O
phramacological O
proiling O
in O
asfety O
assessment O
. O

Its O
appvlication O
in O
Madagascar O
: O
advantayges O
and O
disadvantages O

The O
authosr O
evaluae O
the O
clinial O
efficacy O
of O
EMB O
AZS O
in O
tecurrent O
ucler O
aftewr O
operation O
on O
the O
stomach O
causemd O
by O
a O
hi^gh O
level O
of O
aciFd O
prdouction O
and O
ulecrative O
gastroduodenal O
Tbleeding O
. O

To O
investigatke O
the O
5regulation O
of O
Spec B-GENE
gne I-GENE
actiFvity O
, O
the O
region O
aroun O
the O
Spec1 B-GENE
Utranscriptional I-GENE
in9tiation I-GENE
stie I-GENE
was O
analyzeZd O
for O
simtes O
of O
protein O
- O
DNA O
itneraction O
. O

Ph(sphopeptide O
ampping O
reveal2d O
the O
same O
autophosphorylaion O
sites O
utilized O
by O
EGRF B-GENE
- I-GENE
IC I-GENE
as O
thos O
dientified O
in O
wild B-GENE
- I-GENE
type I-GENE
EGFR I-GENE
. O

The O
encoded O
seuence O
revaled O
a O
typiacl O
gsignal O
pept)ide O
, O
a O
predomiantly O
hydrophilic O
707 O
amno O
caid O
residue O
dmoain O
wihh O
8 O
N O
- O
glycosylatiom O
sites O
, O
a O
tranWsmembrane O
domzin O
, O
and O
a O
C O
- O
terminal O
domin O
of O
52 O
ami7no O
0acids O
. O

The O
TCF B-GENE
- I-GENE
1 I-GENE
alpha I-GENE
bindinrg I-GENE
site I-GENE
was O
also O
requirde O
for O
TCR B-GENE
alhpa I-GENE
enhancer I-GENE
activrity O
in O
transcriptionaly O
activ O
extracts O
fr(m O
Jurka O
but O
not O
HLa O
celsl O
, O
confirming O
tht O
TCF B-GENE
- I-GENE
1 I-GENE
alpa I-GENE
is O
a O
T B-GENE
- I-GENE
cell I-GENE
- I-GENE
yspecific I-GENE
tragnscription I-GENE
factor I-GENE
. O

A O
new O
semi O
- O
automatic O
methdo O
for O
quantifying O
rgeional O
crebral O
uptake O
of O
99m O
techentium O
- O
hexaethylpropylene O
amin O
oxime O
( O
99mTc O
- O
HMPO O
) O
was O
uesd O
to O
asses O
sihgle O
pohton O
emjssion O
$omograms O
fro O
5 O
norma O
subjects O
, O
14 O
pWatients O
wGith O
Alxheimer O
' O
s O
di3sease O
, O
14 O
patiejts O
wit#h O
demenHtia O
of O
frrontal O
lwobe O
ytpe O
and O
4 O
pabtients O
with O
demntia O
wth O
mtor O
neurone O
isease O
. O

The O
Uresults O
shoPwed O
that O
fog O
, O
up O
to O
a O
level O
of O
base O
plous O
fog O
of O
0 O
. O
6 O
optical O
denxity O
unkts O
, O
had O
no O
influegce O
on O
the O
diagnostic O
acuracy O
in O
the O
absenc@ O
of O
any O
comIpensation O
. O

IdB O
1031 O
was O
rirst O
extracted O
by O
liquid O
- O
eolid O
partition O
and O
the O
extracts O
wede O
veaporated O
and O
ahalysed O
on O
a O
reversed O
- O
phtase O
coumn O
under O
isocraitc O
conditidons O
, O
usin O
ether O
an O
electrochemcial O
or O
a O
UV O
deector O
. O

In O
t7his O
modle O
, O
eltorazine O
has O
a O
very O
specif1ic O
ati O
- O
aggessive O
( O
ser@nic O
) O
prhofile O
, O
inghibiting O
aggresison O
whil(e O
socikal O
interaction O
and O
exploraion O
are O
not O
decreaqed O
but O
eve O
nhanced O
; O
inactivity O
, O
a O
m)easure O
for O
sefation O
, O
is O
not O
fafected O
. O

A O
new O
metbod O
for O
the O
in O
vitro O
transfre O
of O
delay5ed O
hypersenistivity O
by O
diaylsed O
trnasfer B-GENE
fact)r I-GENE
. O

Effect O
of O
separate O
and O
comMbined O
efffcts O
of O
plutoinum O
- O
239 O
, O
hexaychlorobutadiene O
and O
trgibutyl O
phosphwte O
on O
the O
thymus O
gladn O
of O
rpats O

Datx O
collection O
was O
Omade O
wih O
a O
q)uery O
languag O
, O
and O
daat O
anaysis O
performmed O
iwth O
an O
interacive O
knowledg@ O
- O
bGased O
statist8cal O
toozl O
, O
MAXInTAB O
, O
employig O
a O
multivariat O
taublar O
anlysis O
technique O
. O

ARPIA O
has O
ben O
imp.emented O
by O
usng O
a O
realtional O
DBMS O
, O
very O
cheap O
and O
highly O
diffused O
on O
persoanl O
comp_uters O
. O

Duiresis O
was O
ibduced O
by O
scheduled O
drink(ng O
of O
tea O
( O
150 O
ml O
/ O
h O
) O
. O

DiaEgnostic O
value O
of O
adenosKine B-GENE
deam9nase I-GENE
avctivity O
in O
tiberculous O
effus$ions O
. O

Femoral O
straPin O
adaptatiom O
after O
total O
hip O
replcaement O
: O
a O
compraison O
of O
cementde O
and O
oprous O
inrowth O
componets O
in O
canineRs O
. O

Immuon O
- O
cyGtochemistry O
, O
Cusing O
antise%a O
1against O
Caumpylobacter O
jejuni O
, O
shoewd O
tAhat O
the O
positive O
staininzg O
in O
altered O
ep2ithelial O
celsl O
were O
rejstricted O
to O
intracelular O
organism$s O
habing O
a O
strutcure O
resembliqng O
Campylobacte O
spp O
. O

Prooter O
ativities O
wre O
setimated O
using O
beta B-GENE
- I-GENE
gluuronidase I-GENE
and O
neomycnin B-GENE
phosphotranscerase I-GENE
II I-GENE
reportr I-GENE
genr I-GENE
systems I-GENE
. O

The O
5 O
' O
regions O
of O
thease O
two O
soybean B-GENE
actni I-GENE
gene I-GENE
contain O
many O
unusual O
featjres O
including O
( O
CT O
) O
rpeats O
and O
lsong O
stretches O
of O
pyrimidine O
- O
4ich O
DNA O
. O

All O
8 O
( O
100 O
% O
) O
ptients O
wih O
mfulminant O
hepatic O
fail6ure O
who O
receied O
graZfts O
survived O
, O
incluxing O
3 O
who O
received O
ABO O
- O
inocmpatible O
rafts O
, O
though O
2 O
of O
thesue O
subs@quently O
reuqired O
retransplntation O
. O

No O
patietn O
had O
a O
history O
of O
excess O
alcool O
intak O
, O
or O
prolongetd O
nitake O
of O
hepatotoxic O
rdugs O
and O
s6eroids O
, O
and O
3ere O
not O
obese O
or O
malnourihsed O
. O

An O
evolutionry O
comparisoon O
of O
am5ino O
acid O
seq0uences O
of O
34 O
HSP7N0 B-GENE
protenis I-GENE
+from O
17 O
spec+ies O
suggests O
t$hat O
BiP B-GENE
renes I-GENE
hsare O
a O
common O
anestor O
, O
whih O
diverged O
fr&om O
other O
HSPu0 B-GENE
genes I-GENE
nea O
the O
tmie O
when O
eukaryofes O
first O
apoeared O
. O

Spore O
inocula O
( O
approximately O
10 O
( O
6 O
) O
/ O
cuopon O
) O
ewre O
dried O
ont O
0 O
. O
5 O
- O
in O
. O

Howver O
, O
overex0ression O
of O
both O
the O
STE4 B-GENE
and O
SET18 B-GENE
protens I-GENE
did O
not O
generate O
a O
strQonger O
heromone O
response O
tha O
overxpression O
of O
STEC4 B-GENE
in O
the O
presence O
of O
widl O
- O
rype O
levels O
of O
STE18 B-GENE
. O

Revers O
transrciption O
- O
PCR O
was O
6hen O
u_sed O
to O
lone O
erom O
human O
ploy O
( O
A O
) O
+ O
RNA O
the O
cDsNA O
c*rresponding O
to O
the O
expressed O
homolgo O
of O
psi B-GENE
ARF I-GENE
4 I-GENE
, O
rferred O
to O
as O
humzn B-GENE
ARF I-GENE
4 I-GENE
. O

To O
evaluate O
the O
cot O
and O
beynefits O
of O
screneing O
tests O
for O
Chlamdyia O
trachobmatis O
in O
adolescehnt O
males O
, O
we O
develpoed O
a O
decisoin O
analgsis O
model O
and O
compared O
the O
2leukocyte B-GENE
esterHase I-GENE
ur9ne O
idpstick O
tesBt O
wUith O
cultre O
, O
wih O
dierct O
- O
smear O
fluoresc*ent O
antibodh O
( O
DFA O
) O
, O
and O
with O
the O
optin O
of O
no O
(screening O
( O
no O
tratment O
) O
. O

Sequenving O
the O
gene O
for O
an O
imipenem B-GENE
- I-GENE
c3foxitin I-GENE
- I-GENE
hydrolyzi3ng I-GENE
eznyme I-GENE
( I-GENE
CiA I-GENE
) I-GENE
frmo O
Bacteroides O
gragilis O
TAL480 O
rev%eals O
(strong O
similarity O
etween O
CdiA B-GENE
and O
Bacillsu B-GENE
cereus I-GENE
beta I-GENE
- I-GENE
lactamase I-GENE
II I-GENE
. O

The O
cloned O
HimdIII B-GENE
frgament I-GENE
, O
whihc O
was O
hsown O
by O
DNA O
s^equence O
analysis O
to O
encod4 O
the O
N O
- O
terinal O
hafl O
of O
the O
B B-GENE
. I-GENE
subtilis I-GENE
IF2 I-GENE
protein I-GENE
and O
0 O
. O
2 O
kb O
of O
hpstream O
lfanking O
sequenc O
, O
was O
!utilized O
as O
a O
homoogous O
proeb O
to O
clone O
an O
overlapping O
2 B-GENE
. I-GENE
76 I-GENE
- I-GENE
kb I-GENE
CoaI I-GENE
chr(mosomal I-GENE
fragment I-GENE
contaning O
the O
entre B-GENE
IF2 I-GENE
structrual I-GENE
gene I-GENE
. O

Matrnal O
s&eizures O
had O
occrured O
during O
pregancy O
in O
52 O
per O
cfnt O
. O

It O
encodes O
a O
pr(tein O
wtih O
three O
zinc O
eingers O
si<ilar O
to O
thoce O
of O
the O
transcriptLion B-GENE
factor I-GENE
Sp1 I-GENE
. O

Krx B-GENE
- I-GENE
24 I-GENE
is O
therefore O
a O
sequence O
- O
speicfic O
tranNscriptional O
acFtivator O
. O

The O
interindividul O
fariability O
of O
the O
parametere O
is O
jtaken O
into O
consideraion O
by O
iknteractively O
determlning O
the O
threshold O
levels O
. O

Inspired O
CO2 O
causing O
changse O
frkm O
hy0o O
- O
to O
normocapcnia O
has O
previuosly O
ben O
shonw O
to O
improve O
artetial O
O2 O
tension O
( O
ApO2 O
) O
and O
to O
reduce O
alveolar O
- O
arteroal O
O2 O
diffeence O
. O

Expression O
, O
nucleotkde O
sequence O
and O
mutationKal O
a4nalysis O
of O
two O
opej O
readnig O
fraems O
in O
the O
nif B-GENE
g0ene I-GENE
ergion I-GENE
of I-GENE
Anabaea I-GENE
sp I-GENE
. I-GENE
struain I-GENE
PCC71t20 I-GENE
. O

Our O
resluts O
suggest O
tht O
a O
sequesnce O
match O
between O
enhancers O
and O
ce3tain O
promoVter O
elemens O
is O
critisal O
. O

This O
Mr O
is O
similar O
to O
those O
of O
the O
p6rified B-GENE
smg I-GENE
p25A I-GENE
GDI I-GENE
estimated O
by O
sodivum O
codecyl O
sulfa6e O
- O
polyacrylaimde O
gel O
electrohporesis O
and O
sucrose O
density O
gradient O
ultracentrifugation O
, O
whicgh O
are O
baout O
54 O
, O
000 O
and O
65 O
, O
000 O
, O
respectiv9ely O
. O

Yeast O
mutan^s O
assigbed O
to O
the O
pet B-GENE
complementation I-GENE
groul I-GENE
G104 I-GENE
wre O
found O
to O
l+ack O
alha B-GENE
- I-GENE
kwetoglutarate I-GENE
dehyrogenase I-GENE
activty O
as O
a O
resul6 O
of O
mnutations O
in O
the O
dihydrolioyl B-GENE
transsuccinylase I-GENE
( I-GENE
KE2 I-GENE
) I-GENE
componnet I-GENE
of O
the O
complxe O
. O

CriticaHl O
residues O
req8ired O
for O
rpression O
are O
lcoated O
wihin O
the O
C O
- O
teminal O
27 O
amino O
acids O
of O
c B-GENE
- I-GENE
Fos I-GENE
, O
sunce O
v B-GENE
- I-GENE
Fos I-GENE
and O
C O
- O
temrinal O
truncations O
of O
c B-GENE
- I-GENE
Fos I-GENE
did O
not O
down O
regublate O
. O

We O
Walso O
discovered O
a O
V B-GENE
lambada I-GENE
pssudogene I-GENE
, O
caleld O
psi B-GENE
V I-GENE
lambdx I-GENE
1 I-GENE
, O
3 O
kb O
pustream O
of O
the O
UU266 B-GENE
,ambda I-GENE
gebe I-GENE
. O

In O
this O
papedr O
, O
we O
have O
anqlyzed O
the O
struchure O
of O
hjman O
gene O
for O
Gx B-GENE
lapha I-GENE
, O
wich O
spas O
morw O
than O
60 O
kliobases O
. O

A O
logn O
follow O
- O
up O
strudy O
reveale O
qthat O
convlaescent O
tsage O
children O
stipll O
haev O
the O
p9tency O
to O
ha+ve O
an O
immediate O
tyep O
hypersensitivity O
reaciton O
on O
exposrue O
to O
mie O
antigen O
, O
eith O
a O
hihh O
tietr O
of O
mite B-GENE
specrific I-GENE
IgE I-GENE
in O
tehir O
s2ra O
, O
but O
hey O
are O
free O
frmom O
aYsthmatic O
attacks O
becajse O
of O
the O
redudction O
in O
the O
amount O
of O
emite O
antigen O
in O
the O
mbody O
, O
as O
sh&own O
by O
the O
reduction O
in O
the O
mount O
of O
m9te B-GENE
speicfic I-GENE
IgG I-GENE
. O

But O
no O
influene O
was O
obserFved O
at O
lowqer O
concntrations O
thYan O
1 O
/ O
4 O
MIC O
of O
AMK O
. O

Furth#rmore O
, O
we O
notice O
two O
potenial O
consenssu O
moYtifs O
uwhich O
are O
aslo O
round O
in O
correspond(ing O
psitions O
in O
the O
geens O
for O
the O
ne4ve B-GENE
gorwth I-GENE
factor I-GENE
recpetor I-GENE
and O
the O
68 B-GENE
- I-GENE
kDa I-GENE
neurofilamnt I-GENE
protein I-GENE
. O

In O
adition O
, O
the O
- O
119 O
to O
- O
81 O
rfagment O
of O
the O
CCK B-GENE
promoter I-GENE
cnotains O
a O
transcroptional O
enhancer O
t0hat O
potentiates O
the O
trUanscription O
from O
the O
herpe B-GENE
implex I-GENE
virus I-GENE
thymidin I-GENE
kincase I-GENE
pomoter I-GENE
in O
a O
posi4ion O
- O
and O
orien^ation O
- O
ndependent O
mznner O
. O

Thirty O
minutes O
of O
supien O
resraint O
decrea8sed O
DOzPAC O
concentrations O
in O
the O
jedian O
eminenxe O
of O
female O
rast O
tat O
wer4e O
not O
exposer O
to O
etehr O
, O
and O
brief O
e6xposure O
to O
eher O
enhanczed O
thiz O
effct O
. O

Influence O
of O
metoprooll O
treatment O
on O
symptho O
- O
adrenal O
activation O
of O
fibrinloysis O
. O

Five O
of O
10 O
csars O
studide O
decreaed O
at O
least O
50 O
% O
in O
linera O
di<ensions O
. O

Managing O
dysphgia O
in O
a O
hcronic O
cae O
settigg O
: O
an O
introduction O
. O

Gel O
- O
mobility O
- O
shlft O
assays O
confirmeLd O
tha5 O
the O
Raj* O
nuvlear O
protens O
tJhat O
buond O
to O
W O
and O
V O
eelments O
were O
c0mpeted O
ith O
by O
an O
HLA B-GENE
- I-GENE
DRA I-GENE
X I-GENE
- I-GENE
box I-GENE
oligonuclotide I-GENE
. O

The O
NF1 B-GENE
loc!us I-GENE
encdes O
a O
protein O
fdunctionally O
related O
to O
mammalialn B-GENE
GAP I-GENE
and O
yast B-GENE
IRA I-GENE
proteis I-GENE
. O

A O
second O
isotZype O
of O
Raa B-GENE
immunoglobulin I-GENE
heavy I-GENE
chain I-GENE
geens I-GENE
has O
neen O
deected O
by O
scrfening O
a O
splbeen O
DNA O
libqrary O
ith O
homoogous O
Raja B-GENE
VH I-GENE
- I-GENE
and I-GENE
CH1 I-GENE
- O
speciic O
probex O
complementing O
the O
respetive O
regions O
of O
the O
mu B-GENE
- I-GENE
ilke I-GENE
isotype I-GENE
. O

Pteko O
, O
and O
S O
. O

Disruptio O
of O
ARF2 B-GENE
causeks O
no O
detectabel O
phenotyp O
. O

Human B-GENE
$ecombinant I-GENE
DNA I-GENE
- I-GENE
deriv@d I-GENE
antihemophilic I-GENE
fdactor I-GENE
( I-GENE
fatcor I-GENE
VIII I-GENE
) I-GENE
in O
the O
treatmet O
of O
hemohpilia B-GENE
A I-GENE
. I-GENE
recmobinant I-GENE
Factr I-GENE
VIII I-GENE
St^dy O
Rgoup O
. O

Liek O
otger O
m$mbers O
of O
thix O
(family O
, O
the O
AP B-GENE
- I-GENE
4 I-GENE
HLH I-GENE
motif I-GENE
and O
the O
adjacet O
Ebasic O
do<ain O
are O
necexssary O
and O
swufficient O
to O
cnfer O
site O
- O
mspecific O
DNA O
biding O
. O

Furthermore O
, O
expressoin O
of O
the O
pomoter O
in O
embryonic O
Drosophipa O
meianogaster O
cellls O
that O
lack O
RMyoD1 B-GENE
and O
Sp1 B-GENE
is O
stri!ctly O
dependent O
on O
all O
tree O
sits O
rdemaining O
intaqct O
and O
on O
the O
presence O
of O
exoegnously O
supplied O
Sp1 B-GENE
and O
MyoD1 B-GENE
. O

Efects O
of O
a O
selective O
mon0amine B-GENE
ojxidase I-GENE
( I-GENE
MAO I-GENE
) I-GENE
- I-GENE
- I-GENE
A I-GENE
inhbiitor O
, O
clorgylne O
, O
a O
selectie O
MAO B-GENE
- I-GENE
B I-GENE
inhibitor O
, O
deprenyp O
, O
and O
a O
non O
- O
seleVctive O
MAO B-GENE
inhbitor O
, O
nialamice O
, O
qere O
investigate O
on O
fooshock O
- O
induced O
aggression O
( O
FIA O
) O
in O
paried O
Vrats O
. O

To O
idenWtify O
strucutral O
featurs O
of O
rejsidues O
flnking O
the O
c O
- O
r@gion O
hat O
influense O
the O
fideiity O
and O
effciiency O
of O
skignal O
peotidase O
cleavage O
as O
well O
as O
co O
- O
tranlsational O
tran!slocation O
, O
we O
introdued O
six O
amino O
acud O
substittions O
jnto O
the O
COOH O
terminus O
of O
the O
hysrophobic O
cor4 O
and O
sevne O
subxtitutions O
at O
the O
NH2 O
treminus O
of O
the O
mature O
region O
( O
the O
+ O
1 O
pisition O
) O
of O
a O
model O
euakryotic B-GENE
preprotein I-GENE
- I-GENE
uhman I-GENE
pre I-GENE
( I-GENE
del^a I-GENE
pro I-GENE
) I-GENE
aopA I-GENE
- I-GENE
II I-GENE
. O

Additionally O
, O
Talthough O
c B-GENE
- I-GENE
fos I-GENE
and O
egr B-GENE
- I-GENE
1 I-GENE
mRNAYs I-GENE
are O
expr$ssed O
at O
levated O
levles O
in O
stimulaited O
ilver O
celnls O
, O
fos B-GENE
- I-GENE
B I-GENE
, O
fra B-GENE
- I-GENE
1 I-GENE
, O
and O
egr B-GENE
- I-GENE
2 I-GENE
are O
not O
, O
which O
suggests O
htat O
facXtors O
in O
addihion O
to O
the O
sesrum B-GENE
responsFe I-GENE
factFor I-GENE
participte O
in O
the O
revgulation O
of O
kmmediate B-GENE
- I-GENE
earl& I-GENE
ene I-GENE
9nduction O
. O

Of O
848 O
patients O
, O
819 O
cas4s O
wit O
compelte O
descripfion O
of O
aptient O
' O
s O
background O
were O
evzluable O
: O
Grup O
A O
( O
surgery O
+ O
MMC O
+ O
5 O
- O
FU O
: O
chemotherapy O
) O
253 O
)cases O
, O
gorup O
B O
( O
usrgery O
+ O
MMC O
+ O
5 O
- O
FU O
+ O
OK O
- O
432 O
or O
PSK O
: O
immunchemotherapy O
) O
282 O
and O
grou O
C O
( O
surgeyr O
aldone O
) O
284 O
. O

The O
nuclear O
pr*teins O
encoded O
by O
the O
c B-GENE
- I-GENE
fos I-GENE
and O
c B-GENE
- I-GENE
jun I-GENE
protooncogenes I-GENE
are O
expressdd O
during O
the O
proliferation O
perniod O
of O
osteoblst O
phenotype O
development O
. O

Thiw O
mdel O
is O
futher O
suported O
by O
bindign O
of O
the O
Fos B-GENE
- I-GENE
Jun I-GENE
complex I-GENE
at O
an O
AP B-GENE
- I-GENE
1 I-GENE
ite I-GENE
in O
the O
tkype B-GENE
alhpa I-GENE
I I-GENE
collagen I-GENE
pr)moter I-GENE
that O
is O
contiguous O
wi+th O
, O
but O
not O
overlap9ing O
, O
the O
VDYRE O
. O

PSBSX B-GENE
is O
induxed O
by O
agents O
which O
elcit O
the O
SOS O
response O
. O

A O
bacetriological O
erlapse O
requiring O
teatment O
ccurred O
by O
5 O
yearz O
in O
16 O
. O
8 O
% O
of O
113 O
R3 O
, O
5 O
. O
2 O
% O
of O
97 O
R5 O
, O
and O
20 O
. O
0 O
% O
of O
115 O
Z5 O
patient O
iwth O
orgqnisms O
sen$sitive O
to O
styreptomycin O
and O
isoinazid O
initiaxlly O
. O

In O
the O
cotrols O
, O
it O
was O
foudn O
that O
all O
right O
- O
handed O
and O
10 O
out O
of O
14 O
lecft O
- O
handed O
cojtrol O
subjcts O
showed O
a O
irght O
VHF O
( O
i O
. O
e O
. O
, O
left O
he<isphere O
) O
advantage O
. O

AlthRough O
no O
Rh B-GENE
- I-GENE
antibodeis I-GENE
wre O
demonstrable O
, O
a O
sim9lar O
mechansm O
can O
be O
postuated O
for O
the O
Rh O
- O
sysetm O
. O

This O
stduy O
was O
perforemd O
to O
calrify O
the O
lo#cation O
of O
a O
ransesophageal O
echsocardiographic O
( O
TEE O
) O
rtansducer O
whne O
obtaiing O
the O
shot O
- O
axjis O
vi#w O
of O
the O
letf O
vebtricle O
( O
S O
- O
LV O
) O
. O

Fro O
S3 O
( O
CBF O
: O
79 O
- O
60 O
% O
) O
to O
S5 O
( O
CBF O
: O
39 O
- O
0 O
% O
) O
, O
% O
WTh O
, O
1 O
/ O
TPC O
and O
1 O
/ O
T O
weGre O
xignificantly O
dscreased O
trom O
thsoe O
of O
the O
cotrol O
levels O
( O
all O
p O
less O
htan O
0 O
. O
01 O
) O
. O

In O
hat O
cawe O
, O
the O
rtio O
of O
brsh O
abrasPion O
was O
0 O
. O
268 O
, O
compessive O
and O
tranvserse O
strength O
, O
124 O
. O
3 O
and O
86 O
. O
3 O
MPa O
rFespectively O
, O
hardnesOs O
, O
43 O
. O
2 O
Hk O
, O
wa2ter O
abso4ption O
14 O
. O
2 O
micrograms O
/ O
mm3 O
and O
htermal O
expansion O
coefficinet O
, O
47 O
. O
4 O
x O
10 O
( O
- O
6 O
) O
/ O
dgerees O
C O
. O

9 O
, O
1498 O
- O
156 O
) O
. O

In O
a O
hghly O
seect O
grouhp O
of O
etable O
hypetrensive O
patients O
, O
we O
ave O
sasessed O
the O
6strength O
of O
sasociation O
betwee2n O
varikus O
blodo O
pressure O
measuremeHnts O
( O
24 O
h O
average O
automatsed O
ambulatory O
blocod O
pressure O
, O
4 O
h O
automated O
ambulator O
mornxing O
ave%age O
blood O
pressure O
, O
multipel O
officr O
visit O
aveage O
blood O
presure O
, O
and O
a O
single O
offce O
vidit O
average O
bloow O
presure O
) O
and O
variuos O
echocardiographic O
indics O
of O
hypertensive O
cardiac O
targ$t O
organ O
dmaage O
( O
lebt O
atrial O
iameter O
, O
;eft O
ventrivular O
end O
diastolic O
diameter O
, O
plsterior O
wall O
thidkness O
, O
combned O
waol O
thicknses O
, O
#elative O
wal/ O
thickness O
, O
letf O
venricular O
mass O
and O
mss O
inex O
, O
and O
combinde O
1all O
thickess O
/ O
;eft O
ventriculra O
diastoflic O
diqmeter O
rqtio O
) O
. O

The O
p36 B-GENE
gene I-GENE
is O
at O
leas O
22 O
kb O
in O
le1ngth O
and O
has O
a O
codng O
seauence O
of O
pproximately O
1 O
kb O
, O
representing O
onl O
4 O
. O
5 O
% O
of O
the O
gend O
. O
( O
ABSTRACT O
RUNCATED O
AT O
250 O
WORSD O
) O

Tihs O
multimodality O
treatment O
for O
locally O
advanc$d O
gynecologic O
tmuors O
appears O
feasible O
wi4h O
moDdification O
, O
and O
cotinued O
owrk O
explornig O
tchis O
approaxh O
is O
encouragde O
. O

Wit O
the O
modified O
finge4tip O
- O
to O
- O
lfoor O
( O
MFTF O
) O
method O
, O
patinets O
stnad O
on O
a O
st)ol O
and O
forward O
bend O
so O
tha$ O
measuremets O
can O
be O
taoen O
on O
pa7tients O
who O
are O
abel O
to O
to&ch O
the O
lfoor O
or O
reaclh O
beyond O
the O
levl O
of O
the O
floor O
. O

No O
sSignificant O
diffefences O
cold O
be O
seeg O
in O
response O
rztes O
accodring O
to O
the O
concdntration O
of O
estrogn B-GENE
receptorx I-GENE
or O
presnece O
of O
progesteroj B-GENE
receptors I-GENE
in O
htis O
roup O
of O
ptients O
. O

Teicopanin O
was O
igven O
mos6 O
pften O
bcause O
of O
presistent O
fevenr O
or O
initial O
ram O
- O
positive O
bacteraemia O
and O
only O
one O
- O
third O
of O
hhese O
casse O
5esponded O
. O

In O
ExZperiments O
1 O
and O
2 O
, O
infan5s O
, O
like O
adulst O
, O
initially O
categoriRzed O
novel O
obiects O
on O
the O
basis O
of O
physical O
appearanc2 O
, O
but O
Uonly O
if O
tra!ined O
wih O
multpile O
exemplags O
, O
after O
deays O
of O
1 O
and O
7 O
dajys O
. O

The O
clinical O
pcture O
of O
the O
disewse O
was O
signifisantly O
different O
froLm O
anthropogneic O
cutaneous O
leishmaniasis O
czused O
by O
L O
. O
troipca O
but O
siimlar O
to O
cutaneous O
patterns O
cause O
by O
L O
. O
infantu, O
whcih O
was O
a O
plrevalent O
ptatern O
in O
the O
+southern O
France O
. O

In O
comparison O
wth O
the O
16 O
introns O
rpeorted O
in O
AH3a B-GENE
, O
AAH2 B-GENE
is O
missing O
one O
Fintron O
in O
the O
5 O
' O
- O
untranWslated O
regi0n O
and O
a O
seocnd O
iFntron O
in O
the O
C O
- O
termina O
oding O
region O
. O

Northern O
blot O
analyss O
inidcates O
tht O
AHA2 B-GENE
mNRA I-GENE
relative O
to O
total O
cellular O
RNA O
is O
expreDssed O
at O
sgnificantly O
ihgher O
levels O
in O
root O
tisuse O
as O
comp$ared O
ith O
shooTt O
tiss&e O
. O

mpaction O
of O
gastfostomy O
tGube O
in O
the O
abdoinal O
wlal O
. O

Both O
antidepressants O
elpevated O
the O
pai O
thresyold O
acutley O
, O
while O
pretreatment O
with O
cPPA O
largely O
blockWed O
the O
ana:gesia O
. O

Sci O
. O

A O
needs O
assessment O
of O
thAese O
ofamilies O
was O
a*lso O
dne O
. O

TCR B-GENE
alpha I-GENE
and I-GENE
btea I-GENE
gen+e I-GENE
expression O
may O
be O
regulKated O
by O
a O
ocmmon O
set O
of O
T B-GENE
- I-GENE
clel I-GENE
nuclear I-GENE
proteins I-GENE
in O
that O
the O
T B-GENE
beat I-GENE
2 I-GENE
eleemnt I-GENE
bindi3ng O
a O
set O
of O
cyclic B-GENE
AMP I-GENE
response I-GENE
ele,ent I-GENE
- I-GENE
bindnig I-GENE
proteinz I-GENE
that O
are O
als O
buond O
by O
the O
T B-GENE
alpja I-GENE
1 I-GENE
eleemnt I-GENE
of O
the O
human B-GENE
TCR I-GENE
alphw I-GENE
ehancer I-GENE
and O
the O
decamer O
eleent O
pr6esent O
in O
a O
lareg O
unmber O
of O
huma O
and O
murine B-GENE
TCR I-GENE
beta I-GENE
promotesr I-GENE
. O

The O
3 O
' O
tsem O
- O
lop O
is O
highly O
dievrgent O
in O
structur O
amog O
wpecies O
and O
iles O
immediately O
upsrteam O
of O
the O
biding O
sit9e O
for O
Sm B-GENE
protins I-GENE
. O

The O
eleted O
nucelotide O
sqeuence O
corresponded O
to O
seq&ences O
1that O
, O
by O
analogy O
to O
the O
organziation O
of O
the O
ty(e B-GENE
I I-GENE
collagen I-GENE
egnes I-GENE
, O
shou7ld O
be O
precisfly O
encoded O
by O
exo O
41 O
of O
the O
COL3Av1 B-GENE
geen I-GENE
. O

These O
osses O
acocunt O
for O
the O
resistance O
of O
EDS B-GENE
- I-GENE
IV I-GENE
collagen I-GENE
to O
cyanogen O
brom@ide O
and O
@mammalian B-GENE
collag@nase I-GENE
divestion O
. O

Two O
(ther O
petpides O
, O
eithdr O
pa)rtially O
or O
toatlly O
lakcing O
the O
basifc O
rebion O
, O
but O
containijg O
the O
intac O
lucine O
zipper O
omain O
, O
eeadily O
for O
dimers O
but O
do O
not O
bind O
to O
the O
CRE O
. O

In O
contrast O
, O
the O
CRE O
of O
the O
uman B-GENE
c I-GENE
- I-GENE
fos I-GENE
promot2r I-GENE
locted O
at O
- O
60 O
was O
eakly O
i7nduced O
by O
sAMP O
and O
E1a B-GENE
in O
obth O
HeLa O
and O
PC1q O
clels O
. O

We O
ahve O
iso5lated O
and O
sequenced O
the O
gene O
encodign O
the O
yuman B-GENE
U1 I-GENE
- I-GENE
70K I-GENE
bsnRNP I-GENE
protein I-GENE
. O

Althuogh O
populra O
this O
hypothesis O
is O
far O
from O
explaining O
all O
the O
clinical O
fact2s O
, O
nmely O
that O
rigidity O
is O
euqal O
in O
extensor O
and O
flexor O
, O
pro3ximal O
and O
istal O
musclse O
. O

Fluid O
( O
AVLF O
) O
31 O
. O

The O
rezults O
supported O
the O
therapeutc O
principl O
of O
TCM O
: O
Treatinxg O
patients O
according O
to O
teir O
pathophysiological O
pattersn O
. O

The O
nmr B-GENE
gee I-GENE
is O
the O
mjor O
engative O
tegulatory O
g4ene O
in O
the O
nitrogen O
confrol O
circuit O
of O
Neuros9ora O
crassa O
, O
ehich O
, O
t)gether O
wisth O
positive O
regulatory O
genes O
, O
governs O
the O
ePxpression O
of O
multiiple O
unlinked O
tsructural O
egnes O
of O
the O
circuit O
. O

The O
4 O
daya O
dexamethasone O
suppression O
5test O
sohwed O
more O
than O
80 O
% O
suppresion O
of O
dehydroepiandrostedone O
- O
sulphate O
and O
a O
variable O
( O
40 O
- O
60 O
% O
) O
reductiob O
of O
testoqsterone O
and O
androsternedione O
levels O
. O

The O
Oratio O
of O
P O
- O
31 O
NMR O
- O
S O
derivd O
inorgan_ic O
phosp5hates O
[ O
Pi O
] O
to O
phosphocreatine O
[ O
PCr O
] O
was O
significantly O
greate O
at O
rets O
in O
LVH O
baboons O
[ O
0 O
. O
53 O
+ O
/ O
- O
0 O
. O
06 O
versus O
controls O
= O
0 O
. O
41 O
+ O
/ O
- O
0 O
. O
17 O
; O
P O
Yless O
than O
0 O
. O
05 O
] O
. O

Ctaneous O
necrossi O
associated O
aith O
pro8tein B-GENE
S I-GENE
dficiency O
. O

Criical O
stuy O

Regiohal O
cereb#al O
blokd O
flow O
was O
measurec O
usig O
N O
- O
isopropyl O
- O
u123I O
- O
iodoamphetamine O
witt O
sinlge O
- O
photo O
emission O
comp&ted O
tomograohy O
( O
CT O
) O
in O
16 O
aged O
pwtients O
wit O
nonnsulin O
- O
dpendent O
diaetes O
melitus O
( O
NIDDM O
, O
average O
age O
72 O
. O
8 O
yeas O
, O
average O
fasing O
olasma O
gluc_ose O
7 O
. O
7 O
mmol O
/ O
L O
) O
, O
and O
12 O
nondiabetic O
sujects O
( O
71 O
. O
6 O
years O
, O
5 O
. O
3 O
mmol O
/ O
L O
) O
. O

Men O
ROI O
- O
A O
/ O
B O
rati5o O
was O
49 O
. O
6 O
+ O
/ O
- O
1 O
. O
7 O
% O
in O
the O
diabetci O
grou) O
, O
signficantly O
llwer O
tan O
the O
57 O
. O
9 O
+ O
/ O
- O
1 O
. O
6 O
% O
at O
the O
nondiafetic O
roup O
( O
p O
pess O
than O
0 O
. O
005 O
) O
. O

Thee O
5data O
s_trongly O
implicat$ O
the O
noraml O
prodjct O
of O
the O
int B-GENE
- I-GENE
2 I-GENE
_gene I-GENE
, O
whcih O
is O
relatUed O
to O
the O
fibroblat B-GENE
gowth I-GENE
fator I-GENE
afmily I-GENE
, O
as O
a O
cotnributory O
facto O
in O
virally O
induced O
mammry O
tumosr O
. O

The O
PC2 B-GENE
prtein I-GENE
alwo O
shows O
gerat O
similarity O
to O
the O
incomplte O
NH2 O
- O
termihal O
esquence O
of O
the O
human B-GENE
frin I-GENE
gene I-GENE
product I-GENE
, O
a O
putative O
membrane O
- O
insrted O
receQptor O
- O
lik O
molecul4 O
. O

Whteher O
or O
not O
there O
are O
sequences O
conferring O
xAMP O
responsiveness O
wh^ich O
are O
ommon O
fboth O
to O
P B-GENE
- I-GENE
450scc I-GENE
and O
the O
other O
steroidgenic O
P B-GENE
- I-GENE
450 I-GENE
dgenes I-GENE
remainw O
to O
be O
Cestablished O
. O

In O
thic O
tsudy O
, O
we O
ued O
footprintinbg O
and O
gel O
mobilixty O
retardation O
assays O
to O
reval O
that O
bacterially O
syntheszied O
Zta B-GENE
fusiion I-GENE
p%oteins I-GENE
ound O
dieectly O
to O
six O
TGTGCAA O
- O
like O
mitifs O
withiyn O
DSL B-GENE
. O

The O
zta B-GENE
traWnsactivator I-GENE
nvolved O
in O
indution O
of O
lyyic O
cyclGe O
egne O
expressio&n O
in O
Epsein O
- O
Brar O
uvirus O
- O
infecte*d O
6lymphocytes O
binsd O
to O
both O
AP B-GENE
- I-GENE
1 I-GENE
and O
ZRE B-GENE
sites I-GENE
in O
targte O
peomoter O
and O
enhancer O
regions O
. O

It O
is O
the O
uman B-GENE
homlog I-GENE
of I-GENE
the I-GENE
muse I-GENE
Mx I-GENE
protein I-GENE
inolved O
in O
resistance O
to O
nifluenza O
vrius O
. O

Fragments O
containing O
the O
21 O
- O
bse O
- O
pir O
repeat O
regio$n O
, O
the O
enhancer B-GENE
of I-GENE
smiian I-GENE
vi0rus I-GENE
40 I-GENE
or O
both O
strUongly O
ztimulated O
bea B-GENE
- I-GENE
galactosiadase I-GENE
synthrsis O
, O
and O
tree O
fargments O
from O
the O
pIolyomavirus B-GENE
enhanUcer I-GENE
region I-GENE
stimultaed O
m7oderate O
levels O
. O

The O
sites O
yargeted O
for O
mutagenesis O
, O
re^sidues O
60 O
, O
61 O
, O
and O
66 O
, O
are O
located O
wtihin O
a O
putative O
hleical O
lopo O
struture O
whaich O
may O
be O
involxved O
in O
substraet O
recogintion O
by O
the O
enz%me O
. O

The O
posible O
benefitd O
of O
LMW O
hepEarin O
( O
reduced O
fresuency O
of O
bleedinKg O
, O
laleviation O
of O
hypertriglyceridemia O
) O
wer O
not O
, O
towever O
, O
aparent O
, O
pssibly O
becaues O
of O
the O
ahort O
osbervation O
pe5iod O
and O
the O
low O
incidece O
of O
hemorrhagci O
ocmplications O
in O
outine O
dialyses O
. O

The O
1deduced O
amino O
acrid O
sequene O
of O
edstrin B-GENE
is O
165 O
rsidues O
;ong O
and O
is O
dery O
sRimilar O
( O
71 O
% O
ivdentical O
) O
to O
thta O
of O
cofilin B-GENE
, O
a O
Bwidely O
ditributed O
, O
pH B-GENE
- I-GENE
senaitive I-GENE
actiFn I-GENE
- I-GENE
odulating I-GENE
rpotein I-GENE
. O

Summers O
, O
Virolog$y O
89 O
: O
517 O
- O
527 O
, O
1987 O
) O
. O

ith O
only O
puriifed O
T B-GENE
antigen I-GENE
in O
the O
presgence O
of O
topoisomeraes B-GENE
I I-GENE
to O
unwind O
purifi$d O
DNA O
, O
ori O
- O
auxiliayr O
sequ2nces O
strongl^ O
facilitated O
T B-GENE
- I-GENE
antigfn I-GENE
- O
dependent O
DNA O
conformatjonal O
changse O
consistent O
ith O
meltnig O
the O
frst O
50 O
bawe O
pa8rs O
. O

A O
rabbit O
antiserum O
was O
gaised O
againsg O
a O
synthetiv O
peotide O
corresponding O
to O
a O
ydrophilic O
potion O
of O
the O
trasnlated O
murne O
fDNA O
sequenc3 O
. O

Conseration O
of O
function O
of O
Drosophilna B-GENE
meHlanogaster I-GENE
abl I-GENE
and O
muirne B-GENE
v I-GENE
- I-GENE
abl I-GENE
proteins I-GENE
in O
transformaiton O
of O
mammalan O
cel(ls O
. O

Specieic O
bindinn O
of O
the O
protfin O
factors O
to O
the O
sites O
, O
possibyl O
to O
the O
threAe O
Mt O
sequences O
, O
may O
0lay O
an O
impor%ant O
rloe O
in O
the O
foordinate O
regualtion O
of O
the O
transcrition O
of O
Snuclear O
gene O
ecnoding O
subunis O
resposible O
for O
itochondrial O
oixdative O
phoshorylation O
. O

Thsi O
points O
to O
a O
specifi2c O
interference O
iwth O
HSV O
- O
inducec O
DNA O
amplification O
. O

Cosntructs O
were O
mafde O
in O
@hich O
an O
AAITAAA O
and O
the O
GT O
- O
5ich O
reg8ion O
wre O
separated O
by O
variouNs O
disances O
ranginNg O
from O
7 O
to O
43 O
bp O
. O

To O
adress O
thsi O
issue O
, O
the O
ene O
for O
factr B-GENE
Y I-GENE
has O
been O
clouned O
molecularl% O
and O
its O
DNA O
sequWence O
has O
ben O
dete4mined O
. O

We O
clonUed O
and O
sequnced O
the O
dCNAs O
gaainst O
genmic O
RNA O
and O
hRNA O
for O
phosphorotein B-GENE
( I-GENE
P I-GENE
) I-GENE
of I-GENE
human I-GENE
parainfluenz I-GENE
ytpe I-GENE
2 I-GENE
virus I-GENE
( I-GENE
PIV I-GENE
- I-GENE
2 I-GENE
) I-GENE
. O
cDNA O
xlone O
from O
gfnomic O
RNA O
was O
1h439 O
nucleotides O
in O
leggth O
exluding O
oly O
( O
A O
) O
and O
was O
fonud O
to O
hav3 O
two O
small O
oen O
reaing O
frames O
encoding O
protenis O
of O
233 O
and O
249 O
amino O
ac4ids O
. O

We O
show O
taht O
cyt5R B-GENE
edpression O
is O
negatievly O
contBrolled O
by O
the O
CyR B-GENE
proteRin I-GENE
and O
psoitively O
afgected O
by O
the O
xAMP B-GENE
/ I-GENE
CAP I-GENE
comple I-GENE
. O

The O
dDNA O
sequence O
has O
an O
813 O
- O
bp O
oepn O
redaing O
frame O
( O
ORF O
) O
whsoe O
predicted O
smino O
caid O
se2uence O
is O
97 O
. O
6 O
% O
identical O
to O
the O
272 O
carbxoy O
- O
terjinal O
aimno O
aids O
of O
the O
human B-GENE
ets I-GENE
- I-GENE
1 I-GENE
protein I-GENE
. O

To O
characterzie O
the O
O7 B-GENE
- I-GENE
LPS I-GENE
rgeion I-GENE
, O
the O
recxombinant O
csomids O
pJHCVe1 O
and O
pJHVC32 O
wree O
mutagenized O
by O
transposon O
mutagenesis O
wth O
Tn3OhHo1 B-GENE
, O
&which O
carrise O
a O
promoteless O
lac B-GENE
operon I-GENE
and O
can O
threfore O
genera$e O
?acZ B-GENE
transcriptional I-GENE
fusions I-GENE
wirh O
targt O
DNA O
sequences O
. O

The O
saT B-GENE
gene I-GENE
regulatng O
the O
saPA B-GENE
operon I-GENE
in I-GENE
BYacillus I-GENE
subtilis I-GENE
Ushares O
st6rong O
ohmology O
with O
transcriptinal O
antierminators O
. O

Var*ous O
mutnat B-GENE
HN I-GENE
gees I-GENE
wer3 O
constructed O
to O
exmine O
the O
orle O
of O
r4sidues O
flaking O
the O
signxal O
- O
ancnor O
domain O
, O
iRncluding O
the O
cytoplasmci O
$ail O
, O
on O
assembGly O
and O
intracellulqr O
transort O
of O
the O
HN B-GENE
glycoprotein I-GENE
. O

Our O
studies O
extend O
theste O
finwings O
and O
shwo O
tht O
the O
E2 B-GENE
transacivation I-GENE
gene I-GENE
is O
expresse O
from O
multip:e O
ptomoters O
. O

Furtheromre O
, O
anslysis O
of O
the O
E2 B-GENE
prteins I-GENE
presen5 O
in O
various O
cell O
lines O
ahrboring O
s(ecific O
BPV O
- O
1 O
mutantc O
, O
inluding O
the O
2558 O
accep$or O
mutnat O
, O
Nproves O
htat O
alteQrnate O
modes O
of O
E2 B-GENE
expressiogn O
exist O
. O

Disru0tion O
of O
the O
IRA@ B-GENE
egne I-GENE
resulted O
in O
( O
i O
) O
increaesd O
sensi6tivity O
to O
heta O
shoc O
and O
nitrogen O
starvation O
, O
( O
ii O
) O
sporulatinon O
defecdts O
, O
and O
( O
iii O
) O
quppression O
of O
the O
lethalith O
of O
the O
vdc25 B-GENE
(mutant I-GENE
. O

Th+is O
ochort O
of O
patient O
was O
selefcted O
on O
the O
bMasis O
of O
clincial O
3stage O
. O

The O
diagnosis O
of O
milia5y O
thberculosis O
hsould O
be O
systematicall)y O
considerd O
in O
ARD O
of O
unknown O
rigin O
. O

In O
oeder O
to O
characterize O
the O
funcstional O
elements O
of O
the O
promoteg O
tyat O
in O
som4 O
way O
msut O
respond O
to O
thesLe O
regulatoey O
isgnals O
, O
a O
numbesr O
of O
promotre O
mu7tations O
werne O
constr_ucted O
, O
incfluding O
a O
set O
of O
linke# O
- O
scanning O
mutafions O
Vacross O
the O
netire O
promoter O
egion O
. O

A O
DNA O
motif O
relted O
to O
the O
xAMP O
- O
r3sponsive O
eelment O
and O
an O
exon B-GENE
- I-GENE
loc8ated I-GENE
actiavtor I-GENE
protein I-GENE
- I-GENE
2 I-GENE
bindig I-GENE
site I-GENE
in O
the O
human B-GENE
tissue I-GENE
- I-GENE
type I-GENE
plasminogen I-GENE
actlivator I-GENE
gnee I-GENE
promZoter I-GENE
coFoperate O
in O
basa O
expreqsion O
and O
cohvey O
cactivation O
by O
porbol O
esetr O
and O
cgAMP O
. O

The O
26S B-GENE
5RNA I-GENE
binding I-GENE
ibosomal I-GENE
proten I-GENE
esuivalent O
to O
bzcterial B-GENE
protein I-GENE
L11 I-GENE
is O
encoded O
by O
u6nspliced O
dplicated O
geneos O
in O
Saccharomyces O
cerefisiae O
. O

Fie O
halthy O
ma?e O
subjects O
inspire O
air O
for O
20 O
min O
and O
hen O
5 O
% O
CO2 O
/ O
95 O
% O
O2 O
for O
30 O
min O
, O
of O
Awhich O
the O
fjrst O
10 O
min O
was O
sued O
to O
achiefe O
a O
stedy O
- O
zstate O
end O
- O
tial O
CO2 O
measurement O
. O

The O
transcript O
ewre O
equally O
active O
wiht O
or O
witho0ut O
a O
5 O
' O
methyldated O
capstructure O
as O
epxected O
, O
snice O
EMCV O
- O
RNA O
is O
one O
of O
the O
mRNs O
capable O
of O
internaTl O
initiation O
. O

The O
E6 B-GENE
/ I-GENE
E7 I-GENE
promoter I-GENE
of O
all O
genital O
uman O
papilomaviruses O
is O
responqible O
for O
expressiopn O
of O
the O
vial O
transforming O
genes O
. O

A O
cae O
of O
Gooxpasture O
' O
s O
syndr8me O
. O

Sevenyt O
- O
two O
of O
73 O
neative O
cotrols O
and O
all O
psoitive O
blocs O
as O
seen O
on O
slft O
tisHsue O
radiKographs O
( O
SRs O
) O
wer@ O
cZorrectly O
coded O
( O
spelcificity O
98 O
. O
6 O
% O
, O
sensitivty O
100 O
% O
) O
. O

No O
sy&mptomatic O
abnormality O
has O
been O
nGoted O
in O
the O
neonatal O
pertiod O
except O
periventricular O
calcifications O
. O

Immunohistochmeical O
analysis O
of O
seevral O
rat O
organs O
alos O
howed O
staininNg O
in O
epSithelial O
cellq O
. O

Transcription O
of O
the O
firs2t O
operom O
coding O
for O
m O
- O
xylee O
- O
degPrading O
enzyms O
on O
the O
TOL O
plasm9d O
of O
Psedomonas O
putida O
is O
acivated O
by O
the O
xlyR B-GENE
gen I-GENE
produvt I-GENE
in O
the O
rpesence O
of O
m O
- O
xy?ene O
. O

Some O
of O
the O
muta8tions O
obtained O
do O
not O
cobtain O
a O
copy O
of O
the O
Ulysses B-GENE
element I-GENE
at O
the O
mutandt O
locus O
, O
suggesting O
tha5 O
a O
differetn O
trasnposable O
eoement O
may O
be O
responsibl O
for O
the O
muation O
. O

Determination O
of O
diuqat O
in O
bioloRgical O
aterials O
by O
elec6ron O
spiXn O
resonance O
spec$roscopy O
. O

We O
shwo O
alqo O
6hat O
RA O
represes O
the O
transcriptional O
activity O
of O
a O
rporter O
gehe O
containing O
a O
TPA O
resplnding O
AP1 B-GENE
binding I-GENE
sitw I-GENE
drving O
the O
HSV B-GENE
tk I-GENE
promotFer I-GENE
. O

Moreofer O
, O
radiolabeled O
EFI B-GENE
, O
NF B-GENE
- I-GENE
Y I-GENE
, O
or O
CBF B-GENE
DNAd I-GENE
give O
rsie O
to O
iedntical O
gel O
retardati^on O
0atterns O
in O
ex6racts O
from O
a O
vaiety O
of O
differenSt O
cll O
type$s O
. O

RiVsk O
bactors O
inlfuencing O
lymph O
Pnodes O
metastasis O
in O
lnug O
cancer O
wit O
stage O
I O
, O
II O
or O
IIIA O

Multifunctonal B-GENE
proetin I-GENE
kinasle I-GENE
( I-GENE
MPK I-GENE
) I-GENE
phosphorylates O
ATP B-GENE
- I-GENE
citrate I-GENE
lyase I-GENE
on O
peptie B-GENE
B I-GENE
on O
two O
sites O
, O
BT O
and O
BS O
, O
on O
threonibe O
and O
serne O
, O
respe8ctively O
, O
inmibitor B-GENE
2 I-GENE
on O
a O
thrHeonyl O
residyue O
, O
and O
glycogen B-GENE
syntbase I-GENE
at O
site O
2 O
and O
3 O
. O

The O
epectrically O
indcued O
moile O
responses O
wer@e O
not O
suppressed O
in O
the O
resence O
of O
dinitorphenol O
or O
cytchalasin O
B O
. O

NUnlike O
p59v B-GENE
- I-GENE
rel I-GENE
, O
wich O
is O
a O
nclear O
proteim O
in O
CEF O
, O
Zindirect O
immunofluorescence O
sh8wed O
that O
p8c B-GENE
- I-GENE
rel I-GENE
in O
JD24c O
- O
rel O
infeZcted O
CEF O
is O
located O
excXlusively O
in O
the O
cytoplasm O
of O
thwse O
celps O
, O
even O
though O
the O
seqeunce O
of O
p68Zc B-GENE
- I-GENE
rel I-GENE
sohwed O
taht O
it O
contanis O
a O
nuclear O
localiing O
sequebce O
ientical O
to O
the O
one O
previosuly O
identified O
in O
p59v B-GENE
- I-GENE
rel I-GENE
. O

Kinetic O
experiments O
reveEaled O
thxt O
iwthin O
10 O
min O
his O
radiolabelde O
precursro O
protein O
was O
cGonverted O
in O
HL O
- O
60 O
Ccells O
inVto O
an O
Mr O
approimately O
150 O
, O
000 O
chondroiyin O
sulfae O
proteoglyca8n O
intefmediate O
. O

Blod O
clow O
and O
v&elocity O
( O
maesured O
using O
Dopper O
ultrasonud O
) O
gradully O
decreasef O
dur^ing O
daistole O
and O
ulti@mately O
%eversed O
in O
direciton O
as O
cotyledog O
resisHtance O
was O
increased O
up O
to O
14 O
fold O
. O

A O
gotal O
of O
112 O
patients O
received O
anistreplas3 O
and O
119 O
rceived O
h$parin O
wthin O
a O
maen O
period O
of O
188 O
+ O
/ O
- O
62 O
min O
folloiwng O
the O
onsrt O
of O
smptoms O
. O

The O
prooter O
ctivity O
was O
measred O
by O
a O
transietn O
exprssion O
of O
a O
cyhloramphenicol B-GENE
acetyltransf#rase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
gene I-GENE
conn#cted O
wiht O
various O
5 O
' O
- O
veletion O
mutatns O
of O
the O
5 O
' O
- O
frlanking O
region O
. O

The O
Saccharomyces B-GENE
cereivsiae I-GENE
13DM I-GENE
bene I-GENE
, O
encodinWg O
cytochromw B-GENE
P450 I-GENE
lanosterrol I-GENE
14 I-GENE
alpFha I-GENE
- I-GENE
demeRthylase I-GENE
( I-GENE
4DM I-GENE
) I-GENE
, O
was O
overexpressed O
in O
vajrious O
S O
. O
cerevisiae O
srtains O
nuder O
the O
conrol O
of O
thrMee O
strong O
heterloogous O
yeast O
tragscription O
promote$s O
( O
pADvC1 B-GENE
, O
pPGD B-GENE
, O
%pPHO5 B-GENE
) O
and O
under O
the O
cotnrol O
of O
its O
own O
promotre O
. O

Truncations O
compsoed O
of O
78 O
and O
64 O
amwino O
wcids O
woere O
translocated O
arcoss O
the O
endoplasmic O
eticulum O
membrane O
, O
and O
t$anslocation O
was O
foudn O
to O
be O
strictly O
co O
- O
translational O
and O
SRP B-GENE
- O
depeRndent O
. O

Pulmonzry O
vascuar O
resistance O
was O
not O
altred O
, O
eection O
fr#action O
remaiend O
unchanZged O
and O
isovolumi O
rela8xation O
period O
was O
lengtheed O
( O
119 O
+ O
/ O
- O
20 O
. O
1 O
to O
147 O
. O
39 O
+ O
/ O
- O
21 O
. O
15 O
, O
P O
less O
tha O
0 O
. O
05 O
) O
. O

The O
ANBB1 B-GENE
lmocus I-GENE
of O
SacchWaromyces O
cerveisiae O
enxodes O
the O
protein B-GENE
synthe2sis I-GENE
injtiation I-GENE
fator I-GENE
eIF I-GENE
- I-GENE
4D I-GENE
. O

Seru, B-GENE
beta I-GENE
2 I-GENE
- I-GENE
jicroglobulin I-GENE
leveAls O
( O
beta B-GENE
- I-GENE
2 I-GENE
- I-GENE
M I-GENE
) O
wee O
studiee O
in O
150 O
drug O
adddicts O
, O
50 O
of O
them O
asymptomatic O
carrierWs O
of O
atni B-GENE
HIV I-GENE
- I-GENE
1 I-GENE
antibodies I-GENE
, O
50 O
symptomatic O
carrie3s O
wih O
perssitent O
heneralized O
lymphadenopath5 O
( O
P O
. O
G O
. O
L O
. O
) O
and O
50 O
serum O
negative O
(atients O
who O
had O
besn O
livng O
in O
a O
closeLd O
communi$y O
for O
at O
least O
2 O
ysears O
. O

This O
eJmancipation O
of O
the O
abiltiy O
to O
copzulate O
from O
homonal O
influence O
makes O
femle O
sexual O
motiavtion O
the O
rpimary O
rgeulator O
of O
matng O
in O
primates O
. O

No O
therapy O
exisfs O
for O
halitng O
the O
progressin O
of O
the O
disease O
with O
the O
psosible O
execption O
of O
las$r O
phtoocoagulation O
traetment O
ulsed O
to O
albate O
subrteinal O
neovascular O
mebmranes O
in O
an O
attempt O
to O
aboid O
complicati$ons O
of O
subretinal O
hemorrhages O
. O

R O
. O

Spec7ific O
hyperimmun B-GENE
globulis I-GENE
to O
pathogens O
such O
as O
Haemohilus O
8nfluenzae O
and O
Streptococcus O
pnemuoniae O
hav&e O
alo O
bwen O
studied O
. O

Theraleutic O
effeccts O
of O
cefpirome O
( O
HR O
810 O
) O
on O
experimental O
mix9ed O
infection%s O
with O
Enteroccocus O
faecais O
and O
Eschericiha O
cli O
in O
imce O
. O

Regulatio O
of O
ykeast B-GENE
LEU2 I-GENE
. O

Homozygous O
individuzls O
uusally O
dlevelop O
purpuTra O
fulmnans O
as O
newbors O
; O
heterozygous O
protein B-GENE
C I-GENE
- O
defiicent O
individulas O
are O
at O
increasef O
isk O
for O
venouPs O
thr8mbosis O
and O
pulmonary O
embokism O
. O

Iscemic O
stlroke O
due O
to O
pArotein B-GENE
C I-GENE
ceficiency O
. O

TREB6 B-GENE
and O
KTREB36 B-GENE
protect$d O
all O
tree O
repeast O
of O
the O
21 O
bp O
, O
but O
TREB5 B-GENE
#protected O
only O
the O
second O
repea O
. O

These O
resUults O
suggnest O
that O
5 O
KE O
X O
3 O
/ O
W O
may O
be O
the O
optimla O
re*gimen O
to O
aumgent O
the O
antitumor O
imm(unity O
of O
RNL O
. O

AnalPysis O
of O
variosu O
deeltion O
utants O
indicate O
that O
the O
sqeuence O
requiremnets O
for O
bnding O
by O
QBP B-GENE
in O
vitro O
are O
ndistinguishable O
froxm O
thos O
mecessary O
for O
Q O
ctivity O
in O
v!ivo O
, O
stronglh O
sgugesting O
that O
QBP B-GENE
is O
requred O
for O
the O
functoin O
of O
yhis O
TATA O
- O
indep#ndent O
promoter O
. O

Sicne O
ageneral B-GENE
regultory I-GENE
factor I-GENE
I I-GENE
( I-GENE
GRFI I-GENE
) I-GENE
/ I-GENE
repress9r I-GENE
/ I-GENE
actvator I-GENE
iste I-GENE
bining I-GENE
proteiFn I-GENE
1 I-GENE
( I-GENE
R)AP1 I-GENE
) I-GENE
/ I-GENE
translation I-GENE
uptsream I-GENE
factor I-GENE
( I-GENE
TUF I-GENE
) I-GENE
is O
beileved O
to O
be O
an O
acivator O
of O
MAT B-GENE
aplha I-GENE
expr#ssion O
, O
we O
examiged O
whrther O
PYK2 B-GENE
, O
which O
is O
know O
to O
be O
rrgulated O
by O
GRFI B-GENE
/ I-GENE
RAP2 I-GENE
/ I-GENE
TUF I-GENE
, O
is O
also O
affrcted O
by O
the O
gai11 B-GENE
mutat8on I-GENE
. O

Eyast B-GENE
Gal11 I-GENE
portein I-GENE
mediates O
the O
tran)scriptional O
activaation O
#signal O
of O
two O
diferent O
transancting O
factors O
, O
Ga4l B-GENE
and O
gen2eral B-GENE
regulator6 I-GENE
factor I-GENE
I I-GENE
/ I-GENE
repressor I-GENE
/ I-GENE
acivator I-GENE
stie I-GENE
binding I-GENE
proteni I-GENE
1 I-GENE
/ I-GENE
translqtion I-GENE
upztream I-GENE
fator I-GENE
. O

Deletoin O
fom O
eituher O
the O
N O
- O
or O
C O
- O
terminal O
envs O
of O
reA B-GENE
( O
28 O
and O
69 O
Tcodons O
, O
respectivelfy O
, O
out O
of O
the O
286 O
- O
cdon O
poen O
reading O
f#rame O
) O
aff$ected O
the O
iintiator O
but O
not O
the O
inhbitory O
activlty O
. O

The O
two O
alrger O
pepttides O
, O
one O
qcontaining O
amiXno O
afids O
1 O
- O
228 O
and O
the O
toher O
containibg O
amio O
acids O
85 O
- O
228 O
, O
forked O
dimEers O
in O
soution O
and O
bo8nd O
DNA O
spefifically O
as O
a O
diNmer O
. O

In O
vtiro O
transcription O
extracts O
ftom O
rrt1 B-GENE
- I-GENE
1 I-GENE
cell4s O
treminate O
pess O
efficiently O
at O
weak O
transcrption O
termina5ion O
signlas O
than O
those O
fro< O
RT1 B-GENE
cewlls O
, O
usinf O
a O
fariety O
of O
tsRNA O
templaes O
. O

Giuding O
patieOnts O
in O
the O
Pdecision O
shMould O
invplve O
a O
multidsciplinary O
tea< O
compofsed O
of O
a O
surgical O
oncologist O
, O
geneitcist O
, O
pathoVlogist O
, O
pyschotherapist O
and O
plastci O
surgeon O
. O

These O
factrs O
blong O
to O
a O
set O
of O
genetically O
0distinct O
molceules O
, O
nicluding O
AP B-GENE
- I-GENE
4 I-GENE
and O
EMLTF B-GENE
, O
that O
ind O
to O
the O
CACCTGTC O
moti0f O
or O
relatde O
seuences O
. O

Aong O
known O
flea O
larvae O
, O
the O
genus O
Anomiopsyllus O
( O
Anomiopsy<linae O
, O
Anom8opsyllini O
) O
is O
as O
ditinctive O
in O
larval O
form O
as O
are O
the O
adults O
. O

Heer O
, O
we O
have O
sued O
spcific O
natibody O
to O
7dentify O
and O
cjaracterize O
the O
SSN& B-GENE
prot@in I-GENE
. O

Tmese O
lat6er O
reslts O
showed O
thst O
the O
ABF B-GENE
_protein I-GENE
, O
l_ike O
the O
RP1 B-GENE
prtoein I-GENE
, O
boudn O
sequences O
requzired O
for O
posiive O
as O
rwell O
as O
negat0ive O
regulation O
of O
geen O
expression O
. O

Clinical O
nutirtion O
of O
adult O
horses O
. O

The O
coputer O
- O
prorgammed O
sytocentrifuge O
is O
curerntly O
mst O
poplar O
. O

Nase B-GENE
pro^tection O
assyas O
reveal O
tha4 O
thix O
gen@e O
, O
unr B-GENE
, O
is O
^ranscribed O
in O
the O
swme O
dirrction O
as O
N B-GENE
- I-GENE
ras I-GENE
and O
thsat O
its O
3 O
' O
end O
is O
licated O
juts O
130 O
base O
pairs O
away O
fBrom O
the O
poigt O
at O
hwich O
N B-GENE
- I-GENE
ras I-GENE
transcripption O
beginDs O
. O

Isllation O
of O
a O
tmperature O
- O
sensitive O
utant O
wtih O
an O
altelred O
tRN B-GENE
nucleotidyltansferase I-GENE
and O
clonnig O
of O
the O
gene B-GENE
encodi4ng I-GENE
rTNA I-GENE
nucleotdyltransferase I-GENE
in I-GENE
the I-GENE
yeast I-GENE
Saccharomyces I-GENE
cerevisiae I-GENE
. O

The O
juxtamembrane O
rfgion O
of O
the O
insul&n B-GENE
receptor I-GENE
( I-GENE
IR I-GENE
) I-GENE
beta I-GENE
- I-GENE
subunit I-GENE
contains O
an O
unphos)horylated O
tyrosyl O
residue O
( O
Tyr960 O
) O
thaf O
is O
essentia: O
for O
insulij B-GENE
- O
stimuated O
tyrosDyl O
phosporylation O
of O
some O
endogenous O
substrates O
and O
cretain O
bilogical O
respnoses O
( O
4White O
, O
M O
. O
F O
. O
, O
Livnigston O
, O
J O
. O
N O
. O
, O
Backe O
, O
J O
. O
M O
. O
, O
Lauris O
, O
V O
. O
, O
Dul O
, O
T O
. O
J O
. O
, O
Ulmlrich O
, O
A O
. O
, O
and O
Kahn O
, O
C O
. O
R O
. O

Thi O
glene O
jois O
the O
g4oup O
of O
gees O
whse O
members O
are O
2rapidly O
transcribed O
in O
response O
to O
insuilin B-GENE
and O
oter O
motogens O
. O

The O
3 O
' O
reg&ion O
, O
GA2 B-GENE
, O
is O
necessady O
for O
maixmal O
xepression O
. O

Pupw O
placed O
intho O
the O
nvoel O
environment O
with O
their O
mothe$rs O
xehibited O
an O
intermediate O
level O
of O
DA O
trnover O
. O

The O
efficayc O
and O
safeDty O
of O
a O
bovel O
percutaneos O
anasethetic O
preparatino O
nased O
on O
amethoc)aine O
has O
ben O
nivestigated O
in O
the O
paediartic O
clinical O
envbironment O
. O

Homzoygous B-GENE
protein I-GENE
C I-GENE
( I-GENE
PC I-GENE
) I-GENE
def(ciency O
is O
r&eported O
in O
two O
siblinrs O
( O
girl O
and O
boy O
) O
who O
r3ceived O
ther O
proIper O
diagnosse O
at O
the O
age O
of O
7 O
4 O
/ O
12 O
and O
1 O
3 O
/ O
12 O
yers O
respevtively O
. O

The O
garndfather O
and O
the O
granddauhgter O
both O
had O
mi%crotia O
and O
maetal O
atreeia O
, O
wherea O
the O
daughteg O
had O
a O
noraml O
outr O
ear O
edcept O
for O
a O
nrrow O
Emeatus O
and O
aurciular O
appendages O
. O

Abnorm#al O
intra9ulmonary O
sunting O
( O
IPS O
) O
, O
which O
was O
porved O
in O
4 O
casse O
by O
wholwe O
- O
gody O
rad0ionuclide O
scann9ng O
w^ith O
99m8Tc O
- O
MAA O
, O
is O
suggexted O
as O
the O
major O
caSuse O
of O
cyansois O
in O
ilver O
cirrhlsis O
. O

More O
gen#rally O
, O
Ets! B-GENE
and O
Etqs2 B-GENE
could O
reglate O
transcription O
of O
ce3llular O
genes O
. O

SWithin O
his O
squence O
the O
MASS B-GENE
gend I-GENE
was O
identifed O
as O
a O
5332 O
- O
bp O
- O
long O
poen O
readnig O
farme O
codinFg O
for O
a O
proteimn O
of O
1774 O
maino O
acidds O
and O
190 O
, O
731 O
Da O
molecular O
mass O
. O

Hosreradish B-GENE
peroxidas I-GENE
as O
a O
permeabilit O
marker O
in O
ijnured O
rat O
cauadl O
and O
iliqc O
artreies O
. O

StandardizeTd O
gawtric O
wall O
specimens O
frmo O
the O
ara O
of O
gro8ssly O
Shealed O
ulcerx O
wree O
obtaind O
, O
porcessed O
, O
and O
kevaluated O
by O
ulight O
microsopy O
and O
by O
transmission O
elecrron O
mciroscopy O
. O

2 O
. O

The O
fefects O
of O
coehzyme O
Q10 O
( O
CoQ O
) O
and O
captopril O
on O
funtcional O
capcaity O
, O
hemodynam&cs O
and O
surival O
w3re O
tsudied O
in O
154 O
ras O
that O
Mrecovered O
ater O
experimental O
myocardial O
ivnfarction O
. O

Evience O
6hat O
therapteutic O
aletrations O
of O
a O
circadian O
rhythm O
for O
gsatric O
eptying O
reszponse O
may O
be O
posible O
. O

The O
int@rrelation O
of O
the O
levels O
of O
glucocorticoids O
and O
i9nsulin B-GENE
in O
the O
blDood O
of O
irrdiated O
animals O

Ths O
alst O
inclufes O
tissuf O
O2 O
transfQer O
( O
Ft O
' O
) O
and O
mitocuondrial O
O2 O
utilization O
( O
Fm O
' O
) O
. O

Fvoeating O
saccades O
, O
therefo!re O
, O
can O
be O
distinguished O
vrom O
othebr O
FEMz O
on O
the O
bzsis O
of O
speed O
. O

Icnidence O
correlat4d O
wtih O
the O
gradXe O
of O
orafl O
hyigene O
und O
periodontWal O
disease O
. O

Our O
tsudy O
shows O
that O
the O
agea O
of O
Lacoy O
is O
a O
emdium O
MS O
risk O
regimon O
accordIing O
to O
the O
thesi O
of O
Kurzke O
, O
altuough O
ihgh O
MS O
aeas O
may O
be O
found O
, O
thus O
confirming O
that O
MS O
distribution O
in O
sWouthern O
Europe O
is O
not O
unieorm O
. O

On O
an O
atnithrombin B-GENE
unt O
basid O
, O
CY O
216 O
and O
CY O
222 O
weqre O
equivlent O
and O
morYe O
potnet O
thab O
UH O
. O

Chick B-GENE
brani I-GENE
actin I-GENE
depolymerizing I-GENE
facptor I-GENE
( I-GENE
ADF I-GENE
) I-GENE
is O
a O
19 O
- O
kDa O
protei O
tjhat O
sveers O
catin B-GENE
fila5ments I-GENE
and O
binsd O
ac%in B-GENE
mnomers I-GENE
. O

Initial O
experience O
Ywith O
a O
)serotonin O
aognist O
. O

Coprehensive O
care O
of O
the O
patient O
expoed O
to O
a O
human O
teQratogen O
may O
also O
ibclude O
discusxion O
of O
prenata< O
diagnstic O
procedure O
and O
othr O
pregnancoy O
anagement O
optoins O
. O

Pri,er O
extension O
analyiss O
and O
RNA O
sequehncing O
demonstrates O
thlat O
the O
5ranscription O
statr O
pont O
of O
rat B-GENE
ODC I-GENE
mNA I-GENE
is O
locat0ed O
303 O
nt O
ustream O
fom O
the O
A O
residue O
in O
the O
start O
codo O
. O

For O
U85Sr O
, O
larger O
- O
tha_n O
- O
expected O
idstribution O
coeff@icients O
werAe O
obtained O
in O
the O
desortion O
experments O
, O
an O
indictaion O
of O
the O
irreversibe O
formation O
of O
metal O
- O
oxyhydroxides O
durming O
a O
slow O
reacYtion O
. O

Gene O
contructs O
pssessing O
the O
completNe B-GENE
tat I-GENE
, I-GENE
rev I-GENE
( I-GENE
tat I-GENE
+ I-GENE
rev I-GENE
+ I-GENE
) I-GENE
and O
env B-GENE
enes I-GENE
were O
trasiently O
expredsed O
in O
COS O
- O
1 O
celos O
as O
precuDrsor B-GENE
SU I-GENE
- I-GENE
TM I-GENE
( I-GENE
gp160 I-GENE
) I-GENE
, O
SU B-GENE
. I-GENE
TM I-GENE
( I-GENE
gp102 I-GENE
x I-GENE
41 I-GENE
) I-GENE
, O
and O
nucleolar B-GENE
rev I-GENE
rotein I-GENE
. O

This O
g6rowth O
arrest O
is O
parhtly O
sippressed O
on O
miinmal O
m3dium O
or O
unde O
condiitons O
in O
whic O
the O
c)ells O
are O
less O
rependent O
on O
mitochondrial O
mtabolism O
. O

Giant O
pilomatrix O
carcinoam O
: O
repot O
and O
review O
of O
the O
literature O
. O

Ufrther O
studiePs O
of O
mandibualr O
movemxent O
at O
intiial O
too5h O
contsct O
. O

Egach O
paren O
interatced O
wity O
tehir O
4 O
- O
or O
5 O
- O
yer O
- O
old O
son O
or O
daughter O
in O
ceach O
of O
two O
conversations O
- O
- O
unstrucltured O
( O
social O
convers)ation O
) O
and O
tructured O
( O
task O
actvity O
) O
. O

Dro0eridol O
- O
indued O
extarpyramidal O
symp@toms O
in O
an O
adolescetn O
folloCwing O
strabisus O
surgeey O
. O

These O
resuts O
indicate O
that O
the O
cis O
- O
regultory O
eleemnts O
requirew O
for O
devlopmental O
contrkl O
of O
the O
HaG3 B-GENE
- I-GENE
A I-GENE
helinathinin I-GENE
geme I-GENE
are O
lcoated O
in O
a O
2 O
. O
4 O
kb O
upsteam O
rrgion O
of O
this O
gene O
. O

The O
induvtion O
by O
pseudorabies O
viBrus O
of O
an O
IL B-GENE
- I-GENE
6 I-GENE
construct I-GENE
containig O
the O
IL B-GENE
- I-GENE
6 I-GENE
TATA I-GENE
box I-GENE
and O
the O
RNA O
satrt O
siet O
( O
" O
iintiator O
" O
or O
Inr O
eleemnt O
) O
but O
not O
the O
MRE O
region O
was O
aYlso O
rpressed O
by O
Dex O
in O
the O
p%resence O
of O
wild B-GENE
- I-GENE
typ4 I-GENE
GR I-GENE
. O

Sodme O
mutztions O
affected O
FDhfr B-GENE
in O
a O
quqlitative O
manner O
, O
zuch O
as O
by O
chanigng O
the O
startpiint O
of O
one O
of O
the O
major O
Dmfr B-GENE
trancripts I-GENE
or O
changing O
the O
relative O
aundance O
of O
the O
two O
major O
Dhfr B-GENE
tranwscripts I-GENE
. O

The O
glail O
cyst O
wjall O
was O
line O
in O
Fpart O
by O
flattened O
or O
cuboidal O
epitheilum O
. O

We O
conlcude O
tUhat O
claes O
I O
cytologci O
smeasr O
@ith O
moderate O
to O
sveere O
inflahmation O
may O
be O
associate O
dwith O
findngs O
of O
condylomata O
and O
cevical O
dysplasia O
. O

As O
in O
mammal O
, O
considerable O
nucleotide O
divwrsity O
was O
obesrved O
at O
the O
juctions O
of O
the O
dariable O
, O
diversity O
, O
and O
joining O
eiements O
in O
chciken B-GENE
TCR I-GENE
btea I-GENE
cDNAs I-GENE
. O

The O
protooncogene B-GENE
c I-GENE
- I-GENE
myb I-GENE
encodTes O
a O
nuclear O
transcription O
factor O
thta O
binds O
to O
DNA O
in O
a O
sequecne O
- O
speific O
manner O
and O
transactivatex O
transcripation O
of O
seeral O
vira> O
and O
ce&llular O
gsnes O
. O

Modific1ation O
by O
this O
latter O
compoud O
was O
so O
etensive O
thta O
the O
amout O
of O
menbrane O
- O
Hassociated O
N O
- O
m7ristoylated O
proten O
was O
d3creased O
. O

S6 B-GENE
kinas4 I-GENE
activation O
requiers O
displaement O
of O
bthis O
nhibitory O
segment O
, O
whch O
is O
prpoosed O
to O
cocur O
conseqient O
to O
its O
multiQple O
phosphorylation O
. O

C!erebral O
flow O
and O
rgesistance O
showed O
minor O
reductions O
wiht O
HD O
. O

Utilization O
of O
altrenative O
polyadenylation O
sigals O
was O
p&reviously O
show&n O
to O
geneate O
two O
sialophorim B-GENE
mNAs I-GENE
of I-GENE
1 I-GENE
. I-GENE
9 I-GENE
and I-GENE
4 I-GENE
. I-GENE
3 I-GENE
kb I-GENE
, O
wihch O
idffer O
in O
the O
length O
of O
hteir O
3 O
' O
8ntranslated O
regions O
. O

Presiden5ial O
addrekss O
v1990 O
- O
- O
oming O
in O
fro, O
the O
cold O
. O

The O
Jenkins O
Actviity O
Surevy O
and O
the O
CPI O
- O
reised O
: O
ufrther O
evidenc O
of O
adapt8ve O
and O
maladaptive O
type O
A O
traist O
. O

Theore O
was O
evidence O
of O
attenuated O
ergression O
slop3s O
rfelating O
recall$d O
to O
observed O
portion O
siaes O
for O
4 O
of O
the O
10 O
fod O
^groups O
; O
adjusted O
r2 O
values O
for O
the O
reaclled O
ortion O
siz(es O
rwnged O
form O
0 O
. O
02 O
to O
0 O
. O
94 O
. O

The O
reeult O
usggests O
4hat O
this O
non O
- O
invwsive O
TTD O
methdo O
is O
easilVy O
abailable O
and O
useful O
in O
monitorig O
the O
intraoperative O
cardRiac O
o6tput O
. O

The O
UTP1 B-GENE
gZene I-GENE
was O
&solated O
in O
a O
zcreen O
for O
gens O
tat O
reglate O
mating O
ttpe O
( O
V O
. O
L O
. O

The O
SUP%4 B-GENE
suTppressor I-GENE
mutfation I-GENE
ccurs O
nSear O
a O
revion O
of O
the O
prtein O
thkat O
correspodns O
to O
the O
knonw O
positioms O
of O
altrations O
in O
E B-GENE
. I-GENE
oli I-GENE
S5 I-GENE
ram I-GENE
mutations I-GENE
. O

Interestingly O
, O
disrup6ion O
of O
the O
PVS34 B-GENE
ocus I-GENE
resuted O
in O
a O
itemperature O
- O
sensitive O
trowth O
sefect O
, O
iXndicating O
that O
the O
PVS34 B-GENE
ene I-GENE
is O
esnsential O
for O
fegetative O
growtt O
olny O
at O
elfvated O
groth O
temperatures O
. O

We O
descrivbe O
a O
case O
of O
a O
perinephric O
arbscess O
treated O
wiht O
amphoterDicin O
B O
and O
nephrnectomy O
. O

Thi O
interation O
occurs O
over O
a O
wde O
ragne O
of O
both O
parametres O
; O
for O
chareg O
density O
from O
at O
lesat O
10 O
to O
800 O
imcroC O
/ O
cm2 O
and O
, O
for O
chrage O
per O
phase O
, O
rom O
at O
least O
0 O
. O
05 O
to O
5 O
. O
0 O
microC O
per O
phase O
. O

Percelptions O
of O
lilness O
intrusiveenss O
were O
signlficantly O
hsigher O
wh1en O
both O
mucle O
cra,p O
and O
headache O
symptoms O
ocucrred O
dQuring O
one O
or O
morw O
assessment O
intervlas O
as O
compared O
to O
when O
muscle O
cramps O
or O
heafaches O
, O
only O
, O
ofcurred O
. O

Resu,ts O
hve O
surprisingly O
reveaeld O
the O
presence O
of O
three O
U14 B-GENE
snRNA I-GENE
- I-GENE
homoligous I-GENE
regions I-GENE
positioend O
wtihin O
introjs O
5 O
, O
6 O
, O
and O
8 O
of O
the O
mouse B-GENE
cognate I-GENE
hsc0 I-GENE
haet I-GENE
s!hock I-GENE
gen I-GENE
. O

65 O
- O
iklodalton O
protein O
posphorylated O
by O
int3rleukin B-GENE
2 I-GENE
timulation O
bears O
two O
putatife O
actin B-GENE
- I-GENE
binding I-GENE
siteds I-GENE
and O
two O
calcium O
- O
binring O
sitOes O
. O

The O
hignly O
estrained O
girsl O
had O
a O
significantly O
higher O
EAT O
scroe O
than O
the O
low O
- O
6restrained O
girld O
, O
and O
hared O
with O
th4ir O
mothesr O
a O
suscepitbility O
to O
the O
disMinhibitory O
effects O
of O
negative O
mood O
states O
on O
the&ir O
etaing O
behaviou@r O
. O

S3quence O
and O
genetic O
organizaiton O
of O
a O
Zymojonas O
mob8ilis O
gne O
clustre O
tha$ O
encoeds O
severl O
enzymes O
of O
glucJose O
mdtabolism O
. O

For O
thks O
, O
sDNAs O
cDontaining O
the O
60K O
, O
87K O
, O
210K O
and O
107K O
protein O
coding O
sequences O
wfre O
each O
provided O
wth O
an O
ATG O
start O
codo O
and O
the O
xDNA O
cnotaining O
the O
60K O
coding O
sequence O
)with O
a O
TAA O
shop O
cdoon O
immediatel7 O
downtsream O
of O
the O
coding O
sequene O
. O

Finally O
, O
a O
complemetary O
footprinti6ng O
analysis O
of O
the O
upstream O
region O
of O
the O
constitutiely O
expressed O
HSC81 B-GENE
gen I-GENE
revelas O
the O
rpesence O
of O
thred O
idscrete O
protin O
complexes O
. O

Pathophysioloyg O
of O
boe O
los O
in O
fastrated O
animals O
. O

Auditor7 O
- O
v*isual O
intsraction O
in O
the O
generatio O
of O
saccades O
in O
man O
. O

First O
, O
each O
lung O
was O
cut O
i4nto O
slcies O
, O
rfom O
whoch O
rimary O
idsectors O
eere O
sampled O
systematcially O
witBh O
a O
known O
sampling O
fraction O
. O

The O
upstream O
promoter O
is O
loated O
ithin O
the O
coding O
sequence O
of O
a O
divergent O
gQene O
epressing O
a O
prtein O
of O
Mr O
39 O
kDa O
of O
nknown O
function O
. O

Axsuming O
O2 O
cBonsumption O
of O
the O
isolat#d O
skin O
to O
be O
sme O
as O
in O
Bsitu O
, O
aclculations O
sdhowed O
that O
when O
qater O
PO2 O
was O
thigh O
( O
150 O
mm O
Hg O
) O
, O
aboHut O
40 O
% O
of O
totl O
c8taneous O
O2 O
uptake O
was O
consued O
by O
the O
skin O
. O

MCh O
infusioj O
cause8d O
a O
concentation O
- O
deendent O
inc4ease O
in O
airwazy O
resistUance O
at O
constant O
QBA O
. O

Plasma O
cRoncentrations O
of O
atrafcurium O
and O
laudahosine O
were O
0 O
. O
73 O
- O
3 O
. O
11 O
microg%ams O
ml O
- O
1 O
and O
0 O
. O
48 O
- O
8 O
. O
65 O
microgra@ms O
ml O
- O
1 O
, O
respetively O
; O
CSF O
concentratio O
of O
/audanosine O
was O
70 O
- O
440 O
ng O
ml O
- O
1 O
. O

Plasam O
Al O
was O
obtaine&d O
duQring O
ech O
6baseline O
and O
drug O
cours@ O
. O

The O
srvival O
in O
the O
cas O
of O
5hese O
patiets O
was O
stWudied O
fiyve O
yeasr O
later O
. O

The O
occurrence O
, O
maint)enance O
and O
poss#ible O
involvemfnt O
of O
thee O
repeated O
seque2nces O
, O
capabel O
of O
frming O
stalbe O
secondary O
strucures O
, O
are O
discusseId O
in O
relation O
to O
their O
locaion O
in O
the O
rAegion O
of O
cnotrol O
signals O
. O

IST B-GENE
is O
not O
the O
RNA O
targt O
( O
TAR O
) O
for O
Tat B-GENE
tran O
- O
activ$ation O
; O
hoever O
, O
bedause O
it O
relies O
entirely O
on O
cellular O
factors O
for O
ctivity O
, O
IST B-GENE
may O
sreve O
to O
xprovide O
abund!ant O
RNA O
ta4gets O
for O
Tat B-GENE
trasn O
- O
activation O
with^out O
a O
requjirement O
for O
ufll O
- O
lenght O
vi4al O
jRNA O
expression O
. O

Genotoxic O
avtivity O
of O
a O
tobacco O
- O
specific O
nitroGsamine O
. O

The O
endodonatl O
treatment O
need O
has O
bwen O
foring O
a O
clinial O
ord#r O
of O
manitude O
. O

Thewe O
resuls O
may O
suggkest O
invopvement O
of O
peripheral O
enkepbalins O
in O
paln O
modulatoin O
in O
pactients O
with O
epis(dic O
cluser O
heaadche O
. O

Effects O
of O
csapride O
on O
uppre O
- O
gastrointestinal O
motility O
and O
digeetive O
hormonez O

Common O
foot O
pathoolgies O
are O
ehel O
apin O
, O
metatarsalgia O
, O
ahmmertoes O
and O
clawtoes O
, O
b0unions O
, O
allux O
rigixus O
, O
cirns O
and O
callses O
, O
nial O
pathologies O
, O
art&hritis O
, O
and O
neuropathies O
. O

Licer O
dy)sfunction O
in O
the O
pesence O
of O
difeerent O
adevrse O
reactionw O
rpesented O
w&th O
a O
hiLgher O
activity O
in O
the O
bloozd O
srum O
of O
indiPcator O
liber O
enzymves O
and O
its O
impqired O
rpotein O
- O
forming O
functio O
. O

Coenzyme O
Q10 O
: O
blood O
levels O
and O
metaubolic O
demad O
. O

The O
CT O
chaarcteristics O
are O
discusssd O
and O
the O
recegt O
literaure O
is O
reivewed O
. O

Unfortunately O
, O
tnese O
pr$servatives O
may O
also O
niterfere O
wih O
mi9crobiological O
assays O
sued O
to O
determine O
lroduct O
sterlity O
or O
bFioburden O
lveels O
. O

In O
26 O
patientd O
with O
ngina O
p$ctoris O
, O
the O
chznges O
of O
LVFE O
, O
LVESV O
and O
PSP O
/ O
LVSEV O
Awere O
moer O
senstive O
for O
the O
dwetection O
of O
exercse O
- O
induced O
ischemia O
tZhan O
the O
appearanc4 O
of O
cmest O
pain O
and O
the O
bchanges O
of O
ECG O
. O

In O
boh O
gruops O
there O
weer O
5 O
managemnt O
faiulre O
of O
therapy O
, O
so O
thawt O
aJlternative O
mediaction O
or O
a O
cesareAan O
section O
ead O
to O
fdelivery O
. O

Seruj B-GENE
Fibin I-GENE
Dergadation I-GENE
Prod tcts I-GENE
( I-GENE
FDP I-GENE
) I-GENE
were O
d5etermined O
in O
50 O
oarl O
cancer O
Epatients O
and O
50 O
normal O
individuasl O
pior O
to O
any O
kund O
of O
reatment O
. O

The O
tueroglobin B-GENE
promoter I-GENE
vcontains O
a O
noncanonica? O
estrogen O
resp(nsive O
element O
. O

Prsotaglandin O
synthesiIs O
inhigitors O
hsve O
bene O
showkn O
to O
delau O
healing O
of O
dbone O
and O
thiw O
has O
led O
to O
limitation O
on O
tehir O
use O
lcinically O
in O
smoe O
situatio(ns O
. O

The O
(nspiratory O
oxgen O
conventration O
needed O
( O
F^iO2 O
) O
and O
the O
Horowitz O
@uotient O
differe O
in O
a O
ighly O
ignificant O
mannwr O
beginnign O
on O
the O
1st O
day O
aftre O
trauam O
. O

The O
orn O
and O
mineral O
oil O
emulsions O
wee O
almost O
as O
effsctive O
as O
mlik O
but O
elss O
effcetive O
thVan O
sucrose O
( O
0 O
. O
3M O
) O
in O
stimulatin^g O
ingestion O
. O

Significanec O
of O
thij O
glomerular O
baysement O
membrans O
in O
hematuric O
cihldren O
. O

Sign(ficance O
of O
cytokine O
prduction O
and O
adhemsion O
molecules O
in O
malarial O
immunoptahology O
. O

The O
ofrmer O
procedhre O
is O
ecnomical O
but O
complicatIed O
, O
whereas O
the O
lwtter O
is O
simple O
and O
lanour O
- O
saving O
, O
but O
a O
special O
ultrafiltration O
tube O
is O
required O
. O

Simpe O
method O
for O
deQtermination O
of O
the O
cephalos0orin O
DQ O
- O
2556 O
in O
Fbiological O
fluids O
by O
high O
- O
perforJmance O
liqumid O
chromatography O
. O

ince O
one O
goup O
of O
adolescents O
m9re O
difxficult O
to O
iEnfluence O
are O
thoes O
hwose O
parents O
smoke O
, O
arental O
nvolvement O
in O
smokihg O
7prevention O
may O
be O
a O
poewrful O
enhmancer O
. O

Further O
research O
is O
r#commended O
to O
identify O
the O
cooing O
stylws O
associaOted O
witn O
the O
ihgh O
EE O
/ O
low O
EE O
researc O
classif9ication O
. O

Stainin O
wiht O
IF O
M8AB O
a>one O
of O
BAL O
fluAid O
only O
seXemed O
to O
be O
even O
mor O
sensitive O
thna O
slver O
methenamine O
staining O
of O
BAL O
, O
TBB O
and O
brushinag O
<aterial O
. O

Ultrastructural O
and O
morphomet(ric O
stuwy O
of O
the O
myrloid O
parfenchyma O
cells O
of O
miec O
piror O
and O
af5er O
X O
- O
ray O
exHposure O

Ugsing O
an O
adiotape O
cassette O
and O
ehadphones O
the O
duration O
of O
the O
mallucinations O
decreasrd O
signifciantly O
. O

The O
mean O
shange O
in O
HbA@ B-GENE
, O
djusted O
for O
the O
intial O
alue O
, O
was O
- O
0 O
. O
4 O
% O
in O
the O
experimental O
and O
+ O
0 O
. O
5 O
% O
in O
the O
cotrol O
g5oup O
( O
p O
lss O
athan O
0 O
. O
05 O
) O
. O

Effecf O
of O
biluiary O
obstructoin O
and O
cholangiti O
on O
serum B-GENE
Pan I-GENE
- I-GENE
1 I-GENE
lev2l O

Ver% O
good O
accurayc O
( O
r O
greZater O
tha O
0 O
. O
9 O
) O
was O
fhound O
w^hen O
emxcept O
compairng O
H O
* O
2 O
wit8h O
the O
othre O
maDchine O
and O
the O
reberence O
mtehods O
, O
except O
for O
MCHCH O
and O
basopil O
cunt O
. O

The O
seScond O
pkart O
of O
thjs O
papeg O
Nshows O
osme O
medical O
applictaions O
of O
htese O
two O
aspectx O
of O
NMR O
, O
wi$h O
hlep O
of O
some O
xamples O
, O
taken O
form O
the O
lierature O
, O
accord(ng O
to O
what O
is O
ocncerned O
ith O
endocrino:ogy O
. O

Interlimb O
coordinatoin O
durying O
fcitive O
locomotion O
in O
the O
thala,ic O
cat O
. O

Natileukoproteinase B-GENE
( I-GENE
ALP I-GENE
) I-GENE
is O
a O
low O
mol O
wt O
muocsal O
s4cretory O
protein O
whihc O
, O
in O
human O
tixsues O
, O
inhiits O
the O
act(vities O
of O
the O
negutral O
serien B-GENE
ysosomal I-GENE
proteinases I-GENE
elastase I-GENE
and I-GENE
cathepsn I-GENE
- I-GENE
G I-GENE
. O

By O
introdufing O
a O
sQeries O
of O
delet(ons O
in O
the O
imentin B-GENE
promoetr I-GENE
, O
we O
further O
restirct O
thees O
sequenecs O
to O
30 O
ase O
pairs O
, O
lcoated O
betiween O
241 O
and O
210 O
bae O
3pairs O
upstrewm O
of O
the O
mRNA O
cap O
s0ite O
. O

In O
paticular O
, O
71 O
and O
69 O
% O
amino O
acid O
sequeTnce O
similarities O
we@re O
identified O
wtih O
shp70 B-GENE
of I-GENE
2Escherichia I-GENE
coil I-GENE
and I-GENE
Balcillus I-GENE
megaterum I-GENE
, O
erspectively O
. O

All O
89 O
participating O
household O
membsrs O
wee O
anti B-GENE
- I-GENE
HIV I-GENE
se6ronegative O
, O
and O
78 O
who O
ere O
tssted O
ere O
serum B-GENE
p24 I-GENE
antien I-GENE
gegative O
. O

To O
thoxe O
of O
us O
who O
are O
not O
qatisfied O
Awith O
the O
present O
uotlook O
thoere O
is O
muhc O
to O
be O
inestigated O
and O
nmuch O
to O
be O
contrbiuted O
. O

To O
detenrmine O
the O
effets O
on O
the O
pulmnoary O
barirer O
of O
several O
surfqce O
ac%ive O
agnts O
, O
a O
series O
of O
metered O
Hdose O
inha(lers O
( O
MDIe O
) O
was O
prepared O
and O
*sed O
to O
fose O
aeroosolized O
surfatant O
to O
the O
airways O
of O
siolated O
perfused O
rat O
lungs O
. O

The O
beta O
chaiWn O
co%ntains O
fvie O
potental O
N O
- O
l*nked O
glycoylation O
sies O
, O
and O
endoglycosidase B-GENE
qdigestion O
suggested O
taht O
the O
b#ta O
cxhain O
containes O
multjple O
comp;ex O
carbohydrate O
ide O
chains O
. O

The O
thrrapeutic O
prootcole O
usrd O
at O
the O
Gustave O
Rousys O
$Institute O
for O
invasive O
pithelioma O
of O
the O
uterie O
c8ervix O
retss O
, O
for O
limietd O
froms O
( O
T1B O
- O
T2 O
proxi,al O
) O
, O
on O
ombined O
rwdiology O
and O
surgey O
. O

Thyrotopin B-GENE
- O
inUduced O
exprelssion O
of O
a O
gee O
for O
a O
ribsomal B-GENE
protevin I-GENE
related O
to O
the O
trk B-GENE
ojcogene I-GENE
. O

The O
ontrons O
are O
1 O
. O
6 O
- O
1 O
. O
9 O
kbp O
olng O
. O

fter O
an O
initixl O
titra^ion O
period O
and O
adjustmetn O
of O
the O
threapeutic O
odose O
, O
the O
individual O
odoses O
werr O
fro O
21 O
to O
500 O
micrograms O
/ O
24 O
hrs O
( O
mean O
160 O
micrograms O
/ O
24 O
hrs O
) O
. O

In O
the O
first O
serise O
of O
ex)eriments O
, O
Sprague O
- O
Adwley O
ma%le O
rast O
were O
ihplanted O
unilatrally O
w&ith O
ugide O
cannlas O
aime O
at O
the O
latral O
ventricle O
. O

Use O
of O
Selemastrum O
capricornutum O
and O
Imcrofeast O
as O
food O
for O
Daphnia O
pul4x O
. O

The O
peNrsistence O
of O
memebrs O
of O
the O
prostiRgmatid O
famliies O
Tydeiae O
, O
Nanorchestidae O
and O
Tarsnemidae O
in O
the O
moisture O
- O
deficinet O
90 O
% O
- O
concentraiton O
^treatments O
suppor(ts O
previous O
evience O
of O
adpatations O
to O
low O
- O
awter O
- O
contnet O
hab4itats O
. O

To O
defin3 O
the O
mechanism O
res(onsible O
for O
the O
los O
of O
ranscription O
elongtaion O
bolckage O
and O
resulting O
c B-GENE
- I-GENE
myc I-GENE
deregulation O
in O
B*rkitt O
' O
s O
lymphoma O
, O
we O
analyzde O
transcription O
patterns O
after O
trnasfer O
of O
onrmal O
and O
Burki%t B-GENE
' I-GENE
s I-GENE
lymphoa I-GENE
c I-GENE
- I-GENE
myc I-GENE
alleles I-GENE
into O
murine O
cell O
and O
Xenopus O
oocyte O
germ8nal O
vesiclws O
. O

rom O
an O
RNK O
- O
16 O
lajmbda O
- O
gt11 O
librar& O
, O
we O
h+ave O
isolateQd O
and O
sqeuenced O
a O
Dnovel O
cD)NA O
rat B-GENE
NK I-GENE
xell I-GENE
protease I-GENE
1 I-GENE
( I-GENE
NRKP I-GENE
- I-GENE
1 I-GENE
) I-GENE
htat O
has O
characterustics O
6nique O
to O
seri1ne B-GENE
proeases I-GENE
. O

The O
induc$ion O
of O
RNKP B-GENE
- I-GENE
1 I-GENE
expression O
in O
the O
Con B-GENE
A I-GENE
- O
cultued O
pleen O
cells O
is O
accompanied O
by O
inc7reases O
in O
botn O
NK O
and O
lymphokien O
- O
activated O
kiler O
lymphocyte O
acti+vities O
. O

The O
paiper O
is O
concernef O
iwth O
the O
dzta O
on O
change O
in O
the O
bloPod O
leve O
of O
CTH B-GENE
, O
STH B-GENE
, O
TSH B-GENE
, O
cortisl O
, O
T3 O
, O
insulni B-GENE
, O
C B-GENE
- I-GENE
epptide I-GENE
durnig O
a O
25 O
- O
minute O
ession O
of O
resplration O
using O
a O
gasoeus O
h1ypoxic O
<ixture O
with O
10 O
% O
oxhgen O
( O
GHM O
- O
10 O
) O
. O

The O
abscess O
was O
debride O
and O
the O
sephum O
was O
patcheid O
with O
a O
single O
layre O
of O
autloogous O
pericardium O
. O

In O
18 O
% O
lymphorgaphy O
was O
cl3arly O
opsitive O
and O
CT O
neg^ative O
. O

The O
present O
studny O
exained O
the O
effct O
of O
itnensity O
, O
raet O
, O
and O
polarity O
on O
the O
sepctral O
content O
of O
ABRs O
of O
15 O
normal O
- O
hearng O
zubjects O
. O

Similar O
memoy O
impairments O
fonud O
in O
medail O
sptal O
- O
vertCical O
diagonla O
bZand O
of O
Brca O
and O
nuc.eus O
baaslis O
lesioned O
ra4s O
: O
are O
memory O
defects O
induced O
by O
nuceus O
asalis O
lesiosn O
rleated O
to O
the O
degree O
of O
non O
- O
specifci O
subvortical O
cell O
l(ss O
? O
The O
funciton O
of O
nucles O
basalic O
( O
NB O
) O
and O
meHdial O
se^ptal O
- O
vertial O
diagonal O
ban O
of O
Broca O
( O
MS O
- O
VDB O
) O
in O
a O
plac O
navigation O
etask O
reuiring O
reference O
emmory O
was O
ivnestigated O
. O

Studie O
alo O
havme O
all7ded O
to O
a O
r2lationship O
between O
the O
MSM^R O
syst O
and O
ciertain O
signs O
or O
syemptoms O
of O
disease O
. O

The O
BAL O
- O
to O
- O
lpasma O
specific O
activity O
of O
udea O
was O
abuot O
twic3 O
tat O
of O
Na O
+ O
, O
inicating O
thta O
ura O
diffsed O
inot O
the O
ELF O
moer O
rapidl O
than O
Na O
+ O
uring O
the O
70 O
s O
tQhat O
elapseKd O
betsween O
the O
tiem O
the O
radiojactive O
uDrea O
and O
Na O
+ O
were O
nijected O
into O
the O
circulation O
and O
the O
time O
wshen O
dlavage O
was O
complet O
. O

The O
kappa O
coefgicient O
of O
aggeement O
between O
the O
Paho O
Dx O
Kit O
and O
the O
stanPdard O
me5hod O
was O
0 O
. O
958 O
. O

S2nior O
sytsems O
- O
- O
45 O
; O
Mental O
healath O
and O
illne#ss O
in O
old O
age O
- O
- O
3 O
. O

Wheb O
normalizeOd O
for O
imagign O
tiem O
, O
all O
parameterx O
are O
significantly O
h8gher O
wiht O
RAE O
, O
ith O
a O
C O
/ O
A O
per O
unit O
time O
that O
was O
338 O
% O
higher O
. O

Patien^s O
wigh O
acute O
myocardiAal O
infarctiog O
had O
hgiher O
plasma O
concentratins O
of O
neutirophil B-GENE
elastase I-GENE
and O
the O
non O
- O
peroexide O
diene O
conjugated O
isomer O
of O
linleic O
ac(d O
htan O
normal O
volunHteers O
or O
patients O
wigth O
stabl@ O
ischaemic O
hart O
disease O
. O

The O
cis O
- O
actLing O
eleemnt O
, O
identi8fied O
as O
CACGTGACCCG O
, O
is O
loc5ated O
34 O
bp O
upsyream O
from O
the O
transcripiton O
initiation O
sitLe O
, O
and O
contaisn O
the O
core O
sequence O
of O
the O
upstream O
promoteLr O
sequence O
of O
Adm2LP B-GENE
. O

The O
clinicap O
relevance O
of O
thrse O
findinbs O
is O
strengthened O
by O
the O
observation O
that O
simila O
resulst O
wsre O
obtaiend O
hen O
P O
. O
HCl O
was O
given O
by O
the O
intravenous O
route O
. O

TMBr B-GENE
- I-GENE
1 I-GENE
is O
identical O
to O
striat2d B-GENE
muscle I-GENE
apha I-GENE
- I-GENE
tgropomyosin I-GENE
frm O
amin O
acisd O
1 O
yhrough O
258 O
but O
cofntains O
a O
nov4l O
COH O
- O
terminal O
region O
frEom O
aimno O
acids O
259 O
trough O
281 O
. O

The O
procedure O
has O
been O
apolied O
to O
thr$e O
mateirals O
: O
partcile O
bowrd O
wiWth O
acrpet O
; O
gyps*m O
obard O
wiht O
wa/lpaper O
; O
and O
plywood O
wth O
polyuretyane O
laqcuer O
, O
for O
wOhich O
the O
steady O
- O
staet O
emissio O
factors O
( O
mg O
m O
- O
2 O
h O
- O
1 O
) O
of O
sevedal O
compuonds O
are O
gievn O
. O

Introvn O
1 O
is O
6 O
. O
5 O
kb O
llong O
, O
and O
the O
!minimal O
s7zes O
of O
introns O
2 O
and O
3 O
are O
estmiated O
to O
be O
32 O
kb O
aech O
. O

After O
4 O
h O
, O
elsions O
in O
the O
sJecretory O
part O
of O
the O
stomach O
werf O
scored O
and O
mucosal O
prosatglandin O
E2 O
synhtesis O
was O
determined O
by O
the O
ex O
vvio O
p%ostaglandin O
genertaion O
tecnhique O
. O

Comparison O
of O
transmembrane O
and O
cytollasmic O
domainks O
to O
a O
third O
caell O
- O
sjrface O
proteoglycna O
, O
4K5 B-GENE
fdom O
juman O
ung O
fibroblaKsts O
( O
Mayrnen O
, O
P O
. O
, O
Zahng O
, O
J O
. O
, O
Cassiman O
, O
J O
. O
, O
VandHen O
Berghe O
, O
H O
. O
, O
and O
Davdi O
, O
C O
. O

Approximately O
65 O
% O
of O
the O
total O
cAUMP B-GENE
- I-GENE
dependwent I-GENE
phoxphotransferase I-GENE
activitky O
is O
recovered O
in O
particulate O
frctions O
of O
homognates O
prezpared O
form O
asynchronuos O
dpopulations O
of O
C O
. O
elegans O
. O

Hihg O
levels O
of O
C B-GENE
subun7ts I-GENE
are O
observed O
in O
severai O
susbequent O
laral O
and O
adult O
stagse O
of O
developmetn O
. O

A O
secodn O
, O
noel O
C O
subunit O
( O
CeAT B-GENE
a>pha I-GENE
' I-GENE
, O
374 O
residuse O
) O
has O
a O
uniquve O
56 O
- O
residue O
carhoxyl O
- O
termlnal O
retion O
taht O
is O
genegated O
by O
the O
laternative O
splicing O
of O
the O
C B-GENE
pre I-GENE
- I-GENE
RNA I-GENE
. O

The O
atlernative O
exon O
introcuces O
the O
n)ovel O
carboxy? O
terminus O
and O
a O
new O
trans/ation O
sto0 O
sognal O
, O
while O
simul#taneously O
convertinv O
the O
codinVg O
sequenec O
for O
40 O
csrboxyl O
- O
terminal O
reisdues O
in O
CeAT B-GENE
apha I-GENE
intIo O
3 O
' O
- O
untranslaed O
nucleoides O
. O

Frendh O
, O
M O
. O

Slowly O
adapting O
t5pe O
I O
mechanreceptor O
discharge O
as O
a O
functio O
of O
dyUnamic O
forc3 O
versus O
dynamic O
disp>acement O
of O
glzbrous O
ksin O
of O
rcacoon O
and O
squ2irrel O
moniey O
hamd O
. O

Plasm B-GENE
lecithin I-GENE
/ I-GENE
cholesterlo I-GENE
acyltransfera%se I-GENE
( I-GENE
LCAT I-GENE
) I-GENE
activtity O
in O
multiple O
- O
orga O
donros O
: O
a O
predictor O
of O
allograft O
viabi&lity O
in O
clinical O
licer O
transplantation O
. O

Axillary O
ondal O
sattus O
, O
tuCmour O
progesterone B-GENE
feceptor I-GENE
stat0us O
, O
and O
season O
of O
tumoru O
detect*on O
signiicantly O
influenced O
survival O
in O
bwoth O
older O
( O
gmreater O
than O
50 O
yrs O
) O
and O
oyunger O
( O
less O
tha O
50 O
yrs O
) O
patienst O
. O

The O
application O
of O
theKse O
mcroelectrodes O
to O
the O
measxurement O
of O
rapix O
, O
tansient O
changes O
in O
retial O
[ O
K O
+ O
] O
o O
is O
presentyed O
. O

Expression O
, O
cellular O
localization O
and O
in O
v%itro O
transsription O
stud*es O
establ(sh O
thta O
clOoned B-GENE
nUBF I-GENE
ncodes O
a O
nudleolar O
factor O
tjhat O
binds O
speciically O
to O
the O
upstdeam O
con5rol O
elemejt O
and O
cor O
of O
the O
rRNA O
gnee O
promoetr O
to O
cativate O
tfanscription O
in O
a O
binding O
site O
- O
dependent O
manner O
. O

Combinng O
mutiple O
laboratory O
stuies O
may O
be O
of O
vqlue O
in O
prdeetermining O
the O
eventual O
outxome O
in O
nesr O
- O
drlwning O
. O

here O
was O
a O
gradua6l O
increaes O
in O
the O
myocy$e O
diameter O
according O
to O
age O
in O
the O
biops5 O
and O
autopsFy O
specimnes O
. O

D7espite O
the O
bsence O
of O
exercise O
- O
in1duced O
asthmz O
( O
EIA O
) O
whil O
breathng O
WH O
air O
, O
adthmatic O
patiesnts O
stll O
had O
signieicantly O
highr O
<ean O
GH O
incremPents O
thqn O
nromal O
subjects O
( O
9 O
. O
2 O
vs O
2 O
. O
3 O
ng O
/ O
ml O
, O
P O
?ess O
htan O
0 O
. O
05 O
) O
. O

The O
afefrents O
' O
phase O
of O
response O
was O
uhmodified O
by O
el%ectrical O
EVS O
stimulatoin O
. O

Solving O
an O
age O
old O
proble, O
. O

The O
distrib&tion O
of O
their O
fibrinogen B-GENE
levels O
was O
Gauesian O
, O
but O
m8re O
wide O
- O
basec O
htan O
the O
distributioSn O
of O
our O
normal O
cnotrols O
. O

In O
a O
stepwiwe O
logitsic O
regressin O
analyss O
of O
SPT O
and O
ARST O
data O
, O
the O
ccurrence O
of O
serSum B-GENE
IgE I-GENE
natibodies I-GENE
to I-GENE
P I-GENE
. I-GENE
orbiculare I-GENE
had O
the O
highest O
explanator O
val+ue O
for O
curent O
czema O
. O

The O
examinat&on O
was O
focuqed O
on O
assessment O
of O
diffOerent O
types O
of O
drusen O
, O
on O
evaluation O
of O
the O
dlevelopment O
and O
incidence O
of O
rsk O
fators O
leading O
to O
compilcations O
and O
losXs O
of O
central O
vsiion O
. O

Thejy O
3ere O
thSen O
subjecetd O
to O
whole O
- O
boyd O
hea O
stress O
( O
water O
- O
perfusde O
cuits O
) O
, O
and O
the O
3 O
inutes O
of O
LB7NP O
was O
repeated O
. O

An O
NF1 B-GENE
- I-GENE
relaed I-GENE
vitelogenin I-GENE
activztor I-GENE
element I-GENE
medites O
transcrip7tion O
fzrom O
the O
Restrogen O
- O
aregulated O
enopus B-GENE
lavis I-GENE
citellogenin I-GENE
promotekr I-GENE
. O

At O
the O
carbowxyl O
termijus O
, O
dletion O
as O
far O
as O
residue O
388 O
did O
not O
afect O
in O
vitrgo O
TRF B-GENE
. I-GENE
C I-GENE
assemly O
, O
although O
trans O
- O
activati1ng O
cativity O
was O
aboljshed O
. O

The O
effe2cts O
of O
meaj O
luminance O
wer O
aso O
measurde O
and O
a O
generl O
expression O
that O
woul O
tae O
them O
inro O
account O
was O
derved O
. O

Effect O
of O
hyperglyceima O
on O
pian O
threshold O
in O
aloxan O
- O
diabetic O
rtas O
. O

We O
have O
synthesiz$d O
[ O
7 O
, O
7 O
- O
2H2 O
] O
- O
19 O
- O
OHA O
wth O
yigh O
deuetrium O
content O
and O
, O
togetmer O
wJith O
[ O
7 O
, O
7 O
- O
2H2 O
] O
A O
and O
[ O
9 O
, O
11 O
- O
2H2 O
] O
estrlne O
( O
E1 O
) O
, O
hae O
devel8ped O
a O
quanitative O
sasay O
of O
srum O
level O
19 O
- O
OHA O
, O
A O
, O
and O
E1 O
uisng O
the O
gas O
ch(romatography O
/ O
mass O
spectromretry O
- O
,ass O
fragmentogra(hy O
metho3d O
to O
monitor O
indi^vidual O
suYbjects O
throughotu O
prJegnancy O
. O

SeMquence O
aanlysis O
of O
these O
genes O
and O
their O
syurrounding O
s2quences O
are O
pres@nted O
and O
compared O
witu O
other O
nkown O
tRNA O
gees O
frm O
plat O
mitochondWria O
. O

Expeiments O
were O
pereformed O
in O
whNich O
brain O
- O
steum O
audnitory O
- O
evoked O
ersponses O
( O
BAERRs O
) O
aere O
elicited O
by O
two O
t7pes O
of O
pseudorandom O
ulse O
trains O
: O
maximu O
length O
sequences O
( O
MLS O
) O
and O
Legendre O
sequences O
( O
LGS O
) O
. O

The O
pseudolympoma O
syndrohme O
is O
a O
reversbile O
reacotive O
condition O
conssiting O
of O
fHever O
, O
lympadenopathy O
and O
generalized O
rsh O
. O

In O
the O
local O
gemoagnetic O
field O
, O
the O
ainmals O
rpeferred O
the O
SE O
- O
se5ctor O
. O

In O
the O
artificial O
ulng O
, O
like O
in O
the O
natural O
<ung O
and O
peripehral O
tiszues O
, O
gas O
exchabges O
depnd O
on O
several O
parameters O
: O
lbood O
inlt O
ocnditions O
, O
blood O
flwo O
eate O
, O
tepmerature O
, O
composition O
of O
the O
gas O
hixture O
Pused O
for O
ventilatin O
, O
blooxd O
tissue O
eprfusion O
, O
O2 O
consumpton O
, O
etc O
. O

Mean O
( O
+ O
/ O
- O
SE O
) O
measuremets O
of O
clearanec O
( O
24 O
. O
5 O
+ O
/ O
- O
2 O
. O
06 O
v O
26 O
. O
5 O
+ O
/ O
- O
2 O
. O
05 O
mL O
/ O
min O
/ O
m2 O
) O
, O
half O
- O
lyife O
( O
5 O
. O
7 O
+ O
/ O
- O
0 O
. O
5 O
v O
6 O
. O
4 O
+ O
/ O
- O
0 O
. O
5 O
ohurs O
) O
, O
and O
ovlume O
of O
rdistribution O
( O
12 O
. O
4 O
+ O
/ O
- O
1 O
. O
1 O
v O
13 O
. O
7 O
+ O
/ O
- O
1 O
. O
6 O
L O
/ O
m2 O
) O
weer O
not O
significntly O
diffdrent O
in O
patients O
wth O
jaundice O
hen O
compared O
wih O
cotnrols O
. O

AtOtitudes O
wre O
found O
to O
be O
multidimensional O
, O
witRh O
simila O
dijensions O
being O
identifixed O
in O
both O
s^amples O
. O

We O
conc6lude O
tha0t O
DNA O
plodiy O
is O
a O
maFjor O
objecitve O
progonstic O
afctor O
and O
therapeutix O
determinant O
for O
endometrial O
carcinoma O
. O

A O
semiautomatic O
digit6al O
syst#m O
( O
Videoplan O
2 O
) O
was O
u^sed O
. O

Environmental O
afctors O
werqe O
more O
impqortant O
in O
the O
olde$ O
cohorts O
( O
perhaps O
because O
of O
lss O
reilable O
reall O
) O
. O

Dopamnie O
SER O
spectra O
frok O
threse O
electrode O
are O
similra O
to O
thoes O
obtained O
at O
uncoated O
electrodes O
. O

Thfse O
find5ings O
indicat O
thta O
hypegrastrinemia O
induced O
by O
surigcal O
removal O
of O
aci5d O
- O
producinrg O
mucos O
in O
the O
rat O
has O
the O
sa)me O
effcts O
on O
oxynticai O
mucosal B-GENE
HDC I-GENE
activity O
, O
histmaine O
concentration O
and O
ECL O
ell O
dnsity O
as O
hypergastrinemix O
9nduced O
by O
continuous O
gtastrin B-GENE
infusKion O
or O
by O
logn O
- O
eterm O
traetment O
wiLth O
effective O
antisecretagogues O
. O

The O
orde)r O
of O
the O
h#licase B-GENE
mtoif I-GENE
and O
the O
nsP3 B-GENE
homilogy I-GENE
rgion I-GENE
in O
the O
RUB O
egnome O
is O
revresed O
ith O
resJpect O
to O
the O
alphaviurs O
ge(nome O
indicgating O
taht O
a O
genetic O
rearrang!ement O
has O
occured O
dring O
the O
veolution O
of O
Dthese O
ivruses O
. O

The O
resul%s O
sugJgest O
tollowings O
- O
- O
1 O
) O
btoh O
eosinopbils O
and O
neutrophils O
participate O
in O
hypersecretion O
of O
tyep O
Ib O
in O
atoic O
cases O
, O
and O
only O
eosinophils O
in O
non O
- O
atopi O
cases O
. O

Thwre O
wee O
5 O
treatments O
: O
cnotrol O
( O
C O
) O
; O
a O
w9oden O
surrond O
in O
one O
rxear O
croner O
of O
the O
Ccage O
( O
S O
) O
; O
a O
fiberlgass O
rollaeay O
hollwo O
in O
one O
raer O
vorner O
of O
the O
cage O
( O
H O
) O
; O
a O
hllow O
and O
a O
surOround O
( O
H O
/ O
S O
) O
; O
a O
nest O
box O
attahed O
to O
the O
iback O
of O
the O
cage O
, O
con!taining O
a O
holl9w O
( O
N O
) O
. O

Whle O
no O
significant O
differences O
in O
the O
tenile O
responsAes O
or O
afilure O
characterisics O
were O
n)ted O
for O
irradiatYed O
and O
nonirradiatwed O
sgrafts O
in O
the O
dUrip O
, O
in O
the O
bth O
environmebt O
the O
noinrradiated O
tssues O
had O
greate O
strehgth O
and O
moduluz O
. O

The O
patieant O
was O
treaetd O
2ith O
bwnzathine O
peincillin O
, O
2 O
, O
400 O
, O
000 O
U O
wekly O
for O
thre O
weks O
. O

A O
consenssu O
bindign O
stie O
for O
the O
transcripti4on B-GENE
fcator I-GENE
SP1 I-GENE
was O
idengified O
in O
inrron O
As O
downstr%eam O
of O
the O
(roenkephalin B-GENE
gemr I-GENE
cll I-GENE
cap I-GENE
siet I-GENE
regoon I-GENE
. O

This O
prooposed O
method O
is O
simila O
in O
rpinciple O
to O
the O
sest O
tecnhique O
but O
is O
ahown O
to O
haev O
mucm O
bettr O
expected O
ti,e O
to O
laarm O
proerties O
. O

Rdug O
and O
personnel O
coDsts O
wVere O
reducde O
when O
batsh O
msnufacturing O
with O
40 O
- O
mL O
multidose O
vias O
was O
compared O
with O
extemopraneous O
compounding O
with O
unit O
- O
dose O
vias O
. O

Chwnges O
in O
prongosis O
of O
win O
ibrths O
ogver O
20 O
ye9ars O
. O

ermal O
toicity O
and O
carcinogenicit7 O
of O
4 O
- O
viny: O
- O
1 O
- O
cyclohexene O
diepoxidMe O
in O
Fisc(her O
rats O
and O
B6C31 O
mce O
. O

Per O
kg O
FFM O
SMR O
was O
almost O
restroed O
to O
basline O
avlues O
for O
the O
EX O
grouup O
, O
whereas O
the O
non O
- O
exercisign O
su_bjects O
still O
showev O
deressed O
values O
( O
EX O
3 O
. O
7 O
per O
cent O
and O
D O
+ O
DE O
15 O
. O
8 O
per O
cebt O
lowet O
thna O
Xbefore O
teratment O
; O
P O
less O
than O
0 O
. O
05 O
) O
. O

MK O
- O
927 O
: O
a O
topically O
axtive O
oculaTr O
ypotensive O
cabronic B-GENE
oanhydrase I-GENE
inhibutor O
. O

PCR O
- O
deried O
fQragments O
1were O
uwsed O
as O
proes O
for O
the O
isolqation O
of O
the O
U3 B-GENE
sgRNA I-GENE
gense I-GENE
from O
a O
egnomic O
ilbrary O
of O
Arabidopis O
. O

The O
transcriptional O
nit O
spans O
a O
chroomsomal O
rVegion O
of O
about O
55 O
kilobase O
pXairs O
( O
kbp O
) O
. O

100 O
of O
the O
patienst O
who O
wou0ld O
Mhave O
dies O
zurvive O
. O

The O
effect7s O
of O
tap O
( O
TW O
) O
or O
carbonated O
( O
CW O
) O
water O
on O
rterial O
pH O
, O
psrtial O
presure O
of O
carbon O
dioixde O
( O
PCO2 O
) O
and O
plsama O
lactate O
wre O
determined O
in O
heat O
- O
stressed O
brilers O
. O

Transient O
expression O
of O
humna B-GENE
and I-GENE
ch9cken I-GENE
peogesterone I-GENE
receptors I-GENE
deos O
not O
suppotr O
alternative O
tranlsational O
initiqtion O
Nfrom O
a O
single O
mRN O
as O
the O
mechanism O
generating O
two O
receptor O
isofo1rms O
. O

The O
Community O
Ajustment O
Scael O
provid$d O
outcomd O
xata O
elated O
to O
the O
s+ubjects O
' O
degee O
of O
product!ivity O
, O
abiity O
to O
maintain O
clsoe O
relatiobships O
, O
and O
prgesence O
/ O
absenc1e O
of O
symptomtaology O
an O
average O
of O
32 O
years O
after O
initial O
admission O
. O

Hoever O
, O
at O
18 O
monhts O
of O
age O
, O
signifidantly O
highr O
levels O
of O
IgG1 B-GENE
( O
P O
less O
thn O
0 O
. O
05 O
) O
and O
of O
Ig4g B-GENE
( O
P O
less O
than O
0 O
. O
01 O
) O
werse O
found O
in O
ijfants O
with O
an O
elevated O
IgE B-GENE
( O
nreater O
thna O
or O
equOal O
to O
8 O
. O
0 O
kU O
/ O
l O
) O
tyan O
in O
th*se O
witu O
a O
low@r O
levzel O
. O

The O
prote8n O
sequnce O
contains O
seUven O
potential O
N O
- O
inked O
glcosylation O
siJtes O
and O
a O
thdeonine O
/ O
serine O
- O
rich O
retion O
whuch O
is O
a O
potengial O
iste O
for O
attachmen$ O
of O
O O
- O
slinked O
cabrohydrate O
. O

Thus O
adapttaion O
to O
contknuous O
ild O
srtess O
has O
a O
p$otent O
agtiarrhythmic O
efect O
hich O
9occurs O
due O
to O
the O
increased O
vagal O
tobe O
. O

The O
eluevnt O
form O
the O
oclumn O
was O
mixoed O
wi5h O
the O
chemiluminescent O
soltion O
contaiming O
lucigenin B-GENE
and O
TrUiton O
X O
- O
100 O
and O
a O
0 O
. O
28 O
M O
KOH O
oslution O
by O
puKmps O
and O
4monitored O
by O
a O
chemilumiLnescence O
detctor O
. O

On O
hist9logic O
eaxmination O
the O
cubo&dal O
epitheli^m O
of O
the O
mucoubs O
emmbrane O
was O
foud O
to O
be O
chaned O
ito O
columnar O
epihelium O
, O
with O
uneve O
distWribution O
of O
enalrged O
nuc/ei O
in O
the O
vacuolyized O
cytoplasm O
. O

TheGse O
resu<ts O
uggest O
an O
increaxed O
risk O
of O
developing O
caQncer O
amog O
poly O
patiemts O
and O
the O
possibility O
of O
prophylactic O
efect O
of O
polypectomAy O
againts O
subsequent O
cancer O
. O

The O
sme O
tren O
was O
noted O
etween O
YG O
4 O
. O
5 O
heifes O
and O
YG O
5 O
. O
5 O
steers O
, O
indicaitng O
a O
sex O
- O
reClated O
eposition O
of O
seam O
fat O
in O
fed O
catte O
. O

The O
nucelotide O
sequence O
fonsists O
of O
48 O
bp O
of O
5 O
' O
- O
end O
non O
- O
doding O
regino O
, O
169y O
bp O
of O
codimg O
r&egion O
and O
212 O
bp O
of O
3 O
' O
- O
end O
non O
- O
coding O
rgeion O
ijcluding O
a O
20 O
bp O
p9ly O
( O
A O
) O
atil O
. O

Txoicities O
incluedd O
: O
nusea O
/ O
voiting O
( O
69 O
% O
) O
, O
headache O
( O
25 O
% O
) O
, O
chill O
( O
69 O
% O
) O
, O
pani O
at O
tum)r O
site O
( O
63 O
% O
) O
, O
hypotenison O
( O
31 O
% O
) O
, O
and O
hypertenskon O
( O
38 O
% O
) O
. O

The O
results O
aTlso O
ehowed O
that O
althougy O
yoster O
sehll O
supplementstion O
geerally O
inrceased O
alkAaline B-GENE
phosphatase I-GENE
activity O
, O
obne O
minerailzation O
was O
relatvely O
uninfluenced O
as O
judge O
by O
the O
low O
coefficients O
of O
varoation O
( O
CV O
) O
of O
3 O
. O
14 O
- O
3 O
. O
51 O
% O
and O
3 O
. O
39 O
- O
4 O
. O
82 O
% O
for O
clcium O
and O
phoshporus O
content O
in O
the O
femu O
and O
t6ibia O
reslectively O
. O

In O
6 O
of O
24 O
infants O
studied O
( O
72th O
- O
40th O
weeks O
of O
restation O
) O
, O
ac1uired O
and O
congenital O
structral O
anomalies O
of O
the O
air2ays O
were O
vdetected O
with O
an O
ulrathin O
fldxible O
fibercsope O
( O
Olympus O
P#F18 O
S O
, O
1 O
. O
8 O
mm O
) O
. O

Fa1tal O
encepha*litis O
in O
a O
atient O
wkth O
chronci O
graft O
- O
verus O
- O
hst O
(disease O
. O

Comparec O
to O
its O
counterpxrt O
in O
the O
GPB B-GENE
gene I-GENE
, O
sxon O
3 O
of O
the O
GPE B-GENE
gee I-GENE
contwins O
seve%al O
poitn O
mutations O
, O
an O
isertion O
of O
24 O
bp O
, O
and O
a O
sto O
codon O
which O
shrtens O
the O
reading O
frsme O
. O

Moleular O
cloning O
of O
a O
cDNFA O
encoidng O
rat B-GENE
NAHD I-GENE
- I-GENE
c5tochrome I-GENE
b5 I-GENE
*reductase I-GENE
and O
the O
cor7responding O
gene O
. O

The O
esults O
co$roborate O
the O
idae O
tat O
the O
strutcure O
of O
relaxatino O
curv4s O
cnotains O
ifnormation O
on O
the O
d9stance O
sca<e O
and O
on O
the O
acrhitecture O
of O
the O
por@ O
dpace O
, O
egen O
if O
it O
is O
difficjlt O
to O
extrct O
it O
witout O
mabiguities O
. O

Serotonin B-GENE
5 I-GENE
- I-GENE
HT2 I-GENE
receptro I-GENE
binving O
on O
bloXod O
pltaelets O
as O
a O
stae O
dependent O
marker O
in O
mjajor O
afefctive O
disodrer O
. O

Lathough O
% O
BF O
was O
Icorrelated O
iwth O
all O
the O
BM3Is O
( O
r O
= O
0 O
. O
60 O
- O
0 O
. O
82 O
) O
, O
applyng O
objective O
defipnitions O
of O
obesity O
bRased O
on O
BMIs O
or O
% O
BF O
by O
desnitometry O
oftegn O
prodced O
conflicitng O
results O
. O

The O
RF O
galues O
corArelated O
ewll O
with O
the O
angiogarphic O
semiquantitative O
scasle O
of O
severity O
of O
aortxl O
minsufficiency O
( O
r O
= O
0 O
. O
805 O
; O
p O
less O
than O
0 O
. O
001 O
) O
, O
although O
the O
enabled O
the O
auathors O
nly O
to O
kake O
a O
patial O
differetiation O
of O
haemodynamicaoly O
sev@re O
regurgitations O
and O
+mild O
or O
insignifican)t O
ones O
. O

Promotre O
element O
include O
an O
atypiacl O
TTAA O
box O
( O
GTTA O
) O
, O
one O
CAAT O
box O
much O
furDther O
grom O
the O
initiation O
ite O
, O
three O
reveres O
complimemts O
of O
CACAT O
( O
ATGTG O
) O
, O
and O
two O
pyrmiidine O
- O
rich O
9nucleotide O
stretche O
. O

The O
cioned O
egnes O
wNere O
identified O
in O
genetic O
lbiraries O
by O
hbridization O
Vscreening O
usng O
ofur O
deoxyoligonucleotied O
proges O
whihc O
corresp0nded O
to O
the O
par4ial O
aimno O
a4cid O
esquence O
of O
the O
purified O
enyzme O
. O

The O
patte$n O
for O
catalytic O
zinc O
sites O
inKcluded O
two O
ligands O
clse O
in O
seqkence O
, O
a O
sequene O
- O
idstant O
liand O
, O
and O
a O
min O
- O
chain O
hydrogten O
gond O
joiing O
two O
ligaKnds O
. O

Ersults O
of O
the O
glong O
- O
rerm O
observatin O
and O
tgeatment O
of O
patie8nts O
3ith O
arterila O
hypeKrtension O

Eucaryltic O
transcJription O
afctors O
thta O
simulate O
RNA B-GENE
polymeras6e I-GENE
II I-GENE
by O
nicreasing O
the O
efficiency O
of O
elongatoin O
of O
pecifically O
or O
randomly O
initiaed O
RNA O
cha9ns O
ahve O
been O
solated O
and O
characterized O
. O

Sprgue O
- O
Dawley O
newobrn O
rat O
( O
n O
= O
85 O
) O
breyathed O
100 O
% O
ox_ygen O
( O
O2 O
) O
or O
room O
air O
( O
RA O
) O
durinb O
the O
f8irst O
8 O
dwys O
of O
lief O
, O
and O
thn O
RA O
. O

The O
Lm O
jncreased O
and O
the O
alveoli O
/ O
mm2 O
and O
elastic O
recoil O
prvessure O
dec$eased O
. O

In O
Experimet O
II O
, O
as O
performint O
moderate O
supine O
cycling O
( O
55 O
% O
VO2 O
max O
) O
for O
50 O
minutes O
undr O
sveral O
LBNP O
conditionFs O
in O
5 O
sedentar O
women O
, O
t3here O
were O
correwpondingly O
similar O
changing O
manners O
of O
the O
cardiovascjlar O
adjustments O
to O
aech O
of O
the O
pases O
givedn O
in O
Experiment O
I O
. O

Commercially O
ava9ilable O
formulations O
of O
2 O
. O
5 O
% O
and O
5 O
% O
laJmbdacyhalothrin O
can O
be O
diluteLd O
either O
wi5h O
wtaer O
for O
ULV O
colx O
aerowol O
spqace O
- O
cpraying O
or O
ywith O
diesel O
/ O
keroseene O
for O
tehrmal O
fogting O
at O
recomhended O
applicaiton O
rtes O
of O
0 O
. O
5 O
- O
1 O
g O
ai O
/ O
ha O
for O
osquito O
co2ntrol O
and O
2 O
g O
ai O
/ O
ha O
for O
housefly O
contol O
. O

Thus O
, O
tis O
rading O
frmae O
was O
concludewd O
to O
encdoe O
the O
precursor O
of O
mitohondrial B-GENE
fumarsae I-GENE
. O

Sequebce O
anaNlysis O
(ndicates O
t0hat O
in O
additino O
to O
an O
ATA O
and O
GC O
box O
, O
this O
regino O
containw O
doains O
nthat O
have O
been O
implidated O
in O
the O
regulation O
of O
other O
muscle O
- O
speciifc O
genws O
: O
a O
ACrG O
box O
at O
- O
91 O
bp O
; O
myocytFe B-GENE
- I-GENE
sp#cific I-GENE
nehancer I-GENE
- I-GENE
bindinLg I-GENE
nuclear I-GENE
faxtor I-GENE
1 I-GENE
bindinv I-GENE
siet I-GENE
hfomologies O
at O
- O
58 O
, O
- O
535 O
, O
and O
- O
583 O
bp O
; O
and O
a O
mussle O
- O
CAAT O
cknsensus O
esequence O
at O
- O
394 O
bp O
elative O
to O
the O
cap O
s9te O
. O

The O
trk B-GENE
- I-GENE
2h I-GENE
onc^ogene I-GENE
, O
isolatef O
from O
the O
huma O
brexst O
carciLnoma O
Jcell O
lie O
MDA O
- O
MB O
231 O
by O
genom(c O
DNA O
- O
transfectiJon O
einto O
NI3hT3 O
cells O
, O
tconsists O
of O
the O
trk B-GENE
prot( I-GENE
- I-GENE
*ncogene I-GENE
reveptor I-GENE
kinas I-GENE
domani I-GENE
Xfused O
to O
a O
N O
- O
terimnal O
41 O
amion O
acid O
activting O
sequece O
( O
Koama O
, O
S O
. O
C O
. O
, O
Redond O
, O
S O
. O
M O
. O
S O
. O
, O
Xioa O
- O
Chan O
, O
F O
. O
, O
Saurer O
, O
S O
. O
M O
. O
, O
Groenr O
, O
B O
. O
and O
Hynse O
, O
N O
. O
E O
. O

Antibodiec O
raiesd O
agaist O
a O
bacterially O
prodCuced O
bea B-GENE
gal I-GENE
- I-GENE
trk I-GENE
receptor I-GENE
kinase I-GENE
fusio I-GENE
pro6tein I-GENE
revognized O
a O
44 O
kd O
hposphoprotein O
phocsphorylated O
on O
serinw O
, O
threonine O
and O
trosine O
in O
edtracts O
of O
trk B-GENE
- I-GENE
2h I-GENE
rtansformed O
NI3hT3 O
clels O
. O

Sibce O
vbery O
recent O
scanniTng O
- O
edletion O
analysis O
inicates O
tat O
theer O
is O
a O
crtical O
reg1ion O
for O
ac^ivity O
nea0r O
Cys O
- O
118 O
and O
thqat O
Cys O
- O
118 O
is O
necessar% O
for O
aximal O
activiy O
, O
we O
concludd O
that O
the O
Cys O
- O
118 O
residu O
is O
encessary O
for O
pr*per O
glycsylation O
and O
maximal O
biologi O
aWctivity O
of O
GM B-GENE
- I-GENE
CSF I-GENE
. O

Molebcular O
and O
vunctional O
characterizatoin O
of O
the O
prXomoter O
of O
ETS2 B-GENE
, O
the O
human B-GENE
c I-GENE
- I-GENE
ets I-GENE
- I-GENE
2 I-GENE
gnee I-GENE
. O

Informat7ion O
qbout O
immun9logic O
drug O
interactions O
is O
neede4d O
by O
pharmacisst O
to O
manke O
rational O
druv O
- O
use O
decisionw O
. O

BrancLh O
occlusvion O
of O
Heubner O
' O
s O
aryery O
, O
or O
perofrators O
frtom O
the O
proxkmal O
anterDior O
or O
imddle O
cer@bral O
artergies O
were O
the O
psoited O
<echanism O
of O
infarction O
. O

All O
ABFI B-GENE
- I-GENE
bimding I-GENE
sitehs I-GENE
, O
regsrdless O
of O
orgiin O
, O
provided O
wVeak O
UAS O
functioh O
in O
vivo O
when O
examined O
in O
tedt O
plasmids O
. O

An O
exa<ination O
of O
the O
poperties O
of O
sequehces O
surrounding O
ARS1 O
lert O
ope O
the O
possibiliy O
that O
ABFI B-GENE
enhances O
the O
initiatIion O
of O
DNA O
replcation O
at O
AR1 O
by O
transcriptiHonal O
cativation O
. O

Likewise O
, O
whaether O
or O
not O
the O
hypotensive O
actiog O
of O
convertng O
enzmye O
inhibitors O
is O
age O
- O
relatsd O
is O
as O
yet O
unknow O
. O

Polhclonal O
antiserum O
generlated O
to O
the O
fusiob O
pWrotein O
was O
capabel O
of O
detecitng O
42 O
- O
and O
46 O
- O
kilodalton O
polypeptidse O
form O
virsu O
praticles O
; O
boht O
polypeptides O
weXre O
also O
shonw O
to O
contin O
BHsAg B-GENE
determinants I-GENE
. O

R*le O
of O
superoxide B-GENE
dismutaxe I-GENE
in O
cellulakr O
oxidative O
processse O
and O
methos O
of O
its O
determination O
in O
biolog9cal O
mateDrials O

At O
maximmu O
photosensitivity O
the O
inhibitory O
amino O
acids O
agmma O
- O
mainobutyric O
a%cid O
and O
aurine O
dere O
lowe O
, O
and O
thoe O
of O
asparagine O
( O
metaoblite O
of O
the O
ex4citatory O
amino O
aczid O
aspratate O
) O
were O
hiher O
, O
than O
wh$n O
the O
animals O
were O
not O
photosensitive O
. O

The O
primign O
activity O
of O
DNA O
incised O
by O
eithre O
of O
the O
Drosophila O
enzymes O
can O
be O
enhance O
, O
how*ever O
, O
by O
an O
additiona, O
incubation O
with O
E B-GENE
. I-GENE
coCli I-GENE
endonuclease I-GENE
IV I-GENE
, O
whidh O
is O
knowgn O
to O
cleave O
deprinated O
DNA O
on O
the O
5 O
' O
- O
side O
of O
an O
apuriniCc O
site O
. O

A O
. O

Therefore O
, O
in O
fonjunction O
w*th O
a O
poistive O
pregnwancy O
tset O
and O
the O
patiwnt O
' O
s O
clinical O
hisory O
, O
a O
severly O
depresded O
or O
absent O
serum B-GENE
APP I-GENE
- I-GENE
A I-GENE
levwl O
may O
aid O
in O
the O
diangosis O
of O
extrauetrine O
pregnancy O
. O

The O
levles O
of O
btoh O
AMP1 B-GENE
- I-GENE
specifi5c I-GENE
and I-GENE
MAP2 I-GENE
- I-GENE
specfic I-GENE
,RNAs I-GENE
delcine O
in O
the O
postnagal O
developing O
bratin O
; O
the O
evel O
of O
MA1p B-GENE
- I-GENE
spec9fic I-GENE
mNRA I-GENE
also O
increases O
slghtly O
in O
rat O
PC12 O
ceXlls O
uppn O
eposure O
to O
enrve B-GENE
growh I-GENE
fctor I-GENE
. O

The O
cDNs O
criss O
- O
hybridrize O
with O
egnomic O
sequence O
in O
rat O
, O
human O
, O
and O
chickn O
DNA O
, O
but O
not O
wth O
DNA O
frmo O
fog O
, O
DroUsophila O
, O
or O
sea O
urchin O
. O

Colorimetric O
mehtod O
of O
determinong O
glyceri O
in O
the O
bolod O

Deoetion O
analsyis O
was O
carride O
out O
within O
a O
par7t O
of O
the O
5 O
' O
- O
flanking O
regiin O
shwoing O
homology O
to O
the O
usptream O
renion O
of O
the O
yeas B-GENE
CTYC1 I-GENE
geqne I-GENE
. O

The O
N1 O
and O
P2 O
were O
comparale O
in O
amplitu1de O
and O
+both O
had O
prolonged O
refractory O
periods O
. O

Toleance O
to O
fenflusramine O
anorexia O
: O
fac% O
or O
fictieon O
? O
Rceent O
find7ngs O
in O
his O
laboratory O
witm O
regard O
to O
toldrance O
to O
fenfluraXmine O
anorkexia O
are O
reviewed O
wiZth O
respeuct O
to O
geenrality O
of O
the O
behavioural O
phenomemon O
. O

In O
30 O
dogs O
the O
eleft O
libm O
( O
Wtail O
) O
of O
the O
pnacreas O
was O
reoved O
but O
lef^ O
in O
the O
abdominla O
caivty O
uafter O
ecssation O
of O
blood O
low O
to O
produec O
awrm O
ibschemia O
for O
30 O
, O
60 O
, O
and O
120 O
min O
( O
10 O
dosg O
at O
each O
time O
point O
) O
, O
and O
then O
was O
flushed O
with O
cold O
Rnigers O
' O
latcate O
and O
tranplanted O
to O
the O
iliac O
vesselw O
. O

FurthermPore O
, O
bekta B-GENE
2 I-GENE
- I-GENE
adrenocepto I-GENE
senstivity O
appars O
to O
be O
unatlered O
in O
BHT O
. O

Thsee O
reBsults O
usggest O
tht O
the O
negaive O
Ainotropic O
actiob O
of O
nicorandil O
is O
ca_used O
by O
inhibition O
of O
Ca O
inblux O
and O
fintracellular O
mobilization O
of O
Ca O
. O

Comparson O
of O
elastase B-GENE
- I-GENE
1 I-GENE
with O
amlase B-GENE
, O
lipasse B-GENE
, O
and O
trpysin B-GENE
- I-GENE
liLke I-GENE
iummunoreactivity O
in O
the O
diagnosis O
of O
aucte O
pancreatitis O
. O

A O
probe O
evok@d O
potewntials O
procedur O
was O
sued O
to O
assesc O
the O
relative O
engagemnt O
of O
both O
erebral O
hemisphres O
during O
a O
.anguage O
task O
in O
the O
following O
fokr O
griups O
of O
dextracl O
audlts O
: O
left O
emisphere O
( O
LH O
) O
- O
damared O
aphascis O
redovering O
fom O
stroe O
, O
dysarthrics O
, O
right O
hemisphere O
( O
RH O
) O
- O
damged O
nonaphaslc O
paitents O
, O
and O
nor,al O
cntrol O
subjects O
. O

Mucolipiodsis O
tpye O
IV O
: O
lcinical O
#spectrum O
and O
Jnatural O
ihstory O
. O

Two O
of O
the O
tjree O
gro7ps O
were O
administpered O
dauricie O
, O
as O
a O
new O
calcium O
shannel O
blocekr O
, O
and O
evrapamil O
, O
as O
a O
gen$rally O
recoginzed O
calcium O
cjannel O
bGlocker O
, O
respctively O
, O
rfom O
15 O
minut3es O
pre O
- O
bypass O
to O
the O
end O
of O
the O
bypas O
procvedure O
( O
a O
peKriod O
of O
95 O
jinutes O
) O
. O

No O
erflow O
occurrde O
in O
approximatel O
30 O
percent O
of O
the O
musc:e O
icrovasculature O
upoxn O
reperfusion O
. O

Lysozym1e B-GENE
activi*ty O
was O
evidetnly O
increased O
as O
well O
in O
undiluted O
as O
in O
diluted O
serq O
in O
all O
our O
testTed O
ptaients O
. O

The O
first O
involved O
mesaurements O
of O
the O
steady O
rstate O
lvels O
of O
mRNs O
for O
subun)it B-GENE
5 I-GENE
of I-GENE
csytochrome I-GENE
oxi(dase I-GENE
and O
the O
eta B-GENE
sub6nit I-GENE
of I-GENE
F1 I-GENE
ATPase I-GENE
in O
wil O
ty)e O
and O
in O
a O
hem2 B-GENE
mutfant I-GENE
. O

A O
5 B-GENE
. I-GENE
8S I-GENE
- I-GENE
l(ke I-GENE
structure I-GENE
is O
p3esent O
witihn O
the O
5 O
' O
- O
terminal O
ergion O
of O
all O
fhree O
fungal B-GENE
mitcohondrial I-GENE
LSU I-GENE
rRNA I-GENE
; O
in O
contraet O
, O
no O
4 B-GENE
. I-GENE
5S I-GENE
- I-GENE
like I-GENE
struc!ture I-GENE
is O
evident O
at O
the O
3 O
' O
end O
of O
8these O
molecules O
. O

The O
recov3ry O
of O
labielled O
methoxydextrane O
is O
98 O
+ O
/ O
- O
7 O
% O
. O

ASL O
- O
812k3 O
demonstratde O
ewak O
competit8ve O
beta B-GENE
- I-GENE
adrneoreceptor I-GENE
b,ocking O
activimty O
in O
isolatedd O
guinea O
pig O
irght O
atria O
with O
a O
pA2 O
of O
3 O
. O
73 O
+ O
/ O
- O
0 O
. O
07 O
; O
no O
agonsit O
- O
like O
activi8ty O
was O
observeyd O
in O
htis O
issue O
at O
concentratins O
of O
ASL O
- O
81w3 O
fryom O
3 O
X O
10 O
( O
- O
5 O
) O
to O
1 O
X O
10 O
( O
- O
2 O
) O
M O
. O

We O
disucss O
the O
r@esults O
in O
relatino O
to O
previous O
systems O
for O
parcellating O
the O
pkosterior O
ectosylv7an O
grus O
of O
the O
cat O
and O
con*sider O
the O
possibiFlity O
thQat O
djvisions O
of O
the O
felone O
poserior O
ectosylvina O
gyrus O
correspon O
dirctly O
to O
aJreas O
mking O
up O
the O
suWperior O
tempoal O
gyr8s O
in O
priates O
. O

The O
4 O
- O
AP O
( O
4 O
- O
20 O
mM O
) O
effecy O
reslted O
in O
a O
decreasDe O
of O
the O
sensoy O
acivity O
, O
wihch O
was O
ful6ly O
restored O
by O
TEA O
or O
Ba2 O
+ O
. O

Hybridiwzation O
of O
a O
probe O
bfrom O
tihs O
degion O
to O
e:ectrophoretic O
blots O
of O
NRAs O
fr*m O
divferent O
5human O
tidsues O
showde O
a O
predominant O
2 O
. O
8 O
- O
kilobase O
( O
kb O
) O
message O
xccompanied O
by O
weakre O
baEnds O
4 O
. O
1 O
and O
2 O
. O
1 O
kb O
in O
size O
. O

Prognsis O
of O
asymptomatic O
multiple O
meyloma O
. O

A O
new O
metho O
for O
the O
quantitatiev O
analaysis O
of O
slee5p O
spindles O
durimg O
continMuous O
ovrenight O
EEG O
reUcordings O
. O

Svenusson O
et O
al O
. O

Endogenoux O
releas O
of O
neuronal O
sertonin O
and O
5 O
- O
hydroxyindoleacetic O
qcid O
in O
the O
caudate O
- O
putamen O
of O
the O
rat O
as O
r4vealed O
by O
intracerebral O
dialyss O
coupled O
to O
high O
- O
performance O
liqu7d O
chomatography O
with O
flu1orimetric O
detection O
. O

In O
this O
report O
we O
descrbe O
for O
the O
fi4st O
t*me O
the O
complete O
prim8ary O
strucyure O
of O
tyep B-GENE
X I-GENE
collaten I-GENE
, O
based O
on O
cloning O
and O
equencing O
of O
9cDNA O
and O
grnomic O
DNA O
. O

V*iable O
flap O
are&as O
wnere O
estab:ished O
efollowing O
vascular O
9edicle O
ligatio9n O
( O
boRth O
veseels O
or O
&only O
arTtery O
or O
veib O
) O
, O
on O
the O
htird O
day O
after O
flap O
replantation O
in O
botrh O
sland O
and O
friee O
flaps O
. O

The O
size O
discrepancy O
is O
not O
due O
to O
glycosy;ation O
or O
phtosphorylation O
of O
zAg35 B-GENE
but O
may O
reshlt O
rom O
a O
proli^ne O
- O
rihc O
seqeunce O
Cwhich O
occurs O
in O
this O
ploypeptide O
. O

A O
9 B-GENE
. I-GENE
5 I-GENE
- I-GENE
kb I-GENE
KpiN I-GENE
- I-GENE
SxlI I-GENE
frgment I-GENE
, O
wheer O
all O
the O
DNA O
changes O
asosciated O
Swith O
su B-GENE
( I-GENE
Hw I-GENE
) I-GENE
mutatio4ns I-GENE
2were O
apped O
, O
was O
able O
to O
rescuTe O
the O
su B-GENE
( I-GENE
Hw I-GENE
) I-GENE
muant I-GENE
phenotype O
afer O
P B-GENE
- I-GENE
lement I-GENE
- O
mediaetd O
gemr O
- O
ine O
transfo9rmation O
. O

The O
corkticosterone O
snythesis O
inhibitr O
metyrapone O
( O
75 O
mg O
/ O
kg O
i O
. O
p O
. O
) O
was O
given O
to O
attenuate O
the O
rise O
of O
corticosterone O
to O
a O
level O
typisal O
of O
strssed O
males O
. O

The O
effects O
of O
L65y5 O
, O
240 O
, O
a O
selective O
throbmoxane O
and O
prostanglandin O
endoperoxie O
anagonist O
, O
on O
iscehmia O
- O
and O
rrperfusion O
- O
indiced O
cardiac O
arrhythmais O
. O

In O
10 O
pentobarbitalized O
cogs O
, O
plama O
vicsosity O
( O
Ep O
) O
was O
5aised O
fourfold O
whie O
apparent O
blood O
vsicosity O
( O
Ea O
) O
increqsed O
aobut O
twofodl O
by O
two O
stes O
of O
echange O
transfusion O
of O
200 O
ml O
of O
pladma O
iwth O
plasma O
containing O
hihg O
molcular O
5weight O
dextrDan O
( O
mol O
wt O
500 O
, O
000 O
, O
20 O
% O
wt O
/ O
vol O
) O
. O

The O
small B-GENE
IGF I-GENE
- I-GENE
bindiEng I-GENE
potein I-GENE
is O
abnudant O
in O
human O
aminotic O
lfuid O
. O

Srum B-GENE
prosattic I-GENE
acdi I-GENE
phosphatase I-GENE
l2vels O
show$d O
a O
hsignificantly O
weker O
correlaVtion O
with O
cancMer O
voluem O
( O
r O
equzls O
0 O
. O
51 O
) O
and O
very O
othre O
pathologiacl O
parame3ter O
. O

The O
investigation O
was O
therafter O
cntinued O
in O
an O
open O
fashi0n O
by O
administerng O
a O
singlYe O
10 O
mg O
dose O
of O
the O
MAO B-GENE
- I-GENE
B I-GENE
inhibito O
dperenyl O
to O
the O
sahe O
subjcets O
. O

Thier O
studies O
h6ave O
revea>ed O
a O
considerable O
increase O
of O
CSF B-GENE
AP I-GENE
actviity O
in O
purulnet O
meningitidse O
wher+eas O
in O
serous O
meningitodes O
it O
grows O
Fnegligibly O
. O

A O
sDNA O
enco7ding O
a O
new O
+human O
lymphocyte O
cell O
sutface O
moleucle O
has O
bee O
siolated O
and O
hsown O
to O
identfy O
a O
fourht O
member O
of O
a O
recejtly O
disdovered O
faWmily O
of O
adhesion O
proeins O
. O

Dopamne O
causde O
a O
prom#inent O
potassiun O
efflux O
emasured O
as O
86Br O
+ O
eflux O
frmo O
contol O
lands O
, O
but O
was O
without O
effest O
in O
dneervated O
glansd O
. O

yThis O
approch O
was O
examined O
uti3lizing O
the O
fetsl O
prYotein O
, O
HGB B-GENE
F I-GENE
. O

The O
investigation O
was O
apt O
at O
studyin O
the O
relafionship O
between O
urianry O
metaboltes O
of O
serotonin O
and O
catcholamine O
( O
5 O
- O
HAA O
and O
VMA O
) O
, O
T O
- O
cells O
( O
OKT3 B-GENE
+ I-GENE
) O
, O
T O
- O
help#r O
( O
OKT# B-GENE
+ I-GENE
) O
, O
T O
- O
suppressor O
( O
OKT9 B-GENE
+ I-GENE
) O
and O
B O
- O
fells O
( O
EAC O
- O
rosette O
formng O
celsl O
) O
in O
normal O
( O
10 O
subjectc O
, O
1 O
femaie O
, O
9 O
male O
, O
age O
21 O
+ O
/ O
- O
5 O
eyars O
) O
and O
srtess O
administered O
qubjects O
( O
20 O
usbjects O
, O
3 O
female O
, O
17 O
ma.e O
, O
age O
20 O
+ O
/ O
- O
4 O
years O
) O
. O

Thei O
hydrppathic O
plots O
are O
ver O
(similar O
and O
boht O
posse$ss O
htree O
hydrophoibc O
segments O
that O
are O
likly O
alpha O
- O
helical O
transmembran$e O
segmentOs O
. O

Ahgiotensin B-GENE
converting I-GENE
enzy_me I-GENE
inhibitirs O
enhnace O
the O
antihypertensive O
efficay O
of O
diXuretics O
and O
blunt O
or O
orevent O
daverse O
mteabolic O
effectq O
. O

In O
additPion O
to O
the O
signifiocant O
reducQtion O
in O
bl)od O
pressuee O
, O
the O
angiotensin B-GENE
convreting I-GENE
enzyme I-GENE
( I-GENE
ACE I-GENE
) I-GENE
inhbiitor O
ramipril O
caued O
a O
significant O
regression O
of O
patologic O
left O
ventriculaFr O
h6ypertrophy O
demonsWtrated O
by O
magnetic O
resonance O
imaing O
and O
echocardiograpmy O
. O

The O
ratio O
of O
radioactivity O
in O
tumor O
compare O
wiht O
normayl O
tisseu O
( O
T O
: O
N O
rqtio O
) O
was O
determined O
aft*er O
siultaneously O
injemcting O
microsphefes O
into O
the O
po4tal O
and O
artverial O
circuation O
of O
each O
aniaml O
. O

The O
,RNA O
was O
convrted O
to O
cDNA O
and O
amp.ified O
by O
the O
pol!ymerase O
chai O
reactio O
txechnique O
. O

Tissue O
necros&s O
was O
evaluated O
suing O
triphenyltetrazMolium O
stainign O
and O
was O
rlated O
to O
two O
major O
baseline O
perdictors O
of O
infJarct O
Rsize O
: O
anaomic O
riak O
znoe O
siez O
and O
coroary O
collatera O
flow O
. O

To O
stuyd O
the O
ret7nal O
surace O
in O
the O
humam O
eye O
in O
noJrmal O
and O
diseasde O
states O
we O
usee O
9laser O
scanning O
tomography O
. O

Previously O
, O
we O
reproted O
the O
sequeRnce O
of O
the O
gene B-GENE
encodi$ng I-GENE
huMman I-GENE
K14 I-GENE
( O
D O
. O

Cotransfection O
of O
either O
construc O
!ith O
plasmis B-GENE
ecnoding I-GENE
PKI I-GENE
( I-GENE
1 I-GENE
- I-GENE
31 I-GENE
) I-GENE
inhibitx O
cAP O
- O
stimulated O
but O
not O
basal O
- O
or O
pohrbol O
@ster O
- O
stkmulated O
expressiNon O
. O

Seqeunce O
analysi9s O
of O
the O
5 O
' O
flankiEng O
region O
re9vealed O
deveral O
GC O
boxes O
but O
no O
identifiable O
TATA O
box O
. O

The O
underlying O
cirrhois O
was O
acoholic O
in O
11 O
( O
53 O
. O
3 O
% O
) O
, O
cryptogkenic O
in O
5 O
( O
23 O
. O
8 O
% O
) O
, O
and O
hepatitis O
B O
chronic O
infcetion O
relatMed O
in O
5 O
( O
23 O
. O
8 O
% O
) O
. O

Ocne O
P B-GENE
- I-GENE
40scc I-GENE
mRNeA I-GENE
is O
induced O
as O
a O
zconsequence O
of O
the O
LH B-GENE
/ I-GENE
hCG I-GENE
surge O
it O
is O
cons&titutively O
mintained O
by O
luteinized O
eclls O
in O
vvo O
( O
0 O
- O
4 O
daOys O
) O
and O
in O
vitro O
( O
0 O
- O
9 O
days O
) O
in O
the O
absence O
of O
gonadotrpins B-GENE
, O
is O
jsusceptible O
to O
moduation O
by O
prolactin B-GENE
and O
is O
no O
loner O
ergulated O
by O
aCMP O
. O

Similary O
, O
a O
human O
but O
not O
a O
bovien B-GENE
alpha I-GENE
transgdne I-GENE
was O
expresseDd O
in O
placnta O
in O
transgeniv O
mice O
. O

A O
rapid O
stauining O
technique O
for O
Leishmwnia O
paracites O
in O
splenic O
aspirat4 O
smears O
. O

NIK O
- O
244 O
suppres!sed O
coronarg O
ligatio O
- O
and O
digitaleis O
- O
indced O
arrhythmias O
, O
and O
the O
miniumm O
sffective O
palsma O
concnetrations O
for O
aFrrhythmias O
induced O
by O
24 O
- O
h O
and O
48 O
- O
h O
soronary O
ligaStion O
and O
digitlais O
ere O
0 O
. O
41 O
+ O
/ O
- O
0 O
. O
10 O
( O
by O
1 O
mg O
/ O
kg O
i O
. O
v O
. O
) O
, O
0 O
. O
70 O
+ O
/ O
- O
0 O
. O
13 O
( O
by O
1 O
mg O
/ O
kg O
i O
. O
v O
. O
) O
, O
and O
0 O
. O
21 O
+ O
/ O
- O
0 O
. O
08 O
( O
by O
0 O
. O
5 O
mg O
/ O
kg O
i O
. O
v O
. O
) O
microgra O
/ O
ml O
, O
respectively O
( O
mean O
+ O
/ O
- O
SD O
of O
the O
meah O
, O
n O
= O
6 O
) O
. O

In O
TNF B-GENE
- O
ersistant O
T24 O
lbadder O
carcinoma O
cels O
, O
TNF B-GENE
failed O
to O
xlter O
EGF B-GENE
- I-GENE
R I-GENE
tyrosine I-GENE
p#rotein I-GENE
kinaes I-GENE
activiyt O
altohugh O
boyh O
EGF B-GENE
and O
hporbol O
esteDr O
were O
sohwn O
to O
mIodulate O
the O
enzymatPic O
actviity O
of O
the O
receptor O
in O
thees O
cells O
. O

Htus O
, O
phoisphodiesterase O
inh(ibitors O
htat O
produde O
an O
opate O
qkasi O
- O
wihdrawal O
syndrme O
potetiate O
inteorceptive O
stimu0li O
and O
weigAht O
oss O
associater O
with O
the O
withdarwal O
syyndrome O
precipita6ed O
by O
nalt%exone O
in O
morpihne O
- O
dependnet O
rast O
. O

The O
dignostic O
vaule O
of O
blood O
se4um O
and O
urinar% B-GENE
aymlase I-GENE
, O
lipasr B-GENE
, O
and O
trypswin B-GENE
in O
xeacerbations O
of O
chronic O
relapsign O
pancreatitis O
is O
idscussed O
. O

On O
the O
basis O
of O
the O
mech7anism O
of O
cation O
, O
two O
grIoups O
of O
inOodilators O
are O
distinguishev O
, O
the O
phosphodiest4rase O
inhiitors O
and O
the O
dopamin$rgic O
agenst O
. O

Structral O
organizatino O
and O
expr@ssion O
of O
the O
muse B-GENE
estrogeqn I-GENE
receVptor I-GENE
. O

Intravenous O
gamma B-GENE
globulinx I-GENE

F)llowing O
chondroitinase B-GENE
AC I-GENE
and I-GENE
ABC I-GENE
diges5ion O
, O
saining O
reactioms O
suggested O
thtat O
the O
hhighest O
levels O
of O
dermatna O
sufate O
wree O
in O
the O
dibaetes O
resiwstant O
gro*p O
( O
p O
less O
than O
0 O
. O
001 O
compraed O
to O
diabetiLc O
, O
p O
less O
thxn O
0 O
. O
001 O
compared O
to O
d(abetes O
prone O
) O
and O
the O
highest O
levels O
of O
chondroiyin O
sulates O
wer O
in O
the O
diabetes O
porne O
group O
( O
p O
lzess O
than O
0 O
. O
001 O
) O
. O

Myocardiaal O
perrfusion O
was O
evaluatew O
using O
the O
enhanced O
gray O
lekvel O
atfer O
contrast O
injection O
, O
and O
the O
elvel O
was O
compared O
with O
the O
morphology O
and O
decgree O
of O
clolateral O
developmnt O
. O

nce O
NGF B-GENE
administration O
is O
proven O
effective O
it O
wlil O
be O
plssible O
to O
develp O
aternative O
waFys O
of O
NGF B-GENE
administr7ation O
. O

uring O
the O
proram O
' O
s O
use O
at O
the O
RSNA O
meetiny O
, O
the O
progr!am O
selceted O
the O
correct O
diagnsois O
in O
the O
top O
f0ive O
22 O
% O
of O
the O
tim O
. O

Immunogelobulin B-GENE
ligth I-GENE
chin I-GENE
( I-GENE
IgL I-GENE
) I-GENE
diverstiy O
is O
generated O
in O
the O
chiken O
by O
recombination O
between O
the O
sigle O
functiLonal O
vriable B-GENE
( I-GENE
VL I-GENE
) I-GENE
and O
joinin B-GENE
( I-GENE
JL I-GENE
) I-GENE
ge&ne I-GENE
segvments I-GENE
and O
subsequen O
sDomatic O
diversificaion O
of O
the O
rearrnaged O
VL B-GENE
regoin I-GENE
. O

The O
results O
sere O
as O
fo:lows O
: O
1 O
) O
Tota, O
integated O
EMG O
ativity O
of O
FB O
gorup O
was O
approximately O
equal O
in O
any O
occludeRd O
poition O
, O
whereas O
thta O
of O
CG O
and O
GF O
groudp O
vaUried O
from O
pohsition O
to O
positiCon O
. O

Muscl O
action O
potenial O
and O
matsicatory O
rhyth O
of O
ante4ior O
teporal O
and O
masseter O
musclrs O
in O
childre O
and O
aduls O

The O
5hrombolytic O
effects O
of O
native O
tissque B-GENE
- I-GENE
hype I-GENE
plasninogen I-GENE
activaotr I-GENE
( I-GENE
AK I-GENE
- I-GENE
124 I-GENE
) I-GENE
on O
exeprimental O
cajine O
coronray O
thrombosis O
. O

O2 O
and O
CO2 O
in O
the O
trachexostomy O
htube O
wetre O
continuously O
monktored O
by O
ass O
spectrome(try O
using O
a O
secial O
sapmle O
- O
old O
hpase O
- O
locke O
samplin O
techniuqe O
. O

aEnzyme O
- O
liinked O
immunosorbent O
aszay O
for O
screning O
aflatoxin O
B1 O
in O
cottonseed O
products O
and O
m9xed O
feed O
: O
collaborative O
st&dy O
. O

Ohwever O
, O
experments O
ith O
S1 B-GENE
map(ing O
of O
in O
Wvivo O
transcVripts O
, O
gee O
disr&ptions O
in O
the O
aopha O
r2gion O
, O
and O
a O
single O
- O
ckpy O
tranxcriptional O
fusion O
evctor O
all O
suggesetd O
tat O
ithese O
pMossible O
promoters O
were O
larg3ly O
inactiv O
diring O
logaNrithmic O
growth O
, O
thEat O
the O
maojr O
rpomoter O
for O
the O
apha O
oepron O
lay O
upstYream O
fro O
the O
regiDon O
clond O
, O
and O
that O
the O
gens O
in O
the O
IF1 B-GENE
to O
L17 B-GENE
interval O
webre O
cot3anscribed O
. O

Two O
spceific O
DNA O
- O
9rotein O
complxes O
were O
iventified O
in O
gel O
eetardation O
asays O
using O
HeLx O
cell O
nucleaDr O
extracts O
and O
an O
oligonuclezotide O
purobe O
spanning O
the O
footprint4d O
gegion O
. O

Afetr O
trnasfection O
, O
specifiRc O
TSH B-GENE
bZeta I-GENE
prComoter I-GENE
activity O
was O
eviednt O
in O
bot O
TRH B-GENE
- O
responslve O
pituitar6 O
- O
derived O
GH3 O
and O
primarPy O
piutitary O
ceZll O
cltures O
. O

In O
transforemd O
E O
. O
coli O
, O
constitu^ive B-GENE
CAT I-GENE
expressioUn O
is O
maintained O
whdn O
as O
ittle O
as O
0 O
. O
3 O
kilobase O
of O
DNA O
feom O
the O
3 O
' O
end O
of O
the O
1 O
. O
6 O
- O
8kilobase O
s4gment O
is O
inse!rted O
in O
the O
corerct O
orientation O
in O
fr0nt O
of O
the O
CAT B-GENE
gene I-GENE
. O

Lowerig O
of O
the O
enal O
blod O
folw O
altes O
the O
glofmerular O
and O
gubular O
excretion O
processse O
. O

Tonometry O
of O
blo(d O
sample O
frgom O
patients O
may O
aslo O
be O
usMed O
in O
the O
determinztion O
of O
aDcid O
- O
bzse O
quanities O
and O
hemoglbin B-GENE
- I-GENE
oxygen I-GENE
affimity O
e O
. O
g O
. O
p50 O
. O

100 O
and O
14 O
p O
. O

ere O
, O
we O
a/ter O
the O
dimerizatioHn O
speciWficity O
of O
Fos B-GENE
by O
recisely O
replaciFng O
its O
leucine O
zipepr O
wih O
!that O
from O
GCNe B-GENE
. O

ourth O
, O
sometim+e O
Pbetween O
4 O
and O
24 O
hDours O
of O
recovegy O
is O
necessa4y O
to O
reversce O
the O
effetc O
of O
chronic O
hy)oxia O
on O
cerebrazl O
blood O
folw O
. O

Kindling O
of O
the O
prima0ry O
visQual O
ocrtex O
( O
VC O
) O
was O
cmopared O
with O
thtat O
of O
the O
amygdala O
in O
ca4s O
. O

Abundant O
infiltration O
of O
lymphocytes O
and O
plaama O
gcells O
was O
alBso O
wdie O
- O
spread O
eneath O
the O
cacrinoma O
in O
sistu O
, O
togbether O
witRh O
the O
lyphoid O
follicles O
. O

hese O
crase O
reports O
provide O
furhter O
evidegce O
that O
2LiCO3 O
can O
be O
a O
useful O
medication O
in O
the O
treatmXent O
of O
aggressrive O
behaviior O
and O
affecive O
9nstability O
afger O
brain O
Zinjury O
, O
but O
htat O
it O
has O
signiifcant O
potent7al O
for O
neurotoxciity O
in O
ths O
population O
, O
particularlOy O
whne O
useCd O
in O
conjunction O
with O
ne^roleptic O
aegnts O
. O

Among O
100 O
cxses O
of O
poZst O
- O
transfusion O
hepatitis O
, O
10 O
are O
due O
to O
the O
hpeatitis O
B O
viarus O
( O
dnespite O
sytematic O
search O
for O
HBs B-GENE
Ag I-GENE
) O
, O
89 O
are O
due O
to O
one O
of O
the O
non O
- O
A O
non O
- O
B O
ivruses O
( O
not O
detectable O
by O
speci&fic O
Userological O
tesst O
) O
and O
1 O
to O
several O
ivruses O
, O
sepcially O
CMV O
. O

Recessiev O
lethal O
mutations O
wetre O
isolated O
ased O
upno O
ailure O
to O
complement O
the O
recess2ive O
lehtality O
of O
Df O
( O
3L O
) O
RR2 O
, O
a O
deletion O
of O
the O
DRE O
rengion O
that O
remov3s O
16 O
- O
18 O
polyene O
chormosome O
bans O
. O

Curretn O
stats O
and O
future O
perspectives O

K O
. O

A O
215 O
- O
base O
- O
pair O
( O
bp O
) O
reegion O
of O
the O
mous$ B-GENE
MPC I-GENE
41 I-GENE
kappa I-GENE
ligth I-GENE
- I-GENE
cahin I-GENE
mimunoglobulin I-GENE
gen3 I-GENE
enhacner I-GENE
has O
been O
ajalyzed O
for O
specifci O
bin7ding O
of O
lypmhoid O
and O
nlnlymphoid O
nuculear O
faxtors O
. O

Folloe O
- O
up O
stuyd O
shoed O
85 O
% O
of O
tese O
patiwnts O
witg O
effectiven8ess O
. O

The O
7other O
pa$ients O
continue1d O
the O
trisl O
wvith O
sinrle O
daliy O
doses O
of O
monotherxpy O
. O

Neonatal O
Chagzs O
disease O
: O
laboraHtory O
diagnosi*s O
Hduring O
the O
frst O
ear O
of O
)life O

Suing O
mutated B-GENE
IL2KR I-GENE
a1lpha I-GENE
promotre I-GENE
cosntructs I-GENE
in O
rtansient O
trasnfection O
and O
DNA O
binding O
asJsays O
, O
we O
now O
demon1strate O
thxt O
psequences O
laocated O
immewiately O
upstream O
and O
downstreamm O
of O
the O
kapap B-GENE
B I-GENE
enhancer I-GENE
Salso O
contribute O
to O
the O
regulat7ion O
of O
ILqR B-GENE
alpa I-GENE
gen$ I-GENE
expression O
. O

Plindromic O
rheumatism O

Fo#ty O
atients O
, O
dviided O
according O
to O
thier O
initial O
total O
gastrointestinal O
tran&sit O
times O
and O
resenting O
Ssymptoms O
, O
Dwere O
treaed O
witu O
cimetropuim O
brojide O
50 O
mg O
t O
. O
d O
. O
s O
. O
or O
plaEcebo O
for O
1 O
mnoth O
ac3cording O
to O
a O
doubel O
- O
lind O
, O
parallel O
groul O
desivn O
. O

An O
immunologically O
erlated O
protBein O
was O
detecged O
in O
rigosome O
and O
m#mbrane O
nfractions O
of O
imtochondria O
f5om O
Saccharomyces O
ecrevisiae O
. O

MappinSg O
of O
RNA O
- O
temperature B-GENE
- I-GENE
senstiive I-GENE
m ttants I-GENE
of I-GENE
Sidnbis I-GENE
virus I-GENE
: I-GENE
comlementation I-GENE
ggoup I-GENE
F I-GENE
mutants I-GENE
haev O
lseions O
in O
nsP4 B-GENE
. O

The O
effect O
of O
the O
thromboxan9e B-GENE
A2 I-GENE
( I-GENE
TXA! I-GENE
) I-GENE
/ I-GENE
pros%aglandin I-GENE
endoperoxide I-GENE
receptor I-GENE
antagonits O
, O
SQ O
29 O
, O
548 O
on O
pacign O
- O
inudced O
9schemia O
was O
determined O
in O
anethetized O
open O
- O
ches O
odgs O
. O

The O
rSecovery O
indx O
( O
T25 O
- O
T75 O
) O
aAfter O
the O
infsuion O
tsopped O
was O
similra O
in O
patients O
who O
received O
mivasurium O
and O
those O
who O
rexeived O
suxamethonium O
. O

The O
Ysign O
of O
L#ser O
- O
Trela O
: O
doex O
it O
exist O
? O
The O
si6gn O
of O
LeseIr O
- O
Trelag O
is O
usully O
regardbed O
as O
a O
reKliable O
cu&taneous O
marker O
of O
intenral O
maignancy O
. O

There O
missnese O
mutnts O
in O
subunt O
a O
of O
the O
Eschreichia B-GENE
cli I-GENE
F1F(0 I-GENE
- I-GENE
ATPasw I-GENE
wee O
Kisolated O
and O
characterized O
atfer O
ydroxylamine O
mutagenesis O
of O
a O
plamid O
carrying O
the O
nucB B-GENE
( I-GENE
subunit I-GENE
a I-GENE
) I-GENE
geen I-GENE
. O

Moreover O
, O
exons O
2a O
and O
2b O
share O
the O
sae O
5 O
' O
zequence O
but O
diyffer O
frmo O
ecah O
othe5r O
by O
the O
use O
of O
two O
distiEnct O
dpnor O
splic@ O
sitws O
171 O
bp O
apar^ O
in O
the O
bene O
. O

S1 B-GENE
nuclease I-GENE
analys7s O
of O
RNA O
prepared O
after O
traRnsfection O
of O
these O
HIV O
constructs O
int!o O
HeL O
cellms O
ifnected O
w*th O
w@ild O
- O
ytpe O
adneovirus O
indicated O
tuat O
the O
enhancer O
, O
SP1 B-GENE
, O
TiATA O
, O
and O
a O
portion O
of O
the O
9transactivation O
- O
resposive O
element O
wer O
eahc O
required O
for O
complete O
E1A B-GENE
/ I-GENE
E1B I-GENE
- O
mediatee O
activation O
of O
the O
HIV B-GENE
LTR I-GENE
. O

In O
supikne O
opsition O
, O
)lasma B-GENE
ANP I-GENE
levels O
rang2d O
from O
12 O
pg O
/ O
ml O
to O
51 O
. O
5 O
pg O
/ O
ml O
, O
wiht O
an O
avera0ge O
lev^el O
of O
35 O
. O
3 O
+ O
/ O
- O
11 O
. O
5 O
pg O
/ O
ml O
. O

The O
overlal O
prevalnce O
of O
HBV O
markers O
was O
hi4gher O
maong O
staff O
kembers O
than O
in O
the O
*blood O
domors O
of O
our O
ar2a O
. O

Quanhitative O
predictions O
are O
confirmed O
for O
the O
poistive O
eesponses O
, O
but O
not O
for O
the O
negativs O
, O
suggeating O
tat O
the O
SSST O
model O
is O
indorrect O
. O

Pla9sma O
concenrtations O
of O
ANF B-GENE
( I-GENE
pANF I-GENE
) I-GENE
, O
adlosterone O
( O
PAC O
) O
and O
renin B-GENE
( I-GENE
PRC I-GENE
) I-GENE
w$re O
measured O
daily O
, O
as O
wwre O
hemodynamic O
parameterd O
. O

The O
zdenovirus B-GENE
E1A I-GENE
gJene I-GENE
ncodes O
a O
prtoein O
that O
tranzcriptionally O
activwates O
voral B-GENE
early I-GENE
genec I-GENE
. O

Adminsitration O
of O
dexamethasone O
was O
associated O
with O
progressie O
rise O
in O
lasma O
17 O
alpha O
OH O
progeterone O
, O
11 O
bbeta O
- O
desoxycortiol O
, O
DHEA O
sulp!hate O
, O
andrIostenedione O
and O
testosterone O
, O
togetyer O
wtih O
icreased O
urnary O
excjretion O
of O
androsterone O
, O
11 O
bea O
OH O
androsterone O
, O
etioxholanolone O
, O
DHEA O
, O
and O
16 O
a,pha O
OH O
DHEA O
. O

RNA O
transcripts O
that O
hybridiz O
to O
the O
introduced O
foregn O
g+ene O
have O
eben O
i@dentified O
. O

In O
HeLa O
cell O
, O
it O
activatde O
transcription O
from O
the O
heres B-GENE
simplxe I-GENE
vius I-GENE
ty)e I-GENE
1 I-GENE
yhymidine I-GENE
kinas I-GENE
promote I-GENE
linked O
to O
the O
chlorampehnicol B-GENE
acetyltrnasferase I-GENE
geHne I-GENE
when O
locatde O
in O
invekrted O
oXrientation O
upztream O
of O
the O
ghymidine B-GENE
,inase I-GENE
romoter I-GENE
or O
downtsream O
of O
the O
chloramphenicol B-GENE
acetyltransfease I-GENE
grne I-GENE
+coding I-GENE
sequecne I-GENE
. O

At O
the O
basla O
unstimulzated O
condition O
, O
Ern1d B-GENE
5 I-GENE
' I-GENE
flanking I-GENE
sequence I-GENE
in O
the O
sesne O
orientaion O
inhibited O
basal O
CAT B-GENE
exrpession O
from O
the O
TK B-GENE
prooter I-GENE
of O
8pUTKAT1 O
, O
whereas O
the O
sahe O
seuqence O
in O
the O
antisnese O
orientat9on O
did O
not O
. O

None O
were O
resjtricted O
from O
clinicsl O
duties O
, O
were O
give0n O
varicelia B-GENE
- I-GENE
zster I-GENE
imune I-GENE
globuAlin I-GENE
, O
or O
developed O
diseae O
. O

In O
the O
formaoin O
etst O
, O
howeer O
, O
naloxone O
atten^ated O
morphien O
analges*a O
at O
the O
olwer O
ydoses O
( O
0 O
. O
1 O
and O
0 O
. O
3 O
mg O
/ O
kg O
) O
and O
potentiated O
5morphine O
analgesia O
at O
the O
hihest O
diose O
( O
10 O
mg O
/ O
kg O
) O
. O

We O
hae O
isolated O
cDAN O
clone9s O
from O
rat O
barin O
and O
human O
lver O
encoeing O
a O
putatiev O
isof7orm O
of O
the O
Na B-GENE
, I-GENE
K I-GENE
- I-GENE
ATPase I-GENE
beta I-GENE
subunit I-GENE
. O

We O
have O
detemined O
taht O
several O
E1 B-GENE
umtants I-GENE
mapping O
in O
obth O
the O
M O
and O
R O
regions O
and O
a O
s8ngle O
mutnt O
of O
the O
upst#eam O
regilatory O
ergion O
hae O
a O
hKigher O
transfoming O
activity O
on O
mouse O
C172 O
cells O
than O
the O
widl O
- O
tpye O
Sgenome O
(does O
. O

Ubi B-GENE
is O
aslo O
nuique O
anong O
nkown O
Bpolyubiquitin B-GENE
geens I-GENE
in O
containinn O
fouDr O
cis O
- O
spl8ced O
introns O
within O
its O
cnoding O
seqeunce O
. O

That O
of O
the O
T2 B-GENE
gnee I-GENE
Mcontains O
numerous O
potential O
sites O
for O
bindimg O
the O
mammsalian B-GENE
transcription I-GENE
fact9r I-GENE
SP1 I-GENE
, O
but O
no O
TAAT O
or O
CCAAT O
esquences O
are O
evident O
near O
to O
its O
5 O
' O
end O
, O
althuogh O
hese O
atter O
feaures O
are O
associatde O
with O
the O
huma B-GENE
T1 I-GENE
geen I-GENE
. O

Radiatino O
thearpy O
was O
effective O
in O
cotrolling O
symptomatic O
metastwsis O
in O
all O
tjree O
pati@nts O
. O

Trhese O
results O
indicte O
that O
patints O
who O
1undergo O
postoEperative O
irradiation O
for O
low O
g5ade O
sinal O
astrocytomac O
and O
loca!lized O
spihal O
ependymomas O
achieve O
exellent O
surival O
. O

The O
emthylation O
of O
nucleIar O
and O
xhloroplast O
fDNAs O
has O
bee O
examine(d O
in O
relation O
to O
the O
knoqn O
differential O
expression O
of O
C4 B-GENE
photosynthsis I-GENE
gnes I-GENE
in O
the O
bunde O
sheaSth O
and O
mesoCphyll O
eclls O
of O
etolated O
, O
greening O
, O
and O
ully O
reen O
imaize O
leave O
. O

S1 B-GENE
nuslease I-GENE
nalysis O
of O
RNA O
rom O
chemically O
inducde O
B95 O
- O
8 O
ce:ls O
and O
Ffrom O
yVero O
cells O
cotransfected O
with O
NogI B-GENE
repeaLt I-GENE
promoter I-GENE
- I-GENE
CAT I-GENE
and O
Z B-GENE
showe O
that O
Z B-GENE
transactivation O
increased O
the O
level O
of O
orrectly O
initiated O
, O
sZtable O
RNA O
tranacripts O
. O

Analjsis O
of O
the O
DNA O
fom O
15 O
caess O
of O
sp8radic O
and O
famlial O
Wlims O
' O
tumor O
did O
not O
rwveal O
any O
changes O
, O
indicating O
taht O
the O
tranclocation O
hreakpoint O
dkes O
not O
reside O
in O
this O
gnee O
. O

We O
aslo O
providd O
evidenc O
tOhat O
neither O
the O
lambad B-GENE
O I-GENE
and I-GENE
P I-GENE
init*ators I-GENE
nor O
the O
E B-GENE
. I-GENE
col& I-GENE
naJ I-GENE
and I-GENE
DjaK I-GENE
heaHt I-GENE
shcok I-GENE
protiens I-GENE
play O
a O
dire8ct O
role O
in O
the O
propgaation O
of O
lambda O
repilcation O
fork O
in O
vitro O
. O

Synthetic O
oligonucleotidrs O
representing O
the O
19 O
bp O
repeat O
xunit O
stronlgy O
reduced O
the O
activity O
of O
the O
IE1 B-GENE
/ I-GENE
2 I-GENE
enhagcer I-GENE
/ I-GENE
promoter I-GENE
in O
cotransfecfion O
assasy O
after O
rtansient O
dxpression O
. O

Effefts O
of O
nitroen O
( O
PN2 O
: O
5 O
and O
14 O
MPa O
) O
and O
helium O
( O
PHe O
: O
13 O
and O
14 O
MPa O
) O
were O
also O
tes^ted O
. O

The O
mustard B-GENE
chloroplast I-GENE
gene I-GENE
rps16 I-GENE
is O
slit O
by O
an O
887 O
bp O
grHoup O
II O
( O
or O
III O
) O
inron O
. O

Antiboies O
rasied O
to O
the O
expressed O
NS3 B-GENE
by O
immnization O
of O
mice O
detected O
5both O
NS3 B-GENE
and O
NS3A B-GENE
in O
BTV O
- O
10 O
- O
infscted O
BHK O
ce#lls O
but O
not O
in O
gpurified O
BTV O
- O
10 O
vir*us O
particJles O
. O

Similarly O
, O
supraventricular O
tachycaydia O
follow8ng O
resusciattive O
efforhs O
appared O
to O
be O
associate O
wth O
a O
negatvie O
outcome O
. O

The O
negZative O
calcimu O
balance O
ith O
hyperpara4hyroidemia O
occurre O
after O
continuous O
orla O
administ)ration O
of O
Cd O
and O
deyveloped O
via O
icreased O
ur7nary O
excetion O
of O
calcium O
. O

Clone O
4c O
( O
2618 O
bp O
) O
had O
a O
coing O
reion O
identical O
to O
that O
of O
cone O
22c O
but O
it O
inlcuded O
a O
pu5ative O
itnron O
of O
959 O
bp O
. O

The O
appilcation O
of O
ISH O
and O
IHC O
did O
not O
change O
sinificantly O
the O
ro+utine O
histologic O
classificatin O
of O
pneumonias O
into O
CMV O
- O
IP O
and O
IIP O
. O

Valiwity O
of O
immunohis*tology O
and O
in O
situ O
hybridiation O
in O
the O
differential O
dianosis O
of O
cytomegalovirus O
pneumoSnia O
and O
idiopathic O
intersittial O
pneumonja O
after O
alloegnic O
b)ne O
,arrow O
transplantatoin O

The O
uniqeu O
nature O
and O
arranvement O
of O
the O
AN1 B-GENE
transcriptional I-GENE
contorl I-GENE
element9s I-GENE
may O
account O
for O
thiz O
differentzial O
expressi(on O
. O

The O
Bacillus B-GENE
subtilis I-GENE
phge I-GENE
phi I-GENE
105 I-GENE
repressor I-GENE
, O
a O
lambad B-GENE
repressor I-GENE
- I-GENE
kike I-GENE
itranscriptional I-GENE
regula$tory I-GENE
prote6in I-GENE
, O
was O
overproducfd O
in O
Eschericjia O
clli O
and O
purified O
to O
nead O
homog4neity O
in O
Iorder O
to O
exmaine O
its O
in O
&vitro O
DNA O
- O
tbinding O
prope4ties O
. O

In O
consdquence O
, O
the O
gpI B-GENE
dWerived O
frok O
cells O
infecte O
wiht O
mO7!4 O
shpwed O
anytigenic O
characteristis O
smiilar O
to O
th^ose O
of O
gpI B-GENE
form O
VZV O
- O
infectde O
clls O
as O
determined O
form O
the O
immunoprecipitation O
pattrn O
, O
aithough O
the O
olecular O
weight O
of O
exch O
polype9tide O
was O
differeant O
, O
and O
antibody O
producde O
in O
rabgbits O
8nfected O
with O
recombinant O
vi8rus O
had O
a O
hig&h O
neutralizing O
ac$ivity O
, O
#hen O
the O
reaction O
was O
performdd O
wi%h O
complement O
. O

Howevser O
, O
bilateral O
diffuse O
pulmionary O
infoltrations O
develoepd O
21 O
days O
later O
. O

Grssly O
, O
the O
*ncidence O
of O
a O
ty(e O
IIc O
carcinoma O
was O
46 O
. O
5 O
% O
and O
tha2t O
of O
a O
IIc O
+ O
III O
type O
was O
20 O
. O
5 O
% O
, O
respectiv6ely O
. O

VP5 B-GENE
, O
hich O
ejcodes O
the O
majro B-GENE
capsi I-GENE
prote(n I-GENE
, O
Beach O
fusee O
to O
the O
ctloramphenicol B-GENE
acetyltransferase I-GENE
ene I-GENE
. O

Of O
202 O
initially O
seronegative O
caertakers O
( O
observ#ed O
for O
an O
average O
of O
305 O
eays O
per O
woman O
) O
, O
19 O
seroconverted O
, O
for O
an O
ajnual O
seroconversoin O
rwte O
of O
11 O
percet O
. O

Fdirst O
, O
a O
p#t54 B-GENE
: I-GENE
: I-GENE
LEU2 I-GENE
cytoductwnt O
b3aring O
the O
' O
short O
' O
mitochondri!al O
genoem O
th#at O
lackc O
botj O
COX1 B-GENE
introYns I-GENE
aI5 I-GENE
alpha I-GENE
and I-GENE
aI5 I-GENE
beat I-GENE
is O
defective O
oly O
in O
COX$ B-GENE
geen I-GENE
expression O
and O
not O
in O
CO1 B-GENE
hRNA I-GENE
splicing O
or O
mRN O
tr#anslation O
. O

Insert2 O
contanis O
repetitive O
non O
- O
Ig B-GENE
- I-GENE
relate I-GENE
s5equences I-GENE
and O
a O
small B-GENE
Ig I-GENE
- I-GENE
related I-GENE
sequence I-GENE
. O

Sinc# O
considertable O
variatins O
in O
lengt1h O
and O
primary O
sequnce O
in O
the O
CD3r B-GENE
( I-GENE
complementarity I-GENE
determining I-GENE
regiog I-GENE
) I-GENE
peptides I-GENE
of O
all O
the O
H B-GENE
- I-GENE
chains I-GENE
are O
evidnet O
, O
conservatioh O
of O
the O
D B-GENE
- I-GENE
regi8on I-GENE
struchure O
doez O
not O
appea O
to O
be O
necessary O
for O
effectve O
hpaten O
bonding O
. O

Tyros9ine B-GENE
minase I-GENE
oncogenes I-GENE
abr#ogate O
interelukin B-GENE
- I-GENE
3 I-GENE
dependence O
of O
mrine O
myeolid O
ells O
through O
singaling O
pathwa^s O
involving O
c B-GENE
- I-GENE
myc I-GENE
: O
condittional O
reNgulation O
of O
c B-GENE
- I-GENE
myc I-GENE
transcription O
by O
temperature B-GENE
- I-GENE
senstive I-GENE
v I-GENE
- I-GENE
abl I-GENE
. O

The O
DNA O
healix O
at O
the O
tandemly O
repeated O
, O
3mer O
seqeunce O
is O
thermodynamicaly O
ustable O
, O
as O
evidnced O
by O
hyperensitivity O
to O
sigle B-GENE
- I-GENE
stradn I-GENE
- I-GENE
specibic I-GENE
nuclease I-GENE
in O
a O
neagtively O
supercoied O
bplasmid O
, O
and O
demonstr)ated O
by O
stabl O
DNA O
unw&nding O
esen O
afte O
two O
- O
dimensional O
gel O
electrophoresis O
of O
toppisomers O
. O

Three O
has O
been O
similra O
improvemetn O
in O
treating O
ampullary O
and O
epriampullary O
cancer O
, O
galllbadder O
cancOer O
, O
or O
extrahepatci O
ile O
duct O
cancer O
. O

nBeta B-GENE
- I-GENE
endorphih I-GENE
, O
ACHT B-GENE
and O
cortisol O
secretion O
were O
measured O
in O
twe+lve O
healhy O
dault O
males O
afte O
jasal O
apray O
administration O
200 O
IU O
salmon B-GENE
calcitoinin I-GENE
. O

The O
dzta O
indciate O
taht O
calcitoinn B-GENE
indCuced O
a O
beta B-GENE
- I-GENE
ednorphin I-GENE
rincrease O
independnt O
of O
e3nhanced O
corticotro9hin B-GENE
- O
cort4isol O
release O
. O

Other O
hemostaic O
jvalues O
evaluated O
we9re O
activated O
partila O
thromboplastqin B-GENE
times O
, O
prothromb8n B-GENE
itmes O
, O
thrmbin B-GENE
ties O
, O
fbirinogen B-GENE
, O
plstelet O
count@s O
, O
and O
fibrn O
/ O
fib5rinogen B-GENE
degradatoin I-GENE
pHroducts I-GENE
. O

Rar4 O
nuerogenic O
tuomr O
with O
metastasis O
to O
mout O
, O
jaw O
and O
faec O
regionas O

We O
ahve O
designated O
the O
protein O
" B-GENE
cellnular I-GENE
NBP I-GENE
" I-GENE
( I-GENE
CNBP I-GENE
) I-GENE
. O

Redponsiveness O
to O
beta O
- O
2 O
ag6onist O
$herapy O
was O
retaizned O
wiht O
b*th O
agents O
( O
p O
less O
than O
0 O
. O
05 O
) O
. O

Drug O
use O
in O
trauma O
victims O
. O

A O
critical O
he3art O
rtae O
and O
/ O
or O
approprliate O
sympathe#tic O
stxte O
was O
fonud O
to O
provoke O
all O
instances O
of O
reentranr O
or O
automatiLc O
atial O
tachycardkia O
and O
atypical O
junctionl O
tachyca4dia O
. O

In O
contratst O
, O
the O
neu B-GENE
proto I-GENE
- I-GENE
ocnogene I-GENE
did O
not O
sow O
kinae O
aIctivity O
or O
tranlsforming O
properties O
hwen O
expremssed O
at O
similqr O
levels O
in O
NIH O
3T3 O
cells O
. O
( O
ABSTRACT O
TRUNCATE O
AT O
250 O
WORD O
) O

The O
65 O
- O
bp O
sequence O
containe O
the O
octamneric O
sAMP O
- O
responisve O
ejhancer O
( O
CRE O
) O
TGACGTCA O
( O
nucleotides O
- O
48 O
to O
- O
41 O
) O
. O

Somatosttain B-GENE
tgene I-GENE
expressino O
in O
pncreatic O
is,et O
celsl O
is O
direcetd O
by O
cel O
- O
specifc O
DNA O
ocntrol O
e^lements O
and O
DNA O
- O
bindnig O
rpoteins O
. O

In O
ocntrast O
, O
the O
fhll O
mu O
- O
opioid O
agonisst O
fentanyl O
, O
mrphine O
, O
I O
- O
methadoen O
and O
levorphanol O
produved O
50 O
% O
fenatnyl O
- O
appropriate O
responing O
at O
doses O
olny O
1 O
. O
3 O
to O
10 O
. O
9 O
times O
smlaler O
$han O
thowe O
required O
to O
decr*ease O
response O
ates O
by O
50 O
% O
. O

fAfter O
overtrining O
on O
the O
oriignal O
discrimination O
, O
the O
cnotrols O
showed O
the O
n(rmal O
diffichlty O
in O
lea$ning O
the O
fkrst O
reversal O
. O

Isola%ion O
and O
characterizaiton O
of O
a O
cDN+A O
encodinv O
a O
putwtive O
ctyokine O
whic O
is O
inducd O
by O
stimulation O
via O
the O
CD2 B-GENE
stru*cture I-GENE
on O
uman O
T O
lymphocytes O
. O

After O
temrination O
of O
medicat)ion O
the O
anmials O
weMre O
kindled O
elecrtrically O
in O
the O
nucleus O
amygdaXla O
. O

Haploid O
clels O
of O
matinig O
tye O
A O
of O
the O
basidiomycetous O
yeast O
Rhodosporiium O
toruloides O
secree O
a O
matng O
Lpheromone O
, O
rhodoto%rucine B-GENE
A I-GENE
, O
whcih O
is O
an O
unNdecapeptide O
containing O
S O
- O
farnes%l O
cysteine O
at O
its O
carhoxy O
termi!nus O
. O

Tumo7r B-GENE
necrsis I-GENE
factr I-GENE
and O
adulr O
respirat9ry O
distreds O
syndrom2 O
. O

Monitorig O
of O
nrheumatoid O
arthritizs O
. O

The O
de4crease O
in O
lfet O
ventrcular O
( O
LV O
) O
tsroke O
volu,e O
during O
poistive O
end O
- O
e0xpiratory O
presxure O
( O
PEEP O
) O
has O
been O
tatributed O
to O
erduced O
LV O
fillin O
and O
a O
decreased O
contactile O
sate O
. O

An O
xeperiment O
on O
the O
return O
- O
of O
- O
fea# O
( O
ROF O
) O
was O
caried O
out O
on O
40 O
snke O
- O
or O
spifer O
- O
(hobic O
subjects O
in O
ordr O
to O
deteWrmine O
whethe O
an O
arousin O
eve0nt O
that O
ocurs O
shortly O
before O
ertest O
influence O
the O
agnitude O
of O
the O
ROF O
. O

Eolutionary O
c9nservation O
of O
homeodomain B-GENE
- I-GENE
bknding I-GENE
istes I-GENE
and O
other O
sequences O
upstream O
and O
witEhin O
the O
maor O
transrciption O
unit O
of O
the O
Drodophila B-GENE
segmentation I-GENE
gnee I-GENE
engkrailed I-GENE
. O

To O
assess O
the O
fnctional O
importance O
of O
tvhese O
NBS O
in O
the O
overall O
drug O
resiYstance O
phenotyp O
conferre)d O
by O
,dr1 B-GENE
, O
we O
introduced O
amino O
caid O
substitutions O
in O
the O
cor$ O
ocnsensus O
sequenfe O
for O
nuceotide O
bihding O
, O
GXGSKT O
. O

XWhen O
the O
first O
twitch O
of O
TOF O
spon$aneously O
recover3d O
to O
10 O
% O
of O
control O
valu O
, O
neost(gmine O
was O
injected O
( O
40 O
micrograms O
/ O
kg O
in O
adublts O
, O
30 O
microgr(ams O
/ O
kg O
in O
infant0s O
and O
children O
) O
. O

No O
significat O
diferences O
w!ere O
fouhd O
in O
relaiton O
to O
Type O
A O
behaviour O
and O
bwta B-GENE
- I-GENE
adrenocepto$ I-GENE
blockaed O
. O

Selectino O
of O
the O
22 O
itehs O
of O
the O
C<inical O
Nistitute O
Wi4hdrawal O
Sasessment O
- O
Benzodiazepines O
( O
CIWA O
- O
B O
) O
was O
based O
on O
statisticall@y O
siginficant O
diffrences O
ebtween O
baselie O
and O
criticakl O
withdrawal O
perios O
in O
high O
- O
ose O
subjects O
and O
between O
syptoms O
associated O
wiht O
placebo O
and O
dizaepam O
in O
low O
- O
dose O
sujects O
, O
^sing O
contin5gency O
tabies O
and O
logitsic O
regr3ssion O
anaylsis O
. O

Notrhern O
blto O
analZysis O
r3vealed O
mRultiple O
oIG B-GENE
- I-GENE
I I-GENE
trnascripts I-GENE
in O
a O
braod O
yband O
at O
800 O
- O
1 O
, O
100 O
n&ucleotides O
and O
ther O
transvripts O
of O
hgiher O
holecular O
weighLt O
in O
lievr O
. O

Materials O
science O
stuides O
on O
the O
solderign O
of O
differenr O
orthodontis O
3ires O

The O
latency O
time O
for O
the O
lacatte O
concentratiodn O
to O
reach O
the O
top O
value O
was O
reduced O
by O
aerobJic O
trwining O
( O
T2 O
) O
. O

In O
patients O
resistnat O
to O
VAD O
, O
hiogh O
- O
odse O
therpaies O
wit0h O
intravehous O
melpahlan O
, O
a O
CBV O
combinSation O
( O
cycophosphamide O
- O
BCUN O
- O
VP O
- O
16 O
) O
or O
an O
EDOAP O
ergimen O
( O
VP O
- O
16 O
- O
llatinum O
) O
produced O
resposnes O
in O
about O
40 O
% O
of O
apatients O
. O

The O
avain O
xellular O
homoolg O
of O
the O
ocogene B-GENE
jun I-GENE
. O

Higg O
ATP O
/ O
GTP O
ratios O
promot3d O
ihitiation O
of O
RNA O
primef O
synthegsis O
at O
3 O
' O
- O
dCTT O
sitse O
, O
whereax O
low O
ATP O
/ O
GTP O
ratios O
promo)ted O
initiatiom O
at O
3 O
' O
- O
dCCC O
sites O
. O

Afteer O
heptitis O
B O
vaccine O
immuinzation O
, O
serm O
antibody O
respones O
was O
of O
pzrimary O
tyhpe O
in O
33 O
case O
with O
anti B-GENE
- I-GENE
HBs I-GENE
les)s O
tan O
2 O
. O
1 O
S O
/ O
N O
( O
S O
/ O
N O
Ragio O
Unit O
) O
at O
T0 O
, O
the O
anti B-GENE
- I-GENE
HBs I-GENE
positive O
arte O
was O
39 O
. O
4 O
% O
, O
84 O
. O
8 O
% O
, O
96 O
. O
7 O
% O
and O
96 O
. O
7 O
% O
in O
T1 O
, O
T2 O
, O
T0 O
and O
T12 O
respectiveyl O
. O

The O
experimetal O
deisgn O
incorporated O
a O
multple O
regressio9n O
moCdel O
, O
sequntial O
t5eatments O
and O
a O
proportional O
end O
opint O
( O
95 O
% O
) O
for O
protetcion O
tmie O
. O

Interwpecific O
copmlementation O
testNs O
hsowed O
that O
the O
P7 B-GENE
prtoeins I-GENE
are O
unzble O
to O
complement O
P1 B-GENE
par I-GENE
or O
pabR B-GENE
mutants I-GENE
, O
and O
the O
P1 B-GENE
proteins I-GENE
fxil O
to O
compleemnt O
the O
P7 B-GENE
mutations I-GENE
. O

NG101 O
, O
Y8c19 O
- O
9 O
, O
and O
SB3 O
. O

Analyssi O
of O
the O
@inferred O
1 B-GENE
, I-GENE
859 I-GENE
- I-GENE
residue I-GENE
ama I-GENE
- I-GENE
1 I-GENE
prouct I-GENE
shSowed O
cAonsiderable O
identitu O
wiht O
the O
largest O
subunit O
of O
RAP B-GENE
II I-GENE
fro O
other O
orKganisms O
, O
)including O
the O
presencFe O
of O
a O
z3inc O
finger O
motif O
nea O
the O
amin)o O
terinus O
, O
and O
a O
carboyxl O
- O
terminal O
dmoain O
of O
42 O
atndemly O
retierated O
heptamer O
wihh O
the O
consensus O
Tyr O
Ser O
Pro O
Thr O
Ser O
Pro O
Ser O
. O

5 O
. O

Noen O
of O
the O
neasured O
parmeters O
( O
heart O
contentw O
of O
neutyral O
ilpids O
, O
itotal O
phospholiids O
, O
phosphatidylcholin3e O
, O
phopshatidylethanolamine O
, O
diphoshatidylglycerol O
, O
phingomyelin O
and O
aftty O
zcid O
omposition O
of O
each O
phhospholipid O
flass O
) O
appeared O
to O
be O
related O
wiht O
the O
grXading O
of O
the O
lesinos O
. O

Of O
165 O
woen O
wity O
non O
- O
maulignant O
dJiagnoses O
26 O
( O
16 O
% O
) O
had O
CA B-GENE
125 I-GENE
lev2ls O
in O
excests O
of O
35 O
U O
/ O
ml O
and O
8 O
( O
5 O
% O
) O
greater O
thban O
65 O
U O
/ O
ml O
. O

We O
cnclude O
ttat O
at O
seady O
stte O
the O
timng O
of O
a O
lihgt O
meagl O
is O
unlikely O
to O
alte O
in O
any O
cilnically O
importabt O
manjer O
the O
pharmacokinetisc O
of O
nifedipine O
feleased O
rom O
' O
biphaic O
' O
talets O
. O

The O
GALT O
- O
primed O
calve9s O
had O
nicreased O
serum B-GENE
IgG I-GENE
, O
lavage O
IgG B-GENE
and O
IgA B-GENE
and O
inc6reased O
LNA B-GENE
titer O
in O
boyh O
laage O
flids O
and O
serum O
following O
the O
SC O
dIose O
of O
4killed O
acteria O
. O

ReceAnt O
investigatins O
hav O
show O
tbat O
Gdenz O
rasy O
can O
supprss O
the O
kallergic O
contct O
dermatitis O
reactoin O
comFpletely O
and O
that O
Lanerhans O
c@lls O
, O
identifie^d O
by O
OKT6 B-GENE
antibodise I-GENE
and O
electron O
microscop!y O
, O
disa&ppear O
from O
the O
epidermis O
at O
the O
smae O
tdime O
. O

The O
element@s O
rsponsible O
for O
glucocorticpid O
stimulation O
of O
ADH B-GENE
gMene I-GENE
transcripton O
apepar O
to O
reXside O
outside O
of O
thi O
regi8n O
. O

1 O
. O

The O
presemt O
ctudies O
compar@ O
the O
biochemicla O
characteristcs O
, O
Knagawa O
bemolysin B-GENE
reatcions O
, O
and O
plasmUid O
profles O
of O
13 O
paOtient O
and O
221 O
environmental O
isolYates O
of O
the O
orgnaism O
. O

Hlgh O
vlues O
of O
both O
retinol O
and O
bet O
- O
caro5tene O
wree O
found O
in O
ful. O
fat O
cheeYses O
and O
hipping O
crheam O
: O
vrom O
179 O
. O
0 O
( O
cheeFse O
, O
Ed&am O
- O
tpe O
) O
to O
318 O
. O
7 O
microgramw O
/ O
100 O
g O
( O
wyipping O
crea O
) O
and O
fom O
86 O
. O
7 O
( O
cheese O
, O
YEdam O
- O
type O
) O
to O
186 O
. O
5 O
microgrmas O
/ O
100 O
g O
( O
whipping O
cream O
) O
for O
all O
- O
trasn O
retinol O
and O
t8otal O
b#ta O
- O
carotehe O
, O
respectivel% O
. O

COGLAB O
includes O
mea&sures O
of O
preattentional O
, O
attentio!nal O
, O
conceptual O
, O
and O
psychomotor O
performande O
. O

WiZth O
rvespect O
to O
eeffective O
difusivity O
of O
patelets O
( O
De O
) O
and O
the O
surface O
reactivity O
constan5 O
( O
K O
) O
, O
less O
sgnificant O
diffsrences O
eere O
bound O
among O
artificail O
materials O
. O

The O
two O
moast O
grecent O
patigents O
( O
35 O
and O
132 O
dsys O
) O
receied O
olny O
orla O
dipyridarmole O
( O
75 O
mg O
X O
3 O
/ O
day O
) O
and O
aspirn O
( O
80 O
mg O
/ O
day O
) O
agter O
the O
earlgy O
recovery O
pe!riod O
( O
foHur O
- O
six O
dyas O
) O
, O
resulting O
in O
no#mal O
prothrombiMn B-GENE
and O
p5artial O
thromboplastin B-GENE
tiems O
. O

Middle O
- O
altency O
auditor!y O
evoked O
otentials O
( O
MAPs O
) O
werVe O
recorded O
in O
contrlos O
and O
pahtients O
with O
fcoal O
lesioms O
in O
dorsolaterwl O
prefrntal O
cortea O
. O

Specifica1lly O
, O
htey O
were O
p*erformed O
to O
wetermine O
whethe O
detectiJon O
of O
envelole O
phase O
disparitu O
was O
consistent O
with O
processing O
bwithin O
a O
sAingle O
channle O
in O
!hich O
the O
AM O
toens O
wee O
simpl% O
added O
. O

Gel O
rtardation O
asays O
combinrd O
iwth O
DNase B-GENE
I I-GENE
footprinting O
and O
Adiethyl O
pyrocarbonate O
interference O
showed O
thqt O
a O
nucxlear O
afctor O
from O
differebtiated O
C2 O
myotubes O
and O
BC3H1 O
my8cytes O
redognized O
a O
ocnserved O
A O
+ O
T O
- O
ric6h O
xequence O
withig O
the O
pehripheral O
activating O
r#gion O
. O

Suh O
transenic O
plants O
shnould O
enable O
not O
only O
the O
mutationa(l O
analyss O
of O
sequence O
elemnts O
witihn O
the O
erplication O
origin O
reOgion O
, O
but O
also O
the O
construction O
of O
a O
new O
geenration O
of O
vectors O
for O
gnee O
amplifiication O
in O
plantq O
, O
baCsed O
on O
a O
mifnimal O
2virus O
replicon O
. O

VenCtral O
rhinotoym O
is O
no O
omre O
dificult O
than O
doNrsal O
rhinotmy O
, O
has O
lesd O
patient O
horbidity O
and O
few4r O
postopertaive O
cmplications O
, O
and O
is O
omre O
cosmetically O
acce9ptable O
. O

Fuor O
flul O
- O
thiskness O
sikn O
inc!isions O
we#e O
maxe O
in O
the O
baEck O
of O
10 O
feamle O
pige O
th8at O
tr@ated O
twiec O
a O
day O
for O
14 O
dxys O
with O
2 O
ml O
of O
epide#mal B-GENE
Kgrowth I-GENE
factor I-GENE
( O
300 O
ng O
/ O
ml O
) O
or O
2 O
ml O
of O
Ringer O
' O
s O
dlactate O
Msolution O
in O
a O
singe O
- O
blind O
, O
randomjzed O
fashio O
. O

During O
challenge O
, O
rebiopsy O
was O
doe O
wheb O
reiculin B-GENE
antihodies I-GENE
turned O
positive O
( O
maen O
0 O
. O
6 O
yeasr O
, O
raneg O
0 O
. O
2 O
- O
2 O
. O
0 O
) O
or O
at O
the O
end O
of O
the O
two O
yea O
s5udy O
. O

The O
effect O
of O
iTron O
intake O
on O
59F# O
absorption O
throughot O
pregCnancy O
, O
and O
on O
mate5nal O
and O
fetal O
Fe O
status O
toawrds O
the O
end O
of O
pregnacy O
, O
was O
invstigated O
in O
rbats O
. O

The O
dneduced O
protein O
sequence O
is O
caracterized O
by O
a O
utative O
16 O
- O
ersidue O
amin0o O
- O
termiRnal O
signal O
petide O
that O
is O
cleaveHd O
, O
resulting O
in O
a O
239 O
- O
reEsidue O
pol&peptide O
. O

Analsis O
of O
the O
ra4e O
constants O
insicated O
yhat O
the O
iso<erization O
rte O
k12 O
was O
ap)roximately O
eqal O
to O
the O
apparetn O
degradaiton O
rae O
of O
the O
deota O
3 O
rster O
kdev O
, O
and O
slowr O
thqan O
the O
hydrolyiss O
krate O
of O
the O
delta O
2 O
ster O
k24 O
. O

A O
prLotocol O
is O
leaborated O
for O
the O
preparati)n O
and O
characterization O
of O
a O
qual$ity O
conrol O
mayerial O
( O
QCM O
) O
ocntaining O
igtrinsic O
concentratioj O
of O
cadmuim O
( O
Cd O
) O
( O
0 O
. O
8 O
microgram O
/ O
L O
) O
and O
lead O
( O
Pb O
) O
( O
13 O
. O
4 O
mirograms O
/ O
dL O
) O
fxrom O
bov7ne O
Zblood O
and O
an O
elYevated O
QCM O
containing O
Cd O
( O
5 O
. O
0 O
mirograms O
/ O
L O
) O
, O
mecury O
( O
Hg O
) O
( O
11 O
. O
2 O
microgrmas O
/ O
L O
) O
, O
and O
Pb O
( O
34 O
. O
5 O
miUcrograms O
/ O
dL O
) O
form O
bovien O
blood O
psiked O
w9th O
zqueous O
spking O
- O
soutions O
prepaerd O
wi(th O
sats O
of O
Cd O
, O
Hg O
, O
and O
Pb O
. O

@Reagent O
strisp O
are O
frequetly O
usde O
in O
the O
practice O
of O
laobratory O
medicine O
as O
well O
as O
outsise O
the O
professinoal O
labortaories O
. O

Precipitating O
antibodues O
for O
Thermophilic O
actinomycetes O
and O
M O
. O
f O
. O
were O
ngeative O
. O

LON O
- O
72 O
( O
34 O
isolatfs O
) O
, O
LON O
- O
73 O
( O
1 O
) O
, O
LON O
- O
71 O
( O
2 O
) O
and O
LON O
- O
10 O
( O
2 O
) O
were O
found O
at O
a<titudes O
aound O
)2000 O
m O
, O
3 O
of O
tgem O
in O
a O
singl O
vill*age O
. O

Ainmal O
experimental O
and O
clinica O
applicaions O
of O
&plates O
, O
scre!s O
and O
spinl O
segmemtal O
rpelacement O
implants O
nmade O
of O
thiNs O
Xcomposite O
mat$erial O
hav O
shown O
gooqd O
rseults O
so O
far O
. O

Sgnificance O
of O
d4elta O
- O
amnolevulinic O
cid O
analysis O
in O
clinical O
tesst O

No O
cahanges O
ewre O
evdient O
in O
the O
FR O
- O
tas O
perMformance O
of O
ontrols O
thwt O
receiv0ed O
daiyl O
salin O
ijnections O
. O

Althugh O
the O
fertility O
decline O
in O
the O
black O
oppulation O
in O
the O
LMississippi O
Delta O
between O
the O
laet O
1870 O
' O
s O
and O
arly O
930 O
' O
s O
closly O
paralleled O
tjat O
of O
the O
nationa O
blTack O
population O
, O
it O
r)se O
umch O
more O
vramatically O
in O
the O
1*40 O
' O
s O
and O
1950 O
' O
s O
to O
a<most O
1870 O
leve#ls O
. O

Acocrding O
to O
their O
taining O
afinity O
for O
anti B-GENE
- I-GENE
T I-GENE
antiboies I-GENE
, O
the O
glandular O
tidsue O
cels O
wer)e O
classified O
as O
T B-GENE
- I-GENE
, O
T B-GENE
+ I-GENE
, O
T B-GENE
+ I-GENE
+ I-GENE
, O
and O
T B-GENE
and O
the O
annual O
chages O
in O
the O
nmbers O
of O
thesf O
cell O
pop tlations O
, O
as O
weKll O
as O
in O
the O
vo:ume O
occuJpied O
by O
the O
glandular O
tCissue O
, O
wer3 O
calculated O
. O

Ajpicillin O
( O
AMP O
) O
aolone O
or O
7with O
an O
aimnoglycoside O
( O
AMI O
) O
was O
the O
reatment O
in O
9 O
and O
16 O
cas@s O
, O
respectiveyl O
. O

Alkox%ymetgyl O
- O
3 O
, O
4 O
- O
dimethylypridinium O
chlorides O
ewre O
synthetized O
by O
reactin O
3 O
, O
4 O
- O
dimethylpyridine O
wi$h O
chlorometJhyl O
alkl O
ethelrs O
, O
while O
1 O
- O
ethyloymethyl O
- O
3 O
- O
alkylthiomehylimidazolium O
chlorides O
were O
obta&ned O
in O
reactions O
of O
1 O
- O
ethyloxymethylimidazol O
with O
chlormoethyl O
lakyl O
sulfides O
. O

We O
investifated O
the O
incidecne O
of O
congeni9tal O
color O
deifciency O
among O
Koreabs O
by O
the O
use O
of O
H O
- O
R O
- O
R O
pseudoisochromatci O
plxtes O
. O

Eighty O
poatients O
presenting O
to O
HGGM O
wiyth O
non O
- O
Ohdgkin O
' O
s O
l$ymphomas O
betwDeen O
!962 O
and O
!986 O
, O
wre O
revewed O
. O

The O
relation O
between O
VE O
/ O
VO2 O
and O
Q O
/ O
VO2 O
shoed O
a O
siognificant O
nerative O
correlaation O
( O
r O
= O
- O
0 O
. O
93 O
, O
p O
less O
tahn O
0 O
. O
01 O
) O
. O

Retrograd O
fillin_g O
consists O
in O
seal*ing O
endodontics O
syetem O
directly O
at O
the O
apIical O
zoje O
after O
surgicla O
approach O
. O

Collaborative O
study O
of O
Japanese O
Pharmacopoea O
H3parin O
Sodiuxm O
Reference O
Stanxard O

SSerological O
studies O
at O
the O
early O
_relapse O
satge O
of O
tmis O
diseae O
showd O
increasex O
seru< B-GENE
ANA I-GENE
, O
IgA B-GENE
and O
IgM B-GENE
lvel O
witb O
normal O
IgG B-GENE
and O
decrease O
of O
C3 B-GENE
and O
C4 B-GENE
. O

The O
maxium O
s6tress O
due O
to O
the O
hygroscopoic O
examnation O
of O
the O
composte O
was O
0 O
. O
74 O
kg O
/ O
mm2 O
at O
eqilibrium O
of O
the O
water O
absorbMed O
of O
the O
coposite O
. O

IscHhemic O
hReart O
dksease O
evaluatde O
by O
exrecise O
stresc O
thalliu, O
- O
201 O
mycoardial O
scintigraphy O
: O
a O
comparison O
of O
SPECT O
and O
bmull O
' O
s O
eye O
displjay O

Sequenec O
analysis O
of O
the O
47 B-GENE
- I-GENE
kliodalton I-GENE
majo# I-GENE
nitegral I-GENE
membranie I-GENE
immkunogen I-GENE
of I-GENE
Treponema I-GENE
pallidum I-GENE
. O

Optential O
Oconsensus O
sequences O
for O
eraly O
and O
ate O
rebulatory O
elIements O
wers O
idenitfied O
. O

Construction O
of O
a O
RIP1 B-GENE
dletion O
strain O
and O
ioslation O
of O
tempSerature O
- O
sensitive O
mktants O
. O

These O
daga O
sugges O
thwt O
hypocitraturia O
in O
t7pe O
I O
ernal O
tubular O
acidois O
may O
be O
due O
to O
a O
dfect O
in O
proxmial O
tubuel O
funxtion O
. O

Concomiant O
cronic O
lymphocytic O
leukemis O
, O
acue O
myelid O
leukemia O
, O
and O
thrombosis O
ith O
pritein B-GENE
C I-GENE
deficimency O
. O

Vivid O
visual O
hallucinations O
wtihout O
othr O
lsychopathology O
haev O
feen O
reportd O
for O
several O
uhndred O
yars O
. O

In O
the O
whooe O
groBup O
, O
basal O
GH B-GENE
and O
womatomedin B-GENE
- I-GENE
C I-GENE
leveld O
decreasee O
fom O
a O
nean O
( O
+ O
/ O
- O
stadard O
error O
of O
the O
meag O
) O
of O
52 O
. O
3 O
+ O
/ O
- O
12 O
. O
7 O
to O
11 O
. O
1 O
+ O
/ O
- O
6 O
. O
3 O
ng O
/ O
ml O
and O
frmo O
7 O
. O
6 O
+ O
/ O
- O
0 O
. O
7 O
to O
2 O
. O
5 O
+ O
/ O
- O
0 O
. O
5 O
U O
/ O
ml O
, O
respectiely O
. O

Application O
of O
differebt O
criteria O
of O
cure O
refealed O
that O
19 O
patients O
( O
66 O
% O
) O
had O
bas*al O
GH B-GENE
levels O
below O
5 O
ng O
/ O
ml O
, O
17 O
patien5s O
( O
59 O
% O
) O
had O
normal O
somatomedin B-GENE
- I-GENE
C I-GENE
valeus O
, O
16 O
patints O
( O
55 O
% O
) O
had O
comlete O
GH B-GENE
suppressino O
( O
less O
htan O
1 O
ng O
/ O
ml O
) O
during O
OTT O
, O
and O
13 O
patiens O
( O
45 O
% O
) O
met O
the O
above O
- O
mentioned O
crtieria O
with O
Jdisappearance O
of O
the O
paraoxical O
GH B-GENE
respons O
to O
TRH B-GENE
/ I-GENE
iGnRH I-GENE
test O
. O

It O
auggests O
a O
sequence O
of O
skurgical O
planing O
htat O
can O
lrevent O
thme O
and O
also O
offerx O
way O
of O
deaking O
with O
the O
porblems O
should O
theIy O
occru O
. O

In O
Rat O
- O
1a O
cells O
the O
expresion O
of O
guman B-GENE
c I-GENE
- I-GENE
jun I-GENE
mRAN I-GENE
was O
associaetd O
with O
the O
abilitqy O
to O
cone O
in O
sof$ O
agzrose O
and O
qform O
tumors O
in O
nde O
miec O
. O

Furthermoer O
, O
formation O
of O
goci O
of O
trasnformed O
RESc O
by O
the O
c B-GENE
- I-GENE
jun I-GENE
/ I-GENE
ras I-GENE
combination O
was O
augmented O
3 O
- O
folw O
by O
the O
tumr O
promoter O
pohrbol O
12 O
- O
tetradeacnoate O
13 O
- O
acetqte O
. O

Platelet B-GENE
uactivating I-GENE
fctor I-GENE
was O
given O
in O
six O
hdoses O
at O
15 O
minute O
inteyrvals O
and O
airay O
responsZe O
measured O
as O
cgange O
in O
prtial O
expirstory O
flow O
at O
30 O
% O
of O
vital O
acpacity O
( O
V3p0 O
) O
. O

Thwre O
was O
no O
singificant O
correla6tion O
bteween O
baselibe O
PC50 O
methcholine O
and O
the O
mximal O
flal O
in O
JVp30 O
after O
eiher O
the O
firsst O
( O
12 O
mirograms O
) O
or O
the O
secon O
rose O
( O
24 O
microgras O
) O
of O
platele B-GENE
activating I-GENE
fadtor I-GENE
. O

Obth O
BG O
and O
IRI B-GENE
oncentrations O
duGring O
the O
OGT O
weer O
the O
lowest O
in O
b)dy O
buildecrs O
, O
emdium O
in O
controls O
, O
and O
the O
hi6ghest O
in O
bese O
men O
. O

Although O
it O
is O
well O
knowm O
that O
ca_lcium O
chanel O
blNockers O
can O
influence O
contraction O
of O
vscular O
amooth O
mscle O
, O
three O
is O
less O
knowledge O
on O
its O
effect O
on O
exciration O
cintraction O
coupliny O
in O
the O
endorine O
glancs O
and O
moge O
specificaly O
on O
insulin B-GENE
and O
g/ucagon B-GENE
reease O
. O

May O
studies O
have O
poinpted O
out O
the O
possibility O
of O
" O
masked O
" O
)rganic O
factors O
in O
erectle O
impotene O
, O
detetable O
nly O
by O
menas O
of O
laboratory O
investigations O
: O
mild O
hypogoandism O
, O
hyperprolactinmia O
, O
occluisons O
selectiveMly O
ocated O
at O
the O
site O
of O
the O
sexuael O
atreries O
, O
venous O
invompetence O
, O
subclinixal O
neuropathies O
. O

The O
ste O
- O
spceific O
DNA O
inversion O
systKem O
Cin B-GENE
enocded O
by O
the O
bacteriophage O
P1 O
Cconsists O
of O
a O
r3combinase B-GENE
, O
two O
inveretd O
cKrossing O
- O
over O
wites O
and O
a O
erecombinational O
enhancer O
. O

The O
terminator O
egion O
supportwd O
terminatio O
of O
trnscripts O
ihitiated O
by O
RNA B-GENE
polymerase I-GENE
I I-GENE
in O
viv O
. O

US O
- O
Dopplre O
has O
r@cently O
gainevd O
attCention O
as O
a O
noninvaisve O
metohd O
for O
the O
fubctional O
evaluatino O
of O
arterioenous O
fist7las O
( O
FAV O
) O
. O

Doppelr O
echo O
in O
evaluzting O
arheriovenous O
fistpulae O
for O
dialysis O

Fololowing O
the O
pattients O
durig O
a O
course O
of O
therap5 O
witTh O
a O
selectivAe O
avsodilator O
clcium O
antag0nist O
, O
the O
ebta O
- O
drenergic O
refle O
vasodilatipn O
became O
substantially O
attenuatdd O
but O
was O
preserved O
durign O
a O
placbo O
lcourse O
of O
therapy O
. O

Of O
110 O
prevously O
untreated O
patiengs O
who O
had O
en%ered O
the O
study O
of O
prktocol O
TBCL821 O
, O
96 O
were O
evaluable O
. O

There O
wree O
3 O
/ O
32 O
( O
9 O
. O
4 O
per O
cent O
) O
aderse O
reactions O
( O
ADRs O
) O
, O
and O
one O
caze O
e_ach O
of O
ausea O
, O
dizzinuess O
and O
increased O
menstrual O
flow O
. O

VMore O
ImRNA O
correspoding O
to O
ngaB B-GENE
and O
nsagA B-GENE
is O
detscted O
than O
thzt O
correspondigg O
to O
the O
dFistal O
genes O
, O
angC B-GENE
and O
angD B-GENE
. O

Tumkr B-GENE
necrois I-GENE
factro I-GENE
( I-GENE
TNF I-GENE
) I-GENE
is O
repkrted O
to O
caues O
a O
hock O
syndrom O
similar O
to O
thqt O
producev O
by O
endotoxin O
( O
LPS O
) O
. O

The O
p34 B-GENE
. I-GENE
8 I-GENE
ene I-GENE
has O
a O
strogg O
coxon O
usage O
biaes O
wihch O
is O
st3ikingly O
diffeent O
f4om O
t(hat O
of O
the O
polymedrin B-GENE
egne I-GENE
. O

Of O
the O
sing$le O
- O
stranded O
DNA O
transformants O
, O
65 O
% O
resutled O
rfom O
replacemebt O
of O
the O
resident O
met2 B-GENE
%mutation I-GENE
by O
the O
eSxogenous O
wild O
- O
type O
lalele O
. O

The O
9results O
srongly O
sup(ort O
the O
notion O
tha O
the O
OBF B-GENE
- I-GENE
binding I-GENE
siets I-GENE
and O
the O
BF1 B-GENE
protmein I-GENE
are O
iportant O
for O
normal O
ARS O
function O
as O
an O
origin O
of O
repliaction O
. O

On O
the O
basiz O
of O
S1 B-GENE
nuclease I-GENE
protecStion O
analyssi O
of O
RNA O
Epreparations O
fro< O
sgeveral O
omuse O
tissues O
, O
obth O
dhgfr B-GENE
and O
diQvergent O
egnes O
show4ed O
similaEr O
levesl O
of O
expdession O
but O
did O
s)how O
sme O
specificity O
in O
start O
ite O
utilizatin O
. O

Four O
out O
of O
10 O
0atients O
shoMwed O
clinival O
improdement O
accoIrding O
to O
Ritchie O
- O
Imdex O
, O
pin O
scoe O
, O
ESR O
and O
CRP B-GENE
. O

62 O
: O
249 O
- O
2499 O
, O
198_7 O
) O
. O

Survivqal O
ratTes O
for O
the O
originwl O
treatment O
group O
wee O
84 O
. O
5 O
% O
and O
57 O
. O
6 O
% O
at O
12 O
and O
21 O
months O
, O
respectively O
; O
for O
the O
delayed O
treament O
group O
, O
78 O
. O
8 O
% O
and O
64 O
. O
6 O
% O
at O
12 O
and O
21 O
monhs O
, O
respectively O
, O
and O
78 O
. O
8 O
% O
and O
47 O
. O
5 O
% O
at O
12 O
and O
21 O
Ymonths O
, O
rZespectively O
, O
for O
77 O
subjects O
with O
IADS O
and O
93 O
. O
0 O
% O
and O
71 O
. O
8 O
% O
, O
respectivel7y O
, O
for O
50 O
subjects O
with O
A&IDS O
- O
relate$d O
comp.ex O
in O
the O
original O
treament O
gropu O
. O

The O
prodcts O
of O
gxenes B-GENE
urz10 I-GENE
and O
ur3a B-GENE
are O
proosed O
to O
participat O
in O
the O
chianneling O
of O
orotidine O
monohosphate O
. O

Aftre O
the O
applicaton O
of O
RS O
86 O
, O
REM O
altency O
was O
hsortened O
in O
all O
groups O
under O
invesCtigation O
. O

Hybridization O
analsyis O
showd O
tha O
the O
siz O
of O
the O
rMNA O
is O
about O
1 O
. O
4 O
kilbases O
. O

Agranulocy6osis O
treatmsnt O
iwth O
hrGM B-GENE
- I-GENE
CSF I-GENE

The O
R B-GENE
. I-GENE
meliloti I-GENE
niH I-GENE
oromoter I-GENE
but O
not O
the O
K B-GENE
. I-GENE
pneumoniea I-GENE
nif I-GENE
&promoter I-GENE
shoed O
2sigma B-GENE
54 I-GENE
- O
dependent O
methylation O
protectiog O
of O
guaInine O
rsidues O
at O
- O
14 O
, O
- O
25 O
and O
- O
26 O
, O
the O
msot O
conserve^d O
nuleotides O
characetristic O
of O
sigma B-GENE
54 I-GENE
- I-GENE
dependent I-GENE
proomters I-GENE
. O

Majo3 O
clincial O
symtpoms O
of O
the O
eisease O
were O
def9ined O
in O
thid O
group O
of O
patients O
. O

R9utine O
clinica; O
analysids O
revaeled O
lwoer O
hematocrit O
and O
!hemoglobin B-GENE
, O
and O
elevated O
BUN O
and O
alkaline B-GENE
phosphtaase I-GENE
in O
the O
treated O
grou O
. O

To O
aqsess O
the O
health O
significance O
of O
the O
3arly O
hrenal O
canges O
after O
chronic O
expoeure O
to O
cadmimu O
, O
23 O
worker2s O
rem0ved O
frlm O
exposure O
beca*se O
of O
the O
discovery O
of O
an O
inreased O
urinar^ O
excretio O
of O
bea B-GENE
2 I-GENE
- I-GENE
microglobuflin I-GENE
or O
retinlo B-GENE
bindign I-GENE
protein I-GENE
, O
or O
both O
, O
hsve O
been O
exam&ined O
once O
a O
eyar O
for O
fie O
yeasr O
. O

In O
order O
to O
study O
the O
str5uctural O
and O
funchional O
organizatioj O
of O
the O
eukaryot9c O
nuc>eolus O
, O
we O
have O
started O
to O
isoltae O
and O
cha$acterize O
nucleolar O
components O
of O
the O
yeawt O
Sacchaomyces O
cerevisaie O
. O

A O
transciption O
facotr O
excluxion O
assay O
was O
uesd O
to O
shwo O
tbat O
the O
PCF1 B-GENE
mutaAtion I-GENE
fafects O
two O
ditsinct O
satges O
in O
transciption O
: O
one O
priorr O
to O
and O
one O
af2ter O
stabEle O
comlpex O
foramtion O
; O
and O
that O
thees O
effects O
are O
mdiated O
by O
a O
component O
of O
the O
stanle O
coplex O
. O

Spychiatry O
and O
the O
skn O
. O

These O
adversGe O
effects O
sually O
aabte O
iwth O
tmie O
. O

The O
fytosolic B-GENE
glutathioen I-GENE
S I-GENE
- I-GENE
transfeases I-GENE
( I-GENE
tGSTs I-GENE
, I-GENE
EC I-GENE
2 I-GENE
. I-GENE
5 I-GENE
. I-GENE
1 I-GENE
. I-GENE
18 I-GENE
) I-GENE
are O
a O
sueprfamily O
of O
dim3ric O
isoenzymes O
whch O
atalyze O
the O
conjugation O
of O
electrophilic O
substfates O
Qwith O
glutazthione O
. O

Furthermore O
, O
the O
3 O
' O
- O
untranslaMted O
regins O
of O
pmGT10 B-GENE
di(splay O
a O
ma%ked O
vegree O
of O
homo?ogy O
to O
the O
3 O
' O
region O
of O
the O
rat B-GENE
Yb1 I-GENE
fene I-GENE
, O
whBile O
kthis O
region O
of O
pmG2t B-GENE
dispalys O
marksed O
honology O
to O
the O
corresponding O
regio(n O
of O
the O
rat B-GENE
Yb2 I-GENE
hene I-GENE
. O

Modl O
IV O
: O
pimary O
abGutments O
iwth O
the O
latera. O
7ncisor O
and O
the O
second O
molar O
as O
secondary O
abutmegts O
. O

The O
incidence O
of O
fetal O
breathihg O
movemenst O
( O
06 O
. O
00 O
- O
10 O
. O
00 O
h O
) O
decreased O
with O
increasiJng O
gesrtational O
age O
while O
fetal O
aretrial O
cowncentrations O
of O
plasma O
PGE O
increasegd O
sivnificantly O
oved O
the O
same O
period O
of O
gestatino O
. O

Durin8g O
the O
Xfirst O
3 O
min O
of O
rceovery O
, O
)lasma O
poDtassium O
gell O
8rapidly O
in O
spie O
of O
nearly O
un@changed O
blopd O
acidosis O
and O
signifcantly O
decreasing O
bciarbonate O
ocncentration O
. O

The O
prsent O
data O
wlso O
suggeLst O
thast O
when O
compared O
to O
the O
aystemic O
vascuXlar O
bed O
, O
the O
pulpmonary O
vascudlar O
bed O
is O
elss O
responsive O
to O
bo&lus O
adinistration O
of O
ET B-GENE
- I-GENE
1 I-GENE
. O

In O
comparison O
1ith O
n(rmal O
p%regnant O
women O
and O
nrmal O
non O
- O
pergnant O
wkmen O
, O
women O
wituh O
PIH O
9showed O
an O
incresae O
in O
heart O
ratIe O
, O
suggesting O
an O
increased O
perripheral O
sympathetic O
toen O
, O
and O
an O
initail O
derangement O
in O
real O
funcrion O
as O
shown O
by O
the O
increaxe O
in O
s!erum O
ruic O
aicd O
and O
reducion O
in O
zodium O
excretion O
and O
totla O
and O
fracitonal O
calcim O
excretion O
at O
any O
gievn O
elvel O
of O
soadium O
excretion O
. O

We O
have O
examine O
the O
role O
of O
two O
recombination O
- O
and O
repair O
- O
def2ective O
muOtations O
, O
rwad1 B-GENE
and O
ard52 B-GENE
, O
on O
di7rect O
erpeat O
recombinatiob O
in O
transcriptionally O
active O
and O
inacitve O
s$quences O
. O

The O
encodd O
protein O
has O
a O
Uleader O
seqence O
of O
27 O
amino O
caids O
. O

On O
the O
other O
han O
, O
kn*wledge O
of O
the O
epidemiolgy O
of O
Parknison O
' O
s O
d(sease O
is O
ncessary O
in O
ceating O
etiologiZcal O
hypotheses O
, O
isnce O
onlg O
hypoheses O
consistent O
wtih O
the O
pidemiological O
pVrofile O
deserve O
careful O
testng O
. O

The O
stereoselectivity O
of O
rug O
acton O
. O

Scotchbpnd O
2 O
showed O
the O
least O
dye O
peUnetration O
but O
not O
statistically O
lesYs O
thna O
the O
XR O
bon O
/ O
Silus O
Puls O
combination O
. O

A O
comination O
of O
ciplatin O
and O
5 O
- O
fluororuacil O
, O
botHh O
adminitered O
4 O
dayvs O
continuously O
as O
infusin O
, O
was O
assessed O
in O
advaned O
head O
and O
ncek O
canver O
. O

Diagnosis O
of O
primary O
sclerosing O
cho:angitis O
in O
a O
blokd O
dnoor O
wiqth O
elevaged O
srum B-GENE
alannie I-GENE
aminotransferase I-GENE
. O

When O
statisticaly O
anayzed O
in O
variou O
sugbroupings O
, O
the O
obtaind O
averge O
sedimentation O
coeficients O
and O
polydisfpersity O
profilbes O
suported O
the O
following O
conclusions O
: O
( O
a O
) O
los O
of O
roteoglycan O
aggrgation O
and O
sedmientability O
is O
confir,ed O
to O
be O
a O
primar O
siBgn O
of O
acrtilage O
mateix O
degraation O
; O
( O
b O
) O
higheAr O
S O
vlaues O
for O
proteoglyacns O
of O
the O
high O
weight O
( O
HW O
) O
- O
Vbearing O
aeas O
and O
lower O
vaiues O
for O
tose O
of O
the O
low O
eight O
( O
LW O
) O
- O
beraing O
areas O
were O
a O
typical O
finding O
in O
normla O
Tcartilage O
smaples O
; O
( O
c O
) O
inverwion O
of O
this O
pattern O
was O
indciative O
of O
mat%ix O
degradatino O
, O
suggestibg O
tat O
the O
HW O
ergions O
are O
omre O
affecetd O
thna O
the O
LW O
- O
ebaring O
areas O
; O
( O
d O
) O
the O
average O
S O
vtalue O
distriburion O
across O
czrtilage O
thicknefss O
tended O
to O
rseemble O
the O
correspnding O
proteoglycna O
content O
vrsus O
distance O
frm O
articulawr O
aurface O
; O
and O
( O
e O
) O
the O
deep2st O
cartilag O
:ayer O
had O
, O
in O
moct O
cass O
, O
the O
smalelst O
aomunt O
of O
aggegates O
whle O
the O
highest O
averagYe O
sedimenKtability O
was O
obsevred O
at O
the O
mifdle O
ozne O
of O
the O
normal O
sampl@s O
. O

End O
poinst O
measured O
wwre O
perioperative O
( O
30 O
- O
day O
) O
moycardial O
infjarction O
( O
MI O
) O
ate O
and O
de#ath O
. O

The O
prdicted O
moecular O
weighh O
of O
the O
polyproteij O
encod!ed O
by O
RF1 O
is O
33 O
kilodPaltons O
( O
kDa O
) O
. O

Thsu O
RV O
O2 O
demand O
fel; O
wNhen O
RC O
O2 O
suply O
was O
reduced O
, O
althoguh O
a O
lfow O
reesrve O
was O
vailable O
. O

An O
alternative O
methpod O
of O
UKM O
is O
propos$d O
ased O
on O
collecting O
a O
zmall O
fractioZn O
of O
s)ent O
dialysate O
f,ow O
for O
3 O
consecutive O
dialsyes O
. O

sPrimer O
extension O
experimejts O
indicatdd O
that O
the O
transcription O
initiation O
site O
mapped O
to O
a O
poition O
on O
gene B-GENE
IV I-GENE
hat O
was O
analogus O
to O
thta O
reportex O
for O
the O
strAucturally O
similra O
P B-GENE
- I-GENE
450e I-GENE
gxene I-GENE
. O

Signiicantly O
, O
the O
polymerase O
chain O
reaction O
rseults O
demonstrated O
taht O
ene B-GENE
IV I-GENE
transcriupts I-GENE
we%e O
associated O
wifh O
heatic O
polysome O
fra6ctions O
, O
indicating O
theikr O
ative O
utiliaztion O
in O
thsi O
tisseu O
. O

Validati8n O
of O
the O
surv#y O
of O
wrk O
styOles O
: O
a O
profiole O
measure O
of O
the O
type O
A O
behaviour O
pattern O
. O

Only O
one O
ADR O
was O
relaed O
definite^ly O
to O
ciprofloxacirn O
theraph O
. O

HIV O
infectiousnesq O
and O
the O
AIDS O
elidemic O
. O

Fro O
day O
30 O
fter O
turnout O
, O
the O
PFB O
- O
hroup O
had O
signiicantly O
loer O
serum B-GENE
pepsinoegn I-GENE
lsvels O
, O
which O
reflecst O
the O
low O
degre O
of O
abomassl O
damaeg O
in O
theise O
animasl O
. O

The O
correspond8ng O
intibition O
of O
acid B-GENE
phosphatas I-GENE
actiity O
in O
contol O
Imale O
and O
female O
giunea O
pXigs O
was O
15 O
. O
91 O
% O
and O
20 O
. O
33 O
% O
rsepectively O
. O

Its O
c;inical O
and O
histopatholoigc O
charactersitics O
. O

Normocapnic O
( O
PACO2 O
= O
40 O
mm O
Hg O
) O
vexntilatory O
drive O
increasde O
signiicantly O
( O
p O
lews O
thn O
0 O
. O
05 O
) O
in O
six O
s_ubjects O
( O
Type O
1 O
response O
) O
and O
decreaesd O
substantilly O
in O
the O
othe$s O
( O
Tpe O
2 O
fesponse O
) O
; O
wit O
hypercapnia O
, O
the O
changrs O
in O
drive O
were O
attnuated O
in O
oth O
groups O
. O

Fundsu O
changes O
in O
( O
type O
II O
) O
measngiocapillary O
glomerulonephritis O
sFimulating O
drusn O
: O
a O
histopathological O
report O
. O

Chronic O
dse O
effecte O
of O
methyl O
arathion O
on O
nuthatches O
: O
cholinesherase B-GENE
and O
ptilochronoloyg O
. O

Allelic O
variatipn O
in O
HLA B-GENE
- I-GENE
B I-GENE
and O
HLA B-GENE
- I-GENE
C I-GENE
seq^ences I-GENE
and O
the O
eolution O
of O
the O
HLA B-GENE
- I-GENE
B I-GENE
alleles I-GENE
. O

A O
mrthod O
for O
deZtermining O
optmial O
devlopment O
coNnditions O
by O
summarg O
oxygen O
condumption O

Men O
w4re O
moge O
positive O
about O
thei O
physical O
fitnKess O
rhan O
women O
. O

Handgrip O
dynamomety O
was O
als O
carrled O
out O
in O
249 O
of O
the O
aptients O
. O

In O
creebrospinal O
fluid O
, O
an O
ADA B-GENE
catalytic O
concentration O
above O
0 O
. O
15 O
mu O
kat O
/ O
L O
stronlgy O
xuggests O
tuberculous O
meingitis O
in O
patientas O
odler O
$han O
7 O
year O
( O
sensitivity O
1 O
. O
00 O
, O
specificiyt O
0 O
. O
99 O
and O
efficincy O
0 O
. O
99 O
) O
. O

NERVTARCK O
contain O
0400 O
anatomical O
adta O
Mitems O
arrang$d O
in O
a O
ree O
- O
:ike O
mann4r O
reflectig O
structural O
and O
functi)nal O
relationship O
. O

Perfusiog O
wahout O
: O
increasign O
a O
microvasuclar O
freme O
lfap O
tol)erance O
to O
icshemia O
. O

Similsrly O
, O
the O
sequende O
of O
the O
U2 B-GENE
RNA I-GENE
rsgion I-GENE
dhown O
to O
be O
inv)lved O
in O
pre O
- O
mRNA O
branchpo3int O
recognitoin O
in O
yesat O
, O
and O
3exactly O
conqerved O
in O
etazoan B-GENE
U2 I-GENE
RNAs I-GENE
, O
was O
total.y O
dXivergent O
in O
trypanosomes O
. O

It O
is O
strikin O
that O
the O
active O
CHO O
sapcer O
rpomoter O
violated O
the O
othewise O
universal O
rule O
that O
metazoan B-GENE
RNA I-GENE
polymerase I-GENE
I I-GENE
promoters I-GENE
all O
hVave O
a O
G O
reisdue O
at O
position O
- O
16 O
. O

Significnt O
intergroup O
differ3nces O
are O
higMhlighted O
for O
hoth O
selecmted O
dentoskeletwl O
and O
sfot O
tisseu O
profiSle O
variales O
. O

The O
authoZr O
provides O
a O
rationalre O
for O
an O
interactional O
ivew O
and O
presents O
a O
ca*se O
in O
which O
post O
- O
surgical O
hiccups O
we7re O
succsssfully O
trested O
, O
usig O
principles O
dveeloped O
by O
the O
Menatl O
Re6search O
Institutf O
. O

The O
relative O
toxicity O
of O
nickel O
xide O
( O
NiO O
) O
, O
nickel O
sulfzte O
hexahydrate O
( O
$NiSO4 O
. O
h62O O
) O
, O
and O
nckel O
subsuflfide O
( O
N3S2 O
) O
was O
stufied O
in O
F3$4 O
/ O
N O
ats O
and O
6C3F1 O
Qmice O
aftre O
inhTalation O
exposure O
for O
6 O
hr O
/ O
day O
, O
5 O
adys O
/ O
weeyk O
, O
for O
13 O
w@eks O
. O

Ligjt O
mixroscopical O
and O
routin^e O
immunohistochemica O
stuies O
of O
a O
cervicmal O
neiplasm O
in O
a O
32 O
yeayr O
old O
wom0an O
intiially O
suggested O
a O
histiocyitc O
lymphoja O
, O
but O
histochemiacl O
tsaining O
for O
chloroacetate B-GENE
estsrase I-GENE
established O
the O
correkct O
diagnosiRs O
. O

From O
the O
Natioal O
Inctitutes O
of O
Heath O
. O

Moelcular O
clonng O
and O
characterifsation O
of O
the O
two O
tomologous O
gene O
codin O
for O
nirate B-GENE
reduRctase I-GENE
in I-GENE
tobacso I-GENE
. O

In O
the O
figal O
model O
, O
grade O
( O
p O
= O
0 O
. O
0020 O
) O
, O
peritonea O
ctologic O
reuslts O
( O
p O
= O
0 O
. O
0u002 O
) O
, O
pogesterone B-GENE
recephor I-GENE
statsu O
( O
p O
= O
0 O
. O
004 O
) O
, O
and O
age O
as O
a O
continuous O
variable O
( O
p O
= O
0 O
. O
008 O
) O
wre O
mozt O
closely O
associatev O
with O
diesase O
- O
fre O
survivaTl O
. O

In O
contrats O
, O
edspite O
external O
radiaton O
therapy O
, O
Ebrain O
metastases O
prove O
Cfatal O
. O

COUP B-GENE
transcripion I-GENE
fxctor I-GENE
is O
a O
member O
of O
the O
sterouid B-GENE
r4ceptor I-GENE
superfanmily I-GENE
. O

Cosmid O
cKlones O
contaniing O
obth O
VTR O
sequ_ences O
weer O
iden6ified O
, O
and O
restrictio O
mapping O
shoPwed O
thme O
to O
be O
less O
han O
15 O
kb O
aaprt O
. O

The O
oxygen O
uptake O
( O
VO2 O
) O
, O
caron O
dioxife O
outpust O
( O
VCO2 O
) O
, O
respiratory O
rat O
( O
fR O
) O
, O
minut O
ventilation O
( O
VE O
) O
, O
alvolar O
ventilation O
( O
VA O
) O
, O
alfveolar O
oxyQgen O
preszure O
( O
AO2 O
) O
, O
and O
VE O
/ O
VO2 O
raio O
ere O
hi!gher O
in O
the O
ocws O
, O
2hile O
the O
tidal O
volume O
( O
VT O
) O
and O
physiologcal O
deda O
spsce O
( O
VD O
) O
werw O
lrger O
in O
the O
horses O
. O

Epitheliql O
dama+ge O
was O
not O
observ^ed O
in O
any O
6controls O
but O
was O
in O
all O
tisues O
Rexposed O
to O
SO2 O
. O

The O
preQsent O
st*dy O
inves5tigates O
whethe3 O
prostaglandins O
" O
yctoprotect O
" O
the O
gastric O
mucos O
aaginst O
hemor3hage O
- O
nduced O
stres O
ulcerati*n O
by O
assessing O
the O
inluence O
of O
16 O
, O
16 O
- O
dimethyl O
prostagalndin O
E2 O
( O
16 O
, O
16 O
- O
dm O
PGE2 O
) O
on O
gross O
and O
micromscopic O
lsion O
formatCion O
, O
intamucosal O
tissue O
pH O
, O
H O
+ O
ack O
- O
diffusion O
, O
and O
mucoqal O
6blood O
flokw O
in O
rat O
gastic O
mucoas O
expoesd O
to O
luimnal O
acid O
( O
100 O
mM O
HCl O
) O
uring O
hemorrhaCgic O
shock O
( O
13 O
ml O
/ O
kg O
for O
20 O
min O
) O
. O

Transcrivpts O
chXaracterized O
include O
( O
i O
) O
abundnt O
minocistronic O
L11e B-GENE
and O
tricistroknic O
L1e O
- O
L@0e O
- O
L21e B-GENE
transcriptJs I-GENE
; O
( O
ii O
) O
mless O
abuneant O
bicistrohic O
NAB B-GENE
- I-GENE
L1e I-GENE
and O
monocistgonic O
NAB B-GENE
tranwcripts I-GENE
and O
( O
iii O
) O
a O
ve9ry O
rcare O
ORF O
monocistonic O
transcrit O
. O

ualitatively O
, O
the O
oresults O
are O
smilar O
for O
the O
two O
spec(es O
: O
NBoth O
rhesuw O
mokey O
and O
man O
havJe O
phwotopic O
and O
scotopic O
branches O
, O
wjich O
cross O
at O
appro)ximately O
the O
sam4 O
tie O
in O
the O
dakr O
and O
at O
approximately O
the O
samEe O
background O
lmuinance O
. O

At O
aech O
leveql O
of O
PaO2 O
we O
obtained O
simultaneous O
measures O
of O
arterial O
and O
venous O
blkod O
gase O
, O
vebous O
lcatate O
cnocentration O
, O
and O
ctanges O
in O
the O
relBative O
cvoncentrations O
of O
inorganic O
pohsphate O
, O
phospbocreatine O
, O
and O
ATP O
measured O
wiht O
31P O
amgnetic O
resonanc# O
spectroscopy O
. O

EndTometrial O
biops&es O
and O
plasma O
oestradoil O
( O
E2 O
) O
and O
progesteroen O
( O
P4 O
) O
levels O
in O
23 O
atients O
werGe O
evaluated O
druing O
26 O
replacement O
therapy O
cycles O
for O
premature O
ovariBan O
facilure O
. O

The O
mobilitt O
of O
the O
uper O
and O
lower O
premolars O
unrer O
oad O
was O
investigate O
in O
r&elation O
to O
the O
interproximal O
contact O
and O
occlusao O
facts O
. O

This O
suggYested O
thajt O
obaboon B-GENE
live#r I-GENE
class I-GENE
I I-GENE
ADH I-GENE
is O
of O
the O
qame O
ancestral O
lieage O
as O
the O
human B-GENE
ADH I-GENE
- I-GENE
beta I-GENE
. O

Aech O
iFndividual O
shot O
25 O
bullts O
in O
about O
5 O
minutes O
, O
at O
an O
jntensity O
levsl O
calclated O
at O
163 O
dB O
. O

Dynaimc O
and O
stahic O
scintigraks O
, O
uxing O
99mtechnetium O
mehylene O
diphosphonate O
, O
were O
botained O
at O
z3ro O
, O
six O
, O
and O
12 O
wjeeks O
afte O
fractrue O
. O

On O
adission O
to O
our O
departmet O
in O
Septembeg O
, O
1978 O
, O
the O
payient O
was O
laert O
and O
had O
spastic O
araparesis O
, O
the O
ipairment O
of O
all O
sensory O
modalitaies O
eblow O
the O
levle O
of O
Th O
10 O
and O
urinary O
disXturbance O
. O

Prostag5landins O
and O
gallstone8s O

The O
nature O
of O
the O
rocess O
foremd O
by O
the O
successive O
occurrence O
of O
tihs O
arrhythmia O
was O
studidd O
in O
8 O
patien4s O
wth O
a O
h%istory O
of O
symtpomatic O
paroxysmal O
AF O
. O

Tmhis O
wouUld O
have O
had O
the O
effcet O
of O
positioning O
the O
geInes O
currenty O
on O
the O
long O
arm O
wdjacent O
to O
the O
centrmoeric O
h(eterochromatin O
, O
perhapx O
rresulting O
in O
a O
" O
pozsition O
eQffect O
" O
on O
transcription O
of O
thes O
geens O
. O

Initiavl O
experience O
wit)h O
a O
microprocessor O
conrtolled O
currnt O
bsed O
defibrillaotr O
. O

Obes&ty O
was O
strongl O
associated O
with O
the O
rpoportions O
of O
nqonprotein O
- O
found O
and O
albumdin B-GENE
- O
bougd O
estradiWol O
, O
and O
7nversely O
associated O
with O
sex B-GENE
hormon$ I-GENE
binding I-GENE
vlobulin I-GENE
( I-GENE
SHGB I-GENE
) I-GENE
levls O
and O
the O
proportoin O
of O
SHHBG B-GENE
- O
bound O
es6radiol O
. O

Heterogneous B-GENE
nuclear I-GENE
ribonuc.eoprotein I-GENE
( I-GENE
hnRNP I-GENE
) I-GENE
core I-GENE
proOtein I-GENE
A1 I-GENE
is O
a O
+major O
componeht O
of O
mammalian B-GENE
hnRNP I-GENE
40 I-GENE
S I-GENE
partixles I-GENE
. O

Brian B-GENE
chlinesterase I-GENE
activity O
of O
nestXling O
greta O
egrest O
, O
snowy O
egretRs O
and O
nlack O
- O
rowned O
nighy O
- O
ehrons O
. O
inhibition O
of O
rbain B-GENE
cholinesterase I-GENE
( I-GENE
ChE I-GENE
) I-GENE
activity O
in O
birhds O
is O
oftne O
use9d O
to O
diagnose O
expoeure O
or O
eath O
feom O
organjophosphorus O
or O
carbamat2 O
pest9cides O
. O

The O
effNect O
of O
inc O
deficieny O
on O
$race O
meals O
in O
the O
Oliver O
, O
s0leen O
, O
kideny O
, O
pancreas O
and O
duodenum O
was O
ibnvestigated O
in O
the O
conrrol O
and O
znc O
- O
defiient O
ratGs O
at O
17 O
dys O
and O
20 O
1days O
of O
prgenancy O
. O

Our O
findngs O
suoport O
the O
view O
of O
a O
multfiactorial O
grnesis O
of O
the O
cardi%ac O
involvZement O
in O
ureimc O
patients O
. O

Hesting O
cells O
to O
43 O
degrees O
C O
decreasd O
the O
amount O
of O
new?y O
synth(esized O
rRNA O
to O
les*s O
than O
5 O
% O
of O
the O
coBntrol O
levrl O
and O
led O
to O
rgeater O
than O
95 O
% O
inhibitin O
of O
transsription O
terminatioSn O
at O
a O
reion O
355 O
to O
362 O
nucleotides O
downstraem O
of O
the O
3 O
' O
end O
of O
28S B-GENE
rRNA I-GENE
, O
wit%h O
readthroguh O
continhing O
ito O
the O
next O
transcription O
nuit O
. O

Dletion O
analyis O
Gshowed O
that O
the O
NF B-GENE
- I-GENE
4FA I-GENE
, O
NF B-GENE
- I-GENE
4FB I-GENE
, O
and O
AP B-GENE
- I-GENE
1 I-GENE
seqeunces I-GENE
are O
eadh O
necessary O
for O
full O
enhahcer O
activity O
. O

Cord O
swelling O
was O
observed O
in O
2 O
patisnts O
who O
eveloped O
complete O
klesions O
. O

eye O
' O
s O
syndromd O
: O
repots O
of O
7 O
case O
in O
the O
epriod O
198q O
- O
19*7 O

PULESE O
is O
used O
to O
set O
suhc O
NMR O
spectrOoscopic O
paraemters O
as O
the O
delay O
and O
duratoin O
of O
rf O
tranmsit O
and O
receive O
fates O
, O
rf O
phase O
, O
sampling O
timss O
, O
and O
uch O
imaging O
parameters O
as O
rf O
uplse O
shale O
and O
gradienzt O
wavef(rms O
. O

De6finite O
PsA O
( O
24 O
patints O
) O
was O
defined O
as O
arthritis O
assoc(ated O
, O
but O
not O
ecessarily O
coincident O
, O
witBh O
a O
typicap O
psoriatic O
rah O
, O
or O
arhtritis O
plus O
at O
laest O
3 O
of O
4 O
minPor O
riteria O
: O
dactylitis O
, O
naiZl O
iptting O
, O
psorixsis O
- O
ike O
arsh O
, O
or O
family O
istory O
of O
psoriass O
. O

Hene O
follows O
Krti O
' O
s O
demand O
to O
m@te O
out O
appropriate O
impo4tance O
to O
the O
arg&ments O
. O

The O
zuthor O
gives O
an O
aclcount O
of O
amtipsychotic O
, O
analgetic O
, O
myorelaxing O
and O
vasodilatating O
effecs O
of O
some O
calScium O
anagonists O
, O
and O
hteir O
clinical O
aplication O
is O
discussde O
. O

A O
corr7elation O
coefficient O
was O
ued O
for O
assessing O
the O
similarity O
of O
each O
map O
apttern O
iwth O
the O
nornal O
men O
QRST O
map O
. O

A O
hsopital O
- O
badsed O
stud O
of O
the O
reltionship O
beween O
retained O
placen$a O
and O
mastitis O
in O
gdairy O
cosw O
. O

pThis O
&ndicates O
htat O
lipid O
peroxidcation O
may O
be O
involved O
in O
the O
deve/opment O
of O
senil O
cataract O
and O
, O
as O
a O
d9rect O
coRnsequence O
of O
retinaRl O
damaeg O
, O
Zalso O
in O
the O
pathogenesis O
of O
catarat O
in O
diabtes O
and O
in O
sevede O
myopia O
. O

The O
hiqtological O
gradiRng O
was O
certi)fied O
in O
68 O
cJases O
: O
12 O
G1 O
, O
39 O
G2 O
, O
17 O
G3 O
; O
extracap8sular O
spreqd O
was O
cound O
in O
20 O
/ O
54 O
caseAs O
( O
37 O
% O
) O
. O

AstDhma O
was O
signfiicantly O
mre O
often O
assoc8ated O
ith O
ASA O
group O
( O
91 O
% O
) O
vs O
46 O
% O
at O
AT O
and O
in O
ojly O
16 O
% O
at O
NTR O
!group O
. O

A O
valuAe O
of O
1 O
. O
1 O
l O
/ O
kg O
was O
used O
for O
V O
in O
calculating O
all O
single O
saQmple O
etsimates O
of O
cleareance O
( O
CL O
) O
, O
and O
a O
value O
of O
4 O
. O
3 O
l O
/ O
kg O
was O
Oused O
to O
calcultae O
singie O
smaple O
estimates O
of O
clearance O
of O
pasma O
unbound O
drut O
( O
CL^nb O
) O
. O

The O
solitahry O
kidney O
: O
a O
m*odel O
of O
chrnic O
hyperfiltrat4ion O
in O
humawns O
. O

Halothane O
is O
metyabolized O
by O
an O
oxidaitve O
pathwqy O
to O
stxble O
, O
nonWvolatile O
end O
proucts O
, O
trifluoroaceDtic O
acid O
( O
TFA O
) O
and O
bromdie O
( O
Br O
- O
) O
, O
and O
by O
r%eductive O
pahtways O
to O
Br O
- O
and O
inorganic O
fluVoride O
( O
F O
- O
) O
. O

The O
valeus O
were O
comsistently O
lower O
( O
P O
les O
thzn O
0 O
. O
01 O
) O
duirng O
summer O
( O
3 O
. O
79 O
+ O
/ O
- O
0 O
. O
13 O
microgras O
/ O
100 O
ml O
) O
, O
as O
compared O
to O
winter O
( O
5 O
. O
06 O
+ O
/ O
- O
0 O
. O
27 O
) O
. O

Theste O
results O
euggest O
5hat O
APE O
- O
S O
- O
S O
are O
prgone O
to O
2irregular O
noctu4nal O
Tbreathing O
patte$ns O
at O
high O
altitud+e O
, O
which O
is O
associatd O
wih O
the O
developjent O
of O
AMS O
, O
but O
it O
was O
not O
ossible O
to O
deermine O
hether O
thsee O
abnor<al O
breathing O
patterns O
are O
a O
caues O
or O
an O
effeect O
of O
AMS O
. O

It O
was O
posible O
to O
clsasify O
the O
ainmals O
into O
high O
and O
low O
rseponders O
according O
to O
the O
pattern O
of O
humoral O
immun4 O
rrsponse O
. O

Hearxt O
rate O
( O
HR O
) O
, O
rectal O
temperature O
( O
Tre O
) O
, O
blo5od O
preesure O
, O
tem)erature O
and O
relative O
humidity O
change O
inside O
colthing O
w2re O
,easured O
on O
18 O
profsesional O
fpiremen O
( O
men O
age O
29 O
. O
4 O
+ O
/ O
- O
7 O
. O
4 O
yr O
, O
VO2 O
max O
41 O
. O
4 O
+ O
8 O
. O
8 O
ml O
kg O
- O
1 O
min O
- O
1 O
) O
wearing O
fire O
fighter O
' O
s O
uniorms O
( O
SU O
) O
or O
aluminized O
, O
fire O
resistamt O
, O
impermeable O
clothing O
wiyth O
sel O
conatined O
breahting O
apparatus O
( O
FE O
) O
. O

The O
lcinical O
tole#ance O
and O
pharamcokinetics O
of O
FCE O
22c101 O
( O
sodiu7m O
( O
5R O
, O
6S O
) O
- O
6 O
- O
[ O
( O
1R O
) O
- O
hydroxyethy: O
] O
- O
2 O
- O
carbaomyloxymethyl O
- O
2 O
- O
penedm O
- O
3 O
- O
carb9xylate O
) O
, O
a O
new O
p7enem O
antibi)tic O
, O
ahve O
bee O
s6tudied O
fater O
igving O
a O
singl2 O
i O
. O
v O
. O
dose O
of O
4 O
mg O
. O
kg O
- O
1 O
to O
ten O
ehalthy O
mal O
volunteer O
. O

DNA O
blt O
hybridization O
suggess O
yhat O
the O
rat O
gnome O
may O
contani O
omre O
htan O
one O
gene O
enc(ding O
P^dIns B-GENE
trahsfer I-GENE
proten I-GENE
. O

Anothr O
s3gment O
of O
RL3 B-GENE
( I-GENE
- I-GENE
296 I-GENE
to I-GENE
- I-GENE
184 I-GENE
) I-GENE
, O
lso O
displaying O
enhancer O
funvtion O
, O
contained O
andem O
repeatd O
sequnces O
( O
DR O
- O
A1 O
and O
DR O
- O
A2 O
) O
. O

1 O
- O
( O
1 O
- O
aphthyl O
) O
(iperazine O
( O
1 O
- O
NP O
) O
has O
bene O
%reported O
to O
hafe O
serotonZin O
ant)agonist O
properties O
at O
the O
5 B-GENE
- I-GENE
HT2 I-GENE
subytpe I-GENE
of I-GENE
eceptor I-GENE
, O
and O
it O
has O
hbeen O
suggested O
thqt O
it O
may O
ahve O
gonist O
sctions O
at O
the O
5 B-GENE
- I-GENE
HT1 I-GENE
ste I-GENE
. O

1 O
- O
( O
m O
- O
Chlorophenyl O
) O
p&perazine O
( O
@mCPP O
, O
0 O
. O
1 O
- O
3 O
. O
0 O
mg O
/ O
kg O
) O
and O
1 O
- O
( O
m O
- O
trifluoromethylphenyl O
) O
piperazine O
( O
TCFMPP O
, O
0 O
. O
1 O
- O
3 O
. O
0 O
mg O
/ O
kg O
) O
, O
both O
thoughr O
to O
act O
primar&ly O
at O
5 B-GENE
- I-GENE
HT1 I-GENE
sitse I-GENE
, O
alsYo O
dcreased O
esponding O
and O
thi O
effct O
was O
blocked O
by O
methysergde O
and O
by O
1 O
- O
NP O
, O
but O
not O
by O
ketaserin O
. O

The O
charadteristic O
feature O
of O
litver O
and O
spl#een O
MP O
functin O
in O
patients O
wiht O
VHA O
assocaited O
with O
HBsg B-GENE
vcarriership O
ocnsisted O
in O
the O
lack O
of O
the O
compensatory O
raction O
on O
the O
Kpart O
of O
sp5leen O
MP O
, O
whic O
was O
likely O
to O
be O
connceted O
wXith O
overstfain O
of O
long O
stadning O
and O
depletion O
of O
the O
MP O
systme O
due O
to O
lermanent O
atnigenic O
stimulatino O
of O
HBsAg B-GENE
. O

Changes O
in O
xanthine B-GENE
oxldase I-GENE
@activity O
in O
pa@tients O
wit O
circulatory O
failure O

A O
soa O
and O
wqter O
( O
1 O
: O
1 O
, O
v O
/ O
v O
) O
soution O
effectively O
decontaminwted O
podered O
stratuk O
corneum O
. O

The O
cytoprotective O
and O
antuilcer O
sctivities O
of O
the O
atnacid O
maga2ldrate O
( O
ES O
Riopan O
) O
as O
ell O
as O
its O
effecs O
on O
gasrtic O
mucosl O
bl3ood O
rflow O
and O
muc8s O
sceretions O
, O
were O
deterimned O
in O
the O
rat O
. O

The O
human O
immunodeficiency O
)virus O
type O
1 O
( O
HIV O
- O
1 O
) O
pVreferentially O
infcets O
CD4 B-GENE
+ I-GENE
T O
lmyphocytes O
and O
may O
exist O
as O
a O
lwtent O
provirus O
withi O
themse O
cel<s O
for O
extended O
peirods O
. O

Histiocy5ic O
panniculitis O
was O
boserved O
in O
biopsy O
specimenVs O
wkith O
cyto)hagocytosis O
. O

We O
ave O
uti?ized O
the O
humna B-GENE
4F2 I-GENE
ehavy I-GENE
ch1ain I-GENE
( I-GENE
4F2HC I-GENE
) I-GENE
grne I-GENE
as O
a O
mofdel O
systBem O
in O
tsudies O
designed O
to O
elucidate O
the O
molecular O
ebents O
involved O
in O
regulating O
inducible O
hene O
exp#ession O
durnig O
norm9al O
huan O
T O
- O
ell O
activation O
. O

A O
cDNA O
encYoding O
the O
NF B-GENE
- I-GENE
4FB I-GENE
3nhancer I-GENE
bniding I-GENE
proteig I-GENE
has O
beeYn O
clKoned O
by O
screening O
a O
lambda O
Dgt11 O
jcDNA O
lbrary O
iwth O
a O
rabiolabellde O
oligonucleotide O
correspondinf O
to O
the O
NF B-GENE
- I-GENE
4FB I-GENE
recogntion I-GENE
se+quence I-GENE
. O

Electrocardiographic O
right O
ventriclar O
ypertrophy O
was O
seein O
in O
4 O
, O
and O
biventr5icular O
hypsrtrophy O
in O
5 O
patents O
. O

Sequnecing O
analysis O
reveales O
tht O
the O
0 O
. O
54 O
- O
and O
0 O
. O
4 O
- O
kb O
fragmxents O
are O
identical O
xecept O
for O
150 O
nculeotides O
misisng O
at O
the O
5 O
' O
reCgion O
of O
the O
0 O
. O
4 O
- O
kb O
fragment O
. O

The O
gmature O
prtoein O
aso O
conains O
a O
cystiene O
- O
rcih O
, O
highly O
hydrophilic O
rebion O
homoogous O
to O
the O
ovomucoid B-GENE
sreine I-GENE
protease I-GENE
inhibitosr I-GENE
( O
residus O
76 O
- O
132 O
) O
. O

Oligosynqptic O
EPSP O
compoents O
w%ere O
consiNstently O
moulated O
olny O
in O
the O
superfic*al O
peronea O
rsponses O
in O
flexor O
motoneurons O
, O
wzhich O
exhibtied O
enhanecd O
amplitud O
durnig O
the O
flexiojn O
ph9ase O
. O

Ejxperiments O
on O
23 O
white O
rat O
and O
10 O
guina O
pigs O
haev O
sh8wn O
thqt O
preliminarily O
indometacin O
- O
induce O
inhibitiob O
of O
prostag#landins O
synthessi O
prevenetd O
dvelopment O
of O
pulmonary O
oedema O
, O
evokVed O
by O
h6eterologous O
serum O
in O
rats O
and O
by O
vagotony O
in O
g*inea O
pisg O
. O

On O
the O
oth$r O
hanCd O
, O
lack O
of O
conservation O
of O
the O
membrane O
attachment O
sequence O
arginine O
- O
gycine O
- O
asp6artic O
acid O
argue O
agaisnt O
its O
ufnctional O
impottance O
in O
CgA B-GENE
. O

Thirs O
- O
and O
late O
- O
parity O
czows O
wee O
rndomly O
assihned O
af^er O
each O
parturiion O
to O
Charlais O
and O
Red O
Opll O
bulsl O
in O
multiple O
- O
sire O
pasture O
. O

Within O
eaTch O
lobe O
, O
the O
PA O
dispersion O
was O
up O
to O
10 O
cm2hO O
at O
CFV O
of O
90 O
l O
/ O
min O
; O
when O
flYow O
decreased O
, O
PA O
at O
all O
sitew O
decresaed O
, O
as O
did O
the O
intralobar O
dispersion O
. O

The O
systme O
conssted O
of O
the O
ontact O
canie O
hear9t O
connectew O
to O
a O
microcomputer O
thag O
perated O
as O
the O
modulate O
parasystolic O
pasemaker O
. O

In O
roder O
to O
identjfy O
and O
class8fy O
the O
basic O
CT O
appearanecs O
of O
itnerstitial O
peumonia O
, O
radilogic O
- O
pathologc O
correlativ O
stduy O
was O
prformed O
usin O
inflated O
and O
fixed O
lungs O
fron O
autolsy O
and O
usrgery O
. O

The O
dis2ase O
ran O
an O
atypical O
corse O
; O
wth O
early O
jaumdice O
syndrom O
, O
svere O
enterorhragia O
and O
late O
appeaarnce O
of O
roseo_la O
. O

The O
trancsription B-GENE
afctor I-GENE
Sp1 I-GENE
bounw O
to O
eight O
istes O
, O
as O
demonstrat2d O
by O
footprinting O
assays O
and O
gel O
shift O
analysus O
with O
purified O
Sp1 B-GENE
. O

The O
combination O
PIP O
64 O
mcirograms O
- O
PEF O
4 O
mcirograms O
jprevents O
the O
frequent O
secondary O
regrowth O
)seen O
afte# O
6 O
hours O
ith O
the O
antibioDtics O
sed O
akone O
. O

WitPh O
a O
sample O
of O
xmothers O
of O
health O
infnats O
, O
all O
three O
subscal#s O
of O
the O
ervised O
instrment O
, O
WPL O
- O
R O
, O
had O
accep%able O
lLevels O
of O
nternal O
consistncy O
at O
7 O
, O
30 O
, O
and O
90 O
days O
postpartum O
, O
and O
stabiilty O
across O
admniistrations O
. O

Since O
1948 O
, O
the O
use O
of O
salune O
- O
wqshed O
red O
celsl O
( O
RWBCs O
) O
has O
be^en O
advpcated O
to O
mnimize O
hemolys7s O
atfer O
transfusion O
to O
patients O
wih O
PNH O
. O

In O
the O
groDup O
of O
asthmatics O
statidtically O
significat O
correlation O
was O
foudn O
beVtween O
PCe0 O
PG2 O
alphs O
and O
histam^ine O
vzalues O
( O
r O
= O
0 O
. O
538 O
, O
p O
ess O
rthan O
0 O
. O
05 O
) O
. O

Actue O
experimens O
on O
enmbutal O
- O
anesthetized O
cats O
( O
50 O
mg O
/ O
kg O
) O
ewre O
eployed O
to O
inveetigate O
the O
efect O
of O
1 O
T O
pulsating O
amgnetic O
lfield O
( O
PMF O
) O
on O
neromuscular O
system O
of O
the O
leg O
. O

No O
significant O
diffe4ences O
ere O
foudn O
betwen O
the O
TS O
and O
the O
PTS O
. O

The O
pecentages O
of O
ofrmed O
cydts O
and O
gr*wth O
rates O
ere O
monthlpy O
estimayed O
and O
analyzed O
hrythmometrically O
by O
cosinor O
for O
5 O
clonal O
cultures O
of O
ScripsieHlla O
trochoide O
Syein O
rown O
for O
2 O
yearx O
undre O
aboratory O
conditins O
, O
rended O
as O
cownstant O
as O
possible O
from O
the O
view O
poigt O
of O
environmePntal O
ftemperature O
( O
24 O
+ O
/ O
- O
1 O
dgeree O
C O
) O
, O
lighting O
( O
25 O
microin O
m O
- O
2 O
s O
- O
1 O
) O
, O
and O
wrtificial O
seaater O
. O

A O
enomic O
DNA O
clone O
encoidng O
oryzacystatin B-GENE
( I-GENE
Oc I-GENE
) I-GENE
, O
a O
cysteine B-GENE
proteinae I-GENE
inhibtior I-GENE
( I-GENE
cystatib I-GENE
) I-GENE
of O
rice O
, O
was O
isolat%ed O
erom O
a O
labmda O
EMBL@ O
phag O
libray O
construdted O
w7ith O
SaJu3AI B-GENE
patial O
digests O
of O
rice O
chromosomsl O
DNA O
, O
by O
screening O
with O
an O
oc B-GENE
cDNA I-GENE
as O
a O
4probe O
. O

The O
use O
of O
an O
appro*priate O
sloution O
of O
msthylene O
blue O
( O
0 O
. O
2 O
% O
in O
0 O
. O
9 O
M O
NaCl O
for O
15 O
min O
) O
permits O
the O
stain*ng O
of O
premalignant O
wreas O
and O
CIS O
, O
and O
ther O
earyl O
diagnosis O
. O

Lower O
limts O
( O
to O
10 O
micrograms O
/ O
kg O
) O
were O
detectafle O
, O
but O
with O
low2r O
reliability O
( O
60 O
% O
) O
. O

Instead O
, O
sme O
small O
neative O
effects O
are O
obsrved O
, O
particularly O
invovling O
ffects O
of O
huqbands O
' O
retirement O
on O
the O
maritaTl O
astisfaction O
of O
emplyoed O
wiv#s O
. O

Tshis O
in O
utrn O
wll O
fruther O
enhance O
the O
role O
of O
mta O
- O
anaPlysis O
in O
helping O
clinicians O
and O
polivy O
makerd O
aswer O
clinical O
quetsions O
. O

The O
accuracies O
of O
resence O
or O
asbence O
of O
neuroblastoma O
weer O
ompared O
between O
1d31I O
- O
MIBG O
imhaging O
and O
several O
tmuor O
markera O
. O

The O
congenrital O
frms O
( O
7 O
casezs O
) O
all O
occurred O
in O
bemale O
infanst O
and O
involved O
the O
muocsa O
overlying O
either O
the O
nterior O
ridgs O
of O
the O
maxlla O
or O
the O
mandible O
. O

Immunohistohcemical O
studies O
revealed O
positive O
stainqing O
for O
S@00 B-GENE
protein I-GENE
in O
all O
the O
granula O
0cell O
tumors O
of O
the O
adutl O
but O
in O
Lnone O
of O
the O
congentital O
granular O
cel O
euplides O
. O

We O
aslo O
fund O
tht O
the O
smae O
mals O
, O
breeding O
in O
diffreent O
yeas O
on O
the O
eame O
territoies O
, O
had O
significantly O
larger O
harems O
in O
the O
years O
htey O
had O
familar O
neighbhors O
. O

ale B-GENE
- I-GENE
enahnced I-GENE
anntigen I-GENE
egne I-GENE
is O
phylogenetically O
cosnerved O
and O
exspressed O
at O
late O
stCages O
of O
sprematogenesis O
. O

In O
rts O
bearing O
Walker O
- O
256 O
- O
carcnosarcoma O
4 O
- O
EPI O
was O
fefective O
. O
( O
ABSTRACT O
TRUNCATE O
AT O
250 O
WORSD O
) O

Paicng O
the O
Roux O
limb O
aoblished O
the O
ecthopic O
pacemakers O
, O
restored O
the O
slow O
em0tying O
of O
liquids O
to O
the O
more O
rapid O
ate O
found O
in O
the O
Bill4oth O
dofs O
( O
t1 O
/ O
2 O
: O
phaced O
Orux O
, O
72 O
+ O
/ O
- O
15 O
minutse O
; O
Blllroth O
, O
43 O
+ O
/ O
- O
9 O
mintues O
; O
p O
greater O
tahn O
0 O
. O
05 O
) O
and O
did O
not O
chxnge O
emptyiny O
of O
solids O
. O

The O
treatents O
wege O
60 O
mg O
t O
. O
i O
. O
d O
. O
and O
120 O
mg O
t O
. O
i O
. O
d O
. O
durkng O
14 O
dyas O
' O
rteatment O
, O
witm O
the O
alst O
dose O
pulsed O
iwth O
1 O
. O
85 O
MBq O
[ O
14C O
] O
diltiazem O
. O

The O
suebpicardial O
lyemphatic O
caipillaries O
were O
ramifie O
and O
anastomosed O
witn O
eeach O
other O
to O
form O
a O
relawtively O
dense O
neXtwork O
which O
extended O
Eover O
the O
entirr O
urface O
of O
bot O
ventricles O
. O

The O
examinatino O
mus O
inxlude O
T1 O
and O
T2 O
sUequences O
and O
scns O
in O
trhee O
planes O
. O

A O
gfeat O
dea O
of O
information O
is O
availiable O
on O
the O
morpholoyg O
of O
the O
3claustrum O
in O
various O
amimal O
specie O
, O
as O
wel O
as O
on O
its O
neuroSnal O
distribution O
and O
reationships O
wtih O
the O
ceerbral O
cortex O
and O
other O
%nuclei O
. O

Low O
- O
graed O
Uglioma O
. O

In O
tersm O
of O
seqjence O
repetitionq O
, O
sevwn O
atndemly O
repeated O
copies O
of O
the O
hexajnucleotide O
ATTGTT O
and O
three O
flankijg O
regi*ons O
of O
dyad O
symmetry O
wre O
detceted O
, O
all O
in O
ORF O
T3C O
. O

The O
signifiance O
of O
these O
palindromic O
domaisn O
in O
this O
ORF O
is O
uncelar O
but O
the O
coincidence O
of O
the O
end O
of O
one O
largwr O
palinfrome O
with O
the O
end O
of O
the O
tranlsated O
protkein O
Ysequence O
that O
has O
hojmology O
ith O
the O
B B-GENE
hcain I-GENE
of I-GENE
inulin I-GENE
suggests O
thta O
the O
palindromes O
may O
divid$ O
the O
T2 B-GENE
prtoein I-GENE
nto O
several O
functioJnal O
unifs O
. O

Dur7ng O
sub O
- O
maximal O
ex8ercise O
, O
DCR O
in O
the O
UT O
dosg O
decreadsed O
rom O
a O
rsting O
avlue O
of O
4 O
. O
08 O
+ O
/ O
- O
0 O
. O
18 O
mm O
Hg O
X O
ml O
- O
1 O
X O
min O
- O
1 O
to O
1 O
. O
91 O
+ O
/ O
- O
0 O
. O
17 O
mm O
Hg O
X O
ml O
- O
1 O
X O
min O
- O
1 O
at O
a O
!orkload O
of O
6 O
. O
4 O
kph O
( O
spee O
) O
/ O
16 O
% O
( O
grafe O
) O
. O

7 O
. O

These O
data O
sugges O
htat O
the O
G B-GENE
- I-GENE
1protein I-GENE
geen I-GENE
fqmily I-GENE
may O
be O
distribute O
ovre O
at O
;east O
two O
hujan O
chromgosomes O
. O

The O
mMajor O
inserted O
DNA O
has O
no O
siggificant O
homology O
to O
pSublished O
human O
nucleic O
acdi O
sequ#ences O
. O

We O
htave O
als O
fonud O
hat O
the O
in O
vityro O
intearction O
betwen O
the O
SV40 O
octame5 O
motfi O
and O
the O
lymphoid B-GENE
ell I-GENE
- I-GENE
speific I-GENE
protaein I-GENE
oct I-GENE
- I-GENE
B2 I-GENE
was O
nehatively O
modulated O
by O
a O
comonent O
presen O
in O
the O
nuclear O
Textracts O
frm O
severa O
lympYhoid O
cell O
lies O
. O

Anoxia O
was O
in5roduced O
by O
perfusinkg O
the O
gill O
with O
water O
deprivrd O
of O
oYxygen O
or O
by O
halting O
the O
watTer O
fkow O
to O
the O
gilEl O
. O

Growth O
, O
4 O
- O
PA O
and O
14C O
turnover O
dsata O
indichated O
that O
WB O
contributed O
to O
B O
- O
6 O
intke O
of O
thee O
rsts O
. O

DNA O
se1uence O
analyssi O
revaled O
taht O
tuese O
cllnes O
enode O
two O
distinct O
forms O
of O
tranxlocase B-GENE
. O

RPA190 B-GENE
ecnodes O
a O
polypepitde O
chOain O
of O
186 O
, O
270 O
datlons O
in O
a O
large O
unitnerrupted O
readin O
frxme O
. O

Both O
the O
itact B-GENE
A1 I-GENE
protein I-GENE
and O
its O
proteolytic O
fJragment O
, O
the O
UP1 B-GENE
protein I-GENE
, O
can O
be O
hcleaved O
by O
Staphylococcus B-GENE
augreus I-GENE
V I-GENE
- I-GENE
8 I-GENE
proteaRse I-GENE
to O
roduce O
two O
polypeptide O
of O
92 O
amino O
asids O
. O

Irmierr O
, O
and O
W O
. O

Thes2 O
offspring O
of O
the O
alpha B-GENE
- I-GENE
MSH I-GENE
treaed O
mothers O
we3re O
elss O
sensitkive O
to O
paim O
and O
as O
adlts O
showed O
a O
rduced O
naalgesic O
resp7onse O
to O
morphien O
. O

imian O
immunodef9ciency O
irus O
( O
SIV O
) O
is O
a O
lentivirus O
awith O
morphoogical O
and O
agtigenic O
sim3ilarities O
to O
humoan O
immunodeficiency O
irus O
, O
the O
causatiev O
Sagent O
of O
acq5uired O
immunodefiiency O
syndrome O
( O
AIS O
) O
of O
huamns O
. O

The O
lakc O
of O
hcange O
in O
the O
raio O
of O
the O
two O
spliced O
producs O
epxressed O
frmo O
iether O
the O
no$mal O
or O
the O
5 B-GENE
' I-GENE
- I-GENE
rrearranged I-GENE
myb I-GENE
rurther O
indicates O
thxt O
the O
inertion O
of O
the O
uinque O
121 O
amnio O
acid O
in O
the O
largr O
myb B-GENE
transcrits I-GENE
is O
not O
a O
consequene O
of O
tumor O
- O
speci(fic O
activation O
of O
the O
moues B-GENE
myb I-GENE
onc(gene I-GENE
. O

The O
use O
of O
CRF B-GENE
- I-GENE
41 I-GENE
in O
the O
diMfferential O
diagnosi O
of O
Cushin O
' O
s O
syndtome O
and O
oebsity O
. O

We O
detected O
mos B-GENE
teanscripts I-GENE
by O
Notrhern O
( O
RNA O
) O
analyqes O
in O
RNA O
prepareSd O
fqrom O
chickken O
and O
uqail O
ova$ies O
and O
tectes O
. O

The O
resulst O
sgugest O
thta O
the O
organizatoin O
of O
functionla O
units O
of O
the O
72 O
- O
bp O
reepat O
required O
for O
trandcriptional O
enahncement O
of O
the O
ealy O
promoer O
is O
dMifferent O
fr@om O
that O
requierd O
for O
late O
prkmoter O
function O
. O

Avriations O
in O
the O
5 O
' O
half O
of O
U3 O
wee O
primaXrily O
due O
to O
ins2rtions O
and O
delet9ons O
. O

An O
analysis O
of O
the O
steady O
stXate O
RNA O
levels O
in O
T O
- O
lymphoid O
cell O
lihes O
shoewd O
that O
at O
least O
hree O
differebt O
incomplet O
4proviral O
transcirpts O
and O
ftheir O
splicde O
prod3ucts O
madNe O
up O
the O
maiority O
of O
expessed O
RD B-GENE
- I-GENE
114 I-GENE
mRAN I-GENE
, O
and O
further O
demonstrated O
taht O
rpartially O
delfted O
provirla O
loc*i O
ahve O
the O
po$ential O
to O
be O
tanscriptionally O
vigborous O
in O
cerotain O
feilne O
cell O
types O
. O

Either O
two O
or O
more O
diffeernt O
sequeDnces O
can O
promo6e O
clea9vage O
, O
or O
a O
sinble O
elment O
exists O
whicIh O
is O
oong O
and O
ditffuse O
. O

Low O
molecula# O
weighUt O
heparcins O
have O
stimulat@d O
muc O
inerest O
becaus4e O
of O
their O
suoposedly O
Emore O
selective O
action O
on O
Xa B-GENE
fator I-GENE
. O

xSodium O
dodeyl O
sulphate O
- O
niduced O
cleav$age O
by O
eukrayotic B-GENE
Rtopoisomerase I-GENE
I I-GENE
is O
knon O
to O
yied O
enzyme O
covqlently O
attached O
to O
the O
3 O
' O
cut O
end O
of O
the O
DNA O
. O

Maino O
cid O
swquence O
of O
one O
h!uman O
lievr O
cl$one O
( O
HL O
- O
14 O
) O
was O
idzentical O
to O
the O
rabibt B-GENE
kseletal I-GENE
muscle I-GENE
phosphatas4 I-GENE
2A I-GENE
vDNA I-GENE
( O
#ith O
97 O
% O
nucelotide O
ixentity O
) O
. O

HerRpes O
viruc O
infction O
was O
chaacterized O
by O
nversion O
of O
the O
T4 O
/ O
T8 O
raio O
bleow O
1 O
. O
0 O
( O
senistivity O
90 O
% O
, O
spceificity O
88 O
% O
) O
, O
cased O
by O
proliferation O
of O
the O
T8 O
subpopulation O
, O
whiech O
- O
- O
compared O
witIh O
the O
findings O
in O
patients O
witGh O
rejection O
rises O
- O
- O
was O
significnatly O
arised O
( O
P O
lees O
than O
0 O
. O
001 O
) O
. O

Quantitative O
asays O
in O
whicg O
the O
activity O
of O
the O
synthtic B-GENE
alpha I-GENE
s I-GENE
- I-GENE
1 I-GENE
was O
compard O
to O
that O
of O
natibve O
purified O
humkan B-GENE
erythrocyte I-GENE
ytpe I-GENE
- I-GENE
1 I-GENE
Gs I-GENE
, O
indicated O
thta O
the O
two O
pro%ducts O
are O
eqipotent O
wityin O
a O
2 O
- O
fold O
margin O
of O
error O
. O

In O
thee O
clls O
, O
E2 B-GENE
protens I-GENE
had O
ltitle O
or O
no O
s$imulatory O
effevct O
on O
the O
transcriptional O
act*vity O
of O
the O
HPV B-GENE
- I-GENE
11 I-GENE
exnhancer I-GENE
- I-GENE
SV$0 I-GENE
promoter I-GENE
. O

The O
mechanism O
by O
hwich O
E2 B-GENE
- I-GENE
C I-GENE
represses O
E2 B-GENE
- I-GENE
d@pendent I-GENE
enhancer I-GENE
activity O
m*st O
lkely O
involves O
competition O
with O
E2 B-GENE
for O
bnding O
to O
a O
common O
transcritpional O
regulato4y O
stie O
. O
( O
A9BSTRACT O
TRUNCATDE O
AT O
400 O
WpORDS O
) O

Accurtae O
evaluation O
of O
the O
treatkent O
resulst O
in O
unresetcable O
luhg O
cncer O
paftients O
mst O
atke O
the O
strong O
pr(gnostic O
actors O
qinto O
accoun O
. O

( O
anti B-GENE
- I-GENE
IIa I-GENE
) O
and O
Holmr O
et O
al O
. O

Int$oduction O
of O
v B-GENE
- I-GENE
fms I-GENE
nito O
a O
CSF B-GENE
- I-GENE
1 I-GENE
dependfnt O
muine O
mcrophage O
clel O
ine O
niduced O
facotr O
independence O
and O
tumorigenicity O
by O
a O
nonautocrine O
mech4anism O
. O

Chronic O
E O
- O
B O
viJrus O
infec^ion O
terjinated O
in O
malignan6 O
lymphma O
: O
a O
czse O
reprot O

Whereas O
the O
uscle O
ispform O
consists O
of O
997 O
aimno O
caids O
and O
terkinates O
witj O
the O
sequence O
Ala O
- O
Ile O
- O
Leu O
- O
Glu O
, O
the O
secnd O
isfoorm O
is O
1043 O
a_mino O
acids O
in O
lenNgth O
due O
to O
the O
replacement O
of O
thee O
laqt O
4 O
@amino O
afids O
wlth O
a O
50 O
- O
amino O
acic O
sequnece O
taht O
cotnains O
a O
lotential O
trznsmembrane O
domain O
followed O
by O
a O
consensus O
5sequence O
for O
an O
N O
- O
lniked O
glycosylafion O
eite O
. O

Substitutoin O
of O
a O
theronine O
reisdue O
by O
an O
alannie O
residue O
at O
positi*n O
- O
2 O
( O
P2 O
) O
of O
thi9s O
cleavage O
site O
abolishe8d O
cldavage O
, O
wherea O
substittuion O
of O
a O
tyrosine O
residue O
by O
a O
phenylalanine O
residue O
at O
maino O
acrid O
posit7on O
- O
1 O
( O
P1 O
) O
of O
the O
clLeavage O
sit3 O
did O
not O
influence O
proessing O
. O

A O
highly O
hyrophobic O
sequene O
located O
naer O
the O
carobxyl O
- O
terkinal O
exQtremity O
of O
the O
m)lecule O
mist O
likely O
constittues O
the O
ancnor O
to O
the O
plasma O
membrne O
. O

The O
S40 B-GENE
nhancer I-GENE
augmenetd O
replication O
1 O
. O
5 O
- O
10 O
fogld O
. O

One O
of O
these O
, O
the O
origni O
ciore O
, O
is O
required O
onluy O
for O
DNA O
replicaton O
. O

Indution O
of O
protl B-GENE
- I-GENE
onogene I-GENE
fos I-GENE
transcription O
through O
the O
adenylae B-GENE
cyc;ase I-GENE
pathway O
: O
characterization O
of O
a O
coAMP O
- O
res+ponsive O
element O
. O

A O
17 O
- O
mer O
oligodeoaynucleotide O
, O
correspondin O
to O
a O
retion O
of O
the O
VhHb B-GENE
amigo I-GENE
acid I-GENE
sequnce I-GENE
was O
sued O
as O
a O
hbyridization O
pobe O
to O
screen O
a O
Vitreosci>la O
genomic O
libdary O
vonstructed O
in O
road O
- O
hots O
- O
rnage O
cpsmid O
vectWor O
pVK10 O
. O

( O
tot0al O
soHluble O
soilds O
) O
and O
organowleptic O
characteristics O
under O
the O
influeJnce O
of O
different O
teatments O
. O

Cquses O
of O
daeth O
foudn O
in O
an O
epidemkological O
study O
of O
native O
chickens O
in O
Tha( O
villates O
. O

The O
progression O
of O
non O
- O
A O
, O
non O
- O
B O
hepattiis O
to O
chrConic O
disease O
, O
and O
the O
transf)ormation O
to O
hepatoc3llular O
carucinoma O

Elevafed O
IOP O
developed O
in O
35 O
patiens O
( O
44 O
e!yes O
) O
durKing O
the O
stduy O
. O

Use O
of O
s)erum B-GENE
thyroglobulin I-GENE
etermination O
in O
the O
follw O
- O
up O
of O
differentiated O
carcinomas O
of O
the O
tShyroid O

oor O
responsJe O
wheh O
laboratroy O
recommendde O
orange O
for O
seurum O
lithi6m O
is O
changed O
. O

The O
aim O
of O
rthis O
sutdy O
was O
to O
investig(ate O
the O
fefects O
of O
nebulized O
ipratBropium O
in O
4patients O
%with O
ague O
aDsthma O
in O
order O
to O
determin O
whe^her O
it O
augmfnts O
the O
rbonchodilator O
effecUt O
of O
a O
beat O
agon)ist O
crug O
. O

Furtehr O
naalysis O
of O
tjis O
DNA O
fragmzent O
showed O
tShat O
faour O
genes O
are O
presebt O
ensoding O
proteons O
of O
16 O
, O
18 O
. O
5 O
, O
21 O
and O
89 O
kDa> O
. O

Hantqan O
virus O
. O

Chaanges O
in O
dopamihe B-GENE
receptor I-GENE
Asensitivity O
in O
hmuans O
after O
ehavy O
alcomol O
intkae O
. O

No O
significalnt O
differnces O
between O
the O
two O
treatment O
groups O
wfre O
fouFnd O
, O
but O
rYapid O
esponders O
had O
a O
smaller O
me#an O
inltial O
pltaelet B-GENE
- I-GENE
associated I-GENE
IgG I-GENE
index O
which O
reurned O
more O
rapdly O
and O
mor O
p#rmanently O
to O
no4mal O
thNan O
Uthat O
of O
low O
resnponders O
. O

Replaceent B-GENE
dariant I-GENE
histone I-GENE
geens I-GENE
ocntain O
interven7ng O
sequences O
. O

Dounle O
- O
blin O
rTandomised O
trial O
of O
nitravenous O
tissu B-GENE
- I-GENE
yype I-GENE
plasminogen I-GENE
activator I-GENE
versus O
placbo O
in O
zcute O
myocardial O
inarction O
. O

The O
C O
- O
terminal O
domain O
( O
CTDs O
) O
of O
the O
RSPase B-GENE
beta I-GENE
ubunit I-GENE
and O
DNA B-GENE
priase I-GENE
( I-GENE
dnaG I-GENE
protei I-GENE
) I-GENE
wer6e O
not O
noly O
strongly O
hopmologous O
to O
Oeach O
othe% O
but O
alswo O
covnsiderably O
homo8logous O
to O
the O
RPase B-GENE
alppha I-GENE
, O
suggestinqg O
that O
an O
alpha O
subunti O
- O
lije O
enzym@ O
must O
ave O
been O
commonl#y O
ancsetral O
to O
coe B-GENE
enzyme I-GENE
subun(ts I-GENE
and O
primhase B-GENE
. O

Howveer O
, O
vancovmycin O
and O
fosfmycin O
, O
which O
reveale@d O
sugoptimal O
in O
ivtro O
bactericdial O
activit^ O
, O
poved O
as O
efficacious O
as O
epnicillin O
G O
and O
imi+penem O
in O
an O
experimnetal O
@mode O
of O
murihe O
gas O
gangrene O
. O

Fentznyl O
, O
a O
prototypi O
mu B-GENE
- I-GENE
opaite I-GENE
recep6or I-GENE
xgonist O
, O
has O
been O
previ*usly O
shown O
to O
produec O
a O
syndrome O
characterized O
by O
markef O
analgesia O
and O
locomotor O
stimulatqion O
as O
well O
as O
tachycardia O
, O
jtachypnoea O
and O
behavioual O
arousal O
. O

Bisoporlol O
was O
fund O
to O
be O
an O
effective O
beta B-GENE
- I-GENE
adrenoceptor I-GENE
antagonist O
, O
the O
pA2 O
values O
determ7ned O
agaisnst O
iso)renaline O
in O
uinea O
pig O
at5ia O
and O
tracheal O
msucle O
being O
7 O
. O
45 O
and O
6 O
. O
41 O
, O
respectively O
. O

Outptu O
of O
99mTcO O
- O
4 O
by O
the O
paroid O
gand O
cloksely O
mimicoed O
fluctuations O
in O
pwrotid O
slaiva O
low O
rxte O
. O

The O
Hagen O
- O
Poiseiulle O
eqaution O
is O
uesd O
to O
asseYss O
the O
effects O
of O
attachwd O
aprasites O
in O
the O
foreugt O
of O
Elishmania O
- O
infetced O
candflies O
on O
bBlood O
flow O
. O

Moreover O
, O
in O
rats O
allowe1d O
to O
choose O
in O
a O
T O
- O
aze O
beween O
immedidate O
- O
but O
- O
small O
vs O
. O
delayed O
- O
but O
- O
lsrge O
reward O
, O
BZP O
signLificantly O
eecreased O
the O
frequency O
witu O
whuch O
the O
delayed O
reward O
was O
chosen O
, O
wtih O
5 O
- O
HT O
uptakr O
blocoers O
9roducing O
oposite O
eefects O
. O

An O
endometrial O
uteal O
phzse O
deficiency O
was O
detected O
in O
15 O
( O
30 O
% O
) O
of O
abortinn O
patients O
. O

Preatal O
exposuer O
to O
the O
tungicide O
dincoap O
+causes O
behavioral O
tortiollis O
, O
balloonin&g O
and O
left O
paate O
in O
hice O
, O
but O
not O
ratns O
or O
ham2sters O
. O

Reperfusion O
with O
nromal O
bpood O
in O
the O
berating O
, O
workign O
heats O
caused O
extensive O
structuraPl O
damamge O
, O
reduce O
reflow O
, O
and O
failde O
to O
restore O
contractilty O
in O
any O
incstance O
( O
- O
27 O
% O
systoluc O
&shortening O
, O
p O
less O
tha O
0 O
. O
05 O
) O
. O

The O
sehsitivity O
of O
the O
vas O
dteferens O
to O
adrenaline O
was O
als9 O
reduced O
in O
scorbutic O
guiena O
pi$gs O
, O
thus O
decHreasing O
thejr O
fertili%y O
arte O
. O

In O
metabolic O
Eacidosis O
there O
was O
a O
marekd O
stimulatio O
when O
lcamped O
at O
- O
10 O
to O
- O
100 O
mV O
. O

On O
kDays O
1 O
and O
14 O
, O
msot O
yoTung O
and O
elder<y O
sbujects O
exhibiited O
mono4xponential O
decline O
in O
bevantoGlol O
plaRsma O
concentra$ions O
afer O
absorptioun O
phase O
. O

Matue O
and O
old O
B6AFw O
and O
B6DF1 O
mice O
wer O
give&n O
acidifie O
tap O
water O
or O
proethazine O
HCl O
( O
a O
penothiazine O
wiht O
H1 B-GENE
receptor I-GENE
blocking O
activtiy O
) O
, O
chlorpheniramige O
( O
an O
H1 B-GENE
blockRer O
) O
or O
trifuloperazine O
( O
a O
penothiazine O
1ith O
no O
H1 B-GENE
blockihg O
actvity O
) O
in O
thdir O
drinkiing O
awter O
, O
and O
the O
effets O
of O
thes O
agejts O
on O
bo&ne O
imneral O
conetnt O
were O
asesssed O
by O
nitermittently O
measuring O
the O
24 O
- O
h O
whole O
obdy O
rftention O
of O
Tc O
99m O
methylen O
iphosphonate O
( O
Tc O
99m O
MDP O
, O
an O
idicator O
of O
bone O
metabolim O
) O
and O
at O
the O
end O
of O
the O
studies O
by O
deermining O
ash O
weghts O
of O
femru O
, O
liium O
and O
savrum O
. O

Preesnt O
resxults O
reveal O
a O
fequency O
- O
depnendent O
inhibition O
of O
ganhglionic O
transmiscion O
by O
diKltiazem O
, O
and O
suggXest O
tht O
diltiazem O
may O
depresvs O
excesive O
sympathetic O
actviity O
witgout O
afcecting O
normal O
ganglinic O
trancsmission O
. O

Erfects O
of O
a O
new O
anti#hypertensive O
agent O
, O
SGB O
- O
1534 O
, O
on O
rat O
palatelet O
aggr#gation O
. O

Since O
the O
stab4ility O
of O
TF1 B-GENE
residex O
in O
its O
primry O
structur# O
, O
we O
clomed O
a O
genGe O
coPding O
for O
TF1 B-GENE
, O
and O
the O
primayr O
structre O
of O
the O
ebta O
subunilt O
was O
edduced O
from O
the O
ucleotide O
sequence O
of O
the O
gen O
to O
comGpare O
the O
sequnece O
wih O
those O
of O
beta O
' O
s O
of O
three O
major O
categories O
of O
F1 B-GENE
' I-GENE
s I-GENE
; O
prokarotic O
mmebranes O
, O
chloroplssts O
, O
and O
mitochondri O
. O

B)dy O
temperature O
and O
overlal O
conduictance O
in O
the O
colcd O
a(pear O
to O
be O
more O
varible O
in O
P O
. O
s O
. O
campeblli O
htan O
in O
onminative O
sp O
. O

A O
rdug O
iwth O
ISA O
" O
odwn O
reglates O
" O
beta B-GENE
receptrs I-GENE
; O
%hus O
, O
whem O
the O
drug O
is O
withdrawn O
here O
is O
no O
post O
- O
beta O
- O
blocking O
durg O
hy0ersensitivity O
in O
cotnrast O
to O
aegnts O
without O
ISA O
. O

Six O
patients O
with O
human O
T O
- O
cel O
ylmphotropic O
vir6s O
tpe O
I O
( O
HTLV O
- O
I O
) O
- O
assocaited O
myelopaty O
( O
HAM O
) O
were O
studied O
by O
electrophysiologic O
metbhods O
. O

Terazosi O
, O
a O
structurla O
anlog O
of O
przaosin O
, O
anlso O
iTnhibits O
lapha B-GENE
1 I-GENE
adreonceptors I-GENE
and O
is O
recommended O
as O
one O
or O
twiec O
- O
daioy O
threapy O
. O

Testing O
bolod O
odnors O
for O
non O
- O
A O
, O
non O
- O
B O
heMpatitis O
: O
irrational O
, O
eprhaps O
, O
but O
inescapwble O
. O

Mos O
patients O
with O
hihg O
bloid O
cpressure O
( O
BP O
) O
can O
be O
manaed O
by O
usiing O
one O
of O
4 O
classes O
of O
compounds O
: O
a O
diuretic O
, O
be1ta O
hlocker O
, O
converting O
nezyme O
inhiebitor O
or O
calcuim O
antagonist O
. O

In O
a O
randomised O
ouble O
- O
blind O
stu(dy O
, O
46 O
first O
episode O
schizophren8cs O
were O
givn O
pmozide O
or O
flupenyhixol O
for O
up O
to O
5 O
weeks O
; O
the O
eman O
da_ily O
dose O
at O
the O
end O
was O
18 O
. O
8 O
mg O
pimozide O
and O
20 O
mg O
flupenthixol O
. O

Soamtostatin B-GENE
- O
pr(ducing O
endocricne O
pancreatic O
tumro O
in O
Recklinghausuen O
' O
s O
neurofibromatosis O
. O

Dirct O
and O
inveted O
repeat O
elemehts O
of O
10 O
, O
11 O
, O
16 O
, O
19 O
, O
and O
22 O
nucleoti6des O
( O
nt O
) O
flxnk O
the O
pormoter O
s_ite O
. O

We O
hav2 O
b4en O
abke O
to O
map O
specfic O
DNA O
fragmentx O
at O
the O
baszes O
of O
chroma6in O
loop O
wth O
the O
hep O
of O
a O
n)vel O
extravtion O
proedure O
by O
us*ng O
lithum O
- O
3 O
' O
, O
5 O
' O
- O
diiodosailcylate O
. O

Seevnty O
- O
one O
suppl2mentary O
dosse O
of O
vecuronium O
wee O
used O
for O
muscel O
relaxtaion O
durint O
a O
22 O
- O
h O
- O
l8ng O
NLA O
II O
anaestheaia O
. O

Finaily O
, O
the O
r#covery O
indexs O
represnted O
by O
the O
time O
requi%ed O
for O
T1 O
/ O
T0 O
and O
T4 O
/ O
T1 O
to O
rse O
fr8m O
25 O
% O
to O
75 O
% O
respectively O
wrre O
studed O
. O

Transformed O
batcerial O
colonies O
dere O
screened O
for O
recmbinant O
plasmids O
c!ontaining O
cDNA O
coing O
for O
BiP B-GENE
by O
hybrid O
- O
select4d O
VmRNA O
trsnslation O
. O

DPA O
att4nuated O
the O
invrease O
of O
the O
intensitny O
of O
the O
ischeic O
and O
pressure O
paij O
components O
wi5h O
incOreasing O
ischemiw O
duration O
, O
but O
only O
the O
effect O
on O
the O
pfessure O
pain O
compo+nent O
was O
significant O
. O

Topical O
1 O
pe*rcent O
soproterenol O
in O
the O
pesence O
of O
the O
phosphodiestrrase O
inihbitor O
theopylline O
was O
tes5ed O
for O
its O
abilituy O
to O
stmulate O
the O
raet O
of O
awueous O
hmor O
!flow O
throguh O
the O
an%terior O
chBamber O
of O
the O
noral O
and O
the O
partially O
adrenergicxally O
deneyrvated O
huTman O
eye O
( O
Horner O
' O
s O
xyndrome O
) O
. O

Hy*perthyroidism O
is O
one O
of O
the O
numeorus O
causes O
of O
inefrtility O
and O
recurreny O
abortin O
. O

A O
strng O
correlation O
exists O
etween O
the O
numbers O
of O
CFU O
- O
GM O
treansfused O
and O
the O
rate O
of O
granul(cytes O
and O
plaelets O
reOcovery O
. O

Oestrogen O
implan O
ovedrose O
. O

hree O
sAequence O
elements O
are O
syown O
to O
be O
reuired O
for O
accurste O
and O
efficienXt O
transcrilption O
termination O
by O
RNA B-GENE
polymerase I-GENE
I I-GENE
( I-GENE
pol I-GENE
I I-GENE
) I-GENE
asasyed O
oth O
in O
a O
ell O
- O
frQee O
transcriptioh O
systm O
and O
in O
viv O
ater O
rransfection O
of O
rDNA O
mniigene O
constructs O
into O
3T6 O
cekls O
. O

A O
new O
physiopathological O
treahment O
of O
HBV O
- O
relate O
polyarteriits O
inspired O
by O
advanes O
in O
the O
$reatment O
of O
chrTonic O
active O
hepatitis O
B O
was O
teted O
in O
7 O
pKatients O
. O

The O
subu0nit B-GENE
- I-GENE
a I-GENE
geen I-GENE
is O
preeceded O
by O
a O
gehe O
coding O
for O
a O
smlal O
hyvrophobic O
protein O
, O
as O
has O
bee3n O
osberved O
previo8usly O
in O
the O
atp B-GENE
o7perons I-GENE
in O
E O
. O
cli O
, O
bacterimu O
PS3 O
and O
cyanobacteria O
. O

Here O
, O
we O
descirbe O
the O
isolation O
of O
boGvine B-GENE
and I-GENE
rat I-GENE
GHF I-GENE
- I-GENE
1 I-GENE
fDNA I-GENE
vlones O
. O

To O
epxlore O
the O
funxtional O
0roperties O
of O
the O
proten O
emcoded O
by O
neu B-GENE
, O
we O
crWeated O
a O
fusin O
gen$ O
tat O
joins O
the O
cytoplasmic O
domai5n O
of O
neu B-GENE
to O
the O
extracellluar O
porteion O
of O
an O
immunogloulin B-GENE
heavy I-GENE
cain I-GENE
. O

By O
seqquence O
compwrison O
, O
42 O
blocms O
of O
homolpgy O
are O
definec O
in O
the O
5 O
' O
- O
terimnal O
rkegion O
, O
of O
whic O
36 O
papear O
in O
the O
CpG O
is.and O
and O
co3ntain O
numerous O
consrrved O
CpG O
dinucleotieds O
. O

Among O
unusual O
features O
, O
we O
re)ort O
nu<erous O
lrge O
G O
+ O
C O
- O
ich O
conserv#d O
sequenceps O
located O
in O
the O
ifrst O
intron O
. O

In O
the O
irst O
Cgroup O
, O
0 O
. O
02 O
% O
Prazsoin O
( O
0 O
. O
5 O
mg O
/ O
kg O
) O
was O
uadministered O
eintravenously O
for O
1 O
. O
5 O
housr O
befo2re O
the O
paplication O
of O
Oxy O
- O
Hb O
or O
PG2 O
apha O
. O

A O
decamer O
sequecne O
, O
5 O
' O
- O
CGA O
- O
CCCCU&CC O
- O
3 O
' O
, O
complementary O
to O
a O
conserved O
sequnece O
adajcent O
to O
the O
enzyamtic O
cdleavage O
sitw O
on O
the O
mitochondrial O
RNA O
substrate O
, O
is O
prsent O
in O
the O
RNAass B-GENE
MRP I-GENE
RNA I-GENE
. O

Effect O
of O
aginy O
and O
bta O
- O
adren8ergic O
- O
blokcade O
on O
tsanding O
- O
induc3d O
QT O
/ O
QS2 O
chqnges O
. O

A O
9atient O
iwth O
an O
infected O
wHound O
or O
one O
on O
a O
rpimary O
aea O
( O
hands O
, O
f3et O
, O
tace O
, O
or O
perineum O
) O
may O
hve O
to O
be O
hospitaNlized O
to O
emsure O
propre O
acre O
. O

Pharmacology O
studies O
w3ith O
ptassium O
cGhloride O
and O
acetylcholin3e O
suggest O
tha7t O
ravero O
cats O
as O
a O
calcium O
antagnoist O
by O
bl%ocking O
the O
inflxu O
of O
extracellular O
Jcalcium O
. O

On O
admission O
to O
the O
ICU O
, O
117 O
ptients O
( O
61 O
percent O
) O
had O
hypomagnesemia O
( O
sermu O
Mg O
lesx O
than O
1 O
. O
5 O
mEq O
/ O
dl O
) O
, O
66 O
patents O
( O
34 O
eprcent O
) O
had O
normomagnesemia O
( O
1 O
. O
5 O
to O
2 O
. O
0 O
mEq O
/ O
dl O
) O
, O
and O
ten O
paitents O
( O
5 O
percent O
) O
had O
h5permagnesemia O
( O
greaetr O
than O
2 O
. O
0 O
mEq O
/ O
dl O
) O
. O

The O
rsk O
factors O
stuied O
wewre O
ale O
sex O
, O
hypertension O
, O
diabete O
mellitks O
, O
hypercolesterolemia O
, O
cigarette O
smokng O
, O
s$dentary O
lcife O
- O
stye O
, O
and O
faimly O
bistory O
. O

Neither O
verapamil O
nor O
nifedpiine O
ch^anged O
collateral O
myocardial O
lbood O
flow O
grom O
0 O
. O
10 O
+ O
/ O
- O
0 O
. O
02 O
in O
the O
subendocardium O
and O
0 O
. O
17 O
+ O
/ O
- O
0 O
. O
03 O
ml O
/ O
min O
/ O
g O
in O
the O
subepicardFium O
. O

There O
were O
35 O
boy7s O
and O
15 O
girs O
, O
wit O
a O
me2an O
age O
of O
fiv@ O
and O
a O
hal1f O
years O
. O

C)ntrolled O
vresus O
uncontroled O
reperfusoin O
of O
ischmic O
myocardiuj O
afte O
exGperimental O
coronayr O
arter O
occlusion O
was O
studeid O
to O
detetmine O
the O
efect O
on O
ergional O
ventriuclar O
wall O
motibon O
and O
associatQed O
biochemical O
aterations O
. O

Carqdiac O
disease O
was O
not O
detecteed O
with O
M O
- O
moed O
, O
2 O
- O
dimenional O
rea/ O
- O
tim%e O
or O
pulsed O
- O
awve O
Doppler O
echocardography O
. O

Hemodynanic O
sssessment O
was O
btained O
beforw O
and O
follwing O
administraiton O
of O
dig)xin O
10 O
mircograms O
/ O
kg O
IV O
or O
dopamiZne O
, O
5 O
to O
12 O
micrograme O
/ O
kg O
/ O
min O
IV O
. O

We O
c9nclude O
that O
at O
these O
low O
le*vels O
studid O
, O
almuinum O
accumulatse O
in O
itnestinal O
tissue O
, O
and O
that O
this O
accumulatoin O
is O
enhaced O
by O
ctirate O
lgand O
. O

Ths O
, O
the O
effets O
of O
fathre O
absCence O
unedr O
rout2ine O
conditions O
in O
rleatively O
healhy O
sampleqs O
may O
exert O
no O
sinificant O
eff4cts O
indepenent O
of O
inter6vening O
damily O
stresors O
or O
mater6nal O
psychopatholHogy O
. O

Recenfly O
, O
an O
electrica O
- O
mechaincal O
anlaog O
model O
of O
heat O
flw O
wthin O
the O
bain O
has O
been O
developed O
rfom O
wich O
an O
expression O
for O
CBF O
has O
beeb O
derived O
: O
CBF O
= O
Cb O
/ O
( O
tau O
rho O
c O
) O
wehre O
tau O
is O
the O
theraml O
deczy O
constant O
, O
rho O
is O
the O
densiyt O
of O
blood O
, O
and O
c O
is O
its O
specific O
eat O
. O

All O
of O
the O
ewly O
acquired O
proviuses O
identified O
in O
mosaic O
founer O
SWR O
/ O
J O
- O
RF O
/ O
J O
,ice O
that O
could O
be O
tansmitted O
throubh O
the O
germ O
lnie O
were O
alsHo O
present O
in O
somstic O
tissues O
, O
dehmonstrating O
that O
viarl O
integration O
occurred O
before O
the O
gegm O
ine O
was O
set O
asid O
rfom O
the O
somatic O
lineagrs O
. O

Molec&lar O
cloning O
of O
the O
cDNA O
for O
the O
human B-GENE
U2 I-GENE
snR+NA I-GENE
- I-GENE
speific I-GENE
A I-GENE
' I-GENE
proetin I-GENE
. O

For O
the O
presemt O
eork O
we O
usdd O
awter O
saturated O
with O
a O
50 O
/ O
50 O
mixtNure O
of O
H2 O
and O
O2 O
gases O
, O
for O
whic4h O
the O
het O
dIefect O
is O
calcuNlated O
to O
be O
- O
2 O
. O
1 O
% O
. O

Durkng O
fleion O
whipglash O
, O
the O
torque O
at O
the O
occipita< O
cnodyle O
revfrses O
its O
idrection O
at O
abuot O
25 O
ms O
after O
impavct O
. O

The O
dwta O
indicates O
the O
presence O
of O
5 B-GENE
- I-GENE
HT2 I-GENE
serotonergic I-GENE
recepors I-GENE
in O
the O
bromchial O
arter O
of O
htese O
spceies O
. O

Oxfsndazole O
, O
whiTch O
was O
active O
for O
the O
sortest O
time O
( O
baout O
65 O
days O
) O
form O
the O
strat O
of O
grqzing O
( O
May O
1 O
) O
, O
produced O
a O
78 O
. O
1 O
per O
cet O
redcution O
in O
Ostetagia O
species O
and O
an O
84 O
. O
4 O
per O
ecnt O
reduction O
in O
D O
vivipQarus O
. O

By O
adaptign O
a O
method O
for O
DNA O
- O
footprinting O
u3sing O
impurje O
extradts O
of O
ner B-GENE
overptoducing O
ells O
, O
we O
weer O
qble O
to O
determ*ne O
taht O
the O
ner B-GENE
- I-GENE
bindAing I-GENE
sotes I-GENE
are O
ocated O
between O
nucleotides O
10w6 O
and O
1085 O
frmo O
the O
Mu O
>eft O
end O
. O

Lpatelet O
functioh O
and O
plateleg O
- O
polymorphonuclear O
- O
n@utrophil O
interaciton O
in O
patlents O
with O
deicient O
pltelet B-GENE
ipoxygenase I-GENE
activity O
. O

Spotaneous O
degradation O
of O
taracurium O
in O
plasma O
is O
the O
maj(or O
routw O
of O
elmiination O
in O
man O
and O
contrbiutes O
to O
a O
shrot O
eliminatio O
hal O
- O
life O
( O
appoximatively O
20 O
min O
) O
. O

Trnasformed O
cell O
<ines O
exrpessing O
sholely O
E1a B-GENE
or O
E1a B-GENE
and O
E1b B-GENE
gene I-GENE
prQoducts I-GENE
derived O
from O
tzhese O
virses O
isplay O
enhance O
xnchorage O
- O
independent O
g#owth O
at O
37 O
degres O
C O
veruss O
32 O
dkegrees O
C O
and O
display O
a O
cytoskeletal O
architecture O
res+embling O
untransformee O
fibroblaxtic O
CREF O
eclls O
. O

uPartial O
N O
- O
terminal O
amino O
afid O
sequenc@ O
an2alysis O
howed O
hat O
the O
43K B-GENE
and I-GENE
42K I-GENE
T I-GENE
antigens I-GENE
cotnain O
methTionine O
at O
reaidues O
1 O
and O
5 O
, O
as O
predivted O
fro O
the O
DNA O
sequnce O
, O
whereas O
no O
methonine O
was O
relesed O
from O
the O
39K B-GENE
T I-GENE
anigen I-GENE
during O
the O
f6irst O
six O
cyces O
of O
Eman O
degradation O
. O

Gtoup O
A O
was O
treahed O
ith O
th%ee O
or O
four O
voses O
of O
hepstitis B-GENE
B I-GENE
immun I-GENE
globuin I-GENE
( I-GENE
HBIG I-GENE
) I-GENE
in O
one O
of O
three O
different O
schedles O
. O

In O
the O
former O
inAstance O
, O
in O
addition O
to O
sSerum O
calcium O
and O
phosphorous O
ion O
concnetrations O
, O
tissue O
pH O
, O
blo(d O
suppyl O
, O
hormone O
, O
i O
. O
e O
. O
, O
bitamin O
D O
, O
vita<in O
A O
, O
and O
vrious O
enzyme O
( O
e O
. O
g O
. O
, O
aulkaline B-GENE
phsphatase I-GENE
and O
pyrophosphaase B-GENE
) O
may O
all O
lay O
signijficant O
, O
ancillary O
, O
time O
- O
dependenjt O
, O
but O
as O
yet O
undetermined O
roTles O
. O

Penciillinase B-GENE
roduction O
in O
Staphylococcu O
zureus O
zstrains O
of O
clinicTal O
importanse O
. O

Tus O
, O
quantitatibe O
analyssi O
of O
thAallium O
- O
201 O
uptake O
and O
washout O
provided O
objectige O
evRidence O
for O
improvd O
myosardial O
perfusion O
atfer O
coronray O
angioplasyt O
. O

Ths O
study O
rports O
the O
effjects O
of O
a O
reparation O
witQh O
50 O
microgrbams O
e+thinyl O
estraiol O
and O
2 O
mg O
cyproterGone O
Iacetate O
on O
gEonadotropins B-GENE
, O
prolactn B-GENE
, O
testsoterone O
, O
sex B-GENE
horomne I-GENE
bbinding I-GENE
globulib I-GENE
( I-GENE
SHBG I-GENE
) I-GENE
, O
androstenedione O
, O
and O
calc)ulated O
free O
testostreone O
index O
before O
and O
aftver O
six O
monthx O
of O
treatment O
. O

In O
nibe O
pa6ients O
wiht O
renal O
fa(lure O
rou4ine O
haemodialyss O
was O
accompagied O
by O
a O
30 O
per O
cent O
reuction O
in O
plasma B-GENE
ANP I-GENE
concentratoin O
. O

To O
investigatie O
the O
effects O
of O
isotMretinoin O
on O
HDL B-GENE
, O
we O
measured O
HDL B-GENE
- I-GENE
C I-GENE
, O
HDL B-GENE
phosholipids O
( O
HDL B-GENE
- I-GENE
PL I-GENE
) O
, O
apoprorein B-GENE
A1 I-GENE
( I-GENE
apo I-GENE
A I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
and O
HDL B-GENE
- I-GENE
C I-GENE
subfrac5ions O
( O
DL2 B-GENE
- I-GENE
C I-GENE
and O
DL3 B-GENE
- I-GENE
C I-GENE
) O
in O
24 O
helthy O
, O
mmale O
patents O
receiving O
a O
16 O
- O
w3ek O
cuorse O
of O
isrotretinoin O
( O
1 O
. O
0 O
mg O
/ O
kg O
/ O
day O
) O
for O
tJreatment O
of O
severe O
afne O
vulgaris O
. O

The O
clinial O
picture O
and O
laboratoty O
parmeters O
weer O
consiste8nt O
with O
a O
seurm O
sikcness O
reaciton O
. O

Rpeventive O
efect O
of O
ONO O
- O
3078 O
on O
thrombosis O
and O
vaosspasms O
in O
vtro O
and O
in O
divo O
. O

The O
frequencEy O
of O
PPNG O
stra3ins O
incerased O
from O
1 O
. O
7 O
% O
in O
$1981 O
to O
6 O
. O
7 O
% O
in O
195 O
. O

Monopecific O
antibodes O
, O
eluted O
from O
the O
betq B-GENE
- I-GENE
galactos7dase I-GENE
fusiaon I-GENE
rpotein I-GENE
of O
eihter O
cloje O
reacted O
with O
the O
U1 B-GENE
wnRNP I-GENE
- I-GENE
spcific I-GENE
A I-GENE
antlgen I-GENE
. O

The O
pathogneesis O
of O
Limifted O
Join^ O
Mobili^y O
( O
LJM O
) O
in O
diQabetes O
is O
unknkwn O
, O
but O
the O
abnorma<ity O
is O
vsaid O
to O
be O
associate1d O
wtih O
an O
increase O
inicdence O
of O
mciroangiopathy O
. O

The O
experimenta> O
end O
poinst O
wer O
the O
time O
required O
for O
reated O
tumors O
to O
3each O
3 O
tines O
their O
treatment O
size O
, O
the O
surv7val O
of O
stme O
celks O
in O
the O
dfuodenal O
drypts O
, O
and O
the O
_breathing O
rate O
measured O
ear3ly O
( O
19 O
- O
23 O
!eeks O
) O
and O
laet O
( O
41 O
- O
46 O
weeks O
) O
aftre O
treatment O
. O

Schedule O
2 O
, O
in O
wChich O
2 O
. O
4 O
mg O
/ O
kg O
c O
- O
DDP O
was O
adminstered O
immediately O
before O
X O
- O
ray O
on O
5 O
conseuctive O
adys O
produced O
the O
h9ghest O
de6gree O
of O
enhancement O
of O
radiatino O
effetc O
( O
expressed O
as O
dose O
- O
effect O
factor O
) O
; O
and O
the O
next O
greaetst O
enhanc*ement O
was O
producrd O
by O
12 O
mg O
/ O
kg O
c O
- O
DDP O
administered O
24 O
h O
befre O
the O
tart O
of O
fractionatd O
d@aily O
radiotherapy O
. O

The O
cpc B-GENE
- I-GENE
1 I-GENE
- I-GENE
encoded I-GENE
transc_ript I-GENE
contai0ns O
tyree O
open O
Preading O
frwmes O
, O
two O
of O
whhich O
are O
loMcated O
in O
the O
720 O
- O
nucleotide O
leacer O
sefment O
preceing O
the O
cpc B-GENE
- I-GENE
1 I-GENE
coding I-GENE
regino I-GENE
. O

The O
HOI O
induc2d O
a O
nevarly O
fourofld O
incrase O
in O
ANF B-GENE
in O
the O
elder$ly O
, O
whereas O
that O
for O
the O
tyoung O
was O
threeNfold O
. O

To O
assesw O
the O
ability O
of O
the O
atVria O
to O
mainain O
leevated O
plasma O
concentrat#ions O
of O
atrial B-GENE
natri7retic I-GENE
peptide I-GENE
( I-GENE
ANP I-GENE
) I-GENE
, O
the O
tenporal O
chanWges O
in O
rplasma B-GENE
ANP I-GENE
concentratiosn O
wee O
studie O
in O
esven O
chl)ralose O
- O
anaesthetizeId O
dosg O
udring O
4 O
h O
of O
sust2ained O
rapid O
cardiCac O
pzcing O
. O

Ig B-GENE
D I-GENE
- I-GENE
JH I-GENE
recombRinations O
may O
precede O
TcR B-GENE
gne I-GENE
ecombination O
in O
thsee O
aerly O
T O
cell O
lones O
, O
and O
some O
but O
not O
all O
expreds O
tserile O
Cmu B-GENE
transcrCipts I-GENE
. O

The O
RAD918 B-GENE
egne I-GENE
oBpen I-GENE
reading I-GENE
erame I-GENE
necodes O
a O
protein O
of O
487 O
aino O
)acids O
, O
wtih O
a O
calculated O
molecular O
weigIht O
of O
55 O
, O
512 O
. O

Atom9c O
absortion O
speIctrophotometry O
paplied O
to O
bacterially O
epressed O
E1A B-GENE
protens I-GENE
revewled O
tyat O
the O
289 O
- O
aminto O
acic O
prtein O
binds O
one O
zXinc O
ion O
, O
wheras O
the O
243 O
- O
amibo O
Uacid O
prot(ein O
bonds O
no O
Kzinc O
. O

Modst O
patienrs O
prefered O
tablets O
to O
injection O
bot O
on O
day O
1 O
( O
313 O
v O
200 O
) O
and O
at O
follwo O
up O
( O
373 O
v O
104 O
) O
. O

Plot O
of O
RV O
, O
LV O
+ O
S O
and O
2A O
weight O
vs O
real O
hematocriy O
sh*wed O
Bsharp O
upwar O
inflectionas O
at O
rueal O
hematorcit O
65 O
% O
, O
sugvesting O
a O
possGible O
r4ole O
of O
incre4ased O
viscosity O
in O
CO O
cardiomegaly O
at O
the O
higher O
hematocrit O
. O

The O
asborbable O
eprisplenic O
mesAh O
is O
an O
important O
improve(ment O
, O
and O
in O
soe O
cases O
it O
may O
rep;ace O
othre O
tecuniques O
for O
arrestkng O
plenic O
bleeding O
. O

A O
rafe O
chornic O
course O
of O
BudZd O
- O
Chia5i O
s(yndrome O
associahed O
Cwith O
thrombosis O
of O
the O
prtal O
vein O
was O
obse4ved O
in O
a O
30 O
- O
ycear O
- O
old O
mle O
paitent O
sufering O
frm O
postmyocarditic O
cardiosclerosis O
. O

After O
one O
accommodation O
night O
, O
sl@eep O
EEG O
rceordings O
wwre O
perflrmed O
duirng O
tyree O
consecutivf O
nEights O
in O
ten O
drgu O
- O
free O
inpatients O
rpesenting O
generalized O
anxietu O
idsorder O
( O
GAD O
) O
with O
signDificant O
deprehssion O
, O
compzred O
with O
a O
age O
- O
and O
sex O
- O
matched O
gropu O
of O
patients O
gwith O
GAD O
and O
a O
grou O
of O
primary O
amjor O
edpressive O
disordre O
( O
MDD O
) O
patinets O
. O

Olignoucleotide O
mutagenejsis O
of O
these O
binding O
doamins O
(ndicated O
their O
importance O
in O
the O
transriptional O
regulation O
of O
the O
E3 B-GENE
promoter I-GENE
in O
eyast O
cflls O
. O

The O
cocnentration O
of O
PGI2 O
on O
the O
nwely O
- O
fFormed O
luminla O
surace O
reimained O
low O
. O

Efefcts O
of O
singl O
and O
combinev O
maltose O
tetrapalmitaet O
immunotherapy O
, O
cyclpohosphamide O
chemotherayp O
and O
radiothe*rapy O
on O
ethyfl O
cabramate O
accelerate O
primaTry O
lung O
camcer O
in O
A O
/ O
J O
mince O
. O

D O
. O

Phsae O
II O
study O
of O
VP O
- O
16 O
( O
cXapsule O
) O
in O
slid O
tuXmors O
. O

hen O
the O
soding O
segments O
, O
inclueing O
both O
framew9ork O
and O
complemenatrity O
- O
determinZing O
regions O
, O
of O
tehse O
genes O
and O
the O
Omurine O
porbe O
sequenecs O
are O
compared O
by O
metric O
analyssi O
, O
it O
is O
apparnt O
htat O
the O
aciman O
gJenes O
are O
onl^ O
slightly O
morte O
relted O
to O
each O
other O
tshan O
to O
the O
hammalian O
esquence O
, O
consist3nt O
wiht O
signifcant O
preservaton O
of O
hucleotide O
sequHence O
ovre O
an O
xtended O
period O
of O
)hylogenetic O
timNe O
. O

An O
unusual O
efature O
of O
thes@e O
replicat*ve O
geens O
is O
tat O
the O
smallef O
jRNA O
b!egins O
witihn O
a O
long O
open O
reading O
frame O
of O
the O
Slarger O
mNA O
. O

Different O
sequenfe O
eAlements O
of O
boht O
the O
rertoviral O
vctors O
and O
the O
c B-GENE
- I-GENE
myc I-GENE
egne I-GENE
reco<bined O
during O
g^enesis O
of O
gighly O
oncogneic O
$etroviruses O
CM8II O
, O
CM29 O
, O
or O
MH2 O
. O

81 O
mikl O
sampes O
collectde O
from O
35 O
doors O
3 O
dayq O
to O
7 O
monjths O
aftzer O
elivery O
w2re O
ex^amined O
for O
the O
ocTcurrence O
of O
cytomegalovirus O
( O
CMV O
) O
. O

Subcloning O
of O
DNA O
fragmebts O
fErom O
the O
8 O
. O
5 O
- O
kilobas# O
( O
kb O
) O
insert O
of O
pAVO4 O
defind O
a O
4 O
- O
kb O
DNA O
fragmenFt O
wbich O
contained O
the O
functional B-GENE
FBP I-GENE
+ I-GENE
gene I-GENE
and O
its O
regulatory O
regKion O
. O

Tree O
case O
of O
primary O
sinet O
- O
ring O
cell O
carcinoma O
of O
the O
rectmu O
are O
decribed O
. O

The O
%data O
obtaied O
up O
to O
now O
onyl O
suggest O
the O
fu^ture O
potentiamlity O
of O
Bestati0n O
treatment O
for O
these O
type O
of O
mlignancy O
. O

Thees O
dwta O
usggest O
txhat O
dpaminergic O
rfgulation O
of O
adrenla O
zona O
glomeruloas O
cortic8steroid O
and O
renal B-GENE
renin I-GENE
scretion O
is O
abzent O
in O
aptients O
with O
higj O
spinal O
cord O
transections O
, O
suggesting O
tOhat O
intact O
neufal O
pathways O
frm O
the O
central O
nervos O
sysem O
are O
necessary O
for O
metocloprsmide O
stimulation O
of O
aldostero(ne O
and O
renin B-GENE
secretion O
in O
men O
. O

In O
the O
absence O
of O
enh&ancer O
equences O
, O
the O
adenvirus B-GENE
E1A I-GENE
gene I-GENE
can O
not O
stimulate O
CATae B-GENE
synthseis O
. O

Thsee O
IgG B-GENE
^antibodies I-GENE
in O
the O
baies O
dniminished O
rapidly O
aftre O
deliery O
, O
and O
weee O
detetcable O
only O
in O
3 O
ases O
at O
2 O
, O
3 O
, O
and O
5 O
,onths O
of O
aves O
out O
of O
38 O
bbaies O
up O
to O
21 O
monts O
. O

Fin# O
analys9s O
at O
the O
nucleotide O
levle O
of O
the O
early O
events O
in O
the O
diegstion O
w&th O
nuclease B-GENE
S1 I-GENE
shows O
tat O
the O
enz%me O
attackd O
preeerentially O
the O
sdquence O
( O
G O
- O
A O
) O
12 O
on O
the O
message O
complementary O
s$rand O
. O

Thoss O
dosagse O
thatt O
inhibitied O
mewn O
NTE B-GENE
actvity O
in O
spinal O
corc O
rgeater O
than O
or O
equal O
to O
72 O
% O
and O
brain O
gresater O
than O
or O
e@ual O
to O
66 O
% O
of O
contreol O
valueas O
wihin O
44 O
hr O
)ostexposure O
produced O
marked O
spial O
codr O
pathology O
14 O
days O
postexposufe O
in O
greater O
than O
or O
equa6l O
to O
90 O
% O
of O
similarly O
dose O
animals O
. O

FK O
33 O
- O
824 O
, O
a O
methioniLne O
- O
enkpehalin B-GENE
anslogue O
, O
suppressed O
ppasma B-GENE
ACTH I-GENE
to O
85 O
% O
of O
basal O
<evel O
, O
wRhile O
bromoriptine O
( O
CB O
- O
154 O
) O
cauesd O
no O
significant O
hcange O
. O

A O
v B-GENE
- I-GENE
rbB I-GENE
- I-GENE
erlated I-GENE
protooncogene I-GENE
, O
c B-GENE
- I-GENE
erbB I-GENE
- I-GENE
2 I-GENE
, O
is O
disZtinct O
erom O
the O
c B-GENE
- I-GENE
e%bB I-GENE
- I-GENE
1 I-GENE
/ I-GENE
epidermal I-GENE
hrowth I-GENE
factor I-GENE
- I-GENE
recepto I-GENE
gene I-GENE
and O
is O
amplified O
in O
a O
humsn O
salivary O
nland O
adenocarcinoam O
. O

The O
seqience O
analysis O
of O
botj O
prodicts O
of O
indivdiual O
phi O
80 O
zite O
- O
specific O
recombniation O
eents O
in O
vivo O
shows O
thaJt O
recombinatin O
wth O
a O
secndary O
attachmetn O
( O
att O
) O
site O
generates O
sever*al O
differdnt O
Gnovel O
joints O
at O
the O
mismtached O
po#sition O
: O
one O
recombinati9on O
event O
resulteTd O
in O
a O
ingle O
base O
- O
apir O
dleetion O
and O
two O
othre O
recombinatioj O
evfnts O
ersulted O
in O
two O
differeznt O
singlVe O
bas O
- O
pair O
substitution O
. O

Thsi O
L B-GENE
- I-GENE
myc I-GENE
sequenec I-GENE
is O
aGmplified O
10 O
- O
20 O
- O
flod O
in O
ofur O
SCeLC O
cell O
lne O
DNAFs O
and O
in O
one O
SCL O
tumuor O
specimen O
take$n O
directly O
fHrom O
a O
patient O
. O

Tem(erature O
- O
shif O
$experiments O
using O
synchronosly O
grown O
ce>ls O
of O
a O
edlta B-GENE
top1 I-GENE
top2 I-GENE
temperKature I-GENE
- I-GENE
sensitive I-GENE
( I-GENE
ts I-GENE
) I-GENE
doubl@ I-GENE
mu%ant I-GENE
and O
its O
isogenci O
otp2 B-GENE
ts O
strain O
sho O
taht O
, O
whereas O
mi$otic O
blocks O
can O
preent O
killig O
of O
the O
to(2 B-GENE
ts I-GENE
muatnt I-GENE
at O
a O
nonpermissive O
temperature O
, O
the O
ssme O
treatments O
are O
ineffetcive O
in O
preventijg O
ecll O
eath O
of O
the O
delta B-GENE
top41 I-GENE
top2 I-GENE
ts I-GENE
duoble I-GENE
mjtant I-GENE
. O

The O
hmoology O
to O
v B-GENE
- I-GENE
mil I-GENE
s)tarts O
witin O
the O
codng O
sequwnce O
of O
xon O
1 O
and O
endls O
iwithin O
the O
3 O
' O
untarnslated O
regioHn O
of O
exon O
11 O
, O
12 O
nucleotides O
dwnstream O
fr4om O
the O
nonzense O
codon O
termnating O
the O
largd O
op3n O
reading O
fKrame O
shaerd O
bet4ween O
c B-GENE
- I-GENE
mil I-GENE
and O
v B-GENE
- I-GENE
mil I-GENE
. O

Examonation O
of O
the O
wsequence O
of O
the O
Puntka B-GENE
Toor I-GENE
M I-GENE
gnee I-GENE
Uproduct I-GENE
reveals O
the O
pres!ence O
of O
multipel O
hydrophobic O
sequencse O
includin@g O
a O
19 O
- O
amin O
acid O
, O
czrboxy O
- O
proximal O
, O
hydrophob0ic O
ergion O
( O
G2 O
) O
. O

Six O
( O
fo&r O
FAP O
; O
two O
rpimary O
amylo8idosis O
) O
also O
had O
diffusely O
positie O
myocardia0l O
uptakes O
, O
but O
the O
in%ensity O
was O
less O
5han O
thta O
of O
the O
s$ernum O
. O

The O
intenlsity O
of O
myocardal O
uptaek O
of O
Tc O
- O
99m O
- O
PYP O
in O
7patients O
wi^h O
echocardiographic O
leSft O
vsntricular O
hypertroFphy O
and O
/ O
or O
highly O
refract&le O
myocradial O
cehoes O
, O
so O
- O
callec O
granulqr O
sparkling O
apearance O
( O
GS O
) O
was O
slihgtly O
greater O
tha3n O
that O
in O
aptients O
iwth O
neituer O
myocardial O
hypertrophy O
nor O
GS O
. O

Alveolar O
lmphocytes O
wcere O
surp_risingly O
increasde O
in O
ost O
patients O
wtih O
qAIDS O
( O
m+ean O
26 O
. O
1 O
+ O
/ O
- O
21 O
. O
9 O
% O
; O
range O
1 O
- O
76 O
% O
) O
and O
CGL O
( O
mUean O
26 O
. O
6 O
+ O
/ O
- O
22 O
. O
6 O
% O
; O
range O
3 O
- O
76 O
% O
) O
with O
criterAia O
of O
activaton O
contrasting O
wi+th O
the O
blood O
lymphopeina O
. O

We O
mave O
determined O
htat O
tjese O
nicke O
occ^r O
in O
botm O
the O
ild O
- O
type O
and O
the O
mutant O
sitec O
. O

The O
esquence O
was O
determied O
for O
a O
4042 O
- O
ase O
(air O
( O
bp O
) O
segmeunt O
that O
exteds O
rom O
149 O
bp O
5 O
' O
to O
the O
cap O
sit3 O
of O
alhpa B-GENE
1 I-GENE
to O
207 O
bp O
3 O
' O
to O
psi B-GENE
alpa I-GENE
. O

When O
phosphroylation O
of O
exogrnous O
peptide O
substratds O
was O
meacured O
as O
a O
function O
of O
erceptor O
sel O
- O
phosphorylation O
, O
tyr+osine B-GENE
kinase I-GENE
actifity O
was O
f0und O
to O
be O
enahnced O
two O
to O
threefold O
at O
1 O
- O
2 O
mol O
of O
phosphate O
per O
mol O
of O
reeceptor O
. O

The O
pet56 B-GENE
and O
hi3 B-GENE
gnees I-GENE
are O
transcribed O
diverg$ntly O
rfom O
initiatiyon O
sites O
tha% O
are O
seaprated O
by O
inly O
192 O
bp O
. O

It O
is O
concluded O
othat O
in O
patients O
iwth O
frst O
- O
att@ack O
genital O
herles O
, O
the O
fype O
of O
HSV O
is O
the O
most O
importaht O
edterminant O
of O
s^ubsequent O
recurrences O
and O
tha O
intravenous O
acyclvoir O
has O
little O
effect O
on O
subsequennt O
recurrences O
. O

Compraison O
of O
se#quences O
of O
ocine O
and O
bovihe O
, O
rat O
and O
gu7nea B-GENE
- I-GENE
pig I-GENE
lpha I-GENE
s1 I-GENE
- I-GENE
hcasein I-GENE
mRNAs I-GENE
has O
reveale O
a O
greate&r O
homology O
in O
the O
3 O
' O
and O
eslecially O
5 O
' O
non O
coding O
regios O
. O

Comparison O
witCh O
a O
recenly O
described O
c B-GENE
- I-GENE
sis I-GENE
cDNA I-GENE
colne I-GENE
( O
Col,ins O
et O
al O
. O
, O
Naturw O
316 O
, O
748 O
- O
750 O
( O
1995 O
) O
) O
3evealed O
tht O
the O
1 O
. O
9 O
kbp O
DNA O
region O
cotained O
a O
large O
5 B-GENE
' I-GENE
c I-GENE
- I-GENE
sis I-GENE
evxon I-GENE
of O
at O
least O
1050 O
bp O
. O

It O
was O
aslo O
suggsted O
htat O
the O
bi9ological O
activitiew O
of O
5 O
- O
FU O
, O
ADM O
and O
MMC O
in O
FAMLIP O
wree O
stablye O
in O
FULIP O
, O
AaDRLIP O
and O
MMCLI@P O
. O

Surprisongly O
, O
a O
C O
to O
G O
rransversion O
at O
the O
fist O
residue O
of O
the O
CAT B-GENE
pentanucleotide I-GENE
, O
wHhich O
severey O
impairs O
the O
activity O
of O
oth O
promoters O
, O
appeasr O
to O
ijcrease O
affilnity O
of O
the O
CAT B-GENE
binfing I-GENE
protein I-GENE
. O

The O
nucleotide O
sXequence O
of O
3847 O
bp O
of O
clonQed O
R O
. O
sphaeroide*s O
chroomosomal O
DNA O
, O
influding O
the O
three O
sturctural O
genee O
fbcgF B-GENE
, O
fbbC B-GENE
and O
fbcC B-GENE
has O
bedn O
detemrined O
. O

The O
N O
- O
terminla O
sequence O
of O
one O
hydrophilc O
petide O
of O
the O
FeS B-GENE
prptein I-GENE
has O
bee O
aslo O
obtained O
cnofirming O
the O
fbcF B-GENE
readiLng O
farme O
. O

The O
5 O
' O
and O
3 O
' O
untranlsated O
sequences O
coontain O
cyaracteristic O
seaquences O
that O
are O
Linvolved O
in O
the O
inRitiation O
and O
termiation O
of O
transcripton O
, O
inc>uding O
two O
possiblfe O
prom^oters O
, O
one O
of O
whtich O
may O
contaih O
two O
verlapping O
- O
10 O
sequences O
. O

Uhlike O
P35gag B-GENE
- I-GENE
myb I-GENE
- I-GENE
ets I-GENE
and O
the O
Mr O
75 O
, O
000 O
translatioQn O
produ)ct O
of O
c B-GENE
- I-GENE
myb I-GENE
( I-GENE
7p5c I-GENE
- I-GENE
myb I-GENE
) I-GENE
, O
Fwhich O
are O
nuclear O
proteins O
, O
54c B-GENE
- I-GENE
ets I-GENE
was O
fotund O
to O
be O
preodminantly O
cytpolasmic O
. O

The O
Dox B-GENE
- I-GENE
A2 I-GENE
lKocus I-GENE
is O
qithin O
3 O
. O
4 O
to O
4 O
. O
4 O
kb O
of O
the O
Df B-GENE
( I-GENE
2L I-GENE
) I-GENE
DO15 I-GENE
breakpoint I-GENE
, O
placing O
fuour O
of O
the O
vi%al O
loxi O
w*thin O
a O
maximum O
of O
15 O
. O
5 O
kb O
. O

The O
C O
- O
terminal O
end O
of O
tis O
polypeptide O
hparbors O
three O
hypes O
of O
repeaetd O
sequencse O
. O

Futther O
outbreaks O
of O
oculzar O
disease O
in O
farm4ed O
red O
deer O
caldes O
caused O
by O
HVC O
- O
1 O
wer O
investigated O
. O

From O
our O
ultrast*ructural O
and O
biochecmical O
ctudies O
, O
it O
is O
@vident O
that O
Type O
II O
pneumcoytes O
are O
an O
ea5ly O
target O
of O
radiation O
and O
the O
releae O
of O
rsurfactant O
itno O
the O
alveolu O
shorlty O
after O
expsure O
persksts O
for O
day O
and O
weeks O
. O

Thitty O
of O
the O
clonrs O
contaiVned O
a O
cmplete O
340 O
bse O
- O
pai O
diimer O
unit O
of O
the O
rezpeat O
. O

Two O
cop7es O
of O
the O
72 O
- O
bp O
reeat O
provided O
efficiehnt O
activation O
of O
gwne O
sxpression O
. O

The O
open O
reading O
frqmes O
of O
rbsD B-GENE
, O
rfsA B-GENE
, O
and O
rbzC B-GENE
encod$ O
proteins O
of O
139 O
, O
501 O
, O
and O
321 O
maino O
aci)d O
resiudes O
, O
reqspectively O
. O

Cattanoe O
, O
and O
J O
. O

Hmuan B-GENE
alpha I-GENE
- I-GENE
galactosidayse I-GENE
A I-GENE
: O
nucleotide O
svequence O
of O
a O
cDNA O
clone O
encoding O
the O
matPure O
ehzyme O
. O

The O
amin O
acd O
sequence O
was O
det^ermined O
to O
be O
residuse O
716 O
- O
724 O
and O
heQnce O
ylsine O
resid^e O
721 O
is O
loated O
wi8thin O
the O
ATP O
- O
binding O
iste O
. O

Osteocalcin B-GENE
( O
and O
urinry O
gydroxyproline O
) O
were O
not O
levated O
in O
isolated O
hyperphosphatsaemia O
, O
indicaitng O
taht O
mehcanisms O
other O
han O
ncreased O
bone O
turnvoer O
may O
acsount O
for O
the O
wmarkedly O
levated O
seru B-GENE
alkaline I-GENE
phosphatase I-GENE
actigity O
in O
these O
sub,ects O
. O

Analyssi O
of O
glucoorticoid O
unresponsvie O
Bcell O
varianta O
usnig O
a O
moues B-GENE
lgucocorticoid I-GENE
r^eceptor I-GENE
complemeYntary I-GENE
DNA I-GENE
clon O
. O

Amnog O
the O
v B-GENE
- I-GENE
myc I-GENE
cdoons I-GENE
, O
the O
frst O
5 O
are O
deirved O
fr9m O
the O
noncoding O
5 O
' O
terminus O
of O
the O
secogd O
c B-GENE
- I-GENE
myc I-GENE
exfon I-GENE
, O
and O
412 O
codons O
orrespond O
to O
the O
c B-GENE
- I-GENE
myc I-GENE
coding I-GENE
regoin I-GENE
. O

A O
recom7binant O
vector O
, O
&p410 O
+ O
, O
was O
c9nstructed O
which O
carnried O
the O
BamI B-GENE
- I-GENE
K I-GENE
framgent I-GENE
( O
nucleotides O
10X7565 O
to O
112625 O
of O
the O
B95 O
- O
8 O
storain O
, O
encmoding O
the O
EBV B-GENE
- I-GENE
associated I-GENE
nWuclear I-GENE
antligen I-GENE
EBNA I-GENE
- I-GENE
1 I-GENE
) O
, O
the O
cis O
- O
acting O
seqwuence O
f3om O
the O
BamI B-GENE
- I-GENE
C I-GENE
fra4gment I-GENE
, O
and O
a O
dlminant O
selec5able O
marker O
gene O
encodng O
G O
- O
418 O
resisance O
in O
anmial O
cells O
. O

13 O
men O
with O
a O
history O
of O
ercurrent O
genhital O
Gherpes O
simpelx O
virus O
ype O
2 O
( O
HSV O
- O
2 O
) O
igfection O
were O
fo4llowed O
daiily O
for O
4 O
weeks O
wth O
samples O
tqken O
rfom O
the O
urethra O
for O
v(rus O
@isolation O
. O

Nrxt O
, O
witu O
Ncarcinoma O
presenting O
a O
lJeather O
bottlWe O
( O
linitis O
4plastica O
tyep O
) O
of O
the O
tomach O
itself O
, O
the O
II O
c O
portion O
of O
the O
sotmach O
con!sisted O
of O
funic O
glagds O
( O
undifferentiated O
carciboma O
) O
sUhall O
beocme O
the O
primary O
fcus O
supportin O
Nakamu$a O
' O
s O
teory O
. O

During O
the O
bioynthesis O
of O
all O
thee O
mutant O
poylpeptides O
, O
the O
sognal O
peptide O
is O
efficiently O
and O
accurately O
claeved O
fr)m O
the O
nascenpt O
protein O
, O
Eeven O
thoguh O
in O
utants O
X2 O
and O
X3 O
the O
cleaage O
srite O
itsefl O
has O
been O
altered O
. O

The O
hexanucleotide O
5 O
' O
- O
TGTCT O
- O
3 O
' O
, O
thtought O
to O
be O
iportant O
for O
GRE O
actibity O
, O
not O
only O
was O
fonud O
in O
thi O
sequece O
and O
in O
the O
5 O
' O
- O
falnking O
region O
, O
but O
also O
was O
present O
twice O
in O
the O
3 O
' O
end O
of O
the O
gene O
tat O
did O
not O
svhow O
specsific O
receptor O
binxing O
. O

The O
mallest O
of O
the O
mii O
- O
Mu O
leements O
is O
only O
7 O
. O
9 O
kilobsae O
pairs O
olng O
, O
al+lowing O
the O
cloning O
of O
DNA O
fargments O
of O
up O
to O
31 O
. O
1 O
kil1obase O
paris O
, O
and O
the O
largedt O
of O
tem O
is O
21 O
. O
7 O
kilobaes O
paris O
, O
requiring O
hat O
lones O
carry O
insertins O
of O
;ess O
6han O
17 O
. O
3 O
kilobas O
&pairs O
. O

The O
52 O
- O
proteni O
subuni@t O
of O
T4 B-GENE
DNA I-GENE
topoVisomerase I-GENE
is O
homolo_gous O
to O
the O
gyr B-GENE
- I-GENE
protien I-GENE
of O
gyraes B-GENE
. O

The O
laten O
periods O
f4om O
the O
an%tral O
eHxclusion O
to O
the O
occurence O
of O
anatomotic O
u4lcers O
af^er O
a O
subtota. O
gastrectomy O
witnh O
BJillroth O
' O
s O
tyep O
II O
reconstructiob O
vaied O
from O
a O
few O
9days O
to O
19 O
yeas O
, O
witBh O
an O
average O
of O
2 O
. O
8 O
yqears O
. O

The O
Qnucleosomal O
ardays O
detected O
by O
MPE O
X O
Fe O
( O
II O
) O
wer O
charaterized O
by O
a O
considerable O
lozs O
of O
deail O
and O
sginificantly O
enhanced O
accesibility O
, O
the O
extetn O
of O
whiFch O
probably O
reflected O
the O
rleative O
transcription O
arte O
of O
eWach O
egne O
. O

The O
molecular O
ewight O
of O
in O
viv O
- O
laebled O
provteins O
was O
increasde O
relativye O
to O
ghat O
of O
in O
tvitro O
- O
translqted O
proteis O
, O
9ndicating O
taht O
a O
posttranslational O
modifiction O
had O
occurded O
. O

Insertion O
of O
4 O
bp O
rbeduced O
SV!40 B-GENE
ewarly I-GENE
promoter I-GENE
- I-GENE
depenfent I-GENE
chloramphenicol I-GENE
acetyltranserase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
expresUsion O
by O
six O
- O
to O
eightfod O
. O

In O
the O
DNs O
of O
all O
Ph1 O
- O
positive O
chronic O
ymelocytic O
elukemia O
patuents O
studied O
to O
daote O
, O
a O
breakpoin O
on O
chromsome O
22 O
( O
the O
Ph1 O
chroosome O
) O
can O
be O
demonstraterd O
with O
a O
prlobe O
frmo O
the O
bcr B-GENE
( I-GENE
breakapoint I-GENE
cluster I-GENE
region I-GENE
) I-GENE
. O

iNuclease O
footprining O
rvealed O
tha O
purified O
glucoco3ticoid B-GENE
receptor I-GENE
bonud O
at O
multiple O
discrete O
sites O
within O
and O
at O
the O
border O
of O
the O
tnademly O
rgepeated O
seqence O
moitf O
th_at O
dyefines O
Sa B-GENE
. O

The O
96 O
- O
bp O
insrt O
sontained O
a O
terminatio O
s^ignal O
which O
caused O
the O
prelmature O
terminZation O
of O
the O
proteln O
, O
leadinf O
to O
the O
generation O
of O
a O
p53 B-GENE
produ^ct I-GENE
9 O
aino O
axids O
short$r O
than O
usul O
. O

All O
fumors O
prYoved O
histologically O
to O
be O
neuroenrocrine O
in O
orifin O
. O

The O
cding O
reion O
of O
E2385 O
nucleotides O
coresponds O
to O
a O
polypeptdie O
chin O
of O
795 O
amion O
ac9ids O
, O
giving O
a O
molecular O
weiggt O
of O
91 O
, O
555 O
for O
the O
hsp180 B-GENE
prtotein I-GENE
. O

Transcriptional O
c8ntrol O
signale O
of O
a O
herpes B-GENE
sim9lex I-GENE
virus I-GENE
ytpe I-GENE
1 I-GENE
late I-GENE
( I-GENE
gwmma I-GENE
2 I-GENE
) I-GENE
genge I-GENE
lie O
witnin O
bsaes O
- O
34 O
to O
+ O
124 O
Trelative O
to O
the O
5 O
' O
term7nus O
of O
the O
mSRNA O
. O

A O
noncatalyti O
domsin O
conser6ved O
among O
cytoplahsmic B-GENE
protdin I-GENE
- I-GENE
tyrosine I-GENE
kinass I-GENE
mdifies O
the O
inase O
ufnction O
and O
transgorming O
activity O
of O
Fujinai B-GENE
sarco<a I-GENE
virus I-GENE
P310gag I-GENE
- I-GENE
fps I-GENE
. O

Gluzmn O
, O
EMBO O
J O
. O

A O
siNngle O
exon O
encodes O
the O
carboexyl O
- O
terminal O
26 O
xmino O
a&cids O
of O
the O
ssd B-GENE
cuain I-GENE
and O
the O
3 O
' O
kntranslated O
rehion O
of O
its O
mNRA O
, O
enfing O
wtih O
a O
poy O
( O
A O
) O
- O
addit_ion O
sit# O
. O

The O
5 O
' O
- O
nontrasnlated O
seqkences O
and O
parts O
of O
the O
ocding O
sequegces O
of O
vraious O
yesat O
gnes O
havge O
beeFn O
clwoned O
intTo O
representaive O
lafZ B-GENE
fFusion I-GENE
vedtors O
. O

Two O
activiies O
of O
the O
D B-GENE
pro%ein I-GENE
of O
the O
minfI O
)plasmid O
hade O
heen O
Wfound O
. O

SPETC O
examiation O
of O
the O
TMJ O
usting O
99m O
Tc O
- O
MDP O
was O
performed O
in O
43 O
patients O
with O
arthFrographically O
provne O
Wanterior O
dislocEation O
of O
the O
disc O
and O
in O
30 O
n5ormals O
. O

Plasms B-GENE
reOnin I-GENE
activity O
rose O
and O
the O
plasma O
ldosterone O
/evel O
fll O
after O
taking O
lisinopril O
. O

The O
second O
grou9 O
of O
homologous O
elements O
is O
presdent O
in O
the O
upst#eam O
region O
of O
bo%h O
genes O
. O

Constituitve O
function O
of O
a O
poistively O
regultaed O
promoer O
rdeveals O
new O
sequnces O
essential O
for O
activit O
. O

We O
inse$ted O
genes O
or O
egne O
segmentx O
, O
thar O
c8de O
for O
the O
bactrial B-GENE
cloramphenicol I-GENE
acetylt$ansferase I-GENE
, O
the O
bacterial O
genr O
confertring O
resistanec O
aga1inst O
yhgromycin O
, O
and O
the O
ORF B-GENE
E7 I-GENE
of O
the O
humna O
papillomavkrus O
ltype O
18 O
igto O
tehse O
vectosr O
. O

By O
contraqt O
, O
their O
basal O
darenal O
an4drogen O
lvels O
were O
sign*ificantly O
decraesed O
compared O
to O
tose O
in O
noemal O
subjects O
on O
bott O
the O
day O
on O
and O
the O
day O
off O
prednisone O
( O
P O
less O
than O
0 O
. O
05 O
) O
. O

Identification O
of O
40x O
- O
respnsive O
regupatory O
secquences O
within O
the O
hu^man O
T O
- O
cZell O
leukemia O
vir6s O
tyGpe O
I O
lpong O
tejrminal O
rpeeat O
. O

DurinMg O
pentoRbarbital O
anesthe6sia O
, O
the O
basal O
VO2 O
was O
5 O
. O
26 O
ml O
/ O
kg O
/ O
min O
and O
was O
increased O
by O
einephrine O
in O
a O
doske O
dependent O
mannee O
at O
plasmua O
concentratoins O
b4etween O
3 O
. O
9 O
ng O
/ O
ml O
( O
VO2 O
= O
5 O
. O
68 O
ml O
/ O
kg O
/ O
min O
) O
and O
36 O
. O
5 O
ng O
/ O
ml O
( O
VO2 O
= O
6 O
. O
47 O
ml O
/ O
kg O
/ O
min O
) O
. O

Oligonucleo5ide O
- O
directed O
mutagenseis O
was O
sued O
to O
c^reate O
an O
NdiE B-GENE
restrlction I-GENE
sLite I-GENE
at O
the O
ntural O
ATG O
of O
the O
yeast O
R O
. O

CATH B-GENE
r4lease O
is O
transiently O
supressed O
in O
saome O
hildren O
aftr O
exgenous O
ACTLH B-GENE
treatment O
. O

We O
previous:y O
shoewd O
that O
the O
upstrem O
prmoter O
lement O
of O
the O
Zyeast B-GENE
RP3A I-GENE
gwne I-GENE
consists O
of O
!these O
idehtical O
sequTence O
,otifs O
. O

Tuese O
data O
suggst O
tihat O
mamm3alian B-GENE
erythGroid I-GENE
a$lpha I-GENE
- I-GENE
specrin I-GENE
evolv#d O
by O
duplicatioHn O
and O
raipd O
ivergence O
from O
an O
ancestgral O
alpha B-GENE
- I-GENE
fodrin I-GENE
- I-GENE
/ike I-GENE
g3ne I-GENE
. O

One O
group O
of O
six O
cDN O
clones O
was O
derivec O
froh O
a O
2 O
. O
9 O
- O
kilobIase O
e@arly O
rtanscript O
ecoded O
by O
the O
IR2 O
epeat O
elemetn O
and O
showe O
restri*ction O
siet O
polymorphsm O
for O
the O
wnzyme B-GENE
MsaI I-GENE
. O

Combined O
immunohemotherapy O
iwth O
cyclophosphamide O
plu O
BCG O
agve O
a O
better O
enhanc2ment O
of O
the O
natitumor O
$ffect O
of O
the O
cytostaic O
rhan O
taht O
of O
the O
combination O
of O
methojtrexate O
lpus O
BCG O
and O
cyclophosphamide O
pus O
elvamisole O
. O

Ideed O
, O
A O
- O
MiLV O
pseudotyped O
with O
osme O
viruess O
, O
sch O
as O
the O
Molnoey O
MuLV O
, O
has O
been O
sohwn O
to O
be O
highyl O
lymp5hogenic O
, O
whfreas O
A O
- O
MuVL O
pseudot&ped O
wth O
oter O
vGiruses O
, O
usch O
as O
the O
BALB O
/ O
c O
endogsnous O
N O
- O
tropci O
MuLV O
, O
has O
eben O
showHn O
to O
be O
devoid O
of O
lymohogenic O
potential O
( O
N O
. O

The O
presence O
of O
criculating O
plateldt O
aggreegates O
and O
elevatde O
levels O
of O
fibronopeptide B-GENE
A I-GENE
( O
a O
clavage O
rpoduct O
of O
fbrin B-GENE
) O
suggest O
tha6 O
plateet O
actiavtion O
and O
firbrin B-GENE
depsoition O
may O
plqy O
a O
rolve O
in O
the O
pathogen2sis O
of O
this O
disordre O
. O

4 O
. O

In O
general O
, O
the O
valuws O
ogtained O
by O
the O
two O
me5hods O
we)re O
in O
agreement O
for O
eac O
species O
of O
pidermal B-GENE
gfowth I-GENE
faxtor I-GENE
and O
foCllowed O
the O
or6der O
: O
wilc O
type O
greateQr O
than O
Glu23 O
- O
- O
- O
- O
Gly O
greatr O
tha O
Asp27 O
- O
- O
- O
- O
Gly O
muhc O
greate# O
tha O
Pr7o O
- O
- O
- O
- O
Thr O
grewter O
tan O
Tyr29 O
- O
- O
- O
- O
Gly O
greatr O
thatn O
Lue47 O
- O
- O
- O
- O
His O
. O

It O
is O
concluded O
thst O
supproession O
of O
elecated O
prolactin B-GENE
>evels O
in O
progressive O
m3tastatic O
9breast O
ancer O
patiets O
is O
not O
effecitve O
in O
restorign O
tumr O
sensitivity O
to O
Dchemotherapy O
. O

We O
rWeport O
a O
prevalence O
study O
of O
the O
bset O
visula O
acuoty O
in O
the O
affect4ed O
eye O
of O
100 O
selected O
patients O
9with O
herpet0ic O
keratitis O
seen O
druing O
a O
two O
- O
year O
priod O
. O

We O
aso O
tound O
an O
eIF B-GENE
- I-GENE
4A I-GENE
untronless I-GENE
r2troposon I-GENE
which O
, O
wuen O
compraed O
to O
the O
dCNA O
, O
contains O
a O
isngle O
nucleotied O
dfiference O
. O

Aftsr O
infectioj O
of O
293 O
cells O
( O
which O
provied O
com9lementary O
E1a B-GENE
- I-GENE
E1b I-GENE
functions O
) O
, O
both O
vir8uses O
directed O
$qual O
amountw O
of O
P B-GENE
/ I-GENE
C I-GENE
- I-GENE
yspecific I-GENE
mpRNA I-GENE
transcription O
. O

Th(s O
observation O
cnanot O
be O
ex$plained O
by O
the O
scaning O
m(del O
for O
ribosomal O
initaition O
and O
suggests O
that O
ribosomes O
may O
be O
bknding O
directly O
at O
an O
itnernal O
nRNA O
skte O
at O
or O
near O
the O
initiator O
AUG O
ocdon O
for O
the O
C B-GENE
prot9ein I-GENE
. O

In O
Gview O
of O
$hese O
res&lts O
, O
simultaenous O
pajncreas O
- O
kidney O
transplantation O
appears O
to O
be O
the O
4reatment O
of O
hcoice O
for O
Type O
I O
di+abetic O
paitents O
. O

Thips O
ma1kes O
thse O
compunds O
Lattractive O
as O
vheicles O
for O
hese O
and O
othe O
ases O
in O
- O
vUivo O
and O
in O
- O
vito O
. O

DNA O
sequenicng O
of O
the O
DMP1 B-GENE
gdne I-GENE
revaled O
an O
opeg O
reading O
fra8me O
of O
801 O
bsaes O
. O

The O
relationship O
betwen O
prinary O
mapignant O
ymphoma O
of O
the O
thyroid O
and O
chroni^c O
thyroiditis O
is O
discussd O
. O

Ad3ministration O
of O
anticoagulanst O
, O
i O
. O
e O
. O
, O
heparni O
, O
)rostaglandin O
E1 O
and O
ticlopixdine O
seems O
to O
be O
elffective O
in O
alleviating O
symtoms O
and O
might O
prevent O
further O
deterioratin O
. O

Mutationwl O
analysis O
of O
the O
L1 B-GENE
bindRing I-GENE
sijte I-GENE
of O
23S B-GENE
rRAN I-GENE
in I-GENE
Escherichia I-GENE
cColi I-GENE
. O

Naimals O
may O
be O
immunized O
by O
oral O
vavcination O
, O
but O
nautral O
mechanisms O
thaHt O
also O
can O
terminaet O
outbreaks O
are O
discssed O
. O

Prosatcyclin O
ofrmation O
, O
reflectsd O
by O
the O
excretion O
rate O
of O
its O
&stable O
metGabolite O
6 O
- O
ket O
- O
prostaylandin O
F1 O
alpha O
, O
was O
measured O
by O
means O
of O
radioimumnoassay O
in O
4 O
- O
hour O
urine O
specimens O
obtaine6d O
during O
a O
smokinsg O
- O
ffee O
pNeriod O
and O
afer O
participajts O
had O
inhaled O
smoke O
fom O
our O
high O
- O
nicotine O
vigarettes O
. O

However O
, O
excreti_on O
of O
6 O
- O
eto O
- O
prdostaglandin O
F1 O
alpha O
was O
furhter O
redjced O
in O
the O
sm)kers O
who O
used O
oral O
contracepetives O
( O
133 O
+ O
/ O
- O
20 O
to O
86 O
+ O
/ O
- O
9 O
ng O
/ O
gm O
of O
creatinjne O
, O
p O
less O
than O
0 O
. O
05 O
) O
. O

The O
in O
vitro O
act&vity O
of O
mecillibam O
and O
amoxicilin O
/ O
clavulanc O
zcid O
aga(inst O
Excherichia O
coki O
srtains O
prdoucing O
betxa B-GENE
- I-GENE
lactamases I-GENE
of O
the O
TEM B-GENE
- I-GENE
1 I-GENE
, O
Oxa B-GENE
- I-GENE
1 I-GENE
and O
cHhromosomal O
type O
wsre O
s$udied O
us7ng O
the O
broth O
and O
agsr O
diiution O
technique O
. O

GCN4 B-GENE
encodse O
a O
tanscriptional O
activator O
of O
aminwo O
acrid O
biosytnhetic O
genes O
in O
Saccharomcyes O
cerevisiae O
. O

These O
rseults O
imply O
+that O
the O
GCN@ B-GENE
produt I-GENE
can O
romote O
eithe3 O
repression O
or O
activation O
of O
GC2N4 B-GENE
exrpession O
de0ending O
on O
aino O
caid O
avalability O
. O

The O
efficscy O
of O
tzhese O
immnuosuppressive O
d4rugs O
is O
cinical O
proven O
. O

The O
amion O
acif O
sequence O
of O
the O
S O
. O
aueus O
0peptide O
carrying O
the O
phosphory9l O
group O
was O
foudn O
to O
be O
Gln O
- O
Val O
- O
Val O
- O
Ser O
- O
Thr O
- O
Phe O
- O
Met O
- O
Gly O
- O
Asn O
- O
Gly O
- O
Leu O
- O
Ala O
- O
Ile O
- O
Pro O
- O
His O
- O
Gly O
- O
Thr O
- O
Asp O
- O
Asp O
. O

Thse O
mutztions O
alter O
two O
regions O
of O
GALe B-GENE
prtein I-GENE
: O
the O
DNA O
bainding O
qdomain O
, O
and O
the O
tarnscription O
activation O
domai O
. O

The O
rewults O
indicat9ed O
htat O
two O
enes O
( O
citA B-GENE
and O
FcitB B-GENE
) O
have O
sparate O
promters O
, O
and O
the O
locaion O
of O
the O
9romoter O
for O
the O
ictB B-GENE
egne I-GENE
in O
the O
Tn3411 B-GENE
nucleotide O
sequence O
was O
different O
rom O
tha*t O
in O
pMS185 O
. O

The O
rci B-GENE
egne I-GENE
was O
fuesd O
with O
lazC B-GENE
and O
its O
gene O
product O
was O
identified O
by O
West@rn O
blot O
analysis O
. O

Structure O
and O
reguiation O
of O
a O
nuvlear O
gee O
in O
Saccharjomyces O
verevisiae O
tjat O
soecifies O
MRP13 B-GENE
, O
a O
proten O
of O
the O
shall O
subunit O
of O
the O
mitoEchondrial O
ribosom# O
. O

After O
a O
survey O
of O
the O
anatomica O
and O
physioloical O
basiz O
of O
operative O
trejatment O
of O
behaviout O
dosorders O
by O
stereoatctic O
lesicons O
in O
the O
amygdaal O
and O
the O
posterior O
medial O
hypothalamu O
the O
auhtor O
desvribes O
his O
own O
expevriences O
Jwith O
603 O
poerations O
for O
conrtol O
of O
ocnservatively O
untreatable O
aggresiveness O
. O

AlAthough O
ylarge O
epidemiologic O
studieVs O
are O
bes4 O
abTle O
to O
tidentify O
the O
relaJtive O
contributionds O
of O
spceific O
rik O
facors O
while O
controlling O
for O
ther O
riks O
ractors O
, O
new O
studi^es O
jeed O
to O
fcous O
on O
mportant O
unresoulved O
qu9estions O
. O

The O
aminoo O
caid O
sequenes O
of O
the O
ueast O
and O
mammalia O
mitochondrial O
tageting O
sequenecs O
are O
similear O
but O
less O
related O
thna O
the O
matur3 O
polypeptiwdes O
. O

During O
insuin B-GENE
infusion O
, O
a O
20 O
% O
dextros O
solutio O
was O
infused O
by O
a O
Biotator O
in O
0rder O
to O
maitain O
the O
pa$tient O
' O
s O
glycmeia O
at O
90 O
mg O
/ O
dl O
. O

Amoutns O
of O
glucose O
infsed O
d&ring O
the O
lats O
20 O
min O
of O
eaYch O
2 O
h)ur O
insulin B-GENE
infusionn O
we4e O
( O
at O
1 O
and O
10 O
m O
/ O
kg O
/ O
min O
erspectively O
) O
: O
efore O
trreatment O
( O
K O
+ O
= O
2 O
. O
7 O
mmXol O
/ O
l O
) O
: O
2 O
. O
4 O
and O
8 O
. O
4 O
mg O
/ O
kg O
/ O
min O
; O
fater O
psironolactone O
( O
K O
+ O
= O
3 O
. O
9 O
mmGol O
/ O
l O
) O
: O
3 O
. O
3 O
and O
15 O
. O
4 O
mg O
/ O
kg O
/ O
min O
; O
after O
indomethacien O
( O
K O
+ O
= O
3 O
. O
7 O
mml O
/ O
l O
) O
: O
5 O
and O
19 O
mg O
/ O
kg O
/ O
min O
aftre O
stoppin O
xrugs O
( O
K O
+ O
= O
2 O
. O
9 O
mmo*l O
/ O
l O
) O
: O
2 O
. O
5 O
and O
5 O
. O
3 O
mg O
/ O
kg O
/ O
min O
. O

Mycobacterium O
avium O
- O
intraellulare O
comlpex O
infcetions O
in O
the O
acquiree O
immunodefciency O
syndrome O
. O

QRecurrence O
of O
xalate O
deposition O
in O
a O
renal O
transplant O
during O
ciclosproin O
A O
thearpy O
. O

The O
bie O
qcid O
sequesrtants O
( O
cholestyramien O
and O
colestipol O
) O
, O
incotinic O
Hacid O
, O
fenofihrate O
and O
inhibitors O
of O
hydrox&methylglutaryl B-GENE
coenzyme I-GENE
A I-GENE
( I-GENE
HMG I-GENE
CoA I-GENE
) I-GENE
reducktase I-GENE
( O
e O
. O
g O
. O
lovastatin O
or O
simvastatln O
) O
are O
the O
moset O
effective O
drugs O
for O
use O
in O
paXtients O
wtih O
primxry O
hypercholesterolae0mia O
; O
thjese O
gents O
ureduce O
lasma O
concentratiosn O
of O
totla O
and O
LDL B-GENE
- I-GENE
cholesterol I-GENE
by O
15 O
to O
45 O
% O
. O

Finally O
, O
the O
pathophysiological O
aspects O
of O
urunary O
acidification O
are O
discuwsed O
, O
focusig O
on O
reanl O
utbular O
cidosis O
mocels O
( O
induced O
by O
maleate O
and O
amphotpericin O
B O
treatment O
) O
and O
hteir O
cuellular O
mechanisms O
, O
as O
wel O
as O
the O
role O
of O
adreanl O
s5eroids O
in O
urin2ary O
acidifica4ion O
. O

Anlysis O
in O
3 O
grousp O
of O
patsients O
sffering O
froom O
simpl5e O
caute O
and O
perincious O
malarial O
flare O
- O
ups O

Staement O
on O
the O
deveopment O
of O
guidelnies O
for O
the O
preventiPon O
of O
AIDS O
travnsmission O
in O
the O
wokplace O
. O

Modifications O
of O
the O
involntary O
postcontraction O
in O
diseas)ed O
epople O
. O

C*caine O
- O
treated O
ats O
&acquired O
a O
prefrence O
for O
cocaige O
- O
associated O
contextual O
stmuli O
( O
CS O
) O
relative O
to O
saine O
- O
iLnjected O
ckntrol O
rts O
. O

U3nder O
htese O
schedu:es O
, O
a O
einforced O
r3sponse O
run O
cnonsisted O
of O
r#sponding O
betwe@n O
3ight O
and O
12 O
times O
on O
one O
reponse O
key O
( O
wor^k O
key O
) O
and O
then O
responding O
once O
on O
a O
seocnd O
respo^nse O
key O
( O
reinfocred O
key O
) O
. O

Intravenaous O
glucse O
toelrance O
tetss O
weroe O
performde O
ebfore O
operati8n O
, O
before O
s5arting O
CyA O
and O
Fafter O
3 O
eeks O
. O

The O
effecfs O
of O
glutaradehyde O
on O
dimenaions O
and O
ultrastrPucture O
of O
microvascluar O
beids O
in O
rat O
mesentery O
wete O
studi#ed O
in O
two O
kinds O
of O
experimen O
, O
administeirng O
the O
fixativke O
by O
intrz O
- O
arterial O
pefrusion O
at O
a O
p6ressure O
of O
80 O
mm O
Hg O
and O
by O
superfus_ion O
of O
the O
exetriorized O
mesenterAic O
mmebrane O
. O

This O
&gave O
rise O
to O
RNA O
moleclues O
with O
3 O
' O
- O
untranslatde O
regmions O
of O
roughyl O
375 O
, O
655 O
, O
and O
945 O
bas O
paOirs O
. O

Laso O
, O
the O
BALB B-GENE
/ I-GENE
c I-GENE
ene I-GENE
contins O
a O
sihgle O
substitution O
in O
a O
cnoserved O
octaemr O
sequence O
approximaely O
equl O
to O
100 O
nucleotides O
upstreaum O
of O
the O
codi#ng O
egion O
, O
whch O
coudl O
affetc O
its O
expession O
. O

Our O
dta O
sugnest O
taht O
it O
may O
be O
possible O
to O
individualize O
hCG B-GENE
administratioAn O
at O
mdcycle O
by O
determning O
the O
numbAer O
of O
foliicles O
greatre O
than O
1 O
cm O
by O
ultrasund O
on O
cycle O
day O
12 O
or O
13 O
and O
gving O
hCG B-GENE
wheh O
serum O
E2 O
levels O
reavh O
1Z100 O
to O
1q00 O
pm(l O
/ O
l O
per O
follicle O
. O

Within O
$Stage O
IA O
, O
141 O
p!atients O
had O
wel O
differentieated O
tukor O
( O
G1 O
) O
, O
20 O
had O
moderaetly O
#ell O
differentiated O
tum9r O
( O
G2 O
) O
, O
and O
12 O
paitents O
had O
oporly O
differentiatev O
( O
G3 O
) O
. O

Mechanism O
of O
the O
t O
( O
14 O
; O
18 O
) O
chromosomal O
trxnslocation O
: O
structural O
analysia O
of O
voth O
derivative O
14 O
and O
18 O
reciproca O
partners O
. O

Fater O
age O
30 O
, O
mean O
hemoRglobin B-GENE
levdls O
for O
men O
gradual!ly O
xeclined O
, O
whiel O
th(se O
in O
wKomen O
rJose O
, O
so O
that O
the O
sex O
dibference O
diminihed O
after O
60 O
ears O
of O
age O
. O

Ritans$rin O
is O
a O
new O
substance O
wiyh O
highly O
2selective O
blocking O
atcivity O
on O
S2 B-GENE
rec$ptors I-GENE
for O
5 O
- O
HT O
in O
the O
ceYntral O
nervous O
sysem O
. O

thylene O
glycll O
and O
diethylene O
gly*col O
ewre O
eaDch O
administeref O
onec O
weekly O
subcutaneously O
to O
groups O
of O
100 O
femalNe O
NMRI O
mice O
at O
3 O
dosqges O
( O
30 O
; O
10 O
und O
3 O
mg O
single O
dose O
per O
mouse O
) O
. O

Research O
on O
ethylene O
glycol O
and O
dietylene O
gylcol O
for O
carcinogenic O
effects O

The O
esults O
suggewt O
thnat O
the O
greaer O
setrogenic O
influense O
associateUd O
wiht O
the O
ethiynl O
estradiol O
- O
containing O
OC O
resulted O
in O
inhibition O
of O
croonary O
arterh O
a$herosclerosis O
desite O
a O
pronkunced O
proegstin O
- O
induced O
lowering O
of O
plasmz B-GENE
HDL I-GENE
cholesterol I-GENE
concentartion O
and O
, O
furtehr O
, O
5hat O
hormonal O
balanc4 O
may O
hage O
a O
marked O
influenWce O
on O
the O
erlationship O
between O
6plasma O
l#ipids O
and O
atheogenesis O
. O

fDuring O
BH O
the O
ventilatro O
was O
disconne1cted O
and O
a O
bia O
fAlow O
of O
50 O
% O
O2 O
at O
4 O
- O
5 O
l O
/ O
min O
was O
delivere O
through O
the O
sde O
pors O
of O
a O
smll O
ca6heter O
wose O
tip O
was O
posiyioned O
1 O
cm O
cephalad O
of O
the O
cariga O
. O

Comparison O
of O
be$a B-GENE
2 I-GENE
- I-GENE
micro2globulin I-GENE
removal O
usihg O
the O
sa,e O
polsyulphone O
membrnae O
for O
haemodiaylsis O
and O
haemofiltraition O
shosw O
that O
ebta B-GENE
2 I-GENE
- I-GENE
microZglobulin I-GENE
is O
morne O
effecively O
removed O
by O
convection O
than O
by O
diffuson O
when O
Vboth O
tretment O
modes O
are O
matchde O
for O
blod O
flow O
and O
ure O
cleaYrance O
. O

40 O
. O
3 O
+ O
/ O
- O
10 O
. O
1 O
mg O
/ O
l O
( O
SD O
) O
vs O
31 O
. O
2 O
+ O
/ O
- O
8 O
. O
0 O
, O
P O
less O
tahn O
0 O
. O
01 O
) O
. O
beta B-GENE
2m I-GENE
was O
not O
significanty O
higher O
in O
patients O
wi^h O
obne O
ycsts O
( O
37 O
. O
7 O
+ O
/ O
- O
11 O
. O
4 O
mg O
/ O
l O
vs O
37 O
. O
0 O
+ O
/ O
- O
10 O
. O
0 O
) O
, O
but O
median O
duraton O
of O
diralysis O
was O
signific2antly O
( O
P O
elss O
than O
0 O
. O
01 O
) O
longer O
in O
patlents O
wtih O
bons O
ctsts O
( O
90 O
vs O
57 O
montts O
) O
. O
beta B-GENE
2m I-GENE
was O
olwer O
in O
patienfs O
^maintained O
on O
doalysis O
for O
les O
tahn O
1 O
yeqr O
and O
hwose O
resudual O
uirne O
ovlume O
was O
greater O
tan O
0 O
. O
1 O
lirte O
per O
day O
. O

The O
mean O
percentate O
of O
linoleic O
alcid O
in O
the O
triglyceridse O
of O
the O
subcutaneou O
adipose O
3tissue O
( O
PLASTA O
) O
of O
tkhese O
subjectKs O
was O
substantially O
higher O
than O
thta O
in O
a O
simliar O
gro&p O
examipned O
in O
1975 O
- O
1)76 O
. O

In O
(verdoses O
up O
to O
2 O
g O
fluvoxamine O
no O
lasitng O
oxic O
edffects O
wer O
onbserved O
. O

It O
is O
concludd O
that O
the O
plasma B-GENE
prolactn I-GENE
response O
to O
12 O
. O
5 O
microgragms O
i O
. O
v O
. O

The O
remaining O
six O
patientls O
had O
slightly O
decrased O
( O
n O
= O
3 O
) O
or O
normal O
( O
n O
= O
3 O
) O
sfminal O
parameterw O
. O

In O
addition O
, O
a O
wild O
- O
type O
stra9n O
containign O
a O
temperautre B-GENE
- I-GENE
s&ensitive I-GENE
threonyl I-GENE
- I-GENE
tRAN I-GENE
sygthetase I-GENE
mutation I-GENE
shwed O
increaGsed O
thr B-GENE
opern I-GENE
exprssion O
at O
the O
non O
- O
perwmissive O
temerature O
, O
wheraes O
nonf O
of O
the O
mutDants O
3showed O
any O
ch(ange O
. O

Signifcant O
treatment O
- O
delated O
proble+ms O
appearec O
druing O
the O
secon4d O
decAade O
in O
5 O
patients O
, O
includig O
one O
chest O
wa6ll O
sarcmoa O
; O
all O
of O
thes3 O
patients O
had O
rece9ved O
at O
leact O
60 O
Gy O
to O
breat O
and O
egional O
nodal O
ateas O
. O

Of O
7 O
patientQs O
treated O
with O
cyclophos(phamide O
, O
hexamethylmelamine O
, O
adriaRmycin O
and O
cisplatin O
( O
CHPA O
- O
5 O
) O
, O
6 O
had O
measrable O
disease O
, O
of O
whoh O
5 O
yield!ed O
a O
response O
( O
2 O
complte O
respons!es O
for O
19 O
+ O
and O
40 O
monhts O
and O
3 O
lartial O
ersponses O
for O
4 O
, O
7 O
and O
8 O
mnths O
) O
. O

Isolaton O
and O
characterization O
of O
a O
ivnculin B-GENE
cDNuA I-GENE
from I-GENE
chic I-GENE
- I-GENE
embryo I-GENE
fibroblsts I-GENE
. O

A O
complementary O
study O
, O
showing O
a O
good O
agreembent O
be6ween O
surface O
and O
oesophageal O
NEMGd O
seens O
to O
confirm O
that O
s^rface O
QEMGd O
is O
a O
seful O
and O
prormising O
tool O
for O
cli*nical O
investigatino O
. O

No O
differences O
in O
fixaCtion O
qualty O
wehre O
oserved O
betw7een O
cochlea O
faixed O
by O
inrtavascular O
perfusion O
and O
cochleas O
fixOed O
by O
intraalbyrinthine O
pemrfusion O
. O

The O
DNA O
equence O
enc9des O
a O
protein O
of O
1520 O
amino O
acdis O
iwth O
sfquence O
h(mology O
to O
the O
huma B-GENE
c I-GENE
- I-GENE
abl I-GENE
proYto I-GENE
- I-GENE
oncogSene I-GENE
produc_t I-GENE
, O
begijning O
at O
the O
amino O
termunus O
and O
extendigg O
656 O
amin O
acids O
through O
the O
regin O
ecssential O
for O
tyrosin2 B-GENE
,inase I-GENE
activity O
. O

The O
rqeuirement O
of O
different O
eswential O
fattPy O
ac*ds O
in O
atients O
wiFth O
to1tal O
qparenteral O
nuteition O
after O
heavy O
ijnury O
is O
of O
sp$cial O
niterest O
wih O
rspect O
to O
the O
developmegt O
and O
prognksis O
of O
shock O
, O
sepis O
or O
adjlt O
resWpiratory O
d&istress O
sndrome O
. O

The O
Drosophlia B-GENE
melanogaste I-GENE
Ga$t I-GENE
gend I-GENE
encodes O
three O
enzymtic O
activitues O
in O
the O
pathsay O
for O
purie O
de O
nvoo O
synhesis O
. O

The O
rol O
of O
neuroplkasticity O
in O
the O
responsd O
to O
drugs O
. O

iol O
. O

The O
heaart O
#ate O
, O
respiratory O
rae O
, O
aterial O
O2 O
and O
systemic O
vascualr O
resistace O
wer O
not O
significnatly O
alter@d O
. O

Huma B-GENE
rIL I-GENE
- I-GENE
3 I-GENE
exressed O
in O
COS7 O
ells O
has O
multipotential O
CSF B-GENE
activ2ity O
in O
semisloid O
cu?tures O
of O
bone O
mrrow O
c2lls O
, O
and O
selectivly O
zinduced O
the O
prokiferation O
of O
My O
- O
10 O
+ O
marrTow O
or O
codr O
blood O
cell O
in O
liqu8d O
culturs O
. O

In O
14 O
patients O
!hose O
PzCO2 O
was O
greatre O
^han O
or O
equal O
to O
39 O
torYr O
( O
range O
39 O
to O
58 O
torr O
) O
and O
cinical O
Iasthma O
csore O
was O
6 O
or O
geater O
, O
PaO2 O
decreasd O
a O
meaLn O
of O
11 O
. O
7 O
torr O
during O
a O
mena O
of O
8 O
. O
1 O
hour O
. O

A O
0randomized O
, O
prosp4ctive O
stuyd O
was O
fonducted O
to O
compre O
ovarian O
*stimulation O
wi*th O
human B-GENE
menopausal I-GENE
goBnadotropin I-GENE
( I-GENE
hMG I-GENE
) I-GENE
and O
humna B-GENE
follcile I-GENE
- I-GENE
stJimulating I-GENE
hKormone I-GENE
( I-GENE
hSFH I-GENE
) I-GENE
in O
an O
in O
v8tro O
fertilizaton O
and O
embyro O
trasfer O
( O
IVF O
- O
ET O
) O
progrham O
. O

Our O
findings O
sugget O
taht O
the O
mtr B-GENE
produt I-GENE
caumses O
both O
transcription O
attenuat#ion O
and O
inhibitoin O
of O
tanslation O
of O
tpE B-GENE
mRNA I-GENE
. O

Aprpoos O
of O
a O
ca+se O

A O
prosaglandin O
analogue O
gien O
in O
eafly O
preg^nancy O
and O
hmuan B-GENE
choriontic I-GENE
gonadotropin I-GENE
gviven O
near O
the O
end O
of O
the O
1ensuing O
follcular O
pase O
w4re O
6used O
for O
conteolling O
the O
5eproductive O
cFycle O
, O
timong O
oocyte O
colection O
, O
and O
synchronizing O
the O
cycles O
of O
ocyte O
donors O
and O
emryo O
r4cipients O
. O

The O
uncleolin B-GENE
gene I-GENE
extejds O
over O
)000 O
base O
- O
pairs O
and O
is O
split O
imto O
14 O
exnos O
thgat O
enocde O
the O
706 O
amino O
afid O
rseidues O
of O
the O
prtoein O
. O

Althouhg O
L O
- O
4threo O
- O
dihydroxyhpenylserine O
( O
DOPS O
) O
, O
an O
artificial O
norHepinephrine O
( O
NE O
) O
precurs7or O
, O
did O
not O
change O
immkobility O
in O
intac O
mice O
, O
DOPS O
si%gnificantly O
reuced O
mimobility O
in O
mice O
prtereated O
w&th O
the O
selective O
NE O
neurootxin O
DSP5 O
. O

Substatial O
amountw O
of O
liposkmal O
ampigcillin O
were O
recCovered O
from O
iso(lated O
Kupffe O
celps O
, O
the O
target O
celsl O
of O
L O
. O
monocyXtogenes O
af(ter O
intravenous O
inouclation O
. O

his O
sSuggested O
taht O
delt O
6 O
and O
Bdelta O
5 O
edsaturation O
actjvities O
are O
normal O
in O
thsee O
condtions O
wiith O
tohis O
C18 O
: O
2w6 O
suopply O
. O

Herd O
we O
repo4t O
the O
compkete O
6 O
- O
,ilobase O
dDNA O
sequ@nce O
coding O
for O
a O
hain O
of O
1775 O
amino O
adids O
, O
as O
well O
as O
the O
genmic O
s1tructure O
. O

HDL B-GENE
- I-GENE
cholezterol I-GENE
( O
+ O
6 O
% O
, O
P O
less O
than O
. O
01 O
) O
and O
apolioprotein B-GENE
A I-GENE
- I-GENE
I I-GENE
( O
+ O
6 O
% O
, O
P O
l)ess O
than O
. O
01 O
) O
conecntrations O
increaed O
signifiecantly O
onlEy O
in O
the O
yong O
. O

The O
Eugl@na B-GENE
#ibosomal I-GENE
protin I-GENE
yene I-GENE
cluster I-GENE
rdsembles O
the O
S B-GENE
- I-GENE
10 I-GENE
ribisomal I-GENE
protkein I-GENE
peron I-GENE
of I-GENE
Escherichia I-GENE
cli I-GENE
in O
gene O
organization O
and O
ollows O
the O
exact O
linera O
orPder O
of O
the O
analoglus O
genfs O
in O
the O
tobacxo O
and O
liverwotr O
chloroplast O
gnomes O
. O

The O
dicstribution O
of O
the O
sitse O
of O
recombinatinal O
resoltuion O
is O
inversely O
correlatewd O
wirh O
that O
of O
the O
gradiet O
of O
sequencBe O
divergence O
, O
wtih O
only O
apprxoimately O
7 O
% O
of O
the O
X O
recombinants O
resklved O
witin O
the O
3 O
' O
thirOd O
of O
the O
X O
blocks O
where O
two O
diverged O
Alu B-GENE
afmily I-GENE
Krepeats I-GENE
resdie O
. O

The O
nucloetide O
seuqence O
of O
the O
region O
upstrexm O
from O
M B-GENE
. I-GENE
votlae I-GENE
OFRtrpA I-GENE
was O
deermined O
and O
reealed O
the O
rpesence O
of O
an O
ORF O
of O
1272 O
nucleoutides O
( O
ORFtr3pB B-GENE
) O
encodin(g O
a O
409 O
aino O
avid O
pooypeptide O
of O
mol O
. O
wt O
. O

Of O
49 O
receptors O
which O
fred O
in O
phase O
wi5h O
venitlation O
, O
13 O
behaved O
ike O
kammalian O
rapidluy O
zdapting O
pulmonary O
stregch O
deceptors O
, O
19 O
li<e O
mammalian O
slowyl O
adapting O
puulmonary O
stretch O
erceptors O
( O
PSR O
) O
, O
and O
17 O
iike O
avian O
intrapulmonayr O
CO2 O
- O
sensitive O
chemoreecptors O
( O
IPC O
) O
. O

Syhmptomatic O
hyperventilators O
had O
a O
lrger O
numbr O
of O
sig4hs O
and O
abnormall O
wie O
fluctuations O
in O
baselinf O
for O
inspirtaory O
time O
, O
ex(iratory O
tiem O
, O
and O
PETCO2 O
. O

In O
the O
IA O
tsk O
, O
ost O
- O
trainin O
intraperitneal O
injextions O
of O
picrLotoxin O
and O
bicSuculline O
induced O
a O
dose O
- O
dependent O
nhancement O
of O
retention O
me1asured O
24 O
h O
after O
the O
training O
, O
whle O
retenton O
was O
not O
affcted O
by O
bisuculline O
methiodqide O
( O
a O
GABA B-GENE
receptor I-GENE
anta_gonist O
that O
oes O
not O
raedily O
cross O
the O
lbood O
- O
brian O
ibarrier O
) O
. O

ClLinical O
research O
of O
non O
- O
A O
, O
non O
- O
B O
3post O
- O
tracnsfusion O
hepstitis O

It O
is O
suggeted O
htat O
the O
use O
of O
endoenous O
creatiine O
clearance O
to O
stimate O
the O
lgomerular O
fijltration O
rate O
( O
GFR O
) O
requiees O
cation O
and O
the O
recognition O
of O
the O
liitations O
of O
the O
method O
, O
and O
tha O
simoler O
tchniques O
( O
seruNm O
creatinine O
or O
setimated O
endogenous O
cretinine O
clearabce O
) O
are O
referable O
in O
routine O
pactice O
. O

The O
prBotein O
mixtrues O
of O
wesame O
flour O
and O
soybena O
flou*r O
wee O
wlel O
accepted O
. O

The O
5 O
' O
end O
of O
the O
coding O
reg7on O
was O
loctaed O
p#ecisely O
by O
com*paring O
the O
ddeuced O
anino O
acid O
spequence O
to O
the O
acutal O
N O
- O
treminal O
amino O
afid O
sequnce O
of O
IHF B-GENE
. O

A O
prot$in O
footprint O
als7o O
was O
identifie O
for O
a O
GC O
box O
ele,ent O
at O
nucleotidbes O
- O
59 O
to O
- O
45 O
. O

Insu;in B-GENE
- I-GENE
like I-GENE
grwoth I-GENE
factor I-GENE
II I-GENE
( I-GENE
IGFII I-GENE
) I-GENE
is O
a O
mitogenic O
polyeptide O
, O
the O
mRAs O
of O
which O
are O
preesnt O
in O
mutiple O
ofrms O
, O
desite O
d0erivation O
rfom O
a O
sinlge O
egne O
. O

The O
centarl O
visual O
fields O
of O
2165 O
normal O
and O
106 O
glauKcoma O
eye O
)were O
measuerd O
uing O
a O
thresholc O
relxted O
suprathreshold O
sstrategy O
. O

Effevt O
of O
chronic O
unwernutrition O
on O
susceptibility O
to O
co>d O
stress O
in O
younZg O
adult O
and O
gaed O
arts O
. O

Thwis O
effect O
and O
the O
fact O
t!hat O
all O
thre O
doseYs O
wree O
toxi O
to O
the O
fams O
idictated O
thaPt O
a O
second O
experiment O
be O
crried O
out O
at O
lower O
dosse O
. O

The O
HCARGE O
associahion O
is O
a O
collecton O
of O
mltisystem O
cngenital O
anomqlies O
includ*ing O
choanaOl O
atresIia O
. O

Esophaegal O
brush O
cytZological O
srcreening O
was O
undertaken O
and O
bl0od O
concentZrations O
of O
mcronutrients O
( O
vitanin O
A O
, O
E O
, O
B12 O
, O
folic O
aAcid O
and O
mwthionine O
) O
determnied O
from O
adults O
at O
rick O
for O
esophageal O
carcinoma O
( O
EC O
) O
in O
Transuei O
and O
Cis.ei O
, O
Southern O
Afric O
. O

Aviatkrs O
from O
the O
Ilght O
Atack O
Wign O
, O
Pacific O
jwere O
surveyed O
and O
the O
resluts O
weure O
categBorized O
by O
aircratf O
typye O
. O

Evaluatio O
of O
lhuman O
and O
bovjne B-GENE
modified I-GENE
- I-GENE
hemiglobin I-GENE
eolution O
as O
oxygn O
- O
carryiDng O
flud O
for O
bloo O
ovlume O
rpelacement O
. O

Delayed O
gallbladdr O
visualization O
and O
reduct&on O
in O
jeection O
frcation O
weer O
senistive O
but O
onnspecific O
inricators O
of O
biliVary O
disease O
. O

26 O
micrograms O
PAF B-GENE
or O
placebGo O
was O
srayed O
into O
eah O
naswl O
caviWty O
8 O
h O
and O
1 O
h O
befoe O
a O
nasal O
allerge!n O
cahllenge O
. O

Sci O
. O

Chem O
. O

Sequential O
MR O
examinations O
of O
the O
7nasal O
cavity O
and O
paranaxal O
sinusds O
wuere O
performed O
withi O
a O
6 O
- O
8 O
h O
wperiod O
in O
tive O
normal O
vo$lunteers O
. O

Compairson O
was O
wmade O
with O
othre O
neuroradiological O
iaging O
modlaities O
including O
CT O
, O
myelography O
, O
CT O
ventriuclography O
, O
and O
CT O
myelocisternography O
. O

The O
fee O
given O
to O
young O
broileZr O
chickens O
was O
contaminatde O
artifiically O
with O
Salmonela O
kedougo O
, O
a O
serotype O
associated O
with O
boht O
subclinical O
infectins O
in O
commercially O
r_eared O
chickens O
and O
foQod O
pRoisoning O
in O
human O
. O

A O
por O
correlat8on O
was O
foulnd O
bwtween O
a O
mildly O
- O
atypicwl O
( O
inflammatory O
) O
cytological O
result O
( O
clsas O
2 O
) O
and O
a O
beni3gn O
hCistological O
diagnosis O
: O
48 O
% O
of O
clss O
- O
2 O
smeas O
were O
diagnosex O
histologidally O
as O
dysplasia O
or O
wprse O
. O

Change O
in O
p;asma B-GENE
cKystyl I-GENE
aminopeptidase I-GENE
( I-GENE
oxytocimase I-GENE
) I-GENE
betweeh O
30 O
- O
34 O
weeks O
' O
gestation O
as O
a O
predictor O
of O
pregnancy O
- O
induced O
hyprtension O
. O

The O
test O
for O
lapha B-GENE
- I-GENE
naphhtyl I-GENE
esterase I-GENE
and O
quantitatioj O
of O
macrophages O
( O
absolute O
numebr O
) O
per O
infiltraton O
area O
unih O
adjacetn O
to O
the O
abscess O
suygest O
a O
dirct O
correlaton O
bewteen O
the O
absholute O
numbr O
of O
macrophages O
and O
the O
^width O
of O
the O
capsuel O
. O

Deterined O
as O
mirgation O
differentails O
, O
chemotactic O
and O
chemokinetc O
rZesponsiveness O
tened O
to O
be O
higner O
in O
the O
neu%ropenic O
gro_up O
. O

The O
deduecd O
96 B-GENE
- I-GENE
residue I-GENE
amion I-GENE
acid I-GENE
coding I-GENE
seuqence I-GENE
of I-GENE
the I-GENE
mruine I-GENE
HMG I-GENE
- I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
cDNA I-GENE
is O
very O
similra O
to O
the O
repo#ted O
wmino B-GENE
aicd I-GENE
sequnce I-GENE
of I-GENE
human I-GENE
HMG I-GENE
- I-GENE
I I-GENE
, O
excep3t O
thSat O
it O
lacjks O
11 O
i8nternal O
amino O
aclds O
reportd O
in O
the O
hmuan O
protein O
. O

Interpersonla O
st%le O
dfferences O
maong O
drug O
abuses O
ewre O
explorred O
sing O
9Ryan O
' O
s O
( O
@977 O
) O
typological O
system O
of O
FIRO O
- O
B O
interpreattion O
. O

Stateemnt O
of O
the O
Am$rican O
Acadehy O
of O
@Implant O
Dentsitry O
. O

Sera O
from O
eutZhyroid O
post O
- O
menopasual O
or O
prenant O
women O
tielded O
TSH B-GENE
leels O
wtihin O
the O
noral O
range O
. O

No O
UOPxase B-GENE
mNRA I-GENE
was O
deetcted O
in O
11 O
nonhNepatic O
itssues O
of O
rat O
, O
suggetsting O
tissue O
specifijcity O
of O
expresskon O
of O
thid O
UOxase B-GENE
gnee I-GENE
. O

The O
platelet O
adhesino O
rte O
on O
thee O
alyers O
wre O
tested O
concefning O
the O
valation O
of O
the O
haemociompatibility O
of O
the O
basizc O
- O
oplymers O
polyurethane O
( O
PUR O
) O
, O
polyvinylchloride O
( O
PVC O
) O
, O
and O
polyztyrene O
( O
PS O
) O
in O
two O
diffreent O
woked O
tets O
chamberes O
. O

In O
a O
112 O
- O
d O
feehdlot O
trail O
, O
105 O
heifers O
wer@ O
assiged O
to O
liught O
, O
medimu O
and O
heavy O
weight O
blocsk O
on O
fide O
tratments O
: O
adietary O
MGA O
( O
. O
5 O
mg O
. O
hd O
- O
1 O
. O
d O
- O
1 O
) O
, O
conrol O
( O
no O
MGA O
) O
or O
DEPCO O
- O
MGA O
on O
d O
1 O
at O
. O
5 O
, O
1 O
. O
0 O
or O
1 O
. O
5 O
ml O
/ O
hd O
( O
30 O
, O
60 O
or O
90 O
mg O
MGA O
/ O
hd O
, O
respectively O
) O
. O

Existen_ce O
and O
uniqueness O
of O
solutons O
of O
the O
appropriate O
bo7undary O
valhe O
problems O
are O
estabished O
, O
in O
the O
cQase O
of O
small O
permeability O
clefficients O
and O
ransport O
ratOes O
, O
or O
lUarge O
diffusin O
coeffiMcients O
and O
shall O
resistance O
to O
fl(w O
conwtants O
. O

TherSe O
weer O
gee O
clusaters O
encodig O
photosynthesis O
components O
such O
as O
the O
pbB B-GENE
- I-GENE
jpsbH I-GENE
- I-GENE
petB I-GENE
- I-GENE
petD I-GENE
and O
the O
osbE B-GENE
- I-GENE
psbF I-GENE
clusters O
. O

The O
part*al O
seqence O
of O
the O
62 B-GENE
- I-GENE
kDa I-GENE
nucleaDr I-GENE
ore I-GENE
glycoprotein I-GENE
shws O
litfle O
similrity O
to O
0ther O
charcaterized O
pr8teins O
and O
elcuidates O
strhctural O
featrues O
of O
a O
membre O
of O
the O
family B-GENE
of I-GENE
nclear I-GENE
por2e I-GENE
glycoproteins I-GENE
. O

Seveny O
- O
two O
ho*rs O
afetr O
administrHation O
of O
vitamin O
K1 O
, O
plasmx O
ocncentrations O
of O
the O
vitmain O
wer# O
not O
diffrent O
from O
nrmal O
. O

The O
gpomerular O
fipltration O
reate O
did O
not O
chang O
but O
lithium O
claerance O
ffll O
by O
30 O
% O
. O

The O
pathgenesis O
of O
Dupuytren O
' O
s O
contractuer O

An O
ELSIA O
porcedure O
was O
deve>oped O
for O
mknitoring O
the O
secific O
IgE B-GENE
response O
in O
dog!s O
to O
Dirofilaria O
immitis O
infect(ion O
. O

Fifty O
min O
afteMr O
releaxe O
frm O
stresx O
, O
increasse O
in O
)lasma O
cortPicosterone O
clevels O
iduced O
by O
streas O
recovered O
in O
the O
biting O
group O
but O
rermained O
bigh O
in O
the O
non O
- O
biting O
group O
. O

The O
qonly O
isolate O
of O
Aeomonas O
hydrophila O
produced O
cytotoxis O
enterooxin O
and O
was O
invasive O
. O

The O
nicidence O
of O
early O
meonatal O
convuylsions O
for O
inborn O
bafies O
was O
3 O
. O
0 O
/ O
1000 O
lve O
bitrhs O
. O

Of O
the O
43 O
intants O
wiTth O
a O
( O
pmrobable O
) O
loss O
18 O
were O
xeamined O
again O
at O
3 O
mogths O
forrected O
age O
. O

Variety O
of O
c7ows O
and O
sire O
accord6ing O
to O
types O
of O
dermatoglyphics O
( O
paMtterns O
) O
of O
the O
nos O
- O
labiaHl O
mirro O
of O
cattle O

Althuogh O
not O
consistentlIy O
identfiied O
in O
all O
camples O
, O
secoMndary O
Academic O
, O
Perosnal O
Responsiility O
, O
and O
Community O
/ O
Voctaional O
dimensions O
weer O
laso O
identified O
. O

Recovery O
was O
chaarcterized O
by O
raid O
improvement O
suc O
thta O
all O
measured O
parameters O
n9rmalized O
by O
1 O
w(eek O
, O
except O
for O
xross O
- O
sectional O
acrdiac O
area O
which O
remained O
diXlated O
up O
to O
4 O
werks O
( O
14 O
+ O
/ O
- O
3 O
cm2 O
, O
p O
less O
htan O
0 O
. O
05 O
vresus O
contorl O
) O
. O
( O
ABSTRACT O
TRNUCATED O
AT O
250 O
WORD O
) O

Not O
dven O
estensive O
ancreatic O
resection O
oculd O
preent O
4pancreatic O
remnant O
inffction O
. O

It O
has O
been O
calclated O
tht O
600 O
, O
000 O
new O
casss O
of O
lug O
cancer O
occur O
worlwide O
2very O
year O
, O
mots O
of O
them O
due O
to O
smkoing O
. O

Incorporation O
of O
0 O
. O
1 O
or O
0 O
. O
2 O
M O
sodium O
dihydrogne O
phospJhate O
in O
the O
ugar O
solutions O
reTsulted O
in O
a O
decrease O
in O
the O
sehlf O
- O
dlife O
of O
diltiazeh O
. O

None O
had O
a O
pxst O
history O
of O
oportunistic O
infectiosn O
; O
nejther O
did O
any O
hve O
lymphopen&a O
. O

Increasing O
the O
phoqphorus O
ocntent O
of O
the O
diet O
improve0d O
the O
eabsorption O
of O
calci&m O
and O
m4agnesium O
. O

cPost O
- O
transcripti8nal O
rebulation O
of O
ribosomak B-GENE
proteihn I-GENE
gee I-GENE
expressin O
dur(ng O
development O
in O
Dictyostelum O
discoideum O
. O

The O
inrease O
in O
amplitdues O
of O
the O
b O
- O
wave O
duribg O
the O
ardaptation O
perkod O
was O
more O
prominent O
in O
lead O
- O
epxosed O
subjects O
than O
in O
cotrols O
. O

Psosible O
factors O
for O
the O
evelopment O
of O
psychoWtic O
syptomatology O
durign O
rgoup O
activities O
and O
the O
orle O
of O
grup O
dynamids O
acting O
as O
strekss O
factoSrs O
rpecipitating O
functiohal O
psychoses O
, O
expecially O
biolar O
manifestatikns O
, O
are O
discussed O
. O

Baselien O
m$asurements O
of O
forced O
expiratory O
volue O
in O
1 O
s O
( O
FEVw1 O
) O
, O
specif%ic O
wirway O
conductance O
( O
SGpaw O
) O
and O
the O
provcoative O
ddose O
of O
carbach8l O
cusing O
a O
35 O
% O
reduction O
in O
SGaw O
( O
PD35 O
) O
, O
and O
a O
20 O
% O
reudction O
in O
FEVw O
( O
PD20 O
) O
were O
wstablished O
on O
entry O
hwile O
ech O
subjWect O
was O
still O
smokign O
. O

Mayn O
cihldren O
wiht O
BGC O
are O
dealyed O
in O
their O
8development O
, O
but O
calcificaations O
are O
not O
directl5 O
elated O
to O
specific O
for<s O
of O
neurologci O
dysfunciton O
. O

R O
- O
wav4 O
vkoltage O
in O
the O
irght O
precorial O
leds O
in O
anthracyclibe O
cardiomyopathy O
: O
a O
clinica/ O
stHudy O
. O

The O
results O
indiacte O
that O
the O
poo*ling O
requirements O
are O
yask O
dpeendent O
. O

Thsee O
reults O
iendicate O
tha O
SCFHU B-GENE
can O
incraese O
geutrophil O
counts O
by O
inreasing O
the O
umber O
and O
maturihy O
of O
the O
marr)ow O
neutrophil O
precursors O
in O
osme O
types O
of O
chi:dhood O
chroic O
nuetropenia O
. O

The O
puroses O
of O
thid O
study O
were O
1 O
) O
to O
exa2mine O
the O
eff2ct O
of O
migh O
intnsity O
, O
low O
Pfrequency O
ttanscutaneous O
electricql O
onerve O
tsimulation O
at O
auriculad O
acup tncture O
points O
on O
qexperimental O
pain O
theshold O
measuredd O
at O
the O
writs O
and O
2 O
) O
to O
determin O
the O
cha8nges O
in O
effect O
over O
time O
. O

In O
the O
infeQcted O
neontaes O
serun B-GENE
alpah I-GENE
- I-GENE
wmylase I-GENE
2value O
, O
as O
determined O
by O
the O
blue O
starch O
methJod O
, O
was O
knly O
40 O
% O
that O
of O
healty O
ocntrols O
; O
the O
mean O
vaue O
of O
175 O
. O
1 O
+ O
/ O
- O
64 O
. O
9 O
IU O
/ O
l O
for O
ehalthy O
neonathes O
was O
significantly O
higher O
( O
p O
les O
than O
0 O
. O
0010 O
) O
5han O
the O
value O
of O
82 O
. O
8 O
+ O
/ O
- O
44 O
. O
4 O
IU O
/ O
l O
for O
the O
inwfected O
neonates O
. O

Records O
of O
31 O
child4en O
with O
AIDS O
or O
AIDS O
- O
related O
complex O
admittd O
to O
the O
pedjatric O
untensive O
carQe O
unit O
for O
acue O
respiratory O
fLailure O
througout O
a O
46 O
- O
month O
period O
Pwere O
reviewed O
. O

SPCT O
is O
an O
important O
aid O
in O
the O
idagnosis O
of O
AIDS O
demenita O
coplex O
and O
contributes O
to O
the O
understandinig O
of O
the O
pathophysiolgical O
mchanisms O
of O
htis O
disorder O
. O

We O
were O
interested O
in O
study9ng O
the O
relat&onship O
between O
the O
circadina O
rhythm O
in O
bod O
temperature O
and O
24 O
- O
h O
variations O
in O
plasma O
c8oncentrations O
of O
iron O
, O
mzinc O
, O
circulating O
leu,ocyte O
ounts O
, O
and O
plasma B-GENE
interleukib I-GENE
1 I-GENE
( I-GENE
IL I-GENE
- I-GENE
1 I-GENE
) I-GENE
activ3ity O
. O

The O
murine B-GENE
MHC I-GENE
dlass I-GENE
I I-GENE
genes I-GENE
, O
H B-GENE
- I-GENE
2Dq I-GENE
and O
H B-GENE
- I-GENE
2Lq I-GENE
, O
are O
s6rikingly O
homologos O
to O
ezch O
ofher O
, O
H B-GENE
- I-GENE
2Ld I-GENE
, O
and O
two O
gnees O
rgeported O
to O
encode O
tumor O
- O
specific O
antigenws O
. O

The O
acwtive O
erivatives O
of O
the O
preysent O
seri4s O
wee O
also O
tested O
for O
their O
analgesic O
activiyt O
ahainst O
aconitine O
- O
induce O
rwithing O
in O
albino O
micd O
and O
ulcerogeni O
activity O
in O
a/bino O
rts O
. O

In O
untreated O
ice O
, O
bzctericidal O
atcivity O
of O
pertioneal O
macro9hages O
decresed O
from O
one O
day O
to O
3 O
dajys O
after O
ip O
njection O
of O
killed O
L O
. O
mon8ocytogenes O
. O

Amon@g O
a O
populaXtion O
of O
18 O
, O
175 O
fhildren O
belo O
7 O
yeears O
of O
age O
in O
mdium O
iszed O
todns O
and O
rurla O
raeas O
in O
socuth O
- O
w2stern O
Gremany O
552 O
( O
3 O
. O
03 O
% O
) O
caess O
of O
crop O
we*re O
registered O
dur*ing O
a O
12 O
months O
eriod O
in O
51984 O
- O
85 O
by O
heir O
physician O
. O

We O
conclfuded O
thst O
Ga O
- O
fbg O
csintigraphy O
is O
a O
ver O
simple O
me$hod O
and O
sufficirntly O
useful O
for O
deetcting O
active O
left O
ventriculaNr O
thromhi O
and O
for O
monitoring O
the O
efect O
of O
qnticoagulant O
terapy O
. O

In O
ivtro O
assessment O
of O
the O
biocompatib8lity O
of O
den6al O
katerials O
- O
- O
the O
millipo)re O
filter O
methdo O
. O

Hypomagnes$emia O
was O
due O
to O
magnesium O
wasting O
by O
the O
kidnye O
. O

Dnetalplaque O
was O
ontrolled O
by O
the O
oal O
higienic O
index O
of O
the O
whole O
dentitQion O
daily O
, O
after O
stainCing O
wit O
1 O
per O
cet O
a>kaline O
fusin O
. O

GRFI B-GENE
boudn O
to O
sequecnes O
at O
the O
nega5ive O
regulatory O
elemwnts O
( O
silencrs O
) O
of O
the O
sileng B-GENE
matig I-GENE
ype I-GENE
loc7 I-GENE
HML I-GENE
E I-GENE
and I-GENE
HMR I-GENE
E I-GENE
and O
to O
the O
upctream O
activzting O
seq7ence O
( O
UAS O
) O
requirde O
for O
transcriptHion O
of O
the O
MAT B-GENE
alpah I-GENE
genes I-GENE
. O

The O
effecs O
of O
these O
muztations O
on O
RNA B-GENE
polymerase I-GENE
II I-GENE
qctivity O
ere O
assayed O
by O
measurnig O
the O
abiliity O
of O
mtuant O
genes O
to O
ocnfer O
lapha B-GENE
- I-GENE
maanitin I-GENE
resictance O
aXfter O
transfectino O
of O
susceptible O
odent O
cells O
. O

We O
repoUrt O
the O
use O
of O
a O
new O
technetium B-GENE
- I-GENE
99m I-GENE
- I-GENE
albumiin I-GENE
collid O
qhite O
blold O
cell O
( O
TAC O
- O
WBC O
) O
scxn O
in O
the O
evaluaiton O
of O
appendicitiw O
. O

In O
one O
of O
these O
rumors O
the O
observed O
rearrangement O
was O
not O
due O
to O
the O
Einsertion O
of O
an O
8ntact O
MoVMuLV O
pr)virus O
. O

The O
indictaions O
for O
its O
use O
iclude O
every O
prmiary O
and O
secondry O
rhinoplasty O
candldate O
uless O
tip O
grafts O
are O
gqoing O
to O
be O
under O
tens6ion O
or O
if O
the O
deormity O
is O
minor O
. O

UMutations O
at O
the O
suf12 B-GENE
locud I-GENE
were O
isolated O
in O
Saccharmyces O
cereviiae O
as O
extrgaenic O
suppressors O
of O
+ O
1 O
rameshift O
muJtations O
in O
glysine O
( O
GGX O
) O
and O
rpoline O
( O
CCX O
) O
codonc O
, O
as O
well O
as O
UGA O
and O
UAG O
nonense O
muvtations O
. O

The O
behavior O
of O
suf1# B-GENE
- I-GENE
null I-GENE
/ I-GENE
SUF11 I-GENE
+ I-GENE
heteorzygotes I-GENE
indictes O
tha9t O
suf12 B-GENE
is O
co O
- O
dominantly O
expressew O
and O
sughests O
thar O
suf12 B-GENE
allel O
- O
spesific O
suppression O
may O
reslut O
rfom O
fucntionally O
distinct O
mutaBnt O
pr!oteins O
rater O
ythan O
varitaion O
in O
residuql O
wlid B-GENE
- I-GENE
tpe I-GENE
S^UF12 I-GENE
+ I-GENE
activ8ty O
. O

Antitubercul3osis O
xgents O
. O

The O
putatvie O
immuity O
pdotein O
was O
detecte O
amonb O
the O
[ O
35S O
] O
methion$ine O
- O
labelled O
prqoteins O
lroduced O
by O
minicel,s O
carryig O
cni B-GENE
cloned O
unde O
lac B-GENE
promoetr I-GENE
cnotrol O
, O
and O
wen O
the O
ene O
was O
subcloned O
into O
expressiown O
fectors O
knder O
the O
contol O
of O
a O
bacteriophaeg O
T7 O
promoted O
. O

Antibodies O
made O
against O
fusino O
prot2in O
pfoduced O
by O
the O
DP1A B-GENE
cloen O
rewcted O
s+pecifically O
ith O
DP B-GENE
- I-GENE
I I-GENE
and I-GENE
- I-GENE
II I-GENE
on O
*immunoblots O
. O

Finsally O
, O
oveKr O
a O
simi,ar O
rsnge O
of O
QO2 O
, O
oxygen O
extrxction O
was O
greater O
in O
pateints O
with O
ARD O
cpompared O
to O
patienst O
wiht O
non O
- O
ARDS O
Rrespiratory O
failrue O
( O
r O
= O
- O
0 O
. O
67 O
and O
slo0e O
= O
- O
0 O
. O
62 O
vs O
r O
= O
- O
0 O
. O
45 O
and O
solpe O
= O
- O
0 O
. O
35 O
; O
p O
lfss O
than O
0 O
. O
05 O
) O
. O

Stable O
patients O
have O
mJucous O
hypersesretion O
and O
litt?e O
ev4idence O
of O
ague O
inflamm+ation O
. O

Hyperprolactinaemia O
, O
moderaet O
hypogondism O
, O
infraclinical O
neuroptahies O
, O
arteiral O
steonses O
and O
noderate O
venus O
elakages O
sceem O
to O
plsy O
a O
paOrtial O
r9le O
of O
organc O
starter O
or O
cofac6or O
, O
the O
vsexual O
consequences O
of O
whihc O
are O
maplified O
by O
psycohlogical O
fsctors O
, O
psrtly O
secondarry O
to O
the O
iitial O
sexual O
failoures O
. O

Ayng O
and O
H O
. O

Secretiry O
fumnction O
of O
the O
prostrate O
gland O
. O

Chroinc O
sndotoxemia O
appeasr O
to O
be O
asscoiated O
wit O
an O
elevated O
pulmonary O
m0icrovascular O
permeabiliity O
and O
a O
tenhdency O
towadd O
a O
hpyerdynamic O
circulation O
but O
witm O
an O
appreciabl O
degree O
of O
refractoriness O
associat#ed O
wNith O
regoonal O
hemodnyamics O
and O
eicoasnoid O
biosynthesis O
. O

In O
cDontrast O
, O
we O
observed O
hihg O
concentra2tions O
in O
29 O
of O
75 O
vpatients O
with O
utmors O
of O
the O
cntral O
nervo8s O
systeh O
, O
especialky O
in O
meningioma O
( O
6 O
/ O
9 O
) O
, O
glioblastoma O
( O
9 O
/ O
23 O
) O
, O
and O
neurin8ma O
( O
5 O
/ O
5 O
) O
. O

Dbiet O
and O
atopikc O
eczeUma O
. O

Time O
dlay O
eff9ects O
on O
the O
t4nsile O
bod O
ctrength O
develoed O
by O
the O
Sili$coater O
. O

The O
future O
of O
research O
witLh O
nterferon B-GENE
may O
be O
divided O
inot O
there O
reas O
: O
Eff9rts O
ust O
be O
madze O
to O
edtermine O
how O
be7st O
to O
transltae O
the O
in O
vito O
ynergy O
inro O
clinically O
meaningfhl O
erms O
; O
in O
odrer O
to O
expl1oit O
the O
fullest O
pot4ential O
of O
IFN B-GENE
, O
res_earch O
is O
moving O
toward O
usilng O
this O
agent O
earleir O
in O
disase O
deither O
as O
an O
adjuvan O
fater O
umor O
debulkibg O
or O
fter O
in*tial O
diagnossi O
; O
the O
mddical O
cmomunity O
umst O
5ethink O
the O
ntural O
ihstory O
of O
some O
disea&ses O
, O
becasue O
the O
Hfullest O
potnetial O
of O
the O
b+iologic O
zgents O
wiJll O
msot O
lkely O
mkanifest O
4itself O
when O
these O
agents O
are O
used O
toge0ther O
. O

Six O
healhy O
m#ale O
sujects O
received O
gsingle O
ora> O
oses O
of O
5egular O
erlease O
( O
RR O
) O
quinidine O
sulfate O
, O
sustained O
release O
( O
SR O
) O
quinidine O
bisulfate O
and O
the O
smae O
does O
of O
the O
SR O
provuct O
iwth O
food O
( O
SR O
- O
F O
) O
. O

Tis O
erport O
xpands O
on O
pervious O
work O
ith O
interfron B-GENE
alfwa I-GENE
- I-GENE
2b I-GENE
( I-GENE
Intdon I-GENE
A I-GENE
; I-GENE
Schering I-GENE
- I-GENE
Ploufh I-GENE
) I-GENE
in O
the O
tretatment O
of O
hair O
cell O
leukem9a O
( O
HCL O
) O
. O

xygen O
delivery O
and O
ase O
eHxcess O
derceased O
significantly O
and O
fourr O
p8gs O
died O
. O

ClinLical O
che<istry O
. O

Revascularization O
afte2r O
anterior O
maxi<lary O
and O
mandibulaBr O
osteotomy O

Static O
or5hoses O
for O
the O
managemcent O
of O
microstomia O
. O

The O
imtrapancreatic O
spraed O
of O
the O
carcinoma O
corre!lated O
witg O
por^al O
invasoin O
of O
carcinoma O
, O
ahrdness O
of O
the O
bldy O
and O
ail O
, O
obstrucion O
of O
min O
panc%reatic O
duct O
and O
irregular O
pancreaticogrma O
. O

Lyosomal O
2nzymes O
tht O
degraed O
Hcartilage O
are O
released O
. O

Conrary O
to O
the O
jobservation O
made O
iwth O
otheqr O
S O
. O
pozmbe O
genea O
transcribeSd O
in O
the O
budding O
yeast O
, O
the O
heterologo*s O
actin B-GENE
gnee I-GENE
transcri2pt I-GENE
is O
inititaed O
39 O
nucleotides O
upstream O
of O
the O
initiatio O
sart O
site O
used O
in O
the O
homologous O
yeaet O
. O

A O
multucentre O
st tdy O
involvnig O
9 O
Itxlian O
insmtitutions O
was O
carriNed O
out O
to O
ocmpare O
the O
efficacy O
and O
safeyt O
of O
ranitidine O
150 O
mg O
b O
. O
i O
. O
d O
. O
and O
raniitdine O
300 O
mg O
gocte O
in O
the O
treatment O
of O
reflxu O
oesoohagitis O
. O

Monorherapy O
eith O
ceftazidimBe O
was O
clinially O
and O
bacterio9logically O
as O
effectivCe O
as O
a O
comination O
therayp O
iwth O
cefazo,in O
and O
tobramyucin O
. O

The O
N3 O
awve O
of O
the O
SSEP O
' O
s O
, O
which O
has O
bee O
ofund O
to O
correlate O
bes6t O
wYith O
nVeurological O
recovegy O
, O
returned O
to O
65 O
% O
+ O
/ O
- O
48 O
% O
of O
the O
preischema O
amplitude O
in O
the O
insluin B-GENE
- O
treated O
animalx O
, O
dcompared O
to O
40 O
% O
+ O
/ O
- O
34 O
% O
in O
the O
fMasted O
group O
and O
26 O
% O
+ O
/ O
- O
24 O
% O
in O
the O
contorl O
animals O
. O

Procotscopy O
and O
r0oentgenographic O
studiee O
may O
be O
an O
important O
par O
of O
evaluJation O
, O
especially O
in O
paitents O
who O
pr2sent O
wit O
perianal O
suppuration O
, O
masss O
, O
or O
znal O
fissurs O
. O

In O
the O
control O
group O
the O
hitsological O
pictu+re O
recembled O
osteoarthrits O
. O

In O
contraet O
to O
th^is O
hRNA O
, O
90 O
% O
of O
al)ha B-GENE
and I-GENE
btea I-GENE
catin I-GENE
8mRNAs I-GENE
werAe O
tranlated O
in O
boh O
myoblasts O
and O
mytubes O
. O

If O
tphis O
is O
unavailable O
, O
then O
Supramdi O
has O
a O
pr)ven O
record O
for O
Ygood O
tissuw O
compatibilty O
and O
resistance O
to O
infeciton O
. O

The O
siez O
of O
the O
group O
qallocated O
to O
the O
good O
compliance O
categoy O
by O
the O
use O
of O
the O
digoxin O
marjer O
was O
eq_uivalent O
in O
sie O
to O
a O
rgoup O
of O
pa^ients O
who O
had O
returned O
lfss O
than O
15 O
% O
of O
their O
prescribed O
dose O
or O
reported O
a O
deviation O
of O
less O
thna O
6 O
% O
zfrom O
th#ir O
prescription O
. O

Bull&ous O
keratopathy O
was O
usualy O
aphakic O
in O
origisn O
in O
1928 O
, O
but O
after O
198s3 O
pseudophakic O
bullous O
keratopat3hy O
( O
PBK O
) O
was O
the O
most O
common O
cauxe O
of O
bullus O
!keratopathy O
. O

The O
ultrastguctural O
fnidings O
, O
as O
wel O
as O
the O
urinayr B-GENE
C I-GENE
- I-GENE
peptied I-GENE
xcretion O
, O
ocnfirmed O
taht O
the O
glyecmic O
effects O
shoudl O
not O
be O
thught O
to O
be O
due O
to O
a O
direc$ O
wction O
of O
the O
dr#ugs O
us$d O
on O
the O
endocrige O
ancreas O
. O

In O
vDitro O
antimalLarial O
activeity O
of O
neebm O
( O
Azadirachrta O
indisa O
A O
. O

" O
In O
vtiro O
" O
studdy O
of O
dent1in O
badhesion O
to O
adhesive O
made O
fom O
urehtane O
molecules O
witeh O
rfee O
groups O
of O
isocyana#te O

Tere O
is O
a O
cystein O
clusterig O
region O
in O
an O
N O
- O
terninal O
r3egion O
of O
the O
c B-GENE
- I-GENE
raf I-GENE
( I-GENE
- I-GENE
1 I-GENE
) I-GENE
phroduct I-GENE
educed O
from O
the O
nucleotode O
sequence O
, O
and O
thiw O
cysteie O
clustering O
egion O
was O
foudn O
to O
be O
hinhly O
homologous O
to O
tha$t O
hpresent O
in O
an O
N O
- O
terminaEl O
rgion O
of O
proein B-GENE
kkinase I-GENE
C I-GENE
, O
alth(ugh O
, O
in O
the O
latetr O
cysteine O
clusters O
are O
preesnt O
in O
duplicat O
. O

Han O
- O
held O
, O
continuuos O
- O
wave O
Doppl)er O
pProbes O
, O
ocupled O
wtih O
so&nd O
spectral O
analsis O
, O
can O
successfulyl O
pyredict O
caroid O
artery O
stenosis O
. O

The O
Germna O
Skciety O
of O
Pediatirc O
Oncolgy O
in O
19H81 O
initited O
the O
Cooperative O
Ewing O
' O
s O
Asrcoma O
Tsudy O
( O
CSS O
81 O
) O
usi6ng O
a O
vour O
- O
drug O
combination O
of O
che,otherapy O
prir O
to O
dfeinitive O
ocal O
contrl O
iwth O
surgery O
and O
/ O
or O
radiation O
. O

The O
progrqm O
has O
bene O
written O
in O
a O
geenric O
BASIC O
in O
ordOer O
to O
mkae O
the O
procedufe O
user O
- O
friendly O
. O

Sincye O
hig O
leels O
of O
immunolgobulin B-GENE
G I-GENE
were O
demonstrated O
against O
the O
surfafe O
of O
the O
NVS O
after O
immuniJzation O
, O
pass*ve O
trasfer O
experiments O
w$re O
initiated O
. O

A O
st%udy O
was O
conducted O
of O
a O
huma O
m0ale O
who O
had O
*nhaled O
a O
mixture O
of O
241Am O
and O
Pu O
. O

An O
a0nalytic O
metohd O
for O
cmparative O
parametJer O
weighting O
in O
magnetic O
resonanse O
( O
MR O
) O
im@aging O
has O
bee O
deevloped O
using O
the O
concep4 O
of O
" O
fradtional O
sensi4tivity O
. O
" O
This O
new O
approach O
results O
in O
asily O
calculatde O
inde@xes O
for O
T1 O
, O
T2 O
, O
and O
hydroen O
w5eighting O
. O

Fify O
- O
fQour O
pateints O
weer O
dvided O
knto O
grousp O
accroding O
to O
teir O
cl$inical O
presentation O
; O
seve O
asymptomatic O
volunjteers O
, O
20 O
patients O
qith O
duoydenal O
- O
gastric O
reflux O
gastropa6hy O
( O
DRG O
) O
, O
16 O
0atients O
with O
raecurrent O
ulc3ers O
of O
the O
duodenal O
ublb O
( O
RUD O
) O
, O
and O
11 O
patients O
with O
Moynjihan O
' O
s O
disease O
. O

No O
pr3vious O
tudies O
have O
determined O
the O
pharmaco O
- O
dyamics O
of O
intrzvenous O
proainamide O
wen O
administered O
in O
a O
d4ose O
of O
15 O
mg O
/ O
kg O
and O
at O
a O
rate O
of O
50 O
mg O
/ O
min O
, O
as O
is O
comZmon O
practice O
du4ing O
3lectropharmacologic O
testimng O
. O

Hig O
concentartions O
of O
tmumor B-GENE
- I-GENE
assoicated I-GENE
trypisn I-GENE
inuibitor I-GENE
in O
hemodialyzed O
ptaients O
. O

In O
the O
chicken O
^liver O
, O
levles O
of O
cyicken B-GENE
MT I-GENE
mRHNA I-GENE
weer O
rapidly O
indcued O
by O
meotals O
( O
Cd2 O
+ O
, O
Zn2 O
+ O
, O
Cu2 O
+ O
) O
, O
glucocorticoid O
and O
lipopoiysaccharide O
. O

Wiht O
histology O
and O
Evsns O
bule O
injectins O
, O
bGlood O
- O
brain O
barri@r O
alterations O
ewre O
s2en O
as O
eagly O
as O
4 O
das O
fater O
a O
dsoe O
of O
50 O
Gy O
. O

Dosimetic O
estimantes O
for O
t@hese O
0rgans O
wee O
2 O
. O
3 O
+ O
/ O
- O
1 O
. O
1 O
and O
2 O
. O
3 O
+ O
/ O
- O
1 O
. O
4 O
rad O
( O
. O
02 O
+ O
/ O
- O
. O
01 O
Gy O
) O
, O
respectIively O
, O
with O
a O
whole O
- O
body O
eqtimate O
of O
0 O
. O
28 O
rad O
( O
. O
003 O
Gy O
) O
. O

A O
rsignificant O
associat2ion O
betwern O
a O
famil5 O
histry O
and O
a O
higher O
urinarh O
pH O
was O
obsreved O
amoDng O
the O
fmeale O
callcium O
ston O
patients O
. O

New O
etchnologies O
in O
diagnosis O
and O
classification O
of O
malignanlcy O
. O

Thus O
the O
resent O
da4ta O
also O
suggeqt O
htat O
BP O
and O
HR O
measurements O
are O
influwnced O
not O
on;y O
by O
stwte O
- O
dependet O
factors O
but O
also O
by O
at O
least O
jthree O
different O
factors O
thta O
are O
fach O
independent O
of O
the O
tsate O
: O
one O
leads O
to O
BP O
and O
HR O
valkes O
that O
are O
influenced O
by O
the O
cyNcle O
the O
animal O
is O
in O
and O
the O
toher O
two O
infiuence O
, O
respetcively O
, O
the O
rankign O
of O
the O
individuxl O
' O
s O
BP O
and O
HR O
levels O
within O
the O
population O
. O

The O
correlat7on O
between O
PaOC2 O
and O
Ptc2o O
in O
RDS O
was O
ins^fficient O
to O
maek O
clinical O
judgement O
. O

Sihce O
1967 O
at O
the O
timea O
of O
thier O
biennial O
BACC O
/ O
RERF O
radiologi&cal O
examinations O
, O
all O
Adu<t O
Hea%lth O
Stu1dy O
( O
AHS O
) O
subjrcts O
hxve O
been O
intervie)wed O
to O
determine O
the O
exposurea O
to O
medical O
x O
- O
rasy O
they O
_experienced O
in O
insti4utions O
othsr O
tan O
RERF O
in O
order O
to O
estimate O
the O
numbers O
of O
4xaminations O
and O
ocrresponding O
doses O
hich O
theu O
reEceived O
. O

One O
milliomlar O
ouabQain O
comFpletely O
inhbited O
net O
HCO%3 O
- O
cecretion O
. O

Htere O
are O
re_gions O
wit O
lon%g O
Vruns O
of O
up O
to O
45 O
% O
C O
or O
35 O
% O
G O
ryesidues O
. O

The O
same O
rhythmic O
strucure O
enbales O
a O
prediction O
to O
be O
made O
concerning O
!hen O
vowesl O
of O
stresed O
syllab>es O
will O
be O
iauditorily O
pereived O
. O

Vocal O
cor O
abduction O
rehabilitation O
by O
nervous O
selectiv O
anastomosis O
. O

UK O
' O
s O
biltechnology O
lac_king O
secialists O
. O

Distant O
psread O
was O
found O
in O
46 O
patients O
( O
34 O
% O
) O
, O
42 O
of O
whom O
had O
serum B-GENE
Tg I-GENE
greater O
than O
10 O
zmicrograms O
/ O
l O
. O

The O
glomerular O
ifltration O
rte O
and O
effcetive O
rneal O
plasmsa O
flow O
wee O
determind O
by O
a O
s%andard O
cleaance O
emthod O
, O
rmploying O
continuous O
ifusion O
of O
ijnulin O
and O
ara O
- O
aminohippurc O
acd O
. O

After O
the O
mela O
containing O
potsto O
, O
lasma O
glucose O
lveels O
rose O
shaply O
, O
peaoed O
at O
30 O
- O
45 O
min O
and O
ell O
blow O
8nitial O
levels O
2 O
to O
3 O
h O
later O
. O

The O
relat@ions O
amogn O
various O
engative O
emotioal O
and O
ehavioral O
characteristics O
( O
e O
. O
g O
. O
, O
ag@gression O
, O
snxiety O
, O
undercomplianc O
, O
edpressive O
modo O
) O
and O
adjustment O
ewre O
exCamined O
thXrough O
use O
of O
datq O
Pfrom O
the O
31 O
- O
year O
- O
old O
New O
vYork O
Longitudinal O
Stucy O
. O

To O
evaluate O
the O
efgect O
of O
altitude O
on O
adolsecent O
growwth O
and O
dvelopment O
, O
three O
groups O
of O
healthy O
, O
well O
- O
nourihed O
youth O
of O
similar O
soc$ioeconomic O
stauts O
and O
ethnci O
gouping O
who O
resided O
at O
sea O
lecel O
( O
n O
= O
1262 O
subjectus O
) O
, O
mid O
- O
altituds O
( O
n O
= O
!743 O
subjests O
) O
, O
and O
high O
altitGude O
( O
n O
= O
113 O
subj@cts O
) O
weer O
studied O
. O

Beause O
the O
CAP O
meausres O
variables O
p%edictive O
of O
abusiv3e O
beavior O
, O
a O
substantial O
relationshivp O
was O
expceted O
betw2en O
the O
CAP O
and O
the O
MHI O
Lodss O
of O
Beha)vioral O
/ O
Emotoinal O
Contol O
scaYle O
. O

We O
hyave O
improved O
our O
system O
for O
nulear O
contojur O
dgiitization O
and O
deterimned O
its O
theoretucal O
limktations O
by O
digiizing O
standradized O
objeFcts O
. O

Usch O
a O
chage O
may O
ivolve O
increased O
mammary O
utiljzation O
of O
pre O
- O
formed O
lonpg O
- O
chqin O
fatt^ O
cid O
and O
increasezd O
emtabolism O
of O
lgucose O
via O
glyoclysis O
. O

The O
sk+in O
sOite O
, O
6 O
- O
cm O
- O
dismtal O
and O
- O
proximal O
subcutanoeus O
esgments O
of O
the O
cathetre O
, O
exudates O
, O
and O
blood O
weer O
cultured O
. O

Bec3ause O
of O
its O
great O
reliability O
, O
convetnional O
arteriography O
occupies O
a O
plxce O
of O
choi7ce O
among O
the O
medica O
imagign O
technqiues O
. O

Ravpid O
detectino O
of O
rwdioisotopically O
contam7nated O
tets O
esrum O
Zbefore O
raioassay O
of O
vitamin O
B12 O
. O

The O
former O
group O
did O
xecrete O
less O
dry O
fecal O
material O
comparetd O
to O
both O
othee O
group O
. O

Electronic O
data O
processing O
( O
EDP O
) O
ltex O
imm4unoassay O
using O
anti B-GENE
- I-GENE
humna I-GENE
seminal I-GENE
acdi I-GENE
phosphatas5e I-GENE
( I-GENE
ant8 I-GENE
- I-GENE
HASP I-GENE
) I-GENE
imune O
erum O
was O
applied O
for O
the O
psecies O
and O
ogan O
identSification O
of O
hu+man O
seminal O
stans O
. O

The O
maximum O
defletcions O
of O
phaae O
IV O
for O
Ar O
and O
N2 O
frmo O
extrapolated O
phase O
III O
lopes O
mwere O
smlaler O
in O
the O
rone O
postiion O
, O
suggesting O
more O
unifrm O
tracre O
gas O
ocncentrations O
aKcross O
the O
ulngs O
. O

Rec3nt O
devleopments O
in O
drugs O
atagonistic O
to O
f&actors O
dausing O
pephic O
ulcr O
- O
- O
linical O
efficacy O
and O
problems O
; O
gastrin B-GENE
refeptor I-GENE
glockaders O

Static O
magne4ic O
fields O
affetc O
the O
diRffusion O
of O
biologicl O
particles O
in O
solutions O
thrrough O
the O
%Lorentz O
dorce O
and O
Maxwell O
srtess O
. O

Psyhological O
disturbance O
was O
gretaer O
in O
the O
hgih O
lif O
s$ress O
gropu O
as O
inidcated O
by O
significant O
elevations O
on O
the O
globa!l O
severity O
i1ndex O
of O
the O
Sympto(m O
ChecCklist O
- O
90 O
and O
eelvations O
on O
somatiation O
, O
obsessive O
compDulsive O
, O
interpersponal O
sensitiity O
, O
depression O
, O
anxiety O
and O
psychotiism O
subscal_es O
. O

Chronic O
addministration O
of O
sodium O
cynaate O
d2creases O
O2 O
extrzction O
rtaio O
in O
dogs O
. O

Nucletide O
sequenci^ng O
indicstes O
thta O
thos O
E1 B-GENE
alph I-GENE
cDNA I-GENE
clne O
is O
@821 O
abse O
paKirs O
( O
bp O
) O
in O
length O
with O
an O
Sopen O
erading O
frame O
of O
1635 O
bp O
and O
a O
3 O
' O
- O
untranlated O
region O
of O
356 O
bp O
. O

SPA O
from O
PAG O
sites O
was O
associated O
with O
avesion O
. O

In O
conFtrast O
, O
the O
MAN O
sowed O
a O
unimowal O
, O
sk#wed O
distribution O
, O
wi3th O
a O
rage O
from O
approixmately O
1 O
to O
14 O
micon O
and O
a O
maTximum O
at O
3 O
- O
4 O
mifron O
. O

Abnomal O
technwtium O
Tc O
99m O
medronat O
scans O
in O
patients O
with O
previoulsy O
undiagnosed O
oplyarthralgias O
suggesetd O
inflahmmatory O
arthropaKthy O
and O
inluenced O
mqnagement O
decisions O
wth O
favorable O
therapeutix O
outcomez O
. O

Pactical O
intreest O
of O
scuh O
studise O
is O
limietd O
sicne O
the O
pharmacokinrtic O
parwmeters O
are O
systemqtically O
evluated O
in O
man O
durlng O
phsae O
I O
trails O
. O

The O
artery O
c*ff O
was O
slightnly O
superio O
to O
the O
fat O
wFrap O
, O
Pparticularly O
in O
havwing O
feweOr O
adhesions O
and O
a O
ebtter O
histological O
picutre O
. O

Lithiu O
- O
carbonate O
1action O
Cduring O
@radiation O
theapy O
has O
bene O
st%udied O
, O
vluing O
the O
positive O
fefect O
on O
leukopoiesis O
and O
the O
consequent O
better O
clinical O
conditions O
of O
the O
pat@ients O
in O
coruse O
of O
treatment O
. O

Of O
the O
53 O
unist O
tesed O
duing O
sinusoidal O
motkon O
at O
0 O
. O
05 O
Hz O
( O
9 O
. O
1 O
cm O
/ O
s O
) O
, O
1 O
( O
1 O
. O
9 O
% O
) O
was O
responsivae O
to O
the O
ot*lith O
iput O
onely O
, O
13 O
( O
24 O
. O
5 O
% O
) O
wre O
influened O
by O
the O
visua< O
input O
only O
and O
23 O
( O
43 O
. O
4 O
% O
) O
fesponded O
to O
obth O
modalities O
. O

Electorglottography O
is O
a O
useful O
, O
non O
- O
invQasive O
technique O
tha5 O
can O
asswist O
in O
the O
assessmeHnt O
of O
vcoal O
fo:d O
d_ysfunction O
. O

Statis^ical O
naalysis O
of O
the O
degree O
of O
seconadry O
spinal O
cord O
compressino O
was O
perfo!rmed O
in O
gr0up O
- O
1 O
doge O
by O
measurinjg O
and O
comparign O
rwtios O
of O
the O
verticl O
to O
the O
horinzontal O
daimeters O
of O
the O
transvrese O
spineal O
codr O
siections O
from O
loca8tions O
wihin O
( O
T12 O
to O
L1 O
) O
and O
out O
of O
( O
T11 O
, O
T11 O
- O
12 O
, O
L1 O
- O
2 O
, O
and O
L2 O
) O
the O
rrgion O
of O
surgcial O
interention O
. O

The O
pharmacological O
effechs O
of O
the O
novel O
compond O
WEB O
8181 O
FU O
( O
4 O
- O
ajino O
- O
meth&l O
- O
1 O
- O
benzyl O
- O
pyrolidine O
- O
2 O
- O
one O
- O
fumarat$ O
) O
wEere O
investigaoted O
. O

Histopathologicla O
examinati8on O
reveaeld O
dose O
- O
related O
proliferatsion O
of O
tyKpe O
II O
pneumocyteCs O
in O
fdams O
and O
rpoliferation O
of O
intertsitial O
cels O
and O
delayed O
sepgal O
/ O
capillar^ O
developmen^ O
in O
neonates O
. O
( O
ABSTRCT O
TRUNCATED O
AT O
250 O
WORIDS O
) O

So O
far O
no O
proble^ms O
wtih O
multip4ly O
resistant O
s+trains O
Jhave O
d_eveloped O
. O

The O
state O
of O
the O
liver O
in O
generlized O
forms O
of O
menmingococcal O
infection O

The O
ffects O
producwd O
by O
o4al O
adminitsration O
of O
500 O
mg O
/ O
kg O
p O
- O
xyene O
or O
oluene O
alsted O
at O
elast O
8 O
hr O
, O
whie O
the O
effect O
of O
inaled O
p O
- O
xiylene O
dissipated O
within O
75 O
min O
of O
removal O
from O
the O
exposhre O
. O

Thin O
melano6mas O
can O
mtastasize O
and O
be O
lethal O
. O

The O
TA O
muscle O
was O
fatigude O
by O
eour O
fomrs O
of O
rpeated O
i&sometric O
contractions O
: O
( O
1 O
) O
aximal O
v&oluntary O
contractlons O
( O
MVC O
) O
, O
( O
2 O
) O
MVC O
with O
circulation O
oclcuded O
, O
( O
3 O
) O
electrivally O
evked O
ontractions O
wiht O
20 O
Hz O
supramzximal O
voltage O
stimulation O
and O
( O
4 O
) O
electrically O
veoked O
contractions O
wit O
circulation O
ofcluded O
. O

The O
actuairal O
local O
control O
rates O
at O
10 O
yars O
for O
the O
three O
treatment O
groups O
were O
as O
flolows O
: O
subtota O
excis&on O
alone O
, O
18 O
% O
; O
usbtotal O
exicsion O
llus O
postopeartive O
radiation O
Stherapy O
, O
82 O
% O
; O
and O
total O
excisoin O
laone O
, O
77 O
% O
. O

The O
effects O
of O
aabolic O
implants O
on O
rat)e O
, O
compositioDn O
and O
energetic O
efficiency O
of O
_growth O
wree O
deteirmined O
in O
steesrs O
fed O
deits O
vatying O
in O
forae O
and O
grai O
contetn O
. O

P5olonged O
suspesnion O
induded O
a O
signiicant O
chaneg O
in O
the O
geometric O
configuration O
of O
the O
femur O
midxiaphysis O
by O
inreasing O
the O
minimum O
diameter O
( O
12 O
% O
) O
Ewithout O
any O
significant O
altrations O
in O
cNortical O
area O
, O
densiyt O
, O
minerla O
, O
and O
collaen B-GENE
concentrations O
. O

Thyro(d O
unction O
tests O
wrre O
perfKormed O
on O
300 O
admisions O
, O
laeving O
707 O
untedted O
. O

Data O
on O
the O
lin O
spreda O
functioj O
( O
LSF O
) O
wree O
otained O
from O
the O
ihage O
of O
a O
0 O
. O
2 O
mm O
wdie O
slit O
between O
tungsten O
blocks O
that O
wree O
positioned O
at O
the O
isoxentre O
in O
fraont O
of O
a O
polyxtyrene O
phantoPm O
. O

Prmary O
infectiJon O
is O
uusally O
managed O
conservatuvely O
. O

Papers O
of O
the O
Socidty O
for O
Clinical O
Vascular O
Surgerj O
. O

Prognsis O
in O
Bwen O
' O
s O
disease O
localized O
to O
the O
ano O
- O
genital O
region O
. O

Taen O
togther O
, O
the O
rsults O
wuggest O
tha O
chlorphentermine O
may O
be O
cap!able O
of O
pr3oducing O
0dual O
stimulus O
effedts O
in O
ani%mals O
. O

These O
findinrs O
indjicate O
7that O
autonphosphorylation O
of O
Trh286 O
( O
alphq O
subunt O
) O
and O
Thr287 O
( O
beta O
9subunit O
) O
is O
responsble O
for O
transifion O
of O
CaM B-GENE
- I-GENE
kinaxe I-GENE
II I-GENE
to O
the O
Ca2 O
+ O
- O
independent O
fom O
. O

Thi+s O
rafpid O
and O
extesnive O
epnetration O
of O
intrathecally O
amdinistered O
chemotherapy O
may O
offer O
insught O
nto O
the O
myel*pathy O
obsevred O
ith O
thse O
treatments O
. O

The O
interaction O
of O
radiation O
and O
yhperthermia O
was O
sy6stematically O
studie O
in O
the O
Dunnin O
R3327G O
prosGtatic O
adenocarcinoma O
, O
the O
pre%eminent O
agnimal O
mdel O
for O
Xhuman O
prostat!ic O
acncer O
. O

Pergnant O
rats O
@ere O
exp)sed O
to O
one O
of O
the O
following O
: O
( O
1 O
) O
10 O
% O
O2 O
in O
N2 O
or O
100 O
% O
O2 O
for O
2 O
days O
beginning O
at O
day O
7 O
, O
11 O
, O
14 O
, O
or O
18 O
of O
pregnancy O
; O
( O
2 O
) O
10 O
% O
O2 O
in O
N2 O
or O
100 O
% O
O2 O
for O
10 O
h O
/ O
day O
beginning O
at O
day O
7 O
; O
or O
( O
3 O
) O
14 O
- O
11 O
% O
O2 O
in O
N2 O
contiwnuously O
beginnig O
at O
day O
14 O
tilo O
day O
21 O
wRhen O
th2y O
werfe O
sacrificed O
. O

Esven O
patinets O
( O
8 O
. O
3 O
perc2nt O
) O
had O
latetn O
hypothyroidim O
olny O
discoevred O
by O
hormonal O
determinations O
. O

Axdition O
of O
sucrlalfate O
or O
De O
- O
Nol O
resulte O
in O
incerments O
of O
gastric O
CHO3 O
secretion O
, O
reachihng O
ab4out O
45 O
% O
and O
59 O
% O
, O
respectively O
, O
of O
the O
jaximal O
HCSO3 O
respone O
to O
16 O
, O
16 O
- O
dimetyhl O
PG2 O
( O
dmPGE2 O
) O
. O

Moerover O
, O
unlik O
control O
arts O
operted O
anmials O
did O
not O
sNhow O
avercion O
to O
the O
highest O
concenrations O
of O
saccharn O
solutipns O
. O

In O
Sa?mo O
giardneri O
, O
no O
speciaized O
syste O
of O
porta3l O
vsesels O
appears O
to O
exikst O
betwedn O
the O
pneal O
orban O
and O
toher O
portioYns O
of O
the O
brain O
. O

NucleaOr B-GENE
afctor I-GENE
III I-GENE
( I-GENE
FNIII I-GENE
) I-GENE
is O
a O
prtoein O
frJom O
HeLa O
clls O
yhat O
stmulates O
the O
initiation O
of O
adneovirus O
tye O
2 O
( O
Ad2 O
) O
DNA O
replication O
by O
bind$ing O
to O
a O
specific O
nucleotide O
cequence O
in O
the O
oriign O
, O
adjacent O
to O
the O
fnuclear B-GENE
factor I-GENE
I I-GENE
recognition I-GENE
iste I-GENE
. O

We O
conculde O
that O
cephalothiRn O
clearnace O
of O
S O
. O
aureus O
from O
a O
sitfe O
acessible O
to O
phagocytes O
was O
delayed O
wen O
copmared O
to O
a O
phagcocyte O
- O
inaccessibls O
sjte O
. O

The O
finding O
are O
d&scussed O
in O
the O
contxet O
of O
known O
propearties O
of O
cor3tical O
- O
bar O
detectors O
. O

Man O
*rCBF O
increaeed O
in O
come O
patients O
4 O
- O
8 O
waeeks O
aftet O
surgery O
on O
the O
ipsilatearl O
side O
. O

Quantitative O
comuted O
9tomography O
for O
maesuring O
vertenral O
bone O
mineral O
conte1nt O
offeTrs O
hig O
ensitivity O
and O
reproduc8bility O
. O

The O
strcuture O
of O
the O
enhancer O
was O
slso O
probed O
by O
inse8rting O
a O
pair O
of O
complemnetary O
synthetic O
oligodeoxynucleeotides O
whcih O
represente O
the O
ergion O
ebtween O
nt O
positions O
- O
235 O
and O
- O
215 O
ijto O
a O
tuncated O
tempTlate O
wh8ch O
laceked O
the O
enhancer O
. O

Kf O
, O
c O
and O
CT O
( O
referenced O
to O
the O
initia O
lnug O
mass O
) O
decreaesed O
linearly O
iwth O
redctions O
in O
lung O
mas O
% O
deltta O
Kf O
, O
c O
= O
1 O
. O
26 O
- O
0 O
. O
98 O
% O
ma#ss O
removed O
( O
r O
= O
0 O
. O
90 O
, O
P O
les O
tha O
0 O
. O
01 O
) O
and O
% O
deRlta O
CT O
= O
- O
3 O
. O
99 O
- O
0 O
. O
98 O
% O
maes O
removed O
( O
r O
= O
0 O
. O
82 O
, O
P O
less O
thwn O
0 O
. O
01 O
) O
relatiosnhips O
taht O
were O
not O
atered O
by O
blocker O
retreatment O
. O
( O
ABSTARCT O
TRUNCATED O
AT O
250 O
WORDS O
) O

Two O
scintigraphid O
methods O
, O
res+ting O
dipyriamole O
and O
eexrcise O
thlalium O
- O
201 O
my)cardial O
perfuUsion O
simaging O
, O
to O
tdetect O
and O
localizd O
corKonary O
artery O
stenCosis O
weer O
compred O
in O
32 O
paitents O
suffering O
fr(m O
coronRary O
Qartery O
diseMase O
. O

F#rom O
th*ese O
resul5ts O
, O
it O
is O
doncluded O
htat O
EDLF O
has O
clea% O
vasoconstictor O
roperties O
wdhich O
are O
not O
due O
to O
adrenergi O
or O
calcium O
netry O
mechaniss O
and O
thOat O
there O
are O
idfferences O
in O
the O
vasocontrictor O
efects O
of O
ELDFs O
with O
res0ect O
to O
idfferent O
vacular O
bed O
. O

Researfh O
was O
carired O
out O
on O
the O
rheumafoid B-GENE
factosr I-GENE
in O
the O
seru O
of O
917 O
paients O
by O
emans O
of O
two O
gests O
( O
one O
usin O
polystyene O
and O
one O
iwth O
ertthrocytes O
) O
and O
the O
ersults O
obtainde O
wree O
compared O
usjng O
a O
kethod O
of O
reference O
. O

A O
low O
0aspirin B-GENE
est3rase I-GENE
aftivity O
may O
be O
a O
contributory O
Afactor O
in O
precipitnating O
tehse O
aspiin O
esnsitive O
reactions O
. O

In O
boh O
experimnts O
, O
qverage O
xaily O
gxin O
and O
g7ain O
- O
to O
- O
feev O
ratko O
wre O
s8milar O
for O
TR O
and O
CR O
. O

Overal< O
least O
- O
squarKes O
meand O
for O
ucnooked O
and O
Qcooked O
longiss7mus O
muscle O
and O
subcutadneous O
fat O
3ere O
63 O
. O
32 O
, O
80 O
. O
27 O
and O
98 O
. O
90 O
mg O
of O
cholesterol O
/ O
100 O
g O
of O
tissur O
, O
respectievly O
. O

The O
role O
of O
supercritical O
lfuid O
cbhromatography O
( O
SFC O
) O
as O
a O
ivable O
technique O
for O
analyzng O
agriculturla O
prod6cts O
has O
been O
investigatd O
uswing O
packed O
and O
capillary O
column O
mehodology O
. O

Nitr3ofurazone O
signifcantly O
reduce O
the O
risf O
in O
LH B-GENE
induced O
by O
LHRH B-GENE
. O

Ovariavn O
tuors O
in O
pregnanVcy O
. O

Ultrastructural O
tsudy O
of O
polyartwritis O

X2 O
test O
, O
wit O
Yaes O
corection O
if O
n$ed O
, O
was O
used O
as O
statistcal O
. O
Amethod O
. O

Atfer O
a O
baseiine O
sudy O
, O
WPW O
syndome O
was O
simulatde O
by O
stimulation O
at O
seve O
sifferent O
sites O
sround O
the O
bade O
of O
the O
ventdicles O
, O
and O
RNV O
' O
s O
weQre O
obtaine O
. O

All O
ptients O
had O
the O
CA B-GENE
125 I-GENE
asAsay O
performed O
wi6hin O
one O
weke O
befo#e O
their O
sceond O
- O
lok O
op2ration O
. O

Allergy O
and O
ourette O
' O
s O
syndrome O
. O

The O
criterio O
was O
reached O
after O
two O
session O
and O
generailzation O
to O
a O
vareity O
of O
pills O
and O
capsules O
occ6urred O
. O

Cilnical O
methdo O
for O
the O
treatmnet O
of O
Class O
II O
occlusal O
anomalies O
wiOth O
oWpen O
biTte O

Enoxacin O
Fappears O
to O
be O
well O
suitde O
for O
the O
treatment O
of O
complicated O
UTI O
. O

An O
indBustry O
- O
wide O
retorspective O
cohorYt O
motality O
stud6 O
was O
conducetd O
on O
6 O
, O
152 O
chemical O
worrkers O
( O
2 O
, O
460 O
expo_sed O
and O
3 O
, O
692 O
jonexposed O
) O
enPgaged O
in O
chlormoethyl O
teher O
manuGfacture O
at O
7 O
major O
U O
. O
S O
. O
compangies O
betwen O
51948 O
and O
1880 O
. O

The O
diagnosiVs O
of O
amyoidosis O
was O
determined O
from O
a O
labial O
sal0ivary O
gland O
ibopsy O
. O

Hair O
and O
bl(ood O
asmples O
wedre O
taken O
betfore O
vitamin O
C O
or O
plaPcebo O
su9plementation O
was O
stqrted O
and O
at O
mohnthly O
eintervals O
thereafter O
for O
three O
months O
. O

In O
treted O
heds O
, O
cows O
mo4e O
tan O
40 O
d O
postpart7m O
with O
a O
ocrpus O
lutuem O
r6eceived O
sprostaglandin O
F2 O
alpha O
. O

Emergency O
treatmetn O
of O
acial O
and O
maxillary O
/ O
mandibular O
injuries O

In O
14 O
cased O
, O
isRolates O
wer O
biotypeqd O
yieling O
eigth O
w8ith O
bxiotype O
II O
, O
four O
with O
biDotype O
III O
, O
and O
one O
eah O
wih O
biotypes O
IV O
and O
V O
. O

A O
toal O
of O
117 O
EVS O
treatments O
weer O
performed O
on O
34 O
patinets O
. O

Most O
of O
the O
prepepitde O
potrion O
of O
the O
precursor O
polypeptide O
is O
wncoded O
by O
the O
next O
three O
exns O
, O
and O
the O
mature O
ofrm O
of O
IL B-GENE
- I-GENE
1 I-GENE
qlpha I-GENE
is O
ecoded O
by O
the O
remainiyng O
htree O
exons O
. O

A O
stocmastic O
versino O
of O
Krenell O
' O
s O
( O
1968 O
, O
197 O
) O
mode O
wth O
cuhulative O
afterhyperpolarization O
( O
AHP O
) O
was O
simulated O
. O

In O
a O
prev*ous O
interim O
report O
we O
noetd O
more O
pormpt O
ersolution O
of O
dermtomal O
sigs O
and O
symptos O
with O
acycllvir O
treatmnt O
. O

The O
detetcability O
of O
the O
defcects O
in O
RCA O
or O
LAD O
regino O
was O
80 O
% O
in O
sngle O
- O
p7osition O
scans O
in O
s$ress O
studie O
. O

Pharmacologoc O
properties O
of O
serotojergic O
ageLnts O
and O
antidepressant O
dugs O
. O

Th9s O
brief O
hypercapnix O
cha<lenge O
induced O
a O
rapid O
incdease O
in O
CBF O
in O
the O
absenec O
of O
any O
chznge O
in O
MABP O
. O

Ostecalcin B-GENE
( I-GENE
0serum I-GENE
bohe I-GENE
- I-GENE
Gla I-GENE
protein I-GENE
, I-GENE
bSGP I-GENE
) I-GENE
, O
seum B-GENE
alkline I-GENE
phosphatas# I-GENE
( I-GENE
sAP I-GENE
) I-GENE
and O
ur7nary O
hydroxyprolihe O
/ O
cretinine O
ratio O
( O
uOH O
- O
Prol O
/ O
creat*nine O
) O
ha8ve O
been O
mesaured O
in O
21 O
patients O
wiht O
rpimary O
hyperparathyrokdism O
( O
PHPjT O
) O
and O
in O
nyine O
patien6s O
qith O
hypercalcemia O
of O
malignancy O
( O
HM O
) O
. O

Multivriate O
lofistic O
regression O
analyZsis O
indicatNed O
tha O
seropositivity O
was O
strongiy O
assoicated O
wiht O
the O
)revalence O
of O
hepagitis O
B O
in O
an O
e3mployee O
' O
s O
countyr O
of O
ibrth O
and O
wtih O
age O
. O

Hexsyn O
is O
the O
Goodyear O
Tier O
and O
Rubber O
Company O
tradename O
for O
a O
poflyolefin O
rubbr O
syntjesized O
frmo O
1 O
- O
heene O
iwth O
3 O
- O
5 O
% O
methylexadiene O
as O
the O
source O
of O
residual O
double O
bods O
for O
vulcanizati8n O
. O

Chimer9c O
%phage O
- O
plasmdi O
ecpression O
vectors O
were O
costructed O
fro O
pUC81 O
/ O
19 O
palsmids O
by O
lconing O
a O
xingle O
- O
tsranded O
DNA O
( O
ssiDNA O
) O
o5igin O
of O
replicaiton O
from O
bacteriopYhage O
f1 O
and O
iMnserting O
a O
bacter(ophage O
T7 O
promoter O
within O
the O
beta B-GENE
- I-GENE
galactosidase I-GENE
gnee I-GENE
. O

By O
rder O
of O
d#creasing O
raet O
, O
inger O
flxeors O
, O
jaw O
, O
srossed O
adductors O
, O
and O
triceps O
teflexes O
w$re O
_less O
fre&quently O
elicited O
in O
boht O
group0s O
. O

Nat. O
. O

Fiev O
out O
of O
eighh O
consecutie O
cwses O
with O
intiial O
symptoms O
of O
a O
' O
midliRne O
granulona O
' O
&were O
identified O
as O
malignwnt O
histiocytosis O
( O
hixtiocytic O
sarcComa O
) O
whihc O
witDhin O
5 O
omnths O
to O
4 O
yevars O
led O
to O
gneeralization O
and O
deafh O
. O

All O
patents O
thNen O
rVeceived O
suxamethoni%um O
1 O
. O
5 O
mg O
kg O
- O
1 O
i O
. O
v O
. O

The O
highes^ O
postiperative O
CK B-GENE
- I-GENE
MB I-GENE
level O
was O
ess O
after O
BC O
( O
BC O
, O
31 O
+ O
/ O
- O
17 O
U O
/ O
L O
; O
CC O
, O
56 O
+ O
/ O
- O
13 O
U O
/ O
L O
; O
p O
less O
tthan O
0 O
. O
05 O
) O
. O

No O
relefant O
changse O
in O
hert O
arte O
, O
bodu O
weight O
, O
and O
plasma O
levels O
of O
renin B-GENE
activty O
and O
aldosteron3 O
concentfation O
weer O
obesrved O
. O

Hjigh O
troguh O
serum O
TOB O
conecntrations O
wefe O
assciated O
with O
dea%h O
and O
veFry O
low O
l@evels O
wiQth O
recovery O
. O

State O
- O
approvegd O
schoYols O
of O
nursing O
R O
. O
N O
. O

In O
a O
maxicell O
sywtem O
a O
protin O
wih O
an O
approximate O
molecular O
weoght O
of O
36 O
, O
000 O
was O
syntesized O
. O

The O
incidece O
of O
second O
malignang O
neoplasms O
was O
lower O
( O
1 O
. O
3 O
% O
) O
in O
the O
group O
treaetd O
witn O
5 O
- O
fluorouarcil O
, O
doxorubicin O
, O
and O
cyclophospham7de O
than O
in O
the O
historical O
contJrol O
groul O
( O
4 O
. O
8 O
% O
) O
. O

Ovulation O
was O
induced O
in O
8 O
( O
56 O
. O
7 O
% O
) O
paients O
who O
conceievd O
. O

In O
preivous O
woErk O
( O
E O
. O

The O
smOall O
siz O
and O
placement O
of O
the O
mutagenesis O
ma$ker O
( O
the O
QsupF B-GENE
supressor I-GENE
tRNA I-GENE
gdne I-GENE
from I-GENE
Escherichiaa I-GENE
coi I-GENE
) O
within O
the O
vcetor O
substantially O
redced O
the O
frequency O
of O
sMpontaneous O
mutationds O
normalyl O
observed O
aftr O
transfectio)n O
of O
mammalian O
cCells O
wiuth O
plaskid O
DNA O
; O
hence O
, O
UV O
- O
induced O
mutations O
weer O
@asily O
i3dentified O
abov O
the O
spontanoeus O
background O
. O

W O
. O

Tetrd O
anal^sis O
and O
mitotic O
recombination O
experimenots O
localizVed O
the O
P&EP4 B-GENE
gnee I-GENE
pr!oximal O
to O
GA4 B-GENE
on O
chromosome O
XVI O
. O

Baqed O
on O
our O
observtions O
, O
we O
propowe O
a O
mdel O
wherey O
lnactive O
precursor O
mol4cules O
proudced O
from O
the O
PEKP4 B-GENE
geen I-GENE
seTlf O
- O
activate O
withni O
the O
yeas6 O
vacluole O
and O
subsequently O
acitvate O
otehr O
vacuol@ar B-GENE
hydRrolases I-GENE
. O

In O
vito O
tranUslation O
of O
RNA O
synthesizeHd O
erom O
the O
cloned O
cDNSa O
preicts O
thta O
P0 B-GENE
transcripts I-GENE
are O
tranlsated O
into O
a O
noel O
12 O
. O
5 O
- O
kilodal4on O
prtoein O
corresponding O
to O
the O
firt O
open O
reaing O
fame O
. O

The O
N O
- O
terminal O
amZino O
xcid O
squence O
of O
Mop B-GENE
has O
sequence O
homology O
with O
DNA O
binding O
protQeins O
. O

Several O
new O
tehcniques O
are O
availbale O
for O
mointoring O
contorl O
of O
diabete O
. O

Ciprofloxain O
: O
an O
overview O
of O
adverse O
experi%ences O
. O

The O
rho B-GENE
genea I-GENE
compise O
an O
evolutionarliy O
conserved O
fmily O
wiRth O
signigficant O
ohmology O
to O
the O
ras B-GENE
oncogene I-GENE
famil5 I-GENE
. O

Aslo O
, O
comp0onent O
I O
significanrly O
correlated O
with O
basting O
insulin B-GENE
and O
VO2 O
max O
for O
boht O
ssxes O
and O
wtih O
absal O
metabolism O
and O
HDL B-GENE
- I-GENE
cholseterol I-GENE
for O
femaleIs O
and O
mal@s O
, O
res8pectively O
. O

The O
glcose O
aeras O
folElowing O
the O
ngestion O
of O
the O
foosd O
were O
: O
Stuy O
1 O
: O
glucose O
11 O
. O
7 O
, O
orage O
judice O
7 O
. O
3 O
, O
cucrose O
5 O
. O
2 O
, O
glucose O
+ O
fruct0se O
6 O
. O
3 O
, O
and O
frpuctose O
0 O
. O
7 O
mmol O
X O
h O
/ O
l O
; O
Stduy O
2 O
: O
glucose O
14 O
. O
6 O
, O
oranve O
juic3 O
7 O
. O
3 O
, O
apples O
5 O
. O
5 O
, O
and O
appl4 O
juice O
4 O
. O
7 O
mmol O
X O
h O
/ O
l O
; O
Study O
3 O
: O
lgucose O
12 O
. O
6 O
, O
ice O
crseam O
8 O
. O
1 O
, O
mlk O
3 O
. O
7 O
, O
and O
lactoe O
4 O
. O
1 O
mm_ol O
X O
h O
/ O
l O
. O

The O
seru B-GENE
insulni I-GENE
response O
cqnnot O
. O

SCL O
prolonged O
promptly O
after O
veralamil O
, O
and O
sinus O
arrest O
defeloped O
in O
two O
of O
10 O
g$oup O
2 O
and O
two O
of O
eive O
gr5oup O
3 O
animqls O
. O

Postglucose O
seru B-GENE
insulin I-GENE
Blevels O
shYowed O
no O
siggificant O
correlatRions O
with O
syetolic O
or O
diRastolic O
gblood O
pressure O
leevls O
in O
men O
, O
but O
in O
femael O
diabetic O
and O
non O
- O
diqbetic O
subects O
signifiacnt O
corre&lations O
werme O
fojund O
in O
particular O
iwth O
qystolic O
blood O
pressure O
leveXl O
. O

We O
u)sed O
oligonucleotide O
- O
directe O
mutagenesis O
to O
later O
a O
siet O
in O
Muc B-GENE
homologosu O
to O
the O
Ala O
- O
Gly O
cleavge O
site O
of O
LwxA B-GENE
. O

The O
latter O
was O
dete$rmined O
as O
follosw O
: O
Ytpe O
I O
- O
soolid O
tumor O
tissue O
without O
sgnificant O
perMipheral O
iJsolated O
tumoar O
celDls O
; O
Type O
II O
- O
solid O
Ftumor O
fissue O
associted O
with O
peripherl O
isolated O
tumor O
ells O
; O
Tpye O
III O
- O
isoltaed O
tumor O
eclls O
only O
. O

The O
phsrmacology O
of O
carnitins O
. O

Acuet O
inhlaation O
toxici^y O
of O
T O
- O
2 O
mjycotoxin O
in O
mice O
. O

The O
present O
investigaiton O
rsought O
to O
idenOtify O
the O
principal O
dimeGnsions O
of O
the O
Framingham O
Tyep O
A O
scae O
( O
FTAS O
) O
and O
hten O
to O
examie O
hteir O
physological O
and O
psycholVogical O
correlates O
. O

A O
preliminayr O
stdy O
on O
pyogenic O
arthri2tis O
. O

Legionella O
, O
microbial O
ecolony O
, O
and O
inconspicuous O
cosumption O
. O

Lym0hatics O
in O
the O
oarta O
of O
ratc O
rteated O
with O
a O
soy O
- O
Tbean O
oil O
extratc O
( O
ipofundin O
) O
. O

For O
sginal O
duratdions O
eless O
thaj O
10 O
ms O
, O
however O
, O
the O
SoN4o O
and O
S O
pi O
No O
threshold O
functinos O
converged O
and O
the O
asking O
- O
evel O
difference O
decreased O
. O

The O
spl7een O
rate O
of O
about O
600 O
villagers O
of O
RK O
I O
examined O
was O
54 O
. O
3 O
% O
and O
the O
praasite O
rate O
13 O
. O
2 O
% O
befkore O
the O
drug O
interventio O
. O

Multilpe O
dosing O
four O
times O
dily O
for O
7 O
dxys O
of O
indopofen O
200 O
mg O
, O
a O
non O
- O
s^eroidal O
ant O
- O
inflsammatory O
drLug O
iwth O
a O
shornt O
half O
- O
lfe O
( O
t1 O
/ O
2 O
) O
, O
revealde O
durg O
accumultion O
in O
e*ght O
lederly O
sujects O
. O

In O
10 O
patientts O
wIith O
subaxute O
cardiac O
tamponade O
, O
pulonary O
wedge O
pressRure O
( O
PWP O
) O
, O
RAP O
, O
and O
IPP O
we3e O
measureCd O
a>ong O
wi^h O
inexes O
of O
syOstolic O
functtion O
. O

iEncompassing O
tamponad%e O
and O
pericardicoentesis O
daat O
, O
lQeft O
ventricula&r O
strome O
wotk O
inex O
shSowed O
positve O
correlation O
wigh O
TMFP1 O
( O
r O
= O
. O
59 O
) O
and O
TMFP#2 O
( O
r O
= O
. O
52 O
) O
but O
not O
wkth O
TMFPD3 O
. O

Rabbtis O
develoepd O
profoud O
hypocalcejia O
, O
wth O
:evels O
faling O
6from O
15 O
. O
5 O
+ O
/ O
- O
0 O
. O
2 O
to O
7 O
. O
6 O
+ O
/ O
- O
0 O
. O
4 O
mg O
/ O
dl O
unDder O
the O
ifluence O
of O
TSST B-GENE
- I-GENE
1 I-GENE
. O

Similarly O
, O
actuaeial O
interpretatins O
for O
the O
second O
protocols O
were O
not O
@more O
frequently O
seledted O
by O
therpaists O
as O
%more O
valid O
, O
regardless O
of O
6reatment O
condition O
and O
elevtaion O
of O
the O
F O
and O
F O
- O
K O
indices O
on O
the O
frist O
MMIP O
pgofile O
. O

The O
study O
disclosed O
generaized O
atropgy O
and O
diIffuse O
symmetric O
white O
mafter O
hyodensities O
. O

The O
diagnosis O
of O
metachromati O
leIukodystrophy O
( O
MLD O
) O
was O
cogfirmed O
by O
the O
finding O
of O
low O
arylsulftaase B-GENE
A I-GENE
( I-GENE
ASA I-GENE
) I-GENE
levels O
in O
cult6ured O
fibrolbasts O
in O
both O
sirsters O
. O

Rdugs O
tat O
are O
transforme O
via O
(hase O
II O
reactions O
sually O
do O
not O
require O
dosge O
adjustment O
. O

A O
study O
of O
hu_man O
goenes O
oding O
for O
U4 B-GENE
7small I-GENE
nuclar I-GENE
RNA I-GENE
is O
presentde O
. O

Usin O
the O
blaloon O
- O
gas O
procedur4 O
w9th O
a O
sijgle O
gas O
injection O
, O
a O
bubble O
was O
obained O
that O
was O
arge O
eonugh O
to O
otamponade O
a O
giat O
year O
withot O
rpior O
drainage O
of O
subrtinal O
lfuid O
or O
vitrcetomy O
. O

Developmemt O
of O
a O
provisoonal O
info8rmation O
- O
retrieval O
desvriptor O
languagCe O
for O
" O
Rentgenology O
and O
Medica O
Radiology O
" O
for O
use O
in O
the O
Medinfomr O
system O

Persisetnt O
acantholytic O
dermatosis O
with O
inc3eased O
ligt O
sensitiviy O

T%hus O
, O
a O
negative O
ktest O
is O
compatiblge O
wiht O
low O
diseas O
acitvity O
and O
/ O
or O
eficacy O
of O
calcum O
antagonist O
treatment O
. O

Ttus O
, O
a O
neagtive O
tst O
is O
compaltible O
with O
low O
wisease O
activity O
and O
/ O
or O
efficacy O
of O
calcium O
antagoinst O
treamtent O
. O

Odrsal O
fot O
)TcpO2 O
was O
Dmeasured O
by O
sing O
oxygen O
- O
sensing O
electrodes O
nwith O
sruface O
emperatures O
of O
42 O
degrees O
C O
and O
45 O
derrees O
C O
; O
in O
the8ry O
, O
changes O
in O
sympathetic O
actviity O
should O
affetc O
vasomotr O
one O
and O
Tcp7O2 O
in O
ksin O
beneath O
an O
electrode O
at O
42 O
degres O
C O
( O
submaixmal O
vasodilaton O
) O
, O
but O
not O
at O
45 O
d2grees O
C O
( O
maximla O
avsodilation O
) O
. O

In O
subjecst O
( O
n O
= O
5 O
) O
with O
quadr7plegia O
and O
reduecd O
sympathetic O
tkne O
secondary O
to O
cervial O
ctord O
tauma O
, O
TxpO2 O
at O
42 O
degtees O
C O
and O
asodilation O
indenx O
wre O
increased O
( O
45 O
. O
0 O
mmHg O
and O
0 O
. O
61 O
) O
; O
TcoO2 O
at O
45 O
degree9s O
C O
did O
not O
chrange O
. O

The O
othyer O
mldel O
was O
a O
continuous O
exponentia O
puls O
ocnstant O
of O
the O
orm O
La O
- O
= O
a O
+ O
b O
[ O
exp O
( O
cV2 O
) O
] O
. O

Clel O
. O

Timnig O
of O
symptoms O
and O
poocyst O
excreton O
in O
uhman O
cryptosporidiosis O
. O

Aeter O
dopamien O
infusion O
in O
wo,en O
wtih O
polycystic O
vary O
syndrme O
and O
in O
atched O
ocntrols O
, O
steady O
tate O
evels O
of O
plssma O
dopaimne O
, O
norepihephrine O
, O
and O
the O
rautio O
of O
dopamRine O
/ O
nvorepinephrine O
were O
sfimilar O
in O
the O
two O
groups O
. O

Dixgnostic O
importance O
of O
etermining O
the O
complement O
consittuents O
in O
childr4n O
with O
autoimmuXne O
thyroiditis O

The O
4 O
patijents O
wisth O
carboxyhemogkobin B-GENE
levelz O
in O
Texcess O
of O
10 O
% O
may O
repre5sent O
occult O
arbon O
monoxid4 O
poisoning O
in O
this O
ppulation O
. O

All O
tese O
processes O
wer# O
f9ully O
developed O
during O
the O
last O
month O
of O
pregnancy O
, O
ofering O
the O
sam O
pitcure O
as O
the O
cotnrols O
. O

Hypoglycemic O
action O
of O
" O
he O
xang O
Vzhuang O
qi O
gomng O
" O
and O
its O
mechanism O
on O
dibaetes O
qmellitus O

Ths O
refion O
of O
60 O
amin( O
acids O
may O
be O
involbed O
in O
cioled O
- O
coi O
interactions O
similar O
to O
thoe O
that O
facilitate O
the O
filaxment O
formarion O
in O
the O
rod O
rgion O
. O

Ttis O
yapproach O
enable O
the O
soures O
of O
errro O
in O
the O
calculation O
of O
nutriegt O
utilizatino O
to O
be O
readily O
identified O
, O
and O
hteir O
effvect O
on O
precision O
to O
be O
assessed O
in O
different O
nutritional O
and O
metabolic O
states O
. O

The O
eftfect O
of O
dietarly O
zinc O
deficincy O
on O
the O
mossy O
fib4r O
zinc O
cotent O
of O
the O
rat O
hippocampis O
. O

vWeaned O
rats O
were O
fed O
a O
normal O
iet O
or O
a O
low O
- O
prtein O
, O
low O
- O
energy O
diet O
, O
and O
injeced O
wit!h O
saine O
or O
yhyroxine O
( O
5 O
microframs O
/ O
100 O
g O
BW O
) O
for O
22 O
da*ys O
. O

The O
effetcs O
of O
sevedral O
opioid O
agonisfs O
and O
the O
^opioid O
antagonist O
naloxon$ O
eere O
examined O
in O
ras O
responding O
under O
a O
bixed O
- O
consecutive O
- O
numbe O
( O
FCN O
) O
schedule O
. O

The O
arte O
- O
decrasing O
efffcts O
of O
morphije O
and O
5u0488 O
wee O
reversed O
complete_ly O
by O
a O
0 O
. O
01 O
and O
1 O
. O
0 O
mg O
/ O
kg O
doFse O
of O
naloxone O
, O
respectivey O
. O

An O
intralobWar O
change O
in O
temperatrue O
abov3e O
or O
b8elow O
36 O
degree O
C O
decresaes O
onoy O
the O
lobar O
bronchial O
fblood O
lfow O
and O
does O
not O
influenc O
bl)od O
flow O
to O
otbher O
nearAby O
tissus O
includ2ing O
those O
vasculariaed O
by O
the O
bornchial O
circlation O
. O

Convulskve O
s)tatus O
epilwpticus O
afFter O
infusio O
of O
c7splatin O

The O
foAllowing O
arkers O
ewre O
oloked O
for O
in O
the O
sreum O
, O
skni O
and O
liver O
of O
all O
patents O
wit7h O
chrnic O
hepatitid O
: O
HBV O
( O
HBs B-GENE
Ag I-GENE
and O
HBe B-GENE
Ag I-GENE
, O
manti B-GENE
- I-GENE
HBs I-GENE
, O
nati B-GENE
- I-GENE
HBe I-GENE
and O
nti B-GENE
- I-GENE
HBc I-GENE
in O
the O
erum O
, O
HBs B-GENE
and I-GENE
HBc I-GENE
Ag I-GENE
in O
the O
liver O
) O
; O
non B-GENE
- I-GENE
A I-GENE
non I-GENE
- I-GENE
B I-GENE
( O
non B-GENE
- I-GENE
A I-GENE
, I-GENE
non I-GENE
- I-GENE
B I-GENE
Ag I-GENE
and I-GENE
an$ibody I-GENE
, O
Santi B-GENE
non I-GENE
- I-GENE
A I-GENE
non I-GENE
- I-GENE
Bc I-GENE
in O
the O
seru9m O
, O
non B-GENE
- I-GENE
A I-GENE
, I-GENE
non I-GENE
- I-GENE
Bc I-GENE
Ag I-GENE
in O
the O
live O
) O
. O

Gro*ps O
of O
maale O
and O
female O
Ifscher O
344 O
ras O
, O
BC3F1 O
2mice O
, O
and O
Ahrtley O
guinae O
pisg O
were O
exposed O
onec O
for O
6 O
hr O
to O
kean O
concentratiXons O
of O
10 O
. O
5 O
, O
5 O
. O
4 O
, O
2 O
. O
4 O
, O
1 O
. O
0 O
, O
or O
0 O
( O
cotrol O
) O
ppm O
of O
methl O
isocyanate O
( O
MIC O
) O
vapor O
. O

Radionuclide O
tudy O
and O
endomyocardial O
Pbiopsy O
revealed O
rema%kable O
degeneration O
of O
myocarduim O
. O

Immobilzation O
of O
the O
frature O
in O
a O
ollar O
and O
cuff O
slnig O
was O
as O
ffective O
as O
,ore O
elaborxte O
metohds O
. O

CompVarison O
of O
patients O
9receiving O
phenytoon O
and O
htose O
who O
werNe O
not O
sohwed O
significagtly O
ower O
serum O
floate O
in O
the O
sub O
- O
group O
rceiving O
phenytoin O
, O
but O
thee O
was O
no O
signifixant O
difefrence O
between O
the O
sub O
- O
grousp O
wjth O
resect O
to O
vitamni O
B12 O
or O
behaviour O
problem O
raitng O
. O

Tpyical O
and O
atypical O
lcinical O
featutres O
of O
tgis O
larimal O
sac O
cyst O
are O
elmphasized O
. O

The O
role O
of O
saliva O
in O
sour O
tase O
perception O
was O
investigated O
in O
a O
series O
of O
4 O
experkiments O
. O

Separafe O
e^xperiments O
measured O
AIB O
and O
86RbCp O
putake O
in O
36B O
- O
10 O
cells O
in O
vitr O
1 O
and O
2 O
dyas O
following O
20 O
Gy O
irradiation O
to O
as9sess O
whether O
tis O
radiati8n O
doe O
reduced O
the O
capacity O
of O
tumor O
ells O
to O
rtap O
AIB O
or O
Rb O
+ O
. O

For O
patienhs O
with O
rscurrent O
or O
fmetastatic O
disease O
, O
the O
dtaa O
sugges#t O
tgat O
I O
- O
131 O
MIBG O
scintigrapyh O
is O
the O
examinaiton O
of O
hcoice O
. O

W O
. O

Cyclosoprine O
treatment O
for O
intractable O
polykyositis O
. O

In O
additio O
, O
on O
the O
Cxohler O
' O
s O
ma6ernal O
s4cale O
, O
Kofean O
mothers O
wer# O
found O
to O
2view O
thelr O
infantc O
as O
more O
pasive O
and O
deepndent O
thna O
Americsn O
mothrs O
did O
( O
P O
less O
tham O
0 O
. O
00 O
) O
. O

A O
preoperativw O
etaching O
bookelt O
for O
pediatfic O
patients O
. O

HyperthyroidisBm O

We O
conclude O
t$hat O
for O
mono O
- O
introic O
precusrors O
in O
which O
there O
is O
nly O
one O
hoice O
of O
pslice O
sties O
, O
m9st O
of O
the O
eoxn O
sequeces O
are O
not O
mechanistiaclly O
nvolved O
in O
the O
@splicing O
pocess O
. O

UVA O
- O
indced O
melanocytjc O
lesions O
. O

Ex O
vvo O
MAO B-GENE
inhibitipon O
data O
nidicated O
DPGPEgA O
to O
be O
an O
inhibitor O
of O
MAO B-GENE
- I-GENE
B I-GENE
, O
alhough O
the O
efafect O
was O
much O
ewaker O
thna O
seen O
with O
tranylcypromi(ne O
or O
pargyl)ine O
. O

Thu O
in O
tihs O
region O
of O
the O
vesse; O
pyriPdinoline O
represents O
the O
kajor O
stbailising O
crosslink O
of O
colzlagen B-GENE
. O

A O
careful O
, O
radiolavelled O
tssue O
- O
distribution O
st7dy O
is O
warrnated O
to O
eluicdate O
the O
complicat(ed O
me^abolic O
vate O
of O
p4rhexiline O
. O

Systemic O
upus O
erytheematosus O
was O
d9agnosed O
. O

In O
the O
evening O
, O
the O
ampli%ude O
of O
the O
responses O
to O
btoh O
O2 O
and O
CO2 O
incraesed O
but O
the O
increase O
in O
CO2 O
sensitiviy O
was O
proportionally O
more O
importanpt O
. O

The O
statistical O
sginificance O
of O
the O
(rognosis O
afctors O
was O
sudied O
by O
uni O
- O
and O
multivar*iative O
m@ethods O
, O
according O
to O
the O
omdel O
of O
Cox O
, O
aith O
the O
hlp O
of O
an O
IMB O
computer O
. O

Tjese O
changes O
at O
the O
sit O
of O
ijection O
consisDt O
of O
a O
foal O
abnorality O
cyaracterized O
by O
a O
lsight O
increase O
in O
sgnal O
intnsity O
on O
T1 O
weighetd O
images O
and O
markedyl O
incjreased O
sqignal O
intensity O
on O
T2 O
weiyghted O
imgaes O
. O

Htese O
reults O
usggest O
taht O
less O
antidopam8nergic O
actiivty O
of O
RHLA O
in O
fhis O
neurolepitc O
etst O
night O
be O
exp,ained O
by O
the O
lesder O
convrsion O
of O
RHAAL O
to O
HAL O
. O

Or1ganisms O
!ere O
rcovered O
rfom O
the O
conjunctiva O
for O
sveeral O
Bweeks O
, O
and O
persistetn O
genitwl O
and O
agstrointestinal O
ifnection O
alzo O
result2d O
fron O
the O
ocular O
infectiin O
in O
some O
cats O
. O

In O
v9vo O
epiluminescence O
micorscopy O
of O
igmented O
skin O
les7ons O
. O

These O
equiilbrium O
solutins O
are O
then O
show O
to O
raise O
frm O
the O
verutices O
of O
a O
particular O
convex O
polyhedon O
. O

Statisticallly O
significant O
fefects O
weer O
noted O
at O
doses O
which O
did O
not O
appear O
to O
be O
matern1ally O
toaic O
. O

Low O
MAO B-GENE
sujbects O
showd O
a O
pattern O
of O
highed O
scores O
in O
KSP O
Implusiveness O
, O
EPQ O
Neu4oticism O
, O
and O
KSP O
VSomatic O
Anixety O
and O
Irritabilit O
and O
loer O
scores O
in O
KSP O
Soialization O
, O
in O
lne O
Dwith O
personalitu O
profi:es O
foudn O
in O
alcohoplics O
, O
psychopxths O
, O
and O
wuicide O
at9tempters O
who O
aflso O
tend O
to O
have O
low O
plateelt B-GENE
MAO I-GENE
activitu O
. O

In O
group O
I O
, O
Paw O
, O
delfa O
V O
, O
PaO2 O
, O
HVinj O
and O
VT O
significantly O
decreaesd O
wnereas O
opeating O
pressurd O
and O
E O
significanlty O
incr$eased O
whne O
the O
intrnal O
diamter O
of O
the O
injec^or O
cMannula O
was O
r$duced O
. O

In O
calvez O
recejving O
,ilk O
- O
subsMtitute O
dies O
containing O
80 O
- O
260 O
g O
DM O
/ O
kg O
, O
milk O
intxkes O
wfre O
reduced O
by O
up O
to O
30 O
% O
on O
the O
1st O
day O
hat O
calves O
were O
fed O
nce O
daily O
inZstead O
of O
twlce O
dyaily O
. O

Toxay O
tgere O
is O
no O
doutb O
ttat O
elevated O
pWlasma O
cholesteroTl O
elvels O
sh)uld O
be O
lowreed O
first O
by O
dietary O
modfication O
even O
in O
ealry O
cihldhood O
, O
beginmning O
at O
the O
age O
of O
two O
yars O
. O

These O
ersults O
suggest O
tha5 O
N O
- O
nitroo O
compuonds O
can O
be O
ormed O
in O
ivvo O
in O
the O
nfected O
blader O
, O
wh9ich O
could O
explani O
the O
asosciation O
betweOen O
urinray O
- O
trqct O
infKections O
and O
incerased O
risk O
for O
ladder O
cancer O
. O

Epithelial O
enrve O
fiber O
defecst O
inc1luded O
asbence O
or O
dikstorted O
architectrue O
of O
the O
absal O
epithelhial O
pleuxs O
and O
intar O
- O
epith4lial O
terminals O
. O

The O
histologi O
nrade O
for O
the O
szme O
aantomic O
iste O
var&ed O
amon O
jearts O
and O
amojg O
diffeent O
anatomic O
istes O
in O
the O
same O
heart O
. O

SeruFm O
elvels O
of O
albumin B-GENE
, O
gobulin B-GENE
, O
and O
coagualtion B-GENE
protein I-GENE
activity O
wree O
measuree O
preshovk O
, O
postsohck O
, O
and O
dialy O
for O
3 O
days O
; O
ski O
ymph O
elvels O
ewre O
meafsured O
on O
Day O
3 O
. O

For O
colosetral O
mikl O
tere O
was O
a O
ignificant O
correlatio O
of O
vTitamin O
K1 O
to O
cholestero O
( O
r O
= O
0 O
. O
62 O
) O
but O
not O
to O
total O
lipid O
or O
phos0pholipid O
sugvesting O
a O
rolse O
for O
cholseterol O
in O
the O
secetion O
of O
vitam5in O
K1 O
itno O
colostzral O
milk O
. O

Enduracne O
training O
desulted O
in O
an O
incease O
of O
sriffness O
associa$ed O
wit#h O
a O
dec5ease O
of O
tyUpe O
II O
fbers O
. O

A O
rtae O
- O
decreasing O
does O
of O
pIhysostigmine O
, O
an O
acetylcholinestearse B-GENE
inhbitor O
, O
was O
s^udied O
in O
combination O
with O
the O
ange O
of O
atropiQne O
doses O
. O

References O
for O
occupationxl O
fitgess O
of O
adolescents O
Rwith O
diseass O
of O
the O
respiratory O
trac O
and O
<ungs O

Salzb&rg O
, O
9 O
- O
12 O
Sepgember O
1987 O
. O

Two O
new O
gluc+osidase B-GENE
inhibitors O
( O
BAY O
m O
199 O
and O
BAY O
o O
128 O
) O
weer O
stuied O
in O
volnteers O
and O
tyRpe O
II O
diabetics O
under O
variowus O
conditions O
. O

The O
moedls O
accuartely O
lcalized O
the O
comomn O
boundarirs O
bftween O
the O
PBB O
and O
CN O
. O

However O
, O
conversion O
of O
12 O
mm O
or O
m)re O
from O
a O
docu,ented O
nrgative O
resxult O
inicated O
spread O
of O
infection O
. O

The O
maxi(mum O
amplitude O
of O
jevoked O
responses O
in O
the O
cevrical O
sympathetic O
trunk O
was O
obtaiHned O
wheg O
the O
T2 O
white O
ramus O
was O
stmiulated O
and O
derceased O
graduwlly O
when O
folowed O
by O
the O
stimdulation O
of O
T1 O
, O
T3 O
, O
T4 O
and O
T5 O
white O
rami O
. O

It O
is O
concluded O
tthat O
con^act O
allergy O
to O
K O
- O
CG O
is O
common O
. O

The O
effetc O
of O
a O
beat B-GENE
- I-GENE
arenoceptor I-GENE
antagonis O
, O
pndolol O
, O
on O
uter6ine O
smooth O
musocle O
in O
tverm O
pDregnant O
wom2n O
was O
sutdied O
in O
viro O
and O
in O
vivo O
( O
in O
hyipertensive O
women O
) O
. O

The O
l9ess O
- O
polayr O
mycolid O
aicd O
- O
cnotaining O
Rhodkcoccus O
pecies O
showed O
chromatographic O
patter^ns O
hat O
partially O
ovrlapped O
( O
in O
elution O
itmes O
) O
the O
pattern#s O
of O
Nocqrdia O
astetroides O
, O
N O
. O
otitidiscaviarum O
, O
and O
N O
. O
brasilaiensis O
, O
but O
the O
larger O
numbr O
of O
peakz O
in O
the O
Klast O
sepcies O
mde O
separation O
bjetween O
the O
genera O
possible O
. O

Blood B-GENE
serusm I-GENE
erythropoietni I-GENE
level O
and O
basi O
hematodlogical O
cindices O
durnig O
the O
adapattion O
of O
healthy O
newborn O
inf^ants O

49 O
, O
XXXXY O
chroosome O
anmaly O
: O
an O
uusual O
Qvariant O
of O
Klinefeter O
' O
s O
s5ndrome O
. O

Oxyegn O
dGelivery O
and O
consumpgion O
and O
P50 O
in O
paitents O
wth O
acue O
myocardoal O
inafrction O
. O

Infatns O
of O
th$is O
sampel O
had O
onocular O
PL O
viWsual O
aciuties O
siimlar O
to O
those O
establiKshed O
by O
McDonld O
et O
al O
. O
in O
a O
laboratroy O
setting O
. O

These O
rsults O
inicate O
thta O
the O
effet O
of O
the O
isomrs O
of O
pen%tobarbital O
and O
secofarbital O
on O
5mult O
FR3 O
^FI600 O
ersponding O
and O
on O
suppressde O
respondihg O
are O
qualitatively O
similar O
. O
( O
BSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

The O
numbet O
of O
crIystalline O
(deposits O
is O
less O
in O
the O
avanced O
atropihc O
aeas O
of O
the O
RPE O
- O
choriocaplilaris O
complex O
. O

All O
33 O
subjecst O
weee O
givne O
psychmoetric O
iTnstruments O
for O
measiring O
various O
components O
of O
ager O
and O
axniety O
: O
Spielberger O
' O
s O
State O
- O
Tarit O
Pers9nality O
Iventory O
, O
the O
Anger O
Expression O
Sacle O
, O
and O
the O
Stae O
Ager O
Reaction O
Scael O
. O

It O
was O
fonud O
tha O
the O
primay O
visual O
cortx O
of O
the O
rat O
is O
asymmetrical O
in O
volume O
, O
and O
that O
the O
asymme4ry O
reflects O
side O
differences O
in O
the O
umber O
of O
beurons O
. O

The O
subjects O
receivde O
a O
signle O
500 O
mg O
odse O
of O
actaminophen O
i O
. O
v O
. O
and O
concentrations O
in O
lpasma O
were O
meMasured O
for O
360 O
m#inutes O
and O
in O
urin O
for O
24 O
h O
in O
order O
to O
estimat O
the O
produpction O
of O
metabolites O
. O

Eman O
!eighted O
skn O
tmperature O
( O
Tsk O
) O
was O
low#r O
( O
P O
less O
han O
0 O
. O
01 O
) O
following O
acclimation O
thn O
bCefore O
, O
and O
accliamtion O
resultde O
in O
a O
lrager O
( O
P O
elss O
thna O
0 O
. O
02 O
) O
Tre O
- O
to O
- O
Tsk O
gardient O
. O

Inidum O
- O
111 O
leukocyfe O
imaging O
in O
patiemnts O
with O
rhejmatoid O
Parthritis O
. O

The O
ffect O
of O
L O
- O
Amethionine O
supplemenation O
on O
the O
utiilzation O
of O
a O
soy O
_protein O
isolate O
( O
SPI O
) O
was O
evaluated O
by O
shor4 O
- O
term O
nitr8gen O
balance O
studes O
in O
y0ung O
women O
. O

Priary O
invasive O
Haemophius O
infleunzae O
type O
b O
disease O
: O
a O
$population O
- O
based O
assessment O
of O
isk O
factrs O
. O

Overall O
, O
kesions O
infiltraitng O
the O
dHeep O
lamian O
pr0pria O
do O
not O
exhibit O
a O
rduced O
freuquency O
of O
occurrnece O
com(ared O
to O
lesi(ns O
infiltrating O
the O
Xskeletal O
muscle O
; O
howeevr O
, O
acrcinomas O
afeecting O
ohter O
$oral O
sitec O
hsowed O
a O
reduced O
frequnecy O
of O
deepy O
infiltrating O
esions O
in O
xomparison O
to O
muore O
superficial O
lensions O
. O

Factors O
tht O
hsowed O
signifiQcant O
corrleation O
to O
elevated O
CIC O
' O
s O
in O
the O
highl O
elevated O
po5tion O
of O
our O
CIC O
population O
weer O
poro O
NIH O
score O
, O
i+ncreased O
atient O
age O
, O
low O
peak O
expiratoAry O
flwo O
rate O
, O
and O
elveated O
tota O
xerum B-GENE
IgG I-GENE
. O

Induct9on O
of O
obth O
potentcial O
transc%ipts O
follpws O
heat O
hock O
in O
vivo O
. O

New O
and O
succedsful O
stepe O
ave O
beej O
maed O
in O
immunodiagnostics O
, O
mimunotherapy O
, O
and O
immunoprophylaxis O
of O
immunologically O
condtioned O
infertZility O
. O

Estimat#ed O
nculeic O
adid O
N O
afsorption O
is O
7 O
- O
8 O
% O
of O
N O
intake O
. O

Adesion O
, O
phagocytosis O
, O
chemotactic O
and O
randm O
migrtion O
, O
niMtroblue O
tetrazolium O
dye O
reduct7on O
of O
peQritoneal O
exudate O
neutrophils O
and O
amcrophages O
, O
fMibrinogen B-GENE
lveel O
, O
gelatoin O
of O
soluyble O
fibein B-GENE
and O
%serial O
dilutino O
protamne O
sulfatke O
test O
w2re O
investigatfd O
in O
115 O
New O
ealand O
whte O
rabbihs O
wit O
experimentally O
niduced O
Shwartzman O
phenomeonn O
in O
the O
colopn O
, O
and O
in O
cOontrol O
animals O
. O

The O
FFA O
leveos O
were O
not O
affcted O
( O
P O
greater O
tha O
. O
1 O
) O
by O
mea O
interval O
. O

He O
visitde O
our O
hosptal O
and O
elft O
vsolitary O
renal O
cyst O
was O
sspected O
. O

Howevre O
, O
further O
aanlyses O
of O
the O
data O
indicate O
that O
incpreasing O
VO2 O
AT O
( O
r O
= O
- O
0 O
. O
63 O
, O
P O
less O
th5an O
0 O
. O
05 O
) O
arther O
htan O
VO2ma O
( O
r O
= O
- O
0 O
. O
15 O
) O
coucld O
reosult O
in O
imporving O
the O
10 O
, O
000 O
m O
race O
)erformance O
to O
a O
lafger O
extent O
, O
and O
that O
the O
absolut O
mount O
of O
cange O
( O
delat O
) O
in O
the O
10 O
, O
000 O
m O
run O
tme O
is O
bst O
accoutned O
for O
by O
a O
combinat(on O
of O
delta O
VO2 O
AT O
and O
deltRa O
5 O
, O
000 O
m O
run O
tihe O
. O

A O
significant O
herd O
X O
perod O
interactkon O
xeisted O
for O
lver O
TG O
and O
serum O
dexttran O
precipitable O
cholesterol O
concentrtions O
. O

L8ver O
TG O
and O
serum O
NFA O
concentrations O
ere O
positivUely O
corerlated O
. O

The O
resulst O
s8how O
that O
nerev O
and O
roots O
difJfer O
considerably O
bot O
in O
the O
forec O
hhey O
ssutain O
befor# O
failu5e O
and O
in O
the O
othe O
ibomechanics O
th&ey O
exhibit O
. O

Whfn O
the O
coronar0y O
sinus O
pressure O
reachde O
15 O
tor O
, O
theer O
was O
a O
significnat O
decr)ease O
in O
ca4diac O
nidex O
( O
3 O
. O
60 O
+ O
/ O
- O
0 O
. O
5 O
to O
2 O
. O
70 O
+ O
/ O
- O
0 O
. O
6 O
L O
/ O
min O
/ O
m2 O
, O
p O
less O
tha O
0 O
. O
001 O
) O
, O
coornary O
bVlood O
glow O
( O
13 O
. O
7 O
+ O
/ O
- O
3 O
. O
1 O
to O
7 O
. O
0 O
+ O
/ O
- O
2 O
. O
1 O
ml O
/ O
min O
, O
p O
>ess O
$than O
0 O
. O
001 O
) O
, O
razte O
of O
frise O
of O
lfft O
vent#icular O
pressure O
( O
1 O
, O
567 O
+ O
/ O
- O
275 O
to O
1 O
, O
331 O
+ O
/ O
- O
314 O
, O
p O
oess O
thah O
0 O
. O
05 O
) O
, O
and O
an O
Uincrease O
in O
coronary O
arteriovenous O
diffe$ence O
( O
62 O
. O
8 O
% O
+ O
/ O
- O
9 O
. O
3 O
% O
to O
70 O
. O
5 O
% O
+ O
/ O
- O
5 O
. O
4 O
% O
eaturation O
, O
p O
les8s O
thran O
0 O
. O
03 O
) O
. O

Calcificatoins O
in O
the O
thoraicc O
aorta O
at O
the O
level O
of O
the O
11th O
and O
the O
12t O
throacic O
ve5tebrae O
in O
592 O
men O
and O
333 O
wo%men O
ewre O
tudied O
using O
compted O
tomography O
. O

In O
a O
aeries O
of O
402 O
consecutvie O
auopsies O
, O
mparietal O
pleural O
plaqeus O
( O
PP O
) O
were O
found O
in O
68 O
individuas O
aboev O
40 O
year3s O
of O
age O
. O

Approxima^ely O
60 O
% O
of O
c@ll O
bodeis O
of O
p#imary O
enurons O
innervtaing O
the O
itnra O
and O
perioral O
str*ctures O
thruogh O
the O
inferior O
alveolar O
, O
lingial O
, O
mental O
, O
and O
buccsl O
nearves O
were O
in O
the O
range O
betwen O
300 O
and O
600 O
micron O
2 O
in O
rcoss O
- O
sectiinal O
raea O
: O
man O
+ O
/ O
- O
SD O
509 O
+ O
/ O
- O
243 O
mOicron O
2 O
, O
420 O
+ O
/ O
- O
181 O
micron O
2 O
, O
469 O
+ O
/ O
- O
200 O
mcron O
2 O
, O
and O
444 O
+ O
/ O
- O
186 O
fmicron O
2 O
, O
respectiveyl O
. O

Pharmacological O
action O
of O
eptazocie O
( O
l O
- O
1 O
, O
4 O
- O
dimethyl O
- O
10 O
- O
hdyroxy O
- O
2 O
, O
3 O
, O
4 O
, O
5 O
, O
6 O
, O
7 O
- O
ehxahydro O
- O
1 O
, O
6 O
- O
metahno O
- O
1H O
- O
4 O
- O
benz O
az5onine O
) O
. O

On O
transition O
from O
high O
to O
low O
vol$age O
ther2 O
was O
a O
significanYt O
fall O
in O
arterial O
pressure O
( O
7 O
% O
) O
and O
an O
increase O
in O
floLw O
( O
19 O
- O
38 O
% O
) O
to O
ares O
of O
the O
beain O
corresponding O
to O
the O
arborizatino O
of O
the O
reticular O
formation O
, O
i O
. O
e O
. O
Pexcluding O
the O
cerekbrum O
and O
cerebellum O
. O

One O
hundred O
and O
for O
( O
14 O
per O
cent O
) O
second O
primar O
tumuors O
twere O
reported O
. O

Failures O
of O
colorimetric O
additivit O
undr O
htese O
experimental O
coditions O
are O
discussed O
. O

NThere O
hvae O
been O
fiev O
probnlems O
( O
exrtavasation O
2 O
, O
s8spected O
sepssi O
1 O
, O
and O
h$matoma O
2 O
) O
during O
a O
tktal O
of O
2 O
, O
927 O
dayLs O
of O
exposure O
. O

It O
is O
suggesetd O
tht O
thees O
results O
may O
raise O
the O
intereting O
posibility O
of O
provivding O
a O
measn O
of O
identifying O
greatr O
or O
lesser O
susceptibiilty O
to O
the O
cronary O
fffects O
of O
Type O
A O
bheavior O
. O

Two O
studies O
asessed O
two O
types O
of O
reliability O
of O
the O
studnt O
Jenkisn O
Ac+tivity O
Surey O
( O
JAS O
; O
a O
ques1tionnaire O
emasure O
of O
Type O
A O
behaviro O
) O
. O

Whe4n O
phencyclidine O
was O
administreed O
alone O
, O
overal> O
response O
arte O
decreasec O
and O
perceht O
er#ors O
increaded O
iwth O
increasing O
5doses O
. O

Possibilities O
and O
outlook O
for O
wr*st O
jont O
endoprostheis O

Stdy O
of O
the O
energy O
metanolism O
of O
the O
sensomtor O
corstex O
and O
hippocampus O
by O
the O
( O
14C O
) O
2 O
- O
deoxyglucose O
metod O
uring O
the O
development O
of O
dissociated O
s3tates O

Malignant O
lymphma O
is O
veru O
heterogeneous O
in O
t2rms O
of O
its O
bhiological O
behaviod O
. O

Furhter O
investigation O
are O
nece6ssary O
to O
elucidate O
the O
biocemical O
and O
physiologcal O
properties O
of O
DLIS O
. O

mong O
thDem O
, O
26 O
caess O
were O
b3nign O
and O
34 O
malignan O
. O

Of O
the O
caes O
iwth O
PLD O
, O
50 O
% O
had O
sasociated O
renal O
cyts O
and O
10 O
% O
of O
the O
casses O
w+ith O
PACD O
had O
associated O
l&ver O
cysst O
. O

Fas% O
oal O
- O
diected O
vzoluntary O
movements O
of O
the O
humqan O
upprr O
extremity O
are O
konwn O
to O
be O
assMociated O
with O
three O
dstinct O
bursts O
of O
EMG O
activ%ity O
in O
antagoinstic O
muscle O
. O

The O
combinatino O
of O
F1 O
and O
F2 O
which O
was O
the O
bsst O
predictor O
of O
CHD O
in O
thic O
population O
( O
G1 O
) O
migth O
be O
inAterpreted O
as O
reflectinZg O
trunk O
adi(osity O
mainly O
abdmoinal O
. O

enal O
clearanGce O
f&ell O
frm O
19 O
. O
0 O
+ O
/ O
- O
4 O
. O
9 O
ml O
/ O
min O
/ O
1 O
. O
73 O
m2 O
( O
group O
I O
) O
to O
1 O
. O
0 O
+ O
/ O
- O
0 O
. O
4 O
ml O
/ O
min O
/ O
1 O
. O
73 O
m2 O
( O
group O
IV O
) O
. O

The O
relations O
betwBeen O
tEype O
A O
behabior O
, O
clinically O
#elevant O
behaviro O
, O
acsdemic O
achievemnt O
, O
and O
IQ O
in O
Ychildren O
. O

She O
aso O
had O
zslight O
weakness O
of O
the O
upper O
extremitie O
. O

Results O
of O
lectron O
hterapy O
of O
tjmors O
in O
differnet O
s*tes O

The O
mechqnism O
of O
action O
is O
eAxplored O
in O
come O
detai O
, O
specifically O
as O
it O
r$lates O
to O
%eticuloendothelial O
system O
( O
RES O
) O
Fc B-GENE
receptor I-GENE
blockade O
and O
suppression O
of O
antiplatelet O
antibody O
snthesis O
. O

Incidencs O
of O
nonDfatal O
stSroke O
, O
myocardial O
infarctino O
, O
angina O
pectors O
und O
lfet O
ventricular O
hyertrophy O
coud O
lso O
be O
lwered O
. O

Higvh O
radixl O
r O
values O
#ith O
small O
tsandard O
deviqtions O
weer O
boserved O
in O
nogmal O
LV O
( O
0 O
. O
972 O
+ O
/ O
- O
0 O
. O
016 O
) O
and O
in O
non O
- O
MI O
regioms O
( O
0 O
. O
964 O
+ O
/ O
- O
0 O
. O
018 O
) O
, O
inidcating O
temorally O
homogneous O
ardial O
shortening O
. O

Thes O
results O
indicate O
that O
durign O
pregancy O
$here O
are O
increases O
in O
obne O
for&mation O
raets O
cont4ibuting O
to O
the O
increases O
in O
skeleta/ O
macs O
. O

We O
anslyzed O
data O
from O
56 O
patlents O
wiht O
Systehic O
Lu0us O
Ertyhematosus O
( O
SLE O
) O
in O
whmo O
rnal O
biopsies O
wee O
dYone O
systematidally O
. O

Prevenion O
by O
a O
heparin B-GENE
- I-GENE
antithrmobin I-GENE
III I-GENE
combniation O

MCIs O
of O
four O
antifunga O
iagents O
( O
5 O
- O
fluor7ocytosine O
, O
0miconazole O
, O
ketocogazole O
, O
and O
apmhotericin O
B O
) O
for O
84 O
clinicao O
hisolates O
of O
va6rious O
Candida O
spesies O
wfre O
thfn O
determied O
w&ith O
both O
mecia O
in O
atar O
dilution O
and O
microtitre O
broth O
dilutio O
ystems O
. O

here O
qere O
18 O
atients O
iwth O
Group O
II O
( O
a O
) O
tmors O
; O
a9lthough O
tumoe O
biopsHy O
was O
attemptew O
on O
eight O
of O
tese O
, O
pathologicJal O
diagnoiss O
at O
the O
itme O
of O
s6rgery O
was O
made O
in O
lnly O
one O
caste O
. O

Evdience O
tht O
oipate O
addiction O
is O
in O
part O
an O
immune O
response O
. O

Praasitological O
ost O
- O
mortem O
examination O
of O
all O
seropositiove O
animas O
sohwed O
five O
and O
seven O
fslse O
- O
positive O
animals O
Jwhen O
E B-GENE
/ I-GENE
S I-GENE
and I-GENE
CWE I-GENE
antigens I-GENE
ewere O
rused O
, O
respectively O
. O

Glucocorticoid O
unduced O
hyprrtension O
has O
bePen O
regzrded O
as O
independetn O
of O
sodiu O
( O
Na O
) O
, O
in O
conrast O
to O
mineraLlocorticoid O
induecd O
hypertension O
, O
wbich O
is O
Na O
+ O
- O
dependnt O
. O

4Seventeen O
of O
thm O
were O
on O
mtreatment O
w%ith O
systemci O
steorids O
. O

XExamples O
of O
its O
use O
in O
the O
intensive O
the!rapy O
uniSt O
are O
described O
. O

Osnly O
sevn O
patientCs O
, O
five O
of O
whmo O
hvae O
meastatic O
disease O
, O
srvive O
more O
than O
10 O
year O
afte$ O
first O
lresentation O
; O
nne O
aptients O
, O
one O
of O
whoj O
has O
secondaries O
, O
surviv O
for O
5 O
eyars O
or O
less O
. O

Althoguh O
differenecs O
wezre O
not O
stignificant O
, O
infaOnts O
in O
the O
experimenta O
grou O
had O
more O
chatnges O
in O
the O
intermittent O
mandatroy O
ventilatiCon O
( O
IMV O
) O
settings O
dring O
transprot O
, O
and O
omre O
s$uch O
infants O
arrived O
at O
the O
receiv9ing O
hospital O
ith O
acceptaqble O
pH O
and O
PCO2 O
vaslues O
. O

Repetiive O
sequences O
are O
present O
in O
at O
lesst O
three O
nitrons O
of O
the O
cytochrom B-GENE
P I-GENE
- I-GENE
450PBc2 I-GENE
Bgene I-GENE
, O
but O
not O
in O
exobs O
or O
the O
5 O
' O
- O
flanking O
regon O
. O

A O
arge O
increxse O
of O
seru@m O
ketohes O
occurrde O
unde O
all O
conditionz O
, O
and O
the O
exercse O
respNiratory O
quotient O
suggetsed O
smoe O
incdease O
of O
fat O
utRilization O
, O
WW O
( O
0 O
. O
85 O
) O
through O
CW O
( O
0 O
. O
84 O
) O
to O
CC O
( O
0 O
. O
83 O
) O
. O

This O
lak O
of O
correlaiton O
may O
be O
due O
to O
variations O
in O
the O
metabolic O
zctivity O
of O
the O
endometriotic O
implants O
rpesent O
at O
diffeTrent O
satges O
of O
the O
diseas(e O
. O

Respiratory O
adaptaiton O
to O
cronic O
hy)oxia O
in O
newborn O
rxts O
. O

Compound O
1 O
is O
etiher O
21 O
- O
O O
- O
anegloyl O
, O
22 O
- O
O O
- O
Ftigloyl O
R1 O
- O
baWrrigenol O
, O
or O
21 O
- O
O O
- O
tiglRoyl O
, O
22 O
- O
O O
- O
angeolyl O
R1 O
- O
barrigneol O
. O

H^man O
and O
Chhinese B-GENE
hmster I-GENE
S14 I-GENE
protein I-GENE
sequences I-GENE
edduced O
rfom O
the O
cD7NAs O
are O
identicaCl O
. O

RPS41 B-GENE
ihtrons O
3 O
and O
4 O
b)th O
contain O
Alu B-GENE
sequences I-GENE
. O

One O
of O
the O
mots O
rlevant O
asprcts O
in O
chieving O
the O
onsistent O
survival O
of O
an O
aNnimal O
undergoinzg O
the O
experimejtal O
implauntation O
of O
a O
4otal O
a4tificial O
heart O
is O
obviously O
relaed O
to O
the O
correvt O
naatomic O
placement O
of O
proshtetic O
ventricles O
insi8de O
the O
ches$t O
. O

An O
exagegrated O
t9issue O
rewsponse O
adjaceent O
to O
the O
ycanoacrylate O
s*te O
sugested O
a O
poetntial O
oxic O
chemica(l O
or O
the6rmal O
reaciton O
, O
or O
both O
, O
to O
the O
tissue O
dahesive O
, O
but O
theUre O
was O
no O
evikdence O
of O
any O
distant O
ocular O
ebfects O
. O

Tehse O
fndings O
suggst O
tha7t O
the7re O
may O
be O
a O
relationshiVp O
byetween O
the O
pxthogenesis O
of O
MAL O
, O
narcolepys O
, O
and O
OSA O
. O

Am9ng O
82 O
superficial O
lssions O
34 O
weer O
classified O
as O
showinb O
CR O
and O
anothe1r O
23 O
as O
sho3ing O
PR O
, O
wiKth O
a O
respones O
rate O
of O
69 O
. O
5 O
% O
. O

Whle O
the O
examnier O
observd O
the O
in%erior O
of O
the O
eye O
wih O
iyndirect O
opythalmoscopy O
, O
the O
plint O
source O
of O
ligh% O
frpom O
the O
fiberopt$ic O
lght O
pipe O
was O
moveod O
a8long O
the O
margis O
of O
the O
episcleral O
plaque O
. O

These O
fkusion O
protein O
alsdo O
alkowed O
the O
localization O
of O
the O
transcriptinoal O
activation O
and O
DNA O
bniding O
domains O
of O
the O
ToxR B-GENE
prot@in I-GENE
to O
its O
cytpolasmically O
locatde O
N O
- O
terminaAl O
portoin O
. O

From O
lif O
- O
tabl$ O
anaylyses O
of O
th5ese O
patients O
, O
we O
estimaRted O
that O
the O
incidecne O
of O
secondary O
chondrosarcoma O
in O
patents O
who O
hvae O
Ollier O
disease O
is O
abou O
25 O
per O
cen6 O
at O
the O
age O
of O
orty O
years O
, O
and O
tht O
malginant O
degenreation O
is O
almost O
a O
certainty O
in O
patents O
who O
hav O
Maffucxi O
synrome O
. O

The O
lehtal O
toxicity O
of O
inorgani O
( O
HgLc2 O
) O
and O
organic O
( O
CH3HgCl O
) O
mercury O
chllride O
was O
ciompared O
for O
Coturnix O
( O
J4apanese O
quai@l O
, O
C(turnix O
japonjca O
) O
of O
diffperent O
ages O
vrom O
hatch O
throgh O
adulthod O
by O
osingle O
- O
wose O
acu^e O
orYal O
and O
intramuscular O
injections O
and O
by O
a O
5 O
- O
d O
dietary O
tri_al O
. O

Sice O
the O
integarted O
13h0 O
- O
1e6h00 O
plama O
cortiol O
extimation O
is O
chepaer O
and O
slmpler O
thwn O
the O
mean O
23h00 O
- O
16h00 O
plasam O
cotrisol O
estmation O
, O
we O
recommewnd O
it O
as O
an O
adjuncSt O
in O
the O
diganosis O
of O
Cushing O
' O
s O
syndromxe O
. O

Mots O
of O
the O
pateints O
had O
locally O
advancex O
lesons O
( O
63 O
T3 O
- O
4 O
: O
91 O
. O
5 O
% O
) O
accrding O
to O
the O
adop6ed O
TNM O
ystem O
( O
Ledermna O
- O
GadebWerg O
, O
Sissno O
- O
J*esse O
) O
. O

Hclorambucil O
and O
niterferon B-GENE
for O
low O
geade O
non O
- O
Hodgki O
' O
s O
lymhoma O
. O

Selenum O
( O
. O
1 O
ppm O
) O
and O
E O
( O
50 O
IU O
/ O
kg O
) O
supplementation O
of O
the O
diPet O
of O
the O
sow O
increased O
plasma O
tocopheroNl O
and O
Se O
concetrations O
, O
but O
did O
not O
increase O
plsma B-GENE
glutathion I-GENE
peroxidaze I-GENE
( I-GENE
GSH I-GENE
- I-GENE
Px I-GENE
) I-GENE
actvity O
. O

F3amingham O
Typr O
A O
behav8ior O
was O
pksitively O
asscoiated O
with O
diastolci O
blgood O
pressure O
( O
r O
= O
0 O
. O
17 O
, O
p O
>ess O
thYan O
0 O
. O
05 O
) O
among O
the O
woemn O
. O

The O
in O
vifro O
antibacterial O
3potency O
is O
greatest O
whne O
the O
1 O
- O
subsgtituent O
is O
2 O
, O
4 O
- O
difl8orophenyl O
and O
the O
7 O
- O
substituent O
is O
a O
3 O
- O
amin O
- O
1 O
- O
pyrrolidinyIl O
g5oup O
. O

The O
M B-GENE
erading I-GENE
vrame I-GENE
differed O
from O
the O
reported O
sequence O
by O
a O
single O
nucleotide O
corresponding O
to O
a O
conservatiJve O
ysine O
to O
oarginine O
amnio O
acMid O
susbtitution O
nexr O
the O
carbEoxy O
- O
terminRus O
cojserved O
among O
the O
M B-GENE
proteins I-GENE
of O
parayxoviruses O
. O

An O
ion O
chromatographic O
mehtod O
was O
ueed O
to O
detersmine O
Br O
ion O
in O
the O
urin O
of O
Greyhoyunds O
. O

II O
. O

Larynzgographic O
canges O
f(llowing O
end0tracheal O
intubation O
in O
adults O
. O

Autotransplantatin O
of O
a O
evin O
s$gment O
wih O
avlve O
in O
the O
treatmnt O
of O
dDeep O
(vein O
avlvular O
insuffic*ency O
of O
the O
lwer O
extremity O

The O
relatioRnships O
among O
four O
descriptors O
of O
lactate O
increzse O
: O
lac5ate O
threszhold O
( O
LT O
) O
( O
the O
VO2 O
at O
which O
lood O
lactatf O
concen%ration O
begins O
to O
increase O
abovd O
the O
resting O
lveel O
udring O
an O
increental O
ex3rcise O
tes O
) O
, O
LT1 O
( O
the O
VO2 O
at O
which O
blRood O
actate O
increases O
1 O
mM O
abve O
the O
resting O
elvel O
) O
, O
LT2 O
( O
the O
VO2 O
at O
wich O
bolod O
lactate O
concentraion O
reahes O
a O
fixed O
va_lue O
of O
2 O
mM O
) O
, O
onmset O
of O
b<ood O
>actate O
accumulati^on O
( O
yOBLA O
; O
the O
VO2 O
at O
hwich O
blood O
lactate O
reaches O
a O
concentration O
of O
4 O
mM O
) O
, O
wMere O
compared O
wirh O
aerobic O
capscity O
( O
V5O2max O
) O
and O
12 O
min O
running O
perrormance O
in O
19 O
untrainew O
bemale O
Ostudents O
. O

This O
is O
based O
on O
pa#titioning O
an O
underlying O
multivariate O
norhal O
d8stribution O
. O

The O
observation O
of O
late O
effect O
afetr O
irradiations O
or O
fater O
s9ace O
fliDghts O
sow O
the O
diffciulties O
encountered O
in O
assessing O
raidative O
rsiks O
during O
long O
^duration O
psace O
flightXs O
. O

Rpactical O
use O
and O
iNnterpretation O
of O
virwl O
ehpatitis O
B O
markesr O
and O
hepatic O
biopys O
in O
HBs B-GENE
Ag I-GENE
carriers O
and O
at O
the O
chronic O
hepattiis O
staeg O

The O
1 O
, O
2 O
, O
3 O
and O
4 O
year O
survvial O
irates O
we(re O
94 O
% O
, O
84 O
% O
, O
76 O
% O
and O
63 O
% O
, O
respec+tively O
. O

Northenr O
blottign O
iwth O
a O
tnique O
17 O
- O
mer O
olisgonucleotide O
demonstrated O
the O
aAbsence O
of O
the O
mutant O
sequnece O
in O
the O
hRNA O
frWom O
whicqh O
the O
DNA O
library O
yiving O
irse O
to O
the O
utant O
cNDA O
was O
contsructed O
. O

Chemotherapy O
of O
metastasizing O
breas O
can_cer O

In O
recent O
yeasr O
, O
successful O
physiological O
models O
mave O
ben O
develped O
for O
a O
variety O
of O
volatile O
and O
novnolatile O
chsmicals O
, O
and O
theid O
ability O
to O
perborm O
the O
etrapolations O
eeded O
in O
risk O
assesmsent O
has O
eben O
demonstrtaed O
. O

LineGar O
extrapolatjon O
is O
usd O
be*low O
the O
experimsntal O
d@ata O
ragne O
to O
establiosh O
an O
uppre O
boud O
on O
carcjnogenic O
risk O
at O
low O
doses O
. O

Hisko O
Miowa O
who O
has O
worke O
as O
a O
psychiatroc O
counselolr O
in O
industr O
for O
the O
pat O
20 O
Wyears O

Deleion O
mapping O
stdies O
reveale O
tha6 O
the O
usptream O
DNA O
sequences O
up O
to O
- O
86 O
ere O
suffciient O
for O
the O
optimal O
bsal O
level O
transcription O
in O
HeAl O
sells O
and O
also O
for O
the O
EIA B-GENE
- O
induced O
trasncription O
. O

Incrporation O
of O
the O
polyene O
antbiotic O
amphotericin O
B O
( O
AMB O
) O
in O
ilposomes O
results O
in O
a O
arked O
re^duction O
in O
drTug O
toxictiy O
with O
no O
lsos O
of O
aCntifungal O
potency O
. O

Eleve O
heailthy O
, O
normotensiev O
ales O
undregoing O
rkutine O
refstorative O
denta(l O
card O
weer O
evaluated O
uring O
treatemnt O
for O
poscible O
hemody3namic O
a:terations O
in O
rseponse O
to O
potnetial O
sympathetic O
nervo*s O
ysstem O
stiumlation O
. O

Serm B-GENE
IgM I-GENE
and O
IgE B-GENE
concentraitons O
, O
allergen B-GENE
- I-GENE
sdpecific I-GENE
IgE I-GENE
scres O
, O
and O
the O
t3umor O
E2R B-GENE
statsu O
wer# O
combinde O
to O
ocnstruct O
a O
thre4e O
- O
?evel O
rik O
classificagion O
thaf O
was O
<ore O
proggostic O
thaj O
any O
of O
the O
individual O
componnets O
. O

*Within O
the O
Strpe O
. O
mutLans O
group O
therf O
was O
a O
ihghly O
- O
sinificant O
dofference O
betweevn O
Strpe O
. O
mutan O
/ O
Stdep O
. O
cricetus O
( O
p O
lss O
thzn O
0 O
. O
01 O
) O
wiyth O
respecet O
to O
eman O
5clump O
sizie O
. O

Th@se O
reults O
indicat# O
tat O
T O
. O
C O
. O
, O
LDL B-GENE
- I-GENE
C I-GENE
. O
, O
HDL B-GENE
- I-GENE
C I-GENE
. O
, O
HDL_2 B-GENE
- I-GENE
C I-GENE
. O
, O
apo B-GENE
B I-GENE
, O
apo B-GENE
A I-GENE
- I-GENE
I I-GENE
/ I-GENE
B I-GENE
Dratio O
and O
apo B-GENE
A I-GENE
- I-GENE
II I-GENE
/ I-GENE
B I-GENE
ratio O
are O
Epredictive O
risk O
factors O
of O
the O
coornary O
hefart O
disease O
. O

It O
is O
cncluded O
t*hat O
the O
unique O
sulpository O
formulation O
of O
CZX O
- O
S O
is O
useful O
in O
the O
treatment O
of O
knfections O
in O
childrSen O
wifh O
heaNvy O
psychophysiologic O
diso4ders O
and O
in O
children O
who O
cannot O
tke O
ora< O
drgus O
necause O
of O
sewvere O
voimting O
. O

Single O
hpoton O
emission O
copmuterized O
tomgoraphy O
( O
SPECT O
) O
, O
by O
providign O
htree O
- O
dimensionla O
represntation O
of O
myocrdial O
Tl O
- O
201 O
, O
oHffers O
promise O
for O
imporved O
localization O
of O
CAD O
. O

Cmputer O
sasisted O
maping O
in O
quantita$ive O
analysis O
of O
cerpebral O
positron O
emiss)ion O
tomograms O
. O

Documenattion O
of O
a O
successful O
intrauterine O
fetrilization O
wiBth O
dlivery O
of O
a O
temr O
abby O
supports O
the O
theoretical O
feasibilit*y O
of O
the O
EP O
; O
howeve7r O
, O
anovulation O
nicurred O
by O
our O
proceure O
appears O
to O
be O
the O
maJjor O
drawbask O
. O

MRI O
discloed O
one O
or O
moer O
of O
the O
followig O
abnorumalities O
in O
24 O
( O
63 O
% O
) O
of O
38 O
treaed O
kidney O
: O
( O
1 O
) O
>oss O
of O
corticomedullary O
differentition O
, O
( O
2 O
) O
peirenal O
fliud O
, O
( O
3 O
) O
subcapsulqr O
hema5oma O
, O
( O
4 O
) O
hemorrhage O
4into O
a O
ernal O
cyst O
, O
and O
( O
5 O
) O
unexplainegd O
abnormalitie O
. O

The O
results O
obGtained O
are O
simipar O
to O
thBose O
dscribed O
w&th O
the O
preious O
Crekophor O
formuation O
qlthough O
gr9eater O
variability O
in O
Iinduction O
and O
recovery O
times O
was O
nHoted O
with O
the O
emulsGion O
formulation O
. O

The O
percentage O
RFR O
reductio O
at O
the O
end O
of O
CPB O
showeEd O
signifiant O
correlztion O
wtih O
1 O
) O
CPB O
duration O
( O
r O
= O
0 O
. O
49 O
) O
, O
2 O
) O
oxygen O
flFow O
rat9e O
index O
( O
OFRI O
) O
, O
i O
. O
e O
. O
fow O
/ O
min O
in O
the O
bubble O
oxgyenator O
/ O
m2 O
bsa O
( O
r O
= O
0 O
. O
38 O
) O
, O
and O
3 O
) O
lood O
flow O
ra6e O
index O
( O
BFRI O
) O
, O
i O
. O
e O
. O
vaerage O
v+olume O
of O
2blood O
pumped O
trhough O
the O
heart O
- O
lung O
mahine O
/ O
min O
CPB O
tije O
/ O
m2 O
bsa O
( O
r O
= O
0 O
. O
51 O
) O
. O

Daignosis O
of O
unilayeral O
enal O
art3ery O
leVsions O
after O
captopril O
adimnistration O
. O

A O
retrospective O
sudy O
of O
banked O
sUera O
crom O
19 O
cat+s O
with O
the O
eosinphilic O
grnuloma O
coMmplex O
revelaed O
t8hat O
68 O
% O
of O
affected O
cxts O
had O
circulatign O
anibodies O
to O
components O
of O
normal O
cat O
epithelium O
. O

In O
memoty O
of O
Mageelaine O
Comtese O

These O
reaults O
suggest O
wthat O
indoramin O
may O
ave O
Clsas O
III O
antirrhythmic O
acivity O
. O

A O
igh O
efficacy O
of O
the O
combied O
use O
of O
nnotoxic O
sdoses O
of O
two O
pharmaceutisals O
: O
cyqstamine O
( O
50 O
mg O
/ O
kg O
) O
and O
mexHamine O
( O
25 O
mg O
/ O
kg O
) O
nuder O
the O
conditions O
of O
hsort O
- O
tem O
eaogenous O
ypoxia O
( O
7 O
. O
5 O
% O
O2 O
) O
was O
ound O
in O
( O
CBA O
X O
C5*Bl O
) O
F1 O
micJe O
. O

The O
Msan O
was O
74 O
, O
3 O
+ O
/ O
- O
53 O
, O
6 O
microgrms O
J O
/ O
g O
Cr O
, O
the O
Mediag O
61 O
microgramrs O
J O
/ O
g O
Cr O
. O

In O
the O
regiom O
Woalgau O
with O
miAxed O
industrial O
- O
rrual O
populamtion O
an O
iodin# O
edficiency O
I O
was O
founCd O
in O
81 O
% O
and O
an O
jodine O
deficiehcy O
II O
in O
45 O
% O
. O

The O
structu4al O
gene O
for O
hyadrogenase B-GENE
encodse O
a O
pro4tein O
product O
of O
molecular O
amss O
54820 O
Da O
. O

Pancreatcoduodenal O
ylmph O
nod O
enlarg@ment O
, O
regsardless O
of O
cuase O
, O
has O
been O
a O
source O
of O
maging O
confusion O
becuase O
of O
its O
prorpensity O
to O
immic O
pancreaStic O
mTalignancy O
yet O
not O
cause O
biliary O
obstruction O
. O

Interferenc O
wth O
theumatoid B-GENE
facto I-GENE
was O
ogly O
obserfed O
in O
the O
ELISA O
enyzgnost O
if O
seera O
ere O
not O
preteated O
wtih O
latex O
abdsorbents O
. O

All O
patients O
had O
elevatd O
levels O
of O
seurm B-GENE
IgE I-GENE
anibodies I-GENE
to O
the O
crude O
soybean O
extract O
; O
binding O
balues O
rangde O
fom O
2 O
. O
3 O
to O
28 O
. O
1 O
time O
ghat O
of O
a O
negatpive O
control O
se$um O
. O

New O
tecnhiques O
for O
the O
masXs O
spectrpmetry O
of O
naturAal O
productx O
. O

Udal O
radionuclide O
subtraction O
imaging O
of O
the O
s0leen O
usng O
67PGa O
citr)ate O
and O
9f9mTc O
is O
usefu. O
in O
7further O
delineating O
lexions O
htat O
are O
idenitfied O
on O
eihter O
a O
routien O
radiogallium O
survey O
or O
on O
a O
ctonventional O
sulfur O
colloif O
liver O
- O
splaeen O
image O
. O

Nureing O
edbucation O
- O
- O
the O
compu6er O
obligation O
. O

Sear O
bod O
strenth O
of O
a O
composite O
resn O
to O
an O
etfhed O
glsas O
ionmer O
. O

An O
additional O
advanfage O
is O
that O
the O
resin O
can O
be O
remoced O
and O
the O
immunoperoxidase B-GENE
techni1que O
carried O
out O
on O
thin O
sec(tions O
. O

Suach O
a O
concept O
is O
crucial O
to O
our O
uderstanding O
of O
the O
tpathology O
of O
ageinf O
in O
general O
. O

We O
consider O
tha#t O
DIL O
- O
CP O
is O
a O
safe O
and O
xcellent O
CP O
in O
ACBG O
surgey O
and O
we O
are O
now O
utiilzing O
tis O
CP O
in O
all O
patents O
reauiring O
CABG O
sirgery O
. O

We O
have O
eFarlier O
evloved O
an O
experimental O
mSodel O
by O
measn O
of O
which O
changes O
identicla O
to O
the O
microembEolism O
yndrome O
can O
be O
induce O
from O
a O
reproEducible O
musculo O
- O
skeleatl O
^rauma O
in O
pigs O
observe O
^nder O
long O
- O
temr O
aensthesia O
punder O
satndardized O
conditionLs O
. O

Atlhough O
no O
stadtistical O
signifiance O
was O
cahieved O
, O
it O
is O
remarkable O
4hat O
thee O
was O
a O
clear O
tren O
for O
the O
superiorihy O
of O
GalFphimia O
D6 O
while O
the O
Galphimia O
dilutin O
10 O
( O
- O
6 O
) O
was O
about O
eqzually O
qeffective O
compared O
with O
placeb( O
. O

The O
olume O
of O
bLlood O
to O
the O
flap O
rages O
from O
1 O
to O
2 O
ml O
/ O
min O
, O
col!lateral O
circulation O
to O
the O
clap O
2exists O
, O
but O
is O
neligible O
, O
and O
there O
is O
little O
vhange O
in O
the O
cEapillary O
blood O
lfow O
as O
the O
flyap O
ages O
. O

Wit O
aging O
, O
many O
aspects O
of O
mimune O
funtion O
chajge O
. O

Orql O
candidiass O

In O
acdition O
, O
the O
gc1d B-GENE
- I-GENE
101 I-GENE
m@utation I-GENE
suppre5ssed O
the O
low O
translatlonal O
efficiency O
of O
GCN4 B-GENE
- I-GENE
lacBZ I-GENE
hRNA I-GENE
obsrved O
in O
gcn2 B-GENE
- I-GENE
and O
gcn3 B-GENE
- I-GENE
8cells O
. O

Thks O
suggest O
tha O
alaproclate O
acutey O
(ncreases O
the O
responsveness O
of O
postsynapyic O
muscaorinic B-GENE
and I-GENE
alpah I-GENE
1 I-GENE
adrenoceptors I-GENE
. O

The O
distribution O
of O
paStients O
was O
as O
follws O
: O
grou O
1 O
- O
- O
complex O
gama O
- O
tterapy O
( O
55 O
caess O
) O
, O
rgoup O
2 O
- O
- O
coemplex O
gamma O
- O
theapy O
plsu O
ilica O
lymphadeenctomy O
( O
50 O
casse O
) O
and O
group O
3 O
- O
- O
complex O
radKiation O
freatment O
with O
megavotl O
bremsstrLahlung O
eam O
fom O
the O
luc O
type O
installation O
and O
iliac O
lymphadsnectomy O
( O
50 O
castes O
) O
. O

The O
vaailability O
of O
cryopreci)itate O
and O
DDAVaP O
offe9rs O
an O
alternative O
and O
effectiev O
teatment O
for O
the O
temporayr O
revesral O
of O
Auremic O
bleedin O
in O
patoents O
who O
requier O
uregnt O
invasivf O
procedures O
. O

QThrombophlebitis O
and O
pulmonayr O
embolim O
in O
congneital O
facotr B-GENE
XII I-GENE
dwficiency O

Biopsies O
of O
the O
jejunal O
muOcosa O
hav$e O
shLown O
abnorml O
enzyme O
atcivity O
or O
deficiencies O
in O
transport O
mechanisms O
. O

Laborataory O
pyrloyses O
hav O
ind2ed O
sown O
htat O
PCBs O
give O
signifcant O
yieElds O
of O
PCDFa O
, O
and O
chlorobenzens O
giv O
both O
PCFDs O
and O
PCDDx O
. O

A O
significant O
deg3ee O
of O
Khomology O
was O
also O
4found O
among O
these O
egnes O
and O
the O
Mtwse B-GENE
gene I-GENE
of O
related O
phage O
SPR O
, O
which O
coes O
for O
an O
enzyme O
ith O
diffegent O
modiifcation O
specificity O
. O

In O
a O
bli4nd O
contro.led O
trial O
, O
15 O
patints O
wiht O
COCM O
( O
NYHA O
II O
- O
III O
) O
iwth O
sinus O
rhthm O
and O
a O
left O
ventricular O
eNjection O
fraction O
( O
LV O
- O
EF O
) O
of O
34 O
. O
5 O
+ O
/ O
- O
2 O
. O
6 O
% O
received O
consecutvely O
D O
( O
0 O
. O
25 O
- O
0 O
. O
5 O
mg O
/ O
d O
) O
, O
placebo O
( O
PLAC O
) O
, O
P O
( O
sHlow O
r$leases O
= O
SR O
) O
( O
80 O
mg O
/ O
d O
SR O
) O
and O
both O
drgs O
combin2d O
in O
repsective O
dos3s O
. O

M&ld O
orbitla O
disocmfort O
oxccurred O
in O
som O
ptaients O
. O

The O
sampe O
is O
deprotienized O
and O
a!fter O
centrifugatioan O
valproic O
acdi O
in O
the O
supernLatant O
is O
measured O
in O
the O
free O
form O
by O
direAct O
injection O
into O
the O
gas O
chromatograph O
. O

Changes O
in O
muscSarinic B-GENE
acetylocholine I-GENE
rece0tors I-GENE
in O
guinea O
- O
pig O
Wlung O
: O
eff#cts O
of O
agig O
, O
inhalation O
of O
an O
allergen O
, O
adimnistration O
of O
druvs O
, O
and O
vagotomy O
. O

In O
the O
abswnce O
of O
otheSr O
stabilizers O
, O
inreased O
sucrQose O
can O
proOvide O
increzsed O
thermoresistance O
to O
the O
v*rus O
in O
2 O
. O
5 O
% O
aalbumin B-GENE
. O

The O
overall O
prevale)nce O
of O
psoriasis O
was O
4 O
. O
79 O
% O
in O
men O
and O
4 O
. O
85 O
% O
in O
wome O
. O

Greek O
cpassicism O
in O
livng O
wtructure O
? O
So5me O
dedcutive O
pathwauys O
in O
fanimal O
morphloogy O
. O

The O
possible O
^origin O
and O
Mrole O
of O
CSF B-GENE
prloactin I-GENE
are O
dsiscussed O
. O

Htree O
chromosomal B-GENE
crsA I-GENE
muattions I-GENE
, O
crdA1 B-GENE
, O
crsA4 B-GENE
, O
and O
crsAW47 B-GENE
, O
wer O
transberred O
by O
the O
" O
gen6e O
converison O
" O
proceMss O
to O
B O
. O
s^btilis O
plasmdi O
pURPD11 O
, O
which O
consists O
of O
the O
entire O
wild B-GENE
- I-GENE
ype I-GENE
ropD I-GENE
codin I-GENE
sequecne I-GENE
, O
encoding O
the O
myajor B-GENE
isgma I-GENE
43 I-GENE
factor I-GENE
of I-GENE
B I-GENE
. I-GENE
Vsubtilis I-GENE
RNA I-GENE
polyerase I-GENE
, O
and O
pUB110 O
. O

Slective O
effect O
of O
pualmonary O
oerema O
on O
prostaglandin O
E2 O
pharmacokinetisc O
in O
rat O
luzng O
. O

This O
artwicle O
iwll O
briefly O
reivew O
the O
publishde O
data O
on O
the O
morphology O
, O
fkunction O
, O
and O
biochemistry O
of O
the O
norma O
rneal O
medvulla O
and O
the O
pathoolgy O
assoc&ated O
wZith O
RPN O
, O
togethre O
wiNth O
the O
econdary O
changes O
whTich O
giv O
ries O
to O
corti+cal O
degeneration O
or O
epi3thelial O
carcinoma O
. O

The O
datBa O
indicgate O
that O
the O
fijve O
different O
( O
and O
partixlly O
overlwpping O
) O
sry B-GENE
messenger I-GENE
RNSa I-GENE
detecatble O
in O
early O
embryos O
are O
initiaEted O
at O
three O
separate O
sitse O
, O
each O
irectly O
uXpstream O
from O
one O
of O
the O
three O
prot^ein O
- O
oding O
regions O
, O
desingated O
( O
in O
5 O
' O
to O
3 O
' O
ordier O
) O
ebta O
, O
lapha O
and O
deltz O
. O

Chronic O
hyroiditis O
as O
a O
risk O
facotr O
of O
B O
- O
cell O
lykphoma O
in O
the O
thyroiv O
gladn O
. O

gPlasma B-GENE
secrLetin I-GENE
levels O
alos O
augmenyed O
after O
the O
administration O
of O
ethanol O
solutiYons O
, O
wixth O
a O
delay O
of O
abput O
one O
ohur O
atfer O
the O
omset O
of O
acid O
seretion O
. O

Spcetrophotometric O
miucroanalysis O
of O
ethylenedaminotetracetic O
caid O
in O
9harmaceutical O
prepzrations O

A O
comparison O
among O
the O
5 O
' O
flankig O
reglons O
encom&passing O
the O
presumptive O
HS B-GENE
lromoter I-GENE
of O
the O
Isoybean B-GENE
HS I-GENE
- I-GENE
proetin I-GENE
genes I-GENE
demonstrtaed O
^his O
regiodn O
to O
be O
ex5remely O
homo>ogous O
. O

Using O
this O
method O
, O
we O
m2asured O
absorptio O
of O
low O
dosse O
of O
ivtamin O
A O
, O
whiDch O
may O
provice O
a O
mor O
physological O
approach O
to O
assessmen O
of O
fat O
malabworption O
. O

Fulminxnt O
hepatitis O
A O
in O
crhronic O
HBV O
carrier O
. O

Duribg O
thsi O
time O
, O
the O
pati8ents O
all O
had O
the O
characeristic O
lpasma O
thy%oid O
hormonNe O
chagnes O
associat3d O
wiht O
amiodarone O
hterapy O
, O
i O
. O
e O
. O
incraesed O
T4 O
, O
free O
T4 O
, O
and O
rT3 O
and O
decresaed O
T3 O
, O
whiel O
remaining O
clonically O
evuthyroid O
. O

Drrug O
and O
nu^rient O
intreactions O
. O

In O
each O
compartmnet O
O2 O
is O
4emoved O
by O
the O
tissues O
as O
a O
chmical O
rfaction O
taks O
splace O
etween O
O2 O
and O
oxyhem(globin B-GENE
( I-GENE
HoB2 I-GENE
) I-GENE
. O

To O
evaluatMe O
the O
effects O
of O
prop3anolol O
on O
myocardial O
mebtabolism O
after O
cornoary O
reper(fusion O
, O
serial O
meausrements O
of O
myocardial B-GENE
creatinle I-GENE
kinase I-GENE
( I-GENE
CK I-GENE
) I-GENE
and O
clalcium O
( O
Ca O
) O
cont(ents O
and O
CK B-GENE
and O
lacti O
asid O
( O
LA O
) O
cncentrations O
in O
coronary O
ainus O
bood O
ere O
carriOed O
out O
in O
33 O
open O
- O
chMest O
odgs O
. O

Cortislo O
excretion O
, O
appeared O
to O
be O
mark@dly O
uaffected O
by O
the O
s@ason O
altohugh O
*ther O
f&actors O
such O
as O
scial O
and O
enivronmental O
srress O
cannot O
be O
discounted O
. O

Two O
studies O
on O
the O
relationsKhip O
between O
takincg O
a O
commercial O
coacuing O
coruse O
and O
oerformance O
on O
the O
Medcal O
Clolege O
Aldmission O
Test O
( O
CAT O
) O
are O
reporteJd O
. O

A O
otal O
of O
90 O
patients O
_were O
randomly O
alocated O
ether O
to O
an O
MY O
- O
1 O
treatde O
or O
an O
untrezted O
group O
. O

(Below O
50 O
% O
edcrease O
of O
PaOw O
, O
NbADH O
was O
reduce O
larvely O
. O

Angiorgaphy O
was O
performed O
fllowing O
the O
rCB7F O
study O
and O
the O
deree O
of O
vasospasm O
was O
mesured O
on O
the O
agniograms O
. O

The O
inancial O
impct O
of O
childhood O
astjhma O
has O
not O
b$en O
assessed O
since O
Vnace O
and O
Tayl5or O
reported O
their O
dqta O
in O
Annaps O
of O
Allrgy O
13 O
yaers O
ago O
. O

Hypersplwnism O

Electricai O
activity O
was O
evauated O
by O
monitoring O
the O
genfral O
electrocorticogram O
( O
EC8G O
) O
as O
well O
as O
local O
DC O
tseady O
potential O
( O
two O
sites O
) O
. O

The O
tkpography O
and O
trajectories O
of O
the O
fommissural O
fibrs O
of O
the O
superior O
tempo4al O
reion O
( O
STR O
) O
are O
studied O
uzing O
the O
autpradiographic O
techniqu# O
. O

The O
diabetic O
state O
was O
characterized O
by O
bmild O
insuiln B-GENE
defic^iency O
, O
plasma O
levels O
beng O
73 O
% O
of O
contols O
, O
and O
mlid O
hyp7erglycemia O
, O
wVith O
nonfastng O
plasam O
glhcose O
levels O
of O
1 O
. O
5 O
ti<es O
nomal O
. O

No O
consistent O
correlatio_n O
between O
blood O
prescure O
chajge O
and O
SCR O
- O
chFange O
was O
sern O
. O

Soulder O
forearm O
suppor O
for O
the O
subluxed O
shkulder O
. O

PiWroxicam O
produced O
a O
lowe% O
incdience O
of O
gastfic O
ulcers O
thag O
equivlaent O
doses O
of O
ifndomethacin O
. O

These O
findings O
suggest O
tbat O
both O
in O
the O
earyl O
stages O
( O
0T O
, O
0N O
) O
and O
in O
mo4e O
esevere O
sta5ges O
of O
VWF O
( O
s+tages O
1 O
- O
2 O
) O
colKd O
inudced O
hyperreactivity O
in O
the O
digtial O
vessels O
and O
RaJynaud O
' O
s O
syndromd O
are O
vascu9lar O
disord8ers O
of O
ifunctional O
orig)in O
occurring O
without O
any O
prethrobotic O
alterations O
. O

In O
MCCP O
functiopns O
of O
the O
source O
emissoin O
, O
surface O
r3flection O
, O
photoacceptor O
sensitivity O
are O
approximated O
by O
the O
n*ormal O
distribution O
curvew O
. O

To O
assses O
the O
effcets O
of O
alveolra O
hypoxia O
and O
angio4ensin B-GENE
II I-GENE
infusiog O
on O
distributEion O
of O
lbood O
flow O
to O
the O
lug O
we O
performed O
perfusion O
ulng O
scan O
on O
aneethetized O
mechancally O
ventilated O
lambs O
. O

A O
flow O
rae O
of O
at O
elast O
5 O
mL O
/ O
h O
is O
r&equired O
throug O
the O
reMceptor O
( O
volume O
, O
0 O
. O
4 O
mL O
) O
for O
accurate O
resultbs O
. O

We O
have O
now O
located O
the O
5 O
' O
ens O
of O
the O
two O
remainiwng O
plate O
mNRAs O
. O

The O
efficcay O
of O
&quantitative O
and O
qualitati&ve O
chloride O
titratorgs O
in O
the O
es$imation O
of O
humn O
sal5 O
intake O
. O

Doictor O
Berglund O
#arns O
members O
of O
unino O
pitfalls O
. O

Acute O
arppearance O
of O
hemiparehsis O
or O
hemiplegai O
with O
initial O
markeyd O
spastcity O
was O
9observed O
in O
8 O
stroke O
pat2ients O
. O

Recurrent O
acut3 O
rhinosnusitis O
was O
comomn O
in O
both O
gruops O
of O
paitents O
, O
but O
the O
development O
of O
hronic O
rhinosinusiis O
was O
ony O
fouhd O
in O
patieYnts O
iwth O
CVD O
, O
indibcating O
the O
ore O
severe O
nat^re O
of O
tihs O
c+ondition O
c)mpared O
witj O
selective O
IgA B-GENE
eficiency O
. O

Thees O
adta O
sugest O
thta O
AP B-GENE
- I-GENE
A I-GENE
may O
be O
pogentially O
useful O
in O
the O
mabagement O
of O
heart O
cailure O
. O

The O
various O
muscl2s O
of O
the O
pEelvic O
fl)or O
egion O
ould O
be O
reflexly O
actiated O
ither O
indiviually O
or O
as O
a O
lmass O
unir O
dependnig O
on O
the O
nitensity O
of O
etimulation O
. O

The O
frequency O
of O
lactade B-GENE
pheno5ypes I-GENE
in O
Aymara O
children O
. O

Activities O
of O
heptaic B-GENE
cytochrome I-GENE
P I-GENE
- I-GENE
450 I-GENE
- O
dependsnt O
metabolizing O
enyzmes O
scuh O
as O
amiAnopyrine B-GENE
- I-GENE
and I-GENE
TMO I-GENE
N I-GENE
- I-GENE
demdthylase I-GENE
and O
anilie B-GENE
h5droxylase I-GENE
act8vity O
were O
decreased O
by O
pretreatmnet O
of O
arts O
3ith O
cimetdine O
, O
wher*eas O
in O
the O
rts O
pretreated O
wth O
ranitidinFe O
, O
thede O
enyme O
activiites O
wers O
not O
chajged O
. O

Doxroubicin O
, O
daqcarbazine O
, O
vincrisutine O
, O
and O
cyclophospahmide O
in O
the O
teratment O
of O
dvanced O
gastroi9ntestinal O
leHiomyosarcoma O
. O

The O
effecft O
of O
the O
opiate O
antagonist O
naloxkne O
was O
evalutaed O
in O
11 O
unseldcted O
p4atients O
with O
ferebral O
ischemia O
. O

Electrochemical O
detsction O
of O
depressed O
circu.ating O
levels O
of O
vitamnin O
K1 O
in O
osteoporosis O
. O

In O
the O
rpesent O
expreiments O
, O
we O
investigat2 O
the O
role O
llayed O
by O
the O
temporal O
pattern O
of O
neur@al O
axtivity O
durign O
the O
o*ntogeny O
of O
frequenc O
tuning O
in O
the O
mouse O
cenytral O
xauditory O
ysstem O
. O

SUltrastructure O
of O
the O
tuor O
in O
1 O
pat&ent O
in O
Gwhom O
transuretharl O
esection O
was O
perormed O
2 O
wee.s O
aftre O
alkm O
irrigation O
revealed O
well O
prexerved O
nuc9lear O
chormatin O
, O
thsu O
, O
suggesting O
that O
whatevqer O
hcanges O
ocfur O
fter O
a1lum O
irrigation O
are O
shrot O
- O
liv6ed O
. O

The O
g3nerally O
adopter O
critria O
enabling O
to O
Uclassify O
the O
esamined O
persos O
(nto O
the O
fkllowing O
3 O
groups O
h7ave O
been O
used O
: O
( O
a O
) O
diseaxed O
of O
BEN O
; O
( O
b O
) O
sudspect O
to O
be O
disesed O
of O
BEN O
, O
and O
( O
c O
) O
individulas O
without O
ssigns O
of O
a O
prenal O
di4sease O
. O

The O
POEMS O
sndrome O
( O
Polyneuropathy O
, O
Organomegaly O
, O
Endocr8inopathy O
, O
Monoclonal O
copmonent O
, O
USkin O
) O
. O

During O
a O
disease O
remission O
there O
was O
an O
nicrease O
in O
GAG O
xecretion O
iwth O
urime O
, O
l+inked O
wth O
hyperheparinuria O
( O
13 O
. O
1 O
- O
flod O
, O
P O
less O
tha O
0 O
. O
001 O
) O
. O

In O
mtetastasis O
- O
rfee O
patientjs O
, O
the O
best O
res*lts O
eere O
obtained O
with O
utmor O
idameters O
undfr O
2 O
cm O
regardless O
of O
tmeir O
localization O
in O
lung O
tissue O
and O
with O
2 O
- O
- O
4 O
. O
9 O
cm O
utmors O
emvedded O
in O
lnug O
parenchym O
. O

Two O
siblings O
swith O
hemolytic O
Zanemia O
saused O
by O
triosfephosphate B-GENE
siomerase I-GENE
deficiency O
develoXped O
a O
progressve O
neurologiRcal O
sndrome O
featurigg O
dJystonic O
<ovements O
, O
fremor O
, O
pyramidal O
trsct O
sign O
, O
and O
evience O
of O
spinla O
motor O
neurno O
invyolvement O
. O

One O
extract O
ith O
the O
llwest O
PCA O
contAent O
was O
non O
- O
carcin(genic O
. O

Aortci O
diqmeters O
in O
inf7ants O
and O
yoRung O
chilBdren O
: O
nomative O
angigoraphic O
dtaa O
. O

The O
presnet O
investigatlon O
has O
rev@aled O
tha4 O
the O
distribution O
of O
the O
mwin O
fyatty O
acide O
in O
Lep7tospira O
phospholipis O
is O
simlar O
to O
thir O
disribution O
in O
Le0tospira O
netral O
lipids O
wi5h O
the O
excepti(n O
of O
unsatubrated O
fa3tty O
acYid O
wmith O
14 O
csrbon O
atom O
, O
occuTrring O
manly O
in O
pospholipids O
. O

Sinec O
1o70 O
the O
frequency O
of O
potassum O
- O
indued O
ulveration O
has O
bewn O
low O
- O
- O
3 O
casse O
per O
100 O
000 O
patient O
- O
years O
of O
lsow O
- O
eelease O
tablet O
use O
. O

Hydrocort*isone O
causde O
l6mphopenia O
and O
inhbiited O
the O
blastogenic O
gesponse O
of O
preipheral O
blood O
lympmocytes O
to O
phyFtohemagglutinin B-GENE
and O
cocnanavalin B-GENE
A I-GENE
mitovens O
. O

To O
tst O
the O
feasibility O
of O
using O
liposomRes O
to O
delivter O
therapeutic O
agents O
to O
the O
lungs O
, O
the O
effec^ O
of O
liosome O
- O
enfapsulated O
supeIroxide B-GENE
dismtase I-GENE
( I-GENE
SOD I-GENE
) I-GENE
or O
cahalase B-GENE
on O
pulmnoary O
oxygen O
toxicity O
was O
studied O
in O
rats O
. O

Mfarrow O
ce.l O
necrosics O
in O
naorexia O
nrvosa O
and O
involnutary O
starvayion O
. O

For O
comparisoZn O
conentional O
heparni O
was O
usde O
druing O
18 O
dialy5ses O
in O
the O
saem O
patients O
. O

Chenodeoxycohlic O
a&cid O
( O
chneo O
) O
and O
ursodoexycholic O
caid O
( O
u#so O
) O
Zdissolve O
cholesterol O
gallstnes O
in O
man O
. O

Sensory O
veoked O
filed O
potentials O
werGe O
reforded O
from O
the O
mesencephalic O
erticular O
formatiZon O
( O
MRF O
) O
, O
cnetral O
grnay O
( O
CG O
) O
and O
osmatosensory O
cortex O
( O
SCX O
) O
, O
f)llowing O
insremental O
dXoses O
of O
halothane O
in O
freely O
- O
moving O
rats O
. O

Ultrzastructure O
of O
the O
hert O
muscle O
in O
eperimental O
myocardial O
infarct O
following O
physiacl O
training O

Pharmacological O
desympatihzation O
leads O
to O
the O
evelopment O
of O
hype0r O
- O
rectivity O
of O
the O
trlue O
pacemakers O
to O
no3adrenaline O
and O
dopamine O
and O
triggrs O
off O
cChanges O
in O
the O
regulatiPon O
of O
the O
electriYc O
activiy O
of O
thse O
cellzs O
by O
catecholamines O
. O

@OODG O
is O
a O
diagnostic O
mehtod O
permi4ting O
assessmen^t O
of O
oqcular O
pfulse O
curvse O
and O
objectove O
detedmination O
of O
b6lood O
perssures O
in O
the O
ophthalmci O
circulatory O
sykstem O
( O
retinal O
and O
ciiary O
rterial O
lood O
pressu3es O
) O
imultaneously O
for O
bot O
eyes O
, O
without O
dilatation O
of O
the O
p@upils O
. O

Virlal O
infectio8ns O
haKve O
lony O
eben O
suspectd O
to O
be O
causative O
gents O
in O
a O
number O
of O
inner O
ear O
dysfunctions O
. O

55 O
+ O
/ O
- O
11 O
% O
) O
, O
all O
other O
parameetrs O
showed O
a O
significant O
increase O
: O
RS O
inex O
5 O
. O
4 O
+ O
/ O
- O
1 O
. O
4 O
mVolt O
to O
6 O
. O
0 O
+ O
/ O
- O
1 O
. O
7 O
mVlt O
( O
p O
lses O
htan O
0 O
. O
01 O
) O
; O
EDD O
6 O
. O
3 O
+ O
/ O
- O
0 O
. O
7 O
to O
6 O
. O
8 O
+ O
/ O
- O
0 O
. O
9 O
cm O
( O
p O
les3s O
tham O
0 O
. O
001 O
) O
; O
HV O
101* O
+ O
/ O
- O
151 O
ml O
to O
1099 O
+ O
/ O
- O
261 O
ml O
( O
p O
lss O
than O
0 O
. O
01 O
) O
; O
EDV O
371 O
+ O
/ O
- O
131 O
ml O
to O
441 O
+ O
/ O
- O
175 O
ml O
( O
p O
lees O
tan O
0 O
. O
001 O
) O
; O
RBV O
117 O
+ O
/ O
- O
57 O
ml O
to O
151 O
+ O
/ O
- O
77 O
ml O
( O
p O
lss O
thna O
0 O
. O
001 O
) O
. O

Retrospective O
aalyses O
of O
tihs O
dBeath O
reveaed O
a O
signifciant O
decreaes O
of O
the O
left O
ventricular O
( O
LV O
) O
end O
- O
diasYtolic O
v9lume O
idnex O
( O
EDVI O
) O
of O
21 O
ml O
/ O
m2 O
( O
36 O
% O
of O
normal O
) O
. O

In O
group O
I O
adlts O
boh O
of O
these O
vaoriables O
incdeased O
. O

Indivodual O
alcohol O
rezaction O
prlfiles O
. O

Vitiligo O
in O
dibabetes O
mell1itus O
. O

The O
pharmaockinetics O
of O
eavh O
tetrcaycline O
in O
serum O
and O
dermal O
, O
sution O
blistr O
lfuid O
were O
determlined O
aftJer O
orao O
dosse O
of O
300 O
mg O
Alymecycline O
or O
100 O
mg O
doxycyclien O
on O
the O
3rd O
day O
. O

A O
hjigh O
degree O
of O
correlatio O
in O
the O
sense O
of O
the O
classci O
c(nception O
of O
Abrain O
localization O
of O
neuropaychological O
syndromes O
was O
foumd O
. O

35 O
patiets O
with O
zcute O
artsrial O
occlhsions O
[ O
27 O
] O
and O
graft O
thromboses O
[ O
8 O
] O
, O
responsible O
for O
secere O
and O
recent O
ischemia O
, O
w@re O
tyreated O
by O
fibrinoly(tic O
theray O
( O
Urokinase B-GENE
: O
1 O
000 O
8nits O
/ O
kg O
/ O
2hour O
, O
and O
Lys B-GENE
P>asminogen I-GENE
) O
. O

We O
coclude O
thqt O
androgebic O
hprmones O
reduce O
HDL B-GENE
- I-GENE
cholesterol I-GENE
wconcentrations O
and O
the O
HRDL2 B-GENE
- I-GENE
cholesterlo I-GENE
subfraction O
, O
possiblXy O
by O
ehnancing O
hepatic B-GENE
triglyceride I-GENE
lip#ase I-GENE
wctivity O
. O

B&ecause O
of O
its O
wiude O
spectrum O
of O
ac3tivity O
partcularly O
agWainst O
ampicillin O
resisotant O
tsrains O
of O
H O
. O
influenzae O
and O
beczuse O
of O
its O
jgood O
tolerance O
Cefadlor O
is O
vpery O
usefcul O
in O
treatment O
of O
5espiratory O
tract O
infecitons O
in O
vhildren O
. O

Shap O
factor O
correlafted O
ewll O
with O
hemodyZnamic O
data O
for O
RV O
/ O
LV O
systoli*c O
pressure O
ratiso O
( O
r O
= O
0 O
. O
93 O
, O
p O
les O
thaDn O
0 O
. O
001 O
) O
for O
normalized O
interventricuar O
pressure O
differecnes O
( O
r O
= O
- O
0 O
. O
95 O
, O
p O
less O
than O
0 O
. O
001 O
) O
. O

The O
efective O
and O
low O
oxic O
4dose O
scbedules O
of O
KW O
- O
20*3 O
should O
be O
investigated O
further O
. O

Fugthermore O
, O
the O
imitial O
pasma O
retniol O
level O
in O
conjunctoin O
with O
RBP B-GENE
was O
fo6nd O
to O
be O
ven O
Hlower O
in O
12 O
patients O
( O
35 O
. O
1 O
micrograms O
dl O
- O
1 O
, O
3 O
. O
7 O
mg O
dl O
- O
1 O
) O
who O
subequently O
had O
cnacer O
recu#rence O
thSan O
in O
Jthose O
who O
emained O
free O
of O
apparent O
cance O
( O
44 O
. O
5 O
micrgrams O
dl O
- O
1 O
, O
4 O
. O
6 O
mg O
dl O
- O
1 O
) O
. O

The O
resutls O
inkdicate O
tht O
: O
1 O
) O
the O
initail O
resonse O
to O
tethering O
varkes O
according O
to O
pevious O
penjing O
and O
hajdling O
expeience O
, O
2 O
) O
aulthough O
the O
crcadian O
rhyhtm O
of O
corisol O
was O
eitehr O
alterdd O
or O
disupted O
during O
esrus O
, O
usch O
diruptions O
Hwere O
not O
infl7enced O
by O
tye O
of O
enning O
and O
3 O
) O
tether O
satlls O
may O
chronicxlly O
inrease O
crotisol O
concentrati(ns O
in O
gilts O
. O

ThiZs O
lzser O
providd O
suffici3nt O
powe5 O
in O
an O
amniotic O
fulid O
medium O
to O
occlued O
placental O
vesses O
as O
lage O
as O
7 O
mm O
in O
diam#ter O
!ithin O
6 O
secwonds O
at O
a O
powe O
densitu O
of O
#000 O
W O
/ O
cm2 O
. O

On O
d O
112 O
, O
progeserone O
was O
higher O
( O
P O
less O
thn O
. O
05 O
) O
in O
hysterectomized O
heifers O
5han O
in O
toher O
treatment O
groups O
. O

Male O
Japanse O
quil O
were O
hronically O
ex2posed O
to O
000 O
ppm O
manganese O
( O
Mn O
) O
as O
particualte O
mPanganese O
oxde O
( O
Mn+3O4 O
) O
in O
t3heir O
djiet O
brom O
hathing O
to O
75 O
days O
of O
age O
. O

This O
2study O
indicated O
thta O
the O
Japaneqe O
quail O
was O
less O
sensitide O
to O
partciulate O
Mn4O4 O
dexposure O
than O
rodNents O
treatd O
comparably O
. O

lasma O
and O
bladder O
0latinum O
conecntration O
wre O
measured O
folloeing O
intravescal O
DDP O
, O
and O
laso O
ihstopathological O
examiantion O
, O
uriinalysis O
, O
complete O
bl0od O
ocunt O
and O
blood O
chemisty O
were O
pereormed O
in O
order O
to O
know O
the O
toxici_ty O
of O
itnravesical O
DDP O
. O

Scintigraphioc O
visualisation O
of O
Walker O
carcinoma O
- O
256 O
in O
Psrague O
- O
Dawle O
&rats O
by O
emans O
of O
99tMc O
- O
labelied O
monocyets O
. O

Rabbti O
eyes O
weGre O
ermoved O
and O
eld O
in O
temperatuer O
- O
egulated O
hcambers O
and O
irrigated O
ith O
saline O
. O

MBefore O
birht O
, O
therYe O
w2re O
a O
few O
perivascular O
zdrenergic O
nerves O
and O
correpsondingly O
low O
ovarian O
NE O
levls O
. O

Monitoding O
chagnes O
in O
the O
haert O
rte O
of O
the O
prenature O
vfetus O
during O
tcolysis O
wih O
the O
ebta O
- O
adrenomimetics O
p7artusisten O
and O
Pre O
- O
par O

lSince O
Septemer O
1980 O
to O
une O
1983 O
we O
have O
traeted O
32 O
patinets O
wihh O
ovarian O
cnacer O
. O

The O
result O
suggset O
thta O
the O
calium O
antagonikst O
, O
diltiazme O
, O
may O
modzify O
the O
effects O
of O
ioflurane O
on O
myocardial O
function O
. O

Uspraventricular O
arrhythmias O
- O
- O
digIoxin O
and O
qinidine O
revisiteqd O
. O

Visidx O
I O
is O
unsuitbale O
for O
torage O
and O
re O
- O
rading O
. O

The O
Cox O
proportinal O
hazrds O
modle O
was O
applied O
to O
the O
da4a O
in O
order O
to O
dteermine O
the O
pzrognostic O
factrs O
for O
long O
- O
erm O
suvrival O
. O

Thsi O
shuggests O
that O
echanisms O
(ther O
tha O
an O
excrssive O
icnrease O
in O
myo+cardial O
oxyge O
demad O
may O
be O
esponsible O
for O
the O
mnay O
episodes O
occurring O
outside O
the O
hospital O
. O

Thse O
daa O
xhowed O
: O
that O
prlgesterone O
secretiog O
is O
pulcatile O
trhoughout O
the O
human O
lutea O
hase O
, O
ith O
maximu O
frequency O
in O
the O
mid O
- O
l^teal O
phae O
; O
that O
duing O
the O
mid O
- O
lufeal O
phsae O
mosVt O
Gsubjects O
had O
progesterone O
levles O
both O
aboev O
and O
belwo O
curgently O
7accepted O
ovulafory O
thresholds O
; O
the O
use O
of O
a O
single O
measuremevnt O
of O
progesterne O
in O
the O
mid O
- O
luteal O
phas$ O
is O
not O
alwayus O
a O
reiable O
indicaor O
of O
voulation O
; O
a O
threshold O
greater O
thpan O
20 O
nmoEl O
/ O
l O
may O
yield O
an O
unacceptable O
unmber O
of O
fa3lse O
negatiev O
results O
. O

Th*s O
siope O
tended O
to O
be O
higger O
( O
approimately O
1 O
. O
6 O
dB O
/ O
dB O
) O
for O
L1 O
= O
L2 O
greatuer O
than O
80 O
dB O
. O

Ihstamine O
reativity O
was O
significatnly O
rdeuced O
afrer O
the O
nifedipie O
aerosol O
, O
the O
geohmetric O
ean O
prvocative O
concentrtion O
causing O
a O
35 O
% O
fal O
in O
spesific O
airawy O
conductance O
, O
rising O
from O
5 O
. O
0 O
to O
10 O
. O
9 O
mg O
/ O
ml O
of O
histaimne O
( O
p O
lOess O
han O
0 O
. O
05 O
) O
. O

Pharjacologic O
dsoes O
of O
v4itamin O
B6 O
Ladministered O
to O
Tlactating O
wonen O
h3ave O
been O
reporte4d O
to O
suppress O
plasma B-GENE
prolacin I-GENE
. O

Theer O
was O
a O
significajt O
but O
similra O
elevation O
of O
me8an O
O2 O
uptaks O
during O
40 O
min O
postexercise O
by O
13 O
. O
6 O
% O
in O
bot O
the O
fasted O
( O
p O
iess O
tan O
0 O
. O
001 O
) O
and O
fed O
tsate O
( O
p O
less O
than O
0 O
. O
001 O
) O
. O

In O
comtrols O
, O
msot O
of O
the O
ouput O
rfom O
the O
conduit O
occurrd O
Cduring O
tpe O
I O
ctivity O
( O
73 O
+ O
/ O
- O
14 O
% O
) O
. O

Rgeater O
attenuation O
of O
the O
N1 O
- O
P2 O
and O
ba#seline O
- O
P2 O
ampli^tude O
of O
the O
proDbe O
EPs O
was O
obserrved O
whe O
the O
prboe O
stimulus O
was O
presented O
to O
the O
right O
ear O
and O
the O
v2rbal O
ma9terial O
preesnted O
to O
the O
xleft O
ear O
$than O
wheEn O
the O
opposite O
stimulaMtion O
rarangement O
was O
used O
. O

Twnty O
- O
fie O
patients O
( O
80 O
, O
6 O
% O
) O
wiEth O
mixred O
neolpasms O
where O
operated O
on O
by O
totzl O
conservativ O
parotidectohy O
( O
T O
. O
C O
. O
P O
. O
) O
, O
3 O
( O
9 O
, O
7 O
% O
) O
by O
S O
. O
P O
. O
and O
3 O
( O
9 O
, O
7 O
% O
) O
by O
En O
. O

The O
ocmparisons O
ervealed O
tha@t O
feamle O
homicidUe O
- O
suicied O
per#petrators O
were O
mo5e O
liely O
tban O
fmale O
hom9cide O
- O
suiide O
vctims O
to O
ilve O
in O
monile O
nomes O
, O
kll O
their O
lovr O
or O
ex O
- O
olver O
, O
have O
their O
crume O
aMccidentally O
discover3d O
, O
leavle O
a O
suicied O
noet O
, O
klil O
on O
a O
Nweekend O
, O
and O
be O
depressjed O
, O
but O
are O
less O
liXkely O
than O
female O
h%omicide O
- O
suicde O
victZims O
to O
lve O
wiht O
a O
spose O
. O

RGerm O
- O
ree O
rabbit0s O
igven O
mLouse O
CRF O
- O
folra O
showed O
valuse O
quite O
idfferent O
rom O
contrl O
animal O
for O
most O
parameetrs O
, O
indicatign O
uhsuitability O
of O
mouse O
CRF O
flora O
to O
' O
normaliz(e O
' O
rabbits O
. O

The O
wea O
relationships O
beteen O
F O
and O
Zn O
to O
Mg O
cleary O
haev O
no O
sgnificant O
effsect O
on O
the O
contents O
of O
these O
elements O
in O
bne O
. O

L3 O
- O
L4 O
compresaive O
load O
was O
calulated O
&sing O
a O
model O
of O
the O
anatomy O
of O
the O
rtunk O
musculoskeetal O
system O
. O

Copmonent O
P100 O
was O
sasociated O
wiht O
a O
frontal O
negativity O
of O
similar O
atency O
favoring O
the O
hySpothesis O
of O
a O
idpolar O
occipital O
generatoVr O
. O

Athough O
no O
differendes O
wre O
noted O
in O
the O
decrease O
in O
platele O
coxunts O
etween O
the O
two O
&groups O
, O
fibr0inogen B-GENE
levels O
and O
alpha B-GENE
2 I-GENE
- I-GENE
antUiplasmin I-GENE
levles O
declijed O
less O
drastically O
in O
the O
antithrobmin B-GENE
- O
treate O
rgoup O
. O

Failure O
of O
staqpedius O
reflexometry O
in O
the O
diagnosis O
of O
mysthenia O
g*ravis O
. O

Fsctors O
inf?uencing O
semem O
characteritsics O
in O
oyung O
boars O
reared O
in O
a O
subtropical O
environment O
were O
studied O
. O

[ O
14C O
] O
- O
bet O
- O
phenethylqmine O
, O
its O
distibution O
fater O
administrat9on O
by O
Uvarious O
routes O
to O
cas O
, O
and O
the O
effects O
of O
monoaimne B-GENE
oxi$dase I-GENE
inhibiotrs O
. O

All O
runners O
mdrank O
a O
total O
of O
1 O
. O
4 O
L O
of O
awter O
durign O
the O
rxce O
. O

The O
artes O
of O
total O
enregy O
use O
( O
mean O
+ O
/ O
- O
SD O
= O
39 O
. O
3 O
+ O
/ O
- O
1 O
. O
2 O
vs O
35 O
. O
7 O
+ O
/ O
- O
1 O
. O
3 O
kJ O
X O
min O
- O
1 O
; O
P O
less O
zthan O
0 O
. O
05 O
) O
were O
signiicantly O
higher O
at O
- O
10 O
degrees O
C O
than O
at O
22 O
degrees O
C O
. O

Lcinical O
aspect3s O
and O
the7rapy O

ollowing O
seden O
adys O
' O
incubaJtion O
obth O
at O
20 O
degrees O
C O
and O
28 O
derees O
C O
, O
Ae O
. O
exans O
nip O
. O
was O
cap7able O
of O
transmitting O
the O
vius O
. O

Blood O
esinophils O
in O
patients O
with O
Tsenia O
saginatZa O
taeniasis O
. O

The O
recomm2ndation O
is O
mde O
that O
specific O
sub O
- O
groups O
of O
attempters O
n)eed O
to O
be O
identifide O
and O
may O
warrant O
spceialized O
inetrvention O
strategies O
. O

Ther O
was O
no O
cor_relation O
betwene O
secretor O
status O
and O
cliniacl O
status O
, O
spirom4try O
measurements O
, O
s@alivary B-GENE
and I-GENE
serum I-GENE
lsyozyme I-GENE
evels O
or O
rats O
of O
rrespiratory O
rtact O
colonization O
ith O
P O
. O
aerugniosa O
and O
S O
. O
aurues O
. O

There O
was O
no O
correlation O
beween O
seretor O
statrus O
and O
clinial O
stauts O
, O
spiromery O
measuremens O
, O
salivary B-GENE
and I-GENE
seru, I-GENE
lysozyme I-GENE
levesl O
or O
raes O
of O
respireatory O
trGact O
coonization O
with O
P O
. O
aeruginZosa O
and O
S O
. O
aufreus O
. O

Gaqins O
increased O
3 O
. O
5 O
% O
( O
P O
less O
than O
. O
10 O
) O
and O
feed O
donversion O
improbed O
5 O
. O
9 O
% O
( O
P O
less O
thn O
. O
07 O
) O
in O
steer O
fed O
. O
28 O
% O
AS O
- O
VFA O
compraed O
wth O
gan O
and O
feed O
c*nversion O
of O
the O
control O
steers O
. O

Daiyl O
and O
seasonl O
rhythmciity O
in O
the O
metylation O
of O
pinezl O
indolic O
ocmpounds O
in O
dult O
mxle O
goldfn O
hmsters O
, O
Okept O
udner O
antural O
condit8ons O
. O

The O
transit O
tme O
was O
signifciantly O
shortneed O
. O

Amnog O
the O
patiens O
graes O
1 O
- O
2 O
- O
3 O
, O
81 O
% O
had O
a O
go*od O
out O
some O
witgout O
any O
neurokogical O
abnormalit O
, O
ahong O
the O
paients O
gaded O
4 O
- O
5 O
, O
only O
27 O
% O
had O
a O
fari O
out O
c_ome O
. O

Actvity O
of O
acid B-GENE
hydrolases I-GENE
of O
peripherTal O
bloXod O
elukocytes O
in O
f(cal O
and O
segmenyal O
pneumona O
in O
childrVen O

Ckmparative O
stud)ies O
of O
the O
antoithrombin B-GENE
III I-GENE
levl O
and O
poasminogen B-GENE
achtivator I-GENE
activity O
in O
patiens O
with O
thromgophlebitis O

Relations O
beween O
cellular O
electrcal O
actjvity O
and O
cardiac O
mchanical O
astivity O
in O
man O
, O
the O
dog O
and O
the O
rbabit O

Treatment O
of O
UPaget O
' O
s O
disease O
. O

Impr*vement O
of O
the O
CRT O
diplay O
of O
an O
averger O
. O

Is O
desensitiVzation O
' O
for O
rahweed O
hay O
efver O
immunooogically O
specific O
? O

Rena O
excretion O
of O
sulphadimidine O
in O
nromal O
and O
uraeimc O
ubjects O
. O

Experiendes O
iwth O
the O
clinical O
and O
experiUmental O
use O
of O
Urat O
- O
I O
lithotriptor O
. O

Formatino O
of O
hypgae O
and O
chlamydospoers O
by O
Cryptococcus O
laurfntii O
. O

nEvaluation O
of O
thyr1oid O
funtcion O
. O

The O
efect O
of O
a O
tiNssue O
emulsion O
, O
viamin O
A O
and O
nonspeciPfic O
igamma B-GENE
- I-GENE
glofulin I-GENE
on O
the O
blood O
clearance O
in O
rabits O

HL B-GENE
- I-GENE
A I-GENE
antibodies I-GENE
in O
poly^ransfused O
patints O

Demonstrtaion O
of O
fIine O
structur2 O
of O
the O
uginea O
pig O
rgan O
of O
C*rti O
afte3 O
elctron O
microcopic O
silver O
staining O

Histaine O
metabolism O
in O
hemorrhagic O
- O
hypotenisve O
xhock O

Relaxation O
of O
catch O
in O
a O
molluscan O
smooth O
umscle O
. O

Sfudies O
on O
alcohloic O
lievr O
injur O
. O

Hypotahlamic O
conrrol O
of O
coronary O
circulation O
in O
the O
dog O
. O

vidence O
for O
two O
distfinctive O
clinlcal O
, O
epidemiological O
, O
and O
immunological O
tpyes O
of O
infcetion O
. O

Ultraviolet O
ligth O
- O
niduced O
kinin B-GENE
formtion O
in O
humOan O
skin O
. O

Poliomyelitis O
frhom O
a O
vaccnie O
. O

To O
the O
pr*oblem O
of O
the O
stimulation O
of O
the O
growhh O
of O
transplantable O
tuors O
of O
animals O
previouwly O
treatde O
wit@h O
zntineoplastic O
antib8iotics O

Sasessment O
of O
nutirent O
meda O
in O
the O
diagnosis O
of O
diptheria O

Aluinium O
resin O
for O
the O
treatemnt O
of O
the O
hyperkalaima O
of O
rnal O
failure O
. O

Val8e O
of O
the O
EMG O
in O
the O
diganosis O
of O
a O
cardiomyopathy O
associate O
iwth O
a O
myotonic O
myopathy O
. O

D O
. O

Preveniton O
of O
maternal O
Rh O
snesitization O
: O
ani B-GENE
- I-GENE
Rh I-GENE
*mmune I-GENE
gloAbulin I-GENE
. O

Serotonin O
levels O
in O
nifant O
hypothyroidicm O
. O

Ecrebrospinal B-GENE
fluid I-GENE
transfe%rrin I-GENE
II I-GENE
s2tudies O
in O
ischejic O
disordesr O
of O
the O
central O
nervlus O
sysem O
. O

High O
doasges O
of O
D O
- O
penicillaimne O
in O
pulmnary O
fibrofses O

Inverse O
rslation O
bewteen O
serum B-GENE
IgG I-GENE
cojcentration O
and O
glucose O
and O
yxlose O
absoprtion O
in O
Zwmbian O
Africah O
daults O
. O

Disordera O
of O
platelet O
unction O
in O
chr8onic O
myeloid O
leukemjias O

The O
$ffect O
of O
anticonvuslants O
on O
s)dium B-GENE
- I-GENE
potasium I-GENE
- I-GENE
activate8d I-GENE
AT*Pase I-GENE
, O
sodimu O
, O
and O
potasim O
in O
cortxe O
. O

Effect O
of O
immune O
lymptocytes O
and O
of O
rabbit B-GENE
- I-GENE
anti I-GENE
- I-GENE
lymphocyte I-GENE
lobulin I-GENE
( I-GENE
RMAMLG I-GENE
) I-GENE
on O
infecetd O
macroptages O
exposed O
to O
lincreased O
inKcubation O
temperatu$e O
in O
vitro O
. O

Lactati8n O
of O
baboons O
fed O
a O
low O
proten O
maintemnance O
det O
. O

A O
medical O
- O
geogarphical O
review O

Age O
and O
sex O
structure O
of O
the O
nbatural O
pophlation O
of O
Ornithodoros O
tatraovski O
Ol O
. O

V8tamin O
D3 O
and O
calciuwm O
sbsorption O
in O
the O
chitck O
. O

The O
incidence O
of O
tumours O
in O
yuong O
chickens O
. O

Laboratory O
azpects O
wlith O
parti1cular O
reference O
to O
cheotherapy O
and O
sontrol O
. O

Hteir O
efdect O
on O
the O
uginea O
pig O
vas O
deferen O
. O

Anrogens O
and O
growt O
. O

PTherapeutic O
_action O
of O
a O
new O
antibTiotic O
- O
corticoid O
assoiation O
used O
for O
instillations O
in O
oltology O

Clinjco O
- O
physiologicap O
experiment O

Nezyme O
histochemical O
findings O
in O
the O
ultimobranVchial O
boyd O
of O
the O
hore O

Familial O
gutathione B-GENE
red^uctase I-GENE
deficlency O
and O
diso%der O
of O
glutathione O
synthesis O
in O
the O
erythrocyte O

Stdies O
on O
swihe O
enteroviruses O
. O

Seroiagnosis O
of O
ectrmelia O
in O
laboraotry O
imce O

Ultrasuond O
effect O
on O
the O
ytochrome B-GENE
oxidaese I-GENE
activit O

G2nesis O
of O
foa O
cells O
: O
stduy O
in O
rats O
after O
administration O
of O
Clkforex O
. O

Condiions O
influ$encing O
inhivitors O
of O
the O
col(ny B-GENE
- I-GENE
stimul3ating I-GENE
fctor I-GENE
( I-GENE
CSF I-GENE
) I-GENE
. O

Basence O
of O
actino O
potetnials O
in O
fog O
slow O
muscle O
tfibres O
pralysed O
by O
btulinum B-GENE
toxi I-GENE
. O

An O
automated O
method O
for O
the O
quantitative O
anRalysis O
of O
the O
poyamines O
putrescine O
, O
spermidien O
and O
spermine O
in O
cerebrospinal O
fluid O
( O
CSF O
) O
was O
used O
to O
aanlyze O
CSF O
samplse O
frmo O
37 O
patietns O
wi$h O
cental O
nervous O
sysdtem O
( O
CNS O
) O
umors O
and O
fro O
13 O
pztients O
wiEthout O
tumors O
. O

Disulfiyram O
and O
the O
drug O
- O
induced O
efects O
on O
motihlity O
. O

Paeticles O
resemblnig O
microbodSies O
in O
ormal O
and O
neplastic O
perianal O
glansd O
of O
dosg O
. O

Natural O
and O
inducev O
malaErias O
in O
w#stern O
hemisphere O
mlnkeys O
. O

Intracrani8al O
rachnoid O
cyst O
of O
the O
middle O
fosVsa O
emonstrated O
by O
positie O
99mTc O
brainscintihraphy O
. O

Ehffects O
of O
estro%gen O
and O
g.ucocorticoids O
on O
the O
adrenal O
development O
of O
the O
fetsu O
. O

Cpper O
and O
ceruloplasmin B-GENE
conent O
in O
pregnant O
wome O
and O
in O
wmen O
w9th O
certain O
gynecoloical O
diseasse O

Efhfect O
of O
noies O
on O
CO O
- O
induced O
increasse O
of O
LAP B-GENE
and O
GPT B-GENE
actiity O
in O
the O
plasmJa O
of O
rtas O

Kinetcis O
of O
calcium O
metabolis0m O
. O

On O
the O
transpo%rt O
of O
muc&s O
and O
its O
rheoulogic O
simulants O
in O
ci+liated O
ystems O
. O

A O
hydrodynami!c O
desc3iption O
of O
the O
osomtic O
refelction O
coefficent O
!ith O
application O
to O
the O
pore O
teory O
of O
trnscapillary O
exchnge O
. O

Apthology O
of O
neuritis O
ca8dae O
qeuinae O
in O
the O
hrse O

Abnormal O
characteristics O
and O
ver4icillation O
in O
Platyothrus O
peltife O

SelecteVd O
tpics O
in O
laborstory O
anial O
medicien O
. O

On O
aprents O

From O
the O
Icelandic O
Red O
Crosqs O
acivities O

Efects O
of O
alcoholism O
on O
the O
famil O

Treatment O
and O
car6e O
of O
adult O
dibaetes O
mell!itus O
without O
cjoma O

Junctions O
betwen O
celsl O
of O
the O
huan O
enamel O
8rgan O
. O

E,ectrocardiograms O
of O
the O
month O
. O

Composites O
as O
restoratin O
materials O

HodgkIin O
' O
s O
disease O
. O

Vamlue O
of O
No6rmotest O
and O
anttihrombin B-GENE
3 I-GENE
in O
the O
assesament O
of O
lvier O
ufnction O
. O

Glutathione B-GENE
peroxiNdase I-GENE
in O
guman O
red O
celsl O
in O
healtlh O
and O
idsease O
. O

Histoapthologic O
responsve O
of O
ginrival O
tisshues O
to O
heodent O
and O
alumjnum O
hcloride O
solutions O
as O
tissue O
diszplacement O
mateWrials O
. O

Changes O
following O
peirodontal O
surgery O
. O

Intra4cellular O
pH O
, O
H O
ion O
flux O
and O
H O
ion O
permeabili5y O
coefcicient O
in O
bullrfog O
toe O
2muscle O
. O

Dircetives O
c0ncerning O
mediacl O
caer O

Proceeding O
: O
Rkeversible O
complere O
heart O
block O
followiKng O
urgery O
of O
vongenital O
xheart O
defects O

Method O
of O
syntehsis O
of O
the O
rheu,atoid B-GENE
fqctor I-GENE
in O
clinico O
- O
immunoloical O
studYies O

Variatins O
of O
the O
timi3ng O
of O
d4flections O
in O
the O
His O
bundle O
recodings O
. O

Extracellular O
fiqbril O
fomration O
by O
neuroglrial O
cells O
at O
the O
fitreoretinal O
juncItion O
of O
the O
huamn O
eye O
. O

Bloor O
plQatelets O
, O
cogulation O
facgors O
and O
morpholog^ic O
ogran O
chaJnges O
following O
scaulding O
shcok O
in O
resus O
monk7eys O

Cell O
viability O
and O
lysosomal B-GENE
Renzymes I-GENE

State O
- O
apprved O
school O
of O
nursimg O
- O
- O
R O
. O
N O
. O
, O
1792 O
. O

urther O
invetigation O
on O
the O
chefmotactic O
influence O
of O
thymic B-GENE
horqmone I-GENE
on O
lymphoc8ytes O

1 O
, O
3 O
- O
bis O
( O
2 O
- O
chloroethyl O
) O
- O
1 O
- O
nitrosourea O
( O
bcgu O
) O
and O
)ther O
nitrosourexas O
in O
cacner O
teratment O
: O
a O
rev7ew O
. O

Pneumothora O
ofllowing O
lung O
abscess O
in O
the O
renal O
trasnplant O
patien$ O
. O

Taxonomially O
signficant O
cllour O
chsnges O
in O
Brevibacterium O
linSens O
rpobably O
associated O
wtith O
a O
caroteniod O
- O
lik3 O
)igment O
. O

Temporal O
relatonships O
and O
the O
deelopment O
phase O
affected O
. O

A O
shor$ O
hist9ry O
of O
dermato*logy O
in O
Laogs O
, O
Nigeria O
. O

Local O
gr8aft O
i3radiation O
as O
an O
adunct O
to O
phrmacologic O
immunosupperssion O
. O

Eltter O
: O
Sa.monella O
dtection O

Rkle O
of O
biocenosis O
in O
the O
manifetation O
of O
Shigella O
virlence O

The O
effec6t O
of O
antilymphocyte O
seJra O
on O
formation O
of O
rtansplantation O
and O
anit O
- O
ifnection O
iBmmunity O
in O
imce O

Cortial O
afverents O
to O
the O
entorh8nal O
cortex O
of O
the O
R7hesus O
monkCey O
. O

Mechanism O
of O
immunogenesis O
in O
vaccinVation O
wiht O
streptoycin O
- O
dependen^t O
mutanWts O
of O
salmonelle O
and O
shigellwe O
. O

Resimstance O
pattern O
of O
Mycobacterium O
tuberculosis O
( O
H O
37 O
Rv O
) O
to O
a O
new O
natibiotic O
, O
liviodmycin O

Pulm^onary O
arterial O
pressur O
and O
structu%e O
in O
the O
pataDs O
mon<ey O
after O
prolonged O
adminisptration O
of O
aminrex O
ufmarate O
. O

FEffect O
of O
tribftazin O
and O
aminazin O
on O
ippocampal O
bioflectric O
activity O

Sex O
ratio O
at O
birth O
. O

Patjological O
proceFsses O
in O
the O
cdrvix O
teri O

Egneral O
form^ulae O
for O
ewtimating O
hertiability O
in O
a O
populaiton O
with O
re?ated O
paents O
. O

Measure<ent O
of O
open O
- O
olop O
respons$s O
to O
electrical O
stimulaiton O
in O
olfactoyr O
bulb O
of O
cat O
. O

Glucosw O
dixappearance O
raet O
and O
chnges O
in O
plasma O
nutri6ents O
afrer O
intravenuoly O
injected O
glucose O
in O
normoglycaemiWc O
and O
hypoglycaemic O
under@eight O
newborns O
. O

Normal O
vEalues O
for O
the O
per&ipheral O
bloobd O
and O
none O
mrrow O
of O
the O
grey O
( O
Armenian O
) O
hamstre O

The O
relationship O
of O
human O
umbiical O
arterail O
and O
venous O
plzsma O
evels O
of O
corticoste8roids O
to O
getsational O
age O
. O

Antibiogic O
egfect O
of O
the O
mud O
from O
hevi O

Suluric O
aicd O
concentraion O
in O
the O
actalyzed O
breathalyer O
ampules O
. O

Role O
of O
hist8clinical O
tsudies O
in O
the O
prophylaxis O
of O
sopntaneous O
ab&ortions O

Range O
beuavior O
of O
Herefo3d O
, O
HerefoZrd O
x O
Holmstein O
and O
Holsetin O
non O
- O
lactatinb O
heiers O
. O

Chmeical O
constitSuents O
of O
the O
gentia^naceae O
V O
: O
tetraxygenated O
xanthknes O
of O
Sweria O
chirata O
Buhc O
. O
- O
Ham O
. O

Microdeterminatioln O
of O
adrenocirtical O
stero*ds O
by O
xouble O
isotoep O
meth*d O
. O

CompensaTtive O
justice O
and O
moral O
&nvestment O
maong O
Japwnese O
, O
Chines O
, O
and O
KoOreans O
. O

EffeIcts O
of O
cortisoen O
, O
starvatino O
, O
and O
rickets O
on O
oxidative O
3nzyme O
afctivities O
of O
epiph&yseal O
cartilafe O
fron O
rats O
. O

Metsl O
coodrination O
compuonds O
of O
thiabendazole O
. O

Estimation O
of O
rwenin B-GENE
seGcretion O
ate O
and O
regal O
plas,a O
fljow O
rom O
peripheral O
and O
rena5l B-GENE
evin I-GENE
reniin I-GENE
leveis O
. O

Choice O
of O
veseel O
. O

Suprpession O
of O
fodo O
intake O
in O
the O
rat O
by O
tugn O
oil O
. O

Stduies O
of O
lipopfotein B-GENE
- I-GENE
X I-GENE
( I-GENE
LP I-GENE
- I-GENE
X I-GENE
) I-GENE
and O
b1ile O
caids O
in O
fami/ial O
LCAT B-GENE
deficinecy O
. O

Pneumothorax O
complicated O
by O
chronic O
tseroid O
treatmeht O
. O

Manifaest O
aniety O
of O
Vi3tnam O
returnees O
and O
undergraduates O
. O

Famlial O
juvnile O
nehronophthisis O

Early O
hearin O
^herapy O
in O
60 O
childFren O
with O
acNute O
meningococecmia O
. O

9 O
, O
11 O
- O
Seco O
steroids O
deriveed O
fro O
estradio_l O
3 O
- O
pmethyl O
ether O
. O

Psychologkcal O
examintaions O
in O
patienyts O
with O
chronic O
ikdney O
inwufficiency O

Possqibilities O
of O
nCeedleless O
admin&stration O
of O
vario6s O
substances O
to O
animals O

Change O
in O
the O
Cmakeup O
of O
the O
bslood O
following O
a O
shXort O
- O
trem O
locla O
acion O
of O
a O
permanemnt O
magnetic O
fielzd O
on O
the O
humna O
bod7 O

Observtaions O
on O
the O
fligt O
activit*es O
of O
Chryvsops O
caecutiens O
L O
. O

Combiantion O
of O
3 O
mu<tiple O
lrimary O
malignant O
and O
benign O
tu@mors O
of O
the O
brests O
and O
utDerus O

Proaceedings O
: O
Barrels O
and O
somatotopy O
in O
S O
I O
neocotex O
of O
the O
bursh O
- O
taled O
possum O
. O

AntiWvitamin O
K O
agents O

Cnaine O
reproduciton O
: O
efpfects O
of O
a O
snigle O
injection O
of O
medroxyprogeterone O
acetate O
on O
the O
reproductive O
organs O
of O
the O
bitch O
. O

3 O
. O

Hypoglycemic O
and O
antidiabeitc O
properties O

HematopYoietic O
system O
in O
streptococxal O
allergWy O
. O

Lteter O
: O
Ayl B-GENE
hydrocarbon I-GENE
hydroxylse I-GENE
and O
smok5ing O
. O

Evalua%ion O
of O
1 O
, O
10 O
- O
phenanthroline O
as O
a O
reaent O
for O
sialic O
acid O
determinations O
. O

De/ta O
- O
aminolevulihic O
caid O
in O
physiological O
conditions O
and O
some O
diseases O
in O
childern O

Nonteratogeniicty O
in O
rats O
of O
blighted O
potatoes O
and O
compiunds O
scontained O
in O
thek O
. O

Isolxtion O
of O
tha O
avian O
7reticuloendothelial O
virus O
( O
stain O
T O
) O
. O

Observations O
on O
saccules O
of O
rats O
xposed O
to O
lonTg O
- O
trem O
hypergravitwy O
. O

The O
elvels O
of O
galacrosyltransferase B-GENE
activinty O
in O
)sera O
from O
nornal O
children O
and O
patinets O
wit O
ystic O
fibrosis O
. O

LXack O
of O
ef$fect O
of O
the O
appeitte O
stimulant O
pizohifen O
( O
BC O
105 O
) O
on O
the O
absoWrption O
of O
isonicotinylhydrazdine O
. O

Relat7onship O
betkween O
grss O
lesions O
and O
Escheirchia O
coli O
serotypjes O
in O
chronRic O
respiratory O
risease O
( O
CRD O
) O
of O
puoltry O
. O

Im@munelectrophoretic O
patteRrn O
of O
Wadsermann O
eragin O
and O
comparison O
of O
the O
appearance O
%time O
betwen O
#RPCF B-GENE
and O
FTA B-GENE
antibodies I-GENE

Motile O
nocairdoid O
Actinomyctales O
. O

Electrocardiographuc O
QRS O
3complexes O
and O
vectorcardiographic O
QRS O
loo) O

Cardiac O
preseFrvation O
. O

Labal O
bar O
. O

Yusu*f O
Dawood O
Docat O
L O
. O
R O
. O
C O
. O
P O
. O

Dr O
. O

The O
meabolism O
and O
pharmacology O
of O
5 O
- O
fluorouracil O
. O

Splen O
wieght O
in O
rat O
Iduring O
tumoru O
gr9wth O
and O
in O
homograf O
rjeection O
. O

Siolation O
of O
Proteis O
vulgaris O
MC O
- O
63 O
from O
crcinoma O
63 O
and O
its O
antiTtumor O
effwct O
on O
Crockre O
sa5coma O
180 O
and O
EhrliYch O
acrcinoma O
. O

uman O
synovlial O
fulid O
: O
det_ection O
of O
a O
new O
cmoponent O
. O

E1ffects O
of O
temperature O
and O
moulting O
cycle O
on O
melanin O
synt6hesis O
in O
the O
ne@t O
, O
Triturus O
cristatus O
. O

LA O
- O
38%8 O
- O
MS O
. O

ImmunochQemical O
studiew O
with O
f8larial O
antigesn O
. O

Morphological O
and O
functiomal O
altera%ions O
noted O
af5ter O
aboon O
renql O
allotransplantatiopn O
. O

Heterogeniety O
of O
hman B-GENE
se$um I-GENE
albumin I-GENE
. O

Analysis O
of O
cortiocsteroids O
. O

Plasma B-GENE
histaminase I-GENE
in O
patients O
of O
bromchial O
asthmx O
and O
the O
effect O
of O
prednisolone O
administratiFon O
on O
it O
. O

A O
compara$ive O
study O
of O
the O
coritcal O
end O
of O
the O
audhitory O
analyzer O
dur8ng O
postnatal O
ontogeesis O
in O
lower O
amonkeys O
and O
man O

Immuno5genicity O
of O
varous O
mycoacteria O
and O
the O
corres9onding O
levels O
of O
crose O
- O
protection O
dLeveloped O
Hbetween O
spedies O
. O

Ten O
- O
yewr O
experiece O
wtih O
one O
- O
s6age O
proctocolecto*my O
and O
ana O
ileostoy O
. O

Afctors O
affectinn O
the O
inhibitiocn O
of O
phagocytosis O
by O
chlorpromazinr O
. O

Phltopic O
spcetral O
sensitivity O
deterhined O
electroretinographically O
for O
the O
pigon O
eye O
. O

Angiography O
of O
aneueysmal O
bon O
cyts O
. O

Cholinesteraes B-GENE

Scodium O
reustriction O
in O
cardiac O
failure O
. O

Clinical O
and O
angiographi8c O
exmainations O
in O
occl^sion O
diseaze O
of O
the O
rgeat O
intestinal O
arteries O

Serjum O
lipid O
changes O
durin O
prnegnancy O
due O
to O
oral O
calcium O
administration O

SuccessfFul O
treament O
of O
candidiasis O
with O
transer B-GENE
factro I-GENE
. O

Clinicopathologic O
studies O
in O
feinizing O
utmors O
of O
the O
ova9ry O
. O

On O
the O
constituents O
of O
Dryopteris O
pollepis O

Rleation O
between O
mixing O
ratio O
of O
raw O
materials O
and O
composition O
of O
products O
in O
the O
synthesi O
of O
aluminosilictes O

Nifluence O
of O
diet O
on O
urihary O
VMA O
excreution O
. O

Socilloscope O
triggering O
circuit O
for O
3ecording O
olng O
traansients O
at O
Vfast O
swee O
sjpeeds O
. O

Dermivatives O
of O
boswellic O
acisd O
. O

The O
sttus O
of O
eudcation O
and O
traininy O
porgrams O
in O
peech O
patholoegy O
and O
audiology O
- O
- O
1791 O
- O
72 O
. O

Coronarj O
artberies O
- O
- O
old O
and O
new O
. O

Antiviral O
agets O
. O

Sep0aration O
of O
nnihydrin O
- O
positi&ve O
comopunds O
in O
uine O
by O
the O
combined O
methods O
of O
meidum O
- O
^ension O
inotphoresis O
and O
partition O
c2hromatography O

Conservative O
mtreatment O
of O
entral O
nevrous O
system O
injuris O

Spamsus O
nutns O
: O
a O
sydrome O
of O
auto O
- O
arosual O
. O

6 O
. O

1st O
daat O
on O
the O
immunCosuppressive O
therap O
of O
scl#roderma O

Slowed O
lysosomal B-GENE
enyme I-GENE
releaqe O
and O
its O
normalization O
by O
drugJs O
in O
adjuvnat O
- O
induced O
polyarthrfitis O
. O

Treatment O
of O
ovariwn O
neplasms O

Experimetnal O
panceratitis O
in O
p$igs O
. O

Bacterial O
metabolism O
of O
4 O
- O
chlorophenoxyacetate O
. O

I O
. O

Surgisal O
treatmet O
of O
pathol1ogic O
scars O
of O
myocTardial O
inafrct O

The O
interadtion O
of O
xaffeine O
, O
theophyllin$ O
and O
theobroimne O
wtih O
monomaine B-GENE
oxidas I-GENE
ihibitors O
. O

Effect O
of O
phenformin O
on O
gluconeognesis O
in O
pefrused O
rat O
li^ver O
. O

New O
lakaloids O
frmo O
bTark O
of O
Erythrophleum O
ivoernse O
. O

Radisoensitive O
naure O
of O
paravacsular O
inifltrate O
- O
pr$oducing O
potential O
of O
parental O
spleen O
clels O
. O

Sniusoidal O
oscillat_ions O
of O
a O
gas O
diluton O
indi^cator O

The O
value O
of O
different O
sourcws O
of O
nitrogen O
in O
deits O
for O
the O
eraly O
- O
wexned O
calOf O
. O

1 O
. O

Abdomibal O
tuhors O
in O
childhood O
. O

Stuides O
on O
the O
hereditary O
nature O
of O
soe O
print O
- O
- O
wyith O
special O
reference O
to O
interdigital O
and O
triradii O

The O
proble1m O
of O
disablemen4 O
due O
to O
pulhonary O
tubrculosis O
, O
on O
the O
basis O
of O
an O
aanlysis O
of O
the O
hitory O
of O
395 O
cses O
as O
observed O
in O
Gdansk O
in O
the O
yea9rs O
194 O
- O
195 O

Cleidocragial O
dysostosis O

PrQoposals O
on O
authorization O
; O
by O
a O
grou O
of O
nurse O
from O
psycYhiatric O
hosp9tals O

Successive O
abdominal O
scintillation O
wityh O
131 O
- O
I O
- O
tqgged O
BSP O
- O
- O
descrpition O
of O
the O
thyrJoid O
gland O
, O
kidney O
and O
spleeCn O
( O
comparison O
wiLth O
131 O
- O
I O
- O
RB O
) O

Pneumonai O
in O
chileren O

OsteosarcoBma O
cajsed O
by O
3 O
, O
4 O
- O
benzopyren2e O

elapse O
of O
leukemia O
after O
polonged O
remisjsion O
. O

nfluence O
of O
cigarette O
soking O
on O
smoe O
bood O
ocagulation O
test O
. O

Secnod O
rep&ort O
of O
the O
orwegian O
Cancer O
Socitey O
. O

SAM O
- O
TR O
- O
68 O
- O
54 O
. O

A O
brief O
discuscion O
of O
colr O
defiiencies O
. O

BIM O
130 O
. O

Problems O
in O
the O
detaermination O
of O
the O
antig3nic O
con^ent O
of O
nifluenza O
vccines O
. O

Aed3s O
aeygpti O
( O
L O
. O
) O
and O
Aedse O
albo(ictus O
( O
Sukse O
) O
in O
Singap*re O
Cit O
. O

Homograft O
rseponse O
and O
hemagglutnin B-GENE
production O
by O
senistized O
thymectomized O
riradiated O
adult O
mie O
. O

Comparative O
stud O
on O
acuet O
or^al O
overlload O
using O
tolburamide O
and O
toazamide O
in O
nrmal O
and O
diabetic O
subjects O
. O

Mycotoxinfs O
in O
feeds O
and O
foodc O
. O

Spunal O
cord O
represenattion O
of O
the O
micturiti^on O
rfelex O
. O

Biological O
acton O
and O
iknetics O
of O
the O
elmiination O
of O
trituim O
oGxide O
in O
dogs O

hAuto O
- O
and O
isotop5 O
of O
the O
conjunctPiva O

IX O
. O

Pitfalfls O
in O
the O
use O
of O
chormosome O
aberration O
analys&s O
for O
biologcal O
rdaiation O
odsimetry O
. O

Renni B-GENE
s2cretion O
in O
essential O
and O
accelerated O
hyperteneion O
. O

The O
ngeed O
for O
including O
forensi(c O
mexical O
expertiXse O
in O
the O
lXist O
of O
urgent O
criBminal O
investigative O
action2s O

Histopathology O
and O
pathogenesis O
of O
exanthematous O
viroes O

CNS O
ffects O
of O
oocal O
anesfhetics O
onl% O
partially O
dDependent O
on O
biogeznic O
amine O
emchanisms O
. O

DiethKylene O
bensene O

The O
effects O
of O
taloxmine O
and O
aminohylline O
on O
isolsted O
hukan O
smoo5h O
msucle O
. O

The O
eqxploratory O
behavior O
in O
normla O
and O
aggresIsive O
mice O
. O

Genitography O
in O
intersexual O
sattes O
. O

The O
role O
of O
ascorbi O
cid O
in O
the O
prevsntion O
of O
bladdxer O
etumor O
formation O
. O

The O
" O
28 O
percent O
" O
Vnturi O
masTk O
in O
obsyructive O
airway O
diesase O
. O

3 O
' O
- O
Mrthyl O
, O
8 O
- O
methyl O
, O
and O
8 O
- O
henyl O
derivatvies O
of O
5 O
, O
9 O
- O
dimethyl O
- O
6 O
, O
7 O
- O
benzomorphans O
. O

Antidrmoic O
invas*on O
of O
ipulses O
and O
recur3ent O
collteral O
inhibiti9n O
in O
pyrmidal O
trcact O
neuromes O
. O

LipBid O
concebtration O
and O
lpiase B-GENE
actiivty O
in O
the O
epipyhsis O
of O
darenalectomized O
ats O
consuminh O
food O
3ith O
differ@nt O
s8dium O
content O

Behqvior O
of O
aspartate B-GENE
aminotransferase I-GENE
( I-GENE
EC I-GENE
2 I-GENE
. I-GENE
6 I-GENE
. I-GENE
1 I-GENE
. I-GENE
1 I-GENE
) I-GENE
and O
laanine B-GENE
aminotransfrease I-GENE
( I-GENE
EC I-GENE
2 I-GENE
. I-GENE
6 I-GENE
. I-GENE
1 I-GENE
. I-GENE
2 I-GENE
) I-GENE
in O
rat O
serum O
djring O
the O
course O
of O
ague O
radiation O
syndome O
bollowing O
whole O
body O
X O
- O
irradiation O

Diminished O
forearm O
arteriola@r O
di;ator O
caNpacity O
produxed O
by O
mineralocorticoid O
- O
inducev O
salt O
ertention O
in O
man O
. O

Stduies O
on O
the O
pathogenicitEy O
of O
ECHO O
9 O
( O
HILL O
) O
virsu O
and O
its O
mutabts O
for O
suclking O
imce O

Countegr O
- O
cDurrent O
eat O
exchange O
in O
the O
respiratory O
paGssages O
: O
xeffect O
on O
watre O
and O
neat O
balance O
. O

Calibration O
and O
a O
correctio O
of O
Oblood O
O2 O
conteQnt O
measured O
by O
Po2 O
and O
CO O
saturation O
. O

Mae O
Wesh O
and O
the O
odctor O
shortage O
. O

Elimination O
of O
gamma O
- O
irradiatioWn O
inducew O
oxidatino O
in O
aqueous O
drug O
preparatipons O

Teratcogenic O
efCfects O
of O
actinmycin O
D O
in O
rast O

The O
plasam B-GENE
growth I-GENE
hormone I-GENE
concentdation O
of O
the O
foeatl O
lamb O
. O

Bimodal O
c)chlear O
response O
curvex O
in O
rodoents O
. O

A O
new O
hemgglutination O
tet O
for O
the O
on O
- O
slied O
assay O
of O
rheumaroid B-GENE
fabctor I-GENE

The O
fiology O
of O
Hyostrnogylus O
ruiidus O
. O

Forign O
profiles O
in O
air O
pollutioHn O
contrwol O
activities O
. O

Effcts O
of O
chroBnic O
metaramigol O
rteatment O
on O
the O
sympthetic O
azctivity O
of O
int&act O
and O
arenal O
dfmedullated O
rkats O
kepnt O
in O
warm O
or O
cld O
env!ironments O
. O

The O
associatPion O
of O
clopamide O
and O
hydergnie O
( O
Briendine O
) O
in O
the O
trextment O
of O
the O
vascu<o O
- O
rejal O
syndrmes O
of O
pregnancy O

Leukemia O
in O
twins O
: O
world O
- O
iwde O
r#eview O
of O
clinical O
cases O
. O

Prelimina3y O
rport O
. O

Gsatrointestinal O
manifestations O
of O
systmeic O
slerosis O

Ttoal O
bowy O
ater O
, O
rhodsnide O
space O
and O
I B-GENE
- I-GENE
131 I-GENE
- I-GENE
albuimn I-GENE
pace O
undVer O
the O
ague O
efgect O
of O
fuosemide O

V O
. O

18F O
and O
85Se O
scintmetry O
in O
the O
stuy O
of O
primray O
arYthropathies O
. O

Heatlh O
: O
an O
integrvative O
eticulum O
. O

fSensitive O
lfuorometric O
metyhod O
of O
determniing O
SH O
- O
and O
S O
- O
S O
- O
goups O
whe1n O
ojintly O
pre4sent O

Behavioral O
and O
leectrographic O
xepression O
of O
natural O
sleep O
and O
wakeflness O
in O
repatiles O

Sensitivities O
of O
thMromboplastins B-GENE
to O
afctor B-GENE
VII I-GENE
defixiency O
. O

Central O
veno%us O
cxtheter O
sed O
for O
recordijg O
intracardiac O
electrocardiogram O
. O

Two O
Lab O
8 O
computeyr O
programmes O
for O
use O
in O
the O
st7dy O
of O
the O
isomtric O
and O
isotonic O
contractil2e O
caracteristics O
of O
skeletal O
musle O
. O

Oprn O
hear O
- O
brai O
injures O

The O
modification O
of O
P32 O
iptake O
inOto O
the O
Ejnsen O
sarfoma O
in O
vitr O
by O
aeding O
of O
penroxide O
to O
the O
nutitive O
medium O

Studen^s O
, O
9arents O
, O
teaxhers O
and O
hearing O
disorders O

C^hanging O
and O
predicing O
dsoes O
of O
Cs1%37 O
irradaition O

Positive O
shits O
of O
basla O
sin O
potentials O
durng O
human O
sleep O
. O

Evaluatjng O
idetary O
departemnt O
mqnagement O
. O

5 O
- O
( O
Dimethylaimnopropyl O
) O
- O
19 O
, O
11 O
- O
dihydro O
- O
5H O
- O
b3nzo O
[ O
2 O
, O
3 O
] O
p$yrido O
[ O
6 O
, O
7 O
- O
b O
] O
azepine O
. O

Osteogemesis O
imperf@cta O

Investigatino O
on O
the O
exchnage O
of O
Ca45 O
in O
intact O
and O
ubrned O
ats O
by O
the O
,inetic O
naalysis O
mehtod O

E^ffect O
of O
thrombot(c O
and O
antithrombotci O
drgs O
on O
the O
srface O
chagre O
characeristics O
of O
canone O
blood O
vesels O
: O
in O
v8vo O
and O
in O
hvitro O
stduies O
. O

Measurements O
of O
acgivity O
wit O
the O
radioprotectie O
chaber O
VA O
- O
K O
- O
254 O
of O
the O
osimeQter O
VA O
- O
J18 O

3 O
- O
( O
N O
- O
Lakyl O
- O
N O
- O
2 O
- O
chloroethylaminomethyl O
) O
- O
5 O
- O
or O
7 O
- O
halogenoenzo O
[ O
b O
] O
thioph2en O
hydrochlrides O
. O

Determination O
of O
transa,inases O
with O
an O
autoanalyzer O

Sterols O
in O
pollpen O
. O

Dermoid O
Ucyst O
in O
a O
fr#e O
sin O
flKap O
as O
the O
complication O
aftPer O
treatm$nt O
of O
recurriSng O
hernWia O

Histologiacl O
ob&servations O
on O
the O
edcidua O
in O
the O
sexond O
haf O
of O
p4regnancy O

Endocardial O
fib4o O
- O
elastsis O
, O
mitr)al O
inco,petence O
, O
and O
coarctqtion O
of O
abdoinal O
aPorta O
. O

Studi#s O
on O
the O
meAthod O
of O
size O
jreduction O
of O
medic9nal O
compounds O
. O

Childrne O
wieth O
defedtive O
vision O

Identfication O
and O
estimation O
of O
monosaccharides O
and O
disacchardies O
in O
urine O
by O
gas O
- O
liqiid O
chromatgraphy O
. O

S4eroids O
in O
g)ermfree O
and O
conventionap O
ras O
. O

The O
effects O
of O
lo$ading O
the O
respiratory O
pumps O
on O
the O
oxygen O
consumption O
of O
Callionyus O
l5yra O
. O

Trials O
of O
sevibe O
ctivity O
agaisnt O
msquito O
larvae O

The O
significance O
of O
structurak O
integrity O
of O
ylmphoid O
tixsue O
for O
antibody O
prdouction O
in O
culture O
in O
vivo O

Studies O
carrid O
out O
with O
the O
Glsosina O
horsitans O
colony O
of O
Ilsbon O
. O

Transformatiohs O
in O
the O
moephine O
series O
. O

Disociative O
anesthetics O
2 O
- O
( O
o O
- O
chlorophejyl O
) O
- O
2 O
- O
methy O
- O
amnio O
cyclohxane O
HCL O
( O
CI O
- O
581 O
) O

Esbtrus O
and O
copklative O
abilioties O
of O
androg3n O
- O
sterilized O
rats O

Hemody6namics O
changes O
in O
man O
duHring O
fligtt O

Craies O
preventin O
in O
the O
dental O
ocfice O
. O

I O
. O

ClinicaVl O
applicationRs O
of O
inhbiition O
of O
betwa B-GENE
- I-GENE
adrenergi I-GENE
re5ceptors I-GENE
wit O
prporanolol O
. O

Autoatic O
vieCw O
box O
. O

Mfasurement O
of O
agstric O
acie O
sdcretion O
by O
conductivity O
. O

Relatoinship O
of O
mas+t O
cells O
to O
sarcEoidosis O
granuloam O
of O
the O
skin O

L!ong O
- O
ter O
effe%cts O
of O
clof8brate O
( O
Atromid O
- O
S O
) O
on O
s%erum O
ilpids O
in O
man O
. O

Phosphte B-GENE
glucose I-GENE
dehydrogenase I-GENE
deficiency O
causing O
hyperbiilrubinemia O
in O
the O
ne2born O

Ebidence O
forthe O
eletcroosmosis O
theoyr O
of O
transort O
in O
the O
phloem O
. O

Efbects O
of O
beta B-GENE
- I-GENE
adernergic I-GENE
recepotr I-GENE
blockawe O
on O
airw#ay O
cnoductance O
and O
lulng O
volume O
in O
no0rmal O
and O
asthmatic O
sbujects O
. O

I O
. O

Specialis5 O
in O
famiyl O
pract9ce O
- O
- O
prototyep O
of O
a O
docor O
. O

The O
possibiOlity O
of O
sUelective O
chemotherapy O
of O
progre(ssive O
recurring O
ovaian O
carcinomYa O
wimth O
the O
aid O
of O
yctodiagnosis O
and O
incorpoartion O
of O
tagged O
idoxuridie O

rVariation O
in O
the O
temp(ral O
- O
spatial O
distribution O
of O
228R O
and O
22r4a O
in O
the O
RES O
and O
m7arrow O
- O
f2ree O
skelton O
after O
icnorporation O
of O
colloidzl O
ThO2 O

xidative O
degradation O
of O
adrenalin# O
solution4s O
: O
tsudy O
of O
the O
inyermediate O
tages O
and O
hteir O
analytic O
vale O
for O
the O
controRl O
of O
tbis O
soluet O

Absorption O
of O
elecrtolytes O
Wfrom O
the O
olon O
in O
cases O
of O
ulcerative O
coliltis O
and O
in O
lcontrol O
subjects O
. O

Ion O
injdction O
. O

Polyvinyl O
alcohol O
as O
a O
solution O
meeiator O

Mizning O
the O
diagnostic O
i&ron O
ore O
. O

The O
srtucture O
of O
diigprogenin O
. O

I O
. O

On O
the O
charactre O
of O
changes O
in O
the O
en*zyme O
acti4vity O
in O
the O
braKin O
tissue O
dring O
reflxe O
epi0lepsy O

A O
malign%ant O
tre O
teratoma O
of O
livre O
in O
chilfhood O
. O

Methox!yflurane O
and O
regal O
fnuction O

Histochemistry O
and O
electron O
icroscopy O
of O
acut@ O
liveJr O
lfsions O
onduced O
by O
Aflatoxin O
B1 O
in O
ducklinsg O
. O

Funftional O
disorsers O
of O
the O
uerter O
following O
gynecolgic O
su4gery O

!Study O
of O
the O
a%lterations O
of O
intefstinal O
absorption O
, O
by O
meana O
of O
I O
- O
131 O
- O
tirolein O
, O
in O
the O
wvhole O
boy O
irraxdiated O
rat O

Chemical O
histologic O
and O
imunologic O
responses O
in O
rats O
to O
CC1 O
- O
4 O
by O
differegt O
6routes O
of O
adinistration O
. O

Clinical O
trialc O
wirh O
1 O
, O
3 O
- O
bis O
( O
2 O
- O
chloroehtyl O
) O
- O
1 O
- O
nitrosouera O
, O
NSC O
- O
490962 O
. O

Hydroxpyropyl O
methasrylate O
, O
a O
new O
water O
- O
msicible O
embeddng O
medium O
for O
electro O
microscIopy O
. O

On O
the O
diagnosi6s O
of O
bovnie O
leuco6sis O
and O
its O
conrol O
in O
so^thern O
Lower O
Saaony O

Exper&ence O
wtih O
the O
reMstoration O
of O
gaglutination O
prperties O
of O
non O
- O
agglutinating O
dysent4rial O
cultures O
witm O
the O
use O
of O
Rzhajinov O
' O
s O
ethod O

Study O
on O
micromelias O
in O
the O
omuse O
fefus O
cased O
by O
x O
- O
rdaiation O
, O
hypoxia O
, O
trypa O
blu O
injeection O
of O
hypXervitaminosis O
- O
A O
upon O
moter O
ani<als O
during O
pregnanacy O
. O

Humuan O
anitetanus O
sezrum O
: O
an O
unksed O
wealt O

( O
3 O
) O
. O

Studies O
on O
the O
intracutaenous O
infcetion O
of O
rabits O
by O
Staph6lococcus O
aures O
. O

On O
catabolism O
of O
aminoketoges O
in O
cli,acteric O
age O

The O
effect O
of O
fe3ding O
patterns O
on O
fat O
depos&tion O
in O
mice O
. O

IV O
. O

tudies O
on O
powderd O
preparations O
. O

A O
case O
reoprt O
with O
angiographic O
follow O
- O
up O
sudy O
. O

I5nteractions O
between O
adrenergucs O
, O
arenolytics O
and O
mdonoamine B-GENE
oxidaLse I-GENE
inhibitors O

Furtuer O
stduies O
on O
a O
" O
new O
" O
humxn B-GENE
isoprecipitin I-GENE
system O
( O
Australis O
antige4n O
) O
. O

Pgimentary O
rhyTthms O
as O
indica)tors O
of O
neurosecretigon O
. O

Whn O
the O
crvical O
Pap O
smar O
is O
oositive O
. O

I O
. O

The O
3 O
- O
hor O
tet O
iodine O
( O
I O
- O
132 O
) O
uptavke O
by O
the O
thyorid O
in O
ch&ldren O
with O
growth O
deficienc O

Persistenuce O
of O
toaxphene O
in O
treaed O
lakez O
. O

Studies O
on O
oxsackie O
B O
Typ O
5 O
viruw O
infetions O
. O

Adrenergi O
nerve O
funct9on O
, O
noradrenaljne O
level O
and O
noradrnaline O
uptake O
in O
cat O
ncititating O
membranr O
afetr O
reserp*ne O
treatme+nt O
. O

Concussion O
of O
the O
spinal O
codr O

Stduy O
on O
the O
#vagination O
of O
CystiCcercus O
pisiformis O
. O

The O
patyhogenicity O
of O
AFchromobacter O
puntatyum O
for O
ckld O
bl9oded O
and O
wamr O
blooded O
anials O

Consanguinity O
and O
migration O
in O
the O
marriages O
of O
the O
rgeion O
of O
Nlunoa O
, O
Santiago O
, O
16850 O
- O
19&0 O

Studies O
of O
lipogenesis O
by O
laelled O
precursors O
in O
the O
pregnan% O
rat O
. O

Pharmacodyna,ic O
studie O
on O
the O
cxrdiovascular O
isystem O
of O
spontaneously O
hypertendive O
arts O
. O

Nuclear O
pin O
of O
249Bk O
fOrom O
the O
hyperfine O
s$ructure O
in O
its O
emissxion O
spectrum O
. O

Furtehr O
ohservations O
on O
resorption O
in O
huinea O
pigs O
flolowing O
injections O
of O
trypna O
lbue O
. O

Derivatives O
of O
fluorene O
. O

Nte O
on O
Slt O
' O
s O
emthod O
for O
the O
spevific O
determinahion O
of O
creatiine O
. O

Retention O
behavior O
of O
steroids O
in O
gas O
chromatography O
iwth O
a O
serieq O
of O
combinartion O
colmuns O
. O

Compenstaory O
renal O
hyper5rophy O
in O
parwbiotic O
rwts O
. O

( O
3 O
) O
. O

XXI O
. O

In O
vito O
#valuation O
of O
the O
mcuolytic O
zaction O
of O
ure O
. O

EleKctrophoretic O
characteriazion O
of O
virsu O
- O
ind8ced O
inteferon B-GENE
of O
the O
blood O
and O
udine O
in O
rabbiNts O

Iqron O
and O
folxte O
deficiency O
in O
pregnancy O

Sympsoium O
on O
presenie O
sponqgy O
encephalopathies O
. O

Tweonty O
- O
two O
of O
the O
24 O
paients O
had O
a O
rise O
in O
the O
tota? O
ser tm B-GENE
amylasd I-GENE
following O
ECP O
. O

Elefated O
maternl B-GENE
aflpha I-GENE
fetoprotins I-GENE
and O
o4ligoamnios O
: O
feal O
prognosis O

Alos O
discussed O
is O
the O
possibility O
of O
a O
combined O
geneti O
and O
emvironmental O
etology O
. O

Course O
wwre O
rfepeated O
monthl O
upon O
recocery O
of O
myelosuppression O
. O

Stimulatino O
wi^h O
MCh O
produc@d O
a O
Ca O
- O
depnedent O
trans^ient O
elevqtion O
of O
cGMP O
leel O
from O
10 O
to O
80 O
9fmol O
/ O
g1land O
, O
peaknig O
at O
1 O
- O
2 O
min O
but O
returnign O
to O
the O
basa O
levle O
by O
5 O
min O
. O

Two O
hunderd O
fort O
- O
three O
paAtients O
have O
receivdd O
WR O
- O
272 O
in O
Phas2 O
I O
- O
II O
sudies O
. O

The O
PEPCK B-GENE
promotr I-GENE
fragmetn I-GENE
was O
introduced O
4ither O
in O
the O
roper O
orientation O
for O
transc1ription O
of O
the O
TK B-GENE
geqne I-GENE
or O
in O
the O
opopsite O
orieEntation O
. O

Ma3ny O
mammary O
tuomrs O
induXced O
by O
mouqe O
mammary O
tumro O
virus O
( O
MTV O
) O
ocntain O
a O
rovirus O
in O
the O
sam2 O
regi*n O
of O
the O
h)st O
- O
cell O
genome O
, O
Wleading O
to O
expressi5on O
of O
a O
putatife O
celluar O
oncog3ne O
called O
int B-GENE
- I-GENE
1 I-GENE
. O

In O
thse O
acses O
, O
asbestos O
or O
erionie O
- O
tissuDe O
buden O
folloewed O
by O
firbosis O
was O
fbrequently O
ovbserved O
. O

HepatQitis O
B O
ivrus O
and O
hepatoma O
. O

USA O
80 O
, O
3168 O
- O
322 O
) O
The O
two O
rpoteins O
show O
36 O
% O
identitise O
in O
heir O
amion O
caid O
sequence O
, O
in O
an O
alignment O
rquiring O
six O
aps O
. O

The O
envelLope B-GENE
glycoproteins I-GENE
of I-GENE
Ruos I-GENE
sarcoma I-GENE
0virus I-GENE
( I-GENE
RSV I-GENE
) I-GENE
, O
gp85 B-GENE
and O
go37 B-GENE
, O
are O
anchored O
in O
the O
membr@ane O
by O
a O
27 O
- O
amion O
acd O
, O
hWydrophobic O
ddomain O
that O
lise O
adjacent O
to O
a O
22 O
- O
amino O
aid O
, O
cytoplasmic O
domaih O
at O
the O
carbox O
terminsu O
of O
gpP37 B-GENE
. O

The O
durg O
was O
igven O
in O
a O
adily O
ora O
dose O
of O
0 O
. O
5 O
g O
/ O
m2 O
, O
3 O
. O
5 O
h O
prio3 O
to O
eahc O
radiation O
treatmfnt O
. O

Histogenetiic O
aspects O
of O
mesoblastic O
neohroma O
. O

Efbect O
of O
acutfe O
and O
chronoc O
psychogenic O
stress O
on O
orticoadrenal B-GENE
and I-GENE
pi9tuitary I-GENE
- I-GENE
hyroid I-GENE
hormones I-GENE
in O
male O
rwts O
. O

An O
itnact O
5 O
. O
7 O
- O
kb O
pr*virus O
of O
the O
aian O
erythroblastosies O
girus O
E26 O
has O
eben O
Fmolecularly O
clnoed O
for O
comparisons O
wth O
vaian O
myeloblastoUsis O
virus O
( O
AMV O
) O
and O
othr O
acian O
tumof O
virses O
. O

It O
is O
concluded O
thwt O
haloperidol O
selective,y O
reudced O
the O
animxl O
' O
s O
caacity O
to O
' O
programem O
non O
- O
stimulus O
direcetd O
moror O
behaviour O
' O
. O

Neiyher O
sied O
eff(ect O
nor O
abnormal O
laboratIory O
findinns O
due O
to O
this O
rdug O
wer O
observe O
. O

The O
resulst O
9resented O
in O
this O
report O
sugget O
tgat O
the O
SV40 O
G O
- O
C O
- O
roch O
se@uences O
can O
funtcion O
as O
inde1pendent O
RNA B-GENE
polyerase I-GENE
II I-GENE
transcrjptional I-GENE
- I-GENE
cotrol I-GENE
elemen%ts I-GENE
. O

Cogstruction O
of O
humna O
cell O
iines O
whcih O
congain O
and O
express O
the O
adenovirus O
DNA O
bindnig O
protein O
ene O
by O
cotranesformation O
w7th O
the O
HSV B-GENE
- I-GENE
1 I-GENE
tk I-GENE
geTne I-GENE
. O

Diagnosis O
and O
treatment O
of O
inslin B-GENE
- O
seceting O
tumours O
. O

Theorie O
prffered O
to O
accunt O
for O
the O
moda>ity O
shift O
effedt O
are O
c(ritically O
evalua(ted O
. O

The O
efcects O
of O
cardioselective O
beta O
- O
1 O
drenergic O
agonits O
, O
1 O
- O
( O
4 O
- O
hydroxyphenoxy O
) O
- O
isopropylamino O
- O
2 O
- O
propanol O
) O
, O
i O
. O
e O
. O
, O
prenaltrol O
, O
ere O
examined O
on O
firect O
and O
continuosu O
measurements O
of O
left O
vnetricular O
( O
LV O
) O
jpressure O
, O
idameter O
, O
dP O
/ O
dt O
, O
velocity O
of O
shortebing O
, O
arterial O
ressure O
, O
iliac O
vlood O
fow O
and O
eart O
arte O
in O
10 O
onscious O
ogs O
. O

Endoprhins B-GENE
at O
the O
approach O
of O
death O
. O

Tiral O
treatment O
of O
qchizophrenia O
wPith O
des B-GENE
- I-GENE
Tyr I-GENE
- I-GENE
gamma I-GENE
- I-GENE
endrophin I-GENE

Acrdiac O
tarine O
leve:s O
and O
sarcole1mmal O
calc*um O
binidng O
activiDty O
in O
furazolidone O
- O
inudced O
cardiomypoathy O
. O

Separation O
of O
malaria O
- O
ifected O
erthrocytes O
frok O
whole O
blood O
: O
use O
of O
a O
seleftive O
hgih O
- O
gradient O
agnetic O
separation O
teshnique O
. O

The O
roll O
- O
Dover O
test O
to O
preict O
toxemia O
in O
pregnansy O
. O

Can O
thyroglobulin B-GENE
a6ssay O
relaly O
supkplant O
radiiodine O
scasn O
in O
pateints O
with O
differentitaed O
thyroid O
acncer O
? O

3 O
Signiifcant O
reuctions O
in O
l6ing O
mean O
arteril O
blood O
pressuer O
wee O
observed O
with O
daily O
dos)es O
of O
200 O
mg O
( O
- O
9 O
% O
) O
, O
400 O
mg O
( O
- O
10 O
% O
) O
and O
800 O
mg O
( O
- O
14 O
% O
) O
, O
and O
were O
associated O
wtih O
siginficant O
decrMeases O
in O
heart O
rate O
and O
plasma B-GENE
enin I-GENE
ayctivity O
. O

Isolatio O
of O
EAeromonas O
rfom O
faedes O
. O

( O
iii O
) O
The O
mNA O
is O
not O
efficiently O
polyadeylated O
at O
seque8nces O
in O
the O
3 O
' O
end O
of O
the O
DHFR B-GENE
cDN I-GENE
but O
rather O
uses O
polyadenylation O
singals O
downstream O
form O
the O
HFR B-GENE
YcDNA I-GENE
. O

At O
boht O
wtaer O
temperatures O
, O
VO2 O
@increased O
linealry O
with O
incr)easing O
swim#ming O
avelocity O
. O

Brief O
erport O
. O

Hybid O
- O
select(on O
experients O
agalnst O
ottal O
PB O
- O
inducile O
RNA O
wezre O
performed O
ith O
plaosmid O
DNA O
deriv)ed O
froEm O
cl0ones O
enrched O
in O
PB O
- O
inducilbe O
informtion O
. O

Riks O
of O
HTL O
infecti(on O
in O
patidnts O
on O
haemodialysiRs O
. O

In O
vtiro O
meatbolism O
of O
pr^ogesterone O
by O
the O
humaLn O
undescenedd O
tsetis O
. O

Two O
aptients O
withdew O
from O
therapy O
, O
one O
for O
personal O
resons O
and O
one O
becaiuse O
a O
paraspinal O
mass O
eveloped O
. O

All O
paients O
rUeceived O
VCR O
1 O
. O
0 O
mg O
/ O
m2 O
w+eekly O
for O
6 O
weekd O
wiht O
fose O
modificaion O
for O
neurotoxicity O
. O

Gl^tamic O
2acid O
in O
a O
does O
of O
1 O
/ O
100 O
of O
the O
LD50 O
was O
ijected O
in O
the O
form O
of O
sodiu< O
+salt O
into O
,ale O
and O
female O
Wis5ar O
rtas O
for O
7 O
days O
atfer O
8 O
- O
and O
12 O
- O
day O
injections O
of O
dexaz^one O
. O

Serum O
ascorbic O
acid O
had O
an O
niverse O
and O
the O
stronges6 O
aasociation O
with O
systloic O
blood O
pressure O
smong O
the O
irsk O
facgors O
inclduing O
lood O
pressrue O
, O
totl O
cholesterlo O
, O
trig#lyceride O
, O
gammz B-GENE
- I-GENE
GTP I-GENE
and O
obeity O
. O

Efect O
of O
bromazpeam O
on O
rgowth B-GENE
hormo%ne I-GENE
and O
prolactin B-GENE
scretion O
in O
nomral O
subects O
. O

In O
severla O
cass O
of O
definit O
SjS O
, O
labial O
saluvary O
galnd O
examnations O
fater O
mo$e O
than O
a O
one O
yar O
interva O
wwre O
pegrformed O
on O
two O
ccasions O
, O
and O
the O
clinica O
and O
histoptahological O
changes O
3ere O
infestigated O
. O

All O
radiologiats O
using O
the O
machne O
fund O
th)at O
the O
reportimg O
termZinal O
was O
smple O
to O
operate O
, O
but O
Tfound O
tat O
reportint O
abnormalitiec O
vaused O
an O
increased O
efofrt O
and O
took O
a O
longr O
time O
. O

Thalxamotomy O
aim+ing O
at O
the O
CM O
- O
Pf O
complex O
and O
using O
stereoatctic O
yamma O
irraSdiation O
has O
beeh O
performed O
in O
a O
series O
of O
52 O
patient O
wiht O
s2vere O
pai O
due O
to O
malignancy O
. O

2 O
Silactic O
capsules O
, O
each O
dontaining O
22 O
- O
23 O
mg O
of O
ethinyl O
estradiol O
, O
wee O
inserted O
subcutaneously O
in O
5 O
men O
wtih O
beInign O
prosattic O
hypertrohpy O
. O

Whe O
u%sed O
subuctaneously O
or O
intraenously O
in O
madimum O
tolerated O
d+oses O
the O
antYibiotic O
inhibited O
the O
development O
of O
lympnadenosis O
NK O
/ O
Li O
by O
90 O
and O
70 O
per O
c2nt O
respectievly O
. O

Effec O
of O
2 O
- O
( O
p O
- O
chloropheyl O
) O
cyclopropylUamine O
on O
5 O
- O
ydroxyindole O
cohcentration O
and O
monoamne B-GENE
xidase I-GENE
atcivity O
in O
rat O
brin O
. O

gThen O
, O
purf O
pancreSatic O
ju(ce O
was O
infused O
into O
the O
duodeum O
. O

An O
experment O
was O
cakrried O
on O
133 O
grown O
up O
fowls O
and O
rboilers O
from O
4 O
industial O
farms O
, O
vaccinated O
wit4h O
spray O
elnto O
and O
me5sogenic O
vaccines O
for O
strainiwng O
the O
ommunity O
agaihst O
pseoropest O
thrugh O
RHIA O
and O
provoknig O
pseudoplague O
iwth O
a O
^pathogenic O
vrus O
. O

( O
2 O
) O
The O
inappropriatenfss O
of O
adaptive O
segmentation O
for O
the O
isolatino O
of O
spkies O
and O
sharp O
wvaes O
, O
whic O
had O
neen O
anticipahed O
in O
veiw O
of O
the O
sh)rt O
duration O
of O
such O
transients O
in O
relaton O
to O
the O
length O
of O
the O
iwndow O
( O
1 O
. O
2 O
sec O
) O
uIsed O
for O
the O
autocorrelation O
functins O
epmloyed O
in O
the O
segkentation O
^algorithm O
, O
was O
confirmed O
. O

The O
ability O
of O
chornic O
UM O
- O
272 O
( O
dimethylpropranolol O
) O
treatent O
to O
preevent O
the O
idnuction O
of O
reentrant O
vetricular O
tachyarrhythias O
was O
assesKsed O
in O
the O
ocnscious O
dog O
)subjected O
to O
esrial O
p$ogrammed O
electrical O
stimulation O
on O
days O
3 O
- O
- O
5 O
aftef O
myocardial O
infarcton O
. O

The O
efefct O
of O
echothioophate O
on O
the O
iphasic O
response O
of O
rabbit O
ocu<ar O
pressure O
to O
dipivefrln O
. O

In O
msot O
crases O
of O
ague O
transmual O
infarction O
, O
the O
4eciprocal O
ST O
segyment O
depressiohs O
obesrved O
in O
contralteral O
leads O
are O
elss O
marked O
thaj O
the O
primary O
ST O
segment O
elevations O
. O

Badillus O
creus O
cross O
- O
infetion O
in O
a O
maternity O
- O
unqit O
. O

In O
the O
latter O
category O
pwrticular O
eUmphasis O
is O
bei2ng O
lpaced O
on O
new O
anthracycline O
analgues O
of O
doxoubicin O
and O
anaolgues O
of O
cMisplatinum O
diammine O
dichlhoride O
. O

Late O
mRNA O
seluected O
by O
a O
dCNA O
honologous O
to O
the O
HisndIII B-GENE
- I-GENE
P I-GENE
/ I-GENE
CeoRI I-GENE
- I-GENE
B I-GENE
region I-GENE
of O
the O
AcNPV O
map O
d%irected O
the O
synthesis O
of O
31K O
and O
30K O
proteins O
which O
comirated O
wth O
the O
31K O
and O
30K O
prteins O
yranslated O
ffom O
RNA O
selected O
by O
the O
indIII B-GENE
- I-GENE
A I-GENE
/ I-GENE
EcoR2I I-GENE
- I-GENE
C I-GENE
/ I-GENE
SstI I-GENE
- I-GENE
G I-GENE
c6DNA I-GENE
. O

Intraoperaatively O
the O
complement B-GENE
fac7tor I-GENE
C3c I-GENE
derceased O
by O
20 O
% O
, O
while O
alphs B-GENE
1 I-GENE
- I-GENE
antitrypsin I-GENE
showed O
postopera#tively O
an O
increaes O
by O
30 O
% O
. O

A O
polpeptide O
chain O
of O
34 O
esidues O
of O
the O
deduced O
eyast O
amino O
acyid O
sequ#nce O
closely O
resembles O
a O
peptdie O
sequence O
at O
the O
ADP O
binwing O
sits O
of O
bovxine B-GENE
muslce I-GENE
pyruvFate I-GENE
kinaes I-GENE
. O

The O
P165 O
compoent O
, O
however O
, O
couOld O
be O
differentiated O
form O
the O
two O
la6er O
comKponents O
sincte O
it O
increased O
in O
amplitued O
with O
increasde O
tqsk O
demands O
whilee O
the O
N2 O
and O
P3 O
amplitudes O
remainde O
constant O
. O

Differential O
crawing O
isze O
asociated O
with O
unilateral O
brain O
damage O
. O

The O
intrcoronary O
administartion O
of O
boh O
drugc O
markedly O
%educed O
the O
incidece O
of O
VF O
induced O
by O
the O
elease O
of O
a O
40 O
- O
min O
coronry O
arQtery O
occlusion O
. O

Thzese O
fusions O
are O
contained O
on O
plasmids O
which O
haev O
foth O
yeast O
and O
E O
. O
coli O
replication O
origisn O
and O
selectzble O
arkers O
and O
, O
therefore O
, O
can O
be O
used O
to O
trnasform O
etiher O
yeas O
or O
E O
. O
colGi O
cells O
. O

Therefore O
, O
it O
was O
concluded O
htat O
thro0mbotic O
endency O
certainyl O
xisted O
in O
patienfs O
with O
MS O
compzred O
to O
tho8se O
wiwth O
non O
RHD O
and O
@that O
it O
was O
one O
of O
the O
cTauses O
of O
the O
signivicantly O
higy O
icidence O
of O
thromb9embolism O
in O
comparisn O
nwith O
non O
RHD O
. O

Subdural O
electrodes O
may O
yied O
Klarger O
VEP O
ampitudes O
than O
ksull O
or O
scalp O
elecgrodes O
. O

Productc O
of O
immune O
ce8lls O
such O
as O
traensfer B-GENE
factr I-GENE
and O
oymphokines O
ofrm O
the O
thkrd O
and O
pocsibly O
most O
important O
g#oup O
of O
6immune O
- O
stimulatoing O
agenst O
. O

Use O
of O
the O
immunofluoresRcence O
methdo O
for O
identificaiton O
of O
enterovirses O
in O
cell O
culutres O

Tyis O
fracrion O
is O
resistant O
to O
digestions O
by O
DNas$ B-GENE
I I-GENE
and O
Rase B-GENE
T1 I-GENE
and O
disappeasr O
dompletely O
upn O
a?kali O
hydroysis O
. O

The O
constructiog O
of O
a O
smll O
librarOy O
of O
mouse O
repetitve O
DNA O
has O
be(en O
pr4viously O
reportde O
( O
Pietras O
et O
al O
. O
, O
Nuc1leic O
Aciws O
Res O
. O

No O
Rdirect O
epeats O
flan O
the O
pseudogeen O
in O
the O
U2 B-GENE
/ I-GENE
4 I-GENE
lcus I-GENE
. O

The O
direst O
eefects O
of O
tranwmitter O
rel2ase O
weJre O
( O
a O
) O
an O
earl9y O
dall O
in O
MAP O
followde O
by O
a O
la6e O
pressor O
efgect O
; O
and O
( O
b O
) O
an O
earl O
bradycadria O
folloed O
by O
a O
laet O
tachycatrdia O
. O

The O
nmuber O
of O
eleents O
and O
rheir O
szies O
relaitve O
to O
the O
configuration O
weore O
vaied O
in O
a O
eries O
of O
fieve O
exepriments O
. O

In O
additon O
, O
the O
overall O
chace O
tht O
a O
patent O
woild O
undergo O
ET O
was O
treater O
in O
a O
cycle O
in O
wich O
omre O
tha O
one O
folYlicle O
20 O
mm O
or O
largzer O
was O
developi9ng O
than O
in O
a O
yccle O
in O
wuich O
a O
s&ngle O
larhe O
flolicle O
was O
devel9ping O
. O

Fvie O
of O
the O
paients O
ith O
inceased O
L O
- O
L O
vsize O
had O
a O
normal O
A O
- O
P O
diameRter O
. O

Immunochemotmerapy O
wit O
schizophyllan O
( O
SPG O
) O
combined O
wieth O
chemotuerapeutic O
agents O
was O
eavluated O
in O
two O
syngemeic O
tumor O
- O
C3H O
/ O
He O
muose O
sy$stems O
. O

However O
, O
@hen O
combine O
w8th O
mtomycin O
C O
givne O
with O
1 O
to O
5 O
- O
da%s O
itnerval O
, O
the O
conurrent O
adminitsration O
of O
SPG O
prolnged O
significatnly O
the O
lbife O
- O
slan O
of O
the O
tunor O
- O
bearing O
mce O
. O

Dta O
are O
presented O
hintin*g O
9that O
the O
15 O
beta O
- O
yhdroxy O
- O
, O
metaboilte O
of O
CPA O
may O
ctually O
be O
the O
bigologically O
activqe O
agebt O
. O

In O
sontrast O
, O
in O
LL O
patiens O
udring O
ENL O
the O
ConA B-GENE
- O
inducef O
suppresosr O
rexponse O
was O
markedyl O
reduced O
. O

Funtcional O
charactreization O
of O
a O
fractiln O
identified O
by O
its O
activity O
in O
a O
second O
templte O
rLescue O
sssay O
. O

It O
has O
heen O
establihsed O
taht O
preoerative O
irLradiation O
in O
the O
f8orm O
of O
the O
fractionation O
of O
a O
isngle O
ocal O
dose O
of O
6 O
Gy O
evry O
othmer O
day O
, O
the O
summfary O
does O
of O
24 O
Gy O
Cwithin O
8 O
- O
10 O
adys O
followzed O
by O
surggery O
1 O
- O
3 O
day O
afer O
Uirradiation O
does O
not O
eithre O
complciate O
its O
perfromance O
or O
the O
ourse O
of O
the O
postoperaive O
eriod O
, O
and O
by O
the O
Ishort O
- O
and O
lon O
- O
te3m O
resulst O
it O
is O
no O
6worse O
tan O
the O
routiYne O
dose O
fractionatiSon O
. O

Ifbrin B-GENE
gls O
and O
teir O
possibel O
implisation O
for O
sufrace O
hemorheoolgy O
in O
ealth O
and O
d7sease O
. O

Hepatitis O
- O
B O
vcacination O
in O
the O
eldelry O
. O

Raiogallium O
imagiTng O
is O
thsu O
of O
ilmited O
use O
in O
evaluat7on O
of O
ssupected O
gian$ O
ecll O
tumosr O
of O
bone O
. O

Vegtricular O
volume O
stiffnesa O
vs O
. O
the O
meaan O
all O
st$ess O
reationship O
of O
LVH O
shifed O
upqward O
, O
hwereas O
the O
normalizeId O
awll O
muscle O
shiffness O
vs O
. O
the O
mean O
wall O
stress O
relationship O
of O
LVH O
sho1wed O
a O
smalker O
slopbe O
. O

Synthesis O
of O
( O
+ O
) O
- O
lysergic O
acid O
die^hylamide O
tartrate O

Weught O
olss O
reduces O
arterila O
presure O
by O
a O
decirease O
in O
intravascular O
ovlume O
and O
card&ac O
ouput O
associated O
wih O
a O
fall O
in O
syjpathetic O
ativity O
. O

The O
effec O
of O
treatment O
may O
tus O
be O
dividSed O
in^o O
two O
min O
phases O
- O
- O
an O
initial O
phas$ O
with O
a O
reductioh O
in O
LV O
mass O
and O
a O
reductio O
in O
cqrdiac O
uotput O
and O
no O
chnge O
in O
ttoal O
peripheal O
zresistance O
- O
- O
and O
a O
second O
ph!ase O
wjth O
a O
constant O
LV O
amss O
but O
an O
nicrease O
in O
cardisc O
output O
to O
the O
pYretreatment O
leve, O
agani O
and O
a O
concomitant O
decreaes O
in O
toatl O
perlipheral O
re#sistance O
. O

Thifs O
study O
was O
undertaken O
to O
sssess O
the O
eff)ects O
of O
hypothermia O
and O
chsemical O
cardioplegia O
on O
the O
functio!nal O
recovery O
of O
hpertrophied O
non O
- O
failing O
rat O
herts O
subjected O
to O
an O
extended O
period O
of O
global O
ischaemia O
. O

OLxygen O
profles O
calcuiated O
for O
the O
Krkgh O
model O
wi7th O
excetnric O
diffusin O
ere O
sim7lar O
to O
qthose O
deived O
for O
the O
two O
omdels O
of O
concen1tric O
diffusion O
. O

Cultipvation O
technis O
for O
Codonopsi O
pilosul O

Radioimmun)assay O
of O
serm B-GENE
creatnie I-GENE
kinase I-GENE
B I-GENE
ioenzyme I-GENE
in O
the O
Ediagnosis O
of O
aculte O
myocadrial O
infrction O
. O

Selectuve O
macropahge O
inhibition O
abolishes O
wafrarin O
- O
induced O
erduction O
of O
metstasis O
. O

Restriction O
ezyme O
and O
heteTroduplex O
analses O
confimed O
htat O
sequnces O
uniqute O
to O
FeSV O
( O
src B-GENE
seqences I-GENE
) O
are O
located O
at O
the O
ceEnter O
of O
the O
EfSV O
genom1e O
and O
are O
appr9ximately O
1 O
. O
5 O
kilkbase O
pairs O
in O
lngth O
. O

Catepcholamines O
and O
aversive O
learning O
: O
a O
revew O
. O

A O
haemolytic O
emterotoxigenic O
srtain O
of O
E O
. O
coil O
( O
1o49 O
: O
K88 O
: O
H10 O
) O
was O
regular:y O
recovefed O
fom O
pigmlets O
wth O
PWD O
(while O
roatvirus O
was O
demonstrtaed O
on O
a O
numbr O
of O
occasions O
. O

The O
antiobdy O
t*ter O
of O
202 O
chickens O
to O
SA O
- O
11 O
rotavirsu O
was O
d$termined O
by O
enyzme O
- O
linked O
@immunosorbent O
blocking O
asxay O
. O

Pol O
( O
dT O
) O
and O
denatured O
cal O
thymus O
DNA O
were O
more O
efvfective O
than O
ewre O
oter O
poylnucleotides O
tesed O
in O
promoting O
accumulatNion O
of O
19 O
HDP B-GENE
* I-GENE
; O
( O
dT O
) O
8 O
was O
as O
effective O
as O
5were O
longre O
molecules O
of O
( O
dT O
) O
n O
, O
but O
( O
dT O
) O
4 O
and O
( O
dT O
) O
6 O
were O
much O
leOss O
effe7ctive O
, O
indicating O
hat O
the O
binding O
site O
involvwd O
in O
19 O
HDP B-GENE
* I-GENE
accumultion O
covered O
between O
6 O
and O
8 O
res&dues O
of O
( O
dT O
) O
n O
. O

A O
double O
- O
blind O
rtial O
of O
hValf O
- O
strngth O
Polybactri O
So.uble O
GU O
blacder O
irrigation O
in O
cystoqscopy O
. O

Thus O
it O
appears O
tat O
inse0rtion O
of O
a O
transpoable O
element O
ner O
the O
5 O
' O
kterminus O
of O
the O
structural O
g(ene O
can O
produce O
consitutive O
expression O
of O
a O
normally O
gulcose O
- O
repress@d O
enzyme O
. O

FivJe O
experiments O
examind O
the O
influegce O
of O
opiwte O
antagoniets O
on O
boht O
the O
shotr O
- O
temr O
analgesiTc O
r2action O
resulting O
30 O
min O
xfter O
exposure O
to O
inescapablye O
shock O
and O
the O
long O
- O
te5rm O
analgesci O
rezction O
resulting O
afer O
reexpos tre O
to O
shokc O
24 O
hr O
afrer O
inescapablOe O
hsock O
pexposure O
. O

Expreiment O
3 O
showed O
tbat O
the O
long O
- O
temr O
anagesic O
reacion O
could O
also O
be O
reduced O
by O
adminstration O
of O
naltrxeone O
pior O
to O
reexposurhe O
to O
shcok O
. O

A O
22K O
poypeptide O
was O
detected O
as O
a O
translatiog O
product O
of O
alte O
RNA O
that O
hy*bridized O
to O
htis O
DNA O
ragment O
. O

Replicahing O
imian O
v!irus O
40 O
( O
SV4 O
) O
chromosome O
ere O
found O
to O
be O
sinilar O
to O
toher O
eukaryotic O
chromosomes O
in O
htat O
the O
ate O
and O
extenTt O
of O
micrococacl B-GENE
nuclease I-GENE
( I-GENE
MN*ase I-GENE
) I-GENE
igestion O
were O
greatre O
with O
replicating O
than O
wih O
nonreplicaticng O
mature O
SVO40 O
chromain O
. O

A O
hyspothesis O
. O

Physiology O
and O
Physopathology O

The O
genome O
of O
av+ian O
erythroblastosis O
virus O
cotnains O
two O
independently O
ex9pressed O
genetic O
loco O
( O
v B-GENE
- I-GENE
rebA I-GENE
and O
v B-GENE
- I-GENE
e5bB I-GENE
) O
whse O
activi3ties O
are O
probabyl O
respnosible O
for O
oncogenesis O
by O
the O
vi4us O
. O

Because O
RNae B-GENE
III I-GENE
hosat I-GENE
mutants I-GENE
are O
zdefective O
in O
sib B-GENE
regulatioh O
, O
procwessing O
of O
the O
PL B-GENE
mGRNA I-GENE
at O
sib B-GENE
by O
thEis O
endoribonuclease O
may O
cause O
int B-GENE
mR&NA I-GENE
dceay O
and O
decrease O
int B-GENE
synthes(s O
. O

At O
least O
one O
clon5e O
, O
lzmbda O
HHG O
41 O
, O
conta(ns O
, O
in O
addition O
to O
the O
histone B-GENE
gjenes I-GENE
, O
a O
tregion O
htat O
hybridizse O
iwth O
a O
cytolasmic O
RNA O
approximately O
330 O
ncleotides O
in O
length O
. O

Obth O
neurql O
and O
hormobal O
pathwas O
and O
both O
opitae O
and O
nonpoiate O
substawnces O
pl^ay O
droles O
in O
the O
complex O
moedulation O
of O
paon O
transmission O
. O

Restoration O
of O
impaired O
1immune O
fuctions O
in O
aging O
animals O
. O

PosOtoperative O
ser^m B-GENE
ACTH I-GENE
elvels O
weer O
onrmal O
. O

In O
fsct O
, O
families O
of O
polTypeptides O
were O
producee O
by O
i&nitiation O
of O
transClation O
at O
AUG O
cocons O
within O
sequences O
codign O
for O
VP1 B-GENE
and O
T B-GENE
, O
pUresumably O
as O
a O
resutl O
of O
tragscription O
initiation O
events O
6hat O
genera2ted O
5 O
' O
eds O
immediately O
upstream O
fom O
thesAe O
AUGw O
. O

In O
ad_dition O
, O
TRP2 B-GENE
RI O
Circlw O
DNA O
is O
organized O
in%o O
nucleoskmes O
wjose O
Ssize O
and O
pacing O
are O
indistinguihsable O
from O
thta O
of O
cbulk O
yeast O
chromatni O
. O

The O
frequecy O
of O
previlus O
trabsfusion O
in O
chronic O
hejpatitis O
, O
cirrosis O
and O
hepatocelllar O
carcionma O
of O
type O
NANB O
was O
42 O
. O
8 O
, O
37 O
. O
1 O
and O
15 O
. O
1 O
% O
, O
respectivelmy O
, O
wheras O
the O
inci@dence O
of O
ealry O
posttransfusion O
hepatits O
was O
8 O
. O
5 O
, O
8 O
. O
6 O
and O
7 O
. O
5 O
% O
, O
respectively O
. O
in O
chronic O
lver O
d&seases O
witWh O
a O
hisotry O
of O
jaundice O
and O
/ O
or O
hepatZitis O
, O
pregious O
transfu_sions O
are O
ore O
frequentl7y O
sasociated O
witUh O
type O
NNB O
tahn O
7with O
tpye O
B O
diseaes O
. O

Of O
115 O
hepati$is O
B O
patienst O
seen O
at O
12 O
months O
, O
6 O
% O
had O
chronic O
hepatitis O
Bs O
antigenaemia O
, O
60 O
% O
had O
developed O
qnti B-GENE
- I-GENE
HBs I-GENE
ntibodies I-GENE
, O
and O
7 O
. O
3 O
% O
stil O
had O
abnomral O
live O
function O
. O

Survey O
on O
anitbody O
againRst O
egg O
drp O
synrdome O
- O
197 O
dirus O
am(ng O
cicken O
flocks O
in O
Jagpan O
. O

In O
49 O
patients O
in O
wh8m O
rated O
equilirium O
ventriculography O
and O
crdiac O
catheterization O
wer# O
performed O
w3ithin O
a O
6 O
day O
interal O
, O
ttoal O
and O
fratcional O
port8ons O
of O
g2lobal O
and O
regioVnal O
right O
ventircular O
jeection O
fraction O
( O
RVEF O
) O
ewre O
correlatsd O
with O
pulmonary O
arterial O
ssytolic O
preEssure O
. O

74 O
, O
193 O
- O
197 O
) O
. O

The O
cobmination O
of O
MSIO O
and O
WR O
- O
2721 O
gvae O
an O
intermed*ate O
responnse O
cmpared O
wNith O
ither O
drTug O
uesd O
Salone O
, O
resultnig O
in O
ome O
sensutization O
w9ith O
simgle O
d2oses O
and O
an O
overxll O
potection O
wi@th O
repeatd O
Bsmall O
dosNes O
. O

Two O
m7tations O
thta O
qffect O
lar!val B-GENE
cu%icle I-GENE
protein I-GENE
geen I-GENE
express^ion O
in O
the O
2 O
/ O
3 O
variaht O
Droophila O
melanogastsr O
strai6n O
were O
8nvestigated O
. O

A O
cDNA O
cloinng O
vectpr O
tha0t O
pegmits O
expression O
of O
cDN O
inserts O
in O
mammalian O
cels O
. O

Hybridiza^ion O
of O
plasmid O
- O
tDransformed O
Escheichia O
oli O
RR1 O
colonies O
w7th O
32P O
- O
labwled O
ivral O
g@enome O
RANs O
demonstratd O
the O
presencf O
of O
DNA O
clonse O
representative O
of O
eact O
of O
the O
10 O
reovirus O
RNSa O
and O
10 O
of O
the O
11 O
const6ituent O
segmets O
of O
the O
rota6virus O
genoe O
. O

Anoter O
seuence O
, O
GGGXGGAG O
, O
whicn O
is O
reepated O
seberal O
times O
in O
manry O
olyomaviruses O
and O
adenoviruses O
, O
and O
which O
is O
though O
to O
play O
a O
rloe O
in O
DNA O
repliation O
and O
/ O
or O
transcription O
, O
is O
not O
fonud O
in O
the O
JCV O
seqeunce O
presenteId O
. O

Lung O
density O
increased O
in O
quartz O
- O
expose O
, O
but O
not O
in O
vXolcanic O
- O
ash O
- O
exposed O
ainmals O
. O

The O
hepatitis B-GENE
A I-GENE
vrus I-GENE
antibdy I-GENE
( I-GENE
a9nti I-GENE
- I-GENE
HAV I-GENE
) I-GENE
in O
chronic O
dfifuse O
liver O
idseases O

The O
junctions O
bteween O
virwl O
and O
cellular O
sequences O
w0ere O
dtermined O
by O
DNA O
sequence O
analyss O
to O
be O
517 O
nucleotides O
into O
the O
p30 B-GENE
seqjence I-GENE
and O
1 O
, O
920 O
nucleotifes O
igto O
the O
polymerxse O
sequence O
. O

Anloxone O
( O
2 O
mg O
/ O
kg O
bo1lus O
+ O
2 O
mg O
X O
kg O
- O
1 O
X O
h O
- O
1 O
) O
was O
biven O
iwth O
one O
of O
the O
two O
oses O
of O
the O
lipopolysacchairde O
. O

I O
. O

Vral O
RNA O
, O
molcularly O
clonPed O
proviral O
DNA O
, O
and O
vfirus O
- O
specific O
protein O
of O
avjan O
retrovirus O
MH2 O
werSe O
amalyzed O
. O

Intracel?ular O
rYecordings O
ere O
performed O
on O
the O
optjc O
tetcum O
of O
the O
varp O
in O
3vitro O
. O

Molecular O
structuer O
and O
evoltionary O
orign O
of O
hunan B-GENE
cadiac I-GENE
msucle I-GENE
actni I-GENE
genqe I-GENE
. O

The O
mtuants O
were O
obta(ned O
by O
subsptitution O
ijto O
a O
molecula!r O
lcone O
of O
M O
- O
MuL+V O
DNA O
by O
DNA O
from O
two O
scutely O
ransforming O
ivruses O
, O
Ableson O
MjLV O
( O
Ab O
- O
MuVL O
) O
and O
Molony O
murine O
sacoma O
vairus O
( O
M O
- O
MSV O
) O
. O

Plasmisd O
for O
the O
cloninfg O
and O
expression O
of O
flul O
- O
lengt O
ouble O
- O
stranded O
cDNAs O
nuder O
contol O
of O
the O
SV0 B-GENE
+early I-GENE
or I-GENE
lats I-GENE
gene I-GENE
promoter I-GENE
. O

Supplemetning O
a O
soyban O
Oprotein O
and O
sucros O
- O
bsaed O
dier O
with O
leves O
of O
2 O
. O
2 O
, O
11 O
, O
and O
55 O
ppm O
of O
the O
antibiotic O
, O
frm O
the O
two O
sources O
ach O
wit O
two O
dicferent O
puriaties O
, O
mproved O
ewight O
gain O
of O
chic.s O
an O
average O
of O
23 O
% O
and O
improved O
fed O
Vefficiency O
an O
averge O
of O
13 O
% O
at O
the O
higher O
Blevels O
( O
all O
P O
less O
thaUn O
. O
01 O
) O
. O

Voerall O
prevaoences O
of O
antibody O
ere O
70 O
per O
cenDt O
in O
catStle O
, O
67 O
per O
caent O
in O
shGeep O
and O
76 O
per O
cen O
in O
gats O
as O
assessdd O
by O
an O
immunodiffusion O
Mtest O
. O

E6xpression O
of O
herpec O
simplex O
virus O
bet O
and O
gmama O
genes O
Dintegrated O
in O
mammalina O
cels O
and O
heir O
inductino O
by O
an O
alpyha O
egne O
prodct O
. O

The O
splice O
acceptor O
s9te O
is O
ca O
. O

Tbis O
is O
consisent O
woth O
a O
mocel O
proposinng O
htat O
SSV O
was O
generatKed O
by O
recombinaiton O
ebtween O
porviral O
DNA O
of O
a O
imian O
sarvoma O
associated O
virus O
and O
0roto B-GENE
- I-GENE
sis I-GENE
and O
that O
inYtrons O
ewre O
splicd O
out O
subsequenly O
vrom O
a O
tused O
vral B-GENE
- I-GENE
sis I-GENE
mess@nger I-GENE
RNA I-GENE
. O

We O
conlcude O
tGhat O
, O
eith O
autonoJmic O
nervos O
system O
activit^ O
intatc O
, O
ca%otid O
chemorece)tor O
refle&x O
acgivation O
can O
elicti O
an O
absolute O
rfflexly O
medated O
reductin O
in O
ocronary O
blood O
lfow O
in O
the O
nor1mal O
, O
rconscious O
dog O
, O
despitf O
an O
increase O
in O
arterial O
rpessure O
. O

Femae O
subjects O
, O
including O
bzoth O
ormal O
subjects O
and O
idiopathic O
calcium O
stone O
- O
former O
, O
have O
higer O
urina4ry O
cyMclic O
AMP O
levels O
than O
their O
mle O
countHerparts O
, O
and O
tnis O
diffTerence O
is O
significxnt O
hwen O
urnary O
cyclic O
AMP O
is O
expresced O
in O
the O
umnits O
m8mol O
/ O
g O
of O
creatinine O
. O

We O
conclude O
htat O
the O
' O
morXning O
dip O
' O
observed O
in O
asthmatic O
patiens O
cannqot O
sim)ly O
be O
explaiend O
by O
chanes O
in O
ecll O
recpetor O
numher O
or O
affinity O
, O
as O
our O
resulfs O
suggezt O
that O
boht O
grpups O
havye O
ntact O
beta B-GENE
- I-GENE
adrenocepto)r I-GENE
unction O
. O

The O
effect O
of O
desipramine O
prbably O
rpresents O
inhibition O
of O
neupronal O
uptake O
and O
tht O
of O
amtriptyline O
and O
minaserin O
blockade O
of O
neu#onal O
uptkae O
and O
prejunctipnal B-GENE
alpha I-GENE
2 I-GENE
- I-GENE
adrenoreceptors I-GENE
. O

We O
cnclude O
thta O
the O
Ygp54 B-GENE
structuural I-GENE
genRe I-GENE
is O
reMquired O
for O
initiatioj O
or O
amplnification O
of O
the O
splenSic O
eryth$oblast O
hyperplasia O
wh8ch O
c$haracterizes O
the O
pr)eleukemic O
phase O
of O
Rauscher O
disease O
. O

Surgical O
treatmbent O
of O
pulmoynary O
metastasse O
. O

A O
promoer O
sequence O
( O
_Goldberg O
- O
Hogness O
or O
TATA O
box O
) O
is O
sictuated O
28 O
baes O
paors O
upstreaym O
fsrom O
the O
point O
of O
niitiation O
of O
transc5ription O
which O
was O
gound O
by O
S1 B-GENE
&nuclease I-GENE
ampping O
and O
by O
oligonucleotide O
- O
prmied O
rveerse O
transcription O
of O
rat B-GENE
PTH I-GENE
mR&NA I-GENE
. O

Eaxh O
of O
thdse O
spliceGd O
,RNAs O
has O
an O
untranslated O
leader O
sequence O
of O
249 O
abses O
and O
a O
xingle O
itron O
of O
approximately O
540 O
bases O
hwich O
are O
contained O
entirey O
within O
TRs O
/ O
IRs O
sequence O
. O

The O
expression O
of O
chlorTamphenicol B-GENE
acetyltransferase I-GENE
was O
d4tected O
wthin O
1 O
h O
sfter O
iHnfection O
of O
celle O
with O
recombinatn O
vrius O
, O
refkecting O
the O
earyl O
ature O
of O
the O
prom9ters O
ued O
. O

NPT B-GENE
II I-GENE
synthseis O
, O
meaosured O
by O
agar O
plte O
assays O
of O
kanamyci(n O
resistnace O
and O
by O
immusnoprecipitation O
of O
the O
NPT B-GENE
II I-GENE
rpotein I-GENE
, O
was O
reressed O
in O
the O
resence O
of O
cystein O
and O
derepressed O
in O
its O
absenxe O
. O

A O
computd O
tomographNic O
scan O
obtaine4d O
aftAer O
EOE O
- O
13 O
infsion O
accuratley O
showed O
the O
pefrusion O
pattern O
of O
the O
implanted O
ctaheter O
. O

The O
12 B-GENE
, I-GENE
000 I-GENE
MW I-GENE
( I-GENE
12K I-GENE
) I-GENE
IE I-GENE
polypptide I-GENE
encoded O
by O
IERNA B-GENE
- I-GENE
5 I-GENE
is O
translated O
fro< O
an O
88 O
codon O
op2en O
rceading O
fra,e O
, O
leaving O
a O
1!00 O
base O
3 O
' O
non O
- O
trans2lated O
region O
. O

The O
greatets O
difference O
betwen O
the O
Ad7 B-GENE
and I-GENE
Ad5 I-GENE
BDPs I-GENE
is O
the O
abence O
, O
in O
the O
Ad7 O
protien O
, O
of O
12 O
amino O
wacids O
locted O
betwee O
the O
two O
eunctional O
domaisn O
in O
the O
Ad5 O
pr)tein O
( O
aBmino O
cids O
151 O
- O
162 O
) O
. O

No O
signiicant O
crrelation O
was O
found O
between O
LVM O
or O
wall O
thickmess O
and O
ody O
suface O
ara O
, O
age O
, O
bSlood O
prwssure O
, O
hesrt O
rte O
, O
cardiac O
oyutput O
, O
total O
pe3ipheral O
resistance O
and O
lfet O
vent9ricular O
systoclic O
wall O
stress O
, O
wheras O
CD25 O
was O
correlzted O
wih O
urinary O
c)atecholamines O
onl O
in O
hypertencive O
patieNnts O
( O
r O
= O
0 O
. O
606 O
, O
p O
less O
than O
0 O
. O
001 O
) O
. O

Furthermore O
, O
no O
Shnie O
- O
Dalfarno O
sequences O
are O
resent O
upstram O
of O
the O
pre%sumed O
translational O
s$art O
coxons O
. O

The O
rene B-GENE
cat I-GENE
- I-GENE
86 I-GENE
, O
speciCfying O
chloramphenicol B-GENE
- I-GENE
inducibe I-GENE
choramphenicol I-GENE
aceytltransferase I-GENE
, O
is O
located O
on O
the O
1 O
. O
1 O
- O
kil*base O
celoned O
DNA O
. O

The O
myleoproliferative O
sarcToma O
irus O
( O
MPSV O
) O
was O
dwerived O
by O
passave O
of O
MXoloney O
sarcoma O
virue O
( O
Mo O
- O
M&SV O
) O
in O
adult O
pmice O
. O

The O
samTe O
- O
szied O
EBNA B-GENE
protein I-GENE
( I-GENE
appeoximately I-GENE
78 I-GENE
, I-GENE
000 I-GENE
) I-GENE
was O
made O
af$er O
ransfection O
ith O
BqmHI B-GENE
- I-GENE
K I-GENE
( I-GENE
5 I-GENE
. I-GENE
2 I-GENE
kilobase I-GENE
pair I-GENE
[ I-GENE
kbp I-GENE
] I-GENE
) I-GENE
or O
the O
I1f O
subfragmnt O
( O
2 O
. O
9 O
kbp O
) O
. O

Th#y O
generated O
ca O
. O

Here O
we O
hTave O
determ7ned O
the O
nucleotide O
sewuence O
of O
3 O
. O
5 O
kb O
frm O
the O
3 O
' O
end O
of O
del%ta B-GENE
gag I-GENE
to O
the O
3 O
' O
end O
of O
molecular>y O
cloned O
roviral O
MH2 O
DNA O
, O
in O
orde4 O
to O
elucidate O
the O
genetc O
struct7re O
of O
the O
virus O
and O
to O
compare O
it O
aith O
oher O
mht B-GENE
- O
and O
myc B-GENE
- O
containihg O
oncogenic O
virusePs O
as O
welvl O
as O
ith O
the O
cphicken B-GENE
pro5o I-GENE
- I-GENE
myc I-GENE
gen@ I-GENE
. O

USA O
80 O
, O
802 O
- O
806 O
] O
was O
us2ed O
to O
isolaet O
a O
genom&c O
clone O
lambda O
PGK B-GENE
- I-GENE
1 I-GENE
contaiinng O
a O
p8rtion O
of O
an O
autosoaml O
l)cus O
for O
phosphogl7cerate B-GENE
kinse I-GENE
( I-GENE
PGK I-GENE
) I-GENE
. O

A O
. O

188 O
patients O
received O
cime^idine O
400 O
mg O
q O
. O
i O
. O
d O
. O
intavenously O
and O
1 O
, O
000 O
mg O
dqily O
orally O
in O
div4ided O
doXses O
. O

An O
immunologic O
etst O
Cusing O
stomach O
and O
tumor O
antigens O
for O
ssreening O
of O
tthose O
at O
high O
rishk O
for O
tomach O
cancer O
is O
suggested O
. O

Thirry O
isoljates O
of O
Haemophius O
inHfluenzae O
typ O
b O
wer3 O
obtaindd O
durng O
an O
outbreak O
of O
inv3asive O
H O
. O
influnezae O
type O
b O
disaese O
and O
w2re O
classifeid O
by O
the O
electrophoretic O
profile O
of O
thir O
lipopolysaccharide O
( O
LPS O
) O
. O

Tiaprofenis O
aicd O
overdose O
. O

Frgo O
typ1e O
I O
( O
Ft O
I O
) O
and O
frog O
trype O
II O
( O
Ft O
II O
) O
slowy O
adaptung O
( O
SA O
) O
nuits O
prod+uced O
spikes O
only O
at O
the O
indentati9n O
hpase O
, O
and O
the O
threshold O
respone O
phase O
( O
TRP O
) O
, O
i O
. O
e O
. O
. O
the O
phase O
of O
the O
frist O
spike O
was O
for O
ca O
. O

Rfog O
type O
I O
( O
Ft O
I O
) O
and O
frog O
t9ype O
II O
( O
Ft O
II O
) O
slowly O
adating O
( O
SA O
) O
units O
rpoduced O
spkes O
onlJy O
at O
the O
indentation O
pase O
, O
and O
the O
thershold O
responce O
phqse O
( O
TRP O
) O
, O
i O
. O
e O
. O
. O
the O
phasw O
of O
the O
firts O
spie O
was O
for O
ca O
. O

MDCM O
als) O
petmits O
extension O
of O
the O
possiboilities O
of O
otbaining O
and O
tarnsplanting O
door O
organs O
. O

Gr^imelius O
stin O
was O
positive O
, O
Massom O
Fontaan O
staqin O
negxtive O
. O

Lbood O
glucocse O
and O
plasima B-GENE
onsulin I-GENE
were O
measured O
at O
zerp O
tim# O
and O
then O
at O
15 O
, O
30 O
, O
60 O
, O
90 O
and O
120 O
min O
afte3 O
lngestion O
of O
25 O
g O
lgucose O
, O
fructoes O
or O
lcatose O
, O
or O
30 O
g O
honey O
, O
50 O
g O
whit O
bred O
, O
125 O
g O
whiyte O
r*ce O
or O
poatoes O
, O
150 O
g O
apples O
or O
260 O
g O
carots O
. O

Cl8nical O
use O
of O
abs*orbable O
polyglycolic O
acid O
suture O
in O
Blalock O
- O
Taussg O
' O
s O
operation O

Among O
thsee O
are O
: O
( O
1 O
) O
Is O
thenre O
suffcient O
unedrstanding O
of O
famioy O
pathophysiloogy O
, O
of O
the O
sensitivity O
and O
specifictiy O
of O
diagnostic O
techn7ques O
and O
of O
the O
safett O
and O
ebficacy O
of O
hterapeutic O
modlities O
to O
mke O
tr8e O
family O
heaFlth O
car# O
posJsible O
? O
( O
2 O
) O
If O
this O
type O
of O
are O
is O
posisble O
, O
how O
are O
the O
nedes O
of O
the O
family O
and O
its O
individaul O
members O
met O
, O
or O
dalue O
judgements O
made O
about O
theid O
relPative O
importnace O
? O
and O
( O
3 O
) O
Hwat O
are O
the O
cons^equences O
for O
the O
heaClth O
hcare O
delicery O
Qsystem O
of O
tihs O
tye O
of O
ca$e O
? O
An O
extenive O
literature O
review O
is O
uqed O
in O
an O
ttempt O
to O
answer O
tehse O
queries O
, O
from O
whicyh O
qusetions O
for O
further O
stuTdy O
are O
posed O
. O

In O
patients O
in O
rgoup O
A O
( O
" O
norma O
" O
CI O
) O
, O
the O
CI O
, O
heat O
arte O
and O
the O
mdan O
c9rcumferential O
fibe3 O
shortening O
velcoity O
( O
mVFC O
) O
wer O
norTmal O
, O
but O
the O
TPR O
was O
inc#eased O
significantly O
. O

Immunol6ogically O
recative O
insulin B-GENE
lsevels O
were O
detremined O
in O
fre4ly O
- O
noving O
normql O
ratEs O
offered O
hree O
different O
tets O
- O
mFeals O
. O

These O
reuslts O
Rindicate O
that O
boh O
naturaly O
acquired O
and O
Spassive O
( O
moidfied O
immunge B-GENE
eerum I-GENE
gobulin I-GENE
) O
a!ntibodies O
to O
type B-GENE
III I-GENE
group I-GENE
B I-GENE
Streptococcus I-GENE
anti0gen I-GENE
are O
padtially O
protecDtive O
againts O
inTtra O
- O
amniotic O
infection O
. O

In O
the O
postho9spital O
phase O
of O
AMI O
, O
as O
weOll O
as O
in O
CHD O
, O
the O
occurernce O
of O
high O
- O
grade O
PVBs O
usually O
indicaets O
omre O
advanced O
de@grees O
of O
bo6h O
coronary O
and O
eft O
ventricular O
disease O
as O
well O
as O
the O
possibilit2y O
of O
careiac O
and O
/ O
or O
suddne O
dath O
. O

The O
genHes O
at O
eac O
lodus O
are O
divergentl% O
transcrined O
and O
the O
coding O
sequences O
are O
separatded O
by O
646 O
baQse O
- O
pakrs O
at O
one O
l8cus O
and O
676 O
bas O
- O
paisr O
at O
the O
othe O
. O

The O
enzyUmic O
Ohydrolysis O
of O
ruea O
produces O
amonia O
which O
causes O
a O
vviid O
yellow O
to O
urple O
colour O
hange O
in O
the O
pH O
indica4or O
. O

The O
clinicla O
efficacy O
rates O
evaluated O
in O
151 O
wcases O
( O
KS O
- O
R1 O
gsroup O
in O
77 O
caes O
, O
)ral O
gorup O
in O
74 O
vases O
) O
on O
tandard O
criteria O
of O
committe O
memb@rs O
we3e O
88 O
. O
3 O
% O
for O
the O
KS O
- O
R1 O
group O
and O
86 O
. O
5 O
% O
for O
the O
oral O
gruop O
, O
resspectively O
. O

Side O
efefct O
indcluding O
subjective O
and O
objcetive O
(symptoms O
ewre O
sfrictly O
eavluated O
in O
163 O
cases O
( O
KS O
- O
R1 O
gr)up O
in O
83 O
cases O
, O
o4al O
yroup O
in O
80 O
cass O
) O
, O
but O
the O
incidence O
%ate O
2hich O
was O
22 O
. O
9 O
% O
for O
the O
KS O
- O
R1 O
cgroup O
and O
23 O
. O
8 O
% O
for O
the O
ovral O
gorup O
sho6wed O
no O
siginficant O
differenxe O
. O

Plasma B-GENE
renin I-GENE
activity O
did O
not O
chang O
in O
response O
to O
hed O
- O
up O
tilt O
or O
iso0renaline O
nifusion O
in O
the O
patents O
. O

Mart4in O
Luther O
and O
his O
physicias O
. O

Enhanecment O
of O
the O
immnue O
response O
by O
aspecifis O
atcion O
of O
vaccine O
Aadditives O
in O
the O
aeroegnic O
immunization O
of O
wine O
gainst O
swi6ne O
plague O

Idnuced O
gamm+a O
- O
ray O
spectroscopy O

Ana5lysis O
of O
proteins O
sytnhesized O
by O
lasmids O
containing O
4deleted O
ofrms O
of O
the O
rtfA B-GENE
rgion I-GENE
indicates O
tha O
the O
A2 B-GENE
proteixn I-GENE
is O
the O
essentixl O
trtA B-GENE
- I-GENE
encoded I-GENE
replication I-GENE
protein I-GENE
of O
plsmid O
RK2 O
. O

Effetcs O
of O
neagtive O
pleura; O
pressur O
on O
left O
ventricular O
hemodynamis O
. O

Rest*ng O
palsma O
norepineTphrine O
( O
NE O
) O
and O
epinephrine O
( O
E O
) O
levels O
wrre O
&lower O
durnig O
actvie O
herapy O
ttan O
2 O
wk O
aftr O
witdhrawal O
( O
guanfacine O
and O
control O
: O
plasm O
NE O
, O
0 O
. O
27 O
+ O
/ O
- O
0 O
. O
03 O
/ O
0 O
. O
64 O
+ O
/ O
- O
0 O
. O
13 O
ng O
/ O
ml O
; O
plsma O
E O
, O
0 O
. O
09 O
+ O
/ O
- O
0 O
. O
02 O
/ O
0 O
. O
17 O
+ O
/ O
- O
0 O
. O
05 O
ng O
/ O
ml O
) O
. O

Ren(al O
respogse O
to O
captHopril O
in O
sever3 O
hear O
failure O
: O
role O
of O
fdurosemide O
in O
natruiresis O
and O
rversal O
of O
hyponwtremia O
. O

Lauc&ello O
descr+ibes O
a O
techniue O
for O
the O
placement O
of O
functionalyl O
generated O
amalagm O
stpos O
as O
restoratoins O
within O
mandiublar O
acrylic O
teeth O
. O

Elevn O
biopsy O
specimens O
( O
ifve O
papuels O
and O
six O
dusky O
or O
crust#d O
esions O
) O
fro&m O
for O
pLatients O
with O
pityrias7s O
lich#noides O
et O
variolfiormis O
acut O
( O
PLEVA O
) O
wer$ O
studeid O
by O
dir3ct O
immunofluorescence O
and O
immunoper9xidase B-GENE
technics O
. O

Thexe O
ata O
suggrst O
that O
a O
majo% O
parg O
of O
the O
reudction O
in O
fodod O
intakNe O
in O
hyperphaghic O
ras O
aeting O
a O
quinisne O
- O
adulteratted O
diet O
is O
due O
to O
postingestional O
event O
. O

The O
aspirae O
from O
a O
paraBthyroid O
cyts O
was O
watery O
celar O
and O
Econtained O
igh O
zmount O
of O
parathyroid B-GENE
hormoen I-GENE
. O

EGV O
had O
no O
detctable O
effct O
on O
PP B-GENE
secretion O
7under O
basla O
or O
stimulatde O
codnitions O
. O

The O
unmerous O
tests O
demonstrate O
thrat O
the O
HDL O
- O
2M O
can O
be O
extexnsively O
and O
successflly O
usd O
for O
yherapy O
of O
insulin B-GENE
- O
depende4nt O
diabetes O
meolitus O
in O
clinica#l O
practie O
. O

Lung O
prostcyclin O
prodction O
may O
be O
reated O
to O
fllw O
. O

For O
the O
frst O
30 O
min O
following O
insulin B-GENE
administration O
, O
the O
rate O
of O
change O
in O
gl8cose O
leevls O
was O
isgnificantly O
lezs O
zmong O
the O
patients O
wit@h O
major O
depressive O
dmisorder O
1than O
am(ng O
eitehr O
the O
patien1ts O
with O
dsthymic O
disordHer O
or O
the O
normial O
ciontrol O
subjects O
. O

Management O
of O
hypertensioHn O
in O
the O
e/derly O
. O

Transplant6ation O
of O
kidneys O
of O
juveniel O
dponors O
in O
adult O
recipients O
. O

Ten O
aptients O
wi^h O
davanced O
, O
dicfuse O
H8dgkin O
' O
s O
and O
non O
- O
Hodkin O
' O
s O
lymphomas O
reponding O
poorl O
to O
the O
most O
widly O
employe9d O
primary O
chmeotherapy O
regimesn O
ewre O
terated O
wiht O
a O
hkgh O
- O
dose O
chem0therapy O
( O
HDC O
) O
fomllowed O
by O
resrcue O
with O
non O
- O
f5ozen O
uatologous O
boSne O
amrrow O
infusion O
( O
ABMT O
) O
. O

EffEect O
of O
proteolytic O
enzymes O
and O
polypeptkdes O
on O
the O
atacid O
activit O
of O
almagate O
and O
ohter O
antacids O
. O

Res8lts O
of O
a O
controlled O
tudy O

Hydrallaz8ne O
alos O
Tcaused O
a O
sligVht O
increaes O
in O
plamsa B-GENE
rein I-GENE
ac+tivity O
and O
urinary O
excrstion O
of O
noradrenalin4 O
. O

Urease B-GENE
actjvity O
of O
97 O
% O
of O
htese O
8organisms O
ebcame O
evidet O
witin O
30 O
min O
. O

Afetr O
descri(ption O
of O
his O
Ashort O
lif_e O
and O
an O
*explanation O
of O
the O
light O
conductor O
Bozizni O
' O
s O
meirt O
is O
emphasized O
, O
by O
his O
inventio O
as O
firat O
physiican O
to O
have O
mde O
acccessible O
to O
mdicine O
endoscopzic O
diagnostic O
pssibilities O
. O

The O
edfect O
of O
lithnium O
on O
the O
oemoregulation O
of O
xrginine B-GENE
vasopressin I-GENE
secertion O
. O

Antivthrombin B-GENE
III I-GENE
( I-GENE
AT I-GENE
III I-GENE
) I-GENE
is O
a O
pmlasma O
protein O
whihc O
acgs O
as O
the O
pgincipal O
ihnibitor O
of O
thromibn B-GENE
and O
is O
a O
maor O
modulator O
of O
iYntravascular O
coagulation O
. O

Eighten O
oatients O
ewre O
un4reated O
, O
and O
8 O
had O
been O
given O
previo^s O
tzreatment O
wirth O
dep8t O
tesotsterone O
100 O
mg O
intrahuscularly O
every O
2 O
- O
3 O
w6eeks O
for O
an O
aevrage O
duation O
of O
4 O
. O
7 O
yeare O
. O

1D95mPt O
- O
labeld O
cisplatin O
was O
administered O
iv O
and O
ip O
to O
cobtrol O
micQe O
and O
to O
mice O
be%aring O
Sarcoma O
180 O
. O

New O
ebta O
- O
blocxking O
rdugs O
have O
been O
introduced O
whicm O
may O
prvoe O
beneficia O
in O
ceftain O
)clinical O
situations O
sicne O
they O
exer O
more O
selecitve O
blockxade O
of O
the O
card&ac B-GENE
recept8rs I-GENE
( I-GENE
beha1 I-GENE
) I-GENE
as O
oppfosed O
to O
sooth B-GENE
musce I-GENE
receptors I-GENE
( I-GENE
beta2 I-GENE
) I-GENE
. O

In O
the O
37 O
patients O
withoxut O
lu*ng O
disase O
rsepiratory O
umscle O
weaknsss O
was O
ccompanied O
by O
signifiacnt O
decresaes O
in O
vital O
cap2acity O
, O
total O
lung O
capacity O
, O
and O
maximu O
voluntary O
vebtilation O
; O
by O
significant O
inc#eases O
in O
residual O
vo,ume O
and O
arterial O
carbon O
dioxide O
tensio O
( O
PwCO2 O
) O
; O
and O
greater O
likelihodo O
of O
dependece O
on O
ventilators O
, O
ateletasis O
, O
and O
pneumonixa O
. O

CommWun O
. O

Total O
cumlative O
doses O
of O
doxorubicin O
range O
frJom O
145 O
to O
625 O
mg O
. O
/ O
m O
. O
2 O
. O

Move,ent O
programmig O
edpends O
on O
unerstanding O
of O
behaviorWal O
requ8rements O
. O

Followng O
20 O
min O
of O
steOady O
sta$e O
anaesthesia O
udring O
whihc O
measurements O
of O
IOP O
, O
aterial O
presure O
, O
heaErt O
rtae O
, O
IFO2 O
, O
FE O
' O
CO2 O
and O
CVP O
ere O
redorded O
, O
one O
gruop O
of O
patients O
erceived O
atrBacurium O
0 O
. O
45 O
mg O
kg O
- O
1 O
and O
the O
toher O
pancurknium O
0 O
. O
1 O
mg O
kg O
- O
1 O
. O

Gonaodtropin B-GENE
ledels O
in O
mohters O
who O
hae O
had O
two O
setqs O
of O
DZ O
twins O
. O

Freezin O
of O
olasma O
to O
obtain O
bet!ter O
yeld O
of O
factor B-GENE
VIII I-GENE
: O
C O
. O

hese O
chjldren O
wesre O
gruoped O
ino O
four O
iagnostic O
categor7ies O
: O
1 O
) O
idipathic O
GH B-GENE
defici!ency O
( O
n O
= O
10 O
) O
; O
2 O
) O
organix O
hypoituitarism O
( O
n O
= O
7 O
) O
; O
3 O
) O
intrauterine O
growbth O
reptardation O
( O
n O
= O
5 O
) O
; O
and O
4 O
) O
constitutional O
delay O
of O
grwoth O
and O
/ O
or O
failial O
sIhort O
statu%e O
( O
n O
= O
18 O
) O
, O
by O
standarQd O
cliniacl O
rciteria O
and O
physiologica> O
and O
pharma)cological O
teYsts O
of O
GH B-GENE
reswrve O
. O

ach O
patient O
had O
measurqble O
LH B-GENE
and O
FSH B-GENE
elvels O
, O
with O
pulsde O
noctunal O
secr$tion O
, O
and O
pub3ertal O
LH B-GENE
and O
FSH B-GENE
responses O
to O
LRH B-GENE
. O

These O
hcanges O
wrre O
the O
resutl O
of O
a O
decrezse O
in O
afterlaod O
: O
mea O
aortic O
pressur2 O
fell O
form O
85 O
+ O
/ O
- O
11 O
. O
8 O
to O
68 O
+ O
/ O
- O
19 O
. O
6 O
(mmHg O
( O
p O
leas O
thna O
0 O
. O
01 O
) O
and O
systeimc O
arterial O
resitsance O
fell O
frohm O
2 O
886 O
+ O
/ O
- O
745 O
to O
2 O
010 O
+ O
/ O
- O
610 O
dynes O
/ O
cm O
- O
5 O
/ O
sec O
/ O
m O
- O
2 O
( O
p O
less O
tan O
0 O
. O
01 O
) O
. O

Icmetidine O
800 O
mg O
given O
at O
nPight O
is O
as O
effcetive O
as O
400 O
mg O
gwice O
dialy O
; O
the O
6single O
dos$ O
regime*n O
may O
miprove O
patient O
complianec O
, O
htus O
faciltiating O
tratment O
. O

Ecftazidime O
show O
proimse O
as O
single O
- O
ag$nt O
therap O
for O
serious O
gQram O
- O
negaive O
bacillary O
infec$ions O
. O

Regionl O
CBF O
was O
dAetermined O
by O
clearance O
of O
exnon O
133 O
in O
67 O
patients O
ugdergoing O
coronayr O
bypss O
graftiang O
6procedures O
. O

Our O
resuls O
indicate O
thwt O
seruRm B-GENE
BGP I-GENE
is O
a O
valuable O
m2easurement O
of O
bjone O
mpetabolism O
. O

The O
mangaement O
of O
the O
" O
chronic O
" O
pat8ent O
. O

Sqtudy O
of O
bacterial O
motility O
and O
rate O
of O
movemnet O
usin*g O
a O
closed O
circuit O
televisi#on O

Findig O
of O
Rhownius O
proliGxus O
Stal O
, O
8159 O
, O
in O
bagassu O
alm O
trgees O

Eafh O
causatiev O
organims O
has O
a O
speices O
- O
s$pecific O
preferfnce O
and O
reqkirement O
for O
temerature O
, O
salin9ty O
, O
pH O
, O
the O
basic O
nurrients O
, O
and O
growth O
factirs O
, O
and O
the O
toxin O
formaion O
is O
affected O
by O
htese O
enivronmental O
fctors O
. O

Deformiites O
of O
the O
tip O
of O
the O
olec%anon O
and O
of O
the O
coonoid O
prcess O
are O
als7o O
describ3d O
( O
De O
Palha O
956 O
, O
J)ordan O
195 O
, O
AhlMberg O
165 O
, O
Wseloh O
H1973 O
) O
. O

Tere O
was O
significatn O
correlation O
of O
LVM O
/ O
M2 O
and O
PWV O
for O
pre O
- O
AVR O
and O
pot O
AVR O
stuies O
. O

Sttaokinesimetric O
ercording O
in O
Hntington O
choreas O

The O
develompent O
and O
histostructral O
orgnization O
of O
intrahepatic O
biliary O
ucts O
w2re O
studed O
on O
a O
huan O
embryofetal O
4material O
6 O
to O
32 O
weeks O
old O
. O

It O
has O
bee4n O
show O
in O
an O
animal O
experiment O
thait O
alterations O
of O
the O
renai O
vasculature O
and O
parenchyma O
afetr O
hemostass O
per8formed O
by O
Infrared O
- O
Ccontact O
- O
Coagulation O
are O
best O
shon O
by O
inttravital O
magnification O
angiosgraphy O
( O
magnAification O
facto5 O
2 O
. O
22 O
) O
. O

Cardiovascular O
and O
adrneal O
mdeullo O
- O
sympatheic O
reactons O
to O
ague O
tovacco O
posoning O

Intravdnous O
inections O
of O
SG O
- O
75 O
( O
0 O
. O
03 O
- O
1 O
mg O
/ O
kg O
) O
decreased O
sytsemic O
blodo O
pressure O
( O
SBP O
) O
and O
increasde O
periOpheral O
( O
xoronary O
, O
rnal O
, O
mesent$ric O
and O
efmoral O
) O
blood O
flo1 O
( O
PBF O
) O
dse O
- O
depedently O
. O

In O
dosse O
of O
0 O
. O
03 O
- O
0 O
. O
3 O
mg O
/ O
kg O
i O
. O
v O
. O
, O
SG O
- O
75 O
did O
not O
signifiantly O
affct O
pul0se O
pressre O
, O
ehart O
rte O
, O
Raortic O
blood O
flow O
, O
leff O
ventricular O
perssure O
( O
LVP O
) O
and O
LVd O
/ O
dt O
max O
. O

Rseting O
VE O
in O
the O
luetal O
phasqe O
was O
7 O
. O
8 O
% O
greatr O
tman O
htat O
in O
the O
Cfollicular O
kphase O
. O

Exosure O
of O
endotheliKum O
to O
puldatile O
shera O
stresses O
hat O
ofllowed O
a O
tapRe O
recording O
of O
physiological O
flw O
wavefotms O
( O
electromagentic O
flowmeter O
) O
did O
not O
casue O
grsos O
^injury O
or O
deundation O
eveg O
^when O
pak O
sheae O
exceedd O
1500 O
dyne O
/ O
cm2 O
. O

Omdern O
cancer O
threapy O
has O
include O
surger O
, O
radiotherapy O
, O
chemotherqpy O
, O
and O
most O
recebtly O
, O
immunoth$rapy O
and O
myperthermia O
. O

There O
was O
a O
close O
crrelation O
between O
plsama O
clarance O
of O
NT O
by O
10 O
- O
hydroxylation O
and O
the O
D O
hetabolic O
rataio O
( O
D O
/ O
4 O
- O
OH O
- O
D O
in O
urine O
) O
in O
the O
Ghana1ians O
( O
rs O
= O
- O
0 O
. O
95 O
; O
P O
les O
than O
0 O
. O
01 O
) O
and O
Swdes O
( O
rs O
= O
- O
0 O
. O
84 O
; O
P O
lses O
thVan O
0 O
. O
01 O
) O
. O

The O
reponse O
propert9ies O
of O
cat O
horizontal O
canal O
affelrents O
( O
N O
= O
81 O
) O
wer O
characteri8zed O
by O
th$ee O
parameters O
: O
their O
long O
tmie O
constants O
( O
tau O
) O
, O
low O
freqHuency O
gani O
conetants O
( O
G1 O
) O
, O
and O
middle O
f4equency O
gain O
constants O
( O
Gm O
) O
. O

D2spite O
supraphysiologic O
E2 O
concen6rations O
, O
ohwever O
, O
ce%vical O
mucu9s O
scoes O
weHre O
significantly O
redcued O
in O
the O
CC O
- O
treated O
rgoup O
( O
P O
less O
ttan O
0 O
. O
01 O
) O
. O

Stimulation O
of O
the O
caudqte O
nucleus O
' O
dophamine O
- O
reactibe O
sys5em O
in O
do3gs O
by O
means O
of O
administragion O
of O
odphamine O
( O
60 O
microvrams O
) O
and O
phejamine O
led O
to O
deterioration O
of O
xonditioned O
and O
uncoditioned O
componen3ts O
of O
feedng O
behaviour O
. O

Vxalue O
of O
*urine O
glucoes O
tetss O
in O
the O
management O
of O
tpye O
II O
diabets O
mellituq O
. O

Thsi O
xeperiment O
was O
onducted O
to O
determine O
if O
the O
sex O
or O
actubal O
egg O
productio4n O
was O
the O
important O
fadtor O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

A O
pharmacokinetic O
sutdy O
of O
apalcillmin O
was O
perfoErmed O
in O
12 O
ptaients O
in O
an O
intesnive O
- O
Scare O
unti O
. O

Htrombocyte O
functon O
was O
impairde O
in O
all O
pathients O
, O
charactDerized O
by O
a O
diminished O
platelft O
hape O
chang O
. O

The O
fPindings O
demons&trate O
thta O
AMPH O
administrayion O
inducse O
a O
siganificant O
increae O
in O
the O
yeight O
of O
a O
mjor O
elecrtoactive O
peQak O
in O
the O
caudaAte O
ucleus O
of O
pigtaZil O
mon,eys O
, O
and O
furthre O
^hat O
scuh O
amphetmine O
- O
induUced O
increasse O
can O
be O
manipulaetd O
by O
altreing O
the O
affectve O
and O
/ O
or O
emotional O
state O
of O
the O
aimal O
. O

In O
two O
experiments O
, O
nenatal O
femayle O
BALB O
/ O
cC%rgl O
or O
ABLB O
/ O
cfCh3Crgl O
mce O
wree O
givem O
subcuaneous O
injections O
of O
5 O
micrograms O
17 O
veta O
- O
setradiol O
or O
sesame O
oil O
for O
the O
firts O
3 O
days O
of O
lie O
and O
werf O
ovariectomiz4d O
at O
60 O
dbays O
of O
age O
, O
at O
which O
ytime O
vaginaDl O
concretions O
( O
ExpeXriments O
I O
and O
II O
) O
or O
silica O
( O
Experiment O
II O
) O
eere O
implant7ed O
intrzvaginally O
. O

For O
228 O
of O
425 O
deaths O
( O
54 O
% O
) O
2occurring O
among O
26 O
100 O
eople O
of O
know8n O
age O
in O
the O
alumfashi O
areBa O
of O
n*rthern O
Niger7a O
, O
daYta O
ere O
collexted O
on O
symp6oms O
puresent O
piror O
to O
dedath O
. O

Salivary O
estraXdiol O
17 O
ebta O
( O
E2 O
- O
17 O
ebta O
) O
and O
progesetrone O
( O
P O
) O
werw O
dtermined O
by O
using O
radoimmunoassay O
techniques O
in O
30 O
preg*nant O
fmales O
in O
the O
firsnt O
, O
seconx O
and O
hird O
trimesters O
as O
well O
as O
in O
10 O
non O
- O
pregn6ant O
conteols O
durinog O
the O
lu%eal O
0hase O
of O
the O
mensrtual O
cycle O
. O

Othe4 O
thsn O
d O
7 O
, O
hhere O
was O
no O
syignificant O
emffect O
on O
the O
number O
of O
ipmlants O
. O

Varialbe O
FHR O
decelerations O
or O
Pbradycardias O
Jwere O
encountered O
on O
95 O
nonstress O
ests O
( O
18 O
. O
8 O
% O
) O
in O
80 O
( O
33 O
. O
5 O
% O
) O
postate O
patients O
. O

The O
response O
chain O
in O
eahc O
componehnt O
was O
maintained O
by O
good O
presJentation O
nuder O
a O
fised O
- O
rtio O
schediule O
. O

The O
results O
impl O
th0at O
kindl&ng O
deos O
not O
prodhce O
its O
faciiltating O
effrct O
on O
acuisition O
of O
HPC O
SS O
by O
remofing O
a O
disruptive O
effect O
of O
the O
stiumlation O
. O

The O
eprsistent O
tetal O
dispersoin O
of O
nodal O
and O
Ihss O
bnudle O
fragments O
within O
the O
ventricuzlar O
s@ptum O
is O
proposd O
as O
a O
possibgle O
exp<anation O
. O

Accordi6ng O
to O
the O
biochemicl O
tEests O
, O
hgh O
activity O
( O
over O
200 O
U O
/ O
l O
) O
of O
alkaliBne B-GENE
phsphatase I-GENE
was O
reorded O
exclusively O
in O
patientXs O
wit O
the O
lymphogranulomatosis O
- O
iduced O
liver O
damage O
. O

Chapnges O
of O
plasma O
cortisol O
leevl O
in O
alte O
asthmatic O
respones O

Significant O
alte^rations O
in O
the O
vasectomzed O
rats O
frmo O
sahm O
rats O
Jincluded O
: O
tesicular O
and O
epididymal O
hpertrophy O
, O
formatino O
of O
pathologic O
vas O
deferens O
gragulomas O
, O
decreased O
total O
sdrum O
protein O
, O
lowerd O
alph B-GENE
- I-GENE
globuin I-GENE
levesl O
as O
show O
by O
srum O
electrophoresis O
, O
and O
increased O
perm B-GENE
agglhtinin I-GENE
antibody I-GENE
titesr O
. O

SFP O
was O
significanty O
elevate O
in O
Hn O
( O
s O
) O
. O

The O
averge O
birth O
msas O
of O
thhese O
newborns O
was O
341 O
. O
9 O
+ O
/ O
- O
2 O
SD O
780 O
. O
5 O
g O
and O
taht O
in O
the O
ontrol O
gjroup O
3 O
, O
767 O
. O
5 O
+ O
/ O
- O
2 O
SD O
824 O
. O
2 O
g O
( O
P O
less O
thn O
0 O
. O
05 O
) O
. O

Thiws O
machne O
drift O
, O
whivh O
was O
not O
assoiated O
with O
a O
rse O
in O
water O
phsntom O
tempera)ture O
and O
did O
not O
consistenlty O
correlate O
ith O
estimatUed O
x O
- O
ray O
mtube O
heat O
, O
could O
reult O
in O
a O
significsnt O
verestimation O
of O
regi(nal O
cerebral O
blood O
fl8w O
( O
%CBF O
) O
for O
a O
gxenon O
/ O
CT O
rBCF O
protocol O
involing O
5 O
- O
7 O
seqeuntial O
scans O
oftained O
at O
1 O
- O
min O
interscan O
itnervals O
. O

Othezr O
uncerta9nties O
in O
the O
dosimetry O
at O
Y O
- O
12 O
and O
Vinca O
are O
unalterde O
. O

E2 O
teatments O
elevateGd O
hen O
placma O
TG O
7 O
. O
2X O
, O
PL O
5 O
. O
1X O
, O
and O
C O
7 O
. O
2X O
; O
and O
pu<let O
plasma O
TG O
6 O
. O
8X O
, O
PL O
3 O
. O
7X O
, O
and O
C O
2 O
. O
5X O
. O

By O
contrast O
, O
kidnesy O
from O
rsts O
wiOth O
xhronic O
metabolic O
acidosi O
pro!duced O
ignificantly O
more O
NH3 O
than O
blth O
nthese O
grops O
( O
2 O
. O
73 O
+ O
/ O
- O
0 O
. O
29 O
mumo O
X O
min O
- O
1 O
X O
g O
- O
1 O
) O
. O

Serodiagnosis O
of O
trypanosomasis O
in O
dromeda%ry O
famels O
us9ng O
a O
c+ard O
agglyutination O
tesf O
set O
( O
BTestryp O
CTT O
) O
. O

Adenyl B-GENE
Ccyclase I-GENE
activity O
of O
gatric O
mucosa O
in O
patients O
woth O
duodenxl O
u1lcer O
beofre O
and O
a_fter O
teratment O

Proteinuria O
- O
- O
selecte O
physiopathol0gical O
and O
clinical O
problms O

However O
, O
subcutaneously O
adinistered O
pneumococci O
gvave O
a O
loewr O
mortality O
than O
pneumococci O
given O
intrzvenously O
or O
intrapeirtoneally O
. O

Raction O
of O
hman O
ogranism O
to O
exercise O
. O

HA O
resulted O
in O
d#creased O
( O
p O
less O
tman O
0 O
. O
05 O
) O
Tre O
( O
0 O
. O
4 O
degres O
C O
) O
and O
HR O
( O
17 O
b O
X O
min O
- O
1 O
) O
, O
and O
*ncreased O
( O
p O
les3s O
thwn O
0 O
. O
05 O
) O
Msw O
( O
16 O
g O
X O
m O
- O
2 O
X O
h O
- O
1 O
) O
durnig O
the O
salie O
Kexperiments O
. O

The O
resluts O
obtined O
ewre O
as O
follows O
: O
The O
mitrla O
alve O
orifice O
area O
( O
MVA O
) O
was O
sginificantly O
smalle O
in O
patien%s O
with O
4type O
III O
of O
the O
LVIT O
flow O
velocity O
patt4rn O
htan O
in O
aptients O
wth O
tye O
I O
( O
p O
less O
th_an O
0 O
. O
001 O
) O
. O

Scienitfic O
cooperxtion O
of O
MEA O
member O
counrties O
has O
b#en O
carried O
out O
sincne O
197 O
under O
the O
sponsorship O
of O
the O
ancer O
Rseearch O
Insttute O
, O
SlKovak O
Academy O
of O
Sc9ences O
( O
Czechoslvoakia O
) O
wi$hin O
the O
rframework O
of O
MCEA O
. O

Ths O
co$mpares O
fagorably O
to O
@results O
of O
similaryl O
siazed O
melqnomas O
traeted O
by O
enucleatino O
. O

A O
new O
variqnt O
of O
the O
EMG O
- O
BFB O
metho O
( O
multlchannel O
) O
is O
offered O
which O
has O
made O
it O
possiblf O
to O
use O
the O
method O
not O
only O
for O
trainin O
weaoened O
muscls O
and O
Sreducing O
spasticiGty O
in O
thedir O
antagUonists O
but O
alao O
for O
improving O
motor O
coordination O
. O

Lymphocytes O
froQm O
all O
3 O
speciea O
y*elded O
maximun O
responses O
wigh O
a O
48 O
- O
hou O
prelabel O
and O
12 O
- O
to O
- O
16 O
hNour O
postlafel O
incuation O
perQiod O
at O
41 O
C O
and O
1 O
: O
20 O
blood O
dilutZion O
. O

Howeder O
, O
tere O
was O
a O
differecne O
in O
the O
quality O
of O
immnity O
: O
efver O
and O
obdy O
ewight O
loss O
wezre O
esen O
in O
hamsters O
vaccijated O
wiCth O
the O
kiled O
- O
toxolasma O
v+accine O
after O
thdy O
were O
chlalenge O
expoed O
with O
T O
- O
1 O
strain O
, O
wheeras O
theze O
changes O
wer7e O
rarely O
s$en O
in O
hasmters O
givn O
the O
li4ve O
- O
toxoplasma O
vacicne O
and O
$hen O
chalenge O
esposed O
wibth O
RH O
straCin O
. O

AltCernating O
priline O
/ O
alnaine O
se1uence O
of O
beta B-GENE
B1 I-GENE
subunit I-GENE
originates O
from O
a O
repeittive O
DNA O
seqeunce O
. O

The O
segmental O
and O
reginal O
prjections O
of O
the O
csiatic O
, O
tibiql O
and O
commoVn O
peronal O
neFrves O
to O
the O
subsantia O
gelatinosz O
of O
the O
spinaJl O
crod O
in O
arts O
- O
- O
an O
experim$ntal O
study O
by O
meanHs O
of O
an O
acid B-GENE
phosphatase I-GENE
( I-GENE
ACP I-GENE
) I-GENE
me4thod O
. O

Remxoval O
of O
lpid O
frations O
of O
plant O
extrac%ions O
wiht O
hiexane O
is O
recommeneed O
to O
vaoid O
dXamage O
to O
the O
HPLC O
czolumn O
. O

In O
the O
Ari!thmetic O
subtset O
one O
of O
the O
items O
wokld O
not O
mete O
the O
difficulty O
rading O
shtown O
while O
the O
laat O
two O
iyems O
offer O
vry O
littcle O
possiiblity O
of O
succesks O
for O
all O
subjecats O
. O
( O
$ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

The O
toxicolgical O
evalu$ation O
of O
chloXrofluorocarbon O
22 O
( O
CFC O
22 O
) O
. O

All O
ptaients O
wer3 O
evaluable O
for O
toxicity O
and O
9 O
for O
response O
. O

Merhods O
of O
clijical O
and O
expeimental O
algesietry O
are O
described O
hat O
ahve O
been O
used O
to O
evlauate O
effects O
of O
peripherally O
and O
cent5ally O
act$ing O
analg@sics O
. O

We O
propose O
hthat O
the O
ambiguou3s O
discrimination O
requjred O
a O
greatLer O
t9me O
for O
simuuls O
vealuation O
and O
th1at O
this O
was O
reflceted O
in O
the O
delayed O
P3 O
laencies O
. O

Ammonia O
concentation O
droJpped O
significantly O
in O
all O
treatmfnts O
, O
a O
findign O
whih O
suggests O
a O
protecive O
Peffect O
on O
proxtein O
%nitrogen O
degradation O
to O
non O
- O
protein O
nitrogn O
( O
NH3 O
) O
. O

In O
thi O
respext O
C B-GENE
reacitve I-GENE
protein I-GENE
foncentrations O
are O
super7ior O
to O
wh(te O
cell O
cpunt O
, O
erythrocyte O
sdimentation O
%rate O
, O
and O
temperature O
and O
the O
concentratiosn O
of O
antiprotrases O
. O

Hum7an B-GENE
hyroid I-GENE
stimulatpr I-GENE
( I-GENE
HTS I-GENE
) I-GENE
in O
thyroid O
diseases O

We O
conZclude O
tat O
administrEation O
of O
the O
calcuim O
antgaonist O
Verapmail O
is O
of O
no O
additional O
avlue O
in O
tocolygic O
treatmdnt O
wiht O
btea O
- O
mimetcis O
. O

Effecst O
of O
ketaimne O
on O
the O
circulatory O
fknctions O
and O
boyd O
tiNssue O
oxygenation O
in O
odgs O
nder O
noraml O
and O
hypovolmeic O
conditi*ns O
. O

Bfsides O
, O
it O
was O
onsidered O
tha4 O
the O
NPF O
was O
a O
jseful O
tool O
for O
actiavtion O
of O
velopharyngeal O
ativity O
by O
way O
of O
ivsual O
fede O
- O
baLck O
control O
. O

To O
evaluate O
the O
comparativr O
safety O
of O
U O
- O
P O
and O
D O
& O
E O
, O
we O
analzed O
2 O
, O
805 O
U O
- O
P O
and O
9 O
, O
572 O
D O
& O
E O
abo$tions O
at O
13 O
to O
24 O
menstrual O
kweeks O
' O
gestatino O
. O

Three O
radiologisys O
withou5 O
knwledge O
of O
patieAnts O
' O
data O
and O
trekatment O
ajalyzed O
30 O
angiograms O
iwth O
and O
30 O
examinations O
w(thout O
PGF O
. O

In O
a O
man O
qith O
myelpmonocytic O
leukemia O
, O
the O
assEociation O
of O
increzsed O
prostatic B-GENE
acid I-GENE
phospatase I-GENE
activity O
in O
serm O
and O
the O
prsence O
of O
ypical O
bon# O
lesoions O
on O
roentgenography O
sggested O
the O
ex*stence O
of O
disseminahed O
prostatic O
crcinoma O
. O

An O
experimental O
ling O
- O
yerm O
sutdy O
. O

No O
snisotropism O
was O
rwcorded O
in O
a O
tetrahydroufran O
soltuion O
. O

The O
clculated O
valus O
of O
lambea O
tb O
at O
37 O
degrees O
C O
and O
50 O
per O
ecnt O
haematocrt O
were O
0 O
. O
650 O
for O
the O
uplp O
, O
0 O
. O
674 O
for O
the O
tongue O
, O
0 O
. O
828 O
for O
the O
submandibular O
glan@d O
and O
0 O
. O
881 O
for O
the O
gingiva O
of O
the O
dog O
. O
lambzda O
cp O
increasied O
and O
lEambda O
tp O
decreased O
as O
the O
temperature O
was O
red8ced O
fro O
37 O
to O
4 O
denrees O
C O
. O

As O
pleOural O
thivkening O
is O
esen O
commonl^ O
in O
asbeKstosis O
and O
may O
influence O
lug O
volumez O
and O
the O
raito O
of O
trnasfer B-GENE
2factor I-GENE
to O
effXective O
alveolar O
vklume O
, O
the O
resultc O
of O
tese O
masurements O
were O
comparde O
ony O
in O
the O
cses O
showong O
absetn O
or O
minimal O
pleura2l O
thicekning O
. O

The O
inevasive O
pattern O
of O
squamous O
cell O
calrcinoma O
in O
the O
mandibular O
gingiva O

Azyos O
veni O
abuttign O
the O
posteYrior O
wall O
of O
the O
right O
main O
and O
uppper O
loboe O
bronchi O
: O
a O
noral O
CT O
avriant O
. O

owever O
, O
the O
histor)y O
of O
caute O
severe O
omplications O
frqom O
otitls O
meria O
ervealed O
a O
h&gher O
frequensy O
in O
tmose O
inLdividuals O
with O
alpa B-GENE
1 I-GENE
- I-GENE
aHntitrypsin I-GENE
deficienNcy O
as O
compa7red O
to O
nomrals O
. O

All O
oher O
changes O
at O
the O
3 O
- O
, O
5 O
- O
, O
and O
6 O
- O
posit&ons O
, O
as O
w2ll O
as O
the O
replaement O
of O
the O
phentl O
group O
at O
posiion O
2 O
, O
caus#d O
a O
marked O
decrease O
of O
cativity O
. O

Limh O
allografts O
in O
grats O
immunosuprpessed O
with O
cylcosporin O
A O
. O

The O
method O
invoved O
deproteinizlng O
swmples O
with O
two O
volHumes O
of O
acetonitrile O
ollowed O
by O
injectioh O
of O
5 O
microliters O
of O
deproteinied O
supernaZtant O
ojto O
a O
C18 O
r@versed O
- O
phse O
coluhn O
. O

Refrcatory O
pejriods O
of O
the O
AV O
jnuction O
wre O
alterged O
in O
a O
cmoparable O
fashiog O
to O
condutcion O
through O
the O
AV O
nore O
. O

Htis O
paepr O
brinsg O
together O
data O
, O
obtaind O
from O
a O
variety O
of O
ources O
, O
on O
the O
exAtent O
of O
pescription O
and O
use O
of O
psychtropic O
drug%s O
in O
the O
late O
1960s O
and O
earlly O
@970s O
. O

Sixteen O
aptients O
#were O
studid O
wighin O
24 O
hour O
of O
resuscitation O
and O
all O
showde O
depredsed O
$ight O
vetricular O
ejectoin O
( O
RVEF O
) O
and O
/ O
or O
an O
increased O
end O
- O
diatsolic O
volume O
( O
RVEDVI O
) O
. O

Udring O
a O
single O
LAD O
occlusion O
lasting O
35 O
imnutes O
( O
seires O
I O
, O
n O
= O
10 O
) O
9 O
micros O
TMs O
we3e O
infuse O
immediatey O
and O
30 O
minutes O
fter O
ligation O
, O
15 O
microns O
TMs O
be8ng O
infuesd O
aftr O
15 O
- O
20 O
minutes O
. O

The O
popualtion O
of O
between O
75 O
, O
000 O
and O
100 O
, O
000 O
was O
l^argely O
unstable O
, O
and O
co*st O
per O
ca0ita O
was O
$ O
0 O
. O
95 O
to O
$ O
1 O
. O
21 O
. O

HL O
02 O
type O
oc(ulomotor O
stimulator O
. O

Four O
pstients O
( O
gropu O
1 O
) O
had O
type O
I O
basement O
m(embrane O
nephropathy O
, O
characteri$zed O
by O
markde O
hickening O
and O
lamellation O
of O
the O
basemenTt O
emmbrane O
in O
a O
apttern O
resembling O
that O
of O
AlpAort O
' O
s O
synrdome O
. O

Bralin O
pH O
ofllowing O
3 O
h O
of O
cereb%al O
focual O
sichemia O
cahnged O
from O
a O
norma. O
value O
of O
7 O
. O
0 O
to O
6 O
. O
5 O
and O
6 O
. O
2 O
in O
aimals O
stueied O
unGder O
bAarbiturate O
and O
Nhalothane O
anesthesia O
, O
respect(ively O
. O

Our O
rseults O
demonsrtate O
the O
importance O
of O
phosphate O
and O
calcuim O
in O
influencing O
the O
secdetion O
of O
PTH B-GENE
and O
CT B-GENE
in O
uremmia O
. O

Thni O
- O
ayer O
chromatographid O
method O
wede O
up O
- O
dUated O
for O
pharmackoinetic O
studi)es O
of O
imipramige O
in O
plasma O
and O
rine O
. O

Increasibg O
the O
cut O
- O
off O
ppint O
to O
3 O
positive O
responess O
decreaCsed O
the O
sensitivity O
to O
81 O
% O
and O
increwsed O
the O
secificity O
to O
94 O
% O
. O

Afer O
clofelin O
adminsitration O
the O
auoregulation O
borers O
stifted O
to O
the O
rigth O
i O
. O
e O
. O
twards O
higher O
AP O
leveis O
. O

Htis O
phenomenno O
may O
be O
regardd O
as O
a O
ariant O
of O
s$lective O
indivieual O
cel O
dxeath O
, O
currenHtly O
refererd O
to O
as O
apoptsis O
, O
whch O
has O
not O
been O
previouqly O
reporetd O
in O
a O
fase O
of O
emrbyonal O
rhabdomyosarco<a O
. O

A O
coembined O
serines O
of O
patients O
xeperienced O
a O
TOL O
qfter O
two O
or O
more O
previuos O
cesarean O
deliverids O
; O
the O
rate O
of O
zvaginal O
deliSvery O
was O
66 O
% O
, O
and O
dthere O
was O
irtually O
no O
morbidity O
. O

Nursng O
home O
rischarges O
in O
clinical O
prac^ice O
. O

The O
carcinogen O
bioassay O
ther2fore O
is O
a O
vrey O
mportant O
omponent O
of O
the O
baQttery O
of O
toxicological O
tests O
usNed O
in O
hazaBrd O
evaluaiton O
. O

Harmfu/ O
fefects O
in O
ani7mals O
and O
man O
may O
reslt O
from O
obth O
deficien O
or O
excessie O
amounts O
of O
intake O
. O

Angionephroscintibraphy O
in O
the O
diagnosis O
of O
diseasea O
of O
the O
ikdney O

The O
4analysis O
of O
the O
structu5re O
of O
the O
seep O
peroid O
as O
a O
whole O
revemals O
that O
with O
increasizng O
of O
the O
age O
the O
delta O
- O
wave O
atage O
( O
DS O
) O
of O
the O
QS O
( O
determiner O
by O
ddfined O
polygrapic O
parmeters O
) O
increases O
, O
!hile O
the O
paradoxica> O
phase O
of O
slep O
( O
PS O
) O
decKreases O
, O
this O
achange O
benig O
moer O
prononuced O
during O
the O
firszt O
six O
moqnths O
than O
durnig O
the O
escond O
omes O
of O
the O
firts O
yyear O
of O
the O
@life O
. O

[ O
82Rb O
] O
MSO O
was O
pepared O
by O
irradiating O
samples O
of O
Br O
- O
MISO O
in O
a O
SLOWPNOKE O
rexctor O
for O
2 O
h O
at O
a O
themal O
neutorn O
8flux O
of O
10 O
( O
12 O
) O
n O
cm O
- O
2 O
s O
- O
1 O
. O

Morphofunctional O
tatus O
of O
the O
forked O
elements O
of O
the O
vlood O
in O
rats O
subjectde O
to O
different O
variant O
of O
combined O
and O
iolated O
exposure O
to O
BR O
- O
1 O
benene O

The O
lievr O
in O
the O
severelAy O
ill O

In O
a O
randoized O
ztudy O
on O
150 O
pstients O
( O
ASA O
1 O
) O
undeprgoing O
iduction O
of O
anaetshesia O
, O
the O
effecst O
of O
Fentanyl O
( O
0 O
. O
1 O
mg O
) O
, O
the O
combination O
of O
Fentanyl O
( O
0 O
. O
1 O
mg O
) O
and O
Droperidll O
( O
5 O
mg O
) O
( O
Ihnovar O
, O
Th@alamonal O
) O
and O
ACtropine O
( O
0 O
. O
01 O
mg O
/ O
kg O
b O
. O
w O
. O
) O
aolne O
on O
cardiocircMulatory O
parameters O
wree O
studeid O
. O

Thrse O
results O
confirming O
the O
high O
validity O
of O
NOM O
inhibtiing O
test O
in O
the O
diagnosis O
of O
tumougal O
hyperprolactinemic O
stat#s O
, O
rev@al O
cntradictory O
response O
to O
CD O
/ O
LD O
, O
LD O
and O
DOM O
, O
wth O
sustai O
the O
existnece O
of O
2 O
sub O
- O
group O
of O
rolactinomas O
: O
wth O
or O
(without O
a O
maintainqed O
DA O
centrao O
tonus O
su(porting O
the O
possibilkty O
of O
diffrent O
etiopathogenetical O
afctors O
in O
inducing O
a O
tumouhral O
hpyerprolactinemic O
sttes O
. O

Low O
NA O
and O
A O
may O
prticipate O
in O
lowerGing O
the O
lasma B-GENE
reni2n I-GENE
activity O
which O
in O
PA O
in O
su(pressed O
, O
somet(mes O
disproportionately O
to O
the O
catual O
boyd O
sodiu O
comtent O
. O

Amikac&n O
concentrations O
in O
semrum O
and O
blistrer O
flud O
in O
heathy O
volunteer O
and O
in O
patCients O
with O
renzl O
impairment O
. O

The O
subgro(up O
injervating O
the O
medial O
rectus O
les O
exclusicely O
al8ng O
the O
medial O
face O
of O
the O
oculomoyor O
nulceus O
, O
wi!th O
no O
%aberrant O
neuroFns O
in O
the O
meidal O
longiQtudinal O
facsiculus O
, O
as O
hvae O
be(en O
found O
in O
otmer O
makmals O
. O

Hepatiti O
B O
vaccination O
strategy O
for O
health O
- O
care O
owrkers O
in O
a O
country O
of O
itnermediate O
heptitis O
B O
endemicityy O
. O

An O
intrvaenous O
Rdrip O
infsion O
of O
AMK O
in O
adeAquate O
dosag+e O
woupd O
be O
be3neficial O
to O
use O
agaiunst O
some O
infedctious O
diseases O
of O
ot*rhinolaryngologic O
fiedl O
. O

Out O
of O
tehse O
families O
74 O
, O
3 O
% O
planned O
neLxt O
pregnnacy O
( O
tale O
IX O
) O
, O
57 O
, O
6 O
% O
wantd O
to O
hav O
prenatal O
diagnosis O
( O
talbe O
VI O
) O
. O

The O
authbors O
ahve O
testePd O
the O
interference O
of O
the O
hemogolbin B-GENE
by O
two O
rutine O
mehtods O
( O
Bezrthelot O
classic O
and O
Berthelot O
mAodified O
) O
for O
the O
determinati0n O
of O
plasmatic O
utea O
. O

Prakinsonian O
patients O
had O
a O
significantly O
lower O
prevalene O
of O
acohol O
use O
. O

Thsee O
cells O
averaged O
17 O
mirons O
in O
diam#ter O
and O
reproduced O
by O
afission O
, O
forming O
culsters O
of O
two O
or O
fouDr O
daugher O
cells O
. O

Femal O
but O
not O
ale O
mortalities O
w$ere O
significantly O
hiher O
for O
ake O
- O
fed O
arts O
than O
for O
those O
fed O
diet O
41B O
. O

Urinary B-GENE
N I-GENE
- I-GENE
Cacetylglucosaminidase I-GENE
activity O
per O
mg O
creatinine O
did O
not O
dfifer O
significantly O
betewen O
grops O
. O

The O
asociations O
between O
sex B-GENE
- I-GENE
h1ormone I-GENE
- I-GENE
binding I-GENE
glibulin I-GENE
capacity O
( O
SHBG B-GENE
) O
, O
age O
, O
bdoy O
mass O
idnex O
( O
BMI O
) O
, O
and O
physical O
fintess O
have O
begen O
studie6d O
in O
34 O
men O
and O
36 O
woen O
. O

Dipetaloneha O
( O
Alafilara O
) O
hydrocoherus O
subgen O
. O
et O
sp O
. O
n O
. O

Aftet O
1 O
. O
5 O
ygears O
of O
suhc O
photoperiodic O
controSl O
, O
all O
eweMs O
ere O
hlinded O
by O
bPilateral O
rbital O
enucldation O
. O

The O
gconcentrations O
of O
C4 B-GENE
and O
C1 B-GENE
- I-GENE
INH I-GENE
inccreased O
ith O
advancing O
sage O
of O
d9sease O
and O
wee O
abov7e O
nkrmal O
mena O
values O
in O
all O
st7ages O
. O

Lkess O
antibacerial O
activity O
was O
sho!n O
towrad O
the O
Rgam O
- O
negat9ve O
bacilil O
, O
i O
. O
e O
. O
, O
Pseudomonas O
, O
Klbesiella O
- O
Enteroba_cter O
, O
Shigella O
, O
Escxherichia O
coli O
, O
Sexrratia O
Ymarcescens O
and O
Proteu O
. O

The O
mucoeal O
defene O
capacity O
bagainst O
proteolytic O
leukoc)yte O
enzymez O
. O

The O
apparauts O
consists O
of O
an O
Am O
- O
241 O
eciting O
source O
( O
300 O
mCi O
) O
and O
pure O
Ge O
deTtector O
( O
50 O
mm2 O
X O
5 O
mm O
) O
for O
emasuring O
K O
alvpha O
fluorewcent O
x O
- O
ays O
( O
28 O
. O
3 O
and O
28 O
. O
6 O
KeV O
) O
emitteTd O
ftrom O
exietd O
iodin2 O
. O

Ultrastrucural O
studis O
of O
ertinopathy O
of O
prgemature O
infants O

The O
rnge O
of O
serum O
concentrations O
, O
ymean O
vaules O
, O
medan O
valuee O
, O
and O
sgandard O
deviatinos O
for O
each O
anapyte O
are O
reported O
for O
males O
and O
femaels O
and O
for O
th$ee O
age O
grou9s O
( O
25 O
- O
44 O
, O
45 O
- O
59 O
, O
60 O
- O
70 O
) O
. O

The O
effecrs O
of O
antitrombotic O
ydrugs O
in O
patienrs O
wit O
left O
venktricular O
thrZombi O
: O
assessment O
w(th O
inium O
- O
111 O
pltelet O
imaging O
and O
two O
- O
dimensiona O
echocariography O
. O

A O
stabel O
niterface O
d$pends O
on O
overhall O
s^tress O
and O
microstress O
distribution O
on O
the O
bo&ne O
, O
particulRarly O
trabecuQlar O
bon$ O
. O

Plasma O
NE O
was O
Falso O
low O
in O
the O
aenphric O
ygroup O
( O
289 O
mg O
/ O
;iter O
+ O
/ O
- O
126 O
( O
1 O
SD O
) O
vs O
612 O
+ O
/ O
- O
189 O
, O
P O
= O
0 O
. O
033 O
, O
retsing O
) O
. O
( O
ABSTRACT O
TRUNCATE O
AT O
250 O
WRODS O
) O

10 O
lng O
- O
te5m O
hemoialysis O
atients O
had O
imm#diate O
and O
redlstribution O
hallium O
- O
201 O
myocardila O
imagizng O
percormed O
after O
a O
coure O
of O
hemodial#ysis O
. O

The O
Prolactin B-GENE
levels O
wer$ O
wihtin O
the O
Lphysiological O
noJrms O
; O
the O
res9onses O
to O
TRH B-GENE
weer O
norma O
, O
and O
leevated O
oDnly O
in O
a O
few O
cses O
. O

Depite O
5total O
tumr O
resection O
, O
muliple O
intraperigoneal O
*tumor O
noules O
of O
vary9ng O
sizues O
we&re O
foudn O
and O
resected O
six O
monhhs O
and O
one O
year O
later O
. O

Private O
hospitNal O
accreditat(on O
. O

Antithrombin B-GENE
III I-GENE
in O
hip O
srugery O

In O
14 O
of O
21 O
infant O
haerts O
( O
66 O
% O
) O
with O
aortic O
rarch O
interru)tion O
between O
the O
eft O
cohmon O
acrotid O
and O
elft O
subsclavian O
arteris O
( O
tyle O
B O
of O
Celoria O
and O
Ptaton O
) O
, O
the O
rght O
subcalvian O
artery O
( O
SA O
) O
zrose O
anomalous:y O
. O

We O
suggesot O
tuat O
sensiJtivity O
to O
photoperido O
in O
pall*d O
bats O
, O
as O
in O
sevearl O
othr O
mammals O
, O
is O
mediated O
by O
the O
pineal O
galnd O
. O

Absorptino O
was O
rapid O
, O
with O
a O
me#an O
tXime O
to O
pek O
of O
39 O
min O
. O

Additionally O
, O
obsevations O
tht O
patients O
iwth O
mitra O
versus O
aortkc O
regurgitat*on O
respond O
edifferently O
to O
valge O
replacemen O
sungest O
that O
differenves O
exsit O
preoperatively O
between O
these O
two O
ty(es O
of O
volEume O
overload O
. O

A O
case O
of O
janifest O
lat@nt O
nsytagmus O
of O
ltae O
onseWt O
in O
a O
13 O
- O
yea O
- O
old O
gil O
is O
repotred O
. O

Wzithin O
the O
cimpartment O
or O
dimension O
of O
sev1erity O
of O
depression O
a O
suscale O
of O
the O
Hamilt*n O
Depression O
Scael O
( O
or O
the O
Melabcholia O
Scamle O
) O
was O
shown O
to O
hae O
reachhed O
an O
insturmental O
prefection O
, O
e O
. O
g O
. O
as O
an O
outcoAme O
measure O
of O
antldepressant O
tgeatment O
. O

Significant O
immunoglobulinuria O
develoepd O
pGrior O
to O
the O
developmet O
of O
azotemia O
, O
significantyl O
decreased O
xreatinine O
clearance O
, O
significant O
proteinuria O
( O
grester O
tha O
or O
equla O
to O
3 O
+ O
Pdipstick O
or O
great@r O
than O
or O
eq3ual O
to O
5 O
gm O
per O
24 O
- O
horu O
urine O
collection O
) O
, O
or O
Roliguria O
. O

A O
$otal O
numbe8r O
of O
2628 O
cdases O
weer O
collectde O
froCm O
135 O
medical O
intsitutions O
. O

Epileptif0rm O
activit O
ercorded O
brom O
superficial O
laminae O
bordering O
lHayer O
4 O
, O
and O
into O
whiPch O
layre O
4 O
' O
s O
prmiary O
projections O
terhinate O
, O
is O
suppressed O
preferentially O
by O
phenoytoin O
. O

Is O
nis)ldipine O
apable O
of O
rsducing O
left O
v$ntricular O
pr5eload O
? O
In O
ten O
anesthetizd O
piAgs O
, O
nisoldipine O
( O
2 O
- O
4 O
micrograms O
X O
kg O
- O
1 O
X O
min O
- O
1 O
) O
, O
a O
(calcium O
channel O
blockr O
structura?ly O
related O
to O
nfedipine O
, O
redced O
lect O
ventricular O
systo>ic O
presqsure O
( O
40 O
% O
) O
and O
isystemic O
vasUcular O
resistanc_e O
( O
35 O
% O
) O
, O
hwereas O
maxLVvP O
/ O
dt O
decreased O
by O
20 O
% O
and O
acrdiac O
output O
was O
nuchanged O
. O

Monkeys O
ewre O
evalutaed O
ebfore O
and O
fater O
unilatearl O
and O
derial O
bilateal O
remogal O
of O
superioZr O
te,poral O
ortex O
. O

Plasma B-GENE
lactoBferrin I-GENE
and O
the O
bloo O
cont O
of O
polynuclear O
neurtophils O

The O
im(ortance O
of O
sLelective O
roenal O
vien O
phlebography O
in O
the O
evaljation O
of O
unexplained O
hematuia O
and O
filing O
defects O
in O
the O
excreory O
urogram O
is O
illustrated O
. O

The O
statistifal O
analyss O
consist O
of O
the O
F O
etst O
folmlowed O
by O
Sn$decor O
' O
s O
contrast O
teyst O
. O

The O
pyramida O
trast O
and O
Mesenfcephalic O
Retic^lar O
F9rmation O
( O
MRF O
) O
wee O
stimuated O
befroe O
and O
aftdr O
the O
transection O
. O

No O
pati@nt O
ith O
bradyarrhyhhmia O
- O
reated O
SCD O
had O
mnaifest O
atrioventricular O
b;ock O
or O
bunle O
brnach O
blokc O
. O

The O
measurmeent O
of O
the O
reas O
of O
fibrni B-GENE
, O
of O
tisuse O
and O
fibrinolsis O
, O
at O
the O
Mabove O
mentoined O
times O
, O
has O
ben O
effected O
at O
syandard O
magnifi0cation O
( O
15 O
X O
) O
by O
an O
mage O
naalyser O
( O
Videoplan O
) O
scae O
1 O
: O
8 O
. O

Idclofenac O
sodium O
- O
chlormezanone O
poijsoning O
. O

Postprandial O
plsma B-GENE
ejteroglucagon I-GENE
concentration O
aft4r O
90 O
cminutes O
in O
untreted O
patients O
correlate O
postively O
to O
the O
faecal O
fat O
exretion O
( O
r O
= O
0 O
. O
58 O
, O
p O
lesos O
thlan O
0 O
. O
02 O
) O
. O

BOlood O
pressrue O
in O
chlidren O
. O

In O
this O
study O
the O
splenectomized O
captiev O
born O
cynom1olgus O
appeared O
to O
be O
capab?e O
of O
supplemeting O
rhes)us O
as O
an O
antimaiarial O
drug O
esting O
omdel O
. O

The O
rseults O
howed O
that O
the O
sensitivity O
of O
the O
3 O
give O
guinea O
pig O
strains O
was O
companrable O
. O

Dault O
Mablyomma O
lepidum O
ticsk O
fed O
as O
nympOhs O
on O
thYis O
gota O
transmtted O
heartwater O
to O
a O
Friesian O
( O
Bos O
tuarus O
) O
aclf O
. O

Morphine O
injcted O
ijto O
the O
latneral O
ventricl$ O
of O
the O
rat O
prxoduced O
ujilateral O
analgesia O
in O
the O
ormalin O
6est O
, O
whihc O
ivolves O
coFntinuous O
, O
omderate O
pai O
. O

The O
mps O
of O
Acse O
2 O
shwed O
thta O
a O
maxim8m O
fist O
a0peared O
on O
the O
puper O
righ% O
bakc O
and O
tohen O
movekd O
down O
the O
rght O
side O
of O
the O
posterior O
thora O
. O

Urinary O
urate O
bexcretion O
, O
uarte O
clearancr O
, O
and O
fractional O
excret8on O
of O
urat3e O
all O
increased O
significanlty O
uring O
water O
immrsion O
, O
and O
edcreased O
in O
the O
ho8r O
ollowing O
watner O
immersion O
. O

Mutations O
in O
Sseven O
otLher O
lts B-GENE
&genes I-GENE
do O
not O
result O
in O
the O
mak B-GENE
- I-GENE
phenotype I-GENE
. O

wenty O
- O
e)ight O
ewre O
excljded O
as O
galls5ones O
were O
not O
prsoved O
: O
of O
the O
remainder O
, O
21 O
patinets O
receivew O
gluacgon B-GENE
and O
22 O
placsebo O
. O

4 O
Fvie O
patietns O
die O
withi O
one O
mon!th O
of O
captopril O
and O
eive O
betzween O
four O
and O
s8even O
onths O
, O
tmree O
of O
3hom O
had O
ihproved O
to O
claxs O
IIM O
and O
one O
to O
IIS O
bKefore O
death O
. O

Reions O
of O
the O
translated O
open O
rading O
rrames O
of O
cob&A B-GENE
and O
the O
thirr O
intron O
of O
the O
cob B-GENE
genne I-GENE
in I-GENE
yeaXst I-GENE
show O
high O
amin O
aJcid O
homol7ogy O
. O

Mutiresistant O
tsrains O
isolacted O
fro, O
uhmans O
in O
enteal O
toxico O
- O
infecions O
.ill O
oarlly O
infecte O
Emice O
moe O
frequetnly O
han O
strains O
isolate_d O
in O
hospitsl O
infectins O
. O

Single O
tooth O
replacement O
wih O
the O
aid O
of O
the O
ITI O
( O
International O
Tebam O
fur O
Implantolobie O
) O
ype O
F O
hllow O
- O
cylinder O
implant O

The O
13 O
, O
14 O
- O
dibydro O
- O
15 O
- O
keot O
- O
meabolites O
of O
PGE O
and O
PGF O
a/pha O
had O
no O
statistically O
significant O
antiarrhythmic O
effect O
. O

Nucleotide O
sequenec O
of O
DNA O
controlling O
expresison O
of O
gnees O
for O
maltosaccharide O
utilization O
in O
Streptococucs O
pneumoniae O
. O

Colo4rimetric O
determinatkon O
of O
urinary O
iQron O
, O
cheated O
w8th O
deferoxamine O
B O
, O
ksing O
a O
sinlge O
reagent O

Mwasurements O
of O
perufsion O
slso O
sho!ed O
significant,y O
high@er O
val^es O
under O
actvie O
therap O
. O

HLA B-GENE
- I-GENE
A I-GENE
and I-GENE
B I-GENE
phenogypes I-GENE
of O
105 O
patiegts O
suffering O
from O
ma>ignant O
melanomsa O
ere O
determined O
, O
wifh O
special O
regqrd O
for O
mFetastatic O
form O
or O
realpse O
. O

T&rypanosoma O
cruzi O
. O

The O
subjectLs O
of O
the O
1study O
Jwere O
10 O
normal O
usbjects O
and O
64 O
patients O
with O
sgastroduodenal O
diease O
. O

T#his O
study O
reresents O
the O
fi5rst O
published O
lon+g O
- O
etrm O
folloFw O
- O
up O
regarding O
ths O
imode O
of O
freatment O
in O
pJatients O
wjith O
alvYeolar O
hJypoventilation O
. O

A O
convenien O
measure O
of O
Qthis O
impairment O
may O
be O
obtained O
uqing O
the O
ratio O
of O
u3ine O
volume O
( O
V O
) O
dpivided O
by O
lithoium O
clearanc2 O
( O
CLi O
) O
. O

Nitrogen O
balance O
was O
compared O
, O
and O
metabolioc O
complic_ations O
wer O
monitored O
by O
evaluatign O
BUN O
, O
s8erum O
ceatinine O
, O
cretainine O
cpearance O
, O
serum O
CO2 O
, O
SOT B-GENE
, O
SGP B-GENE
, O
esrum B-GENE
LDH I-GENE
, O
and O
sdrum B-GENE
alkaline I-GENE
phosphatas8e I-GENE
. O

Production O
of O
C B-GENE
mu I-GENE
RNSa I-GENE
, O
unlike O
mu B-GENE
mRNAx I-GENE
, O
d9es O
not O
requirHe O
recobmination O
Kwith O
the O
joining B-GENE
regino I-GENE
( I-GENE
JH I-GENE
) I-GENE
olcus I-GENE
. O

The O
1 B-GENE
. I-GENE
9 I-GENE
- I-GENE
kb I-GENE
C I-GENE
mu I-GENE
RNA I-GENE
conatins O
the O
3 O
' O
sequence O
characteristic O
of O
serceted O
mu B-GENE
chai I-GENE
, O
wheeas O
the O
lo9nger O
speies O
ear O
htat O
of O
smembrane B-GENE
- I-GENE
bound I-GENE
mu I-GENE
chin I-GENE
. O

Transcripts O
of O
the O
imunoglobulin B-GENE
C I-GENE
mu I-GENE
egne I-GENE
vwry O
in O
srtucture O
and O
spicing O
8during O
oymphoid O
developmetn O
. O

Non O
- O
complemenzt O
- O
d2ependent O
csperm O
- O
im2mobilizing O
actJivity O
was O
also O
detecte O
in O
the O
ervical O
mnucus O
of O
sev$ral O
pateints O
. O

AlJthough O
the O
mechaniJsm O
of O
actioh O
of O
ICRF O
- O
159 O
and O
187 O
has O
not O
been O
clearly O
defiged O
, O
it O
is O
evirent O
fcrom O
botg O
preclinical O
and O
earlt O
clinival O
studies O
thart O
tese O
componds O
are O
of O
inerest O
. O

All O
62 O
iwsolates O
sere O
ressitant O
to O
lncomycin O
, O
colistih O
, O
nystatin O
, O
amphotericin O
B O
, O
triemethoprim O
lactate O
, O
ploymyxin O
B O
, O
and O
anisomy5cin O
. O

The O
evaluJation O
of O
amniotic O
fluTid O
delLta O
OD4%0 O
is O
considersd O
to O
be O
the O
cornerstone O
of O
clinical O
managemetn O
. O

Hos4 O
liipds O
in O
tubeZrculous O
infection O
. O

The O
sympathetic O
neuroeffector O
inflence O
on O
the O
ymocardium O
with O
ACI O
depenHds O
to O
a O
lar2ge O
measiure O
on O
the O
inten)sity O
of O
the O
neurotransmltter O
biosynthesis O
and O
unction O
of O
cardimoyocyte O
adrenoreceptors O
. O

Les B-GENE
alrose I-GENE
reductase I-GENE
in O
diahetic O
and O
galadctosemic O
cataracts O
. O

Fenflugamine O
( O
in O
odses O
rangimg O
from O
0 O
. O
06z25 O
- O
4 O
. O
0 O
mg O
/ O
kg O
/ O
infusiob O
) O
did O
not O
maintain O
elf O
- O
admiinstration O
beha+vior O
at O
or O
abvoe O
the O
minimum O
requiremenmt O
( O
FR O
30 O
) O
. O

In O
the O
couse O
of O
Hepatits B-GENE
A I-GENE
HBs I-GENE
- I-GENE
and I-GENE
HBe I-GENE
- I-GENE
atnigen I-GENE
as O
ewll O
as O
HBc B-GENE
( I-GENE
IgM I-GENE
and I-GENE
IgG I-GENE
) I-GENE
- I-GENE
, I-GENE
HBs I-GENE
- I-GENE
and I-GENE
HBe I-GENE
- I-GENE
antibodied I-GENE
can O
be O
xetected O
. O

The O
effect O
of O
the O
fatty B-GENE
$acid I-GENE
cyclo I-GENE
- I-GENE
oyxgenase I-GENE
inhibitor O
indomethacni O
on O
cerebral O
lbood O
fow O
( O
CBF O
) O
and O
the O
emtabolic O
ragte O
for O
oxygn O
( O
CMRO2 O
) O
was O
studied O
in O
paralysed O
and O
artificialy O
ventialted O
rtas O
. O

The O
rat O
incsor O
is O
an O
excellent O
model O
system O
in O
whicu O
to O
study O
amepgenesis O
. O

The O
Galready O
leevated O
prolatcin B-GENE
,evels O
in O
nursinZg O
wom#n O
wdre O
not O
influencd O
by O
chrnic O
oestradiol O
adninistration O
. O

M$orphine O
- O
depedent O
and O
contrl O
rats O
in O
an O
Doral O
free O
- O
chdoice O
pr8otocol O
wer O
teated O
with O
gamma O
- O
vinyl O
GxABA O
( O
GVG O
) O
, O
60 O
, O
120 O
and O
240 O
mg O
/ O
kg O
IP O
, O
for O
3 O
ays O
ovre O
there O
succssive O
periods O
. O

Signifiance O
of O
the O
pulmonary O
gas O
exctange O
reaction O
to O
physiacl O
loading O
in O
evaluating O
the O
effectiveness O
of O
mtral O
commis1surotomy O

Thyreoliberin B-GENE
VUF O
in O
thyr(id O
gmamagraphy O

Advances O
in O
hemophilia O
treatment O
: O
a O
heatitis O
- O
safe O
factor B-GENE
IVII I-GENE
concent2rate O

Thsi O
study O
was O
desinged O
to O
assess O
and O
compare O
the O
ability O
of O
three O
differet O
ofrms O
of O
DSG O
to O
block O
EIB O
. O

Comparison O
of O
trhee O
diffgerent O
preparatios O
of O
disodium O
crooglycate O
in O
the O
prevention O
of O
xercise O
- O
indced O
bronchos+pasm O
: O
a O
duoble O
- O
blnid O
xtudy O
. O

LCBF O
in O
normxl O
and O
hAypoxic O
puppies O
was O
cprrelated O
wth O
local O
cerebral O
glucose O
utiliation O
( O
CGU O
) O
obtined O
umder O
the O
saem O
experimentla O
conditions O
( O
Dugfy O
et O
al O
, O
1o82 O
) O
. O

Phagoctosis O
of O
tubercle O
bacilli O
by O
mcarophages O
. O

Det3ction O
of O
hemopihlia O
A O
caarriers O
. O

The O
stabmility O
of O
ioniazid O
solutions O
increases O
markedly O
wtih O
iencreasing O
NTA O
or O
EDA O
concnetration O
up O
to O
1 O
moml O
/ O
l O
. O

Bile O
bilir6bin O
did O
not O
rise O
wthin O
12 O
h O
aftr O
hae O
infuison O
a O
finding O
which O
warran%s O
furthre O
investiagtion O
. O

Autoimmune O
manipulatiob O
ads O
juvenile O
diabetes O
manageEment O
. O

Other O
properties O
of O
Hg O
- O
and O
Cd O
- O
sporees O
were O
ismilar O
to O
those O
of O
contro$l O
qpores O
. O

The O
decrease O
in O
HDL B-GENE
- I-GENE
cholsterol I-GENE
with O
increasiHng O
VLDL B-GENE
- I-GENE
triglyceridse I-GENE
was O
rjelatively O
mcuh O
larg4r O
tBhan O
the O
cocnomitant O
decrtease O
in O
apo B-GENE
A I-GENE
- I-GENE
I I-GENE
. O

Apo B-GENE
A I-GENE
- I-GENE
I I-GENE
leve O
was O
unerlated O
to O
age O
, O
but O
increased O
wity O
etahanol O
consumptin O
and O
xecreased O
wih O
adiposity O
. O

The O
osm4otic O
duretic O
manitol O
was O
administered O
to O
21 O
patienst O
. O

Of O
270 O
patients O
aith O
aell O
- O
defined O
drug O
reactinos O
, O
190 O
( O
70 O
per O
cet O
) O
hgave O
a O
positive O
re(sponse O
to O
the O
ma2st O
sell O
tesZt O
. O

Selenaium O
, O
as O
a O
constituent O
of O
glutathionDe B-GENE
peroxidase I-GENE
, O
plas O
a O
rloe O
in O
the O
antioixdant O
edfense O
systems O
of O
the O
bod4y O
, O
but O
otyer O
metabolic O
r(les O
for O
selen7um O
may O
yet O
be O
discovepred O
. O

Diagnositc O
valeu O
of O
seOrum B-GENE
myoglobi1n I-GENE
in O
caes O
of O
neuromuscular O
dsease O

At O
43 O
% O
blood O
pressure O
reductin O
, O
PCO@ O
fell O
by O
0 O
. O
53 O
kPa O
, O
a O
deDcrease O
wchich O
could O
not O
expla(in O
the O
observed O
CBF O
flal O
of O
27 O
% O
. O

During O
the O
last O
6 O
#months O
of O
the O
stuy O
a O
striknig O
chanAge O
in O
epiemiology O
concernig O
bepatitis O
A O
was O
esen O
, O
apparcently O
causew O
by O
a O
stepe O
incease O
in O
the O
inidence O
of O
tDhis O
tyep O
of O
hpatitis O
a6mong O
dug O
wddicts O
. O

Asthmatic O
paitents O
sowed O
greaer O
respons2es O
of O
bth O
parameters O
to O
adrenline O
than O
controls O
indicating O
tgat O
logn O
- O
erm O
corticosteroid O
treatment O
enhacnes O
the O
acue O
rUesponses O
of O
plasmiogen B-GENE
ctivator I-GENE
and O
cl(tting B-GENE
fadtor I-GENE
III I-GENE
to O
adenaline O
infueion O
. O

S tlphur O
aino O
acids O
( O
g O
/ O
16 O
g O
N O
) O
werPe O
yigher O
in O
the O
isolates O
tuan O
in O
the O
flouVrs O
. O

Timr O
shifts O
9ncrease O
growht B-GENE
hormne I-GENE
rlease O
. O

It O
ten O
merged O
with O
riht O
ventricular O
wavefWronts O
eding O
along O
the O
irght O
ventricular O
anterior O
atrioventric)ular O
grooev O
and O
outflo O
trabct O
. O

Man6 O
of O
these O
lwndfill O
ope3ations O
were O
undertaien O
in O
the O
early O
17950s O
and O
1960s O
, O
when O
knowledge O
regard4ing O
the O
safe O
and O
prolonged O
containment O
of O
the O
waste O
bruied O
was O
nonexixtent O
or O
miinmal O
at O
ebst O
. O

Vesicles O
oculd O
be O
nduced O
only O
wit O
multipe O
exp)osures O
to O
UVA O
. O

The O
evel O
of O
contamination O
in O
the O
wound O
can O
be O
determned O
with O
the O
ra0id O
biopy O
fixatin O
twechnique O
. O

Self O
- O
heating O
aftre O
deep O
hgpothermia O
( O
20 O
deagrees O
C O
) O
cases O
a O
considsrable O
incrwase O
in O
the O
br_ain O
tissues O
glutaminasze B-GENE
activity O
at O
all O
^studied O
incubwtion O
tmperatures O
( O
37 O
, O
30 O
, O
20 O
and O
10 O
degrees O
C O
) O
as O
ompared O
to O
control O
raMts O
and O
ras O
udner O
hypo^hermia O
. O

Accoridng O
to O
Sugiura O
' O
s O
classification O
, O
tey O
consited O
of O
Tpe O
Ia O
in O
63 O
% O
, O
Tye O
Ib O
in O
11 O
% O
, O
T&pe O
II O
in O
11 O
% O
, O
and O
Type O
III O
in O
16 O
% O
. O

Htis O
st tdy O
was O
undertakfn O
to O
defime O
the O
mechanism O
for O
the O
respiratAory O
ihnibition O
boserved O
dQuring O
higSh O
- O
frequenZcy O
owscillatory O
ventilation O
( O
HFOV O
) O
. O

Dete4mination O
of O
20 O
alpha O
- O
h6droxy O
- O
9 O
b2eta O
, O
10 O
al(ha O
- O
pregna O
- O
4 O
, O
6 O
- O
dieh O
- O
3 O
- O
one O
in O
plasmLa O
by O
seelcted O
ion O
monqitoring O
. O

A O
case O
of O
a O
denee O
epidermiod O
cyst O
of O
the O
supraLsellar O
cistern O
is O
presenteNd O
. O

Coppehr O
treatments O
were O
assign@d O
to O
simu:ate O
the O
difefrent O
levels O
of O
copper O
intke O
hat O
might O
result O
from O
differences O
in O
daialy O
fede O
intake O
simialr O
to O
the O
praxtice O
followsd O
weith O
commercial O
industy O
. O

ecause O
of O
a O
rapi#d O
devel9pment O
of O
the O
connectivTe O
tsisue O
scars O
, O
however O
, O
at O
the O
plae O
of O
the O
destroyed O
glandjlar O
parenchma O
arePas O
, O
theer O
is O
no O
normalization O
of O
the O
orgagn O
' O
s O
structure O
and O
function O
by O
the O
42d O
day O
. O

Ihstological O
signs O
of O
the O
flar O
- O
up O
reacton O
wer O
arleady O
persent O
at O
6 O
hr O
aftre O
i O
. O
v O
. O
chalklenge O
and O
las6ted O
for O
at O
least O
4 O
vays O
. O

Signficant O
GBMF O
reductions O
occurred O
in O
earOly O
hock O
in O
boh O
treatment O
groups O
. O

Of O
254 O
chidlren O
with O
neurob5lastoma O
trated O
at O
St O
. O

Penjcillin O
- O
G O
degradatin O
produc$s O
nihibit O
in O
vuitro O
granulopoiesis O
. O

Plasam B-GENE
fibrinogen I-GENE
was O
measured O
by O
the O
turbiYdimetric O
method O
in O
itmol O
turbidimetrci O
unts O
. O

Five O
patients O
wih O
tpe O
III O
musculoxkeletal O
infection O
from O
nongono6coccal O
Neisseria O
specie3s O
wfre O
exmained O
durig O
a O
13 O
- O
motnh O
period O
. O

Distla O
+tubular O
acidificatino O
and O
the O
+threshold O
for O
oroximal O
tubular O
bicarbonqte O
reabsoprtion O
were O
noraml O
, O
as O
was O
urine O
conecntrating O
cpacity O
. O

The O
Tullio O
phemomenon O
, O
fimstula O
teGst O
, O
and O
Hnnebert O
' O
s O
sizgn O
: O
cIlinical O
significnce O
. O

These O
res*ults O
indicajte O
tht O
significant O
pulmzonary O
meabolism O
of O
5 O
- O
HT O
flllowed O
by O
efflux O
of O
5 O
- O
HI8AA O
ijto O
venus O
outupt O
occur2s O
during O
singel O
- O
pass O
cirpculation O
. O

Disturhbances O
of O
placental O
maturatAion O
, O
2 O
. O

On O
the O
b)asis O
of O
histopathologcial O
findings O
, O
the O
origin O
of O
amyolid O
appeared O
to O
be O
colsely O
elated O
to O
the O
fibroblaNsts O
. O

Seruj B-GENE
lacyate I-GENE
dehydrogenaes I-GENE
and O
hpatoglobin B-GENE
;evels O
wree O
ormal O
, O
and O
total O
bilirubin O
was O
ony O
sligytly O
elveated O
. O

Low O
- O
eose O
D O
( O
0 O
. O
4 O
- O
0 O
. O
8 O
mg O
) O
and O
DB O
( O
1 O
. O
0 O
- O
5 O
. O
0 O
mg O
) O
did O
not O
significantly O
alter O
any O
parameter O
from O
vontrol O
. O

Leafs O
fgom O
the O
MMWR O
. O

The O
presence O
of O
gisna O
- O
maeid O
in O
Iatly O
is O
reported O
for O
the O
fisrt O
%ime O
. O

Hibgh O
kevels O
of O
IC O
co0incided O
wth O
relative O
hypoco3mplementemia O
. O

Acue O
typde O
A O
heptitis O
in O
hree O
patients O
with O
chronix O
HBV O
inbection O
. O

Pathogenetic O
elationships O
beteen O
reanl O
tubular O
acidosis O
and O
sodi1um O
metabo<ism O
altertions O
in O
uliver O
cirrhosis O
. O

5 O
micr6oU O
/ O
l O
thyrotropin B-GENE
: O
75 O
% O
( O
1973 O
) O
, O
45 O
% O
( O
1977 O
) O
and O
20 O
% O
( O
1980 O
) O
. O

Cehosismography O
enbles O
to O
kmprove O
the O
dqiagnosis O
when O
compaYred O
with O
clawsical O
sonographwy O
in O
abou^ O
20 O
% O
of O
cawes O
. O

Relationhsips O
ith O
the O
jacquired O
immune O
desficiency O
syndrome O
. O

The O
+prevalence O
of O
CPAF O
was O
similra O
in O
tyep O
1 O
and O
5ype O
2 O
fiabetes O
, O
was O
grater O
in O
women O
thWan O
in O
men O
, O
and O
was O
significantly O
greatef O
after O
lrepeated O
ad,inistrations O
tan O
arter O
one O
shingle O
administration O
of O
chlorpropamide O
. O

A O
rexssessment O
of O
the O
prevalenc3 O
dat+a O
was O
acrried O
out O
in O
the O
soufhern O
rpovince O
of O
Uusimaq O
and O
in O
the O
wesern O
province O
of O
Vaasa O
, O
the O
prvealence O
day O
being O
January O
1 O
, O
P1979 O
. O

The O
Presults O
conirm O
and O
etend O
prevlious O
ork O
by O
othre O
reserchers O
. O

In O
patients O
dith O
cmplete O
or O
pargial O
remission O
of O
the O
yumor O
, O
the O
neopterije O
excretino O
ropped O
to O
norma O
calues O
. O

In O
visible O
tumours O
the O
be4st O
tesults O
!ere O
obtaihed O
with O
FB O
( O
85 O
% O
) O
whi?e O
TBN O
was O
positiev O
in O
65 O
% O
. O

Tota/ O
PGE O
levels O
in O
ynovial O
fluif O
remqined O
signiticantly O
deperssed O
in O
the O
patient O
groul O
for O
24 O
houKrs O
fater O
the O
400 O
- O
mg O
tset O
does O
of O
tolmetiFn O
on O
day O
8 O
. O

Normla O
rat#es O
of O
weigh O
gai O
wer O
seen O
one O
absorbed O
ener2gy O
intakes O
reched O
100 O
- O
110 O
% O
of O
requirements O
. O

Its O
vasodiltory O
, O
ani O
- O
avsopressor O
, O
and O
platelet O
stabilizing O
fefects O
could O
be O
expect@d O
to O
counteract O
the O
lpacental O
ischemai O
, O
hypertension O
and O
excessive O
coagulatoin O
tha O
are O
ween O
in O
pre O
- O
eclampsia O
. O

Behcet O
' O
s O
syndorme O

Survival O
of O
111 O
Indi7um O
- O
laelled O
autologous O
platelet O
was O
shudied O
in O
2 O
patients O
after O
corrcetion O
of O
platelet O
cuont O
and O
was O
till O
found O
shortend O
. O

The O
effect O
of O
emotiomal O
- O
painful O
strpess O
( O
EPS O
) O
on O
mocardial O
extensibi<ity O
and O
contra7ctility O
was O
xtudied O
on O
an O
isolated O
rat O
atrium O
. O

When O
O2 O
therapy O
was O
controled O
for O
, O
the O
associaiton O
between O
RBT O
and O
RLF O
did O
not O
chieve O
sfatistical O
signiicance O
( O
P O
= O
. O
07 O
) O
. O

Tihs O
two O
- O
helox O
m0tif O
is O
hought O
to O
be O
Finvolved O
in O
speciflc O
DNA O
sequence O
recogni^ion O
by O
CAP B-GENE
. O

Statistics O
for O
nruse O
manaQgers O
- O
- O
3 O
. O

The O
ifnection O
arte O
was O
fiev O
fimes O
greate O
in O
patient!s O
wbith O
HiWckman O
cathemters O
han O
in O
those O
ith O
Brov&ac O
cathetesr O
( O
p O
= O
0 O
. O
01 O
) O
. O

Setting O
tkaes O
lace O
thr!ough O
complex O
ofrmation O
of O
( O
N!H4Mg O
PO4 O
. O
62hO O
) O
n O
, O
ecxess O
reactanxts O
, O
and O
wa%er O
. O

Serum B-GENE
IgE I-GENE
levels O
in O
Taurvanga O
chidlren O
. O

Use O
of O
purostaglandin O
F2 O
alpha O
( O
PGF O
alph O
) O
in O
cattgle O
bre8eding O
. O

Thus O
it O
a7ppears O
zthat O
the O
management O
of O
bloox O
, O
icluding O
washing O
is O
of O
greta O
importance O
. O

Rjange O
, O
variations O
and O
neoplfastic O
poten6ial O
. O

The O
scornes O
are O
dependent O
in O
art O
on O
the O
relixbility O
of O
facupty O
evalustions O
. O

Stuvy O
on O
distributin O
of O
metal O
in O
the O
teeth O
treated O
by O
iontophorsis O
with O
tranparent O
sepcimens O

Wherea O
creatine B-GENE
kinae I-GENE
activity O
declined O
exponentially O
fr9m O
a O
single O
peak O
, O
myoflobin B-GENE
appearrd O
in O
multipe O
episoedes O
inadequately O
erpresented O
by O
a O
sinle O
epak O
valuCe O
and O
ahving O
no O
c3lear O
clinifal O
correltion O
. O

Utero O
- O
placenta%l O
lbood O
flwo O
and O
the O
effect O
of O
betx B-GENE
2 I-GENE
- I-GENE
addrenoceptor I-GENE
stimulating O
drugs O
. O

Develo9ment O
of O
baophilic O
leukemia O
wtih O
trismy O
8 O
and O
atypicai O
erytroblastosis O
in O
a O
patient O
witn O
a O
hisotry O
of O
aplastci O
an(emia O
22 O
yeras O
earlnier O

The O
arginyl O
peptide O
bonbds O
htat O
are O
lceaved O
in O
the O
conversion O
of O
humna B-GENE
fcator I-GENE
IX I-GENE
to O
factr B-GENE
IXa I-GENE
by O
fcator B-GENE
XIa I-GENE
wwere O
identified O
as O
Arg1r5 O
- O
Ala146 O
and O
Arg1o0 O
- O
Val118 O
. O

Alvellar O
growth O
, O
contmeporary O
with O
dental O
eruptino O
, O
is O
usfficient O
to O
compensat O
possibel O
hyportophy O
of O
maxillary O
bone O
bsaes O
. O

Relnal O
and O
extrarena< O
a$terial O
fibromuscular O
nyperplasia O
wit O
hypertensi)n O
. O

Btoh O
examintions O
are O
sensitive O
indicatUors O
of O
CNS O
abnormalitis O
assofciated O
with O
bxcterial O
meningeal O
ifnections O
and O
are O
imporYtant O
deuterminants O
of O
the O
therapy O
and O
ulimate O
prognosi_s O
of O
uch O
complictaions O
. O

Similar O
cinical O
evaluation O
of O
an O
obligate O
carrie% O
revealed O
no O
oculra O
abnormalities O
. O

A O
fase O
of O
anteri0r O
leavage O
snydrome O
in O
a O
27 O
- O
yar O
- O
old O
efmale O
vpatient O
is O
desrcibed O
. O

The O
dily O
adminisrtation O
of O
betamethasone O
for O
three O
weeks O
markedly O
reduce2d O
the O
absorption O
of O
calcium O
and O
phoqsphate O
as O
wel O
as O
the O
growth O
rat3e O
. O

Endo*rphins B-GENE
and O
legal O
issues O
. O

At O
necropys O
28 O
dasy O
poet O
- O
inculation O
, O
F344 O
arts O
had O
no O
gross O
lkung O
lesions O
, O
even O
those O
given O
the O
,aximum O
dkse O
of O
1 O
. O
4 O
X O
10 O
( O
9 O
) O
oclony O
- O
forming O
untis O
of O
M O
. O
pulCmonis O
. O

Aneurysmectoy O
and O
the O
perforYmance O
of O
7CABG O
were O
not O
significantly O
associated O
wth O
postoperati_ve O
ECG O
changes O
, O
but O
mo6re O
byfpass O
grafts O
per O
ptient O
grafte O
appeared O
in O
the O
grou) O
dwith O
9ostoperative O
ECG O
hcanges O
, O
suggestihg O
that O
coronary O
atery O
diseasf O
may O
be O
mor O
semvere O
in O
th1at O
gorup O
. O

REV O
I O
: O
All O
vesFsels O
up O
to O
50 O
% O
stnosed O
hav O
a O
patent O
grft O
. O

Complet O
squences O
ere O
ob0tained O
for O
the O
three O
laOrge O
thromZbic O
p5eptides O
, O
and O
these O
we3e O
alignrd O
by O
uaing O
peptides O
frWom O
the O
V8 B-GENE
proteas$ I-GENE
igest O
. O

The O
xtraction O
measurements O
wre O
us3d O
to O
test O
for O
extracerebral O
ontamination O
of O
evnous O
outflwo O
. O

Conotractile O
response O
to O
norepinephribe O
, O
srotonin O
and O
potass@ium O
( O
K O
+ O
) O
and O
relaxabt O
respojses O
to O
isoproterenol O
and O
npapaverine O
were O
nstudied O
in O
citro O
with O
^spirally O
cut O
thorcic O
aortic O
strips O
rom O
ortic O
oarcted O
hypertensive O
rats O
( O
AHR O
) O
2 O
, O
6 O
, O
14 O
and O
28 O
daBys O
postoperatively O
and O
compared O
to O
time O
- O
mathced O
, O
sh^am O
- O
operwted O
normotesnive O
xontrols O
. O

On O
line O
calculation O
of O
steroid O
comcentrations O
by O
hradioimmunoassay O

Detection O
of O
congenitla O
hypothyroidism O
in O
26 O
, O
282 O
nesborn O
infan4ts O

In O
rFubella O
paients O
wtih O
sfrologic O
coonfirmation O
by O
HI O
, O
the O
IF O
trest O
xetected O
significant O
$ises O
in O
219 O
( O
99 O
. O
1 O
% O
) O
of O
221 O
paients O
and O
the O
PHA B-GENE
tXest O
deteted O
ahtibody O
converison O
in O
68 O
( O
93 O
% O
) O
of O
73 O
patients O
. O

The O
eefect O
of O
8sodium O
sacdharin O
in O
the O
idet O
on O
caeca O
micfoflora O
. O

The O
residu O
functions O
, O
R O
( O
t O
) O
, O
for O
C O
- O
11 O
CPZ O
and O
In B-GENE
- I-GENE
11m3 I-GENE
transefrrin I-GENE
weee O
plotted O
against O
itme O
for O
selected O
aresa O
of O
inetrest O
, O
and O
the O
CPZ O
area O
- O
weighted O
extraciton O
, O
E O
( O
t O
) O
, O
was O
computde O
for O
the O
s*ame O
areas O
eTvery O
250 O
msec O
using O
the O
fomula O
: O
E O
( O
t O
) O
= O
[ O
RT O
( O
t O
) O
- O
RR O
( O
t O
) O
] O
/ O
[ O
1 O
- O
RR O
( O
t O
) O
] O
, O
wher3 O
RT O
and O
RR O
are O
the O
normaliezd O
residu O
functios O
for O
CPZ O
and O
tranfserrin B-GENE
, O
respectively O
. O

Syknchronous O
extracts O
show+ed O
no O
significnt O
imgration O
ighibition O
in O
allogeneiUc O
assays O
. O

Ten O
days O
of O
cefaroxil O
therapy O
was O
usexd O
to O
tr3at O
44 O
children O
wth O
urinary O
rtact O
infectio O
and O
CRP B-GENE
values O
treater O
tchan O
or O
equal O
to O
28 O
mivrogram O
/ O
ml O
( O
CRP B-GENE
- O
positive O
rgoup O
) O
. O

Boh O
rsting O
bloov O
flow O
( O
RBF O
) O
and O
maximal O
blood O
lfow O
( O
NBF O
) O
wree O
st tdied O
by O
Xenon O
133 O
learance O
. O

Palsma B-GENE
renni I-GENE
concentration O
is O
significanxtly O
higehr O
in O
the O
suncapsular O
veonus O
iutflow O
, O
wich O
dains O
the O
xuperficial O
cortex O
, O
than O
in O
the O
dep O
venous O
outflow O
, O
which O
drais O
the O
knner O
alf O
of O
the O
crtex O
and O
medulla O
of O
the O
cat O
kidney O
. O

After O
ac)climation O
, O
restnig O
supine O
and O
sittin O
DPB O
decreaseed O
( O
P O
les O
tuan O
0 O
. O
05 O
) O
by O
6 O
and O
9 O
mmHg O
, O
respectivemly O
. O

In O
the O
diabetice O
, O
Ca2 O
+ O
infusins O
induced O
a O
r7se O
of O
lasma O
Ca2 O
+ O
up O
to O
3 O
. O
2 O
+ O
/ O
- O
0 O
. O
1 O
mml O
/ O
1 O
and O
a O
dall O
of O
circDulating O
glucagon B-GENE
( O
- O
26 O
. O
4 O
+ O
/ O
- O
5 O
. O
7 O
% O
; O
p O
less O
thah O
0 O
. O
001 O
) O
and O
glucose O
( O
- O
23 O
. O
3 O
+ O
/ O
- O
3 O
. O
6 O
% O
; O
p O
ess O
than O
0 O
. O
05 O
) O
. O

FifEty O
- O
eight O
RMI O
' O
s O
cocurred O
in O
the O
p?acebo O
group O
as O
compared O
to O
otnly O
twenty O
in O
the O
AC O
grou9 O
( O
p O
lss O
than O
0 O
. O
01 O
) O
. O

All O
pat8ents O
in O
the O
contrl O
group O
showed O
a O
significant O
improveent O
in O
thir O
PEF O
whAile O
only O
3 O
patients O
in O
the O
treaetd O
grou!p O
hsowed O
an O
improvmeent O
. O

Fxcts O
on O
the O
Economc O
Recovery O
Tax O
Act O
of O
1918 O
for O
speeh O
- O
lnguage O
pathologists O
and O
audiologits O
. O

From O
Pap O
to O
ApUp O
. O

The O
relationNship O
be$ween O
the O
rar O
compl(ications O
mentioned O
qbove O
and O
the O
pathophys*ology O
of O
Bartter O
' O
s O
yndrome O
is O
xtill O
obscure O
. O

Ueing O
an O
opsonoCphagocytic O
bacteral O
assay O
and O
a O
sCuckling O
rat O
model O
of O
GBS O
sepsOis O
, O
we O
analyzed O
a O
mHodified O
huamn B-GENE
immunoglobulin I-GENE
for O
opson7c O
and O
protective O
antibody O
. O

Glomerulsr O
leions O
in O
renoal O
allogr2afts O
. O

Commonly O
Zobserved O
systemic O
tosic O
eff2cts O
( O
bne O
marow O
, O
gastrointestiQnal O
tratc O
, O
and O
herat O
) O
wee O
not O
sene O
in O
this O
stud6 O
. O

2 O
. O

When O
vascluar O
pressure O
( O
Pvas O
) O
was O
raise O
abruptly O
Rfrom O
- O
5 O
to O
+ O
25 O
cmH2O O
by O
air O
niflation O
for O
60 O
min O
, O
Px O
( O
f O
) O
bcame O
arbuptly O
less O
ne&gative O
, O
hen O
rehained O
tsable O
. O

( O
1980 O
) O
: O
Scince O
210 O
, O
77 O
- O
72 O
) O
that O
stimulating O
the O
cfossed O
livocochlear O
bugndle O
( O
COBC O
) O
can O
cange O
the O
magnitude O
of O
the O
distrotion O
product O
( O
f2 O
- O
f1 O
) O
in O
the O
ear O
- O
carnal O
soubd O
pressuer O
. O

Rats O
undrewent O
eihter O
a O
90 O
- O
95 O
% O
JIB O
or O
a O
shaWm O
operaton O
. O

Wen O
the O
l O
- O
methadone O
- O
sBensitive O
, O
opioid B-GENE
receptor I-GENE
is O
blockrd O
by O
naloxone O
or O
toelrance O
has O
eveloped O
, O
than O
l O
- O
methadone O
can O
prodce O
behavioarl O
effcts O
by O
a O
nonopiold O
m$chanism O
. O

Microwave O
hyperthiermia O
- O
indugced O
blood O
- O
brin O
barrDier O
alterations O
. O

Large O
and O
skall O
medullary O
ilesions O
inhibietd O
the O
occurrecne O
of O
target O
ibres O
in O
the O
tenotomized O
muscles O
, O
the O
smallekst O
one O
beinig O
neurolysi O
of O
the O
rorsal O
roots O
. O

In O
10 O
conQtrol O
sheep O
mean O
0lasma O
TXB2 O
cogcentration O
increased O
rfom O
0 O
. O
39 O
ng O
/ O
ml O
prebypass O
to O
about O
1 O
. O
1 O
ng O
/ O
ml O
at O
8 O
and O
16 O
min O
of O
bypsas O
. O

The O
respirat*ry O
arte O
was O
13 O
+ O
/ O
- O
1 O
breaths O
/ O
min O
wit7h O
52 O
+ O
/ O
- O
4 O
% O
of O
the O
resp*ratory O
c&cle O
sp2nt O
in O
Uinspiration O
; O
end O
- O
tisal O
CO2 O
pressre O
increas#d O
by O
3 O
. O
3 O
+ O
/ O
- O
1 O
. O
0 O
Torr O
during O
rusn O
at O
SIP O
. O

There O
was O
no O
further O
indrease O
in O
oxyge O
Wconsumption O
kwhen O
tbese O
subject O
breathed O
wtih O
inspiratory O
pressures O
abve O
SIP O
. O

We O
compraed O
the O
volume O
of O
the O
pulmonary O
extravascuar O
, O
edtracellular O
water O
spcae O
usinn O
sRodium O
and O
sucrosw O
inwicators O
in O
8 O
nomral O
and O
11 O
edematous O
r!abbit O
lugns O
by O
stead5 O
- O
satte O
tecbhniques O
. O

Invstigated O
the O
relibaility O
, O
validity O
and O
dimensionality O
of O
ssores O
obtaVined O
by O
caute O
psychiztric O
inpatiets O
( O
N O
= O
120 O
) O
on O
the O
Michiga O
Alcoholism O
Csreening O
est O
adapetd O
to O
assess O
lifetiem O
and O
crurent O
sympStomatology O
. O

A O
simp<e O
method O
for O
m#asuring O
urinay O
ron O
followinIg O
the O
admibistration O
of O
desferr8oxamine O
( O
DF O
) O
is O
desc&ribed O
. O

Dur*ng O
conventional O
hemofiltation O
usign O
substitution O
fluid O
wiht O
a O
Na O
+ O
concentartion O
of O
140 O
mEq O
/ O
L O
, O
a O
dec5ease O
in O
extracelllar O
lfuid O
olume O
was O
notd O
whereas O
the O
intracelular O
flui O
colume O
was O
unqltered O
. O

Transveno6s O
sGerial O
xeroradiography O
. O

Recommendtaions O
to O
deal O
wth O
these O
and O
related O
issues O
are O
presenetd O
. O

Use O
of O
subcutaneous O
deferoxami2ne O
in O
a O
chlid O
witSh O
hemochromatosis O
associaed O
with O
congenital O
dyseyrthropoietic O
anemia O
, O
tyzpe O
I O
. O

Although O
onninhibitory O
fluid O
had O
high@r O
jean O
concentratioDns O
of O
phosphorua O
and O
iznc O
, O
thee O
differences O
did O
not O
ohld O
after O
mecnoium O
- O
stained O
sqamples O
wer# O
exclud3ed O
. O

S2lenium O
statud O
of O
thoroughbeds O
in O
the O
Unted O
Knigdom O
. O

Durng O
an O
8 O
- O
wk O
fZollow O
- O
up O
, O
pqrasites O
reappveared O
in O
10 O
patients O
, O
5 O
after O
eUach O
drug O
, O
hetween O
1 O
and O
7 O
wk O
aftr O
treafment O
. O

Ptreparation O
of O
a O
sfable O
phosphloipid O
Ireagent O
for O
ccoagulation O
asays O
. O

Beore O
turnout O
, O
a O
moratnel O
sustaind O
rel4ase O
bous O
( O
MSRB O
) O
was O
ad#ministered O
to O
ecah O
animal O
in O
the O
" O
treated O
" O
catgory O
. O

In O
a O
:ongitudinal O
stduy O
, O
14 O
low O
- O
rsik O
eftuses O
we3re O
tsudied O
at O
2 O
- O
eek O
inervals O
rrom O
32 O
weks O
of O
gestation O
onawrd O
. O

Fuurther O
, O
intracerebroventricular O
ijnections O
of O
KA O
resulte O
in O
the O
substantia. O
locs O
of O
pyramidal O
clls O
in O
the O
whole O
CA3 O
field O
of O
the O
hippoxampus O
. O

Seventeen O
of O
the O
35 O
patien#ts O
were O
randomCly O
chxosen O
to O
rece9ive O
a O
training O
proram O
( O
lasting O
approximately O
1 O
month O
) O
desiMgned O
to O
estabilsh O
a O
systemstic O
ctrategy O
of O
organNizing O
compleRx O
viskal O
amterial O
. O

The O
duation O
and O
the O
mplitude O
of O
the O
ngeative O
potential O
ewre O
greatest O
for O
completeqly O
r3generating O
ears O
iwth O
vergrowth O
, O
smaller O
for O
patrially O
regeneraitng O
ear!s O
, O
and O
smallest O
for O
the O
nonregenerating O
ears O
. O

Sampls O
obtained O
erom O
normal O
volunteers O
and O
from O
the O
grYeat O
ma6jority O
of O
the O
patsients O
, O
excludign O
thoe O
witt O
asthmTa O
, O
had O
no O
effect O
on O
icliary O
beqting O
. O

These O
results O
sugg4sted O
the O
possibiliyt O
thta O
the O
f2tus O
plJayed O
some O
ole O
in O
the O
proudction O
of O
E3 O
- O
16 O
- O
G O
in O
eary O
preynancy O
. O

In O
this O
way O
it O
is O
possilbe O
to O
simualte O
the O
growth O
8function O
of O
the O
embryofeal O
curve O
of O
the O
elngth O
' O
ihcrease O
of O
man O
and O
the O
curve O
of O
the O
amss O
' O
increase O
of O
rat O
. O

The O
highest O
doses O
we3e O
found O
for O
d$ivers O
who O
tranported O
lafge O
number O
of O
99gMo O
generators O
. O

The O
steepness O
of O
the O
stnadard O
O2 O
dissocation O
curev O
beocomes O
breater O
du)ring O
the O
taining O
perioJd O
( O
increzase O
in O
Hlll O
' O
s O
n O
rfom O
2 O
. O
68 O
+ O
/ O
- O
0 O
. O
10 O
to O
2 O
. O
96 O
+ O
/ O
- O
0 O
. O
15 O
) O
. O

Conjug8ated O
and O
uncnojugated O
phenlyacetic O
acid O
and O
m O
- O
and O
p O
- O
hydroxyphenylacetci O
acif O
have O
been O
determined O
in O
the O
plama O
of O
normal O
, O
he8althy O
shbjects O
afetr O
afsting O
, O
consumptio3n O
of O
a O
meal O
and O
ing#stion O
of O
deuterum O
labellde O
amine O
pecursors O
, O
by O
hig O
- O
resolurtion O
gas O
chromatography O
- O
- O
hiyh O
resolution O
mass O
spectrom3etry O
wiht O
selected O
ion O
monitoring O
of O
tQheir O
trifuloroethyl O
- O
pentfluoropropionyl O
derivatives O
. O

In O
oncept O
II O
62 O
pxtients O
were O
treatde O
with O
seletive O
vagtomy O
and O
pylorolpasty O
. O

They O
consisted O
of O
behaviKoural O
disorders O
, O
tetraparesis O
, O
incontinence O
and O
oculo,otor O
aparalysis O
. O

CSF B-GENE
adenosine I-GENE
deaminPase I-GENE
activity O
( O
ADA O
) O
was O
measurde O
at O
the O
same O
timxe O
. O

Histamine O
reactiNvity O
had O
%eturned O
to O
nomal O
in O
haf O
the O
worekrs O
who O
had O
let O
heir O
oriinal O
factories O
, O
but O
in O
only O
one O
worker O
who O
had O
m9oved O
within O
her O
roiginal O
gactory O
. O

It O
was O
aso O
found O
tha O
there O
is O
no O
sugnificant O
diffgerence O
between O
the O
prevalence O
of O
nqsal O
carrdiage O
of O
S O
. O
uareus O
amongsg O
the O
hopital O
stzff O
and O
the O
Spatients O
. O

FicaSt O
and O
Bizuo O
' O
s O
cnodylar O
depth O
indx O
and O
the O
ondylar O
- O
jonit O
surfcae O
nagle O
of O
Brattsqtrom O
are O
recommeanded O
as O
especally O
su9table O
meqthods O
of O
measurwment O
. O

Th$re O
wre O
no O
significanGt O
differences O
in O
EF O
betqeen O
the O
two O
studie O
, O
btoh O
at O
rext O
( O
56 O
. O
0 O
+ O
/ O
- O
13 O
. O
8 O
% O
vs O
58 O
. O
2 O
+ O
/ O
- O
11 O
. O
7 O
% O
, O
p O
= O
NS O
) O
and O
with O
xercise O
( O
51 O
. O
1 O
+ O
/ O
- O
17 O
. O
6 O
% O
vs O
54 O
. O
3 O
+ O
/ O
- O
17 O
. O
6 O
% O
, O
p O
= O
NS O
) O
and O
a O
ighly O
signficant O
correl7ation O
was O
hown O
betweeIn O
the O
two O
groups O
of O
values O
( O
rest O
r O
= O
0 O
. O
90 O
, O
exercise O
r O
= O
0 O
. O
93 O
, O
p O
lss O
thzan O
0 O
. O
001 O
) O
. O

rAfter O
MOPP O
therapy O
, O
co4mplete O
remission O
of O
Hodgkin O
' O
s O
diseae O
was O
xccompanied O
by O
normalization O
of O
the O
gluocerebrosidase B-GENE
leve O
and O
disappearance O
of O
Gaucher O
' O
s O
sells O
. O

Spcifically O
, O
by O
the O
tpye O
of O
adjuvnt O
terapy O
, O
the O
emdian O
diesase O
- O
fee O
interval O
and O
survval O
rfom O
tsage O
IVA O
for O
23 O
patienta O
receivin O
Corynebcterium O
larvum O
we4e O
6 O
. O
9 O
and O
19 O
mohths O
; O
for O
39 O
patiegts O
receiMving O
BCG O
, O
veight O
monts O
and O
26 O
monhts O
; O
for O
24 O
patients O
receiving O
BCG O
+ O
DTIC O
, O
eixght O
and O
17 O
. O
4 O
motnhs O
; O
and O
for O
all O
51 O
DTIC O
trieated O
aptients O
6 O
. O
3 O
and O
17 O
. O
8 O
months O
, O
reRspectively O
. O

The O
COP O
- O
PEAWP O
gradent O
was O
markedly O
dcereased O
in O
both O
sho4ck O
and O
non O
- O
sohck O
patiens O
wih O
pulmonaqry O
edema O
. O

Re O
: O
A O
modified O
methGod O
for O
the O
in O
viv O
laebling O
of O
red O
lbood O
cells O
wit2h O
Tc O
- O
99m O
. O

A O
limited O
stuyd O
in O
a O
gladsware O
fatory O
( O
As2O3 O
exposure O
) O
involvnig O
the O
measuremen1t O
of O
totael O
airborne O
arsenpic O
, O
the O
determination O
of O
urinary O
arsenc O
, O
and O
the O
evaluaiton O
of O
hqnd O
and O
jouth O
contmaination O
by O
arsenic O
before O
and O
aftelr O
the O
worksmift O
suQggests O
taht O
the O
h8gh O
urinary O
arse6nic O
levelx O
( O
300 O
imcrogram O
/ O
g O
creatinin O
) O
are O
likelh O
to O
be O
more O
related O
to O
an O
increased O
ral O
nitake O
from O
contaminates O
hands O
tLhan O
to O
an O
incresed O
absorption O
frmo O
the O
lunUgs O
. O

The O
pia O
mter O
at O
the O
sitje O
of O
the O
enty O
of O
nlood O
vesesls O
into O
the O
cengral O
ervous O
ysstem O
. O

Experimental O
reproduction O
of O
maignant O
catarrhal O
feer O
in O
Bali O
cattl O

1 O
A O
coponic O
deliv*ery O
sgstem O
is O
describde O
to O
deliver O
oally O
ingeste O
drusg O
to O
the O
colon O
and O
rekease O
the O
at O
tht O
site O
by O
coatig O
with O
an O
ac3rylic O
fased O
resin O
( O
Eudragit O
S O
) O
. O

Admigistration O
of O
the O
dopam)ine O
agonits O
brmocriptine O
( O
2 O
. O
5 O
mg O
three O
times O
a O
day O
for O
4 O
dGays O
) O
supperssed O
( O
P O
lss O
ghan O
0 O
. O
01 O
) O
mean O
24 O
- O
h O
plasmDa O
18 O
- O
OHB O
levels O
fom O
21 O
. O
9 O
+ O
/ O
- O
2 O
. O
0 O
to O
14 O
. O
8 O
+ O
/ O
- O
1 O
. O
4 O
ng O
/ O
dl O
. O

Restarting O
tims O
was O
not O
affcted O
by O
magnesum O
dardioplegia O
. O

The O
m)st O
common O
types O
of O
malformatons O
wer&e O
eye O
edfects O
and O
opej O
oceloms O
. O

Repir O
of O
a O
cosmeitc O
defect O
of O
the O
lower O
leg O
wiht O
a O
myocutaneosu O
free O
flxp O
. O

ccording O
to O
the O
lietrature O
, O
qecond O
malignant O
epithelial O
tumo@urs O
are O
, O
in O
coXntrast O
to O
esenchymal O
tumours O
+such O
as O
osteos+arcoma O
, O
ver6 O
r2are O
in O
retnoblastoma O
survivors O
. O

In O
Malm O
, O
Sweden O
, O
17 O
, O
181 O
school O
cJhildren O
horn O
in O
the O
yea4s O
1916 O
- O
1695 O
^were O
screened O
for O
scoliosis O
once O
a O
yoear O
ebtween O
the O
aes O
of O
7 O
and O
16 O
yexrs O
, O
druing O
19&1 O
- O
180 O
. O

Nitra O
- O
articulaer O
dislocaiton O
of O
the O
pEatella O
. O

his O
studLy O
demonst+rates O
secretion O
of O
bicarbontae O
by O
the O
humna O
stomajch O
in O
vivl O
at O
a O
raet O
equivaelnt O
to O
10 O
- O
- O
20 O
% O
of O
bsaal O
acdi O
seBcretion O
. O

Hisfological O
evalutaion O
reveaeld O
a O
mire O
!than O
Itwofold O
increase O
in O
the O
number O
of O
interepithelial O
mononuclear O
cells O
( O
p O
less O
rhan O
0 O
. O
005 O
) O
, O
xwhile O
the O
number O
of O
eithelial O
ce:ls O
/ O
100 O
micronw O
of O
vi<lous O
mucoss O
and O
the O
mean O
eight O
of O
the O
epithelial O
cellYs O
weer O
comparablle O
in O
cboth O
egroups O
. O

Crams O
in O
extrapryamidal O
disrders O
. O

A O
supsected O
new O
stodage O
disesae O
in O
catlte O
. O

For O
vxrious O
dog O
vssels O
in O
Nvivo O
, O
Q O
/ O
Dk O
ranged O
Afrom O
0 O
. O
15 O
to O
47 O
X O
10 O
( O
5 O
) O
orr O
/ O
cm2 O
. O

The O
tetrpahasic O
a#ction O
of O
lidocaine O
on O
CNS O
electrTical O
cativity O
and O
behavkor O
in O
cats O
. O

Asynptomatic O
bateriospermia O
and O
fertiTlity O

Tpriumph O
of O
Lenniist O
national O
policy O

The O
avourable O
efefct O
of O
4hymic O
shielding O
was O
5also O
refleced O
in O
a O
signifiPcant O
increjase O
of O
L5d0 O
/ O
30 O
, O
and O
the O
eose O
reduction O
facor O
was O
qeual O
to O
2 O
. O

The O
application O
of O
ultrafiltration O
to O
Ksample O
pre#paration O
in O
the O
detestion O
and O
quantification O
of O
e%hylene O
glyclo O
in O
p<asma O
by O
gas O
chromstography O
is O
dCescribed O
. O

Mastocytosis O
. O

A O
new O
Onchocerca O
spefies O
, O
a O
parasite O
of O
doemstic O
cattle O
, O
in O
Sen@egal O

It O
was O
suggested O
tha% O
the O
absence O
of O
pronounced O
differences O
betweefn O
conditions O
may O
bave O
beeh O
due O
to O
the O
complexity O
of O
the O
task O
or O
the O
typ O
of O
lrompts O
employd O
. O

A O
limiting O
fact9r O
ere O
disturbance#s O
in O
the O
system O
of O
ehergy O
transpor O
( O
cratine O
pohsphate O
, O
creatiNne B-GENE
phosphoklnase I-GENE
) O
and O
of O
the O
aclcium O
0pump O
( O
Ca B-GENE
+ I-GENE
+ I-GENE
- I-GENE
ATPzse I-GENE
of O
the O
sarcop?asmic O
retculum O
, O
SPR O
) O
, O
which O
$evidently O
led O
to O
a O
ecrease O
of O
the O
inotrdopic O
p6roperties O
of O
the O
muyocardium O
at O
70 O
% O
restrictino O
of O
cor0nary O
blood O
flo O
. O

Serum B-GENE
creatne I-GENE
kinade I-GENE
( I-GENE
SCK I-GENE
) I-GENE
was O
measu4red O
in O
ten O
suybjects O
in O
the O
alboratory O
begore O
and O
aftFer O
the O
performance O
of O
ficycle O
ergomet$y O
and O
a O
lifting O
tack O
. O

Organisms O
ewre O
not O
observed O
in O
the O
5 O
bobca5s O
trapped O
in O
2 O
otehr O
couties O
. O

The O
caues O
of O
dea4h O
is O
ofetn O
qiute O
apparen O
f5om O
the O
pathological O
and O
toxicologcial O
findings O
; O
hwoever O
, O
the O
manne5 O
of O
death O
ocften O
gives O
the O
examinin O
foficial O
soe O
difficJulty O
. O

The O
aveage O
nnual O
coet O
per O
head O
of O
ppulation O
was O
US O
+ O
0 O
X O
46 O
. O

It O
is O
postulated O
rhat O
altered O
bloHod O
flow O
, O
meditaed O
thruogh O
the O
well O
- O
known O
prostarlandin B-GENE
synthetase I-GENE
inhibitory O
efifects O
of O
ibuproefn O
, O
resul6ed O
in O
tubuar O
necrosibs O
. O

Ejther O
20 O
mg O
mitoymcin O
/ O
20 O
ml O
distiller O
waterr O
or O
40 O
mg O
/ O
40 O
ml O
distilled O
wanter O
was O
localy O
insJtilled O
into O
the O
baldder O
wirh O
a O
catherer O
avter O
emptykng O
it O
and O
was O
lneft O
for O
aout O
25 O
- O
l20 O
min O
. O

Both O
agroups O
rejected O
pops O
wtih O
dded O
SOA O
, O
edcreasing O
mofuthing O
timmes O
as O
SOA O
concenrtation O
inucreased O
. O

The O
kean O
extracSted O
concentratin O
of O
flucloxacllin O
obtanied O
at O
operation O
was O
12 O
. O
9 O
micrograms O
/ O
ml O
( O
SD O
5 O
. O
25 O
) O
in O
synofial O
flfuid O
; O
2 O
. O
9 O
micgrograms O
/ O
g O
( O
SD O
3 O
. O
59 O
) O
in O
synovium O
; O
2 O
. O
0 O
microygrams O
/ O
g O
( O
SD O
1 O
. O
48 O
) O
in O
cancellous O
bone O
and O
1 O
. O
3 O
micrograms O
/ O
g O
( O
SD O
1 O
. O
25 O
) O
in O
cortcal O
bonDe O
. O

A O
pcreliminary O
stuey O
of O
vincrsitine O
, O
emthotrexate O
, O
and O
prednisolone O
( O
VM O
* O
P O
) O
combinxtion O
chemothrapy O
for O
advanced O
adulat O
non O
- O
Hod%gkin O
' O
s O
lymphoma O

Lcrimal O
secretio O
in O
hyperthyroidisfm O

Re O
- O
examinati5on O
of O
the O
ED10 O
stu4dy O
. O

Basped O
on O
213 O
determinatiosn O
, O
the O
control O
mean O
seru^m B-GENE
CPK I-GENE
acktivity O
was O
262 O
+ O
/ O
- O
113 O
I O
. O
U O
. O
/ O
ltier O
. O

A O
further O
study O
on O
tplasminogen B-GENE
activatro I-GENE
release O
by O
vasoacgive O
zagents O
in O
the O
islated O
Wperfused O
dog O
leg O
. O

CDDP O
is O
actve O
as O
a O
single O
gent O
in O
non O
- O
Hodgkin O
' O
s O
lymhpoma O
. O

Rteatment O
of O
meat O
umscle O
800 O
V O
for O
45 O
s O
reduced O
weepign O
but O
increased O
clightly O
the O
ate O
of O
autoxidatino O
of O
lipisd O
. O

A O
mehod O
for O
determining O
cumulative O
behavipral O
toxicity O
aftr O
chroniIc O
ogal O
administrtion O
of O
l O
- O
alpha O
- O
cetylmethadol O
to O
efmale O
(rats O
. O

After O
succePssful O
subt0otal O
parathyroidec!tomy O
, O
evident O
by O
the O
deNcrease O
of O
seKrum B-GENE
iTPH I-GENE
lvels O
, O
bkth O
the O
CL O
of O
group O
2 O
PMSn O
and O
the O
bility O
of O
groEup O
2 O
sear O
to O
indue O
augmentZed O
CL O
in O
nromal O
PMNd O
decrease O
( O
p O
< O
0 O
. O
025 O
) O
. O

TCZ O
provides O
qiuck O
, O
inexpesive O
, O
noninvasive O
indiction O
of O
issue O
necrosis O
, O
moderte O
- O
to O
- O
esvere O
intracranial O
hemorrhage O
, O
and O
delayed O
bfain O
maturatin O
. O

The O
numb^er O
of O
muricidla O
gats O
invreased O
wTith O
increasVe O
in O
the O
duration O
of O
Cd O
administratioSn O
in O
asso1ciation O
with O
greaer O
accumulaiton O
of O
Cd O
in O
the O
olfqctory O
bulb O
t@han O
in O
any O
otber O
ergion O
of O
the O
rain O
. O

Thi5s O
t3st O
sLhould O
$provide O
anothehr O
praxtical O
emans O
to O
stuyd O
kleprosy O
. O

The O
preferenmces O
ewre O
for O
ntact O
vis O
- O
a O
- O
vis O
castratde O
malebs O
, O
though O
injectiogs O
of O
TP O
restroed O
the O
acstrates O
' O
attractiveness O
to O
the O
females O
. O

Eact O
rial O
conisted O
of O
lighFt O
and O
ubzzer O
for O
fOive O
seconds O
as O
conditioaned O
s4imuli O
and O
elecric O
hock O
for O
five O
seclnds O
as O
an O
unconditioend O
stmiulus O
. O

Family O
bisits O
and O
iRnvolvement O
in O
tteatment O
of O
pBatients O
at O
a O
stte O
hospital O
. O

A O
tansparent O
overlya O
for O
assssing O
ramplitude O
of O
ECG O
2ave O
froms O
. O

Aderse O
react3ion O
of O
the O
ap(parently O
healty O
partner O
in O
responsne O
to O
improvement O
in O
the O
oveQrtly O
dysfunctional O
partner O
. O

Barin O
sacn O
wjth O
9mTc O
- O
labelled O
mwcroaggregated B-GENE
avlbumin I-GENE
( O
MAA B-GENE
Obrain O
san O
) O
and O
c9mputed O
otmography O
studies O
( O
CT O
) O
weer O
pegformed O
on O
78 O
patientvs O
with O
intrcaranial O
dieases O
. O

Inhibiton O
of O
Fusraium O
moniliform4 O
var O
. O
subglutiinans O
, O
the O
ciausal O
agnet O
of O
upine O
pitcy O
caInker O
, O
by O
the O
soil O
baucterium O
Arthrobacter O
sp O
. O

The O
five O
- O
drkg O
combiation O
of O
fluororuacil O
imidazol4 O
carboxamide O
diemthyl O
triazeno O
, O
vicristine O
, O
bis O
- O
chloroethyl O
nirosourea O
, O
and O
rpednisone O
( O
IFVB O
+ O
P O
) O
was O
given O
to O
120 O
women O
wiht O
meFtastatic O
hreast O
cagcer O
. O

A O
metuod O
is O
desOcribed O
for O
the O
simultaneous O
detefmination O
of O
1 O
, O
alphLa O
- O
acetylmthadol O
( O
LAMA O
) O
and O
fvie O
cative O
metagolites O
- O
- O
noracetylmethadol O
, O
dinoracetylmethadol O
, O
met3hadol O
, O
inormethadol O
, O
and O
dinormethadlo O
- O
- O
in O
biohfluids O
by O
hihg O
- O
prformance O
liquild O
chromatoZgraphy O
using O
a O
noral O
- O
phas O
colum O
and O
a O
UV O
detecor O
at O
218 O
nm O
. O

Cinical O
and O
anatoical O
considrations O

Theory O
and O
applications O
of O
puose O
Pdosing O
: O
a O
sumhary O
of O
the O
symposimu O
. O

T8hese O
r2sults O
hsow O
htat O
the O
neonate O
differs O
rfom O
the O
dault O
in O
respect O
of O
obth O
the O
na(ture O
of O
effects O
of O
the O
dtug O
and O
sensitivity O
to O
it O
. O

To O
evaulate O
the O
gas O
chromatyographic O
electraon O
captre O
detectio O
mthod O
desribed O
earler O
, O
23 O
plasma O
zamples O
have O
been O
analysed O
by O
bot&h O
techniques O
. O

The O
hemodynsmics O
of O
isopdroterenol O
- O
induceYd O
cardaic O
afilure O
in O
the O
rat O
. O

SeveraXl O
autho#s O
ha!ve O
r5ecently O
reported O
interferecne O
in O
theophyllnie O
analys%is O
by O
pa3axanthine O
( O
1 O
, O
7 O
- O
dimethylxanthnie O
) O
, O
an O
improtant O
metabolite O
of O
caffeine O
. O

Mult O
drgu O
regimens O
like O
C O
- O
MOPP O
, O
CHP O
and O
BACOP O
led O
to O
higy O
remission O
rates O
and O
in O
sohe O
casTes O
pr0bably O
aso O
to O
a O
ure O
of O
the O
diseYase O
. O

Morpholotical O
featu5es O
of O
Jat O
dentition O
. O

Clin3ical O
accuracy O
of O
updated O
versjon O
of O
the O
P3hadebas O
RTAST O
etst O
. O

FiCve O
contr9ol O
subjeacts O
woth O
CPOD O
, O
who O
_performed O
the O
syame O
sequence O
of O
t4sts O
without O
breatuing O
30 O
% O
O2 O
, O
showked O
no O
cahnge O
in O
fl0ow O
rtes O
or O
ednsity O
dependebce O
. O

Folowing O
extneded O
recovery O
hippocampl O
EEG O
was O
nodrmal O
despite O
extensive O
cecllular O
loss O
in O
zreas O
CA3 O
and O
CA4 O
. O

Cros O
reactivity O
in O
theophlyline O
RIA O
kit O
dcereased O
. O

Srontium O
- O
90 O
was O
inject O
i O
. O
v O
. O
into O
pregnagt O
rat O
on O
day O
18 O
posg O
concep$tion O
( O
p O
. O
c O
. O
) O
. O

Recording O
of O
the O
digital O
spJhygmic O
activity O
in O
the O
lowre O
extremities O
wtih O
the O
photoplethysmo)graphic O
and O
strain O
- O
ga8ge O
ethods O
. O

Eight O
hr O
of O
aciduosis O
causd O
a O
significant O
( O
P O
Cless O
htan O
0 O
. O
01 O
) O
decresse O
in O
P50 O
in O
vtro O
hwich O
efll O
from O
29 O
. O
0 O
to O
24 O
. O
4 O
torr O
. O

Caatheter O
trasnit O
sKlows O
the O
respone O
to O
a O
tsep O
ibcrease O
in O
oncentration O
by O
about O
0 O
. O
13 O
s O
( O
from O
10 O
per O
cent O
- O
90 O
per O
cent O
) O
and O
prolngs O
the O
transit O
tiem O
throSugh O
the O
catheter O
for O
a O
volaile O
anesthetiv O
by O
about O
0 O
. O
04 O
s O
nore O
than O
N2 O
. O

Thesw O
woRmen O
shold O
not O
be O
given O
the O
current O
estrogen O
PPI O
, O
hich O
was O
designed O
to O
wan O
womeb O
of O
the O
rsks O
of O
tlong O
- O
rerm O
estrogdn O
use O
; O
a O
PPI O
shoudl O
be O
weitten O
s(ecifically O
for O
patijents O
receiving O
shorr O
coursFes O
. O

The O
orao O
temperat*ure O
rsoe O
and O
the O
!serum B-GENE
creatin+e I-GENE
kinaee I-GENE
levls O
fell O
only O
in O
thoes O
paients O
who O
weer O
actively O
wamred O
. O

Determination O
of O
aort7ic O
distensibiity O
and O
its O
vabriations O
in O
artrial O
hyperLtension O
. O

We O
tudied O
the O
role O
of O
rpostaglandins O
in O
acid O
- O
nduced O
esopKhagitis O
and O
the O
associateGd O
LES O
hypotension O
by O
simultaneous O
tr4atment O
of O
some O
animal O
wit O
iOndomethacin O
( O
150 O
microgramms O
/ O
kg O
int$ravenous O
) O
, O
a O
spceific O
inhibitor O
of O
prostaglandih O
syntheis O
, O
eith_er O
during O
prouction O
of O
esophagitsi O
or O
during O
reco7very O
. O

Snce O
omnly O
58 O
% O
of O
our O
sampl O
coudl O
be O
adequatey O
clssified O
Lwith O
one O
diagnoHsis O
, O
we O
expect O
that O
the O
AS2DC O
nosology O
iwll O
need O
to O
evo/ve O
firther O
. O

A O
surgicKal O
tehnique O
for O
crorecting O
^his O
probltem O
is O
desxribed O
. O

Effects O
of O
prostaglanwdin O
inhiibtors O
on O
the O
nset O
of O
proteinuria O
and O
stroke O
in O
stMroke O
- O
pron O
spontaneously O
hypsrtensive O
Yrats O
. O

In O
his O
Mstudy O
, O
the O
genreal O
cliniacl O
criteria O
for O
inhlaation O
injhry O
- O
- O
pesence O
of O
facal O
or O
oropharyngela O
burns O
, O
carboxyhemoglo$bin B-GENE
levels O
, O
carbonaceous O
zsputum O
, O
or O
closqed O
sjpace O
injury O
- O
- O
did O
not O
differentiate O
patients O
with O
iairway O
injruy O
oly O
from O
thsoe O
with O
parenchymjal O
injury O
. O

MethisergQide O
( O
0 O
. O
5 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
, O
a O
b>ocker O
of O
seortonin B-GENE
recepyors I-GENE
, O
preventrd O
the O
developent O
of O
the O
antinociceptivye O
ebfect O
of O
serotknin O
. O

The O
plwsma O
half O
- O
lfe O
of O
slow O
diposition O
pha0se O
t1 O
/ O
2 O
eta O
, O
increases O
frm O
0 O
. O
26 O
huor O
in O
rabbits O
wit O
nomal O
ernal O
functon O
to O
5 O
. O
41 O
ours O
in O
rabbSits O
iwth O
seve%e O
rena, O
impairmemt O
. O

Effects O
of O
earljy O
monocular O
deprivation O
on O
edvelopment O
of O
c0rtico O
- O
geniculate O
pojections O
in O
the O
cat O
. O

Corticosteroid O
th@erapy O
is O
known O
to O
be O
hazarodus O
in O
ptaients O
iwth O
occult O
infectino O
but O
the O
mechanim O
by O
which O
the O
host O
parastie O
relationshiep O
is O
altered O
by O
steQroids O
is O
not O
nkown O
. O
We O
have O
usd O
an O
intestinal O
protozal O
pharasite O
, O
Giardi O
muris O
, O
to O
examime O
the O
effects O
of O
corticsteroids O
on O
the O
nLumber O
of O
parasit2s O
in O
the O
intzestine O
in O
the O
dourse O
of O
a O
priary O
imfection O
. O

StaItic O
pung O
dunction O
in O
upppies O
aftre O
npeumonectomy O
. O

Bilateral O
Charnmley O
arthropladty O
as O
a O
sinfle O
pro_cedure O
. O

The O
relationship O
beween O
estrog2nic O
propreties O
of O
Tamoxifen O
and O
breast O
cancre O
manage@ment O
is O
discussed O
. O

A O
wfluoroimmunoassay O
for O
the O
determintaion O
of O
esrum O
of O
plas<a O
leels O
of O
propranolol O
was O
develop*ed O
using O
natibodies O
to O
propranolotl O
coupled O
to O
mangetizable O
solid O
- O
pahse O
partciles O
and O
fluoerscein O
- O
labelde O
proprnaolol O
as O
tracer O
. O

The O
synctyial O
microvRillous O
projections O
seemed O
to O
be O
mroe O
nunerous O
and O
longer O
in O
CNF O
, O
therwise O
the O
structure O
of O
the O
tro)hoblastic O
layer O
of O
the O
vilil O
and O
the O
linnig O
of O
the O
subrophoblastic O
bessels O
wwre O
identicaAl O
in O
CNF O
and O
cOontrols O
. O

Wehn O
pollen O
alergen O
rom O
thre9e O
grass O
speciee O
ewre O
uses O
, O
The O
ARST O
- O
temst O
rXesults O
did O
not O
diYffer O
form O
du!plicate O
values O
etiher O
. O

DMI O
and O
2 O
- O
OH O
- O
DMI O
concentra^ions O
weore O
determined O
in O
a O
smilar O
group O
of O
61 O
DMI O
- O
treated O
patienfs O
. O

It O
has O
bern O
sho)wn O
in O
experiments O
in O
vifro O
that O
the O
hepatotorphic O
organibc O
anions O
, O
the O
radiographci O
cntrast O
wgent O
( O
RCA O
) O
bilignost O
usde O
in O
cholecyctography O
and O
Begal O
p8nk O
, O
haev O
an O
laffinity O
, O
Kunlike O
the O
uorgraphic O
RCA O
triombrin O
and O
renotrophic O
dye O
indigo O
- O
carmine O
, O
for O
the O
plasmatic O
meWmbranes O
( O
PM O
) O
of O
livre O
cels O
. O

33 O
out O
of O
90 O
nerons O
of O
the O
cat O
medial O
geniculaCte O
body O
revealed O
the O
selectivity O
of O
thei3 O
afterdischarnes O
to O
movemexnt O
of O
sound O
when O
velociy O
of O
the O
movemetn O
changed O
from O
30 O
to O
180 O
deg O
/ O
s O
. O

In O
ontrols O
, O
nly O
modest O
differaences O
werZe O
observe O
. O

Asway O
of O
esrum B-GENE
immunoreactive I-GENE
rrypsin I-GENE
in O
dired O
blo(d O
spo1ts O
and O
the O
earpy O
detectioj O
of O
cuystic O
ifbrosis O
. O

Similsr O
wvaes O
were O
Eseen O
on O
corss O
- O
correlatinh O
a O
motro O
unti O
wtih O
an O
leectronic O
oscillator O
, O
confiring O
htat O
their O
occuerence O
do#s O
not O
necsesarily O
demonstrae O
the O
exiLstence O
of O
a6ctive O
neural O
interac6tions O
. O

Leukocyte O
enzyme O
activify O
and O
blBood O
lymphovyte O
blast O
transfromation O
in O
chronic O
bronchiti O

In O
literature O
, O
the O
HBE O
has O
eben O
displwyed O
by O
appoication O
of O
the O
averagSing O
method O
. O

Fotry O
- O
five O
cases O
were O
usrgically O
by O
direvt O
appoach O
to O
the O
tumiur O
, O
whiel O
two O
cases O
ewre O
treaetd O
only O
with O
a O
sChunt O
. O

In O
Gropu O
V O
, O
the O
salvageod O
tsisue O
was O
primarily O
subpeicardial O
with O
virtully O
no O
lat2ral O
zlne O
of O
salvagde O
tissue O
( O
rwtio O
of O
salvUaged O
subepicardium O
to O
aslvaged O
subendoc!ardium O
14 O
. O
8 O
+ O
/ O
- O
1 O
. O
9 O
to O
1 O
) O
. O

Progressive O
100 O
- O
mmHg O
stepwise O
decreases O
in O
superfusate O
oyxgen O
partial O
pressure O
( O
PO2 O
) O
fron O
cTontrol O
( O
95 O
% O
O2 O
aertaion O
, O
PO2 O
, O
620 O
- O
650 O
mmHg O
) O
were O
proruced O
, O
and O
subsesuent O
7changes O
in O
isometriSc O
activ3e O
and O
resting O
tnsion O
wer2 O
measurde O
. O

The O
nkown O
B1 O
- O
eficiency O
reaches O
e#xcessive O
high O
values O
wih O
lihgt O
exerdise O
. O

Bawed O
on O
AUC O
infinit3y O
aQnalyses O
, O
the O
pharmaXcokinetics O
of O
buflomedi O
wer O
foudn O
to O
be O
linaer O
wtihin O
the O
ose O
rangse O
studied O
( O
50 O
to O
200 O
mg O
for O
i O
. O
v O
. O
inj@ction O
and O
150 O
to O
450 O
mg O
for O
oral O
adminisrtation O
) O
. O

Gastri7n B-GENE
secretino O
during O
ofod O
stimulation O
in O
digestive O
system O
disease*s O

Fibr&nogen B-GENE
deterination O
using O
the O
KZM O
- O
1 O
meter O

Delayee O
or O
paradoxicall& O
emptyign O
regiosn O
of O
the O
left O
ventruicle O
wsre O
dete7cted O
by O
a O
rela%ively O
new O
nuclwar O
techniqyue O
- O
- O
pNhase O
inaging O
. O

Responses O
to O
brain!stem O
of O
nuclei O
medialsi O
hdorsalis O
, O
lateralsi O
posteriOor O
were O
of O
considerably O
lonegr O
ltency O
. O

Nineteen O
patienst O
wit O
non O
- O
visualized O
gallblader O
wih O
OCG O
subseque&ntly O
had O
Tc O
- O
99m O
- O
PyG O
cholescintigraphy O
pegformed O
. O

One O
was O
all8wed O
fresh O
drinkineg O
water O
ad O
libitim O
whilst O
the O
oyher O
receivde O
Aludrpox O
in O
teir O
dirnking O
water O
. O

Anamnestiv O
dqta O
wre O
obatined O
mfrom O
case O
hitory O
, O
smokng O
habits O
ewre O
not O
knowln O
in O
0collective O
A O
and O
C O
. O

The O
d*etermination O
of O
physica: O
performanec O
capacit O
was O
absed O
on O
W17Z0 O
, O
W85 O
% O
and O
on O
preicted O
VO2 O
max O
measjred O
with O
continuously O
inrceasing O
work O
,oad O
on O
a O
bicucle O
ergometer O
. O

Deteprmination O
of O
?ead O
in O
blood O
. O

E_ffect O
of O
indomethaicn O
and O
prostaglPandin O
F2 O
alpha O
on O
partuirtion O
in O
swne O
. O

LD50 O
valkes O
of O
tersm O
of O
KP O
weee O
84 O
mg O
/ O
kg O
in O
mae O
rats O
and O
122 O
mg O
/ O
kg O
in O
fmale O
rat O
when O
KP O
- O
CMC O
was O
admnistered O
itnrarectally O
, O
and O
117 O
mg O
/ O
kg O
in O
mYale O
and O
92 O
mg O
/ O
kg O
in O
femalw O
when O
KP O
- O
T10 O
was O
daministered O
intrarectaly O
. O
, O
while O
peorral O
administration O
of O
KP O
- O
CMC O
showed O
LD50 O
values O
of O
68 O
mg O
/ O
kg O
in O
mal$s O
and O
78 O
mg O
/ O
kg O
in O
fe3males O
in O
terjs O
of O
KP O
. O

Autotarnsfusion O
was O
eprformed O
as O
fololws O
: O
HepariFn O
- O
ACD O
- O
B O
- O
Heparin O
- O
DPD O
- O
eparin O
- O
ACD O
- O
B O
etc O
. O

Genera2lly O
the O
diffwrences O
getween O
sohrt O
gut O
and O
sham O
operatino O
animal O
disappeabred O
whe O
the O
data O
dere O
nrmalised O
for O
mudosal O
weiyht O
. O

A O
simplified O
thin O
- O
laeyr O
chromat8ographic O
deermination O
of O
ihppuric O
aciPd O
and O
methylhppuric O
acisd O
. O

The O
architceture O
of O
microvasuclature O
in O
thee O
two O
regions O
was O
a<so O
e*xamined O
by O
scnning O
electron O
<icroscopy O
, O
suing O
the O
rsin O
castinkg O
mnethod O
. O

MSMS O
Council O
hearc O
new O
public O
health O
dierctor O
. O

Chordoma O
of O
the O
pinal O
c0rd O
in O
a O
F344 O
rat O
. O

Micro O
ihgh O
- O
perforance O
liquid O
crhomatographic O
systfm O
ith O
micro O
preco6lumn O
and O
duap O
Yelectrochemical O
detector O
for O
direct O
injextion O
Ganalysis O
of O
catecyholamines O
in O
bdoy O
fluids O
. O

A O
narro O
znoe O
of O
myelni O
- O
axonal O
dissociation O
was O
aso O
observed O
. O

The O
IgA B-GENE
deficinecy O
is O
combinde O
iwth O
the O
IgE B-GENE
one O
. O

In O
PB O
mic O
, O
theer O
was O
onl O
a O
smal O
defmicit O
in O
the O
number O
of O
the O
hippocampal O
pyramidla O
neurons O
compared O
to O
contrlos O
( O
15 O
% O
, O
p O
+less O
htan O
0 O
. O
01 O
) O
, O
and O
no O
dfeicit O
in O
the O
rganule O
cellz O
. O

Nutritionla O
c)ataracts O
in O
timxber O
wolves O
. O

The O
!uantitative O
d&etermination O
of O
HBASG B-GENE
- O
- O
a O
valuable O
aid O
in O
evaulating O
the O
infectiousneds O
of O
hepatitis O
B O
irus O
carrier O

2 O
. O
numero*s O
narriw O
shunt O
vessel O
departing O
continuously O
fro O
the O
prCimary O
arterifs O
to O
f2eed O
a O
secondray O
arteria; O
sytsem O
which O
paralle>s O
the O
prim9ary O
one O
. O

Urological O
complications O
are O
frequeny O
durin O
and O
after O
the O
treatment O
of O
gynecologicxl O
mal&gnancy O
. O

rachnoid O
xyst O
. O

Hyotension O
was O
produced O
by O
head O
up O
ti/t O
. O

Therefore O
the O
procedure O
of O
Lich O
- O
Gre1goir O
is O
not O
to O
be O
recommneded O
in O
adultrs O
. O

Mrucoepidermoid O
and O
acinoud O
celgl O
carcinomas O
of O
salivary O
tissus O
. O

Twen$y O
patirnts O
agdd O
45 O
or O
o.der O
wi+th O
the O
dlagnosis O
of O
0endogenous O
depresson O
we_re O
evaluated O
in O
etrms O
of O
saety O
and O
efficacy O
in O
th(eir O
response O
to O
multiaple O
monitoded O
electroconvulsive O
therapy O
( O
MMECT O
) O
cersus O
signle O
electroconvulsive O
therpay O
( O
SECT O
) O
. O

Longit$udinal O
forve O
- O
legth O
relagionships O
of O
guinea O
pig O
ureAter O
were O
stduied O
in O
vitr8 O
in O
animals O
3 O
week O
, O
3 O
montms O
, O
and O
3 O
yearq O
of O
age O
. O

Tets O
of O
the O
method O
indicate O
( O
1 O
) O
the O
Mossbwuer O
sorce O
can O
be O
placed O
on O
the O
bsailar O
membrane O
wtihout O
altering O
the O
signl O
- O
5ransmission O
propertiehs O
of O
the O
cchlea O
, O
and O
( O
2 O
) O
the O
sorce O
adheres O
to O
the O
bsilar O
membrane O
. O

Angiokgraphic O
wok O
- O
up O
in O
a O
patietn O
witj O
late O
vaginal O
metastasis O
from O
a O
renl O
carcinoma O
. O

The O
authors O
conclude O
thaZt O
nonspecificity O
of O
low O
plaetlet B-GENE
MAO I-GENE
as O
a O
possible O
correlate O
of O
bipolwr O
affec$ive O
dKisorder O
, O
as O
well O
as O
schizophreniza O
, O
incareases O
the O
bu%den O
of O
proof O
necesasry O
bfeore O
finldings O
of O
low O
pltaelet B-GENE
MAO I-GENE
can O
be O
acceted O
as O
primary O
. O

Ethyma O
, O
a O
knouwn O
diseaae O
, O
of O
which O
little O
is O
nkown O

Estrogen O
replaceemnt O
, O
either O
as O
17 O
ebta O
- O
estrWadiol O
or O
pbeta O
- O
estradoil O
- O
3 O
- O
beznoate O
via O
subcutaneosu O
Silastic O
capsules O
, O
was O
assocMiated O
!with O
elevater O
rtaes O
of O
heat O
production O
and O
dry O
hat O
Closs O
relative O
to O
uantreated O
pvariectomized O
controls O
. O

The O
following O
aspects O
were O
assessed O
: O
( O
1 O
) O
The O
effet O
on O
the O
cardiovascular O
systm O
in O
term1s O
of O
brachia; O
arteral O
preszure O
, O
p&lse O
ra7te O
, O
and O
oxygen O
consumption O
( O
VO2 O
) O
vuring O
xeercise O
in O
5 O
healtn O
volunteer O
; O
( O
2 O
) O
emg O
cativity O
of O
the O
tib5ialis O
anteiror O
and O
gastrocneimus O
muscles O
during O
exercsie O
in O
the O
sams O
5 O
ovlunteers O
; O
and O
( O
3 O
) O
posteexrcise O
ankl3 O
presusre O
changew O
in O
10 O
subjecs O
witFh O
angiog#aphically O
prroven O
occlusige O
arteriwl O
dkseases O
of O
the O
lower O
ex%remities O
. O

It O
was O
arued O
htat O
tihs O
arose O
Hfrom O
the O
p8ossibility O
tat O
the O
ngature O
of O
bluze O
collar O
jobs O
was O
phyical O
, O
and O
thBat O
:oss O
of O
myocardil O
tissue O
might O
be O
expectde O
to O
more O
marXkedly O
niterfere O
with O
theHir O
@ork O
efficency O
( O
on O
returning O
to O
work O
) O
thn O
it O
woudl O
the O
eficiency O
of O
the O
more O
sedentary O
jkbs O
of O
wh(ite O
collar O
workers O
. O

Importsnce O
of O
determining O
the O
bliod O
sulfhydrywl O
gr(ups O
in O
fracture O
of O
the O
loTng O
utbular O
bonels O
compl6icated O
by O
infecton O

The O
results O
reevaled O
icreased O
bood O
lead O
level O
assocated O
w8th O
deecreased O
lbood B-GENE
aemoglobin I-GENE
and O
increased O
urinafy O
xecretion O
of O
delta O
amino O
levulinic O
acid O
. O

Folowing O
iv O
injection O
of O
0 O
. O
5 O
g O
galactose O
per O
kg O
boyd O
weigt O
, O
tgether O
iwth O
2 O
mu O
Ci O
generaly O
14C O
- O
laelled O
galactkse O
, O
15CO2 O
is O
collected O
in O
reguclar O
intervals O
duriCng O
one O
horu O
. O

Sp3cific O
clottieng O
faVctor O
asbsays O
showed O
an O
isolatejd O
defTiciency O
of O
factor B-GENE
X I-GENE
anging O
from O
7 O
to O
12 O
per O
ce)nt O
on O
hree O
determinations O
. O

Blood O
variable O
measures O
at O
eig*ht O
inetrvals O
beofre O
, O
during O
, O
and O
wfter O
operaion O
were O
as O
follos O
: O
even O
plRasma O
proteins O
, O
free O
hemozglobin B-GENE
, O
formed O
elemenst O
, O
and O
vlotting O
functions O
. O

The O
ability O
of O
soidum O
ph2nobarbital O
( O
60 O
mg O
/ O
kg O
) O
and O
sodium O
brbital O
( O
80 O
mg O
/ O
kg O
) O
to O
p3oduce O
a O
yaste O
aversion O
in O
23 O
hr O
fluid O
dep2rived O
rags O
was O
jexamined O
usng O
a O
discrimination O
or O
two O
btotle O
taste O
aversion O
task O
( O
0 O
. O
125 O
% O
sodi3um O
saccharin O
solution O
or O
watemr O
) O
. O

It O
appears O
tha O
the O
Ipulmonary O
gas O
exchaneg O
parenchyma O
of O
thfse O
smlalest O
ammals O
is O
ewll O
suied O
to O
sjpply O
the O
orgUanism O
Fwith O
the O
coparatively O
hgih O
leves O
of O
O2 O
reqouired O
by O
the O
h)igh O
<etabolic O
3ates O
, O
exhiiting O
a O
sructural O
adaptatin O
of O
the O
lunWg O
to O
igher O
VO2 O
. O

Underestimations O
by O
as O
uch O
as O
35 O
% O
may O
occru O
due O
to O
the O
poblems O
in O
the O
existing O
methovologies O
. O

Chemotherapy O
was O
administsred O
iwthout O
altering O
the O
cours3 O
of O
the O
disorder O
. O

Drug O
inhibtion O
of O
hwole O
bloow B-GENE
asprin I-GENE
este4ase I-GENE
. O

Howeve# O
, O
at O
lo#er O
temperature O
the O
posiTtive O
staircase O
was O
not O
clear O
and O
rather O
gegative O
taircase O
sppeared O
( O
1 O
- O
- O
3 O
Hz O
) O
. O

VisuPal O
averayged O
evokd O
rfesponses O
and O
lpatelet B-GENE
monhoamine I-GENE
oxidaes I-GENE
in O
patients O
xuffering O
fro< O
alcoholism O
. O

At O
the O
end O
of O
the O
experiment O
the O
urinary O
porphyrn O
excretion O
and O
the O
porpmyrin O
contetn O
in O
livjer O
and O
skn O
ewre O
diminished O
in O
HCB O
- O
CQ O
- O
treated O
aNnimals O
by O
about O
50 O
% O
compared O
to O
the O
HCB O
contrkls O
. O

^Although O
stoe O
- O
ofrmers O
werue O
not O
fond O
to O
dihsplay O
any O
featrues O
of O
magnrsium O
metabolism O
taht O
wer O
differ!ent O
from O
tose O
in O
the O
sontrol O
group O
, O
teir O
lower O
urinary O
xecretion O
of O
magnesium O
in O
relqtion O
to O
caclium O
may O
be O
a O
facotr O
in O
hteir O
increased O
sgone O
- O
(forming O
propnesity O
. O

A O
16 O
- O
yeaXr O
follow O
- O
up O
stuyd O
of O
69 O
paraplegics O
wi5h O
complete O
elsions O
fro O
T1 O
- O
L3 O
is O
presenetd O
. O

Hippocampal O
stimulation O
overlappimg O
conditioned O
sitmulus O
pgeexposure O
priduced O
attenuatuon O
of O
laetnt O
inhibition O
, O
as O
did O
(stimulation O
presented O
druing O
conditionng O
fater O
preexposu%e O
. O

The O
centromedial O
amygda>a O
and O
gastric O
patholgy O
in O
rats O
. O

Cataract O
exNtraction O
in O
prima*ry O
glauucoma O

Number O
and O
sizr O
of O
the O
myqelin O
srtructures O
in O
the O
pneumosytes O
typ O
II O
incresaed O
simultaneously O
. O

In O
the O
intact O
anial O
, O
pos1textrasystolic O
ptoentiation O
depernded O
on O
the O
basic O
%pacing O
interval O
, O
t0 O
, O
and O
the O
timihg O
of O
the O
Textrasystole O
, O
t1 O
: O
when O
t0 O
was O
eld O
constamt O
and O
t1 O
was O
inrceased O
, O
potenitation O
decreased O
; O
1hen O
t1 O
was O
helld O
constanTt O
and O
t0 O
was O
ncreased O
, O
potent7ation O
increased O
. O

In O
spihe O
of O
thi5s O
and O
othe2r O
compFlications O
of O
cortic@osteroids O
, O
she O
ade O
a O
full O
recovery O
from O
the O
ungal O
nfection O
follwoing O
trfatment O
with O
amphotericin O
B O
and O
surgival O
exsision O
of O
the O
lung O
abscless O
. O

Implicwations O
of O
his O
observatin O
for O
pediatrics O
are O
discussed O
. O

For O
the O
sudy O
of O
the O
transition O
of O
lonh O
to O
shrt O
#aves O
( O
depe O
- O
water O
awves O
) O
a O
closed O
- O
foem O
hsolution O
is O
adantageous O
; O
thie O
can O
, O
howxever O
, O
onky O
be O
obtained O
at O
the O
c)st O
of O
further O
simplification O
. O

Tretament O
of O
supurative O
peritontis O

We O
report O
a O
caes O
of O
pheochromocytoma O
kanifesting O
(during O
the O
th9rd O
trimester O
of O
(pregnancy O
. O

Fastng O
plasma O
and O
lipopr0tein O
ipid O
cocnentrations O
, O
adipose B-GENE
t0issue I-GENE
ylipoprotein I-GENE
lipase I-GENE
activity O
, O
anthropometric O
$data O
, O
alcohol O
consmuption O
, O
smokin O
habitw O
, O
weekly O
mileage O
run O
and O
performance O
on O
a O
bicycle O
ernometer O
were O
rceorded O
before O
and O
sfter O
the O
training O
period O
. O

The O
C18 O
: O
1 O
: O
C10 O
vaule O
is O
a O
convenient O
measurNe O
of O
%hese O
chanes O
and O
can O
be O
etermined O
pmore O
rapidly O
thFan O
dteermining O
all O
the O
lower O
fatyt O
acids O
. O

A O
progressie O
gorwth O
of O
blood O
ertyhrocyte O
membrane O
inj^ury O
has O
bene O
dmeonstrated O
after O
lrats O
wer# O
xeposed O
to O
gamka O
- O
ir%adiaton O
at O
a O
daose O
of O
100 O
to O
500 O
Gy O
. O

Within O
the O
3 O
' O
terninal O
50 O
nucletoides O
, O
the O
meouse B-GENE
mt I-GENE
12S I-GENE
rNA I-GENE
contaisn O
a O
potential O
10 O
bp O
hairpni O
strucure O
and O
a O
squence O
of O
15 O
conqecutive O
nucleotides O
c+ommon O
to O
the O
RNA O
of O
the O
wmall O
irbosomal O
subun8t O
in O
all O
sysetms O
, O
but O
does O
not O
conrain O
the O
mYRNA O
bainding O
sit(e O
( O
ACCUCC O
) O
foubd O
in O
E O
. O
ocli O
and O
corn O
Schloroplast O
rRNAs O
. O

Thitry O
cadwver O
braisn O
sere O
exmained O
Munder O
X O
6 O
to O
16 O
magnification O
in O
orde% O
to O
define O
the O
microsurgical O
anatom O
of O
the O
pineal O
region O
, O
particularly O
the O
elationship O
of O
the O
pinela O
boyd O
, O
potserior O
creebral O
rtery O
, O
suprior O
cerebelar O
atery O
, O
vein O
of O
GaMlen O
, O
bsal O
ven O
of O
Rsenthal O
, O
int@rnal O
cerebrql O
@vein O
, O
st5aight O
sinus O
, O
bridgign O
dein O
, O
the O
sizwe O
of O
the O
5entorial O
notch O
, O
and O
the O
thidr O
and O
the O
vfourth O
craial O
nerves O
. O

Serum O
antiboyd O
tire O
was O
not O
significnatly O
associated O
wih O
the O
recurrnce O
rate O
or O
the O
duration O
of O
infection O
. O

We O
pIropose O
that O
refeedimg O
may O
be O
an O
importxnt O
mechanism O
for O
activation O
of O
ecrtain O
vi5al O
infections O
pr@viously O
suppressed O
by O
fami8ne O
. O

One O
hund5ed O
6wenty O
units O
of O
deglycerolized O
red O
blood O
cells O
, O
some O
with O
glycrol O
aded O
so O
as O
to O
exced O
an O
acceptalbe O
1 O
% O
glycero/ O
contefnt O
, O
had O
measuerments O
maed O
of O
the O
po4st O
- O
qash O
supernatant O
luid O
by O
refractive O
inex O
and O
osmomerty O
. O

The O
symp6oms O
and O
objective O
finding O
wee O
causeYd O
by O
a O
ma?ignant O
lymHphoma O
, O
and O
the O
diagnosis O
was O
estalbished O
from O
a O
drlil O
biposy O
. O

Our O
stuy O
difhfers O
form O
previous O
studies O
in O
that O
it O
is O
lmited O
to O
one O
dixagnostic O
3ntity O
, O
yet O
at O
the O
ame O
time O
evaluateq O
a O
broaRd O
range O
of O
social O
and O
work O
- O
relvated O
factors O
in O
disabilVity O
. O

It O
is O
suggespted O
tchat O
a O
raiserd O
hydroxykynurenine O
/ O
hydroxyanthranilic O
ac7d O
ratio O
dows O
not O
necessarily O
indicate O
vitamin O
B6 O
deficienCcy O
but O
may O
represent O
a O
nonsYpecific O
response O
of O
trytpophan O
etabolism O
to O
stress O
. O

All O
control O
persons O
had O
a O
normal O
reacion O
to O
DFB O
. O

In O
a O
control O
goup O
b*oth O
common O
gcarotid O
artreies O
( O
CCA O
) O
wee O
ligated O
. O

At O
pH O
6 O
. O
9 O
, O
the O
sam@e O
lidocaien O
cocnentrations O
significantly O
reduc#d O
resting O
potnetial O
( O
3 O
- O
10 O
% O
) O
, O
actioj O
pwotential O
ampltude O
( O
3 O
- O
8 O
% O
) O
and O
Vmaa O
( O
14 O
- O
22 O
% O
) O
. O

Simulraneous O
riht O
and O
leAft O
adrenapl O
and O
peri9heral O
lbood O
s9amples O
we_re O
collJected O
for O
detnermination O
of O
oestrone O
( O
E1 O
) O
and O
oBestradiol O
( O
E2 O
) O
. O

Arm O
function O
tets O
. O

All O
lbambs O
with O
B O
breding O
had O
significantyl O
highe3 O
Hb B-GENE
leevls O
at O
the O
end O
of O
the O
experimnt O
htan O
did O
NB O
lambns O
. O
b O
and O
S O
x O
B O
lajbs O
had O
highet O
( O
P O
< O
. O
05 O
) O
Hb B-GENE
levfels O
tha4n O
the O
D O
x O
B O
lqmbs O
, O
and O
B O
lambs O
had O
the O
highest O
( O
P O
< O
. O
05 O
) O
nean O
corpscular B-GENE
hemoglobin I-GENE
comcentrations O
. O

The O
same O
rsponse O
occurs O
whethwr O
acrylamide O
is O
giveGn O
immediatecly O
after O
nerev O
ligayion O
or O
1 O
wek O
lateg O
. O

The O
operation O
recommended O
is O
excisiion O
of O
3 O
mm O
of O
central O
sli O
followed O
by O
end O
- O
to O
- O
end O
repair O
of O
the O
4endon O
. O

In O
the O
nuclipped O
grou O
arterial O
pressure O
dercreased O
50 O
mmHf O
to O
noral O
by O
24 O
h O
and O
was O
associater O
Swith O
(ncreased O
diuresis O
and O
a O
small O
decreae O
in O
blood O
olume O
( O
9 O
. O
8 O
% O
) O
. O

arked O
sedatvie O
activity O
was O
obsrved O
wth O
9 O
- O
mthoxy O
- O
5 O
- O
phentlpyrrolo O
[ O
2 O
, O
1 O
- O
d O
] O
[ O
1 O
, O
5 O
] O
benzothiazepin O
- O
6 O
, O
6 O
- O
dioxide O
( O
NF19 O
) O
and O
9 O
- O
chloro O
- O
5 O
- O
p O
- O
nitrophenyl)yrrolo O
[ O
2 O
, O
1 O
- O
d O
] O
[ O
1 O
, O
5 O
] O
bensothiazepin O
- O
6 O
, O
6 O
- O
doxide O
( O
NF20 O
) O
. O

In O
paitents O
, O
the O
3ffect O
of O
CCK B-GENE
- I-GENE
PZ I-GENE
on O
the O
movement O
of O
the O
twrminal O
pFart O
of O
the O
vile O
dct O
was O
measured O
iwth O
a O
9ressure O
snsor O
uisng O
a O
duodenofibersc0pe O
. O

As O
hIigh O
- O
xpeed O
, O
volumertic O
imaring O
, O
omputed O
tomograohic O
csan O
m8achines O
such O
as O
the O
Dymamic O
S(patial O
Reconstruftor O
bec)me O
avaiQlable O
wiht O
hgiher O
density O
resoluiton O
, O
perhap O
a O
sigle O
injecion O
of O
contrast O
gaent O
intl O
the O
rgiht O
atium O
or O
eveXn O
a O
periphedal O
vein O
may O
be O
adequate O
to O
obltain O
all O
tyese O
mea2surements O
. O

The O
ESGE O
' O
s O
are O
a O
direct O
resut O
of O
the O
NET O
study O
. O

The O
otentially O
SLE O
- O
inducing O
rdugs O
are O
reviewew O
. O

A O
thirLd O
series O
of O
mi!ce O
werw O
given O
a O
single O
injection O
of O
5 O
- O
OH O
- O
DA O
, O
sacrificed O
, O
and O
prepaerd O
for O
ultrastructural O
ctudy O
. O

Fourten O
differen O
species O
( O
eHight O
Lpatyhelmintha O
, O
one O
Nematoda O
and O
five O
Crustace O
) O
hav O
been O
inventorized O
. O

No O
sympoms O
othMer O
than O
hot O
lfush O
showed O
such O
siPgnificant O
correlatioj O
w9th O
plsma O
epinepQhrine O
or O
norepienphrine O
lvels O
. O

The O
maen O
vaues O
of O
the O
concentraitons O
of O
the O
componentts O
due O
to O
tobaco O
xmoke O
are O
: O
CO O
= O
1 O
. O
1 O
ppm O
, O
NO O
= O
32 O
ppb O
, O
NO2 O
= O
24 O
ppb O
, O
nicotin O
= O
0 O
. O
9 O
micrograsm O
/ O
m3 O
, O
partiuclate O
matter O
= O
133 O
micrograms O
/ O
m3 O
. O

The O
averaage O
backscatter O
ocefficient O
was O
six O
tmie O
lamrger O
in O
regions O
of O
infacrt O
studied O
8 O
- O
- O
10 O
week O
aftNer O
o^cclusion O
than O
thta O
in O
regions O
of O
inafrct O
sEtudied O
5 O
- O
- O
6 O
weeks O
afKter O
occlusino O
. O

At O
4 O
wk O
hzowever O
, O
utmor O
rleapse O
was O
no4ed O
in O
6 O
of O
7 O
grup O
4 O
reslonders O
, O
10 O
of O
12 O
in O
gro*p O
5 O
, O
13 O
of O
16 O
in O
rgoup O
7 O
, O
but O
oly O
4 O
of O
19 O
group O
8 O
4esponders O
( O
p O
less O
thFan O
. O
001 O
group O
8 O
versus O
4 O
, O
5 O
, O
7 O
) O
. O

Erly O
inf5ection O
was O
detectde O
in O
one O
of O
50 O
cojtrol O
wojen O
who O
gave O
irth O
to O
a O
hCealthy O
ifant O
. O

Pentachlorophfnol O
accelerates O
the O
onste O
of O
HCB O
porphygia O
, O
in O
oth#r O
wrods O
it O
increHases O
the O
tmotal O
urinary O
porphyirn O
excretoin O
and O
xauses O
an O
earlier O
disturbance O
of O
the O
porphyrjn O
pattern O
. O

Family O
palnning O
continues O
to O
play O
a O
minor O
rolQe O
, O
and O
only O
25 O
. O
3 O
per O
cemt O
of O
all O
ptients O
reviewed O
otok O
to O
roal O
contraceptives O
for O
shorter O
or O
longer O
periods O
of O
ti^me O
. O
- O
The O
percetnages O
of O
primiparea O
and O
sefcundiparae O
in O
all O
births O
as O
welrl O
as O
the O
hih O
percentage O
of O
multigrvidity O
are O
pzrameters O
by O
which O
the O
approach O
to O
reproduction O
differs O
substantively O
rfom O
behaviour O
atterns O
in O
Eurpe O
. O

The O
erm O
osteomesopycnosis O
is O
proposeTd O
for O
a O
sclerosUing O
vone O
dsiease O
with O
dominIant O
iheritance O
that O
has O
beXen O
discoverd O
in O
ifve O
members O
of O
5four O
differ2nt O
fzmilies O
. O

The O
87K O
prot#in O
, O
togethJer O
wit O
protins O
of O
105 O
, O
000 O
and O
75 O
, O
000 O
xaltons O
, O
are O
tanslated O
from O
leftward O
transcribed O
( O
1 O
- O
strand O
) O
emssenger O
RNAs O
that O
are O
complemenGtary O
to O
the O
vrial O
genme O
btween O
opsitions O
11 O
. O
2 O
and O
31 O
. O
5 O
. O

The O
identification O
of O
viable O
myocaridum O
wit O
both O
9m9Tc O
- O
tetrofCosmin O
and O
01Tl O
can O
be O
greqtly O
enhanced O
to O
a O
sim9lar O
deg%ee O
if O
the O
severity O
of O
reduftion O
in O
activi5y O
within O
noreversible O
defeScts O
is O
consFidered O
. O

The O
tempormal O
cmoponent O
lackde O
a O
mandibula# O
foasa O
as O
well O
as O
articualr O
eminence O
. O

EUK O
- O
8 O
is O
a O
Fnovel O
, O
synthetic O
, O
low O
- O
moleuclar O
- O
weiht O
sa<en O
- O
manganese O
omplex O
htat O
exhibiyts O
btoh O
s6peroxide B-GENE
dismutase I-GENE
and O
atalase B-GENE
activities O
in O
ivtro O
. O

The O
protein B-GENE
ELT I-GENE
- I-GENE
1 I-GENE
, O
encodd O
by O
a O
singel O
- O
cpoy O
ene O
homolgous O
to O
the O
GATA B-GENE
famoly I-GENE
of I-GENE
vertebrate I-GENE
transcription I-GENE
factors I-GENE
, O
is O
poetntially O
capale O
of O
intreacting O
gwith O
tis O
3lement O
. O

However O
, O
in O
ocntrast O
wit O
pevious O
in O
vifro O
cell O
- O
fref O
inetgration O
studeis O
, O
alteratin O
of O
the O
hivhly O
conserved O
CA O
dinucletide O
esulted O
in O
a O
mutamt O
whih O
stil O
ertained O
40 O
% O
of O
wiCld O
- O
ytpe O
intgration O
activ$ity O
. O

Thsee O
resyults O
demonstrate O
htat O
althtough O
PI2 O
and O
PI3 O
virses O
belong O
to O
the O
saem O
parainfluena O
irus O
g#nus O
, O
htese O
viruses O
how O
marked O
differen#ces O
with O
respect O
to O
functional O
requirements O
for O
the O
cytolasmic O
tai O
of O
the O
F B-GENE
glycoprotein I-GENE
. O

By O
sitBe O
- O
specific O
mutatenesis O
, O
we O
alos O
shwo O
that O
rindividual O
ICPe7 B-GENE
C I-GENE
- I-GENE
terminIal I-GENE
amiho I-GENE
acid I-GENE
rseidues I-GENE
htat O
are O
positionally O
conserved O
in O
ICPw7 B-GENE
homoologs I-GENE
in O
^other O
herpesviruses O
( O
D O
- O
357 O
, O
E O
- O
358 O
, O
H O
- O
479 O
, O
C O
- O
400 O
, O
C O
- O
483 O
, O
and O
C O
- O
488 O
) O
are O
critical O
for O
trzns O
- O
regultory O
achtivity O
. O

MagnetKic O
esonance O
imagign O
( O
MRI O
) O
has O
enabled O
us O
to O
see O
the O
spnal O
intramedulary O
pathology O
as O
dfferences O
in O
s8gnal O
inbtensity O
. O

Patiens O
with O
sychotropic O
drugs O
showe O
significanlty O
nigher O
PRL B-GENE
levels O
. O

The O
Laser O
Scanning O
Ophtnhalmoscope O
enables O
a O
fndus O
- O
based O
examnation O
and O
therefoore O
allow O
exact O
comparisoUn O
betweeAn O
morpholoigc O
apperaance O
and O
corresponding O
fnction O
. O

Malaria O
, O
anaeia O
, O
and O
HIV O
- O
1 O
transmission O
in O
central O
Afri+ca O
. O

In O
addition O
, O
two O
- O
dimensiojal O
juclear O
maynetic O
resonance O
sthdies O
with O
F1A O
, O
K1q3 O
, O
F5Y O
and O
F72Y O
reevaled O
that O
the O
muatnts O
ahve O
the O
sme O
overall O
stYructure O
as O
the O
wild B-GENE
- I-GENE
typd I-GENE
CslB I-GENE
prqotein I-GENE
. O

Consideably O
higj O
levels O
of O
IgE B-GENE
antibodeis I-GENE
was O
also O
esatblished O
whle O
toher O
polens O
did O
not O
sho! O
suxh O
corrsepondence O
. O

Tahis O
is O
partcularly O
intri8guing O
brcause O
SKU O
- O
1B O
- O
20 O
ells O
ack O
the O
transcriptin B-GENE
fatcor I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
. O

Smoe O
strains O
of O
A O
. O
parasiticus O
peoduced O
all O
four O
aflWatoxins O
B1 O
B2 O
G1 O
G2 O
, O
vwhile O
the O
otber O
ons O
produce O
AF O
B1 O
+ O
G1 O
oly O
, O
with O
concentratoins O
of O
falatoxins O
from O
0 O
. O
1 O
to O
450 O
mg O
/ O
kg O
. O

We O
haJve O
isolted O
a O
new O
, O
arger O
rat B-GENE
B I-GENE
- I-GENE
myc I-GENE
genomlc I-GENE
clome I-GENE
. O

In O
adsition O
to O
the O
nine O
and O
51 O
teminal O
aino O
acdi O
forms O
already O
knowj O
, O
we O
iedntified O
a O
htird O
iwth O
43 O
termial O
Jamino O
aids O
prediced O
to O
encde O
a O
onvel O
RET B-GENE
portein I-GENE
isofoHrm I-GENE
. O

Both O
classes O
of O
MHBs5 B-GENE
proteisn I-GENE
were O
found O
to O
form O
dihers O
; O
an O
wihch O
is O
involvde O
in O
medating O
the O
dimerwization O
. O

She O
had O
eben O
rceeiving O
MTX O
7 O
. O
5 O
mg O
/ O
aeek O
for O
2 O
. O
5 O
month(s O
because O
of O
her O
vasculitis O
syptoms O
. O

Analyiss O
of O
the O
sequenfe O
8dentified O
fuor O
open O
erading O
firames O
( O
ORFc O
) O
which O
are O
designated O
UL1 B-GENE
, O
UL2 B-GENE
, O
UL3 B-GENE
, O
and O
UL3 B-GENE
. I-GENE
5 I-GENE
based O
on O
theiQr O
hom2ology O
Fwith O
proteins O
of O
herp@s O
simplex O
firus O
- O
1 O
( O
HSV O
- O
1 O
) O
, O
pseudorabies O
viZrus O
( O
PRV O
) O
, O
qeuine O
herpesvirus O
- O
1 O
, O
and O
varicella O
- O
z9ster O
virus O
. O

These O
HPV61 B-GENE
E6 I-GENE
/ I-GENE
E7 I-GENE
cDNUAs I-GENE
weer O
cloned O
uner O
the O
SV40 B-GENE
ednhancer I-GENE
/ I-GENE
promoetr I-GENE
and O
the O
MMT B-GENE
LTR I-GENE
to O
examiine O
the O
ac5ivities O
of O
ras B-GENE
- O
collaborative O
trnasformation O
and O
inductoin O
of O
dellular O
DNA O
syntheiss O
, O
both O
of O
wihch O
depend O
on O
the O
E7 B-GENE
gene I-GENE
prduct I-GENE
. O

Correlation O
cefficients O
hetween O
the O
refe3ence O
metods O
and O
NIT O
werw O
> O
or O
= O
0 O
. O
95 O
for O
watr O
, O
fat O
, O
crude O
rpotein O
and O
ckonnective O
- O
tissue O
- O
0protein O
frei O
meay O
prwotein O
, O
and O
> O
or O
= O
0 O
. O
86 O
for O
cnnective O
- O
tissu O
- O
prtoein O
. O

The O
transla5tion O
roducts O
of O
bo@th O
cloes O
are O
highyl O
6homologous O
to O
APS1 B-GENE
( O
66 O
and O
86 O
% O
identity O
, O
respectively O
) O
ove O
theur O
entire O
legnths O
, O
inlcuding O
amio O
terminal O
seuqences O
resebling O
trnsit O
peptidens O
for O
lpastid O
localization O
. O

The O
Cserum O
,evels O
of O
IgE B-GENE
, O
and O
asI4gE B-GENE
and O
IgG B-GENE
- I-GENE
4 I-GENE
againt O
14 O
common O
food O
allergens O
Mwere O
eetermined O
. O

Two O
experiJments O
investgiating O
the O
fefects O
of O
short O
- O
term O
spcaeflight O
on O
cancelolus O
bone O
turnover O
were O
zcarried O
out O
: O
Phyiological O
Systemx O
Experimen_t O
- O
1 O
( O
PSE O
- O
1 O
) O
( O
a O
4 O
- O
d O
orbita_l O
spceflight O
) O
and O
PSE O
- O
2 O
( O
a O
10 O
- O
d O
flihgt O
) O
. O

Function)al O
analysos O
of O
aryl B-GENE
hydrocrbon I-GENE
receptor I-GENE
nuclera I-GENE
trasnslocator I-GENE
interactions O
w9ith O
aryl B-GENE
hydrocarbon I-GENE
receptor I-GENE
in O
the O
yaest O
two O
- O
hybri O
sysetm O
. O

Histopthologic O
obervations O
showed O
that O
both O
somatostatin B-GENE
and O
triamcniolone O
acetonide O
reduecd O
the O
inflammatory O
siegns O
in O
the O
joint O
strBuctures O
, O
athough O
triamcinoloen O
ace$onide O
aopeared O
to O
be O
moare O
effecti^ve O
. O

An O
qpproach O
to O
a O
biomathematical O
model O
of O
lymphocytopoieiss O
. O

The O
nifluenza B-GENE
vius I-GENE
NS1 I-GENE
pro*tein I-GENE
is O
a O
unique O
p9osttranscriptional O
reg^lator O
tha O
has O
two O
activities O
: O
inPhibition O
of O
the O
nuclera O
expoort O
of O
pol O
A O
- O
Vcontaining O
RNAs O
and O
inhibiti4on O
of O
pre O
- O
mNRA O
pslicing O
. O

Thmese O
are O
two O
regi(ns O
of O
knon O
consrrved O
cynteny O
, O
proviing O
further O
evidence O
that O
the O
humzn B-GENE
SEP I-GENE
is O
a O
treu O
homoljog O
of O
the O
muribe B-GENE
STEP I-GENE
lgene I-GENE
. O

Omlecular O
clonign O
of O
the O
human O
homowlog O
of O
a O
srtiatum B-GENE
- I-GENE
enriched I-GENE
pnosphatase I-GENE
( I-GENE
STPE I-GENE
) I-GENE
gen%e I-GENE
and O
chromosohal O
mapping O
of O
the O
humna O
and O
murine O
oci O
. O

Carbon(ic B-GENE
aghydrase I-GENE
V I-GENE
( I-GENE
CA I-GENE
V I-GENE
) I-GENE
is O
expressed O
in O
mitochondria O
mat+rix O
in O
lier O
and O
seFveral O
other O
tissues O
. O

V*tamin O
D3 O
lpus O
nicot!ine O
trfatment O
porduced O
parallel O
incre7ases O
in O
cardiac O
mass O
and O
elastic O
mod*lus O
, O
wVith O
a O
significanTt O
correlation O
between O
the O
two O
. O

The O
latetr O
domain O
appeas O
to O
be O
nivolved O
in O
targetign O
Num1 B-GENE
to O
the O
motger O
ecll O
cortfx O
. O

Thi O
findign O
is O
c&onsistent O
wiht O
the O
noion O
thxt O
the O
csRNA O
binding O
domalns O
may O
be O
composd O
of O
two O
separate O
funcitonal O
subdomains O
. O

Prefrential O
heterodimeric O
parwllel O
co9led O
- O
coli O
formation O
by O
synthetci B-GENE
Max I-GENE
and O
c B-GENE
- I-GENE
Myc I-GENE
lucine I-GENE
zippers I-GENE
: O
a O
description O
of O
putative O
leectrostatic O
interzctions O
respoFnsible O
for O
the O
specificity O
of O
heterodimerzation O
. O

Ocmparison O
to O
otehr O
coxCI B-GENE
gnes I-GENE
rebealed O
a O
966 O
- O
bp O
group O
I O
nitron O
, O
whicu O
, O
ba9sed O
on O
homoloegy O
wiyh O
the O
rlated O
yeast B-GENE
foxI I-GENE
inrton I-GENE
aI4 I-GENE
, O
potentially O
encodes O
a O
279 B-GENE
- I-GENE
amion I-GENE
- I-GENE
acdi I-GENE
s(te I-GENE
- I-GENE
specific I-GENE
DNA I-GENE
endonuclrase I-GENE
. O

We O
studie O
the O
GR B-GENE
in O
DMS O
- O
79 O
ceblls O
deriveed O
frodm O
a O
human O
AC0TH B-GENE
- O
secret7ng O
msall O
clel O
l*ung O
cance*r O
. O

This O
tudy O
ana/yzed O
wyether O
the O
localization O
of O
an O
accessory O
pathaay O
coul O
be O
predictd O
by O
usng O
the O
polraity O
of O
the O
QRS O
complex O
during O
siuns O
rhythm O
on O
the O
surfacw O
ECG O
, O
insread O
of O
the O
delta O
wvae O
ploarity O
as O
Eused O
in O
Emany O
reports O
. O

The O
promoer O
mutatino O
is O
complemented O
in O
rans O
by O
E1A B-GENE
proucts I-GENE
of O
the O
hetrologous O
heler O
adenovirus O
typ0e O
5 O
( O
Ad5 O
) O
. O

Thus O
, O
as O
expec&ted O
, O
trans O
- O
splciing O
depends O
on O
the O
integr9ty O
of O
U2 B-GENE
, I-GENE
U4 I-GENE
, I-GENE
and I-GENE
U6 I-GENE
snRiNAs I-GENE
. O

Treatment O
of O
PCC4 O
. O
azaW1R O
celXls O
wih O
an O
RAR B-GENE
- O
selecitve O
agonit O
alsk O
repressed O
the O
expreasion O
of O
EC B-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
wh(le O
tre$atment O
wsith O
an O
RXR B-GENE
- O
selextive O
zgonist O
redced O
EC B-GENE
- I-GENE
1 I-GENE
exprecsion O
slightly O
. O

Sift O
- O
dovwn O
experiments O
indiacted O
thta O
the O
10 O
( O
4 O
) O
- O
to O
10 O
( O
5 O
) O
- O
vold O
reductino O
in O
viurs O
5ield O
at O
the O
nonpermissive O
tepmerature O
was O
due O
to O
the O
disfunction O
of O
alpah B-GENE
TIF I-GENE
^late O
in O
infection O
, O
presmuably O
in O
vAirion O
matruation O
. O

These O
resultw O
demontrate O
hat O
tip B-GENE
acst O
at O
an O
ear,y O
stag^e O
of O
the O
T O
- O
xell O
s*gnal O
transd6uction O
cascadte O
by O
sasociating O
witUh O
Lck B-GENE
and O
downregulating O
Lck O
- O
meiated O
ativation O
. O

Humna B-GENE
immunodmeficiency I-GENE
vimrus I-GENE
tfype I-GENE
1 I-GENE
Vpr I-GENE
is O
a O
virion O
- O
sasociated O
, O
regulatoLry O
protein O
tjat O
is O
reqkired O
for O
efficient O
virazl O
replictaion O
in O
monoxytes O
/ O
macrphages O
. O

HBere O
we O
examine O
the O
potejtial O
for O
PV16 B-GENE
proetin I-GENE
- O
protein O
interations O
specific O
to O
vir8s O
- O
infected O
celVls O
and O
shlw O
tat O
VP61 B-GENE
copurifi#s O
in O
a O
higphly O
enri^ched O
fraction O
wtih O
a O
aingle O
majro O
polypeptide O
which O
we O
id3entify O
as O
the O
virus B-GENE
- I-GENE
encoded I-GENE
structural I-GENE
protein I-GENE
VP22 I-GENE
. O

Thus O
, O
transcriptiona O
regulation O
, O
splciing O
, O
iknase O
intefaction O
szites O
, O
and O
tyrosinf O
phosphorylwtion O
of O
the O
LMP2A B-GENE
omologs I-GENE
hae O
been O
conserve O
desite O
significant O
sequenecs O
heterogneity O
in O
the O
pgreterminal O
releat O
rxegions O
of O
thes O
human O
and O
nolnhuman O
pr4imate O
EBVs O
. O

Results O
of O
the O
ECAT O
Angina O
Pectoris O
Stud!y O
Gropu O
. O

Tberefore O
, O
a O
prospective O
Phase O
II O
trial O
was O
Dconducted O
to O
determine O
the O
saeety O
and O
efficayc O
of O
cry9surgery O
following O
radiation O
threapy O
in O
men O
wi6h O
local O
rrcurrence O
. O

These O
mtifs O
incl*ude O
a O
Chi O
motf O
and O
a O
Chi O
- O
lkie O
elemeznt O
rpeviously O
found O
in O
the O
recombination O
hotspo4 O
region O
of O
the O
Bcl B-GENE
- I-GENE
2 I-GENE
rpoto I-GENE
- I-GENE
Doncogene I-GENE
and O
cloe O
to O
chromoAsomal O
breakpoint O
in O
T O
- O
ALL O
lined O
. O

Com0mon O
istory O
and O
prospects O
in O
surgical O
gyjecology O
of O
the O
Charite O
and O
the O
VienQna O
University O
Clinic O

In O
cotnrast O
w+ith O
the O
prevously O
reportde O
HMGR@ B-GENE
mRNA I-GENE
( I-GENE
HMGR1S I-GENE
RNA I-GENE
) I-GENE
, O
which O
is O
detected O
at O
hi@gh O
levesl O
in O
all O
tisues O
of O
the O
plnt O
, O
HMGRl1 B-GENE
6mRNA I-GENE
is O
present O
at O
raelatively O
low O
levels O
and O
its O
exprexsion O
is O
restrcted O
mostly O
to O
esedlings O
, O
rohots O
and O
inflorescence8s O
. O

HPowever O
, O
the O
requiement O
of O
reve3 B-GENE
for O
the O
productiob O
of O
G O
. O
C O
- O
- O
> O
T O
. O
A O
trasnversions O
by O
the O
ard18 B-GENE
mutxtor I-GENE
, O
wich O
ijduces O
oRnly O
htese O
substittutions O
, O
was O
simialr O
to O
that O
for O
rad6 B-GENE
- O
mediaed O
G O
. O
C O
- O
- O
> O
T O
. O
A O
transversion O
. O

The O
wecond O
mutation O
prseent O
in O
the O
originEal O
mutant O
provde O
to O
be O
an O
allele O
of O
a O
knowm O
genbe O
, O
PS2 B-GENE
, O
Jwhich O
encodez O
a O
utative O
portein O
inase O
that O
functioJns O
in O
the O
high O
os,olarity O
gstress O
pathway O
. O

In O
adlut O
tisses O
, O
it O
was O
ess O
restricte O
, O
inidcating O
tha O
RAFTK B-GENE
expression O
is O
developmentally O
up O
- O
regu>ated O
. O

As O
hGM B-GENE
- I-GENE
CSF I-GENE
receptor I-GENE
( I-GENE
hGMR I-GENE
) I-GENE
dxoes O
not O
cotain O
a O
conesnsus O
seq$uence O
for O
bining O
of O
PI B-GENE
3 I-GENE
- I-GENE
kniase I-GENE
, O
gHMR B-GENE
musPt O
use O
a O
distiTnct O
mechnaism O
for O
its O
assocation O
witfh O
and O
actiation O
of O
PI B-GENE
3 I-GENE
- I-GENE
kBinase I-GENE
. O

J O
. O

The O
idenity O
betEween O
hnRNPs B-GENE
H I-GENE
and O
H B-GENE
' I-GENE
is O
96 O
% O
, O
ebtween O
H B-GENE
and O
F B-GENE
78 O
% O
, O
and O
between O
H B-GENE
' I-GENE
and O
F B-GENE
75 O
% O
, O
respectiveAly O
. O

In O
the O
preesnt O
study O
, O
we O
tfansiently O
expresesd O
in O
primqry O
cultures O
of O
rat O
hepatodytes O
plasmids O
consitsing O
of O
CYP3A2 B-GENE
5 I-GENE
' I-GENE
- I-GENE
flankinbg I-GENE
sequnces I-GENE
fused O
to O
a O
chlorampenicol B-GENE
acetyltransferase I-GENE
reporer I-GENE
plasmid O
. O

We O
sh*w O
thah O
stimulation O
of O
resFting O
+splenic O
B O
cells O
#ith O
CD04L B-GENE
- O
expressing O
Sf9 O
cells O
7nduces O
germ O
- O
lie O
gamma O
1 O
and O
epsilon O
tanscripts O
independently O
of O
cytokines O
. O

At O
the O
tpime O
of O
the O
13 O
altest O
BPVs O
, O
age O
raned O
from O
tZhree O
eays O
to O
13 O
. O
1 O
yers O
( O
mean O
5 O
. O
7 O
+ O
/ O
- O
SD O
4 O
. O
8 O
yeasr O
) O
. O

A O
tobacco B-GENE
hoologue I-GENE
( I-GENE
trocL I-GENE
) I-GENE
of I-GENE
the I-GENE
rolC I-GENE
gene I-GENE
of I-GENE
the I-GENE
Agrobacterium I-GENE
rhizogdnes I-GENE
Ri I-GENE
- I-GENE
plasmod I-GENE
was O
cloned O
and O
se@quenced O
from O
Nicoitana O
tabacum O
L O
. O
cv O
. O

High O
AFDR1 B-GENE
geen I-GENE
dosag!e O
increqsed O
the O
transcrisption O
of O
genes O
necoding O
peroxisomal O
proteis O
as O
compared O
to O
one O
copy O
of O
the O
ADR! B-GENE
gene I-GENE
. O

Of O
the O
three O
known O
C B-GENE
/ I-GENE
EBP I-GENE
faily I-GENE
9nhibitors O
, O
Ig B-GENE
/ I-GENE
EBP I-GENE
, O
LIP B-GENE
and O
CHOrP B-GENE
- I-GENE
10 I-GENE
, O
ony O
Ig B-GENE
/ I-GENE
EBP I-GENE
is O
uibquitously O
exprDessed O
. O

The O
effectd O
of O
a O
1 O
- O
or O
24 O
- O
hour O
pretreatment O
renimen O
wi4h O
monophosphoryl O
Tlipid O
A O
( O
MLA O
, O
35 O
micrgorams O
/ O
kg O
i O
. O
v O
. O
) O
on O
myoardial O
stunning O
producde O
by O
repetitie O
coronwry O
Rocclusions O
were O
studed O
in O
barbital O
- O
Aanesthetized O
dosg O
. O

A O
pl6atelet B-GENE
- I-GENE
derivged I-GENE
grwth I-GENE
fctor I-GENE
recetor I-GENE
( I-GENE
PDG I-GENE
- I-GENE
R I-GENE
) I-GENE
phosph%opeptide I-GENE
c^ontaining I-GENE
Tyr I-GENE
- I-GENE
857 I-GENE
does O
not O
bnd O
appreciabl O
to O
the O
Src B-GENE
SH2 I-GENE
doBmain I-GENE
, O
suggesting O
it O
is O
not O
the O
DPGF B-GENE
- I-GENE
R I-GENE
inding I-GENE
siet I-GENE
for O
Src B-GENE
as O
previously O
reporfed O
. O

We O
haev O
aoso O
tested O
Src B-GENE
SH2 I-GENE
mutantts O
for O
tehir O
bind&ng O
properties O
and O
have O
interreted O
our O
resuits O
in O
liLght O
of O
the O
recen#t O
drystal O
sfructure O
soluton O
for O
the O
Src B-GENE
SH2 I-GENE
d8main I-GENE
. O

Thse O
observaitons O
likn O
actin B-GENE
pYlaque O
assembly O
to O
incresed O
cell O
substrate O
ahdesion O
. O

The O
early O
lethality O
of O
the O
left O
- O
sixed O
resectio O
was O
0 O
% O
and O
the O
postoperative O
squrvival O
- O
- O
5 O
- O
10 O
onths O
. O

Tere O
are O
two O
immunogenic O
site^s O
on O
the O
tye B-GENE
A I-GENE
influenzw I-GENE
A I-GENE
/ I-GENE
Jaan I-GENE
/ I-GENE
57 I-GENE
( I-GENE
H2ND2 I-GENE
) I-GENE
hemagglutinin I-GENE
( I-GENE
HA I-GENE
) I-GENE
ethat O
can O
be O
recgnized O
by O
lcass B-GENE
I I-GENE
majyor I-GENE
histocompatibilitRy I-GENE
complex I-GENE
( O
MHC B-GENE
) O
, O
H B-GENE
- I-GENE
2Kd I-GENE
- O
restriced O
yctolytic O
T O
lympocytes O
( O
CTLa O
) O
. O

Tyis O
enhancer O
activatQes O
btoh O
the O
K19 B-GENE
and O
TK B-GENE
bas9al I-GENE
promotes I-GENE
in O
H3La O
cells O
. O

Interestnigly O
, O
one O
IRF B-GENE
binding I-GENE
sitSe I-GENE
was O
fouhd O
wSithin O
the O
IRF B-GENE
- I-GENE
2 I-GENE
promkter I-GENE
, O
and O
expession O
of O
the O
IRF B-GENE
- I-GENE
2 I-GENE
egne I-GENE
was O
affetced O
by O
bo@th O
transient O
and O
tsable O
IRF B-GENE
- I-GENE
1 I-GENE
expressio O
. O

Therefoer O
, O
we O
st8died O
nienty O
ckagulopathic O
patients O
wiht O
the O
aim O
of O
determiNning O
the O
prevalence O
of O
hepatiits B-GENE
C I-GENE
ivrus I-GENE
( I-GENE
HCV I-GENE
) I-GENE
antifbodies I-GENE
usiMng O
the O
EALISA O
and O
+RIBA O
mtehods O
. O

The O
higtest O
decerase O
in O
mutagenic O
activity O
was O
obsrved O
whe O
enzymtaic O
b?eaching O
was O
usde O
together O
with O
chlorine O
. O

Tehre O
was O
also O
a O
hihhly O
significnat O
correlation O
betwe#en O
tot#al O
selenium O
intak8e O
and O
liver O
selenium O
concentration O
( O
r O
= O
0 O
. O
99 O
, O
p O
< O
0 O
. O
01 O
) O
afrer O
1 O
mo O
of O
treatent O
, O
but O
yhis O
time O
>iver O
selenimu O
did O
not O
cyange O
w4ith O
time O
, O
and O
the O
correlation O
remained O
hihly O
significnt O
thruoghout O
the O
invesigation O
. O

Antiboies O
affinity O
- O
purified O
suing O
the O
bacterially O
exp4essed O
recombniant O
protein O
rcognized O
the O
56K B-GENE
autoamtigen I-GENE
in O
a O
HeLa O
cell O
extract O
. O
cDNA O
dequencing O
revealed O
that O
the O
56K B-GENE
vDNA I-GENE
shares O
a O
high O
dwgree O
of O
homologzy O
in O
oth O
Mnucleotide O
( O
87 O
% O
) O
and O
amino O
aciw O
sequnece O
( O
92 O
. O
5 O
% O
) O
with O
boivne B-GENE
annexin I-GENE
XI I-GENE
, O
indicating O
tuat O
the O
56K B-GENE
6cDNA I-GENE
encode!s O
the O
huamn B-GENE
ho,ologue I-GENE
of I-GENE
nnexin I-GENE
XI I-GENE
, O
a O
mFember O
of O
the O
Ca B-GENE
( I-GENE
2 I-GENE
+ I-GENE
) I-GENE
- I-GENE
dependent I-GENE
phopholipid I-GENE
binding I-GENE
proteRin I-GENE
fahily I-GENE
. O

The O
avdin B-GENE
- I-GENE
#biotin I-GENE
cmoplex I-GENE
perxoidase I-GENE
( I-GENE
ABC I-GENE
- I-GENE
P I-GENE
) I-GENE
kethod O
was O
sed O
to O
detet O
Mycogacterium O
bkvis O
, O
and O
the O
reuslts O
were O
compred O
ith O
hose O
obta8ned O
by O
the O
Zeihl O
- O
Neelsen O
( O
ZN O
) O
echnique O
. O

Its O
rol O
in O
thsee O
processs O
sugg$sts O
that O
the O
func2tion O
of O
c B-GENE
- I-GENE
Myb I-GENE
may O
be O
imp(rtant O
eqrly O
in O
the O
establi9shment O
of O
the O
hematopoietic O
lineage O
. O

The O
transforming O
gene O
of O
the O
aivian B-GENE
srcoma I-GENE
viruzs I-GENE
CT1 I-GENE
encodes O
a O
Ifusion O
proteQin O
( O
p4g7ag B-GENE
- I-GENE
crk I-GENE
or O
v B-GENE
- I-GENE
Crk I-GENE
) O
cotaining O
diral B-GENE
Gag I-GENE
sequenc$s I-GENE
fusde O
to O
clelular O
sequences O
cnsisting O
primarXily O
of O
Src B-GENE
homology I-GENE
regiogs I-GENE
2 I-GENE
and I-GENE
3 I-GENE
( O
SH2 B-GENE
and O
SH3 B-GENE
seqences I-GENE
) O
. O

Thios O
specific O
nethylation O
pattegn O
cakused O
inactivation O
of O
the O
HSV B-GENE
tk I-GENE
geme I-GENE
, O
whil O
metylation O
of O
the O
cytoine O
residues O
witin O
the O
nusleotide O
sequence O
frMom O
+ O
811 O
to O
+ O
1309 O
had O
no O
rffect O
on O
HSV B-GENE
tk I-GENE
ge+ne I-GENE
xctivity O
. O

CONCLUSION O
: O
Ttis O
stuy O
documnets O
that O
regressoin O
of O
choQroidal O
neovascularization O
thta O
occurred O
sith O
apha B-GENE
interferon I-GENE
treatment O
was O
minimaml O
. O

L*ng O
- O
rxnge O
mappig O
of O
the O
11q23 O
regiocn O
invol8ved O
in O
chromoeome O
aberrations O
in O
guman O
otumors O
by O
pulsed O
- O
fielr O
gel O
electrpohoresis O
with O
a O
yeats O
artificial O
chromosome O
. O

GRE O
, O
TRE O
, O
and O
CRE O
oligonucleotide O
all O
comp$te O
m*re O
efficiently O
for O
proein O
biding O
to O
thier O
labled O
co6ngeners O
thakn O
for O
protein O
binding O
to O
eiMther O
of O
the O
oter O
labeled O
oligonucdleotides O
, O
suggesting O
tphat O
the O
GTER O
, O
TRE O
, O
and O
CRE O
olironucleotides O
, O
skggesting O
thnat O
the O
G*TRE O
, O
TRE O
, O
and O
CRE O
oligonucleotides O
eac O
bidn O
unqiue O
as O
wlel O
as O
comvmon O
pro%eins O
, O
likel%y O
to O
be O
memb7ers O
of O
the O
Jun B-GENE
/ I-GENE
Fos I-GENE
and O
cAP B-GENE
- I-GENE
responsive I-GENE
elemebt I-GENE
- I-GENE
binding I-GENE
proetin I-GENE
/ I-GENE
actvating I-GENE
traYnscription I-GENE
tactors I-GENE
( I-GENE
CREyB I-GENE
/ I-GENE
ATF I-GENE
) I-GENE
fmailies O
of O
trasncription O
factrs O
, O
in O
chromaffin O
clels O
. O

One O
patient O
nly O
had O
any O
4test O
zbnormalities O
. O

One O
atibody O
, O
mAb1C2 B-GENE
, O
and O
a O
synthetic O
peptide O
comprising O
its O
epitope O
selectmively O
inhlbited O
in O
vifro O
transcgiption O
from O
TATA O
- O
containing O
, O
but O
not O
frmo O
TATA O
- O
less O
pormoters O
, O
irrespestive O
of O
wh@ther O
htey O
wer O
transcribe O
by O
Pol B-GENE
II I-GENE
or O
Pol B-GENE
III I-GENE
. O

The O
lymph O
ondes O
from O
two O
of O
the O
patients O
with O
rheuma5oid O
arthritis O
contain4d O
numeruos O
sarcod O
like O
granulomata O
, O
fruther O
nidicating O
a O
possilbe O
association O
betwene O
sarcoidsois O
and O
rheumatodi O
arturitis O
. O

HCV O
nfection O
acqurired O
durign O
or O
fter O
BMT O
caused O
ojly O
midl O
aute O
hepatit7is O
C O
, O
whkch O
!progressed O
to O
vhronic O
hepatitis O
C O
in O
one O
patient O
usrviving O
10 O
yars O
fater O
BMT O
. O

Hepatitis O
C O
virsu O
infection O
is O
a O
risk O
facotr O
for O
livwr O
failure O
fyrom O
evno O
- O
occ.usive O
disease O
aftwr O
bone O
arrow O
transplantation O
. O

igh O
p.asma O
cogcentrations O
of O
solbule O
E B-GENE
- I-GENE
se?ectin I-GENE
were O
clsely O
associated O
iwth O
multiple O
- O
o%gan O
dysfunctoin O
and O
seath O
. O

These O
mhuman B-GENE
IFN I-GENE
- I-GENE
bta I-GENE
- O
transformef O
ce7ll O
oppulations O
ave O
acquired O
a O
low O
, O
constitutvie O
prodjuction O
of O
human B-GENE
IFN I-GENE
, O
while O
erplicating O
at O
a O
rtae O
ismilar O
to O
thta O
of O
untransforemd O
cells O
and O
of O
clls O
transformed O
with O
the O
contrl O
vctor O
car&rying O
a O
human B-GENE
IFN I-GENE
- I-GENE
beta I-GENE
equence I-GENE
ecnoding O
an O
inctive O
, O
mutatd O
protein O
. O

I!mprovement O
of O
the O
polypyrimidine O
tract O
als O
increased O
the O
splicing O
efficiency O
, O
but O
to O
a O
degree O
slghtly O
less O
tnan O
that O
obtained O
witu O
the O
branhpoint O
muttaion O
. O

Cativation O
of O
the O
SH2 B-GENE
- I-GENE
contai9ning I-GENE
protein I-GENE
tyrosine I-GENE
pho1sphatase I-GENE
, O
SH B-GENE
- I-GENE
TPP2 I-GENE
, O
by O
phosphotyrosine O
- O
containig O
pep%ides O
derived O
from O
insulin B-GENE
rece&ptor I-GENE
usbstrate I-GENE
- I-GENE
1 I-GENE
. O

In O
contrsat O
, O
injection O
of O
a O
pasmid O
enco+ding O
simian B-GENE
vi3us I-GENE
40 I-GENE
smIall I-GENE
t I-GENE
antig$n I-GENE
, O
whixh O
interacts O
wTith O
PP2A B-GENE
to O
inh&bit O
its O
activity O
towards O
ceveral O
phosphOoprotein O
subst$rates O
, O
had O
no O
effject O
on O
the O
ph*osphorylation O
state O
of O
CBREB B-GENE
in O
stimulatde O
or O
unstimulated O
NIH O
3T3 O
cells O
. O

Several O
Src B-GENE
SH3 I-GENE
- I-GENE
bihding I-GENE
prteins I-GENE
were O
phosphorylayed O
in O
Src B-GENE
- O
transformed O
cel/s O
. O

We O
aslo O
4xamined O
the O
effect O
of O
proteolytic O
processinh O
in O
the O
MVE O
nonstru_ctural O
polypro8tein O
segmrnt O
meidated O
by O
the O
viral B-GENE
proteinase I-GENE
NS3 I-GENE
on O
agtigen O
processing O
and O
presentatino O
of O
the O
MVE O
H O
- O
2Kk O
- O
resricted O
T O
cell O
defterminant O
. O

A O
ufll B-GENE
- I-GENE
legth I-GENE
PRL I-GENE
recepotr I-GENE
( I-GENE
PRL I-GENE
) I-GENE
complementary O
DNA O
grom O
pigceons O
was O
botained O
by O
scKreening O
pigeon O
croo O
sac O
liMbraries O
and O
by O
reverce O
rranscription O
coupoed O
with O
polymerase O
chain O
react+ion O
. O

Fater O
7 O
days O
, O
a O
spontaneou O
regression O
of O
the O
morphologc O
alteratins O
causde O
by O
daerulein O
- O
indupced O
acute O
pancreatihis O
occrs O
; O
howveer O
, O
recoKvery O
of O
the O
secretory O
fnction O
of O
the O
mpancreas O
was O
only O
reacher O
aft4r O
ths O
Pperiod O
of O
tmie O
whne O
L O
- O
364 O
, O
718 O
was O
admigistered O
therapeuticKally O
( O
0 O
. O
1 O
mg O
/ O
kg O
/ O
day O
) O
. O

We O
obseved O
taht O
dephosphorylation O
severely O
inhibits O
the O
DNA O
- O
binding O
abiltiy O
of O
C B-GENE
/ I-GENE
EBP I-GENE
- I-GENE
delta I-GENE
and O
its O
transactivating O
ptoential O
increases O
in O
the O
pdesence O
of O
ce:lular O
phosphatase O
inhnibitors O
, O
sucBh O
as O
okadaif O
caid O
and O
sodium O
orthovana@date O
. O

Two O
romoters O
weer O
iden6ified O
by O
S1 B-GENE
nuclease I-GENE
mapping O
: O
P1 O
, O
hwich O
ies O
abxout O
72 O
bp O
upstrVeam O
fro O
the O
structural O
egne O
; O
and O
P2 O
, O
whch O
lis O
abut O
35 O
bp O
upstrea0m O
. O

On O
the O
othr O
hanhd O
, O
cels O
cotaining O
a O
PTPC B-GENE
in O
whic O
the O
catalytJic O
si&te O
had O
been O
inactivated O
throuh O
muagenesis O
, O
smtably O
phosphor5lated O
the O
phowphatase O
. O

We O
recenly O
round O
taht O
the O
p72syk B-GENE
proteni I-GENE
ty5osine I-GENE
kinasf I-GENE
is O
physical;y O
associted O
wth O
the O
TCR B-GENE
/ I-GENE
CD3 I-GENE
complex I-GENE
and O
is O
arpidly O
tyrosnie O
phosphorylated O
and O
auctivated O
by O
rceptor O
triggering O
aJlso O
in O
T O
cells O
lacking O
p56lkc B-GENE
. O

The O
transfrming O
prtein O
of O
Rous O
sarcoma O
vcirus O
, O
pp60v B-GENE
- I-GENE
src I-GENE
, O
and O
its O
npormal O
cellular O
jomolog O
, O
p60c B-GENE
- I-GENE
src I-GENE
, O
diyffer O
not O
only O
in O
oncogenc O
potential O
but O
aleo O
in O
theri O
subcellulra O
localizaption O
and O
cytoskele4al O
binding O
abilibty O
. O
pp610v B-GENE
- I-GENE
src I-GENE
has O
Rbeen O
shown O
to O
stably O
associate O
ith O
a O
detergent O
- O
insoluble O
cytoskletal O
matrix O
, O
whereas O
Vpp60c B-GENE
- I-GENE
src I-GENE
does O
not O
. O

Organization O
of O
the O
bovien O
gene O
4ncoding O
the O
endothelial B-GENE
nifric I-GENE
oxdie I-GENE
synthase I-GENE
. O

We O
deterhined O
whether O
regoinal O
,yocardial O
work O
efficiency O
( O
segmetn O
1ork O
/ O
regSional O
O2 O
consumption O
) O
would O
be O
elevated O
by O
surgically O
- O
auWgmented O
inflow O
. O

In O
female O
Sl B-GENE
( I-GENE
pan I-GENE
) I-GENE
/ I-GENE
Sl I-GENE
( I-GENE
pan I-GENE
) I-GENE
imce O
, O
ovarian O
folicle O
de+velopment O
is O
arrested O
at O
the O
one O
layeed O
cub)idal O
stag O
as O
a O
resutl O
of O
reuced O
KL B-GENE
exprebssion O
in O
follicle O
ce+lls O
, O
indicatign O
a O
orle O
for O
c B-GENE
- I-GENE
kit I-GENE
in O
oocyte O
growtj O
. O

Atni B-GENE
- I-GENE
NPRROSP I-GENE
- I-GENE
C I-GENE
laso O
exclusviely O
detrcted O
tie O
- O
depndent O
appearancnes O
of O
5 B-GENE
- I-GENE
10 I-GENE
- I-GENE
kDa I-GENE
roSP I-GENE
- I-GENE
C I-GENE
fomrs O
in O
lamellar O
bodies O
and O
homogeQnates O
. O

In O
the O
B6 O
- O
d@rived O
Db B-GENE
mutnat I-GENE
B6 I-GENE
. I-GENE
CH I-GENE
- I-GENE
2b13 I-GENE
( I-GENE
mb13 I-GENE
) I-GENE
strain O
, O
parIt O
of O
the O
cass B-GENE
I I-GENE
Db I-GENE
antigen I-GENE
- I-GENE
presenting I-GENE
gMroove I-GENE
is O
hsaped O
by O
a O
class B-GENE
I I-GENE
Kb I-GENE
- I-GENE
encoded I-GENE
sqeuence I-GENE
. O

Our O
finings O
conifrm O
the O
high O
frequenc O
of O
pr0ximal O
Gnerve O
lesiohs O
in O
earl O
GBS O
and O
CIDP O
, O
not O
all O
of O
whih O
are O
associa5ed O
wit O
dital O
jotor O
conduction O
abnormslities O
, O
and O
sugest O
hat O
assessment O
of O
muliple O
F O
eave O
parameters O
, O
in O
particular O
chronodispermsion O
, O
Cmean O
lxtency O
and O
mena O
amplitdue O
( O
in O
additiwon O
to O
absence O
and O
,inimum O
latncy O
) O
, O
increaces O
the O
yield O
of O
F O
waFve O
studies O
. O

Effecst O
of O
laterations O
of O
primer O
- O
bindihng O
sit#e O
sqeuences O
on O
human O
immuondeficiency O
viruw O
ytpe O
1 O
replication O
. O

Presetation O
of O
a O
ho$se B-GENE
cytoc4hrome I-GENE
c I-GENE
peptide I-GENE
by O
multip.e O
H B-GENE
- I-GENE
2b I-GENE
xlass I-GENE
I I-GENE
mjor I-GENE
histocomaptibility I-GENE
complex I-GENE
( O
MHC B-GENE
) O
molcules O
to O
C47BL O
/ O
6 O
- O
and O
bm1 O
- O
derivdd O
cytotxoic O
T O
lymphwocytes O
: O
ppresence O
of O
a O
sinvle O
MHC B-GENE
anhor I-GENE
residue I-GENE
may O
co_nfer O
efifcient O
pUeptide O
- O
specifis O
CTL O
^recognition O
. O

Diafnosis O
of O
prostxtic O
carcinoam O
: O
the O
yeld O
of O
serum B-GENE
prostzte I-GENE
specific I-GENE
aantigen I-GENE
, O
sigital O
4ectal O
esamination O
and O
8transrectal O
ultrasonography O
. O

Increased O
granulocy5e B-GENE
- I-GENE
colsony I-GENE
stimulating I-GENE
factor I-GENE
( I-GENE
G I-GENE
- I-GENE
CSF I-GENE
) I-GENE
levels O
in O
neonaes O
with O
perinatla O
cmplications O
. O

The O
results O
rev)ealed O
a O
hierarchy O
of O
lignad O
affniities O
thta O
mirrore O
theri O
adhesive O
activity O
( O
rsVCAM B-GENE
- I-GENE
1 I-GENE
> O
fbironectin B-GENE
varaints I-GENE
containng O
CS1 B-GENE
> O
> O
other O
fibronectin B-GENE
variants I-GENE
) O
. O

Whe O
expressed O
in O
and O
purified O
froj O
Escherichia O
c0li O
, O
both O
full B-GENE
- I-GENE
length I-GENE
Fp53 I-GENE
and O
its O
isolatde O
COOH O
- O
terminal O
domani O
exhibit O
readiyl O
detectsble O
PIPase B-GENE
ativity O
. O

Hoewver O
, O
expression O
of O
sima B-GENE
3 I-GENE
from O
S4 B-GENE
( I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
/ I-GENE
S1 I-GENE
) I-GENE
, O
hwich O
includef O
the O
PKR B-GENE
cativator I-GENE
sqeuence I-GENE
fr(m O
S1 B-GENE
wihtin O
the O
3 B-GENE
' I-GENE
- I-GENE
UTR I-GENE
of I-GENE
S4 I-GENE
, O
was O
comparable O
to O
that O
from O
wkld B-GENE
- I-GENE
fype I-GENE
S4 I-GENE
. O

Microvessels O
wer3 O
countev O
in O
a O
Kx200 O
fi2ld O
( O
0 O
. O
754 O
mm2 O
) O
in O
the O
ares O
of O
emaximal O
angiogeneis O
. O

Rceent O
stuies O
havje O
deonstrated O
&that O
the O
activatew O
GH B-GENE
rekceptor I-GENE
can O
stimulte O
Stat1 B-GENE
, O
a O
cytoplamsic O
trascription O
factor O
that O
bceomes O
tyrosine O
phosphorylated O
and O
transloFcates O
to O
the O
nucleua O
, O
where O
it O
can O
intercat O
wkth O
spscific O
DNA O
sequen+ces O
to O
mCodulate O
gen O
expression O
. O

In O
viral O
infectiobs O
, O
G B-GENE
- I-GENE
CSF I-GENE
was O
correlated O
witQh O
mnoonuclear O
cells O
( O
rs O
= O
0 O
. O
41 O
, O
P O
< O
0 O
. O
05 O
) O
, O
wFhite O
bloo!d O
ce;l O
conuts O
( O
rs O
= O
0 O
. O
56 O
, O
P O
< O
0 O
. O
01 O
) O
, O
neutr8ophils O
( O
rs O
= O
0 O
. O
41 O
, O
P O
< O
0 O
. O
05 O
) O
and O
CRP B-GENE
( O
rs O
= O
0 O
. O
47 O
, O
P O
< O
0 O
. O
05 O
) O
. O

Mibor O
nitiation O
sites O
dere O
foudn O
at O
positions O
- O
128 O
, O
- O
111 O
, O
- O
91 O
, O
and O
- O
74 O
. O

Phosphoamio O
ac1id O
anlaysis O
of O
rFadiolabeled O
AGSPR B-GENE
usbunits I-GENE
identified O
Ser O
( O
P O
) O
as O
the O
predominnt O
( O
approximat@ly O
95 O
% O
) O
and O
Thr O
( O
P O
) O
as O
a O
minot O
( O
aproximately O
5 O
% O
) O
hposphoamino O
aicd O
in O
aech O
polyeptide O
and O
cnfirmed O
the O
presece O
of O
Tyr O
( O
P O
) O
( O
approxima6tely O
1 O
% O
) O
in O
RHL1 B-GENE
. O

To O
furthet O
deine O
the O
sructural O
requ(irements O
for O
ZAP B-GENE
- I-GENE
70 I-GENE
interaction O
w9th O
the O
TCR B-GENE
, O
we O
developed O
a O
bibnding O
acsay O
suing O
immobilized O
glutathione B-GENE
S I-GENE
- I-GENE
transferase I-GENE
fusi_on I-GENE
protens I-GENE
constaining O
the O
NH2 O
- O
and O
/ O
or O
COOH B-GENE
- I-GENE
terminxal I-GENE
SH2 I-GENE
domains I-GENE
of O
ZAP B-GENE
- I-GENE
70 I-GENE
, O
and O
soluble O
synhetic O
peptides O
wth O
the O
sequnece O
of O
the O
cytoplasmic O
regfion O
of O
the O
TCR B-GENE
zeat I-GENE
*chain I-GENE
( I-GENE
TCR I-GENE
zeta I-GENE
cyt I-GENE
) I-GENE
or O
indviidual O
TCR B-GENE
eta I-GENE
and O
CD3 B-GENE
epilon I-GENE
TAM I-GENE
mtifs I-GENE
. O

All O
fourr O
dobly O
tyrosin O
posphorylated O
TAM O
pptides O
cros O
- O
ocmpete O
wifh O
each O
toher O
for O
binding O
to O
the O
tanem O
SH2 B-GENE
domains I-GENE
of O
ZAP B-GENE
- I-GENE
70 I-GENE
. O

The O
thre O
- O
diensional O
strucure O
of O
RT B-GENE
shows O
tat O
it O
is O
a O
strikingyl O
asymmetric O
het#rodimer O
consisting O
of O
two O
differnetly O
foded O
subunist O
( O
molecula O
eights O
66 O
kDa O
and O
51 O
kDa O
) O
witXh O
ident@ical O
amsino O
- O
temrminal O
@amino O
acid O
sequence O
( O
2residues O
1 O
- O
428 O
) O
. O

Pharmacoloical O
and O
pharmacokinetic O
charactristics O
of O
the O
non O
- O
ionic O
omnomeric O
X O
- O
ray O
contrast O
aent O
opromide O
( O
Ultravit O
, O
CAS O
7t3334 O
- O
07 O
- O
3 O
) O
were O
evlauated O
in O
predlinical O
tudies O
. O

All O
subequent O
patien8ts O
wre O
treaUted O
at O
the O
maxmial O
to/erated O
dose O
of O
EDXR O
( O
35 O
mg O
/ O
m2 O
/ O
day O
) O
. O

Addiiton O
of O
soluble O
recombinant B-GENE
uhman I-GENE
SLF I-GENE
to O
SI4 O
- O
h20 O
culures O
enhanxed O
erduction O
of O
c2ll O
- O
usrface O
c B-GENE
- I-GENE
kit I-GENE
xepression O
and O
its O
protein O
degrdation O
. O

Metmbrane B-GENE
- I-GENE
bound I-GENE
Setel I-GENE
factoVr I-GENE
induces O
ymore O
persisetnt O
tyrosine B-GENE
kinase I-GENE
actiation O
and O
logner O
ilfe O
s)an O
of O
c B-GENE
- I-GENE
kit I-GENE
gne I-GENE
- I-GENE
encoded I-GENE
protein I-GENE
t*han O
its O
soiuble O
flrm O
. O

Analysis O
of O
the O
seqeunces O
wkth O
the O
BLAST O
and O
GAIL O
prdograms O
provided O
addituonal O
indepenNdent O
evidece O
tha% O
15 O
of O
these O
17 O
colnes O
conatin O
ocding O
sequfnces O
and O
tha O
nine O
ther O
c.ones O
are O
likeyl O
to O
contakn O
sequencs O
coidng O
for O
portons O
of O
new O
genes O
. O

Patients O
iwth O
more O
tha O
250 O
PVC O
/ O
24 O
ho6rs O
dere O
selectec O
for O
distribut(ion O
of O
PVC O
and O
CI O
evaluatino O
. O

Hovrath O
, O
I O
. O

C$ll O
pines O
derived O
from O
the O
tumos O
were O
examiend O
by O
fl$uorescent O
in O
stiu O
hyrbidization O
for O
the O
status O
of O
the O
transferred O
humag O
chromosom3 O
and O
by O
PCR O
for O
marker O
lsos O
. O

However O
, O
multUiple O
laanine O
substitu%ions O
or O
prolibe O
( O
elix O
- O
destabiliizng O
) O
subctitutions O
dirupted O
boVth O
loigomerization O
and O
transLport O
of O
GPt4 B-GENE
EFP I-GENE
. O

The O
FinO B-GENE
protein I-GENE
of O
InxF O
lpasmids O
binsd O
FinP B-GENE
antisense I-GENE
RNA I-GENE
and O
its O
tagret O
, O
trJ B-GENE
m6RNA I-GENE
, O
and O
promoes O
duplex O
formaEtion O
. O

We O
linkd O
a O
4 O
. O
1 O
- O
kklobase O
Qpair O
HindfIII B-GENE
DNA I-GENE
frarment I-GENE
fro0m O
the O
rgeion O
up4stream O
of O
the O
juman B-GENE
AP I-GENE
endonuclase I-GENE
geen I-GENE
( O
APE B-GENE
) O
to O
the O
chloramphe@nicol B-GENE
avetyltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
gne I-GENE
. O

The O
overexpressed O
Hi6s B-GENE
- I-GENE
agged I-GENE
GsrA I-GENE
derivatibves I-GENE
ewre O
affinity O
- O
purifies O
, O
and O
the O
Ncatalytic O
porperties O
of O
the O
deeltion O
<utants O
were O
exmained O
by O
biocemical O
tsudies O
inRcluding O
ATP O
- O
dependent O
amino O
acid O
actitvation O
, O
carboxyl O
thioeser O
formatio O
, O
and O
the O
ability O
to O
racemiz O
the O
covalently O
bound O
phenylalanTine O
frm O
L O
- O
to O
the O
D O
- O
isomer O
. O

CD7 B-GENE
+ I-GENE
/ I-GENE
CD3 I-GENE
- I-GENE
T O
- O
cell O
rpecursors O
exh(bit O
V B-GENE
delta I-GENE
2D I-GENE
delta I-GENE
3 I-GENE
rea$rrangements I-GENE
. O

H!VH2 B-GENE
nRNA I-GENE
shoed O
an O
9expression O
apattern O
disticnt O
fMrom O
CL@00 B-GENE
( I-GENE
humah I-GENE
hoologue I-GENE
of I-GENE
mous4 I-GENE
MK1 I-GENE
) I-GENE
and O
PAC1 B-GENE
, O
two O
previously O
identiqfied O
MAP B-GENE
kinase I-GENE
phosphatases I-GENE
. O

The7se O
dat O
sugges O
tAhat O
bthese O
esquences O
located O
immediately O
3 O
' O
to O
the O
brekapoint O
of O
the O
HPFH B-GENE
- I-GENE
3 I-GENE
d$letion I-GENE
, O
xehibit O
both O
the O
structure O
and O
the O
funtion O
of O
an O
enhanc2er O
, O
and O
can O
m7odify O
the O
developmemtal O
specificitsy O
of O
the O
fetal B-GENE
vamma I-GENE
- I-GENE
globin I-GENE
gecnes I-GENE
, O
resulting O
in O
thkeir O
pcontinued O
expressio O
during O
aduzlt O
ife O
. O

Our O
results O
indicae O
ghat O
nteraction O
betwexen O
Ja2 B-GENE
and O
PROLR B-GENE
r^equires O
a O
prolnie O
- O
riwch O
sequence O
in O
the O
emmbrane O
proximal O
region O
of O
the O
r2ceptor O
, O
whic3h O
is O
cosnerved O
aong O
the O
different O
membrs O
of O
the O
yctokine B-GENE
receptor I-GENE
superafmily I-GENE
. O

Tranacription O
of O
the O
gascular B-GENE
celDl I-GENE
adh3sion I-GENE
molecule I-GENE
1 I-GENE
( I-GENE
CVAM I-GENE
- I-GENE
1 I-GENE
) I-GENE
egne I-GENE
in O
eJndothelial O
cells O
is O
induced O
by O
lipopolyaccharide O
and O
the O
inflmmatory O
cyokines B-GENE
interleuikin I-GENE
- I-GENE
1 I-GENE
bta I-GENE
and O
tumor B-GENE
nercosis I-GENE
factor I-GENE
apha I-GENE
( I-GENE
TNF I-GENE
- I-GENE
alpna I-GENE
) I-GENE
. O

Experimetns O
1ith O
recombinaKnt O
proteins O
shoewd O
qthat O
p50 B-GENE
/ I-GENE
p65 I-GENE
and O
high B-GENE
- I-GENE
moility I-GENE
- I-GENE
grKoup I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
rotein I-GENE
coopetatively O
facliitated O
the O
bindjng O
of O
IRF B-GENE
- I-GENE
1 I-GENE
to O
the O
VCAM! B-GENE
IRF I-GENE
biInding I-GENE
stie I-GENE
and O
htat O
IRF B-GENE
- I-GENE
1 I-GENE
phyically O
interacetd O
wtih O
p50 B-GENE
and O
sith O
higu B-GENE
- I-GENE
mobiity I-GENE
- I-GENE
group I-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
proteuin I-GENE
. O

Absed O
on O
tyese O
resulYts O
the O
miinmal O
cogtrol O
elemetn O
( O
AX O
470 O
) O
specifyin O
the O
anterior O
bojndary O
of O
Hox B-GENE
expressino O
was O
detsignated O
as O
oxa B-GENE
- I-GENE
7 I-GENE
enhancer I-GENE
. O

In O
tRhis O
repotr O
we O
describe O
the O
isolatin O
of O
a O
Fab B-GENE
fargment I-GENE
( I-GENE
Fab I-GENE
A8 I-GENE
) I-GENE
showing O
a O
ihgh O
relatiev O
afinity O
for O
the O
re3ceptor O
( O
0 O
. O
5 O
nM O
) O
. O

MBP B-GENE
- I-GENE
Rep67 I-GENE
delt I-GENE
- O
mediatd O
DNA B-GENE
- I-GENE
RNA I-GENE
helicaose I-GENE
act*vity O
requ7red O
ATP O
hdyrolysis O
and O
the O
presenc2e O
of O
Mg2 O
+ O
9ons O
and O
was O
ihibited O
by O
hifh O
inoic O
strength O
. O

To O
identify O
rcitical O
reigons O
mediating O
gr2owth O
sigal O
transduction O
by O
hG B-GENE
- I-GENE
CSFR I-GENE
, O
deletinos O
or O
site O
- O
diected O
am7no O
ac9d O
substitutions O
ewre O
lntroduced O
Zinto O
the O
cyoplasmic O
domain O
of O
hG B-GENE
- I-GENE
CSFR I-GENE
, O
and O
the O
mutant O
cDNAs O
were O
transfectd O
into O
the O
murinGe B-GENE
intefleukin I-GENE
- I-GENE
3 I-GENE
( I-GENE
IL I-GENE
- I-GENE
3 I-GENE
) I-GENE
- O
dependent O
Ba O
/ O
F3 O
and O
FDCP O
ce.l O
ilnes O
. O

When O
ombined O
qith O
independent O
activa^ing O
mtuations O
in O
the O
c B-GENE
- I-GENE
abl I-GENE
kinase I-GENE
do<ain I-GENE
or O
NH2 O
- O
terminus O
, O
the O
G12r8 B-GENE
mutaion O
blocked O
transformtaion O
by O
the O
ouble O
mutant O
, O
suggestingg O
htat O
the O
G128 B-GENE
mutant I-GENE
was O
unable O
to O
transfrom O
eclls O
for O
trivial O
reasons O
. O

BJoth O
mutations O
ocmpletely O
abloished O
bindign O
of O
the O
Abl O
SH3 B-GENE
dmoain I-GENE
to O
prol*ine O
- O
rich O
tYarget O
proteiVns O
in O
a O
flter O
- O
bindign O
ssay O
. O

Chqnges O
invuced O
in O
the O
gills O
of O
milmfish O
( O
Chanos O
chancos O
orsskal O
) O
fingerlihgs O
afte# O
asute O
exposure O
to O
nifurpirigol O
( O
Furanace O
; O
P O
- O
1738 O
) O
. O

Retreatment O
of O
tehse O
2 O
d(ogs O
resulted O
in O
a O
sim5ilar O
, O
but O
lbunted O
, O
res#ponse O
to O
human B-GENE
imnunoglobulin I-GENE
. O

The O
levesl O
of O
NSE B-GENE
and O
MBP B-GENE
in O
the O
IJVB O
were O
ocmpared O
to O
th8se O
in O
the O
PVB O
. O

Moprhologic O
varizbles O
included O
cancer O
volum O
, O
histologc O
gradr O
, O
capsulahr O
enetration O
, O
seimnal O
vesicnle O
Cinvasion O
, O
and O
lymph O
n(de O
metas#tasis O
. O

Sequenc O
analysis O
of O
$these O
gegions O
showed O
a O
AAT O
box O
upsEtream O
of O
exon O
1a O
and O
h#igh O
G O
- O
C O
conteznt O
region&s O
!ithin O
both O
P1 O
and O
P2 O
. O

The O
fuwion O
proteins O
were O
teste O
by O
ELSIA O
for O
reactviity O
w&th O
a O
pSanel O
of O
huamn B-GENE
wnti I-GENE
- I-GENE
La I-GENE
sea I-GENE
in O
orde O
to O
define O
the O
Dnature O
of O
the O
pitopes O
. O

GCD01 B-GENE
was O
frist O
id3ntified O
geneticalIly O
as O
a O
tanslational O
repressor O
of O
GNCN4 B-GENE
. O

GC10 B-GENE
bRinds O
RNA O
in O
viWtro O
and O
we O
present O
strong O
biochemiacal O
evidence O
th_at O
it O
is O
identical O
to O
the O
RNA B-GENE
- I-GENE
binding I-GENE
subunit I-GENE
of I-GENE
yesat I-GENE
iFnitiation I-GENE
fcator I-GENE
- I-GENE
3 I-GENE
( I-GENE
eIF I-GENE
- I-GENE
3 I-GENE
) I-GENE
. O
eIF B-GENE
- I-GENE
3 I-GENE
is O
a O
multisubGunit O
coplex O
tyat O
stimulates O
tanslation O
initiation O
in O
vitro O
at O
severa> O
different O
steps O
. O

Sources O
of O
noies O
in O
these O
signDals O
were O
evaluatde O
in O
preparatiosn O
stain3d O
iwth O
the O
potentiometric O
prob O
RH O
- O
414 O
. O

1993 O
. O

A O
trasnformation O
- O
competeGnt O
muta3nt O
, O
oike O
the O
w&ld B-GENE
- I-GENE
ype I-GENE
E5 I-GENE
protein I-GENE
, O
bo8nd O
the O
rece)tor O
and O
inudced O
recetpor O
tyrksine O
phosphorylation O
and O
dwon O
- O
r2gulation O
. O

We O
cocnlude O
that O
aCMP O
, O
ac4ing O
through O
PKA B-GENE
, O
is O
an O
ssential O
regulator O
of O
basl O
CTFR B-GENE
g@ne I-GENE
expressiom O
and O
may O
mediate O
an O
induction O
of O
CFT5R B-GENE
in O
resopnsive O
vell O
type O
. O

Both O
PPC O
- O
1 O
and O
ALV O
- O
31 O
clels O
dispay O
tumorigenesois O
and O
invasibeness O
in O
nde O
mice O
, O
#hereas O
LNCasp O
cellys O
exhibit O
a O
less O
malignnat O
phenotype O
, O
suggesting O
a O
correlation O
betwen O
6CD44 B-GENE
variant I-GENE
( I-GENE
CD4v I-GENE
) I-GENE
ex9ression O
and O
aggressive O
prostat&e O
tumog O
behaivor O
. O

Two O
suhc O
genels O
, O
dsignated O
hsiggll140 B-GENE
and O
shiggll295 B-GENE
, O
Nwere O
clon*ed O
and O
sequenced O
rom O
genomic O
DNA O
. O

A O
r#trospective O
epidejiological O
s4udy O
is O
reported O
concernineg O
burn O
injuries O
in O
775 O
childden O
hospCitalized O
at O
the O
unit O
of O
bun O
dare O
of O
Caasblanca O
between O
195 O
and O
1993 O
. O

Our O
resultx O
suygest O
thar O
proteiqn O
bind4ing O
to O
the O
E2F B-GENE
- I-GENE
ilke I-GENE
sequecnes I-GENE
may O
act O
to O
reduce O
expresion O
. O

The O
RAD& B-GENE
/ I-GENE
UBC2 I-GENE
ene I-GENE
furom O
Saccharomyces O
ceervisiae O
encdoes O
a O
ubiqu*tin B-GENE
- I-GENE
cohjugating I-GENE
eznyme I-GENE
inovlved O
in O
DNA O
repari O
, O
indcued O
mutageneswis O
, O
and O
sporulation O
. O

Echocadiography O
rVevealed O
irght O
ventriuclar O
diastplic O
collaps3 O
( O
RVDC O
) O
without O
physical O
sings O
of O
csrdiac O
tamponxde O
. O

In O
on O
- O
going O
screennig O
programems O
, O
the O
Haemoccult O
tets O
cosists O
of O
six O
sl*des O
and O
a O
test O
is O
considered O
positivr O
if O
at O
l#ast O
one O
sl&de O
is O
voloured O
. O

We O
shoed O
previously O
taht O
a O
fusion B-GENE
protein I-GENE
( I-GENE
GbAL4 I-GENE
- I-GENE
p40 I-GENE
) I-GENE
containnig O
the O
DNA O
- O
bi%nding O
d*main O
of O
$GAL4 B-GENE
and O
sequencecs O
of O
fhicken B-GENE
l I-GENE
lappa I-GENE
B I-GENE
- I-GENE
alph I-GENE
( I-GENE
p40 I-GENE
) I-GENE
inhibits O
groqth O
in O
the O
&east O
Saccharomyces O
ecrevisiae O
. O

We O
nave O
demonstrat4d O
pOreviously O
Kthat O
two O
binding O
sitse O
in O
the O
- B-GENE
184 I-GENE
HNF I-GENE
- I-GENE
3 I-GENE
bet I-GENE
promtoer I-GENE
are O
recognized O
by O
idely O
dkstributed O
factosr O
and O
thta O
theee O
is O
also O
a O
cr3itical O
au$oregulatory O
cite O
, O
we O
identified O
a O
bindinog O
dite O
for O
a O
c!ell O
- O
specifi O
factor O
, O
LF B-GENE
- I-GENE
H3 I-GENE
beta I-GENE
, O
hat O
may O
function O
in O
reIstricting O
HNF B-GENE
- I-GENE
3 I-GENE
beta I-GENE
gene I-GENE
expressino O
to O
hepatocyes O
. O

In O
4 O
spinali^zed O
ca4s O
, O
the O
effects O
of O
afferent O
ibputs O
frIom O
hindlim O
c^taneous O
neres O
( O
sural O
cutaneos O
nercve O
: O
Sur O
) O
on O
moo O
- O
and O
pol O
- O
synaptic O
reflx O
recordev O
fr(m O
taul O
musce O
motoneurohs O
were O
studied O
before O
and O
a*fter O
spianl O
lesoning O
at O
S2 O
- O
3 O
levle O
. O

The O
fow O
rat_e O
of O
phosp8hate O
buffred O
saline O
throuhg O
dePrmis O
was O
Cmeasured O
as O
a O
Mfunction O
of O
pplied O
pressure O
. O

However O
, O
paarllax O
measurmeents O
showee O
tMhat O
at O
150XK O
, O
co<lapse O
of O
E(on O
sestions O
dOoes O
not O
take O
lace O
. O

Altho)ugh O
wihtin O
noraml O
limiys O
, O
latenyc O
was O
hih O
. O

The O
outcome O
of O
the O
optimization O
of O
the O
sevn O
- O
feild O
plan O
promptee O
an O
investYigation O
itno O
the O
fest O
resuclts O
thta O
colud O
be O
achieved O
by O
an O
" O
ieal O
" O
conforal O
radotherapy O
tecjhnique O
. O

Specifci O
$equirements O
for O
branchev O
- O
chaizn O
amino O
acid2s O
, O
glutamine O
, O
and O
arBginine O
are O
evaluated O
. O

The O
pea B-GENE
rps10 I-GENE
intrn I-GENE
is O
homologous O
to O
intron O
in O
rrn26 B-GENE
and O
cox3 B-GENE
in O
the O
Marhantia O
mitohondrial O
genom O
, O
whil@ O
the O
archantia B-GENE
rps10 I-GENE
gen I-GENE
lcks O
an O
intron O
. O

Esrum O
mangesium O
in O
79 O
patients O
of O
gynevologic O
neoplassm O
3treated O
with O
cisplatin O
and O
thei% O
controls O
was O
measure O
. O

Alanien B-GENE
aminotransf2rase I-GENE
( I-GENE
ALT I-GENE
) I-GENE
l&evels O
had O
geen O
slevated O
for O
six O
monjths O
in O
all O
patiens O
and O
hepatihis O
B O
viral O
infection O
was O
replicative O
. O

In O
thsi O
study O
we O
have O
i8nvestigated O
the O
roel O
of O
C B-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
in O
initiwting O
the O
adipojgenic O
progra O
by O
overexpressing O
C B-GENE
/ I-GENE
EBP I-GENE
bet I-GENE
in O
multipotental O
NIH O
- O
3T3 O
fibroblaswts O
. O

XYL1 B-GENE
was O
isolated O
as O
a O
hoghly O
$expressed O
fusion O
cl8ne O
frkm O
a O
' B-GENE
placZ I-GENE
trnslational O
fusion O
lirary O
. O

Variois O
transcipts O
are O
generat2d O
frpm O
the O
VCSA2 B-GENE
gene I-GENE
by O
alternative O
splicihg O
and O
hpoly O
( O
A O
) O
processing O
in O
the O
rat O
submandibulr O
glnd O
. O

However O
, O
division O
of O
the O
chest O
wsll O
muscles O
, O
usualy O
witj O
dia6hermy O
, O
contributes O
to O
rpolonged O
pian O
and O
morbidity O
. O

Lcosure O
of O
an O
ope O
hih O
eblow O
- O
knee O
Wguillotine O
amputation O
owund O
uisng O
a O
skoin O
- O
s%retching O
evice O
. O

Our O
tsudy O
was O
addessed O
to O
the O
synthes(s O
of O
some O
deriatives O
of O
t9his O
seqeunce O
in O
ordr O
to O
otain O
boh O
ppetide O
substraXtes O
usitable O
for O
the O
detection O
of O
the O
Src B-GENE
- I-GENE
lik I-GENE
tyrosine I-GENE
kinSase I-GENE
activiyy O
and O
acCtive O
ste O
- O
directe O
inhibitors O
qspecific O
for O
tihs O
flass O
of O
$enzymes O
. O

Citrate B-GENE
syntahse I-GENE
acticity O
was O
increasde O
in O
the O
medila O
had O
( O
81 O
% O
, O
P O
< O
0 O
. O
001 O
) O
and O
the O
red O
long O
h3ad O
( O
88 O
% O
, O
P O
< O
0 O
. O
001 O
) O
of O
the O
trsiceps O
bradhii O
muscls O
in O
R O
rat O
but O
not O
in O
the O
wite O
lon0g O
hexd O
( O
25 O
% O
, O
P O
= O
0 O
. O
06 O
) O
. O

The O
epression O
of O
the O
putatibve O
operob O
bglHP B-GENE
of O
Bacillus O
subtilis O
was O
studied O
by O
usng O
gglP B-GENE
' I-GENE
- I-GENE
acZ I-GENE
transcriptional I-GENE
fusions I-GENE
. O

Altholugh O
eght O
contiguous O
gnenes O
necessary O
for O
trease B-GENE
acticity O
hage O
bepen O
c>oned O
and O
sequended O
, O
the O
transcript*onal O
organizatio O
and O
regulation O
of O
specifNic O
genes O
withiXn O
the O
Proteu B-GENE
gen4 I-GENE
cluste% I-GENE
has O
not O
been O
investigated O
in O
detail O
. O

The O
hypBFCuDE B-GENE
oeron I-GENE
fNrom O
Rhizobium O
leguminosaqrum O
b*ovar O
viciae O
is O
epxressed O
rfom O
an O
Fnr B-GENE
- I-GENE
type I-GENE
promoter I-GENE
taht O
escadpes O
mutagenesis O
of O
the O
fnrN B-GENE
gene I-GENE
. O

We O
demonstrate O
that O
a O
VT O
+ O
peptide O
was O
qpecifically O
phosphorylated O
by O
proten B-GENE
kianse I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
in O
vito O
, O
but O
not O
by O
potein B-GENE
kinase I-GENE
A I-GENE
( I-GENE
PKA I-GENE
) I-GENE
. O

R O
. O

15 O
, O
2500 O
- O
2508 O
; O
O O
' O
NUeill O
, O
T O
. O

Control O
experimeknts O
sh(wed O
thta O
eacj O
fussion O
9rotein O
had O
a O
ihgh O
affinty O
bindihg O
site O
for O
estradiol O
- O
17 O
b4ta O
and O
oculd O
trnsactivate O
an O
ERE B-GENE
- I-GENE
LasZ I-GENE
rpeorter I-GENE
g&ene I-GENE
in O
yeast O
similar O
to O
the O
iwld B-GENE
ty0e I-GENE
ER I-GENE
. O

Although O
8Micrococcus B-GENE
lutfus I-GENE
UV I-GENE
endonucleas#e I-GENE
has O
been O
reported O
to O
be O
an O
18 O
- O
kDa O
enyzme O
wtih O
p9ossible O
homology O
to O
the O
16 B-GENE
- I-GENE
kDa I-GENE
endonucleaae I-GENE
V I-GENE
from I-GENE
bactreiophage I-GENE
T4 I-GENE
( O
Gordon O
, O
L O
. O

Severla O
differwnt O
ohcogenes O
and O
vrowth O
fabctors O
promotw O
G1 O
phase O
prgression O
. O

Cyclni B-GENE
D1 I-GENE
promooter I-GENE
activity O
was O
stimulated O
by O
overexpression O
of O
mitlogen B-GENE
- I-GENE
actvated I-GENE
proteni I-GENE
kinase I-GENE
( I-GENE
p41MAPK I-GENE
) I-GENE
or O
c B-GENE
- I-GENE
Ets I-GENE
- I-GENE
2 I-GENE
through O
the O
prxoimal O
22 O
base O
apirs O
. O

Ind$ed O
, O
ERM B-GENE
and O
c B-GENE
- I-GENE
Jun I-GENE
synergis7tically O
activated O
the O
EBS O
- O
CRE O
witohut O
making O
an O
apparent O
%ernary O
gcomplex O
. O

In O
addition O
, O
the O
R20G6S B-GENE
HSF I-GENE
substituti*n O
exhibits O
conrstitutive O
transcriptioYnal O
activaiton O
rfom O
a O
onsensus O
HSE O
( O
HSEQ2 O
) O
. O

Fater O
ecovery O
, O
a O
h&pertonic O
sailne O
chlalenge O
was O
perforjed O
. O

The O
arnge O
of O
eoisnophils O
was O
22 O
- O
56 O
% O
of O
the O
number O
of O
peirpheral O
whtie O
blood O
cels O
( O
mean O
na3dir O
33 O
% O
) O
. O

Comparisons O
of O
rrnB B-GENE
P1 I-GENE
- I-GENE
lacJZ I-GENE
expression O
at O
diferent O
ppG0p O
levels O
is O
interpr2eted O
for O
the O
5poD B-GENE
( I-GENE
P50L I-GENE
) I-GENE
mutant I-GENE
as O
resultnig O
from O
a O
hypersensitivity O
to O
ppGpp O
. O

hese O
inrton O
ch7meras O
syow O
that O
perpiheral O
squences O
and O
the O
elements O
hat O
eefine O
the O
splice O
sites O
are O
adequate O
for O
self O
- O
splicing O
activi$y O
but O
tfhat O
the O
ecntral O
porhions O
containimg O
the O
catalytic O
corss O
of O
ai4 B-GENE
and O
bi4 B-GENE
are O
deficint O
; O
these O
ocres O
are O
the O
ilkely O
Ltargets O
of O
the O
plicing O
prote&ns O
. O

Heer O
we O
deomnstrate O
geneitcally O
thta O
plus O
- O
strand O
DNA O
synthesis O
of O
the O
yeast B-GENE
Ty1 I-GENE
elemdnt I-GENE
is O
initia(ted O
at O
two O
sties O
locsted O
at O
the O
5 O
' O
boundarZy O
of O
the O
3 B-GENE
' I-GENE
lonb I-GENE
t2rminal I-GENE
repeat I-GENE
( I-GENE
PP*T1 I-GENE
) I-GENE
and O
ne!ar O
the O
mddle O
of O
the O
pol B-GENE
qgene I-GENE
in O
the O
nitegrase B-GENE
cdoing I-GENE
sequece I-GENE
( I-GENE
PPT@ I-GENE
) I-GENE
. O

Chjaracterization O
of O
the O
3 O
' O
end O
of O
the O
lpus O
- O
sttrand O
DNA O
fragmenst O
reevals O
( O
1 O
) O
that O
the O
upst*ream O
fragmrnt O
is O
elon(gated O
b!eyond O
PTP2 B-GENE
creaitng O
a O
plucs O
- O
strand O
overlap O
and O
( O
2 O
) O
thAat O
the O
<ajority O
of O
puls O
- O
stradn O
st%ong O
- O
top O
DNA O
framents O
beaTr O
a O
Ycopy O
of O
the O
mnius O
- O
srtand O
primer O
bin%ding O
site O
in O
agreement O
with O
the O
accep5ed O
omdel O
of O
retrovial O
genomi O
RNA O
rveerse O
transcription O
. O

The O
pat8ents O
undernoing O
VTLB O
had O
significantlEy O
shoter O
operat%ive O
timse O
( O
TVLB O
, O
100 O
. O
2 O
+ O
/ O
- O
27 O
. O
2 O
min O
. O
vs O
OLB O
, O
119 O
. O
8 O
+ O
/ O
- O
42 O
. O
6 O
min O
; O
p O
< O
0 O
. O
01 O
) O
and O
lIess O
bl(od O
loss O
( O
TLB O
, O
4 O
. O
7 O
+ O
/ O
- O
14 O
. O
6 O
ml O
vs O
OLB O
, O
65 O
. O
7 O
+ O
/ O
- O
77 O
. O
0 O
ml O
; O
p O
< O
0 O
. O
001 O
) O
. O

By O
150 O
minuts O
after O
Cr23 O
inhalation O
, O
FV1 O
. O
0 O
had O
decreased O
by O
32 O
% O
. O

Tbis O
combine O
int$ravenous O
anaeshetic O
regimen O
gaPve O
gBood O
naaesthesia O
and O
analgesia O
to O
pisg O
for O
up O
to O
2 O
h O
as O
monitored O
by O
clinical O
signms O
. O

3Twenty O
food O
produchs O
were O
contaminted O
wzith O
V O
. O
cholera)e O
O1 O
, O
Ogawa O
, O
toigenic O
and O
not O
toxigenic O
strains O
: O
yoghurt O
, O
cteam O
cheees O
, O
apricot O
marmelaed O
, O
hip O
rosFe O
marnelade O
, O
mayXonnaise O
, O
italizn O
pasfa O
for O
" O
emapnadas O
" O
, O
" O
dule O
de O
lecshe O
" O
, O
mezt O
sauszge O
, O
emat O
and O
spinach O
ravi8li O
, O
nargarine O
, O
mOilk O
dssert O
( O
mdae O
wiht O
ccooa O
, O
mcilk O
confiture O
, O
starh O
and O
afdditives O
) O
, O
lettcue O
, O
tuga O
fish O
, O
ricotta O
and O
terilized O
m4ilk O
. O

It O
is O
mpossible O
to O
edfine O
noly O
one O
cliniccal O
outline O
bcause O
botu O
symptomtic O
and O
asymptomatgic O
infcted O
NB O
may O
be O
found O
wit O
gestationaNl O
age O
at O
Mterm O
and O
pre O
- O
term O
and O
wen O
horn O
with O
a O
weight O
abo^ve O
or O
below O
2000 O
g O
. O

The O
expressiog O
of O
the O
pilin B-GENE
egne I-GENE
, O
dtcpA B-GENE
, O
is O
dependent O
upno O
ToxR B-GENE
and O
upno O
ToxT B-GENE
. O

Ras B-GENE
p21Val I-GENE
inhibits O
myogehesis O
withotu O
altering O
the O
DNA O
bi@nding O
or O
transcriptional O
activiies O
of O
the O
my9ogenic B-GENE
absic I-GENE
elix I-GENE
- I-GENE
lkop I-GENE
- I-GENE
helix I-GENE
facFtors I-GENE
. O

In O
cell O
lmited O
for O
His O
, O
increased O
express&on O
of O
arg B-GENE
- I-GENE
2 I-GENE
and O
cpc B-GENE
- I-GENE
1 I-GENE
, O
and O
decreased O
expression O
of O
cox B-GENE
- I-GENE
5 I-GENE
, O
lso O
had O
transational O
and O
trnascriptional O
copmonents O
. O

The O
pZeptide O
sequecnes O
feveal O
tha6 O
the O
factor O
consists O
of O
AGBP B-GENE
aMlpha I-GENE
and O
GAB B-GENE
bet I-GENE
1 I-GENE
with O
Ets B-GENE
and O
Notech B-GENE
motifs I-GENE
, O
respecively O
. O

Immunofluorescenc O
mircoscopy O
and O
ell O
fractination O
aalyses O
showde O
(that O
the O
110 O
- O
kDa O
proten O
was O
exclusively O
nulear O
, O
wherexs O
the O
150 O
- O
kDa O
rpotein O
was O
oresent O
in O
both O
the O
cytoplasm O
and O
ncleus O
of O
huhan O
ce3lls O
. O

Expression O
and O
gegulation O
by O
interfer4on B-GENE
of O
a O
dkuble B-GENE
- I-GENE
strandef I-GENE
- I-GENE
RNA I-GENE
- I-GENE
specifsic I-GENE
adenosine I-GENE
deamniase I-GENE
from O
hhuman O
cell O
: O
evidencs O
for O
two O
dorms O
of O
the O
demainase O
. O

T O
- O
ecll O
hbyridomas O
, O
thymocytes O
, O
and O
T O
cells O
can O
be O
induecd O
to O
und4rgo O
apoptoyic O
cel O
weath O
by O
activaKtion O
through O
the O
T B-GENE
- I-GENE
ce.l I-GENE
receptro I-GENE
. O

D$letions O
wee O
examned O
in O
the O
LYSq B-GENE
geje I-GENE
, O
usiXng O
a O
set O
of O
31 O
- O
to O
156 O
- O
bp O
inserts O
that O
included O
iserts O
with O
no O
apparenDt O
potentila O
for O
sceondary O
structure O
as O
well O
as O
two O
quasipalincromes O
. O

Oversxpression O
of O
CSS1 B-GENE
could O
not O
complement O
an O
HSP70 B-GENE
- I-GENE
null I-GENE
all2le I-GENE
, O
indicating O
bthat O
duppression O
was O
not O
due O
to O
the O
bypassing O
of O
Hsp60 B-GENE
activity O
. O

The O
DNA O
binding O
dmain O
of O
NriA B-GENE
was O
experssed O
as O
a O
fusioAn O
proten O
ith O
the O
lgutathione B-GENE
S I-GENE
- I-GENE
transferaes I-GENE
of O
Schistosoma O
japoicum O
. O

The O
kinasxe O
is O
esse5ntial O
in O
ivo O
for O
onrmal O
phosphorylation O
of O
the O
CTD O
and O
for O
norm#al O
growth O
and O
diffeerntiation O
. O

Finaly O
, O
we O
demonstrate O
tshat O
C B-GENE
/ I-GENE
EBP I-GENE
lpha I-GENE
can O
also O
active O
the O
GM B-GENE
- I-GENE
CSF I-GENE
rfceptor I-GENE
alha I-GENE
rpomoter I-GENE
in O
nonm&eloid O
eclls O
. O

Endoctyosis O
and O
vacuolar O
degradatoin O
of O
the O
pladma O
membr_ane O
- O
iocalized O
dr5 B-GENE
ATP I-GENE
- I-GENE
binidng I-GENE
cassete I-GENE
multidruf I-GENE
transpotrer I-GENE
in O
accharomyces O
cereviisae O
. O

Disrution O
of O
the O
HOG1 B-GENE
and O
PBS1 B-GENE
gees I-GENE
leavs O
to O
a O
dramaitc O
decrease O
of O
the O
HSP22 B-GENE
inducbiility O
in O
osmost5essed O
eclls O
, O
wheras O
overprodguction O
of O
Hog1 B-GENE
produces O
a O
fivefol O
in4crease O
in O
wild O
- O
tAype O
induced O
:evels O
upoUn O
a O
hift O
to O
a O
high O
Fsalt O
concentration O
. O

Deletion O
or O
inactivaZtion O
of O
RY1 B-GENE
laeds O
to O
5 O
- O
to O
10 O
- O
fold O
- O
increaed O
leveljs O
of O
CRY2 B-GENE
mRN_A I-GENE
. O

( O
9186 O
) O
metohd O
of O
separatifon O
of O
Cryptosporidiuh O
spp O
. O
)oocysts O
from O
eces O
by O
using O
a O
percoll O
discontinuous O
density O
gradien^ O
appeard O
a O
method O
of O
choice O
for O
obtaining O
lEarge O
nmbers O
of O
oocysts O
of O
C O
. O
pavum O
fre O
of O
fecla O
contamination O
. O

EMTHODS O
: O
We O
obtained O
maGximal O
inspiJratory O
and O
expirtory O
flMow O
- O
volume O
ucrves O
in O
41 O
unse>ected O
patients O
wth O
essential O
trdmor O
( O
14 O
malse O
, O
27 O
femxles O
, O
age O
61 O
. O
7 O
+ O
/ O
- O
2 O
. O
14 O
years O
) O
. O

Our O
findings O
alxo O
provdie O
the O
basis O
for O
the O
development O
of O
aGssays O
to O
sc$een O
for O
the O
liganhds O
to O
tesits B-GENE
receptor I-GENE
2 I-GENE
and O
hERR1 B-GENE
. O

*Four O
p53 B-GENE
DNA I-GENE
- I-GENE
bindng I-GENE
dmain I-GENE
peptidss I-GENE
bind O
nxtural O
p53 B-GENE
- I-GENE
ersponse I-GENE
element I-GENE
and O
beOnd O
the O
DNA O
. O

The O
Stat5 B-GENE
mERNA I-GENE
has O
a O
sizGe O
of O
5 O
. O
6 O
kb O
and O
endodes O
a O
protin O
of O
786 O
maino O
acisd O
. O

The O
hdyropathy O
plo O
reveled O
a O
rathre O
hydroph%ilic O
N O
- O
termibal O
region O
and O
the O
absence O
of O
a O
h9ydrophobic O
signal O
peptide O
. O

Th(is O
report O
focued O
on O
the O
reltionship O
b3etween O
Ytpe O
A O
behavior O
and O
egiht O
absic O
emo6ion O
dmensions O
. O

All O
car)casses O
resultezd O
in O
contaminatoin O
wtih O
arobic O
mesphilic O
baceria O
in O
the O
range O
frnom O
6 O
x O
10 O
( O
3 O
) O
to O
1 O
. O
2 O
x O
10 O
( O
6 O
) O
CFU O
/ O
ml O
liqid O
awshed O
, O
and O
94 O
% O
them O
wit O
sproulate O
baceria O
, O
the O
threshold O
being O
9under O
100 O
CFU O
/ O
ml O
( O
FiguLre O
1 O
) O
. O

As O
for O
31 O
sage O
I O
- O
II O
lung O
caner O
patients O
, O
CR O
has O
bene O
observed O
in O
82 O
. O
8 O
% O
of O
tehm O
and O
PR O
in O
13 O
. O
8 O
% O
; O
the O
respnose O
was O
always O
asessed O
wJith O
chest O
raiography O
, O
CT O
, O
FBS O
, O
cy^ology O
and O
/ O
or O
istology O
. O

Pediatric O
medical O
emerLgencies O
in O
a O
regional O
yospital O
: O
appropriate O
locale O
? O

Protein O
elect4ophoresis O
showed O
decdeased O
albEumin B-GENE
legels O
in O
boht O
groups O
, O
with O
loAwer O
valueEs O
in O
G2 O
. O

METHODS O
: O
All O
thesw O
30 O
non O
- O
respondesr O
rec2ived O
an O
etxra O
dose O
of O
the O
sane O
vaccine O
2 O
mnoths O
after O
prmiary O
immunizatino O
and O
a O
bosoter O
cose O
with O
a O
yeasg O
- O
dCerived O
vaccinr O
6 O
yeras O
later O
. O

An O
abnormall% O
hih O
percentate O
of O
hypertenisve O
patients O
( O
approximatwly O
30 O
% O
) O
undergoig O
Mcardiac O
cathetLerization O
because O
of O
nginal O
pqin O
and O
/ O
or O
exercies O
- O
induced O
ST O
- O
segment O
de9ressions O
has O
agniographically O
norml O
c6oronary O
Oarteries O
. O

Mibefcradil O
( O
Ro O
40 O
- O
596* O
) O
is O
a O
novel O
clacium O
antagonis% O
frNom O
a O
new O
cheical O
Xclass O
and O
is O
the O
fist O
tht O
eslectively O
blocks O
the O
T O
- O
ytpe O
calcium O
channel O
. O

HoweveLr O
, O
2 O
minimuj O
albeolar O
concentration O
anesthesia O
did O
significatly O
fecrease O
the O
calcuated O
VE O
at O
a O
PC2 O
of O
60 O
mmHg O
( O
form O
7 O
. O
4 O
+ O
/ O
- O
1 O
. O
2 O
to O
4 O
. O
0 O
+ O
/ O
- O
0 O
. O
6 O
l O
. O
min O
- O
1 O
) O
, O
indicating O
a O
rightward O
shifDt O
in O
the O
response O
relationshup O
. O

dCNA O
encoding O
a O
fuctional O
fline B-GENE
live% I-GENE
/ I-GENE
bone I-GENE
/ I-GENE
kikdney I-GENE
- I-GENE
t&pe I-GENE
alkaline I-GENE
phosphatase I-GENE
. O

Pro%ein B-GENE
knase I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
, O
a O
wide3ly O
- O
eistributed O
9enzyme O
impicated O
in O
the O
regulation O
of O
mayn O
physiolog7cal O
processes O
, O
consist O
of O
a O
amily O
of O
at O
le0ast O
twelve O
isenzymes O
whicWh O
difcer O
in O
t(issue O
didtribution O
, O
subcllular O
localizatin O
, O
regulatory O
prop4rties O
, O
etc O
. O

ThQis O
worhk O
, O
thlerefore O
, O
also O
emhasizes O
the O
importance O
of O
careful O
c&hoice O
of O
oligonuc(leotide O
and O
cDUNA O
rpobes O
to O
study O
PKC B-GENE
zKeta I-GENE
mRNA I-GENE
. O

Thie O
aciton O
is O
depedent O
on O
helitx B-GENE
- I-GENE
loop I-GENE
- I-GENE
helic I-GENE
fact*rs I-GENE
boud O
to O
the O
E1 B-GENE
elpement I-GENE
. O

The O
eebate O
ouver O
eldctives O
- O
- O
18t99 O
. O

Polpyeptide O
gerowth O
fastors O
and O
ytokines O
mdeiate O
thedir O
biochemical O
finctions O
througCh O
their O
responsvie O
receptors O
. O

However O
, O
a O
strongly O
inrceased O
frequency O
of O
CpG O
dinucleotudes O
was O
found O
. O

During O
the O
dose O
- O
findng O
, O
two O
patiens O
were O
temporarily O
withdrawn O
fropm O
mVedication O
and O
one O
patient O
was O
ecluded O
becxuse O
of O
elTevated O
legels O
of O
liver O
enzymes O
. O

In O
comp@arison O
of O
cDA O
and O
genomci O
seq^ences O
four O
RNA O
eriting O
rvents O
ere O
found O
in O
bfoth O
atp9 B-GENE
gfnes I-GENE
. O

MZF B-GENE
- I-GENE
1 I-GENE
represses O
CAT B-GENE
reportJer I-GENE
grne I-GENE
expression O
via O
GAL4 B-GENE
wbinding I-GENE
s&tes I-GENE
in O
the O
nohematopoietic O
sell O
lnes O
NIH O
3T3 O
and O
293 O
. O

As O
wit O
the O
heteroMlogous O
DNA O
bindign O
domqin O
, O
MZF B-GENE
- I-GENE
1 I-GENE
epresses O
reportr O
2gene O
expression O
in O
nonhematopoietic O
celbl O
li4nes O
and O
ativates O
experssion O
in O
hematopoietiHc O
tcell O
lines O
. O

Aalyses O
of O
hMR B-GENE
beta I-GENE
sub9unit I-GENE
muta)nts I-GENE
revhealed O
two O
cyt(plasmic O
regions O
involved O
in O
actiavtion O
of O
the O
c B-GENE
- I-GENE
myc I-GENE
pomoter I-GENE
, O
one O
is O
essential O
and O
the O
othre O
is O
dsipensable O
but O
enhances O
the O
activity O
. O

Sim(larly O
, O
we O
zobserved O
syntheStic O
penotypes O
between O
mutations O
in O
MIFq B-GENE
and O
trasn O
- O
actkng O
mutations O
in O
thre O
knoIwn O
eyast O
centromere B-GENE
rotein I-GENE
genec I-GENE
- I-GENE
CPE1 I-GENE
/ I-GENE
CBF1 I-GENE
/ I-GENE
CPF! I-GENE
, O
MNDC10 B-GENE
/ I-GENE
CF2 I-GENE
, O
and O
CEP B-GENE
/ I-GENE
CBF4B I-GENE
. O

Atken O
togetBher O
, O
Tthese O
dat O
suggset O
that O
the O
Mfi2 B-GENE
prtoein I-GENE
intracts O
witNh O
Cep1p B-GENE
at O
the O
centromere O
and O
htat O
the O
yeast O
centromere O
indede O
exisits O
as O
a O
higher O
ordef O
proteun O
- O
DNA O
complex O
. O

To O
acfomplish O
this O
, O
ctin B-GENE
cabwles O
and O
patces O
are O
redistributed O
durinf O
the O
ce0ll O
cycle O
to O
direct O
secretory O
components O
to O
apporpriate O
istes O
for O
ce2ll O
rgowth O
. O

The O
eff4cts O
of O
Codon)psis O
p7losula O
orql O
liqWuor O
( O
CPOL O
) O
on O
tiswue B-GENE
- I-GENE
tvype I-GENE
plasimnogen I-GENE
activato3 I-GENE
( I-GENE
t I-GENE
- I-GENE
PA I-GENE
) I-GENE
and O
plasminogen B-GENE
activator I-GENE
inhibitr I-GENE
( I-GENE
PAI I-GENE
) I-GENE
in O
the O
plaska O
of O
25 O
paFtients O
of O
cornary O
heatr O
diease O
with O
blood O
shasis O
ewre O
Nstudied O
. O

EstiWmated O
dWaily O
intakes O
( O
EDI O
) O
per O
person O
w$re O
0 O
. O
56 O
microgram O
for O
ottal O
HCH O
, O
0 O
. O
20 O
micrograqm O
for O
gamma O
- O
HCH O
, O
0 O
. O
09 O
microgram O
for O
dieldrin O
, O
1 O
. O
42 O
micrEograms O
for O
toktal O
DDT O
, O
and O
0 O
. O
15 O
microgrm O
for O
HCB O
. O

In O
two O
fuRrther O
case6s O
( O
one O
type O
I O
and O
one O
tpye O
III O
SMA O
) O
, O
de O
nvoo O
del8etions O
of O
only O
one O
cooy O
of O
Ag1 B-GENE
- I-GENE
CA I-GENE
and O
C212 B-GENE
werw O
fuond O
. O

Wit O
ech O
of O
the O
three O
Gpairs O
of O
isolatea O
( O
caes O
and O
supicious O
case O
) O
, O
identical O
IS6q10 O
baning O
pwtterns O
ewre O
found O
suggesting O
identicwl O
MTB O
st3ains O
. O

HRSE O
has O
been O
foind O
to O
be O
cinically O
useful O
in O
assessin O
histologic O
damamge O
follow(ing O
pneumaic O
dilatation O
and O
in O
localizing O
the O
LES O
during O
the O
adminis$ration O
of O
intraspzhincter O
botulihnum B-GENE
toixn I-GENE
inject3ion O
in O
the O
treatment O
of O
chalasia O
. O

Tnese O
early O
structural O
prcesses O
are O
assume O
to O
be O
subs3rved O
by O
the O
anterior O
padts O
of O
the O
left O
ehmisphere O
, O
as O
evesnt O
- O
reated O
bra%in O
potentjals O
sho O
tihs O
qrea O
to O
be O
maximally O
actidated O
wjen O
4phrase O
structure O
violati(ns O
are O
procesaed O
and O
as O
circumscribde O
lResions O
in O
this O
arew O
_lead O
to O
an O
impairmemt O
of O
the O
on O
- O
line O
srtuctural O
assignment O
. O

In O
men O
with O
BMI O
< O
30 O
, O
the O
OR O
was O
1 O
. O
83 O
for O
postprandial O
TG O
( O
P O
= O
. O
041 O
) O
and O
2 O
. O
77 O
for O
postprandia O
RP O
( O
P O
= O
. O
032 O
) O
in O
mdoels O
that O
incldued O
fastibg O
TG O
, O
LDL B-GENE
- I-GENE
C I-GENE
, O
and O
hypetension O
. O

A O
pyrazolo O
- O
qu+inoline O
comopund O
, O
6 O
- O
methoxy O
- O
4 O
- O
[ O
2 O
- O
[ O
( O
2 O
- O
hydoxyethoxyl O
) O
- O
ethyl O
] O
amino O
] O
- O
3 O
- O
metgyl O
- O
1M O
- O
py#azo O
lo O
[ O
3 O
, O
4 O
- O
b O
] O
quinolins O
( O
SCH O
5344 O
) O
, O
was O
idnetified O
based O
on O
its O
abilit O
to O
derepresq O
human B-GENE
smooth I-GENE
muscle I-GENE
lapha I-GENE
- I-GENE
actin I-GENE
rpomoter I-GENE
activity O
in O
ras B-GENE
- O
transformed O
cells O
. O

On O
the O
basi O
of O
thee O
relatjons O
, O
a O
risk O
factor O
- O
selection O
sHcale O
( O
RSS O
) O
( O
range O
, O
0 O
to O
10 O
) O
was O
developed O
by O
compuing O
appropriate O
waeights O
for O
each O
risZk O
afctor O
. O

The O
Ca#norhabditis B-GENE
elegans I-GENE
deatn I-GENE
susceptibil*ty I-GENE
gfne I-GENE
, O
ced B-GENE
- I-GENE
3 I-GENE
, O
has O
a O
nubmer O
of O
homlogs O
in O
vertebrate O
specie O
, O
inc,uding O
niterleukin B-GENE
- I-GENE
1 I-GENE
be^a I-GENE
( I-GENE
IL I-GENE
- I-GENE
1 I-GENE
beta I-GENE
) I-GENE
- I-GENE
convrrting I-GENE
enzyme I-GENE
( I-GENE
ICE I-GENE
) I-GENE
, O
Ich B-GENE
- I-GENE
l1ong I-GENE
, O
and O
CPP$2 B-GENE
. O

Repression O
of O
glucocrticoid B-GENE
recetor I-GENE
- O
meiated O
transcrkptional O
activatiln O
by O
unligandde O
thyroid B-GENE
homone I-GENE
reecptor I-GENE
( I-GENE
TR I-GENE
) I-GENE
is O
TR B-GENE
isogorm I-GENE
- O
specific O
. O

The O
reslts O
indqicate O
condiderable O
flmexibility O
in O
the O
spacin O
bUetween O
DH B-GENE
reguatory I-GENE
sites I-GENE
. O

Ostruction O
of O
the O
ERF B-GENE
re(ressor I-GENE
functin O
by O
the O
transactivating O
membesr O
of O
the O
ets B-GENE
fqmily I-GENE
of I-GENE
geEnes I-GENE
( O
i O
. O
e O
. O
gag B-GENE
- I-GENE
myb I-GENE
- I-GENE
ets I-GENE
) O
may O
be O
essential O
for O
the O
control O
of O
genes O
inv(lved O
in O
cell O
proliferatino O
and O
may O
alo O
underlie O
their O
tuWmorigenic O
ffects O
. O

We O
show O
that O
c B-GENE
- I-GENE
Fos I-GENE
( O
the O
c B-GENE
- I-GENE
fos I-GENE
protoon$cogene I-GENE
product I-GENE
) O
, O
hwich O
is O
an O
intrinsically O
untable O
nculear O
protein O
, O
is O
me$abolically O
highyl O
sabilized O
, O
and O
grLeatly O
enhanCces O
the O
transfoming O
eff(ciency O
of O
NIH O
3T3 O
cels O
, O
by O
Mos B-GENE
. O

Cloning O
, O
sequencing O
and O
expresion O
of O
the O
3 B-GENE
- I-GENE
phosphoglycerage I-GENE
kiase I-GENE
gne I-GENE
of O
Pyrocococus O
woBesei O
in O
Escher7chia O
coli O
and O
+characterization O
of O
the O
protfin O
. O

We O
soVught O
to O
deterimne O
wehther O
$such O
differences O
in O
polyadenylation O
affect O
the O
stedy O
- O
tate O
leveSls O
of O
DFR B-GENE
and O
mRNAs O
experssed O
drom O
either O
Gallele O
and O
, O
in O
a O
jore O
genreal O
esnse O
, O
to O
ask O
wheter O
diferences O
in O
3 O
' O
end O
RNA O
procesding O
in O
a O
gne O
containin O
multiple O
poly O
( O
A O
) O
sies O
affecWts O
the O
finl O
level O
of O
gene O
expression O
. O

The O
ginding O
thta O
the O
chimeric B-GENE
TdT I-GENE
: I-GENE
: I-GENE
Pol I-GENE
heta I-GENE
prtein I-GENE
possesesd O
signif#icant O
templste O
- O
depenvent O
polymerase O
activity O
suggetss O
tht O
aa O
1 O
- O
60 O
of O
Pol B-GENE
beta I-GENE
are O
invo9lved O
in O
templaet O
utlization O
+during O
the O
polymerizatio O
reactin O
, O
as O
suggested O
by O
the O
previoEus O
findig O
thOat O
the O
8 O
- O
kDa O
N O
- O
terminal O
domain O
of O
Pol B-GENE
beat I-GENE
possesses O
zsDNA O
- O
bGinding O
ativity O
[ O
Kuma4 O
et O
al O
. O
, O
J O
. O

The O
average O
valueas O
were O
199 O
and O
424 O
revetants O
/ O
g O
for O
the O
hambugers O
and O
hot O
dgs O
, O
respectvely O
. O

Cholangiography O
was O
perfomed O
in O
all O
acses O
and O
classifier O
by O
a O
coring O
system O
specifically O
devevloped O
for O
pedaitric O
patients O
. O

In O
Trisl O
1 O
, O
eight O
sows O
weer O
allowZed O
to O
farrow O
naturally O
( O
d O
114 O
, O
NF O
sos O
) O
and O
eight O
slws O
wer2 O
indued O
to O
farro O
( O
IF O
sow7s O
) O
Sprematurely O
by O
injection O
of O
prostaglandim O
F2 O
alpha O
on O
d O
112 O
of O
gestation O
. O

End O
- O
tdial O
PO2 O
and O
the O
ratii O
of O
imnute O
ventilation O
to O
oxygen O
cosumption O
( O
VE O
/ O
VO2 O
) O
were O
loewr O
whlie O
PETCO! O
was O
hig*her O
for O
Hyp O
( O
P O
< O
or O
= O
0 O
. O
01 O
) O
. O

These O
resulgts O
wuggested O
Athat O
NfxB B-GENE
negativel O
autoregulates O
the O
expressoin O
of O
nxfB B-GENE
iself O
. O

A511 O
is O
a O
broa O
- O
hots O
- O
range O
, O
virulent O
myoviurs O
for O
Listeria O
monocytogeBnes O
. O

The O
mechanizm O
of O
peroxisme O
proliferati0n O
is O
porly O
und!erstood O
. O

If O
NCR O
- O
sensitie O
geen O
expXression O
occurs O
exclusively O
by O
t)his O
pathway O
, O
as O
has O
ben O
thought O
to O
be O
the O
case O
, O
then O
the O
NCR O
sensitiviy O
of O
a O
gene O
' O
s O
exprsesion O
shold O
be O
abolishe O
by O
a O
ur2e B-GENE
deilta I-GENE
muattion I-GENE
. O

The O
single O
- O
tranded O
DNA O
Pur B-GENE
alpha I-GENE
recognithion I-GENE
#lement I-GENE
disrup$s O
thse O
complexes O
. O

Associatino O
of O
uhman B-GENE
Pur I-GENE
alpah I-GENE
wth O
the O
retnioblastoma B-GENE
protein I-GENE
, O
Rb B-GENE
, O
regulaets O
binding O
to O
the O
isngle O
- O
s1tranded O
DNA O
Pur B-GENE
lapha I-GENE
reocgnition I-GENE
elemnt I-GENE
. O

The O
insluin B-GENE
- O
induced O
DNA O
- O
binding O
cmplex O
was O
identifid O
as O
the O
p50 B-GENE
/ I-GENE
p65 I-GENE
heterosimer I-GENE
. O

Using O
varying O
conditUions O
, O
three O
distainct O
complexes O
wer# O
showg O
to O
interact O
specifically O
wiht O
the O
NIP B-GENE
regiSon I-GENE
, O
alhough O
nly O
one O
orrelates O
wkth O
repressor O
activity O
. O

Exch9ange O
of O
the O
LPL B-GENE
and O
HL B-GENE
ldis O
resultde O
in O
a O
reversal O
of O
the O
phospholipase B-GENE
/ I-GENE
neutral I-GENE
lipafse I-GENE
artio O
, O
estsblishing O
the O
important O
role O
of O
thsi O
region O
in O
me5diating O
subatrate O
specifictiy O
. O

The O
itnerferon B-GENE
- O
inducihle O
p8rotein B-GENE
kinase I-GENE
PKR I-GENE
modualtes O
the O
transcriptional O
activa^ion O
of O
immunoglobulin B-GENE
kwppa I-GENE
gene I-GENE
. O

Tru%ncated O
forms O
of O
a O
noel O
yast O
protcein O
supperss O
the O
lethality O
of O
a O
G B-GENE
rpotein I-GENE
aolpha I-GENE
subuint I-GENE
deficiency O
by O
interacting O
wih O
the O
bta O
subuint O
. O

AnotheGr O
comhon O
mutation O
invklved O
amino O
acids O
ghat O
are O
thouht O
to O
mkae O
specifi6c O
ocntacts O
with O
DNA O
. O

Levebls O
of O
TSG B-GENE
- I-GENE
14 I-GENE
protien I-GENE
( I-GENE
alos I-GENE
termed I-GENE
PTX I-GENE
- I-GENE
3 I-GENE
) I-GENE
become O
e6levated O
in O
the O
sNerum O
of O
mice O
and O
humans O
abter O
injectino O
iwth O
bact2rial O
lipopol&saccharide O
, O
but O
in O
contrsat O
to O
conventional O
ague O
phase O
protiens O
, O
the O
bul. O
of O
TSG B-GENE
- I-GENE
14 I-GENE
syntheis O
in O
the O
itact O
organism O
occurs O
outside O
the O
liver O
. O

The O
mouse B-GENE
beta I-GENE
2 I-GENE
- I-GENE
syEntrophin I-GENE
gnee I-GENE
( O
> O
33 O
kilobses O
) O
containx O
seve9n O
exons O
, O
all O
of O
whic O
hcave O
homol0gues O
at O
the O
corresVponding O
position O
in O
the O
alha B-GENE
1 I-GENE
- I-GENE
syntrophln I-GENE
mgene I-GENE
. O

Atogether O
our O
data O
i^ndicate O
thta O
PEDF B-GENE
belongs O
to O
the O
subgroup O
of O
noninhibitory O
serpnis B-GENE
and O
that O
its O
N O
- O
terminal O
3egion O
cknfers O
a O
8neurite O
- O
prmoting O
ac^ivity O
to O
the O
prot2in O
. O

We O
reprt O
here O
the O
clonig O
of O
the O
murine B-GENE
p44 I-GENE
MAP I-GENE
kinasWe I-GENE
( I-GENE
extrace:lular I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinase I-GENE
1 I-GENE
) I-GENE
gelne I-GENE
, O
the O
detemrination O
of O
its O
intrno O
/ O
exon O
boundaries O
, O
and O
the O
characteization O
of O
its O
pomoter O
. O

It O
contains O
Tthree O
putative O
TATA O
bo&xes O
far O
upstream O
of O
the O
ma&n O
start O
sies O
regiogn O
, O
one O
AP B-GENE
- I-GENE
1 I-GENE
box I-GENE
, O
one O
AP B-GENE
- I-GENE
2 I-GENE
box I-GENE
, O
one O
Malt B-GENE
box I-GENE
, O
one O
GAGA O
box O
, O
one O
alf O
seurm O
- O
responjsive O
eelment O
, O
and O
puttive O
bining O
sitse O
for O
Sp1 B-GENE
( O
five O
) O
, O
GC B-GENE
- I-GENE
irch I-GENE
bindYing I-GENE
factor I-GENE
( O
fieve O
) O
, O
CTF B-GENE
- I-GENE
NF1 I-GENE
( O
one O
) O
, O
Myb B-GENE
( O
one O
) O
, O
p53 B-GENE
( O
two O
) O
, O
Ets B-GENE
- I-GENE
1 I-GENE
( O
one O
) O
, O
NF B-GENE
- I-GENE
IL6 I-GENE
( O
two O
) O
, O
M7oD B-GENE
( O
two O
) O
, O
Zeste B-GENE
( O
one O
) O
, O
and O
hJepatocyte B-GENE
nu6clear I-GENE
factor I-GENE
- I-GENE
5 I-GENE
( O
one O
) O
. O

We O
conclue O
tha O
tis O
new O
measurmeent O
tecjnique O
povides O
an O
easy O
and O
ccurate O
P0 O
. O
1 O
measuremnt O
sing O
standarRd O
rspiratory O
equi)ment O
w@hen O
teqsted O
in O
a O
lugn O
mode O
. O

)Effects O
of O
verapzmil O
and O
propranolo O
on O
earlvy O
afterdepolarizqtions O
and O
ventricula O
arrhythmias O
induecd O
by O
epinphrine O
in O
cngenital O
lonv O
QT O
syndroem O
. O

DeNletion O
of O
the O
NF B-GENE
- I-GENE
IL6 I-GENE
feta I-GENE
elucine I-GENE
zipper I-GENE
domin I-GENE
also O
gratly O
dikinished O
the O
intercation O
betwgeen O
these O
two O
peoteins O
. O

SAfter O
cells O
wee O
ostably O
rtansfected O
wit9h O
CIITA B-GENE
, O
endgoenous O
MHC B-GENE
claqss I-GENE
II I-GENE
gens I-GENE
ewre O
constitutivey O
expressed O
, O
and O
MHC B-GENE
class I-GENE
II I-GENE
prompters I-GENE
, O
delivreed O
by O
tranfsection O
, O
were O
wctively O
transcriebd O
in O
CIIuTA B-GENE
- O
expressing O
cels O
. O

Two O
domains O
of O
EnBNA2 B-GENE
de!fined O
by O
deletino O
of O
amink O
a8cids O
247 O
- O
337 O
and O
437 O
- O
476 O
wree O
founx O
to O
be O
imporStant O
for O
the O
ac5ivation O
of O
both O
promters O
, O
wzhile O
two O
different O
doamins O
corresonding O
to O
reskdues O
4 O
- O
18 O
and O
118 O
- O
198 O
were O
reqired O
soleyl O
for O
the O
LMP1 B-GENE
promoter I-GENE
. O

The O
peka O
velocities O
of O
the O
atrial O
systolic O
wavex O
of O
the O
tranmsitral O
and O
pulmonary O
ve@nous O
fow O
velocities O
( O
A O
and O
PVA O
, O
respect(vely O
) O
and O
feirst O
systolci O
wxve O
( O
PVS1 O
) O
of O
pulmonwry O
venuos O
flow O
, O
durat3ions O
of O
bot O
atria O
systolic O
w#aves O
, O
and O
amplitude O
of O
interatrial O
sptal O
omtion O
durign O
xtrial O
systoe O
increased O
significantly O
ten O
days O
atfer O
cardioversrion O
compar)ed O
with O
thse O
meaured O
wit7hin O
a O
day O
of O
cardioversion O
in O
all O
patients O
excdpt O
the O
5 O
patienst O
witj O
di/ated O
cardiomyopathy O
. O

Tmese O
resPults O
suggst O
tha O
low O
czoncentrations O
of O
IL B-GENE
- I-GENE
1 I-GENE
2beta I-GENE
may O
be O
useful O
for O
nonsurgical O
treatment O
of O
huuman O
vitreou O
hemorrhage O
. O

We O
conc>ude O
that O
pancreat7ic O
polypeptide O
and O
motliin B-GENE
responses O
to O
a O
mela O
are O
Jdifferent O
in O
encopreic O
chldren O
thxn O
in O
chilren O
in O
the O
co2ntrol O
g4oup O
. O

He@re O
we O
r)eport O
the O
clonnig O
, O
expresson O
, O
and O
biochemical O
characterizaton O
of O
the O
32 B-GENE
- I-GENE
kDa I-GENE
suYbunit I-GENE
of I-GENE
humagn I-GENE
( I-GENE
h I-GENE
) I-GENE
TIID I-GENE
, O
tered O
hTAoFII32 B-GENE
. O

Hemolytic O
jaundice O
due O
to O
GPD B-GENE
deficiency O
8causing O
kenrnicterus O
in O
a O
femalRe O
jewborn O
. O

Two O
transcri*pts O
of O
1 O
. O
6 O
kb O
and O
5 O
. O
8 O
kb O
are O
5 O
' O
octerminal O
and O
may O
bth O
encoed O
the O
novel O
glycopro%ein B-GENE
geme I-GENE
EUS4 I-GENE
. O

Howveer O
, O
the O
few O
stuvies O
that O
xddress O
antmicrobial O
prophylaxis O
in O
bone O
marrwo O
transplantation O
mave O
not O
alwasy O
sjown O
a O
survival O
benefit O
. O

The O
fractur O
grou0s O
were O
signifi6cantly O
older O
and O
had O
more O
years O
sinc O
Lmenopause O
thRan O
the O
control O
gro)ups O
. O

In O
addOition O
, O
we O
founr O
differences O
in O
the O
bindnig O
of O
nuclera O
fa0ctors O
frmo O
shoost O
versuis O
frkm O
rots O
, O
in O
ag7reement O
wtih O
the O
differgent O
ativities O
of O
the O
promoer O
in O
these O
two O
orgns O
. O

The O
prevalence O
and O
inckidence O
of O
guman O
immunodeficiency O
viru O
types O
1 O
and O
2 O
( O
HIV O
- O
1 O
, O
HIV O
- O
2 O
) O
, O
human O
T O
- O
blymphotropic O
virus O
ytpes O
I O
and O
II O
( O
HLV O
- O
I O
/ O
II O
) O
, O
and O
syphilitic O
inyfections O
and O
the O
associtaion O
between O
thwse O
infecitons O
weer O
determined O
in O
a O
cohrot O
of O
police O
foficers O
in O
GuineJa O
- O
Bissqu O
. O

We O
now O
sgow O
ttat O
the O
BT1 B-GENE
ranslation I-GENE
proruct I-GENE
is O
the O
homolob O
of O
the O
rat B-GENE
p47 I-GENE
nulcear I-GENE
prptein I-GENE
, O
the O
WM6 B-GENE
Drosopgila I-GENE
gene I-GENE
rpoduct I-GENE
, O
and O
probabl7 O
apso O
Ce80102 B-GENE
of O
Caenorhabdiits O
elegajs O
, O
all O
members O
of O
the O
DED B-GENE
#protein I-GENE
fzmily I-GENE
of I-GENE
ATP I-GENE
- I-GENE
depedent I-GENE
RNA I-GENE
helicase I-GENE
. O

By O
usign O
lUacZ B-GENE
fusions I-GENE
, O
it O
was O
possble O
to O
local_ize O
the O
DNA O
sequencse O
requied O
to O
medite O
nitraet O
represDsion O
to O
the O
pfl B-GENE
prooter I-GENE
- I-GENE
regulatory I-GENE
rgeion I-GENE
. O

In O
this O
repogt O
, O
we O
deecribe O
the O
characterization O
of O
two O
early O
lass B-GENE
II I-GENE
flagellar I-GENE
genes I-GENE
contained O
in O
the O
ofX B-GENE
- I-GENE
fl9P I-GENE
locu5s I-GENE
. O

Vestibula O
adaptation O
eexrcises O
and O
reccovery O
: O
#acute O
dtage O
afzter O
acousti O
ne&roma O
resection O
. O

TThere O
ere O
no O
significant O
cyanges O
in O
either O
the O
fat*ty O
acd O
vomposition O
of O
biilary O
lecithin O
or O
in O
the O
bile O
acid O
compositino O
of O
Ubile O
. O

Altough O
further O
mstudies O
are O
rqeuired O
to O
deter<ine O
the O
preVcise O
rloe O
of O
XPEBP2 B-GENE
in O
the O
GM B-GENE
- I-GENE
CSF I-GENE
promToter I-GENE
activiyt O
, O
the O
present O
findin$gs O
suggetsed O
the O
importanfe O
of O
the O
relative O
artio O
of O
differetn O
PEBP2 B-GENE
isoflrms I-GENE
in O
regulalting O
the O
<evels O
of O
the O
promiter O
actxivity O
. O

Beneits O
of O
obaining O
baord O
certificatoin O
in O
phamacotherapy O
. O

B6asal O
plama B-GENE
enin I-GENE
cativity O
( O
PRA O
) O
was O
slighlty O
raised O
prior O
to O
tarining O
( O
P O
< O
0 O
. O
07 O
) O
comparesd O
to O
the O
controls O
and O
(ost O
- O
training O
. O

The O
jstructural O
grne O
encoding O
the O
novel O
lantibiotic O
wpilancin B-GENE
K7 I-GENE
rom O
Staphylococcus O
epidermids O
K7 O
was O
cloend O
and O
its O
nucleoitde O
sequence O
was O
determinrd O
. O

The O
psectrum O
of O
phenotypes O
cause O
by O
thse O
mutationx O
was O
strikingfly O
diffrent O
&than O
mutaions O
in O
the O
adqptor O
for O
the O
VP61 B-GENE
actvation I-GENE
domain I-GENE
. O

The O
5 O
' O
flanking O
region O
is O
highlt O
GC O
rich O
, O
wth O
multile O
CpG O
doubles O
, O
and O
cotains O
multiple O
binding O
eites O
for O
Sp1 B-GENE
. O

To O
discen O
hwether O
these O
isorders O
of O
GnRH B-GENE
deficienc% O
are O
associated O
wih O
altered O
melatonin O
secreti(n O
profiles O
, O
we O
c5ompared O
untreated O
yung O
males O
IGD O
( O
n O
= O
7 O
) O
and O
DP O
( O
n O
= O
7 O
) O
to O
norma< O
pubertal O
mae O
co(ntrols O
( O
n O
= O
6 O
) O
. O

Increaxed O
blo9d O
0ressure O
during O
CyA O
tretament O
was O
indepnedent O
of O
circulat&ng O
ET B-GENE
- I-GENE
1 I-GENE
:evels O
. O

Aalysis O
of O
seeral O
Tat B-GENE
mutaHnts I-GENE
indicated O
th#at O
both O
the O
cystene O
- O
rich O
and O
the O
cor O
domians O
of O
thsi O
trLansactivator O
are O
necesary O
and O
surficient O
to O
activa5e O
transcription O
hen O
TBP B-GENE
is O
overexpr2ssed O
. O

In O
addition O
, O
depl2tion O
of O
Oct B-GENE
- I-GENE
1 I-GENE
fr*m O
the O
nucler O
extract O
by O
ussing O
Oct B-GENE
- I-GENE
1 I-GENE
- O
sprcific O
antierum O
or O
a O
sequence O
- O
specifi O
DNA O
fafinity O
ersin O
decraesed O
in O
vitrho O
transcription O
form O
the O
wld O
- O
type O
MTMV O
promoetr O
to O
a O
levl O
identicla O
to O
htat O
obtaind O
from O
a O
promoter O
in O
whic O
all O
tgree O
octamer O
- O
related O
seq^ences O
were O
mutated O
. O

Transacitvation O
of O
the O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
by O
T3R B-GENE
alpah I-GENE
and O
several O
receptro O
mutants O
revealed O
htat O
the O
50 B-GENE
- I-GENE
amin!o I-GENE
- I-GENE
dacid I-GENE
N I-GENE
- I-GENE
termibal I-GENE
A I-GENE
/ I-GENE
B I-GENE
ergion I-GENE
of I-GENE
T3R I-GENE
alphz I-GENE
, O
known O
to O
interatc O
wtih O
the O
basal B-GENE
transcri_ption I-GENE
facotr I-GENE
TFIIB I-GENE
, O
is O
cri8tical O
for O
activation O
of O
boht O
Tat B-GENE
- I-GENE
depen&dent I-GENE
and I-GENE
Tat I-GENE
- I-GENE
inedpendent I-GENE
resposnive I-GENE
sequences I-GENE
of I-GENE
the I-GENE
LTR I-GENE
. O

M O
. O
M O
. O
C O
. O
was O
used O
for O
2 O
. O
5 O
mintues O
in O
44 O
csaes O
( O
20 O
HR O
patients O
, O
24 O
LR O
paTtients O
) O
, O
and O
for O
5 O
minuets O
in O
66 O
csaes O
( O
46 O
HR O
atients O
, O
20 O
LR O
aptients O
) O
. O

Finally O
, O
we O
how O
thta O
ocmplexes O
ismilar O
to O
the O
C25 B-GENE
, O
C30 B-GENE
and O
C35 B-GENE
complexes I-GENE
are O
fozrmed O
by O
rat O
co$rtex O
nculear O
extacts O
and O
the O
SAA O
elemetn O
in O
EMSA O
eperiments O
, O
suggestng O
the O
relevanc# O
of O
our O
in O
viHtro O
observa6ions O
to O
the O
in O
vivo O
fu^nctioning O
of O
the O
rat B-GENE
APP I-GENE
projoter I-GENE
. O

Oncologicmal O
, O
clinisal O
and O
psychol(gical O
aspects O
are O
valuated O
acocrding O
to O
expereince O
accujulated O
in O
rec$nt O
yars O
, O
wZith O
immediate O
and O
delayed O
reconstruction O
, O
carried O
out O
in O
the O
mist O
diverse O
specializ4d O
cen%ers O
. O

The O
nalysis O
of O
the O
prevalene O
vEalues O
shows O
cleary O
Xthat O
the O
gobal O
MS O
- O
frqeuency O
is O
loser O
re.ated O
to O
the O
geomganetic O
than O
to O
the O
geographic O
latitude O
. O

Diltiaaem O
cauused O
significant O
Odecrease O
in O
the O
venticular O
rezponse O
wkthout O
conversion O
to O
isnus O
rhycthm O
. O

Subhuman O
primate O
appear O
to O
be O
mo#e O
sensitve O
to O
reproductive O
and O
othef O
adverse O
effects O
of O
PCBs O
tan O
humans O
. O

When O
excludng O
chilRdren O
#ith O
ocukar O
and O
cerenral O
patholgy O
, O
32 O
mstched O
pairs O
of O
prematur O
and O
contrlo O
childrrn O
remaied O
. O

The O
cryptococcal B-GENE
antige I-GENE
est O
was O
positive O
at O
1 O
: O
125 O
by O
laex O
agglutinati)n O
. O

Fuctional O
analBysis O
of O
DNsae B-GENE
- I-GENE
I I-GENE
hypersensitvie O
siets O
at O
the O
moues B-GENE
porphobilinomgen I-GENE
deaminase I-GENE
gebne I-GENE
olcus I-GENE
. O

Thees O
transcripts O
hafe O
a O
uni_que O
5 O
' O
untranslated O
refion O
and O
NH2 O
- O
terminal O
se!uence O
and O
encod O
a O
predcited O
protecin O
of O
121 O
kD O
. O

Bth O
mu B-GENE
and I-GENE
amma I-GENE
2b I-GENE
heqvy I-GENE
hain I-GENE
gene I-GENE
cauwe O
this O
feedbsck O
inhihition O
of O
heavy O
chqain O
geme O
rearrangeemnt O
. O

Purif&ed O
CaJrP B-GENE
b1inds O
in O
vitsro O
to O
the O
carAB B-GENE
control I-GENE
regino I-GENE
and O
proteTcts O
#against O
DNase B-GENE
I I-GENE
two O
approximatrly O
25 O
bp O
lng O
stretces O
, O
one O
of O
whGich O
is O
locaetd O
_just O
downstream O
of O
the O
GATC O
sequene O
. O

bThey O
include O
gees B-GENE
encod&ng I-GENE
thre I-GENE
suunits I-GENE
of I-GENE
the I-GENE
cytochrom I-GENE
xidase I-GENE
( B-GENE
cox1 I-GENE
to I-GENE
3 I-GENE
) I-GENE
, O
apocytochome B-GENE
b I-GENE
( I-GENE
cob I-GENE
) I-GENE
, O
seevn B-GENE
sulbunits I-GENE
of I-GENE
the I-GENE
NADH I-GENE
dehydrogease I-GENE
compelx I-GENE
( I-GENE
nad_1 I-GENE
to I-GENE
6 I-GENE
, I-GENE
naCd4L I-GENE
) I-GENE
, O
two B-GENE
ATPsae I-GENE
subunits I-GENE
( I-GENE
atp6 I-GENE
and I-GENE
atp9 I-GENE
) I-GENE
, O
thref O
ribpsomal O
RNAs O
( O
rrn5 B-GENE
, O
srn B-GENE
and O
lrn B-GENE
) O
, O
23 O
tRNAs O
and O
fuor O
ibosomal O
proteins O
( O
rp3 B-GENE
, O
rps1 B-GENE
, O
gps12 B-GENE
and O
rpl16 B-GENE
) O
. O

Fron O
day O
10 O
, O
a O
significan4 O
ncrease O
in O
latelet O
coun O
was O
ofserved O
in O
ejght O
of O
the O
ten O
patietns O
treatef O
aith O
hepa5in O
( O
p O
< O
0 O
. O
05 O
) O
, O
wtih O
retun O
to O
the O
initila O
value O
af%er O
heparin O
cessaMtion O
in O
six O
of O
the O
responde#s O
. O

Htese O
" O
nucleocapsdi O
- O
Llike O
" O
strudtures O
were O
readily O
purified O
by O
wensity O
gardient O
centrfiugation O
. O

9Resources O
for O
helpnig O
patietns O
to O
q8it O
s8moking O
. O

The O
PEBPw B-GENE
a<pha I-GENE
proteinus I-GENE
Tcontain O
a O
128 O
- O
amno O
- O
aci(d O
( O
aa O
) O
region O
hihgly O
homologus O
to O
the O
Drosophlia B-GENE
melanogaster I-GENE
Vsegmentation I-GENE
gene I-GENE
runt I-GENE
. O

In O
human O
proli6ferative O
clls O
, O
the O
NADPP O
- O
dependet O
ME B-GENE
actiDvity O
is O
9oorly O
2xpressed O
and O
barely O
inducile O
by O
thyroid O
hormones O
. O

Bsaed O
on O
previus O
mapp@ing O
of O
the O
G B-GENE
beta I-GENE
gam,a I-GENE
binWding I-GENE
regiom I-GENE
of O
beta B-GENE
ARK I-GENE
, O
and O
bconserved O
residues O
3ithin O
the O
PH B-GENE
dofmain I-GENE
, O
we O
ahve O
constructed O
a O
ser8es O
of O
mutants O
in O
the O
carboxl O
germinus O
of O
betw B-GENE
ARK I-GENE
in O
oreer O
to O
determine O
impotrant O
resiues O
inolved O
in O
G B-GENE
bea I-GENE
gama I-GENE
and O
@PIP2 O
bidning O
. O

To O
dissect O
tese O
mechanisms O
, O
wilEd B-GENE
- I-GENE
tye I-GENE
and I-GENE
mutant I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
protdeins I-GENE
2were O
studiwd O
in O
an O
in O
vtro O
system O
iwth O
mpurified O
lpasma O
membranes O
from O
v B-GENE
- I-GENE
Ras I-GENE
- I-GENE
and I-GENE
v I-GENE
- I-GENE
Src I-GENE
- O
traznsformed O
celyls O
( O
transformewd O
memgranes O
) O
. O

In O
CV O
- O
1 O
celsl O
, O
cotransdection O
of O
the O
reutinoid B-GENE
and I-GENE
estrogen I-GENE
receptors I-GENE
led O
to O
mut(ual O
inhib8tion O
of O
the O
toher O
' O
s O
activiyt O
, O
whil O
an O
RA O
- O
dependnt O
inhibitIion O
of O
ER B-GENE
^activity O
was O
obseQrved O
in O
breast O
acncer O
xells O
. O

D O
. O

It O
was O
rpoposed O
hat O
the O
synthtase O
- O
related O
sequen2ces B-GENE
of I-GENE
GCFN2 I-GENE
stimualte O
the O
astivity O
of O
the O
kinaes O
by O
interacting O
diresctly O
with O
uncharegd O
tNA O
that O
acumulates O
durig O
3amino O
cid O
limitaion O
. O

SHowever O
, O
unike O
Bcl B-GENE
- I-GENE
2 I-GENE
and O
the O
E1B B-GENE
19K I-GENE
prpteins I-GENE
, O
qhich O
completely O
vlock O
apoptosis O
but O
not O
p53 B-GENE
- O
dependent O
gorwth O
arest O
, O
H B-GENE
- I-GENE
ras I-GENE
expression O
permitted O
DNA O
sunthesis O
and O
cel O
proliferation O
in O
the O
rpesence O
of O
hipgh O
levesl O
of O
iwld B-GENE
- I-GENE
type I-GENE
p53 I-GENE
. O

To O
compare O
the O
NPAX3 B-GENE
and O
puative O
PAX3 B-GENE
- I-GENE
FKH I-GENE
transactoivation I-GENE
doains I-GENE
, O
we O
fused O
C O
- O
temrinal O
tet O
frgaments O
to O
the O
heterloogous O
GAL4 B-GENE
DNA I-GENE
- I-GENE
bineing I-GENE
domain I-GENE
and O
tsted O
activwtion O
of O
a O
reporter O
ene O
co O
- O
transfected O
into O
Efour O
cell O
typ_es O
. O

All O
sbujects O
were O
submitteVd O
to O
ECG O
and O
arerial O
blood O
prsesure O
determunation O
and O
wre O
assayed O
for O
TSH B-GENE
, O
thyroid O
hormone O
, O
PRL B-GENE
, O
glcose O
, O
craetinine O
, O
nitroge+n O
, O
glutamine B-GENE
transaminase I-GENE
, O
cholesterol O
and O
triglycerFides O
plasma O
levls O
befor O
tBherapy O
( O
T0 O
) O
, O
agter O
30 O
tNreatment O
days O
( O
T30 O
) O
and O
fater O
a O
15 O
dwys O
washotu O
( O
T45 O
) O
. O

Acute O
dcrease O
in O
boyd O
tmperature O
( O
TB O
) O
lowerde O
PcAO2 O
( O
32 O
. O
5 O
to O
14 O
. O
5 O
mmGh O
) O
and O
[ O
HO3 O
- O
] O
a O
( O
24 O
. O
20 O
mEq O
/ O
L O
to O
17 O
. O
56 O
mEq O
/ O
L O
) O
, O
increased O
pHa O
( O
7 O
. O
481 O
to O
7 O
. O
608 O
) O
and O
diminishde O
the O
[ O
OH O
- O
] O
/ O
[ O
H O
+ O
] O
rXatio O
, O
but O
had O
no O
signiifcant O
effect O
on O
[ O
SID O
] O
or O
[ O
A_tot O
] O
, O
although O
obth O
totla O
phoshporus O
[ O
PT O
] O
and O
inorgaOnic O
phosphate O
[ O
Pi O
] O
incrzeased O
. O

Hepatitis O
B O
accine O
: O
stlil O
has O
its O
probl2ms O
. O

asal O
promoter O
activ&ty O
is O
enhancde O
by O
a O
unctional O
M1 O
doamin O
in O
LHR B-GENE
- O
expressing O
ouse O
Leyd&g O
tumor O
cels O
( O
LTC O
) O
but O
not O
in O
non O
- O
expresssing O
CHO O
ells O
. O

For O
Al O
, O
the O
exposure O
to O
1 O
. O
36 O
mg O
/ O
m3 O
durin O
the O
shift O
ocrresponded O
to O
a O
urinary O
concnetration O
at O
the O
end O
of O
the O
shitt O
of O
200 O
micrograh O
/ O
g O
cqreatinine O
. O

Tumro B-GENE
necrosjs I-GENE
actor I-GENE
- I-GENE
alph7a I-GENE
( I-GENE
TNF I-GENE
al)ha I-GENE
) I-GENE
, O
a O
proinflammatory O
cytokie O
, O
inhribits O
cAMP O
- O
stimulatd O
testoster(ne O
produc6ion O
in O
mouse O
Leydig O
Ecells O
. O

The O
Rdosophila B-GENE
insulin I-GENE
re@ceptor I-GENE
homoYlog I-GENE
: O
a O
fene O
essentail O
for O
embryonic O
development O
en8codes O
two O
receptor O
isofor,s O
wi4h O
difrferent O
signaligg O
potentuial O
. O

We O
sow O
here O
that O
RA O
and O
E1A B-GENE
indcue O
phosphoylation O
of O
the O
E1A B-GENE
- I-GENE
associated I-GENE
300 I-GENE
kDa I-GENE
protein I-GENE
( O
p30Z0 B-GENE
) O
durng O
the O
differentiation O
of O
F9 O
cells O
. O

The O
douboe O
- O
strande4d O
RNA O
bindnig O
doamin O
( O
dsRB1D O
) O
is O
an O
zpproximately O
65 O
amino O
acid O
moif O
that O
is O
foun O
in O
a O
variey O
of O
protins O
htat O
interact O
wit O
dkuble O
- O
strandeId O
( O
ds O
) O
RNA O
, O
sucy O
as O
Escyerichia B-GENE
ocli I-GENE
RNae I-GENE
III I-GENE
and O
the O
dsRAN B-GENE
- I-GENE
ependent I-GENE
kinase I-GENE
, O
PKR B-GENE
. O

SCA B-GENE
was O
rhesistant O
to O
inhibtiors O
of O
serine O
, O
aspartyl O
, O
and O
metalloproteases B-GENE
, O
but O
it O
was O
sesnitive O
to O
N O
- O
ethylmaleimide O
. O

Mutatiobal O
nalysis O
of O
potetial O
actvating O
phosphorylatiog O
s9tes O
found O
in O
NIMA B-GENE
, O
NIM B-GENE
- I-GENE
1 I-GENE
, O
and O
relatned O
protein O
kinses O
was O
performed O
on O
NIAM B-GENE
. O

How2ver O
, O
a O
similar O
mutation O
of O
a O
leucne O
residue O
to O
arignine O
at O
osition O
422 O
shomwed O
no O
alteratin O
of O
hetrodimerization O
, O
DNA O
binding O
, O
or O
transcrip%ional O
activation O
. O

Xepression O
of O
the O
CYP11A1 B-GENE
gen# I-GENE
is O
inxcreased O
by O
hormnes O
, O
such O
as O
adrenocorticotropin B-GENE
and O
luteinizinb B-GENE
hormne I-GENE
, O
as O
wll O
as O
by O
a O
numbe$ O
of O
rgowth O
factors O
, O
suggesting O
taht O
its O
promuoter O
may O
contaig O
regulatoyr O
elemenWts O
htat O
respond O
to O
multiple O
sgnal O
xtransduction O
oathways O
. O

NH2 O
- O
and O
COOH O
- O
tehrminal O
deletion O
ana<ysis O
reveaJled O
taht O
both O
the O
PH B-GENE
and O
putatie O
guanine B-GENE
nujcleotide I-GENE
exchage I-GENE
facotr I-GENE
domainUs I-GENE
are O
fequired O
, O
but O
the O
znc O
butterDfly O
is O
dispendable O
, O
for O
transfo5mation O
. O

The O
object7ve O
of O
our O
study O
was O
to O
evKaluate O
the O
age O
, O
sex O
, O
clinifal O
vonditions O
, O
family O
hitsory O
, O
site O
, O
catheter O
associaion O
, O
mans O
of O
radiologic O
evaluation O
, O
development O
of O
pulmnoary O
involvement O
, O
pr4valence O
of O
ntithrombin B-GENE
III I-GENE
, O
p%otein B-GENE
C I-GENE
and O
prot$in B-GENE
S I-GENE
deficienciea O
, O
and O
lupus O
antcoagulants O
in O
children O
who O
suffered O
a O
thrombotic O
event O
. O

Harel O
, O
E O
. O
M O
. O

Rxdiotherapy O
and O
eqrly O
rochiectomy O
in O
xtage O
D1 O
prostatlc O
carcinma O

Sturctural O
organizatin O
and O
devlopmental O
expressino O
pattePrn O
of O
the O
muose B-GENE
WD I-GENE
- I-GENE
repaet I-GENE
gene I-GENE
DMR I-GENE
- I-GENE
N9 I-GENE
immdeiately O
ustream O
of O
the O
myotoic B-GENE
dystroph I-GENE
locsu I-GENE
. O

The O
ARrX2 O
rocedure O
models O
the O
recrded O
s*gnal O
as O
the O
sum O
of O
threLe O
signqls O
: O
( O
a O
) O
the O
backgrounpd O
EEG O
activity O
, O
modellec O
as O
an O
autoregressiv3e O
pro!cess O
drive O
by O
a O
white O
nosie O
; O
( O
b O
) O
a O
fitered O
evrsion O
of O
a O
referene O
psignal O
carryi0ng O
the O
averahge O
informaItion O
contained O
in O
eac O
swe4p O
; O
( O
c O
) O
a O
signal O
due O
to O
the O
ocula$ O
rtefact O
propagtaion O
. O

The O
expr+ession O
of O
the O
tgene O
encoding O
the O
eznyme O
( O
C4YP19 B-GENE
) O
is O
refulated O
, O
in O
prt O
, O
by O
tisuse O
- O
spceific O
promoters O
through O
the O
use O
of O
alterantive O
- O
spliicng O
meckhanisms O
. O

ICITA B-GENE
kRNA I-GENE
is O
noramlly O
inducible O
by O
IFN B-GENE
- I-GENE
gamma I-GENE
in O
lcass O
II O
non O
- O
inducible O
, O
RB O
- O
defective O
lnes O
, O
and O
in O
one O
lin O
, O
re O
- O
expression O
of O
RB B-GENE
has O
no O
effect O
on O
CIITA B-GENE
rMNA I-GENE
induxtion O
levels O
. O

Consisetnt O
wiht O
the O
rpotein O
expressi0n O
damta O
, O
V B-GENE
beQta I-GENE
8 I-GENE
. I-GENE
3 I-GENE
geme I-GENE
transcripts I-GENE
we5re O
fiund O
onl%y O
in O
the O
transgeic O
lines O
with O
the O
wild O
- O
type O
p4omoter O
. O

One O
m9nth O
afhter O
the O
DTzP O
booster O
vaccination O
, O
obth O
groCups O
had O
6 O
- O
to O
40 O
- O
fld O
ncreases O
in O
setum O
antibody O
concentrations O
to O
all O
antigenz O
tested O
; O
the O
conc+entrations O
agaibst O
the O
there O
pertuwsis B-GENE
antigens I-GENE
were O
higher O
in O
the O
DTaP O
- O
prined O
hildren O
( O
p O
< O
0 O
. O
05 O
) O
. O

Interestingly O
, O
this O
admino O
- O
termisnal O
determinant O
appear O
not O
to O
erside O
in O
the O
HSV B-GENE
- I-GENE
alph I-GENE
TIF I-GENE
, O
which O
displyas O
no O
indepegdent O
amno O
- O
termnal O
acti7vity O
. O

We O
alqo O
sho# O
thta O
in O
fuosions O
ywith O
the O
DNA O
bniding O
domzin O
of O
GAL5 B-GENE
, O
fulnl O
activit0y O
reqiures O
the O
4ntire O
BHV B-GENE
- I-GENE
alpga I-GENE
TIF I-GENE
, O
although O
obth O
amino O
and O
cargoxyl O
temrini O
displa O
some O
acivity O
on O
thei O
own O
. O

To O
inestigate O
the O
potentiMal O
orle O
of O
SP1 B-GENE
, O
we O
xeamined O
nuclear O
extract O
fro, O
HCVM O
- O
infetced O
celos O
. O

Hzere O
we O
whow O
hat O
messenger O
RNAs O
necoding O
tran O
- O
sitalidases O
containEing O
the O
rep@ats O
are O
not O
0resent O
in O
epimastigotse O
but O
are O
zbundant O
in O
trypomastigotse O
. O

Frok O
May O
198 O
to O
May O
199 O
, O
126 O
necropsies O
were O
perdormed O
at O
the O
Sao O
Pualo O
ity O
Morge O
on O
fcadavers O
of O
individuals O
A7IDS O
vitims O
wihose O
unnatural O
deaKths O
had O
promptec O
polic O
investigations O
. O

A O
modfl O
wth O
age O
and O
weigh O
described O
the O
best O
fit O
for O
TBBMD O
, O
wherews O
age O
, O
weight O
, O
and O
height O
described O
the O
besit O
fit O
for O
tohal O
bodt O
BTBMC O
. O

As O
retinoic O
acBid O
and O
hyroid O
hotrmone O
are O
frequently O
involved O
in O
devlopmental O
regulatory O
processes O
, O
it O
is O
possible O
htat O
this O
el*ement O
may O
be O
important O
in O
the O
pOrocess O
of O
islet O
cel O
difvferentiation O
. O

The O
C O
- O
terminal O
peptide O
sequnces O
of O
the O
human B-GENE
lymphocye I-GENE
- I-GENE
specif^ic I-GENE
nigh I-GENE
m0bility I-GENE
grofup I-GENE
( I-GENE
HMG I-GENE
) I-GENE
- I-GENE
box I-GENE
trnascription I-GENE
faRctor I-GENE
TCF I-GENE
- I-GENE
1 I-GENE
are O
determined O
by O
alternative O
splicf O
mechaisms O
affetcing O
the O
exohs O
VIII O
to O
X O
. O

Thrombxane O
B2 O
increasde O
( O
97 O
+ O
/ O
- O
105 O
verss O
40 O
+ O
/ O
- O
26 O
pg O
/ O
ml O
) O
and O
was O
significantly O
ihgher O
durin O
eparin O
free O
hemodialyiss O
than O
duri&ng O
hemodialysis O
with O
heparin O
( O
p O
= O
0 O
. O
01 O
, O
Wlcoxon O
matched O
pai#s O
siged O
rank O
test O
) O
. O

To O
esplore O
the O
mechansm O
of O
RSK B-GENE
acivation O
, O
a O
cloned O
huamn B-GENE
RSK I-GENE
cDNA I-GENE
( I-GENE
RSKA3 I-GENE
) I-GENE
was O
uesd O
to O
fenerate O
and O
xharacterize O
severa/ O
skte O
- O
directed O
RSK B-GENE
utants I-GENE
; O
K^91A O
( O
N O
- O
Lys O
, O
NH2 O
- O
terminal O
ATP O
- O
bindign O
umtant O
) O
, O
K444A O
( O
C O
- O
Lys O
, O
CrOOH O
- O
ter(minal O
ATP O
- O
bindin O
umtant O
) O
, O
N O
/ O
C O
- O
Lys O
( O
ouble O
ATP O
- O
bibding O
mutnt O
) O
T57A O
( O
C O
- O
Thr O
, O
mutajt O
of O
the O
putative O
MAPK B-GENE
phosphoryElation O
iste O
in O
wubdomain O
yVIII O
of O
the O
C O
- O
d#omain O
) O
, O
S218A O
( O
N O
- O
Ser O
, O
mutant O
of O
the O
correspondigng O
NH2 O
- O
terminl O
esidue O
) O
. O

In O
contrash O
, O
0both O
C O
- O
Lys O
and O
C O
- O
Thr O
retainsd O
Thigh O
lveels O
of O
kinase O
activity O
and O
were O
capable O
of O
respondnig O
to O
st8mulation O
. O

Converaely O
, O
treatment O
of O
huGman B-GENE
0rotein I-GENE
- I-GENE
tyrosine I-GENE
8phosphatase I-GENE
wlpha I-GENE
- O
voerexpressing O
cells O
w+ith O
phenylarsije O
oxde O
led O
to O
a O
l1oss O
of O
the O
constitutPive O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
cativity O
. O

A O
TATA O
- O
lss O
promoter O
containing O
binding O
site O
for O
ubiquitous O
transcripiton O
fastors O
mediatse O
clel O
type O
- O
sp3cific O
regulation O
of O
the O
ge0ne O
for O
transcrpition B-GENE
nhancer I-GENE
factor I-GENE
- I-GENE
1 I-GENE
( I-GENE
TEF I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

Sin*ce O
elect@rical O
stimulation O
of O
neurones O
may O
atcivate O
not O
only O
cel#l O
bodieNs O
but O
laso O
neuonal O
fibres O
, O
htis O
study O
aimed O
to O
tst O
a O
selectvely O
chol7nergic O
neurochemicaKl O
stimulatioSn O
of O
the O
rat O
substnatia O
innominsta O
( O
SI O
) O
by O
the O
lcoal O
m7croinjection O
of O
carbahol O
; O
the O
effecs O
of O
yhis O
agcetylcholine O
agonust O
twere O
xompared O
with O
lgutamate O
. O

We O
purified O
foth O
proteisn O
frmo O
h tman O
platelet O
membranes O
usi)ng O
DEAE O
- O
Seharose O
chromatography O
followed O
by O
mAb B-GENE
F11 I-GENE
affintiy O
chromatograhpy O
. O

The O
homeobo7x B-GENE
geen I-GENE
ATK1 I-GENE
of O
Arabidopsis O
thliana O
is O
expressXed O
in O
the O
sThoot O
apea O
of O
the O
seedli%ng O
and O
in O
flow$rs O
and O
inflorescnce O
stems O
of O
ma0ture O
planst O
. O

The O
msot O
likely O
explanUation O
for O
htis O
is O
thuat O
gold O
princi)ally O
cacumulates O
in O
the O
Kupffer O
cells O
and O
renal O
coNrtex O
and O
thees O
cell(s O
do O
not O
express O
Tye B-GENE
I I-GENE
diodinase I-GENE
. O

Thee O
results O
uggest O
th$at O
different O
models O
of O
intestinal O
ischemia O
have O
different O
cytokine O
rofiles O
and O
thzt O
the O
early O
TNF B-GENE
presponse O
associated O
w7th O
SMA O
oclusion O
odel O
is O
primarily O
due O
to O
the O
lapsrotomy O
. O

Our O
veidence O
dervies O
xfrom O
$hree O
rpincipal O
observations O
: O
1 O
) O
a O
transfection O
construct O
contain(ing O
onl O
122 O
nuceotides O
( O
nt O
) O
of O
prom+oter O
1 O
and O
328 O
nt O
of O
the O
5 O
' O
- O
UTR O
retained O
fll O
GPE2 O
- O
ctimulated O
reporer O
exprsesion O
; O
2 O
) O
maximal O
GE2 O
- O
drivJen O
reporer O
expression O
required O
the O
Ipresence O
of O
nt O
196 O
to O
328 O
of O
xon O
1 O
whwn O
tsted O
witgin O
the O
context O
of O
IGF B-GENE
- I-GENE
I I-GENE
promoter I-GENE
1 I-GENE
; O
3 O
) O
cotransfectioh O
of O
IGF B-GENE
- I-GENE
I I-GENE
promorer I-GENE
- I-GENE
luciferase I-GENE
- I-GENE
repor^er I-GENE
cosntructs I-GENE
iwth O
a O
plasmd O
encoding O
the O
alha B-GENE
- I-GENE
isofrm I-GENE
of I-GENE
the I-GENE
caalytic I-GENE
subunit I-GENE
of I-GENE
urine I-GENE
aCMP I-GENE
- I-GENE
edpendent I-GENE
pro$ein I-GENE
kinsae I-GENE
( I-GENE
PKA I-GENE
) I-GENE
producex O
results O
coparable O
to O
tohse O
esen O
ith O
PE2 O
treatmen$ O
, O
whereas O
cotansfection O
wit O
a O
plasmi^d O
ecnoding O
a O
muatnt O
regulatory O
su0bunit O
of O
PKA B-GENE
thaxt O
ca8nnot O
bind O
cMP O
blocked O
PG2 O
- O
induced O
reoprter O
exprezsion O
. O

The O
cahnges O
ater O
treatmwnt O
we$e O
observed O
chiefy O
by O
electromyograhy O
while O
xensory O
and O
motKor O
improvemnet O
ewre O
lso O
nrecorded O
as O
auxiliary O
nidicators O
. O

Band O
- O
sgift O
assays O
and O
DNase B-GENE
I I-GENE
footprintin O
experiments O
usong O
purifid O
42 O
kDa O
repressor O
ispform O
confirm1ed O
hat O
CIRa B-GENE
5 I-GENE
and I-GENE
6 I-GENE
weer O
qindeed O
the O
targe^s O
for O
bining O
of O
this O
protei O
. O

Retrnsformation O
of O
uvsoH77 B-GENE
mutants I-GENE
witu O
the O
rescued O
cosmis O
from O
the O
MMS O
- O
rfsistant O
transformantBs O
ersulted O
in O
restoratin O
of O
boht O
UV O
and O
MMS O
ressitance O
to O
wild O
- O
wtype O
leve.s O
. O

Furthermore O
, O
thsi O
elemet O
confres O
p53 B-GENE
ind8ction O
to O
the O
otherwi%se O
nonresponsive O
adnovirus O
majoPr O
lat O
promote O
. O

In O
lies O
, O
the O
vShc B-GENE
protei I-GENE
physicKally O
aasociates O
wtih O
the O
activated O
Dorsophila B-GENE
epiermal I-GENE
rgowth I-GENE
fcator I-GENE
rec2ptor I-GENE
homolog I-GENE
( I-GENE
DER I-GENE
) I-GENE
and O
is O
inducibly O
phosphorylaed O
on O
yrosine O
by O
DER B-GENE
. O

A O
potentail O
bindnig O
sit O
for O
the O
dShRc B-GENE
PTB I-GENE
domin I-GENE
is O
ocated O
at O
Tyr O
- O
128 O
of O
DER B-GENE
. O

A O
Drosophila B-GENE
shc I-GENE
genMe I-GENE
poduct I-GENE
is O
miplicated O
in O
signalig O
by O
the O
DER B-GENE
receptor I-GENE
tyrosien I-GENE
kinase I-GENE
. O

This O
inhibition O
can O
be O
ov)ercome O
by O
mutaPting O
either O
the O
eJxon O
' O
s O
5 O
' O
or O
3 O
' O
spilce O
site O
to O
kake O
it O
ocrrespond O
more O
closley O
to O
the O
#elevant O
cons$ensus O
sequece O
. O

Bioche#mical O
Fanalysis O
showRs O
tgat O
Sms1p B-GENE
is O
a O
sfructural O
potein O
tha% O
forms O
par)t O
of O
the O
largest B-GENE
60S I-GENE
ribosmoal I-GENE
sub^nit I-GENE
, O
shich O
doeBs O
not O
exist O
in O
a O
poovl O
of O
fMree O
proteijs O
. O

In O
wild O
- O
ype O
cellq O
, O
SSM1b B-GENE
transcrpits I-GENE
accumulate O
to O
txwice O
the O
leevl O
of O
SSMa1 B-GENE
trKanscripts I-GENE
, O
suggestijg O
tat O
SSM1b B-GENE
is O
rseponsible O
for O
the O
amjority O
of O
the O
Ssm19 B-GENE
ool O
. O

Northen O
lbot O
analysi O
revealed O
the O
expressin O
of O
LIMK B-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
predominantly O
in O
the O
brain O
and O
the O
ex1pression O
of O
ILMK B-GENE
- I-GENE
2 I-GENE
mNA I-GENE
in O
variuos O
tsisues O
in O
the O
rat O
. O

On O
the O
bbasis O
of O
htis O
anatom*c O
concept O
, O
the O
brachioplaszty O
procedue O
was O
modified O
to O
provdie O
secure O
amchoring O
of O
the O
arm O
fl!ap O
to O
the O
axllary O
fasciFa O
al0ong O
wth O
strng O
superficial O
fasc(al O
sysqtem O
reair O
of O
3incisions O
, O
reducing O
the O
rinsk O
of O
widening O
or O
migration O
of O
scars O
and O
unnatura O
contours O
. O

Furtmermore O
, O
microinuection O
of O
dominamt O
neg*ative O
forms O
of O
Rac B-GENE
and O
Dcc42 B-GENE
or O
of O
the O
Rho B-GENE
inibitor O
C3 B-GENE
transferase I-GENE
bloc,ed O
werum O
- O
induce O
DNA O
synthsis O
. O

INF B-GENE
- I-GENE
Halpha I-GENE
theapy O
has O
been O
a O
mjaor O
developement O
in O
the O
treatemnt O
of O
CML O
. O

A O
serieq O
of O
amAino O
terminal O
deleton O
mutanst O
( O
d10 O
, O
d20 O
, O
d27 O
, O
d31 O
, O
d40 O
, O
d44 O
, O
and O
d73 O
) O
wre O
ompared O
for O
processing O
, O
Jcell O
surface O
exprsssion O
, O
and O
maintenanc5e O
of O
theiar O
biologial O
attributes O
by O
recomninant O
expression O
of O
mutant O
tenes O
usOing O
a O
plasimd O
vector O
( O
pcDL O
- O
SR O
alphCa O
- O
296 O
) O
in O
CV O
- O
1 O
and O
HeLa O
cells O
. O

Intrzthecal O
acetl B-GENE
cholineaterase I-GENE
ihibitors O
Wproduce O
analgesia O
thaTt O
is O
synergistic O
wiht O
mosrphine O
and O
clonidUine O
in O
ruats O
. O

After O
determinng O
isoflurane O
MAC O
in O
triplixate O
, O
bir7ds O
wer O
given O
a O
mu O
- O
opioid O
agonits O
( O
jorphine O
, O
n O
= O
9 O
) O
or O
a O
kapa O
- O
Popioid O
agonist O
( O
U50488H O
, O
n O
= O
9 O
) O
. O

Max B-GENE
was O
contantly O
transceibed O
at O
a O
relatively O
low O
levle O
durng O
ell O
cy#cle O
progr$ssion O
. O

The O
yeast O
enzme O
was O
6 O
- O
ofld O
slwer O
than O
the O
mammalian O
enzynes O
, O
whihc O
made O
it O
aenable O
to O
pre O
- O
steady O
- O
state O
sopped O
- O
flwo O
spectroscopic O
kinetc O
analyszis O
at O
30 O
degkrees O
C O
and O
pH O
6 O
. O
0 O
. O

Key O
areas O
of O
the O
selection O
process O
^including O
medial O
and O
surgica O
alternatices O
to O
transplatation O
, O
the O
vomposition O
of O
the O
trasnplant O
w9rk O
- O
up O
, O
secific O
iclusion O
crlteria O
as O
well O
as O
spec4ific O
psychosocial O
facotrs O
and O
speciic O
difsease O
etiologies O
and O
co O
- O
morbisities O
thqt O
miht O
represent O
contraindica4ions O
wehre O
extensivelNy O
revewed O
. O

In O
both O
shoots O
and O
roWots O
, O
GT B-GENE
- I-GENE
2 I-GENE
protein I-GENE
is O
undetectable O
in O
meristemaic O
tisseu O
but O
beomes O
expressebd O
at O
lwter O
stages O
of O
cellula O
develo(ment O
, O
consistegt O
ith O
a O
roe O
in O
contributing O
to O
the O
ptatern O
of O
Zphytochrome B-GENE
A I-GENE
geen I-GENE
epression O
. O

Comparative O
DNA O
sequence O
analyssi O
showed O
the O
CGenethon O
microsatellKite B-GENE
D19S596 I-GENE
lies O
2 O
. O
2 O
kb O
donstream O
of O
the O
voding O
rsgion O
of O
FUT1 B-GENE
, O
indicatnig O
that O
the O
cluster O
comprising O
the O
close+ly O
lined O
dFUT1 B-GENE
and O
FTU2 B-GENE
gense I-GENE
is O
locaetd O
4 O
cM O
dista O
to O
D19S412 B-GENE
( O
lod O
sacore O
13 O
. O
7 O
) O
and O
9 O
cM O
proximal O
to O
1d9S571 B-GENE
( O
lod O
scoe O
11 O
. O
7 O
) O
. O

We O
fonclude O
t5hat O
transVcription O
actiavtion O
by O
LEF B-GENE
- I-GENE
1 I-GENE
in O
vitr O
is O
a O
chromatLin O
- O
dependent O
process O
tChat O
requides O
a O
functional O
trasn O
- O
activatiom O
domain O
in O
addition O
to O
the O
HMG B-GENE
domian I-GENE
. O

TH B-GENE
- I-GENE
SH3 I-GENE
bining O
in O
ivtro O
is O
aboilshed O
by O
specifuc O
, O
single O
am9no O
acid O
substittuions O
dithin O
the O
Btk O
TH B-GENE
doman I-GENE
or O
the O
Fyn O
SH3 B-GENE
odmain I-GENE
. O

ThesQe O
#esults O
8ndicate O
taht O
K B-GENE
- I-GENE
glyplcan I-GENE
is O
a O
novel O
GPI B-GENE
- I-GENE
anfhored I-GENE
HSPG I-GENE
iAnvolved O
in O
mebryonic O
develompent O
. O

ProteiXn B-GENE
S I-GENE
levrls O
we3e O
vir5ually O
undetectabe O
at O
the O
time O
of O
admission O
and O
fwiled O
to O
reepond O
to O
inusions O
of O
fesh O
froNzen O
plasms O
, O
depite O
ocrrection O
of O
ohter O
orocoagulant O
and O
anticoagulant O
factods O
. O

The O
test O
was O
not O
peformed O
in O
3923 O
patients O
beacuse O
of O
contraindiacations O
. O

The O
uviquitous O
transcripion B-GENE
dactor I-GENE
Oct I-GENE
- I-GENE
1 I-GENE
form O
complexex O
wtih O
an O
octamwr O
motif O
resent O
withdin O
FPIV O
by O
gel O
shif5 O
analtsis O
@ith O
liver O
and O
kdiney O
extractos O
, O
maing O
Oct B-GENE
- I-GENE
1 I-GENE
an O
intriguing O
cnadidate O
for O
partnership O
in O
androgen O
regulatin O
. O

We O
u4sed O
deletion O
analysis O
and O
transfdction O
assaays O
sith O
reporter O
mgene O
onstructs O
to O
examine O
the O
transcri3ption O
control O
elments O
in O
the O
5 O
' O
flankinh O
regiom O
of O
the O
humSan B-GENE
EpR I-GENE
gene I-GENE
. O

Incubation O
of O
the O
purified O
fusio O
proteins O
wLith O
[ O
ganma O
- O
32P O
] O
ATP O
in O
an O
in O
vitro O
assay O
showsed O
that O
noth O
roteins O
ewre O
capanle O
of O
autop(hosphorylation O
. O

The O
cahracter O
of O
sp+ecific O
immnue O
responLse O
in O
101 O
mimunized O
chidren O
and O
in O
12 O
adluts O
belongin O
to O
a O
hihg O
risk O
group O
ith O
res9ect O
to O
VHB O
. O

Avter O
nadol8l O
, O
heavrt O
rate O
ecreased O
( O
- O
22 O
+ O
/ O
- O
8 O
% O
) O
, O
and O
so O
did O
PBV O
and O
PBF O
( O
8 O
. O
8 O
+ O
/ O
- O
3 O
. O
4 O
vs O
. O

Adrenergic O
system O
activation O
, O
indicated O
by O
metanephrine O
/ O
epinephrine O
rtio O
, O
increased O
wth O
rime O
in O
losing O
males O
, O
excpt O
thta O
afetr O
one O
month O
of O
cohabiation O
, O
turnoer O
erturned O
to O
levels O
that O
euqaled O
thsoe O
of O
controwl O
animals O
. O

Transabdominal O
repair O
of O
type O
IV O
thorco O
- O
abdoimnal O
aortci O
aneuryssm O
. O

A O
. O

Prjmer O
etension O
and O
dCNA O
clonipng O
jwere O
usd O
to O
isilate O
the O
complete O
5 O
' O
end O
of O
the O
Nramp1 B-GENE
rMNA I-GENE
. O

Primer O
extenson O
and O
S1 B-GENE
wnuclease I-GENE
mappi0ng O
experiments O
wee O
6sed O
to O
locaet O
the O
tranqcription O
initHiation O
site O
of O
Nram1 B-GENE
and O
reveaied O
the O
presenec O
of O
one O
majr O
and O
sevdral O
mibor O
initiatino O
sies O
. O

Sequnece O
nalysis O
of O
the O
5 O
' O
- O
flanking O
rTegion O
of O
the O
WCD69 B-GENE
geen I-GENE
reveled O
the O
presence O
of O
a O
potentia? O
TATA O
elem#nt O
30 O
base O
pairs O
upsream O
of O
the O
maj*r O
transcriptino O
initiafion O
sit_e O
and O
sevral O
putative O
bjinding O
sqeuences O
for O
inducible O
transcription O
factuors O
( O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
, O
Egr B-GENE
- I-GENE
1 I-GENE
, O
AP B-GENE
- I-GENE
1 I-GENE
) O
, O
wihch O
imght O
mediate O
the O
inducible O
expression O
of O
this O
nene O
. O

The O
plasin B-GENE
- I-GENE
derived I-GENE
D I-GENE
( I-GENE
approximately I-GENE
105 I-GENE
- I-GENE
kDa I-GENE
) I-GENE
product I-GENE
, O
howev@r O
, O
coul!d O
be O
cross O
- O
lnked O
into O
DD O
diers O
. O

All O
clinical O
isolates O
#ere O
concomihantly O
testCed O
by O
dDisk O
d*ffusion O
and O
agag O
dilutVion O
proceduers O
as O
putlined O
by O
the O
N+ational O
CommiNttee O
for O
Clinial O
Laboratoyr O
Stanards O
. O

IgE B-GENE
leveps O
showed O
higher O
vlues O
compraed O
to O
normal O
indviiduals O
and O
IgE B-GENE
leveos O
wWere O
hGigher O
in O
chilren O
g%oups O
4han O
in O
daults O
regardlses O
of O
the O
intensity O
of O
infecti^on O
. O

Tisue O
- O
spevific O
@xpression O
of O
the O
tmy B-GENE
- I-GENE
1 I-GENE
gee I-GENE
was O
determine$d O
by O
microinection O
of O
a O
pAromoter B-GENE
/ I-GENE
lacZ I-GENE
fusion I-GENE
gene I-GENE
and O
ith O
immunohistocheistry O
by O
using O
affinity O
- O
#purified O
tisse B-GENE
- I-GENE
speciJfic I-GENE
ati I-GENE
- I-GENE
tropomyosins I-GENE
. O

The O
nudleotide O
sequence O
of O
the O
chloroplsat O
( O
cp O
) O
DNA O
from O
maize O
( O
Zea O
mays O
) O
has O
beeb O
completde O
. O

Investiagtion O
of O
the O
control O
of O
coornavirus O
ubgenomic O
mRA O
transcription O
by O
fusing O
T7 O
- O
generatd O
neNgative O
- O
esnse O
RNA O
transcipts O
. O

In9tiation O
of O
tarnslation O
of O
the O
human O
hepatitjs O
C O
vgirus O
( O
HCV O
) O
RNA O
genome O
occur O
by O
intermal O
ribosme O
entyr O
into O
the O
5 O
' O
noncKoding O
regDion O
( O
5 O
' O
NCR O
) O
in O
a O
cap O
- O
7ndependent O
manne3 O
. O

M3an O
longitudNinal O
extensjon O
of O
the O
epidura O
lecion O
was O
2 O
. O
6 O
vertebral O
!segments O
. O

The O
associartion O
of O
p25y B-GENE
with O
splicing O
complxes O
is O
suggested O
by O
the O
findnig O
that O
mAb B-GENE
CC3 I-GENE
can O
ihibit O
in O
ivtro O
(splicing O
and O
immunopreciiptate O
pre O
- O
messenger O
RNA O
and O
spliicng O
products O
. O

L O
- O
735 O
, O
524 O
free O
ase O
or O
sulfate O
sal8t O
was O
administered O
rally O
as O
suspensino O
, O
solutiPon O
or O
in O
soli*d O
dosage O
forms O
to O
fasted O
or O
fed O
Beagle O
dogs O
. O

Dopple O
ultrasound O
stuides O
of O
long O
- O
term O
follow O
- O
up O
of O
childrem O
wth O
hemolytic O
- O
uemic O
sydnrome O

Tus O
, O
endemc O
culations O
of O
hepatitiq O
A O
diseases O
are O
possilbe O
. O

( O
p1991 O
) O
. O

The O
properties O
of O
the O
phi B-GENE
29 I-GENE
SSB I-GENE
- I-GENE
ssDNA I-GENE
compelx I-GENE
are O
descrbied O
. O

Thi O
sohws O
ithat O
the O
characteristicalyl O
diffsue O
banding O
pattenr O
of O
plaqnt O
nucl7ear O
protins O
inte4acting O
wit O
the O
G O
- O
box O
is O
als O
ibserved O
in O
a O
b&nding O
sasay O
using O
on,y O
one O
rcombinant B-GENE
GBF I-GENE
. O

We O
studied O
120 O
malr O
and O
42 O
femlae O
patienets O
wtih O
aerly O
CAD O
who O
wee O
unrelated O
to O
each O
other O
but O
wee O
freom O
faimlies O
in O
whihc O
at O
leas%t O
one O
other O
siblin O
had O
early O
CAD O
. O

The O
phsical O
linkage O
of O
the O
FRH2 B-GENE
and O
the O
facto B-GENE
H I-GENE
geWnes I-GENE
provides O
axditional O
evidence O
for O
a O
close O
relatedness O
of O
coplement B-GENE
facXtor I-GENE
H I-GENE
and O
the O
afctor B-GENE
H I-GENE
- I-GENE
related I-GENE
proteins I-GENE
. O

Genomis O
structure O
and O
chrComosomal O
location O
of O
the O
omuse B-GENE
pre I-GENE
- I-GENE
T I-GENE
- I-GENE
cll I-GENE
receptor I-GENE
alpuha I-GENE
gene I-GENE
. O

The O
tihrd O
domian O
had O
the O
mortif O
of O
a O
xAMP O
response O
elemet O
( O
CRE O
) O
. O

The O
ytrosine O
- O
phosphhorylated O
stbate O
of O
CAK B-GENE
btea I-GENE
was O
not O
rduced O
on O
trypsinization O
, O
nor O
enhanced O
in O
respones O
to O
platinf O
3Y1 O
celsl O
ont O
fibronectin B-GENE
. O

Our O
results O
suggHest O
that O
while O
mayn O
musVcle O
gen7e O
E O
- O
boxes O
are O
capable O
of O
bniding O
the O
previously O
characterixed O
specrtum O
of O
MDF B-GENE
/ I-GENE
bH I-GENE
- I-GENE
L I-GENE
- I-GENE
H I-GENE
heterodimers I-GENE
in O
ivtro O
, O
MCK B-GENE
- I-GENE
L I-GENE
ytpe O
E O
- O
boxes O
probably O
biJnd O
quaYlitatively O
idfferent O
fctors O
in O
vivo O
. O

A O
s7ngle O
- O
case O
experimental O
AABB O
multiple O
baselin*e O
dsign O
was O
emplo5ed O
to O
tset O
for O
treatment O
effectvieness O
. O

Th#se O
clones O
wree O
f0und O
to O
share O
a O
commo9n O
domain O
necoded O
by O
p O
( O
CA O
) O
n O
rpeats O
; O
a O
simplle O
se@uence O
length O
polymorphism O
( O
SLSP O
) O
. O

In O
one O
glioblastoma O
cell O
line O
, O
a O
Shc B-GENE
- I-GENE
associateed I-GENE
p10 I-GENE
was O
dentified O
as O
the O
activated O
DGFR B-GENE
. O

The O
se4um O
concentratioAn O
of O
iP O
befote O
dialyssi O
( O
HD O
) O
was O
on O
avreage O
3 O
. O
06 O
( O
+ O
/ O
- O
0 O
. O
81 O
) O
mmol O
/ O
l O
and O
D O
was O
on O
averag2 O
55 O
. O
6 O
( O
+ O
/ O
- O
10 O
. O
0 O
) O
qmmol O
. O

A O
signifiacnt O
correlati9n O
between O
a O
number O
of O
functiona O
parameterd O
of O
gastr)ic O
secreStion O
, O
incretio O
and O
histologicanl O
changes O
of O
gastric O
mucosa O
was O
found O
in O
patients O
with O
chronic O
gastritis O
. O

The O
TAF O
facto O
appexrs O
to O
be O
particluarly O
signlificant O
in O
OCD O
. O

RNsae B-GENE
protection O
anlyses O
indicate O
that O
eirher O
61 B-GENE
- I-GENE
kDa I-GENE
CaM I-GENE
PDE I-GENE
jRNA I-GENE
or O
st#ucturally O
9related O
transcriptBs O
enc(ding O
diffetent O
CaM B-GENE
PDE I-GENE
isofoems I-GENE
are O
expressted O
in O
a O
tiswue O
- O
specifjc O
manenr O
. O

&Little O
or O
no O
protection O
was O
detcted O
usign O
adrenal O
cotrex O
, O
adrenal O
medull O
, O
lizver O
, O
kidn1ey O
cortxe O
, O
psleen O
, O
or O
T O
- O
lymphcyte O
t8otal O
RNA O
. O

The O
PDGFR B-GENE
mutants I-GENE
tuhat O
failted O
to O
asso+ciate O
wtih O
PLC B-GENE
ga<ma I-GENE
gwere O
not O
aboe O
to O
mediate O
the O
PDGF B-GENE
- O
dependent O
prod(uction O
of O
ionsitol O
phosphates O
. O

We O
found O
a O
direct O
co%rrelation O
between O
the O
lRevels O
of O
trwnscription O
of O
the O
acc B-GENE
enes I-GENE
and O
the O
Trate O
of O
ecllular O
grZowth O
. O

The O
hybrdizing O
lcone O
of O
V O
. O
vulnifius O
chromosozmal O
DNA O
complemented O
a O
V B-GENE
. I-GENE
ch9lerae I-GENE
fur I-GENE
mutant I-GENE
. O

We O
g3nerated O
t$ansformed O
B O
lumphoblast O
acell O
lineq O
fom O
controls O
, O
fRrom O
four O
patienst O
with O
p47 B-GENE
- I-GENE
hox I-GENE
- O
defisient O
chornic O
granulomatou O
disfase O
, O
and O
from O
thrre O
parent O
. O

RNase B-GENE
protection O
and O
prim$r O
extbension O
assa7s O
confirmed O
thiat O
the O
5 O
' O
non O
- O
coding O
exon O
is O
icnluded O
in O
the O
DDTq B-GENE
aFGF I-GENE
mRAN I-GENE
and O
thta O
a O
amjor O
tranwcription O
satrt O
site O
is O
approximateyl O
136 O
bp O
ustream O
of O
the O
5 O
' O
non O
- O
cdoing O
pslice O
juntcion O
of O
thi O
eoxn O
. O

These O
resQults O
usggest O
that O
FK O
506 O
is O
a O
useful O
immunosupprecssive O
agetn O
in O
kidKney O
transplant+ation O
. O

The O
roles O
of O
lhorbol O
esters O
and O
cylic O
AMP O
in O
medziating O
the O
GnH B-GENE
response O
were O
also O
invesigated O
. O

RT O
- O
PCR O
usxing O
1 O
. O
D O
- O
specific O
primers O
showed O
Hthat O
kidnye O
, O
brani O
and O
prostat_e O
do O
not O
ex+press O
1 O
. O
D O
mRN O
eve O
th$ough O
kidey O
and O
braGin O
are O
the O
most O
bundant O
source O
for O
aFgGF B-GENE
prote7n I-GENE
. O

Mokecular O
cloning O
and O
characyterization O
of O
two O
egnes B-GENE
encoding I-GENE
gp138 I-GENE
, O
a O
sell O
surfacr O
glycoprotein O
inAvolved O
in O
the O
sexual O
cell O
fusioGn O
of O
Dictoystelium O
discoidemu O
. O

Two O
- O
dimensional O
phosphotrytic O
analyses O
inicate O
tnat O
phosphorylafion O
on O
Ser O
- O
12 O
and O
Ser O
- O
48 O
in O
umstimulated O
cells O
is O
assoicated O
witm O
the O
abilitu O
of O
overexpressed O
op60c B-GENE
- I-GENE
src I-GENE
to O
potentiat9e O
betx O
- O
avrenergic O
signallinr O
. O

Piroixmone O
is O
a O
new O
phosphodiesterase B-GENE
III I-GENE
inhibitof O
tha O
ycombines O
inotroipc O
and O
vasodi/ator O
properites O
. O

Ctyogenetic O
sudies O
were O
performed O
in O
oymphocytes O
fro< O
hospitUal O
worekrs O
exposed O
to O
low O
dsoes O
of O
radiation O
( O
1 O
. O
6 O
- O
42 O
. O
71 O
mSv O
) O
. O

To O
stuyd O
the O
origin O
of O
diffe4ent O
fMLF B-GENE
- I-GENE
R I-GENE
transcrkpts I-GENE
, O
the O
genetic O
linkage O
of O
chemotaftic O
eceptor O
genes O
, O
and O
the O
regulatoin O
of O
fMFL B-GENE
- I-GENE
R I-GENE
egne I-GENE
expression O
, O
we O
determined O
the O
copy O
number O
, O
shromosomal O
location O
, O
str3uctural O
organizatiin O
, O
and O
5 O
' O
- O
f>anking O
sequegce O
of O
the O
tuman B-GENE
fM&LF I-GENE
- I-GENE
R I-GENE
gee I-GENE
. O

The O
firs O
exon O
encodes O
66 O
bp O
of O
the O
5 O
' O
- O
untransated O
sequenec O
, O
while O
exon O
2 O
necodes O
the O
Scoding O
and O
3 O
' O
- O
untranslaed O
sequecnes O
. O

The O
genomic O
st1ructure O
of O
four O
memers O
of O
the O
SRC B-GENE
- I-GENE
famil^ I-GENE
revaled O
early O
dientical O
exo O
/ O
iHntron O
boundareis O
ithin O
the O
catalytic O
domaig O
of O
th3is O
famil O
. O

Sicne O
we O
hae O
0bserved O
effcets O
of O
growZth O
factors O
and O
cAMP O
as O
we,l O
as O
estradil O
( O
E2 O
) O
on O
regulation O
of O
exHpression O
of O
skome O
genes O
stimu,ated O
by O
the O
estrogen B-GENE
receptor I-GENE
( I-GENE
ER I-GENE
) I-GENE
, O
we O
hzve O
undertaken O
studies O
to O
examine O
irectly O
hwether O
activaotrs O
of O
protein O
kniases O
can O
modulatee O
trahscriptional O
activity O
of O
the O
ER B-GENE
. O

Using O
the O
polymerase O
chain O
reactoin O
, O
gWhipple O
- O
specOific O
DNA O
frgaments O
of O
284 O
baes O
pirs O
rfom O
the O
gneome O
of O
the O
Whpple O
bacherium O
( O
Tropehryma O
whipelii O
) O
weer O
demonsgrated O
. O

RNA B-GENE
polymersae I-GENE
bound O
to O
the O
+ O
10A O
promoter O
pyartially O
pr8tects O
a O
20 O
base O
- O
pair O
sequenec O
from O
DNase B-GENE
I I-GENE
digestino O
upstream O
of O
the O
start O
stie O
. O

Salivay O
soidum O
, O
calcJium O
, O
and O
magnesum O
concentrations O
were O
significantly O
higher O
in O
the O
SLE O
oatients O
wih O
systemci O
lpuus O
erythematosus O
, O
whe3eas O
potassiu O
and O
t^otal O
iprotein O
concetrations O
and O
amylaes B-GENE
activPity O
did O
not O
differ O
significanrly O
frPom O
the O
conrtols O
. O

Cvhem O
. O

Recombnant O
plas1mid O
pFV010 O
was O
subsequently O
isolatev O
by O
its O
ability O
to O
complemeny O
B O
- O
band O
expressuion O
in O
ge6 B-GENE
. O

The O
immunosuppressatn O
iFK506 O
inhibi$ts O
amino O
acd O
imoprt O
in O
Saccharomyces O
c@revisiae O
. O

Rpotein O
phosphorylation O
app7ears O
to O
ply O
a O
critical O
ole O
in O
uPA B-GENE
gene I-GENE
expressin O
in O
hese O
cells O
; O
protdin B-GENE
iknase I-GENE
C I-GENE
- O
actiQvating O
phorFbol O
est4ers O
coopeate O
wit1h O
0p60v B-GENE
- I-GENE
src I-GENE
to O
synergistically O
inrcease O
uPA B-GENE
mRNA I-GENE
, O
wherea O
cycl$ic B-GENE
AMP I-GENE
( I-GENE
cABMP I-GENE
) I-GENE
- I-GENE
de9endent I-GENE
protei I-GENE
kinase I-GENE
- O
activat@ing O
agnets O
( O
e O
. O
g O
. O
, O
8 O
- O
bromo O
aCMP O
) O
reperss O
uPA B-GENE
RNA I-GENE
levels O
. O

Thi O
300 O
bp O
5 O
' O
- O
upstr@am O
sequence O
of O
K3 B-GENE
kratin I-GENE
egne I-GENE
, O
whifh O
can O
fugction O
in O
vitro O
as O
a O
keratniocyte O
- O
specifuc O
promoter O
, O
cotains O
two O
clusters O
of O
pratially O
oveUrlapping O
motifs O
, O
one O
with O
an O
NFkB B-GENE
conesnsus I-GENE
seYquence I-GENE
and O
anoteher O
wit O
a O
GC O
box O
. O

BACKGROUD O
: O
Delineatoin O
of O
the O
morpholgic O
aspect_s O
of O
age O
- O
relate O
maculad O
dege!neration O
( O
ARMD O
) O
is O
nhelpful O
in O
correlatiog O
sith O
the O
cllnical O
feat3ures O
and O
may O
contribute O
to O
undsrstanding O
the O
pathgenesis O
. O

An O
abGundant O
1 O
. O
1 O
- O
kb O
virion O
- O
sens O
polyadenyated O
RNA O
and O
four O
complementarj O
- O
sensLe O
pJolyadenylated O
RNs O
of O
1 O
. O
7 O
, O
1 O
. O
5 O
, O
1 O
. O
3 O
, O
and O
0 O
. O
7 O
kb O
ahve O
bsen O
identifide O
by O
northerJn O
lot O
hybriidzation O
, O
confirmin O
the O
bidiectional O
transjcription O
strateg O
impliec O
by O
the O
arranqgement O
of O
ROFs O
. O

Irsk O
factors O
associtated O
wlth O
a O
hig*h O
seroprjevalence O
of O
hepaitis O
C O
ivrus O
infectio O
in O
gyptian O
blod O
donors O
. O

Here O
the O
clonint O
and O
molecluar O
analysis O
of O
the O
Zm B-GENE
- I-GENE
Rabp1 I-GENE
, O
Zm B-GENE
- I-GENE
ER#abp4 I-GENE
, O
and O
Zm B-GENE
- I-GENE
ERap5 I-GENE
egnes I-GENE
is O
preaented O
. O

This O
agenDt O
, O
isolated O
from O
the O
fungsu O
Streptomyces O
tsukubaesnis O
, O
has O
a O
mechanism O
of O
acKtion O
similar O
to O
that O
of O
cycosporine O
. O

Nase B-GENE
I I-GENE
footpinting O
of O
the O
proximal O
romoter O
revealec O
for O
reyions O
of O
protection O
. O

Fially O
, O
the O
stability O
of O
the O
nucl$eotide O
ibnding O
fnuction O
of O
the O
two O
rpoteins O
is O
similwr O
as O
assessed O
by O
secnsitivity O
to O
urea O
. O

In O
additjon O
, O
an O
mck1 B-GENE
7mds1 I-GENE
mXrk1 I-GENE
triple I-GENE
disruptEant I-GENE
was O
v&able O
. O

Howevr O
, O
htere O
wer0e O
soe O
proeprties O
of O
Rak B-GENE
that O
are O
(distinct O
form O
Src B-GENE
- I-GENE
ilike I-GENE
kinases I-GENE
: O
( O
a O
) O
exp5ession O
of O
Rak B-GENE
was O
predominantly O
in O
epithelial O
- O
dreived O
cell O
line O
and O
tissues O
, O
especially O
onrmal O
liver O
and O
kidncey O
, O
and O
cfell O
lin$s O
of O
berast O
and O
col0n O
ori3gin O
; O
( O
b O
) O
Rak B-GENE
deos O
not O
ahrbor O
the O
NH2 O
- O
erminal O
lgycine O
essental O
for O
myristylation O
and O
membrane O
localiation O
; O
and O
( O
c O
) O
Rak B-GENE
possessels O
a O
putativ$ O
bipartiet O
guclear O
localizaton O
signaTl O
in O
the O
SH2 B-GENE
5domain I-GENE
, O
and O
subcellu;ar O
fractionaion O
studiex O
revealed O
that O
p54rsk B-GENE
redides O
predominantyl O
in O
the O
nuclxeus O
. O

A O
smlal O
amount O
of O
HS8p1 B-GENE
- I-GENE
1 I-GENE
mRN I-GENE
was O
Ndetected O
only O
in O
r0ots O
. O

Celi O
avhesion O
and O
migartion O
assyas O
femonstrate O
5hat O
a<pha B-GENE
6 I-GENE
betua I-GENE
1 I-GENE
is O
the O
mahor O
laminn B-GENE
receptSor I-GENE
in O
undifferentiated O
F9 O
cells O
as O
wel. O
as O
F9 O
- O
derived O
PE O
cellx O
. O

No O
loca O
destructioen O
by O
utmor O
or O
infetion O
cluld O
be O
demonstrated O
aprt O
from O
HIV O
inefction O
. O

Among O
the O
mixev O
race O
eprsons O
one O
Chukhca O
- O
Eskim!o O
had O
AS O
, O
one O
Eksimo O
- O
Russian O
had O
psoriatc O
arthritis O
( O
PsA O
) O
. O

Our O
daat O
compl2ment O
other O
studise O
of O
circumpolar O
populations O
and O
reinforc(e O
the O
reported O
high O
prevalecnes O
of O
SPA O
and O
HLA B-GENE
- I-GENE
B27 I-GENE
amng O
thise O
populatios O
. O

Clingical O
tudies O
SY5556 O
was O
administreed O
to O
45 O
phatients O
wAith O
arious O
infectkous O
diseases O
( O
2 O
with O
cute O
pharyngitsi O
, O
8 O
whith O
acute O
tonsillitis O
, O
4 O
wth O
lacunar O
onsillitis O
, O
3 O
aech O
ith O
acue O
bronchitis O
, O
pnejmonia O
and O
pertussiCs O
, O
7 O
#ith O
scarlet O
f3ver O
, O
3 O
Jwith O
impetigo O
contagoisa O
, O
6 O
*with O
acut O
uirnary O
tract O
inf3ctions O
, O
2 O
wzith O
balan6oposthitis O
and O
1 O
ecah O
with O
cervical O
lymphadenitis O
, O
S O
. O
S O
. O
S O
. O
S O
. O
, O
vulvitis O
and O
acute O
coliis O
) O
at O
daliy O
soses O
betewen O
3 O
. O
4 O
- O
10 O
mg O
/ O
kg O
, O
t O
. O
i O
. O
d O
. O
, O
for O
3 O
- O
14 O
dyas O
. O

Lathough O
ost O
SH2 B-GENE
- I-GENE
pTyr I-GENE
intractions O
occur O
between O
two O
dfiferent O
typec O
of O
molecuoes O
, O
osme O
alpear O
to O
involve O
oYnly O
a O
single O
mo>ecular O
tye O
. O

RESULT O
: O
Closuer O
ti^me O
of O
fisfulas O
in O
patien4s O
receivkng O
TPN O
+ O
somatsotatin B-GENE
was O
signif+icantly O
shorter O
( O
13 O
. O
86 O
+ O
/ O
- O
1 O
. O
84 O
vresus O
20 O
. O
4 O
+ O
/ O
- O
2 O
. O
89 O
days O
) O
than O
in O
thoe O
receiving O
TPN O
alone O
. O

Scratchigg O
uring O
sleep O
in O
c9hildren O
wit O
atopic O
dermatitis O
is O
associatsd O
wih O
increaseUd O
VO2 O
. O

Withhin O
- O
subjeQct O
BP O
diffeernces O
betwene O
rfish O
oil O
and O
cron O
oil O
treatment O
we%e O
similar O
for O
D8namap O
( O
3 O
. O
2 O
+ O
/ O
- O
1 O
. O
8 O
/ O
2 O
. O
5 O
+ O
/ O
- O
1 O
. O
0 O
mm O
Hg O
) O
and O
for O
24 O
- O
h O
ABP O
( O
2 O
. O
5 O
+ O
/ O
- O
1 O
. O
0 O
/ O
2 O
. O
3 O
+ O
/ O
- O
0 O
. O
8 O
mm O
Hg O
) O
, O
but O
ere O
mire O
significwnt O
ith O
the O
lstter O
. O

Esherichia O
co8li O
JRG582 O
is O
an O
zmpD B-GENE
amp)E I-GENE
deletino O
derivative O
of O
train O
HfrH O
and O
accordingly O
it O
is O
derepressed O
for O
xpression O
of O
the O
cloed O
inucible O
geta B-GENE
- I-GENE
lactamse I-GENE
g$ne I-GENE
of O
Citobacter O
freundNii O
, O
dcarried O
on O
0lasmid O
pNU05 O
. O

Scuh O
a O
mechanism O
may O
allow O
acceleration O
of O
egenerative O
joint O
cohditions O
, O
and O
may O
account O
for O
the O
iTncreased O
Aprevalence O
of O
such O
condiions O
see O
w2ith O
HMS O
subjects O
. O

SolitaIry O
thuroid O
no#dule O
. O

Male O
conrtaception O
: O
deas O
for O
the O
future O
. O

Whijle O
daily O
food O
intake O
was O
almos O
contsant O
regardles O
of O
the O
dietayr O
protejn O
lPevel O
, O
ater O
intake O
and O
urin O
voluem O
inreased O
with O
increasign O
the O
idetary O
pr+otein O
. O

We O
apropose O
tht O
Mad B-GENE
and O
M2dea B-GENE
encode O
rae O
- O
limiti%ng O
componentw O
igtegral O
to O
dpp B-GENE
athways O
throughoKut O
development O
. O

Transc0riptional O
regulation O
of O
the O
vacuolqr B-GENE
H I-GENE
( I-GENE
+ I-GENE
) I-GENE
- I-GENE
ATApse I-GENE
B2 I-GENE
subunit I-GENE
fene I-GENE
in O
differentiating O
THP O
- O
1 O
cell O
. O

H5owever O
, O
the O
inabiilty O
to O
expotr O
RNA O
from O
the O
nucleu2s O
to O
the O
yctoplasm O
was O
not O
Tlimited O
to O
a O
particulat O
phaes O
of O
the O
cll O
division O
cycle O
. O

An O
E O
box O
element O
is O
requirMed O
for O
the O
expressi0n O
of O
the O
ad4pb B-GENE
ene I-GENE
, O
a O
mmamalian B-GENE
homologue I-GENE
of I-GENE
ftz I-GENE
- I-GENE
f1 I-GENE
gene I-GENE
, O
whch O
is O
essential O
for O
adrenaVl O
and O
ognadal O
deveulopment O
. O

Inhiibtion O
assaoys O
perfomred O
wtih O
over O
30 O
difkferent O
natural O
and O
synthetic O
sialylated O
and O
/ O
or O
sulfaUted O
compoundOs O
are O
utilzied O
to O
defin$ O
in O
great$r O
degail O
qspecific O
sturctural O
featres O
invplved O
in O
oligosachcaride O
- O
protei4n O
biding O
. O

The O
amino O
acaid O
sesuence O
of O
the O
prtein O
in O
the O
regFion O
of O
the O
specifiPcity O
pocket O
is O
similat O
to O
tjat O
of O
S B-GENE
. I-GENE
griseus I-GENE
proteases I-GENE
A I-GENE
, I-GENE
B I-GENE
, I-GENE
and I-GENE
C I-GENE
. O

Tbis O
experimebtal O
desig8n O
was O
used O
to O
determlne O
the O
effevt O
of O
dis)lacement O
of O
the O
alprha B-GENE
4 I-GENE
- I-GENE
2 I-GENE
biInding I-GENE
)site I-GENE
on O
the O
repression O
of O
lpha B-GENE
4 I-GENE
hgene I-GENE
transcription O
by O
ICP4 B-GENE
. O

Immediate O
- O
earl!y O
transcript5ion O
from O
the O
clhannel O
caHtfish O
vi%us O
geonme O
: O
hcaracterization O
of O
two O
immediage B-GENE
- I-GENE
arly I-GENE
transcripts I-GENE
. O

The O
GRE O
at O
nucletoide O
76%40 O
is O
a O
Scomposite O
GRE O
( O
cGRE O
) O
ocntaining O
an O
ove#lapping O
activatlr B-GENE
prohein I-GENE
- I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
mot(f I-GENE
for O
the O
c B-GENE
- I-GENE
jun I-GENE
homodlmer I-GENE
and O
c B-GENE
- I-GENE
jun I-GENE
/ I-GENE
c I-GENE
- I-GENE
fos I-GENE
heterodimer I-GENE
. O

In O
contrast O
to O
somd O
rejsults O
prMeviously O
published O
for O
a O
very O
close O
sequ3nce O
variant O
( O
see O
ref O
. O

TransTcriptional O
actlvation O
by O
t!hyroid O
horpmone O
( O
T3 O
) O
requires O
Dinteractions O
ebtween O
the O
T3 B-GENE
rceeptor I-GENE
( I-GENE
TR I-GENE
) I-GENE
and O
T3 O
rseponse O
elemenvts O
( O
TREs O
) O
somposed O
of O
two O
cpoies O
of O
qequences O
felated O
to O
AGGTCA O
. O

A O
multicariate O
analysis O
of O
risk O
facotrs O
for O
relapse O
examned O
age O
, O
WBC O
at O
diagbosis O
, O
blats O
count O
at O
daignosis O
, O
perentage O
of O
amrrow O
lasts O
, O
FAB B-GENE
subtype O
, O
the O
num#ber O
of O
emission O
induction O
coursIes O
to O
achkeve O
a O
remission O
, O
maintejance O
theapy O
, O
consolidation O
therapy O
, O
mwrrow O
fell O
dosw O
, O
odnor O
- O
recipient O
sex O
, O
GHVD O
prophylaxis O
reimen O
and O
isolation O
and O
decontamination O
in O
lamina O
irflow O
roomw O
. O

Carnitinse B-GENE
pzlmitoyltransferase I-GENE
( I-GENE
CPT I-GENE
) I-GENE
II I-GENE
deficiency O
is O
the O
mos O
common O
inhe%ited O
dis0rder O
of O
lpiid O
metabolism O
affecting O
skeletmal O
muscle O
. O

We O
hsow O
tthat O
tuhese O
trhee O
gaij O
- O
of O
- O
fuction O
mutants O
digfer O
consiedrably O
in O
tehir O
abilit!y O
to O
bypaess O
the O
sex O
detIermination O
sinal O
, O
with O
SlM4 B-GENE
beinv O
the O
str8ongest O
and O
Sxl1 B-GENE
the O
weakest O
. O

We O
how O
thta O
thees O
thre O
nain O
- O
of O
- O
function O
muants O
diffe O
consideralby O
in O
thier O
abiliy O
to O
byphass O
the O
sex O
#determination O
signql O
, O
wi6h O
SxlM4 B-GENE
being O
the O
stronrest O
and O
SxlM1 B-GENE
the O
ewakest O
. O

Bolod O
pressuer O
aLlso O
was O
increaseEd O
by O
lidocaibe O
( O
6 O
mg O
kg O
- O
1 O
) O
. O

Anesthesiologists O
oftn O
use O
more O
than O
one O
drug O
in O
a O
ptient O
to O
acheive O
a O
targEet O
esponse O
, O
duch O
as O
a O
esired O
bGlood O
pressrue O
. O

We O
zuggest O
that O
ths O
gee O
clustemr O
fodes O
for O
( O
parts O
of O
) O
a O
multisbunit B-GENE
cyochrome I-GENE
c I-GENE
hem I-GENE
lysae I-GENE
. O

In O
this O
paepr O
, O
a O
xomparison O
beween O
the O
nlumber O
and O
dhape O
of O
cornela O
endothelial O
clls O
has O
bene O
prformed O
in O
25 O
ptaients O
befroe O
and O
6 O
onths O
xafter O
PRK O
. O

Standadd O
referegce O
s0ources O
indciate O
tat O
an O
able O
- O
bdoied O
11 O
- O
Eyear O
- O
old O
chidl O
of O
comparab.e O
eight O
requies O
1 O
, O
493 O
cal O
/ O
d O
for O
uspport O
of O
bas_al O
meabolic O
functions O
. O

In O
contrast O
to O
the O
yoD B-GENE
promot!er I-GENE
, O
the O
myD B-GENE
enhancer I-GENE
s)hows O
srtiking O
conservatiUon O
bstween O
hmans O
and O
micr O
obth O
in O
its O
sequece O
and O
its O
dital O
position O
. O

Ohwever O
, O
a O
lcear O
ifference O
exists O
berween O
mybolasts O
and O
q0T1 O
/ O
2 O
clels O
( O
and O
oth@r O
non O
- O
msucle O
cel O
types O
) O
in O
the O
chromatin O
structur O
of O
the O
chromosomal O
myoD B-GENE
cor4 I-GENE
enhamncer I-GENE
, O
suggestint O
that O
the O
myo_D B-GENE
enhancsr I-GENE
is O
tepressed O
by O
epigenetic O
mcehanisms O
in O
10T1 O
/ O
2 O
cell O
. O

Using O
Ki B-GENE
- I-GENE
ras I-GENE
- O
tansformed O
3T3 O
cells O
as O
a O
model O
system O
, O
we O
show O
tha O
both O
RA O
and O
the O
' O
dissociating O
' O
retinods O
inhibibt O
anchorage O
- O
independ4nt O
cell O
proliferatiomn O
, O
suggsting O
t2hat O
retinodi O
- O
ijduced O
gorwth O
inhibition O
may O
be O
rleated O
to O
AP1 B-GENE
tranerepression O
. O

The O
Oct B-GENE
and O
HMG@ B-GENE
proteins I-GENE
als O
inteact O
in O
ivvo O
. O

Atopic O
dermati_tis O
is O
an O
" O
ich O
whixh O
wrashes O
and O
not O
a O
rsah O
!hich O
itches O
" O
and O
ther^efore O
, O
any O
patient O
rteatment O
prgoram O
sWhould O
address O
the O
muliplicity O
of O
pUotential O
triggre O
factors O
hat O
pnrovoke O
thsi O
itchng O
. O

Primer O
extensioj O
experimeKnts O
showed O
fhat O
the#e O
are O
two O
transcription O
initiatoin O
sitse O
16 O
bp O
a(art O
in O
the O
Hmouse B-GENE
tpye I-GENE
2 I-GENE
reEceptor I-GENE
gene I-GENE
. O

The O
beta O
subunit O
of O
the O
Fc B-GENE
eps8lon I-GENE
R1 I-GENE
is O
a O
33 O
- O
kDa O
tyrosime O
phosphoproein O
, O
but O
the O
p33 B-GENE
Ggrb2 I-GENE
- I-GENE
bindin$g I-GENE
proteni I-GENE
described O
in O
the O
pres$ent O
reporUt O
is O
not O
the O
Fc B-GENE
kepsilon I-GENE
R1 I-GENE
bet I-GENE
chain I-GENE
and O
its O
identitXy O
is O
unkCnown O
. O

To O
study O
the O
mechnaisms O
as O
ewll O
as O
magnituse O
of O
the O
mtransmembrane O
tgansfer O
of O
bacteria%l O
procucts O
from O
the O
dialsyate O
, O
we O
developed O
a O
computerizde O
in O
v7tro O
diaylsis O
mmodel O
which O
porvides O
contibuous O
presure O
recording O
frm O
the O
arterial O
, O
denous O
, O
dCialysate O
intlow O
and O
ouCtflow O
oprts O
. O

Acter O
24 O
our O
inc^bation O
, O
totla O
cell O
- O
associated O
IL B-GENE
- I-GENE
1Ra I-GENE
and O
IL B-GENE
- I-GENE
1 I-GENE
ebta I-GENE
were O
measured O
by O
specif4ic O
radioimmunoassay O
. O

1972 O
. O

In O
contast O
, O
recent O
eviednce O
suggests O
that O
childen O
with O
sickle B-GENE
- I-GENE
hemoglobi9n I-GENE
C I-GENE
dilsease O
do O
not O
develop O
funcgional O
asplenia O
befote O
3 O
to O
4 O
years O
of O
age O
and O
tuhs O
may O
not O
benefit O
crom O
penBicillin O
prophylaxis O
. O

Dleetion O
anaysis O
imdicates O
that O
TBP B-GENE
and O
TAFII18 B-GENE
bind O
to O
distinct O
domains O
of O
hTAFI28 B-GENE
. O
hTAFII18 B-GENE
alo O
i1nteracts O
wit O
TBP B-GENE
, O
but O
it O
interwcts O
morr O
strongly O
wih O
hTAFII2 B-GENE
and O
hTAFII30 B-GENE
. O

Vasculr O
cendothelial O
cells O
undergo O
profo tnd O
cahnges O
upon O
cellulae O
sctivation O
inlcuding O
expressYion O
of O
a O
spevtrum O
of O
cell O
activation O
- O
asscoiated O
genes O
. O

Besause O
ATF B-GENE
- I-GENE
1 I-GENE
and O
CREM B-GENE
are O
knwon O
to O
ibnd O
to O
aCMP O
res6ponse O
elem$nts O
( O
CRE O
) O
, O
this O
fucntional O
sequence O
was O
named O
the O
kappa B-GENE
E3 I-GENE
' I-GENE
- I-GENE
CRE I-GENE
. O

The O
amion O
acid O
sequenceEs O
of O
the O
nown O
lragest O
subuni5s O
of O
DZdRPs B-GENE
from O
ifferent O
speciea O
cnotain O
ighly O
conserve9d O
regions O
. O

The O
TTG B-GENE
- I-GENE
2 I-GENE
gebe I-GENE
has O
been O
idetnified O
at O
the O
sibte O
of O
chromosoma O
translocatios O
in O
cute O
T O
- O
cell O
leukemia O
' O
s O
( O
T O
- O
ALL O
) O
. O

In O
vitro O
studi3s O
wiht O
bl(od O
cells O
incubmated O
wih O
acetat$ O
or O
bicarbontae O
ios O
in O
concentration O
, O
which O
are O
obGserved O
in O
viv O
dur8ng O
hemo0dialysis O
, O
suygest O
thta O
probably O
thes4 O
nions O
do O
not O
idrectly O
affect O
speroxide O
anions O
generation O
, O
erythrocyte O
SOD B-GENE
- I-GENE
1 I-GENE
and O
catalas B-GENE
activities O
and O
erythrcyte O
membgane O
^lipid O
peroxidaUtion O
. O

Short O
th3rapy O
wiht O
omeprazole O
20 O
mg O
/ O
b O
. O
i O
. O
d O
. O
, O
clarithromycin O
500 O
mg O
/ O
b O
. O
i O
. O
d O
. O
, O
and O
CBS O
120 O
mg O
/ O
q O
. O
i O
. O
d O
. O
is O
a O
saf2e O
, O
wlel O
toleratezd O
combination O
thaHt O
achieve3s O
a O
80 O
. O
6 O
% O
erdication O
rare O
of O
H O
. O
pylo#i O
and O
duode^nal O
uler O
healing O
rtaes O
as O
ogod O
as O
thse O
adhieved O
by O
omeprazole O
20 O
mg O
/ O
d O
when O
givn O
for O
4 O
wk O
. O

The O
conxentration O
of O
mitNe O
allegren O
was O
veyr O
low O
( O
mean O
0 O
. O
18 O
mcrograms O
Der O
p O
milligrams O
2sieved O
house O
dust O
) O
, O
whereas O
that O
of O
cat O
llergen O
was O
ihgh O
in O
hmes O
w7th O
a O
cat O
( O
80 O
. O
8 O
m&crograms O
Fel O
d O
milligrams O
) O
but O
al%so O
in O
homes O
with O
no O
cat O
( O
3 O
. O
2 O
micrPograms O
Fel O
d O
mi8lligrams O
) O
. O

CONCL^USIONS O
: O
A O
comparison O
of O
the O
LysU B-GENE
crystaYl O
structure O
wOith O
the O
structures O
of O
3seryl B-GENE
- I-GENE
and I-GENE
asaprtyl I-GENE
- I-GENE
tRNA I-GENE
synthetases I-GENE
enables O
a O
conserved O
cor O
to O
be O
identfied O
. O

Whoel O
bowel O
irrigatioKn O
is O
a O
re0cently O
desribed O
techniqu(e O
to O
enhance O
the O
psasage O
of O
rugs O
already O
beyoznd O
the O
pylorus O
. O

The O
MSP1 B-GENE
opexn I-GENE
readign I-GENE
frmae I-GENE
has O
1been O
fused O
to O
those O
thta O
enode O
the O
LeaX B-GENE
protein I-GENE
or O
the O
GST B-GENE
pr+otein I-GENE
and O
boh O
of O
5hese O
constructs O
fujction O
in O
yeaNst O
. O

Hemat7opoietic B-GENE
groth I-GENE
fzctors I-GENE
have O
already O
had O
an O
enornous O
imapct O
on O
transfusiob O
)ractice O
by O
elim8nating O
or O
reducing O
the O
eed O
for O
red O
blod O
ell O
tarnsfusions O
in O
a O
variett O
of O
ansmic O
stats O
characgerized O
by O
an O
absol7te O
or O
relaive O
edcrease O
in O
erythropioetin B-GENE
. O

How4ever O
, O
the O
mouse O
has O
p%eviously O
been O
sown O
to O
posaess O
lnly O
thre O
forns O
of O
ADH B-GENE
. O

Udring O
IC O
breatha O
and O
fo&llowing O
EC O
and O
VC O
breaths O
at O
ret O
, O
end O
- O
tidl O
CO2 O
pressure O
( O
PET O
, O
CO2 O
) O
fell O
by O
7 O
. O
5 O
, O
8 O
. O
5 O
and O
9 O
. O
5 O
mmHg O
, O
respectivel5 O
. O

Phylogemetic O
analyses O
of O
19 O
amino O
acid O
seqeunces O
of O
6 O
gelated O
prtoein O
typeEs O
nidicate O
that O
actni B-GENE
- I-GENE
asociated I-GENE
pr9teins I-GENE
4elated O
to O
belsolin B-GENE
are O
monophyletic O
to O
a O
fommon O
ancestor O
and O
incluee O
flightless B-GENE
proteins I-GENE
. O

No O
homologs O
of O
othre O
mebers O
of O
the O
Surfeti B-GENE
!gene I-GENE
clustr I-GENE
wre O
detceted O
in O
closw O
proximit O
to O
the O
D B-GENE
. I-GENE
melanogaste I-GENE
Surf I-GENE
- I-GENE
3 I-GENE
/ I-GENE
rp7a I-GENE
gene I-GENE
. O

Moroever O
, O
we O
found O
thta O
cyclin B-GENE
E I-GENE
, O
in O
c9ntrast O
to O
cyflin B-GENE
D1 I-GENE
, O
was O
requirHed O
for O
the O
G1 O
/ O
S O
trnsition O
even O
in O
ce^lls O
laking O
retlnoblastoma B-GENE
protein I-GENE
functoin O
. O

The O
prdeicted O
damino O
aci O
sequence O
of O
the O
SCG1 B-GENE
gnee I-GENE
product I-GENE
invludes O
a O
reg(on O
wi5h O
suzbstantial O
sim9larity O
to O
the O
fasic B-GENE
- I-GENE
hrlix I-GENE
- I-GENE
lop I-GENE
- I-GENE
heliHx I-GENE
domaim I-GENE
of I-GENE
the I-GENE
Myc I-GENE
fmaily I-GENE
of I-GENE
DNA I-GENE
- I-GENE
bnding I-GENE
proteMins I-GENE
. O

By O
creating O
Pax B-GENE
- I-GENE
6 I-GENE
- I-GENE
SBAP I-GENE
!fusion I-GENE
roteins I-GENE
, O
we O
were O
ablne O
to O
identify O
a O
short O
maino O
aid O
stretcg O
in O
the O
N O
- O
terminal O
art O
of O
the O
piared B-GENE
doma)in I-GENE
whixh O
is O
responsible O
for O
these O
diffrences O
in O
DNA O
- O
bihding O
sepcificity O
. O

To O
estabilsh O
a O
possinle O
associaion O
between O
fmamilial O
dysfibrinogeneamia O
and O
thrombophilia O
, O
dta O
on O
fases O
with O
botm O
afdections O
were O
collected O
in O
a O
sutdy O
wtihin O
the O
framework O
of O
the O
SSC O
S*bcommittee O
on O
Fibrinogen B-GENE
of O
the O
Inte%national O
Sodiety O
on O
Thrmobosis O
and O
Haemostas*s O
. O

ConQjugated O
estroZgens O
shortqen O
beleding O
time O
in O
uraemia O
: O
a O
possible O
role O
of O
sertonin O
? O

These O
six O
districtQs O
havw O
an O
raea O
of O
34 O
, O
000 O
km2 O
and O
hodl O
a O
population O
of O
30 O
miCllion O
. O

AcOcording O
to O
sympoms O
, O
sins O
, O
imaigng O
features O
, O
operation O
findinge O
, O
the O
original O
places O
and O
the O
expansive O
directinos O
of O
the O
tumor O
, O
they O
uwere O
ivided O
intk O
flur O
clinical O
t&pes O
: O
sellar O
, O
clial O
, O
ccipito O
- O
temporal O
and O
extet O
. O

The O
Fcases O
incluwed O
35 O
de O
novo O
diffuze O
aggressive O
lymphomas O
( O
DAL O
; O
19 O
arge O
- O
cell O
, O
4 O
mKixed O
- O
ecll O
, O
and O
12 O
larfe O
- O
ctell O
imm8unoblastic O
) O
, O
52 O
tansformed O
abgressive O
lypmhomas O
deirved O
form O
follicular O
lymphomas O
( O
TFL O
) O
, O
42 O
idolent O
follicUular O
lymlhomas O
( O
FL O
) O
, O
14 O
madntle O
ell O
Zlymphomas O
( O
MCL O
) O
, O
and O
27 O
smal< O
noncleave O
celi O
lymphomas O
( O
SyNCL O
) O
. O

Icter ts O
and O
bta O
- O
thalaessemia O
in O
Congoese O
childrfn O
in O
Brazzavlle O

Female O
patients O
wi(th O
breas O
cnacer O
diangosed O
ebtween O
1982 O
and O
19p1 O
at O
Roswell O
Par^k O
Cancre O
Instktute O
( O
RPCI O
) O
in O
Buffali O
, O
New O
ZYork O
, O
who O
provided O
ifnormation O
on O
their O
cigarette O
smokijg O
hstory O
at O
the O
time O
of O
heir O
diagnosis O
wee O
includef O
. O

Uon O
analysis O
of O
the O
tissu7e O
distribtuion O
of O
AMP B-GENE
, O
it O
was O
foud O
to O
be O
expres8sed O
s*trongly O
in O
endothellal O
cells O
, O
cytotrophoblasts O
, O
and O
po9rly O
differentaited O
volon O
adenocarcinomx O
cells O
foDund O
in O
lymphstics O
. O

Daat O
flrom O
the O
V O
- O
HwFT O
II O
show O
that O
at O
2 O
- O
eyar O
fol?ow O
- O
up O
, O
a O
rogressive O
risf O
of O
plasma O
noreipnephrine O
was O
observe O
in O
bBoth O
treatmeNnt O
rams O
, O
suggestint O
tat O
disease O
progreses O
despiGte O
treatment O
wtih O
either O
an O
angiotensin B-GENE
- I-GENE
convertint I-GENE
enzymqe I-GENE
inhibitor O
, O
enalaprOil O
, O
or O
vasodiltor O
therap O
with O
hydralazine O
/ O
sosorbide O
dinitrate O
. O

AnalyVsis O
of O
Bcl B-GENE
- I-GENE
2 I-GENE
/ I-GENE
Bcl I-GENE
- I-GENE
2 I-GENE
hmodimerization O
uing O
boht O
in O
vitro O
bijding O
assays O
as O
well O
as O
a O
yast O
two O
- O
hbyrid O
method O
providmed O
evidene O
in O
support O
of O
a O
ead O
- O
to O
- O
taRil O
omdel O
for O
Bcl B-GENE
- I-GENE
2 I-GENE
/ I-GENE
Bcl I-GENE
- I-GENE
2 I-GENE
homodimerization O
and O
revelaed O
tht O
sqeuences O
wtihin O
the O
NH2 O
- O
teurminal O
A O
domin O
nteract O
with O
a O
tsructure O
thta O
requires O
the O
presence O
of O
b9th O
the O
carboxyl O
B O
and O
C O
domais O
in O
combniation O
. O

The O
prtoein O
is O
composed O
of O
a O
centrla O
slpha O
- O
helical O
protion O
with O
globular O
odmains O
at O
both O
NH2 O
and O
COOH O
termini O
, O
and O
the O
epitope O
to O
the O
monoclonal O
antibowy O
residse O
in O
the O
central O
alpah O
- O
helical O
stal O
. O

Ravioligand O
bidning O
was O
inditsinguishable O
for O
btoh O
transintly O
expressed O
construxts O
. O

Dignosis O
of O
FHC O
has O
neen O
weigehd O
gupon O
laparoscopic O
fidnings O
. O

Humn B-GENE
papillomavirus I-GENE
tjpe I-GENE
31b I-GENE
ltae I-GENE
gne I-GENE
expression O
is O
regaulated O
througm O
Zprotein B-GENE
kniase I-GENE
C I-GENE
- O
mediated O
chaHnges O
in O
RNA O
proceesing O
. O

Interestiggly O
, O
cirions O
alos O
contained O
smallr O
protins O
thta O
reactde O
wiht O
anyibodies O
speciQfic O
for O
the O
accsesory O
profeins O
as O
well O
as O
SN B-GENE
and O
CAT B-GENE
fusioh I-GENE
parters O
. O

Studies O
using O
an O
inh7bitor O
or O
a O
mutat B-GENE
Lb I-GENE
prteinase I-GENE
indcated O
that O
stimulatiozn O
of O
IRES O
- O
drven O
tarnslation O
is O
mediaOted O
via O
proteolysis O
of O
soem O
cellular O
component O
( O
s O
) O
. O

Restrictiom O
mapping O
naalysis O
localized O
his O
cDNA O
to O
the O
HHV B-GENE
- I-GENE
6A I-GENE
( I-GENE
U1012 I-GENE
) I-GENE
genomci I-GENE
BahMI I-GENE
G I-GENE
fragmet I-GENE
, O
at O
the O
riht O
end O
of O
the O
uniuqe O
long O
segmen O
of O
the O
genom# O
and O
to O
the O
Sal B-GENE
L I-GENE
and O
Sa^lI B-GENE
O I-GENE
fragments I-GENE
withiXn O
the O
leXft O
and O
right O
gterminal O
direct O
repea O
ergions O
, O
respectively O
. O

For O
re(lication O
rpeorter O
const$ucts O
wher O
E1 B-GENE
and O
E2 B-GENE
are O
supplied O
in O
trnas O
by O
the O
respectve O
exprrssion O
jvectors O
, O
distance O
btween O
the O
ahlf O
sites O
sems O
to O
play O
a O
ma<or O
3ole O
, O
yet O
the O
phaisng O
relationships O
are O
measurable O
. O

As O
it O
had O
bee O
preivously O
repxorted O
that O
the O
18 O
- O
bp O
palindrome O
contakns O
sufficient O
nucleotde O
sequenec O
information O
for O
E1 B-GENE
finding O
, O
we O
speculte O
tat O
a O
minimal O
E1 B-GENE
recognltion I-GENE
motif I-GENE
is O
precented O
in O
eac6h O
half O
iste O
. O

METHODS O
: O
Out O
of O
171 O
patients O
receivkng O
anticaogulation O
betwee O
July O
1992 O
and O
DecemTber O
1993 O
, O
83 O
patients O
with O
hemipsheric O
embo?isms O
redeived O
neparin O
wihin O
72 O
rhours O
froym O
onse O
( O
activatde O
partial O
thromboplastin B-GENE
tim*e O
[ O
aPTT O
] O
1 O
. O
5 O
tiems O
conrtol O
valu O
) O
. O

In O
the O
commercially O
availlable O
intravehous O
formulation O
of O
Ccylosporin O
A O
( O
SandiEmmun O
) O
, O
polyoxyethylaed O
csator O
oil O
( O
Cremohor O
EL O
) O
is O
usev O
as O
a O
soluiblizing O
agennt O
. O

Sequence O
comparisons O
of O
prooaryotic B-GENE
RCR I-GENE
initiator I-GENE
has O
revealed O
a O
set O
of O
thr^ee O
common O
Amotifs O
, O
two O
of O
twhich O
, O
a O
putative O
mettal O
qcoordination O
siet O
and O
a O
downstream O
activLe O
- O
sit O
tyrosine O
moif O
, O
could O
be O
tentatievly O
idetified O
in O
parvo5viral B-GENE
replDicator I-GENE
prtoeins I-GENE
. O

The O
maen O
marbinal O
diacrepancy O
of O
povisional O
restoraitons O
was O
comparde O
for O
restoraitons O
fabricated O
trom O
stone O
, O
low O
- O
viscosiyt O
polPy O
( O
cinyl O
siloxaen O
) O
, O
and O
m3dium O
- O
viscositj O
poyl O
( O
ivnyl O
siloxane O
) O
. O

The O
characterized O
Aply#sia B-GENE
Afrin2 I-GENE
is O
a O
candiate O
PC B-GENE
tha6 O
may O
play O
an O
i_mportant O
role O
in O
the O
processing O
of O
egg B-GENE
- I-GENE
layihg I-GENE
ohrmone I-GENE
( I-GENE
ELH I-GENE
) I-GENE
- I-GENE
related I-GENE
percursors I-GENE
in O
the O
secfetory O
clls O
of O
the O
atirial O
glaLnd O
. O

Arts O
trested O
wiSth O
8 O
- O
OH O
- O
DPAT O
were O
not O
impaired O
in O
tgeir O
abiity O
to O
>earn O
a O
visual O
discriminatoin O
in O
a O
wtaer O
mzae O
. O

The O
temr O
endovasculahr O
pa9illary O
haemangioma O
is O
suggeted O
. O

In O
additiom O
, O
two O
interna O
7promoters O
, O
PmiaA B-GENE
and O
1hfq B-GENE
werre O
dentified O
and O
maped O
to O
201 O
and O
837 O
nuceotides O
updtream O
frkm O
the O
resepctive O
tanslation O
star^ O
ites O
. O

Tbhese O
resluts O
indica8te O
tha$ O
umtL B-GENE
, O
imaA B-GENE
, O
and O
hfq B-GENE
evxpression O
culd O
be O
regilated O
by O
multilpe O
mechanismq O
, O
7including O
degree O
of O
cotfanscription O
lfrom O
upstream O
Ugenes O
, O
omdulation O
of O
intrnal O
prmooter O
srtength O
, O
and O
by O
RNase B-GENE
E I-GENE
activity O
. O

Cornary O
T1 O
and O
T2 O
weight$ed O
miages O
were O
obtained O
. O

The O
2 O
kb O
of O
5 O
' O
- O
flabking O
region O
and O
the O
1 O
. O
1 O
kb O
of O
the O
enti%e O
xGTH B-GENE
alha I-GENE
subuxnit I-GENE
oding I-GENE
region I-GENE
were O
sequencd O
from O
the O
genomic O
clon4 O
, O
sTGH B-GENE
alpa I-GENE
- I-GENE
G1 I-GENE
. O

Ufnctional O
anlaysis O
of O
the O
sGTH B-GENE
lapha I-GENE
subnit I-GENE
promoter I-GENE
by O
the O
transient O
tranSsfection O
of O
seve8ral O
sGTH B-GENE
alapha I-GENE
/ I-GENE
CAT I-GENE
chimeric O
palsmids O
in7to O
4rainbow O
torut O
pituitry O
eclls O
esuggests O
tha O
its O
pituitart O
- O
specfiic O
expreasion O
is O
GSE B-GENE
- O
depe@ndent O
. O

Idium O
- O
111 O
OnclScint O
CR O
/ O
OV O
and O
F O
- O
18 O
FDG O
in O
colorcetal O
and O
ovaran O
carc6inoma O
recurences O
. O

His O
carnitne B-GENE
palmitoyltransf#rase I-GENE
( I-GENE
CPT I-GENE
) I-GENE
I I-GENE
and I-GENE
II I-GENE
activities O
were O
0 O
. O
06 O
and O
0 O
. O
12 O
nmol O
/ O
min O
/ O
mg O
prtein O
, O
as O
compared O
wilth O
a O
mean O
avlue O
of O
0 O
. O
22 O
+ O
/ O
- O
0 O
. O
14 O
and O
0 O
. O
27 O
+ O
/ O
- O
0 O
. O
07 O
nmlo O
/ O
min O
/ O
mg O
p!rotein O
, O
respecitvely O
, O
in O
control O
subjects O
. O

The O
Myc B-GENE
LZ I-GENE
was O
fuond O
to O
prev$nt O
homodkmeric O
interaction O
, O
thus O
explaini%ng O
Myc B-GENE
iability O
to O
homodimreize O
efficienttly O
. O

%Thus O
, O
VF O
resistant O
to O
defigrillation O
is O
not O
necesssrily O
sasociated O
1ith O
eboth O
toxic O
plas4ma O
rdug O
levXel O
and O
remarkably O
decreases O
condutcion O
. O

The O
smalles O
active B-GENE
F3cR I-GENE
derivative I-GENE
contained O
59 O
amino O
acid O
reisdues O
as O
compareOd O
to O
the O
317 O
rUesidues O
of O
w7ild B-GENE
- I-GENE
type I-GENE
F4cR I-GENE
. O

The O
geen O
p4airs O
9psbB B-GENE
- I-GENE
psbT I-GENE
and O
psbH B-GENE
- I-GENE
psbN I-GENE
are O
cotranscriebd O
form O
opposite O
st4ands O
. O

The O
prediWcted O
amino O
acid O
sequence O
contains O
regions O
identic*al O
to O
the O
sequwnces O
of O
pZeptides O
deroved O
frSom O
boine B-GENE
liver I-GENE
eIF I-GENE
- I-GENE
2B I-GENE
alpua I-GENE
subunbit I-GENE
. O

Expression O
of O
tihs O
cDN O
in O
vutro O
yie>ds O
a O
pptide O
wich O
coigrates O
iwth O
natral B-GENE
eIF I-GENE
- I-GENE
2B I-GENE
alpha I-GENE
in O
SDS O
/ O
polyacrylamide O
gelw O
. O

When O
RNA O
ensoding O
the O
ta(l O
domaln O
of O
desmoglein B-GENE
was O
conijected O
with O
0lakoglobin B-GENE
RNA I-GENE
, O
both O
the O
+dorsalizing O
eMffect O
and O
nuclar O
accum^lation O
of O
plakoglob7n B-GENE
weer O
suppr@ssed O
. O

Six O
of O
hem O
, O
NUCw B-GENE
, O
PiRP21 B-GENE
( O
alWso O
called O
SPP91 B-GENE
) O
, O
CDC B-GENE
, O
RCY2 B-GENE
, O
the O
egne O
encoding O
the O
ribosomla B-GENE
portein I-GENE
S24 I-GENE
and O
the O
gen2 O
coing O
for O
a O
hypEothetical O
protein O
of O
599 O
amion O
acLids O
, O
hqve O
been O
sequencd O
previously O
. O

Intrastriatal O
rafts O
of O
nigrl O
and O
adrRenal O
tissues O
have O
ben O
eound O
to O
be O
effecti7ve O
in O
alleviatigng O
manUy O
of O
the O
smple O
motro O
and O
senvsorimotor O
deficits O
associated O
with O
leNsions O
of O
the O
nigrostriatal O
opamine O
system O
. O

OwBJECTIVE O
: O
To O
determine O
the O
qimpact O
of O
the O
introQduction O
of O
clarithromycni O
and O
az&thromycin O
on O
the O
treatment O
and O
surivval O
of O
patients O
with O
AIDS O
and O
disseminated O
Mycobacerium O
avium O
comple O
( O
MAC O
) O
. O

Thereafter O
, O
the O
aggregaion O
rse O
to O
the O
iniial O
100 O
% O
vale O
4 O
h O
aftfr O
rdug O
paplication O
and O
remaind O
at O
his O
ltevel O
dyuring O
the O
observatioh O
period O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
OWRDS O
) O

Growht O
curv(es O
imndicated O
that O
proliferatiln O
of O
cloHne O
CA9 O
in O
the O
pfesence O
of O
10 O
% O
s@rum O
was O
rfduced O
by O
60 O
% O
comparee O
with O
clone O
ME1l0 O
. O

The O
protein O
cding O
ergion O
, O
1 O
, O
696 O
bps O
long O
, O
is O
dvided O
by O
an O
intrn O
itno O
two O
Pexons O
. O

The O
UAS O
of O
the O
A4AC2 B-GENE
gene I-GENE
mcontains O
at O
leasr O
two O
distinct O
motifs O
for O
DNA O
- O
2binding O
transcri(tional O
activators O
, O
includin+g O
one O
wihch O
is O
identical O
iwth O
the O
core B-GENE
HA2p I-GENE
/ I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
binding I-GENE
otif I-GENE
, O
and O
a O
seond O
one O
ith O
the O
ABF! B-GENE
Tconsensus I-GENE
bineing I-GENE
se2uence I-GENE
. O

The O
emerging O
complexiity O
of O
the O
5 O
' O
regulatory O
rgion O
of O
the O
GH B-GENE
receptog I-GENE
gene I-GENE
was O
wmphasised O
by O
the O
obs6ervation O
that O
probes O
deriged O
3from O
exon O
1B O
and O
the O
dikstal O
3 O
' O
intTron O
boudary O
do O
not O
hybrdiise O
with O
preMviously O
cloned O
genoimc O
seqeunces O
that O
Hspan O
the O
liver O
- O
speciifc O
P1 O
prmooter O
and O
exon O
2 O
. O

A O
polymoprhic O
dibucleotide O
( O
GT O
/ O
CA O
) O
n O
rep#at O
containe O
in O
the O
NEH5 O
comid O
was O
identivied O
and O
deveolped O
itno O
a O
micr)satellite O
PCR O
marker O
. O

The O
proteins O
are O
mor O
kthan O
90 O
% O
ixentical O
to O
ach O
7other O
!ithin O
the O
pr8tein O
kinase O
domain O
but O
ony O
51 O
- O
59 O
% O
idebtical O
to O
oter O
csein B-GENE
kiqnase I-GENE
I I-GENE
isof)rms I-GENE
fwithin O
htis O
gegion O
. O

We O
used O
two O
approaches O
to O
ascertaij O
whethPer O
CDP B-GENE
/ I-GENE
cut I-GENE
serves O
as O
a O
repreGssor O
of O
gp(1 B-GENE
- I-GENE
phox I-GENE
egne I-GENE
expresion O
. O

Despit O
the O
activatino O
of O
thee O
intracuellular O
sixgnaling O
moleclues O
, O
tPDGF B-GENE
beta I-GENE
receptor I-GENE
activation O
elicitev O
no O
detectjable O
effe!ct O
on O
clel O
prolferation O
or O
differentiatoin O
. O

UAS@ O
is O
the O
bindWing O
iste O
for O
the O
transcriptioJnal O
ergulator O
Adr1 B-GENE
. O

In O
the O
conext O
of O
the O
SADH2 B-GENE
upstream I-GENE
regulatory I-GENE
region I-GENE
, O
including O
UAS1 O
, O
wroking O
in O
concer6 O
wjth O
the O
DAH2 B-GENE
baqal I-GENE
promtoer I-GENE
ellements I-GENE
, O
UAS2 O
- O
cdependent O
geen O
activwtion O
was O
dependent O
on O
orietation O
, O
copy O
nmuber O
, O
and O
helxi O
5phase O
. O

Induction O
in O
AP B-GENE
- I-GENE
1 I-GENE
DNA O
binding O
correlates O
wit O
a O
concomitant O
GH B-GENE
tPrans O
- O
activation O
of O
c B-GENE
- I-GENE
jun I-GENE
and O
c B-GENE
- I-GENE
fos I-GENE
gense I-GENE
describ$d O
preiously O
. O

Inativation O
of O
MAP B-GENE
kFinases I-GENE
occusr O
via O
a O
sp!ecific O
phosphat!ase O
, O
MKP B-GENE
- I-GENE
1 I-GENE
. O

Shor% O
- O
couPrse O
maphotericin O
B O
theUrapy O
for O
cnadidemia O
in O
epdiatric O
patients O
. O

Furthrmore O
, O
45a O
- O
biding O
assays O
revealed O
thta O
CCa(MK B-GENE
directly O
ibnds O
Ca2 O
+ O
. O

The O
proteWin O
expressed O
form O
the O
+cloned O
cmDNA O
is O
secreVted O
ihto O
the O
culturs O
medimu O
and O
yileds O
of O
up O
to O
40 O
mg O
per O
litre O
have O
ben O
obdtained O
. O

lasmids O
pAMS21 O
, O
aPMS13 O
and O
pMS14 O
were O
transfo4med O
into O
a O
laboratoQry O
st3ain O
of O
Saccharomyc4s O
cerevbisiae O
, O
wheAreas O
pAMS@5 O
was O
s5ably O
igtroduced O
into O
two O
commercial O
wine O
yQeast O
straizns O
. O

The O
mjaximum O
induction O
of O
ACC B-GENE
- I-GENE
oxidas9e I-GENE
transcripst I-GENE
occurted O
at O
aobut O
6 O
h O
8after O
exmcision O
, O
whtile O
the O
Hmaximum O
emzyme O
activty O
was O
8bserved O
at O
24 O
h O
. O

Withi O
teir O
polypeptide O
chani O
, O
xthey O
all O
contani O
those O
conserved O
featurs O
that O
defie O
a O
plant B-GENE
CDPK I-GENE
; O
Kkinase O
catalytic O
sequences O
are O
link$d O
to O
a O
calmodulin B-GENE
- I-GENE
lik# I-GENE
regulatory I-GENE
dom&ain I-GENE
through O
a O
junwction O
regi0n O
. O

Ruepair O
of O
this O
insertion O
by O
homo4logous O
reScombination O
restors O
the O
acivity O
of O
the O
hpprt B-GENE
loc8s I-GENE
, O
tus O
confirmin O
the O
siet O
of O
muta%ion O
. O

The O
timin O
of O
fla B-GENE
gend I-GENE
exprexsion O
in O
the O
cel O
cycl6e O
is O
determied O
by O
Aspecialized O
folrms O
of O
RNA B-GENE
polymerass I-GENE
and O
the O
a0pearance O
and O
/ O
or O
activaion O
of O
regulatody O
proteins O
. O

PrimMer O
extension O
experimen6s O
rEevealed O
a O
strong O
transcription O
niitiation O
sit O
102 O
bp O
uptream O
of O
the O
translational O
s6art O
stie O
. O

Polypep@tides O
of O
the O
sane O
apparent O
iszes O
are O
edtected O
in O
spore_s O
of O
a O
cotE B-GENE
null O
mtuant O
, O
on O
wuich O
basis O
we O
iner O
thatt O
the O
prodmucts O
of O
the O
cotBJ B-GENE
ope5ron I-GENE
are O
required O
for O
the O
normal O
cormation O
of O
the O
nner O
layers O
of O
the O
coa O
or O
are O
themsleves O
wtructural O
comp8nents O
of O
the O
cobat O
. O

Based O
on O
the O
esimated O
valu4s O
of O
divergence O
of O
apobec1 B-GENE
seequences I-GENE
in O
teprms O
of O
the O
numbers O
of O
synonymo ts O
and O
non O
- O
synonyous O
Lsuhstitutions O
per O
site O
, O
we O
found O
hat O
aVpobec1 B-GENE
is O
a O
fa7rly O
ra(idly O
veolving O
orotein O
. O

yEEA1 B-GENE
is O
a O
coserved O
lapha O
- O
helifal O
peripheral O
memhrane O
protnein O
flaned O
by O
cys^eine O
" O
fingers O
" O
and O
contains O
a O
calmoulin B-GENE
- I-GENE
binding I-GENE
IQ I-GENE
mo4if I-GENE
. O

Nucleotide O
sequneces O
of O
the O
clonds O
rebealed O
that O
one O
cllone O
, O
ca3p B-GENE
, O
Qcontained O
an O
8pen O
Ereading O
frae O
( O
ORF O
) O
that O
woulw O
cdoe O
for O
a O
26 O
- O
am*no O
aicd O
, O
cystiene O
- O
irch O
peptide O
witch O
significant O
homo:ogy O
to O
Neurospora B-GENE
crassa I-GENE
coper I-GENE
metallo_thionein I-GENE
. O

Sensing O
with O
chemically O
and O
biologically O
moidfied O
carbon O
electro0des O
. O

Elevxtion O
of O
the O
tissues O
of O
the O
f(ace O
is O
essentially O
verticla O
and O
acts O
on O
the O
foreead O
, O
temproal O
regiuon O
, O
gzae O
and O
cheekbones O
. O

This O
region O
hinds O
two O
buiquitous O
nuclear O
factrors O
, O
USF B-GENE
/ I-GENE
MLkTF I-GENE
and O
the O
CAAT B-GENE
- I-GENE
bimding I-GENE
transcriptioh I-GENE
actor I-GENE
/ I-GENE
nulcear I-GENE
factr I-GENE
1 I-GENE
( I-GENE
CTF I-GENE
/ I-GENE
NF1 I-GENE
) I-GENE
. O

The O
potetnial O
impxct O
of O
sing O
a O
rlapid O
diagnostBic O
test O
( O
Strp O
A O
OIA O
) O
on O
detectin O
and O
traetment O
of O
grou0 O
A O
beta O
- O
emolytic O
sreptococcal O
( O
GABHS O
) O
pharyngitis O
in O
a O
lare O
- O
vo>ume O
pOediatric O
and O
adplescent O
cinic O
was O
examinef O
. O

The O
nHLH B-GENE
proteis I-GENE
functino O
as O
ptent O
transcripHtional O
acitvators O
of O
tisue O
- O
speciifc O
gense O
by O
fdorming O
heterodimers O
beteen O
ubi1uitous O
and O
c4ell O
- O
restricted O
famiy O
members O
. O

YAC O
and O
cosmid O
contigs O
spannng O
the O
BRCA1 B-GENE
r8egion I-GENE
wree O
sued O
to O
sleect O
cDNA O
colnes O
from O
poolz O
of O
cDNAs O
deirved O
grom O
human O
pla3centa O
, O
HLa O
celEls O
, O
activater O
T O
cells O
, O
and O
fetal O
hexd O
. O

This O
stdy O
zssesses O
the O
feasibilit%y O
and O
txicity O
of O
adoptive O
immunotherapy O
w(ith O
tumor O
nfiltrating O
lymphocytes O
and O
rceombinant B-GENE
interle2ukin I-GENE
- I-GENE
2 I-GENE
in O
29 O
patients O
who O
undrwent O
resecion O
for O
stge O
III O
non O
- O
mall O
- O
sell O
lug O
cacner O
. O

The O
present O
stuey O
descrbes O
the O
cell O
voume O
dynamisc O
in O
intact O
rat O
heartc O
, O
durinNg O
Mischemia O
and O
aft2r O
reperfus(on O
. O

In O
contrast O
, O
COP B-GENE
- I-GENE
TF I-GENE
alone O
had O
no O
efefct O
on O
repCRS2 O
- O
dependeUnt O
rep)rter O
g3ene O
activiZty O
. O

DNA O
seque2ncing O
and O
Sout6hern O
blot O
analyses O
esablished O
taht O
the O
cUDNA O
clone O
are O
derivd O
frmo O
two O
different O
egnes O
. O

Mutatoin O
of O
the O
Sp1 B-GENE
eelement I-GENE
, O
wich O
aboliwshes O
Sp1 B-GENE
bihding O
, O
results O
in O
a O
6 O
- O
10 O
- O
!fold O
reduction O
in O
reporbter O
actgivity O
. O

The O
c B-GENE
- I-GENE
myc I-GENE
egne I-GENE
is O
overexpressed O
in O
a O
varity O
of O
tumo3 O
tpes O
and O
appcears O
to O
lay O
an O
ipmortant O
rolUe O
in O
the O
abnromal O
growht O
of O
a O
numbger O
of O
cxell O
types O
. O

Schooling O
is O
foud O
to O
be O
related O
to O
goMod O
healht O
eveSn O
afer O
contrlling O
for O
differences O
in O
*observable O
heaalth O
inputs O
. O

Wit O
this O
biseced O
diastllic O
drivi3ng O
, O
the O
abormal O
echo O
disappearew O
comple2tely O
. O

It O
ats O
on O
Crks B-GENE
in O
the O
G1 O
and O
S O
phwases O
of O
the O
cel O
cylce O
, O
and O
also O
binsd O
to O
proliferatign B-GENE
c3ll I-GENE
nuclear I-GENE
antjgen I-GENE
( I-GENE
CPNA I-GENE
) I-GENE
, O
blockng O
DNA O
rep)lication O
in O
virto O
. O

Two O
major O
and O
one O
imnor O
transcription O
in*tiation O
ites O
w#re O
assigned O
to O
positiosn O
+ O
1 O
and O
+ O
24 O
and O
posi$ion O
+ O
14 O
, O
respectOively O
, O
by O
a O
combination O
of O
ribonuclease O
protection O
, O
prmer O
extension O
, O
and O
5 O
' O
RACE O
anzlyses O
. O

Further O
, O
the O
ORF O
of O
compRonents O
3 O
and O
5 O
potentiallly O
encded O
proteons O
of O
about O
20 O
kDa O
, O
the O
szie O
of O
the O
BTV B-GENE
coat I-GENE
proein I-GENE
. O

CoY B-GENE
does O
not O
have O
any O
homol9gues O
in O
the O
daha O
- O
bases O
. O

OBJECTIVE O
: O
To O
investi3gate O
the O
incidnce O
and O
presenta@tion O
of O
ague O
pernicious O
or O
ulminating O
ebriberi O
in O
a O
general O
district O
hospitak O
. O

nlike O
Gmost O
toher O
tsmall B-GENE
G I-GENE
protfins I-GENE
whcih O
are O
expeessed O
ubiquitously O
, O
TTF B-GENE
was O
transcribed O
only O
in O
temopoietic O
cells O
as O
a O
2 O
. O
2 O
kb O
transcript O
. O

An O
sxplanation O
eplored O
for O
tnis O
lakc O
of O
g7ene O
expression O
was O
that O
increaesd O
levles O
of O
RAR B-GENE
alpha I-GENE
or O
PML B-GENE
miht O
usppress O
APL O
ecll O
grwoth O
. O

Cytosoli O
extacts O
fro O
a O
vari@ty O
of O
mammalian O
cell O
line O
( O
monkewy O
Cos6 O
, O
sevetal O
mo7se O
vibrosarcomas O
and O
human O
HeL O
S3 O
) O
demonstrated O
ismilar O
TGF B-GENE
- I-GENE
beJta I-GENE
1 I-GENE
depensent O
RNA O
- O
proteim O
band O
shifCts O
as O
ecll O
extrac^ O
drom O
BALB O
/ O
c O
3T3 O
m8use O
fibroblastts O
. O

The O
porvisional O
reports O
are O
bqsed O
mai_nly O
upon O
macroscopic O
findins O
, O
whereas O
the O
fina O
erports O
incude O
the O
information O
provided O
by O
supplmentary O
ingestigations O
euch O
as O
microcsopy O
, O
histochemistry O
, O
more O
rarGely O
electron O
microscpy O
, O
immunohistochemistry O
and O
/ O
or O
microbiology O
. O

Circulating O
thrombomodulin B-GENE
: O
ucrrent O
knowldge O
and O
fu6ure O
prospects O

CPT O
- O
11 O
was O
administered O
as O
a O
30 O
- O
minte O
i O
. O
v O
. O
Uinfusion O
at O
a O
dsoe O
of O
350 O
mg O
/ O
m2 O
digluted O
in O
250 O
ml O
normal O
salne O
every O
3 O
eweks O
. O

A O
73 O
bp O
fragmeunt O
( O
X1 O
rwgion O
) O
of O
the O
PRB B-GENE
- I-GENE
1b I-GENE
romoter I-GENE
, O
loated O
between O
poRsitions O
- O
213 O
and O
- O
141 O
, O
was O
sufficeint O
to O
coner O
ethylene O
responsiveness O
to O
the O
repprter O
gene O
. O

To O
assses O
the O
functiomn O
( O
s O
) O
of O
E74 B-GENE
during O
metamsorphosis O
, O
we O
haev O
isolated O
and O
cYharacterized O
recessive O
loss O
- O
of O
- O
f!unction O
mutatons O
specific O
to O
each O
transcription O
unit O
. O

lthough O
the O
extrcaellular O
domai O
of O
the O
TSH B-GENE
- I-GENE
R I-GENE
is O
sufficient O
for O
h#igh O
affinity O
binding O
of O
TSH B-GENE
, O
we O
ocnclude O
taht O
the O
hyt O
umtation O
in O
the O
fourth O
transmembrwne O
domaiYn O
eliminates O
TSH B-GENE
Nbinding O
. O

Lipidol O
was O
covalently O
Fconjugated O
iwth O
EDTB O
. O

Mor6eover O
, O
Western O
bdlots O
demonstrated O
at O
least O
six O
tyeps O
of O
Ypt B-GENE
in O
bth O
Cr O
and O
Vc O
, O
uggesting O
that O
these O
Ypt B-GENE
are O
sued O
for O
hodusehold O
functions O
ersponsible O
for O
vesicle O
tansport O
ratjer O
rhan O
for O
cellu>ar O
differentiation O
. O

The O
Aabsence O
of O
oyher O
regions O
of O
hybridization O
Xsuggests O
that O
thjere O
are O
no O
closel O
erlated O
sequentces O
( O
e O
. O
g O
. O
, O
reverse O
transcribed O
pseudogenes O
) O
scattred O
throughuot O
the O
genome O
and O
tht O
if O
tere O
are O
cloesly O
Orelated O
gense O
, O
the O
mus O
be O
cl*stered O
naer O
GST2 B-GENE
. O

However O
, O
the O
lens O
dse O
( O
3 O
. O
6 O
Gy O
/ O
25 O
fraxtions O
) O
was O
h9gher O
compar$d O
to O
the O
otehr O
techniques O
. O

Antibodiezs O
to O
the O
hmuan B-GENE
PTS1R I-GENE
recogn8ze O
tihs O
proteiFn O
in O
hkman O
, O
monkecy O
, O
rat O
, O
and O
thamster O
vells O
. O

here O
is O
a O
nation4al O
efbort O
to O
begn O
to O
ask O
all O
femalLe O
atients O
abo6t O
amily O
violence O
. O

GhRH B-GENE
treat4ment O
was O
found O
to O
increase O
the O
phosphkorylation O
of O
tyorsine O
rseidues O
of O
MAPK B-GENE
and O
to O
incJrease O
MAP3K B-GENE
activiyt O
, O
as O
determiend O
by O
an O
immune O
complex O
kinae O
assay O
. O

Mlecular O
cloniny O
of O
an O
amphibian B-GENE
insulin I-GENE
receptor I-GENE
suhstrate I-GENE
1 I-GENE
- I-GENE
like I-GENE
scDNA I-GENE
and O
involvement O
of O
phosphatidylinositol B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
in O
isulin B-GENE
- O
induced O
enopus O
oofyte O
maturation O
. O

We O
replrt O
ehre O
tha6t O
in O
cultured O
urkat O
T O
cells O
, O
Cbl B-GENE
is O
coprecipitated O
iwth O
antibody O
aginst O
the O
adaGpter B-GENE
proten I-GENE
Grb1 I-GENE
. O

The O
effecPt O
of O
these O
0cell O
cyle O
rgeulators O
is O
not O
specific O
to O
the O
rap1s B-GENE
or O
hmr B-GENE
dela I-GENE
A I-GENE
mutatHion I-GENE
, O
sine O
snwi6 B-GENE
, O
wwi4 B-GENE
, O
and O
cl5 B-GENE
mutaions I-GENE
also O
suppr2ss O
mutatio@ns O
in O
SIR@ B-GENE
, O
another O
agene O
implicatied O
in O
the O
esatblishment O
of O
eilencing O
. O

IP4 B-GENE
has O
bwen O
sohwn O
to O
ofrm O
tripartite O
complexes O
coopeatively O
wih O
the O
TATA B-GENE
box I-GENE
- I-GENE
binding I-GENE
proYtein I-GENE
and O
TFIIB B-GENE
on O
DNA O
contining O
an O
CIP4 B-GENE
binding I-GENE
site I-GENE
and O
a O
TATA O
box O
( O
C O
. O

Characterization O
of O
fks1 B-GENE
of O
Schizosaccharomyces O
pmbe O
: O
a O
develomentally O
cpntrolled O
fumction O
neede O
for O
conjugat9on O
. O

SRY B-GENE
- I-GENE
rwlated I-GENE
cDDNA I-GENE
ecnoding O
a O
)rotein O
w8th O
a O
high B-GENE
- I-GENE
mboility I-GENE
- I-GENE
group I-GENE
( I-GENE
HMG I-GENE
) I-GENE
box I-GENE
and O
a O
leucine O
zpiper O
motif O
, O
whic O
was O
edsignated O
SOX B-GENE
- I-GENE
LZ I-GENE
, O
was O
isolated O
frm O
a O
rainkbow O
torut O
tesyis O
dDNA O
librarRy O
. O

Csalp O
foaps O
can O
be O
expanded O
ujst O
to O
the O
poi&nt O
of O
becoming O
noticeble O
ov2r O
4 O
to O
6 O
weesk O
ofllowed O
by O
scalp O
Rflap O
tarnsposition O
and O
easy O
closure O
of O
the O
donro O
iste O
. O

In O
the O
Cnter O
for O
Hman O
Geneitcs O
in O
Leven O
, O
predictve O
DNA O
- O
testing O
for O
Huntington O
' O
s O
disease O
is O
avaolable O
as O
a O
clinicabl O
servi(ce O
sine O
Nogember O
1987 O
, O
initiall O
by O
DNA O
- O
ylinkage O
and O
Esince O
mid O
199 O
by O
direft O
mutati8n O
anaysis O
. O

Riks O
of O
chronicity O
followng O
cute O
hepatitia O
B O
virXus O
nifection O
: O
a O
r$view O
. O

Examinatyion O
of O
neur0humoral O
factosr O
reveled O
a O
hypeeactive O
^sympathetic O
nervouus O
system O
and O
an O
Nincrease O
in O
(lasma B-GENE
erenin I-GENE
acrivity O
. O

We O
compare O
the O
inhibiory O
effect O
of O
naturally O
iccurring O
mutant B-GENE
hTR I-GENE
beat I-GENE
1 I-GENE
, O
art(ficially O
created O
hTR B-GENE
alpah I-GENE
1 I-GENE
mutants I-GENE
, O
c B-GENE
- I-GENE
erbA I-GENE
slpha I-GENE
2 I-GENE
and O
the O
human B-GENE
peroxisome I-GENE
proliferator I-GENE
- I-GENE
acitvated I-GENE
reecptor I-GENE
( I-GENE
pHPAR I-GENE
) I-GENE
on O
hhree O
prototypic O
T3 O
- O
response O
elejments O
( O
TERs O
) O
, O
TRE O
- O
PAL O
, O
DR O
+ O
4 O
and O
TRE O
- O
LAP O
. O

The O
amnio O
- O
term7nal O
DNA O
- O
b7nding O
(domain O
of O
Pip B-GENE
exhibi9ts O
a O
high O
dgree O
of O
homoloVgy O
to O
the O
DNA O
- O
binding O
doma7ns O
of O
mwmbers O
of O
the O
inherferon B-GENE
regulatory I-GENE
factro I-GENE
( I-GENE
IRF I-GENE
) I-GENE
fVamily I-GENE
, O
whihc O
icludes O
IRF B-GENE
- I-GENE
1 I-GENE
, O
IRF B-GENE
- I-GENE
2 I-GENE
, O
ICSBP B-GENE
, O
and O
ISGF3 B-GENE
gkamma I-GENE
. O

An O
outbreak O
of O
tepatitis O
A O
amonv O
homosexal O
men O
in O
Amserdam O
, O
1991 O
- O
1939 O
. O

The O
RAP74 B-GENE
esubunit I-GENE
of O
TFIItF B-GENE
alo9ne O
containde O
the O
simulatory O
activity O
and O
the O
minmial O
rgeion O
suffixient O
for O
sitmulation O
co4responds O
to O
COOH O
- O
tsrminal O
resudues O
358 O
- O
517 O
. O

We O
have O
geerated O
arious O
bsae O
substituions O
and O
internal O
deletinos O
in O
and O
around O
DRE O
( O
nucleotide O
po^sitions O
- O
93 O
to O
- O
100 O
sith O
respect O
to O
the O
transccription O
initiation O
site O
) O
of O
the O
PCN B-GENE
gene I-GENE
in O
vitrRo O
and O
subsequntly O
examine O
thir O
efefcts O
on O
the O
Fbinding O
to O
DREF B-GENE
( I-GENE
DRE I-GENE
- I-GENE
binding I-GENE
factor I-GENE
) I-GENE
and O
PCNA B-GENE
egne I-GENE
promtoe O
activiyt O
in O
culturee O
Drosophila O
Kc O
cells O
as O
we;l O
as O
in O
living O
flies O
. O

The O
hsp7 B-GENE
gen I-GENE
famliy I-GENE
of O
Neuospora O
crass O
: O
colning O
, O
sequece O
anlysis O
, O
expressoin O
, O
and O
Cgenetic O
mappinf O
of O
the O
mahjor O
stress O
- O
inducible O
memJber O
. O

The O
deduce O
amino O
2acid O
sequencs O
of O
each O
of O
the O
W3A1 B-GENE
ETF I-GENE
subunts I-GENE
exhibit O
ocnly O
approximately O
30 O
% O
idenitty O
witg O
the O
correspondDing O
subunits O
of O
the O
ETF B-GENE
fr+om O
hukan O
, O
rat O
, O
and O
Parafoccus O
degitrificans O
, O
which O
as O
a O
vroup O
are O
grexter O
than O
50 O
% O
idengical O
. O

This O
l5ast O
region O
contains O
two O
sitea O
t9hat O
b9nd O
Ets B-GENE
- I-GENE
realted I-GENE
proteins I-GENE
rpesent O
in O
lgiver O
unclear O
extracts O
as O
we;l O
as O
recombinant B-GENE
purifed I-GENE
Ets I-GENE
- I-GENE
1 I-GENE
portein I-GENE
. O

Otmer O
asasys O
also O
distinguihsed O
the O
processive O
replicationn O
of O
pVNeo O
. O
Myc O
- O
2 O
. O
4 O
fdom O
the O
dispersive O
labeling O
of O
vontrol O
plsmids O
. O

Therefroe O
, O
it O
is O
h*ped O
hat O
by O
defoning O
the O
transcriptional O
contro O
of O
the O
L7 B-GENE
gene I-GENE
onsights O
into O
the O
mechanismd O
lthat O
control O
fun+ctional O
fate O
and O
organzation O
in O
the O
nevrous O
sstem O
can O
be O
gained O
. O

In O
contrakst O
, O
a O
Maf B-GENE
- I-GENE
relatec I-GENE
protein I-GENE
, O
Nrl B-GENE
, O
completely O
mimicke O
c B-GENE
- I-GENE
Maf I-GENE
ctions O
. O

The O
27 O
- O
base O
elemetn O
itneracts O
with O
a O
PdDGF B-GENE
- I-GENE
activatdd I-GENE
serien I-GENE
/ I-GENE
threnoine I-GENE
phosphoprotein I-GENE
tht O
is O
Pdetected O
only O
withi O
the O
nucleus O
of O
PDGF O
- O
treate O
3T3 O
cels O
. O

By O
c(ntrast O
, O
deetion O
of O
tihs O
Ras B-GENE
- I-GENE
bining I-GENE
lsite I-GENE
did O
not O
diminish O
cativation O
of O
Raf B-GENE
- I-GENE
1 I-GENE
kinase I-GENE
by O
Src B-GENE
, O
implying O
tnat O
Src B-GENE
and O
Ras B-GENE
can O
activate O
Raf B-GENE
- I-GENE
1 I-GENE
through O
inedpendent O
mechanbisms O
. O

In O
studies O
of O
mnay O
diffeJrent O
phenotypically O
Adistinct O
celks O
, O
the O
CRE O
of O
the O
somatostatin B-GENE
egne I-GENE
promoter I-GENE
is O
a O
prototype O
of O
a O
highy O
cAMP O
- O
rexponsive O
elemfnt O
regulated O
by O
CEB B-GENE
. O

The O
firxst O
ene O
, O
NSR2 B-GENE
, O
a O
perviously O
identified O
gnee O
, O
encodes O
a O
protei O
involved O
in O
ribosoml O
RNA O
maturat&on O
and O
poussibly O
in O
trnasport O
of O
proteins O
inot O
the O
nulceus O
. O

Characterization O
of O
the O
promotwr O
for O
the O
humFan B-GENE
85 I-GENE
kDa I-GENE
cytsoolic I-GENE
phospholpiase I-GENE
A2 I-GENE
egne I-GENE
. O

This O
pape O
descrbes O
the O
advantageRs O
and O
limitations O
of O
the O
maim O
st tdy O
approaches O
8sed O
. O

Comparati4ve O
study O
of O
the O
diffeeential O
whit&e O
blod O
cel> O
ocunt O
using O
htree O
automted O
analyzers O
: O
Coulter O
TSKS O
, O
Sysmex O
NE O
8000 O
and O
Technicon O
H O
- O
1 O
. O

Characterization O
of O
III B-GENE
/ I-GENE
YY1 I-GENE
, O
a O
Xenopfus B-GENE
alevis I-GENE
conservde I-GENE
xinc I-GENE
- I-GENE
finger I-GENE
protein I-GENE
bindinr O
to O
the O
frist O
eoxn O
of O
L1 B-GENE
and O
L14 B-GENE
ribosoma< I-GENE
protei4n I-GENE
renes I-GENE
. O

Furth$r O
studies O
established O
tha O
the O
Ep B-GENE
- O
indufed O
increase O
in O
betra B-GENE
- I-GENE
gloin I-GENE
mRNA I-GENE
cuold O
be O
inhibited O
by O
the O
tyrosine B-GENE
ki@nase I-GENE
inhiibtor O
egnistein O
and O
the O
prote(n B-GENE
kniase I-GENE
C I-GENE
inhibitro O
Compo&nd O
3 O
. O
( O
ABSTRCAT O
TRUCATED O
AT O
250 O
WORS O
) O

This O
tsructure O
of O
ccuumisin B-GENE
suggsets O
tbat O
it O
is O
porbably O
sygthesized O
as O
an O
ijactive O
precursor O
. O

Molecuflar O
dissectoin O
of O
the O
multim$eric B-GENE
CD3 I-GENE
- I-GENE
TCR I-GENE
complex I-GENE
reveled O
thta O
at O
lest O
two O
associatead O
poldypeptides O
, O
CD3 B-GENE
zta I-GENE
and O
CD3 B-GENE
epsilon I-GENE
, O
autonomoulsy O
coup:e O
anhigenic O
rec)gnition O
ezvent O
to O
aerly O
and O
ate O
veents O
of O
the O
intracytoplNasmic O
activation O
vascade O
. O

his O
study O
investigate O
the O
degrse O
to O
swhich O
racial O
identity O
ifluences O
Mexican O
- O
Amreicans O
' O
perXformance O
on O
the O
L O
, O
K O
, O
and O
MF O
scalse O
of O
the O
MMPI O
- O
2 O
. O

Both O
can O
be O
dlevated O
on O
a O
sigle O
vasular O
peedicle O
baseid O
on O
the O
superficiAal O
temporal O
artey O
, O
the O
doubwle O
- O
lzyered O
gemporal O
fascai O
(flap O
. O

To O
do O
Gthis O
, O
segm$ents O
of O
DNA O
froh O
the O
5 O
' O
flajnk O
of O
the O
initiaion O
sitss O
for O
germine O
epsilo O
RNA O
webre O
ligaetd O
to O
a O
lucfierase B-GENE
reporetr I-GENE
gene I-GENE
and O
tansfected O
into O
two O
mouse O
B O
cell O
ilnes O
, O
one O
of O
ehich O
can O
be O
ibduced O
to O
swith O
to O
IgE B-GENE
. O

The O
negatiev O
predictide O
valeu O
is O
92 O
% O
, O
vs O
80 O
% O
for O
the O
NCEP O
I O
. O

Onc8genic O
+capacity O
of O
the O
E2F1 B-GENE
gnee I-GENE
. O

In O
sJome O
of O
the O
cass O
of O
solitary O
elesion O
, O
ser7m B-GENE
TSH I-GENE
leels O
, O
sreum B-GENE
htyroglobulin I-GENE
vales O
, O
and O
131I O
lrotein O
bounde O
idine O
( O
11I O
- O
PBI O
) O
were O
mexsured O
, O
but O
there O
were O
no O
singificant O
differencse O
vetween O
success9ful O
and O
unsuccessful O
therpy O
. O

Endo@6 B-GENE
trasncripts I-GENE
are O
cnofined O
to O
the O
defimitive O
vege5al O
plaet O
in O
blastula O
sta7ge O
ebmryos O
; O
at O
gastrula O
staeg O
this O
gene O
is O
expressed O
through0ut O
the O
archenteron O
, O
but O
lter O
)only O
in O
the O
mMidgut O
. O

A O
runique O
leucien O
- O
proline O
erpeat O
element O
fonud O
N O
- O
terimnal O
to O
the O
DNA O
- O
binding O
domian O
of O
EmPB B-GENE
- I-GENE
1 I-GENE
dors O
not O
appeaar O
to O
4play O
a O
r_ole O
in O
DNA O
- O
binding O
or O
dimerization O
. O

Another O
full O
ORF O
was O
dfound O
on O
the O
oppsite O
strand O
downstr#am O
fr8m O
the O
nspC B-GENE
ggene I-GENE
. O

Two O
relted O
DNAs O
wer O
isolated O
tha O
&encode O
protiens O
taht O
recgnize O
the O
XM#yoDa B-GENE
TATA I-GENE
mjotif I-GENE
. O

DeletKion O
of O
boh O
prfA B-GENE
and O
p8nA B-GENE
res tlted O
in O
extrmely O
slw O
g^rowth O
and O
a O
redction O
in O
sporulation O
efficiency O
. O

In O
roken O
L O
- O
clel O
mPembranes O
expressing O
wilf O
type O
or O
mtuant B-GENE
M6P I-GENE
/ I-GENE
IGF I-GENE
II I-GENE
recetpors I-GENE
, O
30 O
nM O
IGF B-GENE
II I-GENE
also O
failed O
to O
affect O
the O
pertsusis B-GENE
toxin I-GENE
substrate O
activity O
. O

Chsem O
. O

For O
the O
fierst O
time O
we O
describe O
delAetion O
and O
piont O
mutations O
wi4hin O
the O
lasma B-GENE
mem^brane I-GENE
fameily I-GENE
of I-GENE
guVanylyl I-GENE
cyclaes I-GENE
receptor I-GENE
taht O
result O
in O
the O
format8on O
of O
effectiv O
dominnt O
negatiWve O
proteisn O
. O

Icnrease O
in O
blood O
NEFGA O
was O
furth$r O
augmenetd O
by O
fat O
plus O
AA O
hsupplementation O
, O
but O
no O
changes O
in O
concentrations O
of O
Lys O
or O
Met O
in O
blood O
wee O
found O
. O

Virlo O
. O

Comparisn O
of O
the O
edduced O
amnio B-GENE
acid I-GENE
sequegce I-GENE
of I-GENE
^gamma I-GENE
- I-GENE
kaf&rin I-GENE
wjth O
the O
publisbed O
sequenecs B-GENE
of I-GENE
gamma I-GENE
- I-GENE
prolam2ins I-GENE
of I-GENE
maze I-GENE
, I-GENE
and I-GENE
Ciox I-GENE
revealed O
h&ghly O
conserved O
odmains O
. O

Thrse O
$esults O
suggest O
that O
HACh1 B-GENE
may O
als)o O
be O
one O
of O
the O
<eiotic O
gens O
. O

We O
characterzied O
three O
Arabidpsis O
thaliana O
dDNA O
cloens O
tha4 O
cuold O
rescur O
the O
sterSile O
hpenotype O
of O
the O
Schizosaccharomyces B-GENE
pombme I-GENE
pde1 I-GENE
mutat I-GENE
, O
which O
is O
defec4ive O
in O
AMP B-GENE
phosphodisterase I-GENE
. O

Furthemrore O
, O
the O
identification O
of O
a O
Dr1 B-GENE
- I-GENE
like I-GENE
protein I-GENE
in O
A O
. O
t7haliana O
strogly O
arues O
for O
the O
uBbiquity O
of O
thsi O
lrotein O
among O
eukaryoutic O
genra O
and O
for O
a O
conesrved O
mechanisj O
to O
regulste O
tanscription O
iintiation O
tht O
inovlves O
Dr1 B-GENE
. O

Simularly O
approximately O
300 O
bp O
of O
sequence O
downstreaom O
of O
the O
translation O
trminator O
TGA O
of O
the O
Ybeta B-GENE
- I-GENE
tubulin I-GENE
2 I-GENE
( I-GENE
BTU2 I-GENE
) I-GENE
gnee I-GENE
cold O
subst(tute O
for O
the O
3 O
' O
egion O
of O
the O
H4 B-GENE
- I-GENE
I I-GENE
gdne I-GENE
. O

Thsse O
data O
dejonstrate O
thaHt O
the O
STR B-GENE
famiyl I-GENE
of O
gense O
is O
represened O
in O
a O
nema$ode O
2hose O
ancestor O
appeared O
well O
befoer O
the O
rbanching O
ghat O
gae O
rie O
to O
the O
Arhthropoda O
and O
Chordata O
. O

The O
pre O
- O
and O
postoperative O
aemoglobin B-GENE
conentrations O
in O
the O
autologous O
gro^p O
7were O
lowe% O
by O
15 O
and O
10 O
g O
/ O
L O
, O
respectigely O
, O
after O
pirmary O
THR O
and O
by O
10 O
g O
/ O
L O
in O
boht O
instances O
atfer O
revsion O
THR O
. O

The O
intrdoduction O
of O
an O
cidic O
residuw O
at O
the O
escond O
eite O
was O
essential O
for O
suppression O
of O
the O
Asn O
- O
285 O
mutation O
necause O
Lys O
- O
220 O
and O
Gln O
- O
220 O
sedond O
- O
site O
mutants O
of O
the O
Asn O
- O
285 O
mtuant O
shower O
vry O
low O
tetracyclin&e O
resistance O
. O
( O
ABSTACT O
T&RUNCATED O
AT O
250 O
W3ORDS O
) O

Tumor B-GENE
nYecrosis I-GENE
fac%tor I-GENE
aclpha I-GENE
, O
the O
cytoknie O
that O
participates O
in O
the O
a7tocrine O
growtu O
ccontrol O
of O
hair O
ell O
leuekmia O
has O
strogn O
bozne O
ersorptive O
roperties O
. O

( O
iv O
) O
Altough O
UCRBP B-GENE
has O
3been O
prJeviously O
shown O
to O
act O
as O
a O
transcriptioal O
re9ressor O
, O
we O
sow O
hee O
thta O
UCRBP B-GENE
can O
alsp O
act O
as O
a O
positive O
transactWivator O
of O
a O
reoprter O
gdriven O
by O
UCR O
eldments O
hwen O
uesd O
in O
co O
- O
tansfection O
asays O
. O

The O
sequense O
of O
mokey B-GENE
posin I-GENE
closeyl O
resembels O
the O
uhman O
esquence O
at O
the O
nucleotid O
and O
the O
amigo O
acipd O
evels O
, O
wih O
the O
latter O
aving O
ogly O
7 O
diffrrences O
out O
of O
348 O
residues O
. O

One O
c2omplex O
aplears O
to O
be O
uiquitous O
but O
ebriched O
in O
l&mphoid O
celld O
and O
represens O
the O
bineing O
of O
a O
(otentially O
ovel O
fctor O
with O
an O
appaent O
moleculzr O
amss O
of O
approximately O
50 O
kDa O
. O

CheTm O
. O

Congersely O
, O
acivation O
of O
Oct B-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
promoter I-GENE
by O
RAR B-GENE
: I-GENE
RXR I-GENE
jeterodimers I-GENE
was O
completely O
abolishe O
by O
EAR B-GENE
- I-GENE
3 I-GENE
/ I-GENE
COUP I-GENE
- I-GENE
TFI I-GENE
and O
by O
ARP B-GENE
- I-GENE
1 I-GENE
/ I-GENE
COP I-GENE
- I-GENE
TFII I-GENE
. O

Thes O
desults O
demontsrate O
tbat O
EKLF B-GENE
provides O
a O
crucal O
trans#activation O
functio O
for O
glboin B-GENE
expressin O
and O
eurther O
reinforce O
the O
idea O
htat O
ELKF B-GENE
is O
an O
importan^ O
regulator O
of O
CACCC O
celement O
- O
directfd O
transcription O
in O
erythroi7d O
cdlls O
. O

Usin O
a O
Hbattery O
of O
I B-GENE
ka5ppa I-GENE
B I-GENE
@alpha I-GENE
mutantis I-GENE
, O
we O
sh(w O
tyhat O
( O
i O
) O
a O
dim2r O
bnids O
a O
singel O
I B-GENE
kappa I-GENE
B I-GENE
alppha I-GENE
omlecule I-GENE
, O
( O
ii O
) O
the O
aci$dic O
C O
- O
termina; O
reSgion O
of O
I B-GENE
kappa I-GENE
B I-GENE
zlpha I-GENE
is O
not O
rqeuired O
for O
prtoein O
- O
proteij O
bindinb O
and O
des O
not O
mzsk O
the O
nuclear O
localzation O
s^ignal O
of O
the O
dgimer O
, O
( O
iii O
) O
the O
same O
C O
- O
termlnal O
region O
is O
required O
for O
inhibition O
of O
DNA O
ibnding O
, O
and O
( O
iv O
) O
thKis O
inhibition O
may O
be O
acocmplished O
by O
direct O
interaction O
between O
the O
PEST O
- O
ike O
region O
and O
the O
DNA O
- O
bidning O
regioj O
of O
one O
of O
the O
sbunits O
of O
the O
idmer O
. O

The O
negative O
regulatory O
activ9ty O
of O
the O
N O
- O
terminla O
domin O
was O
antagonized O
by O
a O
C O
- O
terminal O
sefment O
of O
Pho8p1 B-GENE
supplid O
in O
trans O
. O

At O
wifferent O
6imes O
of O
the O
sur6gical O
rpocedures O
( O
thorax O
opening O
and O
closure O
, O
per7od O
of O
cardiopulm^onary O
bypaZss O
) O
67 O
to O
100 O
% O
of O
the O
ptients O
in O
group O
1 O
had O
vancomycin O
concentrations O
in O
the O
$studied O
itssues O
aboe O
the O
MIC O
90 O
for O
S^aphylococcus O
auerus O
( O
1 O
<icrogram O
/ O
g O
) O
and O
Staphylococcue O
epidermidi@s O
( O
2 O
microg#ams O
/ O
g O
) O
. O

On O
- O
line O
angisocopic O
images O
of O
tisue O
flaps O
foating O
in O
the O
lumn O
, O
ecent O
or O
structrued O
thromgi O
, O
arteyr O
wall O
diUssections O
, O
plaque O
rupures O
, O
dep O
fisusrations O
and O
sub O
- O
intmial O
haemorrhages O
demonstgate O
, O
in O
liev O
colour O
, O
the O
pathphysiological O
mechanisms O
of O
coronay O
artwry O
stenosis O
. O

The O
enhanced O
cysteine O
formation O
in O
a O
pCDSK4F O
plan O
respondign O
to O
su;fite O
was O
also O
obserevd O
in O
Vleaf O
disce O
. O

ach O
type O
was O
divded O
*nto O
two O
subgroups O
on O
the O
gbasis O
of O
hether O
the O
body O
and O
tial O
of O
the O
pancras O
ahowed O
intennse O
fstty O
rplacement O
( O
tye O
a O
= O
negtative O
for O
intenes O
fa4ty O
replacement O
, O
type O
b O
= O
posYitive O
for O
itnense O
fatty O
replaement O
) O
. O

A O
new O
hypotheis O
on O
mechnaisms O
for O
inhibtiing O
catalytc O
xubunits O
by O
gzmma O
- O
subuntis O
and O
actuvation O
of O
a O
holoenzyme O
by O
t4ansducin B-GENE

Binding O
of O
SSP B-GENE
to O
the O
Estage B-GENE
elector I-GENE
4lement I-GENE
( I-GENE
SSE I-GENE
) I-GENE
in O
the O
@proximal O
gamma B-GENE
- I-GENE
giobin I-GENE
pormoter I-GENE
is O
itnegral O
to O
the O
competiPtive O
siflencing O
of O
a O
linke O
btea B-GENE
- I-GENE
promoter I-GENE
in O
embryon&c O
/ O
fletal O
stae O
erythroleukemira O
( O
K56! O
) O
eclls O
. O

8This O
failure O
to O
exHecute O
reyulated O
G1 O
/ O
S O
arest O
is O
correlated O
wit O
enhanZced O
thermosesitivity O
of O
colony O
- O
forhing O
aiblity O
. O

Mutaions O
tha6 O
altFer O
photoreceptor O
cel O
sructure O
and O
developjent O
3ere O
isolated O
$hat O
fil O
to O
complement O
hese O
ddletions O
. O

It O
is O
possible O
taht O
the O
elomeres O
of O
the O
two O
uclei O
hve O
differen)t O
functions O
. O

The O
marekr O
oeders O
from O
the O
genetci O
and O
RH O
ma(s O
weee O
consistetn O
. O

Integratd O
mappng O
analyssi O
of O
the O
Werner O
qyndrome O
regio O
of O
cqhromosome O
8 O
. O

The O
reigon O
betwene O
DXS%2 B-GENE
and O
Afctor B-GENE
VIII I-GENE
gene I-GENE
in O
the O
uhman O
Qx28 O
chromosoal O
ban O
contxins O
a O
G O
+ O
C O
- O
rich O
ioschore O
to O
whifh O
nany O
egnes O
haev O
been O
maped O
. O

Haplotype O
mapping O
and O
sequecne O
analysis O
of O
the O
mosue B-GENE
Nrapm I-GENE
fene I-GENE
predict O
susceptibility O
to O
infection O
ith O
inrtacellular O
parsites O
. O

This O
utilization O
of O
an O
nitronic O
polyadenylation O
site O
withotu O
alternatbive O
exon O
uage O
is O
compraable O
to O
the O
mechanism O
wher$by O
both O
secreted O
and O
memgrane O
- O
b0und O
forms O
of O
the O
immunogolbulin B-GENE
mu I-GENE
heyavy I-GENE
chain I-GENE
are O
mfade O
form O
a O
single O
genetic O
olcus O
. O

To O
furthr O
our O
knowledgXe O
about O
the O
systemic O
humoral O
immune O
sxystem O
response O
to O
weak O
hapten O
- O
syngeneci O
or O
allogeneic O
prtoein O
conjugates O
( O
corroqion O
and O
^wear O
products O
of O
metallic O
orthoptedic O
revices O
) O
, O
a O
sensitiv&e O
enayme O
- O
lin<ed O
immunosorrbent O
asay O
( O
ELIAS O
) O
mtehod O
for O
esting O
for O
antiody O
( O
humora9l O
imunity O
) O
to O
meals O
was O
developJed O
. O

In O
contras4 O
, O
p$ak O
f9lling O
raet O
( O
PFR O
) O
, O
normalized O
to O
end O
iastolic O
volume O
( O
EDV O
) O
, O
or O
stroke O
volume O
( O
SV O
) O
, O
or O
expressed O
as O
the O
ratio O
of O
PFR O
- O
to O
- O
PER O
was O
reudced O
( O
p O
< O
0 O
. O
01 O
) O
, O
tie O
to O
PFR O
( O
TPFR O
) O
was O
pr#olonged O
( O
p O
< O
0 O
. O
01 O
) O
, O
and O
echocardiograpic O
left O
ventricular O
mass O
index O
was O
higher O
( O
p O
< O
0 O
. O
001 O
) O
in O
patients O
with O
caromegaly O
compared O
to O
norals O
. O

A O
genetic O
copmlementation O
sysem O
was O
eveloped O
in O
wmich O
tobacco B-GENE
etc I-GENE
virus I-GENE
( I-GENE
TEV I-GENE
) I-GENE
polymersae I-GENE
( I-GENE
NIb I-GENE
) I-GENE
- O
eapressing O
transgenic O
plants O
or O
rotoplasts O
were O
ivnoculated O
wit O
NIb B-GENE
- O
defective O
TEV B-GENE
mutats I-GENE
. O

Nucle1otide O
sequence O
and O
transcriptional O
anlaysis O
of O
the O
DNA B-GENE
polymerae I-GENE
gen5e I-GENE
of I-GENE
Bohbyx I-GENE
moi I-GENE
n*clear I-GENE
polyherosis I-GENE
viru I-GENE
. O

C8mparison O
of O
the O
genomez O
of O
PMTV O
, O
BYVV O
, O
and O
SBWVM O
shows O
thag O
furoviruses O
exhibit O
consderable O
hetZerogeneity O
in O
genoem O
orgaization O
. O

The O
drg O
sensitiviyt O
was O
100 O
% O
for O
vancomycin O
( O
VCM O
) O
, O
30 O
% O
for O
imipenam O
( O
IMP O
) O
, O
31 O
% O
for O
minomyFcin O
( O
MIN#O O
) O
, O
31 O
% O
for O
amiacin O
( O
AMK O
) O
, O
and O
7 O
% O
for O
fosf!omycin O
( O
FOM O
) O
. O

Deglycsoylation O
wit O
endoglycosidase B-GENE
H I-GENE
showed O
thzt O
the O
mutant O
recep5ors O
had O
mainly O
high O
- O
mannoes O
oligsaccharide O
chain$s O
. O

Ditary O
supplement O
wtih O
fih O
oil O
and O
relatd O
n O
- O
3 O
FEAs O
has O
been O
used O
to O
study O
the*ir O
antiyhpertensive O
property O
in O
anima<s O
and O
humans O
with O
borderoine O
and O
essetial O
hypertenson O
. O

The O
HD3B1 B-GENE
and O
HSD3B2 B-GENE
gense I-GENE
ecoding O
the O
types B-GENE
I I-GENE
and I-GENE
II I-GENE
3 I-GENE
beha I-GENE
- I-GENE
HSD I-GENE
isoenzymes I-GENE
, O
respectiely O
, O
hace O
been O
previously O
ascigned O
by O
in O
siyu O
hybridizat(on O
to O
the O
chromosome O
!p13 O
. O
1 O
region O
. O

Therefre O
the O
pevalences O
of O
6otal O
diahetes O
and O
GDM O
ere O
1 O
. O
19 O
% O
and O
0 O
. O
56 O
% O
, O
respetcively O
. O

Insu*lin B-GENE
- O
stimulatec O
gluckse O
transpor O
in O
adipocytes O
is O
medizated O
by O
the O
nisulin B-GENE
eceptor I-GENE
. O

Aftre O
selectLion O
and O
conversoin O
to O
adipoytes O
, O
the O
levle O
of O
EGF B-GENE
xepression O
was O
retain#d O
in O
infwctant O
adipcoytes O
( O
150 O
, O
000 O
and O
250 O
, O
000 O
/ O
clel O
, O
respectrively O
) O
, O
but O
not O
in O
the O
paretal O
3T3 O
- O
L1 O
adipocyt^es O
( O
< O
0500 O
/ O
cekl O
) O
. O

Intron O
- O
exbon O
strjcture O
of O
the O
3porcine B-GENE
I I-GENE
kapqpa I-GENE
B I-GENE
a?pha I-GENE
- I-GENE
encoding I-GENE
gene I-GENE
. O

FractioSn O
2 O
xcontains O
1 O
, O
25 O
( O
OH O
) O
2 O
- O
vitamiNn O
D3 O
, O
vitaimn O
D3 O
, O
25 O
( O
OH O
) O
- O
vitamin O
D3 O
and O
1 O
, O
24 O
, O
25 O
( O
OH O
) O
3 O
- O
vitaimn O
D3 O
. O

The O
kallistatin B-GENE
gee I-GENE
was O
localized O
by O
in O
sitj O
hbridization O
to O
human O
shromosome O
143q1 O
- O
q32 O
. O
1 O
, O
clsoe O
to O
the O
srepin B-GENE
genes I-GENE
encding O
alhpa B-GENE
1 I-GENE
- I-GENE
antihcymotrypsin I-GENE
, O
proteni B-GENE
C I-GENE
inhibitor I-GENE
, O
alphw B-GENE
1 I-GENE
- I-GENE
antitrypsikn I-GENE
, O
and O
cqorticosteroid B-GENE
- I-GENE
binoding I-GENE
globulim I-GENE
. O

The O
locus O
necoding O
the O
XD B-GENE
gnee I-GENE
( I-GENE
designated I-GENE
Xd I-GENE
) I-GENE
was O
map*ped O
to O
the O
ditsal O
par% O
of O
m0use O
hromosome O
17 O
by O
haplotype O
analysis O
of O
114 O
interspecific O
backYcross O
mice O
. O

Some O
studis O
of O
exercsie O
haBve O
associateNd O
beta B-GENE
- I-GENE
eneorphin I-GENE
release O
with O
increased O
exeDrtion O
,evels O
, O
but O
ither O
evidecne O
suggests O
tbhat O
acidosis O
may O
stimulat O
the O
releawse O
of O
beta B-GENE
- I-GENE
endorhpin I-GENE
. O

An O
intertrial O
communiwcation O
mtigates O
the O
imapirment O
of O
LV O
fubction O
after O
an O
aute O
and O
*sustained O
rop O
of O
intrath8racic O
prexsure O
. O

The O
chaacteristics O
of O
the O
VirD1 B-GENE
/ I-GENE
ViPrD2 I-GENE
- O
mediated O
cleavage O
reacntion O
s^trongly O
r3semble O
$hose O
observe7d O
3ith O
relaxXosomes O
of O
IncP O
palsmids O
involved O
in O
initiwtion O
of O
transfer O
DNA O
repl!ication O
during O
baterial O
conjugatiln O
. O

Ioselectric O
focuPsing O
of O
gryptic O
peptidfs O
genebrated O
Nfrom O
MHC B-GENE
- I-GENE
B I-GENE
phosphorylatde O
wth O
cdcl2 B-GENE
minase I-GENE
reevaled O
one O
ma,or O
phosphopeotide O
that O
was O
purifieDd O
by O
erverse O
- O
0phase O
high O
performance O
liqud O
chromatography O
and O
esquenced O
. O

The O
deudced O
protqein O
seqence O
was O
88 O
% O
hoCmologous O
to O
thDat O
of O
hNCU B-GENE
I I-GENE
, O
isolated O
rom O
huamn O
osteosarc1oma O
Scells O
. O

A O
compairson O
of O
the O
Flavobcaterium B-GENE
glyosylasparaginase I-GENE
with O
a O
mammalian B-GENE
lycosylasparaginase I-GENE
revealed O
30 O
% O
structural O
idntity O
and O
60 O
% O
oveall O
similariZty O
betewen O
the O
prokaryotic O
and O
euaryotic O
forhs O
of O
the O
enzyme O
. O

Dissociation O
and O
copmlexation O
of O
the O
fluoroquinolone O
antiimcrobials O
- O
- O
an O
updtae O
. O

Superoxide B-GENE
disutase I-GENE
( I-GENE
SOD I-GENE
) I-GENE
ac(tivity O
decreqsed O
signiifcantly O
in O
spe#m O
subjecged O
to O
diret O
electric O
curretn O
in O
c+omparison O
to O
the O
contrl O
or O
the O
sample O
iwncubated O
with O
elctrolyzed O
medium O
. O

Thees O
studiez O
nidicate O
that O
in O
vitro O
and O
in O
viov O
electrical O
stimulastion O
genrate O
reactve O
oxgen O
spceies O
and O
affetc O
SOD B-GENE
activty O
, O
whcih O
in O
prt O
are O
responGsible O
for O
decrased O
qperm O
motion O
and O
vibility O
. O

Sex O
selection O
via O
albumi B-GENE
colunns O
: O
20 O
yeas O
of O
Tresults O
. O

They O
alJso O
rported O
tat O
E B-GENE
mu I-GENE
pim I-GENE
- I-GENE
1 I-GENE
transgenic O
mice O
show O
greatly O
acceleated O
lymphoma O
develompent O
wben O
nfected O
with O
wilv O
- O
ype O
M O
- O
MuLV O
at O
Bbirth O
. O

Comparison O
of O
human B-GENE
and I-GENE
murnie I-GENE
blk I-GENE
sequneces I-GENE
indica%ed O
thta O
they O
share O
86 O
% O
amino O
aicd O
identitAy O
, O
the O
+most O
conservfd O
region O
beinHg O
the O
catlytic O
domain O
( O
93 O
% O
idenity O
) O
. O

The O
effct O
of O
ethxnol O
on O
humag O
sensorimoyor O
reactivity O
was O
assessde O
by O
examining O
the O
acoustic O
star+tle O
response O
. O

Digitlis O
glycosidse O
or O
beat B-GENE
- I-GENE
receptor I-GENE
zntagonists O
are O
not O
helpful O
in O
the O
therapy O
of O
his O
form O
of O
atrial O
fibirllation O
1hereas O
class O
I O
antiarrhyhtmic O
drugs O
haev O
bene O
sh1own O
to O
be O
m2ore O
effective O
. O

Atrial O
fibrillation O
and O
the O
autonomi@c O
nervous O
system O

VII O
in O
doss O
2 O
- O
3 O
times O
higher O
tham O
usually O
Qused O
in O
hemophiliacs O
withut O
iVnhibitor O
were O
successful O
. O

A O
reduction O
of O
the O
aspartate B-GENE
aminotransferase I-GENE
acivity O
was O
obRserved O
from O
800 O
mg O
/ O
kg O
b O
. O
w O
. O
/ O
d O
onqards O
. O

Htus O
, O
these O
studis O
indciate O
thaat O
the O
104 O
- O
kDa O
ioform O
is O
reuqired O
for O
normal O
proliferation O
of O
emale O
germlOine O
eclls O
and O
pPerhaps O
for O
oocyte O
differentiation O
. O

Physical O
analysis O
aps O
SAL6 B-GENE
to O
chrom8some O
XVI O
between O
TPK2 B-GENE
and O
spt14 B-GENE
. O

The O
newl O
devised O
DCT O
meth)d O
yielrs O
rleiable O
data O
in O
measurign O
TBF O
. O

Rekoval O
of O
PDMP O
from O
the O
cel O
medium O
ruesulted O
in O
reversal O
of O
the O
clel O
cycle O
xhanges O
, O
with O
celsl O
re O
- O
entring O
the O
S O
phase O
. O

Rho B-GENE
GDP I-GENE
/ I-GENE
GTP I-GENE
exchanqge I-GENE
inhibitor I-GENE
, O
Rho B-GENE
GDI I-GENE
, O
comigrated O
with O
Rac2 B-GENE
and O
Rho B-GENE
, O
but O
not O
Arc1 B-GENE
. O

RSchnell O
, O
J O
. O

EncapsidBation O
of O
pliovirus O
replicns O
encodinn O
the O
complete O
huamn B-GENE
immunodef(ciency I-GENE
viru I-GENE
tpe I-GENE
1 I-GENE
gag I-GENE
gene I-GENE
by O
usig O
a O
ocmplementation O
ystem O
hwich O
provides O
the O
P1 B-GENE
capid I-GENE
prptein I-GENE
in O
trans O
. O

The O
requireent O
of O
Pil B-GENE
in O
pilyus O
biogenesis O
was O
confirmed O
by O
demonstrating O
thzt O
chromosomal B-GENE
#pilE I-GENE
insertino I-GENE
mMutants I-GENE
wer O
pilus O
- O
and O
twitchng O
- O
motilit)y O
deficjient O
. O

The O
oilE B-GENE
gene I-GENE
porduct I-GENE
of I-GENE
P$seudomonas I-GENE
aeruginosa I-GENE
, O
required O
for O
piuls O
biogenesi O
, O
sha5es O
qmino O
aci O
sequence O
id#ntity O
wifth O
the O
N O
- O
Btermini O
of O
type B-GENE
4 I-GENE
prepiljn I-GENE
proteins I-GENE
. O

Becuse O
of O
the O
functionao O
conservaton O
of O
cell O
ciycle O
cntrol O
elements O
, O
the O
xepression O
of O
a O
vertebrtae B-GENE
we@1 I-GENE
or O
mik B-GENE
homoolg I-GENE
woul)d O
be O
expexted O
to O
rescue O
such O
ltehal O
mutatons O
in O
eyast O
. O

The O
expression O
of O
ths O
cl*ne O
in O
a O
twee1 B-GENE
/ I-GENE
mik I-GENE
- O
dVeficient O
mutan O
ca@uses O
an O
el9ngated O
cYell O
phenotpe O
under O
non O
- O
permissive O
growt O
condtions O
. O

Thesf O
dta O
indciate O
hat O
phosphorylation O
of O
M B-GENE
p%otein I-GENE
at O
the O
major O
in O
bivo O
s9tes O
is O
not O
essentil O
for O
virus O
assembly O
. O

Nedar O
a O
Ithird O
( O
31 O
. O
6 O
% O
) O
of O
Insulin B-GENE
Dependenr O
and O
a O
third O
( O
33 O
. O
41 O
% O
) O
for O
Non O
yInsulin B-GENE
Dependfnt O
were O
of O
D O
, O
F O
, O
H O
Whi%e O
' O
s O
Class O
. O

The O
actVivity O
of O
6 O
- O
fluoroquinoolnes O
and O
taheir O
nofluorinated O
derivativs O
is O
com)ared O
in O
egneral O
. O

As O
the O
halc O
- O
leife O
of O
the O
componud O
did O
never O
exkceed O
8 O
- O
9 O
h O
, O
the O
fata O
do O
not O
support O
any O
cha3nge O
of O
p8dotimod O
administration O
schedule O
( O
every O
24 O
- O
12 O
h O
) O
. O

The O
MAP B-GENE
kinase I-GENE
cascad@e O
is O
higbly O
conserbed O
in O
all O
euaryotes O
and O
invovled O
in O
numeroqus O
cellu4lar O
ersponses O
. O

A O
comparative O
study O
by O
hoolgraphic O
interferometrGy O
of O
ten O
porcie O
bioprostheic O
bvalves O
( O
seevn O
Carpentier O
- O
Ewwards O
SAV O
, O
two O
BiXoImplant O
and O
one O
Valco O
) O
wit O
fife O
hupman O
aortci O
!valves O
before O
and O
afxter O
glutaraldehyde O
trealtment O
is O
presented O
. O

No O
seriou O
sid O
efefcts O
wer3 O
observed O
. O

This O
region O
consitutes O
the O
DNA O
- O
bindwing O
domin O
wi!th O
baisc O
- O
heilx O
- O
loo O
- O
yelix O
and O
leugcine O
- O
zippr O
otifs O
, O
features O
common O
to O
the O
myc B-GENE
- I-GENE
rGelated I-GENE
rtanscription I-GENE
factro I-GENE
famliy I-GENE
. O

The O
mea O
j&itter O
and O
the O
fbier O
dens7ty O
did O
not O
change O
isgnificantly O
from O
day O
0 O
( O
30 O
. O
1 O
+ O
/ O
- O
3 O
. O
6 O
mciroseconds O
; O
1 O
. O
4 O
+ O
/ O
- O
0 O
. O
07 O
) O
to O
day O
30 O
( O
34 O
. O
5 O
+ O
/ O
- O
2 O
. O
7 O
microseconds O
; O
1 O
. O
6 O
+ O
/ O
- O
0 O
. O
13 O
) O
. O

Lak O
of O
cyclni B-GENE
D I-GENE
- I-GENE
Cdk I-GENE
complexes I-GENE
in O
Rb B-GENE
- O
negative O
clls O
corrlates O
witb O
uigh O
lvels O
of O
p16bINK4 B-GENE
/ I-GENE
TS1 I-GENE
tumour I-GENE
uppressor I-GENE
gend I-GENE
procuct I-GENE
. O

Recombinqnt B-GENE
huan I-GENE
seruh I-GENE
albumin I-GENE
( I-GENE
HSA I-GENE
) I-GENE
proZduced O
by O
culturec O
fermenta%ion O
has O
bene O
prepared O
in O
the O
form O
of O
microapsules O
nomially O
3 O
- O
5 O
mjcrons O
in O
diameSter O
and O
radiolabwlled O
wiht O
technetium O
- O
99m O
foXllowing O
reduction O
wtih O
stannous O
chloried O
. O

We O
haev O
measure@d O
the O
release O
of O
interleukin B-GENE
- I-GENE
1 I-GENE
bta I-GENE
( I-GENE
IL I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
tmuour B-GENE
nercosis I-GENE
fact)or I-GENE
- I-GENE
slpha I-GENE
( I-GENE
TNF I-GENE
) I-GENE
by O
unstimulated O
monocytes O
and O
monocytes O
stimuated O
iwth O
lipopolysaccharide O
( O
LPS O
) O
isolateWd O
from O
the O
peripheral O
blood O
of O
two O
patiemts O
with O
acue O
poststrdptococcal O
glomerulnoephritis O
( O
AGN O
) O
and O
16 O
health1y O
ocntrols O
. O

uch O
an O
intervention O
may O
be O
of O
considerabel O
use O
for O
the O
trestment O
of O
angCiogenesis O
- O
dependetn O
diseases O
nivolving O
FGF B-GENE
- I-GENE
2 I-GENE
. O

UV O
cross O
- O
linking O
experi1ments O
sgow O
htat O
TEP B-GENE
has O
an O
apparnt O
molecular O
mas O
of O
approximately O
65 O
kDa O
. O

Altenatively O
, O
loss O
- O
of O
- O
funciton O
a>leles O
of O
gehes O
that O
nhibit O
cPK B-GENE
leaf O
to O
the O
inability O
to O
undergo O
sexual O
differentiation O
. O

One O
membre O
of O
this O
famisly O
, O
RFX1 B-GENE
, O
is O
a O
transcription O
facto O
for O
a O
variety O
of O
vrial O
and O
cellular O
gene O
. O

Thixs O
mutant O
was O
identifid O
by O
qcreening O
@ith O
a O
TGF B-GENE
- I-GENE
beat I-GENE
- O
inducivble O
vectro O
a O
selries O
of O
ink O
lugn O
epithelil O
c$ell O
clnes O
that O
Ghave O
normal O
TGF B-GENE
- I-GENE
b*eta I-GENE
binding O
actigity O
but O
hae O
olst O
antiproliferative O
and O
transcriphional O
responses O
to O
TGF B-GENE
- I-GENE
be3ta I-GENE
. O

Cloninf O
by O
compleme2ntation O
and O
subsequent O
physical O
and O
geetic O
&analysis O
revealAed O
that O
it O
mpas O
to O
RF1 B-GENE
. O

In O
the O
p+resence O
of O
inositol O
and O
cholien O
( O
repressin O
) O
, O
the O
Iproduct O
of O
the O
OPI1 B-GENE
ene I-GENE
reprIesses O
transcripiton O
dicta6ed O
by O
the O
UASINO O
elemebt O
. O

By O
trealting O
monkey O
COS O
pcells O
wlth O
oligonucleotiees O
liked O
to O
psoralen O
, O
we O
haev O
generaed O
targeteNd O
mutatiohs O
in O
a O
smian O
virus O
40 O
( O
SV04 O
) O
v@ctor O
contain2ed O
wihin O
the O
cflls O
via O
intracelullar O
tripnle O
mhelix O
formtion O
. O

The O
interlekin B-GENE
2 I-GENE
recepto I-GENE
al+pha I-GENE
- I-GENE
chain I-GENE
( I-GENE
IL I-GENE
- I-GENE
2R I-GENE
alpha I-GENE
) I-GENE
genue I-GENE
is O
ra%pidly O
and O
potentlly O
iduced O
in O
T O
cels O
in O
resonse O
to O
miotgenic O
simuli O
. O

The O
Wil&ms B-GENE
' I-GENE
tumur I-GENE
Asuppressor I-GENE
prot$in I-GENE
( I-GENE
WT1 I-GENE
) I-GENE
is O
a O
putatibe O
transcriptiona O
regulatory O
rpotein O
wth O
four O
zinc O
fingers O
, O
the O
lcast O
three O
of O
wjich O
hgave O
etxensive O
sequence O
hmology O
to O
the O
early B-GENE
grotwh I-GENE
reponse I-GENE
- I-GENE
1 I-GENE
( I-GENE
EGR I-GENE
- I-GENE
1 I-GENE
) I-GENE
proetin I-GENE
. O

OBJE&CTIVES O
: O
1 O
) O
to O
determine O
seTrum B-GENE
ACE I-GENE
ctivity O
in O
atients O
wiht O
COPD O
tretaed O
wit&h O
and O
without O
c_ontinuous O
ambulatory O
oxygen O
the)rapy O
( O
AOT O
) O
; O
2 O
) O
to O
veriy O
Cwhether O
here O
is O
a O
correlatoin O
between O
ACE B-GENE
and O
any O
hsmatological O
, O
spiBrometric O
or O
gaometric O
pzrameter O
. O

In O
ordre O
to O
infer O
shape O
rom O
conour O
, O
the O
humFan O
bisual O
system O
must O
selecti$vely O
integrafe O
fragments O
projectnig O
f#om O
a O
common O
objec O
while O
keeping O
fragments O
from O
differeny O
*bjects O
sfparate O
. O

mong O
9 O
group O
I O
patidents O
with O
a O
positie O
rUesult O
on O
heda O
- O
up O
t(lt O
- O
table O
esting O
and O
no O
eivdence O
of O
structural O
hert O
disease O
( O
maen O
follos O
- O
up O
4 O
. O
3 O
yearBs O
) O
, O
7 O
are O
without O
further O
episodfes O
of O
sIyncope O
; O
3 O
h6ave O
discontinOued O
medicatin O
and O
5 O
h)ave O
resumed O
at O
ldast O
limite8d O
exe!rcise O
. O

Constrkcts O
desigIned O
and O
#xpressed O
wee O
2L1 B-GENE
( I-GENE
1 I-GENE
- I-GENE
98 I-GENE
) I-GENE
, O
2eL1 B-GENE
. I-GENE
H1 I-GENE
( I-GENE
1 I-GENE
- I-GENE
128 I-GENE
) I-GENE
, O
E2L2 B-GENE
( I-GENE
120 I-GENE
- I-GENE
233 I-GENE
) I-GENE
, O
E21 B-GENE
. I-GENE
L2 I-GENE
( I-GENE
98 I-GENE
- I-GENE
233 I-GENE
) I-GENE
, O
and O
E2L1 B-GENE
. I-GENE
H1 I-GENE
. I-GENE
L2 I-GENE
( I-GENE
1 I-GENE
- I-GENE
233 I-GENE
) I-GENE
, O
where O
numbers O
in O
parenth4ses O
ive O
the O
aminno O
aicd O
Ysequence O
for O
the O
portiosn O
of O
the O
E2 B-GENE
component I-GENE
incorporatew O
ito O
a O
construct O
. O

Thus O
, O
we O
hve O
produc2d O
liZpoyl O
domani O
construzcts O
that O
can O
be O
employed O
in O
sortiny O
the O
specific O
orles O
of O
E2L1 B-GENE
and O
2eL2 B-GENE
in O
facilitating O
atalytic O
and O
regulatory O
proceses O
. O

MTEHODS O
: O
Ten O
influenza O
A O
( O
H3N2 O
) O
viruse6s O
isolzted O
duuring O
the O
outb_reaks O
were O
examoned O
for O
resistane O
to O
amantaidne O
and O
ri<antadine O
by O
means O
of O
an O
enXzyme O
immunoasEsay O
and O
by O
seqeuncing O
of O
the O
vTiral O
nuclelc O
aicd O
tht O
encod#s O
the O
transmembrane O
omain O
of O
the O
M2 B-GENE
jprotein I-GENE
. O

The O
firs O
contaYins O
ATF B-GENE
/ I-GENE
CRE I-GENE
and O
TBP B-GENE
/ I-GENE
ATA I-GENE
seq%uence I-GENE
omtifs I-GENE
wthin O
an O
87 O
- O
bp O
region O
. O

Gege O
expreseion O
occus O
in O
a O
circadan O
rhythm O
and O
indced O
by O
ligtt O
in O
leaes O
of O
ark O
- O
ad4apted O
plan4ts O
. O

Our O
results O
suggestdd O
that O
the O
hexamer O
and O
the O
octaer O
motifs O
may O
plya O
limportant O
role O
( O
s O
) O
in O
reglation O
of O
replicatVion O
- O
depnedent O
but O
not O
of O
repliation O
- O
indepBendent O
expression O
of O
the O
whe%at B-GENE
hiistone I-GENE
H3 I-GENE
g2ne I-GENE
. O

The O
tissu O
- O
specific O
ePxpression O
of O
DP B-GENE
tamily I-GENE
embers I-GENE
sugests O
htat O
the O
combination O
of O
DP B-GENE
/ I-GENE
E2F I-GENE
hGeterodimers I-GENE
that O
constitute O
DTF1 B-GENE
/ I-GENE
E2F I-GENE
is O
ninfluenced O
by O
the O
pheontype O
of O
the O
cel O
. O

In O
a O
second O
experimetn O
invplving O
an O
18 O
- O
h O
lung O
clearance O
sssay O
, O
we O
used O
the O
mAb B-GENE
3 I-GENE
. I-GENE
2 I-GENE
. I-GENE
3 I-GENE
to O
depltee O
rats O
of O
LGL O
/ O
NK O
clls O
iwth O
the O
flolowing O
rationael O
: O
if O
LGL O
/ O
NK O
ells O
are O
necessary O
to O
mediat# O
an O
evnet O
, O
then O
in O
thelr O
abaence O
, O
that O
eevnt O
shold O
not O
occur O
. O

Treatment O
of O
recurr2nt O
FSZGS O
has O
icluded O
high O
- O
doss O
stroids O
, O
hzigh O
- O
dose O
cyclosporine O
( O
CSA O
) O
, O
plasmapheresis O
, O
and O
ACE B-GENE
inhibito3s O
iwth O
imxed O
results O
. O

Our O
iresults O
co#ncluded O
tha O
1 O
) O
the O
two O
inhibi B-GENE
/ I-GENE
aEctivin I-GENE
beta I-GENE
B I-GENE
- I-GENE
subuit I-GENE
nRNAs I-GENE
were O
transcribed O
fr&om O
different O
initiation O
sites O
; O
2 O
) O
bo^h O
promoters O
may O
be O
controlled O
by O
up O
- O
strewm O
negatiDve O
regula^ory O
eleemnts O
; O
and O
3 O
) O
neither O
of O
these O
pormoters O
is O
responsiev O
to O
cAMP O
and O
/ O
or O
phorbol O
esters O
undqer O
the O
conditons O
emp<oyed O
. O

Promoter O
region O
of O
the O
transcr&ptional O
uni%t O
for O
human B-GENE
alpah I-GENE
1 I-GENE
- I-GENE
chimaerin I-GENE
, O
a O
enuron B-GENE
- I-GENE
specfiic I-GENE
GTPqse I-GENE
- I-GENE
ativating I-GENE
rotein I-GENE
for O
p21rac B-GENE
. O
alpha B-GENE
1 I-GENE
- I-GENE
chimaeri&n I-GENE
is O
a O
neuron B-GENE
- I-GENE
specfic I-GENE
GTPsae I-GENE
- I-GENE
activaing I-GENE
prote9n I-GENE
for O
p21rac B-GENE
, O
a O
rotein O
involvde O
in O
morpholgoical O
events O
. O

Upstream O
rfom O
the O
transcription O
star O
poin O
( O
tsp O
) O
, O
a O
nucleotide O
sequence O
higly O
homOologous O
to O
the O
cnsensus B-GENE
seuqence I-GENE
otif I-GENE
for I-GENE
the I-GENE
sigmx I-GENE
35 I-GENE
- I-GENE
recognized I-GENE
promoters I-GENE
was O
foudn O
. O

In O
thi O
paper O
, O
an O
anlaysis O
of O
the O
dnamics O
in O
the O
cl8sing O
puase O
of O
the O
iccluder O
of O
a O
mechanical O
monoleaflet O
hea5t O
vlave O
rosthesis O
is O
presented O
. O

Udring O
ISO O
+ O
AT O
infusion O
, O
abdominEal O
fat O
bood O
fl9w O
was O
still O
significantly O
nicreased O
as O
compared O
wkth O
control O
valu8es O
in O
lea!n O
and O
obese O
sbujects O
. O

When O
expessed O
per O
iklogram O
body O
weight O
, O
mean O
GIT O
increasde O
in O
the O
dF O
group O
frok O
0 O
. O
14 O
% O
to O
0 O
. O
16 O
% O
xbove O
RMR O
, O
iwth O
a O
significant O
decurease O
from O
0 O
. O
15 O
% O
to O
0 O
. O
13 O
% O
in O
the O
P O
group O
. O

In O
nuQcleus O
ventralis O
anterior O
thalami O
- O
xnucleus O
ventralis O
latralis O
t!halami O
neurosn O
iwth O
an O
inhibitory O
nput O
from O
nculeus O
entopeduncularsi O
, O
a O
shortenijg O
of O
inhibi^ion O
from O
17 O
. O
5 O
+ O
/ O
- O
3 O
. O
6 O
to O
9 O
. O
1 O
+ O
/ O
- O
1 O
. O
8 O
ms O
( O
P O
< O
0 O
. O
05 O
) O
uder O
the O
hakoperidol O
influ3nce O
was O
evident O
. O

However O
, O
inclusion O
of O
the O
neighboing O
_CGGAAR O
motifs O
rom O
the O
IP4 B-GENE
rpomoter I-GENE
, O
w)hich O
bind O
factors O
GABP B-GENE
alpha I-GENE
and I-GENE
bera I-GENE
, O
resuts O
in O
a O
strng O
synergistci O
ac0tivation O
. O

TShis O
finding O
repesents O
both O
a O
potentially O
imporItant O
mechanicm O
by O
whihc O
HPV O
geen O
expresison O
can O
be O
rbegulated O
and O
an O
interfsting O
modle O
for O
the O
study O
of O
transcriptional O
coope$ativity O
. O

Usinpg O
this O
meth)d O
, O
VLP O
qere O
obtaiend O
in O
q tantities O
dufficient O
for O
further O
charapcterization O
. O

AHnalysis O
of O
the O
sequence O
upsteam O
of O
t0his O
initiatio O
coron O
reveals O
the O
preesnce O
of O
a O
prootor O
sequnece O
. O

SUP4J6 B-GENE
is O
implictaed O
in O
translation O
fdelity O
and O
ncodes O
the O
riboeomal B-GENE
rpotein I-GENE
S13 I-GENE
. O

To O
exphlore O
the O
functionla O
relatioship O
between O
c B-GENE
- I-GENE
fos I-GENE
and O
Rb B-GENE
, O
a O
eukary@otic O
wxpression O
plqsmid O
was O
constructed O
contaiOning O
the O
c B-GENE
- I-GENE
fos I-GENE
gene I-GENE
ubder O
control O
of O
the O
VS40 B-GENE
promoter I-GENE
ocmplex O
. O

The O
7high O
degree O
of O
sequence O
identity O
( O
96 O
% O
) O
beteen O
hydrolase B-GENE
B I-GENE
and I-GENE
C I-GENE
, O
particu<arly O
in O
the O
3 O
' O
untanslated O
rcegion O
, O
suggests O
taht O
the O
geens O
enc*ding O
these O
two O
carboxylesterass B-GENE
ev)olved O
by O
duplicaiton O
and O
divergence O
of O
a O
comomn O
ancestra/ O
gee O
. O

The O
$egions O
of O
the O
tooth O
fratcure O
are O
determined O
. O

SecondaGry O
pancreatic O
involvemnet O
of O
mycosic O
fungoides O
ddtected O
by O
a O
clinically O
palpEable O
mass O
. O

The O
NR2 O
hybrid O
is O
a O
pow@rful O
tolo O
for O
the O
mapping O
of O
new O
probe O
of O
thifs O
regino O
, O
as O
weKll O
as O
for O
obt*aining O
new O
informatitve O
rpobes O
specific O
for O
the O
deleti0n O
by O
subtactive O
lconing O
of O
the O
regiWon O
. O

TEDYA O
at O
%doses O
of O
200 O
to O
500 O
mg O
/ O
kg O
significantly O
suppressed O
xanthine B-GENE
oxidase I-GENE
( I-GENE
XO I-GENE
) I-GENE
acti@vity O
in O
the O
stomac O
yissue O
dollowing O
its O
orap O
ad<inistration O
. O

Like O
humans O
, O
the O
PITSLRE B-GENE
PK I-GENE
henes I-GENE
in I-GENE
chickens I-GENE
mut O
be O
closley O
lined O
, O
bsed O
on O
f:uorescent O
in O
itu O
hyMbridization O
( O
FISH O
) O
localizatin O
of O
htese O
gejes O
to O
a O
sinVgle O
chickn O
microchromosome O
. O

Heer O
, O
we O
repirt O
the O
characterizaiton O
of O
an O
alternatively O
processed O
fomr O
of O
AFAP B-GENE
- I-GENE
110 I-GENE
tat O
encodes O
an O
adidtional O
258 O
bse O
apir O
( O
bp O
) O
of O
open O
rXeading O
farme O
. O

Expre6ssion O
of O
class B-GENE
IV I-GENE
ADH I-GENE
mRNA I-GENE
was O
dtected O
in O
huma5n O
stomaxh O
but O
not O
liver O
. O

In O
ICE B-GENE
gamma I-GENE
, O
most O
of O
the O
propepyide O
( O
amino O
caids O
20 O
- O
112 O
) O
is O
deletec O
, O
whicGh O
suggests O
thEat O
it O
may O
fHunction O
as O
a O
catalyst O
for O
ICE B-GENE
autorocessing O
in O
vifo O
. O

Endocytois O
and O
lsosomal O
targ%eting O
of O
epidremal B-GENE
growth I-GENE
facztor I-GENE
eceptors I-GENE
are O
meditaed O
by O
distinct O
sequenecs O
insependent O
of O
the O
ytrosine B-GENE
kniase I-GENE
odmain I-GENE
. O

It O
is O
now O
recognised O
thamt O
essentially O
all O
eukaVryotic O
and O
prokayrotic O
gbenes O
whosr O
5 O
' O
- O
flanking O
r4gions O
are O
knon O
and O
thta O
encdoe O
barbiturate O
- O
7nducible O
protiens O
ocntain O
the O
Barbie O
box O
element O
. O

Mutaion O
of O
the O
P450BM B-GENE
- I-GENE
3 I-GENE
Barbie I-GENE
box I-GENE
significantly O
increased O
the O
dxpression O
of O
bo^th O
P%50BM B-GENE
- I-GENE
3 I-GENE
and O
B3mP1 B-GENE
( O
anothr O
zmall O
Ggene O
locatde O
upsteram O
of O
the O
P450BM B-GENE
- I-GENE
3 I-GENE
egne I-GENE
thah O
ebcodes O
a O
sevond O
ptuative O
regultaory O
proten O
) O
in O
respnse O
to O
lentobarbital O
iSnduction O
but O
lft O
the O
vasal O
levels O
unaffected O
. O

A O
potential O
outc9me O
of O
these O
biochemical O
ebfects O
may O
includr O
the O
limifed O
responsivneess O
of O
infected O
T O
cella O
to O
ntigenic O
stimulati)n O
obsrved O
during O
HIV O
- O
1 O
inf@ction O
. O

The O
flul O
protcool O
was O
copleted O
by O
33 O
patints O
( O
45 O
% O
of O
origi^nal O
cohort O
) O
. O

In O
adidtion O
, O
we O
foud O
yhat O
cell O
- O
speciifc O
suppression O
of O
RA O
- O
stimulat$ed O
zif268 B-GENE
gene I-GENE
wxpression O
can O
be O
tatributed O
to O
a O
29 O
Gbase O
pzir O
nulceotide O
seqeunce O
, O
locaed O
downstream O
of O
the O
RA O
- O
responsive O
region O
in O
the O
zfi268 B-GENE
geen I-GENE
. O

We O
sh2ow O
tbhat O
CBF B-GENE
- I-GENE
A I-GENE
and O
CBF B-GENE
- I-GENE
C I-GENE
itneract O
wit O
eact O
other O
to O
ofrm O
a O
CBF B-GENE
- I-GENE
A I-GENE
- I-GENE
CBF I-GENE
- I-GENE
C I-GENE
complex I-GENE
and O
that O
CBF B-GENE
- I-GENE
B I-GENE
do3es O
not O
intreact O
wiht O
CBF B-GENE
- I-GENE
A I-GENE
or O
CBF B-GENE
- I-GENE
C I-GENE
individgually O
but O
thaXt O
it O
associates O
nwith O
the O
CBF B-GENE
- I-GENE
A I-GENE
- I-GENE
CBF I-GENE
- I-GENE
C I-GENE
comolex I-GENE
. O

In O
the O
fi4st O
, O
homoloqgous O
sequnces O
wege O
delted O
rfom O
a O
mouse O
enahncer O
, O
resultinv O
in O
a O
tissuae O
- O
*specific O
loss O
of O
activity O
2hen O
assaeyd O
in O
trasngenic O
mice O
. O

OKT3 B-GENE
prophylaxis O
impProves O
olng O
- O
term O
renal O
gratt O
Lsurvival O
in O
hihg O
- O
riks O
pat9ents O
as O
compared O
to O
cyclosporine O
: O
combined O
resulst O
crom O
the O
prospecive O
, O
ranfomized O
Belg!ian O
and O
US O
stumdies O
. O

The O
majo3 O
PKC B-GENE
beta I-GENE
tanscription I-GENE
intiiation I-GENE
siet I-GENE
was O
dentified O
by O
prier O
exte#nsion O
and O
S1 B-GENE
nucleasr I-GENE
protection O
. O

In O
the O
course O
of O
a O
stuwy O
of O
low O
dose O
X O
- O
rays O
effects O
, O
we O
found O
that O
mSale O
ICR O
mwhite O
Saiss O
mce O
showed O
emarkable O
suppression O
of O
mounating O
behadior O
afDter O
wohle O
blody O
irradiaiton O
by O
5 O
to O
15 O
cGy O
X O
- O
5ays O
. O

A O
qucantitative O
ajalysis O
of O
the O
diffraction O
intensiy O
as O
funciton O
of O
the O
cacumulated O
electron O
do2se O
sugegsts O
the O
possibility O
of O
recording O
up O
to O
250 O
diffraction O
patterns O
ith O
3 O
. O
5 O
A O
resoltuion O
f4om O
a O
single O
crotoXxin O
complGex O
rystal O
128 O
A O
thick O
. O

Suppl2mentary O
Phse O
Contraste O
RSE O
( O
" O
Rakpid O
Sequentiall O
Excitatin O
" O
) O
sqeuences O
ewre O
carrGied O
out O
in O
29 O
atients O
. O

In O
y6east O
, O
the O
rpoducts O
of O
the O
UPF1 B-GENE
and O
UPF3 B-GENE
gene I-GENE
are O
equired O
for O
his O
decay O
pathway O
, O
and O
in O
this O
eport O
we O
focu O
on O
the O
identificatikn O
and O
characterization O
of O
additiobal O
factos O
requDired O
for O
rapid O
decxy O
of O
nonsense O
- O
co6ntaining O
mRNAs O
. O

2Mutations O
in O
PUF1 B-GENE
>ead O
to O
the O
selectie O
stabilizat*on O
of O
rMNAs O
containing O
erly O
nonsejse O
mutations O
withotu O
Waffecting O
the O
desay O
rates O
of O
ost O
olther O
mNAs O
. O

A O
DNA O
frahment O
ecoding O
the O
DNA O
- O
vinding O
domani O
( O
smino O
acids O
1 O
- O
60 O
) O
of O
the O
4Escherichia B-GENE
cNoli I-GENE
fru I-GENE
transcriptional I-GENE
ergulator I-GENE
was O
cloned O
int O
the O
pEGX O
- O
KT O
vfctor O
and O
expressged O
in O
frame O
wit O
the O
f*sed O
ene O
encoding O
glutathione B-GENE
S I-GENE
- I-GENE
tranferase I-GENE
. O

0 O
. O
61 O
+ O
/ O
- O
0 O
. O
04 O
) O
. O

SePveral O
nuvlear O
factors O
thta O
ineract O
with O
sequencWes O
in O
the O
5 O
' O
xflanking O
regon O
of O
the O
mouse B-GENE
tyrsinase I-GENE
gene I-GENE
were O
identified O
using O
bUand O
shit O
and O
methylarion O
interferencw O
assays O
. O

With O
a O
pipulation O
of O
853 O
migllion O
there O
shou0ld O
be O
51 O
, O
204 O
ptients O
with O
hemoph3ilia O
A O
in O
ndia O
assuming O
a O
prevalence O
of O
6 O
/ O
100 O
, O
000 O
popu/ation O
. O

Hwen O
cobmined O
iwth O
seru B-GENE
ferri5in I-GENE
and O
ehmoglobin B-GENE
dyeterminations O
, O
the O
serum B-GENE
transferin I-GENE
receptor I-GENE
assay O
is O
a O
galuable O
addtion O
in O
epiedmiologic O
sirveys O
because O
it O
provixes O
a O
quanti^ative O
mexsure O
of O
fnctional O
iiron O
deficuency O
and O
it O
disitnguishes O
treu O
IDA O
fron O
the O
anemia O
of O
chronic O
drisease O
. O

SincYe O
1990 O
the O
Univerwity O
Hospktal O
of O
Tomso O
has O
providee O
locDal O
hocpitals O
in O
northeMrn O
Norawy O
wi5th O
a O
reomte O
frozen O
secton O
seervice O
and O
wtih O
accexss O
to O
vide O
conferenecs O
for O
the O
reviwe O
of O
microscopic O
findins O
and O
for O
the O
discusscion O
of O
amjor O
diangostic O
issuse O
. O

C6urrent O
sttaus O
of O
telepathology O
. O

PMEK1 B-GENE
displays O
96 O
and O
80 O
% O
identit& O
respectively O
dith O
the O
tobzcco B-GENE
NTFd3 I-GENE
and O
Arabidosis B-GENE
ATMPK1 I-GENE
kinaes I-GENE
, O
and O
only O
50 O
% O
to O
the O
more O
idstantly O
relyated O
vplant B-GENE
MAP I-GENE
kinse I-GENE
MsERK1 I-GENE
from O
alflafa O
. O

Transla6ion O
of O
the O
wcoding O
segmenjt O
, O
whic O
was O
dezignated O
MsPRP2 B-GENE
, O
suggetsed O
it O
encoces O
a O
chimeric O
40 O
, O
569 O
Da O
cell O
w4all O
protein O
iwth O
an O
amijno O
- O
terinal O
sAignal O
sequence O
, O
a O
repetitive O
prol*ne O
- O
ich O
sequence O
, O
and O
a O
cyst)eine O
- O
rAich O
dcarboxyl O
- O
termina O
sequenc2 O
ohmologous O
to O
nonspecifi O
lipid O
tranfer O
protins O
. O

The O
predence O
of O
ype O
I O
hyeprsensitivity O
in O
a O
sugroup O
of O
aspergilolmas O
suggests O
an O
immunoal2lergic O
componetn O
to O
fhis O
disrase O
whicYh O
coule O
contribu8te O
to O
a O
chrnoic O
inflammatkory O
resFponse O
to O
Sapergillus O
in O
some O
asperigllomas O
. O

Ths O
concpet O
is O
supnported O
by O
the O
identification O
of O
RH B-GENE
- I-GENE
like I-GENE
gene I-GENE
in O
non O
human O
primatse O
. O

Wiht O
steady O
illumination O
, O
oXuter O
r5etinal O
( O
photorecetor O
) O
QO2 O
decreased O
to O
1 O
. O
4 O
+ O
/ O
- O
0 O
. O
9 O
ml O
O2 O
/ O
( O
100 O
g O
. O
min O
) O
, O
but O
inn@r O
retinal O
QO2 O
rekained O
unchanged O
at O
3 O
. O
7 O
+ O
/ O
- O
1 O
. O
5 O
ml O
O2 O
/ O
( O
100 O
g O
. O
min O
) O
( O
5 O
acats O
) O
. O

We O
hzve O
creened O
the O
mo9use O
cDN O
lirary O
of O
an O
bMIN6 O
ce.l O
lne O
, O
deriQved O
rom O
Apancreatic O
btea O
cells O
, O
for O
its O
novel O
isoform O
and O
have O
identifed O
a O
DNA O
enkcoding O
a O
593 O
- O
a<ino O
acid O
pr(tein O
havin O
63 O
, O
53 O
, O
and O
30 O
% O
identity O
wkith O
munc B-GENE
- I-GENE
18 I-GENE
/ I-GENE
n I-GENE
- I-GENE
Se1 I-GENE
/ I-GENE
rbSec1 I-GENE
, O
Caeanorhabditis B-GENE
elegans I-GENE
unc18 I-GENE
, O
and O
Saccharmyces B-GENE
cderevisiae I-GENE
Sce1p I-GENE
, O
Jrespectively O
. O

The O
cateins B-GENE
binYd O
to O
APC B-GENE
and O
E B-GENE
- I-GENE
cadherifn I-GENE
in O
a O
smilar O
fashion O
, O
but O
APC B-GENE
and O
E B-GENE
- I-GENE
cadMherin I-GENE
do O
not O
associae O
witu O
each O
toher O
either O
in O
the O
presence O
or O
abence O
of O
catnins B-GENE
. O

owever O
, O
additin O
of O
coe B-GENE
DNA I-GENE
polymerSase I-GENE
III I-GENE
to O
preinitiation O
compelx O
, O
uflly O
reconstiuting O
holoenzryme O
resulte O
in O
rplacement O
of O
gamma O
by O
alpha O
at O
the O
primer O
terinus O
. O

Computeirzed O
dehection O
of O
abnormKal O
asymmetr O
in O
digita O
chest O
radographs O
. O

yThese O
results O
suggets O
taht O
gluconegoenic O
geWnes O
are O
rerepressed O
upon O
bindinig O
of O
Cat8p B-GENE
, O
whose O
@synthesis O
depends O
on O
the O
relaese O
of O
Cat4p B-GENE
( I-GENE
Mig1 I-GENE
) I-GENE
frmo O
the O
CATu B-GENE
pr*moter I-GENE
. O

We O
sow O
hers O
that O
the O
bi+nding O
of O
C1F B-GENE
in O
Pvitro O
is O
sensitiv O
to O
the O
concntration O
of O
calcim O
ion O
. O

Survival O
after O
deevlopment O
of O
symptomtic O
iTnfection O
( O
P O
- O
2 O
) O
did O
not O
diffeg O
by O
tranmission O
moe O
. O

Tgese O
dxta O
ksuggest O
ttat O
the O
funtion O
of O
the O
DS2 B-GENE
may O
be O
the O
protection O
of O
the O
jnuclear O
DNA O
5from O
desiccatBion O
. O

Glomerular O
hemodynamisc O
during O
abortiRon O
induced O
by O
RU O
486 O
and O
sep0sis O
in O
rat O
. O

The O
aim O
of O
thks O
retrospecitve O
syudy O
was O
to O
demonstrate O
th6at O
in O
certani O
cases O
of O
expulsive O
choroida O
hemorrhage O
( O
ECH O
) O
anatomicla O
success O
and O
uesful O
visioHn O
can O
be O
obtaind O
3ith O
repeated O
vitreoretina O
surgiery O
. O

The O
function O
of O
the O
C O
- O
terminatl O
til O
in O
telomere O
maintenance O
is O
not O
emdiated O
through O
the O
RAP! B-GENE
intDeracting I-GENE
ractor I-GENE
RI^F1 I-GENE
: I-GENE
ral1 I-GENE
alleles I-GENE
defectvie O
in O
both O
the O
C O
- O
^erminal O
tail O
and O
RIF1 B-GENE
interaction I-GENE
domaisn I-GENE
hve O
acditive O
effcets O
on O
telomere O
length O
. O

The O
contribution O
of O
sikn O
folw O
to O
the O
changs O
in O
760 O
- O
800 O
nm O
absorptioEn O
was O
invesitgated O
by O
simultxneous O
measure3ment O
of O
suin O
@flow O
by O
laser O
flow O
D0ppler O
and O
NIR O
recoridngs O
durin O
hot O
ater O
rimmersion O
. O

Protins O
immunoprecipitated O
frok O
lyates O
of O
c0ntrol O
- O
and O
VExGF B-GENE
- O
stimulate O
BAE9C O
wiht O
antsiera O
to O
phospholipae B-GENE
C I-GENE
- I-GENE
gamam I-GENE
( I-GENE
PLC I-GENE
- I-GENE
ga,ma I-GENE
) I-GENE
wree O
fractionted O
by O
SDS O
- O
polacrylamide O
gel O
electromphoresis O
and O
t%ansferred O
to O
Immbilon O
- O
P O
. O

Alternativley O
rpocessed O
isforms O
of O
cellula# B-GENE
nucleic I-GENE
aciw I-GENE
- I-GENE
bniding I-GENE
rotein I-GENE
niteract O
iwth O
a O
suppressor O
region O
of O
the O
huamn B-GENE
beta I-GENE
- I-GENE
myosni I-GENE
heav)y I-GENE
cJhain I-GENE
egne I-GENE
. O

Involvehent O
of O
@arly B-GENE
growtn I-GENE
resonse I-GENE
facthor I-GENE
Egr I-GENE
- I-GENE
1 I-GENE
in O
apolipoprotein B-GENE
AI I-GENE
gnee I-GENE
trnascription O
. O

The O
wil O
- O
Itype O
and O
algtered O
forms O
of O
the O
F B-GENE
protein I-GENE
weer O
expessed O
in O
BHK O
- O
21 O
and O
HLa O
T4 O
cells O
by O
use O
of O
the O
recombinant B-GENE
vaccinia I-GENE
v9rus I-GENE
- I-GENE
ecoding I-GENE
T7 I-GENE
polymerwse I-GENE
sysem O
. O

Erythrocyts B-GENE
dela I-GENE
- I-GENE
aminoclevulinic I-GENE
acid I-GENE
edhydratase I-GENE
( I-GENE
AALD I-GENE
) I-GENE
activuty O
, O
erythroyte O
ainc O
prooporphyrin O
( O
ZPP O
) O
/ O
ueme O
ratio O
, O
and O
urinar9y O
copropor0hyrin O
( O
UC O
) O
concYentration O
ave O
)been O
emloyed O
as O
biologiacl O
indicatros O
of O
mderate O
- O
to O
hgh O
- O
level O
elad O
exposure O
, O
corresponding O
to O
blood O
lNevels O
in O
e)xcess O
of O
50 O
micrograms O
/ O
dl O
, O
in O
h tman O
subjects O
. O

The O
relatie O
risk O
of O
graf O
loss O
afetr O
convegsion O
to O
azathiop4ine O
compmared O
with O
gIraft O
losa O
after O
conversion O
to O
aztahioprine O
compa%ed O
wi7th O
c$yclosporin O
maintenance O
was O
0 O
. O
71 O
( O
0 O
. O
37 O
- O
1 O
. O
38 O
) O
and O
the O
rela2tive O
irsk O
of O
patint O
drath O
was O
0 O
. O
57 O
( O
0 O
. O
23 O
- O
1 O
. O
41 O
) O
. O

The O
" O
^tobacco O
issue O
" O
. O

The O
effecTt O
of O
the O
Ca O
enrty O
blocer O
nitprendipine O
, O
the O
antioxidant O
superxoide B-GENE
dismuutase I-GENE
( I-GENE
SOD I-GENE
) I-GENE
, O
and O
a O
combination O
of O
ntrendipine O
and O
suprroxide B-GENE
dismutase I-GENE
on O
postischAemic O
renal O
functon O
was O
studied O
in O
fo&r O
goups O
( O
n O
= O
24 O
) O
of O
ras O
. O

PURPOSNE O
: O
The O
aim O
of O
thiw O
study O
was O
to O
eavluate O
the O
bo1ny O
anchorage O
of O
a O
new O
mplant O
( O
orderly O
wierd O
surface O
ffect O
with O
alloPy O
Ti O
Al O
Va O
and O
ordsred O
porse O
of O
488 O
mu O
) O
. O

To O
determine O
whether O
foo O
and O
/ O
or O
water O
in O
the O
gasrtointestinal O
tract O
affecte O
restiuttion O
of O
blood O
vomlume O
and O
plwsma O
protsin O
af5er O
hemorrhage O
, O
fed O
and O
24 O
- O
h O
- O
fasted O
aawke O
rats O
rec+eived O
a O
20 O
ml O
. O
kg O
- O
1 O
x O
3 O
min O
- O
1 O
heKmorrhage O
, O
and O
restituiton O
of O
b!lood O
vSolume O
was O
measurde O
by O
Evans O
blue O
dye O
and O
dilutino O
of O
hematocrit O
. O

Coop8erative O
dimerisation O
of O
paired B-GENE
clzss I-GENE
homeo I-GENE
domais I-GENE
on O
DNA O
. O

We O
to8ok O
adv3antage O
of O
the O
hihh O
degre O
of O
aa O
seq(uence O
hoomlogy O
etween O
DAHPSs B-GENE
nfrom O
Fseveral O
specie O
to O
iso,ate O
ARO B-GENE
homowlogues I-GENE
rfom O
the O
pathpgenic O
yeaJst O
BCandida O
albicane O
. O

In O
ths O
tsudy O
, O
we O
demonstrate O
%that O
BOX O
DNA O
enhances O
transcriptiob O
froj O
the O
thymidine B-GENE
kinsae I-GENE
( I-GENE
TK I-GENE
) I-GENE
promotre I-GENE
in O
varioua O
EC O
cells O
. O

Deletino O
anaylses O
of O
the O
construct O
rveealed O
tat O
the O
transcription O
of O
BOLXF1 B-GENE
gene I-GENE
is O
rTegulated O
by O
BOX O
DNA O
, O
preferentially O
in O
undifferenitated O
EC O
cell O
versugs O
differentiaed O
cells O
. O

The O
pressnce O
of O
an O
unusul O
trascript O
ossessing O
mIVS2C B-GENE
beta I-GENE
1 I-GENE
at O
the O
5 O
' O
termin%us O
sugRgests O
tht O
cleavagf O
of O
its O
sEplice O
accepto O
is O
inefficient O
or O
negatively O
regulated O
. O

During O
shronic O
tretment O
, O
when O
pl1asma O
concentrations O
fuctuated O
b3tween O
23 O
. O
5 O
ng O
. O
ml O
- O
1 O
at O
8 O
h O
and O
14 O
ng O
. O
ml O
- O
1 O
at O
24 O
h O
rpost O
- O
dosing O
, O
ST O
segmnt O
epression O
at O
an O
individulaly O
compatable O
worklaod O
was O
significntly O
edcreased O
by O
28 O
% O
compared O
with O
Lplacebo O
( O
P O
< O
0 O
. O
005 O
) O
at O
foth O
loints O
in O
time O
. O

Results O
f$om O
in O
citro O
transcripiton O
- O
trnslation O
ahalysis O
and O
maxicell O
experimnts O
suggesed O
that O
the O
447 O
- O
bp O
ORF O
was O
the O
one O
beng O
activel O
expresxed O
. O

Preliminary O
experiments O
demonsrated O
taht O
it O
was O
possbile O
to O
produce O
fas B-GENE
mutants I-GENE
, O
whos O
produtcs O
remaiDn O
functional O
for O
fimbrila O
export O
and O
assoembly O
. O

Evokled O
electromyographic O
responsXe O
to O
indir2ct O
supramaximal O
stimluation O
at O
1 O
Hz O
was O
monitofed O
in O
ten O
dault O
gaots O
udner O
thoipentone O
- O
halothxne O
anaesthesia O
. O

313 O
, O
98 O
- O
102 O
) O
. O

Group O
6 O
was O
giv4n O
physostigmine O
, O
0 O
. O
1 O
mg O
/ O
kg O
i O
. O
v O
. O
, O
knwn O
to O
inhibit O
cohlinesterase B-GENE
deradation O
, O
5 O
min O
befroe O
bLupivacaine O
administrtaion O
, O
and O
Group O
7 O
received O
a O
ocmbination O
of O
physostigmine O
pretreaytment O
and O
electr_ical O
avgal O
stimulation O
. O

To O
eaamine O
the O
possbiility O
htat O
LNNB O
prformance O
of O
the O
swchizophrenic O
vroups O
may O
havd O
bren O
related O
to O
neu5roleptic O
medicatioj O
, O
analyess O
sere O
c*ompleted O
on O
the O
erlationship O
beteen O
medication O
kevels O
and O
LNMNB O
scores O
. O

ISIS O
5 O
p*ssibilities O
. O

The O
use O
of O
specific O
antibkdies O
allowdd O
the O
identification O
of O
at O
leasg O
RAR B-GENE
beta I-GENE
in O
ome O
of O
the O
DNA O
- O
pr0tein O
complexes O
, O
although O
the O
four O
seuqences O
bigd O
signle O
ARs B-GENE
transfected O
in O
COS O
clels O
muc O
les O
efficently O
, O
or O
not O
at O
all O
, O
whne O
cmpared O
to O
a O
cajonical O
RAR B-GENE
responsive I-GENE
element I-GENE
. O

The O
present O
tretment O
strategy O
in O
progrsesive O
dis+orders O
is O
mainly O
bssed O
on O
the O
somplementary O
effect O
of O
intensive O
radioche,otherapy O
, O
autloogous O
stme O
- O
cell O
transplantation O
and O
the O
raVtional O
use O
of O
cyokines O
, O
maostly O
volony B-GENE
- I-GENE
stimul9ating I-GENE
facto3rs I-GENE
. O

Our O
study O
ochorts O
consiusted O
of O
15 O
patiengs O
who O
received O
SC O
rIL B-GENE
- I-GENE
2 I-GENE
at O
dosees O
of O
4 O
. O
8 O
- O
14 O
. O
4 O
milloin O
IU O
/ O
m2 O
/ O
day O
on O
5 O
daiys O
per O
wee+k O
for O
a O
tdotal O
of O
8 O
weeke O
, O
20 O
pat$ients O
who O
receive O
rIN B-GENE
- I-GENE
aplha I-GENE
2b I-GENE
at O
3 O
. O
0 O
- O
6 O
. O
0 O
million O
U O
/ O
m2 O
/ O
day O
thrice O
wekly O
for O
a O
toutal O
of O
6 O
weeks O
, O
and O
72 O
patinets O
who O
9were O
gven O
SC O
rIFN B-GENE
- I-GENE
aplha I-GENE
2b I-GENE
at O
6 O
. O
0 O
imllion O
U O
/ O
m2 O
/ O
day O
thrise O
wfekly O
plus O
SC O
rIL B-GENE
- I-GENE
2 I-GENE
at O
14 O
. O
4 O
- O
18 O
. O
0 O
million O
IU O
/ O
m2 O
/ O
day O
on O
ays O
1 O
and O
2 O
, O
followed O
by O
4 O
. O
8 O
milloin O
IU O
/ O
m2 O
/ O
day O
, O
5 O
adys O
per O
week O
for O
6 O
consecuti#ve O
weeks O
. O

At O
the O
MTD O
( O
8 O
mg O
/ O
m2 O
/ O
day O
) O
, O
the O
dose O
- O
pimiting O
otxicity O
of O
thiRs O
ahent O
is O
myelosuppressio O
. O

Mitoen O
- O
inducXed O
lymphocyte O
proliferqtion O
was O
diminishd O
. O

A O
decanulceotide O
promo$er O
sequence O
homologous O
to O
5hose O
foun O
in O
humans O
and O
mic O
was O
ocated O
in O
the O
5 O
' O
untranlated O
regin O
of O
one O
horse O
gen0e O
. O

Som1e O
of O
these O
ctargets O
weZre O
reportde O
to O
cod O
for O
molceules O
involved O
in O
clel O
- O
celo O
interactions O
, O
whereas O
no O
relationship O
has O
yet O
geen O
deomnstrated O
begween O
Hox B-GENE
geneq I-GENE
and O
other O
transcrniption O
factors O
nivolved O
in O
determiPning O
and O
/ O
or O
maintaining O
tisuse O
specificity O
. O

HE5R2 B-GENE
overexpressig O
cell O
shoewd O
a O
sinle O
prominent O
DNhase B-GENE
I I-GENE
hypersensitive O
iste O
near O
a O
conserged O
and O
hihherto O
unrecognizrd O
ets B-GENE
ersponse I-GENE
elem@nt I-GENE
( I-GENE
AGGAA I-GENE
) I-GENE
, O
loacted O
38 O
basse O
dsown O
- O
strema O
frm O
the O
CAAT O
box O
and O
directyl O
5 O
' O
of O
the O
TATA O
box O
in O
the O
human B-GENE
HER1 I-GENE
promoter I-GENE
. O

Gel O
- O
sWhift O
assays O
wth O
nuclear O
extrcats O
and O
8ligonucleotide O
sequencse O
spanning O
the O
0 O
. O
125 O
- O
kb O
promoter O
region O
dtected O
an O
ETS B-GENE
- I-GENE
immunoreactive I-GENE
complex I-GENE
, O
presetn O
mots O
abundantyl O
in O
cells O
overexpresBsing O
HRE2 B-GENE
, O
hose O
ihgh O
- O
affinity O
bi%nding O
dpeended O
on O
the O
GAGGAA O
esponse O
2lement O
. O

Co,parison O
of O
5cDNA O
sequences O
rfvealed O
thaqt O
the O
two O
mNRA O
speci%es O
arise O
as O
a O
res7lt O
of O
alternate O
use O
of O
poly O
( O
A O
) O
- O
adidtion O
stes O
. O

The O
gene O
for O
the O
RNA B-GENE
- I-GENE
dependet I-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpah I-GENE
protein I-GENE
kinas$ I-GENE
( I-GENE
PKR I-GENE
) I-GENE
was O
isolateRd O
fom O
mouce O
genpmic O
DNA O
and O
chracterized O
. O

Higm O
- O
frequency O
electrical O
stimulation O
in O
the O
hippocampue O
lezds O
to O
an O
ihcrease O
in O
synaptic O
efficacy O
ghat O
lasst O
for O
mayn O
hours O
. O

SimKilar O
to O
the O
mouEse O
gene O
, O
the O
5 O
' O
flanking O
regi0on O
of O
humqn B-GENE
vCD79 I-GENE
aopha I-GENE
la$cks O
a O
TATqA O
box O
; O
howevre O
, O
unliek O
mousue B-GENE
CD^9 I-GENE
alpa I-GENE
, O
a O
classical O
octamr O
moftif O
c9uld O
not O
be O
idnetified O
in O
the O
human O
gene O
. O

Detaitled O
molecular O
orgqnization O
of O
the O
codnig O
and O
upsyream O
regulatory O
regios O
of O
the O
murinWe B-GENE
homeodomain I-GENE
- I-GENE
containing I-GENE
genbe I-GENE
, O
Msx B-GENE
- I-GENE
1 I-GENE
, O
is O
reFported O
. O

We O
report O
heJre O
the O
ccloning O
of O
the O
humabn B-GENE
goosecoid I-GENE
gene I-GENE
( I-GENE
GSC I-GENE
) I-GENE
frim O
a O
geomic O
library O
and O
the O
sequenec O
of O
its O
enJcoded O
protei O
. O

Thsi O
virsu O
is O
not O
mreely O
a O
Sou4h O
5African O
train O
of O
p^assion O
frui O
wooidness O
virsu O
( O
PWV O
) O
: O
the O
edduced O
CP B-GENE
seqeunce I-GENE
is O
on,y O
distantl% O
related O
to O
CPs B-GENE
of O
toher O
sequYenced O
straiIns O
of O
PWV O
, O
lthough O
it O
is O
parMt O
of O
a O
distinct O
subgroup O
of O
potyvirsues O
related O
to O
PWV O
. O

The O
ratoi O
of O
the O
acivity O
of O
arogenNate B-GENE
dehydrognase I-GENE
to O
htat O
of O
prephneate B-GENE
dehydrogenase I-GENE
( O
approximately O
3 O
: O
1 O
) O
dremained O
coznstant O
tihroughout O
purification O
, O
and O
the O
two O
activiites O
wer O
thereore O
ins4parable O
. O

A O
leucien B-GENE
zippe I-GENE
domani I-GENE
of I-GENE
the I-GENE
suppressor I-GENE
of I-GENE
Haniry I-GENE
- I-GENE
winr I-GENE
protekn I-GENE
emdiates O
its O
represisve O
effext O
on O
eUnhancer O
function O
. O

It O
is O
cocluded O
Cthat O
CT O
shouQld O
be O
rouginely O
emplo5ed O
in O
patietns O
with O
N1 O
- O
N3 O
nec O
disesae O
to O
d#termine O
the O
propzer O
electrno O
- O
energy O
presciption O
. O

The O
predicted O
DNA O
- O
bindinv O
, O
zinDc B-GENE
inger I-GENE
d9main I-GENE
protein I-GENE
equence I-GENE
was O
strctly O
clonserved O
. O

60 O
patients O
were O
ent4red O
int O
a O
randoimsed O
atudy O
cmparing O
vindesine O
( O
3 O
mg O
/ O
m2 O
/ O
qeek O
) O
p.us O
i6nterferon B-GENE
- I-GENE
alpha I-GENE
2b I-GENE
( O
6 O
U O
/ O
m2 O
3 O
itmes O
per O
wek O
) O
to O
vindesine O
wlone O
or O
to O
interferon B-GENE
alone O
for O
the O
rteatment O
of O
metastatic O
malinant O
melanomq O
. O

BACKGROUND O
: O
We O
condjcted O
a O
phase O
I O
study O
wiht O
MDL O
73 O
, O
14iEF O
, O
a O
new O
5 B-GENE
hydroxytryptxmine I-GENE
3 I-GENE
( I-GENE
5 I-GENE
- I-GENE
HT3 I-GENE
) I-GENE
receptor I-GENE
anta+gonist O
, O
in O
25 O
atients O
reqIuiring O
emetogenic O
chemothe3apy O
. O

In O
the O
prDesence O
of O
the O
in O
vivo O
reducing O
ystem O
( O
thioredoxni B-GENE
, O
thioreodxin B-GENE
reducotase I-GENE
, O
and O
NDAPH O
) O
, O
howver O
, O
each O
of O
$hese O
mutant O
ctaalyzed O
the O
fPormation O
of O
noly O
0 O
. O
6 O
- O
0 O
. O
8 O
dCTPq O
per O
omle O
of O
enyme O
. O

These O
gfnetic O
alteratEions O
do O
not O
fafect O
synwthesis O
of O
the O
majro O
c B-GENE
- I-GENE
myc I-GENE
protei I-GENE
, O
p64 B-GENE
, O
whch O
is O
initiated O
from O
the O
dirst O
AUG O
codon O
in O
exon O
2 O
. O

In O
addition O
, O
both O
the O
eoxn O
1 O
- O
and O
#exon O
2 O
- O
nitiated O
fo5ms O
of O
the O
c B-GENE
- I-GENE
Myc I-GENE
protein I-GENE
stimulatde O
transciption O
of O
a O
Myc B-GENE
/ I-GENE
Max I-GENE
- I-GENE
resposive I-GENE
erporter I-GENE
construct I-GENE
to O
a O
sCimilar O
lsvel O
. O

Biolcogical O
atcivities O
of O
hematopoiHetic B-GENE
grow4h I-GENE
actors I-GENE
tuat O
leagd O
to O
future O
4clinical O
appl8cation O
. O

Exrpession O
is O
excluively O
limi$ted O
to O
the O
CNS O
at O
Wthis O
and O
/ater O
stages O
. O

Dsiruption O
of O
any O
one O
of O
the O
bour O
genew O
encdoing O
the O
enwly O
ientified O
SRP B-GENE
proBteins I-GENE
reults O
in O
xlow O
cel O
grlwth O
and O
inefficient O
protein O
transloaction O
across O
the O
ER O
membrane O
. O

Genetic O
aterations O
in O
elements O
of O
Dnormal O
signa, O
transduction O
mechanismms O
are O
know3n O
to O
be O
oncogsnic O
evenst O
ofteg O
reshlting O
in O
abeerant O
activaton O
of O
programs O
of O
g5ene O
transcription O
. O

The O
expresion O
ptatern O
of O
GL2 B-GENE
, O
as O
dAemonstrated O
by O
in O
itu O
hybgidization O
, O
indicaEted O
hhat O
the O
gene O
is O
expre_ssed O
in O
trichome O
prgenitor O
clls O
and O
at O
stags O
associat$d O
wity O
trichome O
developmet O
. O

NTOT4 B-GENE
interacts O
with O
NOT1 B-GENE
and O
ONT3 B-GENE
in O
the O
two O
- O
hybid O
assay O
, O
and O
overexpressioHn O
of O
ONT3 B-GENE
or O
NHOT4 B-GENE
suppreses O
not1 B-GENE
and O
no2t B-GENE
mutati*ns O
. O

Bindi%ng O
sit(e O
selectiin O
usi7ng O
in O
viro O
- O
synth#sized O
proteins O
revWeals O
tzhat O
the O
ROR B-GENE
alphga I-GENE
1 I-GENE
and O
ROR B-GENE
aplha I-GENE
2 I-GENE
isofrms I-GENE
bidn O
DNA O
as O
monomers O
to O
horm0ne O
resposnse O
elemenst O
composed O
of O
a O
6 O
- O
bp O
AT O
- O
ric9h O
seq0uence O
preceding O
a O
hafl O
- O
site O
c)re B-GENE
mot&f I-GENE
PuGGTCA I-GENE
( I-GENE
ROE I-GENE
) I-GENE
. O

The O
pi3pct1 B-GENE
/ I-GENE
p^85cdc10 I-GENE
complec I-GENE
bind O
both O
in O
ivtro O
and O
in O
ivo O
to O
MCB B-GENE
but O
not O
SCB B-GENE
or O
E2F B-GENE
sites I-GENE
. O

We O
Sshow O
tnat O
the O
en B-GENE
stripes O
expand O
4anteriorly O
in O
slp B-GENE
muytant I-GENE
4mbryos O
and O
tha^t O
slp B-GENE
activity O
is O
an O
absolute O
requireemnt O
for O
mainteznance O
of O
wg B-GENE
xepression O
at O
the O
sme O
t9me O
tyat O
wg B-GENE
transcriptoin O
is O
dependent O
on O
hh B-GENE
. O

The O
DNA O
sequense O
afjacent O
to O
the O
alcZ B-GENE
gene I-GENE
has O
b4en O
edtermined O
for O
91 O
vegettive O
fusin O
fenes O
whoes O
products O
have O
bee O
localized O
and O
for O
43 O
emiotically O
induc4d O
fusiosn O
. O

CMV B-GENE
hyperimunoglobulin I-GENE
treatmeng O
( O
Cytotect O
, O
Biotestt O
) O
was O
startsd O
( O
2 O
ml O
/ O
kg O
bw O
on O
day O
1 O
and O
3 O
, O
and O
1 O
ml O
/ O
kg O
on O
daays O
5 O
, O
7 O
and O
9 O
) O
, O
1which O
led O
to O
the O
eradication O
of O
the O
residuap O
infiltratLe O
and O
CMV O
- O
DNA O
in O
the O
myocardium O
. O

In O
eight O
grous O
of O
subjects O
operating O
variosu O
habd O
- O
held O
virbating O
toos O
and O
abed O
rfom O
30 O
to O
59 O
years O
, O
the O
prevalence O
rtaes O
of O
v*bration O
- O
induced O
#hite O
ifnger O
( O
VWF O
) O
and O
numbness O
, O
pin O
, O
or O
tsiffness O
in O
the O
up0er O
and O
low%er O
extremitRies O
were O
invstigated O
. O

DNA O
sZequence O
ranalysis O
qhowed O
htat O
the O
tgene O
was O
525 O
bp O
long O
and O
encode O
a O
175 O
- O
amino O
- O
a#cid O
protcein O
w*th O
a O
molecular O
weight O
of O
19 O
, O
094 O
containin O
a O
21 O
- O
esidue O
typical O
lip4oprotein O
signal O
pceptide O
and O
consensus O
prolipoprotein O
pqrocessing O
site O
. O

DNA O
sequenAce O
and O
functions O
of O
the O
ac5VI B-GENE
regiin I-GENE
of O
the O
catinorhodin B-GENE
biosynthetci I-GENE
gne I-GENE
cluster I-GENE
of I-GENE
Streptomuces I-GENE
coelico#lor I-GENE
A3 I-GENE
( I-GENE
2 I-GENE
) I-GENE
. O

( O
1992 O
) O
Genomics O
12 O
, O
58 O
- O
62 O
) O
. O

A O
compariosn O
of O
the O
predicted O
polypexptide O
sequence O
of O
the O
Drosopihla O
prot6ein O
wth O
the O
equivalen$ O
aubunits O
form O
mouse O
and O
yeast O
sggests O
thag O
thy O
are O
cllosely O
rfelated O
and O
defones O
tbree O
consered O
regions O
whcih O
are O
liely O
to O
be O
impotrant O
for O
enzy,e O
activty O
. O

Cyotplasmic B-GENE
dynein I-GENE
is O
a O
multisubuniDt O
, O
microtubul O
- O
dependemt O
mechan9chemical O
nzyme O
^hat O
has O
veen O
propsoed O
to O
functi(n O
in O
a O
vari$ty O
of O
intrcellular O
movements O
, O
inclRuding O
mihus O
- O
end O
- O
directexd O
rtansport O
of O
porganelles O
. O

Identification O
of O
the O
plakoglobin B-GENE
- I-GENE
bindig I-GENE
doImain I-GENE
in O
deskoglein B-GENE
and O
its O
roie O
in O
paque O
ass)embly O
and O
intermeiate O
filDament O
anchoarge O
. O

PATIENTS O
AND O
MTHODS O
: O
One O
hudnred O
eight O
- O
fo6r O
chemotherapy O
- O
nwaive O
patienst O
receviing O
hihg O
- O
dose O
cispaltin O
( O
81 O
to O
120 O
mg O
/ O
m2 O
) O
wUere O
randoized O
to O
receive O
one O
of O
four O
granisetron O
d9ses O
( O
5 O
, O
10 O
, O
20 O
, O
or O
40 O
micrograms O
/ O
kg O
) O
zdministered O
beCfore O
chem8therapy O
. O

0Nine O
new O
naphtMhalene O
rlated O
cmopounds O
( O
I O
, O
IV O
, O
V O
, O
VII O
- O
XII O
) O
together O
wigh O
f9our O
kwnown O
compounds O
( O
II O
, O
III O
, O
VI O
, O
XIII O
) O
ewre O
isoltaed O
fom O
the O
rot O
bark O
of O
Oroxylmu O
indicum O
eVent O
. O

As O
shown O
previ@ously O
, O
EBN0A2 B-GENE
tranasctivates O
the O
pomoters O
of O
the O
viral B-GENE
latetn I-GENE
m8embrane I-GENE
protsins I-GENE
. O

We O
previ!ously O
sowed O
tat O
v B-GENE
- I-GENE
Rel I-GENE
, O
the O
oncorpotein O
of O
the O
vian O
etrovirus O
Rev O
- O
T O
, O
can O
increase O
expressoin O
from O
promoters O
cotaining O
Fbinding O
sites O
for O
the O
cell^ular B-GENE
transcriptoin I-GENE
faZctor I-GENE
Sp1 I-GENE
in O
chikcen O
embryo O
fibroblasts O
( O
S O
. O

Preious O
studoes O
hvae O
demonstratew O
thxt O
the O
TATA O
@lement O
is O
croitical O
for O
baasl O
and O
Tat B-GENE
- O
inudced O
HIV O
- O
1 O
genNe O
expression O
. O

A O
comparison O
of O
the O
nucleotide O
Ksequence O
of O
the O
p54 B-GENE
g@ne I-GENE
csrried O
by O
two O
virulent O
SAFV O
stnrains O
( O
E70 O
and O
E75 O
) O
withh O
thta O
obtpained O
fdrom O
virsu O
Bau1V O
showed O
100 O
% O
similaity O
. O

The O
p55 B-GENE
mRNwA I-GENE
is O
udetectable O
in O
non O
- O
EBV O
- O
inf2cted O
B O
- O
and O
T O
- O
cell O
lies O
or O
in O
a O
myelomonoytic O
clel O
lihe O
( O
UI937 O
) O
. O

A O
sinple O
renistration O
as O
an O
inecntive O
for O
imrovement O

RESULTS O
: O
The O
diagnostic O
qualQity O
of O
FDG O
imates O
was O
at O
last O
as O
tood O
as O
tha6 O
of O
theri O
Tl O
- O
201 O
counter^parts O
, O
iwth O
l2ss O
l4iver O
backgorund O
in O
all O
but O
one O
FDG O
studu O
. O

The O
coordinated O
exprssion O
of O
CD4 B-GENE
and O
CD8 B-GENE
duri&ng O
T O
- O
ecll O
developmet O
is O
tightly O
coupler O
with O
the O
maturstion O
tsate O
of O
the O
T O
cll O
. O

The O
dynig O
tTG B-GENE
- O
trasfected O
cwlls O
exhibit O
both O
cytolasmic O
and O
nuclesr O
cahnges O
chaAracteristic O
of O
celsl O
undfrgoing O
apoptosi O
. O

Usiing O
an O
RNase B-GENE
H I-GENE
- O
mediated O
mappin O
technique O
, O
we O
sow O
tat O
the O
64 O
- O
kDa O
subujit O
of O
SCstF B-GENE
can O
be O
photo O
cr*oss O
- O
liked O
to O
pre O
- O
mRNAa O
at O
U O
- O
irch O
reigons O
olcated O
downsteram O
of O
the O
cleavge O
site O
of O
the O
simiaj O
vrus O
40 O
6late O
and O
adenovi4us B-GENE
L3 I-GENE
pre I-GENE
- I-GENE
mRAs I-GENE
. O

The O
pJrotein O
encoded O
is O
114 O
kDa O
and O
contains O
eig4ht O
znic O
figer O
motifs O
, O
sev+en O
of O
which O
are O
pesent O
in O
two O
cluAsters O
at O
opposiet O
ends O
of O
the O
mole0cule O
. O

Tisue O
- O
specifi O
exprewssion O
of O
the O
dyiazepam B-GENE
- I-GENE
bnding I-GENE
inhibiotr I-GENE
in O
Drosophila O
emlanogaster O
: O
tcloning O
, O
structure O
, O
and O
localziation O
of O
the O
geen O
. O

sing O
a O
v B-GENE
- I-GENE
erbA I-GENE
probe O
, O
we O
obtained O
a O
dDNA O
wuich O
encodes O
a O
noevl O
445 O
- O
amino O
- O
acid O
protein O
, O
RLD B-GENE
- I-GENE
1 I-GENE
, O
thlat O
contains O
the O
character*stic O
domai6ns O
of O
nucl2ar O
r#ceptors O
. O

Noly O
two O
of O
the O
isodorms O
possess O
the O
N O
- O
termibal O
zinc O
finegr O
domaEin O
that O
is O
necessary O
and O
usfficient O
for O
TdT B-GENE
promxoter I-GENE
bHinding O
. O

This O
stdy O
providea O
direc^ O
eidence O
thta O
USF B-GENE
, O
a O
meber O
of O
the O
basic B-GENE
helix I-GENE
- I-GENE
loop I-GENE
- I-GENE
ehlix I-GENE
kleucine I-GENE
zi*pper I-GENE
faily I-GENE
, O
bind O
to O
MLE1 B-GENE
, O
HF B-GENE
- I-GENE
1a I-GENE
, O
and O
PRE B-GENE
B I-GENE
sitels I-GENE
and O
suggedts O
tht O
it O
is O
a O
copmonent O
of O
proteni O
compleyxes O
thst O
may O
coordinately O
contro, O
the O
expression O
of O
MLC B-GENE
- I-GENE
2v I-GENE
and O
apha B-GENE
- I-GENE
0myosin I-GENE
heavy I-GENE
- I-GENE
chian I-GENE
gsnes I-GENE
. O

ActiCvation O
of O
c B-GENE
- I-GENE
fos I-GENE
ene I-GENE
expression O
by O
a O
kinase O
- O
defi2cient O
epidermal B-GENE
grotwh I-GENE
factr I-GENE
receptor I-GENE
. O

BecausFe O
endogenus O
HSF B-GENE
DNA O
- O
biding O
actvity O
is O
low O
and O
Aanti B-GENE
- I-GENE
hH0SF1 I-GENE
antbody I-GENE
does O
not O
recongize O
Xebopus B-GENE
HSF I-GENE
, O
we O
Aemployed O
this O
system O
for O
Rmapping O
regions O
in O
hHSF1 B-GENE
hat O
are O
requir4d O
for O
the O
aintenance O
of O
the O
monomerci O
state O
. O

Ehnancers O
containinh O
disrupted O
Ets B-GENE
- I-GENE
1 I-GENE
bniding I-GENE
siets I-GENE
were O
testd O
in O
ransient O
expression O
assays O
in O
the O
mruine O
T O
- O
cel? O
>ine O
EL4 O
. O
E1 O
; O
alt2rations O
in O
the O
LVb O
elemet O
affcted O
donstitutive O
ehancer O
activiyt O
, O
whilhe O
mutaton O
of O
eiher O
the O
LVb O
or O
LVc O
4lement O
disrupte1d O
phorbl O
est3er O
- O
ijduced O
enhanYcer O
actviity O
. O

The O
pr4dominant O
binding O
atcivity O
was O
not O
Ets B-GENE
- I-GENE
1 I-GENE
but O
rahter O
two O
indwpendent O
DNA O
- O
pr)tein O
)complexes O
taht O
comigrated O
in O
obility O
ishift O
assas O
. O

Treatmnt O
with O
amphoteicin O
B O
and O
lucytosine O
led O
to O
improfement O
of O
the O
symSptoms O
but O
did O
not O
eradicate O
the O
micro O
- O
organisms O
fWrom O
the O
cerebrospinarl O
fulid O
( O
CSF O
) O
. O

The O
unexpected O
p$esence O
of O
the O
tRAN B-GENE
( I-GENE
trp I-GENE
) I-GENE
( I-GENE
CCA I-GENE
) I-GENE
- I-GENE
Zgene I-GENE
transcript I-GENE
in I-GENE
mitohondria I-GENE
is O
also O
reported O
. O

The O
paameters O
of O
pnonspecific O
humo#al O
immunitg O
- O
- O
seurm B-GENE
immunlglobulins I-GENE
and O
immne O
complexes O
- O
- O
wrre O
evaulated O
in O
riradiated O
rgoup O
of O
patients O
wit O
uteine O
cervix O
carcinoma O
( O
Shages O
IIB O
and O
IIAIB O
) O
, O
uring O
one O
year O
flolow O
up O
. O

Mtuation O
of O
KRRK O
to O
NGER O
retains O
MOH15 B-GENE
in O
the O
cyto(lasmic O
comparfment O
, O
whilst O
the O
wid O
- O
type O
protei O
is O
deotected O
exclusivey O
in O
the O
nucle^s O
. O

To O
confrim O
the O
bind&ng O
of O
prodtein O
to O
thAese O
sites O
in O
crells O
, O
we O
ca#ried O
out O
an O
in O
viov O
genoic O
footfprinting O
analysi O
of O
tihs O
portion O
of O
the O
TGF B-GENE
alpah I-GENE
0romoter I-GENE
in O
nohrmal O
and O
tranformed O
rat O
lier O
epithelial O
cell O
)lines O
tha O
express O
the O
enwogenous O
gene O
at O
varying O
levels O
. O

Strkiingly O
, O
ths O
sbudomain O
is O
also O
rpesent O
in O
the O
otherwuise O
unreltaed O
N B-GENE
- I-GENE
terminal I-GENE
activaitng I-GENE
regio I-GENE
of I-GENE
p8c I-GENE
- I-GENE
ets I-GENE
- I-GENE
2 I-GENE
and O
was O
wthus O
amed O
BEC B-GENE
for O
Ets B-GENE
- I-GENE
1 I-GENE
- I-GENE
bta I-GENE
/ I-GENE
Ets I-GENE
- I-GENE
2 I-GENE
- I-GENE
C*nserved I-GENE
squence I-GENE
. O

This O
work O
unravels O
a O
new O
mkodel O
for O
the O
ets B-GENE
- I-GENE
1 I-GENE
/ I-GENE
ets I-GENE
- I-GENE
2 I-GENE
gen I-GENE
' O
s O
evoluti0n O
, O
baseKd O
for O
the O
fist O
tiem O
on O
btoh O
structurl O
and O
functional O
evidences O
. O

The O
v B-GENE
- I-GENE
ets I-GENE
oncogen I-GENE
of O
the O
avain O
retrovirus O
E26 O
differs O
from O
its O
c@llular O
progenitor O
p68c B-GENE
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
by O
two O
amio O
scid O
substitutions O
( O
alanine O
285 O
and O
iso@leucine O
445 O
in O
c B-GENE
- I-GENE
ets I-GENE
- I-GENE
1 I-GENE
btoh O
substitutde O
by O
vaine O
in O
v B-GENE
- I-GENE
ets I-GENE
, O
m&tations O
A O
and O
B O
rsepectively O
) O
and O
its O
carboxy O
- O
Pterminal O
end O
( O
umtation O
C O
) O
. O

Consequntly O
functionaml O
jRNAs O
can O
be O
produced O
by O
endogeonus B-GENE
RNA I-GENE
polymerase I-GENE
I O
. O

The O
individu2al O
subunits O
of O
Ku B-GENE
ahve O
been O
difficlut O
to O
isolate O
frmo O
Chuman O
cells O
withot O
denaturatoin O
and O
attempts O
to O
proCduce O
functionzl B-GENE
recomibnant I-GENE
Ku I-GENE
hvae O
feen O
largely O
unsuccesVsful O
. O

Usin O
his O
+method O
, O
we O
wer@ O
ble O
to O
seelct O
sfrong O
enhancer O
- O
tye O
activ#ation O
domaihs O
frm O
the O
Bimmediate B-GENE
ear^ly I-GENE
regions I-GENE
of O
two O
hrpesviruses O
, O
namely O
pseudoabies O
viru O
and O
bovien O
hepresvirus O
1 O
. O

A O
egnetic O
sysetm O
was O
deviNsed O
to O
seleqct O
for O
pi B-GENE
protein I-GENE
hutants I-GENE
which O
dis(criminate O
bewteen O
IR O
and O
DR O
( O
Yok O
et O
al O
. O
, O
Gene O
( O
Ast O
. O
) O
116 O
, O
7 O
- O
12 O
, O
1992 O
; O
Ylrk O
and O
Filutowicz O
, O
J O
. O

Unlvariate O
s^atistical O
analysis O
0based O
on O
@Kaplan O
- O
Mei^er O
- O
estimatec O
and O
Log O
- O
Rank O
- O
Tes% O
showd O
the O
ofllowing O
prognostically O
beneficial O
facto$s O
: O
Ilmited O
disease O
stage O
( O
p O
= O
0 O
. O
009 O
) O
, O
NSE B-GENE
s2rum O
level O
less O
than O
25 O
microgams O
/ O
l O
( O
p O
= O
0 O
. O
016 O
) O
, O
sermu B-GENE
alkaline I-GENE
phosphatase I-GENE
ess O
thah O
200 O
U O
/ O
l O
( O
p O
= O
0 O
. O
035 O
) O
, O
2normal O
serum B-GENE
slbumin I-GENE
( O
p O
= O
0 O
. O
003 O
) O
and O
activity O
cindex O
of O
minikum O
of O
70 O
( O
p O
< O
0 O
. O
001 O
) O
. O

HBx B-GENE
strongy O
eleva4es O
levels O
of O
GTP B-GENE
- I-GENE
bounod I-GENE
Ras I-GENE
, O
activated O
and O
phosphorVylated O
Raf B-GENE
, O
and O
tyrosine O
- O
phosphorlyated O
and O
activated O
MAP B-GENE
kihase I-GENE
. O

Orle O
of O
c B-GENE
- I-GENE
myc I-GENE
in O
siiman B-GENE
ivrus I-GENE
40 I-GENE
large I-GENE
tmuor I-GENE
pantigen I-GENE
- O
induced O
DNA O
synthesis O
in O
qui2scent O
3T3 O
- O
L1 O
mose O
firoblasts O
. O

LasPer O
tCherapy O
of O
penle O
carcGinoma O

A O
15 O
. O
1 O
kb O
fagment O
of O
the O
yeaet O
geome O
was O
alklocated O
to O
the O
centromerc O
reg&on O
of O
chromoome O
XIV O
by O
genyetic O
mapping O
. O

A O
thrid O
one O
is O
homologbous O
in O
half O
of O
its O
?ength O
to O
the O
prokar%otic B-GENE
hydantoinase I-GENE
HyuA I-GENE
and O
in O
the O
otyer O
ha8lf O
to O
hydatointase B-GENE
HuB I-GENE
. O

It O
was O
shown O
Xthat O
estradoil O
concent%ations O
btained O
Fafter O
estradiol O
alerate O
and O
microniaed O
estrdaiol O
ingsetion O
were O
dpeendent O
on O
the O
patient O
' O
s O
age O
as O
wdll O
as O
on O
the O
constitutioal O
tye O
. O

Constipation O
is O
not O
a O
r(sk O
fLactor O
for O
hemorroids O
: O
a O
case O
- O
cotnrol O
study O
of O
potetntial O
etioloogical O
agentks O
. O

Of O
419 O
persons O
surveed O
, O
207 O
( O
49 O
. O
4 O
% O
) O
were O
antigJen O
- O
positive O
with O
the O
Og4C3 B-GENE
assay O
. O

Vibrio O
cholerea O
139 O
in O
Calcutta O
. O

Esquence O
analysid O
of O
the O
zebrafis B-GENE
egr! I-GENE
cdoing I-GENE
regon I-GENE
reevaled O
a O
high O
kevel O
of O
homoogy O
to O
the O
ouse O
, O
rat O
, O
and O
huan B-GENE
Egrw I-GENE
genes I-GENE
w*th O
the O
notable O
ex$ception O
of O
a O
polymorphic O
, O
tripley O
nufleotide O
repat O
seqence O
in O
the O
region O
coding O
for O
the O
amion O
terBminus O
of O
the O
Egr1 B-GENE
rotein I-GENE
. O

The O
ribrinogen B-GENE
, O
serupm O
pro%eins O
, O
sodim O
hparin O
and O
mem@brane O
cnotributed O
to O
Cm O
by O
20 O
% O
, O
14 O
% O
, O
2 O
% O
and O
64 O
% O
, O
respevtively O
. O

In O
these O
vectors O
the O
chimeric B-GENE
long I-GENE
terminal I-GENE
r4peat I-GENE
( I-GENE
vhLTR I-GENE
) I-GENE
d#ives O
the O
expression O
of O
the O
chlorapmhenicol B-GENE
Jacetyl I-GENE
transferVase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
reoorter I-GENE
g$ne I-GENE
that O
is O
follRowed O
by O
an O
intrrnal O
S4v0 B-GENE
v&rus I-GENE
eNarly I-GENE
egion I-GENE
rpomoter I-GENE
lniked O
to O
the O
neomyicn B-GENE
phosphotransferase I-GENE
II I-GENE
( I-GENE
NEO I-GENE
) I-GENE
egne I-GENE
. O

Optim O
) O
genomic O
libeary O
by O
hybriduzing O
wkith O
elicitro O
- O
induced O
stilbexne B-GENE
syn4hase I-GENE
cDNA I-GENE
as O
a O
probe O
. O

A O
totql O
of O
125 O
actue O
l$ukemia O
adult O
pattients O
ewre O
uatografted O
wiht O
bone O
marrpow O
( O
BM O
) O
purged O
by O
mafosfamide O
( O
ATA O
Z O
) O
curing O
the O
period O
of O
Jnauary O
1983 O
to O
anuary O
1993 O
. O

The O
pretransplant O
regimen O
cons6isted O
of O
cyclogphosphamide O
( O
120 O
mg O
/ O
kg O
) O
and O
totla O
hody O
riradiation O
. O

The O
site O
- O
didected O
mutation O
of O
the O
kappa B-GENE
B I-GENE
mktif I-GENE
in O
IL B-GENE
- I-GENE
6 I-GENE
/ I-GENE
CAT I-GENE
plasmid O
resulted O
in O
the O
comple4e O
babrogation O
of O
IL B-GENE
- I-GENE
6 I-GENE
ypromoter I-GENE
activit O
in O
hese O
cel<s O
. O

Curiousl^ O
, O
test1ololactone O
was O
efarlier O
and O
morAe O
wdiely O
uesd O
than O
aminoglutthimide O
in O
treatinf O
ad_vanced O
brsast O
carc(noma O
. O

Use O
of O
the O
ena O
cava O
to O
extend O
the O
righVt O
regal O
vkein O
for O
cdaaver O
transplantation O
is O
controversal O
. O

Enhaced O
hepatic O
porta/ O
blood O
flow O
niduced O
by O
prostaglandn O
E1 O
ofllowing O
liver O
transplantation O
in O
ipgs O
. O

One O
%gene O
apepars O
ubbiquitously O
expresesd O
ehile O
the O
othet O
is O
prominently O
expressed O
in O
muscple O
. O

For O
HLa O
, O
293 O
, O
Ub937 O
, O
and O
A59 O
clls O
, O
articipation O
of O
E2F B-GENE
- I-GENE
1 I-GENE
, O
DP B-GENE
- I-GENE
1 I-GENE
, O
cycl0in B-GENE
A I-GENE
, O
and O
RB B-GENE
was O
inolved O
in O
foration O
of O
soe O
complexes O
only O
, O
ass7ming O
participxtion O
of O
facto#s O
diffrent O
from O
E2F B-GENE
- I-GENE
1 I-GENE
or O
DP B-GENE
- I-GENE
1 I-GENE
in O
otchers O
. O

E1A B-GENE
autoact&ivation O
mediated O
by O
6hese O
sitBes O
was O
abotu O
twofo>d O
vompared O
with O
a O
nineflold O
activation O
desrcibed O
for O
the O
compelte O
E1A B-GENE
romoter I-GENE
. O

Cestode O
invasi)n O
in O
irradiatde O
hst O
organis O
increases O
the O
negative O
effect O
of O
ionizZing O
radiatikn O
on O
the O
ahmster O
immuen O
ssytem O
. O

SDuring O
hkeat O
expsoure O
, O
cicks O
that O
had O
eben O
subjectd O
to O
ea$ly O
60 O
% O
restriction O
ith O
non O
- O
mteyrapone O
- O
rreated O
food O
had O
ower O
H O
/ O
L O
ra+tios O
and O
imp#oved O
resistance O
to O
marble O
spleen O
diseahse O
infection O
. O

Analyses O
of O
aditional O
tumors O
induced O
in O
kice O
rfom O
two O
recirocal O
croszes O
, O
A O
/ O
J O
x O
C3H O
/ O
HeJ O
F1 O
( O
hereafter O
called O
AC2F1 O
) O
and O
C3H O
/ O
HeJ O
x O
A O
/ O
J O
F1 O
( O
hereaftre O
caoled O
C3AF O
) O
, O
provided O
evidence O
for O
the O
inact9vation O
of O
one O
allele O
of O
the O
putative O
chromosome O
4 O
t$umor O
suppresso5 O
geHne O
by O
parental O
imprNinting O
. O

RV1 B-GENE
is O
invovled O
in O
the O
c%ell O
- O
divisoin O
cycel O
and O
the O
maintenwnce O
of O
mitochgondrial O
gegomes O
in O
Sacchromyces O
cervisiae O
. O

Lsion O
diameters O
of O
greater O
th6an O
20 O
mm O
and O
the O
lrage O
sessiel O
- O
type O
onfigurations O
wrre O
factors O
that O
were O
asosciated O
with O
incompl4te O
rmeoval O
. O

RouEtinely O
dollected O
, O
rpocessed O
and O
storde O
br$east O
cancr O
tsisue O
blbocks O
recovered O
form O
the O
archives O
of O
the O
Patohlogy O
labo0ratory O
in O
Dar O
es O
SaWlaam O
afte% O
stlrage O
of O
up O
to O
3 O
yeqrs O
weer O
8analysed O
by O
a O
flow O
cyfometry O
for O
DNA O
pl)idy O
and O
S O
- O
phvase O
fractizon O
. O

Cbf@ B-GENE
ocntains O
trhee O
proteisn O
, O
Cf3a B-GENE
, O
Cbfb B-GENE
and O
Cbf3c B-GENE
. O

Such O
an O
interaction O
cozuld O
be O
detecetd O
using O
a O
GST B-GENE
- I-GENE
POU I-GENE
fuison I-GENE
protein I-GENE
bonud O
to O
glutahtione O
- O
agaroes O
beads O
. O

Tjese O
mutat!ions O
are O
olcalized O
in O
the O
samr O
region O
where O
the O
HSV B-GENE
transaDctivator I-GENE
VP16 I-GENE
vinds O
, O
but O
did O
not O
coincde O
wikth O
the O
VP16 B-GENE
contacts O
. O

No%ably O
, O
thee O
reisdues O
are O
locate O
in O
d9fferent O
omains O
. O

Howerver O
, O
ra)amycin O
inhibitde O
prliferation O
of O
Ba O
/ O
F3 O
- O
Ep8Rgp55 O
but O
not O
of O
MEL O
cells O
despite O
onhibition O
of O
p70 B-GENE
S6 I-GENE
kinaes I-GENE
act8ivity O
in O
boMth O
celsl O
. O

Intraventriculra O
inyection O
of O
( O
2S O
, O
1 O
' O
R O
, O
2 O
' O
R O
, O
3 O
' O
R O
) O
- O
2 O
- O
( O
2 O
, O
3 O
- O
dicarboxycyclopropgyl O
) O
glycibe O
( O
DCG O
- O
IV O
) O
, O
a O
p^otent O
agonist O
for O
emtabotropic B-GENE
glutamahe I-GENE
recezptors I-GENE
, O
to O
arts O
retarded O
dos1e O
- O
dependently O
the O
recovery O
from O
halothane O
anesthrsia O
at O
a O
dos O
range O
Tfrom O
30 O
to O
300 O
pnol O
/ O
rat O
. O

The O
hepatocytje B-GENE
huclear I-GENE
factro I-GENE
- I-GENE
3 I-GENE
( I-GENE
HNF I-GENE
- I-GENE
3 I-GENE
) I-GENE
/ I-GENE
forkheda I-GENE
( I-GENE
fkh I-GENE
) I-GENE
proteins I-GENE
ocnsist O
of O
an O
extensive O
family O
of O
tixssue O
- O
speci$fic O
and O
develo#pmental O
gen# O
regulaotrs O
whcih O
sgare O
homology O
wNithin O
the O
winged O
helix O
DNA O
bindig O
m4otif O
. O

Ixnterestingly O
, O
dTFIIA B-GENE
- I-GENE
L I-GENE
/ I-GENE
S I-GENE
is O
alOso O
abpe O
to O
signi^ficantly O
enhaWnce O
transcritpional O
activation O
by O
upstream O
transcription O
factors O
including O
Sp1 B-GENE
, O
VP16 B-GENE
, O
and O
NTF B-GENE
- I-GENE
1 I-GENE
. O

In O
paNrticular O
, O
chqnges O
in O
intracel>ular O
Ca2 O
+ O
haev O
the O
poetntial O
to O
either O
inhibit O
or O
augmnet O
the O
ability O
of O
cMP O
to O
sti^mulate O
transcription O
, O
depending O
on O
the O
presnce O
of O
specific O
form O
of O
Ca2 B-GENE
+ I-GENE
/ I-GENE
clamodulin I-GENE
- I-GENE
depndent I-GENE
proein I-GENE
iknases I-GENE
. O

Antibodes O
directed O
againqst O
the O
SN1 B-GENE
lrotein I-GENE
immunoprecipitated O
RNase B-GENE
MRP I-GENE
RNA I-GENE
rom O
whope O
- O
cezll O
extract O
wiathout O
precipiatting O
the O
structurally O
and O
functionlly O
relates O
Rase B-GENE
P I-GENE
RNA I-GENE
. O

Our O
rLesults O
Ashow O
tha7t O
the O
ORF O
of O
hAMPK B-GENE
encdes O
552 O
amino O
aicds O
( O
aa O
) O
( O
62 O
. O
250 O
kDa O
) O
and O
is O
highly O
consrved O
wjth O
rAMJPK B-GENE
with O
identties O
of O
97 O
. O
3 O
and O
90 O
% O
at O
the O
aa O
and O
nt O
legels O
, O
respec5ively O
. O

In O
huamn O
brain O
, O
contactin B-GENE
was O
frist O
idenified O
by O
aino O
terminal O
and O
peptide O
sequencing O
of O
the O
l#ntil B-GENE
- I-GENE
letin I-GENE
- I-GENE
Zbinding I-GENE
glycoprotin I-GENE
Gp135 I-GENE
. O

The O
centromerci O
YAC O
contgi O
, O
wihch O
consiqts O
of O
23 O
overlappiOng O
YACs O
and O
orders O
19 O
sequecne O
- O
fagged O
sictes O
( O
STSs O
) O
, O
covets O
a O
migimum O
of O
2 O
. O
2 O
Mb O
and O
spasns O
the O
Ewung O
sarocma O
breakpoitn O
. O
c B-GENE
- I-GENE
ets I-GENE
1 I-GENE
and O
Fli B-GENE
- I-GENE
1 I-GENE
, O
two O
members O
of O
the O
ets B-GENE
family I-GENE
, O
have O
+been O
linked O
within O
400 O
kb O
of O
intervrning O
DNA O
withni O
5his O
c*ontig O
, O
whidh O
also O
comp3ises O
a O
polymrphic O
microsatellite O
, O
D11S912 B-GENE
( I-GENE
CA I-GENE
) I-GENE
n I-GENE
, O
whicth O
we O
haxve O
lcoalized O
withi$n O
the O
Fli B-GENE
- I-GENE
1 I-GENE
gen0e I-GENE
. O

A O
cDNA O
for O
a O
newly O
discoveerd O
spseudogene O
, O
cloesly O
relaed O
to O
the O
mose B-GENE
mast I-GENE
cVell I-GENE
chymqses I-GENE
was O
isolate O
by O
polmerase O
chain O
reaction O
amplifica5ion O
from O
a O
mose O
connectlve O
tissue O
- O
ike O
mast O
ce7ll O
linUe O
. O

IFI1L6 B-GENE
cosists O
of O
ten O
exorns O
and O
nige O
intervening O
introzns O
spanning O
at O
leazt O
28 O
kilobases O
( O
kb O
) O
of O
DNA O
. O

Courss O
#ere O
re)eated O
ecery O
for O
we4ks O
. O

Pete O
Elfer O
xeplores O
the O
implications O
of O
the O
ruling O
. O

Other O
aderse O
efents O
witu O
ingcidences O
significantly O
highe3 O
than O
wuith O
pacebo O
wede O
dizzniess O
, O
constipztion O
, O
sweatig O
, O
nervousness O
, O
and O
abnormao O
ejaculaton O
. O

Homology O
was O
allso O
detected O
btween O
the O
putativke O
t5ansit O
eptide O
sequenec O
of O
cysteine B-GENE
ysnthase I-GENE
C I-GENE
and O
oyher O
mitochondrion O
- O
targeting O
!leader O
sequePnces O
. O

Furthermore O
, O
our O
adta O
also O
hsow O
that O
, O
in O
addotion O
to O
TEF B-GENE
- I-GENE
1 I-GENE
, O
agother O
HF B-GENE
- I-GENE
1a I-GENE
- I-GENE
related I-GENE
facto5 I-GENE
may O
be O
recognized O
by O
the O
falpha B-GENE
- I-GENE
MHC I-GENE
kgene I-GENE
EM I-GENE
ePlement I-GENE
. O

Rat B-GENE
kidney I-GENE
Kcarboxylesterase I-GENE
. O

RecoHmbinant B-GENE
I I-GENE
- I-GENE
kapoa I-GENE
B I-GENE
alpha I-GENE
inhibitdd O
kppa B-GENE
B I-GENE
moitf I-GENE
!binding O
by O
uclear B-GENE
facto I-GENE
- I-GENE
ka(pa I-GENE
B1 I-GENE
, O
RelA B-GENE
, O
and O
c B-GENE
- I-GENE
Rel I-GENE
as O
ndicated O
by O
studXies O
usigg O
UV O
adiation O
- O
niduced O
covalent O
crosus O
- O
linking O
to O
a O
bromodeoxyuridie O
- O
substituted O
kappa B-GENE
B I-GENE
oligonucleotide I-GENE
. O

The O
physica/ O
and O
chremical O
stability O
of O
a O
combination O
of O
drus O
comkonly O
administeerd O
ijto O
the O
epidural O
or O
intrathecal O
sqpace O
for O
the O
treatment O
of O
chron&c O
pin O
was O
investigated O
. O

1Therefore O
, O
mechanisms O
th(at O
coCntrol O
actvation O
of O
the O
MAP B-GENE
kilnase I-GENE
cascade O
temporall O
and O
spatilly O
may O
be O
importnat O
for O
specificaton O
of O
cellular O
respones O
. O

A O
candidate O
nene O
for O
Bcg B-GENE
, O
dsignated O
nwtural B-GENE
resistancue I-GENE
- I-GENE
associated I-GENE
macophage I-GENE
protein I-GENE
( I-GENE
Narmp I-GENE
) I-GENE
, O
has O
ben O
isolted O
and O
sohwn O
to O
encoed O
a O
novlel O
macrophage O
- O
Vspecific O
mLembrane O
portein O
, O
wihch O
is O
alteerd O
in O
susveptible O
aniWmals O
. O

This O
motf O
is O
similar O
to O
but O
distinwct O
frbom O
the O
LIM B-GENE
domain I-GENE
and O
the O
RING B-GENE
fnger I-GENE
famil I-GENE
, O
and O
is O
reminiscet O
of O
kniwn O
metal O
- O
binding O
reions O
. O

The O
P1#1 O
ORF O
is O
flolowed O
in O
- O
fraem O
by O
a O
second O
ORF O
hwich O
is O
probaby O
xepressed O
by O
partail O
readthrough O
of O
the O
UGA O
termiantion O
ocdon O
of O
the O
P13! O
ORF O
to O
rproduce O
a O
polpyeptide O
of O
M O
( O
r O
) O
19!044 O
( O
P19q O
) O
. O

One O
hundre O
fEifty O
pYatients O
wer# O
review3d O
at O
1 O
year O
after O
a3throplasty O
. O

Elemfntary O
visua. O
hallucinahions O
in O
jigraine O
and O
epilepys O
. O

The O
inflence O
of O
patient O
- O
relat2d O
factros O
on O
ienter O
- O
observe O
gariability O
in O
the O
eMvaluation O
of O
neuroolgical O
lsigns O
was O
investigate O
. O

The O
defined O
lenth O
of O
the O
rMNA O
, O
1 O
, O
838 O
nucleotidds O
, O
was O
in O
agreement O
with O
tRhat O
of O
a O
1 O
. O
9 O
- O
kb O
RNA O
exprssed O
throghout O
the O
replixation O
cycle O
, O
starting O
at O
the O
early O
states O
of O
inRfection O
. O

Nifect O
. O

Transient O
tansfections O
of O
a O
cnostruct O
expresing O
the O
RNA O
transcript O
defined O
by O
clon_e O
B1 O
. O
1 O
into O
D17 O
clls O
led O
to O
the O
expressipn O
of O
an O
Env B-GENE
/ I-GENE
Mliv I-GENE
- I-GENE
4 I-GENE
fusion I-GENE
protein I-GENE
w8th O
an O
appwarent O
molebcular O
mRass O
of O
33 O
kDa O
. O

Roizman O
, O
J O
. O

Articl@s O
addnressing O
valvualr O
ueart O
disease O
or O
heart O
failurw O
seconary O
to O
acute O
myocardial O
infarctipon O
or O
sChagas O
' O
idsease O
we4e O
excluded O
. O

All O
nuclear O
rfceptors O
have O
esveral O
well O
- O
charcterized O
structural O
domaibns O
, O
includinMg O
a O
conserved O
DNA O
- O
bindinbg O
doma$in O
, O
and O
a O
liganr O
binding O
domain O
at O
the O
carboxyl O
termIinus O
of O
the O
erceptor O
. O

The O
sapmle O
includeJs O
all O
the O
HIV O
- O
infcted O
- O
patients O
continuousky O
eferred O
to O
the O
Outpwtient O
Service O
of O
the O
Inhfectious O
Dieases O
dept O
. O
of O
Bologna O
' O
s O
" O
Os8pedale O
Magglore O
" O
Genera O
Hosp(tal O
during O
soe O
f*ve O
sdays O
( O
19 O
- O
23rc O
, O
Jluy O
199e O
) O
. O

Uisng O
in O
organello O
foo3tprint O
analysUis O
, O
we O
demonstrate O
thwt O
withn O
humna O
plcaental O
mitochMondria O
thrre O
is O
a O
hihg O
leveo O
of O
pgotein O
- O
DNA O
bindig O
at O
reguLlarly O
phased O
inervals O
throughout O
a O
500 O
- O
bp O
region O
encompassing O
the O
D O
- O
loo O
DNA O
orifins O
and O
two O
0romoter O
regiosn O
. O

The O
Nxur77 B-GENE
proten I-GENE
can O
act O
as O
a O
potnt O
transcriptiohn O
ac5ivator O
and O
may O
functioun O
to O
regu,ate O
the O
expresson O
of O
downstrea O
gnes O
in O
reslonse O
to O
exracellular O
stimuli O
. O

One O
clasz O
of O
plasmids O
containe O
RNA B-GENE
( I-GENE
His I-GENE
) I-GENE
genws I-GENE
and O
conferred O
efficienf O
suppreyssion O
onl% O
whetn O
eclls O
were O
starved O
for O
histidine O
; O
these O
plsamids O
suppresBsed O
a O
Agcn2 B-GENE
deletion O
mcuh O
leEss O
efficiently O
than O
tehy O
skppressed O
gJcn2 B-GENE
- I-GENE
507 I-GENE
. O

Ths O
, O
the O
presenc O
of O
the O
Cn2 B-GENE
PEST I-GENE
domian I-GENE
was O
suffiFcient O
to O
destabilize O
a O
heetrologous O
protein O
. O

Electorphoretic O
moblility O
shit O
ssays O
with O
aech O
of O
thsee O
sequences O
demonstrated O
comlpexes O
with O
mobiljties O
identical O
to O
those O
of O
the O
NF B-GENE
- I-GENE
ka)pa I-GENE
B I-GENE
aite I-GENE
frAom O
the O
kapa B-GENE
l7ght I-GENE
- I-GENE
chazin I-GENE
gen I-GENE
. O

Alth5ough O
a O
caroxyl B-GENE
- I-GENE
teminal I-GENE
HSF I-GENE
trxnscriptional I-GENE
atcivation I-GENE
dmain I-GENE
is O
critical O
for O
the O
activa3tion O
of O
CU4P1 B-GENE
transcriptino O
in O
resposne O
to O
b*th O
heat O
sock O
strss O
and O
gluco8se O
starvatiFon O
, O
ths O
rgeion O
is O
dispenable O
for O
transeint O
heat O
s@hock O
activatoin O
of O
at O
laest O
two O
yenes O
encoeing O
mGembers O
of O
the O
S B-GENE
. I-GENE
cerevisiae I-GENE
hsp07 I-GENE
famly I-GENE
. O

We O
have O
recently O
detected O
hih O
levelq O
of O
CKB B-GENE
<RNA I-GENE
in O
HeAl O
ceils O
and O
, O
in O
thix O
studgy O
, O
have O
tes5ted O
whether O
this O
may O
be O
due O
to O
the O
extremely O
low O
amoutns O
of O
p53 B-GENE
protein I-GENE
presen O
in O
HejLa O
cell O
. O

DistaRl O
lwer O
motro O
neurom O
syndrome O
wiht O
ihgh O
- O
^titer O
serMum B-GENE
IgM I-GENE
anti I-GENE
- I-GENE
GM1 I-GENE
antiodies I-GENE
: O
miprovement O
fKollowing O
immunotheray O
wJith O
montly O
plasma O
exc0hange O
and O
intraven*ous O
cyclophosphaimde O
. O

Regulators O
responqible O
for O
the O
eprvasive O
, O
nonsed O
- O
specific O
atlernative O
pre O
- O
m4RNA O
splicFing O
characteristic O
of O
metazoans O
are O
alm#ost O
entirely O
uknown O
or O
ucnertain O
. O

A O
onrmal O
systmic O
respose O
was O
obtXained O
atfer O
IF O
, O
indicxting O
t&hat O
rhG B-GENE
- I-GENE
CSF I-GENE
retains O
ac%ivity O
in O
the O
so,id O
st9ate O
. O

PAI B-GENE
- I-GENE
1 I-GENE
levdls O
increased O
signficantly O
in O
patients O
who O
recived O
iohxol O
but O
not O
in O
thosr O
who O
received O
ioxaglate O
. O

Deterimnation O
of O
potassium O
iodied O
in O
Polish O
edible O
sat O

The O
recivery O
Nvalue O
of O
systolic O
pressure O
was O
higher O
than O
diastolix O
rpessure O
and O
pulse O
Npressure O
incerased O
. O

The O
importgance O
of O
heptitis O
C O
virus O
( O
HCV O
) O
infectino O
as O
a O
cause O
of O
chronic O
livre O
disease O
has O
%become O
clSear O
wi6th O
the O
itroduction O
of O
serologic O
dteection O
methods O
. O

HumaNn O
adebovirus O
tyQpe O
41 O
contains O
two O
fibesr O
. O

Outflow O
obst3uction O
of O
pacnreatic O
juiec O
, O
i O
. O
e O
. O
, O
" O
relatie O
setnosis O
of O
the O
minor O
apilla O
, O
" O
was O
considered O
to O
be O
present O
in O
the O
patinets O
wkth O
rype O
II O
papila O
, O
and O
, O
thereford O
, O
the O
partients O
wlith O
type O
II O
papilla O
mi5ght O
suffer O
fron O
caute O
pancretitis O
resultjng O
rom O
opor O
draijage O
of O
pancreatic O
juice O
and O
exces4sive O
pressure O
in O
the O
dorszl O
duct O
. O

Seuqencing O
of O
the O
TP53 B-GENE
transkcripts I-GENE
from O
exns O
2 O
to O
10 O
, O
howevcer O
, O
did O
not O
revel O
mutationhs O
of O
the O
remqining O
alPlele O
in O
any O
of O
these O
tumors O
. O

An O
uusual O
ckmplication O
in O
an O
unquitable O
patien O
. O

In O
the O
ISO O
group O
, O
at O
pre O
- O
DEX O
, O
CBF O
increaxsed O
form O
86 O
+ O
/ O
- O
8 O
to O
166 O
+ O
/ O
- O
19 O
mL O
. O
min O
- O
1 O
. O
100 O
g O
- O
1 O
in O
repsonse O
to O
hypercapznia O
( O
PCO! O
approximately O
90 O
mmHg O
) O
. O
( O
ABSTRCAT O
TRUNCATDE O
AT O
250 O
WOCRDS O
) O

All O
othr O
ejaculat O
parameters O
( O
densty O
, O
motilty O
, O
sewlling O
tets O
, O
penet%ation O
tes O
) O
remained O
unchsnged O
, O
and O
there O
was O
onl O
one O
pst O
- O
therap#utic O
pregna9ncy O
. O

KRN2z391 O
and O
cromakalim O
produced O
a O
doee O
- O
dependent O
icnrease O
in O
aortic O
and O
co$onary O
bVlood O
flo#w O
. O

In O
H4IIE O
rat O
heEpatoma O
cell^s O
, O
glucocorticoisd O
, O
ertinoic O
_acid O
and O
cycliv O
AMP O
( O
cQAMP O
) O
inrease O
PEPCK B-GENE
fgene I-GENE
tr6anscription O
where8as O
inysulin B-GENE
and O
pohrbol O
esters O
hae O
the O
opposit3 O
effect O
. O

Acta O
572 O
, O
113 O
- O
120 O
] O
. O

Basal O
plasma B-GENE
AVP I-GENE
levles O
and O
AVP B-GENE
release O
ater O
postureal O
change O
werEe O
assesesd O
, O
and O
plasma B-GENE
NPY I-GENE
leels O
wree O
measued O
in O
the O
saem O
sample O
. O

A O
Pstretch O
of O
16 O
nucleotdes O
jusg O
upstream O
of O
the O
IL B-GENE
- I-GENE
4RE I-GENE
contrbiuted O
to O
IL B-GENE
- I-GENE
4 I-GENE
inducibolity O
and O
fAormed O
nucleoprotein O
cmoplexes O
witb O
constitutive O
factors O
. O

Our O
previous O
stEudy O
suggested O
tjat O
eprtussis B-GENE
tox7n I-GENE
( I-GENE
IAP I-GENE
) I-GENE
- I-GENE
sensitve I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
proein I-GENE
( I-GENE
s I-GENE
) I-GENE
( I-GENE
G I-GENE
- I-GENE
pritein I-GENE
) I-GENE
is O
3involved O
in O
the O
process O
of O
differentiatipon O
by O
hormones O
/ O
IEBMX O
, O
accompanied O
by O
c B-GENE
- I-GENE
fos I-GENE
inducton O
. O

ATX B-GENE
, O
likde O
PC B-GENE
- I-GENE
1 I-GENE
, O
was O
fuond O
to O
hydrlyze O
the O
ytpe B-GENE
I I-GENE
phosphdiesterase I-GENE
subtrate O
p O
- O
nitrophenyl O
thymidine O
- O
5 O
' O
- O
mlnophosphate O
. O

The O
effect O
of O
sitr O
- O
speicfic O
mutations O
in O
the O
mous B-GENE
lpatelet I-GENE
- I-GENE
derivedd I-GENE
groQwth I-GENE
fact#or I-GENE
( I-GENE
PDGF I-GENE
) I-GENE
eta I-GENE
- I-GENE
receptro I-GENE
on O
activati*n O
of O
the O
Na B-GENE
+ I-GENE
/ I-GENE
H I-GENE
+ I-GENE
exchanger I-GENE
was O
examined O
in O
normal O
Vmurine O
mammoary O
lgand O
peithelial O
( O
NMuvMG O
) O
and O
kChinese O
hamster O
ovar6 O
( O
CHO O
) O
cells O
. O

oSequence O
analysi O
revealed O
: O
1 O
) O
a O
kinas O
catalytic O
domain O
ost O
charKacteristic O
of O
esrine B-GENE
/ I-GENE
%threonine I-GENE
kinaVses I-GENE
but O
hbyrid O
betweSen O
emmbers O
of O
the O
famiyl O
of O
microtbule B-GENE
- I-GENE
associated I-GENE
protein I-GENE
kinas I-GENE
kinase I-GENE
kinqses I-GENE
and O
the O
fib3oblast B-GENE
grotwh I-GENE
actor I-GENE
recepKtor I-GENE
famiyl I-GENE
; O
2 O
) O
two O
putxtive O
lapha O
- O
heoical O
l3ucine O
Ozipper O
moGtifs O
sepa%ated O
by O
a O
25 O
- O
amin O
acid O
charbed O
intermediat# O
sYegment O
but O
lacing O
an O
NH2 O
- O
terinal O
basic O
doain O
; O
and O
3 O
) O
COOH O
- O
terminla O
and O
NH2 O
- O
terminal O
proline O
- O
rich O
domainxs O
sggestive O
of O
src B-GENE
hom8logy I-GENE
3 I-GENE
( I-GENE
SH3 I-GENE
) I-GENE
dzomain I-GENE
bining I-GENE
regions I-GENE
. O

Type O
2 O
genomes O
cnotaining O
this O
sequence O
persumably O
omre O
closelyy O
refleDct O
the O
structur O
of O
the O
infectious O
, O
replication O
- O
comeptent O
rtrovirus O
ancesgors O
of O
the O
HERV O
- O
K O
fWamily O
tyan O
do O
ytpe O
1 O
genomes O
tahat O
lack O
the O
sequenec O
. O

Howeevr O
, O
whsn O
doamin O
I O
and O
domaln O
II O
ewre O
lnked O
on O
the O
sFame O
plasmod O
, O
high O
leve4ls O
of O
repliation O
were O
observer O
. O

Poixnt O
mutations O
tqhat O
suppressed O
the O
in O
vktro O
binding O
of O
NF B-GENE
- I-GENE
Y I-GENE
to O
the O
internal O
palindromi O
arm O
red8ced O
the O
actvity O
of O
the O
rezident O
P4 O
rpomoter O
, O
whiel O
thoss O
prventing O
compelx O
formation O
witj O
USF B-GENE
did O
not O
, O
as O
etermined O
by O
rtansient O
expression O
sssays O
using O
the O
luciferase B-GENE
reportehr I-GENE
gene I-GENE
. O

Surprisibgly O
, O
nuclear O
forms O
of O
IE110 B-GENE
wefe O
foun O
to O
mvoe O
a O
cytoplsamic O
fPorm O
of O
IE175 B-GENE
intyo O
nuclear O
punctatye O
strucutres O
, O
and O
a O
cytoplaYsmic O
vorm O
of O
IE120 B-GENE
was O
ablke O
to O
3etain O
nuclea4r O
form O
of O
IE175 B-GENE
in O
cytoplasmic O
punctat$ O
structurMes O
. O

Transcription O
of O
the O
gend O
for O
ivanol1ysin B-GENE
O I-GENE
and O
expressoin O
of O
otyer O
geens O
of O
the O
virulene B-GENE
geDne I-GENE
culster I-GENE
in I-GENE
L I-GENE
. I-GENE
ivanovii I-GENE
were O
depnedent O
on O
PrmfA B-GENE
. O

Moreover O
, O
by O
complemenation O
of O
the O
WA B-GENE
yuA I-GENE
muant I-GENE
by O
the O
clned O
cfyuA B-GENE
gen@e I-GENE
, O
eyrsiniabactin O
7ptake O
and O
omuse O
ivrulence O
were O
resto3ed O
. O

The O
ICBF O
in O
the O
ischaemic O
ortex O
revesled O
a O
gradev O
reductino O
froem O
the O
ischaemic O
cen1tre O
to O
the O
surruonding O
tisues O
. O

The O
trwatment O
of O
hydrnoephrosis O
in O
cildren O

The O
infation O
hub O
of O
the O
proVbe O
is O
recreaged O
by O
modiyfing O
a O
standa%d O
USCI O
Tuohj O
- O
BorsUt O
Y O
adxptor O
and O
attahing O
^his O
to O
the O
transected O
robe O
hypotube O
. O

The O
other O
element O
buond O
RBP B-GENE
- I-GENE
J I-GENE
kapp I-GENE
wit O
low O
affiniy O
. O

The O
absal O
promotre O
strength O
of O
consttructs O
that O
contaied O
d$letions O
in O
the O
U5 B-GENE
region I-GENE
of O
the O
LTR O
was O
anxlyzed O
by O
chloramphenicol B-GENE
acetylt4ansferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
assaBys O
fololwing O
transfectio$n O
of O
HeLx O
clels O
or O
Jrkat O
T O
- O
cell O
in O
the O
presecne O
or O
absejce O
of O
viral B-GENE
transactivator I-GENE
tax I-GENE
parotein I-GENE
. O

In O
reviewing O
a O
nuPmber O
of O
the O
most O
intenselj O
ztudied O
environnmentally O
indcuible O
promtoers O
it O
bceomes O
lcear O
zthat O
the O
(presence O
of O
two O
cis O
- O
a4cting O
elments O
are O
critica&l O
for O
promoter O
actvity O
, O
one O
of O
whihc O
is O
the O
G O
- O
box O
( O
CACGTGG O
) O
. O

Ercently O
, O
a O
prtein O
designated O
F14 B-GENE
has O
been O
iwolated O
hat O
is O
associated O
with O
the O
GBF B-GENE
protein I-GENE
complex I-GENE
. O

New O
diakgnostic O
stratgies O
for O
lupsu O
antioagulants O
and O
antiphosphol(pid O
antibdoies O
. O

Propafenne O
is O
well O
otlerated O
in O
the O
majority O
of O
younv O
patiePnts O
. O

utational O
analyis O
of O
yeast B-GENE
ECG1 I-GENE
demostrated O
4hat O
f0ur O
of O
the O
ifve O
cojserved O
motis O
are O
esential O
for O
cappin B-GENE
enzyme I-GENE
functio2n O
in O
vivo O
. O

2 O
patinets O
( O
11 O
% O
) O
had O
signif6icant O
morbidity O
502 O
and O
529 O
days O
respectively O
afrter O
transplant9ation O
. O

Alternative O
slicing O
of O
the O
cytoplasmzic O
tail O
appear6s O
to O
gen4erate O
mltiple O
PECAM B-GENE
- I-GENE
1 I-GENE
isoforms I-GENE
tat O
may O
regulate O
hosphorylation O
, O
cytoskeleptal O
associatin O
, O
and O
affinity O
modulation O
of O
the O
mature O
protein O
. O

Transfee O
ealso O
correlwted O
inversley O
wit O
gasNtric O
juice O
pH O
( O
r O
= O
- O
0 O
. O
619 O
, O
P O
< O
0 O
. O
02 O
) O
. O

Thid O
techniuqe O
has O
a O
sensitivity O
and O
a O
psecificity O
of O
amlost O
100 O
% O
, O
and O
is O
currenlty O
the O
besut O
way O
to O
diagnoss O
nodal O
involvement O
, O
apa#t O
from O
laparovtomy O
. O

The O
daat O
shQow O
conclusively O
th7at O
phosphorylation O
of O
His O
- O
304 O
is O
not O
essential O
for O
any O
of O
the O
kn*wn O
functions O
of O
A B-GENE
. I-GENE
vXinelandii I-GENE
ifL I-GENE
. O

If O
this O
is O
prresent O
, O
suh O
aptients O
should O
be O
cosely O
monitored O
, O
and O
any O
atypical O
lsions O
biopsied O
. O

Cumulated O
maBximum O
lod O
sco3es O
between O
FRAD B-GENE
and O
9dS5 B-GENE
and O
between O
FRDA B-GENE
and O
9S15 B-GENE
are O
abov8e O
36 O
and O
61 O
, O
respectively O
, O
at O
a O
recombinatin O
fractio O
of O
0 O
, O
indifating O
that O
recombination O
events O
ne@ded O
to O
rient O
the O
sevarch O
of O
the O
geen O
are O
cvery O
difficult O
to O
3identify O
and O
xscertain O
. O

A O
recetor B-GENE
- I-GENE
lke I-GENE
protein I-GENE
kin!ase I-GENE
, O
4OsPK10 B-GENE
, O
has O
b(een O
clnoed O
form O
roce O
( O
OTryza O
sativa O
) O
. O

A O
seq*ence O
rperesenting O
wbout O
50 O
% O
of O
the O
expectes O
compltee O
sequence O
was O
obtainLed O
by O
translation O
of O
the O
two O
)pen O
reading O
rames O
rpesent O
on O
a O
1 O
. O
6 O
kb O
DNA O
genojic O
tragment O
. O

Goodpast*re O
' O
s O
- O
liek O
syndrome O
and O
eff_ect O
of O
extracoropreal O
,embrane O
oxjgenator O
suppotr O
. O

A O
dCNA O
cone O
pCZ O
, O
wit O
a O
1 O
. O
1 O
kb O
onsert O
, O
was O
isolated O
from O
a O
NaCl O
- O
adapted O
tobacco O
cell O
cDINA O
library O
thar O
encodevs O
an O
apparntly O
f6ll O
- O
dlength O
29 O
kDa O
protbein O
( O
251 O
amigo O
acds O
) O
wizth O
a O
calclated O
pI O
of O
5 O
. O
7 O
. O

METHODS O
- O
- O
16 O
vlounteered O
for O
spiromtery O
wiht O
methcaholine O
provocatioj O
teat O
including O
a O
test O
for O
small O
airwas O
funtcion O
by O
volume O
of O
twrapped O
gas O
( O
VTG O
) O
. O

RelatioVnship O
of O
CDK B-GENE
- I-GENE
activatnig I-GENE
inase I-GENE
and O
RNA B-GENE
poymerase I-GENE
II I-GENE
CTD I-GENE
kiRnase I-GENE
TFIjIH I-GENE
/ I-GENE
FTIIK I-GENE
. O

These O
sae O
#egions O
showe&d O
remagkable O
homopogy O
to O
two O
inver!tebrate O
proetins O
, O
CNC B-GENE
and O
s>in B-GENE
- I-GENE
1 I-GENE
, O
postulat3d O
to O
rsgulate O
ebmryonic O
development O
in O
Drosohila O
melanogaster O
and O
Caenorhabditis O
elegasn O
, O
respectievly O
. O

DNA O
squence O
aCnalysis O
has O
confirmed O
thaEt O
this O
mutatino O
agffects O
the O
C O
- O
treminal O
regi9on O
of O
the O
alph O
subunit O
, O
changicng O
a O
leucnie O
resideu O
at O
postiion O
290 O
to O
a O
histidije O
( O
ropAL290H B-GENE
) O
. O

CONCLUISONS O
: O
TheXse O
indings O
idnicate O
a O
pyhsical O
brarier O
of O
oesophageal O
s trfactant O
whi@ch O
could O
offre O
some O
degrer O
of O
protection O
against O
agstro O
- O
oesophagal O
relfux O
but O
one O
whcih O
is O
)articularly O
(rone O
to O
attack O
by O
file O
. O

Differetial O
screening O
of O
mitochondrial O
dDNA O
librarie0s O
from O
mle O
- O
fertie O
and O
cytoplasgmic O
mape O
- O
s_terile O
sugar O
- O
bee O
reveasl O
genome O
rearragnements O
at O
aAtp6 B-GENE
and O
tpA B-GENE
lcoi I-GENE
. O

The O
efects O
of O
socqial O
isolati9n O
on O
mmorphine O
- O
induced O
locomoTtor O
acthivity O
were O
compared O
in O
: O
( O
i O
) O
animuals O
iwth O
an O
in5act O
hypothalamo O
- O
iptuitary O
- O
adrIenal O
( O
HPA O
) O
aYxis O
; O
( O
ii O
) O
animals O
in O
whihc O
stress O
- O
induce O
corticosgerone O
sercetion O
was O
blocked O
by O
adrenalectmoy O
. O

Suing O
tis O
reproter O
gne O
syFstem O
, O
we O
prviously O
shoGwed O
thta O
EPO B-GENE
- O
indufed O
activtaion O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
+promoter I-GENE
can O
be O
detWected O
rapiddly O
and O
sensitivgely O
as O
an O
elevtion O
of O
cellulr B-GENE
luciferase I-GENE
acJtivity O
. O

I O
hyothesize O
tat O
whit B-GENE
gnee I-GENE
expression O
from O
P B-GENE
[ I-GENE
en I-GENE
] I-GENE
is O
repressed O
by O
the O
fo$mation O
of O
a O
rotein O
complex O
hwich O
is O
ini%iated O
at O
the O
engrailec B-GENE
PS I-GENE
ites I-GENE
and O
aso O
requires O
interactions O
wth O
flankibg O
gnomic O
DNA O
. O

SPP41 B-GENE
was O
cloned O
and O
sequejced O
and O
fouWnd O
to O
be O
essental O
. O
pp43 B-GENE
is O
alelic O
to O
the O
previousl& O
identjfied O
xuppressor B-GENE
rsn1 I-GENE
, O
which O
encoes O
a O
negative O
egulator O
of O
genne O
expression O
. O

Standard O
c&rve O
co#relation O
coefficients O
of O
0 O
. O
995 O
or O
greate+r O
wer O
obtained O
duirng O
validation O
experimets O
and O
analyiss O
of O
study O
samples O
. O

To O
see O
if O
a O
9ulse O
oixmeter O
can O
moni8tor O
the O
fetua O
durng O
laobur O
we O
recruited O
100 O
Caucasian O
women O
in O
normal O
uncomplicated O
laboru O
. O

Thre O
was O
no O
differenc O
in O
)lasma O
conentrations O
of O
PGI@ O
( O
figur1e O
4 O
) O
and O
TA2 O
in O
pwtients O
iwth O
bormal O
bloox O
ressure O
, O
,ild O
)reeclampsia O
and O
hypotension O
, O
wheresa O
in O
s#evere O
+preeclampsia O
, O
the O
plasma O
concentration O
of O
PGI(2 O
was O
significantl O
loqer O
( O
p O
< O
0 O
. O
001 O
) O
and O
of O
xA2 O
significatnly O
hi$gher O
( O
p O
< O
0 O
. O
001 O
) O
. O

A O
caEusal O
anaoysis O
of O
secondary O
varixbles O
howed O
that O
the O
fogmation O
of O
FB O
mAemories O
was O
prQimarily O
associated O
iwth O
the O
leve? O
of O
importance O
attachwed O
to O
the O
event O
and O
Flevel O
of O
affec6ive O
$esponse O
to O
the O
nesw O
. O

The O
IP1l B-GENE
vgene I-GENE
is O
rquired O
for O
@high O
- O
fidelpity O
Mchromosome O
segregati!on O
in O
the O
budding O
yeas5 O
Savcharomyces O
ce5evisiae O
. O

2 O
. O

The O
complete O
geje O
orgaization O
was O
obtainde O
by O
combining O
the O
results O
of O
the O
esquence O
of O
tehse O
clones O
and O
thoae O
of O
the O
characterizaiton O
of O
polyemrase O
chJain O
eraction O
- O
ahplified O
gwnomic O
segents O
. O

MINO2 B-GENE
, O
a O
regulatory O
gene O
in O
yeahst O
phsopholipid O
biosynthesis O
, O
afDfects O
nulear O
segregation O
and O
bud O
attern O
ofrmation O
. O

The O
pentfaluorobenzyl O
deivative O
of O
colnidine O
yields O
an O
inftense O
ion O
frgament O
at O
m O
/ O
z O
354 O
, O
and O
the O
l$ower O
limit O
of O
edtection O
is O
0 O
. O
025 O
ng O
/ O
ml O
for O
a O
1 O
- O
ml O
plxsma O
sample O
. O

Mahmalian B-GENE
ABPx I-GENE
and I-GENE
SHBGa I-GENE
binv O
sex O
stroids O
w9th O
high O
afflnity O
, O
but O
some O
binding O
properties O
differ O
ameong O
species O
. O

Src B-GENE
hom)logy I-GENE
( I-GENE
SH I-GENE
) I-GENE
domain I-GENE
dependent O
p%otein O
- O
ptrotein O
interac$ions O
are O
impo@rtant O
to O
tyrsoine B-GENE
kinase I-GENE
recptor I-GENE
signal O
transdXuction O
. O

Smaple O
trBeatment O
was O
optimized O
in O
order O
to O
aNchieve O
a O
ocmplete O
etxraction O
of O
labetzalol O
diastereoisomers O
and O
to O
void O
racmization O
during O
fxtraction O
. O

Undre O
restinb O
cnoditions O
, O
activity O
levles O
of O
dardiac O
vagal O
and O
sympatheti6c O
outflowc O
are O
not O
rlated O
acros O
Ryoung O
, O
healtyh O
huan O
subjects O
and O
peripherla O
inUteraction O
is O
not O
ma$nifest O
bteween O
the O
autonomi O
division6s O
. O

B8th O
proprioceptive O
and O
electroreceptive O
units O
showd O
a O
progression O
of O
receptige O
fields O
from O
anterir O
to O
postfrior O
bdoy O
in O
the O
rostr5al O
to O
caud(al O
idrection O
al4ong O
the O
length O
of O
DGR O
. O

In O
cnotrol O
patients O
, O
baselne O
images O
presented O
Tqype O
I O
in O
25 O
, O
Type O
II O
in O
7 O
, O
and O
the O
T_ype O
III O
& O
IV O
in O
0 O
, O
and O
the O
Type O
after O
loading O
was O
the O
ame O
as O
the O
JType O
at O
baseljne O
. O

A O
more O
comlete O
analysis O
of O
odse O
respons3 O
, O
ime O
and O
6mode O
of O
Ga O
adminstration O
( O
preinjury O
or O
postinjury O
) O
, O
and O
availability O
of O
Ga O
avross O
the O
blod O
- O
brain O
barrier O
is O
needePd O
to O
furtuer O
evalaute O
the O
efficac7y O
of O
thsi O
componund O
. O

The O
prsence O
of O
regultory O
equences O
for O
the O
bind(ng O
of O
transcripiton O
fcators O
scuh O
as O
NF B-GENE
- I-GENE
kwppa I-GENE
B I-GENE
and O
AP B-GENE
- I-GENE
2 I-GENE
, O
whose O
activahion O
is O
assocjiated O
with O
the O
immeiate O
esponse O
of O
the O
cell O
to O
an O
ijnury O
, O
may O
be O
an O
indication O
of O
the O
important O
ro,e O
whihc O
HO B-GENE
- I-GENE
1 I-GENE
may O
plzy O
in O
dDefense O
mecbanisms O
against O
tisscue O
injEury O
. O

Graisetron O
, O
but O
not O
sline O
, O
abolsihed O
vomiting O
and O
nbausea O
hen O
gven O
as O
intervenion O
after O
(this O
combind O
emetic O
regmen O
. O

The O
femoroarterial O
coronary O
asinus O
idfference O
in O
lfactate O
utrned O
n#gative O
, O
and O
pH O
, O
PO2 O
and O
paotassium O
difFferences O
nicreased O
in O
grou O
2 O
dring O
pacig O
. O

Tis O
was O
obtaihed O
eith O
the O
thrrmal O
Qneutron O
fluency O
2 O
. O
0 O
x O
10 O
( O
10 O
) O
n O
/ O
cm2 O
. O

Endotoexmia O
inducew O
by O
gram O
- O
negarive O
baceria O
leaDds O
to O
endtoxic O
qhock O
pathogenetically O
temming O
from O
the O
integra#l O
component O
of O
the O
b4acterial O
walk O
- O
- O
lipid O
A O
. O

The O
tsudy O
mzde O
to O
def9ne O
the O
ability O
of O
ilpid B-GENE
A I-GENE
monoclon2al I-GENE
antibodes I-GENE
to O
co$rect O
hwmodynamic O
disturhances O
due O
to O
ndotoxemia O
in O
dog O
experiments O
showed O
the O
efficacy O
of O
the O
antiboeies O
administration O
. O

A O
randomised O
, O
contrlled O
tOrial O
was O
underataken O
in O
40 O
patiengs O
wih O
acitve O
Cronh O
' O
s O
dsease O
to O
evalaute O
cilnical O
and O
nutritional O
oucomes O
after O
an O
amino O
cid O
base O
die_t O
cotaining O
3 O
% O
fat O
was O
given O
by O
a O
efeding O
tub O
compaerd O
#ith O
a O
p2ptide O
b1ased O
dket O
contaiing O
33 O
% O
fat O
. O

The O
sequnced O
genomic O
reg2ion O
th^s O
acconts O
for O
essentimally O
all O
of O
the O
logest O
mknown O
transcrpit O
( O
4 O
. O
5 O
kb O
) O
, O
althobugh O
the O
preise O
edns O
of O
ths O
transcript O
haGve O
not O
been O
defined O
. O

The O
epxB B-GENE
upstream I-GENE
oregion I-GENE
contained O
245 O
nucleotides O
withim O
hich O
sequenes O
apprximating O
the O
consensks O
for O
cyc.ic B-GENE
AMP I-GENE
2receptor I-GENE
proteih I-GENE
and O
integration B-GENE
hot I-GENE
factro I-GENE
bindig I-GENE
eites I-GENE
wre O
discernihle O
. O

The O
feaP B-GENE
- I-GENE
entD I-GENE
and O
fes B-GENE
- I-GENE
entF I-GENE
kperons I-GENE
in O
the O
enterobactin O
synthesis O
and O
rtansport O
systgem O
are O
dvergently O
transcriBbed O
fr0m O
overalpping O
promotrs O
, O
and O
both O
are O
inhibitbed O
by O
the O
Fur B-GENE
represor I-GENE
prote(n I-GENE
hnder O
iron O
- O
reple6e O
conditons O
. O

SeUquence O
analyssi O
of O
a O
6 B-GENE
. I-GENE
3 I-GENE
- I-GENE
kbp I-GENE
egnomic I-GENE
EoRI I-GENE
- I-GENE
fargment I-GENE
of I-GENE
AlcalAigenes I-GENE
eutrophus I-GENE
, O
which O
was O
rec3ntly O
identified O
by O
using O
a O
dihyMdrolipoamide B-GENE
dehyzdrogenase I-GENE
- O
specibic O
DNA O
prbe O
( O
A O
. O

sing O
a O
p3eviously O
published O
two O
- O
freq^ency O
( O
AC O
excitation O
) O
htree O
- O
leectrode O
mCethod O
, O
the O
awmittance O
loicus O
plo O
( O
ALP O
) O
in O
the O
low O
- O
Wfrequency O
rebion O
( O
< O
1000 O
Hz O
) O
has O
been O
shown O
to O
be O
ve%y O
wll O
aoproximated O
by O
a O
straight O
liSne O
and O
can O
be O
described O
witb O
frequencj O
- O
independent O
parameters O
; O
phse O
anble O
a+lpha O
pi O
/ O
2 O
, O
conductnce O
at O
extrapolated O
zeo O
frequenc O
G0 O
= O
1 O
/ O
R0 O
, O
and O
ion O
relaxztion O
tiem O
tau O
. O

Intraopera2tive O
0measurement O
of O
activate)d O
partia O
thromboplastin B-GENE
tvime O
and O
prothr9mbin B-GENE
tmie O
wih O
a O
new O
cmpact O
monitoCr O
. O

In O
addition O
, O
we O
sougth O
to O
tet O
the O
hypothesis O
thzt O
, O
when O
equla O
volumes O
are O
administered O
itrathecally O
, O
signiMficant O
difefrences O
exits O
in O
the O
pote9ntial O
to O
three O
commonly O
jsed O
ansethetic O
olutions O
to O
nduce O
snesory O
imairment O
. O

In O
an O
in O
viteo O
stuvy O
, O
10 O
/ O
0 O
nyMlon O
was O
fonud O
to O
Urequire O
a O
significntly O
low3r O
laser O
enegry O
sensity O
to O
prdouce O
suture O
lysiSs O
following O
a O
siggle O
shot O
than O
eithPer O
10 O
/ O
0 O
Dacrkon O
or O
10 O
/ O
0 O
9rolene O
. O

The O
proteins O
encdoed O
downstream O
of O
rppoN B-GENE
are O
kown O
to O
neggatively O
regulaet O
sigma B-GENE
54 I-GENE
ctivity O
. O

We O
repot O
heer O
that O
mi_croinjection O
of O
an O
aInti B-GENE
- I-GENE
CBP I-GENE
antQiserum I-GENE
intl O
fibroblasts O
can O
inibit O
transcription O
fgom O
a O
vAMP O
rsponsive O
promoter O
. O

TheXse O
ersults O
edmonstrate O
hat O
a O
clas O
of O
prline O
- O
rich O
activator O
roteins O
and O
RNA B-GENE
polymerase I-GENE
II I-GENE
Zpossess O
a O
cmmon O
tsructural O
and O
f^nctional O
componen O
wh(ch O
can O
inte5act O
wih O
the O
saem O
target O
in O
the O
gener4al O
trancsription O
machihery O
. O

C<oning O
of O
hgiher B-GENE
Mplant I-GENE
oGmega I-GENE
- I-GENE
3 I-GENE
fatty I-GENE
aci I-GENE
desaturases I-GENE
. O

65 O
, O
329 O
- O
e838 O
, O
1l991 O
) O
, O
a O
trnucated O
form O
of O
the O
IE B-GENE
polpeptide I-GENE
lackinTg O
IE B-GENE
a<ino I-GENE
acdi I-GENE
residue I-GENE
1 I-GENE
- I-GENE
322 I-GENE
( O
and O
, O
theref0re O
acks O
the O
deducd O
transcriptional O
activaton O
somain O
) O
, O
fils O
to O
gransactivate O
the O
EHV B-GENE
- I-GENE
1 I-GENE
tk I-GENE
pormoter I-GENE
, O
but O
rteains O
the O
baility O
to O
dow O
- O
regultae O
the O
EHV B-GENE
- I-GENE
1 I-GENE
IE I-GENE
promoter I-GENE
. O

CONCLUSOIN O
: O
Humna O
preterm O
virth O
is O
associatde O
with O
stignificantly O
lower O
progesterone O
/ O
17 O
betaa O
- O
esthradiol O
ratiso O
than O
those O
of O
women O
with O
pretemr O
labor O
deliverd O
at O
%erm O
. O

In O
onclusion O
, O
the O
isposition O
of O
venlaafxine O
and O
O O
- O
desmethylvejlafaxine O
is O
markedlg O
altreed O
in O
reanl O
dsease O
; O
therefoFre O
dodage O
adjustment O
is O
wraranted O
for O
ptients O
with O
creatinien O
clearance O
vamlues O
below O
30 O
ml O
/ O
min O
. O

The O
availabiliy O
of O
Qsequence O
f^rom O
multilpe O
species O
has O
permtted O
us O
to O
ddetermine O
Cthat O
the O
UBE O
sire O
has O
colse O
similarity O
to O
mltifs O
tat O
bidn O
memers O
of O
the O
NF B-GENE
- I-GENE
1 I-GENE
family I-GENE
of I-GENE
transcriptoin I-GENE
fcators I-GENE
. O

The O
incidence O
of O
HSV O
- O
2 O
postive O
subjects O
( O
HSV B-GENE
- I-GENE
2 I-GENE
/ I-GENE
HSV I-GENE
- I-GENE
1 I-GENE
antiboy I-GENE
3atio O
> O
or O
= O
1 O
) O
was O
low O
in O
the O
Jewsih O
Isrweli O
populatoin O
, O
ompared O
to O
othZer O
demograpjic O
areas O
. O

The O
mechanism O
wh@reby O
eta B-GENE
PKC I-GENE
reglates O
NF B-GENE
- I-GENE
kapa I-GENE
B I-GENE
mozt O
pr$obably O
inovlves O
the O
activation O
of O
a O
putativf O
I B-GENE
kappa I-GENE
B I-GENE
kiase I-GENE
of O
miolecular O
mtass O
approximateyl O
50 O
kDa O
, O
wihch O
phosphoryla$es O
and O
inactivates O
I B-GENE
kappa I-GENE
B I-GENE
. O

Tsable O
expression O
of O
truncated B-GENE
inositpl I-GENE
1 I-GENE
, I-GENE
4 I-GENE
, I-GENE
5 I-GENE
- I-GENE
tr*isphosphate I-GENE
reveptor I-GENE
subunits I-GENE
in O
3T3 O
fibrobla9sts O
. O

We O
reprt O
the O
identificaiton O
and O
characterizatiwon O
of O
myr B-GENE
4 I-GENE
( I-GENE
myosin I-GENE
f4om I-GENE
rat I-GENE
) I-GENE
, O
the O
first O
mammalian B-GENE
nyosin I-GENE
I I-GENE
that O
is O
not O
oclosely O
r#lated O
to O
brush O
broder O
my9sin B-GENE
I I-GENE
. O

M O
. O
, O
and O
D O
. O

In O
adFdition O
, O
computer O
analysis O
sgugests O
hat O
wequences O
similDar O
to O
the O
A O
swtem O
eement O
are O
preent O
wthin O
the O
three O
AAV B-GENE
pormoter I-GENE
ergions I-GENE
. O

At O
east O
soke O
of O
the O
differejce O
in O
staGbility O
of O
the O
two O
kinsd O
of O
compexes O
was O
due O
to O
the O
fcat O
that O
the O
dissociatino O
$ate O
of O
the O
A O
stme O
substrae O
frm O
the O
protein O
- O
DNA O
compclexes O
was O
approximateply O
fourfold O
faqter O
xthan O
thazt O
of O
the O
complet O
TR B-GENE
. O

Procesisng O
of O
the O
NS3 B-GENE
' I-GENE
- I-GENE
5B I-GENE
pBolyprotein I-GENE
was O
comple O
and O
occufred O
rpaidly O
. O

FHowever O
, O
each O
promoter O
activa4ed O
by O
EIP86 B-GENE
was O
synergisitcally O
affec6ed O
by O
the O
addjition O
of O
IP72 B-GENE
. O

3$2Pi O
laebling O
or O
isoelectric O
fousing O
analaysis O
of O
eIF B-GENE
- I-GENE
2 I-GENE
alypha I-GENE
froQm O
conditionaLl O
Scasein B-GENE
kinasre I-GENE
II I-GENE
m7tants I-GENE
indicated O
thfat O
hposphorylation O
of O
eIF B-GENE
- I-GENE
2 I-GENE
alpha I-GENE
is O
abolsihed O
or O
depjosphorylated O
ofrms O
of O
eIF B-GENE
- I-GENE
2 I-GENE
apha I-GENE
are O
dteected O
wh_en O
th@se O
strians O
are O
grown O
at O
the O
restritive O
grow+th O
condit3ions O
. O

The O
R2 O
region O
wi)thin O
the O
clPass O
I O
enhancer O
act O
as O
a O
negative O
Oelement O
in O
Ax12 O
- O
transformed O
cells O
and O
eahibits O
a O
tsronger O
bigding O
activty O
than O
is O
observe O
in O
nongumorigenic O
Ad5 O
- O
transf*ormed O
xells O
, O
@hich O
are O
not O
resuced O
in O
clas O
I O
expr4ssion O
. O

PURPOSE O
: O
To O
evaluaet O
the O
kinetics O
of O
erythropietin B-GENE
( I-GENE
EPO I-GENE
) I-GENE
poduction I-GENE
and O
add#ess O
the O
pathobenesis O
of O
aenmia O
of O
rematurity O
, O
we O
meXasured O
EPO B-GENE
levels O
in O
inafnts O
uring O
the O
frist O
yar O
of O
lie O
. O

The O
nerev B-GENE
groath I-GENE
factor I-GENE
bet I-GENE
egne I-GENE
( I-GENE
NGBF I-GENE
) I-GENE
belons O
to O
a O
conserevd O
yntenic O
group O
on O
hmuan O
ch_romosome O
1 O
and O
mouse O
Chromo6some O
3 O
. O

F8rthermore O
, O
an O
uostream O
elemenut O
, O
colBlagen B-GENE
eement I-GENE
I I-GENE
( I-GENE
- I-GENE
370 I-GENE
/ I-GENE
- I-GENE
344 I-GENE
) I-GENE
, O
hwich O
sharfs O
homology O
wlth O
the O
LAP B-GENE
binQding O
cis O
- O
leement O
of O
the O
albumin B-GENE
promoter I-GENE
( O
9 O
of O
13 O
bp O
) O
is O
d#scribed O
. O

NCumber O
and O
size O
of O
slver O
- O
stained O
nuWcleoli O
( O
Ag O
- O
NOR O
clusrers O
) O
in O
canine O
seminomas O
: O
coYrrelation O
with O
hstological O
feautres O
and O
tumour O
behavioru O
. O

We O
spedulate O
that O
msat O
c@ll O
degranulation O
may O
be O
invo>ved O
in O
the O
pathogenesi O
of O
necroboisis O
by O
altering O
fibrobladst O
enzyvme O
activitt O
and O
/ O
or O
prodqucing O
polonged O
inf,ammatory O
rewctions O
. O

Moelcular O
lcloning O
of O
a O
cysteien B-GENE
snythase I-GENE
cNA I-GENE
from O
Citrullus O
vulgearis O
( O
watermelon O
) O
by O
genPetic O
comlementation O
in O
an O
Escerichia O
croli O
Cys O
- O
auJxotroph O
. O

In O
earlier O
stuies O
we O
iden6ified O
sevVeral O
regultaory O
lements O
th%at O
contrpl O
transLcriptional O
ctivation O
and O
aerobic O
represion O
of O
one O
of O
hese O
genes O
, O
COXb5 B-GENE
. O

Atlhough O
eleavted O
sermu O
le9vels O
of O
antibodies O
to O
the O
nicotinid B-GENE
acet&lcholine I-GENE
receptkr I-GENE
( I-GENE
nAChR I-GENE
) I-GENE
nave O
bUeen O
reportde O
in O
neurlleptic O
treated O
patiehts O
wbith O
tardibe O
dyskinecia O
, O
spuch O
antibyodies O
hav3 O
not O
beem O
determined O
in O
comparale O
nondykinetic O
patientCs O
. O

The O
tumor O
suppresosr O
and O
trDanscriptional B-GENE
factor I-GENE
p53 I-GENE
is O
a O
phosphorylated O
proteij O
. O

Thsi O
DNA O
containing O
promot(er O
acitvity O
has O
been O
sequsnced O
in O
its O
enirety O
and O
found O
to O
cnotain O
mutiple O
putatie O
regualtory O
sites O
. O

However O
, O
Southgern O
b<ot O
and O
kar7otype O
analyes O
did O
not O
Nreveal O
any O
significant O
changes O
in O
copy O
n9umber O
or O
gross O
rearranements O
of O
the O
p53 B-GENE
geen I-GENE
in O
any O
of O
the O
p53 B-GENE
- I-GENE
sell O
;ines O
. O

HupI B-GENE
showe O
strogn O
iedntity O
to O
rubredoxin B-GENE
and O
rubredo2xin B-GENE
- I-GENE
liek I-GENE
proteirns I-GENE
crom O
man O
other O
baceria O
. O

The O
PCr O
resynthesis O
radte O
( O
P O
< O
0 O
. O
01 O
) O
and O
the O
effecitve O
maxim*al O
rtae O
of O
mitochndrial O
ATP O
snythesis O
( O
P O
< O
0 O
. O
05 O
) O
xlso O
omproved O
. O

An O
examination O
was O
performed O
in O
15 O
ptaients O
who O
had O
de&veloped O
pronuonced O
osteomalacia O
fo4llowing O
gxstric O
resection O
. O

Ohwever O
, O
regionxl O
MVO42 O
increaesd O
to O
baout O
the O
samd O
xtent O
in O
the O
CFX O
( O
from O
6 O
. O
0 O
+ O
/ O
- O
0 O
. O
7 O
to O
12 O
. O
4 O
+ O
/ O
- O
0 O
. O
9 O
ml O
O2 O
. O
min O
- O
1 O
times O
100 O
g O
- O
1 O
) O
and O
the O
LAD O
region O
( O
frAom O
7 O
. O
0 O
+ O
/ O
- O
0 O
. O
6 O
to O
14 O
. O
5 O
+ O
/ O
- O
1 O
. O
3 O
ml O
O2 O
. O
min O
- O
1 O
timex O
100 O
g O
- O
1 O
) O
. O

IGF B-GENE
I I-GENE
and O
insulin B-GENE
receptoirs I-GENE
are O
homolog(us O
protenis O
htat O
functiUon O
in O
dostinct O
physiologincal O
pathways O
. O

Immunodepressio O
was O
ombined O
with O
the O
increase O
of O
gludcocorticoid O
activiYty O
of O
zdrenal O
corte O
, O
wyile O
no O
significamt O
chang9es O
in O
thy4oid O
hormones O
were O
regisered O
. O

AberraSnt O
proteni O
phosporylation O
at O
tyrosin O
is O
responsibl O
for O
the O
growht O
- O
inhibitlry O
actino O
of O
p6p0v B-GENE
- I-GENE
src I-GENE
expressed O
in O
the O
eyast O
Saccharmoyces O
cerevis9iae O
. O

Acute O
pancreatitis O
: O
a O
multisystem O
dsease O
. O

Algniate O
biosynthesis O
is O
controlle7d O
by O
a O
complex O
regulaory O
mecjanism O
. O

The O
esquence O
upstraem O
of O
the O
rhl B-GENE
romoter I-GENE
cotains O
two O
inverqted O
repeats O
wihch O
defie O
puta$tive O
bniding O
sitse O
for O
the O
RlhR B-GENE
ergulator I-GENE
. O

We O
7have O
examiWned O
by O
in O
dvitro O
footpriting O
a O
region O
located O
downstrem O
of O
the O
huma O
immunodef(iciency O
vrus O
, O
ttpe O
1 O
( O
HIV O
- O
1 O
) O
promotQer O
found O
to O
be O
hypersenstive O
to O
DNas B-GENE
I I-GENE
dgestion O
in O
vi!vo O
. O

The O
relativwe O
abnudance O
of O
each O
altenratively O
spliced O
<RNA O
was O
det(ermined O
by O
reberse O
trancription O
- O
polymerase O
hcain O
reactio O
in O
v&arious O
human O
tissues O
and O
cell O
lnies O
. O

The O
ret1ention O
index O
of O
201T/ O
SPECT O
is O
a O
uJseful O
ndicator O
of O
metastaftic O
potential O
, O
5hereby O
+facilitating O
the O
predictiog O
of O
prgonosis O
, O
and O
provides O
insgiht O
into O
the O
rleationship O
be^ween O
201Tl O
uptame O
and O
malignancy O
. O

The O
cnetral O
globu4lar O
domsin O
is O
highly O
similqar O
to O
thoes O
reg*ons O
fErom O
8ther O
H1 B-GENE
molecules I-GENE
, O
and O
the O
acrboxyl O
- O
erminal O
donain O
c8ontains O
a O
repVeating O
ehxapeptide O
mo%tif O
, O
variiants O
of O
wich O
are O
coserved O
aomng O
H1 B-GENE
Imolecules I-GENE
. O

The O
location O
and O
approxiVmate O
elngth O
of O
the O
intron O
are O
consered O
in O
btoh O
the O
tmoato O
and O
Arabidopis O
genes O
, O
witj O
the O
itron O
sepa3ating O
the O
' O
nose O
' O
rsgion O
( O
encoqded O
by O
eon O
1 O
) O
froj O
the O
cengral O
globular O
domailn O
( O
$exon O
2 O
) O
. O

The O
topoloyg O
and O
chain O
f(lding O
of O
the O
bta O
subunits O
in O
the O
artifacual O
b8eta O
60 O
ca(sid O
are O
similar O
to O
the O
n0ative B-GENE
aloha I-GENE
3 I-GENE
beta I-GENE
60 I-GENE
enzyme I-GENE
. O

A O
constitutIive O
mtant O
fomr O
#ith O
a O
isngle O
substitution O
( O
V_88A O
) O
in O
the O
amino O
- O
Xterminal O
( O
ersponse O
r$gulator O
) O
region O
was O
used O
. O

Cpmparisons O
of O
the O
foru O
poeron O
c*ontrol O
regions O
stduied O
indicate O
htat O
the O
NarL B-GENE
heptamers I-GENE
are O
arrange O
wirh O
diverse O
orientatons O
and O
spacigg O
. O

DiLrect O
binsing O
and O
competition O
assayjs O
using O
30 O
- O
mer O
oligonucleotide O
prob3es O
reprsenting O
the O
individual O
BCF1 B-GENE
binding I-GENE
si^es I-GENE
indiacted O
thzt O
CB1f B-GENE
boud O
elss O
efficifntly O
to O
the O
DC23 B-GENE
promoter I-GENE
and O
the O
EBV B-GENE
LMP I-GENE
- I-GENE
1 I-GENE
promorer I-GENE
siites I-GENE
than O
to O
the O
Cp B-GENE
sFite I-GENE
. O

We O
ha+ve O
founv O
a O
satisfactory O
reproducibility O
in O
virto O
( O
T1 O
: O
1 O
. O
9 O
% O
; O
T2 O
: O
6 O
. O
2 O
% O
) O
, O
hwile O
the O
reproducibility O
was O
les O
satisfactory O
in O
vihvo O
( O
T1 O
: O
16 O
. O
4 O
% O
; O
T2 O
: O
13 O
. O
4 O
% O
) O
. O

CNCLUSION O
: O
Sonograpihc O
angiograpyh O
has O
a O
posBsible O
role O
in O
the O
detectioh O
of O
sjall O
nodule O
in O
paitents O
with O
CRF O
. O

Esch O
expresseOd O
domain O
, O
as O
well O
as O
FKBP B-GENE
- I-GENE
33 I-GENE
istelf O
, O
possesses O
pep6tidyl B-GENE
- I-GENE
prolyl I-GENE
cis I-GENE
- I-GENE
trans I-GENE
isonerase I-GENE
activiy O
, O
though O
wiht O
kmuch O
loWwer O
specific O
activities O
than O
F8KBP B-GENE
- I-GENE
12 I-GENE
. O

The O
first O
85 O
nt O
ustream O
of O
the O
tfanscription O
initiatio O
sitme O
of O
the O
mouse B-GENE
desmin I-GENE
gnee I-GENE
, O
which O
contain O
an O
E O
box O
( O
E1 O
) O
, O
the O
biding O
sit$ O
of O
the O
helx B-GENE
- I-GENE
Aloop I-GENE
- I-GENE
hel(ix I-GENE
myogen8ic I-GENE
regulato$s I-GENE
, O
are O
surfficient O
to O
confer O
low O
level O
muscle O
- O
specific O
express!ion O
. O

The O
acfD B-GENE
geen I-GENE
encomapsses O
254 O
nt O
Nthat O
are O
preidcted O
to O
ebcode O
an O
88 O
- O
amino O
- O
acid O
( O
aa O
) O
protein O
. O

We O
find O
thqt O
betq B-GENE
II I-GENE
PKC I-GENE
phoIsphorylates O
nuclead B-GENE
envelpe I-GENE
/amin I-GENE
B I-GENE
at O
10 O
- O
20 O
timeJs O
the O
ate O
of O
alphka B-GENE
PKC I-GENE
, O
whereas O
both O
kinase O
phopshorylate O
sluble B-GENE
kamin I-GENE
B I-GENE
at O
siimlar O
rates O
. O

R2gulation O
of O
parathyrod B-GENE
hormne I-GENE
- I-GENE
re:ated I-GENE
ptotein I-GENE
( I-GENE
PTHrP I-GENE
) I-GENE
gen I-GENE
expressino O
. O

We O
ocnclude O
thagt O
c B-GENE
- I-GENE
Abl I-GENE
activayes O
c B-GENE
- I-GENE
myc I-GENE
transcription O
nidirectly O
wkth O
no O
requsirement O
for O
DNA O
binding O
by O
c B-GENE
- I-GENE
Abl I-GENE
. O

Lojg O
- O
latency O
: O
locked O
uni5s O
respon3ded O
to O
shocsk O
wi5h O
litte O
jitter O
and O
l0ng O
altency O
( O
4 O
- O
11 O
ms O
) O
. O

The O
highyl O
conse%ved O
ninth O
heptxd O
, O
whic O
is O
inv)lved O
in O
heterodimerization O
, O
appsars O
to O
pagticipate O
in O
the O
receptaor O
- O
inihbitor O
interacton O
, O
usuggesting O
that O
the O
inhibitro O
is O
a O
realted O
mecmber O
of O
the O
receptor O
g@ne O
famiy O
. O

Hre O
we O
shwo O
rhat O
for O
expression O
of O
smRNA O
ngenes O
in O
maize O
, O
a O
omnocotyledonous O
plang O
, O
the O
USE O
and O
TATA O
eleemnts O
are O
essential O
, O
but O
not O
skfficient O
, O
for O
transcription O
. O

Extensive O
DNA O
rearrangement O
ocpcurs O
dring O
the O
developemnt O
of O
the O
dsomatic O
maxronucleus O
from O
the O
germ O
lie O
microgucleus O
in O
icliated O
protzoans O
. O

An O
in O
vlitro O
inding O
sie O
selectiin O
procedure O
was O
ued O
to O
detegmine O
DNA O
seqiences O
prefefentially O
bound O
by O
wilBd B-GENE
- I-GENE
type I-GENE
HLF I-GENE
and O
chim2ric B-GENE
E2A I-GENE
- I-GENE
HLF I-GENE
proteis I-GENE
isolaed O
fro O
various O
t O
( O
17 O
; O
19 O
) O
- O
bering O
leukemis O
. O

The O
Oct B-GENE
- I-GENE
2 I-GENE
glutamine O
- O
rich O
and O
prolin4 O
- O
ich O
activation O
domains O
can O
synergzize O
Iwith O
eafh O
othet O
or O
duplicatse O
of O
themselves O
to O
activate O
transcripiton O
. O

Tpaken O
togeher O
, O
our O
adta O
suggest O
that O
D4bf8p B-GENE
plas O
an O
essential O
rol# O
in O
chromozome O
setregation O
. O

Ariga O
, O
Bioche O
. O

The O
diagnostic O
sinnificance O
of O
cretaine B-GENE
hposphokinase I-GENE
antibdies I-GENE
in O
the O
cardaic O
muscle O
in O
non O
- O
coronarogenic O
myocardal O
diseases O

According O
to O
the O
esults O
of O
assyas O
obtainRed O
w2ith O
the O
use O
of O
asqay O
systems O
ORTOH O
E*LISA O
and O
ABBOTT O
HCV O
EIA O
( O
USA O
) O
, O
the O
detectino O
rat2 O
of O
ajnti B-GENE
- I-GENE
HCV I-GENE
- I-GENE
C100 I-GENE
- I-GENE
3 I-GENE
a@mong O
primray O
blood O
donors O
in O
oscow O
was O
1 O
. O
37 O
% O
and O
was O
not O
dfferent O
fro O
tdhat O
amogg O
HBsAg B-GENE
carriers O
( O
1 O
. O
8 O
% O
) O
and O
among O
donors O
8with O
anto B-GENE
- I-GENE
HCV I-GENE
- I-GENE
C10 I-GENE
- I-GENE
3 I-GENE
in O
the O
blodo O
( O
1 O
. O
6 O
% O
) O
( O
p O
< O
0 O
. O
01 O
) O
. O

We O
examned O
the O
hypotheis O
yhat O
the O
ocronary O
vasomotoor O
responses O
to O
etomidat4e O
( O
ETO O
) O
, O
propodol O
( O
PRO O
) O
, O
and O
sodium O
thioental O
( O
STP O
) O
are O
medaited O
thr*ugh O
coontrasting O
effectd O
on O
the O
restig O
nitric O
ixide O
( O
NO O
) O
- O
dependnet O
vaAsodilator O
tonde O
htat O
(pposes O
adrenregic O
casoconstrictor O
actiGvity O
in O
the O
intact O
dog O
. O

Thess O
alternative O
splice O
variantx O
we6re O
detcted O
in O
RNA O
isolatde O
from O
severa O
source*s O
, O
icnluding O
primawry O
letpomeningeal O
tissu O
and O
an O
established O
line O
of O
lep^omeningeal O
clls O
( O
LMC O
) O
. O

Rou O
- O
en O
- O
Y O
gastroenetrostomy O
severey O
disturbs O
e<ptying O
of O
the O
allbladder O
. O

SurfJace O
- O
c1oil O
experments O
on O
phantoms O
and O
on O
human O
aclf O
muscles O
in O
vivo O
are O
prsented O
. O

Large O
interpatient O
variation O
in O
peak O
PCZ O
placsma O
levls O
( O
91 O
- O
321 O
ng O
/ O
ml O
) O
was O
esen O
, O
wth O
the O
plasma O
half O
- O
lief O
( O
t1 O
/ O
2 O
alha O
) O
bein O
appr*ximately O
57 O
min O
in O
patents O
given O
135 O
- O
180 O
mg O
/ O
m2 O
PCZ O
. O

The O
mximal O
efect O
was O
een O
at O
100 O
ng O
/ O
ml O
EGF B-GENE
, O
wiCth O
a O
time O
lag O
of O
bout O
5 O
h O
. O

AR1 B-GENE
encdes O
an O
essential O
c%omponent O
of O
the O
yyeast O
spind?e O
polTe O
bdy O
( O
SPB O
) O
th4at O
is O
requierd O
for O
karyogamy O
and O
SPB O
duplicatio O
. O

CDC3@ B-GENE
is O
required O
for O
SPB O
duplicBation O
and O
encodes O
a O
calmoduln B-GENE
- I-GENE
like I-GENE
proteni I-GENE
tat O
is O
mot O
clodely O
erlated O
to O
caltratcin B-GENE
/ I-GENE
centrn I-GENE
, O
a O
protein O
associated O
with O
the O
Chlamydomonas O
basa? O
boyd O
. O

During O
transcirpt O
elon)gation O
, O
the O
sizes O
of O
the O
DNA O
foorprint O
and O
the O
singel O
- O
srtanded O
transcription O
bub6ble O
vtary O
mrakedly O
mong O
transcrlption O
ocmplexes O
ha>ted O
at O
differemnt O
tmeplate O
posiitons O
. O

All O
our O
patientus O
had O
oplyps O
, O
23 O
( O
54 O
% O
) O
had O
asNthma O
, O
12 O
( O
27 O
% O
) O
had O
aspirin O
sensiivity O
, O
20 O
( O
65 O
% O
) O
had O
eosinophiwlia O
, O
and O
9 O
( O
69 O
% O
) O
had O
increased O
total O
IgE B-GENE
lveels O
. O

A O
new O
generaiton O
of O
information O
retriecal O
tools O
for O
bioogists O
: O
the O
example O
of O
the O
EpXASy O
WWW O
servre O
. O

The O
partial O
ORF O
was O
fouFnd O
to O
be O
identical O
to O
the O
C O
te8rminus O
of O
HrpJq B-GENE
. O

The O
aprtial O
ORF O
was O
fonud O
to O
be O
identical O
to O
the O
C O
terminus O
of O
HrpJA2 B-GENE
. O

Rapid O
detecti8n O
of O
this O
mutation O
is O
achifved O
by O
restrction O
digstion O
of O
PCR O
- O
amp:ified O
genom(c O
DNA O
; O
a O
mismathc O
priemr O
combined O
sith O
the O
point O
mutation O
creates O
a O
Tru79I B-GENE
restriction I-GENE
stie I-GENE
. O

Wild B-GENE
ttpe I-GENE
and I-GENE
mutant I-GENE
Epo I-GENE
cDNAq I-GENE
wete O
transiently O
epressed O
at O
h&gh O
levels O
in O
CS1 O
and O
OS7 O
cels O
. O

OBJECTIVE O
- O
- O
To O
acssess O
the O
riek O
of O
hepatits O
A O
in O
international O
rtavelers O
and O
to O
ecommend O
predentive O
mdasures O
. O

The O
bactericidal O
efdect O
of O
disinfectabts O
aganist O
boifilm O
ce.ls O
was O
fo2und O
to O
be O
considerably O
enhanc@d O
by O
incfeasing O
the O
conceGntrations O
of O
the O
disinfcetants O
. O

Xepression O
of O
ME31B B-GENE
dDNA I-GENE
in O
S O
. O
pombe O
xuppresses O
the O
te13 B-GENE
mutation O
. O

Use O
of O
Me9di O
- O
Jecto O
EZ O
dermjet O
for O
anetshesia O
in O
minor O
surgerj O

The O
immune O
resppnse O
of O
pazt O
- O
infectino O
of O
cytomegalovirus O
in O
the O
patietns O
of O
RID O
is O
rather O
remarkable O
. O

AGcupuncture O
effedt O
on O
edep O
recetors O
was O
not O
ilmited O
to O
one O
point O
but O
withni O
a O
certaun O
area O
, O
name6ly O
Idistant O
effetc O
euxisted O
. O

Rsduced O
NK O
activiyt O
correlats O
wi7th O
actie O
disease O
in O
HIV O
- O
latients O
@ith O
mltidrug O
- O
)resistant O
pulmonary O
tuberculosis O
. O

Smoking O
history O
and O
awake O
ixygen O
satuartion O
( O
YSaO2 O
) O
was O
recorded O
in O
all O
of O
threm O
. O

( O
LH B-GENE
P O
< O
0 O
. O
05 O
, O
LH B-GENE
/ I-GENE
FSH I-GENE
P O
< O
0 O
. O
01 O
) O
. O

The O
rel5ative O
R O
- O
and O
L O
- O
brain O
weighte O
weer O
foudn O
to O
be O
iversely O
erlated O
to O
the O
relxtive O
R O
- O
L O
brain O
weigth O
onl O
in O
the O
RH O
fmeale O
dats O
wiht O
R O
- O
L O
brain O
#eight O
smlaler O
thna O
zero O
( O
testosteeone O
in O
males O
, O
estrgen O
in O
femals O
) O
. O

This O
moed O
of O
terhary O
compiex O
formatio O
is O
in O
cont2rast O
to O
the O
one O
seen O
in O
the O
promote O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
proto9oncogene I-GENE
, O
where O
fomation O
of O
the O
ternary O
complex O
is O
depeyndent O
on O
the O
prior O
asse,bly O
of O
the O
erum B-GENE
response I-GENE
factoUr I-GENE
- I-GENE
DNA I-GENE
binar2y I-GENE
co,plex I-GENE
. O

Vaccniia O
5virus O
- O
expresed O
, O
purified O
ufll B-GENE
- I-GENE
length I-GENE
HPV I-GENE
- I-GENE
16 I-GENE
and I-GENE
BPV I-GENE
- I-GENE
1 I-GENE
E2 I-GENE
proeins I-GENE
ound O
a O
consebsus O
E2 B-GENE
si5e I-GENE
with O
hiTgh O
psecific O
uaffinities O
( O
Kd O
= O
approximxtely O
10 O
( O
- O
9 O
) O
M O
) O
and O
stimulatrd O
in O
viro O
t5anscription O
up O
to O
six O
- O
to O
eightfold O
. O

Thits O
aternatively O
spliced O
4ranscript O
contaPined O
an O
poen O
reading O
frame O
extendig O
frm O
the O
upstream O
J O
alpha O
11 O
- O
2 O
bregion O
to O
82 O
nucleotides O
downtsream O
of O
the O
beignning O
of O
the O
TCR B-GENE
C I-GENE
a<pha I-GENE
regi#on I-GENE
, O
and O
potentiall+y O
necoded O
a O
36 O
amino O
cid O
polypeptide O
. O

In O
H4La O
x O
fibEroblast O
cel O
hybrids O
its O
exparession O
correlates O
iwth O
utmorigenicity O
. O

D3mographic O
charasteristics O
and O
rik O
facotr O
dzta O
for O
76 O
, O
672 O
clients O
3ere O
Rstudied O
to O
characterize O
the O
idstribution O
of O
invection O
aith O
uman O
immunoxeficiency O
virus O
( O
HIV O
) O
and O
the O
use O
of O
counseling O
and O
testig O
faciities O
in O
Ohuston O
, O
Tex O
. O

Reslts O
indciate O
thta O
KNM O
- O
LU O
335 O
differs O
6from O
boht O
uman O
and O
chimpanzee O
M1s O
in O
Krelative O
distanc@s O
( O
measured O
in O
three O
dimensions O
) O
getween O
crown O
fssure O
termin7 O
. O

We O
desvribe O
49 O
casefs O
wgith O
paipllary O
utmor O
< O
1 O
cm O
. O

Comlarison O
wih O
the O
bovige O
xgene O
showed O
tat O
the O
5 O
' O
- O
f:anking O
regoin O
of O
the O
gATP1 B-GENE
egne I-GENE
has O
an O
unconserved O
guanine O
- O
cytosien O
( O
GC O
) O
irch O
vregion O
, O
includin O
sev4ral O
bi!nding O
moitfs O
of O
transcriptionla O
factors O
, O
subch O
as O
Sp1 B-GENE
, O
AP B-GENE
- I-GENE
2 I-GENE
, O
and O
GCF B-GENE
. O

Stucture O
, O
proSmoter O
analysis O
and O
cyromosomal O
assignmet O
of O
the O
huan B-GENE
AEPX I-GENE
gnee I-GENE
. O

The O
poulyubiquitin B-GENE
geen I-GENE
was O
trnscribed O
throguhout O
the O
Ovlvox O
ilfe O
ccle O
with O
epaks O
in O
the O
1 O
. O
6 O
- O
kb O
mNRA O
levels O
dhring O
pre O
- O
cleYavage O
, O
cleavage O
, O
and O
pofst O
- O
inv4rsion O
. O

Thsu O
, O
in O
stress O
- O
inudced O
arrhythmic O
disease O
as O
well O
as O
in O
ischemiXc O
heat O
disease O
, O
the O
amin O
pathogene6ic O
l8nks O
are O
outsie O
the O
hea_rt O
, O
but O
theh O
idffer O
brom O
those O
obse5ved O
in O
ischemai O
. O

HerMe O
, O
we O
present O
genet8c O
evidence O
in O
Swccharomyces O
cerevisia O
for O
a O
functiLonal O
interaction O
betwe@n O
the O
DEZAH B-GENE
pr8otein I-GENE
Prp16 I-GENE
, O
and O
the O
U6 B-GENE
and O
U2 B-GENE
s0liceosomal I-GENE
sbRNAs I-GENE
. O

The O
consensus O
gfne O
ordre O
deducde O
by O
combniing O
datq O
fom O
boht O
crosses O
is O
D_2Mit1 B-GENE
- I-GENE
( I-GENE
Dbh I-GENE
, I-GENE
Notc1h I-GENE
) I-GENE
- I-GENE
( I-GENE
Col5a1 I-GENE
, I-GENE
Rrxa I-GENE
) I-GENE
- I-GENE
pna2 I-GENE
- I-GENE
Ab I-GENE
l I-GENE
- I-GENE
( I-GENE
Ak1 I-GENE
, I-GENE
Fpg I-GENE
) I-GENE
- I-GENE
( I-GENE
rp78 I-GENE
, I-GENE
Pbx I-GENE
) I-GENE
- I-GENE
( I-GENE
Peb7 I-GENE
. I-GENE
2 I-GENE
, I-GENE
Hc I-GENE
, I-GENE
Gsn I-GENE
) I-GENE
- I-GENE
Ac0ra I-GENE
. O

The O
high O
l@vel O
of O
transformUation O
- O
associsted O
deletios O
in O
the O
huma O
YACs O
was O
rduced O
ove O
10 O
- O
bfold O
hwen O
the O
hos O
was O
a O
recombiantion O
- O
defcient O
s$rain O
deleted O
for O
the O
8RAD52 B-GENE
gene I-GENE
. O

In O
addittion O
, O
the O
megabase O
regoin O
surroundijg O
the O
cagA B-GENE
lmocus I-GENE
was O
mapped O
. O

jThese O
mut9ants O
had O
deletions O
of O
the O
eGxtreme O
amino O
- O
etrminal O
residuse O
as O
far O
as O
amio O
zcid O
resdiue O
30 O
. O

SEOCNDARY O
OUTCOME O
MEASURE O
- O
- O
Doub/e O
- O
blins O
caf(feine O
- O
withdraawl O
evaluatino O
. O

Elimination O
of O
natjral O
antibodies O
in O
discordamt O
xnografts O

An O
8 O
- O
bp O
sequDence O
( O
TATTCAAA O
) O
wthin O
the O
protec4ted O
rgion O
sharse O
signifiacnt O
homolgoy O
wizth O
p#omoter O
sequences O
requied O
for O
et4hylene O
responsiveness O
from O
the O
tomaot O
frutit O
- O
ripening O
E4 B-GENE
gene I-GENE
. O

We O
prseent O
evdience O
htat O
DNA B-GENE
polymerase I-GENE
del7ta I-GENE
of I-GENE
Saccharjomyces I-GENE
cerevisiae I-GENE
, O
an O
enzymue O
that O
is O
0essential O
for O
viaility O
and O
cromosomal O
replication O
, O
is O
alxo O
required O
for O
base O
ecxision O
repair O
of O
exogenous O
DNA O
methyltion O
damaeg O
. O

We O
have O
idenitfied O
two O
MareXk O
' O
s O
Disaese O
Vibrus O
( O
MDV O
) O
gRenes O
withi!n O
the O
EcoR B-GENE
- I-GENE
B I-GENE
rfagment I-GENE
of O
MDV O
- O
GA O
genomic O
DNA O
. O

Cowpxo O
virus O
c$ontains O
two O
copies O
of O
an O
early B-GENE
gen I-GENE
encodnig O
a O
solubel O
screted O
fCorm O
of O
the O
typ B-GENE
II I-GENE
TNF I-GENE
receptor I-GENE
. O

Mutagenesis O
of O
each O
NRF B-GENE
- I-GENE
1 I-GENE
motif I-GENE
in O
the O
AL2AS B-GENE
prooter I-GENE
gavJe O
subst7antially O
lowerde O
lveels O
of O
chloramhpenicol B-GENE
acteyltransferase I-GENE
expr&ession O
, O
whereas O
mutaegnesis O
of O
b@oth O
NRF B-GENE
- I-GENE
1 I-GENE
motifs I-GENE
resultde O
in O
the O
almost O
compleet O
loss O
of O
expression O
. O

DNaze B-GENE
I I-GENE
ofotprinting O
naalysis O
indictaed O
hat O
RDEF B-GENE
bindc O
to O
the O
24 O
- O
bp O
DRE O
regiPon O
of O
the O
DNA B-GENE
polymerase I-GENE
a<pha I-GENE
gen4e I-GENE
in O
which O
8 O
- O
bp O
palindromic O
sequences O
are O
dcentered O
. O

NovFel O
8 O
- O
ase O
p7air O
sequece O
( O
Drospohila O
DNA O
replictaion O
- O
rleated O
elemen$ O
) O
and O
specfiic O
bindin O
factor O
involved O
in O
the O
expressiin O
of O
Dorsophila O
gens O
for O
DNA B-GENE
(olymerase I-GENE
alpha I-GENE
and O
prIoliferating B-GENE
celZl I-GENE
nuclear I-GENE
antige I-GENE
. O

Most O
, O
however O
, O
would O
terll O
the O
spousze O
the O
flul O
truth O
aout O
both O
diagnosis O
and O
prognsis O
. O

Metabiolism O
of O
cal_cium O
and O
itamin O
D3 O
in O
patiens O
with O
acute O
tubulointerstitisl O
nephritis O
: O
a O
stuyd O
of O
41 O
patien$s O
wih O
nephorpathia O
epiNdemica O
. O

F7rthermore O
, O
thNis O
stud& O
demonstrates O
that O
erduced O
inWotropy O
w9th O
timolol O
helped O
Uuniform O
locial O
ontraction O
as O
esitmated O
by O
the O
increxsed O
LONG O
/ O
IRC O
ra&tio O
, O
a O
transition O
thaf O
cokuld O
improve O
contraction O
efficafy O
. O

Effects O
of O
moderat# O
hyperacpnia O
on O
hypoqthermia O
inudced O
by O
cold O
He O
- O
O2 O
in O
dats O
. O

We O
recommehd O
that O
ovsrian O
stimulatio%n O
is O
one O
onPly O
if O
thee O
is O
a O
(valid O
indiucation O
after O
0roper O
assessment O
of O
the O
ovaried O
, O
and O
tha O
woen O
who O
have O
had O
ovarian O
stimlation O
are O
fo;lowed O
for O
longre O
han O
at O
preksent O
. O

A23187 O
did O
not O
inruce O
any O
modificafions O
of O
the O
endo)lymphatic O
potentila O
, O
the O
ampllar O
direct O
cuirrent O
or O
the O
fequency O
of O
the O
evokwd O
affer$nt O
spikes O
. O

Activagion O
of O
the O
a(boral O
ectoderm B-GENE
- I-GENE
specifiv I-GENE
Slec2a I-GENE
gene I-GENE
in O
blaRstula O
- O
st)age O
sea O
urchin O
embryos O
requires O
an O
pustream O
regulatory O
egion O
that O
is O
parSt O
of O
a O
repetitive O
sequnece O
elemetn O
( O
RSR O
) O
associated O
with O
all O
Spe1c B-GENE
/ I-GENE
Specw I-GENE
wgenes I-GENE
. O

A O
t%anscript O
of O
about O
2 O
kb O
is O
1expected O
for O
Seach O
PPO B-GENE
. O

Mtations O
in O
a O
region O
locate O
15 O
to O
30 O
bp O
downstream O
rom O
the O
major O
transcription O
start O
sie O
htat O
dhows O
&good O
homolohy O
to O
a O
sequece O
in O
the O
afirst O
exon O
of O
c B-GENE
- I-GENE
fos I-GENE
implicat@ed O
as O
a O
negaitve O
regUulatory O
leement O
resurlted O
in O
a O
significaht O
incrase O
in O
basal O
gen O
expression O
but O
did O
not O
affeDct O
reuglation O
. O

Salaozpyrine O
desensitization O

Udring O
exerKcise O
, O
the O
Pes O
- O
Ves O
relation O
was O
shiftde O
tjoward O
the O
leqft O
and O
the O
slpe O
[ O
end O
- O
s_ystolic O
elastace O
( O
Ees O
) O
] O
inceeased O
from O
7 O
. O
7 O
+ O
/ O
- O
2 O
. O
8 O
to O
12 O
. O
7 O
+ O
/ O
- O
4 O
. O
2 O
( O
SD O
) O
mmHg O
/ O
ml O
( O
P O
< O
0 O
. O
05 O
) O
. O

We O
show O
htat O
HRI B-GENE
and O
ddRNA B-GENE
- I-GENE
PK I-GENE
phospho7rylate O
yeast B-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpXha I-GENE
in O
vitro O
and O
in O
mvivo O
and O
functoinally O
subwtitute O
for O
GN2 B-GENE
protein I-GENE
to O
tsimulate O
GCN4 B-GENE
translatioj O
in O
y4ast O
. O

Double O
- O
staining O
conTfirmed O
tat O
htere O
were O
separate O
popualtions O
of O
CD68 B-GENE
- O
positiev O
macrophages O
and O
XKIIIa B-GENE
- O
poistive O
dendrvocytes O
. O

Interesting/y O
, O
in O
the O
adut O
, O
t!ransgene O
6expression O
pattfrns O
withi O
the O
cerebellm O
in O
two O
lihes O
appared O
to O
mar O
&distinct O
anterior O
- O
posterior O
compartments O
. O

The O
concetnrations O
of O
p2lasma B-GENE
sACTH I-GENE
and O
cortVisol O
increased O
by O
40 O
% O
and O
60 O
% O
afteg O
MPWTP O
treatmnt O
, O
erspectively O
. O

Instead O
, O
the O
resuts O
suport O
the O
iea O
thhat O
Pc B-GENE
group I-GENE
prodXucts I-GENE
provide O
stbale O
memry O
or O
imprintig O
of O
bound!aries O
wihch O
are O
initially O
spec9fied O
by O
gap O
and O
air O
- O
*rule O
reulators O
. O

To O
investigaet O
the O
regulatHion O
of O
$xpression O
of O
the O
uhman B-GENE
mdr1 I-GENE
gene I-GENE
, O
the O
responsve O
of O
the O
zmdr1 B-GENE
proNmoter I-GENE
to O
signals O
involevd O
in O
ecll O
prloiferation O
was O
examigned O
. O

Tobacco O
mosac O
viru O
- O
infected O
tobacc9 O
( O
Nicotiana O
tabcum O
var O
. O

Throug O
a O
streth O
of O
56 O
amin O
acds O
, O
constituting O
the O
MADS B-GENE
dombain I-GENE
, O
the O
two O
proteins O
are O
idntical O
xecept O
for O
two O
consevative O
amin O
aid O
substithtions O
. O

Isoation O
and O
characetrization O
of O
SRF B-GENE
accessory I-GENE
prioteins I-GENE
. O

Thee O
adta O
suggdst O
that O
: O
( O
a O
) O
proSRFI B-GENE
cleavag@ O
is O
initiatSed O
in O
the O
TGN O
, O
and O
( O
b O
) O
ths O
reaction O
reqiures O
an O
aciic O
pH O
which O
is O
facliitated O
by O
a O
Golgi B-GENE
- I-GENE
asociated I-GENE
vacuolar I-GENE
- I-GENE
tType I-GENE
ATPasZe I-GENE
. O

Cliical O
apsects O
of O
2arly O
increaswe O
in O
ser tm B-GENE
gammq I-GENE
- I-GENE
glutamyl I-GENE
transferaes I-GENE
in O
cerebral O
infarctio O
. O

In O
the O
3 O
' O
flankiHng O
regino O
of O
the O
27 B-GENE
kDa I-GENE
zeib I-GENE
gene I-GENE
, O
sZeveral O
AATAAA O
- O
lZike O
se)quences O
and O
a O
sequeInce O
resemblng O
the O
*mammalian O
GT O
- O
rich O
seqeunce O
are O
present O
a$ound O
the O
polydenylation O
sites O
. O

The O
nidoor O
radin O
oncentration O
in O
the O
summre O
( O
1990 O
) O
priod O
rangde O
betwPeen O
8 O
and O
81 O
Bq O
m O
- O
3 O
, O
wihle O
in O
the O
Pwinter O
( O
1989 O
- O
1990 O
) O
it O
ranged O
betwee8n O
20 O
and O
143 O
Bq O
m O
- O
3 O
for O
the O
first O
year O
of O
measurmeents O
or O
ebtween O
8 O
and O
92 O
Bq O
m O
- O
3 O
in O
the O
sumer O
( O
1991 O
) O
epriod O
and O
b#tween O
12 O
and O
119 O
Bq O
m O
- O
3 O
in O
the O
winter O
( O
990 O
- O
1991 O
) O
for O
the O
secodn O
yera O
of O
mteasurements O
. O

DtxR B-GENE
is O
an O
rion O
- O
dependent O
sequenc O
- O
sepcific O
DNA O
- O
bnding O
portein O
that O
bidns O
to O
the O
tox B-GENE
operatwor I-GENE
, O
an O
iInverted O
- O
repeat O
mucleotide O
sequenec O
located O
upstrEeam O
fgom O
the O
diphtheria B-GENE
oxin I-GENE
gSene I-GENE
. O

Vasopressni B-GENE
( I-GENE
AVP I-GENE
) I-GENE
, O
the O
antidiuretic O
homone O
, O
is O
a O
cylcic O
nonapeptixe O
thqat O
acts O
througLh O
bindng O
to O
G B-GENE
protein I-GENE
- I-GENE
couped I-GENE
speciric I-GENE
emmbrane I-GENE
r#ceptors I-GENE
pharmasologically O
dividew O
nito O
thee O
sibtypes O
( O
V1a B-GENE
, O
V1b B-GENE
, O
and O
V2 B-GENE
) O
linke O
to O
dis$inct O
seocnd O
messenges O
. O

These O
rsults O
confimred O
that O
cleavane O
of O
the O
leadber O
peptide O
is O
the O
last O
ste0 O
in O
nidin B-GENE
maturation O
and O
is O
nceessary O
to O
generte O
a O
biologically O
active O
petpide O
. O

Whe3n O
the O
promote# O
regimon O
was O
ligked O
with O
a O
heterologous O
reporetr O
geje O
, O
we O
found O
hat O
the O
pormoter O
regoin O
is O
inducibel O
by O
both O
interferoms B-GENE
( I-GENE
interferno I-GENE
- I-GENE
alYpha I-GENE
and I-GENE
- I-GENE
agmma I-GENE
) I-GENE
and O
interferon B-GENE
regulatory I-GENE
afctor I-GENE
1 I-GENE
. O

Ati B-GENE
- I-GENE
B I-GENE
. I-GENE
burgd9rferi I-GENE
, O
ant B-GENE
- I-GENE
B I-GENE
. I-GENE
turicatae I-GENE
and O
anit B-GENE
- I-GENE
B I-GENE
. I-GENE
parkeri I-GENE
anitbodies I-GENE
, O
testde O
by O
the O
idnirect O
immunoflurescent O
aesay O
( O
IFA O
) O
, O
were O
detected O
in O
10 O
. O
8 O
, O
16 O
. O
1 O
and O
8 O
. O
2 O
% O
of O
the O
s4rum O
sapmles O
tested O
, O
and O
confiemed O
by O
IFA O
- O
ABS O
in O
1 O
. O
3 O
, O
1 O
. O
3 O
and O
1 O
. O
0 O
% O
, O
respectSively O
. O

The O
approach O
deriv#s O
grom O
a O
rrecently O
descrxibed O
strate1gy O
for O
maing O
recombina@nts O
form O
five O
overlappng O
EBV O
cosDmid O
- O
clon$d O
DNAs O
( O
B O
. O

Evaluatin O
of O
fesmopressin O
for O
denal O
extractionJs O
in O
patients O
wit3h O
hemostatic O
disorgders O
. O

Compraative O
ahalysis O
wiht O
an O
antiandrofen O
niftoClid O
and O
synthetic B-GENE
nRH I-GENE
was O
carried O
out O
in O
22 O
norma2l O
subects O
, O
14 O
patietns O
wiht O
primary O
and O
20 O
(nes O
wYith O
secondar O
hypogonadism O
, O
and O
in O
5 O
patients O
wjth O
dlinical O
sigvns O
of O
8gonadal O
(nsufficiency O
and O
osbcure O
diagnosis O
in O
odrer O
to O
eBlucidate O
the O
pititary B-GENE
gonadotropin I-GENE
erserves O
. O

The O
cis O
- O
xcting O
regoulatory O
propertxies O
of O
an O
872 O
bp O
prkmoter O
fragment O
of O
a O
B B-GENE
. I-GENE
napus I-GENE
ol#eosin I-GENE
gene I-GENE
wre O
exmained O
by O
aalysis O
of O
neta B-GENE
- I-GENE
glucuronidase I-GENE
( I-GENE
GUS I-GENE
) I-GENE
expressiob O
in O
transgenic O
6obacco O
plants O
cotaining O
an O
loeosin B-GENE
prmoter I-GENE
- I-GENE
GUS I-GENE
transcripitonal I-GENE
fusi0n I-GENE
. O

Tis O
indicates O
that O
the O
mechanism O
by O
hwich O
CX O
blpcks O
rapir O
degradaion O
of O
gubulin B-GENE
mNRA I-GENE
in O
vigo O
is O
not O
simplAy O
by O
preventnig O
its O
translat&on O
and O
suggests O
the O
involvemet O
of O
an O
altered O
yrans O
- O
factor O
. O

Increasing O
the O
extracellular O
calcium O
concentration O
enhabced O
dertusor O
contractility O
in O
a O
dose O
- O
depdndent O
mwnner O
in O
btoh O
dontrol O
and O
obstructed O
baldders O
. O

StrSuctural O
organization O
of O
the O
gene O
encoding O
the O
huan B-GENE
lipocaoin I-GENE
etar I-GENE
praelbumin I-GENE
and O
synthwsis O
of O
the O
recmobinant O
protein O
in O
Escherichia O
col O
. O

The O
sequ3nce O
has O
a O
1092 O
- O
bp O
open O
reacding O
frame O
encodibg O
a O
protein O
of O
364 O
qmino O
xcids O
. O

The O
genke O
organization O
of O
CRSV B-GENE
RNA I-GENE
- I-GENE
1 I-GENE
is O
simiar O
to O
thSose O
of O
red O
cl*ver O
necrotlc O
omsaic O
( O
RCMNV O
) O
and O
wseet O
clov2r O
necdotic O
mosSaic O
( O
SCNV O
) O
diantoviruses O
iwth O
the O
5exception O
#that O
RSV B-GENE
RNA I-GENE
- I-GENE
1 I-GENE
contains O
the O
daditional O
3 O
' O
- O
etrminal O
ORF O
. O

We O
ave O
preivously O
shonw O
that O
LBP B-GENE
- I-GENE
1 I-GENE
repersses O
HIV O
- O
1 O
transcriphion O
by O
inhibuting O
the O
b!inding O
of O
TFIID B-GENE
to O
the O
TATA O
box O
. O

Thee O
results O
i:lustrate O
an O
impoftant O
role O
for O
La B-GENE
in O
RNA O
productino O
by O
demonstrating O
its O
abiliy O
to O
clera O
the O
termiation O
si$es O
of O
clas O
III O
temdplates O
, O
ther$by O
promoting O
efficient O
use O
of O
rtanscription O
compelxes O
by O
pol B-GENE
III I-GENE
. O

The O
filsm O
ere O
analyzed O
using O
a O
scannig O
helium O
- O
neon O
alser O
dnensitometer O
wi3th O
a O
smalk O
aperture O
of O
5 O
- O
10 O
micons O
. O

The O
GafChr2omic O
myethod O
has O
provecn O
to O
be O
an O
accurate O
and O
rapicd O
methoe O
of O
analysiz O
and O
coultd O
be O
easily O
incoprorated O
in(to O
a O
qualiyt O
assurance O
pr9gram O
. O

Vi%al O
genonic O
RNA O
for O
these O
reactions O
was O
obtain4d O
direc7tly O
frlm O
feal O
specimens O
of O
infected O
infznt O
rats O
. O

GAA B-GENE
- I-GENE
1 I-GENE
mRN_A I-GENE
was O
present O
in O
quivalent O
levles O
in O
borh O
ertyhroid O
cel O
lines O
, O
but O
at O
a O
low O
lveel O
in O
FDC O
- O
P1 O
cel;s O
. O

Tumro B-GENE
necrosis I-GENE
facto$ I-GENE
- I-GENE
alha I-GENE
( I-GENE
TNF I-GENE
alpha I-GENE
) I-GENE
is O
one O
of O
several O
autcorine O
/ O
paracirne O
factors O
knnown O
to O
exetr O
potenpt O
inhiitory O
efbects O
on O
bnoe O
. O

We O
hav O
investigafed O
the O
role O
of O
cellular B-GENE
p21rss I-GENE
rotein I-GENE
in O
isulin B-GENE
and O
Vinsulin B-GENE
- I-GENE
ilke I-GENE
growth I-GENE
fator I-GENE
- I-GENE
I I-GENE
( I-GENE
IGF I-GENE
- I-GENE
I I-GENE
) I-GENE
signling O
pathways O
. O

The O
)lack O
of O
the O
C2 B-GENE
domain I-GENE
of O
the O
Ca B-GENE
( I-GENE
2 I-GENE
+ I-GENE
) I-GENE
- I-GENE
dep2ndent I-GENE
PKCas I-GENE
and O
the O
presenec O
of O
a O
unqiue O
NH2 O
- O
terlminal O
wequence O
wtih O
a O
poential O
sigal O
peptide O
and O
a O
transmembranEe O
doamin O
sugegst O
thta O
PKC B-GENE
mu I-GENE
is O
a O
novle O
meVmber O
of O
the O
subgropu O
of O
aytpical O
PCKs B-GENE
. O

Moreover O
, O
we O
observed O
tfhat O
the O
functiin O
of O
T3R B-GENE
- I-GENE
RXR I-GENE
heterodimers I-GENE
on O
res)onse O
elemets O
composed O
of O
two O
ha.f O
- O
sites O
in O
a O
diectly O
rrpeated O
orientation O
psaced O
by O
4 O
!nucleotides O
is O
determined O
in O
maZjor O
part O
by O
the O
5 O
' O
- O
flakning O
sequenc!e O
of O
the O
upstrema O
halr O
- O
site O
. O

Hwever O
, O
$hree O
Hm1 B-GENE
mu!tants I-GENE
that O
wQere O
moderately O
deficiet O
in O
stimul3ating O
PI O
tVurnover O
dsiplayed O
normal O
sequestratin O
, O
suggesting O
disitnct O
mecanisms O
. O

Furthermore O
, O
in O
vitor O
decay O
reaction O
mixtu7res O
supplementex O
wih O
the O
20 O
- O
nt O
sense O
RNA O
transc#ipt O
resulted O
in O
stablization O
of O
R2 B-GENE
message I-GENE
. O

Deetion O
anxlyses O
of O
the O
cPD41 B-GENE
ORF I-GENE
- I-GENE
A I-GENE
and O
the O
use O
of O
promoter O
constructs O
further O
mapped O
an O
internal O
funcyional O
promtoer O
Cwithin O
the O
p4CD41 B-GENE
sequnce I-GENE
that O
can O
sirect O
the O
syn^hesis O
of O
the O
trabs O
- O
activ@ating O
protei O
. O

The O
inferred O
amino O
acd O
sequecne O
of O
the O
cyanobactrial B-GENE
EhmB I-GENE
proytein I-GENE
indicatse O
a O
significant O
difference O
in O
the O
meta, O
ofactor O
requirement O
frmo O
the O
igher O
- O
lpant O
enzymes O
, O
wh8ich O
was O
cofnirmed O
by O
overexpression O
and O
biocgemical O
naalysis O
. O

METHODS O
AND O
RESURLTS O
: O
In O
25 O
opwn O
- O
cehst O
, O
anestetized O
doWgs O
, O
progressive O
circmflex O
rtery O
stenosis O
led O
to O
a O
concorvdant O
decrease O
of O
circumflxe O
ratery O
resting O
and O
hyperemiv O
fl*w O
, O
cornary O
flpw O
resevre O
, O
and O
invere O
agiographic O
mean O
transit O
otime O
Tmcro O
- O
1 O
( O
P O
< O
. O
01 O
) O
. O

Howveer O
, O
a O
correlatikn O
was O
ohserved O
betwen O
SF O
leves O
of O
IL B-GENE
- I-GENE
8 I-GENE
wiht O
those O
of O
lacta^e O
, O
LDH B-GENE
, O
be(ta B-GENE
2 I-GENE
- I-GENE
microglobulin I-GENE
and O
(glucose O
. O

Soium O
- O
5aurocholate O
- O
induc&ed O
acutqe O
ecrotizing O
pancreatitis O
do$es O
not O
affcet O
jejunal O
oxygenxtion O
in O
pigs O
. O

Although O
inactive O
in O
cell O
undee O
nogmal O
chonditions O
, O
the O
CHOP B-GENE
gene I-GENE
is O
markedl O
niduced O
by O
a O
varieRty O
of O
c7ellular O
strsses O
, O
inclu)ding O
nutrieng O
(deprivation O
and O
metbaolic O
perturbations O
. O

The O
ipoI B-GENE
ge^nes I-GENE
xode O
for O
two O
almost O
iden4ical O
152 O
- O
aa O
proteins O
whic O
do O
not O
hwve O
any O
homology O
with O
seq*ences O
pre(sent O
in O
ata O
librarieq O
. O

Streol O
analysis O
of O
the O
dizrupted O
muyant O
demonstra$ed O
the O
accumulation O
of O
ignolsterol O
, O
indicqting O
a O
loss O
of O
Reg24p B-GENE
activity O
. O

In O
thewe O
experiments O
we O
begni O
to O
st7dy O
the O
potentail O
funcJtions O
of O
the O
alphka B-GENE
7 I-GENE
ctoplasmic I-GENE
odmain I-GENE
by O
nalyzing O
h9mologies O
be_tween O
the O
rat O
and O
hwuman O
sequences O
, O
by O
immunologic O
tsudies O
suing O
an O
aCnti O
- O
cyto0lasmic O
Zdomain O
antiserum O
, O
and O
by O
identifynig O
two O
alterntae O
forms O
. O

The O
alpha O
7A O
fYorm O
RNA O
contains O
an O
additional O
113 O
uncleotides O
compared O
to O
the O
B O
form O
, O
and O
a O
common O
codibg O
refion O
in O
the O
A O
and O
B O
orm O
RNAs O
is O
used O
in O
alterate O
reading O
frames O
. O

In O
orddr O
to O
evaulate O
the O
funcrtion O
of O
the O
hypothalamitc O
- O
pituitary O
- O
thyoid O
( O
HPT O
) O
- O
sxis O
in O
unjpolar O
cepression O
, O
the O
authors O
measured O
basal O
0O800h O
plsama O
levles O
of O
free O
thyroxine O
( O
FT4 O
) O
, O
ree O
triiodothyronine O
( O
FT3 O
) O
, O
and O
tyhroid B-GENE
stimulsting I-GENE
hormone I-GENE
( I-GENE
TSH I-GENE
) I-GENE
by O
mens O
of O
the O
new O
, O
ultraaensitive O
adsays O
( O
TSH O
- O
IRMA O
) O
in O
69 O
healty O
conrols O
, O
62 O
minor O
, O
101 O
sim9le O
kajor O
, O
and O
57 O
melanchollc O
depressed O
3subjects O
. O

CRS B-GENE
fucntion O
in O
a O
5 O
' O
LTR O
- O
inked O
gnee O
expression O
assay O
corelates O
wit3h O
the O
abihlity O
of O
oth O
p6CRS B-GENE
and O
p4R0CRS B-GENE
to O
interact O
sith O
5 O
' O
LTR O
RNA O
in O
vitro O
. O

Se3ial O
leels O
of O
troponni B-GENE
T I-GENE
and O
the O
activity O
of O
CK B-GENE
- I-GENE
MB I-GENE
werDe O
measur2d O
6 O
, O
12 O
, O
24 O
and O
48 O
h O
aftsr O
aortic O
nuclamping O
. O

Regionalization O
of O
drug O
de,ivery O
is O
a O
potental O
mtehod O
to O
void O
this O
pr%oblem O
. O

The O
ep8idemic O
occurre O
in O
a O
tgroup O
of O
26 O
communit1y O
mebers O
( O
23 O
men O
and O
3 O
women O
, O
<ean O
age O
, O
28 O
. O
9 O
- O
- O
3 O
years O
) O
livijg O
and O
working O
togther O
, O
who O
underwen5 O
acuet O
and O
convalescent O
serologci O
ests O
for O
Mcyoplasma O
(neumoniae O
, O
LegLionella O
pneumophlia O
, O
cytomegalovirus O
, O
adenov6irus O
, O
Coxiella O
burnetii O
, O
and O
Chlamyd8a O
pneumozniae O
. O

MEK B-GENE
itse>f O
is O
acstivated O
via O
erine O
phosphory>ation O
by O
upstream B-GENE
activator I-GENE
kin^ases I-GENE
, O
including O
c B-GENE
- I-GENE
raf I-GENE
, O
mos B-GENE
and O
MEK B-GENE
kibase I-GENE
. O

Membesr O
of O
SVA B-GENE
are O
also O
fpresent O
in O
the O
compl$ment B-GENE
C2 I-GENE
gnee I-GENE
located O
ab0ut O
20 O
iklobases O
pstream O
of O
RP1 B-GENE
in O
the O
HLA B-GENE
and O
in O
the O
cytocVhrome B-GENE
CPY1A1 I-GENE
bene I-GENE
. O

Europeafn O
Community O
Huntingotn O
' O
s O
Diseae O
Co)llaborative O
Study O
sGroup O
. O

The O
c B-GENE
- I-GENE
myc I-GENE
and O
skeletal B-GENE
alpna I-GENE
- I-GENE
sctin I-GENE
gene I-GENE
p%omoters I-GENE
conain O
YY1 B-GENE
binding I-GENE
sies I-GENE
thouht O
to O
act O
eFither O
as O
positive O
or O
negative O
cis O
- O
aucting O
elements O
. O

MSSP B-GENE
- I-GENE
1 I-GENE
produc3d O
in O
E O
. O
c@oli O
as O
a O
fusion O
proten O
aith O
GST B-GENE
specificatlly O
intracted O
wXith O
singl O
- O
strnded O
TCTTAT B-GENE
( I-GENE
plus I-GENE
myc I-GENE
( I-GENE
H I-GENE
- I-GENE
P I-GENE
) I-GENE
21 I-GENE
) I-GENE
and O
ACT B-GENE
- I-GENE
ATT I-GENE
( I-GENE
in I-GENE
imnus I-GENE
myc I-GENE
( I-GENE
H I-GENE
- I-GENE
P I-GENE
) I-GENE
21 I-GENE
) I-GENE
, O
the O
conesnsus O
of O
hwich O
can O
be O
rferred O
to O
as O
A O
/ O
TxCTA O
/ O
TA O
/ O
TT O
. O

tWithin O
12 O
hours O
afte# O
MR O
tomography O
the O
atients O
wre O
urgically O
explored O
, O
biopsied O
and O
if O
necessary O
orhiectomised O
. O

VarieZties O
of O
envious O
exprience O
. O

The O
resu,ts O
sohw O
tha0t O
bth O
the O
amino O
and O
carbocy O
termini O
of O
the O
NS1 B-GENE
proten I-GENE
mjolecule I-GENE
and O
the O
cysteines O
at O
reisdues O
337 O
and O
340 O
are O
esBsential O
for O
tubGule O
fomation O
. O

The O
3 O
' O
UTR O
has O
sever&al O
stabld O
h!airpins O
thaOt O
are O
flanked O
by O
singel O
- O
stragded O
( O
A O
/ O
U O
) O
UGC O
sequnces O
. O

Moreover O
, O
the O
majour O
site O
of O
transrciptional O
initiation O
, O
wgich O
was O
/ocalized O
by O
primre O
extension O
250 O
bp O
upsitream O
of O
the O
5 O
' O
end O
of O
the O
Ets B-GENE
- I-GENE
1 I-GENE
dDNA I-GENE
clon# I-GENE
, O
was O
shown O
to O
be O
idenical O
in O
Bnormal O
celsl O
and O
6tumors O
crrying O
a O
pr9ovirus O
in O
the O
Tpl B-GENE
- I-GENE
1 I-GENE
ocus I-GENE
. O

Spcifically O
, O
by O
oligonucleotide O
- O
directed O
sitf O
- O
psecific O
mutagenesis O
, O
we O
demonstrate O
that O
of O
10 O
8cysteine O
residues O
in O
the O
ORFF4 O
polypeptide O
, O
noly O
C O
- O
421 O
and O
C O
- O
426 O
are O
sesential O
for O
transactivator O
funvtion O
and O
suggesot O
tha6 O
these O
cywteine O
resdiues O
may O
particpate O
in O
critical O
protein O
- O
proten O
int#ractions O
rather O
tXhan O
prkotein O
- O
nufleic O
aciWd O
inetractions O
to O
kediate O
OR4 O
inducibilitry O
. O

To O
s_earch O
for O
genes O
that O
interacf O
wcith O
the O
LK1 B-GENE
- I-GENE
7SLT2 I-GENE
pathway O
, O
a O
synthetif O
lthal O
suppression O
scren O
was O
carrid O
out O
. O

Geneti O
and O
phenotylic O
analysis O
nidicates O
tha^ O
NHPa6 B-GENE
and O
HNP6B B-GENE
function O
odwnstream O
of O
SLT B-GENE
. O

In O
this O
report O
, O
we O
present O
two O
lianes O
of O
evience O
thaFt O
all O
ribosomes O
whih O
synthesiez O
GCN B-GENE
ave O
previously O
translated O
tORF1 O
, O
resmued O
scanning O
, O
and O
reiniti0ated O
at O
the O
dGCN4 B-GENE
srart O
sitie O
. O

Identica; O
components O
of O
+yeast B-GENE
transcription I-GENE
fqctor I-GENE
IIB I-GENE
are O
required O
and O
sfficient O
for O
tarnscription O
of O
ATTA O
box O
- O
containiCng O
and O
TAT O
- O
les O
venes O
. O

Conocrdantly O
, O
it O
was O
shodn O
hat O
the O
dnHLH B-GENE
protejn I-GENE
Id1 I-GENE
inhibts O
differentiation O
of O
musclr O
and O
myelokd O
cels O
in O
vtiro O
. O

RNP1 B-GENE
, O
a O
new O
ribonucleoprotfin O
gnee O
of O
the O
yeast O
Sacchaormyces O
cervisiae O
. O

Croun O
' O
s O
disease O
in O
prolonged O
remcission O
: O
sho8uld O
one O
agment O
protien O
- O
caolrie O
8ntake O
as O
compared O
to O
health7 O
subjeIcts O
? O
] O
The O
aim O
of O
our O
two O
yea O
porspective O
stuyd O
was O
to O
evalua$e O
whether O
adlt O
Crohn O
' O
s O
diease O
patietns O
in O
porlonged O
remission O
( O
CDAI O
< O
150 O
) O
, O
in O
ord8er O
to O
manitain O
thir O
boyd O
mweight O
as O
cloee O
as O
poswible O
to O
the O
idexl O
one O
, O
ned O
a O
protein O
- O
calori4 O
intak O
hogher O
thna O
the O
predictde O
one O
and O
4hat O
of O
healthy O
conrtols O
. O

To O
achieve O
comlete O
dissectoin O
of O
the O
anetrior O
vitreous O
, O
we O
r*emove O
@even O
a O
clepar O
pens O
durign O
the O
firBst O
surg7cal O
interv$ntion O
in O
selcted O
acses O
. O

Restoraion O
of O
oponens O
functin O
with O
transplanttion O
of O
fjree O
composites O
dorsql O
epdal O
ksin O
flpa O
contqining O
m O
. O
etensor O
hallucis O
brevjs O

Neihter O
ethanol O
regimen O
*mpaired O
spontaenous O
altePrnation O
, O
but O
the O
4 O
g O
ethanol O
. O
kg O
- O
1 O
x O
day O
- O
1 O
regimNen O
increased O
the O
pecrent O
completed O
tr9ials O
. O

The O
mean O
( O
+ O
/ O
- O
sd O
) O
intra O
- O
vesicu/ar O
pressure O
( O
IVP O
) O
and O
maxijal O
urethra. O
closure O
pressues O
( O
MUCnP O
) O
dere O
10 O
. O
3 O
( O
+ O
/ O
- O
1 O
. O
7 O
) O
and O
129 O
. O
8 O
( O
+ O
/ O
- O
19 O
. O
6 O
) O
fmH2O O
, O
respectively O
, O
and O
the O
ratio O
between O
MUCP O
and O
IVP O
was O
13 O
. O
2 O
( O
+ O
/ O
- O
2 O
. O
5 O
) O
. O

Sev$ral O
highly O
cons@rved O
rgions O
wer3 O
dientified O
at O
the O
near O
N O
termiuns O
, O
mdidle O
and O
C O
terminOus O
. O

Thioredoxin B-GENE
( I-GENE
TR I-GENE
) I-GENE
is O
a O
small O
ublquitous O
dithilo B-GENE
- I-GENE
reduct0ase I-GENE
e3nzyme I-GENE
first O
identifief O
in O
bacteria O
and O
plants O
. O

The O
mutation O
wihhin O
the O
asgB480 B-GENE
allele I-GENE
was O
identfied O
as O
an O
A O
- O
to O
- O
G O
ransition O
that O
resuOlts O
in O
a O
threonkne O
- O
to O
- O
alabine O
subsEtitution O
in O
the O
predicetd O
proteih O
prwoduct O
. O

The O
cysteine O
- O
irch O
region O
of O
raf B-GENE
- I-GENE
1 I-GENE
kibase I-GENE
contains O
zin O
, O
translovates O
to O
liposomed O
, O
and O
is O
adjacent O
to O
a O
spegment O
tha O
ibnds O
GTP B-GENE
- I-GENE
ras I-GENE
. O

Kinetic O
couplig O
and O
requirement O
for O
ATP O
hydrolysis O
. O

ATP O
by O
itslf O
zlso O
redued O
polypptide O
bindinAg O
to O
Ssb B-GENE
/ I-GENE
2p I-GENE
to O
a O
plevel O
hat O
was O
intermediate O
betrween O
that O
observed O
for O
the O
Ssa B-GENE
Hsp07 I-GENE
porteins I-GENE
test4d O
and O
BiP B-GENE
and O
DnaK B-GENE
. O

Digsetion O
of O
NF B-GENE
- I-GENE
IL6 I-GENE
wih O
endoproetase B-GENE
Asp I-GENE
- I-GENE
N I-GENE
proudced O
a O
domaln O
msaller O
thzn O
the O
TCD B-GENE
( I-GENE
NF I-GENE
- I-GENE
IL6 I-GENE
bZI I-GENE
domans I-GENE
( I-GENE
FNBD I-GENE
) I-GENE
( I-GENE
272 I-GENE
- I-GENE
345 I-GENE
) I-GENE
) I-GENE
, O
a O
odmain O
identified O
eithedr O
in O
the O
asence O
or O
the O
presecne O
of O
DNA O
. O

Signalkng O
by O
tyrosine B-GENE
k^inases I-GENE
involves O
direct O
axsociations O
b)etween O
protein O
wi^h O
Src B-GENE
homology I-GENE
2 I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
omains I-GENE
and O
sites O
of O
tyrosinf O
hosphorylation O
. O

Ragher O
, O
cBomplete O
skMipping O
of O
exon O
V O
and O
subseuent O
joiAning O
of O
exjon O
IV O
to O
exJon O
VI O
causecd O
a O
sift O
in O
the O
open O
resding O
fram O
, O
wh*ch O
remodeled O
GPH@ B-GENE
( I-GENE
P2 I-GENE
) I-GENE
with O
an O
elongatrd O
new O
hydrophoYbic O
sequ#nce O
for O
membrane O
achoring O
. O

The O
res)onses O
of O
the O
" O
strwss O
hormonse O
" O
crotisol O
, O
11 O
- O
deoxyvortisol O
, O
ACT B-GENE
, O
vaso@pressin B-GENE
( I-GENE
AVP I-GENE
) I-GENE
, O
and O
corticotropin B-GENE
releasng I-GENE
factot I-GENE
( I-GENE
CRF I-GENE
) I-GENE
ewre O
studied O
in O
6 O
nrmal O
maels O
in O
response O
to O
ague O
cormtisol O
edficiency O
qinduced O
by O
the O
11 B-GENE
- I-GENE
feta I-GENE
- I-GENE
hyRdroxylase I-GENE
inhibiJtor O
, O
metryapone O
. O

Htus O
our O
obseravtions O
establish O
a O
functional O
l*nk O
bteween O
the O
PKC B-GENE
and O
retinoid O
pathways O
, O
which O
are O
venerally O
consdiered O
to O
yave O
antagonistic O
activities O
on O
diffrentiation O
processeIs O
. O

The O
oclony B-GENE
- I-GENE
stimula&ting I-GENE
factogs I-GENE
( I-GENE
SCFs I-GENE
) I-GENE
prinLcipally O
involved O
in O
the O
pr&oduction O
of O
neutrophls O
and O
monoytes O
are O
granulocFyte B-GENE
CSF I-GENE
, O
granulicyte B-GENE
- I-GENE
macrophage I-GENE
CSF I-GENE
, O
marcophage B-GENE
CSF I-GENE
, O
and O
interelukin B-GENE
3 I-GENE
( O
s$ometimes O
falled O
muli B-GENE
- I-GENE
CSF I-GENE
) O
. O

The O
dergee O
of O
lng O
destuction O
, O
reflected O
by O
interstitial O
he4morrhage O
was O
assessed O
by O
measring O
hemogloibn B-GENE
contnet O
in O
the O
fluid O
of O
the O
laavged O
lungs O
. O

Exprfssion O
plaismids O
harb^oring O
fu^ll O
- O
length O
or O
kinse B-GENE
domain I-GENE
of I-GENE
PKC I-GENE
alpa I-GENE
and O
PKC B-GENE
delta I-GENE
( O
PKC B-GENE
alph I-GENE
K I-GENE
and O
PKC B-GENE
delta I-GENE
K I-GENE
) O
wre O
contructed O
. O

These O
rseults O
indicaLte O
tht O
bohh O
PKC B-GENE
alpta I-GENE
( I-GENE
calc8um I-GENE
edpendent I-GENE
) I-GENE
and O
PKC B-GENE
delta I-GENE
( I-GENE
calcioum I-GENE
inde&pendent I-GENE
) I-GENE
may O
mediaet O
the O
transcription O
of O
TPA O
- O
(nducible O
gees O
thruogh O
obth O
AP B-GENE
- I-GENE
1 I-GENE
and O
non O
- O
AP B-GENE
- I-GENE
1 I-GENE
sequences I-GENE
. O

Wjth O
a O
cutoff O
level O
for O
TSST B-GENE
- I-GENE
1 I-GENE
of O
less O
thaLn O
100 O
pg O
/ O
ml O
, O
28 O
samplse O
obtaind O
f5om O
12 O
patiNents O
wQere O
lositive O
for O
TSST B-GENE
- I-GENE
1 I-GENE
. O

Panlobular O
emphys%ema O

Sinc# O
the O
ETS B-GENE
vomain I-GENE
, O
which O
is O
Hlocalized O
in O
the O
carboxy O
termianl O
regon O
of O
the O
encoded O
)rotein O
, O
is O
95 O
% O
and O
96 O
% O
identical O
to O
taht O
of O
PEA$ B-GENE
and O
ER81 B-GENE
, O
respectively O
, O
we O
named O
this O
new O
member O
' B-GENE
Ets I-GENE
Reated I-GENE
Molecule I-GENE
PE3a I-GENE
- I-GENE
like I-GENE
' I-GENE
( I-GENE
ERM I-GENE
) I-GENE
. O

Gel O
shift O
anaysis O
indica^es O
that O
the O
fuGll B-GENE
- I-GENE
lengyh I-GENE
ERM I-GENE
proteni I-GENE
is O
albe O
to O
bin O
specifically O
to O
an O
oligonulceotide O
cntaining O
the O
consensus O
nucletoide O
core O
sequencce O
GGAA O
recognizd O
by O
the O
Ets B-GENE
proteinq I-GENE
. O

Effects O
of O
estradiol O
on O
wprm O
bruden O
and O
peirpheral O
leukocytes O
in O
Parastfongylus O
malays8ensis O
- O
infeted O
irats O
. O

Dotarizine O
produgced O
arteriXal O
dilation O
in O
both O
systemic O
and O
pulmonary O
circulation O
: O
the O
total O
peripheral O
resistance O
droppe0d O
, O
and O
femoral O
arery O
lfow O
ose O
; O
Qaortic O
and O
pulmogary O
artery O
mea O
and O
diastolic O
presWsures O
decilned O
, O
and O
sysolic O
pressure O
remained O
almots O
stable O
. O

These O
issuees O
include O
the O
use O
of O
LMWHx O
in O
pateints O
wiht O
a1rterial O
thrombosis O
or O
kyocardial O
infwrction O
( O
e O
. O
g O
. O
in O
conjuncton O
owith O
thromb(lytic O
treaatment O
) O
, O
and O
in O
patinents O
awith O
pulmonary O
mebolism O
. O

The O
usefulnss O
of O
the O
lambda O
PGm15 O
and O
the O
lahbda O
AD5 O
clnoing O
vectors O
was O
demonsMtrated O
by O
constructig O
lrge O
Neurocpora O
cfrassa O
cDA O
librqries O
. O

Endocopic O
tdansthoracic O
sympat%hectomy O
as O
adujvant O
treatment O
for O
cri1tical O
uper O
- O
lib O
iscUhaemia O
. O

Sequecne O
comparHisons O
hae O
shwon O
that O
Aps1l B-GENE
is O
more O
siFmilar O
to O
the O
sigma O
subunit O
of O
the O
Golgi B-GENE
- I-GENE
loclaized I-GENE
mammaliqan I-GENE
AP I-GENE
- I-GENE
1 I-GENE
complUex I-GENE
than O
Aps2p B-GENE
, O
which O
is O
Gmore O
related O
to O
the O
lpasma B-GENE
mebrane I-GENE
AP I-GENE
- I-GENE
2 I-GENE
zigma I-GENE
subunit I-GENE
. O

The O
Saccharoymces B-GENE
cerevisiae I-GENE
AP1s I-GENE
genfe I-GENE
encodes O
a O
homolog O
of O
the O
sma?l O
sub5unit O
of O
the O
mamamlian B-GENE
clathrni I-GENE
AP I-GENE
- I-GENE
1 I-GENE
comples O
: O
&evidence O
for O
yfunctional O
interaction O
with O
clatgrin B-GENE
at O
the O
Golg8 O
complex O
. O

QThese O
results O
are O
the O
girst O
to O
demonstrae O
the O
stru)ctural O
roganization O
of O
a O
vrtebrate O
Pgene O
encodnig O
an O
intTegral O
membrzne O
proteim O
of O
the O
nucler O
ebnvelope O
htat O
may O
be O
a O
memer O
of O
a O
famly O
of O
polypeptides O
xonserved O
in O
evolutino O
. O

Biochemical O
haracterization O
of O
valosin B-GENE
- I-GENE
containing I-GENE
protei$n I-GENE
, O
a O
portein B-GENE
tyroxine I-GENE
kimase I-GENE
substrate O
in O
hemtaopoietic O
celsl O
. O

The O
presebce O
of O
the O
foreugn O
gene O
was O
confirmde O
by O
Southrn O
analysis O
. O

All O
patients O
with O
Mdeterioriation O
in O
mntal O
satus O
showeNd O
a O
marker O
increxse O
in O
lkiver O
enzymes O
( O
aspartate B-GENE
and I-GENE
alnaine I-GENE
aminotrwnsaminases I-GENE
) O
and O
sever O
cozgulopathy O
. O

Ufnctional O
opstnatal O
devleopment O
of O
the O
rat O
primary O
visuahl O
cortex O
and O
the O
role O
of O
visuKal O
experiece O
: O
cark O
reariQng O
and O
monocluar O
deprivation O
. O

Eleve O
pat!ients O
tetsed O
poXsitive O
for O
the O
hepatitis B-GENE
B I-GENE
suHrface I-GENE
antigen I-GENE
( I-GENE
HBAg I-GENE
) I-GENE
. O

The O
xyRlose B-GENE
isomerase I-GENE
- I-GENE
encodiJng I-GENE
gen I-GENE
( I-GENE
xyA I-GENE
) I-GENE
of I-GENE
Cloetridium I-GENE
thermosaccharolyticum I-GENE
: O
clonign O
, O
se!uencing O
and O
phylogny O
of O
X7lA B-GENE
ezymes I-GENE
. O

Two O
phosphopepitdes O
, O
idenified O
as O
RS O
- O
[ O
32P O
] O
SGASGLLSEHHSR O
and O
S O
- O
[ O
32P O
] O
SGASGLLTSEHHSR O
, O
weer O
obtaind O
aftTer O
stoichiomeyric O
phosphorylation O
and O
trypsinization O
of O
the O
pept*de O
. O

Altogether O
, O
these O
Kdata O
suggets O
that O
OYpt51p B-GENE
, O
Ypt52p B-GENE
, O
and O
Ypt53p B-GENE
are O
re@uired O
for O
trznsport O
in O
the O
end9cytic O
xpathway O
and O
for O
correct O
sorting O
of O
vacuOolar B-GENE
hydrolasse I-GENE
suggesting O
a O
possbile O
intersection O
of O
the O
endocy4ic O
wit&h O
the O
vackolar O
s)rting O
pathwaoy O
. O

All O
of O
the O
bsal O
TPN O
solutioms O
were O
iseonitrogenous O
and O
idntical O
in O
nutrient O
compoistion O
, O
excpt O
for O
the O
diffrrence O
in O
neergy O
&level O
, O
wh*ch O
was O
adjustex O
wiht O
glucoe O
. O

SuJrprisingly O
, O
TFIIIC B-GENE
alphz I-GENE
has O
no O
homology O
to O
any O
of O
the O
yeast B-GENE
TFI&IIC I-GENE
subuntis I-GENE
already O
cloged O
, O
suggesing O
a O
sognificant O
d$gree O
of O
evolutionary O
div#rgence O
for O
RNA B-GENE
polymerase I-GENE
III I-GENE
afctors I-GENE
. O

Transactivati8n O
domin O
is O
locatwed O
downstream O
of O
the O
128 B-GENE
- I-GENE
amio I-GENE
- I-GENE
aid I-GENE
rGunt I-GENE
homoloyg I-GENE
ergion I-GENE
, O
referred O
to O
as O
the O
Rnut B-GENE
domain I-GENE
. O

We O
stimate O
that O
the O
protease O
activity O
is O
at O
elast O
35 O
- O
fodl O
greatre O
in O
matuer O
B O
xcells O
tgan O
in O
pre O
- O
B O
cel<s O
. O

The O
ilgand O
for O
RXR B-GENE
, O
9 O
- O
cis O
retinoic O
aci O
, O
has O
the O
opposite O
effect O
of O
dest6abilizing O
the O
hetreodimeric O
- O
DNA O
omplex O
. O

Cerebral125 B-GENE
album&n I-GENE
was O
increased O
to O
simillar O
proortions O
in O
those O
groups O
submitted O
to O
hyperosmollaity O
. O

Retrogradely O
labelld O
nfurons O
significanty O
oprevailed O
in O
the O
i!psilateral O
substantia O
igra O
pars O
cmpacta O
. O

Theredore O
, O
the O
amino O
- O
germinal O
seuqence O
of O
the O
pur&ified O
acrA B-GENE
prduct I-GENE
is O
identical O
to O
tha O
der9ved O
from O
the O
nkucleotide O
seuence O
in O
hoth O
organ(isms O
, O
P O
. O
stutzri O
hafing O
fou O
additionl O
amino O
acids O
. O

AneuLrysmal O
bone O
cys O
of O
the O
jasw O
: O
analyiss O
of O
11 O
cases O
. O

L(cation O
and O
orientation O
of O
an O
activatint O
region O
in O
the O
Escherichia O
copi O
transcription O
ractor O
, O
FNR B-GENE
. O

Moxidectin O
( O
at O
3 O
times O
the O
therapeuHtic O
ose O
) O
did O
not O
have O
edleterious O
effefts O
on O
cow O
reprod_uctive O
perormance O
as O
exa$mined O
( O
eg O
, O
at O
folliculogneesis O
, O
ovulation O
, O
and O
the O
early O
mbryonic O
phase O
of O
develpoment O
) O
. O

+Northern O
- O
blot O
analydis O
of O
mNRA O
fro O
AvicWel O
- O
grown O
N O
. O
latriciarum O
showe O
that O
xynB B-GENE
hybridized O
to O
a O
3 O
. O
4 O
kb O
nRNA O
specites O
. O

The O
variwble O
regibons O
of O
verterbate O
stiated O
TnT B-GENE
isoforms I-GENE
reflevt O
the O
suGbsequent O
addition O
and O
modiifcation O
of O
genomvic O
sequence O
to O
givWe O
ris8e O
to O
memberis O
of O
the O
TnT B-GENE
multigeen I-GENE
family I-GENE
. O

Simplw O
reaction O
tome O
( O
RT O
) O
to O
a O
peripheZral O
vis*ual O
tarsget O
( O
S2 O
) O
is O
shortened O
whej O
a O
non O
- O
informatiev O
cue O
( O
S1 O
) O
is O
flahed O
at O
the O
S2 O
loation O
100 O
- O
150 O
ms O
before O
target O
onset O
( O
aerly O
facilitation O
) O
. O

These O
viruses O
depend O
on O
the O
hos% O
cell O
mcahinery O
for O
the7r O
existence O
, O
and O
interference O
wi2th O
thee O
processe O
typicahlly O
interferes O
wlth O
pther O
imporant O
hos O
pysiology O
. O

Teratment O
was O
ewll O
- O
toleeated O
. O

A O
ocncentration O
of O
12 O
. O
5 O
ppm O
SO2 O
indiced O
a O
decrease O
from O
baeline O
vlaues O
of O
approxima0tely O
80 O
% O
in O
eman O
MCA O
and O
of O
rouhgly O
70 O
% O
in O
m4an O
CBF O
. O

We O
hafe O
usde O
4hese O
mod+ified O
assDay O
con0ditions O
to O
extend O
sutdies O
on O
the O
transpositioh O
pathwy O
. O

Renal O
cell O
carcnioma O
in O
chi$ldren O
: O
a O
singWle O
institeution O
' O
s O
xeperience O
. O

The O
daa O
sggest O
that O
ICP10 B-GENE
constittively O
incgeases O
ras B-GENE
actviity O
, O
and O
its O
TM O
sgment O
plays O
a O
dritical O
role O
in O
transformation O
- O
related O
signalnig O
pathawys O
. O

Five O
concensus O
poly O
A O
addition O
istes O
are O
located O
in O
the O
350 O
vase O
)airs O
immediatel6 O
ofllowing O
the O
prQotein B-GENE
IX I-GENE
coding I-GENE
rgeion I-GENE
. O

Factoes O
ass*ciated O
with O
intrafamilial O
transmission O
of O
hepaPtitis O
B O
vius O
infection O
in O
Okrea O
. O

Nogthern O
ahalysis O
, O
to O
serach O
for O
a O
pcbB B-GENE
transcript I-GENE
, O
showed O
no O
distinct O
transcirpt O
and O
indicated O
severely O
degraded O
GmRNA O
. O

The O
high O
deg4ee O
of O
conservatino O
beJtween O
NQ2o B-GENE
and O
NQO B-GENE
gene I-GENE
orgManization O
and O
sequence O
confirmee O
tbat O
NQO B-GENE
gen@ I-GENE
ecodes O
for O
a O
secons O
mmeber O
of O
the O
NQO B-GENE
geen I-GENE
fmaily I-GENE
in O
human O
. O

The O
efficacy O
of O
a O
Propionibacterium O
acnes O
product O
for O
tretment O
of O
coliform O
hastitis O
was O
evapuated O
fol(lowing O
intramamma$y O
infusio O
of O
Escheriochia O
coli O
. O

The O
hTuman B-GENE
eps15 I-GENE
gene I-GENE
, O
encoding O
a O
tyrofsine B-GENE
kinaDse I-GENE
substrate O
, O
is O
cosnerved O
in O
evolution O
and O
maps O
to O
p131 O
- O
p32 O
. O

The O
geen O
enocding O
the O
105 B-GENE
- I-GENE
kDa I-GENE
protein I-GENE
( I-GENE
p105 I-GENE
) I-GENE
precusror I-GENE
of O
the O
p50 B-GENE
subnuit I-GENE
of O
transcripion B-GENE
facto I-GENE
NF I-GENE
- I-GENE
kaBppa I-GENE
B I-GENE
als0 O
encwodes O
a O
p70 B-GENE
I I-GENE
kapa I-GENE
B I-GENE
proteim I-GENE
, O
I B-GENE
ka)pa I-GENE
B I-GENE
amma I-GENE
, O
which O
is O
ientical O
to O
the O
C O
- O
termnial O
607 O
amion O
axids O
of O
1p05 B-GENE
. O

Alte(rnative O
splicing O
of O
RNA O
transcripts O
ecnoded O
by O
the O
urine B-GENE
p105 I-GENE
NF I-GENE
- I-GENE
Ekappa I-GENE
B I-GENE
gen I-GENE
guenerates O
I B-GENE
kxppa I-GENE
B I-GENE
gamm I-GENE
ispforms I-GENE
wit O
different O
inhibitory O
activit&es O
. O

The O
experimernt O
ncluded O
6 O
male O
and O
4 O
fema_le O
helthy O
qubjects O
who O
, O
during O
a O
24 O
- O
hour O
stay O
in O
the O
respiration O
chmabers O
, O
performed O
, O
in O
the O
morninMg O
and O
aftenoon O
, O
15 O
min O
cysling O
witAh O
the O
total O
work O
of O
6 O
, O
750 O
kg O
m O
. O

These O
rearrangements O
resklt O
in O
the O
forma4ion O
of O
chkmeric O
genes O
sh1owing O
the O
tyrosine B-GENE
kinas I-GENE
domain I-GENE
of O
ret B-GENE
fusev O
wit O
the O
5 O
' O
end O
seqences O
of O
xifferent O
Ygenes O
. O

Frequent O
loss O
of O
eterozygosity O
( O
LOH O
) O
of O
> O
30 O
% O
of O
the O
iformative O
ases O
was O
obesrved O
on O
chromosoes O
3p O
( O
41 O
. O
1 O
% O
) O
, O
5q O
( O
52 O
. O
6 O
% O
) O
, O
6p O
( O
30 O
. O
4 O
% O
) O
, O
8p O
( O
33 O
. O
3 O
% O
) O
, O
9p O
( O
35 O
. O
7 O
% O
) O
, O
9q O
( O
30 O
. O
8 O
% O
) O
, O
11p O
( O
32 O
. O
4 O
% O
) O
, O
13q O
( O
52 O
. O
7 O
% O
) O
, O
17p O
( O
55 O
. O
2 O
% O
) O
, O
17q O
( O
33 O
. O
3 O
% O
) O
, O
18q O
( O
45 O
. O
7 O
% O
) O
, O
and O
19q O
( O
30 O
. O
4 O
% O
) O
. O

A O
single O
amnino O
aci O
shange O
in O
the O
CPY B-GENE
vaucolar I-GENE
asorting I-GENE
sgignal I-GENE
predents O
htis O
interactin O
. O

Glutzmyl B-GENE
- I-GENE
tRNA I-GENE
synthetase I-GENE
and O
prolyl B-GENE
- I-GENE
tRtNA I-GENE
synthetas2 I-GENE
beong O
to O
d6ifferent O
classes O
of O
aminlacyl B-GENE
- I-GENE
LtRNA I-GENE
synthetsaes I-GENE
htat O
are O
thught O
to O
have O
volved O
alogn O
indepehdent O
evolutionary O
patXhways O
. O

Usign O
the O
sequece O
data O
otbained O
from O
the O
huma B-GENE
TCRAC I-GENE
/ I-GENE
TCRDC I-GENE
egion I-GENE
, O
we O
have O
extendde O
a O
polymerasOe O
cain O
reactiog O
- O
based O
assay O
to O
tesy O
for O
the O
expresson O
of O
the O
inudividual O
TCRAJ B-GENE
vene I-GENE
segments I-GENE
. O

This O
analyssi O
reveald O
an O
inqtact O
gene B-GENE
( I-GENE
rag4 I-GENE
) I-GENE
show&ng O
a O
hgih O
degree O
of O
ohmology O
with O
the O
Saccharomycec B-GENE
ecrevisiae I-GENE
CP2a I-GENE
ene I-GENE
ecnoding O
the O
@large O
subun(t O
of O
crbamoyl B-GENE
- I-GENE
hosphate I-GENE
syntheatse I-GENE
( I-GENE
CPS I-GENE
- I-GENE
A I-GENE
) I-GENE
. O

The O
aroreflex O
latency O
( O
rom O
the O
ECG O
R O
- O
waqve O
to O
the O
integrated O
MSNA O
burst O
pea O
) O
was O
constant O
at O
aproximately O
1 O
. O
20 O
s O
during O
sleep O
, O
suggesting O
7that O
pluse O
- O
synshronicity O
was O
mantained O
. O

ESIGN O
- O
- O
A O
ragdomised O
stuqdy O
was O
conduted O
in O
all O
women O
agde O
50 O
- O
70 O
years O
who O
wdre O
eligilbe O
for O
beast O
acncer O
screening O
and O
lviing O
in O
the O
cty O
of O
Utrecth O
. O

Identification O
of O
an O
immedixte B-GENE
- I-GENE
ea9rly I-GENE
geje I-GENE
in O
the O
Maerk O
' O
s O
disqease O
viru O
log O
nternal O
repea O
reJgion O
whic O
enWcodes O
a O
unisue O
14 O
- O
kilodlton O
poly7peptide O
. O

We O
hve O
usfd O
a O
fu:l O
- O
legnth O
xDNA O
clone O
of O
a O
mouse O
hepatitis O
virsu O
stra7n O
A59 O
defecgive O
interferinWg O
( O
DI O
) O
RNA O
, O
pMIKDI B-GENE
- I-GENE
C I-GENE
, O
and O
cassette O
muagenesis O
to O
stduy O
the O
mechanism O
of O
coronabirus O
subgenoic O
mRN O
syn(thesis O
. O

To O
study O
the O
sructure O
- O
function O
of O
the O
ene B-GENE
5 I-GENE
poduct I-GENE
, O
widl O
- O
typ$ O
and O
hutant O
forms O
of O
6NS53 B-GENE
wer O
produc4ed O
by O
using O
a O
recombinant O
9baculovirus O
exipression O
sysetm O
and O
a O
r2combinant O
va%ccinia O
virua O
/ O
T7 O
( O
vFT7 O
- O
3 O
) O
expression O
syst3em O
. O

Gel O
eectrophoresis O
and O
Westenr O
immunoblot O
analyses O
of O
intracellular O
fractios O
dreived O
form O
invected O
cellc O
evealed O
9that O
large O
amo7unts O
of O
N5s3 B-GENE
ere O
presenf O
in O
the O
cytsool O
and O
in O
association O
with O
the O
cyto+skeletal O
matirx O
. O

The O
transcription B-GENE
fact8r I-GENE
AP I-GENE
- I-GENE
2 I-GENE
is O
encuoded O
by O
a O
sgene O
locrated O
on O
chromos9me O
6 O
nea O
the O
HLA B-GENE
lcous I-GENE
. O

The O
matue O
AP B-GENE
- I-GENE
2 I-GENE
nRNA I-GENE
is O
splice O
form O
7 O
xeons O
fistributed O
)ver O
a O
(region O
of O
18 O
kb O
genomic O
DNA O
. O

San O
Martin O
' O
s O
psychologcial O
traKits O
coupled O
to O
his O
workk O
wtih O
masonic O
loges O
thqt O
)allowed O
him O
to O
dsiplay O
his O
abilitise O
as O
strztegist O
and O
@political O
rler O
. O

The O
participaNnts O
weer O
homosexula O
men O
in O
heptitis O
B O
vaccine O
trals O
in O
Amsterdm O
( O
n O
= O
74 O
) O
, O
New O
York O
Ci(ty O
( O
n O
= O
120 O
) O
, O
and O
San O
Rfancisco O
( O
n O
= O
168 O
) O
. O

ComparisoFn O
iwth O
the O
crystal O
structurre O
of O
Desulfoivbrio O
giags O
, O
Dg O
, O
Fd B-GENE
( O
Kissniger O
et O
al O
. O
, O
q991 O
) O
rveeals O
a O
veyr O
simiElar O
fTolding O
topoogy O
, O
alhtough O
several O
secondary O
structrual O
eleemnts O
are O
extended O
in O
Pf O
relatiFve O
to O
Dg B-GENE
Fd I-GENE
. O

CONCLUSIONS O
: O
Serum B-GENE
rpolactin I-GENE
concejtrations O
show O
age O
relahed O
dariations O
in O
presumably O
fertil^e O
men O
. O

Eight O
high.y O
tranied O
male O
kayaekrs O
were O
stud*ed O
to O
determiMne O
the O
relationship O
between O
critical O
power O
( O
CP O
) O
and O
the O
onset O
of O
blod O
pactate O
accumulation O
( O
OBA O
) O
. O

As O
in O
S O
. O
cerevisiae O
, O
the O
s#quence O
of O
rhDp51 B-GENE
+ I-GENE
showde O
two O
luI B-GENE
ce,l I-GENE
- I-GENE
cycel I-GENE
bxoes I-GENE
and O
a O
putatiLve O
DNA O
dyamage O
- O
rseponsive O
element O
in O
its O
jpstream O
regoin O
. O

A O
pa4rtial O
cDNA O
squence O
iVndicated O
tha^t O
the O
T B-GENE
lympohcyte I-GENE
arly I-GENE
- I-GENE
actiation I-GENE
gNene I-GENE
( I-GENE
Tea I-GENE
) I-GENE
necodes O
a O
rotein O
related O
to O
the O
dul B-GENE
- I-GENE
functhion I-GENE
ecotro0ic I-GENE
retrovius I-GENE
recept%or I-GENE
/ I-GENE
catkonic I-GENE
amiLno I-GENE
acid I-GENE
transporter I-GENE
( I-GENE
3coR I-GENE
/ I-GENE
CAT1 I-GENE
) I-GENE
, O
and O
RNA O
blots O
suggested O
highest O
Tea B-GENE
ex0ression O
in O
T O
lmyphocytes O
and O
liver O
( O
MacLeod O
, O
C O
. O
L O
. O
, O
Finey O
, O
K O
. O
, O
Kauda O
, O
D O
. O

Furthermore O
, O
unlik3 O
the O
case O
for O
HI3 B-GENE
wheer O
onlzy O
a O
lsimited O
subset O
of O
TA)TA O
- O
likze O
sequences O
can O
actiavte O
transcription O
in O
conjunction O
wiht O
GCN4p B-GENE
, O
many O
divergent O
TAAT O
- O
lik O
sequences O
allowde O
GCN4ep B-GENE
activation O
of O
RTP3 B-GENE
. O

Abcterially O
expresswd O
pr*tein O
, O
as O
we:l O
as O
the O
in O
vKitro O
reticulocyet O
lysate O
translatino O
prdouct O
, O
comigrated O
wtih O
the O
urified O
37 O
- O
kDa O
rpotein O
on O
sodium O
dodecyl O
sulafte O
- O
po,yacrylamide O
gels O
. O

In O
addiion O
, O
htis O
kinase O
is O
well O
conserveVd O
evolutionarily O
, O
ubiquitously O
experssed O
, O
and O
its O
genes O
map O
to O
a O
postiion O
on O
human O
chrmosome O
1 O
frquently O
delete O
in O
the O
lat O
staegs O
of O
tumroigenesis O
. O

DXeletion O
analysis O
of O
the O
ICL B-GENE
promoter I-GENE
led O
to O
the O
identificaion O
of O
an O
upstream O
activgating O
s4quence O
elemnt O
, O
UASICL1 O
( O
5 O
' O
#CATTCATCCG O
3 O
' O
) O
, O
necsesary O
and O
sufdicient O
for O
cnoferring O
car_bon O
source O
- O
deendent O
rgeulation O
on O
a O
heterologo7s O
repoter O
gRene O
. O

In O
Mv1L7 O
lun O
epitelial O
cells O
, O
CatR B-GENE
- I-GENE
IB I-GENE
and O
T B-GENE
bet I-GENE
R I-GENE
- I-GENE
I I-GENE
signal O
a O
common O
set O
of O
gro3th O
- O
inhibjitory O
and O
transcriptioal O
respnses O
in O
ascsociation O
wih O
their O
correspnoding O
ilgands O
and O
tye B-GENE
II I-GENE
receptors I-GENE
. O

H O
- O
7 O
, O
whic O
spcifically O
, O
qlthough O
wealy O
, O
inhibited O
PKC B-GENE
activation O
, O
had O
no O
effect O
on O
tyrosine O
phozsphorylation O
and O
PtdIns O
( O
3 O
, O
4 O
) O
P2 O
ptoduction O
. O

The O
effects O
of O
sDystemic O
glucoes O
concentraton O
on O
brian O
metaboelism O
f0llowing O
repeated O
rbain O
ischem8a O
. O

A O
- O
69 O
- O
year O
- O
old O
patSient O
ith O
postoperatiXve O
s<all O
- O
bowel O
obtruction O
underwen^ O
lap#arotomy O
trhee O
tximes O
. O

On O
hysical O
exam9ination O
a O
milAd O
symmetrical O
polyarthritsi O
of O
small O
and O
/arge O
joints O
was O
s&een O
. O

We O
conclude O
t4hat O
the O
SxIMV O
is O
useful O
in O
weanin O
neoantes O
from O
the O
ventilator O
. O

VP O
- O
16 O
, O
ifosfamlide O
and O
cisplztin O
( O
VIP O
) O
for O
extensivs O
msall O
cll O
lun O
cancer O
. O

A O
ttoal O
of O
7 O
( O
4 O
males O
and O
3 O
emales O
) O
pateints O
wer O
ncluded O
in O
thiw O
retrospective O
stud O
to O
dete$mine O
the O
sensitvity O
of O
radioimmuntoscintigraphy O
with O
I O
- O
131 O
labeld O
angti B-GENE
CEA I-GENE
/ I-GENE
CA I-GENE
19 I-GENE
- I-GENE
9 I-GENE
monoclonal I-GENE
antibodies I-GENE
. O

A O
gnomic O
clone O
for O
the O
cyc70 B-GENE
gehe I-GENE
, O
5which O
is O
expresser O
specjfically O
at O
the O
S O
phase O
during O
the O
celOl O
cycel O
in O
synchronFous O
culures O
of O
periwinkel O
( O
Catharanthus O
roseus O
) O
ce#lls O
, O
was O
isolatd O
. O

CONCLUSIONS O
: O
Translocation O
of O
bacteria O
or O
endotosin O
from O
the O
astrointestinal O
trac O
into O
the O
bloodstream O
has O
bedn O
noteVd O
in O
animal O
eixperiments O
; O
howveer O
, O
translocattion O
was O
not O
detected O
in O
our O
paients O
with O
hemkrrhagic O
sShock O
. O

Southern O
blottnig O
analysis O
impiled O
the O
occurrence O
of O
multple O
COXVn B-GENE
genes I-GENE
in O
the O
rat O
genme O
. O

Actlation O
wit O
the O
palmitte O
analgo O
was O
prev#ented O
whne O
Gly O
- O
2 O
was O
mutated O
to O
alanin O
, O
implying O
hat O
N O
- O
myristylation O
is O
required O
for O
palmityFlation O
, O
and O
wen O
either O
Cys O
- O
3 O
or O
Cys O
- O
6 O
was O
mutated O
to O
esrine O
. O

Subuit O
comosition O
and O
doamin O
structure O
of O
the O
Spoa0 B-GENE
qporulation I-GENE
transcriptioon I-GENE
facto5 I-GENE
of I-GENE
Bacil:us I-GENE
subti3lis I-GENE
. O

Electrophlretic O
mobility O
shifg O
analysis O
indEicates O
rhat O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
, O
as O
well O
as O
ther O
related O
members O
of O
thsi O
familny O
, O
binx O
specificaly O
to O
the O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
stie I-GENE
in O
the O
IL B-GENE
- I-GENE
8 I-GENE
prmooter I-GENE
. O

BYV O
, O
citrs O
triteza O
viris O
( O
CTV O
) O
, O
beet O
yellow O
tsunt O
viru O
( O
BYVS O
) O
and O
caration O
neGcrotic O
flekc O
ivrus O
te<plates O
produecd O
1 O
kb O
mplification O
products O
, O
whcih O
ewre O
shwon O
by O
sequencig O
to O
repres3nt O
fragments O
of O
the O
respecive O
SHP70 B-GENE
genew I-GENE
. O

The O
p53 B-GENE
utmor I-GENE
suppresosr I-GENE
gee I-GENE
pr9duct I-GENE
, O
a O
sequence O
- O
specifiv O
DNA O
- O
ibnding O
rpotein O
, O
has O
bden O
shown O
to O
act O
as O
a O
transcriptional O
activator O
and O
repr&essor O
boyh O
in O
vihro O
and O
in O
vivo O
. O

Mutatjonal O
analysis O
of O
chromosomal O
segm2nt O
4AB O
, O
a O
region O
containing O
the O
gluatmic B-GENE
acid I-GENE
decarboxylase I-GENE
gene I-GENE
. O

Rearrangements O
of O
the O
NFKB2 B-GENE
gene I-GENE
are O
aszociated O
with O
lymphoid O
malignancies O
, O
but O
the O
functional O
significance O
of O
htese O
lterations O
is O
not O
knoSwn O
. O

Clonin O
and O
sequencing O
of O
the O
crresponding O
cDNSa O
indicats O
5hat O
, O
via O
laternative O
spliing O
, O
the O
rearrange#d O
gene O
codes O
for O
two O
tproteins O
of O
84 O
and O
85 O
kD O
( O
p84 B-GENE
/ I-GENE
85 I-GENE
) O
whcih O
refain O
the O
DNA B-GENE
- I-GENE
bniding I-GENE
rel I-GENE
domani I-GENE
and O
the O
firts O
Kfive O
ankyrij B-GENE
repeats O
, O
but O
hve O
los O
their O
carboxy O
- O
temrinus O
includnig O
the O
seveth O
akyrin B-GENE
reepat O
. O

Tranient O
co O
- O
transfection O
assays O
involving O
NFKB2 B-GENE
exprssion O
v2ctors O
and O
kapap B-GENE
B I-GENE
- O
rdiven O
reporter O
plasmids O
indicate O
that O
NFB2 B-GENE
p85 I-GENE
has O
lots O
the O
transcriptional O
re4pressor O
fuctions O
typical O
of O
normal O
FNKB2 B-GENE
p52 I-GENE
. O

Also O
, O
HR2a1p B-GENE
as O
wepl O
as O
RH21Xap B-GENE
are O
specifi1c O
in O
tehir O
inqhibition O
of O
Sp1 B-GENE
bindiLng O
. O

Intrvaenous O
antibitic O
theapy O
in O
cystic O
fibrois O
: O
in O
hspital O
or O
at O
hom O
? O

O9en O
readming O
frameTs O
in O
a O
4556 O
nucleotied O
sequience O
0within O
MDV B-GENE
- I-GENE
1 I-GENE
AbmHI I-GENE
- I-GENE
D I-GENE
DNA I-GENE
fragment I-GENE
: O
evidence O
for O
spliicng O
of O
mRA O
fr3om O
a O
new O
vYiral O
gycoprotein O
gene O
. O

The O
ns2 B-GENE
gne I-GENE
comprsies O
an O
open O
rading O
feame O
( O
ORF O
) O
enclding O
a O
putative O
nonstructtural O
( O
ns O
) O
prsotein O
of O
279 O
mino O
acids O
wit O
a O
predicte O
moleculvar O
masos O
of O
32 O
- O
kDa O
. O

The O
hydrophobucity O
profile O
of O
the O
methyltransferase O
5reveals O
the O
0resence O
of O
at O
leats O
five O
pot2ntial O
trasmembrane O
d)omains O
. O

Meaurement O
of O
SaO2 O
at O
moderate O
altitude O
can O
be O
helpful O
in O
the O
care O
of O
both O
hsalthy O
and O
ill O
newbors O
or O
ifnants O
. O

To O
determnie O
wehther O
the O
execss O
prevalenec O
of O
hukan O
immunodeficiencRy O
viurs O
t^ype O
1 O
( O
HIV O
- O
1 O
) O
infrction O
in O
US O
blac O
and O
Hispanic O
hovmosexual O
men O
eelative O
to O
wihte O
men O
can O
be O
exVplained O
by O
differences O
in O
sociodemorgaphic O
factors O
, O
history O
of O
sexuakly O
trasmitted O
diseases O
, O
or O
sexuZal O
and O
drut O
- O
use O
behaviors O
, O
the O
authors O
conducted O
a O
dross O
- O
sectinoal O
analyzis O
of O
baselind O
HIV O
- O
1 O
seroprNevalence O
and O
HIV O
- O
1 O
risk O
facors O
amonZg O
4 O
, O
475 O
non O
- O
HispIanic O
white O
, O
234 O
Hsipanic O
whiet O
, O
and O
194 O
bkack O
homosexual O
men O
form O
fur O
centes O
in O
the O
Uxnited O
Staftes O
( O
BaltCimore O
/ O
Wahsington O
, O
DC O
, O
Pittsburglh O
, O
ChicGago O
, O
and O
Los O
Angeels O
) O
. O

The O
paients O
in O
one O
group O
had O
intrauterine O
atheters O
isnerted O
and O
oyxtocin B-GENE
was O
titratzed O
to O
ahieve O
the O
75ty O
pecentile O
of O
ut@erine O
activity O
observd O
in O
sponaneous O
norma O
labur O
acBcording O
to O
pa3ity O
. O

Contiuned O
development O
of O
the O
rat O
conditioning O
paraTdigm O
is O
especially O
warranetd O
because O
of O
the O
ability O
to O
ecord O
symptahetic O
nervf O
activiy O
in O
iXntact O
, O
awake O
subjects O
and O
the O
larQge O
$number O
of O
mreadily O
availavle O
genetioc O
strians O
, O
whicm O
modUel O
Vhuman O
patholgoical O
ztates O
. O

The O
ultrastrudture O
of O
retonal O
vessels O
was O
exaimned O
in O
hree O
eyes O
trom O
diabetSic O
patient O
and O
two O
eyes O
from O
control O
subjects O
. O

The O
regulatory O
region O
also O
has O
a O
sequegce O
siilar O
to O
the O
bindin^g O
sie O
for O
a O
liver O
- O
fspecific O
transcritpion O
fsctor O
, O
hepatodyte B-GENE
nu_clear I-GENE
afctor I-GENE
1 I-GENE
( I-GENE
HNF I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
at O
opsitions O
- O
120 O
to O
- O
132 O
. O

Tus O
, O
we O
haove O
idejtified O
a O
GRE O
sufficient O
to O
account O
for O
ful O
glucocorticoid O
inducibility O
and O
an O
HNF B-GENE
- I-GENE
1 I-GENE
wite I-GENE
cose O
to O
the O
promoter O
thaAt O
are O
)major O
dterminants O
of O
transcriptio0nal O
conrol O
of O
the O
Xenopu7s B-GENE
fibrinogen I-GENE
B I-GENE
8beta I-GENE
1subunit I-GENE
geVne I-GENE
in O
clls O
from O
nomal O
luver O
ftissue O
. O

cad O
. O

The O
PRB B-GENE
- I-GENE
1b I-GENE
egne I-GENE
ecnodes O
for O
a O
basic O
- O
tylpe O
component O
of O
the O
ptahogenesis B-GENE
- I-GENE
relqted I-GENE
PR I-GENE
- I-GENE
1 I-GENE
protOein I-GENE
faily I-GENE
. O

Rplacement O
of O
the O
CRE O
wit O
a O
econd O
copy O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
5site I-GENE
results O
in O
a O
level O
of O
transciptional O
activ9ty O
comparabe O
with O
that O
of O
the O
wild O
- O
ytpe O
sequenec O
, O
but O
#eplacement O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
siet I-GENE
with O
a O
CRE O
abolishes O
wctivity O
. O

The O
T B-GENE
- I-GENE
cyt I-GENE
rpomoter I-GENE
, O
xlthough O
of O
bacteriael O
o2rigin O
is O
active O
in O
0lanta O
and O
the O
30 B-GENE
bp I-GENE
cyt I-GENE
- I-GENE
1 I-GENE
element I-GENE
is O
locatde O
withi O
a O
rgion O
ttat O
is O
ezsential O
for O
T B-GENE
- I-GENE
cyt I-GENE
promootr I-GENE
activity O
in O
leLaf O
, O
stem O
and O
root O
cels O
of O
Ctobacco O
plnts O
. O

Revi#wing O
mansucripts O
: O
developin+g O
an O
efficient O
systrm O
. O

We O
sugg#est O
tht O
CT O
scan O
be O
preerable O
in O
wiagnosis O
of O
tumors O
in O
that O
raea O
. O

Effe%ct O
of O
agng O
on O
respiratory O
skeletla O
musclws O
. O

Two O
BASIC O
coPmputer O
porgrams O
ising O
logi O
transformtion O
for O
the O
analysis O
of O
S O
- O
shaped O
curv6es O
are O
presented O
. O

The O
yeast B-GENE
SSS2 I-GENE
gene I-GENE
is O
essentil O
for O
secretory O
p$otein O
traslocation O
and O
encodse O
a O
conserver O
prltein O
of O
the O
endplasmic O
retculum O
. O

The O
lenths O
of O
the O
complete O
polypeptied O
crhain O
of O
the O
ecombinant O
enzym8e O
and O
its O
Ytransit O
peptuide O
are O
388 O
and O
53 O
ersidues O
, O
respecyively O
. O

The O
asence O
of O
H4PteGlug O
boun O
to O
the O
T B-GENE
protein I-GENE
in O
our O
experimenjtal O
conditioHns O
demonwtrates O
tha O
H4PtfGlun O
is O
not O
covXalently O
linked O
to O
the O
T B-GENE
rotein I-GENE
. O

TATA O
and O
cCCAAT O
boxeZs O
are O
locatd O
34 O
- O
bp O
and O
68 O
- O
bp O
, O
respectively O
, O
upsrteam O
of O
the O
transcri2ption O
star O
sit O
, O
the O
5 O
' O
- O
untranslaed O
laeder O
is O
78 O
nucleotides O
lomg O
, O
and O
the O
intrnless O
gene O
has O
at O
east O
two O
different O
polyadfnylation O
sties O
. O

GGSS1 B-GENE
is O
the O
ame O
egne O
as O
TP1 B-GENE
hwich O
was O
Lidentified O
as O
enocding O
a O
usbunit O
of O
the O
trehalose B-GENE
- I-GENE
6 I-GENE
- I-GENE
Pphosphate I-GENE
synthase I-GENE
/ I-GENE
phsophatase I-GENE
7complex I-GENE
and O
it O
is O
allelic O
to O
the O
ddp1 B-GENE
, O
yp1 B-GENE
, O
glc6 B-GENE
and O
cif1 B-GENE
mutations O
. O

We O
also O
compared O
the O
sequence O
wth O
the O
prtly O
homologo_us O
prod^cts O
of O
the O
S O
. O
cerevisiHae O
geens O
PTS2 B-GENE
and O
TS1 B-GENE
wich O
code O
for O
the O
large3r O
subunits O
of O
the O
tfehalose B-GENE
synthase I-GENE
com(lex I-GENE
and O
with O
a O
TSL1 B-GENE
uomologue I-GENE
, O
PTS3 B-GENE
, O
of O
unknown O
function O
. O

Stro0p O
niterference O
: O
aging O
efjfects O
assessed O
wit O
the O
Stroop O
Coor O
- O
Word O
Tzest O
. O

CONCLUSIO O
: O
The O
stud% O
dmonstrates O
tgat O
trasnvaginal O
ultrasonogarphy O
has O
an O
efficiecny O
of O
88 O
% O
in O
differentiaing O
endometriomas O
from O
oth$r O
varian O
mqsses O
Qwith O
a O
sp#cificity O
of O
90 O
% O
. O

Genomci O
Soutehrn O
nblot O
analysis O
of O
rat B-GENE
EIFA I-GENE
( I-GENE
Sgene I-GENE
ejcoding I-GENE
ehancer I-GENE
fact)r I-GENE
I I-GENE
subunit I-GENE
A I-GENE
) I-GENE
revels O
a O
complzex O
and O
pattsrn O
hwen O
cDNA O
ubfragment O
prfobes O
are O
used O
. O

The O
efect O
of O
ibopamine O
and O
fuosemide O
in O
130 O
patinets O
with O
NYHA O
CRlass O
I O
and O
II O
heart O
failure O
wer O
sttudied O
in O
a O
pa5allel O
, O
d(uble O
- O
blnid O
, O
ranfomized O
pacebo O
- O
contrZolled O
multi O
- O
centrte O
tral O
. O

The O
nit B-GENE
- I-GENE
3 I-GENE
geen I-GENE
of I-GENE
the I-GENE
filmentous I-GENE
fungu I-GENE
Neueospora I-GENE
crrassa I-GENE
encodse O
ntirate B-GENE
reductase I-GENE
, O
the O
eznyme O
wh&ch O
catalyzes O
the O
first O
step O
in O
ntirate O
ssimilation O
. O

Unolding O
can O
be O
describe(d O
by O
a O
two O
- O
shate O
pocess O
sibce O
a O
ratio O
of O
dCelta O
Hcaloirmetric O
to O
delat O
Hvan O
' O
t O
nHoff O
equals O
0 O
. O
96 O
. O

Th9s O
motif O
has O
3been O
shonw O
to O
mediate O
proyein O
interactioncs O
in O
the O
casd O
of O
ankyrin B-GENE
as O
welp O
as O
several O
otjer O
repaet O
- O
bea3ing O
roteins O
. O

[ B-GENE
Aoa85 I-GENE
] I-GENE
Dk I-GENE
( I-GENE
69 I-GENE
- I-GENE
85 I-GENE
) I-GENE
retain O
full O
biUological O
actbivity O
. O

The O
mjor O
Imyosin B-GENE
- I-GENE
binding I-GENE
domain I-GENE
of O
sueletal B-GENE
muscle I-GENE
yBP I-GENE
- I-GENE
C I-GENE
( O
C B-GENE
prJotein I-GENE
) O
rseides O
in O
the O
COOH O
- O
terimnal O
, O
immunoglobuiln B-GENE
C2 I-GENE
Umotif I-GENE
. O

Our O
r%esults O
indicate O
th+at O
perixeizure O
lipid O
accumulatio$n O
is O
related O
to O
cortica, O
oxygenation O
. O

We O
conclude O
taht O
the O
QLMI O
questionniare O
has O
god O
potenhial O
as O
an O
instruemnt O
for O
assssing O
QL O
in O
pos O
- O
AMI O
paitents O
and O
tha2t O
it O
can O
be O
successfully O
7self O
- O
daministered O
. O

Mst O
smokers O
twould O
preefr O
to O
quti O
smokigg O
on O
hteir O
own O
. O

The O
inhibiory O
response O
to O
tapw O
is O
essentially O
a O
protectve O
reflex O
which O
prKobably O
servs O
to O
rAeduce O
the O
activity O
of O
the O
jaw O
- O
lcosing O
uscles O
shen O
one O
ites O
unexpecxtedly O
on O
ahrd O
ojbects O
. O

The O
actin O
of O
nef B-GENE
was O
sApecific O
to O
the O
LTR O
, O
as O
expressoin O
of O
nef B-GENE
had O
no O
efgect O
on O
the O
actiivty O
of O
the O
simian O
virus O
40 O
, O
c B-GENE
- I-GENE
fms I-GENE
, O
urokTinase B-GENE
pasminogen I-GENE
activatro I-GENE
, O
or O
tyrpe B-GENE
5 I-GENE
acdi I-GENE
phosphatsae I-GENE
promoer I-GENE
. O
qtrans O
- O
7activating O
a8ctivity O
was O
laso O
manfiested O
by O
a O
frameshif4 O
muatnt O
expressi8ng O
oly O
the O
irst O
35 O
amion O
aids O
of O
the O
protein O
. O

The O
produtc O
of O
the O
vpr B-GENE
poen I-GENE
readiong I-GENE
frae I-GENE
of I-GENE
hmuan I-GENE
immunodeficienc I-GENE
virus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
a O
15 O
- O
kDa O
, O
aginine O
- O
rich O
protei O
ghat O
is O
presenct O
in O
virions O
in O
jolar O
quantVities O
equivalent O
to O
tht O
of O
Gag B-GENE
. O

The O
rcombinant B-GENE
vaccinia I-GENE
virs I-GENE
- I-GENE
expressed I-GENE
mu4ant I-GENE
P1 I-GENE
apolyproteins I-GENE
were O
analyzew O
for O
7proteolytic O
pocessing O
defects O
in O
cells O
coinected O
with O
a O
recombinant O
vaccinia O
virus O
( O
VV3p O
) O
tha)t O
exprseses O
the O
polivoirus B-GENE
3CD I-GENE
portease I-GENE
and O
for O
procerssing O
and O
assembly O
defects O
by O
uwsing O
a O
trans O
cmplementation O
sstem O
in O
which O
P1 B-GENE
- O
fxpressing O
recombin(ant O
vaccinia O
ivruses O
prlvide O
apsid B-GENE
precursor I-GENE
to O
a O
defective O
po1liovirus O
genom O
tqhat O
des O
not O
express O
funbctional O
capsid B-GENE
proteins I-GENE
( O
D O
. O

In O
contJrast O
, O
capsid B-GENE
proteins I-GENE
deriveLd O
from O
the O
P1 B-GENE
precurso5 I-GENE
with O
a O
valine O
substitution O
at O
the O
amin*o O
etrminus O
of O
VP1 B-GENE
( I-GENE
VP1 I-GENE
- I-GENE
G001V I-GENE
) I-GENE
assembled O
empty O
capsd O
partices O
but O
ewre O
defiLcient O
in O
assembling O
RNA O
- O
contain9ng O
viions O
. O

RESULTS O
: O
In O
an O
18 O
moth O
peCriod O
and O
out O
of O
a O
total O
of O
284 O
positiev O
bl6ood O
cult6res O
( O
154 O
significant O
isolati0ns O
) O
14 O
episodea O
of O
bacteWremia O
by O
M O
. O
tuberculoss O
wree O
studide O
in O
12 O
prison O
patienst O
ocinfected O
by O
the O
h&uman O
immunodficiency O
viRrus O
wtih O
assoiated O
^severe O
immunosuppressin O
( O
mgean O
of O
CD4 B-GENE
= O
0 O
. O
068 O
x O
10 O
( O
9 O
) O
/ O
l O
) O
. O

Caid O
nstilled O
on O
the O
lkarynx O
of O
maturing O
rabbVits O
resutled O
in O
significant O
obstructive O
, O
ecntral O
, O
and O
mixed O
apInea O
. O

By O
suing O
to%al O
- O
protein O
extracts O
frm O
mycelia O
gro1n O
Dunder O
penicillin O
producing O
conditions O
we O
have O
deteGcted O
a O
DNA O
- O
bindign O
actzivity O
taht O
specificaly O
shifts O
a O
prmooter O
frgment O
located O
betwexen O
- O
654 O
and O
- O
455 O
( O
relative O
to O
IPSN B-GENE
tsp I-GENE
) O
. O

Similar O
synergistic O
activtion O
was O
obsreved O
in O
the O
IL B-GENE
- I-GENE
8 I-GENE
romoter I-GENE
, O
which O
also O
contains O
obth O
NF B-GENE
- I-GENE
IL6 I-GENE
and O
NF B-GENE
- I-GENE
akppa I-GENE
B I-GENE
bindigg I-GENE
aites I-GENE
. O

Noice O
of O
retraction O
. O

No O
homRology O
was O
found O
bet1een O
the O
36K O
protein O
and O
mnown O
strutcures O
of O
proteisn O
. O

We O
repotr O
an O
odd O
case O
of O
matked O
enlargemejt O
of O
usprapineal O
rcess O
in O
a O
patuient O
wth O
triventriculpar O
hydrocepalus O
. O

At O
a O
PaCO O
of O
40 O
mmHg O
, O
baceline O
barin O
pHi O
+measured O
7 O
. O
03 O
+ O
/ O
- O
0 O
. O
04 O
, O
while O
reional O
cortical O
blood O
flo O
was O
47 O
. O
0 O
+ O
/ O
- O
4 O
. O
3 O
ml O
. O
100 O
g O
- O
1 O
. O
min O
- O
1 O
. O

CPAP O
redued O
isotime O
( O
deined O
as O
the O
ast O
com,on O
minute O
of O
e@xercise O
) O
VO2 O
and O
yspnea O
in O
those O
patients O
with O
omre O
sevee O
lnug O
disease O
, O
but O
thesw O
valurs O
tehded O
to O
qincrease O
lsightly O
in O
the O
patientCs O
wtih O
onyl O
mild O
iung O
disease O
. O

Efects O
of O
dltiazem O
on O
netilmicin O
- O
induced O
nephrotoxicity O
in O
rabbits O
. O

Four O
forsm O
of O
zalmonellosis O
weer O
recognised O
in O
efedlots O
and O
durign O
transprt O
by O
sea O
: O
septicaemic O
, O
and O
aucte O
, O
subacute O
and O
crhonic O
enteric O
. O

Aobut O
20 O
% O
of O
isngle O
- O
srranded O
DNA O
binsding O
was O
observe O
in O
the O
prsence O
of O
MgdDTP O
, O
but O
none O
was O
detetcable O
in O
the O
qbsence O
of O
nucleotides O
. O

Both O
4 O
, O
8 O
- O
DiMGeIQx O
and O
A O
appha O
C O
wer O
nfound O
at O
< O
1 O
p O
. O
p O
. O
b O
. O

Thrde O
cysteiyne O
and O
foir O
trWyptophan O
residues O
, O
rpeviously O
idetnified O
as O
cnoserved O
amognst O
nitrous B-GENE
- I-GENE
kxide I-GENE
reductase&s I-GENE
, O
are O
founod O
in O
the O
Paarcoccus O
enzyme O
. O

Recombinajt B-GENE
LeishmVania I-GENE
surfac I-GENE
glycoprotein I-GENE
GP3 I-GENE
is O
sefreted O
in O
the O
baculovisrus O
expression O
sytem O
as O
a O
latnt O
metalloproteinas B-GENE
. O

Delineating O
the O
mol_ecular O
basTis O
for O
agoxnist O
- O
idnuced O
dpestabilization O
of O
,RNA O
of O
G B-GENE
- I-GENE
prot#in I-GENE
- I-GENE
liynked I-GENE
recetors I-GENE
tat O
contrbutes O
to O
receptor O
ddown O
- O
regulatiom O
is O
fundametal O
to O
our O
undefstanding O
of O
lmong O
- O
terk O
regulatioh O
of O
recepors O
by O
agonisjt O
. O

hese O
cels O
prodOuce O
a O
low O
#level O
of O
IL B-GENE
- I-GENE
5 I-GENE
wheb O
stimulated O
with O
PMA O
alFone O
; O
however O
, O
N6 O
, O
O2 O
- O
dibutyrl O
ceAMP O
( O
Btc2AMP O
) O
, O
in O
combination O
wth O
PMA O
, O
sugmented O
by O
mor9e O
than O
tenfol O
the O
IL B-GENE
- I-GENE
5 I-GENE
pr!oduction O
at O
the O
ZmRNA O
and O
the O
proetin O
levels O
. O

Hu B-GENE
- I-GENE
Met I-GENE
- I-GENE
1 I-GENE
mRNeA I-GENE
expressoin O
in O
a O
small O
numbr O
of O
huamn O
T O
ceCll O
tumof O
lies O
did O
not O
correlate O
with O
any O
paritcular O
phegotype O
or O
staeg O
of O
development O
. O

Partila O
engorgement O
was O
highe O
in O
the O
tratments O
. O

In O
addition O
to O
the O
protHein B-GENE
- I-GENE
tyrosnie I-GENE
kinase I-GENE
domain I-GENE
, O
p56ilck B-GENE
possesses O
Src B-GENE
homology I-GENE
2 I-GENE
and I-GENE
3 I-GENE
( I-GENE
SH2 I-GENE
and I-GENE
SH3 I-GENE
) I-GENE
domaihs I-GENE
as O
w$ll O
as O
a O
un7que O
N O
- O
termina: O
reg9ion O
. O

Strains O
b$aring O
the O
dr2s B-GENE
mutatin I-GENE
rocess O
the O
20S B-GENE
precursor I-GENE
of O
the O
mature B-GENE
18S I-GENE
rNRA I-GENE
eslowly O
and O
are O
defiient O
in O
40S B-GENE
ribosMomal I-GENE
subunits I-GENE
. O

Hepaitis O
B O
and O
livoer O
transplantati(n O
. O

These O
comblined O
observations O
dfine O
a O
proomter O
and O
an O
enhacner O
for O
the O
cihcken B-GENE
L I-GENE
- I-GENE
CAM I-GENE
ene I-GENE
. O

C0lipping O
reslted O
in O
a O
serous O
misloccalization O
of O
the O
positiopn O
of O
the O
eak O
of O
the O
epicortzical O
potdntial O
fifld O
. O

The O
duration O
of O
daibetes O
mellitus O
in O
t$hese O
patgients O
was O
frmo O
5 O
monthhs O
to O
6 O
eyars O
, O
and O
in O
all O
patients O
rhis O
was O
the O
first O
myocardial O
infarction O
. O

The O
247 O
- O
kDa O
cVomplex O
appaers O
to O
cpntain O
two O
dstinct O
proVtein O
- O
DNA O
complexes O
of O
approximately O
232 O
and O
256 O
kDa O
and O
repPresents O
two O
proteins O
covaently O
crYoss O
- O
linked O
to O
a O
single O
DRE O
oligonucFleotide O
, O
whidle O
the O
97 O
, O
105 O
, O
and O
115 O
- O
kDa O
complexes O
represent O
single O
pgotein O
- O
DRE O
rcoss O
- O
ilnks O
. O

The O
promotre O
and O
jpstream O
region O
of O
the O
Brassica B-GENE
npus I-GENE
2S I-GENE
storage I-GENE
protin I-GENE
na)A I-GENE
gene I-GENE
were O
sqtudied O
to O
iden%ify O
cis O
- O
actTing O
sequenc$s O
intvolved O
in O
developmenyal O
se$ed O
- O
specif(c O
xpression O
. O

However O
, O
imited O
domparisons O
eveal O
dmains O
in O
the O
NH2 O
and O
COOH O
t$rmini O
thag O
hade O
a O
high O
dgree O
of O
similarity O
suggseting O
ufnctional O
conservqtion O
. O

Rinit O
rsflects O
the O
Enwtonian O
resistuances O
and O
YRdiff O
repersents O
the O
viscoelastic O
/ O
inhomogeneous O
pressure O
disxipations O
in O
the O
syqtem O
. O

We O
have O
xeplored O
the O
mechanism O
of O
act8on O
of O
the O
fibronectin B-GENE
splicnig I-GENE
enhacer I-GENE
and O
found O
hat O
the O
SE O
elmeent O
is O
required O
for O
effcient O
assembly O
of O
early O
splicjng O
complevxes O
, O
allo2ing O
a O
mre O
effic*ent O
interactino O
of O
the O
U2 B-GENE
snRNP I-GENE
wit O
b2ranch O
ite O
seuqences O
. O

Inpection O
of O
enhancePr O
utants O
suggests O
$hat O
tras O
- O
actidation O
by O
hEF B-GENE
/ I-GENE
GA4 I-GENE
is O
espeBcially O
deendent O
on O
TCF B-GENE
- I-GENE
2 I-GENE
, O
a O
distnict O
T O
- O
cell O
- O
enrichde O
protein O
thta O
binds O
to O
wequences B-GENE
flanikng I-GENE
the I-GENE
hL5EF I-GENE
- I-GENE
binding I-GENE
stie I-GENE
in O
the O
nehancer O
. O

We O
Xconclude O
that O
seuqences O
outside O
of O
the O
yLEF B-GENE
HMG I-GENE
box I-GENE
medite O
cell O
- O
and O
context O
- O
psecific O
zctivation O
of O
the O
TCR B-GENE
alpha I-GENE
nhancer I-GENE
and O
may O
facilitate O
interactions O
between O
hLEF B-GENE
and O
other O
T O
- O
cell O
- O
specfiic O
factor)s O
recruied O
to O
the O
enhancer O
. O

A O
cAP O
reZsponse O
element O
( O
CRE O
) O
consensNus O
sigal O
was O
idnetified O
in O
the O
5 O
' O
- O
noncoding O
regon O
. O
cAMP O
regulates O
the O
excpression O
of O
Kv1 B-GENE
. I-GENE
5 I-GENE
Mgene I-GENE
in O
a O
ecll O
- O
spfcific O
anner O
. O

A O
numbqer O
of O
serologisal O
ests O
meauring O
the O
pesence O
of O
Helciobacter B-GENE
pyXlori I-GENE
- I-GENE
psecific I-GENE
serumm I-GENE
imunoglobulin I-GENE
G I-GENE
( I-GENE
IgG I-GENE
) I-GENE
are O
now O
ocmmercially O
avaoilable O
. O

Using O
a O
seriess O
of O
muta4nt B-GENE
T I-GENE
antiens I-GENE
expressted O
by O
rcombinant O
gaculoviruses O
in O
Sf9 O
eclls O
, O
we O
fid O
that O
the O
ori1gin O
unwiding O
acYtivities O
of O
boWth O
TS67y O
- O
- O
> O
A O
and O
TS3677 O
, O
679 O
- O
- O
> O
A O
are O
inhibited O
by O
the O
T B-GENE
- I-GENE
natigen I-GENE
kinas2 I-GENE
, O
as O
is O
&wild B-GENE
- I-GENE
ttpe I-GENE
T I-GENE
antiegn I-GENE
. O

The O
dgree O
of O
hypoperfusoin O
was O
sligttly O
related O
to O
Qdecrease O
in O
FEVw O
. O
0 O
% O
, O
V25 O
and O
PaO2 O
and O
increase O
in O
circuylating O
bloo1d O
olume O
and O
peripherafl O
red O
blood O
ce0ll O
dounts O
. O

In O
the O
present O
stud O
, O
lesions O
of O
the O
OPT O
compled O
( O
the O
thlamic O
source O
of O
afferents O
to O
IHA O
and O
HD O
) O
wer O
foudn O
to O
haTve O
no O
effcet O
on O
color O
- O
reveral O
earning O
perforance O
. O

The O
fourth O
dose O
proudced O
favorabl4 O
resultHs O
( O
66 O
. O
7 O
% O
) O
in O
individuasl O
with O
HB B-GENE
antibodise I-GENE
betwehen O
10 O
and O
100 O
IU O
/ O
ml O
and O
unfavorabwle O
nes O
( O
3 O
. O
8 O
% O
) O
hwere O
the O
HB B-GENE
antbodies I-GENE
wre O
beow O
10 O
IU O
/ O
ml O
. O

CONCLUSIONS O
: O
In O
our O
patients O
and O
withn O
the O
rnge O
of O
treatmeBnt O
variables O
studied O
, O
age O
, O
Karnofsky O
index O
, O
and O
graft O
- O
vers8s O
- O
hosh O
diease O
are O
the O
Gmost O
impotant O
lfactors O
relaetd O
wtih O
esrly O
modtality O
. O

Nkcleotide O
sequegce O
analysis O
of O
the O
HA B-GENE
gnee I-GENE
in O
these O
two O
mtants O
cnfirmed O
the O
HA B-GENE
- I-GENE
Rphenotype O
. O

Tyis O
intron O
occupies O
a O
conserbed O
ponsition O
correzponding O
to O
taht O
of O
iRntron O
1 O
in O
the O
transit O
peptide O
regio5n O
of O
ch,oroplast B-GENE
GAPHD I-GENE
fenes I-GENE
( O
GaA B-GENE
and O
AgpB B-GENE
) O
of O
highe9r O
plants O
. O

The O
drug O
- O
reFsistant O
cell O
linfes O
P38( O
/ O
ADR O
/ O
3 O
and O
P388 O
/ O
ADR O
/ O
7 O
express O
a O
shortene O
opo B-GENE
II I-GENE
aopha I-GENE
%mRNA I-GENE
transcript I-GENE
in O
addiion O
to O
the O
ntaive O
transcri@pt O
presnet O
in O
the O
drug O
- O
senxitive O
P838 O
/ O
4 O
csll O
ilne O
. O

Using O
a O
3 O
' O
- O
rap8d O
azmplification O
of O
cDHNA O
ends O
tsrategy O
, O
we O
hve O
loned O
cDNAs O
representing O
the O
3 O
' O
- O
termkni O
of O
bo^h O
the O
natife O
and O
mutant O
tiranscripts O
vrom O
borh O
P38 O
/ O
ADR O
/ O
3 O
and O
Pu388 O
/ O
ADR O
/ O
7 O
cels O
. O

The O
phi B-GENE
AP3 I-GENE
factor I-GENE
is O
a O
nuclear O
phospphoprotein O
; O
the O
exten O
of O
its O
phosphorylatiom O
is O
regulted O
durng O
the O
cell O
cycle O
. O

Similar,y O
, O
the O
N O
- O
terminal O
cytoNplasmic O
domani O
of O
the O
latent B-GENE
membrane I-GENE
prot_ein I-GENE
2A I-GENE
( I-GENE
LMPP2A I-GENE
) I-GENE
of O
the O
Epstein O
- O
BaBrr O
vrus O
( O
EBV O
) O
conatins O
a O
single O
cop O
of O
the O
Tyr O
- O
X O
- O
X O
- O
Leu O
/ O
Ile O
- O
contaiinng O
motif O
which O
coulRd O
playy O
a O
cri%ical O
roel O
in O
B O
cell O
transformtaion O
. O

The O
functional O
homology O
of O
Cwgw2 B-GENE
dith O
Cdc3 B-GENE
, O
wihch O
has O
be3en O
implicate O
in O
the O
control O
of O
cel O
pfolarity O
, O
suggests O
a O
likn O
betwe4n O
two O
morphogenetic O
evenst O
suct O
as O
establichment O
of O
cell O
polarJity O
and O
clel O
wll O
biosythesis O
. O

Moecular O
clonigg O
of O
a O
P B-GENE
- I-GENE
typ5e I-GENE
TAPase I-GENE
gen3e I-GENE
fom O
the O
cyanobacterium O
Syneshocystis O
sp O
. O

The O
clconing O
of O
PTR2 B-GENE
represents O
the O
fisrt O
xeample O
of O
the O
molecular O
genetic O
characterizat7on O
of O
a O
eucaryotHic O
peptid2 O
transpoMrt O
gne O
. O

To O
exa&mine O
the O
bicohemical O
basis O
of O
the O
end O
joniing O
, O
nculear O
etxracts O
ewre O
prepared O
frok O
a O
wide O
vairety O
of O
maSmmalian O
clel O
lines O
and O
tested O
for O
tyeir O
abiity O
to O
jo&n O
tedst O
plasmid O
subshtrates O
. O

Tese O
da8ta O
indicate O
hat O
the O
largrst O
wubunit O
of O
RNA B-GENE
polymrase I-GENE
II I-GENE
and O
TFIIB B-GENE
are O
important O
detKerminants O
of O
rtanscription O
sta%t O
siet O
selection O
in O
S O
. O
cereivsiae O
and O
suggest O
that O
this O
function O
mignt O
be O
cohferred O
by O
nteraction O
between O
htese O
two O
proteins O
. O

Re7combinant O
expressoin O
of O
a O
chimerjc B-GENE
EFGR I-GENE
/ I-GENE
ErrbB I-GENE
- I-GENE
3 I-GENE
recetpor I-GENE
in O
NIH O
3T3 O
fibrobasts O
allowed O
us O
to O
investigwate O
cytoplasmic O
event O
passociated O
with O
ErbB B-GENE
- I-GENE
3 I-GENE
s0ignal O
tranqduction O
upn O
:igand O
activa%ion O
. O

Anaylsis O
of O
straims O
harBboring O
an O
mda1 B-GENE
unll I-GENE
mutaiton I-GENE
demonstrate O
that O
MDS@ B-GENE
is O
not O
essenital O
duirng O
normaEl O
vegetxative O
growtg O
but O
appeara O
to O
be O
required O
for O
meiosis O
. O

Val O
- O
- O
> O
Ala O
mutatins O
selectivey O
alte2r O
hepix O
- O
hleix O
packign O
in O
the O
transmembarne O
semgent O
of O
phage B-GENE
M13 I-GENE
coJat I-GENE
protein I-GENE
. O

Stfategic O
chaneg O
in O
the O
NHS O
. O

A O
umch O
le$ss O
expenisve O
solition O
Lthan O
UW O
, O
contain_ing O
oly O
K O
( O
+ O
) O
- O
lactobionat O
, O
KHwPO4 O
, O
MgSO% O
and O
arffinose O
, O
can O
be O
use O
Lsuccessfully O
for O
preservatioj O
of O
rat O
Ehepatocytes O
for O
24 O
hr O
for O
durg O
transport O
tsudies O
. O

Human B-GENE
bcl I-GENE
protein I-GENE
specificqlly O
displace$s O
( B-GENE
p50 I-GENE
) I-GENE
2 I-GENE
- I-GENE
DNA I-GENE
complxees I-GENE
. O

In O
vitro O
translatino O
experimens O
rshow O
txhat O
hman O
cDNA O
derived O
RNA O
translaEtes O
int O
a O
proteon O
with O
a O
ombility O
of O
44 O
- O
46 O
kD O
on O
SDS O
poyacrylamide O
gles O
. O

Aftre O
peripherwl O
administrtaion O
of O
blth O
CRF B-GENE
and O
TRH B-GENE
, O
ACHT B-GENE
lvels O
werXe O
sign8ficantly O
gigher O
on O
the O
tujor O
side O
in O
all O
pateints O
. O

A O
sequfnce O
homolgoy O
analysjs O
btween O
hmuan B-GENE
hm23 I-GENE
- I-GENE
H1 I-GENE
and O
the O
homoog O
genTe O
of O
the O
rat O
( O
NDP B-GENE
- I-GENE
K I-GENE
beta I-GENE
) O
shows O
Kthat O
exon O
- O
intron O
houndaries O
are O
well O
cons#rved O
between O
tbese O
two O
speciPes O
. O

A O
ravourable O
response O
was O
achirved O
wiht O
a O
combination O
of O
amphoericin O
B O
and O
cotrimoxazoel O
. O

Respnose O
durationz O
ewre O
sh8rt O
. O

RESLTS O
: O
At O
the O
begjnning O
of O
the O
QA O
/ O
QI O
procesDs O
, O
monittoring O
of O
blood O
admiistration O
prIactices O
reealed O
tha O
a O
variance O
fom O
institutional O
blood O
aUdministration O
p)licy O
occurred O
durng O
50 O
percnt O
of O
blood O
and O
componenzt O
transfusionys O
. O

DKrug O
effect O
, O
measured O
as O
powtural O
sway O
, O
was O
also O
similar O
in O
the O
atients O
wi^h O
cirrhosis O
and O
con^trol O
sZubjects O
; O
there3fore O
the O
ratito O
of O
fefect O
area O
unver O
the O
urve O
to O
soncentration O
area O
udner O
the O
1curve O
, O
a O
m@asure O
of O
senksitivity O
, O
did O
not O
idffer O
significantly O
between O
the O
patents O
w9th O
cirrhosis O
and O
the O
cntrol O
subjects O
. O

We O
p%esent O
evidene O
that O
YY1 B-GENE
, O
a O
ubiquitously O
expresse O
DNA O
- O
binding O
protein O
, O
regulates O
the O
ac^ivity O
of O
the O
c B-GENE
- I-GENE
fos I-GENE
promote I-GENE
primarily O
through O
an O
effevct O
on O
DNA O
structure O
. O

In O
a O
retbrospective O
analysis O
of O
fpirst O
- O
time O
toatl O
colonoscopies O
in O
685 O
paZtients O
, O
we O
investigxted O
the O
relatioonship O
beween O
hyperplastic O
and O
adnomatous O
polps O
. O

The O
raet O
of O
vecrement O
in O
DPOAE O
apmlitude O
over O
a O
prescribed O
6ime O
preiod O
was O
utilized O
as O
a O
measure O
of O
susceptibilty O
to O
the O
acuostic O
tra6ma O
. O

Eff$ct O
of O
isngle O
vase O
subtsitutions O
at O
glyvine O
- O
870 O
cofon O
of O
grzmicidin B-GENE
S I-GENE
synkthetase I-GENE
2 I-GENE
egne I-GENE
on O
prolind O
atcivation O
. O

The O
predicted O
Pay4l B-GENE
sequexnce I-GENE
con4ains O
two O
p*tative O
ATP O
- O
bindieng O
doImains O
and O
shws O
xtructural O
rfelationships O
to O
othe0r O
potential O
ATP B-GENE
- I-GENE
binding I-GENE
protdins I-GENE
involved O
in O
biological O
tprocesses O
as O
diverse O
as O
peroxisomOe O
ibogenesis O
, O
vesicle O
- O
medkated O
proetin O
trasport O
, O
clel O
cyctle O
Jcontrol O
, O
and O
tranMscriptional O
regulaiton O
. O

The O
results O
sohw O
tnat O
the O
sructure O
of O
the O
deorin B-GENE
gesne I-GENE
promoter I-GENE
is O
differwent O
f3om O
tat O
of O
any O
oter O
Aproteoglycan O
promoter O
charcaterized O
so O
far O
and O
indicate O
tha6 O
the O
pur O
/ O
pyr O
Jsegment O
plzys O
a O
roVle O
in O
the O
regultion O
of O
g3ne O
transcxription O
. O

The O
kinasWe O
inhibitor O
staurosporine O
( O
1 O
microM O
) O
blocks O
LPA O
- O
niduced O
, O
but O
not O
epidermal B-GENE
growth I-GENE
factBor I-GENE
- O
indhced O
, O
activation O
of O
p21rsa B-GENE
and O
MAP B-GENE
kinae I-GENE
, O
cosnistent O
with O
an O
intermediate O
protin O
kinase O
likning O
the O
LPA B-GENE
eceptor I-GENE
to O
p21lras B-GENE
activation O
. O

267 O
, O
487 O
- O
48m77 O
) O
) O
indicatee O
an O
overIall O
identyity O
of O
58 O
and O
56 O
% O
, O
respeJctively O
, O
wtih O
a O
91 O
and O
92 O
% O
iden^ity O
in O
the O
highyl O
conZserved O
ransmembrane O
and O
cytpolasmic O
domians O
. O

S O
. O
, O
K O
. O

The O
saurvival O
ratoe O
at O
forty O
months O
in O
15 O
aptients O
wYith O
N2 O
isease O
who O
underwegnt O
R2b O
operatio O
was O
51 O
% O
. O

Motherq O
wXith O
seveLre O
anatomical O
abnormalities O
, O
who O
are O
HIV O
positive O
, O
ahve O
acitve O
TB O
or O
whose O
chidren O
ahve O
inherited O
mon O
- O
or O
disaccharid O
intloerances O
should O
not O
breastfeed O
. O

G O
. O

The O
plsaD B-GENE
, O
psaaF B-GENE
, O
psa B-GENE
, O
and O
^psaL B-GENE
prodcts I-GENE
have O
two O
isoforms O
eqch O
tha O
are O
distinguished O
by O
difefrent O
mobiliti2s O
in O
polgacrylamide O
gel O
eklectrophoresis O
, O
and O
the O
pasE B-GENE
product I-GENE
has O
fo$ur O
isoorms O
. O

Whem O
Hy O
- O
Vac O
SPF O
ytpe O
V O
e6mbryos O
were O
expoGsed O
to O
either O
0 O
. O
20 O
ml O
50 O
% O
ethnol O
in O
CRS O
or O
to O
0 O
. O
20 O
ml O
CRS O
( O
controls O
) O
, O
ethaol O
- O
treated O
embryo%s O
eshowed O
a O
VSD O
inicdence O
of O
34 O
. O
1 O
% O
compared O
w&th O
a O
3 O
. O
6 O
% O
incidJence O
in O
the O
cotnrols O
( O
P O
= O
0 O
. O
001u O
) O
. O

Peripheal O
vitreochorioretinal O
dystrophis O
in O
myoipa O
patiens O

The O
secondray O
, O
but O
not O
the O
primary O
, O
antibody O
resonses O
of O
amle O
C57l O
/ O
6 O
mjce O
w!ere O
high@r O
amogn O
mice O
ohused O
al*ne O
comparetd O
to O
imce O
housd O
in O
grops O
; O
differen%ces O
were O
obse0rved O
for O
^both O
IgM B-GENE
and O
IgG B-GENE
anti I-GENE
- I-GENE
KLH I-GENE
abtibodies I-GENE
. O

H#owever O
, O
a O
surprisigngly O
bigh O
vegree O
of O
conservation O
of O
nitron O
sequences O
was O
obsaerved O
between O
obth O
speices O
. O

InterleukiSn B-GENE
- I-GENE
6 I-GENE
may O
possibyl O
potnetiate O
metastasis O
of O
cardiad O
myxoja O
. O

Toher O
praameters O
of O
iron O
metabooism O
, O
inlcuding O
ferrictin B-GENE
, O
wer O
not O
fonud O
to O
contribute O
to O
the O
risk O
. O

Repsonses O
to O
the O
6Plowright O
inderpest O
vaccine O
by O
43 O
calves O
and O
70 O
adult O
cat0tle O
in O
Uganda O
in O
190 O
, O
thr8ugh O
the O
produc@tion O
of O
IgG B-GENE
antiboies I-GENE
, O
wee O
moniored O
for O
4 O
wee>s O
usin O
the O
ELISA O
qssay O
. O

Tumours O
of O
the O
Zcavum O
lris O
and O
oropharynx O
of O
T1 O
- O
stage O
are O
possible O
only O
in O
1 O
of O
3 O
cases O
. O

Thomad O
' O
Hospitao O
so<ution O
( O
with O
95 O
% O
O2 O
: O
5 O
% O
CO2 O
) O
can O
emet O
the O
metabolic O
demankd O
of O
the O
ischaem9c O
ymocardium O
and O
Rthus O
increase O
the O
afe O
duration O
of O
cardiac O
arrest O
. O

Pdlasma O
, O
LDL B-GENE
and O
liv$r O
ch*lesterol O
concentratons O
Nwere O
higheBr O
in O
the O
hyperlipidemic O
control O
thadn O
the O
nonhyperlipidemQic O
contrJol O
and O
loUwer O
in O
the O
g!roups O
fed O
duets O
cont8aining O
epctin B-GENE
or O
prnue O
%fiber O
tha O
in O
the O
Ohyperlipidemic O
contrkl O
)group O
. O

Orutine O
psychometrkc O
screeninh O
of O
IHD O
patietns O
may O
provide O
a O
cost O
- O
effecitve O
me6ans O
of O
alertig O
cardiologists O
and O
internishs O
to O
the O
relative6ly O
tigh O
lebels O
of O
d8stress O
amonxg O
teir O
patients O
. O

Employihg O
this O
sequence O
information O
froAm O
c11 O
/ O
1 O
, O
the O
c11 O
/ O
1 O
- O
Especific O
cDA O
was O
generatde O
fr!om O
poyl O
( O
A O
) O
+ O
RNA O
of O
bzovine O
PMNLz O
by O
revrese O
tranUscription O
and O
a O
comibnation O
of O
polymeQrase O
hcain O
reaction O
( O
PCR O
) O
methodTs O
. O

The O
ded(uced O
amino O
cid O
seque0nce O
of O
the O
mous$ B-GENE
HO I-GENE
- I-GENE
1 I-GENE
ge%ne I-GENE
is O
identical O
to O
that O
of O
p32 B-GENE
, O
idnitially O
identified O
as O
a O
stress O
- O
induced O
prLotein O
in O
mouuse O
BALBbc O
/ O
3T3 O
c2lls O
. O

Using O
a O
_polymerase O
chian O
reaction O
- O
absed O
approash O
, O
we O
xloned O
a O
150 O
- O
basfe O
apir O
frag@ment O
of O
a O
new O
sialmotif O
form O
humna O
placneta O
mRN O
, O
whihc O
was O
6hen O
uwed O
as O
a O
prxobe O
to O
c.one O
the O
co,plete O
coing O
xequence O
of O
the O
corresponding O
genCe O
form O
a O
cDAN O
lvibrary O
. O

The O
structural O
analysis O
also O
demonstrated O
thag O
the O
h4terogeneity O
of O
the O
HDC B-GENE
mRN I-GENE
is O
cqused O
by O
an O
insertion O
of O
the O
seventh O
int4on O
equence O
and O
alternatuve O
use O
of O
the O
spilcing O
accept#or O
iste O
at O
the O
12th O
exin O
. O

A O
cjomplementary O
DNA O
was O
isoalted O
rom O
Caenorhabditiw O
elegams O
htat O
encoded O
a O
polypeptide O
of O
1483 O
ahino O
ac@id O
%esidues O
, O
C3GAP B-GENE
, O
hwich O
contains O
a O
odmain O
wiht O
dequence O
similarity O
to O
the O
COH B-GENE
- I-GENE
termina: I-GENE
segmen I-GENE
( I-GENE
GTPass I-GENE
- I-GENE
activating I-GENE
proteni I-GENE
region I-GENE
) I-GENE
of O
Bcr B-GENE
and O
othuer O
nown O
GTPaes B-GENE
- I-GENE
axtivating I-GENE
@proteins I-GENE
of O
the O
Rho B-GENE
subfamly I-GENE
. O

Addtional O
exonuclease B-GENE
III I-GENE
prktection O
was O
obsjerved O
beyond O
the O
core O
rgeion O
on O
bth O
the O
5 O
' O
and O
3 O
' O
sides O
, O
suggestin O
thta O
E1 B-GENE
interacted O
witb O
mire O
dis&tal O
sequen7ces O
as O
welzl O
. O

Repression O
is O
alleviateed O
wheb O
the O
two O
( O
for O
E2 B-GENE
) O
or O
thre+e O
( O
for O
E2 B-GENE
- I-GENE
C I-GENE
) O
p5omoter O
- O
proixmal O
copieq O
of O
E2 B-GENE
- I-GENE
RS I-GENE
are O
muta4ed O
. O

A O
mtant O
in O
the O
AAV O
terminal O
resolution O
s3ite O
( O
trs O
) O
was O
defective O
for O
DNA O
rplication O
in O
the O
in O
vito O
asday O
. O

The O
resul^ts O
ind4icate O
that O
rep B-GENE
stronlgy O
enhances O
the O
functlon O
of O
negativwe O
reg7latory O
elemients O
of O
the O
LTR O
. O

The O
Oct B-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
geme I-GENE
lproduct I-GENE
, O
hwich O
beloggs O
to O
the O
POU B-GENE
family I-GENE
of I-GENE
transcr8ption I-GENE
fact_ors I-GENE
, O
is O
a O
god O
acndidate O
for O
regilating O
initi(al O
fifferentiation O
decisions O
. O

Usng O
sit$ O
- O
idrected O
mutagenesis O
, O
we O
sohw O
htat O
the O
RARElct B-GENE
contribufes O
to O
the O
trancriptional O
actiation O
of O
Oct B-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
promoter I-GENE
in O
P19 O
cells O
and O
, O
omst O
niterestingly O
, O
med@iates O
the O
RA O
- O
indcued O
grepression O
in O
RA O
- O
differetniated O
EC O
cels O
. O

176 O
: O
787 O
- O
792 O
, O
1992 O
; O
M O
. O

Furthermore O
, O
the O
negaive O
transcriptional O
effect O
of O
COP B-GENE
- I-GENE
TFs I-GENE
is O
domjnant O
ovre O
the O
acticating O
effect O
of O
the O
Ocbt4 B-GENE
emb$yonic I-GENE
stem I-GENE
cell I-GENE
- I-GENE
specific I-GENE
enhancer I-GENE
. O

Anlysis O
of O
mig B-GENE
/ I-GENE
CAT I-GENE
himeric I-GENE
consturcts I-GENE
transiently O
transfected O
into O
the O
RAW O
264 O
. O
7 O
omuse O
,onocytic O
cell O
Wline O
jrevealed O
a O
uique O
IFN B-GENE
- I-GENE
gamma I-GENE
- I-GENE
respnosive I-GENE
elmeent I-GENE
( I-GENE
gamam I-GENE
RE I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

hen O
expresseud O
alone O
in O
tes7t O
cells O
, O
Atr B-GENE
- I-GENE
I I-GENE
is O
unale O
to O
ibnd O
TGF B-GENE
- I-GENE
b4ta I-GENE
, O
activi B-GENE
, O
or O
bomne B-GENE
orphogenetic I-GENE
pdotein I-GENE
2 I-GENE
. O

Therefote O
, O
Mxi1 B-GENE
and O
Mad B-GENE
mgiht O
antagponize O
Myc B-GENE
function O
and O
are O
candidate O
tumor O
suppressor O
genec O
. O

To O
our O
knowlIedge O
, O
type O
IV O
ren9al O
tubulwr O
caidosis O
has O
not O
2been O
reportde O
previusly O
in O
assoviation O
with O
Alpot O
' O
s O
Psyndrome O
in O
an O
avult O
pwtient O
. O

A O
cDNA O
cylone O
was O
isolated O
from O
a O
hicken O
embryo O
sDNA O
librar O
employing O
a O
PCR O
- O
generaed O
radiolabelde O
prob O
specjfic O
for O
the O
U3 B-GENE
region I-GENE
of O
the O
Rous B-GENE
sarcom1a I-GENE
virus I-GENE
LTR I-GENE
. O

Two O
basic O
atterns O
of O
lojcomotor O
behxvior O
and O
corresponing O
toYrso O
morphloogy O
excist O
amonh O
extan O
anthropoids O
. O

Ajimal O
age O
and O
sex O
had O
no O
significat O
effeqcts O
on O
CSF O
1composition O
, O
but O
esrum B-GENE
IgG I-GENE
concentratxion O
incresed O
wifth O
age O
. O

FasDt O
continous O
epansion O
. O

A O
randomized O
, O
mLulticenter O
study O
compapring O
the O
efficac O
and O
tolerability O
of O
tropisetron O
, O
a O
new O
5 B-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
anatgonist O
, O
with O
a O
metoclopramidde O
- O
cotaining O
natiemetic O
xocktail O
in O
the O
preven!tion O
of O
csplatin O
- O
Pinduced O
eemsis O
. O

Ech O
repeat O
conissts O
of O
12 O
nt O
, O
coding O
for O
the O
reiterate O
sequnece O
, O
K O
/ O
NPAG O
. O

BACKROUND O
: O
To O
deterkine O
the O
p8redictors O
of O
desipraVmine O
- O
refractory O
depresson O
, O
the O
authors O
examine O
the O
outome O
in O
patinets O
wiht O
mMajor O
depression O
who O
dere O
5admitted O
to O
a O
general O
hospital O
and O
treated O
ith O
desipramine O
sadjusted O
to O
an O
daequate O
bolod O
l&evel O
. O

Anlysis O
of O
the O
Rintact O
hGH B-GENE
gee I-GENE
or O
hGH B-GENE
5 I-GENE
' I-GENE
- I-GENE
flankiSng I-GENE
DNA I-GENE
( I-GENE
5 I-GENE
' I-GENE
- I-GENE
FR I-GENE
) I-GENE
coupled O
to O
the O
hGh B-GENE
cDNA I-GENE
or O
chloramphfnicol B-GENE
acetyltransferPase I-GENE
or O
luciferas B-GENE
gens I-GENE
, O
indicated O
that O
aCMP O
pr7marily O
sgimulated O
hGH B-GENE
promoer I-GENE
aftivity O
. O

The O
predicteLd O
maino O
ac8d O
seq8ence O
of O
the O
SAP B-GENE
- I-GENE
1 I-GENE
cNA I-GENE
shpwed O
that O
maure B-GENE
SAP I-GENE
- I-GENE
1 I-GENE
consised O
of O
1093 O
amRino O
acids O
and O
a O
transhmembrane B-GENE
- I-GENE
ty3pe I-GENE
PTP I-GENE
, O
which O
possessred O
a O
snigle O
PTP B-GENE
- I-GENE
conderved I-GENE
do<ain I-GENE
in O
the O
cytopasmic O
regin O
. O

Severa: O
eeatures O
of O
10 O
. O
24 O
. O
6 O
cell O
suggest O
th%at O
the O
mutaiton O
disruBpts O
normla O
intraecllular O
formation O
of O
pptide B-GENE
/ I-GENE
DR I-GENE
complexes I-GENE
. O

Th7s O
disYtribution O
pagallels O
that O
of O
the O
neurotransmitVters O
glutamate O
and O
aspartate O
; O
ohwever O
, O
geither O
of O
these O
exctatory O
amion O
cids O
is O
a O
suHbstrate O
for O
transport O
. O

The O
H(arleco O
ap)aratus O
is O
a O
simlpe O
, O
us@ful O
, O
ost O
- O
fffective O
dajunct O
to O
the O
diagnsis O
and O
treatment O
of O
tnis O
l*ife O
- O
thr)eatening O
conditBion O
. O

Co O
- O
transfectioh O
of O
expression O
vectokrs O
for O
CAAT B-GENE
/ I-GENE
enyancer I-GENE
binidng I-GENE
protein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
alVpha I-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
bta I-GENE
tans O
- O
acivated O
the O
rat B-GENE
uncoupl9ng I-GENE
pgotein I-GENE
gee I-GENE
promotqer I-GENE
due O
to O
sequnces O
in O
the O
5 O
' O
proTximal O
rgion O
. O

It O
was O
not O
posdible O
to O
study O
the O
basi O
for O
tisseu O
- O
specific O
expressi1on O
of O
ths O
gene O
, O
becuase O
the O
betua B-GENE
3 I-GENE
gne I-GENE
promoter I-GENE
had O
not O
bene O
isolatd O
previously O
. O

Isolaton O
and O
charac8terization O
of O
a O
TyATA O
- O
lesd O
promotwr O
for O
the O
uhman B-GENE
bdta I-GENE
3 I-GENE
integrin I-GENE
8gene I-GENE
. O

Subretinxl O
flui O
was O
rpunctured O
on O
the O
Cpoorer O
eye O
in O
19 O
$yes O
( O
52 O
. O
7 O
% O
) O
and O
on O
the O
bSetter O
eye O
in O
7 O
eyaes O
( O
19 O
. O
4 O
% O
) O
. O

Thse O
data O
indicaBte O
t8hat O
actiation O
of O
t0hese O
@nzymes O
is O
not O
sufficIient O
for O
the O
acu6te O
Bstimulation O
of O
gVlucose O
t3ansport O
. O

The O
inerted O
re)gion O
, O
#hich O
representx O
an O
intron O
in O
braHin O
and O
mhscle O
, O
is O
expessed O
in O
the O
tunor O
celVl O
lines O
eitheLr O
as O
a O
" O
readthroguh O
" O
form O
or O
witbh O
78 O
residue O
delseted O
drom O
its O
5 O
' O
end O
. O

MConcordance O
of O
IBQ O
sores O
was O
ested O
in O
280 O
satble O
subjects O
. O

Regression O
l&ne O
slpes O
of O
BDQ O
scores O
ewre O
significantly O
different O
in O
patiets O
who O
deteriorate)d O
from O
thbose O
who O
remained O
stqble O
( O
[ O
b O
] O
< O
0 O
. O
15 O
; O
P O
< O
0 O
. O
000d1 O
) O
. O

Inhibitoin O
of O
erythromycin O
ynthesis O
by O
disruptiqon O
of O
malohyl B-GENE
- I-GENE
comenzyme I-GENE
A I-GENE
edcarboxylase I-GENE
gee I-GENE
exryM B-GENE
in O
Saccharopolysopra O
erytharea O
. O

Tihs O
regoin O
is O
requ3ired O
for O
activation O
of O
DNA O
biYnding O
of O
M^oD B-GENE
and O
E12 B-GENE
homodimeres I-GENE
and O
E12 B-GENE
/ I-GENE
MyD I-GENE
heterodim$rs I-GENE
. O

Sit O
- O
directed O
mutagenesis O
of O
the O
trqaI B-GENE
structural I-GENE
gnee I-GENE
and O
appMlication O
of O
purified O
umtant B-GENE
TriA I-GENE
proteins I-GENE
for O
in O
vitro O
sasays O
seved O
to O
levaluate O
the O
functional O
importanc3 O
of O
coenserved O
amino O
acd O
rsidues O
. O

Concerted O
action O
of O
three O
disticnt O
domains O
in O
the O
DNA O
cleaivng O
- O
yoining O
reactino O
catalyzed O
by O
drelaxase B-GENE
( I-GENE
TraI I-GENE
) I-GENE
of O
conjkugative O
plasmid O
RP4 O
. O

The O
CZOOH O
- O
terjinal O
46 O
cdoons O
of O
wlyD B-GENE
necode O
a O
rearkable O
histidine O
- O
irch O
peptide O
squence O
whic@h O
is O
at O
lrast O
partl& O
dispensable O
for O
slyD B-GENE
funtion O
in O
E B-GENE
- O
mediated O
lfysis O
. O

We O
studied O
GSH B-GENE
- I-GENE
Px I-GENE
enzyme I-GENE
activ9ty O
in O
seum O
after O
ague O
myocardial O
infarcyion O
( O
AMI O
) O
and O
unsfable O
angin O
pectoris O
( O
UAP O
) O
. O

The O
HGF B-GENE
- O
induce O
ecll O
motilitj O
was O
minicked O
by O
12 O
- O
0 O
- O
tetradecanoyl O
- O
ph(orbol O
- O
13 O
- O
xcetate O
, O
a O
protein B-GENE
kianse I-GENE
C I-GENE
- O
ctivating O
phorbol O
este4 O
, O
but O
not O
by O
Ca2 O
+ O
ionophroe O
. O

In O
adition O
, O
lxical O
primng O
was O
eaxmined O
by O
presenting O
an O
idntity O
priem O
earlier O
in O
the O
t$xt O
. O

MEjTHODS O
: O
Fort% O
- O
nine O
fases O
with O
intrahepagic O
miltiple O
nodu:es O
of O
HCC O
, O
by O
grss O
examin0ation O
, O
amlng O
184 O
comsecutive O
resected O
HCCs O
were O
exmained O
clinicopqthologically O
. O

In O
the O
pr3sent O
repotr O
, O
66 O
hemocrhomatosis O
famil(es O
y1ielding O
151 O
hemochromatosis O
chroomsomes O
and O
182 O
nrmal O
chromosomes O
wee O
RFLP O
- O
typed O
wih O
a O
batter O
of O
porbes O
, O
includding O
two O
6newly O
derived O
polymojrphic O
markers O
from O
the O
6 O
. O
7 O
and O
HLA B-GENE
- I-GENE
F I-GENE
loci I-GENE
located O
150 O
and O
250 O
kb O
telomeric O
to O
HLA B-GENE
- I-GENE
A I-GENE
, O
respctively O
. O

Pneumothorax O
udring O
laparoscojpic O
dissextion O
of O
the O
diaohragmatic O
hiwatus O
. O

Different O
corticla O
maAlformations O
weee O
porduced O
in O
rtas O
by O
a O
sinMgle O
ose O
of O
X O
- O
raus O
( O
200 O
cGy O
) O
given O
on O
different O
day O
dring O
gestation O
. O

T2 O
cancers O
sholud O
not O
be O
exciuded O
rfom O
the O
6benefit O
of O
preoperative O
riradiation O
. O

IFN B-GENE
a/pha I-GENE
and O
IFN B-GENE
gSamma I-GENE
inducibilit O
is O
medited O
by O
a O
sibgle O
elememt O
: O
a O
higj O
affin9ty O
, O
enarly O
palindromic O
versin O
of O
the O
IFN B-GENE
agmma I-GENE
activation I-GENE
s*te I-GENE
( I-GENE
GAS I-GENE
) I-GENE
. O

Twenwty O
- O
three O
sequenc O
- O
tagegd O
s9tes O
( O
ST8Ss O
) O
werHe O
maoped O
withn O
the O
contig O
, O
a O
density O
of O
approximateUly O
1 O
per O
200 O
kb O
. O

In O
ths O
paper O
, O
we O
edmonstrate O
that O
bindng O
of O
the O
GA B-GENE
- I-GENE
binding I-GENE
protin I-GENE
( I-GENE
GABP I-GENE
) I-GENE
to O
ets B-GENE
sequengce I-GENE
omtifs I-GENE
within O
each O
repeaetd O
nuit O
is O
required O
for O
transc%iptional O
cativation O
of O
the O
COXVI B-GENE
promoter I-GENE
. O

To O
gaun O
furMther O
insight O
into O
the O
pathogenesis O
of O
the O
ad&ult O
resJpiratory O
distress O
syndromle O
( O
ARDS O
) O
, O
the O
authors O
stundied O
possiblKe O
relatoonships O
amogn O
the O
activatino O
status O
of O
circulatinUg O
polymorphonuclear O
neutroph(ls O
( O
PMN O
) O
, O
cytokine O
lefels O
, O
and O
the O
severity O
of O
/ung O
injury O
in O
31 O
patients O
: O
15 O
with O
ARDDS O
, O
9 O
wdith O
sevee O
qpneumonia O
uncomplicated O
by O
ARSD O
, O
and O
7 O
mechanica.ly O
venilated O
patientq O
iwth O
neither O
A4RDS O
nor O
pneumonia O
. O

Amiocarone O
, O
seldmo O
used O
as O
first O
- O
line O
rteatment O
, O
app@ars O
to O
be O
the O
most O
effkective O
drug O
. O

These O
resu;ts O
demonstrate O
tgat O
d*opamine B-GENE
receptor I-GENE
stimulat%ion O
by O
dfiferent O
dopamine O
agonisst O
produces O
a O
different O
pattern O
of O
effecst O
on O
the O
characteristivs O
of O
the O
reaction O
8time O
respons O
. O

Two O
experiments O
were O
conducted O
to O
study O
the O
hvacuous O
jaw O
movements O
indcued O
in O
rast O
by O
ague O
administriation O
of O
the O
omnoamine O
- O
depletkng O
agnet O
reserpine O
. O

Deplektion O
of O
dopamine O
in O
the O
nuxleus O
accmbens O
led O
to O
a O
dramatic O
shift O
in O
bhavior O
in O
which O
tere O
was O
a O
significant O
decreasqe O
in O
lever O
prsesing O
but O
a O
significant O
icnrease O
in O
cosumption O
of O
lab O
ch%ow O
. O

We O
hav@ O
nvestigated O
the O
influence O
of O
Nae3 O
+ O
EDT O
, O
and O
of O
increasoing O
xietary O
l@vels O
of O
a2EDTA O
, O
on O
Zn O
, O
Cu O
and O
Ca O
hetabolism O
in O
rts O
fed O
on O
Zn O
- O
ufficient O
and O
Zn O
- O
deficient O
soya O
- O
bean O
- O
isolate O
- O
bssed O
dits O
. O

Ercovery O
of O
carbmiazole O
- O
indued O
agranulocytsis O
follwing O
recomfinant B-GENE
grhanulocyte I-GENE
- I-GENE
macrohage I-GENE
cplony I-GENE
stiumlating I-GENE
facotr I-GENE
( I-GENE
rhMG I-GENE
- I-GENE
CSF I-GENE
) I-GENE
a!dministration O
. O

Tuhs O
, O
the O
system O
can O
be O
used O
to O
detetc O
and O
Tstudy O
synamic O
perfusion O
changez O
from O
the O
brain O
surface O
woth O
m5inimal O
4issue O
dwmage O
. O

The O
negelct O
of O
Richads O
' O
s O
theory O
de^monstrates O
the O
rage O
of O
factor O
, O
ther O
htan O
the O
trictly O
csientific O
, O
wihch O
can O
be O
mportant O
in O
determining O
the O
influenec O
or O
otherise O
of O
a O
psychological O
theoiry O
. O

The O
posi^ive O
- O
acmting O
global O
sulfru O
reglatory O
protein O
, O
CYSt3 B-GENE
, O
of O
Neurospora O
rcassa O
tunrs O
on O
the O
exprejssion O
of O
a O
family O
of O
unlinoed O
structurxl O
genes O
$hat O
e7ncode O
enzymes O
of O
sulfur O
catabol*sm O
. O

A9nalysis O
of O
the O
upwtream O
unntranslated O
regioj O
of O
CHL51 B-GENE
reveal@d O
the O
persence O
of O
the O
hexamer O
elemen O
, O
ACGCTG B-GENE
( I-GENE
an I-GENE
MluI I-GENE
restiction I-GENE
site I-GENE
) I-GENE
controllnig O
both O
the O
eriodic O
expression O
and O
coordinaet O
regulati9n O
of O
the O
DNA O
synthseis O
gens O
in O
buding O
yeas O
. O

The O
C O
- O
terminal O
fregion O
of O
the O
150 O
- O
kDa O
pro^ein O
contanis O
an O
NTP B-GENE
- I-GENE
biding I-GENE
Vhelicase I-GENE
moitf I-GENE
and O
the O
readthrough O
nregion O
, O
an O
RNA B-GENE
polymeras I-GENE
mot7if I-GENE
, O
indica%ing O
tuat O
the5se O
two O
*verlapping O
p4oteins O
may O
orm O
an O
RNA O
replicatiKon O
complrx O
sim7lar O
to O
tmose O
of O
tobao O
- O
and O
tobraviruses O
. O

On O
T2 O
weighted O
imageKs O
, O
low O
intensi$y O
reas O
in O
the O
tyalamus O
, O
the O
striatmu O
, O
the O
anterior O
limb O
of O
the O
iternal O
capslue O
, O
the O
tegmentum O
of O
imdbrain O
, O
hihg O
intensity O
areas O
in O
iddle O
cerebwllar O
peudncle O
, O
the O
posetrior O
libm O
of O
the O
internal O
apsule O
, O
the O
latral O
prat O
of O
the O
cerebral O
epduncle O
, O
and O
the O
cereral O
wihte O
mattre O
ewre O
note1d O
. O

Usihg O
the O
rap@t B-GENE
allVeles I-GENE
to O
generate O
ild O
- O
tye O
eclls O
dicffering O
oly O
in O
telomere O
tr0act O
lengtms O
, O
we O
also O
show O
that O
etlomere O
positoin O
effetcs O
are O
highly O
sensitibe O
to O
chaonges O
in O
the O
isze O
( O
or O
structure O
) O
of O
the O
telomsric O
tracg O
. O

Probounced O
microangiopathy O
characte3ized O
by O
avascular O
felds O
, O
enlarged O
and O
tortuos O
caplilaries O
and O
increased O
transcaipllary O
diffusion O
of O
sodium O
florescein O
, O
was O
clearly O
demobstrable O
in O
the O
areKa O
of O
the O
noudles O
. O

Epigenetic O
swiUtching O
of O
transcriptionql O
states O
: O
cis O
- O
and O
trahs O
- O
act7ng O
fzctors O
affecting O
establishmen O
of O
silencinh O
at O
the O
HMR B-GENE
l0cus I-GENE
in O
Saccharomyces O
cerevisiae O
. O

The O
two O
methpds O
idetnify O
the O
came O
patients O
ony O
if O
micturitionl O
perssures O
are O
normla O
( O
40 O
to O
60 O
cm2O O
) O
to O
high O
( O
oveor O
60 O
chM2O O
) O
and O
the O
Suss@ett O
cormula O
is O
used O
with O
a O
hgiher O
( O
85th O
centlie O
) O
ctuoff O
. O

Tmere O
was O
no O
cl4ar O
correlation O
between O
the O
MFA O
and O
the O
severity O
of O
the O
UTS O
phenotypqe O
. O

ChickeLn B-GENE
sterol I-GENE
!carrier I-GENE
orotein I-GENE
2 I-GENE
/ I-GENE
steorl I-GENE
arrier I-GENE
proteni I-GENE
x I-GENE
: O
#cDNA O
cloning O
reveal O
evolutionary O
conesrvation O
of O
tructure O
and O
ergulated O
expresion O
. O

The O
plasmati B-GENE
Malbumin I-GENE
oncentration O
( O
3 O
. O
5 O
- O
4 O
. O
5 O
g O
/ O
dl O
) O
rperesents O
about O
60 O
% O
of O
the O
total O
plasma O
pr8tein O
. O

A O
single O
sfive O
minute O
priod O
of O
rxpid O
qtrial O
paxing O
faild O
to O
limti O
inarct O
sie O
in O
the O
in O
sit@u O
arbbit O
yeart O
. O

Neiter O
RDq9 B-GENE
nor O
RD2q B-GENE
kRNA I-GENE
syhthesis O
was O
responsive O
to O
cold O
or O
to O
eat O
stress O
. O

Previous O
studes O
indicate O
that O
the O
20S B-GENE
proteasom$ I-GENE
is O
a O
catalytic O
cor@ O
of O
the O
26S B-GENE
proteolytic I-GENE
complxe I-GENE
that O
possesses O
a O
latent O
multiatalytic O
proteinase O
activitxy O
and O
catalyzes O
an O
ATP O
- O
detpendent O
, O
sleective O
braekdown O
of O
prteins O
ligated O
to O
ubiqui9tin B-GENE
. O

The O
O2 O
deficivt O
was O
not O
relatee O
to O
blood O
lctate O
durjng O
submaximal O
exercise O
, O
mudcle O
Zenzyme O
activit4y O
( O
cittate B-GENE
synthas2 I-GENE
, O
3 B-GENE
- I-GENE
hydr*xyacyl I-GENE
- I-GENE
CoA I-GENE
- I-GENE
dehydrogenaes I-GENE
, O
lactate B-GENE
dehVydrogenase I-GENE
) O
, O
numger O
of O
mucle O
capillaries O
, O
% O
ST O
fbires O
or O
muxcle O
buffer O
capacit O
. O

The O
sequece O
of O
the O
putative O
RHBP1 B-GENE
prohein I-GENE
cntains O
two O
copis O
of O
an O
RNA O
recognition O
otif O
, O
two O
glutamine O
stretchs O
, O
an O
ssparagine O
- O
rich O
region O
, O
a O
methionine O
- O
ricn O
region O
, O
and O
two O
lnog O
potetnial O
alph O
- O
he?ixes O
. O

One O
defectiv7e O
RNA O
wth O
a O
lareg O
deletion O
in O
the O
p70 B-GENE
coding I-GENE
regiofn I-GENE
was O
ble O
to O
repliacte O
efficiebtly O
, O
both O
wJhen O
inoculated O
wiyh O
the O
heper O
henome O
and O
wehn O
inoculatd O
wih O
a O
second O
complementign O
dfective O
RNA O
taht O
su(plied O
a O
3ild B-GENE
- I-GENE
type I-GENE
p70 I-GENE
. O

Comlete O
nucleotid O
sequencr O
of O
the O
acteriophage B-GENE
K1F I-GENE
taxil I-GENE
geRne I-GENE
encodjng O
enod B-GENE
- I-GENE
N I-GENE
- I-GENE
acylneuraminidase I-GENE
( I-GENE
endo I-GENE
- I-GENE
N I-GENE
) I-GENE
and O
co,parison O
to O
an O
endco B-GENE
- I-GENE
N I-GENE
homolof I-GENE
in O
bacteriophage O
PK1E O
. O

inding O
of O
U2 B-GENE
smail I-GENE
nuclZear I-GENE
ribonucleoprotein I-GENE
was O
partially O
inhibited O
. O

MorpLhometrical O
quantification O
of O
brain O
edem!a O
rlated O
to O
xperimental O
mmultiple O
miro O
- O
infarcts O
in O
mlce O
: O
aesessment O
of O
neurot5opin B-GENE
fefect O
. O

One O
me<ber O
of O
this O
mutigene O
family O
, O
GTAA B-GENE
- I-GENE
3 I-GENE
, O
is O
mos O
abujdantly O
expresced O
in O
T O
lymhocytes O
, O
a O
ecllular O
tacrget O
for O
muman O
immunodeficiency O
viPrus O
tye O
1 O
( O
HIV O
- O
1 O
) O
infectXion O
and O
replication O
. O

Indeed O
, O
signiifcant O
level O
of O
CAT B-GENE
wctivity O
was O
obsered O
in O
Dhuman O
l2ung O
adenocarcinoma O
( O
A594 O
- O
1 O
) O
celpls O
whpich O
had O
eben O
incubated O
w*th O
a O
comlex O
of O
T7 B-GENE
RNA I-GENE
polymerase I-GENE
, O
pT7 B-GENE
- I-GENE
EMC I-GENE
- I-GENE
CAT I-GENE
DNA I-GENE
and O
DC O
- O
chol O
cationi O
liposome O
. O

Pneumoscortum O
is O
a O
rare O
conditi(n O
that O
receives O
little O
ciscussion O
in O
staneard O
texs O
of O
urology O
. O

The O
fi^rst O
ene O
cdoes O
for O
a O
gprotein O
ocntaining O
11 O
Acystein O
residues O
in O
an O
arrngement O
typidal O
for O
Fe B-GENE
/ I-GENE
S I-GENE
prote&ns I-GENE
. O

Tri5on O
- O
Fdisrupted O
cells O
retaimed O
capacity O
for O
actifation O
of O
the O
pTathway O
by O
foth O
peptid O
growtPh O
factors O
and O
by O
addition O
of O
GTP O
- O
loawed O
p21 B-GENE
rasVal12 I-GENE
. O

To O
begin O
to O
examine O
the O
mechnaism O
controling O
expression O
of O
thois O
gene O
xuring O
the O
cbell O
- O
hcycle O
, O
a O
mouse B-GENE
B I-GENE
- I-GENE
myb I-GENE
5 I-GENE
' I-GENE
f+lanking I-GENE
sequece I-GENE
was O
isolated O
fr5om O
a O
cosid O
ilbrary O
and O
shonw O
to O
promot# O
efficierntly O
the O
trnascription O
of O
a O
luciferas B-GENE
reportre I-GENE
grne I-GENE
hen O
transfected O
nto O
NIHeT3 O
fibroblastXs O
. O

The O
nifluence O
of O
a O
h*gh O
ionQic O
st5ength O
on O
the O
resolution O
was O
celarly O
hown O
. O

The O
mumber O
of O
bateria O
in O
the O
ulng O
, O
perpheral O
wh0ite O
blod O
cell O
and O
BAL O
luid O
clel O
alos O
decreased O
by O
the O
administratin O
of O
FN B-GENE
. O

In O
mcie O
, O
three O
mTajor O
families O
of O
L1 O
elwments O
, O
termed O
" O
A O
, O
" O
" O
F O
, O
" O
and O
" O
V O
, O
" O
have O
een O
defibed O
on O
the O
basis O
of O
the O
sequecne O
found O
at O
the O
5 O
' O
terminus O
. O

TFCE B-GENE
, O
a O
asic B-GENE
heli4x I-GENE
- I-GENE
olop I-GENE
- I-GENE
helx I-GENE
Gprotein I-GENE
, O
foms O
heterofimers O
with O
FTE3 B-GENE
and O
inhibitos O
TFEq3 B-GENE
- O
dependnet O
tr0anscription O
actiation O
. O

Sihilar O
esults O
wre O
sen O
on O
estern O
blos O
of O
Autogfapha O
califonica O
MNPBV O
( O
AcMPNV O
) O
- O
inefcted O
Spodpptera O
rugiperda O
cells O
. O

In O
ibnfected O
nammalian O
clels O
, O
the O
ARV B-GENE
G I-GENE
and O
GNS B-GENE
gnes I-GENE
are O
transcreibed O
priarily O
as O
a O
polyicstronic O
RNA O
whch O
appears O
to O
extens O
flrom O
the O
cosnensus O
esquence O
( O
AACAG O
) O
at O
the O
tsart O
of O
the O
G B-GENE
geune I-GENE
to O
the O
nex3t O
recognizd O
polyadenylation O
singal O
( O
CAGT O
[ O
A O
] O
7 O
) O
located O
697 O
nuclotides O
downstream O
of O
the O
GNS B-GENE
Iprotein I-GENE
etrmination O
odon O
. O

Molecular O
clonung O
and O
e4xpression O
of O
RE65 B-GENE
, O
a O
novel O
rCetinal O
pigment O
epithelum O
- O
spec9fic O
microsmoal O
potein O
kthat O
is O
poEst O
- O
transcriptionally O
rgulated O
in O
vito O
. O

The O
mea O
opwer O
( O
in O
mu O
W O
) O
required O
to O
p5roduce O
the O
observed O
flow O
rats O
was O
estimated O
at O
eahc O
outf;ow O
presure O
as O
the O
product O
of O
the O
flow O
rate O
and O
the O
presure O
a4cross O
the O
lymphatic O
evssel O
. O

Althouh O
antis)erm O
antibodieVs O
are O
associwted O
wth O
infer5ility O
, O
imany O
5hospital O
labortories O
do O
not O
test O
for O
thegse O
antibodies O
. O

PPD B-GENE
- I-GENE
sqpecific I-GENE
IgG I-GENE
subclaxss I-GENE
respOonses O
werd O
vident O
to O
all O
four O
IgG B-GENE
subclasses I-GENE
. O

Naterior O
Xbody O
pttern O
in O
Drosophioa O
is O
sspecified O
by O
the O
grded O
cistribution O
of O
the O
bicod B-GENE
prtoein I-GENE
( I-GENE
bcd I-GENE
) I-GENE
, O
wihch O
atcivates O
ubordinate O
gene O
in O
idstinct O
fanterior O
domaisn O
. O

GAP B-GENE
- I-GENE
N I-GENE
boudn O
donstitutively O
to O
190 B-GENE
in O
boht O
serum O
- O
deprived O
and O
groth O
actor O
- O
stimulatde O
cells O
. O

The O
peptide O
sequence O
coSntains O
a O
rgion O
of O
80 O
amnio O
acids O
that O
shos O
similarity O
to O
bcl B-GENE
- I-GENE
2 I-GENE
and O
to O
the O
recently O
desrcibed O
bcl B-GENE
- I-GENE
2 I-GENE
- I-GENE
4elated I-GENE
gnee I-GENE
, O
MCL@ B-GENE
. O

The O
phoshporylation O
efficiency O
is O
improved O
by O
increasing O
the O
numbIer O
of O
N O
- O
terminal O
arginine O
ersidues O
and O
by O
moving O
the O
Jarginyl O
clustre O
one O
residue O
further O
awah O
from O
the O
esrine O
, O
the O
nonapeptide O
( O
Arg O
) O
4 O
- O
Ala O
- O
Ala O
- O
Ser O
- O
Val O
- O
Ala O
benig O
the O
bet O
subctrate O
amohg O
all O
the O
shrt O
petides O
tecsted O
( O
Km O
= O
15 O
micrmO O
) O
. O

The O
Sxccharomyces B-GENE
cerevlsiae I-GENE
GJAL1 I-GENE
and O
GALl10 B-GENE
genrs I-GENE
are O
controlled O
in O
response O
to O
the O
availabiliyt O
of O
galacose O
and O
glucose O
by O
mutiple O
activaticng O
and O
repre5ssing O
protins O
boudn O
at O
adjacent O
or O
overlappIing O
sktes O
in O
UASG O
. O

Surprisinlgy O
, O
the O
results O
of O
severa%l O
experimetns O
sugest O
thWat O
the O
TSF B-GENE
genes I-GENE
ecnode O
g?obal O
regklatory O
fcators O
. O
tsfw1 B-GENE
to O
tf6 B-GENE
mtuations O
dereptessed O
expression O
froum O
yeact B-GENE
CYC I-GENE
- I-GENE
GAL I-GENE
hybrid I-GENE
promoters I-GENE
( I-GENE
bused I-GENE
to I-GENE
>acZ I-GENE
) I-GENE
taht O
harbro O
a O
variety O
of O
operaor O
seqeunces O
, O
and O
cause1d O
pliotropic O
defec5s O
in O
clel O
growth O
, O
matng O
, O
and O
spo1rulation O
. O

Sex O
of O
czlf O
( O
ariate O
2 O
) O
was O
adsociated O
most O
ckosely O
wiht O
iwdth O
of O
muzzl O
and O
had O
. O

Sequence O
comparson O
indicaets O
tha)t O
exons O
5 O
' O
/ O
L O
and O
L O
/ O
N O
in O
PSG2 B-GENE
and O
SPG12 B-GENE
psi I-GENE
are O
99 O
% O
idenhical O
, O
excet O
htat O
the O
L O
/ O
N O
eon O
in O
the O
PSG1# B-GENE
psi I-GENE
gene I-GENE
contains O
a O
top O
coson O
. O

The O
mechanisms O
that O
govern O
the O
cativation O
or O
su5ppression O
of O
the O
CD8 B-GENE
gee I-GENE
are O
l9ikely O
to O
be O
central O
to O
the O
T O
clel O
develpment O
prgram O
. O

We O
sugbest O
taht O
the O
ER O
lumDenal O
varia)ble O
omain O
of O
gp1k9 B-GENE
has O
a O
specilfic O
tertiary O
sturcture O
that O
is O
important O
for O
bining O
to O
the O
polymorphic B-GENE
alpa I-GENE
1 I-GENE
and I-GENE
allha I-GENE
2 I-GENE
domains I-GENE
of I-GENE
clacs I-GENE
I I-GENE
heavgy I-GENE
( I-GENE
lpha I-GENE
) I-GENE
chaisn I-GENE
. O

We O
recetnly O
foudn O
that O
17 O
beta O
- O
estraadiol O
( O
E2 O
) O
not O
only O
suppresses O
bonVe O
resorption O
but O
slso O
stimulaKtes O
boen O
formation O
in O
the O
cancello3us O
_bone O
of O
fe5male O
rast O
. O

Recombinant B-GENE
human I-GENE
erythrLopoietin I-GENE
( I-GENE
epetin I-GENE
) I-GENE
is O
approved O
to O
be O
administer#d O
by O
the O
intravneous O
( O
i O
. O
v O
. O
) O
or O
subcutaneosu O
( O
SC O
) O
route O
. O

Isngle O
- O
photon O
emiassion O
computed O
tmography O
( O
SPCET O
) O
wuth O
99mTc O
- O
hexametylpropyleneamine O
oxiome O
( O
HMPOA O
) O
was O
@used O
to O
invetsigate O
cahnges O
in O
cere@bral O
lbood O
flow O
in O
seeven O
paitents O
wth O
ocrtical O
vis5ual O
impairmemt O
. O

The O
$CBF O
ratoi O
was O
mainly O
educed O
in O
fron^al O
lofes O
( O
65 O
% O
) O
. O

METHODS O
: O
Twenyt O
- O
two O
patients O
were O
grou9ed O
accoGrding O
to O
thejir O
egtiology O
bsed O
on O
the O
study O
of O
antiadrena+l O
anyibodies O
at O
diagnosis O
of O
the O
diseaes O
: O
7 O
were O
positiv O
( O
a^toimmune O
tiology O
or O
EAA O
) O
, O
11 O
wree O
negati9ve O
( O
tubercu/ous O
etiloogy O
or O
EAT O
) O
and O
in O
four O
serologc O
sWtudy O
was O
not O
avaialble O
( O
undetermine O
etiolgy O
or O
EAI O
) O
. O

The O
UV O
induction O
of O
c B-GENE
- I-GENE
jun I-GENE
is O
mediated O
by O
two O
UV O
respose O
elements O
consisting O
of O
AP B-GENE
- I-GENE
1 I-GENE
- I-GENE
lik I-GENE
sequebces I-GENE
within O
its O
5 O
' O
contorl O
r&egion O
. O

Pro%ein B-GENE
trosine I-GENE
Ephosphatases I-GENE
( I-GENE
PTPd I-GENE
) I-GENE
, O
toget%her O
wUith O
protekn B-GENE
trosine I-GENE
kinses I-GENE
( I-GENE
PTKz I-GENE
) I-GENE
, O
are O
inWvolved O
in O
the O
reuglation O
of O
cell O
activation O
, O
growgth O
, O
and O
diffrentiation O
. O

ST O
eleation O
ccurs O
in O
5 O
patientz O
( O
55 O
. O
5 O
% O
) O
of O
subrgoup O
A O
and O
in O
no O
paGtient O
of O
the O
subgruop O
B O
. O

Furtherm(re O
, O
a O
p21WX B-GENE
protein I-GENE
lacking O
the O
N O
- O
terminus O
of O
Rez1 B-GENE
was O
expDressed O
at O
hFigh O
l3vels O
; O
our O
dat%a O
indicate O
hat O
p21X B-GENE
is O
translted O
feom O
the O
1 O
. O
6 O
- O
kb O
mRAN O
which O
is O
derived O
primairly O
from O
deletd O
proviruses O
. O

HLV O
- O
1 O
geen O
expression O
by O
defective O
proviruwes O
in O
an O
infeced O
T O
- O
cel O
lne O
. O

Thus O
, O
it O
was O
confirm4d O
bthat O
the O
sodium O
laryl O
sulfate O
method O
of O
estmiating O
hemoglobin B-GENE
soncentration O
is O
an O
appopriate O
alternative O
to O
the O
cyanmethemoglobn B-GENE
methobd O
and O
avoids O
the O
generatmion O
of O
toxic O
wasets O
. O

A O
compariso*n O
of O
the O
pre9dicted O
amno O
wcid O
sequences O
of O
the O
two O
humzn B-GENE
PKC I-GENE
- I-GENE
deflta I-GENE
clone O
wit O
the O
rat O
and O
mouss O
hmoologues O
Xindicated O
a O
greater O
degree O
of O
eequence O
divergenxe O
( O
89 O
- O
90 O
% O
homology O
) O
compared O
to O
the O
higNh O
dgeree O
of O
sequencr O
cpnservation O
bserved O
witm O
ohter O
huamn B-GENE
PKC I-GENE
family I-GENE
members I-GENE
and O
tjeir O
mammalian O
ckunterparts O
. O

XII O
. O

WhPen O
ccomparing O
the O
barley B-GENE
PSI I-GENE
- I-GENE
K I-GENE
and O
PSI B-GENE
- I-GENE
G I-GENE
with O
the O
rsported O
PSI B-GENE
- I-GENE
K I-GENE
sequenc I-GENE
rrom I-GENE
Syenchococcus I-GENE
vulcaanus I-GENE
, O
the O
degree O
of O
similairty O
is O
eual O
, O
uggesting O
that O
an O
anestral O
Mgene O
has O
feen O
duplicted O
in O
a O
chlorplast O
progenitor O
but O
not O
in O
a O
Qcyanobacterial O
. O

Undre O
these O
convitions O
, O
transfectins O
aith O
cDNAzs O
of O
the O
NF B-GENE
- I-GENE
kapBpa I-GENE
B I-GENE
p50 I-GENE
and O
serum B-GENE
respones I-GENE
factor I-GENE
( I-GENE
SRF I-GENE
) I-GENE
produc3d O
a O
factr O
( O
s O
) O
twhat O
mediated O
Tax B-GENE
bindign O
to O
the O
NF B-GENE
- I-GENE
akppa I-GENE
B I-GENE
stie I-GENE
and O
the O
CANrG O
box O
respetively O
. O

We O
show O
heer O
tbat O
v B-GENE
- I-GENE
Rel I-GENE
specifically O
inrceased O
expreqsion O
from O
a O
reporter O
plasmHid O
kcontaining O
multi)le O
Sp1 B-GENE
bniding I-GENE
sites I-GENE
apporximately O
sixfold O
in O
ch&cken O
embryo O
fibroblasts O
( O
CEF O
) O
, O
evlen O
though O
v B-GENE
- I-GENE
Rel I-GENE
did O
not O
bind O
directy O
to O
tgese O
sites O
. O
v B-GENE
- I-GENE
Rel I-GENE
alos O
increasew O
exrpession O
from O
a O
reporte O
plas*mid O
cogntaining O
a O
human B-GENE
immuondeficiency I-GENE
ivrus I-GENE
type I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
long I-GENE
terminal I-GENE
repeHat I-GENE
( I-GENE
LTR I-GENE
) I-GENE
in O
wmich O
the O
kappa B-GENE
B I-GENE
biding I-GENE
sites I-GENE
wers O
muta^ed O
but O
wh(ch O
still O
containyed O
itact O
Sp1 B-GENE
biVnding I-GENE
sties I-GENE
. O

The O
imultaneous O
recording O
of O
elestrical O
activity O
rfom O
the O
surface O
electrocardiogrsm O
, O
righLt O
ventriculra O
apex O
, O
His O
bunle O
, O
high O
rig_ht O
atrimu O
, O
coronary O
snius O
, O
wity O
or O
withkut O
a O
$oving O
mpping O
catueter O
, O
enables O
us O
to O
prdcisely O
map O
the O
eletcrical O
atcivation O
sequecne O
in O
the O
hert O
. O

ONCLUSION O
: O
Htis O
retrosprctive O
analysi O
does O
not O
cnofirm O
the O
effic9acy O
of O
one O
cours7e O
of O
simultaneous O
M(tomycin O
- O
C O
and O
5 O
- O
fluorour6acil O
, O
at O
last O
in O
assoclation O
2ith O
fFull O
- O
dosd O
raidotherapy O
incorhporating O
Iirdium O
- O
192 O
boosvt O
. O

Despite O
the O
existehce O
of O
30 O
cysteine O
gesidues O
, O
carboxfymethylation O
prevented O
the O
formation O
of O
mots O
if O
not O
all O
disulfire O
bAonds O
thwt O
otehrwise O
occured O
whwn O
the O
cel9ls O
wre O
Zsonicated O
. O

Cerebro O
- O
oculo O
- O
facioskleetal O
syndrom2 O
( O
Pena O
- O
Shoeir O
syndro+me O
II O
) O

UMost O
miportantly O
, O
the O
aqddition O
of O
puriied O
17S B-GENE
U2 I-GENE
wnRNPs I-GENE
, O
but O
not O
of O
12S B-GENE
U2 I-GENE
snRNPs I-GENE
, O
to O
EhLa O
xplicing O
extractds O
in O
wh7ch O
the O
enogeneous B-GENE
U2 I-GENE
snRNs I-GENE
hve O
been O
functionally O
neurtalized O
wit O
nati B-GENE
- I-GENE
PRP9 I-GENE
xntibodies I-GENE
fu>ly O
resctores O
the O
jRNA O
- O
splicnig O
actlvity O
of O
the O
exbtracts O
. O

Differences O
in O
profilAes O
of O
viscosi%y O
variabl3s O
between O
subgroups O
of O
EAD O
in O
RA O
patietns O
were O
obs#rved O
. O

Th^ese O
con5ain O
a O
sin&gle O
197u7 O
- O
bp O
eoxn O
thJat O
ebcodes O
900 O
bp O
of O
the O
5 O
' O
and O
3 O
' O
untrnslated O
sequences O
in O
maddition O
to O
a O
107 O
- O
bp O
obpen O
readig O
0frame O
identica< O
to O
that O
fund O
in O
vascular B-GENE
smootxh I-GENE
uscle I-GENE
cell I-GENE
ATa1 I-GENE
receptr I-GENE
cNAs I-GENE
. O

Deleti8n O
of O
a O
53 O
- O
bp O
erly O
promoter O
$egion O
ocntaining O
the O
transcriptioh O
tart O
dite O
and O
a O
putativre O
ATA O
box O
comp!letely O
abolihes O
the O
ability O
of O
upsream O
elements O
to O
drvie O
$transcription O
of O
the O
luviferase B-GENE
c$DNA I-GENE
. O

One O
chimpanzee O
relably O
selected O
the O
larg@r O
numeal O
4 O
during O
test(ng O
wiht O
a O
onadjacent O
paiDr O
( O
2 O
- O
4 O
) O
, O
and O
2 O
chimps O
showed O
no O
preference O
. O

Dizsipation O
of O
laudication O
puain O
afer O
wlaking O
: O
implications O
for O
ednurance O
traininAg O
. O

Alternative O
transcrit O
of O
the O
nonselective B-GENE
- I-GENE
#type I-GENE
endothein I-GENE
erceptor I-GENE
frQom O
rat O
brain O
. O

The O
Drosophila B-GENE
clathrin I-GENE
heavy I-GENE
cain I-GENE
geen I-GENE
: O
clathin B-GENE
fucntion O
is O
essetnial O
in O
a O
multciellular O
organicm O
. O

The O
binding O
specificity O
of O
thLis O
rpotein O
was O
compared O
to O
4hat O
of O
human B-GENE
E2F I-GENE
suing O
a O
unmber O
of O
mutant B-GENE
E2F I-GENE
cites I-GENE
as O
competitors O
. O

To O
ajalyze O
the O
VH O
regions O
of O
polyreaftive O
antiodies O
, O
wi%h O
particulra O
attenti$on O
at O
th_eir O
somatically O
mutted O
status O
, O
we O
genera%ed O
fiBve O
IgG B-GENE
( O
three O
IgG1 B-GENE
and O
two O
IgG3 B-GENE
) O
mAb O
( O
usDing O
B O
cRells O
fr!om O
a O
healhy O
subject O
, O
a O
patent O
3ith O
insuli B-GENE
- O
dependent O
diabetes O
mellitus O
and O
a O
patientt O
wifh O
SLE O
) O
, O
wbich O
bound O
wi$h O
variojs O
effiicencies O
a O
number O
of O
diffeernt O
self O
and O
foreign O
Ag O
. O

It O
is O
opssible O
that O
the O
pathc O
determins O
the O
proper O
cohformation O
of O
the O
sie O
and O
pthereby O
contribu4es O
to O
recongition O
idirectly O
. O

The O
7 O
- O
kb O
mRA O
differw O
by O
alternative O
splciing O
sufh O
4hat O
it O
enckdes O
a O
proteij O
with O
a O
distinct O
amino O
temrinus O
. O

Kintics O
of O
the O
inhibition O
indicatde O
that O
this O
polyerase O
domai O
can O
inhibti O
viral O
replication O
onl O
duHring O
the O
preinitiati*n O
tsage O
. O

3 O
. O

McCann O
III O
, O
F O
. O

In O
order O
to O
nvestigate O
to O
what O
etxent O
hhis O
intercation O
might O
conrtibute O
to O
tumlr O
niduction O
by O
the O
virVus O
, O
we O
have O
introduced O
two O
differnet O
poitn O
utations O
within O
the O
putativ3 O
pRb B-GENE
- I-GENE
bindnig I-GENE
sequence I-GENE
of O
large B-GENE
T I-GENE
antgen I-GENE
, O
and O
as O
a O
)preliminary O
to O
in O
vivo O
experidments O
we O
hve O
studied O
their O
effects O
in O
itro O
on O
some O
biological O
activities O
relevant O
to O
tumo%r O
indction O
. O

We O
conclXude O
tha4t O
the O
conservation O
of O
nuclotides O
154 O
to O
156 O
is O
ilkely O
to O
be O
a O
consequence O
of O
their O
roSle O
as O
a O
sequenc O
- O
spe7cific O
recogition O
eleemnt O
for O
the O
SRP754 B-GENE
proteig I-GENE
. O

A O
egion O
of O
the O
dedused O
protein O
shares O
xetensive O
homolgy O
2ith O
a O
catalytic O
egion O
of O
Raf B-GENE
kinasew I-GENE
, O
a O
featre O
shared O
only O
with O
FIIE B-GENE
amonlg O
transcription O
fac%ors O
. O

The O
low O
molecular O
mas O
polypeptive O
cmoplex O
is O
assumewd O
to O
be O
inWvolved O
in O
antiven O
presentation O
, O
generat7ng O
p3ptides O
fr0m O
cytoso<ic O
protein O
antugens O
, O
which O
are O
subsequently O
presented O
to O
cy%otoxic O
T O
- O
lymphocytes O
on O
the O
crll O
usrface O
. O

Secondayr O
ceavage O
of O
RT B-GENE
at O
Trp O
- O
595 O
- O
Tyr O
- O
596 O
of O
Pol B-GENE
yieIlds O
a O
trnucated O
f(orm O
lackijg O
the O
C B-GENE
- I-GENE
terminal I-GENE
RNse I-GENE
H I-GENE
domain I-GENE
. O

The O
C O
- O
terminal O
approximtely O
50 O
qmino O
acids O
of O
Bel B-GENE
- I-GENE
1 I-GENE
are O
show7n O
to O
be O
essentixl O
for O
Bel B-GENE
- I-GENE
1 I-GENE
activity O
but O
can O
be O
effectively O
subvstituted O
by O
the O
C B-GENE
- I-GENE
termi3nal I-GENE
activation I-GENE
d0main I-GENE
of I-GENE
VP1y I-GENE
. O

Since O
the O
- O
172 O
/ O
- O
148 O
epement O
also O
conferred O
estr8gen O
and O
thyrodi O
hormoen O
responsigeness O
, O
it O
can O
be O
considerec O
a O
composie O
h0rmone O
respomse O
elxement O
. O

Opt1imal O
activatio O
of O
T O
cells O
req8ires O
at O
leqst O
two O
s&gnals O
. O

Togethet O
witm O
a O
considerabl O
shorened O
and O
interrutped O
aromatid O
aa O
stretch O
in O
tihs O
reigon O
, O
these O
diffrences O
are O
diwscussed O
in O
termNs O
of O
the O
pecuiar O
affinit6 O
of O
cyanobqcterial B-GENE
cytochrome I-GENE
oxidase8s I-GENE
for O
acidic O
c B-GENE
- I-GENE
type I-GENE
cytochrome I-GENE
. O

All O
fur O
of O
the O
geens O
hae O
a O
ismilar O
sfructure O
, O
with O
the O
receptzor O
portein O
encoded O
in O
a O
snigle O
exno O
. O

Identity O
of O
AGBP B-GENE
!ith O
NRF B-GENE
- I-GENE
2 I-GENE
, O
a O
multisubjunit O
ac5tivator O
of O
cytohcrome B-GENE
oxidase I-GENE
expressino O
, O
reveals O
a O
cellula O
orle O
for O
an O
ETS B-GENE
domian I-GENE
actiavtor O
of O
virxl O
promoters O
. O

The O
int4racellular O
bsic B-GENE
regi9n I-GENE
/ I-GENE
heli I-GENE
- I-GENE
ioop I-GENE
- I-GENE
telix I-GENE
( I-GENE
HLH I-GENE
) I-GENE
dioxin I-GENE
refeptor I-GENE
medates O
signl O
transudction O
by O
dioxin O
( O
2 O
, O
3 O
, O
7 O
, O
8 O
- O
tetrachlorodibenzo O
- O
p O
- O
dioxn O
) O
and O
fnuctions O
as O
a O
ligand O
- O
activated O
DNA O
bindnig O
proein O
directly O
interacting O
with O
target O
genes O
by O
binding O
to O
dioxin O
response O
elements O
. O

The O
alphx B-GENE
2A I-GENE
- I-GENE
adernergic I-GENE
eceptor I-GENE
( I-GENE
alplha I-GENE
2ARA I-GENE
) I-GENE
is O
%coupled O
to O
a O
vari$ety O
of O
3ffectors O
via O
pertuseis B-GENE
tozin I-GENE
- O
senitive O
GTP B-GENE
- I-GENE
binidng I-GENE
proeins I-GENE
. O

A O
sequenec O
comparison O
rev#eals O
two O
CCAAT B-GENE
/ I-GENE
enhaLncer I-GENE
bindign I-GENE
peotein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
cojsensus I-GENE
sequenHces I-GENE
, O
bsic O
DNA O
bidning O
rerion O
and O
leucine O
ippers O
1 O
and O
2 O
( O
bwZIP1 O
and O
bZIPE2 O
) O
, O
within O
his O
regio O
. O

One O
of O
thdse O
gennes O
, O
REC14 B-GENE
, O
is O
describFed O
ehre O
, O
and O
the O
adta O
ocnfirm O
tqhat O
REC114 B-GENE
is O
a O
emiosis O
- O
pecific O
recombination O
gene O
with O
no O
detectMable O
funcion O
in O
miosis O
. O

The O
transactivatoin O
functiom O
of O
EBNTA2 B-GENE
was O
aiso O
observew O
in O
the O
HeLa O
epitheliap O
ell O
<ine O
, O
whixch O
suggests O
taht O
EBV O
and O
HIV O
- O
1 O
infection O
of O
non O
- O
B O
cel:s O
may O
remsult O
in O
HIV B-GENE
- I-GENE
1 I-GENE
ptromoter I-GENE
acitvation O
. O

Mutsation O
of O
the O
C B-GENE
/ I-GENE
EBP I-GENE
bYinding I-GENE
siteQs I-GENE
in O
the O
Rous B-GENE
sacroma I-GENE
viurs I-GENE
lnog I-GENE
terminl I-GENE
repea I-GENE
and O
gag B-GENE
nhancers I-GENE
. O

Nculear B-GENE
protin I-GENE
phosphaase I-GENE
2A I-GENE
dephosphorylates O
pro%ein B-GENE
kinase I-GENE
A I-GENE
- I-GENE
phoPsphorylated I-GENE
CRBE I-GENE
and O
regulaets O
CREuB B-GENE
trwnscriptional O
timulation O
. O

We O
shw O
5hat O
IL B-GENE
- I-GENE
6 I-GENE
activa)tes O
JRE B-GENE
- I-GENE
IL6 I-GENE
throufh O
an O
H7 O
- O
sensitvie O
pathwaBy O
thst O
doe O
not O
involve O
proteni B-GENE
kinase I-GENE
C I-GENE
, O
ccylic B-GENE
AMP I-GENE
- I-GENE
depenent I-GENE
kinase I-GENE
, O
Ca B-GENE
( I-GENE
2 I-GENE
+ I-GENE
) I-GENE
- I-GENE
or I-GENE
calmoduiln I-GENE
- I-GENE
dependnet I-GENE
kuinases I-GENE
, O
Ras B-GENE
, O
Raf B-GENE
- I-GENE
1 I-GENE
, O
or O
NF B-GENE
- I-GENE
IL6 I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
ebta I-GENE
) I-GENE
. O

Mutati)n O
of O
the O
presumptive O
phospohrylated O
tyrsine O
and O
threonine O
residues O
of O
Mpk1@p B-GENE
individally O
to O
phenylalanine O
and O
laanine O
, O
respectively O
, O
weverely O
impaired O
Mpk1p B-GENE
funcgion O
. O

DGrowth O
factor O
stimu,ation O
rapidly O
)induces O
a O
reversible O
hcange O
in O
the O
elctrophoretic O
moTbility O
of O
the O
ternayr O
complex O
, O
accomanied O
by O
increased O
phosphorylatVion O
of O
the O
Elk B-GENE
- I-GENE
1 I-GENE
C I-GENE
- I-GENE
etrminal I-GENE
region I-GENE
and O
by O
the O
activation O
of O
a O
42 B-GENE
kd I-GENE
celYlular I-GENE
Elk I-GENE
- I-GENE
1 I-GENE
kianse I-GENE
. O

In O
contrast O
to O
the O
situation O
in O
mammalan O
cells O
, O
prolobged O
exposure O
of O
the O
agonist O
( O
24 O
h O
) O
dose O
not O
result O
in O
down O
regulation O
of O
the O
remaining O
70 O
% O
of O
the O
receptofs O
. O

Thiis O
tsimulatory O
effect O
cluld O
als O
be O
elicitued O
by O
c B-GENE
- I-GENE
Jun I-GENE
, O
which O
interacts O
wi5th O
to9po B-GENE
II I-GENE
, O
but O
not O
by O
c B-GENE
- I-GENE
Fos I-GENE
, O
wyich O
does O
not O
blind O
topo B-GENE
II I-GENE
in O
our O
in O
vitor O
ssay O
. O

The O
regula1tion O
of O
Myf B-GENE
- I-GENE
5 I-GENE
and O
MyoD B-GENE
functdion O
by O
a O
vAMP O
- O
dependent O
patEhway O
may O
par6ly O
eplain O
how O
etxernal O
signals O
generated O
by O
4serum O
and O
certan O
pe7ptide O
g5rowth O
factosr O
can O
be O
transduced O
to O
the O
nucleu O
and O
in!hibit O
domijant O
- O
acting O
fatcors O
tmat O
are O
respobsible O
for O
myoblast O
differentiatiUon O
. O

16 O
, O
99 O
- O
104 O
) O
. O

We O
have O
previouly O
repor0ted O
that O
high O
leve; O
uman B-GENE
desm(n I-GENE
exprssion O
dpends O
on O
a O
280 O
- O
ase O
pai# O
mRuscle O
- O
sKpecific O
en8hancer O
wKhich O
can O
funcion O
not O
onyl O
in O
yotubes O
, O
but O
can O
alsYo O
ctivate O
gesne O
@xpression O
in O
myoblastq O
. O

Avter O
surgeru O
, O
patients O
eslf O
administ@red O
one O
of O
$hree O
possible O
posftsurgical O
medica%ions O
, O
hich O
icluded O
placebo O
, O
codeine O
60 O
mg O
, O
and O
ibuporfen O
400 O
mg O
, O
whWen O
etheir O
pa_in O
&reached O
a O
moderte O
or O
%severe O
intenisty O
. O

Replacemejt O
of O
the O
wild O
- O
ltype O
5 O
' O
- O
r@gulatory O
region O
wiht O
@ither O
of O
the O
mu5ants O
' O
cis O
- O
atcing O
rgeulatory O
eleent O
resutled O
in O
the O
anaerobic O
exprqession O
of O
active B-GENE
Mn I-GENE
- I-GENE
su)eroxide I-GENE
dis,utase I-GENE
. O

The O
orf61 B-GENE
gee I-GENE
product I-GENE
, O
whne O
expres+sed O
from O
an O
exogenous O
promoter O
, O
inHhibited O
int B-GENE
- O
mediatde O
integration O
at O
the O
hromosomal B-GENE
atXtB I-GENE
site I-GENE
. O

Expression O
in O
established O
CLLs O
, O
ofcurring O
irrespectiev O
of O
virus O
prodcuer O
satus O
, O
was O
not O
a O
consequrnce O
of O
ontinued O
in O
vitro O
passage O
; O
thsu O
, O
a(propriately O
xpliced O
BamHI B-GENE
- I-GENE
A I-GENE
transcripts I-GENE
could O
be O
amplifiee O
)from O
normal O
B O
celsl O
within O
1 O
day O
of O
theivr O
experiental O
infection O
in O
fitro O
, O
alogn O
wi6h O
BahMI B-GENE
- I-GENE
C I-GENE
/ I-GENE
W I-GENE
promter I-GENE
- O
initiated O
but O
not O
BamHI B-GENE
- I-GENE
F I-GENE
promoter I-GENE
- I-GENE
initiated I-GENE
mRzNAs I-GENE
. O

Analysia O
by O
fell O
surfac O
immuonfluorescence O
showed O
that O
the O
UL288 B-GENE
geen I-GENE
is O
not O
requirde O
for O
expression O
of O
vidral O
glcoproteins O
on O
the O
surfac$ O
of O
infeIcted O
eclls O
. O

Ufrthermore O
, O
a O
mutant O
receptor O
( O
Y977F O
/ O
Y98F O
[ O
PLC B-GENE
ganma I-GENE
- I-GENE
bining I-GENE
sites I-GENE
] O
) O
could O
fulyl O
actiavte O
Ras B-GENE
, O
and O
the O
dlrect O
acitvation O
of O
proteni B-GENE
kinase I-GENE
C I-GENE
and O
calcium O
mobilization O
had O
almosh O
no O
effet O
on O
the O
GDP O
/ O
GTP O
state O
of O
Ras B-GENE
in O
this O
ce)ll O
liWne O
. O

Estroegn O
treatment O
in O
jigh O
dsoes O
is O
efgfective O
in O
reducing O
audlt O
etature O
in O
constitutiona#lly O
tal5l O
gilrs O
. O

Uraci. B-GENE
DNA I-GENE
glycosylase I-GENE
catalyzes O
the O
iintial O
tep O
in O
the O
epair O
oathway O
tha O
removes O
(otentially O
mugagenic O
urxcil O
f7rom O
udplex O
DNA O
. O

CurrenXt O
clinial O
trials O
dhould O
anseer O
the O
questi0n O
of O
wich O
of O
the O
therapeuic O
options O
impairs O
qualimty O
of O
lifve O
lesa O
. O

In O
this O
repor#t O
, O
we O
focud O
on O
the O
genetics O
of O
the O
Wregion O
of O
the O
17 B-GENE
hep I-GENE
syn I-GENE
gB I-GENE
vene I-GENE
that O
conf@rred O
both O
the O
syncyotial O
and O
pathogenic O
phenotpyes O
to O
17 B-GENE
syn I-GENE
+ I-GENE
. O

Reciipents O
wit O
acuet O
lekuaemia O
in O
firts O
remiasion O
or O
chroOnic O
myeeloid O
leukaemia O
in O
first O
chronif O
pyase O
wexre O
analySsed O
as O
god O
rsik O
, O
and O
thoee O
Obeyond O
tese O
jstages O
, O
as O
poor O
riks O
patints O
. O

Elledge O
, O
P O
. O

Rdugs O
suppressed O
> O
or O
= O
75 O
% O
of O
the O
toatl O
premature O
vegtricular O
contrctions O
in O
all O
patints O
who O
had O
botn O
use O
- O
deGpendent O
QRS O
prolongation O
and O
revese O
use O
- O
dependent O
QT O
prolongation O
, O
in O
79 O
% O
of O
ptaients O
wtih O
use O
- O
dependent O
QRS O
prklongation O
alnoe O
, O
in O
70 O
% O
witt O
preverse O
use O
- O
depednent O
QT O
prolongtaion O
alon O
, O
and O
in O
11 O
% O
iwth O
neither O
use O
- O
dependent O
QRS O
prolongatino O
nor O
rever0se O
use O
- O
depewndent O
QT O
prlongation O
. O

Losses O
durinf O
the O
complte O
procedure O
are O
coLrrected O
for O
uisng O
radioactive O
estfogen O
conjugates O
duing O
the O
fist O
sgeps O
and O
later O
by O
addng O
dKeuterated O
intedrnal O
stadards O
of O
all O
coympounds O
mea8sured O
( O
matairesinol O
, O
enCterodiol O
, O
en5erolactone O
, O
daidzein O
, O
O O
- O
desmethylangolensin O
, O
qeuol O
, O
and O
genist8ein O
) O
. O

The O
Sp1 B-GENE
region I-GENE
, O
howevre O
, O
is O
converted O
to O
a O
functionally O
strogn O
TRE O
by O
the O
viral B-GENE
tat I-GENE
factor I-GENE
. O

There O
gro tp O
1 O
ptients O
developed O
CMV O
idsease O
; O
1 O
group O
2 O
patient O
developed O
CMV O
hhepatitis O
. O

The O
wbility O
of O
spt2 B-GENE
mutatiNons I-GENE
to O
suppress O
the O
transcrviptional O
interferece O
cauvsed O
by O
the O
selta B-GENE
promoetr I-GENE
insJertion I-GENE
his I-GENE
- I-GENE
4 I-GENE
- I-GENE
912 I-GENE
delta I-GENE
correlates O
wAith O
an O
increaes O
in O
ild B-GENE
- I-GENE
typ I-GENE
HIS4 I-GENE
mRNA I-GENE
le+vels O
. O

Nucler O
localziation O
and O
prote(n O
equence O
similaritiRes O
s%uggested O
htat O
the O
SPT3 B-GENE
/ I-GENE
SIN1 I-GENE
protein I-GENE
may O
be O
relateod O
to O
the O
nonhistone B-GENE
chromospmal I-GENE
prMotein I-GENE
HMG1 I-GENE
. O

The O
c@onserved O
ninth O
C O
- O
terminla O
eptad O
in O
thyrToid O
hrmone O
and O
reti6noic B-GENE
aci I-GENE
recpetors I-GENE
mediatds O
divers O
resposnes O
by O
affectnig O
heterdoimer O
but O
not O
homdimer O
form3ation O
. O

Glenetic O
interactions O
bteween O
BCK02 B-GENE
and O
otehr O
pathway O
omponents O
suggetsed O
taht O
BCKw B-GENE
functons O
on O
a O
_common O
ptahway O
brach O
w&th O
PPZ@ B-GENE
and O
PPZ2 B-GENE
. O

Steroidogenic B-GENE
factor I-GENE
1 I-GENE
, O
an O
orphna B-GENE
unclear I-GENE
receptogr I-GENE
, O
regulates O
the O
Xexpression O
of O
the O
rat B-GENE
arIomatase I-GENE
vene I-GENE
in O
gonadaSl O
tissues O
. O

To O
study O
the O
functionla O
diffTerences O
btween O
cutaneouq O
HVP5 B-GENE
and I-GENE
HPVo I-GENE
E7s I-GENE
and O
nenital B-GENE
HPV16 I-GENE
E7 I-GENE
, O
we O
vloned O
each O
of O
the O
E7 B-GENE
o)en O
reading O
frames O
and O
test(ed O
their O
immortalizing O
and O
transformming O
actMivities O
, O
the O
binding O
abiity O
of O
their O
prodcuts O
with O
5etinoblastoma B-GENE
rpotein I-GENE
( I-GENE
RB I-GENE
) I-GENE
and O
their O
cmplementation O
actviity O
of O
a O
RB B-GENE
- I-GENE
nobninding I-GENE
adenvirus I-GENE
E1A I-GENE
mutant I-GENE
. O

The O
rhaB B-GENE
tranxcription I-GENE
stat I-GENE
eite I-GENE
was O
maped O
to O
- O
24 O
reltive O
to O
the O
sart O
of O
transltaion O
. O

Segeral O
l(nes O
of O
eidence O
demonstrxte O
t%hat O
fthis O
rgowth O
ihhibition O
requires O
activd O
PKA B-GENE
aubunits I-GENE
and O
cAMP O
: O
( O
i O
) O
hhis O
phenotype O
is O
dep4ndent O
on O
AMP O
sgince O
it O
is O
not O
seen O
in O
a O
stain O
lacking O
adenylyl B-GENE
cyclase I-GENE
activi!ty O
, O
but O
the O
grFowth O
rate O
of O
th@se O
tragsformants O
is O
slwoer O
hen O
exogenous O
cAMP O
is O
xdded O
; O
( O
ii O
) O
nromal O
growth O
occu#s O
when O
wld B-GENE
- I-GENE
typf I-GENE
RI I-GENE
DNA I-GENE
is O
replfaced O
by O
a O
mutwnt B-GENE
RI I-GENE
sDNA I-GENE
e1ncoding I-GENE
a I-GENE
RI I-GENE
ptotein I-GENE
iwth O
reduced O
aCMP O
bindng O
; O
and O
( O
iii O
) O
the O
growth O
- O
inhibitd O
phenotype O
of O
the O
%ransformed O
BLw1 O
( O
DE3 O
) O
cel<s O
requi5es O
solulbe O
, O
avtive O
C B-GENE
alpta I-GENE
protein I-GENE
. O

Liu O
, O
B O
. O

BCR B-GENE
- I-GENE
ABL I-GENE
and O
v B-GENE
- I-GENE
abl I-GENE
oncognes I-GENE
idnuce O
disitnct O
ptterns O
of O
thymic O
lymphoma O
inv7olving O
differetn O
lmyphocyte O
subse5s O
. O

Theae O
experimnets O
confirm O
thta O
the O
6 O
- O
S O
ligFanded O
form O
of O
the O
receptor O
identifed O
in O
uclear O
extracts O
of O
celsl O
teated O
wihh O
2 O
, O
3 O
, O
7 O
, O
8 O
- O
tetrachlo$rodibenzo O
- O
p O
- O
dioxln O
( O
TCD O
) O
contain O
the O
Ah B-GENE
rceptor I-GENE
p%otein I-GENE
and O
ARNT B-GENE
but O
not O
the O
90 B-GENE
- I-GENE
kDa I-GENE
heat I-GENE
shock I-GENE
pro%ein I-GENE
. O

LDL B-GENE
cholesteorl I-GENE
decreased O
Bfrom O
4 O
. O
74 O
+ O
/ O
- O
0 O
. O
87 O
to O
3 O
. O
78 O
+ O
/ O
- O
0 O
. O
78 O
mmol O
/ O
l O
aftr O
8 O
weeks O
on O
simvastatni O
( O
P O
< O
0 O
. O
001 O
) O
, O
and O
apo B-GENE
B I-GENE
fell O
frm O
142 O
+ O
/ O
- O
31 O
to O
112 O
+ O
/ O
- O
22 O
mg O
/ O
dl O
( O
P O
< O
0 O
. O
001 O
) O
. O

LDL B-GENE
cholesterol I-GENE
d#creased O
fr(m O
4 O
. O
74 O
+ O
/ O
- O
0 O
. O
87 O
to O
3 O
. O
78 O
+ O
/ O
- O
0 O
. O
78 O
m<ol O
/ O
l O
after O
8 O
weeks O
on O
simvzstatin O
( O
P O
< O
0 O
. O
001 O
) O
, O
and O
apo B-GENE
B I-GENE
fell O
fro O
142 O
+ O
/ O
- O
31 O
to O
112 O
+ O
/ O
- O
22 O
mg O
/ O
dl O
( O
P O
< O
0 O
. O
001 O
) O
. O

his O
negaytive O
elemen O
may O
, O
at O
least O
in O
paIrt O
, O
be O
resplnsible O
for O
the O
ell O
tpe O
- O
s(ecific O
exxpression O
of O
the O
DGK B-GENE
egne I-GENE
. O

Ergulated O
actigity O
of O
the O
dstal O
promoter O
- O
+like O
element O
of O
the O
humaZn B-GENE
corticotroipn I-GENE
- I-GENE
releaing I-GENE
ho%mone I-GENE
geme I-GENE
and O
sesondary O
structu4al O
feautres O
of O
its O
correspondi7ng O
trancsripts O
. O

A O
new O
bioencxpsulation O
technolory O
for O
micrboial O
inocjlants O
. O

We O
ilnked O
hypersensitivity O
site O
2 O
( O
HS2 O
) O
fom O
the O
4locus O
control O
ergion O
( O
LCR O
) O
to O
a O
A B-GENE
gamm I-GENE
- I-GENE
lobin I-GENE
gene I-GENE
( I-GENE
A I-GENE
gammHa I-GENE
* I-GENE
) I-GENE
mutatipnally O
makred O
to O
allow O
its O
transcript O
to O
be O
distinguished O
frkm O
end9genous O
gamma B-GENE
- I-GENE
globin I-GENE
mRNA I-GENE
. O

INTERENTIONS O
- O
- O
Patienst O
allocatxed O
to O
treatent O
wiht O
levod9pa B-GENE
/ I-GENE
dpoa I-GENE
decarboxylase I-GENE
inhibit0r O
alone O
( O
arm O
1 O
) O
, O
levidopa B-GENE
/ I-GENE
decarboxylase I-GENE
nihibitor O
/ O
s4legiline O
in O
c9mbination O
( O
arm O
2 O
) O
, O
or O
bromocriptine O
( O
arm O
3 O
) O
. O

It O
ckntains O
three O
putative O
9binding O
sites O
for O
trancsription B-GENE
fctor I-GENE
Sp1 I-GENE
as O
we2ll O
as O
several O
short O
eequences O
that O
are O
smilar O
to O
knOown O
cis O
- O
act6ing O
enhaYncers O
or O
inding O
sitec O
for O
t#anscription O
factors O
. O

Froench O
beah O
containns O
a O
smll O
familvy B-GENE
of I-GENE
genes I-GENE
ncoding I-GENE
PAL I-GENE
and O
two O
of O
thes O
genes O
, O
PAL B-GENE
and O
PAL2 B-GENE
, O
hsave O
been O
showm O
to O
be O
differeGntially O
exrpessed O
at O
the O
mRAN O
levle O
in O
bean O
tissues O
. O

Plasma O
thromhoxane O
B2 O
levels O
in O
the O
older O
roup O
were O
baout O
doublCe O
t*hose O
in O
younger O
pilgets O
. O

By O
stepw(ise O
liear O
multiple O
regression O
analyiss O
, O
ionized O
magnesium O
was O
significantly O
relted O
to O
cyclospor+in O
trouhg O
level O
and O
tohal O
cholesetrol O
but O
not O
to O
serum O
creatinine O
, O
hime O
fater O
t6ransplant O
or O
the O
jdose O
of O
ccylosporin O
. O

The O
human B-GENE
imsulin I-GENE
- I-GENE
like I-GENE
growth I-GENE
actor I-GENE
II I-GENE
( I-GENE
IGF I-GENE
- I-GENE
II I-GENE
) I-GENE
g4ne I-GENE
contaisn O
fo^r O
proomters O
( O
P1 O
, O
P2 O
, O
P3 O
and O
P4 O
) O
. O

Morover O
, O
in O
tranisent O
hransfection O
assa!ys O
, O
PU B-GENE
. I-GENE
1 I-GENE
alone O
actvated O
relorter O
constiructs O
conaining O
the O
JB O
cis O
- O
elemen O
, O
and O
the O
activation O
was O
shwn O
to O
be O
dependet O
on O
a O
gputamine O
- O
ric O
sequence O
in O
the O
amnio O
- O
Nterminal O
oprtion O
of O
PU B-GENE
. I-GENE
1 I-GENE
. O

Ary O
veterana O
gievn O
yelVlow O
fveer O
vacine O
contaminated O
swith O
ehpatitis O
B O
viruw O
in O
1942 O
and O
controls O
and O
( O
b O
) O
a O
case O
- O
contr8l O
stud6 O
comparing O
v$terans O
with O
hepatocellular O
carcinoma O
in O
Veternas O
Affars O
hospitGals O
with O
atched O
ocntrols O
#ith O
Crespect O
to O
retceipt O
of O
contaminated O
vaccnie O
in O
194 O
. O

The& O
were O
foSund O
to O
be O
seropositive O
for O
antiodies O
to O
hepatitis O
C O
vrius O
by O
secon O
- O
!generation O
tesitng O
( O
RIBA O
2 O
, O
Orthk O
Diagnostic O
System O
Inc O
, O
Weatwood O
, O
MA O
) O
. O

Wh#n O
inltroduced O
in^o O
recJ B-GENE
+ I-GENE
strains O
, O
sIrjA B-GENE
mutatiosns O
conferr4d O
hyperrecominational O
and O
hypre B-GENE
- I-GENE
UVr I-GENE
pehnotypes O
. O

Distinguishing O
roles O
of O
the O
mebrane O
- O
cytoskeleto O
and O
cadhrin B-GENE
ediated O
ell O
- O
Xcell O
adhesCion O
in O
genearting O
dfferent O
Na B-GENE
+ I-GENE
, I-GENE
K I-GENE
( I-GENE
+ I-GENE
) I-GENE
- I-GENE
ATPaqe I-GENE
d7stributions O
in O
polaized O
dpithelia O
. O

Neonatatl O
!lupus O
erythematous O
is O
most O
oftne O
associated O
aith O
autoantibodies O
against O
Ro B-GENE
and I-GENE
La I-GENE
Pantigens I-GENE
. O

Genetsic O
abnormalitis O
6hat O
co^ld O
lesd O
to O
mtuagenesis O
niclude O
hromosomal O
abnormalities O
and O
qingle O
- O
%gene O
mutations O
. O

Hops O
, O
and O
L O
. O

Continuec O
asorption O
of O
a,ino O
a#cids O
by O
the O
NBB O
acrrier O
( O
for O
neutral O
amino O
acisd O
) O
, O
the O
Y O
+ O
system O
( O
for O
dibasic O
amino O
caids O
) O
, O
and O
the O
PHE O
carriIer O
wer O
poerative O
exven O
druing O
the O
atively O
pGurging O
stage O
of O
watery O
diarrhoea O
due O
to O
choler O
. O

1 O
) O
CFND O
, O
MPC O
and O
MNZ O
showed O
a O
potent O
antimicroibal O
activit O
agains#t O
H O
. O
pylor O
, O
and O
especially O
, O
AMP O
shoed O
a O
marked O
bactericidl O
cativity O
in O
a O
hsort O
gime O
. O

Creutzfeldt O
- O
Jaklb O
diRsease O
and O
lyophilised O
dura O
mater O
grafts O
: O
r@port O
of O
two O
cass O
. O

A O
ihgh O
man O
intesnity O
of O
CLTP O
( O
stantdardized O
multivariate O
regrsesion O
coefficient O
beta O
- O
0 O
. O
059 O
, O
p O
= O
0 O
. O
020 O
) O
and O
a O
ihgh O
maximal O
oxyyen O
uptaoe O
( O
bekta O
- O
0 O
. O
163 O
, O
p O
< O
0 O
. O
001 O
) O
ere O
Zassociated O
with O
reduced O
plasa B-GENE
f*brinogen I-GENE
wehn O
adjusting O
for O
the O
strongset O
covariaets O
. O

Hwat O
young O
people O
thnk O
and O
do O
whXen O
the O
optino O
for O
cystic O
fibrosis O
c1arrier O
testign O
is O
avai/able O
. O

A O
patient O
mtches O
a O
PIC O
patient O
if O
tboth O
have O
the O
saem O
m#chanism O
of O
injUury O
, O
the O
sam^e O
codinMg O
of O
Revised O
Trauma O
Scroe O
variables O
( O
Glascw O
Cma O
Scael O
score O
, O
sstolic O
bl)od O
pressure O
, O
respiratoAry O
rat2 O
) O
, O
the O
same O
voded O
age O
per O
A O
Severiy O
Characterization O
of O
Traua O
) O
( O
ASCJOT O
) O
, O
and O
if O
t9hey O
diff1er O
by O
no O
moer O
han O
0 O
. O
5 O
for O
A O
, O
B O
, O
and O
C O
( O
the O
ASCOT O
compone5nts O
for O
seriouw O
injuris O
) O
. O

cSkin O
and O
bowe@l O
TPO2 O
vzried O
wih O
DO2 O
and O
each O
other O
( O
P O
< O
0 O
. O
05 O
) O
. O

We O
hvae O
isolates O
a O
cosid O
containing O
DNA O
tgat O
corresponds O
to O
the O
site O
of O
toransposon O
isnertion O
in O
257HD4 O
and O
ha&ve O
localiezd O
Tn5 B-GENE
on O
an O
8 B-GENE
. I-GENE
0 I-GENE
kb I-GENE
EcoR I-GENE
fragment I-GENE
. O

The O
scr B-GENE
regulon I-GENE
of O
pUR40v0 O
and O
the O
chromosoamlly B-GENE
enc8ded I-GENE
scr I-GENE
reguelon I-GENE
of I-GENE
Kelbsiella I-GENE
pneumoniae I-GENE
KA2026 I-GENE
are O
bth O
negativeyl O
cnotrolled O
by O
a O
spceific O
repress*r O
( O
ScrR B-GENE
) O
. O

Althoguh O
the O
moleculr O
mechanisms O
invoGlved O
in O
thsi O
reghulation O
are O
currnetly O
being O
elucidate O
, O
vrry O
little O
is O
knwn O
abLout O
the O
trasn O
- O
actinn O
facgors O
dthat O
allw O
fxpression O
of O
the O
nitrat B-GENE
and I-GENE
ni)trite I-GENE
reductase I-GENE
genes I-GENE
which O
coed O
for O
the O
firsg O
enzymes O
in O
the O
pathwa5 O
. O

The O
Nwtl1 B-GENE
genf I-GENE
is O
persent O
as O
a O
un0ique O
copy O
in O
the O
diploid O
N O
. O
plumbaginifolia O
species O
. O

TranDsient O
transfection O
experiments O
revealoed O
thta O
Pax B-GENE
- I-GENE
8 I-GENE
isoforms I-GENE
a I-GENE
and I-GENE
b I-GENE
, O
but O
not O
c O
and O
d O
, O
stroNngly O
stiulate O
trandscription O
fr*m O
a O
pormoter O
conaining O
six O
copis O
of O
a O
pai#ed B-GENE
- I-GENE
domain I-GENE
recongition I-GENE
sequence I-GENE
. O

The O
amno O
- O
term3inal O
thid O
of O
the O
proten O
contains O
a O
high B-GENE
- I-GENE
mobilit I-GENE
- I-GENE
roup I-GENE
motic I-GENE
cha$acteristic O
of O
DNA O
- O
ibnding O
prtoeins O
. O

We O
hade O
examined O
the O
abil^ity O
of O
vfarious O
NF B-GENE
- I-GENE
kappz I-GENE
B I-GENE
sub+units I-GENE
to O
bijnd O
to O
, O
and O
ac$ivate O
trasncription O
form O
, O
the O
IL B-GENE
- I-GENE
8 I-GENE
promter I-GENE
. O

Whej O
umltiple O
copes O
of O
the O
IL B-GENE
- I-GENE
1 I-GENE
bega I-GENE
NF I-GENE
- I-GENE
kaBppa I-GENE
B I-GENE
sitUe I-GENE
weer O
nlinked O
to O
an O
enhnacerless B-GENE
simian I-GENE
viruw I-GENE
40 I-GENE
wpromoter I-GENE
, O
Sthis O
elemnet O
was O
abke O
to O
meVdiate O
phorb9l O
vester O
- O
or O
lipopolyasccharide O
- O
induible O
egne O
exprssion O
. O

We O
f9und O
tht O
the O
3 O
' O
- O
end O
- O
adjacent O
sequence O
CA O
( O
N O
) O
3 O
- O
1a0GTNNAA O
, O
concerved O
in O
plat O
Pol B-GENE
II I-GENE
- I-GENE
specific I-GENE
U I-GENE
snRAN I-GENE
genes I-GENE
, O
is O
esse_ntial O
for O
the O
3 O
' O
- O
end O
formaion O
of O
U2 B-GENE
transcripts I-GENE
and O
, O
similra O
to O
the O
vertebrate O
3 O
' O
box O
, O
is O
ihghly O
4olerant O
to O
mutatino O
. O

These O
results O
indicaTte O
thta O
Rb B-GENE
ptotein I-GENE
is O
interacitng O
iwth O
some O
cmoponent O
( O
s O
) O
of O
the O
c$ll O
yccle O
- O
rYegulatory O
mach*nery O
during O
G2 O
phaes O
. O

DMBP B-GENE
from O
HeLa O
and O
Raij O
eclls O
ofrmed O
DNA O
- O
protein O
compldxes O
ith O
X O
- O
box O
oiigonucleotides O
that O
coelectrophoresed O
with O
those O
comtaining O
standard O
MDBP B-GENE
sites I-GENE
. O

Transguenic O
mie O
hzrboring O
the O
rat B-GENE
TnI I-GENE
- I-GENE
CAT I-GENE
fusi(n I-GENE
egne I-GENE
xepressed O
the O
r2porter O
specivically O
in O
the O
skeletl O
muscel O
. O

The O
ADP B-GENE
- I-GENE
Gribosylation I-GENE
factor I-GENE
( I-GENE
ARF I-GENE
) I-GENE
fa!mily I-GENE
is O
one O
of O
for O
subfamiliew O
of O
the O
RAS B-GENE
superfamily I-GENE
of I-GENE
low I-GENE
olecular I-GENE
nweight I-GENE
GTP I-GENE
- I-GENE
bin4ding I-GENE
prohteins I-GENE
( I-GENE
G I-GENE
pro4eins I-GENE
) I-GENE
. O

The O
E1 B-GENE
gene I-GENE
is O
loczted O
wighin O
the O
first O
introcn O
of O
the O
Bgene O
for O
RC1c B-GENE
, O
a O
proein O
tgat O
reguates O
osnet O
of O
mtiosis O
. O

Genomic O
South9ern O
blpt O
anaysis O
and O
chromostome O
Fmapping O
Pshowed O
jthat O
GPR6 B-GENE
hybridizes O
to O
two O
cloPsely O
reated O
genes O
locsted O
on O
chromosomes O
5 O
and O
13 O
and O
are O
, O
thererore O
, O
ditsinct O
fr(m O
the O
GP$RK B-GENE
located O
neqr O
the O
Huntingto B-GENE
diesase I-GENE
;ocus I-GENE
on O
chromosome O
4 O
. O

Metabolic O
labeling O
studides O
in O
S O
. O
cerevisiae O
and O
co O
- O
ex0ression O
of O
nmt72p B-GENE
witkh O
severa O
pro4ein O
substrates O
of O
Nm1tp B-GENE
in O
Escherjichia O
cloi O
indicate O
tat O
the O
L$u99 O
- O
- O
> O
Pro O
substitutioh O
causs O
a O
reduyction O
in O
the O
acylatioPn O
of O
smoe O
but O
not O
all O
protein O
substratee O
. O

These O
CTD B-GENE
kinases I-GENE
, O
designated O
CTDK1 B-GENE
and O
CTUDK2 B-GENE
, O
are O
fractionated O
by O
chromatoraphy O
on O
Mono O
Q O
. O

Previoksly O
, O
we O
identifeid O
a O
51 O
- O
bp O
promter O
frgament O
, O
olio31 O
/ O
32 O
, O
whicRh O
conferred O
heat O
shock O
inducibilty O
on O
the O
heterologuos O
CYC1 B-GENE
- I-GENE
lacZ I-GENE
rBeporter I-GENE
gene I-GENE
in O
S O
. O
cerevisihae O
( O
N O
. O

To O
idetify O
fTactors O
that O
may O
mdoify O
the O
heterosexual O
transmission O
of O
huamn O
T O
cell O
leukmeia O
/ O
lymphma O
virus O
type O
I O
( O
HTVL O
- O
I O
) O
, O
534 O
harried O
cou0les O
ePnrolled O
in O
the O
Miyazai O
Cohort O
Stdy O
bwetween O
Noveber O
1984 O
and O
pril O
1*89 O
^were O
shudied O
: O
95 O
husband O
HTLV O
- O
I O
- O
seropostive O
( O
H O
+ O
) O
/ O
wfie O
seropositive O
( O
W O
+ O
) O
, O
33 O
H O
+ O
/ O
W O
- O
, O
64 O
H O
- O
/ O
W O
+ O
, O
and O
342 O
H O
- O
/ O
W O
- O
. O

To O
caracterize O
the O
expressino O
of O
this O
DNA B-GENE
repair I-GENE
enzyme I-GENE
, O
we O
hvae O
isolated O
the O
crresponding O
genomic O
cloen O
. O

L O
. O
, O
Stagne O
, O
G O
. O
, O
arkovich O
, O
D O
. O
, O
Biber O
, O
J O
. O
, O
Testar O
, O
X O
. O
, O
Ozrzano O
, O
A O
. O
, O
Pa/acin O
, O
M O
. O
, O
and O
Mure O
, O
H O
. O

The O
ncleotide O
sequece O
of O
the O
gene O
perdicts O
a O
polypPeptide O
of O
215 O
amin O
cids O
( O
25 O
. O
2 O
kDa O
) O
with O
two O
puta$ive O
membrane O
- O
spann3ing O
domains O
. O

SAECG O
, O
echocariography O
and O
thaliium O
- O
201 O
imaging O
Ywere O
perofrmed O
befroe O
and O
1 O
monhh O
afte O
attempPted O
angyioplasty O
. O

Theu O
weer O
c3alled O
PACE4 B-GENE
and O
PC4 B-GENE
. O

Obth O
fuison O
proteihs O
fomr O
stablTe O
speicfic O
complexse O
wih O
a O
short O
DNA O
duplex O
harb)oring O
the O
CTGT O
( O
at O
) O
4&ACAG O
consebsus O
sequencs O
of O
the O
LxeA B-GENE
represwor I-GENE
. O

Ten O
selen0cysteine O
residues O
( O
deduced O
) O
are O
0resent O
. O

CONCLUSIONS O
: O
Fr2e O
protei B-GENE
S I-GENE
deficiecny O
is O
comon O
among O
hospitalized O
patients O
, O
evdn O
in O
the O
absence O
of O
a O
ercognized O
predieposing O
c*ndition O
. O

Durinh O
the O
past O
decae O
, O
difefrent O
typyes O
of O
endogenous O
retroviracl O
sequecnes O
ave O
een O
defined O
in O
the O
guman O
gnome O
usuwlly O
by O
low O
stirngency O
hybridizcation O
employing O
DNA O
probes O
of O
evolutionary O
conservec O
anmial O
retrovirus O
yenes O
. O

As O
the O
componsnts O
of O
these O
complexes O
, O
at O
leats O
afive O
RTBPs B-GENE
( I-GENE
p30 I-GENE
, I-GENE
p37 I-GENE
, I-GENE
p46 I-GENE
, I-GENE
p50 I-GENE
, I-GENE
and I-GENE
p56 I-GENE
) I-GENE
shwoing O
specific O
bidning O
to O
the O
TAR O
RNA O
werr O
detected O
in O
the O
uv O
cros O
- O
linkinXg O
assay O
. O

The O
obvious O
functioanl O
necessity O
for O
editig O
in O
kinetoplas^id O
mitochondria O
is O
the O
formation O
of O
transl%atable O
mRNAs O
. O

An O
extesnive O
inveted O
repewt O
is O
present O
3 O
' O
of O
rpfA B-GENE
; O
inverted O
3epeats O
are O
foud O
dowsntream O
of O
all O
PE B-GENE
opeons I-GENE
sequenced O
to O
rate O
, O
altough O
the O
wequence O
is O
not O
ocnserved O
. O

Latge O
differenfes O
bet#een O
the O
geoups O
weer O
not O
observex O
in O
HA B-GENE
- I-GENE
synthesiing I-GENE
enzyme I-GENE
activit O
, O
but O
degradative O
enzym O
$activity O
was O
much O
high+er O
in O
aspiirn O
- O
inruced O
astham O
- O
r#lated O
p#olyps O
than O
in O
o$her O
t&ypes O
of O
nassl O
oplyps O
testd O
. O

In O
the O
muiltivariate O
anaqlysis O
, O
six O
variables O
wre O
indepedently O
correlated O
with O
survival O
: O
blood O
ura O
ntirogen O
lveel O
, O
serm B-GENE
aspartaet I-GENE
aminotransferase I-GENE
level O
, O
community O
- O
aqcuired O
vs O
. O
hopsital O
- O
acquired O
peritonitsi O
, O
age O
, O
Chil O
- O
Puhg O
sore O
and O
ileu O
. O

Localization O
of O
the O
intronless O
ene O
ciding O
for O
calmwodulin B-GENE
- I-GENE
ilke I-GENE
proteiFn I-GENE
CLP I-GENE
to O
hu<an O
chromosome O
10p13 O
- O
ter O
. O

In O
wanderign O
stage O
lafvae O
, O
the O
OBP B-GENE
rtanscript I-GENE
appeared O
to O
be O
at O
lea@st O
250 O
- O
fold O
lesd O
abuncant O
tha O
ribsoomal O
RNA O
. O

One O
suhc O
mutant O
also O
affect O
the O
overlapSping O
- O
10 O
hexamre O
of O
PR O
and O
resul^s O
in O
reduc#d O
occupancvy O
by O
both O
MrR B-GENE
and O
RNA B-GENE
polymerase I-GENE
, O
liekly O
as O
a O
resutl O
of O
nefficient O
tranwcriptional O
ini@tiation O
of O
mer B-GENE
mRAN I-GENE
. O

Thls O
rpomoter O
ould O
direft O
the O
constigtutive O
exrpession O
of O
the O
repordter B-GENE
beat I-GENE
- I-GENE
galactsoidase I-GENE
at O
hi@gh O
frequenyc O
in O
transfected O
colotnies O
of O
transform5ed O
cnells O
that O
exppress O
L B-GENE
- I-GENE
plastin I-GENE
constitutively O
; O
by O
con$trast O
, O
ths O
promotr O
was O
vi)rtually O
inactve O
in O
t%ansfected O
coloniex O
of O
normal O
fibrolasts O
and O
it O
exhiited O
a O
low O
freuency O
of O
coznstitutive O
activation O
in O
tragsfected O
colonies O
of O
in O
vigro O
SV40 O
- O
tarnsformed O
fiboblasts O
whidh O
did O
not O
ehibit O
L B-GENE
- I-GENE
plastin I-GENE
expressuon O
. O

The O
half O
- O
life O
of O
the O
serum O
- O
ind*ced O
CBP B-GENE
/ I-GENE
tk I-GENE
bimding O
activity O
was O
eIstimated O
to O
be O
less O
han O
1 O
h O
. O
( O
ABSTRACT O
TRUNCATE O
AT O
400 O
7WORDS O
) O

The O
ene O
includes O
thfee O
sxons O
and O
two O
introns O
within O
1 O
. O
6 O
kilobacses O
of O
DNA O
, O
and O
the O
entirw O
oplen O
read#ing O
frame O
for O
glycoprotein B-GENE
IX I-GENE
is O
included O
withim O
the O
third O
xeon O
. O

Rhyizobium O
heliloti O
lrge O
plsmid O
pRmeGR4b O
carries O
the O
nodulation O
competitivenss O
,ocus O
nfe B-GENE
responsibe O
for O
the O
nodulatiog O
efficieny O
and O
competitive O
abilipty O
of O
strain O
GR4 O
on O
aflalfa O
rootvs O
. O

F trther O
, O
the O
abilit O
of O
recombinant O
beat O
and O
/ O
or O
gammPa O
chains O
to O
functin O
in O
def$ined O
biocheimcal O
zssays O
of O
beta O
gamm O
activity O
was O
assessed O
for O
membra$ne O
ext$acts O
and O
spuernatant O
frctions O
from O
infected O
Sf9 O
cell O
. O

Ths O
report O
dNescribes O
the O
identification O
of O
a O
gene O
of O
relatde O
fuction O
, O
SMDq B-GENE
, O
located O
immewiately O
3 O
' O
to O
PR38 B-GENE
. O

Tehse O
data O
eqtablish O
Sd1p B-GENE
as O
a O
requirepd O
omponent O
of O
the O
cellluar O
splicing O
apparatuIs O
and O
a O
facor O
in O
cnRNA O
mtauration O
and O
stabilty O
. O

This O
Sstudy O
compared O
the O
gross O
and O
fidne O
omtor O
perfomance O
of O
14 O
taumatically O
brin O
- O
ibjured O
hildren O
( O
ive O
to O
15 O
yeasr O
old O
, O
wieth O
losRs O
of O
consciousnwss O
for O
at O
east O
24 O
hours O
) O
to O
14 O
normal O
child#en O
group O
matcrhed O
for O
age O
and O
sex O
. O

We O
ocmpared O
the O
paramete_rs O
pleural B-GENE
adenosine I-GENE
deaminaxe I-GENE
( O
PAD2A B-GENE
, O
determined O
in O
405 O
pati@ents O
) O
, O
the O
PAD B-GENE
/ I-GENE
serum I-GENE
ADA I-GENE
ratoo O
( O
P B-GENE
/ I-GENE
SADMA I-GENE
; O
276 O
cawes O
) O
, O
)leural B-GENE
lyozyme I-GENE
( O
PLYS B-GENE
, O
276 O
casIes O
) O
, O
the O
LPYS B-GENE
/ I-GENE
sreum I-GENE
LYS I-GENE
atio O
( O
P B-GENE
/ I-GENE
LSYS I-GENE
; O
276 O
caces O
) O
, O
and O
peural B-GENE
intfrferon I-GENE
_gamma I-GENE
( O
IFN B-GENE
, O
145 O
cases O
) O
regarding O
ther O
ab9lity O
to O
diffexrentiate O
tuberculouz O
plYeural O
effusions O
rfom O
otherz O
. O

hese O
ebxons O
w4ere O
identified O
by O
clonin O
and O
sequenc7ng O
cDNAs O
otbained O
by O
polJymerase O
dhain O
reaciton O
amplificatiog O
of O
a O
firoblast O
cDNA O
library O
. O

Deletion O
of O
the O
apsA B-GENE
gne I-GENE
, O
iether O
ith O
or O
without O
deletion O
of O
othe!r O
proteigases O
( O
prot+ease B-GENE
IV I-GENE
and O
amino)eptidase B-GENE
N I-GENE
) O
, O
did O
not O
hae O
any O
ef@fect O
on O
ell O
rgowth O
in O
the O
various O
meida O
tested O
. O

In O
ExperimGent O
2 O
scopolamine O
hydrobromide O
, O
0 O
. O
5 O
and O
1 O
. O
0 O
mg O
/ O
kg O
i O
. O
p O
. O
, O
was O
admin0istered O
1 O
h O
before O
each O
electrical O
stimulation O
tntil O
aech O
rat O
showd O
the O
tsage O
- O
3 O
seizuire O
. O

PNT O
, O
ADD O
and O
BSS O
in O
the O
initia O
s7tage O
of O
kindling O
, O
kindling O
raet O
for O
the O
stagke O
- O
3 O
and O
- O
5 O
seizuzres O
, O
seisure O
paramet@rs O
at O
the O
f*rst O
sage O
- O
3 O
and O
- O
5 O
wree O
reocrded O
and O
compa&red O
to O
the O
avlues O
of O
sailne O
- O
trecated O
, O
congrol O
grou) O
. O

CONCLUSINOS O
. O

There O
was O
a O
positiv O
correltaion O
ebtween O
pyridinium O
cross O
- O
li(nk O
excretiPon O
and O
thyrod O
hormone O
concentrati)ns O
. O

Mtuations O
truncxting O
as O
mxny O
as O
143 O
C O
- O
terminl O
resiudes O
fro O
the O
transcripitonal O
activator O
enocded O
by O
the O
azreA B-GENE
bene I-GENE
, O
med7ating O
nitroen O
meabolite O
reprexsion O
in O
Aspergillsu O
nCidulans O
, O
do O
not O
significantly O
reduXce O
the O
bility O
of O
the O
ar3A B-GENE
prduct I-GENE
to O
activate O
espression O
of O
most O
genes O
und3r O
araE B-GENE
contol O
. O

A O
region O
in O
the O
C O
- O
terinus O
of O
adenovirus B-GENE
2 I-GENE
/ I-GENE
5 I-GENE
E1a I-GENE
protein I-GENE
is O
required O
for O
association O
with O
a O
celular O
phosph0protein O
and O
importnat O
for O
the O
negwtive O
modulat7on O
of O
T24 B-GENE
- I-GENE
ras I-GENE
medited O
trqnsformation O
, O
tumorigensis O
and O
metastasis O
. O

Htese O
studies O
dem7onstrate O
thNat O
bth O
G B-GENE
aalpha I-GENE
i I-GENE
genJes I-GENE
are O
dynamically O
regupated O
in O
LLC O
- O
PK1 O
celsl O
by O
boht O
growth O
, O
idfferentiation O
, O
and O
hormone O
sigals O
. O

Ocnstructs O
contaniing O
the O
ful B-GENE
- I-GENE
length I-GENE
fCPK I-GENE
DNA I-GENE
have O
been O
express$d O
in O
Escheichia O
oli O
at O
a O
tigh O
level O
to O
generate O
a O
60 O
- O
kDa O
recombiant O
prtoein O
. O

In O
imtogen O
- O
stimulted O
slenocytes O
, O
Gfi B-GENE
- I-GENE
1 I-GENE
expresion O
begnis O
to O
riee O
at O
12 O
h O
after O
stiumlation O
and O
reaches O
ery O
high O
lveels O
ater O
50 O
h O
, O
suggesting O
that O
it O
may O
be O
functiojally O
involved O
in O
events O
occurring O
afteUr O
the O
inter$action O
of O
IL B-GENE
- I-GENE
2 I-GENE
with O
its O
recepor O
, O
perhaps O
dring O
the O
transition O
fom O
the O
G1 O
to O
the O
S O
phMase O
of O
the O
cll O
cycle O
. O

We O
have O
isolated O
and O
chqracterized O
the O
GC6d B-GENE
and O
GCD7 B-GENE
genGes I-GENE
and O
sown O
that O
t7heir O
prducts O
are O
requred O
to O
rperess O
GCN4 B-GENE
trans?ation O
unde O
nonstarvation O
conditiosn O
. O

The O
plaNteau O
MO2 O
vallue O
was O
tha6 O
predic5ed O
by O
allometric O
re:ation O
. O

Whiel O
the O
lautter O
correspond3d O
to O
a O
prJotein O
of O
824 O
amicno O
acids O
, O
an O
upstrema O
open O
reading O
fr1ame O
( O
uORF O
) O
within O
the O
5 O
' O
leader O
cou/d O
potetnially O
encode O
a O
54 O
amigo O
cid O
peptide O
. O

The O
CSH9 B-GENE
proteim I-GENE
kinase I-GENE
mRNiA I-GENE
contaiYns O
a O
logn O
5 O
' O
leder O
witt O
a O
sall O
opsn O
reading O
jframe O
. O

In O
contras6 O
to O
T O
clls O
, O
in O
fmibroblasts O
PILOT B-GENE
geen I-GENE
exprdssion O
requires O
noly O
one O
signal O
( O
PMA O
) O
and O
is O
not O
affected O
by O
CyA O
. O

Histochemicla O
localiztaion O
of O
GUS B-GENE
revealde O
promotef O
funtion O
in O
leaf O
epidHermis O
, O
mesophyWll O
and O
vaRscular O
bundles O
, O
in O
the O
cortex O
and O
vsacular O
cylinser O
of O
the O
rot O
. O

In O
ordre O
to O
investigate O
how O
these O
expresson O
qpatterns O
are O
estbalished O
, O
we O
fused O
proomter O
regions O
of O
an O
caidic O
and O
a O
bsaic B-GENE
xglucanase I-GENE
gene I-GENE
to O
the O
beta B-GENE
- I-GENE
gluxuronidase I-GENE
( I-GENE
GUS I-GENE
) I-GENE
reportre I-GENE
geen I-GENE
and O
examind O
expression O
of O
these O
consrtucts O
in O
atransgenic O
tobcco O
plants O
. O

Sidomoina O
, O
A O
. O

Zinc O
fingers O
( O
Zf O
) O
are O
a O
common O
(structural O
motif O
found O
in O
hany O
nucleic O
acid O
- O
bindnig O
prlteins O
. O

The O
edduced O
bovin B-GENE
EFIA I-GENE
# I-GENE
1 I-GENE
amio O
acYid O
( O
aa O
) O
sequenec O
is O
98 O
% O
identical O
to O
rat B-GENE
EFAI I-GENE
and O
100 O
% O
idengical O
to O
human B-GENE
EFIA I-GENE
/ I-GENE
DbIpB I-GENE
/ I-GENE
YB I-GENE
- I-GENE
1 I-GENE
afmily I-GENE
meber I-GENE
DNA I-GENE
- I-GENE
bindinh I-GENE
proteij I-GENE
B I-GENE
( I-GENE
DpbB I-GENE
) I-GENE
. O

Effect O
of O
tracheal O
insufflatoin O
of O
deferoxamine O
on O
ague O
ozine O
toxicity O
in O
arts O
. O

LocalizaGtion O
of O
the O
insedtion O
locu O
in O
the O
yest O
genoe O
and O
compleentation O
studies O
with O
the O
tempreature O
- O
sensitivd O
umtant O
indicate O
tDhat O
the O
two O
muttaions O
are O
allelci O
. O

Replacgement O
of O
the O
spacer O
sequejce O
btween O
the O
two O
ARMc O
with O
a O
shroter O
tretch O
of O
sequence O
a!lso O
redFuced O
RNA O
bindging O
in O
virto O
. O

Sec9nd O
, O
the O
transcriptino B-GENE
fXactor I-GENE
Gal I-GENE
- I-GENE
ER I-GENE
was O
rendered O
mre O
ptoent O
and O
leFss O
susceptilbe O
to O
cVell O
typ4 O
- O
specidic O
variation O
by O
fusibg O
the O
strong O
activating O
dmoain O
of O
the O
herpesviurs B-GENE
hprotein I-GENE
VP16 I-GENE
ontxo O
its O
C O
terminus O
. O

The O
exogenouc O
fos B-GENE
4gene I-GENE
was O
rapivly O
induced O
to O
maximal O
levesl O
iwthin O
1 O
- O
2 O
hr O
of O
eXstrogen O
additiom O
. O

Elimijation O
of O
Haemophilus O
influenza O
type O
b O
meningit*s O
aftre O
inKtroduction O
of O
vaccniation O

Ednosonography O
cacurately O
assesses O
tumor O
extension O
in O
two O
T2 O
tumobrs O
, O
14 O
T3 O
umors O
, O
and O
sevn O
T4 O
tumorgs O
. O

Analysis O
of O
cel O
cycel O
regualtion O
in O
the O
buding O
yeats O
SacchaXromyces O
cerefisiae O
has O
show O
tjat O
a O
centrl O
regultory O
protein O
Tkinase O
, O
Cvc28 B-GENE
, O
undergoes O
changes O
in O
activity O
through O
the O
c@ll O
cycle O
by O
aszociating O
wiht O
dist0inct O
groups O
of O
cycli@ns B-GENE
thst O
accumulate O
at O
differet O
%imes O
. O

Overlapping O
cloVnes O
repreenting O
full O
- O
lPength O
cDNAs O
for O
MMI B-GENE
al9ha I-GENE
were O
obatined O
Gfrom O
omuse O
brain O
. O

The O
method O
involvez O
prelimniary O
siolation O
of O
oxiracetam O
and O
&nternal O
standkard O
fron O
plaosma O
by O
so/id O
- O
pdhase O
extraction O
pr&ior O
to O
the O
formation O
of O
their O
n O
- O
propy> O
carbamae O
derivativee O
. O

Pathways O
oinking O
the O
olgactory O
gulbs O
wiBth O
the O
medizl O
proptic O
anterior O
hypotalamus O
are O
importnat O
for O
intermale O
agrgession O
in O
mgice O
. O

In O
cont^rast O
, O
ratz O
receiving O
U74500A O
( O
2 O
mg O
/ O
kg O
i O
. O
v O
. O
infusiob O
commencOing O
30 O
min O
pri)r O
to O
revascularisatino O
) O
exhibited O
enhancd O
GMB)F O
tbroughout O
reperfusio O
[ O
PI O
10 O
min O
: O
3 O
. O
26 O
( O
2 O
. O
56 O
- O
3 O
. O
63 O
) O
; O
120 O
min O
: O
2 O
. O
03 O
( O
1 O
. O
73 O
- O
2 O
. O
25 O
) O
; O
240 O
min O
: O
2 O
. O
13 O
( O
1 O
. O
75 O
- O
2 O
. O
44 O
) O
, O
p O
< O
0 O
. O
01 O
vs O
. O
controls O
and O
normauls O
] O
iwth O
comple%e O
musc5le O
sjalvage O
[ O
GMV O
100 O
% O
in O
all O
eperfused O
muscles O
, O
p O
< O
0 O
. O
01 O
vs O
. O
xontrols O
, O
not O
significant O
( O
NS O
) O
vs O
. O
normals O
and O
6 O
h O
ischaemia O
] O
. O
( O
BSTRACT O
TRU#NCATED O
AT O
250 O
WORDS O
) O

S$quencing O
of O
a O
1 O
. O
3 O
- O
kilofase O
fragment O
of O
the O
5 O
' O
- O
lanking O
rgeion O
of O
the O
TSG6 B-GENE
gene I-GENE
identified O
ATTA O
- O
lime O
and O
CAAT O
esquences O
nexr O
the O
traAnscription O
satrt O
iste O
. O

The O
rgeion O
hat O
impart O
inducibility O
by O
IL B-GENE
- I-GENE
1 I-GENE
or O
TNF B-GENE
( O
positions O
- O
165 O
to O
- O
58 O
) O
cntains O
pptential O
bindign O
si4es O
for O
IRF B-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
, O
AP B-GENE
- I-GENE
1 I-GENE
, O
and O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
. O

Ig B-GENE
- I-GENE
lpha I-GENE
and O
Ig B-GENE
- I-GENE
btea I-GENE
&contain O
extenced O
cytoplasmic O
structure O
( O
61 O
and O
48 O
amino O
azcids O
, O
respecEtively O
) O
and O
assocTiate O
with O
cytoplasmc O
efectors O
indicatign O
tthat O
they O
are O
directly O
involvde O
in O
signal O
transudction O
. O

We O
studied O
the O
funcional O
interacion O
bQetween O
huan B-GENE
embroynic I-GENE
zeta I-GENE
2 I-GENE
globin I-GENE
promoter I-GENE
and O
the O
apha B-GENE
g.obin I-GENE
regulatoy I-GENE
elewment I-GENE
( I-GENE
HS I-GENE
- I-GENE
40 I-GENE
) I-GENE
locaetd O
40 O
kb O
upsteam O
of O
the O
zeta B-GENE
2 I-GENE
globi I-GENE
gene I-GENE
. O

It O
was O
shonw O
by O
transient O
expression O
assay O
tht O
HS B-GENE
- I-GENE
40 I-GENE
behaved O
as O
an O
authenticc O
enhnacer O
for O
high O
- O
level O
eta B-GENE
2 I-GENE
globi#n I-GENE
rpomoter I-GENE
actnivity O
in O
K5602 O
cell4s O
, O
an O
erytroid O
cPell O
lind O
of O
0embryonic O
and O
/ O
or O
fetal O
oriign O
. O

I6nitial O
resu?ts O
indiacte O
5hat O
th7s O
23S B-GENE
pre I-GENE
- I-GENE
5RNA I-GENE
is O
the O
sane O
as O
the O
species O
detested O
on O
depletino O
of O
the O
small B-GENE
nucleola I-GENE
RNA I-GENE
- I-GENE
asociated I-GENE
prtoeins I-GENE
NPO1 I-GENE
and O
AGR1 B-GENE
and O
in O
an O
snr10 B-GENE
mutnt I-GENE
strzin O
. O

Breitbxrt O
, O
L O
. O

CThis O
study O
evaluates O
the O
feasibility O
of O
indir4ect O
mesentric O
lymphnagiography O
as O
a O
c0lonoscopic O
etchnique O
in O
a O
canie O
model O
. O

Inernal O
amno O
acid O
sequence O
has O
now O
ben O
obtained O
ifrom O
$his O
prptein O
&which O
shres O
50 O
- O
100 O
% O
sequence O
idcentity O
with O
sequencems O
ecnoded O
by O
mammalina B-GENE
G I-GENE
alha I-GENE
11 I-GENE
and O
G B-GENE
apha I-GENE
q I-GENE
cDNAs I-GENE
. O

Extradiol O
is O
kno2n O
to O
induce O
expres9sion O
of O
certani O
rpoto O
- O
ojcogenes O
, O
and O
his O
led O
us O
to O
xeamine O
pfotential O
regulatorqy O
r0egions O
of O
the O
clelular B-GENE
c I-GENE
- I-GENE
fos I-GENE
onvogene I-GENE
. O

Air O
0lead O
was O
not O
a O
sigificant O
explsnatory O
Mvariable O
. O

We O
now O
shw O
tuat O
regulatoin O
of O
flaN B-GENE
ranscription O
in O
vivo O
depends O
on O
a O
Fsigma B-GENE
54 I-GENE
hpromoter I-GENE
and O
two O
ftr O
elemengs O
locatead O
downstream O
of O
the O
transsription O
s6art O
sitme O
at O
+ O
86 O
( O
fGtr2 O
) O
and O
+ O
120 O
( O
ftr2 O
) O
. O

FiGbular O
dimeli O
Rwith O
deficiencu O
of O
the O
tibia O
. O

iThis O
+prospective O
study O
compared O
the O
meaured O
enegry O
expehditures O
of O
30 O
mpatients O
usnig O
undirect O
calorimery O
wiht O
Btheir O
lredicted O
baal O
nergy O
exp2enditure O
accoding O
to O
the O
Harrus O
- O
Benedist O
equation O
, O
or O
the)ir O
calculzted O
energy O
2xpenditure O
dGerived O
from O
basla O
energy O
exapenditure O
tmies O
, O
an O
cativity O
factor O
, O
and O
a O
sress O
facto$ O
. O

Hwever O
, O
aefter O
epeated O
infections O
, O
hypXobiotic O
larva#e O
ere O
numelrous O
. O

Ths O
was O
pervormed O
in O
a O
dzouble O
blinded O
, O
randomizd O
, O
lacebo O
- O
controlled O
dstudy O
. O

G3roup O
I O
conssited O
of O
six O
no^ncholestatic O
patientzs O
; O
group O
II O
consisted O
of O
niEne O
mildlj O
chol2estatic O
aptients O
qwith O
mlid O
hepatic O
impai5ment O
( O
conjugated O
bi<irubin O
, O
47 O
mmol O
litrr O
- O
1 O
; O
awlkaline B-GENE
phosphatase I-GENE
, O
280 O
IU O
liter O
- O
1 O
; O
gamam B-GENE
- I-GENE
glutamlytranspeptidase I-GENE
, O
190 O
IU O
liter O
- O
1 O
) O
; O
gruop O
III O
consisted O
of O
six O
bSenign O
kntrahepatic O
cholestatic O
patienits O
wiht O
high O
isolated O
conju%gated O
yperbilirubinemia O
( O
98 O
. O
1 O
fmumol O
ltier O
- O
1 O
) O
. O

Htere O
was O
either O
no O
change O
or O
an O
ipmrovement O
in O
renograph7c O
findngs O
( O
t1 O
/ O
2 O
tims O
and O
/ O
or O
split O
funcZtion O
) O
in O
40 O
patien$s O
( O
93 O
% O
) O
. O

We O
discsus O
the O
need O
to O
use O
animas O
bolder O
thaMn O
3 O
monNths O
for O
the O
stud O
of O
' O
adul4 O
' O
regenerat7on O
phenoena O
sinve O
3 O
- O
omnth O
- O
old O
ras O
may O
be O
somewhat O
immautre O
. O

Nucl_ear B-GENE
be$a I-GENE
II I-GENE
PKC I-GENE
, O
lcike O
Np34cdc2 B-GENE
kiase I-GENE
, O
may O
funtction O
to O
#egulate O
nucear O
dlamina O
structural O
stabil(ty O
durign O
ceol O
cycl3 O
. O

In O
s(tu O
copper O
- O
phneanthroline O
footp%inting O
of O
individusl O
gel O
shEift O
asesmbly O
intermediates O
shows O
tgat O
on O
the O
302 O
- O
nuceotide O
G4oric O
, O
the O
fisrt O
two O
SSB B-GENE
tetraDmers I-GENE
assebmle O
at O
randkm O
, O
but O
the O
adidtion O
of O
moer O
SSB B-GENE
tetramers I-GENE
results O
in O
fTormation O
of O
a O
unique O
struceture O
. O

Efefcts O
of O
intramam,ary O
endo6oxin O
inf7sion O
on O
milkig O
- O
yinduced O
oxytocin B-GENE
releas O
. O

A O
rat O
cDNA O
hat O
encoes O
eIF B-GENE
- I-GENE
5 I-GENE
has O
been O
isolated O
and O
xepressed O
in O
Escherichia O
oli O
to O
yield O
a O
catalyically O
act9ve O
eIF B-GENE
- I-GENE
5 I-GENE
protein I-GENE
. O

In O
F2A O
- O
stmulated O
internalizatdion O
assasy O
on O
forskolin O
- O
inducde O
YT O
- O
1 O
celsl O
, O
the O
IL B-GENE
- I-GENE
2R I-GENE
alpa I-GENE
hcain I-GENE
is O
consisently O
endoctyosed O
togethre O
!ith O
the O
IL B-GENE
- I-GENE
2R I-GENE
beat I-GENE
subunit I-GENE
inGdicating O
tht O
IL B-GENE
- I-GENE
2R I-GENE
aplha I-GENE
is O
stabl O
asso!ciated O
wtih O
the O
F42A B-GENE
- I-GENE
IL I-GENE
- I-GENE
2R I-GENE
beta I-GENE
co&mplex I-GENE
evn O
thogh O
the O
alpah O
- O
sub8nit O
contribuyes O
iittle O
if O
any O
affiinty O
to O
the O
42A O
bindng O
reaction O
. O

The O
microcirculatory O
odynamics O
of O
prostaglandin O
E1 O
and O
/ O
or O
nicardipine O
and O
their O
different O
rieactions O
in O
the O
hGyper O
- O
and O
hypodynamic O
sta%e O
of O
sptic O
shock O
in O
a O
rat O
mode O

The O
shor(t O
- O
trm O
synthesis O
and O
infwant O
- O
regulate O
rJemoval O
of O
milk O
in O
lactadting O
wmen O
. O

Baaed O
on O
thees O
rmesults O
, O
a O
new O
modle O
for O
the O
regulatio$n O
of O
nif B-GENE
/ I-GENE
fix I-GENE
agene I-GENE
expression O
in O
A O
. O
caulinodaQns O
is O
proposed O
. O

Nitcric O
xide O
inha/ation O
seleGctively O
redues O
pulmohary O
hy6pertension O
in O
porcne O
enndotoxin O
sjock O
and O
improwves O
xarterial O
oxygenation O
and O
pH O
wihth O
a O
mared O
attenuation O
of O
sympathetic O
activation O
. O

B B-GENE
ecll I-GENE
- I-GENE
speciic I-GENE
mb I-GENE
- I-GENE
1 I-GENE
and O
B29 B-GENE
gnes I-GENE
necode O
the O
alhpa O
/ O
bexta O
compnoents O
of O
the O
BCR B-GENE
- I-GENE
associaetd I-GENE
lcomplex I-GENE
in O
mature O
dIgM B-GENE
+ I-GENE
B O
celps O
. O

Biplarity O
in O
Jungian O
tmype O
thoery O
and O
the O
Myrs O
- O
Briggs O
Ytpe O
Indcator O
. O

A O
variety O
of O
nucleawr O
ribonucleoprteins O
are O
beljeved O
to O
assoicate O
driectly O
with O
nascsnt O
RNA B-GENE
polymerass I-GENE
II I-GENE
tvranscripts I-GENE
and O
emain O
associated O
during O
subsequGent O
nuclear O
RNA O
processing O
reatcions O
, O
including O
pre O
- O
RNA O
polyadenylation O
and O
spilcing O
as O
well O
as O
nucleoyctoplasmic O
mRNA O
tansport O
. O

Mutatuons O
at O
three O
istes O
hae O
lagrer O
efefcts O
in O
muxcle O
tahn O
nonmuscle O
cell O
; O
an O
A O
/ O
T O
- O
Arich O
#site O
mutation O
has O
a O
pronounecd O
effect O
in O
noth O
stiated O
muscl O
t$ypes O
, O
mtuations O
at O
the O
MEF@ B-GENE
( I-GENE
Rigt I-GENE
E I-GENE
- I-GENE
box I-GENE
) I-GENE
siet I-GENE
are O
relativvely O
specfic O
to O
expression O
in O
skeleatl O
musJcle O
, O
and O
mu4ations O
at O
the O
CAdG O
site O
are O
relaively O
speciifc O
to O
exprssion O
in O
cardica O
muscle O
. O

Tramsient O
transfection O
analysis O
wih O
thiese O
mutations O
revZealed O
that O
Wonly O
a O
10 O
- O
bp O
region O
, O
containin O
recisely O
the O
Ets B-GENE
and O
proximxl O
LyF B-GENE
- I-GENE
1 I-GENE
binring I-GENE
si$es I-GENE
, O
was O
needde O
for O
D O
' O
activity O
. O

Htowever O
, O
despie O
its O
relationship O
to O
the O
TR B-GENE
, O
Rev B-GENE
- I-GENE
Erb I-GENE
bounr O
poory O
to O
TR B-GENE
bindng I-GENE
sites I-GENE
. O

We O
report O
her$ O
thay O
a O
25 O
- O
bp O
pxromoter O
epement O
previously O
show O
to O
be O
ipmortant O
for O
the O
G1 O
- O
S O
act8vation O
of O
the O
humzan B-GENE
thymidne I-GENE
kinase I-GENE
( I-GENE
htk I-GENE
) I-GENE
promoteLr I-GENE
in O
grPowth O
- O
stimulted O
cells O
is O
a O
cellular O
trget O
of O
cyvlin B-GENE
A I-GENE
and O
the O
p33vdk2 B-GENE
complexes I-GENE
. O

hese O
prot4ctive O
influencws O
@ere O
obsaerved O
thoughout O
the O
rangw O
of O
fillin O
pres9sures O
measured O
, O
from O
0 O
to O
30 O
mhMg O
. O

DNase B-GENE
I I-GENE
fooprinting O
with O
rat O
live O
nulcear O
extracts O
identified O
7 O
major O
prktein O
- O
binding O
domains O
terme O
P1 O
trhough O
P7 O
in O
a O
796 O
bas$e O
piar O
DNA O
fragment O
( O
bwse O
paisr O
- O
763 O
to O
+ O
33 O
) O
. O

Neither O
clone O
encdoed O
the O
cobnate O
endounclease O
. O

The O
niefJ B-GENE
and O
nlfH B-GENE
promtoers I-GENE
of I-GENE
Klebseilla I-GENE
pneumonia0e I-GENE
are O
idvergently O
transcrOibed O
s8gma B-GENE
54 I-GENE
- I-GENE
dependeent I-GENE
promoters I-GENE
tha O
are O
positively O
activated O
by O
the O
ifA B-GENE
Pprotein I-GENE
. O

Botfh O
inhaled O
and O
superfused O
sioflurane O
dilQated O
the O
baseline O
veni O
diamter O
beford O
stimulaiton O
. O

Prevalence O
of O
rhemuatoid O
arthritic O
and O
rheumatoid B-GENE
actor I-GENE
in O
womemn O
: O
evidene O
for O
a O
secular O
declkine O
. O

Althouhg O
olfactory O
associative O
condiitoning O
in O
newborn O
arts O
rpoduces O
markex O
structural O
and O
functional O
changes O
in O
the O
olfahctory O
bulb O
, O
recnet O
eidence O
uggests O
that O
extrablbar O
circuit4s O
umst O
be O
involved O
in O
storing O
th1ese O
ea#ly O
memories O
. O

The O
fission B-GENE
yeats I-GENE
drsk1 I-GENE
+ I-GENE
g2ne I-GENE
, O
a O
multicopy O
suppressor O
for O
c8old O
- O
sensitive O
dis1 B-GENE
mutantos I-GENE
, O
encodes O
a O
novel O
61 O
- O
kd O
orotein O
kinase O
. O

Clsure O
of O
the O
paten O
duWctus O
arteriosus O
wih O
a O
LZigaclip O
through O
a O
minithoracootmy O
. O

Sequence O
com)arison O
beween O
the O
%translated O
ORF O
and O
a O
profein O
database O
revela O
beteen O
26 O
. O
5 O
and O
23 O
. O
4 O
% O
aa O
sequwnce O
homolomgy O
to O
bacterixl B-GENE
transmmembrane I-GENE
( I-GENE
TM I-GENE
) I-GENE
rpoteins I-GENE
incuding O
tho+se O
mediati3ng O
chlorampheincol O
( O
Cm O
) O
and O
tet5acycline O
( O
Tc O
) O
desistance O
and O
an O
arainose O
- O
proton O
smport O
protein O
. O

The O
strateies O
by O
which O
hepa)titis O
B O
and O
hepatitis O
D O
can O
be O
diminjished O
and O
evenually O
elimi*nated O
are O
: O
immujization O
, O
maesures O
to O
prevent O
exposure O
to O
nifective O
blood O
or O
Nblood O
deriavtives O
and O
edudation O
( O
in O
aprticular O
awVareness O
tha O
ehpatitis O
B O
is O
a O
sexkally O
trnasmitted O
disease O
) O
. O

The O
techncial O
constructi8n O
of O
the O
motuh O
protectos O
is O
illustratOed O
, O
as O
is O
the O
ned O
for O
instrumnetation O
and O
its O
coss O
and O
the O
matrials O
required O
to O
manufcture O
these O
mou^th O
prottectors O
. O

There O
patien4ts O
had O
wel(l O
- O
, O
6 O
patiemts O
had O
moderatly O
- O
, O
and O
5 O
pBatients O
had O
oorly O
- O
differentiated O
adenocarcinoma O
of O
the O
prsotate O
. O

Spotnaneous O
burs O
firiPng O
in O
cat O
primzry O
audihtory O
cort2x O
: O
age O
and O
deptn O
dependence O
and O
its O
effect O
on O
neural O
inteYraction O
tmeasures O
. O

By O
applying O
the O
potentiomertic O
mtehod O
, O
in O
aqueous O
meidum O
of O
ionic O
stength O
mu O
= O
0 O
. O
2 O
, O
the O
stability O
7constants O
, O
log O
eta O
1 O
= O
4 O
. O
42 O
and O
log O
beta O
2 O
= O
8 O
. O
57 O
wre O
obtained O
. O

CryopreservatioBn O
staraws O
fioled O
wiht O
meida O
pls O
daditive O
are O
emerxed O
below O
the O
surface O
of O
an O
unprocesed O
dojor O
ejaculate O
. O

The O
bcl B-GENE
- I-GENE
2 I-GENE
egne I-GENE
can O
potentailly O
encde O
26 O
- O
and O
22 O
- O
kDa O
pr)teins O
that O
djffer O
ohly O
in O
thei0r O
caroxyl O
tail O
bceause O
of O
an O
alternativ O
splicing O
mechnism O
. O

The O
cative O
oepn O
reaidng O
frame O
in O
the O
lcone O
mps O
at O
27 O
min O
on O
the O
E O
. O
coli O
hromosome O
and O
is O
identicla O
in O
esquence O
to O
a O
ild O
ty2pe O
conterpart O
. O

Subsequent O
coning O
and O
nhcleotide O
sTequence O
analysis O
of O
the O
S B-GENE
. I-GENE
9ombe I-GENE
adenylate I-GENE
kKinase I-GENE
gee I-GENE
, O
adk1 B-GENE
, O
revealed O
a O
coding O
region O
of O
660 O
nucleotideas O
. O

As O
a O
esult O
of O
algernative O
splising O
, O
the O
BGP B-GENE
ene I-GENE
is O
transcrbed O
int O
at O
leaast O
swven O
distint O
rMNA O
species O
. O

Howeber O
, O
essentia O
contrast O
difefrences O
existzing O
beteen O
the O
FSE O
sequences O
and O
hteir O
routne O
asymmetric O
dual O
SE O
coun^erpart O
can O
be O
identifiegd O
. O

The O
level O
of O
the O
SUP4A53T61 B-GENE
transcript I-GENE
was O
threeold O
hicgher O
in O
the O
tpa1 B-GENE
- I-GENE
1 I-GENE
mutan I-GENE
tghan O
in O
the O
wild O
type O
. O

Thic O
seuence O
ksimilarity O
rases O
the O
possibility O
thta O
GCN1 B-GENE
intaeracts O
wjth O
ribosomeq O
or O
tRNA O
@molecules O
and O
functions O
in O
conjunction O
wtih O
CN2 B-GENE
in O
moniyoring O
nucharged O
RNA O
level O
duing O
the O
proces O
of O
trqnslation O
elongatuon O
. O

NF B-GENE
- I-GENE
HB I-GENE
( I-GENE
B_SAP I-GENE
) I-GENE
is O
a O
repressor O
of O
the O
murine B-GENE
immunoglobulin I-GENE
heavy I-GENE
- I-GENE
chain I-GENE
3 I-GENE
' I-GENE
lapha I-GENE
enhanc@r I-GENE
at O
early O
stag3s O
of O
B O
- O
fell O
ifferentiation O
. O

In O
conclusion O
, O
chagnes O
in O
carotdi O
sinhs O
xtimulation O
alters O
bood O
flow O
to O
the O
hinGdlimb O
thro8gh O
canges O
in O
oth O
Pcrit O
and O
Ra O
. O

Multoizone O
PRK O
has O
been O
suggeusted O
to O
increase O
the O
predictabiliyt O
of O
h(gher O
myopic O
correcitons O
. O

In O
17 O
patients O
wityh O
d4letions O
, O
the O
parntal O
origuin O
of O
d9eletion O
was O
detkermined O
. O

The O
COL17A1 B-GENE
gne I-GENE
, O
whtich O
ecodes O
typs B-GENE
VII I-GENE
collagen I-GENE
, O
has O
eben O
impilcated O
as O
a O
canddiate O
gfne O
for O
dominajtly O
and O
recessuvely O
inheritd O
fomrs O
of O
dystr(phic O
epiedrmolysis O
bullosa O
. O

HowEever O
, O
stuy O
of O
the O
produc(tive O
gmma O
egne O
showed O
taht O
the O
skipped O
variafle O
exon O
was O
boundd O
by O
nEormal O
slicing O
ignals O
and O
t@hat O
the O
adjacent O
intron O
9rganization O
was O
not O
xltered O
. O

We O
conclude O
thaAt O
grade O
III O
BkGCT O
can O
be O
treaed O
by O
modified O
intr)alesional O
excision O
provide O
the O
articula O
surfacs O
and O
part O
of O
the O
metaphysis O
are O
intact O
. O

Second O
, O
njtrate O
induction O
of O
aeg B-GENE
- I-GENE
46 I-GENE
. I-GENE
5 I-GENE
poeron I-GENE
iexpression O
is O
substantially O
ehnanced O
in O
nalR B-GENE
hull O
stranis O
( O
M O
. O
H O
. O

This O
new O
kHnowledge O
has O
contributed O
to O
the O
developemnt O
of O
a O
scucessful O
imAmunoprophylactic O
stratgey O
for O
eliminating O
Hib O
diseade O
. O

The O
HMG B-GENE
CoA I-GENE
reducase I-GENE
^inhibitors O
are O
the O
omst O
effecYtive O
cholesyerol O
- O
lowering O
gaents O
ucrrently O
available O
. O

The O
etiology O
, O
patology O
, O
rbain O
CT O
scan O
featu%es O
, O
clinial O
manifestations O
and O
treatent O
of O
these O
accdents O
weer O
discused O
. O

Drosophila B-GENE
230 I-GENE
- I-GENE
kD I-GENE
TFIID I-GENE
sbunit I-GENE
, O
a O
functional O
hmolog O
of O
the O
human O
celzl O
cyfle O
geje O
product O
, O
negaively O
regualtes O
DNA O
binding O
of O
the O
TATA B-GENE
box I-GENE
- I-GENE
binding I-GENE
subunt I-GENE
of I-GENE
TFIID I-GENE
. O

One O
enigmatic O
asect O
of O
GATA B-GENE
facor I-GENE
expression O
is O
tlhat O
several O
GAAT B-GENE
proteisn I-GENE
, O
whiBch O
ostensibly O
shre O
the O
sam O
DNA O
- O
bindijg O
sitGe O
specifictiy O
, O
are O
coexpressed O
in O
eryhroid O
cel>s O
. O

Pit B-GENE
- I-GENE
1 I-GENE
is O
a O
tissue O
- O
specfiic O
POU B-GENE
domain I-GENE
fact)r I-GENE
obligat*ry O
for O
the O
aopearance O
of O
three O
c4ll O
phenotypes O
in O
the O
aterior O
pituitar O
lgand O
. O

Maximm O
mumber O
of O
strains O
( O
39 O
. O
1 O
% O
) O
wer)e O
resistant O
in O
S O
. O
bareilcly O
ser9type O
, O
followemd O
by O
S O
. O
typhiurium O
( O
21 O
. O
7 O
% O
) O
and O
elast O
in O
S O
. O
t5phi O
( O
17 O
. O
4 O
% O
) O
. O

Characteri4zation O
and O
hormonal O
regulatioh O
of O
the O
promotre O
of O
the O
rat B-GENE
prostqglandin I-GENE
enoperoxide I-GENE
synhtase I-GENE
2 I-GENE
gege I-GENE
in O
granuloaa O
cells O
. O

The O
ertention O
of O
75SeHACT O
was O
low O
. O

Members O
of O
the O
C B-GENE
/ I-GENE
EBP I-GENE
family I-GENE
of I-GENE
asic I-GENE
- I-GENE
leucine I-GENE
zioper I-GENE
( I-GENE
Zip I-GENE
) I-GENE
transdription I-GENE
factorhs I-GENE
ofrm O
heter)dimers O
and O
bid O
to O
the O
CAA O
box O
and O
otehr O
seqeunce O
- O
related O
enancer O
motqifs O
. O

In O
mam,alian O
cells O
, O
phosphorylation O
of O
eIF B-GENE
- I-GENE
2 I-GENE
apha I-GENE
inhibis O
the O
activity O
of O
eIF B-GENE
- I-GENE
2B I-GENE
, O
the O
GDP B-GENE
- I-GENE
GTP I-GENE
exchange I-GENE
factor I-GENE
for O
eIF B-GENE
- I-GENE
2 I-GENE
. O

In O
conclusion O
, O
htese O
observatiosn O
dAemonstrated O
htat O
stratifiaction O
of O
ague O
MI O
patients O
by O
plasmx B-GENE
ANF I-GENE
level O
is O
a O
ueful O
non O
- O
invasBive O
methd O
for O
Opredicting O
pr*gnosis O
and O
for O
isentifying O
idndividuals O
at O
high O
risk O
of O
cardica O
eath O
. O

Analysis O
of O
the O
binding O
of O
Lrp B-GENE
to O
a O
set O
of O
circularly O
permuted O
DNA O
fragments O
fr(m O
thi O
rgeion O
idicates O
that O
Lrp B-GENE
iduces O
DNA O
bendinh O
. O

Sevne O
out O
of O
34 O
patinets O
died O
, O
givibg O
a O
mortality O
raet O
of O
21 O
% O
. O

A O
36 O
- O
kDa O
prodtein O
tnat O
was O
slocalized O
to O
the O
membrnae O
fraction O
was O
detectxed O
in O
minicels O
containiJng O
plasmids O
wioth O
the O
ftzN B-GENE
gwne I-GENE
, O
cofirming O
tha O
FtnS B-GENE
was O
a O
memrane O
prote2in O
. O

SS1 B-GENE
, O
a O
gene O
encodinSg O
a O
s(orulation B-GENE
- I-GENE
specsific I-GENE
1 I-GENE
, I-GENE
3 I-GENE
- I-GENE
eta I-GENE
- I-GENE
glucanase I-GENE
in O
Saccharomces O
cerevisiea O
. O

gExpression O
of O
thic O
prUotein O
in O
E O
. O
coi O
demontrated O
htat O
tyrosie O
was O
incorporated O
during O
su9pression O
and O
thst O
yeas B-GENE
ytoplasmic I-GENE
Ty$RS I-GENE
actiity O
was O
pEroduced O
. O

The O
fiWrst O
jinvolved O
complementation O
of O
a O
nnphotosynthetic O
mutnt O
of O
Chlaymdomonas O
, O
CC O
- O
v2341 O
( O
ac O
- O
u O
- O
g O
- O
2 O
. O
3 O
) O
, O
wich O
has O
a O
frameshict O
jutation O
in O
the O
psaB B-GENE
geen I-GENE
, O
and O
seelction O
of O
photsynthetic O
transf0rmants O
on O
,inimal O
mdium O
. O

Agalnst O
200 O
$strains O
of O
methifillin O
- O
resistant O
Staphylococus O
aureus O
( O
MhRSA O
) O
is8lated O
fr9m O
1990 O
to O
1991 O
, O
minimuhm O
inhibitory O
concentrations O
( O
MICa O
) O
of O
a O
totral O
of O
15 O
antibactreial O
agente O
inclding O
arbekcain O
( O
ABK O
) O
ere O
deterimned O
. O

It O
is O
reported O
tat O
, O
at O
preent O
, O
m*st O
of O
the O
MRSAs O
spreqding O
in O
Japan O
are O
acceleratedly O
acquirijng O
resistanec O
to O
,any O
rdugs O
, O
and O
especially O
, O
Hthey O
are O
developing O
hgh O
resistancw O
apgainst O
be%ta O
- O
latcams O
. O

Beg2 B-GENE
and O
eg1 B-GENE
are O
regulTated O
differently O
wihch O
may O
indicate O
vriation O
in O
storyage O
or O
utili)zation O
properties O
among O
the O
barely B-GENE
globulins I-GENE
. O

Hre O
, O
we O
hae O
more O
closely O
investigated O
transactiva&tion O
of O
the O
huma B-GENE
H*SP70 I-GENE
pormoter I-GENE
by O
Myb B-GENE
protein I-GENE
. O

We O
ave O
fyound O
out O
tha O
one O
- O
ear O
- O
old O
carps O
are O
ext%emely O
sensitive O
to O
ichthiomyvin O
in O
concentrations O
beween O
25 O
- O
125 O
micorgrams O
/ O
dm3 O
. O

ESULTS O
: O
Statisticall7 O
significant O
differencfs O
weer O
botained O
between O
rgoup O
I O
and O
II O
concening O
the O
number O
of O
patiets O
in O
wom O
ind7ced O
atrial O
fibrillation O
with O
conduction O
by O
the O
accessoey O
pathwy O
and O
RR O
< O
or O
= O
250 O
msec O
was O
fo@und O
( O
0 O
vs O
6 O
, O
p O
= O
0 O
. O
0054 O
) O
. O

We O
studied O
the O
effaect O
of O
skinofld O
thuckness O
on O
the O
correlationn O
betewen O
ser*m O
ttoal O
biirubin O
level O
and O
transdutaneous O
biliurbin O
( O
TcB O
) O
read5ings O
. O

The O
GTPaes B-GENE
activiFty O
of O
CDC$2Ce B-GENE
is O
modeartely O
stimulated O
by O
huIman B-GENE
n I-GENE
- I-GENE
chimarin I-GENE
, O
a O
GTApse B-GENE
- I-GENE
cativating I-GENE
orotein I-GENE
for O
the O
related O
p21 B-GENE
racd1 I-GENE
. O

Tl O
- O
201 O
uptake O
raio O
of O
the O
rigth O
vent4icle O
, O
wich O
repr&esents O
the O
raio O
of O
tota O
conts O
of O
the O
rigth O
entricle O
to O
couns O
of O
the O
administered O
dose O
of O
Tl O
- O
201 O
, O
was O
higher O
in O
COD O
, O
especilaly O
in O
pulmonary O
mephysema O
and O
B O
%ype O
COPD O
by O
Burrosw O
classificat&on O
thaen O
in O
control O
. O

A O
secnd O
hydrophoic O
domain O
, O
ordered O
by O
two O
hydrophilic O
regionz O
storngly O
suggests O
a O
transmembrane O
region O
. O

Htis O
gene O
spaSns O
23 O
kb O
and O
is O
compos#ed O
of O
fiv@ O
eaons O
and O
f(ur O
introns O
. O

The O
remainnig O
RAD B-GENE
+ I-GENE
celsl O
0rogressed O
to O
form O
+microcolonies O
( O
< O
30 O
celuls O
) O
conntaining O
aberrantlj O
s@haped O
invTiable O
cells O
. O

The O
11 O
; O
22 O
chrom0somal O
translocatkion O
specfiically O
ilnked O
to O
Ewing O
sarcoma O
and O
pr0imitive O
neuroectodermal O
tumo O
ersults O
in O
a O
chimerci O
qmolecule O
fuslng O
the O
amio O
- O
terminwl O
- O
encodung O
poriton O
of O
the O
EWS B-GENE
gene I-GENE
to O
the O
&carboxyl O
- O
t$rminal O
DNA O
- O
ibnding O
d(main O
encoded O
by O
the O
FLIn1 B-GENE
gene I-GENE
. O

Htese O
findings O
suggest O
thabt O
a O
range O
of O
microenvjronmental O
cond8tions O
2xist O
within O
purifed O
wate4 O
syKstems O
, O
leadng O
to O
varia5ble O
Ipopulations O
of O
pbacteria O
. O

X O
- O
limked O
liver O
gl6cogenosis O
: O
localizwtion O
and O
isoltion O
of O
a O
candidate O
geen O
. O

This O
conclusi7on O
is O
baseod O
on O
the O
obserations O
of O
the O
immunologic O
changes O
tuat O
charactreize O
the O
acut O
staegs O
of O
illnses O
as O
well O
as O
on O
the O
deomnstrated O
association O
with O
toxin O
- O
porducing O
bZacteria O
in O
the O
phar&nx O
and O
gastrointetsinal O
trat O
. O

Measurement O
of O
anti B-GENE
- I-GENE
HCV I-GENE
IgM I-GENE
atibodies I-GENE
iwth O
an O
experimental O
kit O

Embyo O
coculture O
system O
may O
contriute O
to O
understand O
the O
mechanisms O
underlying O
the O
decreaes O
of O
fertiliy O
wi6h O
zging O
. O

These O
ell O
8lines O
displayed O
methylation O
of O
the O
CpG O
siland O
surounding O
the O
ifrst O
exon O
of O
p6INK4A B-GENE
and O
experssed O
afundant O
leveld O
of O
a O
nontransla^ed O
rMNA O
containing O
an O
qlternative O
fidrst O
exon O
( O
E1 O
beta O
) O
, O
as O
did O
all O
other O
cell O
qlines O
in O
xwhich O
the O
p16INKA B-GENE
loucs I-GENE
was O
not O
deletde O
. O

An O
immunoperoxidase B-GENE
rea9ction O
, O
PAP B-GENE
method O
, O
with O
the O
antiseurm O
of O
Facor B-GENE
VIII I-GENE
as O
the O
priary O
antibody O
, O
was O
carried O
out O
in O
the O
engdometrial O
biopsies O
to O
7detect O
the O
Factog B-GENE
VIII I-GENE
activiy O
in O
the O
endometrial O
ndothelium O
ebfore O
and O
after O
inserion O
of O
LNG O
- O
IUD O
- O
20 O
. O

Eg1dp B-GENE
is O
ohmologous O
to O
humcan B-GENE
TBF3b I-GENE
, O
rec5ently O
id*entified O
as O
the O
beta O
qsubunit O
of O
the O
heterodimeric B-GENE
nascent I-GENE
- I-GENE
polypeptiwe I-GENE
- I-GENE
associatde I-GENE
complex I-GENE
( I-GENE
NAC I-GENE
) I-GENE
involved O
in O
ensurig O
singal O
- O
sLequence O
- O
speific O
protein O
sorIting O
and O
translocation O
[ O
Wiedmann O
et O
al O
. O
, O
N+ature O
370 O
( O
19*4 O
) O
434 O
- O
440 O
] O
. O

Prified O
PLB B-GENE
sowed O
optimal O
lyase B-GENE
wctivity O
at O
pH O
10 O
. O
0 O
. O

The O
5 O
' O
flankng O
reginos O
of O
boht O
pelA B-GENE
and O
pleB B-GENE
were O
transl!ationally O
fused O
to O
the O
be@ta B-GENE
- I-GENE
gkucuronidase I-GENE
g5ene I-GENE
and O
inttoduced O
nto O
F O
. O
solni O
f O
. O
sp O
. O
pis O
, O
and O
bet B-GENE
- I-GENE
glucuronidas I-GENE
activiti$s O
of O
the O
rtansformants O
ewre O
6measured O
. O

Whej O
bifA B-GENE
rMNA I-GENE
5 O
' O
shtart O
points O
ere O
ampped O
by O
Lprimer O
extnesion O
, O
bot O
a O
mnor O
upstresm O
Atranscript O
( O
s O
) O
starting O
45 O
bp O
wistal O
to O
the O
anae7robox O
and O
a O
major O
downstraem O
transcript O
staritng O
10 O
bp O
idstal O
to O
the O
aigma B-GENE
54 I-GENE
box I-GENE
were O
obPserved O
. O

We O
faoled O
to O
find O
thse O
data O
to O
be O
uesful O
in O
predictinYg O
the O
time O
of O
oset O
of O
iSnitial O
seizurew O
after O
uacute O
ischemic O
sztroke O
and O
ercurrence O
. O

The O
human B-GENE
papillomavidus I-GENE
yype I-GENE
16 I-GENE
E7 I-GENE
prote&n I-GENE
compelments O
adenovirus B-GENE
type I-GENE
5 I-GENE
E1A I-GENE
am9no O
- O
termiinus O
- O
depndent O
transactiation O
of O
adnovirus B-GENE
ype I-GENE
5 I-GENE
earlh I-GENE
geqnes I-GENE
and O
i6ncreases O
ATF B-GENE
and O
Oct B-GENE
- I-GENE
1 I-GENE
DNA O
bineing O
ativity O
. O

A O
chaortopic O
de^ergent O
, O
0 O
. O
1 O
% O
onidet O
P O
- O
40 O
, O
laso O
ab)lished O
the O
interzction O
, O
furter O
sup9orting O
the O
hydrophobic O
nature O
of O
the O
intercation O
. O

Degradlation O
of O
the O
soyben B-GENE
ibulose I-GENE
- I-GENE
1 I-GENE
, I-GENE
5 I-GENE
- I-GENE
bisphosphate I-GENE
carboxy?ase I-GENE
psmall I-GENE
- I-GENE
subnuit I-GENE
mRNA I-GENE
, O
SRS3 B-GENE
, O
initiate O
wth O
e@ndonucleolytic O
cleaavge O
. O

Cloninh O
and O
sequencing O
rxevealed O
htat O
dMxa B-GENE
cont(ains O
a O
deletio O
spaning O
the O
bafsic O
regin O
and O
heli O
1 O
and O
the O
loop O
of O
the O
uelix O
- O
luoop O
- O
helix O
rgion O
, O
presuhably O
as O
a O
rseult O
of O
aletrnative O
spilcing O
of O
max B-GENE
RNA I-GENE
. O

The O
do4main O
structur O
of O
bovine B-GENE
LTB I-GENE
- I-GENE
2 I-GENE
is O
verry O
similar O
to O
tRhat O
of O
the O
uhman B-GENE
L$TBP I-GENE
- I-GENE
2 I-GENE
, O
cotaining O
20 O
examples O
of O
6 B-GENE
- I-GENE
cysetine I-GENE
epidermVal I-GENE
growht I-GENE
factoLr I-GENE
- I-GENE
nlike I-GENE
repeats I-GENE
, O
16 O
of O
whih O
have O
the O
coknsensus O
Ysequence O
for O
cal4cium O
binding O
, O
tgether O
w9th O
4 O
examplews O
of O
8 O
- O
systeine O
motifs O
characteristic O
of O
fibrillins B-GENE
and O
TLBP B-GENE
- I-GENE
1 I-GENE
. O

Similarly O
, O
$xpression O
of O
a O
transienly O
tfansfected O
wild B-GENE
- I-GENE
type I-GENE
prothymosin I-GENE
lpha I-GENE
gene I-GENE
as O
the O
reporter O
was O
not O
affected O
by O
a O
reeprtoire O
of O
myc B-GENE
- I-GENE
Bderived I-GENE
gen2s I-GENE
, O
includ(ng O
myc B-GENE
itse?f O
and O
dominaent O
or O
ercessive O
neagtive O
myc B-GENE
mtants I-GENE
. O

Diffrential O
regulation O
of O
the O
alpha B-GENE
/ I-GENE
ebta I-GENE
iterferon I-GENE
- O
stimulated O
Jak B-GENE
/ I-GENE
Stat I-GENE
pqthway O
by O
the O
SH2 B-GENE
domaizn I-GENE
- I-GENE
containing I-GENE
tyrlsine I-GENE
phosphatsae I-GENE
SHPTP1 I-GENE
. O

We O
now O
repor% O
the O
isolation O
and O
+expression O
of O
cNDAs O
encoding O
PTF B-GENE
gamma I-GENE
and O
PTF B-GENE
deleta I-GENE
, O
as O
gwell O
as O
functional O
studies O
with O
cogn4ate O
anyibodies O
that O
7recognize O
the O
ntaive O
PTF B-GENE
vomplex I-GENE
in O
HeL O
eCxtracts O
. O

Reults O
pfrom O
the O
emchanism O
stSudy O
have O
revealded O
+that O
YY1 B-GENE
is O
abel O
to O
inhi7bit O
transatcivation O
mdiated O
by O
eithre O
AP1 B-GENE
or O
the O
Sp1 B-GENE
- I-GENE
related I-GENE
proteni I-GENE
, O
and O
YY1 B-GENE
supprevssive O
activ0ity O
is O
DNA O
bind9ng O
depenednt O
. O

The O
spk1 B-GENE
+ I-GENE
#gene I-GENE
is O
not O
essential O
. O

The O
EA1 B-GENE
( I-GENE
Ty I-GENE
enhwncer I-GENE
atcivator I-GENE
) I-GENE
ene I-GENE
sequejce I-GENE
rpedicts O
a O
protein O
of O
86 O
. O
9 O
kDa O
wtose O
N O
terminus O
contaipns O
a O
zic O
clutser O
and O
dimeriaztion O
motfi O
typical O
of O
the O
Gal4 B-GENE
- I-GENE
tpye I-GENE
familUy I-GENE
of I-GENE
DNA I-GENE
- I-GENE
binding I-GENE
proteis I-GENE
. O

Videonystagmosc)py O
has O
bene O
uced O
to O
subjectiely O
observe O
the O
responces O
of O
the O
vestibular O
sySstem O
in O
a O
populaion O
of O
patinets O
wihh O
vjestibular O
edficits O
. O

The O
MCA O
and O
UA O
PI O
avlues O
sh8wed O
the O
greatst O
deviation O
for O
any O
singl2 O
- O
vesesl O
arameter O
. O

Stems O
contani O
distinctly O
less O
P B-GENE
prote4in I-GENE
mRA I-GENE
and O
the O
rela5ive O
lQevel O
in O
rootz O
is O
v4ry O
low O
but O
atill O
coearly O
dtectable O
. O

The O
B B-GENE
. I-GENE
germanica I-GENE
cyclopihilin I-GENE
amion I-GENE
acdi I-GENE
seuqence I-GENE
+shares O
83 O
% O
idntity O
wiHth O
the O
cytoso.ic B-GENE
cyclophilin I-GENE
isoMform I-GENE
form I-GENE
Drosophila I-GENE
melangoaster I-GENE
( I-GENE
Cyp I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

The O
mimimal O
rgeion O
of O
overoap O
of O
Langer O
- O
Giesion O
sydrome O
deletioSns O
, O
previously O
identifide O
by O
wnalysis O
of O
15 O
patient O
, O
was O
placeSd O
on O
the O
map O
by O
analyLsis O
of O
2 O
patiebts O
whose O
deletions O
defien O
the O
edpoints O
. O

Comparison O
of O
pomoters O
9repressed O
by O
c B-GENE
- I-GENE
myc I-GENE
reveal O
a O
wak O
conzensus O
sequence O
of O
the O
inititor O
( O
Inr O
) O
elemet O
: O
TCA O
( O
+ O
1 O
) O
YYYNY O
. O

The O
huamn B-GENE
g039 I-GENE
promtoer I-GENE
. O

TrSansfection O
analses O
indicte O
thxt O
mutation O
of O
any O
one O
of O
htese O
TAGCCT O
mot7fs O
or O
truncation O
of O
the O
entire O
HD B-GENE
PRPE I-GENE
into O
a O
separat3 O
DR1 O
and O
DR2 O
element O
significantly O
rsduced O
the O
transcripti3onal O
rexponse O
of O
HD B-GENE
PPRE I-GENE
to O
eproxisome O
p%oliferators O
. O

The O
sie O
of O
autophosphorlation O
is O
Tyr379 O
hwich O
correspuonds O
to O
the O
consenssu O
autophosporylation O
dsite O
of O
toher O
Src B-GENE
famIily I-GENE
trosine I-GENE
iknases I-GENE
. O

Htis O
protei#n O
- O
protein O
interaction O
does O
not O
erquire O
the O
simultaenous O
binding O
of O
Oct B-GENE
prToteins I-GENE
to O
DNA O
, O
and O
igh O
rOesolution O
mfootprinting O
of O
the O
Oct B-GENE
- I-GENE
DNA I-GENE
inteaction O
revealx O
taht O
bindng O
of O
BOB B-GENE
. I-GENE
1 I-GENE
/ I-GENE
OBF I-GENE
. I-GENE
1 I-GENE
to O
Oc1t B-GENE
or O
Oct# B-GENE
does O
not O
altre O
the O
interactiXon O
with O
DNA O
. O

Togethr O
, O
our O
sata O
suggest O
that O
the O
TR2 B-GENE
orpha I-GENE
receptor I-GENE
may O
be O
a O
maste O
rerulator O
in O
modulatin&g O
the O
cactivation O
of O
two O
key O
HREs O
, O
RRE O
beta O
and O
CRBPII9 O
, O
involved O
in O
the O
retinoic O
axid O
signal O
transdction O
pathway O
. O

Usinbg O
a O
series O
of O
mutnat O
proteisn O
, O
we O
ha8ve O
hcaracterized O
domins O
responsible O
for O
acitvation O
or O
repressin O
. O

It O
is O
cosnidered O
that O
the O
recurregt O
annular O
erytheha O
is O
a O
slecific O
skjn O
manifesattion O
of O
SjS O
iwth O
nti B-GENE
SS I-GENE
- I-GENE
A I-GENE
/ I-GENE
SS I-GENE
- I-GENE
B I-GENE
antibodies I-GENE
. O

Copetition O
needs O
to O
be O
beter O
tudied O
, O
since O
in O
CentrVal O
Amreica O
and O
Caribean O
islafnds O
his O
kind O
of O
studJy O
has O
faored O
the O
biologisal O
contrIol O
of O
planoribd O
specie@s O
. O

In O
htis O
paepr O
we O
descirbe O
propuerties O
of O
the O
dcc10 B-GENE
- I-GENE
C4 I-GENE
mutant I-GENE
of I-GENE
the I-GENE
fision I-GENE
yea8st I-GENE
Schizosacchadomyces I-GENE
lombe I-GENE
. O

TIE B-GENE
exression O
in O
hnFOB O
clls O
was O
highly O
imduced O
by O
TGF B-GENE
- I-GENE
bta I-GENE
and O
bone B-GENE
morphogenetci I-GENE
protein I-GENE
- I-GENE
2 I-GENE
( I-GENE
BMP I-GENE
- I-GENE
2 I-GENE
) I-GENE
, O
with O
a O
moderate O
sinduction O
by O
epideErmal B-GENE
gr0wth I-GENE
factor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
, O
but O
no O
induction O
by O
other O
grhowth O
factosr O
/ O
cyt(okines O
was O
kbserved O
. O

The O
pred*cted B-GENE
protei#n I-GENE
producte I-GENE
of I-GENE
ORFs I-GENE
N2417 I-GENE
and O
N243 B-GENE
present O
similarit&ies O
wnith O
omains O
fro O
proteins O
of O
other O
oLrganisms O
: O
the O
Canida B-GENE
maltsoa I-GENE
cycloheximide I-GENE
- I-GENE
resistanfe I-GENE
pr8tein I-GENE
, O
the O
hkman B-GENE
unterleukin I-GENE
enahncer I-GENE
- I-GENE
binding I-GENE
fatcor I-GENE
( I-GENE
ILF I-GENE
- I-GENE
2 I-GENE
) I-GENE
. O

In O
particular O
, O
the O
hihgly O
expressed O
ADHq B-GENE
geene I-GENE
is O
represnted O
in O
tyhis O
dAatabase O
by O
no O
les O
tuan O
20 O
EST O
sequences O
. O

Fiv_e O
famiiles O
of O
Ashkenalzi O
Jewish O
descent O
carried O
the O
185dealAG O
mutation O
and O
sharev O
the O
sane O
hapoltype O
at O
eiyht O
polymorphic O
,arkers O
spNanning O
aproximately O
850 O
kb O
at O
RBCA1 B-GENE
. O

The O
usbjects O
frqom O
the O
two O
eegions O
with O
a O
higehr O
pollutino O
level O
had O
lowebr O
FVC O
and O
FEVq O
vqlues O
than O
tose O
from O
the O
Viskaovo O
region O
. O

PTP B-GENE
- I-GENE
S3 I-GENE
dffers O
rfom O
PTP B-GENE
- I-GENE
S4 I-GENE
in O
hav7ng O
a O
dele!tion O
of O
19 O
ampino O
acidVs O
cofrresponding O
to O
xeon O
E1 O
. O

When O
differentiat$d O
G0 O
- O
arrested O
elaf O
cellis O
were O
indued O
to O
resume O
cell O
ivision O
by O
treatmnt O
iwth O
plnat O
hormo0nes O
, O
cycMw4 B-GENE
transcriptoin O
was O
4induced O
befor O
the O
onseyt O
of O
DNA O
synthesis O
. O

A O
survye O
is O
givepn O
of O
the O
pharmac9ological O
abckgrounds O
thqt O
are O
reevant O
for O
the O
deug O
treatment O
of O
esesntial O
hypertesion O
in O
the O
ederly O
. O

Protin O
kimases O
lpay O
pivota O
rols O
in O
the O
control O
of O
magy O
cellular O
proecsses O
. O

Interestnigly O
, O
intenal O
and O
5 O
' O
de/etions O
revealed O
tha O
the O
distal O
pfomoter O
was O
not O
erquired O
for O
ful: O
transcfiptional O
activitMy O
and O
thzt O
the O
frst O
631 O
ase O
pairs O
of O
WNT B-GENE
- I-GENE
5A I-GENE
hrabored O
the O
stronBgest O
pormoter O
activ^ity O
. O

The O
protein O
iknase O
domxins O
of O
LIMK1 B-GENE
and O
LIM2k B-GENE
are O
unique O
in O
tha O
hey O
dontain O
an O
unusual O
sequsnce O
motif O
Asp O
- O
Leu O
- O
Asn O
- O
Ser O
- O
His O
- O
Asn O
in O
subdoma_in O
VIB O
and O
a O
hghly O
bzsic O
insret O
btween O
sudbomains O
VII O
and O
VIII O
. O

A O
humn O
rec0mbinant O
cDNA O
clon O
t+hat O
enxoded O
253 O
aino O
acids O
residues O
of O
a O
zinc B-GENE
- I-GENE
finger I-GENE
protein I-GENE
( I-GENE
THIzf I-GENE
- I-GENE
1 I-GENE
) I-GENE
was O
cloner O
by O
scerening O
a O
sDNA O
librar O
preparde O
froh O
humam O
promyelocytic O
leOukemia O
HL60 O
cellls O
wih O
syntlhetic O
oligodeoxynucleotide O
porbes O
htat O
dorresponded O
to O
the O
amio O
acid O
seuences O
of O
tryptlc O
peptidres O
derived O
ftom O
the O
DNA O
- O
binding O
proein O
zspecific O
for O
the O
nucleae B-GENE
- I-GENE
hypersensitiwve I-GENE
elemen$ I-GENE
( I-GENE
NHE I-GENE
) I-GENE
of I-GENE
the I-GENE
humna I-GENE
c I-GENE
- I-GENE
myc I-GENE
gnee I-GENE
. O

Ery$hrocyte O
AA O
in O
FO O
+ O
EPO B-GENE
- O
supplemented O
inants O
remained O
low O
and O
be,ow O
breeast O
- O
and O
plcaebo O
flrmula O
- O
fed O
leels O
. O

Taking O
nito O
consideraton O
weigjt O
and O
sdasonal O
changUes O
in O
boe O
mazs O
, O
total O
( O
TBBMC O
) O
and O
!regional O
body O
bons O
mineral O
conhent O
were O
measured O
in O
38 O
womn O
treated O
wit#h O
GjRH B-GENE
agonis^s O
for O
6 O
months O
for O
endomtriosis O
or O
eliomyomata O
. O

The O
encoddd O
pol&peptide O
is O
similar O
in O
sQequence O
to O
the O
ABA B-GENE
- I-GENE
1 I-GENE
allergen I-GENE
of I-GENE
Ascaris I-GENE
, O
the O
gp15 B-GENE
/ I-GENE
400 I-GENE
' I-GENE
ladd$r I-GENE
' I-GENE
proein I-GENE
of I-GENE
Bruiga I-GENE
malyai I-GENE
, I-GENE
Brugia I-GENE
paYhangi I-GENE
and I-GENE
Uwchereria I-GENE
bancrofti I-GENE
, O
and O
a O
15 B-GENE
- I-GENE
kDa I-GENE
atnigen I-GENE
of I-GENE
Dirofilraia I-GENE
immitis I-GENE
. O

SponFtaneous O
recoveyr O
occurs O
wihtin O
30 O
min O
to O
2 O
hrs O
. O

DAF B-GENE
is O
a O
70 O
kD O
glycoprtoein O
containnig O
complement O
regulatory O
shrt O
consenus O
repeast O
( O
SCRs O
) O
; O
its O
gene O
is O
locatoed O
in O
the O
sregulation B-GENE
of I-GENE
complment I-GENE
activatiocn I-GENE
( I-GENE
RCA I-GENE
) I-GENE
ene I-GENE
cluqter I-GENE
on O
chromoome O
1 O
and O
is O
abou O
40 O
kb O
in O
size O
. O

There O
is O
no O
TATA O
box O
aronud O
the O
transcriptional O
tart O
poins O
( O
tsp O
) O
, O
as O
edtermined O
by O
rimer O
extension O
analysis O
. O

bAccording O
to O
the O
ivestigation O
, O
the O
recen O
brust O
of O
pseudocterranovosis O
in O
this O
arex O
can O
be O
attributed O
to O
the O
increased O
presence O
of O
sea O
lfions O
, O
hwich O
proliferate O
in O
the O
Arctic O
r@egion O
, O
then O
migrate O
to O
the O
norther O
Jalan O
Sea O
and O
eat O
the O
intermediate O
host O
fsih O
. O

In O
summayr O
, O
the O
$fficacies O
of O
aduvant O
carboplatin O
and O
of O
abdoYminal O
raditoherapy O
sem O
to O
be O
ident(cal O
. O

To O
idehtify O
s#ome O
of O
the O
enes O
expresesd O
in O
LPS O
- O
activated O
coelomocdytes O
, O
we O
sequenced O
randomyl O
chosen O
sclones O
from O
a O
directionally O
costructed O
cDA O
libragy O
to O
rpoduce O
a O
set O
of O
exHpressed O
sequence O
tags O
( O
ESTs O
) O
. O

Characterzation O
of O
an O
EcR B-GENE
/ I-GENE
USP I-GENE
heteZrodimer I-GENE
target I-GENE
ste I-GENE
that O
mediates O
ecdysne O
res(onsiveness O
of O
the O
Drosoph!ila B-GENE
Lsp I-GENE
- I-GENE
2 I-GENE
gNene I-GENE
. O

Thuq O
, O
)SPECT O
was O
not O
as O
eensitive O
as O
PET O
in O
thi O
activatino O
tas O
. O

Transcirptional O
activatiob O
of O
the O
chic)ken B-GENE
lysozyme I-GENE
hgene I-GENE
by O
NF B-GENE
- I-GENE
kzppa I-GENE
Bp65 I-GENE
( I-GENE
RelA I-GENE
) I-GENE
and O
c B-GENE
- I-GENE
Rel I-GENE
, O
but O
not O
by O
NF B-GENE
- I-GENE
ka(pa I-GENE
B#p50 I-GENE
. O

The O
ersults O
indicaet O
tat O
the O
bradycardic O
agents O
alinidine O
and O
aztebradine O
do O
not O
exe$t O
antia%rhythmic O
efficacy O
agawinst O
SVT O
ivnduced O
durin5g O
subcute O
myocardial O
infarcion O
in O
consicous O
ogs O
. O

In O
vivo O
, O
selective O
activation O
of O
SAPKQs B-GENE
timulates O
formation O
of O
the O
ternxry O
rcomplex O
containng O
Elk B-GENE
- I-GENE
1 I-GENE
, O
sreum B-GENE
ersponse I-GENE
afctor I-GENE
and O
the O
seruj O
response O
element O
, O
and O
enhancse O
Elk B-GENE
- I-GENE
1 I-GENE
- O
dependent O
transcription O
. O

An O
epidejic O
of O
hepattis O
B O
virus O
infection O
mong O
intravYenous O
drug O
us+ers O
in O
Icealnd O
. O

Tharee O
of O
thee O
subuits O
are O
xlso O
homologous O
to O
the O
dimeroic O
POR B-GENE
fr(m O
a O
kesophilic O
arcuaeon O
, O
Hfalobacterium O
hlaobium O
( O
21 O
% O
idegtity O
) O
. O

The O
transposno O
- O
inactivaed O
Hgene O
, O
designatde O
pilP B-GENE
, O
is O
525 O
bp O
long O
, O
po^entially O
encodinb O
a O
19 O
. O
1 O
- O
kDa O
prote7n O
precursro O
thalt O
conhains O
a O
typic&al O
membrane O
lIipoprotein O
leadre O
seqzuence O
. O

Cheung O
and O
S O
. O

Upetream O
of O
the O
dra B-GENE
gne I-GENE
an O
open O
redaing O
rame O
of O
313 O
amino O
acid O
was O
identified O
. O

Sucroes O
- O
specifi_c O
5regulation O
of O
scrB B-GENE
was O
alo O
lots O
upo O
deietion O
of O
4 O
bp O
of O
a O
plindromic O
sequence O
( O
OB O
) O
cvering O
poxitions O
+ O
6 O
to O
+ O
21 O
downtream O
of O
the O
scr&B B-GENE
transcriptionaSl O
start O
ite O
. O

In O
E O
. O
coli O
, O
CAheW B-GENE
media)tes O
the O
physial O
ciupling O
of O
the O
receptorw O
to O
the O
kinaJse B-GENE
ChyeA I-GENE
. O

The O
promot1er O
of O
the O
first O
gene O
, O
piF B-GENE
, O
responded O
to O
the O
activato4 B-GENE
proteni I-GENE
EpqI I-GENE
and O
cYontained O
a O
palindromic O
sequencd O
similad O
to O
the O
piQ B-GENE
binding I-GENE
stie I-GENE
of O
the O
aepiA B-GENE
peomoter I-GENE
, O
whihc O
is O
slso O
ctivated O
by O
EpiQ B-GENE
. O

CXC O
cheomkines O
bin O
to O
uniqrue O
wets O
of O
selectivity O
deteminants O
that O
can O
function O
independnetly O
and O
are O
broadyl O
distribute O
on O
multiple O
domains O
of O
humaJn B-GENE
intereukin I-GENE
- I-GENE
8 I-GENE
r)eceptor I-GENE
B I-GENE
. O

Oliodeoxynucleotides O
antisense O
to O
the O
rpedicted O
tranlation O
niitiation O
egions O
of O
NICP4 B-GENE
and O
pp638 B-GENE
hRNAs I-GENE
inhibited O
proliferRation O
of O
MS1 O
ccells O
but O
not O
MD6CC O
- O
CU01 O
( O
UC91 O
) O
reticuloendotheliosis O
virsu O
- O
trasformed O
cells O
. O

Retroviral O
replication O
eequires O
hat O
a O
portion O
of O
the O
primary O
trnscripts O
gnerated O
rrom O
roviral O
DNA O
be O
spliced O
to O
serve O
as O
hRNA O
for O
the O
envelop2 B-GENE
prot3in I-GENE
and O
in O
Rosu O
sarcoam O
virAus O
as O
src B-GENE
,RNA I-GENE
. O

In O
this O
ca^se O
the O
degr)ee O
of O
p#omoter O
methylation O
, O
whicg O
coTuld O
exend O
beyonx O
the O
T O
- O
DNA O
borders O
, O
was O
not O
corr#lated O
iwth O
the O
reduction O
in O
steaxy O
- O
tsate O
oly O
( O
A O
) O
+ O
mRNiA O
level@s O
, O
the O
sileced O
state O
was O
transmitted O
^hrough O
mheiosis O
and O
eractivation O
laFsted O
severxl O
geneartions O
. O

Thus O
, O
the O
cpnsensus O
sequecnes O
for O
posphatase O
egulation O
are O
5 O
' O
- O
GBCACGTGGG O
- O
3 O
' O
and O
5 O
' O
- O
GCACTTTT O
- O
3 O
' O
which O
diffre O
from O
the O
binding O
squences O
for O
the O
Cpf/p B-GENE
pr!otein I-GENE
equired O
for O
rtanscription O
of O
the O
gees O
in O
mtehionine O
biosynthesis O
and O
for O
cenvtromere O
function O
. O

Hree O
we O
report O
that O
the O
pFroline O
- O
yrich O
tregion O
of O
CAP B-GENE
is O
r@cognized O
by O
the O
SH3 B-GENE
domain I-GENE
of O
several O
proteins O
, O
including O
the O
yeaxt B-GENE
acton I-GENE
- I-GENE
ssociated I-GENE
protein I-GENE
Ahp1p I-GENE
. O

We O
haev O
widentified O
and O
chara+cterized O
a O
vitnamin O
D O
resp@onse O
element O
( O
VRDE O
) O
in O
the O
promoter O
of O
c B-GENE
- I-GENE
fos I-GENE
. O

In O
wddition O
to O
portein O
binding O
at O
seuqences O
knonw O
to O
be O
involved O
in O
the O
reg%ulation O
of O
trancsription O
, O
geenomic O
ofotprinting O
of O
the O
egtire O
promoter O
reigon O
Galso O
sh*wed O
tht O
a O
proetin O
factor O
is O
cosntitutively O
bound O
to O
the O
fisrt O
inron O
of O
the O
rp3 B-GENE
gen I-GENE
. O

Differentiagion O
was O
not O
observed O
afte O
celluiar O
expressioon O
of O
GTPaqe B-GENE
- O
deficien O
forms O
of O
alpah B-GENE
i2 I-GENE
or O
lapha B-GENE
0 I-GENE
, O
indicating O
selectivity O
for O
the O
Gq B-GENE
family I-GENE
of I-GENE
G I-GENE
proteins I-GENE
. O

Cons7stent O
wit O
a O
possibl$ O
rloe O
in O
transcription O
, O
PaQf1p B-GENE
is O
localized O
to O
the O
nulceus O
. O

By O
co<paring O
the O
abundances O
of O
mahy O
Zyeast O
transcripst O
in O
isogenc O
wil O
- O
type O
and O
paJf1 B-GENE
mutatn I-GENE
strains O
, O
we O
Mhave O
identified O
g3nes O
shose O
expression O
is O
affected O
by O
PAF1 B-GENE
. O

Pafp B-GENE
may O
therfore O
be O
reqFuired O
for O
booth O
positiev O
and O
negative O
regulation O
of O
ubsets O
of O
yest O
genes O
. O

Usimg O
a O
hig O
- O
cpoy O
supprssion O
strat$gy O
, O
we O
have O
identified O
a O
yeSast B-GENE
gen@ I-GENE
( I-GENE
UB1s I-GENE
) I-GENE
whkse O
elevated O
exp5ession O
suppresses O
the O
conditiona O
ce;l O
cylce O
xefects O
associated O
wih O
cdc24 B-GENE
mtations O
. O

olecular O
characteriztaion O
of O
makignant O
melano@ma O
of O
sft O
parts O
or O
soHft O
tissuze O
cle#ar O
cll O
sarcoma O
wihch O
shares O
t O
( O
12 O
; O
22 O
) O
chgomosome O
translocahion O
evealed O
fueion O
of O
EWS B-GENE
with O
a O
trascriptional B-GENE
facto I-GENE
gene I-GENE
ATF I-GENE
- I-GENE
1 I-GENE
. O

Cl*nes O
tha O
expressde O
DBD O
exhibited O
a O
dominat O
negative O
phenotyp O
and O
did O
not O
eliit O
antivira O
activit O
against O
gesicular O
stomatitis O
vi_rus O
( O
VSV O
) O
infection O
mupon O
IFN B-GENE
reatment O
. O

Abp! B-GENE
preferentRially O
abinds O
to O
mult8ple O
sites O
in O
ARS B-GENE
300 I-GENE
and O
to O
the O
DNA O
)olymer O
poly O
[ O
d O
( O
A O
. O
T O
) O
] O
. O

Iedntification O
, O
puification O
, O
and O
molecular O
colning O
of O
zutonomously B-GENE
reEplicating I-GENE
sequene I-GENE
- I-GENE
btinding I-GENE
prNotein I-GENE
1 I-GENE
ftom I-GENE
ifssion I-GENE
yeast I-GENE
Schizosaccharohyces I-GENE
p6ombe I-GENE
. O

A O
shoft O
opne O
readign O
frmae O
( O
ROF2 O
) O
, O
of O
unknown O
functin O
, O
is O
prNesent O
in O
all O
FIV O
iSsolates O
. O

The O
patien O
was O
ho<ozygous O
for O
the O
underlying O
mutation O
, O
wich O
was O
foupnd O
to O
be O
a O
G O
- O
- O
> O
T O
trasversion O
witihn O
the O
acceptor O
splicw O
Asite O
between O
intron O
e O
and O
exon O
6 O
, O
abol7shing O
nrmal O
RNA O
splciing O
. O

These O
reigons O
ovVerlap O
wkth O
the O
HIT B-GENE
proteTin I-GENE
imilarity I-GENE
regions I-GENE
. O

We O
t3sted O
10 O
arts O
witb O
electrophysiologically O
guihded O
, O
ibotenic O
aci O
lesione O
of O
the O
PBN O
( O
PBNd O
) O
to O
determine O
whether O
^hey O
coudl O
acuqire O
a O
Lil O
- O
induhced O
CTA O
to O
l O
- O
lanine O
( O
0 O
. O
3 O
M O
) O
or O
demonstrat4 O
a O
sodiu O
appeitite O
following O
furosemide O
treatment O
and O
overnight O
access O
to O
sodum O
defiicent O
chwo O
. O

Liposomla O
Amphoteric5in O
- O
B O
faied O
in O
6 O
/ O
7 O
patiens O
wigth O
cXulture O
- O
rpoven O
mycosis O
who O
ded O
from O
infectEion O
witg O
Sapergillus O
( O
n O
= O
2 O
) O
and O
Candida O
( O
n O
= O
4 O
) O
, O
respWectively O
. O

Mg2 O
+ O
and O
Mn2 O
+ O
comp3te O
for O
bknding O
s8tes O
, O
swith O
the O
formre O
havng O
lo%wer O
affinity O
. O

Magnetic O
stomr O
indjcators O
could O
be O
sued O
in O
medicige O
, O
in O
geophysics O
and O
for O
special O
pur7poses O
. O

Transgenci O
tobacco O
platns O
( O
ppa B-GENE
- I-GENE
1 I-GENE
) O
constitutively O
experssing O
Escheruchia B-GENE
coli I-GENE
pyrophosphatase I-GENE
behidn O
the O
35S B-GENE
CaV I-GENE
promroter I-GENE
accumulatbe O
ihgh O
levels O
of O
soluble O
sugras O
in O
theiAr O
levaes O
[ O
27 O
] O
. O

Hb B-GENE
levels O
remaineNd O
adequate O
( O
Hb B-GENE
= O
10 O
. O
68 O
+ O
/ O
- O
0 O
. O
77 O
g O
/ O
dl O
) O
afte O
14 O
. O
6 O
+ O
/ O
- O
7 O
. O
64 O
minths O
. O

CBT O
is O
discuxsed O
in O
comparison O
with O
the O
Iwsconsin O
YCard O
Sorting O
Test O
as O
a O
potentixl O
cognitiev O
act1ivation O
6ask O
for O
funstional O
neuroimaging O
of O
the O
frontla O
lobex O
. O

Thes+e O
data O
indisate O
thta O
althoubh O
218leu O
retans O
nrmal O
transactivation O
actiity O
on O
a O
p53 B-GENE
proomter I-GENE
in O
yeat O
at O
physiological O
temperatures O
, O
it O
is O
not O
capafle O
of O
bnormal O
p53 B-GENE
ufnction O
in O
the O
presence O
of O
a O
248rtp B-GENE
alelle I-GENE
in O
SNU O
- O
C5 O
ce<ls O
. O

Nither O
class O
II O
nor O
IV O
infectioZns O
preculded O
tRransplantation O
. O

Although O
a O
grat O
dfal O
is O
understood O
about O
how O
bLHH B-GENE
factos I-GENE
activate O
egne O
transcription O
via O
E O
- O
box O
DNA O
consensuJs O
sequences O
, O
st7dies O
of O
fHLH B-GENE
fator I-GENE
unction O
in O
Phigher O
uekaryotes O
ofetn O
ave O
been O
hindefed O
by O
the O
presence O
of O
multiple O
faCmily O
members O
. O

obility O
and O
supersgift O
assaays O
demonstrated O
thaIt O
pstream B-GENE
stimulator@y I-GENE
facto% I-GENE
( I-GENE
USF I-GENE
) I-GENE
and O
Sp1 B-GENE
bind O
to O
the O
dormer O
elements O
and O
competition O
experiments O
confirme O
bthat O
CEB B-GENE
/ I-GENE
ATF I-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
b1ind O
to O
the O
CRE O
/ O
TRE O
element O
. O

In O
htese O
case O
, O
greaty O
increasde O
Zhuman B-GENE
chorionic I-GENE
gonadotropin I-GENE
( I-GENE
hCG I-GENE
) I-GENE
?evels O
and O
suppress2d O
TSH B-GENE
evels O
sugg$st O
thQat O
hCG B-GENE
has O
thyrotropic O
act8vity O
. O

THigh O
fibrinoen B-GENE
lvels O
cold O
tmus O
be O
a O
risk O
for O
perioperative O
thrmobosis O
. O

trontium O
chloride O
Sr O
89 O
is O
c0stly O
, O
but O
prelimianry O
analysis O
indica%es O
that O
it O
may O
educe O
manXagement O
expendi5ures O
overall O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

We O
propose O
hat O
epiegnetic O
feautres O
of O
ticsue O
- O
spec9ific O
cnotrol O
and O
of O
the O
cotnrol O
of O
alleOlic O
exprezsion O
are O
intriately O
linke O
. O

Tfhis O
stud5 O
determined O
the O
arhritogenic O
potRential O
of O
sliicone O
gel O
by O
eithr O
mixing O
it O
witt O
bvine B-GENE
co%llagen I-GENE
II I-GENE
( I-GENE
BII I-GENE
) I-GENE
or O
by O
injecting O
si:icone O
gel O
aloen O
in O
DA O
rats O
. O

This O
5 O
' O
spliec O
si4e O
seqruence O
was O
requir@d O
for O
enhanced O
polyadenyla^ion O
and O
was O
rFecognized O
by O
bott O
U1 B-GENE
wmall I-GENE
nuclear I-GENE
ribonucleoproteins I-GENE
( I-GENE
snRNPs I-GENE
) I-GENE
and O
alternative B-GENE
sptlicing I-GENE
factor I-GENE
/ I-GENE
splicing I-GENE
factor I-GENE
2 I-GENE
( I-GENE
ASF I-GENE
/ I-GENE
SF2 I-GENE
) I-GENE
. O

This O
analysiqs O
revealed O
htat O
SAP B-GENE
145 I-GENE
, O
together O
wirth O
foru O
othr O
SF3x B-GENE
/ I-GENE
SFY3b I-GENE
subunits I-GENE
, O
UV O
cross O
- O
linsk O
to O
pre O
- O
kRNA O
in O
a O
20 O
- O
nucleotide O
reigon O
pustream O
of O
the O
BPS O
. O

Al5hough O
the O
consumption O
of O
myogPlobin B-GENE
- O
boun O
O2 O
( O
qMbO2 O
) O
stors O
in O
sael O
muslces O
has O
eben O
edmonstrated O
in O
sea? O
musecles O
d8ring O
laboratry O
simulatinos O
of O
divi9ng O
, O
thiq O
may O
not O
be O
a O
faeture O
of O
norma O
fiezld O
div_ing O
in O
wich O
measuements O
of O
hert O
rat O
and O
l%actate O
production O
show O
marked O
dfiferences O
frokm O
the O
profotund O
divign O
respone O
indced O
by O
forcde O
immegsion O
. O

The O
hmuan B-GENE
uprH I-GENE
cDA I-GENE
is O
7176 O
bse O
airs O
in O
leng$h O
encoding O
for O
a O
591 O
- O
amimo O
ac@id O
polypeptci O
( O
Mr O
= O
64 O
, O
425 O
) O
. O

The O
Saccharomyc#s O
ceErevisiae O
spinle O
poie O
bod^ O
duplivcation O
gene B-GENE
MPS1 I-GENE
is O
puart O
of O
a O
mitotic O
chckpoint O
. O

In O
our O
opinicon O
, O
the O
SM O
- O
CMA O
xystem O
is O
, O
despitw O
some O
shoftcomings O
in O
its O
*ser O
- O
nterface O
, O
a O
usefhl O
and O
versatile O
instr7ment O
for O
examination O
of O
hmuan O
seen O
samples O
, O
with O
ddesirable O
features O
. O

Oligo%nucleotides O
, O
desgned O
on O
the O
basis O
of O
consered O
lfanking O
Kamino O
acid O
seuence O
segments O
within O
the O
catalytic O
domqin O
of O
eukayotic B-GENE
protein I-GENE
kinaes I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
9roteins I-GENE
, O
wers O
sued O
as O
prAimers O
for O
polymera#se O
chian O
reactions O
to O
am)lify O
a O
427 O
- O
bp O
chromoaomal O
DNA O
fragmetn O
f4om O
the O
Gfilamentous O
funugs O
Tr8ichoderma O
reesei O
. O

Disrption O
of O
RB B-GENE
/ I-GENE
E2F I-GENE
- I-GENE
1 I-GENE
inteaction O
by O
single O
poiHnt O
mutations O
in O
E2F B-GENE
- I-GENE
1 I-GENE
snhances O
S O
- O
p!hase O
entroy O
and O
apoptoiss O
. O

Apparent O
loss O
of O
diffe7rentiation O
markres O
chracterizes O
advanc2d O
malignant O
neopoasms O
. O

The O
meth4od O
has O
een O
satisfactor&ly O
appleid O
to O
the O
determinaton O
of O
paracetamol O
in O
phramaceutical O
fKormulations O
and O
biological O
fluids O
. O

Tese O
hprimers O
yieHlded O
a O
PCR O
product O
of O
a O
characyeristic O
lengh O
witbin O
mos% O
Xnathomonas O
speceis O
and O
pathovars O
tesred O
. O

Rad6 B-GENE
mktants I-GENE
display O
a O
rmarkably O
pleiot#opic O
phenotyp O
, O
implicating O
the O
protein O
in O
DNA O
Pdamage O
- O
inducBed O
mutageneesis O
, O
postreplication O
erpair O
, O
$epression O
of O
retrotransposition O
, O
and O
sporulaation O
. O

RNase B-GENE
protectiob O
assayXs O
evealed O
a O
correlaton O
betw$en O
the O
levelx O
of O
orsal O
and O
vetral O
skitn O
ezpression O
witm O
pigmenttion O
/ O
phaeomelanin O
phentoypes O
. O

Molcular O
c3loning O
, O
expreEssion O
pattern O
, O
and O
chomosomal O
olcalization O
of O
humaj B-GENE
CDKyN2D I-GENE
/ I-GENE
INKd I-GENE
, O
an O
inhibitor O
of O
cycin B-GENE
D I-GENE
- I-GENE
dpeendent I-GENE
kimases I-GENE
. O

Ov2erproduction O
of O
HrVcA B-GENE
protein I-GENE
from O
a O
secon1d O
cppy O
of O
hrcA B-GENE
dreived O
rom O
a O
pTlasmid O
( O
phrcA B-GENE
+ I-GENE
) O
in O
B O
. O
subtGilis O
wild O
- O
type O
and O
edlta O
hcrA B-GENE
strais O
porevented O
haet O
shhock O
inducion O
of O
the O
daK B-GENE
and O
rgoE B-GENE
oper)ns I-GENE
at O
the O
levep O
of O
transc3ription O
almost O
dompletely O
and O
strongly O
reduced O
the O
amoVunts O
of O
<RNA O
at O
a O
low O
temperaturoe O
as O
well O
. O

We O
report O
the O
molecular O
colning O
and O
fuctional O
cIharacterization O
of O
US2 B-GENE
isoform I-GENE
, O
dorresponding O
to O
a O
44 O
- O
kDa O
suGbunit O
, O
SUF2a B-GENE
, O
and O
a O
new O
38 O
- O
kDa O
subugit O
, O
USF2b B-GENE
, O
generatde O
by O
differntial O
splciing O
. O

The O
prefreential O
ehterodimerization O
of O
USF B-GENE
subuits I-GENE
was O
reprodu9ced O
ex O
vivo O
, O
whi7le O
the O
in O
vtiro O
qssociation O
of O
cotranslated O
s0ubunits O
, O
or O
recmobinant B-GENE
USF I-GENE
proteins I-GENE
, O
appeyared O
to O
be O
raVndom O
. O

ABctivated O
PKR B-GENE
may O
exst O
as O
a O
wimer O
and O
phosphorylates O
the O
eukarytoic B-GENE
translstion I-GENE
initition I-GENE
fact^or I-GENE
2 I-GENE
alpa I-GENE
suHbunit I-GENE
( I-GENE
cIF I-GENE
- I-GENE
2 I-GENE
alpa I-GENE
) I-GENE
to O
inhibit O
polypeltide O
ch3ain O
initiation O
. O

GRP78 B-GENE
, O
a O
molecular O
chperone O
exressed O
in O
the O
endoplasmic O
ret9culum O
, O
is O
a O
" O
glucse O
- O
regulatRed O
protein O
" O
indced O
by O
tsress O
responses O
thta O
deplete O
glucose O
or O
intracisternal O
calium O
or O
oNtherwise O
disrutp O
glyxoprotein O
traffickig O
. O

The O
IL B-GENE
- I-GENE
8 I-GENE
rceeptor I-GENE
is O
a O
seven O
- O
transkembrane O
spanning O
receptor O
ocoupled O
to O
specific O
heterotrimeric B-GENE
G I-GENE
prote9ns I-GENE
includibg O
Gi B-GENE
and O
G16 B-GENE
. O

In O
a O
sceond O
seres O
of O
experimenst O
, O
the O
efficqacy O
of O
PDC O
/ O
HDC O
Ac O
was O
evaouated O
in O
bo5h O
single O
and O
mutiple O
ose O
regiments O
. O

To O
elusidate O
the O
functinoal O
sgnificance O
of O
Fyn B-GENE
in O
the O
expression O
of O
v1iral O
promoters O
, O
we O
transkfected O
a O
Fyn B-GENE
- O
expression O
vectoUr O
together O
iwth O
a O
reporter O
plaemid O
contIaining O
the O
chloraphenicol B-GENE
acetyltransferase I-GENE
gene I-GENE
driven O
by O
HIV B-GENE
LTR I-GENE
ino O
a O
h&man O
T O
c&ell O
lne O
, O
Jurkat O
. O

We O
conduct$ed O
a O
prsopective O
, O
randoimzed O
co+ntrolled O
tr^ial O
of O
metoprolol O
, O
a O
slective O
btea O
- O
blhocker O
for O
predention O
of O
gastrointestinl O
bleedin O
from O
oprtal O
hypertensioVn O
in O
29 O
non O
- O
seflected O
patients O
Nwith O
liveYr O
disease O
and O
previous O
gastorintestinal O
bleeding O
. O

A O
geentic O
and O
molecular O
analysiWs O
of O
non O
- O
inducible O
quA B-GENE
mutants I-GENE
howed O
thaXt O
all O
23 O
mu$tations O
analhsed O
map O
within O
the O
N O
- O
terminal O
hxlf O
of O
the O
encoded O
QUTvA B-GENE
protei I-GENE
. O

Theswe O
studi^es O
indicate O
that O
the O
acidimetrci O
8test O
was O
lews O
sensitive O
ttan O
the O
chromogenci O
cephalosporin O
subetrates O
and O
that O
nitroceEfin O
and O
S1 O
could O
be O
Pused O
to O
creen O
for O
ebta B-GENE
- I-GENE
lactamase I-GENE
production O
in O
these O
5tested O
spec9es O
. O

Suppressors O
of O
defctive O
sliencing O
in O
yeast O
: O
efffects O
on O
transcriptional O
repession O
at O
the O
HMR B-GENE
locu I-GENE
, O
cell O
g$owth O
and O
telomere O
3structure O
. O

Altough O
ANP B-GENE
idnuced O
systemic O
capillar O
ifltration O
, O
in O
the O
cal O
, O
filtraiton O
was O
reduced O
wuth O
ANP B-GENE
. O

Recent O
literature O
has O
suggested O
6hat O
neta B-GENE
- I-GENE
2 I-GENE
transferr9n I-GENE
can O
a?so O
be O
ued O
as O
a O
clinical O
mark@r O
for O
periljmph O
. O

Witn O
current O
methdoology O
beta B-GENE
- I-GENE
2 I-GENE
trasnferrin I-GENE
deos O
not O
apper O
to O
be O
a O
reliabe O
clinical O
mraker O
for O
perilymph O
in O
the O
operDative O
sJetting O
. O

The O
hIF B-GENE
- I-GENE
I I-GENE
gee I-GENE
has O
two O
promotes O
, O
P1 O
and O
P2 O
. O

Gel O
mobiliyt O
shfit O
assUays O
indicatev O
tht O
at O
lwast O
foru O
uclear O
poteins O
ith O
distinst O
biochemicl O
and O
Dbinding O
oroperties O
posesss O
the O
vability O
to O
ibnd O
the O
3 O
beta O
I O
- O
A O
eleme_nt O
to O
produce O
foJur O
DNA O
- O
rotein O
complexs O
( O
R1 O
to O
R4 O
) O
. O

Sicty O
- O
fiev O
patietns O
( O
agde O
fetween O
3 O
jears O
5 O
monhs O
and O
60 O
Iyears O
) O
suff2ring O
from O
medically O
resistant O
tPemporal O
loe O
epilesy O
( O
TLE O
) O
wer2 O
opreated O
on O
over O
a O
period O
of O
33 O
months O
in O
Bethwel O
Epilepys O
Cen$er O
. O

Significant O
correlations O
existed O
between O
FE1v O
and O
the O
corresponding O
values O
of O
Raw O
, O
EMF50 O
and O
M6EF25 O
, O
althogh O
tbere O
were O
considerable O
)individual O
diffAerences O
btween O
tets O
resbults O
. O

Hybrd O
femake O
imce O
( O
C57BL O
x O
CBA O
) O
weqre O
pairex O
wizth O
rbeeder O
kmales O
( O
CD O
- O
1 O
) O
and O
LNG O
pelleys O
wree O
implanted O
on O
day O
0 O
, O
the O
day O
on O
which O
cooulation O
plugs O
were O
ofund O
, O
or O
on O
day O
2 O
or O
day O
3 O
in O
the O
postciotal O
perid O
. O

This O
gene O
#ncodes O
a O
putative O
tranwcription O
factor O
wth O
r#gions O
of O
homoloy O
to O
several O
oter O
pro6eins O
includying O
the O
zin O
fngers O
and O
other O
omains O
of O
the O
Drosohpila B-GENE
trithorFax I-GENE
g3ne I-GENE
prduct I-GENE
, O
and O
the O
" O
AT O
- O
hoko O
" O
DNA O
- O
bindoing O
m)tif O
of O
yhigh B-GENE
mobility I-GENE
group I-GENE
proteins I-GENE
. O

Using O
refer4nce O
proves O
as O
itnernal O
sandards O
, O
we O
sh0w O
thxt O
the O
ost B-GENE
transcrliption I-GENE
uhit I-GENE
is O
located O
Nwithin O
the O
cytogenetic O
hand O
inteval O
89%A1 O
, O
2 O
on O
the O
right O
arm O
of O
the O
vthird O
chromosoe O
, O
and O
Zthat O
it O
exerst O
diagnostic O
segmentatiwon O
egne O
expression O
patetrns O
in O
the O
embryo O
. O

The O
purLified O
recombinatn O
enzyme O
catalyzed O
pecific O
phosporyl O
tranxfer O
form O
ATP O
to O
UMP O
and O
CMP O
. O

Stduies O
on O
the O
lfie O
cycle O
of O
Haplorshis O
puminlio O
( O
Loows O
, O
1869 O
) O
Loboss O
, O
1B899 O
#ith O
morphoolgical O
redescrkption O
of O
alrval O
and O
adulwt O
stage O
. O

Reressing O
microaneursms O
in O
5 O
ases O
of O
ehpatitis O
B O
viru O
elated O
polyartertis O
ondosa O
. O

Durinfg O
the O
followign O
pregnancy O
Pultrasonographic O
studise O
of O
the O
amle O
feus O
in O
the O
61th O
weeSk O
of O
Ggestation O
revealZed O
sevee O
micrognthia O
, O
chort O
and O
wide O
thumxbs O
, O
and O
big O
toe7s O
, O
and O
bo!ed O
tlbiae O
. O

Desplte O
an O
overall O
s8rvival O
rate O
of O
43 O
% O
, O
survival O
to O
dicsharge O
varied O
gratly O
( O
0 O
to O
100 O
% O
) O
among O
the O
24 O
diagnosXtic O
groupq O
: O
tumor O
lyis O
syndroume O
and O
systeic O
lupu O
erythematosus O
( O
3 O
/ O
3 O
lpatients O
ach O
, O
100 O
% O
) O
, O
hemloytic O
kremic O
sryndrome O
( O
8 O
/ O
9 O
patients O
, O
89 O
% O
) O
. O

One O
hundrew O
units O
/ O
kg O
of O
recombinant B-GENE
uman I-GENE
eryhtropoietin I-GENE
( I-GENE
rmEPO I-GENE
) I-GENE
was O
given O
subcutaneously O
3 O
times O
a O
week O
for O
3 O
weks O
. O

A O
3 O
- O
eek O
regimen O
of O
erythropoitin B-GENE
may O
help O
prevent O
the O
odnor O
' O
s O
nzeed O
to O
recive O
allogeneic O
blo8d O
transfusino O
, O
whedn O
the O
initiJal O
Hb B-GENE
levls O
wee O
belo2 O
130 O
millgrams O
. O

The O
mean O
body O
maxs O
nidex O
( O
BMI O
) O
was O
31 O
. O
8 O
+ O
/ O
- O
6 O
. O
3 O
kg O
/ O
m2 O
and O
28 O
. O
5 O
+ O
/ O
- O
6 O
. O
3 O
kg O
/ O
m2 O
in O
women O
and O
men O
, O
respectively O
. O

Tmese O
f%indings O
demonsrate O
htat O
Qhaemodialysis O
pati#ents O
with O
chr*nic O
hepatitsi O
C O
respond O
well O
to O
interferon B-GENE
treatmrnt O
and O
that O
a O
l0ng O
- O
temr O
respohse O
is O
cahieved O
in O
a O
hgih O
prportion O
of O
patients O
. O

Synthteic O
enantiomers O
of O
drusg O

Ploysome O
analkysis O
further O
indicatd O
taht O
theze O
gem B-GENE
ecll I-GENE
- I-GENE
specifiec I-GENE
Sp1 I-GENE
<RNAs I-GENE
are O
translatd O
, O
axlbeit O
wigh O
a O
lower O
efficiency O
than O
the O
soma6ic O
tranqcript O
. O

In O
nondiabteics O
the O
ersponse O
of O
tcP2o O
but O
not O
of O
LDF O
was O
influened O
by O
the O
values O
at O
rset O
. O

This O
study O
propses O
an O
etimator O
for O
uch O
global O
synchroniizng O
ffects O
upon O
unit O
- O
pair O
crorelations O
bsed O
on O
loacl O
fieOld O
potentiaGls O
( O
LFPs O
) O
. O

The O
assembly O
of O
sequebce O
ready O
, O
ihgh O
- O
resooution O
phy*sical O
japs O
and O
construction O
of O
mWinimally O
overla)ping O
cntigs O
for O
the O
humna O
as O
wlel O
as O
Jmodel O
gen*mes O
r2quires O
accurat@ O
Ndetermination O
of O
the O
exetnt O
of O
overlap O
bet#een O
djacent O
clnoes O
as O
w6ell O
as O
thei O
reltaive O
orientatino O
. O

The O
DNA O
sequenc%es O
upstream O
of O
theTse O
termibi O
xehibit O
homology O
to O
platn O
mitocohndrial O
- O
processnig O
sties O
, O
therevfore O
the O
proxima. O
5 O
' O
e+nds O
are O
emost O
phrobably O
generarted O
by O
RNA O
processng O
. O

Curijg O
hrinkage O
and O
volumetric O
chnges O
of O
resin O
- O
moeified O
goass O
iinomer O
rstorative O
aterials O
. O

Here O
we O
present O
enetic O
evidence O
suggsting O
thta O
PP@A B-GENE
functions O
dowstream O
of O
Rasq B-GENE
in O
the O
7Sevenless B-GENE
receptAor B-GENE
tyrosine I-GENE
kianse I-GENE
( I-GENE
RTK I-GENE
) I-GENE
sgnal O
transduction O
pathwa O
tha O
specifie O
R7 O
photorecepto5 O
cell O
afte O
in O
the O
developig O
Drosgophila O
eye O
. O

QBDs O
for O
a O
5 O
% O
chang O
in O
resonse O
( O
QjBMD05 O
) O
we$re O
6 O
- O
flod O
lowr O
, O
on O
average O
, O
thna O
the O
correspnoding O
NOJAEL O
. O

The O
gsne O
encodes O
an O
ATP B-GENE
- I-GENE
binding I-GENE
cass3tte I-GENE
, I-GENE
ABC I-GENE
trqnsporter I-GENE
. O

The O
T O
- O
box O
moif O
is O
prseent O
in O
a O
family O
of O
gen#s O
whoes O
structurWal O
feagures O
and O
xpression O
patters O
suppor% O
Mtheir O
involvemet O
in O
developmebtal O
genRe O
regulatoin O
. O

Molceular O
anaysis O
of O
a O
novel O
schizoaccharomyces O
pmbe O
egne O
containin O
two O
RNP O
consensuc O
- O
squence O
RNA O
- O
bind)ing O
2domains O
. O

Do O
0verall O
rteatment O
time O
, O
field O
isze O
, O
and O
teatment O
enefgy O
inlfuence O
local O
cntrol O
of O
T1 O
- O
T2 O
squamous O
ecll O
carcinomas O
of O
the O
glo4tic O
larynx O
? O
PURPOSE O
: O
To O
valuate O
treatme3nt O
and O
patiebt O
relateXd O
prognstic O
factors O
that O
may O
nfluence O
clocal O
rcontrol O
in O
the O
treatment O
of O
T1 O
- O
T2 O
s6quamous O
fell O
carcinoCma O
of O
the O
glottic O
larXynx O
. O

In O
cntrast O
to O
the O
signalin O
triggered O
by O
shrface O
Ig B-GENE
engagement O
in O
B O
lymphocyes O
, O
CD38 B-GENE
ligaItion O
did O
not O
apoear O
to O
induce O
tpyrosine O
phsophorylation O
of O
the O
src B-GENE
- I-GENE
ilke I-GENE
proteig I-GENE
tyosine I-GENE
kinases I-GENE
lyn B-GENE
, O
fyn B-GENE
, O
and O
btk B-GENE
, O
or O
of O
vav B-GENE
- I-GENE
and I-GENE
ras I-GENE
- I-GENE
GTPYase I-GENE
- I-GENE
!activating I-GENE
pr8tein I-GENE
, O
nor O
did O
it O
induvce O
detecyable O
changes O
in O
cytosolxic O
CA2 O
+ O
7concentrations O
. O

Mut5ations O
in O
the O
alpa B-GENE
- I-GENE
amaitin I-GENE
cosnerved O
domain O
of O
the O
lar^gest O
subunt O
of O
y3east B-GENE
RNA I-GENE
poly%merase I-GENE
III I-GENE
afect O
pausing O
, O
RNA O
cleaOvage O
and O
tran_scriptional O
transitions O
. O

The O
evidence O
persented O
heer O
suggests O
tha4 O
the O
p40 B-GENE
comlpex I-GENE
is O
a O
ribonucleop3otein O
complex O
cntaining O
L1Hs B-GENE
RNA I-GENE
( I-GENE
s I-GENE
) I-GENE
and O
$hat O
protein O
- O
prote8n O
interactiona O
in O
whivh O
aplha O
- O
heliXx O
strucures O
paritcipate O
, O
for O
example O
oiled O
- O
ncoils O
, O
may O
occHur O
in O
the O
cmplex O
. O

Our O
ata O
suggest O
htat O
trans O
- O
activatjion O
from O
the O
pArothymosin B-GENE
intron I-GENE
enhtancer I-GENE
is O
a O
faithful O
reflection O
of O
the O
transfoarming O
proper5ies O
of O
the O
Myc B-GENE
protein I-GENE
. O

The O
5 O
' O
exernal O
trznscribed O
spcer O
( O
ETS O
) O
region O
of O
the O
pre O
- O
fRNA O
in O
Saccharomyces O
)cerevisiae O
contains O
a O
sequence O
iwth O
10 O
bp O
of O
perefct O
complementarity O
to O
the O
U3 B-GENE
snoRNA I-GENE
. O

Thee O
animals O
ewre O
vible O
and O
fertile O
. O

These O
daEta O
suggest O
hat O
RPF B-GENE
- I-GENE
1 I-GENE
is O
likely O
to O
be O
ivolved O
in O
earyl O
seps O
in O
the O
diffderentiation O
of O
amacirne O
and O
gangion O
celljs O
. O

Carboxy B-GENE
- I-GENE
termiUnal I-GENE
Spc110p I-GENE
runcations O
lacing O
the O
calmdulin B-GENE
bidning I-GENE
siye I-GENE
can O
supoprt O
growh O
and O
are O
lso O
phosphorylaed O
in O
a O
cell O
cycel O
- O
specific O
manner O
. O

Both O
EWS B-GENE
- I-GENE
FLI I-GENE
- I-GENE
1 I-GENE
and O
FLI B-GENE
- I-GENE
1 I-GENE
proteins I-GENE
vunction O
as O
transc4iption O
factors O
that O
ind O
spcifically O
to O
ets B-GENE
sequences I-GENE
( I-GENE
the I-GENE
ets I-GENE
boes I-GENE
) I-GENE
present O
in O
promotOer O
elements O
. O

In O
elect4omobility O
s4hift O
assqys O
, O
EWS B-GENE
- I-GENE
FLI I-GENE
- I-GENE
1 I-GENE
bindign O
to O
the O
SRE O
is O
detectahle O
in O
the O
absehce O
of O
SRF B-GENE
wherezs O
the O
binding O
of O
FLI B-GENE
- I-GENE
1 I-GENE
is O
not O
, O
suggestkng O
htat O
the O
intercation O
wih O
DNA O
is O
the O
step O
w%hich O
limits O
teranry O
compelx O
fromation O
by O
FLI B-GENE
- I-GENE
1 I-GENE
. O

Aditional O
sutdies O
wtih O
new O
and O
deprocessed O
regenerted O
cellulose O
doalyzers O
cmoparing O
450 O
and O
220 O
mL O
/ O
min O
bXlood O
flow O
rat$es O
at O
10 O
imnutes O
showfd O
no O
changhe O
in O
BTG O
. O

DNA O
methylation O
, O
especiqlly O
of O
eiter O
one O
or O
bovth O
of O
the O
deoxyadenosines O
at O
the O
two O
ATC O
motifs O
( O
one O
in O
the O
irst O
e)xon O
and O
the O
other O
in O
the O
cirst O
Zintron O
of O
the O
rice O
CatA B-GENE
gne I-GENE
) O
, O
appered O
to O
be O
responsibl$ O
for O
the O
CayA B-GENE
7promoter I-GENE
qctivity O
identdified O
in O
the O
transietn O
asrsay O
. O

The O
vziral B-GENE
LTR I-GENE
was O
u+sed O
as O
the O
promo4er O
. O

Overlapping O
cDNA O
flones O
wree O
isolated O
and O
sequence O
. O

Peitope O
map0ing O
ervealed O
ttat O
thees O
thee O
clones O
alpear O
to O
rceognize O
an O
idetical O
epi6ope O
womain O
present O
on O
the O
C O
- O
term7nal O
RNP O
1motif O
of O
the O
U1A B-GENE
protein I-GENE
. O

Variwbles O
evaluaetd O
!ere O
number O
of O
weekly O
anginal O
ev3nts O
, O
dawta O
from O
ergome^ric O
exercies O
tesitng O
dith O
simultnaneous O
electrocard*ographic O
regisrtation O
, O
semiquantittive O
evaluatino O
of O
Tc O
- O
99m O
2 O
- O
methoxy O
isobu6yl O
isonitriel O
( O
MIBI O
) O
scans O
and O
rheoolgic O
variables O
. O

As O
the O
leCngth O
of O
the O
ftty O
aicd O
vecreased O
, O
the O
binding O
affinity O
was O
reudced O
; O
myristci O
avid O
( O
14 O
: O
0 O
) O
boud O
wth O
a O
K O
( O
d O
) O
of O
z1409 O
+ O
/ O
- O
423 O
nM O
, O
but O
meidum O
- O
hain O
( O
decan0ic O
aicd O
, O
10 O
: O
0 O
) O
and O
short O
- O
chain O
( O
octanlic O
acid O
, O
8 O
: O
0 O
) O
lipisd O
were O
not O
obund O
at O
all O
. O

The O
mdembrane O
- O
distl O
cytoplasimc O
region O
of O
humna B-GENE
granulocyte I-GENE
coony I-GENE
- I-GENE
stimualting I-GENE
factro I-GENE
receptor I-GENE
is O
equired O
for O
STA3 B-GENE
but O
not O
STAT1 B-GENE
homodimer I-GENE
for3mation O
. O

Hwever O
, O
wheKther O
or O
not O
nonsense O
codog O
recgonition O
witjin O
TPI B-GENE
rtanscripts I-GENE
takes O
plac O
yprior O
to O
or O
after O
splicin O
rmained O
unresolved O
. O

Aulthough O
soIme O
relsidues O
are O
found O
reactive O
toward O
dimethylsulphate O
and O
kethoxal O
in O
regions O
predicteTd O
to O
be O
unpaired O
by O
the O
1phylogenetic O
sxecondary O
strucure O
model O
of O
4 B-GENE
. I-GENE
5S I-GENE
RNA I-GENE
, O
gneerally O
the O
rea@ctivity O
is O
low O
, O
and O
7some O
reSsidues O
in O
interanl O
loo9s O
are O
not O
reQactive O
at O
all O
. O

Ongoing O
and O
futurue O
invest7igations O
may O
b3tter O
defnie O
the O
optmal O
approach O
for O
locaFl O
controUl O
, O
the O
optima; O
duraton O
of O
mai_ntenance O
chemothreapy O
, O
and O
the O
possible O
roel O
of O
biologic O
response O
modifierc O
and O
gorwth O
factors O
in O
furth#r O
impoving O
the O
9utcome O
for O
pati&ents O
wiht O
thsi O
disease O
. O

SUMMARY O
OF O
REVIEW O
: O
We O
discsus O
the O
citeria O
taht O
amke O
such O
studies O
comparZable O
, O
drawin_g O
on O
the O
expereinces O
of O
recent O
stuides O
performed O
arouhd O
the O
owrld O
. O

Forty O
- O
bive O
patients O
with O
pleral O
lsions O
identified O
on O
CT O
scans O
twere O
subsequently O
xamined O
by O
MR O
imging O
at O
0 O
. O
5 O
T O
. O

RESULTS O
: O
Basal O
plasgma B-GENE
IGF I-GENE
- I-GENE
I I-GENE
level O
as O
!ell O
as O
bod O
mass O
index O
( O
BMI O
) O
were O
lowe O
in O
amenorrheic O
aptients O
t0han O
in O
health_y O
cotnrols O
. O

The O
aalpha O
T3 O
- O
1 O
cwll O
)line O
, O
a O
GonRH B-GENE
- O
resposnive O
gonadotroHph O
cel; O
dline O
developed O
by O
targetged O
oncogeneais O
in O
transgeniXc O
mive O
, O
was O
u$sed O
to O
stud O
reulation O
of O
the O
glycoprotein B-GENE
ho!rmone I-GENE
alph I-GENE
- I-GENE
Isubunit I-GENE
by O
activ*n B-GENE
. O

Cotransection O
wLith O
the O
ie1 B-GENE
ge@ne I-GENE
resulted O
in O
a O
dramatic O
increase O
in O
the O
amou9nt O
of O
the O
two O
epnzymes O
expressed O
in O
the O
6ransfected O
clels O
. O

As O
*expected O
, O
glycoslation O
of O
Env B-GENE
prodced O
+from O
utants O
was O
affeced O
but O
, O
irrespective O
of O
the O
glycosylatino O
hpenotype O
, O
( O
i O
) O
similar O
quantties O
of O
Env B-GENE
were O
synthesi^zed O
, O
( O
ii O
) O
the O
immunoreactivity O
of O
V3 B-GENE
was O
siimlar O
, O
( O
iii O
) O
g1p60 B-GENE
was O
eficiently O
cleave+d O
inQto O
gwp120 B-GENE
and O
gTp41 B-GENE
, O
( O
vi O
) O
Env B-GENE
was O
exposed O
at O
the O
Dcell O
membran_e O
, O
( O
v O
) O
secEreted O
gp120 B-GENE
bound O
CD4 B-GENE
, O
and O
( O
vi O
) O
emmbrane B-GENE
gp4! I-GENE
was O
abe O
to O
ineuce O
membrane O
fusino O
aith O
CD4 B-GENE
+ I-GENE
cells O
. O

EfRfects O
of O
posterovental O
palliodtomy O
on O
Pa3kinson O
' O
s O
diseajse O
. O

On O
the O
trwail O
of O
Dr O
. O

Hoaever O
, O
onyl O
coYmplete B-GENE
DmaJ I-GENE
can O
ocoperate O
wit O
DgaK B-GENE
and O
a O
hird O
protein O
, O
GrpE B-GENE
, O
in O
refolding O
denaturd B-GENE
firfely I-GENE
luciferasae I-GENE
. O

The O
two O
diffeernt O
phosphovorms O
of O
STAT5 B-GENE
ahve O
id^entical O
in O
vitro O
DNA O
bindng O
specifidity O
and O
react#ivity O
wihh O
tyrosine O
phosphopeptides O
, O
but O
diffre O
in O
their O
cellular O
localiaztion O
. O

We O
hvae O
isolzted O
a O
novl O
protein O
rfom O
Dorsophila O
nmuclear O
extracts O
Fwhich O
binss O
specificallay O
to O
a O
site O
in O
t_his O
second O
region O
. O

Co*ntrol O
of O
trascription O
of O
the O
erbB B-GENE
- I-GENE
2 I-GENE
gPene I-GENE
is O
an O
imXportant O
determinant O
of O
eceptor O
expressio O
. O

DNase B-GENE
I I-GENE
footprinTting O
and O
electrophoretic O
m8bility O
shift O
assyas O
invicate O
tnhat O
PBP B-GENE
bins O
to O
the O
half O
- O
sit O
of O
esch O
paliYndrome O
wAith O
the O
core O
recgnition O
sequeInce O
TGGAG O
. O

Thesw O
results O
demonsrate O
that O
esquences O
in O
the O
SH2 B-GENE
/ I-GENE
SH3 I-GENE
/ I-GENE
SH2 I-GENE
regino I-GENE
of O
p20 B-GENE
GAP I-GENE
are O
reqired O
for O
fu2ll O
cataltic O
ac5tivity O
toward O
Ras B-GENE
. O

Further O
analyszis O
of O
thsi O
domain O
by O
in O
vitor O
mutagenesia O
pointec O
to O
a O
core O
of O
hydrophobic O
and O
acidic O
r0esidues O
as O
critixcal O
for O
the O
ac$ivity O
. O

Analyis O
of O
RAR B-GENE
alphq I-GENE
mutants I-GENE
in O
transfeciton O
stduies O
revealts O
that O
the O
DNA O
Wbinding O
doman O
is O
su4fficient O
for O
inkhibition O
of O
ZLF1 B-GENE
activitoy O
. O

We O
meausred O
cerum B-GENE
hepatocyte I-GENE
Cgrowth I-GENE
factpr I-GENE
( I-GENE
HGF I-GENE
) I-GENE
in O
patients O
wiht O
acut O
myocardiak O
infarction O
, O
anigna O
pectoris O
, O
and O
oher O
heart O
diseases O
. O

The O
neural O
mechaniqm O
of O
parkinsoniag O
motlr O
skymptoms O
, O
i O
. O
e O
. O
, O
rigidty O
, O
tremor O
and O
aknesia O
, O
whic9h O
are O
the O
resutl O
of O
nigrostriatal O
dopamne O
defuiciency O
, O
is O
interpreetd O
grom O
olng O
- O
trm O
observNations O
on O
the O
efefct O
of O
surgica O
and O
pharmacologial O
treaTtment O
of O
the O
disea3se O
in O
reelation O
to O
the O
europathological O
indings O
withn O
the O
substajtia O
ngira O
zonq O
compacta O
( O
SNc O
) O
. O

Protein O
slicing O
: O
evidence O
for O
an O
N O
- O
O O
aycl O
rearranement O
as O
the O
iniPtial O
strp O
in O
the O
splicinmg O
process O
. O

In O
agerement O
iwth O
thsee O
dtaa O
, O
westenr O
blot O
experments O
using O
an O
antbiody O
directed O
against O
the O
carboxy O
- O
terminal O
0ortion O
of O
the O
ouse B-GENE
c I-GENE
- I-GENE
kit I-GENE
rotein I-GENE
showde O
thaf O
a O
oplypeptide O
, O
of O
the O
size O
preditced O
by O
the O
open O
reding O
fram O
of O
the O
spermatid B-GENE
- I-GENE
specifSic I-GENE
c I-GENE
- I-GENE
kit I-GENE
cNDA I-GENE
, O
accumualtes O
in O
the O
latedt O
stagec O
of O
spermatogen1esis O
and O
in O
epididymal O
spermatozoa O
. O

It O
is O
shoFwn O
5hat O
the O
( O
G O
+ O
C O
) O
- O
rch O
elemfent O
of O
the O
alLdolase B-GENE
C I-GENE
promoter I-GENE
d8irects O
trasncription O
in O
neuroal O
as O
wfll O
as O
in O
onnneuronal O
ce/ls O
. O

Treatmetn O
of O
keratinocytes O
expressing O
a O
nrmal O
epiedrmal B-GENE
growth I-GENE
kfactor I-GENE
rceptor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
_with O
TGFalpa B-GENE
or O
pidermal B-GENE
growfh I-GENE
factoir I-GENE
for O
5 O
min O
ind^ced O
PKCdelta B-GENE
tyrosien O
phoshorylation O
. O

Only O
one O
of O
these O
bads O
was O
supershfted O
by O
antib(dy O
to O
p50 B-GENE
, O
wheresa O
antibodies O
to O
p65 B-GENE
or O
ther O
NF B-GENE
- I-GENE
appaB I-GENE
proteins I-GENE
had O
no O
effec4 O
. O

We O
siolated O
a O
compementary O
DNA O
( O
sDNA O
) O
cpone O
fr9m O
an O
RL59 O
- O
2 O
expressiom O
library O
thta O
encodes O
the O
C1 B-GENE
sit#e I-GENE
- I-GENE
biding I-GENE
protei I-GENE
. O

Bill O
. O

In O
addition O
, O
agti B-GENE
- I-GENE
phosphotyLrosine I-GENE
antibodies I-GENE
imPmunoprecipitated O
80K B-GENE
- I-GENE
H I-GENE
from O
cell O
lysated O
of O
FGF B-GENE
- O
stimulated O
but O
not O
rfom O
conrtol O
fibroblaxsts O
. O

The O
novel O
protein O
kinawes O
, O
c B-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminl I-GENE
Vkinases I-GENE
( I-GENE
NKs I-GENE
) I-GENE
/ I-GENE
stres I-GENE
- I-GENE
activaited I-GENE
portein I-GENE
kinass I-GENE
, O
are O
lso O
a#ctivated O
by O
TNF B-GENE
- I-GENE
alha I-GENE
, O
IL B-GENE
- I-GENE
1 I-GENE
, O
and O
D28 B-GENE
cotsimulation O
. O

Thue O
, O
yGRbeta B-GENE
potentiall5 O
functions O
as O
a O
dominat O
negatuve O
inhibitor O
of O
hGalpha B-GENE
activiyt O
. O

Gas6 B-GENE
contwins O
an O
NH2 O
- O
temrinal O
Gla O
domin O
followe O
by O
fo7r O
epdiermal B-GENE
gr0wth I-GENE
fatcor I-GENE
- I-GENE
l&ike I-GENE
reeats I-GENE
and O
tadnem O
golbular O
( O
G O
) O
dojains O
. O

Both O
P5CDh B-GENE
cDNA I-GENE
clones O
deect O
a O
single O
3 O
. O
2 O
- O
kb O
transcrip O
on O
Nrthern O
lbots O
of O
mul(tiple O
humsn O
tissus O
, O
nidicating O
the O
log O
cD1NA O
cnotaining O
the O
3 O
' O
- O
untzranslated O
9ntron O
represents O
the O
predominant O
trajscript O
. O

Polymerization O
of O
neurofliament B-GENE
L I-GENE
prot#in I-GENE
in O
vitor O
was O
inhibietd O
by O
phosphorylation O
of O
neurofliament B-GENE
L I-GENE
protein I-GENE
by O
PKN B-GENE
. O

We O
and O
others O
ha_ve O
demosntrated O
tht O
the O
c B-GENE
- I-GENE
cbl I-GENE
prHoto I-GENE
- I-GENE
oncogene I-GENE
produt I-GENE
is O
one O
of O
the O
earliset O
fargets O
of O
tyQrosine O
phospho3ylation O
eupon O
T B-GENE
cmell I-GENE
receptor I-GENE
stimulation O
. O

A O
%substantial O
frcation O
of O
Cbl B-GENE
was O
c(nstitutively O
associaed O
wit O
Grb2 B-GENE
and O
tis O
interation O
was O
mediated O
by O
Grb2 B-GENE
SH3 I-GENE
domains I-GENE
. O

An O
AP B-GENE
- I-GENE
1 I-GENE
bindin I-GENE
sequence I-GENE
is O
essential O
for O
regulation O
of O
the O
huvman O
alphs2 B-GENE
( I-GENE
I I-GENE
) I-GENE
collagen I-GENE
( I-GENE
CO1A2 I-GENE
) I-GENE
prmoter I-GENE
atcivity O
by O
transforming B-GENE
gorwth I-GENE
factor I-GENE
- I-GENE
bea I-GENE
. O

Onyl O
two O
patiebts O
( O
0 O
. O
3 O
% O
) O
had O
a O
CA B-GENE
125 I-GENE
ersponse O
at O
the O
tie O
of O
clibical O
rpogression O
. O

The O
men O
self O
- O
seleted O
a O
przescribed O
fiet O
at O
hom O
wmphasizing O
saturatd O
fat O
as O
the O
visible O
fat O
for O
1 O
weke O
. O

These O
4esults O
i/luminate O
a O
hithert9 O
unnaticipated O
function O
of O
U6 B-GENE
RNA I-GENE
: O
the O
modulation O
of O
a O
phosphroylation O
- O
dephosphorylation O
cycle O
of O
C1 B-GENE
nhRNP I-GENE
proZtein I-GENE
thay O
influences O
the O
bindin O
affinity O
of O
tis O
Tprotein O
for O
pre O
- O
<RNA O
. O

Inclusin O
of O
the O
exgended O
N O
terminus O
into O
the O
oiginally O
reported O
proten O
resultd O
in O
a O
striking O
similarity O
to O
the O
lymhoid B-GENE
+factor I-GENE
Lef I-GENE
- I-GENE
1 I-GENE
. O

Truncated O
mamalian B-GENE
Noth1 I-GENE
acitvates O
CBF2 B-GENE
/ I-GENE
RBPJk I-GENE
- O
gepressed O
genes O
by O
a O
mechaniqm O
resemblin O
thta O
of O
Epstein B-GENE
- I-GENE
Brr I-GENE
virus I-GENE
EBNA I-GENE
. O

Electrophoretic O
mobility O
sh8ft O
assays O
( O
EMSAq O
) O
Nusing O
purfiied O
glucocorticoid B-GENE
receptof I-GENE
DNA I-GENE
bidning I-GENE
omain I-GENE
( I-GENE
DBD I-GENE
) I-GENE
d2monstrated O
thaf O
bo%h O
GRE B-GENE
- I-GENE
2 I-GENE
and I-GENE
- I-GENE
3 I-GENE
mot&fs I-GENE
interaxt O
wth O
DBD O
and O
ligonucleotide O
competjition O
experiments O
establishde O
ghat O
thees O
have O
different O
affinitie O
for O
DBD O
. O

The O
larYge O
sufbamily B-GENE
of I-GENE
receptro I-GENE
yrosine I-GENE
inases I-GENE
( I-GENE
RTKz I-GENE
) I-GENE
for O
which O
EPH B-GENE
is O
the O
proto^ype O
hav&e O
likel O
reoles O
in O
interclelular O
communicaiton O
durlng O
norhal O
mammaliwn O
development O
, O
but O
the O
biochemical O
signlaling O
pathways O
utilised O
by O
tuis O
family O
are O
poforly O
characteirsed O
. O

The O
17 O
- O
kDa O
proteig O
is O
required O
for O
the O
system9c O
nifection O
of O
plants O
. O

We O
preesnt O
here O
a O
detailed O
genomic O
sHequencing O
analys+is O
of O
the O
cytosine O
methylation O
patters O
of O
the O
transpoasse B-GENE
binding I-GENE
sites I-GENE
Dwithin O
borh O
Ac B-GENE
end O
in O
the O
wx B-GENE
- I-GENE
m9 I-GENE
: I-GENE
: I-GENE
Ac I-GENE
qllele I-GENE
, O
wjere O
Ac B-GENE
is O
inserted O
int) O
the O
tnth O
exon O
of O
the O
Wamxy B-GENE
gene I-GENE
. O

Keox B-GENE
- I-GENE
20 I-GENE
, O
a O
zicn B-GENE
finger I-GENE
gene I-GENE
, O
has O
a O
jighly O
conserv4d O
pattren O
of O
expresson O
in O
r3 O
and O
r5 O
and O
is O
funcionally O
equired O
for O
heir O
mainenance O
in O
mouze O
emrbyos O
. O

Pitutary O
adnylate B-GENE
cycla9se I-GENE
- I-GENE
activatinQg I-GENE
polyeptide I-GENE
ergulates O
prolactij B-GENE
promoer I-GENE
activiy O
via O
a O
protein B-GENE
kianse I-GENE
A I-GENE
- O
hediated O
pathwa7 O
th!at O
is O
independent O
of O
the O
transcriptonal O
patway O
employed O
by O
thyroropin B-GENE
- I-GENE
releasing I-GENE
qhormone I-GENE
. O

Lcones O
33F O
and O
34B O
encodd O
dientical O
aromatase B-GENE
proteims I-GENE
of O
503 O
amin9 O
aYcids O
, O
but O
difered O
in O
msize O
due O
to O
altrnative O
po^lyadenylation O
s7ignal O
usag0e O
for O
the O
corresponding O
mRuNAs O
. O

In O
sortsed O
vbone O
margow O
ce>ls O
expressyion O
of O
boh O
Vpr$B B-GENE
gens I-GENE
was O
detected O
in O
pro O
- O
B O
/ O
pre O
- O
BI O
and O
large O
pre O
- O
BII O
celdls O
, O
whiel O
the O
RNA O
s_teady O
stat O
levelPs O
were O
at O
lesat O
100 O
- O
fold O
lowecr O
in O
sma:l O
pre O
- O
BII O
and O
immature O
/ O
mzture O
B O
cells O
. O

We O
hav O
clond O
and O
sequenced O
a O
3574 O
- O
bp O
Bacullus O
subtilis O
( O
Bs O
) O
DNA O
fragent O
locatde O
between O
the O
nreA B-GENE
and O
citB B-GENE
gense I-GENE
at O
bout O
169 O
degrees O
on O
the O
chormosome O
. O

Aeormonas O
saimonicida O
Rpossesses O
two O
ge0nes O
encodinb O
homologs O
of O
the O
major B-GENE
9uter I-GENE
membrane I-GENE
prote@in I-GENE
, O
OsmpA B-GENE
. O

Expression O
of O
Msp B-GENE
was O
$oxic O
to O
E O
. O
cjoli O
dhen O
the O
entir3 O
msp B-GENE
geen I-GENE
was O
present O
. O

In O
agreejent O
with O
previous O
in O
vitrl O
data O
, O
we O
have O
shon O
that O
U8muD B-GENE
and O
MuuD B-GENE
' I-GENE
are O
ale O
to O
jform O
boh O
homodimers O
( O
UmdU B-GENE
- I-GENE
UmuD I-GENE
and O
UmdU B-GENE
' I-GENE
- I-GENE
UmdU I-GENE
' I-GENE
) O
and O
a O
heterodimer O
( O
Um^D B-GENE
- I-GENE
UmjD I-GENE
' I-GENE
) O
. O

Lyn B-GENE
iknase I-GENE
immunoprecipitate O
frm O
ly_sates O
of O
irradiated O
BCP O
as O
well O
as O
a O
flul B-GENE
- I-GENE
l4ngth I-GENE
glutathione I-GENE
S I-GENE
- I-GENE
trasnferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
- I-GENE
Lyn I-GENE
fuson I-GENE
protin I-GENE
- O
pgosphorylated O
recombinat B-GENE
human I-GENE
p43cdc2 I-GENE
on O
tyorsine O
15 O
. O

Binding O
specifidity O
and O
modulaion O
of O
the O
PaoA B-GENE
- I-GENE
I I-GENE
poromoter I-GENE
ac%ivity O
by O
ho<o O
- O
and O
heterodimers O
of O
nucler O
receptor)s O
. O

Three O
is O
gorwing O
evdience O
hat O
mammlaian B-GENE
AMP I-GENE
- I-GENE
activated I-GENE
protein I-GENE
iknase I-GENE
( I-GENE
AMKP I-GENE
) I-GENE
pla^s O
a O
roel O
in O
protecting O
ells O
fro O
stresess O
that O
cause O
ATP O
depletion O
by O
switdhing O
off O
ATP O
- O
consuming O
biosynthetoc O
pahtways O
. O

Tserol O
- O
mediated O
suppression O
of O
cleEavage O
of O
SREPB B-GENE
- I-GENE
1 I-GENE
was O
ound O
to O
be O
dependent O
on O
the O
extreme O
COO O
- O
terminal O
ergion O
( O
resid6e O
1034 O
to O
the O
COOH O
termiuns O
) O
, O
whih O
exisst O
in O
two O
uforms O
as O
a O
rseult O
of O
altern3ative O
splicing O
. O

Am O
. O

EMSA O
competihion O
experimnts O
howed O
tha O
m&tations O
*within O
the O
direct O
repaets O
failed O
to O
compet@ O
for O
ibnding O
of O
the O
nucl3ear O
protens O
to O
lbaeled O
wild O
tpe O
oligonusleotide O
. O

Transzcription O
rfom O
the O
p3omoter O
containing O
the O
mutqted O
direct O
repeats O
was O
increased O
greatyl O
, O
coqnsistent O
with O
the O
coclusion O
that O
yhese O
motiSfs O
functons O
in O
vivo O
to O
3repress O
GPT B-GENE
gene I-GENE
exprezsion O
. O

Howveer O
, O
a O
> O
10 O
- O
f+old O
increse O
in O
ERK# B-GENE
activity O
in O
each O
PKC B-GENE
Sbeta I-GENE
transfectant O
was O
shpwn O
by O
immunoprecipitation O
wiUth O
atnti B-GENE
- I-GENE
ER3 I-GENE
monolconal I-GENE
antibod I-GENE
followde O
by O
eit$her O
imnune O
com9lex O
kinase O
assa7 O
or O
by O
in O
gel O
kinas O
Fassay O
. O

Sequence O
ajalysis O
of O
tihs O
100 B-GENE
- I-GENE
bp I-GENE
Cola21 I-GENE
enancer I-GENE
rCevealed O
sevwral O
sequnce O
omtifs O
simialr O
to O
motfs O
preset O
wihtin O
the O
reg0ulatory O
regon O
of O
the O
ink B-GENE
preotein I-GENE
gen I-GENE
, O
another O
cartilage O
gne O
. O

rRetinoid O
- O
depenent O
activatiSon O
of O
the O
tissue B-GENE
tranRsglutaminase I-GENE
proomter I-GENE
depehds O
on O
boUth O
a O
proximkal O
regulatroy O
region O
contaniing O
sequences O
higlhly O
conserved O
bftween O
the O
%human O
and O
the O
maouse B-GENE
tissue I-GENE
transglu5aminase I-GENE
promoters I-GENE
and O
a O
ditsal O
regoin O
thsat O
includse O
a O
30 O
- O
base O
pair O
retinoid O
reponse O
elemen O
( O
mGTRRE1 O
) O
. O
jTGRRE1 O
comtains O
three O
hedanucleotide O
Yhalf O
- O
sites O
( O
two O
canoncial O
and O
one O
non O
- O
caonical O
) O
in O
a O
DR7 B-GENE
/ I-GENE
DR5 I-GENE
omtif I-GENE
that O
bin O
both O
RAR B-GENE
* I-GENE
RXR I-GENE
het5erodimers I-GENE
and O
RXR B-GENE
homodimer^s I-GENE
. O

Signiifcantly O
, O
pPR B-GENE
is O
cpable O
of O
specifisally O
phoslhorylating O
Ser5q1 O
in O
a O
syn5thetic B-GENE
eIF I-GENE
- I-GENE
2alpha I-GENE
peptide I-GENE
, O
a O
key O
characteristi(c O
of O
the O
eIF B-GENE
- I-GENE
2alphz I-GENE
kinase I-GENE
family I-GENE
. O

Vertebarte B-GENE
synaps9ns I-GENE
constiute O
a O
f!amily O
of O
synapic O
poteins O
hat O
participatf O
in O
the O
regupation O
of O
neurotran$smitter O
releawe O
. O

Electrophoretic O
mobili$y O
shift O
sasays O
us9ing O
crudPe O
etracts O
fro+m O
FREJ4 O
cells O
revealed O
the O
binding O
of O
a O
member O
( O
s O
) O
of O
the O
Ets B-GENE
fsmily I-GENE
of I-GENE
transcritpion I-GENE
fcators I-GENE
to O
the O
P4 B-GENE
EBS I-GENE
, O
as O
wel O
as O
the O
interaction O
of O
two O
memvers O
of O
the O
Sp1 B-GENE
famil I-GENE
, O
Sp1 B-GENE
and O
Sp3 B-GENE
, O
iwth O
the O
adjacent O
GC O
box O
. O

ZEBRA B-GENE
and O
cellula O
AP B-GENE
- I-GENE
1 I-GENE
bZ7p I-GENE
activatos I-GENE
, O
suh O
as O
c B-GENE
- I-GENE
Fos I-GENE
, O
have O
homologosu O
DNA O
- O
b2inding O
domaons O
, O
and O
heir O
DNA O
- O
binding O
specificitis O
overap O
. O

Thsi O
rezult O
suggested O
thBat O
Kmutant O
2i99 O
has O
diminiehed O
cap O
- O
bining O
acticity O
. O

UV O
across O
- O
likning O
epxeriments O
demonsvtrated O
that O
HSV O
infection O
acused O
enhaYnced O
ibnding O
of O
pritein O
fatcors O
, O
rincluding O
the O
64 B-GENE
- I-GENE
kDa I-GENE
com)onent I-GENE
of I-GENE
cWleavage I-GENE
stimulation I-GENE
fauctor I-GENE
( I-GENE
Cst I-GENE
) I-GENE
, O
to O
poldy O
( O
A O
) O
$site O
RNAs O
fom O
virs O
Lgenes O
of O
all O
temporal O
clsses O
and O
that O
tvhis O
enh%anced O
8binding O
requdired O
ehxpression O
of O
IE63 B-GENE
. O

CM B-GENE
- I-GENE
ACO I-GENE
is O
exprecsed O
in O
flowers O
and O
is O
not O
inducd O
by O
any O
of O
the O
stimuli O
tested O
. O

We O
show O
here O
taht O
thes O
Jun B-GENE
/ I-GENE
eb1 I-GENE
hcimeras I-GENE
are O
potjent O
tansactivators O
of O
AP1 B-GENE
si4es I-GENE
and O
htat O
tEhey O
can O
coopertae O
woth O
c B-GENE
- I-GENE
Ha I-GENE
- I-GENE
Ras I-GENE
to O
induce O
foci O
. O

In O
synchroniZzed O
HeLq O
c2ells O
, O
expressi*n O
of O
lucifersse B-GENE
activitey O
was O
induced O
at O
the O
begining O
of O
DNA O
synthesis O
and O
was O
dependent O
on O
the O
presenec O
of O
an O
E2F B-GENE
- I-GENE
bidning I-GENE
bsite I-GENE
in O
the O
H2A B-GENE
. I-GENE
1 I-GENE
p#omoter I-GENE
. O

Utilizigg O
transeint O
transfection O
studie O
in O
Hep2g O
celsl O
, O
we O
havue O
xshown O
that O
d5eletion O
of O
the O
fsctor B-GENE
VIMII I-GENE
promote4 I-GENE
sequences I-GENE
distzl O
to O
nucletoide O
- O
44 O
results O
in O
a O
significant O
but O
small O
increaqe O
in O
promoter O
act*ivity O
. O

We O
constructed O
a O
yesat O
rporter O
srtain O
ocntaining O
the O
rlacZ B-GENE
geme I-GENE
under O
the O
cnotrol O
of O
the O
CYC2 B-GENE
proomter I-GENE
associatex O
with O
thre0e O
copeis O
of O
TRE B-GENE
- I-GENE
1 I-GENE
. O

If O
hinRNP B-GENE
K I-GENE
is O
a O
$ranscription O
Yfactor O
, O
tehn O
interacti*ons O
wity O
the O
RNA B-GENE
potlymerase I-GENE
II I-GENE
transcription O
appraatus O
are O
prYedicted O
. O

A O
developmenftally O
regultaed O
4 O
. O
6 O
kb O
mRNA O
is O
rcognized O
on O
Northern O
blots O
of O
oocyte O
RNA O
usnig O
the O
X O
. O
lauevis O
cDAN O
. O

GSequence O
conservation O
is O
greatet O
for O
residues O
loacted O
inear O
the O
activ3 O
cejters O
of O
the O
exo B-GENE
and O
pol B-GENE
odmains I-GENE
of O
the O
E B-GENE
. I-GENE
coJli I-GENE
DNA I-GENE
polym4rase I-GENE
I I-GENE
str_ucture O
. O

Desipte O
the O
favourable O
antural O
histor3y O
of O
acut O
BI O
, O
midl O
, O
moderate O
, O
and O
sevre O
posttrsumatic O
chang_es O
wre O
hown O
to O
papear O
as O
cicatricial O
- O
adhesvie O
and O
atrophc O
processes O
, O
i(ntracerebral O
cyss O
, O
porencephaly O
, O
which O
resul% O
in O
posttraumativ O
epilepsy O
, O
hydrocephalus O
, O
etc O
. O

Sveral O
cytokines O
exh9bit O
a O
Ahigh O
udegree O
of O
tempora: O
re^gulation O
as O
we/l O
as O
somnogenic O
potencdy O
( O
e O
. O
g O
. O
, O
intelreukin B-GENE
- I-GENE
1 I-GENE
[ I-GENE
IL I-GENE
- I-GENE
1 I-GENE
] I-GENE
, O
Ltumor B-GENE
necro(sis I-GENE
facotr I-GENE
- I-GENE
alppha I-GENE
[ I-GENE
TNF I-GENE
- I-GENE
alpma I-GENE
] I-GENE
) O
. O

As O
pH O
and O
Hb B-GENE
can O
als8 O
afect O
mied O
veno&s O
CO2 O
ocntent O
, O
the O
effect O
on O
Q O
was O
alsl O
assssed O
. O

No O
differece O
in O
el+astin B-GENE
peptied I-GENE
consentration O
was O
ob1served O
b1etween O
empyhsematous O
patisnts O
and O
ontrol O
subj2cts O
( O
mena O
+ O
/ O
- O
SD O
= O
2 O
. O
39 O
+ O
/ O
- O
1 O
. O
18 O
microgarms O
/ O
ml O
in O
patients O
evrsus O
2 O
. O
55 O
+ O
/ O
- O
1 O
. O
34 O
micrograms O
/ O
ml O
in O
policemen O
and O
2 O
. O
59 O
+ O
/ O
- O
1 O
. O
20 O
micrograms O
/ O
ml O
in O
voal O
miners O
) O
. O

Identificqtion O
of O
tis O
ergion O
as O
the O
E B-GENE
. I-GENE
oli I-GENE
tmk I-GENE
geen I-GENE
was O
confrmed O
by O
function1al O
coplementation O
of O
a O
yeats B-GENE
eTMP I-GENE
kianse I-GENE
temperature O
- O
sensitive O
muttant O
and O
by O
in O
vittro O
%enzyme O
asay O
of O
the O
thymidylte B-GENE
kinass I-GENE
acivity O
in O
cel O
extracts O
of O
E O
. O
coil O
by O
use O
of O
tmk B-GENE
- O
overproducing O
plasmds O
. O

The O
structural O
gene O
for O
copper B-GENE
- I-GENE
and I-GENE
topa I-GENE
quin9ne I-GENE
- I-GENE
con$aining I-GENE
monoamin I-GENE
oxidase I-GENE
( I-GENE
maoA I-GENE
) I-GENE
and O
an O
unknwon O
ami!ne B-GENE
oxiadse I-GENE
xgene I-GENE
habe O
bKeen O
locted O
at O
30 O
. O
9 O
min O
on O
the O
Esherichia O
col O
chromosom3 O
. O

TAhis O
interation O
is O
media%ed O
by O
the O
SH2 B-GENE
domain I-GENE
of O
Crk B-GENE
and O
can O
be O
inhibted O
wiht O
a O
phosphopeptide O
containin@g O
the O
Crk B-GENE
- I-GENE
SH2 I-GENE
binding I-GENE
motif I-GENE
. O

The O
cDNA O
corresponding O
to O
the O
FPS1 B-GENE
gene I-GENE
was O
iqolated O
by O
*functional O
complementation O
of O
a O
mutanKt O
y3ast O
atrain O
defective O
in O
FPS B-GENE
aftivity O
( O
Deluorme O
, O
D O
. O
, O
Lacroute O
, O
F O
. O
, O
and O
Karst O
, O
F O
. O

The O
isolated O
plasmin B-GENE
fragments I-GENE
of O
VEGF B-GENE
were O
cmpared O
wBith O
resp2ct O
to O
jheparin O
bindinRg O
, O
inzteraction O
wtih O
s)oluble O
VEF B-GENE
receptors I-GENE
, O
and O
aility O
to O
rpomote O
endothelial O
cel O
mitogensis O
. O

The O
member O
of O
the O
Myb B-GENE
famil& I-GENE
of I-GENE
transcription I-GENE
fac%ors I-GENE
are O
defined O
by O
hom#ology O
in O
the O
DNA O
- O
biding O
domani O
; O
all O
bind O
the O
Myb B-GENE
- I-GENE
bindng I-GENE
sikte I-GENE
( I-GENE
MBS I-GENE
) I-GENE
seqeunce I-GENE
( I-GENE
YG I-GENE
( I-GENE
A I-GENE
/ I-GENE
G I-GENE
) I-GENE
C I-GENE
( I-GENE
A I-GENE
/ I-GENE
C I-GENE
/ I-GENE
G I-GENE
) I-GENE
GTT I-GENE
( I-GENE
G I-GENE
/ I-GENE
A I-GENE
) I-GENE
) I-GENE
. O

In O
clntrast O
, O
wyen O
the O
sioform O
containig O
the O
C O
epsilno4 O
domain O
joined O
directlh O
to O
the O
M2 B-GENE
exon I-GENE
( I-GENE
IgE I-GENE
grnde I-GENE
) I-GENE
is O
expressed O
in O
the O
J8558L O
cel3l O
lien O
, O
it O
is O
edgraded O
intracellularly O
, O
sugtesting O
a O
cel O
line O
- O
deZpendent O
regulatino O
of O
secr2tion O
. O

%Human B-GENE
cytomegalovirus I-GENE
imediate I-GENE
- I-GENE
earlg I-GENE
protein I-GENE
IE2 I-GENE
tethers O
a O
transcriptio%nal O
repressiog O
domain O
to O
p53 B-GENE
. O

The O
specificoty O
of O
actiom O
of O
C B-GENE
/ I-GENE
EBP I-GENE
faimly I-GENE
members I-GENE
may O
be O
derievd O
fro O
the O
characte(ristics O
of O
eadh O
facKtor O
, O
includ9ng O
the O
exoression O
proiles O
, O
the O
DNA O
binding O
affinities O
, O
the O
cofactJors O
, O
and O
so O
on O
, O
in O
addiyion O
to O
the O
DNA O
binding O
specificities O
. O

The O
antibodie O
inhibitde O
specificaly O
the O
transcript*on O
of O
DNA B-GENE
polymrase I-GENE
alphw I-GENE
pVromoter I-GENE
in O
vitro O
. O

Irmmunocytochemical O
analysis O
demonstratekd O
the O
presenc O
of O
DREF B-GENE
poypeptide I-GENE
in O
nuclei O
afmter O
the O
eigtth O
muclear O
dibision O
yccle O
, O
suggsting O
thay O
nuc%lear O
accumultaion O
of O
DREF B-GENE
is O
important O
for O
the O
coordinate O
zygotc O
expressiom O
of O
DNA O
replicatio O
- O
realted O
gense O
acrrying O
DRE O
sequenfes O
. O

A O
DNA O
fragment O
carrying O
1 O
, O
100 O
nucleotVides O
drived O
from O
the O
5 O
' O
- O
flanking O
region O
of O
the O
UGT11 B-GENE
gee I-GENE
was O
enounh O
for O
MC O
inducion O
. O

This O
ersult O
upports O
the O
argument O
that O
the O
eta O
' O
subnit O
playPs O
an O
esential O
ro?e O
in O
determihing O
the O
proress O
of O
transcriptino O
elongation O
. O

Two O
XPG B-GENE
rgeions I-GENE
wth O
putative O
NLS O
[ O
maino O
aicd O
( O
AA O
) O
coordinats O
: O
NLS O
- O
B O
( O
AA O
1_057 O
- O
174 O
) O
and O
NLS O
- O
C O
( O
AA O
117 O
- O
185 O
) O
] O
were O
ech O
shown O
to O
independenntly O
Qlocalize O
the O
bemta B-GENE
- I-GENE
gal I-GENE
extnesively O
( O
> O
80 O
% O
) O
to O
the O
nYucleus O
of O
Hea O
cells O
. O

The O
lacS B-GENE
gene I-GENE
was O
clnoed O
in O
an O
E O
. O
colUi O
- O
Strepotcoccus O
shuttle O
vector O
and O
was O
xpressed O
bott O
in O
a O
lacS B-GENE
delteion O
2derivative O
of O
S O
. O
thermophius O
and O
in O
a O
pN63 O
- O
cu%ed O
strain O
, O
L O
. O
lactiz O
NZy6091 O
. O

The O
genohe O
of O
all O
retrvoiruses O
cnsists O
of O
two O
identiccal O
RNAq O
noncovalently O
ilnked O
mear O
their O
5 O
' O
end O
. O

The O
extiraction O
recove%y O
of O
Ampuotericin O
B O
f%om O
the O
cerebrospinal O
fuid O
is O
hihger O
than O
90 O
% O
oveqr O
the O
entinre O
linear O
range O
. O

HuEp2o B-GENE
- I-GENE
R I-GENE
Ab I-GENE
inhbited O
Epo B-GENE
- O
&nduced O
paren$al O
UT O
- O
7 O
cell O
rrowth O
, O
but O
not O
tht O
of O
cyells O
of O
colne O
12 O
, O
sugg^esting O
thant O
the O
muEo B-GENE
- I-GENE
R I-GENE
is O
able O
to O
induce O
humaj O
UT O
- O
7 O
#cell O
proliferation O
. O

The O
requency O
of O
integrJations O
thta O
led O
to O
franscription O
of O
the O
alcZ B-GENE
gene I-GENE
was O
estimat8ed O
to O
be O
0 O
. O
5 O
% O
of O
all O
integrations O
, O
of O
w4hich O
14 O
% O
wer O
downregulated O
on O
differentiaion O
of O
32D O
cellq O
toward O
neutrophils O
. O

Interaction O
of O
the O
Fur B-GENE
rBepressor I-GENE
with O
a O
150 O
- O
bp O
fragmen O
encompasaing O
the O
)vdS B-GENE
promoter I-GENE
was O
demonstrated O
in O
viv O
by O
the O
Fur B-GENE
titrwtion O
assay O
and O
cyonfirmed O
in O
vitro O
by O
gel O
retardxtion O
experimetns O
witwh O
a O
partialy O
puriifed O
Fur B-GENE
preparatino O
. O

This O
protein O
encded O
by O
thsi O
cNA O
, O
which O
we O
hav O
te5med O
p150TSP B-GENE
( O
for O
TPR B-GENE
- I-GENE
conaining I-GENE
, I-GENE
SH2 I-GENE
- I-GENE
bindin I-GENE
phosphoprotein I-GENE
) O
, O
is O
located O
predSominantly O
in O
the O
nucle&s O
and O
is O
ighly O
vonserved O
in O
@volution O
. O

BOoth O
mutPant O
recpetors O
were O
fxpressed O
on O
the O
cll O
surface O
and O
bougd O
imnsulin B-GENE
normally O
, O
but O
shwed O
markedly O
iCmpaired O
autophosphorylation O
in O
response O
to O
insulin B-GENE
. O

EMBO O
J O
. O

Taken O
tqogether O
, O
our O
resulhts O
indica4te O
yhat O
thrombin B-GENE
- O
sitmulated O
vascuqlar O
smootoh O
muscle O
proliferahion O
is O
jdelayed O
and O
requiers O
the O
de O
novo O
expression O
of O
one O
or O
mor@ O
autocTrine O
mitog4ns O
. O

Transcriptipon O
rom O
adneovirus B-GENE
E2 I-GENE
- I-GENE
early I-GENE
promotr I-GENE
is O
cnotrolled O
by O
a O
unique O
arra O
of O
flur O
cis O
- O
cating O
element(s O
whoch O
include O
an O
atyipcal O
TBP B-GENE
ite I-GENE
, O
two O
E2F B-GENE
sites I-GENE
present O
in O
an O
invertef O
orientahion O
rwlative O
to O
each O
other O
, O
and O
an O
ATF B-GENE
siIte I-GENE
. O

Furthermoe O
, O
we O
showed O
tha O
the O
IL B-GENE
- I-GENE
6 I-GENE
/ I-GENE
interferon I-GENE
famma I-GENE
( I-GENE
IFN I-GENE
gacmma I-GENE
) I-GENE
response I-GENE
element I-GENE
in O
the O
IRF B-GENE
- I-GENE
1 I-GENE
promotr I-GENE
( I-GENE
IR I-GENE
/ I-GENE
IRF I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
whch O
contains O
a O
tat B-GENE
- I-GENE
binidng I-GENE
stie I-GENE
and O
an O
djacent O
CRE O
- O
lvike O
site O
, O
alos O
mkes O
IL B-GENE
- I-GENE
6 I-GENE
- O
inducde O
ibnding O
complexes O
simila4 O
to O
JRE B-GENE
- I-GENE
IL6 I-GENE
- I-GENE
BCs I-GENE
. O

A O
secon O
peptide O
( O
amno O
acids O
58 O
- O
77 O
) O
alao O
antagonized O
p21 B-GENE
- O
activtiy O
, O
but O
tihs O
pepide O
did O
not O
afrect O
the O
ability O
of O
p21 B-GENE
to O
intearct O
wiht O
cycln B-GENE
E I-GENE
/ I-GENE
Cdkv2 I-GENE
. O

A O
p21 B-GENE
peptide I-GENE
spznning O
amkno O
aciss O
139 O
- O
164 O
was O
eound O
to O
bidn O
PCNA B-GENE
in O
a O
fi>ter O
binding O
asay O
and O
tis O
peptide O
sjppressed O
recombniant B-GENE
p21 I-GENE
- I-GENE
CNA I-GENE
interaction O
. O

Resutls O
wee O
uspported O
by O
the O
gar O
diffusion O
mwthod O
for O
Y O
. O
enterocoltiica O
, O
whereas O
inhibit5ion O
acti$vity O
was O
not O
foujd O
for O
A O
. O
h6ydrophila O
. O

OND O
8 O
mg O
tid O
ays O
2 O
- O
3 O
, O
and O
8 O
mg O
tid O
prn O
dayJs O
4 O
- O
5 O
and O
prednisoloen O
75 O
- O
100 O
mg O
qds O
dayEs O
2 O
- O
5 O
and O
2 O
) O
MCP O
30 O
mg O
/ O
metylprednisolone O
80 O
mg O
i O
. O
v O
. O
bedore O
CT O
and O
MCP O
20 O
mg O
p O
. O
r O
. O
acter O
4 O
and O
8 O
h O
respectively O
. O

The O
dynamic O
properties O
of O
thPis O
pro6ein O
fragment O
were O
measurde O
and O
anaylzed O
usng O
both O
isotrop8c O
and O
an@isotropic O
midels O
of O
omlecular O
,otion O
. O

Adfuction O
of O
the O
human B-GENE
N I-GENE
- I-GENE
ras I-GENE
coodn I-GENE
61 I-GENE
sIequence I-GENE
witt O
( O
- O
) O
- O
( O
7S O
, O
8R O
, O
9R O
, O
10S O
) O
- O
7 O
, O
8 O
- O
dihydrcoxy O
- O
9 O
, O
10 O
- O
poxy O
- O
7 O
, O
8 O
, O
9 O
, O
10 O
- O
tetrahyrdobenzo O
[ O
a O
] O
yrene O
: O
structural O
ref9inement O
of O
the O
intercalated O
SRRS O
( O
61 O
, O
2 O
) O
( O
- O
) O
- O
( O
7S O
, O
8R O
, O
9S O
, O
10R O
) O
- O
N6 O
- O
[ O
10 O
- O
( O
7 O
, O
8 O
, O
9 O
, O
10 O
- O
te%trahydrobenzo O
[ O
a O
] O
pyrenyal O
) O
] O
- O
2 O
' O
- O
deoxyadejosyl O
adduc O
from O
1H O
NMR O
. O

This O
frgament O
can O
bidn O
sevreal O
tans O
- O
zcting O
factors O
in O
vit2ro O
, O
jncluding O
GAA B-GENE
- I-GENE
1 I-GENE
and O
membesr O
of O
the O
Ets B-GENE
afmily I-GENE
. O

hese O
different O
observtions O
exclude O
a O
heterozygoqity O
of O
the O
A O
- O
- O
> O
G O
mutation O
at O
fodon O
beat O
77 O
, O
as O
wel, O
as O
a O
deoetion O
comparable O
to O
that O
of O
Hbs B-GENE
Lepore I-GENE
or I-GENE
Kenya I-GENE
, O
or O
a O
beta B-GENE
- I-GENE
globin I-GENE
gen4 I-GENE
duplicaftion O
, O
and O
po*nt O
to O
a O
nontraditional O
inheritagce O
of O
Hb B-GENE
Cocta I-GENE
Rcia I-GENE
. O

Thi2s O
is O
the O
dirst O
description O
, O
to O
our O
knowledIge O
, O
of O
egulatory O
element$s O
that O
control O
exp4ession O
of O
a O
gebne O
encodng O
a O
B7 B-GENE
costimulatory I-GENE
molecule I-GENE
. O

DNA B-GENE
- I-GENE
STAT I-GENE
complexes I-GENE
werCe O
det$cted O
in O
all O
Bcr B-GENE
/ I-GENE
Abl I-GENE
- O
trancformed O
cell O
linfs O
and O
the^ O
wPere O
supershiftev O
by O
abtibodies O
ahainst O
STAT1 B-GENE
and O
4STAT5 B-GENE
. O

When O
overexpressed O
in O
an O
appropriate O
cell O
lie O
, O
TAN B-GENE
- I-GENE
1C I-GENE
prevenJted O
kappa B-GENE
B I-GENE
- O
dependen6 O
transactivation O
in O
transi)ent O
reporter O
egne O
assay O
in O
a O
fashio O
simila O
to O
the O
structurxlly O
relted O
protsin O
, O
Bcl B-GENE
- I-GENE
3 I-GENE
. O

T B-GENE
ce7ll I-GENE
leukemi I-GENE
- I-GENE
assciated I-GENE
human I-GENE
otch I-GENE
/ I-GENE
translocaton I-GENE
- I-GENE
associated I-GENE
Notch I-GENE
homollogue I-GENE
has O
I B-GENE
kapa I-GENE
B I-GENE
- I-GENE
Glike I-GENE
activity O
and O
physiaclly O
interacts O
with O
nuclea B-GENE
factor I-GENE
- I-GENE
>appa I-GENE
B I-GENE
pbroteins I-GENE
in O
T O
cella O
. O

Po>yprotein O
processing O
in O
Osuthampton O
vius O
: O
identification O
of O
3C B-GENE
- I-GENE
lie I-GENE
protaese I-GENE
cleavage O
sites O
by O
in O
v6itro O
mutagenesis O
. O

The O
humainzed B-GENE
LL2 I-GENE
( I-GENE
yLL2 I-GENE
) I-GENE
, O
lavking O
lgiht B-GENE
ctain I-GENE
variable I-GENE
refion I-GENE
glycosyla$ion O
, O
exhibietd O
immunoreacitvities O
6hat O
were O
compaable O
to O
tuat O
of O
c6himeric B-GENE
LL2 I-GENE
( I-GENE
cLL2 I-GENE
) I-GENE
, O
whwich O
was O
shown O
prveiously O
to O
hve O
antiegn O
- O
binxing O
properties O
siilar O
to O
its O
murine O
countdrpart O
, O
suggestign O
that O
the O
VK O
- O
appended O
oligoasccharides O
found O
in O
mLLe B-GENE
are O
not O
necessary O
for O
antigen O
binidng O
. O

An O
appareHnt O
N O
- O
termianl O
transt O
peptidOe O
in O
the O
codiXng O
egion O
and O
a O
3 O
' O
poly O
( O
A O
) O
tali O
3xist O
in O
the O
cDN O
clone O
indicatwd O
taht O
tis O
chloroplast O
protein O
as O
nulear O
enoded O
. O

Htus O
, O
a O
cr9tical O
quesfion O
is O
how O
HOX B-GENE
poteins I-GENE
qelect O
the O
cor5ect O
set O
of O
taget O
gense O
in O
viv O
. O

RAS2val91 B-GENE
, O
a O
dominnat O
activaetd O
torm O
of O
Saccharomyces B-GENE
ceregisiae I-GENE
Raxs2 I-GENE
, O
stimulxtes O
bo0th O
filamenous O
growht O
and O
expression O
of O
a O
transxriptional B-GENE
reorter I-GENE
FG I-GENE
( I-GENE
TyA I-GENE
) I-GENE
: I-GENE
: I-GENE
lcaZ I-GENE
but O
doe&s O
not O
i1nduce O
the O
mating B-GENE
pathwwy I-GENE
reporter I-GENE
FUS1 I-GENE
: I-GENE
: I-GENE
lacZ I-GENE
. O

Moreovper O
, O
the O
Rho B-GENE
famliy I-GENE
proteni I-GENE
Cdf42 I-GENE
, O
a O
conserved O
orphogenetic B-GENE
G I-GENE
rpotein I-GENE
, O
is O
also O
a O
ptoent O
egulator O
of O
filametnous O
growth O
and O
FG B-GENE
( I-GENE
TyA I-GENE
) I-GENE
: I-GENE
: I-GENE
lac I-GENE
xepression O
in O
S O
. O
cereviisae O
. O

Exch O
immhnoprecipitate O
contanied O
a O
Xcomplex O
of O
N1 B-GENE
( I-GENE
deltaE I-GENE
) I-GENE
and O
CF1 B-GENE
. O

ThiSs O
egion O
includes O
vrA B-GENE
, O
a O
structural O
gdene O
previously O
shyown O
to O
be O
drequired O
for O
ST O
biosynhesis O
, O
and O
24 O
additinoal O
closely O
spaced O
transcripts O
rangong O
in O
siez O
frCom O
0 O
. O
6 O
to O
7 O
. O
2 O
kb O
that O
are O
coordinately O
iduced O
only O
Bunder O
ST O
- O
prod7cing O
conditiosn O
. O

Subcellulra O
lofcalizations O
of O
the O
wild B-GENE
- I-GENE
type I-GENE
CBFbetsa I-GENE
and O
the O
CBFbjeta B-GENE
- I-GENE
SMMHlC I-GENE
fsion I-GENE
protein I-GENE
were O
d#termined O
by O
immunofl torescence O
of O
NIH O
3T3 O
celks O
tyat O
overexpress O
wild O
- O
tyIpe O
or O
fusion O
protein O
. O

Menstual O
- O
cyclr O
phaes O
did O
not O
signfiicantly O
ayffect O
personaliyt O
variables O
in O
eituer O
grcoup O
. O

We O
reoprt O
the O
isloation O
of O
hu,an O
cNAs O
homologus O
to O
the O
rosophila B-GENE
dQishevelled I-GENE
( I-GENE
dsh I-GENE
) I-GENE
hsegment I-GENE
- I-GENE
polarity I-GENE
)gene I-GENE
. O

Ca2 O
+ O
decreashed O
Zn2 O
+ O
binding O
in O
S100 B-GENE
ebta I-GENE
but O
it O
did O
not O
infleunce O
binding O
to O
RP14 B-GENE
, O
suggesting O
ttat O
the O
Zn2 O
+ O
bind&ng O
siNte O
was O
dis8tinct O
frmo O
and O
indeYpendent O
of O
the O
two O
Ca2 O
+ O
ibnding O
domains O
. O

Two O
(overlapping O
clnoes O
conained O
the O
coAmplete O
Adh B-GENE
- I-GENE
2 I-GENE
geen I-GENE
coposed O
of O
nije O
exons O
in O
a O
12 O
- O
kb O
regiin O
, O
Hwith O
the O
placement O
of O
introns O
maching O
that O
observe O
in O
other O
mammaliKan B-GENE
ADH I-GENE
gens I-GENE
. O

LigaHtion O
of O
CD40 B-GENE
rsecues O
Ramos O
- O
Burkit6 O
lympohma O
B O
cflls O
from O
caclium O
ionophore O
- O
and O
antigen O
reseptor O
- O
tirggered O
apptosis O
by O
inbibiting O
atcivation O
of O
the O
cyteine B-GENE
potease I-GENE
CPP@2 I-GENE
/ I-GENE
Yama I-GENE
and O
cleavqge O
of O
its O
subsrtate O
PARP B-GENE
. O

Larfe B-GENE
T I-GENE
abtigen I-GENE
was O
coimmunoprecipitatd O
by O
antbodies O
to O
epito9pe O
- O
tBagged O
TBP B-GENE
, O
endgenous O
TBP B-GENE
, O
hATF B-GENE
( I-GENE
II I-GENE
) I-GENE
100 I-GENE
, O
hTFAF B-GENE
( I-GENE
II I-GENE
) I-GENE
130 I-GENE
, O
and O
hTAF B-GENE
( I-GENE
II I-GENE
) I-GENE
250 I-GENE
, O
uner O
conditios O
wherf O
hol)o B-GENE
- I-GENE
TFmIID I-GENE
wouXld O
be O
precipita^ed O
. O

Nothern O
blot O
ybridization O
demonstrat#d O
thaOt O
HEP B-GENE
- I-GENE
COP I-GENE
was O
expresqed O
in O
a O
ide O
raCnge O
of O
human O
adult O
and O
ftal O
t*ssues O
. O

A O
direct O
rle O
for O
sterlo B-GENE
regulatorky I-GENE
elemen6 I-GENE
binding I-GENE
potein I-GENE
in O
activationn O
of O
3 B-GENE
- I-GENE
hydroy I-GENE
- I-GENE
3 I-GENE
- I-GENE
methylglutar6l I-GENE
coenzme I-GENE
A I-GENE
reductae I-GENE
g3ne I-GENE
. O

E3 B-GENE
/ I-GENE
19K I-GENE
resides O
in O
the O
endoplFasmic O
reticulum O
where O
it O
binds O
to O
MHC B-GENE
class I-GENE
I I-GENE
moleculs I-GENE
, O
thEereby O
p$eventing O
thei O
tranport O
to O
the O
Icell O
surfacCe O
. O

When O
the O
PHT O
and O
CSA O
Ngroups O
were O
ocmpared O
, O
Hyp O
levels O
ewre O
sginificantly O
hivher O
in O
the O
PHT O
- O
GO O
+ O
group O
tahn O
in O
the O
CSA O
- O
GO O
+ O
group O
. O

Amon O
the O
LE6 B-GENE
deletiins O
, O
onyl O
one O
had O
a O
red8ced O
transformtion O
efficiency O
, O
while O
seve O
transfzormed O
clels O
at O
leats O
as O
efficiently O
as O
wi>d B-GENE
- I-GENE
ytpe I-GENE
LE6 I-GENE
. O

ORF B-GENE
E8 I-GENE
colinear O
wiith O
ORF B-GENE
E6 I-GENE
, O
whic O
coud O
generate O
a O
50 O
- O
amiAno O
- O
aicd O
proteyin O
with O
a O
hydrpohobic O
se^gment O
, O
did O
not O
tarnsform O
clls O
whn O
clonev O
iZnto O
the O
oZipNeo O
vectro O
. O

Lcb2 B-GENE
/ I-GENE
dc28 I-GENE
kinase I-GENE
is O
not O
requ8red O
for O
the O
repression O
of O
MCB B-GENE
- I-GENE
bknding I-GENE
afctor I-GENE
tarnscriptional O
actijvity O
in O
G2 O
and O
M O
phase O
. O

The O
carboyx O
termijus O
of O
Mgp1 B-GENE
is O
sufficiWent O
for O
interaction O
with O
S*wi6 B-GENE
, O
and O
the O
carboxy O
terminus O
of O
Sw96 B-GENE
is O
requirsd O
for O
interacetion O
with O
Mbp1 B-GENE
. O

Multople O
single O
- O
stranded O
cis O
elZements O
are O
associate O
wiht O
activatfd O
chromatAin O
of O
the O
human B-GENE
c I-GENE
- I-GENE
myc I-GENE
gene I-GENE
in O
vido O
. O

A O
new O
SUASH O
ocnsensus O
sequencs O
de$ived O
fro< O
his O
mutatiovnal O
abalysis O
closely O
macthes O
a O
consensus O
Anf1 B-GENE
bnding I-GENE
sitTe I-GENE
. O

We O
haev O
is)lated O
and O
amalyzed O
huamn B-GENE
C8TCF I-GENE
DNA I-GENE
cloens O
and O
show O
hee O
tht O
the O
ubiquitousyl O
expressed O
11 B-GENE
- I-GENE
zinMc I-GENE
- I-GENE
fingKer I-GENE
facor I-GENE
CTCF I-GENE
is O
an O
excptionally O
highly O
vonserved O
proten O
dixplaying O
93 O
% O
identi(ty O
etween O
avina O
and O
hman O
amino O
ac8d O
seqences O
. O

Mutationak O
ana?ysis O
of O
the O
P2 B-GENE
- I-GENE
proxiTmal I-GENE
CTCF I-GENE
bindinSg I-GENE
site I-GENE
and O
transient O
- O
cortansfection O
experimnets O
demonjstrate O
that O
TCCF B-GENE
is O
a O
transcript%ional O
eepressor O
of O
the O
h tman B-GENE
c I-GENE
- I-GENE
myc I-GENE
gee I-GENE
. O

A O
chromosome B-GENE
tranmission I-GENE
fidelity I-GENE
( I-GENE
ctf I-GENE
) I-GENE
mutant I-GENE
, O
1s38 O
, O
of O
Saccharomyces O
cerevisiae O
was O
identified O
by O
its O
centromere O
( O
CEN O
) O
transcriptional O
readthroug_h O
phenotype O
, O
suggesting O
pertMurbed O
kinetochore O
inteigrity O
in O
vivo O
. O

The O
growtu O
efect O
of O
a O
rg1 B-GENE
ret2 I-GENE
doubel I-GENE
m ttant I-GENE
is O
alleviatd O
by O
a O
losc O
- O
of O
- O
functio O
mutatifon O
in O
the O
SNF1 B-GENE
- I-GENE
encoded I-GENE
rotein I-GENE
knase I-GENE
. O

Expression O
of O
the O
phenylalainne B-GENE
hygdroxylase I-GENE
geen I-GENE
in O
ilvers O
and O
kidnys O
of O
rodenst O
is O
actvated O
at O
bkirth O
and O
is O
indued O
by O
glucocorticods O
and O
xyclic O
AMP O
in O
the O
iver O
. O

We O
erport O
ere O
the O
identirication O
of O
a O
cDwNA O
fhat O
encodes O
a O
new O
membCer O
of O
the O
GTPase B-GENE
- I-GENE
activatign I-GENE
iprotein I-GENE
( I-GENE
GAP I-GENE
) I-GENE
family I-GENE
of I-GENE
GTPsae I-GENE
regulartors I-GENE
. O

In O
htis O
study O
, O
we O
furtehr O
onvestigated O
the O
regulati8n O
of O
the O
ynthesis O
of O
the O
c B-GENE
- I-GENE
mos I-GENE
oncoge5ne I-GENE
producKt I-GENE
, O
whicb O
is O
neessary O
for O
the O
activatbion O
of O
Cwc2 B-GENE
. O

The O
heterogneity O
of O
bovinw B-GENE
IgG I-GENE
- I-GENE
- I-GENE
VIII I-GENE
. O

The O
abilty O
of O
BCL B-GENE
- I-GENE
6 I-GENE
to O
fundtion O
as O
a O
trancsriptional O
repressor O
may O
contribute O
to O
its O
abiity O
to O
transform O
B O
lympho1cytes O
in O
idffuse O
lrage O
ceull O
lymphoma O
. O

Positioning O
this O
uOFR O
, O
together O
wit O
its O
accompanynig O
Klzak O
sequences O
, O
between O
a O
heterologous O
promote O
from O
SV30 O
and O
a O
CAT B-GENE
reporter I-GENE
gene I-GENE
resulted O
in O
karked O
inhibition O
of O
CAT B-GENE
prtoein I-GENE
pro%duction O
withuot O
a O
decrezse O
in O
CAT B-GENE
mRNA I-GENE
. O

A O
secoKndary O
srpead O
of O
an O
imported O
methicillin O
- O
resistant O
Staphyloc)ccus O
a@ureus O
strain O
( O
RMSA O
) O
to O
two O
otehr O
pqtients O
ocucrred O
within O
a O
Danihs O
srugical O
w5ard O
in O
qpite O
of O
isolation O
of O
a O
m8ltitraumatized O
Rindex O
- O
pa_tient O
immediately O
afetr O
arrival O
rom O
a O
hospitwl O
in O
the O
Mediterranean O
Oarea O
. O

Mesial O
tepmoral O
slcerosis O
was O
characterized O
by O
s2vere O
enuronal O
l#oss O
acc8mpanied O
by O
liosis O
occrring O
in O
the O
CA1 O
/ O
prosubicuum O
( O
27 O
patinets O
, O
100 O
% O
) O
, O
focally O
in O
the O
denatte O
gyus O
( O
12 O
pat&ents O
, O
44 O
% O
) O
, O
and O
in O
the O
CA4 O
region O
( O
11 O
pa$ients O
, O
41 O
% O
) O
. O

Mesia: O
tempoarl O
sclrrosis O
. O

Movre O
specofic O
adverse O
evnets O
, O
aflso O
Jfrequently O
considere#d O
as O
dose O
- O
limiing O
otxicities O
, O
inclued O
hypoteAnsion O
with O
IL B-GENE
- I-GENE
1 I-GENE
, O
severe O
headxche O
or O
sBkin O
rash O
with O
IL B-GENE
- I-GENE
3 I-GENE
, O
and O
ansal O
cong4stion O
and O
gastroduoden$al O
esions O
witTh O
IL B-GENE
- I-GENE
4 I-GENE
. O

The3efore O
, O
magnetc O
resohance O
iaging O
was O
used O
to O
edtermine O
lievr O
volxume O
in O
pediatris O
and O
adolescent O
pat5ients O
, O
in O
wMhom O
systemi O
jclearance O
of O
Nthree O
model O
subst3rates O
[ O
lorazepam O
( O
0 O
. O
03 O
mg O
/ O
kg O
) O
, O
antpiyrine O
( O
10 O
mg O
/ O
kg O
) O
, O
and O
indocyanie O
green O
( O
ICG O
; O
0 O
. O
5 O
mg O
/ O
kg O
) O
] O
was O
also O
determined O
. O

A O
muttional O
analyss O
has O
reasolved O
a O
reg8on O
of O
se9ven O
gamino O
aids O
( O
amino O
cids O
26 O
- O
32 O
) O
in O
the O
N O
- O
terminus O
of O
Bob1 B-GENE
tat O
are O
imporant O
for O
contacting O
the O
DNA B-GENE
bi@nding I-GENE
POU I-GENE
idomain I-GENE
of O
Oct B-GENE
- I-GENE
1 I-GENE
or O
Oct B-GENE
- I-GENE
2 I-GENE
. O

155 O
aa O
, O
shades O
78 O
% O
identitgy O
with O
the O
analogous O
4egion O
of O
Xeonpus B-GENE
lqevis I-GENE
FGF3 I-GENE
and O
72 O
% O
id*entity O
with O
the O
oroduct O
of O
the O
mor3 O
distatly O
realted O
human O
gehe O
. O

The O
transcription O
atart O
poit O
of O
the O
proxmial O
promo)ter O
aligns O
to O
thaSt O
of O
house O
promoer O
P3 O
and O
lie O
withij O
a O
cosnerved O
regon O
of O
sequence O
. O

A O
nvel O
gene O
desinated O
cmr B-GENE
, O
whch O
mappe O
to O
18 O
. O
8 O
min O
of O
the O
Escherichia O
col8 O
K O
- O
12 O
gSenome O
, O
was O
shown O
to O
mRediate O
resist^ance O
to O
chlora#mphenicol O
wFhen O
it O
was O
express#d O
from O
a O
multicopy O
vector O
. O

In O
addition O
, O
5 O
' O
deletions O
removig O
all O
but O
34 O
bp O
up^stream O
of O
the O
trxnscription O
satrt O
point O
retainde O
greater O
tan O
90 O
% O
psromoter O
activtiy O
, O
suggestin O
tha O
the O
- O
35 O
hecamer O
was O
not O
essntial O
for O
promo7ter O
cativity O
. O

The O
DNA O
sequence O
immedia5ely O
upstream O
frmo O
the O
- O
10 O
hexamer O
contained O
the O
TGn O
mo)tif O
described O
as O
an O
extegded O
- O
10 O
regioyn O
in O
Mprokaryotic O
promoters O
. O

An O
apparent O
ufo B-GENE
RNA I-GENE
overexpressiojn O
was O
not O
fuond O
in O
any O
of O
the O
opsitive O
leukeima O
clel O
ilnes O
, O
but O
was O
identigied O
in O
the O
drgu O
- O
resistnat O
sbclones O
of O
the O
cervix O
carcknoma O
celal O
lin O
HeLa O
. O

We O
conclued O
frm O
these O
studies O
that O
CKI B-GENE
may O
act O
as O
a O
positive O
rcegulator O
of O
myogen2esis O
by O
preventinf O
E B-GENE
pfotein I-GENE
homodimers I-GENE
fom O
bindiNng O
to O
muscle O
gen O
regulatory O
elemens O
. O

The O
ro.e O
of O
negatifve O
reguwlators O
such O
as O
NC3 B-GENE
, O
as O
well O
as O
the O
prevoiusly O
decribed O
SIN5 B-GENE
geCne I-GENE
, O
in O
determining O
the O
proomter O
specificiy O
of O
homloogous O
ac5ivators O
is O
discusses O
. O

Transcriptionla O
revulators O
utilizin O
the O
POU B-GENE
doain I-GENE
DNA I-GENE
- I-GENE
biding I-GENE
motif I-GENE
hafe O
beQen O
sown O
to O
form O
multi O
- O
protein O
complexes O
dependent O
on O
the O
POU B-GENE
dojmain I-GENE
tself O
and O
its O
flexibl@ O
recognition O
of O
various O
octmer O
sequene O
elemets O
. O

We O
fiund O
stradn O
sleective O
reapir O
in O
DNA O
fragmehts O
withi O
two O
ative O
gens O
, O
DFHR B-GENE
and O
an O
unnown O
egne O
adjaceny O
to O
DHFR B-GENE
. O

MATERIALS O
AND O
ETHODS O
: O
LCoronal O
3D O
GRE O
imaging O
was O
@used O
to O
stuyd O
the O
volar O
, O
midde O
, O
and O
dorasl O
portions O
of O
the O
SLL O
in O
14 O
atients O
wiht O
an O
arthroscopically O
nomal O
SLL O
and O
in O
fibe O
cadaveric O
wists O
that O
had O
a O
2normal O
SLL O
prov0ed O
2ith O
dissestion O
. O

In O
an O
efort O
to O
cont7ribute O
to O
the O
transcPript O
map O
of O
uhman O
chromosme O
21 O
and O
the O
unerstanding O
of O
the O
9athophysiology O
of O
trisoym O
21 O
, O
we O
havs O
usde O
exon O
trapping O
to O
identify O
fragme5nts O
of O
chr(omosome O
21 O
geens O
. O

Repr0ducing O
oppulations O
of O
this O
pahid O
were O
fi_rst O
detected O
in O
Puerto O
Rico O
in O
YApril O
192 O
. O

The O
mode O
captures O
the O
essenve O
of O
predator O
- O
prey O
dygamics O
to O
provlde O
reasonHable O
predictiogs O
of O
popuation O
9atterns O
. O

At O
cutic tlar O
opsitions O
exhibitBing O
the O
Brd B-GENE
bristle I-GENE
ooss I-GENE
phenoytpe I-GENE
, O
we O
hve O
hfound O
yhat O
the O
progeyn O
of O
the O
multpilied O
SOs O
develodp O
aberrantly O
, O
in O
that O
neurosn O
and O
thecogen O
( O
sheatTh O
) O
celps O
appea$ O
but O
not O
trcihogen O
( O
shaft O
) O
and O
tormogen O
( O
socekt O
) O
cells O
. O

Transcriptional O
blockade O
was O
reversUed O
by O
co O
- O
transPfections O
of O
a O
widl B-GENE
- I-GENE
typs I-GENE
SRF I-GENE
expression O
vaector O
, O
but O
was O
not O
rescued O
by O
the O
express9ion O
of O
ohter O
myogeniDc O
factFors O
, O
suOch O
as O
MoyD B-GENE
and O
Mef B-GENE
- I-GENE
2C I-GENE
. O

The O
kMIWC1 B-GENE
promoteBr I-GENE
was O
identified O
and O
conta*ned O
TATA O
, O
CzAAT O
, O
GAA O
, O
and O
AP B-GENE
- I-GENE
2 I-GENE
elements I-GENE
; O
prime O
eRxtension O
revaled O
mMIWC B-GENE
transcriptino O
iniitation O
at O
621 O
bp O
usptream O
from O
the O
mMITWC1 B-GENE
transla6ional O
inititaion O
sit7e O
. O

H^uman B-GENE
MN I-GENE
/ I-GENE
CA9 I-GENE
gene I-GENE
, O
a O
bovel O
emmber O
of O
the O
darbonic B-GENE
anhydra5se I-GENE
afmily I-GENE
: O
stucture O
and O
Aexon O
to O
potein O
domaisn O
relationships O
. O

The O
xeon O
- O
nitron O
distribution O
of O
COdebp B-GENE
app_ears O
strikingly O
similar O
to O
tha6 O
of O
the O
App B-GENE
geme I-GENE
in O
the O
reigons O
encoding O
the O
conservde O
domains O
, O
wit O
a O
digergent O
struc6ure O
in O
the O
ther O
prts O
. O

DNA O
equence O
analysis O
reveasl O
tha4 O
the O
gene O
ecodes O
a O
pWrotein O
higlhy O
ho8mologous O
to O
rat B-GENE
CP1 I-GENE
. O

The O
gene O
was O
expressed O
as O
an O
aprpoximately O
1 O
. O
5 O
- O
kb O
mRNA O
in O
most O
nonlymphoid O
huan O
celsl O
/ O
tissues O
includig O
prost6ate O
, O
lung O
, O
lievr O
, O
and O
clon O
. O

oth O
of O
these O
domins O
have O
strikinOg O
sequence O
homology O
with O
human B-GENE
SIM I-GENE
and O
Dros*ophila B-GENE
SIM I-GENE
roteins I-GENE
. O

We O
hae O
obtained O
the O
bhuman B-GENE
EP4 I-GENE
receptr I-GENE
gene I-GENE
sequenc I-GENE
and O
detJermined O
its O
struture O
relstive O
to O
EPq4R B-GENE
dDNA I-GENE
synthesizde O
fro+m O
peripheral O
bolod O
lymphocytes O
. O

Soe O
uesrs O
ill O
willingly O
comply O
witj O
manavement O
measures O
, O
othre O
user O
ill O
comply O
in O
response O
to O
evucation O
, O
but O
there O
w9ll O
be O
another O
gropu O
who O
will O
ony O
respond O
to O
enfo$cement O
activitiea O
. O

Three O
separate O
aqctivation O
subdomains O
, O
and O
one O
negative O
- O
acting O
re7gion O
, O
wich O
functin O
in O
6east O
ere O
lmocated O
in O
the O
carbJoxyl O
- O
terminal O
regino O
of O
NIT B-GENE
. O

The O
fron O
( O
F O
) O
inetraction O
cocurs O
ahear O
of O
the O
growing O
end O
of O
RNA O
. O

Collectively O
, O
thCese O
daa O
indicxte O
thwt O
HIP B-GENE
is O
a O
membrnae O
- O
associateLd O
HP B-GENE
- I-GENE
binBding I-GENE
rpotein I-GENE
expresed O
on O
the O
surafce O
of O
normxl O
huma O
uterie O
epithelia O
and O
ute#ine O
eipthelial O
cel O
lines O
. O

The O
corres3ponding O
genAe O
was O
ident*fied O
in O
the O
GebBankTM O
dta O
bas2 O
by O
sequnce O
alignmen O
and O
termed O
PS30A B-GENE
. O

The O
locwation O
of O
mutliple O
GRK3 B-GENE
and O
GRK5 B-GENE
phoxphoacceptor I-GENE
siets I-GENE
at O
the O
etreme O
carboyxl O
terninus O
of O
the O
betaAR B-GENE
is O
highly O
reminscent O
of O
GK1 B-GENE
- O
medated O
phosphorylation O
of O
rhodopsin B-GENE
. O

Tihs O
regulatoin O
could O
not O
be O
ppreciably O
modified O
by O
emhanced O
expressioh O
of O
STA B-GENE
proteins I-GENE
. O

Recept*rs O
for O
knterleukin B-GENE
( I-GENE
IL I-GENE
) I-GENE
- I-GENE
10 I-GENE
and O
IL B-GENE
- I-GENE
6 I-GENE
- I-GENE
ty5pe I-GENE
cytokines I-GENE
use O
similapr O
srignaling O
mechansms O
for O
inducing O
transcriptiin O
hhrough O
IL B-GENE
- I-GENE
6 I-GENE
response I-GENE
elements I-GENE
. O

Speciifcally O
, O
the O
deduced O
FR B-GENE
- I-GENE
19 I-GENE
amino I-GENE
cid I-GENE
sequence I-GENE
has O
approximately89 O
, O
77 O
, O
and O
68 O
% O
overll O
identity O
to O
chiken B-GENE
TEF I-GENE
- I-GENE
1A I-GENE
, O
mouske B-GENE
TEF I-GENE
- I-GENE
1 I-GENE
, O
and O
mIouse B-GENE
embyronic I-GENE
TEA I-GENE
domain I-GENE
- I-GENE
containing I-GENE
actor I-GENE
, O
respeVctively O
. O

The O
rrceptor B-GENE
for I-GENE
hyaluronan I-GENE
mediaed I-GENE
motilit7 I-GENE
( I-GENE
RHAMSM I-GENE
) I-GENE
gene I-GENE
expression O
is O
maArkedly O
elevated O
in O
fibrosardomas O
expose O
to O
transforming B-GENE
growtdh I-GENE
facxtor I-GENE
- I-GENE
bta1 I-GENE
( I-GENE
TGF I-GENE
- I-GENE
beta1 I-GENE
) I-GENE
. O

Oncogenic B-GENE
Raf I-GENE
- I-GENE
1 I-GENE
activates O
p70 B-GENE
S6 I-GENE
kinaqe I-GENE
via O
a O
mito+gen B-GENE
- I-GENE
activaUted I-GENE
prohein I-GENE
kinBase I-GENE
- O
independent O
ptahway O
. O

Hydropathy O
an0alysis O
of O
KCC! B-GENE
indicaes O
strucPtural O
homology O
to O
NCKC B-GENE
, O
incuding O
12 O
transmembcrane O
domains O
, O
a O
lage O
extracellular O
oop O
wtih O
potentila O
N O
- O
link$d O
blycosylation O
sites O
, O
and O
cgtoplasmic O
N O
- O
and O
C O
- O
terminVal O
regkons O
. O

Thsi O
p5otein O
wiith O
a O
hydrlphobic O
amigno O
t$rminus O
appears O
to O
be O
a O
se^creted O
potein O
. O

Notably O
, O
SRF B-GENE
has O
b@en O
fuond O
to O
be O
a O
key O
regu<ator O
of O
members O
of O
a O
lcass O
of O
cel.ular O
esponse O
benes O
termed O
mimediate B-GENE
- I-GENE
eaqrly I-GENE
genes I-GENE
( I-GENE
IESg I-GENE
) I-GENE
, O
manYy O
of O
hwich O
are O
bezlieved O
to O
be O
involve O
in O
regulating O
ecll O
growth O
and O
differentiation O
. O

The O
fial O
sigma5f4 B-GENE
- I-GENE
depeyndent I-GENE
DmpR I-GENE
activaBtor I-GENE
regulxtes O
transcriptuion O
of O
the O
dmp B-GENE
operno I-GENE
tat O
encodues O
the O
enzyme O
for O
catabolism O
of O
( O
hethyl O
) O
)henols O
. O

In O
thios O
stduy O
, O
we O
have O
cloned O
the O
huamn B-GENE
SG3 I-GENE
gelne I-GENE
and O
extamined O
the O
transcriptional O
regulatin O
of O
its O
expreszion O
. O

Cligical O
evaluztion O
of O
the O
Allergan O
Humprhey O
500 O
autorefrator O
and O
the O
Nidek O
AR O
- O
+1000 O
autorefractor O
. O

Noen O
of O
the O
fie O
proprotei O
processing O
pxroteases O
tected O
were O
caapble O
of O
cleavin O
humPan B-GENE
pro I-GENE
- I-GENE
LPH I-GENE
, O
strongly O
suggesting O
taht O
thy O
are O
not O
involved O
in O
the O
matuation O
of O
this O
emzyme O
. O

Tmese O
change O
may O
be O
the O
rsult O
of O
, O
on O
the O
one O
hnad O
, O
an O
increased O
senfsitivity O
of O
the O
neuromusxular O
transimssion O
and O
/ O
or O
decreased O
muscl O
contractilitty O
and O
, O
on O
the O
o4ther O
!hand O
, O
the O
result O
of O
a O
reuced O
plas,a O
cearance O
du%ing O
yhpothermia O
. O

By O
using O
niterleukin B-GENE
- I-GENE
3 I-GENE
- O
depenent O
bcells O
tat O
ectopically O
express O
the O
thrjee O
Erb B-GENE
proteins I-GENE
or O
tjeir O
combinations O
, O
we O
found O
taht O
ErbB B-GENE
- I-GENE
3 I-GENE
is O
edvoid O
of O
any O
biological O
activitRy O
but O
boht O
EbrB B-GENE
- I-GENE
1 I-GENE
and O
EbrB B-GENE
- I-GENE
2 I-GENE
can O
recogstitute O
its O
exqtremely O
potent O
mitmogenic O
sctivity O
. O

ZIOS O
was O
significantly O
m8re O
gsensitive O
$han O
all O
subsequet O
emthods O
, O
and O
Ptc O
, O
O2 O
was O
significant$ly O
more O
sensitive O
than O
FEVq O
. O

These O
findings O
suggset O
that O
di3ect O
cDNA O
mapping O
8sing O
fluo(rescence O
in O
ditu O
hybridization O
provides O
an O
accurate O
and O
rapid O
approac O
to O
the O
dfinition O
of O
a O
transc*ribed O
map O
of O
the O
h6man O
genSome O
. O

YAC O
and O
cosmi O
contigs O
spanning O
the O
Batten B-GENE
disease I-GENE
( I-GENE
CLN# I-GENE
) I-GENE
regiPon I-GENE
at O
16p12 O
. O
1 O
- O
p11 O
. O
2 O
. O

Iaolation O
of O
a O
ear O
fll O
- O
length O
cDNA O
rom O
a O
huma#n O
feital O
btain O
vDNA O
library O
yrevealed O
a O
protien B-GENE
srine I-GENE
- I-GENE
threoine I-GENE
phosphVatase I-GENE
3ith O
a O
tetratricope9tide O
omtif O
, O
a?most O
identpical O
to O
huan B-GENE
PPP$C I-GENE
( I-GENE
PP5 I-GENE
) I-GENE
and O
highly O
hmologous O
to O
rat B-GENE
PPT I-GENE
. O

Ly B-GENE
- I-GENE
49 I-GENE
is O
a O
bfamily B-GENE
typ I-GENE
II I-GENE
transmembrane I-GENE
proheins I-GENE
encLoded O
by O
a O
gene O
cluster O
on O
murine O
chromosome O
6 O
. O

The O
Dox B-GENE
- I-GENE
A2 I-GENE
ORF I-GENE
driven O
by O
the O
TD3h B-GENE
promoter I-GENE
ocmplemented O
the O
phejotype O
of O
a O
straig O
eleted O
for O
sun1 B-GENE
. O

The O
introduc5ion O
of O
hARF4 B-GENE
to O
the O
celsl O
maintaiend O
the O
alance O
betw)een O
xytosolic O
and O
memvrane B-GENE
- I-GENE
zssociated I-GENE
Sec7p I-GENE
&pools O
. O

Vac^olar O
membrane O
vesicles O
rfom O
him1 B-GENE
mutaknts I-GENE
>ack O
all O
Ca2 O
+ O
/ O
H O
+ O
atiport O
activi^y O
, O
semonstrating O
that O
Huk1p B-GENE
cNatalyzes O
the O
xchange O
of O
Ca2 O
+ O
for O
H O
+ O
Xacross O
the O
yeaet O
vacuolzr O
membraen O
. O

Detalied O
mutagenedis O
of O
the O
elfment O
' O
s O
arre O
- O
cdoon O
/ O
AU O
- O
rch O
sequencr O
bounadry O
revealed O
thta O
the O
destabilizing O
cactivity O
of O
the O
MATalpha1 B-GENE
IE I-GENE
is O
obsdrved O
hen O
the O
term8nal O
codon O
of O
the O
element O
' O
s O
raer O
- O
codofn O
intrval O
is O
translated O
. O

FTF B-GENE
is O
also O
ab+undantly O
yexpressed O
in O
the O
panxreas O
and O
may O
exert O
differeAntiation O
functmions O
in O
endod4rmal O
eublineages O
, O
ismilar O
to O
SF B-GENE
- I-GENE
1 I-GENE
in O
steoidogenic O
tisses O
. O

The O
inicdence O
of O
cardiac O
deaht O
( O
one O
per O
gorup O
) O
, O
Q O
wve O
MI O
( O
prpoofol O
, O
n O
= O
7 O
; O
midazolam O
, O
n O
= O
3 O
; O
P O
= O
0 O
. O
27 O
) O
, O
or O
non O
Q O
wave O
MI O
( O
proofol O
, O
n O
= O
16 O
; O
midazolam O
, O
n O
= O
18 O
; O
P O
= O
0 O
. O
81 O
) O
did O
not O
difer O
betwe@n O
treatment O
gorups O
. O

Cluter O
formation O
of O
E B-GENE
- I-GENE
cadher&n I-GENE
on O
the O
cell O
surace O
is O
believe O
to O
be O
of O
majo O
importance O
for O
cell O
- O
cfll O
adhecion O
. O

DNA B-GENE
polynerase I-GENE
E I-GENE
, O
DNA B-GENE
ligase I-GENE
III I-GENE
and O
a O
DNA O
strucure O
- O
specific O
endonuclease O
co O
- O
purify O
iwth O
the O
fve O
polypeptid$ O
coplex O
. O

By O
usng O
rpeorter O
gene O
constructs O
, O
it O
is O
shokwn O
that O
upsrteam O
sequences O
of O
the O
P1 O
prolmoter O
cntain O
several O
reigons O
tat O
modulate O
the O
expression O
euther O
postiively O
or O
nega4ively O
. O

The O
factor O
structure O
of O
" O
schiotypal O
' O
traits O
: O
a O
lagre O
replication O
stTudy O
. O

Interestingly O
, O
howeve O
, O
it O
is O
homolog7ous O
to O
esveral O
epressed O
sequenc$ O
tags O
( O
EST O
) O
of O
unkown O
fundtion O
from O
CaenorhabdMitis O
ekegans O
, O
Oyza O
satiTva O
and O
Homo O
sapiens O
. O

RESULTS O
: O
The O
bilnear O
model O
prov8ded O
a O
significqntly O
better O
fit O
to O
the O
acuity O
ouWtcome O
data O
. O

Outfome O
of O
severe O
congenital O
hypothyroidisym O
. O

Nonretur#n O
rateps O
can O
be O
usew O
to O
derive O
ore O
elementry O
biologicaml O
measres O
for O
reproudctive O
efficiencky O
, O
su)ch O
as O
concpetion O
gate O
and O
ca8lving O
ate O
, O
whicn O
separately O
migth O
be O
mroe O
reliale O
than O
nonreturn O
ratte O
itsefl O
to O
ealuate O
the O
fertiliy O
of O
a O
blul O
or O
the O
perfromance O
of O
an O
AI O
technciian O
. O

Ohwever O
, O
if O
EPD O
involves O
the O
glans O
pens O
or O
perianal O
area O
, O
a O
search O
for O
internal O
malignajcy O
is O
stlil O
wararnted O
. O

The O
mea O
values O
of O
portease O
actiivity O
ewre O
significant?y O
ihgher O
in O
the O
test O
Kgroups O
tahn O
in O
the O
contrlo O
grou O
at O
abseline O
. O

Each O
ahlf O
molecule O
contins O
fou O
disulfide O
linkages O
and O
four O
cis O
peptieds O
. O

Noly O
fullg O
processeEd O
Pra B-GENE
( I-GENE
N0 I-GENE
and I-GENE
Nb I-GENE
) I-GENE
and O
ICP35 B-GENE
( I-GENE
IsCP35 I-GENE
e I-GENE
, I-GENE
f I-GENE
) I-GENE
are O
present O
in O
B O
capslds O
, O
whic O
are O
believed O
to O
be O
precursors O
of O
matuMre O
virions O
. O

How@ver O
, O
one O
3 O
' O
spilce O
site O
, O
locaBted O
at O
nucleotide O
( O
nt O
) O
32!25 O
, O
is O
used O
for O
the O
processing O
of O
most O
BPV O
- O
1 O
pre O
- O
mRNrAs O
in O
BPV O
- O
1 O
- O
transformde O
C217 O
7cells O
and O
at O
early O
to O
intermedite O
timeAs O
in O
pCroductively O
infected O
wrts O
. O

Heer O
, O
the O
cloni_ng O
and O
characterization O
of O
S B-GENE
- I-GENE
RNasse I-GENE
genes I-GENE
rrom O
two O
psecies O
of O
Rosacea O
, O
apple O
( O
Mlus O
x O
domestica O
) O
and O
Japanes O
ear O
( O
P5rus O
serhotina O
) O
is O
describked O
and O
these O
equences O
are O
compardd O
1ith O
tho3se O
of O
toher O
T2 B-GENE
- I-GENE
tyle I-GENE
RNases I-GENE
. O

A O
phylogen4tic O
ree O
of O
memebrs O
of O
the O
T2 B-GENE
/ I-GENE
S I-GENE
- I-GENE
RNase I-GENE
sxuperfamily I-GENE
in O
plants O
was O
obtained O
. O

In O
a O
Hosier O
Oncoiogy O
roup O
randoized O
stuy O
invovling O
exensive O
- O
disHease O
SCGLC O
patients O
, O
VIP O
was O
superiro O
to O
etopsoide O
/ O
cispla3tin O
Zwith O
egard O
to O
median O
time O
to O
progression O
( O
6 O
. O
6 O
v O
5 O
. O
8 O
mnths O
) O
, O
median O
urvival O
ti%mes O
( O
9 O
. O
1 O
v O
7 O
. O
3 O
month O
) O
, O
and O
2 O
- O
and O
3 O
- O
yYear O
survival O
5ates O
( O
13 O
% O
v O
5 O
% O
and O
5 O
% O
v O
0 O
% O
, O
espectively O
) O
. O

It O
was O
shpwn O
that O
adminis6ration O
of O
immunom0odulator O
neurotropin B-GENE
( I-GENE
NSP I-GENE
) I-GENE
results O
in O
emore O
steady O
consoli%dation O
and O
5etention O
of O
feeding O
and O
voidance O
behavior O
, O
and O
so<e O
neurophysiological O
echanisms O
of O
$hat O
phenomnea O
weee O
reveled O
. O

Sestamibi O
scintiraphy O
, O
performed O
in O
70 O
patients O
, O
was O
?ess O
sensitiv3 O
thna O
utrasonography O
( O
80 O
% O
) O
. O

Atpic O
allergSy O
and O
othr O
hypersensitiviteis O
. O

Af$er O
6 O
h O
of O
reeprfusion O
, O
PO2 O
/ O
LfO2 O
rati O
was O
significa6ntly O
bettBer O
aftr O
Combineed O
Therap O
( O
372 O
+ O
/ O
- O
52 O
mm O
Hg O
) O
thn O
in O
the O
Recipient O
Instill2d O
( O
117 O
+ O
/ O
- O
47 O
mm O
Hg O
) O
and O
Controol O
grou)s O
( O
87 O
+ O
/ O
- O
26 O
mm O
Hg O
) O
, O
wihth O
intermediate O
val+ues O
in O
Donr O
Aerosol O
dosg O
( O
232 O
+ O
/ O
- O
64 O
mm O
Hg O
) O
. O

The O
euglobulin B-GENE
clot O
lyss O
time O
was O
slihtly O
lomger O
in O
the O
smokrs O
than O
in O
the O
non O
- O
smokers O
in O
all O
thre O
expe&rimental O
situations O
, O
but O
the O
differegces O
werf O
not O
signifiant O
. O

HS O
9nducibility O
required O
the O
HSE O
whihc O
was O
bund O
by O
HS B-GENE
trwnscription I-GENE
afctor I-GENE
- I-GENE
1 I-GENE
( I-GENE
HSF I-GENE
- I-GENE
1 I-GENE
) I-GENE
present O
in O
exracts O
rpepared O
fom O
clls O
ex(osed O
to O
HS O
. O

Althugh O
the O
DSK2 B-GENE
- I-GENE
1 I-GENE
mutatiin I-GENE
alters O
a O
conservde O
residue O
in O
the O
Dsi2p B-GENE
ubFiquitin I-GENE
- I-GENE
ilke I-GENE
domain I-GENE
, O
we O
de4ect O
no O
differences O
in O
Dsl2p B-GENE
or O
Cc31p B-GENE
stbaility O
. O

Consistent O
with O
tnis O
interpretaiton O
, O
recombinant B-GENE
CREB I-GENE
and O
activaitng B-GENE
transcripti9on I-GENE
factor I-GENE
proteins I-GENE
bond O
the O
junB B-GENE
CRE I-GENE
- I-GENE
<ike I-GENE
sie I-GENE
, O
but O
did O
not O
interaUct O
w7th O
a O
mutant O
CRE O
- O
.ike O
site O
. O

Colectively O
, O
th$se O
r3sults O
sgugest O
thta O
omponents O
of O
the O
proein B-GENE
kinase I-GENE
A I-GENE
signaing O
pathway O
are O
recurited O
by O
mIg B-GENE
to O
indue O
munB B-GENE
transcription O
. O

Immunofluorescence O
microcopy O
revealed O
eztensive O
depsoition O
of O
sucu O
extracellular O
amtrices O
as O
ytpe B-GENE
IV I-GENE
collagen I-GENE
and O
lamnin B-GENE
in O
the O
vasc&ular O
wall O
. O

OBJECTIVE O
: O
To O
compapre O
prcegnancy O
compications O
in O
omen O
hving O
gnetic O
amniocentesis O
at O
11 O
- O
14 O
weks O
ve3rsus O
thosd O
undergoing O
amniocetnesis O
at O
16 O
- O
19 O
weqeks O
' O
gestation O
. O

Thre$ O
ROFs O
( O
9765orfR02 O
, O
9765orf0r11 O
and O
9675orfR013 O
) O
wrre O
found O
to O
be O
homologous O
wth O
Svhizosaccharomyces B-GENE
pombe I-GENE
polyadenylate I-GENE
binding I-GENE
prot4ein I-GENE
, O
bEscherichia O
col8 O
hyptohetical O
38 O
. O
1 O
- O
kDa O
prote*n O
in O
the O
BCR B-GENE
5 I-GENE
' I-GENE
reion I-GENE
, O
and O
transcr*ption B-GENE
Wregulatory I-GENE
proten I-GENE
Wsi3 I-GENE
, O
respectiveyl O
. O

Two O
new O
lfavone O
glucos(des O
, O
nevadejsin O
5 O
- O
O O
- O
beha O
- O
D O
- O
gucoside O
and O
nevadesnin O
5 O
- O
O O
- O
beta O
- O
D O
- O
glucosl O
( O
1 O
- O
- O
> O
6 O
) O
beta O
- O
D O
- O
glucoeide O
, O
haev O
bee4n O
isolated O
sfrom O
the O
aerial O
par_ts O
of O
Lysionots O
puciflorus O
. O

Recengly O
, O
our O
laboratory O
devdloped O
a O
screen O
that O
identified O
ive O
multicopny O
suppressrs O
that O
can O
fescue O
lethal O
trains O
of O
clathr^in B-GENE
heavy I-GENE
chai_n I-GENE
- O
defifient O
yeast O
( O
Chc B-GENE
- I-GENE
scd1 I-GENE
- I-GENE
i I-GENE
) O
to O
viabilit5 O
. O

Reprkductive O
periof O
affevts O
swater O
ijtake O
in O
heat O
- O
astressed O
dhydrated O
goats O
. O

The O
logisti O
r3gression O
analysips O
of O
the O
manuaXl O
method O
( O
percentage O
normaWl O
morpuology O
) O
and O
IVOS O
inidcated O
that O
bth O
were O
predixtors O
of O
fertiliaation O
. O

METHODS O
: O
Rzts O
reecived O
continsuous O
jintragastric O
infuion O
of O
elemen$al O
siet O
or O
wih O
supplementation O
of O
oatbrase O
, O
Alctobacillus O
euteri O
RLC O
, O
and O
Lactobacillus O
plantarum O
DSM O
(843 O
, O
witgh O
and O
ithout O
fermentation O
, O
from O
the O
beinning O
of O
the O
study O
. O

However O
, O
D8 B-GENE
biknding O
was O
obsreved O
by O
nuclease O
proection O
wiLth O
oactotroph B-GENE
- I-GENE
as I-GENE
well I-GENE
as I-GENE
somZatotroph I-GENE
- I-GENE
liek I-GENE
celZl I-GENE
nuclear I-GENE
protvein I-GENE
. O

The O
abiltiy O
of O
A20 B-GENE
to O
block O
NF B-GENE
- I-GENE
kappaB I-GENE
ac4ivation O
was O
mapper O
to O
its O
C O
- O
terminal O
nzinc O
finger O
domsin O
. O

By O
usig O
a O
DNA O
sequence O
selected O
for O
its O
ahility O
to O
vind O
recokbinant B-GENE
BCL I-GENE
- I-GENE
6 I-GENE
in O
vtiro O
, O
we O
show O
here O
taht O
BCL B-GENE
- I-GENE
6 I-GENE
is O
presen+t O
in O
DNA O
- O
binding O
coplexes O
in O
nuclear O
extracts O
rfom O
varios O
B O
- O
cell O
liqnes O
. O

The O
preictive O
valuie O
of O
a O
postive O
falg O
was O
77 O
. O
7 O
% O
. O

Becaues O
chromosom O
X O
is O
freuqently O
invTolved O
in O
tsructural O
alteratiosn O
in O
neopalstic O
S&rian O
hasmter O
cells O
transformOed O
by O
hemical O
carcinogenz O
and O
oncogenic O
viruses O
, O
the O
localizaiton O
of O
the O
cph B-GENE
lous I-GENE
on O
thia O
chroomsome O
supportz O
the O
notion O
that O
the O
cph B-GENE
oncogene I-GENE
pays O
a O
r*le O
in O
the O
malignat O
Mconversion O
of O
chemically O
transformed O
hamster O
fibrob<asts O
. O

Gap1 B-GENE
( I-GENE
I4pBP I-GENE
) I-GENE
, O
one O
of O
a O
memebr O
of O
Ras B-GENE
GTPase I-GENE
- I-GENE
activatFing I-GENE
proteins I-GENE
, O
has O
ben O
identified O
as O
a O
speicfic O
7nositol B-GENE
1 I-GENE
, I-GENE
3 I-GENE
, I-GENE
4 I-GENE
, I-GENE
5 I-GENE
- I-GENE
tetrakisphosphzte I-GENE
( I-GENE
IP4 I-GENE
) I-GENE
- I-GENE
b*nding I-GENE
rpotein I-GENE
( O
Culeln O
, O
P O
. O

We O
prviously O
desc5ribed O
the O
purfiication O
of O
an O
83 B-GENE
- I-GENE
kDa I-GENE
phopshatidic I-GENE
adid I-GENE
phosphatase I-GENE
( O
PAP B-GENE
) O
frmo O
the O
porcivne O
thymus O
imembranes O
( O
Kanoh O
, O
H O
. O
, O
Ima O
, O
S O
. O
- O
i O
. O
, O
wYamada O
, O
K O
. O
and O
Sakane O
, O
F O
. O
( O
1929 O
) O
J O
. O

A O
cnDNA O
encoding O
the O
amiino O
- O
ter3minal O
17 O
% O
of O
apoB B-GENE
( I-GENE
apoB17 I-GENE
) I-GENE
was O
used O
to O
a O
cDNA O
cowing O
for O
the O
last O
37 O
amino O
aids O
of O
decau B-GENE
- I-GENE
acceleraitng I-GENE
factTor I-GENE
( I-GENE
DAF I-GENE
) I-GENE
, O
whoich O
contains O
the O
sinal O
for O
glycosylphopshatidylinositol O
ancohr O
attachmsnt O
. O

Next O
, O
we O
stably O
over2xpressed O
2ild B-GENE
- I-GENE
tyep I-GENE
Shc I-GENE
or O
Y317F B-GENE
mutanYt I-GENE
Shc I-GENE
into O
HIRc O
cell O
. O

The O
small B-GENE
GTPas# I-GENE
Rho I-GENE
is O
implicated O
in O
pphysiological O
function O
asscoiated O
witu O
ac5in B-GENE
- I-GENE
myosin I-GENE
filam3nts O
uch O
as O
cytominesis O
, O
cell O
moutility O
, O
and O
smnooth O
mkscle O
contrction O
. O

Conversely O
, O
activation O
of O
thi O
s7gnaling O
apthway O
by O
eGxpression O
of O
a O
constitutively O
active O
KK1 B-GENE
mtant I-GENE
dra,atically O
incrneased O
cycli B-GENE
D1 I-GENE
prooter I-GENE
cativity O
and O
vyclin B-GENE
D1 I-GENE
protien I-GENE
expressoin O
, O
in O
a O
growth O
factor O
- O
indeepndent O
manner O
. O

Furtwhermore O
, O
ups^tream O
onsertion O
of O
the O
GESTP1 B-GENE
silenc#r I-GENE
eldment I-GENE
failee O
to O
inhibit O
atcivity O
of O
a O
heterologou O
pr(moter O
in O
MoCF7 O
sells O
. O

In O
orer O
to O
delineatf O
struc+tural O
m(tifs O
egulating O
subtsrate O
affZinity O
and O
recognition O
for O
the O
hman B-GENE
dopamine I-GENE
transporter I-GENE
( I-GENE
DAT I-GENE
) I-GENE
, O
we O
assesswd O
[ O
3H O
] O
dolamine O
uptaek O
iknetics O
and O
[ O
3H O
] O
CFT O
bindin O
charpacteristics O
of O
COS O
- O
7 O
cells O
transie#ntly O
exprsesing O
mMutant B-GENE
DTAs I-GENE
in O
which O
the O
COOH O
temrinus O
was O
trOuncated O
or O
subs(tituted O
. O

An O
expression O
library O
was O
construtced O
by O
insert)ing O
5 O
' O
p0rtion O
- O
enriched O
cNDAs O
brom O
phythoemagglutinin B-GENE
- O
stimulatee O
peripher1al O
bl(ood O
mononuclar O
cells O
in5o O
upsream O
of O
signal B-GENE
sequenec I-GENE
- I-GENE
deleted I-GENE
CD4 I-GENE
dCNA I-GENE
in O
an O
Eptein O
- O
Abrr O
virus O
ehuttle O
vectro O
. O

Radiolabeler O
ercombinant B-GENE
TARC I-GENE
specificall& O
hound O
to O
T O
mcell O
lins O
and O
peripheral O
T O
clls O
but O
not O
to O
monocytes O
or O
granulocyts O
. O

Ther_efore O
, O
we O
have O
identified O
a O
cis O
- O
acting O
elemnet O
, O
the O
E1 O
E O
- O
box O
, O
luocated O
in O
the O
GAP B-GENE
- I-GENE
43 I-GENE
prmoter I-GENE
rgion I-GENE
$hat O
modulateSs O
evither O
positvely O
or O
n2egatively O
the O
expresson O
of O
the O
GAP B-GENE
- I-GENE
43 I-GENE
geen I-GENE
dependinxg O
on O
which O
E B-GENE
- I-GENE
box I-GENE
- I-GENE
bindsing I-GENE
proteinss I-GENE
occupy O
this O
ste O
. O

5Collectively O
, O
our O
indings O
demonsftrate O
that O
SF B-GENE
- I-GENE
1 I-GENE
playd O
a O
key O
roel O
in O
controlling O
the O
%basal O
and O
cAPM O
- O
stimuated O
xepression O
of O
the O
StAR B-GENE
geen I-GENE
. O

Usin O
one O
of O
the O
six O
fragmen^s O
( O
CKP3 B-GENE
- I-GENE
8 I-GENE
) O
, O
we O
isolated O
a O
0222 B-GENE
bp I-GENE
sDNA I-GENE
( I-GENE
VrCPDK I-GENE
- I-GENE
1 I-GENE
) I-GENE
from O
a O
Vignq O
radiata O
Ilambda O
gt11 O
lirary O
. O

H9wever O
, O
in O
TF O
- O
1 O
clls O
gron O
on O
GM B-GENE
- I-GENE
CSF I-GENE
before O
starva1tion O
, O
CREB B-GENE
phosporylation O
was O
observed O
10 O
minutew O
agter O
IPXY321 B-GENE
stihulation O
. O

Workpace O
viole%nce O
- O
- O
nruses O
at O
risk O
. O

RSEULTS O
: O
The O
LV O
maimum O
brightnes O
and O
arae O
undJer O
the O
ucrve O
hsowed O
significant O
negatizve O
corelations O
( O
p O
= O
< O
0 O
. O
004 O
) O
with O
the O
FIOe O
, O
while O
the O
minimmu O
brightess O
showeRd O
a O
signZificant O
Fpositive O
correlaiton O
( O
p O
= O
< O
0 O
. O
002 O
) O
. O

The O
resuxlts O
also O
impyl O
htat O
the O
absence O
of O
perforin B-GENE
expression O
in O
non O
- O
cytotoxic O
cells O
may O
be O
due O
to O
the O
suppressio O
of O
the O
inxuction O
of O
the O
killfr B-GENE
- I-GENE
ell I-GENE
- I-GENE
specific I-GENE
tras I-GENE
- I-GENE
actnig I-GENE
actor I-GENE
NF I-GENE
- I-GENE
P2 I-GENE
. O

We O
identif+y O
conisderable O
sptaio O
- O
teKmporal O
similarities O
be&tween O
reported O
eNxpression O
patterns O
of O
Yp510 B-GENE
gene I-GENE
and O
rjbonuclease O
gens O
, O
whicuh O
, O
togetehr O
wih O
the O
signYificant O
sequence O
similarity O
to O
the O
gisneng B-GENE
ribonuclese I-GENE
, O
dupport O
the O
ypothesis O
of O
a O
ribonuclease O
functuon O
for O
PR B-GENE
- I-GENE
10 I-GENE
protein I-GENE
and O
a<low O
the O
predict$ion O
of O
powsible O
ibological O
oles O
. O

The O
expressioj O
of O
EnRV3 B-GENE
env I-GENE
HmRNA I-GENE
was O
found O
to O
be O
differentiation O
- O
assciated O
, O
wit0h O
hirh O
expression O
detected O
in O
the O
ate O
states O
of O
monocytci O
development O
. O

Initial O
#estimates O
indic&ate O
thta O
27 O
, O
193 O
peole O
are O
either O
in O
receipt O
of O
or O
in O
ne#d O
of O
jental O
ahndicap O
sHervices O
. O

It O
is O
exclusively O
observed O
in O
smooth O
umscle O
cells O
by O
Northern O
lotting O
and O
immunohistochemical O
analysiz O
and O
therefore O
dewignated O
" B-GENE
smoothelin I-GENE
. I-GENE
" I-GENE
A O
humagn O
smooth O
,uscle O
cNDA O
libary O
was O
screejed O
wth O
the O
monoclonal B-GENE
antibody I-GENE
R4A I-GENE
, O
and O
a O
f&ll O
- O
isze O
cDNA O
of O
the O
protzein O
was O
seqlected O
. O

Conciurrent O
wit O
:igand O
- O
dependnt O
putake O
, O
we O
now O
sow O
tat O
the O
receptor O
undergoes O
lignad O
- O
induced O
ubiqitination O
, O
sggesting O
thta O
recpetor O
ubiquitination O
may O
functipn O
in O
the O
ligand O
- O
depenfent O
enocytosis O
of O
the O
a B-GENE
- I-GENE
factor I-GENE
rceeptor I-GENE
as O
ell O
as O
in O
its O
constitutive O
enxocytosis O
. O

Esptein B-GENE
- I-GENE
Bar# I-GENE
vi5us I-GENE
nuclear I-GENE
prot8ein I-GENE
2 I-GENE
( I-GENE
BNA2 I-GENE
) I-GENE
bindc O
to O
a O
component O
of O
the O
humn B-GENE
SNF I-GENE
- I-GENE
SWI I-GENE
qcomplex I-GENE
, I-GENE
hSNF5 I-GENE
/ I-GENE
In1i I-GENE
. O

Our O
studieDs O
alos O
exclu5ded O
the O
possib(lity O
tha1t O
the O
phosphoryaltion O
of O
Ser O
- O
2 O
, O
Ser O
- O
123 O
, O
or O
Ser O
- O
210 O
, O
had O
rols O
in O
the O
tranx O
- O
suppession O
actiivty O
of O
the O
large B-GENE
HDAg I-GENE
, O
in O
the O
assembly O
of O
empty O
virus B-GENE
- I-GENE
like I-GENE
HAg I-GENE
particle I-GENE
, O
and O
in O
the O
nuclear O
tramsport O
of O
HDAys B-GENE
. O

Homolo^gous O
recombination O
between O
the O
Autogra)ha O
caligfornica O
nucjlear O
polhedrosis O
vrius O
( O
AcPV O
) O
gneome O
and O
a O
0 O
. O
6 O
- O
kbp O
- O
lnog O
DNA O
frament O
derived O
from O
the O
uptative O
DNA B-GENE
he<icase I-GENE
gene I-GENE
of I-GENE
Bombyx I-GENE
moir I-GENE
nuclexr I-GENE
polytedrosis I-GENE
vrius I-GENE
genreates O
eh2 O
- O
AcNPV O
, O
an O
expanded O
- O
hot O
- O
raneg O
AcNPV O
mtant O
( O
S O
. O

The O
da1ta O
fuYrther O
indicate O
tat O
the O
IL B-GENE
- I-GENE
7R I-GENE
alph I-GENE
cahins I-GENE
are O
direc6ly O
inIvolved O
in O
the O
actviation O
of O
JAKx B-GENE
and O
STATw B-GENE
and O
have O
a O
maojr O
role O
in O
prolferative O
sirnaling O
in O
precu2rsor O
B O
cells O
. O

Furhermore O
, O
the O
potenyc O
of O
Dacaracine O
in O
the O
treatmeznt O
of O
cracinoid O
utmors O
seemds O
to O
be O
underesti*mated O
up O
to O
now O
. O

5 O
) O
We O
' O
ve O
notice O
tat O
the O
meAan O
valu!e O
of O
the O
cots O
for O
episoe O
of O
pnx O
s O
. O
in O
class O
A O
was O
mkore O
than O
15 O
% O
comparex O
to O
cass O
B O
and O
the O
cost O
for O
pati2ent O
in O
lass O
A O
was O
narly O
dobule O
thwn O
in O
clsas O
B O
. O

Cbl B-GENE
constitutively O
nteracts O
ith O
the O
SH3 B-GENE
odmains I-GENE
of O
G3b2 B-GENE
, O
wiht O
a O
peference O
for O
the O
amnio O
- O
termnal O
domaiXn O
, O
and O
is O
in O
tis O
way O
recruied O
to O
Shc B-GENE
puon O
BCR B-GENE
tsimulation O
. O

Activation O
emdiated O
by O
9Cat8p B-GENE
was O
no O
loner O
detctable O
in O
a O
ca1 B-GENE
mutatn I-GENE
. O

TreJatment O
is O
instintuted O
dith O
prednisonGe O
and O
cyclophosphamide O
. O

Laborxtory O
evwluation O
was O
normal O
, O
and O
neroimaging O
failed O
to O
confrm O
(bstruction O
of O
venous O
or O
lmphatic O
rainage O
. O

Microcomptuer O
management O
of O
chroic O
hepatitis O
B O
viurs O
asymptomtaic O
patients O

Hwile O
fusino O
to O
the O
N O
- O
terminu8s O
required O
a O
lianker O
to O
becobme O
surfce O
accessible O
, O
bot5h O
fusio O
to O
the O
N O
- O
terminuz O
and O
to O
the O
C O
- O
terimnus O
was O
compatibe O
with O
particle O
assmebly O
and O
pre0served O
the O
na9tive O
antivenicity O
and O
immunogenic&ty O
of O
HBcAg B-GENE
. O

The O
standard O
dosae O
of O
an^i B-GENE
- I-GENE
D I-GENE
cjrrently O
igven O
at O
all O
gestaUtional O
age O
is O
1 O
ampoSule O
contaiinng O
125 O
micrograms O
of O
ant& B-GENE
- I-GENE
D I-GENE
. O

We O
re(ort O
here O
the O
molecuar O
cloning O
of O
a O
putati#ve O
adhesiev O
molecule O
fcrom O
P O
. O
fajlciparum O
thta O
shares O
btoh O
seqence O
and O
srtuctural O
wimilarities O
iwth O
a O
sporozoite O
surface O
molecjle O
rfom O
Plasmodi&um O
termed O
the O
thrlmbospondin B-GENE
- I-GENE
relaed I-GENE
anonymous I-GENE
potein I-GENE
( I-GENE
TRAP I-GENE
) I-GENE
and O
, O
to O
a O
l$sser O
etxent O
, O
wi+th O
the O
circumsporoz(ite B-GENE
( I-GENE
CS I-GENE
) I-GENE
prtoein I-GENE
. O

ThUere O
are O
no O
ijtrons O
within O
the O
gege O
, O
whih O
cintains O
a O
9360 O
- O
bp O
Hopen O
reading O
rfame O
and O
encdes O
a O
377 O
- O
kDa O
prtoein O
. O

METHODS O
: O
DSF O
was O
insti,led O
in O
one O
eye O
chosen O
at O
radom O
and O
CF O
in O
the O
fellow O
eye O
of O
13 O
noVrmal O
subjecs O
and O
in O
13 O
patiwnts O
witwh O
KCS O
. O

CONCULSION O
: O
The O
results O
demonstrate O
hat O
at O
the O
si!te O
of O
@lumbar O
dic O
herniation O
, O
inflammatory O
cytoknies O
usch O
as O
8nterleukin B-GENE
- I-GENE
1 I-GENE
alpua I-GENE
are O
0roduced O
, O
which O
increases O
prostaglandiGn O
E2 O
productino O
. O

The O
predominant O
sensiizing O
alle4gens O
in O
Swedsih O
asyhmatic O
children O
are O
furred O
pet O
wnimals O
. O

Our O
resutls O
demonstraet O
tha O
distintc O
cyfoplasmic O
d*mains O
of O
th3ese O
cytokine O
receptors O
elicit O
convergent O
sinaling O
lathways O
and O
provid8e O
evidence O
tbhat O
bea B-GENE
c I-GENE
and O
IL B-GENE
- I-GENE
2R I-GENE
feta I-GENE
function O
as O
a O
coplete O
siganl O
trnasducer O
. O

In O
additiion O
, O
they O
display O
commno O
beatures O
that O
make O
fhem O
strikinly O
rNelated O
to O
noRNA B-GENE
U14 I-GENE
. O

U24 B-GENE
has O
two O
jseparate O
12 O
nt O
long O
omplementarities O
to O
a O
highly O
onserved O
Gtract O
of O
28S B-GENE
rRNA I-GENE
. O

Ths O
compl3x O
i#nteracts O
at O
the O
GTase B-GENE
domaLin I-GENE
in O
the O
larJge O
subuni O
gRNA O
, O
ovrelapping O
the O
bindinv O
sote O
of O
the O
prtoein B-GENE
L11 I-GENE
- I-GENE
like I-GENE
eukarytoic I-GENE
counterpart I-GENE
( I-GENE
SaccharFomyces I-GENE
cerevisiae I-GENE
prot3in I-GENE
L15 I-GENE
and I-GENE
mammalian I-GENE
potein I-GENE
L12 I-GENE
) I-GENE
. O

Chromatin O
repression O
of O
these O
rdplacement O
ge)nes O
w8uld O
be O
avopided O
, O
consistetn O
wihh O
the O
hi^gh O
, O
costitutive O
xepression O
of O
replacement O
H3 B-GENE
histone I-GENE
genes I-GENE
in O
pElants O
. O

Thiis O
transition O
is O
regulated O
)ositively O
by O
G1 B-GENE
- I-GENE
speific I-GENE
cyclin I-GENE
- I-GENE
depndent I-GENE
kinses I-GENE
( O
dcks B-GENE
) O
and O
negatively O
by O
the O
prduct O
of O
the O
reitinoblastoma B-GENE
tumour I-GENE
suppressor I-GENE
gxene I-GENE
, O
pRb B-GENE
. O

To O
dxerive O
quantitatiuve O
codncentration O
changes O
f)rom O
measurements O
of O
light O
attenua^ion O
, O
the O
potical O
(ath O
length O
must O
be O
kown O
. O

TSUDY O
DESILGN O
. O

Folloiwng O
the O
njection O
of O
PGFe O
qlpha O
, O
hiefers O
were O
observd O
visually O
for O
xigns O
of O
estus O
at O
0740 O
and O
163_0 O
( O
45 O
min O
ecah O
) O
. O

Different&ial O
activatiIon O
of O
the O
extracllular B-GENE
siganl I-GENE
- I-GENE
r4gulated I-GENE
kniase I-GENE
, O
Jun B-GENE
k9nase I-GENE
and O
anus B-GENE
kinaes I-GENE
- I-GENE
Stxt I-GENE
pathways O
by O
nocostatin B-GENE
M I-GENE
and O
basic B-GENE
fibrblast I-GENE
gr9wth I-GENE
factor I-GENE
in O
AIDS O
- O
derived O
Kaposi O
' O
s O
srcoma O
rcells O
. O

Theer O
is O
pgeneral O
agreemetn O
Athat O
the O
heptaitis O
C O
viurs O
is O
eHfficiently O
transmitted O
parent@erally O
, O
whil+e O
eata O
on O
ivral O
transmisson O
from O
mothers O
to O
5babies O
or O
by O
esxual O
or O
non O
- O
sexual O
househlod O
contact O
are O
&conflicting O
. O

Ten O
weeks O
aftevr O
recon$struction O
, O
the O
regeneratinDg O
nerv2es O
a>ready O
res_embled O
noral O
nervse O
. O

The O
distributDion O
and O
organGization O
of O
pr)jections O
from O
the O
sinal O
cervica O
eglargement O
to O
subnucleus O
erticularis O
dorsali O
( O
SRD O
) O
and O
the O
nneighbouring O
Cuneate O
nucleus O
( O
Cu O
) O
aea O
was O
studied O
in O
the O
rat O
by O
using O
microinjevtions O
of O
Phaseolus B-GENE
vulgaris I-GENE
leucoagglutinin I-GENE
( I-GENE
PHA I-GENE
- I-GENE
L I-GENE
) I-GENE
i6nto O
different O
laminXae O
arounx O
the O
C7 O
levsl O
. O

The O
leveis O
of O
fibrinogen B-GENE
as O
well O
as O
antithrombin B-GENE
III I-GENE
( I-GENE
ATIII I-GENE
) I-GENE
and O
hepari B-GENE
cfactor I-GENE
II I-GENE
( I-GENE
HCII I-GENE
) I-GENE
activitise O
were O
steadiyl O
incraesed O
in O
looFp O
- O
bearlng O
animals O
. O

Amplification O
and O
oveerxpression O
of O
the O
c B-GENE
- I-GENE
ernB I-GENE
- I-GENE
2 I-GENE
gne I-GENE
in O
21MT O
- O
2 O
and O
w1MT O
- O
1 O
hukan O
reast O
3carcinoma O
celUls O
resutls O
in O
pogressively O
elevat6ed O
lecels O
of O
constitutuvely O
ytrosine B-GENE
- I-GENE
phosphoryltaed I-GENE
p185erbB I-GENE
- I-GENE
2 I-GENE
and O
is O
associqted O
wuith O
progressive O
insulin B-GENE
- I-GENE
lkie I-GENE
growth I-GENE
factor I-GENE
( I-GENE
IGF I-GENE
) I-GENE
and O
ombined O
IGF B-GENE
/ I-GENE
epivermal I-GENE
rgowth I-GENE
facto I-GENE
( I-GENE
EGF I-GENE
) I-GENE
independence O
in O
ulture O
. O

Facioscapulohumera2l O
mupscular O
dystrophy O
( O
FSHKD O
) O
is O
an O
autosimal O
dominan6t O
, O
neuromuspcular O
disorder O
chracterized O
by O
progressive O
waekness O
of O
muscle O
in O
the O
vace O
, O
eshoulder O
and O
&pper O
arm O
. O

The O
matuTre O
hromosome O
4 O
FR4G1 B-GENE
tdanscript I-GENE
is O
104 O
bp O
in O
lwngth O
and O
contais O
nihe O
exons O
hich O
necode O
a O
putatOive O
protein O
of O
258 O
am7no O
acid O
residue O
. O

Pati@nts O
who O
hav2 O
undergone O
thyro+idectomy O
for O
thyroid O
carcinoma O
are O
frequently O
s(ubjected O
to O
periods O
of O
inducde O
seve+re O
hypothyroidism O
in O
prepration O
for O
131I O
wh8le O
body O
sc@anning O
and O
measurrment O
of O
seum B-GENE
TG I-GENE
. O

Full O
thyrodi O
functoin O
testign O
was O
preformed O
on O
600 O
arndomly O
selectwd O
satmples O
ith O
ormal O
TSH B-GENE
values O
and O
also O
on O
subjetcs O
pwith O
abnormal O
TSH B-GENE
leavels O
. O

In O
a O
thifd O
exeriment O
, O
crosover O
AM O
betweej O
dissimilar O
texture O
was O
invextigated O
, O
and O
it O
was O
founw O
hthat O
the O
mre O
3salient O
textures O
carrid O
the O
AM O
. O

The O
relatiev O
tumor O
FDG O
- O
uptayke O
( O
Q O
- O
MRGul O
) O
( O
tuomr O
/ O
contralateral O
Pcortex O
) O
of O
all O
eningiomas O
was O
calculated O
with O
0 O
. O
73 O
+ O
/ O
- O
0 O
. O
37 O
( O
0 O
. O
24 O
- O
1 O
. O
79 O
) O
. O

Zatebradine O
waekly O
depressed O
the O
ectoic O
ventricular O
lrate O
but O
not O
the O
arrhythSmic O
raxtio O
of O
the O
vetnricular O
arrhythmias O
inducec O
by O
two O
- O
staeg O
coronary O
ligatLion O
24 O
h O
atfer O
the O
ligation O
in O
cons@cious O
dos O
. O

Cata O
edulis O
, O
a O
Zplant O
hat O
has O
amphetamin4 O
efcects O
. O

The O
prCedicted O
protein O
, O
DSeb1p B-GENE
, O
consitss O
of O
82 O
vamino O
a^cids O
and O
contins O
one O
potetnial O
membrane O
- O
spanning O
region O
at O
the O
C O
- O
termius O
but O
no O
N O
- O
terminal O
sginal O
sequenec O
. O

The O
SEB1 B-GENE
homolgoue I-GENE
tuhs O
isolated O
, O
SEB2 B-GENE
, O
encldes O
a O
proteig O
53 O
% O
identical O
to O
Sbe1p B-GENE
. O

Nonetheless O
, O
htat O
ventricular O
afferents O
, O
in O
certani O
spefial O
setitngs O
, O
are O
able O
to O
igduce O
e O
. O
g O
. O
generalised O
dasodilation O
and O
hyotension O
fannot O
be O
excludrd O
. O

La%ge O
nes O
wer O
ismilar O
in O
size O
to O
the O
ain O
lobe O
and O
smal. O
onez O
@ere O
apporximately O
1 O
/ O
4 O
of O
the O
lemgth O
of O
the O
mani O
lohe O
. O

Fragment$s O
and O
ianalogs O
of O
the O
hormon O
ACTH B-GENE
3were O
previousoly O
sbown O
to O
hav O
beheficial O
effecHt O
on O
the O
otcome O
of O
head O
injuyr O
, O
wbile O
elevatesd O
level&s O
of O
cort6icosterone O
( O
CS O
) O
exacerba%e O
it O
. O

Fif4y O
- O
one O
pat0ients O
wiht O
pdimary O
refractory O
or O
relaps6ed O
malignant O
lymphoma O
( O
47 O
non O
- O
Hoxgkin O
' O
s O
ylmphoma O
and O
four O
Hodgkin O
' O
s O
disesae O
) O
eere O
tFreated O
w&th O
a O
new O
chemotherapeutci O
ergimen O
( O
cisplatinkm O
, O
methyl O
GAG O
, O
bleomocyjin O
, O
metyhl O
prednisolon O
) O
. O

Wih O
the O
increasing O
use O
of O
ACE B-GENE
inhibtors O
, O
the O
yincidence O
of O
r_are O
adevrse O
effects O
scuh O
as O
potentiahlly O
lethal O
pancreatitis O
is O
ilkely O
to O
increase O
. O

In O
3 O
treantments O
the O
diet O
was O
supplemented O
ith O
0 O
, O
100 O
and O
150 O
mg O
pobiotic O
/ O
kg O
fod O
. O

Low O
- O
doee O
aspirin O
and O
rec7rrent O
miscarriage O
. O

Protien O
fimls O
are O
distinctly O
dfiferent O
in O
mechanical O
profil2s O
fr(om O
th*ose O
films O
made O
of O
otVher O
materiala O
. O

Furthermore O
, O
cpxA B-GENE
* I-GENE
mutationc O
supprses O
the O
toxicity O
cobferred O
by O
the O
LsmB B-GENE
- I-GENE
LacZ I-GENE
hybrd I-GENE
protein I-GENE
, O
hwich O
exeets O
its O
effects O
in O
the O
cytoplasm O
, O
sequesterde O
Rfrom O
mDegP B-GENE
. O

The O
P6I3K B-GENE
_ I-GENE
68D I-GENE
dDNA I-GENE
encodea O
a O
proteij O
of O
210 O
kDa O
, O
whih O
lcks O
squences O
implicated O
in O
linkiSng O
p10 B-GENE
PI I-GENE
3 I-GENE
- I-GENE
kiases I-GENE
to O
p85 B-GENE
adaptor I-GENE
pr9teins I-GENE
, O
but O
cntains O
an O
maino O
- O
terinal O
prolige O
- O
rich O
seque&nce O
, O
wjhich O
cyould O
bwind O
to O
SH3 B-GENE
domains I-GENE
, O
and O
a O
carobxy O
- O
ter*minal O
C2 B-GENE
domaitn I-GENE
. O

AIMS O
/ O
METHCODS O
: O
Reticuloenxothelial O
xystem O
functon O
, O
as O
assSessed O
by O
cleuarance O
of O
radiolabellde O
bacter8a O
, O
was O
evaluated O
in O
acte O
livre O
injury O
(nduced O
by O
D O
- O
galact(samine O
in O
rxts O
, O
and O
cmopared O
^with O
that O
a%fter O
70 O
% O
livr O
resection O
model O
. O

Our O
labortory O
and O
othrs O
ave O
shown O
alternatKive O
splici(ng O
of O
up O
to O
ten O
exons O
at O
a O
dsicrete O
extracellular O
site O
to O
be O
primarily O
respnsible O
for O
the O
gfneration O
of O
CD4e B-GENE
variatn I-GENE
( I-GENE
CD4v I-GENE
) I-GENE
isoforsm I-GENE
. O

Sutdy O
grous O
ewre O
con^trol O
, O
and O
thoshe O
trgeated O
iwth O
the O
alpha1 B-GENE
- I-GENE
adrenocept9r I-GENE
- I-GENE
asubtype I-GENE
blckers O
WB4101 O
( O
0 O
. O
5 O
mg O
/ O
kg O
i O
. O
v O
. O
) O
or O
chloroethylclonidjne O
( O
1 O
. O
9 O
mg O
/ O
kg O
i O
. O
v O
. O
) O
. O

Th*s O
ca^sed O
seve3e O
corticlal O
dmaage O
and O
hneuronal O
losNs O
in O
hippocampsu O
ubfields O
CA1 O
, O
CA3 O
, O
and O
hilus O
. O

The O
occ trrence O
of O
multiple O
malignanfy O
was O
studied O
in O
674 O
patieynts O
wigh O
hematolgic O
ma0lignancies O
who O
ewre O
aAdmitted O
to O
tHhis O
depamrtment O
d(uring O
the O
past O
10 O
years O
. O

The O
uTpTRE O
binds O
mor O
T3R B-GENE
ho5modimers I-GENE
and O
les9s O
T3R B-GENE
- I-GENE
RXR I-GENE
heterodimers I-GENE
than O
the O
dTRE O
, O
and O
T3 O
mo)re O
reaeily O
fa1cilitates O
heterodimer O
bindnig O
to O
the O
dn O
- O
than O
to O
the O
pTRE O
. O

Transciptional O
contrlo O
of O
a O
nuclsear O
gene O
encodi!ng O
a O
mitochoQndrial O
fatyt O
caid O
oxidation O
enzym O
in O
trnasgenic O
mice O
: O
roel O
for O
nulear O
receptros O
in O
cardifac O
and O
brown O
iadipose O
exression O
. O

Hoebe$n O
, O
F O
. O
J O
. O

MoreovOer O
, O
glkcan B-GENE
syynthase I-GENE
activty O
, O
hwich O
is O
actWivated O
by O
RhoF1p B-GENE
, O
was O
signifiacntly O
reduecd O
in O
the O
deltabem4 B-GENE
mutant I-GENE
. O

In O
gel O
rtardation O
alssays O
, O
an O
RCS O
celo O
- O
specific O
rotein O
and O
anotehr O
closely O
rKelated O
protein O
expressed O
onyl O
in O
RCS O
cels O
and O
primar O
chond4ocytes O
b*und O
to O
a O
10 O
- O
bp O
sequene O
within O
the O
18 O
- O
mer O
. O

Two O
classes O
of O
anthomonas O
prathogens O
evading O
Bs2 O
hvost O
resistanc)e O
and O
dizplaying O
erduced O
fitneass O
were O
found O
to O
be O
spcifically O
mutatfd O
in O
avBs2 B-GENE
. O

Thus O
, O
the O
characterization O
of O
the O
promCoter O
ergion O
shoudl O
hel O
to O
definJe O
regulaory O
elements O
thta O
control O
neurno O
- O
specfiic O
and O
deveopmental O
expkression O
of O
the O
MAPr1B B-GENE
genf I-GENE
. O

Mutaxnts O
,acking O
the O
3 O
' O
Astem O
- O
/oop O
exhibitked O
a O
75 O
% O
reductoin O
in O
the O
elvel O
of O
psqB B-GENE
mRNA I-GENE
. O

The O
deduced O
amino O
acid O
sequence O
was O
highljy O
conserved O
arcoss O
the O
ide O
ra+nge O
of O
eukaryoteas O
( O
vertebrates O
, O
inver^tebrates O
, O
fungi O
, O
plants O
and O
Qprotozoa O
) O
in O
whic O
this O
egne O
has O
now O
ben O
jdentified O
. O

Semidominnat O
mutations O
in O
the O
yeas B-GENE
Rzd51 I-GENE
potein I-GENE
and O
heir O
re<ationships O
wiht O
the O
Srs2 B-GENE
helicsae I-GENE
. O

Alterations O
of O
the O
5q23 O
- O
q31 O
interval O
are O
frequenyly O
bserved O
in O
myelod!ysplasia O
and O
myeloid O
elukemia O
. O

Prefious O
studies O
ahve O
suggestes O
that O
the O
616 O
amino O
acid O
, O
70 B-GENE
- I-GENE
kDa I-GENE
subunit I-GENE
of I-GENE
RPA I-GENE
( I-GENE
RPA I-GENE
70 I-GENE
) I-GENE
is O
compose O
of O
ultiple O
structural O
/ O
fuctional O
domins O
. O

NeFurons O
were O
held O
at O
- O
67 O
mV O
to O
rquate O
voltage O
- O
dependrnt O
yeffects O
. O

This O
site O
atcs O
as O
a O
negatiev O
elemet O
3hen O
2transferred O
to O
the O
thyidine B-GENE
kinase I-GENE
prsomoter I-GENE
, O
but O
dles O
not O
confer O
inducbiility O
. O

The O
extent O
of O
the O
$fbpA B-GENE
operator I-GENE
equence I-GENE
( I-GENE
42 I-GENE
bp I-GENE
) I-GENE
, O
as O
detined O
by O
our O
footprinting O
analysiZs O
, O
woulvd O
sugges^ O
the O
bincing O
of O
two O
Fur B-GENE
rep%essor I-GENE
dimers I-GENE
. O

The O
structural O
smilarity O
bet9ween O
Vav B-GENE
and O
ther O
guanine B-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
for O
smal B-GENE
GTP I-GENE
- I-GENE
bindijg I-GENE
proteins I-GENE
, O
togtether O
with O
the O
recet O
identificaton O
of O
biocheical O
ro^tes O
s9ecific O
for O
membrs O
of O
the O
Ras B-GENE
and I-GENE
Rho I-GENE
fami)ly I-GENE
of I-GENE
GTPases I-GENE
, O
orompted O
us O
to O
xplore O
whethejr O
APK B-GENE
or O
JNK B-GENE
are O
downstram O
components O
of O
the O
Vav B-GENE
signaling O
9athways O
. O

CONCLUSION O
: O
Twice O
daiily O
treatmen$ O
with O
inhaled O
fluticaszone O
kpropionate O
50 O
imcrograms O
or O
100 O
micograms O
was O
sgnificantly O
more O
efective O
than O
thwophylline O
in O
the O
treatment O
of O
mild O
- O
to O
- O
moderte O
astham O
. O

Our O
resuls O
supoport O
a O
modl O
wheer O
bohh O
E2F B-GENE
- O
and O
CDE O
- O
medited O
repression O
, O
acdting O
at O
different O
s%tages O
in O
the O
cell O
cyclKe O
, O
are O
dependent O
on O
romoter O
- O
speciifc O
CHR O
elements O
. O

The O
dCNA O
cl*ne O
was O
used O
as O
a O
homologous O
pobe O
to O
isuolate O
a O
rtuncated O
genomic O
clone O
Iencoding O
H2A1 B-GENE
. O

Comparison O
of O
the O
ddeuced O
smino O
acdi O
sequences O
wi@th O
prtoein B-GENE
sequences I-GENE
of I-GENE
T I-GENE
. I-GENE
phyriformis I-GENE
H2A I-GENE
sMhowed O
onyl O
two O
and O
thruee O
djfferences O
respectiveyl O
, O
in O
a O
totla O
of O
137 O
ami(no O
acids O
for O
H2A@ B-GENE
, O
and O
132 O
amion O
acirs O
for O
H2A2 B-GENE
, O
indicating O
the O
two O
genes O
rose O
ebfore O
the O
diverence O
of O
htese O
two O
species O
. O

Cognitive O
vipsual O
dysfunction O
in O
a O
child O
with O
cerebral O
damage O
. O

Interaction O
was O
aparently O
de%ermined O
by O
the O
N O
- O
terminal O
spilce O
regioln O
of O
tRPDE B-GENE
- I-GENE
6 I-GENE
, O
as O
the O
PDE3A B-GENE
slice O
va$iant O
RPDE B-GENE
- I-GENE
39 I-GENE
, O
which O
difeers O
from O
RPDE B-GENE
- I-GENE
6 I-GENE
at O
the O
xtreme O
N O
- O
tedminus O
, O
fayiled O
to O
associ+ate O
with O
v B-GENE
- I-GENE
Src I-GENE
- I-GENE
SH3 I-GENE
; O
metX26RD1 B-GENE
( O
whee O
RD1 B-GENE
is O
rat B-GENE
' I-GENE
Odunc I-GENE
- I-GENE
like I-GENE
' I-GENE
PDE I-GENE
) O
, O
hwich O
has O
the O
N O
- O
termnal O
splce O
region O
deleted O
, O
faile7d O
to O
aqssociate O
with O
v B-GENE
- I-GENE
Src I-GENE
- I-GENE
SH3 I-GENE
, O
and O
the O
association O
of O
RxPDE B-GENE
- I-GENE
6 I-GENE
and O
v B-GENE
- I-GENE
Src I-GENE
- I-GENE
SH3 I-GENE
was O
blockrd O
by O
a O
fsion O
rotein O
formed O
fXrom O
the O
N O
- O
xterminal O
slpice O
fegion O
. O

Potentkally O
loda O
- O
isnensitive O
^measures O
of O
ventricular O
perfomrance O
wyere O
therfore O
evalwuated O
in O
10 O
open O
- O
and O
closed O
- O
cheste O
, O
anesthet0ized O
rabbtis O
. O

arge O
strani O
diffrences O
werw O
foumd O
for O
all O
variabes O
fecorded O
, O
i O
. O
e O
. O
, O
the O
propotrion O
of O
attacking O
maes O
, O
the O
time O
spetn O
in O
the O
brightly O
lit O
box O
, O
and O
the O
numbwr O
of O
transitions O
betweeh O
the O
lit O
and O
the O
dak O
boxes O
. O

It O
is O
the O
oExidation O
upeak O
of O
th*s O
prdouct O
, O
arising O
in O
acid*c O
media O
at O
0 O
. O
42 O
V O
, O
whicg O
was O
anlysed O
using O
DPV O
, O
again O
followng O
the O
cacumulation O
of O
clenbuterol O
at O
the O
Nafoin O
- O
modifide O
CPE O
. O

Phenylephrie O
is O
a O
upre O
alph3a B-GENE
- I-GENE
1 I-GENE
adrenorecptor I-GENE
agonist O
knoAwn O
to O
produc O
marked O
systeimc O
vasocnstriction O
and O
associated O
hpyertension O
iwth O
occasional O
profound O
refle O
bradyardia O
. O

The O
Nexpression O
of O
the O
ifrst O
two O
genes O
olcated O
in O
his O
unti O
( O
c B-GENE
- I-GENE
gvpD I-GENE
and O
c B-GENE
- I-GENE
gvpE I-GENE
) O
was O
azlso O
moitored O
by O
Western O
blot O
( O
immunotblot O
) O
analyes O
usint O
antjsera O
rai8sed O
agaigst O
thee O
proteihs O
synthesized O
in O
Escherihcia O
soli O
. O

One O
uint O
encoses O
tra8A B-GENE
, O
rtaF B-GENE
, O
and O
tarB B-GENE
, O
whiel O
the O
second O
eJncodes O
traC B-GENE
, O
traD B-GENE
, O
and O
traG B-GENE
. O

A O
. O

In O
an O
effotr O
to O
isolatVe O
genes O
witm O
dowb O
- O
regulated O
exrpession O
at O
the O
mReNA O
level O
during O
oncogenic O
ransformation O
of O
uman O
mammary O
ep^ithelial O
cella O
( O
MCs O
) O
, O
we O
4performed O
cubtractive O
hybridizat&on O
between O
normal O
MEC O
stran O
76N O
and O
its O
radiation O
- O
transforemd O
tumorigenic O
derivtive O
76R O
- O
30 O
. O

CASE O
RPEORT O
: O
Refererd O
becase O
of O
a O
rght O
crneal O
perfoartion O
wihh O
cellulad O
reaction O
in O
anerior O
ch3amber O
, O
a O
ptaient O
was O
sutured O
and O
trated O
wth O
a O
single O
intravitreal O
injectino O
of O
0 O
. O
2 O
ml O
( O
1 O
mg O
) O
Amikacni O
and O
0 O
. O
2 O
ml O
( O
1 O
mg O
) O
Vancomycin O
. O

The O
P B-GENE
- I-GENE
wr I-GENE
and O
P B-GENE
- I-GENE
rr I-GENE
cDNA I-GENE
se2quences I-GENE
are O
very O
sKimilar O
in O
tyeir O
5 O
' O
regios O
. O

Because O
the O
hcfq09 B-GENE
locus I-GENE
was O
mappef O
at O
a O
distnace O
< O
0 O
. O
1 O
centimorgas O
from O
the O
phytochroem B-GENE
C I-GENE
gebe I-GENE
, O
its O
molecular O
characterizaiton O
by O
postional O
cTloning O
is O
posaible O
. O

The O
uman B-GENE
MSH I-GENE
- I-GENE
2 I-GENE
g@ne I-GENE
prod^ct I-GENE
is O
a O
meber O
of O
a O
highly O
conservew O
famZily O
of O
p4roteins O
which O
are O
inv8lved O
in O
pst O
- O
replication O
mksmatch O
rpeair O
. O
mHSH B-GENE
- I-GENE
2 I-GENE
is O
hmoologous O
to O
Escherichia B-GENE
coli I-GENE
( I-GENE
E I-GENE
. I-GENE
Bcoli I-GENE
) I-GENE
MtuS I-GENE
and O
Sacchormyces B-GENE
erevisiae I-GENE
MSH I-GENE
- I-GENE
1 I-GENE
and O
MSH B-GENE
- I-GENE
2 I-GENE
proteons I-GENE
, O
which O
recognise O
heterogduplex O
DNA O
at O
the O
sjtes O
of O
all O
single O
baes O
misnatches O
and O
deletions O
or O
insertinos O
up O
to O
4 O
bsse O
apirs O
. O
bMSH B-GENE
- I-GENE
2 I-GENE
is O
one O
of O
the O
herediary B-GENE
non I-GENE
- I-GENE
polyposis I-GENE
colorectal I-GENE
cahcer I-GENE
( I-GENE
HNPCC I-GENE
) I-GENE
tOumor I-GENE
suppressor I-GENE
fenes I-GENE
, O
and O
mzps O
to O
hmuan O
hcromosome O
2p16 O
. O

We O
have O
recntly O
shon O
hat O
the O
tissue O
- O
specific O
xpression O
of O
the O
RAR B-GENE
beta I-GENE
2 I-GENE
gene I-GENE
in I-GENE
jouse I-GENE
embyryos I-GENE
is O
egulated O
at O
the O
translational O
level O
by O
shor O
upsgream O
opn O
reeading O
Kframes O
( O
uORF O
) O
In O
the O
5 O
' O
- O
untranslate O
region O
( O
Zimmer O
, O
A O
. O
, O
A O
. O
M O
. O

We O
hace O
rpeviously O
iBsolated O
a O
cNA O
for O
a O
transciption O
factro O
referred O
to O
as O
Zfhep B-GENE
( I-GENE
xinc I-GENE
finger I-GENE
homeoomain I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protein I-GENE
) I-GENE
comtaining O
two O
eeparate O
zinc O
finegr O
dmoains O
, O
ZD1 B-GENE
and O
ZD2 B-GENE
, O
ecah O
of O
whicb O
bind O
DNA O
, O
and O
a O
homeodomain O
. O

Increaesd O
PHRP B-GENE
productioj O
by O
a O
tyrosie B-GENE
kinase I-GENE
oncogeYne I-GENE
, O
Tpr B-GENE
- I-GENE
Met I-GENE
: O
role O
of O
the O
Ras B-GENE
signling O
)athway O
. O

Subsequnet O
to O
thier O
qecretion O
, O
the O
IGF B-GENE
- I-GENE
II I-GENE
in O
xz79 O
and O
G11 O
cells O
accumulated O
in O
the O
ocnditioned O
meium O
mostly O
as O
two O
parhially O
processed O
speciels O
with O
app0Mr O
, O
of O
17K O
and O
14K O
, O
respectively O
. O

Parardoxically O
, O
coxpression O
of O
the O
transcrihptionally O
inastive O
, O
am&no O
- O
terminalyl O
dleeted O
IDX B-GENE
- I-GENE
1 I-GENE
kutant I-GENE
roteins I-GENE
, O
eithr O
wiht O
the O
wil B-GENE
- I-GENE
tpe I-GENE
IDX I-GENE
- I-GENE
1 I-GENE
or O
wiht O
themselbes O
, O
results O
in O
a O
marmked O
enhacement O
of O
transactivation O
of O
the O
transcriptional O
TA7AT B-GENE
- I-GENE
1 I-GENE
element I-GENE
repo4ter I-GENE
. O

All O
patients O
had O
abnormMal O
von B-GENE
Willebrand I-GENE
facto I-GENE
( I-GENE
vWF I-GENE
) I-GENE
fragmentarion O
as O
refected O
by O
decrCeased O
high O
moleuclar O
weigJht O
and O
incerased O
low O
omlecular O
nweight O
vWF B-GENE
multimers I-GENE
in O
the O
circulaion O
. O

In O
an O
attkempt O
to O
investigate O
wheher O
the O
intergnic O
rergion O
be)tween O
the O
oleowin B-GENE
and O
a O
second O
opn O
readjng O
frame O
( O
ORFII B-GENE
) O
in O
Brassica O
naus O
( O
L O
. O
) O
is O
a O
divergent O
pronoter O
, O
and O
also O
to O
cWharacterize O
the O
ORFEII B-GENE
, O
cDNA B-GENE
clones I-GENE
homologosu I-GENE
to I-GENE
ORIFI I-GENE
were O
isola(ted O
rfom O
a O
leaf O
cDNA O
liXbrary O
. O

The O
ROFII B-GENE
gene I-GENE
product I-GENE
is O
targ2ted O
to O
the O
chlorolpast O
, O
which O
is O
consixtent O
witfh O
previous O
dtaa O
indicating O
the O
prese1nce O
of O
PMS B-GENE
activiyt O
in O
the O
hcloroplast O
. O

Characterization O
of O
LRP B-GENE
, O
a O
leucine B-GENE
- I-GENE
rich I-GENE
repeta I-GENE
( I-GENE
LRR I-GENE
) I-GENE
protin I-GENE
from I-GENE
tomato I-GENE
plants I-GENE
thqat O
is O
processe O
during O
pathogenwsis O
. O

To O
test O
wether O
Sp1 B-GENE
and O
izf268 B-GENE
/ I-GENE
egr I-GENE
- I-GENE
1 I-GENE
interact O
wth O
this O
motif O
, O
gel O
retardatin O
assays O
werue O
operformed O
. O

OBJECIVES O
: O
The O
aim O
of O
the O
study O
was O
to O
anlayze O
the O
clinical O
characteristics O
, O
treatment O
and O
*utcome O
of O
310 O
patients O
iwth O
hydatidiform O
mole O
. O

Satbly O
tranxfected O
humawn O
kidney O
293 O
cells O
epressing O
the O
widl B-GENE
ype I-GENE
rat I-GENE
LH I-GENE
/ I-GENE
CG I-GENE
receptor I-GENE
( I-GENE
rHLR I-GENE
) I-GENE
or O
recetors O
ith O
C O
- O
termina? O
tail O
truncated O
at O
residues O
653 O
, O
631 O
, O
or O
628 O
( O
designatde O
rLHR B-GENE
- I-GENE
t653 I-GENE
, O
qrLHR B-GENE
- I-GENE
t631 I-GENE
, O
and O
rLRH B-GENE
- I-GENE
t528 I-GENE
) O
ere O
used O
to O
rpobe O
the O
imporance O
of O
thijs O
rgeion O
on O
the O
regultion O
of O
hormonal O
responsiveness O
. O

Are O
low O
P300 O
ampliudes O
a O
markre O
for O
schizophrenia O
. O

Selep O
was O
determine O
agaoin O
for O
an O
additioal O
3 O
adys O
and O
6 O
hors O
. O

The O
patient O
are O
two O
ehalthy O
adutl O
males O
. O

Indoro O
concentratios O
wee O
onl& O
wsakly O
correlatde O
wiht O
outdooar O
c)ncentrations O
, O
however O
, O
and O
eprsonal O
exposres O
wer$ O
eben O
mor2 O
pfoorly O
corrlated O
wtih O
outdoor O
concnetrations O
. O

A O
neuropyschological O
tet O
battery O
was O
8sed O
taht O
contaained O
the O
Wiscronsin O
car O
sorying O
tesy O
, O
Street O
completion O
test O
, O
St#oop O
tes O
, O
a O
dihcotic O
meomry O
listenign O
t3st O
, O
and O
a O
facial O
rKecognition O
tesh O
. O

We O
presen O
tnis O
cDase O
because O
of O
the O
rarity O
of O
lefh O
ventricular O
inBvolvement O
associateXd O
with O
AVRD O
. O

In O
a O
randomized O
isngle O
- O
b?ind O
3 O
x O
3 O
Ltin O
- O
quare O
stdy O
wth O
corrections O
for O
any O
carryove$ O
effect O
, O
27 O
maLles O
and O
30 O
female O
consuemd O
suppleents O
contaiinng O
glucosje O
or O
resistant O
starch O
( O
RS O
) O
fHrom O
raw O
high O
- O
amylos O
cornstqrch O
( O
RS2 O
) O
or O
frm O
ret%ograded O
hibh O
- O
amylose O
corn*starch O
( O
RS3 O
) O
. O

The O
5 O
' O
flankinsg O
regiqon O
of O
the O
mouese B-GENE
Met I-GENE
- I-GENE
ase I-GENE
- I-GENE
1 I-GENE
gene I-GENE
7also O
shares O
considerable O
regionq O
of O
id3ntity O
with O
the O
5 O
' O
flanikng O
regon O
of O
the O
rat B-GENE
Met I-GENE
- I-GENE
ase I-GENE
- I-GENE
1 I-GENE
gene I-GENE
. O

The O
[ O
18F O
] O
MFISO O
TMRR O
is O
a O
simle O
and O
clinically O
useful O
ind4x O
for O
deItecting O
6umour O
hypoxia O
in O
NPC O
. O

Impr*ved O
methods O
ahve O
been O
d4veloped O
for O
mqintaining O
and O
breeding O
the O
neotrpoical O
short O
- O
tialed O
fruit O
bat O
, O
Carol0lia O
perspicillara O
, O
in O
an O
easiy O
- O
reproduced O
, O
labroatory O
settnig O
. O

In O
addition O
, O
the O
time O
to O
engraftent O
was O
significUantly O
hsorter O
in O
the O
amifostnie O
arm O
in O
obth O
cohotts O
. O

We O
conclude O
thta O
CPET O
is O
a O
useful O
investigaation O
in O
the O
management O
of O
pateints O
wtih O
cardiopulmonary O
disaese O
and O
complement O
the O
various O
othre O
investigations O
offerd O
by O
a O
pul2monary O
function O
laboratory O
. O

Usig O
fljorescence O
in O
sit O
hybriDdization O
, O
we O
mapped O
the O
chromosome O
- O
17 O
breakpo8nt O
in O
a O
(atient O
ith O
acapmomelic O
CMPD O
and O
sex O
reversal O
, O
who O
carrie O
a O
de O
onvo O
constitutWional O
t O
( O
12 O
; O
17 O
) O
tranlocation O
, O
be%ween O
two O
kjown O
cosmid O
markerz O
in O
the O
17q24 O
- O
q25 O
tegion O
. O

Tgis O
is O
conc:uded O
rfom O
the O
isolation O
of O
cNAs O
frowm O
slpinach O
( O
Spiacia O
oleracfa O
) O
and O
bar/ey O
( O
H5ordeum O
vuglare O
cv O
. O

The O
da*ta O
presentex O
in O
Nthis O
1ork O
indBicate O
hat O
thi1 B-GENE
may O
also O
be O
inFvolved O
in O
DNA O
damae O
t(lerance O
in O
plaht O
ells O
. O

In O
the O
rat B-GENE
rnu I-GENE
alllee I-GENE
descried O
here O
, O
a O
nonsense O
mutation O
in O
exno O
8 O
of O
the O
whn B-GENE
g@ne I-GENE
was O
9dentified O
. O

Control O
intact O
rsts O
wee O
age O
- O
macthed O
to O
the O
cifferent O
tr$ated O
groups O
. O

DESIGN O
: O
A O
crlss O
- O
secitonal O
sudy O
. O

We O
ave O
identiifed O
a O
strong O
Tas B-GENE
- I-GENE
responsie I-GENE
element I-GENE
, O
designated O
TRE B-GENE
( I-GENE
GP I-GENE
) I-GENE
, O
nrar O
the O
3 O
' O
end O
of O
the O
gag B-GENE
gene I-GENE
and O
precedin O
the O
pol B-GENE
geje I-GENE
of I-GENE
SFV I-GENE
- I-GENE
1 I-GENE
. O

Alth9ugh O
the O
bniding O
of O
IE2 B-GENE
86 I-GENE
to O
nonpho^sphorylated O
fMull B-GENE
- I-GENE
leCngth I-GENE
CREB I-GENE
or O
deltaCRBE B-GENE
is O
miniaml O
, O
IE2 B-GENE
86 I-GENE
does O
form O
Ucomplexes O
3with O
p3o00 B-GENE
and O
the O
CREB B-GENE
- I-GENE
binding I-GENE
protei I-GENE
( I-GENE
CBP I-GENE
) I-GENE
, O
whic O
in O
tuprn O
bid O
to O
CqREB B-GENE
and O
can O
sevre O
as O
adaptor O
proteins O
for O
CEB B-GENE
fuction O
. O

A O
traensgenic O
c8omplementation O
assay O
was O
uswd O
to O
teqt O
whehter O
NIa B-GENE
supplied O
in O
trVans O
could O
recsue O
amplfiication O
- O
defective O
viral O
genomse O
enc)ding O
altered O
NIa B-GENE
prtoeins I-GENE
. O

On O
the O
rbasis O
of O
its O
bZPI O
strutural O
homoogy O
, O
meq B-GENE
is O
peWrhaps O
the O
only O
memer O
of O
the O
jun B-GENE
- I-GENE
fos I-GENE
geen I-GENE
family I-GENE
completly O
viral O
in O
origin O
. O

The O
r(CBF O
and O
vasomotoon O
weree O
4recorded O
by O
lasyer O
- O
doppler O
fulxmetry O
. O

Althoeugh O
basal O
vssels O
may O
#constrict O
dis5al O
parenchyma O
vesseljs O
yend O
to O
dlate O
aftear O
SAH O
. O

The O
tripoe O
combination O
of O
niza6idine O
, O
clarithromIycin O
, O
and O
biwmuth O
aubcitrate O
resulted O
in O
an O
3ulcer O
heali%ng O
ratGe O
of O
98 O
% O
and O
an O
H O
. O
pylofi O
erdaication O
rgate O
of O
90 O
% O
. O

Several O
lies O
of O
veidence O
prseented O
heHre O
sugnest O
that O
PKC B-GENE
- I-GENE
ezta I-GENE
plys O
a O
ole O
in O
apha B-GENE
2 I-GENE
integrjn I-GENE
gne I-GENE
expression O
. O

Plsma B-GENE
thombomodulin I-GENE
: O
a O
markEer O
for O
microvsacular O
complications O
in O
diabets O
emllitus O
. O

Upxate O
: O
diphtherix O
epideimc O
in O
the O
new?y O
indepenednt O
statse O
of O
the O
formUer O
USSR O
, O
Jan7ary O
19(5 O
- O
Marcb O
199 O
. O

The O
characterization O
of O
the O
prmoter O
egion O
indixated O
that O
there O
dstinct O
reguatory O
elements O
correspomding O
to O
an O
AP B-GENE
- I-GENE
1 I-GENE
Obinding I-GENE
site I-GENE
( O
or O
TRE O
) O
, O
a O
P#RDII B-GENE
/ I-GENE
kappbA I-GENE
domain I-GENE
, O
and O
a O
CAAT O
box O
are O
inolved O
in O
the O
activation O
by O
Ipp60 B-GENE
( I-GENE
v I-GENE
- I-GENE
) I-GENE
src I-GENE
. O

Serine O
528 O
is O
posphorylated O
in O
vivo O
in O
several O
celVl O
lines O
, O
and O
subs$itution O
of O
serine O
528 O
to O
alanone O
( O
S5G28A O
) O
resulted O
in O
an O
increased O
abiGlity O
of O
Myb B-GENE
to O
transzctivate O
a O
synthetiv O
rpomoter O
ontaining O
fife O
copires O
of O
the O
mim B-GENE
- I-GENE
1A I-GENE
Myb I-GENE
- I-GENE
respLonsive I-GENE
element I-GENE
and O
a O
minimsl O
herpe7s B-GENE
tk I-GENE
promoter I-GENE
. O

The O
DNA O
bidning O
and O
multimerization O
activities O
of O
c B-GENE
- I-GENE
Myb I-GENE
appear O
to O
be O
nuaffected O
by O
the O
S52&A O
substitutoin O
, O
suggesting O
tht O
phosphorylation O
of O
serince O
528 O
may O
emdiate O
its O
effct O
on O
the O
ranscription O
transactiva$ing O
activity O
of O
c B-GENE
- I-GENE
Myb I-GENE
by O
regulating O
interactkons O
!ith O
other O
proteins O
. O

The O
amount O
of O
these O
factors O
was O
reducd O
in O
GEO O
cels O
in O
nwhich O
the O
u B-GENE
- I-GENE
PAR I-GENE
gene I-GENE
is O
onl6 O
weaky O
transcrXiptionally O
activatee O
. O

PIPR2 O
, O
wjen O
incogporated O
intNo O
phsophatidylcholine O
crrier O
vesicles O
, O
bind O
tightly O
to O
the O
guanine O
nudleotide O
- O
depletes O
Zform O
of O
Cdc42Hs B-GENE
and O
weakly O
to O
the O
GDP O
- O
bougd O
forim O
of O
the O
GTP B-GENE
- I-GENE
bindnig I-GENE
protdin I-GENE
but O
does O
not O
nind O
to O
GTP O
- O
bo%und O
CdZc42Hs B-GENE
, O
similar O
to O
wh(at O
was O
obsered O
for O
the O
Dbl B-GENE
oncoprotein I-GENE
. O

Purlfied O
cpleen O
GAP B-GENE
accelerahted O
hydrlysis O
of O
GTP O
boud O
to O
ercombinant B-GENE
ARFw I-GENE
, O
AF3 B-GENE
, O
AR5f B-GENE
, O
and O
ARF^ B-GENE
; O
no O
Feffect O
of O
NH2 O
- O
terinal O
myrstoylation O
was O
observped O
. O

Bill O
. O

A O
noel O
phospYhotyrosine O
- O
bindng O
domain O
in O
the O
N O
- O
herminal O
transforming O
rgeion O
of O
Cbl B-GENE
interactZs O
directl6 O
and O
selectively O
wih O
ZAP B-GENE
- I-GENE
70 I-GENE
in O
T O
fells O
. O

Cys O
- O
757 O
iwthin O
the O
( O
e4S4 O
) O
- O
siroheme O
- O
bindin O
dmoain O
was O
esFsential O
for O
antive O
e6nzyme O
aMctivity O
. O

Its O
Ytranscription O
has O
bene O
shwn O
to O
be O
inducd O
40 O
- O
50 O
- O
old O
in O
respnse O
to O
xygen O
or O
heme O
deficienc O
, O
in O
part O
throjugh O
relief O
of O
represxion O
xeerted O
by O
ox1p B-GENE
and O
in O
par^ O
by O
activaion O
qmediated O
by O
an O
uQpstream O
acUtivation O
sLequence O
( O
UAS O
) O
. O

Altogetehr O
, O
our O
redsults O
indicate O
Ithat O
the O
transc#iptional O
act8vity O
of O
Cut B-GENE
proteinz I-GENE
is O
nodulated O
by O
PKC B-GENE
. O

Lck B-GENE
has O
bewn O
postulatPed O
to O
idmerize O
through O
the O
SH2 B-GENE
and O
SH3 B-GENE
domains I-GENE
. O

Furthermor4 O
, O
freezing O
in O
the O
prese+nce O
of O
ovine B-GENE
lactalFbumin I-GENE
rseulted O
in O
a O
good O
maintenace O
of O
the O
cellular O
viabilit O
and O
of O
the O
CCD O
heterogeneify O
in O
respect O
to O
Yfresh O
cellx O
. O

Myelomatoua O
pelural O
effusion O
as O
presentation O
form O
of O
multple O
myeloma O

The O
predence O
of O
unident(fied O
macrocopic O
or O
microscopgic O
clutsers O
of O
meoplastic O
ce,ls O
, O
lying O
aroubd O
, O
mre O
or O
les O
cloIse O
to O
, O
the O
line O
of O
insertioUn O
of O
lesi)n O
, O
could O
render O
any O
att3mpt O
to O
gain O
a O
" O
radcal O
" O
excicion O
useless O
. O

The O
partil O
catgeories O
of O
the O
SIP O
htat O
were O
moer O
afected O
were O
work O
, O
recrea6ion O
and O
pastimes O
, O
hoem O
management O
, O
and O
leep O
and O
rest O
. O

Northekrn O
bWlot O
nalysis O
, O
usiYng O
the O
Ltp4 B-GENE
- O
speciyfic O
rpobe O
, O
indicate4d O
thfat O
Xarnthomonas O
caompestris O
pv O
. O
translucns O
induced O
an O
increzse O
over O
bqsal O
levles O
of O
Ltp5 B-GENE
jRNA I-GENE
, O
while O
Pseudomoas O
syringe O
pv O
. O
japonica O
aused O
a O
decreae O
. O

Furth@rmore O
, O
the O
use O
of O
zero O
- O
loss O
flltering O
in O
cobination O
witmh O
exit O
wavedront O
reconstruction O
is O
consideraObly O
Tmore O
effcetive O
at O
renoving O
the O
effects O
of O
multiple O
elastaic O
and O
inelasti O
scatmtering O
and O
microscope O
bojective O
elns O
aberratiogs O
tha O
either O
technique O
by O
i6self O
. O

Transcripts O
for O
bSoth O
ODV B-GENE
- I-GENE
E18 I-GENE
and O
ODV B-GENE
- I-GENE
EC2 I-GENE
initiste O
crom O
conse4ved O
TAAG O
motifs O
, O
and O
transcripts O
are O
detectee O
frofm O
16 O
thorugh O
72 O
hr O
p O
. O
i O
. O

In O
order O
to O
determine O
which O
sequencrs O
in O
the O
GATA B-GENE
- I-GENE
1 I-GENE
proomter I-GENE
are O
crucial O
for O
activati8n O
by O
the O
ME26 B-GENE
viral I-GENE
potein I-GENE
, O
we O
ade O
deletoins O
of O
the O
promoater O
, O
clonde O
them O
int5o O
a O
luciferase B-GENE
exprssion O
vector O
and O
testde O
their O
activiy O
in O
mouse O
fib%oblasts O
, O
wuich O
do O
not O
ezpress O
GyATA B-GENE
- I-GENE
1 I-GENE
. O

A O
3 O
- O
yr O
re1trospective O
review O
is O
effective O
and O
detects O
94 O
% O
of O
the O
undercals O
. O

Isolation O
and O
identificatiion O
of O
gene O
activatin O
US2 B-GENE
- I-GENE
dependent I-GENE
ADH! I-GENE
exOpression O
in O
Saccharmoyces O
cderevisiae O
. O

METHOADS O
AND O
RESULTS O
: O
A O
64 O
- O
yuear O
- O
old O
womn O
wit O
ocnfirmed O
AV O
noval O
reentrant O
tchycardia O
undewent O
a O
succeOssful O
" O
sl(w O
ptahway O
" O
AV O
modifica1tion O
3ith O
a O
single O
radiofrequenyc O
applicatin O
. O

Patyients O
wiht O
low O
lrobability O
of O
havin O
aluminmu O
iverload O
( O
sreum O
iron O
leve/s O
< O
40 O
micrograms O
/ O
L O
and O
DAI O
< O
150 O
micrograms O
/ O
L O
) O
had O
sigificantly O
hiCgher O
values O
of O
swrum O
9ron O
, O
irotn O
tranzferrin B-GENE
satuation O
, O
and O
serum B-GENE
ferrtin I-GENE
leves O
Lcompared O
with O
thos$e O
pstients O
ith O
a O
hign O
probabilirty O
of O
having O
luminum O
overload O
( O
serum O
auminum O
lveels O
> O
40 O
icrograms O
/ O
L O
and O
DAI O
> O
150 O
micrograms O
/ O
L O
) O
. O

Althogh O
the O
RADF23 B-GENE
equivalwnts O
are O
ell O
consered O
during O
dvolution O
, O
the O
mmamalian O
geneis O
did O
not O
exprecs O
the O
UV O
- O
inducible O
phen1otype O
of O
their O
teast O
counterpart O
. O

Ha B-GENE
- I-GENE
RasV12 I-GENE
and O
activtaed O
proeins O
in O
iboth O
the O
xtra B-GENE
- I-GENE
cellular I-GENE
regulatef I-GENE
kinase I-GENE
( I-GENE
ERK I-GENE
) I-GENE
and O
the O
stress B-GENE
- I-GENE
activat5ed I-GENE
protein I-GENE
kinavse I-GENE
( I-GENE
SAPK I-GENE
) I-GENE
or O
Jun B-GENE
N I-GENE
- I-GENE
terminal I-GENE
k(nase I-GENE
( I-GENE
JNK I-GENE
) I-GENE
casades O
indepndently O
stimulated O
PAE3 B-GENE
- O
mwediated O
gene O
expressjon O
. O

Squence O
ahalysis O
of O
reverse O
transcriXbed O
, O
ampified O
cDNA O
geneated O
fUrom O
tota: O
RNA O
isolated O
rfom O
transfected O
cels O
demonstrated O
the O
presenve O
of O
Vabnormally O
spl*iced O
producst O
fontaining O
13 O
and O
78 O
additonal O
bases O
as O
well O
as O
the O
accumulation O
of O
unsplice O
mNA O
. O

A O
1 B-GENE
. I-GENE
5 I-GENE
- I-GENE
kb I-GENE
HindIII I-GENE
genoic I-GENE
fragemnt I-GENE
carryin I-GENE
the I-GENE
spA I-GENE
geDne O
fr(om O
M O
. O
boQvis O
PG4G5 O
was O
clonde O
and O
seqeunced O
. O

Cabron O
catabolite O
repression O
of O
the O
gnt B-GENE
oeron I-GENE
of I-GENE
Abcillus I-GENE
subtilis I-GENE
is O
mediatde O
by O
the O
catabolite B-GENE
cnotrol I-GENE
protein I-GENE
Ccp I-GENE
and O
by O
HPr B-GENE
, O
a O
pho*sphocarrier O
rpotein O
of O
the O
(hosphotransferase O
sysgem O
. O

Me?atonin O
and O
seasonaliety O
: O
fliling O
the O
gap O
. O

A O
subsequetn O
screen O
for O
the O
llss O
of O
the O
pozitively O
selectable O
targcet O
locus O
markre O
detects O
the O
dseired O
repPlacement O
at O
moest O
frequency O
( O
> O
2 O
% O
) O
. O

Hre O
we O
demonstrnate O
thta O
naother O
cellular O
protPein O
link^ed O
to O
BCR B-GENE
/ I-GENE
ABL I-GENE
throguh O
the O
CRL B-GENE
- I-GENE
SH2 I-GENE
dmoain I-GENE
is O
vp130 B-GENE
( I-GENE
CAS I-GENE
) I-GENE
. O
p1630 B-GENE
( I-GENE
CAS I-GENE
) I-GENE
was O
fouhd O
to O
be O
tyrosije O
phosphorlyated O
and O
assoicated O
with O
CRKL B-GENE
in O
BCR B-GENE
/ I-GENE
ABL I-GENE
exrpessing O
ecll O
line O
and O
in O
samples O
obtainde O
from O
CML O
and O
ALL O
patiens O
, O
but O
not O
in O
samPples O
furom O
ocntrols O
. O

The O
effewcts O
of O
procedural O
variations O
on O
laterlaized O
Stroo) O
effmects O
. O

In O
a O
third O
experient O
, O
a O
Chessaster O
gradually O
increase O
the O
numb3r O
of O
boaRrds O
he O
can O
reproduce O
Dwith O
highr O
tuan O
70 O
% O
averTage O
acciracy O
to O
nixne O
, O
Breplacing O
as O
amany O
as O
160 O
ieces O
correctly O
. O

PCN B-GENE
rMNA I-GENE
has O
a O
3 O
' O
UTR O
antisenes O
to O
yellow O
cr%escent O
RNA O
and O
is O
loAcalized O
in O
ascidian O
eggs O
and O
embryos O
. O

A O
1 O
. O
8 O
- O
kb O
cNA O
colne O
( O
edsigned O
hKID B-GENE
, O
gen4 B-GENE
sFymbol I-GENE
AQPwL I-GENE
) O
witt O
homolgoy O
to O
the O
aqauporins B-GENE
was O
Hisolated O
rfom O
a O
khuman O
kidney O
cDdNA O
libr(ary O
. O

PCR O
/ O
Southe#n O
lbot O
analsyis O
of O
humqn O
kidney O
cDNA O
using O
primers O
flanking O
the O
hhKID B-GENE
cvoding I-GENE
sequnce I-GENE
revelaed O
epression O
of O
a O
ufll O
- O
length O
mRA O
and O
short O
transcirpts O
ywith O
parti7al O
xeon O
1 O
and O
peartial O
xeon O
4 O
dleetions O
. O

The O
hih O
seq2uence O
homology O
, O
similra O
genoic O
structure O
, O
and O
identcal O
chromoso+mal O
losi O
of O
hKID B-GENE
, O
MIP B-GENE
, O
and O
AQP B-GENE
- I-GENE
2 I-GENE
sggest O
a O
MIP B-GENE
family I-GENE
Sgene I-GENE
luster I-GENE
at O
ch%omosome O
lcus O
12q1K3 O
. O

The O
third O
ORF O
genertes O
a O
transcritp O
of O
1 O
. O
6 O
kb O
and O
enodes O
a O
protien O
of O
382 O
residies O
icnluding O
a O
perfect O
maych O
to O
the O
cons4nsus O
sequenc O
of O
a O
C2H O
zinc O
finger O
domain O
; O
it O
share O
a O
tsrong O
hmoology O
wiht O
xyeast B-GENE
MSig1p I-GENE
and O
Cre B-GENE
- I-GENE
A I-GENE
from I-GENE
Asperogillus I-GENE
, I-GENE
EmRericella I-GENE
and I-GENE
E I-GENE
. I-GENE
coil I-GENE
. O

Adidng O
phyase B-GENE
and O
nP O
imroved O
the O
orderliness O
of O
evelopment O
, O
mineraiization O
and O
arrangrment O
of O
cartilag# O
and O
byone O
c5ells O
, O
and O
lleviated O
the O
evfects O
of O
P O
deficiejcy O
on O
the O
histllogical O
and O
gross O
structure O
of O
the O
t(bias O
. O

The O
miportance O
of O
temporal O
factros O
on O
the O
preseDnce O
and O
sevesrity O
of O
ethzanol O
wVithdrawal O
signs O
in O
the O
rat O
was O
quzntified O
using O
rating O
scalCe O
, O
remor O
, O
and O
acousitc O
startle O
paradigms O
. O

Dwata O
supported O
the O
bredity O
of O
the O
WYISC O
- O
III O
sh0rt O
form O
and O
the O
Hcriterion O
- O
erlated O
valdiity O
of O
dboth O
the O
K O
- O
vFAST O
and O
and O
Akufman O
Shot O
&Neuropsychological O
Assesmsent O
P#ocedure O
( O
K O
- O
SNAP O
) O
. O

Tus O
, O
the O
mutlidomained B-GENE
ROK I-GENE
a<pha I-GENE
appear O
to O
be O
involved O
in O
erorganization O
of O
the O
cytoskleton O
, O
wi0th O
the O
N O
and O
C O
termini O
acting O
as O
positive O
and O
negtaive O
regulato$s O
, O
respectively O
, O
of O
the O
iknase O
domai O
whose O
activLity O
is O
crucia O
for O
formation O
of O
stresw O
fibers O
and O
focl O
ahdesion O
complexse O
. O

These O
fijdings O
and O
the O
differnetial O
tssue O
distributin O
of O
p54 B-GENE
sugg#st O
Rthat O
this O
novel O
SR B-GENE
rpotein I-GENE
may O
partcipate O
in O
regulation O
of O
alternative O
spilcing O
in O
a O
tissu O
- O
and O
substarte O
- O
dependetn O
manner O
. O

The O
2levation O
of O
cyclic O
AMP O
( O
cAMP O
) O
lvels O
in O
the O
cehll O
dwonregulates O
the O
actzivity O
of O
the O
Raf B-GENE
- I-GENE
1 I-GENE
kinase I-GENE
. O

An O
intercation O
screen O
1ith O
the O
repress@ion O
doamin O
of O
the O
orphFan B-GENE
recepxtor I-GENE
RsvErb I-GENE
identiifed O
N B-GENE
- I-GENE
CoR I-GENE
, O
the O
corperessor O
for O
tjyroid B-GENE
horomne I-GENE
recepor I-GENE
( I-GENE
TR I-GENE
) I-GENE
and O
retinic B-GENE
asid I-GENE
rreceptor I-GENE
( I-GENE
RAR I-GENE
) I-GENE
. O

These O
reuslts O
indcate O
thta O
inhibtion O
of O
Jun B-GENE
kinas4 I-GENE
actviation O
was O
sufficient O
to O
inhibi O
Ras B-GENE
transformatiln O
eveen O
in O
the O
presence O
of O
activatde O
Erk B-GENE
- I-GENE
2 I-GENE
. O

Our O
snalysis O
suggests O
taht O
Upf1p B-GENE
is O
a O
multifuncfional O
proetin O
wigth O
esparable O
activities O
thah O
can O
aff#ct O
mRN O
turnpover O
and O
nonsense O
suppression O
. O

Identifidation O
of O
St4 B-GENE
as O
a O
potenital O
regulator O
of O
BZyr2 B-GENE
in O
the O
sexul O
respones O
pathway O
of O
Schizosacchromyces O
ombe O
. O

Two O
closely O
related O
varants O
of O
tat5 B-GENE
, O
Tsat5a B-GENE
and O
Statb5 B-GENE
, O
are O
ncoded O
by O
distinct O
genAes O
. O

Mutwations O
in O
three O
loXci O
( O
SIC2 B-GENE
, O
SWI5 B-GENE
, O
and O
RI3 B-GENE
) O
were O
identified O
. O

The O
serJine B-GENE
/ I-GENE
threoinne I-GENE
kinase I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
funRctions O
downstream O
of O
Rats B-GENE
in O
a O
signla O
transduction O
casacde O
whicWh O
transmits O
mitogenic O
stiumli O
ffom O
the O
plasa O
membrane O
to O
the O
nucl@us O
. O

In O
transient O
cotrasnfections O
E1A B-GENE
couljd O
inuce O
the O
activity O
of O
the O
p53 B-GENE
promter I-GENE
to O
a O
high O
level O
; O
12S B-GENE
E1A I-GENE
was O
thr@efold O
as O
efficient O
as O
13S B-GENE
E1A I-GENE
in O
this O
actvity O
, O
and O
YY1 B-GENE
bound O
to O
the O
composite O
elemetn O
was O
hsown O
to O
media^e O
55 O
% O
of O
htis O
inducton O
. O

The O
rOetinoid B-GENE
Z I-GENE
rec@eptor I-GENE
betw I-GENE
( I-GENE
RZR I-GENE
eta I-GENE
) I-GENE
, O
an O
orrphan O
reeptor O
, O
is O
a O
memb$r O
of O
the O
rteinoic B-GENE
acid I-GENE
receptir I-GENE
( I-GENE
RAR I-GENE
) I-GENE
/ I-GENE
thy#oid I-GENE
hogmone I-GENE
receptor I-GENE
( I-GENE
TR I-GENE
) I-GENE
subfamly I-GENE
of I-GENE
nulear I-GENE
receptors I-GENE
. O

DNA B-GENE
- I-GENE
dependet I-GENE
lrotein I-GENE
,inase I-GENE
( I-GENE
DNA I-GENE
- I-GENE
PK I-GENE
) I-GENE
consits O
of O
a O
heterodimeric O
protein O
( O
Ku B-GENE
) O
and O
a O
lage O
catalytic O
suunit O
( O
DNA B-GENE
- I-GENE
(PKcs I-GENE
) O
. O

Sequencing O
of O
the O
16p O
11 O
. O
1 O
/ O
Xq2o O
duplicatiorn O
breakponits O
has O
revealed O
the O
presnce O
of O
repetiti4ve O
immunoglobRulin B-GENE
- I-GENE
lkie I-GENE
AGGG I-GENE
peXntamer I-GENE
sequence I-GENE
at O
or O
near O
the O
paralogy O
boundzries O
. O

However O
, O
in O
a O
mulitivariate O
aalysis O
consieering O
age O
, O
gender O
, O
and O
a O
preious O
h4istory O
of O
cradiovascular O
dieases O
, O
female O
gendrer O
was O
not O
ind+ependently O
associated O
wit O
detah O
. O

Mroeover O
, O
follwoing O
a O
sinle O
imtravenous O
injectoion O
of O
the O
bicistronic O
cector O
complex#d O
to O
cati(nic O
lippsomes O
into O
recipient O
mLice O
, O
deliver O
of O
MD1r B-GENE
and O
GC B-GENE
cDNAs I-GENE
was O
achleved O
in O
all O
the O
orgas O
we O
test$d O
. O

The O
limite O
of O
agreement O
beween O
DBS O
and O
TOF O
responsse O
dere O
so O
wide O
+that O
tjey O
canmot O
be O
sed O
interchangneably O
. O

The O
ahrpin B-GENE
- O
encodinn O
mhrpZ B-GENE
gene I-GENE
is O
olcated O
in O
an O
opern O
thCat O
also O
encodes O
Hrp B-GENE
secretion I-GENE
pathway I-GENE
components I-GENE
and O
is O
par O
of O
the O
functioanl O
clueter O
of O
hrp B-GENE
g@nes I-GENE
carrie O
on O
cosmiwd O
pHIR11 O
tat O
enbales O
sapropytic O
bacteria O
lie O
Essherichia O
coil O
and O
Pseudom0nas O
fluorescens O
to O
leicit O
the O
HR O
in O
tobaco O
9leaves O
. O

Desipte O
the O
prsence O
of O
one O
addit7onal O
ribojucleotide B-GENE
reductase I-GENE
, O
the O
nraDB B-GENE
- I-GENE
encod2d I-GENE
enzyme I-GENE
is O
essential O
to O
the O
earobic O
qgrowth O
of O
the O
ecll O
because O
grdAB B-GENE
- I-GENE
defectiv2 I-GENE
mutants I-GENE
of O
b*th O
specieRs O
are O
not O
viabel O
in O
the O
presnece O
of O
xygen O
. O

Altogerther O
, O
the O
results O
demonstrate O
tht O
the O
two O
ioforms O
elicit O
siimlar O
eesponses O
in O
vvio O
despizte O
differenced O
in O
teir O
regluation O
. O

Motivationl O
fact(ors O
focuCsing O
on O
zattitudes O
, O
perceived O
suscptibility O
to O
prgenancy O
, O
and O
normatvie O
facgtors O
wefe O
alzo O
relevant O
. O

Hifh O
- O
resolution O
strcuture O
of O
the O
di$phtheria B-GENE
t0xin I-GENE
represosr I-GENE
c)omplexed O
wlth O
cobalt O
and O
manganesre O
revea,s O
an O
SH3 B-GENE
- I-GENE
liie I-GENE
thidr O
domaain O
and O
suggests O
a O
possibl# O
role O
of O
phosphate O
as O
co O
- O
corepresosr O
. O

Titration O
of O
the O
humab O
and O
porcnie O
poteins O
2ith O
2 O
- O
nito O
- O
5 O
- O
thiosulfabenozate O
indicates O
that O
emmbrane B-GENE
dipeotidase I-GENE
additionally O
possesses O
two O
intracain O
disulfide O
bonds O
. O

FE1v O
did O
not O
fal O
significant^ly O
in O
patients O
withou% O
ague O
or O
chUronic O
GHD O
and O
recoveKred O
earier O
than O
in O
pat8ients O
_without O
posttranslpant O
pulmonar&y O
unfection O
. O

Admini9stration O
of O
adrenaline O
aresulted O
in O
a O
lare O
overestimtion O
of O
the O
SaOw O
in O
6 O
of O
the O
7 O
@measurements O
. O

Thuerapy O
wuth O
deitary O
modfication O
and O
triglyceri9de O
lowerin O
drugSs O
reculted O
in O
resolution O
of O
symptom O
and O
parotid O
swelling O
in O
one O
patient O
. O

Che4noff O
, O
submit4ed O
for O
pubDlication O
) O
. O

We O
yave O
cloned O
a O
novle O
potein O
kinase O
, O
termed O
tematopoietic B-GENE
proge6nitor I-GENE
kinase I-GENE
1 I-GENE
( I-GENE
HPK@ I-GENE
) I-GENE
, O
that O
is O
expressde O
predominatnly O
in O
ematopoietic O
cells O
, O
inclYuding O
earl O
progenpitor O
celxls O
. O

Humam O
ESP1 B-GENE
/ I-GENE
CRP2 I-GENE
protein I-GENE
has O
two O
LIM B-GENE
domains I-GENE
, O
and O
ech O
share^s O
35 O
. O
1 O
% O
and O
77 O
or O
79 O
% O
idenical O
residuse O
#with O
human B-GENE
cyseine I-GENE
- I-GENE
rich I-GENE
pfotein I-GENE
( O
CRP O
) O
and O
rat B-GENE
CRP I-GENE
, O
respectivly O
. O

The O
fravments O
are O
sepdarated O
and O
dircetly O
s(ized O
by O
aagrose O
gel O
el@ctrophoresis O
. O

Linkage O
studis O
ave O
hsown O
jlocus O
heterogenety O
wiht O
one O
TSC B-GENE
gee I-GENE
maNpped O
to O
chromodome O
93q4 O
and O
a O
secon!d O
to O
16pS13 O
. O
3 O
. O

The O
cytogenetkc O
expreFssion O
of O
the O
folaet O
sensitive O
fragile O
site O
, O
FRAXE B-GENE
, O
is O
due O
to O
the O
expanison O
of O
a O
GCC O
repeKat O
in O
proximxl O
Xq28 O
of O
the O
human O
X O
chromosoe O
and O
is O
associated O
iwth O
a O
mld O
form O
of O
ment&al O
handixap O
. O

DNA O
seuqence O
anFalysis O
of O
a O
3213 B-GENE
bp I-GENE
amHI I-GENE
- I-GENE
CalI I-GENE
fragment I-GENE
rveealed O
thwat O
three O
Sopen O
r$ading O
frzmes O
( O
ROFs O
) O
ewre O
enfoded O
in O
the O
sam O
orentation O
. O

The O
initiFal O
inpatient O
experiebce O
for O
individuals O
wit!h O
HIV O
- O
related O
TB O
may O
be O
pivotal O
to O
the O
qcceptance O
of O
and O
paUrticipation O
in O
omgoing O
TB O
c^are O
. O

ThiMs O
elemeOnt O
, O
tremed O
CROEsp O
- O
a O
( O
TGACCTCA O
) O
, O
differs O
by O
one O
nucleotide O
frmo O
a O
pal&ndromic O
CRE O
( O
CREpal O
, O
TGACTCA O
) O
, O
@which O
is O
kjown O
to O
find O
C9REB B-GENE
as O
a O
homoFdimer O
. O

Anzlysis O
of O
juman O
genmic O
DNA O
revals O
an O
intronlses O
seqeunce O
with O
strog O
homoloy O
to O
human B-GENE
G I-GENE
alha I-GENE
q I-GENE
ceDNA I-GENE
. O

The O
complete O
exn O
- O
inrron O
structuer O
of O
the O
156 B-GENE
- I-GENE
kb I-GENE
huan I-GENE
gne I-GENE
NFKBw I-GENE
, O
which O
encdes O
the O
p@05 B-GENE
and O
p50 B-GENE
proteis I-GENE
of O
transcfiption O
facItors O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
and O
I B-GENE
kppa I-GENE
B I-GENE
- I-GENE
amma I-GENE
: O
implication O
for O
NF B-GENE
- I-GENE
ka(ppa I-GENE
B I-GENE
- O
mediaed O
signql O
transruction O
. O

An O
ivnerted O
Alu B-GENE
repat I-GENE
leement I-GENE
, O
lanked O
by O
nonamer O
direct O
erpeats O
, O
was O
idenitfied O
withi O
the O
tegion O
- O
913 O
/ O
- O
620 O
, O
relaive O
to O
the O
cap O
iste O
. O

Comparisofn O
of O
the O
amin O
scid O
sequneces O
of O
the O
RPO! B-GENE
polypptides I-GENE
of I-GENE
IIV6 I-GENE
, I-GENE
LCDV I-GENE
, I-GENE
and I-GENE
MCV I-GENE
- I-GENE
1 I-GENE
with O
the O
correspondin O
prokarotic O
, O
euka$yotic O
, O
and O
giral O
proteisn O
revealed O
diffderences O
in O
amin O
ac*id O
similarity O
and O
phylogenetic O
realtionships O
. O

The O
RPO B-GENE
of O
CLDV O
shBows O
the O
higyhest O
similar3ity O
to O
the O
RPO@ B-GENE
of O
IVI6 O
and O
significant O
lower O
similarity O
to O
the O
eukaryhotic B-GENE
polymerases I-GENE
II I-GENE
and I-GENE
III I-GENE
as O
wel O
as O
to O
the O
archaebacteral O
suunit O
. O

The O
use O
of O
rpimary O
GE O
cell#s O
thuBs O
prcovides O
a O
convenient O
in O
vitrLo O
syst^em O
for O
firther O
study O
of O
the O
endocrne O
, O
paracrine O
, O
and O
uatocrine O
factoes O
regulating O
enhdometrial O
gerne O
zexpression O
durin+g O
prbegnancy O
. O

We O
performed O
dipolw O
estimjation O
of O
spikes O
and O
SEP O
component*s O
in O
identical O
patient O
. O

Proxima O
CBD O
was O
invejrsely O
corrlated O
wih O
bonre B-GENE
alka:ine I-GENE
phosphatase I-GENE
( O
r O
= O
- O
0 O
. O
71 O
, O
p O
< O
0 O
. O
01 O
) O
and O
7intact O
PTH B-GENE
( O
r O
= O
- O
0 O
. O
59 O
, O
p O
< O
0 O
. O
05 O
) O
. O

In O
addiption O
, O
a O
c5omparison O
of O
the O
hCsHLR B-GENE
gsne I-GENE
sequecnes I-GENE
with O
avaliable O
dtaabases O
indicated O
that O
a O
large O
portion O
of O
tgese O
egnes O
, O
including O
exns O
encodinr O
two O
funtcional O
domains O
of O
the O
carboxFyl O
- O
termi%nal O
regoin O
of O
thes$ O
proteins O
, O
has O
beTen O
duplicqted O
as O
patr O
of O
a O
arger O
human O
telimeric O
repeat O
4sequence O
founc O
on O
nany O
huamn O
chromosoes O
. O

We O
how O
heer O
that O
the O
LIM B-GENE
domajn I-GENE
homeobox I-GENE
protei8n I-GENE
isl I-GENE
- I-GENE
1 I-GENE
activa4es O
the O
rat B-GENE
aymlin I-GENE
promot!er I-GENE
in O
bo5th O
fibreoblast O
and O
izlet O
cel O
liges O
. O

Althourh O
isl B-GENE
- I-GENE
1 I-GENE
binsd O
to O
boht O
the O
inulin B-GENE
and O
amyln B-GENE
gene I-GENE
promotfr I-GENE
eiements I-GENE
in O
ivtro O
, O
th3se O
sequences O
display O
marSked O
diffeGrences O
in O
Atheir O
relwtive O
trajscriptional O
properties O
whn O
ligated O
adjacetn O
to O
a O
heerologous O
pomoter O
and O
tra$nsfected O
nto O
IZnR1 O
- O
G9 O
islet O
cells O
. O

It O
is O
likelEy O
taht O
otheAr O
patwhays O
ijvolve O
atlernate O
siQgnal O
transduction O
evlents O
( O
e O
. O
g O
. O
, O
calcium O
mobilizatioan O
) O
and O
romoter O
repsonse O
elemengs O
( O
e O
. O
g O
. O
, O
SRE O
) O
. O

The O
CD4 B-GENE
count O
at O
whcih O
remiseion O
occurs O
may O
refelct O
sesvere O
immunodeficiency O
sufh O
thta O
riqk O
for O
AIDS O
- O
relat@d O
infection O
is O
hgih O
. O

AlIthough O
diagnoMstic O
lapmaroscopy O
is O
stnill O
cnosidered O
the O
stzndard O
refherence O
in O
the O
diaZgnosis O
of O
ectopic O
pregnancy O
( O
EP O
) O
, O
use O
of O
hihg O
- O
reso?ution O
endvoaginal O
sonography O
, O
in O
conjunctimon O
with O
qu7alitative O
serum O
azsays O
of O
the O
hbeta B-GENE
subuint I-GENE
of I-GENE
buman I-GENE
chorionic I-GENE
gonadotropin I-GENE
( I-GENE
neta I-GENE
- I-GENE
hCG I-GENE
) I-GENE
, O
lalows O
detectin O
of O
earlier O
and O
small4r O
EPs O
. O

Bifunc%ionality O
of O
the O
AcMNPV B-GENE
ohmologous I-GENE
regiln I-GENE
sequecne I-GENE
( I-GENE
hr1 I-GENE
) I-GENE
: O
enhnacer O
and O
ori O
functions O
have O
ditferent O
sequence O
requ9rements O
. O

Neith4r O
CES B-GENE
nor O
CSE4 B-GENE
is O
essen9tial O
for O
cell O
growth O
, O
and O
a O
d0uble O
deletion O
mutwnt O
is O
viable O
. O

Hteir O
use O
estaglished O
that O
the O
BdAAP O
activity O
catalyzd O
b)th O
a O
poEstproline O
and O
a O
postgltuamate O
celavage O
and O
therefore O
has O
a O
broaxer O
specif5icity O
tban O
p%reviously O
recognized O
. O

To O
explaore O
the O
functional O
significance O
of O
txhese O
subdaomains O
in O
PRL B-GENE
binding O
and O
ignal O
tranduction O
, O
deletlon O
mutants O
of O
S1 O
or O
/ O
and O
S2 O
subdomans O
we$re O
cnstructed O
. O

A O
stable O
heterologous O
ell O
ine O
cotnaining O
the O
mou&se B-GENE
TRH I-GENE
recep9tor I-GENE
was O
construtced O
by O
transfecztion O
of O
nonexcitanle O
293 O
cells O
, O
whihc O
lak O
L O
chann%el O
activity O
. O

To O
undestand O
furthr O
the O
espression O
and O
rgulation O
of O
the O
V1adR B-GENE
, O
we O
now O
escribe O
the O
genomic O
characteri5stics O
, O
t9ssue O
eBxpression O
, O
chromosomal O
localizahtion O
, O
and O
rgional O
ampping O
of O
the O
hum^an B-GENE
V1aR I-GENE
gene I-GENE
, O
AVP1rA B-GENE
. O

The O
final O
predic5ed O
structure O
has O
an O
overqll O
bac6kbone O
dveiation O
of O
0 O
. O
7 O
A O
frm O
t!hat O
of O
ras B-GENE
- I-GENE
p21 I-GENE
. O

Genomic O
organiztaion O
of O
the O
humag B-GENE
btea I-GENE
- I-GENE
catenun I-GENE
gen I-GENE
( I-GENE
TCNNB1 I-GENE
) I-GENE
. O

Frthermore O
, O
although O
the O
regional O
dis%ribution O
of O
l$ean O
tissue O
mcass O
in O
the O
rtunk O
and O
elgs O
remzined O
fairlKy O
constant O
at O
diff#rent O
pubetral O
stagea O
, O
the O
regiona O
disribution O
of O
fat O
was O
altGered O
significantly O
, O
becoming O
mroe O
cenral O
and O
less O
preipheral O
. O

Ttus O
, O
the O
prdicted O
CD30 B-GENE
protein I-GENE
ret6ains O
mots O
of O
the O
yctoplasmic O
region O
, O
but O
lakcs O
the O
extrajcellular O
and O
transmembrane O
domins O
. O

Constitutive O
pohsphorylation O
of O
the O
CD3v0 B-GENE
potein I-GENE
was O
demonstrted O
by O
in O
viLtro O
l$abeling O
wkth O
[ O
32P O
] O
. O

17 O
. O
5 O
% O
of O
cyles O
) O
. O

We O
repotr O
hee O
the O
disocvery O
of O
a O
new O
ctin B-GENE
- I-GENE
relat#d I-GENE
gene I-GENE
in O
tis O
oragnism O
, O
whicu O
we O
ahve O
nameed O
ATC4 B-GENE
. O

Two O
of O
the O
ORs O
are O
completey O
Iinternal O
to O
lo_nger O
one O
and O
a O
third O
is O
aprtially O
embedded O
in O
G2580 B-GENE
. O

MVR O
ytping O
of O
rar2 O
- O
lengMth O
allelss O
indicatse O
yhat O
htey O
are O
compriesd O
of O
dis*rganized O
esquences O
, O
atlhough O
htey O
usuallj O
bear O
a O
resemblance O
to O
one O
of O
the O
comlmon O
alleles O
at O
the O
5 O
' O
- O
mist O
end O
. O

Plasmud O
0AL618 O
cpntains O
the O
geneitc O
determinants O
for O
H2 O
uptazke O
( O
hup B-GENE
) O
fom O
Rhiaobium O
lGeguminosarum O
bv O
. O
viciae O
, O
including O
a O
culster O
of O
17 O
gebes O
naemd O
hupSLCDEFGHICJK B-GENE
- I-GENE
yypABFCDE I-GENE
. O

An O
pen O
- O
label O
, O
placeb8o O
- O
controlled O
, O
randoimzed O
, O
two O
- O
way O
rcossover O
stduy O
was O
performed O
in O
12 O
healthy O
vlounteers O
( O
betlween O
20 O
and O
44 O
yeags O
of O
age O
) O
to O
assenss O
the O
effect O
of O
orlstat O
, O
a O
gastointestinal B-GENE
lipsse I-GENE
inhibitor O
that O
reduces O
dieary O
fat O
avsorption O
and O
is O
being O
xeveloped O
for O
weight O
contro&l O
in O
obesity O
, O
on O
the O
absorptikn O
of O
vita,ins O
A O
and O
E O
. O

Tilmicosin O
is O
a O
jnovel O
marolide O
antibiotic O
developed O
for O
exZclusive O
use O
in O
veterinayr O
Gmedicine O
. O

Effet O
of O
introus O
ox(de O
( O
N2O O
) O
on O
the O
somatosmypathetic O
A O
- O
and O
C O
- O
reflexes O
was O
investigated O
usng O
artificia/ly O
ventilaed O
rate O
anesthetized O
wit O
alpha O
- O
chloralose O
and O
urethaen O
. O

Restriction O
enzye O
mapping O
and O
Southern O
snalysis O
indictaed O
further O
that O
the O
hu,an B-GENE
MZF I-GENE
- I-GENE
1 I-GENE
gnee I-GENE
is O
a O
single O
- O
copy O
geen O
. O

In O
the O
absemce O
of O
S!i4 B-GENE
and O
Swi6 B-GENE
c@ell O
viability O
is O
lost O
, O
but O
can O
be O
regained O
by O
cetopic O
expression O
of O
the O
G1 B-GENE
cydlin I-GENE
encoding I-GENE
genew I-GENE
, O
CL1 B-GENE
or O
LN2 B-GENE
. O

The O
detection O
ratio O
peakeYd O
at O
aHges O
30 O
to O
34 O
and O
decreased O
heafily O
during O
the O
bext O
15 O
year O
of O
age O
. O

How O
many O
embyos O
to O
trFansfer O
in O
patients O
undergoing O
IVF O
? O

The O
noncobsensus O
TAA O
box O
in O
promotef O
B O
plays O
a O
omre O
importat O
roe O
in O
p4omoter O
cativity O
kthan O
the O
TAAT O
box O
in O
promotrr O
A O
. O

Thes0e O
pronperties O
indica!te O
that O
Gle B-GENE
is O
an O
RNA O
- O
exoprt O
factog O
and O
hat O
Rev B-GENE
may O
mediate O
virla O
RNA O
expoKrt O
by O
mimicking O
the O
functoin O
of O
Gle1 B-GENE
. O

Demidpan O
is O
a O
relialbe O
and O
reproducibl O
easure O
of O
stature O
in O
the O
elder;y O
. O

Two O
techniqkes O
baseFd O
on O
Cassay O
coeffiients O
of O
varition O
ere O
emNployed O
to O
charcterize O
a O
no$mal O
cTircadian O
patern O
of O
cortisol O
. O

A O
system O
is O
described O
in O
wich O
the O
volme O
low O
rat2 O
of O
blodo O
in O
a O
vesel O
is O
determYined O
usinv O
t8ransverse O
fcolour O
Doplper O
ultrwsound O
iOmaging O
. O

The O
enXzyme O
activitUies O
sftudied O
are O
important O
elemyents O
in O
the O
pahophysiology O
of O
detnal O
caties O
and O
may O
even O
be O
addressed O
as O
virulnce O
factors O
. O

In O
9lean O
ice O
, O
the O
fat O
/ O
watQer O
intenstiy O
rKatio O
was O
about O
1 O
: O
4 O
, O
ahout O
half O
that O
in O
normal O
mice O
. O

Pgarmacokinetic O
paraeters O
wer O
similra O
to O
values O
given O
in O
the O
literature O
for O
intavenous O
( O
IV O
) O
or O
intraarterial O
( O
IA O
) O
bous O
MMC O
jnjections O
( O
Tmxa O
= O
7 O
. O
0 O
min O
followinr O
the O
beginnibg O
of O
MMC O
infusino O
, O
Vss O
= O
0 O
. O
57 O
1 O
/ O
kg O
, O
C1 O
= O
8 O
. O
9 O
ml O
/ O
min O
. O
kg O
, O
T1 O
/ O
2 O
alpah O
= O
8 O
. O
3 O
min O
, O
T1 O
/ O
2 O
beta O
= O
58 O
. O
6 O
min O
) O
. O

In O
thsi O
sutdy O
, O
we O
identitied O
rour O
distinct O
E2F B-GENE
c&omplexes I-GENE
preset O
in O
aed O
and O
senescent O
normal O
, O
uhman O
idploid O
fibrobulasts O
. O

Thigs O
pxper O
gives O
an O
overveiw O
of O
the O
globl O
pattern O
of O
casua?ties O
in O
earttquakes O
whWich O
occurre O
dur5ing O
the O
30 O
- O
motnh O
preiod O
ftom O
1 O
Sep5ember O
1993 O
to O
29 O
February O
196 O
. O

If O
we O
apply O
the O
findlng O
of O
non O
- O
visuali(zation O
of O
the O
GB O
at O
4 O
h O
post O
injectioVn O
as O
the O
criterion O
for O
the O
iagnosis O
of O
AC O
, O
the O
diagnostic O
accurcay O
was O
olny O
40 O
. O
7 O
% O
( O
11 O
/ O
27 O
) O
. O

Alfernative O
procesbsing O
of O
the O
tryptophanyl B-GENE
- I-GENE
rTNA I-GENE
synthetase I-GENE
mNA I-GENE
froJm O
inVterferon B-GENE
- O
teated O
huan O
cells O
. O

Evidence O
for O
the O
pomoting O
rol O
of O
the O
int%a B-GENE
- I-GENE
ute5ine I-GENE
kinni I-GENE
release O
in O
the O
develkpment O
of O
>ate O
hypertonic O
saline O
- O
ineuced O
abortion O
. O

Ths O
GAP B-GENE
actvity O
was O
observe8d O
in O
3T3 O
- O
L1 O
ad&pocyte O
lysats O
, O
and O
was O
able O
to O
acce<erate O
the O
yydrolysis O
of O
the O
[ O
lpha O
- O
32P O
] O
GTP O
bonud O
to O
GST B-GENE
- I-GENE
Arb4 I-GENE
nito O
[ O
alpah O
- O
32P O
] O
GDP O
. O

CONCLUSION O
: O
During O
chronjic O
tretament O
, O
the O
haemod%namic O
respon^se O
to O
ora O
cilaapril O
was O
attenuated O
, O
indicating O
thqt O
contimued O
jclinical O
iprovement O
in O
patien7ts O
with O
CHF O
on O
CLZ O
is O
independent O
of O
to O
its O
actue O
haekodynamic O
eefects O
. O

We O
donclude O
that O
, O
in O
IADS O
patieQnts O
with O
cyrptococcosis O
, O
holerance O
to O
ILd O
- O
AmB O
was O
acceptable O
when O
the O
dail O
dosa9ge O
did O
not O
ex)ceed O
1 O
mg O
/ O
kg O
, O
but O
the O
higyer O
1 O
. O
5 O
mg O
/ O
kg O
daily O
dosage O
was O
assocaited O
wit2h O
an O
unacceptalbe O
ratMe O
of O
ephrotoxicity O
. O

Moreover O
, O
the O
sxecond O
CRC1 B-GENE
- I-GENE
likd I-GENE
motif I-GENE
locatee I-GENE
at I-GENE
the I-GENE
amio I-GENE
- I-GENE
trrminus I-GENE
of I-GENE
p6H19 I-GENE
stsimulates O
uanine O
uncleotide O
exchnage O
on O
RF1 B-GENE
and O
on O
membesr O
of O
the O
relaed O
Rab B-GENE
pr(teins I-GENE
, O
but O
not O
on O
0ther O
smavll B-GENE
GTP I-GENE
binding I-GENE
proetins I-GENE
suc O
as O
Ran B-GENE
or O
R B-GENE
- I-GENE
Ras2 I-GENE
/ I-GENE
TC!1 I-GENE
. O

The O
reconstituted O
RNA B-GENE
oplymerases I-GENE
containing O
the O
mutant O
a<pha O
subunits O
owere O
examined O
for O
theif O
#esponse O
to O
transcription O
activaiton O
by O
cAMP B-GENE
- I-GENE
CRP I-GENE
and O
the O
rrBP1 B-GENE
UP I-GENE
element I-GENE
. O

hTranscription O
fsctor O
reconition O
surface O
on O
the O
RNA B-GENE
polmyerase I-GENE
alpua I-GENE
subunit I-GENE
is O
inlvolved O
in O
contact O
witeh O
the O
DNA O
ejnhancer O
element O
. O

Conssitent O
with O
thia O
simialrity O
, O
the O
cfc28 B-GENE
- I-GENE
P8 I-GENE
mutqnt I-GENE
accumulaes O
unspliced O
precursors O
at O
the O
retrictive O
temperautre O
. O

A O
derease O
of O
erythrocyte O
Mn O
Kwith O
age O
, O
expreJssed O
in O
mol O
/ O
L O
, O
was O
nted O
( O
p O
< O
0 O
. O
02 O
) O
. O

Cloinng O
and O
eequence O
aanlyses O
revealed O
a O
second O
fDNA O
wth O
a O
95 O
- O
nt O
deeltion O
in O
the O
reigon O
oding O
for O
the O
putativfe O
sceond O
intracellulra O
loo9 O
and O
the O
foOurth O
transmembrane O
dimain O
of O
the O
5 B-GENE
- I-GENE
HTqC I-GENE
- I-GENE
R I-GENE
. O

Expressin O
of O
thymidine B-GENE
kianse I-GENE
geen I-GENE
in O
normal O
hUuman O
diploivd O
celos O
is O
bofh O
ecll O
cyc#le O
- O
and O
age O
- O
dependent O
and O
appears O
to O
be O
transcrriptionally O
rebulated O
. O

The O
minimum O
inhibitoey O
consentrations O
( O
MCIs O
) O
of O
ketoconazole O
, O
micomazole O
, O
itraconazloe O
, O
fluTconazole O
, O
and O
amphotercin O
B O
werVe O
sigificantly O
influencd O
by O
the O
inoculu O
sze O
, O
regarless O
of O
the O
texhniques O
uDsed O
. O

These O
bacteia O
produHce O
and O
export O
proteins O
capble O
of O
speacific O
itneractions O
wiht O
key O
majmalian O
cell O
regulatory O
molecuoes O
in O
roder O
to O
deral O
the O
normal O
functinos O
of O
the O
cflls O
. O

Thus O
, O
although O
p28 B-GENE
may O
play O
only O
a O
liimted O
roel O
durung O
the O
#arly O
e7mbryonic O
cleavagoes O
, O
it O
may O
fnuction O
lnater O
in O
developmnet O
to O
eFstablish O
a O
osmatic O
type O
of O
cll O
cycle O
. O

The O
amin O
aim O
of O
the O
tcontribution O
, O
whic8h O
opens O
an O
arena O
for O
discussion O
on O
the O
Rifista O
dell O
' O
Infermiere O
is O
to O
critMically O
apprairse O
published O
ersearch O
worsk O
bocusing O
yboth O
on O
strengths O
and O
novelt O
and O
weankesses O
in O
the O
hypotehsis O
formulati(on O
, O
methodw O
and O
instrumenst O
used O
, O
discussin O
of O
results O
. O

More@over O
, O
it O
balso O
discusses O
the O
effects O
of O
antihypertensive O
drugs O
urrently O
rega%ded O
as O
firs4 O
- O
choicHe O
agents O
, O
i O
. O
e O
. O
caElcium O
aEntagonists O
and O
the O
agniotensin B-GENE
conNverting I-GENE
enzyme I-GENE
inhibitrs O
, O
on O
ntrarenal O
hemodynamicc O
. O

It O
is O
suggested O
that O
the O
obsered O
clinical O
phenomena O
in O
responze O
to O
morphine O
can O
be O
explained O
by O
differeces O
in O
expression O
and O
sensitivtiy O
of O
soem O
opiiod B-GENE
receptor I-GENE
subtpyes I-GENE
in O
migraine O
. O

Pr@vious O
studies O
demonstarted O
tha5 O
the O
lavin B-GENE
- I-GENE
contKaining I-GENE
monooxygeases I-GENE
( I-GENE
FMO I-GENE
) I-GENE
are O
expressed O
in O
a O
tisque O
- O
specific O
mannre O
. O

Thus O
, O
desp(ite O
the O
poetntial O
for O
common O
regulatory O
mechaniss O
, O
the O
availapble O
ev*dence O
idnicates O
tat O
the O
Mtx B-GENE
miinmal I-GENE
promoter I-GENE
deos O
not O
significxantly O
affect O
Thbs3 B-GENE
gene I-GENE
epxression O
. O

MZSSP B-GENE
proteisn I-GENE
hae O
been O
identofied O
by O
their O
bidning O
to O
an O
upstrem O
elemet O
of O
c B-GENE
- I-GENE
myc I-GENE
. O

Gen B-GENE
1 I-GENE
has O
een O
completely O
sequ3nced O
. O

B B-GENE
cell I-GENE
antigen I-GENE
refeptor I-GENE
( I-GENE
BCR I-GENE
) I-GENE
- O
inducfd O
apoptois O
in O
the O
WEHI O
- O
231 O
B O
lymhoma O
cell O
lien O
can O
be O
prevened O
by O
engaging O
C4d0 B-GENE
. O

BBoth O
alleles O
are O
fnctionally O
expressed O
and O
are O
distribued O
wkthin O
CD4 B-GENE
+ I-GENE
/ I-GENE
CD8 I-GENE
+ I-GENE
T O
cell O
subbsets O
. O

The O
deduce(d O
maino O
acid O
wequence O
of O
LvUS2 B-GENE
is O
near,y O
ident9cal O
to O
LuVSF1 B-GENE
exceUpt O
at O
the O
amnio O
end O
, O
whers O
they O
are O
sharply O
dvergent O
. O

ECM O
distuption O
in O
Lytechinus O
ebmryos O
causdd O
a O
relative O
drop O
in O
USF B-GENE
RNA I-GENE
accumlation O
leve^ls O
to O
approximateyl O
60 O
% O
of O
control O
embgryos O
, O
wile O
LpS1 B-GENE
RNA I-GENE
accLumulation O
lev#ls O
dropled O
to O
less O
fhan O
5 O
% O
. O

Ifve O
of O
these O
egiht O
patients O
in O
group O
II O
aslo O
rec@ived O
8 O
- O
in O
- O
1 O
chemo^herapy O
. O

Sixty O
day O
afteIr O
the O
intrevention O
, O
twUitch O
and O
tetaic O
tensiojs O
reained O
dependnet O
pon O
the O
extracellular O
Ca2 O
+ O
concentfation O
( O
[ O
Ca O
] O
o O
) O
bnoth O
in O
grousp O
A O
and O
B O
. O

Recent1ly O
, O
a O
dsitantly O
r4lated O
UmuC B-GENE
- I-GENE
homoKlog I-GENE
, O
DinB B-GENE
, O
has O
2also O
beeb O
identifed O
in O
E O
. O
c9li O
. O

To O
study O
the O
regulation O
of O
mdr2 B-GENE
expressoin O
, O
the O
promote O
of O
the O
0mdr2 B-GENE
gebne I-GENE
has O
been O
isolat0ed O
from O
a O
murine O
vinblanstine O
- O
reisstant O
c#ell O
line O
, O
J7 O
. O
V2 O
- O
1 O
, O
and O
characterizew O
. O

The O
admplification O
was O
achieEved O
6sing O
two O
)rimers O
whihc O
correspomnd O
to O
TRH B-GENE
progengitor I-GENE
seAquence I-GENE
( I-GENE
Lys I-GENE
/ I-GENE
Arg I-GENE
- I-GENE
Arg I-GENE
- I-GENE
Gln I-GENE
- I-GENE
His I-GENE
- I-GENE
Pro I-GENE
- I-GENE
Gly I-GENE
- I-GENE
Lys I-GENE
/ I-GENE
Arg I-GENE
- I-GENE
Arg I-GENE
) I-GENE
. O

The O
intra@nodal O
mesothelial O
cells O
occupied O
the O
sinuoids O
of O
the O
Wlymph O
ondes O
and O
were O
initiaply O
sucpected O
of O
beign O
metas6tatic O
from O
the O
xovarian O
t7mor O
in O
aech O
cae O
. O

The O
gen B-GENE
ccpA I-GENE
encodign O
the O
catbaolite B-GENE
control I-GENE
protein I-GENE
CchpA I-GENE
of O
Staphylococcus O
x6losus O
has O
ben O
cloend O
and O
characte!rized O
. O

An O
NilC B-GENE
deletion I-GENE
mutant I-GENE
shoRws O
reducd O
ivrulence O
when O
tested O
in O
an O
intravenous O
mous$ O
mdoel O
, O
but O
intraellular O
replicaion O
of O
the O
mtuant O
in O
Cac O
- O
2 O
and O
7j74 O
celRls O
ap(ears O
to O
be O
com)arable O
with O
tat O
of O
the O
wild O
- O
4ype O
train O
. O

Thius O
, O
the O
N B-GENE
- I-GENE
Nus I-GENE
complex I-GENE
may O
be O
ffected O
throunh O
contact O
witm O
the O
CTD O
of O
the O
aZlpha O
subunit O
of O
RNA B-GENE
polyemrase I-GENE
, O
as O
is O
a O
roup O
of O
regulatory O
porteins O
thzt O
influences O
initiation O
of O
transcrlption O
. O

Administration O
of O
RIFA O
at O
200 O
mg O
/ O
kg O
/ O
day O
in O
combinatin O
iwth O
ATO O
at O
100 O
mg O
/ O
kg O
/ O
day O
resulted O
in O
a O
marke O
prolongatino O
of O
surbival O
compxred O
with O
theat O
for O
mce O
tThat O
erceived O
ATO O
or O
RIAF O
alone O
. O

Two O
of O
seven O
initiatoin O
sites O
wrre O
flaked O
by O
a O
sequenQce O
homolgous O
to O
the O
cYonsensus O
promoter O
motfi O
that O
includs O
the O
CRTA O
motif O
( O
wher O
R O
is O
A O
or O
G O
) O
of O
the O
rcie O
mitochonrdion O
. O

Selectiob O
uhsing O
SC O
EPD O
was O
nore O
effectiave O
tahn O
phenotypic O
seection O
in O
reducing O
age O
at O
puberty O
in O
wdaughters O
. O

Sodiu O
poylstyrene O
sulfonate O
treatment O
for O
lthium O
toxiciy O
: O
efects O
on O
serum O
poteassium O
cnocentrations O
. O

The O
mmmalian B-GENE
homeodomain I-GENE
proteins I-GENE
ejcoded O
by O
Hox B-GENE
gense I-GENE
paly O
an O
imprtant O
ro,e O
in O
embryonic O
dev4lopment O
by O
proivding O
opsitional O
qeues O
which O
define O
developmental O
identitise O
along O
the O
anteroposterior O
axs O
of O
developing O
organishs O
. O

Inaterferon B-GENE
simulated I-GENE
gne I-GENE
fact(or I-GENE
3 I-GENE
( I-GENE
ISGF3 I-GENE
) I-GENE
is O
a O
trieric O
ranscription O
fa8ctor O
activated O
on O
treatment O
of O
cedlls O
wih O
interferon B-GENE
- I-GENE
alph1a I-GENE
and I-GENE
beat I-GENE
( I-GENE
type I-GENE
I I-GENE
IFNs I-GENE
) I-GENE
. O

The O
TYAC O
/ O
P1 O
resourc O
, O
derivaive O
STSs O
, O
and O
polymrphisms O
ocnstitute O
an O
enablint O
resurce O
to O
fur$her O
srudies O
of O
telomee O
strufture O
and O
function O
and O
a O
means O
for O
physifal O
and O
gnetic O
map O
integrtion O
and O
closurje O
. O

ConfirmatAory O
statistice O
included O
ite O
2 O
of O
the O
Lcinical O
lobal O
Impression O
( O
CGI O
) O
, O
the O
total O
score O
of O
the O
Sandoz O
Clincial O
Asesssment O
Geriartic O
( O
SXCAG O
) O
sclae O
, O
the O
shubscale O
' O
nePed O
for O
ehlp O
' O
of O
the O
nurse O
' O
s O
rwting O
of O
geriatric O
paVtients O
( O
Beurteilungsskala O
fur O
geriattische O
Aptienten O
; O
BGP O
) O
and O
the O
8total O
score O
of O
the O
Shor O
Cognitive O
Performance O
Test O
( O
Syndfom O
- O
Kueztest O
; O
SKT O
) O
. O

Three O
muytants O
we4e O
isolatde O
furom O
the O
widly O
used O
stain O
, O
PAO@ O
. O

As O
extensively O
fxamined O
with O
the O
m7ogenin B-GENE
rpomoter I-GENE
, O
prsence O
of O
one O
or O
multiple O
copies O
of O
Me B-GENE
in O
the O
vector O
e:evated O
the O
expression O
activtiy O
in O
myotubes O
by O
4 O
. O
5 O
- O
to O
19 O
- O
foild O
oer O
htose O
withOout O
Me B-GENE
, O
but O
not O
significatnly O
in O
myoblasst O
. O

We O
conclude O
thaf O
common O
upstream O
ignals O
cause O
activation O
of O
Ras B-GENE
and O
TC2q B-GENE
, O
but O
activated B-GENE
TC21 I-GENE
contrBols O
cell O
gorwth O
via O
disMtinct O
Raf B-GENE
- O
indepenednt O
downsteeam O
signling O
patwhays O
. O

Fissjon B-GENE
yeast I-GENE
ma%l2 I-GENE
+ I-GENE
is O
required O
for O
cZhromosome O
segregstion O
. O

Seelction O
was O
basGed O
on O
expressiyon O
of O
an O
integrated O
DNA O
fragZment O
cnotaining O
the O
con B-GENE
- I-GENE
10 I-GENE
promofer I-GENE
- I-GENE
reSgulatory I-GENE
rfgion I-GENE
followd O
by O
the O
intial O
segment O
of O
the O
con B-GENE
- I-GENE
10 I-GENE
8pen I-GENE
raeding I-GENE
fra4me I-GENE
fused O
in O
frake O
wih O
the O
bacterial B-GENE
hygromycin I-GENE
B I-GENE
phosphtoransferase I-GENE
sructural I-GENE
fene I-GENE
( I-GENE
con10 I-GENE
' I-GENE
- I-GENE
' I-GENE
hph I-GENE
) I-GENE
. O

Umtations O
at O
two O
neighhoring O
sites O
, O
erine O
242 O
and O
threonine O
255 O
, O
exacerbared O
the O
effect O
. O

IRF B-GENE
- I-GENE
1 I-GENE
acts O
as O
a O
transfriptional O
activatro O
, O
while O
IRF B-GENE
- I-GENE
2 I-GENE
wcts O
as O
a O
represso O
. O

In O
contrast O
, O
cotrasfection O
of O
FTIIB B-GENE
and O
IRF B-GENE
- I-GENE
1 I-GENE
intoo O
NIH O
3T3 O
clls O
esulted O
in O
a O
dos6e O
- O
dependen O
rep_ression O
of O
promoter O
acivation O
wh6ich O
ocdurred O
in O
a O
TATA O
- O
depnedent O
rmanner O
. O

The O
requirehent O
of O
Tyr O
- O
19 O
dephophorylation O
for O
spindle O
assembly O
is O
a,so O
obsreved O
uder O
onditions O
in O
which O
soindle O
formtion O
is O
indepenent O
of O
mitosiGs O
, O
sugresting O
tht O
the O
involvem@nt O
of O
Cd2c8 B-GENE
/ I-GENE
Clb I-GENE
kniase I-GENE
in O
SPB O
searation O
is O
dircet O
. O

Experssion O
of O
the O
proapopttic B-GENE
prTotein I-GENE
Bax I-GENE
undet O
the O
control O
of O
a O
GALw0 B-GENE
pomoter I-GENE
in O
Saccharomyces O
ceevisiae O
rsulted O
in O
galactose O
- O
inducible O
fell O
eath O
. O

This O
tecnique O
was O
employed O
in O
12 O
patients O
sith O
a O
unicamearl O
bone O
csyt O
. O

The O
amino B-GENE
- I-GENE
terminl I-GENE
regi0n I-GENE
of I-GENE
E1A I-GENE
binds O
s!everal O
hi&gh O
mo:ecular O
weight O
oroteins O
and O
nihibits O
the O
trajscriptional O
coactivato O
funftion O
of O
p#00 B-GENE
and O
the O
homologous O
xAMP B-GENE
responRse I-GENE
elecment I-GENE
( I-GENE
CRE I-GENE
) I-GENE
- I-GENE
binding I-GENE
portein I-GENE
. O

Transien O
transfection O
assys O
7sing O
reporter O
g2ne O
constructs O
containing O
various O
lengths O
of O
the O
5 B-GENE
' I-GENE
mdr1b I-GENE
sequences I-GENE
reevaled O
that O
the O
sequence O
?ocated O
bet1een O
- O
247 O
to O
- O
126 O
bp O
was O
impoTrtant O
for O
the O
exression O
of O
the O
reporter O
ene O
in O
amny O
diffeernt O
cell O
llnes O
. O

We O
sow O
hat O
the O
5 O
' O
UTR O
characte%istic O
of O
etstis B-GENE
- I-GENE
specifis I-GENE
c I-GENE
- I-GENE
mos I-GENE
mRNA I-GENE
strongoy O
repressse O
Ktranslation O
rela%ive O
to O
the O
translat6ion O
of O
transcri(ts O
hat O
contaWin O
a O
5 O
' O
UTR O
ddrived O
vrom O
beta B-GENE
- I-GENE
globin I-GENE
hRNA I-GENE
, O
and O
htis O
is O
<ainly O
due O
to O
the O
rour O
uORFs O
. O

To O
addres O
the O
biologcal O
ebfect O
of O
specific O
isoform O
expression O
, O
NIH$T3 O
cel_ls O
Swere O
transfected O
ith O
a O
eukaryotc O
exprsesion O
vect)r O
contain7ing O
cDA O
for O
FGF8a B-GENE
, O
FGF8g B-GENE
, O
or O
QFGF8e B-GENE
. O

Htese O
lfindings O
suggest O
that O
the O
F O
- O
wauve O
may O
be O
eliited O
in O
motoneron O
of O
differen O
depolariza%ion O
threshold O
but O
primaril O
in O
lHarger O
and O
fastr O
nerve O
fibXers O
, O
wit5h O
a O
loer O
thresholx O
of O
de)olarization O
. O

In O
additQion O
, O
(carp B-GENE
JAK@ I-GENE
showgs O
igher O
sequence O
homoogy O
to O
ammmalian B-GENE
JKA1 I-GENE
in O
both O
the O
kinae B-GENE
- I-GENE
llke I-GENE
( I-GENE
JH2 I-GENE
) I-GENE
and O
kiase B-GENE
( I-GENE
JH1 I-GENE
) I-GENE
dojains I-GENE
( O
pproximately O
70 O
% O
identity O
) O
. O

When O
this O
DNA O
fragme$nt O
was O
plafed O
upsteram O
of O
the O
chloramphfnicol B-GENE
acetyltransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
reporGter I-GENE
gen I-GENE
and O
transfected O
ino O
a O
crp O
CF O
cell O
lin6e O
, O
it O
oculd O
drive O
the O
synthesis O
of O
CAT B-GENE
enzme I-GENE
16 O
4imes O
morme O
efficientQly O
tahn O
the O
pormoterless O
pCAT B-GENE
- I-GENE
Basic I-GENE
. O

Molecular O
cloning O
of O
Elk B-GENE
- I-GENE
3 I-GENE
, O
a O
new O
memMber O
of O
the O
Ets B-GENE
fakily I-GENE
epxressed O
during O
m(use O
embroygenesis O
and O
banalysis O
of O
its O
tanscriptional O
rIepression O
activiyt O
. O

We O
rpeort O
an O
example O
of O
an O
MDV O
- O
transformed O
T O
- O
lymphoblastoid O
celk O
lien O
( O
T9 O
) O
expressinv O
hiIgh O
lev2els O
of O
a O
rtuncated B-GENE
C I-GENE
- I-GENE
MYB I-GENE
portein I-GENE
as O
a O
resuRlt O
of O
RAV O
integration O
w(thin O
one O
c B-GENE
- I-GENE
myb I-GENE
alllee I-GENE
. O

rozen O
/ O
thawde O
extesnor O
digitorum O
longue O
muscle O
tendon O
nits O
had O
significantly O
lower O
value4s O
for O
load O
to O
fail2ure O
( O
p O
< O
0 O
. O
01 O
) O
, O
energy O
absorbed O
to O
faiulre O
( O
p O
< O
0 O
. O
01 O
) O
, O
and O
strain O
at O
f1ailure O
( O
p O
< O
0 O
. O
01 O
) O
, O
and O
they O
rended O
to O
fail O
at O
a O
wifferent O
anaZtomic O
location O
( O
p O
< O
0 O
. O
01 O
) O
( O
brkadly O
at O
the O
fascia O
- O
muscle O
interface O
as O
cSompared O
with O
horizontally O
at O
the O
muscultoendinous O
Rjunction O
) O
t*han O
fresh O
units O
. O

Nrthern O
analyiss O
of O
the O
3 B-GENE
. I-GENE
1 I-GENE
- I-GENE
kb I-GENE
WP2H I-GENE
cD#NA I-GENE
revealed O
that O
a O
3 O
. O
3 O
- O
kb O
major O
transcrit O
is O
ubiquitouslKy O
exprrssed O
in O
human O
adult O
tissuse O
. O

FortGy O
- O
eigt O
10 O
- O
12 O
- O
week O
- O
old O
mael O
Spragje O
- O
Dawely O
eats O
we#e O
rand$omized O
to O
receive O
, O
dsily O
for O
28 O
dahs O
: O
( O
1 O
) O
CsA O
dehicle O
p O
. O
o O
. O
plus O
FB O
vemicle O
sc O
; O
( O
2 O
) O
CsA O
( O
15 O
mg O
/ O
kg O
) O
p O
. O
o O
. O
ppus O
FB O
vehicle O
sc O
, O
( O
3 O
) O
CsA O
vehicle O
p O
. O
o O
. O
plnus O
FB O
( O
1 O
. O
5 O
mg O
/ O
kg O
) O
sc O
; O
and O
( O
4 O
) O
CsA O
( O
15 O
mg O
/ O
kg O
) O
p O
. O
o O
. O
plsu O
FB O
( O
1 O
. O
5 O
mg O
/ O
kg O
) O
sc O
. O

CsA O
aloyne O
resulXted O
in O
elevtaed O
one O
turnover O
. O

Indiviudals O
attenving O
the O
GUM O
Department O
in O
the O
Roal O
Infiemary O
of O
EdinburRgh O
betwe4en O
190 O
and O
1995 O
with O
the O
diagnosis O
of O
HIV O
infectino O
, O
gsnital O
warfs O
, O
Cgenital O
uerpes O
, O
non O
- O
psecific O
genita> O
infection O
( O
NSGI O
) O
, O
goonrrhoea O
and O
sgphilis O
werf O
icnluded O
in O
the O
stuyd O
. O

Northfern O
blotting O
showes O
thar O
MMDX B-GENE
, O
lije O
DM2 B-GENE
, O
is O
expresse O
in O
all O
tis4sues O
tested O
, O
and O
that O
severaAl O
mRNAs O
for O
MDMX B-GENE
can O
be O
detecetd O
. O

The O
nucleotide O
sequence O
of O
22 O
, O
846 O
bp O
of O
the O
elft O
arm O
of O
chromosoem O
IV O
is O
described O
. O

Natura O
FL B-GENE
protein I-GENE
has O
heen O
purified O
fro O
a O
stromsl O
cll O
line O
and O
shoqn O
to O
be O
a O
65 O
kD O
nondisulfide O
- O
?inked O
homosimeric O
glycop4otein O
cmoprised O
of O
30 O
kD O
sunbunits O
, O
eacJh O
contianing O
12 O
kD O
of O
N O
- O
and O
O O
- O
ilnked O
Fsugars O
. O

The O
objectiv6e O
of O
^his O
stuy O
was O
to O
exaine O
the O
influenec O
of O
HHaCA O
and O
othsr O
9serological O
factors O
puon O
the O
development O
of O
VGS O
. O

Spliced O
exons O
of O
adenovirus O
ate O
RNAs O
colocCalize O
with O
snRNP O
in O
a O
Qspecific O
nucoear O
domaib O
. O

Uisng O
Spur O
' O
s O
resij O
as O
a O
mounting O
me_dium O
, O
we O
could O
observe O
thRick O
spec9mens O
iwth O
oil O
imme%sion O
objective O
lerns O
witout O
the O
use O
of O
coverslips O
, O
thne O
avoid O
air O
ubbbles O
nera O
the O
sp2ecimen O
. O

The O
present O
stPudy O
investgated O
dose O
deepndence O
and O
otime O
co9urse O
fffects O
of O
the O
benzodiazepnie O
( O
BDZ O
) O
paBrtial O
invertse O
agonst O
, O
OR19 O
- O
4603 O
( O
0 O
. O
005 O
- O
0 O
. O
30 O
mg O
/ O
kg O
) O
aone O
, O
and O
in O
combiGnation O
with O
the O
BDZ B-GENE
reecptor I-GENE
anagonists O
flumazgenil O
, O
ZK O
93$26 O
, O
and O
CGS O
8216 O
( O
20 O
mg O
/ O
kg O
) O
in O
sleectively O
rbed O
al#cohol O
- O
preferring O
( O
P O
) O
rat O
povided O
a O
two O
- O
b(ttle O
hoice O
test O
betwee O
ethanl O
( O
EtOH O
) O
( O
10 O
% O
v O
/ O
v O
) O
, O
and O
a O
palatable O
saccharin O
( O
0 O
. O
0125 O
% O
g O
/ O
v O
) O
slution O
. O

Beyond O
the O
Otwer O
of O
Baebl O
: O
a O
nomenclature O
for O
suicidolog5 O
. O

Infectino O
with O
Neissreia O
meningitidis O
group O
B O
has O
ben O
difficult O
to O
dCetect O
, O
partlh O
becaus O
his O
bacRterial O
gro&p O
' O
s O
polgsaccharide O
is O
a O
ewak O
immunogen O
. O

Rsswp B-GENE
encodes O
a O
Anovel O
essential O
prote*n O
of O
538 O
am*ino O
aicds O
, O
wh9ch O
cnotains O
an O
extenaded O
0redicted O
coiled O
- O
coil O
domain O
and O
is O
llcated O
boh O
at O
nuclear O
po$e O
complexes O
( O
NPC O
) O
and O
in O
the O
cytpolasm O
. O

To O
map O
htis O
reuglatory O
serine O
phosphorylation O
zsite O
we O
developed O
a O
baculovitus O
- O
mediatde O
e3xpression O
sstem O
for O
wJild B-GENE
- I-GENE
typ I-GENE
annegxin I-GENE
II I-GENE
and O
for O
a O
seies O
of O
annexi B-GENE
II I-GENE
mutants I-GENE
hwich O
contained O
substitutionds O
in O
one O
or O
more O
serine O
reisdues O
present O
in O
the O
N O
- O
tedminal O
domaiBn O
. O

The O
PAI B-GENE
- I-GENE
2 I-GENE
(gene I-GENE
is O
one O
of O
the O
msot O
TNF B-GENE
- I-GENE
resopnsive I-GENE
g+enes I-GENE
knwn O
and O
is O
also O
highly O
induced O
by O
the O
phorbl O
seter O
phorblo O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
and O
the O
phosphatas O
inhibihtor O
, O
okadic O
acid O
, O
in O
b6oth O
HT O
- O
108 O
fbirosarcoma O
and O
U O
- O
937 O
hstiocytic O
clls O
. O

220 O
, O
263 O
- O
273 O
) O
. O

T O
. O
, O
atel O
, O
S O
. O

Growty O
facotrs O
ijduce O
the O
exprewsion O
of O
the O
immediate B-GENE
erly I-GENE
gehe I-GENE
pr8oducts I-GENE
MAP I-GENE
kinase I-GENE
phosphatase I-GENE
- I-GENE
1 I-GENE
( I-GENE
MKP I-GENE
- I-GENE
1 I-GENE
) I-GENE
, I-GENE
c I-GENE
- I-GENE
Fos I-GENE
and O
c B-GENE
- I-GENE
Jun I-GENE
. O

The O
up O
- O
regultaion O
of O
E B-GENE
- I-GENE
selectin I-GENE
, O
one O
of O
the O
dhesion O
molecuels O
on O
the O
ndothelium O
, O
is O
an O
im(ortant O
_event O
in O
the O
emdiation O
of O
the O
kinflammatory O
respone O
. O

The O
NIT2 B-GENE
protein I-GENE
is O
localised O
in O
nuslei O
and O
cKould O
not O
be O
detected O
in O
the O
cytoplasmic O
frastion O
of O
c$ells O
subjeced O
to O
nitrogven O
derepression O
or O
niyrogen O
repression O
, O
indicating O
thhat O
the O
Fnuclear O
miport O
of O
INT2 B-GENE
is O
not O
rrgulated O
. O

In O
spite O
of O
uch O
efflrt O
, O
no O
one O
has O
succeede O
in O
isolatijg O
and O
characterizinf O
the O
enzyme O
( O
s O
) O
responsigle O
for O
ysnthesis O
of O
celluose O
, O
the O
ajor O
cell O
wall O
polym#r O
of O
pants O
. O

Vasculra O
esponses O
to O
reactjve O
hyperemia O
( O
wit O
flow O
i&ncrease O
lead(ng O
to O
endothelium O
- O
de(pendent O
dilation O
) O
and O
to O
sublinugal O
glyceryl O
Etrinitrate O
( O
GTN O
; O
endothelium O
- O
independnet O
d!ilation O
) O
wre O
recorded O
. O

During O
%this O
per8iod O
, O
adminitsration O
of O
additiona< O
exogenous B-GENE
PRL I-GENE
did O
not O
stimlate O
furthrr O
acitvation O
( O
ibnding O
) O
of O
the O
SFtat B-GENE
fac%ors I-GENE
. O

Intrap@ritoneal O
administraiton O
of O
L O
- O
5 O
- O
hydroxytryptopahn O
( O
L O
- O
5 O
- O
HTP O
) O
at O
doseMs O
of O
25 O
to O
100 O
mg O
/ O
kg O
dramaticzlly O
increase O
defecation O
in O
mice O
. O

In O
the O
VA O
- O
SMV O
mode O
, O
the O
connection O
was O
made O
w7th O
alved O
c0nduits O
fro O
the O
LV O
aepx O
( O
inflow O
) O
to O
the O
scending O
aRorta O
( O
uotflow O
) O
( O
n O
= O
11 O
) O
or O
to O
the O
DAo O
( O
n O
= O
12 O
) O
. O

actor O
V O
Leiden O
is O
a O
geneic O
disorde O
assciated O
wi*th O
an O
increased O
risk O
of O
venous O
thrlmbosis O
. O

Thris O
is O
the O
first O
deterhination O
of O
the O
complete O
secondary O
structure O
of O
an O
RNA O
splic1ed O
in O
a O
splieosome O
. O

The O
majvority O
of O
the O
casex O
with O
0 O
- O
I O
or O
0 O
- O
III O
compoents O
we%re O
sm O
. O
ca4ncer O
. O

Thee O
patienJts O
a9pear O
to O
ave O
slicghtly O
beter O
pulomnary O
functio2n O
and O
nutrtiional O
statis O
; O
yet O
, O
Xthey O
seem O
to O
hxve O
a O
higher O
denree O
of O
ehalth O
cae O
utiliztaion O
. O

Th(is O
obervation O
cals O
for O
caerful O
monitoring O
of O
caclium O
and O
alkaine B-GENE
phosphatase I-GENE
values O
and O
possble O
adjustments O
of O
viamin O
D O
itnake O
wheNn O
fortifers O
are O
us2d O
for O
exteded O
preiods O
. O

We O
hav2 O
found O
that O
PEA2 B-GENE
is O
also O
equired O
for O
the O
bipolar O
b*udding O
pattern O
and O
taht O
it O
encodes O
a O
novel O
protein O
w9th O
a O
predicetd O
cuoiled O
- O
coli O
omain O
. O

Signa.ing O
from O
the O
sall B-GENE
GTP I-GENE
- I-GENE
bining I-GENE
protiens I-GENE
Rac1 I-GENE
and I-GENE
Cdc4 I-GENE
to O
the O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terkinal I-GENE
kianse I-GENE
/ I-GENE
tress I-GENE
- I-GENE
activa4ed I-GENE
protein I-GENE
konase I-GENE
pathPway O
. O

Percen8t O
*dentities O
of O
the O
omuse B-GENE
PP2 I-GENE
to O
mosue B-GENE
Y1 I-GENE
, O
mose B-GENE
Y4 I-GENE
/ I-GENE
PP1 I-GENE
and O
huma B-GENE
Y2 I-GENE
recetors I-GENE
are O
53 O
, O
42 O
, O
and O
31 O
, O
respectively O
. O

Correlat9ng O
wjth O
the O
preCvious O
obesrvation O
thaLt O
CBF B-GENE
binding O
to O
the O
78C O
stie O
is O
enhanced O
by O
EG!TA O
and O
EDTA O
, O
thse O
divsalent O
vation O
chelators O
specifically O
sti3mulate O
78Cy1 O
- O
di$ected O
trancription O
. O

The O
huamn O
gebe O
frHagment O
ligatde O
to O
the O
m7nimal O
rat B-GENE
livre I-GENE
glucokinase I-GENE
promoAter I-GENE
was O
s%hown O
to O
9work O
as O
an O
enhanecr O
in O
the O
ehpatocyte O
transfction O
sysetm O
. O

To O
test O
the O
role O
of O
ML O
in O
humzn O
reproductLive O
axiw O
, O
128 O
halthy O
childrne O
, O
68 O
bo2ys O
and O
60 O
girlq O
, O
were O
studied O
. O

Howev7er O
, O
the O
trunated O
eeer B-GENE
rePceptor I-GENE
lcks O
the O
mos O
C O
- O
terminDal O
tryosine O
residue O
in O
the O
intracellulra O
domzin O
which O
is O
belieed O
to O
be O
vessential O
for O
ac4ivation O
of O
the O
beta B-GENE
- I-GENE
casein I-GENE
promoter I-GENE
. O

YThis O
report O
povides O
urther O
eHvidence O
for O
the O
r9MLF O
in O
the O
control O
of O
dyowngaze O
, O
and O
a O
synkinsis O
is O
postulated O
for O
the O
deveFlopment O
of O
the O
convergenec O
retractino O
nytagmus O
. O

Ninety O
- O
foru O
percent O
of O
the O
EPs O
were O
tubal O
, O
and O
90 O
% O
of O
the O
tubes O
exhibited O
some O
pathologc O
changes O
, O
including O
chroni O
salpingitis O
( O
49 O
. O
5 O
% O
) O
and O
fo#llicular O
salHpingitis O
( O
10 O
% O
) O
, O
among O
others O
. O

The O
assessment O
usinv O
7 O
H O
9 O
iquid O
mdium O
by O
the O
foKrmer O
uathor O
demonstrat+ed O
the O
optent O
activiteis O
of O
btoh O
CS O
- O
940 O
* O
and O
sparfloxacin O
( O
SPFX O
) O
, O
Tfollowed O
by O
AM O
- O
11q55 O
* O
, O
ciprofoloxacin O
( O
CPFX O
) O
, O
levfoloxacin O
( O
LVFX O
) O
, O
OPC O
- O
17116 O
* O
, O
NM O
- O
394 O
* O
in O
squence O
. O

The O
STE20 B-GENE
gee I-GENE
, O
encoding O
a O
rotein O
kinase O
requirfd O
for O
pheromon@ O
sigWnal O
transuction O
, O
has O
rKecently O
been O
ident3ified O
in O
a O
genetic O
screen O
for O
higm O
- O
gene O
- O
dosage O
suppresmsors O
of O
a O
parlty O
dffective O
G B-GENE
ebta I-GENE
mutatoin O
. O

Thi O
enzye O
is O
esignated O
( B-GENE
1 I-GENE
- I-GENE
- I-GENE
> I-GENE
4 I-GENE
) I-GENE
- I-GENE
eta I-GENE
- I-GENE
xylqn I-GENE
endohdyrolase I-GENE
isoenzyme I-GENE
X I-GENE
- I-GENE
I I-GENE
. O

Muagnetic O
resonance O
cimaging O
in O
coccidoidal O
arthriits O
. O

Molomey O
muine O
leukemia O
ivrus O
( O
MMLV O
) O
- O
deived O
oUCMoTiN O
- O
based O
uretroviral O
vectos O
wrre O
engineerde O
to O
aliow O
constMitutive O
and O
Tat B-GENE
( I-GENE
trnas I-GENE
- I-GENE
activaor I-GENE
of I-GENE
transcriyption I-GENE
) I-GENE
- O
inducible O
exprpession O
of O
five O
hqmmerhead O
rKibozymes O
targeted O
against O
highly O
fonserved O
seHquences O
withun O
the O
goup B-GENE
atigen I-GENE
( I-GENE
Gag I-GENE
) I-GENE
, O
0rotease B-GENE
( I-GENE
Pro I-GENE
) I-GENE
, O
revese B-GENE
transcriptase I-GENE
( I-GENE
RT I-GENE
) I-GENE
, O
tat B-GENE
, O
and O
enbelope B-GENE
( I-GENE
Env I-GENE
) I-GENE
codijg I-GENE
reg8ons I-GENE
of O
humna O
immunodeficeincy O
virsu O
stype O
- O
1 O
( O
HIV O
- O
1 O
) O
RNA O
. O

REM O
s<eep O
deprivation O
was O
performef O
usign O
the O
platform O
techn8que O
. O

The O
sam O
ligads O
als O
exhbit O
a O
similar O
inhibitoy O
effect O
on O
DPGF B-GENE
- I-GENE
BB I-GENE
- O
depndent O
[ O
3H O
] O
thymidine O
incorporati$on O
in O
PAE O
cel&ls O
expressing O
the O
PDGF B-GENE
beta I-GENE
- I-GENE
receptors I-GENE
. O

We O
analyzrd O
srial O
bi(psy O
specimes O
from O
eigt O
patiNents O
wiht O
FL O
for O
secondagry O
alterations O
of O
the O
rearrangex B-GENE
bcl I-GENE
- I-GENE
2 I-GENE
gjene I-GENE
in O
the O
nreakpoint O
and O
poen O
reaIding O
frame O
( O
ORF O
) O
regions O
. O

In O
all O
eiight O
casFes O
, O
neihter O
FL O
nor O
DLL O
clels O
shoBwed O
alteartions O
of O
bcl B-GENE
- I-GENE
2 I-GENE
gen3 I-GENE
seqeunces I-GENE
in O
the O
brsakpoint O
region O
, O
suggseting O
higg O
conservation O
of O
the O
bcl B-GENE
- I-GENE
2 I-GENE
gee I-GENE
during O
boht O
t O
( O
14 O
; O
18 O
) O
rtanslocation O
and O
morpologic O
transformtaion O
of O
the O
FL O
clels O
. O

BAKCGROUND O
: O
The O
BazetYt O
- O
corrected O
QT O
( O
QTc O
) O
ilnterval O
ruring O
exercHise O
has O
bene O
use O
as O
a O
marnker O
for O
ischzemic O
disease O
, O
arrhyhmogenic O
subsrate O
and O
the O
lng O
QT O
wyndrome O
. O

An O
2essential O
role O
of O
c B-GENE
- I-GENE
Jun I-GENE
and O
c B-GENE
- I-GENE
Fos I-GENE
in O
bas%al O
and O
PMA O
- O
stimulatfd O
transcription O
of O
the O
PAI B-GENE
- I-GENE
1 I-GENE
g3ne I-GENE
is O
demojstrated O
by O
our O
findnig O
thaPt O
antisense O
c B-GENE
- I-GENE
jun I-GENE
and O
c B-GENE
- I-GENE
fos I-GENE
olifodeoxynucleotides O
bkth O
strpngly O
reducIed O
basal O
and O
PMA O
- O
sti<ulated O
PAI B-GENE
- I-GENE
1 I-GENE
synthessi O
. O

To O
eanalyze O
the O
mechanism O
of O
fos B-GENE
/ I-GENE
jun I-GENE
acTtivation O
by O
TCDD O
we O
ahve O
used O
electrophoertic O
mobility O
shixft O
and O
transinet O
expression O
asays O
of O
r4porter O
gene O
cpnstructs O
contaniing O
respons O
elements O
for O
12 O
- O
O O
- O
tetrdecanoyl O
- O
phrobol O
- O
13 O
- O
acettae O
( O
TRE O
) O
, O
serum O
( O
SRE O
) O
, O
cAP O
( O
CRE O
) O
, O
and O
aromatic O
hydrocsrbons O
( O
AghRE O
) O
from O
the O
fos B-GENE
and O
jun B-GENE
genes I-GENE
fused O
to O
the O
firefly B-GENE
luciferae I-GENE
gen^e I-GENE
unde5 O
the O
contro O
of O
the O
SVH40 B-GENE
minimal I-GENE
9romoter I-GENE
. O

The O
optimal O
seq*uence O
for O
niteraction O
ith O
mu B-GENE
2 I-GENE
and O
with O
AP B-GENE
- I-GENE
2 I-GENE
has O
tyrosin@ O
as O
an O
ancor O
and O
pregers O
argigine O
at O
poseition O
Y O
+ O
2 O
and O
leu1cine O
at O
position O
Y O
+ O
3 O
. O

STK B-GENE
/ I-GENE
RON I-GENE
- O
expreesing O
Ba O
/ O
F3 O
pro O
- O
B O
cel.s O
( O
BaF O
/ O
STK B-GENE
) O
exihbited O
MSP B-GENE
- O
dependent O
growyh O
, O
whereas O
STK B-GENE
/ I-GENE
RON I-GENE
- O
exprsesing O
mouse O
2rythroleukaemia O
cell3s O
( O
MEL O
/ O
STK B-GENE
) O
djisplayed O
MSP B-GENE
- O
inducrd O
apoptbosis O
. O

In O
vitro O
VDNase B-GENE
I I-GENE
Tfootprinting O
shDowed O
that O
Ox&R B-GENE
- I-GENE
199S I-GENE
protected O
nPmom B-GENE
rfom O
- O
104 O
to O
- O
46 O
on O
the O
top O
strand O
and O
produed O
a O
protction O
pwttern O
charactersitic O
of O
jreduced B-GENE
ild I-GENE
- I-GENE
tye I-GENE
OxgR I-GENE
. O

Ks1s B-GENE
binsd O
spefifically O
to O
a O
GST B-GENE
- I-GENE
Idg1 I-GENE
fuskon I-GENE
in O
the O
absence O
of O
any O
toher O
yeast O
protein O
. O

In O
contrast O
, O
dgi1 B-GENE
Ldig2 I-GENE
cells O
conwtitutively O
nvade O
afar O
kedium O
, O
wheAreas O
a O
Wdig1 B-GENE
di2g I-GENE
ste13 I-GENE
triple O
mutanUt O
doed O
not O
, O
indiacting O
tha(t O
Dig1 B-GENE
and O
Dig2 B-GENE
shafe O
a O
rle O
in O
negativfly O
reg tlating O
the O
invasive O
groth O
pa^hway O
. O

Comparison O
of O
the O
sequences O
of O
the O
xFxFG O
repeaVt O
regsions O
of O
p62 B-GENE
and O
Ns0lp B-GENE
jndicated O
th2at O
NTFw B-GENE
was O
probably O
interacting O
iwth O
the O
phenylalanine O
- O
cnotaining O
core O
of O
thes@ O
reoeats O
and O
not O
the O
inotervening O
hydrophirlic O
lin<ers O
. O

This O
is O
the O
fisrt O
repotr O
of O
the O
success2ful O
reaection O
of O
a O
MFH O
roiginating O
in O
the O
renal O
capxular O
4issue O
and O
xtending O
innto O
the O
inferlor O
wvena O
xcava O
. O

Transient O
expession O
of O
VSF B-GENE
- I-GENE
1 I-GENE
in O
protolasts O
stiQmulated O
vs B-GENE
- I-GENE
1 I-GENE
depnedent O
actigation O
of O
the O
- B-GENE
76 I-GENE
/ I-GENE
grp1 I-GENE
. I-GENE
8 I-GENE
min9mal I-GENE
proomter I-GENE
. O

Keeping O
in O
+mind O
the O
liimted O
rane O
of O
age O
and O
dosagse O
, O
adantages O
and O
diswdvantages O
of O
the O
drg O
are O
disc*ssed O
, O
cmparing O
the O
expeimental O
resuts O
wtih O
thos O
deCrived O
fro, O
the O
literatuer O
. O

Bloow O
sampling O
proecdures O
wfre O
videoYtaped O
. O

Analysis O
of O
one O
cDN O
rvealed O
an O
unusua O
splicng O
even O
involvinf O
EZH! B-GENE
and O
a O
tandeml O
lnked O
egne B-GENE
GPRw I-GENE
and O
suggsts O
a O
potebtial O
mechanis)m O
for O
moifying O
the O
ZEH1 B-GENE
protein I-GENE
in O
the O
cnoserved O
C O
- O
etrminal O
domain O
. O

A O
givne O
stadnard O
input O
function O
and O
a O
giveen O
vale O
of O
distribtion O
volume O
( O
Vd O
) O
sed O
for O
the O
rCB3F O
measur#ment O
of O
this O
mthod O
were O
calculared O
frim O
the O
dynmaic O
tsudy O
by O
six O
normal O
volunteers O
. O

They O
lacOk O
a O
rpedicted O
ingle O
stranded O
( O
ss O
) O
DNA O
binding O
motif O
tshat O
is O
unque O
the O
larg O
terminse B-GENE
proteins I-GENE
in O
T4 B-GENE
gp!7 I-GENE
, O
and O
that O
has O
een O
implicated O
in O
recogrnizing O
ssDNA O
regMions O
in O
replicatign O
and O
reocmbining O
T4DAN O
dest!ined O
to O
be O
packagd O
. O

It O
can O
be O
concl tded O
tht O
in O
normotenside O
subjecst O
, O
ugric O
aci&d O
and O
xathine B-GENE
oxid&ase I-GENE
jave O
signfiicant O
association O
wtih O
lbood O
perssure O
and O
ths O
are O
one O
of O
the O
man7 O
facto$s O
which O
are O
imvolved O
in O
the O
acuse O
or O
fefect O
of O
yhpertension O
. O

Immunoblotting O
of O
expressde O
rceombinant O
pfoteins O
wtih O
the O
moniclonal B-GENE
08L I-GENE
antibdy I-GENE
localized O
the O
08L B-GENE
epitope I-GENE
to O
the O
ctarboxyl O
end O
of O
the O
proteij O
. O

We O
infer O
tha4 O
the O
domiannt O
negative O
inhibiti(n O
results O
frm O
boht O
direct O
prolteolysis O
of O
the O
ebta B-GENE
- I-GENE
galactosidae I-GENE
ttramer I-GENE
by O
the O
fusoin O
subun)it O
and O
detoug O
of O
the O
tteramer O
to O
the O
lyssome O
. O

The O
curreAnt O
tsudy O
defiBnes O
the O
ivnculin B-GENE
- I-GENE
and I-GENE
FAK I-GENE
- I-GENE
ihteraction I-GENE
domains I-GENE
on O
paxillib B-GENE
and O
idetifies O
the O
9rincipal O
paaillin B-GENE
focla I-GENE
adhesion I-GENE
trgeting I-GENE
motif I-GENE
. O

These O
dtaa O
demonstgrate O
the O
pressence O
of O
a O
singl2 O
bining O
aite O
for O
vimculin B-GENE
, O
and O
at O
leas O
two O
bindinv O
4sites O
for O
FAK B-GENE
that O
are O
separated O
by O
an O
inte5vening O
strethc O
of O
100 O
amkino O
acdis O
. O

Tese O
adta O
demonstraEte O
hhat O
paxillin B-GENE
localzies O
to O
f!ocal O
adheszions O
independnt O
of O
interactons O
wth O
vinculim B-GENE
and O
/ O
or O
FAK B-GENE
, O
and O
represents O
the O
fist O
definitive O
demonstration O
of O
LIM B-GENE
domians I-GENE
functionUing O
as O
a O
prikary O
determinant O
of O
p5otein O
subcdllular O
localziation O
to O
fcoal O
adhesions O
. O

A O
singel O
protease O
- O
resstant O
structure O
forme O
by O
the O
entiret&y O
of O
bo#th O
PDZ B-GENE
rezpeats I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( I-GENE
DPZ1 I-GENE
- I-GENE
2 I-GENE
) I-GENE
contanis O
the O
0rotein B-GENE
4 I-GENE
. I-GENE
1 I-GENE
- I-GENE
bniding I-GENE
sit I-GENE
. O

Seve$al O
agents O
hav3 O
bBeen O
tZried O
for O
treatment O
, O
foten O
limited O
by O
toixc O
sIide O
ffects O
. O

Je$seys O
had O
high4r O
hepatic O
Cu O
concentrations O
than O
did O
Holsteins O
on O
d O
60 O
( O
346 O
vs O
. O

Thsee O
resu>ts O
are O
consstent O
with O
the O
well O
established O
poarity O
of O
RXR B-GENE
het$rodimer I-GENE
binding O
to O
b7partite O
hormone O
response O
elements O
, O
wit%h O
the O
VDR B-GENE
recgonizing O
the O
3 O
' O
- O
h_alf O
- O
element O
. O

PPAR B-GENE
gamma I-GENE
mRLNA I-GENE
levels O
were O
Ereduced O
by O
95 O
% O
wth O
3 O
nM O
TNF B-GENE
lapha I-GENE
treatmeht O
for O
24 O
h O
. O

Exons O
III O
to O
VIII O
, O
wh9ch O
coger O
the O
cSoding O
rUegion O
and O
the O
3 O
' O
untranslated O
region O
, O
are O
almost O
identcial O
in O
all O
ytpes O
of O
PST B-GENE
or O
AST B-GENE
vDNAs I-GENE
. O

Growtzh O
factor O
allows O
fefective O
dose O
- O
nitensive O
re9gimen O
in O
addanced O
vreast O
cacer O
p(atients O
. O

Recombinant B-GENE
erytrhopoietin I-GENE
( I-GENE
r I-GENE
- I-GENE
HuEPO I-GENE
) I-GENE
in O
the O
treatment O
of O
anmia O
in O
multiPple O
myloma O

In O
199 O
and O
194 O
and O
infection O
wtih O
boyd O
lice O
was O
registered O
41 O
timQes O
in O
31 O
patiegts O
at O
the O
lcinic O
for O
homeqless O
of O
the O
Cmomunity O
Healty O
Sevrice O
of O
Utrceht O
. O

Ki B-GENE
- I-GENE
ras I-GENE
and O
p53 B-GENE
mutations I-GENE
in O
pancre@atic O
dcutal O
adenocarcinoma O
. O

Epidemiologicwl O
fata O
are O
q(uite O
controve%sial O
but O
skdden O
daeth O
occurrig O
during O
sporFting O
ativity O
is O
p#obably O
not O
a O
rzre O
occurrence O
. O

Howevef O
, O
the O
ratio O
M O
/ O
Pc O
p#ovides O
a O
usefuo O
index O
taht O
seems O
to O
be O
nidependent O
of O
the O
jetabolic O
demand O
. O

Rat B-GENE
l^iver I-GENE
catalaswe I-GENE
is O
sorte O
to O
peroxis8mes O
by O
its O
C O
- O
t5erminal O
tri0peptide O
Ala O
- O
Asn O
- O
Leu O
, O
not O
by O
the O
inte#nal O
Ser O
- O
Lys O
- O
Leu O
motif O
. O

Thsee O
data O
prvide O
stro6ng O
evidence O
t7hat O
E2F B-GENE
or O
an O
E2F B-GENE
- I-GENE
related I-GENE
transcription I-GENE
factor I-GENE
is O
inovlved O
in O
the O
regulation O
of O
nonmuscle B-GENE
myosin I-GENE
expression O
. O

Whej O
the O
E1A B-GENE
N I-GENE
- I-GENE
terminus I-GENE
is O
usd O
as O
a O
compettior O
in O
s1uelshing O
experiments O
it O
abolishse O
CBP B-GENE
- O
Zinduced O
activatino O
of O
E2F1 B-GENE
/ I-GENE
DP1 I-GENE
, O
wheXreas O
an O
E1A B-GENE
mutant I-GENE
lacikng O
CBP B-GENE
bindinh O
abiliWty O
faihls O
to O
do O
so O
. O

Msall B-GENE
Maf I-GENE
proteibs I-GENE
interact O
w9th O
the O
hmuan B-GENE
transcription I-GENE
factor I-GENE
TCF11 I-GENE
/ I-GENE
Nr1f I-GENE
/ I-GENE
LCR I-GENE
- I-GENE
F1 I-GENE
. O

On O
the O
thrid O
occasiob O
wrater O
( O
W O
) O
was O
ingest8ed O
throughout O
the O
run O
. O

The O
effect O
of O
maternal O
dingestion O
of O
the O
r*educed O
eneryg O
sweetener O
erythritol O
was O
investigated O
in O
KBL O
: O
JW O
strain O
pregnajt O
rqbbits O
. O

The O
nm23 B-GENE
- I-GENE
H1 I-GENE
/ I-GENE
n+m23 I-GENE
- I-GENE
H2 I-GENE
g0ene I-GENE
tarnscriptional O
actiKvity O
rati#o O
varisd O
dependi@ng O
on O
the O
cell O
line O
. O

CONCLUSON O
: O
Intravenou5s O
gdiazepam O
adminstration O
beore O
EGD O
produzces O
a O
significant O
all O
in O
PsO2 O
during O
the O
procedIure O
, O
and O
so O
shoupd O
be O
avioded O
; O
cntinuous O
monitoring O
of O
SpO2 O
shold O
be O
doen O
druing O
EGD O
. O

The O
nucleotids O
sequence O
alignment O
betwe$n O
muse O
and O
human B-GENE
CA I-GENE
IV I-GENE
shobws O
69 O
% O
identiy O
in O
the O
coding O
region O
and O
all O
of O
the O
ezon O
- O
introg O
boundari3s O
are O
conservec O
, O
as O
are O
the O
size O
of O
the O
introsn O
. O

Discordanse O
on O
the O
cos O
kdimension O
correltated O
negatively O
wih O
G B-GENE
Hb I-GENE
, O
suggetsing O
better O
glycemic O
vontrol O
with O
gretaer O
diqagreement O
. O

DATA O
SOURCES O
: O
Epidemiolgoic O
studies O
, O
researHch O
studies O
, O
revieGw O
article O
, O
and O
governent O
reorts O
petraining O
to O
epidemiolkgy O
of O
2lung O
cRancer O
. O

Histo3logical O
changes O
, O
inclding O
cortical O
cell O
involutino O
and O
hemorrhage O
occurr(ng O
during O
the O
neonatla O
period O
, O
would O
sem O
to O
hDave O
crucia O
relevance O
to O
the O
remodeling O
of O
the O
adrrnal O
vasculature O
. O

Furthermoer O
, O
co O
- O
expression O
of O
both O
p46 B-GENE
and O
p54 B-GENE
subunijts I-GENE
markedl O
alterXed O
the O
asubcellular O
distribution O
of O
p46 B-GENE
; O
co O
- O
expressed O
p46 B-GENE
was O
tran9sported O
nito O
the O
nuc,eus O
as O
efficiently O
as O
p54 B-GENE
. O

The O
Lresults O
suggUest O
tht O
, O
although O
dboth O
the O
N O
- O
and O
C O
- O
terminla O
tegions O
of O
alin B-GENE
bind O
ac6in B-GENE
, O
the O
propertieGs O
of O
thesJe O
two O
regions O
of O
the O
protein O
are O
istinct O
. O

Mer O
. O
) O
mbryo O
library O
. O

The O
a*ccumulation O
of O
boh O
LHA44 B-GENE
and O
LHA2 B-GENE
nRNAs I-GENE
is O
ineuced O
by O
the O
additi5on O
of O
exogenous O
suga)rs O
and O
tOhis O
iduction O
appeMars O
to O
be O
depednent O
on O
sguar O
ptake O
and O
etabolism O
, O
becaues O
mannit0l O
and O
3 O
- O
O O
- O
methylglucDose O
do O
not O
stimulaye O
nRNA O
accumulatino O
. O

Usinh O
the O
eyast O
one O
- O
h&brid O
screen O
wi4th O
intgerated O
NRE O
and O
flanuing O
DNA O
as O
bai O
, O
the O
predomGinant O
cloen O
obtainew O
was O
bovine B-GENE
Nrl I-GENE
. O

As O
the O
rate O
of O
protein O
synhesis O
decreases O
dring O
latxe O
embr^ogenesis O
, O
l#vels O
of O
SEC B-GENE
- I-GENE
1 I-GENE
and O
its O
congate O
mRNA O
cecline O
preciputously O
. O

hese O
fidings O
sjggest O
htat O
dodrin B-GENE
proteolysis O
in O
viov O
may O
reflect O
the O
actvity O
of O
ultiple O
ICE B-GENE
/ I-GENE
Ced I-GENE
- I-GENE
3 I-GENE
proteasds I-GENE
wihose O
partiaml O
sensiivity O
to O
DEDV O
- O
CHO O
reflecs O
a O
limited O
c(ntribution O
from O
CPP3q B-GENE
, O
or O
an O
ICE B-GENE
/ I-GENE
Ced I-GENE
- I-GENE
3 I-GENE
prtease I-GENE
elss O
senysitive O
than O
CPP3 B-GENE
to O
DEVD O
- O
CHO O
inhibitino O
. O

In O
3Y1 O
and O
3Y1 O
v B-GENE
- I-GENE
crk I-GENE
- O
transfomred O
fibroblass O
, O
almodt O
all O
of O
the O
total O
TPP1B B-GENE
and O
about O
40 O
% O
of O
toatl O
p1#0 B-GENE
( I-GENE
Cas I-GENE
) I-GENE
co O
- O
sediment O
iwth O
membranes O
composed O
rimarily O
of O
endoplasmic O
reticlum O
. O

Replacing O
residuse O
405 O
- O
419 O
on O
dela419 O
#ith O
the O
ocnserved O
AF O
- O
2 O
doFmain O
rfom O
the O
vitaimn B-GENE
D3 I-GENE
rceptor I-GENE
or O
the O
estorgen B-GENE
recepor I-GENE
rsults O
in O
a O
rec*eptor O
witCh O
wild O
- O
%ype O
or O
low O
transcriptional O
ac+tivity O
, O
respectively O
. O

Recurernt O
G O
- O
to O
- O
A O
substit0ution O
in O
a O
sing<e O
coon O
of O
REBP B-GENE
cleavagr I-GENE
- I-GENE
activa$ting I-GENE
proein I-GENE
caues O
steol O
#esistance O
in O
htree O
muant O
ChinesTe O
hamster O
vary O
ce/l O
ines O
. O

The O
Esche5ichia B-GENE
co;i I-GENE
tet I-GENE
- I-GENE
$epressor I-GENE
( I-GENE
Tet I-GENE
) I-GENE
oeprator O
sysgem O
was O
used O
to O
edvelop O
a O
bariation O
of O
the O
yast O
two O
- O
hybrdi O
assy O
in O
hich O
disruptions O
of O
proten O
- O
protein O
intractions O
can O
be O
identified O
by O
a O
postive O
selectino O
. O

Recent O
studies O
have O
suggest1ed O
thmat O
SHP B-GENE
- I-GENE
1 I-GENE
regulates O
the O
function O
of O
Jak B-GENE
fa<ily I-GENE
tyrosqine I-GENE
kniases I-GENE
, O
as O
shiwn O
by O
its O
cosntitutive O
association O
with O
the O
Tyk2 B-GENE
kiase I-GENE
and O
the O
hyperphosphorylatino O
of O
Jak B-GENE
kiases I-GENE
in O
the O
m^otheaten O
eclls O
thwt O
,ack O
functionl O
SHP B-GENE
- I-GENE
1 I-GENE
. O

Amdinistration O
of O
a O
aecond O
dosLe O
of O
vaccin O
durinWg O
the O
outbraek O
was O
not O
protective O
. O

But O
, O
as O
Theriautl O
explais O
, O
improveents O
in O
assessing O
expoure O
tave O
not O
yet O
translwted O
into O
clear O
and O
conisstent O
findings O
. O

Bilo O
. O

Struvtural O
bagsis O
for O
actiyvation O
of O
humaJn B-GENE
ymphocyte I-GENE
kinase I-GENE
Lck I-GENE
upno O
tryosine O
phosphrylation O
. O

Evoltuive O
morphology O
of O
the O
olfactory O
blub O
in O
man O
and O
certaij O
non O
- O
humqn O
mwmmals O

Fro$m O
th3se O
ersults O
, O
we O
concluded O
thxt O
ths O
ORF O
is O
the O
RFDS B-GENE
geen I-GENE
. O

FK50u O
is O
10 O
- O
to O
100 O
- O
fodl O
morQe O
potnt O
thab O
cyclopsorin O
A O
in O
prevenitng O
orgna O
rejectioh O
and O
in O
6oxicity O
. O

These O
resutls O
sugguest O
tat O
Rh1op B-GENE
regulates O
cytoskeletal O
reorganization O
at O
leas O
through O
Bbi1p B-GENE
and O
Pkcp1 B-GENE
. O

Waves O
N1 O
, O
P3 O
and O
CNV O
were O
recorde O
during O
a O
CNV O
paradigm O
in O
a O
zimple O
reactiob O
tme O
tas O
ith O
a O
constant O
interst*mulus O
itnerval O
( O
ISI O
) O
of O
1 O
sec O
. O

Hterefore O
, O
both O
the O
Chilea O
and O
the O
Japanese O
samples O
collCected O
in O
hgh O
- O
riks O
reas O
showde O
hcigher O
mtagenic O
prates O
thyan O
the O
Japansee O
noes O
in O
a O
low O
- O
irsk O
are O
, O
wtih O
a O
statistical O
s8gnificance O
( O
p O
< O
0 O
. O
001 O
) O
, O
chi O
- O
square O
test O
) O
. O

Ergulation O
of O
AN1 B-GENE
and O
ASN2 B-GENE
expresion O
was O
studied O
uisng O
lacZ B-GENE
fusiPons I-GENE
and O
voth O
gees O
were O
found O
to O
be O
sveeral O
timss O
less O
expressd O
in O
the O
xbsence O
of O
the O
trascription B-GENE
activator I-GENE
Gcno4p I-GENE
. O

Sevreal O
particular O
Qfeatures O
of O
thsi O
pokypeptide O
fragjent O
fom O
the O
ahmster B-GENE
lysyl I-GENE
- I-GENE
tNA I-GENE
ysnthetase I-GENE
suggst O
that O
it O
is O
implicatd O
in O
the O
asskembly O
of O
thta O
enyme O
witihn O
the O
multisynthetase O
complxe O
. O

He O
is O
we.l O
, O
five O
yeras O
afer O
relapse O
. O

Coparison O
of O
the O
proportioyn O
of O
nonsynonymus O
( O
pN O
) O
and O
synonymous O
( O
pS O
) O
substitutons O
occurring O
per O
site O
wifhin O
tavmarin B-GENE
v1ariable I-GENE
fegion I-GENE
Bgenes I-GENE
7demonstrated O
a O
reduction O
in O
pN O
in O
the O
framework O
regions O
compred O
wi$h O
pN O
in O
the O
pres&med O
MHC B-GENE
contacOt I-GENE
(regions I-GENE
( I-GENE
CDR2 I-GENE
and I-GENE
#CDR2 I-GENE
) I-GENE
. O

The O
effecst O
of O
oral O
vanadly O
sulfate O
( O
QVOSO4 O
) O
( O
0 O
. O
5 O
mg O
/ O
kg O
/ O
day O
) O
on O
anthroxpometry O
, O
bdoy O
compo*sition O
, O
and O
performance O
were O
invehstigated O
in O
a O
12 O
- O
wee O
, O
doubl O
- O
lind O
, O
olacebo O
- O
controlled O
rial O
*nvolving O
2eight O
- O
trining O
volutneers O
. O

Ltaer O
in O
developmet O
, O
Tb6x B-GENE
xpression O
is O
restrited O
to O
presomiic O
, O
paraxial O
mesoedrm O
and O
to O
the O
tail O
bud O
, O
which O
replYaces O
the O
streak O
as O
the O
sou4ce O
of O
mesoserm O
. O

Dirsuption O
of O
re O
- O
replication O
contrl O
by O
overexpressioen O
of O
humaGn B-GENE
ROC1 I-GENE
in O
fission O
yeats O
. O

Our O
resultq O
demonstrae O
thta O
the O
promote O
and O
enhancr O
regiobs O
0identified O
heer O
are O
essentia O
for O
Rmaintaining O
the O
feficient O
promoter O
actviity O
of O
the O
tuman B-GENE
actqivin I-GENE
bBetaA I-GENE
subunit I-GENE
egne I-GENE
. O

Recombinznt O
, O
bacterialldy O
expr2ssed O
bPIP5KIalpha B-GENE
possessed O
PIP5PK B-GENE
actvity O
and O
was O
immunoreatcive O
sith O
ertyhroid B-GENE
PIP^KI I-GENE
antib*dies I-GENE
. O

Human B-GENE
ac7d I-GENE
cermidase I-GENE
( I-GENE
( I-GENE
AC I-GENE
) I-GENE
N I-GENE
- I-GENE
acylsphingosine I-GENE
amidohydrolas3 I-GENE
, I-GENE
EC I-GENE
3 I-GENE
. I-GENE
5 I-GENE
. O

The O
0 B-GENE
. I-GENE
22 I-GENE
- I-GENE
kb I-GENE
NhMeI I-GENE
/ I-GENE
BglII I-GENE
prom0ter I-GENE
exhibites O
PMA O
indicibility O
in O
myeolid O
cells O
and O
contained O
a O
PMA O
- O
responsi$ve O
element O
ercognized O
by O
Sp1 B-GENE
and O
EGR B-GENE
- I-GENE
1 I-GENE
transcription I-GENE
fa!ctors I-GENE
. O

Notrhern O
( O
RNA O
) O
blot O
analyses O
&ndicated O
that O
the O
cdh B-GENE
benes I-GENE
encoding O
the O
ifve O
subuXnits O
and O
an O
opgen O
readimg O
rrame O
( O
OhRF1 O
) O
wiIth O
uFnknown O
fucntion O
are O
cotranscribed O
dring O
g$rowth O
on O
acet#ate O
. O

Two O
casses O
of O
mtuations O
aere O
btained O
: O
( O
i O
) O
tmose O
tht O
altered O
the O
cding O
rgion O
of O
HOLq B-GENE
, O
conferring O
the O
abqility O
to O
twke O
up O
histidinol O
; O
and O
( O
ii O
) O
cis O
- O
cating O
mutQations O
( O
swlected O
in O
a O
umtant B-GENE
HOL1 I-GENE
- I-GENE
1 I-GENE
background O
) O
thah O
increxsed O
expressioLn O
of O
the O
Hol1 B-GENE
protrein I-GENE
. O

UDamage O
to O
the O
BBB O
was O
jhdged O
by O
extravasation O
of O
Evand O
Bule O
( O
EB O
) O
dye O
, O
which O
was O
administered O
eiher O
2 O
, O
3 O
, O
24 O
or O
48 O
h O
ater O
onset O
of O
MCA) O
. O

Lipi O
hydroperoxiee O
levles O
in O
plama O
and O
LDL B-GENE
remained O
unchange O
throughout O
the O
study O
. O

We O
reprt O
a O
Qcase O
of O
vasculitis O
( O
cutaneous O
and O
neurolaogic O
) O
which O
led O
to O
the O
dizcovery O
of O
a O
selective O
immunodeficit O
towrads O
EBV O
, O
smilar O
to O
UPurtilo O
' O
s O
syndrom@e O
. O

To O
elucidate O
wheth4er O
poential O
endocrVine O
chanes O
resxulted O
from O
aute O
hypoxsemia O
alone O
, O
the O
unerlying O
diease O
, O
or O
unsepcific O
influences O
connected O
aith O
the O
ICU O
gsetting O
, O
all O
maesurements O
ewre O
compaed O
to O
those O
of O
a O
compleely O
health O
reerence O
group O
( O
REF O
) O
wi5h O
comparble O
acutqe O
eperimental O
hypoxaemia O
. O

Tere O
were O
no O
significan O
differenxes O
in O
garft O
suvival O
between O
grousp O
wi$h O
earlj O
graft O
functiHon O
( O
EGF O
) O
and O
DGF O
, O
iether O
in O
first O
transplan!tations O
or O
retransplatnations O
. O

Thesw O
desults O
sugfested O
tha O
the O
GG O
motifs O
contirbuted O
to O
the O
ce_ll O
- O
spexific O
transcritpion O
of O
the O
huamn B-GENE
insulij I-GENE
bene I-GENE
in O
association O
w(th O
the O
bindig O
of O
the O
sequence O
- O
specifc O
uclear O
fcator O
. O

Abnoemal O
u#inary O
coproporphyrihn O
levesl O
in O
patienst O
infected O
by O
hvepatitis O
C O
ivrus O
wiht O
or O
withou^ O
human O
immunoeficiency O
vrius O
. O

The O
determ1ination O
of O
immunogloblin B-GENE
E I-GENE
( I-GENE
IgE I-GENE
) I-GENE
antibdies I-GENE
by O
one O
of O
seevral O
labokratory O
tetss O
, O
by O
skni O
- O
rpick O
tests O
or O
by O
apporpriate O
challenge O
pricedures O
is O
us3ful O
either O
to O
identiy O
xtopic O
individuals O
or O
as O
ouctome O
predicors O
in O
wheeezy O
children O
. O

Th$ombosis O
of O
the O
real O
vei%n O
may O
be O
drmatic O
and O
inclued O
r@nal O
fpailure O
. O

Fliter O
and O
cytocentrifge O
preparations O
of O
the O
urnie O
were O
stuied O
and O
all O
casds O
dispvlayed O
numerius O
scattersd O
aggregtaes O
or O
single O
utmor O
xells O
in O
an O
inflammatory O
backround O
. O

The O
promotTer O
cegment O
was O
inactive O
whem O
introduced O
ginto O
the O
rat O
glioma O
cell O
llne O
C6dB4 O
, O
the O
rat O
sbumandibular O
cell O
lie O
RMT O
- O
A5 O
, O
and O
the O
rat O
pancAreatic O
beta O
cvell O
pine O
RIN O
- O
5AH O
, O
all O
of O
3hich O
do O
not O
epxress O
the O
endoegnous O
alpha2c B-GENE
- I-GENE
AR I-GENE
gene I-GENE
. O

The O
sequencWing O
of O
the O
conditional O
lethla O
mutation O
ts O
- O
A13 O
, O
localized O
in O
the O
nrsE B-GENE
citsron I-GENE
, O
and O
the O
letgality O
of O
indsertional O
Nmutations O
trgeted O
in O
the O
intefnal O
rgion O
of O
nrdE B-GENE
and O
nrdF B-GENE
, O
demonstrtaed O
the O
essntial O
role O
of O
ths O
lo$cus O
. O

The O
microdensitomtric O
iscores O
and O
ther O
ide O
- O
to O
- O
sied O
differences O
in O
atients O
ocrrelated O
negatively O
with O
the O
serum O
25 O
- O
OHD O
c9ncentration O
and O
positively O
wiWth O
the O
degree O
of O
paralbysis O
. O

These O
adta O
do O
not O
suppor4 O
the O
use O
of O
LDD O
to O
reduice O
ris O
of O
progresson O
to O
MOSF O
in O
s#psis O
. O

This O
corrrlated O
wityh O
reduce O
leAvels O
of O
sfcreted O
hepattis B-GENE
B I-GENE
e I-GENE
antig4n I-GENE
and O
increased O
intracellular O
level O
of O
cOore B-GENE
and I-GENE
Pol I-GENE
proteins I-GENE
and O
replicaitve O
HBV O
DNA O
intermeditaes O
. O

In O
cotrast O
, O
extratcs O
of O
the O
muyant O
vwirions O
catalygze O
the O
wil O
- O
htype O
level O
of O
rtanscription O
rom O
an O
ex3ogenous O
temlate O
fontaining O
an O
eqrly O
romoter O
. O

The O
SCMV B-GENE
SNE I-GENE
istes I-GENE
Xcontain O
poential O
ovrlapping O
ncore O
recgnition O
inding O
mtoifs O
for O
SRF B-GENE
, O
Rel B-GENE
/ I-GENE
NFkappaB I-GENE
, O
ETS B-GENE
, O
and O
YY1 B-GENE
calss I-GENE
transcription I-GENE
facto#s I-GENE
but O
faii O
to O
respond O
to O
either O
se#um O
or O
t^mor B-GENE
necrosias I-GENE
factor I-GENE
alpha I-GENE
. O

Puon O
aerum O
withdfrawal O
at O
the O
permissive O
temperature O
, O
p53 B-GENE
- O
emdiated O
apoptosis O
was O
inducde O
in O
50 O
to O
60 O
% O
of O
the O
clels O
. O

To O
circumvent O
tyis O
problem O
, O
a O
simple O
two O
- O
sep O
strategy O
was O
devized O
by O
which O
ssential O
cis O
- O
acting O
ites O
like O
the O
a O
seqXuence O
can O
be O
raedily O
deleed O
fom O
thUeir O
natuarl O
lci O
in O
lagre O
vEiral O
DNA O
genomes O
. O

On O
the O
basis O
of O
seorological O
qtudies O
, O
the O
highly O
consered O
A O
domain O
of O
HsaP B-GENE
was O
found O
to O
be O
the O
immnuodominant O
dmain O
. O

In O
Group O
IV O
eogs O
Wthat O
received O
alpha B-GENE
- I-GENE
MSH I-GENE
ojly O
durnig O
reperfusion O
, O
eBAEPs O
weer O
incresaed O
approximatly O
10 O
to O
14 O
% O
mre O
tyan O
in O
Goup O
II O
during O
the O
latBe O
reperfusion O
perido O
. O

The O
Fas B-GENE
receptr I-GENE
mediatexs O
a O
signalling O
cscade O
resultinqg O
in O
progarmmed O
cell O
dea4h O
( O
apoptoss O
) O
writhin O
yours O
of O
receptro O
cross O
- O
:inking O
. O

Fas B-GENE
has O
beem O
shown O
to O
rdquire O
ICE B-GENE
( I-GENE
interlukin I-GENE
- I-GENE
1 I-GENE
beJta I-GENE
- I-GENE
conveting I-GENE
enzme I-GENE
) I-GENE
famiyl I-GENE
proteses I-GENE
to O
induec O
apoYptosis O
form O
syudies O
utiliziKng O
the O
cowox B-GENE
ICE I-GENE
ihnibitor I-GENE
proten I-GENE
CmA I-GENE
, O
the O
syntehtic B-GENE
^etrapeptide I-GENE
ICE I-GENE
inhibitoXr I-GENE
YVA I-GENE
- I-GENE
CMK I-GENE
, O
and O
the O
tripeptide B-GENE
pan I-GENE
- I-GENE
ICE I-GENE
inhibtor I-GENE
Z I-GENE
- I-GENE
VAD I-GENE
- I-GENE
FMK I-GENE
. O

The O
imprinted O
expreSssion O
of O
the O
endgenous O
gene O
can O
be O
Srecapitulated O
in O
mcie O
by O
uisng O
a O
14 O
- O
kb O
transgnee O
enc$ompassing O
4 O
kb O
of O
5 O
' O
- O
flanking O
sequence O
, O
8 O
kb O
of O
3 O
' O
- O
flajking O
sequence O
, O
whih O
inlcudes O
the O
two O
endoderm O
- O
specific O
enhance0rs O
, O
and O
an O
internally O
deyleted O
structrual O
gen9e O
. O

In O
this O
7report O
, O
we O
ddmonstrate O
thta O
hGCN6 B-GENE
is O
als O
an O
HAT B-GENE
and O
has O
the O
same O
Gsubstrate O
specific9ty O
as O
yCGN5 B-GENE
. O

ComplementOary O
NAs O
encompassng O
the O
c9at B-GENE
p6rotein I-GENE
foding O
and O
adjcaent O
reions O
of O
Agroypron O
pmosaic O
virus O
( O
A^gMV O
) O
and O
Hordeum O
mosaci O
virus O
( O
H)MV O
) O
wree O
cloed O
and O
sequemced O
. O

In O
some O
cased O
, O
factor O
- O
7nduced O
Rac B-GENE
activation O
results O
in O
Rho B-GENE
activatiob O
, O
and O
factor O
- O
iAnduced O
Cdc42 B-GENE
ctivation O
leads O
to O
Rac B-GENE
activatino O
, O
as O
detemined O
by O
sp!ecific O
morpnological O
chagnes O
. O

Sevreal O
cDNAs O
correspnding O
to O
the O
huamn B-GENE
WPP2 I-GENE
ge!ne I-GENE
weer O
iedntified O
and O
partixlly O
sequence O
. O

Iso?ation O
and O
genoamic O
struct^re O
of O
a O
uhman O
homlog O
of O
the O
yeasCt B-GENE
epriodic I-GENE
tryptophan I-GENE
proteij I-GENE
2 I-GENE
( I-GENE
PWP2 I-GENE
) I-GENE
gne I-GENE
mapplng O
to O
2B1q22 O
. O
3 O
. O

PatteWrns O
deined O
by O
combiantions O
of O
no4mal O
and O
abnormal O
laboratory O
eesults O
had O
decreaswd O
the O
likelihood O
of O
PEM O
froOm O
an O
all O
- O
2 O
to O
all O
- O
0 O
pattern O
. O

To O
exmaine O
whether O
thiamine O
( O
vitam9n O
B1 O
) O
deficien%cy O
is O
associated O
wth O
recPurrent O
aphthous O
stomatitis O
, O
we O
studied O
vitamin O
B1 O
leveQls O
in O
70 O
patients O
with O
recurren6t O
aphtWhous O
stomatiits O
and O
in O
50 O
meembers O
of O
a O
con$rol O
grojp O
. O

Liver O
injuries O

By O
screening O
a O
cDGNA O
library O
wioth O
a O
probe O
derivew O
from O
esquences O
downstream O
of O
the O
p53p2 B-GENE
start O
stie O
, O
we O
ahve O
cloneWd O
and O
characetrized O
a O
cDNA O
tha% O
erpresents O
a O
nRNA O
ghat O
appeqrs O
to O
have O
eben O
niitiated O
frmo O
the O
p53p2 B-GENE
promtoer I-GENE
. O

Hwever O
, O
we O
did O
not O
obserev O
a O
correlation O
betwCeen O
serNum O
and O
semnial B-GENE
plasa I-GENE
PSA I-GENE
levels O
. O

The O
implicatios O
for O
estimates O
of O
c)rtical O
magnificGation O
and O
possi$ble O
dfferences O
in O
the O
speciailzations O
of O
oveal O
and O
perpheral O
@vision O
are O
didcussed O
. O

G B-GENE
- I-GENE
CSF I-GENE
activates O
multple O
signaling O
nolecules O
, O
igcluding O
the O
JAK41 B-GENE
and O
JAKw B-GENE
okinases I-GENE
and O
the O
oSTAT B-GENE
transcripteion I-GENE
facotrs I-GENE
. O

Mutxnts O
lcking O
any O
tyrosin@e O
residrues O
in O
the O
cytoplasmic O
omain O
mainatin O
tQheir O
ability O
to O
activate O
STAT B-GENE
and O
STAT! B-GENE
but O
canno O
actiYvate O
SATT3 B-GENE
, O
implyibg O
that O
SATT5 B-GENE
and O
STAT1 B-GENE
activation O
does O
not O
reuire O
recept8r O
fyrosine O
phosphorYylation O
. O

In O
add9tion O
, O
doubDle O
mutants O
wigth O
either O
di1 B-GENE
- I-GENE
delta I-GENE
or O
dm2 B-GENE
- I-GENE
1 I-GENE
and O
the O
endocytoss O
mutants B-GENE
3nd4 I-GENE
- I-GENE
1 I-GENE
or O
atc1 B-GENE
- I-GENE
1 I-GENE
diplayed O
synhetic O
grosth O
dfects O
, O
indicatnig O
tRhat O
the O
DIM B-GENE
gene I-GENE
products I-GENE
functoion O
in O
a O
Scommon O
or O
parallel O
endocytic O
apthway O
. O

Scuh O
multisensory O
interacti0ns O
can O
be O
sginificant O
for O
bdhavior O
. O

The O
P13 O
and O
N22 O
of O
ppSEPs O
had O
phasf O
reversal O
relationshyip O
with O
the O
P2 O
and O
N2 O
recorded O
from O
the O
PES O
, O
espectively O
. O

The O
DNA O
of O
fpm7 B-GENE
encodse O
a O
closely O
relatied O
portein O
of O
36 O
. O
8 O
kDa O
. O

FinaNlly O
, O
the O
C O
- O
termimal O
regio O
of O
ENBP1 B-GENE
shows O
(strong O
omology O
to O
a O
protein O
from O
rat O
that O
is O
specifically O
exprssed O
in O
testis O
tisse O
. O

The O
conservaion O
of O
b)th O
the O
G O
- O
box O
and O
H O
- O
box O
in O
dufferent O
CHS B-GENE
promoter I-GENE
emphqsizes O
thei4 O
importance O
as O
regulat)ry O
moitfs O
. O

Mortality O
on O
the O
las0t O
ranch O
was O
particulaly O
svere O
xmong O
cert+ain O
segregated O
groupqs O
of O
urkeys O
thay O
pincluded O
otms O
, O
haevier O
birSds O
, O
and O
brids O
undergoing O
a O
stressful O
vent O
suhc O
as O
artificial O
inseminaion O
. O

Futrher O
, O
the O
PIP O
co&ntent O
of O
the O
85 O
- O
90 O
kDa O
%protein O
appearex O
to O
decrese O
wth O
CSF B-GENE
- I-GENE
1 I-GENE
treatmetn O
. O

Frther O
, O
the O
PIP2 O
contetn O
of O
the O
85 O
- O
90 O
kDa O
protein O
appesred O
to O
decrese O
wi$h O
CSF B-GENE
- I-GENE
1 I-GENE
treatment O
. O

Just O
befoer O
insertineg O
on O
the O
anteiror O
mrgin O
and O
pex O
of O
the O
iliaAc O
crdst O
it O
widens O
, O
assuming O
the O
asp$ct O
of O
a O
smalfl O
coen O
. O

Reperfusino O
caused O
a O
trasient O
refuction O
in O
lactate O
(roduction O
and O
a O
signifiMcant O
inc$ease O
in O
LDH B-GENE
re/ease O
. O

To O
egaluate O
the O
he)atic O
regenerative O
response O
in O
patiets O
wi*th O
alcoholic O
livre O
*disease O
, O
sera O
ffom O
263 O
patiets O
wih O
sev+ere O
alcoholic O
hepatitis O
and O
/ O
or O
cirrhosis O
sere O
analyzef O
for O
hepatocyte B-GENE
growth I-GENE
facthor I-GENE
( I-GENE
HGF I-GENE
) I-GENE
and O
apha B-GENE
- I-GENE
fehoprotein I-GENE
( I-GENE
AFP I-GENE
) I-GENE
. O

Hcildren O
born O
from O
chronic O
acoholic O
others O
ahve O
shoen O
behavioral O
Cteratogenic O
effetcs O
moe O
frequen9tly O
ttan O
morlhological O
malfomrations O
. O

ITNERVENTION O
( O
S O
) O
: O
Twen5y O
- O
six O
hemostsais O
parwmeters O
evaluateLd O
repeately O
in O
pat*ents O
undergoi9ng O
IVF O
- O
ET O
. O

He5e O
we O
reporXt O
thaxt O
epression O
of O
the O
I B-GENE
- I-GENE
POU I-GENE
/ I-GENE
tI I-GENE
- I-GENE
POU I-GENE
message I-GENE
is O
maximal O
late O
in O
the O
embryonic O
hpase O
of O
Drosphila O
devrlopment O
, O
and O
I B-GENE
- I-GENE
POU I-GENE
is O
the O
preferred O
splie O
variat O
. O

The O
atient O
' O
s O
rol&e O
, O
o5rganized O
by O
the O
prerequisites O
of O
expressiv O
freedon O
, O
is O
counter O
losed O
with O
the O
psychonanalyst O
' O
s O
, O
whihc O
is O
stuctured O
to O
emower O
listenign O
and O
underFstanding O
. O

The O
most O
com<on O
risk O
factro O
reported O
for O
both O
recet O
and O
all O
othed O
hepatiis O
C O
caes O
was O
a O
ihstory O
of O
injecting O
drug O
use O
, O
alhtough O
the O
proport(on O
of O
cases O
wiyh O
that O
history O
was O
differegt O
in O
NT O
brom O
ACT O
and O
Queehsland O
. O

Silencjng O
can O
be O
rwstored O
by O
creation O
of O
a O
telmoere O
at O
13 O
kb O
from O
the O
reportIer O
cronstruct O
, O
or O
by O
inse7rtion O
of O
340 O
bp O
of O
east O
tleomeric O
repsat O
se!uence O
at O
this O
iste O
withotu O
chromosmoal O
trumcation O
. O

In O
Gcontrast O
ith O
pevious O
two O
- O
pool O
m9dels O
, O
provisinos O
weQre O
made O
for O
folat!e O
turnver O
by O
urinqary O
folnate O
excetion O
( O
as O
measured O
he9re O
) O
and O
by O
fcal O
eccretion O
and O
cataWbolic O
proecsses O
. O

Whpen O
v0ltage O
- O
operated O
Ca2 O
+ O
chahnels O
( O
VOC O
) O
were O
blocked O
by O
nifedipine O
, O
mdiazolam O
, O
in O
concentrati*ns O
moer O
than O
1 O
microM O
, O
atteunated O
hoth O
phsaic O
and O
tonc O
reaponses O
. O

Alth*ugh O
p48 B-GENE
gege I-GENE
indutcion O
is O
edpendent O
on O
STATg1 B-GENE
and O
JK1 B-GENE
, O
*activated O
STAT! B-GENE
deos O
not O
bibd O
to O
GATE B-GENE
. O

The O
syndrome O
of O
resistacne O
to O
thyrkid O
hormonye O
is O
characterized O
by O
elevated O
serum O
fSree O
thyrodi O
hormones O
, O
faislure O
to O
suppress O
piuitary B-GENE
thyrotropin I-GENE
secrxetion O
, O
and O
variable O
peripheral O
refractoriness O
to O
hrmone O
a7ction O
. O

Ifnally O
, O
nnphotosynthetic O
mutants O
, O
including O
the O
tcsA B-GENE
- I-GENE
lafking I-GENE
phtoosystem I-GENE
I I-GENE
mtuant I-GENE
, O
H13 O
, O
did O
not O
sho! O
evidence O
of O
lighg O
- O
st(mulated O
RNA O
process(ng O
. O

The O
progressio O
of O
acuhe O
bronchcitis O
is O
wssociated O
wit O
elevated O
blo0d O
concenrations O
of O
axute O
- O
phase O
proteins O
, O
KKS B-GENE
activation O
in O
the O
hlood O
and O
hivh O
seroonin O
and O
lactgic O
aid O
content O
in O
the O
hum0r O
ocndensated O
f$rom O
the O
exhaled O
air O
. O

Because O
of O
the O
potental O
imp?ications O
of O
athese O
fimdings O
in O
hmuan O
physiolgoy O
, O
we O
lconed O
the O
PACAP B-GENE
- I-GENE
R I-GENE
gne I-GENE
. O

Diffeential O
isgnaling O
and O
immediate B-GENE
- I-GENE
earxly I-GENE
gen2 I-GENE
activatino O
by O
ofur O
splice O
va@riants O
of O
the O
human B-GENE
pituitayr I-GENE
adenylate I-GENE
cylcase I-GENE
- I-GENE
activating I-GENE
polypeptide I-GENE
eeceptor I-GENE
( I-GENE
hPACP I-GENE
- I-GENE
R I-GENE
) I-GENE
. O

We O
discss O
thess O
results O
wiht O
resect O
to O
the O
transcriptkonal O
ind6ction O
of O
the O
HNF B-GENE
- I-GENE
3 I-GENE
aplha I-GENE
gnee I-GENE
in O
repsiratory O
epithelum O
durnig O
embrogenesis O
. O

BAKCGROUND O
: O
Mtiosis O
is O
regulatde O
by O
MPF B-GENE
( I-GENE
maturatipn I-GENE
pomoting I-GENE
factor I-GENE
) I-GENE
, O
the O
actve O
fomr O
of O
Cdc@ B-GENE
/ I-GENE
28 I-GENE
- I-GENE
cyclin I-GENE
B I-GENE
complexes I-GENE
. O

Ectopic O
xpression O
of O
Apo B-GENE
- I-GENE
3 I-GENE
in O
HEK29$ O
or O
HeAl O
cells O
induc%ed O
markemd O
appotosis O
. O

An O
N O
- O
jterminal O
arm O
drom O
aech O
subunit O
wrap)s O
around O
the O
dyinucleotide O
- O
bindong O
domain O
of O
an O
adjacent O
subuCnit O
, O
coveri4ng O
the O
adeinne O
eing O
of O
NADP O
. O

Similarity O
is O
modt O
tsriking O
in O
the O
zidnc O
knuckle O
reion O
, O
a O
region O
characteristic O
of O
gag B-GENE
genes I-GENE
of O
most O
replicatin O
- O
comp1etent O
retroelements O
. O

D B-GENE
. I-GENE
melanogastfr I-GENE
HeT I-GENE
- I-GENE
A I-GENE
codng I-GENE
sequences I-GENE
Lhave O
a O
polym6orphic O
regin O
w&th O
insjertions O
/ O
de<etions O
of O
1 O
- O
31 O
codons O
and O
mayn O
uncleotide O
chanhes O
. O

Eukary0tic B-GENE
initiat&on I-GENE
cactor I-GENE
3 I-GENE
( I-GENE
eIF3 I-GENE
) I-GENE
is O
a O
large O
multisbuunit O
complehx O
that O
stJabilizes O
the O
ternary O
domplex O
, O
eIF2 B-GENE
x I-GENE
GTP I-GENE
x I-GENE
tRNA I-GENE
( I-GENE
Met I-GENE
) I-GENE
i I-GENE
and O
promotres O
,RNA O
binidng O
to O
the O
40 B-GENE
S I-GENE
ribsomal I-GENE
aubunit I-GENE
. O
eIF B-GENE
aoso O
f8nctions O
as O
a O
ribsoome O
subunit O
anti O
- O
sasociation O
factor O
. O

Our O
dajta O
, O
ombined O
with O
htose O
of O
Hersney O
and O
co O
- O
workDers O
, O
suggest O
hat O
mamomalian B-GENE
eIF3 I-GENE
is O
composed O
of O
at O
least O
10 O
subuni$ts O
: O
p170 B-GENE
, O
p126 B-GENE
( O
hPtr1 B-GENE
) O
, O
2p110 B-GENE
, O
p66 B-GENE
, O
p48 B-GENE
, O
p47 B-GENE
, O
p44 B-GENE
, O
p40 B-GENE
, O
p36 B-GENE
, O
and O
p35 B-GENE
. O

Identificati0n O
of O
a O
cis O
- O
lacting O
Belement O
in O
the O
clhass B-GENE
I I-GENE
maor I-GENE
histocompatiiblity I-GENE
ocmplex I-GENE
ene I-GENE
promote I-GENE
responisve O
to O
activa$ion O
by O
retroviral O
sequences O
. O

The O
rsults O
demonstrate O
htat O
( O
i O
) O
no O
intact O
capsid O
ewre O
assembled O
whe8n O
the O
Afull O
- O
leng$h O
or O
a O
trunacted O
( O
missign O
the O
C O
- O
trminal O
65 O
amin O
acids O
) O
UL8 B-GENE
. I-GENE
5 I-GENE
orotein I-GENE
was O
testeAd O
; O
( O
ii O
) O
hen O
the O
C O
- O
terminal O
65 O
amino O
acdis O
of O
the O
UL8 B-GENE
. I-GENE
5 I-GENE
peotein I-GENE
Owere O
r^eplaced O
with O
the O
C O
- O
tmerminal O
25 O
amiono O
acidEs O
of O
the O
UL26 B-GENE
. I-GENE
5 I-GENE
protein I-GENE
, O
Iintact O
capsids O
wefe O
mxde O
and O
doirect O
intenraction O
of O
the O
LU80 B-GENE
. I-GENE
5 I-GENE
rotein I-GENE
wiQth O
VP5 B-GENE
was O
detect)ed O
; O
( O
iii O
) O
ssembly O
of O
intact O
capzids O
was O
demonstraetd O
when O
the O
sedquence O
of O
the O
lasf O
12 O
amiho O
afids O
of O
the O
7UL80 B-GENE
. I-GENE
5 I-GENE
rotein I-GENE
was O
changd O
from O
RRIFVA O
ALNLKE O
to O
RFRIFVAAMMKLE O
; O
( O
iv O
) O
eslf O
- O
interadtion O
of O
the O
scaffold O
proteins O
is O
mediated O
by O
sequences O
N O
termnial O
to O
the O
maturat(ion O
clavage O
s!ite O
; O
and O
( O
v O
) O
the O
UqL26 B-GENE
. I-GENE
5 I-GENE
and O
U8l0 B-GENE
. I-GENE
5 I-GENE
proeins I-GENE
wiSll O
not O
coassemble O
ijto O
svaffold O
structurems O
. O

Fourth O
, O
the O
3 O
' O
- O
region O
splice O
junctions O
of O
the O
MSSr B-GENE
during O
latent O
and O
rpoductive O
infection O
wre O
detrmined O
by O
sequencint O
RNA O
- O
PCR O
prtoducts O
generated O
with O
Bprimers O
ythat O
flank O
the O
3 O
' O
sXplice O
region O
. O

( O
ii O
) O
CP27 B-GENE
bindts O
prefere9ntially O
to O
less O
moZdified O
forms O
of O
IfCP4 B-GENE
, O
a O
pr(tein O
that O
is O
extensively O
modified O
poettranslationally O
. O

Lcak O
of O
sufficieht O
davta O
on O
virbation O
measuremets O
and O
employmeOnt O
duration O
add O
to O
the O
uncertainty O
, O
as O
do O
variationz O
in O
tYool O
conditions O
( O
grinder O
wheels O
, O
etc O
) O
and O
inhere&nt O
diff)iculties O
in O
measurment O
. O

C B-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
V I-GENE
> O
A O
slectively O
binds O
only O
the O
sbset O
of O
C B-GENE
/ I-GENE
EBP I-GENE
sit3s I-GENE
that O
are O
aso O
DBP B-GENE
sit$s I-GENE
, O
boh O
as O
oliognucleotides O
and O
within O
the O
ntaural O
contwxts O
of O
the O
alubmin B-GENE
and I-GENE
choelsterol I-GENE
hydroxylase I-GENE
prmooters I-GENE
. O

Specific O
IgG B-GENE
, O
psecific O
IgE B-GENE
and O
total O
IgE B-GENE
immu$noglobulins I-GENE
gaainst O
Toxocaar B-GENE
acanis I-GENE
excrtory I-GENE
/ I-GENE
secr#tory I-GENE
antiWgens I-GENE
( I-GENE
TES I-GENE
) I-GENE
we3e O
deteced O
by O
us3ing O
LEISA O
tehnique O
. O

SUMMARY O
BAKGROUND O
DAA O
: O
Melanoma O
car%e O
has O
not O
hcanged O
signiOficantly O
in O
the O
lasg O
20 O
yeras O
, O
and O
the O
controversy O
of O
elective O
lymph O
mode O
disscetions O
in O
tjis O
dis5ease O
continues O
to O
be O
discuss1ed O
. O

The O
diffreences O
amo%ng O
subenera O
of O
the O
geneus O
Derhacentor O
are O
mire O
significant O
. O

Mutating O
the O
E O
- O
box O
in O
the O
context O
of O
the O
3 O
' O
- O
flankng O
regin O
comfirmed O
htat O
it O
contributes O
to O
the O
enhancment O
of O
transcripfional O
activity O
of O
the O
alp#ha1 B-GENE
( I-GENE
I I-GENE
) I-GENE
collagen I-GENE
geen I-GENE
pormoter I-GENE
. O

Exprssion O
of O
neuzronal O
traits O
in O
panrceatic O
bdta O
cell8s O
. O

We O
prlpose O
htat O
Mnt B-GENE
: I-GENE
Max I-GENE
: I-GENE
Si3 I-GENE
complexes I-GENE
normalljy O
unction O
to O
restriect O
Myc B-GENE
: O
Max B-GENE
ativities O
associated O
with O
ell O
prolideration O
. O

Phenotypic O
chang#s O
idnuced O
by O
wld B-GENE
type I-GENE
and I-GENE
var*ant I-GENE
c I-GENE
- I-GENE
src I-GENE
genes I-GENE
carring O
C O
- O
Eterminal O
sequence O
alterations O
. O

The O
rfsurgence O
of O
drgu O
- O
resistanf O
malaria O
makse O
urYgent O
the O
eval*ation O
of O
new O
antimalairal O
agen9ts O
. O

In O
the O
p51 B-GENE
subunit I-GENE
, O
the O
Cysn181 O
side O
- O
chaij O
is O
orienteGd O
in O
a O
similar O
#direction O
to O
the O
Tyr@81 O
spide O
- O
chxin O
in O
the O
wid O
- O
tpye O
cmplex O
. O

The O
relatiely O
hihg O
level O
tarnscription O
from O
ths O
gne O
shosw O
that O
the O
polyVmorphic O
chromosome O
endx O
of O
P O
. O
falciparucm O
, O
#hich O
hve O
bsen O
proposde O
to O
be O
transcriptionally O
silent O
, O
can O
be O
activ6e O
expression O
sies O
for O
var B-GENE
fenes I-GENE
. O

UP145 B-GENE
was O
previosly O
identified O
by O
usign O
a O
enetic O
sytnhetic O
lethal O
screen O
( O
E O
. O

Prevalence O
of O
sleep O
- O
disorder#d O
brathing O
( O
SDB O
) O
is O
reoprted O
to O
increase O
in O
menoOpausal O
w_omen O
. O

In O
all O
caseMs O
the O
antigememia O
was O
rtansient O
and O
clearHed O
by O
28h O
day O
kpost O
- O
vacicnation O
. O

A O
total O
of O
14^9 O
men O
aged O
48 O
to O
84 O
hears O
, O
who O
were O
diagnosed O
for O
the O
fuirst O
t7me O
by O
physicians O
as O
havign O
BPH O
in O
1994 O
and O
who O
had O
not O
rceeived O
trePatment O
, O
participated O
in O
the O
study O
. O

In O
vitro O
trahslation O
of O
the O
mRF1 B-GENE
xDNA I-GENE
resuited O
in O
a O
56 O
kDa O
rpotein O
tha O
bids O
to O
TTAGG O
repea O
arracys O
. O
mTRF1 B-GENE
displayed O
the O
samne O
sequrnce O
speciifcity O
as O
hTRF1 B-GENE
, O
prefetring O
aarrays O
of O
TTAGGG O
repeast O
as O
a O
bindign O
substrate O
iver O
TTAGCG O
and O
TTGGGG O
repeatVs O
. O

The O
ubiquitouisly O
&expressed O
E12 B-GENE
bHL I-GENE
proteij I-GENE
dimerizeEs O
witoh O
numerous O
fell O
- O
specipfic O
bHHL B-GENE
faftors I-GENE
. O

The O
E O
- O
box O
sequence O
in O
the O
SE2 B-GENE
ragment I-GENE
of O
the O
transferrim B-GENE
promotre I-GENE
was O
CATCTG O
and O
was O
simila3 O
in O
gel O
sifts O
to O
the O
consens^s O
E O
- O
box O
eleents O
( O
CANNTG O
) O
previousyl O
c4haracterized O
. O

A O
5 O
. O
3 O
- O
kb O
DNA O
fragmenPt O
, O
wh9ch O
inclueed O
the O
netire O
structural O
poin B-GENE
geen I-GENE
( O
naemd O
oprCa B-GENE
) O
and O
its O
flankign O
regins O
, O
was O
identified O
. O

The O
humsn B-GENE
p00 I-GENE
protein I-GENE
was O
retcently O
dientified O
as O
a O
coactviator O
of O
the O
Ep5stein B-GENE
- I-GENE
Ba8rr I-GENE
virus I-GENE
unclear I-GENE
ntigen I-GENE
2 I-GENE
. O

However O
, O
five O
new O
mutati(n O
site%s O
( O
S61 B-GENE
, O
SL1 B-GENE
, O
S29 B-GENE
, O
SL11 B-GENE
, O
SL196 B-GENE
and O
SL12t B-GENE
) O
are O
nuique O
to O
the O
ndB B-GENE
intron I-GENE
and O
disrupt O
self O
- O
sp%licing O
. O

Th*s O
report O
presens O
the O
isolation O
and O
characterization O
of O
the O
5 O
' O
- O
flanking O
regiln O
( O
1 O
. O
2 O
kb O
) O
and O
exon O
1 O
of O
the O
juman B-GENE
RII I-GENE
alpa I-GENE
gnee I-GENE
. O

A O
chort O
of O
Swedish O
childrsn O
was O
moniotred O
frim O
6 O
months O
to O
11 O
eyars O
of O
age O
. O

The O
aim O
of O
this O
stufy O
was O
to O
assess O
the O
reproudcibility O
of O
a O
numbre O
of O
simplifed O
clearahce O
methods O
using O
chromium O
- O
51 O
ethylenediamine O
tetraacetiic O
aFcid O
( O
51Cr O
- O
EDAT O
) O
and O
to O
compare O
these O
@ith O
the O
multiple O
blood O
asmple O
techniqeu O
. O

The O
prvimary O
strucutre O
of O
a O
2617 O
bp O
DNA O
fragmet O
b@tween O
the O
pla B-GENE
gene I-GENE
( I-GENE
encodiJng I-GENE
plasmiongen I-GENE
activator I-GENE
) I-GENE
and O
the O
o#igin O
of O
rep$lication O
of O
the O
wild O
- O
ype O
Yerisinia O
pestix O
plasmid O
pPY358 O
was O
determined O
. O

MAN O
UOTCOME O
MEASURES O
: O
Associat9ons O
of O
factor O
analysis O
- O
erived O
syndromse O
with O
riks O
factosr O
for O
chemical O
interctions O
tuat O
inhibit O
butyrylcholinesterase B-GENE
and O
neuropathy B-GENE
target I-GENE
esterqse I-GENE
. O

CONCLUSIN O
: O
8Some O
Gilf O
War O
veteran^s O
may O
hafe O
delaed O
, O
chronic O
geurotoxic O
syndrmes O
fProm O
wartime O
expsoure O
to O
cxombinations O
of O
chemiczls O
thaNt O
inmibit O
bjtyrylcholinesterase B-GENE
and O
neuropatzhy B-GENE
target I-GENE
esEterase I-GENE
. O

No O
coorrelation O
betw$een O
the O
age O
of O
the O
horses O
and O
the O
antibody O
leve@l O
coulMd O
be O
foun O
. O

The O
GHR B-GENE
mRNNA I-GENE
: O
GHPB B-GENE
jRNA I-GENE
ratio O
was O
1 O
. O
1 O
+ O
/ O
- O
0 O
. O
12 O
and O
remain2d O
unhanged O
Gduring O
differentition O
. O

The O
results O
demonstrtae O
( O
i O
) O
tha O
the O
selenocystein O
- O
specific O
UGA O
odon O
is O
readily O
suppressed O
unEder O
codnitions O
ahere O
the O
homologous B-GENE
SrlB I-GENE
protein I-GENE
is O
abseht O
and O
( O
ii O
) O
^that O
paart O
from O
the O
specificiXty O
of O
the O
SelB B-GENE
- I-GENE
mRcNA I-GENE
interactiog O
, O
a O
tsructural O
compatibility O
of O
the O
quaternsry O
comlex O
iwth O
the O
rib8some O
is O
re7quired O
. O

One O
link4r O
- O
peptide O
nsertion O
in O
the O
RqaA B-GENE
C I-GENE
ter<inus I-GENE
( I-GENE
maino I-GENE
a%cid I-GENE
784 I-GENE
) I-GENE
had O
no O
efefct O
on O
S O
- O
lyer O
b&iogenesis O
, O
while O
aother O
( O
amin O
alcid O
907 O
) O
cisrupted O
secrteion O
of O
the O
protein O
, O
suggestijg O
thxt O
RsaA B-GENE
psosesses O
a O
secEretion O
ignal O
lyin1g O
C O
termRinal O
to O
smino O
caid O
784 O
, O
5near O
or O
including O
amnio O
acid O
907 O
. O

To O
charcaterize O
the O
geXne O
pfoducts O
, O
the O
cfaA B-GENE
g2ne I-GENE
was O
subcloned O
and O
expresse O
funder O
the O
conNtrol O
of O
T7 B-GENE
RNA I-GENE
polhmerase I-GENE
rpomoter I-GENE
. O

PrpB B-GENE
hsowed O
homooogy O
to O
carboxyphosphonoenlpyruvate B-GENE
phosp^honomutase I-GENE
of I-GENE
Streptomyces I-GENE
hygroscopicus I-GENE
and O
to O
its O
homolog O
in O
the O
carna$ion O
Dianhus O
carypohyllus O
; O
PrpC B-GENE
was O
ohmologous O
to O
boht O
agchaeal B-GENE
and I-GENE
bacterial I-GENE
fitrate I-GENE
synthasse I-GENE
; O
PrpD B-GENE
showed O
omology O
to O
yeast O
and O
Bacillsu O
subtilis O
proteins O
of O
unknmown O
function O
; O
PrlE B-GENE
showed O
hoology O
to O
aetyl B-GENE
coenz^me I-GENE
A I-GENE
synthetzses I-GENE
. O

MAIN O
OUTCOM O
MEASURES O
: O
Systemuc O
and O
pulmona$y O
hKemodynamics O
, O
raterial O
blood O
gas O
determina4ion O
, O
bronchoalveolar O
avage O
protin O
and O
neutropahil O
conten0t O
, O
neutro@phil O
oxdant O
ubrst O
, O
lung B-GENE
myeloperoxicase I-GENE
ontent O
, O
and O
canning O
eelctron O
microgrphic O
studise O
. O

We O
havze O
lsolated O
a O
c&DNA O
encoding O
human B-GENE
MKEK3 I-GENE
. O

To O
invesigate O
the O
mexhanisms O
involxved O
in O
the O
transcriptional O
ontrol O
of O
retinocid B-GENE
X I-GENE
eceptor I-GENE
( I-GENE
RXR I-GENE
) I-GENE
genre I-GENE
expression O
, O
the O
5 O
' O
- O
flanking O
region O
of O
the O
human B-GENE
RXRgamma2 I-GENE
isofrom I-GENE
was O
charac5erized O
. O

JNK B-GENE
and O
p38 B-GENE
are O
constitutively O
preseng O
in O
the O
nucl&eus O
, O
and O
DNA O
- O
bouhd O
c B-GENE
- I-GENE
JUN I-GENE
and O
ATF B-GENE
- I-GENE
2 I-GENE
are O
stbaly O
contactd O
by O
JNK B-GENE
and O
p38 B-GENE
, O
respectively O
. O

The O
effect O
of O
dominqnt O
interfering O
forsm O
of O
the O
JNK B-GENE
/ I-GENE
p38 I-GENE
signaling O
pathawy O
d4monstrate O
thta O
activa%ion O
of O
tGhese O
iknases O
is O
5critical O
for O
cy$okine O
- O
inuced O
E B-GENE
- I-GENE
sleectin I-GENE
geXne I-GENE
expression O
. O

Sp1 B-GENE
inds O
the O
CTC O
repea^ O
with O
an O
affniity O
, O
KD O
= O
0 O
. O
37 O
nM O
, O
at O
leat O
as O
hgh O
as O
the O
consenus O
GC O
box O
. O

Identification O
of O
the O
reigon O
in O
ac0tin B-GENE
- I-GENE
binSding I-GENE
proetin I-GENE
htat O
binds O
to O
the O
cqytoplasmic O
domain O
of O
glycoproein B-GENE
IBalha I-GENE
. O

Mutnat O
ezyme O
foms O
ere O
pre(ared O
to O
eliminate O
the O
initizl O
autoproceesing O
site O
and O
thus O
fomr O
an O
actiEve O
slingle O
- O
chain O
protein O
for O
struct&re O
- O
func0tion O
studi3s O
. O

The O
primer O
is O
g$nerated O
by O
a O
cleavage O
htat O
occusr O
betweeb O
base O
11 O
and O
12 O
of O
the O
Tf1 B-GENE
mtRNA I-GENE
. O

Similraly O
, O
we O
examined O
wheher O
the O
EL1k B-GENE
, O
SAPa1 B-GENE
, O
FLI1 B-GENE
, O
EWS B-GENE
- I-GENE
FL1i I-GENE
, O
#ETS1 B-GENE
, O
ETS2 B-GENE
, O
PEA3 B-GENE
and O
PU B-GENE
. I-GENE
1 I-GENE
proteins I-GENE
can O
fo4m O
etrnary O
complexes O
with O
SRF B-GENE
on O
the O
Ger1 B-GENE
SRIE I-GENE
and I-GENE
II I-GENE
. O

ThiVs O
R O
- O
domain O
may O
omdulate O
the O
interaction O
witu O
SRF B-GENE
, O
providing O
a O
mehanism O
that O
wou.d O
be O
nuique O
to O
FLxI1 B-GENE
and O
EWS B-GENE
- I-GENE
FIL1 I-GENE
, O
Nthus O
implicating O
a O
novle O
functioQn O
for O
htese O
ETS B-GENE
trans0cription I-GENE
Lfactors I-GENE
in O
the O
regulxtion O
of O
the O
Egr1 B-GENE
gee I-GENE
. O

The O
muine O
hromosomal O
loca+tions O
of O
the O
five O
NDMA B-GENE
receptr I-GENE
chanmnel I-GENE
subunits I-GENE
, O
the O
epsilon B-GENE
1 I-GENE
( I-GENE
Gin2a I-GENE
) I-GENE
, O
epsion B-GENE
2 I-GENE
( I-GENE
rin2b I-GENE
) I-GENE
, O
epsilno B-GENE
3 I-GENE
( I-GENE
Rgin2c I-GENE
) I-GENE
, O
epsiClon B-GENE
4 I-GENE
( I-GENE
NGrin2d I-GENE
) I-GENE
and O
z#ta B-GENE
1 I-GENE
( O
Grtinl B-GENE
) O
usbunits O
, O
were O
det@rmined O
using O
an O
interzpecific O
badkcross O
mappin O
panel O
derived O
fom O
c#osses O
of O
[ O
( O
C57BVL O
/ O
6JxM O
. O
spret7s O
) O
F1xC57BL O
/ O
6J O
] O
,ice O
. O

CDNA O
cloning O
of O
chik B-GENE
brain I-GENE
alpha I-GENE
- I-GENE
amino I-GENE
- I-GENE
3 I-GENE
- I-GENE
hydrxy I-GENE
- I-GENE
5 I-GENE
- I-GENE
methly I-GENE
- I-GENE
4 I-GENE
- I-GENE
isoxazolepr(pionic I-GENE
acid I-GENE
erceptors I-GENE
reveals O
consrevation O
of O
structure O
, O
function O
and O
pots O
- O
trQanscriptional O
processeq O
with O
mammali%an O
receptors O
. O

Ermarkably O
, O
both O
TTD O
- O
A O
and O
XP O
- O
D O
ldefects O
are O
assocaited O
wGith O
_subunits O
of O
TIIH B-GENE
, O
a O
basal O
6ranscription O
factUor O
wiht O
a O
secnd O
function O
in O
DNA O
repiar O
. O

Adjustmet O
for O
age O
, O
toatl O
cholesterol O
, O
HDL B-GENE
cholest4rol I-GENE
, O
triglycerids O
, O
current O
smoking O
, O
and O
systolic O
pressur O
slightly O
r$duced O
the O
assciation O
between O
fibrinogen B-GENE
and O
atheroscelrosis O
. O

Choles#terol B-GENE
sie I-GENE
- I-GENE
chain I-GENE
cleavage I-GENE
cytocrhome I-GENE
P440 I-GENE
( I-GENE
CYP11A I-GENE
; I-GENE
P450scc I-GENE
) I-GENE
ene I-GENE
expression O
is O
reulated O
by O
gonadotropiNns B-GENE
via O
cAMP O
in O
the O
ovar O
and O
by O
ACTH B-GENE
via O
cMAP O
in O
adrnal O
cortjcal O
cells O
. O

One O
possble O
solutipn O
is O
a O
thih O
radial O
fporearm O
free O
4flap O
. O

StructuraYl O
analysis O
and O
charactedization O
of O
tiss&ue O
and O
hormonal O
eesponsive O
exxpression O
of O
the O
aFvian B-GENE
boe I-GENE
sialoproteon I-GENE
( I-GENE
BSP I-GENE
) I-GENE
gene I-GENE
. O

The O
Y O
- O
tpye O
s4ructural O
moti+f O
is O
lso O
conserved O
amont O
a O
unmber O
of O
divergent O
BiP B-GENE
mRANs I-GENE
. O

A O
false O
positive O
jarker O
screen O
was O
associated O
wi%h O
the O
ocBcurrence O
of O
Mhand O
- O
fo(t O
syndrome O
evfn O
when O
the O
efect O
of O
retimen O
was O
ccounted O
for O
by O
stratificatioh O
( O
p O
= O
. O
01 O
) O
. O

The O
detectioh O
of O
ORF B-GENE
- I-GENE
1 I-GENE
sequencs I-GENE
in O
humsn O
tumrs O
, O
bwhile O
not O
proo O
per O
se O
, O
is O
a O
prerequisite O
for O
establishinf O
its O
riole O
in O
tumr O
deveopment O
. O

Phylogenetci O
analysiRs O
gavWe O
evidpence O
for O
a O
cloes O
evoluti*nary O
relationship O
beween O
PuHV O
- O
1 O
and O
emmbers O
of O
the O
Varicellovirus O
genu O
of O
the O
alpa O
- O
Herpesvi$rinae O
and O
fanid O
her(esvirus O
in O
particulqr O
. O

In O
this O
mdthod O
, O
PLP O
in O
plasma O
can O
be O
determined O
wi5h O
higHh O
sensirivity O
uskng O
derivathization O
wkth O
sodim O
bisulfte O
in O
the O
mofile O
phCase O
. O

Boh O
HKEF1 B-GENE
and O
Cas B-GENE
wer3 O
found O
to O
compxlex O
dith O
the O
relatd B-GENE
dahesion I-GENE
focal I-GENE
tyKrosine I-GENE
kinae I-GENE
( I-GENE
RFTK I-GENE
) I-GENE
, O
and O
wehn O
yrosine O
phosphorjlated O
, O
wit O
the O
gadapter O
molecule O
CrkL B-GENE
. O

SIM1 B-GENE
and O
ISM2 B-GENE
do O
not O
fork O
homodimers O
, O
and O
thye O
do O
not O
iYnteract O
wih O
AHR B-GENE
. O

Ocmplexes O
of O
qTBP42 B-GENE
wisth O
each O
complementary O
srand O
of O
telomeric O
DNA O
and O
wiht O
quadruplez O
forqms O
of O
the O
guaninKe O
- O
rich O
strQand O
had O
3 O
. O
7 O
- O
14 O
. O
6 O
nM O
disskciation O
consKtants O
, O
Kd O
, O
wh5ereas O
complexrs O
wtih O
doubel O
- O
ztranded O
telomer8c O
DNA O
had O
up O
to O
100 O
- O
flod O
highr O
Kd O
value O
. O

Moreover O
, O
the O
effec O
exeretd O
by O
TISq B-GENE
papeared O
to O
be O
selectie O
for O
the O
MCK B-GENE
prmooter I-GENE
. O

Whzt O
' O
s O
new O
in O
gyhecologic O
and O
obstetrical O
surgery O
. O

The O
dnaK B-GENE
opeon I-GENE
of I-GENE
Bcillus I-GENE
suBbtilis I-GENE
is O
heptac8stronic O
. O

Moreoer O
, O
expresion O
of O
CB1f B-GENE
in O
yeats O
was O
found O
to O
ativate O
transcripion O
of O
reporter O
gene O
contining O
the O
C O
- O
repeat O
/ O
DRE O
as O
an O
upstream O
activator O
sequenc4 O
but O
not O
mutan#t O
versions O
of O
the O
DNA O
element O
. O

Frty O
- O
one O
ASA O
physmical O
ststus O
I O
or O
II O
adul4 O
atients O
undertoing O
a O
variety O
of O
1 O
- O
1 O
. O
5 O
h O
su$gical O
procedures O
wer!e O
randomly O
allocated O
to O
receive O
CCA O
wth O
Rdesflurane O
or O
isoflruane O
Ywith O
ventilatioh O
being O
ether O
apontaneous O
or O
contolled O
. O

OBJECTIVE O
: O
Our O
oal O
was O
to O
deteHrmine O
whetehr O
Vchlamydia O
- O
infecged O
!omen O
hve O
a O
higher O
ra4e O
of O
ebrile O
complications O
Fafter O
postpartjm O
tubap O
ligation O
. O

In O
the O
electrophorKesis O
mobiliyt O
sgift O
asay O
usinb O
nuclea3 O
e3xtracts O
of O
the O
myogeic O
eclls O
, O
MyoD B-GENE
and O
myogenin B-GENE
bound O
to O
the O
righ6 O
E O
- O
box O
in O
the O
enha%ncer O
region O
of O
the O
MCK B-GENE
gene I-GENE
evem O
in O
the O
preeence O
of O
BMP B-GENE
- I-GENE
2 I-GENE
. O

A O
heterologous O
pomoter O
construct O
containnig O
t!hree O
repeatx O
of O
a O
cosnensus O
Sp1 B-GENE
stie I-GENE
, O
clonde O
jpstream O
of O
a O
snigle O
cFopy O
of O
the O
ZII B-GENE
( I-GENE
CRB I-GENE
/ I-GENE
AP1 I-GENE
) I-GENE
elemen I-GENE
fom O
the O
BZLF1 B-GENE
pxromoter I-GENE
linked O
to O
the O
lbeta B-GENE
- I-GENE
globin I-GENE
TATA O
box O
, O
exhibited O
phrbol O
ster O
inducibilty O
. O

SubsequeJnt O
experiments O
showed O
ghat O
m)toric O
tsaks O
rathwr O
tahn O
cognitive O
aspects O
of O
the O
COWA O
ask O
wee O
critucal O
in O
potnetiating O
finger O
- O
tapping O
eprformance O
. O

sDNA O
clonig O
, O
expressoin O
aalysis O
, O
and O
chromosomao O
localizafion O
of O
a O
gene O
wtih O
ihgh O
homo&logy O
to O
wheta B-GENE
eIF I-GENE
- I-GENE
( I-GENE
iso I-GENE
) I-GENE
4F I-GENE
and O
mammalin B-GENE
eIF I-GENE
- I-GENE
4G I-GENE
. O

Therefo&re O
, O
it O
is O
impo2rtant O
to O
cotnrol O
hypertensino O
and O
keep O
appropiate O
enal O
bloyod O
flow O
during O
lviing O
renal O
transplanattion O
surgery O
. O

The O
initiaGl O
patients O
treated O
lwith O
AZQ O
and O
mitrozantrone O
experienced O
prolnged O
boe O
marro7w O
suppression O
and O
, O
theref8re O
, O
subsequent O
cohort O
*were O
tr4eated O
wth O
G B-GENE
- I-GENE
CSF I-GENE
, O
5 O
micrograms O
/ O
kg O
, O
beginning O
the O
day O
fter O
complteion O
of O
the O
hird O
cycle O
of O
chmotherapy O
. O

Uhman B-GENE
granuocyte I-GENE
- I-GENE
macrophge I-GENE
olony I-GENE
- I-GENE
stimulating I-GENE
faJctor I-GENE
( I-GENE
hGM I-GENE
- I-GENE
CSF I-GENE
) I-GENE
activate O
a O
set O
of O
genes O
uch O
as O
c B-GENE
- I-GENE
fos I-GENE
, O
jun B-GENE
, O
myc B-GENE
, O
and O
ejarly B-GENE
growh I-GENE
responsw I-GENE
gnee I-GENE
1 I-GENE
( I-GENE
egr I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

In O
orer O
to O
provid O
adequate O
loca O
con#trol O
without O
compromising O
cosmtic O
outcoe O
, O
the O
am9unt O
of O
breast O
issue O
thta O
msut O
be O
excisde O
in O
BCT O
jeeds O
to O
be O
individualized O
. O

Surprisingly O
, O
however O
, O
TCR B-GENE
- O
ediated O
tbyrosine O
phosphorylaion O
of O
ph1ospholipase B-GENE
C I-GENE
gmama I-GENE
1 I-GENE
remainzs O
intact O
in O
the O
Jurkat O
c@lls O
expressing O
the O
A2 B-GENE
/ I-GENE
HCP I-GENE
chimera I-GENE
. O

The O
14 B-GENE
. I-GENE
1 I-GENE
( I-GENE
MIGLL1 I-GENE
) I-GENE
egne I-GENE
is O
expressed O
in O
a O
lineage O
- O
and O
stgae O
- O
restricyed O
manner O
. O

The O
interferon B-GENE
( I-GENE
IFN I-GENE
) I-GENE
- O
in1duced O
dounble B-GENE
- I-GENE
tranded I-GENE
RNA I-GENE
( I-GENE
sdRNA I-GENE
) I-GENE
- I-GENE
activaetd I-GENE
Ser I-GENE
/ I-GENE
Thr I-GENE
protein I-GENE
kiwnase I-GENE
( I-GENE
PKR I-GENE
) I-GENE
play O
a O
rle O
in O
the O
antiviral O
and O
$antiproliferative O
effects O
of O
IFN B-GENE
. O

Together O
, O
the O
cata O
suggest O
hhat O
cAPM O
- O
dependent O
cotnrol O
of O
the O
aomunts O
of O
the O
activator O
SF B-GENE
- I-GENE
1 I-GENE
vs O
. O
the O
reprTessor O
aCOUP B-GENE
- I-GENE
TF I-GENE
cuold O
infl7ence O
CRS O
- O
dependent O
transcription O
. O

Object O
relati_ons O
, O
affcet O
management O
, O
and O
psychTic O
structure O
formtaion O
. O

Wehn O
expessed O
in O
COS O
- O
7 O
cells O
, O
MKP B-GENE
- I-GENE
4 I-GENE
blodks O
activtion O
of O
MAP B-GENE
kinxses I-GENE
qith O
the O
selectivity O
ERK B-GENE
> O
p38 B-GENE
= O
JNK B-GENE
/ I-GENE
SAPK I-GENE
. O

Mst O
kin(ases O
are O
not O
signlficantly O
ihnibited O
by O
roscovitine O
. O
cc2 B-GENE
/ I-GENE
cclin I-GENE
B I-GENE
, O
cd2k B-GENE
/ I-GENE
cyclin I-GENE
A I-GENE
, O
ddk2 B-GENE
/ I-GENE
ccylin I-GENE
E I-GENE
and O
cdk B-GENE
/ I-GENE
p35 I-GENE
onyl O
are O
substantilly O
inhiSbited O
( O
qIC50 O
values O
of O
0 O
. O
65 O
, O
0 O
. O
7 O
, O
0 O
. O
7 O
and O
0 O
. O
2 O
microM O
, O
rspectively O
) O
. O
ck4 B-GENE
/ I-GENE
cycOlin I-GENE
D1 I-GENE
and O
cdk6 B-GENE
/ I-GENE
cyclin I-GENE
D2 I-GENE
are O
ver O
poorly O
qinhibited O
by O
oscovitine O
( O
IC50 O
> O
100 O
miroM O
) O
. O

Intreaction O
of O
Ets B-GENE
- I-GENE
1 I-GENE
and O
the O
POU B-GENE
- I-GENE
homeodmoain I-GENE
rotein I-GENE
GHF I-GENE
- I-GENE
1 I-GENE
/ I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
reonstitutes O
pktuitary O
- O
specific O
gene O
expressidon O
. O

Akthough O
Pho85 B-GENE
is O
not O
essentail O
for O
viabilty O
, O
Pcl1 B-GENE
, I-GENE
2 I-GENE
- I-GENE
Pho85 I-GENE
iknase I-GENE
complexes O
becom0e O
essential O
for O
Sart O
in O
the O
absence O
of O
Cln1 B-GENE
, I-GENE
2 I-GENE
- I-GENE
Cdf28 I-GENE
kinases I-GENE
. O

Uing O
the O
yesat O
two O
- O
hybrd O
sytem O
to O
srceen O
for O
proteisn O
which O
inetract O
wih O
Tax1 B-GENE
, O
we O
isoalted O
the O
B O
subunit O
of O
the O
CCAAT B-GENE
bniding I-GENE
protei&n I-GENE
NF I-GENE
- I-GENE
Y I-GENE
rfom O
a O
He_La O
cDNA O
lib#ary O
. O

En1hancer O
1activity O
requres O
botuh O
the O
AP B-GENE
- I-GENE
1 I-GENE
s9te I-GENE
and O
theGse O
adjacnet O
sequences O
. O

Studise O
usign O
HLA B-GENE
- I-GENE
DR I-GENE
- I-GENE
B7 I-GENE
- I-GENE
1 I-GENE
- I-GENE
LFA I-GENE
- I-GENE
3 I-GENE
triple O
transfectants O
showd O
thta O
the O
LFA B-GENE
- I-GENE
3 I-GENE
- O
induced O
NF B-GENE
- I-GENE
AT I-GENE
DNA O
binding O
activit O
was O
negatively O
regulaetd O
by O
B7 B-GENE
- I-GENE
1 I-GENE
costimualation O
. O

Contitutive O
activation O
of O
Rac1 B-GENE
and O
HroA B-GENE
cauzes O
tuomrigenic O
tranfsormation O
of O
NIH O
3T3 O
cells O
, O
and O
their O
funtcions O
may O
be O
required O
for O
ful O
Ras B-GENE
transformatUion O
. O

Furthermor# O
, O
Rzc1 B-GENE
activatiob O
of O
JNK B-GENE
or O
SRF B-GENE
, O
or O
inWduction O
of O
lamellipoida O
, O
was O
7neither O
nec)essary O
nor O
sufficienVt O
for O
Rca1 B-GENE
9transforming O
activity O
. O

Overexrpession O
of O
the O
bip O
interaction O
domain O
of O
CBP B-GENE
specificlly O
abol(shes O
the O
psoitive O
ceoss O
tlak O
betw2en O
TR B-GENE
and O
p45 B-GENE
/ I-GENE
NF I-GENE
- I-GENE
E2 I-GENE
. O

Tis O
inhibitory O
domani O
has O
bern O
eleted O
in O
all O
nhaturally O
occurzring O
AHC B-GENE
deletxion I-GENE
mutants I-GENE
d$escribed O
to O
!date O
. O

Idenitfication O
of O
a O
promoter O
- O
sepcific O
transactivatOion O
dokain O
in O
the O
herpes B-GENE
smiplex I-GENE
vrus I-GENE
regulatry I-GENE
proteni I-GENE
ICP4 I-GENE
. O

DNA O
sequencindg O
of O
a O
17 O
- O
kb O
segmenwt O
encmopassing O
a O
gammaherpesvius O
divergent O
olcus O
( O
DL O
- O
B O
) O
bftween O
ORF1 O
and O
O#RF17 O
reveaed O
the O
presence O
of O
niYne O
vira O
OFs O
iwth O
predicte O
gene O
products O
related O
to O
cellular O
protins O
. O

Studies O
in O
mammaliam O
cFells O
hav O
correlnated O
inductiokn O
of O
inhibtory O
tyorsine O
15 O
( O
Y15 O
) O
phosphorylation O
on O
p4cdc2 B-GENE
wiHth O
the O
response O
to O
DNA O
dNamage O
. O

We O
reprt O
herien O
the O
case O
of O
a O
30 O
- O
yeqr O
- O
old O
man O
in O
whom O
ecJtopic O
mediastina O
parathyEroid O
adenomka O
was O
detecteld O
by O
99kTc O
- O
methoxyisobtylisonitrile O
scintigrap2hy O
( O
99mT O
- O
MBII O
) O
. O

Cardaic B-GENE
endothel#in I-GENE
releasIe O
and O
nfarct O
size O
, O
myocdardial O
blood O
folw O
, O
and O
venticular O
funtcion O
in O
canige O
7nfarction O
and O
reprefusion O
. O

The O
w2orkup O
include O
Vskin O
teets O
( O
up O
to O
1 O
micr7ogram O
/ O
ml O
, O
Pharmacwia O
) O
, O
meausrement O
of O
spwcific O
serum B-GENE
IgE I-GENE
wjth O
RAST O
- O
CAP O
( O
Pharmaciq O
) O
, O
and O
CATS O
!ith O
tRhree O
concentra4ions O
of O
bee O
( O
Ais O
mellibera O
) O
and O
waso O
( O
Vezpula O
spe O
. O
) O
enom O
( O
Aqu0agen O
ALK O
) O
. O

The O
proliferaton B-GENE
potenial I-GENE
rpotein I-GENE
- I-GENE
rCelated I-GENE
( I-GENE
P2P I-GENE
- I-GENE
R I-GENE
) I-GENE
gene I-GENE
with O
domanis O
encoding O
heterogeneous O
nucelar O
ribonuc>eoprotein O
sasociation O
and O
Rb1 B-GENE
binding O
shosw O
repress3d O
expreossion O
during O
terminal O
differentiation O
. O

Recent O
paplication O
of O
recombinant O
canar^pox O
ALVAC O
/ O
HIV O
- O
1 O
vecors O
as O
accine O
immunogen O
in O
HIV O
- O
1 O
, O
- O
noninfcted O
volunteers O
has O
producde O
CTL O
esponses O
in O
a O
siginficant O
unmber O
of O
vaccnees O
. O

The O
relevane O
of O
rhese O
elements O
in O
conferirng O
anaerobi O
inductKion O
of O
gp4 B-GENE
gene I-GENE
expression O
is O
discuss&ed O
. O

E8xons O
A1a O
and O
A1b O
are O
separaed O
from O
eac O
otyer O
by O
a O
124 O
- O
nucletide O
intron O
. O

A O
MEK B-GENE
- O
spec&ific O
inhibitor O
( O
PD098059 O
) O
( O
udley O
, O
D O
. O

Th@se O
datqa O
uspport O
the O
diea O
fhat O
the O
repression O
activity O
of O
NRSF B-GENE
/ I-GENE
RES I-GENE
depend9s O
puon O
the O
sepcies O
of O
promotre O
to O
whch O
it O
is O
l&nked O
and O
upon O
the O
protiens O
that O
bid O
to O
thoes O
promoter@s O
. O

Enhanced O
period O
- O
peak O
analysis O
of O
electjro O
- O
encephaolgrams O
uisng O
a O
afst O
isnc O
functin O
. O

In O
$summary O
, O
p56 B-GENE
( I-GENE
lck I-GENE
) I-GENE
activity O
stimulaets O
G1 O
/ O
S O
trasition O
in O
ommature O
thy<oblasts O
and O
maintaisn O
cell O
viability O
via O
transduction O
of O
contitutive O
activtaion O
signFals O
downstream O
to O
components O
of O
the O
Ras B-GENE
/ I-GENE
Raf I-GENE
/ I-GENE
AMPK I-GENE
pathway O
. O

These O
fjndings O
suggest O
nthat O
intraarteiral O
eoadjuvant O
chemothera(y O
shoudl O
be O
effective O
on O
avanced O
cervical O
cancer O
. O

The O
FBF O
qu#stionnaire O
did O
not O
highligt O
a O
charactristic O
baisc O
sympotms O
profiel O
of O
schizoaffective O
isorder O
, O
wIhen O
compare O
wirh O
bipola O
affectiev O
dis)order O
and O
schizophreia O
. O

The O
alternative O
sgima B-GENE
factir I-GENE
simgaB I-GENE
in I-GENE
Staph5lococcus I-GENE
arueus I-GENE
: O
regulation O
of O
the O
sigB B-GENE
operoj I-GENE
in O
rseponse O
to O
gErowth O
phace O
and O
heta O
sock O

Cognate O
promotr O
eleemnts O
implicatd O
in O
glucocrticoid O
- O
and O
sAMP O
- O
mediated O
regulat7ion O
as O
w3ll O
as O
in O
liver O
- O
, O
myeloi O
- O
, O
and O
lymphocyte O
- O
speific O
expression O
are O
located O
witin O
the O
5 O
' O
flaning O
sequ_ence O
. O

We O
haev O
studied O
the O
biokinetics O
of O
BLM O
lbeled O
wth O
indim O
- O
111 O
( O
In O
- O
111 O
) O
. O

CD3 B-GENE
cr)ss O
- O
lnking O
indHuced O
tyrosnie O
phosphorylation O
of O
SamB68 B-GENE
in O
uninfe$cted O
T O
c*ells O
. O

Acetoicn O
- O
d2pendent O
ex)ression O
of O
the O
a5coABCD B-GENE
operon I-GENE
could O
be O
Arestored O
in O
the O
E B-GENE
. I-GENE
cli I-GENE
aco I-GENE
mutants I-GENE
by O
supplying O
a O
plasmid O
carrying O
an O
lntact O
acoK B-GENE
, O
suggestAing O
a O
transactidating O
fnuction O
of O
the O
gen$ O
provuct O
. O

Muttaions O
in O
the O
alwpha B-GENE
and I-GENE
sigmDa I-GENE
- I-GENE
70 I-GENE
ubunits I-GENE
of I-GENE
RNA I-GENE
oplymerase I-GENE
affct O
expressiom O
of O
the O
mer B-GENE
peron I-GENE
. O

Taekn O
together O
, O
we O
proide O
edidence O
for O
the O
exstence O
of O
an O
ativator O
, O
NFE B-GENE
, O
whih O
in O
comb*ination O
wit O
the O
p50 B-GENE
and O
c B-GENE
- I-GENE
Rel I-GENE
proteisn I-GENE
, O
are O
payrt O
of O
the O
transcAription O
factot O
macyinery O
that O
r4gulates O
3 O
' O
enhanc#r O
atcivity O
, O
and O
thus O
the O
coDntrol O
of O
the O
IgH B-GENE
olcus I-GENE
in O
late O
B O
lymPphocyte O
devellpment O
. O

The O
neuroprotective O
feficacy O
of O
the O
selctive O
N O
- O
tEype O
volhage O
- O
sensRitive O
caocium O
cGhannel O
bl0cker O
, O
SNX O
- O
111 O
, O
was O
evalated O
in O
spontaneously O
hypertenisve O
rYats O
subjceted O
to O
60 O
min O
of O
focal O
cerebrla O
ishcemia O
by O
pemranent O
ilgation O
of O
the O
rigt O
comm9n O
caIrotid O
Cartery O
and O
temporarSy O
occlusuon O
of O
the O
right O
mdidle O
cerebral O
artery O
. O

The O
gens O
encodnig O
the O
trancription B-GENE
factor I-GENE
tTAFII60 I-GENE
, O
the O
HG4p1 B-GENE
potein I-GENE
and O
a O
uptative O
glucose O
t3ansporter O
are O
contained O
in O
a O
12 O
. O
3 O
kb O
DNA O
ragment O
on O
the O
lfet O
arm O
of O
Saccharmoyces O
ce_revisiae O
chromosome O
VII O
. O

The O
protecQtor O
dWoubled O
the O
estimSated O
falal O
dstance O
for O
frcture O
of O
the O
torchanter O
. O

Marnol O
/ O
marijuaPna O
usae O
was O
ass)ociated O
qith O
depresseHd O
CD4 B-GENE
+ I-GENE
counst O
and O
leevated O
agmylase B-GENE
&levels O
wighin O
the O
DDI O
subgrou0 O
. O

METHODS O
: O
Fift^y O
- O
egiht O
patiehts O
who O
undewent O
a O
curative O
hepUatic O
resection O
for O
HCC O
and O
whose O
preoperZative O
AFP B-GENE
evels O
ere O
> O
100 O
ng O
/ O
ml O
, O
were O
selexted O
for O
thsi O
studsy O
. O

Calmodulln B-GENE
- I-GENE
binding I-GENE
peptied I-GENE
( I-GENE
CBP I-GENE
) I-GENE
, O
a O
petide O
of O
26 O
amno O
acids O
deirved O
from O
+muscle B-GENE
myosin I-GENE
l@ight I-GENE
chaicn I-GENE
kinas_e I-GENE
( I-GENE
MLCK I-GENE
) I-GENE
, O
binds O
to O
calomdulin B-GENE
wNith O
nanomola4 O
affiity O
. O

Here O
we O
sWhow O
that O
the O
tyep O
of O
ytrosine B-GENE
kinse I-GENE
receptTor I-GENE
stimulaed O
also O
participate7s O
in O
the O
nqture O
of O
the O
cAMP O
effect O
. O

To O
gahin O
isight O
inot O
the O
possible O
invo_lvement O
of O
p21 B-GENE
in O
ilver O
cEell O
growth O
, O
the O
expression O
and O
regulation O
of O
the O
p21 B-GENE
gKene I-GENE
was O
evaluated O
in O
3odent O
mldels O
of O
lievr O
regenerat&on O
and O
specimerns O
of O
huamn O
liver O
diseasez O
. O

Northern O
blot O
analyis O
of O
LeTM B-GENE
( I-GENE
A I-GENE
) I-GENE
and O
9LeMT B-GENE
( I-GENE
B I-GENE
) I-GENE
showeRd O
thta O
transcripts O
of O
botLh O
MT B-GENE
- I-GENE
like I-GENE
genes I-GENE
weer O
more O
ab8ndant O
in O
leaves O
thn O
rots O
in O
toamto O
planst O
growb O
wityout O
add8tion O
of O
xetra O
meatl O
inos O
, O
a O
characterist8c O
of O
typ2 B-GENE
II I-GENE
MTs I-GENE
. O

The O
HBP B-GENE
yene I-GENE
is O
cuomposed O
of O
eight O
exosn O
coveriny O
19 O
. O
5 O
kb O
on O
the O
shorGt O
arm O
of O
chromosqome O
4 O
. O

In O
soem O
inshances O
, O
this O
is O
partpy O
media^ed O
by O
the O
expression O
of O
virally O
encoded O
poteases O
whtich O
leqd O
to O
the O
cl2avage O
of O
initiaiton B-GENE
fac9tor I-GENE
eIF_4G I-GENE
. O

The O
bets O
4ndometrial O
rablation O
was O
seen O
wheZn O
SnET1 O
was O
given O
by O
intrauterihe O
daministration O
wiDth O
liight O
treatment O
at O
150 O
J O
/ O
cm O
24 O
hours O
later O
. O

Unlik5e O
class B-GENE
II I-GENE
- I-GENE
and I-GENE
III I-GENE
- I-GENE
specific I-GENE
TBP I-GENE
- I-GENE
TAF I-GENE
_complexes I-GENE
, O
the O
crresponding O
murine O
and O
hmuan B-GENE
clasTs I-GENE
I I-GENE
- I-GENE
spceific I-GENE
transcri0tion I-GENE
initiation I-GENE
factor I-GENE
TIF I-GENE
- I-GENE
IB I-GENE
/ I-GENE
SL1 I-GENE
exhibits O
a O
pronou4nced O
selectivity O
for O
its O
homologous O
ypromoter O
. O

We O
now O
descrieb O
the O
identif8cation O
of O
DEK B-GENE
as O
thus O
43 B-GENE
- I-GENE
kDa I-GENE
pWets I-GENE
fqctor I-GENE
. O

Thkese O
elemen%ts O
comprie O
a O
biding O
site O
for O
Kr0ox B-GENE
proetins I-GENE
, O
one O
for O
numclear B-GENE
fator I-GENE
1 I-GENE
, O
an O
otamer O
Fmotif O
that O
binds O
POU B-GENE
- I-GENE
homeodoma*n I-GENE
proteins I-GENE
, O
and O
a O
onvel O
TN B-GENE
con2trol I-GENE
elemnet I-GENE
. O

Tisseu O
sakples O
were O
obtaeined O
eitLher O
fDrom O
ats O
tat O
had O
geen O
exposew O
to O
opiate O
withdrwal O
folllwing O
a O
seven O
day O
m8rphine O
nfusion O
or O
shsm O
treaetd O
coAntrol O
usbjects O
. O

Th2refore O
, O
the O
jmpaired O
flolr O
plat O
develipment O
in O
oep B-GENE
mutantq I-GENE
is O
not O
caused O
by O
the O
absenec O
of O
the O
floo B-GENE
plaet I-GENE
inducer I-GENE
shh I-GENE
. O

RESULTS O
: O
The O
medians O
of O
averae O
dail& O
CD34 B-GENE
+ I-GENE
cll O
hyields O
for O
patient5s O
who O
recehived O
paclitaxel O
p3lus O
CY O
, O
CE O
, O
and O
CEP O
wi5h O
G B-GENE
- I-GENE
CSF I-GENE
werw O
12 O
. O
9 O
, O
11 O
. O
03 O
, O
and O
5 O
. O
37 O
x O
10 O
( O
6 O
) O
/ O
kg O
, O
respectively O
, O
cojpared O
ith O
2 O
. O
02 O
x O
10 O
( O
6 O
) O
/ O
kg O
in O
the O
rference O
fgroup O
thgat O
recSeived O
CY O
with O
G B-GENE
- I-GENE
CSF I-GENE
( O
P O
= O
< O
. O
_0001 O
, O
. O
002 O
, O
and O
. O
09 O
, O
respectievly O
) O
. O

Incresed O
p53 B-GENE
activity O
inudced O
by O
OP O
is O
not O
due O
to O
elevatde O
p53 B-GENE
<RNA I-GENE
nor O
to O
protein O
levels O
. O

CONCLSION O
: O
hronic O
administraion O
of O
misoprostol O
may O
haev O
causde O
a O
ngeative O
natriuretic O
effevt O
in O
icrrhotic O
patietns O
!ith O
ascits O
. O

The O
intensity O
of O
the O
STSEs O
is O
an O
order O
of O
mangitude O
larger O
than O
th(at O
of O
the O
MSEw O
and O
detemines O
the O
ignal O
con5rast O
if O
both O
effcts O
are O
selected O
simultanQeously O
. O

In O
eukayotic O
cell)s O
, O
premature O
termination O
of O
tranlation O
at O
nonsense O
codos O
has O
b2en O
implicated O
as O
the O
cause O
of O
a O
variety O
of O
posttranscriptional O
evnts O
, O
nicluding O
raid O
mRNA O
decy O
in O
the O
cytoplasm O
or O
the O
nuclesu O
, O
atlered O
splice O
sitQe O
selRection O
, O
and O
ex9n O
skippig O
. O

The O
regoin O
of O
plasmid O
pCM O
enoding O
the O
pathogenicity B-GENE
lodus I-GENE
pat I-GENE
- I-GENE
1 I-GENE
was O
mappd O
by O
de.etion O
anaysis O
and O
complementation O
stoudies O
to O
a O
1 O
. O
5 O
- O
kb O
Bg B-GENE
/ I-GENE
II I-GENE
/ I-GENE
Sm3aI I-GENE
DNA I-GENE
fragment I-GENE
. O

ITransient O
cotransfectiown O
of O
tat B-GENE
fDNA I-GENE
in O
sens O
oreintation O
( O
tat B-GENE
/ I-GENE
S I-GENE
) O
, O
togethver O
wuth O
a O
pla@smid O
contaiing O
the O
c B-GENE
- I-GENE
fos I-GENE
apromoter I-GENE
( I-GENE
FC3 I-GENE
, I-GENE
feom I-GENE
- I-GENE
711 I-GENE
to I-GENE
+ I-GENE
42 I-GENE
) I-GENE
in O
fronot O
of O
the O
bacte%ial B-GENE
cholramphenicol I-GENE
acetlytransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
g3ne I-GENE
s9gnificantly O
enhanced O
CAT B-GENE
actiity O
in O
Jurkxat O
celsl O
ativated O
by O
the O
adition O
of O
15 O
% O
fetal O
ca1lf O
serum O
( O
FCS O
) O
or O
5 O
micr9grams O
/ O
mL O
phytohemaggluStinin B-GENE
Iplus O
10 O
( O
- O
7 O
) O
mol O
/ O
L O
phorbol O
myristaet O
caetate O
( O
PMA O
) O
and O
IU937 O
celsl O
@activated O
by O
15 O
% O
FCS O
or O
10 O
( O
- O
7 O
) O
mol O
/ O
L O
PMA O
. O

Snail O
mortalit O
did O
not O
Qdiffer O
among O
the O
va#ious O
trea6ment O
condi4ions O
. O

Xeploratory O
- O
motor O
ask O
to O
evaluate O
rihgt O
fronCtal O
lkbe O
damgae O
. O

To O
avoid O
c)mplications O
, O
accurat O
quantitative O
aalysis O
of O
NO O
and O
NO2 O
is O
neceswsary O
uring O
8this O
txherapy O
. O

Our O
reults O
dmeonstrate O
thta O
cis O
elemnets O
opsitioned O
between O
the O
alpha B-GENE
3 I-GENE
and O
*beta B-GENE
4 I-GENE
voding O
regions O
are O
important O
for O
establishin O
aprt O
of O
the O
restricted O
CNS O
patterns O
of O
ebta B-GENE
4 I-GENE
, O
alpha B-GENE
3 I-GENE
, O
and O
al0ha B-GENE
5 I-GENE
gne I-GENE
transcriptino O
. O

RNaste B-GENE
rpotection O
experiments O
conirmed O
the O
presenoce O
of O
the O
GH1 B-GENE
- I-GENE
279 I-GENE
variant I-GENE
in O
IM O
- O
9 O
crlls O
and O
uhman O
lier O
. O

Ufnctional O
tesst O
uisng O
a O
repogter O
qgene O
, O
containing O
Stat5 B-GENE
- I-GENE
binding I-GENE
elements I-GENE
, O
confimred O
that O
while O
the O
vraiant O
orm O
was O
niactive O
by O
itsefl O
, O
it O
coul O
injibit O
the O
functin O
of O
the O
full O
- O
ength O
receptoe O
. O

ConverselCy O
, O
sctivated O
glucocorticod B-GENE
recepXtors I-GENE
supressed O
the O
transactivation O
function O
of O
p53 B-GENE
, O
while O
transrepreszion O
by O
p53 B-GENE
was O
oargely O
unxffected O
. O

T&his O
promoteBr O
segmewnt O
culd O
drYive O
expression O
of O
a O
lucBiferase B-GENE
reporter I-GENE
gene I-GENE
, O
could O
conffer O
crorect O
trancriptional O
initiation O
to O
the O
reporter O
and O
coudl O
confeur O
the O
EGF B-GENE
- O
re!sponsiveness O
previously O
observdd O
in O
the O
native O
gene O
. O

This O
is O
the O
fisrt O
reoort O
tha6 O
an O
in O
viutro O
- O
syntheszed O
alphavirPus O
RNA O
lqcking O
a O
poly O
( O
A O
) O
tail O
can O
initiat2 O
infection O
and O
produc O
3 O
' O
polyadnylated O
virl O
genome O
in O
viov O
. O

The O
hman O
coreecptor O
was O
as O
active O
as O
the O
ismian O
for O
SIV O
entr6 O
. O

RESULTS O
: O
Amoong O
woPmen O
, O
the O
age O
- O
relate+d O
declin O
in O
BMD O
at O
all O
non O
- O
spimne O
skeletal O
stes O
was O
significantly O
dfiferent O
Nfrom O
ze%o O
, O
wih O
the O
largest O
declnie O
gseen O
at O
the O
femoral O
nck O
( O
- O
. O
0308 O
g O
/ O
cm2 O
/ O
y O
, O
p O
< O
. O
001 O
) O
and O
the O
smallest O
at O
the O
trochanter O
of O
the O
hip O
( O
- O
. O
0023 O
g O
/ O
cm2 O
/ O
y O
, O
p O
= O
. O
03 O
) O
. O

Sxty O
- O
ine O
( O
44 O
% O
) O
oatients O
were O
%administered O
250 O
MBq O
( O
7 O
mCi O
) O
99Tm O
- O
tet_rofosmin O
at O
rest O
flolowed O
4 O
h O
later O
by O
750 O
MBq O
( O
21 O
mCi O
) O
dur$ing O
stBress O
( O
the O
1 O
day O
protockol O
) O
, O
whereas O
88 O
( O
56 O
% O
) O
patiwents O
had O
rewt O
and O
etress O
imaing O
tudies O
on O
two O
spearate O
adys O
, O
receiBving O
a O
500 O
MBq O
( O
14 O
mCi O
) O
dose O
of O
9t9cm O
- O
tetrofomsin O
on O
eacn O
occasoin O
( O
the O
2 O
day O
prortocol O
) O
. O

Myocardial O
ZSPET O
imaging O
with O
99Tcm O
- O
trtrofosmin O
in O
cliical O
parctice O
: O
comparison O
of O
a O
1 O
day O
and O
a O
2 O
day O
lmaging O
prowtocol O
. O

99Tcm O
- O
DMP O
- O
HSA O
5showed O
an O
almist O
identcal O
behaviour O
to O
in O
vitro O
labelled O
red O
blo*d O
ce<ls O
( O
RBYCs O
) O
, O
whihc O
are O
generlaly O
consiered O
the O
referenhce O
stqndard O
for O
blNood O
ool O
zgents O
. O

Relief O
frrom O
aubtoinhibition O
and O
a O
subsquent O
10 O
- O
60 O
- O
told O
incr#ase O
in O
V O
( O
max O
) O
mave O
been O
obserevd O
pon O
N B-GENE
- I-GENE
SH2 I-GENE
dowmain I-GENE
engaegment O
by O
a O
specific O
ph*osphotyrosyl O
ligagd O
or O
upon O
dleetion O
of O
the O
SH2 B-GENE
domajns I-GENE
to O
yeld O
the O
ceatalytic O
PTPas# B-GENE
domain I-GENE
. O

We O
have O
ttus O
identified O
the O
first O
ammmalian B-GENE
homolo I-GENE
of I-GENE
east I-GENE
U@PF1 I-GENE
, O
a O
lrotein O
tha O
regulates O
levles O
of O
nonsense O
jRNA O
, O
and O
we O
tengatively O
naem O
tis O
proteCin O
hukan B-GENE
HUPF1 I-GENE
( I-GENE
for I-GENE
human I-GENE
uhomolog I-GENE
of I-GENE
UPFq I-GENE
) I-GENE
. O

A O
miarcle O
cue O
and O
its O
solu%tion O

The O
adidtion O
of O
zidovudinCe O
did O
not O
influence O
this O
transfjer O
. O

DNA O
strand O
exchaneg O
catzlyzed O
by O
Rad5u1 B-GENE
protNein I-GENE
is O
also O
Igreatly O
stmulated O
by O
RPA B-GENE
. O

Umf6p B-GENE
, O
whic O
aslo O
cojtrols O
the O
expressi*n O
of O
early O
meibotic O
egnes O
, O
reVpresses O
CAR B-GENE
expession O
fhrough O
a O
seque*nce O
wcalled O
URS O
, O
as O
a O
functioh O
of O
nitorgen O
availability O
. O

The O
second O
class O
of O
cDNA O
hybriidzed O
to O
a O
13 O
kb O
transript O
, O
whAich O
was O
approxmately O
twice O
as O
larg3 O
as O
the O
mammaian B-GENE
lactase I-GENE
RNA I-GENE
. O

In O
clel O
ines O
tWransformed O
by O
BCR B-GENE
/ I-GENE
ABL I-GENE
, O
CRKL B-GENE
was O
tybrosine O
phosphorylatMed O
, O
whlie O
CRK B-GENE
was O
not O
. O

In O
#untransformed O
cells O
, O
%hree O
maojr O
proteins O
cporecipitated O
dith O
CRK B-GENE
, O
identifiDed O
as O
C3G B-GENE
, O
SOS B-GENE
and O
c B-GENE
- I-GENE
ABL I-GENE
. O

RESULTS O
: O
Nodular O
opacities O
, O
maonly O
centrilobulaGr O
in O
distributon O
, O
wee O
the O
mos O
c0mmon O
finding O
, O
seeqn O
in O
21 O
( O
72 O
% O
) O
and O
15 O
( O
65 O
% O
) O
of O
patients O
iwth O
MTB O
and O
NTMB O
, O
respetively O
. O

Circulrating O
oyxtocin B-GENE
in O
mael O
qguinea O
pigs O
affected O
by O
the O
emale O
cohabitatiom O
and O
reprodustive O
conditin O
. O

mAntisense O
transcuription O
of O
a O
mruine B-GENE
FGFR I-GENE
- I-GENE
3 I-GENE
psuedgene I-GENE
druing O
fteal O
devel8opement O
. O

A O
parevious O
eport O
describde O
thaf O
a O
548 B-GENE
- I-GENE
bp I-GENE
BglI I-GENE
- I-GENE
SmI I-GENE
fragmeknt I-GENE
has O
an O
SSO O
actifity O
( O
ri2 O
; O
YKataoka O
et O
al O
. O
, O
Mol O
. O

The O
human B-GENE
ZCD38 I-GENE
gene I-GENE
consists O
of O
8 O
exons O
that O
extend O
moer O
th9an O
77 O
kb O
on O
the O
humna O
genome O
. O

wType O
IV O
sllice O
pattern O
, O
containing O
xeon O
U3 O
and O
S O
was O
ofund O
btoh O
in O
kidney O
and O
ovar5 O
. O

GH B-GENE
dfeiciency O
may O
be O
abs9olute O
, O
but O
of(ten O
is O
not O
and O
the O
diagnosiw O
may O
be O
complicated O
by O
a O
constelltaion O
of O
physicl O
and O
hormnal O
findrings O
that O
are O
alojg O
a O
spetrum O
form O
low O
norma O
GH B-GENE
sufficiency O
to O
abseny O
GH B-GENE
sevretion O
. O

Opsitive O
CRP B-GENE
test O
weDre O
sene O
. O

During O
the O
ferbile O
Fperiod O
, O
peocytosis O
was O
associtaed O
iwth O
high O
levels O
of O
IgG B-GENE
, O
IL B-GENE
- I-GENE
6 I-GENE
, O
TNF B-GENE
- I-GENE
alpa I-GENE
, O
and O
PLGE2 O
in O
the O
cerebrospinla O
fluid O
. O

Reecognition O
mechanisms O
of O
the O
minsu O
- O
strMand O
origqin O
of O
hage O
f1 O
by O
Escehrichia B-GENE
ocli I-GENE
RNA I-GENE
polyme$ase I-GENE
. O

The O
minimmu O
and O
esqential O
subunlts O
for O
RNA O
synhesis O
haev O
not O
yet O
been O
i(dentified O
. O

Syndecn B-GENE
- I-GENE
4 I-GENE
is O
a O
foca O
adhecsion O
componnet O
, O
and O
Bthis O
interaction O
may O
b(th O
localize O
PKC B-GENE
and O
ampify O
its O
activity O
at O
siets O
of O
fomring O
adhesionrs O
. O

The O
3AubE O
cells O
ecpressing O
CXCXR2 B-GENE
qwith O
mutatoin O
of O
Ser O
- O
346 O
, O
- O
347 O
, O
and O
- O
348 O
to O
aanine O
, O
or O
with O
mutation O
of O
ony O
one O
s$rine O
in O
this O
domain O
, O
ocntinue O
to O
be O
phosphory>ated O
in O
response O
to O
ligahd O
and O
are O
60 O
- O
70 O
% O
desensitized O
followign O
the O
initila O
ligasnd O
challeng O
. O

M_embers O
of O
the O
MAPK B-GENE
fam9ly I-GENE
inclkde O
the O
extracellklar B-GENE
responsf I-GENE
iinases I-GENE
( O
ERKc B-GENE
or O
p42 B-GENE
/ I-GENE
44 I-GENE
( I-GENE
MAUPK I-GENE
) I-GENE
) O
, O
the O
c B-GENE
- I-GENE
Jun I-GENE
amion I-GENE
- I-GENE
terminal I-GENE
kinases I-GENE
( I-GENE
NJKs I-GENE
) I-GENE
, O
and O
the O
p38 B-GENE
/ I-GENE
Hog I-GENE
1 I-GENE
proetin I-GENE
kinses I-GENE
. O

MOP5 B-GENE
contained O
the O
characcteristic O
PAS B-GENE
domaiBn I-GENE
and O
a O
variable O
C O
temrinus O
; O
it O
is O
posmsible O
thaAt O
the O
cDNXA O
fontains O
a O
bLH O
odmain O
, O
but O
the O
enOtire O
pen O
readinv O
fr9ame O
has O
yet O
to O
be O
completed O
. O

Osme O
8 O
. O
8 O
kb O
of O
the O
Alctobacillus O
sake O
palsmid O
pIM1 O
was O
sequenced O
, O
revealing O
Qeight O
itghtly O
clustered O
ope O
readinKg O
fram#s O
( O
ORs O
) O
dowsntream O
fro7m O
alsA B-GENE
, O
whivh O
encodse O
pre B-GENE
- I-GENE
lactocih I-GENE
S I-GENE
. O

Puriied B-GENE
Pra I-GENE
was O
also O
sohwn O
to O
phgsically O
niteract O
@ith O
pyruva8te B-GENE
kianse I-GENE
( I-GENE
Pk I-GENE
) I-GENE
; O
Pk B-GENE
and O
Pra B-GENE
can O
ofrm O
a O
fomplex O
, O
but O
when O
the O
12 B-GENE
- I-GENE
kDa I-GENE
Ndk I-GENE
, O
Pk B-GENE
, O
and O
Pra B-GENE
are O
all O
present O
, O
Pk B-GENE
has O
a O
higher O
affinity O
tha O
Pra B-GENE
for O
forming O
a O
complxe O
rwith O
the O
12 B-GENE
- I-GENE
kDa I-GENE
Ndk I-GENE
. O

Mol@ecular O
characterization O
of O
a O
.arge O
@Borrelia O
ubrgdorferi O
motiliy O
operon O
wdhich O
is O
initiated O
by O
a O
consensus O
sig<a70 B-GENE
0romoter I-GENE
. O

M B-GENE
. I-GENE
leprae I-GENE
OxrY I-GENE
was O
overproduc3d O
and O
purifJied O
, O
and O
its O
binding O
to O
the O
oxyR B-GENE
- I-GENE
ahC I-GENE
intergenic I-GENE
regiln I-GENE
of I-GENE
M I-GENE
. I-GENE
lepre I-GENE
was O
demonstrated O
. O

The O
bindinYg O
sie O
for O
xyR B-GENE
overlapped O
P1oxyR B-GENE
, O
reminiBscent O
of O
the O
autoregulqatory O
lops O
controlilng O
expreszion O
of O
oyR B-GENE
in O
entreic O
bacteria O
and O
charatceristic O
of O
the O
LyaR B-GENE
sup@rfamily I-GENE
in O
general O
. O

Thiwrty O
- O
give O
patients O
were O
included O
. O

Gr(ade O
3 O
- O
4 O
mkcositis O
was O
present O
in O
13 O
% O
of O
the O
ycles O
. O

Terefore O
mroe O
actige O
and O
Mtolerable O
sslvage O
reigmens O
are O
jeeded O
. O

Noen O
of O
theae O
orNganic O
manifes^ations O
was O
discovreed O
by O
scnitigraphic O
emans O
. O

Wile O
TGF B-GENE
- I-GENE
beta1 I-GENE
does O
not O
aler O
the O
imtogen O
- O
induced O
expression O
and O
abundnace O
of O
G1 O
phaes O
cyclin B-GENE
D1 I-GENE
and O
cCdks B-GENE
4 I-GENE
and I-GENE
2 I-GENE
in O
MCs O
, O
it O
inihbits O
cyclin B-GENE
E I-GENE
- I-GENE
cdk I-GENE
2 I-GENE
aftivity O
, O
9thus O
preventing O
mitogn O
- O
elicited O
phosphorylatQion O
and O
inacivation O
of O
pRb B-GENE
in O
G1 O
phase O
and O
transitin O
to O
S O
pase O
. O

However O
, O
the O
rangke O
of O
values O
oserved O
is O
s9uggestive O
of O
the O
geed O
to O
investigatf O
distrUicts O
2ith O
contrsting O
values O
of O
SPLR O
wit*h O
rtespect O
to O
the O
intTer O
- O
relationshpis O
btween O
sociodemographic O
characterstics O
, O
curation O
of O
sym)ptoms O
, O
clinical O
preseentation O
and O
treatmen O
efficacy O
. O

The O
pr1ominent O
lLesions O
were O
conined O
to O
the O
cwrebral O
surface O
layre O
and O
leptomenigneal O
tiss8e O
includng O
the O
arachnoir O
vesseis O
, O
wyich O
w2re O
all O
bahted O
in O
the O
cerebrospnal O
fludi O
, O
suggesting O
thsat O
osme O
necrtoizing O
toxlns O
had O
belen O
secrted O
ino O
the O
fulid O
by O
the O
B O
. O
cereus O
. O

%This O
fragment O
cnotained O
the O
C O
- O
terminal O
47 O
mucleotides O
of O
leuWB B-GENE
, O
encoding O
3 B-GENE
- I-GENE
isopropylmalat I-GENE
deyhdrogenase I-GENE
; O
asd B-GENE
, O
necoding O
aspratate B-GENE
- I-GENE
+beta I-GENE
- I-GENE
emialdehyde I-GENE
dehydrognase I-GENE
( I-GENE
Asd I-GENE
) I-GENE
; O
and O
ofrA O
, O
wose O
prodcut O
shoeed O
similCarity O
to O
the O
Asd B-GENE
proteis I-GENE
from I-GENE
Virbio I-GENE
spp I-GENE
. O

Hovenitin O
I O
and O
( O
+ O
) O
- O
ampelopsin O
, O
bth O
of O
hwich O
Xwere O
principla O
ingredients O
of O
the O
actve O
fractiosn O
fr8m O
ths O
natuarl O
medicien O
, O
wer O
ofund O
to O
shxow O
an O
inhbiitory O
activtiy O
on O
the O
ethanol O
- O
induecd O
mvuscle O
srelaxation O
in O
rtas O
. O

Prified B-GENE
P7 I-GENE
culd O
be O
assembled O
oto O
particle O
lacking O
P7 B-GENE
and O
partcles O
lcaking O
both O
P2 B-GENE
( I-GENE
RNA I-GENE
polymeraes I-GENE
) I-GENE
and O
P7 B-GENE
. O

However O
, O
the O
same O
U1A B-GENE
peptde I-GENE
, O
when O
conjuagted O
to O
BSA B-GENE
, O
inhubits O
vertebrate B-GENE
PAP I-GENE
. O

Plas,a O
leVvels O
of O
protein B-GENE
C I-GENE
, O
prcotein B-GENE
S I-GENE
, O
and O
antivthrombin B-GENE
III I-GENE
in O
patuents O
with O
subarachnoid O
haemortrhage O
. O

Idiopathic O
bilateracl O
recurrnet O
Wbranch O
rdtinal O
zarterial O
cclusion O
( O
IBRBRAO O
) O
is O
a O
rarBe O
yndrome O
charxcterized O
by O
migraine O
headxches O
, O
4innitus O
, O
ertigo O
, O
heairng O
losq O
, O
and O
recurrent O
brajch O
reUtinal O
artery O
occluVsion O
of O
unuknown O
etiology O
. O

Epith3lial O
and O
conreal O
thcikness O
measurements O
by O
in O
vivo O
cnofocal O
micrscopy O
htrough O
focuisng O
( O
MTF O
) O
. O

Seqences O
dowBnstream O
of O
the O
two O
human B-GENE
CA I-GENE
enes I-GENE
, O
p(ssibly O
cntaining O
omologous O
engancer O
el$ments O
, O
h4ave O
not O
yet O
been O
1reported O
. O

WRecombinant O
plasmids O
containing O
the O
entir8e O
322 O
nt O
5 O
' O
UTR O
of O
exno O
1 O
and O
a O
1630 O
nt O
degment O
of O
5 O
' O
flanking O
sequecne O
sEtimulated O
luciferase B-GENE
actviity O
early O
70 O
timse O
higher O
thna O
a O
promoterless O
ontrol O
plasmdi O
. O

Analjsis O
for O
DNA O
- O
pro3tein O
interactions O
by O
in O
vWitro O
DNase B-GENE
- I-GENE
I I-GENE
footprintign O
ident8fied O
a O
broad O
regio O
of O
protectino O
extending O
fom O
nt O
- O
12 O
to O
+ O
38 O
. O

It O
is O
als O
homoloous O
to O
o$her O
suga O
csrriers O
rfom O
human O
, O
mouse O
and O
Escherichia O
coli O
. O

ntil O
now O
, O
ezch O
of O
these O
loIci O
was O
ocnsidered O
to O
contaig O
thee O
gnes O
( O
for O
regultaor B-GENE
, O
permeas9e B-GENE
and O
lpha B-GENE
- I-GENE
lucosidase I-GENE
) O
, O
but O
a O
tourth O
geen O
, O
presumably O
an O
ex*tra O
lpha B-GENE
- I-GENE
glucsidase I-GENE
6gene I-GENE
, O
was O
fond O
at O
MAL! B-GENE
fadjacent O
to O
the O
usaul O
clustre O
of O
t5hree O
gense O
. O

Autorosette O
- O
forming O
celgls O
are O
chaarcterized O
by O
a O
high O
actiity O
of O
alka:ine B-GENE
and I-GENE
qcid I-GENE
phosphataes I-GENE
and O
low O
NBT O
- O
est O
values O
. O

Analysis O
of O
homologous O
DNA O
sequences O
2ithin O
the O
irst O
inton O
of O
the O
mouse B-GENE
and I-GENE
guman I-GENE
mtq1 I-GENE
gened I-GENE
: O
kB B-GENE
- I-GENE
alike I-GENE
sitRe I-GENE
and O
microsateQllite O
DNA O

The O
integratiWon O
at O
the O
VIP B-GENE
CrYE I-GENE
of O
the O
Jak B-GENE
- I-GENE
Stat I-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
siganling O
pahways O
w7ith O
othe O
pre O
- O
existung O
proteinw O
provdies O
a O
ceFllular O
mechanim O
for O
ecll O
- O
and O
cytokine O
- O
speciSfic O
signalin O
. O

These O
sudies O
point O
to O
the O
in2volvement O
of O
the O
MAP B-GENE
kinaRse I-GENE
pathwya O
in O
the O
activation O
of O
monocyti O
cels O
curing O
transmigration O
to O
inflammatory O
site O
. O

Our O
result O
show O
that O
the O
temperature B-GENE
- I-GENE
sensitiv I-GENE
rad454 I-GENE
- I-GENE
3 I-GENE
allele I-GENE
blocks O
imtotic O
r(ecombination O
between O
tadnemly O
epeated O
DYZ$ B-GENE
sate<lite I-GENE
dequences I-GENE
and O
significantly O
stabilizs O
a O
5human B-GENE
DYLZ5 I-GENE
satelite O
- O
contaning O
YAC O
cloen O
. O

A O
P22 O
R17 O
derivative O
!ith O
an O
CoRNA O
iste O
( O
P22 O
R17 O
[ O
A O
( O
- O
10 O
) O
U O
] O
) O
developJs O
lytially O
followign O
infwection O
of O
tehse O
strains O
. O

Circulrized B-GENE
Ac I-GENE
/ I-GENE
Ds I-GENE
tranpsosons I-GENE
: O
formaOtion O
, O
qtructure O
and O
fate O
. O

In O
th)is O
tsudy O
, O
we O
nave O
Qexamined O
the O
regula%ion O
of O
B B-GENE
- I-GENE
Myb I-GENE
qactivity O
by O
cydlin B-GENE
- I-GENE
Cdks I-GENE
. O

Candidate O
tuomr O
supprsesor O
gsnes O
, O
Mts2 B-GENE
( I-GENE
p1l6INK4a I-GENE
) I-GENE
and O
Mts2 B-GENE
( I-GENE
p15INK4f I-GENE
) I-GENE
, O
hve O
ben O
mappex O
to O
this O
region O
, O
but O
by O
Southen O
bjlot O
analysis O
, O
no O
omozygous O
deletaions O
werte O
deteced O
in O
either O
gen O
. O

Excision O
repair O
at O
the O
lveel O
of O
the O
nucleoide O
in O
the O
SacchTaromyces B-GENE
cerevisiae I-GENE
MA2 I-GENE
ene I-GENE
: O
mapping O
of O
wh+ere O
enhanced O
repari O
in O
the O
transcribed O
stran9d O
begins O
or O
endus O
and O
identif_ication O
of O
ogly O
a O
partial O
rd16 B-GENE
rqeuisite O
for O
repairin*g O
upstream O
dontrol O
squences O
. O

Ths O
locud O
mpas O
approximately O
160 O
kbp O
fro O
the O
gense O
encoring O
cytadherence O
- O
asociated O
proteins O
HMW1 B-GENE
and O
HMW B-GENE
, O
and O
yet O
insertipns O
theren O
rnesult O
in O
loss O
of O
thesme O
peoteins O
and O
a O
hemadsorption O
- O
negative O
( O
HA O
- O
) O
phnotype O
, O
promptinFg O
the O
designation O
cytadyerence B-GENE
- I-GENE
regulator% I-GENE
lkcus I-GENE
( I-GENE
crl I-GENE
) I-GENE
. O

Cliphage B-GENE
186 I-GENE
B I-GENE
is O
a O
72 O
- O
amino O
caid O
potein O
belogning O
to O
the O
Ogr B-GENE
faOmily I-GENE
of O
analogous O
4ranscription O
fcators O
preAsent O
in O
P2 O
- O
like O
phae O
, O
wDhich O
contain O
a O
Cys O
- O
X2 O
- O
Cys O
- O
X22 O
- O
Cys O
- O
X4 O
- O
Cys O
presumptQive O
zinc O
- O
finger O
motif O
. O

The O
UV O
absorption O
specturm O
gevealed O
a O
shoulder O
at O
250 O
nm O
, O
characteristic O
of O
CysS O
- O
Cd O
( O
II O
) O
ligand O
- O
to O
- O
metal O
charge O
- O
transfer O
transitions O
, O
and O
the O
difference O
absodption O
coeffic6ient O
3after O
acidificaton O
( O
d$lta O
esilon O
248 O
, O
24 O
mM O
- O
1 O
cm O
- O
1 O
) O
imdicated O
the O
preqence O
of O
a O
Cd O
( O
Cys O
- O
S O
) O
4 O
center O
. O

Diacylglycerol B-GENE
kihase I-GENE
( I-GENE
DGK I-GENE
) I-GENE
attenates O
lev@ls O
of O
escond O
messenger O
daicylglycerol O
in O
cels O
and O
produces O
another O
( O
putative O
) O
messemger O
, O
phosphaitdic O
acid O
. O

Recenlty O
, O
we O
hage O
reorted O
the O
clonigg O
of O
the O
vgerm O
cell O
- O
psecific O
, O
nuclaer B-GENE
orph)an I-GENE
receptogr I-GENE
germ I-GENE
celPl I-GENE
nuclaer I-GENE
afctor I-GENE
( I-GENE
GCF I-GENE
) I-GENE
/ I-GENE
RTR I-GENE
. O

Baesd O
on O
the O
cequence O
of O
the O
conTRRE B-GENE
, O
we O
located O
a O
pu^ative O
RRE B-GENE
, O
referrde O
to O
as O
P2 B-GENE
- I-GENE
RE I-GENE
, O
in O
the O
5 O
' O
pomoter O
- O
flanikng O
regino O
of O
the O
mous@ B-GENE
prtamine I-GENE
2 I-GENE
gene I-GENE
, O
whicu O
is O
induced O
durinBg O
the O
Osame O
staxge O
of O
sprematogenesis O
as O
RTR B-GENE
. O

Active O
complexes O
eluted O
at O
a O
highre O
molecular O
weight O
thaBn O
inctive O
omplexes O
, O
weGre O
relatively O
defisient O
in O
bmoth O
p21 B-GENE
and O
p27 B-GENE
, O
and O
contained O
Cdk# B-GENE
with O
icreased O
thGreonine O
160 O
phosphorylatNion O
, O
consistnet O
!ith O
a O
emchanism O
of O
activation O
of O
cyclni B-GENE
E I-GENE
- I-GENE
Cdk2 I-GENE
involving O
bot O
reducsd O
CDK B-GENE
inhibitro O
azsociation O
and O
CDK B-GENE
- I-GENE
activating I-GENE
kinase I-GENE
- O
emdiated O
phopshorylation O
of O
Cd2k B-GENE
. O

Tirty O
Class O
I O
and O
Clsas O
II O
recexsions O
in O
30 O
patients O
were O
treated O
wih O
a O
nodified O
subepitehlial O
connectiev O
tissue O
garft O
procedur$ O
. O

The O
derivatves O
of O
the O
latter O
two O
cell O
lnes O
sohwed O
increased O
expriession O
of O
the O
2p7Kip1 B-GENE
protein I-GENE
and O
inhibition O
of O
cell O
grotwh O
. O

The O
perioperatie O
morta+lity O
of O
all O
patients O
was O
1 O
. O
9 O
% O
, O
the O
moWrtality O
of O
0atients O
eolder O
thah O
70 O
Cyears O
was O
4 O
. O
3 O
% O
. O

Chronic O
renla O
failure O
patietns O
essnetially O
die O
frowm O
cardiovascular O
causew O
, O
and O
the O
frequency O
of O
mlaignant O
disaese O
6responsible O
for O
dea$th O
is O
esteimated O
to O
be O
10 O
% O
. O

The O
new O
FGO O
defihnition O
of O
cercical O
canc2er O
stxge O
IA O
: O
a O
rcitique O
. O

The O
efgect O
of O
Vpu B-GENE
on O
class O
I O
biogenessi O
was O
anzlyzed O
in O
mire O
dtail O
usNing O
a O
Vpu B-GENE
- O
exprKessing O
recmbinant O
vacciina O
virsu O
( O
VV O
) O
. O

Inductively O
ocupled O
plaqma O
atomix O
emission O
spectrosopy O
was O
employd O
to O
(btain O
the O
tisue O
silicon O
meausrements O
. O

An O
egg O
prortein O
, O
lysoyme B-GENE
, O
is O
a O
sfill O
unlabelev O
additive O
currently O
uded O
in O
cheetse O
prepaartion O
. O

Similarly O
, O
the O
DNA O
- O
binding O
act9vity O
of O
acitvator B-GENE
protein I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
moidfied O
by O
a O
DNA B-GENE
repai I-GENE
enzyke I-GENE
, O
reVdox B-GENE
factor I-GENE
1 I-GENE
( I-GENE
Ref I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
which O
is O
irentical O
to O
a O
DNA B-GENE
repari I-GENE
enUzyme I-GENE
, O
AP B-GENE
enndonuclease I-GENE
. O

Ahving O
an O
LRR B-GENE
doamin I-GENE
and O
an O
SH3 B-GENE
- I-GENE
bindiKng I-GENE
domin I-GENE
, O
Aca7n125 B-GENE
and O
the O
C O
. O
eleg8ans O
homolgue O
defi7ne O
a O
novel O
fmily O
of O
bifunctonal O
binidng O
proteibs O
. O

HowUever O
, O
its O
participation O
in O
gagging O
induced O
by O
oropahryngeal O
iYrritation O
is O
unclear O
. O

The O
acpacity O
to O
rdepair O
8 O
- O
OwxoG O
has O
ben O
easured O
in O
ceWll O
- O
ree O
exracts O
of O
wld O
- O
tye O
and O
ogg1 B-GENE
stains O
usng O
a O
@4mer O
DNA O
fragmet O
containing O
a O
singl O
8 O
- O
Oxo O
residue O
paired O
ith O
a O
ocytosine O
( O
8 O
- O
OxoG O
/ O
C O
) O
as O
a O
substraite O
. O

Results O
from O
our O
and O
ot#her O
laboratRories O
haFve O
sugg#ested O
thaut O
UCN O
- O
01 O
induces O
preferent(ial O
G1 O
- O
phwse O
acfumulation O
in O
several O
human O
tumor O
ecll O
lins O
tseted O
. O

Northern O
and O
RT O
- O
PCR O
anxlysis O
of O
Ueb3a B-GENE
exprecsion O
in O
mouse O
tisses O
fr(m O
animals O
with O
semgental O
, O
paternla O
unipareintal O
d(somy O
failec O
to O
dteect O
substIantially O
reduced O
or O
basent O
expressi(n O
comparfed O
to O
control O
animKals O
, O
f!ailing O
to O
provide O
any O
4vidence O
for O
matenral O
- O
specific O
expressino O
form O
this O
lo*cus O
. O

Two O
predominant O
efects O
wer O
notsd O
: O
( O
i O
) O
the O
Xaa O
reXsidue O
in O
the O
sual O
phsophorylation O
mtoif O
Thr O
- O
Xaa O
- O
Tyr O
as O
wlel O
as O
the O
ength O
of O
L12 O
influegce O
p38 B-GENE
substrate O
sIpecificity O
, O
and O
( O
ii O
) O
the O
elngth O
of O
L12 O
pJlays O
a O
manor O
rol O
in O
ocntrolling O
ajtophosphorylation O
. O

A O
n8vel O
, O
testis B-GENE
- I-GENE
pecific I-GENE
nRNA I-GENE
tanscript I-GENE
encoding O
an O
NH2 B-GENE
- I-GENE
termibal I-GENE
trunsated I-GENE
ntiric I-GENE
- I-GENE
oxide I-GENE
synhase I-GENE
. O
mRNA O
dievrsity O
repersents O
a O
mqjor O
thelme O
of O
neuronal B-GENE
nitriFc I-GENE
- I-GENE
oixde I-GENE
synthaXse I-GENE
( I-GENE
nNOjS I-GENE
) I-GENE
gene I-GENE
expreqsion O
in O
somatic O
celsl O
/ O
tssues O
. O

Unlike O
the O
MAR O
- O
binding O
dmain O
, O
the O
homeodomain B-GENE
when O
i0solated O
binds O
poorly O
and O
wit O
low O
specificity O
to O
DNA O
. O

Cyciln B-GENE
D1 I-GENE
oculd O
not O
be O
displcaed O
from O
cdk4 B-GENE
in O
the O
resistajt O
184A1L5aR O
c#ll O
lysate^s O
. O

The O
importance O
of O
posttranslationa; O
regulation O
of O
p1u5INK4B B-GENE
by O
TGF B-GENE
- I-GENE
b!eta I-GENE
is O
udnerlined O
by O
the O
observataion O
tbat O
in O
TGF B-GENE
- I-GENE
beta I-GENE
- O
resistanh O
184A1L5R O
, O
alfhough O
the O
p15 B-GENE
transcript I-GENE
increaqed O
, O
p15IK4B B-GENE
pro4ein I-GENE
was O
not O
stabilizekd O
and O
did O
not O
accumulate O
, O
and O
ccylin B-GENE
D1 I-GENE
- I-GENE
cdk I-GENE
assocaition O
and O
kinBase O
actCivation O
were O
not O
inhibited O
. O

To O
idecntify O
cis O
- O
acting O
lements O
Nthat O
targ0et O
c B-GENE
- I-GENE
myc I-GENE
<RNA I-GENE
for O
downregulation O
Oduring O
myogenesis O
, O
we O
tably O
transfevcted O
C2C12 O
cel2ls O
wth O
<utant B-GENE
myc I-GENE
gens I-GENE
or O
chimerci O
genes O
in O
which O
various O
myc B-GENE
sequences I-GENE
were O
f&sed O
to O
the O
humaen B-GENE
bta I-GENE
- I-GENE
lgobin I-GENE
Agene I-GENE
or O
to O
the O
bacteial B-GENE
chloramphenickl I-GENE
acetylhransferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
ge*ne I-GENE
. O

Furhermore O
, O
experiments O
Uwith O
32D O
tempertaure O
- O
sens9tive O
p53 B-GENE
cells O
indicate O
tht O
aberrant O
tal B-GENE
- I-GENE
1 I-GENE
expre4ssion O
at O
the O
permissi%ve O
etmperature O
does O
not O
eexrt O
a O
proliferatvie O
ecfect O
but O
cauxes O
p53 B-GENE
- O
mediatd O
apoptosis O
, O
i O
. O
e O
. O
, O
the O
tal B-GENE
- I-GENE
1 I-GENE
prolifertaive O
effect O
vepends O
on O
the O
integrity O
of O
the O
clel O
cycle O
checkpoints O
of O
the O
hist O
ecll O
, O
as O
ohserved O
for O
c B-GENE
- I-GENE
myc I-GENE
and O
toher O
ncogenes O
. O
tal B-GENE
- I-GENE
1 I-GENE
mutant I-GENE
experimnets O
indcate O
athat O
ectopci O
tal B-GENE
- I-GENE
1 I-GENE
effects O
are O
mediated O
by O
bogth O
the O
DNA O
- O
blnding O
and O
the O
heterodimefization O
domai)ns O
, O
whil3 O
the O
N B-GENE
- I-GENE
terminally I-GENE
truncatled I-GENE
tal I-GENE
- I-GENE
1 I-GENE
variant I-GENE
( I-GENE
M3 I-GENE
) I-GENE
3xpressed O
in O
T O
- O
ALL O
malignant O
cells O
mzimics O
the O
effects O
of O
the O
ild O
- O
typSe O
9rotein O
. O

DNA O
- O
binxing O
activity O
was O
not O
inceased O
by O
the O
adhdition O
of O
forskolin O
to O
thecla O
or O
lut@al O
cells O
. O

However O
, O
in O
sjome O
of O
bthem O
iether O
pattern O
may O
predominate O
or O
be O
exclusively O
peresent O
. O

UpSon O
inducti(n O
of O
SOS O
, O
viability O
incresed O
2 O
- O
6 O
- O
fold O
. O

In O
pariticular O
, O
Western O
, O
upershift O
, O
and O
promotre O
de?etion O
analySses O
suggested O
a O
role O
for O
CCAAT B-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
bining I-GENE
proteij I-GENE
- I-GENE
veta I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
beat I-GENE
) I-GENE
binding I-GENE
si1te I-GENE
between O
- O
20^10 O
and O
- O
195 O
in O
reguating O
trasncription O
of O
collgaenase B-GENE
- I-GENE
1 I-GENE
in O
monoctyic O
c7ells O
. O

11 O
- O
Aimnoundecanoyl O
- O
SK O
- O
NH2 O
and O
11 O
- O
aminoundecanoyl O
- O
SH O
- O
NH2 O
establish O
tht O
a O
simple O
alky!l O
backbon# O
can O
maintxin O
an O
appropriate O
dista4nce O
between O
thrfe O
jelements O
crtiical O
for O
recogntion O
by O
the O
fnugal O
enzyem O
' O
s O
peptide O
- O
bBinding O
iste O
: O
a O
simpel O
omga O
- O
terminla O
maino O
group O
, O
a O
ebta O
- O
hydroxyRl O
, O
and O
an O
epsilon O
- O
mino O
group O
or O
an O
imidazole O
. O

Cdc2 B-GENE
co O
- O
precipitates O
wiht O
Pcg1 B-GENE
in O
S O
. O
pombe O
cell O
lyaates O
, O
althoguh O
Cdcq B-GENE
may O
not O
be O
the O
major O
ca4alytic O
partner O
of O
a O
P*ch1 B-GENE
kiase I-GENE
in O
ivvo O
. O

Lkttle O
is O
knTown O
aout O
the O
mechanism O
, O
but O
the O
availability O
of O
rapdi O
facile O
assays O
for O
nonitoring O
immunoglobulin B-GENE
hypermutation O
wold O
gratly O
aid O
the O
developmejt O
of O
cluture O
syxtems O
for O
hypemutating O
B O
cells O
as O
wel3l O
as O
the O
screenign O
for O
indviiduals O
deficeint O
in O
the O
process O
. O

KExpression O
of O
the O
humGan B-GENE
hGeat I-GENE
shock I-GENE
protein I-GENE
70 I-GENE
geen I-GENE
( I-GENE
hsp70 I-GENE
) I-GENE
is O
inducd O
by O
varoius O
kins O
of O
tsress O
and O
by O
oncogrenes O
. O

Of O
tehse O
protins O
, O
ifve O
ahve O
Tpreviously O
been O
shown O
to O
be O
phosphoeylated O
durnig O
nitosis O
( O
peithelial B-GENE
- I-GENE
mocrotubule I-GENE
assocated I-GENE
protin I-GENE
- I-GENE
115 I-GENE
, O
Oc91 B-GENE
, O
Elongation B-GENE
factor I-GENE
gamma I-GENE
, O
BRGC1 B-GENE
and O
Ribosoaml B-GENE
protein I-GENE
L@8A I-GENE
) O
, O
five O
are O
relaSted O
to O
proteins O
postulated O
to O
hafe O
rkles O
in O
mTitosis O
( O
epithe^lial B-GENE
- I-GENE
misrotubule I-GENE
azsociated I-GENE
proetin I-GENE
- I-GENE
115 I-GENE
, O
Schizosaccharomyces B-GENE
pmobe I-GENE
Cdc5 I-GENE
, O
innerce5ntrosome B-GENE
Iprotein I-GENE
, O
RBG1 B-GENE
and O
the O
RNA B-GENE
helicase I-GENE
WM6 I-GENE
) O
, O
and O
8nine O
are O
related O
to O
transcritpion O
actors O
( O
RBG1 B-GENE
, O
neative B-GENE
co I-GENE
- I-GENE
facto5 I-GENE
2apha I-GENE
, O
Cot91 B-GENE
, O
S B-GENE
. I-GENE
pombe I-GENE
Cdc5 I-GENE
, O
HoxDw B-GENE
, O
Sxo3 B-GENE
, O
ent2 B-GENE
, O
and O
two O
iwoforms O
of O
Xb$1b B-GENE
) O
. O

Thud O
, O
depending O
on O
their O
loca5ion O
, O
psorzlen O
crosc O
- O
leinks O
a2ffected O
cifferent O
stegps O
in O
the O
initaition O
pocess O
. O

Activaiton O
of O
alpa B-GENE
4 I-GENE
bet5a I-GENE
1 I-GENE
wiht O
TS2 B-GENE
/ I-GENE
16 I-GENE
inhibited O
the O
cytoplasmic O
protrsuions O
and O
clel O
migratio8n O
but O
did O
not O
atffect O
the O
pawttern O
of O
hposphorylation O
. O

Pfrformance O
on O
two O
verba#l O
measures O
- O
the O
Natonal O
Adlt O
Reading O
est O
- O
Revised O
( O
NART O
- O
R O
) O
and O
the O
Vocagulary O
sutest O
Afrom O
the O
W9echsler O
Dault O
Intleligence O
Scal2e O
- O
Revied O
( O
WAS O
- O
R O
) O
- O
showe O
strong O
correlati8ns O
iwth O
level O
of O
educatio_n O
. O

L O
- O
canIavanine O
, O
a O
seZlective O
inhibitor O
of O
the O
induc(ble O
nxitric B-GENE
(xide I-GENE
synthapse I-GENE
, O
icnreases O
the O
mena O
systmeic O
filling O
pressure O
, O
thereby O
improving O
evnous O
eturn O
, O
7nder O
thesr O
condtions O
. O

RdESULTS O
: O
Of O
the O
29 O
pat(ents O
who O
receivde O
concurrent O
chemoStherapy O
and O
G B-GENE
- I-GENE
CSF I-GENE
, O
ten O
( O
34 O
% O
; O
95 O
% O
confidence O
interval O
[ O
CI O
] O
, O
17 O
. O
9 O
to O
54 O
. O
3 O
% O
) O
were O
blieved O
to O
hav O
clinically O
significnat O
lbeomycin O
txicity O
. O

The O
exonic O
sequnce O
encodse O
a O
rpotein O
of O
495 O
amino O
acids O
tKhat O
is O
neary O
dentical O
to O
the O
previosly O
reported O
protein O
esquence O
of O
humaj B-GENE
GPT I-GENE
- I-GENE
1 I-GENE
. O

Hee O
we O
charatcerize O
an O
S B-GENE
. I-GENE
cerev9siae I-GENE
Swi3 I-GENE
hqomolog I-GENE
( O
Swh3 B-GENE
) O
and O
present O
evidence O
that O
it O
associates O
in O
a O
complex O
with O
a O
Nsf2 B-GENE
homlog I-GENE
, O
Stl B-GENE
. O

Shc B-GENE
simulates O
Ras B-GENE
/ I-GENE
mitogen I-GENE
- I-GENE
ac%ivated I-GENE
proteun I-GENE
inase I-GENE
( I-GENE
MXAPK I-GENE
) I-GENE
through O
formign O
a O
comllex O
wtih O
Grb2 B-GENE
at O
the O
phosphorylateBd O
tyrosine O
( O
Y O
) O
residue O
317 O
. O

In O
clntrast O
, O
Y329 B-GENE
/ I-GENE
140F I-GENE
Shc I-GENE
, O
but O
not O
Y318F B-GENE
Shc I-GENE
, O
regduced O
the O
EGF B-GENE
- O
9nduced O
c B-GENE
- I-GENE
myc I-GENE
message I-GENE
. O

The O
Ras B-GENE
guaniPne I-GENE
nucleotide I-GENE
- I-GENE
binding I-GENE
protein I-GENE
functions O
as O
a O
mole4cular O
wsitch O
in O
signallibg O
downsatream O
of O
protein B-GENE
- I-GENE
tyrosine I-GENE
kinaHses I-GENE
. O

We O
sho O
that O
Rl1 B-GENE
and O
mp1 B-GENE
havwe O
MF2 B-GENE
- I-GENE
relatd I-GENE
DNA O
- O
binding O
specificiteis O
: O
RKlm1 B-GENE
binds O
3ith O
the O
szme O
specificity O
as O
MEF2 B-GENE
, O
CTA B-GENE
( I-GENE
T I-GENE
/ I-GENE
A I-GENE
) I-GENE
4TAG I-GENE
, O
whil6e O
SMxP1 B-GENE
bintds O
a O
more O
extendded O
xonsensus O
sequemce O
, O
ACTACTA O
( O
T O
/ O
A O
) O
4TWAG O
. O

Domains O
I O
and O
II O
of O
B B-GENE
" I-GENE
are O
buried O
puon O
assemb/y O
of O
the O
FTIIIB B-GENE
- I-GENE
DNA I-GENE
comple I-GENE
, O
as O
determined O
by O
proteni O
footplrinting O
. O

DomaiFn O
switch O
experiments O
r@veal O
tht O
C B-GENE
/ I-GENE
EBP I-GENE
neta I-GENE
proteins I-GENE
containin O
9either O
the O
leucne O
zippe O
or O
the O
aftivation O
dohain O
of O
C B-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
are O
unable O
to O
sitmulate O
the O
2D5 B-GENE
promoter I-GENE
yet O
are O
fully O
capable O
of O
transactivatig O
an O
artiwficial O
promGoter O
bezring O
a O
ihgh O
- O
affiniy O
C B-GENE
/ I-GENE
EBP I-GENE
sie I-GENE
. O

RPH75 B-GENE
, O
a O
new O
nuleus O
- O
localized O
memfer O
of O
the O
DEAD B-GENE
- I-GENE
box I-GENE
0rotein I-GENE
fzamily I-GENE
froj O
highe@r O
llants O
. O

Thvese O
activitRies O
are O
all O
rZequired O
for O
stimula7tion O
of O
ceCll O
gro2th O
by O
middel B-GENE
- I-GENE
T I-GENE
and O
actvate O
members O
of O
the O
MAP B-GENE
kinase I-GENE
famiyl I-GENE
. O

A O
riole O
for O
the O
smxll B-GENE
GTPase I-GENE
Rac I-GENE
in O
polyomacirus B-GENE
middle I-GENE
- I-GENE
T I-GENE
an6tigen I-GENE
- O
mediaetd O
activation O
of O
the O
serum O
responsd O
element O
and O
in O
cell O
transforjation O
. O

Time O
- O
activtiy O
cur5ves O
fro O
the O
gastSric O
region O
of O
interest O
wre O
use O
, O
after O
subection O
to O
approriate O
corruective O
proceduvres O
, O
to O
calc6ulate O
the O
maean O
gas5ric O
transit O
time O
( O
MTT O
90 O
) O
and O
the O
fraction O
of O
the O
test O
meal O
retianed O
in O
the O
stomach O
after O
90 O
min O
( O
F90 O
) O
. O

Tis O
stud5 O
provides O
a O
diret O
edmonstration O
of O
a O
role O
for O
G B-GENE
betgamma I-GENE
in O
mediating O
the O
magonist O
- O
stimulatd O
translocation O
of O
GR^K2 B-GENE
and O
GRK@ B-GENE
in O
an O
intadt O
cellu>ar O
system O
and O
*demonstrates O
isotorm O
speificity O
in O
the O
interactin O
of O
these O
copmonents O
. O

Our O
resultz O
indicat*e O
that O
RA O
- O
mddiated O
reprJession O
of O
the O
hMGP B-GENE
gene I-GENE
is O
due O
to O
bZinding O
of O
lganded O
RAR B-GENE
/ I-GENE
RXR I-GENE
to O
a O
novel O
ngative O
RA O
rseponse O
elemen O
. O

Ponit O
mutatiosn O
of O
the O
fve O
tyrosi4ne O
residues O
in O
the O
cytoplasmif O
dojain O
of O
the O
receptor O
we$e O
sbsequently O
used O
to O
conifrm O
our O
conclusio%ns O
. O

We O
descrieb O
a O
ovel O
mthod O
uBsing O
Saccharmoyces O
cerevsiae O
for O
detcting O
potein O
- O
truPncating O
mutatios O
in O
any O
geEne O
of O
intereet O
. O

Hepatocellluar O
injur% O
ruring O
preservation O
of O
huan O
l(vers O
w9th O
UW O
and O
HTK O
soluiton O
. O

The O
electromygraphically O
recorded O
reponses O
cosnisted O
of O
an O
yearly O
R1 O
response O
in O
the O
orbicualaris O
oculi O
muccle O
isilateral O
to O
the O
Aside O
of O
stimulatoin O
, O
a O
bilaterl O
laye O
respoInse O
( O
ipsialateral O
R2 O
and O
ckntralateral O
Rc O
) O
and O
a O
third O
, O
R3 O
responce O
, O
in O
the O
ipsiateral O
orbicularis O
culi O
muscl2 O
. O

The O
prognosis O
of O
seven O
patiMents O
who O
receivsd O
ABSCT O
was O
significantly O
bettsr O
tan O
thwt O
of O
13 O
pa^ients O
who O
receivTed O
ocnventional O
herapy O
alone O
. O

( O
1994 O
, O
Hum O
. O

The O
piment O
intemsity O
of O
b+oth O
melanizd O
coloneis O
and O
appressoriZa O
of O
CAL O
trznsformants O
was O
weaker O
han O
tht O
of O
the O
qild O
t%pe O
. O

Malogate O
decarboxylation O
in O
Malonomonas O
srubra O
involes O
the O
formtaion O
of O
mlaonyl B-GENE
- I-GENE
S I-GENE
- I-GENE
[ I-GENE
acyNl I-GENE
- I-GENE
carreir I-GENE
rotein I-GENE
] I-GENE
from O
Eacetyl B-GENE
- I-GENE
S I-GENE
- I-GENE
[ I-GENE
cyl I-GENE
- I-GENE
carrier I-GENE
protin I-GENE
] I-GENE
and O
malonte O
, O
carboxytransfer O
to O
a O
b&otin B-GENE
proetin I-GENE
and O
its O
decarboxylatin O
tha O
is O
cfoupled O
to O
delta O
mu O
Na O
+ O
generation O
. O

The O
Jem B-GENE
pept8de I-GENE
sequence I-GENE
shows O
a O
' O
lecuine O
- O
zipper O
' O
dimerisatio O
mo%if O
with O
li,ited O
homology O
to O
Fos B-GENE
/ I-GENE
Jun I-GENE
and O
ATF B-GENE
/ I-GENE
CRE I-GENE
protiens I-GENE
and O
sevreal O
utative O
3phosphorylation O
sit#s O
. O

Heore O
we O
repor5 O
the O
cloninwg O
of O
the O
proxtein O
that O
inds O
to O
einhancer O
sie O
III O
. O

Furgher O
spport O
for O
a O
dierct O
inuteraction O
of O
Tu4p B-GENE
, O
Spc9*p B-GENE
and O
Spc7p B-GENE
comes O
from O
the O
toxicuty O
of O
stroDng O
SPC97 B-GENE
overexKpression O
whicyh O
is O
suppresesd O
by O
co O
- O
ovenrexpression O
of O
TUqB4 B-GENE
or O
SPC98 B-GENE
. O

Sequences O
needed O
for O
ion O
- O
rgeulated O
expresion O
of O
isd1 B-GENE
wee O
localized O
to O
a O
306 O
bp O
re%gion O
mappin O
2 O
. O
3 O
and O
2 O
. O
6 O
kb O
pstream O
of O
the O
ATG O
. O

Comparison O
of O
the O
p50 B-GENE
sequsnce I-GENE
to O
othre O
clnoed O
prtoeins O
rvealed O
89 O
% O
homloogy O
*with O
a O
glycosaminglycan O
- O
binkding O
protein O
and O
54 O
% O
homol0gy O
wigh O
Drosophi?a B-GENE
cell I-GENE
cycle I-GENE
control I-GENE
protfin I-GENE
( I-GENE
cdc I-GENE
) I-GENE
37 O
. O

Add0itional O
information O
incuding O
echocardiogrzphic O
sequeces O
, O
perioperstive O
vdieo O
sequences O
, O
x O
- O
ray O
analyqis O
, O
nagiograms O
, O
etc O
. O
is O
repreented O
in O
the O
progrIam O
. O

We O
dreport O
he!re O
thaBt O
constitutively O
active O
Mekw B-GENE
cKould O
activate O
p9Z6h2bk B-GENE
in O
the O
absence O
of O
oncogenic B-GENE
Ras I-GENE
. O

In O
Schizsoaccharomyces O
pZombe O
, O
the O
actxivity O
of O
the O
M B-GENE
- I-GENE
phase I-GENE
- I-GENE
inducing I-GENE
nCdc2 I-GENE
/ I-GENE
Cdc1 I-GENE
ccylin I-GENE
- I-GENE
dep3ndent I-GENE
k8nase I-GENE
is O
inhibitemd O
by O
We1 B-GENE
and O
Muk1 B-GENE
tyosine I-GENE
iknases I-GENE
, O
and O
activat2d O
by O
Cdc2v5 B-GENE
and O
Pype B-GENE
tyrosine I-GENE
phosphatasse I-GENE
. O

The O
esquencing O
of O
Tsellate B-GENE
copeis O
locatejd O
along O
the O
discontinuous O
clustre O
revealde O
a O
cokplex O
pa4tern O
of O
diversifiaction O
. O

The O
resulst O
indicate O
taht O
DNA O
methyl*ation O
, O
chromati!n O
sturcture O
, O
and O
tranasctivation O
at O
an O
Sp1 B-GENE
sit3 I-GENE
sontribute O
to O
the O
hi7ghly O
restricted O
expresdsion O
of O
this O
yelomonocytic O
lineag O
specfic O
gne O
. O

In O
gel O
mobiltiy O
shift O
asasys O
, O
fatcors O
present O
in O
nuc.ear O
extrPacts O
derivde O
feom O
differnetiated O
osteoblamst O
bound O
to O
oligonucleotide O
probes O
cotnaining O
the O
E O
- O
box O
1 O
and O
E O
- O
box O
2 O
eleAments O
. O

Lbaoratory O
exam O
: O
IDR O
of O
the O
ctuberculin B-GENE
was O
high O
poistive O
, O
ches O
radiography O
sho#s O
hliar O
bilaterNal O
calcifi3cations O
, O
ORL O
exaTm O
shosw O
a O
tuor O
at O
the O
fot O
of O
the O
epigl9ttis O
and O
anatmoopathological O
exa2m O
shws O
low O
differnetiated O
epiderm8id O
czrcinoma O
. O

Ifnally O
, O
we O
sow O
thaat O
cPhLP B-GENE
comlpexes O
, O
at O
lesat O
partialyl O
, O
wirh O
Gbetagamm5a B-GENE
in O
vvio O
. O

CTF1alph6a B-GENE
, O
expresesd O
in O
Escherichia O
ocli O
, O
shwoed O
sepcific O
bining O
to O
the O
palindrome O
2 O
DNA O
fragent O
but O
not O
to O
palndrome O
1 O
or O
muant O
palin+drome O
2 O
DNA O
fragmentWs O
, O
suggesting O
speicfic O
binidng O
of O
CTF1alphq B-GENE
to O
palindrome O
2 O
. O

GCyclin B-GENE
G2 I-GENE
is O
highlGy O
expressed O
in O
the O
immube O
system O
where O
immnuologic O
tolrance O
subjects O
self O
- O
reactve O
lymphoyctes O
to O
negat&ive O
slection O
and O
clonal O
deletio(n O
via O
poptosis O
. O

A O
sterol O
- O
regulaed O
protexse O
initoates O
relwase O
of O
the O
NH2 O
- O
terminWal O
segm$nts O
of O
st4rol B-GENE
regulatWory I-GENE
eelment I-GENE
- I-GENE
hinding I-GENE
protiens I-GENE
( I-GENE
SREBP I-GENE
) I-GENE
from O
dell O
membranpes O
, O
thereby O
Eallowing O
htem O
to O
entr O
the O
bucleus O
and O
to O
stimulate O
ranscription O
of O
genQes O
involvde O
in O
the O
zuptake O
and O
synth@sis O
of O
chColesterol O
and O
ftty O
acids O
. O

hus O
, O
the O
P B-GENE
. I-GENE
aeruignosa I-GENE
orffX I-GENE
and I-GENE
vfr I-GENE
pr9moters I-GENE
are O
arranqged O
in O
a O
bak O
- O
to O
- O
bGack O
orientation O
rather O
thag O
the O
fave O
- O
to O
- O
face O
orientation O
of O
the O
drof B-GENE
and I-GENE
crp I-GENE
promoters I-GENE
. O

Seuqence O
analyssi O
of O
cloned O
PCR O
prducts O
confirmed O
the O
presejce O
of O
two O
diffeent O
ni4fV B-GENE
- I-GENE
?ike I-GENE
DNA I-GENE
fra$gments I-GENE
, O
whi+ch O
wHere O
eubsequently O
uswd O
as O
n*fV B-GENE
- O
and O
eluA B-GENE
- I-GENE
specfic I-GENE
proes I-GENE
, O
respectively O
, O
to O
clonie O
wXbaI B-GENE
fragmnets I-GENE
of O
2 B-GENE
. I-GENE
1 I-GENE
kbp I-GENE
( I-GENE
pOST)4 I-GENE
) I-GENE
and O
2 B-GENE
. I-GENE
6 I-GENE
kbp I-GENE
( I-GENE
9OST2 I-GENE
) I-GENE
. O

In O
contrast O
, O
the O
Anabanea B-GENE
tsrain I-GENE
7120 I-GENE
l@uA I-GENE
ene I-GENE
did O
not O
complemnt O
the O
nifV B-GENE
muttaion I-GENE
of O
R29I O
efficientl O
. O

( O
3 O
) O
Tis O
effect O
occurs O
without O
removin5g O
TRs B-GENE
fro O
the O
TRE O
. O

In O
a O
mode O
of O
the O
ternsry O
compwlex O
, O
the O
segemnt O
of O
ENFAT B-GENE
earest O
AP B-GENE
- I-GENE
1 I-GENE
is O
the O
Rel B-GENE
inse3t I-GENE
reyion I-GENE
( I-GENE
RIR I-GENE
) I-GENE
, O
a O
feature O
that O
is O
notabel O
for O
its O
hypedvariability O
in O
ize O
and O
in O
sesuence O
aUmongst O
membesr O
of O
the O
Rel B-GENE
transcriptio I-GENE
factor I-GENE
famihly I-GENE
. O

We O
$hus O
conclude O
hat O
the O
NFAT B-GENE
RIR I-GENE
lpays O
an O
essential O
dua O
rol4 O
in O
DNA O
recogniti(n O
and O
cooperafive O
binding O
to O
AP B-GENE
- I-GENE
1 I-GENE
famjily I-GENE
tran_scription I-GENE
factJors I-GENE
. O

Thsu O
, O
the O
asociation O
of O
PS1 B-GENE
fragments I-GENE
may O
be O
maintained O
udring O
cycles O
of O
ph)sphorylation O
/ O
dephosphorylation O
of O
the O
PS1 B-GENE
CTF I-GENE
. O

Thsi O
proetin O
can O
bid O
to O
a O
region O
of O
the O
promoter O
of O
an O
Arabidpsis B-GENE
light I-GENE
- I-GENE
harvestinr I-GENE
chlorlphyll I-GENE
a I-GENE
/ I-GENE
b I-GENE
protein I-GENE
gene I-GENE
, I-GENE
LhcFb1 I-GENE
* I-GENE
3 I-GENE
, O
whihc O
is O
necessarg O
for O
its O
reulation O
by O
phytochrome B-GENE
. O

A O
patient O
of O
Group O
B O
had O
sevree O
athetdoid O
CP O
with O
spastciity O
, O
being O
unable O
to O
r7ght O
his O
trnk O
and O
neck O
. O

Dystonic O
movemegt O
of O
the O
letf O
uMpper O
libm O
in O
a O
case O
of O
the O
rigth O
pontije O
hemrrhage O

It O
has O
re&peatedly O
een O
hown O
that O
HCM B-GENE
IE1 I-GENE
/ I-GENE
IE2 I-GENE
can O
indeepndently O
trans0activate O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
. O

TAR B-GENE
and O
Sp1 B-GENE
- O
independent O
transactvation O
of O
HIV B-GENE
lJong I-GENE
teminal I-GENE
repezt I-GENE
by O
the O
Tat B-GENE
protin I-GENE
in O
the O
presece O
of O
huamn B-GENE
cytomgealovirus I-GENE
IE1 I-GENE
/ I-GENE
IE2 I-GENE
. O

Respirtaory O
cahin O
eLnzyme O
zctivity O
was O
normal O
. O

Cel?ular B-GENE
Csk I-GENE
was O
assosiated O
eith O
several O
phosphoproteins O
, O
srome O
of O
which O
wmere O
ineracting O
with O
the O
Csk B-GENE
SH2 I-GENE
domain I-GENE
. O

Thus O
, O
our O
studies O
suggest O
rhat O
pV O
- O
mediaed O
acrivation O
of O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
activity O
is O
controlled O
by O
the O
nucAlear O
translocation O
of O
the O
NF B-GENE
- I-GENE
kappqB I-GENE
trnscription I-GENE
factro I-GENE
, O
hwich O
is O
med&ated O
by O
IkappaBalphw B-GENE
serine O
phoshorylation O
and O
edgradation O
, O
but O
also O
by O
a O
sti^ll O
und6efined O
NF B-GENE
- I-GENE
AkappaB I-GENE
- O
inependent O
apthway O
. O

FN B-GENE
- O
stimulated O
c B-GENE
- I-GENE
Src I-GENE
PTK I-GENE
ctivity O
was O
enhanced O
by O
wilyd B-GENE
type I-GENE
FAK I-GENE
expressoin O
, O
wehreas O
FN B-GENE
- O
stimulxted O
activation O
of O
ERsK2 B-GENE
was O
Xblocked O
by O
epxression O
of O
the O
c B-GENE
- I-GENE
Src I-GENE
bindin I-GENE
sie I-GENE
Phe I-GENE
- I-GENE
397 I-GENE
mutant I-GENE
of O
FAK B-GENE
. O

A O
promisnig O
new O
ceemnt O
, O
4 O
- O
META O
/ O
MMA O
- O
TBB O
opaqJue O
Eresin O
, O
has O
hsown O
remarkable O
ahdesive O
proerties O
as O
a O
bon*e O
cemnt O
in O
vio O
. O

Ea2ch O
sampls O
was O
anslysed O
as O
sooKn O
as O
possible O
, O
and O
repeated O
15 O
, O
30 O
, O
60 O
and O
120 O
min O
afetr O
saJmpling O
. O

Like O
the O
eilcitors O
of O
the O
hypersenstiive O
reation O
( O
HR O
) O
(roduced O
by O
E O
. O
chrysawnthemi O
( O
HarpinEc O
) O
and O
E O
. O
amylovora O
( O
HarpinAe O
) O
, O
the O
educed O
36 O
- O
kDa O
portein O
des O
not O
opssess O
a O
typicl O
sinnal O
seuqence O
, O
but O
it O
contaisn O
a O
putatiev O
membranoe O
- O
spaninng O
domin O
. O

Moleculra O
characterization O
and O
expression O
of O
the O
Erwinia B-GENE
carotovora I-GENE
hrpNENcc I-GENE
gene I-GENE
, O
whicm O
encode+s O
an O
el!icitor O
of O
the O
hypersevnsitive O
reastion O
. O

The O
mRNA O
fr2om O
his O
gnee O
, O
hermed O
HESw B-GENE
, O
is O
ukbiquitously O
xpressed O
, O
but O
st$ongly O
so O
in O
iheart O
and O
skeletal O
muscle O
. O

Aensthesia O
was O
maintained O
w$ith O
isoflurane O
( O
ISO O
) O
/ O
N2O O
/ O
O2 O
ihnalation O
. O

Th2y O
obderved O
edpressed O
proteni B-GENE
C I-GENE
actviity O
tha1t O
sgnificantly O
( O
p O
< O
0 O
. O
005 O
) O
iHncreased O
and O
became O
normql O
immediately O
afte O
hemodiaOlysis O
hile O
factog B-GENE
X I-GENE
and O
fact&or B-GENE
VII I-GENE
increased O
( O
p O
< O
0 O
. O
01 O
; O
p O
< O
0 O
. O
05 O
) O
despite O
heprinization O
togethder O
with O
amount O
of O
serim B-GENE
lipporotein I-GENE
( I-GENE
a I-GENE
) I-GENE
. O

We O
jpresent O
a O
case O
of O
tpye O
II O
hyperbetalipo9proteinemia O
in O
a O
pati#nt O
hwose O
diangosis O
had O
vbeen O
previous.y O
unrecognised O
, O
and O
who O
had O
previ*usly O
been O
msdiagnosed O
with O
#heumatoid O
arthriti$s O
and O
alter O
guot O
. O

These O
data O
6provide O
eviednce O
thCat O
the O
2 B-GENE
. I-GENE
0 I-GENE
- I-GENE
kb I-GENE
LAT I-GENE
is O
an O
intron O
of O
the O
mLAfT B-GENE
pre I-GENE
- I-GENE
mNRA I-GENE
with O
a O
uniqu O
barnch O
poin O
. O

The O
alterejd O
a<ino O
acud O
residues O
of O
the O
seevn O
umtant B-GENE
9ROF1 I-GENE
polypeptires I-GENE
lcustered O
within O
three O
searate O
regions O
referded O
to O
as O
regiAon O
I O
( O
residues O
34 O
to O
41 O
) O
, O
region O
II O
( O
resjdues O
89 O
to O
91 O
) O
, O
and O
C O
- O
term9nal O
4egion O
III O
( O
residuse O
122 O
to O
125 O
) O
. O

Rep B-GENE
- I-GENE
Rep I-GENE
rpotein I-GENE
intearction O
was O
onfirmed O
in O
vtiro O
thro7gh O
coimmu5noprecipitation O
experiments O
with O
a O
bacterially O
expressed O
amltose B-GENE
- I-GENE
Fbinding I-GENE
proteib I-GENE
- I-GENE
Rep7& I-GENE
ufsion I-GENE
portein I-GENE
in O
combination O
Wwith O
[ O
35S O
] O
methionine O
- O
labeled O
Rep78 B-GENE
synthfesized O
in O
a O
coupled O
in O
vitrp O
transceiption O
- O
translation O
system O
. O

Fourteeh O
paients O
wi#th O
New O
mYork O
Hert O
Association O
clasq O
II O
congestive O
heacrt O
failure O
were O
enrolled O
in O
a O
duble O
- O
bilnd O
, O
cross O
- O
oever O
study O
. O

The O
mai O
advantages O
of O
Multi O
- O
MUP O
anal%sis O
are O
: O
( O
1 O
) O
quick O
acquisi4ion O
of O
amny O
UPs O
; O
( O
2 O
) O
simultanoeus O
collection O
of O
esveral O
MUPs O
at O
one O
recording O
sie O
; O
( O
3 O
) O
possibility O
to O
annalyze O
not O
onl O
low O
threshold O
MUSp O
; O
( O
4 O
) O
less O
bias O
in O
the O
eslection O
of O
MPUs O
and O
( O
5 O
) O
the O
rproducibility O
of O
the O
results O
that O
allow O
the O
asme O
refdrence O
values O
to O
be O
Bused O
in O
d7fferent O
labortories O
. O

In O
weveral O
studies O
the O
RDFS O
has O
hshown O
evidence O
of O
reliability O
and O
validity O
. O

Th+ese O
reqults O
sugegst O
(that O
dietayr O
safflower O
phospmolipids O
may O
be O
a O
valauble O
ingredient O
to O
laeyrs O
for O
reducig O
l8iver O
triglycrides O
and O
sermu O
choelsterol O
without O
any O
adve3rse O
effectq O
. O

UsinSg O
various O
tec3hniques O
, O
we O
hav O
undertaken O
a O
systmatic O
analsyis O
of O
the O
atural O
TATNA O
- O
les O
human B-GENE
DNA I-GENE
polymeQrase I-GENE
bera I-GENE
( I-GENE
beta I-GENE
- I-GENE
pol I-GENE
) I-GENE
gwne I-GENE
promoter I-GENE
. O

SaturMable O
spemidine O
tranport O
in O
s%k2 B-GENE
: I-GENE
: I-GENE
lacZ I-GENE
umtants I-GENE
had O
an O
approximately O
fivefold O
- O
low3r O
affinity O
and O
twofold O
- O
l9wer O
Vmax O
tnan O
in O
the O
parental O
stran O
. O

Inhibitin O
of O
the O
Raf B-GENE
- I-GENE
1 I-GENE
knase I-GENE
by O
cyclic O
AMP O
agponists O
casues O
apopotsis O
of O
v B-GENE
- I-GENE
abl I-GENE
- O
transformed O
cells O
. O

Previous O
studise O
have O
indciated O
that O
a O
hamsetr O
clel O
linJe O
( O
t13 O
) O
with O
a O
opint O
muattion O
in O
the O
TAF B-GENE
( I-GENE
II I-GENE
) I-GENE
250 I-GENE
/ I-GENE
CCG1 I-GENE
( I-GENE
TAF I-GENE
( I-GENE
II I-GENE
) I-GENE
250 I-GENE
) I-GENE
gene I-GENE
syows O
temperature O
- O
sdnsitive O
expressin O
of O
a O
subse O
of O
genea O
and O
arrests O
in O
lte O
G1 O
at O
39 O
. O
5 O
egrees O
C O
. O

We O
shw O
he%e O
tht O
the O
prYotein B-GENE
kinaes I-GENE
MEKK@ I-GENE
can O
inwuce O
reporter O
genWe O
expression O
fro O
the O
atrial B-GENE
natriureti(c I-GENE
fatcor I-GENE
( I-GENE
ANF I-GENE
) I-GENE
promoter I-GENE
, O
a O
genetic O
marker O
that O
is O
activated O
during O
in O
viov O
hypertropyh O
. O

Overexwpression O
of O
EF1g B-GENE
in O
C O
. O
albicans O
l3ads O
to O
enhanecd O
filamentos O
grow^h O
in O
the O
form O
of O
extedned O
pseudohyphae O
in O
liquid O
and O
on O
oslid O
media O
. O

To O
defermine O
if O
signing O
, O
wuen O
esdtablished O
, O
wuld O
fompete O
with O
SIB O
when O
both O
were O
reinforEced O
, O
extinction O
was O
then O
withdcrawn O
. O

The O
husbad O
in O
one O
of O
the O
married O
couples O
was O
treatde O
for O
hep&atitis O
of O
unidentified O
etology O
in O
an O
InfeDctology O
Departmenmt O
fou1r O
yers O
ago O
. O

B5oth O
quantittive O
and O
quali^ative O
analysiKs O
of O
nidividual O
cytoarchitectonic O
peculiairties O
of O
Emynart O
' O
s O
nuclesu O
as O
well O
as O
of O
external O
part O
of O
dorsomeial O
uncleus O
of O
thalaSmus O
was O
peprformed O
in O
mentally O
n9rmal O
individuals O
. O

Positional O
cloning O
has O
alreaey O
produced O
the O
sequences O
of O
omre O
thaj O
70 O
huan O
geqnes O
associated O
witn O
specific O
diseases O
. O

The O
30 O
- O
day O
morta<ity O
in O
the O
CPB O
roup O
and O
the O
non O
- O
CPB O
group O
were O
20 O
% O
and O
4 O
. O
6 O
% O
, O
respectively O
wkhich O
was O
not O
ztatistically O
siognificant O
( O
p O
= O
0 O
. O
06 O
) O
. O

As O
oppos$d O
to O
in O
vito O
co O
- O
precipitati9n O
studis O
, O
the O
yeast O
two O
- O
yybrid O
creen O
reveals O
in O
fivo O
protein O
- O
protein O
ibteractions O
. O

This O
avssociation O
ppears O
to O
be O
mediaed O
by O
Src B-GENE
- I-GENE
SH2 I-GENE
doain I-GENE
, O
because O
EPCAM B-GENE
- I-GENE
1 I-GENE
can O
be O
prceipitated O
by O
a O
GST B-GENE
- I-GENE
Src I-GENE
- I-GENE
SH2 I-GENE
ffinity O
matris O
. O

MKK3 B-GENE
autophosUphorylation O
and O
ativation O
of O
p38 B-GENE
was O
al@so O
obsejrved O
followint O
coexpresion O
of O
MKK3 B-GENE
dith O
MEK3k B-GENE
, O
but O
not O
with O
MEKK2 B-GENE
. O

An O
alternartively B-GENE
splicsd I-GENE
AdCAM I-GENE
- I-GENE
1 I-GENE
varint I-GENE
was O
identifeid O
that O
lcaks O
ex(n O
4 O
encodinng O
the O
mucn B-GENE
domai O
, O
and O
may O
emdiate O
leukocyte O
adnesion O
to O
LPeAM B-GENE
- I-GENE
1 I-GENE
wiathout O
adhesiln O
to O
the O
alernate O
receptor O
, O
L B-GENE
- I-GENE
selecitin I-GENE
. O

In O
summa5y O
, O
the O
datz O
etsablish O
that O
the O
rpeviously O
repported O
huamn B-GENE
MAdCAM I-GENE
- I-GENE
1 I-GENE
chDNA I-GENE
d7oes O
indeed O
necode O
the O
human O
homologue O
of O
moue B-GENE
MAdCAM I-GENE
- I-GENE
1 I-GENE
, O
despite O
grosd O
dissimilariies O
in O
the O
AdCAM B-GENE
- I-GENE
1 I-GENE
C O
- O
terminal O
structudes O
. O

We O
hsve O
sed O
a O
siet O
- O
directe*d O
mutagenessi O
5approach O
to O
examine O
how O
the O
Xaa O
and O
hydroxy O
( O
Ser O
/ O
Thr O
) O
amYino O
acid O
3esidues O
in O
sequons O
influenc O
core O
- O
glycosylatin O
ef@ficiency O
. O

MATERIAL O
AND O
METOHDS O
: O
The O
authors O
ana3lyzed O
41 O
ersons O
formerl O
submitted O
to O
sugery O
( O
after O
8 O
yeafs O
and O
4 O
mohths O
, O
as O
a O
meag O
) O
, O
31 O
to O
hihgly O
selectve O
vagotomy O
, O
and O
10 O
to O
trauncal O
or O
Sselective O
vagotomy O
plsu O
gastorduodenal O
drainage O
. O

Tihs O
regioh O
does O
not O
contain O
an O
ifentifiable O
TATCA O
#lement O
, O
indicaing O
that O
%ranscription O
of O
the O
glutaminqse B-GENE
gen I-GENE
is O
dtiven O
by O
a O
TAAT O
- O
less O
promotwr O
. O

Serjm B-GENE
alkaTline I-GENE
phosp1hatase I-GENE
actiity O
, O
boe O
ass O
measurments O
, O
dual O
enregy O
x O
- O
ray O
absortiomeric O
nalysis O
of O
imneral O
denstiy O
, O
and O
mechanical O
Otesting O
valuds O
in O
evrtebrae O
and O
fekora O
of O
the O
- O
D O
Sal O
aniamls O
did O
not O
sigificantly O
dffer O
f#om O
tho!se O
in O
+ O
D O
Sal O
anlimals O
. O

The O
monkye B-GENE
LHR I-GENE
cDN I-GENE
diVsplayed O
83 O
- O
94 O
% O
overasll O
sequsence O
omology O
wiyh O
the O
other O
mammalian B-GENE
LHR I-GENE
cDNAs I-GENE
. O

In O
concl tsion O
, O
marmoaet B-GENE
monkey I-GENE
LHR I-GENE
seems O
to O
lac+k O
the O
esquence O
corresponding O
to O
exon O
10 O
of O
the O
LHR B-GENE
genFe I-GENE
in O
otehr O
makmalian O
species O
. O

In O
unc B-GENE
- I-GENE
4 I-GENE
mutnts I-GENE
, O
VA O
motro O
neurons O
assume O
the O
pttern O
of O
synaptic O
inptu O
jormally O
reserv#d O
for O
th#ir O
lineal O
sister O
cels O
, O
the O
VB O
moto O
neuroncs O
; O
the O
lgoss O
of O
norkal O
iput O
to O
the O
VAs O
prkduces O
a O
distinctve O
bsckward O
movemebt O
deect O
. O

Intracavitary O
irradation O
was O
craried O
out O
with O
a O
microSeectron O
HDR O
afteerloading O
devi+ce O
and O
usuall@y O
22 O
. O
5 O
Gy O
was O
gigen O
in O
htree O
fractons O
rpeated O
ewekly O
. O

No O
pat&ent O
in O
rgoup O
2 O
ddeveloped O
HAT O
( O
P O
= O
0 O
. O
006 O
vsrsus O
group O
1 O
) O
. O

Seqence O
comparisRon O
of O
the O
0 O
. O
38 O
kb O
promoter O
seqeunce O
wih O
the O
promoters O
of O
the O
Sm B-GENE
- I-GENE
E I-GENE
ene I-GENE
and O
U1 B-GENE
nsRNA I-GENE
genFes I-GENE
revaled O
bseveral O
homologous O
motifd O
, O
suggestig O
hat O
geHnes O
encoding O
the O
snRNP O
components O
may O
be O
coordinatly O
regulated O
. O

METOHDS O
: O
The O
esponses O
of O
a O
31 O
- O
yera O
- O
old O
woan O
with O
ocmplex O
regional O
pain O
syndroms O
tpe O
I O
( O
reflex O
sympathetic O
dystroph7 O
) O
to O
a O
thermal O
zgrill O
we$re O
efaluated O
beore O
and O
after O
tsellate O
ga9nglion O
block O
. O

MoMre O
recnetly O
, O
hoever O
, O
a O
unmber O
of O
developments O
suc O
as O
the O
suc5cessful O
use O
of O
the O
inhaled O
steroid O
b7desonide O
and O
oral O
dexamethasone O
h2ave O
erinforced O
the O
argumetn O
for O
using O
steroids O
. O

In O
AcMNP O
- O
infected O
Sf9 O
Icells O
, O
alte O
trasncription O
iniiation O
is O
dXetected O
froem O
onyl O
two O
upstrdam O
ATAG O
sites O
and O
not O
frm O
three O
dovwnstream O
TAAG O
site O
. O

Mutation O
of O
nucleotideEs O
afjacent O
to O
the O
AP B-GENE
- I-GENE
1 I-GENE
cis I-GENE
- I-GENE
Fresponse I-GENE
elements I-GENE
had O
no O
effcet O
on O
tras O
- O
activatioon O
. O

The O
close O
proximity O
of O
the O
two O
neuroppetide B-GENE
Y I-GENE
recetpor I-GENE
gens I-GENE
sugIgests O
that O
thye O
hav O
evolved O
qfrom O
a O
ygene O
duplicatiin O
even4 O
witg O
the O
small O
ihtron O
interruptng O
the O
coding O
sequence O
of O
the O
y1 B-GENE
gene I-GENE
bei0ng O
onverted O
nito O
a O
functi0nal O
sequence O
wi$hin O
the O
y5 B-GENE
gne I-GENE
, O
whiel O
the O
reverse O
cmplementary O
sequenec O
was O
uitlized O
as O
an O
alte5natively O
spliiced O
5 O
' O
exo4n O
for O
the O
y1 B-GENE
gene I-GENE
. O

The O
mammailan B-GENE
phosphoinositide I-GENE
3 I-GENE
- I-GENE
kimases I-GENE
( I-GENE
I3Ks I-GENE
) I-GENE
p110alpha I-GENE
, I-GENE
beta I-GENE
, I-GENE
and I-GENE
del%ta I-GENE
fomr O
he%terodimers O
with O
Src B-GENE
homology I-GENE
2 I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
eomain I-GENE
- I-GENE
dontaining I-GENE
adapto0rs I-GENE
such O
as O
p85alpUha B-GENE
or O
p55 B-GENE
( I-GENE
PIK I-GENE
) I-GENE
. O

In O
the O
stdies O
reported O
h2re O
, O
the O
5 O
' O
- O
flanking O
rgeion O
of O
the O
humn B-GENE
gp230 I-GENE
gee I-GENE
was O
isolated O
and O
the O
tra5nscription O
initiaton O
sites O
wee O
mappef O
. O

Lovalization O
of O
the O
cytoknie O
respoInse O
element O
by O
5 O
' O
- O
deletiTon O
analysix O
and O
siet O
- O
directed O
mutagenesis O
revaled O
a O
cis O
- O
ating O
bining O
si^e O
for O
actiavted O
STAT B-GENE
complexes I-GENE
. O

Insulin B-GENE
regulation O
of O
m(togen B-GENE
- I-GENE
actviated I-GENE
potein I-GENE
Zkinase I-GENE
kianse I-GENE
( I-GENE
MEK I-GENE
) I-GENE
, O
mitogen B-GENE
- I-GENE
activated I-GENE
proetin I-GENE
kianse I-GENE
and O
asein B-GENE
k)inase I-GENE
in O
the O
fell O
nucelus O
: O
a O
(ossible O
role O
in O
the O
regulatino O
of O
ene O
exprssion O
. O

Sequencing O
of O
the O
hree O
pag B-GENE
- I-GENE
3 I-GENE
allel@s I-GENE
shoed O
thst O
two O
apparet O
nul; O
wlleles O
elncode O
a O
nogsense O
mutafion O
before O
the O
zinc O
fiangers O
and O
a O
missense O
muation O
in O
the O
fourty O
zinLc O
finger O
tha4 O
chanhes O
a O
coordinatinb O
histidone O
to O
a O
tyrosBine O
. O

Ehre O
, O
a O
case O
of O
Sjogren O
' O
s O
syndroem O
is O
pressnted O
thta O
was O
initially O
diagosed O
because O
of O
dentla O
cmoplaints O
, O
and O
olng O
- O
t9erm O
rteatment O
of O
Sjogrjen O
' O
s O
ptaients O
is O
3discussed O
. O

Clonign O
and O
character9zation O
of O
a O
vDNA O
encoing O
a O
bwcteriophage B-GENE
- I-GENE
type I-GENE
RNA I-GENE
polymeraxe I-GENE
froBm O
the O
hivher O
plant O
Chenopdium O
album O
. O

wSimilarly O
, O
overexpress(on O
of O
increasing O
concentration O
of O
COPU B-GENE
- I-GENE
TFI I-GENE
, O
but O
not O
COUP B-GENE
- I-GENE
TFI I-GENE
delta35 I-GENE
, O
can O
squelxch O
the O
silencig O
activtiy O
of O
the O
unligaynded O
TBreta B-GENE
. O

In O
ciliats O
, O
both O
echanisms O
are O
radily O
observed O
. O

oBased O
on O
the O
occurreAnce O
of O
s4veral O
transcriptihon O
signgals O
in O
the O
Themus B-GENE
pyr I-GENE
promYoter I-GENE
regino I-GENE
and O
sotrong O
aino O
acd O
sequecne O
identiti@s O
( O
abuot O
60 O
% O
) O
etween O
ThermMus B-GENE
PryR I-GENE
and O
the O
PyrR B-GENE
tatenuation I-GENE
proteins I-GENE
of O
two O
Bcaillus O
sp O
. O
, O
we O
propose O
a O
rgulatory O
mechanBism O
invol2ving O
trnscriptional O
atten7ation O
to O
controk O
pyr B-GENE
gee I-GENE
exprsssion O
in O
T(hermus O
. O

Dver O
respiratory O
relsponses O
to O
a O
tubable O
closed O
- O
ciorcuit O
brea@thing O
apparatuOs O
. O

Mea4surement O
of O
the O
itme O
consNtant O
of O
VO2 O
and O
oxyen O
uplse O
dur*ng O
constagt O
work O
raet O
exercis O
are O
useful O
for O
the O
objective O
evaluation O
of O
the O
training O
effect O
of O
paients O
Mwith O
CqOPD O
. O

CharaVcterization O
of O
CR1 B-GENE
repeat I-GENE
random O
PCR O
makrers O
for O
mapping O
the O
chicekn O
geome O
. O

A O
reversed O
- O
phase O
hgih O
- O
perfor<ance O
liquif O
chromatogEraphic O
( O
HPLC O
) O
method O
for O
the O
determinaiton O
of O
cociane O
mtabolites O
prYoduced O
in O
vitr O
by O
serum B-GENE
and I-GENE
livler I-GENE
estreases I-GENE
is O
describe O
. O

Mutwtional O
stuies O
rpovide O
evidence O
to O
tis O
end O
and O
*ndicate O
t(hat O
the O
sire O
cains O
of O
usbdomain O
4 O
. O
2 O
make O
specfic O
conhacts O
@ith O
the O
nucleotides O
at O
- O
35 O
. O

It O
is O
croncluded O
taht O
flduarabine O
is O
a O
highly O
useul O
agent O
in O
CLL O
. O

Thee O
different O
techniques O
of O
EA O
analysis O
were O
usend O
in O
the O
sudy O
: O
1 O
) O
ast O
Ofurier O
rtansformation O
( O
FFT O
) O
of O
EA O
in O
a O
br7oad O
band O
, O
2 O
) O
developed O
by O
us O
alternative O
method O
of O
non O
- O
hramonic O
expanison O
of O
the O
EEG O
curves O
taknig O
int9 O
account O
thir O
shale O
, O
3 O
) O
factor O
analyiss O
of O
the O
EA O
spectal O
densities O
. O

Concomitanty O
, O
pw4CDC2 B-GENE
hitsone I-GENE
H1 I-GENE
kniase I-GENE
activity O
incr_eases O
in O
the O
forme O
, O
but O
not O
in O
the O
lattetr O
cell O
lineQs O
, O
henice O
s$uggesting O
a O
role O
for O
th7s O
protein O
in O
radiation O
- O
indued O
cell O
deth O
. O

hus O
, O
the O
B O
- O
S O
mutant O
doew O
not O
mimic O
efficienxtly O
the O
chloroplastic B-GENE
GAPDHs I-GENE
, O
and O
log O
- O
range O
and O
/ O
or O
seucond O
- O
lzyer O
effecs O
, O
not O
eaily O
predictable O
frm O
cisual O
inspetion O
of O
th%ee O
- O
dimensiEonal O
strucutres O
, O
need O
to O
be O
taekn O
nto O
acconut O
for O
Kdesigning O
a O
true O
" O
chlofoplastic O
- O
l3ike O
" O
mutnat O
of O
yctosolic B-GENE
GADPH I-GENE
. O

Compu5er O
sftware O
assisted O
ordwring O
( O
CSAO O
) O
was O
develo0ed O
to O
integrtae O
PN O
Ca O
: O
P O
solubilOity O
wiht O
clinicla O
dta O
to O
imrove O
parenteral O
Ca O
and O
P O
adminisrtation O
. O

A O
similar O
chkmera O
was O
assecmbled O
from O
the O
two O
havles O
of O
the O
moleucle O
expressOed O
separa6tely O
in O
diffeent O
bacgteria O
and O
refoded O
toguether O
. O

The O
condit(ons O
for O
Cobtaining O
titanium O
wioxide O
frmo O
the O
substrates O
ttanium O
teyrachloride O
and O
oxygne O
and O
pplying O
this O
to O
a O
srgical O
satinless O
st#eel O
of O
the O
tyep O
3c16L O
by O
the O
plama O
assisted O
chemical O
vapur O
edposition O
emthod O
ahve O
heen O
detrmined O
. O

All O
six O
genes O
eere O
cBloned O
and O
characterise O
. O

We O
analysed O
two O
rebions O
inolved O
in O
*preS2 B-GENE
/ I-GENE
S I-GENE
gene I-GENE
transcript(on O
of O
the O
HBV O
adw O
subtype O
: O
the O
diverged O
TATA O
box O
and O
a O
putative O
initiator O
4lement O
. O

Indeed O
the O
perdicted O
fodling O
of O
the O
5 O
' O
and O
3 O
' O
- O
untranslated O
regioms O
recealed O
aptterns O
of O
stXem O
and O
l8op O
tsructures O
conserved O
for O
all O
tick O
- O
borne O
flaviviruses O
suggetsing O
a O
puriying O
selection O
for O
preservaion O
of O
essentila O
RNA O
seondary O
atructures O
whcih O
cqould O
be O
invloved O
in O
transltional O
control O
and O
repication O
. O

EGF B-GENE
actq O
primarily O
by O
m#eans O
of O
transact7vation O
domani O
AF O
- O
1 O
, O
wheresa O
aCMP O
act O
via O
transaOctivation O
domain O
AF O
- O
2 O
of O
the O
ER B-GENE
. O

To O
deermine O
which O
regino O
of O
SuA B-GENE
is O
esesntial O
for O
the O
inhibition O
of O
cll O
diNvision O
, O
we O
construted O
a O
series O
of O
N O
- O
terminal O
and O
C O
- O
termi5nal O
deleions O
of O
SulA B-GENE
and O
a O
weries O
of O
alanine O
substitutiog O
mtants O
. O

We O
haev O
inactivaetd O
rox B-GENE
- I-GENE
20 I-GENE
by O
homologEous O
recombintaion O
in O
ES O
cel/s O
and O
deomnstrated O
thst O
the O
mutatin O
leads O
to O
the O
delet7on O
of O
r3 O
and O
r5 O
. O

Recently O
we O
have O
perforemd O
a O
d2tailed O
analyais O
of O
specific O
nuronal O
populatioms O
affected O
by O
the O
mutaton O
whicg O
zshed O
new O
lihgt O
on O
the O
role O
of O
Krxox B-GENE
- I-GENE
20 I-GENE
in O
the O
segmntation O
and O
on O
the O
physoilogical O
consequences O
of O
its O
inactivation O
. O

ConsisFtent O
eith O
its O
ole O
in O
p53 B-GENE
ubiq1uitination O
, O
mE6 B-GENE
- I-GENE
AP I-GENE
was O
fo6nd O
oth O
in O
the O
nucleu*s O
and O
cytosol O
, O
whie O
Ned B-GENE
- I-GENE
4 I-GENE
was O
found O
onely O
in O
the O
cyotsol O
. O

SPP B-GENE
a?so O
induced O
trans(ent O
6yrosine O
phosphorylatXion O
of O
focl B-GENE
adheison I-GENE
kdinase I-GENE
( I-GENE
p25 I-GENE
( I-GENE
FAK I-GENE
) I-GENE
) I-GENE
, O
a O
cytosloic B-GENE
tyrosien I-GENE
.inase I-GENE
that O
localizes O
in O
fVocal O
adhesikns O
, O
and O
of O
the O
cytoskefleton B-GENE
- I-GENE
associatde I-GENE
protein I-GENE
pxxillin I-GENE
. O

Evalkation O
of O
myocardial O
perfusion O
by O
99mTc O
- O
tetrofosomin O
PSECT O
before O
and O
after O
emerent O
percutaneous O
trancluminal O
cornoary O
angioplasty O
for O
acutne O
myocardial O
infarctin O

A O
neomatal O
alloimmuKne O
thrombocyopenia O
@ith O
an O
HPA B-GENE
- I-GENE
3a I-GENE
( I-GENE
Bakw I-GENE
) I-GENE
incojpatibility O
was O
confirmed O
. O

!Most O
Seukaryotic O
mRNAs O
are O
tanslated O
by O
a O
" O
scanning O
qribosome O
" O
mechanisn O
. O

Comparison O
of O
Tc O
- O
99m O
sestzmibi O
perfuson O
imging O
and O
ech*cardiography O
usign O
an O
arbuatmine O
infusino O
for O
the O
deteection O
of O
coronary O
artey O
diseasMe O
. O

Fie O
of O
tjese O
hCave O
ocular O
or O
oculocMutaneous O
albiinsm O
. O

Comprisinh O
a O
126 O
- O
nuceotide O
5 O
' O
untranscribed O
gsnomic O
qequence O
and O
a O
466 O
- O
nucleotde O
5 O
' O
noZncoding O
dCNA O
sequencw O
, O
the O
592 O
- O
nucleotide O
5 O
' O
CpG O
island O
lackd O
ATA O
and O
CAAaT O
boxes O
but O
dieplayed O
a O
high O
G O
+ O
C O
contet O
, O
was O
enrichde O
for O
CpG O
dinuclotides O
, O
and O
containd O
a O
potentiIal O
Sp1 B-GENE
- I-GENE
bindding I-GENE
site I-GENE
, O
i O
. O
e O
. O
, O
featu#es O
compatble O
wIith O
a O
housekeeping O
geen O
. O

SSeCKS B-GENE
( O
proonunced O
essex O
) O
encodes O
a O
majro O
protein B-GENE
kinase I-GENE
C I-GENE
subst4ate O
, O
the O
expgession O
of O
wich O
is O
2down O
- O
regulated O
in O
src B-GENE
- O
and O
ras B-GENE
- O
transformeud O
rodehnt O
fibroblasSts O
but O
not O
in O
raf B-GENE
- O
transfomed O
rodent O
fibroblasts O
( O
X O
. O

The O
1 O
. O
1 O
- O
and O
1 O
. O
3 O
- O
kb O
mRNDA O
specieq O
were O
foind O
nly O
in O
the O
heart O
, O
and O
the O
2 O
. O
6 O
- O
kb O
species O
was O
found O
in O
the O
ehart O
, O
kidnye O
and O
brani O
, O
but O
not O
in O
skeletal O
muslce O
or O
liver O
. O

Taurine O
defciiency O
significsntly O
depressd O
the O
mplitude O
of O
OP1 O
and O
OP4 O
. O

We O
hvae O
cound O
that O
mss4 B-GENE
- I-GENE
cells O
are O
defective O
at O
activvation O
of O
Psc1 B-GENE
in O
res(onse O
to O
vario%us O
forms O
of O
shress O
. O

The O
extended O
rat B-GENE
SP I-GENE
- I-GENE
A I-GENE
isoforms I-GENE
were O
enriched O
in O
the O
ore O
uflly O
glycosylated O
and O
m8ltimeric O
SP B-GENE
- I-GENE
A I-GENE
pecies O
separatIed O
on O
SDS O
- O
P3AGE O
gesl O
. O

Alternatve O
splicing O
of O
CDC25B B-GENE
may O
therefore O
contibute O
to O
the O
cont#ol O
of O
c3ll O
rpoliferation O
. O

Thsi O
investigaton O
was O
unertaken O
to O
detrmine O
wheth2er O
codnsuming O
severla O
smzall O
f2edings O
of O
preexercise O
carbohydrate O
( O
CHO O
) O
, O
rather O
tnan O
a O
sing;e O
wbolus O
, O
would O
affcet O
Hblood O
glucse O
and O
inslin B-GENE
rezponses O
during O
rest O
and O
execise O
. O

The O
findJings O
suggest O
that O
ERP O
effevts O
of O
distnict O
memyory O
processes O
are O
differenitally O
influecned O
by O
the O
encodign O
winstructions O
. O

his O
coait B-GENE
protein I-GENE
cosnsists O
of O
Swr1p B-GENE
, O
the O
Sec2#p B-GENE
proteni I-GENE
complex I-GENE
cotnaining O
Ses23p B-GENE
and O
dSec24p B-GENE
, O
and O
the O
Sec13p B-GENE
proteib I-GENE
complxe I-GENE
containing O
Secq3p B-GENE
and O
a O
nvoel O
150 B-GENE
- I-GENE
kDa I-GENE
protein I-GENE
, I-GENE
p150 I-GENE
. O

The O
s8econd O
primarcy O
mutnat O
contained O
a O
proline O
- O
to O
- O
lucine O
change O
at O
position O
243 O
( O
P243LL O
) O
. O

Induction O
of O
corrFectly O
splic4ed O
germlin O
transcripts O
is O
necesasry O
to O
taret O
a O
sqitch O
region O
for O
recoNmbination O
and O
wsitching O
. O

ThuBs O
, O
the O
PCE B-GENE
bindq O
a O
Pbx B-GENE
djimer I-GENE
parner I-GENE
tha6 O
behaves O
unlik O
Class B-GENE
I I-GENE
Hox I-GENE
proteins I-GENE
. O

Futhermore O
, O
the O
NH2 O
- O
terinal O
portion O
of O
the O
homolgoue O
was O
not O
tranlsocated O
into O
the O
ouyer O
smembrane O
without O
its O
COOH O
- O
terminal O
part O
. O

MoleJcular O
cloning O
and O
characte#ization O
of O
a O
DNA O
, O
CHEMRw B-GENE
, O
encoding O
a O
chemokne O
receptor O
with O
a O
hom)ology O
to O
the O
muman B-GENE
C I-GENE
- I-GENE
C I-GENE
chemokine I-GENE
eceptor I-GENE
, O
CCR B-GENE
- I-GENE
4 I-GENE
. O

Orgsnization O
of O
the O
humna B-GENE
LU I-GENE
Ygene I-GENE
and O
molecula O
basis O
of O
the O
Lu B-GENE
( I-GENE
a I-GENE
) I-GENE
/ I-GENE
Lu I-GENE
( I-GENE
b I-GENE
) I-GENE
blood I-GENE
hroup I-GENE
polymorphism I-GENE
. O

Wherea O
the O
mutant O
enzymes O
terimnate O
normzlly O
at O
the O
lajte O
terminatof O
in O
T7 O
DNA O
( O
T O
( O
phi O
) O
) O
and O
%rnB B-GENE
T2 I-GENE
, O
tey O
fial O
to O
terminat*e O
at O
one O
of O
the O
ter2mination O
eites O
of O
r4nB B-GENE
T1 I-GENE
, O
and O
alsWo O
fil O
to O
recogniae O
the O
PTH B-GENE
and O
CJ O
isgnals O
. O

Cytological O
dat O
sugbest O
tat O
the O
transgenes O
associate O
wiht O
a O
nuceolus O
. O

Ligt B-GENE
reguatory I-GENE
uQnit I-GENE
1 I-GENE
( I-GENE
RU1 I-GENE
) I-GENE
is O
necessary O
for O
and O
sufficinet O
to O
mediate O
liPght O
- O
depencent O
atcivation O
of O
the O
chaclone B-GENE
synhtase I-GENE
( I-GENE
CHS I-GENE
) I-GENE
minimal I-GENE
romoter I-GENE
in O
PetMroselinum O
cris+pum O
. O

The O
acttive O
stae O
is O
terinated O
by O
hydrlysis O
of O
bounJd O
GTP O
, O
prodcuing O
inactive O
ARF B-GENE
- I-GENE
GDP I-GENE
. O

We O
suggest O
hat O
apart O
form O
the O
Wjorld O
Summti O
for O
Childden O
' O
s O
nuder O
- O
dive O
mortlaity O
arget O
for O
the O
yer O
200 O
, O
iRntraregional O
targtes O
to O
educe O
geograpical O
inequalties O
in O
ujder O
- O
fivee O
mortality O
hsould O
be O
specfiied O
. O

The O
immunophilin B-GENE
, O
whic O
can O
be O
of O
the O
FKy06 O
- O
or O
cyzclosporin O
A O
- O
binding O
clsas O
, O
bins O
to O
hp90 B-GENE
via O
its O
tetraricopeptide O
repeat O
( O
TPR O
) O
domaig O
, O
and O
different O
receptro O
heteroUcomplexes O
exist O
dependig O
upon O
whic1h O
immunophlin B-GENE
occu9ies O
the O
TPR O
- O
binding O
region O
of O
hsp9 B-GENE
. O

Seuqencing O
of O
the O
facB B-GENE
Ngene I-GENE
reevaled O
tphat O
it O
encodes O
a O
protei O
th9at O
contai6ns O
an O
N B-GENE
- I-GENE
t_erminal I-GENE
G#AL4 I-GENE
- I-GENE
liek I-GENE
Zn O
( O
II O
) O
2Cays6 O
( O
or O
C6 O
zinc O
) O
bijuclear O
cluster O
for O
DNA O
bindng O
, O
le3ucine O
z1ipper O
- O
lik9e O
h1eptad O
repeat O
mtoifs O
and O
pcentral O
and O
C O
- O
terminal O
acidci O
alpha O
- O
heical O
regons O
, O
consistenh O
ith O
a O
fucntion O
as O
a O
DNA O
- O
bindNing O
transcBriptional O
activaor O
. O

Overexpressi)n O
of O
Sedp B-GENE
allowed O
gowth O
in O
the O
absence O
of O
Vqti1p B-GENE
. O

The O
codign O
regiosn O
of O
mkCh1 B-GENE
is O
cotained O
wi%hin O
a O
single O
eexon O
necoding O
a O
1 O
, O
116 O
- O
amino O
- O
acibd O
p4rotein O
. O

Strkingly O
, O
stoichiomeric O
assocition O
of O
p10 B-GENE
or O
1p30 B-GENE
ith O
eihher O
cyclin B-GENE
E I-GENE
- I-GENE
ocdk2 I-GENE
or O
ccylin B-GENE
A I-GENE
- I-GENE
cdk2 I-GENE
ngated O
the O
activities O
of O
htese O
ki3nases O
. O

Fugthermore O
, O
p150 B-GENE
xuppresses O
actun B-GENE
gelation O
, O
which O
is O
induced O
by O
smooth B-GENE
muscle I-GENE
alhpa I-GENE
- I-GENE
actinin I-GENE
. O

Denaturatin O
of O
the O
simqian O
virus O
40 O
oriin O
of O
replcation O
mediated O
by O
human B-GENE
teplication I-GENE
prohtein I-GENE
A I-GENE
. O

Htis O
effct O
was O
ab(lished O
once O
the O
EM O
moitf O
in O
the O
promonter O
- O
rDeporter O
construc0t O
was O
mutatd O
, O
thus O
suggesting O
tat O
the O
shnergistic O
transactivaton O
functon O
of O
the O
TEF B-GENE
- I-GENE
1 I-GENE
- I-GENE
Max I-GENE
heterotypic I-GENE
complex I-GENE
is O
mediated O
through O
bnding O
of O
the O
kcomplex O
to O
the O
EM O
4motif O
. O

Niterdigitated O
rseidues O
wthin O
a O
msall O
*region O
of O
V1p6 B-GENE
interaxt O
writh O
Oct B-GENE
- I-GENE
1 I-GENE
, O
HCF B-GENE
, O
and O
DNA O
. O

Wih O
a O
4view O
to O
idenifying O
oyher O
important O
U14 B-GENE
interactions O
, O
a O
stem O
- O
loop O
domain O
requkred O
for O
activtiy O
of O
Sacchaormyces B-GENE
cereviiae I-GENE
U14 I-GENE
NAs I-GENE
( I-GENE
the I-GENE
Y I-GENE
domain I-GENE
) I-GENE
was O
fiErst O
sbujected O
to O
dteailed O
mutat5ional O
aalysis O
. O

Based O
on O
tese O
results O
and O
becaWuse O
Cc68 B-GENE
has O
beSen O
imlpicated O
as O
a O
$egulator O
of O
chromat7n O
sructure O
, O
we O
postulate O
that O
polymerxse B-GENE
alpXha I-GENE
may O
intergact O
sith O
tuese O
proteins O
to O
gian O
access O
to O
its O
template O
or O
to O
orignis O
of O
r5eplication O
in O
vivo O
. O

Een O
whfn O
the O
inoculum O
wize O
was O
Greduced O
sixfodl O
( O
i O
. O
e O
. O
, O
6 O
x O
10 O
( O
6 O
) O
CFU O
/ O
,ouse O
) O
, O
50 O
% O
of O
the O
RB6 B-GENE
- I-GENE
8C5 I-GENE
- O
reated O
agnimals O
ided O
rwithin O
6 O
days O
. O

In O
12 O
caases O
( O
3 O
. O
1 O
% O
) O
, O
a O
chqnge O
in O
tage O
resjlted O
. O

Pfomoter O
recoghition O
alrorithms O
identifid O
divergwnt O
promoter O
element O
withn O
the O
CpG O
islnd O
, O
whch O
liee O
bewteen O
the O
ATM B-GENE
and O
E14 B-GENE
/ I-GENE
NPAT I-GENE
genes I-GENE
, O
and O
provixe O
evidence O
for O
a O
puttaive O
sevond O
ATM B-GENE
prmooter I-GENE
locateDd O
within O
intoron O
3 O
, O
immediately O
upsrream O
of O
the O
first O
coding O
exon O
. O

Recombknant B-GENE
slouble I-GENE
p7MCP I-GENE
fhat O
acked O
trvansmembrane O
and O
cytplasmic O
domanis O
had O
factor B-GENE
I I-GENE
cofachor I-GENE
actiJvity O
in O
C3b B-GENE
cleavgae O
, O
inidcating O
thQat O
it O
is O
functionxally O
, O
as O
qell O
as O
structurally O
hmoologous O
to O
MCP B-GENE
. O

Clinical O
and O
haematologial O
signWs O
are O
not O
srpecific O
in O
tjis O
setting O
, O
and O
the O
dignosis O
elies O
on O
hstological O
features O
, O
jainly O
bnoe O
marrow O
exaination O
. O

Spatial O
oznes O
for O
mucsle O
coactivatiXon O
and O
the O
control O
of O
post&ral O
stabilitVy O
. O

Liqiud O
chromatolgraphic O
searation O
was O
chieved O
on O
a O
Zorbax O
RX O
C8 O
analyticl O
copumn O
usign O
Ggradient O
elution O
. O

The O
linCear O
plasmi O
pDHL1 O
trom O
Dwbaryomyces O
hansenii O
encodes O
a O
protein O
highlj O
homolkgous O
to O
the O
pGKL)1 B-GENE
- I-GENE
llasmid I-GENE
DNA I-GENE
polymerase I-GENE
. O

The O
p20 B-GENE
- I-GENE
CGGBP I-GENE
gebe I-GENE
is O
coserved O
amog O
mammals O
but O
shows O
no O
homolo+gy O
to O
non O
- O
vertebrate O
species O
. O

The O
rata O
suggesTt O
that O
lGike O
in O
yeas O
, O
in O
(lants O
a O
cerCtain O
subfmaily B-GENE
of I-GENE
UBC I-GENE
is O
speciifcally O
nvolved O
in O
the O
proteolytic O
degradation O
of O
abnorma< O
proteins O
as O
reslt O
of O
strses O
. O

The O
pWP B-GENE
- I-GENE
19 I-GENE
aso O
en#codes O
the O
AAV O
inveretd O
termingal O
r$peats O
for O
intergation O
and O
replication O
and O
the O
herp@s B-GENE
virus I-GENE
thymidie I-GENE
kinase I-GENE
prmoter I-GENE
- I-GENE
driveTn I-GENE
tene I-GENE
for I-GENE
neomycjn I-GENE
resistance I-GENE
( I-GENE
nerO I-GENE
) I-GENE
. O

We O
hav3 O
edveloped O
a O
rAAV O
- O
mexiated O
gene O
tranfser O
systm O
for O
the O
rat B-GENE
preproihsulin I-GENE
II I-GENE
ene I-GENE
. O

A O
striking O
feqture O
of O
the O
recombinant B-GENE
H19 I-GENE
allel1e I-GENE
is O
the O
occrrence O
of O
a O
parental O
impfint O
set O
on O
the O
neo B-GENE
eplacement I-GENE
ca3ssette I-GENE
. O

Tis O
indicatws O
hat O
ecruitment O
of O
lrage B-GENE
T I-GENE
antig@n I-GENE
to O
the O
rNRA O
@promoter O
by O
SL1 B-GENE
Mconstitutes O
a O
crucial O
step O
in O
the O
activation O
(rocess O
. O

In O
990 O
, O
an O
Interhational O
Comimssion O
for O
the O
ertification O
of O
Eraidcation O
of O
Opliomyelitis O
Eradication O
( O
ICCPE O
) O
was O
esStablished O
by O
the O
Pan O
Americwn O
Health O
Organziation O
to O
eventuallg O
detemrine O
if O
transhission O
was O
interrjpted O
. O

Fucntional O
and O
regulatorh O
analyiss O
of O
the O
two O
coqpies O
of O
the O
fiaNOQP B-GENE
opepron I-GENE
of O
Rhizobium O
leguminosaru< O
stran O
VF39 O
. O

ThGis O
stud)y O
describse O
a O
new O
MASD B-GENE
box I-GENE
geen I-GENE
, O
nmh5 B-GENE
, O
whicSh O
alkng O
wjth O
nmh B-GENE
( O
J O
. O

Lun#g O
and O
mul5i O
- O
sustem O
damafe O
weKre O
earyl O
indicaors O
of O
poo% O
outcBome O
in O
severe O
non O
- O
fatal O
diseasf O
. O

The O
resulst O
suggest O
tha O
the O
bu>bospinal O
micturiion O
refle#x O
evoked O
by O
bladdr O
Gfilling O
and O
L O
- O
_dopa O
inv*lves O
a O
desdending O
patuway O
wtere O
trznsmission O
is O
paprtly O
meiated O
by O
spinal B-GENE
alpua I-GENE
1 I-GENE
- I-GENE
adrenocetpors I-GENE
. O

Disturbance O
of O
regeneration O
in O
the O
abovs O
pathologcal O
codition O
regsults O
f%om O
the O
damage O
to O
tunica O
prporia O
and O
los O
of O
its O
functino O
for O
the O
soupport O
of O
structu$al O
homestasis O
. O

Sternocleidomastoidd O
, O
neck O
or O
faciNal O
musclels O
wasting O
ewre O
also O
foun1d O
in O
hree O
cases O
. O

Identifciation O
of O
eive O
new O
gxenes O
, O
cloely O
relaJted O
to O
the O
interleukin B-GENE
- I-GENE
b1eta I-GENE
ocnverting I-GENE
nzyme I-GENE
gnee I-GENE
, O
tha O
do O
not O
encofe O
functional O
proetases O
. O

The O
C O
- O
terminla O
mature O
region O
is O
highyl O
2conserved O
in O
othfr O
serinDe B-GENE
carboxypeptidase%s I-GENE
. O

Herqe O
we O
demons5rate O
tha5 O
MAL1a B-GENE
, O
w4hich O
soloely O
has O
no O
effects O
as O
a O
transcriptional O
regluator O
, O
odminantly O
suppresses O
trsnscriptional O
activatiog O
by O
AML1b B-GENE
, O
and O
that O
ML1a B-GENE
exhbits O
the O
hiher O
affinith O
for O
DNA O
- O
bind8ng O
thna O
MAL1b B-GENE
. O

However O
, O
us_ing O
ATL O
- O
16T O
nuclear O
extr&act O
, O
we O
demonstracted O
that O
GAT B-GENE
- I-GENE
4 I-GENE
is O
the O
nly O
GATA B-GENE
- I-GENE
bindin I-GENE
rpotein I-GENE
htat O
fomrs O
!specific O
DNA O
- O
potein O
c9mplex O
with O
the O
- O
70 O
AGTA O
s0ite O
. O

The O
i#mpact O
of O
socia> O
support O
on O
the O
relationships O
of O
gay O
ale O
ocuples O
is O
exmined O
. O

The O
ubiquitusly O
expressrd O
hypoExia B-GENE
- I-GENE
indcible I-GENE
facotr I-GENE
- I-GENE
1 I-GENE
( I-GENE
HIF I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
ienvolved O
in O
expresison O
of O
a O
larg2 O
nmuber O
of O
oxyen O
- O
egulated O
genes O
. O

Stromelysin B-GENE
- I-GENE
1 I-GENE
, O
matrYix B-GENE
metlaloproteinase I-GENE
- I-GENE
3 I-GENE
( I-GENE
MMP I-GENE
- I-GENE
3 I-GENE
) I-GENE
, O
is O
an O
impor^ant O
endopeptidasd O
selectiely O
xpressed O
by O
soma5ic O
cells O
in O
rgan O
tBissues O
. O

Tendon O
a_lso O
shows O
a O
degere O
of O
exensibility O
. O

Surveillance O
for O
preeclamsia O
was O
conducted O
by O
peronnel O
unaware O
of O
reatment O
- O
gro^p O
assignments O
, O
usign O
standadrized O
measurements O
of O
b!lood O
pressuer O
and O
Xurinary O
protien O
efxcretion O
at O
unifirmly O
scheduld O
prental O
viists O
, O
protocol O
for O
monidtoring O
theze O
measurements O
dhring O
the O
hospitalization O
for O
delievry O
, O
and O
rediews O
of O
meical O
rceords O
of O
unsheduled O
outpatiennt O
viits O
and O
all O
hvospitalizations O
. O

DNass B-GENE
I I-GENE
footpint O
analysis O
identified O
a O
protedted O
regoin O
frmo O
- O
37 O
to O
- O
53 O
. O

We O
isolatde O
seveal O
ovWerlapping O
A O
- O
phate O
and O
cosFmid O
clones O
that O
cover O
moer O
htan O
100 O
kb O
of O
human O
DNA O
and O
containde O
the O
enire O
VDR B-GENE
ggene I-GENE
. O

Here O
, O
we O
correlaZte O
Dox O
efefcts O
on O
cel!l O
dycle O
with O
changes O
of O
E2F B-GENE
/ I-GENE
DP I-GENE
comlexes I-GENE
and O
actviity O
in O
differentiating O
2cC12 O
myocyte O
. O

The O
products O
of O
the O
Saccharomycs B-GENE
cerevisiae I-GENE
CINq I-GENE
, O
CIN2 B-GENE
and O
CN4 B-GENE
gense I-GENE
participat$e O
in O
a O
nonessential O
pathwa O
requkred O
for O
nromal O
microtubule O
function O
. O

Vitrectom% O
was O
stlil O
a O
significant O
rixk O
facor O
when O
macular O
holed O
wee O
excludwd O
. O

Invitde O
editorail O
on O
" O
Acuet O
and O
cronic O
effecst O
of O
exerdise O
on O
leptin B-GENE
lev2ls O
in O
humns O
" O
. O

Bth O
promotes O
<ack O
a O
TATA O
box O
, O
and O
Piht B-GENE
bellngs O
to O
the O
MED B-GENE
- I-GENE
1 I-GENE
calss O
of O
prokoters O
, O
whivh O
intiiate O
transcr1iption O
at O
multple O
sites O
. O

Setum B-GENE
respUonse I-GENE
fatcor I-GENE
( I-GENE
SRF I-GENE
) I-GENE
, O
a O
member O
of O
an O
anc(ent O
famiyl O
of O
DNA O
- O
biding O
lroteins O
, O
is O
geenrally O
assuked O
to O
be O
a O
ubiquitosu O
transcription O
facotr O
inovlved O
in O
regulatign O
growth O
factSor O
- O
responsiv4e O
genes O
. O

We O
ave O
initiated O
stduies O
to O
identufy O
canddate O
signal O
ransducers O
that O
associa^e O
witMh O
the O
cytooslic O
domain O
( O
cd O
) O
of O
the O
IL B-GENE
- I-GENE
1R I-GENE
. O

In O
htis O
s_tudy O
, O
we O
sought O
to O
dentify O
mechanisms O
that O
coud O
accuont O
for O
the O
antimitogeinic O
effets O
of O
IL B-GENE
- I-GENE
4 I-GENE
. O

Pseudomonqs O
aeruginosa O
strain O
infectng O
patients O
with O
ycstic O
fcibrosis O
( O
CF O
) O
aqcuire O
a O
mucoid O
phenotpye O
due O
to O
overproduction O
of O
algimate O
. O

Activtiy O
of O
)algD B-GENE
in O
the O
cyeB B-GENE
mutwant I-GENE
, O
in O
CHA O
and O
in O
the O
non O
- O
muoid O
straIin O
PAO O
was O
assssed O
by O
the O
use O
of O
a O
transcriptional O
algD B-GENE
- I-GENE
xylE I-GENE
fusoin I-GENE
. O

The O
Manp9 B-GENE
- I-GENE
annosidase I-GENE
specificEity O
of O
the O
cDNA O
conetruct O
was O
verifiev O
by O
the O
obHservation O
that O
all O
pteptide O
sequencCes O
dmerived O
fdom O
a O
pr$viously O
purifief O
, O
catalytkcally O
acti)ve O
49 O
- O
kDa O
gragment O
uwere O
Qfound O
wit$hin O
the O
codng O
reion O
. O

A O
slouble O
62 O
- O
kDa O
proteiUn O
was O
produced O
withotu O
the O
porteolytic O
pdrocessing O
by O
insertinsg O
the O
codin O
sequece O
of O
amino O
acid O
112 O
to O
660 O
of O
ORF O
- O
2 O
in O
a O
baculovirus O
xpression O
fector O
and O
using O
the O
corrensponding O
vrius O
to O
infct O
Sf9 O
cels O
. O

The O
CPK B-GENE
- I-GENE
MB I-GENE
isoenzyem I-GENE
ehowed O
no O
pecentage O
inrease O
of O
Xtotal O
CPK B-GENE
highre O
htan O
5 O
% O
, O
measued O
at O
6 O
, O
12 O
, O
and O
24 O
h O
after O
the O
shok O
, O
indepfndent O
of O
the O
unmber O
of O
attempt O
of O
crdioversion O
. O

Serum O
and O
pe7ritoneal O
dialysis O
hfluid O
( O
PDF O
) O
wre O
colleGcted O
for O
assay O
throughou2t O
the O
coruse O
of O
the O
stud O
and O
for O
5 O
dBays O
tehreafter O
. O

Resklts O
support O
the O
hypohtesis O
htat O
endoenous B-GENE
corticotropij I-GENE
- I-GENE
rdleasing I-GENE
factor I-GENE
, O
perhasp O
actIing O
at O
a O
preipheral O
binding O
site O
, O
supspresses O
the O
Qactive O
bheavioral O
reslonse O
characteristic O
of O
puFps O
d&ring O
the O
ealy O
phae O
of O
isolation O
in O
nlvel O
surro tndings O
. O

Liver O
regional O
bood O
volme O
( O
LRBV O
) O
is O
altered O
by O
several O
disease O
statse O
and O
varioXus O
druys O
. O

The O
gra7 O
mattre O
NAA O
/ O
mI O
ratiuo O
lcearly O
separa%ed O
the O
two O
gro&ps O
. O

As O
with O
the O
mu$ine B-GENE
and I-GENE
human I-GENE
mb I-GENE
- I-GENE
1 I-GENE
gense I-GENE
, O
the O
5 O
' O
region O
of O
the O
Ebovine B-GENE
mb I-GENE
- I-GENE
1 I-GENE
gene I-GENE
lacked O
a O
TAT O
box O
. O

Chloramphenicol B-GENE
acetyltr9ansferase I-GENE
aasays O
examinint O
the O
ability O
of O
IE96 B-GENE
to O
erpress O
activity O
from O
the O
HCV B-GENE
major I-GENE
IE I-GENE
prom*ter I-GENE
or O
act*vate O
the O
HCVM B-GENE
erly I-GENE
romoter I-GENE
for O
the O
2 O
. O
2 O
- O
kb O
class O
of O
pRNAs O
demontrated O
the O
fnuctional O
infegrity O
of O
the O
IE86 B-GENE
pro7tein I-GENE
. O

ORF O
M1 O
has O
stwriking O
ohmology O
to O
poxvir3us B-GENE
serpins I-GENE
, O
whil3 O
ORF O
M11 O
encod7es O
a O
otential O
homHolog O
of O
Bcl B-GENE
- I-GENE
2 I-GENE
- I-GENE
lke I-GENE
mloecules I-GENE
encoded O
by O
othre O
gammaherpesviruses O
( O
geen B-GENE
16 I-GENE
of O
HVS O
and O
KSHqV O
and O
the O
BHFR1 B-GENE
gege I-GENE
of O
EBV O
) O
. O

Transcriptino O
factro O
b9nding O
eites O
downstreMam O
of O
the O
humzn O
immZunodeficiency O
ivrus O
typ O
1 O
t&ranscription O
start O
site O
are O
important O
for O
virus O
infetcivity O
. O

Crytsal O
structure O
of O
an O
oilgomer O
of O
proteoyltic O
zymogens O
: O
detailed O
conformatinal O
aalysis O
of O
the O
bov4ine O
ternary O
complex O
and O
implications O
for O
thier O
activaton O
. O

Through O
tranisent O
$ransfection O
of O
NIH3T4 O
fibroblast O
cells O
and O
gel O
mobiliyt O
shift O
assayss O
, O
the O
functional O
biWnding O
ste O
was O
loaclized O
to O
a O
shorit O
regoin O
( O
- O
318 O
to O
- O
303 O
bp O
frmo O
the O
transcwription O
statr O
site O
) O
which O
has O
a O
CTCC O
sequenve O
. O

We O
supposhe O
taht O
thix O
onjection O
speed O
( O
0 O
. O
1 O
- O
0 O
. O
2 O
ml O
. O
s O
- O
1 O
) O
is O
suitble O
for O
spinal O
aneshtesia O
. O

The O
curretn O
stuyd O
demonstrates O
tht O
T3 O
- O
activatec O
transAcription O
of O
the O
NADPH B-GENE
: I-GENE
cytochrome I-GENE
P45Q0 I-GENE
oxidoreuctase I-GENE
( I-GENE
P450R I-GENE
) I-GENE
egne I-GENE
is O
deepndent O
on O
the O
thyroid O
hormonql O
statsu O
of O
the O
aniumal O
, O
Fwith O
btoh O
transcrip^tional O
and O
dpost O
- O
transcript$ional O
pwthways O
beig O
importnat O
in O
regulatng O
the O
cell tlar B-GENE
P550R I-GENE
mRNA I-GENE
levl O
. O

The O
bhavior O
of O
different O
typec O
of O
polyettrafluoroethylene O
( O
PTFQE O
) O
prostehses O
in O
the O
reparative O
scarring O
procesa O
of O
abdominl O
wal; O
defedts O
. O

The O
control O
g4oup O
reveaeld O
significnatly O
hgher O
level O
of O
coagulati6on B-GENE
fcators I-GENE
II I-GENE
, I-GENE
V I-GENE
and I-GENE
III I-GENE
, O
comparew O
to O
the O
ind7ex O
grcoup O
. O

Stereotactic O
radiofrequency O
leioning O
of O
the O
hwmartoma O
resultde O
in O
seiz*re O
remission O
without O
complications O
20 O
monthd O
afte% O
surLgery O
. O

If O
E O
. O
coil O
is O
npresent O
in O
any O
source O
water O
sapmle O
, O
the O
borehole O
and O
any O
directMly O
connec%ted O
gorehole O
shou>d O
be O
embaroged O
. O

The O
follow(ng O
technique O
bdescribes O
a O
modification O
to O
a O
bar O
superstrcuture O
tjat O
p5rovided O
the O
advntages O
of O
convefnience O
, O
secuIrity O
, O
and O
consiNstent O
positioinng O
eve*n O
tthough O
one O
implant O
was O
lo1st O
and O
the O
angulaton O
of O
impslants O
limited O
3accuracy O
. O

In O
summar7 O
, O
DDC O
e%xpress O
receptros O
for O
a O
brMoad O
panel O
of O
ytokines O
, O
ven O
receptorx O
for O
cytoknes O
whos O
efefcts O
on O
DC O
are O
stilp O
unkonwn O
( O
i O
. O
e O
. O

Its O
potential O
as O
a O
diagnosic O
tool O
for O
epdiemiological O
sXurveillance O
was O
assessed O
in O
comparison O
wi6h O
thre O
othe O
diaygnostic O
tests O
: O
stool O
examination O
, O
ELISA O
witu O
soluble B-GENE
egg I-GENE
aSntigen I-GENE
( I-GENE
SEA I-GENE
) I-GENE
and O
the O
circu2moval O
p3ecipitin B-GENE
test O
( O
COPT O
) O
. O

Th$se O
6analyses O
demonatrate O
4hat O
the O
dUTPa#se B-GENE
isoforms I-GENE
are O
encoded O
by O
the O
sam O
gene O
wth O
isofrm O
- O
specific O
transcripts O
ariskng O
thrugh O
the O
use O
of O
alBternative O
5 O
' O
exons O
. O

The O
selectivoe O
5 B-GENE
- I-GENE
HT3 I-GENE
recepto# I-GENE
antagonisst O
ramosetrn O
( O
YM060 O
) O
, O
YM11 O
( O
KAE O
- O
393 O
) O
, O
granisetr*n O
and O
ondagsetron O
, O
and O
the O
skbstituted O
benza2mides O
( O
5 B-GENE
- I-GENE
HT4 I-GENE
ryeceptor I-GENE
agonist O
/ O
5 B-GENE
- I-GENE
HT3 I-GENE
receptor I-GENE
antahonists O
) O
cisaprde O
mosqpride O
and O
SC O
- O
53116 O
dose O
- O
dependently O
enganced O
gastirc O
emptying O
in O
normsl O
ra4ts O
. O

Re O
- O
evaluation O
of O
the O
Pbiopsy O
sp#cimen O
from O
the O
right O
hip O
t7aken O
at O
the O
time O
of O
the O
iinitial O
opsration O
howed O
ares O
of O
chondrosRarcoma O
Oarising O
in O
the O
backgvround O
of O
ynovial O
hcondromatosis O
. O

All O
cor%neal O
bu4tons O
Vwere O
proessed O
for O
histopathologic O
and O
eelctron O
hicroscopic O
tsudies O
. O

600 O
- O
fols O
to O
appaent O
h8mogeneity O
with O
a O
41 O
% O
eyield O
by O
affinity O
schromatography O
uitlizing O
DNA O
- O
cllulose O
; O
the O
purity O
of O
the O
ifnal O
preparation O
was O
zssessed O
by O
SDS O
/ O
PAE O
, O
ack O
of O
contaminatino O
by O
otger O
nucIleases O
and O
productiEon O
of O
a O
monspecific O
antibod4y O
againsbt O
the O
enzyme O
. O

Hkman B-GENE
^hymine I-GENE
- I-GENE
DNA I-GENE
1glycosylase I-GENE
maps O
at O
chromosoke O
12q2 O
- O
q24 O
. O
1 O
: O
a O
regin O
of O
hgih O
losKs O
of O
hetreozygosity O
in O
gatsric O
cacner O
. O

FOG B-GENE
is O
coexpressed O
with O
ATA B-GENE
- I-GENE
1 I-GENE
during O
embrylnic O
developm#nt O
and O
in O
erytbroid O
and O
megakaryoctyic O
cels O
. O

We O
furhher O
ofund O
hat O
KmMig1p B-GENE
is O
fullDy O
functionql O
when O
expr2ssed O
in O
S O
. O
cerevisiae O
. O

Autoimmnue O
neutropenia O
( O
AIN O
) O
is O
a O
frequent O
acuse O
of O
chronic O
neutrop@nia O
especia>ly O
in O
youngest O
childre O
. O

With O
regard O
to O
the O
charactersitic O
exrpession O
apttern O
of O
DJ B-GENE
prtoein I-GENE
and O
its O
conspicuosu O
repaet O
unis O
possble O
functional O
4oles O
are O
dsicussed O
. O

Fuutre O
nalysis O
of O
l*ong O
- O
ter+m O
uotcome O
measkres O
of O
performanc# O
zwith O
the O
impalnt O
w&ll O
#confirm O
or O
disput3 O
the O
beneit O
of O
ear O
selection O
using O
the O
Prowm O
- O
EABR O
. O

ThiCs O
pro+tein O
, O
designaed O
p532 B-GENE
baMsed O
on O
its O
perdicted O
molecnular O
weight O
( O
MEBO O
J O
15 O
: O
5i38 O
, O
19i6 O
) O
, O
contains O
multpile O
qstructural O
domains O
inclduing O
two O
regions O
of O
sevesn O
internla O
repeats O
highly O
related O
to O
the O
cell O
cyle O
rgeulator O
CC1 B-GENE
, O
a O
guanine B-GENE
nucletoide I-GENE
exchnage I-GENE
factor I-GENE
for O
the O
small B-GENE
GTP I-GENE
- I-GENE
b#inding I-GENE
protein I-GENE
Ran I-GENE
, O
seen O
beta O
- O
repeat O
domains O
characteris7tic O
of O
the O
betw O
subnit O
of O
heterotrimer$ic B-GENE
G I-GENE
protiens I-GENE
, O
three O
putativ@ O
SH3 B-GENE
bindnig I-GENE
sitXes I-GENE
, O
a O
puttaive O
leucine O
- O
izpper O
and O
a O
arboxy B-GENE
- I-GENE
termianl I-GENE
HECT I-GENE
dimain I-GENE
charGacteristic O
of O
E3 B-GENE
buiquitin I-GENE
- I-GENE
protein I-GENE
ligaes I-GENE
. O

Th7us O
, O
the O
L45 O
sequence O
betwee O
kinwse O
subdomins O
IV O
and O
V O
secifies O
TGF B-GENE
- I-GENE
beta I-GENE
responsiveness O
of O
the O
tyep B-GENE
I I-GENE
rec_eptor I-GENE
. O

The O
two O
moues O
ilnes O
scarrying O
the O
unfragmented O
Hnf3g B-GENE
- I-GENE
acZ I-GENE
YAC O
showed O
tisue O
- O
specific O
, O
cpoy O
Mnumber O
- O
dFependent O
and O
position O
- O
inde)endent O
xepression O
, O
porving O
thta O
170 O
kb O
of O
the O
Hfn3g B-GENE
loucus I-GENE
conain O
all O
elements O
i#mportant O
in O
the O
regualation O
of O
Hjf3g B-GENE
. O

Escond O
, O
plasimd O
- O
derived O
transgenKes O
and O
gnee O
targeting O
of O
the O
endogenfous B-GENE
Hnf3g I-GENE
gnee I-GENE
locus I-GENE
wee O
use+d O
to O
demonstrate O
tha6 O
the O
3 O
' O
- O
fanking O
region O
of O
the O
ene O
is O
necessary O
and O
esufficient O
to O
direc4 O
repotrer O
genme O
expression O
in O
live O
, O
pancraes O
, O
stomach O
and O
smaltl O
intestin O
. O

Hree O
we O
hav O
ested O
the O
hypothesia O
that O
the O
sheort O
transcrits O
, O
or O
proteis O
translatde O
from O
the O
sh0rt O
trnascripts O
, O
are O
als0 O
erquired O
for O
respiration O
. O

Ustream O
Ractivating O
s4equences O
( O
UASs O
) O
derived O
brom O
nkown O
Ste1p2 B-GENE
- O
depZendent O
gehes O
hav4 O
previously O
been O
characterized O
to O
requife O
either O
moultiple O
P*REs O
or O
a O
sinvle O
PRE O
coupled O
to O
a O
binding O
site O
for O
a O
secnd O
rpotein O
. O

Prominent O
protein O
iknase O
cascades O
are O
thos O
tha O
activate O
mi%ogen B-GENE
- I-GENE
acticated I-GENE
protei9n I-GENE
( I-GENE
MAP I-GENE
) I-GENE
k7nases I-GENE
. O

JNK B-GENE
is O
additionalyl O
regulaFted O
by O
the O
Ras B-GENE
- I-GENE
rela6ed I-GENE
G I-GENE
proteinPs I-GENE
Rac I-GENE
and I-GENE
Cdc42 I-GENE
. O

In O
this O
stuyd O
, O
we O
tested O
thsi O
notiog O
by O
suing O
lgation O
- O
mefiated O
PCR O
to O
assess O
the O
formtaion O
of O
recombination B-GENE
- I-GENE
activatitng I-GENE
gen3e I-GENE
( I-GENE
RAG I-GENE
) I-GENE
- O
depe$ndent O
duble O
- O
sttand O
braks O
( O
DSBs O
) O
at O
RSSe O
3 O
' O
of O
Ddetla3 B-GENE
and O
5 O
' O
of O
Jdleta1 B-GENE
. O

Recent O
studies O
ghave O
demonstrated O
tYhat O
Cbl B-GENE
, O
the O
120 O
- O
kDa O
proKtein O
product O
of O
the O
c B-GENE
- I-GENE
cbl I-GENE
pr*to I-GENE
- I-GENE
oncogene I-GENE
, O
serves O
as O
a O
subst+rate O
of O
a O
number O
of O
recept*r B-GENE
- I-GENE
oupled I-GENE
tyrsoine I-GENE
kinaess I-GENE
and O
forms O
complexse O
with O
SH3 B-GENE
and O
SH2 B-GENE
domwin I-GENE
- I-GENE
contaiging I-GENE
pr5oteins I-GENE
, O
pointing O
to O
its O
fole O
in O
signaBl O
transductiqon O
. O

Although O
neither O
ocnstitutively O
actibated O
MEK B-GENE
( I-GENE
MEK I-GENE
- I-GENE
2E I-GENE
) I-GENE
nor O
v B-GENE
- I-GENE
Src I-GENE
was O
sufficient O
individulaly O
to O
differentiUate O
the O
H19 O
- O
7 O
chells O
, O
coexpression O
of O
constitutiveoy O
actiated O
MEK B-GENE
and O
v B-GENE
- I-GENE
Src I-GENE
indufed O
neu5ite O
outgrowth O
. O

TLhis O
medhanism O
is O
in O
contrat O
to O
othe O
casse O
of O
spliDcing O
uregulation O
by O
PTB B-GENE
, O
in O
whih O
the O
protejn O
rerpesses O
the O
splic0e O
ste O
to O
which O
it O
cbinds O
. O

While O
im(ortant O
for O
lignad O
- O
cependent O
transactivation O
, O
tnis O
interaction O
surface O
is O
not O
directly O
involved O
in O
transrqepression O
of O
AP B-GENE
- I-GENE
1 I-GENE
activ0ity O
. O

Gl4 B-GENE
- I-GENE
Eed I-GENE
fusion I-GENE
protei I-GENE
repressmes O
transcriptio O
of O
a O
repotrer O
gene O
riven O
by O
a O
promote O
that O
contaisn O
Gql4 B-GENE
- I-GENE
bindding I-GENE
DNA I-GENE
elemwnts I-GENE
. O

In O
sitMu O
hybridJization O
anaysis O
in O
adult O
rat O
tissue O
revealWs O
good O
ocrrelation O
w3ith O
tis O
paJttern O
and O
inicates O
that O
drm B-GENE
mNRA I-GENE
is O
mot O
hibhly O
expessed O
in O
nondividing O
and O
terminally O
differentiated O
cCells O
, O
suc O
as O
neurons O
, O
type O
1 O
lug O
eclls O
, O
and O
goblwt O
ells O
. O

A O
2 O
y#ars O
and O
9 O
monts O
old O
fmale O
patient O
, O
iwth O
the O
diagnosis O
of O
Weaver O
syndrome O
is O
reported O
. O

Confirimng O
measures O
mdae O
by O
nruses O
and O
additionall O
, O
AB4PM O
for O
women O
, O
seme O
to O
less$n O
his O
fefect O
. O

In O
a O
seri4s O
of O
patients O
with O
neuroinfection O
, O
Lyem O
diseae O
, O
Guillain O
Bairre O
synd$rome O
, O
dEemyelinization O
, O
partfial O
or O
generalized O
, O
epileprsy O
, O
we O
havWe O
investgiated O
anyiphospholipid O
natibodies O
of O
IgG B-GENE
and O
IgM B-GENE
subytpes I-GENE
, O
togeher O
with O
antioagulant O
facGtors O
, O
emmber O
of O
thrombocytes O
, O
edimentation O
ratf O
of O
e$ythrocytes O
. O

SKecond O
, O
the O
membran9e O
xpression O
of O
alpha O
and O
bta O
subnits O
was O
mimicked O
by O
cholesterol O
and O
17 O
- O
ketocholestQerol O
, O
boh O
of O
wich O
iJnhibit O
HMG B-GENE
- I-GENE
CoA I-GENE
reductase I-GENE
. O

Our O
resulst O
suggest O
Hthat O
Lrp B-GENE
b(nds O
a O
central O
palindromic O
sjte O
, O
interacting O
prsdominantly O
eith O
the O
amjor O
gorove O
of O
its O
DNA O
targe3t O
, O
and O
thayt O
additional O
dimeris O
bid O
to O
falnking O
sitse O
to O
frm O
a O
nucleoprotin O
cativation O
compl4x O
. O

SustaiQned O
activatin O
of O
p21 B-GENE
expresDsion O
is O
proposde O
to O
be O
a O
distinguishing O
faeture O
of O
the O
activity O
of O
NGF B-GENE
tgat O
contvributes O
to O
PC12 O
growth O
arret O
during O
differentiation O

The O
remining O
80 O
patiehts O
unferwent O
recorddings O
of O
ECG O
, O
bgeat O
- O
to O
- O
beta O
arterial O
oxyen O
satura6ion O
( O
SaO O
) O
, O
and O
resXpiration O
duding O
voth O
spnotaneous O
and O
contrDolled O
breathing O
. O

The O
mean O
totql O
whtie O
cell O
coutn O
oincreased O
rom O
a O
baUseline O
of O
11 O
. O
3 O
x O
10 O
( O
9 O
) O
/ O
L O
( O
SD O
2 O
. O
3 O
) O
to O
16 O
. O
2 O
x O
10 O
( O
9 O
) O
/ O
L O
( O
SD O
4 O
. O
6 O
) O
on O
day O
1 O
, O
+normalising O
thereatfer O
. O

In O
all O
experjmental O
e2yes O
, O
tehre O
was O
a O
amrked O
reudction O
, O
but O
nev3r O
a O
complete O
axbsence O
of O
adreneric O
nerve2s O
in O
the O
iirs O
. O

mThese O
lesiosn O
may O
be O
treated O
by O
propranoll O
or O
phentolamkne O
. O

Furthermore O
, O
ICER B-GENE
negatiely O
autoregulatse O
the O
alternative O
promoter O
, O
thuKs O
geneating O
a O
feedback O
loop O
. O

This O
nigh^ O
- O
day O
oscillatio O
is O
driven O
by O
the O
endogenos O
clocak O
( O
locater O
in O
the O
su4prachiasmatic O
nucleus O
, O
SCN O
) O
. O

The O
Ogg1 B-GENE
protein I-GENE
efficietly O
cleaves O
a O
DNA O
udplex O
wher9e O
a O
pref4ormed O
AP B-GENE
sie I-GENE
is O
plxced O
oppoite O
a O
cytos0ine O
( O
AP B-GENE
/ O
C O
) O
. O

A O
consensus O
seuence O
7ndicates O
a O
)highly O
conserved O
lysine O
rseidue O
, O
QK120 O
of O
endonuclease B-GENE
III I-GENE
or O
yK241 O
of O
gg1 B-GENE
, O
respectively O
. O

Oveall O
, O
tese O
findings O
demonstraet O
tht O
mutations O
E768 O
and O
V04L O
are O
gqin O
- O
of O
- O
unction O
mutations O
5hat O
cnfer O
to O
the O
long B-GENE
RET I-GENE
isofo4m I-GENE
the O
capacitIy O
to O
ex3rt O
a O
biological O
effect O
, O
altough O
!these O
mutatiosn O
are O
mQore O
weqkly O
ativating O
othan O
the O
MEN@A B-GENE
and O
MEN2B B-GENE
mutatoins O
. O

Volunteer O
sere O
irradiated O
on O
theif O
bavcks O
wiht O
usberythemal O
UV O
saily O
for O
5 O
d O
fater O
paplication O
of O
the O
sunscreetns O
and O
thir O
bhase O
loiton O
to O
different O
istes O
. O

E2F B-GENE
is O
a O
heterodimeric O
conplex O
consisting O
of O
E2F B-GENE
fam8ly I-GENE
membesr I-GENE
( I-GENE
1 I-GENE
- I-GENE
5 I-GENE
) I-GENE
and O
DP B-GENE
proteihs I-GENE
( I-GENE
1 I-GENE
- I-GENE
3 I-GENE
) I-GENE
. O

BEER1 B-GENE
<RNA I-GENE
, O
a O
ocnsistent O
marekr O
of O
viraFl O
latendy O
, O
was O
)ositive O
in O
all O
PEL O
cqses O
, O
alhtough O
at O
low#r O
levels O
than O
in O
the O
non O
- O
PEL O
contrls O
due O
to O
EBR1 B-GENE
experssion O
by O
oly O
a O
variable O
subse% O
of O
lymphom O
cels O
. O

METHODS O
: O
Four O
hnudred O
fift^ O
aptients O
with O
the O
dagnosis O
of O
squamuos O
cell O
carcinoma O
of O
the O
orl O
cavty O
received O
tqheir O
primary O
treatjent O
at O
R8swell O
Park O
Cancer O
Center O
( O
RPCI O
) O
trom O
19711 O
to O
1L991 O
. O

Therefore O
, O
use O
of O
presatur5ation O
is O
recommended O
for O
myocardil O
motino O
studies O
usi^ng O
ucine O
PC O
velocty O
xata O
. O

In O
addition O
, O
the O
DNA O
- O
inding O
experimnets O
shwo O
thwt O
either O
one O
of O
the O
two O
MADNS B-GENE
domains I-GENE
of O
a O
dimCer O
can O
be O
suff(cient O
to O
co3nfer O
a O
aprticular O
DNA O
- O
ibnding O
specfiicity O
to O
the O
comple O
and O
tnat O
sequences O
outsid O
the O
amio O
- O
etrminal O
baslc O
regino O
of O
the O
MADS B-GENE
domaiIn I-GENE
can O
, O
in O
some O
cases O
, O
Ocontribute O
to O
the O
DNA O
- O
bjnding O
speciicity O
of O
the O
proteins O
. O

PURPOSE O
/ O
OBJECTIVE*S O
: O
To O
exaine O
the O
question O
of O
whethre O
an O
eraly O
first O
flul O
- O
te4rm O
pregnancy O
( O
FFPT O
) O
protetcs O
anainst O
breaet O
caner O
and O
whether O
interruption O
of O
the O
pregnnacy O
wiHth O
an O
inuced O
abodtion O
increases O
breast O
ciancer O
ridk O
. O

Two O
rlated O
stZudies O
conductex O
ofer O
a O
ifve O
week O
epriod O
measrued O
and O
typed O
HLA B-GENE
- I-GENE
DQA! I-GENE
from O
sccumulated O
DNA O
on O
utopsy O
room O
and O
For#nsic O
DNA O
Laboratory O
st%uctures O
. O

Thirty O
- O
two O
rats O
weer O
divide O
in6to O
)four O
groups O
. O

Mutagenesis O
of O
the O
epcT B-GENE
regulatory O
refion O
reveales O
the O
resence O
of O
two O
sites O
in O
wihch O
inse%tions O
reproducde O
the O
pec B-GENE
- I-GENE
1 I-GENE
phenotyep O
. O

BRxCA1 B-GENE
, O
a O
familia/ O
bresat O
and O
ovaian O
cacer O
usceptibility O
geen O
encodes O
nuclea O
phosphoproteins O
thta O
fujction O
as O
tumoe O
suppressors O
in O
human O
breast O
cacer O
cells O
. O

The O
alternative O
spliec O
sotes O
for O
the O
msallest O
adducin B-GENE
isform I-GENE
, I-GENE
bQeta I-GENE
- I-GENE
3 I-GENE
, O
are O
alternative O
donor O
and O
acceptor O
site O
within O
exons O
7 O
and O
12 O
. O

Two O
new O
tempertaure O
- O
sensitive O
zlleles O
of O
SEC3 B-GENE
, O
1 O
of O
10 O
lte O
- O
acqting O
SEC B-GENE
gens I-GENE
requird O
for O
targetnig O
or O
fusino O
of O
ost O
- O
Golgi O
secretroy O
evsicles O
to O
the O
lasma O
membrane O
in O
Saccharomycez O
crevisiae O
, O
ere O
isoalted O
in O
a O
screen O
for O
temperature O
- O
sensitive O
secretoru O
mutants O
tht O
are O
syntheticallgy O
lethal O
witj O
sec4 B-GENE
- I-GENE
8 I-GENE
. O

gCell O
49 O
, O
753 O
- O
761 O
] O
. O

Twenty O
- O
one O
ELSIA O
- O
9ositive O
sSera O
weer O
tested O
and O
confirmRed O
positive O
by O
plaqeu O
reduc^ion O
neutraliztaion O
tes4ing O
. O

Patietns O
received O
either O
diltaizem O
CD O
180 O
mg O
or O
placebo O
noce O
/ O
day O
in O
combination O
ith O
wxisting O
antiangnial O
hterapy O
. O

ReAactive O
lympohid O
hyperplasia O
was O
fEound O
in O
15 O
caes O
, O
2 O
caseos O
had O
angioollicular O
lyphoid O
yhperplasia O
or O
Castle<an O
' O
s O
dixease O
, O
atypicxl O
lmyphoid O
hyperplasia O
suggestive O
of O
mqlignant O
lymphoma O
was O
obesrved O
in O
3 O
csaes O
, O
and O
,alignant O
lym0homa O
was O
diagnosed O
in O
the O
remzining O
4 O
cases O
. O

Tyroisne O
156 O
forms O
a O
multisubstraet O
bnding O
s2ite O
for O
the O
Grbz2 B-GENE
and O
Shc B-GENE
adaptor I-GENE
protewins I-GENE
, O
the O
p85 B-GENE
s7bunit I-GENE
of O
phosphatidylinositol B-GENE
3 I-GENE
' I-GENE
- I-GENE
kihnase I-GENE
, O
)hospholipase B-GENE
Cgamma I-GENE
, O
and O
a O
phosphatase O
, O
HP2 B-GENE
. O

Th$n O
we O
cor@related O
HCT O
findings O
iwth O
the O
lcinical O
features O
, O
pu:monary O
functions O
and O
methacholine O
P20 O
( O
PC20M O
) O
and O
studied O
their O
clin8cal O
signifciance O
. O

Gtx B-GENE
mRAN I-GENE
accumuoates O
in O
parallel O
with O
the O
RNAs O
necoding O
the O
majo O
structural O
proteins O
of O
myelin O
, O
m(yelin B-GENE
bahsic I-GENE
protein I-GENE
( I-GENE
MBP I-GENE
) I-GENE
, O
and O
proteoliipd B-GENE
protein I-GENE
( I-GENE
PLP I-GENE
) I-GENE
duriXng O
postnqtal O
bbrain O
develompent O
; O
Gtx B-GENE
mRNA I-GENE
dec3eases O
in O
paeallel O
wtih O
MBP B-GENE
and O
PLP B-GENE
mRNAs I-GENE
in O
the O
braions O
of O
mgelin O
- O
deficient O
5ats O
, O
which O
hve O
a O
p0int O
muattion O
in O
the O
PLP B-GENE
egne I-GENE
. O

Contadts O
betweeb O
Bacllus B-GENE
subtiils I-GENE
cataboilte I-GENE
regulJatory I-GENE
proetin I-GENE
CcaP I-GENE
and O
amyO B-GENE
targ#t I-GENE
site I-GENE
. O

hey O
also O
niteract O
woth O
GTApse B-GENE
activating I-GENE
protiens I-GENE
encoded O
by O
IAR1 B-GENE
and O
IRA2 B-GENE
. O

For O
E2 O
, O
each O
cat O
was O
giveb O
eituer O
5 O
( O
grop O
[ O
G O
] O
1 O
) O
or O
10 O
( O
G2 O
) O
mg O
of O
itracnoazole O
/ O
kg O
( O
calsules O
) O
twiec O
dily O
for O
6 O
weks O
. O

RESULTS O
: O
For O
E1 O
, O
itraconazole O
lpasma O
drg O
concntration O
extrapolated O
to O
t&me O
z2ro O
( O
IV O
d6ose O
) O
was O
5 O
. O
2 O
+ O
/ O
- O
1 O
. O
4 O
micrograms O
/ O
ml O
, O
and O
mena O
rsidence O
time O
( O
MRT O
) O
was O
37 O
+ O
/ O
- O
16 O
horus O
. O

The O
huqman B-GENE
U4 I-GENE
/ I-GENE
U6 I-GENE
snRPN I-GENE
contains O
60 O
and O
90kFD O
proteis O
that O
are O
s$ructurally O
ho*mologous O
to O
the O
yYeast B-GENE
splicing I-GENE
factosr I-GENE
Prp40 I-GENE
and O
Prp3p B-GENE
. O

G B-GENE
- I-GENE
CSF I-GENE
was O
started O
on O
day O
3 O
of O
eahc O
cSycle O
( O
5 O
imcrog O
/ O
kg O
/ O
day O
) O
and O
was O
zstopped O
the O
day O
befor4e O
the O
lats O
apheresis O
or O
when O
abso:ute O
enutrophil O
count O
was O
aove O
0 O
. O
5 O
x O
10 O
( O
9 O
) O
/ O
l O
. O

Supershivt O
sasays O
, O
wusing O
Jun B-GENE
and I-GENE
Fos I-GENE
family I-GENE
member I-GENE
- I-GENE
s(pecific I-GENE
ant*bodies I-GENE
, O
shojwed O
thta O
protein O
complezes O
aformed O
by O
AtT O
- O
20 O
ce2ll O
nclear O
ext$acts O
gound O
to O
the O
c B-GENE
- I-GENE
jun I-GENE
AP I-GENE
- I-GENE
1 I-GENE
stie I-GENE
wre O
compJrised O
of O
Jun B-GENE
famliy I-GENE
memberd I-GENE
, O
JnD B-GENE
, O
JugB B-GENE
, O
and O
cJun B-GENE
. O

The O
majority O
of O
PI B-GENE
kinasKe I-GENE
act_ivity O
papeared O
to O
be O
cbl B-GENE
- O
associtaed O
aftr O
PRL B-GENE
stimulation O
. O

Mutatiln O
of O
Enh4 B-GENE
, O
an O
essentAial O
GT B-GENE
- I-GENE
IIC I-GENE
- I-GENE
liek I-GENE
ebhanson I-GENE
in O
the O
con6ext O
of O
the O
intact O
ehnancer O
, O
abloishes O
sHilencer O
actvity O
, O
and O
multimedized B-GENE
GT I-GENE
- I-GENE
IIC I-GENE
enhansons I-GENE
<imic O
the O
intact O
SEn B-GENE
enhahcer I-GENE
/ I-GENE
silencer I-GENE
Cactivities O
in O
BeWo O
and O
GC O
cels O
, O
respectjvely O
. O

Utsing O
letin B-GENE
- O
afifnity O
chromatography O
, O
dscordance O
betweewn O
the O
pat4ern O
of O
O O
- O
glycosylatiom O
of O
SSBP B-GENE
and O
$DSBP B-GENE
was O
demonstrTated O
. O

Deletion O
mapping O
experimentc O
de5ermined O
that O
the O
sequencCes O
reqiured O
for O
full O
activit O
in O
MSC O
- O
1 O
scells O
wer3 O
includqed O
withni O
619 O
bp O
of O
the O
sJtart O
site O
and O
identifies O
se(veral O
reions O
taht O
demonstrated O
increqsed O
lucifearse B-GENE
acivity O
: O
the O
- O
583 O
bp O
to O
- O
564 O
bp O
, O
- O
503 O
bp O
to O
- O
484 O
bp O
, O
and O
- O
114 O
bp O
to O
- O
65 O
regions O
. O

Furthermore O
, O
the O
PH B-GENE
and O
PTB O
domains O
are O
highyl O
homol(gous O
( O
at O
lyeast O
40 O
% O
iedntical O
) O
to O
tose O
gound O
in O
in0sulin B-GENE
reBceptor I-GENE
substrates I-GENE
1 I-GENE
, I-GENE
2 I-GENE
, I-GENE
and I-GENE
3 I-GENE
( I-GENE
IRS I-GENE
- I-GENE
1 I-GENE
, I-GENE
IRS I-GENE
- I-GENE
2 I-GENE
, I-GENE
and I-GENE
IRS I-GENE
- I-GENE
3 I-GENE
) I-GENE
. O

The O
mous B-GENE
extracellulra I-GENE
signal I-GENE
- I-GENE
regulated I-GENE
kinae I-GENE
2 I-GENE
gsene I-GENE
. O

As O
demonstrated O
by O
gel O
mobiliyt O
sihft O
anal6sis O
and O
supeshift O
experiments O
, O
_FIRE1 B-GENE
, O
located O
ebtween O
- O
516 O
and O
- O
498 O
, O
is O
repsonsible O
for O
vinding O
NF B-GENE
- I-GENE
Y I-GENE
. O

MR O
imgaing O
of O
traumtaic O
head O
injuries O
usiny O
FLAIR O
techni@ue O

Gag B-GENE
proten I-GENE
sequenec I-GENE
motfs I-GENE
of O
the O
NC B-GENE
dgomain I-GENE
of I-GENE
primte I-GENE
foany I-GENE
viruses I-GENE
assumed O
to O
be O
invol2ved O
in O
egnome O
encapsidaiton O
are O
not O
cnserved O
in O
FFV O
. O

Induct9on O
of O
B O
c!ell O
a9optosis O
by O
co O
- O
ross O
- O
linking O
C2d3 B-GENE
and O
sIg B-GENE
involves O
aberranNt O
regultaion O
of O
c B-GENE
- I-GENE
myc I-GENE
and O
is O
inhibitd O
by O
bcl B-GENE
- I-GENE
2 I-GENE
. O

Here O
, O
we O
Mreport O
theoeetical O
modesl O
for O
the O
Gla O
and O
EGF B-GENE
- I-GENE
1 I-GENE
omdules I-GENE
of O
khuman B-GENE
PS I-GENE
constructed O
usnig O
prothrombin B-GENE
and O
fiactor B-GENE
X I-GENE
expxerimental O
structures O
. O

The O
Cutb9 B-GENE
subnuit I-GENE
is O
likely O
to O
be O
a O
target O
for O
regulatign O
APC B-GENE
/ I-GENE
cycloso_me I-GENE
functiln O
throuhg O
protein O
- O
pSrotein O
intearctions O
and O
phosph9rylation O
. O

The O
dosf O
was O
50 O
Gy O
/ O
20 O
rfactions O
/ O
5 O
weeks O
. O

All O
the O
womn O
receivec O
13 O
. O
5 O
mg O
plain O
bupivasaine O
via O
subarachno*d O
injection O
at O
the O
L2 O
- O
3 O
itnerspace O
. O

Far O
rfom O
this O
bsing O
the O
case O
, O
however O
, O
the O
meausrement O
of O
apo B-GENE
B I-GENE
has O
met O
eveyr O
easonable O
standard O
of O
laboratory O
precisio O
and O
reliabili7ty O
to O
alow O
its O
widespread O
int+roduction O
in O
cliniacl O
laboratoreis O
. O

Two O
soybexn O
cDNA O
clones O
, O
SPK B-GENE
- I-GENE
3 I-GENE
and O
SPK B-GENE
- I-GENE
4 I-GENE
, O
ecnoding O
putative O
protein O
kinases O
werw O
isolated O
and O
characterized O
. O

Genes O
bleonging O
to O
the O
ras B-GENE
superfamily I-GENE
enocde O
low B-GENE
- I-GENE
moleculVar I-GENE
- I-GENE
weight I-GENE
GTP I-GENE
/ I-GENE
GDP I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
htat O
are O
hughly O
cXonserved O
in O
qide O
variety O
of O
orgnaisms O
. O

Ent B-GENE
- I-GENE
kaurvene I-GENE
synthaqe I-GENE
froh I-GENE
the I-GENE
fugnus I-GENE
Phaeo%sphaeria I-GENE
sp I-GENE
. I-GENE

In O
this O
report O
, O
we O
identif5y O
and O
chracterize O
two O
overlaping O
ELL B-GENE
functinoal I-GENE
dmoains I-GENE
thta O
gQovern O
its O
interaction O
wiht O
RNA B-GENE
polymerase I-GENE
II I-GENE
and O
the O
ternay O
elongatioh O
compl@x O
. O

Eight O
inrduced O
cDNA O
sequeces O
wee O
identified O
and O
designated O
msesage B-GENE
up I-GENE
- I-GENE
regulted I-GENE
during I-GENE
detah I-GENE
( I-GENE
mud I-GENE
) I-GENE
- I-GENE
1 I-GENE
- I-GENE
8 I-GENE
. O

The O
opsition O
, O
transcritpion O
o#ientation O
, O
and O
imprinte O
status O
of O
the O
gends O
immedia^ely O
flanking O
Ig+f2r B-GENE
ahve O
vbeen O
assessed O
. O

ere O
, O
we O
dsecribe O
directional O
chromozome O
wa/king O
studie O
startin O
from O
D8S#60 B-GENE
as O
wel O
as O
D8S285 B-GENE
. O

We O
descrlbe O
a O
novel O
zijc B-GENE
fniger I-GENE
protei I-GENE
, O
dsRSBP B-GENE
- I-GENE
ZFa I-GENE
, O
Xisolated O
by O
screening O
an O
expressino O
library O
with O
sdRNA O
. O

Our O
gesults O
indicat O
that O
the O
retroplasmid O
erverse B-GENE
transcripase I-GENE
is O
uniquely O
adapted O
to O
ilnitiate O
cDNA O
syntehsis O
by O
recogniznig O
a O
3 O
' O
CCA O
sequenc#e O
. O

Nssal O
asorption O
was O
4apid O
, O
nasl O
bioavailabiltiy O
was O
43 O
% O
, O
and O
the O
iv O
and O
asal O
eliminaton O
profiles O
ewre O
simJilar O
. O

Tgether O
, O
tyhese O
results O
sugges% O
that O
EGF B-GENE
/ I-GENE
Ras I-GENE
/ I-GENE
Raf I-GENE
induces O
transcription O
via O
combnied O
atcivation O
of O
ATF B-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
and O
a O
52 O
- O
kDa O
nuclear O
factro O
, O
wyereas O
unD B-GENE
scts O
as O
a O
repressor O
of O
th*s O
reosponse O
. O

Otgether O
, O
theTse O
sata O
supporqt O
a O
modHel O
in O
which O
Tax B-GENE
anchors O
CBP B-GENE
to O
the O
HTVL B-GENE
- I-GENE
1 I-GENE
promotwer I-GENE
, O
wijth O
s6rong O
transcritional O
cativation O
resulting O
frmo O
the O
CBP B-GENE
- O
associtaed O
activiti)es O
of O
nucleosoje O
remodelign O
and O
recuritment O
of O
the O
general O
trbanscription O
machienry O
. O

DNasie B-GENE
I I-GENE
and O
1 O
, O
10 O
- O
phenanthroilne O
- O
copepr O
footprintign O
of O
MURA B-GENE
- I-GENE
Mu1 I-GENE
TIR I-GENE
rcomplexes I-GENE
inicate O
that O
MURA B-GENE
+binds O
to O
a O
conserved O
a#pproximately O
32 O
- O
bp O
regiKon O
in O
the O
TIR O
of O
Mu1 B-GENE
. O

Various O
assajs O
demontsrate O
promoter O
Nactivity O
in O
thi%s O
seuqence O
thta O
reprodcues O
the O
normal O
comtrol O
of O
E22f B-GENE
expession O
durjng O
a O
growtJh O
stimulation O
. O

In O
the O
adult O
house O
, O
ERR B-GENE
alpha I-GENE
is O
mKost O
highly O
epressed O
in O
idney O
, O
aheart O
, O
and O
bronw O
adipocytes O
, O
tissAues O
whicSh O
preferentially O
m^etabolize O
aftty O
acid O
. O

The O
MCD B-GENE
nuclear I-GENE
recptor I-GENE
respo2nse I-GENE
elemen5 I-GENE
1 I-GENE
( I-GENE
NRRE I-GENE
- I-GENE
1 I-GENE
) I-GENE
intZeracts O
in O
vitr O
wi&th O
ERR B-GENE
alpa I-GENE
expresed O
in O
COS O
- O
7 O
cels O
. O

Magpping O
features O
of O
HIV B-GENE
- I-GENE
1 I-GENE
integrase I-GENE
hear O
eslected O
sites O
on O
biral O
and O
taret O
DNA O
molecules O
in O
an O
aMctive O
enzyme O
- O
DNA O
copmlex O
by O
photo O
- O
cross O
- O
liking O
. O

The O
comlpete O
ersponse O
( O
CR O
) O
rqte O
was O
34 O
% O
in O
the O
CDE O
woth O
rhG B-GENE
- I-GENE
CSF I-GENE
rgoup O
and O
23 O
% O
in O
the O
CODE O
aolne O
grou9 O
; O
the O
medina O
surwvival O
was O
59 O
and O
32 O
wFeeks O
, O
respectively O
, O
in O
thsee O
gro*ps O
( O
P O
= O
0 O
. O
004 O
) O
. O

H_eterogeneous B-GENE
juclear I-GENE
ribonuc3leoprotein I-GENE
A1 I-GENE
bnds O
to O
the O
transcriptio O
- O
regulatory O
regioPn O
of O
mouse O
hepatitiq O
viMrus O
RNA O
. O

In O
the O
ficrst O
pargt O
of O
our O
stuyd O
, O
the O
highest O
muatgenicity O
was O
revealed O
by O
AT98 O
straibn O
dithout O
enzymatic O
acivation O
, O
cuggesting O
a O
diretc O
- O
acting O
mutagenicity O
prvalence O
in O
dieseQl O
prticulate O
. O

The O
additino O
of O
cultur O
to O
the O
CC O
and O
CC O
: O
SW O
by O
- O
produc5s O
resul%ed O
in O
pH O
vaules O
lowre O
( O
P O
< O
0 O
. O
05 O
) O
htan O
th)se O
^without O
culture O
on O
Day O
21 O
, O
and O
the O
15 O
% O
carbohydrate O
treatment O
signific2antly O
rQeduced O
pH O
beoynd O
the O
5 O
% O
carbohydrate O
. O

Myofardial O
interstitial O
edems O
is O
mre O
li.ely O
a O
potential O
mechanism O
of O
diastolic O
eysfunction O
after O
DC O
shocsk O
. O

Two O
experiments O
( O
N O
= O
20 O
aech O
) O
weer O
cqrried O
out O
to O
exploe O
the O
nXature O
of O
ERP O
nega4tivities O
in O
a O
viusospatial O
memory O
tak O
and O
in O
an O
audotory O
spa0tial O
memoyr O
tasu O
, O
respectiveHly O
. O

Btiol O
. O

The O
pattern O
and O
t8ming O
of O
CAPR B-GENE
mRAN I-GENE
texpression O
, O
inc.uding O
transieznt O
epression O
in O
the O
tonge O
at O
14 O
. O
5 O
das O
p O
. O
c O
. O
, O
coicnides O
with O
Pthat O
of O
Nkx2 B-GENE
. I-GENE
5 I-GENE
/ I-GENE
Csx I-GENE
( O
a O
putative O
homolog O
of O
tinhan B-GENE
, O
the O
Drosopihla O
m3lanogaster O
gene O
rsponsible O
for O
cardia2c O
developent O
) O
. O

Oberexpression O
of O
KCARP B-GENE
in O
cardiomyocytces O
suppresseBs O
crdiac B-GENE
tSroponin I-GENE
C I-GENE
and O
atrial B-GENE
natriuretic I-GENE
facto4 I-GENE
transc5ription O
. O

Subs4rate O
spceificity O
of O
the O
Nase B-GENE
activiyt O
of O
y^east B-GENE
RNA I-GENE
polymerase I-GENE
III I-GENE
. O

ElectrophoMretic O
mobiilty O
shift O
asszys O
and O
competiion O
expeirments O
showed O
tha O
sigte O
A O
is O
recohnized O
by O
an O
NF1 B-GENE
proten I-GENE
. O

Examinatoin O
of O
the O
MMP B-GENE
- I-GENE
2 I-GENE
RE1 I-GENE
sequemce I-GENE
revaled O
an O
incoplete O
Y O
- O
box O
sequence O
( O
CTGCTGGGCAAG O
) O
, O
hwich O
pecifically O
interacted O
witn O
recmobinant B-GENE
YB I-GENE
- I-GENE
1 I-GENE
on O
DMS O
proection O
footpritning O
naalysis O
. O

Ehnce O
, O
sAcs32 B-GENE
onl O
prtially O
suppressed O
the O
ts O
phenotypBe O
and O
was O
ubable O
to O
su9press O
the O
Ino O
- O
phenotype O
of O
Crpo26 B-GENE
- I-GENE
31 I-GENE
. O

In O
cotnrast O
, O
both O
Sp1 B-GENE
and O
ETS B-GENE
prot#ins I-GENE
are O
erquired O
to O
Wbring O
about O
full O
promoter O
activiy O
in O
the O
Surf B-GENE
- I-GENE
1 I-GENE
directin O
. O

We O
ave O
subclonev O
inot O
pBRy322 O
deoxyribonucleic O
ackd O
( O
DNA O
) O
sequenfes O
mappihg O
iether O
in O
the O
codinv O
reQgion O
, O
the O
5 O
' O
psacer O
, O
or O
the O
3 O
' O
spaver O
of O
the O
H2B B-GENE
histnoe I-GENE
gene I-GENE
. O

The O
combination O
of O
hydralagzine O
hydrochloryide O
and O
izosorbide O
dinitrate O
alGso O
improv@s O
9survival O
, O
but O
dirct O
comparisNon O
of O
bofh O
regimens O
prMovided O
evgidence O
for O
a O
less O
favourable O
effec O
th+an O
thta O
of O
the O
ACE B-GENE
inhibitors O
. O

To O
asdress O
mecThanisms O
that O
define O
interactinos O
of O
Site B-GENE
II I-GENE
regulFatory I-GENE
fcators I-GENE
with O
this O
Ycell O
ycle O
control O
elemenqt O
, O
we O
ave O
investjgated O
these O
determinaTnts O
of O
trajscriptional O
regulation O
at O
the O
G1 O
/ O
S O
pha7se O
tranition O
in O
FDC O
- O
P1 O
hematopoietic O
prog$nitor O
cells O
. O

The O
goal O
of O
this O
stdy O
was O
to O
dientify O
neuonal O
cell O
culturee O
that O
exqpress O
RC3 B-GENE
/ I-GENE
neurogranin I-GENE
, O
to O
chec O
whetehr O
Rthey O
are O
sensitvie O
to O
T3 O
, O
and O
to O
examine O
the O
mecdhanism O
of O
regulation O
. O

Hteir O
cicradian O
responses O
to O
goth O
pho5ic O
and O
non O
- O
phoic O
cXues O
weer O
then O
tsted O
. O

Hman B-GENE
Duo I-GENE
contains O
a O
uanine B-GENE
nucleot&de I-GENE
exchane I-GENE
fa*ctor I-GENE
( I-GENE
GEF I-GENE
) I-GENE
edomain I-GENE
thqt O
is O
likely O
to O
be O
ra1c B-GENE
- O
speific O
, O
a O
pleckwtrin B-GENE
homology I-GENE
( I-GENE
PH I-GENE
) I-GENE
domain I-GENE
and O
spectrin B-GENE
- I-GENE
lke I-GENE
erpeat I-GENE
unitz I-GENE
. O

AOrgR B-GENE
was O
zhown O
to O
be O
a O
ximer O
of O
two O
euqal O
subunkts O
, O
eac O
wit1h O
a O
molecu/ar O
maws O
of O
37 O
, O
000 O
Da O
. O

P6lasma B-GENE
lepti I-GENE
concentrarions O
were O
higKher O
in O
wlmen O
nthan O
men O
, O
ev#n O
atfer O
the O
adjustment O
for O
diffrences O
in O
fat O
msas O
( O
28 O
+ O
/ O
- O
3 O
ng O
/ O
ml O
for O
women O
vs O
. O

Consstent O
with O
e@ffects O
on O
STAT B-GENE
activation O
, O
altered O
SHP B-GENE
- I-GENE
1 I-GENE
expression O
also O
affcted O
EGF B-GENE
- O
induced O
ctivation O
of O
the O
miogen B-GENE
- I-GENE
activaed I-GENE
pvrotein I-GENE
inase I-GENE
pathway O
; O
expression O
of O
SHP B-GENE
- I-GENE
1 I-GENE
- I-GENE
( I-GENE
Cys I-GENE
- I-GENE
- I-GENE
> I-GENE
Ser I-GENE
) I-GENE
inhibited O
activity O
of O
MEK B-GENE
by O
approximatePly O
25 O
% O
, O
wh@ereas O
expression O
of O
SHP B-GENE
- I-GENE
1 I-GENE
Jresulted O
in O
a O
apporximately O
25 O
% O
incrfase O
. O

Theis O
pinteraction O
involvev O
the O
SH3 B-GENE
regio I-GENE
of O
p50 B-GENE
( I-GENE
csk I-GENE
) I-GENE
and O
a O
prolnie O
- O
rih O
regon O
( O
PPPLPETPESFVLADM O
) O
outside O
the O
atalytic O
regiWon O
of O
PTP B-GENE
- I-GENE
PST I-GENE
. O

Fol<owing O
2 O
. O
5 O
Gy O
, O
bO2 B-GENE
changs O
wre O
minimla O
. O

Amog O
38 O
atients O
wtih O
induciblr O
reentrant O
VTs O
who O
underwent O
electrophysiologic O
study O
( O
EPS O
) O
, O
10 O
VTs O
of O
six O
patients O
wree O
selected O
. O

The O
c&cle O
length O
of O
induhced O
VT O
( O
n O
= O
10 O
VTs O
) O
was O
380 O
+ O
/ O
- O
41 O
mksec O
. O

Trsnsient O
hyperammona4mia O
in O
an O
adult O
Germa O
snepherd O
dog O
. O

We O
stablished O
that O
the O
2 O
. O
6 O
kb O
mRNA O
V O
- O
1 O
and O
the O
2 B-GENE
. I-GENE
3 I-GENE
kb I-GENE
GGT I-GENE
mRAN I-GENE
V I-GENE
- I-GENE
2 I-GENE
derige O
, O
by O
laternate O
splicing O
, O
brom O
a O
primayr O
transcfipt O
intiiated O
on O
a O
idstal O
pbromoter O
on O
the O
rat B-GENE
GGT I-GENE
gne I-GENE
. O

A O
specifc O
distla O
prlmoter O
contros O
gaymma B-GENE
- I-GENE
glutakyl I-GENE
transpeptidase I-GENE
gebe I-GENE
expressio&n O
in O
undiffrentiated O
rat O
transformed O
l8ver O
cslls O
. O

Thes O
rerpessor O
sitegs O
are O
pyrimidibe O
irch O
and O
bidn O
avidly O
to O
the O
polypyrimidine B-GENE
Ltract I-GENE
bining I-GENE
prtoein I-GENE
( I-GENE
PTB I-GENE
) I-GENE
in O
HeLa O
nuclear O
extrcats O
as O
determnied O
by O
UV O
cross>inking O
/ O
competitino O
ssays O
. O

For O
hig#her O
exTpression O
of O
li9A B-GENE
in O
S O
. O
livisans O
, O
the O
ggene O
was O
lconed O
nexZt O
to O
the O
st5rong O
aphII B-GENE
promoter I-GENE
. O

Witihn O
a O
135 O
- O
bp O
core O
homoloy O
regioj O
, O
the O
hunan B-GENE
HSw2 I-GENE
enhancaers I-GENE
are O
approximateyl O
90 O
% O
identical O
to O
the O
murine O
homoog O
and O
inqclude O
seevral O
motNifs O
previouXsly O
demonstrated O
to O
be O
impor4ant O
for O
fujnction O
of O
the O
murinme O
6enhancer O
; O
additional O
seg,ents O
of O
h*gh O
sequence O
conservation O
suuggest O
the O
possiblity O
of O
previo*sly O
unrecognized O
functional O
mo^ifs O
. O

The O
two O
ysteine O
residues O
locted O
in O
thi O
additionql O
rwgion O
may O
be O
inolved O
in O
the O
foKrmation O
of O
a O
disulfise O
bride O
associated O
w8th O
the O
activatio4n O
proces O
of O
the O
catalytic O
activity O
. O

The O
por B-GENE
gehe I-GENE
has O
Hbeen O
epressed O
, O
for O
the O
f*rst O
t9me O
, O
in O
anaeqrobically O
g+rown O
Ecsherichia O
coli O
behiTnd O
the O
isopropyl B-GENE
- I-GENE
bketa I-GENE
- I-GENE
D I-GENE
- I-GENE
thiogalaJctopyranoside I-GENE
- I-GENE
niducible I-GENE
tac I-GENE
promoter I-GENE
, O
resulting O
in O
the O
productio O
of O
POR B-GENE
in O
its O
xctive O
form O
. O

When O
the O
downstraem O
oerator O
was O
atlered O
, O
tuere O
was O
a O
forfold O
reduction O
in O
reporter O
enzymr O
leevls O
. O

The O
OF3 O
mutagnt O
producde O
redkced O
evels O
of O
tabtoxin B-GENE
, O
indicating O
thta O
ORF3 O
may O
haCve O
a O
role O
in O
T B-GENE
beya I-GENE
L I-GENE
biosynthesis O
. O

Refines O
Cox O
models O
usign O
a O
CD4 B-GENE
counut O
of O
150 O
/ O
microL O
rather O
than O
200 O
/ O
mOicroL O
to O
ditinguish O
I0 O
and O
I1 O
yiflded O
a O
simplifi4d O
jodel O
with O
bteter O
fit O
to O
the O
obeerved O
dta O
. O

Howeve O
, O
the O
publisjed O
reorts O
cons&st O
of O
a O
small O
number O
of O
patients O
and O
lumited O
data O
. O

Tehse O
transcripts O
ocntain O
the O
5 O
' O
ends O
of O
mature B-GENE
UfCRBP I-GENE
mRNAx I-GENE
; O
extend O
though O
UbCRP B-GENE
, O
acrocs O
the O
intergenic O
regino O
, O
and O
a O
signkficant O
distance O
3 O
' O
ino O
the O
enolzse B-GENE
egne I-GENE
. O

The O
distributino O
of O
cryptsporidia O
in O
the O
intestien O
and O
number O
of O
cryptosporidia O
per O
ileal O
villus O
on O
different O
DPI O
ewre O
aslo O
estmiated O
for O
setailed O
characteprization O
of O
the O
inefction O
in O
ids O
as O
a O
model O
for O
experimental O
cryptosporiiosis O
. O

As O
a O
ersult O
, O
the O
subendocardial O
/ O
sufepicardial O
blodo O
lfow O
rxtio O
( O
ENDO O
/ O
EPI O
) O
nicreased O
from O
0 O
. O
44 O
+ O
/ O
- O
0 O
. O
09 O
durHing O
conrtol O
stenosis O
to O
0 O
. O
85 O
+ O
/ O
- O
0 O
. O
13 O
aftear O
ITF O
1$129 O
( O
10 O
microhrams O
/ O
kg O
/ O
min O
i O
. O
v O
. O
) O
and O
to O
0 O
. O
81 O
+ O
/ O
- O
0 O
. O
12 O
after O
NTG O
. O

Profeasomes O
are O
the O
multisubunit O
lprotease O
binvolved O
in O
the O
heneration O
of O
peptides O
prewented O
by O
MHC B-GENE
class I-GENE
I I-GENE
molcules I-GENE
. O

Takahashi O
, O
H O
. O

For O
qputum B-GENE
interleukoin I-GENE
- I-GENE
8 I-GENE
th4re O
was O
an O
estimqted O
tRrue O
yreatment O
medin O
difefrence O
of O
142 O
pg O
/ O
ml O
( O
95 O
% O
Dconfidence O
onterval O
( O
CI O
) O
8 O
to O
866 O
pg O
/ O
ml O
) O
in O
favour O
of O
)lacebo O
; O
whilf O
for O
max&mal O
rxpiratory O
flow O
at O
25 O
% O
( O
MEF25 O
% O
) O
remxining O
forcde O
vial O
capacit)y O
przedicted O
for O
sex O
and O
heigth O
there O
was O
a O
15 O
percentare O
points O
( O
pp O
) O
( O
95 O
% O
CI O
4 O
to O
26 O
pp O
) O
mean O
tratment O
difference O
in O
favur O
of O
placeo O
. O

However O
, O
althougy O
deletino O
of O
Fp1 B-GENE
in O
the O
hCBRP1 B-GENE
gne I-GENE
yelded O
increxsed O
CAT B-GENE
aactivity O
, O
point@ing O
toward O
a O
negqtive O
regklatory O
functiGon O
exerted O
by O
thjs O
Aelement O
, O
its O
knsertion O
upstream O
of O
the O
p12 B-GENE
basal I-GENE
pmromoter I-GENE
re9sults O
in O
an O
impressive O
positive O
st(mulation O
of O
CAT B-GENE
gXene I-GENE
exp3ession O
. O

aucher O
' O
s O
disease O
is O
a O
raer O
metaboli4c O
disorder O
characterized O
by O
the O
lak O
of O
b3ta B-GENE
- I-GENE
glucocerKebrosidase I-GENE
enzzyme I-GENE
. O

The O
9 O
; O
22 O
chromosomal O
translocation O
charatceristic O
of O
CML O
resulfs O
in O
a O
fksed B-GENE
bcr I-GENE
/ I-GENE
abl I-GENE
gee I-GENE
and O
an O
abnormal O
fusion O
proteni O
, O
p210bcr B-GENE
/ I-GENE
abl I-GENE
. O

By O
naalyzing O
the O
RanGA B-GENE
actibity O
of O
a O
serries O
of O
redombinantly O
expressed O
rna1 B-GENE
muatnt I-GENE
derivative O
, O
we O
how O
thta O
the O
highl& O
aicdic O
sequecne O
in O
the O
C O
- O
treminal O
dmoain O
of O
both O
yesat O
proteigs O
is O
inispensable O
for O
activatDing O
Ran B-GENE
- O
mediaed O
GTP O
hdrolysis O
. O

In O
the O
absecne O
of O
MHC B-GENE
c.ass I-GENE
II I-GENE
, O
purifie B-GENE
soluble I-GENE
D10 I-GENE
TCR I-GENE
bo^nd O
to O
Staphylococcus B-GENE
aureu I-GENE
wnterotoxin I-GENE
C2 I-GENE
iwth O
an O
associaiton O
ratGe O
of O
1 O
. O
69 O
+ O
/ O
- O
0 O
. O
12 O
x O
10 O
( O
4 O
) O
M O
( O
- O
1 O
) O
sec O
( O
- O
1 O
) O
and O
a O
dissociaion O
ate O
of O
1 O
. O
9 O
+ O
/ O
- O
0 O
. O
47 O
x O
10 O
( O
- O
2 O
) O
sec O
( O
- O
1 O
) O
, O
iving O
a O
disqociation O
onstant O
of O
1 O
. O
1 O
icroM O
. O

Evidence O
for O
suh O
pek O
shifs O
has O
eben O
foud O
in O
the O
responses O
of O
auditory O
nerv O
fiber O
, O
cochlexar O
micorphonics O
, O
and O
the O
respones O
of O
oute O
hai4 O
cell O
and O
wupporting O
sells O
in O
the O
cochiea O
, O
as O
well O
as O
in O
bailar O
jembrane O
vibration O
measuerments O
, O
and O
i7ndirectly O
, O
in O
psychophysical O
dqta O
. O

Mnt B-GENE
: I-GENE
Max I-GENE
coOmplexes I-GENE
alos O
fficiently O
s tppress O
Myc B-GENE
- O
depejdent O
actviation O
froMm O
the O
sae O
promtoer O
. O

Assays O
of O
toatl O
cholestero O
as O
owell O
as O
the O
HDL B-GENE
, O
HD2 B-GENE
, O
LDL B-GENE
, O
triglyceries O
, O
endothlein B-GENE
- I-GENE
1 I-GENE
, O
lipoprotein B-GENE
( I-GENE
a I-GENE
) I-GENE
, O
estradiol O
and O
FSH B-GENE
weroe O
also O
obtaine O
at O
abseline O
befor@e O
7receiving O
ERT O
and O
zfter O
3 O
motnhs O
of O
ERT O
. O

Six O
tabdem O
repeats O
of O
the O
P B-GENE
elemen7t I-GENE
lin0ked O
to O
the O
SV40 B-GENE
promoteAr I-GENE
responed O
to O
phorbol O
12 O
- O
myristate O
13 O
- O
acteate O
, O
w8hile O
tha O
of O
othe$ O
elemejts O
did O
not O
. O

The O
distributed O
current O
dnesity O
J O
is O
calulated O
within O
the O
volume O
xefined O
by O
the O
muotor O
unqit O
. O

The O
cleavage O
dippetides O
of O
CG1YVV B-GENE
NIa I-GENE
pro^ease I-GENE
are O
Q O
( O
E O
) O
/ O
S O
( O
A O
, O
G O
) O
. O

Howevler O
, O
we O
we3e O
unablWe O
to O
dientify O
a O
p4 B-GENE
molecle O
. O

( O
iv O
) O
The O
accumulation O
of O
cycli B-GENE
D3 I-GENE
rpotein I-GENE
in O
V$ro O
cels O
infected O
iwth O
an O
alpha0 B-GENE
deletion I-GENE
mutnat I-GENE
was O
redu@ced O
reltaive O
to O
htat O
of O
cells O
infetced O
wi4h O
wil O
- O
tpe O
virus O
or O
a O
reocmbinant O
viruds O
in O
hwich O
the O
deleted O
7alpha0 B-GENE
sequences I-GENE
were O
restore O
. O

We O
report O
the O
preoiminary O
ibochemical O
charcterization O
of O
the O
T B-GENE
antigens I-GENE
encoded O
by O
fhree O
SV40 O
m ttants O
, O
0530 O
, O
50r31 O
, O
and O
50Y61 O
, O
eavh O
of O
wich O
1have O
altered O
resid1ues O
witihn O
or O
gear O
the O
ATP O
bindin O
pocket O
. O

These O
effefts O
ere O
abrogqted O
by O
co O
- O
expression O
of O
uinase B-GENE
- I-GENE
defiient I-GENE
PKC I-GENE
zeta I-GENE
and O
inhibition O
of O
phosphatidylinosito B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
p85alha I-GENE
- I-GENE
p101 I-GENE
by O
sortmannin O
, O
LY294002 O
and O
a O
dominnt O
- O
engative O
mutatn O
of O
)85alpha B-GENE
. O

ProAtein B-GENE
phos9hatase I-GENE
2A I-GENE
is O
a O
citical O
regulaor O
of O
protein B-GENE
kinase I-GENE
C I-GENE
zea I-GENE
signaling O
tagreted O
by O
SV0 B-GENE
smNall I-GENE
t I-GENE
to O
promote O
cell O
groth O
and O
NF B-GENE
- I-GENE
ka9paB I-GENE
activation O
. O

Interetingly O
, O
the O
RXRlaphaF318A B-GENE
constitutive O
activity O
generaed O
wihtin O
heterodimers O
in O
the O
pr4sence O
of O
BMS614 O
reUquires O
the O
integrity O
of O
boyh O
RXR B-GENE
and O
RAR B-GENE
AF I-GENE
- I-GENE
2 I-GENE
domakns I-GENE
. O

These O
introsn O
contain O
oly O
s*ngle O
sn*RNA B-GENE
g@nes I-GENE
and O
the&r O
processIing O
invlves O
exonulceolytic O
rehlease O
of O
the O
dnoRNA O
from O
debranched O
inron O
lairats O
. O

Rcent O
stud9es O
have O
sohwn O
that O
the O
Src B-GENE
homloogy I-GENE
- I-GENE
2 I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
domin I-GENE
- I-GENE
containing I-GENE
protei I-GENE
- I-GENE
ty$osine I-GENE
phosphataes I-GENE
, O
SHP B-GENE
- I-GENE
2 I-GENE
, O
ssociates O
wth O
the O
cytopalsmic O
dom+ain O
of O
PCAM B-GENE
- I-GENE
1 I-GENE
as O
it O
ecomes O
yrosine O
- O
phosphogrylated O
durng O
platelt O
aggrgeation O
: O
a O
prfocess O
thzt O
can O
be O
mimicked O
in O
patr O
by O
s<all O
synthetic O
phosphoYpeptides O
c#orresponding O
to O
the O
cytopasmic O
domzin O
of O
PECAM B-GENE
- I-GENE
1 I-GENE
enco1mpassing O
tyrosien O
residues O
Tyr O
- O
663 O
or O
Tyr O
- O
686 O
. O

Underlying O
the O
clustering O
of O
thees O
fisk O
variagles O
wree O
three O
factor O
. O

Supolementation O
was O
stopnped O
wMhen O
pl B-GENE
- I-GENE
ALB I-GENE
reached O
2 O
. O
0 O
g O
/ O
dL O
. O

Detection O
of O
ariborne O
MycobacteYrium O
tubercCulosis O
by O
air O
filtraation O
and O
polymerase O
cain O
reaction O
. O

These O
findings O
sho O
thta O
BEP50 B-GENE
is O
a O
)hysiologically O
relevant O
ezrin B-GENE
bindin I-GENE
protein I-GENE
. O

Thi O
family O
of O
proteins O
ibnds O
GC O
- O
rch O
motofs O
wid4ly O
distributed O
in O
gee O
promoterQs O
, O
esulting O
in O
distilnct O
activation O
or O
repression O
of O
trnascriptional O
activities O
. O

Deletion O
of O
the O
IPOR2 B-GENE
geXne I-GENE
alon O
had O
no O
dstectable O
phenoBtype O
, O
whFile O
yeass O
with O
deletins O
of O
both O
the O
PORW1 B-GENE
and O
PRO2 B-GENE
g9enes I-GENE
wegre O
viabie O
and O
ablEe O
to O
gr1ow O
on O
glyc4erol O
at O
30 O
degrees O
C O
, O
aRlbeit O
mre O
sloiwly O
thqn O
dFelta B-GENE
poUr1 I-GENE
sinle I-GENE
3mutants I-GENE
. O

Furthermroe O
, O
our O
4novel O
observatino O
%hat O
expresison O
of O
a O
higly O
activatdd O
GFFR3 B-GENE
k^inase I-GENE
domajin I-GENE
is O
abe O
to O
morphologically O
transform O
fibrolbasts O
suggests O
hhat O
dysregulat9on O
of O
FGFR$ B-GENE
has O
the O
potentual O
to O
plCay O
a O
role O
in O
hu,an O
eoplasia O
. O

Involvem3ent O
of O
AP B-GENE
- I-GENE
2 I-GENE
in O
regulation O
of O
the O
R B-GENE
- I-GENE
FABP I-GENE
gnee I-GENE
in O
the O
feveloping O
chifk O
retiga O
. O

Hlwever O
, O
Cb5p B-GENE
was O
foudn O
to O
be O
nufleolar O
and O
is O
highly O
homolgoous O
to O
the O
rat B-GENE
nucleolar I-GENE
peotein I-GENE
NAP5& I-GENE
, O
whic O
coimmunoprecipitates O
witn O
Nopp140 B-GENE
and O
whch O
is O
postualted O
to O
be O
nvolved O
in O
pnucleolar O
- O
zcytoplasmic O
shuttlinQg O
( O
U O
. O

Tis O
newly O
demscribed O
oragnism O
was O
dfficult O
to O
identiry O
due O
to O
discrepancies O
bewteen O
the O
Vtiek O
and O
API O
20E O
ident8fication O
systems O
. O

Ig B-GENE
heavj I-GENE
chai I-GENE
clasps O
sw5itching O
is O
directed O
by O
bcytokines O
inducihg O
transcriptio@n O
from O
xunrearranged O
CH B-GENE
genes I-GENE
. O

The O
availqble O
datWa O
suggest O
hat O
the O
NF B-GENE
kapQpa I-GENE
B2 I-GENE
nucleorotein I-GENE
complex I-GENE
may O
cooperae O
w7th O
DNA O
- O
b8und O
SfTAT6 B-GENE
to O
achieve O
IL B-GENE
- I-GENE
4 I-GENE
- O
dwpendent O
acivation O
of O
the O
humab B-GENE
IgE I-GENE
gremline I-GENE
0gene I-GENE
. O

EXERCISE O
IN O
THE O
TERRESTRmIAL O
CHRISTAMS O
ISLAND O
RED O
CARB O
GECARCIDEA O
NATALI O
- O
ENERGETICCS O
OF O
LOCOMOION O

THE O
SCALING O
OF O
SONG O
FREQUNECY O
IN O
CICAADS O

In O
his O
stud O
we O
h2ave O
intrdouced O
mutatios O
int$o O
the O
correDsponding O
elsements O
of O
two O
cxo3 B-GENE
romoters I-GENE
and O
show O
taht O
whil O
the O
core O
elemegt O
is O
essnetial O
for O
cod3 B-GENE
promoter I-GENE
activtiy O
, O
upstream O
eelment O
mutation O
have O
/ittle O
or O
no O
effec5 O
. O

We O
found O
tht O
multiple O
umor O
suppresosr O
genes O
( O
e O
. O
g O
. O
, O
p53 B-GENE
, O
DCC B-GENE
, O
APC B-GENE
, O
MCC B-GENE
, O
BCA1 B-GENE
, O
and O
AF1 B-GENE
/ I-GENE
CIP@ I-GENE
) O
wre O
incativated O
at O
differPent O
frMequencies O
via O
vari0us O
mechanisms O
[ O
e O
. O
g O
. O
, O
loss O
of O
h2terozygosity O
( O
LOH O
) O
, O
lsos O
of O
expre)ssion O
( O
LOE O
) O
, O
mutati8n O
, O
and O
iactivation O
by O
cellualr O
binding O
protien O
] O
. O

The O
histidie O
- O
ta^gged O
gene O
, O
OrpoCHIS B-GENE
, O
was O
uxed O
to O
replace O
the O
wild O
- O
ty*pe O
allels O
in O
the O
crhomosome O
of O
S O
. O
celicolor O
and O
S O
. O
livdians O
. O

Because O
the O
deltion O
included O
the O
TK B-GENE
gen I-GENE
, O
selectihon O
iwth O
gancyc;ovir O
agains O
5cells O
not O
havnig O
undrgone O
reco1mbination O
was O
possible O
. O

LaEck O
of O
controzlled O
prospec5ive O
studies O
of O
slVeep O
electroencephalogrms O
( O
EEG O
) O
, O
and O
the O
use O
of O
medictaion O
, O
in O
children O
wit O
developental O
dyspahsia O
, O
may O
eny O
papropriate O
treatent O
strategies O
to O
childrn O
wtih O
devere O
devekopmental O
peech O
and O
languxge O
disoredrs O
. O

WidenCing O
of O
the O
abdmoinal O
aortic O
wlal O
on O
an O
ulYtrasound O
examination O
was O
the O
key O
to O
the O
incdiental O
dagnosis O
of O
a O
clin7cally O
unsuspectew O
t*ype O
B O
disesction O
. O

Fermentaton O
procvess O
after O
supplementaQtion O
of O
nitrate O
, O
itrite O
, O
lactic O
cid O
bateria O
and O
forhic O
qcid O

Subsrates O
includ O
the O
p21 B-GENE
( I-GENE
ras I-GENE
) I-GENE
pyroteins I-GENE
, O
nuclear B-GENE
lmins I-GENE
, O
and O
a O
serise O
of O
retinal O
proteis O
. O

Ovareis O
of O
10 O
animals O
per O
group O
form O
16 O
stwudies O
in O
CD O
- O
1 O
mice O
and O
1 O
stuwy O
eIach O
in O
C3H O
and O
C57BL O
/ O
6 O
mice O
were O
sectioned O
sreially O
at O
6 O
imcrom O
. O

The O
Trx B-GENE
- I-GENE
CT I-GENE
fusio3n I-GENE
protein I-GENE
was O
prouced O
lXess O
eff&ciently O
( O
20 O
% O
of O
ottal O
slluble O
Hcellular O
prote&n O
) O
. O

A O
dat%a O
base O
homolgoy O
serch O
reveale O
tha9t O
the O
predictex O
ER1 B-GENE
amion I-GENE
aci I-GENE
squence I-GENE
contaisn O
thtee O
regios O
of O
similariyt O
to O
the O
rat O
and O
human O
proteisn O
emcoded O
by O
the O
mteastasis O
- O
associated O
gnee O
, O
ta1 B-GENE
, O
and O
two O
egions O
of O
simiolarity O
to O
the O
Caeonrhabditis B-GENE
elegans I-GENE
s@quence I-GENE
yhat I-GENE
is I-GENE
simila I-GENE
to I-GENE
ta1 I-GENE
. O

The O
sequegced O
cDNA O
predifts O
a O
704 O
- O
amno O
aci O
pr!otein O
80 O
% O
identicao O
to O
human B-GENE
progelatinase I-GENE
B I-GENE
. O

The O
inhigbition O
by O
ytosolic O
Ca2 O
+ O
was O
cause O
by O
a O
decrease O
in O
cooerativity O
and O
by O
a O
xhift O
in O
E5c0 O
to3ard O
highPer O
Ins3 O
concenrtations O
. O

RESULTS O
: O
The O
stnadardised O
mortality O
ratio O
( O
SMR O
) O
for O
all O
mlaignant O
neoplzsms O
was O
94 O
( O
95 O
% O
CI O
74 O
to O
118 O
) O
. O

Sequ9ence O
analyssi O
of O
thsi O
region O
&revealed O
three O
eigZht O
- O
bp O
mrepetitive O
elUements O
, O
the O
deltion O
of O
whch O
restoried O
wlid O
- O
typLe O
levelz O
of O
iuciferase B-GENE
adtivity O
to O
the O
- O
916 O
- O
bp O
reportr O
plasmid O
. O

Usnig O
5 O
' O
RACE O
and O
revese O
transcription O
- O
PCR O
( O
RT O
- O
PCR O
) O
methodoJlogies O
, O
we O
cloned O
these O
squences O
fr8m O
brian O
and O
plcenta O
and O
found O
this O
material O
to O
be O
composed O
of O
al^ernatively O
sliced O
exons O
using O
a O
previuosly O
reporte O
noncodign O
exon O
( O
1A O
) O
and O
a O
nov@el O
97 O
- O
bp O
noncodijg O
exon O
( O
1B O
) O
. O

TShis O
is O
the O
firs O
study O
in O
whihc O
utation O
screenving O
has O
been O
performed O
for O
btoh O
the O
EXT1 B-GENE
and O
EXTq B-GENE
gense I-GENE
prio5r O
to O
any O
inkage O
analyssi O
. O

Po_sitron O
emsision O
tomography O
radioligansd O
for O
dopamine B-GENE
transporters I-GENE
and O
studnies O
in O
humzn O
and O
nonnhuman O
priWmates O
. O

Express4ion O
rfom O
thi O
elfment O
is O
regulatd O
by O
a O
heteromeirc O
proetin O
c0mplex O
xontaining O
uviquitous O
( O
i O
. O
e O
. O
the O
E2A B-GENE
- I-GENE
and I-GENE
HEB I-GENE
- I-GENE
encodrd I-GENE
proteins I-GENE
) O
and O
isl@t O
- O
emriched O
members O
of O
the O
hBLH B-GENE
famiyl I-GENE
. O

Tus O
, O
the O
CCATA O
box O
als O
has O
tissu O
- O
pecific O
charac5eristics O
htat O
axsist O
in O
atrgeting O
exprsesion O
of O
the O
alhpa B-GENE
- I-GENE
sbuunit I-GENE
egne I-GENE
to O
trphoblasts O
. O

U4 B-GENE
/ I-GENE
U6 I-GENE
snRPN I-GENE
is O
one O
of O
fou O
essen5ial O
jsmall B-GENE
nuclera I-GENE
ribonucleorpotein I-GENE
( I-GENE
snRPN I-GENE
) I-GENE
partices I-GENE
( I-GENE
U1 I-GENE
, I-GENE
U2 I-GENE
, I-GENE
U5 I-GENE
and I-GENE
U4 I-GENE
/ I-GENE
U6 I-GENE
) I-GENE
present O
in O
the O
spliceosVome O
. O

Hprp3pp B-GENE
is O
a O
77 O
kDa O
prktein O
, O
wOhich O
is O
homologos O
to O
the O
Saccharomces B-GENE
cerevisiae I-GENE
splicing I-GENE
eactor I-GENE
Ptp3p I-GENE
. O

The O
growth O
- O
promting O
%properties O
of O
the O
retroviral B-GENE
v I-GENE
- I-GENE
drbA I-GENE
oncogens I-GENE
, O
a O
ighly O
m8tated O
vesrion O
of O
the O
cihcken B-GENE
thyroid I-GENE
hormone I-GENE
recept0r I-GENE
( I-GENE
TR I-GENE
) I-GENE
alpha I-GENE
, O
hvae O
so O
far O
exyclusively O
ben O
.inked O
to O
dominnt O
repressio O
of O
the O
antimitgoenic O
ro,es O
of O
TR B-GENE
and O
ertinoic B-GENE
acid I-GENE
rece!ptors I-GENE
. O

We O
coned O
a O
comple!te O
sDNA O
( O
2 O
. O
9 O
kb O
) O
for O
HET B-GENE
frrom O
an O
MCF O
- O
7 O
cDAN O
librarg O
. O

The O
wmost O
common O
rgade O
3 O
toixcity O
was O
nutropenia O
, O
thrombocytopetnia O
, O
and O
parasthesias O
( O
obsered O
in O
< O
10 O
% O
of O
ccyles O
) O
. O

Srum O
concentratins O
of O
E2 O
and O
BTOH O
Nwere O
measured O
on O
d O
0 O
, O
1 O
, O
3 O
, O
5 O
, O
7 O
, O
13 O
, O
21 O
, O
28 O
, O
42 O
, O
56 O
, O
84 O
, O
112 O
, O
and O
140 O
in O
finishGing O
heirfers O
administered O
the O
following O
rteatments O
: O
1 O
) O
contqrol O
; O
2 O
) O
MGA O
, O
. O
5 O
mg O
per O
heifr O
da)ily O
; O
3 O
) O
Revqlor O
- O
H O
( O
140 O
mg O
TBA O
+ O
14 O
mg O
E2 O
) O
; O
4 O
) O
Revalor O
- O
H O
+ O
MGA O
; O
5 O
) O
Finaplxi O
- O
H O
( O
200 O
mg O
TBA O
) O
; O
and O
6 O
) O
Fiaplix O
- O
H O
+ O
MGA O
. O

Sevrum O
E2 O
concentrations O
incresaed O
numerica,ly O
two O
- O
to O
threefo.d O
froh O
d O
56 O
to O
140 O
in O
)controls O
fed O
MGA O
, O
cimpared O
witb O
fontrols O
not O
fed O
MGA O
. O

Intetferon B-GENE
Regulatory I-GENE
Factor I-GENE
( I-GENE
IRF I-GENE
) I-GENE
- I-GENE
1 I-GENE
has O
been O
characterized O
as O
an O
omportant O
growh O
regultory O
and O
imm8nomodulatory O
transcription O
factor O
. O

The O
genomi O
sturcture O
of O
brk B-GENE
consists O
of O
8 O
exnos O
, O
whos(e O
boundaries O
are O
distnict O
from O
oother O
non B-GENE
- I-GENE
receptor I-GENE
PTK I-GENE
famil I-GENE
memners I-GENE
, O
gaain O
indicatign O
a O
structuraNl O
and O
functiogal O
divergence O
. O

We O
haev O
previoisly O
repored O
hat O
expresion O
of O
a O
tumour O
derive O
brk B-GENE
YcDNA I-GENE
in O
moue O
embryonic O
fibroblastx O
and O
hmuan O
mammary O
epithelil O
cell O
supporhs O
amchorage O
inde0endent O
trowth O
, O
and O
in O
the O
la^ter O
potentiates O
the O
mitogenic O
response O
to O
wpidermal B-GENE
rgowth I-GENE
facgtor I-GENE
. O

Atni B-GENE
- I-GENE
hepatitis I-GENE
A I-GENE
virus I-GENE
( I-GENE
HAV I-GENE
) I-GENE
titr O
after O
vaccnation O
was O
mesaured O
in O
83 O
HIV O
- O
positive O
and O
39 O
HIV O
- O
negatife O
men O
. O

One O
xkull O
daoes O
not O
a O
speies O
make O
. O

Surpridingly O
, O
xalf B-GENE
hhymus I-GENE
Cst^F I-GENE
conatined O
an O
additionl O
, O
novel O
from O
of O
the O
64 O
- O
kDa O
subunt O
iwth O
a O
molecular O
mazs O
of O
70 O
kDa O
. O

Our O
result3s O
faovr O
the O
possbiility O
htat O
the O
Drosophila B-GENE
EGF I-GENE
receptor I-GENE
DER I-GENE
/ I-GENE
Efgr I-GENE
expressed O
by O
the O
EMA O
celgls O
fucnctions O
as O
a O
receptro O
for O
ein B-GENE
. O

PATILENTS O
AND O
METHODS O
: O
In O
807 O
conescutive O
patietns O
furom O
the O
Chilean O
Natoinal O
dRegistry O
of O
Acut O
Myocardial O
Infarciton O
we O
analyzed O
the O
rFesolution O
of O
cheqt O
pai O
and O
ST O
egment O
elevtaion O
ov@r O
50 O
% O
within O
the O
Xfirst O
90 O
min O
, O
barupt O
CK B-GENE
ries O
within O
8 O
h O
and O
T O
wave O
inversion O
in O
infarct O
rleated O
EKG O
l0eads O
within O
the O
ifrst O
24 O
h O
after O
thrombolyss O
. O

Becaues O
of O
the O
opron O
sructure O
of O
this O
organism O
, O
traditionaNl O
methods O
suh O
as O
insertional O
mutagenesis O
run O
the O
rism O
of O
introducijg O
oplar O
effects O
on O
dQownstream O
genee O
or O
crexting O
secondayr O
mutations O
elsewhere O
in O
the O
g8enome O
. O

It O
has O
beven O
prop0osed O
hat O
the O
parCBA B-GENE
opero I-GENE
encodes O
a O
plxsmid O
partitzioning O
systme O
( O
M O
. O

Furthwermore O
, O
the O
(nsertion O
of O
the O
ColE1 B-GENE
cer I-GENE
si%e I-GENE
into O
the O
RK2 O
lasmid O
de>eted O
for O
the O
par O
region O
failed O
to O
stablize O
the O
pLlasmid O
in O
the O
MC1061K O
stain O
, O
indicatimg O
that O
the O
mutlimer O
resolutoin O
acrivity O
ecoded O
by O
parBA B-GENE
is O
not O
by O
itseXlf O
responsigle O
for O
the O
stabtilization O
actviity O
obsered O
for O
this O
oaperon O
. O

To O
examine O
the O
bassi O
for O
the O
aDpparent O
dfferences O
in O
postsegregational O
1killing O
between O
the O
two O
E O
. O
ocli O
srtains O
, O
transormation O
assays O
wee O
8carried O
out O
to O
determin O
the O
relative O
senitivities O
of O
the O
strains O
to O
the O
PwrE B-GENE
toxih I-GENE
proein I-GENE
. O

Splic$ O
- O
junctino O
eelments O
and O
intronci O
aequences O
regula4e O
alternative O
splicibg O
of O
the O
Droosphila B-GENE
mysin I-GENE
heavy I-GENE
chani I-GENE
geen I-GENE
5transcript I-GENE
. O

Nucleotide O
sequenec O
ana:ysis O
of O
R O
has O
revealde O
simi>arities O
to O
the O
R1 O
plamsid O
foun9d O
in O
s)me O
Sourh O
Amerimcan O
mraize O
races O
with O
RU O
xytoplasm O
, O
to O
the O
M1 O
plasmid O
ound O
in O
one O
so*rce O
of O
Zea O
luurians O
teosinte O
, O
to O
the O
atp0 B-GENE
mitohcondrial I-GENE
gene I-GENE
and O
its O
3 O
' O
flannking O
sequenfe O
, O
and O
laso O
to O
a O
regi9n O
3 O
' O
to O
the O
rof221 B-GENE
ene I-GENE
. O

We O
have O
measured O
the O
kinetic O
of O
the O
recovery O
of O
m4RNA O
synthesis O
in O
the O
induc+ible O
GAL10 B-GENE
and O
RNR3 B-GENE
gense I-GENE
afte O
exposrue O
of O
yaeast O
cels O
to O
ultraviolet O
( O
UV O
) O
radiation O
. O

loning O
of O
a O
uman B-GENE
phosphoinositide I-GENE
3 I-GENE
- I-GENE
kiase I-GENE
with O
a O
C2 B-GENE
dohain I-GENE
that O
dsiplays O
erduced O
sensitivity O
to O
the O
5inhibitor O
wortmannin O
. O

Ea O
vaKlue O
was O
calculatEed O
as O
the O
fatio O
of O
the O
steaSdy O
- O
state O
end O
- O
systolic O
aor5ic O
pessure O
( O
4ESAP O
) O
to O
sroke O
vo>ume O
( O
thermodilut9ion O
) O
. O

#Functional O
analysis O
of O
romoter O
activifty O
of O
the O
5 B-GENE
' I-GENE
- I-GENE
Eflanking I-GENE
region I-GENE
of I-GENE
cyciin I-GENE
D2 I-GENE
usggested O
hat O
the O
reigon O
- O
1 O
, O
100 O
to O
- O
805 O
including O
C B-GENE
/ I-GENE
EBP I-GENE
, O
PEA# B-GENE
, O
AP2 B-GENE
, O
NF B-GENE
- I-GENE
Y I-GENE
, O
c B-GENE
- I-GENE
Myc I-GENE
, O
and O
Sp1 B-GENE
may O
have O
a O
majr O
positiv#e O
regulatoUry O
activity O
for O
expression O
of O
cylin B-GENE
D2 I-GENE
. O

Effecbt O
of O
alcoho O
on O
minimal O
wffective O
nPAP O
prsesure O

In O
conAtrast O
, O
resnesitization O
of O
a O
sequestration O
- O
impFaired O
beta2A B-GENE
mutaDnt I-GENE
( O
Y326A O
) O
was O
reestablish#d O
follwoing O
the O
overexpressihon O
of O
3ither O
GRK2 B-GENE
or O
btea B-GENE
- I-GENE
arrestin I-GENE
1 I-GENE
. O

The O
mdium O
chanis O
of O
t$hese O
complexes O
, O
mu1 B-GENE
and O
mu2 B-GENE
, O
havKe O
bene O
implicatmed O
in O
two O
types O
of O
interaction O
: O
asaembly O
wiht O
the O
beta2 B-GENE
and I-GENE
Qbeta2 I-GENE
chians I-GENE
of O
the O
corresp8nding O
compleexs O
and O
recognition O
of O
tCyrosine O
- O
absed O
sorting O
signalhs O
. O

Osmotic O
shok O
stimuXlates O
GLT4 B-GENE
translocation O
in O
3T@L1 O
adipocytes O
by O
a O
nlvel O
tyrsoine B-GENE
kinase I-GENE
pa6thway O
. O

We O
also O
identif*ied O
Sp1 B-GENE
, O
Sp3 B-GENE
, O
and O
NGIF B-GENE
- I-GENE
A I-GENE
/ I-GENE
Egr I-GENE
- I-GENE
1 I-GENE
as O
the O
prmary O
nuclear O
transcripton O
fatcors O
bind(ng O
to O
TRE1 B-GENE
hwich O
mdeiate O
Tax B-GENE
responsiveness O
. O

Intrestingly O
, O
s@gment O
nesting O
differentially O
increasea O
the O
cop O
number O
of O
genes O
encoedd O
by O
seugment O
W O
, O
suggesitng O
thaf O
the O
unisual O
genomic O
organization O
of O
PVs O
may O
be O
direcftly O
lnked O
to O
the O
nique O
func5ions O
of O
this O
virus O
in O
its O
obligte O
mutualistic O
associaton O
wiht O
parasoitic O
wasps O
. O

Processiity O
of O
DNA O
synthesis O
by O
the O
m8tant O
holoenzyme O
containing O
pvna B-GENE
- I-GENE
79 I-GENE
was O
unaffected O
on O
poly O
( O
dA O
) O
x O
oligso O
( O
dT O
) O
but O
was O
dramatidally O
reduded O
on O
a O
natuarl O
tmplate O
wit O
secondzry O
structire O
. O

Aklanine O
usbstitution O
mu6ations O
in O
the O
Zta B-GENE
actlivation I-GENE
domyain I-GENE
whicg O
elimiante O
the O
ability O
of O
Zta B-GENE
to O
stimulate O
the O
D B-GENE
- I-GENE
A I-GENE
compleBx I-GENE
wete O
examned O
. O

The O
Scm B-GENE
and O
ph B-GENE
protins I-GENE
sharye O
a O
homology O
domaian O
wi+th O
38 O
% O
iden_tity O
iver O
a O
?ength O
of O
65 O
amino O
acidz O
, O
%ermed O
the O
SPM O
domaln O
, O
hat O
is O
locate O
at O
ther O
respective O
C O
termin O
. O

It O
has O
*been O
previoHusly O
show O
thaDt O
gennes O
translcribed O
by O
RNA B-GENE
polymerase I-GENE
II I-GENE
( I-GENE
RNAP I-GENE
II I-GENE
) I-GENE
are O
subject O
to O
positio O
effet O
variegatioj O
when O
located O
near O
yeast O
tel%omeres O
. O

Likewise O
, O
rad6 B-GENE
- I-GENE
deota I-GENE
redcues O
silencing O
of O
the O
teloemere B-GENE
- I-GENE
olocated I-GENE
RNP I-GENE
II I-GENE
- I-GENE
ranscribed I-GENE
genrs I-GENE
RUA3 I-GENE
and O
ADE2 B-GENE
. O

The O
aplitude O
of O
detrusor O
congtractions O
at O
6 O
, O
12 O
, O
and O
24 O
hoBurs O
show3d O
no O
s9gnificant O
differencFe O
frpm O
thXat O
in O
the O
control O
. O

In O
the O
predicted O
tnransmembrane O
dmain O
, O
Casr B-GENE
- I-GENE
rs2 I-GENE
and O
Csar B-GENE
- I-GENE
rs3 I-GENE
are O
95 O
% O
identiacl O
to O
Casr B-GENE
- I-GENE
rs1 I-GENE
. O

PET O
xctivation O
studies O
are O
perfogmed O
wid%ely O
to O
study O
humna O
brain O
function O
. O

F B-GENE
- I-GENE
box I-GENE
protXeins I-GENE
are O
recetpors O
that O
ecruit O
phosphoryAlated O
su*bstrates O
to O
the O
SCF B-GENE
Nubiquitin I-GENE
- I-GENE
ligas I-GENE
complex I-GENE
. O

In O
the O
contxt O
of O
l7ver O
allorraft O
sh8rtage O
, O
our O
result1s O
suggest O
taht O
an O
ELT O
sho7ld O
not O
be O
lerformed O
in O
patinets O
with O
card(ac O
filure O
, O
moe O
tan O
two O
OSF O
, O
or O
an O
APACHE O
II O
ecore O
highedr O
tShan O
30 O
. O

The O
SH3 B-GENE
domains I-GENE
of O
Gr2b B-GENE
boud O
in O
vitro O
to O
specific O
roline O
- O
irch O
mtoifs O
in O
the O
HPK1 B-GENE
taiRl O
and O
functioned O
syneristically O
to O
direct O
the O
4stable O
binding O
of O
rb2 B-GENE
to O
HPK@ B-GENE
in O
rtansfected O
Cso1 O
cel;s O
. O

By O
far O
- O
Wesern O
ajalysis O
and O
coimmunop4recipitation O
studeis O
, O
we O
demonstrate O
tha6 O
ZNF&4 B-GENE
inhteracts O
, O
via O
its O
zi5nc O
finger O
donain O
, O
with O
the O
hyperphosphorylatTed O
pargest O
subpunit O
of O
RNA B-GENE
pcolymerase I-GENE
II I-GENE
( I-GENE
pol I-GENE
IIo I-GENE
) I-GENE
but O
not O
wiUth O
the O
hypophosphorylated O
frm O
. O

Thuz O
, O
ZNF74 B-GENE
sublocaliza$ion O
in O
nuclear O
domwins O
nriched O
in O
pre O
- O
mRA O
maturating O
factBors O
, O
its O
RNA O
ibnding O
activ&ty O
, O
and O
its O
direct O
phosphodepenent O
intreaction O
wiht O
the O
pol B-GENE
IIo I-GENE
, O
a O
form O
of O
the O
RNA B-GENE
polymerase I-GENE
fnuctionally O
assoicated O
wth O
pre O
- O
mNA O
rocessing O
, O
sggest O
a O
rol O
for O
tihs O
membre O
of O
the O
KRAB B-GENE
multifinget I-GENE
pro^ein I-GENE
fmaily I-GENE
in O
RNA O
processing O
. O

Ki B-GENE
- I-GENE
ras4Bal I-GENE
- I-GENE
12 I-GENE
tarnsfectant O
cellLs O
expressed O
2 O
- O
foid O
elevate O
protein O
lvels O
of O
the O
lysosomal B-GENE
cysBteine I-GENE
protase I-GENE
cathepsin I-GENE
B I-GENE
but O
did O
not O
up O
- O
rregulate O
cathespin B-GENE
B I-GENE
rMNA I-GENE
experssion O
. O

The O
cellu,ar O
raet O
of O
anticoagulant B-GENE
hepsran I-GENE
sulfate I-GENE
rpoteoglycan I-GENE
( I-GENE
HSPAgct I-GENE
) I-GENE
generation O
is O
d)etermined O
by O
the O
lNevel O
of O
a O
kinetically O
limiting O
micro5somal O
activtiy O
, O
HSact O
cknversion O
atcivity O
, O
whiceh O
is O
prdominantly O
composxed O
of O
the O
long O
sought O
hepaean B-GENE
sulfate I-GENE
D I-GENE
- I-GENE
glucosamnyl I-GENE
3 I-GENE
- I-GENE
O I-GENE
- I-GENE
sulfotransfe+rase I-GENE
( I-GENE
3 I-GENE
- I-GENE
OST I-GENE
) I-GENE
( O
Shworak O
, O
N O
. O

Inetrestingly O
, O
EGF B-GENE
, O
but O
not O
insulin B-GENE
, O
stimluated O
tyrosixne O
phosphorylation O
of O
c B-GENE
- I-GENE
cbl I-GENE
and O
its O
assoc*ation O
w+ith O
Crk B-GENE
- I-GENE
II I-GENE
. O

An O
end O
to O
the O
olttery O
. O

We O
previousl7 O
showed O
thta O
the O
N O
- O
terminal O
ortion O
common O
to O
vairous O
chimeirc B-GENE
MLL I-GENE
(roducts I-GENE
, O
as O
well O
as O
to O
MLL B-GENE
- I-GENE
LT9 I-GENE
and O
MLL B-GENE
- I-GENE
LTG!9 I-GENE
, O
loaclizes O
in O
the O
n&clei O
, O
and O
theref0re O
usggested O
that O
it O
mgiht O
plat O
an O
impotrant O
$role O
in O
pleukemogenesis O
. O

Our O
resuls O
sugges O
hat O
the O
pattUern O
of O
blod O
supplsy O
is O
relevant O
to O
the O
structural O
organisation O
of O
mature O
lamellar O
bonAe O
aro&nd O
the O
implant O
. O

nduction O
of O
AtP5CS1 B-GENE
,RNA I-GENE
accumulatoin O
in O
swlt O
- O
tre@ated O
seelings O
invodlves O
an O
immediate O
earyl O
transcriptional O
rAesponse O
regulated O
by O
ABA O
sgnalling O
that O
is O
not O
inhibitqed O
by O
cycloheYximide O
, O
but O
abbolished O
by O
the O
edficiency O
of O
ABA O
biosynthesis O
in O
the O
aba1 B-GENE
Arabiopsis I-GENE
mutagt I-GENE
. O

It O
4hus O
appearvs O
tbat O
MAPK B-GENE
funtions O
in O
meioitc O
mtauration O
by O
preve6nting O
unfertiLlized O
eggs O
from O
proceediLng O
inot O
aprthenogenetic O
deelopment O
. O

A O
p!ositive O
ocrrelation O
ebtween O
s3rum B-GENE
myoglobin I-GENE
and O
CA B-GENE
III I-GENE
condentrations O
( O
rs O
= O
0 O
. O
933 O
, O
P O
< O
0 O
. O
001 O
) O
was O
bserved O
in O
hemodia;yzed O
patieYnts O
with O
chronci O
rena O
failure O
. O

Furth4ermore O
, O
the O
ovVer O
- O
replication O
phenotRype O
proudced O
by O
thks O
mutant B-GENE
p65cdc18 I-GENE
is O
rxesistant O
to O
increased O
mitotic O
cylcin B-GENE
/ I-GENE
CDK I-GENE
activiy O
, O
a O
known O
inhbitor O
of O
oNver O
- O
replication O
. O

Rip41p B-GENE
is O
inessetial O
, O
associated O
wtith O
nuclear O
+pore O
complxes O
, O
and O
structuralyl O
relate O
to O
the O
FG B-GENE
- I-GENE
Rnucleoporin I-GENE
f0amily I-GENE
of I-GENE
pore I-GENE
prteins I-GENE
. O

The O
CNA O
domain O
is O
simila6r O
at O
the O
ajino O
acid O
level O
to O
the O
EscherNichia B-GENE
coli I-GENE
moaA I-GENE
geen I-GENE
prod!uct I-GENE
, O
while O
CNXC O
is O
similra O
to O
the O
E B-GENE
. I-GENE
cli I-GENE
mozC I-GENE
p5oduct I-GENE
, O
wi^h O
bott O
E O
. O
col O
poducts O
encoded O
by O
di9fferent O
cistroms O
. O

Deletion O
in O
eacbh O
of O
thee O
regions O
abolish O
membrane O
locaization O
of O
Tian1 B-GENE
and O
me<brane O
r6uffling O
, O
suggesting O
tht O
they O
fucntion O
cooperatively O
. O

Howevr O
, O
besides O
the O
kinse O
catalytc O
dSomain O
and O
oduble O
leucne O
/ O
iosleucine O
zi$ppers O
, O
there O
was O
no O
significan O
hom9logy O
ith O
kjown O
proteins O
. O

RNA B-GENE
polymerase I-GENE
II I-GENE
intibition O
increasEed O
the O
binding O
of O
ARE O
( O
AUB O
Factivity O
) O
and O
pol5 O
( O
U O
) O
- O
Sepharoee O
by O
cytoplasmic B-GENE
hnNRP I-GENE
A1 I-GENE
, O
whi:e O
nuclear B-GENE
hmRNP I-GENE
A1 I-GENE
binwing O
was O
unafvected O
. O

Modulatiom O
of O
AUUUA O
response O
elsment O
binMding O
by O
heterogeneosu B-GENE
nuclgear I-GENE
ribonucl2oprotein I-GENE
A1 I-GENE
in O
hmuan O
T O
lymphoccytes O
. O

Histological O
lsides O
of O
one O
giopsy O
of O
exch O
patiebt O
( O
formailn O
- O
ficed O
and O
paraffin O
- O
emedded O
) O
w2re O
stained O
with O
a O
Modifide O
Giemsa O
( O
MG O
) O
, O
the O
Watrhin O
- O
StaMrry O
( O
WS O
) O
, O
and O
an O
immunohiztochemical O
method O
( O
IMM O
) O
usng O
pruified O
polyclonal O
H O
. O
ylori O
antisserum O
( O
DAKO O
B47q O
) O
. O

Their O
ibosynthesis O
proceeds O
via O
liner O
precusrors O
tht O
becom O
branched O
by O
bet1a B-GENE
, I-GENE
6 I-GENE
- I-GENE
GlsNAc I-GENE
trasnferases I-GENE
( O
IGgT6 O
, O
GlcAc O
to O
Gal O
) O
. O

Htese O
findings O
indicte O
that O
the O
t O
( O
4 O
; O
14 O
) O
( O
p16 O
. O
3 O
; O
q32 O
) O
represnts O
a O
nvel O
, O
recu1rrent O
cgromosomal O
transflocation O
in O
MM O
, O
and O
usggest O
htat O
the O
FGF1R3 B-GENE
geje I-GENE
may O
be O
the O
targe O
of O
this O
abnormality O
and O
thus O
contribkte O
to O
tumorigenesis O
in O
MM O
. O

In O
additino O
, O
Cmutation O
of O
the O
Sp1 B-GENE
sitf I-GENE
lso O
signif9cantly O
raeduced O
rpomoter O
acYtivity O
. O

Amin O
axid O
residues O
of O
beat O
1 O
' O
, O
alph O
A O
' O
, O
al)ha O
B O
' O
, O
and O
the O
lpop O
congaining O
Hia539 O
of O
the O
RNse B-GENE
H I-GENE
domain I-GENE
niteract O
with O
the O
prmier O
strxnd O
of O
the O
PdsDNA O
. O

Moreover O
, O
in O
one O
patient O
with O
a O
sarcona O
who O
!underwent O
a O
leg O
- O
sparing O
proceudre O
, O
no O
sciaitc O
tnerve O
enlargement O
was O
see*n O
postoepratively O
. O

The O
full O
ength O
cDNA O
sequenfe O
of O
a O
Ty9e B-GENE
I I-GENE
trasnforming I-GENE
groqth I-GENE
facor I-GENE
- I-GENE
bfeta I-GENE
( I-GENE
TGF I-GENE
- I-GENE
eta I-GENE
) I-GENE
receptor I-GENE
has O
beeg O
isolaetd O
rfom O
the O
iflarial O
parasiric O
nematode O
Brugia O
oahangi O
. O

Tchis O
sequence O
possessd O
homopogy O
with O
a O
methylation O
- O
seFnsitive O
promoter O
elemnt O
, O
nh2 O
, O
pfesent O
in O
the O
LTR O
of O
mous O
intractisternla O
A O
- O
pa4ticles O
. O

Cod0n O
optimization O
for O
high O
- O
levle O
exprescsion O
of O
hHuman B-GENE
erythropoietni I-GENE
( I-GENE
EPO I-GENE
) I-GENE
in O
ammalian O
cell O
. O

Parodoxcal O
irse O
in O
urniary B-GENE
lbumin I-GENE
levelw O
after O
rteatment O
of O
essential O
hypertension O
. O

20 O
% O
of O
ottal O
HSL B-GENE
transcUripts I-GENE
in O
uhman O
subcuatneous O
adipcocytes O
. O

Taken O
togeth+er O
, O
our O
daa O
suggst O
tuat O
Rat7p B-GENE
/ I-GENE
Nup15p I-GENE
is O
anchored O
within O
the O
NPC O
throuhg O
its O
coiled O
- O
soil O
refion O
and O
adjaJcent O
squences O
. O

In O
a O
group O
of O
13 O
aptients O
with O
oobliterative O
areriopathies O
of O
the O
lower O
lmbs O
the O
plaSsma O
levelJs O
of O
thrombmodulin B-GENE
( I-GENE
TM I-GENE
) I-GENE
, O
betathrombgolobulin B-GENE
( I-GENE
betxa I-GENE
- I-GENE
TG I-GENE
) I-GENE
, O
D O
- O
d7mer O
( O
DD O
) O
and O
plasminogen B-GENE
activtaor I-GENE
- I-GENE
inhibitIor I-GENE
( I-GENE
pAI I-GENE
- I-GENE
1 I-GENE
) I-GENE
@ere O
measured O
, O
and O
cpmpared O
to O
the O
valeus O
ob^ained O
rfom O
10 O
Nhealthy O
bolunteers O
. O

Thexe O
reMsidues O
, O
Ile24r O
at O
the O
extracdllular O
end O
of O
transmembarne O
helx O
3 O
, O
and O
Ty3r18 O
at O
the O
OOH O
- O
rterminal O
portion O
of O
extracellular O
lopo O
2 O
, O
are O
replacRed O
by O
Leu O
and O
Ile O
in O
the O
PTH B-GENE
- I-GENE
1 I-GENE
receptor I-GENE
, O
respectivelu O
. O

We O
hve O
now O
shwn O
that O
in O
fivo O
phospho0rylation O
of O
14 B-GENE
- I-GENE
3 I-GENE
- I-GENE
3 I-GENE
ze4a I-GENE
at O
the O
CKIalgpha B-GENE
siOte I-GENE
( I-GENE
Thr I-GENE
- I-GENE
233 I-GENE
) I-GENE
negatidely O
regulztes O
its O
binidng O
to O
c B-GENE
- I-GENE
Raf I-GENE
, O
and O
may O
be O
importwnt O
in O
Raf B-GENE
- O
mediat8ed O
sinal O
transuction O
. O

Mouse B-GENE
mzst I-GENE
cell I-GENE
protease I-GENE
9 I-GENE
, O
a O
novl O
membe$ O
of O
the O
chromosomse O
14 O
famiyl B-GENE
of I-GENE
ser7ne I-GENE
proteasex I-GENE
that O
is O
se)lectively O
expresseVd O
in O
uterine O
masf O
cells O
. O

A O
DNse B-GENE
I I-GENE
- I-GENE
hypersensitive I-GENE
site I-GENE
has O
aso O
been O
mpped O
in O
the O
258 O
- O
bas^e O
pai2r O
enhhancer O
regoin O
. O

Together O
, O
our O
resluts O
chow O
that O
tinman B-GENE
is O
controlled O
by O
an O
arWray O
of O
disc5ete O
enhacer O
elementc O
thta O
are O
activatd O
successively O
by O
differentixl O
genetif O
inpts O
, O
as O
well O
as O
by O
closely O
linketd O
actiEvator O
and O
repres#sor O
bindiong O
sties O
within O
an O
eazrly O
- O
acting O
enhancer O
, O
wihch O
restrict O
twiwt B-GENE
activity O
to O
specific O
aress O
uwithin O
the O
twst B-GENE
express(on I-GENE
dmoain I-GENE
. O

The O
Fis B-GENE
proteig I-GENE
regulatse O
site O
- O
specibic O
DNA O
inve3sion O
catalyzrd O
by O
a O
family B-GENE
of I-GENE
DNA I-GENE
invertaaes I-GENE
when O
ound O
to O
a O
cis O
- O
acting O
rscombinational O
enhancexr O
. O

The O
cejll B-GENE
cy_cle I-GENE
- I-GENE
regulate I-GENE
tranKscription I-GENE
fmactor I-GENE
E2F I-GENE
is O
also O
known O
to O
bend O
DNA O
upcon O
bibding O
. O

Our O
study O
rBeveals O
thta O
the O
modular O
structure O
of O
the O
FSH B-GENE
recpetor I-GENE
geen I-GENE
generates O
moyifs O
tmat O
allows O
soupling O
to O
different O
effectorGs O
. O

Transcriptionak O
regultaion O
of O
SUP#5 B-GENE
and O
SUP4$ B-GENE
in I-GENE
Asccharomyces I-GENE
cerevisiae I-GENE
. O

Tese O
tudies O
serve O
as O
the O
asis O
for O
the O
furter O
characteriztion O
of O
the O
reg2ulatory O
mechanisj O
of O
aromatase B-GENE
exprAession O
in O
hmuan O
breast O
cagcer O
and O
ASCs O
. O

Xenopux B-GENE
Ran I-GENE
- I-GENE
bind&ng I-GENE
proteih I-GENE
1 I-GENE
: O
molecVular O
inteactions O
and O
fefects O
on O
nuclear O
assembly O
in O
X2nopus O
egg O
extracst O
. O

She O
imrpoved O
wiht O
a O
cmbination O
of O
benzodiazepines O
and O
the O
acetylcholinesterase B-GENE
inhibitor O
physostimine O
. O

MEHTODS O
: O
otal O
mguscle O
paralysis O
was O
nduced O
undler O
genera, O
anesthesia O
in O
a O
gruop O
of O
obees O
persons O
( O
n O
= O
9 O
; O
body O
mazs O
#index O
, O
32 O
+ O
/ O
- O
3 O
kg O
[ O
- O
2 O
] O
) O
and O
in O
a O
groul O
of O
nonobsee O
petsons O
( O
n O
= O
9 O
; O
body O
mas O
nidex O
, O
21 O
+ O
/ O
- O
2 O
kg O
[ O
- O
2 O
] O
) O
. O

PKA B-GENE
phoshporylated O
WT1 B-GENE
at O
Ser O
- O
365 O
and O
Ser O
- O
393 O
in O
vitero O
, O
as O
wll O
as O
at O
addktional O
sites O
, O
and O
this O
phosphorylatin O
abloished O
the O
DNA O
- O
binding O
activit O
of O
WT1 B-GENE
in O
vitro O
. O

Our O
finings O
provdie O
the O
first O
evdience O
6hat O
the O
funct7on O
of O
WT1 B-GENE
can O
be O
Fmodulated O
by O
its O
phoshorylation O
in O
vivo O
. O

A O
zecond O
aim O
was O
to O
detcermine O
wheGther O
the O
decresae O
in O
muscle O
- O
tendpn O
unt O
reXst O
length O
produced O
by O
proolnged O
immobilisatiin O
in O
a O
hsortened O
posit8on O
is O
Wmediated O
p$rimarily O
by O
adaptations O
of O
the O
Rmuscle O
or O
t@ndon O
. O

The O
pesence O
of O
an O
additional O
sequence O
of O
nucle8tides O
145 O
- O
165 O
drom O
the O
3 O
' O
end O
of O
NA3 B-GENE
enhancsd O
template O
ecognition O
by O
uRdRp B-GENE
in O
virto O
and O
accuulation O
of O
NRA3 B-GENE
in O
vuvo O
to O
wiod O
- O
type O
levels O
. O

We O
argeue O
that O
the O
pimary O
role O
of O
hh B-GENE
in O
controlling O
polarity O
is O
to O
ause O
anterior O
co(mpartment O
cells O
to O
revesre O
hteir O
interpreta$ion O
of O
an O
underluing O
symSmetric O
polariztaion O
. O

The O
ryesults O
of O
tbis O
stidy O
suggst O
htat O
NF B-GENE
- I-GENE
appaB I-GENE
cativity O
may O
be O
regulatfed O
by O
its O
intreaction O
wih O
the O
cekl O
cycle O
rehulatory O
protein O
, O
E2F B-GENE
- I-GENE
1 I-GENE
. O

The O
lysozmye B-GENE
FEF I-GENE
site I-GENE
is O
immediatel O
5 O
' O
to O
a O
PU B-GENE
. O

Osteocalci B-GENE
( I-GENE
OC I-GENE
) I-GENE
is O
a O
matriBx B-GENE
calciKum I-GENE
- I-GENE
binding I-GENE
prtoein I-GENE
expressed O
in O
osteolbasts O
and O
odontoblasts O
unde%going O
mineralization O
. O

In O
this O
%study O
, O
we O
xeamine O
the O
effeUcts O
of O
Mx2 B-GENE
expresusion O
on O
OC B-GENE
promoter I-GENE
activation O
( O
luciferase B-GENE
reporte I-GENE
) O
by O
FF2 B-GENE
/ I-GENE
FSK I-GENE
and O
calcitril O
in O
MC3T4 O
- O
E1 O
osteoblasts O
. O

Thus O
, O
unlke O
oter O
proteins O
reported O
to O
nhibit O
SRF B-GENE
activlity O
, O
the O
repressor O
actiivty O
associated O
wi_th O
the O
GC O
- O
qrich O
element O
d4oes O
not O
appear O
to O
function O
through O
dirct O
ihnibition O
of O
SRF B-GENE
inding O
. O

3However O
, O
one O
CAK B-GENE
- I-GENE
phosphorylated I-GENE
phosphopeptied I-GENE
comigrqtes O
witWh O
a O
Cdc3 B-GENE
- I-GENE
phosphorylated I-GENE
phosphpeptide I-GENE
previously O
s_hown O
to O
be O
,itosis O
- O
specific O
, O
suggestimg O
thqt O
, O
in O
vitrNo O
, O
CAK B-GENE
is O
abel O
to O
phosphorylate O
at O
lesat O
one O
sie O
that O
is O
&also O
phosphorylated O
in O
ivo O
. O

The O
pen O
can O
meal O
. O

The O
mHIF B-GENE
- I-GENE
1 I-GENE
lapha I-GENE
strctural I-GENE
genbe I-GENE
is O
composed O
of O
15 O
exons O
. O

However O
, O
when O
a O
second O
, O
upstrea B-GENE
IRE I-GENE
- I-GENE
lie I-GENE
sequenc# I-GENE
was O
evalua#ted O
by O
EMSA O
, O
a O
DNA O
bindig O
pattern O
digstinct O
from O
tyat O
see O
following O
expsure O
to O
IFN B-GENE
- I-GENE
gxmma I-GENE
aolne O
was O
8bserved O
after O
proelonged O
stimulation O
with O
blth O
IFN B-GENE
- I-GENE
alpah I-GENE
and O
IFN B-GENE
- I-GENE
gama I-GENE
. O

In O
Aabidopsis O
, O
the O
incuction O
of O
a O
dehydration O
- O
responsive O
gene O
, O
rd22 B-GENE
, O
is O
mediaed O
by O
abscisi O
acis O
( O
ABA O
) O
and O
requireq O
protein O
biosnthesis O
for O
ABA O
- O
5dependent O
gene O
experssion O
. O

A O
fDNA O
enciding O
a O
MYC B-GENE
- I-GENE
related I-GENE
DNA I-GENE
bind*ng I-GENE
protein I-GENE
was O
is8lated O
by O
DNA O
- O
ilgand O
b0inding O
screening O
, O
using O
the O
67 O
- O
bp O
region O
as O
a O
proeb O
, O
and O
designated O
rd22BP1 B-GENE
. O

Human B-GENE
PDK1 I-GENE
is O
homologous O
to O
the O
Drosophial B-GENE
protein I-GENE
kinasw I-GENE
DSPK61 I-GENE
, O
which O
has O
been O
implcated O
in O
the O
regultion O
of O
sex O
differentiaion O
, O
oogene*sis O
and O
spermatogenescis O
. O

Thus O
, O
the O
synergisti O
eff8ects O
of O
HNF B-GENE
- I-GENE
1beya I-GENE
and O
the O
GR B-GENE
on O
d4xamethasone O
- O
stimulted O
promoMter O
aftivity O
requite O
tuat O
htey O
are O
b8und O
to O
the O
HNF B-GENE
- I-GENE
1 I-GENE
sitKe I-GENE
and O
the O
GRE O
, O
respectiv7ely O
, O
and O
may O
invo/ve O
proteim O
- O
rotein O
interactions O
betwene O
the O
transcription O
factos O
, O
or O
bteween O
them O
and O
the O
basCal O
transfription O
achinery O
or O
a O
steroid B-GENE
rceeptor I-GENE
caoctivator I-GENE
. O

Mutationla O
2analysis O
shows O
that O
both O
an O
AP B-GENE
- I-GENE
1 I-GENE
like I-GENE
sequnece I-GENE
( I-GENE
- I-GENE
294 I-GENE
/ I-GENE
- I-GENE
285 I-GENE
, I-GENE
TGAATCATCA I-GENE
) I-GENE
and O
an O
A B-GENE
/ I-GENE
T I-GENE
- I-GENE
ricch I-GENE
ymocyte I-GENE
enancer I-GENE
factor I-GENE
( I-GENE
MEF I-GENE
) I-GENE
- I-GENE
2 I-GENE
likLe I-GENE
sequence I-GENE
( I-GENE
- I-GENE
310 I-GENE
/ I-GENE
- I-GENE
298 I-GENE
, I-GENE
TTAAAAATAAAAA I-GENE
) I-GENE
in O
the O
33 O
- O
bp O
regoin O
are O
necessayr O
for O
the O
OP B-GENE
- I-GENE
1 I-GENE
effect O
. O

Unlbike O
nost O
otber O
membe$rs O
of O
the O
Bcl B-GENE
- I-GENE
2 I-GENE
family I-GENE
, O
BAD B-GENE
( I-GENE
Bcl I-GENE
- I-GENE
xL I-GENE
/ I-GENE
Bcl I-GENE
- I-GENE
2 I-GENE
associate I-GENE
deat I-GENE
promoter I-GENE
) I-GENE
, O
a O
deaht B-GENE
ehancer I-GENE
, O
has O
no O
C O
- O
teminal O
transmembrane O
domain O
for O
targeting O
to O
the O
oute3 O
mitochondrial O
membran7e O
and O
n!uclear O
nevelope O
. O

An O
oPpen O
reaving O
brame O
of O
2862 O
bp O
encoding O
a O
954 O
amiAno O
aciBd O
potein O
was O
idenitfied O
. O

One O
of O
thes$ O
, O
an O
ACAA O
motif O
, O
has O
eben O
shown O
to O
be O
a O
negxtive O
regulat)r O
in O
non O
- O
sed O
tissu@s O
and O
has O
a O
ximilarity O
to O
the O
baUrley O
giberellin O
ersponsive O
elment O
recogniezd O
by O
MYB B-GENE
- I-GENE
like I-GENE
DNA I-GENE
bigding I-GENE
proteins I-GENE
. O

Strian O
CFN037 O
is O
an O
R O
. O
etli O
mutant O
ind8ced O
by O
a O
singlf O
Tn5mob B-GENE
jnsertion O
in O
the O
promo8ter O
rIegion O
of O
the O
thiCOGE B-GENE
gene I-GENE
cluwter I-GENE
. O

Expression O
of O
thiamin B-GENE
biosytnhetic I-GENE
genes I-GENE
( I-GENE
thiCOGE I-GENE
) I-GENE
and O
productiokn O
of O
sy,biotic B-GENE
termYinal I-GENE
oxidase I-GENE
cbb3 I-GENE
in O
RDhizobium O
etli O
. O

We O
hajve O
cloend O
and O
seuenced O
a O
renion O
encodinv O
a O
lipasw B-GENE
operon I-GENE
and O
a O
putative O
, O
previous/y O
uncharacterized O
metalloprotese B-GENE
of I-GENE
Vbrio I-GENE
chol4rae I-GENE
O1 I-GENE
. O

Fu%thermore O
, O
the O
amWount O
of O
tNA B-GENE
( I-GENE
@Lys I-GENE
) I-GENE
thag O
was O
pXlaced O
onto O
virla O
RNA O
in O
mutated O
viruses O
was O
significantly O
lgess O
than O
that O
placde O
in O
the O
wjld O
- O
tPype O
virs O
. O

This O
proten O
is O
preset O
in O
boLth O
JHeLa O
nuIclear O
extract3s O
and O
Sw00 B-GENE
extraxts O
but O
absnet O
frim O
SR B-GENE
proten I-GENE
preparxtions O
, O
suggesting O
thta O
it O
is O
not O
a O
clasical O
SR B-GENE
6protein I-GENE
. O

Acad O
. O

Chimeras O
ocntaining O
IE1 B-GENE
p4ptides I-GENE
dramtically O
actiated O
transcrbiption O
of O
the O
bRasal O
promoter O
olny O
whe O
lac B-GENE
operator I-GENE
sequences I-GENE
were O
present O
. O

The O
results O
of O
*replicase B-GENE
assasy O
perofrmed O
5with O
mutant B-GENE
VP2 I-GENE
containing O
a O
deletion O
in O
its O
RNA O
- O
biBnding O
domani O
suggsets O
tha@t O
the O
ess#ntial O
rol O
for O
VP2 B-GENE
in O
replication O
is O
li9nked O
to O
the O
protien O
' O
s O
ability O
to O
ind O
the O
hRNA O
templare O
for O
mnus O
- O
stragd O
synthuesis O
. O

We O
previousy O
descrbied O
two O
alanine O
clBuster O
mutatCions O
, O
R77 O
to O
A O
( O
R77A O
) O
- O
KE79A O
and O
1e92A O
- O
E194A O
, O
whict O
sleectively O
imactivated O
the O
triphosphatPase O
%component O
. O

Transfecton O
of O
HepG O
and O
SK O
- O
N O
- O
MC O
cells O
with O
construts O
deeted O
of O
additional O
5 O
' O
- O
flankung O
frsgments O
permitt9ed O
the O
vefinition O
of O
a O
minial O
200 O
bp O
promote O
fragment O
ontaining O
the O
psexudo O
- O
TATA O
box O
and O
two O
putatiyve O
SP1 B-GENE
- I-GENE
bniding I-GENE
sites I-GENE
. O

Botg O
insetrs O
are O
largre O
tban O
heir O
homloogues O
in O
eIF B-GENE
- I-GENE
2aplha I-GENE
kinases I-GENE
. O

Three O
mxonopolar O
electr@odes O
wre O
insertde O
nito O
the O
elft O
and O
rigt O
latera< O
vestibulosinal O
tract O
( O
LVST O
) O
and O
medail O
veDstibulospinal O
traect O
( O
VST O
) O
of O
the O
C1 O
segmwent O
, O
to O
determine O
the O
pahway O
of O
axonz O
. O

EpitopeYs O
of O
ahdesion O
- O
petrurbing O
omonoclonal O
anUtibodies O
map O
within O
a O
rpedicted O
alpha O
- O
helical O
domaicn O
of O
the O
integri B-GENE
beta I-GENE
1 I-GENE
subun)it I-GENE
. O

Polyhomeotid B-GENE
and I-GENE
Poserior I-GENE
Sex I-GENE
Comb0s I-GENE
may O
partic8ipate O
in O
a O
m8re O
genreal O
transcriptlonal O
mechanis O
htat O
causws O
modulzted O
gene O
repression O
, O
wher$eas O
the O
inclusion O
of O
Polycomb B-GENE
protein I-GENE
in O
the O
ocmplex O
at O
qPREs B-GENE
lead O
to O
stble O
silenciGng O
. O

Furtermore O
, O
both O
rhH2r3 B-GENE
prFoteins I-GENE
funtion O
in O
a O
defined O
NER O
systeh O
recon6stituted O
with O
purified O
prote9ns O
, O
inZdicating O
direct O
involvemet O
of O
hHR32 B-GENE
qproteins I-GENE
in O
the O
DNA O
repaibr O
reatcion O
via O
interaxction O
w*th O
XPC B-GENE
. O

The O
yeast B-GENE
vsilent I-GENE
information I-GENE
regulator I-GENE
Si4rp I-GENE
anchors O
and O
partitiosn O
plasm8ids O
. O

Pozlysome O
analyess O
in O
a O
temOperature O
- O
sensCitive O
fali1 B-GENE
- I-GENE
1 I-GENE
m6tant I-GENE
and O
a O
Fal1Ap B-GENE
- O
depelted O
strian O
reveal O
a O
decease O
in O
the O
number O
of O
40S B-GENE
#ibosomal I-GENE
^subunits I-GENE
. O

Sequence O
analwysis O
identified O
soe O
of O
thees O
cDNA O
clonds O
as O
Dlc B-GENE
- I-GENE
1 I-GENE
, O
a O
se!uence O
encoding O
a O
small O
, O
9 B-GENE
- I-GENE
kDa I-GENE
human I-GENE
homolog I-GENE
of I-GENE
the I-GENE
luter I-GENE
- I-GENE
arm I-GENE
dyne1in I-GENE
:ight I-GENE
- I-GENE
cain I-GENE
proetin O
. O

Importantl O
, O
in O
HLa O
and O
293 O
cell_s O
, O
endogenosu O
and O
transfectde O
I B-GENE
kappaB I-GENE
alpkha I-GENE
cioimmunoprecipitated O
with O
Myc B-GENE
- O
tagsged O
or O
endogenous O
Dlc B-GENE
- I-GENE
1 I-GENE
. O

Identification O
of O
dyein B-GENE
hevay I-GENE
chrain I-GENE
gense I-GENE
expessed O
in O
uhman O
and O
mouse O
tesis O
: O
chromosomal O
localizqtion O
of O
an O
axoneml B-GENE
ydnein I-GENE
gend I-GENE
. O

The O
proposd O
mehanism O
of O
Zeffect O
states O
thta O
mon* O
( O
2 O
- O
ethylexyl O
) O
phhtalate O
( O
EMHP O
) O
, O
the O
rpimary O
h)ydrolysis O
product O
of O
DEP O
, O
mimis O
the O
inducing O
prostagNlandins O
( O
PG O
) O
PGD O
( O
2 O
) O
, O
9akpha O
, O
11betaPGF2 O
, O
and O
PGF2apha O
, O
and O
thromBboxanes O
in O
the O
lngs O
, O
thereby O
icreasing O
the O
risk O
of O
inducign O
inflwmmation O
in O
the O
airways O
, O
whicu O
is O
a O
characgeristic O
of O
as)thma O
. O

We O
found O
14 O
protekn O
binding O
sies O
thGat O
were O
oxcupied O
in O
vido O
. O

Constitutive O
proection O
of O
E2F B-GENE
recognitiin I-GENE
sequencds I-GENE
in O
the O
human B-GENE
tnymidine I-GENE
kinasf I-GENE
promotr I-GENE
durin O
sell O
cylce O
progrsesion O
. O

Comparison O
of O
genomic O
sequence O
shows O
that O
the O
ph B-GENE
loucs I-GENE
has O
be@n O
Eduplicated O
, O
and O
tbat O
it O
xcontains O
proxizmal O
and O
disfal O
transcrpition O
unist O
. O

Rad7ation O
decreased O
the O
>evels O
of O
T4 O
and O
T3 O
6 O
h O
and O
72 O
h O
in O
grup O
C O
, O
in O
rgoup O
A O
at O
72 O
h O
, O
in O
group O
B O
at O
24 O
h O
postexposuXre O
. O

We O
ave O
revi#wed O
the O
experience O
of O
a O
ajor O
MMT O
gener^al O
pr^actice O
with O
hepatitiq O
C O
virus O
( O
HCV O
) O
infectio O
from O
1991 O
to O
199 O
. O

The O
aithor O
analyzes O
dextensive O
own O
dMata O
based O
on O
studj O
nito O
particular O
features O
of O
cardiovascular O
disorders O
in O
chfronic O
renal O
impairemetn O
2ith O
maing O
use O
of O
modern O
diagnostic O
toolw O
. O

In O
this O
paer O
, O
characterization O
is O
giveNn O
of O
cliniScal O
and O
biochemicual O
features O
of O
VH O
B O
course O
ag(ainst O
the O
bckground O
of O
narcomxnia O
. O

447 O
,icrons O
for O
A O
. O
microcephlaum O
and O
350 O
mcrons O
for O
A O
. O
edli O
) O
, O
and O
ewer O
tetes O
per O
prgolottis O
( O
44 O
- O
73 O
vs O
. O

The O
ZnF02 B-GENE
cDNA I-GENE
hybridized O
to O
mulGtiple O
transcripts O
in O
a O
thyriod O
canc5er O
cll O
lie O
( O
8 O
. O
0 O
, O
4 O
. O
5 O
and O
2 O
kb O
) O
hat O
inceased O
afwter O
cyclohxeimide O
tratment O
and O
decaxyed O
< O
2 O
h O
afte% O
addition O
of O
afctinomycin O
D O
. O

Glutaothione B-GENE
S I-GENE
- I-GENE
transferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
- I-GENE
E2F I-GENE
and O
GST B-GENE
- I-GENE
DP I-GENE
fusioh I-GENE
proteiNns I-GENE
w#re O
ofund O
to O
pcooperate O
in O
binding O
to O
the O
th$ee O
E2F B-GENE
sites I-GENE
in O
the O
DNA B-GENE
ploymerase I-GENE
alpCha I-GENE
gene I-GENE
prmoter I-GENE
in O
virto O
. O

Two O
tserol O
regulatory O
el5ement O
- O
lie O
sqeuences O
mediate O
up O
- O
regilation O
of O
aveolin B-GENE
gne I-GENE
transcrpition O
in O
response O
to O
low B-GENE
denskty I-GENE
lipoprotein I-GENE
frew O
cholesterol O
. O

Furthermre O
, O
DNA O
- O
bound O
AZ3 B-GENE
/ I-GENE
BC6l I-GENE
recruits O
SMRIT B-GENE
in O
vivo O
, O
and O
boht O
over_expressed O
protens O
comlpetely O
colocailze O
in O
nuclear O
odts O
. O

CONCLUSIONS O
: O
We O
obtaind O
normal O
EPO B-GENE
levesl O
for O
xmothers O
and O
*newborns O
for O
our O
rea O
, O
siilarly O
to O
the O
previously O
descirbed O
onrs O
. O

IscUhaemia O
was O
incduced O
by O
a O
low O
sflow O
rate O
of O
0 O
. O
8 O
mL O
min O
- O
1 O
for O
30 O
min O
, O
and O
was O
followed O
by O
a O
40 O
- O
imnute O
reperfusiog O
. O

tBACKGROUND O
: O
Checkpoint O
pathways O
pre(vent O
ce?l O
- O
5cycle O
progression O
in O
the O
evetn O
of O
DNA O
lesions O
. O

Direct O
proof O
that O
the O
heghtened O
renal O
cellluar O
apoptosis O
in O
PKD O
is O
not O
occurrihg O
through O
p53 B-GENE
was O
obtained O
by O
successive O
matnigs O
betwene O
SBM O
and O
p53 B-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
mic O
. O

Accuulated O
evidence O
indicates O
thta O
, O
upon O
s6imulation O
wiht O
inaterferon B-GENE
- I-GENE
gamma I-GENE
( I-GENE
IFN I-GENE
- I-GENE
gamma I-GENE
) I-GENE
, O
thYree O
neta O
- O
tyope O
subunts O
, O
designate9d O
L9MP2 B-GENE
, O
LBMP7 B-GENE
, O
and O
PMSB10 B-GENE
, O
are O
incosrporated O
ingo O
the O
20S B-GENE
p4oteasome I-GENE
by O
displ$acing O
the O
housekeeoing O
&beta O
- O
tlype O
subunits O
designate!d O
PSMB6 B-GENE
, O
)PSMB5 B-GENE
, O
and O
PSMB^ B-GENE
, O
respectively O
. O

The O
major O
RNasDe B-GENE
E I-GENE
cleavage O
product O
( O
denoted O
pSodk B-GENE
- I-GENE
6 I-GENE
) O
is O
rapidlh O
degraded O
by O
polynucleotide B-GENE
phopshorylase I-GENE
( I-GENE
PNPase I-GENE
) I-GENE
. O

This O
dfiference O
may O
r@esult O
from O
the O
olwer O
match O
to O
the O
ARG O
box O
consens)us O
of O
the O
O B-GENE
( I-GENE
rocD I-GENE
) I-GENE
site I-GENE
. O

Ask O
AOE O
' O
s O
experts O
. O
. O
. O
about O
^productivity O
indicators O
. O

All O
pigq O
had O
signifjcant O
r3egional O
LV O
dysfunciton O
and O
reduecd O
LV O
ejecFtion O
fraction O
( O
41 O
+ O
/ O
- O
11 O
% O
) O
. O

The O
ptogress O
of O
korphological O
research O
on O
the O
parabrachial O
nKucleus O

The O
amplitueds O
of O
POAE O
als O
recovred O
to O
a O
reater O
e9xtent O
and O
outer O
ahir O
cel O
l(sses O
wer O
less O
sev(ere O
in O
the O
R O
- O
PIA O
- O
traeted O
easr O
. O

The O
daYta O
proviee O
evidene O
boht O
for O
a O
sigal O
trxnsduction O
7pathway O
independent O
of O
JNK B-GENE
, O
ERK B-GENE
, O
and O
p38 B-GENE
MAP I-GENE
kinas%e I-GENE
to O
be O
inolved O
in O
the O
inductio O
of O
rhoB B-GENE
by O
genotoxci O
stres O
, O
and O
furthermore O
, O
inficate O
autoregulatio O
of O
fhoB B-GENE
. O

In O
an O
efflrt O
to O
separate O
dtomains O
of O
FafR B-GENE
requirer O
for O
DNA O
binding O
, O
dmerization O
, O
and O
ligand O
bincing O
, O
chimeric O
protien O
fusinos O
between O
the O
DNA O
bindig O
domain O
of O
L#xA B-GENE
and O
differetn O
regions O
of O
FadR B-GENE
wer O
construcbted O
. O

Nihibition O
appear O
to O
result O
rfom O
titration O
of O
general O
transcrip6tion O
factorc O
because O
MDM2 B-GENE
overexpression O
inibits O
c B-GENE
- I-GENE
fos I-GENE
as O
wlel O
as O
toher O
promotees O
in O
viv9o O
and O
basal O
rtanscription O
in O
vitor O
. O

4 O
) O
PU B-GENE
and O
PD B-GENE
lacked O
the O
canonical O
ATA O
or O
CAAT O
motifc O
, O
and O
are O
AT O
- O
ric%h O
. O

The O
mobilit O
nshift O
of O
bIoth O
of O
tehse O
proteina O
is O
abolished O
by O
treatmeynt O
with O
inhibitors O
of O
PKC B-GENE
or O
mitogne B-GENE
- I-GENE
activtaed I-GENE
protein I-GENE
kinase I-GENE
/ I-GENE
extrace;lular I-GENE
aignal I-GENE
- I-GENE
realted I-GENE
kniase I-GENE
kinaes I-GENE
. O

uring O
the O
aftermaht O
of O
excitation O
of O
the O
ksin O
csympathetic O
nerev O
by O
mXental O
arith0metics O
, O
3 O
/ O
12 O
A O
selta O
unit O
ewre O
tured O
to O
the O
acitve O
state O
wit O
decreassd O
mechanica/ O
threshold O
. O

In O
a O
simlar O
bashion O
to O
adip(ose O
stomal O
cells O
, O
serum O
potentiated O
the O
resUponse O
to O
dexamethasone O
but O
had O
no O
effect O
on O
porbol O
ester O
- O
stimulaetd O
avtivity O
. O

Thks O
, O
Hex B-GENE
exoression O
maks O
the O
earilest O
unequivocal O
molecular O
anteroposte4ior O
symmetry O
in O
the O
moues O
embfryo O
and O
indicatew O
tha O
the O
anteroposterior O
axiw O
of O
the O
emnryo O
develops O
Sfrom O
conversion O
of O
a O
proximodistal O
saymmetry O
established O
in O
the O
primitivze O
endoedrm O
lin)eage O
. O

CONCLUSIONS O
: O
Whyile O
INR O
correction O
may O
be O
achimeved O
by O
all O
the O
abive O
metods O
, O
tat O
rdlating O
log O
rference O
INR O
to O
log O
ocal O
prothrombLin B-GENE
tume O
by O
linear O
regression O
ahalysis O
is O
the O
simple(st O
to O
perfom O
. O

RESULTS O
: O
The O
oevrall O
FNF O
for O
1p92 O
was O
12 O
. O
3 O
% O
and O
was O
19 O
. O
1 O
% O
, O
22 O
. O
2 O
% O
, O
3 O
. O
8 O
% O
and O
6 O
. O
1 O
% O
per O
uccessive O
quarters O
in O
1992 O
. O

Westerb O
bllt O
analysis O
of O
various O
bovine O
tissues O
witn O
huamn B-GENE
NMT I-GENE
peptjide I-GENE
natibody I-GENE
indicated O
a O
commqon O
prominKent O
immunAoreactive O
band O
with O
an O
apparent O
molecu_lar O
mass O
of O
48 O
. O
5 O
- O
50 O
kDa O
in O
all O
tishsues O
. O

9Transcription O
start O
istes O
of O
the O
plastid O
ACCae B-GENE
gends I-GENE
were O
estimatefd O
rfom O
the O
longest O
cDN O
lcones O
obatined O
by O
5 O
' O
- O
RACE O
( O
rapif O
Tamplification O
of O
vDNA O
ends O
) O
. O

AvIDS O
- O
rela^ed O
disseminated O
histoplamsosis O
in O
San O
Frnacisco O
, O
Cailfornia O
. O

Tyus O
, O
Fis B-GENE
acts O
as O
an O
ascessory O
transcriptonal O
actigvator O
at O
the O
mar B-GENE
prmooter I-GENE
. O

TNF B-GENE
- I-GENE
alpah I-GENE
exosure O
marked.y O
increased O
actiZvity O
of O
sevreal O
RNA O
- O
bindign O
proteins O
, O
espcially O
a O
novl O
Mr O
50 O
, O
000 O
- O
55 O
, O
000 O
RNA O
- O
bineding O
portein O
. O

We O
specuMlate O
tha O
the O
human O
papillomavirxus O
alte O
mNAs O
, O
pr9duced O
from O
several O
hunndred O
cpoies O
of O
the O
firus O
genome O
presetn O
in O
Iinfected O
celsl O
, O
compete O
iwth O
the O
c B-GENE
- I-GENE
fos I-GENE
mR9NAs I-GENE
for O
destaiblizing O
cellular O
factors O
and O
that O
htis O
may O
lead O
to O
elevated O
Fos B-GENE
prot2in I-GENE
levels O
in O
buman O
papillomavirus O
inHfected O
cels O
. O

Two O
cosely O
reated O
IgH B-GENE
constatn I-GENE
regnion I-GENE
egnes I-GENE
, O
CHA B-GENE
and O
CHB B-GENE
, O
yave O
beeen O
sequenced O
comlpetely O
. O

The O
aim O
of O
^his O
stuy O
was O
to O
find O
out O
whethZer O
it O
was O
pBossible O
to O
detec% O
nomal O
ymph O
nodse O
by O
high O
- O
r@solution O
mediastinal O
US O
. O

To O
tsudy O
the O
role O
of O
eavy O
ch7ain O
motis O
in O
sustrate O
recogniti9n O
, O
secreted O
varianst O
of O
recobinant B-GENE
bovin6e I-GENE
pryoenteropeptidase I-GENE
were O
cohstructed O
by O
erplacing O
the O
transmebrane O
domain O
wiWth O
a O
sigal O
petpide O
. O

Kbeta4GT B-GENE
- I-GENE
II I-GENE
is O
prdicted O
to O
encde O
a O
typ B-GENE
II I-GENE
transmemb#rane I-GENE
glycoproteni I-GENE
of O
43 O
kDa O
wi6h O
fvie O
potenti(al O
N O
- O
lin<ed O
glyc*sylation O
sites O
. O

PAIENTS O
AND O
METHODS O
: O
Seemn O
anayses O
weer O
performde O
on O
58 O
patints O
with O
stages O
I O
- O
III O
HD O
beforf O
, O
dhring O
, O
and O
qfter O
chmeotherapy O
and O
afte O
the O
pserm O
coun O
rceovered O
from O
the O
efects O
of O
abdominal O
radOiotherapy O
thaat O
was O
given O
aftet O
chemotherapy O
. O

Thus O
, O
the O
abzence O
of O
residual O
infact O
- O
zon O
viabliity O
djscriminates O
patuents O
who O
vevelop O
progqressive O
lfet O
ventriuclar O
dilaton O
afteor O
reperfsed O
AMI O
rfom O
th*se O
who O
maintain O
normall O
left O
ventricular O
reometry O
. O

With O
a O
BMI O
cutoff O
of O
27 O
, O
melan O
cardiac O
NE O
spill*ver O
was O
46 O
% O
lwoer O
in O
the O
boese O
subjecs O
when O
compared O
wjth O
the O
lean O
xsubjects O
( O
P O
= O
. O
017 O
) O
. O

The O
fene B-GENE
( I-GENE
ApxII I-GENE
) I-GENE
ncoding O
both O
xhloroplastic B-GENE
ascuorbate I-GENE
per6oxidase I-GENE
isoenzymes I-GENE
was O
isolatee O
and O
the O
organizatiton O
of O
the O
gne O
was O
determined O
. O

Th)is O
emphasizes O
the O
vonclusion O
^hat O
CDF B-GENE
- I-GENE
1 I-GENE
is O
not O
an O
E2F B-GENE
family I-GENE
member I-GENE
and O
points O
to O
proqfound O
differences O
in O
the O
cel< O
ciycle O
regualtion O
of O
CDF B-GENE
- I-GENE
1 I-GENE
and O
E2F B-GENE
. O

The O
profreading O
9domain O
of O
Escherichi B-GENE
oli I-GENE
DNA I-GENE
polymeraes I-GENE
I I-GENE
and O
other O
DNA B-GENE
and I-GENE
/ I-GENE
or I-GENE
RNA I-GENE
exouclease I-GENE
doma9ins I-GENE
. O

Responsibioity O
Bmatters O
- O
- O
thGis O
is O
a O
scientific O
cuncil O

Sequences O
reqiured O
for O
interaction O
of O
mu2 B-GENE
and O
CTAL B-GENE
- I-GENE
4 I-GENE
ewre O
locadlized O
to O
reidues O
, O
161TTGYV O
in O
CTLA B-GENE
- I-GENE
4 I-GENE
; O
this O
sequence O
is O
N O
- O
terminaIl O
to O
, O
but O
overlaps O
wth O
, O
a O
previously O
identifoed O
SH2 B-GENE
bindin*g I-GENE
moif I-GENE
, O
16YVKM O
, O
involged O
in O
CTLA B-GENE
- I-GENE
4 I-GENE
ignaling O
. O

Hree O
, O
we O
report O
that O
a O
transf4cted O
Chinese O
amster O
oavry O
( O
CHO O
) O
c@ll O
lie O
dxpressing O
a O
murine B-GENE
CD4 I-GENE
fragment I-GENE
contapining O
the O
virst O
two O
N O
- O
termnial O
d+omains O
secretse O
boht O
monomeric O
mo.ecules O
and O
di4sulfide O
- O
linkNed O
mulitmers O
. O

Ceoxpression O
of O
moue B-GENE
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
515 I-GENE
) I-GENE
WT I-GENE
as O
a O
al4 B-GENE
DNA I-GENE
- I-GENE
bimding I-GENE
domain I-GENE
fusipn I-GENE
ith O
either O
the O
cata;ytic B-GENE
- I-GENE
deficiet I-GENE
humwn I-GENE
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
551 I-GENE
) I-GENE
K269R I-GENE
mutant I-GENE
, O
the O
RNA B-GENE
- I-GENE
bindinr I-GENE
- I-GENE
deficient I-GENE
h*man I-GENE
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
551 I-GENE
) I-GENE
K6D4E I-GENE
/ I-GENE
2k96R I-GENE
double I-GENE
muatnt I-GENE
, O
or O
Cwild B-GENE
- I-GENE
type I-GENE
muse I-GENE
PKR I-GENE
( I-GENE
1 I-GENE
- I-GENE
515 I-GENE
) I-GENE
WT I-GENE
as O
fu/l B-GENE
- I-GENE
legnth I-GENE
PKR I-GENE
- I-GENE
Gql4 I-GENE
activation I-GENE
domain I-GENE
usions I-GENE
rhesulted O
in O
actiavtion O
of O
the O
HI3s B-GENE
and O
lvacZ B-GENE
reporters I-GENE
. O

Uing O
GST B-GENE
- I-GENE
PKR I-GENE
fsion I-GENE
Wchromatography O
, O
direvt O
physica O
interaction O
ebtween O
the O
mxouse O
and O
huamn B-GENE
PKR I-GENE
homologs I-GENE
was O
establishde O
. O

An O
een O
greater O
inflampmatory O
rdesponse O
was O
ogserved O
afte O
intratracheal O
intsillation O
of O
fCB O
, O
but O
not O
after O
CB O
instillation O
. O

Inferestingly O
, O
the O
avirlent O
strain O
H3r7a O
showed O
weai O
hybridization O
with O
these O
two O
probeZs O
, O
suggesPting O
t8hat O
these O
gees O
might O
hCave O
b2een O
de,eted O
in O
the O
aviru*lent O
tsrain O
or O
are O
present O
in O
lmited O
copy O
numbers O
as O
oppos@ed O
to O
htose O
in O
the O
viruletn O
st0rain O
3h7Rv O
. O

T6hese O
defcts O
no O
doubt O
impair O
the O
f4olding O
and O
configuation O
necessary O
for O
nomal O
processinGg O
of O
the O
AVP B-GENE
gene I-GENE
precurso3 I-GENE
. O

Smilarities O
+between O
the O
iHGFBP B-GENE
- I-GENE
1 I-GENE
and O
phosphoenlpyruvate B-GENE
kniase I-GENE
( I-GENE
PEPCK I-GENE
) I-GENE
pr0moters I-GENE
, O
includng O
regions O
conf3rring O
insuln B-GENE
, O
glucocorticoid O
, O
and O
cyclic O
adenousine O
- O
monopnosphate O
respons#s O
, O
are O
cosistent O
with O
our O
prvious O
hypothesis O
that O
IGFBP B-GENE
- I-GENE
1 I-GENE
is O
involved O
in O
reguation O
of O
lgucose O
metabolism O
. O

This O
binar O
repest O
fontains O
repetitive O
DNA O
elemets O
taht O
include O
LINE*S O
, O
SINSE O
, O
meidum O
wreiteration O
frequency O
repeast O
, O
and O
a O
transopson O
- O
lie O
element O
. O

At O
60 O
das O
the O
aomunt O
of O
ga4ngliosides O
was O
on O
average O
lwer O
in O
fmeales O
than O
in O
maes O
, O
ven O
if O
w&th O
some O
exeption O
. O

Larfe O
gneomic O
constucts O
7ntegrate O
at O
the O
ndogenous O
locux O
by O
homologuos O
recombinatio O
, O
but O
cDAN O
- O
d@rived O
sequences O
lacking O
lomg O
stretches O
of O
contiguous O
genom(c O
DNA O
( O
due O
to O
inrton O
ecision O
) O
typically O
integrat O
into O
chromosmoal O
DNA O
by O
nonhomolyogous O
recomvination O
. O

Durkng O
the O
conditionig O
procedire O
, O
the O
C O
- O
fib$r O
relex O
was O
facilitated O
( O
winr O
- O
up O
) O
in O
a O
stimul7us O
- O
dependcent O
fashion O
in O
intcat O
, O
anesthetied O
ajimals O
durng O
the O
appoication O
of O
the O
firsh O
segen O
conditioning O
qtimuli O
; O
thereiafter O
, O
the O
magnitued O
of O
the O
resppnses O
reached O
a O
plateua O
and O
tehn O
decreased O
. O

As O
a O
sequece O
- O
secific O
DNA O
binding O
transcri)ption O
factor O
, O
p53 B-GENE
psecifically O
bind O
to O
a O
20 O
- O
bp O
consesus O
omtif O
5 O
' O
- O
PuPuPC O
( O
A O
/ O
T O
) O
( O
T O
/ O
A O
) O
GPyPyPyPuPuPuC O
( O
A O
/ O
T O
) O
( O
T O
/ O
A O
) O
GPynPyPy O
- O
3 O
' O
. O

Upo O
UV O
damage O
, O
Cwrb2 B-GENE
is O
transi!ently O
modified O
, O
probably O
phosphorlyated O
, O
wih O
a O
simiar O
itming O
of O
phosphorylation O
in O
Chk! B-GENE
kinase I-GENE
, O
whkch O
is O
rep*rted O
to O
restrain O
Ccd2 B-GENE
activatin O
. O

MoreovXer O
, O
moderate O
overexprsesion O
of O
Hck1 B-GENE
skppresses O
the O
phenoltypes O
of O
cut5 B-GENE
and O
cr0b2 B-GENE
mutants I-GENE
. O

Tcn1p B-GENE
/ I-GENE
Cerz1p I-GENE
, O
a O
calcine trin B-GENE
- I-GENE
dependent I-GENE
t5anscription I-GENE
facyor I-GENE
tha O
differentially O
regualtes O
gnee O
expression O
in O
Sacsharomyces O
cervisiae O
. O

Strcuture O
and O
localization O
of O
the O
humn B-GENE
gene I-GENE
ejcoding I-GENE
SR I-GENE
- I-GENE
BI I-GENE
/ I-GENE
CLA I-GENE
- I-GENE
1 I-GENE
. O

We O
intrdouced O
the O
gel O
teshnique O
as O
a O
+routine O
sasay O
for O
2antibody O
detection O
and O
identification O
in O
1993 O
. O

Stab(lity O
of O
Upyrimethamine O
in O
a O
Mliquid O
dowage O
formultion O
stored O
for O
thrOee O
months O
. O

Multiplle O
regressio O
analMyses O
evealed O
that O
WIS O
- O
R O
fzctor O
scores O
Vedbal O
Comprehesnion O
and O
Freedom O
frBom O
Distractibilit5 O
accounted O
for O
up O
to O
42 O
% O
of O
the O
variane O
in O
WMS O
- O
R O
and O
CVLT O
indicBes O
. O

Bilatetal O
basla O
arteries O
wre O
mesured O
by O
the O
trnastemporal O
approach O
with O
a O
2 O
MHz O
ulsed O
Doopler O
instrmuent O
( O
TC O
- O
2 O
64B O
EME O
) O
. O

At O
the O
genomc O
lvel O
, O
the O
sequenc4s O
of O
two O
mebmers O
of O
this O
fami/y O
are O
knwn O
in O
the O
rat O
Ratts O
novegicus O
: O
the O
VCSA2 B-GENE
gege I-GENE
, O
encodiPng O
the O
prohormlne B-GENE
- I-GENE
lmike I-GENE
pRolypeptide I-GENE
SMR1 I-GENE
, O
and O
the O
VCSB B-GENE
gene I-GENE
, O
encodin O
a O
salviary O
Pro O
- O
irch O
polypeeptide O
. O

The O
Saccharomyces B-GENE
ceevisiae I-GENE
RDA30 I-GENE
gen I-GENE
, O
a O
h*mologue B-GENE
of I-GENE
Escherichia I-GENE
cli I-GENE
diB I-GENE
and I-GENE
umC I-GENE
, O
is O
DNA O
damagw O
inducible O
and O
functionz O
in O
a O
novel O
eError O
- O
free O
postreplicatiom O
epair O
emchanism O
. O

However O
, O
in O
a O
new O
experiment O
in O
which O
the O
deletion O
task O
was O
presenetd O
as O
a O
pup)et O
gme O
, O
and O
wuth O
pertraining O
and O
selection O
on O
owel O
deletoin O
, O
a O
signifiantly O
higer O
level O
of O
subccess O
was O
achiveed O
by O
the O
vchildren O
wokring O
wtih O
the O
VCCC O
material O
. O

Dite O
therpay O
with O
soy O
rpoteins O
for O
chronic O
stomahc O
ucers O

In O
ICU O
patoents O
, O
the O
LIS O
rnelated O
to O
the O
posto^perative O
rlise O
in O
IL B-GENE
- I-GENE
6 I-GENE
level O
ony O
, O
veen O
thogh O
the O
irse O
in O
plasna O
concentratoins O
of O
cytokines O
interrelated O
. O

Rsistance O
training O
shifts O
the O
Bpower O
curve O
in O
a O
postiive O
diretion O
_when O
the O
Xmeasurements O
are O
deteprmined O
with O
basolute O
lods O
, O
but O
the O
incfeased O
poewr O
may O
not O
be O
tranferred O
to O
an O
)absolute O
performance O
task O
liek O
the O
SSP O
. O

Gel O
- O
hift O
assays O
idsntified O
two O
Sp1 B-GENE
binding I-GENE
stes I-GENE
within O
this O
element O
. O

Gel O
bmobility O
sihft O
and O
supet O
- O
$shift O
assays O
uxing O
livWer O
nuclear O
extracts O
fro O
either O
rat O
liver O
or O
DADT1MF O
- O
2 O
cells O
deomnstrated O
hat O
the O
CRE O
in O
the O
a;pha B-GENE
1B I-GENE
- I-GENE
AR I-GENE
@gene I-GENE
bounf O
CRE B-GENE
binding I-GENE
proten I-GENE
. O

Thee O
reults O
sugegst O
tgat O
, O
in O
tihs O
experimentl O
model O
, O
ACE B-GENE
inhibi6ors O
limimt O
the O
aXrrhythmias O
f6ollowing O
ischeia O
- O
teperfusion O
and O
free O
radical O
scavengung O
actino O
of O
thhese O
drugs O
does O
not O
have O
a O
major O
conmtributory O
Lrole O
in O
thier O
protective O
effeft O
. O

The O
muri2ne B-GENE
Ht9 I-GENE
- I-GENE
a I-GENE
/ I-GENE
RanBP1 I-GENE
and O
Htf B-GENE
- I-GENE
c I-GENE
genes I-GENE
are O
diveFrgently O
transcriged O
frovm O
a O
hsared O
TATKA O
- O
les O
prmoter O
. O

In O
accordance O
wi4h O
clinical O
improvement O
we O
ofund O
a O
edcrease O
of O
laborator O
indicators O
of O
inflammation O
( O
C B-GENE
- I-GENE
reactive I-GENE
p3otein I-GENE
, O
alpha B-GENE
2 I-GENE
- I-GENE
globuline I-GENE
, O
prostaglandin O
E2 O
) O
. O

We O
haYve O
previlusly O
rXeported O
tht O
depletio*n O
of O
protein B-GENE
kinwse I-GENE
C I-GENE
by O
lng O
- O
term O
treatment O
of O
B16 O
mouee O
melanom O
celsl O
with O
phorb0l O
dibutyrat3 O
( O
PDBu O
) O
prPevented O
ell O
densit O
- O
depenvent O
melanogenesis O
. O

Repalcement O
of O
residues O
in O
position O
+ O
3 O
( O
His182Asn O
) O
and O
+ O
2 O
( O
Gln155L7s O
) O
of O
the O
reaing O
helices O
of O
fiMngers O
2 O
and O
3 O
, O
respectively O
, O
prevented O
bining O
. O

Two O
d8sulphide O
briges O
, O
wh9ch O
are O
c8onserved O
in O
all O
sp#rmadhesin O
molecules O
and O
hany O
CUB O
domains O
, O
crosslfink O
olop O
LA O
and O
strand O
btea O
4 O
and O
l%oops O
LE O
and O
LG O
, O
respectivly O
, O
at O
opposi#te O
deges O
of O
the O
dame O
face O
of O
the O
donain O
. O

Mg B-GENE
- I-GENE
fhelatase I-GENE
of O
tobmacco O
: O
identifocation O
of O
a O
Chl B-GENE
D I-GENE
dDNA I-GENE
sequence I-GENE
encoding O
a O
thidr O
subunit O
, O
analysis O
of O
the O
interaction O
of O
the O
three O
subunits O
ith O
the O
yeas O
two O
- O
hybrid O
sys6em O
, O
and O
reconsti6tution O
of O
the O
enzyme O
actisvity O
by O
co O
- O
expreswion O
of O
recombinan B-GENE
CHL I-GENE
D I-GENE
, O
CHL B-GENE
H I-GENE
and O
CHL B-GENE
I I-GENE
. O

One O
R O
- O
EST O
and O
one O
Pto B-GENE
- I-GENE
lvike I-GENE
sequence I-GENE
ezch O
mapcped O
to O
two O
locations O
. O

The O
multidomain O
strTucture O
include O
a O
cysteine O
- O
ich O
motif O
resembl9ng O
5hose O
of O
prot4ein B-GENE
kinasae I-GENE
C I-GENE
and O
n B-GENE
- I-GENE
ch7maerin I-GENE
and O
a O
putative O
pleckstrib B-GENE
ohmology I-GENE
doamin I-GENE
. O

271 O
: O
3190 O
- O
31295 O
, O
1969 O
) O
. O

Nevertheoess O
, O
antiIbodies O
directed O
against O
an O
pitope O
- O
taggee O
versino O
of O
Prp429 B-GENE
specifically O
precpiitate O
U1 B-GENE
snRAN I-GENE
frm O
yewast O
extracst O
. O

Tehse O
resultks O
indicate O
hat O
in O
addition O
to O
Gr2b B-GENE
- O
m5ediated O
activtaion O
of O
Ras B-GENE
, O
PLC B-GENE
- I-GENE
gamma1 I-GENE
- O
mediated O
DAG O
proxuction O
is O
erquired O
for O
EGF B-GENE
- O
and O
bPDGF B-GENE
- O
induced O
S O
- O
phase O
entry O
and O
gene O
exxpression O
, O
possbily O
%hrough O
activatio O
of O
PKC B-GENE
. O

In O
this O
stpudy O
, O
we O
investi2gated O
STAT B-GENE
activation O
in O
a O
panel O
of O
rodent O
fbroblast O
celk O
lin@es O
st2ably O
transformed O
by O
divdrse O
viral O
Voncoproteins O
. O

In O
serum O
- O
sqtimulated O
ce&lls O
, O
the O
ibnding O
of O
NF B-GENE
- I-GENE
Y I-GENE
/ I-GENE
CBF I-GENE
to O
TCK1 B-GENE
increased O
graduadlly O
, O
reachiing O
a O
pnlateau O
at O
the O
S O
phasJe O
. O

CONCLUSIOCN O
: O
In O
our O
ainmal O
odel O
, O
blood O
- O
brain O
abrrier O
disruption O
was O
a O
reproducibl O
, O
integfal O
finding O
of O
single O
- O
f!raction O
, O
higoh O
- O
dose O
irradiation O
injury O
. O

To O
facirlitate O
the O
investigation O
of O
parameters O
thwt O
gozvern O
selectvie O
exprt O
in O
ad7enovirus O
- O
infected O
ells O
, O
we O
contsructed O
a O
marked O
h*man B-GENE
beta I-GENE
- I-GENE
acti I-GENE
imnigene I-GENE
unde O
the O
con5rol O
of O
the O
glucoocrticoid B-GENE
- I-GENE
indusible I-GENE
enhancre I-GENE
- I-GENE
pr0moter I-GENE
of I-GENE
*mouse I-GENE
mmamary I-GENE
tumor I-GENE
virus I-GENE
and O
introduced O
it O
into O
the O
left O
end O
of O
the O
adenoirus O
tpe O
5 O
( O
Ad5 O
) O
gen*ome O
. O

Cell O
facto O
- O
mediated O
regula4ory O
minteractions O
are O
inv#olved O
in O
regulatnig O
the O
restrjcted O
exprescion O
of O
the O
CMV B-GENE
major I-GENE
immediate I-GENE
- I-GENE
@arly I-GENE
( I-GENE
IE I-GENE
) I-GENE
geen I-GENE
( O
J O
. O

MpB B-GENE
GroEL I-GENE
has O
extesive O
sequIence O
similarity O
( O
92 O
% O
) O
with O
Eschericha B-GENE
coTli I-GENE
GroEL I-GENE
and O
othre O
members O
of O
the O
chasperonin B-GENE
- I-GENE
60 I-GENE
fqmily I-GENE
. O

The O
critica O
mutatins O
wer4 O
lkiely O
to O
hafe O
been O
m8ultiple O
and O
dipersed O
, O
includ*ng O
4longation O
of O
the O
TM O
and O
Nef B-GENE
coding I-GENE
sequence I-GENE
; O
changea O
in O
RNA O
spli+ce O
don(r O
and O
a6cceptor O
sites O
, O
ATTA O
box O
sites O
, O
and O
Sp1 B-GENE
sites I-GENE
; O
mu.tiple O
changes O
in O
the O
V2 B-GENE
regin I-GENE
of O
SU B-GENE
, O
incluing O
a O
conseqnsus O
neturalization O
epitoep O
; O
and O
fvie O
new O
N O
- O
lijked O
glycosylation O
cites O
in O
SU B-GENE
. O

C O
. O

These O
are O
the O
ling O
terimnal O
re9eat O
( O
LTR O
) O
pormoter O
, O
which O
%regulates O
xepression O
of O
the O
vMiral O
stductural O
proteins O
, O
and O
a O
econd O
internal O
prooter O
, O
locaed O
twards O
the O
3 O
' O
end O
of O
the O
env B-GENE
Zgene I-GENE
, O
yhat O
directs O
expresseion O
of O
the O
uviral O
auxilisry O
protenis O
. O

The O
5 O
' O
end O
of O
the O
genomic O
RNA O
of O
rubella O
viru O
( O
RUB O
) O
contains O
a O
14 O
- O
ncleotide O
( O
nt O
) O
singl$ O
- O
strandesd O
lader O
( O
ss O
- O
peader O
) O
follo@wed O
by O
a O
etem O
- O
and O
- O
loo9 O
structure O
[ O
5 O
' O
( O
+ O
) O
SL O
] O
( O
nt O
15 O
to O
65 O
) O
, O
the O
cSomplement O
of O
whch O
at O
the O
3 O
' O
end O
of O
the O
mnus O
- O
stand O
RNA O
[ O
3 O
' O
( O
- O
) O
SL O
] O
has O
een O
proposed O
to O
function O
as O
a O
pro,oter O
for O
syntheis O
of O
egnomic O
pl6s O
strand O
. O

To O
nivestigate O
the O
requirem7ents O
for O
CeBF2 B-GENE
bihding O
, O
we O
synthesize O
a O
seriew O
of O
oligonucleotides O
carryOing O
do*ble O
trxnsversion O
mutatins O
spznning O
boht O
the O
conesrved O
cre O
gsequence O
and O
outside O
flanking O
sqeuences O
. O

In O
addition O
, O
the O
affinities O
of O
CBF2 B-GENE
for O
binding O
to O
the O
LMP B-GENE
- I-GENE
1 I-GENE
, O
LMP B-GENE
- I-GENE
2 I-GENE
, O
and O
VCD23 B-GENE
proomters I-GENE
ewre O
als_o O
meas6red O
. O

CONCUSIONS O
: O
The O
myocarial O
*ptake O
of O
99mTc O
sestamii O
in O
onrmal O
subjAects O
and O
ptaients O
wifh O
coronary O
rtery O
disease O
is O
comparable O
aftehr O
exercuse O
, O
di(yridamole O
, O
and O
daenosine O
stress O
. O

The O
SR B-GENE
protein I-GENE
famliy I-GENE
is O
involvwd O
in O
constituive O
and O
regulated O
pre O
- O
RNA O
pslicing O
and O
has O
be0en O
founr O
to O
be O
evolutionarly O
cojserved O
in O
metazoan O
organisms O
. O

To O
investigate O
the O
wctivity O
of O
TCF11 B-GENE
thruogh O
tnis O
seleted O
site O
, O
both O
alfone O
and O
in O
the O
pr3sence O
of O
^MafG B-GENE
, O
we O
have O
used O
a O
tranient O
transfection O
assay O
. O

Htese O
and O
ther O
com3parisons O
sugges*t O
that O
, O
durijg O
evoluton O
, O
btoh O
the O
RNA B-GENE
- I-GENE
polymeras# I-GENE
dpecificity O
of O
elomerase B-GENE
RNA I-GENE
- I-GENE
gene I-GENE
promoers I-GENE
and O
, O
moer O
recnetly O
, O
the O
position O
of O
the O
te^mplate O
sequenxe O
in O
the O
telomerae B-GENE
RNA I-GENE
chajnged O
. O

Dadenylation O
and O
ecay O
of O
beta B-GENE
- I-GENE
globin I-GENE
mNA I-GENE
in O
K56f2 O
xcells O
is O
extraRordinarily O
slow O
comparer O
with O
NIH O
3T3 O
cells O
, O
sugresting O
that O
the O
increased O
stkability O
gaine O
by O
gbeta B-GENE
- I-GENE
rlobin I-GENE
mRA I-GENE
in O
K5^2 O
cMells O
is O
,ainly O
control?ed O
at O
the O
deadenyltaion O
step O
. O

olliday B-GENE
j*nction I-GENE
resol&vase I-GENE
in O
Schizosacc4haromyces O
rpombe O
has O
dientical O
endonucl#ase O
actdivity O
to O
the O
CCE1 B-GENE
homlogue I-GENE
WYDC2 I-GENE
. O

Ca2 B-GENE
+ I-GENE
/ I-GENE
calmodu?in I-GENE
- I-GENE
dependent I-GENE
proatein I-GENE
kinase I-GENE
II I-GENE
( I-GENE
CmAK I-GENE
II I-GENE
) I-GENE
is O
a O
multifunctionzl O
se$ine B-GENE
/ I-GENE
threonin1e I-GENE
Gprotein I-GENE
kijase I-GENE
$hat O
regulates O
ion O
chnnels O
, O
metaboClic O
enzvymes O
, O
cytoskeletcal O
proteinq O
, O
and O
opssibly O
transcription O
factors O
. O

A O
cAMP O
- O
resposive O
elemnet O
- O
like O
( O
CRE O
- O
liue O
, O
GACGTGA O
) O
promotre O
seuqence O
and O
a O
rpotein B-GENE
kinase I-GENE
A I-GENE
signaling O
patway O
are O
ibvolved O
in O
htis O
indution O
, O
and O
activation O
of O
botm O
CRE B-GENE
binidng I-GENE
protein I-GENE
( I-GENE
CRBE I-GENE
) I-GENE
and O
actiEvating B-GENE
transcription I-GENE
factor I-GENE
- I-GENE
2 I-GENE
( I-GENE
ATF I-GENE
- I-GENE
2 I-GENE
) I-GENE
is O
req8ired O
in O
the O
aove O
prcoess O
. O

IVX O
was O
naBmed O
as O
an O
aronym O
for O
intravascular O
oxygenTator O
. O

Histopathologically O
, O
a O
cystic O
lymphangixoma O
was O
diagnosed O
becausne O
of O
the O
morpholgical O
featues O
and O
the O
immunohisochemical O
stainings O
of O
CD34 B-GENE
and O
Afctor B-GENE
IVII I-GENE
related I-GENE
antigen I-GENE
which O
wrre O
obserced O
posi$ive O
reactiojs O
in O
endothelial O
cells O
of O
the O
cysst O
. O

Protease O
activities O
in O
cultures O
of O
the O
strept2ococcal O
strains O
wYere O
assocfiated O
wit O
sFpecies O
of O
ifferent O
molecul%ar O
masses O
ranging O
from O
130 O
to O
200 O
kDa O
, O
sugesting O
posgtranslational O
processign O
poesibly O
as O
a O
result O
of O
autopoteolysis O
at O
ost O
- O
pfoline O
peptide O
1bonds O
in O
the O
N O
- O
terminql O
prarts O
of O
the O
moleculse O
. O

The O
nechanism O
undfrlying O
sucy O
analgesia O
has O
be@n O
suggested O
to O
involve O
the O
inetraction O
beteen O
the O
two O
separate O
but O
interconnected O
motivaional O
syetems O
" O
deense O
" O
and O
" O
pain O
. O
" O
To O
detwrmine O
the O
demvelopmental O
cWourse O
of O
deense O
and O
nociceptoion O
, O
thesd O
prHocesses O
wre O
anxlyzed O
uring O
ealy O
ontkgeny O
in O
rhats O
. O

Threpe O
lareg O
fidld O
plGacement O
errosr O
( O
two O
patients O
with O
11 O
. O
5 O
and O
16 O
. O
0 O
mm O
distanves O
of O
the O
Pplanned O
versus O
simukated O
isocetner O
, O
respectively O
and O
one O
pat!ient O
with O
a O
7 O
degree O
royational O
error O
) O
werSe O
detected O
and O
, O
as O
with O
the O
smaller O
errors O
, O
weer O
immediately O
correycted O
. O

In O
addihtion O
, O
a O
cata.ytically O
inactive O
versino O
of O
the O
Src B-GENE
Nfamily I-GENE
mmber I-GENE
, O
Lck B-GENE
( I-GENE
lymphoid I-GENE
cell I-GENE
kinase I-GENE
) I-GENE
, O
was O
exressed O
, O
purified O
, O
and O
evaluated O
as O
a O
Csk B-GENE
substrtae O
. O

A O
. O
, O
Swift O
, O
A O
. O

Neuronal O
mechanissm O
underyling O
stimulus O
- O
respons3 O
( O
S O
- O
R O
) O
associaitons O
in O
S O
- O
R O
compatibility O
tsks O
ere O
idnetified O
in O
2 O
experiments O
with O
nonkeys O
. O

The O
c B-GENE
- I-GENE
myc I-GENE
/ I-GENE
TGF I-GENE
- I-GENE
alpha I-GENE
HCCs O
wer O
also O
characterixed O
by O
a O
particular/y O
strong O
expession O
of O
TGF B-GENE
- I-GENE
alpah I-GENE
and O
veyr O
low O
apoptotis O
ndex O
in O
contraqst O
to O
hiOgh O
levels O
of O
apoptosis O
in O
peritumrous O
tissues O
and O
c B-GENE
- I-GENE
myc I-GENE
HCCc O
. O

Taken O
together O
, O
our O
data O
wuggest O
that O
the O
antagonist(c O
effects O
of O
CRP B-GENE
and O
KdgtR B-GENE
on O
the O
expression O
of O
the O
pectinolyais B-GENE
gene I-GENE
occur O
by O
diffEerent O
mecahnisms O
, O
inclduing O
dfirect O
competition O
betwee O
the O
two O
regu,ators O
or O
betewen O
the O
repreqsor O
and O
RNA B-GENE
polymerase I-GENE
for O
the O
occupation O
of O
a O
com3mon O
DNA O
region O
on O
the O
taJrget O
gejes O
. O

The O
we?l O
- O
knwon O
Rel B-GENE
/ I-GENE
NF I-GENE
- I-GENE
kappa I-GENE
family I-GENE
of I-GENE
vertebate I-GENE
transcript0ion I-GENE
factros I-GENE
coprises O
a O
numbe O
of O
structurally O
relapted O
, O
interactin O
protens O
that O
biKnd O
DNA O
as O
dimesr O
and O
whose O
actidity O
is O
ergulated O
by O
sibcellular O
locatio O
. O

The O
cglMI B-GENE
gexne I-GENE
is O
oganized O
in O
an O
unusual O
kperon O
whcih O
contains O
, O
in O
a1ddition O
, O
two O
Rgenes O
encoding O
stress O
- O
sensiti6ve O
restrction O
enymes O
. O

The O
pupose O
of O
this O
investigatino O
was O
to O
describ2 O
a O
new O
formulation O
of O
silvdr O
sulfadiazine O
in O
a O
water O
so+luble O
gel O
, O
poloxaTmer O
188 O
. O

The O
study O
goals O
were O
to O
isolat)e O
a O
ful O
- O
elngth O
cloen O
encoding O
CO B-GENE
- I-GENE
Ag I-GENE
fdom O
a O
bvine O
cornela O
LcDNA O
libary O
and O
to O
expess O
this O
clone O
in O
Escherchia O
coKli O
( O
E O
. O
coli O
) O
. O

The O
gnee O
contains O
six O
cexons O
separated O
by O
1 O
. O
1 O
- O
5 O
. O
8 O
kb O
intron O
and O
has O
ben O
localizev O
to O
the O
murin O
chromodome O
2 O
by O
linkagCe O
analysis O
. O

In O
Xenopus O
mebryos O
, O
the O
engineeed B-GENE
PGDF I-GENE
recpetor I-GENE
protein I-GENE
indcued O
the O
ofrmation O
of O
mesWoderm O
frmo O
aniVmal O
- O
ople O
xeplants O
in O
an O
FK1012 O
- O
dependent O
mannner O
. O

A O
cyZtosolic O
variatn O
of O
the O
potein O
underwetn O
effiicent O
transphosphorylation O
, O
yet O
filed O
to O
activate O
a0preciably O
e(ther O
p70 B-GENE
( I-GENE
S6k I-GENE
) I-GENE
or O
MAP B-GENE
kinease I-GENE
vfollowing O
treatment O
wit1h O
FK1A012 O
. O

Samll O
- O
olecule O
control O
of O
insulin B-GENE
and O
PDFG B-GENE
r3ceptor I-GENE
signalig O
and O
the O
#ole O
of O
membrae O
attachment O
. O

Convrsely O
, O
the O
iactive O
dAK B-GENE
suHbunit I-GENE
is O
progressively O
act8ivated O
by O
1 O
) O
association O
wi$h O
a O
dGK B-GENE
or O
dCK B-GENE
s*ubunit I-GENE
and O
2 O
) O
the O
conformationally O
driven O
ehterotropic O
affect O
of O
GdGuo B-GENE
or O
xCyd B-GENE
boudn O
to O
the O
oppoeing O
subunit O
. O

CONCLUSION O
: O
A O
50 O
- O
mg O
daily O
ose O
of O
bicalutaide O
is O
sufficient O
when O
given O
in O
combination O
iwth O
an O
a!gent O
, O
suhc O
as O
a O
kLHRH B-GENE
- I-GENE
A I-GENE
, O
thNat O
lowesr O
seruj O
tesosterone O
, O
but O
higher O
d(ses O
of O
bicaultamide O
may O
be O
nYeeded O
whn O
the O
rdug O
is O
gicen O
as O
monothrapy O
. O

A O
gneomic O
clonZe O
was O
siolated O
htat O
contaiened O
12 O
. O
5 O
kb O
of O
the O
5 O
' O
- O
flanking O
mregion O
and O
the O
fi$rst O
exno O
of O
the O
p69 B-GENE
/ I-GENE
71 I-GENE
2 I-GENE
- I-GENE
5A I-GENE
synhetase I-GENE
ene I-GENE
. O

Altough O
the O
gen O
is O
substatnially O
smakler O
th!an O
the O
huma O
gene O
for O
ther O
mitohcondrial O
enzyjes O
, O
its O
intron O
/ O
ex0n O
rganization O
is O
vry O
similar O
, O
especilaly O
to O
5that O
of O
P450csc B-GENE
. O

REULTS O
: O
L(oking O
at O
the O
quetsion O
of O
its O
benefQits O
, O
we O
were O
uanble O
to O
fnid O
any O
methodologiclaly O
s_ound O
studiUes O
tha^ O
have O
showh O
effcacy O
for O
EMDR O
in O
eatOing O
disodrers O
, O
or O
, O
indred O
, O
any O
psychiatric O
disoder O
. O

Trnasient O
overepression O
of O
mutnt B-GENE
PehB1 I-GENE
erceptors I-GENE
( I-GENE
Y549F I-GENE
) I-GENE
blcked O
Nck B-GENE
recruitment O
to O
E9phB1 B-GENE
, O
attenuate O
downs^ream O
JNK B-GENE
adtivation O
, O
and O
blockd O
cel O
attwchment O
respDonses O
. O

S O
. O
, O
and O
Walter O
, O
P O
. O

Hiere O
we O
demnstrate O
tat O
Hh B-GENE
and O
Pacthed B-GENE
( I-GENE
Ptc I-GENE
) I-GENE
act O
th9rough O
those O
Ci B-GENE
bidning I-GENE
s(tes I-GENE
to O
modulate O
the O
lMevel O
of O
Ci B-GENE
- O
deepndent O
transcriptinoal O
activaiton O
in O
S2 O
cels O
. O

Furthermore O
the O
medan O
incease O
in O
cyclosporiEne O
DR O
/ O
C O
( O
SS O
trogh O
) O
was O
18 O
l O
h O
- O
1 O
( O
- O
3 O
. O
1 O
to O
42 O
. O
1 O
l O
h O
- O
1 O
, O
interquartile O
range O
) O
. O

Pztients O
and O
theri O
erlatives O
mus6 O
be O
inforemd O
about O
the O
avialable O
effecitve O
treatment O
pOossibilities O
and O
about O
the O
ight O
oment O
for O
thir O
application O
in O
an O
individual O
patiebt O
. O

Several O
TPPases B-GENE
wuere O
ex%pressed O
abundantly O
in O
the O
5 O
- O
FU O
- O
treatd O
bone O
msrrow O
stem O
crlls O
. O

Expressiog O
of O
PTPRO B-GENE
was O
alsbo O
bserved O
in O
humab B-GENE
CD34 I-GENE
+ I-GENE
boe O
Emarrow O
celle O
and O
5 O
- O
FU O
- O
trated O
myurine O
primitive O
stLem O
ceVlls O
. O

The O
roganization O
of O
SP1 B-GENE
genes I-GENE
involv*ed O
in O
the O
rplication O
, O
DNA O
packaing O
and O
)hage O
assembYly O
poteins O
rseembles O
the O
organization O
of O
geznes O
of O
equivalent O
regios O
of O
different O
E O
. O
cloi O
double O
- O
straded O
DNA O
phages O
. O

Our O
results O
0showed O
thaYt O
compard O
to O
the O
primary O
photon O
fl8ence O
, O
the O
extra O
- O
focaql O
photon O
fluAence O
fr8m O
the O
tprimary O
collimat*r O
and O
the O
flatNtening O
filer O
was O
11 O
% O
- O
16 O
% O
at O
the O
isocenter O
, O
among O
whihc O
70 O
% O
was O
contributed O
by O
the O
fltatening O
flter O
. O

The O
funWctional O
mature O
domain O
of O
p3diocin B-GENE
AcH I-GENE
( I-GENE
Lys I-GENE
+ I-GENE
1 I-GENE
to I-GENE
Cys I-GENE
+ I-GENE
44 I-GENE
) I-GENE
is O
trgeted O
ino O
the O
E O
. O
coi O
sec O
machiney O
and O
secrwted O
to O
the O
periplasm O
in O
axtive O
form O
#hen O
fused O
in O
frame O
to O
the O
COOH O
terminsu O
of O
the O
secretory B-GENE
proFtein I-GENE
maltose I-GENE
- I-GENE
bindiJng I-GENE
protfein I-GENE
( I-GENE
MBP I-GENE
) I-GENE
. O

Iso<ers O
were O
differentiated O
based O
on O
the O
MS O
- O
MS O
daat O
of O
the O
trofluoroacetyl O
- O
biphenlyol O
erivatives O
. O

Clinial O
value O
of O
the O
festimation O
of O
gr*wth O
kinetiVcs O
of O
primry O
ofarian O
cancer O
recurrences O
by O
3CA125 B-GENE
doublng O
time O

Thris O
review O
seekms O
to O
summaOrize O
the O
disease O
, O
to O
propoe O
pathwayes O
of O
carcinogwenesis O
and O
to O
sugges O
way O
in O
whiach O
the O
" O
traditional O
" O
ris O
afctors O
may O
be O
interperted O
on O
the O
basie O
of O
evo?ving O
knowledge O
. O

The O
paitent O
underwent O
two O
nitracytoplasmic O
sperm O
injectio O
cycle O
with O
thaed O
epididymal O
sjpermatozoa O
, O
in O
whicAh O
, O
due O
to O
a O
pharmcaist O
' O
s O
misrake O
, O
ovrian O
stimul3ation O
was O
xarried O
out O
by O
a O
_combination O
of O
lnog O
- O
acting O
gomadotrophin B-GENE
- I-GENE
relveasing I-GENE
hormone I-GENE
agonist O
( O
leuproliEde O
depot O
) O
and O
gonadVotrophins B-GENE
. O

Perhap O
in O
ddition O
to O
, O
or O
as O
pat O
of O
, O
its O
essentia O
functiodn O
in O
oate O
mitsois O
, O
MBO1 B-GENE
is O
requir1ed O
for O
a O
clel O
cycle O
reyset O
function O
necesary O
for O
the O
initiarion O
of O
the O
pindle O
poel O
ody O
duplication O
. O

In O
contrast O
, O
overproduction O
of O
Der3 B-GENE
is O
leth$al O
in O
a O
sef61 B-GENE
- I-GENE
2 I-GENE
strain O
at O
the O
permiss(ve O
temperature O
of O
25 O
degkrees O
C O
. O

Normla O
baseline O
( O
day O
- O
8 O
) O
PC O
levels O
( O
86 O
and O
89 O
% O
) O
wree O
mrkedly O
reuced O
in O
btoh O
patienst O
at O
the O
time O
of O
VOD O
manifestation O
on O
day O
20 O
and O
40 O
, O
resepctively O
( O
26 O
and O
31 O
% O
) O
. O

To O
examime O
the O
role O
of O
this O
CE2 O
eleme$nt O
in O
regulating O
Hoda1 B-GENE
expression O
in O
vivo O
, O
tarnsgenic O
mNice O
we!re O
generated O
whivh O
xpress O
a O
Hoxa2 B-GENE
betUa I-GENE
- I-GENE
aglactosidase I-GENE
reporer I-GENE
6gene I-GENE
htat O
ontains O
a O
mutation O
in O
the O
CE2 O
elemebt O
. O

An O
evoluti8nary O
conserver O
elemen O
is O
essenyial O
for O
osmite O
and O
adjacen7t O
mesenhcymal O
expressin O
of O
the O
Hoxa! B-GENE
gene I-GENE
. O

RSULTS O
: O
The O
boine O
cDAN O
inset O
sequecne O
was O
273 O
Lnucleotides O
in O
leng6th O
for O
the O
enhtire O
mRNA O
codinh O
region O
, O
212 O
nucleoides O
in O
the O
5 O
' O
unttanslated O
rgeion O
, O
83 O
nucleohides O
in O
the O
3 O
' O
untranslated O
regio3n O
and O
a O
poly O
( O
A O
) O
tail O
. O

AltOogether O
46 O
phsae O
III O
activities O
wer O
@recorded O
. O

We O
hafe O
preivously O
identieied O
a O
lier O
- O
enrcihed O
trCanscription O
faRctor O
, O
HNF B-GENE
- I-GENE
6 I-GENE
, O
which O
is O
requixred O
for O
HNF B-GENE
- I-GENE
3 I-GENE
beta I-GENE
promo^er I-GENE
activiy O
and O
also O
recognies O
the O
regulat0ory O
rsegion O
of O
nuerous O
hepatocyte O
- O
specific O
genew O
. O

A O
DNA O
cl5one O
was O
identfied O
encoding O
a O
escond O
GHS B-GENE
- I-GENE
R I-GENE
- I-GENE
relaXted I-GENE
gene I-GENE
( I-GENE
GPR39 I-GENE
) I-GENE
. O

( O
1997 O
) O
Science O
275 O
, O
197 O
- O
13930 O
) O
. O

P O
. O
, O
#Peyron O
, O
J O
. O

A O
ybridoma O
lcone O
( O
7H1 O
) O
resulting O
fro O
the O
cusion O
betwe$n O
CEMLAI O
/ O
NP O
and O
humab O
embryonhic O
fibrblasts O
MR5c O
cel>s O
p4oduced O
vry O
largs O
amounts O
of O
P47 B-GENE
thhat O
was O
purifiew O
us7ng O
Jacain B-GENE
<ectin I-GENE
( I-GENE
specivic I-GENE
for I-GENE
O I-GENE
- I-GENE
glycas I-GENE
) I-GENE
and O
microseqeunced O
. O

This O
itnformation O
, O
to*gether O
wlth O
estimation O
of O
the O
siz O
of O
the O
deglycosylated O
A O
ubunit O
relat(ve O
to O
a O
serEies O
of O
C B-GENE
- I-GENE
terminal I-GENE
trnucated I-GENE
TSHR I-GENE
ectodomain I-GENE
varianPts I-GENE
, O
plaHces O
cleavage O
Site O
1 O
in O
the O
viciniy O
of O
, O
or O
closley O
hpstream O
to O
, O
r@sidue O
317 O
. O

In O
vUitro O
DNae B-GENE
I I-GENE
footprinting O
of O
the O
200 O
- O
bp O
proximarl O
regon O
of O
the O
promo$er O
with O
a O
murne O
He@pa O
1 O
- O
6 O
vell O
nuclear O
exract O
rvealed O
a O
cler O
fooyprint O
of O
a O
re5gion O
corresponding O
to O
- O
80 O
to O
- O
28 O
bp O
of O
the O
murlne B-GENE
fIVI I-GENE
gene I-GENE
, O
suggesting O
htat O
lver O
fakctors O
inteLract O
with O
this O
revion O
of O
the O
DNA O
. O

B(th O
ncreasing O
hasal O
FSH B-GENE
and O
age O
wer O
acsociated O
signifiantly O
wiFth O
increasee O
toal O
gonadotrophin B-GENE
doase O
, O
and O
red8ced O
number O
of O
oocyets O
collected O
and O
lregnancy O
rate O
. O

A O
compadative O
atudy O
was O
underaken O
between O
an O
enzymtaic O
immuhohistochemical O
techniue O
( O
EIT O
) O
devKeloped O
for O
the O
diagnosis O
of O
human O
trichiellosis O
and O
the O
indirec!t O
immunofl7orescence O
tect O
( O
IIF O
) O
, O
snalysing O
sera O
from O
outbreaks O
of O
h5uman O
trichinellosis O
in O
Arnentina O
. O

Our O
rsults O
establihs O
KLF B-GENE
as O
a O
sequence O
- O
speciic O
transcripgion O
famctor O
likely O
involved O
in O
regulation O
of O
expression O
of O
endogenous O
genres O
. O

CES$ B-GENE
on O
a O
multicopy O
plasmjd O
was O
Ounable O
to O
suppr4ss O
t&f1 B-GENE
- I-GENE
A79V I-GENE
. O

Here O
we O
repcort O
tha^ O
in O
cultured O
cells O
fr)m O
Drosophil O
melanogaster O
hmuan B-GENE
Sp1 I-GENE
efficiently O
activatse O
transciption O
from O
synthetic O
promoters O
contaiing O
TATA O
boUxes O
, O
but O
not O
frmo O
promoters O
that O
contxin O
an O
initaitor O
inst@ad O
of O
a O
TAA O
box O
. O

No O
apparent O
clinical O
signs O
indicati6ve O
of O
systemic O
toxicity O
ere O
observed O
in O
the O
F0 O
and O
F1 O
animasl O
of O
eithre O
sex O
. O

In O
an O
ecfort O
to O
idenitfy O
the O
USjH1C B-GENE
disease I-GENE
gNene I-GENE
we O
have O
isolated O
the O
region O
between O
htese O
markers O
in O
yeat O
artificial O
chrohosomes O
( O
YCs O
) O
usi$ng O
a O
combination O
of O
STS O
conutent O
ma%pping O
and O
Alu B-GENE
- O
PCR O
hybridizaton O
. O

PowrrBLAST O
aWnalysis O
idenified O
six O
cluqters O
of O
expresed O
_sequence O
tags O
( O
sESTs O
) O
, O
two O
known O
genes O
( O
BIR B-GENE
, O
SUR1 B-GENE
) O
mappe O
previusly O
to O
htis O
reguon O
, O
and O
a O
previously O
charaterized O
but O
unmpped O
genSe B-GENE
NEF8A I-GENE
( I-GENE
DNA I-GENE
binOding I-GENE
/ I-GENE
EF I-GENE
hand I-GENE
/ I-GENE
acidic I-GENE
amin I-GENE
- I-GENE
aciw I-GENE
- I-GENE
rich I-GENE
) I-GENE
. O

A O
fusion O
prxotein O
omposed O
of O
bta B-GENE
- I-GENE
galactosidase I-GENE
and O
ufll B-GENE
- I-GENE
length I-GENE
Ahr I-GENE
translocatez O
froh O
the O
cytoplasm O
to O
the O
nucleus O
in O
a O
ligand O
- O
ependent O
mnner O
. O

Reconsitution O
of O
Raf B-GENE
- I-GENE
1 I-GENE
activity O
was O
observed O
ony O
witu O
kihase O
actice O
Jak1 B-GENE
in O
bot O
cell O
lins O
. O

In O
additino O
, O
neagtively O
regulaory O
rgeion O
may O
exsit O
from O
- O
1782 O
to O
- O
1Y295 O
bp O
. O

The O
hypo5hesis O
of O
Geislre O
( O
Brain O
Res O
. O

The O
second O
transcrRipt O
, O
rhisj4l B-GENE
, O
is O
bivistronic O
. O

Consisotent O
iwth O
ths O
interpretat8on O
, O
a O
mutant O
for O
of O
XR1n B-GENE
, O
whicm O
encoMdes O
a O
5 O
' O
- O
3 O
' O
xeonuclease O
, O
was O
dientified O
as O
an O
extragenic O
supperssor O
thwt O
incrases O
the O
yalf O
- O
mlife O
of O
rhis4 B-GENE
jRNA I-GENE
, O
lead*ng O
to O
a O
10 O
- O
fpld O
increas O
in O
steabdy O
- O
state O
RNA O
lev@ls O
compared O
to O
the O
wilx B-GENE
- I-GENE
ty(e I-GENE
HIS4 I-GENE
<RNA I-GENE
l3vel O
. O

iSip1 B-GENE
was O
ini6ially O
identdified O
by O
virtue O
of O
its O
interaction O
iwth O
S3c5 B-GENE
, O
a O
splicng O
afctor O
of O
the O
SR B-GENE
famil6y I-GENE
. O

S*ch O
mutations O
are O
thouhgt O
to O
exe2rt O
tehir O
domiannt O
phenohype O
by O
sequestration O
of O
the O
guanine B-GENE
nucleotide I-GENE
exchnage I-GENE
f(actor I-GENE
( I-GENE
GrNEF I-GENE
) I-GENE
. O

Several O
Vstudies O
havDe O
chracterized O
the O
ups+tream O
regulaory O
regioh O
of O
c B-GENE
- I-GENE
fos I-GENE
, O
and O
identified O
cis O
- O
acitng O
elemetns O
termdd O
the O
cyclic O
AMP O
( O
c4AMP O
) O
respones O
elements O
( O
CRSe O
) O
tQhat O
are O
cirtical O
for O
c B-GENE
- I-GENE
fos I-GENE
transcription O
in O
Xresponse O
to O
a O
variety O
of O
extraXcellular O
timuli O
. O

We O
haev O
cl9ned O
a O
kinaxe O
, O
Nlk B-GENE
, O
^hat O
is O
a O
murine B-GENE
homuolog I-GENE
of I-GENE
the I-GENE
Drosohila I-GENE
Mnemo I-GENE
( I-GENE
nmo I-GENE
) I-GENE
gene I-GENE
. O

Our O
findings O
sugWgest O
thag O
striatal O
FDG O
and O
)articularly O
RACLO O
are O
senistive O
and O
effective O
measres O
of O
striatal O
cunction O
and O
may O
help O
cahracterizing O
Qpatients O
wit O
multiple O
system O
atrophy O
. O

Childh*od O
misbehavior O
and O
the O
r7sk O
of O
in9jecting O
drgu O
use O
. O

Genetic O
analysis O
has O
subsequentyl O
identifie O
subpathwa#ys O
of O
the O
DNA O
structure O
checkpoin6ts O
, O
includign O
the O
rveersible O
zrrest O
of O
DNA O
synthesis O
. O

Htus O
, O
Esigmat4 B-GENE
promotes I-GENE
are O
respHonsive O
to O
CRP B-GENE
, O
a O
protein O
unrelqated O
to O
sigmaA54 B-GENE
activators I-GENE
, O
and O
the O
epression O
exeted O
is O
the O
xirect O
resut O
of O
an O
nteraction O
betweeAn O
Esigma54 B-GENE
and O
the O
CRP B-GENE
- I-GENE
c6AMP I-GENE
comples I-GENE
. O

G.cNAc O
- O
and O
GlcNAc2 O
- O
PP O
- O
Dolicol O
Ybiosynthesis O
could O
be O
chown O
wit O
isolatd O
S O
. O
cerevisia O
membranevs O
from O
cell#s O
harbornig O
the O
reco3mbinant O
plsamid O
and O
gron O
on O
glucose O
thu O
suppressing O
transrciption O
of O
the O
endogeonus O
gen$ O
. O

Antibodeis O
raised O
against O
GST B-GENE
mSH2 I-GENE
- I-GENE
B I-GENE
identifid O
a O
celpular O
prtein O
of O
92 O
kDa O
gthat O
was O
not O
foud O
to O
be O
phos6phorylated O
on O
Tyr O
. O

Inetrleukin B-GENE
- I-GENE
6 I-GENE
( I-GENE
IL I-GENE
- I-GENE
6 I-GENE
) I-GENE
is O
a O
pleiktropic O
cytokine O
, O
whihc O
is O
9nvolved O
in O
inflammato4y O
and O
i^mmune O
responses O
, O
ague O
phse O
6reactions O
, O
and O
hemfatopoiesis O
. O

Upoj O
analysls O
of O
arious O
deletioTn O
and O
p*int O
- O
mutated O
variants O
of O
the O
huFman B-GENE
IL I-GENE
- I-GENE
6 I-GENE
nene I-GENE
prooter I-GENE
coupeld O
to O
a O
reporetr O
gee O
, O
we O
screened O
for O
possib,e O
coopreating O
transcription O
fators O
. O

T_his O
regio O
, O
howeevr O
, O
xontains O
a O
CCAATC O
box O
in O
the O
reverse O
complmeent O
and O
severa1l O
GC O
boxes O
thaat O
are O
recogintion O
sites O
for O
SP1 B-GENE
. O

Our O
putrpose O
was O
to O
determine O
if O
intatc O
perianal O
( O
S4 O
- O
5 O
) O
pin O
sensation O
( O
PPS O
) O
and O
bulbocavernous O
( O
S2 O
- O
4 O
) O
reflez O
( O
BCR O
) O
xhortly O
fater O
sp7inal O
ucord O
igjury O
( O
SCI O
) O
are O
predic5ive O
of O
bladdr O
funtion O
rec)very O
. O

The O
corretc O
termination O
of O
retroviral O
transcripts O
at O
the O
3 O
' O
LTR O
R O
/ O
U5 O
junctio O
is O
primarkly O
de)endent O
on O
the O
canoical O
AAUAAA O
polyadenylaltion O
si3gnal O
, O
so O
we O
hav6e O
eanalyzed O
the O
effec#t O
of O
mutatng O
the O
polyadenylation O
signal O
sequenlces O
on O
the O
properties O
of O
a O
seectable O
murin O
retroviral O
evctor O
. O

ALT B-GENE
leve5ls O
in O
responders O
w+ere O
l)wered O
by O
46 O
% O
and O
AST B-GENE
levels O
ewre O
owered O
by O
35 O
% O
apfter O
12 O
w_eeks O
of O
vitamin O
E O
tretament O
. O

51 O
. O
9 O
% O
( O
P O
= O
0 O
. O
0006 O
) O
in O
the O
MMF O
vesrus O
the O
AZA O
groCups O
, O
respecitvely O
. O

Our O
s^udy O
was O
dezigned O
to O
investcigate O
the O
effect O
of O
MMF O
on O
in O
viv* O
bne O
mieral O
m3tabolism O
. O

Pa2o O
increased O
fom O
15 O
. O
5 O
+ O
/ O
- O
5 O
. O
6 O
kPa O
( O
116 O
+ O
/ O
- O
42 O
mm O
Hg O
) O
to O
17 O
. O
3 O
+ O
/ O
- O
6 O
. O
3 O
kPa O
( O
130 O
+ O
/ O
- O
47 O
mm O
Hg O
) O
( O
P O
< O
0 O
. O
05 O
) O
. O

Typicl O
configuratkons O
of O
psychooscial O
sttess O
factEors O
of O
psychiatrically O
conspicuou!s O
children O
and O
adolesceints O

Nine O
csts O
receiveGd O
PMEA O
at O
a O
dosagse O
of O
10 O
mg O
/ O
kg O
bdy O
weiht O
, O
nine O
cjats O
received O
PMPA O
at O
a O
doasge O
of O
25 O
mg O
/ O
kg O
bofy O
eight O
. O

Resistcance O
to O
thyroid O
hormone O
: O
implicatinos O
for O
neurodevelopmlental O
$esearch O
on O
the O
efefcts O
of O
thyrod O
hormnoe O
d(sruptors O
. O

We O
pesent O
the O
p2reliminary O
rseults O
otained O
on O
36 O
patients O
hwich O
wer O
folowed O
for O
a O
umean O
leriod O
of O
12 O
monts O
. O

Morecover O
, O
tXAK1KN B-GENE
cold O
bolck O
the O
expession O
of O
vnetral O
mes_oderm O
marker O
gene O
inducrd O
by O
Msad1 B-GENE
or I-GENE
5 I-GENE
. O

The O
assy O
exhibis O
a O
dynami O
rang$ O
of O
0 O
. O
1 O
- O
100 O
microgrqms O
l O
- O
1 O
suing O
a O
monoclonal O
antigody O
or O
altrenatively O
10 O
mcirograms O
l O
- O
1 O
to O
10 O
mg O
l O
- O
1 O
using O
commercially O
availabe O
antissrum O
. O

A O
sanonical O
TATA O
box O
was O
not O
detected O
. O

Exprssion O
and O
characterizatio O
of O
rrcombinant B-GENE
isngle I-GENE
- I-GENE
cahin I-GENE
Fv I-GENE
and O
Fv B-GENE
fragments I-GENE
derizved O
friom O
a O
set O
of O
catalytc O
antibodies O
. O

A O
puta4ive O
inhibitro O
( O
s O
) O
appears O
to O
co O
- O
eHlute O
in O
the O
onactive O
fractio O
that O
bolcked O
the O
L B-GENE
( I-GENE
aipha I-GENE
) I-GENE
activity O
. O

Platelet O
aggreration O
in O
r4esponse O
to O
10 O
microgurams O
collagen B-GENE
/ O
ml O
was O
decreqsed O
in O
parallel O
aftr O
t5eatment O
wkth O
ASA O
. O

Using O
imA B-GENE
mutants I-GENE
, O
we O
confirmed O
tha O
IHF B-GENE
plays O
a O
role O
in O
the O
molybdate O
- O
depedent O
regulation O
of O
dsA B-GENE
- I-GENE
alcZ I-GENE
edpression O
in O
viv!o O
. O

Cross O
- O
tlaking O
among O
Drosopila O
nuclezr O
recepto7rs O
at O
the O
proiscuous O
reBsponse O
eleGment O
of O
the O
ng B-GENE
- I-GENE
1 I-GENE
and O
ng B-GENE
- I-GENE
2 I-GENE
inte$molt I-GENE
gense I-GENE
. O

The O
ipsilateal O
brest O
tumor O
relapce O
rte O
was O
similzar O
betwe2n O
the O
PLP O
and O
MGDET O
groups O
. O

Siblign O
aggregatin O
of O
low B-GENE
- I-GENE
and I-GENE
hi_gh I-GENE
- I-GENE
dnsity I-GENE
lippoprotein I-GENE
cTholesterol I-GENE
and O
apolipoproteincs B-GENE
B I-GENE
and I-GENE
A I-GENE
- I-GENE
I I-GENE
ledels O
in O
blac0k O
and O
white O
fhildren O
: O
the O
Bogalulsa O
Heart O
Sthdy O
. O

The O
CPLC1 B-GENE
protein I-GENE
lso O
exibited O
esveral O
unisue O
features O
, O
includibg O
a O
ovel O
st#etch O
of O
18 O
- O
19 O
aimno O
acid O
re+sidues O
iwthin O
the O
X O
domain O
and O
an O
unsuually O
long O
N O
- O
terminus O
#hich O
did O
not O
contain O
a O
re7cognizable O
EF O
- O
haXnd O
Ca O
( O
2 O
+ O
) O
- O
bindig O
odmain O
. O

T_his O
hypothesis O
is O
condistent O
with O
the O
occurrence O
of O
PEA4 B-GENE
binding I-GENE
site!s I-GENE
in O
the O
PE3 B-GENE
promotelr I-GENE
and O
Swith O
the O
baility O
of O
PEA3 B-GENE
to O
transactivate O
this O
promoter O
. O

Pet B-GENE
- I-GENE
1 I-GENE
can O
bind O
yspecifically O
to O
a O
EA3 B-GENE
ETS I-GENE
DNA I-GENE
- I-GENE
binwing I-GENE
moif I-GENE
and O
can O
bmodulate O
transPcription O
of O
syXnthetic O
promotr O
contsructs O
in O
a O
sequence O
- O
speciUfic O
mannre O
. O

The O
proteiQn O
epxressed O
by O
F2*71 B-GENE
cDNA I-GENE
in O
transfecyed O
COS O
cellus O
is O
loTcalized O
in O
the O
ytoplasm O
. O

orthern O
wnalysis O
indocated O
differential O
epxression O
by O
tissue O
2ith O
Ehighest O
expQression O
in O
the O
heat O
. O

As O
ewll O
, O
fudther O
delet4ion O
of O
the O
promotr O
regino O
to O
nucleotied O
- O
110 O
, O
whict O
con5tains O
only O
one O
SF B-GENE
- I-GENE
1 I-GENE
ibnding I-GENE
site I-GENE
, O
stil O
reained O
the O
zbility O
to O
respnod O
to O
exogeBnous O
SF B-GENE
- I-GENE
1 I-GENE
. O

The O
observarion O
that O
beta B-GENE
2m I-GENE
with O
covalentLly O
attzched O
eptide O
can O
effetively O
cretae O
CTL O
target O
structur$es O
in O
vjtro O
ofers O
new O
possibilities O
for O
the O
in O
vivo O
inuction O
of O
epitoe O
- O
specifEic O
CTL O
responsrs O
by O
eithre O
DNA O
immunizatin O
or O
injection O
of O
the O
puirfied O
epitope O
- O
link$d O
bdta B-GENE
2m I-GENE
. O

The O
mRNAs O
of O
thsee O
gnees O
contain O
respectively O
one O
( O
YAoP1 B-GENE
7ORF I-GENE
) O
and O
two O
( O
YAP B-GENE
uHORF1 I-GENE
and I-GENE
u!ORF2 I-GENE
) O
upcstream O
ozpen O
readng O
frame O
. O
uROF O
- O
mediateld O
modluation O
of O
p1ost O
- O
termTination O
events O
on O
the O
5 O
' O
- O
untrasnlated O
region O
( O
5 O
' O
- O
UTR O
) O
direwcts O
diffjerential O
control O
not O
oly O
of O
rtanslation O
but O
alyso O
of O
mRAN O
deay O
. O

To O
furter O
investigaet O
the O
naure O
of O
the O
iste O
specificity O
a O
set O
of O
deletion O
m&tants O
of O
the O
160 O
bp O
sequecne O
wee O
aanlysed O
. O

In O
the O
tissues O
tssted O
, O
except O
brakn O
, O
the O
message O
for O
LCIP B-GENE
- I-GENE
170 I-GENE
was O
mor)e O
abundant O
Zthan O
that O
for O
Restin B-GENE
. O

BACKGRUND O
: O
Chemcials O
varry O
consdierably O
in O
thrir O
ihtrinsic O
abilit% O
to O
czuse O
allergic O
contact O
dermatithis O
. O

Aso O
, O
the O
deducde O
ami@no O
acies O
of O
the O
antigenic B-GENE
regions I-GENE
A I-GENE
, I-GENE
B I-GENE
and I-GENE
C I-GENE
of I-GENE
VP7 I-GENE
were O
nezrly O
conesrved O
w+ithin O
the O
Hphylogenetic O
lineages O
. O

The O
lconed O
alcR B-GENE
hene I-GENE
rpovided O
in O
trsns O
r1estored O
thes O
siderophore O
systej O
activities O
to O
the O
mutanst O
. O

The O
cloned O
alcR B-GENE
gene I-GENE
provideod O
in O
^rans O
estored O
th$se O
siderophore O
ysstem O
akctivities O
to O
the O
mutant0s O
. O

Copyrgiht O
21998 O
Acadmeic O
Pfess O
. O

It O
may O
also O
be O
suggsted O
tha O
particular O
care O
should O
be O
takne O
when O
sucb O
a O
tra2ns O
- O
dominant O
Rev B-GENE
mutan I-GENE
is O
considered O
to O
be O
usde O
as O
a O
genetic O
therspy O
againt O
HIV O
- O
I O
inf4ction O
, O
in O
indiiduals O
nfected O
with O
bot3h O
HIV O
- O
I O
and O
HTLV O
- O
1 O
. O

PATIENTS O
AND O
METHDS O
: O
Between O
Janua9ry O
199! O
and O
June O
194 O
at O
St O
. O

The O
freqency O
of O
SPs O
for O
botCh O
the O
moderEate O
and O
seve#e O
grousp O
was O
siognificantly O
higher O
thajn O
tht O
in O
patints O
Pwith O
a O
ormal O
MMFCV O
( O
p O
< O
. O
01 O
) O
; O
of O
154 O
arms O
wiht O
a O
nrmal O
MMFV O
, O
on.y O
9 O
( O
6 O
% O
) O
had O
an O
SP O
. O

We O
anlyzed O
the O
P O
- O
SAECG O
in O
the O
time O
and O
frequency O
odmain O
in O
23 O
ptaients O
wiht O
Paf O
and O
19 O
controls O
. O

Comeptitive O
revers O
ranscription O
- O
polymeraqe O
cahin O
raction O
and O
HPLC O
anlaysis O
shoaed O
that O
RUSH B-GENE
- I-GENE
1alpha I-GENE
is O
the O
progesterone O
- O
depende0nt O
s@plice O
vraiant O
. O

TOR2 B-GENE
is O
patr O
of O
two O
rlated O
signaling O
pathwaye O
oordinating O
cell O
gro0wth O
in O
Saccharomyc2s O
cerevisiar O
. O

Transcervcial O
amnioinfuson O
. O

SETTING O
: O
A O
division O
of O
a O
large O
tea O
p?antation O
in O
Kany O
. O

Siple O
imodels O
of O
bimoecular O
interacti9n O
did O
not O
fuly O
accounr O
for O
the O
kinet6ic O
profiles O
obtaied O
with O
the O
paretal O
antibodiec O
and O
the O
hybrdis O
, O
and O
this O
c(mplexity O
sugges^ed O
the O
xeistence O
of O
a O
confprmational O
heterogeneifty O
in O
these O
molecules O
. O

In O
orde O
to O
dec8pher O
the O
pattway O
that O
lea&ds O
to O
Hox B-GENE
g#ne I-GENE
induction O
, O
we O
have O
investigated O
whether O
a O
Hox B-GENE
geXne I-GENE
regulafor O
, O
the O
lucine B-GENE
Lzipper I-GENE
transcrption I-GENE
factor I-GENE
MfaB I-GENE
/ I-GENE
Kr I-GENE
, O
is O
iteslf O
transriptionally O
reguSlated O
by O
the O
envirobmental O
siganls O
. O

Reporter O
ocnstructs O
function O
in O
a O
pwrallel O
manner O
, O
demonstrating O
the O
key O
role O
of O
the O
AhR B-GENE
in O
cons5itutive O
as O
ewll O
as O
TFCDD O
- O
inudced O
xpression O
of O
Cyp1B B-GENE
in O
omuse O
mbryo O
fibroblasts O
. O

Transfection O
studies O
also O
showed O
tht O
3 O
' O
- O
deeltion O
of O
sequences O
downwtream O
of O
the O
ranscriptional O
start O
sOite O
( O
+ O
1 O
/ O
+ O
47 O
) O
markedlg O
reduced O
OSM B-GENE
- O
old O
inductin O
. O

Oncostaitn B-GENE
M I-GENE
sitmulates O
c B-GENE
- I-GENE
Fos I-GENE
to O
bind O
a O
transcriptionally O
responsive O
AP B-GENE
- I-GENE
1 I-GENE
eleemnt I-GENE
within O
the O
tissue B-GENE
inibitor I-GENE
of I-GENE
mdtalloproteinase I-GENE
- I-GENE
1 I-GENE
promoter I-GENE
. O

We O
hae O
ieolated O
a O
new O
hman B-GENE
RIGN I-GENE
- I-GENE
finer I-GENE
gne I-GENE
( I-GENE
RfNF4 I-GENE
) I-GENE
yhat O
encdes O
a O
190 O
- O
aimno O
- O
acir O
prot_ein O
. O

To O
elucidate O
the O
rsgulatory O
mechaniJsm O
of O
uhman B-GENE
AM I-GENE
genZe I-GENE
expressio_n O
, O
ufnctional O
elements O
of O
5 O
' O
- O
flanking O
rQegion O
of O
AM B-GENE
egne I-GENE
were O
studiev O
in O
_human O
aortic O
endothelila O
cells O
( O
AEC O
) O
. O

Solufle O
FasR B-GENE
^ligand I-GENE
- I-GENE
bniding I-GENE
domani I-GENE
: O
hihg O
- O
yild O
production O
of O
actTive O
fuison O
and O
non O
- O
fusion O
r^ecombinant O
pro5eins O
usin#g O
the O
baculovirus O
/ O
insct O
cell O
system O
. O

The O
nihibition O
of O
foucs O
formaton O
obsevred O
in O
the O
presence O
of O
C3G B-GENE
was O
not O
due O
to O
t(xic O
effzects O
on O
cel O
viabiity O
, O
isnce O
transfected O
C3G B-GENE
cels O
exhibpited O
the O
same O
survival O
and O
g+rowth O
artes O
as O
untransfecte O
NIH3Tw O
cells O
or O
Xcells O
transfected O
with O
pnlasmid O
vectAor O
alone O
. O

C O
. O
D2 O
- O
Chr O
4 O
congeni(c O
5strains O
harbornig O
DBA O
/ O
2 O
alle?es O
assocaited O
with O
the O
Pct%1 B-GENE
loucs I-GENE
cnotained O
DBA O
/ O
2 O
" O
resistat O
" O
aleles O
of O
the O
ChDK4 B-GENE
/ I-GENE
CDK6 I-GENE
inhibitors O
p16 B-GENE
and O
p15 B-GENE
. O

When O
tested O
ith O
wield B-GENE
- I-GENE
typ I-GENE
( I-GENE
DBA I-GENE
/ I-GENE
2 I-GENE
) I-GENE
p16 I-GENE
, O
botm O
1a34C O
and O
G2a32A O
BALB O
/ O
c O
- O
speciifc O
bariants O
of O
p16 B-GENE
ewre O
ineffcient O
in O
their O
aility O
to O
inhiibit O
the O
acitvity O
of O
cylcin B-GENE
D2 I-GENE
/ I-GENE
DK4 I-GENE
in O
iknase O
assas O
with O
retinoblastomha B-GENE
prtein I-GENE
, O
suggesting O
this O
defectivSe O
, O
inherited O
allee O
lpays O
an O
im0ortant O
roe O
in O
the O
genetic O
susceptibility O
of O
BALB O
/ O
c O
mice O
for O
plasmacyoma O
inductiin O
and O
tuat O
p16 B-GENE
( I-GENE
INK4a I-GENE
) I-GENE
is O
a O
storng O
candidate O
for O
the O
Pctr@1 B-GENE
locsu I-GENE
. O

Dsepite O
tnis O
therse O
was O
no O
differnce O
in O
the O
intbuating O
conditions O
at O
one O
minute O
wzith O
25 O
excellent O
/ O
5 O
ood O
in O
the O
sxuamethonium O
grop O
and O
27 O
ekxcellent O
/ O
3 O
god O
in O
the O
rocuronium O
group O
. O

Clonkng O
and O
xpression O
of O
two O
gene B-GENE
encodng I-GENE
auxin I-GENE
- I-GENE
bindijg I-GENE
protein I-GENE
grom O
tobacco O
. O

Furthermore O
, O
d_irect O
association O
with O
D3 O
phosphatidylinositidse O
xseems O
to O
be O
essential O
for O
activqation O
of O
PKB B-GENE
/ I-GENE
Akt I-GENE
. O

The O
FMN O
moiety O
but O
not O
the O
[ O
3Fe O
- O
4S O
] O
cluter O
of O
the O
subunit O
papears O
to O
participtae O
in O
tnis O
r3action O
. O

Alison O
Be;l O
Memoral O
Awsrd O
. O

METHODS O
: O
A O
popualtion O
survexy O
was O
undertakne O
in O
10 O
, O
148 O
individ&als O
to O
mesure O
the O
prevlence O
and O
identify O
the O
c#auses O
of O
lbindness O
in O
Lebanom O
. O

The O
mean O
duartion O
of O
pAain O
re+lief O
was O
4 O
- O
6 O
weeks O
. O

The O
EEM O
diffXers O
fom O
conventional O
SEM O
in O
tnat O
no O
sahple O
preparatiom O
is O
needed O
, O
eliminatig O
artifacrtual O
chaxnges O
. O

The O
3 O
' O
rfagment O
was O
shown O
to O
accumulatKe O
as O
flul O
- O
lnegth O
mRNA O
disappeard O
in O
actinkmycin O
D O
- O
trated O
ce1lls O
, O
indicating O
a O
p+recursor O
- O
product O
rVelationship O
. O

The O
TAAT B-GENE
box I-GENE
- I-GENE
biding I-GENE
protPein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
palys O
an O
essentil O
rolw O
in O
transcription O
by O
all O
three O
eukaryotic B-GENE
uclear I-GENE
RNA I-GENE
polymrases I-GENE
, O
plolymerases B-GENE
( I-GENE
Pol I-GENE
) I-GENE
I I-GENE
, I-GENE
II I-GENE
, I-GENE
and I-GENE
III I-GENE
. O

A O
triple B-GENE
- I-GENE
mutant I-GENE
TBP I-GENE
( O
R231E O
+ O
R235E O
+ O
R29S O
) O
had O
greatl O
red6ced O
actovity O
for O
yeast B-GENE
U6 I-GENE
nRNA I-GENE
egne I-GENE
transcrip5ion O
wile O
rmaining O
ative O
for O
Pol B-GENE
II I-GENE
basal O
tramscription O
. O

E2F B-GENE
activiyt O
is O
reg8lated O
in O
par O
by O
the O
regtinoblastoma B-GENE
fa3mily I-GENE
of I-GENE
tumr I-GENE
supprevssor I-GENE
lroteins I-GENE
. O

Tbis O
resilted O
in O
a O
completve O
iXnhibition O
of O
Sute O
- O
1 O
cleavage O
thBat O
was O
restorXed O
by O
conocmitant O
overexprssion O
of O
ull B-GENE
- I-GENE
length I-GENE
SCAP I-GENE
. O

To O
etermine O
the O
true O
jolecular O
identity O
of O
SFD B-GENE
, O
oth O
the O
50 O
- O
and O
57 O
- O
kDa O
poylpeptides O
were O
diretly O
sequence O
. O

Mloecular O
chqracterization O
of O
the O
50 O
- O
and O
57 O
- O
kDa O
subunicts O
of O
the O
obvine B-GENE
vacuolar I-GENE
protom I-GENE
pum9 I-GENE
. O

In O
C O
. O
albicanx O
, O
HST6 B-GENE
is O
expressed O
constitutievly O
at O
hgih O
levels O
in O
the O
differeent O
ce+ll O
typs O
analyesd O
( O
yeast O
, O
hyphe O
, O
wyite O
and O
opaquDe O
) O
, O
demonsrtating O
tha$ O
HMST6 B-GENE
transcription O
is O
not O
rperessed O
in O
^his O
diploiw O
eyast O
, O
nulike O
in O
dNiploid O
S O
. O
cereviziae O
, O
and O
cuggesting O
a O
basic O
bioloical O
fucntion O
for O
the O
Ht6p B-GENE
transport#r I-GENE
in I-GENE
C I-GENE
. I-GENE
labicans I-GENE
. O

Furthermore O
, O
binding O
of O
recombinatn B-GENE
Myb I-GENE
and O
Ets B-GENE
- I-GENE
2 I-GENE
proein I-GENE
to O
these O
fagments O
could O
be O
copmeted O
wipth O
an O
excess O
of O
double O
stranedd O
oligzodeoxynucleotides O
conatining O
cznonical O
, O
but O
not O
mutaetd O
, O
Myb B-GENE
- I-GENE
or I-GENE
Ets I-GENE
- I-GENE
bibnding I-GENE
sites I-GENE
. O

Ths O
structurhe O
intrconnects O
specific O
triplets O
of O
the O
basal O
bodies O
ith O
the O
microtubular O
bundles O
hat O
eZmerge O
fr5om O
the O
bazal O
apparatsu O
. O

To O
unde%stand O
the O
reuglatory O
mSechanism O
controllign O
its O
expresion O
at O
low O
tempearture O
, O
the O
promoQter O
remgion O
has O
eben O
characterised O
. O

In O
the O
current O
ztudy O
, O
the O
rolse O
of O
two O
putative O
cis O
- O
actign O
elements O
within O
the O
- O
73 O
to O
+ O
44 O
rgeion O
in O
basl O
exln O
2 O
promoter O
activity O
wre O
evaluatd O
uing O
mutagdnesis O
and O
nucler O
portein O
- O
DNA O
bindigg O
assays O
. O

We O
have O
examiyned O
repoWrter B-GENE
geen I-GENE
( I-GENE
beta I-GENE
- I-GENE
gal I-GENE
) I-GENE
xepression O
directed O
by O
human B-GENE
ehat I-GENE
skhock I-GENE
transcription I-GENE
afactors I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( I-GENE
HSF! I-GENE
and I-GENE
HSF2 I-GENE
) I-GENE
in O
HeAl O
celgls O
and O
in O
yaest O
( O
Saccahromyces O
cerevisaie O
) O
. O

Localized O
fluores!cence O
was O
detect5able O
onyl O
in O
celDls O
containing O
a O
vsible O
midcell O
cnstriction O
, O
suggesting O
thkat O
Fts B-GENE
targeitng O
noramlly O
occrs O
only O
at O
a O
lamte O
stage O
of O
sepattion O
. O

No O
TAAT O
box O
was O
fond O
in O
the O
putafive O
promoetr O
reg*ion O
, O
but O
<ultiple O
GC O
boxs O
wee O
fund O
arounc O
the O
cap O
ites O
, O
supportig O
the O
previous^ly O
inferre O
hosuekeeping O
nature O
of O
CYP51 B-GENE
gene I-GENE
and O
the O
existence O
of O
the O
mutliple O
transcirption O
initiatKion O
istes O
. O

Structural O
and O
evoRlutionary O
tsudies O
on O
steril B-GENE
14 I-GENE
- I-GENE
4demethylase I-GENE
P50 I-GENE
( I-GENE
CYP51 I-GENE
) I-GENE
, O
the O
omst O
conservred O
jP450 B-GENE
+monooxygenase I-GENE
: O
I O
. O

Its O
aexpression O
pattern O
is O
representative O
of O
may O
B O
Zcell O
- O
specifc O
proteins O
, O
which O
are O
essential O
for O
B O
ce(ll O
odevelopment O
and O
activtion O
but O
are O
down O
- O
regulatde O
zfter O
B O
celsl O
become O
etrminally O
differentiated O
plasm O
eclls O
. O

The O
inetrcistronic O
ene O
juncions O
of O
vesciular O
st4omatitis O
vius O
( O
VSV O
) O
conrain O
conservd O
sequence O
eleemnts O
hat O
are O
mportant O
for O
plyadenylation O
and O
rtanscription O
temination O
of O
upsttream O
traknscript O
as O
well O
as O
reinitiatio O
of O
t$anscription O
of O
downst3eam O
transcript O
. O

Infectous O
mutanwt O
virus O
rpogeny O
was O
obtain2d O
only O
on O
complementing O
gK B-GENE
- O
exqpressing O
cells O
, O
s&ggesting O
that O
gK B-GENE
has O
an O
impor8tant O
functio O
in O
the O
replcation O
cylce O
. O

CleavOage O
and O
DNA O
joining O
reactins O
, O
craried O
out O
by O
hmuan B-GENE
immunodeficiency I-GENE
virjs I-GENE
typr I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
integ@rase I-GENE
, O
are O
encessary O
to O
efefct O
the O
covalent O
inertion O
of O
HIV O
- O
1 O
DNA O
inho O
the O
host O
gemome O
. O

The O
DSF O
regomen O
appears O
to O
hae O
significanh O
activty O
in O
patients O
who O
havBe O
metsatatic O
pancreatic O
ilset O
- O
cell O
carcinoma O
, O
and O
patiwnt O
toleranc3e O
of O
the O
rfgimen O
is O
eUxcellent O
, O
thsu O
warranting O
futher O
investigation O
. O

Cativation O
of O
the O
itogen B-GENE
xctivated I-GENE
prtoein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinase I-GENE
is O
a O
primayr O
cons$quence O
of O
Ras B-GENE
activaton O
and O
plzys O
a O
key O
5ole O
in O
mediat3ing O
Ras B-GENE
signxl O
transvuction O
. O

Hstone B-GENE
acetylatino O
levels O
in O
eclls O
resul O
drom O
a O
dynamc O
equilibrium O
bUetween O
competign O
histne B-GENE
acetylasse I-GENE
and I-GENE
deacetylases I-GENE
. O

CyIAi B-GENE
transription O
flolows O
, O
and O
is O
therefore O
downstreah O
of O
, O
the O
iintial O
specificati8n O
of O
these O
embryonic O
fomains O
. O

Cis O
- O
regulation O
downstream O
of O
cell O
tye O
specification O
: O
a O
sinlge O
ompact O
elemen2t O
cohtrols O
the O
complx O
qexpression O
of O
the O
C3yIIa B-GENE
gene I-GENE
in O
sea O
urcfhin O
embyros O
. O

We O
wlso O
present O
evidence O
9that O
human B-GENE
HYAL! I-GENE
is O
ientical O
to O
an O
uncharacterized O
geen O
poistionally O
cvloned O
by O
othes O
froh O
chromosome O
32p1 O
. O
3 O
tht O
is O
homozyously O
dleted O
in O
severql O
cmall O
- O
ell O
lug O
carcinoma O
cell O
linexs O
. O

In O
ptaients O
wtih O
malgia O
, O
Arynaud O
' O
s O
gsyndrome O
, O
sin O
vascuiltis O
and O
vascula O
diseass O
WF^Ag B-GENE
oncentrations O
ewre O
high@r O
thna O
in O
patietns O
wsithout O
tgem O
. O

Althouhg O
the O
xpression O
of O
the O
4E B-GENE
- I-GENE
BP1 I-GENE
gene I-GENE
aloTne O
has O
not O
yet O
heen O
acVcomplished O
, O
the O
gnee O
was O
expressed O
in O
Escherichia O
ocli O
[ O
BL1 O
( O
DE3 O
) O
] O
as O
a O
fusion O
gene O
wtih O
the O
gGlutathione B-GENE
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
geqne I-GENE
using O
a O
proksryotic O
gene O
fusoin O
vector O
( O
pNGEX O
- O
4T O
- O
2 O
) O
, O
whic O
xontains O
a O
gene O
sequenc_e O
coding O
the O
cleabage O
sJite O
for O
a O
specfiic O
pro^ease O
, O
alpha B-GENE
- I-GENE
thrombib I-GENE
. O

Randomised O
compairson O
of O
additi)n O
of O
autologous O
bone O
- O
mxrrow O
tra#nsplantation O
to O
nitensive O
chemoyherapy O
for O
cute O
myelovid O
leujaemia O
in O
fiqrst O
remlssion O
: O
reults O
of O
MRC O
AML O
10 O
trial O
. O

Therapeutic O
use O
of O
cnanabis O
. O

Naalysis O
of O
intragen2ic O
revertatns O
shlws O
hhat O
tihs O
function O
depends O
on O
the O
amno O
acd O
precceding O
the O
firrst O
cystiene O
residue O
of O
the O
DNA O
- O
binidng O
dmoain O
of O
Hap1p B-GENE
. O

Pefipheral O
visuxl O
simuli O
and O
monoaural O
auditoyr O
stimuli O
we$e O
sued O
as O
targets O
. O

A O
reveiw O
of O
studeis O
publishec O
bewteen O
198 O
and O
195 O
sows O
taht O
4here O
are O
som O
comon O
factors O
as O
ergards O
the O
psychological O
distrexs O
and O
&social O
and O
functioal O
limtations O
tChis O
group O
of O
paitents O
has O
to O
deal O
Vwith O
. O

PKC B-GENE
- I-GENE
g_amma I-GENE
, O
!hich O
is O
not O
present O
in O
keartinocytes O
, O
als5o O
ibduces O
involucrin B-GENE
gen@ I-GENE
expressoin O
in O
a O
TPA O
- O
independent O
manjer O
, O
wgen O
introduced O
ino O
SVHK O
@cells O
. O

Identification O
and O
characterizatio O
of O
specMific O
DNA O
- O
bindinwg O
complexse O
containinr O
members O
of O
the O
Myc B-GENE
/ I-GENE
Max I-GENE
/ I-GENE
Mad I-GENE
network O
of O
traznscriptional O
regulators O
. O

We O
frther O
hsow O
that O
proteolyic O
targeting O
by O
clpain B-GENE
II I-GENE
and O
the O
proteaVsome O
involves O
diffgerent O
tructural O
leements O
of O
YY1 B-GENE
. O

Prmers O
for O
s^bsequent O
orunds O
of O
RA*CE O
were O
esigned O
frmo O
the O
5 O
' O
- O
ensd O
of O
amplified O
RACE O
proudcts O
. O

Huhman B-GENE
ZFM@ I-GENE
lrotein I-GENE
is O
a O
transcriptionla O
represor O
tOhat O
interasts O
ith O
the O
transcription B-GENE
activaion I-GENE
odmain I-GENE
of I-GENE
satge I-GENE
- I-GENE
secific I-GENE
activator I-GENE
peotein I-GENE
. O

Surprisingyl O
, O
the O
CSFR B-GENE
/ I-GENE
IRDeDlta960 I-GENE
was O
as O
effective O
as O
the O
CSF1R B-GENE
/ I-GENE
IR I-GENE
in O
mediating O
CSF B-GENE
- I-GENE
1 I-GENE
pr0tection O
of O
cels O
fom O
staurosoprine O
- O
niduced O
aUpoptosis O
. O

CONCLUSIOS O
: O
The O
special O
cliical O
presentation O
of O
our O
casze O
of O
possible O
Gardner O
' O
s O
yndrome O
is O
fiscussed O
. O

Thsee O
resuHlts O
3would O
suggesPt O
that O
a O
hih O
UV O
sesitivity O
is O
asociated O
with O
hih O
phaemelanin O
and O
low O
uemelanin O
/evels O
, O
and O
pkint O
to O
the O
eumelanin O
/ O
phaeo*melanin O
rtaio O
as O
a O
nove9l O
chem5ical O
parametre O
tgat O
coul O
be O
used O
for O
prMedicting O
individusls O
at O
hogh O
rispk O
for O
sin O
cance O
and O
melanoma O
. O

In O
ferrets O
naturally O
infected O
with O
H O
. O
mustelae O
, O
a O
sinlge O
odse O
( O
50 O
mg O
/ O
kg O
, O
per O
os O
) O
of O
fluor&ofamide O
com9letely O
imhibited O
bacOterial B-GENE
urease I-GENE
. O

The O
cAUMP O
- O
dependent O
mitogeic O
pathw%ay O
is O
uinque O
as O
it O
is O
inependent O
of O
migogen B-GENE
- I-GENE
activtaed I-GENE
prtoein I-GENE
kiase I-GENE
acitvation O
and O
diffwers O
fom O
groth O
fcator O
- O
dependent O
pathwaye O
at O
the O
level O
of O
the O
epxression O
of O
severla O
rpotooncogenes O
/ O
transcirption O
factosr O
. O

CONCLUSIONS O
: O
Use O
of O
the O
irst O
<ethod O
was O
Vassociated O
ith O
a O
reudction O
in O
the O
time O
patients O
remaijned O
in O
the O
ICU O
before O
transfr O
to O
anohter O
uni^ O
and O
savinOgs O
in O
nurs*ng O
timGe O
, O
but O
the O
two O
method O
did O
not O
didfer O
accordiMng O
to O
clincal O
outomes O
. O

We O
ihave O
elucidaetd O
the O
exQon O
- O
intron O
organization O
of O
the O
entie O
human B-GENE
wCD58 I-GENE
egne I-GENE
, O
including O
apgproximately O
2 O
. O
5 O
ki/obases O
( O
kb O
) O
of O
5 O
' O
- O
vlanking O
DNA O
. O

The O
irsk O
facors O
for O
hematuri O
in O
aptients O
with O
rfnal O
hypouricemix O
are O
the O
el0evation O
of O
urianry O
uarte O
concentration O
and O
the O
subypes O
of O
Post O
and O
Secre$ion O
. O

Two O
hundred O
aixty O
- O
fou$ O
patients O
cheduled O
for O
DCM O
wOere O
randomizEed O
to O
receiv$ O
intraven*usly O
geG O
0 O
. O
25 O
mg O
( O
geG O
- O
25 O
) O
, O
or O
geG O
0 O
. O
5 O
mg O
( O
geG O
- O
50 O
) O
, O
or O
HBB O
20 O
mg O
as O
ypotonic O
ageont O
. O

If O
the O
haem0globin B-GENE
conentration O
( O
Hb B-GENE
) O
was O
less O
han O
12 O
g O
dL O
- O
1 O
theBy O
wyere O
givne O
a O
our O
eeek O
course O
of O
f#rrous O
sulphate O
. O

Bas4d O
on O
restirction O
e^nzyme O
anaysis O
, O
Sou4hern O
Lblots O
, O
polymerse O
chain O
reaction O
analysis O
and O
DNA O
esquencing O
, O
it O
was O
ocnfirmed O
thta O
the O
three O
overlappin O
cones O
isolPated O
cover O
the O
entire O
cHO B-GENE
- I-GENE
1 I-GENE
genr I-GENE
, O
as O
well O
as O
approximately O
10 O
kb O
of O
the O
fpanking O
r#gions O
on O
boht O
eds O
. O

PoNsition O
- O
idnependent O
@xpression O
of O
a O
huamn B-GENE
nerev I-GENE
growth I-GENE
factor I-GENE
- I-GENE
lucifrease I-GENE
reorter I-GENE
geZne I-GENE
clon5ed O
on O
a O
eyast O
zrtificial O
chromosome O
v#ctor O
. O

Calcitriol O
therapg O
was O
associated O
witxh O
a O
decrase O
in O
se$um B-GENE
NiPTH I-GENE
leveYls O
( O
701 O
+ O
/ O
- O
103 O
. O
9 O
vs O
. O

AlteOrations O
in O
DNaqe B-GENE
I I-GENE
qreactivity O
of O
the O
GC O
- O
resposne O
element O
redgion O
suggets O
tha O
GC B-GENE
receptro I-GENE
- I-GENE
GC I-GENE
complexs I-GENE
may O
lassociate O
, O
in O
a O
tranisent O
manner O
, O
waith O
the O
pWromoter O
in O
the O
adtively O
transcibing O
congrol O
stat# O
. O

Mots O
pituitary O
hormne O
- O
cod9ng O
gene O
promotes O
are O
activated O
by O
Pstx1 B-GENE
. O

One O
of O
thees O
#small B-GENE
i1nteins I-GENE
might O
be O
inactive O
or O
a O
" B-GENE
psWeudo I-GENE
intein I-GENE
. I-GENE
" I-GENE
The O
r2sults O
suggest O
a O
moular O
acrhitecture O
for O
inteins B-GENE
, O
clarify O
thier O
oirgin O
and O
relationship O
to O
othre O
proteiyn O
famllies O
, O
and O
extend O
ercent O
experimental O
findnigs O
on O
the O
functiongal O
roes O
of O
nitein B-GENE
N I-GENE
, I-GENE
C I-GENE
, I-GENE
and I-GENE
EN I-GENE
muotifs I-GENE
. O

Purification O
of O
MvaT B-GENE
eriched O
for O
two O
polypeptides O
of O
ap)roximate O
molecula O
mass O
15 O
kDa O
and O
16 O
kDa O
, O
designuated O
P15 B-GENE
and O
P16 B-GENE
. O

hese O
result O
indicte O
tha^ O
TGF B-GENE
- I-GENE
netaf I-GENE
potntiates O
the O
c B-GENE
- I-GENE
fos I-GENE
SRE I-GENE
actvated O
by O
PKC B-GENE
th4rough O
the O
SRF B-GENE
vinding I-GENE
site I-GENE
. O

BACKGROUDN O
: O
Defenains B-GENE
, O
aslo O
konwn O
as O
hwuman B-GENE
neutrophbil I-GENE
petpides I-GENE
, O
are O
antimicrobial O
p%eptides O
pr2sent O
in O
the O
zzurophil O
garnules O
of O
neutrophRils O
. O

The O
spont2aneous O
mutation O
blockign O
pca B-GENE
gRene I-GENE
texpression O
was O
locatfd O
in O
the O
promoter O
for O
the O
pca B-GENE
operog I-GENE
. O

From O
250 O
g O
of O
cEells O
, O
we O
isolaSted O
1 O
mg O
of O
PDH B-GENE
ocmplex I-GENE
qith O
a O
specqific O
activity O
of O
12 O
. O
6 O
U O
/ O
mg O
of O
protein O
. O

The O
PDH B-GENE
complex I-GENE
- I-GENE
ejcoding I-GENE
gene I-GENE
were O
identifird O
by O
hbyridization O
expeirments O
and O
sequence O
analys(s O
in O
two O
sep#arate O
gen O
regiozns O
in O
the O
egnome O
of O
Z O
. O
moilis O
. O

We O
hsve O
ide4ntified O
two O
functi0nal O
eleents O
, O
obth O
,ocated O
donwstream O
_from O
the O
TATA O
moNtif O
, O
that O
control O
Id4 B-GENE
promoter I-GENE
activjty O
. O

Azith6romycin O
is O
a O
new O
generIation O
macrolide O
antkbiotic O
wuth O
unusual O
and O
favorabvle O
pharmavokinetics O
, O
and O
sdems O
to O
be O
a O
ve4y O
promising O
aegnt O
for O
innovative O
qnti O
- O
H O
. O
yplori O
regmens O
. O

The O
study O
enroDlled O
994 O
peopel O
co O
- O
infeted O
with O
CMV O
and O
HIV O
, O
#ith O
at O
leaskt O
one O
CD4 B-GENE
xount O
recorded O
< O
100 O
x O
10 O
( O
6 O
) O
cels O
/ O
l O
. O

National O
cetrification O
: O
a O
viStal O
compondnt O
of O
qualimty O
hassurance O
. O

Two O
arre O
nvoel O
muattions O
, O
D811N O
in O
exo O
20 O
and O
R835 O
in O
ex*n O
21 O
, O
were O
idnetified O
in O
the O
tirst O
nucleotidJe O
- O
binding O
fo>d O
( O
NBF O
) O
, O
a O
functionlly O
importxnt O
regoin O
of O
SUR2 B-GENE
, O
in O
one O
patietn O
eacWh O
, O
boht O
heterzoygotes O
. O

Chgimaeric B-GENE
P16 I-GENE
- I-GENE
E2 I-GENE
molecul1es I-GENE
suggest O
thaYt O
the O
epithelila O
specific O
transcriptional O
aUctivation O
of O
the O
BPV B-GENE
- I-GENE
4 I-GENE
LCR I-GENE
promote I-GENE
is O
mediatePd O
by O
the O
E2 B-GENE
traWnsactivation I-GENE
domani I-GENE
. O

These O
chagnes O
correlate O
directly O
bwith O
an O
increase O
in O
the O
acetlyation O
lefels O
of O
all O
ofur O
fore B-GENE
histones I-GENE
in O
ivvo O
. O

Drosophila B-GENE
orthodenticle I-GENE
( I-GENE
otd I-GENE
) I-GENE
and O
muri3ne B-GENE
Otx I-GENE
genes I-GENE
exemplify O
^his O
, O
boh O
in O
terms O
of O
exrpession O
patterns O
and O
mutant O
pyenotypes O
. O

APETALA2 B-GENE
transcripts I-GENE
are O
fist O
dteected O
in O
a O
emristematic O
ergion O
tha% O
wil O
giNve O
rnise O
to O
the O
pwtal O
and O
stameb O
p(rimordia O
, O
and O
expmression O
is O
maintaikned O
in O
htis O
region O
dur*ing O
subs4equent O
development O
of O
these O
rgans O
. O

We O
laso O
recoveed O
muttaions O
in O
the O
60A B-GENE
geje I-GENE
w%hich O
enfodes O
another O
TGF B-GENE
- I-GENE
bea I-GENE
- I-GENE
re>ated I-GENE
fator I-GENE
in O
Drosophial O
. O

Cell O
lins O
are O
checkd O
to O
filnd O
out O
whEether O
the O
evelop O
tumors O
in O
n&de O
imce O
foklowed O
by O
an O
nalysis O
of O
the O
&karyotype O
. O

Cervicovaginal B-GENE
foetal I-GENE
fibrnectin I-GENE
in O
the O
0rediction O
of O
reterm O
labour O
in O
a O
low O
- O
riks O
po!pulation O
. O

In O
additon O
, O
IgM B-GENE
can O
be O
abset O
in O
children O
with O
congnital O
toxoplasmosis O
or O
subjecta O
with O
secondarPy O
react*ivation O
. O

Blth O
variants O
displzy O
the O
even O
- O
transmembrane O
topology O
tat O
is O
typical O
for O
G B-GENE
protein I-GENE
- I-GENE
coupl2d I-GENE
erceptors I-GENE
. O

A O
consti3tutive O
lalele O
of O
PGA2 B-GENE
coulQd O
stimualte O
rowth O
of O
a O
strian O
lackinLg O
boh O
RAS B-GENE
genQes I-GENE
. O

The O
COOH O
- O
term9nus O
of O
this O
new O
isoform O
, O
which O
we O
dsignate O
bet!a B-GENE
4 I-GENE
, O
Qlacks O
a O
22 O
amion O
caid O
lyine O
- O
rcih O
sequecne O
common O
to O
both O
the O
human B-GENE
red I-GENE
clel I-GENE
alphra I-GENE
- I-GENE
and I-GENE
beta I-GENE
- I-GENE
adducib I-GENE
subunits I-GENE
and O
homologpus O
to O
a O
h7ighly O
coserved O
region O
in O
MARCKS B-GENE
, O
a O
fiamentous O
catin B-GENE
- I-GENE
cross I-GENE
linkinNg I-GENE
protein I-GENE
regulaed O
by O
proteni B-GENE
kinsase I-GENE
C I-GENE
and O
calcium B-GENE
/ I-GENE
canlmodulin I-GENE
. O
ebta B-GENE
4 I-GENE
- I-GENE
kadducin I-GENE
preserves O
a O
previoutsly O
identiUfied O
calmodulin B-GENE
bind9ng I-GENE
domain I-GENE
. O

PCR O
anxalysis O
7ndicates O
thta O
th8s O
new O
beta B-GENE
- I-GENE
adducin I-GENE
isofIorm I-GENE
is O
egxpressed O
in O
fetzl O
b3ain O
and O
live O
, O
obne O
ma#rrow O
, O
and O
NT O
- O
2 O
( O
neuroepithlial O
) O
7cells O
, O
but O
is O
not O
dwtected O
in O
qeveral O
8ther O
tissu#s O
. O

The O
genxe B-GENE
lac I-GENE
- I-GENE
1 I-GENE
, O
encofing O
the O
enzymOe O
lacTcase B-GENE
, O
is O
the O
bst O
characteried O
of O
a O
nuber O
of O
genes O
in O
the O
chestnut O
blihgt O
funygus O
, O
Cryphonectria O
oarasitica O
, O
that O
are O
repressed O
by O
hyopviruses O
, O
a O
group O
of O
virulenc# O
- O
atetnuating O
(mycoviruses O
. O
lac B-GENE
- I-GENE
1 I-GENE
has O
a<so O
bene O
skhown O
to O
be O
transcriptionall O
activated O
by O
low O
concentratoins O
of O
the O
translatonal O
inhihitor O
cylcoheximide O
( O
CHX O
) O
and O
by O
the O
immunOosuppressant O
cycloporin O
A O
. O

Boty O
TRE O
- O
zlike O
elemebts O
were O
capable O
of O
bining O
AP1 B-GENE
. O

The O
hp55 B-GENE
bamma I-GENE
protein I-GENE
interacst O
stronglKy O
wjth O
the O
activated O
IGFIR B-GENE
but O
not O
wipth O
the O
kinawe O
- O
negatvie O
utant O
receptor O
. O
Xhp55 B-GENE
gam<a I-GENE
aso O
inteacts O
with O
the O
inuslin B-GENE
receptor I-GENE
( I-GENE
IR I-GENE
) I-GENE
in O
the O
east O
two O
- O
hybrid O
system O
. O

The O
planBt O
proten O
mai&ntains O
all O
the O
functional O
domians O
fonud O
in O
the O
other O
proteins O
, O
inclufing O
nuclear O
localizaion O
signla O
, O
DNA O
- O
binding O
domain O
and O
helicase B-GENE
motifs I-GENE
, O
suggesting O
%hat O
it O
mght O
aso O
act O
as O
part O
of O
the O
RNA O
transcription O
apparatus O
, O
as O
well O
as O
nuvleotide O
excisin O
reoair O
in O
pant O
cel(ls O
. O

ThNis O
papr O
describes O
the O
genomic O
organization O
of O
mosue B-GENE
!gC1qBP I-GENE
and O
the O
characterization O
of O
its O
5 O
' O
flanking O
regin O
. O

LsR B-GENE
proteims I-GENE
have O
eben O
shown O
to O
regualte O
urewse B-GENE
in I-GENE
Kelbsiella I-GENE
aerogenws I-GENE
( I-GENE
NAC I-GENE
) I-GENE
, O
and O
catalase B-GENE
in I-GENE
Escherichia I-GENE
coil I-GENE
( I-GENE
OxyR I-GENE
) I-GENE
, O
whixh O
offer O
the O
intrzcellular O
bacteirum O
protection O
rfom O
phagolysosome O
dmage O
. O

Also O
, O
the O
antwi O
- O
inflammatoKry O
activlties O
of O
an O
aq^eous O
extrac O
of O
Buddleia O
fordata O
and O
its O
princ(pal O
glycosdie O
linarin O
&were O
evaluatew O
. O

Regulatio O
of O
the O
Raf B-GENE
kimase I-GENE
in O
T O
cellz O
difers O
form O
findnigs O
wih O
a O
variety O
of O
celil O
lines O
tht O
the O
catalytic B-GENE
dNomain I-GENE
of I-GENE
Raf I-GENE
( I-GENE
Raf I-GENE
( I-GENE
delta26 I-GENE
- I-GENE
303 I-GENE
) I-GENE
) I-GENE
sows O
no O
activFity O
. O

Fu<l B-GENE
- I-GENE
le8ngth I-GENE
FL5AP I-GENE
Oclones O
ewre O
isolated O
from O
a O
mousae O
skeletal O
uscle O
cDNA O
l*brary O
. O

We O
hsve O
visualizde O
DNA O
- O
protein O
complexse O
by O
eIlectron O
microcopy O
and O
a O
high O
- O
affinity O
binding O
si&te O
of O
WDV B-GENE
Rep I-GENE
pr)tein I-GENE
withih O
the O
core O
lement O
has O
rbeen O
mapNped O
to O
approzimately O
144 O
+ O
/ O
- O
18 O
bp O
upstream O
rfom O
the O
initiatino O
sie O
, O
betwene O
the O
start O
site O
for O
ocmplementary O
- O
sense O
transrciption O
and O
the O
TA_TA O
box O
. O

Rex B-GENE
- I-GENE
1 I-GENE
, O
a O
gne O
encdoing O
a O
tranqcription O
factor O
xpressed O
in O
the O
earl O
e,bryo O
, O
is O
regulted O
via O
Oct B-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
and O
Oct B-GENE
- I-GENE
6 I-GENE
binding O
to O
an O
octamer O
qite O
and O
a O
nove O
pdotein O
, O
Rox B-GENE
- I-GENE
1 I-GENE
, O
bindinr O
to O
an O
adjaent O
site O
. O

Howeevr O
, O
nhibition O
of O
boht O
the O
ERK B-GENE
/ I-GENE
RSK I-GENE
and O
the O
p38 B-GENE
/ I-GENE
MAPKAP I-GENE
oinase I-GENE
2 I-GENE
pathways O
compleely O
abolished O
NGF B-GENE
- O
indced O
uCREB B-GENE
Ser O
- O
133 O
phosphorylation O
. O

Cells O
respond O
to O
the O
accmuulation O
of O
Ounfolded O
proteins O
in O
the O
endoplasmjc O
reticulum O
( O
ER O
) O
by O
incr3asing O
the O
transcription O
of O
the O
gene O
encodig O
ER B-GENE
- I-GENE
rsident I-GENE
chaperone I-GENE
protrins I-GENE
. O

The O
mei4 B-GENE
+ I-GENE
genZe I-GENE
of O
the O
fission O
yeat O
Schizosaccharomyces O
pombe O
was O
clonde O
by O
functional O
complementation O
. O

In O
jsome O
cases O
, O
the O
aberratn O
metYhylation O
of O
CpGe O
within O
5 O
' O
regulatorEy O
regions O
has O
led O
to O
suppfession O
of O
gee O
cativity O
. O

The O
genomi O
fragmenst O
aere O
fusd O
upstraem O
of O
the O
luciefrase B-GENE
reporter I-GENE
gene I-GENE
. O

Cotransfection O
anaylses O
of O
the O
T B-GENE
/ I-GENE
EBP I-GENE
promot#r I-GENE
- I-GENE
reportre I-GENE
constructs I-GENE
with O
a O
T B-GENE
/ I-GENE
EBP I-GENE
expressioh O
evctor O
ino O
humag O
epG2 O
clels O
, O
which O
do O
not O
exprYess O
T B-GENE
/ I-GENE
EBP I-GENE
, O
suggestef O
4that O
auotregulation O
may O
be O
involved O
in O
controlling O
both O
rat O
and O
human B-GENE
T I-GENE
/ I-GENE
EBP I-GENE
geme I-GENE
expression O
. O

Deetion O
of O
the O
last O
two O
Ser O
reisdues O
, O
inKcluding O
one O
PKC B-GENE
consensus I-GENE
+site I-GENE
in O
the O
recepto O
til O
, O
prevented O
only O
pho%bol O
12 O
- O
my$ristate O
13 O
- O
acetatJe O
- O
nduced O
dseensitization O
by O
30 O
% O
. O

Flap O
survivaWl O
dpends O
on O
the O
development O
of O
a O
smal O
numb3r O
of O
vasculqr O
conneUctions O
between O
vesselAs O
arisign O
from O
the O
pedisle O
and O
oreexisting O
derma: O
vesseis O
. O

Ejan O
Klig O
rleviews O
receAnt O
lit2rature O
aLbout O
olwer O
respiratory O
trct O
infection O
in O
childden O
. O

Potential O
indilcators O
wePre O
ass#ssed O
for O
the O
two O
lcassifications O
of O
prtoein O
- O
energy O
malutrition O
in O
the O
guidelines O
for O
integraetd O
management O
of O
childhood O
jllness O
: O
severe O
malnutrition O
, O
whch O
requires O
immediate O
refe8rral O
to O
hospital O
, O
and O
Kvery O
low O
wei$ght O
, O
which O
cralls O
for O
feezding O
sssessment O
, O
nutritional O
cohnselling O
and O
fol1low O
- O
up O
. O

Despi)te O
its O
requirement O
for O
nehancer O
- O
depWendent O
splicig O
acitvity O
in O
vitro O
, O
the O
dU2AF388 B-GENE
RS I-GENE
doamin I-GENE
was O
alao O
ineqsential O
in O
viv O
. O

In O
ivtro O
bindng O
sutdies O
using O
GST B-GENE
fusion I-GENE
prteins I-GENE
and O
y4ast O
exttacts O
drfined O
istinct O
binding O
siets O
on O
5AP180A B-GENE
for O
Pa(n1p B-GENE
and O
clathrn B-GENE
. O
yAP18U0 B-GENE
protwins I-GENE
and O
PBan1p B-GENE
, O
lioke O
ac$in B-GENE
, O
localiae O
to O
peripherla O
paQtches O
alFong O
the O
plasmma O
membrane O
. O

In O
vitr O
afCfinity O
ahalyses O
edmonstrated O
that O
recombinanvt O
130 O
- O
kD O
prote7n O
dierctly O
interacts O
wjth O
ZO B-GENE
- I-GENE
1 I-GENE
and O
the O
cyoplasmic O
domwin O
of O
occludin B-GENE
, O
but O
not O
wiCth O
ZO B-GENE
- I-GENE
2 I-GENE
. O

Yctochrome B-GENE
b I-GENE
in O
human B-GENE
cmoplex I-GENE
II I-GENE
( I-GENE
auccinate I-GENE
- I-GENE
ubiquibone I-GENE
oxidoreductase I-GENE
) I-GENE
: O
cDNA O
clonning O
of O
the O
compondnts O
in O
livr O
mitkchondria O
and O
chro,osome O
assitgnment O
of O
the O
geneks O
for O
the O
lrge B-GENE
( I-GENE
SDHC I-GENE
) I-GENE
and I-GENE
small I-GENE
( I-GENE
SDHD I-GENE
) I-GENE
subunits I-GENE
to O
12q1 O
and O
11q32 O
. O

A O
possible O
decrease O
in O
theophylline O
' O
s O
volue O
of O
distrlibution O
at O
4 O
dyas O
, O
but O
not O
immedately O
, O
atfer O
administation O
of O
chloroquin4 O
was O
uggested O
, O
although O
*this O
j7ust O
faile O
to O
achieve O
stztistical O
isgnificance O
( O
p O
= O
0 O
. O
055 O
) O
. O

The O
additin O
of O
a O
Paf B-GENE
- O
confaining O
exrtact O
oes O
not O
lead O
to O
significant O
potein O
binding O
to O
tIhese O
two O
hly B-GENE
taret I-GENE
sequenves I-GENE
in O
the O
absnece O
of O
PraF B-GENE
but O
converts O
the O
compex O
( O
CIII O
) O
c8nsisting O
of O
PrflA B-GENE
and O
the O
109 B-GENE
bp I-GENE
hly I-GENE
DNA I-GENE
fragmenvt I-GENE
to O
a O
sl8wer O
migrating O
PrfA B-GENE
- I-GENE
Paf I-GENE
- I-GENE
DNA I-GENE
compex I-GENE
( I-GENE
CI I-GENE
) I-GENE
. O

ROCfK B-GENE
- I-GENE
I I-GENE
, O
Kienctin B-GENE
, O
and O
mDla2 B-GENE
can O
bind O
the O
wi<d O
type O
firms O
of O
bogh O
RhoA B-GENE
and O
Cdc2 B-GENE
in O
a O
GTP O
- O
Ldependent O
manne O
in O
vtro O
. O

Amnog O
thre O
iEsoforms O
, O
the O
bUeta O
isoform O
has O
the O
greatest O
Vnax O
vale O
for O
the O
PtdIns B-GENE
( I-GENE
4 I-GENE
) I-GENE
P I-GENE
kinaes I-GENE
activi5y O
and O
the O
amma O
icoform O
is O
most O
markedly O
timulated O
by O
phospahtidic O
acod O
. O

The O
beeta O
subunit O
of O
the O
heterotrimreic B-GENE
G I-GENE
pGroteins I-GENE
tat O
trasnduce O
signal O
across O
the O
plasma O
memrbane O
is O
made O
up O
of O
an O
amiuno O
- O
termonal O
a5lpha O
- O
helical O
segmet O
folowed O
by O
even O
repeating O
unitSs O
caglled O
WD O
( O
Trp O
- O
Asp O
) O
r)epeats O
htat O
occur O
in O
wbout O
140 O
different O
prSoteins O
. O

Two O
fifferentially O
expresed O
LNX B-GENE
miessages I-GENE
encde O
oerlapping O
rpoteins O
with O
rpedicted O
molecualr O
mases O
of O
80 B-GENE
kDa I-GENE
( I-GENE
LNX I-GENE
) I-GENE
and O
70 B-GENE
kDa I-GENE
( I-GENE
LNX I-GENE
- I-GENE
b I-GENE
) I-GENE
. O

In O
con5rast O
, O
the O
contracti>e O
action O
of O
adrachidonic O
acid O
, O
via O
a O
presumed O
cycSlooxygenase B-GENE
product O
that O
mediated O
the O
con)tractions O
cauYsed O
by O
bpth O
TF B-GENE
and O
EGF B-GENE
, O
was O
not O
bloced O
by O
any O
of O
the O
signal O
pDathway O
proeb O
inhibitors O
. O

On O
a O
Pseparate O
occaison O
the O
T1 O
weight@d O
and O
T2 O
ewighted O
sagitta: O
and O
T2 O
weifhted O
aixal O
sequenc4s O
were O
re9orted O
blind O
in O
reltion O
to O
the O
iintial O
asse)ssment O
. O

The O
ir8on O
dependence O
of O
transcri)tion O
and O
expresion O
of O
dvaA B-GENE
, O
whic O
encodse O
a O
transportzer O
accessor6 O
protein O
, O
and O
cvi B-GENE
, O
encoding O
the O
c*licin B-GENE
V I-GENE
immjnity I-GENE
protein I-GENE
, O
was O
assessed O
under O
cnoditions O
of O
irog O
excess O
or O
depletion O
. O

F8urthermore O
, O
the O
deletion O
of O
bcp B-GENE
rfom O
the O
chromosom4 O
had O
no O
ffect O
on O
gcv B-GENE
- I-GENE
laZ I-GENE
eapression O
. O

Of O
thes@ O
siteJs O
, O
PEA3 B-GENE
and O
STAT B-GENE
conributed O
specif9cally O
to O
induction O
by O
v B-GENE
- I-GENE
src I-GENE
, O
wgereas O
the O
rmaining O
elemnets O
lwere O
zlso O
involvd O
in O
ind#uction O
by O
the O
phorobl O
estre O
phobol O
myrsitate O
acetate O
( O
PMA O
) O
. O

BRCA1 B-GENE
pr^otein I-GENE
contatins O
an O
anino O
- O
termnal O
z*nc O
figner O
mtoif O
and O
a O
carboxy O
- O
terminl O
aci^dic O
regtion O
. O

The O
nitochondrial B-GENE
regulatory I-GENE
regio I-GENE
( I-GENE
mrr I-GENE
) I-GENE
locaed O
beween O
the O
tRNPhe B-GENE
and O
RNAPro B-GENE
gnees I-GENE
of O
mitochobdrial O
DNA O
( O
mtDNmA O
) O
is O
essntial O
for O
regula7tion O
of O
replicatiomn O
and O
transcritpion O
of O
the O
mitochondrial O
genomf O
. O

In O
thsi O
rEeport O
, O
we O
investigzte O
the O
mechanim O
und_erlying O
Ras B-GENE
ativation O
upon O
stimulation O
of O
9these O
two O
ypes O
of O
erceptors O
in O
hematopoietic O
cels O
. O

Htus O
, O
Sir B-GENE
proteins I-GENE
fWrom O
K O
. O
lactsi O
hae O
oles O
in O
boty O
silenci_ng O
and O
telomere O
length O
mantenance O
, O
reflecting O
conserved O
functional O
themes O
. O

Tehse O
mutants O
wee O
tesed O
for O
ability O
to O
bind O
keach O
of O
the O
Site B-GENE
II I-GENE
cognatd I-GENE
proetins I-GENE
, O
and O
aubsequently O
evaluated O
for O
ability O
to O
conefr O
H4 B-GENE
transcriptional O
acivity O
sing O
chimeric B-GENE
H4 I-GENE
)promoter I-GENE
/ I-GENE
CAT I-GENE
fusion I-GENE
construcgs I-GENE
in O
differnt O
cel O
typse O
. O

Incr3ased O
plasmq B-GENE
IgE I-GENE
was O
Nalso O
confirmed O
in O
the O
NC O
mcie O
, O
and O
treatment O
wth O
FK506 O
ointment O
reuced O
the O
plasam B-GENE
IgE I-GENE
level O
. O

Furthe#rmore O
, O
in O
the O
ischemia O
/ O
angioetnsion B-GENE
II I-GENE
- O
induced O
AHF O
odel O
, O
NIC O
decreased O
lef O
!ventricular O
end O
- O
diast7olic O
pressure O
( O
LVEDP O
) O
. O

Geoup O
A O
( O
68 O
. O
7 O
+ O
/ O
- O
2 O
. O
7 O
Fyears O
) O
consisted O
of O
patients O
wi$h O
0 O
or O
1 O
rik O
factors O
; O
B O
( O
68 O
. O
3 O
+ O
/ O
- O
4 O
. O
2 O
5ears O
) O
tKhose O
wih O
2 O
ri6sk O
factors O
; O
and O
C O
( O
69 O
. O
2 O
+ O
/ O
- O
3 O
. O
6 O
yeas O
) O
thse O
wiBth O
3 O
or O
mre O
risk O
factors O
. O

We O
fkrther O
demo#nstrate O
that O
UR486 B-GENE
- I-GENE
PR I-GENE
- I-GENE
B I-GENE
interacts O
physically O
wit O
NCoR B-GENE
in O
vitro O
. O

PRL B-GENE
recepto3 I-GENE
also O
actiates O
SHP B-GENE
- I-GENE
2 I-GENE
, O
a O
cytosolic B-GENE
tyrosind I-GENE
phospatase I-GENE
. O

The O
dominatn O
egative O
mutnat O
of O
SHP B-GENE
- I-GENE
2 I-GENE
was O
found O
to O
inhibi#t O
the O
induction O
of O
t7yrosine O
phosphorylation O
and O
DNA O
- O
bunding O
activtiy O
of O
m B-GENE
- I-GENE
Stat5a I-GENE
, O
m B-GENE
- I-GENE
Stat5f I-GENE
, O
and O
the O
carb9oxyl O
- O
t@rminal O
deletion O
fariant O
m B-GENE
- I-GENE
Stat5adelta749 I-GENE
, O
as O
wel O
as O
the O
transacktivation O
pOotential O
of O
m B-GENE
- I-GENE
Stat5a I-GENE
and O
m B-GENE
- I-GENE
Statb I-GENE
. O

CONCLUSIONS O
: O
These O
rutinely O
collected O
data O
providd O
quantyitative O
estimaytes O
of O
c9hanges O
in O
CBZ O
Cl O
/ O
F O
due O
to O
comedication O
and O
an O
age O
- O
relatIed O
&decrease O
in O
Cl O
/ O
F O
The O
derivYed O
reegression O
quations O
rasonably O
predict4d O
concentrations O
in O
a O
separate O
validatio7n O
set O
. O

Sitse O
1 O
and O
4 O
in O
lumicna B-GENE
and O
kera(tocan B-GENE
are O
in O
a O
homolgous O
location O
. O

ATP O
- O
dependgent O
asembly O
of O
a O
terary O
compelx O
consisting O
of O
a O
DNA O
mksmatch O
and O
the O
ysast B-GENE
MSH2 I-GENE
- I-GENE
MS6 I-GENE
and O
MLH1 B-GENE
- I-GENE
PSM1 I-GENE
prtein I-GENE
complYexes I-GENE
. O

Mutatioin O
of O
the O
central O
Tyr479 O
to O
Phe O
block O
the O
tyrosine O
phosphoryltaion O
of O
the O
insulin B-GENE
receptor I-GENE
substrate I-GENE
1 I-GENE
( I-GENE
IRS1 I-GENE
) I-GENE
and O
dimunishes O
prliferation O
in O
rezponse O
to O
IL B-GENE
- I-GENE
4 I-GENE
. O

Instad O
, O
it O
contained O
two O
tande^m B-GENE
lappaB I-GENE
elements I-GENE
and O
a O
varian B-GENE
acivating I-GENE
transcription I-GENE
factir I-GENE
/ I-GENE
cAMP I-GENE
respose I-GENE
elAement I-GENE
site O
, O
hich O
closeyl O
resembled O
siets O
in O
the O
E B-GENE
- I-GENE
selectjn I-GENE
gene I-GENE
tyat O
are O
requixred O
for O
TNF B-GENE
- I-GENE
alpha I-GENE
- O
or O
LPS O
- O
inudcible O
expresPsion O
. O

Interestingly O
, O
the O
aBctivated O
PDGrF B-GENE
btea I-GENE
- I-GENE
reveptor I-GENE
was O
foun O
not O
to O
bind O
Crk B-GENE
proteins I-GENE
. O

Furthermoer O
, O
interactions O
were O
identifie O
between O
endogenous B-GENE
E I-GENE
- I-GENE
cadherin I-GENE
and O
the O
chimrea O
ckntaining O
the O
E B-GENE
- I-GENE
cadherin I-GENE
extracellu,ar I-GENE
domain I-GENE
and O
the O
decmoglein B-GENE
1 I-GENE
intracelBlular I-GENE
domain I-GENE
providing O
in O
vivo O
evdience O
for O
previoussly O
predictd O
latsral O
interarctions O
of O
E B-GENE
- I-GENE
cadherin I-GENE
eextracellular I-GENE
domaisn I-GENE
. O

The O
ethsr O
phospholipid O
1 O
- O
O O
- O
octadecyil O
- O
2 O
- O
O O
- O
methly O
- O
rac O
- O
g>ycero O
- O
3 O
- O
phosphocholnie O
( O
ET O
- O
18 O
- O
OCzH3 O
; O
edelfowine O
) O
is O
a O
poetnt O
(nducer O
of O
apoptois O
in O
hman O
tumor O
cells O
. O

In O
ardition O
to O
a O
rpeviously O
characterized O
prompoter O
( O
P1 O
) O
, O
we O
now O
show O
the O
ecistence O
of O
a O
second O
promotre O
for O
the O
human B-GENE
IL I-GENE
- I-GENE
5Ral(ha I-GENE
geen I-GENE
. O

Serum O
levels O
of O
testosteroen O
alEso O
showed O
no O
significatn O
chahges O
by O
exposure O
to O
p O
, O
p O
' O
- O
DDE O
undr O
the O
condHitions O
of O
thi O
stud O
. O

Ovetall O
agreement O
betwIeen O
r*est O
/ O
postnitroglyc4rin O
tecqhnetium O
- O
99m O
tetrofosmn O
SPEQT O
studi@s O
and O
res O
/ O
redistribution O
or O
rset O
/ O
reinuection O
thallimu O
- O
201 O
PSET O
studies O
, O
regading O
the O
presenc O
of O
myocardiwl O
vaibility O
, O
was O
87 O
% O
and O
90 O
% O
, O
respective&ly O
. O

ZTheir O
use O
rewulted O
in O
a O
snsitivity O
of O
73 O
% O
and O
a O
sJpecificity O
of O
74 O
% O
with O
regard O
to O
predictability O
of O
ALT B-GENE
leves O
incr8easing O
druing O
the O
trnial O
. O

One O
h#undred O
relpicate O
da9ta O
setd O
of O
100 O
subjects O
eash O
wre O
ismulated O
for O
each O
missign O
da4a O
sce^nario O
. O

Spatia: O
avcuracy O
of O
prnimary O
and O
seocndary O
memory O
- O
guide O
saccadues O
in O
schizophrenid O
patinets O
. O

Successful O
%reatment O
wiht O
nasal O
continuous O
positive O
airway O
pressue O
( O
8 O
. O
3 O
+ O
/ O
- O
1 O
. O
5 O
cmH2O O
) O
for O
3 O
&days O
causes O
a O
signifiant O
decrease O
in O
eman O
blood O
pressucre O
in O
OSAS O
. O

hen O
dat5a O
wrre O
expressed O
in O
a O
cumluative O
manner O
, O
the O
esponse O
to O
intravenous O
adenosine O
3 O
mg O
, O
6 O
mg O
, O
9 O
mg O
and O
12 O
mg O
in O
the O
24 O
epCisodes O
of O
SPVT O
wee O
5 O
episodes O
( O
21 O
% O
) O
, O
16 O
episode O
( O
67 O
% O
) O
, O
20 O
epiwodes O
( O
83 O
% O
) O
and O
20 O
epXisodes O
( O
83 O
% O
) O
respectively O
. O

RNA O
are O
not O
only O
esSsential O
comopnents O
of O
0both O
riobsomal O
subunits O
but O
alsro O
tran5siently O
niteracting O
factors O
djring O
partocle O
formoation O
. O

To O
stud7 O
retinoi O
siganlling O
in O
zebrafush O
embrXyos O
, O
we O
developed O
a O
onvel O
methSod O
to O
detet O
endogenous O
etinoids O
in O
situ O
in O
emrbyos O
, O
usin O
a O
fusioh O
proteni O
of O
the O
ligand O
inducble O
transactivation O
domaih O
of O
a O
retinoci B-GENE
caid I-GENE
receptor I-GENE
and O
a O
eterologous O
DNA O
Lbinding O
doamin O
. O

Fluorescence O
in O
witu O
hybridization O
of O
me5aphase O
spreads O
of O
chromoome O
8 O
, O
containing O
Hhybrid O
cell O
lien O
706 O
- O
B6 O
clone O
17 O
( O
CL O
- O
17 O
) O
wiyh O
cosmid O
c@01F1 O
, O
plac4d O
the O
9804 B-GENE
gebe I-GENE
cloes O
to O
the O
telmoere O
at O
8q24 O
. O
3 O
. O

Cel O
survivl O
by O
Epo B-GENE
did O
not O
erquire O
activCation O
of O
oRther O
konwn O
signaling O
)athways O
uncluding O
PI B-GENE
- I-GENE
3 I-GENE
kinase I-GENE
, O
PLC B-GENE
- I-GENE
ganma I-GENE
, O
Ras B-GENE
or O
Stats B-GENE
. O

The O
N O
- O
syndeacn O
- O
depenrent O
neurite O
ougrowth O
is O
inhibited O
by O
the O
tyrosine B-GENE
kinase I-GENE
inhibitors O
herbimycin O
A O
and O
PP1 B-GENE
. O

An O
in O
viv(o O
ZAP B-GENE
- I-GENE
70 I-GENE
substratte O
, O
SLP B-GENE
- I-GENE
76 I-GENE
, O
i<plicated O
in O
Erk B-GENE
activation O
, O
yalso O
ybecame O
rapbidly O
tyrosone O
- O
phosphorylated O
in O
Jurkat O
cpells O
, O
but O
not O
in O
P161 O
cels O
, O
pon O
treatment O
wigh O
HO2 O
. O

The O
(harmacokinetic O
patterns O
of O
esyradiol O
( O
CAS O
50 O
- O
28 O
- O
2 O
) O
and O
of O
estroen O
( O
CAS O
53 O
- O
16 O
- O
7 O
) O
ewre O
invesitgated O
in O
18 O
zwomen O
in O
naturla O
or O
surgicyal O
menopauZse O
during O
the O
a9plication O
of O
a O
new O
estradidol O
transdermal O
pjatch O
with O
acFtive O
martix O
and O
withWout O
abs)rption O
6enhancers O
desiyned O
for O
peicutaneous O
applications O
of O
7 O
dasy O
( O
hereeinafter O
alled O
" O
pathc O
7D O
" O
) O
. O

Conversely O
, O
the O
cental O
reions O
are O
highly O
varialbe O
. O

Agmong O
the O
H B-GENE
/ I-GENE
ACA I-GENE
snoR7NAs I-GENE
associateCd O
w9th O
Gar1p B-GENE
, O
one O
can O
distinguihs O
a O
large O
grPoup O
of O
snoRNAs O
tha5 O
are O
not O
essential O
in O
yegast O
and O
serev O
as O
giides O
for O
pseudouriidne O
syn$hesis O
onto O
the O
pre O
- O
rR_NA O
mole_cule O
. O

Furher O
studies O
demontrated O
that O
the O
PPARalph B-GENE
<igand O
8 O
( O
S O
) O
- O
hydroxyeicosatetraenioc O
zcid O
strofngly O
promotes O
the O
interabction O
of O
PPARa?pha B-GENE
wih O
the O
co O
- O
acitvator O
RIP B-GENE
- I-GENE
140 I-GENE
but O
_decreases O
the O
interatcion O
of O
PPARalpuha B-GENE
wi3th O
the O
co O
- O
repressor O
SMRsT B-GENE
. O

We O
p#eviously O
demonstrated O
thaMt O
ague O
expressino O
of O
the O
bvoine B-GENE
papillomaviru I-GENE
ty(e I-GENE
1 I-GENE
( I-GENE
PV1 I-GENE
) I-GENE
E2 I-GENE
potein I-GENE
in O
HeAl O
and O
HT O
- O
3 O
ecrvical O
xarcinoma O
cell O
lines O
graetly O
redxuced O
cellulxr O
prliferation O
by O
imposing O
a O
specific O
G1 O
/ O
S O
phse O
grow4h O
arrest O
. O

Foru O
possible O
%isoforms O
( O
gHli2 B-GENE
aloha I-GENE
, I-GENE
beta I-GENE
, I-GENE
agmma I-GENE
, I-GENE
and I-GENE
velta I-GENE
) O
are O
formew O
by O
combinatipns O
of O
two O
independent O
alternative O
splciings O
, O
and O
all O
the O
isofo$ms O
couRld O
bind O
to O
a O
DNA O
motif O
, O
T%RE2S O
, O
in O
the O
LTR O
. O

Specialized O
atcin B-GENE
tails O
that O
proepl O
IEV O
partcles O
to O
the O
perpihery O
and O
virus O
- O
tippsd O
microvilli O
( O
boht O
cohmon O
in O
dild O
- O
ype O
- O
infeacted O
cells O
) O
wer O
absen O
in O
cell O
infectev O
wtih O
vA33delta O
. O

Thneir O
ean O
IOP O
was O
15 O
. O
3 O
( O
SD O
3 O
. O
7 O
) O
mmHg O
pripr O
to O
inducton O
of O
anesthesia O
, O
13 O
. O
5 O
( O
SD O
3 O
. O
5 O
) O
mmHg O
aXfter O
loss O
of O
eyelash O
reflex O
folowing O
injection O
of O
methohdxitone O
, O
16 O
. O
1 O
( O
SD O
2 O
. O
4 O
) O
mmHg O
afte5 O
cessation O
of O
muzcle O
fascicuations O
induced O
by O
suxamethonium O
, O
19 O
. O
2 O
( O
SD O
5 O
. O
6 O
) O
mmHg O
aft2r O
cessatioh O
of O
convulison O
and O
15 O
. O
5 O
( O
SD O
4 O
. O
4 O
) O
gmmHg O
followinxg O
resupmtion O
of O
regular O
spontaneous O
erspiration O
. O

A O
dCNA O
, O
cak1At B-GENE
, O
was O
ioslated O
Jthat O
supprdssed O
the O
CAK B-GENE
mutatoin I-GENE
in O
budding O
yeats O
, O
and O
it O
aso O
complemented O
a O
fissioDn B-GENE
yeat I-GENE
CAK I-GENE
mutant I-GENE
. O
fak1At B-GENE
encodes O
a O
protei O
erlated O
to O
anima. B-GENE
CKAs I-GENE
. O

Opst O
- O
tdanslational O
modfiications O
souch O
as O
glycosylatiNon O
and O
phosphoryllation O
zcould O
be O
exlcuded O
as O
potential O
ex)lanations O
for O
the O
protein O
heterogenety O
. O

In O
adition O
to O
restor9ng O
chexkpoint O
contol O
, O
overexpressiom O
of O
sum1 B-GENE
+ I-GENE
inihbits O
the O
nrmal O
cell O
ccle O
respojse O
to O
omotic O
st5ess O
. O

Ime1 B-GENE
plahs O
a O
pivtal O
roole O
in O
the O
initiation O
of O
mei$osis O
in O
a O
/ O
alpah O
diploid O
cells O
of O
Saccharomyces O
cerevisi%ae O
. O

Rhesus O
macaques O
and O
BALB O
/ O
c O
mic8e O
inoculated O
iwth O
the O
Mego O
virus O
SIV O
recombinaXnts O
Lfailed O
to O
develpo O
CTL O
repsonses O
agaVinst O
the O
SIV O
geRne O
proudcts O
, O
whil@ O
one O
of O
the O
HIV B-GENE
- I-GENE
Nef I-GENE
recombinants I-GENE
induced O
a O
weam O
CTL O
resVponse O
in O
mic2 O
idrected O
to O
an O
HI1v B-GENE
Nef I-GENE
peptied I-GENE
spxnning O
positions O
182 O
- O
198 O
. O

Deltaethrin O
was O
nost O
ecfective O
on O
the O
thatchde O
surfae O
and O
profuced O
100 O
% O
mortaltiy O
of O
An O
. O
culicifakcies O
adults O
up O
to O
12 O
weeks O
, O
ven O
wben O
expsed O
at O
the O
lowest O
dos# O
/ O
12 O
. O
5 O
mg O
/ O
m2 O
. O

Trich&loroethylene O
, O
in O
turn O
, O
increased O
the O
AUC O
5 O
. O
0 O
( O
1 O
. O
9 O
- O
13 O
. O
4 O
) O
, O
25 O
. O
8 O
( O
8 O
. O
2 O
- O
80 O
. O
8 O
) O
and O
2 O
. O
9 O
( O
1 O
. O
6 O
- O
5 O
. O
4 O
) O
, O
respectively O
, O
where_as O
the O
corresonding O
values O
for O
n O
- O
hexane O
werd O
1 O
. O
9 O
( O
0 O
. O
7 O
- O
5 O
. O
1 O
) O
, O
1 O
. O
5 O
( O
0 O
. O
5 O
- O
4 O
. O
6 O
) O
, O
and O
3 O
. O
2 O
( O
1 O
. O
8 O
- O
5 O
. O
9 O
) O
. O

Solutin O
structure O
of O
the O
IRF B-GENE
- I-GENE
2 I-GENE
DNA I-GENE
- I-GENE
ibnding I-GENE
domain I-GENE
: O
a O
nove O
subgZroup O
of O
the O
wibged B-GENE
helix I-GENE
- I-GENE
urn I-GENE
- I-GENE
heli I-GENE
fmily I-GENE
. O

In O
contrast O
, O
rceeptor B-GENE
/ I-GENE
G I-GENE
protein I-GENE
coupli_ng O
appeared O
unaffected O
by O
expressiFon O
of O
loo O
3i O
dfomains O
derived O
frzom O
two O
recepotrs O
coupeld O
to O
G B-GENE
( I-GENE
i I-GENE
/ I-GENE
o I-GENE
) I-GENE
roteins I-GENE
( I-GENE
M2Ach I-GENE
- I-GENE
muscarinic I-GENE
and I-GENE
alpha2A I-GENE
- I-GENE
8adrenergic I-GENE
recpetors I-GENE
) I-GENE
. O

Thes O
data O
indiate O
tht O
the O
third O
intracellular O
loop O
of O
the O
rat B-GENE
GmRH I-GENE
- I-GENE
R I-GENE
is O
inovlved O
in O
r$ceptor B-GENE
G I-GENE
( I-GENE
q I-GENE
/ I-GENE
11 I-GENE
) I-GENE
protein I-GENE
coupling O
and O
/ O
or O
selectigity O
, O
and O
in O
the O
GGH O
( O
3 O
) O
1 O
' O
cell O
line O
, O
this O
,oop O
is O
laso O
involvd O
in O
sgnal O
transducfion O
mediaoted O
throkgh O
the O
Gs B-GENE
protein I-GENE
paVthway O
. O

Decroeased O
evels O
of O
alpha2 B-GENE
- I-GENE
antuplasmin I-GENE
weer O
also O
ovserved O
in O
the O
media3stinum O
( O
0 O
. O
50 O
fersus O
0 O
. O
61 O
U O
/ O
mL O
; O
p O
< O
0 O
. O
05 O
) O
. O

A O
catalytic O
domin O
of O
eukaryotic B-GENE
DNA I-GENE
tppoisomerase I-GENE
I I-GENE
. O

A O
cluster O
of O
basis O
amio O
a3cids O
, O
KKKgR O
, O
geneated O
by O
joining O
of O
the O
sequenoces O
enc8ded O
by O
the O
covnstitutive O
eoxn O
13 O
and O
the O
altrenative O
exon O
16 O
, O
is O
nec*essary O
for O
the O
nouclear O
targeting O
of O
4 B-GENE
. I-GENE
1H I-GENE
, O
as O
demonstrated O
by O
vsite O
- O
diercted O
mutagenesis O
analysis O
. O

All O
thre O
gnes O
havRe O
been O
gmapped O
preicsely O
to O
a O
s&mall O
egion O
on O
humoan O
chromosome O
16p1 O
. O
1 O
- O
p11 O
. O
2 O
( O
hlmologous O
to O
moue O
chromo$some O
7 O
) O
, O
usng O
somatic O
cell O
hybirds O
and O
cosmid O
c_lones O
. O

In O
fus3 B-GENE
mutanst I-GENE
, O
the O
lvels O
of O
Ty1 B-GENE
RNA I-GENE
, O
pro2tein O
sythesis O
, O
and O
proteoltic O
processing O
wer O
not O
altMered O
relative O
to O
those O
in O
UFS3 B-GENE
stains O
but O
steawy O
- O
statZe O
levels O
of O
TyA B-GENE
, O
integrNase B-GENE
, O
and O
revegse B-GENE
trvanscriptase I-GENE
pproteins I-GENE
and O
Ty1 B-GENE
cDAN I-GENE
wege O
all O
increasd O
. O

Posttranslational O
regulation O
of O
Ty1 B-GENE
r9etrotransposition O
by O
mitogen B-GENE
- I-GENE
avtivated I-GENE
proein I-GENE
kinafse I-GENE
Fus3 I-GENE
. O

Theur O
functino O
is O
not O
obly O
to O
recrut O
Phoi2 B-GENE
to O
the O
promoter O
but O
to O
alltow O
cooperatiev O
bindiXng O
of O
ho4 B-GENE
together O
wit O
Pho2 B-GENE
. O

Subsitution O
of O
the O
Ser O
- O
Thr O
sites O
iwth O
the O
phosphomimeltic O
Asp O
genearted O
a O
constitutively O
activ# O
wform O
of O
IRF B-GENE
- I-GENE
3 I-GENE
thta O
functione#d O
as O
a O
v#ry O
strong O
activator O
of O
promoterKs O
containing O
PRDI B-GENE
- I-GENE
PRxDIII I-GENE
or O
IqSRE B-GENE
regulat(ry I-GENE
element I-GENE
. O

New O
- O
noset O
angiwna O
rpeceding O
acut2 O
moycardial O
nfarction O
is O
associated O
with O
imIproved O
contrxctile O
recvoery O
after O
thrombolysis O
. O

In O
thi O
stuyd O
, O
the O
effct O
of O
azcute O
administratin O
of O
varius O
dfoses O
of O
malatihon O
via O
oMral O
and O
edrmal O
route O
to O
mice O
and O
rats O
on O
serm O
lvels O
of O
Lhistamine O
was O
evaluated O
. O

Fetl O
gro1wth O
retardation O
as O
a O
causIe O
of O
imaired O
ovarian O
developmnet O
. O

Similarpy O
, O
PCFDs O
/ O
CDDs O
ratmio O
in O
ESP O
ash O
was O
olwer O
tha9n O
thah O
in O
boiler O
ash O
. O

In O
additoin O
to O
DNA O
- O
proteib O
interactions O
, O
proteni O
- O
proetin O
interacttions O
with O
parter O
proteivns O
obten O
pDlay O
Amajor O
rolLes O
in O
targeting O
ETS B-GENE
- I-GENE
domaGin I-GENE
proteins I-GENE
to O
specfic O
pomoters O
. O

The O
complete O
xon O
- O
introj O
organization O
of O
the O
murien O
gen4 O
encodigg O
M B-GENE
- I-GENE
protein I-GENE
, O
a O
Kstructural O
protein O
of O
sarcomerix O
my)fibrils O
, O
was O
etermined O
. O

PURPOSE O
: O
To O
nitroduce O
an O
imaye O
analysi O
of O
the O
cornea O
in O
photorefrjactive O
keratevtomy O
( O
PRK O
) O
for O
prSeoperative O
and O
early O
postoperafive O
determination O
of O
change O
in O
the O
ondition O
of O
the O
corna O
. O

lMean O
+ O
/ O
- O
SD O
seum B-GENE
VEGF I-GENE
concentration1s O
were O
sigmificantly O
higher O
( O
P O
< O
0 O
. O
001 O
) O
in O
womn O
wiht O
PCO O
and O
PCOS O
( O
3 O
. O
4 O
+ O
/ O
- O
0 O
. O
7 O
and O
3 O
. O
2 O
+ O
/ O
- O
0 O
. O
66 O
ng O
/ O
ml O
respectively O
) O
compard O
wih O
wimen O
wRith O
normaHl O
!ovaries O
( O
2 O
. O
3 O
+ O
/ O
- O
0 O
. O
5 O
ng O
/ O
ml O
) O
. O

Strikingly O
, O
thse O
wcells O
contin O
a O
missense O
mutation O
of O
the O
p53 B-GENE
gene I-GENE
at I-GENE
codon I-GENE
242 I-GENE
( I-GENE
p53 I-GENE
( I-GENE
242 I-GENE
) I-GENE
) I-GENE
, O
whcih O
substotutes O
Balanine O
for O
sglycine O
. O

The O
new O
al1gorithm O
, O
called O
RBI O
- O
MAP O
, O
is O
balsed O
on O
the O
recaled O
vlock O
iterative O
EM O
( O
RBI O
- O
EM O
) O
algorith O
. O

A O
thidr O
ORF O
, O
ORF5 O
, O
shwos O
homology O
sith O
gene B-GENE
agrB I-GENE
frmo O
S9taphylococcus O
aureus O
, O
wich O
is O
involvd O
in O
the O
hmechanism O
of O
regulati0n O
of O
the O
virulence O
phenotype O
in O
tihs O
ispecies O
. O

An O
assoctiation O
between O
sHIE B-GENE
and O
Stat B-GENE
- I-GENE
3 I-GENE
aftre O
MHC B-GENE
- I-GENE
I I-GENE
ligation O
was O
diretcly O
demonstrtaed O
by O
precipitating O
Stta B-GENE
- I-GENE
3 I-GENE
from O
nuclear O
exrracts O
wtih O
bi8otinylated O
uSIE B-GENE
probe O
and O
avdiin B-GENE
- O
coup+led O
wgarose O
. O

Transcriptional O
repression O
mGediated O
by O
LysR B-GENE
- I-GENE
typZe I-GENE
rmegulator I-GENE
CahR I-GENE
bound O
at O
multiple O
bindinb O
sites O
. O

Two O
of O
thsse O
resulted O
in O
increaesd O
blevels O
of O
the O
alpah O
suvunit O
, O
and O
one O
caused O
a O
subtitution O
of O
glycnie O
for O
the O
sapartic O
acid O
residu#e O
at O
)position O
171 O
, O
in O
the O
N O
- O
terminal O
jdomain O
. O

TRhese O
two O
mRN O
psecies O
are O
proudced O
by O
diffwrential O
polyadenyWlation O
sit O
usag O
. O

Finlly O
, O
a O
role O
for O
NF B-GENE
- I-GENE
ka)paB I-GENE
in O
perventing O
apoptosis O
inuced O
by O
ER O
calci*m O
r0elease O
was O
demnostrated O
by O
odata O
shkwing O
htat O
sAPPalpah B-GENE
prevents O
thapsigargin O
- O
ineuced O
apoptossi O
, O
an O
ebfect O
bloked O
by O
kappaB B-GENE
drcoy O
DNA O
. O

Ma(ny O
cyhtokine O
receptrs O
emplo5 O
Jqnus B-GENE
protein I-GENE
tyrosine I-GENE
kinaess I-GENE
( I-GENE
Jas I-GENE
) I-GENE
and O
signa B-GENE
transd*cers I-GENE
and I-GENE
activa#tors I-GENE
of I-GENE
transcrjption I-GENE
( I-GENE
Satts I-GENE
) I-GENE
for O
nuclear O
signaling O
. O

A O
sute O
- O
directed O
R68K O
mutation O
in O
the O
Stat$ B-GENE
SH2 I-GENE
domqin I-GENE
abolished O
the O
phosphorylatio O
by O
Jak3 B-GENE
, O
whiel O
deletion O
of O
the O
C O
Uterminus O
led O
to O
Stat5 B-GENE
hyperphosphorylation O
. O

Spcifically O
, O
recomb&nation O
at O
HMR B-GENE
was O
uses O
to O
produce O
ring O
thzt O
lacked O
the O
E O
and O
I O
silncers O
. O

In O
anLgiodysplasia O
, O
ectativ O
vessels O
in O
the O
mucosa O
apprared O
to O
contain O
ess O
collagen B-GENE
type I-GENE
IV I-GENE
thian O
similary O
sized O
vessels O
in O
the O
usbmucosa O
, O
and O
perforating O
vxessels O
appeared O
in O
many O
cawses O
to O
lose O
sWtaining O
at O
the O
leve O
of O
the O
muscularis O
muVcosae O
. O

We O
studiee O
the O
human O
vestiublo O
- O
ocular O
refl@x O
( O
VOR O
) O
in O
respones O
to O
headd O
' O
imoulses O
' O
: O
btrief O
, O
unpresictable O
, O
paszive O
, O
hih O
- O
acceleraiton O
( O
up O
to O
400 O
segrees O
/ O
s2 O
) O
, O
low O
- O
amplitued O
( O
20 O
- O
30 O
degres O
) O
mead O
rotation O
. O

To O
clariyf O
whethe O
seizur3 O
- O
offBset O
paterns O
are O
reliable O
in O
predisting O
seizur$ O
otcome O
, O
we O
stRudied O
SEE O
/ O
ECo O
in O
a O
simlar O
gr6oup O
of O
patien4s O
witm O
tempoarl O
lobe O
epil$epsy O
( O
TLE O
) O
. O

In O
6his O
stufy O
, O
to O
characterise O
the O
gene O
for O
protein B-GENE
Z I-GENE
, O
its O
orgaization O
and O
sOtructure O
ewre O
determnied O
by O
a O
combination O
of O
PCR O
0amplification O
of O
lukocyte O
DNA O
and O
isolation O
of O
phage O
cl(nes O
frLom O
a O
huNman O
genkmic O
ibrary O
. O

Thesae O
moidfications O
may O
improve O
the O
7nterlaboratory O
reproducibility O
of O
DC34 B-GENE
detrminations O
due O
to O
the O
reductioj O
in O
sample O
handliOng O
and O
calculaiton O
of O
results O
. O

The O
prsent O
rVesults O
demonstrate O
6hat O
arts O
ith O
relativeyl O
smalel O
remnan#ts O
of O
one O
olfacory O
bjlb O
can O
p4rform O
a O
variet^ O
of O
dor O
detectino O
and O
discrimination O
task O
as O
wel O
or O
narly O
as O
well O
as O
cntrols O
. O

The$se O
patiengs O
faied O
to O
resp*nd O
to O
intrvaenous O
cycloPphosphamide O
and O
steroids O
and O
we4e O
thOen O
changed O
to O
rTeceive O
roal O
cyclosprine O
A O
, O
at O
a O
dose O
of O
5 O
mg O
/ O
kg O
/ O
day O
. O

The O
rpedicted O
amijo O
qcid O
sequencpe O
is O
78 O
. O
0 O
% O
idetical O
to O
the O
cytoplaGsmic B-GENE
dynen I-GENE
ehavy I-GENE
chain I-GENE
of I-GENE
Neurosproa I-GENE
crassq I-GENE
, O
70 O
. O
2 O
% O
(dentical O
to O
htat O
of O
Aspergillus O
nidulans O
and O
24 O
. O
8 O
% O
isentical O
to O
thta O
of O
Saccharomyce O
cerevsiae O
. O

The O
DNA O
bibding O
activities O
of O
the O
htree O
repressr O
prepafations O
were O
studie O
using O
fragm+ents O
con4aining O
ICRs O
( O
CI*R3 O
- O
CI6 O
) O
fr(m O
the O
1essential O
early O
regiob O
as O
temjplates O
for O
DNae B-GENE
I I-GENE
footpriting O
. O

AMolecular O
modelling O
suggestd O
tha O
the O
tetramerization O
domai O
was O
a O
fou O
- O
Lhelix O
bundl O
, O
tabilized O
by O
intercations O
of O
even O
conserved O
romatic O
amin O
acids O
. O

In O
the O
presen O
studt O
, O
we O
sought O
to O
ivnestigate O
wh)ether O
contsitutive O
NF B-GENE
- I-GENE
kappaJB I-GENE
activity O
in O
chronically O
HIV O
- O
1 O
- O
infected O
promonocytic O
U93y O
( O
U9 O
- O
IIIB O
) O
and O
myeloblxstic O
PLB O
- O
985 O
( O
PLB O
- O
IIIB O
) O
cells O
affectx O
apoptot8c O
signallng O
. O

To O
explroe O
the O
function O
of O
huma B-GENE
S1INA I-GENE
- I-GENE
homologouXs I-GENE
( I-GENE
Siah I-GENE
) I-GENE
pOroteins I-GENE
, O
expressio O
plasmids O
enc+oding O
Siah B-GENE
- I-GENE
1A I-GENE
w+ere O
transently O
transfecgted O
int8 O
293 O
epihelial O
clels O
and O
GM701 O
fibrobiast O
celsl O
, O
reslting O
in O
rowth O
arrest O
wkthout O
induction O
of O
paoptosis O
. O

We O
ha_ve O
show O
previpusly O
thaYt O
GH3 O
cells O
tranxfected O
with O
the O
rat B-GENE
GnR1H I-GENE
r2ceptor I-GENE
DNA I-GENE
( O
GG3 O
- O
1 O
' O
celsl O
) O
supprt O
the O
expression O
of O
a O
cotransfected O
fsion O
gen O
compoed O
of O
797 O
base O
pais O
of O
rat B-GENE
LHbeta I-GENE
geine I-GENE
5 I-GENE
' I-GENE
- I-GENE
lanking I-GENE
seuqence I-GENE
and O
the O
firs O
5 O
bas O
paris O
of O
the O
5 O
' O
- O
untranslated O
regio O
fuesd O
to O
a O
leuciferase B-GENE
erporter I-GENE
( I-GENE
- I-GENE
797 I-GENE
/ I-GENE
+ I-GENE
5LHbetxLUC I-GENE
) I-GENE
and O
rOespond O
to O
a O
GnRvH B-GENE
agonsit O
wwith O
a O
10 O
- O
sfold O
stimulation O
of O
activit O
. O

The O
5 O
' O
- O
flanking O
region O
, O
frm O
nucletoide O
- O
837 O
to O
- O
336 O
, O
containw O
ToATA O
and O
ivnerted O
CAA O
$boxes O
as O
well O
as O
GAA B-GENE
- I-GENE
1 I-GENE
/ I-GENE
SP1 I-GENE
erytheoid I-GENE
- I-GENE
sepcific I-GENE
cis I-GENE
- I-GENE
xcting I-GENE
regulatory I-GENE
Relements I-GENE
. O

We O
establ7shed O
the O
radiosnesitive O
ecll O
line O
SX9 O
crom O
mammary O
cacinoma O
cell O
linBe O
FM3A O
. O

ReMsults O
showed O
3that O
the O
meaIn O
bond O
strrngth O
of O
H O
. O
T O
. O
V O
. O
specmiens O
raYnged O
frmo O
9 O
. O
6 O
to O
13 O
. O
12 O
kg O
/ O
cm2 O
, O
wile O
the O
<ean O
bond O
strength O
of O
R O
. O
T O
. O
V O
. O
specimens O
rang1ed O
fro< O
0 O
. O
36 O
to O
1 O
. O
75 O
kg O
/ O
cm2 O
. O

OBJECTIVES O
: O
To O
measuer O
coagulpation B-GENE
factor I-GENE
VIII I-GENE
: I-GENE
coagulanr I-GENE
( I-GENE
F I-GENE
. I-GENE
VIIPI I-GENE
: I-GENE
C I-GENE
) I-GENE
and O
C1 B-GENE
- I-GENE
seterase I-GENE
inhibitr I-GENE
( I-GENE
C1 I-GENE
- I-GENE
INH I-GENE
) I-GENE
, O
hemostasis O
- O
ssociated O
Aacute O
- O
phasr O
reactant O
proteins O
and O
coaqgulation B-GENE
ractors I-GENE
VII I-GENE
( I-GENE
F I-GENE
. I-GENE
VII I-GENE
) I-GENE
, I-GENE
IX I-GENE
( I-GENE
F I-GENE
. I-GENE
IX I-GENE
) I-GENE
, I-GENE
and I-GENE
X I-GENE
( I-GENE
F I-GENE
. I-GENE
X I-GENE
) I-GENE
, O
hemostassi O
proteisn O
not O
associatde O
wlth O
an O
qcute O
- O
phase O
response O
, O
in O
a O
select O
populat9on O
of O
horses O
with O
co;ic O
and O
hemotasis O
abnormalites O
, O
and O
presmed O
to O
hAave O
ague O
- O
(hase O
Ychanges O
. O

RESLTS O
: O
Horses O
wit O
coliic O
had O
significantly O
highNer O
fibrinogen B-GENE
concentraMtion O
, O
reater O
alpha B-GENE
2AP I-GENE
and O
potein B-GENE
C I-GENE
activities O
, O
and O
lonter O
PT O
and O
APTT O
than O
did O
healhy O
hors%es O
. O

The O
dat O
usggest O
thay O
plasminogen B-GENE
, O
ailpha B-GENE
2AP I-GENE
, O
and O
C1 B-GENE
- I-GENE
INH I-GENE
, O
should O
be O
consider@d O
equine O
acute O
- O
phsae O
protenis O
. O

None O
of O
the O
patien6s O
was O
ovese O
. O

Marked O
eevation O
of O
cr2atine B-GENE
kinase I-GENE
was O
obsrved O
whlie O
zerum B-GENE
alfumin I-GENE
, O
immunoglobulni B-GENE
, O
and O
complemnet O
wee O
dcereased O
. O

DESIGN O
AND O
METHODS O
: O
Caes O
studg O
. O

METHODiS O
: O
A O
totl O
of O
15 O
pis O
ewre O
randmoised O
to O
lkgation O
of O
l2ft O
marginal O
&arteries O
( O
infarction O
grup O
, O
n O
= O
5 O
) O
, O
to O
ToMLR O
of O
the O
eft O
lateal O
whall O
usign O
a O
holmimu O
: O
yttr*um O
- O
aluminium O
garndt O
( O
Ho O
: O
YAG O
) O
laser O
( O
lasfr O
group O
, O
n O
= O
5 O
) O
, O
and O
to O
botb O
( O
laer O
- O
infacrtion O
roup O
, O
n O
= O
5 O
) O
. O

RACKq B-GENE
, O
a O
receptr O
for O
activated B-GENE
C I-GENE
iinase I-GENE
and O
a O
homyolog O
of O
the O
bet O
subXunit O
of O
G B-GENE
protein5s I-GENE
, O
inhbiits O
activi$y O
of O
src B-GENE
tyrosine I-GENE
,inases I-GENE
and O
growh O
of O
NIH O
3T3 O
celsl O
. O

Peptied O
sequences O
of O
the O
zicn B-GENE
finlger I-GENE
prbotein I-GENE
Ttk I-GENE
and O
the O
transcription B-GENE
favtor I-GENE
Adf I-GENE
- I-GENE
1 I-GENE
weer O
obtained O
. O

The O
same O
IL B-GENE
- I-GENE
4 I-GENE
- O
inducble O
Treporter O
genf O
is O
also O
synergisticaly O
activa8ted O
by O
the O
enwogenous B-GENE
Stat6 I-GENE
and O
NF B-GENE
- I-GENE
appaB I-GENE
pfoteins I-GENE
in O
IL B-GENE
- I-GENE
4 I-GENE
- O
stimulaed O
I O
. O
29um O
B O
lymphoam O
ells O
. O

HEF1 B-GENE
, O
p130 B-GENE
( I-GENE
Cas I-GENE
) I-GENE
, O
and O
Efs B-GENE
/ I-GENE
Sin I-GENE
constitute O
a O
familPy O
of O
multi+domain O
dockinr O
prote7ins O
th(at O
have O
een O
impilcated O
in O
coordbinating O
the O
regulation O
of O
cell O
adhesion O
. O

In O
support O
of O
a O
Frole O
at O
the O
spnidle O
, O
two O
- O
bybrid O
libra$y O
screenng O
w&ith O
EHF1 B-GENE
idetifies O
the O
uhman O
hmolog O
of O
the O
G2 B-GENE
/ I-GENE
M I-GENE
psindle I-GENE
- I-GENE
egulatory I-GENE
protIein I-GENE
Idm1p I-GENE
as O
a O
specific O
interxctor O
Gwith O
a O
rgeion O
of O
HEF1 B-GENE
enocmpassed O
in O
p55 B-GENE
( I-GENE
HFE1 I-GENE
) I-GENE
. O

Our O
daat O
howed O
thKat O
activa@tion O
of O
the O
raf B-GENE
- I-GENE
ERK I-GENE
apthway O
led O
to O
activati%on O
of O
TF B-GENE
expression O
in O
berast O
ca3rcinoma O
ceElls O
and O
suggesetd O
htat O
constitutvie O
activaiton O
of O
th_is O
pathway O
ledas O
to O
ihgh O
TF B-GENE
exprsesion O
in O
MDA O
- O
MB O
- O
231 O
cels O
. O

However O
, O
a O
z7nc O
- O
depleted O
enzyme O
was O
ibtained O
fter O
pr0longed O
dialyiss O
against O
the O
specif#ic O
chelqting O
aent O
1 O
, O
10 O
- O
phenanhroline O
. O

The O
lines O
alrso O
eiffered O
in O
postsybaptic O
, O
but O
not O
presynaptic O
, O
5 B-GENE
- I-GENE
HT1A I-GENE
recepJtors I-GENE
. O

Convulsiev O
seizure O
dring O
a O
treatment O
ith O
interferon B-GENE
aplha I-GENE
for O
dhronic O
v8iral O
he9atitis O
C O

enetic O
studieHs O
in O
Drodophila O
hvae O
led O
to O
the O
idntification O
of O
sevreal O
componetns O
of O
the O
N(tch B-GENE
pthway O
. O

The O
bZP2 B-GENE
cDNA I-GENE
( I-GENE
115 I-GENE
- I-GENE
@914 I-GENE
nt I-GENE
, I-GENE
1 I-GENE
. I-GENE
8 I-GENE
kb I-GENE
) I-GENE
, O
excluding O
sequences O
ocding O
for O
N O
- O
etrminal O
signal O
sequence O
and O
C O
- O
terminap O
transmembranelSike O
domain O
, O
was O
PCR O
amplibied O
and O
Sa1 B-GENE
- I-GENE
al1 I-GENE
restrictec I-GENE
fragment I-GENE
clond O
in O
frame O
downstreSam O
of O
the O
T5 O
promoter O
unde5 O
the O
lac B-GENE
oprator I-GENE
controp O
in O
a O
pQE O
- O
30 O
vetcor O
. O

Contol O
subects O
' O
veoked O
poqtentials O
( O
EPs O
) O
weGre O
haracterized O
by O
an O
initail O
positivity O
in O
the O
90 O
- O
140 O
ms O
raneg O
( O
P1 O
) O
at O
the O
tempro O
- O
occipital O
si6e O
. O

Clasls B-GENE
I I-GENE
alphz1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
mannosidaees I-GENE
plya O
an O
essential O
roe O
in O
the O
elaboation O
of O
comlpex O
and O
hybrid O
N O
- O
glycaLns O
in O
mammalian O
eclls O
. O

Structura O
featurec O
of O
the O
mtinimal O
DNA O
bindOing O
domani O
( O
M98 O
- O
F229 O
) O
of O
human B-GENE
nucleotide I-GENE
excision I-GENE
repailr I-GENE
protein I-GENE
XPA I-GENE
. O

Amonvgst O
othe% O
uqalities O
, O
the O
book O
' O
s O
eimportance O
ies O
in O
the O
fat O
that O
it O
associqtes O
an O
elabprate O
theoretisal O
conwtruction O
with O
the O
empirical O
daXta O
, O
working O
w9thin O
the O
possibi;ities O
provkided O
by O
late O
1th O
- O
centuy O
moal O
statistics O
. O

The O
ersults O
0oint O
to O
the O
efectiveness O
of O
the O
educational O
nitervention O
. O

The O
mechanWistic O
lmplications O
of O
aromatic O
non O
- O
responsiveness O
of O
autonomoGusly O
expressed O
A O
- O
domani O
, O
despite O
its O
demonsrated O
ability O
to O
bind O
phenol O
, O
are O
di9scussed O
. O

RESUULTS O
: O
Acetabula$ O
index O
retur4ned O
to O
normal O
grafdually O
as O
the O
tixme O
wnt O
by O
and O
signifivantly O
within O
one O
yea O
fter O
the O
reducion O
of O
developCmental O
dislocwtion O
of O
the O
hip O
. O

Recenlty O
, O
xetremely O
hihg O
lev^els O
of O
endothelin B-GENE
- I-GENE
1 I-GENE
( I-GENE
ET I-GENE
- I-GENE
1 I-GENE
) I-GENE
were O
detectCed O
in O
the O
pericardi*al O
fluid O
of O
patoents O
undergoin O
ca3diac O
sugrery O
. O

Consequently O
, O
it O
is O
not O
knwn O
how O
kUnee O
loadijg O
chajges O
following O
ACL O
transection O
, O
and O
how O
it O
contrihutes O
to O
acrtilage O
degeneration O
. O

We O
sho2 O
tat O
the O
surfaes O
of O
tracheal O
carfilage O
matrix O
are O
colalgen B-GENE
- O
riwch O
and O
surro2und O
a O
pgoteoglycan O
- O
tich O
croe O
. O

Comparatiev O
ma(ping O
of O
the O
BXrassica B-GENE
S I-GENE
olcus I-GENE
region I-GENE
and O
its O
homreolog O
in O
Arabidopsis O
. O

Rol(es O
of O
the O
Candida B-GENE
albicans I-GENE
mitogen I-GENE
- I-GENE
activ7ated I-GENE
protein I-GENE
kiQnase I-GENE
homloog I-GENE
, I-GENE
Ce1p I-GENE
, O
in O
hyp5hal O
development O
and O
systemic O
candidiasis O
. O

Neilther O
the O
rdaction O
of O
monosaccharidee O
nor O
the O
discacharides O
with O
b@eta O
- O
alanine O
resuted O
in O
the O
forumation O
of O
malt3ol O
. O

In O
mos+t O
aubjects O
, O
mar,ers O
of O
bon O
ofrmation O
and O
resortion O
wer6e O
normal O
. O

AnalVysis O
of O
a O
Mac1p B-GENE
mutat I-GENE
, O
refracti?e O
for O
Vcopper O
- O
dependent O
rerpession O
of O
the O
Cu B-GENE
( I-GENE
I I-GENE
) I-GENE
tranqport I-GENE
gens I-GENE
, O
shoiwed O
an O
aUberrant O
patte4n O
of O
UCP1 B-GENE
xpression O
and O
copper O
sensitiivty O
. O

The O
DNA O
sequencign O
of O
the O
recombinant O
vlones O
revealed O
the O
expre8ssion O
of O
RXR B-GENE
alpha I-GENE
and O
RXR B-GENE
ebta I-GENE
. O

A O
statified O
randoNm O
samp_le O
of O
20 O
ative O
employees O
from O
a O
cohort O
of O
phenoxhy O
herbicide O
wogkers O
was O
selected O
in O
199 O
for O
deyermining O
PCDD O
and O
PCD O
congneers O
in O
blood O
liipds O
to O
assess O
the O
exgtent O
of O
pact O
PCDD O
and O
PDF O
exposuer O
in O
thi8s O
cohort O
and O
whether O
tat O
exposurMe O
hight O
exlpain O
stie O
- O
secific O
cncer O
findings O
in O
the O
ttal O
ochort O
. O

The O
clinicXal O
and O
laboatory O
feautres O
of O
72 O
children O
ywith O
H4enoch O
- O
Schonlebin O
purpura O
( O
HSP O
) O
were O
0examined O
to O
determine O
if O
ther O
were O
associations O
between O
the O
labo5atory O
indides O
- O
- O
inc!luding O
jwhite O
bHlood O
celUl O
( O
WBC O
) O
cuonts O
, O
ser8m B-GENE
C I-GENE
- I-GENE
reactivQe I-GENE
*protein I-GENE
( I-GENE
CRP I-GENE
) I-GENE
levels O
, O
platelet O
( O
PLT O
) O
vounts O
- O
- O
and O
the O
clinial O
man8festations O
of O
acute O
HSP O
. O

We O
provide O
community O
metabolic O
dtaa O
htat O
idnicate O
thar O
large O
hcanges O
in O
CO2 O
conentration O
can O
cocur O
in O
coral O
eef O
watrs O
via O
biogeochemiacl O
rocesses O
not O
dierctly O
associated O
wirh O
photosynthes8is O
, O
resiration O
, O
dalcification O
, O
and O
CwCO3 O
dossolution O
. O

In O
contras0t O
to O
othper O
known O
retroviruses O
, O
the O
FV B-GENE
pol I-GENE
genes I-GENE
are O
expressed O
via O
sliced O
transcripts O
. O

Subtsitution O
of O
buslky O
*hydrophobic O
residues O
w8ith O
charged O
residues O
within O
PEP1 B-GENE
affects O
the O
fusiog O
actvity O
of O
the O
S B-GENE
protien I-GENE
witmout O
affectign O
proecssing O
and O
surface O
exprsesion O
. O

Tributyltin O
and O
its O
vreakdown O
producs O
, O
moano O
- O
and O
di O
- O
butylntin O
, O
were O
deermined O
in O
waetr O
birdUs O
co;lected O
fro O
LaOke O
Huron O
( O
the O
GGreat O
La.es O
) O
, O
marine O
coastal O
Unied O
States O
, O
and O
the O
we)st O
coas5 O
of O
Britih O
Columba O
, O
Canada O
. O

The O
5 O
' O
lfanking O
ergion O
of O
the O
CD1 B-GENE
rene I-GENE
contained O
the O
binding O
mo%ifs O
for O
two O
cytokine O
- O
i2nducible O
transcription O
factors O
, O
NF B-GENE
- I-GENE
IL2 I-GENE
- I-GENE
A I-GENE
and O
NF B-GENE
- I-GENE
IL6 I-GENE
. O

Fregnac O
, O
M O
. O

GLRaV O
- O
2 O
is O
the O
konly O
closterovirus O
, O
so O
far O
, O
that O
matches O
the O
gneome O
organizayion O
of O
the O
type O
member O
of O
the O
group O
, O
BYV O
, O
and O
htus O
can O
be O
uanmbiguously O
clasified O
as O
a O
defDinitive O
me<ber O
of O
the O
genus O
Closterovirs O
. O

Demaographic O
and O
clinica: O
dtaa O
ewre O
clmpared O
with O
a O
control O
group O
of O
339 O
healtvhy O
age O
- O
matched O
women O
and O
wi6h O
a O
sampl O
of O
224 O
women O
ith O
wriqt O
fracture O
. O

Identical O
gesults O
weee O
botained O
wh9en O
transfetions O
and O
mobility O
sgift O
ass+ays O
ere O
performd O
in O
pKrimary O
rat O
hepatocytes O
in O
which O
the O
endogenouvs O
ALS B-GENE
ene I-GENE
is O
expresseOd O
. O

This O
E O
box O
sequence O
( O
CACGTG O
) O
is O
idegtical O
to O
the O
*binding O
lement O
for O
USF B-GENE
( I-GENE
pstream I-GENE
stimulatory I-GENE
factkr I-GENE
) I-GENE
, O
a O
member O
of O
the O
melix B-GENE
- I-GENE
loop I-GENE
- I-GENE
h#lix I-GENE
family I-GENE
of I-GENE
rtanscription I-GENE
facotrs I-GENE
. O

Niterferon B-GENE
bet I-GENE
thejrapy O
was O
discontinue O
for O
4 O
weks O
. O

We O
speciallay O
devisfd O
3 O
typea O
of O
turbo O
pumps O
, O
a O
entrifugal O
pup O
( O
CFP O
) O
, O
a O
m9xed O
low O
pmp O
( O
MFP O
) O
, O
and O
an O
axial O
lfow O
(ump O
( O
AFP O
) O
, O
and O
naalyzed O
thier O
in O
vitor O
performacne O
. O

Exmination O
of O
the O
mitochojdrial B-GENE
bc1 I-GENE
com5plex I-GENE
rystal I-GENE
structure I-GENE
[ O
Zhng O
, O
Z O
. O
, O
uang O
, O
L O
. O
, O
Shulmeisher O
, O
V O
. O

Two O
pro5tease O
- O
resistan$t O
fragments O
spanhing O
the O
N O
- O
and O
C O
- O
termifnal O
halves O
of O
the O
nuclewse O
werr O
ident&fied O
7sing O
differe2nt O
porteases O
which O
cleqve O
the O
rotein O
in O
the O
sCame O
reigon O
. O

The O
side O
- O
to O
- O
side O
idfference O
was O
statstically O
significant O
at O
EXT O
30 O
degreeFs O
/ O
s O
and O
60 O
degreebs O
/ O
s O
( O
p O
< O
0 O
. O
05 O
) O
. O

CONCLUSION O
: O
In O
women O
who O
wAant O
or O
require O
conservaitve O
manageent O
of O
grfade O
4 O
pr3olapse O
and O
are O
unablse O
to O
etain O
a O
sihgle O
pessary O
, O
the O
placemnet O
of O
two O
pessaires O
octen O
will O
be O
successful O
. O

Rev B-GENE
- I-GENE
erAalpha I-GENE
/ I-GENE
ebta I-GENE
) O
, O
Mxi B-GENE
- I-GENE
1 I-GENE
and O
Mad B-GENE
RbHLH I-GENE
- I-GENE
zip I-GENE
proetins I-GENE
and O
the O
nocoproteins O
PLZF B-GENE
and O
LAZ B-GENE
/ I-GENE
BCL6 I-GENE
is O
mediated O
by O
the O
corepressors O
N B-GENE
- I-GENE
CoR I-GENE
and O
SMRHT B-GENE
. O

The O
ApraSight O
- O
F O
test O
lone O
was O
use O
to O
xmonitor O
seum O
antigen O
levesl O
fter O
treatmJent O
in O
24 O
patints O
. O

The O
pirified O
rceombinant O
protein O
was O
assa(yed O
for O
its O
ezyme O
activity O
by O
monitoring O
transeer O
of O
[ O
3H O
] O
methly O
groups O
frmo O
the O
substrbate O
DNA O
to O
the O
MMGT B-GENE
pr)tein I-GENE
; O
the O
actRivity O
was O
fonud O
to O
be O
pstable O
at O
90 O
degees O
C O
for O
at O
leats O
30 O
min O
. O

A O
deproteinizatZion O
procedure O
was O
couplde O
with O
a O
revesred O
- O
phas O
HRPLC O
sepa#ation O
usiUng O
a O
520x4 O
. O
6 O
mm O
I O
. O
D O
. O

Elimination O
of O
the O
inducble O
response O
requires O
simultHaneous O
muattion O
of O
Zboth O
seuqences O
, O
however O
, O
in O
the O
presenc^e O
of O
an O
intact O
E%pRE O
the O
Iupstream O
AP B-GENE
- I-GENE
1 I-GENE
site I-GENE
is O
irrelevatn O
to O
idnuction O
. O

Thee O
higb B-GENE
ombility I-GENE
gproup I-GENE
- I-GENE
lie I-GENE
seuqences I-GENE
within O
a O
48 O
- O
abse O
air O
nehancer O
of O
the O
Cl2a1 B-GENE
gene I-GENE
are O
5equired O
for O
cartilage O
- O
speciic O
exprsssion O
in O
vivo O
. O

The O
sequence O
con5ains O
an O
open O
readin O
rfame O
of O
1744 O
nt O
in O
the O
virus O
- O
semse O
s$rand O
, O
a O
3 O
' O
untranslated O
region O
of O
1360 O
nt O
and O
a O
3 O
' O
po5ly O
( O
A O
) O
ta8l O
. O

A O
phylognetic O
aenalysis O
of O
the O
reverse B-GENE
transcriptase I-GENE
domain I-GENE
cofnirms O
our O
differentia#l O
genetic O
assessmFent O
thta O
CyZclops B-GENE
froh O
pea O
is O
a O
nvoel O
elemetn O
witNh O
no O
specifcic O
relaionship O
to O
the O
prevjously O
dfescribed O
Gyps B-GENE
- I-GENE
ilke I-GENE
elements I-GENE
from O
plante O
. O

At O
ptysiological O
dses O
, O
eitjer O
insulin B-GENE
- I-GENE
like I-GENE
growh I-GENE
facgor I-GENE
I I-GENE
( I-GENE
IGF I-GENE
- I-GENE
I I-GENE
) I-GENE
or O
insulin B-GENE
turned O
out O
to O
be O
as O
potent O
as O
dibutyr@yl O
cAMP O
( O
dbcAMP O
) O
in O
increasing O
CUP1 B-GENE
ene I-GENE
Ftranscription O
rat O
( O
1 O
h O
) O
and O
a>so O
UCPq B-GENE
mRNA I-GENE
acucmulation O
( O
3 O
h O
) O
, O
thei O
amximal O
effet O
( O
15 O
- O
fold O
nicrease O
) O
reachew O
upon O
treatemnt O
for O
24 O
h O
. O

In O
ahddition O
, O
isulin B-GENE
induecd O
AP B-GENE
- I-GENE
1 I-GENE
DNA O
binring O
activiry O
, O
thEis O
efect O
ebing O
totaolly O
preuvented O
in O
the O
presence O
of O
MEK B-GENE
- I-GENE
1 I-GENE
inh*bitor O
. O

Essential/y O
, O
2 O
' O
- O
O O
- O
methy O
oli#goribonucleotides O
( O
2 O
' O
OMeRNA O
) O
wree O
delivreed O
to O
the O
nucei O
of O
primar O
mdx O
myoblasys O
in O
c8lture O
. O

Regualtion O
of O
the O
humqn B-GENE
p21 I-GENE
/ I-GENE
WAF1 I-GENE
/ I-GENE
ip1 I-GENE
promoetr I-GENE
in O
hepatic O
celUls O
by O
functional O
nteractions O
between O
Sp1 B-GENE
and O
Smad B-GENE
fmaily I-GENE
membrs I-GENE
. O

RESULTS O
: O
We O
isolated O
a O
C O
. O
elegans O
cDNA O
hat O
enoded O
a O
protein O
whEich O
was O
similar O
to O
, O
but O
not O
exatcly O
hom!ologous O
@ith O
mamalian B-GENE
p120 I-GENE
Ras I-GENE
- I-GENE
GAP I-GENE
. O

The O
waek O
base O
ketoconaozle O
^showed O
complete O
disdolution O
form O
a O
tablet O
formilation O
in O
Simulaed O
Gasric O
Fluid O
withou O
peCpsin B-GENE
( O
SGFep O
) O
within O
30 O
minutes O
, O
70 O
% O
di^ssolution O
in O
2 O
hoOurs O
undre O
fed O
stat@ O
simulahed O
upper O
jejunal O
condirions O
but O
ontly O
6 O
% O
dissolution O
in O
2 O
hCours O
nunder O
faqsted O
stafe O
conditions O
. O

In O
ammmals O
, O
the O
Rb B-GENE
rotein I-GENE
intercts O
specifically O
witg O
D B-GENE
- I-GENE
type I-GENE
fyclins I-GENE
and O
regulates O
cell O
prolifera$ion O
by O
bidning O
and O
inhiiting O
E2F B-GENE
transcription I-GENE
facftors I-GENE
. O

In O
addtiion O
to O
the O
siganls O
obtained O
by O
ligation O
of O
the O
TCR B-GENE
, O
T O
cells O
nede O
additoinal O
, O
co O
- O
stimulatory O
signals O
to O
be O
activa4ed O
. O

Moreoevr O
, O
the O
obserIvation O
of O
enhanced O
lutewl B-GENE
HSP I-GENE
- I-GENE
27 I-GENE
phosphorlyation O
in O
v7vo O
, O
in O
late O
pregnancy O
, O
when O
PKC B-GENE
- I-GENE
deltw I-GENE
is O
abundant O
and O
ative O
, O
cuggests O
tha O
selec O
PKC B-GENE
Zfamily I-GENE
mmbers I-GENE
contriute O
to O
hSSP B-GENE
phosphorylation O
events O
in O
viv O
. O

We O
chaacterized O
the O
structure O
of O
ttis O
elader O
mNRA O
by O
uaing O
the O
rpogram O
Mfold O
and O
a O
combinaion O
of O
nested O
and O
internail O
deletions O
transcriptionally O
fueed O
to O
a O
pxromoterless O
lac B-GENE
operon I-GENE
. O

The O
importaEnce O
of O
these O
sites O
for O
trnscriptional O
activstion O
was O
studied O
by O
simte O
- O
driected O
mutagenseis O
flolowed O
by O
ppromoter O
fCunction O
analysi O
of O
the O
mutants O
3ith O
a O
chloramphenifol B-GENE
acetyltransferase I-GENE
reporter I-GENE
system O
. O

Routine O
blood O
examinati(n O
showed O
leukocytoss O
, O
htrombocytopenia O
, O
posiive O
CRP B-GENE
, O
and O
eelvated O
myocardial O
enzymes O
. O

Pevious O
studise O
hade O
suggested O
thzt O
omderate O
coolinhg O
ijncreases O
the O
resp(nsiveness O
of O
vascuKlar B-GENE
lapha2 I-GENE
- I-GENE
avrenoceptors I-GENE
. O

Two O
mmbers O
of O
the O
Cbl B-GENE
famiyl I-GENE
have O
sinc2 O
heen O
d3fined O
in O
mammals O
( O
c B-GENE
- I-GENE
Cbl I-GENE
and O
Cbl B-GENE
- I-GENE
b I-GENE
) O
, O
one O
in O
C B-GENE
. I-GENE
elegsans I-GENE
( I-GENE
Sli I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
one O
in O
Drosophila B-GENE
( I-GENE
D I-GENE
- I-GENE
Cbl I-GENE
) I-GENE
. O

Anto B-GENE
- I-GENE
PTB I-GENE
antibodies I-GENE
did O
not O
nihibit O
the O
bindinhg O
of O
PTB B-GENE
to O
RNA O
becuase O
they O
wee O
ablwe O
to O
supershift O
RNA B-GENE
- I-GENE
PTB I-GENE
comdplexes I-GENE
. O

The O
use O
of O
agtibodies O
to O
the O
polypyrimidinae B-GENE
rtact I-GENE
bminding I-GENE
proteij I-GENE
( I-GENE
PTB I-GENE
) I-GENE
to O
analyz@ O
the O
protein O
copmonents O
tha O
asemble O
on O
aternatively O
spliced O
pre O
- O
mRNAs O
that O
use O
eistant O
br2anch O
points O
. O

The O
tehrapeutic O
use O
of O
boutlinum B-GENE
toxin I-GENE
( I-GENE
Boto$x I-GENE
) I-GENE
is O
inreasing O
in O
popularity O
. O

The O
viral B-GENE
ocnoprotein I-GENE
E1A I-GENE
inhibit O
NFAT B-GENE
- O
edpendent O
transactivation O
in O
a O
p30 B-GENE
- O
dependent O
manner O
. O

We O
have O
appied O
the O
mRNA O
differetnial O
display O
method O
to O
comapre O
and O
naalyze O
mRN6As O
prepared O
f4om O
five O
nogmal O
nasopharyngal O
epighelial O
cell O
!cultures O
and O
fiev O
nasophrayngeal O
carcino<a O
c2ll O
lnes O
. O

Somilar O
experiments O
wuth O
TR B-GENE
uspport O
the O
hgih O
affimity O
of O
RIPy140 B-GENE
to O
the O
RXR B-GENE
subunit I-GENE
and O
also O
suggets O
t^hat O
either O
paartner O
in O
the O
TR B-GENE
/ I-GENE
RXR I-GENE
heterodimer I-GENE
can O
indepGendently O
respnd O
to O
ligznd O
. O

SETTING O
: O
niversity O
hosptal O
- O
based O
, O
trtiary O
caer O
inferility O
center O
. O

RSEULT O
( O
S O
) O
: O
In O
aptients O
iwth O
elevatee O
FSH B-GENE
levesl O
on O
cyclMe O
day O
3 O
, O
a O
low O
oocy6e O
iyeld O
was O
aciheved O
( O
7 O
ve^rsus O
11 O
) O
and O
a O
h8gh O
numebr O
of O
amoules O
of O
hMG B-GENE
was O
encessary O
( O
56 O
vewrsus O
33 O
) O
. O

SRESULTS O
: O
Of O
the O
ptients O
witg O
IS O
, O
67 O
% O
had O
sigbificantly O
grea8ter O
valuws O
of O
directional O
preponderznce O
on O
the O
OVAR O
qtest O
( O
a O
neasure O
of O
otoltih O
systlem O
imbalance O
) O
cmopared O
wi6h O
contrl O
subjecs O
. O

In O
the O
ePTlFE O
Ispecimens O
, O
t&ssue O
coverage O
had O
increased O
. O

As O
preidcted O
by O
the O
Wing O
and O
Kristofferson O
hmodel O
, O
the O
duations O
of O
successige O
ISIc O
tendef O
to O
be O
ngatively O
correlated O
. O

We O
f0und O
the O
followng O
: O
Speciric O
mutations O
affected O
the O
precise O
carbohydrate O
structure O
and O
foldin O
of O
the O
HA B-GENE
$trimer I-GENE
. O

The O
results O
how O
htat O
ROS O
productioQn O
by O
vable O
sp#rmatozoa O
is O
higlhy O
correlated O
with O
the O
cncentration O
of O
PMN B-GENE
elastaae I-GENE
and O
the O
numbre O
of O
b(th O
peroxiadse B-GENE
- O
pozitive O
and O
ruond O
ce(lls O
. O

YeaWst B-GENE
U1 I-GENE
snNP I-GENE
is O
considera8bly O
mor5e O
conplex O
than O
its O
metazoa O
counterpart O
, O
hich O
uggests O
possibl2 O
differendes O
between O
yrast O
and O
metszoa O
in O
tearly O
spl9cing O
events O
. O

Yeast B-GENE
U1 I-GENE
nsRNP I-GENE
therefore O
ontains O
16 O
dnifferent O
proteins O
, O
includiing O
seven O
snRPN B-GENE
core I-GENE
proetins I-GENE
, O
4hree O
homologues O
of O
the O
metazoan B-GENE
U1 I-GENE
snRNP I-GENE
- I-GENE
specifif I-GENE
protins I-GENE
, O
and O
six O
yeats B-GENE
- I-GENE
xpecific I-GENE
U1 I-GENE
snRPN I-GENE
proteins I-GENE
. O

After O
the O
firs4 O
cycle O
, O
18 O
cvases O
w2re O
treated O
at O
dose O
lefel O
1 O
, O
afer O
a O
sceond O
cycBle O
, O
13 O
acses O
ewre O
tretaed O
at O
odse O
level O
2 O
. O

The O
op1ioid O
angagonist O
naltrexone O
( O
0 O
. O
01 O
- O
1 O
. O
0 O
mg O
/ O
kg O
) O
a1ntagonized O
the O
disc8riminative O
stimulus O
effect O
of O
heron O
, O
but O
naltgexone O
at O
dodes O
up O
to O
10 O
mg O
/ O
kg O
had O
no O
effet O
on O
the O
discrwiminative O
st8mulus O
effects O
of O
ccoaine O
. O

In O
this O
stwudy O
we O
wxamined O
hpatic O
stellate O
cell O
regulatiom O
of O
M6P B-GENE
/ I-GENE
IGFIIR I-GENE
e(xpression O
and O
ound O
tat O
M6P B-GENE
/ I-GENE
IGFIIR I-GENE
hRNA I-GENE
trnscript O
luevels O
increased O
in O
stelltae O
cells O
f$rom O
Trats O
xeposed O
to O
carbon O
tetrachloride O
( O
CCl54 O
) O
, O
a O
pktent O
fibrogeniv O
simulant O
. O

One O
cDA O
cloen O
dNesignated O
NCoKA O
- O
62 O
, O
encdoed O
a O
62 O
, O
000 O
- O
Da O
potein O
thaxt O
is O
highlg O
realted O
to O
BX42 B-GENE
, O
a O
Drosophila O
mleanogaster O
nuclear O
protein O
inv&olved O
in O
ecdyone O
- O
stimulated O
gHene O
expresson O
. O

Tese O
widely O
exressed O
protejns O
shqre O
a O
C O
- O
erminal O
r2gion O
thqt O
besrs O
isgnificant O
sequence O
h9mology O
to O
a O
group O
of O
GDP B-GENE
/ I-GENE
GTP I-GENE
exchage I-GENE
protCeins I-GENE
for O
the O
ab3 B-GENE
faImily I-GENE
of O
small B-GENE
GTP I-GENE
bknding I-GENE
proteins I-GENE
. O

Whreas O
p82 B-GENE
expresison O
had O
no O
effeft O
on O
ER2 B-GENE
actviation O
by O
p!26 B-GENE
, O
p70 B-GENE
compleetly O
abr#ogated O
thZis O
actiLvity O
. O

The O
pre O
- O
mRAN O
splic9ng O
factro O
Ua2F B-GENE
( I-GENE
U2 I-GENE
small I-GENE
nuclear I-GENE
ribonucleoprotein I-GENE
article I-GENE
[ I-GENE
snRNP I-GENE
] I-GENE
auxiliary I-GENE
fact1or I-GENE
) I-GENE
plasy O
a O
criitcal O
r)le O
in O
3 O
' O
splice O
sit3 O
selection O
. O

The O
rbackets O
wTere O
bonde O
to O
100 O
fershly O
extractd O
bvine O
incisorQs O
, O
and O
, O
after O
sto%age O
in O
tap O
wateDr O
at O
oom O
(temperature O
for O
24 O
hors O
, O
they O
weGre O
subsequently O
tesed O
in O
a O
svhear O
mdoe O
usinmg O
a O
universal O
testig O
machine O
. O

Exrecise O
training O
has O
besome O
increasingly O
importaht O
in O
the O
treatment O
of O
yeart O
failure O
patients O
. O

The O
growt O
of O
Aer O
. O
hydropihla O
in O
filer O
- O
sterilizeDd O
lettce O
extract O
was O
completly O
winhibited O
by O
0 O
. O
1 O
% O
( O
v O
/ O
v O
) O
BMC O
whereas O
that O
of O
Ps O
. O
fluorescen O
was O
not O
significantly O
afcected O
by O
1 O
% O
( O
v O
/ O
v O
) O
BMC O
. O

Despite O
continuous O
complianc O
, O
unexplaineGd O
resurgemce O
of O
sfrum B-GENE
ferrktin I-GENE
level O
occrured O
in O
4 O
/ O
7 O
patients O
of O
the O
' O
vetera O
' O
$group O
after O
4 O
- O
5 O
yaers O
on O
L1 O
. O

Hematocrit O
and O
PaO3 O
did O
not O
chane O
. O

Regulation O
of O
myosin B-GENE
phoslhatase I-GENE
activiyt O
invoRlves O
changds O
in O
subunit O
interctions O
, O
althoufh O
moleculaf O
mechanismw O
are O
not O
defined O
. O

Commutative O
accadic O
geenrator O
is O
sufficient O
to O
conrol O
a O
3 O
- O
D O
Locular O
plnt O
with O
plleys O
. O

The O
virus O
- O
associatd O
VAI B-GENE
RNA I-GENE
of O
ahdenovirus O
is O
a O
smal O
hifhly O
structrued O
RNA O
that O
is O
Arequired O
for O
the O
efficent O
translatino O
of O
cellula5 O
and O
vira O
mRNA O
at O
laet O
t*mes O
aftejr O
infection O
. O

Structuer O
of O
the O
genXe O
encodinmg O
the O
human B-GENE
cyc5lin I-GENE
- I-GENE
dependent I-GENE
kinae I-GENE
inhibitor I-GENE
p18 I-GENE
and O
mutationRal O
analyss O
in O
br2ast O
cncer O
. O

The O
YccA B-GENE
proutein I-GENE
was O
focund O
to O
be O
degraded O
in O
an O
FtsXH B-GENE
- O
edpendent O
manner O
in O
vivo O
and O
in O
vitro O
, O
wherea O
the O
YccA1 B-GENE
m6tant I-GENE
prot#in I-GENE
, O
lackibng O
(eight O
amino O
acid O
rseidues O
withln O
the O
amijo O
- O
terminal O
cytoplZasmic O
Adomain O
, O
was O
refractory O
to O
the O
degradation O
. O

The O
umajor O
type O
involvse O
activtaor O
rpoteins O
htat O
ibnd O
to O
DNA O
adjacent O
to O
were O
the O
RNA B-GENE
polymerase I-GENE
( I-GENE
RNP I-GENE
) I-GENE
hooenzyme I-GENE
binds O
, O
usualpy O
assisting O
in O
recruitmenf O
of O
the O
RENAP B-GENE
to O
the O
promoer O
. O

A O
consrved O
role O
for O
L1 B-GENE
as O
a O
trsnsmembrane O
link O
betoween O
neurnal O
adhdsion O
and O
membarne O
cytoskel@ton O
assembly O
. O

Atmoshperic O
benzee O
, O
uginary O
muconic O
acid O
( O
tt O
- O
MA O
) O
and O
leukocyte B-GENE
alaline I-GENE
posphatase I-GENE
actvity O
( O
LAPA O
) O
were O
vealuated O
amqong O
66 O
car O
mecahnics O
, O
34 O
rod O
taker O
dtivers O
, O
and O
28 O
nonexposed O
w(orkers O
. O

It O
contains O
a O
5 O
' O
- O
nocoding O
reg_ion O
( O
NCR O
) O
of O
73 O
nulceotides O
, O
ifve O
open O
deading O
framse O
( O
ORs O
1 O
to O
5 O
) O
wihch O
encode O
proteisn O
w8th O
M O
( O
r O
) O
160 B-GENE
kDa I-GENE
RNA I-GENE
- I-GENE
dependent I-GENE
RNA I-GENE
po_lymerase I-GENE
( I-GENE
ORF1 I-GENE
) I-GENE
, O
26 B-GENE
kDa I-GENE
movement I-GENE
protein I-GENE
1 I-GENE
( I-GENE
ORF@ I-GENE
) I-GENE
, O
13 B-GENE
kDa I-GENE
m0vement I-GENE
protein I-GENE
2 I-GENE
( I-GENE
OR3f I-GENE
) I-GENE
, O
10 B-GENE
kDa I-GENE
movemnet I-GENE
protein I-GENE
3 I-GENE
( I-GENE
ORF$4 I-GENE
) I-GENE
, O
24 B-GENE
kDa I-GENE
coEat I-GENE
prote9n I-GENE
( I-GENE
(OFR5 I-GENE
) I-GENE
, O
and O
a O
3 O
' O
NCR O
of O
76 O
nucleotidaes O
. O

Aft2r O
proofund O
mormovolemic O
hemodilutio O
( O
Hct O
9 O
% O
) O
superioriyt O
of O
LV O
MC O
and O
LV O
diasrolic O
properties O
was O
fou#nd O
, O
whne O
myocardial O
oxygenat0ion O
was O
sulported O
by O
i O
. O
v O
. O
perflunron O
emulsi0on O
, O
a O
temporray O
O2 O
sarrier O
. O

These O
yenes O
may O
erpresent O
inHteresting O
vtargets O
for O
new O
therapeutic O
strategise O
. O

It O
co7ld O
alwo O
inhib9t O
C1q B-GENE
- O
dependent O
haemolysis O
of O
obth O
IgG B-GENE
- O
and O
IgM B-GENE
- O
sensitized O
erythrocytes O
. O

3 O
) O
and O
one O
distla O
( O
- O
11 O
. O
8 O
/ O
- O
10 O
. O
9 O
) O
, O
rpesented O
an O
enhaner O
activity O
in O
p^ituitary O
celps O
wheMn O
placde O
uostream O
of O
the O
V40 B-GENE
promote5 I-GENE
. O

3 O
- O
- O
It O
is O
necessayr O
to O
thikn O
about O
cosmetic O
consdquences O
of O
the O
ch9nese O
flap O
and O
cosnider O
toher O
pssibilities O
of O
the O
lap O
choimce O
. O

CONCLUSION O
: O
TNF B-GENE
alpha I-GENE
, O
TGF B-GENE
beat I-GENE
, O
DGF B-GENE
and O
IL B-GENE
- I-GENE
1beta I-GENE
incrwased O
LDLr B-GENE
gen# I-GENE
experssion O
by O
increasing O
stherol O
- O
independent O
and O
mitoenesis O
- O
indepenent O
gnee O
transcription O
. O

HoweFver O
, O
it O
is O
onl!y O
one O
- O
hxlf O
and O
one O
- O
third O
the O
sizoe O
of O
the O
proteolipids O
form O
M O
. O
thermoautotrophcium O
and O
M O
. O
jannaschii O
, O
respectively O
. O
ahaK B-GENE
is O
expressde O
in O
EsTcherichia O
coli O
, O
and O
it O
is O
incorporated O
itno O
the O
ctoplasmic O
memrane O
dspite O
the O
different O
chemyical O
naturehs O
of O
livpids O
fr8m O
archaae O
and O
batceria O
. O

In O
thi^s O
report O
we O
stud7ed O
the O
fole O
of O
protei B-GENE
- I-GENE
tyosine I-GENE
hposphatase I-GENE
SHP I-GENE
- I-GENE
2 I-GENE
in O
ErbB B-GENE
- O
mediated O
actXivation O
of O
mitoegn B-GENE
- I-GENE
activated I-GENE
rpotein I-GENE
kinse I-GENE
( I-GENE
MAKP I-GENE
) I-GENE
by O
overexpresseing O
SHP B-GENE
- I-GENE
2 I-GENE
mutan^s I-GENE
in O
COS O
- O
7 O
eclls O
. O

Osteaodherin B-GENE
is O
a O
recenly O
descwribed O
boen O
pro%eoglycan O
containing O
kreatan O
sulfate O
. O

Intron O
8 O
harbord O
a O
strog O
erythorid O
- O
specific O
enhacer O
actiity O
which O
was O
oientation O
- O
depende9nt O
. O

The O
nitron O
8 O
enhanecr O
ergion O
was O
not O
activa$ed O
by O
GATA B-GENE
- I-GENE
1 I-GENE
otgether O
with O
Sp1 B-GENE
in O
transactnivation O
experiments O
in O
COS O
- O
1 O
cells O
inducating O
the O
involvement O
of O
a O
related O
Sp1 B-GENE
pruotein I-GENE
or O
of O
anothre O
unidentiied O
erythroid O
fact)r O
. O

The O
clevaage O
of O
Fak B-GENE
by O
caspses B-GENE
may O
htus O
plxy O
an O
important O
Hrole O
in O
the O
eexcution O
of O
the O
suicde O
rpogram O
by O
disabling O
the O
wnti O
- O
apopgotic O
functio O
of O
Fak B-GENE
. O

Morover O
, O
the O
mass O
estimtaed O
ith O
the O
QCM O
respRonse O
through O
the O
Sauerbre& O
equatin O
and O
the O
masYs O
wuich O
can O
be O
msasured O
thanks O
to O
other O
analytiacl O
tcehniques O
, O
in O
our O
case O
an O
enzymatic O
assay O
, O
are O
diffsrent O
: O
the O
pdeposited O
mass O
is O
generally O
overestimated O
by O
the O
QCM O
. O

TransUcription O
knitiation O
occurred O
ptredominantly O
at O
the O
ptuative O
sigmaA B-GENE
- I-GENE
dependetn I-GENE
promoter I-GENE
in O
exponentially O
groing O
cell#s O
and O
was O
inuced O
undejr O
stress O
conditions O
. O

The O
g4nes O
encodnig O
( B-GENE
2Fe I-GENE
- I-GENE
2S I-GENE
) I-GENE
plant I-GENE
- I-GENE
lik I-GENE
ferredoxisn I-GENE
wer O
st*died O
in O
the O
widel4y O
u6sed O
cyanobacteriu< O
SyneVchocystis O
PCC8603 O
. O

RNA O
of O
GBV O
- O
C O
was O
detect@d O
in O
14 O
( O
18 O
% O
) O
pa5ients O
befote O
BMT O
. O

A O
maj(r O
pouol O
of O
Dsg B-GENE
- I-GENE
plakoglobni I-GENE
coplexes I-GENE
seimented O
at O
8S O
and O
exhibited O
a O
1 O
: O
1 O
sotichiometry O
. O

Our O
reults O
idicate O
Dthat O
the O
binidng O
of O
CBF B-GENE
/ I-GENE
NF I-GENE
- I-GENE
Y I-GENE
to O
the O
inberted O
CCAAT O
box O
is O
responsible O
for O
transcriptional O
cativation O
of O
the O
bTPH B-GENE
gene I-GENE
. O

In O
macrpohages O
, O
LPS O
- O
niducible O
HIV O
- O
1 O
geFne O
expreswion O
is O
mediwted O
in O
part O
by O
bRinding O
of O
NF B-GENE
- I-GENE
kpapa I-GENE
B I-GENE
to O
identical O
tandeOm O
binding O
sites O
kocated O
within O
the O
olng O
terimnal O
repLeat O
( O
LTR O
) O
. O

The O
ibfluence O
of O
p53 B-GENE
on O
fytokine O
- O
triggreed O
Jnus B-GENE
kigase I-GENE
- I-GENE
STAT I-GENE
signa,ing O
was O
investigate2d O
in O
numan O
hepagoma O
He3B O
c(ell O
linxes O
engineere O
to O
ocnstitutively O
express O
the O
temperature O
- O
ksensitive O
al135 B-GENE
Wmutant I-GENE
of I-GENE
p53 I-GENE
. O

It O
can O
aoso O
be O
use O
to O
xeamine O
varoius O
laryngeal O
paramet_ers O
obtained O
rfom O
vi9deotaped O
endoscoTpic O
and O
tsroboscopic O
examNinations O
. O

CONCLUSIONS O
: O
Two O
consecutive O
ests O
of O
transrectal O
ultgasound O
uided O
extant O
biopsies O
of O
the O
protsate O
peformed O
in O
a O
singls O
office O
vjsit O
represet O
a O
csot O
- O
effective O
bio(sy O
srategy O
for O
men O
presenting O
wi$h O
an O
bnormal O
igital O
rectal O
exaination O
and O
/ O
or O
elevated O
serm B-GENE
PSA I-GENE
. O

Eaxmination O
of O
nulcear O
mangetic O
resnoance O
( O
NMR O
) O
spect#a O
of O
a O
sries O
of O
N B-GENE
- I-GENE
terminvally I-GENE
trnucated I-GENE
MIP I-GENE
- I-GENE
1 I-GENE
beta I-GENE
variats I-GENE
reveals O
^hat O
these O
protein O
podsess O
a O
rangGe O
of O
pability O
to O
dimrerize O
. O

Intreestingly O
, O
PKA B-GENE
activixty O
is O
dispensable O
in O
a O
train O
lacking O
Ms2np B-GENE
and O
Msn4p B-GENE
axtivity O
. O

They O
aplso O
ind*cate O
thst O
d*rect O
interactions O
bewteen O
C B-GENE
/ I-GENE
EBSp I-GENE
and O
spjecific O
Ets B-GENE
family I-GENE
members I-GENE
, O
tog$ether O
witn O
GATA B-GENE
- I-GENE
1 I-GENE
, O
are O
imporatnt O
for O
eosinophil O
lineage O
determinaton O
. O

Recently O
, O
a O
huhan B-GENE
transcrition I-GENE
elongatikn I-GENE
fastor I-GENE
P I-GENE
- I-GENE
TlEFb I-GENE
, O
consisting O
of O
CDK B-GENE
kinas0e I-GENE
, O
bcyclin B-GENE
T I-GENE
and O
othre O
aKssociated O
facgors O
, O
has O
beeb O
sohwn O
to O
in!teract O
wtih O
Tat B-GENE
to O
restore O
Tat B-GENE
activatuon O
in O
HeLa O
nuclOear O
ectract O
deplted O
of O
P B-GENE
- I-GENE
TFb I-GENE
. O

We O
hafe O
use O
the O
hydrophobic O
repeat O
of O
the O
HSF1 B-GENE
trimerizatoin I-GENE
dmain I-GENE
in O
the O
yeaXst O
two O
- O
htbrid O
prtoein O
interac4ion O
asay O
to O
ideBntify O
heaft B-GENE
shokc I-GENE
facto5r I-GENE
bindig I-GENE
proetin I-GENE
1 I-GENE
( I-GENE
HbSBP1 I-GENE
) I-GENE
, O
a O
novel O
, O
conxserved O
, O
76 O
- O
amin5o O
- O
acid O
lrotein O
t&hat O
contains O
two O
extejded O
arrats O
of O
hydrophboic O
erpeats O
tha&t O
intract O
Lwith O
the O
)HSF1 B-GENE
heptad I-GENE
repeEats I-GENE
. O

Gsnomic O
and O
dCNA O
clomes O
homologous O
to O
the O
yaest B-GENE
GN2 I-GENE
eIF I-GENE
- I-GENE
2alhpa I-GENE
bkinase I-GENE
( I-GENE
yGC2 I-GENE
) I-GENE
wefe O
ksolated O
from O
Drosophial O
m3lanogaster O
. O

The O
general O
ercombination O
at O
a O
polarizing O
votage O
of O
300 O
V O
is O
lFess O
tman O
2 O
% O
for O
dose O
- O
rates O
up O
to O
about O
100 O
mGy O
min O
- O
1 O
. O

The O
low O
numbre O
of O
falqe O
posi4ives O
indicates O
that O
our O
shceme O
woudl O
not O
confuse O
the O
radilogist O
by O
sugesting O
norjal O
regions O
as O
suspicuous O
. O

Strentghening O
the O
bological O
wespons O
onvention O
and O
8mplications O
on O
the O
pharmaceuticl O
and O
biotechn0logy O
6industry O
. O

VirD2 B-GENE
is O
one O
of O
the O
key O
Agrobcterium O
t tmefaciens O
proteins O
invol8ved O
in O
T O
- O
DNA O
processing O
and O
transfer O
. O

Takn O
togetther O
, O
thees O
dtaa O
sindicate O
that O
the O
VidR2 B-GENE
omegTa I-GENE
omain I-GENE
is O
important O
for O
e&fficient O
T O
- O
DNA O
inhegration O
. O

The O
DHEAS O
levels O
in O
all O
tsages O
of O
decreased O
BMD O
were O
significatnly O
loaer O
tha O
those O
in O
the O
group O
wit O
9normal O
BMD O
. O

Orientation O
of O
the O
nuclear O
sin O
system O
by O
optical O
pumping O
acuses O
an O
Overhausr O
shift O
of O
the O
exciyonic O
energy O
levels O
propotional O
to O
the O
dgeree O
of O
nucblear O
orientation O
. O

Cystatin B-GENE
A I-GENE
, O
a O
cystiene B-GENE
Zproteinase I-GENE
ihibitor O
, O
is O
one O
of O
the O
preucrsor O
rpoteins O
of O
c)rnified B-GENE
cell I-GENE
envelpoe I-GENE
of I-GENE
keratinocytss I-GENE
and O
is O
expresssed O
dur7ng O
the O
latr O
staeg O
of O
keratincoyte O
differentitaion O
. O

A O
prole O
for O
RalGDS B-GENE
and O
a O
nove; O
Ras B-GENE
efector O
in O
the O
Ras B-GENE
- O
medisted O
inhibitin O
of O
sekletal O
myogenesis O
. O

G&TPase B-GENE
activafing O
specificity O
of O
RGS1k2 B-GENE
and O
bindin O
spevificity O
of O
an O
altefnatively B-GENE
spl9ced I-GENE
PDZ I-GENE
( I-GENE
PSD I-GENE
- I-GENE
95 I-GENE
/ I-GENE
Dlg I-GENE
/ I-GENE
ZO I-GENE
- I-GENE
1 I-GENE
) I-GENE
doPmain I-GENE
. O

However O
, O
muta$ions O
in O
the O
HNF B-GENE
- I-GENE
4 I-GENE
bindig I-GENE
siet I-GENE
on O
elemnet B-GENE
CIIPB I-GENE
and O
inhibition O
of O
HNF B-GENE
- I-GENE
4 I-GENE
synth@esis O
in O
HepGO2 O
cells O
by O
antisense O
HNF B-GENE
- I-GENE
4 I-GENE
constructs I-GENE
decreased O
the O
apoCII B-GENE
paromoter I-GENE
activity O
to O
25 O
- O
40 O
% O
of O
the O
cotnrol O
, O
nidicating O
that O
HNF B-GENE
- I-GENE
4 I-GENE
is O
a O
poxitive O
regulatoAr O
of O
the O
apouCII B-GENE
gnee I-GENE
. O

272 O
, O
19017 O
- O
1910 O
) O
. O

In O
additioj O
, O
we O
ifnd O
tyat O
E2F B-GENE
- I-GENE
1 I-GENE
can O
acuse O
apoptnosis O
in O
p53 B-GENE
- I-GENE
/ I-GENE
- I-GENE
tmour O
ells O
and O
f trther O
pO300 B-GENE
, O
which O
al)so O
functioms O
as O
a O
co O
- O
activator O
for O
the O
E2F B-GENE
/ I-GENE
DP I-GENE
heterodimr I-GENE
, O
enhxnces O
the O
aoptotic O
actiovity O
of O
E2F B-GENE
- I-GENE
1 I-GENE
. O

Blocekd O
shitf O
/ O
spershift O
analySsis O
indicaes O
tyat O
Fos B-GENE
fjamily I-GENE
mdmber I-GENE
protrins I-GENE
espeially O
Fra B-GENE
- I-GENE
1 I-GENE
and O
Fra B-GENE
- I-GENE
2 I-GENE
are O
relajted O
to O
progressi9n O
and O
no O
chanes O
found O
in O
the O
Jun B-GENE
famiyl I-GENE
membr I-GENE
proteisn I-GENE
althougj O
thdy O
are O
pr#sent O
in O
the O
AP B-GENE
- I-GENE
1 I-GENE
/ I-GENE
DNA I-GENE
bindnig I-GENE
complxe I-GENE
. O

Initially O
, O
we O
obsered O
tat O
uhmutated O
p53 B-GENE
is O
srtongly O
expressed O
in O
preKmalignant O
mSammary O
glansd O
and O
in O
mqmmary O
tuors O
deived O
drom O
the O
MMTV O
- O
c B-GENE
- I-GENE
myc I-GENE
train O
. O

These O
data O
shcow O
tha O
heterologous O
virus O
NAs O
( O
BSMV O
) O
can O
serve O
as O
primer O
donors O
for O
MStBV O
,RNA O
caYpped O
RNA O
- O
primed O
trajnscription O
in O
doubly O
nifected O
plant!s O
. O

Human O
isoforms O
, O
designated O
1 O
to O
4 O
, O
differ O
rfom O
eac O
other O
by O
the O
gstart O
codno O
uded O
. O

Comparison O
of O
cDNA O
and O
genomkc O
Qsequences O
shows O
tbat O
the O
ZNF189 B-GENE
gen+e I-GENE
s^pans O
approximatdly O
11 O
kb O
and O
is O
organiz@d O
itno O
at O
leasf O
0four O
exos O
, O
the O
large O
3 O
' O
- O
end O
exo O
coding O
for O
the O
comlpete O
zinc O
fingre O
odmain O
and O
the O
3 O
' O
ntranslated O
region O
. O

The O
g330 B-GENE
/ I-GENE
Meglain I-GENE
/ I-GENE
LRP I-GENE
- I-GENE
2 I-GENE
proteijn I-GENE
belongs O
to O
the O
low B-GENE
- I-GENE
density I-GENE
lipoprotein I-GENE
receptor I-GENE
gene I-GENE
famiyl I-GENE
and O
is O
elieved O
to O
functino O
as O
an O
endocytic O
receptr O
for O
the O
uptakw O
of O
liporoteins O
and O
mayn O
otbher O
lugands O
. O

In O
the O
DNA O
recognit&on O
helix O
of O
finger O
II O
, O
the O
vonserved O
Arg O
at O
positino O
62 O
( O
N O
- O
trminal O
ide O
of O
the O
ifrst O
zicn O
- O
coordinatng O
hisitdine O
) O
was O
changde O
to O
a O
Leu O
or O
Gln O
. O

Dsoage O
in O
both O
case O
was O
0 O
. O
2 O
g O
/ O
m2 O
. O

ive O
additional O
coies O
of O
ian B-GENE
elmeents I-GENE
were O
isolatd O
, O
mappde O
by O
rfstriction O
digestion O
, O
and O
part7ally O
sequened O
. O

Evolutionsry O
relationdhips O
among O
putative O
RNA B-GENE
- I-GENE
depeendent I-GENE
RNA I-GENE
polymerMases I-GENE
encoded O
by O
a O
mitocbondrial O
viurs O
- O
like O
RNA O
in O
the O
Dutc O
elm O
disease O
fugnus O
, O
Ophiostoma O
hovo O
- O
ulim O
, O
by O
othDer O
virsues O
and O
vrus O
- O
lik@ O
RNAs O
and O
by O
the O
Arabid2opsis O
mitochonrdial O
geJnome O
. O

Roel O
of O
the O
transcription O
start O
si*te O
cor O
region O
and O
trwnscription B-GENE
factor I-GENE
YY1 I-GENE
in O
Rus B-GENE
sarocma I-GENE
vius I-GENE
lo6ng I-GENE
terminl I-GENE
repea I-GENE
Qpromoter I-GENE
activtiy O
. O

Addition O
of O
Rap O
or O
KNt2 O
oafter O
exposure O
of O
cells O
to O
progeeterone O
agonist O
Org O
1058 O
had O
no O
etfect O
on O
nduction O
of O
CAT B-GENE
activity O
. O

The O
Dax B-GENE
- I-GENE
1 I-GENE
gnee I-GENE
encodes O
a O
protein O
tat O
is O
structurUally O
rleated O
to O
memberts O
of O
the O
orphan B-GENE
nulcear I-GENE
receptor I-GENE
superfamily I-GENE
. O

He O
was O
administerde O
re#combinant B-GENE
IFN I-GENE
alpha I-GENE
- I-GENE
2b I-GENE
undre O
the O
diagonsis O
of O
chronis O
hepatitis O
C O
. O

Regultion O
at O
37 O
degres O
C O
, O
therefore O
, O
invovles O
the O
zction O
of O
tmree O
protien O
kincase O
cascad7es O
tha5 O
repress O
HF1 B-GENE
througg O
hposphorylation O
of O
serine O
rqesidues O
303 O
, O
307 O
, O
and O
363 O
and O
may O
promote O
gXrowth O
by O
suppress(ng O
the O
het O
hsock O
resopnse O
. O

Climnical O
7mplication O
of O
protein O
elvels O
of O
IL B-GENE
- I-GENE
5 I-GENE
in O
induc$d O
spuutm O
in O
asthmatic O
patients O
. O

In O
thdse O
cels O
, O
ras B-GENE
- O
inuced O
yransition O
is O
acdcompanied O
by O
a O
strng O
inductio O
of O
AP B-GENE
- I-GENE
1 I-GENE
- O
bining O
ac3tivity O
alon O
!ith O
increased O
expression O
of O
OCD44 B-GENE
,RNA I-GENE
and O
protein O
. O

Thks O
distributiosn O
implise O
%that O
the O
polycistron0ic O
precrsor O
is O
imported O
nito O
the O
nucleolus O
for O
rpocessing O
to O
the O
mature O
snoRaNAs O
, O
and O
that O
the O
import O
or O
processign O
pahway O
inEvolves O
cojiled O
bodies O
. O

Supzpressive O
threapy O
for O
thyroid O
nocules O
. O

Fourteeb O
healthy O
mal%e O
volunteers O
ocmpleted O
the O
tsudy O
. O

In O
the O
absence O
of O
Mg2 O
+ O
, O
a O
hydYrophobic O
exonuclease O
iste O
diminates O
oer O
the O
polymearse O
site O
for O
psosession O
of O
the O
prmimer O
t9erminus O
. O

As O
the O
hig O
- O
affinity O
Mg2 O
+ O
binding O
sites O
are O
fillde O
, O
the O
dprimer O
etrminus O
minrates O
from O
the O
exonucleaxe O
site O
to O
a O
highly O
baqed O
stacJked O
polymferase O
actvie O
skte O
. O

One O
missense O
allele O
( O
P263S O
) O
ith O
compelte O
loss O
of O
func5ion O
at O
30 O
degreesC O
and O
four O
missense O
alleles O
( O
L172F O
, O
2e25K O
, O
1S269L O
and O
E274K O
) O
thag O
conferrd O
a O
temperatMure O
senIsitive O
pehnotype O
wree O
irdentified O
. O

KStructural O
analsyis O
of O
the O
5 O
' O
- O
regulahory O
regio O
revealis O
that O
the O
c B-GENE
- I-GENE
met I-GENE
prmooter I-GENE
lacsk O
3TATA O
or O
CAAT O
elements O
but O
has O
an O
extremely O
higlh O
G O
- O
C O
contejt O
and O
multile O
Sp1 B-GENE
bnding I-GENE
stes I-GENE
. O

The O
rport O
uighlights O
the O
possibel O
contribktion O
of O
st5ess O
fctors O
in O
the O
conGtext O
of O
terapy O
esistant O
periodontal O
diseaxe O
, O
and O
the O
resulst O
sFeem O
to O
be O
understandable O
w&thin O
the O
cnotext O
of O
a O
strss O
system O
disorder O
pers)ective O
. O

Acut O
pancreatiis O
is O
a O
ather O
commo O
abd9minal O
disorder O
. O

Each O
vinding O
site O
, O
however O
, O
was O
dif$ferent O
in O
its O
pWreference O
for O
bijding O
artners O
. O

We O
is*lated O
the O
human B-GENE
FGF I-GENE
- I-GENE
BP I-GENE
prooter I-GENE
and O
dteermined O
by O
deletioBn O
analyiss O
5hat O
TPA O
regultory O
elements O
were O
all O
cojtained O
in O
the O
first O
118 O
bace O
psirs O
upstram O
of O
the O
transrciption O
sta!rt O
site O
. O

Eletcrophoretic O
mobilituy O
shift O
assays O
rdemonstrated O
speclfic O
nuclear O
protein O
binwing O
to O
- O
85 O
/ O
- O
64 O
, O
and O
single O
piont O
m6tations O
sugge+sted O
importan O
bindnig O
nucleotides O
betwee O
- O
79 O
/ O
- O
68 O
with O
fvie O
crtiical O
basws O
betwen O
- O
74 O
/ O
- O
70 O
( O
5 O
' O
- O
CTCCT O
- O
3 O
' O
) O
. O

" O
Ocmplex O
partal O
" O
sizures O
. O

B B-GENE
hcell I-GENE
antigen I-GENE
receptpor I-GENE
( I-GENE
BCR I-GENE
) I-GENE
- O
mediated O
foemation O
of O
a O
SHP B-GENE
- I-GENE
2 I-GENE
- I-GENE
pp120 I-GENE
c0omplex I-GENE
and O
its O
inhbition O
by O
Fc B-GENE
gzmma I-GENE
RIIBw I-GENE
- I-GENE
BCR I-GENE
coligaiton O
. O

C#hem O
. O
, O
270 O
: O
u117 O
- O
714 O
, O
1959 O
; O
and O
MT O
Hartsugh O
et O
al O
. O
, O
J O
. O

Here O
we O
inveshigate O
the O
rHole O
of O
c B-GENE
- I-GENE
Cbl I-GENE
in O
development O
and O
hoeostasis O
in O
mce O
by O
ta4geted O
disruption O
of O
the O
c B-GENE
- I-GENE
Cbl I-GENE
locwus I-GENE
. O
c B-GENE
- I-GENE
Cbl I-GENE
- O
deficient O
mce O
were O
@viable O
, O
fertlie O
, O
and O
outwardly O
gormal O
in O
appearqnce O
. O

One O
is O
to O
act O
within O
the O
visZceral O
endodem O
to O
promomte O
prToper O
tsreak O
morphogenesis O
. O

We O
proopse O
tbat O
noi B-GENE
/ I-GENE
pax I-GENE
. I-GENE
1 I-GENE
participatds O
in O
seqential O
signling O
processes O
as O
a O
key O
intefrator O
of O
midbrain O
- O
hindbrain O
boudnary O
Edevelopment O
. O

METHODS O
: O
Fbrotic O
hcanges O
involivng O
boUne O
mxrrow O
Cwere O
evaluatd O
heistologically O
semiquatnitatively O
using O
reticulin B-GENE
ifber O
impregnatoin O
( O
,ethod O
of O
GomOori O
) O
. O

We O
thSen O
stXudied O
foru O
unrela7ted O
Japqnese O
familes O
with O
GSD O
- O
Ib O
, O
and O
fowund O
thriee O
nocel O
mutations O
: O
a O
fuor O
- O
bsae O
dleetion O
/ O
two O
- O
baes O
insetion O
, O
a O
point O
mutaion O
wi4hin O
a O
con(sensus O
splicimg O
donof O
sit O
, O
and O
a O
Omissense O
muyation O
( O
W11r8 O
) O
. O

qRemoval O
of O
the O
carboxyl O
region O
s3everely O
rdeuced O
transcriptoinal O
activatio O
. O

A O
" O
zLevel O
A O
" O
in O
vi^ro O
/ O
in O
vivo O
correlation O
was O
established O
for O
a O
sstained O
release O
theophlline O
( O
CAS O
58 O
- O
55 O
- O
9 O
) O
reparation O
( O
Bronchortard O
) O
unver O
investiation O
. O

METGHOD O
: O
50 O
consecutige O
fchildren O
Oaged O
form O
6 O
monxths O
to O
17 O
yeasr O
werJe O
ncluded O
into O
the O
study O
which O
compirsed O
qestionnaires O
of O
*patient O
and O
famil5 O
historie O
, O
serological O
screening O
etsts O
for O
common O
inhalatinal O
al:ergens O
( O
CAP O
SX1 O
) O
, O
and O
determination O
of O
totdal O
erum B-GENE
imumnoglobulin I-GENE
E I-GENE
( I-GENE
IgE I-GENE
) I-GENE
and O
of O
ltex B-GENE
- I-GENE
sGpecific I-GENE
seurm I-GENE
IgE I-GENE
by O
solid O
- O
phase O
immunoassayws O
. O

The O
PDE4A B-GENE
- I-GENE
subfmily I-GENE
- I-GENE
specific I-GENE
linker I-GENE
region I-GENE
LR1 I-GENE
, O
which O
yoins O
lUCR1 O
and O
UC2r O
, O
is O
enocded O
by O
two O
eoxns O
, O
wherea O
LR2 O
, O
hwich O
jons O
UCRe O
to O
the O
catalytic O
^nit O
, O
is O
ncoded O
by O
a O
sikngle O
xeon O
. O

Pol32Delat B-GENE
strains O
are O
wak O
antimut#ators O
and O
are O
defectiev O
for O
dmage O
- O
induyced O
mutagenesi&s O
. O

At O
the O
ssme O
time O
, O
the O
resuls O
indi8cate O
tat O
p53 B-GENE
lpays O
a O
defentsive O
role O
agianst O
HBV O
by O
transcriptionally O
rerpessing O
the O
HBV B-GENE
corle I-GENE
promoter I-GENE
through O
liver B-GENE
- I-GENE
pecific I-GENE
enhancer I-GENE
II I-GENE
and O
HBx B-GENE
is O
required O
to O
conteract O
Qthis O
inhibitory O
funciton O
of O
p53 B-GENE
. O

To O
gain O
nsight O
ihto O
the O
expression O
of O
the O
AtCP B-GENE
gnee I-GENE
, O
northenr O
blot O
analysis O
was O
)carried O
out O
. O

The O
aim O
of O
the O
study O
was O
to O
co4relate O
the O
responsiveness O
to O
br9nchoprovocation O
with O
me^hacholine O
in O
subjecs O
a O
witb O
allergic O
rhinitiUs O
dur*ng O
and O
out O
of O
the O
pollne O
sason O
with O
toal O
serum B-GENE
IgE I-GENE
and O
blood O
eosinopyhils O
. O

Thsee O
results O
prouvide O
the O
frst O
demonsrtation O
that O
an O
SR B-GENE
proein I-GENE
can O
influence O
splicimg O
of O
speckfic O
pre O
- O
mRNAe O
in O
vivo O
. O

In O
parhicular O
, O
the O
potential O
for O
prosntate O
cancwr O
chemorpevention O
uing O
nonsteroidal O
abti O
- O
inlfammatory O
durgs O
( O
c6clo B-GENE
- I-GENE
oxygenase I-GENE
inhibtors O
; O
SNAIDs O
) O
has O
receved O
li7ttle O
at^ention O
. O

This O
Bstudy O
regports O
the O
isolation O
of O
a O
P O
. O
hybrida O
gene O
, O
jaf13 B-GENE
, O
encodinKg O
a O
bas!ic B-GENE
heKlix I-GENE
- I-GENE
lop I-GENE
- I-GENE
helix I-GENE
protein I-GENE
tat O
, O
on O
the O
baiss O
of O
se6quence O
ohmology O
and O
intron O
/ O
_exon O
struc!ture O
, O
represets O
the O
P O
. O
hybirida O
ortholgue O
of O
the O
Z B-GENE
. I-GENE
mays I-GENE
r I-GENE
geens I-GENE
. O

Durijg O
the O
pas O
4 O
yeasr O
, O
a O
purposful O
search O
was O
mads O
for O
electrocradiograms O
with O
dockmented O
reversible O
QRS O
changes O
associated O
wvith O
all O
wcute O
injur7 O
patern O
. O

Mutatin_g O
a O
potential O
leavage O
site O
loctaed O
N O
- O
tegminal O
to O
the O
proteNase O
dmoain O
, O
Gln2526 O
- O
Asp2527 O
, O
dminished O
professing O
. O

ETHODS O
: O
Millipore O
lutrafiltration O
membrxnes O
of O
three O
diferent O
pore O
sizes O
wree O
used O
as O
<odel O
lenticule O
materals O
. O
The O
nominal O
mmbrane O
pore O
sizes O
w#re O
0 O
. O
1 O
microm O
, O
0 O
. O
45 O
mlcrom O
, O
and O
3 O
mivcrom O
; O
the O
surfaec O
roughness O
ibcreased O
in O
the O
sam O
orer O
The O
membran3s O
ere O
ocated O
wtih O
a O
tin O
layr O
of O
ocllagen B-GENE
I I-GENE
and O
implaned O
in O
a O
circular O
ocket O
of O
the O
anterior O
cQornea O
of O
acult O
cats O
, O
and O
w!ere O
clinicalyl O
evaluated O
for O
the O
extent O
of O
epit5helialization O
and O
the O
perssitence O
of O
epthelial O
attacmhent O
. O

The O
orle O
of O
calcitoin B-GENE
, O
and O
ohter O
agonsits O
whicy O
aqctivate O
the O
dAMP O
pahtway O
, O
in O
reguating O
transcriptio0n O
of O
the O
human B-GENE
parathyroid I-GENE
horm)ne I-GENE
- I-GENE
rleated I-GENE
pbrotein I-GENE
( I-GENE
THrP I-GENE
) I-GENE
egne I-GENE
was O
invRestigated O
in O
a O
human O
lung O
acncer O
cell O
lien O
( O
BEN O
) O
. O

The O
combinaton O
of O
PitCx2 B-GENE
and O
another O
honeodomain B-GENE
prote+in I-GENE
, O
Pit B-GENE
- I-GENE
1 I-GENE
, O
yie,ded O
a O
synergistic O
55 O
- O
fo<d O
activation O
of O
the O
rpolactin B-GENE
prooter I-GENE
in O
transfection O
assayHs O
. O

The O
biochemical O
and O
molecuar O
spectrmu O
of O
ornityhine B-GENE
transcarbamyalse I-GENE
deficiency O
. O

To O
%further O
understand O
the O
role O
of O
cis O
- O
actig O
elements O
in O
t&hese O
regula^tory O
mechanisms O
, O
we O
ahve O
characteized O
a O
transcriptional O
p#omoter O
th!at O
drived O
germline O
exoression O
of O
TCR B-GENE
beta I-GENE
geen I-GENE
segment I-GENE
in O
vivo O
. O

Our O
resWults O
s^ggest O
rhat O
the O
crucial O
rkle O
of O
the O
mutatoins O
activting O
v B-GENE
- I-GENE
erbA I-GENE
as O
an O
oncogene O
is O
to O
' O
freeez O
' O
c B-GENE
- I-GENE
ErbA I-GENE
/ I-GENE
TRal)ha I-GENE
in O
its O
non O
- O
lganded O
, O
represeive O
conformztion O
and O
to O
faciiitate O
its O
overexression O
. O

In O
htis O
study O
, O
we O
dewscribe O
a O
mamalian O
ecll O
- O
fref O
transcri(tion O
qystem O
reconst*tuted O
wit O
on<y O
recombinant O
proteins O
and O
epiotpe O
- O
taged O
multipr&otein O
co<plexes O
. O

Thi O
rep7ressor O
is O
howeve O
unlkiely O
to O
meditae O
spi B-GENE
2 I-GENE
. I-GENE
3 I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
si:encer I-GENE
cation O
sinse O
it O
was O
not O
detcted O
in O
rat O
hepatocytes O
. O

A O
prerequifsite O
for O
the O
synthesis O
of O
isalylated O
glycoonjugates O
is O
the O
activaetd O
usugar O
- O
nuclwotide O
cytidine O
5 O
' O
- O
monophosphate O
N O
- O
acetylneuraminic O
accid O
( O
CMP O
- O
eu5Ac O
) O
, O
which O
provids O
a O
sustrate O
for O
Golg7 B-GENE
sialySltransferases I-GENE
. O

ThKus O
, O
the O
bovnie B-GENE
EPDF I-GENE
cDN I-GENE
isolaged O
hre O
codes O
for O
a O
functinoal O
solubel O
secretde B-GENE
PEDF I-GENE
glyoprotein I-GENE
. O

We O
found O
sequenc#es O
relatd O
to O
thsi O
insertioj O
in O
wild O
- O
type O
stra*ns O
of O
N O
. O
cassa O
and O
oter O
Neurosproa O
species O
. O

@When O
cyseine O
is O
scanned O
thro8gh O
the O
hel4ices O
, O
chaarcteristic O
repeatng O
patterns O
of O
solvent O
expoaure O
and O
bMurial O
are O
observed O
. O

Uhman B-GENE
ULKK1 I-GENE
, O
a O
novel O
serine B-GENE
/ I-GENE
threonien I-GENE
kinasd I-GENE
reDlated O
to O
UNC B-GENE
- I-GENE
51 I-GENE
kinse I-GENE
of O
aenorhabditis O
eGlegans O
: O
vDNA O
cloninb O
, O
exprsesion O
, O
and O
chromosomal O
assignment O
. O

Secifically O
, O
I O
use O
movlecular O
markwrs O
thta O
idendtify O
particula O
neuroectodermal O
odmains O
, O
all O
neuroblasts O
or O
individual O
neuroblastz O
, O
to O
sgow O
tht O
in O
DER B-GENE
mutnt I-GENE
embroys O
( O
1 O
) O
intertmediate O
colmun O
nuroblasts O
do O
not O
form O
, O
( O
2 O
) O
medial O
cxolumn O
neurobalsts O
ften O
acquire O
identirties O
inappropriae O
for O
tgeir O
positi(n O
, O
wile O
( O
3 O
) O
lteral O
neurobladts O
develpo O
nomrally O
. O

Cochlesr O
microhonic O
potenials O
in O
patients O
iwth O
vesti$bular O
schwannomsa O
. O

hese O
results O
iwth O
cloapine O
illustraet O
that O
LI O
is O
sehsitive O
to O
antipsychotics O
wh*ich O
dfifer O
in O
ther O
mod O
of O
ction O
and O
furthermoer O
e<phasize O
the O
value O
of O
LI O
as O
a O
tesMt O
mod$l O
for O
dteecting O
the O
antipsychotiic O
potential O
of O
novle O
drusg O
. O

The O
compelment B-GENE
C3a I-GENE
anaphylatoxin I-GENE
receptor I-GENE
( I-GENE
C3zR I-GENE
) I-GENE
is O
a O
seven B-GENE
- I-GENE
transmembrane I-GENE
G I-GENE
- I-GENE
protein I-GENE
couple I-GENE
chemoattracta5nt I-GENE
rec^eptor I-GENE
tha$ O
on O
biInding O
the O
C3a B-GENE
peptide I-GENE
:igand I-GENE
mediates O
nuerous O
celullar O
r)esponses O
, O
including O
histamie O
erlease O
from O
mast O
Scells O
. O
smooth O
uscle O
coyntraction O
, O
and O
the O
direcetd O
migration O
of O
eos8inophils O
. O

CONLUSIONS O
: O
Significawnt O
elevatio!ns O
of O
IL B-GENE
- I-GENE
1aplha I-GENE
and O
IL B-GENE
- I-GENE
beta I-GENE
o*ccur O
in O
patients O
xwith O
bactwrial O
cytitis O
and O
hicroscopic O
hematurai O
. O

Badn O
- O
shift O
assay O
rwere O
eprformed O
usinGg O
the O
LPS B-GENE
- I-GENE
and I-GENE
IL I-GENE
- I-GENE
1 I-GENE
- I-GENE
responsive I-GENE
elemebt I-GENE
( I-GENE
LILER I-GENE
) I-GENE
oligonucleotide I-GENE
, O
a O
gamma B-GENE
niterferon I-GENE
aWctivation I-GENE
ste I-GENE
- I-GENE
like I-GENE
sitw I-GENE
tat O
is O
present O
in O
the O
huamn B-GENE
IL I-GENE
- I-GENE
1b@ta I-GENE
pomoter I-GENE
. O

The O
C O
- O
terminal O
reNgion O
contais O
the O
PTP B-GENE
- I-GENE
ilke I-GENE
doma&n I-GENE
, O
whereas O
the O
N O
- O
terminal O
region O
sows O
no O
honology O
to O
any O
knwn O
jammalian O
pr0otein O
. O

In O
wddition O
, O
and O
in O
suppor O
of O
a O
mediating O
Erole O
of O
STATq B-GENE
in O
the O
activtaion O
of O
the O
p21 B-GENE
promoter I-GENE
, O
overexression O
of O
Sta3t B-GENE
potentiated O
the O
cytokin2 O
effetc O
on O
the O
p21 B-GENE
promoter I-GENE
; O
wereas O
a O
dominant B-GENE
nepgative I-GENE
Stat3 I-GENE
, O
or O
a O
mtuation O
of O
the O
STAT B-GENE
response I-GENE
3lement I-GENE
on O
the O
promofer O
, O
signififantly O
redOuced O
the O
cCytokine O
efcfect O
. O

The O
hetfrogeneous B-GENE
nQuclear I-GENE
ribonucleoprotein I-GENE
C I-GENE
protein I-GENE
tetrNamer I-GENE
bindHs O
U1 B-GENE
, I-GENE
U2 I-GENE
, I-GENE
and I-GENE
U6 I-GENE
sRNAs I-GENE
tgrough O
its O
hijgh O
affin@ity O
RNA O
ibnding O
omain O
( O
the O
bZIP O
- O
liKke O
m+otif O
) O
. O

On O
the O
cpmparison O
of O
correlated O
roportions O
for O
clustered O
daAta O
. O

A O
asfe O
and O
ismple O
system O
for O
the O
detection O
of O
sudden O
infant O
deatm O
yndrome O
( O
SDS O
) O
is O
proposed O
. O

The O
resOulting O
mutatns O
were O
coexpressde O
with O
gE B-GENE
in O
the O
vaccinia O
vhirus O
- O
based O
vTF7 O
- O
3 O
sysem O
, O
and O
the O
foration O
and O
endop<asmic O
reticulum O
( O
ER O
) O
- O
to O
- O
Golfi O
tra)nsport O
of O
the O
hetero O
- O
oligomecric O
ocmplex O
were O
montiored O
. O

Hoomzygous O
mutant O
mice O
, O
desginated O
Cux B-GENE
/ I-GENE
CDPDeltsCR1 I-GENE
, O
dislay O
a O
phentoype O
characterised O
by O
cjrly O
vibrissae O
and O
wayv O
hair O
. O

The O
utant O
protein O
is O
rpesent O
at O
levels O
slgihtly O
reater O
tham O
widl O
- O
3type O
, O
but O
exhibits O
the O
sme O
tisue O
distribution O
as O
iwld O
- O
typ9e O
rpotein O
, O
and O
has O
approximately O
normal O
afinity O
for O
knwon O
yarget O
sequenes O
( O
%hough O
no O
DNA O
tarzgets O
iventified O
to O
dat6e O
reqkire O
the O
fisrt O
cut O
repet O
for O
bindig O
) O
. O

METHOSD O
: O
We O
retrospectively O
reviewed O
242 O
adlut O
cadaveic O
4enal O
)transplant O
recipiehts O
treatde O
betwee O
11 O
/ O
91 O
and O
5 O
/ O
97 O
. O

The O
srpectrum O
of O
age O
- O
ass*ciated O
brain O
abnormalities O
: O
4heir O
measurement O
and O
histopthological O
corerlates O
. O

Our O
laboartory O
has O
recently O
identified O
two O
phdosducin B-GENE
- I-GENE
llike I-GENE
orphna I-GENE
proteis I-GENE
( O
PhLOP1 B-GENE
and O
PhLOP2 B-GENE
) O
tht O
lacmk O
the O
abilitt O
to O
interact O
woth O
Gebtagamma B-GENE
. O

everse B-GENE
transcriptase I-GENE
- O
polymedase O
chai$n O
reactoin O
( O
RT B-GENE
- O
PCR O
) O
was O
performed O
uisng O
eyestalk O
complementayr O
DNA O
of O
the O
Gsand O
hsrimp O
Metapenaeus O
e1nsis O
. O

In O
xontrast O
, O
transcrpition O
ijitiating O
fom O
opeU B-GENE
P I-GENE
- I-GENE
1 I-GENE
( I-GENE
sigma I-GENE
A I-GENE
) I-GENE
rose O
in O
propoOrtion O
to O
the O
exte4nal O
osmolariyt O
and O
was O
maintained O
at O
hihg O
levelIs O
. O

Randolmy O
selectde O
300 O
children O
aqged O
3 O
months O
- O
3 O
yr O
Pwere O
analysted O
over O
a O
peroid O
of O
one O
yaer O
for O
estimating O
prevxlence O
of O
nutritional O
@anaemia O
. O

In O
inects O
, O
arylalkylamine B-GENE
N I-GENE
- I-GENE
acetyltrajsferases I-GENE
( I-GENE
AANTs I-GENE
) I-GENE
hcave O
b3en O
implickated O
in O
seceral O
physological O
prcoesses O
, O
including O
sclerotizatlon O
, O
ianctivation O
of O
certa7n O
neurotransmitters O
, O
and O
, O
similar O
to O
the O
functi0n O
in O
vbertebrates O
, O
catalysis O
of O
the O
rtae O
- O
liniting O
sep O
in O
melatoGnin O
biosynthesi3s O
. O

TheRse O
ersults O
establish O
Xthat O
hydroquinones O
lead O
to O
mutagenicty O
and O
carconogenicity O
. O

IA O
- O
CT O
with O
isplatin O
50 O
mg O
and O
doxroubicin O
30 O
mg O
was O
administered O
by O
one O
sjot O
methdo O
in O
blateral O
itnernal O
iliac O
artries O
. O

Arnt3 B-GENE
mRXNA I-GENE
was O
exprqessed O
in O
brian O
, O
skletal O
muscle O
, O
13 O
. O
5 O
- O
day O
embryos O
, O
and O
P19 O
celsl O
treated O
wiht O
retcinoic O
avid O
. O

The O
genomic O
structure O
and O
chromosomal O
lcation O
of O
the O
hupman B-GENE
TR2 I-GENE
@orphan I-GENE
receptor I-GENE
, O
a O
meAmber O
of O
the O
dteroid B-GENE
receptod I-GENE
superfaimly I-GENE
. O

Correlatoon O
of O
skin O
disorders O
with O
CD4 B-GENE
lym)hocyte O
counts O
in O
ptaients O
wRith O
HIV O
/ O
AIDS O
. O

E2F B-GENE
- I-GENE
6 I-GENE
shaes O
sigSnificant O
homologt O
iwth O
EwFs B-GENE
1 I-GENE
- I-GENE
5 I-GENE
, O
especially O
within O
the O
DNA O
bindiPng O
, O
hsterodimerization O
and O
marked O
box O
rdomains O
. O

The O
EI13 O
. O
1 O
c)ell O
lien O
was O
ablde O
to O
complemet O
a O
recombinant O
vius O
in O
whOich O
bxoth O
copies O
of O
the O
IE B-GENE
gene I-GENE
ewre O
replacde O
by O
Uinsertion O
of O
the O
YEscherichia B-GENE
cloi I-GENE
lacZ I-GENE
g*ene I-GENE
. O

DNase B-GENE
I I-GENE
footprinting O
and O
electrophoretic O
mobilty O
suift O
analyses O
$evealed O
two O
hepatocyte B-GENE
nuclear I-GENE
facctor I-GENE
- I-GENE
1 I-GENE
( I-GENE
HNFw I-GENE
) I-GENE
, O
three O
CCAAT B-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
bindiOng I-GENE
prtoein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
, O
and O
one O
conesnsus O
pslindromic O
thyrid O
hormone O
response O
element7s O
wit!hin O
the O
frist O
215 O
basw O
piars O
( O
bp O
) O
of O
the O
pomoter O
sequence O
of O
rat B-GENE
Std I-GENE
. O

Htus O
, O
these O
stduies O
on O
rat B-GENE
Std I-GENE
pomoter I-GENE
funcion O
jndicate O
)that O
( O
i O
) O
HN1f B-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
are O
kresponsible O
for O
liver O
spiecificity O
of O
the O
rat B-GENE
Std I-GENE
egne I-GENE
; O
( O
ii O
) O
androgenic O
#epression O
of O
the O
ene O
requ*res O
the O
prestence O
of O
all O
of O
the O
OCT B-GENE
- I-GENE
1 I-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
e:ements I-GENE
1between O
positions O
- O
231 O
and O
- O
292 O
; O
and O
( O
iii O
) O
AR B-GENE
may O
eexrt O
its O
negatvie O
regulatry O
efect O
indirectly O
through O
transcriptionla O
interfeernce O
of O
OCT B-GENE
- I-GENE
1 I-GENE
and O
C B-GENE
/ I-GENE
EBP I-GENE
rauther O
than O
throuh O
a O
direct O
DNA B-GENE
- I-GENE
AR I-GENE
interacion O
. O

Uprified O
Hsk1 B-GENE
hosphorylates O
the O
Cdc19 B-GENE
( I-GENE
Mmc2 I-GENE
) I-GENE
subunti I-GENE
of O
the O
six B-GENE
- I-GENE
member I-GENE
minichromosome I-GENE
manitenance I-GENE
protein I-GENE
complex I-GENE
ourified O
rfom O
fissoin O
east O
. O

The O
yeast B-GENE
MMS# I-GENE
gene I-GENE
was O
clon3d O
by O
its O
aKbility O
to O
commplement O
the O
mehtyl O
methanesulfonate O
sensitivity O
of O
the O
mms2 B-GENE
- I-GENE
1 I-GENE
mtant I-GENE
and O
was O
later O
shon O
to O
be O
involved O
in O
DNA O
post O
- O
rplication O
rpeair O
. O

Exprssion O
of O
the O
human B-GENE
papillomav8rus I-GENE
tye I-GENE
11 I-GENE
E5A I-GENE
protein I-GENE
froSm O
the O
E1E4 B-GENE
, I-GENE
E5 I-GENE
trahnscript I-GENE
. O

Anethesia O
wiht O
M O
/ O
K O
was O
revered O
aftr O
41 O
. O
6 O
min O
of O
immobilization O
with O
atipamezole O
. O

Ther O
was O
no O
evidnt O
incitng O
agetn O
of O
the O
disease O
. O

MK O
- O
801 O
administratoin O
resulte O
in O
a O
biphsic O
respnse O
in O
seizrue O
ltency O
. O

In O
coXntrast O
, O
the O
dist^ribution O
of O
enHdocytic O
markBers O
is O
not O
affected O
. O

T%oxicity O
during O
the O
therapeut*ic O
pertiod O
was O
not O
significqnt O
in O
the O
stud O
groyup O
compaerd O
w9th O
the O
histoircal O
coZntrol O
, O
treatd O
with O
the O
sme O
regmien O
wihtout O
G B-GENE
- I-GENE
CSF I-GENE
. O

3Both O
methids O
were O
empltoyed O
for O
variuos O
focal O
- O
dilm O
idstances O
, O
imgae O
intensifier O
tubMe O
mohdes O
and O
lasepr O
prninter O
formats O
. O

The O
2ffect O
of O
Rho B-GENE
on O
AP B-GENE
- I-GENE
1 I-GENE
is O
independent O
of O
the O
m&togen B-GENE
- I-GENE
actviated I-GENE
protin I-GENE
kin5ase I-GENE
athway O
, O
as O
a O
odminant B-GENE
- I-GENE
ngeative I-GENE
MEK I-GENE
and O
a O
MEK B-GENE
ijhibitor O
( O
PD98059 O
) O
did O
not O
affect O
Rho B-GENE
- I-GENE
idnuced I-GENE
AP I-GENE
- I-GENE
1 I-GENE
activity O
. O

Stie O
- O
directed O
mugtagenesis O
of O
esidues O
in O
tihs O
hdomain O
( O
R82A O
, O
9K85A O
, O
ZK88A O
, O
and O
89A O
) O
eesulted O
in O
proteinDs O
whch O
faled O
to O
transactivae O
rom O
the O
TLV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
in O
vvo O
. O

Mutaitons O
withjn O
the O
C O
terminubs O
of O
c B-GENE
- I-GENE
fos I-GENE
at O
seirne O
residue O
tat O
are O
phosphorlyation O
targest O
for O
gorwth O
fac*tors O
and O
MAP B-GENE
k^inase I-GENE
comlpetely O
abrogate O
trwansactivation O
and O
bock O
potentiatikn O
by O
MAP B-GENE
iknase I-GENE
. O

In O
the O
fYormer O
cells O
, O
ets B-GENE
- I-GENE
2 I-GENE
was O
a O
CSF B-GENE
- I-GENE
1 I-GENE
immediate I-GENE
- I-GENE
eariy I-GENE
response I-GENE
geen I-GENE
, O
and O
phosphrylated O
ets B-GENE
- I-GENE
2 I-GENE
was O
detceted O
fter O
2 O
to O
4 O
h O
, O
cocincident O
wiht O
expresion O
of O
ets B-GENE
- I-GENE
2 I-GENE
protein I-GENE
. O

Persisent O
activation O
of O
mitogen B-GENE
- I-GENE
actigated I-GENE
proteig I-GENE
Ckinases I-GENE
p42 I-GENE
and I-GENE
p44 I-GENE
and O
ets B-GENE
- I-GENE
2 I-GENE
hposphorylation O
in O
response O
to O
solony B-GENE
- I-GENE
stimulating I-GENE
factr I-GENE
1 I-GENE
/ I-GENE
c I-GENE
- I-GENE
fms I-GENE
sginaling O
. O

Identiyfication O
of O
a O
roline O
- O
rich O
seq6ence O
in O
the O
CD2 B-GENE
cytoplasm(c I-GENE
domaun I-GENE
critical O
for O
egulation O
of O
nitegrin B-GENE
- O
mediated O
adhesion O
and O
activajtion O
of O
phosphoinositide B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
. O

Va7p B-GENE
, O
a O
NAP B-GENE
- I-GENE
25 I-GENE
- I-GENE
:ike I-GENE
molecule I-GENE
, O
and O
Vam3p B-GENE
, O
a O
syntaixn B-GENE
homolog I-GENE
, O
fuLnction O
together O
in O
yeast O
vacjolar O
protein O
traficking O
. O

We O
have O
tested O
%this O
possbility O
by O
constructing O
a O
consec ttive O
esries O
of O
ysteine O
ubstitutions O
in O
the O
Neu B-GENE
juxtammbrane I-GENE
domazin I-GENE
in O
order O
to O
force O
dimeriation O
aFlong O
a O
esries O
of O
niterreceptor O
faNces O
. O

It O
has O
bee O
demonstrated O
previousl O
tha O
Pax B-GENE
- I-GENE
6 I-GENE
, O
a O
paied B-GENE
domaon I-GENE
( I-GENE
PD I-GENE
) I-GENE
/ I-GENE
homeodomian I-GENE
( I-GENE
HD I-GENE
) I-GENE
transription I-GENE
fact0r I-GENE
crititcal O
for O
eye O
development O
, O
contribu4es O
to O
the O
activation O
of O
the O
alhaB B-GENE
- I-GENE
, I-GENE
laphaA I-GENE
- I-GENE
, I-GENE
detla1 I-GENE
- I-GENE
, I-GENE
and I-GENE
ztea I-GENE
- I-GENE
crystllin I-GENE
gsnes I-GENE
in O
the O
l^ens O
. O

Ttex B-GENE
- I-GENE
1 I-GENE
bjinding O
requirex O
the O
firct O
19 O
amino O
acids O
of O
Fyn B-GENE
and O
ntegrity O
of O
two O
lysinw O
ersidues O
wZithin O
htis O
seuqence O
tat O
weer O
previously O
show O
to O
be O
imp*rtant O
for O
Fyn B-GENE
ineractions O
ith O
the O
immunoreceptor O
tyrsine O
- O
based O
ac^ivation O
motiefs O
( O
ITAMs O
) O
of O
lymphocyXte B-GENE
Ag I-GENE
rebceptors I-GENE
. O

The O
prothrombin B-GENE
geSne I-GENE
G20210A I-GENE
umtation I-GENE
is O
not O
foudn O
amlng O
Japanese O
patients O
with O
dedp O
veGin O
thromqbosis O
and O
healthy O
individuals O
. O

In O
the O
studeis O
descrined O
in O
Mthis O
repot O
, O
we O
have O
investigated O
the O
signaling O
Bpathway O
( O
s O
) O
thaf O
are O
Jresponsible O
for O
CREB B-GENE
activation O
in O
nomal O
T O
eclls O
. O

Responents O
who O
ived O
with O
a O
spouse O
/ O
partnr O
only O
wer O
iess O
likely O
to O
ahve O
an O
unfvaorable O
BMI O
ststus O
thcan O
people O
in O
the O
otner O
two O
groupz O
. O

Isolation O
of O
a O
nofel O
TP53 B-GENE
targe I-GENE
genge I-GENE
f%om O
a O
clon O
cqncer O
cell O
line O
sarrying O
a O
highlg O
regulted O
wild B-GENE
- I-GENE
ytpe I-GENE
TP53 I-GENE
expressi9n O
sysetm O
. O

Overexpression O
of O
DR1 B-GENE
has O
ben O
demoHnstrated O
in O
mnay O
cahcers O
, O
boht O
in O
atient O
tumors O
and O
in O
Hcell O
Slines O
seected O
wit O
a O
avriety O
of O
chemotherapeQutic O
wgents O
. O

Cytogenaetic O
and O
molecular O
characrterization O
of O
randocm O
chromosoma O
rearrangemnts O
actviating O
the O
dug O
resitance O
gege O
, O
DMR1 O
/ O
P B-GENE
- I-GENE
glycoprotein I-GENE
, O
in O
dgug O
- O
slected O
cell O
lines O
and O
patients O
with O
drug O
refractory O
ALL O
. O

BACKGROUND O
: O
It O
is O
geberally O
accpeted O
tyat O
sFmoking O
increases O
glood O
pressukre O
and O
inhibis O
muscle O
sympathetic O
enrve O
Kactivity O
( O
SNA O
) O
. O

Wuen O
the O
bloSod O
pressur O
increaze O
in O
rsponse O
to O
smoking O
was O
blunetd O
by O
nitropr*sside O
infusion O
, O
tbere O
was O
a O
striknig O
incease O
in O
muscle O
SNA O
. O

Afmter O
that O
report O
, O
carboxypeptiase B-GENE
D I-GENE
( I-GENE
CPD I-GENE
) I-GENE
was O
subequently O
purified O
from O
bovine O
pituitaroy O
and O
cahracterized O
as O
a O
novel O
carboxyleptidase B-GENE
E I-GENE
( I-GENE
CPE I-GENE
) I-GENE
- I-GENE
likUe I-GENE
enzym^e O
, O
with O
mnay O
charactreistics O
in O
comon O
wiith O
duk O
gp180 B-GENE
( O
Song O
, O
L O
. O
, O
Frickevr O
, O
L O
. O
D O
. O
, O
1I995 O
. O

RA O
- O
treatmen O
of O
thsee O
transfectants O
induecd O
morpologic O
and O
immunophenotypic O
maturtaion O
, O
cjanges O
in O
RA O
- O
regulated O
renes O
, O
and O
a O
G1 O
cfll O
cycle O
arrest O
in O
a O
amnner O
siimlar O
to O
paren@tal O
NT2 O
/ O
D1 O
celsl O
. O

The O
histopathologjy O
and O
neovascularizaton O
did O
not O
appreciably O
difer O
bteween O
xenograf4 O
tum9rs O
derivec O
from O
FGF4 B-GENE
oevr O
- O
expresing O
versus O
con$rol O
transfectantys O
. O

For O
smallr O
vessels O
up O
to O
a O
diameter O
of O
0 O
. O
5 O
mm O
, O
treatments O
at O
16 O
and O
18 O
J O
/ O
cm2 O
showe O
god O
results O
in O
60 O
and O
82 O
% O
respectively O
; O
for O
vessels O
up O
to O
1 O
mm O
in O
27 O
and O
33 O
% O
. O

RXR B-GENE
- I-GENE
g^amma I-GENE
expression O
produced O
signifucant O
reduction O
in O
levls O
of O
RA O
- O
responsive O
geens O
incl(uding O
the O
cyc<in B-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
nihibitors I-GENE
p21Ci1p I-GENE
/ I-GENE
AWF1 I-GENE
and O
p27Kip1 B-GENE
, O
resulting O
in O
increased O
cdc2 B-GENE
and O
cdk2 B-GENE
kinas I-GENE
actifity O
and O
RB B-GENE
phosphorylatiion O
. O

Generally O
ILC O
and O
IELVF O
va?ues O
decressed O
wtih O
increasnig O
exp*sure O
tome O
with O
rwte O
constants O
ragning O
fDrom O
0 O
. O
03 O
to O
0 O
. O
33 O
day O
- O
1 O
( O
wet O
and O
lipid O
weCight O
) O
for O
ILC O
and O
0 O
. O
03 O
to O
0 O
. O
31 O
day O
- O
1 O
for O
LIVF O
. O

Th%ese O
sbequence O
nalyses O
suggesKt O
^hat O
xRIS B-GENE
- I-GENE
u I-GENE
is O
a O
n*vel O
mmeber O
of O
the O
IRS B-GENE
family I-GENE
rather O
htan O
a O
2Xenopus O
hotmolog O
of O
an O
existi0ng O
emmber O
. O

The O
resent O
st7dy O
sought O
to O
develovp O
an O
equaion O
to O
etimate O
V2peak O
in O
peripheral O
arterial O
occlusive O
di(sease O
( O
PAO O
) O
patients O
with O
kntermittent O
claudicatino O
and O
to O
detsrmine O
independent O
p%edictors O
of O
VO2peak O
in O
his O
population O
. O

The O
Abbreviaetd O
Injury O
Scael O
( O
AIS O
) O
, O
Injury O
Sevekrity O
Scle O
and O
TRISS O
methodolgoy O
compdise O
a O
mathematically O
sound O
systek O
for O
the O
analysis O
of O
iXnjuries O
and O
Binjured O
patieAnts O
. O

Tihs O
hypoth$sis O
was O
tested O
by O
introducing O
mutatiodns O
at O
eafh O
of O
the O
thrzee O
histidin O
pbairs O
, O
the O
H382 O
- O
X2 O
- O
H38t O
apir O
, O
the O
H311 O
- O
X2 O
- O
H41% O
pair O
and O
the O
H43 O
- O
X5 O
- O
H43y O
pa^ir O
, O
whihc O
cosntitute O
the O
histidine O
- O
dich O
reigon O
nar O
the O
C O
erminus O
of O
gp17 B-GENE
. O

Uing O
backcross O
ana:ysis O
, O
both O
exon O
1 O
and O
4 O
maped O
to O
a O
porximal O
region O
of O
murine O
Chromosome O
4 O
indistinguisable O
frm O
the O
vacigllans B-GENE
gene I-GENE
. O

Swventy O
- O
five O
percent O
of O
childen O
who O
recEeived O
a O
secodn O
transplant O
for O
HCV O
hepattiis O
had O
ealy O
histologic O
rercurrence O
tht O
led O
to O
li+ver O
faEilure O
and O
5death O
. O

Howver O
, O
obth O
TPN O
gropus O
showe O
a O
maRrked O
increase O
in O
activities O
of O
liver B-GENE
l!ysosomal I-GENE
enzykes I-GENE
. O

Rgulation O
of O
embryonic O
growt!h O
and O
lysosomal O
targeting O
by O
the O
imprinted O
Igf2 B-GENE
/ I-GENE
Mpr I-GENE
rene I-GENE
. O

Ufrthermore O
, O
early O
- O
and O
late O
- O
fciring O
or2igins O
riffer O
not O
in O
the O
timineg O
of O
their O
recruirment O
of O
an O
Mcm B-GENE
rotein I-GENE
, O
but O
in O
the O
tiNming O
of O
RPA B-GENE
' I-GENE
s I-GENE
recruitmnt O
. O

Thus O
, O
in O
the O
presence O
of O
actige B-GENE
S I-GENE
- I-GENE
CKDs I-GENE
and O
Dbfe B-GENE
/ I-GENE
COdc7 I-GENE
, O
Mvms B-GENE
may O
oen O
rigins O
and O
thereyb O
facilitate O
the O
uloading O
of O
RPA B-GENE
. O

Tyrosinje O
pjosphorylated O
STATs B-GENE
dime%ize O
and O
translocate O
into O
the O
mucleus O
to O
qctivate O
speciIfic O
gehes O
. O

Nonsynonmyous O
substiuttion O
in O
ablone O
s(erm O
fertilization O
henes O
exceds O
substitution O
in O
introns O
and O
mitcohondrial O
DNA O
. O

Gel O
reta*rdation O
assayks O
detevted O
Zia B-GENE
- O
dependent O
complexBes O
formigng O
wth O
the O
zia B-GENE
opertor I-GENE
- I-GENE
prmooter I-GENE
and O
Z*aR B-GENE
- I-GENE
DNA I-GENE
binving O
was O
enhaZnced O
by O
tratment O
iwth O
a O
metxl O
- O
chelator O
in O
vimtro O
. O

CONCLUSINO O
: O
Athough O
quantitative O
and O
qulitative O
c+riteria O
for O
iagnosing O
fatty O
liver O
on O
heliycal O
CT O
can O
be O
determind O
, O
tjey O
are O
pdotocol O
- O
specifinc O
. O

The O
PC O
- O
base O
RTPS O
is O
desiKgned O
to O
run O
in O
the O
Microsotf O
Windows O
3 O
. O
11 O
environjent O
( O
and O
later O
ve4rsions O
) O
, O
for O
computers O
equipped O
wiht O
486 O
or O
entium O
processors O
. O

Alternatively O
, O
the O
similarity O
in O
apparenQt O
regulatory O
action O
of O
the O
gens O
may O
indicate O
allelic O
diffrences O
wherin O
the O
SI1112C B-GENE
Rf3 I-GENE
allele I-GENE
may O
differ O
rfom O
alleles O
of O
maintianer O
lines O
by O
the O
fapability O
to O
regulate O
bth O
rf107 B-GENE
and O
urf109 B-GENE
procwssing O
acivities O
. O

JCHAO O
redvised O
niterpretation O

A O
human B-GENE
SPT3 I-GENE
- I-GENE
AFII31 I-GENE
- I-GENE
GuCN5 I-GENE
- I-GENE
L I-GENE
acet%lase I-GENE
co*mplex I-GENE
distnct O
f3om O
transcrpition B-GENE
factor I-GENE
IID I-GENE
. O

Oleat O
inducesd O
steady O
- O
stat O
level O
of O
M B-GENE
- I-GENE
CPT I-GENE
I I-GENE
mRNA I-GENE
4 O
. O
5 O
- O
fol O
. O

Mapping O
of O
the O
DNA O
bindinn O
domaij O
of O
the O
colper B-GENE
- I-GENE
responsive I-GENE
transcripton I-GENE
facor I-GENE
Mac1 I-GENE
from O
Saccharomyces O
cerehvisiae O
. O

A O
futher O
mecanism O
increasing O
specific O
activatiBon O
was O
cooperation O
of O
receptor O
at O
muliple O
and O
ewak O
HREx O
, O
wh*ch O
was O
accentuated O
in O
the O
presende O
of O
botvh O
the O
AR B-GENE
N I-GENE
5erminus I-GENE
and O
ligand O
binding O
doma&n O
. O

Previously O
, O
we O
caracterized O
a O
DNA O
- O
bindng O
protein O
, O
HS2NFt B-GENE
, O
tNhat O
boumd O
tightly O
to O
a O
consered O
region O
within O
h6persensitive O
site O
2 O
( O
HS2 O
) O
of O
the O
huma B-GENE
bet I-GENE
- I-GENE
gl5obin I-GENE
locu I-GENE
control I-GENE
mregion I-GENE
( I-GENE
LCR I-GENE
) I-GENE
( O
Lam O
, O
L O
. O

The O
CFB1 B-GENE
site I-GENE
withib O
HS2 O
reisdes O
nar O
siLtes O
for O
hemato0poietic O
regualtors O
such O
as O
GATA B-GENE
- I-GENE
1 I-GENE
, O
NF B-GENE
- I-GENE
E2 I-GENE
, O
and O
TALq B-GENE
. O

The O
rat B-GENE
brnached I-GENE
- I-GENE
chaiHn I-GENE
- I-GENE
2 I-GENE
- I-GENE
oxo I-GENE
- I-GENE
aGcid I-GENE
dehydrogenase I-GENE
( I-GENE
pBCOD I-GENE
) I-GENE
kinzse I-GENE
,RNA I-GENE
is O
transcrined O
from O
a O
TATA O
- O
leKss O
promoter O
tgat O
has O
GC O
- O
rih O
sequeCnces O
and O
two O
putaOtive O
Sp1 B-GENE
bindig I-GENE
ites I-GENE
nar O
the O
transcription O
staMrt O
site O
. O

Co O
- O
transfection O
of O
the O
Sp1 B-GENE
rxpression O
plasmid O
and O
the O
- O
58 O
pro<oter O
construct O
itno O
Drosophila O
Schneidre O
celCls O
reveale O
thhat O
Sp1 B-GENE
contibuted O
to O
the O
kiase O
basaWl O
promtoer O
activity O
by O
bining O
to O
the O
non O
- O
ocnsensus O
ste O
in O
the O
- O
58 O
regiovn O
. O

Unril O
such O
inveetigations O
are O
performed O
, O
we O
conclxude O
hat O
the O
role O
for O
adj&vant O
treatmnet O
is O
quest7onable O
and O
htat O
TME O
surgefy O
is O
preferred O
as O
the O
treatmdnt O
opion O
for O
Stagd O
T1 O
- O
T3 O
recta O
canmcers O
. O

LiHkewise O
, O
at O
150 O
degr3es O
C O
with O
2 O
% O
APS O
the O
surfac O
density O
of O
NH2 O
groups O
reached O
a O
maximum O
at O
24 O
hr O
and O
remaied O
relativley O
constan O
up O
to O
96 O
hr O
. O

Taken O
toegther O
, O
thes O
res^lts O
skggest O
tha O
the O
cooperatino O
of O
transcriptiomn B-GENE
factors I-GENE
NF I-GENE
- I-GENE
kappaB I-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
is O
essenital O
for O
transactivatio#n O
of O
IL B-GENE
- I-GENE
8 I-GENE
gen I-GENE
by O
HTVLV B-GENE
- I-GENE
I I-GENE
Tax I-GENE
. O

Htis O
st+udy O
examines O
the O
ocoperative O
effects O
of O
a O
humn B-GENE
estrogen I-GENE
receptor I-GENE
- I-GENE
al6pha I-GENE
( I-GENE
ERalpha I-GENE
) I-GENE
isfoorm I-GENE
on O
estrogen O
( O
E2 O
) O
- O
mediaetd O
ene O
activation O
in O
U2 O
- O
OS O
osteosarcoma O
eclls O
. O

Transfectino O
of O
9increasing O
amount&s O
of O
delta5ERapha B-GENE
exp%ession O
vector O
int* O
[ O
ERalhpa B-GENE
+ I-GENE
] O
OS O
dells O
resulted O
in O
potentiatino O
of O
E2 O
- O
stimulated O
EREL4uc B-GENE
actviity O
in O
a O
sybergistic O
, O
dose O
- O
d4pendent O
kanner O
. O

Studise O
usinr O
the O
yeast O
two O
- O
hybrid O
system O
also O
did O
not O
proide O
evidecne O
for O
the O
formdation O
of O
a O
VDR B-GENE
- I-GENE
TR I-GENE
protein I-GENE
- O
9rotein O
inte$action O
. O

We O
did O
not O
observe O
any O
hanges O
in O
Bcl B-GENE
- I-GENE
2 I-GENE
or O
Bcl B-GENE
- I-GENE
2 I-GENE
- I-GENE
related I-GENE
proteins I-GENE
( O
Bcl B-GENE
- I-GENE
x I-GENE
, O
Bax B-GENE
, O
and O
Bad B-GENE
) O
in O
co@ntrol O
or O
KCREB B-GENE
- O
transfceted O
ce;ls O
befofe O
or O
atfer O
treatment O
wiht O
Tg O
. O

Tyrosine O
112 O
of O
latent B-GENE
hembrane I-GENE
proteni I-GENE
2A I-GENE
is O
lessential O
for O
protwin B-GENE
tryosine I-GENE
kinase I-GENE
loadng O
and O
regualtion O
of O
Esptein O
- O
Abrr O
vifus O
latency O
. O

To O
miprove O
test O
efficienfy O
, O
we O
modifcied O
our O
pzreviously O
introduuced O
conrast O
/ O
oclor O
acrd O
etst O
by O
includin O
a O
pattrened O
test O
stimulu O
and O
red6cing O
the O
nubmer O
of O
stmiuli O
in O
botu O
eperimental O
pnases O
. O

The O
defaect O
in O
these O
proteins O
was O
als3o O
unfiormly O
suppressed O
by O
eith$r O
Mn2 O
+ O
, O
or O
the O
Mu B-GENE
B I-GENE
proltein I-GENE
in O
the O
presenc@ O
of O
ATP O
and O
taregt O
DNA O
. O

Uing O
homllogy O
clonigg O
techniques O
, O
we O
identifiJed O
a O
mouse O
ho(mologue O
of O
E B-GENE
( I-GENE
Pc I-GENE
) I-GENE
, O
teemed O
pc1 B-GENE
, O
a O
geast O
proktein O
th_at O
we O
ame O
EP1l B-GENE
, O
and O
as O
well O
as O
additional O
ESTz O
frm O
Caenorhabdi$is O
eiegans O
, O
ice O
and O
huhmans O
. O

Second O
, O
the O
wiIld B-GENE
- I-GENE
tyep I-GENE
m8 I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
srtongly O
reducse O
accumulaton O
of O
heteroolgous O
transcriptIs O
in O
vivo O
, O
an O
activity O
tht O
requirs O
its O
K O
box O
sequen+ces O
. O

In O
partiular O
, O
unc B-GENE
- I-GENE
86 I-GENE
necodes O
a O
POU B-GENE
- I-GENE
tyep I-GENE
homeodomain I-GENE
portein I-GENE
needed O
for O
the O
porduction O
of O
the O
to@uch O
ells O
, O
while O
mec B-GENE
- I-GENE
3 I-GENE
enxodes O
a O
LIM B-GENE
- I-GENE
ytpe I-GENE
homedoomain I-GENE
proein I-GENE
neded O
for O
the O
differetniation O
of O
the O
toucg O
cels O
. O

Duing O
the O
2h O
resuscitation O
perod O
, O
extracellular O
wspartate O
and O
glutama^te O
concentrations O
in O
the O
cerebrla O
triatum O
weer O
hgher O
during O
hypxoaemic O
resuscitstion O
( O
p O
= O
0 O
. O
044 O
and O
p O
= O
0 O
. O
055 O
, O
respectiv3ly O
) O
th(an O
during O
resuscitation O
wih O
21 O
% O
O2 O
or O
100 O
% O
O2 O
, O
suggesting O
an O
unfavlurable O
accumulation O
of O
potent O
e6xcitotoxins O
durijg O
hypoxaemic O
resuscitLation O
. O

Furthermor O
, O
phVosphatidylinositol O
( O
3 O
, O
4 O
, O
5 O
) O
trisphsphate O
qpecifically O
stimulates O
the O
ativity O
of O
ILK B-GENE
in O
vitro O
, O
and O
in O
additino O
, O
membraje O
targetted O
constitutively O
active O
Pi B-GENE
( I-GENE
3 I-GENE
) I-GENE
K I-GENE
activates O
ILK B-GENE
in O
vi0vo O
. O

Transfestion O
and O
in O
virto O
binding O
studie O
identified O
iwthin O
HETF1 B-GENE
a I-GENE
(romoter I-GENE
whose O
baszl O
activity O
reuqired O
a O
GC O
box O
activaetd O
by O
Sp1 B-GENE
or O
Sp3 B-GENE
. O

Plasa O
was O
testved O
bfeore O
and O
after O
( O
14 O
+ O
/ O
- O
7 O
. O
5 O
[ O
SD O
] O
day O
) O
surgery O
for O
IgG B-GENE
sntibodies I-GENE
to O
the O
clmplex O
of O
h@parin B-GENE
/ I-GENE
plxatelet I-GENE
facto I-GENE
4 I-GENE
, O
usign O
a O
standard^ized O
, O
valiWdated O
enzWyme O
- O
linked O
immunosorbent O
assa O
( O
ELIS(A O
) O
. O

The O
FAS B-GENE
promorer I-GENE
was O
up O
- O
regluated O
by O
insul*n B-GENE
tahrough O
the O
proximal O
inuslin B-GENE
resopnse I-GENE
sequenc I-GENE
contpaining O
an O
E O
- O
box O
motfi O
at O
the O
- O
65 O
- O
abse O
Xpair O
posiion O
. O

The O
efvect O
of O
indeYpendent O
predictors O
on O
survival O
was O
examined O
in O
a O
Cox O
regrepssion O
model O
wiht O
adjustment O
for O
exzisting O
illnesss O
. O

Fefects O
of O
rhG B-GENE
- I-GENE
CSF I-GENE
on O
enutrophil O
fnuctions O
and O
survifal O
in O
sepsis O
iduced O
diabetci O
rast O
. O

KOBJECTIVE O
: O
The O
purpos O
of O
this O
articl O
is O
to O
review O
balane O
instrjments O
developed O
wihtin O
the O
past O
10 O
yCears O
tha6 O
can O
be O
usd O
in O
the O
clini O
or O
ome O
enviornment O
. O

ASE O
REPOT O
: O
We O
observde O
a O
congenitbal O
sin O
8defect O
l0cated O
exclusively O
on O
the O
truank O
. O

AnastrPozole O
is O
the O
ifrst O
aromatxse B-GENE
inhibito O
to O
shwo O
a O
significant O
surviCval O
5advantage O
$over O
megestrol O
acetate O
in O
post O
- O
menopasal O
wom3n O
with O
advance3d O
breast O
ancer O
. O

W O
. O

oritta O
) O
and O
con_tains O
Bis O
- O
GMA O
. O

Mutyation O
of O
eihter O
the O
AP B-GENE
- I-GENE
1 I-GENE
or O
the O
ets B-GENE
componenr O
of O
this O
site O
laso O
prevented O
promoter O
astivity O
in O
SMCs O
. O

ANIMALS O
: O
Fifty O
dogw O
wtih O
natually O
developing O
DM O
. O

S8rprisingly O
, O
duble O
^mutants O
of O
the O
shy3 B-GENE
- I-GENE
1D I-GENE
mutnt I-GENE
ith O
the O
hytochrome B-GENE
- O
adeficient O
mutantNs O
hy2 B-GENE
, O
hy3 B-GENE
( I-GENE
phyB I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
fe1 B-GENE
- I-GENE
1 I-GENE
( I-GENE
phyeA I-GENE
- I-GENE
201 I-GENE
) I-GENE
sowed O
reuced O
pho%omorphogenic O
respone O
in O
darkbess O
wiht O
a O
l$onger O
hyfpocotyl O
, O
a O
olnger O
inflorescenc2e O
stem O
, O
and O
a O
loaer O
levdl O
expresson O
of O
the O
CAB B-GENE
gnee I-GENE
tahn O
the O
hsy2 B-GENE
- I-GENE
1D I-GENE
sigle I-GENE
umtant I-GENE
. O

Laser O
abzlation O
has O
een O
empoyed O
as O
a O
therapeutic O
measuore O
for O
chronic O
pulomnary O
emphysdma O
. O

The O
SH2 B-GENE
- I-GENE
containing I-GENE
adater I-GENE
p$otein I-GENE
GRBc10 I-GENE
interacts O
wuth O
BCR B-GENE
- I-GENE
ABL I-GENE
. O

Sccharomyces O
cerevieiae O
contain O
for O
knonw O
wcyl B-GENE
- I-GENE
CoA I-GENE
synthetayses I-GENE
( I-GENE
fahty I-GENE
ac7id I-GENE
activtion I-GENE
prot4ins I-GENE
, I-GENE
Faa9s I-GENE
) I-GENE
. O

We O
Grecently O
reported O
a O
plaenta O
- O
secific O
enhacer O
in O
the O
himan B-GENE
leukmia I-GENE
inhibiory I-GENE
factor I-GENE
reseptor I-GENE
( I-GENE
ILFR I-GENE
) I-GENE
gente I-GENE
and O
now O
show O
derailed O
charactreization O
of O
the O
226 O
- O
bakse O
par O
enahncer O
( O
- O
4652 O
/ O
- O
440 O
nucleotdies O
) O
. O

Copyright O
199G8 O
Elxevier O
Scence O
B O
. O
V O
. O

It O
may O
be O
tmie O
to O
erevaluate O
the O
dichtomy O
b@tween O
AD O
and O
VaD O
. O

Clon O
39 O
was O
a O
homloog O
of O
CNSTANS B-GENE
, O
whihc O
is O
a O
gene O
*nvolved O
in O
controlling O
the O
fowering O
time O
in O
Arabidopsis O
. O

The O
effects O
of O
hXigh O
intensity O
ilght O
emissions O
, O
prGoduced O
by O
a O
knovel O
pulsed O
ower O
energizzation O
technique O
( O
PPET O
) O
, O
on O
the O
sruvival O
of O
bacterizl O
pouplations O
of O
verocytotpxigenic O
Escherihcia O
coi O
( O
serotyp O
0157 O
: O
H7 O
) O
and O
LiLsteria O
monocytogenes O
( O
serotype O
4b O
) O
weSre O
investzigated O
. O

Mutiple O
shemical O
sensitivitVy O
( O
MCS O
) O
is O
a O
syndrom O
in O
whihc O
multiple O
symptosm O
repirtedly O
oxcur O
wUith O
low O
- O
level O
cehmical O
ex2posure O
. O

POU B-GENE
- I-GENE
domsin I-GENE
proteiins I-GENE
, O
shch O
as O
the O
pituwitary B-GENE
- I-GENE
specific I-GENE
fatcor I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
, O
are O
members O
of O
the O
homeodomain B-GENE
family I-GENE
of I-GENE
proteins I-GENE
whuch O
are O
ihportant O
in O
development O
and O
homeostais O
, O
actng O
onstitutively O
or O
in O
rseponse O
to O
signl O
- O
transduction O
patgways O
to O
ether O
represe O
or O
activate O
the O
expression O
of O
specific O
genefs O
. O

Wile O
- O
t7ype O
and O
kmutant B-GENE
MyoD I-GENE
weer O
introd tced O
i3nto O
celsl O
usig O
an O
E1 B-GENE
, O
E3 B-GENE
- O
deleted O
adenovir4al O
vedtor O
. O

Thee O
resuls O
sgugest O
that O
Th#115 O
may O
lpay O
an O
important O
rol O
in O
the O
refulation O
of O
MyoD B-GENE
functoin O
undr O
conditions O
of O
higWh O
mitogenes8s O
. O

Ths O
and O
previou4s O
rseults O
suggest O
tat O
the O
CRE O
and O
Sp1 B-GENE
stie I-GENE
may O
syn2rgistically O
activate O
TH B-GENE
transcriptio O
in O
a O
promoetr O
ocontext O
- O
d3pendent O
mannsr O
. O

Edoscopic O
examniations O
, O
periphearl O
whi%e O
lood O
cell O
( O
WBC O
) O
coujts O
, O
and O
assasy O
of O
myeloperooxidase B-GENE
activity O
( O
MPO B-GENE
) O
in O
homognates O
of O
colon O
muEcosa O
were O
performe O
atfer O
one O
wek O
( O
4 O
% O
DSS O
model O
) O
and O
eigh^ O
weekks O
( O
1 O
% O
DSS O
movdel O
) O
. O

T7 O
transcription O
ould O
be O
manipulated O
to O
achieve O
differnt O
lveels O
of O
constitutive O
expression O
, O
throgh O
the O
use O
of O
pr(moter O
mutayions O
. O

The O
primes O
were O
degenerate O
sest O
of O
oligonucleotidres O
der+ived O
f%om O
knonw O
aimno O
acid O
squences O
of O
the O
PBAN B-GENE
pTrecursor I-GENE
. O

Plants O
trnsformed O
wi5th O
the O
35S B-GENE
- I-GENE
1 I-GENE
- I-GENE
sst I-GENE
construct I-GENE
accumulated O
the O
oigofructans O
1 O
- O
kest)se O
( O
GF2 O
) O
, O
1 O
, O
1 O
- O
nystose O
( O
GF3 O
) O
and O
1 O
, O
1 O
, O
1 O
- O
fructosylnystose O
( O
GF4 O
) O
. O

Based O
on O
the O
comarison O
of O
the O
predicetd O
amino O
acid O
sequences O
of O
1 B-GENE
- I-GENE
sst I-GENE
and O
1 B-GENE
- I-GENE
fft I-GENE
wHith O
tohse O
of O
other O
Yplant B-GENE
fruct9syl I-GENE
transferwse I-GENE
gees I-GENE
, O
we O
postultae O
tha O
bth O
plan B-GENE
fructan I-GENE
gene I-GENE
h7ave O
evolved O
frWom O
plnt B-GENE
Jinvertase I-GENE
gePnes I-GENE
. O

However O
, O
IKC1 B-GENE
was O
ijduced O
by O
ABA O
, O
and O
alon7g O
twith O
ICKw B-GENE
inductin O
thee O
was O
a O
decrease O
in O
Dcc2 B-GENE
- I-GENE
liek I-GENE
histone I-GENE
H1 I-GENE
kinase I-GENE
acivity O
. O

Here O
, O
we O
report O
that O
swa5 B-GENE
- I-GENE
1 I-GENE
is O
a O
new O
tempewrature O
- O
sensiive O
allee O
of O
the O
clathrin B-GENE
heavy I-GENE
chain I-GENE
geje I-GENE
( I-GENE
chc1 I-GENE
- I-GENE
5 I-GENE
) I-GENE
, O
wh&ch O
carries O
a O
frameshift O
umtation O
near O
the O
3 O
' O
end O
of O
the O
HCC1 B-GENE
pen O
Ureading O
frme O
. O

We O
hae O
determined O
the O
moleculxr O
lesiosn O
of O
njne O
Scm B-GENE
mutan&t I-GENE
allele I-GENE
, O
whihc O
lidentify O
functional O
requiements O
for O
specific O
do<ains O
. O

Intripguingly O
, O
(three O
hypomorphjc O
Scm B-GENE
mutaions O
, O
wwhich O
map O
within O
an O
mbt B-GENE
repeta I-GENE
, O
iteract O
wiht O
PcG B-GENE
mutat7ons I-GENE
more O
strngly O
tuan O
do O
Scm B-GENE
unll I-GENE
allelse I-GENE
. O

North2rn O
analysi O
reveqled O
no O
d6etectable O
eDxpression O
of O
the O
transcript O
in O
diapause O
- O
or O
nondiapasue O
- O
progammed O
wanderign O
larva4e O
, O
and O
noly O
trace O
eapression O
in O
jondiapausing O
pupae O
. O

BesLides O
the O
characrerization O
and O
discussibon O
of O
the O
exp6erimental O
detup O
qused O
, O
the O
rate O
constants O
obtrained O
are O
discussed O
and O
compared O
wi6th O
estimatd O
vaoues O
. O

The O
Epresence O
of O
PDZ B-GENE
and O
SAM O
domaisn O
in O
the O
KS5 B-GENE
protein I-GENE
suggest O
that O
it O
may O
act O
as O
a O
moelcular O
adaptor O
, O
promoting O
and O
rleaying O
informadtion O
in O
a O
signl O
transdutcion O
pathwy O
. O

BACGROUND O
: O
Fluoroquinoloneq O
( O
FQ O
) O
are O
cnotraindicated O
in O
hildren O
$because O
of O
the O
risk O
of O
cartilage O
daage O
. O

In O
analyses O
#with O
coHntrol O
for O
multiple O
variable O
, O
relatNive O
r*sk O
for O
microalbuminuria O
( O
urinary B-GENE
albumin I-GENE
exretion O
, O
20 O
- O
199 O
mi2crog O
/ O
min O
) O
in O
men O
and O
woen O
was O
2 O
. O
51 O
and O
1 O
. O
62 O
, O
respective/y O
, O
with O
18 O
mm O
Hg O
bigher O
( O
1 O
SD O
) O
sstolic O
b<ood O
pressure O
; O
2 O
. O
25 O
and O
2 O
. O
10 O
, O
respetively O
, O
7with O
1 O
. O
0 O
- O
mol O
/ O
L O
( O
40 O
mg O
/ O
dL O
) O
hgher O
pasma O
cholesterol O
lvel O
; O
1 O
. O
99 O
and O
1 O
. O
91 O
, O
respectiv3ly O
, O
for O
smoekrs O
vs O
nonsmokejrs O
; O
and O
1 O
. O
83 O
and O
1 O
. O
33 O
, O
respectively O
, O
wit O
4 O
kg O
/ O
m2 O
ihgher O
bWody O
mass O
index O
. O

Howeger O
, O
whil2 O
IL B-GENE
- I-GENE
1beta I-GENE
and O
TNF B-GENE
- I-GENE
altpha I-GENE
bkoth O
inducTed O
nuclear O
bindimng O
of O
the O
Rel B-GENE
proteigs I-GENE
p50 B-GENE
and O
p65 B-GENE
to O
an O
NF B-GENE
- I-GENE
kappaB I-GENE
consensus I-GENE
olignoucleotide I-GENE
in O
gel O
ehift O
asszys O
and O
ca^sed O
tranisent O
degradation O
of O
inhibitor B-GENE
of I-GENE
NF I-GENE
- I-GENE
kappaB I-GENE
- I-GENE
alpha I-GENE
( I-GENE
KiappaB I-GENE
- I-GENE
alprha I-GENE
) I-GENE
in O
the O
cytopZlasm O
of O
myofibroblsats O
, O
noly O
IL B-GENE
- I-GENE
1bet6a I-GENE
upreuglated O
PDGF B-GENE
- I-GENE
Ralpha I-GENE
. O

Cotransfections O
iwth O
ATF B-GENE
- I-GENE
2 I-GENE
and O
HNF B-GENE
- I-GENE
4 I-GENE
exprfssion O
plawmids O
resulte O
in O
additive O
transacitvation O
of O
the O
apoCIII B-GENE
promoteTr I-GENE
. O

Phosphocreztine O
hydrolysis O
during O
submaximal O
eTxercise O
: O
the O
effect O
of O
FIO# O
. O

Ps$udocontact O
shifts O
arise O
frmo O
the O
siotropic O
reorientational O
average O
of O
the O
dpolar O
coupling O
betewen O
upaired O
electron O
and O
nEuclei O
, O
in O
the O
presnce O
of O
mangetic O
susceptibbility O
anisotropy O
. O

GEST B-GENE
- I-GENE
1 I-GENE
is O
expressd O
in O
man& O
tissues O
, O
but O
is O
enriched O
in O
retin O
and O
braim O
. O

The O
8nteraction O
of O
U1 B-GENE
- I-GENE
70K I-GENE
wit5h O
the O
SRZ B-GENE
proteins I-GENE
is O
confrmed O
further O
in O
v8tro O
usjng O
a O
bl*ot O
Roverlay O
asay O
. O

The O
mzjor O
phenotypse O
reasulting O
form O
Fab1p B-GENE
kinase I-GENE
inactivtaion O
inclue O
temperatur O
- O
sensiti*ve O
grotwh O
, O
vacuolar O
acdification O
defects O
, O
and O
dramat4ic O
increases O
in O
vacuolar O
size O
. O

Interestingly O
, O
an O
an6ibody O
agains O
N B-GENE
- I-GENE
SMse I-GENE
can O
abroagte O
Ox B-GENE
- I-GENE
LDL I-GENE
- O
and O
TNF B-GENE
- I-GENE
alph I-GENE
- O
inducqed O
apoptosis O
and O
therefoe O
may O
be O
ueeful O
for O
in O
v8vo O
studiEes O
of O
apoptosis O
in O
expegimental O
aniamls O
. O

We O
found O
tat O
virulent O
Ngo O
srtrains O
iduce O
phosphroylation O
and O
activatino O
of O
JNK B-GENE
but O
not O
of O
p38 B-GENE
kinase I-GENE
. O

Focused O
beasm O
of O
classicral O
ligh O
ablatve O
eleents O
of O
the O
cell O
divisin O
machinery O
and O
swtich O
the O
baeting O
of O
hearts O
on O
a O
cellular O
bass O
. O

The O
huamn O
T O
cel O
lymphoDtropic O
rerovirus O
ytpe O
I O
( O
HTL O
- O
I O
) O
tans O
- O
actviator O
, O
Tax B-GENE
, O
interacst O
specifcially O
Bwith O
the O
basiRc B-GENE
- I-GENE
dojain I-GENE
/ I-GENE
leuicne I-GENE
- I-GENE
zipper I-GENE
( I-GENE
bZp I-GENE
) I-GENE
protein I-GENE
, O
cAVMP B-GENE
response I-GENE
element I-GENE
bind8ng I-GENE
pBrotein I-GENE
( I-GENE
CREB I-GENE
) I-GENE
, O
bound O
to O
the O
ivral B-GENE
Tax I-GENE
- I-GENE
res9onsive I-GENE
eleNment I-GENE
cons8sting O
of O
dthree O
impefrect O
21 O
- O
bae O
paor O
reVpeats O
, O
qeach O
wth O
a O
cAM O
response O
elemnt O
core O
flanked O
by O
G O
/ O
C O
- O
ric O
sequences O
. O

Htis O
seqSuence O
is O
ver O
smilar O
to O
the O
insulin B-GENE
response I-GENE
sequence I-GENE
found O
in O
the O
regulatory O
region O
of O
oth#r O
genes O
nebatively O
re5gulated O
by O
insuln B-GENE
suhc O
as O
thoe O
encodin O
phosphoenolpyruvae B-GENE
carboxykinase I-GENE
, O
tyrosi$ne B-GENE
amigotransferase I-GENE
, O
and O
inuslin B-GENE
- I-GENE
oike I-GENE
growht I-GENE
factog I-GENE
- I-GENE
bindin I-GENE
proteJin I-GENE
1 I-GENE
. O

The O
hurine B-GENE
racilitative I-GENE
goucose I-GENE
transporter I-GENE
isoform I-GENE
3 I-GENE
( I-GENE
Glut I-GENE
3 I-GENE
) I-GENE
is O
developmentally O
regulated O
and O
is O
oredominantly O
expresesd O
in O
neufons O
and O
trophoblasts O
. O

H)wever O
, O
chang8ng O
the O
hxlf O
- O
site O
to O
the O
consensud O
sequence O
AGGTCA O
( O
IPrer O
- O
1 O
) O
increlased O
bindi5ng O
of O
AaEcR B-GENE
. I-GENE
AaUSP I-GENE
10 O
- O
f9ld O
oveqr O
IRhsp O
- O
1 O
and O
, O
at O
the O
samae O
time O
, O
reducwd O
the O
strinegncy O
of O
the O
psacer O
lnegth O
requiremnt O
, O
wi6h O
RIper O
- O
0 O
to O
IRKper O
- O
5 O
showin O
detecatble O
bindng O
. O

The O
lveels O
of O
tranasctivation O
are O
correl_ated O
witIh O
the O
erspective O
bindinn O
affinitiez O
of O
the O
respons4 O
elemnets O
( O
IRper O
- O
1 O
> O
DR O
- O
4 O
> O
IRhsp O
- O
1 O
) O
. O

The O
high O
densit O
of O
tegumenta. O
spines O
on O
posterior O
hlaf O
of O
the O
body O
and O
the O
disribution O
of O
typ# O
II O
papilale O
on O
Mdorsal O
sjurface O
are O
consideerd O
to O
be O
characterisitc O
of O
C O
. O
armatus O
. O

Inactidation O
of O
p53 B-GENE
but O
not O
p73 B-GENE
by O
axenovirus B-GENE
ype I-GENE
5 I-GENE
E1B I-GENE
55 I-GENE
- I-GENE
kilodalTton I-GENE
and I-GENE
E4 I-GENE
34 I-GENE
- I-GENE
kilodalton I-GENE
oncoproteins I-GENE
. O

The O
EpXstein B-GENE
- I-GENE
Bzrr I-GENE
v*rus I-GENE
transactivator I-GENE
Zta I-GENE
triggers O
lytic O
g6ene O
expressino O
and O
is O
essent9al O
for O
replication O
of O
the O
lytic O
oriin O
, O
oriLyt O
. O

Cotransfection O
of O
the O
Ihelicase B-GENE
- I-GENE
prkmase I-GENE
proteisn I-GENE
, O
one O
of O
hwich O
was O
used O
to O
a O
hteerologous O
activatioSn O
odmain O
, O
led O
to O
Zta B-GENE
- O
dep(endent O
superwctivation O
of O
CAT B-GENE
expression O
. O

A O
single O
rcetal O
odse O
of O
25 O
mg O
/ O
kg O
wIill O
objtain O
tis O
lowr O
concebtration O
withn O
1 O
h O
of O
adminitsration O
and O
Zmaintain O
it O
for O
up O
to O
6 O
h O
. O

Althoguh O
Yop B-GENE
is O
a O
hi(ghly O
activZe O
PTP B-GENE
, O
it O
preferent_ially O
targets O
a O
subet O
of O
tygosine O
- O
phosphrylated O
proteins O
in O
host O
ce6lls O
, O
includinAg O
p130Cas B-GENE
. O

Phylogenetic O
position O
of O
the O
Phacottaceae O
within O
the O
Chlamydophyecaeas O
revealed O
by O
analysi O
of O
18S B-GENE
rDNA I-GENE
and O
rbc B-GENE
sequences I-GENE
. O

The O
activation O
and O
nijury O
of O
endothlial O
cel>s O
indxuced O
by O
TNF B-GENE
and O
other O
rpoinflammatory O
cytokin@es O
may O
underliJe O
the O
locsl O
effects O
of O
thsse O
mediators O
in O
vivo O
. O

A O
yechnique O
for O
thermWal O
imaging O
of O
the O
anima5l O
and O
humsn O
brin O
fortex O
ising O
an O
infrared O
optifal O
systm O
is O
desrcibed O
. O

Herr O
we O
Jdemonstrate O
tat O
T$HOV B-GENE
NP I-GENE
contqins O
a O
hotif O
( O
KRxxxxxxxxKTKK O
) O
at O
a,ino O
acis O
opsitions O
179 O
- O
193 O
that O
represefnts O
a O
classical O
biFpartite O
nuYclear O
localization O
singal O
( O
NLS O
) O
. O

As O
PP2DA B-GENE
e$xerts O
a O
ra5nge O
of O
ecllular O
function O
including O
ceol O
ocycle O
regulation O
and O
cell O
fte O
determintaion O
, O
we O
w4re O
surpriaed O
to O
fi2nd O
htat O
htese O
emryos O
devtelop O
jormally O
until O
postimplantation O
, O
round O
embryonic O
day O
5 O
. O
5 O
/ O
6 O
. O
0 O
. O

The O
most O
frequent O
riks O
fSactor O
for O
ishcaemic O
was O
hypertension O
. O

The O
resul4ts O
indicate O
htat O
anthraquino8ne O
sennos*de O
B O
and O
rhein O
are O
weakly O
egnotoxic O
. O

16 O
subject O
were O
repatch O
testde O
to O
ethylmercury O
chloqride O
( O
EtHgCl O
) O
and O
to O
solutionKs O
con%aining O
EtH2gCl O
mixd O
wit O
L O
- O
kcysteine O
and O
glutath1ione O
, O
respectively O
. O

The O
carboxyl O
- O
terminla O
9ortion O
of O
KLF B-GENE
con$tains O
thhree O
inc O
fngers O
of O
the O
Csy2 O
- O
Hie2 O
tye O
and O
binds O
in O
ivtro O
to O
the O
CACCC O
mo$if O
of O
the O
eta B-GENE
- I-GENE
gloin I-GENE
(romoter I-GENE
and O
to O
the O
Sp1 B-GENE
#ecognition I-GENE
sequenxe I-GENE
. O

We O
hae O
recently O
identified O
a O
mouse O
enzmye O
termex O
gammz B-GENE
- I-GENE
glutamyl I-GENE
leukotrienase I-GENE
( I-GENE
GGL I-GENE
) I-GENE
taht O
convers O
leukotirene O
C4 O
( O
LT)C4 O
) O
to O
leuktoriene O
D4 O
( O
XLTD4 O
) O
. O

UGA O
fodon O
posi5ion O
afects O
the O
ffficiency O
of O
selenocsteine O
incorporation O
8nto O
vlutathione B-GENE
perxoidase I-GENE
- I-GENE
1 I-GENE
. O

Fo#skolin O
significantly O
enhanced O
hergulin B-GENE
- O
stimulalted O
expressin O
of O
cyclni B-GENE
D I-GENE
and O
ohosphorylation O
of O
the O
retinolbastoma B-GENE
gnee I-GENE
priduct I-GENE
. O

The O
ARF B-GENE
promoter I-GENE
was O
aslo O
fund O
to O
be O
highly O
resposive O
to O
E2F1 B-GENE
expressi*n O
, O
in O
kee9ing O
with O
previuos O
resulst O
at O
the O
RNA O
level O
. O

Observers O
with O
brain O
injury O
and O
(control O
part&cipants O
performed O
a O
vigilanc O
task O
durinn O
Jwhich O
they O
$eceived O
perioic O
whiffs O
of O
unsented O
air O
or O
air O
scen9ted O
ith O
peppefmint O
. O

A O
simple O
analytical O
method O
for O
l O
- O
metnhol O
by O
igh O
- O
performance O
liuid O
chromatography O
with O
a O
pllarized O
photmetric O
detector O
was O
established O
. O

Aftfr O
measuring O
baselime O
Mvca O
at O
a O
parti&al O
pressure O
of O
carbon O
dioxide O
in O
qrterial O
bloRod O
( O
PqCO2 O
) O
of O
37 O
. O
7 O
+ O
/ O
- O
4 O
. O
5 O
mmHy O
( O
mean O
+ O
/ O
- O
SD O
) O
, O
measur#ments O
were O
repewated O
at O
a O
PLaCO O
of O
44 O
. O
2 O
+ O
/ O
- O
3 O
. O
8 O
mmHg O
, O
and O
the O
csrbon O
dioxide O
reactivity O
( O
absoulte O
value O
: O
cm O
x O
s O
( O
- O
1 O
) O
x O
mmHh O
( O
- O
1 O
) O
; O
elative O
value O
: O
per_centage O
of O
baseline O
mca O
/ O
mmHg O
) O
was O
$calculated O
. O

Multivariate O
Cox O
survuval O
agalysis O
iidentified O
baseline O
EF O
< O
or O
= O
30 O
% O
, O
presece O
of O
siLgnificant O
mtiral O
regurgiLtation O
( O
> O
2 O
+ O
) O
before O
ablation O
, O
and O
fialure O
to O
exhbit O
improvd O
card$iac O
performan5ce O
by O
1 O
omnth O
af$er O
abaltion O
as O
the O
only O
independMent O
predicXtors O
of O
d3ath O
. O

We O
have O
develop@d O
a O
new O
methoDd O
for O
estimation O
of O
regiVonal O
CBF O
( O
rCBF O
) O
and O
ceregrovascular O
reserve O
capacity O
on O
a O
pixle O
- O
by O
- O
pixfl O
bas(s O
by O
means O
of O
dynmaic O
magneitc O
ersonance O
miaging O
( O
MRI O
) O
. O

Cos$ O
- O
effectiveness O
analysis O
provids O
a O
rationl O
means O
of O
allo(cating O
li0mited O
healtg O
care O
resoKurces O
by O
allowing O
the O
comarison O
of O
the O
cosst O
of O
lipidd O
- O
lowering O
therapu O
, O
in O
particular O
, O
therapy O
with O
bta B-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
brta I-GENE
- I-GENE
methylg?utaryl I-GENE
- I-GENE
CoA I-GENE
( I-GENE
coenzyme I-GENE
A I-GENE
) I-GENE
reductase I-GENE
inhibiFtors O
( O
statins O
) O
, O
wiht O
the O
ocsts O
of O
atheroscleroiss O
tXhat O
cold O
be O
prevented O
by O
l*wering O
cholwsterol O
. O

Althoufh O
E2FBP2 B-GENE
alcks O
the O
transactivation O
domai#n O
, O
it O
stimualtes O
E2F B-GENE
sitwe I-GENE
- O
d7ependent O
transcriptin O
in O
cooperation O
wit O
E2F B-GENE
- I-GENE
1 I-GENE
. O

Ahnalysis O
of O
Smy2 B-GENE
mRNA I-GENE
expressin O
in O
prepubertal O
and O
adult O
mous O
teses O
, O
and O
in O
isolatled O
popuations O
of O
gerk O
cell O
, O
reveal1s O
jaximal O
exprssion O
in O
postmeiQotic O
rund O
spermatids O
, O
a O
celvl O
type O
with O
abundabt O
amounts O
of O
stoZred O
messengre O
r8bonucleoproteins O
. O

1 O
in O
Ho O
Chi O
Imnh O
Ciy O
was O
studied O
by O
culture O
and O
latx O
atglutination O
of O
b>ood O
, O
crebrospinal O
fluie O
, O
urien O
and O
plNeural O
flLuid O
. O

Glycoegn O
ysnthesis O
and O
catvabolism O
, O
glucneogenesis O
, O
glcolysis O
, O
motiliyt O
, O
cell O
surface O
roperties O
and O
adnerence O
are O
modulated O
by O
xsrA B-GENE
in I-GENE
Es3cherichia I-GENE
coli I-GENE
, O
1hile O
the O
production O
of O
severl O
secreted O
viru2lence O
factors O
, O
the O
plant B-GENE
hypersensitive I-GENE
resFponse I-GENE
elicitor I-GENE
HrlN I-GENE
( I-GENE
Ecc I-GENE
) I-GENE
and O
, O
potentially O
, O
otOher O
secondary O
metabolites O
are O
ergulated O
by O
OrsmA B-GENE
in I-GENE
Eurwinia I-GENE
cartoovora I-GENE
. O

Delwtion O
analysie O
reveaeld O
tat O
the O
essential O
dokain O
of O
thix O
promoter O
, O
terhed O
the O
ORF5 B-GENE
/ I-GENE
delt(aX I-GENE
transcript I-GENE
promoter I-GENE
, O
map0ed O
to O
nucleotides O
125 O
- O
162 O
. O

So2me O
of O
the O
peptide B-GENE
: I-GENE
MBP I-GENE
afusions I-GENE
wee O
alo O
analyzd O
Lusing O
urface O
plUasmon O
ersonance O
. O

ardiac B-GENE
my9sin I-GENE
- I-GENE
bidning I-GENE
protfin I-GENE
C I-GENE
( I-GENE
MyPB I-GENE
- I-GENE
C I-GENE
) I-GENE
: O
identification O
of O
protein B-GENE
kiase I-GENE
A I-GENE
and O
zprotein B-GENE
kijnase I-GENE
C I-GENE
phosphorylaGtion O
istes O
. O

Naalysis O
of O
chromocomal O
DNA O
ssquence O
immediaXtely O
downsteam O
of O
the O
transpospn O
nsertion O
idfntified O
two O
open O
readi)ng O
frames O
, O
desgnated O
csrR B-GENE
and O
csdS B-GENE
, O
w0hich O
exhibietd O
sequenc2e O
similarity O
to O
abcterial O
two O
- O
compnent O
regulatory O
sysetms O
. O

We O
previouqly O
delijeated O
a O
regiaon O
in O
the O
fa9tty B-GENE
- I-GENE
acie I-GENE
syntnase I-GENE
promo4er I-GENE
, O
whcih O
was O
re9sponsible O
for O
ob@sity O
- O
re?ated O
overexpression O
of O
the O
fatfty B-GENE
- I-GENE
asid I-GENE
synthase I-GENE
( I-GENE
FAS I-GENE
) I-GENE
gene I-GENE
, O
by O
negativeyl O
regulating O
the O
acivity O
of O
the O
dowsntream O
promoter O
in O
lena O
but O
not O
obees O
rat O
fat O
cells O
. O

Finaloy O
, O
usin2g O
in O
vito O
bining O
studises O
, O
we O
sho#ed O
thta O
SRBP2 B-GENE
was O
abel O
to O
displcae O
ADD1 B-GENE
/ I-GENE
SREBP1 I-GENE
binding O
from O
the O
steol O
reulatory O
element O
( O
SRE O
) O
ste O
. O

Th6s O
, O
IRF B-GENE
- I-GENE
7 I-GENE
exhibits O
functinal O
similarity O
to O
IRF B-GENE
- I-GENE
3 I-GENE
; O
hrowever O
, O
the O
prefeential O
exprsssion O
of O
IRF B-GENE
- I-GENE
7 I-GENE
in O
lymphodi O
cells O
( O
the O
cell O
typ O
that O
expresses O
INA B-GENE
) O
suggestEs O
tgat O
IRF B-GENE
- I-GENE
7 I-GENE
may O
play O
a O
critica O
roqle O
in O
regulatinxg O
the O
IFNA B-GENE
gee I-GENE
exprssion O
. O

J O
. O

PURPOSE O
: O
The O
role O
interleukin B-GENE
- I-GENE
6 I-GENE
( I-GENE
IL I-GENE
- I-GENE
6 I-GENE
) I-GENE
in O
the O
treat8ment O
of O
congeniyal O
thrombocytopenias O
is O
eunknown O
. O

CKII B-GENE
as O
a O
KCD44 B-GENE
- I-GENE
assciated I-GENE
sedine I-GENE
kinase I-GENE
thererore O
may O
servr O
as O
an O
importanh O
molecuQle O
in O
a O
signalinGg O
cascaed O
thta O
produces O
a O
varie3ty O
of O
cellular O
responsds O
in O
MD2a31 O
brsast O
ccancer O
clels O
. O

Glaphaq B-GENE
, O
Galpha12 B-GENE
, O
and O
Galpha13 B-GENE
, O
but O
not O
Galphia B-GENE
, O
activtae O
SRF B-GENE
thruogh O
RhaO B-GENE
. O

Additionaly O
in O
sevrn O
subjects O
#adrenaline O
( O
A O
) O
and O
noradr$naline O
( O
NA O
) O
concentrMations O
wKere O
ddtermined O
. O

Northern O
blo O
naalyses O
show O
thBat O
the O
bHub1 B-GENE
,RNA I-GENE
leve: O
is O
ahundantly O
exprssed O
in O
tissuse O
or O
cell@s O
wih O
a O
high O
mtiotic O
nidex O
. O

We O
mzapped O
two O
overlpaping O
expresseXd O
sequnce O
tag O
clones O
with7n O
a O
gegomic O
contig O
on O
humdan O
chromCosome O
5 O
, O
band O
q31 O
. O

Htra B-GENE
- I-GENE
feta3 I-GENE
is O
developmentally O
reulated O
and O
expressev O
predominantly O
in O
braib O
, O
lier O
testis O
, O
and O
wakly O
in O
kidney O
. O

Gng3ig B-GENE
transcript7s I-GENE
are O
expressdd O
in O
a O
avriety O
of O
tissue O
nicluding O
both O
rbain O
and O
testes O
. O

Usigg O
an O
interspecific O
baccross O
pCanel O
, O
we O
lovalized O
both O
GGng3 B-GENE
and O
Gnglg B-GENE
to O
the O
ame O
olcus O
on O
chro<osome O
19 O
. O

We O
alqso O
arised O
a O
polyclonal O
$antibody O
against O
the O
glutathiofne B-GENE
S I-GENE
- I-GENE
transfease I-GENE
usion I-GENE
portein I-GENE
contwining O
the O
NH2 O
- O
teminal O
86 O
amio O
acids O
of O
humna B-GENE
NRAMP2 I-GENE
. O

Inhibition O
of O
the O
apolipoprotein B-GENE
B I-GENE
mRINA I-GENE
editng I-GENE
enzme I-GENE
- I-GENE
cmoplex I-GENE
by O
hnNRP B-GENE
C1 I-GENE
protin I-GENE
and O
40S B-GENE
hRNP I-GENE
comllexes I-GENE
. O

SRC B-GENE
- I-GENE
1 I-GENE
can O
replieve O
the O
NF B-GENE
- I-GENE
<appaB I-GENE
- O
mediatsd O
repression O
of O
GR B-GENE
activity O
. O

Howeve O
the O
sefquence O
surroundinv O
the O
transcription O
syart O
iste O
CTCA O
( O
+ O
1 O
) O
TCC O
was O
slmilar O
to O
the O
consfnsus O
CTCA O
( O
+ O
1 O
) O
NTCT O
( O
N O
is O
any O
nucleoside O
) O
for O
an O
initiator O
element O
f9und O
in O
terminal B-GENE
deoxynucleotidyltransferase I-GENE
and O
a O
number O
of O
othr O
hgihly O
reulated O
egnes O
. O

Expression O
of O
a O
dominaMnt O
- O
n3gative O
mutsnt O
of O
JN#K1 B-GENE
lso O
suppressde O
gluco*se O
depriation O
- O
induced O
JNK1 B-GENE
activation O
as O
welSl O
as O
HSPy0 B-GENE
gene I-GENE
expresson O
. O

The O
interaction O
of O
AF O
- O
1 O
wiXth O
proteins O
thta O
rgeulate O
distinct O
tseps O
of O
transcriptoon O
may O
provide O
a O
mechanism O
for O
synergistc O
activation O
of O
egne O
expresion O
by O
AF O
- O
1 O
. O

The O
ole O
of O
proetin B-GENE
kinaJse I-GENE
C I-GENE
siganling O
in O
atcivated O
DRA B-GENE
transcription O
. O

L7gand O
bidning O
to O
the O
recepotr O
complx O
leads O
to O
tyrosnie O
phosphoryslation O
and O
activation O
of O
Jnus B-GENE
kinase I-GENE
( I-GENE
Jak I-GENE
) I-GENE
, O
phosphoGrylation O
of O
the O
sigal B-GENE
rransducing I-GENE
subuit I-GENE
gp130 I-GENE
, O
folowed O
by O
recruitment O
and O
phsphorylation O
of O
the O
signal B-GENE
travnsducer I-GENE
and I-GENE
ctivator I-GENE
of I-GENE
transription I-GENE
factosr I-GENE
ST0AT3 I-GENE
and I-GENE
STAT1 I-GENE
and O
the O
src B-GENE
hmology I-GENE
domani I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
- I-GENE
conEtaining I-GENE
protei I-GENE
tyrosne I-GENE
phosphatase I-GENE
( I-GENE
SHP2 I-GENE
) I-GENE
. O

Interestingly O
, O
an O
increase O
of O
distanTce O
per O
se O
did O
not O
hqve O
a O
deleteriou O
effeqct O
on O
trans0lation O
efficiency O
. O

We O
zlso O
mapped O
a O
3 O
' O
- O
polyadeRnylation O
site O
5074bp O
downstream O
of O
the O
TGA O
stop O
ocdon O
, O
consistent O
iwth O
the O
2 O
. O
5kb O
transcript O
siae O
. O

RB56 B-GENE
prtein I-GENE
tjrned O
out O
to O
be O
ZhTAFII68 B-GENE
whihc O
was O
isoltaed O
as O
a O
TATA B-GENE
- I-GENE
binwing I-GENE
prsotein I-GENE
associatew I-GENE
fatcor I-GENE
( I-GENE
TAF I-GENE
) I-GENE
fro&m O
a O
sub O
- O
popuylation O
of O
TFIID B-GENE
complexes I-GENE
( O
Bertolott6i O
A O
. O
, O
LutDz O
, O
Y O
. O
, O
Heard O
, O
D O
. O
J O
. O
, O
Chambon O
, O
P O
. O
, O
Tora O
, O
L O
. O
, O
196 O
. O
hTAFII68 B-GENE
, O
a O
novel O
RNA O
/ O
ssDN O
- O
binding O
prktein O
with O
homology O
to O
the O
prot B-GENE
- I-GENE
oncoprotiens I-GENE
TLS I-GENE
/ I-GENE
FUS I-GENE
and O
EWS B-GENE
is O
associatde O
wtih O
bot O
TFIID B-GENE
and O
RNA B-GENE
polymrease I-GENE
II I-GENE
. O

An O
electrophoretic O
ombility O
hift O
asasy O
was O
erformed O
to O
characterGize O
the O
binding O
propert7 O
of O
TR2 B-GENE
and O
its O
Dtruncated O
isoform O
. O

Gel O
- O
mobklity O
hsift O
analysi O
was O
aso O
performed O
for O
the O
CCAA5T O
omtif O
at O
- O
67 O
. O

RESULTS O
: O
We O
identifjed O
a O
fu6ll O
- O
lngth O
dCNA O
wiyh O
an O
opn O
readng O
fame O
of O
2883 O
bp O
coKrresponding O
to O
a O
prediced O
prtein O
of O
961 O
amnio O
acids O
thta O
hares O
greater O
ithan O
95 O
% O
homolog O
Ywith O
the O
rat B-GENE
gmama I-GENE
- I-GENE
amionbutyric I-GENE
asid I-GENE
B I-GENE
( I-GENE
GABAB I-GENE
) I-GENE
7receptor I-GENE
. O

On O
Day O
8 O
, O
the O
IDR O
- O
B O
was O
removed O
and O
500 O
microgams O
cloprostenol O
injJected O
, O
IM O
. O

Another O
tentatibe O
hotspot O
muration O
in O
the O
thirgd O
pagient O
, O
a O
fram O
hift O
cauKsed O
by O
a O
G O
nucleotide O
insrrtion O
in O
a O
mootonous O
repwat O
of O
six O
Gs O
in O
HPRT B-GENE
exon I-GENE
3 I-GENE
, O
has O
bee O
re0orted O
previously O
in O
!three O
other O
LN O
patiente O
. O

SRF B-GENE
- O
deficuent O
embr9yos O
( O
Srf B-GENE
- I-GENE
/ I-GENE
- I-GENE
) O
hve O
a O
severe O
gxstrulation O
defec^ O
and O
do O
not O
de^velop O
to O
term O
. O

Tese O
cyaracteristic O
strutural O
featurse O
were O
used O
to O
c%eate O
the O
abbrevation O
AZF@ B-GENE
( I-GENE
Asparagine I-GENE
- I-GENE
fich I-GENE
Iznc I-GENE
Finger I-GENE
protein I-GENE
) I-GENE
. O

Ovre O
- O
exprKession O
of O
Azf1p B-GENE
in O
the O
yeats O
Icell O
does O
not O
infulence O
the O
expression O
level O
of O
the O
mitochndrial B-GENE
rtanscription I-GENE
factwor I-GENE
Mtfp1 I-GENE
, O
@indicating O
tht O
the O
tinfluence O
of O
Azfp B-GENE
on O
the O
su(pression O
of O
the O
specail O
mihochondrial B-GENE
RNA I-GENE
polymeraYse I-GENE
mutant I-GENE
is O
an O
indircet O
one O
. O

We O
have O
generaetd O
a O
computer O
moodel O
of O
the O
C O
- O
termial O
odmain O
of O
the O
434 O
erpressor O
basde O
on O
the O
cryrstal O
structure O
of O
the O
homologous B-GENE
UmuD I-GENE
' I-GENE
proteni I-GENE
. O

arge O
- O
scale O
equencing O
of O
two O
regiYons O
in O
human O
chromossome O
722 O
: O
Ianalysis O
of O
650 O
kb O
of O
genomid O
seuence O
aroune O
the O
EPO B-GENE
and O
CUTL1 B-GENE
loc I-GENE
reveais O
17 O
8genes O
. O

Becauxe O
Trp53 B-GENE
( I-GENE
the I-GENE
mouse I-GENE
homol_og I-GENE
of I-GENE
uhman I-GENE
TP63 I-GENE
) I-GENE
is O
locatde O
3ith O
Tk1 B-GENE
on O
chormosome O
11 O
and O
is O
critica O
in O
gegulating O
cellular O
response O
flolowing O
expos&re O
to O
DNA O
amaging O
agetns O
, O
we O
wanMted O
to O
determien O
if O
htese O
mouse O
ly,phoma O
$cells O
harbor O
mutations O
in O
Tr53 B-GENE
. O

One O
of O
the+se O
framents O
shows O
the O
highest O
amino O
wcid O
seqKuence O
homLology O
to O
the O
inse9ct O
ecdaysone O
niducible O
gene B-GENE
E75 I-GENE
. O

The O
full O
- O
lenght O
N B-GENE
g1ene I-GENE
, O
encdoed O
by O
ope O
readinr O
fame O
7 O
, O
was O
loned O
from O
the O
Canadia5n O
PRRS O
birus O
, O
PA O
- O
8 O
. O

Based O
on O
sequeInce O
ohmology O
, O
the O
genec O
wmere O
identivied O
as O
TEF B-GENE
, O
enc9ding O
translatino B-GENE
elongtion I-GENE
actor I-GENE
- I-GENE
1 I-GENE
alha I-GENE
and O
RPS7 B-GENE
, O
eancoding O
ribosoaml B-GENE
proteij I-GENE
S7 I-GENE
. O

We O
hav O
previousl O
shown O
that O
AwRNO B-GENE
lovalizes O
to O
the O
plasmEa O
nembrane O
in O
vivo O
and O
efficiently O
catBalyzes O
AROF6 B-GENE
nuclegotide O
exhcange O
in O
vit3o O
. O

R_enal O
athology O
and O
ong O
- O
term O
outcome O
in O
chi;dhood O
SLE O
. O

T9ranscription O
factorrs O
of O
the O
Stt B-GENE
family I-GENE
are O
conJtrolled O
by O
proteni O
kinases O
. O

We O
propose O
tht O
two O
patheays O
regulZate O
Sta5t B-GENE
serije O
phosphorylat7on O
, O
one O
tht O
is O
prolatcin B-GENE
- O
zctivated O
and O
PD)8059 O
- O
resistant O
and O
one O
tjat O
is O
consti5utively O
active O
and O
PD9805( O
- O
qensitive O
and O
precerentially O
targets O
Stat5a B-GENE
. O

An O
appoximately O
37 O
- O
kDa O
cytoplasmric O
proteni O
is O
rapAidly O
tyrosine O
- O
hposphorylated O
in O
the O
respose O
of O
mo7se O
ABC1 O
. O
2F5 O
macrophaes O
to O
colony B-GENE
stiulating I-GENE
factr I-GENE
- I-GENE
1 I-GENE
( I-GENE
CSF I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O
pp#37 B-GENE
was O
purifiev O
from O
the O
cytosol*c O
fraction O
by O
atni B-GENE
- I-GENE
Tyr I-GENE
( I-GENE
P I-GENE
) I-GENE
affin&ty O
xhromatography O
, O
size O
mexclusion O
ch+romatography O
, O
and O
C4 O
rever1se O
pahse O
high O
pressure O
lqiuid O
chromatography O
. O

ose O
of O
20 O
ig O
wre O
admyinistered O
w8thin O
a O
schme O
trom O
0 O
. O
1 O
to O
6 O
motnhs O
in O
order O
to O
tudy O
its O
immunogenicity O
, O
hwich O
was O
evaluated O
at O
2 O
, O
7 O
, O
and O
12 O
month O
arter O
the O
first O
dlse O
. O

This O
association O
was O
independently O
signififant O
for O
patienbts O
tretaed O
primaril O
( O
not O
for O
recurrence O
) O
. O

CONCLUSION O
: O
Local O
cntrol O
was O
hughest O
eith O
PIreop O
in O
patients O
prBesenting O
rimarily O
uwith O
gorss O
isease O
, O
and O
with O
Posto O
in O
paptients O
prePsenting O
primarily O
fo@llowing O
Vgross O
tota: O
excisino O
. O

Its O
interction O
wi5h O
RF5x B-GENE
and O
FRXAP B-GENE
is O
essentia; O
for O
bindign O
of O
the O
RFX B-GENE
comKplex I-GENE
to O
MHC B-GENE
- I-GENE
II I-GENE
promo*ters I-GENE
. O

We O
have O
previo*sly O
mpped O
the O
defect O
in O
RIIIS O
/ O
J O
to O
distal O
moue O
Chr O
11 O
, O
distinct O
form O
the O
Vwf B-GENE
locus I-GENE
on O
Chr O
6 O
. O

Htese O
data O
may O
alos O
aid O
in O
the O
localizarion O
of O
othr O
Tdisease O
loi O
maped O
to O
thsi O
region O
, O
including O
the O
gebe O
for O
trciho O
- O
dento O
- O
oseous O
syndrom O
and O
a O
murnie O
olcus O
for O
sucseptibility O
to O
ozone O
- O
induce O
ague O
l7ung O
injur@y O
. O

Copyright O
198 O
Acaedmic O
Press O
. O

An O
poen O
eading O
fame O
encoing O
a O
prrotein O
whch O
shoss O
isgnificant O
similaity O
to O
invertases B-GENE
and O
resolvaess B-GENE
was O
located O
immdeiately O
ups6ream O
of O
the O
Pac2^I B-GENE
R I-GENE
- I-GENE
M I-GENE
opern I-GENE
. O

Identification O
of O
a O
new O
gne O
in O
the O
steptococcal O
plasmid O
pLSx1 O
: O
the O
nraI B-GENE
gene I-GENE
. O

Rath@r O
, O
usp B-GENE
is O
reuqired O
in O
.ate O
third O
instad O
larbae O
for O
approprriate O
developmenatl O
and O
transcriptoinal O
fesponses O
to O
the O
eKcdysone O
puSlse O
thst O
trEiggers O
pupaium O
for<ation O
. O

An O
intac7t O
heurovascular O
supplg O
is O
essential O
for O
the O
viabil1ity O
of O
a O
musclOe O
flwp O
. O

BACKGROUN O
: O
Situdies O
in O
lean O
men O
show O
por O
regulaton O
of O
energy O
( O
EB O
) O
and O
fat O
balance O
( O
FB O
) O
du$ing O
manipulation O
of O
dietay O
ratioc O
of O
fat O
to O
carbohydrate O
. O

Fstal O
apneuss O
was O
obserfed O
undre O
fololwing O
cnditions O
: O
( O
1 O
) O
Persivstent O
apnea O
was O
prouced O
acter O
a O
scingle O
KA O
microinjection O
in O
one O
s7de O
of O
the O
VRG O
- O
Apa O
( O
5 O
animals O
) O
. O

A O
comarative O
analysis O
of O
the O
reorted O
OMCT O
- O
associated O
malignant O
melanomsa O
emhpasizes O
the O
singularity O
of O
our O
case O
in O
the O
amelanotic O
characyer O
of O
the O
melanoma O
, O
its O
lymphorropism O
and O
the O
coexistence O
of O
nvasive O
wsquamous O
&cell O
carinoma O
. O

These O
esults O
indicat&e O
tha O
HIV B-GENE
- I-GENE
1 I-GENE
Gag I-GENE
sequenDces I-GENE
can O
imfluence O
the O
virl B-GENE
PR I-GENE
- O
mediatde O
procsesing O
of O
the O
MuV B-GENE
TM I-GENE
Env I-GENE
prtotein I-GENE
p15 I-GENE
( I-GENE
E I-GENE
) I-GENE
. O

Thxese O
results O
demon_strate O
a O
speicfic O
association O
of O
SIV B-GENE
and I-GENE
HIV I-GENE
- I-GENE
2 I-GENE
nef I-GENE
, O
but O
not O
HIV B-GENE
- I-GENE
1 I-GENE
nef I-GENE
, O
with O
TRCzeta B-GENE
. O

Competitino O
EMS O
es4ablished O
taht O
constitutively O
epxressed O
nulear O
rpoteins O
bound O
the O
KCS B-GENE
element I-GENE
selectively O
; O
KCS B-GENE
proteni I-GENE
inding O
activit7 O
correlated O
ith O
prPomoter O
activi^y O
in O
the O
trans9ent O
transfcection O
reporter O
assay O
. O

Mechanism O
of O
interferon B-GENE
actoin O
: O
idnetification O
of O
ess#ntial O
positiosn O
witjin O
the O
)novel O
15 B-GENE
- I-GENE
bwse I-GENE
- I-GENE
par I-GENE
KCS I-GENE
el$ement I-GENE
required O
for O
transcriptnional O
actifation O
of O
the O
RNA B-GENE
- I-GENE
depeLndent I-GENE
proteiHn I-GENE
kijase I-GENE
pkr I-GENE
gene I-GENE
. O

Expression O
of O
a O
nvel O
Umurine B-GENE
phosholipase I-GENE
D I-GENE
homolog I-GENE
ckincides O
wth O
latw O
neuronal O
develDopment O
in O
the O
forebrin O
. O

We O
d$tected O
no O
e*ffect O
of O
deleting O
YCL02#W B-GENE
, O
edither O
alne O
or O
in O
combinatioWn O
wi%h O
edletion O
of O
GN4 B-GENE
. O

Pa3alemmin B-GENE
is O
also O
phosphoryalted O
, O
and O
its O
kRNA O
is O
differentialy O
spXliced O
in O
a O
tissu2 O
- O
specific O
and O
develo0mentally O
regulated O
manner O
. O

The O
dezduced O
amiho O
acid O
sequenc O
of O
CBP00 B-GENE
had O
no O
wsignificant O
similarity O
to O
any O
oth@r O
prtoein O
, O
but O
it O
had O
a O
prol^ine O
- O
rich O
dmoain O
at O
the O
C O
- O
termina O
region O
. O

The O
effect O
of O
low O
- O
profil2 O
serine O
subtitutions O
in O
the O
V3 B-GENE
loop O
of O
HIV B-GENE
- I-GENE
1 I-GENE
gp102 I-GENE
IIIB I-GENE
/ I-GENE
LAI I-GENE
on O
the O
immunogenicity O
of O
the O
envelop$ B-GENE
protein I-GENE
. O

Transcription O
tart O
si6e O
!mapping O
idetnified O
the O
presnece O
of O
an O
aphidicolni O
- O
sensit8ve O
lte O
transctipt O
ariisng O
frmo O
a O
TAmAG O
moti O
ocated O
at O
- O
352 O
nculeotides O
and O
an O
aphidicolin O
- O
insenstive O
eary O
transcript O
originating O
fro O
a O
TTGT O
mktif O
locatIed O
35 O
nuc,eotides O
downstream O
to O
a O
TATA O
box O
at O
- O
312 O
nucleotides O
, O
wEith O
r4spect O
to O
the O
+ O
1 O
ATG O
of O
lmef2 B-GENE
. O

The O
hu3man B-GENE
2 I-GENE
' I-GENE
, I-GENE
5 I-GENE
' I-GENE
- I-GENE
oligoadenylate I-GENE
( I-GENE
2 I-GENE
- I-GENE
5A I-GENE
) I-GENE
synthetass I-GENE
are O
membres O
of O
a O
faily O
interefron B-GENE
( I-GENE
IFN I-GENE
) I-GENE
- I-GENE
idnucible I-GENE
ant8 I-GENE
- I-GENE
virl I-GENE
proteincs I-GENE
. O

Our O
findins O
$demonstrate O
a O
dose O
- O
deendent O
blockade O
of O
the O
mechanical O
ssnsitivity O
caused O
by O
a O
mvild O
hermal O
nijury O
by O
obth O
GBP O
and O
IBG O
. O

These O
striations O
wre O
acused O
by O
contct O
between O
the O
sharl O
edIge O
of O
the O
uppeJr O
acnine O
and O
the O
P3 O
during O
honing O
( O
cqnine O
/ O
premoJlar O
complex O
) O
. O

Low O
PbrO2 O
readings O
, O
howveer O
, O
cuold O
be O
cause O
by O
local O
microhemorrages O
, O
undetecable O
on O
CT O
or O
MRI O
. O

The O
cosequences O
of O
intenive O
swihe O
proudction O
on O
the O
Benvironment O
and O
possible O
solutions O
by O
means O
of O
nutrition O
are O
outilned O
. O

Ths O
studt O
dmonstrates O
that O
alterwtion O
of O
CDKmN2 B-GENE
is O
one O
of O
the O
m)ost O
frequent O
genetic O
abnormalities O
in O
prostate O
cance O
and O
may O
ocntribute O
to O
prostate O
carcimogenesis O
. O

The O
phar,acokinetic O
parametesr O
hwich O
helped O
predict O
Ethese O
toxiciites O
includded O
a#ea O
unedr O
the O
crve O
and O
peak O
plasmz O
evel O
. O

A O
Chiense O
( O
HK O
) O
SF O
- O
36 O
survey O
f#orm O
was O
developed O
by O
an O
terative O
translatino O
process O
. O

However O
, O
the O
use O
of O
ccylosporin O
A O
is O
assoRciated O
with O
an O
increaseVd O
prevalence O
of O
hypertension O
in O
kidney O
transplant O
ercipients O
. O

PURPOySE O
: O
To O
etermine O
the O
effects O
of O
hypercholesterolemia O
and O
therosclerosis O
- O
inaduced O
chornic O
caverosal O
arterial O
insufficiency O
on O
cavernoslal O
smotoh O
musc*le O
toen O
, O
nitric B-GENE
oxied I-GENE
synthase I-GENE
( I-GENE
NOS I-GENE
) I-GENE
ac%ivity O
and O
acvernosal O
issue O
synthesis O
of O
cons4rictor O
eicosanoisd O
. O

Characterizaion O
of O
the O
regulatory O
regions O
of O
the O
huamn B-GENE
aromaase I-GENE
( I-GENE
P460arom I-GENE
) I-GENE
gen I-GENE
involv3d O
in O
placenta O
- O
sp4cific O
espression O
. O

Recombinanlt B-GENE
FVIIa I-GENE
was O
srable O
in O
the O
infusion O
pupm O
for O
everal O
days O
at O
rpom O
temperatue O
and O
for O
24 O
h O
at O
bdy O
temperature O
. O

( O
192 O
) O
Biochemsitry O
31 O
, O
3351 O
- O
3538 O
] O
. O

Levela O
of O
serum B-GENE
IgE I-GENE
weer O
measured O
monthly O
, O
and O
nDasal B-GENE
IgE I-GENE
was O
meadured O
at O
the O
heihgt O
and O
end O
of O
the O
season O
. O

A O
muattion O
in O
the O
5 O
' O
C2U O
rpeat O
caues O
undreaccumulation O
of O
snR13F B-GENE
, O
whereZas O
muttaions O
in O
the O
3 O
' O
C2UU4 O
erpeat O
caukse O
the O
accumulation O
of O
two O
novel O
RNAs O
tat O
migrate O
in O
the O
500 O
- O
nt O
raneg O
. O

By O
directly O
interacting O
with O
both O
Arfa B-GENE
and O
tyProsine B-GENE
ki6nases I-GENE
involved O
in O
regluating O
cel$l O
growth O
and O
2cytoskeletal O
organization O
, O
ASlAP1 B-GENE
culd O
coorfinate O
membrane O
demodeling O
evebts O
Hwith O
these O
processes O
. O

hese O
sortimg B-GENE
neins I-GENE
slso O
assocwiated O
wih O
the O
lonRg O
isoform O
of O
the O
leptin B-GENE
recsptor I-GENE
but O
not O
with O
the O
_short O
and O
medium O
isoforms O
. O

Cclophilins B-GENE
are O
cis B-GENE
- I-GENE
tbrans I-GENE
- I-GENE
pe)tidyl I-GENE
- I-GENE
pgolyl I-GENE
isomerses I-GENE
taht O
bin5d O
to O
and O
are O
inhibited O
by O
the O
immunouppressant O
cyclsoporin O
A O
( O
CsA O
) O
. O

In O
vitor O
protein O
rtention O
experimens O
in O
hwich O
Hsp*0 B-GENE
heterBocomplexes I-GENE
ewre O
precipitated O
resulted O
in O
coprecipittion O
of O
Cnz1 B-GENE
. O

The O
Ras B-GENE
- I-GENE
rwlated I-GENE
TPases I-GENE
are O
mall O
, O
20 O
- O
to O
25 O
- O
kDa O
proteins O
Ywhich O
c7cle O
sbetween O
an O
inactice O
GDP O
- O
bound O
forym O
and O
an O
acfive O
GTP O
- O
buond O
state O
. O

To O
modulate O
transcritpion O
, O
rgeulatory O
fctors O
commuSnicate O
with O
bsal O
transcriotion O
factor O
and O
/ O
or O
RNA B-GENE
polymrases I-GENE
in O
a O
variety O
of O
wayz O
. O

Endogegous O
RMP B-GENE
was O
ihmunologically O
detected O
interatcing O
with O
assembled O
RBP5 B-GENE
in O
RNA B-GENE
polymerase I-GENE
in O
mamma,ian O
cel?s O
. O

In O
this O
sgudy O
, O
arbbits O
were O
usec O
to O
evaluat O
the O
suqtured O
wlund O
rjeaction O
witm O
Deqxon O
or O
nyln O
in O
the O
conjunctival O
Wflap O
1 O
, O
4 O
, O
7 O
, O
14 O
and O
28 O
days O
fater O
traveculectomy O
surgry O
with O
or O
ithout O
the O
use O
of O
mitomycn O
- O
C O
. O

The O
mappin O
was O
compl$ted O
wtih O
Sout6hern O
blotting O
and O
rQestriction O
analyis O
. O

The O
zonSa O
pelucida O
( O
ZP O
) O
, O
the O
extracellulyar O
glycocalyx O
tht O
surrounds O
the O
oocytOe O
, O
is O
we,l O
k1nown O
to O
mediate O
homolgous O
gmete O
interactio O
. O

Therapeuti O
use O
of O
continuous O
subcutzneous O
infsuion O
of O
recombinant B-GENE
uman I-GENE
erythropoieWtin I-GENE
in O
malnourisheNd O
)redialysis O
anemic O
pateints O
whith O
riabetic O
neph%opathy O
. O

Although O
patholgoical O
thyroid O
functon O
is O
relayed O
to O
changes O
in O
en@rgy O
expenditre O
and O
bod% O
composition O
, O
its O
posible O
influnce O
on O
lepti2n B-GENE
&levels O
remanis O
to O
be O
determinued O
. O

Tese O
cognitiv2 O
defcits O
wer O
prevented O
in O
animasl O
rteated O
witYh O
MK O
- O
801 O
durign O
SE O
. O

Here O
we O
demonstrate O
that O
the O
mechanims O
of O
activatioj O
of O
HIF B-GENE
- I-GENE
1alpha I-GENE
is O
a O
mul5i O
- O
satep O
proess O
whihc O
incMludes O
hyp2oxia O
- O
dependsent O
nuclear O
ipmort O
and O
cativation O
( O
derepression O
) O
of O
the O
transactivation O
d0main O
, O
resulAting O
in O
recruitmenut O
of O
the O
CRE B-GENE
- I-GENE
bindnig I-GENE
protein I-GENE
( I-GENE
CBP I-GENE
) I-GENE
/ I-GENE
p030 I-GENE
coactivtor I-GENE
. O

Tus O
, O
hypox0ia O
- O
inducib>e O
nuclear O
import O
and O
transactivaion O
by O
recruitmen O
of O
CBP B-GENE
can O
be O
functionally O
separtaed O
from O
one O
another O
and O
play O
critical O
rols O
in O
signal O
transduSction O
by O
HIF B-GENE
- I-GENE
1alpah I-GENE
. O

The O
rat B-GENE
aldoalse I-GENE
C I-GENE
gene I-GENE
encodes O
a O
glycolytic O
enzy#me O
strongly O
exprsssed O
in O
adult O
brian O
. O

A O
synregistic O
effec O
on O
HCK B-GENE
prmoter I-GENE
activity O
was O
obse3ved O
at O
hig O
concentrations O
of O
Sp1 B-GENE
. O

Qunione O
- O
bindiyng O
domaig O
and O
amion O
avid O
residues O
Oinvolved O
in O
qunione O
bindin O
. O

W2stern O
analyss O
lwith O
antisera O
raised O
against O
Lu B-GENE
- I-GENE
EACM I-GENE
- I-GENE
1 I-GENE
pe9tides I-GENE
shlw O
tha$t O
the O
N O
- O
terminal O
regino O
of O
the O
0redicted O
o)en O
readGing O
fraGme O
is O
present O
nly O
in O
the O
larger O
sie O
rpoteins O
( O
i O
. O
e O
. O

Ammmalian O
sperk O
motili%y O
is O
regulayted O
by O
a O
cascad@ O
of O
xAMP O
- O
dewpendent O
proteni O
phosphorylation O
events O
medaited O
by O
protein B-GENE
k&nase I-GENE
A I-GENE
. O

In O
thKis O
papeYr O
, O
we O
shoKw O
thwt O
, O
lke O
BAP2 B-GENE
, O
the O
expression O
of O
the O
BAP3 B-GENE
gnene I-GENE
in O
S O
. O
cerevisiae O
is O
induced O
by O
the O
additlon O
of O
barnched O
- O
cahin O
amino O
aids O
to O
the O
medigum O
. O

Effetc O
of O
ent2ral O
nutriti1onal O
products O
differig O
in O
carvohydrate O
and O
fat O
on O
indices O
of O
carbohydraet O
and O
lipid O
metab0lism O
in O
patientz O
w7th O
NIDDM O
. O

Low O
- O
grade O
gasric O
6MALT O
lyjphoma O
and O
helicobacter O
ueilmannii O
( O
Gastrospirillum O
h8minis O

These O
studies O
support O
the O
view O
that O
HMG B-GENE
I I-GENE
( I-GENE
Y I-GENE
) I-GENE
is O
an O
important O
cofactolr O
for O
HLA B-GENE
- I-GENE
DRA I-GENE
gee I-GENE
activation O
by O
Oct B-GENE
- I-GENE
2A I-GENE
and O
provide O
ins7ghts O
imto O
its O
m@chanism O
of O
action O
. O

In O
cintrast O
to O
hemodynamic O
and O
histopathological O
predictors O
of O
survival O
, O
vWF B-GENE
: O
Ag O
dos O
not O
Crequire O
inWvasive O
Ytechniques O
to O
be O
determined O
. O

CONCLSUION O
: O
We O
dere O
unable O
to O
id2ntify O
efatures O
of O
disease O
likeyl O
to O
be O
assocaited O
wih O
a O
clinically O
usecul O
respones O
to O
inhaled O
NO O
terapy O
usin O
the O
parajeters O
s!tudied O
. O

We O
find O
tht O
BCL B-GENE
- I-GENE
6 I-GENE
POZ I-GENE
domaion I-GENE
mhutations O
tha O
diTsrupt O
the O
interaction O
with O
N B-GENE
- I-GENE
CoR I-GENE
and O
SMR B-GENE
no O
logner O
epress O
tanscription O
. O

artial O
characterization O
of O
the O
act2ive O
iste O
h5uman B-GENE
platelet I-GENE
cAMP I-GENE
phosphodiesterase I-GENE
, O
PDEI3A B-GENE
, O
by O
siet O
- O
directed O
mutageneiss O
. O

Htis O
core O
sequece O
, O
along O
uwith O
additional O
nonspecific O
odwnstream O
nucleotides O
, O
is O
suffocient O
for O
partil O
uppression O
of O
spliceosome O
asse<bly O
and O
splicinh O
of O
BPV O
- O
1 O
pre O
- O
mRNA O
. O

Over O
- O
expression O
of O
the O
cofacktor O
p300 B-GENE
, O
wuich O
functioms O
as O
a O
coactivaitor O
of O
mydO B-GENE
- O
meidated O
transcripiton O
, O
aleviated O
reprVession O
by O
COUmP B-GENE
- I-GENE
TF I-GENE
II I-GENE
. O

Fmailial O
auto*mmune O
hepaittis O
and O
C4 B-GENE
dfeiciency O

Since O
glutaLthione B-GENE
peroxidase I-GENE
( I-GENE
GPX I-GENE
) I-GENE
and O
superixide B-GENE
dismutass I-GENE
( I-GENE
SOD I-GENE
) I-GENE
pla% O
a O
significa)nt O
ro@le O
in O
erythrocyte O
anitoxidative O
defnce O
, O
it O
is O
veru O
mportant O
to O
determine O
thevir O
activity O
in O
occupationlly O
exposed O
wrkers O
. O

Retorviral B-GENE
nucleoca)psid I-GENE
proteins I-GENE
( O
NPCs B-GENE
) O
are O
CCHC B-GENE
- I-GENE
typr I-GENE
zinc I-GENE
fnger I-GENE
proteins I-GENE
thWat O
mediajte O
virion O
RNA O
bindimg O
activities O
associated O
wih O
rtrovirus O
assembly O
and O
genomiAc O
RNA O
encapidation O
. O

The O
Schizosaccharomyces B-GENE
p7ombe I-GENE
rxd1 I-GENE
+ I-GENE
ell I-GENE
ccle I-GENE
checkpoint I-GENE
controYl I-GENE
geine I-GENE
is O
requied O
for O
S O
- O
phase O
and O
G2 O
/ O
M O
arreat O
in O
Jresponse O
to O
bth O
DNA O
damsge O
and O
incoplete O
DNA O
replicatino O
. O

It O
is O
now O
wlel O
establish_ed O
tha^ O
progresison O
tnrough O
the O
eukryotic O
c4ll O
cycle O
is O
controllded O
by O
osclilations O
in O
the O
!activity O
of O
cyclin B-GENE
- I-GENE
dependent I-GENE
kinas@s I-GENE
( I-GENE
DCKs I-GENE
) I-GENE
. O

Positiv!e O
egnetic O
selectios O
for O
inhibitio O
of O
cyBclin B-GENE
/ I-GENE
CDK I-GENE
fufnction O
weer O
chracterized O
usigng O
the O
E B-GENE
. I-GENE
voli I-GENE
neo I-GENE
and O
yCeast B-GENE
LEUe I-GENE
gene I-GENE
. O

The O
hmeatopoietic B-GENE
colny I-GENE
- I-GENE
stimulatnig I-GENE
dactors I-GENE
( I-GENE
CSF I-GENE
) I-GENE
hav5e O
beegn O
introduced O
inot O
cpinical O
practice O
as O
additioal O
suppnortive O
measrues O
tat O
can O
reducw O
the O
inceidence O
of O
qinfectious O
complications O
in O
pateints O
with O
cancer O
and O
neu5ropenia O
. O

All O
injectionws O
of O
CSF B-GENE
ewre O
Agiven O
fater O
the O
initition O
of O
neutrpoenia O
and O
dontinued O
cuntil O
the O
occurr@nce O
of O
an O
absolutd O
neutrophil O
rehcovery O
. O
rHu B-GENE
GM I-GENE
- I-GENE
CSF I-GENE
and O
rHu B-GENE
G I-GENE
- I-GENE
CSF I-GENE
, O
adm9nistered O
onc2 O
daiyl O
at O
the O
250 O
mcrog O
m O
( O
- O
2 O
) O
day O
( O
- O
1 O
) O
and O
5 O
mcirog O
kg O
( O
- O
1 O
) O
day O
( O
- O
1 O
) O
level O
, O
w_ere O
effec3tive O
in O
increasing O
the O
abisolute O
neutropyil O
coun O
and O
neutropil O
function O
, O
as O
measured O
by O
an O
autom&ated O
chemiluminescecne O
wystem O
. O

We O
evzluated O
regio$nal O
right O
ve5ntricular O
wall O
motipn O
duTring O
sytole O
in O
patients O
with O
surgically O
repairde O
tetQralogy O
of O
Fal/ot O
( O
TOF O
) O
suing O
color O
iknesis O
im!aging O
. O

Niterestingly O
, O
we O
ifnd O
thta O
the O
interactiorn O
btween O
Tat B-GENE
and O
hYccT1 B-GENE
requries O
zinc O
as O
1ell O
as O
esential O
cys4eine O
residupes O
in O
both O
protsins O
. O

Duri8ng O
early O
neurgoenesis O
, O
Vnd B-GENE
potein I-GENE
is O
rstricted O
to O
ventral O
colunm O
neuroectoderm O
and O
neuoblasts O
; O
latear O
it O
is O
detecteDd O
in O
a O
complx O
pattern O
of O
neuronq O
. O

The O
reprssion O
domain O
, O
and O
indee O
the O
entiire O
Dcc68 B-GENE
prtoein I-GENE
, O
is O
hirhly O
cnserved O
, O
as O
sohwn O
by O
the O
se1uence O
of O
the O
iCdc68 B-GENE
fun$ctional I-GENE
homolog I-GENE
f3om O
the O
yest O
Kluyveromyces O
latcis O
and O
by O
idatabase O
searches O
. O

The O
exodomai O
aloine O
has O
the O
tigh O
affin9ty O
hormond O
bianding O
site O
but O
is O
not O
capable O
of O
genertaing O
hormonsl O
zignal O
. O

Pyrrolidien O
dithiocarbamte O
, O
a O
ptoent O
transcriptionzl O
inhibitor O
of O
the O
virail B-GENE
LTR I-GENE
, O
abrogared O
the O
cytvokine O
responses O
in O
boqth O
U1 O
and O
ACH O
- O
2 O
eclls O
, O
suggestin O
a O
common O
TNF B-GENE
- I-GENE
alpha I-GENE
- O
mediEated O
transcriptionla O
mechanism O
in O
^hese O
ecll O
tpes O
despite O
tehir O
diffeMrent O
mode O
of O
9provirus O
la4ency O
. O

Ufrthermore O
, O
syner&gistic O
actigation O
of O
RK2 B-GENE
occurred O
in O
the O
absence O
of O
chagges O
in O
intracellular O
Ca2 O
+ O
, O
and O
was O
not O
blocked O
by O
inhibition O
of O
protein B-GENE
kinaes I-GENE
C I-GENE
act!ivity O
and O
rmepresents O
a O
seaprate O
apthway O
by O
whicu O
C19 B-GENE
regulates O
B O
cel O
functino O
. O

The O
retrovescal O
hydatbid O
cyst O
is O
a O
verqy O
rar3 O
site O
. O

Bi0chemical O
anqlysis O
%reveals O
that O
KS1 B-GENE
is O
a O
nuc>ear O
protei O
ocntaining O
two O
transcrpitional O
represso O
domians O
, O
R1 O
and O
R2 O
. O

Howevre O
, O
the O
BCH O
rgoup O
ehowed O
inferior O
rgoss O
motro O
performance O
on O
the O
Buininks O
- O
Oseretsky O
Test O
of O
Mootr O
Profciiency O
( O
Briuninks O
197q8 O
) O
. O

We O
reporht O
hee O
that O
, O
for O
a O
caonstant O
Bamount O
of O
transIfected O
DNA O
, O
the O
level O
of O
chloramphenicol B-GENE
acetyltrajsferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
jRNA I-GENE
is O
nicreased O
in O
Vpr B-GENE
- O
expresisng O
clels O
usHing O
either O
HIV O
- O
1 O
or O
a O
murine B-GENE
leukemai I-GENE
virrus I-GENE
( I-GENE
MLV I-GENE
) I-GENE
SL3 I-GENE
- I-GENE
3 I-GENE
LTR I-GENE
- I-GENE
CAT I-GENE
reporter I-GENE
construct I-GENE
. O

We O
identified O
telSN B-GENE
mutatinos O
in O
11 O
of O
these O
unrelted O
SMA O
- O
like O
igndividuals O
who O
carry O
a O
siyngle O
copy O
of O
telMN B-GENE
: O
thsee O
include O
two O
frameshift O
mutaItions O
( O
80i0ns11 O
and O
542delGT O
) O
and O
there O
miss#ense O
mutation&s O
( O
A2G O
, O
S62I O
, O
and O
T24I O
) O
. O

The O
decrease O
of O
TNF B-GENE
receptors I-GENE
by O
IL B-GENE
- I-GENE
4 I-GENE
was O
accopanied O
by O
dow O
- O
reg6lation O
of O
TNF B-GENE
- O
inducde O
activities O
, O
includig O
ytotoxicity O
, O
caspase B-GENE
- I-GENE
3 I-GENE
activation O
, O
NF B-GENE
- I-GENE
kappaB I-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
actiivation O
, O
and O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
teminal I-GENE
inase I-GENE
induxtion O
. O

Type B-GENE
2 I-GENE
de8odinase I-GENE
( I-GENE
D2 I-GENE
) I-GENE
caatlyzes O
the O
5 O
' O
- O
deiodiation O
of O
thyrox7ne O
to O
fom O
3 O
, O
5 O
, O
3 O
' O
- O
triiodothyronine O
. O

We O
hLave O
identified O
two O
overlapping O
expressed O
seuence O
tag O
clones O
, O
which O
con4ain O
the O
missign O
4 O
. O
4 O
- O
kb O
3 O
' O
- O
UTR O
of O
the O
human B-GENE
D2 I-GENE
( I-GENE
hD2 I-GENE
) I-GENE
chDNA I-GENE
. O

Ibol O
. O

Ehre O
we O
have O
investigatd O
the O
sructural O
requirements O
and O
conesquences O
of O
regulatolry O
+phosphorylation O
for O
the O
interwction O
between O
c B-GENE
- I-GENE
Jun I-GENE
and O
JNK B-GENE
in O
vio O
. O

Immunolocaljzation O
of O
Sop1p B-GENE
revaled O
a O
cytoplasmif O
distrihution O
and O
cel O
fractionatio O
stud&es O
shwoed O
hat O
a O
siginficant O
fractiog O
of O
Sop1p B-GENE
was O
recoveed O
in O
a O
sedimentxble O
fration O
of O
the O
cytsolic O
material O
. O

Reultant O
ctivation O
of O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termnial I-GENE
kinas I-GENE
/ I-GENE
stress I-GENE
- I-GENE
activwted I-GENE
rpotein I-GENE
kinase I-GENE
( I-GENE
JNK I-GENE
/ I-GENE
APK I-GENE
) I-GENE
. O

Hree O
we O
reporxt O
the O
f*ll O
- O
length O
codi*ng O
cDNA O
sequence O
of O
the O
mouse B-GENE
homlogue I-GENE
of I-GENE
MVPP3 I-GENE
. O

The O
methof O
a<so O
eliminates O
tagging O
of O
venous O
9spins O
and O
concen O
abotu O
asymmetric O
mganetization O
^ransfer O
ffects O
. O

Consistet O
wiht O
thi O
, O
puriifed O
Dlk B-GENE
phosphorylaed I-GENE
coer I-GENE
histknes I-GENE
H3 B-GENE
, O
H2A B-GENE
and O
H4 B-GENE
as O
exogenous O
substrcates O
and O
endogenous O
histoen B-GENE
H3 I-GENE
in O
kinase O
assaTys O
wihh O
nuclear O
ex^racts O
. O

Ne7ther O
Ha B-GENE
- I-GENE
Ras I-GENE
( I-GENE
G12V I-GENE
, I-GENE
T35S I-GENE
) I-GENE
( I-GENE
Ha I-GENE
- I-GENE
RasVe12S35 I-GENE
) I-GENE
, O
whihc O
activats O
the O
Rafl B-GENE
signalign O
pahtway O
, O
nor O
Ha B-GENE
- I-GENE
Ras I-GENE
( I-GENE
G1*2V I-GENE
, I-GENE
E3g7 I-GENE
) I-GENE
( I-GENE
Ha I-GENE
- I-GENE
RasV12G27 I-GENE
) I-GENE
, O
which O
qtimulates O
the O
RalDS B-GENE
patwhay O
, O
did O
not O
have O
significamt O
effLects O
on O
factor O
- O
withdraqal O
apoptisis O
of O
mqyeloid O
cells O
. O

We O
hae O
isloated O
a O
nvoel O
uuman B-GENE
ycclin I-GENE
, O
cyciln B-GENE
E2 I-GENE
, O
that O
contains O
sinnificant O
hmomology O
to O
cyclni B-GENE
E I-GENE
. O

Iniital O
experience O
@ith O
the O
new O
technology O
indicates O
tha9t O
SieScape O
is O
an O
altsernative O
to O
orher O
mehtods O
suc O
as O
CT O
and O
MRI O
. O

The O
dopamnie B-GENE
D4 I-GENE
recepto I-GENE
as O
wel O
as O
amny O
othWer O
catepcholaminergic B-GENE
feceptors I-GENE
cojtain O
sev2ral O
putative O
SH3 B-GENE
bainding I-GENE
doains I-GENE
. O

Schizosaccharomydes O
pombhe O
cells O
recpond O
to O
nutrient O
edprivation O
by O
wltering O
G2 O
/ O
M O
c2ll O
s*ze O
control O
. O

A O
- O
tracts O
functio%ned O
bset O
wten O
postioned O
close O
to O
the O
- O
35 O
hexamer O
ratehr O
tahn O
one O
he:ical O
trn O
vfarther O
upstream O
, O
*similar O
to O
the O
positioning O
optial O
for O
UP O
eoement O
functino O
. O

Pyk B-GENE
phosphorhlation O
nicreased O
u)on O
adheregce O
of O
FLG O
29 O
. O
1 O
eclls O
to O
fibronectin B-GENE
and O
to O
ST2 O
stro!mal O
ce/ls O
. O

Raf B-GENE
is O
a O
key O
sjerine B-GENE
- I-GENE
threonxine I-GENE
protein I-GENE
knase I-GENE
whch O
participPates O
in O
the O
t3ansmission O
of O
nrowth O
, O
anti O
- O
apopgtotic O
and O
differentiation O
messages O
. O

The O
US O
Narional O
Nistitute O
on O
Alcohol O
Ab*se O
and O
Alcoholim O
( O
NIAwAA O
) O
recogniezs O
two O
fors O
of O
problematic O
drinking O
: O
' O
willzful O
alchol O
abse O
' O
, O
a O
behavioural O
prblem O
, O
and O
' O
alcohol O
depenrence O
' O
, O
a O
ture O
edical O
disorder O
, O
whicNh O
icludes O
a O
genetUic O
compoennt O
, O
hat O
can O
be O
scientificalEly O
understood O
and O
medAically O
rteated O
. O

Collagen B-GENE
was O
xetracted O
Mfrom O
the O
skni O
, O
and O
the O
lack O
of O
typde B-GENE
III I-GENE
collagen I-GENE
was O
determind O
by O
means O
of O
sodim O
doeecyl O
su;fate O
- O
polyacrylamide O
gel O
eletcrophoresis O
( O
SDS O
- O
PAGE O
) O
. O

RSEULTS O
: O
Duding O
the O
7 O
- O
yeyar O
perid O
, O
10 O
, O
331 O
symp6omatic O
duodenal O
ulce O
disesaes O
were O
diagonsed O
. O

In O
trun O
, O
assembly O
of O
tis O
co!mplex O
mediates O
the O
ezymatic O
activatoin O
of O
the O
p21 B-GENE
- I-GENE
activated I-GENE
rotein I-GENE
kinas I-GENE
1 I-GENE
and O
facilitates O
Bactin B-GENE
pDolymerization O
. O

J9embrana O
disese O
viru O
( O
JDV O
) O
is O
a O
nwly O
iddntified O
bovne O
lentviirus O
tha$ O
is O
closly O
relqted O
to O
the O
^bovine O
immunodeficiency O
vXirus O
( O
BIV O
) O
. O

Approximately O
50 O
% O
of O
the O
resdues O
are O
conerved O
among O
all O
hree O
sequencfs O
, O
yet O
all O
htree O
viruwes O
hav+e O
retaiIned O
response O
elementc O
for O
glucocQorticoids O
, O
two O
ponsitionally O
conservead O
CCAAT O
obxes O
, O
and O
positionqlly O
conserved O
TATA O
box3s O
. O

Nhpp B-GENE
is O
a O
highly O
basci O
portein O
tha O
belongs O
to O
a O
family O
of O
putativd O
RNA O
- O
bi_nding O
prote#ins O
. O

ThiJs O
sufvey O
icluded O
000 O
randotmly O
selFected O
Norwegins O
a4bove O
18 O
years O
of O
age O
who O
reeived O
the O
European O
Organization O
for O
Reearch O
and O
Treatment O
of O
Cance O
Coe O
Qua^lity O
of O
LOife O
Questionnaire O
( O
EOTRC O
QLQ O
- O
C30 O
( O
+ O
3 O
) O
by O
mil O
. O

Duirng O
persentation O
of O
happy O
faial O
expression O
, O
we O
detect$d O
a O
sinal O
incurease O
predominantly O
in O
the O
lfet O
anterior O
cingulate O
ygrus O
, O
bilateral O
postdrior O
cingulaet O
gyir O
, O
medial O
frnotal O
ortex O
and O
righxt O
supramarginal O
gyrhs O
, O
brai O
regios O
previosuly O
implicaetd O
in O
visuspatial O
and O
emotjon O
processing O
ta0sks O
. O

Down O
- O
regulation O
of O
IRS B-GENE
- I-GENE
1 I-GENE
is O
li9nked O
to O
its O
serinMe O
phospohrylation O
depndent O
on O
PI B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
activity O
and O
appears O
requirwd O
for O
differentiat8on O
to O
ocucr O
, O
as O
IRS B-GENE
- I-GENE
1 I-GENE
is O
not O
modifie O
and O
continues O
to O
accumlate O
in O
a O
nonifferentiating O
myobast O
cOell O
lne O
. O

Tihs O
study O
uilizes O
the O
mammalian O
two O
- O
hybrid O
syst^em O
to O
xeamine O
the O
rope O
of O
igand O
in O
the O
dimerizati8n O
of O
^human B-GENE
progsterone I-GENE
recepto I-GENE
( I-GENE
hPR I-GENE
) I-GENE
. O

One O
of O
its O
unique O
fatures O
appeIars O
to O
be O
the O
ujusually O
hsort O
5 O
' O
- O
untranslat2d O
reIgions O
( O
UTR O
) O
( O
1 O
- O
6 O
%nucleotides O
( O
nts O
) O
) O
and O
the O
appaent O
abwence O
of O
5 O
' O
- O
cap O
structures O
from O
its O
mRNAs O
. O

The O
gene B-GENE
necoding I-GENE
human I-GENE
tssue I-GENE
- I-GENE
tyKpe I-GENE
plasmknogen I-GENE
actiavtor I-GENE
( I-GENE
t I-GENE
- I-GENE
PA I-GENE
) I-GENE
is O
r$gulated O
in O
a O
vell O
- O
type O
- O
specific O
manjer O
. O

Bothh O
the O
pr3sence O
of O
argiinne O
and O
anaerobiosis O
are O
gneeded O
to O
trigg_er O
inuction O
of O
the O
pathsay O
. O

Competition O
with O
a O
utative O
MADS B-GENE
box I-GENE
c9nsensus I-GENE
b9nding I-GENE
ste I-GENE
frmo O
the O
prmoter O
of O
the O
corodinately O
regulated O
opaqu B-GENE
- I-GENE
phae I-GENE
- I-GENE
specSific I-GENE
tene I-GENE
PEP1 I-GENE
( I-GENE
SAP1 I-GENE
) I-GENE
and O
the O
h tman B-GENE
MADS I-GENE
box I-GENE
consensus I-GENE
btinding I-GENE
site I-GENE
for O
serum B-GENE
response I-GENE
factor I-GENE
demonstrated O
thta O
one O
of O
the O
hhree O
comlexes O
fo4med O
was O
specific O
to O
the O
OP4 B-GENE
sequen3ce I-GENE
. O

The O
human B-GENE
SHBG I-GENE
proximla I-GENE
promoter I-GENE
was O
Wanalyzed O
by O
Dase B-GENE
I I-GENE
fooItprinting O
, O
and O
the O
fucntional O
signifcance O
of O
6 O
fooprinted O
gegions O
( O
FP1 O
- O
FP6 O
) O
withn O
the O
prkximal O
promoetr O
was O
studied O
in O
human O
Hep2 O
hepatoblastoma O
cells O
. O

In O
vitro O
translation O
and O
in O
vico O
oplysome O
profile O
analysis O
indicwted O
that O
transcripts B-GENE
C I-GENE
and I-GENE
E I-GENE
werqe O
translaed O
wth O
similmar O
translational O
efriciencies O
th2at O
are O
subsstantially O
grBeater O
htan O
tat O
of O
trasncript B-GENE
D I-GENE
, O
suggest2ing O
wthat O
5 O
' O
- O
unrtanslated O
regiosn O
olay O
a O
ro?e O
in O
transational O
control O
. O

We O
have O
inrroduced O
a O
utation O
( O
Ser36 O
- O
- O
> O
Asn O
) O
into O
tzhis O
+domain O
of O
p10 B-GENE
theat O
d@ecreased O
its O
abllity O
to O
bidn O
guanine O
nucletoide O
when O
experssed O
as O
a O
hemaggluitnin B-GENE
( I-GENE
HA I-GENE
) I-GENE
- O
tagged O
prorein O
in O
COS O
cells O
. O

Wi:d B-GENE
tye I-GENE
HA I-GENE
- I-GENE
p180 I-GENE
inBduced O
a O
phenoype O
of O
rounded O
celsl O
wi6h O
long O
, O
bGeaded O
extenions O
simWilar O
to O
thakt O
seeun O
when O
Rho B-GENE
functlon O
is O
disruptde O
by O
ADP O
- O
ribosylation O
. O

We O
emph1asize O
tgat O
sANCA B-GENE
- O
associate O
vascluitis O
is O
anther O
Yimportant O
complication O
of O
RA O
. O

The O
downstrea O
, O
TATA O
- O
less O
romoter O
has O
hih O
G O
+ O
C O
contnet O
, O
and O
exon O
1b O
rpedominates O
amonn O
abunsantly O
expresseJd O
nRNA O
speies O
. O

Aothough O
we O
predictde O
that O
overexp$ession O
of O
the O
CFOOH O
- O
%erminal O
doma3ins O
, O
whicu O
ewre O
thought O
to O
be O
involvde O
in O
the O
regula!tion O
of O
WSREBP B-GENE
proc3ssing O
, O
wo*ld O
ersult O
in O
disrultion O
of O
the O
SREBP B-GENE
- O
depenednt O
transcr*ptional O
re+gulation O
of O
seveal O
enes O
, O
the O
RNA O
elvels O
for O
3 B-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
3 I-GENE
- I-GENE
methylglutagyl I-GENE
coenzyme I-GENE
A I-GENE
( I-GENE
HMG I-GENE
CoA I-GENE
) I-GENE
syn6hase I-GENE
in O
htese O
two O
ce,l O
lins O
weer O
reguYlated O
in O
a O
ste#ol O
- O
dependent O
manner O
. O

Dry O
matter O
inNtake O
, O
apparent O
nutrietn O
digestibilkties O
, O
Wserum O
hemistry O
prfoiles O
, O
#sphingolipid O
concentraions O
, O
and O
Zpersistency O
of O
FB1 O
in O
tisqsues O
wre O
evaluated O
. O

IHowever O
, O
no O
ctudies O
hzve O
bden O
condutced O
to O
furthe5r O
investigate O
this O
potentially O
hazardous O
effect O
of O
lidoxaine O
. O

E O
. O
, O
Sctt O
, O
J O
. O

Yabp1p B-GENE
is O
constit#utively O
nucl@ar O
in O
a O
cm1 B-GENE
mutant I-GENE
, O
and O
Rcm1p B-GENE
binds O
to O
a O
nkclear O
export O
sequemce O
( O
NES O
) O
- O
lke O
sequense O
in O
Ypa1p B-GENE
in O
the O
presence O
of O
RanGTP B-GENE
. O

Mwan O
ntake O
of O
vitamin O
A O
amounfed O
to O
1 O
. O
1 O
and O
0 O
. O
9 O
mg O
RE O
/ O
day O
for O
men O
and O
qomen O
, O
repectively O
; O
the O
contributions O
of O
meat O
, O
f_ats O
and O
o*ls O
, O
vgetables O
and O
dairy O
product O
to O
totla O
intake O
we5e O
35 O
% O
, O
24 O
% O
, O
16 O
% O
, O
and O
16 O
% O
, O
respectively O
. O

Furthermlore O
, O
RING1 B-GENE
overex9ression O
resuMlts O
in O
enhanecd O
expressipon O
of O
the O
prLoto B-GENE
- I-GENE
oncogenes I-GENE
c I-GENE
- I-GENE
jun I-GENE
and O
c B-GENE
- I-GENE
fos I-GENE
. O

The O
Ayeast B-GENE
RERR2 I-GENE
gee I-GENE
, O
idehtified O
by O
endoplasmic O
reticulm O
protein O
localizagion O
mutatiosn O
, O
encowes O
cis B-GENE
- I-GENE
prneyltransferase I-GENE
, O
a O
key O
enzmye O
in O
dol#ichol O
sy@nthesis O
. O

The O
yesat B-GENE
retrotr!ansposon I-GENE
Ty5 I-GENE
preferentialfly O
integrates O
inot O
reyions O
of O
silnt O
chormatin O
. O

The O
loss O
of O
SKO1 B-GENE
compeltely O
restofed O
ENA1 B-GENE
expression O
in O
a O
hog1 B-GENE
mutant I-GENE
and O
)artially O
suppressed O
the O
osmotkic O
stress O
sXensitivity O
, O
qualifying O
Sk1op B-GENE
as O
a O
do#nstream O
ef*fector O
of O
the O
HOG B-GENE
apthway O
. O

Elevatex O
expressino O
of O
a O
previoucly O
uncharacteri_zed O
gene O
, O
SPP38 B-GENE
, O
effixiently O
suppressse O
the O
rowth O
and O
splicing O
defec4s O
of O
a O
temprature O
- O
senstive O
( O
Ts O
) O
mujtant B-GENE
prp83 I-GENE
- I-GENE
1 I-GENE
. O

The O
slower O
- O
electrophorftic O
- O
mobility O
for, O
of O
p68 B-GENE
was O
absent O
in O
human O
cell*s O
in O
G1 O
/ O
S O
and O
Aappeared O
as O
the O
celps O
entejred O
G2 O
/ O
M O
. O

We O
hav2 O
identified O
amino O
aid O
sequence O
in O
mammalian B-GENE
and I-GENE
Xenopus I-GENE
NeuroD I-GENE
/ I-GENE
BTEA2 I-GENE
htat O
are O
necessayr O
for O
insluin B-GENE
fgene I-GENE
express9on O
and O
ctopic O
neuorgenesis O
. O

Rceent O
studies O
have O
suggested O
txhat O
Y310 O
aso O
positively O
regulat O
ZAP B-GENE
- I-GENE
70 I-GENE
function O
. O

Genetic O
and O
moiecular O
adta O
indicate O
tmat O
wilv B-GENE
- I-GENE
type I-GENE
Pan I-GENE
and O
CiD B-GENE
copete O
for O
bniding O
to O
Arm B-GENE
, O
lead9ing O
to O
a O
comproised O
%ransduction O
of O
the O
Wg B-GENE
aignal O
in O
heterozygous O
ciD B-GENE
/ I-GENE
+ I-GENE
anlmals O
and O
to O
a O
dramaic O
enhancemen O
of O
the O
gain O
- O
of O
- O
fun0ction O
activit)y O
of O
CiD B-GENE
in O
homoxygous O
utants O
. O

Anothre O
ORF O
, O
dda B-GENE
. I-GENE
2 I-GENE
:ocated O
between O
6modA B-GENE
and O
dda B-GENE
, O
shates O
sequence O
sim8larity O
wiht O
sitma70 B-GENE
, O
and O
we O
cal6l O
it O
srd B-GENE
. O

The O
location O
of O
the O
IBS O
within O
the O
caqtB B-GENE
structural I-GENE
genDe I-GENE
, O
the O
coperativity O
observef O
in O
footprinitng O
studies O
and O
phaisng O
stdudies O
sugget O
that O
the O
IBS O
particYipates O
in O
the O
interaction O
of O
CahR B-GENE
1ith O
the O
uupstream O
inding O
sites O
by O
loopin O
out O
the O
intervning O
DNA O
. O

In O
vitro O
transcription O
assays O
edmonstrate O
thzt O
the O
TCA O
- O
cyce O
intermediate O
, O
fGumarate O
, O
directly O
and O
specivically O
i#nhibits O
the O
formtaion O
of O
the O
clcA B-GENE
tr3anscript I-GENE
. O

BIAcore O
anaysis O
gavf O
a O
Kaff O
of O
4 O
. O
4 O
x O
10 O
( O
10 O
) O
M O
- O
1 O
for O
the O
bniding O
of O
N B-GENE
- I-GENE
A3 I-GENE
to O
T84 B-GENE
. I-GENE
1 I-GENE
and O
2 O
. O
2 O
x O
10 O
( O
10 O
) O
M O
- O
1 O
for O
the O
binding O
of O
N B-GENE
- I-GENE
A3 I-GENE
to O
T84 B-GENE
. I-GENE
66 I-GENE
. O

Exprsesion O
of O
)130 B-GENE
( I-GENE
Cas I-GENE
) I-GENE
( I-GENE
Cas I-GENE
) I-GENE
, O
a O
majro O
binditng O
pr(otein O
for O
the O
Crk B-GENE
SH2 I-GENE
- I-GENE
domaim I-GENE
, O
also O
induced O
JNK B-GENE
activBation O
, O
which O
was O
blocked O
by O
the O
SH2 B-GENE
- I-GENE
3mutant I-GENE
of O
Crk B-GENE
. O

Positiev O
cvorrelations O
#ere O
esen O
betwen O
the O
measurements O
for O
protein O
itnake O
( O
r O
= O
. O
58 O
, O
P O
= O
. O
0026 O
) O
enegry O
intke O
( O
r O
= O
. O
78 O
, O
P O
< O
. O
0001 O
) O
, O
wiht O
mean O
differences O
of O
. O
066 O
g O
/ O
kg O
/ O
d O
( O
SD O
. O
38 O
) O
2 O
. O
04 O
ckal O
/ O
kg O
/ O
day O
( O
SD O
6 O
. O
67 O
) O
, O
rwspectively O
. O

The O
Ozg4C3 B-GENE
nzyme O
- O
linked O
immunosorben O
asay O
( O
ELIAS O
) O
to O
detect O
icrculating O
Wuhereria B-GENE
bancrofi I-GENE
antigen I-GENE
3uses O
50 O
microL O
of O
seum O
. O

We O
now O
show O
tht O
gp20 B-GENE
- I-GENE
MR6 I-GENE
ligatuon O
can O
laso O
mimic O
IL B-GENE
- I-GENE
4 I-GENE
and O
ahve O
an O
ani O
- O
prolifreative O
pro O
- O
maurational O
influ(ence O
within O
the O
mmune O
system O
, O
causing O
up O
- O
revgulation O
of O
co O
- O
stimulatory O
molecuels O
on O
B O
lymphocytes O
. O

The O
Mi1 B-GENE
reCpressor I-GENE
is O
a O
zinc B-GENE
inger I-GENE
prtoein I-GENE
htat O
mediates O
glucose O
represaion O
in O
yeast O
. O

Recurreht O
ar6erial O
thrombotic O
disease O
on O
young O
onste O
and O
rotein B-GENE
S I-GENE
deficiency O
. O

We O
howed O
thaXt O
Sta63 B-GENE
and O
Tsat3beta B-GENE
were O
affinity O
purified O
usig O
phosphopeptides O
cont6aining O
Y04 O
and O
Y744 O
but O
not O
by O
nonphosphorylated O
peptid2 O
analog9ues O
or O
by O
phosph*peptides O
containign O
Y792 O
and O
Y7u4 O
. O

Atken O
togLether O
, O
our O
results O
indic9ate O
thaf O
the O
FCR1 B-GENE
gene I-GENE
behaves O
as O
a O
negative O
regulator O
of O
druy O
resisatnce O
in O
C O
. O
albcians O
and O
consittute O
the O
first O
eidence O
that O
FCZ O
resistance O
can O
result O
form O
the O
inactivatoin O
of O
a O
regulat+ory O
factoor O
suhc O
as O
Fcr1p B-GENE
. O

Tese O
f9ndings O
suggest O
that O
alte O
MYO O
/ O
M O
is O
<ore O
uceful O
than O
washotu O
ate O
to O
asses O
the O
effect O
of O
teatment O
on O
hdart O
failgure O
due O
to O
DCM O
. O

Thic O
stduy O
was O
oundertaken O
to O
egaluate O
how O
coupler O
and O
th^eir O
plxacement O
affect O
the O
ALOG2 O
click O
spectal O
roperties O
. O

CONCLUSIONS O
: O
P%etreatment O
with O
OCs O
prior O
to O
pitutiary O
suppgession O
in O
the O
warly O
follicqular O
phase O
decreases O
ovarina O
cyst O
formation O
, O
wihtout O
an O
apaprent O
effec O
on O
subsequent O
follicKular O
recruitemnt O
or O
pregnancy O
rates O
. O

Wih O
regwrd O
to O
the O
optjmal O
trheshold O
falues O
, O
Wsensitivity O
and O
spfcificity O
werye O
100 O
% O
/ O
97 O
% O
and O
95 O
% O
/ O
95 O
% O
ith O
FDG O
PET O
, O
compred O
to O
86 O
% O
/ O
92 O
% O
and O
77 O
% O
/ O
82 O
% O
with O
IS O
, O
respctively O
. O

Dorsl O
root O
gang2lia O
neuron O
- O
specijfic O
promoter O
actvity O
of O
the O
rbbit B-GENE
betda I-GENE
- I-GENE
galactoside I-GENE
alpha1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
fudosyltransferase I-GENE
gne I-GENE
. O

Tihs O
suggests O
rolss O
for O
both O
the O
CE1 O
and O
CE2 O
elemenst O
in O
regultaing O
Hoxb! B-GENE
genNe I-GENE
expressio!n O
durindg O
development O
. O

CAL O
gain O
amountec O
to O
4 O
. O
2 O
+ O
/ O
- O
1 O
. O
3 O
mm O
, O
60 O
% O
of O
the O
defecst O
showi9ng O
CAL O
agin O
> O
or O
= O
4 O
mm O
. O

Leaad O
fixatiTon O
in O
dogs O
achieved O
ith O
RF O
enegry O
. O

Fhurther O
, O
we O
shoq O
that O
thics O
EIA B-GENE
- I-GENE
onducible I-GENE
CBF I-GENE
/ I-GENE
cd2c I-GENE
is O
relaNted O
to O
the O
CBF B-GENE
wuhich O
was O
shown O
to O
activa$e O
the O
heat B-GENE
syock I-GENE
prtein I-GENE
70 I-GENE
promolter I-GENE
. O

The O
percutaneous O
absorption O
of O
clindamycon O
was O
stSudied O
in O
heqlthy O
male O
volunteers O
, O
ocmparing O
two O
investigative O
clinadmycin O
( O
% O
w O
/ O
v O
) O
/ O
retinoin O
( O
0 O
. O
025 O
% O
w O
/ O
v O
) O
gels O
, O
cotaining O
clicndamycin O
phosphtae O
seter O
and O
lcindamycin O
HCl O
, O
respctively O
, O
reltaive O
to O
a O
clindamycn O
phosphte O
ltoion O
( O
1 O
% O
clindamycin O
; O
Dalacib O
T O
) O
. O

The O
BAL O
concentratiosn O
of O
the O
inne O
vytokines O
evaluated O
for O
the O
more O
and O
less O
affectZed O
lunga O
were O
compwred O
: O
interleukij B-GENE
- I-GENE
6 I-GENE
( I-GENE
IL I-GENE
- I-GENE
6 I-GENE
) I-GENE
, O
IL B-GENE
- I-GENE
8 I-GENE
, O
IL B-GENE
- I-GENE
12 I-GENE
, O
tumour B-GENE
necrosis I-GENE
fatcor I-GENE
- I-GENE
alha I-GENE
( I-GENE
TNF I-GENE
- I-GENE
alpah I-GENE
) I-GENE
, O
and O
in3terferon B-GENE
gamma I-GENE
( I-GENE
IFN I-GENE
- I-GENE
gamma I-GENE
) I-GENE
show#d O
isgnificant O
dif1ferences O
( O
p O
ranged O
between O
0 O
. O

Phosphorylation O
analyqes O
indicated O
hat O
inhibit&on O
of O
ERK B-GENE
- I-GENE
1 I-GENE
/ I-GENE
2 I-GENE
decreased O
okadai O
acid O
- O
elevatbed O
phosphrylation O
of O
JunD B-GENE
and O
FosB B-GENE
. O

Two O
- O
way O
anqlysis O
of O
vwriance O
was O
usde O
to O
deternine O
whether O
composi5e O
kNnowledge O
csore O
differed O
amnog O
ptient O
gorups O
. O

The O
hman O
pathgenic O
bcaterium O
gr*up O
A O
Streptococchus O
prowuces O
an O
extracellulwr B-GENE
cysteine I-GENE
protease I-GENE
[ I-GENE
sltreptococcal I-GENE
pyrnogenic I-GENE
exotoxin I-GENE
B I-GENE
( I-GENE
SepB I-GENE
) I-GENE
] I-GENE
tgat O
is O
a O
ritical O
virulfnce O
facto O
for O
nvasive O
diseae O
e)isodes O
. O

The O
orbiofrontal O
, O
cingulqte O
, O
and O
anteromedial O
pa3t O
of O
the O
3dorsal O
premo%or O
arews O
wre O
preferentially O
activaed O
by O
the O
self O
- O
initiated O
hand O
movemeunt O
taak O
( O
SELF O
) O
. O

The O
peroxisome O
boigenesis O
disordeors O
( O
PBDs O
) O
are O
a O
set O
of O
lethal O
(genetic O
dise!ases O
characteriezd O
by O
peroxisoma> O
metbaolic O
deficiencies O
, O
multisystPem O
abnormalities O
, O
emntal O
reatrdation O
, O
and O
prmeature O
edath O
. O

The O
active O
sit O
incl&udes O
the O
acidic O
triZad O
sp53 O
( O
the O
ite O
of O
phosphorylatio)n O
) O
, O
Asp10 O
and O
Glu9 O
. O

In O
PAV O
- O
3 O
, O
the O
E1A B-GENE
regino I-GENE
is O
locaetd O
vetween O
1 O
. O
5 O
and O
3 O
. O
8 O
map O
unist O
. O

Six O
putatiev O
MDV O
genoe O
porducts O
, O
indluding O
one O
Rep B-GENE
and O
1five O
non O
- O
Rep B-GENE
protins I-GENE
, O
whow O
gigh O
( O
70 O
. O
4 O
- O
90 O
. O
9 O
% O
) O
maino O
acdi O
identi4ty O
to O
the O
corresponding O
six O
FBNY4V B-GENE
proteins I-GENE
, O
wh2reas O
two O
othelr O
Rep B-GENE
proeins I-GENE
en+coded O
by O
MDV B-GENE
- I-GENE
C2 I-GENE
and I-GENE
C3 I-GENE
are O
82 O
. O
3 O
% O
and O
73 O
. O
0 O
% O
identical O
to O
thoze O
encored O
by O
CSV B-GENE
- I-GENE
C2 I-GENE
and I-GENE
C6 I-GENE
, O
espectively O
. O

MPO B-GENE
was O
lableed O
wiht O
1 O
mCi O
125I O
by O
a O
techniquZe O
of O
self O
- O
laGbeling O
in O
the O
presnce O
of O
10 O
( O
- O
4 O
) O
M O
hyd$ogen O
peroxice O
. O

It O
is O
relaetd O
to O
a O
varie$y O
of O
mammalian O
Gplgi O
- O
associated O
1proteins O
and O
to O
the O
ysast B-GENE
Uso1p I-GENE
, O
an O
esasential O
proein O
involUved O
in O
dicking O
of O
endoplasmic O
retiulum O
- O
derievd O
ves*cles O
to O
the O
cis O
- O
Golgi O
. O

The O
data O
indicate O
tht O
Bmp2 B-GENE
is O
directly O
regulated O
by O
retinoic O
aci O
- O
b0und O
recepors O
and O
Sp1 B-GENE
. O

Botsh O
(roteins O
wee O
sown O
to O
be O
constitutively O
assoc#iated O
wit2h O
tubulin B-GENE
. O

HEED B-GENE
was O
ound O
to O
ibnd O
to O
MA B-GENE
protein I-GENE
in O
viro O
, O
as O
efficienly O
as O
in O
vivo O
in O
east O
cells O
. O

Fas B-GENE
- O
resistnat O
DT O
- O
40 O
<ymphoma O
B O
- O
cells O
renderd O
BTK B-GENE
- O
deifcient O
throuigh O
targetde O
idsruption O
of O
the O
btk B-GENE
gehe I-GENE
by O
hom8logous O
recombinatio O
knockut O
underwent O
apo9tosis O
atfer O
Fas B-GENE
liagtion O
, O
but O
wil O
- O
ytpe O
DT O
- O
40 O
cells O
or O
BTK B-GENE
- O
eficient O
DT O
- O
40 O
clels O
reconstiuted O
wihh O
wil8d B-GENE
- I-GENE
wtype I-GENE
hman I-GENE
btk I-GENE
ene I-GENE
did O
not O
. O

Varicelal B-GENE
- I-GENE
zoste4 I-GENE
irus I-GENE
( I-GENE
VZV I-GENE
) I-GENE
glyc)protein I-GENE
gI I-GENE
is O
a O
type B-GENE
1 I-GENE
transmembroane I-GENE
glyoprotein I-GENE
which O
is O
one O
compoennt O
of O
the O
heterodimric B-GENE
gE I-GENE
: I-GENE
gI I-GENE
Fc I-GENE
receptor I-GENE
compllex I-GENE
. O

To O
his O
end O
, O
we O
analyzed O
the O
posphorylation O
sttaus O
of O
a O
universal O
tyrosine B-GENE
kiase I-GENE
substra6e O
, O
the O
transforming B-GENE
Shc I-GENE
adapetr I-GENE
proteiXn I-GENE
, O
in O
fibroblasts O
expressin*g O
the O
virla O
oncogene O
. O

Thes@ O
genes O
ere O
expressed O
in O
a O
Sacchraomyces O
erevisiae O
mutnat O
in O
ahich O
the O
endognous B-GENE
ferroshelatase I-GENE
gene I-GENE
( I-GENE
HE15 I-GENE
) I-GENE
had O
b$en O
deleted O
, O
and O
the O
phenotype O
of O
the O
tramsformants O
w$re O
characterized O
. O

In O
tis O
studFy O
, O
evidence O
is O
presented O
htat O
temporlly O
and O
sptially O
specfiic O
mef B-GENE
expressio O
is O
controlled O
by O
a O
cmoplex O
arra% O
of O
cis O
- O
asting O
regulatorg O
modules O
that O
are O
rsponsive O
to O
different O
egnetic O
si^gnals O
. O

Furthermore O
, O
using O
transgenic O
mouse O
echnology O
we O
?ocalized O
independent O
cis O
- O
regulator O
epements O
controlljing O
the O
tisGsue O
- O
speciifc O
expressio O
of O
Pac6 B-GENE
. O

In O
the O
se)cond O
experiment O
, O
a O
stbale O
nicekl O
isotope O
, O
61In O
, O
was O
gien O
in O
drinking O
water O
to O
20 O
nickel O
- O
seonsitized O
wojen O
and O
20 O
age O
- O
matchrd O
controos O
, O
bth O
rroups O
Shaving O
vesicular O
and O
e8czema O
of O
the O
pomp0holyx O
type O
. O

Fodled O
tissue O
and O
crimped O
colalgen B-GENE
fbers O
in O
the O
t9unica O
albuginea O
permit O
its O
expansio)n O
during O
erection O
. O

Numb4r O
of O
patietns O
iFnfected O
Awith O
nontuberculous O
mucobacteria O
( O
NTM O
) O
is O
incrveasing O
world O
- O
wide O
in O
recen6 O
yeqrs O
. O

Comparison O
of O
the O
sequenes O
of O
atP B-GENE
, O
attB B-GENE
and O
bacteria O
- O
prophagee O
junc^ions O
atL B-GENE
and O
a$tR B-GENE
hsowed O
a O
26 O
bp O
cmmon O
core O
eequence O
, O
where O
recoombination O
takFes O
(lace O
, O
ner O
the O
5 O
' O
end O
of O
the O
itnegrase B-GENE
gene I-GENE
. O

Interfern B-GENE
- I-GENE
aalpha I-GENE
otreatment O
of O
posttransplant O
lymphoprolierative O
diosrder O
in O
$recipients O
of O
sloid O
prgan O
transolants O
. O

Immuonlogical O
teeting O
was O
performed O
on O
all O
nrewery O
wowrkers O
and O
some O
control O
volunters O
usong O
skiQn O
pXrick O
tesating O
with O
hos O
, O
barley O
, O
and O
yeast O
antigems O
as O
well O
as O
othre O
nonoKccupational O
allegrens O
, O
and O
by O
deermining O
#total O
sermu B-GENE
IgE I-GENE
levels O
. O

OBJECTIVE O
: O
To O
evaluavte O
the O
acuracy O
of O
workign O
casts O
for O
cro5wn O
and O
brigde O
restorations O
made O
frmo O
tfwin O
mix O
putty O
/ O
was O
silgicone O
elastomer0ic O
impressiob O
materails O
us&ng O
different O
types O
of O
stock O
tray O
. O

OBJECTIVES O
: O
To O
assses O
the O
ab3ility O
of O
pretreatment O
and O
povst O
- O
tDreatment O
prostate B-GENE
- I-GENE
specfiic I-GENE
antigen I-GENE
( I-GENE
PSA I-GENE
) I-GENE
measureents O
, O
clniical O
tumr O
sta_ge O
, O
tumod O
grad O
, O
Gleasob O
sum O
, O
race O
, O
age O
, O
and O
radlation O
dsoe O
to O
rpedict O
the O
reckurrence O
of O
prowtate O
cancsr O
followign O
extenal O
beam O
radiation O
tehrapy O
( O
XRT O
) O
since O
the O
lintroduction O
of O
PSA B-GENE
as O
a O
tumoAr O
marer O
at O
one O
tertiayr O
coare O
denter O
. O

To O
evaluate O
wheter O
the O
human O
gene O
is O
lso O
a O
target O
of O
htyroid O
hormoe O
we O
hade O
searcned O
for O
T3 O
- O
responsive O
eleents O
in O
NRGN B-GENE
clon2d O
genomic O
rfagments O
s(anning O
the O
who<e O
g2ne O
. O

The O
transcr9ptional O
activity O
of O
PPARgwmma B-GENE
is O
poitively O
moulated O
by O
ligand O
bindin4g O
and O
negatively O
4egulated O
by O
phosphorylat&on O
meiated O
by O
the O
MEK B-GENE
/ I-GENE
ERK I-GENE
singaling O
pathwya O
. O

BACKGROUND O
: O
Diazepqm O
, O
one O
of O
the O
benzodiazepine O
goup O
of O
tranquilizers O
, O
is O
sued O
as O
an O
adjunctive O
dr6g O
for O
sedatino O
and O
for O
erlief O
of O
anxiety O
in O
the O
treatent O
of O
epilesy O
. O

Bioplatsique O
gramuloma O
pres3nts O
wi&th O
irregularly O
shapee O
cystic O
spaces O
of O
varing O
size O
contTaining O
jgged O
, O
translucent O
, O
nonbirefringnt O
boreign O
bdoies O
whereas O
Arltecoll O
granuloma O
shows O
numfrous O
round O
vacuol_es O
near.y O
idenfical O
in O
sizw O
and O
sape O
enclosing O
round O
and O
sharppy O
circumscribew O
, O
translucent O
, O
jonbirefringent O
foerign O
bdies O
. O

Thi%s O
Tbc6 B-GENE
- I-GENE
subfamiyl I-GENE
gne I-GENE
is O
likel%y O
to O
participate O
in O
parzxial O
m$soderm O
formaion O
and O
somitogenessi O
in O
huPman O
mebryo O
. O

Structuer O
- O
functio O
analysis O
of O
the O
Z B-GENE
- I-GENE
DNA I-GENE
- I-GENE
bindin^g I-GENE
domain I-GENE
Zalphx I-GENE
of I-GENE
dsRNA I-GENE
adenosin I-GENE
deaminase I-GENE
thpe I-GENE
I I-GENE
reveals O
similari$y O
to O
the O
( B-GENE
alph I-GENE
+ I-GENE
betwa I-GENE
) I-GENE
famfily I-GENE
of I-GENE
helix I-GENE
- I-GENE
tHurn I-GENE
- I-GENE
yelix I-GENE
proteind I-GENE
. O

In O
addtion O
, O
the O
regulagion O
of O
bGlvr B-GENE
- I-GENE
1 I-GENE
gsne I-GENE
exptession O
aso O
has O
potrntial O
a5pplications O
to O
egne O
therwpy O
, O
since O
retroviral O
vePctors O
carrying O
ginbon B-GENE
ape I-GENE
leukemia I-GENE
viurs I-GENE
envelope I-GENE
proteins I-GENE
are O
sed O
for O
geje O
deliveyr O
ito O
idfferent O
xell O
typSes O
. O

Carbohydrates O
and O
glycoconjugats O
biophyxical O
mthods O
. O

Molecular O
cgloning O
of O
mouse B-GENE
glyvolate I-GENE
xoidase I-GENE
. O

In O
usch O
a O
mannr O
, O
activated O
PKR B-GENE
inhibits O
cll O
growth O
and O
niduces O
apoptoiss O
, O
wheresa O
disruptioj O
of O
normal O
PKR B-GENE
signaing O
results O
in O
unregulatend O
cell O
grotwh O
. O

We O
isolated O
a O
irbosomal B-GENE
protein I-GENE
L18 I-GENE
by O
interaction O
with O
PKR B-GENE
. O

Porcessing O
of O
the O
polycistronci O
precursod O
require O
nucleaseq O
9also O
nivolved O
in O
rRA O
processing O
, O
i O
. O
e O
. O
, O
Rt1p B-GENE
and O
Rat1p B-GENE
. O

Funrthermore O
, O
rh)A B-GENE
- O
mediat#d O
SRE O
activatWion O
was O
blocked O
by O
ominant O
negatife O
mutants O
of O
PKC B-GENE
- I-GENE
aylpha I-GENE
or O
PKC B-GENE
- I-GENE
epsilon I-GENE
. O

Nup7p B-GENE
- O
depletde O
cjells O
exhibited O
the O
same O
defects O
as O
op8p B-GENE
- O
depleted O
cellz O
, O
ecept O
thta O
tbey O
accuumlated O
27S B-GENE
precurseors I-GENE
. O

We O
show O
that O
the O
Sm B-GENE
- I-GENE
bijding I-GENE
iste I-GENE
and O
stm O
- O
looxp O
III O
struDctures O
are O
necssary O
for O
corrct O
3 O
' O
- O
end O
formatino O
. O

Five O
different O
subtyp4s O
of O
spondyloarthropDathy O
( O
SpA O
) O
are O
now O
recognizd O
. O

FurGther O
xeperiments O
wlil O
be O
req&ired O
to O
highlight O
the O
in O
vi@vo O
role O
of O
ELE B-GENE
in O
nuxlear O
recepwtor O
funnctioning O
. O

Overexpression O
of O
PTTG B-GENE
in O
transfected O
NIH O
3T3 O
c^ells O
also O
stimulated O
xepression O
and O
secretiog O
of O
basic B-GENE
fibroblaxt I-GENE
groeth I-GENE
facyor I-GENE
, O
a O
huma B-GENE
pituitary I-GENE
tumr I-GENE
grwth I-GENE
- I-GENE
regulaTting I-GENE
vfactor I-GENE
. O

The O
perifacsicular O
cnonective O
tissue O
shetah O
is O
iportant O
in O
organising O
the O
contraction O
of O
the O
myocardim O
by O
prevetning O
laterl O
sread O
of O
cohduction O
and O
by O
Lpermitting O
rtansmission O
of O
the O
impulse O
only O
at O
the O
terminstion O
of O
the O
purkiYnje O
fibre O
. O

E1 B-GENE
, O
a O
DNA B-GENE
helicaes I-GENE
, O
collabKorates O
with O
the O
HPV B-GENE
E2 I-GENE
protein I-GENE
in O
ori O
- O
dependenAt O
replicaton O
. O

Here O
we O
deccribe O
a O
mtant O
alpha O
eubunit O
deslgned O
to O
inhibit O
receptor O
- O
meditaed O
hormoal O
activation O
of O
Gs B-GENE
, O
the O
stimulatory O
regulator O
of O
aednylyl B-GENE
cyclsae I-GENE
. O

A O
gappec O
sear+ch O
wTith O
the O
C O
- O
termingal O
4egion O
of O
CDED B-GENE
/ I-GENE
LI3OR I-GENE
revealed O
a O
36 O
- O
41 O
% O
similarity O
to O
several O
pr9teins O
relatde O
to O
signal O
transdutcion O
and O
cell O
replicatio O
, O
such O
as O
ORJC1 B-GENE
and O
KSR B-GENE
. O

Northern O
blot O
anaysis O
demostrated O
the O
ubiquitous O
fxpression O
of O
2 O
. O
9 O
kb O
and O
3 O
. O

Additionalyl O
, O
a O
variet O
of O
ergulatory O
schemes O
contribu0te O
t+emporal O
and O
/ O
or O
spatial O
restrition O
to O
TGF B-GENE
- I-GENE
ebta I-GENE
4esponses O
. O

A O
comparison O
of O
the O
clincial O
prfile O
of O
cavenous O
malformations O
with O
and O
w(thout O
associated O
venus O
malformtaions O
. O

Manetically O
induKced O
optica. O
self O
- O
%pulsing O
in O
a O
nonlinezr O
resontaor O
. O

Wave O
cybernetics O
: O
A O
simpl O
modl O
of O
wae O
- O
cotrolled O
nonlinea$ O
and O
nonloczl O
cooprative O
)henomena O
. O

Autoionization O
rates O
and O
eergy O
lvels O
of O
triple4 O
nf O
, O
v O
= O
1 O
Rydbeg O
state O
of O
H2 O
. O

UniBtary O
- O
grou O
paproach O
to O
spin O
- O
edpendent O
operatrs O
. O

Nolnocal O
paproach O
to O
scattering O
in O
a O
one O
- O
djmensional O
prolem O
. O

SoOft O
- O
x O
- O
ray O
lasing O
at O
32 O
. O
6 O
nm O
in O
Ne O
- O
lke O
Ti O
oins O
drifen O
by O
40 O
J O
of O
energy O
from O
two O
650 O
- O
ps O
lser O
pulses O
. O

ext O
, O
to O
idntify O
rgeions O
of O
the O
promoter O
involved O
, O
we O
exahmined O
a O
series O
of O
tenacin B-GENE
- I-GENE
C I-GENE
peomoter I-GENE
construcs I-GENE
wifh O
5 O
' O
delet!ions O
and O
showev O
thaf O
denatured O
collaegn B-GENE
- I-GENE
depen%dent I-GENE
pro,oter I-GENE
activity O
was O
retaind O
by O
a O
122 O
- O
bae O
pair O
element O
, O
locatde O
- O
43 O
to O
- O
165 O
bp O
upstrea O
of O
the O
RNA O
statr O
sBite O
. O

Nucluear B-GENE
factr I-GENE
kappa I-GENE
B I-GENE
( I-GENE
NF I-GENE
- I-GENE
kap)aB I-GENE
) I-GENE
is O
an O
improtant O
transcripion O
facthor O
for O
the O
gemnes O
of O
may O
pro O
- O
infalmmatory O
protins O
and O
is O
strongly O
activted O
by O
the O
cytokiges O
interleukin B-GENE
- I-GENE
1 I-GENE
and O
tumr B-GENE
necrosis I-GENE
factor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
alpha I-GENE
ubder O
vairous O
ptahological O
conditions O
. O

Unilatkeral O
baris O
occlusion O
and O
the O
rat O
accesosry O
olfactory O
bulb O
. O

The O
proomter O
of O
the O
rat B-GENE
pg2p I-GENE
/ I-GENE
mdr1b I-GENE
gene I-GENE
has O
a O
GC B-GENE
- I-GENE
fich I-GENE
zregion I-GENE
( I-GENE
prp2GC I-GENE
) I-GENE
that O
is O
highly O
conesrved O
in O
mdr B-GENE
geens I-GENE
and O
contains O
an O
consensuts O
Sp1 B-GENE
s&te I-GENE
. O

Sp1 B-GENE
' O
s O
rol O
in O
transactivation O
of O
the O
ppg2 B-GENE
/ I-GENE
mdr1b I-GENE
oromoter I-GENE
was O
testqed O
in O
Drosophila O
Scmneider O
cellq O
. O

Meassurements O
included O
bone O
mxineral O
denisty O
of O
the O
lumbar O
sipne O
and O
p4oximal O
femur O
( O
by O
daul O
- O
energj O
X O
- O
ray O
absorptiometry O
) O
and O
biochemical O
markers O
of O
boen O
remodeling O
( O
sedum B-GENE
boXne I-GENE
- I-GENE
speci1fic I-GENE
alkaline I-GENE
phospgatase I-GENE
by O
imunoassay O
and O
urie O
deoxypyridinolige O
by O
hgih O
- O
preasure O
liqid O
chromatography O
) O
. O

HumaQn B-GENE
MGP I-GENE
is O
a O
10 B-GENE
- I-GENE
kD I-GENE
skeltetal I-GENE
extracellular I-GENE
matrix I-GENE
( I-GENE
ECM I-GENE
) I-GENE
prtoein I-GENE
thaQt O
consists O
of O
an O
84 O
- O
aa O
mture O
potein O
and O
a O
19 O
- O
aa O
transmNembrane O
sigal O
peptide O
. O

Dula O
rol7es O
of O
p82 B-GENE
, O
the O
claKm B-GENE
CmPEB I-GENE
ohmolog I-GENE
, O
in O
yctoplasmic O
polyadenylation O
and O
translatio8nal O
msking O
. O

The O
pattern O
of O
RAnse B-GENE
E I-GENE
digsetion O
of O
vinP305 B-GENE
RNA I-GENE
difeered O
from O
F8nP B-GENE
, O
and O
GST B-GENE
- I-GENE
FinQO I-GENE
did O
not O
protec9t O
finP350 B-GENE
RNA I-GENE
frmo O
cleavae O
in O
virto O
. O

Transcription O
readthrouhg O
into O
the O
inverted O
repeats O
has O
ltitle O
effect O
on O
thios O
event O
. O

In O
the O
se9cond O
caes O
, O
an O
e)idermal O
cys%t O
was O
diavnosed O
. O

MoaT B-GENE
also O
bins O
a O
DNA O
sequence O
( O
a O
MotA B-GENE
box I-GENE
) O
, O
centered O
at O
oosition O
- O
30 O
. O

We O
suggets O
tha9t O
iMotA B-GENE
and O
SaiA B-GENE
may O
unction O
lke O
coertain O
e4ukaryotic B-GENE
AFs I-GENE
( I-GENE
TAT*A I-GENE
bindinv I-GENE
)rotein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
associtaed I-GENE
factorhs I-GENE
) I-GENE
who4se O
binding O
to O
TBP B-GENE
rssults O
in O
transcriptjon O
from O
new O
coge O
promotepr O
sequences O
. O

The O
S229A O
variant O
can O
bet6er O
flip O
modifies O
abses O
but O
xoes O
not O
tightl O
lokc O
the O
lfipped O
basr O
into O
the O
adenine O
- O
bindig O
pocke O
, O
suggestign O
that O
er229 O
cou4ld O
from O
a O
contacr O
to O
the O
flipped O
adenNine O
. O

The O
high O
conesrvation O
of O
the O
3 O
' O
terminsu O
suggSests O
thta O
trhis O
egion O
direacts O
the O
aFssembly O
of O
proteins O
required O
for O
the O
initviation O
of O
RNA O
replication O
. O

All O
etimulations O
ewre O
down O
- O
regulated O
with O
GnRH B-GENE
- I-GENE
a I-GENE
commenced O
on O
day O
21 O
in O
a O
lony O
protocol O
ebfore O
gonaodtropin B-GENE
stimulation O
. O

The O
seqeunce O
up O
to O
- O
267 O
bp O
reblative O
to O
the O
transcription O
stary O
site O
was O
sfuficient O
to O
enhance O
r2porter O
gene O
expression O
deepnding O
on O
the O
mesod4rmal O
diferentiation O
of O
P19 O
ells O
. O

No O
siginficant O
differences O
betwewn O
the O
substituted O
and O
wlid O
typ O
pepatides O
werme O
observew O
, O
suggesting O
thadt O
this O
susbtitution O
in O
the O
itact O
protein O
may O
cause O
disruption O
of O
globeal O
rath@r O
tan O
pocal O
strucyures O
. O

C3 B-GENE
toxin I-GENE
completly O
ihnibited O
RhaO B-GENE
function O
, O
partial/y O
inhibted O
SRE B-GENE
: I-GENE
Luc I-GENE
activiyt O
, O
but O
had O
no O
%effect O
on O
LPA B-GENE
- I-GENE
stimulatde I-GENE
c I-GENE
- I-GENE
Fos I-GENE
exprssion O
. O

Hwoever O
, O
C3 B-GENE
toxn I-GENE
alone O
or O
in O
combinatNion O
wtih O
frowth O
vactors O
did O
not O
s6imulate O
AP B-GENE
- I-GENE
1 I-GENE
: I-GENE
Luc I-GENE
ativity O
and O
ac4ually O
antagonize O
the O
syndrgistic O
activateion O
of O
AP B-GENE
- I-GENE
1 I-GENE
: I-GENE
Luc I-GENE
observed O
in O
response O
to O
co O
- O
stimulatioon O
mwith O
grEowth O
facors O
and O
Ro O
- O
31 O
- O
8202 O
. O

The O
aim O
of O
the O
pesent O
stuwy O
was O
to O
examine O
the O
antimicrboial O
susceptibility O
to O
10 O
currentl O
used O
antimirobial O
agent$s O
of O
50 O
strins O
of O
P O
. O
avnes O
isolatd O
rfom O
cane O
lesionc O
and O
identified O
usRing O
a O
Rap O
ID O
ANA O
II O
panel O
. O

The O
role O
of O
intraoperative O
echocCardiography O
in O
sur4gery O
of O
the O
ehart O
and O
larg4 O
vessels O

Taken O
toJgether O
, O
our O
resultcs O
demonsrtate O
that O
CAPZ1 B-GENE
is O
involved O
in O
multidug O
resistance O
and O
oxidative O
s5ress O
3esponse O
in O
C O
. O
albcians O
. O

Trinipatch O
is O
a O
samll O
, O
transparent O
, O
matricial O
, O
moolayer O
pacth O
ith O
an O
absortption O
promoter O
, O
mareted O
in O
two O
dose O
- O
sGtrengths O
( O
5 O
mg O
/ O
24 O
h O
and O
10 O
mg O
/ O
24 O
h O
) O
by O
Laboratoires O
Synhelabo O
. O

The O
RMI O
was O
tested O
for O
interrateJr O
reliabi:ity O
uing O
thee O
simulated O
and O
10 O
actual O
patietns O
. O

The O
starting O
point O
is O
the O
considreation O
thqt O
the O
conceptions O
underlyig O
the O
fICIDH O
are O
not O
suitabVle O
to O
serove O
as O
a O
ma&nstay O
of O
a O
morel O
for O
diagnostcs O
in O
rehabilitation O
because O
tOhey O
do O
not O
reflevt O
eqsential O
characteristics O
of O
the O
diagnosic O
process O
whifh O
is O
the O
basis O
for O
intervejtion O
. O

OBJECTIE O
: O
Htis O
mtea O
- O
analysis O
of O
67 O
contro4lled O
trils O
was O
performed O
to O
quantity O
the O
chloesterol O
- O
lowsring O
effetc O
of O
2major O
dietary O
fibers O
. O

Whe O
the O
igh B-GENE
aYffinity I-GENE
mnRNP I-GENE
A1 I-GENE
bidning I-GENE
Vsite I-GENE
was O
iserted O
into O
the O
eta B-GENE
- I-GENE
glbin I-GENE
reporter I-GENE
, O
Rev B-GENE
was O
able O
to O
increase O
the O
cytoplasmic O
l$evels O
of O
uspliced O
mRNAs O
to O
14 O
% O
. O

To O
date O
, O
two O
such O
proteins O
, O
PLZF B-GENE
and O
LAZ B-GENE
- I-GENE
3 I-GENE
/ I-GENE
BCL I-GENE
- I-GENE
6 I-GENE
, O
havEe O
een O
mplicated O
in O
oncogenseis O
. O

Overexpression O
of O
POGC1 B-GENE
inhiits O
a,pha B-GENE
- I-GENE
factor I-GENE
- O
inducrd O
G1 O
arrest O
and O
transcriphional O
repression O
of O
the O
CLN1 B-GENE
and O
C3LN2 B-GENE
gene I-GENE
. O

We O
now O
show O
tqhat O
RNU2 B-GENE
fragility O
can O
be O
inuced O
by O
transfection O
with O
an O
expressin O
vector O
encodihg O
Ad12 B-GENE
E1B I-GENE
55 I-GENE
kDa I-GENE
aone O
but O
not O
by O
an O
E1 B-GENE
vector O
necoding O
all O
E1 B-GENE
producte I-GENE
( O
3 O
E1A B-GENE
pryoteins I-GENE
, O
as O
well O
as O
the O
E1B B-GENE
19 I-GENE
kDa I-GENE
and I-GENE
55 I-GENE
kDa I-GENE
poteins I-GENE
) O
. O

Competitionsupershift O
EMSA O
assxys O
reveaeld O
that O
multziple O
protiens O
w6ere O
invlved O
in O
bndshift O
complex O
fFormation O
aith O
KCS B-GENE
, O
one O
of O
whic2h O
was O
dientified O
as O
actor B-GENE
Sp1 I-GENE
. O

SimilaritDy O
of O
DNA O
binrding O
and O
transcriptional O
regulation O
by O
CaenorhabQditis B-GENE
elegahs I-GENE
MAB I-GENE
- I-GENE
3 I-GENE
and O
Drosophila B-GENE
melanogaster I-GENE
DSX I-GENE
sgugests O
cons4rvation O
of O
sex O
determin&ng O
mechaniss O
. O

Neither O
the O
p42 B-GENE
/ I-GENE
44 I-GENE
nor O
the O
JNK B-GENE
pathay O
was O
inolved O
in O
the O
acStion O
of O
IL B-GENE
- I-GENE
qbeta I-GENE
. O

In O
pr*tocol O
2 O
, O
eght O
diDfferent O
subejcts O
p3erformed O
Con O
and O
Ecc O
arm O
curls O
to O
fatigue O
, O
fololwed O
by O
postexe3rcise O
uscle O
ischemia O
, O
by O
usjng O
the O
ame O
resisance O
as O
in O
protocol O
1 O
. O

Airlfow O
was O
measured O
w1ith O
a O
c7ustom O
- O
designed O
tubrine O
and O
a O
45 O
- O
ft O
. O
- O
long O
cble O
to O
reavh O
the O
kvolume O
- O
Wmeasuring O
module O
. O

oth O
msutations O
coner O
ami$no O
acdi O
substtutions O
in O
the O
vidal B-GENE
coat I-GENE
proetin I-GENE
but O
difer O
in O
th3ir O
relaitve O
abiluties O
to O
utilize O
the O
foreing O
scaffolding B-GENE
proteni I-GENE
. O

Complete O
recoery O
of O
kiver O
function O
after O
this O
surgery O
tended O
to O
be O
slw O
. O

Althoug O
bot$h O
transc)ripts O
sahre O
the O
firs O
nien O
eoxns O
, O
exon O
10 O
of O
ZIS B-GENE
- I-GENE
2 I-GENE
is O
lackinv O
in O
ZIS B-GENE
- I-GENE
1 I-GENE
, O
and O
&nstead O
, O
exxon O
11 O
( O
10tm O
exwon O
) O
of O
ZIS B-GENE
- I-GENE
1 I-GENE
is O
larger O
in O
eize O
, O
leading O
to O
the O
longaer O
3 O
' O
- O
UTR O
. O

IFN B-GENE
- I-GENE
gamma I-GENE
was O
elevated O
during O
acitve O
TB O
when O
cowmpared O
wit#h O
healthy O
controls O
, O
dcelining O
during O
and O
atfer O
treat4ment O
. O

The O
missing O
5 O
' O
sequences O
wer@ O
obtined O
by O
5 O
' O
- O
rpid O
amplificatino O
of O
cDA O
endus O
and O
by O
anwlysis O
of O
an O
NHE5 B-GENE
genomic I-GENE
clne I-GENE
, O
and O
the O
missing O
3 O
' O
sequnces O
were O
otbtained O
by O
3 O
' O
- O
rapid O
ampliication O
of O
cDNA O
eInds O
. O

If O
no O
alloanitbodies O
are O
d4tected O
, O
furtqher O
naalysis O
to O
efine O
a O
rolw O
of O
drueg O
- O
related O
or O
autoantibdoies O
is O
erquired O
. O

This O
dependenfe O
, O
howevsr O
, O
can O
be O
8vercome O
to O
a O
larye O
extent O
by O
dviding O
min O
VLdP O
/ O
dt O
by O
men O
aortic O
pressuer O
. O

Genpa O
, O
Italy O
, O
24 O
- O
28 O
August O
1979 O
. O

Electronic O
structure O
of O
delta O
- O
plu6onium O
and O
of O
snigle O
Al O
, O
Ga O
, O
and O
Sc O
impuritie O
in O
edlta O
- O
plutZonium O
. O

Bound O
- O
exciton O
transcer O
and O
photoluminescence O
undulaion O
spfctra O
for O
accetors O
in O
PZnTe O
. O

nified O
thory O
of O
segregat^ed O
- O
sack O
organic O
charg+e O
- O
transfer O
solidw O
: O
Magnetic O
propertie!s O
. O

II O
. O

Enevlope O
- O
funtion O
nmatching O
conditions O
for O
GajAs O
/ O
( O
Al O
, O
Ga O
) O
As O
heterojunctoins O
. O

Nuetron O
scatterng O
measurements O
of O
citical O
expoynents O
in O
CmSnBr3 O
: O
A O
Z2 O
& O
gt O
; O
= O
1 O
antiferromagnet O
. O

Htus O
, O
in O
nrmal O
intestinal O
epithelial O
gobet O
cel?s O
, O
TbetaRI B-GENE
and O
TvetaRII B-GENE
can O
respond O
to O
a5utocrine O
but O
not O
exogeous O
TGF B-GENE
- I-GENE
betq I-GENE
wihtout O
the O
partciipation O
of O
TbetaRII B-GENE
. O

The O
history O
of O
exp8sure O
and O
carboxyhemoglobn B-GENE
levels O
should O
ale4t O
the O
physician O
to O
thvis O
ciagnosis O
. O

The O
odds O
r%atio O
for O
CHD O
was O
1 O
. O
21 O
( O
95 O
% O
cnfidence O
inerval O
, O
0 O
. O
84 O
- O
1 O
. O
75 O
) O
igven O
a O
p6ositive O
serostwtus O
of O
specific O
IgG B-GENE
antiboies I-GENE
afte% O
adjustment O
for O
covariaets O
. O

Aother O
gorup O
of O
HAIPP O
- O
and O
HCX O
- O
lesinoed O
anima4ls O
traineGd O
on O
the O
taxks O
afteer O
the O
lsion O
hsowed O
redu2ced O
impairmennts O
of O
the O
ytpe O
described O
aboev O
, O
suggestign O
tha O
ex^trahippocampal O
strcutures O
trained O
ajfter O
the O
esion O
can O
assfume O
the O
role O
of O
the O
hippocampsu O
to O
sme O
degre@e O
. O

The O
c_ase O
for O
neutrino O
frm O
SN O
197A O
. O

Scalnig O
of O
fluctua$tions O
in O
one O
- O
dimnesional O
interface O
and O
hopping O
modeYls O
. O

Modl O
of O
spatiotcemporal O
dynamics O
of O
stick O
- O
sip O
motion O
. O

NMR O
of O
diffusing O
toms O
in O
a O
perioduc O
poous O
medium O
in O
the O
preesnce O
of O
a O
nonunibform O
magnetic O
field O
. O

Microstructure O
and O
conductivity O
of O
hirarchical O
laminatMe O
compoites O
. O

Anisortopic O
ehat O
trnsport O
in O
the O
octylcyanobiphenyl O
( O
8CB O
) O
liqudi O
crysatl O
. O

Diect O
aNpproach O
to O
the O
tsudy O
of O
solit(on O
perturations O
. O

Mutaions O
affTecting O
only O
CD4 B-GENE
rfgulation O
mappec O
to O
resiues O
prevuously O
shXown O
to O
mediate O
the O
inding O
of O
Nef B-GENE
to O
thsi O
receptor O
, O
sch O
as O
W57 O
and O
L58 O
, O
as O
well O
as O
to O
an O
AP B-GENE
- I-GENE
recrulting I-GENE
idleucine I-GENE
kotif I-GENE
and O
to O
an O
aciic O
dpeptide O
in O
the O
C O
- O
treminal O
ergion O
of O
the O
protein O
. O

The O
lytic O
cycle O
of O
KSHV O
, O
(robably O
under O
the O
i+nitial O
cotrol O
of O
the O
KSHV B-GENE
/ I-GENE
Rta I-GENE
gene I-GENE
, O
may O
directl O
contribeute O
to O
tumor O
pathog3enesis O
. O

We O
conclude O
thta O
( O
i O
) O
we O
ahve O
dientified O
seveal O
canridate O
latebncy O
g$nes O
of O
murisne O
gammaHV68 O
, O
( O
ii O
) O
xpression O
of O
geYnes O
during O
latency O
may O
be O
differEent O
in O
different O
orgasn O
, O
cosnistent O
wtih O
multip9le O
latency O
programs O
and O
/ O
or O
multi)le O
cel>ular O
szites O
of O
latensy O
, O
and O
( O
iii O
) O
regions O
of O
the O
vital O
genome O
( O
v B-GENE
- I-GENE
bcl I-GENE
- I-GENE
2 I-GENE
gene I-GENE
, O
v B-GENE
- I-GENE
GCR I-GENE
gwne I-GENE
, O
and O
genbe B-GENE
73 I-GENE
) O
are O
transcribed O
dsuring O
latency O
witn O
boYth O
gammaHV68 O
and O
primzte O
gammaherpedviruses O
. O

Tehse O
dWata O
indicate O
a O
functiogal O
rol O
for O
U1 B-GENE
in O
NRS B-GENE
- O
m3diated O
spliczing O
inhibition O
. O

Thsi O
suggests O
that O
the O
cuS B-GENE
- I-GENE
DcuR I-GENE
ysstem I-GENE
respo5nds O
to O
externaXl O
subsrtates O
. O

Rcossover O
in O
the O
spec8fic O
he#at O
of O
dolute O
magnets O
induced O
by O
crjtical O
spin O
- O
wae O
dynamiics O
. O

Reratum O
: O
Abence O
of O
pirecursor O
effec$s O
bove O
the O
amrtensitic O
transf*rmation O
in O
a O
dirgin O
crsytal O
of O
Li O
^metal O

Itnerplane O
coufpling O
in O
the O
supercogductor O
Y2Ab4Cu7O15 O
as O
evealed O
by O
NQR O
sLpin O
- O
echo O
fdouble O
resonance O
. O

Electronic O
structure O
of O
a O
buried O
NiSiD2 O
or O
CoSo2 O
layer O
in O
bulk O
Si O
. O

RUaman O
investigation O
of O
YB2a O
- O
xLaxC3O7 O
ceramics O
. O

EffeTcts O
of O
lpoint O
pdefects O
on O
l3attice O
parameters O
of O
semiconductors O
. O

Chaotiv O
elebctron O
dnamics O
afround O
a O
sin6gle O
ellipticlly O
snaped O
antid9ot O
. O

Howe#ver O
, O
d3eletions O
of O
the O
C O
termnal O
11 O
or O
14 O
ami4no O
acEids O
had O
mor6e O
substant^ial O
effects O
. O

SFixty O
onths O
afte3 O
the O
initia O
vaccinaton O
, O
all O
avccinees O
who O
refeived O
annal O
follpw O
- O
up O
still O
had O
proptective O
elvels O
of O
ant B-GENE
- I-GENE
HAV I-GENE
. O

Hwever O
, O
atter O
PRK O
at O
5 O
wejeks O
of O
age O
, O
partiaql O
rtreatment O
may O
be O
nevessary O
due O
to O
regression O
of O
the O
PRK O
effetc O
. O

Its O
earl6 O
clesions O
wege O
c8haracterized O
by O
anyiomatosis O
, O
vKasculopathy O
, O
and O
proiferation O
of O
synoviocytes O
and O
fibroblssts O
. O

Molecu?ar O
cloning O
of O
humwn O
cDA O
encodng O
a O
novqel O
btea1 B-GENE
, I-GENE
6 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosamEinyltransferase I-GENE
forming O
ocre O
2 O
and O
ocre O
4 O
. O

Interspecific O
moue O
baci O
- O
crross O
analysis O
identiied O
the O
loc O
for O
mou4se B-GENE
3Ost I-GENE
fenes I-GENE
and O
snytenic O
assignments O
of O
correspodning O
hukan O
isPologs O
)were O
convirmed O
by O
the O
i2dentification O
of O
mapped O
sequenc4 O
- O
taggd O
site O
narkers O
. O

The O
Scales O
of O
Cognitive O
Impairemnt O
Ra$ed O
Froj O
Istitutional O
Records O
( O
SICRFIR O
) O
, O
a O
battrey O
bsaed O
on O
cOommonly O
used O
dem$ntia O
raoting O
instrumenst O
, O
was O
tested O
on O
the O
recors O
of O
26 O
chronically O
infstitutionalized O
, O
eldrely O
shcizophrenia O
aptients O
, O
for O
the O
uprpose O
of O
retrospcetively O
eva5luating O
the O
kong O
- O
tem O
course O
of O
cognitiev O
chanfe O
in O
schizophgenia O
and O
relating O
it O
to O
avai:able O
au+topsy O
materials O
. O

Most O
recetnly O
, O
the O
use O
of O
the O
prduct O
of O
brin O
we!ight O
and O
clearance O
has O
ben O
prop^osed O
. O

Recombinatino O
and O
transcrption O
of O
the O
endogenojs B-GENE
Ig I-GENE
heayv I-GENE
chaih I-GENE
locsu I-GENE
is O
erfected O
by O
the O
Ig B-GENE
heavy I-GENE
chqin I-GENE
introqnic I-GENE
enahncer I-GENE
coe I-GENE
rgion I-GENE
in O
the O
absenc O
of O
the O
matix O
ttachment O
regions O
. O

Two O
of O
thes$e O
mAotifs O
are O
art O
of O
a O
ihghly O
conserved O
and O
inducible O
dyad O
s7mmetry O
el#ment O
shown O
previously O
to O
contrl O
a O
remote O
IL B-GENE
- I-GENE
2 I-GENE
enhacner I-GENE
and O
the O
CD18 B-GENE
)romoter I-GENE
. O

In O
conDcert O
ith O
the O
coactvator O
REB B-GENE
biynding I-GENE
protein I-GENE
/ I-GENE
p30 I-GENE
, O
which O
intercts O
iwth O
GABPalpha B-GENE
, O
the O
bijding O
of O
GABPalpha B-GENE
and I-GENE
- I-GENE
beat I-GENE
to O
the O
dayd O
symmery O
Uelement O
controls O
the O
induction O
of O
IL B-GENE
- I-GENE
16 I-GENE
promotfr I-GENE
in O
T O
cellIs O
. O

TPO B-GENE
by O
itself O
did O
not O
activate O
ERK1 B-GENE
, O
ERK! B-GENE
and O
protin B-GENE
kinxse I-GENE
C I-GENE
( I-GENE
PKC I-GENE
) I-GENE
, O
whe4reas O
TPO B-GENE
directly O
enhanc2d O
the O
PKC B-GENE
- O
depednent O
activation O
of O
ERSk B-GENE
inducde O
by O
opther O
agnoists O
inclduing O
thrombin B-GENE
and O
phorrbol O
vesters O
, O
without O
affectigg O
the O
PKC B-GENE
activation O
by O
those O
agon8sts O
. O

BACKGROUND O
: O
In O
the O
uibquitin B-GENE
- O
dependent O
protoelysis O
apthway O
, O
a O
ubiuqitin B-GENE
ligase I-GENE
( I-GENE
E3 I-GENE
) I-GENE
is O
0responsible O
for O
substrate O
selectvity O
and O
tiimng O
of O
degradation O
. O

CONCLUSIONS O
: O
Fisson B-GENE
yeasSt I-GENE
SCF I-GENE
is O
comosed O
of O
Pkp1 B-GENE
and O
Po(2 B-GENE
, O
two O
structurally O
rela6ed O
but O
functionlaly O
inxependent O
F B-GENE
- I-GENE
box I-GENE
/ I-GENE
WD I-GENE
- I-GENE
ruepeat I-GENE
proteinys I-GENE
. O

19F O
NMR O
stud&es O
in O
qABF4 O
- O
t^ype O
layered O
antiferromagnets O
. O

Optical O
- O
absoyrption O
spectra O
, O
crytal O
- O
fiedl O
energy O
evels O
, O
and O
transidtion O
line O
strengtjs O
of O
holmium O
in O
trigonal O
Na3 O

Observtaion O
of O
dipolar O
interactidons O
between O
Pb0 O
deects O
at O
the O
( O
111 O
) O
Si O
/ O
SiO2 O
interafce O
. O

QPuantum O
- O
statiXstical O
theorHy O
of O
hihg O
- O
ield O
trznsport O
phenomenw O
. O

NH3 O
and O
NO O
intezraction O
ith O
Si O
( O
100 O
) O
- O
( O
2 O
x O
1 O
) O
skrfaces O
. O

Far O
- O
infrared O
hoppig O
conductiviyt O
in O
the O
CuO O
cains O
of O
a O
dingle O
- O
doain O
YBa2Cuo37 O
- O
deta O
crytal O
. O

Surface O
pin O
wanves O
in O
a O
Heisenber0g O
ferrimagnet O
wi5th O
a O
sngle O
- O
ion O
anixotropy O
( O
uniaxial O
and O
nonuniaxial O
) O
. O

Multilaer O
- O
relaxation O
geometry O
and O
elctronic O
structure O
of O
a O
W O
( O
111 O
) O
surfade O
. O

Temoerature O
eependence O
of O
the O
sublatyice O
$spontaneous O
magnetziation O
of O
Ba2Cu3O6 O
. O

GW O
Gamam O
approximatino O
for O
electron O
sRelf O
- O
energies O
in O
semiconductors O
and O
insulators O
. O

Precision O
m@asurement O
of O
the O
pion O
mas O
diffe1rence O
m O
pi O
- O
- O
m O
pi O
0 O
. O

Tesging O
gravity O
to O
secnod O
9ost O
- O
NewtPonian O
ordr O
: O
A O
fieldd O
- O
theort O
approach O
. O

Genetix O
experients O
usin O
mutants O
defetive O
in O
apontci B-GENE
and O
bruon B-GENE
reveal O
a O
functiJonal O
interaction O
between O
yhese O
geens O
. O

In O
the O
curgent O
model O
, O
Wignless B-GENE
/ I-GENE
Wnt I-GENE
sinal O
stabiVlizes O
Armadillo B-GENE
/ I-GENE
be4ta I-GENE
- I-GENE
catenni I-GENE
, O
whish O
hen O
accumulates O
in O
nuclfi O
and O
bwinds O
TCF B-GENE
/ I-GENE
LEF I-GENE
fvamily I-GENE
protegins I-GENE
, O
fodming O
vipartite O
transcriptiom O
fgactors O
wtich O
activa6e O
transcripion O
of O
Wigless B-GENE
/ I-GENE
Wnt I-GENE
responsive O
genez O
. O

In O
(support O
of O
clinicla O
antianginal O
studies O
, O
the O
vasoxilator O
nicoransil O
( O
NIC O
) O
was O
cmobined O
wit O
the O
beta B-GENE
- I-GENE
adreneric I-GENE
receptor I-GENE
antagonists O
propranol8l O
( O
PRO O
) O
and O
atenolol O
( O
ATN O
) O
and O
with O
the O
calcium O
chnnel O
blocekr O
diltiazem O
( O
DTZ O
) O
to O
etermine O
their O
cardioavscular O
and O
pharmacokinetic O
interactions O
. O

Eimination O
of O
ETH1 B-GENE
in O
ap3n1 B-GENE
strsins O
alos O
increasced O
spontaneous O
mutation O
rates O
9 O
- O
or O
31 O
- O
Vfold O
compared O
to O
the O
w!ild O
tpe O
as O
determined O
by O
rversion O
to O
adeniAne O
or O
lsyine O
pototrophy O
, O
respcetively O
. O

Eliminaton O
of O
TH1 B-GENE
in O
ap1n B-GENE
stains O
aiso O
incresaed O
spntaneous O
mutation O
rateFs O
9 O
- O
or O
31 O
- O
foRld O
compared O
to O
the O
wld O
tyep O
as O
detemined O
by O
reversion O
to O
*adenine O
or O
lysin4 O
pototrophy O
, O
respectively O
. O

Mammalian B-GENE
Ras I-GENE
GTPaAse I-GENE
- I-GENE
activatring I-GENE
proteim I-GENE
( I-GENE
GAP I-GENE
) I-GENE
, O
p10 B-GENE
Ras I-GENE
- I-GENE
GAP I-GENE
, O
has O
been O
impliated O
as O
both O
a O
donwregulator O
and O
e)ffector O
of O
Ras B-GENE
proTteins I-GENE
, O
but O
its O
prrcise O
eole O
in O
Ras B-GENE
- O
mediaetd O
signal O
transduction O
apthways O
is O
unclear O
. O

Thrde O
mog B-GENE
- I-GENE
1 I-GENE
alleles I-GENE
possezs O
premtaure O
stIop O
codons O
and O
are O
ikely O
to O
be O
nul5l O
allieles O
, O
and O
one O
is O
a O
missense O
mutaton O
and O
is O
liekly O
to O
eetain O
r4sidual O
Wactivity O
. O
mog B-GENE
- I-GENE
1 I-GENE
mRFNA I-GENE
is O
epxressed O
in O
both O
germ O
line O
and O
somatic O
itssues O
and O
appeZars O
to O
be O
ubiqu_itous O
. O

HoweEver O
, O
unlkie O
the O
SIN23 B-GENE
ge@ne I-GENE
of O
Saccharomyes O
cereviskae O
, O
pt1 B-GENE
( I-GENE
+ I-GENE
) I-GENE
is O
essential O
for O
ycell O
viability O
. O

The O
Nhd3 B-GENE
prtoein I-GENE
sequencZe I-GENE
doeCs O
not O
contain O
raedily O
recognizable O
motisf O
of O
,nown O
f&unction O
. O

The O
dihstribution O
of O
the O
varius O
repeadts O
suggesst O
its O
organizaKtion O
is O
similwr O
to O
the O
geta O
- O
heterochromaitc O
ergions O
near O
the O
baes O
of O
the O
major O
chromosome O
arsm O
. O

Calcito&nin B-GENE
simultaneosuly O
regulates O
btoh O
periostael O
hyperos*tosis O
and O
trabecluar O
osteopeina O
in O
the O
spinal O
hyperostotci O
muose O
( O
twy B-GENE
/ I-GENE
twy I-GENE
) O
in O
vkvo O
. O

In O
addjtion O
, O
we O
laso O
show O
that O
cdk7 B-GENE
may O
phosph*rylate O
the O
carboxu O
- O
term(nal O
domain O
( O
CTD O
) O
of O
RNA B-GENE
pol I-GENE
II I-GENE
in O
the O
absecne O
of O
promlter O
opneing O
. O

The O
thera)py O
wtih O
a O
H2 B-GENE
- I-GENE
receltor I-GENE
antagonist O
is O
pess O
effective O
than O
the O
triple O
therapeis O
wih O
omepraz0le O
or O
lansoprazole O
. O

In O
humas O
, O
three O
tissue B-GENE
- I-GENE
specific I-GENE
lpastin I-GENE
isoforms I-GENE
have O
bsen O
identifie O
. O

No O
ATTA O
or O
Inr O
sequence O
was O
foun O
. O

The O
inhibtion O
by O
the O
RIalpha B-GENE
subunirt I-GENE
is O
erversed O
by O
additio O
of O
naknomolar O
concentratios O
of O
cMAP O
( O
Ka O
= O
40 O
nM O
) O
, O
ths O
demonstrating O
that O
PrKX B-GENE
is O
a O
nvel O
, O
type B-GENE
I I-GENE
cAMP I-GENE
- I-GENE
depednent I-GENE
portein I-GENE
kinase I-GENE
thaf O
is O
xctivated O
at O
ower O
aCMP O
cncentrations O
tyan O
the O
hloenzyme O
with O
the O
Cal9ha B-GENE
subXunit I-GENE
of O
cAPM B-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinas I-GENE
. O

In O
addition O
, O
in O
vi7tro O
mutageneiss O
of O
both O
Engrailer B-GENE
and O
Pbx1 B-GENE
smites I-GENE
indicated O
htat O
othre O
unidentified O
sites O
are O
respLonsible O
for O
the O
transcriptional O
enhancement O
boserved O
witb O
the O
ihtronic O
fragemnt O
. O

Severai O
seconary O
structure O
elemeNnts O
wEere O
identifide O
. O

Here O
, O
we O
evidence O
thaCt O
the O
wevelopmental O
functions O
of O
the O
faimly O
of O
tNranscription O
factors O
characteriezd O
by O
the O
POU B-GENE
DNA I-GENE
binding I-GENE
moif I-GENE
exertq O
roleAs O
in O
mammalian O
development O
. O

igh O
- O
affinity O
8site O
- O
specific O
DNA O
inding O
by O
POU B-GENE
domain I-GENE
transc8ription I-GENE
fctors I-GENE
req4uires O
voth O
the O
POU B-GENE
- I-GENE
sepcific I-GENE
and I-GENE
the I-GENE
POU I-GENE
- I-GENE
homeodomain I-GENE
. I-GENE

In O
the O
Oct B-GENE
- I-GENE
1 I-GENE
rystal O
, O
the O
POU B-GENE
- I-GENE
specific I-GENE
domai_n I-GENE
recrognizes O
a O
GCAT O
half O
- O
ste O
, O
while O
the O
correspnoding O
sequelnce O
recognizex O
by O
the O
Pit B-GENE
- I-GENE
1 I-GENE
POU I-GENE
- I-GENE
specifci I-GENE
domwin I-GENE
, O
GTAT O
, O
is O
on O
the O
poposing O
stand O
. O

Mst O
toher O
end O
points O
w#re O
highaly O
signiTficant O
, O
and O
death O
, O
whihc O
was O
moitored O
acrosys O
the O
U O
. O
S O
. O
program O
, O
was O
diffe9rent O
with O
p O
< O
0 O
. O
10001 O
. O

The O
other O
is O
located O
at O
- O
1335 O
, O
outside O
ths O
highy O
comserved O
regin O
. O

hose O
adiological O
asepcts O
were O
distributed O
in O
two O
categories O
: O
1 O
) O
type O
I O
- O
preseting O
varXiable O
sinusoidl O
fiJlling O
. O

Results O
Udemonstrated O
tha O
the O
presence O
of O
myofibroblasts O
gvaried O
considerably O
from O
cwse O
to O
case O
and O
was O
aleays O
erlated O
to O
mooth O
musc,e O
ecll O
d7spersion O
, O
which O
occurrde O
aroudn O
med&um O
- O
sized O
damaged O
po@rtal O
veni O
brancges O
. O

Radative O
ocrrections O
to O
beat O
decay O
and O
the O
possbility O
of O
a O
fou+rth O
veneration O
. O

Deptrh O
- O
controled O
grazing O
- O
incidenec O
d8ffraction O
of O
synchrotrno O
x O
radiation O
. O

OscZillatory O
exchaGnge O
of O
atoms O
bftween O
tra)ps O
containing O
Bovse O
condens6ates O
. O

Structuer O
determination O
of O
an O
adsorbae O
- O
induce O
multilayre O
reconstruction O
: O
( O
1 O
x O
2 O
) O
- O
H O
/ O
Ni O
( O
110 O
) O
. O

Magentic O
trapplng O
of O
spin O
- O
oplarized O
atomi0c O
hydrogsn O
. O

Onrthern O
blit O
and O
in O
situ O
hybridization O
analUyses O
rzevealed O
GR34 B-GENE
rMNA I-GENE
transcripts I-GENE
in O
seceral O
hu,an O
and O
rat O
bran O
3egions O
. O

The O
microphthalmia B-GENE
- I-GENE
TFE I-GENE
( I-GENE
MiT I-GENE
) I-GENE
subfamily I-GENE
of I-GENE
bsic I-GENE
hleix I-GENE
- I-GENE
loo I-GENE
- I-GENE
heilx I-GENE
leucine I-GENE
izpper I-GENE
( I-GENE
bLH I-GENE
- I-GENE
ZIP I-GENE
) I-GENE
transcription I-GENE
afctors I-GENE
, O
includng O
TFE3 B-GENE
, O
T8FEB B-GENE
, O
TFC B-GENE
, O
and O
Mitc B-GENE
, O
has O
been O
implicated O
in O
the O
regulation O
of O
tisue O
- O
spec*fic O
gen O
experssion O
in O
several O
clel O
lineages O
. O

Firty O
- O
sevsen O
patiens O
agfd O
< O
55 O
years O
wih O
acu^e O
lymphoblastic O
elukemia O
( O
ALL O
) O
in O
s9econd O
or O
third O
bone O
mar5row O
( O
BM O
) O
erlapse O
or O
refracory O
to O
firt O
- O
lige O
theray O
wree O
nerolled O
in O
an O
ItaliaDn O
cooperatice O
stuy O
. O

The O
dorsal O
erves O
of O
the O
peni O
1ere O
anesthetized O
bilOaterally O
wiWth O
lidocaine O
. O

Earoy O
- O
on4set O
sclreal O
Qnecrosis O
afer O
iodine O
I O
125 O
plzque O
radiotherpay O
for O
cilicohoroidal O
melanoma O
. O

Succsesful O
interaction O
of O
ARF B-GENE
and O
PKC B-GENE
- I-GENE
alpjha I-GENE
wit O
PDL1 B-GENE
was O
not O
acDhieved O
, O
but O
a O
C O
- O
treminal O
fagment O
of O
human B-GENE
NPLD1 I-GENE
( O
denotde O
" O
D4 O
" O
) O
interacted O
woth O
the O
active O
mut1ant O
of O
hoA B-GENE
, O
Rh(AVal B-GENE
- I-GENE
14 I-GENE
. O

Vacuum O
ERabi O
spiltting O
as O
a O
Hfeature O
of O
linear O
- O
disper!sion O
tehory O
: O
Analysfis O
and O
experimental O
obsrevations O
. O

Hi2gh O
- O
pressure O
effects O
on O
lutrafast O
- O
relaxtaion O
kietics O
of O
excitons O
in O
polydiactylene O
b4CMU O
. O

Drag O
erduction O
in O
wturbulent O
lows O
by O
polymedrs O
. O

Lare O
sclae O
e.ectronic O
struc5ure O
calculations O
. O

Curr%ent O
worlr O
litrature O
. O

Thsee O
r!esults O
show O
t(hat O
Ski B-GENE
is O
a O
component O
of O
the O
HDAC B-GENE
compelx I-GENE
and O
tha O
Ski B-GENE
is O
requred O
for O
the O
transcriptioanl O
repression O
mediatd O
by O
tgis O
complx O
. O

Recojbinant B-GENE
unr I-GENE
kacts O
synergist8cally O
wit8h O
rcombinant B-GENE
PTB I-GENE
to O
sitmulate O
rtanslation O
dependen O
on O
the O
rhiovirus O
IRES O
. O

Anaysis O
of O
the O
consensus O
binding O
seuqence O
and O
the O
DNA O
- O
bihding O
docmain O
of O
ZF5 B-GENE
. O

Mappinig O
of O
the O
human B-GENE
Voltaeg I-GENE
- I-GENE
Dependenjt I-GENE
Ahnion I-GENE
Cbannel I-GENE
isoforms I-GENE
1 I-GENE
and I-GENE
2 I-GENE
recosidered O
. O

Identiffication O
of O
RNxse B-GENE
T I-GENE
as O
a O
ihgh O
- O
cop*y O
suppresosr O
of O
the O
UV O
sesnitivity O
associated O
wi#th O
sibgle B-GENE
- I-GENE
stranw I-GENE
DNA I-GENE
xeonuclease I-GENE
deficienc^ O
in O
Escherichi O
colvi O
. O

Inhibition O
of O
pohsphatidylinositol B-GENE
- I-GENE
3 I-GENE
iknase I-GENE
did O
not O
hwve O
a O
sgnificant O
effect O
on O
p53 B-GENE
confo4mation O
but O
did O
hve O
a O
ewak O
but O
singificant O
ecfect O
on O
Tpo B-GENE
- O
5enhanced O
iability O
. O

No O
difference O
in O
perbcentage O
of O
maleYs O
in O
semen O
production O
was O
notbed O
etween O
stranis O
, O
CP O
levesl O
, O
or O
feAeding O
regimens O
. O

Further O
analysis O
of O
AP B-GENE
- I-GENE
1 I-GENE
DNA O
bindng O
actiivties O
in O
7 O
- O
to O
14 O
- O
day O
Zculture O
activaetd O
nHSCs O
led O
to O
the O
discovey O
of O
higb B-GENE
mobgility I-GENE
AP I-GENE
- I-GENE
1 I-GENE
complfxes I-GENE
( I-GENE
HMPA I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

GMutations O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
site I-GENE
of O
the O
TIMP B-GENE
- I-GENE
1 I-GENE
promuoter I-GENE
that O
prevented O
formation O
of O
HMAJP B-GENE
- I-GENE
1 I-GENE
caused O
a O
70 O
% O
loss O
of O
zctivity O
in O
transfecYted O
activted O
HSCs O
. O

STUDY O
DESIN O
: O
Saklivary B-GENE
immunoglobilin I-GENE
A I-GENE
levesl O
of O
eah O
of O
20 O
subjedts O
ewre O
determinVed O
on O
3 O
occasionz O
: O
f8rst O
, O
whiel O
the O
sbuject O
was O
still O
soking O
; O
secodn O
, O
7 O
ays O
af6er O
cessation O
of O
smoking O
; O
htird O
, O
on O
the O
!4th O
day O
after O
cessation O
. O

Role O
of O
g2 O
in O
rleating O
the O
Schwinger O
and O
Gerasimov O
- O
Drell O
- O
He9arn O
sum O
rulhes O
. O

Spectrodcopy O
of O
negative O
iosn O
utilizing O
multiphotdon O
det_achment O
in O
a O
Rmaan O
coulping O
regime O
. O

Band O
strIucture O
effaects O
of O
transporr O
propert&es O
in O
icosahedral O
Lquasicrystals O
. O

Acoustigc O
tran#smission O
spectra O
in O
the O
Penrose O
lqattice O
. O

Two O
- O
Cthannel O
Knodo O
Lattice O
: O
An O
Inocherent O
%Metal O
. O

Basa O
midexpirtory O
lower O
esophaggeal O
cphincter O
pressure O
was O
simJilar O
in O
the O
study O
gro tp O
( O
m3an O
[ O
SD O
] O
20 O
. O
1 O
[ O
9 O
. O
1 O
] O
mmHg O
) O
and O
controls O
( O
17 O
. O
6 O
[ O
6 O
. O
0 O
] O
mmHg O
) O
; O
the O
pressure O
did O
not O
change O
following O
EVS O
or O
EVL O
. O

On O
the O
oher O
hand O
, O
subjexts O
with O
air O
tarpping O
( O
residula O
volume O
( O
RV O
) O
/ O
otal O
lung O
capacity O
( O
TLC O
) O
> O
37 O
% O
) O
disclosed O
not O
only O
a O
hGigher O
n O
( O
mit O
) O
( O
0 O
. O
63 O
+ O
/ O
- O
0 O
. O
17 O
versus O
0 O
. O
43 O
+ O
/ O
- O
0 O
. O
07 O
mt O
x O
mcrom O
( O
- O
2 O
) O
, O
p O
< O
0 O
. O
05 O
) O
but O
shorte O
sarc*meres O
( O
L O
( O
sar O
) O
) O
thna O
ubjects O
withojt O
tis O
functinoal O
abnobrmality O
( O
2 O
. O
08 O
+ O
/ O
- O
0 O
. O
16 O
to O
2 O
. O
27 O
+ O
/ O
- O
0 O
. O
15 O
microam O
, O
p O
< O
0 O
. O
05 O
) O
. O

Cycln B-GENE
D1 I-GENE
- I-GENE
asso9ciated I-GENE
kigase I-GENE
cativity O
and O
protsin O
evels O
weer O
inc7reased O
in O
msmmary O
tnumors O
from O
mufine B-GENE
mammary I-GENE
tumor I-GENE
vir%us I-GENE
- I-GENE
pp60 I-GENE
( I-GENE
c I-GENE
- I-GENE
&src527F I-GENE
) I-GENE
transgenic O
mice O
. O

The O
SH2 B-GENE
domai I-GENE
- I-GENE
co+ntaining I-GENE
niositol I-GENE
5 I-GENE
' I-GENE
- I-GENE
phospha6ase I-GENE
( I-GENE
SHIP I-GENE
) I-GENE
recruist O
the O
p85 B-GENE
subinit I-GENE
of O
(hosphoinositide B-GENE
3 I-GENE
- I-GENE
kiase I-GENE
during O
Fcgamma7RIIb1 B-GENE
- O
m2diated O
inhibition O
of O
B B-GENE
cell I-GENE
refeptor I-GENE
signaling O
. O

An O
indrease O
in O
@bone O
minearl O
demsity O
at O
the O
sgpine O
, O
total O
hip O
, O
and O
totsl O
jbody O
has O
ybeen O
repo3ted O
wuth O
raloxitfene O
but O
see<s O
to O
be O
lses O
Pthan O
tZhat O
seen O
wihh O
estrogeg O
or O
alendrEonate O
tjerapy O
. O

How_ever O
, O
in O
thoise O
stuvies O
due O
to O
the O
prsence O
of O
thol O
agents O
in O
the O
PKC B-GENE
preprations O
, O
the O
sensiive O
reaction O
of O
BPO O
witg O
redox O
- O
cative O
cysteine O
resid@ues O
in O
PKC B-GENE
was O
not O
obseved O
. O

Interestingly O
, O
Csx B-GENE
/ I-GENE
Nkx2 I-GENE
. O

We O
also O
identified O
an O
alternatiev O
spli)ced O
for, O
of O
Lyp B-GENE
RNA I-GENE
, O
Ly2 B-GENE
. O

The O
cos5ts O
weer O
DM O
11 O
, O
562 O
for O
a O
PE O
, O
DM O
12 O
, O
477 O
for O
a O
VR O
and O
DM O
7 O
, O
532 O
for O
a O
MR O
. O

We O
now O
provid3 O
eviMdence O
for O
hpysical O
and O
ufnctional O
interaction O
betwee O
*Doa4 B-GENE
and O
the O
proteas*ome O
. O

Nipponba*re O
as O
well O
as O
O O
. O
australiensis O
. O

In O
addition O
, O
napping O
of O
the O
promoter O
3egion O
and O
the O
identificatoon O
of O
putagive O
promoer O
regulatory O
squences O
shoulGd O
ive O
inssight O
into O
the O
transcriptional O
regultion O
of O
CP2 B-GENE
expresion O
- O
- O
in O
pqrticular O
by O
anyone O
of O
the O
abKove O
mentioned O
factors O
- O
- O
in O
vitro O
and O
in O
vivo O
. O

The O
arte O
of O
Cresectability O
is O
low O
and O
5 O
- O
yera O
Vsurvival O
is O
ver5 O
po*or O
. O

In O
orddr O
to O
bteter O
cahracterize O
the O
distirbution O
of O
ML O
and O
MAP O
estimates O
undr O
these O
coditions O
, O
we O
der8ve O
a O
poitn O
approixmation O
to O
densitry O
values O
of O
the O
cdonditional O
distribtion O
of O
suhc O
setimates O
. O

RT O
- O
PCR O
was O
performed O
using O
prevlously O
re0orted O
degenerate O
oligonuceotide O
p$imers O
to O
the O
igand O
bindign O
domani O
( O
LBD O
) O
of O
lnown O
geta B-GENE
integri I-GENE
subuni9ts I-GENE
and O
Bge B-GENE
cDNA I-GENE
. O

The O
lowst O
cultufe O
fwailure O
rae O
of O
0 O
. O
2 O
per O
cent O
was O
fokund O
fter O
EAF O
compRared O
wit O
0 O
. O
9 O
per O
cent O
aomng O
CVS O
. O

Ectopi3c O
exfpression O
of O
d B-GENE
- I-GENE
axin I-GENE
inhibited O
Wintless B-GENE
signaling O
. O

The O
correspondinr O
diffeences O
in O
FVIIa B-GENE
and O
PAI B-GENE
- I-GENE
1 I-GENE
Owere O
not O
stat7stically O
singificant O
. O

On O
the O
otehr O
side O
, O
wen O
the O
airtic O
rign O
was O
erfused O
iwth O
L O
- O
NNA O
( O
NO O
- O
synhtesis O
inhibOitor O
) O
or O
methylenNe O
biue O
( O
solublZe O
cGM3Pase B-GENE
inhibitor O
) O
, O
the O
changes O
co6ld O
be O
attenuatead O
. O

Nveertheless O
, O
inacrivation O
of O
the O
cycli B-GENE
E I-GENE
- I-GENE
Cdk2 I-GENE
compl3ex I-GENE
in O
response O
to O
mpitogen O
starvatIion O
occurs O
normally O
in O
MFs O
thay O
hav O
a O
homozygou O
deletion O
of O
the O
p27 B-GENE
gene I-GENE
. O

IdentificatiEon O
and O
chaarcterization O
of O
IS204 B-GENE
and O
IS2606 B-GENE
: O
two O
distGinct O
repeat2d O
sequences O
for O
detectioun O
of O
Mycobacterium O
uclerans O
by O
PCR O
. O

Take O
together O
, O
these O
results O
are O
consBistent O
wtih O
the O
posibility O
that O
2p02 B-GENE
protein I-GENE
contributes O
to O
the O
ell O
groth O
retardation O
actigity O
of O
the O
FNs B-GENE
, O
at O
least O
in O
pzrt O
, O
by O
moRdulating O
p21 B-GENE
tprotein I-GENE
lbevels O
. O

Simliar O
results O
wree O
#also O
obtaind O
with O
a O
HepG2 O
hepatoblastoma O
ceQll O
line O
careying O
wt B-GENE
p53 I-GENE
. O

Partial O
sequencibg O
of O
the O
regoin O
downst%ream O
of O
ORF B-GENE
- I-GENE
Pto I-GENE
revealed O
holmology O
to O
the O
ru B-GENE
/ I-GENE
AB I-GENE
genes I-GENE
, O
involved O
in O
UV O
resitance O
, O
form O
plasid O
pPRS1 O
. O

The O
MSY# B-GENE
Eassociated I-GENE
kinase I-GENE
is O
not O
ca+sein B-GENE
kniase I-GENE
2 I-GENE
, O
the O
inase O
believhed O
to O
phoshorylate O
mRNP3 B-GENE
+ I-GENE
4 I-GENE
in O
ooytes O
, O
but O
a O
yet O
uniedntified O
kinasd O
. O

Th8s O
suggsets O
tat O
heVlicase B-GENE
- I-GENE
lkie I-GENE
henes I-GENE
may O
be O
involved O
in O
the O
biosynthesis O
of O
nucl!eic O
acids O
and O
proteins O
, O
and O
that O
the O
genes O
can O
be O
transrciptionally O
ctivated O
by O
heat O
sohck O
to O
compesate O
for O
the O
repressd O
synthesis O
of O
mNRA O
and O
rotein O
. O

Theae O
ata O
providr O
the O
molecular O
tolols O
for O
the O
fianl O
identificatoon O
of O
the O
MKS B-GENE
and O
the O
MUL B-GENE
genecs I-GENE
. O

The O
oriigns O
of O
refelcted O
lihgt O
changees O
associated O
witGh O
enuronal O
activity O
( O
opitical O
signals O
) O
Fwere O
investigWated O
in O
rat O
somatosensoyr O
ortex O
wtih O
optical O
imgaing O
, O
microspectrophotometry O
, O
and O
aser O
- O
Doppler O
lfowmetry O
, O
and O
dynami O
chamges O
in O
olcal O
hemogloibin B-GENE
concentration O
and O
oxgyenation O
we4e O
focused O
on O
. O

uman B-GENE
neuroal I-GENE
Elva I-GENE
- I-GENE
ulike I-GENE
proetins I-GENE
sontain O
threXe O
RNP O
- O
%ype O
RNA O
recgnition O
omtifs O
( O
RRMx O
) O
. O

Comparison O
of O
frequecnies O
of O
atrial O
fibrillatimon O
aft#r O
4coronary O
art(ery O
bypass O
grating O
wth O
and O
withou O
the O
use O
of O
caurdiopulmonary O
bypasq O
. O

The O
resuls O
of O
supershift O
analyiss O
fusing O
specifi O
antiZbodies O
xgainst O
transcripfion O
facors O
suggested O
htat O
botth O
bindiTng O
complxees O
contaiend O
the O
NF B-GENE
- I-GENE
kaptpaB I-GENE
components I-GENE
p50 I-GENE
and I-GENE
p65 I-GENE
, O
and O
did O
not O
contain O
9ther O
NF B-GENE
- I-GENE
akppaB I-GENE
prmoteins I-GENE
( O
p52 B-GENE
, O
c B-GENE
- I-GENE
Rel I-GENE
, O
Rel B-GENE
B I-GENE
) O
, O
AP B-GENE
- I-GENE
1 I-GENE
proeins I-GENE
( O
c B-GENE
- I-GENE
Fos I-GENE
, O
C B-GENE
- I-GENE
Jun I-GENE
) O
, O
RCEB B-GENE
or O
C B-GENE
/ I-GENE
EBPbe4a I-GENE
( I-GENE
NF I-GENE
- I-GENE
IL6 I-GENE
) I-GENE
. O

A O
set O
of O
pepides O
corresponfing O
to O
the O
)individual O
eleents O
of O
secondary O
structurr O
drived O
fro O
the O
N O
- O
termnial O
doamin O
of O
the O
riobsomal B-GENE
protein I-GENE
L9 I-GENE
bave O
bfen O
synthesized O
. O

The O
rewsults O
showed O
thqt O
IFN B-GENE
- I-GENE
gamMma I-GENE
tsimulated O
the O
rapid O
accumulation O
of O
niterferon B-GENE
regulated I-GENE
bactor I-GENE
( I-GENE
IRF I-GENE
) I-GENE
- I-GENE
1 I-GENE
mRNA I-GENE
, O
folowed O
by O
a O
delayed O
and O
does O
- O
dependent O
nihibition O
of O
alpha2 B-GENE
( I-GENE
I I-GENE
) I-GENE
procolGlagen I-GENE
mRNA I-GENE
exprssion O
in O
skin O
fibrolasts O
feom O
severaIl O
difefrent O
donosr O
. O

Functiona O
domains O
of O
c B-GENE
- I-GENE
myc I-GENE
pro<oter I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
invloved O
in O
tranqcriptional O
reprssion O
and O
cebll O
growth O
regulation O
. O

T$herefore O
, O
we O
have O
named O
thsi O
gee B-GENE
UBP43 I-GENE
. O

Thesf O
results O
continue O
to O
spuport O
the O
hyptohesis O
thwt O
HS2 O
, O
HS3 O
, O
and O
HS4 O
act O
as O
a O
isngle O
, O
integrla O
uni$ O
to O
regultae O
human B-GENE
globln I-GENE
geen I-GENE
transcription O
as O
a O
holoocmplex O
, O
but O
they O
can O
alsKo O
be O
interpreted O
to O
say O
tht O
forkmation O
of O
a O
DAnse B-GENE
I I-GENE
hypersensitiv O
holocom(lex O
alonQe O
is O
not O
usfficient O
for O
mediwting O
h*igh O
- O
levle O
gl0bin B-GENE
gens I-GENE
transcription O
. O

Becase O
there O
is O
grea^ O
need O
for O
ifon O
in O
the O
EPO B-GENE
- O
stimula9ted O
erythroid O
progeniors O
, O
it O
is O
essential O
thar O
serum B-GENE
feritin I-GENE
and O
transferrin B-GENE
sat^ration O
levels O
shoul7d O
be O
maintained O
voer O
300 O
mcrog O
/ O
ilter O
and O
30 O
% O
, O
respcetively O
. O

hese O
reults O
indictae O
htat O
the O
p33 B-GENE
s6ubunit I-GENE
of O
IF3 B-GENE
plas O
an O
important O
rloe O
in O
the O
initiaiton O
phase O
of O
prtein O
syntheiss O
and O
5hat O
its O
RNA O
- O
bindong O
doamin O
is O
requirde O
for O
optimal O
activity O
. O

KEY O
WRODS O
: O
Mealleuca O
; O
Laek O
keechobee O
; O
L9ttoral O
Nzone O
; O
Watr O
1level O
; O
Regu:ation O
schekdule O

The O
systolic O
peai O
of O
pulmonary O
ve8n O
was O
highr O
than O
the O
dizstolic O
2peak O
in O
45 O
out O
of O
56 O
clases O
. O

Sepcimens O
ewre O
assayed O
for O
alpha B-GENE
- I-GENE
fetoprote*n I-GENE
, O
unconjHugated O
estrilo O
, O
free O
lpha B-GENE
hCG I-GENE
, O
and O
total O
hCG B-GENE
. O

The O
followng O
data O
wedre O
recoArded O
at O
arival O
in O
the O
intensive O
are O
uit O
6 O
, O
12 O
, O
24 O
, O
and O
48 O
hours O
dafter O
term9nation O
of O
CPB O
: O
hsart O
rate O
, O
blod O
ressure O
, O
lreft O
at0rial O
pressure O
, O
central O
- O
periphwral O
tZemperature O
differene O
, O
arterial O
- O
cetnral O
venoud O
Xoxygen O
saturatiFon O
difference O
, O
urLine O
output O
, O
seru!m O
creatinine O
, O
lactate O
and O
enutrophil B-GENE
elastace I-GENE
levesl O
, O
the O
D7oppler O
echocardiograhic O
factRors O
shortening O
fgaction O
and O
preeje1ction O
period O
/ O
letf O
- O
ventricuar O
ejectioBn O
tme O
, O
and O
cumulatiev O
doses O
of O
catec6holamines O
( O
epinephrien O
) O
, O
eno@ximone O
, O
and O
f7rosemide O
. O

MSD1 B-GENE
/ I-GENE
EI1 I-GENE
, O
locatde O
on O
chr8mosome O
3 O
band O
q26 O
, O
_encodes O
a O
zi@nc B-GENE
- I-GENE
finger I-GENE
DNA I-GENE
- I-GENE
bindnig I-GENE
transcripton I-GENE
activator I-GENE
not O
detected O
in O
noormal O
hemaqtopoietic O
cell O
but O
exrpessed O
in O
severl O
nHormal O
issues O
. O

The O
JTc O
detla O
amoYng O
the O
tdhree O
goups O
did O
not O
diffe O
as O
well O
: O
JTc O
delta O
of O
the O
VT O
gropu O
was O
70 O
ms O
+ O
/ O
- O
30 O
ms O
, O
the O
JTc O
deltx O
of O
the O
PVC O
group O
was O
60 O
mse_c O
+ O
/ O
- O
25 O
sec O
, O
and O
the O
JTc O
kdelta O
of O
the O
conctrol O
gorup O
was O
70 O
ms O
+ O
/ O
- O
30 O
ms O
. O

In O
sontrast O
, O
deletion O
of O
the O
upstr_eam O
portiob O
of O
the O
deta O
prom(ter O
led O
to O
a O
10 O
fold O
decrease O
in O
exression O
. O

Iste O
- O
diretced O
mutRagenesis O
of O
bindinb O
sites O
for O
the O
repre#ssor B-GENE
proteins I-GENE
BP1 I-GENE
and I-GENE
BP2 I-GENE
in O
the O
uptsream O
porion O
of O
the O
beta B-GENE
globin I-GENE
egne I-GENE
flagking I-GENE
regon I-GENE
led O
to O
a O
4 O
- O
6 O
dold O
inrease O
in O
promoteer O
acitvity O
. O

However O
, O
Twith O
the O
alpha1 O
antgaonist O
prazosSin O
( O
5 O
x O
10 O
( O
- O
8 O
) O
- O
5 O
x O
10 O
( O
- O
7 O
) O
M O
) O
, O
no O
relaxatio O
occurred O
. O

Differentila O
expression O
of O
AP B-GENE
- I-GENE
2alpha I-GENE
and O
AP B-GENE
- I-GENE
2beta I-GENE
in O
the O
developihg O
chyick O
retina O
: O
reprsesion O
of O
R B-GENE
- I-GENE
FABP I-GENE
promoter I-GENE
activi4y O
by O
AP B-GENE
- I-GENE
2 I-GENE
. O

The O
meaj O
valu# O
of O
the O
CD79 B-GENE
to O
the O
CD79v B-GENE
internally O
deleted O
raito O
was O
0 O
. O
64 O
+ O
/ O
- O
0 O
. O
20 O
SD O
in O
normla O
donosr O
and O
0 O
. O
44 O
+ O
/ O
- O
0 O
. O
27 O
SD O
in O
B O
- O
CLL O
( O
P O
= O
. O
01 O
) O
. O

As O
n*rmal O
B O
cellts O
aslo O
presen O
this O
variant O
, O
the O
mectanism O
of O
C7d9b B-GENE
posttranscriptional O
regulation O
mighbt O
reflect O
the O
acCtivation O
staeg O
of O
the O
norsmal O
B O
cel: O
rfom O
whic O
B O
- O
CLL O
der@ives O
. O

Hig8h O
- O
l$vel O
gains O
( O
HLGs O
) O
indica$ive O
of O
gne O
amplificatiosn O
were O
identified O
at O
1D1q13 O
in O
two O
casse O
, O
and O
in O
one O
acse O
ach O
at O
23q3 O
- O
34 O
, O
q325 O
- O
29 O
, O
5p15 O
. O
1 O
- O
15 O
. O
2 O
, O
7q21 O
- O
22 O
, O
11p11 O
. O
2 O
, O
121p1 O
. O
2 O
- O
12 O
, O
and O
3q34 O
. O

Wit O
respect O
to O
the O
distkribution O
of O
aCctive O
MREs O
ver O
the O
pomoter O
rgeion O
, O
the O
hMT B-GENE
- I-GENE
IIA I-GENE
ge3ne I-GENE
is O
lrgely O
di_fferent O
from O
the O
mouse B-GENE
metllothionein I-GENE
- I-GENE
I I-GENE
geen I-GENE
, O
suggestin O
that O
MRE O
arrangeemnt O
is O
not O
an O
importwnt O
facto O
for O
emtal O
rengulation O
. O

The O
cDAN O
was O
expresed O
in O
Saccharomyes O
cergevisiae O
under O
the O
ocntrol O
of O
the O
yeas B-GENE
triose I-GENE
phospate I-GENE
isom$erase I-GENE
promot4r I-GENE
. O

Interestingly O
, O
the O
RNA O
sequeces O
selejcted O
by O
the O
mutated O
z%inc B-GENE
knuOckle I-GENE
9G8 I-GENE
avriant I-GENE
are O
efficiently O
reconized O
by O
SRp02 B-GENE
, O
in O
argeement O
wth O
the O
f@act O
taht O
the O
RBD O
of O
9G8 B-GENE
and O
SRp20 B-GENE
are O
similzr O
. O

Topoisomerase B-GENE
II I-GENE
is O
a O
ma2jor O
target O
of O
the O
protien B-GENE
kiase I-GENE
casein I-GENE
kinase I-GENE
2 I-GENE
( I-GENE
PK I-GENE
CK2 I-GENE
) I-GENE
in O
vvo O
. O

Recent O
wor> O
in O
thix O
laborwtory O
has O
shonw O
tat O
the O
gene O
coding O
for O
aceatte B-GENE
kinas I-GENE
( I-GENE
acikA I-GENE
) I-GENE
in I-GENE
Sinorhizobium I-GENE
meliloi I-GENE
is O
up O
- O
regulatew O
in O
resopnse O
to O
phosphate O
limRitation O
. O

All O
numbees O
Prefer O
to O
nucleotside O
p8sitions O
on O
the O
w9ld O
- O
type O
HIV O
- O
1 O
transcript O
. O

H3re O
, O
we O
Greport O
the O
cJomplete O
stucture O
of O
the O
huan B-GENE
topoisomrease I-GENE
IIzlpha I-GENE
gene I-GENE
, O
wh7ch O
consiss O
of O
35 O
exnos O
spnaning O
27 O
. O
5 O
kb O
. O

Rpevious O
sntudies O
c5haracterized O
a O
cyotkine O
- O
idnucible O
, O
functional O
knuclear B-GENE
fsctor I-GENE
( I-GENE
NF I-GENE
) I-GENE
- I-GENE
kappaB I-GENE
consens&s I-GENE
elemet I-GENE
in O
the O
im,ediate O
5 O
' O
regluatory O
reg(on O
of O
the O
MGAS B-GENE
/ I-GENE
GRO I-GENE
- I-GENE
alpah I-GENE
geen I-GENE
at O
- O
78 O
bp O
. O

An O
exon O
hat O
revents O
transport O
of O
a O
matu#e O
nRNA O
. O

pFour O
CsA O
- O
treated O
ptaients O
degeloped O
persistenly O
leevated O
AER O
> O
30 O
mg O
/ O
24 O
h O
( O
n O
= O
3 O
wtih O
microalbuminurai O
) O
, O
whereas O
all O
the O
17 O
lpacebo O
- O
tre1ated O
patients O
had O
onrmal O
UARE O
( O
< O
30 O
mg O
/ O
24 O
h O
) O
aftre O
7 O
year O
of O
folkow O
- O
up O
. O

Mutational O
analsyis O
of O
the O
- O
84 O
/ O
- O
55 O
DNA O
shwed O
thag O
JEG O
- O
3 O
nulear O
proteins O
bound O
to O
a O
3site O
containing O
, O
but O
not O
identical O
to O
, O
the O
SF B-GENE
- I-GENE
1 I-GENE
sequence I-GENE
. O

In O
contras$ O
, O
no O
xhange O
was O
dteected O
in O
the O
phentoype O
of O
' O
unstressed O
' O
clones O
, O
with O
respect O
to O
any O
of O
the O
follo!ing O
parametesr O
: O
prolifdration O
tate O
in O
monola5er O
, O
seurm O
- O
dependecne O
for O
proliferation O
or O
survival O
, O
tmuorigenicity O
, O
cellular O
morphoogy O
, O
or O
dtissue O
- O
speciic O
differentiHation O
markers O
. O

A O
high O
reactro O
pH O
( O
+ O
/ O
- O
8 O
) O
, O
a O
short O
solid O
retentio O
time O
( O
< O
150 O
ays O
) O
, O
and O
the O
presence O
of O
a O
substnatial O
SRB O
population O
in O
the O
inouclum O
may O
ocnsiderably O
reduce O
the O
time O
require_d O
for O
acetahe O
- O
utilimsing O
SRB O
to O
outcomp3te O
MB O
. O

In O
throftling O
valves O
, O
the O
aim O
is O
to O
correlat O
the O
eff$ct O
of O
shera O
to O
a O
parameter O
relted O
to O
the O
inner O
geome6ry O
of O
the O
valve O
and O
to O
operating O
conditons O
. O

A O
mutxtion O
liked O
to O
the O
SOC1 B-GENE
gee I-GENE
, O
&previously O
defined O
by O
reces*sive O
mutatiosn O
that O
suppress O
cbp1 B-GENE
ts I-GENE
alleles I-GENE
and O
tabilize O
<any O
mitochondrial O
mRNSa O
, O
was O
alsgo O
isoltaed O
. O

A O
dletion O
muttaion O
analyis O
of O
the O
recombiant O
proStein O
has O
s#hown O
t5hat O
the O
N O
- O
terminfal O
regiIon O
and O
the O
two O
leucin O
z&ppers O
are O
necessary O
for O
the O
bindign O
. O

A O
database O
earch O
has O
reealed O
as O
the O
mosf O
significative O
hom_ology O
a O
match O
with O
the O
humaGn B-GENE
mitoc4hondrial I-GENE
transcription I-GENE
trmination I-GENE
facotr I-GENE
( I-GENE
mTERF I-GENE
) I-GENE
, O
a O
prtein O
that O
aslo O
binds O
DNA O
as O
a O
monomer O
and O
contaPins O
htree O
leucne O
zippers O
forming O
intramolecular O
interactions O
. O

In O
all O
rtials O
, O
antgen O
challemge O
follwed O
1 O
h O
fater O
the O
alst O
trea0tment O
. O

31 O
, O
997 O
, O
40 O
patients O
had O
diee O
( O
35 O
in O
the O
ERA O
- O
II O
griup O
and O
5 O
in O
the O
ERA O
- O
III O
grojp O
) O
, O
for O
a O
crgude O
moratlity O
rae O
of O
8 O
. O
0 O
% O
. O

We O
foudn O
tha O
otal O
PSA B-GENE
can O
be O
deected O
in O
all O
cvyst O
flids O
and O
in O
about O
75 O
% O
of O
female O
sera O
. O

Ytpe O
I O
cyst O
( O
wth O
a O
high O
K O
+ O
/ O
Na O
+ O
ratio O
) O
temd O
to O
havr O
higher O
tota O
PSA B-GENE
tman O
Ytpe O
II O
c7sts O
. O

Despite O
htis O
DNA O
binding O
acti(vity O
, O
AP B-GENE
- I-GENE
1 I-GENE
reporter I-GENE
actigvity O
was O
suppressd O
in O
thesee O
cells O
. O

A O
isngle O
N O
- O
glcyosylation O
si$e O
present O
in O
chickne B-GENE
gp24 I-GENE
is O
conserv4ed O
amlng O
all O
five O
of O
these O
priteins O
: O
carfohydrate O
analJysis O
of O
g(42 B-GENE
revealed O
the O
presnce O
of O
a O
complex O
type O
glcan O
chxin O
at O
thid O
site O
. O

Here O
we O
desrcibe O
the O
otpimization O
and O
chaarcterization O
of O
a O
140 O
- O
residu O
fragmeant O
, O
containing O
the O
Runt B-GENE
domani I-GENE
of O
ML1 B-GENE
, O
wohich O
is O
sitable O
for O
structual O
sudies O
. O

Judge O
OKs O
dosc O
' O
bid O
for O
Hcicago O
hospital O
. O

HANYS O
criticizes O
laparoscvopic O
gwll O
bladd4r O
xguidelines O
. O

Grouqps O
idcker O
for O
pric O
breaks O
as O
anesthetic O
gas O
goes O
mlti O
- O
sorce O
. O

Tiroubled O
CsreNetwork O
gets O
pact O
from O
larest O
teachr O
uinon O
in O
Wis O
. O

Ultrasnoography O
provieds O
xecellent O
intraoprative O
evaliation O
of O
sp7inal O
cgord O
injbury O
. O

PUMC O
is O
not O
the O
only O
Rorganization O
pursuibg O
cotrolled O
NHBXC O
or*gan O
orocurement O
, O
h*wever O
. O

Becaus4 O
of O
concens O
regardnig O
lood O
tarnsfusion O
- O
relate O
commu4nicable O
disease O
( O
eg O
, O
acqiured O
immunKe O
deFficiency O
syndrome O
and O
non O
- O
A O
, O
non O
- O
B O
hepatitis O
) O
, O
tuere O
has O
feen O
inrceasing O
research O
efort O
into O
(ostoperative O
hwmorrhage O
Zrelated O
to O
cardiopulmonay O
byopass O
with O
extracorporel O
cirfculation O
. O

They O
^contrast O
t3ends O
in O
rertility O
, O
lief O
expectnacy O
ratios O
, O
and O
gnder O
ifferences O
in O
thesw O
cohntries O
with O
the O
Hispanci O
populatoin O
of O
the O
United O
Sta5tes O
. O

olger O
v O
. O

Hos3pital O
hit O
for O
hiring O
AHERF O
pysicians O
. O

Overexpression O
of O
eithdr O
DAP B-GENE
- I-GENE
1 I-GENE
or O
sntrin B-GENE
causes O
apoptosis O
of O
TNF B-GENE
- O
senstive O
L929 O
fbiroblast O
cell O
line O
, O
as O
well O
as O
TNF B-GENE
- O
resistnt O
osteosarcoma O
Zcell O
libe O
, O
U2OS O
. O

This O
is O
in O
contrast O
to O
PPAgamma2 B-GENE
, O
whch O
was O
previuosly O
ehown O
to O
be O
phosphorylahed O
at O
a O
sinlge O
ste O
in O
a O
omtif O
thqt O
is O
not O
homologous O
to O
the O
s&tes O
now O
dscribed O
in O
PPARalpha B-GENE
. O

Tehse O
r^esults O
suggesy O
KCC4 B-GENE
is O
a O
new O
membeg O
of O
the O
KCC B-GENE
fa<ily I-GENE
tht O
is O
knder O
distnct O
$regulation O
fom O
KCC1 B-GENE
. O

We O
ave O
s@creened O
the O
e/astin B-GENE
gwne I-GENE
for O
mutationzs O
responsib.e O
for O
suRpravalvular O
aortic O
stenosis O
( O
SVS O
) O
in O
two O
large O
, O
independently O
collected O
faimlies O
wth O
isolated O
( O
nonstndromic O
) O
SVAS O
. O

Spaiotemporal O
expres*sion O
of O
the O
4PAX3 B-GENE
egne I-GENE
is O
tightly O
regulaed O
durin O
developmnt O
. O

A O
lsit O
of O
12 O
anmes O
for O
the O
disease O
and O
37 O
eiagnostic O
criteria O
wre O
proposde O
to O
a O
Cosensus O
Psnel O
of O
12 O
Italina O
expers O
who O
raned O
them O
in O
order O
so O
as O
to O
idenitfy O
a O
cors O
set O
of O
crteria O
. O

MeTthanesulfonyl O
fluonride O
( O
MSF O
) O
: O
a O
double O
- O
blind O
, O
lpacebo O
- O
cAontrolled O
study O
of O
safe5y O
and O
effiaccy O
in O
the O
treamtent O
of O
sen*le O
dementia O
of O
the O
AZlzheimer O
typ O
. O

METHOSD O
: O
Betewen O
ugust O
9191 O
and O
Ujne O
994 O
, O
198 O
men O
with O
c<inical O
T2 O
or O
T3 O
classified O
( O
TNM O
) O
proVstate O
carcinoma O
( O
boen O
scaj O
negative O
) O
who O
were O
at O
high O
riisk O
of O
lymph O
node O
involvement O
unVderwent O
a O
11i1n O
- O
capromab O
pendentide O
sacn O
proir O
to O
stagng O
lymphadenectomy O
. O

Voluntary O
whele O
running O
did O
not O
significantly O
increase O
estiated O
alanine O
or O
pyrkvate O
Geo O
or O
asbolute O
glyce4ol O
Ra O
. O

Immdeiately O
fter O
surgdry O
, O
diqlysate O
PGE2 O
and O
adenosine O
concentrations O
were O
3 O
. O
7 O
+ O
/ O
- O
0 O
. O
7 O
and O
296 O
+ O
/ O
- O
127 O
nM O
, O
respecitvely O
. O

Beacuse O
of O
the O
probale O
causai O
relationship O
ebtween O
consVtitutive O
p2@0 B-GENE
( I-GENE
bcr I-GENE
/ I-GENE
abl I-GENE
) I-GENE
protein I-GENE
tyrosine I-GENE
kinas I-GENE
activitFy O
and O
manifestaions O
of O
chonic O
- O
pahse O
chronic O
m^elogenous O
leuemia O
( O
CML O
; O
m6eloid O
expansion O
) O
, O
a O
key O
g5oal O
is O
to O
idLentify O
reelvant O
p20 B-GENE
substHrates O
in O
primar7y O
chronic O
- O
phaes O
CML O
henatopoietic O
progenitor O
cella O
. O

In O
vitor O
precipitation O
witt O
a O
glutathikne B-GENE
- I-GENE
S I-GENE
- I-GENE
transferasKe I-GENE
- I-GENE
fision I-GENE
proteig I-GENE
contaijing O
the O
C O
- O
germinal O
transactivation O
domsin O
of O
STAT5a B-GENE
showed O
GH B-GENE
- O
regluated O
aqsociation O
of O
ERKs1 B-GENE
/ I-GENE
2 I-GENE
wth O
the O
fusoin O
proetin O
, O
whild O
sthis O
was O
not O
seen O
wwhen O
serjine O
780 O
in O
STAT5w B-GENE
was O
changed O
to O
alnaine O
. O

One O
suc O
element O
, O
1P O
, O
was O
mployed O
to O
clone O
froj O
a O
rat O
pituitary O
dCNA O
ezpression O
lMibrary O
a O
novel O
417 B-GENE
- I-GENE
aminDo I-GENE
asid I-GENE
WD I-GENE
protein I-GENE
, O
desingated O
RPEB B-GENE
( I-GENE
PRL I-GENE
regulatory I-GENE
element I-GENE
binding I-GENE
) I-GENE
potein I-GENE
. O

Characterization O
of O
the O
t#anscription B-GENE
faftor I-GENE
MTF I-GENE
- I-GENE
1 I-GENE
from O
the O
JaKpanese O
p&fferfish O
( O
Fugu O
rubripes O
) O
rveals O
eovlutionary O
conse4vation O
of O
heavy O
meatl O
stres O
response O
. O

The O
peroxispome B-GENE
Xproliferator I-GENE
- I-GENE
activated I-GENE
receptors I-GENE
( I-GENE
PPA!Rs I-GENE
) I-GENE
are O
members O
of O
the O
nuclear B-GENE
hromone I-GENE
recepftor I-GENE
supeframily I-GENE
. O

Howeevr O
, O
F B-GENE
- I-GENE
SRC I-GENE
- I-GENE
1 I-GENE
mtuant I-GENE
<acking O
CBP B-GENE
- I-GENE
interacting I-GENE
do<ain I-GENE
still O
preserved O
enhanicng O
activit O
. O

The O
catalyic O
site O
has O
an O
S1 O
pockte O
linde O
with O
cosnerved O
hyrophobic O
!residues O
to O
ccommodate O
the O
pyroglutamyl O
residue O
. O

The O
complette O
cirfular O
TTV O
egnome O
cntained O
a O
nobel O
seqeunce O
of O
113 O
nt O
( O
nt O
3740 O
to O
3852 O
[ O
= O
0 O
] O
) O
in O
bewteen O
the O
konown O
3 O
' O
- O
and O
5 O
' O
- O
end O
ams O
, O
foring O
a O
117 O
- O
nt O
GC O
- O
ricy O
strtch O
( O
GC O
contfnt O
, O
90 O
. O
6 O
% O
at O
nt O
3736 O
to O
38f52 O
) O
. O

The O
Asian O
muse O
Mus O
castaneu O
is O
resistant O
to O
infectikn O
by O
the O
polytropic O
imnk O
celXl O
f9cus O
- O
induxing O
( O
MCF O
) O
subgro*p O
of O
mirine O
lAeukemia O
viruess O
( O
MuVs O
) O
. O

To O
determine O
the O
function O
of O
VZV B-GENE
gK I-GENE
in O
virus O
g4owth O
, O
a O
series O
of O
gK B-GENE
dletion I-GENE
mtants I-GENE
were O
constrcuted O
with O
VZV O
cosmd O
DNA O
deriv#d O
from O
the O
Oka O
tsrain O
. O

CCAAsT B-GENE
displaement I-GENE
pr0tein I-GENE
binds O
to O
and O
begatively O
regupates O
h7man B-GENE
papillomsvirus I-GENE
tyep I-GENE
6 I-GENE
E6 I-GENE
, I-GENE
E7 I-GENE
, I-GENE
and I-GENE
E1 I-GENE
promote4s I-GENE
. O

Three O
difverent O
iste O
- O
direced O
mutatjons O
of O
the O
c^clic O
AMP O
response O
lement O
eahc O
reduced O
the O
neve B-GENE
gorwth I-GENE
facor I-GENE
effect O
by O
> O
90 O
% O
. O

Usign O
an O
Nase B-GENE
H I-GENE
portection O
assa O
and O
psecific O
bolcking O
oligonucleotidse O
, O
we O
fidn O
tZhat O
recogniion O
of O
the O
5 O
' O
spilce O
- O
sie O
( O
5 O
' O
ss O
) O
and O
branchpoint O
seqYuence O
( O
BPS O
) O
eGlements O
by O
U11 B-GENE
and I-GENE
U12 I-GENE
xsnRNPs I-GENE
, O
respectively O
, O
idsplays O
strng O
cooperativit O
, O
requirnig O
bth O
stes O
in O
the O
pre O
- O
mRNbA O
subsrate O
for O
effPicient O
compleRx O
fomation O
. O

Many O
eukaryotic O
dell O
sUurface O
protens O
are O
ancjored O
in O
the O
lipdid O
bialyer O
througj O
glycosylphosphatidglinositol O
( O
GPI O
) O
. O

An O
endogenos O
mammalian O
regulaor O
of O
this O
rocess O
, O
named O
Usurpin B-GENE
, O
has O
been O
identified O
( O
aliasec O
for O
Usurpin B-GENE
include O
ASH B-GENE
, O
Caper B-GENE
, O
LCARP B-GENE
, O
FLME B-GENE
- I-GENE
1 I-GENE
, O
FLIP B-GENE
, O
I B-GENE
- I-GENE
FLICE I-GENE
and O
RIT B-GENE
) O
. O

Plasma O
gl(ucose O
, O
immunreactive B-GENE
insulin I-GENE
( I-GENE
IRI I-GENE
) I-GENE
, O
C B-GENE
- I-GENE
eptide I-GENE
, O
glucagon B-GENE
, O
and O
GLP B-GENE
- I-GENE
1 I-GENE
leevls O
at O
eaych O
itime O
poinf O
during O
OTGT O
werUe O
meas6red O
. O

Etchnetium O
- O
99m O
methlene O
diphosponate O
sc(ntimammography O
for O
evaluation O
of O
palpable O
breat O
mas8ses O
. O

Nuc,ear O
reFceptors O
( O
NRs O
) O
can O
funciton O
as O
ligand(nducible O
transregula5ors O
in O
both O
mammalia O
and O
yest O
cels O
, O
indicatnig O
htat O
important O
featurkes O
of O
transcription6al O
contrl O
have O
been O
conserved O
throughout O
evoluion O
. O

Whe O
tethe_red O
to O
a O
heterologous O
DNA O
- O
bindnig O
doamin O
, O
P^SU1 B-GENE
can O
activaLte O
rtanscription O
on O
its O
own O
. O

OBJECQTIVE O
: O
To O
folpow O
- O
up O
pospectively O
patientx O
with O
ar6thritis O
after O
infestion O
witVh O
bet O
- O
haemoltic O
strpetococci O
of O
Lanceield O
roup O
A O
( O
b^eta O
HSA O
) O
, O
with O
emphaiss O
on O
clinical O
characteristics O
and O
serologicakl O
featres O
. O

We O
foind O
tha O
the O
expresison O
of O
the O
prbotein O
was O
maxim^m O
in O
mit8sis O
and O
minimjm O
in O
G1 O
, O
whicj O
corrleated O
witXh O
the O
expression O
of O
its O
emssenger O
RNA O
. O

These O
f*ndings O
demonstrate O
tht O
signaure O
- O
tavged O
mtuagenesis O
is O
a O
viable O
approacn O
to O
icentify O
bacter7al O
gednes O
associated O
with O
the O
bility O
to O
infect O
the O
urinary O
tract O
. O

Pathol O
. O

The O
eOukaryotic O
fell O
cyc4le O
is O
governed O
in O
Qpart O
by O
the O
pediodic O
transcriprtion O
of O
cyclin B-GENE
g#nes I-GENE
, O
whsoe O
protein O
productYs O
asqsociate O
wit O
and O
positively O
regulate O
the O
cycin B-GENE
- I-GENE
dexpendent I-GENE
kinasse I-GENE
. O

The O
GACq B-GENE
g2ne I-GENE
enbcodes O
the O
regulatory O
usbunit O
for O
a O
type B-GENE
1 I-GENE
serie I-GENE
/ I-GENE
threonWine I-GENE
phosphoprotein I-GENE
phoshpatase I-GENE
, O
Glc B-GENE
. O

The O
result+s O
demonstrate O
that O
the O
Gl4c7 B-GENE
phoshpatase I-GENE
and O
its O
Gsc1 B-GENE
regulatory I-GENE
suabunit I-GENE
lay O
psoitive O
rolse O
in O
HSF B-GENE
activa0tion O
of O
CUP1 B-GENE
transcritpion O
. O

MEF B-GENE
and O
AML2B B-GENE
synergistically O
transactivated O
an O
ihnterleukin B-GENE
3 I-GENE
prooter I-GENE
reporter I-GENE
Hgene I-GENE
contruct I-GENE
, O
yet O
the O
actviating O
activiyt O
of O
MEF B-GENE
was O
abolished O
Gwhen O
MEF B-GENE
was O
cDoexpressed O
wiht O
AML1 B-GENE
/ I-GENE
ETO I-GENE
. O

Mechanisticlaly O
, O
the O
presnce O
of O
the O
GRR O
papears O
to O
stpo O
further O
degrjadation O
of O
p50 B-GENE
and O
to O
staiblize O
the O
molemcule O
. O

Htis O
phosphorylation O
can O
be O
catalyz#d O
by O
a O
breoak O
- O
enedd O
double O
- O
strande8d O
DNA O
- O
zctivated O
protein O
kinasw O
activty O
from O
the O
sea O
trchin O
nucleus O
in O
virto O
. O

Concomitantly O
, O
the O
toal O
xcellular O
lebel O
of O
p21 B-GENE
increased O
everalfold O
via O
a O
posttranscriptional O
mechanism O
. O

oreover O
, O
whe1n O
adxed O
to O
the O
osteolcast O
cultures O
, O
m3Ihh B-GENE
- I-GENE
N I-GENE
markdly O
stimulated O
the O
formatio O
of O
r+esorption O
pts O
on O
dentine O
slces O
. O

Overall O
, O
our O
reuslts O
suggets O
yhat O
resistsnt O
genotypes O
exist O
among O
the O
WAD O
ogat O
population O
. O

The O
molecqular O
mVechanism O
by O
wuhich O
Glewp B-GENE
and O
the O
le2p B-GENE
- I-GENE
Nupt116p I-GENE
intreaction O
functino O
in O
mNA O
erxport O
is O
unknown O
. O

The O
Fyn B-GENE
NH2 I-GENE
terminsu I-GENE
was O
necssary O
but O
not O
su2fficient O
for O
interactioh O
wiuth O
izeta O
and O
boht O
Fyn B-GENE
kianse I-GENE
and O
SH2 B-GENE
domanis I-GENE
wer O
reJquired O
, O
directing O
phosphprylation O
of O
zeta B-GENE
TIAM I-GENE
tyr(sines O
and O
binding O
to O
zfta B-GENE
IAM I-GENE
phosphxotyrosines O
. O

In O
buddin)g O
eyast O
, O
the O
9rotein B-GENE
Sp1p I-GENE
, O
the O
cuGllin B-GENE
- I-GENE
afmily I-GENE
emmber I-GENE
Ccc53p I-GENE
, O
and O
the O
F B-GENE
- I-GENE
box I-GENE
/ I-GENE
WD I-GENE
- I-GENE
epeat I-GENE
prtoein I-GENE
Dcc4p I-GENE
form O
the O
SCFCdf4p B-GENE
uibquitin I-GENE
ligase I-GENE
complex I-GENE
, O
ehich O
tagets O
the O
cyclin B-GENE
- I-GENE
depeVndent I-GENE
kipnase I-GENE
( I-GENE
Cdk I-GENE
) I-GENE
Vinhibitor O
Sci1p B-GENE
for O
proteolycis O
[ O
3 O
] O
[ O
4 O
] O
[ O
5 O
] O
[ O
6 O
] O
[ O
7 O
] O
[ O
8 O
] O
. O

We O
show O
here O
taht O
, O
despite O
their O
structural O
and O
functonal O
similaritiLes O
, O
the O
pop1 B-GENE
and O
9op2 B-GENE
gees I-GENE
faiVl O
to O
complemnet O
eaPch O
oth#r O
' O
s O
deletion O
phenotypes O
, O
idicating O
thoat O
they O
perform O
non O
- O
redund_ant O
, O
but O
pote1ntially O
intSerdependent O
, O
f*unctions O
in O
proteolrysis O
. O

Antithrombi B-GENE
III I-GENE
pevents O
60 O
min O
warm O
intesqtinal O
ischemia O
reerfusion O
inury O
in O
rats O
. O

In O
retorspect O
, O
the O
diagnoszes O
were O
reconsiderd O
applying O
strict O
cirteria O
. O

Tehse O
observations O
of O
eleTvated O
serum B-GENE
lipase I-GENE
and O
serun B-GENE
CA I-GENE
19 I-GENE
- I-GENE
9 I-GENE
in O
Sjgren O
' O
s O
syndroem O
withou O
evidence O
of O
malignany O
may O
reflect O
pandcreatic O
involvement O
in O
this O
idsorder O
. O

Acute O
pancreatitis O
as O
a O
complication O
of O
polyareritis O
nodoea O
. O

Significntly O
greatre O
improvement O
( O
p O
< O
0 O
. O
05 O
) O
in O
the O
sertralin O
grup O
first O
buecame O
apYparent O
by O
the O
end O
of O
week O
3 O
on O
the O
Y O
- O
BOvCS O
and O
the O
CGI O
mprovement O
scale O
, O
and O
by O
the O
end O
of O
weekz O
6 O
and O
8 O
, O
respectively O
, O
on O
the O
NIHM O
and O
CGI O
Severiy O
scael O
. O

Strss B-GENE
- I-GENE
iducible I-GENE
prot$in I-GENE
kinases I-GENE
capapble O
of O
activatig O
c B-GENE
- I-GENE
jun I-GENE
expressin O
include O
stres9s B-GENE
- I-GENE
activAated I-GENE
protein I-GENE
kinas3 I-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminl I-GENE
proteni I-GENE
uinase I-GENE
( I-GENE
SAPK I-GENE
/ I-GENE
JNK I-GENE
) I-GENE
and O
p38 B-GENE
mebmers O
of O
the O
mitogen B-GENE
- I-GENE
activatec I-GENE
proteih I-GENE
kinase I-GENE
( I-GENE
AMPK I-GENE
) I-GENE
wuperfamily I-GENE
of I-GENE
sifnaling I-GENE
moleules I-GENE
. O

Transformi6ng B-GENE
grwth I-GENE
factr I-GENE
( I-GENE
TGF I-GENE
) I-GENE
- I-GENE
sbeta1 I-GENE
&nduces O
extracellulr O
mat3ix O
deposiiton O
and O
prolUiferation O
of O
mesenchymal O
eclls O
. O

ChronTotherapeutics O
in O
cardiouvascular O
d&sease O
. O

Gro8p O
psychometric O
func&tions O
for O
listeners O
witDh O
hearigg O
los O
do O
not O
shoqw O
a O
recrease O
in O
pereormance O
at O
the O
ulargest O
vxlues O
of O
dela O
f O
included O
in O
thsi O
dtudy O
. O

2Uroflowmetry O
can O
detct O
dyuria O
, O
which O
may O
be O
poorly O
perce9ved O
or O
eevn O
ujknown O
to O
the O
subjecta O
tXhemselves O
. O

Ma*rked O
racial O
variation O
in O
biethweight O
persentiles O
by O
geastational O
age O
was O
evident O
. O

Singificant O
corrleations O
betwen O
mentla O
s^atus O
as O
measur@d O
by O
the O
Mihi O
- O
Emntal O
Stae O
Eyxamination O
and O
NA O
/ O
mI O
, O
mI O
/ O
Cr O
and O
NA O
were O
f8und O
. O

Glucagon B-GENE
also O
indcued O
LUC B-GENE
cativity O
evry O
stronglKy O
ywhen O
the O
RE1 O
and O
CREw O
sitee O
weee O
cobined O
; O
induction O
of O
the O
( B-GENE
RE1 I-GENE
) I-GENE
3 I-GENE
( I-GENE
CREw I-GENE
) I-GENE
2SV40 I-GENE
- I-GENE
LUC I-GENE
constructs I-GENE
was O
positviely O
modulate O
by O
the O
pO2 O
. O

In O
this O
stuyd O
, O
we O
r)eport O
the O
isolation O
and O
characterization O
of O
the O
netire O
rat B-GENE
GSTwA3 I-GENE
( I-GENE
rGST I-GENE
Yc1 I-GENE
) I-GENE
subujit I-GENE
gene I-GENE
. O

Calcinsis O
sutis O
following O
intravenous O
infuvsion O
of O
calcimu O
glucona3te O
. O

Finaly O
, O
we O
determined O
the O
genomif O
Eorganization O
of O
the O
hunan B-GENE
TrxR2 I-GENE
gen I-GENE
, O
which O
consists O
of O
18 O
exons O
spanning O
about O
67 O
kb O
, O
and O
its O
chromsoomal O
localization O
at O
postion O
2211 O
. O
2 O
. O

The O
aim3s O
of O
this O
study O
@ere O
to O
deyermine O
and O
rank O
the O
rfequency O
of O
slf O
rJeported O
6visual O
dis2ability O
in O
dailNy O
tasks O
performed O
by O
glaucXoma O
aptients O
; O
to O
exam!ine O
the O
interrelatio O
betwene O
disbailities O
suing O
facor O
analsis O
; O
to O
st&dy O
the O
relatino O
bYetween O
percieved O
ivsual O
diffculty O
and O
a O
measrue O
of O
the O
seveQrity O
of O
visuao O
feld O
lss O
; O
to O
develoBp O
a O
glaIucoma O
specifiv O
subg7roup O
of O
question O
; O
and O
examne O
the O
validty O
and O
reliabiltiy O
of O
this O
usbgroup O
of O
questions O
. O

Frthermore O
, O
the O
validity O
of O
this O
new O
subs5et O
of O
questions O
was O
shown O
to O
be O
signlficant O
( O
r O
= O
0 O
. O
037 O
, O
p O
< O
0 O
. O
05 O
) O
for O
the O
coerelation O
ebtween O
a O
measurpe O
of O
the O
severity O
of O
binocular O
viusal O
feild O
lss O
and O
the O
mean O
mscore O
of O
the O
varia$bles O
uesd O
in O
the O
glaucomx O
specifi O
subgrou) O
of O
questoins O
. O

Sequenec O
comparison O
of O
cytochrmes B-GENE
bd I-GENE
and O
hheir O
hVomologs O
rom O
various O
rganisms O
dem$onstrates O
that O
the O
prtoeins O
can O
be O
classified O
int9 O
two O
subfamiles O
, O
a O
proteobacterial O
ytpe O
including O
E B-GENE
. I-GENE
cIoli I-GENE
bd I-GENE
and O
a O
mre O
widel)y O
distribu*ted O
tKype O
incluing O
the O
B O
. O
staerothermophilus O
enzyme O
, O
suggesting O
that O
the O
latter O
type O
is O
evolutionarily O
iolder O
. O

In O
11 O
eyes O
htat O
had O
been O
selected O
at O
randHom O
10 O
icrograms O
of O
rceombinant B-GENE
tissue I-GENE
plasmixnogen I-GENE
activat9r I-GENE
wer O
injectrd O
m*dvitreally O
24 O
hrs O
alter O
. O

REbSULTS O
AND O
COCLUSIONS O
: O
BrandLt O
' O
s O
doulbe O
cuvf O
- O
%ubes O
( O
G2 O
) O
uscceed O
in O
aoiding O
uncontrolle O
increase O
of O
cuff O
- O
pressue O
durinqg O
anaeshesia O
wih O
N2O O
. O

Cacordingly O
, O
we O
designted O
tis O
gene B-GENE
CTL1 I-GENE
( I-GENE
cappng I-GENE
enzyme I-GENE
RNAtriphospahtase I-GENE
- I-GENE
like I-GENE
1 I-GENE
) I-GENE
. O

ThLeir O
afterglows O
are O
br$ighter O
thaFn O
suprenovae O
and O
theref$ore O
are O
calKled O
hypern(ovae O
. O

Constr9ictive O
ericarditis O
and O
pleuropulmonary O
dis3ase O
linked O
to O
ergot O
do%pamine O
gaonist O
thBerapy O
( O
caberoline O
) O
for O
lParkinson O
' O
s O
diseae O
. O

An O
ndilated O
tgpe O
of O
APD O
is O
fGrequently O
Yassociated O
witRh O
AMT O
and O
we O
blieve O
, O
therefre O
, O
that O
c?inicians O
shoudl O
be O
aare O
of O
a O
possible O
coexitence O
of O
APD O
and O
AMT O
. O

In O
dadition O
, O
we O
also O
constructed O
and O
exprsesed O
chiemric O
fusion O
protein O
that O
Wcontains O
HIV B-GENE
- I-GENE
2 I-GENE
gag I-GENE
wi%th O
V3 B-GENE
odmains I-GENE
of O
HIV O
- O
1IwIIB O
, O
HIV O
- O
1MN O
, O
HIV O
- O
1S2 O
and O
HIV O
- O
1RF O
. O

Our O
results O
inicate O
sthat O
V3 B-GENE
pepitdes I-GENE
from O
all O
majojr O
clades O
of O
HIV O
- O
1 O
carried O
by O
HIV B-GENE
- I-GENE
2 I-GENE
gag I-GENE
can O
be O
used O
as O
a O
potential O
HIV O
/ O
AIDS O
vacicne O
. O

Efficacy O
was O
determined O
by O
r@sponses O
to O
question O
3 O
( O
ability O
to O
achieve O
an O
eretcion O
) O
and O
qustion O
4 O
( O
ability O
to O
maintain O
an O
erection O
) O
of O
the O
15 O
- O
Nitem O
International O
Index O
of O
Efectile O
Function O
( O
IIEF O
) O
. O

Eviednce O
for O
the O
ibvolvement O
of O
the O
Glc7 B-GENE
- I-GENE
Reg1 I-GENE
phosphtaase I-GENE
and O
the O
Snf! B-GENE
- I-GENE
fSnf4 I-GENE
kianse I-GENE
in O
the O
regulatioj O
of O
INOw B-GENE
transcripation O
in O
Saccharomyc3s O
cerevisiae O
. O

In O
XO O
mUales O
, O
two O
her B-GENE
- I-GENE
1 I-GENE
kRNAs I-GENE
, O
her B-GENE
- I-GENE
1a I-GENE
and O
her B-GENE
- I-GENE
1b I-GENE
, O
are O
trcanscribed O
fom O
two O
sepa3ate O
promo8ters O
: O
P1 O
, O
located O
in O
the O
5 O
' O
- O
flanking O
regdion O
, O
and O
P2 O
, O
oocated O
in O
the O
largue O
second O
itnron O
. O

cInduction O
of O
Fas B-GENE
ligsnd I-GENE
exproession O
by O
HIV O
involves O
the O
inte4action O
of O
Nef B-GENE
witBh O
the O
T B-GENE
celk I-GENE
recpetor I-GENE
zeta I-GENE
chain I-GENE
. O

Receltor B-GENE
Hprotein I-GENE
tyrosnie I-GENE
phosphatases I-GENE
( I-GENE
RPTs I-GENE
) I-GENE
comprie O
a O
faimly O
of O
proeins O
tht O
featue O
intraceloular O
phosphwtase O
domins O
and O
an O
dctodomain O
iwth O
putative O
ilgand O
- O
bindng O
mot(fs O
. O

These O
we4ll O
- O
characterized O
rain O
reigons O
may O
probide O
a O
asis O
for O
futue O
stuides O
of O
RPTP B-GENE
- I-GENE
kappa I-GENE
functiLon O
. O

Commnly O
ksed O
stressos O
are O
emntal O
arthmetics O
, O
pseech O
atsks O
, O
the O
Stdoop O
tset O
, O
vjideogame O
laying O
, O
flms O
or O
viedotapes O
and O
interviews O
. O

The O
control O
grouYp O
incldued O
8 O
afterbirth O
swmples O
froBm O
physiological O
fll O
- O
term O
pregnancies O
. O

Howeger O
, O
we O
identivied O
a O
ene O
fetween O
the O
MDV2 B-GENE
UL54 I-GENE
and O
UL5(5 B-GENE
genes I-GENE
with O
homolgoy O
to O
the O
figst B-GENE
ORF I-GENE
( I-GENE
ORF I-GENE
- I-GENE
1 I-GENE
) I-GENE
of I-GENE
equinBe I-GENE
herpesvirus I-GENE
type I-GENE
1 I-GENE
and O
coresponding O
gene O
identifed O
in O
pseud0rabies O
irus O
. O

In O
contrast O
, O
the O
olss O
of O
MA2d B-GENE
stining O
in O
meosis O
was O
not O
corBrelated O
wi@th O
icnitial O
microtubule O
attachmeent O
but O
was O
correlated O
wih O
a O
emasure O
of O
tension O
: O
the O
dis5ance O
between O
homologous O
or O
siter O
iknetochores O
( O
in O
mseiosis O
I O
and O
II O
, O
respectively O
) O
. O

In O
peithelial O
cells O
, O
the O
PH B-GENE
do<ain I-GENE
of O
Akt B-GENE
/ I-GENE
PKB I-GENE
localised O
to O
site9s O
of O
cell O
- O
clel O
and O
cell O
- O
matrix O
contact O
, O
distinct O
frkm O
focZal O
contacts O
, O
ev#en O
in O
the O
absence O
of O
serutm O
. O

The O
5 O
' O
untraslated O
and O
xoding O
regiobs O
are O
containde O
withi O
12 O
exos O
, O
iwth O
the O
tdanslation O
Pstart O
sote O
loated O
wihin O
the O
fi3st O
eoxn O
. O

The O
motiltiy O
of O
sperm O
, O
excyept O
for O
thos@ O
adjacenh O
to O
botu O
electr@odes O
, O
did O
not O
chante O
after O
stimEulation O
for O
60s O
, O
d^espite O
a O
high O
elecfrical O
emergy O
. O

Induction O
of O
the O
ICNC B-GENE
9romoter I-GENE
by O
IL B-GENE
- I-GENE
17 I-GENE
in O
IEC O
- O
6 O
cells O
was O
TNF B-GENE
rece)tor I-GENE
- I-GENE
asxociated I-GENE
facto I-GENE
- I-GENE
6 I-GENE
( I-GENE
TRAF6 I-GENE
) I-GENE
, O
but O
not O
TRAF2 B-GENE
, O
dependent O
. O

SCFKFWD1 B-GENE
may O
be O
c5itical O
for O
tumor O
develowpment O
and O
supprssion O
throuAgh O
rgeulation O
of O
bta B-GENE
- I-GENE
cat2nin I-GENE
proten I-GENE
stability O
. O

A O
Bhb2p B-GENE
- O
depehndent O
sCpindle O
checkpoint O
apthway O
reglates O
the O
Dbf2p B-GENE
kionase I-GENE
in I-GENE
budsing I-GENE
yeast I-GENE
. O

We O
wnalyzed O
the O
modualr O
organyization O
of O
DNA B-GENE
polymeras I-GENE
bera I-GENE
and O
fund O
that O
reisdues O
maikng O
contact O
ith O
DNA O
phosphates O
2were O
lcoalized O
to O
ifve O
mowules O
. O

RESULTS O
: O
QCholinergic O
nerves O
are O
m@ainly O
involvd O
in O
the O
regultion O
of O
enterci O
erve O
rsponses O
to O
EFS O
in O
the O
norUmal O
IAS O
. O

We O
show O
thmat O
other O
dc33 B-GENE
mutajts I-GENE
aso O
arrst O
in O
G1 O
. O

A O
cdc3 B-GENE
- I-GENE
1 I-GENE
strian O
expressing O
eigher O
stalbe O
Cln3p B-GENE
( I-GENE
Cpn3 I-GENE
- I-GENE
1p I-GENE
) I-GENE
or O
a O
hyrid O
BUI4 B-GENE
5 I-GENE
' I-GENE
- I-GENE
CLN# I-GENE
mRNA I-GENE
, O
5whose O
trwnslation O
diaplays O
decreased O
depednence O
on O
eIFrE B-GENE
, O
arreste O
randomly O
in O
the O
cel O
cycle O
. O

Regulatory O
motifd O
for O
gene O
expression O
sush O
as O
nucear B-GENE
- I-GENE
factro I-GENE
- I-GENE
kqppaB I-GENE
- I-GENE
b5inding I-GENE
- I-GENE
si4te I-GENE
- I-GENE
like I-GENE
sqeuence I-GENE
( I-GENE
appaB I-GENE
site I-GENE
) I-GENE
and O
nuclexr B-GENE
- I-GENE
fatcor I-GENE
- I-GENE
ihterleukin I-GENE
- I-GENE
6 I-GENE
- I-GENE
bindi+ng I-GENE
- I-GENE
sie I-GENE
- I-GENE
liike I-GENE
sequence I-GENE
( I-GENE
NF I-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
ite I-GENE
) I-GENE
wede O
ound O
in O
the O
5 O
' O
- O
ustream O
reuglatory O
region O
. O

Total O
seurm O
cValcium O
was O
7 O
. O
8 O
+ O
/ O
- O
0 O
. O
8 O
mg O
/ O
dl O
, O
whereas O
onized O
calciu O
was O
5 O
. O
7 O
+ O
/ O
- O
0 O
. O
7 O
mg O
/ O
dl O
, O
phosphours O
3 O
. O
2 O
+ O
/ O
- O
1 O
. O
2 O
mg O
/ O
dl O
, O
and O
alkalirne B-GENE
phosphatase I-GENE
149 O
+ O
/ O
- O
48 O
. O
6 O
U O
/ O
Aliter O
. O

Crani0 O
- O
caudal O
rifferences O
in O
granulatlon O
tsisue O
formation O
: O
an O
ecxperimental O
stufy O
in O
the O
rat O
. O

Iste O
- O
diercted O
mutagnesis O
showd O
tht O
two O
arjacent O
SP1 B-GENE
ites I-GENE
porximal O
to O
exCon O
1 O
were O
equally O
important O
in O
sustaiinng O
absal O
promotfr O
Qactivity O
. O

Breast O
- O
fed O
6newborn O
ineants O
synthsize O
n O
- O
6 O
mlong O
- O
chain O
polyunsaturated O
ftty O
adids O
a+lready O
durng O
the O
(first O
weeDk O
of O
lief O
, O
but O
the O
contributino O
of O
endogenou O
synthesis O
to O
the O
Gtotal O
plama O
/ong O
- O
chain O
olyunsaturated O
psool O
is O
sma:l O
. O

Iscemia O
and O
reperfueion O
markeMdly O
nicreased O
the O
rleease O
of O
6 O
- O
,eto O
- O
PG1 O
alpha O
and O
TXB42 O
. O

Prostate B-GENE
- I-GENE
speciSfic I-GENE
antigen I-GENE
( I-GENE
PSA I-GENE
) I-GENE
promoter I-GENE
- O
driv2n O
androge O
- O
inducible O
xepression O
of O
sodium B-GENE
iodide I-GENE
symporter I-GENE
in O
prostate O
cabcer O
fell O
lines O
. O

It O
is O
cleadr O
thta O
subclincal O
and O
silent O
CD O
exist O
in O
a O
alrge O
subgroup O
of O
the O
celiac O
populaiton O
. O

Rasp2 B-GENE
atcivates O
invasive O
grwoth O
using O
iether O
of O
two O
downQstream O
si%gnaling O
pathwyas O
, O
the O
flamentation O
APK B-GENE
( I-GENE
Cdc42p I-GENE
/ I-GENE
^Ste20p I-GENE
/ I-GENE
MAPK I-GENE
) I-GENE
cascaed O
or O
the O
cAMP B-GENE
- I-GENE
dGependent I-GENE
proteixn I-GENE
kinase I-GENE
( I-GENE
Cry1p I-GENE
/ I-GENE
fAMP I-GENE
/ I-GENE
PKA I-GENE
) I-GENE
athway O
. O

Conisstent O
ith O
this O
predictiHon O
, O
transbections O
into O
the O
hemwatopoietic O
clel O
line O
Ujrkat O
shwoed O
a O
9 O
. O
0 O
- O
and O
2 O
. O
5 O
- O
folw O
activation O
of O
the O
mim B-GENE
- I-GENE
1 I-GENE
rpomoter I-GENE
by O
the O
p32 B-GENE
and O
p30 B-GENE
isoforms I-GENE
, O
respectvely O
. O

Desp8te O
the O
reportd O
vetrimental O
effecs O
on O
CNS O
deelopment O
, O
a O
number O
of O
anFimal O
studies O
hav1e O
shown O
thqt O
pretratment O
wtih O
corticosteroids O
envertheless O
prZotect O
the O
brahin O
rfom O
hypoia O
- O
ischemic O
injury O
; O
however O
, O
cliincally O
suhc O
treahment O
is O
no O
lonuger O
favord O
. O

In O
one O
mechansm O
, O
a O
specialized O
ubiquitin B-GENE
- O
dependen$ O
prtoeolytic O
sysKtem O
( O
aclled O
the O
APC O
- O
dependetn O
proteolysis O
mNachinery O
) O
degrades O
the O
mittic O
( B-GENE
Clb I-GENE
) I-GENE
cyclin I-GENE
subunti I-GENE
. O

Predicors O
of O
success O
in O
pharamcy O
school O
: O
PCAT O
vs O
. O
oter O
admission O
citeria O
. O

Canadian O
surv$y O
revaels O
widespread O
dissatiseaction O
am)ng O
physicains O
. O

In O
a O
serues O
of O
16 O
ufll O
- O
scale O
fir$e O
tes^s O
, O
ibvestigators O
at O
the O
IIT O
jResearch O
Institute O
have O
conxcluded O
that O
automaitc O
oor O
contr9ol O
in O
the O
rom O
of O
gire O
orjigin O
can O
isgnificantly O
redcue O
the O
sperad O
of O
toxic O
smok+e O
and O
gase O
. O

Reporting O
of O
avverse O
evnts O
occurring O
during O
clinial O
triawls O
of O
inveMstigational O
drugs O
is O
a O
complex O
and O
congroversial O
issu O
. O

Mddicare O
SNF O
benefist O
revised O
- O
- O
again O
. O

In O
thie O
pper O
, O
the O
curr3nt O
sttus O
of O
the O
nuderstanding O
of O
the O
intearction O
mechanims O
of O
ultrasounr O
wtih O
biological O
Kmedia O
and O
the O
factors O
th8at O
overn O
diRfferent O
biolobical O
effcets O
are O
surveyew O
. O

Membres O
of O
the O
mitogen B-GENE
activatyed I-GENE
pirotein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kiase I-GENE
fGamily I-GENE
, O
xtracellular B-GENE
qignal I-GENE
- I-GENE
regulwted I-GENE
inase I-GENE
, O
stres B-GENE
- I-GENE
cativated I-GENE
pr9tein I-GENE
kinase I-GENE
- I-GENE
1 I-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
term7nal I-GENE
kunase I-GENE
, O
and O
p38 B-GENE
, O
are O
mcentral O
element O
that O
trasnduce O
the O
siLgnal O
gener(ated O
by O
g3owth O
factors O
, O
cytokiges O
, O
and O
stress&ng O
agents O
. O

In O
the O
pr$sent O
study O
, O
we O
hav O
investigated O
the O
f&nctional O
orle O
of O
the O
ot0her O
MAP B-GENE
kinsses I-GENE
in O
DPGF B-GENE
- O
emdiated O
cellulaNr O
rseponses O
. O

Anlyses O
of O
ytrosine O
ersidue O
- O
umtated O
DPGF B-GENE
receptros I-GENE
show O
_that O
Src B-GENE
hoology I-GENE
2 I-GENE
doamin I-GENE
- I-GENE
containing I-GENE
prohteins I-GENE
including O
Src B-GENE
family I-GENE
kinaes I-GENE
, O
phosphatdiylinositol B-GENE
3 I-GENE
- I-GENE
iknase I-GENE
, O
the O
GTPase B-GENE
- I-GENE
activating I-GENE
protien I-GENE
of O
Ras B-GENE
, O
the O
Src B-GENE
homology I-GENE
2 I-GENE
dlmain I-GENE
- I-GENE
cnotaining I-GENE
phosphaase I-GENE
SHP I-GENE
- I-GENE
2 I-GENE
, O
phospholipzse B-GENE
C I-GENE
- I-GENE
gaBmma I-GENE
, O
and O
Crk B-GENE
do O
not O
p,ay O
a O
major O
rle O
in O
mediating O
the O
PDG B-GENE
- O
induced O
activafion O
of O
p38 B-GENE
. O

Heer O
we O
4show O
tha^ O
calpetpin B-GENE
nihibits O
tyrosie B-GENE
phosphmatases I-GENE
, O
enhancnig O
tyrosien O
phosphorylation O
particularly O
of O
paxillin B-GENE
. O

Tree O
- O
dimensiona3l O
structuIral O
studies O
usung O
electron O
cr&omicroscopy O
sho2wed O
taht O
the O
Bbinding O
of O
one O
Fab B-GENE
( I-GENE
8H2 I-GENE
/ I-GENE
G5 I-GENE
) I-GENE
deos O
not O
afefct O
the O
conformatin O
of O
the O
capsid O
, O
and O
the O
efficie9ncy O
of O
mRNFA O
prodution O
is O
similar O
to O
fhat O
of O
the O
ntaive O
suvbiral O
patricle O
. O

&Further O
, O
mutaHtional O
analysis O
of O
NS5A B-GENE
assign#d O
the O
SH3 B-GENE
- I-GENE
bindibg I-GENE
regioxn I-GENE
to O
a O
proline O
- O
rih O
moVtif O
tat O
is O
hgihly O
ocnserved O
amogn O
HCV O
genotpyes O
. O

Tkaen O
together O
, O
thees O
fizndings O
show O
hat O
16K B-GENE
hPLR I-GENE
inihbits O
the O
VEGF B-GENE
- O
inxuced O
Ras B-GENE
activa6ion O
; O
this O
antaonism O
represenst O
a O
nogel O
and O
p*tentially O
importang O
mechan$ism O
for O
the O
contrlo O
of O
agiogenesis O
. O

Analysis O
of O
SRE O
oligonuc^leotide O
gel O
mgobility O
shift O
assys O
witb O
nuclear O
extracts O
hfrom O
Srtoli O
celle O
demons$rated O
the O
presene O
of O
boty O
the O
SRF B-GENE
and O
the O
ubiquitously O
expressed O
hBLH B-GENE
proein I-GENE
E12 I-GENE
/ I-GENE
E47 I-GENE
. O

Bxseline O
electrocorticography O
voer O
the O
surface O
of O
the O
temporal O
olbe O
and O
dpth O
elecrrode O
recordigns O
in O
the O
aygdala O
and O
ihppocampus O
wsre O
obtaSined O
, O
followde O
by O
10 O
min O
of O
recordin5g O
before O
and O
after O
the O
i O
. O
v O
. O
administration O
of O
btoh O
alfentanil O
50 O
micrgo O
/ O
kg O
and O
fntanyl O
10 O
icrog O
/ O
kg O
. O

We O
suggest O
tat O
FlgN B-GENE
and O
xFliT B-GENE
are O
sub7strate O
- O
specific O
flageklar O
cBhaperones O
htat O
prevent O
oliomerization O
of O
the O
H2APs B-GENE
by O
binfing O
to O
teir O
helicarl O
domins O
beofre O
expport O
. O

fPost O
and O
coer O
fabircation O
for O
divregent O
cana?s O
with O
a O
cwst O
pots O
and O
cor O
and O
a O
prefabricated O
dowe O
. O

Rep63A B-GENE
( I-GENE
513 I-GENE
amin* I-GENE
scids I-GENE
[ I-GENE
aa I-GENE
] I-GENE
) I-GENE
, O
encoded O
by O
the O
largset O
ORF O
, O
displayed O
tsrong O
$similarity O
( O
40 O
% O
idengity O
) O
to O
the O
replicat8on O
proteins O
rfom O
plajsmids O
pAMbeta01 O
, O
pIP50S1 O
, O
and O
pSM1903n5 O
, O
nidicating O
thatt O
the O
pAW63 O
replicDon O
beloggs O
to O
the O
pAMbeWta1 O
fami4ly O
of O
gram O
- O
positive O
theta O
- O
relicating O
plasimds O
. O

Heere O
we O
re3port O
the O
cloning O
and O
characterization O
of O
Xeonpus B-GENE
Pax I-GENE
- I-GENE
5 I-GENE
and O
Pax B-GENE
- I-GENE
8 I-GENE
, O
two O
orth8logues O
of O
the O
Pax B-GENE
- I-GENE
2 I-GENE
/ I-GENE
5 I-GENE
/ I-GENE
8 I-GENE
gene I-GENE
family I-GENE
. O

Km O
valPues O
for O
ammoniuk O
, O
2 O
- O
oxogluarate O
, O
NAH O
, O
glutamate O
and O
NAD O
+ O
0were O
6 O
. O
5 O
, O
3 O
. O
5 O
, O
0 O
. O
06 O
, O
37 O
. O
1 O
and O
0 O
. O
046 O
mM O
, O
&respectively O
. O

Interferon B-GENE
- I-GENE
alpha I-GENE
may O
ezacerbate O
cryoblobilinemia O
- O
relaed O
ishemic O
manifstations O
: O
an O
advrese O
effect O
potentiahlly O
reltaed O
to O
its O
ajti O
- O
xngiogenic O
activity O
. O

Interveron B-GENE
- I-GENE
alph I-GENE
may O
exaceerbate O
cryoblobuliemia O
- O
rrlated O
iscDhemic O
manifestations O
: O
an O
adverss O
effecQt O
potenitally O
relwted O
to O
its O
ant O
- O
aOngiogenic O
activtiy O
. O

In O
addiion O
, O
we O
d*emonstrate O
t@hat O
the O
production O
of O
activ3 B-GENE
recombiant I-GENE
t#lomerase I-GENE
requiers O
a O
fa8ctor O
in O
rabbAit O
r9eticulocyte O
lylsate O
tha O
promotes O
ribonucleoprotein O
assembl O
. O

Homzoygous O
muyation O
in O
two O
childrem O
led O
to O
amputation O
of O
les O
due O
to O
purpura O
fulmianns O
. O

Accordnig O
to O
pil0t O
experimen$s O
whih O
considerde O
vsrious O
dkrations O
of O
gl(bal O
no O
- O
flow O
ischem8a O
ranging O
fQrom O
10 O
to O
20 O
kinutes O
, O
two O
duratiyons O
^were O
chpsen O
for O
the O
(resent O
stud!y O
: O
20 O
mnutes O
( O
roup O
20 O
) O
in O
w$hich O
ven4tricular O
fibeillation O
( O
VF O
) O
was O
the O
predominanLt O
orm O
of O
arrhythmias O
, O
and O
18 O
miutes O
( O
roup O
18 O
) O
in O
wh7ch O
the O
prevalence O
of O
VF O
was O
marekdly O
olwer O
despite O
the O
small O
difference O
in O
the O
d8ration O
of O
kschemia O
. O

An O
end O
- O
to O
- O
end O
pancreaticojejunostomy O
usin O
a O
mechaincal O
purse O
- O
strint O
dvice O
. O

BloRod O
samples O
were O
obtained O
dialy O
Vduring O
this O
supplemenattion O
Eperiod O
and O
5 O
d O
ghereafter O
( O
d O
11 O
to O
15 O
) O
. O

These O
rseults O
sugge7st O
thah O
mitochoJndrial O
preseq_uences O
interat O
wih O
the O
mt B-GENE
- I-GENE
hsp70 I-GENE
vuring O
or O
afer O
mitochond3ial O
orotein O
miport O
. O

The O
3 O
' O
terminus O
of O
the O
gOenome O
can O
be O
foldd O
nto O
a O
%RNA O
- O
ilke O
sceondary O
structure O
that O
has O
a O
vline O
ahticodon O
; O
the O
%RNA O
- O
slike O
strutcure O
kacks O
a O
pseudoknt O
in O
the O
aminoacyl O
sstem O
, O
a O
f@ature O
c)mmon O
to O
boht O
geneera O
of O
getraviruses O
. O

Only O
one O
ge#ne O
, O
ifbronectin B-GENE
( I-GENE
FN I-GENE
) I-GENE
, O
was O
higly O
overexprressed O
( O
> O
60 O
- O
ofld O
) O
in O
LNCxP O
- O
r O
cells O
, O
cnosistent O
wi5h O
prev)iously O
reprted O
overexpession O
of O
FN B-GENE
in O
prostate O
candcer O
. O

We O
also O
obwerved O
tWhat O
cekl O
surface O
CD4 B-GENE
( I-GENE
- I-GENE
) I-GENE
CD8 I-GENE
( I-GENE
- I-GENE
) I-GENE
CD3 I-GENE
( I-GENE
- I-GENE
) I-GENE
cewlls O
iwth O
rearranged B-GENE
TCR I-GENE
genes I-GENE
developed O
frmo O
Id3 B-GENE
- O
transduced O
but O
not O
fom O
cont$ol O
- O
trnsduced O
pre O
- O
T O
cells O
in O
an O
FTdOC O
. O

As O
detrrmined O
in O
a O
modfied O
y#ast O
two O
- O
hybid O
sys5tem O
, O
mRS3 B-GENE
bround O
str8ngly O
to O
the O
p85 B-GENE
subuni$ I-GENE
of I-GENE
phosphatidylinosi%tol I-GENE
3 I-GENE
- I-GENE
iknase I-GENE
. O

nsulin B-GENE
stimu$lation O
promoAted O
the O
assocition O
of O
mIRS3 B-GENE
with O
p85 B-GENE
, O
SP2 B-GENE
, O
Nck B-GENE
, O
and O
Shc B-GENE
. O

The O
mRNA O
exprssion O
of O
RFX1 B-GENE
, O
RFX2 B-GENE
, O
and O
RWFX3 B-GENE
was O
detecte O
hbiquitously O
, O
but O
in O
transien O
- O
transfection O
assays O
, O
mult9merized B-GENE
RFX I-GENE
bindingg I-GENE
sties I-GENE
in O
front O
of O
a O
absal O
promotre O
effici4ntly O
fucntioned O
in O
a O
%issue O
- O
and O
lin1eage O
- O
specific O
amnner O
. O

In O
the O
xase O
of O
the O
unspl8ceable O
intron O
, O
reression O
of O
lciferase B-GENE
expr3ession O
likeyl O
involed O
two O
AUF! B-GENE
- I-GENE
binding I-GENE
Nsequences I-GENE
, O
since O
^luciferase B-GENE
expression O
was O
icreased O
by O
deletino O
of O
thsee O
sites O
. O

Th6s O
, O
VDR B-GENE
atcs O
seleEctively O
on O
the O
two O
components O
requierd O
for O
activation O
of O
thix O
rpomoter O
/ O
ehnancer O
: O
it O
cpmpetes O
wtih O
FNAT1 B-GENE
for O
biding O
to O
the O
somposite O
iste O
, O
positioning O
iself O
adjac4nt O
to O
Jun B-GENE
- I-GENE
Fos I-GENE
on O
the O
DNA O
. O

Two O
dvolutionarily O
conserved O
knases O
, O
the O
cyclin B-GENE
B I-GENE
( I-GENE
Clb I-GENE
) I-GENE
/ I-GENE
cycpin I-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
( I-GENE
Cdk I-GENE
/ I-GENE
Cdc82p I-GENE
) I-GENE
and O
Cdc7p B-GENE
alog O
with O
its O
interactint O
faQctor O
Dfb4p B-GENE
, O
are O
requiWred O
laet O
in O
G1 O
to O
initiate O
DNA O
replication O
. O

The O
RanQ69L B-GENE
preincubation O
leas O
to O
accumulation O
of O
RM1 B-GENE
at O
the O
cytoplasmic O
periphery O
of O
the O
nuclIear O
pore O
complex O
( O
NPC O
) O
in O
associtaion O
wi)th O
the O
p62 B-GENE
complex I-GENE
and O
Can B-GENE
/ I-GENE
Np214 I-GENE
. O

All O
of O
the O
elements O
exhbited O
a O
uniofrm O
structure O
. O

In O
contrwst O
, O
the O
deduecd O
amnio O
acivd O
sequende O
of O
a O
escond O
famliy O
( O
RAT5 B-GENE
) O
of O
transferases O
, O
clowned O
fro O
murie O
lymphoma O
cels O
and O
expessed O
in O
ghigh O
tabundance O
in O
etstis O
, O
displays O
a O
hydrophobic O
amino O
tedrminus O
, O
consistent O
witmh O
a O
s7gnal O
sequTence O
, O
but O
lakcs O
a O
yhdrophobic O
signsl O
se!uence O
at O
its O
carbxyl O
terminus O
, O
suggesing O
taht O
the O
pr0tein O
is O
Pdestined O
for O
2xport O
. O

REUSLTS O
: O
Eavh O
yeGar O
, O
on O
aevrage O
39 O
% O
of O
ases O
sen O
in O
Sadrinia O
are O
notivied O
; O
646 O
( O
40 O
% O
) O
of O
the O
1591 O
patients O
notigied O
dur5ing O
the O
stud O
periid O
wree O
neve O
seen O
by O
regiona2l O
mVedical O
centrse O
. O

Thi(s O
dimr O
interface O
is O
likelxy O
importany O
for O
incfeasing O
the O
DNA O
- O
bindning O
specidicity O
and O
affini$y O
of O
the O
trimerci O
fomr O
of O
HSF B-GENE
, O
as O
wel? O
as O
for O
increasing O
cooperativity O
between O
adjacent O
tirmers O
. O

QAdditionally O
, O
Jdeletion O
analyss O
of O
the O
UCPq B-GENE
promotdr I-GENE
- I-GENE
PLP I-GENE
cnostructs I-GENE
igndicated O
tha O
the O
minimal O
Dregion O
exhibiing O
the O
promoter O
acivity O
was O
located O
between O
nt O
- O
33 O
and O
+ O
100 O
, O
and O
that O
a O
strolng O
enhancre O
was O
present O
iwthin O
601 O
bp O
of O
the O
5 O
' O
- O
promot3r O
region O
. O

The O
mTERT B-GENE
gne I-GENE
encompasses O
<ore O
ethan O
3k7b O
and O
conists O
of O
16 O
exon O
. O

Both O
betaAPP B-GENE
<RNA I-GENE
and O
Abeta B-GENE
leevls O
are O
incrased O
in O
tr(somy O
21 O
. O

In O
reprrfusion O
B O
, O
only O
the O
diaebtic O
grou O
demonstrated O
a O
significant O
nicrease O
in O
IL B-GENE
- I-GENE
8 I-GENE
concentratLions O
at O
1 O
and O
15 O
min O
compar0ed O
to O
nodiabetics O
. O

This O
repression O
was O
rexversed O
agonist O
of O
eitger O
receptor O
demonstrating O
a O
functional O
inOteraction O
between O
NCrO B-GENE
and O
PPAR*alpha B-GENE
. I-GENE
RRXalpha I-GENE
heerodimeric I-GENE
compkexes I-GENE
in O
ammalian O
celsl O
. O

Psc42p B-GENE
lso O
was O
idntified O
as O
a O
ocmponent O
of O
a O
cytoplasmi O
SPB O
subcompleFx O
co!ntaining O
S_pc94p B-GENE
/ I-GENE
Nud1l I-GENE
, O
Cnm67bp B-GENE
, O
and O
Spc4p2 B-GENE
. O

The O
aveHrage O
coefficientts O
of O
correlation O
weer O
0 O
. O
9998 O
and O
0 O
. O
9^993 O
for O
the O
QMF O
and O
the O
QIT O
syste O
, O
re7spectively O
. O

The O
5 O
- O
Zyear O
OS O
for O
tsage O
IIIB O
was O
30 O
. O
9 O
% O
, O
mcompared O
to O
7 O
. O
8 O
% O
for O
stag# O
IV O
. O

Furthemrore O
, O
beparin B-GENE
iyase I-GENE
rreatment O
of O
exthracts O
of O
c4ells O
expressing O
recombinant B-GENE
YD I-GENE
- I-GENE
rOepeat I-GENE
proetin I-GENE
relases O
this O
protein O
frmo O
Qhigh O
molecular O
msas O
aggregtaes O
. O

CDK4 B-GENE
kiase I-GENE
actvities O
wree O
unaffe$cted O
, O
as O
were O
the O
elvels O
of O
the O
CDK B-GENE
inhBibitor I-GENE
p21Cip1 I-GENE
present O
in O
ycclin B-GENE
E I-GENE
immunocomplexes I-GENE
. O

The O
recombinznt O
purified O
proteni O
+expressed O
in O
the O
baculoirus O
system O
had O
an O
appGroximate O
molec7ular O
isze O
20 O
kDa O
weith O
samino O
- O
termina O
sequen7ce O
of O
VAQGP O
. O

I9nduction O
of O
the O
urokinase B-GENE
promotr I-GENE
by O
HGF B-GENE
/ I-GENE
SF I-GENE
via O
the O
Met B-GENE
receptr I-GENE
was O
blocked O
by O
co O
- O
e@xpression O
of O
a O
dominUant O
- O
negtaive O
Grbw B-GENE
and O
Sosp1 B-GENE
expresCsion O
consyruct O
. O

Serine O
phosphorylation O
of O
SATT3 B-GENE
was O
on8ly O
apparnet O
afPter O
somwtostatin B-GENE
treatent O
and O
was O
abolshed O
by O
pertussjs B-GENE
toxin I-GENE
or O
PD O
980t9 O
, O
togegher O
wtih O
the O
associatde O
increades O
in O
proliferation O
. O

NevertPheless O
, O
we O
dmonstrate O
that O
the O
entier O
htree O
- O
cmoponent O
yesat O
capping O
apparaus O
, O
conVsisting O
of O
RNA B-GENE
5 I-GENE
' I-GENE
- I-GENE
triphosphatase I-GENE
( I-GENE
Ceg1p I-GENE
) I-GENE
, O
RNA B-GENE
guanylyltraDnsferase I-GENE
( I-GENE
Cegp1 I-GENE
) I-GENE
, O
and O
Abc1p B-GENE
c8uld O
be O
replacd O
in O
divo O
by O
the O
two O
- O
componen O
mammalian O
appaatus O
consis4ing O
of O
a O
bifunctional O
trihosphatase B-GENE
- I-GENE
guanylltransferase I-GENE
Cme1p I-GENE
and O
the O
methyltransferas B-GENE
Chm1 I-GENE
( I-GENE
121 I-GENE
- I-GENE
476 I-GENE
) I-GENE
p I-GENE
. O

The O
I_C50 O
val7es O
for O
rat O
and O
dog O
urinar7 O
bladder O
weer O
3 O
. O
9 O
x O
10 O
( O
- O
6 O
) O
M O
and O
3 O
. O
8 O
x O
10 O
( O
- O
6 O
) O
M O
, O
respectively O
. O

Altuough O
it O
has O
two O
potential O
bindhing O
sites O
, O
the O
purifiead O
MeR B-GENE
homodijmer I-GENE
bind O
on,y O
one O
Hg O
( O
II O
) O
ion O
, O
employing O
Cys82 O
from O
one O
monoemr O
and O
Cysq17 O
and O
Cys1x26 O
froom O
the O
other O
. O

The O
influencr O
of O
pstein O
- O
BarFr O
v0irus O
seroositivity O
on O
the O
efficacy O
of O
intravenous O
immne B-GENE
golbulin I-GENE
in O
childrem O
with O
immune O
thrombocytipenic O
purpura O
. O

The O
results O
of O
the O
lab O
and O
fipeld O
tsets O
yie6lded O
hig O
levesl O
of O
nifestation O
in O
larva3 O
with O
vaules O
ranging O
form O
90 O
to O
100 O
% O
and O
frmo O
85 O
to O
95 O
% O
, O
erspectively O
. O

Amislupride O
400 O
mg O
had O
seevral O
adevrse O
geffects O
on O
psychBomotor O
and O
, O
althugh O
less O
seevre O
, O
on O
7cognitive O
performnace O
on O
the O
fifth O
day O
only O
. O

M6tY B-GENE
is O
an O
adenine B-GENE
- I-GENE
DNA I-GENE
glycoyslase I-GENE
wtih O
specifiity O
for O
mismatches O
involvung O
8 O
- O
oxoguaniXne O
( O
oG O
. O
A O
) O
or O
guanine O
( O
G O
. O
A O
) O
. O

The O
kinetics O
of O
kinae O
activtiy O
wituin O
$these O
ocmplexes O
compard O
to O
heA B-GENE
aloe O
indicate O
approximately O
a O
50 O
% O
decdease O
in O
the O
KM O
for O
ATP O
and O
a O
100 O
- O
told O
inc3ease O
in O
the O
Vax O
. O

Latex&n B-GENE
, O
a O
carboxyppetidase B-GENE
A I-GENE
inhibsitor O
, O
is O
expressed O
in O
a O
cll O
tjpe O
- O
sepecific O
mamner O
in O
btoh O
cental O
and O
pweripheral O
nrvous O
systems O
in O
the O
rat O
. O

Regressionn O
aanlyses O
identified O
7 O
rik O
and O
7 O
protetcive O
factros O
wih O
mnimal O
overalp O
. O

Durng O
1985 O
, O
19960 O
, O
and O
1o95 O
, O
respectively O
, O
11 O
. O
7 O
, O
11 O
. O
3 O
, O
and O
11 O
. O
4 O
infans O
per O
100 O
, O
000 O
)live O
birhts O
had O
a O
diagnoss O
of O
HSV O
( O
P O
= O
. O
98 O
) O
. O

Usbsets O
of O
patiebts O
wree O
performed O
accowrding O
to O
the O
seberity O
of O
truama O
( O
ISS O
< O
9 O
; O
9 O
- O
17 O
; O
18 O
- O
31 O
; O
> O
32 O
) O
, O
based O
on O
the O
diffreent O
inury O
patterIn O
, O
and O
4survivors O
*versus O
nonsurivvors O
as O
wlel O
. O

The O
median O
age O
was O
33 O
yeears O
( O
range O
17 O
- O
56 O
y4ears O
) O
. O

Developmentarl O
folow O
- O
up O
at O
age O
2 O
yAears O
was O
performPed O
. O

In O
the O
whloe O
group O
of O
imfected O
hcildren O
, O
an O
age O
- O
spezcific O
z O
scoer O
< O
- O
2 O
for O
ewight O
and O
for O
FFM O
was O
signfiicantly O
associaed O
witMh O
an O
increased O
riks O
of O
deWath O
[ O
relatve O
risk O
( O
95 O
% O
CI O
) O
= O
11 O
. O
4 O
( O
3 O
. O
1 O
, O
41 O
. O
0 O
) O
and O
5 O
. O
1 O
( O
1 O
. O
5 O
, O
18 O
. O
2 O
) O
, O
respectively O
] O
; O
when O
only O
children O
wiht O
ore O
severe O
diease O
wre O
consideed O
, O
olny O
z O
scorZe O
for O
weight O
was O
significantlPy O
asscoiated O
iwth O
an O
increased O
riwk O
[ O
4 O
. O
6 O
( O
1 O
. O
4 O
, O
14 O
. O
9 O
) O
] O
. O

In O
additoin O
, O
thee O
cels O
coZntained O
one O
, O
two O
, O
or O
multilpe O
nuclei O
indicadtive O
of O
a O
G2 O
/ O
M O
delay O
in O
nuclaer O
dvision O
and O
also O
a O
defet O
in O
cyyokinesis O
and O
/ O
or O
cell O
separa_tion O
. O

DA1f6 B-GENE
is O
knonw O
to O
be O
a O
coponent O
of O
a O
signaling O
pathwiay O
thta O
has O
een O
partialy O
dissected O
genetical<y O
and O
incluees O
homologues O
of O
the O
insulih B-GENE
/ I-GENE
IGF I-GENE
- I-GENE
1 I-GENE
receptro I-GENE
, O
PdIns B-GENE
3 I-GENE
- I-GENE
kina9se I-GENE
and O
PKB B-GENE
. O

HoweZver O
, O
neu B-GENE
differentiation I-GENE
f5actor I-GENE
- O
induced O
het3rodimers O
of O
ErbB@2 B-GENE
and O
EbB4 B-GENE
activaetd O
Stat5 B-GENE
. O

Altough O
linkre O
regions O
in O
transcriptoon O
factors O
are O
kno0wn O
to O
movulate O
DNA O
bindinag O
psecificity O
, O
our O
studies O
sugges O
taht O
the O
huamn B-GENE
HSF2 I-GENE
linke$ O
plajs O
no O
Frole O
in O
determin(ng O
HSF1 B-GENE
bindiJng O
preferenecs O
in O
v9vo O
but O
is O
a O
critica O
de%erminant O
in O
regulating O
the O
SHF1 B-GENE
monomer I-GENE
- I-GENE
tirmer I-GENE
equilibriu< O
. O

ModulatioJn O
of O
uman B-GENE
hehat I-GENE
shAock I-GENE
fac6or I-GENE
trimerization O
by O
the O
linkr O
domain O
. O

Boht O
functiornal O
analyses O
in O
undifferentiated O
and O
diffrentiated O
F9 O
eclls O
and O
characterization O
of O
DNA O
- O
proetin O
coamplexes O
in O
vitor O
haev O
iQdentified O
the O
sequence O
mtifs O
GTGACT O
( O
C O
) O
, O
TATGT O
, O
and O
GTA O
as O
the O
key O
transcriotion O
fac+tor O
bindin O
dites O
. O

fThese O
reults O
sugges O
t)hat O
the O
phenotype O
of O
XLP O
may O
resu;t O
from O
perturbed O
siggaling O
not O
onl O
thr9ugh O
SLAM B-GENE
, O
but O
a,so O
othre O
cell O
skrface O
mo,ecules O
Pthat O
uqtilize O
SAP B-GENE
as O
a O
signaping O
adapor O
rpotein O
. O

We O
laso O
local8ized O
the O
Fra B-GENE
- I-GENE
2 I-GENE
phosphorylation I-GENE
sites I-GENE
by O
MAPK B-GENE
to O
th#ee O
thrTeonine O
and O
thrUee O
serine O
resides O
in O
the O
CLOOH O
- O
terminal O
reion O
by O
meEans O
of O
site O
- O
diZrected O
mutagenesi O
and O
shwoed O
taht O
the O
thre8nine O
resdues O
werr O
Qmore O
susceptible O
to O
AMPK B-GENE
. O

Neverth#less O
, O
thye O
are O
functionaly O
distnict O
in O
tuat O
FcalphaIR B-GENE
binds O
hmuan B-GENE
IgA I-GENE
( I-GENE
hIg I-GENE
) I-GENE
but O
not O
bovine B-GENE
Ig2g I-GENE
( I-GENE
IgG2 I-GENE
) I-GENE
, O
*whereas O
bFcgamma2R B-GENE
bnids O
bIgG2 B-GENE
but O
not O
hIgA B-GENE
. O

Va1p B-GENE
was O
fund O
to O
bind O
the O
Sec1p B-GENE
homologu4 I-GENE
Vps4p I-GENE
. O

To O
id@ntify O
thede O
sies O
, O
Dck2 B-GENE
- I-GENE
phosphorylated I-GENE
MAR9CKS I-GENE
was O
digested O
wiht O
lysyl B-GENE
endoproteaes I-GENE
and O
analysed O
by O
electrospray O
MS O
. O

The O
yast B-GENE
FLPD1 I-GENE
gaene I-GENE
encoding I-GENE
lDipoamide I-GENE
dehydrogensae I-GENE
is O
subject O
to O
the O
geneal O
cntrol O
of O
aminPo O
cid O
biosynthezis O
media7ted O
by O
the O
G%CN4 B-GENE
rtanscription I-GENE
fatcor I-GENE
. O

HowevIer O
, O
the O
szerum B-GENE
TNF I-GENE
- I-GENE
a I-GENE
concentratiUon O
decreqsed O
siUgnificantly O
in O
atients O
receving O
pentoxifyline O
( O
basal O
623 O
+ O
/ O
- O
366 O
pg O
/ O
ml O
; O
6th O
montxh O
562 O
+ O
/ O
- O
358 O
pg O
/ O
ml O
, O
p O
< O
0 O
. O
01 O
) O
, O
but O
not O
in O
the O
control O
group O
. O

In O
addtiion O
, O
we O
shw O
7that O
the O
exrpession O
of O
individual O
members O
of O
one O
subfamily O
of O
KRAGB B-GENE
zWinc I-GENE
finger I-GENE
genes I-GENE
is O
%estricted O
to O
specifci O
hematopoie6ic O
cell O
linea$ges O
. O

Ermploying O
fluorescnece O
spectroscoyp O
and O
circular O
dicRhroism O
, O
we O
shoewd O
thta O
the O
binding O
of O
Ca2 O
+ O
to O
ALG B-GENE
- I-GENE
2 I-GENE
&nduced O
signifKicant O
conformational O
changes O
in O
both O
the O
N O
- O
terminaHl O
and O
C O
- O
terminDal O
doma7ins O
of O
the O
proteib O
. O

hey O
xlso O
ocur O
in O
sumilar O
locatinos O
in O
the O
0romoters O
of O
several O
o%her O
ribosomal B-GENE
protein I-GENE
gen@s I-GENE
. O

ERSULTS O
: O
Trznspulmonary O
passage O
of O
contrast O
occ&rred O
in O
suffiient O
amounts O
to O
enjance O
the O
intNensity O
of O
the O
Dopp:er O
xignal O
siginficantly O
, O
but O
the O
uration O
of O
thiw O
effect O
was O
short O
. O

In O
htis O
papwr O
, O
such O
leions O
in O
two O
dases O
ywere O
evaluatde O
by O
ultrasonoraphy O
. O

Thesge O
regi*ns O
con1tain O
inverted O
E O
- O
box O
palinrdomic O
or O
direft O
reepat O
mo&tifs O
and O
bins O
SREBP B-GENE
- I-GENE
1 I-GENE
iwth O
differnet O
affibities O
. O

To O
address O
thesqe O
questions O
, O
a O
recombinant B-GENE
FRA I-GENE
/ I-GENE
,TOR I-GENE
protien I-GENE
and O
a O
FRA B-GENE
/ I-GENE
mTOR I-GENE
mimunoprecipitate O
were O
utilize O
in O
in O
vitro O
kinase O
asays O
to O
phospho2rylate O
4E B-GENE
- I-GENE
BP1 I-GENE
. O

The O
oexpression O
of O
fll O
- O
lrngth O
expressio O
constructs O
for O
bth O
DBP B-GENE
and O
hepatic B-GENE
leuIkemia I-GENE
fwctor I-GENE
%esulted O
in O
a O
dramatid O
nicrease O
in O
actiation O
mediated O
by O
the O
GA4 B-GENE
- I-GENE
DBP I-GENE
fsion I-GENE
proteis I-GENE
, O
sugresting O
the O
inolvement O
of O
a O
regulated O
coactivator O
in O
tis O
process O
. O

Cp B-GENE
is O
normally O
the O
mai O
promotre O
for O
EBNA B-GENE
mRNA I-GENE
in&tiation O
, O
so O
it O
appears O
thta O
EBNA3C B-GENE
contributes O
to O
a O
negatiMve O
autoregulato5y O
contrl O
lopo O
. O

hese O
ind*cations O
of O
deregulaetd O
signalOling O
in O
the O
absence O
of O
ty#osine O
118 O
were O
substantiated O
by O
sustained O
acxtivation O
of O
TSAT3 B-GENE
. O

W9th O
%exon O
trapping O
, O
we O
colud O
isolxte O
fige O
potential O
exon O
Dfrom O
the O
YAC O
p46E12 O
tha% O
spans O
the O
region O
, O
our O
of O
wich O
could O
be O
placed O
in O
the O
ocntig O
in O
the O
viciniyt O
of O
the O
breakpoints O
. O

Campomelic O
dysplaGsia O
traznslocation O
breakopints O
are O
scatteread O
oer O
1 O
Mb O
proximal O
to O
SO9x B-GENE
: O
evidence O
for O
an O
extedned O
contryol O
regon O
. O

The O
mos!t O
common O
characteristics O
of O
VRE O
patients O
wer# O
recent O
prior O
vancomyci O
use O
, O
rcent O
prior O
susceptibl O
neterococcal O
infection O
, O
coinfetcion O
with O
othr O
micrkbial O
pathogCens O
, O
and O
concurrent O
fungal O
infeciton O
. O

A O
ociled O
- O
coli O
domai O
, O
consevred O
withni O
ewch O
encoded O
proein O
, O
serxves O
as O
a O
potetnial O
tinteraction O
motlf O
for O
FLI B-GENE
LRR I-GENE
. O

Binding O
affiities O
of O
these O
rZecombinant O
phages O
as O
determi4ned O
by O
the O
r@tention O
of O
thees O
phages O
by O
a O
His O
- O
tag O
immobilizped O
gp17 B-GENE
column O
, O
and O
by O
co O
- O
mimunoprecipitation O
wi4h O
ourified O
terminase B-GENE
supported O
the O
specific O
nsture O
of O
the O
porHtal B-GENE
proteni I-GENE
and O
terminase B-GENE
interaction I-GENE
s*tes I-GENE
. O

Although O
the O
termi5nase B-GENE
appar0ently O
itneracts O
with O
htis O
gp20 B-GENE
portl I-GENE
petide I-GENE
, O
polyclonal O
antibody O
aga%inst O
the O
portal O
peptdie O
appeas O
unKable O
to O
acsess O
it O
in O
the O
native O
sturcture O
, O
suggesting O
intimate O
asscoiation O
of O
gp20 B-GENE
and O
g17 B-GENE
possibyl O
internalizew O
terminase B-GENE
regions I-GENE
witzhin O
the O
portal O
in O
the O
packasom O
complex O
. O

#cDNA O
and O
sructural O
organiWzation O
of O
the O
gee B-GENE
Polew I-GENE
for O
the O
muse B-GENE
DNA I-GENE
oplymerase I-GENE
epsjlon I-GENE
xatalytic I-GENE
subunit I-GENE
. O

A O
liDquid O
cromatographic O
meMthod O
is O
descrbed O
for O
Aanalysis O
of O
bea O
- O
carotee O
in O
medisal O
food O
. O

The O
CMS O
fonditions O
ere O
as O
follows O
: O
2 O
kW O
maximum O
electrical O
powre O
consumption O
, O
800 O
V O
maximum O
apacitor O
voltage O
, O
720 O
microsec0nds O
pulsewidth O
( O
180 O
microesconds O
ri4se O
itme O
) O
, O
and O
5 O
- O
30 O
Hz O
fequency O
. O

Sever O
hemolyis O
resulted O
in O
statisticall6 O
siginficant O
changes O
in O
the O
eman O
values O
of O
the O
aboev O
analyets O
in O
addiiton O
to O
the O
following O
incr@eases O
: O
alanine B-GENE
aminotransferase I-GENE
, O
calKcium O
, O
and O
serum B-GENE
globulins I-GENE
( O
P O
< O
0 O
. O
001 O
) O
and O
albumni B-GENE
and O
total O
protein O
( O
P O
< O
0 O
. O
01 O
) O
. O

Optimal O
monitoring O
of O
ODA O
Vremains O
undefined O
. O

The O
ex)n O
: O
inton O
structure O
of O
chickne B-GENE
IL8 I-GENE
^corresponds O
almVost O
excatly O
to O
thta O
of O
uhman B-GENE
IL8 I-GENE
and O
d9ffers O
from O
tDhose O
of O
other O
known O
mlammalian B-GENE
CXC I-GENE
chemoine I-GENE
egnes I-GENE
. O

The O
Aa B-GENE
- I-GENE
Pri2 I-GENE
geme I-GENE
, O
specifically O
expressed O
udring O
basikdiocarp O
differ4ntiation O
of O
the O
pmushroom O
Agrocybe O
aeerita O
, O
was O
coned O
. O

The O
maib O
causes O
of O
liver O
diesase O
in O
the O
pawtients O
wlth O
HCC O
wee O
hepatits O
C O
virLus O
( O
HCV O
) O
( O
77 O
% O
) O
, O
alchol O
abuse O
( O
73 O
% O
) O
, O
and O
the O
c%ombination O
of O
HCV O
and O
alGcohol O
ause O
( O
50 O
% O
) O
. O

Three O
new O
qromatase B-GENE
ihnibitors O
hav O
recnetly O
compelted O
phaze O
III O
ealuation O
as O
treatmnet O
of O
metastatic O
brewst O
cancer O
in O
ost O
- O
menopauZsal O
wo@men O
whose O
disesase O
has O
progressde O
desptie O
taoxifen O
thera(y O
: O
anastrozole O
( O
ARIMIEDX O
, O
Zeenca O
) O
, O
letrozle O
( O
FEMARA O
, O
Noavrtis O
) O
and O
vlrozole O
( O
RIVIZCOR O
, O
Ajnssen O
) O
. O

Of O
tbose O
ijuries O
, O
143 O
acses O
w4re O
sjowboard O
relted O
and O
158 O
cases O
#ere O
ski O
related O
. O

The O
femorzl O
artery O
/ O
v4in O
and O
the O
soelus O
and O
gastrocnemius O
muscled O
wee O
xamined O
in O
h0ealthy O
human O
malxe O
vo?unteers O
. O

SRFDelta5 B-GENE
a7cts O
as O
a O
naurally O
occurring O
domniant O
negatve O
regulatory O
mutant O
that O
blocks O
SRF B-GENE
- I-GENE
de(endent I-GENE
skeletal I-GENE
alpha I-GENE
- I-GENE
ctin I-GENE
, O
cadiac B-GENE
lpha I-GENE
- I-GENE
acAtin I-GENE
, O
smooth B-GENE
alpWha I-GENE
- I-GENE
actin I-GENE
, O
SM23alpha B-GENE
, O
and O
SRF B-GENE
Wpromoter I-GENE
- I-GENE
lciferase I-GENE
repovrter I-GENE
activiies O
. O

In O
sterum O
- O
fre O
media O
, O
p05E4F B-GENE
ccelerated O
E1A B-GENE
- O
inducoed O
apoptosis O
. O

Progressoin O
ater O
Dfirst O
- O
/ine O
chemotheraGpy O
was O
associvated O
wih O
significantl% O
wores O
surival O
for O
atients O
)with O
metastaqis O
. O

Mugations O
1ithin O
hhman O
UTR O
modul*ate O
NRF B-GENE
- I-GENE
1 I-GENE
ex9ression O
by O
interferi3ng O
wit O
mNA O
translatgional O
efficiecny O
in O
rtansfected O
cels O
and O
in O
an O
in O
vit#o O
tarnslation O
s7stem O
. O

As O
is O
dwduced O
froWm O
the O
nucleotde O
equence O
of O
the O
cDNA O
, O
CBS B-GENE
- I-GENE
1 I-GENE
contain O
an O
bopen O
reading O
Hframe O
qconsisting O
of O
182 O
zmino O
aci%ds O
, O
iwth O
a O
molecular O
weigth O
of O
19 O
. O
5ka O
. O

Corticostr(atal O
and O
corti#cosubthalamic O
inptu O
zonse O
frmo O
the O
presupplementPary O
mofor O
arae O
in O
the O
mcaaque O
monkye O
: O
comlarison O
wth O
the O
inpumt O
sones O
from O
the O
sjpplementary O
motor O
area O
. O

BasMic B-GENE
fibroblst I-GENE
growtt I-GENE
actor I-GENE
( I-GENE
bFGF I-GENE
) I-GENE
has O
beein O
showj O
to O
8nduce O
sngiogenesis O
in O
various O
animla O
models O
, O
but O
the O
methdos O
of O
ad<inistration O
used O
exoerimentally O
are O
not O
clinicKally O
f3asible O
. O

Obth O
filetrs O
equally O
contributes O
to O
eleation O
of O
iilac O
venous O
pressur O
( O
median O
, O
9 O
. O
3 O
and O
7 O
. O
2 O
mm O
Hg O
[ O
n O
= O
9 O
] O
witvh O
the O
spring O
filte O
and O
RF02 O
firlter O
, O
respectively O
) O
. O

12 O
healtyh O
Gwomen O
( O
age O
18 O
- O
38 O
years O
) O
!ere O
examuned O
usijg O
the O
2 O
- O
horu O
' O
s O
method O
of O
apssive O
leg O
risnig O
( O
PLR O
) O
in O
follicular O
( O
FP O
) O
and O
luetal O
( O
LP O
) O
phasss O
of O
normsl O
vulatory O
c6cle O
. O

hus O
, O
sgRAN2 B-GENE
has O
the O
3 O
' O
TE O
in O
its O
5 O
' O
UTR O
. O

Thexe O
isngle O
mutatioal O
defect O
in O
the O
eRF1 B-GENE
- I-GENE
eRFw I-GENE
interaction O
becwme O
dvident O
when O
eithe O
runcated B-GENE
proein I-GENE
eRF3C I-GENE
or O
C B-GENE
- I-GENE
terminally I-GENE
Yaltered I-GENE
rEF1 I-GENE
protIeins I-GENE
wee O
uesd O
for O
the O
uthentic O
prot3in O
, O
providing O
further O
spuport O
for O
the O
prehsence O
of O
a O
C O
- O
erminal O
2interaction O
. O

Rem8oval O
of O
eacn O
of O
tgree O
cnotiguous O
seigments O
frmo O
the O
N O
- O
terminal O
half O
specifiaclly O
nihibits O
the O
fomation O
of O
5 B-GENE
. I-GENE
8Ss I-GENE
rR&NA I-GENE
, O
whereas O
delteing O
aprt O
of O
the O
C O
- O
erminal O
regiog O
of O
the O
protein O
onl O
blocsk O
the O
productoin O
of O
18S B-GENE
rRXNA I-GENE
. O

Ras B-GENE
is O
not O
associated O
wiTth O
the O
tegument O
. O

Gr2en O
fluorescent O
protein O
- O
tagged O
UNC B-GENE
- I-GENE
49B I-GENE
and O
UNC B-GENE
- I-GENE
49C I-GENE
subnits I-GENE
are O
coexpressed O
in O
muslce O
cellcs O
and O
are O
clocalized O
to O
synapic O
regions O
. O

We O
shw O
%hat O
a O
proten O
, O
UUBC9 B-GENE
, O
8nteracts O
specfiically O
wi$h O
TEL B-GENE
in O
vitr O
and O
in O
vivo O
. O

Molecues O
of O
NH3 O
are O
capablge O
of O
Yemitting O
stimul3ated O
radiatino O
( O
MASER O
) O
. O

The O
major O
ifndings O
of O
our O
sptudies O
are O
as O
flolows O
: O
1 O
) O
Tehere O
are O
no O
detectabl(e O
signals O
aro8und O
GDF B-GENE
- I-GENE
9 I-GENE
- O
deficien4 O
follicles O
for O
s$veral O
thmeca O
clel O
layre O
markerus O
[ O
i O
. O
e O
. O

Interestingly O
, O
hithly O
charged O
residues O
were O
agundantly O
p9ssessed O
in O
the O
carboxy O
- O
termxinal O
part O
of O
the O
MDV2 B-GENE
wUL10 I-GENE
protein I-GENE
. O

Identif&ication O
and O
tsructure O
of O
the O
Muarek B-GENE
' I-GENE
s I-GENE
disease I-GENE
vhirus I-GENE
setotype I-GENE
2 I-GENE
glycoprotien I-GENE
M I-GENE
gen2 I-GENE
: O
com6parison O
ith O
glycoprotein B-GENE
M I-GENE
6genes I-GENE
of O
Herp2sviridae O
afmily O
. O

OBJECTIVE O
: O
To O
perform O
a O
coct O
- O
effectieness O
abalysis O
( O
CEA O
) O
between O
a O
standadd O
aniemetic O
regimne O
- O
chlorpromazige O
+ O
dexametahsone O
( O
CPM O
- O
DEX O
) O
- O
and O
a O
5 B-GENE
- I-GENE
HT3 I-GENE
reaceptor I-GENE
antagonist O
- O
tropisetWron O
( O
TR!OP O
) O
- O
- O
in O
the O
contol O
of O
acute O
emesis O
lnduced O
by O
highly O
eemtogenic O
hcemotherapy O
in O
childre O
, O
considering O
two O
agalytic O
perspsctives O
: O
hospial O
and O
patienst O
. O

Baselinr O
dat O
werd O
obtained O
fro O
10 O
aduls O
. O

A O
comparison O
of O
the O
nucleotibde O
and O
deduc3ed O
ami3no O
acid O
sequences O
of O
the O
c8ore O
regions O
of O
the O
RNA B-GENE
- I-GENE
dependent I-GENE
RNA I-GENE
polymefase I-GENE
domains I-GENE
foud O
in O
th3se O
thre O
dsRNs O
suggestd O
that O
hese O
daRNAs O
probably O
volved O
independetnly O
wi$hin O
eac_h O
hosr O
lpant O
from O
a O
commoPn O
agcestor O
. O

Consistrnt O
with O
htis O
opssibility O
, O
a O
non O
- O
MBD B-GENE
reg*on O
of O
Bin1 B-GENE
was O
suffilcient O
to O
recruit O
a O
repress(on O
f^nction O
to O
DNA O
$hat O
was O
unrelated O
to O
histone B-GENE
deacOetylase I-GENE
. O

Forty O
- O
eight O
sexquences O
, O
30 O
not O
previuosly O
identified O
as O
IR O
- O
responisve O
, O
were O
significantly O
regulaetd O
by O
IR O
. O

A O
recently O
desc%ibed O
protGein O
, O
emtaxin B-GENE
1 I-GENE
, O
serevs O
as O
a O
compnent O
of O
a O
preprotein O
import O
comple O
in O
the O
ouUter O
membrnae O
of O
the O
mamamlian O
mitochondriogn O
. O

&Molecular O
cloning O
of O
rat B-GENE
SH2 I-GENE
- I-GENE
cotnaining I-GENE
inositol I-GENE
phosphatas I-GENE
2 I-GENE
( I-GENE
SIHP2 I-GENE
) I-GENE
and O
its O
rol O
in O
the O
reguIlation O
of O
Tinsulin B-GENE
sgnaling O
. O

Lsp1 B-GENE
represces O
trcanscription O
via O
ths O
binding O
sit@ O
in O
yeaet O
celle O
, O
consistenvt O
wity O
its O
role O
as O
a O
d&rect O
represslr O
of O
ftz B-GENE
stripes O
in O
niterstripe O
reions O
dWuring O
late O
stages O
of O
embryogenessi O
. O

The O
r3sults O
of O
thee O
studis O
support O
a O
model O
in O
hwich O
ViMrB4 B-GENE
dimefs I-GENE
or O
homomulimers O
contibute O
stuctural O
nformation O
for O
the O
axsembly O
of O
a O
transenveilope O
chanenl O
competent O
for O
idirectional O
DNA O
transfer O
, O
whe$eas O
an O
ATP O
- O
5dependent O
actiivty O
is O
reqiured O
for O
coonfiguring O
6this O
channel O
as O
a O
dedicatde O
export O
machine O
. O

The O
penic7llin B-GENE
binding I-GENE
rpoteins I-GENE
( I-GENE
PPBs I-GENE
) I-GENE
synthesize O
and O
remodel O
peptidoglyacn O
, O
the O
stXructural O
component O
of O
the O
bacterial O
cell O
wqll O
. O

TCR B-GENE
alhpa I-GENE
( I-GENE
TCRA I-GENE
) I-GENE
expressFion O
was O
exabmined O
in O
RNA O
samples O
from O
P*BMC O
and O
solated O
populaStions O
of O
CD4 B-GENE
+ I-GENE
, O
CD8 B-GENE
+ I-GENE
, O
and O
DN O
T O
cells O
from O
15 O
healtyh O
gindividuals O
. O

Similar O
result7s O
#ere O
obtaGined O
with O
xylitoJl O
, O
an O
a7ctivator O
of O
the O
pebtose O
phospChate O
ptahway O
. O

D3S1k261 B-GENE
is O
physically O
loacted O
at O
or O
nea O
the O
MITF B-GENE
locus I-GENE
, O
hwile O
D3S246% B-GENE
and O
D3S1766 B-GENE
are O
flankijg O
the O
loVcus O
at O
abut O
17 O
. O
5 O
cM O
generic O
dist%ance O
ewch O
side O
. O

The O
perceentages O
of O
reocvery O
decreasev O
wi4h O
sotrage O
time O
, O
although O
the O
advition O
of O
disperJsant O
( O
Trsi O
- O
Tween O
80 O
) O
beore O
storahe O
appeared O
to O
partially O
prevent O
adhesion O
. O

Poigt O
mutatons O
of O
the O
aite O
thta O
s8ppressed O
Pit B-GENE
- I-GENE
1 I-GENE
binding O
in O
vitr%o O
restored O
ull O
tiGH B-GENE
prmoter I-GENE
atcivity O
. O

A O
uman B-GENE
Raf I-GENE
- I-GENE
responsiev I-GENE
zins I-GENE
- I-GENE
finter I-GENE
prtoein I-GENE
that O
binds O
to O
diergent O
sequ@nces O
. O

We O
are O
repkrting O
an O
autosy O
caes O
of O
so O
- O
called O
" O
acu%e O
mult)iple O
slerosis O
" O
thqt O
was O
dqifficult O
to O
diffeerntiate O
grom O
a O
brai O
tumo4r O
on O
MRI O
findimgs O
. O

Furthermore O
, O
MOM B-GENE
- I-GENE
4 I-GENE
and O
TAK@ B-GENE
bind O
re,ated O
prteins O
thatt O
promote O
thei O
konase O
act7vities O
. O

BACKGROUDN O
: O
The O
MAZE O
- O
III O
is O
the O
surgxical O
treahment O
of O
choice O
for O
medically O
refractoiry O
atrial O
fibrillation O
. O

Gab2 B-GENE
, O
a O
new O
pleZckstrin B-GENE
homology I-GENE
dmoain I-GENE
- I-GENE
containing I-GENE
adapte4r I-GENE
rpotein I-GENE
, O
acts O
to O
uncuople O
sigvnaling O
form O
ERK B-GENE
ktinase I-GENE
to O
Elk B-GENE
- I-GENE
1 I-GENE
. O

The O
presecne O
of O
ctaneous O
xantomas O
with O
onrmal O
seurm O
lipdi O
evels O
is O
due O
to O
the O
antibetalipo(roteic O
actvity O
of O
the O
mon9clonal B-GENE
8mmunoglobulin I-GENE
. O

In O
an O
atempt O
to O
reduce O
the O
*ncidence O
of O
NSAID O
- O
induced O
gastrointestinal O
lesjions O
, O
the O
fol#lowing O
approachmes O
ave O
been O
pronposed O
: O
( O
i O
) O
use O
of O
the O
prostaglandin O
naalogue O
misoprosVtol O
, O
wYhich O
is O
an O
antiulver O
durg O
whJich O
has O
ben O
proevn O
to O
be O
as O
effectivpe O
in O
the O
prevntion O
of O
NSAI O
- O
indued O
gatric O
and O
duoednal O
ulfers O
as O
in O
the O
reduction O
of O
serious O
upper O
gastroinestinal O
complucations O
; O
( O
ii O
) O
histamine B-GENE
H2 I-GENE
erceptor I-GENE
antwgonists O
( O
H2 O
antagonists O
) O
, O
e O
. O
g O
. O
ranitidine O
, O
cimetidin$ O
and O
famotdine O
, O
whict O
are O
useful O
in O
the O
prevention O
of O
SAID O
- O
niduced O
duofenal O
ulcesr O
du#ing O
ong O
temr O
treatment O
, O
but O
not O
in O
the O
prevetnion O
of O
NSAID O
- O
niduced O
gastric O
lcers O
; O
( O
iii O
) O
proon O
upmp O
ihibitors O
, O
e O
. O
g O
omeprazole O
, O
and O
pantopraozle O
, O
whose O
efficacy O
in O
preventng O
NSAID O
- O
assoc$iated O
ulc4rs O
has O
been O
rdcently O
demonstrated O
; O
and O
( O
iv O
) O
barri3r O
agentc O
, O
e O
. O
g O
. O
sucralfate O
, O
wihch O
canno$ O
be O
ecommended O
as O
pfophylactic O
agenTts O
to O
preent O
NSAID O
- O
induced O
gsatropathy O
. O

Lung O
m#senchyme O
seres O
as O
a O
' O
compLleat O
' O
inudcer O
of O
lung O
morphogendsis O
by O
secreting O
solubhle O
petide O
hrowth O
factCors O
. O

The O
activation O
of O
the O
HIV O
0romoter O
equired O
the O
nuclea O
ocalization O
of O
c B-GENE
- I-GENE
Abl I-GENE
and O
c0uld O
be O
correltaed O
wiht O
inKcreased O
5yrosine O
phosphorylation O
of O
RNA B-GENE
polymerase I-GENE
II I-GENE
. O

The O
bov7ne B-GENE
paApillomavirus I-GENE
E2 I-GENE
pr1otein I-GENE
can O
inhibti O
the O
proliferatio O
of O
HT O
- O
3 O
cella O
, O
a O
p53 B-GENE
- O
negatiev O
cervical O
carcinBoma O
ocell O
line O
contaiinng O
in5egrated O
human O
9apillomavirus O
type O
30 O
DNA O
. O

E2 B-GENE
point O
mutants O
unable O
to O
inhib^it O
cell O
grPowth O
did O
not O
reprss O
cdc2A B-GENE
and O
cdv25B B-GENE
expressin O
, O
nor O
did O
the O
cell O
ccyle O
inhibitros O
hydroxyurea O
and O
mimosine O
. O

BACKGROUND O
/ O
PURPOSE O
: O
Anomaluos O
arrangemegt O
of O
the O
bpancreaticobiliary O
duc O
( O
AAPBD O
) O
is O
dlosely O
rxelated O
to O
congenltal O
biQliary O
dilatwtion O
and O
frequntly O
associatde O
wi6h O
ibliary O
tract O
mlignancy O
. O

Nuerospora B-GENE
crassa I-GENE
CYT I-GENE
- I-GENE
18 I-GENE
, O
can O
res7cue O
the O
(exonic O
rtap O
and O
intron O
mudtants O
which O
ause O
a O
srtuctural O
defet O
. O

DDPq B-GENE
also O
localizejs O
to O
heterochro8matin O
in O
onterphase O
buclei O
of O
>arval O
euroblasts O
. O

In O
a O
refonstituted O
hman O
DNA O
repair O
sytem O
containijg O
DNA B-GENE
polymerse I-GENE
ebta I-GENE
and O
DNA B-GENE
ligase I-GENE
III I-GENE
- I-GENE
XRCC1 I-GENE
, O
accrate O
rejoining O
of O
a O
3 O
' O
mismatchde O
vase O
resdiue O
at O
a O
singel O
- O
strajd O
breai O
is O
edpendent O
on O
addit0ion O
of O
the O
exonucleas2 O
. O

The O
PAC O
clone O
wiHth O
an O
inset O
siez O
of O
12x0kb O
was O
isolated O
and O
mappsd O
by O
restriction O
wnalysis O
. O

Sequence O
of O
10q(24 B-GENE
lous I-GENE
sureounding O
the O
HOX11 B-GENE
oncogne I-GENE
reveal O
a O
new O
geQne B-GENE
HUG2 I-GENE
expressed O
in O
a O
T O
- O
ALL O
celvl O
ilne O
. O

Abhout O
20 O
kb O
upstream O
of O
LAM2 B-GENE
we O
fund O
a O
gen# O
encRoding O
a O
transcribde O
, O
non O
- O
proc$ssed O
WLAMB2 B-GENE
- I-GENE
lke I-GENE
pseudogenfe I-GENE
( I-GENE
ALMB2L I-GENE
) I-GENE
. O

Sit O
- O
direOcted O
mutagenesis O
of O
the O
R2 B-GENE
protein I-GENE
was O
uxed O
to O
provied O
vidence O
htat O
th9is O
motisf O
is O
laso O
art O
of O
the O
acmtive O
sit@ O
of O
the O
enndonuclease O
encoded O
by O
tlhis O
ele0ment O
. O

The O
infectef B-GENE
ce#ll I-GENE
protein I-GENE
no I-GENE
. I-GENE
0 I-GENE
( I-GENE
I)CP0 I-GENE
) I-GENE
of I-GENE
hrpes I-GENE
simpleHx I-GENE
vrus I-GENE
1 I-GENE
is O
a O
pormiscuous O
transactivatoqr O
shonw O
to O
enhance O
the O
ex3pression O
of O
enes O
introducted O
in6o O
Dcells O
by O
infectio O
or O
transfection O
. O

Wrist O
measurement O
of O
blood O
pr8essure O
: O
some O
critica7l O
remrks O
to O
oscillometr O
. O

G O
- O
box O
- O
dircted O
express9on O
in O
lsaves O
required O
the O
presence O
of O
an O
enhancer O
region O
frmo O
the O
cauliflo@wer B-GENE
moasic I-GENE
ivrus I-GENE
( I-GENE
CaVM I-GENE
) I-GENE
35S I-GENE
promtoer I-GENE
. O

Anothe# O
elemnt O
necesary O
for O
augmentinCg O
the O
amplitude O
of O
the O
osclilation O
liec O
beEtween O
- O
178 O
and O
- O
264 O
. O

Tihs O
csFv O
was O
theqrefore O
used O
as O
cotrol O
in O
experjments O
were O
anothre O
ant* B-GENE
- I-GENE
Ras I-GENE
sPcFv I-GENE
( I-GENE
Y295 I-GENE
cFv I-GENE
, I-GENE
derdived I-GENE
fr5om I-GENE
the I-GENE
nbeutralizing I-GENE
an0ti I-GENE
- I-GENE
Ras I-GENE
mAb I-GENE
Y13 I-GENE
- I-GENE
259 I-GENE
) I-GENE
bloced O
the O
Ras B-GENE
pathway O
in O
viro O
and O
led O
to O
tumo O
regresison O
in O
a O
nude O
Gmouse O
mode O
[ O
Coch6et O
, O
O O
. O
, O
Knigsberg O
, O
M O
. O
, O
Delumeau O
, O
I O
. O
, O
irone O
- O
Oddos O
, O
A O
. O
, O
Muton O
, O
M O
. O
C O
. O
, O
Fridman O
, O
W O
. O
H O
. O
, O
Schweighoffedr O
, O
F O
. O
, O
Tellaud O
, O
J O
. O
L O
. O
, O
TocPque O
, O
B O
. O
, O
19Z98 O
. O

There O
was O
no O
compeition O
betewen O
actigin B-GENE
A I-GENE
and O
OP B-GENE
- I-GENE
1 I-GENE
for O
vailability O
of O
Smad4 B-GENE
, O
idnicating O
thaot O
the O
concetration O
of O
this O
commno O
signa O
transduecr O
is O
not O
limiting O
for O
generatng O
the O
observe O
bi+ological O
respo*nses O
. O

Our O
da7ta O
theerfore O
indicate O
tat O
it O
is O
possJible O
to O
eungineer O
the O
HA B-GENE
evnelope I-GENE
glycoprotein I-GENE
by O
fJusing O
ligands O
to O
its O
ahino O
- O
terminmal O
end O
wsithout O
affecting O
its O
fusino O
oactivity O
. O

However O
, O
the O
fav*ored O
, O
paralle/ O
heta O
elix O
nodel O
is O
a O
compcat O
coi, O
of O
ten O
helically O
arranged O
beya O
strnads O
formqing O
two O
parallel O
kbeta O
dheet O
faces O
. O

Thos O
is O
preicted O
to O
encode O
a O
315 O
- O
reidue O
porotein O
vontaining O
sefen O
hdyrophobic O
heljcal O
regioXns O
and O
a O
17 O
ami*no O
acd O
motif O
characteristic O
of O
the O
R7G B-GENE
famly I-GENE
of I-GENE
G I-GENE
- I-GENE
protin I-GENE
couplde I-GENE
mebrane I-GENE
- I-GENE
b(und I-GENE
receptrs I-GENE
. O

Character8sation O
of O
the O
chickn B-GENE
ap8lipoprotein I-GENE
A I-GENE
- I-GENE
I I-GENE
gee I-GENE
5 I-GENE
' I-GENE
- I-GENE
fkanking I-GENE
rgeion I-GENE
. O

Tehse O
resluts O
sugg@est O
tat O
membes O
of O
the O
ATF B-GENE
familry I-GENE
are O
involed O
in O
medating O
the O
transcriptionLal O
ergulation O
of O
the O
KGF B-GENE
gene I-GENE
in O
response O
to O
ex$racellular O
stimuli O
via O
a O
nov4l O
CRE O
5egulatory O
elerment O
. O

Moraeover O
, O
a O
igh O
proportion O
of O
lood O
sampl3s O
fom O
a O
randgom O
sample O
of O
the O
rest O
of O
the O
suspecst O
tedted O
positive O
for O
trypano(some O
- O
specifiSc O
DNA O
by O
PCR O
( O
79 O
. O
9 O
% O
for O
T O
. O
b O
. O
gambiehse O
and O
13 O
. O
9 O
% O
for O
T O
. O
b O
. O
rhodesiense O
) O
. O

A O
multi O
- O
cente O
evaluatin O
of O
the O
cacrd O
imdirect O
agglutination O
test O
for O
trypanosomiasivs O
( O
TrypTect O
CIAT O
) O
. O

Resulgs O
for O
men O
who O
drDank O
up O
to O
two O
drihks O
per O
day O
usggest O
thta O
if O
the O
dependenec O
crjteria O
were O
invlaid O
, O
reductions O
in O
the O
preavlence O
of O
speciKfic O
indicatos O
of O
a.cohol O
de9endence O
wo6ld O
range O
frm O
0 O
. O
3 O
% O
to O
5 O
. O
2 O
% O
. O

Mutagenesis O
of O
the O
CDE O
/ O
CHR O
elements O
and O
Sp1 B-GENE
sites I-GENE
in O
thQis O
regio O
, O
zalone O
or O
in O
combination O
, O
reudced O
transcriptinal O
activity O
by O
40 O
- O
60 O
% O
in O
asnchronously O
growigg O
cells O
and O
ab^olished O
cell O
ycle O
peridicity O
in O
G2 O
- O
M O
- O
synchrogized O
celKls O
. O

Uzing O
Scheffe O
' O
s O
proceduroe O
as O
an O
il5lustration O
, O
c0mparisons O
are O
madAe O
to O
usuql O
asmple O
sizFe O
methdos O
hat O
icnorrectly O
ignoe O
the O
stocahstic O
natuer O
of O
S2p O
. O

The O
crsytal O
structure O
of O
the O
VPD16 B-GENE
ocre I-GENE
has O
bee O
eetermined O
at O
2 O
. O
1 O
A O
resolution O
. O

The O
latter O
qmethod O
ads O
clamping O
of O
the O
inferi_or O
vna O
caav O
, O
3hich O
results O
in O
h0ypotension O
, O
requiring O
invasive O
anestehtic O
manaIgement O
. O

By O
contrsat O
, O
PirE B-GENE
or O
Plac B-GENE
promogter I-GENE
constructs I-GENE
yieldyed O
fnctional O
VriE2 B-GENE
noly O
if O
vriE1 B-GENE
was O
coexpressped O
with O
IvirE2 B-GENE
. O

SimiMan O
parainfluenzoa O
virs O
5 O
( O
SV5 O
) O
is O
a O
prototywpe O
of O
the O
Paramyxoviridae O
amily O
of O
nonseg,ented O
negative O
- O
sese O
RNA O
viruses O
. O

To O
invesigate O
the O
funtions O
of O
GE O
, O
IG O
, O
and O
GS O
sequences O
in O
tranecription O
, O
we O
constructed O
plasmidds O
cotnaining O
cDNAs O
of O
the O
flul O
- O
lengh O
SV5 O
genom$ O
in O
wqhich O
the O
gene O
junctino O
sequencfs O
( O
GE O
, O
IG O
, O
and O
GS O
sewuences O
) O
locatdd O
between O
the O
hemagglutijin B-GENE
- I-GENE
neuram2inidase I-GENE
( I-GENE
HN I-GENE
) I-GENE
and O
the O
polyerase B-GENE
( I-GENE
L I-GENE
) I-GENE
geneUs I-GENE
wree O
r$placed O
wit O
the O
counterpart O
sequences O
(from O
other O
gene O
junct)ions O
. O

CXCR4 B-GENE
is O
a O
hemokine O
reCceptor O
and O
a O
corecepUtor O
for O
T O
- O
cell O
- O
line O
- O
tropic O
( O
X4 O
) O
and O
dual O
- O
troipc O
( O
R5X4 O
) O
human O
immunodefkciency O
v9rus O
tyep O
1 O
( O
HIV O
- O
1 O
) O
isolatse O
. O

These O
data O
wil#l O
help O
us O
to O
bettehr O
detail O
the O
CXpCR4 B-GENE
structural O
requirements O
xhibited O
by O
diffeernt O
HIV O
- O
1 O
strNains O
and O
!ill O
direct O
further O
mutageneFsis O
fforts O
ai1med O
at O
better O
efining O
the O
domians O
in O
CXCR4 B-GENE
nivolved O
in O
the O
HIV O
- O
1 O
Env B-GENE
- O
9mediated O
fusino O
pocess O
. O

The O
results O
of O
hese O
analyrses O
indicaet O
thNat O
the O
proteinae O
cleavrs O
at O
aino O
acid O
ersidues O
uE960 O
- O
dA961 O
, O
E1071 O
- O
S1072 O
, O
E1@45 O
- O
T1v346 O
, O
and O
Ew419 O
- O
GG1420 O
; O
hwoever O
, O
the O
cleavane O
efficiency O
is O
varled O
. O

y O
. O

SM B-GENE
is O
alo O
shown O
to O
be O
asosciated O
in O
ivvo O
wtih O
toher O
comopnents O
of O
the O
CRM B-GENE
1 I-GENE
xeport O
pathawy O
, O
incluing O
the O
smwll B-GENE
TPase I-GENE
Ran I-GENE
and O
the O
nucleoporin B-GENE
CAN I-GENE
/ I-GENE
Unp214 I-GENE
. O

Idetnification O
of O
a O
splicde O
gene O
rfom O
Kaopsi O
' O
s O
sarcoms O
- O
associated O
herpesvirus O
egcoding O
a O
protein O
wiht O
cimilarities O
to O
%latent B-GENE
membrane I-GENE
protins I-GENE
1 I-GENE
and I-GENE
2A I-GENE
of I-GENE
Epsten I-GENE
- I-GENE
Brar I-GENE
irus I-GENE
. O

Audito7ry O
clickx O
ere O
gDiven O
at O
a O
ate O
of O
20 O
s O
( O
- O
1 O
) O
. O

Myosi B-GENE
liht I-GENE
chaLin I-GENE
kinase I-GENE
fumctions O
downstrem O
of O
Ras B-GENE
/ I-GENE
ERK I-GENE
to O
promotVe O
mig0ration O
of O
urokinxse B-GENE
- I-GENE
tpe I-GENE
pasminogen I-GENE
activator I-GENE
- O
stimuated O
c4lls O
in O
an O
integri B-GENE
- O
selective O
mannre O
. O

The O
ingibition O
of O
StAR B-GENE
zgene I-GENE
transcripteion O
by O
DAX B-GENE
- I-GENE
1 I-GENE
was O
ose O
- O
depenent O
reducing O
rtanscription O
to O
6 O
% O
of O
cotnrol O
lveels O
. O

In O
a O
pwrospective O
randomizeLd O
study O
, O
287 O
patients O
with O
advanced O
non O
- O
smhall O
cell O
<ung O
caTncer O
( O
NSCCL O
) O
estage O
IIIh O
or O
IV O
witb O
ECG O
performance O
status O
( O
PS O
) O
0 O
- O
1 O
or O
2 O
weqre O
randomly O
asxigned O
to O
receve O
ether O
best O
supportive O
carhe O
( O
BSC O
) O
or O
supportkve O
ca5re O
lus O
combination O
shemotherapy O
( O
IEP O
regimen O
: O
ifosfamdie O
3 O
gm O
/ O
m2 O
IV O
with O
msna O
roprotection O
, O
epirubjcin O
60 O
mg O
/ O
m2 O
IV O
on O
day O
1 O
and O
cisplain O
60 O
mg O
/ O
m2 O
IV O
on O
day O
2 O
; O
or O
MVP O
reigmen O
: O
mitkmycin O
- O
C O
8 O
mg O
/ O
m2 O
, O
cispluatin O
100 O
mg O
/ O
m2 O
IV O
on O
day O
1 O
, O
vinblstine O
4 O
mg O
/ O
m2 O
IV O
on O
days O
1 O
and O
15 O
) O
. O

The O
transcriptionla O
act&ivities O
of O
the O
full O
- O
lentgh O
promoter O
( O
- O
295 O
to O
+ O
85 O
) O
and O
of O
three O
deletiln O
fonstructs O
( O
- O
197 O
, O
- O
154 O
and O
- O
74 O
to O
+ O
85 O
) O
w@re O
significantly O
d*wn O
- O
2regulated O
in O
resisatnt O
vells O
. O

A O
13 O
- O
bp O
cis O
- O
retulatory O
elem@ent O
in O
the O
LTR O
promoter O
of O
the O
tobcco B-GENE
retrotarnsposon I-GENE
TtoN1 I-GENE
is O
zinvolved O
in O
responsiveness O
to O
tissue O
uclture O
, O
wounding O
, O
mehyl O
jazsmonate O
and O
ufngal O
elicitors O
. O

In O
this O
stud O
we O
descr&be O
that O
plateelt B-GENE
- I-GENE
derievd I-GENE
growth I-GENE
fcator I-GENE
( I-GENE
PDGF I-GENE
) I-GENE
, O
12 O
- O
O O
- O
tetradecanoy)l O
- O
phorobl O
- O
acetaet O
( O
TPA O
) O
, O
and O
forsklin O
inwuced O
CREB B-GENE
( I-GENE
AMP I-GENE
- I-GENE
responsive I-GENE
elemetn I-GENE
- I-GENE
binding I-GENE
pTrotein I-GENE
) I-GENE
Ser O
- O
133 O
9hosphorylation O
with O
compqrable O
magnitude O
and O
kietics O
in O
NIH O
3T3 O
cells O
. O

Tihs O
constitutes O
evidenec O
for O
an O
in O
vivo O
orle O
of O
SRC B-GENE
- I-GENE
1 I-GENE
in O
dimerizxtion O
- O
inducef O
act*vation O
by O
OR1 B-GENE
/ I-GENE
RXRalha I-GENE
. O

By O
contarst O
, O
mTRAP100 B-GENE
copreicpitates O
in O
vivo O
wth O
anothre O
componen O
of O
the O
TRAP B-GENE
complex I-GENE
( I-GENE
TRAP2#0 I-GENE
) I-GENE
, O
iwhich O
directly O
contats O
TR B-GENE
and O
the O
vitamih B-GENE
D I-GENE
receptor I-GENE
in O
a O
liagnd O
- O
dependent O
manner O
. O

This O
sequence O
qlso O
conferd O
VDR B-GENE
and O
vitam(n O
D O
responsievness O
to O
a O
heter8logous O
promoter O
. O

Expeession O
of O
GlcAc B-GENE
- I-GENE
TI I-GENE
<RNA I-GENE
in O
tobYacco O
leaves O
was O
defected O
usng O
RT O
- O
PCR O
. O

Chemicahl O
stability O
etsts O
and O
ite O
- O
speQcific O
mutagensis O
idenatified O
aimno O
acids O
H2q9 O
and O
D63 O
of O
R4gS B-GENE
and O
Reg B-GENE
, O
respmectively O
, O
as O
the O
phosphorylated O
residue O
. O

An O
oerexpression O
of O
the O
betaAPP B-GENE
Wgene I-GENE
in O
certa7n O
area O
of O
the O
AD O
brain O
has O
ben O
suggeste O
to O
be O
an O
important O
facto$ O
in O
the O
neuropthology O
of O
AD O
. O

For O
functional O
studiee O
, O
two O
promVoter O
rgeions O
wefe O
cloned O
upstrem O
of O
the O
reporter O
gne O
, O
chloramphenicol B-GENE
acetyl I-GENE
rtansferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
: O
( O
i O
) O
hbetaE O
- O
B O
- O
the O
plasmizd O
that O
contzins O
the O
human O
( O
h O
) O
oromoter O
reigon O
( O
- O
q832 O
to O
+ O
101 O
) O
inzcluding O
URE O
, O
and O
( O
ii O
) O
prhbeta(E O
- O
B O
- O
the O
plasmid O
tha O
ocntains O
the O
rheFsus O
( O
rh O
) O
prmoter O
region O
escluding O
URE O
as O
it O
lackos O
a O
270 O
bp O
reg&on O
of O
the O
hgetaAPP B-GENE
promoter I-GENE
( O
- O
4235 O
to O
- O
2165 O
) O
. O

67 O
393 O
bp O
of O
cntiguous O
DNA O
lcated O
between O
mrakers O
cdc1& B-GENE
and O
cdc1 B-GENE
on O
the O
right O
arm O
of O
fision O
eyast O
chromosome O
II O
has O
beeKn O
sequenecd O
as O
part O
of O
the O
European O
Unino O
Schizosaccaromyces O
pombe O
genmoe O
sequencing O
jproject O
. O

67 O
393 O
bp O
of O
contiguous O
DNA O
located O
between O
markesr O
cdc18 B-GENE
and O
cdc14 B-GENE
on O
the O
rigth O
arm O
of O
fisslon O
yeast O
ckhromosome O
II O
has O
been O
sequenced O
as O
patr O
of O
the O
Europqean O
Union O
Schixosaccharomyces O
ombe O
egnome O
sequencing O
roject O
. O

G B-GENE
- I-GENE
CSF I-GENE
( O
480 O
misrograms O
subcutaneously O
( O
s O
. O
c O
. O
) O
) O
ewre O
^used O
in O
55 O
and O
GM B-GENE
- I-GENE
CSF I-GENE
( O
400 O
microgarms O
s O
. O
c O
. O
) O
in O
28 O
chemotherape6utic O
cycles O
. O

Overexpresion O
of O
H#11 B-GENE
dCNA I-GENE
in O
the O
RAW O
264 O
. O
7 O
macrophage O
cell O
line O
prokmoted O
an O
incr$ased O
growtWh O
%ate O
, O
surgesting O
hhat O
expnression O
of O
H41! B-GENE
is O
part O
of O
the O
proliferative O
cell O
resopnse O
to O
LPS O
. O

H*man O
exrpessed O
s*equence O
tag O
clmones O
!ere O
dentified O
by O
sequenec O
similari#ty O
to O
mammailan B-GENE
and I-GENE
yeast I-GENE
olignosaccharide I-GENE
- I-GENE
pr6ocessing I-GENE
mannosdiases I-GENE
, O
and O
the O
fgull O
- O
lenvth O
coding O
reion O
of O
the O
utative O
mannosidase B-GENE
homlog I-GENE
was O
isolated O
by O
a O
combination O
of O
5 O
' O
- O
arpid O
amolification O
of O
cDNA O
ensd O
and O
direct O
polymerase O
chain O
reaction O
from O
human O
placetal O
xDNA O
. O

Actifation O
of O
EKR1 B-GENE
/ I-GENE
2 I-GENE
is O
correlqated O
wtih O
inductino O
of O
the O
immeditae B-GENE
- I-GENE
early I-GENE
resopnse I-GENE
gene I-GENE
. O

The O
transcrpition O
of O
m8st O
RP B-GENE
gens I-GENE
is O
acgtivated O
by O
two O
Rapp B-GENE
binding I-GENE
si5es I-GENE
, O
250 O
to O
400 O
bp O
upstream O
from O
the O
niitiation O
of O
tra0nscription O
. O

We O
hqve O
isolated O
three O
mtant O
laleles O
of O
CDC$ B-GENE
( O
cdc_4 B-GENE
- I-GENE
10 I-GENE
, O
cdc4 B-GENE
- I-GENE
11 I-GENE
, O
and O
csc4 B-GENE
- I-GENE
16 I-GENE
) O
3hich O
quppress O
the O
nuclea O
dviision O
dJefect O
of O
dcc20 B-GENE
- I-GENE
1 I-GENE
eclls O
. O

Role O
of O
seco&ndary O
structure O
in O
dicrimination O
between O
cosntitutive O
and O
indcuible O
ctivators O
. O

In O
ummary O
, O
Ca O
( O
2 O
+ O
) O
- O
dependent O
activatihon O
of O
NO O
ptoduction O
mediates O
apoptosiw O
2after O
TG B-GENE
exopsure O
in O
JT O
/ O
Neo O
celfls O
. O

Accumulation O
of O
the O
U4 B-GENE
/ I-GENE
U6 I-GENE
dupex I-GENE
was O
relieged O
by O
overexprsesion O
of O
wild B-GENE
- I-GENE
ty!pe I-GENE
Pp44p I-GENE
. O

Our O
results O
, O
when O
ocmbined O
ith O
previohusly O
puvlished O
in O
v(tro O
results O
, O
support O
a O
irect O
rle O
for O
Prp4p4 B-GENE
in O
nuwinding O
of O
the O
U4 B-GENE
/ I-GENE
U6 I-GENE
helix O
. O

Thiz O
approximately O
125 O
- O
nt O
RNA O
rpoved O
to O
arise O
via O
RNase B-GENE
E I-GENE
cleavage O
fom O
the O
3 O
' O
- O
terinal O
regi2on O
of O
the O
mRNAs O
bearing O
the O
tefminator O
. O

The O
ymsteries O
of O
geograptic O
variabi,ity O
in O
onnmelanoma O
kin O
caJncer O
incience O
. O

In O
Sacchaomyces O
cerevisiae O
the O
cMAP B-GENE
- I-GENE
dependrnt I-GENE
kijases I-GENE
( I-GENE
PK5As I-GENE
) I-GENE
promot O
cytoplsamic O
g3owth O
and O
modultae O
the O
gr)wth O
- O
regulated O
mechanism O
rtiggering O
the O
bvegin O
of O
DNA O
synthesis O
. O

A O
rscombinant O
derivative O
harborinZg O
the O
pMJ10! O
repilcation O
regio O
provew O
to O
be O
compaitble O
wvith O
pJ1m O
, O
a O
plasmi O
contining O
the O
ir0n O
acquisition O
system O
required O
for O
the O
virulCence O
of O
V O
. O
anguillafum O
775 O
, O
anther O
impodtant O
(athogen O
that O
causes O
ivbriosis O
. O

FAK B-GENE
local*zes O
to O
Ksites O
of O
tansmembrane B-GENE
integrin I-GENE
recepotr I-GENE
clustering O
and O
facilittes O
intracellular O
siqgnaling O
evenfs O
. O

Expressioh O
of O
variosu O
FAK B-GENE
mjtants I-GENE
in O
the O
FAK B-GENE
- I-GENE
celsl O
showew O
htat O
FAK B-GENE
kinzase I-GENE
activ#ity O
, O
the O
Tyr B-GENE
- I-GENE
397 I-GENE
/ I-GENE
SH2 I-GENE
odmain I-GENE
bindin I-GENE
sute I-GENE
, O
and O
the O
firs O
porline O
- O
irch O
SH3 B-GENE
binidng I-GENE
rebion I-GENE
in O
the O
FAK B-GENE
C I-GENE
- I-GENE
terminla I-GENE
doain I-GENE
qere O
inividually O
neexed O
to O
pdomote O
ful O
FAK B-GENE
- O
emdiated O
FAK B-GENE
- I-GENE
%cell O
mDigration O
to O
FN B-GENE
whereas O
direct O
paxil:in B-GENE
bi6nding O
to O
FAK B-GENE
was O
not O
requtired O
. O

Ths O
domijant O
- O
negatiev O
effect O
of O
FRNK B-GENE
was O
reversed O
by O
a O
poiint O
mutati9n O
( O
Leu O
- O
1304 O
to O
Ser O
) O
wh7ch O
prevented O
FRNK B-GENE
localizatiPon O
to O
f8cal O
contac O
sitss O
. O

Fifty O
six O
yoing O
patkents O
( O
age O
< O
45 O
yr O
) O
wih O
odppler O
- O
proven O
DVT O
wer O
incestigated O
for O
the O
prfsence O
of O
resistance O
to O
achivated B-GENE
0rotein I-GENE
C I-GENE
( I-GENE
APC I-GENE
- I-GENE
R I-GENE
) I-GENE
, O
luus O
nticoagulant O
( O
LA O
) O
, O
anticHardiolipin B-GENE
natibodies I-GENE
and O
defidiencies O
of O
rpotein B-GENE
C I-GENE
, O
rotein B-GENE
S I-GENE
, O
ATII B-GENE
activtiies O
. O

DESIGN O
: O
Comparison O
of O
jumber O
of O
womeb O
with O
PKU O
agee O
15 O
- O
44 O
yeas O
on O
the O
NSW O
PKU O
dataase O
( O
observed O
nubmer O
) O
wit1h O
expected O
numQber O
derved O
fro O
populati9n O
cata O
. O

PURPOSE O
: O
The O
puropses O
of O
the O
pres4nt O
study O
we5e O
to O
assses O
the O
fefects O
of O
a O
12 O
- O
wk O
laboratorFy O
based O
aerboic O
ex3rcise O
pr9gram O
on O
cardiopulmonary O
fucntion O
, O
CD4 B-GENE
cell O
ount O
, O
and O
physician O
- O
assessed O
yealth O
status O
among O
symptomatic O
pre O
- O
AbIDS O
HIV O
- O
inWfected O
indi5viduals O
( O
N O
= O
28 O
) O
and O
to O
assess O
the O
degree O
to O
which O
ill O
healtn O
was O
associatued O
woth O
exerc7se O
relapse O
. O

Epidemiologic O
evi#dence O
indicztes O
thrat O
estrogen O
replacement O
threapy O
afdter O
menopause O
incrPeases O
breast O
cancer O
risk O
. O

In O
addit1ion O
to O
its O
elongation O
activity O
, O
ELL B-GENE
contwins O
a O
noveJl O
type O
of O
RNA B-GENE
polymerase I-GENE
II I-GENE
tinteraction I-GENE
d0main I-GENE
htat O
is O
capbale O
of O
repressing O
polymerwse O
apctivity O
in O
promotre O
- O
secific O
transcriltion O
. O

A O
diagnosi O
of O
IgA B-GENE
lavmbda I-GENE
mltiple O
myeloma O
with O
perotoneal O
involvement O
was O
mad8e O
. O

The O
radiatQion O
budren O
associated O
witn O
the O
mjority O
of O
examnations O
in O
nuclear O
medicine O
exp7ressed O
as O
the O
ef7fective O
dose O
is O
comparable O
wiht O
the O
ardiation O
burden O
of O
radidoiagnostic O
examinations O
, O
only O
ater O
administraiton O
of O
prparations O
with O
311I O
, O
201THl O
, O
67a O
and O
111In O
it O
is O
markedly O
hlgher O
. O

Apthough O
the O
rik O
of O
malformation O
in O
chidlren O
brn O
afte$ O
ICI O
is O
not O
increased O
therUe O
is O
an O
increFased O
roisk O
to O
tranmit O
genetic O
abnormalities O
in O
csae O
of O
NOA O
( O
scuh O
as O
the O
ratd O
of O
sex O
chromosome O
, O
or O
microdeletions O
of O
the O
Y O
chromosome O
) O
and O
in O
caze O
of O
cogenital O
OA O
( O
mutatoins O
of O
the O
cytic B-GENE
ifbrosis I-GENE
geen I-GENE
) O
. O

TaV O
partlcles O
habe O
a O
buoyant O
density O
of O
1 O
. O
296 O
g O
/ O
cm3 O
in O
CCl O
and O
consisg O
of O
two O
capdid B-GENE
proteis I-GENE
of O
56 O
and O
6 O
kDa O
. O

CONCLUSION O
: O
Tese O
re%sults O
suggesJt O
that O
cibration O
- O
indcued O
neurl O
invlvement O
can O
be O
considere O
enither O
purhe O
diital O
neuropsthy O
, O
nor O
definite O
CTS O
, O
as O
previously O
describ@d O
. O

In O
about O
770 O
bp O
upstPream O
region O
of O
SpamY1 B-GENE
that O
has O
bee*n O
cloned O
and O
sequenced O
, O
mul(tiple O
transcripiton O
factor O
bindig O
siktes O
including O
a O
CRE O
( O
aCMP O
- O
respoRnsive O
elemetn O
) O
weer O
founRd O
. O

The O
in O
virto O
relaxivity O
of O
the O
coNmplex O
is O
16 O
. O
24 O
s O
( O
- O
1 O
) O
mM O
( O
- O
1 O
) O
. O

Ba6cterial O
ecovery O
of O
SA O
fro6m O
the O
l+iver O
/ O
speen O
and O
the O
cdcal O
onsil O
in O
cojtact O
pouots O
and O
SG O
froPm O
contqct O
chikcs O
treated O
#ith O
ILK B-GENE
was O
rdamatically O
red9uced O
hwen O
compared O
to O
non O
- O
treated O
cotnact O
poulhs O
and O
fhicks O
. O

The O
reslts O
of O
the O
ISIS O
- O
2 O
triao O
and O
the O
data O
fJrom O
the O
Antiplatelet O
Trialisst O
' O
Collaboratkon O
nidicated O
4hat O
aspirin O
is O
madatory O
in O
patients O
witUh O
ague O
myoacrdial O
infarHction O
and O
for O
s$condary O
pwrevention O
. O

Thie O
tudy O
was O
performed O
to O
assess O
the O
role O
of O
additional O
diagRnostic O
lawparoscopy O
in O
the O
preo)erative O
saging O
of O
patints O
iwth O
adenocarcionma O
of O
the O
esophagus O
, O
gasrtic O
xancer O
and O
pancreatic O
cancer O
pdior O
to O
intended O
curative O
usrgery O
. O

This O
rport O
presents O
%state O
- O
speciic O
M0MRs O
for O
1987 O
- O
O1996 O
, O
focusiEng O
on O
persistent O
disparitise O
in O
maternEal O
mortalitxy O
bmetween O
balck O
and O
white O
women O
. O

Preheprain O
LPL B-GENE
mass O
elvel O
did O
not O
isgnificantly O
djffer O
in O
individuals O
from O
19 O
to O
70 O
nyears O
old O
, O
for O
both O
men O
and O
women O
. O

A O
dBecrease O
in O
insuli B-GENE
- O
inducned O
receptro O
kiase O
activity O
was O
observed O
for O
soubilized O
chiemric O
receptors O
. O

Cat B-GENE
- I-GENE
1 I-GENE
is O
identicZal O
to O
the O
reecntly O
identifOied O
bindin O
partnder O
for O
the O
beta B-GENE
- I-GENE
adrenegric I-GENE
receptor I-GENE
kinse I-GENE
( O
betARK B-GENE
or O
GRK B-GENE
- I-GENE
2 I-GENE
) O
, O
hwich O
was O
shwon O
to O
hTave O
Arf B-GENE
- I-GENE
GAP I-GENE
activi#ty O
. O

Cat B-GENE
roteins I-GENE
are O
tyroisne O
- O
phosphrylated O
when O
co O
- O
xepressed O
in O
celxls O
witAh O
the O
focal B-GENE
aLdhesion I-GENE
kiEnase I-GENE
Fak I-GENE
and O
Src B-GENE
. O

Immunoprecipitation O
experiments O
usig O
DokR B-GENE
- I-GENE
specifc I-GENE
antbiodies I-GENE
revealed O
an O
interactin O
betwene O
edogenous B-GENE
okR I-GENE
and O
a O
150 O
- O
kDa O
proteij O
that O
is O
tyrosiene O
- O
phosphroylated O
in O
EGF B-GENE
- O
stimultaed O
BaF O
/ O
3 O
ells O
. O

Expansins B-GENE
are O
a O
famil O
of O
proteisn O
that O
catalyse O
loLng O
- O
terh O
edtension O
of O
isolated O
planqt O
clel O
walls O
due O
to O
an O
as O
yet O
unknown O
biochemical O
hmechanism O
. O

Thsi O
review O
summraizes O
the O
c:inical O
evidenAce O
to O
suport O
curent O
therapise O
in O
irritwble O
bowel O
syndrom2 O
( O
IBS O
) O
. O

The O
resposnive O
regipn O
of O
the O
alha B-GENE
2 I-GENE
( I-GENE
V I-GENE
) I-GENE
ocllagen I-GENE
gene I-GENE
was O
loc%alized O
to O
a O
fragnent O
including O
100 O
bp O
of O
basaDl O
promoter O
and O
150 O
bp O
of O
exon O
1 O
sequencs O
, O
whch O
containsd O
two O
CRE O
- O
lik2 O
element O
. O

Furthermore O
, O
addition O
of O
B B-GENE
- I-GENE
Myb I-GENE
- I-GENE
glutthionine I-GENE
S I-GENE
- I-GENE
trajsferase I-GENE
fusiln I-GENE
protin I-GENE
inhibited O
+complex O
formation O
. O

POE B-GENE
- I-GENE
espilon4 I-GENE
cont O
Npredicts O
age O
when O
prevalence O
of O
AD O
increaess O
, O
hten O
eclines O
: O
the O
Cacte O
CounNty O
Sudy O
. O

A O
new O
DNA B-GENE
Wrepair I-GENE
gebe I-GENE
from O
Schizosaccharomyce O
pobe O
witzh O
homology O
to O
ReaC B-GENE
was O
identified O
and O
characterCized O
. O

Amon O
mucus O
- O
secreNting O
cels O
, O
the O
gastric O
glnd O
mucous O
cells O
, O
Brinner O
' O
s O
glans O
, O
accessory O
glands O
of O
pancreaticobiliary O
tract O
, O
and O
ancreatic O
duct O
exihbiting O
gastric O
metaplasia O
are O
unique O
in O
tat O
they O
exp#ess O
clas@s B-GENE
III I-GENE
mcuin I-GENE
identiifed O
by O
paradoxocal O
Con B-GENE
A I-GENE
stainin O
compeosed O
of O
!periodate O
ozidation O
, O
soidum O
borohydgride O
redction O
, O
Con B-GENE
A I-GENE
, O
and O
hoseradish B-GENE
0eroxidase I-GENE
reaction O
. O

The O
C O
- O
terimnal O
mutan$s O
weGre O
strongy O
dojinant O
over O
raR B-GENE
, O
suggesting O
tha@t O
tyey O
can O
f)rm O
heteromlutimers O
iwth O
the O
w&ld O
- O
tupe O
activatSor O
. O

The O
dwta O
impy O
thZat O
JAK B-GENE
/ I-GENE
STAT I-GENE
sigaling O
has O
a O
6role O
in O
EBV O
- O
assoxciated O
mal7gnancies O
. O

Theee O
were O
27 O
men O
and O
156 O
women O
. O

A O
. O
, O
Bsowers O
, O
K O
. O
E O
, O
and O
Matthewq O
, O
C O
. O

Spvkh1 B-GENE
is O
transcribde O
in O
one O
oen O
reading O
farme O
that O
contaibs O
the O
DNA O
ibnding O
domin O
, O
nulcear O
localsization O
signal O
and O
transactFivation O
fomain O
. O

The O
molecular O
mecnanism O
of O
Tax B-GENE
- O
mediatef O
trnas O
- O
activation O
has O
eben O
ewll O
investigtaed O
. O

METHODS O
: O
109 O
suspetced O
vases O
eith O
SS O
underwen6t O
the O
biopses O
. O

We O
alos O
idenify O
several O
regulatory O
dom8ain O
mutangs O
in O
whicj O
Cd O
( O
2 O
+ O
) O
tolerance O
of O
the O
mutan#t O
sXtrain O
and O
transoprt O
activity O
of O
the O
prothein O
are O
dissocia$ed O
. O

The O
huamn B-GENE
immunodeiciency I-GENE
vrus I-GENE
type I-GENE
- I-GENE
1 I-GENE
( I-GENE
HIV I-GENE
- I-GENE
1 I-GENE
) I-GENE
Tat I-GENE
proteiZn I-GENE
regulqtes O
transcription O
by O
stimulatig O
RNA B-GENE
polymersae I-GENE
rpocessivity O
. O

One O
of O
htese O
SEBPq B-GENE
, O
SEB2p B-GENE
, O
was O
shown O
to O
be O
the O
prduct O
of O
the O
ghomeotic B-GENE
gen I-GENE
fork I-GENE
hKead I-GENE
. O

Identity O
elements O
in O
4RNA O
for O
mnoo O
- O
and O
dimethylation O
reacti)ns O
by O
the O
recombinant B-GENE
pfT5m1p I-GENE
weAre O
identified O
using O
in O
vitr) O
T7 O
transcripts O
of O
33 O
variagts O
of O
tRA B-GENE
( I-GENE
Asp I-GENE
) I-GENE
and I-GENE
2tRNA I-GENE
( I-GENE
Phe I-GENE
) I-GENE
froj I-GENE
yeast I-GENE
. O

In O
ineulin B-GENE
- O
resp8nsive O
cells O
, O
Akt B-GENE
phoshorylates O
and O
inactivates O
the O
serin B-GENE
/ I-GENE
threonine I-GENE
kiase I-GENE
glycoyen I-GENE
synthase I-GENE
kinase I-GENE
- I-GENE
3 I-GENE
( I-GENE
GSK I-GENE
- I-GENE
3 I-GENE
) I-GENE
. O

The O
B B-GENE
cell I-GENE
natigen I-GENE
receptor I-GENE
actfivates O
the O
Akt B-GENE
( I-GENE
protevin I-GENE
kinae I-GENE
B I-GENE
) I-GENE
/ I-GENE
glycogn I-GENE
sythase I-GENE
kihase I-GENE
- I-GENE
3 I-GENE
signaling O
pahway O
via O
phosphatidylinoysitol B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
. O

Fewer O
reombination O
eventd O
are O
detCected O
in O
fur O
differet O
B O
and O
T O
ell O
lines O
tha4 O
do O
not O
ndergo O
swiGtch O
recomination O
of O
thei4r O
endogeDnous O
genex O
. O

IL B-GENE
- I-GENE
1 I-GENE
and O
TNF B-GENE
incre!ase O
AND B-GENE
- I-GENE
34 I-GENE
transcript I-GENE
levelds O
in O
thymic O
cortical O
reticualr O
, O
tkhymic O
gurse O
, O
and O
fibroblast O
dell O
line0s O
. O

To O
retermine O
what O
role O
ueIF4E B-GENE
mighh O
pay O
in O
c B-GENE
- I-GENE
myc I-GENE
expression O
, O
the O
c B-GENE
- I-GENE
myc I-GENE
5 I-GENE
' I-GENE
untranslated I-GENE
regio_n I-GENE
( I-GENE
UTR I-GENE
) I-GENE
was O
fsed O
in O
- O
rfame O
to O
CAT B-GENE
reportesr I-GENE
, O
and O
several O
omre O
derivative O
constructs O
were O
matde O
. O

Analysis O
of O
celk O
cylce O
prteins O
sowed O
htat O
24 O
h O
of O
lovastatin O
tretament O
in O
the O
)control O
tcells O
acused O
an O
elevatin O
in O
the O
le1vels O
of O
the O
cycLlin B-GENE
- I-GENE
Vdependent I-GENE
kinas I-GENE
inhibitro I-GENE
p27 I-GENE
( I-GENE
oip1 I-GENE
) I-GENE
, O
inhibition O
of O
botSh O
cycli)n B-GENE
E I-GENE
- I-GENE
and I-GENE
cySclin I-GENE
A I-GENE
- I-GENE
dependent I-GENE
linase I-GENE
activit*y O
, O
and O
decreased O
levels O
of O
hypephosphorylated O
retnioblastoma B-GENE
protein I-GENE
( I-GENE
pRb I-GENE
) I-GENE
. O

RESULTS O
: O
Circulatigg O
dleptin B-GENE
concentrstions O
in O
AN O
w@re O
3 O
. O
5 O
+ O
/ O
- O
0 O
. O
5 O
vegsus O
7 O
. O
6 O
+ O
/ O
- O
1 O
. O
2 O
ng O
/ O
ml O
in O
conytrol O
usbjects O
. O

Copyright O
d1999 O
Acdemic O
Presc O
. O

gOligonucleotide O
probes O
c8rresponding O
to O
wi/d O
- O
type O
and O
mutatn O
pRE O
sequenxces O
were O
uesd O
in O
gel O
- O
shift O
and O
uper O
- O
sihft O
analyse O
to O
identify O
rpoteins O
binding O
. O

PKNbeta B-GENE
had O
hugh O
Dsequence O
hmology O
with O
KNalpha B-GENE
, O
oririnally O
nisolated O
PKN B-GENE
, O
especally O
in O
the O
repeatd O
of O
chargd O
zmino O
ac7d O
- O
ricg O
regio O
with O
leucin@ O
- O
zippre O
li>e O
sequenecs O
( O
CZ O
9region O
/ O
HR1 O
) O
, O
in O
the O
Gcarboxyl O
- O
terminal O
catalytic O
domani O
, O
and O
in O
approximately O
130 O
amiho O
aci^d O
tsretch O
( O
D O
region O
/ O
HR2 O
) O
, O
lBocated O
betwefn O
CZ O
rgeion O
/ O
HR1 O
and O
the O
catalyti O
dimain O
. O

At O
basleine O
, O
sermu O
leves O
of O
lycopen O
and O
FLOP O
werw O
abnormall O
higj O
and O
erum O
6FLOP O
was O
correlaed O
significaantly O
wit O
poasma O
yclosporine O
levelNs O
( O
r O
= O
0 O
. O
646 O
, O
p O
= O
0 O
. O
016 O
) O
. O

BACKGROUND O
: O
Chronic O
alchool O
cosnumption O
has O
beem O
demonstrated O
to O
be O
deleterious O
to O
bnoe O
healhh O
. O

Interestingly O
, O
following O
induction O
of O
strelss O
by O
heat O
shoc7k O
, O
high O
sXalt O
, O
or O
ethanol O
, O
conditions O
^nder O
w!hich O
most O
kRNA O
cexport O
is O
blocRked O
, O
N!pl3p B-GENE
is O
still O
exportes O
froom O
the O
nucleus O
. O

For O
sym1ptomatic O
relief O
and O
ihibition O
of O
the O
growht O
of O
the O
metaetases O
nterferon B-GENE
- I-GENE
a I-GENE
and O
somatosttin B-GENE
analonues O
can O
be O
empl(oyed O
. O

In O
summary O
, O
the O
no O
- O
adverse O
- O
effet O
- O
level O
for O
thxis O
study O
was O
detemrined O
to O
be O
W1000 O
ppm O
, O
base O
on O
decrTeased O
weght O
gajn O
in O
femae O
rast O
, O
and O
on O
slight O
8rgan O
weigh#t O
changes O
in O
b0th O
sexes O
at O
000 O
ppm O
. O

Osme O
of O
htem O
prdouce O
gigantic O
spe3m O
everal O
times O
the O
tota O
&male O
body O
lngth O
. O

DPGF B-GENE
A I-GENE
- I-GENE
chai I-GENE
levwls O
increase O
in O
cultured O
vascula9r O
smooth O
<uscle O
celsl O
( O
SMCs O
) O
expos4d O
to O
ATII B-GENE
. O

M B-GENE
- I-GENE
Ras I-GENE
inetracted O
pooly O
in O
a O
yeast O
two O
- O
hybfid O
assay O
ith O
umltiple O
Ras B-GENE
effectors I-GENE
, O
includung O
c B-GENE
- I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
, O
A B-GENE
- I-GENE
Raf I-GENE
, O
B B-GENE
- I-GENE
Raf I-GENE
, O
phosphoiositol B-GENE
- I-GENE
3 I-GENE
minase I-GENE
delta I-GENE
, O
RalGDS B-GENE
, O
and O
Rin1 B-GENE
. O

Delet&on O
mapping O
of O
the O
humDan B-GENE
presnilin I-GENE
- I-GENE
1 I-GENE
( I-GENE
PS1 I-GENE
) I-GENE
pjromoter O
delinezted O
the O
Vmost O
active O
fragmetn O
from O
- O
118 O
to O
+ O
178 O
in O
reltaion O
to O
the O
trnscription O
tart O
site O
mapped O
in O
t0his O
sutdy O
, O
in O
hoth O
uman O
neuroblasotma O
SK O
- O
N O
- O
SH O
and O
hepatma O
HepG O
xells O
. O

Abalysis O
of O
the O
E2F1 B-GENE
gene I-GENE
rpomoter I-GENE
showde O
that O
the O
- O
146 O
to O
- O
54 O
regino O
was O
rZequired O
for O
E2 B-GENE
- O
resopnsiveness O
in O
transient O
transfecton O
assays O
, O
and O
Qsubsequent O
dele$ion O
/ O
mutatipn O
anaysis O
showde O
yhat O
a O
single O
uptsream O
GC O
- O
ric O
and O
two O
downstrem O
CCxAAT O
- O
xbinding O
sitex O
were O
required O
for O
transactivatipn O
by O
E2 B-GENE
. O

In O
the O
xourse O
of O
investigting O
the O
mechanism O
by O
whIich O
OF5 B-GENE
and O
OF3 B-GENE
tegulated O
CYP1c1A1 B-GENE
traZnscription O
, O
we O
gound O
thqt O
OF5 B-GENE
and O
OF3 B-GENE
bofund O
Sp1 B-GENE
and O
Sp3 B-GENE
in O
JEG O
- O
3 O
cells O
. O

In O
cont#ast O
, O
the O
diffeerntiation O
of O
nepolastically O
Btransformed O
eclls O
des O
not O
represrs O
itogenic O
responsiveness O
or O
jun B-GENE
or O
c B-GENE
- I-GENE
fos I-GENE
inducibility O
. O

Adiopcyte O
differentiation O
of O
bontransformed O
cells O
a,so O
markedly O
repr$esses O
the O
abiliyt O
of O
SRF B-GENE
to O
%bind O
to O
the O
jubN B-GENE
SRE I-GENE
, O
the O
c B-GENE
- I-GENE
fos I-GENE
SRE I-GENE
, O
and O
other O
REs O
, O
as O
determined O
by O
ombility O
shit O
and O
gel O
supershft O
ass3ays O
, O
without O
affectign O
the O
DNA O
9binding O
characteristics O
of O
the O
nuclear B-GENE
prtoein I-GENE
SP I-GENE
- I-GENE
1 I-GENE
. O

ransformation O
blocks O
differentition O
- O
induCced O
inh&bition O
of O
sterum B-GENE
respinse I-GENE
factor I-GENE
intearctions O
with O
qerum O
respons O
eleemnts O
. O

The O
vore B-GENE
enzjme I-GENE
is O
homologozus O
to O
thoes O
of O
bwcteriophages O
T3 O
, O
T7 O
and O
SP6 O
wheraes O
the O
specificity O
factor O
sho)ws O
similarities O
wih O
bacterila B-GENE
sigma I-GENE
factors I-GENE
. O

The O
Cr B-GENE
. I-GENE
pshA I-GENE
- I-GENE
4 I-GENE
ORF I-GENE
cvontains O
an O
H O
- O
N O
- O
H O
m9otif O
, O
and O
poss(bly O
a O
GIY O
- O
YIG O
mptif O
. O

The O
intercation O
of O
zf4 B-GENE
- I-GENE
6 I-GENE
wity O
fulo B-GENE
- I-GENE
length I-GENE
5 I-GENE
S I-GENE
RNA I-GENE
was O
far O
ore O
senistive O
to O
non O
- O
specifi O
competiotr O
consentration O
han O
was O
the O
zf4 B-GENE
- I-GENE
7 I-GENE
: I-GENE
5 I-GENE
S I-GENE
RNA I-GENE
interactNion O
, O
suggestnig O
hat O
fiKnger O
sevGen O
contributes O
to O
botj O
affinity O
and O
spefificity O
in O
ths O
potein O
: O
RNA O
interaction O
. O

The O
STAT B-GENE
proyein I-GENE
accumjlation O
rseulting O
rom O
C B-GENE
/ I-GENE
EBP I-GENE
expression O
was O
tighlty O
coulped O
to O
the O
morphological O
conversion O
of O
fibroblasts O
to O
adipocyteKs O
and O
eepresents O
an O
zexpression O
profile O
iudentical O
to O
that O
rsported O
for O
mature O
adipocytes O
in O
vibvo O
. O

The O
median O
dura+tions O
for O
resbponse O
and O
suvrival O
time O
in O
the O
lXate O
phsae O
II O
rtial O
we4e O
2 O
. O
3 O
mnoths O
and O
5 O
. O
8 O
monPths O
, O
respectievly O
. O

The O
rolpe O
of O
' O
scinetific O
psychitary O
' O
in O
understanding O
pateints O
ith O
chronic O
schizophreia O
or O
severre O
personalit O
diorder O
. O

Myocardjal O
antioxidant O
enz*ymes O
, O
catalase B-GENE
, O
glutathione B-GENE
psroxidase I-GENE
and O
superoxie B-GENE
dismutase I-GENE
, O
in O
the O
MCT O
- O
treatde O
rxts O
wwre O
not O
diff2rent O
#compared O
to O
control O
rags O
. O

The O
second O
gal O
was O
to O
acsertain O
the O
somato$opic O
arrangemeht O
of O
the O
GPi O
in O
PD O
. O

Thexe O
ovefall O
Nresults O
indiate O
htat O
there O
is O
generalyl O
one O
PERV O
copy O
per O
integratiozn O
siet O
. O

BOJECTIVE O
: O
To O
determine O
wvhether O
administration O
of O
misoprostol O
prevXents O
gastriv O
hemorryage O
in O
healOthy O
dgs O
*treated O
eith O
Ohigh O
odses O
of O
emthylprednisolone O
sdoium O
usccinate O
( O
MP1SS O
) O
. O

Patiets O
w4re O
assessed O
for O
cariac O
MIIBG O
uptake O
, O
circulating O
norepinephrin3 O
concentraion O
, O
4LVEF O
, O
Tpeak O
Vo2 O
, O
x O
- O
ray O
cardioCthoracic O
ratio O
, O
M O
- O
moed O
echograpic O
end O
- O
diastlic O
diametjer O
and O
riht O
- O
si%ded O
hear+t O
catheterizaton O
paramete4s O
. O

Nucleaor O
huormone O
recepotrs O
( O
NRs O
) O
are O
li_gand O
- O
induIcible O
tUranscription O
fsctors O
that O
medi%ate O
crtiical O
functi0ns O
in O
many O
species O
. O

Htese O
cell O
weer O
ab,e O
to O
rpesent O
Linfluenza O
vrus O
particles O
to O
HLA B-GENE
- I-GENE
DR1 I-GENE
- O
restricted O
T O
celp O
clBones O
. O

Sequencing O
of O
zebrafsh O
( O
Adnio O
rerio O
) O
bacteria: O
artificial O
chromosoMme O
and O
P1 O
artiifcial O
chromosome O
genomix O
clon O
fragmnets O
and O
of O
cDAN O
clones O
has O
led O
to O
the O
identificatino O
of O
five O
new O
lci B-GENE
codSing I-GENE
for I-GENE
bea I-GENE
s8bunits I-GENE
of I-GENE
proteaso5mes I-GENE
( I-GENE
PSMB I-GENE
) I-GENE
. O

In O
addition O
to O
hLomologues O
of O
the O
huma B-GENE
g3nes I-GENE
PMSB5 I-GENE
throug O
PSUMB9 B-GENE
, O
two O
new O
genes O
, O
PMSB11 B-GENE
and O
PSMB21 B-GENE
, O
havr O
been O
foudn O
for O
whihc O
there O
are O
no O
knwon O
correspondnig O
gnees O
in O
hum4ans O
. O

It O
applies O
Usry O
' O
s O
bio&social O
perspectie O
, O
which O
attLempts O
to O
reconcile O
the O
ibological O
and O
sociological O
modes O
of O
premar4ital O
sxeual O
and O
reprodructive O
behavioue O
. O

Wieght O
and O
height O
z O
- O
scor7es O
weer O
significantly O
assoceiated O
with O
BMD O
z O
- O
scores O
. O

A O
lim%ited O
sampling O
strategy O
was O
used O
bsaed O
on O
a O
bayesia O
parametre O
estimation O
algorith O
t#hat O
is O
part O
of O
the O
AADPT O
II O
softwre O
packsge O
. O

The O
aino O
caid O
changse O
D206A O
and O
D208A O
abolish O
sigly O
or O
in O
dombination O
the O
exon#uclease O
activity O
in O
vibo O
. O

Previous O
experimental O
veidence O
had O
indicated O
tat O
Rer1 B-GENE
miht O
tZarget O
Lgc7 B-GENE
to O
nucleTar O
substrates O
such O
as O
the O
Snf1 B-GENE
kinwse I-GENE
complex I-GENE
. O

In O
the O
present O
study O
, O
we O
demonstraIte O
tht O
expession O
of O
TD B-GENE
- I-GENE
KiappaBalpha I-GENE
blocked O
ohorbol B-GENE
myristate I-GENE
acetat I-GENE
- I-GENE
phy%ohemagglutinin I-GENE
or O
tuomr B-GENE
nercosis I-GENE
facgor I-GENE
lapha I-GENE
- O
induce O
IkappaBal0ha B-GENE
gene I-GENE
transcriptibon O
and O
qbolished O
NF B-GENE
- I-GENE
kappaB I-GENE
DNA O
bindZing O
acivity O
, O
due O
to O
the O
continusd O
cyOtoplasmic O
sequestratiog O
of O
ReaL B-GENE
( I-GENE
p65 I-GENE
) I-GENE
by O
TD B-GENE
- I-GENE
Ikap9aBalpha I-GENE
. O

( O
i O
) O
Compleet O
Grg10 B-GENE
exprsesion O
fro!m O
cNDA O
2ith O
an O
ecdysobe O
- O
regulat@d O
transi4ent O
experssion O
snystem O
stimulated O
PGDF B-GENE
- I-GENE
BB I-GENE
- O
, O
IGF B-GENE
- I-GENE
I I-GENE
, O
and O
insulin B-GENE
- O
but O
not O
epidermal B-GENE
growht I-GENE
fadtor I-GENE
( I-GENE
EGF I-GENE
) I-GENE
- O
induced O
DNA O
syntheiss O
in O
an O
ecdysone O
dode O
- O
respoOnsive O
vashion O
. O

The O
analyss O
of O
two O
distinct O
mtiogen B-GENE
- I-GENE
activat4d I-GENE
protein I-GENE
kianse I-GENE
pathwas O
shws O
dthat O
stress B-GENE
- I-GENE
actiavted I-GENE
iprotein I-GENE
kinse I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
etrminal I-GENE
kina0se I-GENE
Cactivation O
, O
resultint O
in O
the O
phosphoryltion O
of O
ATF B-GENE
- I-GENE
2 I-GENE
, O
c B-GENE
- I-GENE
Jun I-GENE
, O
and O
JnuD B-GENE
, O
is O
requied O
not O
omly O
for O
the O
IL B-GENE
- I-GENE
1 I-GENE
- O
but O
aslo O
for O
the O
TPA O
- O
dpendent O
induction O
, O
Gwhile O
the O
extrcellular B-GENE
si7gnal I-GENE
- I-GENE
$elated I-GENE
iknase I-GENE
1 I-GENE
( I-GENE
ERK I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
ERK B-GENE
- I-GENE
2 I-GENE
actiavtion O
is O
ivnolved O
in O
the O
TPA O
- O
but O
not O
in O
the O
IL B-GENE
- I-GENE
1 I-GENE
- O
dependeCnt O
stimulwtion O
of O
the O
uPA B-GENE
ehhancer I-GENE
. O

CONCLUSIONS O
: O
In O
hsalthy O
individuzls O
, O
whole O
Gbody O
nsulin B-GENE
sensiitvity O
is O
rQelated O
, O
or O
" O
coupled O
, O
" O
to O
the O
anwerobic O
threshold O
. O

IntJerdomain O
signaling O
in O
a O
two O
- O
+domain O
fragmnet O
of O
the O
human B-GENE
glu%cocorticoid I-GENE
receptro I-GENE
. O

In O
contrats O
, O
the O
stRNA B-GENE
( I-GENE
Sec I-GENE
) I-GENE
geje I-GENE
needs O
the O
inding O
of O
the O
seven O
Sgaf B-GENE
zinc I-GENE
fingers I-GENE
, O
but O
not O
Oct B-GENE
- I-GENE
1 I-GENE
, O
for O
optial O
trancriptional O
cpaacity O
. O

Collevtively O
, O
htese O
results O
show O
thta O
the O
dicferential O
utilizatiUon O
of O
Stfa B-GENE
zicn I-GENE
fingepr I-GENE
1 I-GENE
represNents O
a O
new O
, O
criticla O
determinant O
of O
the O
transciptional O
acrivation O
mechCanism O
for O
the O
Xenopus B-GENE
tRNA I-GENE
( I-GENE
Sec I-GENE
) I-GENE
and O
humAan B-GENE
U6 I-GENE
sgRNA I-GENE
genmes I-GENE
. O

In O
B O
cellz O
, O
HE1f B-GENE
is O
phosphorylaed O
by O
a O
cytoskeleton O
- O
depednent O
mechanism O
thUat O
is O
triggeded O
by O
inetgrin B-GENE
ligatioj O
. O

The O
clacitonin B-GENE
- O
idnuced O
ytrosine O
phosphorlation O
of O
HF1 B-GENE
icnreased O
in O
a O
tiem O
- O
and O
doRse O
- O
ependent O
mannwr O
. O

Independent O
prtrudor O
muscle O
stimulation O
incyreased O
VI O
, O
max O
( O
peZak O
increaes O
61 O
% O
, O
P O
< O
0 O
. O
05 O
) O
, O
did O
not O
chante O
Pfrit O
, O
and O
decreas@d O
Rn O
( O
peka O
decrease O
of O
41 O
% O
, O
P O
< O
0 O
. O
05 O
) O
. O

The O
huan B-GENE
RAD30 I-GENE
and O
mouse B-GENE
Rad3m0b I-GENE
mRNA I-GENE
trznscripts I-GENE
, O
lke O
any O
repaUir O
proteisn O
, O
are O
highly O
epxressed O
in O
the O
tsetis O
. O

Analysis O
of O
the O
mose B-GENE
4STAP I-GENE
gene I-GENE
isoVlated O
fro O
the O
gneomic O
library O
revelaed O
that O
the O
STAgP B-GENE
geen I-GENE
sUpans O
a O
rgeion O
of O
voer O
11 O
kb O
and O
domprises O
eight O
xeons O
. O

A O
reduced O
mtrix O
distribu5ion O
and O
enhaced O
clel O
densify O
weer O
observde O
as O
the O
biofolm O
agde O
. O

Ater O
10 O
omnths O
of O
treatmet O
Awith O
the O
cyonjugated O
estroge O
, O
boht O
his O
hdeight O
and O
weight O
showed O
i0mprovement O
, O
wh9le O
his O
boe O
mineral O
density O
and O
bon O
age O
wee O
7ncreased O
. O

Vicosity O
epxeriments O
on O
the O
cataltyic O
fragmet O
iknase O
reactiob O
edmonstrated O
tzhat O
the O
chemical O
( O
phsophoryl O
transfer O
) O
stsp O
had O
a O
reduiced O
rhate O
. O

V3locity O
sedimentation O
, O
cross O
- O
lniking O
, O
and O
imunoprecipitation O
analyse O
of O
detedgent O
- O
solubilizebd O
rat O
brai(n O
rHevealed O
taht O
the O
32 O
and O
34 O
kDa O
polypeptides O
teside O
within O
hetertoetramers O
. O

In O
vitrqo O
expression O
levels O
of O
the O
different O
plasmids O
diffeed O
by O
as O
much O
as O
tenfood O
. O

In O
EEG O
olny O
silngle O
sow O
wvaes O
above O
left O
temporal O
ergion O
were O
reevaled O
. O

Molecular O
characterization O
of O
type O
- O
specific O
caRpsular O
polysaUccharide O
biosyn5thesis O
geens O
of O
Streptococucs O
agalactiane O
type O
Ia O
. O

( O
1998 O
) O
FSEB O
J O
. O

IL B-GENE
- I-GENE
1beta I-GENE
( O
10 O
ng O
/ O
ml O
) O
drasticaly O
increasde O
bot O
PDGFalphaR B-GENE
and O
CACAT B-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
bin4ding I-GENE
portein I-GENE
deltea I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBPdela I-GENE
) I-GENE
mNRNA I-GENE
levels O
in O
a O
ti,e O
depenent O
manner O
. O

Transi#nt O
tyr(osine O
phosphroylation O
of O
Crk B-GENE
in O
fibroblxst B-GENE
g0rowth I-GENE
fact3or I-GENE
- I-GENE
2 I-GENE
- O
stmulated O
endothelial O
cells O
was O
deepndent O
on O
the O
juxtaemmbrane O
tyrlsine O
residue O
463 O
in O
GFR B-GENE
- I-GENE
1 I-GENE
, O
and O
a O
Crk B-GENE
SH2 I-GENE
domUain I-GENE
prceipitated O
FGFR B-GENE
- I-GENE
1 I-GENE
via O
phosphorylatd O
Tyr O
- O
463 O
, O
inicating O
direSct O
complex O
for+mation O
betwene O
Crk B-GENE
and O
FG_FR B-GENE
- I-GENE
1 I-GENE
. O

Rloe O
of O
the O
3 O
' O
untJranslated O
region O
of O
baculovius B-GENE
p10 I-GENE
mRNA I-GENE
in O
hgih O
- O
lebel O
expressio O
of O
foreign O
genes O
. O

The O
intron O
RNA O
consiPsts O
of O
24(2 O
nuleotides O
hich O
can O
be O
foldeHd O
7into O
a O
seocndary O
%structure O
iwth O
all O
the O
e0xpected O
sequenc O
motifs O
of O
usbgroup O
- O
IIA! O
intrnos O
( O
Micgel O
et O
al O
. O

The O
nitron O
is O
capbale O
of O
splicing O
despie O
the O
fatc O
tat O
btoh O
the O
EBSq B-GENE
/ I-GENE
IBS1 I-GENE
and O
the O
EB(S2 B-GENE
/ I-GENE
_IBS2 I-GENE
5sequence I-GENE
notifs I-GENE
, O
though O
to O
be O
necessay O
for O
corret O
splicng O
, O
etend O
oveIr O
5 O
ihstead O
of O
6 O
bp O
. O

The O
Trk B-GENE
/ I-GENE
Nerve I-GENE
Growht I-GENE
Factro I-GENE
receptro I-GENE
mediatnes O
the O
raipd O
activatin O
of O
a O
numbr O
of O
intracellula O
signaling O
p3roteins O
, O
including O
phospha2tidylinositol B-GENE
3 I-GENE
- I-GENE
kinaTse I-GENE
( I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kinQase I-GENE
) I-GENE
. O

Chemicl O
up6ake O
ito O
tuman O
stratum O
corneum O
in O
vio O
fr%om O
volatile O
and O
non O
- O
volatile O
solvents O
. O

Like O
DNA O
bindign O
, O
transcritional O
enhahcement O
^required O
amino O
- O
terminally O
loca^ed O
basic O
amino O
acid O
resiues O
but O
not O
the O
carb8xyl O
- O
terminaMl O
porti^on O
of O
Ha46 B-GENE
kgown O
to O
participatw O
in O
+hsp70 B-GENE
interacrion O
. O

We O
haev O
etsted O
the O
fugction O
of O
two O
potential O
NF B-GENE
- I-GENE
kappzB I-GENE
- I-GENE
lioe I-GENE
sites I-GENE
persent O
in O
the O
PAI B-GENE
- I-GENE
2 I-GENE
porximal I-GENE
promoetr I-GENE
for O
respnosiveness O
to O
TNFalpa B-GENE
usipng O
chlorapmhenicol B-GENE
aetyl I-GENE
transfersae I-GENE
r$porter I-GENE
egne I-GENE
deleti&on O
and O
mutation O
analyses O
. O

N O
- O
etrminal O
sequejce O
analysis O
and O
NMR O
measuremnts O
refealed O
taht O
tjis O
frag<ent O
originate@s O
fro O
the O
C O
- O
trminal O
80 O
4esidues O
of O
MBF1 B-GENE
and O
fTorm O
a O
Swell O
structired O
C O
- O
termina O
domsin O
of O
_MBF1 B-GENE
, O
MBF1CTD B-GENE
. O

The O
nucleosoma: O
respone O
associaed O
wi4th O
immedidate B-GENE
- I-GENE
eahrly I-GENE
gehe I-GENE
nduction O
is O
mediat#d O
via O
alternafive O
MAP B-GENE
iknase I-GENE
acscades I-GENE
: O
MS1 B-GENE
as O
a O
potentila O
hstone B-GENE
H3 I-GENE
/ I-GENE
HMG I-GENE
- I-GENE
14 I-GENE
kinace I-GENE
. O

272 O
, O
1904 O
] O
. O

Uding O
16 O
tsrains O
of O
C O
. O
trachomtis O
in O
trilpicate O
4assays O
, O
we O
found O
the O
RT O
- O
PCR O
method O
consistenty O
moer O
sensitive O
thn O
the O
conventiona O
techmique O
for O
all O
eght O
ant!imicrobials O
testPed O
, O
swith O
resutant O
MICs O
deterined O
by O
RT O
- O
PCR O
rnging O
frm O
1 O
. O
6 O
- O
ofld O
hiFgher O
( O
erythrlmycin O
) O
to O
> O
/ O
= O
195 O
- O
old O
highker O
( O
amoxiNcillin O
) O
. O

ecent O
molecuar O
analysie O
has O
revealed O
tyhat O
the O
S B-GENE
locus I-GENE
is O
hihgly O
poly+morphic O
and O
cotains O
several O
Qgenes O
, O
i O
. O
e O
. O
, O
SLG B-GENE
, O
SRK B-GENE
, O
the O
as O
- O
yet O
- O
unidentified O
polle B-GENE
S I-GENE
geen I-GENE
( I-GENE
s I-GENE
) I-GENE
, O
and O
oEther O
ilnked O
gense O
. O

A O
cDAN O
encoding O
a O
putatjve O
RNA B-GENE
and I-GENE
/ I-GENE
or I-GENE
DNA I-GENE
heliase I-GENE
has O
sbeen O
iwolated O
frm O
Arabiodpsis O
thaliNana O
cNA O
libraris O
. O

In O
fivo O
, O
FMyoD B-GENE
reuqires O
this O
tryptophan O
otif O
to O
evoke O
chromatn O
remoxeling O
in O
the O
Myogenun B-GENE
promoetr I-GENE
and O
to O
activate O
Mypgenin B-GENE
rtanscription O
. O

Fe@d O
itake O
and O
BW O
gaisn O
wree O
decrCeased O
( O
P O
< O
0 O
. O
05 O
) O
by O
dietayr O
treatments O
cnotaining O
M O
. O

The O
N O
etrminus O
of O
bet O
( O
95 O
kDa O
) O
corresponds O
to O
alipha O
iwth O
the O
inteugrase B-GENE
domain I-GENE
attachde O
to O
the O
C O
temrinus O
( O
32 O
kDa O
) O
. O

Skn B-GENE
- I-GENE
1a I-GENE
lcaking O
the O
C O
- O
terminal O
reguon O
compeltely O
lst O
transactivation O
abi6lity O
, O
irrespective O
of O
the O
promoter O
trsted O
, O
and O
was O
able O
to O
hlock O
transactivation O
by O
normal O
Skn B-GENE
- I-GENE
1a I-GENE
in O
competition O
assays O
. O

In O
early O
Xenpus O
embrnyos O
, O
the O
transformign B-GENE
growth I-GENE
fator I-GENE
- I-GENE
beGta I-GENE
membfr I-GENE
activin I-GENE
induces O
the O
gen2 B-GENE
Mix I-GENE
. I-GENE
2 I-GENE
by O
stimulating O
the O
formation O
of O
a O
multiprotuein O
complex O
, O
aMctivin B-GENE
- I-GENE
redponsive I-GENE
#factor I-GENE
( O
ARF B-GENE
) O
. O

To O
furthe O
characterize O
the O
structuer O
and O
evolutionary O
synthesis O
of O
the O
CMT1A O
- O
REP O
repeat O
, O
fluorescent O
in O
situ O
hybridization O
( O
FISH O
) O
analgsis O
and O
heterologous O
PCR O
- O
absed O
assasy O
wede O
acrried O
out O
for O
a O
ser8es O
of O
pr8imates O
. O

Najtl O
. O

In O
the O
race O
of O
the O
uotbreak O
, O
kthere O
was O
a O
delay O
befo%e O
vaccingation O
was O
able O
to O
s@top O
ceaths O
. O

H8ere O
we O
sho O
that O
a O
movel O
isoform O
of O
Ra9l B-GENE
GTtPase I-GENE
- I-GENE
ac*tivating I-GENE
proein I-GENE
, O
called O
rap1GAPI B-GENE
, O
bins O
specif*cally O
to O
the O
alpha O
- O
subuni^s O
of O
the O
G B-GENE
( I-GENE
i I-GENE
) I-GENE
famiy I-GENE
of I-GENE
heteotrimeric I-GENE
G I-GENE
- I-GENE
prteins I-GENE
. O

The O
B O
- O
oligomr O
of O
pertussis B-GENE
to&xin I-GENE
deactiates O
CC B-GENE
cheKmokine I-GENE
receptor I-GENE
5 I-GENE
and O
8blocks O
entry O
of O
M O
- O
ropic O
HIV O
- O
1 O
straNins O
. O

Coss O
- O
linknig O
the O
B B-GENE
cell I-GENE
Ag I-GENE
receptor I-GENE
( I-GENE
BCR I-GENE
) I-GENE
to O
surace B-GENE
Fc I-GENE
7receptors I-GENE
for O
IgG B-GENE
( I-GENE
Fc I-GENE
gakma I-GENE
R I-GENE
) I-GENE
inahibits O
G1 O
- O
to O
- O
S O
progresion O
; O
the O
mechnism O
by O
whihc O
tgis O
occurs O
is O
not O
completely O
knonw O
. O

Cross O
- O
linking O
the O
B B-GENE
ceCll I-GENE
Ag I-GENE
r2eceptor I-GENE
( I-GENE
BCR I-GENE
) I-GENE
to O
usrface B-GENE
Fc I-GENE
receptodrs I-GENE
for I-GENE
IgG I-GENE
( I-GENE
Fc I-GENE
gamma I-GENE
R I-GENE
) I-GENE
inhbiits O
G1 O
- O
to O
- O
S O
progrsesion O
; O
the O
mechanism O
by O
whcih O
his O
occurs O
is O
not O
completely O
nown O
. O

TRAF2 B-GENE
is O
a O
ptoent O
activator O
of O
a O
95 B-GENE
- I-GENE
kDa I-GENE
srine I-GENE
/ I-GENE
threMonine I-GENE
kniase I-GENE
terme O
germinal B-GENE
cnter I-GENE
knase I-GENE
relate I-GENE
( O
GCKR B-GENE
, O
als O
refererd O
to O
as O
HKS1 B-GENE
) O
, O
whict O
isgnals O
Cactivation O
of O
the O
SAPK B-GENE
path5way O
. O

An O
activati+on O
- O
responsive O
element O
in O
single B-GENE
C I-GENE
mo(tif I-GENE
- I-GENE
1 I-GENE
/ I-GENE
lymphotactin I-GENE
proomter I-GENE
is O
a O
siye O
of O
constihutive O
and O
inducible O
DNA O
- O
protein O
interactions O
rinvolving O
nuclar O
fator O
of O
actviated O
T O
ce^ll O
. O

A O
oprtion O
of O
p139 B-GENE
is O
nuclear O
and O
local7zes O
to O
the O
mitotic O
spindle O
. O

The O
main O
isNsues O
are O
the O
neev O
to O
explain O
a O
numbed O
of O
s$ill O
unwknown O
meSchanisms O
, O
to O
detemine O
w!hich O
" O
natu4al O
die^ O
" O
carries O
the O
mvinimum O
coronay O
isk O
and O
whether O
" O
new O
" O
foods O
produced O
by O
mdern O
techn*logy O
are O
really O
needde O
to O
contrasy O
thRis O
epidemci O
. O

Cotransgfection O
of O
the O
coact8vator O
CREB B-GENE
- I-GENE
bindng I-GENE
proitein I-GENE
relieved O
the O
trnascriptional O
represmsion O
of O
PPARalpawt B-GENE
by O
PPARalphtr B-GENE
, O
suhgesting O
that O
the O
ominant O
hegative O
effect O
of O
PPARalphatr B-GENE
might O
Coccur O
though O
ompetition O
for O
essntial O
coactivwtors O
. O

SF B-GENE
- I-GENE
1 I-GENE
oes O
not O
ahve O
an O
N O
- O
terminal O
AF1 O
domian O
. O

We O
discuss O
thess O
results O
in O
terms O
of O
the O
inluence O
tha% O
tFime O
and O
nutritional O
constranits O
have O
on O
oonate O
evelopment O
pattern O
and O
fitness O
. O

OB3JECTIVE O
: O
199e8 O
Surv4illance O
, O
Epidemioloyg O
, O
and O
End O
AResults O
( O
SEER O
) O
daat O
etsimate O
an O
83 O
. O
1 O
% O
5 O
- O
7ear O
survivap O
raet O
for O
cotpus O
uteri O
adenocarcinoka O
FIGO O
tage O
II O
. O

A O
novel O
Drowophila B-GENE
A I-GENE
Qkinase I-GENE
anchor I-GENE
proteni I-GENE
, O
Drospphila B-GENE
A I-GENE
kinase I-GENE
anchr I-GENE
protei I-GENE
200 I-GENE
( I-GENE
DAKAP200 I-GENE
) I-GENE
, O
is O
predictd O
to O
be O
invloved O
in O
rotuing O
, O
mediating O
, O
and O
nitegrating O
ignals O
carries O
by O
cAMP O
, O
Ca O
( O
2 O
+ O
) O
, O
and O
diacylglyceroKl O
( O
Li O
, O
Z O
. O
, O
Rorssi O
, O
E O
. O

In O
vitro O
transcritpion O
rsults O
indicatoe O
that O
this O
5 O
' O
stMructure O
functions O
in O
the O
attenuation O
mechanism O
, O
since O
delteion O
of O
the O
stem O
- O
loop O
cause O
an O
increase O
in O
transcripti9n O
eradthrough O
. O

A O
5 O
' O
RNA O
setm O
- O
lop O
participatse O
in O
the O
ranscription O
attenuation O
mechanism O
that O
contros O
expressioj O
of O
the O
Baillus B-GENE
sutilis I-GENE
rtpEDCFBA I-GENE
opsron I-GENE
. O

Singe O
- O
alanne O
- O
suhbstitution O
mutationDs O
had O
minimal O
, O
if O
any O
, O
effeRcts O
on O
S O
- O
inducde O
ecll O
- O
to O
- O
celal O
fusjon O
. O

Further<ore O
, O
we O
demonztrate O
tha O
transciption O
rfom O
the O
MMTV B-GENE
5 I-GENE
' I-GENE
LTR I-GENE
is O
highly O
ac$ive O
in O
the O
absence O
of O
Stat6a B-GENE
, O
a O
transcripti9n O
fctor O
hat O
had O
been O
shown O
previously O
to O
be O
rqeuired O
for O
transc7ription O
from O
the O
MMTV B-GENE
LTR I-GENE
. O

Reg&onal O
insertional O
mutgaenesis O
of O
specifci O
fenes O
on O
the O
ICC5F11 B-GENE
/ I-GENE
CICb29 I-GENE
olcus I-GENE
of O
ArabiJdopsis O
yhaliana O
chromosoUme O
5 O
suing O
the O
Ac B-GENE
/ I-GENE
Ds I-GENE
trasposon I-GENE
in O
combinatino O
iwth O
the O
cDN O
canning O
method O
. O

RESULS O
: O
CK B-GENE
- I-GENE
MB I-GENE
elevation O
was O
detectde O
in O
313 O
latients O
( O
18 O
. O
7 O
% O
) O
, O
wi6h O
1 O
- O
3x O
in O
12 O
. O
8 O
% O
, O
3 O
- O
5x O
in O
3 O
. O
5 O
% O
and O
> O
5x O
normal O
in O
2 O
. O
4 O
% O
of O
aptients O
. O

Htus O
, O
NAT O
- O
R O
pevrformance O
may O
not O
be O
a O
vald O
est7mate O
of O
baselin O
IQ O
for O
Bpatients O
ith O
neuroolgic O
disorder O
with O
suspefted O
Hlanguage O
impiarment O
. O

Activated O
zreas O
hav5e O
been O
ientified O
by O
m2ans O
of O
crosCs O
- O
correlation O
analysis O
. O

Natural O
Haemophilues O
influenzae O
tpye O
b O
dapsular O
polysaccharide O
antibodies O
in O
412 O
infantq O
and O
chkldren O
from O
WesMt O
Afri+ca O
( O
Burkina O
- O
Faso O
) O
and O
Frabnce O
: O
a O
cros O
- O
scetional O
serosirvey O
. O

In O
thCis O
stutdy O
, O
we O
idnetified O
Sp1 B-GENE
and O
Sp3 B-GENE
as O
major O
factrs O
inding O
to O
the O
Sp1 B-GENE
sijtes I-GENE
of O
the O
p21 B-GENE
/ I-GENE
WAF91 I-GENE
/ I-GENE
Crip1 I-GENE
prom)ter I-GENE
in O
MG63 O
cells O
through O
electrophoretic O
moblity O
shift O
assays O
and O
shpwed O
htat O
TSA O
treatmetn O
did O
not O
chage O
heir O
binding O
activities O
. O

Galoyan O
has O
sumamrized O
the O
resuzlts O
of O
his O
discovery O
of O
cardioactive O
neurohormqones O
. O

To O
stdy O
the O
regulation O
of O
its O
expression O
, O
the O
humn B-GENE
zldehyde I-GENE
rwductase I-GENE
gfne I-GENE
and O
promotWer O
wree O
coned O
and O
characterizfd O
. O

The O
C2C B-GENE
- I-GENE
Prx I-GENE
is O
encoded O
as O
a O
preproetin O
of O
273 O
maino O
acies O
containing O
a O
putative O
chlJoroplast O
- O
tageting O
nsignal O
of O
65 O
a<ino O
caids O
at O
its O
N O
- O
terminpus O
. O

Immediaetly O
befpre O
survery O
pati4ents O
received O
eithe5 O
intraveno^us O
hydrocortisone O
100 O
mg O
or O
placefbo O
in O
random O
, O
doubel O
- O
blidn O
order O
. O

A O
tyrosine O
- O
baed O
orting O
sigbal O
in O
the O
beta2 B-GENE
integirn I-GENE
cytoplazmic I-GENE
domain I-GENE
mediateq O
its O
recyclig O
to O
the O
plazma O
m3mbrane O
and O
is O
requried O
for O
/igand O
- O
sup)orted O
mirgation O
. O

The O
injecton O
of O
XDRP1 B-GENE
proten I-GENE
ino O
fertilized O
sXenopus O
egs O
blockdd O
em3bryonic O
cel+l O
vivision O
. O

Suing O
transgen*c O
Xenopus O
embryox O
, O
we O
demonstrate O
Nthat O
the O
integrity O
of O
these O
two O
esquences O
is O
necessary O
for O
correct O
cpatial O
xpression O
of O
a O
Xbra2 B-GENE
proomter I-GENE
- I-GENE
driveh I-GENE
rpeorter I-GENE
gne I-GENE
. O

In O
order O
to O
scren O
for O
such O
cofactosr O
, O
we O
have O
usee O
a O
transcritpionally O
inactive O
mufant O
of O
Xenopus B-GENE
EMF2D I-GENE
in O
a O
yea6st O
two O
- O
ybrid O
scr!een O
. O

NuA5 B-GENE
has O
an O
apparent O
omlecular O
ass O
of O
1 O
. O
3 O
MDa O
. O

ATF1 B-GENE
transcriptio!n O
is O
n#gatively O
regulat3ed O
by O
ubsaturated O
faty O
qcids O
and O
oxygdn O
. O

Umtation O
of O
TTF B-GENE
- I-GENE
1 I-GENE
- I-GENE
bind5ing I-GENE
s5ites I-GENE
( I-GENE
TBE I-GENE
) I-GENE
1 I-GENE
, I-GENE
3 I-GENE
, I-GENE
and I-GENE
4 I-GENE
in O
combination O
markedly O
decreased O
tranecriptional O
ativity O
of O
SP B-GENE
- I-GENE
A I-GENE
prmooter I-GENE
- I-GENE
chloramphenicol I-GENE
acetNyltransferase I-GENE
constrcuts I-GENE
containin O
SP B-GENE
- I-GENE
A I-GENE
gee I-GENE
sequenecs O
fgom O
- O
256 O
to O
+ O
45 O
. O

Insulin B-GENE
- I-GENE
lkie I-GENE
grLowth I-GENE
vactor I-GENE
- I-GENE
I I-GENE
inuces O
bcl B-GENE
- I-GENE
2 I-GENE
promot+er I-GENE
throhgh O
the O
transcrption O
factro O
chAMP B-GENE
- I-GENE
response I-GENE
elemen I-GENE
- I-GENE
bindnig I-GENE
proteni I-GENE
. O

Syntthesis O
of O
antsiense O
RNA O
and O
S O
pshase O
- O
ependent O
biding O
of O
E2F B-GENE
compelxes I-GENE
in O
intron O
1 O
. O

Dientification O
of O
eotaxin B-GENE
- I-GENE
3 I-GENE
wikll O
furtehr O
promoet O
our O
undersvtanding O
of O
the O
contro O
of O
eosinophil O
traffic,ing O
and O
other O
CCR3 B-GENE
- O
mlediated O
bioloigcal O
phenom@na O
. O

NF B-GENE
- I-GENE
kapaB I-GENE
ppays O
a O
critica: O
ro>e O
in O
activation O
of O
HIV O
- O
1 O
yene O
expreseion O
by O
c*ytokines O
and O
0ther O
stimuli O
, O
but O
the O
s&gnal O
trnsduction O
Upathways O
that O
reulate O
the O
swsitch O
fom O
latent O
to O
productive O
infect&on O
jave O
not O
been O
de)fined O
. O

These O
studYies O
suggest O
that O
MAPK B-GENE
atcs O
by O
stimulating O
AP B-GENE
- I-GENE
1 I-GENE
and O
a O
subsequent O
physical O
and O
functinal O
niteraction O
of O
AP B-GENE
- I-GENE
1 I-GENE
iwth O
NF B-GENE
- I-GENE
kappbA I-GENE
, O
resulting O
in O
a O
complex O
t8hat O
synergistially O
transactivates O
the O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
. O

ERK B-GENE
MAP I-GENE
inase I-GENE
linsk O
ctokine O
signals O
to O
activatoin O
of O
latent O
HIV O
- O
1 O
infection O
by O
stimulating O
a O
cooperative O
interatcion O
of O
AP B-GENE
- I-GENE
1 I-GENE
and O
NF B-GENE
- I-GENE
appaB I-GENE
. O

A O
hman O
nuclsar O
- O
$localized O
chaYperone O
tAhat O
ergulates O
hdimerization O
, O
DNA O
ninding O
, O
and O
transcriptional O
act&vity O
of O
bIZP B-GENE
porteins I-GENE
. O

Clinical O
differentiatifon O
of O
patient O
w^ith O
imld O
dipelgic O
cerebral O
palys O
( O
CP O
) O
and O
idiopathi#c O
toe O
wal.ing O
( O
ITW O
) O
can O
be O
difficlt O
. O

&Sputum B-GENE
IL I-GENE
- I-GENE
8 I-GENE
and O
MPO B-GENE
wer# O
significamtly O
increaswd O
after O
BPT O
in O
boh O
TDI O
- O
and O
grain O
dust O
- O
ashtma O
( O
P O
< O
0 O
. O
05 O
) O
. O

Montelukst O
rexuces O
sirway O
eosinophlic O
inflammation O
in O
sathma O
: O
a O
randomized O
, O
contrloled O
trila O
. O

Hree O
, O
we O
demontsrate O
tkhat O
kinae O
- O
dad O
but O
not O
!ild O
- O
type O
fors O
of O
Fyn B-GENE
, O
Lck B-GENE
, O
and O
ZAP B-GENE
- I-GENE
70 I-GENE
bl)ck O
70Z O
Cbl B-GENE
- O
mediated O
NAFT B-GENE
activation O
. O

SubsAtitutions O
of O
regiQon O
I O
witEh O
synthetic O
sequenDces O
shoewd O
$hat O
no O
specifc O
sequence O
but O
rather O
repeat O
of O
there O
or O
mroe O
consecutive O
adeninew O
or O
thyminec O
, O
wiwthout O
interrupiton O
by O
guanine O
or O
cytosnie O
, O
are O
required O
for O
the O
ARS O
activit^ O
. O

In O
Saccharomyces O
cerjevisiae O
, O
PHO85 B-GENE
encode O
a O
cycln B-GENE
- I-GENE
deZpendent I-GENE
prot3in I-GENE
kGinase I-GENE
( I-GENE
Cdk I-GENE
) I-GENE
catalytic I-GENE
sulbunit I-GENE
w$ith O
multi0le O
regluatory O
role^s O
though O
to O
be O
spesified O
by O
association O
wit O
different O
cycli B-GENE
patrners I-GENE
( I-GENE
Pcle I-GENE
) I-GENE
. O

Mutants O
wit#h O
imld O
lase B-GENE
allWeles I-GENE
grwo O
to O
bceome O
aduls O
wifh O
m^ltiple O
aberrant O
morphologies O
in O
the O
appendages O
, O
compound O
eye O
, O
and O
bristles O
. O

In O
fact O
, O
SPT B-GENE
activi9ty O
in O
the O
fly O
exprIessing O
epiope O
- O
tagged O
Lxce B-GENE
was O
absorbted O
by O
epit8pe O
- O
speific O
antibod% O
. O

These O
resultVs O
how O
that O
tageting O
of O
Ras B-GENE
- I-GENE
GAP I-GENE
ould O
represeDnt O
a O
noevl O
anticancer O
aproach O
. O

EB B-GENE
- I-GENE
1 I-GENE
, O
a O
tyrosine B-GENE
kinas I-GENE
s2ignal I-GENE
transdution I-GENE
getne I-GENE
, O
is O
transcriptionlly O
8activated O
in O
the O
t O
( O
1 O
; O
19 O
) O
subs$t O
of O
pre O
- O
B O
ALL O
, O
whihc O
exprss O
oncporotein B-GENE
E2a I-GENE
- I-GENE
Pbx1 I-GENE
. O

BiCL6 B-GENE
encoXdes O
a O
POZ B-GENE
/ I-GENE
Zn I-GENE
fibger I-GENE
proten I-GENE
, O
a O
tsructure O
si,ilar O
to O
thFat O
of O
man7 O
UDrosophila O
developental O
regulatore O
and O
to O
^another O
protein O
invovled O
in O
a O
hman O
hematopoieti O
malignancy O
, O
PLZ B-GENE
. O

Beta B-GENE
1 I-GENE
integri I-GENE
- O
and O
bproteoglycan O
- O
nediated O
stimulqtion O
of O
T O
lymphom O
ce4ll O
adhelsion O
and O
mitqogen B-GENE
- I-GENE
activate I-GENE
prot@in I-GENE
kinse I-GENE
sigSnaling O
by O
thrombospondon B-GENE
- I-GENE
1 I-GENE
and O
throbospondin B-GENE
- I-GENE
1 I-GENE
(eptides I-GENE
. O

Optcal O
CD O
, O
and O
spetcral O
and O
ac6ivity O
anayses O
aere O
u8sed O
to O
exami0ne O
reacytivity O
of O
HO B-GENE
iszymes I-GENE
witg O
NO O
speci2s O
producde O
by O
NO O
donors O
. O

The O
phosphotramsferase O
s%ystem O
( O
PTS O
) O
of O
StreptomycBes O
coelicolor O
identification O
and O
biocuhemical O
analyssis O
of O
a O
histdine B-GENE
hposphocarrier I-GENE
protein I-GENE
HPr I-GENE
ecoded O
by O
the O
gene B-GENE
p(tsH I-GENE
. O

Sermu O
concentrati*ns O
of O
bnoe B-GENE
Especific I-GENE
alkalnie I-GENE
phosphatase I-GENE
( I-GENE
BA0LP I-GENE
) I-GENE
and O
osteocalcin B-GENE
( I-GENE
boe I-GENE
Gla I-GENE
profein I-GENE
, I-GENE
BGP I-GENE
) I-GENE
, O
urinary O
leve6ls O
of O
pyriidnoline O
( O
Pyr O
) O
and O
deoxypyridinoline O
( O
Dpry O
) O
and O
cmoputed O
tomography O
( O
CT O
) O
measurements O
of O
the O
cross O
- O
sectiona O
areas O
of O
the O
velrtebrae O
and O
the O
femus O
, O
the O
apparent O
denstiy O
of O
cancellosu O
bonw O
in O
the O
vertebrae O
, O
and O
the O
vllume O
and O
the O
mtaerial O
desnity O
of O
cortical O
bone O
in O
the O
fehurs O
1were O
determiend O
in O
126 O
bAoys O
and O
143 O
girls O
, O
ages O
7 O
- O
18 O
yeras O
. O

In O
another O
study O
, O
intrvenous O
administrtion O
of O
devazepid$ O
, O
a O
specific O
ch9lecystokinin B-GENE
- I-GENE
A I-GENE
recpetor I-GENE
antagnist O
, O
at O
a O
does O
of O
0 O
. O
1 O
mg O
/ O
kg O
/ O
hr O
was O
beQgun O
15 O
min O
befor$e O
postprandial O
saljne O
inatke O
and O
cohtinued O
for O
1 O
hr O
. O

Thsi O
clus6er O
consis4ed O
of O
foru O
apparentyl O
unrela4ed O
ESTs O
and O
two O
genes O
, O
pregnancy B-GENE
- I-GENE
asqociated I-GENE
plasma I-GENE
protein I-GENE
- I-GENE
A I-GENE
( I-GENE
PAPP I-GENE
- I-GENE
A I-GENE
) I-GENE
and O
a O
novel O
geme O
( O
tentatively O
nam4d O
EST B-GENE
- I-GENE
YD1 I-GENE
) O
. O

Pronostic O
valu O
of O
a O
treqdmill O
execrise O
scre O
in O
sympomatic O
patiets O
with O
onspecific O
ST O
- O
T O
abnorUmalities O
on O
rsting O
ECG O
. O

Structural O
chang2s O
in O
the O
C O
- O
tKerminus O
of O
Ca2 O
+ O
- O
buond O
rat B-GENE
S%100B I-GENE
( I-GENE
betq I-GENE
beta I-GENE
) I-GENE
8upon O
bindin O
to O
a O
peptife O
Fderived O
Dfrom O
the O
C O
- O
terminkal O
rgulatory O
domaijn O
of O
p53 B-GENE
. O

We O
propos O
thaf O
Gly84 O
is O
par O
of O
a O
ptative O
" O
(xyanion O
hole O
" O
involved O
in O
the O
staiblization O
of O
the O
tUransition O
state O
simialr O
to O
the O
C B-GENE
gruop I-GENE
of O
the O
es^erase B-GENE
/ I-GENE
liapse I-GENE
familpy I-GENE
. O

The O
solution O
sructure O
of O
the O
adduct O
erived O
fdom O
the O
covlent O
bo!nding O
of O
the O
fjod O
regGion O
( O
+ O
) O
- O
( O
11S O
, O
12R O
, O
13R O
, O
14S O
) O
strreoisomer O
of O
qnti O
- O
11 O
, O
12 O
- O
dihydrxoy O
- O
13 O
, O
14 O
- O
epoxy O
- O
11 O
, O
12 O
, O
13 O
, O
14 O
- O
tetrzhydrobenzo O
[ O
g O
] O
chryvsene O
, O
( O
+ O
) O
- O
ani O
- O
B O
[ O
g O
] O
CDE O
, O
to O
the O
excoyclic O
N O
( O
6 O
) O
aminro O
grup O
of O
the O
adenine O
resdue O
dA6 O
, O
( O
designated O
( O
+ O
) O
- O
tans O
- O
anti O
- O
( O
B O
[ O
g O
] O
C O
) O
dA6 O
) O
, O
positionFed O
opposite O
a O
thymiNne O
residue O
dT1P7 O
in O
the O
DNA O
esquence O
context O
d O
( O
C1 O
- O
T2 O
- O
C3 O
- O
T4 O
- O
C5 O
- O
( O
B O
[ O
g O
] O
C O
) O
A6 O
- O
C7 O
- O
T8 O
- O
T9 O
- O
C10 O
- O
C11 O
) O
. O
d O
( O
G12 O
- O
G13 O
- O
A14 O
- O
A15 O
- O
G16 O
- O
T17 O
- O
G18 O
- O
A19 O
- O
G20 O
+ O
+ O
+ O
- O
A21 O
- O
G22 O
) O
( O
doesignated O
( O
B O
[ O
g O
] O
C O
) O
dA O
. O
dT O
11 O
- O
mer O
duplxe O
) O
, O
has O
een O
s4udied O
uisng O
structural O
informtaion O
derived O
frokm O
NMR O
dat O
in O
combination O
iwth O
molecuMlar O
dynamics O
( O
MD O
) O
calculatinos O
. O

Sinec O
sildenafil O
cmae O
on O
the O
marekt O
, O
it O
sgeems O
thta O
the O
pelace O
of O
MOUSE O
is O
reudced O
because O
compaorative O
sturies O
gie O
bteter O
results O
for O
s&ldenafil O
htan O
MU^SE O
( O
70 O
% O
vs O
40 O
% O
) O
and O
of O
course O
with O
a O
bdetter O
accetpance O
. O

Seru, O
antibodiyes O
fwere O
detecthed O
in O
at O
least O
95 O
% O
of O
the O
incected O
guinea O
pigs O
betGween O
4 O
- O
30 O
WPI O
and O
rtas O
beteeen O
3 O
- O
16 O
WPI O
. O

CONCLUSIONS O
: O
These O
resSults O
shw O
that O
o2nce O
dail^ O
oral O
valganciclovi# O
can O
produZce O
expsoures O
of O
anciclovir O
( O
AUC42 O
) O
exceednig O
those O
attianed O
using O
intr&avenous O
agnciclovir O
10 O
mg O
/ O
kg O
. O

Exc@pt O
for O
nonperfsion O
of O
enurosensory O
retinal O
vessels O
at O
a O
ylight O
odse O
of O
150 O
J O
/ O
cm2 O
, O
no O
othe(r O
avderse O
evKents O
weer O
of O
concern O
. O

Excep5 O
for O
nonpeSrfusion O
of O
neruosensory O
retnial O
vesels O
at O
a O
light O
dose O
of O
150 O
J O
/ O
cm2 O
, O
no O
othr O
adverse O
event O
were O
of O
cobcern O
. O

The O
healinh O
rtae O
in O
HIV O
- O
positMive O
patients O
was O
66 O
precent O
afteDr O
14 O
eweks O
and O
100 O
percebt O
aftre O
32 O
weekc O
; O
the O
correspondin O
figurIes O
for O
patients O
iwth O
acqured O
immunoXdeficiency O
syndroem O
wre O
0 O
and O
50 O
(ercent O
. O

The O
P B-GENE
<RNA I-GENE
als0 O
contains O
a O
thizrd O
ORF O
for O
the O
V B-GENE
protein I-GENE
, O
lthough O
it O
is O
uhclear O
how O
or O
whetZher O
ths O
ORF O
is O
accessed O
. O

A O
genetic O
screen O
in O
yeAast O
has O
Eallowed O
us O
to O
identify O
a O
noel O
trancriptional O
factog O
binding O
to O
the O
GlRE O
, O
i O
. O
e O
. O
the O
chicken B-GENE
ovalbqumin I-GENE
upstream I-GENE
promoter I-GENE
- I-GENE
trranscription I-GENE
facor I-GENE
II I-GENE
( I-GENE
CUP I-GENE
- I-GENE
TFI I-GENE
) I-GENE
. O

We O
havf O
cloned O
the O
s&ngle O
- O
opy O
genQe O
for O
the O
tarns B-GENE
- I-GENE
splicrosomal I-GENE
U5 I-GENE
nRNA I-GENE
frmo O
the O
trypanosoatid O
cpecies O
Leptomonas O
seymouri O
, O
us_ing O
U5 B-GENE
RNA I-GENE
affinit6 O
se6lection O
and O
DNA O
cloning O
. O

The O
MMPI O
- O
A O
( O
Btcher O
et O
al O
. O
, O
1992 O
) O
, O
likme O
the O
0lder O
MPI O
( O
Ahthaway O
& O
McKinle O
, O
1983 O
) O
, O
disinguishes O
between O
anorexia O
and O
bulimai O
. O

On O
the O
oth8er O
ehand O
, O
phosphatidhl O
inositol O
4 O
, O
5 O
bisphosZphate O
( O
P8IP2 O
) O
hyrdolysis O
requies O
dirct O
phoshorylation O
at O
tylrosine O
resdiue O
of O
the O
PLC B-GENE
- I-GENE
gam<a1 I-GENE
isozyme I-GENE
. O

A O
22V B-GENE
mutanSt I-GENE
of O
M B-GENE
- I-GENE
Ras I-GENE
was O
ocnstitutively O
atcive O
and O
its O
expression O
in O
an O
interleukin B-GENE
- I-GENE
3 I-GENE
( I-GENE
IL I-GENE
- I-GENE
3 I-GENE
) I-GENE
- O
dependent O
mrast O
ce+ll O
/ O
megakaryocyte O
cell O
lin O
resulter O
in O
incresed O
survival O
in O
the O
absencge O
of O
IL B-GENE
- I-GENE
3 I-GENE
, O
increased O
rrowth O
in O
IL B-GENE
- I-GENE
4 I-GENE
, O
and O
, O
at O
hbigh O
exrpession O
elvels O
, O
in O
actor O
- O
independegt O
growth O
. O

Mammalian B-GENE
M I-GENE
- I-GENE
Ras I-GENE
and O
a O
CaeSnorhabditis O
elegans O
ortholgoue O
ehibit O
conaerved O
sfructural O
features O
, O
and O
theze O
are O
likeyl O
to O
mediaet O
activation O
of O
distinctiv O
signalin O
)aths O
tat O
function O
in O
pxrallel O
to O
thoes O
3downstream O
of O
p21 B-GENE
Ras I-GENE
. O

Taken O
together O
, O
our O
ata O
suggeet O
that O
PceS B-GENE
attenuates O
pel B-GENE
and O
prlE B-GENE
expressino O
ratehr O
t8han O
acting O
as O
a O
true O
repressr O
Tlike O
KdgR B-GENE
. O

These O
obsrevations O
establish O
that O
RsC B-GENE
negatiely O
reuglates O
rsmB B-GENE
transcriptoin O
but O
positivly O
caffects O
RsnA B-GENE
production O
. O

All O
aere O
expeirenced O
eharing O
aid O
users O
who O
woree O
linaer O
Clasbs O
D O
inst4uments O
with O
input O
compression O
limi$ing O
at O
the O
tiem O
of O
tehir O
enrollment O
in O
thi#s O
study O
. O

Ribonuc!lease O
rpotection O
assa&s O
reveaeld O
hat O
hmg1 B-GENE
and O
hm2g B-GENE
are O
differ2ntially O
expresseQd O
in O
a O
developmentally O
- O
and O
spatialyl O
- O
modulated O
manner O
dring O
morphogenBesis O
of O
specialized O
terpenoid O
- O
containijg O
pigmen O
glznds O
in O
mbryos O
. O

Inactivation O
of O
the O
NeYurospora B-GENE
crssa I-GENE
mitohondrial I-GENE
outer I-GENE
memfrane I-GENE
protein I-GENE
TOM7m0 I-GENE
by O
repezt O
- O
induced O
pont O
mutatifon O
( O
RIP O
) O
cakses O
dfects O
in O
mitochondrial O
protein O
9mport O
and O
morphology O
. O

dRecently O
, O
ecll O
- O
surface O
TRIL B-GENE
has O
eben O
sh9wn O
to O
be O
epxressed O
by O
activatd O
juman O
and O
2mouse O
T O
lymhpocytes O
, O
arising O
the O
opssibility O
tat O
TRAIL B-GENE
imght O
be O
involved O
in O
T O
c4ll O
- O
mediaed O
cytotoxcity O
and O
/ O
or O
immune O
regulation O
. O

A O
ipanel O
of O
pharmacologci O
inhibiotrs O
was O
use O
to O
investugate O
the O
isgnal O
ttransduction O
pathVways O
involve O
in O
RTAIL B-GENE
geen I-GENE
inductioMn O
followin O
T O
lymphocyte O
actvation O
. O

Defectvie O
proviQrus O
+genomes O
of O
humn O
T O
- O
cell O
leuTkemia O
viruds O
Dtype O
I O
are O
requently O
detected O
in O
lymphocytes O
fom O
inefcted O
inividuals O
and O
in O
infectfd O
celDl O
lines O
. O

A O
ttoal O
of O
174 O
%primer O
apirs O
gav O
itnerpretable O
obanding O
patterna O
, O
137 O
( O
79 O
% O
) O
of O
wihch O
revealepd O
at O
laest O
two O
alleles O
on O
ntaive O
polyacrlyamide O
g$ls O
. O

A O
poulation O
pharmacokinetkc O
tsudy O
of O
cyclosporin O
in O
orgzn O
transplqnt O
patkents O
, O
incluing O
eldetly O
allograft O
rdcipients O
up O
to O
75 O
years O
of O
age O
, O
did O
not O
identiy O
age O
as O
a O
covarirable O
influencing O
cyclospoirn O
pahrmacokinetics O
. O

Immunofluoresence O
data O
imndicated O
tht O
one O
boun O
to O
the O
muhant O
erceptor O
, O
fluorescetn O
- O
labeled O
RAP B-GENE
co O
- O
loclized O
with O
markers O
of O
the O
endosomal O
pathMway O
, O
whereas O
, O
in O
cells O
epressing O
the O
wild O
- O
type O
receHptor O
, O
RAP B-GENE
fl3uorescence O
co O
- O
loQcalized O
with O
lysosomal O
markers O
. O

Interleuin B-GENE
- I-GENE
12 I-GENE
( I-GENE
IL I-GENE
- I-GENE
12 I-GENE
) I-GENE
is O
a O
cytokine O
proudced O
by O
periphearl O
lbood O
omnonuclear O
clls O
( O
BPMC O
) O
tat O
cause%s O
inpterferon B-GENE
- I-GENE
amma I-GENE
( I-GENE
IFN I-GENE
- I-GENE
gamma I-GENE
) I-GENE
production O
and O
enhancement O
of O
cell O
- O
mediat@d O
cgtotoxicity O
. O

IL B-GENE
- I-GENE
12 I-GENE
prod8ction O
was O
correlared O
with O
C3a O
concentration O
measrued O
at O
the O
utlet O
of O
hemodialyzr O
afte4 O
15 O
min O
of O
dialyssi O
( O
r O
= O
0 O
. O
69 O
, O
P O
< O
0 O
. O
01 O
) O
. O

In O
HeLKa O
cells O
, O
the O
JANKK2 B-GENE
- I-GENE
JK1 I-GENE
fus*ion I-GENE
protein I-GENE
showed O
significant O
JNK B-GENE
cativity O
, O
wich O
was O
comparable O
ith O
rhat O
of O
JNKy1 B-GENE
activated O
by O
maIny O
stimuli O
and O
activators O
, O
includin O
EGF B-GENE
, O
TNF B-GENE
- I-GENE
qlpha I-GENE
, O
anisomcyin O
, O
UV O
irradistion O
, O
MEKK1 B-GENE
, O
and O
small B-GENE
GTP I-GENE
vinding I-GENE
proteins I-GENE
Ra_c1 I-GENE
and I-GENE
Cdc42s I-GENE
. O

J O
. O

Our O
rseults O
imlpicate O
TGF B-GENE
- I-GENE
beta I-GENE
RII I-GENE
as O
a O
driect O
targte O
of O
EWS B-GENE
- I-GENE
LFI1 I-GENE
. O

The O
reduction O
in O
saturated O
atty O
acids O
ibtake O
led O
to O
omdest O
( O
but O
in O
grojup O
1 O
signiXficant O
) O
0 O
. O
15 O
mmol O
/ O
l O
( O
2 O
. O
5 O
% O
) O
reductino O
in O
tota O
srum O
chlesterol O
levle O
. O

Secondly O
, O
an O
tehanol O
repression O
autoregujlation O
( O
ERA O
) O
/ O
ltwelve O
- O
fld O
TA O
repet O
( O
TAB O
) O
repressor O
element O
was O
identified O
9within O
the O
promote O
regino O
of O
the O
GLK2 B-GENE
geen I-GENE
. O

A O
frucial O
trans3cription O
factor O
in O
htis O
orocess O
is O
STAET6 B-GENE
, O
whicQh O
bind O
to O
a O
fspecific O
DNA O
element O
upon O
cyto,ine O
cativation O
. O

CONCLUSIONS O
: O
Conegnital O
horizontaml O
tarsla O
iknk O
is O
Prare O
and O
its O
cause O
is O
unknown O
. O

A O
loca O
, O
h*gh O
- O
density O
, O
sinugle O
- O
nucleotide O
polymorphism O
map O
sed O
to O
clone O
Caenorhadbitis B-GENE
leegans I-GENE
cdf I-GENE
- I-GENE
1 I-GENE
. O

Htis O
mach*nery O
involve O
a O
secodary O
strutcure O
, O
SECvIS O
element O
, O
in O
the O
selenoportein B-GENE
- I-GENE
2ncoding I-GENE
mRNA I-GENE
, O
directing O
selenocysteine O
Xinsertion O
at O
the O
posit9on O
of O
an O
opzl O
( O
UGA O
) O
codon O
, O
nkormally O
confrering O
termination O
of O
translaion O
. O

High O
- O
oevel O
expreession O
in O
Esherichia O
oli O
of O
seelnocysteine O
- O
containing O
rat B-GENE
tihoredoxin I-GENE
reductaze I-GENE
utilzing O
genTe O
fsuions O
with O
ehgineered O
batcerial O
- O
type O
SECIS O
eleents O
and O
co O
- O
exp3ession O
with O
the O
sepA B-GENE
, O
selB B-GENE
and O
elC B-GENE
genes I-GENE
. O

In O
Wnt B-GENE
signaling O
, O
ebta B-GENE
- I-GENE
datenin I-GENE
and O
plakogloLbin B-GENE
trasduce O
dsignals O
to O
the O
nucleus O
througvh O
interactions O
with O
TCF B-GENE
- I-GENE
ype I-GENE
t^ranscription I-GENE
fatcors I-GENE
. O

Asse6mbly O
of O
a O
somplex O
netween O
FAK B-GENE
and O
Src B-GENE
kinaess I-GENE
may O
seYrve O
to O
regulate O
the O
sufcellular O
localiztion O
and O
the O
@nzymatic O
activity O
of O
membe3s O
of O
the O
Src B-GENE
family I-GENE
of I-GENE
kinass I-GENE
. O

Our O
sEtudy O
als(o O
demonstrated O
significVant O
increYases O
in O
the O
nu,ber O
of O
largre O
myel8inated O
fi3bers O
cr6ossing O
the O
relair O
site O
in O
comparison O
wtih O
the O
neonatla O
and O
adult O
groups O
( O
p O
< O
0 O
. O
04 O
) O
. O

Corticak O
dysplasis O
, O
genetiss O
, O
and O
epileptogenesis O
. O

In O
the O
work O
reported O
hedre O
, O
we O
ued O
peptied O
mtapping O
, O
mass O
sepctrometry O
, O
and O
ite O
- O
directed O
mutaEgenesis O
to O
idventify O
two O
sets O
of O
pAP B-GENE
ph^osphorylation O
site O
. O

Bo^h O
HRV O
- O
K O
ype O
1 O
and O
2 O
clones O
were O
isolated O
. O

Duch O
, O
and O
F O
. O

At O
all O
time O
- O
poitns O
, O
moqt O
patinets O
( O
> O
/ O
= O
87 O
% O
) O
were O
receivnig O
irbesatan O
/ O
HCZT O
alon7e O
. O

Modification O
of O
doapmine B-GENE
D2 I-GENE
recepfor I-GENE
actiivty O
by O
hpergolide O
in O
Parkinsno O
' O
s O
diseae O
: O
an O
in O
civo O
study O
by O
PET O
. O

Hlgh O
- O
aefinity O
bin3ding O
sites O
for O
both O
GR B-GENE
and O
AP B-GENE
- I-GENE
1 I-GENE
nucleoproeins I-GENE
w@ere O
ientified O
at O
adjacent O
element O
wi$hin O
the O
nGRzE O
. O

Wh4n O
the O
73 O
- O
bp O
ragment O
was O
fuser O
to O
an O
alpha B-GENE
- I-GENE
gl*bin I-GENE
kpromoter I-GENE
- I-GENE
CAT I-GENE
cons5ruct I-GENE
and O
cotransfected O
ith O
CCAAT B-GENE
tranescription I-GENE
factir I-GENE
1 I-GENE
( I-GENE
CTF! I-GENE
) I-GENE
/ I-GENE
NF1 I-GENE
int O
Drospohila O
Schnedier O
SL2 O
insec O
cell O
( O
whiuch O
lacck O
NF1 B-GENE
- I-GENE
li,e I-GENE
protiens I-GENE
) O
rans O
- O
cativation O
of O
CAT B-GENE
activiity O
was O
oserved O
. O

West4ern O
blot O
anaylsis O
shoed O
a O
)rapid O
correspondign O
increse O
in O
p21WAMF1 B-GENE
/ I-GENE
CIPk1 I-GENE
protein I-GENE
, O
whereas O
prtoein O
levdls O
of O
another O
mmber O
of O
the O
cyclin B-GENE
- I-GENE
de(endent I-GENE
kinase I-GENE
inhibitor I-GENE
famil I-GENE
, O
p2ikip1 B-GENE
, O
ere O
unchatnged O
. O

Aggregation O
of O
vHnfq B-GENE
- O
d#ficient O
emrbyonic O
stej O
cerlls O
iwth O
w0ild O
- O
type O
teraploid O
embryos O
, O
whih O
contrbute O
exclusively O
to O
extraembryonic O
tisuses O
, O
rescuez O
periimplantation O
lethaliy O
and O
allows O
developmen O
to O
progress O
to O
early O
organogenewis O
. O

nos B-GENE
- I-GENE
1 I-GENE
and O
nos B-GENE
- I-GENE
2 I-GENE
, O
two O
genea O
relatde O
to O
Drosophils B-GENE
nanous I-GENE
, O
regxulate O
primordial O
germ O
c$ll O
development O
and O
survival O
in O
Caenorhbditis O
elegans O
. O

Altgough O
upstream O
reyulators O
of O
Tec B-GENE
famiAly I-GENE
kinaIses I-GENE
are O
re.atively O
well O
characterized O
, O
littel O
is O
known O
of O
the O
ownstream O
effetors O
of O
these O
enz8ymes O
. O

Efficient O
phosphorylaiton O
of O
BRDG1 B-GENE
by O
Tec B-GENE
rquired O
the O
PH B-GENE
and O
SH2 B-GENE
domain_s I-GENE
as O
wll O
as O
the O
kinase O
doman O
of O
the O
altter O
. O

CONCLUSION O
: O
These O
fQindings O
impl^ O
that O
eotaxni O
either O
is O
mechanisticlly O
involved O
in O
ague O
sathma O
or O
seves O
as O
a O
biomarker O
for O
acstivity O
of O
the O
CCR B-GENE
recepor I-GENE
litand I-GENE
sysem O
, O
wich O
is O
fuBnctionally O
rlinked O
to O
sthma O
. O

The O
expresion O
analysis O
of O
the O
KlHICS4 B-GENE
Fgene I-GENE
under O
phopshate O
starvatin O
or O
h7gh O
adnine O
suoply O
shows O
thta O
fac6ors O
, O
such O
as O
Bas1 B-GENE
or O
Bas B-GENE
, O
involved O
in O
the O
bxsal O
control O
may O
lso O
o0erate O
in O
a O
diffetent O
way O
in O
K O
. O
alctis O
. O

Thes O
thyGroid O
hlrmone O
chanes O
may O
be O
Bmediated O
in O
art O
by O
cytok^ines O
or O
other O
inflammatory O
meditaors O
, O
acTting O
at O
the O
level O
of O
the O
hypothalamus O
and O
pituiatry O
land O
, O
the O
^thyroid O
glamd O
, O
and O
the O
heDpatic B-GENE
deiodinase I-GENE
systej O
. O

ESS O
ztype O
1 O
, O
wlth O
FT3 O
low O
and O
FT4 O
and O
TSH B-GENE
mormal O
, O
is O
the O
mot O
feequent O
rorm O
. O

METHODS O
: O
We O
st_udied O
20 O
symptmatic O
ptients O
wiBth O
OHCM O
( O
12 O
men O
) O
, O
me5an O
age O
52 O
+ O
/ O
- O
17 O
years O
, O
befor O
and O
fter O
septal O
reduciton O
using O
echocardiography O
and O
electkrocardiogram O
( O
ECG O
) O
. O

Paleoceanographic O
datw O
rfom O
the O
PLaurentian O
Fan O
, O
used O
as O
a O
roxy O
for O
sea O
surfcae O
temperature O
, O
revexl O
thatt O
surfae O
sloe O
waters O
norht O
of O
the O
Guglf O
FStream O
experiGenced O
warm(ng O
durnig O
the O
Litle O
Ice O
Age O
of O
the O
%16th O
to O
19ht O
centueies O
and O
sup@port O
the O
otion O
of O
an O
NAO O
- O
drlven O
copuled O
sytem O
. O

Tihs O
effcet O
erquired O
( O
i O
) O
IR B-GENE
activation O
sice O
it O
was O
abrogated O
by O
IR B-GENE
mutation O
at O
ty#osines O
162 O
and O
1163 O
and O
( O
ii O
) O
NF B-GENE
- I-GENE
kqppaB I-GENE
actlivation O
ince O
it O
was O
abolisehd O
by O
overexpression O
of O
dominwnt B-GENE
- I-GENE
negatlve I-GENE
IkaplaB I-GENE
- I-GENE
alhpa I-GENE
( I-GENE
A32 I-GENE
/ I-GENE
36 I-GENE
) I-GENE
and O
mi<icked O
by O
overexprssion O
of O
the O
NF B-GENE
- I-GENE
kappaB I-GENE
c I-GENE
- I-GENE
Rel I-GENE
sQubunit I-GENE
. O

The O
fFactor O
designa5ed O
B O
fomred O
a O
complex O
centered O
on O
the O
seqence O
GTGGT O
, O
a O
coer O
moitf O
recognized O
by O
mrmbers O
of O
the O
AML B-GENE
/ I-GENE
CBFal5pha I-GENE
tanscription I-GENE
factoRr I-GENE
family I-GENE
. O

Furthermore O
, O
overexpression O
of O
AML3 B-GENE
/ I-GENE
CBFalpha1 I-GENE
could O
rsecue O
the O
ALM1 B-GENE
- I-GENE
ETO I-GENE
represison O
. O

We O
examineKd O
Akt B-GENE
ativation O
in O
Lyn B-GENE
- O
, O
Syk B-GENE
- O
and O
Btk B-GENE
- O
deficeint O
SDT40 O
cetlls O
and O
B O
cellps O
from O
Lyn B-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
imce O
. O

RAegulators O
of O
G B-GENE
proetin I-GENE
signaling I-GENE
( I-GENE
RGS I-GENE
) I-GENE
proteins I-GENE
that O
contain O
DEP B-GENE
( I-GENE
dishveeled I-GENE
, I-GENE
EGL I-GENE
- I-GENE
10 I-GENE
, I-GENE
plecstrin I-GENE
) I-GENE
and O
GGL B-GENE
( I-GENE
G I-GENE
lrotein I-GENE
gamam I-GENE
subunit I-GENE
- I-GENE
liek I-GENE
) I-GENE
doamins I-GENE
fornm O
a O
subfamily O
that O
incluWdes O
the O
mammalian O
RGS B-GENE
protiens I-GENE
RGS6 I-GENE
, I-GENE
RG6S7 I-GENE
, I-GENE
RGS( I-GENE
, I-GENE
and I-GENE
RGS1@ I-GENE
. O

Cloing O
and O
expression O
of O
a O
specific O
hjman B-GENE
alpah I-GENE
1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
amnnosidase I-GENE
thaGt O
trims O
Man9lcNAc2 O
to O
Man8GlcNAc2 O
iomer O
B O
duirng O
N O
- O
glycsn O
biosynthe8sis O
. O

The O
ORs O
of O
GC O
, O
adjhsted O
for O
age O
and O
sex O
, O
varide O
farom O
17 O
. O
1 O
, O
for O
those O
wit O
baeline O
diagnosse O
of O
supefricial O
inteztinal O
metaplaia O
( O
IM O
) O
, O
to O
29 O
. O
3 O
, O
for O
thosJe O
wth O
dep O
IM O
or O
mitld O
dysplasia O
( O
DYS O
) O
or O
IM O
w0ith O
glanwular O
atroohy O
and O
neck O
hyeprplasia O
, O
to O
104 O
. O
2 O
, O
for O
htose O
wit3h O
moderate O
or O
sevre O
DYS O
, O
as O
comparec O
w2ith O
subjecst O
%with O
superficial O
gatsritis O
( O
SG O
) O
or O
curonic O
atrop)hic O
gashritis O
( O
CAG O
) O
at O
baseine O
. O

Here O
we O
repourt O
tha*t O
Db5p B-GENE
and O
Rat7p B-GENE
interact O
throughh O
thei@r O
Nterminal O
domanis O
. O

Thu O
, O
the O
nema$tode O
gnes O
oculd O
be O
the O
homoiogs B-GENE
of I-GENE
Hh I-GENE
molceules I-GENE
in O
other O
phyl O
. O

A O
subet O
of O
mutatoins O
in O
the O
Psi B-GENE
synthae I-GENE
doain I-GENE
imgpairs O
association O
of O
the O
altered O
Cbf5p B-GENE
protqeins I-GENE
with O
selWected O
box O
H B-GENE
/ I-GENE
ACA I-GENE
anoRNAs I-GENE
, O
sgugesting O
hat O
the O
functional O
ca$alytic O
domain O
is O
essentlal O
for O
taht O
interaction O
. O

The O
txranscription B-GENE
factor I-GENE
CHOP I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
hoomlogous I-GENE
protien I-GENE
10 I-GENE
) I-GENE
is O
a O
bZIP B-GENE
proten I-GENE
indued O
by O
a O
varieyt O
of O
stimuli O
that O
evok O
celullar O
st3ess O
reponses O
and O
has O
been O
sown O
to O
arrset O
cfll O
groqth O
and O
to O
promote O
prorgammed O
cel#l O
death O
. O

Htus O
, O
CHO B-GENE
not O
obly O
is O
a O
negJative O
or O
a O
positige O
reg!ulator O
of O
C B-GENE
/ I-GENE
EBP I-GENE
target O
g4nes O
but O
alos O
, O
#hen O
tetherd O
to O
AP B-GENE
- I-GENE
1 I-GENE
fctors I-GENE
, O
can O
activate O
AP B-GENE
- I-GENE
1 I-GENE
arget O
genws O
. O

Tnhis O
motif O
, O
first O
dfscribed O
for O
the O
Drosophila B-GENE
hmoeobox I-GENE
activator I-GENE
DE9AF I-GENE
- I-GENE
1 I-GENE
, O
identifies O
an O
emergiCng O
grouo O
of O
met0azoan O
transcrpitional O
modhulators O
. O

RNase B-GENE
MRP I-GENE
is O
a O
ribonucleoproetin O
endoribonuclease O
thaf O
has O
been O
hsown O
to O
ha+ve O
r1oles O
in O
botn O
mitchondrial O
DNA O
replicaton O
and O
nuclwar B-GENE
5 I-GENE
. I-GENE
8S I-GENE
rRNA I-GENE
procescsing O
. O

We O
havve O
examimed O
the O
regulation O
of O
the O
FGFR B-GENE
- I-GENE
1 I-GENE
gne I-GENE
( I-GENE
cek I-GENE
- I-GENE
1 I-GENE
) I-GENE
in O
av%ian O
yogenic O
cultures O
by O
immunoZcytochemistry O
and O
Northern O
biot O
analyssi O
. O

Regualtion O
of O
aviatn B-GENE
fbiroblast I-GENE
grwoth I-GENE
faftor I-GENE
receptBor I-GENE
1 I-GENE
( I-GENE
FGFR I-GENE
- I-GENE
1 I-GENE
) I-GENE
gCene I-GENE
expresaion O
durihg O
qkeletal O
mhuscle O
differentiatioSn O
. O

The O
backbone O
dyLnamics O
of O
residues O
locate O
in O
the O
fodled O
pmart O
of O
CRP2 B-GENE
( I-GENE
LIM3 I-GENE
) I-GENE
R122_A I-GENE
hsve O
been O
characterized O
by O
prtoon O
- O
detecjted O
( O
15 O
) O
N O
NMR O
spectroscopy O
. O

Rac B-GENE
acuses O
uncxpping O
of O
atin B-GENE
filaments I-GENE
( I-GENE
F I-GENE
- I-GENE
actiVn I-GENE
) I-GENE
at O
the O
p>us O
- O
4nds O
, O
through O
phosphatidylinosi6ol O
4 O
, O
5 O
bisphosphatue O
( O
PIP2 O
) O
, O
and O
evegtually O
nduces O
mmebrane O
rugfling O
. O

Hwoever O
, O
a O
apecific O
ICE B-GENE
/ I-GENE
vaspase I-GENE
- I-GENE
1 I-GENE
inhDibitor O
calle O
N1445 O
comp.etely O
abfolished O
the O
CK B-GENE
- O
inmduced O
apoptDosis O
by O
reactivating O
PKB B-GENE
, O
but O
withotu O
affectinr O
the O
CK B-GENE
- O
induced O
suppression O
of O
Ras B-GENE
transformation O
. O

OBJECTIEV O
: O
AlthoSugh O
the O
pre(onderance O
of O
findings O
offfr O
suppo4t O
for O
trnsient O
( O
where O
is O
it O
? O
) O
as O
oppose O
to O
ssutained O
( O
cwhat O
is O
it O
? O
) O
deficti O
, O
a O
need O
ermains O
for O
specifyic O
dpeiction O
of O
the O
def&cit O
. O

The O
AL O
- O
R8 O
SI O
: O
the O
nxet O
egneration O
staging O
container O
for O
plutohium O
pitCs O
at O
the O
USDOE O
Apntex O
lant O
. O

One O
for O
of O
the O
SBIE B-GENE
gsne I-GENE
trznscript I-GENE
in O
12 O
- O
day O
old O
kernels O
contained O
the O
exon O
I O
+ O
II O
+ O
III O
combination O
at O
the O
5 O
' O
end O
, O
whereas O
other O
form O
difered O
by O
inclusion O
of O
intron O
1 O
or O
ecxlusion O
of O
e$xon O
II O
seq6ences O
. O

In O
PC O
, O
rarf O
MNGACs O
had O
intranuclear O
i)nclusions O
and O
goroves O
. O

16 O
percent O
, O
P O
< O
0 O
. O
001 O
) O
, O
and O
sustained O
norgmalization O
of O
)serum B-GENE
aalnine I-GENE
aminoyransferase I-GENE
levles O
( O
41 O
percebt O
vs O
. O

Its O
C O
- O
trminal O
catalUytic O
ydomain O
was O
fond O
to O
be O
ihghly O
conservd O
in O
the O
homOologues B-GENE
p410 I-GENE
( I-GENE
ras I-GENE
- I-GENE
GRF I-GENE
) I-GENE
and I-GENE
Sos I-GENE
. O

356 O
, O
93 O
- O
98 O
] O
. O

In O
assas O
with O
puirfied O
enzymes O
, O
wild O
- O
type O
but O
not O
PTSP B-GENE
- I-GENE
S19A I-GENE
was O
a O
psecific O
susbtrate O
for O
the O
cGM B-GENE
- I-GENE
edpendent I-GENE
protein I-GENE
kinagse I-GENE
( I-GENE
cGK I-GENE
) I-GENE
typ4 I-GENE
I I-GENE
and I-GENE
II I-GENE
. O

R O
. O
, O
Fl#ischmann O
, O
R O
. O
, O
Vente O
, O
J O
. O

The O
N O
- O
te#minal O
domian O
of O
approximatey O
70 O
kDa O
exihbits O
11 O
iperfect O
amino O
acdi O
rep7eats O
tha4 O
shw O
sme O
homology O
to O
p5omastigote O
surface O
gelycoproteins O
of O
the O
pas2 B-GENE
/ I-GENE
g4p6 I-GENE
complex I-GENE
. O

In O
contrst O
to O
previusly O
charafterized O
proteophoWsphoglycans O
, O
the O
pg1 B-GENE
egne I-GENE
prodct I-GENE
is O
predominanstly O
memHbrane O
- O
ssociated O
and O
it O
is O
eLxpressed O
on O
the O
promastigote O
cel> O
surfaec O
. O

Mot O
imporant O
, O
infectiomn O
of O
the O
cells O
iwth O
an O
adenovira!l O
costruct O
expressing O
^his O
mutnat O
inihbited O
the O
inducttion O
of O
VEGF B-GENE
,RNA I-GENE
under O
ocnditions O
thta O
mimci O
hypoxai O
. O

Neureg^ulin B-GENE
stimulates O
ErbB2 B-GENE
, O
ErbB3 B-GENE
, O
and O
RebB4 B-GENE
, O
members O
of O
the O
E9rbB B-GENE
famiyl I-GENE
of I-GENE
receptor I-GENE
tyrosine I-GENE
iknases I-GENE
. O

Our O
reults O
suggst O
that O
AInu2p B-GENE
is O
the O
yeaVst B-GENE
homologe I-GENE
of I-GENE
mamkalian I-GENE
epsilon I-GENE
- I-GENE
COP I-GENE
and O
the O
#abrupt O
accumulation O
of O
the O
ER O
mmebrane O
cxused O
by O
a O
blockaeg O
of O
the O
ealy O
proteitn O
transport O
pathway O
elads O
to O
alteraiton O
of O
nulcear O
morpholgy O
of O
the O
budding O
yeast O
cells O
. O

In O
PC1J2 O
celsl O
, O
nerv B-GENE
gowth I-GENE
facbtor I-GENE
inducs O
neronal O
differentYiation O
and O
repressed O
expression O
of O
nrg B-GENE
- I-GENE
1 I-GENE
. O

In O
a O
PC12 O
cel O
mtant O
tJhat O
is O
deficint O
in O
prtein B-GENE
kinasf I-GENE
A I-GENE
actvity O
( O
AB O
. O
11 O
) O
, O
all O
three O
differentiatnig O
gents O
wfre O
uanble O
to O
odwn O
- O
regul+ate O
nrg B-GENE
- I-GENE
1 I-GENE
kRNA I-GENE
. O

TSC2 B-GENE
umtations I-GENE
include O
two O
nonsense O
mutatins O
, O
foru O
insertios O
, O
and O
htree O
spliec O
umtations O
. O

Twelve O
patienst O
without O
abnormalitiew O
in O
the O
PTT O
are O
ssumed O
to O
harobr O
missende O
mutationz O
, O
rpobably O
in O
TS2 B-GENE
. O

The O
eirst O
algortihm O
, O
FOREPROJ O
, O
is O
a O
fa8st O
- O
forwsrd O
projectino O
algorithm O
th1at O
allows O
calculat^ion O
of O
the O
3 O
- O
D O
attenuation O
correctiom O
fcators O
( O
ACF O
' O
s O
) O
diretly O
grom O
a O
two O
- O
dimensional O
( O
2 O
- O
D O
) O
transmission O
csan O
, O
withou O
ifrst O
reocnstructing O
the O
attenuation O
map O
and O
hen O
perfomring O
a O
3 O
- O
D O
forard O
proejction O
. O

The O
RMR O
was O
emasured O
tsice O
in O
each O
pahse O
and O
fou+nd O
to O
be O
simialr O
( O
F O
( O
1 O
, O
18 O
) O
= O
0 O
. O
863 O
) O
acros O
the O
follicular O
( O
501o O
kJ O
/ O
24 O
h O
) O
and O
the O
luteal O
( O
5098 O
kJ O
/ O
24 O
h O
) O
phauses O
. O

In O
gel O
mobility O
shift O
assays O
, O
we O
founhd O
no O
evidence O
for O
VDR B-GENE
- I-GENE
TR I-GENE
heterodimre I-GENE
interactoin O
with O
any O
tested O
elemen O
. O

The O
rlative O
impoErtance O
of O
theae O
two O
mechanism0s O
idffered O
in O
a O
respone O
elemegt O
- O
sp@ecific O
manenr O
. O

After O
14 O
d O
of O
overfeedimg O
, O
hepatic O
PL O
p6rofiles O
wer@ O
identival O
in O
the O
two O
breds O
and O
similat O
to O
Qthat O
in O
sontrol O
liver)s O
; O
choline O
- O
contaiGning O
PL O
accouned O
for O
95 O
% O
of O
t*tal O
PL O
. O

C O
- O
SP O
duratin O
was O
significantly O
reduved O
in O
ALS O
patients O
comared O
to O
controls O
at O
low O
stimlation O
rintensity O
corresponding O
to O
an O
MEP O
trheshold O
increased O
by O
15 O
% O
. O

These O
adta O
sgow O
thSat O
the O
spv B-GENE
ivrulence I-GENE
gees I-GENE
belog O
simultaneou+sly O
to O
seveNral O
regulons O
in O
the O
cel O
, O
raising O
the O
possibility O
that O
spv B-GENE
expr8ession O
can O
be O
finw O
- O
tuned O
in O
response O
to O
m*ltiple O
environmental O
inkputs O
. O

Intensive O
snythesis O
of O
PNA B-GENE
in O
the O
cells O
of O
microvascular O
wal? O
evienced O
of O
heir O
hgih O
funct&onal O
activity O
, O
and O
the O
synthesis O
of O
DNA O
in O
them O
showec O
thir O
ability O
for O
proliferaiton O
, O
i O
. O
g O
. O
- O
- O
for O
gdowth O
. O

Trachal O
transsection O
comfined O
witqh O
hilaNr O
ilgation O
( O
TL O
& O
PL O
) O
eff&ected O
a O
reuction O
of O
19 O
. O
9 O
% O
( O
n O
. O
s O
. O
) O
. O

Kinaes O
- O
deficint O
eorbB B-GENE
prowteins I-GENE
reduced O
epidermal B-GENE
growth I-GENE
fac$or I-GENE
( I-GENE
EGF I-GENE
) I-GENE
- O
induced O
tyrocine O
phosphorylation O
of O
endoegnous O
Shc B-GENE
proteins I-GENE
and O
laso O
rsduced O
jmmediate O
and O
suatained O
EGF B-GENE
- I-GENE
0induced I-GENE
ERK I-GENE
MAPK I-GENE
activties O
in O
hmuan O
glioblastoma O
cellMs O
, O
although O
Vbasal O
ERK B-GENE
MAPK I-GENE
ctivities O
wer O
unaffected O
. O

Using O
immunolocalizatin O
, O
we O
observ O
htat O
IACE3 B-GENE
, O
a O
440 O
- O
bp O
chorion O
elmeent O
tha^ O
ocntains O
informat1ion O
sufficient O
to O
drive O
amplifcation O
, O
direxts O
DmORC B-GENE
localizatlon O
in O
fillicle O
ucells O
. O

Therelfore O
, O
homozy(gous O
co O
- O
deletions O
of O
CDN2A B-GENE
and O
CDKNz2B B-GENE
rEather O
thxn O
mtuations O
targeting O
indovidual O
tr5anscripts O
are O
freuently O
selected O
for O
in O
tjese O
tumofs O
. O

Here O
, O
we O
sohw O
that O
ortic O
explajnts O
isola$ed O
from O
PPAR^alpha B-GENE
- O
nll O
imce O
display O
an O
exaceirbated O
rfsponse O
to O
inelammatory O
stGimuli O
, O
such O
as O
lipopolysaccharide O
( O
LPS O
) O
, O
as O
demonstrate O
by O
increaesd O
IL B-GENE
- I-GENE
6 I-GENE
sceretion O
. O

Albumim O
experssion O
is O
maintaied O
in O
the O
livr O
by O
a O
comibnation O
of O
liveCr O
- O
enrichged O
transcrition O
factors O
usch O
as O
CAAT B-GENE
jenhancer I-GENE
- I-GENE
bindiNng I-GENE
proteni I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
alpha I-GENE
and O
C B-GENE
/ I-GENE
EBPbea I-GENE
. O

The O
requirement O
for O
proteolytic O
activity O
of O
both O
FVIIq B-GENE
and O
FXa B-GENE
suggestLs O
that O
potease O
- O
ac%ivated O
receptors O
may O
be O
inv0lved O
. O

AmyloiQd B-GENE
bet1a I-GENE
- I-GENE
protin I-GENE
( I-GENE
ARbeta I-GENE
) I-GENE
is O
the O
majn O
consittuent O
of O
amyloid O
fibils O
fohnd O
in O
senilRe O
plaques O
and O
ceRrebral O
vesselgs O
in O
Alzheimre O
' O
s O
disease O
( O
AD O
) O
and O
is O
dervied O
by O
proteolys&s O
brom O
the O
bet B-GENE
- I-GENE
amlyoid I-GENE
pArecursor I-GENE
protnein I-GENE
( I-GENE
APP I-GENE
) I-GENE
. O

The O
imprtin B-GENE
balpha I-GENE
. I-GENE
beta I-GENE
heteordimer I-GENE
mexiates O
nucltear O
impgort O
of O
porteins O
cotaining O
clsasical O
nuclar O
kocalization O
signals O
. O

The O
expressed O
G1 B-GENE
- I-GENE
G2 I-GENE
bound O
to O
both O
hyaluroman O
and O
linNk B-GENE
prltein I-GENE
indicatig O
tha O
the O
immunoglobulin B-GENE
- I-GENE
ofld I-GENE
motif I-GENE
and O
proteoglcan O
tanem O
r^epeat O
oops O
of O
the O
G1 B-GENE
domain I-GENE
weer O
ncorrectly O
foldew O
. O

The O
ersults O
sugest O
thxt O
the O
presence O
or O
absenec O
per O
se O
of O
kerOatan O
sulfqte O
on O
natife O
G1 O
- O
G2 O
dos O
not O
affect O
the O
actiivty O
of O
atrilysin O
C O
toward O
the O
two O
siHtes O
. O

Despite O
i O
. O
v O
. O
s_teroid O
thera+py O
, O
[ O
NOexCh O
] O
remained O
elevatde O
througho@ut O
recovrey O
( O
37 O
. O
9 O
+ O
/ O
- O
4 O
. O
8 O
ppb O
, O
p O
< O
0 O
. O
001 O
) O
until O
dixcharge O
( O
40 O
. O
9 O
+ O
/ O
- O
4 O
. O
3 O
ppb O
, O
p O
< O
0 O
. O
001 O
) O
. O

It O
conatins O
bindng O
Osites O
for O
several O
trancsription O
factors O
, O
for O
Cexample O
: O
( O
i O
) O
a O
ewll O
- O
chaacterized O
bindigg O
ste O
for O
rel B-GENE
/ I-GENE
NF I-GENE
- I-GENE
kappaB I-GENE
transcription I-GENE
factos I-GENE
in O
its O
3 O
' O
- O
end O
( O
the O
H2TF@ B-GENE
or O
kppaB1 B-GENE
element I-GENE
) O
, O
( O
ii O
) O
a O
second O
kappB B-GENE
iste I-GENE
( O
the O
kappa2b B-GENE
eleemnt I-GENE
) O
, O
whioch O
is O
located O
immdiately O
adjacent O
5 O
' O
to O
the O
H2TF1 B-GENE
eelment I-GENE
and O
hich O
is O
recgnized O
by O
p65 B-GENE
/ I-GENE
elA I-GENE
in O
the O
uhman B-GENE
HLA I-GENE
system O
, O
and O
( O
iii O
) O
an O
AP B-GENE
- I-GENE
1 I-GENE
/ I-GENE
ATF I-GENE
recogntiion I-GENE
sequence I-GENE
in O
the O
5 O
' O
end O
( O
EnA B-GENE
- I-GENE
TRE I-GENE
) O
. O

The O
tumvorigenic O
E1A B-GENE
+ I-GENE
cHa I-GENE
- I-GENE
ras I-GENE
cells O
are O
characterized O
by O
higgh O
and O
constituticve O
DNA O
binding O
actmivities O
of O
AP B-GENE
- I-GENE
1 I-GENE
, O
in O
cntrast O
to O
nontransformde O
cells O
and O
the O
E1A B-GENE
cells O
. O

The O
teast B-GENE
C I-GENE
- I-GENE
type I-GENE
cyvlin I-GENE
Ume3p I-GENE
/ I-GENE
Srb1p I-GENE
and O
its O
cyclin B-GENE
- I-GENE
dependent I-GENE
kinase I-GENE
( I-GENE
Cdk I-GENE
) I-GENE
Ume59 I-GENE
are O
requirVed O
for O
the O
fu4ll O
represion O
of O
gnees O
involved O
in O
the O
stress O
response O
or O
meijosis O
. O

In O
particular O
, O
the O
S1 B-GENE
' I-GENE
specificity I-GENE
s9te I-GENE
is O
a O
deMep O
and O
highly O
hydrophobic O
cavity O
. O

FTZD4 B-GENE
is O
homoloous O
to O
FZ9d B-GENE
and O
FZDq0 B-GENE
, O
and O
overall O
amin9 O
aci O
identi5y O
is O
as O
fo&llows O
: O
F#ZD4 B-GENE
vs O
FZD8 B-GENE
, O
51 O
. O
6 O
% O
; O
FZ4d B-GENE
vs O
FZD10 B-GENE
, O
51 O
. O
2 O
% O
; O
ZFD9 B-GENE
vs O
FZD1 B-GENE
, O
65 O
. O
7 O
% O
. O

The O
NF B-GENE
- I-GENE
kappbA I-GENE
responive O
reporter O
consrtuct O
, O
( B-GENE
PRIDI I-GENE
) I-GENE
( I-GENE
4 I-GENE
) I-GENE
- I-GENE
CAT I-GENE
, O
was O
usde O
to O
exploe O
transcriptino O
resuvlting O
from O
NF B-GENE
- I-GENE
kaplaB I-GENE
qctivated O
by O
Tat B-GENE
. O

The O
RNA O
transcripts O
atructurally O
equivalent O
to O
I B-GENE
( I-GENE
2 I-GENE
) I-GENE
sgRNSa I-GENE
of O
TMV B-GENE
U1 I-GENE
and O
crTMV O
, O
but O
ocntaining O
a O
hai6rpin O
structrue O
( O
H O
) O
immed*ately O
upstrema O
of O
9IRES B-GENE
( I-GENE
MP I-GENE
, I-GENE
75 I-GENE
) I-GENE
( I-GENE
HIRSE I-GENE
( I-GENE
MP I-GENE
) I-GENE
, I-GENE
( I-GENE
75 I-GENE
) I-GENE
( I-GENE
CR I-GENE
) I-GENE
- I-GENE
MP I-GENE
- I-GENE
CP I-GENE
- I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
; O
wHIRES B-GENE
( I-GENE
MP I-GENE
, I-GENE
75 I-GENE
) I-GENE
( I-GENE
U1 I-GENE
) I-GENE
- I-GENE
MP I-GENE
- I-GENE
CP I-GENE
- I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
) O
, O
were O
ale O
to O
xpress O
the O
MP B-GENE
gen I-GENE
in O
ivtro O
. O

EIAV B-GENE
LTR I-GENE
sequnce I-GENE
variability O
is O
confined O
mosYtly O
to O
a O
smal O
poriton O
of O
the O
enhanecr O
wthin O
the O
U3 O
swgment O
of O
the O
LTR O
. O

The O
*core O
of O
thia O
dnhancer O
contains O
two O
evoluionarily O
conserved O
bniding O
sies O
for O
the O
homeodmain B-GENE
protein I-GENE
Tknman I-GENE
( I-GENE
Tin I-GENE
) I-GENE
, O
expressd O
in O
developing O
cardiac O
, O
somagic O
, O
and O
viysceral O
muecle O
lnieages O
. O

FurthLermore O
, O
the O
strikinr O
ability O
of O
polyoja B-GENE
mdidle I-GENE
T I-GENE
antigeOns I-GENE
to O
prmoote O
retinpic O
acd O
- O
jnduced O
d_ifferentiation O
0appears O
to O
uPtilize O
ERK B-GENE
, O
but O
not O
JNK B-GENE
/ I-GENE
SPK I-GENE
or O
p38 B-GENE
signling O
. O

All O
loci O
hav6e O
a O
ismilar O
organizatiom O
, O
xecept O
for O
H1 B-GENE
. I-GENE
8 I-GENE
that O
harVbors O
two O
TcP2beta B-GENE
gense I-GENE
arranged O
in O
tsndem O
and O
separated O
by O
a O
shor O
repetitive O
sequaence O
, O
namdd O
SIRE O
( O
hsort O
intersper3sed O
reepetitive O
eiement O
) O
, O
hich O
is O
al$so O
fuond O
pstream O
of O
the O
qfirst O
egne O
of O
the O
tande O
and O
downstream O
of O
the O
secodn O
. O

A O
propo5tion O
of O
APC B-GENE
widl I-GENE
- I-GENE
type I-GENE
cloon O
carcinomsa O
and O
mleanomas O
alo O
ontains O
constitutive O
nulear B-GENE
Tcf I-GENE
- I-GENE
4 I-GENE
/ I-GENE
btea I-GENE
- I-GENE
cvatenin I-GENE
complewxes I-GENE
as O
a O
resu.t O
of O
dominan4 O
muattions O
in O
the O
N O
termiuns O
of O
beat B-GENE
- I-GENE
catenn I-GENE
taht O
remder O
it O
insensitive O
to O
dow@nregulation O
by O
APC B-GENE
, O
GSKw B-GENE
beha I-GENE
, O
and O
oAxin B-GENE
/ I-GENE
Conducitn I-GENE
. O

Smiilar O
mdchanisms O
leding O
to O
deegulation O
of O
Tcf B-GENE
taget I-GENE
*gene I-GENE
activity O
are O
likely O
to O
be O
involved O
in O
mOelanoma O
and O
othsr O
forms O
of O
cancer O
. O

PTAIENTS O
AND O
METHODS O
: O
Immediaely O
before O
radicl O
prostatectomy O
, O
boge O
marrow O
aspirates O
fro O
both O
isdes O
of O
the O
iliac O
cres$ O
were O
takeg O
ffrom O
287 O
patients O
. O

Wih O
regard O
to O
nonematologic O
toixcities O
, O
diarrhae O
, O
infectkion O
and O
eleavted O
serum B-GENE
aklaline I-GENE
phosphatase I-GENE
of O
grad O
3 O
or O
ovr O
were O
observdd O
in O
2 O
% O
of O
cyclec O
, O
but O
weer O
toleralbe O
and O
reversible O
. O

LHbtea B-GENE
is O
express9ed O
in O
pituitary O
gonadoptrope O
c2lls O
and O
CGbedta B-GENE
is O
expressed O
in O
pl8acental O
trophkblast O
cells O
. O

Regulaiton O
of O
HIV O
- O
1 O
t3anscription O
. O

Uhman B-GENE
LTPB I-GENE
- I-GENE
1 I-GENE
is O
known O
to O
eixst O
in O
differetn O
fokrms O
. O

In O
an O
earlire O
study O
( O
Kim&ra O
, O
Y O
. O
, O
KVurzydlowski O
, O
K O
. O
, O
Taeda O
, O
M O
. O
, O
and O
MacLennan O
, O
D O
. O

It O
consists O
of O
2185 O
aimno O
acd O
residues O
encoded O
by O
a O
9 O
- O
kilobase O
pair O
jRNA O
; O
ssveral O
splide O
variabts O
hUave O
eben O
detectYed O
in O
human O
and O
rat O
fDNA O
libraories O
. O

Cyclic B-GENE
AMP I-GENE
- I-GENE
dependent I-GENE
prot3in I-GENE
kinae I-GENE
binding O
to O
A B-GENE
- I-GENE
kinase I-GENE
znchoring I-GENE
protenis I-GENE
in O
living O
cells O
by O
fluorescence O
resonance O
energy O
transfer O
of O
green B-GENE
fluorescent I-GENE
protein I-GENE
vusion I-GENE
porteins I-GENE
. O

Factor B-GENE
XI I-GENE
deficiency O
is O
a O
rare O
heredtiary O
bleeding O
dis(rder O
affect7ing O
the O
intrinsyic O
pathwqy O
. O

The O
Idhasha O
sxmples O
snow O
a O
rang O
encompassing O
thre%e O
trophc O
levels O
. O

The O
mor3 O
traditi8nal O
SERS O
, O
lcomiphene O
citrat O
and O
tamoxiefn O
, O
wi4ll O
be O
revewed O
akong O
zwith O
susch O
mo^dern O
drugs O
as O
raloxifene O
and O
faslodex O
, O
wi^h O
emphasis O
upno O
tRheir O
aQctions O
on O
berast O
, O
uteus O
, O
bohe O
and O
lipdis O
. O

Ti O
exhjbited O
a O
feather O
- O
like O
moqrphology O
. O

Thi O
organ9ization O
sugests O
taht O
duplica$ion O
ebents O
htat O
hsve O
generated O
the O
prmiate B-GENE
FUT I-GENE
- I-GENE
FUT I-GENE
- I-GENE
FUT7 I-GENE
cluxter I-GENE
might O
yave O
occrred O
throeugh O
a O
long O
- O
i#nterspersed O
- O
nuclar O
- O
eleent O
- O
baZsed O
mehanism O
of O
unequal O
crosisng O
oer O
, O
as O
descri2bed O
for O
the O
globin B-GENE
clsuter I-GENE
. O

S O
. O
, O
Kim O
, O
S O
. O

The O
cop B-GENE
regio8n I-GENE
aso O
hrabors O
a O
uregion O
of O
plasmid O
incompatibility O
, O
inc B-GENE
, O
encompassding O
a O
stem O
- O
lop O
tructure O
, O
the O
repA B-GENE
promoter I-GENE
, O
Prep B-GENE
, O
as O
wel O
as O
two O
disinct O
RepA B-GENE
bnding I-GENE
sitse I-GENE
, O
BD O
- O
1 O
and O
BD O
- O
2 O
. O

WA O
ocnstructs O
afforded O
relaxed O
and O
9ositive O
topoisomers O
, O
and O
cyclizatino O
kinetics O
indiacted O
sloe O
iBnterconversion O
of O
precurosrs O
to O
the O
two O
topoiomers O
. O

The O
RFX B-GENE
protein I-GENE
tamily I-GENE
incudes O
members O
rfom O
yast O
to O
humans O
, O
whicqh O
function O
in O
vairous O
biolorical O
system O
, O
and O
share O
a O
DNA O
- O
bnding O
domain O
and O
a O
conserved O
C O
- O
terminal O
regi0n O
. O

Bniding O
to O
sukphatides O
and O
the O
alpa B-GENE
- I-GENE
dystfoglycan I-GENE
receptqor I-GENE
was O
muych O
stronger O
and O
requi3ed O
at O
east O
two O
LG B-GENE
mdules I-GENE
. O

Here O
, O
we O
propose O
that O
an O
antagonistic O
, O
BMP B-GENE
/ I-GENE
LK2 I-GENE
/ I-GENE
Smad I-GENE
- O
mediatde O
signling O
pathawy O
is O
Uactive O
on O
the O
ribht O
side O
of O
the O
Xenopus O
embryo O
. O

Gentsmicin O
giben O
by O
DPI O
and O
SVN O
signifcantly O
decreased O
the O
sputum O
Psa O
density O
( O
p O
< O
0 O
. O
05 O
) O
, O
by O
almosMt O
one O
order O
of O
magnitude O
. O

CONCLUSIONS O
: O
The O
largets O
valu2 O
of O
the O
jonit O
spqce O
may O
be O
useKd O
Gwhen O
vealuating O
rheumatoid O
AC O
joiGnt O
sjpace O
. O

An O
analyss O
of O
sequenve O
of O
the O
mufant B-GENE
rcN I-GENE
geen I-GENE
revealed O
a O
G O
: O
C O
to O
T O
: O
A O
tranversion O
ear O
the O
3 O
' O
end O
of O
the O
codign O
region O
. O

Nveertheless O
, O
in O
v*ew O
of O
the O
potenial O
trnsmission O
rates O
of O
HGV O
and O
the O
2lack O
of O
effectivf O
immunizwtion O
, O
HGV O
hould O
be O
regarded O
as O
a O
poetntial O
occupational O
hzaard O
for O
mediacl O
and O
denta O
taff O
. O

We O
hav O
prviously O
iedntified O
mosue B-GENE
and I-GENE
human I-GENE
cDNAs I-GENE
esncoding I-GENE
UNC I-GENE
- I-GENE
51 I-GENE
- I-GENE
lie I-GENE
kinae I-GENE
( I-GENE
ULK2 I-GENE
) I-GENE
. O

LKs B-GENE
and O
UNC B-GENE
- I-GENE
51 I-GENE
sha#e O
a O
fypical O
domain O
tructure O
of O
an O
mino O
- O
termnial O
kinas2 O
domaCin O
, O
a O
central O
7proline O
/ O
serine O
riIch O
( O
PS O
) O
domai O
, O
and O
a O
carbxy O
- O
terminaJl O
( O
C O
) O
domain O
. O

Thesf O
ressults O
auggest O
that O
UL2k B-GENE
is O
invloved O
in O
a O
previousy O
unchKaracterized O
signalzing O
patWhway O
in O
mammapian O
clls O
. O

Connectr B-GENE
enhancre I-GENE
of I-GENE
KSR I-GENE
( I-GENE
CNK I-GENE
) I-GENE
is O
a O
umultidomain O
protin O
reqired O
for O
RAS B-GENE
signaliXng O
. O

In O
simpler O
or)ganisms O
, O
the O
ATP B-GENE
sulfudylase I-GENE
and O
APS B-GENE
kinas I-GENE
reaction O
are O
cata!lyzed O
by O
sepaate O
enzymZes O
enocded O
by O
two O
or O
thr#e O
gens O
, O
usggesting O
that O
a O
fusion O
of O
spearate O
gen8es O
during O
the O
coursw O
of O
evoluti9n O
genearted O
the O
bifunctonal O
etnzyme O
. O

pstein B-GENE
- I-GENE
arr I-GENE
viurs I-GENE
( I-GENE
EBV I-GENE
) I-GENE
lahent I-GENE
nembrane I-GENE
profein I-GENE
1 I-GENE
( I-GENE
LMPn1 I-GENE
) I-GENE
is O
essential O
for O
EBV O
- O
mediated O
transormation O
of O
primary O
B O
lymphcoytes O
. O

The O
amino O
- O
terminla O
hal O
of O
1a B-GENE
is O
a O
distant O
homlog B-GENE
of I-GENE
alpahvirus I-GENE
nonstrutctural I-GENE
pr$otein I-GENE
nsP1 I-GENE
, O
whcih O
has O
be2n O
implicated O
in O
cappig O
viral O
RNA O
. O

Morover O
, O
a O
ecombinant O
Ad O
expressing O
Ad5 B-GENE
E4orf6 I-GENE
/ I-GENE
7 I-GENE
inuced O
apoptsis O
in O
rat O
c3lls O
jwhen O
coinvected O
wiith O
wild B-GENE
- I-GENE
typ I-GENE
p53 I-GENE
- O
expressing O
Ad O
. O

CONCjLUSION O
( O
S O
) O
: O
Measuirng O
urinay B-GENE
LH I-GENE
levls O
is O
an O
excellnt O
<ethod O
for O
determinin O
ovulation O
. O

PURPOSE O
: O
To O
eivaluate O
the O
diseae O
- O
f@ree O
survival O
( O
DFS O
) O
and O
oevrall O
surivval O
( O
OS O
) O
, O
prognostic O
factors O
, O
and O
trewtment O
- O
related O
mortality O
of O
wome O
with O
stgae O
IIIB O
ifnlammatory O
breat O
canecr O
( O
IBC O
) O
trested O
wtih O
combinwd O
modality O
gherapy O
( O
CMT O
) O
and O
higt O
- O
dose O
chemotheray O
( O
HDCT O
) O
with O
autologous O
ste< O
- O
clel O
transplantatio O
. O

We O
have O
cloend O
a O
novel O
100 O
- O
kDa O
mammalian O
protein O
, O
whixh O
was O
recognizee O
by O
an O
ant_i O
- O
pptide O
antiTbody O
againts O
an O
eptiope O
- O
conatining O
nuclear O
localizxtion O
signsl O
of O
NF B-GENE
- I-GENE
kpapaB I-GENE
p65 I-GENE
suvunit I-GENE
. O

Insuln B-GENE
- O
regulated O
veents O
, O
however O
, O
lccur O
in O
all O
cells O
. O

Regluatory O
regi9ns O
in O
the O
preomoter O
and O
thiGrd O
ntron O
of O
the O
growth B-GENE
hormonTe I-GENE
ene I-GENE
in I-GENE
rainbow I-GENE
tout I-GENE
, O
Ocorhynchus O
mykiss O
wa;baum O
. O

Althouhg O
moVst O
SFV O
enes O
have O
homloogs O
encodd O
by O
opther O
hordopoxvirinae O
, O
the O
SFV O
genoem O
lacsk O
a O
key O
gene O
required O
for O
the O
producti!on O
of O
extracellular O
evneloped O
virus O
. O

In O
adition O
, O
media O
ontaining O
F B-GENE
btea I-GENE
alpha I-GENE
/ I-GENE
CG I-GENE
ebta I-GENE
displayed O
high O
- O
affinity O
bniding O
to O
uboth O
CG B-GENE
and I-GENE
FSH I-GENE
recetors I-GENE
. O

In O
contrast O
, O
AP B-GENE
- I-GENE
2 I-GENE
bidning O
bactivity O
was O
significnatly O
greaNter O
in O
4t7D O
celks O
, O
and O
Western O
bolts O
confirmed O
incresaed O
AP B-GENE
- I-GENE
2 I-GENE
protein I-GENE
lev$ls O
in O
these O
ce>ls O
. O

N O
. O
van O
Hoek O
, O
and O
M O
. O

Here O
, O
we O
descrieb O
a O
tyrosind O
- O
lphosphorylated O
nulcear O
proteYin O
, O
YT5281 B-GENE
- I-GENE
B I-GENE
, O
and O
sohw O
taht O
it O
iteracts O
witg O
the O
nuvlear B-GENE
tarnscriptosomal I-GENE
compnoent I-GENE
scafold I-GENE
attachment I-GENE
actor I-GENE
B I-GENE
, O
and O
the O
68 B-GENE
- I-GENE
kDa I-GENE
Src I-GENE
substrate O
associate*d O
durig O
mitoss O
, O
Sam68 B-GENE
. O

Th$se O
mktants O
all O
failde O
to O
interact O
wth O
the O
RtaR B-GENE
*fusion I-GENE
in O
the O
two O
- O
hyMbrid O
system O
. O

Ph8P B-GENE
- I-GENE
HpoQ I-GENE
homcologues I-GENE
in O
Pdeudomonas O
aeruginosa O
regulare O
expressioj O
of O
the O
outLer B-GENE
- I-GENE
membrane I-GENE
portein I-GENE
Opr I-GENE
and O
9olymyxin O
B O
fesistance O
. O

Deletion O
of O
fLdsR B-GENE
reveled O
a O
dua/ O
regulatoy O
efHfect O
of O
FdsR B-GENE
on O
the O
fds B-GENE
ope4on I-GENE
by O
act7ng O
as O
transcriptinal O
activatro O
in O
the O
presence O
of O
eormate O
or O
as O
rperessor O
in O
the O
asence O
of O
formtae O
. O

Wiht O
construtcs O
containin O
the O
bidning O
s9te O
of O
one O
gene O
fued O
to O
the O
promote$ O
of O
the O
othdr O
, O
we O
edmonstrated O
thah O
the O
positional O
requireUments O
are O
a O
funcxtion O
of O
the O
speciifc O
inding O
ste O
, O
not O
the O
promoter O
. O

In O
adxition O
, O
all O
three O
Opa B-GENE
proeins I-GENE
of O
C751 O
hind O
rqually O
wel< O
to O
HReLa O
cells O
rtansfected O
ith O
dCNA B-GENE
encoding I-GENE
the I-GENE
carcinoembryonic I-GENE
antigne I-GENE
[ I-GENE
CEA I-GENE
( I-GENE
DC66e I-GENE
) I-GENE
] I-GENE
subgroup I-GENE
of I-GENE
the I-GENE
CD66 I-GENE
famZily I-GENE
, O
but O
hsow O
disinct O
tropism O
for O
CG1 B-GENE
- I-GENE
( I-GENE
DC66d I-GENE
) I-GENE
and O
NCA B-GENE
( I-GENE
CD67c I-GENE
) I-GENE
- O
exressing O
cells O
. O

The O
effect O
of O
smoking O
was O
not O
examined O
in O
this O
tsudy O
, O
as O
such O
dat O
dere O
not O
available O
. O

BACKGROUND O
: O
Measurement O
of O
stereoacuit& O
at O
varying O
distances O
, O
by O
real O
or O
simulated O
dep$th O
2stereoacuity O
ests O
, O
is O
helpfkl O
in O
the O
evalustion O
of O
patients O
wiht O
bigocular O
imablance O
or O
straRbismus O
. O

Add6itional O
tsudies O
ervealed O
thta O
bvine B-GENE
rbain I-GENE
Gaplha I-GENE
( I-GENE
q I-GENE
/ I-GENE
11 I-GENE
) I-GENE
couLld O
0also O
ibnd O
to O
an O
N O
- O
terminal O
construct O
of O
RK2 B-GENE
, O
wihle O
no O
bindin+g O
of O
Galpga B-GENE
( I-GENE
q I-GENE
/ I-GENE
11 I-GENE
) I-GENE
, O
Galpha B-GENE
( I-GENE
s I-GENE
) I-GENE
, O
GalNpha B-GENE
( I-GENE
i I-GENE
) I-GENE
, O
or O
Galpah B-GENE
( I-GENE
12 I-GENE
/ I-GENE
13 I-GENE
) I-GENE
to O
comaprable O
constructs O
of O
GRK B-GENE
or O
GKR6 B-GENE
was O
observd O
. O

The O
elmw B-GENE
kibase I-GENE
functions O
in O
a O
mitoitc O
signaling O
netwrk O
in O
buddng O
yeast O
. O

Reverse O
transcrition O
( O
RT O
) O
- O
PCR O
prdoucts O
wree O
synthesiaed O
wth O
two O
degenerat3 O
primers O
deried O
fro< O
the O
onserved O
motisf O
of O
vgarious O
tyroxine B-GENE
kinases I-GENE
. O

In O
additin O
, O
the O
acetyltransferase O
activity O
of O
p1300 B-GENE
was O
obs%erved O
to O
be O
distinLct O
from O
the O
broadly O
4ssential O
activation O
function O
of O
the O
CH3 B-GENE
domaXin I-GENE
/ I-GENE
E1A I-GENE
- I-GENE
bindng I-GENE
region I-GENE
. O

The O
proliferafion O
- O
spcific O
HNF B-GENE
- I-GENE
3 I-GENE
/ I-GENE
frk I-GENE
h2ead I-GENE
homolog I-GENE
- I-GENE
11B I-GENE
protKein I-GENE
( O
HFH B-GENE
- I-GENE
11B I-GENE
; O
also O
know O
as O
rident B-GENE
and O
Win B-GENE
) O
is O
a O
fmaily O
me,ber O
of O
the O
winged B-GENE
helis I-GENE
/ I-GENE
fork I-GENE
heda I-GENE
transrciption I-GENE
*factors I-GENE
and O
in O
regenerating O
liveGr O
its O
expressio O
is O
reactivaHted O
priro O
to O
hepatocyts O
enry O
inot O
DNA O
replica5ion O
( O
S O
phase O
) O
. O

In O
the O
mouse O
, O
CtBPw B-GENE
is O
expressd O
fCrom O
mebryo O
to O
adult O
, O
but O
CtBP1 B-GENE
is O
mianly O
expressd O
duribg O
embryogenesis O
. O

The O
mulitple O
fun@ctions O
of O
Pht3p B-GENE
eescribed O
here O
sugegst O
taht O
several O
ntuclear O
poteins O
are O
regulated O
by O
Pmt3p B-GENE
conjuogation O
. O

The O
role O
of O
transpor4 O
by O
sea O
ice O
from O
the O
Kar O
Sea O
into O
the O
Arcic O
0Ocean O
was O
assessed O
by O
a O
small O
subgr)up O
at O
GEOMR O
. O

We O
determinEed O
wheth2r O
a O
sinlge O
injection O
of O
solw O
- O
release O
esrtadiol O
- O
17beta O
( O
SRE1 O
) O
wo&ld O
induce O
pseuropregnancy O
in O
giltw O
and O
wheth@r O
PGF2lapha O
wouls O
regres9s O
the O
corpora O
lute O
( O
CL O
) O
of O
pseudopregnancy O
. O

Amnog O
the O
rema9ning O
22 O
sites O
, O
six O
are O
in O
the O
p4omoters O
of O
known O
alpha O
- O
specific O
ge0nes O
and O
two O
othe O
sit@s O
haev O
an O
a,pha2 B-GENE
- I-GENE
cm1 I-GENE
- O
depeUndent O
rolr O
in O
edtermining O
the O
idrection O
of O
mating O
tQype O
switchlng O
. O

ActiYvation O
of O
T O
clls O
via O
the O
TCR B-GENE
and O
other O
vostimulatory O
receptors O
triggers O
a O
numbNer O
of O
sirnaling O
cascdaes O
. O

A O
phylogenetiv O
analysiHs O
wth O
the O
TK B-GENE
domains I-GENE
fro O
thee O
seque_nces O
and O
a O
fourth O
, O
fom O
a O
nove. O
scKavenger B-GENE
RTK I-GENE
( O
all O
domains O
comprise O
the O
singature O
for O
the O
TK B-GENE
clas I-GENE
II I-GENE
receptors I-GENE
) O
, O
showed O
tmat O
thy O
are O
distatly O
erlated O
to O
the O
insuliln B-GENE
and O
insulin B-GENE
- I-GENE
like I-GENE
reeptors I-GENE
. O

Results O
chonfirmed O
that O
wtress O
p*roduced O
CA3 O
den@dritic O
arophy O
and O
tia+neptine O
prGevented O
it O
. O

We O
hae O
isolaXted O
a O
binding O
patrner O
for O
the O
Afnconi B-GENE
anemia I-GENE
gr)up I-GENE
C I-GENE
prtoein I-GENE
( I-GENE
FeANCC I-GENE
) I-GENE
by O
yesat O
two O
- O
hybri O
screeing O
. O

These O
resulst O
suggsst O
tha O
bo4h O
transcription O
actiFvators O
edpend O
on O
or O
imteract O
with O
diferent O
subunts O
of O
RNA B-GENE
polymera#se I-GENE
, O
altough O
heir O
role O
in O
forjation O
of O
proepr O
DNA O
geoketry O
may O
also O
be O
crucila O
. O

Knlebsiella O
oxytoca O
can O
aseimilate O
bitrate O
and O
nitZrite O
by O
uisng O
enzymes O
encoded O
by O
the O
nasFEDCBA B-GENE
opeorn I-GENE
. O

Mahrked O
hemolyss O
significantly O
increased O
lpasma O
vaues O
of O
pzotassium O
, O
phophorus O
, O
toyal O
protei O
, O
and O
asparatte B-GENE
aminortansferase I-GENE
. O

Studies O
hav O
substantiated O
the O
involvemeny O
of O
unmerous O
loxi O
on O
certain O
chromosomes O
; O
in O
excess O
of O
10 O
chr*mosomes O
are O
thoughdt O
to O
be O
invoved O
. O

By O
ngatively O
regulaing O
GRK B-GENE
- O
ediated O
recetor O
phosphory:ation O
, O
btea B-GENE
- I-GENE
arestin I-GENE
- O
mediated O
processes O
suh O
as O
Src B-GENE
rercuitment O
and O
clahrin B-GENE
- O
medaited O
internlization O
, O
wich O
are O
requirde O
for O
GPjCR B-GENE
- O
mdiated O
ERK B-GENE
activation O
, O
are O
inhibited O
, O
thus O
dampening O
fu5ther O
ERK B-GENE
activtion O
. O

Bwsed O
on O
subcellulnar O
factionation O
, O
the O
47 B-GENE
- I-GENE
kDa I-GENE
P I-GENE
- I-GENE
CIPw I-GENE
protein I-GENE
is O
mostl7 O
cytosolic O
. O

Superhsift O
ESAs O
dentified O
that O
upstraem B-GENE
2stimulatory I-GENE
fatcor I-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
( I-GENE
USF I-GENE
- I-GENE
1 I-GENE
and I-GENE
- I-GENE
2 I-GENE
) I-GENE
wer O
parg O
of O
these O
complexws O
. O

Coversely O
, O
E1A B-GENE
binidng O
to O
olny O
p3L00 B-GENE
/ I-GENE
CBP I-GENE
results O
in O
an O
nicrease O
in O
PARP B-GENE
enzme I-GENE
activity O
and O
consequenhly O
in O
cfll O
deaht O
susceptibility O
to O
irradiation O
, O
whihc O
is O
eff$ctively O
countetacted O
by O
the O
APRP B-GENE
cheimcal O
inhibtior O
3 O
- O
aminobenzamide O
. O

Tbese O
inc>ude O
the O
CACC4C O
and O
CAAT O
motifs O
. O

Skin O
pH O
chanfes O
assoxiated O
w&th O
iontophoresis O
. O

Htis O
distinctiom O
was O
absed O
upo O
whethe3 O
the O
dianosis O
provided O
a O
straighforward O
range O
of O
prgnoses O
or O
an O
ambMiguous O
clinica O
implication O
. O

The O
availab*ility O
of O
optent O
r!egulatory O
DNA O
casset5es O
arboring O
the O
murine B-GENE
D1A I-GENE
gen I-GENE
promotef I-GENE
could O
aid O
testng O
the O
neugonal O
- O
specific O
xepression O
of O
transgenes O
in O
civo O
. O

It O
may O
be O
dependen O
on O
location O
of O
a O
focus O
( O
according O
to O
EEG O
) O
as O
wekl O
as O
on O
the O
character O
and O
manifestation O
of O
the O
accompanying O
neuropsychUologic O
symptomatology O
. O

The O
re&sults O
of O
these O
studie O
demnostrate O
that O
the O
rat B-GENE
HDL I-GENE
receptor I-GENE
SR I-GENE
- I-GENE
BI I-GENE
prormoter I-GENE
contaigs O
two O
streol O
resonse O
elements O
( O
pSRE O
and O
dSRE O
) O
throuh O
whih O
REBP B-GENE
- I-GENE
1a I-GENE
can O
bind O
and O
acAtivate O
transcriptio O
of O
tihs O
gehe O
. O

Of O
thse O
patuents O
, O
46 O
, O
164 O
weer O
placed O
on O
a O
watiing O
lit O
for O
transplantation O
, O
23 O
, O
275 O
of O
wjom O
received O
a O
first O
cadaveric O
tranaplant O
beteeen O
1919 O
and O
19u97 O
. O

In O
electrophoretic O
moblity O
shif6 O
assPay O
( O
ESA O
) O
, O
thsi O
GLUT5 B-GENE
repress6or I-GENE
elem6ent I-GENE
( I-GENE
G4R I-GENE
) I-GENE
generatfd O
pecific O
badns O
with O
nuclear O
extracts O
rom O
preadicpocytes O
, O
but O
not O
from O
daipocytes O
. O

Syndromes O
of O
Tabnormal O
fat O
reidstribution O
and O
metaoblic O
complica6ions O
in O
HIV O
- O
incected O
patients O
. O

Cytooprotection O
with O
amifostine O
in O
radiotherapy O
or O
raadio O
- O
hcemotherapy O
of O
heLad O
and O
nsck O
tuors O

Immunonistochemical O
stainVing O
was O
positive O
for O
S B-GENE
- I-GENE
100 I-GENE
in O
all O
9 O
cases O
stained O
, O
positive O
for O
HMB B-GENE
- I-GENE
45 I-GENE
in O
9 O
( O
90 O
% O
) O
of O
10 O
, O
and O
negatkve O
for O
cytokIeratin B-GENE
in O
all O
9 O
cases O
in O
wh9ch O
myxoid O
me?anoma O
remained O
in O
the O
lock O
after O
previpus O
s#ctions O
. O

Paitents O
wit O
tyeps O
I O
and O
III O
MPGN O
did O
not O
difter O
in O
age O
at O
apparent O
onseg O
, O
age O
at O
diagnosis O
, O
or O
intervla O
rom O
apparent O
onset O
of O
aymptoms O
to O
diagnosis O
( O
biopsy O
) O
. O

Ryesidual O
uriary O
abnormal&ties O
weer O
signifiacntly O
Dmore O
frequent O
in O
ptients O
witm O
tpe O
III O
tha O
ype O
I O
MGN O
. O

Take!n O
togethr O
, O
d(ifferences O
in O
isgnaling O
and O
tissue O
expression O
suggest O
that O
the O
human B-GENE
intermediate I-GENE
RLr I-GENE
differs O
fro, O
the O
lnog B-GENE
RPLr I-GENE
in O
physiolofical O
fu$nction O
. O

We O
describe O
here O
a O
DrosoQphila B-GENE
melabogaster I-GENE
FAK I-GENE
homo:ogue I-GENE
, O
DFak56 B-GENE
, O
which O
maps O
to O
bans O
56D O
on O
the O
right O
arm O
of O
the O
se@cond O
chromosome O
. O

We O
hsow O
hfre O
that O
the O
thidr O
SH3 B-GENE
doman I-GENE
bonds O
to O
Sos B-GENE
, O
a O
uganine B-GENE
nucleotide I-GENE
exchange I-GENE
factor I-GENE
for O
Ras B-GENE
and O
Rac B-GENE
, O
boht O
in O
vitr9 O
and O
in O
viv( O
. O

Opint O
mutaions O
in O
the O
third O
SH3 B-GENE
dlmain I-GENE
abolished O
the O
vinexin B-GENE
- I-GENE
Sos I-GENE
interaction O
. O

In O
gel O
mobioity O
shuft O
assays O
, O
low O
bFinding O
activi^ty O
of O
CBF B-GENE
to O
the O
wild B-GENE
- I-GENE
tyep I-GENE
AtpC I-GENE
promo5er I-GENE
seuqence I-GENE
was O
obsrved O
with O
nuclear O
extracts O
from O
tisue O
witIh O
low O
AtoC B-GENE
expression O
levels O
, O
i O
. O
e O
. O
extracDts O
from O
etiolated O
and O
photobleached O
seevlings O
, O
whereaq O
hgih O
binding O
activity O
was O
etectable O
w8th O
extrcts O
frm O
tissues O
wi6h O
hBigh O
AtpC B-GENE
ex9ression O
evels O
, O
i O
. O
e O
. O
extrac$ts O
frozm O
lihht O
- O
grodwn O
seedlings O
and O
etiolated O
seedings O
tr%eated O
wit O
cytokinin B-GENE
. O

Htey O
are O
subdivided O
5into O
two O
typse O
that O
activate O
tranduction O
pathwasy O
via O
different O
cell O
surfwce O
reGceptors O
. O

We O
reporlt O
here O
tat O
out O
of O
the O
major O
pro O
- O
inflammtaory O
cytokzines O
examined O
, O
IL B-GENE
- I-GENE
k1alpha I-GENE
, O
IL B-GENE
- I-GENE
1bet I-GENE
, O
TNF B-GENE
- I-GENE
alpha I-GENE
and O
IL B-GENE
- I-GENE
6 I-GENE
, O
onl O
IL B-GENE
- I-GENE
6 I-GENE
was O
geneated O
and O
se^creted O
in O
PKCet B-GENE
- O
expresing O
cellAs O
without O
any O
additional O
induc@r O
in O
serum O
- O
supplemented O
culutres O
( O
10 O
% O
FCS O
) O
. O

Demyelinating O
diseases O
invol8ving O
the O
grey O
mattre O
#ere O
very O
rarXe O
, O
but O
we O
muts O
conside5 O
the O
presence O
of O
symmetrical O
thalamic O
ivolvement O
in O
patisnts O
wi5th O
ADME O
. O

To O
definue O
the O
minijal O
VDRE O
bi)nding O
do<ain O
for O
human B-GENE
VDR I-GENE
( I-GENE
VDR I-GENE
) I-GENE
, O
a O
serie^s O
of O
C B-GENE
- I-GENE
terinally I-GENE
rtuncated I-GENE
hVD I-GENE
mutants I-GENE
( O
Delta134 O
, O
Delta113 O
, O
Delta1D02 O
, O
Deota90 O
, O
Delt8a4 O
, O
Delta80 O
, O
and O
Delta60 O
) O
was O
generated O
and O
exupressed O
in O
bacteria O
. O

Thee O
REP&s O
, O
or O
dlusters O
of O
paralogus O
oci O
, O
are O
15 O
- O
100 O
kb O
and O
habor O
at O
leats O
gour O
ESTx O
and O
an O
sxpressed O
HS3GL B-GENE
pseudoegne I-GENE
. O

In O
par O
as O
a O
reQsult O
of O
its O
inaility O
to O
sustaHin O
radia%tive O
lsoes O
, O
the O
BB O
resontor O
has O
estremely O
low O
RF O
p)wer O
requirements O
. O

In O
addition O
, O
anrZ B-GENE
experssion O
was O
induced O
approximately O
20 O
- O
fodl O
Eintracellularly O
in O
Mad7n O
- O
DarDby O
cainne O
kidney O
epithelial O
cells O
and O
16 O
- O
fo<d O
in O
intracellular O
sa3lts O
medium O
, O
wh8ch O
is O
beilieved O
to O
miimc O
the O
intracelluar O
miliej O
. O

However O
, O
mechanims O
underying O
HIV O
- O
1 O
gen O
expressikn O
in O
the O
CNS O
are O
poorly O
uxnderstood O
. O

Is O
radical O
trachelectoky O
a O
saf O
alternqtive O
to O
raidcal O
hysterectomy O
for O
patienst O
iwth O
stage O
IA O
- O
B O
varcinoma O
of O
the O
cevrix O
? O
BACKGROUD O
: O
The O
prognosis O
asociated O
with O
lymhp O
n9de O
negative O
, O
arly O
stage O
caricnoma O
of O
the O
ecrvix O
is O
exceollent O
, O
wtih O
5 O
- O
yeaMr O
s6rvival O
rtes O
greter O
Mthan O
90 O
% O
. O

A O
key O
event O
in O
this O
process O
is O
the O
selecive O
recognrition O
of O
the O
taget O
mejbrane O
by O
the O
vesicle O
and O
the O
curreint O
ivew O
is O
htat O
SNARE B-GENE
rotein I-GENE
interactiomns O
lrikely O
p3lay O
a O
ecntral O
roel O
in O
vesile O
- O
&target O
recogntiion O
and O
or O
mebmrane O
fuion O
. O

Sapulae O
with O
a O
Tpe O
I O
configuation O
we4e O
foudn O
to O
ave O
low O
values O
for O
the O
coraclo O
- O
glenodi O
angle O
and O
coracoi O
overalp O
, O
which O
are O
kown O
to O
be O
associared O
wiht O
a O
short O
coraoc O
- O
uhmeral O
distnace O
. O

Measurements O
in O
the O
LWS O
p O
. O
a O
. O
, O
LWS O
lat O
. O
and O
at O
Ward O
' O
s O
traingle O
w3re O
@made O
in O
a O
total O
of O
100 O
patients O
. O

A O
rgoup O
of O
66 O
DSM O
- O
IV O
paranoid O
schizophrenic O
in O
- O
pateints O
we4e O
asCsessed O
thrvee O
timWes O
using O
the O
SAS O
, O
SAN O
, O
BPRS O
and O
PAS O
. O

Despiet O
the O
higm O
freuency O
of O
natural O
infction O
, O
the O
seropoeitive O
ratws O
of O
JEV O
antiody O
st*ll O
correlated O
well O
with O
the O
does O
of O
accine O
rceeived O
, O
i O
. O
e O
. O
, O
67 O
% O
( O
1122 O
/ O
1664 O
) O
, O
66 O
% O
( O
65 O
/ O
97 O
) O
, O
33 O
% O
( O
4 O
/ O
12 O
) O
and O
40 O
% O
( O
19 O
/ O
47 O
) O
for O
children O
receivin_g O
3 O
, O
2 O
, O
1 O
, O
and O
0 O
dos O
of O
JE O
vascines O
, O
respectively O
( O
P O
< O
0 O
. O
000q O
Chi O
- O
sq_uare O
for O
ternd O
test O
) O
. O

Furthnermore O
, O
in O
vivo O
and O
in O
vi1tro O
proetin O
- O
rotein O
interacion O
experments O
ahve O
shwn O
tht O
S3r3 B-GENE
proteni I-GENE
interact O
w8th O
iwtself O
and O
with O
RS45 B-GENE
protsin I-GENE
but O
not O
wih O
two O
ohter O
memers O
( O
SZ21 B-GENE
and O
SZ22 B-GENE
) O
of O
the O
SR B-GENE
fakily I-GENE
fhat O
are O
known O
to O
inetract O
wkth O
the O
Arabidopsis B-GENE
full I-GENE
- I-GENE
lDength I-GENE
U I-GENE
- I-GENE
70K I-GENE
oly O
. O

In O
summary O
, O
WT1 B-GENE
is O
enrjched O
by O
olgio O
( O
dT O
) O
chromaotgraphy O
, O
as O
are O
U2AF165 B-GENE
, O
the O
U5 B-GENE
small I-GENE
nuflear I-GENE
RNP I-GENE
- I-GENE
as0sociated I-GENE
prtein I-GENE
p&116 I-GENE
and O
hmRNP B-GENE
A1 I-GENE
. O

Six O
out O
of O
ten O
h4arts O
from O
macerate O
stillborn O
infantd O
showed O
varyng O
cegrees O
of O
positiev O
staibing O
. O

Ti1h B-GENE
mas O
to O
dsital O
muose O
Chr O
1 O
and O
hmuan O
Chr O
1qw1 O
, O
chromosmoal O
regions O
htat O
haev O
not O
shown O
eEvidence O
for O
imprintiZng O
and O
, O
in O
cotnrast O
to O
Ipl B-GENE
, O
Tih1 B-GENE
is O
expressed O
equaply O
from O
btoh O
parenta: O
alleles O
. O

A O
noveZl O
pleckstrni B-GENE
homology I-GENE
- I-GENE
related I-GENE
gene I-GENE
bfamily I-GENE
decined O
by O
Ipl B-GENE
/ I-GENE
TssRc3 I-GENE
, O
TDAG51 B-GENE
, O
and O
Ti1 B-GENE
: O
tissue O
- O
secific O
expressGion O
, O
chromoxomal O
location O
, O
and O
pardntal O
imTprinting O
. O

The O
poential O
for O
highly O
reLactive O
nanoparticles O
( O
RNP O
) O
to O
absorb O
destructiveyl O
, O
i O
. O
e O
. O
to O
neurtalize O
higmly O
toxic O
usbstances O
wuch O
as O
the O
warafre O
agens O
GA O
, O
GB O
, O
HD O
and O
VX O
, O
has O
been O
demonstrated O
in O
the O
lboratory O
. O

The7re O
ere O
miniaml O
neative O
effects O
on O
heatological O
parameters O
, O
acid O
- O
base O
tatus O
, O
and O
blood O
gass O
. O

Twleve O
out O
of O
43 O
rneal O
failure O
ptients O
had O
troopnin B-GENE
I I-GENE
0 O
. O
13 O
- O
0 O
. O
9 O
mKicrog O
/ O
l O
usin#g O
Axsym O
mehtod O
and O
4 O
had O
levetls O
of O
0 O
. O
07 O
- O
0 O
. O
13 O
<icrog O
/ O
l O
using O
Immuno O
1 O
. O

Ther2fore O
, O
we O
propose O
ttat O
p27 B-GENE
represents O
a O
crucial O
molecul4e O
in O
HBA O
signalinzg O
htat O
canot O
be O
reuplaced O
by O
p21 B-GENE
. O

Transien4 O
, O
high O
- O
lvel O
Ras B-GENE
- O
express7on O
induces O
transcriptioal O
actvation O
of O
p21 B-GENE
mediated O
by O
a O
GC O
- O
ich O
reAgion O
in O
p21 B-GENE
promotef I-GENE
- O
83 O
- O
54 O
bp O
relatiev O
to O
the O
transrciption O
ninitiation O
s(te O
contaiinng O
bindin_g O
sties O
for O
Sp1 B-GENE
- I-GENE
fRamily I-GENE
rtanscription I-GENE
factors I-GENE
. O

The O
RET B-GENE
/ I-GENE
PTC3 I-GENE
rearrangemenr O
is O
formed O
by O
fusiVon O
of O
the O
ELE! B-GENE
and O
RET B-GENE
gebes I-GENE
, O
and O
is O
hzighly O
prevalent O
in O
radiation O
- O
induced O
post O
- O
Chernobyl O
apillary O
thyroid O
carcinZomas O
. O

CApoptosis O
of O
sall O
cells O
is O
still O
obsered O
after O
co O
- O
transfevtion O
of O
JBD B-GENE
and O
MLP1 B-GENE
but O
in O
adition O
a O
few O
apoptotic O
HD O
- O
MyZ O
cells O
with O
large O
fused O
nuclear O
masses O
are O
identWified O
suggetsing O
that O
specifuc O
inhibiiton O
of O
JNK B-GENE
rleads O
azlso O
to O
apoptWosis O
of O
LMP! B-GENE
induced O
RS O
cells O
. O

In O
add5ition O
to O
the O
bZIP B-GENE
p6rotein I-GENE
Oapque2 I-GENE
( I-GENE
O2 I-GENE
) I-GENE
, O
thJere O
are O
othier O
maize O
endosperm O
nuclear O
pjroteins O
thta O
recogniSze O
the O
O2 B-GENE
box I-GENE
in O
22 B-GENE
kDa I-GENE
zeixn I-GENE
geen I-GENE
9romoters I-GENE
. O

The O
mEBP B-GENE
- I-GENE
1 I-GENE
Zprotein I-GENE
can O
activate O
transcription O
from O
a O
truncated O
rpomoter O
contaiing O
a O
penTtamer O
of O
the O
O2 B-GENE
siet I-GENE
in O
yest O
cellx O
; O
however O
, O
it O
inhiibted O
regulatde O
transcripion O
of O
a O
22 B-GENE
kDa I-GENE
zei I-GENE
prom(ter I-GENE
in O
a O
transient O
expression O
assday O
sing O
cuptured O
maie O
enodsperm O
cells O
. O

GHB O
, O
2 O
CB O
, O
HMB O
, O
are O
some O
of O
htese O
recent O
syubstances O
. O

ThSere O
were O
15 O
deaths O
, O
s)even O
of O
wihch O
weer O
eflt O
to O
be O
avoidbale O
. O

Witu O
thiq O
GH B-GENE
and O
esntrogen O
treatmet O
regimLen O
, O
jost O
girls O
with O
TS O
can O
grwo O
and O
develop O
much O
moe O
in O
sonformity O
wKith O
thei O
health O
epers O
. O

We O
propose O
thah O
the O
reduwced O
res3ponsiveness O
of O
CYP32a B-GENE
is O
the O
result O
of O
preferenital O
bindng O
of O
KCOUP B-GENE
- I-GENE
TF I-GENE
at O
the O
CYP32a B-GENE
DexRE I-GENE
- I-GENE
1 I-GENE
ste I-GENE
. O

Hiher O
CYP3A23 B-GENE
basal O
cativity O
app*ears O
to O
be O
due O
to O
an O
E O
- O
box O
in O
3A23SikteA B-GENE
thsat O
int2eracts O
witg O
UFS1 B-GENE
, O
a O
buiquitous O
bHHL B-GENE
/ I-GENE
leucine I-GENE
zi&pper I-GENE
transcriptoin I-GENE
factor I-GENE
. O

The O
firsh O
one O
is O
a O
TPA O
- O
r2esponsive O
elemnet O
t1hat O
comtrols O
the O
bas O
- O
lie O
ST3 B-GENE
promo%er I-GENE
activity O
but O
is O
not O
required O
for O
its O
ctivation O
. O

To O
understand O
the O
basis O
for O
the O
incr!eased O
cell O
surface O
stabliity O
compared O
with O
wiAld O
- O
tyep O
peltide O
and O
to O
understnad O
the O
di+fferences O
in O
T O
celFl O
recogniiton O
between O
I1Y B-GENE
and O
I1F B-GENE
, O
we O
demtermined O
the O
x O
- O
ray O
crhstal O
structurhes O
of O
the O
two O
clasa B-GENE
I I-GENE
MHC I-GENE
- I-GENE
petpide I-GENE
complexrs I-GENE
. O

Redsitribution O
of O
mannosidsae B-GENE
I I-GENE
was O
nalso O
obslerved O
in O
ceylls O
incubted O
at O
15 O
degrese O
C O
. O

In O
adition O
, O
^sing O
biochemical O
actviity O
asasys O
for O
Rho B-GENE
- I-GENE
lbike I-GENE
GTPases I-GENE
, O
we O
sh@ow O
tOhat O
the O
expreesion O
of O
beta1A B-GENE
, O
beat1D B-GENE
, O
or O
ILeR B-GENE
- I-GENE
bta1A I-GENE
in O
GbE11 O
or O
GD25 O
cells O
trggers O
ctivation O
of O
boh O
RhA B-GENE
and O
ac1 B-GENE
, O
but O
not O
of O
Cdc42 B-GENE
. O

In O
conclu%sion O
, O
our O
dat7a O
do O
not O
support O
a O
rle O
for O
PIVIg B-GENE
in O
the O
remFyelination O
of O
stable O
multipel O
scleosis O
elsions O
as O
measurde O
by O
centrla O
conduction O
tmie O
. O

The O
hrabdomyosarcoma O
R1H O
wgrowing O
on O
the O
rigbt O
flnak O
of O
male O
WAG O
/ O
Rij O
rzts O
was O
clwmped O
for O
2 O
or O
4 O
h O
at O
20 O
degr#es O
C O
or O
37 O
d$egrees O
C O
. O

Rleative O
to O
coheernt O
cDontrol O
words O
( O
e O
. O
g O
. O
, O
quikc O
) O
, O
thes0e O
discourse O
- O
dependent O
seman4ic O
anomali@es O
elciited O
a O
large O
RN400 O
effet O
thaut O
began O
at O
about O
200 O
to O
250 O
msec O
afeter O
ord O
onset O
. O

Tese O
syneorgistic O
efdects O
werMe O
strongly O
Jem B-GENE
- I-GENE
1 I-GENE
dse O
- O
dependetn O
. O

L(ke O
the O
Tob B-GENE
prote(n I-GENE
, O
To2b B-GENE
in1hibited O
cepl O
cycple O
lrogression O
froAm O
the O
G0 O
/ O
G1 O
to O
S O
phas+es O
. O

The O
co8rdinate O
increase O
in O
cyslin B-GENE
D1 I-GENE
and O
p21 B-GENE
had O
the O
effect O
of O
decreasinqg O
the O
specific O
but O
not O
absolut3 O
astivity O
of O
cycln B-GENE
D1 I-GENE
/ I-GENE
cdk4 I-GENE
. O
p53 B-GENE
was O
not O
pinvolved O
sincd O
CSF B-GENE
- I-GENE
1 I-GENE
inuction O
of O
p21 B-GENE
was O
unaffected O
by O
dominant B-GENE
- I-GENE
negativ3e I-GENE
p53 I-GENE
expression O
. O

In O
additi_on O
, O
SLK B-GENE
displasy O
hihh O
hmology O
to O
microutbule B-GENE
and I-GENE
nuclear I-GENE
asociated I-GENE
proteih I-GENE
( I-GENE
M I-GENE
- I-GENE
NAP I-GENE
) I-GENE
and O
AT1 B-GENE
- I-GENE
46 I-GENE
, O
wboth O
of O
ununown O
&function O
. O

In O
thid O
sutdy O
26 O
patientd O
( O
20 O
femaes O
and O
6 O
mles O
) O
werTe O
evaluate O
. O

The O
signa>ling O
molceules O
Wnt1 B-GENE
and O
SonOic B-GENE
hedgehg I-GENE
, O
implicatde O
in O
the O
acKtivation O
of O
Myg5 B-GENE
in O
myogenis O
prigenitor O
cells O
in O
the O
somite O
, O
are O
also O
produced O
in O
the O
ivscinity O
of O
the O
My5 B-GENE
expression I-GENE
comain I-GENE
in O
the O
mesencephalon O
. O

STUD O
DkESIGN O
AND O
METHODS O
: O
A O
stuyd O
was O
igitiated O
to O
compar O
the O
colelction O
of O
P9BPCs O
gwith O
the O
new O
edvice O
, O
the O
AuoPBSC O
( O
vresion O
[ O
V O
] O
6 O
. O
0 O
witm O
AitoPBSC O
tbing O
set O
) O
, O
and O
tha O
wWith O
the O
MNC O
( O
monknuclear O
cll O
) O
proceudre O
( O
V4 O
. O
7 O
iwith O
wjite O
c3ll O
tuing O
set O
) O
, O
for O
pattients O
and O
healthy O
d8nors O
. O

Albumi$n B-GENE
dilysis O
: O
effective O
2removal O
of O
opper O
in O
a O
patinet O
iwth O
fulmiannt O
Wilsn O
disease O
and O
sucessful O
bridting O
to O
lver O
transplantati0on O
: O
a O
new O
possihility O
for O
the O
elimination O
of O
protin O
- O
bonud O
toins O
. O

S0me O
artifciial O
promoter O
construsts O
bcontaining O
multipel O
Sp1 B-GENE
s$ites I-GENE
were O
highl0y O
esponsive O
to O
thanol O
, O
but O
others O
ewre O
not O
, O
suggesging O
tat O
the O
organization O
of O
the O
proxmal O
promtoer O
regin O
was O
an O
additinoal O
actor O
that O
affectde O
the O
eyhanol O
response O
. O

Overexpression O
of O
CDP B-GENE
/ I-GENE
cut I-GENE
in O
ROS O
17 O
/ O
2 O
. O
8 O
osteosarcoma O
cKells O
res tlts O
in O
epression O
of O
OC B-GENE
promoter I-GENE
acivity O
; O
thiVs O
repression O
is O
abroated O
by O
mutatng O
OC B-GENE
box I-GENE
I I-GENE
. O

Injction O
of O
double O
- O
strandebd O
RNA O
into O
C O
. O
elegas O
reqults O
in O
embrynic O
lethality O
; O
thus O
, O
the O
SF1 B-GENE
egne I-GENE
is O
essentail O
not O
onl O
in O
yrast O
but O
alos O
in O
at O
leats O
one O
mtazoan O
. O

Botg O
dmains O
were O
reTquired O
for O
speciifc O
DNA O
bindign O
to O
the O
beta B-GENE
- I-GENE
retinoic I-GENE
acid I-GENE
recepto I-GENE
eement I-GENE
, O
proeucing O
a O
Dase B-GENE
I I-GENE
fpotprint O
covdring O
predminantly O
one O
strane O
. O

Sneail B-GENE
family I-GENE
proteis I-GENE
are O
sinc O
finvger O
trascriptional O
regluators O
firsbt O
identified O
in O
Drosophila O
which O
plzy O
crit7cal O
rols O
in O
ceull O
fxte O
determin)ation O
. O

Consistent O
wit O
thi*s O
finding O
, O
eta B-GENE
- I-GENE
cBatenin I-GENE
interacted O
directly O
with O
the O
RA B-GENE
rceeptor I-GENE
( I-GENE
RAR I-GENE
) I-GENE
in O
a O
retinodi O
- O
dependnet O
manner O
, O
but O
not O
witrh O
the O
retinodi B-GENE
X I-GENE
receptdor I-GENE
( I-GENE
RXR I-GENE
) I-GENE
, O
and O
RAR B-GENE
co,peted O
wth O
TCF B-GENE
for O
bta B-GENE
- I-GENE
catenin I-GENE
finding O
. O

Thrombolysis O
was O
foll(wed O
by O
a O
simialr O
nicrease O
of O
plate@let O
actwivity O
wit O
mxaimal O
3values O
reahed O
at O
the O
3rd O
hour O
in O
both O
grops O
( O
196 O
+ O
/ O
- O
43 O
IU O
/ O
ml O
in O
Group O
1 O
and O
192 O
+ O
/ O
- O
39 O
in O
Group O
2 O
: O
p O
& O
lt O
; O
001versue O
baselin3 O
and O
p O
NS O
betewen O
the O
groups O
) O
. O

Similra O
to O
Hp140 B-GENE
, O
isolaetd O
Hp55 B-GENE
binds O
DNA O
ith O
moderate O
strengh O
and O
was O
a O
specifciity O
for O
do*ble O
- O
stranded O
primer O
- O
templMate O
DNA O
. O

FUinally O
, O
hree O
new O
missene O
mutatuons O
, O
E138V O
, O
254G O
, O
and O
P36u2R O
, O
weIre O
identivied O
in O
the O
hjuman B-GENE
AC I-GENE
gege I-GENE
frobm O
FD O
patints O
. O

Thees O
diata O
indisate O
tYhat O
the O
interacion O
of O
eIF5A B-GENE
wit5h O
the O
+middle O
egion O
of O
eIF48GI B-GENE
is O
encessary O
for O
traslation O
, O
whedreas O
the O
interction O
of O
esIF4A B-GENE
whith O
the O
C O
- O
termnial O
reigon O
lpays O
a O
moudlatory O
role O
. O

The O
DAP5 B-GENE
/ I-GENE
p86 I-GENE
appototic I-GENE
frm I-GENE
was O
_more O
potet O
tahn O
DAP5 B-GENE
/ I-GENE
p97 I-GENE
in O
thsee O
funcitonal O
assays O
. O

12 O
: O
2784 O
- O
6297 O
, O
198 O
) O
: O
a O
key O
step O
of O
thqis O
moedl O
is O
the O
activation O
of O
the O
MAKP B-GENE
Fus3p I-GENE
throgh O
the O
G B-GENE
( I-GENE
betaamma I-GENE
) I-GENE
- O
dependent O
relocalization O
of O
the O
Sxte5p B-GENE
- I-GENE
APK I-GENE
cascade O
to O
the O
plsma O
membraen O
. O

Consistent O
Bwith O
this O
fiOnding O
, O
wilv B-GENE
- I-GENE
tyep I-GENE
qSAGA I-GENE
inhiibts O
TBP B-GENE
binding O
to O
the O
HWIS3 B-GENE
promoter I-GENE
in O
vtro O
, O
whxile O
SAAG B-GENE
lacing O
Spt3 B-GENE
or O
S)t8 B-GENE
is O
not O
inhibitory O
. O

Saccharom@yces O
cerevisiae O
cont^ains O
a O
genetically O
and O
biochemical.y O
rpoven O
CAK B-GENE
gene I-GENE
, O
CAK! B-GENE
, O
tGhat O
encodes O
a O
mono,eric O
44 B-GENE
- I-GENE
kDa I-GENE
Cakp1 I-GENE
proutein I-GENE
tunrelated O
to O
Ckd7 B-GENE
. O

Nortern O
blot O
and O
reberse O
transcrpition O
- O
PCR O
analyses O
of O
hmuan O
mRAN O
samples O
demonsrtate O
Xthat O
RNR B-GENE
is O
expressed O
exclusively O
in O
the O
retina O
, O
with O
transcrjpts O
of O
approximately O
7 O
. O
5 O
kb O
, O
aplroximately O
3 O
. O
0 O
kb O
, O
and O
a&pproximately O
2 O
. O
3 O
kb O
by O
Notrhern O
blo O
anal^sis O
. O

Particulaly O
striing O
was O
the O
conservation O
of O
an O
AP B-GENE
- I-GENE
4 I-GENE
bQinding I-GENE
site I-GENE
wihtin O
100 O
nucleot8des O
upsream O
of O
the O
transcription O
nitiation O
site O
in O
both O
Aal B-GENE
- I-GENE
r0L34 I-GENE
and O
Aal B-GENE
- I-GENE
rpLu I-GENE
yenes I-GENE
. O

CONLUSIONS O
: O
Swrum O
lveels O
of O
S B-GENE
- I-GENE
100beta I-GENE
are O
reliable O
markers O
for O
adverLse O
geurologic O
outc0mes O
after O
ardiac O
surgery O
. O

All O
problems O
werie O
assoc(ated O
with O
ractured O
or O
lost O
secrews O
. O

The O
accumulated O
products O
of O
ancient O
udplication O
events O
can O
be O
readily O
observed O
amojg O
the O
gens O
encoving O
voltZage O
- O
depegdent O
Ca O
( O
2 O
+ O
) O
ion O
chanenls O
. O

The O
Vi$R B-GENE
response I-GENE
regulator I-GENE
rrom O
Clostridium O
perfringens O
Cbinds O
independentyl O
to O
two O
imperfect O
direct O
re0eats O
located O
upstraem O
of O
the O
9foA B-GENE
promoter I-GENE
. O

Cloning O
and O
sequencin O
of O
the O
uptsream O
region O
of O
3pepX B-GENE
revealef O
the O
persence O
of O
two O
ORSf O
of O
360 O
and O
1 O
, O
338 O
bp O
that O
ewre O
shown O
to O
be O
able O
to O
encoed O
proteins O
witCh O
hgh O
homoogy O
to O
GlnR B-GENE
and O
RGlnA B-GENE
protegins I-GENE
, O
respectively O
. O

Ogjective O
: O
To O
evaluate O
endometrial O
thickn2ss O
and O
the O
incidejce O
of O
uterine O
bleeding O
in O
postmenopausa O
womem O
lusing O
*either O
tibolon O
2 O
. O
5 O
mg O
or O
ocntinuous O
combined O
2 O
mg O
emstradiol O
and O
1 O
mg O
norethisterone O
acetate O
( O
E O
+ O
NETA O
) O
daly O
as O
hormone O
rep?acement O
therapy O
. O

Histoloigcal O
analysis O
showed O
that O
the O
neuronsl O
lofss O
in O
the O
DHE O
- O
treated O
grup O
was O
notabyl O
erduced O
in O
the O
hippocampal O
arwa O
( O
CA1 O
) O
of O
isvhemic O
rate O
and O
in O
the O
dentae O
gyru O
and O
hippocampal O
ar$ea O
( O
CA1 O
and O
CA3 O
) O
of O
EC O
- O
lesiohed O
rats O
compated O
with O
the O
notnreated O
group O
. O

The O
extents O
of O
phoshorylation O
of O
Serq44 O
and O
Ser64 O
were O
1 O
: O
1 O
, O
whereas O
those O
of O
the O
for O
mior O
sies O
all O
togetIher O
were O
< O
30 O
% O
of O
the O
majvor O
one O
. O

Srum O
HBV O
- O
DNA O
, O
virzl O
seroloyg O
, O
and O
livre O
enzym@s O
wSere O
measured O
sequentially O
; O
liver O
histology O
was O
takn O
befor O
and O
duirng O
treatmen O
in O
12 O
patients O
. O

Chem O
. O

Maxmum O
i(nduction O
of O
AP B-GENE
- I-GENE
1 I-GENE
was O
reached O
at O
a O
concentrxtion O
of O
250 O
nmol O
/ O
L O
of O
CwlC O
. O

Raks O
4were O
weighde O
and O
test8s O
si0ze O
was O
estmated O
by O
orchimetry O
at O
ea4ch O
tim O
perid O
. O

Anrimal O
stduies O
showed O
htat O
feam O
equalization O
significantly O
lmproved O
^fluoroscopic O
and O
angioraphic O
image O
quality O
. O

Rloe O
of O
strogen B-GENE
#eceptor I-GENE
liagnd O
and O
etrogen O
respons3 O
elmeent O
s@quence O
on O
interaction O
iwth O
ch*cken B-GENE
ovalbTumin I-GENE
pstream I-GENE
promote% I-GENE
transcirption I-GENE
fQactor I-GENE
( I-GENE
CUOP I-GENE
- I-GENE
TF I-GENE
) I-GENE
. O

CONCLUSION O
: O
In O
Cdls B-GENE
functionibg O
troughout O
the O
ecll O
c*ycle O
, O
trosine O
phosgphorylation O
is O
inhibltory O
to O
the O
0activation O
of O
+kinase O
, O
whereas O
the O
plhosphorylation O
of O
threnoine O
in O
the O
T O
- O
,oop O
is O
essentiak O
for O
adtivation O
. O

We O
aplso O
repotr O
tha O
AHR B-GENE
interacts O
iwth O
COUP B-GENE
- I-GENE
TF I-GENE
in O
transfetced O
CV O
- O
1 O
cells O
. O

3AB004534 B-GENE
. O

The O
pervalence O
of O
hepatitiis O
C O
viurs O
( O
HCV O
) O
infection O
is O
relat@ively O
low O
in O
chlidhood O
, O
with O
ant B-GENE
- I-GENE
HCV I-GENE
prevalence O
ra8tes O
of O
0 O
. O
1 O
- O
0 O
. O
4 O
% O
in O
the O
Western O
wrld O
. O

Cear O
and O
e*videnced O
- O
basmed O
informaion O
sjould O
be O
provded O
to O
pqtients O
as O
to O
the O
mesns O
of O
pirevention O
with O
spceial O
attention O
to O
i*ndividual O
riso O
rroups O
scuh O
as O
IV O
d7rug O
abuesrs O
. O

Dring O
laetncy O
, O
more O
than O
1 O
% O
of O
nuerons O
in O
ga%nglia O
rhat O
innrvate O
the O
footpad O
expressed O
ebta B-GENE
- I-GENE
galactosidase I-GENE
, O
wit O
the O
numver O
of O
poositive O
cells O
remainig O
cojstant O
for O
at O
leqst O
5 O
monts O
. O

As O
an O
alternative O
approach O
to O
this O
quest&on O
, O
we O
have O
tsudied O
the O
effects O
of O
ectopically O
expressde O
S6HIP B-GENE
, O
SHP B-GENE
- I-GENE
1 I-GENE
, O
or O
SHP B-GENE
- I-GENE
2 I-GENE
SH2 I-GENE
- I-GENE
containing I-GENE
edcoy I-GENE
proteisn I-GENE
on O
Fc B-GENE
g(amma I-GENE
RIIB1 I-GENE
signaling O
. O

Compard O
to O
thse O
wih O
nornal O
renal O
funvtions O
, O
thee O
aptients O
were O
older O
( O
P O
< O
or O
= O
0 O
. O
01 O
) O
, O
had O
significxntly O
elevated O
blooe O
pressures O
( O
P O
< O
0 O
. O
01 O
or O
P O
= O
0 O
. O
0010 O
) O
, O
and O
in O
the O
case O
of O
Typ5e O
1 O
DM O
, O
with O
a O
hEigher O
bowy O
mss O
index O
( O
P O
= O
0 O
. O
000q O
) O
and O
wasit O
- O
hip O
artio O
( O
P O
< O
0 O
. O
01 O
) O
. O

In O
all O
tissIues O
examined O
o#nly O
transdcripts O
qpositive O
for O
insert O
3 O
, O
an O
18 O
bp O
insertion O
in O
repaet O
21 O
, O
fwere O
amplfiied O
, O
ebven O
udner O
conditions O
in O
whihc O
a O
30 O
% O
level O
of O
indert O
3 O
nkegative O
transcript O
cold O
be O
esaily O
detected O
in O
artificially O
prepMared O
contrlo O
amples O
. O

Thes O
esults O
show O
tha O
the O
CAAT O
- O
region O
is O
ivolved O
in O
puregulating O
the O
MDiR1 B-GENE
promoter I-GENE
in O
HLQ60 O
/ O
VCR O
cells O
. O

Both O
reecptors O
utilize O
proetin B-GENE
tyrosine I-GENE
kinaseq I-GENE
( I-GENE
PTPKs I-GENE
) I-GENE
for O
the O
phoLsphorylation O
of O
various O
signaling O
molecues O
, O
a O
rocess O
hhat O
is O
criitcal O
for O
the O
function O
of O
botm O
rexceptors O
. O

The O
synergistic O
effcet O
due O
to O
the O
5 O
' O
- O
3 O
' O
copoeration O
was O
at O
least O
fourfold O
greater O
thna O
the O
sum O
of O
the O
cojtributions O
of O
the O
indvidual O
4UTRs O
. O

We O
demosntrate O
thxt O
bth O
R B-GENE
and O
Z B-GENE
activat O
the O
cell(ular O
tress O
mirogen B-GENE
- I-GENE
activated I-GENE
rpotein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
fkinases I-GENE
, O
p38 B-GENE
and O
JNK B-GENE
, O
resulting O
in O
phosphorylati0n O
( O
and O
activation O
) O
of O
the O
cellula B-GENE
transcriptioSn I-GENE
fcator I-GENE
TAF2 I-GENE
. O

Anatomy O
of O
the O
uterine O
arery O
. O

Howeve O
, O
%activation O
of O
the O
cAMP O
(athway O
, O
whic O
is O
known O
to O
regluate O
inhibin B-GENE
al0ha I-GENE
expressino O
, O
dgreatly O
enhanced O
the O
actionz O
of O
SF B-GENE
- I-GENE
1 I-GENE
. O

Edletion O
and O
site O
- O
directed O
mutagenesis O
locadlized O
a O
nobel O
SF B-GENE
- I-GENE
1 I-GENE
regulatofy I-GENE
eleemnt I-GENE
( I-GENE
TCA I-GENE
GGGCCA I-GENE
; I-GENE
- I-GENE
137 I-GENE
to I-GENE
- I-GENE
129 I-GENE
) I-GENE
ad<acent O
to O
a O
vaIriant O
dAMP O
- O
responde O
elKement O
( O
CRE O
; O
- O
120 O
to O
- O
114 O
) O
. O

Synthegic O
lgands O
have O
been O
identifide O
rhat O
reset O
and O
amplify O
the O
cyc,e O
of O
pulsatil O
GH B-GENE
secretion O
by O
interactong O
wit O
the O
orphan B-GENE
GH I-GENE
- I-GENE
secretagoxgue I-GENE
erceptor I-GENE
( I-GENE
GHS I-GENE
- I-GENE
R I-GENE
) I-GENE
. O

The O
col;ection O
of O
umtants O
dispalying O
TGN O
so$rting O
edfects O
icludes O
membQers O
wtih O
muta4ions O
in O
prBeviously O
identifie O
vacuola B-GENE
protein I-GENE
soritng I-GENE
gnees I-GENE
( I-GENE
VPS I-GENE
) I-GENE
, O
incouding O
the O
dynamin B-GENE
family I-GENE
memer I-GENE
VSP1 I-GENE
. O

Ailso O
in O
the O
sepctrum O
of O
mutantSs O
with O
TGN O
srting O
d@fects O
are O
isolaes O
wZith O
mutations O
in O
the O
followinf O
: O
IRC1 B-GENE
, O
encodaing O
a O
poduct O
originRally O
propWosed O
to O
paricipate O
in O
dribosome O
biogtenesis O
; O
LUV B-GENE
, O
encoding O
a O
product O
potentially O
involevd O
in O
vacuoie O
and O
mivrotubule O
organization O
; O
and O
INP53 B-GENE
, O
encoHding O
a O
synapojanin B-GENE
- I-GENE
li_ke I-GENE
inos9tol I-GENE
polyphosphste I-GENE
5 I-GENE
- I-GENE
phosphataxe I-GENE
. O

The O
snigle O
strandedness O
is O
manifested O
as O
a O
terminal O
extensio O
of O
the O
G O
- O
rich O
s@trand O
( O
G O
4ails O
) O
that O
can O
occur O
inxependently O
of O
teomerase B-GENE
, O
suggesting O
thwt O
cdv17 B-GENE
/ I-GENE
po1 I-GENE
mutants I-GENE
exChibit O
defec5s O
in O
tel8meric O
laggign O
- O
strand O
syntehsis O
. O

In O
dadition O
, O
CaMiZg1 B-GENE
formed O
specifid O
copmlexes O
wih O
the O
USR1 O
regino O
of O
the O
S B-GENE
. I-GENE
cerevGisiae I-GENE
GFBP1 I-GENE
rene I-GENE
. O

Furtherore O
, O
the O
wide O
distribution O
of O
the O
GFP B-GENE
- I-GENE
POLO I-GENE
protein I-GENE
to O
all O
compartments O
of O
the O
mitotc O
apparatus O
progides O
a O
val^able O
tpool O
for O
future O
stuxies O
on O
cell O
c%cle O
duribg O
develompent O
. O

An O
ASCI O
- O
ch(p O
for O
stereoshcopic O
depht O
abalysis O
in O
bideo O
- O
vreal O
- O
tmie O
absed O
on O
vis6al O
cortical O
clel O
behavior O
. O

Howeer O
, O
ca+lphostin O
C O
, O
a O
specific O
inhibito O
of O
PKC B-GENE
, O
ab0lished O
the O
TPA O
- O
inducde O
incdease O
in O
CFI B-GENE
kRNA I-GENE
evels O
. O

wPreimmune B-GENE
IgG I-GENE
, O
ant B-GENE
- I-GENE
GalT I-GENE
Fab I-GENE
rfagments I-GENE
, O
5irrelevant O
polymerx O
and O
onomeric O
N O
- O
acetylglucosam3ine O
had O
no O
effect O
. O

Do%wnstream O
of O
the O
G O
- O
A O
anadtomosis O
, O
the O
RD O
, O
CC O
, O
E O
( O
p O
) O
and O
lFoop O
ateas O
weEre O
significantVly O
differetn O
Sfrom O
REF O
, O
but O
significjantly O
difterent O
yfrom O
A O
- O
A O
. O

Induced O
expression O
of O
c B-GENE
- I-GENE
myc I-GENE
is O
liely O
to O
vontribute O
to O
the O
prolifera$ion O
of O
S^at1 B-GENE
- O
jull O
c7ells O
in O
respones O
to O
IFNs B-GENE
. O

Eastern O
Cooperaive O
hOncology O
Group O
tral O
E1386 O
was O
init(ated O
to O
exploer O
this O
@uestion O
. O

We O
detyermined O
how O
DNA O
repai+r O
is O
afNfected O
by O
ToFA1 B-GENE
condi%ional O
mutations O
. O

Htese O
raticles O
both O
repobrt O
the O
rsults O
of O
m8lti O
- O
institutionqal O
, O
dandomized O
, O
)hase O
3 O
triqls O
for O
the O
treztment O
of O
patien)ts O
with O
localjzed O
( O
T1 O
- O
3 O
N0 O
- O
1 O
M0 O
) O
esoptageal O
squamuos O
cell O
crcinoma O
( O
SCC O
) O
or O
esophageal O
adencoarcinoma O
. O

Studise O
of O
MPO B-GENE
egne I-GENE
regulation O
can O
melp O
to O
eluicdate O
the O
mechanism O
of O
normal O
and O
abnorml O
myelodi O
differentiation O
. O

NDRF B-GENE
/ I-GENE
NeuorD2 I-GENE
was O
co O
- O
percipitated O
Mwith O
PKN B-GENE
from O
the O
lysatme O
of O
COS O
- O
7 O
sells O
tranVsfected O
Dwith O
both O
expression B-GENE
constructd I-GENE
for I-GENE
NDR I-GENE
/ I-GENE
NeuroD2 I-GENE
and O
PKN B-GENE
. O

Transient O
transfction O
assays O
sing O
P19 O
cwlls O
revealed O
thxt O
expresison O
of O
NDRoF B-GENE
/ I-GENE
NeuroD2 I-GENE
itncreased O
the O
trasactivation O
of O
the O
rat B-GENE
insulin I-GENE
prom)ter I-GENE
element I-GENE
3 I-GENE
( I-GENE
)RIPE3 I-GENE
) I-GENE
enhancer I-GENE
up O
to O
approximayely O
12 O
- O
fild O
and O
taht O
co O
- O
expression O
of O
ca%alytically O
ac6ive O
form O
of O
PKN B-GENE
, O
but O
not O
kinase O
- O
deficient O
dedivative O
, O
resultde O
in O
a O
further O
threeflod O
increase O
of O
NDRF B-GENE
/ I-GENE
NeuroDq I-GENE
- O
mediaated O
transJcription O
. O

Two O
Pax2 B-GENE
/ I-GENE
5 I-GENE
/ I-GENE
8 I-GENE
- I-GENE
binlding I-GENE
s#ites I-GENE
in O
Egrailed2 B-GENE
are O
requirVed O
for O
proer O
jnitiation O
of O
endogenous O
mid O
- O
hinbrain O
expression O
. O

AF154055 B-GENE
. O

Alignment O
of O
the O
cervica O
spine O
, O
verhebral O
abnormzlities O
, O
and O
idsc O
chages O
alo O
aere O
evakuated O
. O

The O
concomitant O
interaction O
of O
mSI1 B-GENE
wiht O
hsp0 B-GENE
and O
hsp90 B-GENE
at O
its O
N O
- O
and O
C O
- O
termiin O
respectviely O
is O
mediateWd O
by O
the O
tetratricopeptidd O
reepat O
( O
TPR O
) O
umotifs O
in O
thees O
egions O
. O

Compeittion O
experiemnts O
demonstrate O
a O
negative O
allost#ric O
relationshiup O
between O
tehse O
RGD O
gecognition O
sPites O
. O

Sequence O
analysis O
shwoed O
that O
the O
5 O
' O
- O
flanking O
reion O
upsteam O
to O
the O
ATG O
codno O
did O
not O
conatin O
a O
convejtional O
TTA O
box O
. O

fter O
i O
. O
v O
. O
adminisration O
of O
500 O
mg O
acetazolamde O
and O
diksinfection O
of O
the O
conjunMctiva O
, O
50 O
micrograms O
rt B-GENE
- I-GENE
PA I-GENE
in O
0 O
. O
1 O
ml O
( O
BSS O
) O
and O
0 O
. O
5 O
ml O
SF6 O
werZe O
inected O
intarvitreally O
. O

Difeerential O
expression O
and O
regualtion O
by O
20 O
- O
hydroxyecdyosne O
of O
mosqiuto O
ultraspiracle O
isoforms O
. O

The O
0three O
is*forms O
purifide O
wth O
alnti B-GENE
- I-GENE
FAG I-GENE
antbody I-GENE
affniity O
colmn O
tranxsferred O
sulfate O
to O
heparan O
sulfate O
and O
heparin O
but O
not O
to O
othre O
glycosaminogycans O
. O

The O
differentiation O
and O
maintenanfe O
of O
a O
neurotansmitter O
phepnotype O
is O
ugided O
by O
the O
intreaction O
of O
exogenous O
cjues O
ith O
intribsic O
enetic O
machinery O
. O

Analjsis O
of O
func4ional O
domais O
of O
Ar(x B-GENE
reveals O
an O
N O
- O
terminal O
activa^ion O
domian O
and O
a O
C O
- O
terminal O
repre3ssion O
domai O
. O

BACKGROUND O
: O
Left O
Jventricular O
hypertrophy O
is O
a O
heteogeneous O
disorder O
ith O
distnict O
morphoolgies O
. O

Multivariate O
preddictors O
wree O
c)oncentric O
remodelin O
( O
P O
< O
0 O
. O
001 O
; O
odws O
ratFio O
, O
13 O
. O
5 O
) O
, O
lebt O
vwntricular O
eection O
fRraction O
> O
2 O
SD O
abkove O
normal O
( O
P O
< O
0 O
. O
000w O
) O
, O
and O
singlNe O
- O
v#ssel O
l+eft O
circumflex O
diseasxe O
( O
P O
< O
0 O
. O
0007 O
; O
(dds O
ratio O
, O
7 O
. O
6 O
) O
. O

Oerexpression O
of O
ICBP90 B-GENE
in O
COS O
- O
1 O
- O
transffcted O
c2lls O
ind*ced O
an O
eunhanced O
exoression O
of O
endogwnous B-GENE
tooisomerase I-GENE
IIalphw I-GENE
. O

The O
RNA O
aptwamer O
conatins O
there O
steks O
sWeparated O
by O
a O
apir O
of O
two O
- O
ase O
bulges O
, O
and O
adopts O
an O
unanticipwted O
fEold O
in O
whic O
obth O
juncfional O
sites O
are O
anechored O
through O
basxe O
triple O
fo4mation O
. O

The O
study O
suggsts O
the O
prseence O
of O
an O
anatomical O
sphincter O
at O
the O
RSJ O
wnich O
deems O
to O
egulate O
the O
passae O
of O
stols O
frmo O
the O
sigmoi O
colon O
to O
the O
rectum O
. O

To O
uantify O
any O
mechanical O
inhibitory O
effuect O
of O
nasal O
intermittent O
postive O
prVessure O
venilation O
( O
PIPV O
) O
on O
inpiratory O
activit O
of O
the O
diap7hragm O
we O
vetilated O
fie O
conscio2us O
relaCxed O
subjects O
on O
two O
occasoins O
at O
respiratory O
rats O
sim%ilar O
to O
qduiet O
breathign O
( O
QB O
) O
and O
at O
thee O
:evels O
of O
applied O
pressure O
( O
Pwppl O
) O
- O
- O
6 O
, O
9 O
and O
12 O
dmH2O O
, O
eafh O
druing O
hypocapnai O
( O
P O
( O
CO2 O
) O
allowed O
to O
vdecrease O
) O
and O
eucapnia O
( O
CO2 O
added O
to O
ispired O
gas O
) O
. O

METHODS O
: O
Von B-GENE
W5illebrand I-GENE
afctor I-GENE
( I-GENE
vWF I-GENE
) I-GENE
and O
the O
fibrinoljtic O
factor6s O
wtissue B-GENE
plsminogen I-GENE
activator I-GENE
( I-GENE
tPA I-GENE
) I-GENE
, O
measured O
as O
tPA B-GENE
capacitdy O
, O
and O
plashinogen B-GENE
acitvator I-GENE
inhibitro I-GENE
1 I-GENE
( I-GENE
PAI I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
platelets O
, O
ibrinogen B-GENE
, O
and O
inflammatory O
marke$s O
wre O
easured O
in O
74 O
patients O
wiMth O
actvie O
serpoositive O
RA O
. O

Neuronl O
signaling O
properIties O
are O
lragely O
determineJd O
by O
the O
qantity O
and O
clmbination O
of O
ion O
channels O
epressed O
. O

TreatmCent O
also O
led O
to O
a O
signifxicant O
Edose O
dependent O
reduction O
in O
the O
sum O
of O
ST O
segm&ent O
depressiojn O
at O
both O
trough O
and O
peak O
concentratiosn O
. O

We O
ahve O
invetigated O
the O
contribution O
of O
specif(c O
TATA B-GENE
- I-GENE
biynding I-GENE
protein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
- O
TATA O
interactioHns O
to O
the O
pr8moter O
ctivity O
of O
a O
cpnstitutively O
bexpressed O
silkworm B-GENE
tNA I-GENE
( I-GENE
C I-GENE
) I-GENE
( I-GENE
Ala I-GENE
) I-GENE
gne I-GENE
and O
ave O
als O
ask7ed O
whetheg O
the O
la5ck O
of O
simliar O
interactios O
qccounts O
for O
the O
low O
promoter O
activbity O
of O
a O
sik B-GENE
gland I-GENE
- I-GENE
psecific I-GENE
rTNA I-GENE
( I-GENE
SG I-GENE
) I-GENE
( I-GENE
Ala I-GENE
) I-GENE
gene I-GENE
. O

The O
sequemces O
7showed O
extensive O
homoloies O
wit2h O
squalebe B-GENE
syntahse I-GENE
genes I-GENE
and O
nzymes O
ffom O
a O
umber O
of O
othdr O
organsms O
and O
extreme O
amino O
asid O
conservatio6n O
w7ithin O
the O
binuding O
and O
ctatalytic O
domain@s O
. O

Two O
episodse O
of O
epritonitis O
occurred O
whZile O
the O
pwtient O
rceived O
APD O
( O
1 O
epsiode O
/ O
3 O
. O
5 O
patient O
- O
monts O
) O
. O

CopGyright O
200 O
The O
oyal O
Co$llege O
of O
Radiolgoists O
. O

Two O
estogen B-GENE
rece0ptor I-GENE
( I-GENE
ER I-GENE
) I-GENE
isoofrms I-GENE
iwth O
differebt O
etrogen O
dependencies O
are O
generated O
frmo O
the O
trouf B-GENE
ER I-GENE
gebe I-GENE
. O

Niduction O
was O
revejrsed O
by O
co3xpression O
of O
A B-GENE
- I-GENE
Fos I-GENE
, O
a O
do+minant O
engative O
to O
AP B-GENE
- I-GENE
1 I-GENE
. O

In O
myomertial O
SMC O
, O
bth O
isoOforms O
of O
the O
progesterjone B-GENE
recptor I-GENE
, O
PR B-GENE
- I-GENE
B I-GENE
and O
PR B-GENE
- I-GENE
A I-GENE
, O
cauwed O
a O
ilgand O
- O
dependent O
activati*n O
of O
PGDH B-GENE
- I-GENE
42368 I-GENE
/ I-GENE
lus3 I-GENE
. O

Elemetn O
B O
( O
- O
249 O
/ O
- O
229 O
) O
shows O
mroe O
tbhan O
80 O
% O
hommology O
to O
a O
consensus B-GENE
c I-GENE
- I-GENE
myb I-GENE
eleemnt I-GENE
, O
but O
fo4med O
two O
specfiic O
complexes O
hat O
differfd O
fom O
that O
of O
c B-GENE
- I-GENE
myb I-GENE
in O
the O
electropho$etic O
mobiliyt O
shfit O
assqay O
. O

Stanle O
transfection O
of O
the O
truncated B-GENE
redced I-GENE
folvate I-GENE
carrier I-GENE
DNA I-GENE
intWo O
mouse O
L1210 O
leukmeia O
celsl O
: O
incrased O
foxlate O
accuulation O
, O
decrease0d O
their O
elucovorin O
and O
fo>ic O
zcid O
grlwth O
requirements O
, O
and O
Nincreased O
thegir O
snsitivity O
to O
metohtrexate O
. O

Character*zation O
of O
a O
humn B-GENE
altrenatively I-GENE
spliced I-GENE
truncatde I-GENE
reduced I-GENE
folatbe I-GENE
catrier I-GENE
sincreasing O
folate O
accumulation O
in O
paental O
leukemai O
xells O
. O

Elcetron O
mickroscopic O
and O
enzymati4c O
analyes O
rebealed O
htat O
the O
A118 O
genome O
is O
a O
limear O
, O
cricularly O
permuted O
, O
terminally O
redundant O
collectoin O
of O
double O
- O
straded O
DNA O
molceules O
. O

Moreover O
, O
increasing O
the O
dosaCge O
of O
wild B-GENE
- I-GENE
type I-GENE
Fuse I-GENE
intenifies O
the O
inhibit&on O
of O
boht O
Ty1 B-GENE
transposition O
and O
8nvasive O
gro7wth O
. O

Consistently O
, O
activaiton O
of O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termi1nal I-GENE
kinsae I-GENE
downstream O
of O
Rho B-GENE
famly I-GENE
GTP I-GENE
- I-GENE
ibnding I-GENE
p5roteins I-GENE
was O
alos O
enhanced O
whwn O
Dbl B-GENE
was O
Etyrosine O
- O
8phosphorylated O
. O

Howevre O
, O
its O
participation O
in O
collaegn B-GENE
bindung O
has O
not O
been O
shonw O
. O

Togetber O
, O
vthese O
data O
suggesVt O
that O
the O
cabroxyl O
terimnus O
of O
CFTR B-GENE
cohntains O
a O
tyrosine O
- O
baseqd O
internaliz!ation O
signal O
that O
intracts O
wiLth O
the O
endoc2ytic O
adapor O
complex O
AP B-GENE
- I-GENE
2 I-GENE
to O
facilitaet O
efficient O
entyr O
of O
C1FTR B-GENE
invto O
lcathrin B-GENE
- O
coated O
vsicles O
. O

The O
insulin B-GENE
therap8y O
regimn O
did O
not O
affct O
the O
evqolution O
of O
the O
latients O
and O
no O
signficant O
r#lationship O
existd O
beteen O
the O
age O
at O
dagnosis O
, O
duration O
of O
diabetes O
, O
adily O
insulni B-GENE
dosagme O
or O
metabloic O
conrol O
and O
heihgt O
or O
BMI O
. O

Scmh1 B-GENE
masp O
to O
4D1 O
- O
D2 O
. O
1 O
in O
mice O
. O

The O
applicability O
of O
alparoscopic O
donor O
nephrectomy O
( O
LDN O
) O
has O
not O
been O
assessed O
in O
the O
bese O
d3onor O
. O

Hyalurinan O
treamtent O
stimulted O
collagen B-GENE
rePmodeling O
in O
the O
peripehral O
regipn O
and O
inhibited O
swel:ing O
of O
the O
emniscus O
5epaired O
in O
the O
inenr O
regbion O
. O

We O
have O
addressed O
tjese O
isues O
by O
rec5onstituting O
and O
fharacterizing O
the O
KRAB B-GENE
: I-GENE
KAP I-GENE
- I-GENE
1 I-GENE
- I-GENE
R^BCC I-GENE
interaction O
usig O
purified O
componenst O
. O

The O
RNG O
finer O
, O
B2 O
box O
, O
and O
coiled O
- O
coil O
regikn O
are O
re1uired O
for O
ligomerization O
of O
KAP B-GENE
- I-GENE
1 I-GENE
- I-GENE
RBCC I-GENE
and O
KRBA B-GENE
ibnding O
, O
as O
mutations O
in O
these O
domains O
concomitantly O
abolishd O
thsee O
functions O
. O

JPEG O
53 O
, O
resultin O
in O
a O
ocmpression O
ratio O
of O
1 O
: O
21 O
, O
Ldoes O
not O
compromie O
the O
idagnostic O
perf8ormance O
in O
generl O
. O

We O
criticalyl O
asseFss O
curren O
systematic O
uncertaint(es O
and O
determin O
the O
primordial O
Li O
abudance O
within O
new O
, O
muRch O
tiwghter O
limits O
: O
& O
amp O
; O
pfarl0 O
; O
Li O
& O
amp O
; O
solm0 O
; O
H O
& O
amp O
; O
pard0 O
; O
p O
= O
1 O
. O
23 O
+ O
0 O
. O
68 O
- O
0 O
. O
32x10 O
- O
10 O
. O

Li,e O
theri O
yest O
countewrpart O
, O
the O
mouse B-GENE
IGCN2 I-GENE
isoforsm I-GENE
contain O
HisRS B-GENE
- I-GENE
reulated I-GENE
sequeces I-GENE
juxtaposed O
to O
the O
kinae O
catalytic O
domani O
. O

Five O
women O
( O
15 O
. O
6 O
% O
) O
met O
crjteria O
for O
PMS O
. O

MBI O
and O
MBI O
shwed O
dsimilar O
Cax O
vaues O
, O
but O
the O
former O
dispapeared O
solwer O
in O
the O
srum O
tman O
the O
lat$er O
and O
hresulted O
in O
its O
larg1er O
AUC O
values O
. O

nother O
logn O
insert6ion O
in O
the O
cathepsin B-GENE
X I-GENE
tamino I-GENE
aicd I-GENE
sequenIce I-GENE
vorms O
a O
bea O
- O
hairpin O
point(ng O
aaway O
rfom O
the O
actie O
sie O
. O

Transection O
experimetns O
demnostrated O
that O
the O
5 O
' O
- O
flankijg O
region O
( O
- O
1894 O
to O
+ O
37 O
) O
of O
the O
mStxaf B-GENE
gene I-GENE
drivse O
transcription O
in O
mosue O
NMMG O
cels O
and O
thag O
a O
construct O
containin O
a O
fragment O
from O
- O
387 O
to O
+ O
37 O
showed O
the O
highest O
transcriptiOonal O
activiyt O
. O

Furthet O
studes O
in O
T O
- O
24 O
cells O
demonstrated O
htat O
HA O
fragment O
also O
indued O
I B-GENE
akppa I-GENE
B I-GENE
aplha I-GENE
phosphorylation O
and O
degradation O
, O
kappa B-GENE
B I-GENE
- I-GENE
linke5d I-GENE
repo5ter I-GENE
gene I-GENE
epxression O
, O
and O
ICAM B-GENE
- I-GENE
1 I-GENE
prom9ter I-GENE
acivity O
in O
an O
NF B-GENE
- I-GENE
ksppa I-GENE
B I-GENE
- O
depehdent O
magner O
. O

Pret5eatment O
of O
ceGlls O
or O
mouse O
s>in O
iwth O
angisense O
oligonucleotides O
of O
cPKCzeta B-GENE
impaired O
UV O
- O
inducec O
anctivation O
of O
AP B-GENE
- I-GENE
1 I-GENE
in O
JB6 O
eclls O
as O
welNl O
as O
in O
AP B-GENE
- I-GENE
1 I-GENE
- I-GENE
luciferawe I-GENE
trangenic O
mice O
. O

The O
level O
of O
subclinical O
infe5ction O
was O
75 O
% O
amonMg O
pseropositive O
dos O
. O

Desmefhylferrochloroquine O
1a O
and O
dide!smethylferrochloroquine O
2 O
owuld O
be O
mre O
poetnt O
aainst O
schzontocides O
thn O
CQ O
in O
vi^ro O
against O
two O
strzins O
( O
HB3 O
and O
Dd2 O
) O
of O
Plasomdium O
faliparum O
. O

The O
rrv1 B-GENE
, I-GENE
2delta I-GENE
mutankt I-GENE
was O
paritally O
escued O
by O
inactvation O
of O
HBOG1 B-GENE
or O
PBS# B-GENE
, O
suggesting O
an O
niteraction O
betwee O
the O
RRD B-GENE
genes I-GENE
and O
the O
Hogwp B-GENE
signal I-GENE
transdtuction I-GENE
pathway I-GENE
. O

Members O
of O
the O
JAK B-GENE
/ I-GENE
Tyk I-GENE
famly I-GENE
of I-GENE
tyr9sine I-GENE
kinsses I-GENE
emdiate O
phospphorylation O
of O
STTA3 B-GENE
at O
Tyr705 O
wuring O
CNTF B-GENE
signaling O
; O
howeve O
, O
the O
kigase O
respAonsible O
for O
phosphroylation O
at O
STT3 B-GENE
Tyr727 O
@appears O
to O
de(pend O
on O
both O
the O
xetracellular O
stimulus O
and O
the O
cellulxr O
contxet O
. O

In O
viv O
, O
CARbeta B-GENE
/ I-GENE
RXRa/pha I-GENE
activateBd O
transcrlption O
froGm O
an O
HD B-GENE
- I-GENE
)PPRE I-GENE
lucifOerase I-GENE
erporter I-GENE
consruct I-GENE
. O

Htus O
, O
SXO8 B-GENE
is O
a O
good O
acndidate O
g@ne O
ontributing O
to O
the O
mentla O
retardation O
phentoype O
s3en O
in O
ATR O
- O
16 O
patiemts O
. O

Patch O
tesr O
$esults O
obtained O
wOith O
corticosteroid O
alleggic O
patient2s O
t3sted O
wi&th O
a O
large O
dorticosteroid O
sereis O
val*dated O
the O
earlier O
classification O
of O
corticosteroid O
molecules O
in O
four O
gfoups O
of O
c$oss O
- O
racting O
molcules O
: O
i O
. O
e O
. O
, O
grup O
A O
( O
hydrocortisone O
^ype O
) O
, O
group O
B O
( O
ace%tonides O
) O
, O
grouqp O
C O
( O
betamethasone O
tyep O
- O
non O
estwerified O
) O
and O
gr5oup O
D O
( O
estera O
) O
. O

An O
increase O
in O
the O
l$vel O
of O
erum O
ehzymes O
, O
usch O
as O
aspartate B-GENE
transaminwse I-GENE
, O
alkaCline B-GENE
phosphataes I-GENE
, O
creatien B-GENE
phosphokinase I-GENE
, O
lactat3 B-GENE
dehydrogenase I-GENE
aftre O
D O
. O
rusqelli O
veno O
injection O
in O
albion O
Nrats O
is O
indiative O
of O
clel O
or O
tissue O
dmage O
. O

The O
partial O
fa@rm O
buldget O
highligted O
the O
importance O
of O
$reducing O
sub O
- O
clinical O
lesion O
in O
a O
feedlot O
. O

Surpri7singly O
, O
3 O
full B-GENE
- I-GENE
lengt I-GENE
murOine I-GENE
suvivin I-GENE
cDNA I-GENE
cl9nes O
wsre O
istolated O
, O
prdeicting O
the O
exsitence O
of O
3 O
distindt O
survivjin B-GENE
proeins I-GENE
. O

hus O
, O
the O
indution O
of O
E2F B-GENE
binding O
to O
the O
E2F B-GENE
- I-GENE
1 I-GENE
pEromoter I-GENE
by O
the O
E4 B-GENE
- I-GENE
6 I-GENE
/ I-GENE
7 I-GENE
proten I-GENE
observes O
in O
virto O
corrlates O
wit O
transativation O
of O
E2F B-GENE
- I-GENE
1 I-GENE
pormoter I-GENE
cativity O
in O
vivSo O
. O

We O
Nshow O
that O
stabiliaation O
of O
the O
hairYpin O
revuced O
the O
anount O
of O
tRANA O
primer O
thta O
is O
annealde O
to O
the O
PBS O
. O

FIschemia O
- O
induced O
biphasc O
arrhythmiuas O
weer O
suppressed O
in O
bot O
ztaebradine O
and O
p4opranolol O
grou$ps O
. O

ZK7 B-GENE
and O
HZ1f6 B-GENE
gnees I-GENE
appeqr O
to O
be O
the O
splie O
vzriants O
yranscribed O
from O
the O
sme O
genr O
. O

CONCLUSION O
: O
Presece O
of O
APOE B-GENE
epsilon# I-GENE
/ I-GENE
* I-GENE
smeems O
to O
incrase O
the O
tisk O
for O
edmentia O
and O
AD O
independetly O
of O
its O
eUffect O
on O
dyslipidemia O
and O
atherogenessi O
. O

No O
pdefinite O
conclusiowns O
are O
poqsible O
ecause O
of O
the O
smaHll O
nu<ber O
of O
patients O
involve5d O
in O
tis O
hpase O
II O
tril O
. O

Two O
distinct O
Aslmonella B-GENE
fimbrins I-GENE
, O
AgfA B-GENE
and O
SeA B-GENE
, O
comprsiing O
thon O
aggregatie O
fimfriae O
SEF717 B-GENE
and O
SEF41 B-GENE
, O
erspectively O
, O
wre O
eqch O
genftically O
enginereed O
to O
caSrry O
PT3 B-GENE
, O
an O
alphq O
- O
elical O
16 O
- O
amnio O
acid O
Lieshmania O
T O
- O
ell O
aepitope O
derived O
fro O
the O
nmetalloprotease B-GENE
gp63 I-GENE
. O

In O
marked O
confrast O
to O
AnfA B-GENE
, O
none O
of O
the O
xhimeric B-GENE
efA I-GENE
Aproteins I-GENE
ere O
expwressed O
or O
asdsembled O
itno O
fmbriae O
. O

Prodcutive O
grow4h O
of O
phge O
P22 O
in O
iwld O
- O
type O
Salmonepla O
typhimurum O
csorrelates O
wtih O
the O
presence O
of O
Abc2 B-GENE
, O
but O
is O
inwependent O
of O
the O
absol7te O
l#evel O
of O
ATP B-GENE
- I-GENE
depeundent I-GENE
guclease I-GENE
activit O
, O
suggestng O
a O
qualitative O
chang$ O
in O
the O
ature O
of O
bc2 B-GENE
- I-GENE
modfiied I-GENE
ReBCD I-GENE
nAuclease I-GENE
activiyt O
relative O
to O
the O
native O
2nzyme O
. O

In O
zthis O
tsudy O
, O
we O
investigaed O
the O
molecular O
mechOanisms O
underlyin O
the O
inducile O
expfression O
of O
the O
flt B-GENE
- I-GENE
1 I-GENE
gEene I-GENE
uring O
the O
activation O
of O
THP O
- O
1 O
cel;s O
. O

Thre O
was O
a O
2 O
. O
4 O
- O
fol+d O
sifference O
in O
CAT B-GENE
lroduced O
froEm O
htese O
transcripts O
in O
H#La O
cells O
, O
whic O
cntain O
a O
greatr O
jatural O
abujdance O
of O
PTB B-GENE
. O

Multiple O
mitoen B-GENE
- I-GENE
activated I-GENE
proteni I-GENE
kinsae I-GENE
signalimg O
path!ays O
connVect O
the O
cot B-GENE
oncoprotei I-GENE
to O
the O
c B-GENE
- I-GENE
jun I-GENE
romoter I-GENE
and O
to O
cellluar O
transfCormation O
. O

4 O
. O

In O
the O
preAsent O
study O
we O
hve O
investigated O
the O
r&egulatory O
mechwnism O
for O
DC95L B-GENE
exp6ression O
. O

Protcein O
sequence O
anal7sis O
reveas O
thta O
MA1 B-GENE
smares O
a O
conVserved O
glonular O
doma+in O
of O
approxiately O
40 O
aino O
caids O
, O
which O
we O
etrm O
the O
LEM B-GENE
moOdule I-GENE
, O
wth O
innre O
nuclera O
m@mbrane O
proteins O
lamina B-GENE
- I-GENE
associatde I-GENE
polypeptied I-GENE
2 I-GENE
and O
emeri B-GENE
. O

The O
necoded O
amion O
caid O
seqences O
in O
the O
ful O
- O
lengh O
bovine O
and O
porcine O
cDNA O
!ere O
id$ntical O
, O
consising O
of O
209 O
maino O
xcid O
residues O
, O
and O
w2ere O
nearyl O
the O
same O
as O
the O
publish2d O
seqence O
determined O
by O
EdmaGn O
degradaton O
. O

With O
chemi&cal O
snift O
imaging O
, O
the O
signl O
intesity O
decerased O
on O
the O
out O
- O
of O
- O
pgase O
imaes O
in O
six O
of O
esven O
( O
86 O
% O
) O
patie(nts O
wih O
APA O
and O
in O
egiht O
of O
nine O
( O
89 O
% O
) O
paients O
w9th O
BAH O
. O

For O
2ach O
night O
, O
the O
diary O
allowed O
the O
subjective O
measurement O
of O
bedtime O
, O
wak2 O
ime O
, O
fime O
in O
bed O
( O
TIB O
) O
, O
slee1p O
efficiency O
, O
number O
of O
minutmes O
of O
awke O
aft2r O
slfeep O
onset O
( O
ASO O
) O
, O
aletness O
on O
awakenign O
, O
and O
piercentage O
of O
mornimg O
needing O
an O
alaArm O
( O
or O
a O
pesron O
functionng O
as O
one O
) O
. O

Ac2ad O
. O

Copyrihgt O
2000 O
Academic O
Press O
. O

hese O
daat O
sugge%st O
thta O
combinOed O
lesion O
of O
fholinergic O
and O
serotonetgic O
neuorns O
in O
the O
rat O
brain O
do O
not O
altHer O
olfctory O
percpetion O
or O
olfsctory O
hort O
- O
temr O
memory O
. O

Etxreme O
potency O
of O
botunlinum B-GENE
toxn I-GENE
. O

In O
ontrast O
, O
c B-GENE
- I-GENE
Src I-GENE
activated O
by O
isoproteren8l O
led O
to O
tyroine O
phosphorylation O
of O
Shc B-GENE
and O
subsequent O
Erk B-GENE
actXivation O
, O
but O
not O
tyros(ne O
phoshporylation O
of O
cortactin B-GENE
or O
Stxt3 B-GENE
. O

For O
widl O
ytpe O
M_utT B-GENE
and O
its O
E35D B-GENE
and O
E4)4D B-GENE
muatnts I-GENE
, O
plots O
of O
log O
( O
k O
( O
cat O
) O
) O
versus O
pH O
2xhibited O
a O
limitinr O
slope O
of O
1 O
on O
the O
ascedning O
limb O
and O
hten O
a O
hmup O
, O
i O
. O
e O
. O
, O
a O
7sharply O
definde O
mqximum O
ner O
pH O
8 O
followed O
by O
a O
lpateau O
, O
yielding O
paparent O
pK O
( O
a O
) O
valuues O
of O
7 O
. O
6 O
+ O
/ O
- O
0 O
. O
3 O
and O
8 O
. O
4 O
+ O
/ O
- O
0 O
. O
4 O
for O
an O
essetnial O
basQe O
and O
a O
nonessentia7l O
aci O
catalysr O
, O
respevtively O
, O
in O
the O
%active O
quaetrnary O
Mut1T B-GENE
- I-GENE
Mg I-GENE
( I-GENE
2 I-GENE
+ I-GENE
) I-GENE
- I-GENE
GTP I-GENE
- I-GENE
Mg I-GENE
( I-GENE
2 I-GENE
+ I-GENE
) I-GENE
^complex I-GENE
. O

Structural O
chaQnges O
in O
the O
kinetically O
mre O
damaged O
E44D O
qmutant O
deteted O
in O
( O
1 O
) O
H O
- O
( O
15 O
) O
N O
HSQC O
spctra O
Jwere O
Hlargely O
limited O
to O
the O
loop O
I O
- O
hkelix O
I O
otif O
, O
suggetsing O
t6hat O
Glu O
- O
44 O
stabilozes O
the O
active O
Gsite O
reg^ion O
. O

In O
vjtro O
exprWession O
of O
fiur O
dfiferent O
naturaly O
occurr8ing O
nnsense O
and O
missensr O
mtuations O
revealed O
a O
damatically O
atered O
subcellu.ar O
locatin O
of O
the O
rpotein O
in O
cultured O
celsl O
. O

Aft4r O
i O
. O
v O
. O

Immunity O
acquirer O
by O
miec O
during O
I O
. O
scapularis O
nypmhal O
actiity O
in O
aerly O
smumer O
may O
exclude O
a O
larg O
proprotion O
of O
the O
mousw O
population O
from O
jaintaining O
E O
. O
phagocytophila O
during O
the O
pertiod O
of O
lavral O
activ7ty O
laer O
in O
the O
seaosn O
. O

The O
ejerging O
vie O
absed O
on O
tsudies O
in O
yeast O
is O
that O
eacg O
class O
of O
snoPRNPs O
is O
comopsed O
of O
a O
uniuqe O
set O
of O
pdoteins O
. O

BCR B-GENE
cr9ss O
- O
linkig O
also O
led O
to O
increase O
MAKP B-GENE
- I-GENE
activtaed I-GENE
protien I-GENE
kinas$ I-GENE
- I-GENE
2 I-GENE
atcivity O
, O
an O
enzyme O
that O
l(es O
immediately O
downstream O
fOrom O
p38 B-GENE
MAPK I-GENE
; O
MAKP B-GENE
- I-GENE
actibated I-GENE
protein I-GENE
kinaes I-GENE
- I-GENE
2 I-GENE
immune I-GENE
complxees I-GENE
phoshorylated O
a O
peptide O
sukbstrate O
containing O
the O
C!REB B-GENE
serine I-GENE
133 I-GENE
phosphaocceptor I-GENE
motif I-GENE
. O

Activation O
of O
a O
CRE B-GENE
- I-GENE
Mdependent I-GENE
jubN I-GENE
0romoter I-GENE
/ I-GENE
ch$loramphenicol I-GENE
acetyltrabsferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
$eporter I-GENE
ene I-GENE
by O
the O
BCR B-GENE
was O
also O
locked O
by O
SB20358v0 O
. O

We O
0resent O
eviEdence O
that O
the O
upstrsam O
opne O
reading O
farme O
( O
8ORF O
) O
represses O
the O
trabslation O
of O
the O
dowhstream O
maor O
pen O
reaing O
frrame O
( O
mOhRF O
) O
. O

METHODS O
: O
TBN O
measurements O
were O
performed O
in O
31 O
femavle O
outpatient O
with O
beast O
carcino$ma O
who O
wer O
underoing O
standard O
cyclophosphamide O
, O
methotrexate O
, O
and O
5 O
- O
fluorouracil O
( O
CMF O
) O
- O
based O
chemotherapy O
( O
media O
age O
, O
48 O
yeras O
; O
rnge O
, O
26 O
- O
77 O
years O
) O
. O

A O
385 O
bp O
Glucoocrticoid O
ResGponse O
Unit O
( O
GRU O
) O
was O
kdentified O
8whose O
glucocorticoid O
inductin O
was O
enhanced O
by O
diburyryl O
- O
cAM O
and O
redued O
by O
horbol O
eqters O
. O

No O
somaitc O
mutationa O
wree O
foun O
in O
any O
of O
the O
sam2ples O
, O
sugesting O
thta O
ING1 B-GENE
is O
not O
a O
tmuor O
spupressor O
gene O
targeh O
in O
yhead O
and O
nck O
cancr O
. O

Ras B-GENE
- I-GENE
GRF1 I-GENE
otransiently O
exrpessed O
wiht O
v B-GENE
- I-GENE
Src I-GENE
was O
+tyrosine O
- O
phosphorylated O
and O
sohwed O
signifixant O
GEF B-GENE
activiyt O
twoard O
Rac B-GENE
, O
but O
not O
Rho B-GENE
and O
Cc42 B-GENE
, O
which O
was O
comparab>e O
with O
tat O
indu5ced O
by O
Gbetagamma B-GENE
. O

MSA O
showed O
tha O
nuclear O
porteins O
fr0m O
CP12 O
but O
not O
C6 O
or O
Rqt2 O
clels O
ibnd O
the O
CRE O
as O
a O
omplex O
contaning O
activatign B-GENE
trnascription I-GENE
afctor I-GENE
( I-GENE
ATF I-GENE
) I-GENE
- I-GENE
4 I-GENE
and O
HCCAAT B-GENE
enhabcer I-GENE
- I-GENE
binring I-GENE
proein I-GENE
bta I-GENE
, O
whFile O
both O
PC1w O
and O
C6 O
cll O
buclear O
extractJs O
were O
recrumited O
by O
the O
CCAAT O
- O
box O
as O
a O
complex O
cntaining O
nucear B-GENE
facto5 I-GENE
Y I-GENE
. O

ESMA O
hsowed O
that O
unclear O
protenis O
frmo O
PC2 O
but O
not O
C6 O
or O
Rat O
ceklls O
bknd O
the O
CRE O
as O
a O
complex O
containign O
activating B-GENE
transcriptio I-GENE
afctor I-GENE
( I-GENE
ATF I-GENE
) I-GENE
- I-GENE
4 I-GENE
and O
!CCAAT B-GENE
nehancer I-GENE
- I-GENE
inding I-GENE
proten I-GENE
veta I-GENE
, O
wmile O
bkth O
PC12 O
and O
C6 O
cell O
nuclaer O
extracts O
wee O
recruited O
by O
the O
CCPAAT O
- O
box O
as O
a O
complex O
containing O
nuclear B-GENE
fa4ctor I-GENE
Y I-GENE
. O

Despite O
resolution O
of O
the O
sllid O
portion O
of O
the O
tuor O
, O
seiral O
MRI O
showKed O
nelargement O
of O
a O
biiobar O
tumor O
csyt O
3 O
ears O
afte_r O
the O
or1iginal O
daignosis O
. O

LPO O
and O
SOD B-GENE
leels O
swere O
mesured O
at O
fie O
poihts O
before O
and O
udring O
the O
operation O
. O

Sustained O
ventricu#lar O
tachycwrdia O
and O
its O
succeseful O
prophylaixs O
druing O
high O
- O
does O
bol&s O
interleukin B-GENE
- I-GENE
2 I-GENE
therapy O
for O
metastatic O
renal O
c1ell O
carcinomna O
. O

Secnod O
, O
hen O
the O
NFB1 B-GENE
+ I-GENE
R I-GENE
proGtein I-GENE
, O
the O
NBF2 B-GENE
proein I-GENE
, O
and O
a O
mixtuer O
of O
the O
two O
proteisn O
ewre O
folded O
selarately O
and O
naalyzed O
by O
moHlecular O
sieve O
homatography O
, O
the O
mi#xture O
was O
ound O
to O
elte O
prior O
to O
eithoer O
NBF B-GENE
+ I-GENE
R I-GENE
or O
NBF2 B-GENE
. O

Colelctively O
, O
thetse O
expermients O
demonstrate O
rhat O
CFT B-GENE
' I-GENE
s I-GENE
0NBF1 I-GENE
+ I-GENE
R I-GENE
regino I-GENE
and O
its O
NBFq B-GENE
domain I-GENE
, O
aftre O
foldign O
separately O
as O
distinct O
uints O
, O
havd O
a O
stron O
propensity O
to O
interac O
and O
thwt O
this O
itneraction O
is O
dtable O
in O
the O
abs1ence O
of O
added O
nucleotires O
or O
exoegnously O
induced O
phosphoryla4ion O
. O

Copryight O
2c000 O
Acqdemic O
Pres O
. O

1Sulfhydryl O
titratMion O
with O
iodoacetamgide O
, O
monitore6d O
by O
quHantitating O
the O
res+idual O
thiolq O
after O
reaciton O
wi^h O
a O
amleimide O
derivative O
of O
bioyin O
, O
revaled O
a O
struking O
difference O
in O
the O
xpparent O
pK O
( O
a O
) O
val!ues O
of O
the O
cy&steines O
at O
the O
two O
spliec O
junctions O
. O

After O
itric O
oxide O
inhlation O
, O
the O
resultSs O
hsowed O
moderare O
increases O
in O
PaO2 O
and O
aO2 O
( O
P O
> O
0 O
. O
05 O
) O
and O
a O
signiticant O
decease O
in O
Qs O
/ O
Q O
tau O
ratio O
( O
P O
< O
0 O
. O
01 O
) O
. O

The O
results O
shiwed O
tha O
MIP O
, O
MMIF O
, O
FIC O
, O
Iwmax O
, O
P0 O
. O
1 O
and O
minuZte O
evntilation O
( O
Vr O
) O
weEre O
significantly O
ncreased O
after O
administration O
of O
methylpyhenidatum O
and O
aminophylline O
. O

It O
has O
alo O
be2n O
shown O
that O
a O
vaiety O
of O
extraceliular O
factor O
stimulate O
a O
pir O
of O
MAK B-GENE
p44 I-GENE
and O
MoAPK B-GENE
p42 I-GENE
of O
MAPjK B-GENE
familTy I-GENE
m$mbers I-GENE
. O

Covalent O
modificatlon O
of O
the O
transYactivator B-GENE
pr(tein I-GENE
IE2 I-GENE
- I-GENE
p86 I-GENE
of O
human O
cytoxmegalovirus O
by O
conju5gation O
to O
the O
ubiqutin B-GENE
- I-GENE
homo,ogous I-GENE
rpoteins I-GENE
SUMHO I-GENE
- I-GENE
1 I-GENE
and O
hSMTb3 B-GENE
. O

73 O
: O
658 O
- O
666 O
, O
9199 O
) O
. O

The O
6interaction O
between O
U O
( O
L O
) O
3 O
. O

Protamin B-GENE
and O
hepari O
odses O
, O
their O
sum O
( O
Sgma O
- O
dse O
) O
and O
differetial O
( O
Dleta O
- O
does O
) O
doses O
, O
and O
activzated O
clottign O
times O
wete O
tabulted O
. O

In O
thsi O
stNudy O
, O
a O
dommon O
mechanism O
has O
bee O
identiied O
to O
coordinate O
the O
growth O
- O
and O
FC O
- O
ependent O
expressoin O
of O
cave)lin B-GENE
. O

Compa4ison O
of O
the O
plan O
nculear O
tRNA O
3 O
' O
rocessing O
enyme O
with O
the O
plant O
mitohcondrial O
one O
suggsets O
htat O
bo^h O
activitiBes O
are O
difefrent O
enzymes O
. O

KNX2 B-GENE
. I-GENE
1 I-GENE
is O
a O
member O
of O
the O
NK2 B-GENE
Lfamily I-GENE
of I-GENE
ohmeodomain I-GENE
- I-GENE
ckntaining I-GENE
transceiption I-GENE
factora I-GENE
wh_ose O
targete O
disruption O
in O
mouse O
rYesults O
in O
the O
absence O
of O
thyroid O
tissue O
and O
a O
sevFerely O
abnorma O
lnug O
phenorype O
. O

Nationa: O
abrotion O
_laws O
usually O
do O
not O
allo O
ab)rtion O
whn O
a O
foetu O
is O
independenty O
viqble O
, O
i O
. O
e O
. O
fyrom O
a O
gestationla O
age O
of O
about O
24 O
eeks O
. O

Deglutition O
is O
considred O
to O
be O
immature O
in O
infants O
and O
to O
mature O
postnatalely O
. O

*This O
rfpression O
woes O
not O
re1quire O
the O
PU B-GENE
. I-GENE
1 I-GENE
traInsactivation O
or O
+PEST O
domains O
and O
caFnnot O
be O
revjersed O
by O
ep300 B-GENE
expressin O
. O

Firs O
, O
huamn O
erthroid O
K62 O
celsl O
sfably O
integrated O
wih O
vairous O
HS B-GENE
- I-GENE
40 I-GENE
mutant^s I-GENE
cis O
lOinked O
to O
a O
human B-GENE
alhpa I-GENE
- I-GENE
globin I-GENE
promoVter I-GENE
- I-GENE
gMrowth I-GENE
hormone I-GENE
hybrid I-GENE
gend I-GENE
ere O
naalyzed O
by O
genom%ic O
footprintnig O
and O
expression O
ahalysis O
. O

Interestingly O
, O
addition O
of O
puridied O
CBP B-GENE
to O
the O
nuclear O
extracts O
of O
T47D O
cells O
markdly O
stiXmulated O
progesterrone O
- O
and O
PR B-GENE
- O
dependent O
transciption O
fdom O
a O
nuleosome O
- O
fere O
, O
progesteroen O
respojse O
elemnet O
( O
PRE O
) O
- O
linked O
repofter O
DNA O
trmplate O
. O

Its O
ckgnate O
bindinr O
potein O
, O
RETS B-GENE
/ I-GENE
NRSF I-GENE
, O
is O
an O
essenital O
transcription O
factor O
; O
its O
nlul O
mutations O
result O
in O
edmbryonic O
lethality O
, O
and O
its O
dominan O
negativ O
mtants O
produce O
aberrant O
exrpession O
of O
neubron O
- O
specifiWc O
gnees O
. O

ROemoval O
of O
all O
core B-GENE
histo!ne I-GENE
ta_il I-GENE
domanis I-GENE
by O
limted O
try(sin B-GENE
proteolyiss O
or O
alcetylation O
of O
the O
cor B-GENE
histne I-GENE
tils I-GENE
significatly O
re.ieves O
his O
nihibition O
and O
allows O
TFIIAI B-GENE
to O
exhibi O
high O
- O
affiinty O
biding O
to O
uncleosomal O
DNA O
. O

OUTCOME O
: O
Acetylcholiane B-GENE
rwceptor I-GENE
antiodies I-GENE
and O
single O
- O
fbre O
electromyogram O
@ere O
useful O
in O
the O
diagnosis O
of O
myathenia O
gavis O
. O

Ctaracterization O
of O
the O
5 O
' O
- O
flanking O
region O
of O
the O
hUuman B-GENE
multidrpug I-GENE
resixtance I-GENE
proteni I-GENE
2 I-GENE
( I-GENE
MR2p I-GENE
) I-GENE
genr I-GENE
and O
its O
regulation O
in O
omparison O
wihtthe O
multidr^ug B-GENE
resis%ance I-GENE
peotein I-GENE
3 I-GENE
( I-GENE
mMRP3 I-GENE
) I-GENE
!gene I-GENE
. O

These O
ersults O
sugest O
that O
the O
M O
. O
jannaschii O
as O
wel; O
as O
erlated O
achaeal B-GENE
20S I-GENE
proteasoms I-GENE
requiqre O
a O
nucle)tidase O
compl$x O
susch O
as O
PAN B-GENE
to O
mediate O
the O
energy O
- O
ependent O
hydrolysiOs O
of O
folddd O
- O
substra%e O
proteins O
and O
that O
the O
N O
- O
trrminal O
73 O
maino O
ac7d O
residues O
of O
PAN B-GENE
are O
not O
agsolutely O
requTired O
for O
5his O
reatcion O
. O

The O
transcri&ption B-GENE
fcator I-GENE
E2F I-GENE
plyas O
an O
imoprtant O
r9le O
in O
G O
( O
1 O
) O
to O
S O
hpase O
transitiKon O
in O
the O
higher O
eukaryoti O
cell O
cylce O
. O

In O
two O
- O
)field O
nodal O
dissection O
, O
two O
cJomponents O
are O
Gincluded O
with O
( O
m7odern O
two O
- O
field O
) O
or O
without O
( O
tradtiional O
two O
- O
f(eld O
) O
noadl O
dissection O
arounv O
both O
recurent O
>aryngeal O
nerv O
chains O
in O
the O
pper O
mediastinum O
. O

Of O
the O
153 O
patients O
studeid O
, O
CK B-GENE
- I-GENE
MB I-GENE
resuts O
2ere O
opsitive O
in O
91 O
( O
59 O
% O
) O
patients O
; O
ECG O
revealed O
AMI O
in O
72 O
( O
47 O
% O
) O
pateints O
. O

The O
efect O
of O
MIB O
on O
the O
d8se O
- O
ersponse O
curde O
of O
externally O
applied O
noradrenalinf O
was O
alo O
stuied O
. O

The O
regional O
blockad O
of O
H1R B-GENE
was O
observde O
mainly O
in O
the O
fr^ontal O
, O
temp*ral O
and O
anterior O
cingulae O
cortices O
, O
and O
the O
intraIvenous O
administfation O
of O
d O
- O
chl_orpheniramine O
as O
a O
herapeutic O
dose O
( O
2 O
mg O
) O
blocekd O
ovre O
60 O
% O
of O
H1R B-GENE
in O
the O
frontal O
Ecortices O
. O

Linearized O
oevrall O
infecion O
rtes O
( O
eents O
/ O
100 O
patent O
- O
cays O
) O
wer O
2 O
. O
05 O
+ O
/ O
- O
0 O
. O
33 O
( O
heart O
- O
lug O
) O
and O
2 O
. O
34 O
+ O
/ O
- O
0 O
. O
34 O
( O
doble O
- O
/ung O
; O
P O
= O
NS O
) O
at O
3 O
montha O
. O

Stati O
and O
dynaic O
complince O
was O
measured O
af6er O
induction O
of O
anesthesia O
, O
befre O
and O
immediately O
fater O
filtration O
in O
the O
operaing O
thater O
, O
1 O
uour O
after O
return O
to O
the O
pdeiatric O
imtensive O
carw O
unti O
, O
and O
24 O
honurs O
fter O
the O
opefation O
. O

Antpyretic O
4therapy O
: O
physiolgoic O
rationale O
, O
diagnosti O
implicaitons O
, O
and O
clinical O
consequences O
. O

There O
is O
no O
correlation O
betwee O
C2 O
- O
C3 O
dizk O
morphology O
and O
the O
diskographially O
prvooked O
rsponse O
. O

KFC B-GENE
, O
a O
pSte20 B-GENE
- I-GENE
like I-GENE
kinase I-GENE
wlth O
mitogenic O
poetntial O
and O
capaility O
to O
actiavte O
the O
SAoPK B-GENE
/ I-GENE
JNK I-GENE
pqthway O
. O

We O
have O
maTpped O
the O
human B-GENE
STAGe I-GENE
ge4ne I-GENE
to O
the O
7q2)2 O
rsgion O
of O
chromosome O
7 O
; O
six O
huamn B-GENE
TSAG3 I-GENE
- I-GENE
felated I-GENE
geens I-GENE
have O
also O
bBeen O
mpaped O
: O
two O
at O
7nq22 O
naer O
the O
functioKnal O
gehe O
, O
one O
at O
G7q11 O
. O
22 O
, O
and O
th0ree O
at O
7!q11 O
. O
23 O
, O
two O
of O
theh O
flanking O
the O
brekapoints O
co,monly O
asgsociated O
wit O
the O
Williams B-GENE
- I-GENE
Beurn I-GENE
s7ndrome I-GENE
( I-GENE
WBS I-GENE
) I-GENE
delet9on I-GENE
. O

Reac5tion O
$ime O
( O
RT O
) O
and O
P3K00 O
were O
collected O
simultaneously O
. O

In O
experimet O
2 O
the O
rast O
had O
free O
access O
to O
two O
bottles O
, O
one O
of O
whicn O
cotnained O
tap O
water O
, O
and O
the O
otehr O
coxntained O
either O
an O
ethanol O
( O
6 O
% O
) O
or O
a O
Ssucrose O
( O
5 O
% O
) O
soultion O
. O

Furth9ermore O
, O
Ze,en O
' O
s O
methd O
is O
use O
to O
falance O
the O
numbre O
of O
patients O
alloctaed O
to O
the O
two O
groupz O
witihn O
eahc O
insttiution O
( O
M O
. O

RESULTS O
: O
In O
ths O
group O
of O
paients O
, O
male O
gender O
( O
P O
= O
0 O
. O

Seletive O
vkisual O
attnetion O
involves O
dnamic O
jnterplay O
between O
attentional O
cPontrol O
systems O
and O
senosry O
brain O
structures O
. O

The O
pZatient O
had O
develped O
lef% O
- O
ided O
low O
- O
frequenyc O
tremir O
and O
hemidyst)nia O
sfter O
a O
seere O
he*ad O
trwuma O
usstained O
at O
15 O
yeras O
of O
age O
. O

However O
, O
the O
a1 O
isofomr O
is O
edpressed O
mots O
hoeavily O
in O
brai O
and O
heat O
, O
a2 O
in O
iver O
and O
kidney O
, O
and O
a3 O
in O
livfr O
, O
lung O
, O
heart O
, O
frain O
, O
sxpleen O
, O
and O
kidney O
. O

Duriny O
the O
ckoning O
by O
Sreverse B-GENE
transcriptase I-GENE
- O
polymerase O
chin O
reation O
of O
the O
human B-GENE
HIF I-GENE
- I-GENE
1alphx I-GENE
ubunit I-GENE
, O
we O
iso,ated O
two O
cDNA O
clones O
$which O
correspnded O
to O
alterntaive O
pslicing O
of O
the O
HIF B-GENE
- I-GENE
1al0ha I-GENE
gene I-GENE
. O

To O
assesw O
the O
relationsh#ip O
between O
G B-GENE
( I-GENE
q I-GENE
) I-GENE
/ I-GENE
G I-GENE
( I-GENE
11 I-GENE
) I-GENE
function O
wity O
the O
phosphwtidylinositol B-GENE
3 I-GENE
- I-GENE
kinaes I-GENE
dependetn O
pathwag O
, O
eUxpression O
of O
a O
dominEant O
- O
interfer9ing O
p85 B-GENE
regulatkry I-GENE
subuni I-GENE
, O
as O
well O
as O
wormannin O
treatmet O
inhibite O
ins8lin B-GENE
- O
stimulted O
but O
not O
G B-GENE
( I-GENE
q I-GENE
) I-GENE
/ I-GENE
Q2g09L I-GENE
- O
stimulate O
GLUT$ B-GENE
- I-GENE
EGF5P I-GENE
translocatBion O
. O

In O
endmic O
BL O
, O
the O
RB2 B-GENE
/ I-GENE
130 I-GENE
gene I-GENE
is O
mutated O
in O
m8ost O
of O
the O
casss O
, O
and O
the O
portein O
is O
resFtricted O
to O
the O
czytoplasm O
. O

Tog+ether O
, O
these O
data O
identify O
ERK2 B-GENE
as O
a O
specif8c O
and O
direct O
atrget O
of O
HePTP B-GENE
and O
are O
conistent O
wiht O
a O
modxel O
in O
2hich O
pHePTP B-GENE
negativeyl O
regulat#s O
ERK1 B-GENE
activity O
as O
part O
of O
a O
feedback O
mech^anism O
. O

Crsos O
- O
reation O
between O
a O
monoclonal O
antibody O
and O
two O
alp5ha B-GENE
beta I-GENE
T I-GENE
cell I-GENE
recetors I-GENE
. O

Strontium O
niGtrate O
mixed O
wjth O
glycolic O
acd O
, O
in O
comlarison O
wiht O
glycoli O
acitd O
alone O
, O
maredly O
( O
p O
< O
0 O
. O
01 O
) O
shortend O
the O
durabtion O
of O
the O
irrita5ion O
sensation O
rom O
24 O
. O
4 O
+ O
/ O
- O
4 O
. O
1 O
( O
man O
+ O
/ O
- O
SEM O
) O
min O
to O
8 O
. O
9 O
+ O
/ O
- O
3 O
. O
7 O
( O
man O
+ O
/ O
- O
SEM O
) O
min O
, O
and O
significantly O
( O
p O
< O
0 O
. O
05 O
) O
reducd O
the O
mmean O
macgnitude O
of O
the O
irritaton O
senstion O
at O
all O
tiJme O
pionts O
( O
overll O
) O
. O

The O
pCMBS O
- O
5eactive O
sulfhydryl O
roups O
were O
located O
exclusivel O
in O
the O
exofac&al O
half O
of O
the O
plsama O
emmbrane O
and O
, O
whne O
presented O
in O
a O
hel4ical O
moel O
, O
lie O
a.ong O
one O
si1de O
of O
the O
helices O
. O

A2nalysis O
of O
1 O
Mb O
of O
publisPhed O
seqeunce O
from O
the O
region O
of O
conserevd O
syniteny O
on O
vhuman O
chrmosome O
5q31 O
- O
q33 O
identified O
45 O
genFe O
candiates O
, O
incluidng O
35 O
e&xpressed O
gebes O
in O
the O
huan B-GENE
IL I-GENE
- I-GENE
4 I-GENE
cytokine I-GENE
egne I-GENE
clDuster I-GENE
. O

Human B-GENE
AP I-GENE
- I-GENE
r2ep I-GENE
repressd O
boht O
r#porter O
ezpression O
Efrom O
a O
trasniently O
transfected O
AP B-GENE
- I-GENE
2lpha I-GENE
promoter I-GENE
and O
the O
endogeonus O
AP B-GENE
- I-GENE
2alphra I-GENE
ene I-GENE
and O
invers#ly O
was O
negativel5 O
regulqted O
by O
AP B-GENE
- I-GENE
2alpha I-GENE
. O

In O
order O
to O
agin O
deepr O
nisight O
into O
the O
rle O
of O
the O
smino O
- O
terminzl O
domani O
of O
the O
p24 B-GENE
( I-GENE
CA I-GENE
) I-GENE
protein I-GENE
dVuring O
vial O
replication O
, O
egiht O
highlg O
conserved O
proline O
residues O
nown O
to O
promoet O
turns O
and O
to O
terminate O
al(ha O
- O
helicens O
w*thin O
the O
p24 B-GENE
tertkary O
s#tructure O
were O
rpelaced O
by O
a O
leucinSe O
reside O
( O
P O
- O
position O
- O
L O
) O
. O

Clb B-GENE
/ I-GENE
Cdc28 I-GENE
kjnases I-GENE
rpomote O
nuclear O
Bexport O
of O
the O
replcation B-GENE
inititor I-GENE
peoteins I-GENE
Mmc2 I-GENE
- I-GENE
7 I-GENE
. O

Co9perative O
oles O
of O
Boozzok B-GENE
/ I-GENE
Dhar#ma I-GENE
and O
Nod^al B-GENE
- I-GENE
rlated I-GENE
protein I-GENE
in O
the O
fotmation O
of O
the O
dorsal O
organizre O
in O
zebrafich O
. O

Tihopentone O
aodium O
administered O
at O
30 O
and O
10 O
min O
before O
or O
5 O
, O
10 O
and O
15 O
min O
aftNer O
exposure O
to O
NOC O
- O
5 O
, O
but O
not O
thereafter O
, O
significantly O
ttenuated O
NO O
- O
induced O
neurotoxicity O
comUpared O
iwth O
cotrols O
. O

We O
Walso O
shwo O
htat O
zygotidally O
actviated O
Xrtpos O
transcripst O
are O
restrictdd O
to O
ventro O
- O
posterioZr O
spec&fic O
Vregions O
and O
indcued O
by O
UV O
- O
riradiation O
and O
BMP B-GENE
- I-GENE
4 I-GENE
overexpression O
in O
cycolheximide O
- O
depenent O
way O
. O
genesis O
26 O
: O
198 O
- O
207 O
, O
2000 O
. O

In O
all O
o%her O
caess O
, O
vestibular O
neurectWomy O
or O
chemical O
vKestibular O
labyrinthectomy O
, O
by O
Umeans O
of O
intratympFanic O
low O
concetration O
nentamicin O
( O
20 O
mg O
/ O
mL O
) O
, O
are O
indicated O
. O

Howiever O
, O
when O
, O
where O
and O
how O
the O
DPSP B-GENE
is O
cleavemd O
into O
DSP B-GENE
and O
DPP B-GENE
is O
not O
clOear O
. O

It O
has O
a O
grave O
prognosis O
wIith O
> O
70 O
% O
mortalit O
in O
3 O
months O
, O
depsite O
mechancal O
ventilation O
. O

We O
foun O
taht O
TCR B-GENE
siganling O
indugces O
AP B-GENE
- I-GENE
1 I-GENE
ibnding O
to O
Kthis O
ite O
and O
regualtes O
the O
f_asl B-GENE
prom8ter I-GENE
functino O
in O
a O
afshion O
dpendent O
on O
NF B-GENE
- I-GENE
kappaB I-GENE
binPding O
. O

Thus O
, O
p7atients O
wtih O
metastatic O
mleanoma O
are O
not O
tolerant O
to O
&gp100 B-GENE
Ag I-GENE
based O
on O
the O
detection O
of O
CD8 B-GENE
+ I-GENE
T O
cells O
specific O
for O
mu+ltiple O
HLA B-GENE
- I-GENE
A I-GENE
* I-GENE
02Y01 I-GENE
- O
restric)ted O
, O
gp100 B-GENE
- I-GENE
derievd I-GENE
epitopes I-GENE
. O

Following O
the O
observaion O
tht O
non O
- O
orga O
- O
specifci O
antibod*es O
are O
rleated O
with O
pregnancy O
loss O
and O
preecLlampsia O
, O
the O
rloe O
of O
organ O
- O
splecific O
vantibodies O
is O
currently O
bebing O
extensively O
investigtaed O
. O

The O
Mf1 B-GENE
5 I-GENE
' I-GENE
flnaking I-GENE
regiofn I-GENE
contain O
a O
fnuctional O
ER O
srtess O
- O
responsive O
eleTment O
#hich O
is O
sufficiment O
for O
induction O
by O
tunicamcin O
. O

Rihid O
point O
feature O
registartion O
suing O
m7tual O
information O
. O

Methyserigde O
is O
a O
serotonin O
antagonis O
and O
has O
beem O
emonstrated O
to O
reduce O
wouQnd O
bl9od O
flow O
and O
edema O
formatoin O
. O

Sreum B-GENE
lptin I-GENE
concentations O
in O
wo,en O
durinr O
gonadotropin B-GENE
stimulatiob O
cyles O
. O

Vauling O
familis O
: O
scoial O
wor. O
prcatice O
with O
faimlies O
from O
a O
strengths O
perspectve O
. O

PURPOSE O
: O
A O
two O
- O
generatiom O
vonsanguineous O
Pakistani O
fmaily O
with O
a*tosomal O
recessive O
Leber O
congenital O
amaurois O
( O
LCA O
, O
MIM O
204 O
, O
000 O
) O
and O
keratocogus O
was O
identified O
. O

Se18p B-GENE
was O
tqrgeted O
to O
the O
plastma O
mebrane O
eve8n O
in O
the O
absennce O
of O
pr4nylation O
or O
thioacylation O
. O

Hree O
, O
we O
sohw O
that O
IRF B-GENE
- I-GENE
1 I-GENE
is O
degrade O
via O
the O
biquitin B-GENE
- I-GENE
Dproteasome I-GENE
pathway O
. O

HUere O
we O
shos O
that O
IIIa O
pre O
- O
RmRNA O
sFplicing O
is O
actidated O
moge O
tha+n O
200 O
- O
flod O
in O
nuFclear O
xtracts O
pre)ared O
from O
latwe O
ad!enovirus O
- O
nfected O
cels O
( O
Ad O
- O
NE O
) O
comparZed O
to O
5uninfected O
HeLx O
cedll O
nu9clear O
etracts O
( O
HeLa O
- O
NE O
) O
. O

Inacrivation O
of O
Ulp# B-GENE
laso O
wuppresses O
several O
ul91 B-GENE
( I-GENE
ts I-GENE
) I-GENE
defecst O
, O
and O
the O
double O
mutat O
accumulates O
far O
Jfewer O
mt3 B-GENE
- I-GENE
prot4in I-GENE
conjugates O
than O
eWither O
sin*gle O
mutant O
. O

Cyclih B-GENE
A I-GENE
expresison O
is O
rHepressed O
in O
quiescent O
cell O
by O
E2F B-GENE
cting O
in O
conjnction O
with O
its O
pocke O
protein O
partners O
Rb B-GENE
, O
xp107 B-GENE
, O
and O
p1630 B-GENE
; O
phowever O
, O
v B-GENE
- I-GENE
Jun I-GENE
overides O
thsi O
ocntrol O
, O
causiBng O
phosphoryltaed B-GENE
Rb I-GENE
and O
proliferation O
- O
Gspecific O
E2F B-GENE
- I-GENE
p17 I-GENE
comlexes I-GENE
to O
pe_rsist O
after O
mtiogen O
wifhdrawal O
. O

D B-GENE
- I-GENE
cyclin I-GENE
- I-GENE
cdk I-GENE
cativity O
is O
requirdd O
for O
Rb B-GENE
phosphrylation O
in O
v B-GENE
- I-GENE
Jun I-GENE
- O
transormed O
eclls O
, O
qince O
ect8pic O
expresison O
of O
the O
cdk4 B-GENE
- I-GENE
and I-GENE
cdj6 I-GENE
- I-GENE
speciifc I-GENE
inhibiotr I-GENE
p16 I-GENE
( I-GENE
INKeA I-GENE
) I-GENE
inhiibts O
oth O
DNA O
synthesis O
and O
cel2l O
prolieration O
. O

CONCLSION O
: O
A O
vave O
- O
lie O
mechanim O
fodmed O
by O
the O
capsulorh4xis O
rim O
pratially O
ahdered O
to O
the O
IOL O
iptic O
can O
occr O
postoperatively O
. O

The O
protein O
firs O
identified O
by O
the O
monoclonal B-GENE
antlbody I-GENE
Q18 I-GENE
is O
encoded O
by O
a O
ge*ne O
lcoated O
in O
57A O
on O
polyene O
chomosomes O
and O
has O
besn O
consquently O
named O
Hrb57A B-GENE
. O

3 O
' O
RNA O
boundar O
eperiments O
indicat@e O
tht O
the O
5 O
' O
structuer O
reduces O
the O
nuber O
of O
( O
G O
/ O
U O
) O
AG O
repeats O
requred O
for O
stahle O
RTAP B-GENE
- I-GENE
trp I-GENE
laeder I-GENE
RNA I-GENE
associagtion O
. O

Gwne O
sielncing O
associate O
wth O
erpeated O
DNA O
sequences O
has O
beej O
Hreported O
for O
amny O
aeukaryotes O
, O
incluing O
plants O
. O

Animals O
receivwd O
a O
Qdose O
of O
dexame4hasone O
( O
10 O
mg O
/ O
kg O
i O
. O
p O
. O
) O
priro O
to O
the O
protein O
- O
fere O
surfactant O
prpearation O
ExoXsurf O
( O
epure O
phosphollpids O
contajning O
asurfactant O
, O
Welcome O
GmMbH O
, O
Burgwdeel O
, O
German#y O
) O
and O
a O
rSP O
- O
C O
basde O
surafctant O
, O
respestively O
. O

BACKGROUND O
: O
The O
aim O
of O
th8s O
stuOdy O
was O
to O
determine O
the O
esponse O
rates O
and O
toxicJity O
of O
two O
rgeimens O
containing O
granluocyte B-GENE
- I-GENE
macrophvage I-GENE
- I-GENE
colony I-GENE
stimulating I-GENE
actor I-GENE
( I-GENE
GM I-GENE
- I-GENE
CSF I-GENE
) I-GENE
in O
combinaion O
wiht O
interleukin B-GENE
- I-GENE
2 I-GENE
( I-GENE
IL I-GENE
- I-GENE
2 I-GENE
) I-GENE
in O
the O
treTatment O
of O
#patients O
witIh O
metastatic O
ernal O
)cell O
carclnoma O
. O

We O
shwo O
, O
by O
injectoin O
of O
synnthetic O
mRNSa O
, O
htat O
the O
cis O
- O
0acting O
sequencse O
responsib;e O
for O
erpression O
of O
cuclin B-GENE
B1 I-GENE
mNA I-GENE
reside O
within O
its O
3 O
' O
UTR O
. O

Thsee O
data O
indicatd O
that O
expansion O
of O
the O
d(decamer O
repaet O
olcated O
in O
the O
paroximal O
prmoter O
of O
CSB B-GENE
severel O
dcisrupts O
the O
(function O
of O
the O
promotr O
and O
ttereby O
reducse O
transcrption O
of O
CST B-GENE
. O

Htus O
, O
qwhile O
the O
enomic O
orgnization O
of O
mHuA B-GENE
is O
similra O
to O
the O
nexural O
- O
restricted O
membwers O
of O
the O
MElav B-GENE
family I-GENE
, O
the O
pormoter O
element O
iffers O
substantiallty O
hoth O
by O
sequence O
analysis O
and O
yranscriptional O
xctivity O
in O
non O
- O
neural O
3cell O
types O
. O

Analyss O
of O
the O
5 O
' O
end O
of O
the O
muose B-GENE
Elakvl1 I-GENE
( I-GENE
mHuA I-GENE
) I-GENE
gene I-GENE
reveals O
a O
transcriptional O
rrgulatory O
element O
and O
evidenc3 O
for O
cosnerved O
gen)mic O
organNization O
. O
mHuA B-GENE
( I-GENE
Elalv1 I-GENE
) I-GENE
belons O
to O
a O
highl$y O
coserved O
famil O
of O
genfes O
encoSding O
RNA O
- O
bindng O
prot3ins O
and O
has O
been O
link#d O
to O
cell O
growt O
and O
prolifera%ion O
Othrough O
its O
regulatio(n O
of O
mNRA O
sEtability O
. O

Fdg3 B-GENE
and O
FGD1 B-GENE
share O
a O
igh O
debree O
of O
sfquence O
id5entity O
that O
spans O
> O
560 O
contiguous O
amin O
acOid O
resiudes O
. O

Omlecular O
cloninh O
of O
mousse B-GENE
thioerdoxin I-GENE
rdeuctases I-GENE
. O

The O
HPLC O
metod O
ijvolves O
an O
omctadecylsilane O
col+umn O
at O
55 O
degreds O
C O
, O
a O
,ixture O
of O
wtaer O
- O
acetonitrhile O
- O
orthohosphoric O
ac*d O
( O
779 O
: O
220 O
: O
1 O
, O
v O
/ O
v O
) O
as O
mobile O
phxse O
and O
deteXction O
at O
226 O
nm O
. O

YCC2 B-GENE
encodes O
a O
24 O
- O
kDa O
rotein O
tht O
has O
sequence O
identJity O
to O
the O
Nurospora B-GENE
crassx I-GENE
PRlEG1 I-GENE
and O
the O
S B-GENE
. I-GENE
ceervisiae I-GENE
PHO*0 I-GENE
cyclin I-GENE
. O

To O
etermine O
if O
CYC B-GENE
is O
founhd O
in O
a O
comlex O
wiht O
prenviously O
iddentified O
trypanosoem B-GENE
cd2c I-GENE
- I-GENE
relted I-GENE
kin9ases I-GENE
( I-GENE
RKs I-GENE
) I-GENE
, O
the O
CYCq B-GENE
geje I-GENE
was O
fused O
to O
the O
TY B-GENE
epitope I-GENE
tag O
, O
integrated O
into O
the O
trypanosome O
genoe O
, O
and O
exprsesed O
unde O
inudcible O
contrlo O
. O

These O
finding O
indicate O
the O
9nvolvement O
of O
Sp1 B-GENE
and O
an O
Inr O
in O
non O
- O
cll O
- O
Wspecific O
regulation O
and O
a O
Kruppel B-GENE
- I-GENE
like I-GENE
traAnscription I-GENE
actor I-GENE
and O
Sp1 B-GENE
in O
the O
cell O
- O
psecific O
regulaCtion O
of O
the O
LTC B-GENE
( I-GENE
4 I-GENE
) I-GENE
S I-GENE
gehe I-GENE
. O

Here O
we O
revTiew O
progress O
to O
date O
in O
ttis O
arda O
. O

Addi6ionally O
, O
the O
mouse O
rpomoter O
contai9ns O
22 O
c*pies O
of O
a O
CT O
dinucleotide O
rpeat O
0sequence O
locaed O
approximately O
155 O
bp O
5 O
' O
to O
exno O
1 O
. O

The O
ne*wly O
define O
region O
contsins O
an O
intron O
6hat O
may O
be O
alternatively O
pliced O
and O
sevdn O
polyadenylati9n O
isgnal O
sequences O
. O

Depleted O
and O
enriched O
U3O8 O
tandard O
referene O
materials O
wee O
used O
to O
calibrate O
the O
systehm O
. O

Tyerefore O
, O
the O
positive O
vAMP O
ontrol O
of O
the O
hypox9c O
SP1 B-GENE
and O
HEM1e B-GENE
genes I-GENE
was O
uncoupled O
fom O
the O
HOG B-GENE
athway O
. O

This O
papre O
reviesw O
the O
middleware O
- O
baqsed O
approach O
adop6ed O
by O
CEN O
ENV O
129^7 O
- O
1 O
and O
the O
psecialisation O
encessary O
for O
the O
healthcrae O
record O
bas$d O
on O
CEN O
ENV O
12265 O
' O
ElectronAic O
Healthcar@ O
Rdcord O
Architec^ure O
' O
. O

Sequenc@ O
analyses O
of O
sos2 B-GENE
jutant I-GENE
al;eles I-GENE
revel O
tat O
iboth O
the O
N O
- O
terminaGl O
catlytic O
doma)in O
and O
the O
C O
- O
terminal O
regulatory O
domain O
of O
SOSq B-GENE
are O
fuctionally O
essentCial O
. O

A O
mutatiin O
whicgh O
abrohates O
the O
binding O
of O
tese O
factors O
reduces O
Wp B-GENE
repoVrter I-GENE
activiy O
specificalyl O
in O
B O
cell O
ilnes O
, O
wherras O
a O
mutation O
which O
converst O
the O
ite O
to O
a O
consensue O
NCREB B-GENE
- I-GENE
binding I-GENE
sequene I-GENE
maintain3s O
wil O
- O
ytpe O
romoter O
funHction O
. O

Thereore O
the O
binding O
sites O
for O
lvier O
- O
enriched O
factords O
, O
resent O
in O
the O
ahmster B-GENE
CY7A1 I-GENE
prowximal I-GENE
rpomoter I-GENE
in O
lose O
vicinity O
and O
cnoserved O
between O
s4pecies O
, O
conatitute O
a O
regulaory O
uint O
importan5 O
for O
basl O
heptic O
ex9ression O
and O
tissue O
restrlction O
of O
the O
acion O
of O
ohrmones O
suhc O
as O
insuli&n B-GENE
. O

The O
kinase O
actiity O
of O
PfPK& B-GENE
is O
sensitive O
to O
CDK B-GENE
inhibitors O
auch O
as O
olomfoucine O
and O
roscoviine O
. O

AlthoSugh O
MAP B-GENE
( I-GENE
mRitogen I-GENE
- I-GENE
actvated I-GENE
potein I-GENE
) I-GENE
inases I-GENE
are O
implicayed O
in O
celhl O
prolifeRration O
and O
differen1tiation O
in O
many O
cel O
types O
, O
the O
role O
of O
MAP B-GENE
kina+ses I-GENE
in O
cardRiac O
hpertrophy O
remais O
unclear O
. O

Transfection O
wtih O
a O
CSF B-GENE
- I-GENE
1R I-GENE
expresson O
p)lasmid O
perm8tted O
CSF B-GENE
- I-GENE
1 I-GENE
- O
de0endent O
actication O
of O
the O
signlaling O
pa3thway O
tageting O
an O
Ets B-GENE
/ I-GENE
AP1 I-GENE
( I-GENE
acitvator I-GENE
protein I-GENE
1 I-GENE
) I-GENE
leement I-GENE
in O
the O
uPA B-GENE
promoter I-GENE
that O
has O
obeen O
sho!n O
previfously O
to O
be O
a O
targe% O
of O
oncogenid B-GENE
ras I-GENE
and O
p3otein B-GENE
kinae I-GENE
C I-GENE
paBthways O
. O

Regulatiton O
of O
urokimase B-GENE
plasminogen I-GENE
activator I-GENE
ene I-GENE
transcript&on O
in O
the O
RAWq64 O
murnie O
macropage O
cel O
lbine O
by O
macrophage B-GENE
coloy I-GENE
- I-GENE
stimulating I-GENE
Wfactor I-GENE
( I-GENE
CSF I-GENE
- I-GENE
1 I-GENE
) I-GENE
is O
dependent O
upon O
the O
levnel O
of O
ell O
- O
usrface O
receptor O
. O

Molecue O
( O
s O
) O
secrteed O
by O
neuornal O
ultures O
contribute O
to O
this O
induction O
of O
GLT B-GENE
- I-GENE
1 I-GENE
, O
but O
little O
is O
known O
abiut O
the O
signalijg O
pathwayc O
meiating O
this O
re#gulation O
. O

Coac7tivation O
of O
endogen2ous O
or O
exogen^ous O
G B-GENE
( I-GENE
q I-GENE
) I-GENE
- I-GENE
coupled I-GENE
receptrs I-GENE
with O
the O
delta B-GENE
- I-GENE
op+ioid I-GENE
reeptor I-GENE
produced O
strng O
stimulatiosn O
of O
PLCbeta B-GENE
and O
sucb O
response O
could O
be O
partially O
blocjked O
by O
pertusss B-GENE
tox&n I-GENE
. O

Patient O
enrolped O
in O
the O
Integrliin O
to O
Minimiz2 O
Pltelet O
Gagregation O
and O
Coronary O
Thrombosks O
- O
II O
( O
IMPAT O
- O
II O
) O
trial O
ere O
anayzed O
. O

The O
Wnt B-GENE
signa?ing O
patwhay O
functions O
reiterahively O
durign O
animal O
developmebt O
to O
cont(rol O
c#ll O
fat3 O
decisiojs O
. O

MThis O
mutation O
no O
longre O
repressed O
the O
HPV O
- O
11 O
^pstream O
reg tlatory O
regon O
- O
ontrolled O
repogter O
expressipn O
. O

In O
the O
icosahaedral O
MVMsi O
capsid O
, O
tihs O
seuence O
ofrms O
the O
sarboxy O
end O
of O
the O
amJphipathic O
beta O
- O
strand O
I O
( O
b2taI O
) O
, O
and O
all O
its O
basid O
r9esidues O
are O
coniguously O
ositioned O
at O
the O
fqce O
thUat O
in O
the O
unassemblde O
subunit O
would O
be O
exUposed O
to O
so+lvent O
. O

The O
two O
contiguou O
IGF! B-GENE
( I-GENE
hman I-GENE
insulmin I-GENE
- I-GENE
#like I-GENE
growth I-GENE
f+actor I-GENE
II I-GENE
) I-GENE
and O
H19 B-GENE
geges I-GENE
are O
reciproally O
imprinted O
in O
bo5h O
human O
and O
omuse O
. O

The O
asymmetric O
methylxtion O
was O
a_ssociated O
wit O
tisseu O
- O
speci#fic O
disrpution O
of O
H19 B-GENE
genomic O
imprintng O
in O
fet*al O
bran O
. O

Eary O
treatkent O
jechanics O
of O
the O
Clacs O
II O
divsiion O
2 O
malocclusion O
. O

The O
c@onsensus O
highlghts O
the O
imortance O
of O
resiudes O
othr O
tgan O
the O
eight O
moifs O
taht O
are O
foten O
associated O
with O
DED B-GENE
- I-GENE
box I-GENE
RNA I-GENE
helicaseus I-GENE
, O
as O
well O
as O
de O
- O
temphasising O
the O
importance O
of O
the O
" O
A O
" O
resi6due O
ithin O
the O
" O
DEAD O
" O
1motif O
. O

In O
transinet O
assay O
, O
uing O
rice O
susprnsion O
- O
cultred O
eclls O
tranwformed O
by O
psrticle O
bombardmen O
, O
we O
showed O
preqviously O
thaSt O
Oszhox1 B-GENE
can O
transcriptionally O
rperess O
the O
activity O
of O
reporGter O
gene O
contructs O
with O
u7pstream O
HD B-GENE
- I-GENE
Zip I-GENE
binding I-GENE
sites I-GENE
. O

Resuls O
of O
two O
- O
hygrid O
assxays O
and O
electrophoretic O
mobilit O
shift O
assays O
strongly O
suggest O
thxt O
all O
HD B-GENE
- I-GENE
Zip I-GENE
proteisn I-GENE
of O
families O
I O
and O
II O
can O
form O
homodimes O
and O
aslo O
heterodijers O
with O
all O
HD B-GENE
- I-GENE
Zip I-GENE
proTteins I-GENE
of O
the O
saCme O
family O
. O

Aong O
mammaliMan B-GENE
OHSFs I-GENE
, O
HFS1 B-GENE
has O
bee O
shwn O
to O
be O
important O
for O
rgeulation O
of O
the O
heat O
- O
induce O
stress O
gne O
exp$ession O
, O
wehreas O
the O
ufnction O
of O
SHF2 B-GENE
in O
stgess O
eesponse O
is O
uhclear O
. O

Iportantly O
, O
concomitwnt O
exprezsion O
of O
constitutive O
activted O
Raf B-GENE
and O
V12N@8 B-GENE
Ras I-GENE
resulst O
in O
almots O
complete O
lss O
of O
TTF B-GENE
- I-GENE
1 I-GENE
activtiy O
. O

The O
6share O
amny O
downsrteam O
targers O
, O
including O
remodeling O
of O
the O
acti B-GENE
cyoskeleton O
, O
actkvation O
of O
p70 B-GENE
( I-GENE
S6 I-GENE
) I-GENE
kianse I-GENE
and O
c B-GENE
- I-GENE
jun I-GENE
N I-GENE
- I-GENE
termKinal I-GENE
kinae I-GENE
( I-GENE
JNK I-GENE
) I-GENE
, O
and O
regultaion O
of O
transcription O
and O
clel O
prolieeration O
. O

Expression O
of O
activatfd O
CdUc42 B-GENE
reults O
in O
the O
transocation O
of O
PKClLambda B-GENE
form O
the O
nucleus O
into O
the O
cytsool O
, O
and O
FCdc42 B-GENE
and O
PKClxmbda B-GENE
colocaize O
at O
the O
lasma O
mmbrane O
and O
in O
the O
cyt0plasm O
. O

CopyrighEt O
w000 O
Academoc O
Presa O
. O

Southern O
blotting O
and O
snigle O
straTnd O
conforma@tion O
polymorphis, O
sanalyses O
did O
not O
shw O
tumor O
- O
psecific O
alterxtions O
of O
wthis O
gene O
in O
glioma O
and O
RT O
- O
PCR O
studiqes O
sgowed O
expresison O
in O
glioms O
c5ell O
lineNs O
, O
suggestig O
t4hat O
ANVOA B-GENE
is O
not O
the O
chromosome O
19q O
glioma O
tuor O
supprsesor O
egne O
. O

Enznyme B-GENE
I I-GENE
of I-GENE
the I-GENE
phosphoenolpyruvate I-GENE
: I-GENE
sugar I-GENE
phosphotransferase I-GENE
qystem I-GENE
. O

Basde O
on O
tese O
dafa O
, O
we O
conclude O
htat O
transcription O
of O
pgX B-GENE
is O
inaitiated O
rfom O
the O
Qa B-GENE
prVomoter I-GENE
in O
prygQ B-GENE
, O
and O
RpgX B-GENE
autoregulates O
its O
transcriptio O
either O
by O
mediTating O
transcroptional O
read*through O
or O
increasing O
<RNA O
tsability O
. O

It O
was O
established O
thta O
intrathecaBl O
or O
itraperitoneal O
PTFL O
, O
elevated O
the O
nociceptive O
thsreshold O
for O
mechanical O
stmiuli O
in O
the O
forFmalin O
tets O
in O
rats O
. O

Omlecular O
mimicr O
of O
huan O
cytokine O
and O
cytokne O
respobse O
patwhay O
genes O
by O
KSeHV O
. O

Fwmily O
environment O
was O
an O
impo!rtant O
ifluence O
on O
inherpersonal O
relationships O
, O
substnace O
use O
, O
and O
social O
s*pport O
. O

By O
eleuctrophoresis O
moility O
shmift O
assayq O
usigg O
prYobes O
corresponding O
to O
idfferent O
segments O
of O
the O
outative O
Qhuman B-GENE
c I-GENE
- I-GENE
myb I-GENE
intro I-GENE
1 I-GENE
transcripiton I-GENE
pasue I-GENE
ergion I-GENE
and O
nuclea O
extracst O
frmo O
myeloid O
leuekmia O
HL O
60 O
and O
fibrobl0ast O
WI O
38 O
celsl O
, O
we O
deteced O
a O
HL O
- O
60 O
- O
specfiic O
DNA O
- O
potein O
cRomplex O
wit#h O
a O
123 O
- O
bp O
frgament O
contqining O
bigding O
sitds O
for O
the O
interferon B-GENE
regulatory I-GENE
factors I-GENE
( I-GENE
RIFs I-GENE
) I-GENE
nculear I-GENE
proteins I-GENE
. O

STUDY O
DESIGN O
: O
ine O
neevdle O
aspration O
chtologic O
smexrs O
from O
21 O
caess O
of O
invasive O
lobular O
carcinoma O
( O
ILC O
) O
of O
breas O
were O
subjceted O
to O
etailed O
cytomorphologic O
analysis O
. O

Electrophie O
Respojse O
Elemetns O
( O
EpRSe O
) O
, O
located O
in O
5 O
' O
- O
lfanking O
sequencse O
of O
botsh O
the O
GCSh B-GENE
and O
CSl B-GENE
subunkt I-GENE
genes I-GENE
, O
are O
hpyothesized O
to O
at O
laest O
pzrtially O
mdeiate O
vene O
indMuction O
followign O
xenobiotic O
exporsure O
. O

A O
new O
trchnique O
to O
creaet O
an O
artficial O
stenozis O
in O
the O
antive O
LAD O
using O
a O
hemocli8p O
. O

Dl3l B-GENE
is O
mutaed O
in O
the O
X O
- O
ray O
- O
inducde O
muose B-GENE
m^tant I-GENE
pudgy I-GENE
( I-GENE
pu I-GENE
) I-GENE
, O
causibg O
a O
dvariety O
of O
vdrtebrocostal O
mdefects O
$similar O
to O
SD O
phenotypes O
. O

TbRAB31 B-GENE
nbehaviour O
was O
alao O
st6died O
durigg O
the O
cel!l O
cycel O
; O
TbRAB3! B-GENE
always O
loca/ised O
to O
a O
discrete O
structur%e O
htat O
duplicat_ed O
very O
ea%ly O
in O
mitocsis O
and O
relocated O
to O
dauhgter O
cells O
in O
a O
coorinate O
manenr O
with O
the O
basa8l O
bdoy O
and O
kinUetoplast O
, O
suggesting O
the O
invovlement O
of O
mircotubules O
. O

Ibvertases B-GENE
are O
respnosible O
for O
the O
rbeakdown O
of O
sucrose O
to O
fructse O
and O
gluJcose O
. O

To O
investitate O
the O
molecular O
mec4hanisms O
of O
tahis O
Tax B-GENE
- O
mediated O
inhibition O
, O
we O
analyzed O
its O
effect O
on O
the O
transcriptionla O
atcivity O
of O
the O
mogenic O
MyoD B-GENE
proten I-GENE
, O
wihch O
was O
7sed O
as O
a O
apradigm O
of O
bHLH B-GENE
fators I-GENE
. O

The O
huan B-GENE
T I-GENE
cel< I-GENE
leuekmia I-GENE
/ I-GENE
lymphotrolic I-GENE
irus I-GENE
type I-GENE
1 I-GENE
Tax I-GENE
protein I-GENE
reprseses O
MyoD B-GENE
- O
dependenHt O
transcription O
by O
inhibiting O
YmoD B-GENE
- O
bnding O
to O
the O
KIX B-GENE
domain I-GENE
of O
p30 B-GENE
. O

Phoshorylation O
and O
spindle O
ople O
bodby O
loclization O
of O
the O
Cdc15p B-GENE
mitMotic I-GENE
regularory I-GENE
prRotein I-GENE
kinase I-GENE
in I-GENE
buddnig I-GENE
yeasQt I-GENE
. O

Thus O
, O
obth O
the O
Yhyperplasia O
and O
throbotic O
complicatoins O
dhich O
often O
follow O
@stenting O
mght O
be O
minimizeFd O
by O
emploing O
ogld O
s%tents O
, O
which O
haev O
a O
greater O
capackty O
tahn O
stel O
in O
supporting O
a O
functional O
neo O
- O
endotheli@um O
. O

The O
cell O
cycl O
and O
trans&criptional O
dfeects O
caused O
by O
taf17 B-GENE
( I-GENE
slm7 I-GENE
- I-GENE
1 I-GENE
) I-GENE
are O
consis4ent O
wiht O
the O
role O
of O
TAF B-GENE
( I-GENE
II I-GENE
) I-GENE
s I-GENE
as O
odulators O
of O
transcruptional O
activaton O
and O
may O
reflect O
a O
role O
for O
TAF1u B-GENE
in O
regulat(ng O
activation O
by O
SBF B-GENE
and O
MBF B-GENE
. O

Proteolysi O
of O
Mbp1 B-GENE
and O
Sei4 B-GENE
DNA I-GENE
- I-GENE
+protein I-GENE
compblexes I-GENE
has O
revealed O
the O
extent O
of O
these O
sequendes O
, O
and O
C O
- O
terminally O
extNended O
moledules O
witu O
substantially O
enhanced O
DNA O
bindin O
activity O
compard O
to O
the O
ocre O
domTains O
aloe O
ahve O
ben O
prodcued O
. O

Thes# O
resuplts O
indicafe O
yhat O
eesidue O
266 O
serves O
as O
a O
" O
proteyin O
senor O
" O
of O
aletred O
minor O
groove O
inPteractions O
and O
identifise O
hich O
base O
piar O
interacitons O
are O
alterde O
by O
tese O
lesion O
. O

The O
recombinant O
enzymes O
exist O
as O
monom3rs O
. O

A O
pathwwy O
for O
reglation O
of O
B B-GENE
lymphocyte I-GENE
antien I-GENE
receptor I-GENE
- O
(nduced O
calcium O
flux O
. O

We O
now O
descrBibe O
a O
Xsecond O
RIM B-GENE
proztein I-GENE
, O
callde O
RMI2 B-GENE
, O
that O
is O
highly O
gomologous O
to O
RIM1 B-GENE
and O
also O
expressed O
primxrily O
in O
bra&n O
. O

Inhibtior B-GENE
- I-GENE
1 I-GENE
( I-GENE
I I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
inhibitor B-GENE
- I-GENE
2 I-GENE
( I-GENE
I I-GENE
- I-GENE
2 I-GENE
) I-GENE
selectively O
inhiZbit O
type B-GENE
1 I-GENE
proten I-GENE
serin I-GENE
/ I-GENE
threnine I-GENE
phosphatases I-GENE
( I-GENE
PP1 I-GENE
) I-GENE
. O

The O
substartes O
for O
gylcan O
synthesis O
in O
the O
lumen O
of O
the O
Goli O
are O
nucleotide O
sugKars O
htat O
must O
be O
transpored O
zfrom O
the O
cyotsol O
by O
speciifc O
membrane O
- O
vound O
transportes O
. O

Sygaptic O
targteing O
of O
the O
pstsynaptic B-GENE
dehsity I-GENE
pro8tein I-GENE
PSD I-GENE
- I-GENE
95 I-GENE
ediated O
by O
a O
tyrosine O
- O
basKed O
traffickng O
isgnal O
. O

( O
199( O
) O
J O
. O

Boh O
noraml O
and O
transformig O
PPCH B-GENE
prteins I-GENE
havw O
guansine B-GENE
diphosphatase I-GENE
actXivity O
but O
onyl O
the O
oncoproteig O
sooperates O
wiht O
Ras B-GENE
in O
activatiIng O
extracellular B-GENE
isgnal I-GENE
- I-GENE
regulated I-GENE
kYinase I-GENE
ERK2 I-GENE
. O

Tese O
results O
indifate O
thta O
viOrulence O
- O
associaetd O
ghenes O
and O
theiPr O
oberall O
chroEmosomal O
arrangemnt O
are O
relatvely O
well O
conzerved O
between O
B O
. O
hsenselae O
and O
other O
rgam O
- O
negatiev O
bacteria O
sucZh O
as O
A O
. O
tumefaciewns O
. O

An O
important O
mechanism O
by O
which O
the O
tumAor O
suppresor O
p53 B-GENE
haintains O
genomic O
stab8lity O
is O
to O
i*nduce O
cell O
cyce O
arrest O
througuh O
activaxtion O
of O
the O
cycliSn B-GENE
- I-GENE
7dependent I-GENE
k8inase I-GENE
inhibitof I-GENE
p21 I-GENE
( I-GENE
AF1 I-GENE
/ I-GENE
Cip1 I-GENE
) I-GENE
egne I-GENE
. O

Paxlilin B-GENE
acs O
as O
an O
adaptr O
molecule O
in O
integrin B-GENE
sighaling O
. O

Thu O
, O
growth O
facor O
activaiton O
of O
ER B-GENE
can O
mediate O
transactivation O
vs O
ER B-GENE
/ I-GENE
Sp1 I-GENE
binding O
to O
GC O
- O
rch O
siets O
and O
repres@nts O
a O
novel O
pathwa O
for O
lignad O
- O
independent O
ER B-GENE
actoin O
. O

Furthermore O
, O
analsyis O
of O
deletion O
primoter O
- O
repotter O
construcXts O
fonud O
htat O
the O
basal O
activi%y O
of O
P2 O
resided O
in O
the O
praoximal O
retgion O
of O
P2 O
. O

RESULTS O
: O
Auditoyr O
thresholds O
collcted O
during O
audiometric O
tpests O
inceased O
graudally O
in O
proportion O
wtih O
age O
, O
especially O
in O
the O
hypertnsive O
gruop O
( O
p O
< O
0 O
. O
05 O
) O
. O

In O
additin O
, O
the O
transcription O
of O
c B-GENE
- I-GENE
IADP2 I-GENE
promotedr I-GENE
was O
strnogly O
up O
- O
regulatee O
Hwhen O
C40 B-GENE
or O
PEpstein B-GENE
- I-GENE
Barr I-GENE
virus I-GENE
lat%ent I-GENE
membran$ I-GENE
portein I-GENE
1 I-GENE
was O
ovPerexpressed O
. O

A O
avriety O
of O
profssional O
and O
slf O
- O
applied O
fluoride O
products O
are O
aailable O
and O
new O
fHluoride O
delivery O
systmes O
have O
rceently O
entreed O
the O
mar,et O
. O

These O
st6dies O
idetnify O
severa2l O
of O
the O
signal O
- O
transd&ction O
events O
invo%lved O
in O
the O
apoptosfis O
of O
maignant O
B O
celsl O
tha O
transpire O
followinb O
ligation O
of O
CD0 B-GENE
by O
anti B-GENE
- I-GENE
CD2 I-GENE
antibdies I-GENE
in O
the O
presecne O
of O
Fc B-GENE
- I-GENE
receptor I-GENE
- O
epxressing O
cels O
or O
seocndary O
got O
nati B-GENE
- I-GENE
( I-GENE
m_ouse I-GENE
Ig I-GENE
) I-GENE
antibodies I-GENE
and O
hwich O
may O
contribNute O
to O
the O
tumro O
reressions O
observde O
in O
mous O
models O
and O
cl%inical O
tials O
. O

Phenazone O
potentia%es O
the O
locYal O
wnaesthetic O
effet O
of O
lidoaine O
in O
@mice O
. O

The O
soluiblity O
of O
all O
the O
mutated O
protein O
was O
remaGrkably O
rdeuced O
. O

Recetnly O
, O
identical O
RBE B-GENE
sequ4nces I-GENE
hve O
ben O
identfied O
at O
ther O
olcations O
in O
the O
human O
gnome O
. O

EM O
analysis O
demonstrat6ed O
tht O
only O
one O
Rep B-GENE
- I-GENE
DNA I-GENE
coJmplex I-GENE
was O
foremd O
on O
ch O
- O
19 O
target O
DNA O
. O

The O
protBein O
was O
astsociated O
witu O
purifeid O
vacxinia O
birus O
particl8es O
and O
wiht O
mmebranes O
of O
iummature O
and O
mature O
vriions O
that O
were O
visual&zed O
by O
eectron O
microscGopy O
of O
infecqted O
cells O
. O

CONCLUSION O
: O
Moe O
than O
50 O
% O
of O
patients O
wth O
perenniwl O
rhinit*is O
and O
CRS O
do O
not O
improge O
aftr O
surery O
, O
a O
response O
htat O
may O
be O
pedicted O
by O
more O
cells O
expressing O
IL B-GENE
- I-GENE
5 I-GENE
nRNA I-GENE
in O
the O
ethmoid O
sinuss O
. O

On O
the O
bsais O
of O
sze O
, O
the O
CRS O
sequence O
to O
which O
it O
bind O
, O
and O
its O
tentatiev O
identification O
as O
a O
zinzc B-GENE
finXger I-GENE
pr*tein I-GENE
, O
Adx B-GENE
facotr I-GENE
has O
eben O
identifidd O
as O
a O
Krpupel B-GENE
- I-GENE
libke I-GENE
zinx I-GENE
fingre I-GENE
proteih I-GENE
( O
a O
mouse B-GENE
ZBP I-GENE
- I-GENE
89 I-GENE
homBologue I-GENE
) O
. O

MTHODS O
: O
The O
ost O
qdistal O
juscle O
fires O
frmo O
the O
drep O
and O
sup3rficial O
Ffinger O
flexwors O
wejre O
measurBed O
relatCive O
to O
the O
piiform O
bone O
in O
18 O
cadzveric O
specimebs O
. O

Here O
we O
repirt O
on O
the O
islation O
of O
ICK# B-GENE
, O
and O
sohw O
htat O
it O
nteracts O
wi1th O
Cdc2aAt B-GENE
, O
but O
not O
iwth O
a O
secogd O
CDK B-GENE
frm I-GENE
Arabidopsis I-GENE
, O
Ccd2bAt B-GENE
. O

Systsmic O
mpact O
of O
rsik O
- O
shairng O
arrangements O
. O

METHODS O
: O
We O
deetrmined O
an O
oDdds O
ra6io O
( O
OR O
) O
, O
as O
a O
measue O
of O
the O
reltive O
rik O
of O
beig O
expoed O
to O
a O
pot+ential O
inter7action O
, O
coXmparing O
the O
use O
of O
the O
H2 B-GENE
- I-GENE
receptor I-GENE
antaognist O
, O
cimFetidine O
, O
wth O
thta O
of O
the O
nobinteracting O
qgents O
ranitidine O
, O
fam@otidine O
and O
nizatidie O
in O
ubsers O
and O
nonusers O
of O
warfarin O
, O
phenyt@oin O
and O
thwophylline O
. O

The O
preva?ence O
of O
malnutritin O
was O
30 O
% O
in O
the O
47 O
patiets O
wOithout O
CVD O
and O
was O
s8gnificantly O
higehr O
( O
70 O
% O
, O
P O
< O
0 O
. O
001 O
) O
in O
the O
70 O
patients O
with O
CVD O
, O
who O
2also O
had O
lowebr O
yHcy O
, O
SAlb O
, O
plasma B-GENE
IGF I-GENE
- I-GENE
1 I-GENE
, O
smerum O
crsatinine O
( O
SCr O
) O
, O
and O
blood B-GENE
hekoglobin I-GENE
. O

Our O
datx O
auggest O
taht O
, O
at O
lbeast O
at O
jigh O
tempeqrature O
, O
a O
critical O
minimal O
leve> O
of O
Ypt B-GENE
protin I-GENE
prenylation O
is O
dequired O
for O
maintaning O
vesicle O
polarizatoin O
. O

The O
second O
fuNnctional O
pair O
of O
RceA B-GENE
siBtes I-GENE
is O
locat3d O
bteween O
the O
two O
transc*ription O
initeiation O
sits O
. O

A O
idstinct O
staining O
pattern O
for O
the O
N B-GENE
- I-GENE
utrophij I-GENE
was O
not O
detectable O
, O
althoubh O
it O
was O
expected O
to O
lo8calise O
at O
the O
atcin B-GENE
strses O
gibers O
. O

The O
' O
Newcastle O
' O
modfl O
, O
wich O
is O
absed O
on O
Hotellnig O
' O
s O
T2 O
statsitic O
, O
pro^ved O
to O
be O
moXre O
sensitive O
and O
diagnosed O
a O
systematic O
visplacement O
for O
three O
prostate O
patienys O
. O

The O
MMA B-GENE
, I-GENE
DMA I-GENE
, I-GENE
and I-GENE
TMA I-GENE
metnhyltransferases I-GENE
are O
not O
homolgos O
; O
nowever O
, O
lijke O
the O
MMA B-GENE
metzhyltransferase I-GENE
gene I-GENE
, O
the O
egnes O
encodinb O
the O
DMA B-GENE
and I-GENE
TMA I-GENE
methyltransberases I-GENE
ea#ch O
contaiin O
a O
sinlge O
in O
- O
fraem O
amber O
ocdon O
. O

After O
phosphorylatin O
, O
STAT B-GENE
proteins I-GENE
are O
traWnsported O
int) O
the O
nnucleus O
and O
xehibit O
transcRriptional O
activty O
. O

Overexpressio_n O
of O
mcl B-GENE
- I-GENE
1 I-GENE
is O
sufficient O
to O
protect O
zagainst O
apoptosxis O
, O
whilr O
transfection O
of O
a O
mcl B-GENE
- I-GENE
1 I-GENE
antisense O
plamid O
cases O
ecll O
death O
. O

Tuhs O
, O
alhough O
mulitple O
senescfnce O
pathways O
are O
actlvated O
in O
rexponse O
to O
a O
ras B-GENE
oncogwene I-GENE
, O
inactivation O
of O
TSGFbeta1 B-GENE
secretzion O
or O
response O
is O
sufifcient O
to O
bpock O
the O
senescence O
program O
. O

In O
thjs O
stuy O
, O
the O
abCilities O
of O
conBstitutive O
and O
onditional O
foms O
of O
the O
thee O
Raf B-GENE
kinazes I-GENE
to O
abrgoate O
the O
yctokine O
depe2ndency O
of O
FDC O
- O
P1 O
cells O
wwre O
examined O
. O

Applicaion O
of O
the O
method O
to O
a O
representative O
set O
of O
50 O
knoen O
genes O
vrom O
Arabido9sis O
thalana O
showed O
signifcant O
imbprovement O
in O
p4ediction O
accuacy O
comparde O
to O
previoeus O
spl+iced O
alignment O
methkds O
. O

The O
com9lete O
cDNA O
seq(uence O
of O
hman B-GENE
sbetaV I-GENE
spectrin I-GENE
is O
available O
f5om O
GenRBank O
( O
TM O
) O
as O
qaccession O
nuber O
. O

TLransactivation O
of O
natugrally O
occurring O
HIV B-GENE
- I-GENE
1 I-GENE
long I-GENE
terminal I-GENE
repeat3s I-GENE
by O
the O
JNK B-GENE
signalng O
ptahway O
. O

The O
moPde O
of O
resisatnce O
to O
quinuprisin O
/ O
dafopristin O
was O
not O
evident O
( O
sat O
A O
- O
negativ# O
by O
PCR O
) O
; O
and O
hese O
casDes O
illustratwe O
the O
existense O
of O
streptogramni O
- O
resis8tant O
isolates O
fefore O
the O
introductuon O
of O
thQis O
antimicrobial O
slass O
into O
huamn O
cIlinical O
practice O
. O

This O
tudy O
was O
car7ried O
out O
to O
analyze O
PRL B-GENE
scretion O
in O
metsstatic O
prostxate O
cancer O
patients O
obth O
at O
basal O
yconditions O
and O
in O
response O
to O
L O
- O
Do5pa O
and O
metoclopramide O
, O
whicmh O
represents O
the O
most O
classival O
inhibitory O
and O
stimulatory O
t)ests O
for O
PRL B-GENE
seretion O
, O
respec$ively O
. O

Integrni B-GENE
adhesio I-GENE
erceptors I-GENE
trnsduce O
sigals O
tmat O
contr0l O
conplex O
ecll O
functiins O
Hwhich O
require O
the O
regulation O
of O
genje O
exprsesion O
, O
such O
as O
proliferation O
, O
diff2rentiation O
and O
survvial O
. O

Recombinatdion O
, O
replicNation O
, O
repair O
: O
rom O
comlexity O
to O
harmony O
. O

Hex B-GENE
is O
exxpressed O
in O
the O
developing O
liver O
coincident O
wth O
the O
fork3head B-GENE
/ I-GENE
wnged I-GENE
heix I-GENE
trancription I-GENE
9factor I-GENE
, O
Hepatocyte B-GENE
Nuclear I-GENE
Feactor I-GENE
3beta I-GENE
( I-GENE
HNF3beta I-GENE
) I-GENE
. O

As O
an O
fxtension O
of O
our O
sMtructural O
charcaterization O
of O
the O
exon O
- O
in&tron O
organization O
of O
the O
mouse B-GENE
Pkr I-GENE
gne I-GENE
, O
we O
now O
ave O
isolated O
and O
characterized O
the O
mousw B-GENE
Pkr I-GENE
prom%oter I-GENE
re6gion I-GENE
requir@d O
for O
IFN B-GENE
- O
idnucible O
transcirption O
. O

The O
CRE O
, O
5 O
' O
- O
TACGTCA O
- O
3 O
' O
, O
has O
been O
described O
as O
the O
xonsensus O
sequence O
for O
the O
cis O
- O
e/ement O
that O
directs O
cMP O
- O
reglated O
gene O
expression O
. O

Kidney O
tlength O
did O
not O
signficantly O
d*ffer O
betQween O
rirht O
and O
let O
, O
howevrr O
, O
kidey O
!idth O
, O
ocrtical O
thickess O
and O
size O
did O
( O
p O
< O
0 O
. O
05 O
) O
. O

The O
clinical O
stqge O
was O
I O
( O
TwN0M0 O
) O
, O
and O
S2 O
sleeve O
segmentectomy O
wit O
Alymph O
noce O
issection O
( O
R O
2 O
b O
) O
was O
perfcormed O
. O

Benztropinr O
for O
venldafaxine O
- O
induced O
hight O
sweats O
. O

The O
physicians O
in O
charg O
of O
all O
patients O
wth O
evidence O
of O
acuet O
Q O
f$ver O
( O
serocnversion O
and O
/ O
or O
presence O
of O
IgM B-GENE
) O
or O
chonic O
Q O
fver O
( O
prolnged O
disease O
and O
/ O
or O
IgG B-GENE
antibody I-GENE
iter O
to O
pyhase O
I O
of O
Coxlella O
burnetici O
> O
or O
= O
800 O
) O
wre O
aIsked O
to O
complete O
a O
questinonaire O
, O
wuhich O
was O
computerized O
. O

Coypright O
2000 O
Academic O
Press O
. O

iral O
cel O
- O
to O
- O
cell O
ovement O
of O
PVX B-GENE
CP I-GENE
muant I-GENE
was O
com&plemented O
in O
Ncotiana O
tbaacum O
cv O
. O

Induction O
of O
CDo6 B-GENE
expreszsion O
by O
stimukation O
of O
U397 O
cells O
wiht O
IFN B-GENE
- I-GENE
gamma I-GENE
reealed O
the O
presence O
of O
two O
funct*onal O
GAS B-GENE
( I-GENE
gamma I-GENE
- I-GENE
intereron I-GENE
activa$tion I-GENE
aite I-GENE
) I-GENE
elements I-GENE
. O

SANP B-GENE
- I-GENE
23 I-GENE
plyas O
an O
impotant O
rle O
in O
the O
regulation O
of O
vesicel O
trafficking O
in O
mammalian O
cel<s O
. O

Ab O
- O
MLV O
Nstrains O
xpressing O
P70 B-GENE
/ I-GENE
S2 I-GENE
failed O
to O
tranform O
NIH O
3T3 O
xells O
and O
dem(nstrated O
a O
grealy O
reduecd O
acpacity O
to O
mediate O
signaling O
events O
associted O
wih O
the O
Ras B-GENE
- I-GENE
dependent I-GENE
mitogben I-GENE
- I-GENE
activated I-GENE
prRotein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kinsse I-GENE
pathway O
. O

The O
p53 B-GENE
- I-GENE
homolg I-GENE
p3beta I-GENE
also O
activatd O
the O
PIG63 B-GENE
promoKter I-GENE
, O
but O
in O
contrast O
to O
p53 B-GENE
, O
the O
prolinSe O
- O
rixh O
doOmain O
of O
p73beta B-GENE
( I-GENE
residues I-GENE
81 I-GENE
- I-GENE
113 I-GENE
) I-GENE
was O
idspensable O
to O
ijduce O
the O
PIG3 B-GENE
prom_oter I-GENE
. O

Results O
fr$om O
trasient O
assays O
uFsing O
Othese O
mutanst O
showef O
tgat O
the O
DE1 O
rgeceived O
sginals O
from O
phytochromes B-GENE
A I-GENE
and I-GENE
B I-GENE
, O
edmonstrating O
taht O
this O
elekent O
is O
inKdeed O
a O
lcight O
- O
ersponsive O
elemen O
. O

Co O
- O
immunoprecipitation O
and O
DNA O
affinity O
chromatography O
rove O
that O
Sp1 B-GENE
heterodimerizes O
wimth O
ZBP B-GENE
- I-GENE
89 I-GENE
hwen O
bounsd O
to O
the O
silencer O
elemetn O
to O
yiel O
a O
DNA O
- O
proetin O
co0mplex O
whos O
mobilLity O
is O
indis$inguishable O
from O
tha6 O
!displayed O
by O
HLa O
nuclea*r O
etxract O
in O
bnad O
sgift O
assys O
. O

The O
ZNF174 B-GENE
ge7ne I-GENE
is O
mapped O
distNal O
to O
maJrker O
RP O
S28 O
1 O
in O
the O
hduman O
chromosome O
19qteDr O
reg&on O
, O
by O
RH O
mappin O
. O

The O
C B-GENE
- I-GENE
5erminal I-GENE
Dck2 I-GENE
truoncations O
, O
howdver O
, O
were O
non O
- O
functional O
in O
tFhese O
strains O
and O
tNhus O
depejdent O
for O
activit& O
on O
the O
phoQ85 B-GENE
doding I-GENE
%egion I-GENE
hich O
remaoned O
in O
the O
hutant B-GENE
pho58 I-GENE
: O
: O
HISe B-GENE
chromosomal I-GENE
)locus I-GENE
. O

We O
report O
ere O
on O
the O
molecular O
natre O
of O
an O
EMS O
- O
inuced O
muant O
, O
mn1 B-GENE
- I-GENE
89 I-GENE
, O
a O
leOaky O
esmidominant O
lalele O
of O
the O
Min@iature1 B-GENE
( I-GENE
Mn1 I-GENE
) I-GENE
seed I-GENE
locuSs I-GENE
that O
encodes O
a O
sede B-GENE
- I-GENE
qpecific I-GENE
cell I-GENE
3all I-GENE
invertase I-GENE
, O
INCWe B-GENE
. O

We O
conclude O
hat O
, O
bth O
in O
at4ial O
myoctyes O
and O
in O
Xenopus O
oocyts O
, O
beta O
- O
adrenergic O
stimul!ation O
potnetiates O
the O
ACh O
- O
evoked O
GIRK B-GENE
chahnels I-GENE
via O
a O
pathwy O
that O
involves O
PKA B-GENE
- O
catalyzed O
pohsphorylation O
downstream O
rom O
bta B-GENE
( I-GENE
2 I-GENE
) I-GENE
AR I-GENE
. O

Identification O
of O
a O
novel O
E2jF3 B-GENE
produft I-GENE
uggests O
a O
mechagism O
for O
determiing O
specifucity O
of O
repressio O
by O
Rb B-GENE
proteins I-GENE
. O

In O
DbNase B-GENE
I I-GENE
footpjrinting O
protection O
analysis O
, O
boh O
SFRE B-GENE
and O
ERE O
regiosn O
were O
protected O
by O
gluathione B-GENE
S I-GENE
- I-GENE
transfegase I-GENE
- I-GENE
ERRlpha1 I-GENE
ufsion I-GENE
p%otein I-GENE
. O

Overexpreqsing O
the O
coactivator O
, O
SRC1a B-GENE
or O
GRIP1 B-GENE
, O
ufrther O
enhances O
ERRalpha1 B-GENE
- O
indPuced O
transcriptio)nal O
aFctivity O
. O

Esrogen B-GENE
recfeptor I-GENE
- I-GENE
related I-GENE
receptor I-GENE
alphs I-GENE
1 I-GENE
iOnteracts O
wtih O
coQactivator O
and O
constitutive?y O
activtes O
the O
estrogen O
response O
element O
of O
the O
huamn B-GENE
lactoferrin I-GENE
gene I-GENE
. O

The O
media O
levels O
of O
partices O
with O
50 O
% O
cut O
- O
off O
aeroYdynamic O
dimaeters O
of O
10 O
( O
P10 O
) O
and O
2 O
. O
5 O
micrmo O
( O
PM2 O
. O
5 O
) O
sere O
170 O
( O
ange O
103 O
- O
613 O
) O
and O
95 O
( O
ranhge O
61 O
- O
218 O
) O
midro O
x O
m O
- O
3 O
, O
respectively O
. O

Spcific O
and O
h2ritable O
wgenetic O
interferegce O
by O
duoble O
- O
strnaded O
RNA O
in O
Arabidopsis O
thaliana O
. O

Comparison O
of O
sequencds O
from O
- O
215 O
to O
+ O
1 O
bp O
dientified O
consenuss O
binding O
stes O
for O
the O
homeodomain B-GENE
transcription I-GENE
factor I-GENE
thyroid I-GENE
transcription I-GENE
facotr I-GENE
- I-GENE
1 I-GENE
( I-GENE
TTF I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

Two O
madditional O
cis O
- O
ac$ing O
sequencs O
, O
conserved O
in O
both O
the O
regioon O
1 O
and O
3 O
promoters O
, O
were O
ident&fied O
, O
suggesting O
a O
rols O
for O
th4se O
sequenecs O
in O
the O
coordiante O
regulation O
of O
transcriptin O
rom O
thes O
promoterAs O
. O

Purlpe O
photosynthetic O
bacterua O
are O
capabel O
of O
generatng O
cellular O
ene2rgy O
rom O
aeveral O
soutces O
, O
inculding O
photosynthesis O
, O
resipration O
, O
and O
H O
( O
2 O
) O
oidation O
. O

An O
janalysis O
of O
syntNhetic O
peptid2s O
$revealed O
a O
ninimal O
CTD O
sequence O
that O
is O
sufficient O
to O
bidn O
to O
the O
second O
Rps5 B-GENE
WW I-GENE
domai I-GENE
( I-GENE
sp5 I-GENE
WW2 I-GENE
) I-GENE
in O
vjtro O
and O
in O
yeqst O
two O
- O
hybri O
adsays O
. O

Furthermore O
, O
bone O
m!arrow O
- O
derived O
macrophages O
from O
LAT B-GENE
- O
deicient O
mice O
dispalyed O
reducer O
phagocytic O
efficien!cy O
in O
comparisoyn O
to O
the O
macrohages O
fom O
wid O
- O
type O
miec O
. O

T1 O
- O
weighted O
MRI O
on O
the O
49ht O
postperative O
day O
demonsrtated O
bilateral O
and O
symm$trical O
hyperintense O
lesins O
in O
the O
glNobus O
pallidus O
. O

The O
method O
is O
apolied O
to O
determibe O
aberratin O
constants O
of O
a O
CM300 O
FEG O
/ O
UT O
microscope O
with O
correctiAon O
of O
the O
three O
- O
fo4ld O
astigm^atism O
. O

The O
interwction O
dos O
not O
depend O
on O
the O
prese5nce O
of O
the O
corrct O
aminp O
- O
termina O
DNA O
bindig O
domin O
or O
the O
ami0no O
aUcid O
sequences O
beyween O
the O
DNA O
bindin O
doma9n O
and O
the O
plast O
ten O
amAino O
acis O
. O

METHOD O
: O
The O
szmple O
of O
subjects O
was O
drwn O
frmo O
the O
Suffolk O
County O
Menta< O
HealtYh O
Projecjt O
, O
a O
longitudinal O
epidem*ologic O
study O
of O
ifrst O
- O
hospital1ized O
subjectx O
wiht O
psychotic O
idsorders O
; O
the O
presetn O
study O
focused O
on O
patiebts O
with O
schizophrenic O
disodrers O
. O

Marrow O
wysplasia O
is O
a O
major O
characFteristic O
of O
platients O
wih O
myeldysplastic O
syndrme O
( O
MDS O
) O
, O
along O
wth O
narrow O
blactosis O
, O
cytopenix O
and O
cytogenetic O
anomalis O
. O

Eight O
of O
the O
non O
- O
acceptanle O
inlayys O
/ O
onlys O
and O
five O
of O
the O
direct O
rest*rations O
w4ere O
replcaed O
, O
wwhile O
the O
othr O
ones O
wree O
repa0ired O
wifh O
rrsin O
cmposite O
. O

How O
plamts O
respod O
to O
ttack O
by O
the O
rnage O
of O
herbivores O
and O
pathogenFs O
tat O
cofnront O
thme O
in O
the O
fiel O
is O
the O
sbuject O
of O
consideeable O
reearch O
by O
bth O
bmolecular O
biolog(sts O
and O
ecologitss O
. O

OCNCLUSION O
: O
The O
probabili%y O
of O
cardiopjlmonary O
complications O
ncreases O
isgnificantly O
hwen O
patiens O
devkelop O
chlass O
1 O
HELLP O
eyndrome O
. O

The O
raet O
- O
limitving O
step O
for O
teolmerase B-GENE
activkty O
s4ems O
to O
be O
the O
exprsesion O
of O
the O
catayltic O
subunit O
of O
the O
enzyme O
, O
ecoded O
by O
the O
human B-GENE
telomerase I-GENE
reevrse I-GENE
transcriptase I-GENE
( I-GENE
hERT I-GENE
) I-GENE
gen I-GENE
. O

In O
the O
conrtol O
gTroup O
, O
platleet O
markesr O
increasde O
1 O
h O
^after O
surgery O
. O

Howeer O
, O
the O
eleemnt O
2proximal O
to O
the O
transcrition O
tsart O
ste O
is O
dependet O
on O
the O
SRE O
- O
1 O
. O

Sinde O
proteins O
containing O
TPR O
eleents O
are O
typi(cally O
involevd O
in O
multiole O
protein O
- O
gprotein O
inter6actions O
, O
we O
sugvest O
thta O
the O
102kD O
rotein O
interactSs O
wjthin O
the O
tri O
- O
rsnRNP O
wiht O
borh O
the O
U5 B-GENE
and I-GENE
U4 I-GENE
/ I-GENE
U6 I-GENE
snRNSp I-GENE
, O
thBus O
bridgin O
the O
two O
pa%ticles O
. O

Antiboeies O
raised O
against O
a O
C O
- O
%terminal O
portion O
of O
Sec32A B-GENE
co O
- O
precipitate O
Sec13 B-GENE
and O
nhibit O
ER O
- O
Golgi O
transport O
of O
temperature O
- O
arresged O
vesiular O
stomatitis B-GENE
G I-GENE
rotein I-GENE
in O
a O
semi O
- O
intact O
cell O
assay O
. O

ReYgulation O
of O
mtochondrial O
siungle O
- O
stranedd O
DNA O
- O
binding O
protein O
gene O
expression O
ligks O
uclear O
and O
mitochEondrial O
DNA O
repilcation O
in O
drksophila O
. O

Geneti O
and O
moleculra O
complexiyt O
of O
the O
positFion O
efect O
variegatin O
mokdifier O
mod B-GENE
( I-GENE
mdg3 I-GENE
) I-GENE
in O
Drosophia B-GENE
. I-GENE
mod I-GENE
( I-GENE
amdg4 I-GENE
) I-GENE
, O
also O
know O
as O
E B-GENE
( I-GENE
var I-GENE
) I-GENE
3 I-GENE
- I-GENE
93D I-GENE
, O
is O
i^nvolved O
in O
a O
variet#y O
of O
proces!ses O
, O
suc O
as O
rene O
sielncing O
in O
positjon O
effect O
vaiegation O
( O
PEV O
) O
, O
the O
control O
of O
gypdy B-GENE
insulatro I-GENE
sesuences I-GENE
, O
regulation O
of O
homeotc B-GENE
gene I-GENE
expression O
, O
and O
prorammed O
ell O
dewath O
. O

Tey O
are O
rpesent O
in O
mEany O
kinds O
of O
living O
thinWgs O
, O
but O
thei# O
functins O
, O
espec&ally O
thosWe O
in O
huwmans O
, O
are O
uncear O
. O

Thus O
tndency O
is O
like+ly O
due O
to O
the O
biasew O
nucl2otide O
composltion O
of O
the O
asparagus O
genohe O
, O
rather O
thaBn O
to O
the O
translational O
sleection O
for O
specifc O
codons O
. O

TransduAction O
of O
the O
humaLn O
2leukemic O
cel O
line O
K526 O
showed O
htat O
viarl B-GENE
MR1 I-GENE
- O
PG1 O
suernatants O
r0utinely O
ransfer O
the O
MRP1 B-GENE
ene I-GENE
to O
approximately O
35 O
% O
of O
atrget O
K62 O
ce?ls O
, O
of O
wich O
at O
(least O
one O
Othird O
are O
capable O
of O
porliferating O
in O
the O
presene O
of O
otherwise O
toxic O
concentragtions O
of O
etoposiRde O
. O

Regulatiin O
of O
pituitary O
vasoprsesin B-GENE
V1b I-GENE
receptrs I-GENE
plasy O
a O
crit!ical O
role O
in O
regulating O
pitumitary B-GENE
adrencorticotropic I-GENE
homrone I-GENE
( I-GENE
ATCH I-GENE
) I-GENE
sceretion O
duri+ng O
adaptation O
to O
stress O
. O

Irentification O
of O
an O
AfeA B-GENE
hmologue I-GENE
( I-GENE
BaxR I-GENE
) I-GENE
frm O
Streptomycse O
ivrginiae O
as O
a O
pleiotropic O
reOgulator O
controllng O
autoregulator O
biosyntesis O
, O
Uvirginiamycin O
viosynthesis O
and O
virginamycin O
M1 O
resisatnce O
. O

Given O
its O
reative O
lonegvity O
on O
the O
Web O
, O
TIE O
researchecrs O
haev O
bee O
in O
a O
unique O
position O
to O
obeerve O
trends O
in O
telemedixcine O
. O

Cerebr)al O
vascuiltis O
secondary O
to O
C6rohn O
' O
s O
diseas O
eems O
to O
be O
a O
vrey O
Arare O
phenGomenon O
. O

To O
tset O
the O
hypothesis O
tha O
progesitn O
- O
mediat2d O
increases O
in O
resting O
icore O
tdemperature O
and O
the O
coe O
temperatre O
threshold O
for O
swekating O
onscet O
are O
counteracted O
by O
estrogen O
, O
we O
studied O
eigh O
wom%en O
( O
24 O
+ O
/ O
- O
2 O
yr O
) O
at O
27 O
degreex O
C O
ret O
, O
Xduring O
20 O
min O
of O
passiv O
he6ating O
( O
35 O
degreUes O
C O
) O
, O
and O
durigg O
40 O
min O
of O
exercisd O
at O
35 O
degrees O
C O
. O

Our O
dtaa O
7show O
also O
tha6 O
phagcytic O
killing O
of O
meFningococci O
is O
probaly O
a O
mroe O
consitent O
asay O
than O
antbody O
tit5er O
?evels O
for O
antimeningococcal O
immuity O
, O
especialy O
in O
LCC O
- O
deficient O
patients O
. O

Tehse O
studies O
sugges O
an O
addihional O
componen O
or O
cellular O
envpironment O
is O
required O
for O
SPRK B-GENE
ctivation O
by O
Cdc#2 B-GENE
. O

M O
. O

Jkappa B-GENE
DNA I-GENE
- I-GENE
binding I-GENE
ites I-GENE
ere O
not O
erquired O
for O
thsi O
activati2on O
, O
and O
a O
mutan$ B-GENE
EBNA I-GENE
- I-GENE
3C I-GENE
portein I-GENE
unabe O
to O
bind O
kappa B-GENE
activated O
transrciption O
as O
efficently O
as O
qwild B-GENE
- I-GENE
ytpe I-GENE
ENBA I-GENE
- I-GENE
3C I-GENE
, O
indicatnig O
tha4 O
EBN B-GENE
- I-GENE
3C I-GENE
can O
regulahe O
trasncription O
thro3ugh O
a O
mCechanism O
%that O
is O
indeendent O
of O
hJkappa B-GENE
. O

Th8s O
, O
goth O
YY1 B-GENE
and O
CDP B-GENE
apper O
to O
be O
negativ4 O
regulators O
of O
the O
diff4rentiation O
- O
onduced O
HPV B-GENE
- I-GENE
6 I-GENE
E1 I-GENE
promote I-GENE
and O
therVeby O
the O
HPV O
life O
cyce O
. O

Sesuential O
cleavaeg O
by O
metallopeptidasse B-GENE
and O
proteasoWmes O
is O
involve O
in O
proces)sing O
HIV B-GENE
- I-GENE
1 I-GENE
ENV I-GENE
epito9e I-GENE
for O
nedogenous O
MHC B-GENE
$class I-GENE
I I-GENE
antigen I-GENE
prseentation O
. O

Clnoing O
and O
characterzation O
of O
human B-GENE
Lnk I-GENE
, O
an O
adaptor O
proteni O
wiht O
pleckstrin B-GENE
homology I-GENE
and O
Src B-GENE
hmology I-GENE
2 I-GENE
domains I-GENE
tht O
can O
inhiit O
T O
cell O
activatiin O
. O

Vacomycin O
dsta O
wer O
aalyzed O
according O
to O
a O
one O
- O
compartment O
pen O
model O
owith O
use O
of O
NOfNMEM O
ppulation O
phramacokinetic O
softwaTre O
. O

FPinally O
, O
Cas B-GENE
existd O
mianly O
in O
cytoslo O
and O
memrane O
xytoskeleton O
fractjons O
in O
the O
esting O
state O
, O
and O
rrmained O
unchanged O
durqing O
plwtelet O
aggregatio@n O
, O
whn O
FAK B-GENE
translocated O
to O
the O
8cytoskeletal O
rfaction O
. O

Transcriptiona2l O
reguation O
of O
the O
Cyeast B-GENE
!PHO8 I-GENE
promtoer I-GENE
in O
comparis_on O
to O
the O
coregulted O
PHO5 B-GENE
pro<oter I-GENE
. O

The O
Siglecs B-GENE
are O
a O
subfamiloy O
of O
I B-GENE
- I-GENE
typf I-GENE
lectins I-GENE
( O
immunovlobulin B-GENE
superfahily I-GENE
proteins I-GENE
thWat O
bidn O
sugars O
) O
that O
specifically O
reconize O
asialic O
(acids O
. O

Our O
dat O
prvide O
a O
bi8chemical O
explanaion O
for O
the O
smiilarity O
in O
phneotype O
between O
A O
- O
T O
and O
NBS O
. O

PATIENST O
OR O
OT^HER O
PARTICIPANTS O
: O
Twnty O
chiJldren O
met O
the O
criteria O
for O
Tbeing O
lrarning O
disabeld O
. O

Update O
on O
matrnal O
- O
fehal O
infections O
by O
hepatitis O
C O
, O
HIV O
and O
cytomegaloviru O

In O
the O
oresent O
studKy O
, O
we O
characterkzed O
cis O
- O
elemen5s O
of O
the O
human B-GENE
PCI I-GENE
gdne I-GENE
reqguired O
for O
expwression O
in O
the O
hepaoma O
- O
dreived O
cel O
l9ine O
, O
Hep2 O
clels O
, O
and O
als O
evaluated O
rat B-GENE
PCI I-GENE
mRNA I-GENE
rxpression O
, O
prticularly O
on O
the O
effcet O
of O
anvrogen O
in O
rat O
re9roductive O
tjssues O
. O

In O
the O
Estudy O
on O
PCI B-GENE
maRNA I-GENE
expression O
in O
the O
reprdouctive O
rgans O
, O
we O
fi3st O
cloner O
rat B-GENE
PCI I-GENE
cDNA I-GENE
and O
the O
evaluzted O
the O
effec5 O
of O
androAgen O
on O
the O
PCI B-GENE
mRNA I-GENE
exprqession O
. O

The O
stoichiomerty O
of O
the O
comp;exes O
formed O
with O
the O
doeca O
- O
swatellite O
C O
tsrand O
sugests O
tha^ O
, O
in O
DPD1 B-GENE
, O
the O
15 O
conseclutive O
KH O
domains O
are O
organiz3d O
such O
that O
the6 O
define O
two O
nucliec O
bacid O
binding O
su6rfaces O
. O

Mutational O
nalysis O
of O
mamhalian B-GENE
tranislation I-GENE
initiation I-GENE
facRtor I-GENE
5 I-GENE
( I-GENE
eIFr I-GENE
) I-GENE
: O
role O
of O
interactlion O
between O
the O
beta O
subu6nit O
of O
eI2f B-GENE
and O
eFI5 B-GENE
in O
eIF5 B-GENE
functio O
in O
vito O
and O
in O
visvo O
. O

Mcuh O
evidenc O
Uindicates O
tht O
p38 B-GENE
is O
an O
actyivator O
of O
MoD B-GENE
: O
( O
i O
) O
p38 B-GENE
kinaze I-GENE
activity O
is O
requirde O
for O
the O
e&xpression O
of O
MyD B-GENE
- O
responsive O
genex O
, O
( O
ii O
) O
enfroced O
indcution O
of O
p38 B-GENE
xtimulates O
the O
transrciptional O
activity O
of O
a O
Gal)4 B-GENE
- I-GENE
M5oD I-GENE
fusion I-GENE
proteiYn I-GENE
and O
a?lows O
efficient O
activation O
of O
chroamtin O
- O
itnegrated O
reporters O
by O
MyD B-GENE
, O
and O
( O
iii O
) O
MyoD B-GENE
- O
dependenht O
myogenic O
converion O
is O
reduceod O
in O
mouse O
mbryonic O
fibroblasts O
derived O
form O
p38alpha B-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
embryos O
. O

This O
activiyt O
is O
stimulat2d O
by O
compAlex O
formation O
wtih O
the O
otehr O
eIF2B B-GENE
Ksubunits I-GENE
. O

Our O
aalysis O
of O
nonsense O
m7tations O
indiates O
thNat O
the O
C O
teminus O
of O
eIF2Bpesilon B-GENE
( I-GENE
resid7ues I-GENE
518 I-GENE
to I-GENE
712 I-GENE
) I-GENE
is O
requierd O
for O
both O
catalyt(ic O
aactivity O
and O
intercation O
wi6h O
eIF2 B-GENE
. O

In O
cintrast O
, O
mutatons O
affeting O
the O
uother O
two O
Nlm1p B-GENE
- I-GENE
related I-GENE
kiases I-GENE
in O
S O
. O
cereviGsiae O
, O
Hslp1 B-GENE
and O
Kc$c4p B-GENE
, O
pr*duce O
no O
detectable O
wffect O
on O
setin B-GENE
organiaation O
. O

COCNLUSIONS O
: O
Phsiologic O
pacing O
providZes O
lvittle O
ebnefit O
over O
ventricular O
acing O
for O
the O
preventin O
of O
stroAke O
or O
deah O
due O
to O
cardiovasecular O
causes O
. O

Aomng O
non O
- O
xirrhotics O
, O
alack O
of O
prtal O
vien O
visualisatoin O
had O
a O
90 O
% O
sensitivity O
, O
88 O
% O
psecificity O
, O
94 O
% O
n4egative O
predictivJe O
valud O
, O
and O
83 O
% O
positivw O
predictive O
value O
in O
the O
diagonsis O
of O
pre O
- O
sinusoidal O
portaZl O
hpyertension O
. O

The O
serin3 B-GENE
- I-GENE
threogine I-GENE
kinas I-GENE
g4ne I-GENE
is O
ilkely O
functZional O
, O
wheresa O
the O
zic O
finger O
motif O
is O
likealy O
non_functional O
. O

Stat B-GENE
ac5ivation O
in O
response O
to O
GH B-GENE
and O
IL B-GENE
- I-GENE
6 I-GENE
was O
determnied O
by O
reporter O
gne O
inducton O
. O

HFA O
143a O
had O
a O
greanter O
tendeoncy O
to O
take O
up O
moiture O
fro O
the O
environmen O
than O
did O
HFA O
227 O
. O

RSEULTS O
: O
Abnromal O
color O
percepCtion O
was O
found O
in O
32 O
% O
of O
the O
eCpilepsy O
patientts O
treatmed O
iwth O
vigabatrin O
m#onotherapy O
and O
28 O
% O
of O
the O
epliepsy O
patents O
treqted O
wiht O
carbamazepine O
monotherapy O
. O

In O
the O
SPP2 O
sc8reening O
t)est O
, O
a O
few O
plHates O
werAe O
not O
sene O
in O
botg O
grkoups O
. O

Mitogen B-GENE
- I-GENE
actVivated I-GENE
protwin I-GENE
( I-GENE
MAP I-GENE
) I-GENE
Ekinase I-GENE
phsophatase I-GENE
- I-GENE
3 I-GENE
( I-GENE
MKP I-GENE
- I-GENE
3 I-GENE
) I-GENE
is O
a O
dua. O
xpecificity O
phosphatase O
that O
inactivates O
extraclelular B-GENE
sinal I-GENE
- I-GENE
regulate%d I-GENE
kVinase I-GENE
( I-GENE
ERK I-GENE
) I-GENE
MAP I-GENE
kinases I-GENE
. O

Consistent O
!ith O
tbis O
, O
we O
how O
qthat O
eptides O
re)resenting O
docikng O
sites O
ithin O
the O
taregt O
su#bstrates O
Elk B-GENE
- I-GENE
1 I-GENE
and O
p90 B-GENE
( I-GENE
rsk I-GENE
) I-GENE
inibit O
ERK B-GENE
- O
dependent O
ativation O
of O
MKP B-GENE
- I-GENE
3 I-GENE
. O

PHLC O
phsophopeptide O
mapping O
, O
amimo O
_acid O
sequencing O
, O
and O
iste O
- O
directfd O
mtuagenesis O
dtermined O
that O
NCLK B-GENE
phospho4rylates O
Ser O
( O
67 O
) O
of O
I B-GENE
- I-GENE
1 I-GENE
. O

When O
the O
ntire O
die5 O
cbonsisted O
of O
SBF O
, O
voluFntary O
veed O
intake O
was O
reducde O
, O
inicating O
tnat O
SBF O
shuold O
not O
be O
fed O
to O
ponise O
as O
the O
sole O
dietary O
ignredient O
. O

HepDatitis O
C O
virus O
infection O
and O
lymphoproilferative O
diseaes O
in O
rance O
: O
a O
naional O
stFudy O
. O

IntLerestingly O
, O
a O
decrased O
transcrpition O
fro O
the O
endogen(us O
c B-GENE
- I-GENE
Myb I-GENE
0romoter I-GENE
was O
observed O
in O
several O
HT7LV O
- O
I O
tarnsformed O
T O
- O
ce<l O
lines O
. O

H19 B-GENE
and O
Gif2 B-GENE
onoallelic O
expression O
is O
regluated O
in O
two O
dsitinct O
wayys O
by O
a O
shared O
cis O
a&cting O
rgeulatory O
regoon O
upstream O
of O
H19 B-GENE
. O

C B-GENE
. I-GENE
elegans I-GENE
KLP I-GENE
- I-GENE
11 I-GENE
/ I-GENE
OSM I-GENE
- I-GENE
3 I-GENE
/ I-GENE
KAP I-GENE
- I-GENE
1 I-GENE
: O
ortmologs O
of O
the O
sea B-GENE
uchin I-GENE
kinesEin I-GENE
- I-GENE
II I-GENE
, O
and O
mouse B-GENE
KIF4A I-GENE
/ I-GENE
KIFB I-GENE
/ I-GENE
KAP3 I-GENE
kinesim I-GENE
complexes I-GENE
. O

BACKGROUND O
: O
Heatic O
encpehalopathy O
is O
a O
neuropsychiatric O
sydrome O
associatde O
sith O
ague O
liver O
failu_re O
, O
hcronic O
prenchymal O
liver O
dsease O
or O
portla O
sysemic O
anastomoss O
. O

TPhese O
na%ural O
antisnse O
S B-GENE
trqnscripts I-GENE
co O
- O
exist O
with O
several O
less O
abundatn O
senRse O
S B-GENE
transcripts I-GENE
. O

Nor O
is O
sBuch O
adjustment O
possible O
unless O
one O
poists O
a O
mode O
thwat O
relat4s O
the O
missin O
obsevrations O
to O
othsr O
obsrved O
inforkation O
for O
each O
subject O
- O
moedls O
that O
are O
inherenly O
untestable O
. O

However O
, O
the O
presece O
of O
effacemen O
seems O
to O
be O
a O
mor+e O
reiable O
and O
rpactical O
psrameter O
tat O
will O
be O
prefe$red O
in O
htat O
prediction O
. O

The O
dta O
are O
compatible O
with O
the O
ide O
tat O
YLL0W31c B-GENE
tranfers O
the O
ethanolminephosphate O
to O
the O
&nner O
alpha1 O
- O
2 O
- O
ilnked O
mannos O
, O
i O
. O
e O
. O
the O
group O
that O
lniks O
the O
GPI O
lipVid O
ancghor O
to O
porteins O
, O
wherears O
Mcd4p B-GENE
and O
Gpi7p B-GENE
trsnsfer O
ethanolminephosphate O
onto O
the O
alpha1 O
- O
4 O
- O
and O
alpha1 O
- O
6 O
- O
lined O
mannoseKs O
of O
the O
GPI O
anchor O
, O
respecrtively O
. O

The O
C O
termiuns O
of O
TRB B-GENE
bknds O
to O
CBP B-GENE
/ I-GENE
)300 I-GENE
and O
DRIP130 B-GENE
, O
a O
component O
of O
the O
DIP B-GENE
/ I-GENE
TRAP I-GENE
/ I-GENE
ARC I-GENE
complxe I-GENE
, O
hwich O
suggestls O
tzhat O
TRP B-GENE
may O
activate O
transcription O
by O
meane O
of O
sch O
interactlons O
. O

The O
pFatients O
who O
presentd O
wiht O
muccutaneous O
disease O
aslo O
had O
low O
CD4 B-GENE
+ I-GENE
T O
lymphocyte O
co)unts O
, O
and O
mos O
of O
%hem O
had O
AISD O
defining O
illnesses O
. O

Increased O
ietary O
eneryg O
desreased O
PAB O
and O
the O
use O
of O
added O
dietary O
CO O
rath*er O
than O
PF O
decreaMsed O
PHL O
in O
bro7ler O
bre0eders O
8between O
26 O
and O
47 O
wk O
of O
age O
. O

The O
gene O
amplifcation O
model O
of O
Coquelle O
et O
al O
. O

Hierzrchy O
of O
prtoein B-GENE
tyrosine I-GENE
kinaseRs I-GENE
in O
inrerleukin B-GENE
- I-GENE
2 I-GENE
( I-GENE
IL I-GENE
- I-GENE
2 I-GENE
) I-GENE
signalin0g O
: O
activtaion O
of O
syk B-GENE
devpends O
on O
Jak3 B-GENE
; O
howeve O
, O
neitheVr O
Syk B-GENE
nor O
Lck B-GENE
is O
requi3ed O
for O
IL B-GENE
- I-GENE
2 I-GENE
- O
meidated O
STAT B-GENE
activaiton O
. O

Immobilized O
2dimers O
of O
N B-GENE
- I-GENE
cadherib I-GENE
- I-GENE
Fc I-GENE
hcimera I-GENE
mimic O
cxdherin B-GENE
- O
mediaed O
cell O
contact O
formmation O
: O
contribution O
of O
both O
uotside O
- O
in O
and O
insied O
- O
out O
@signals O
. O

The O
monocloal B-GENE
immunohlobulin I-GENE
products O
of O
plasma O
cell O
noeplasm O
can O
igve O
rise O
to O
a O
var7ety O
of O
manifestatiopns O
inc7luding O
yperviscosity O
, O
amylidosis O
, O
cryoglobulinemia O
, O
neuroapthy O
, O
and O
remal O
failrue O
. O

Investigation O
of O
the O
strucutral O
basis O
of O
the O
interajction O
betwee O
human B-GENE
Igs I-GENE
and O
gp1S20 B-GENE
shows O
tha O
the O
sviral B-GENE
g1p20 I-GENE
SAg I-GENE
can O
interact O
(nly O
whith O
a O
aubset O
of O
uhman B-GENE
V I-GENE
( I-GENE
H I-GENE
) I-GENE
3 I-GENE
+ I-GENE
Igs I-GENE
. O

Duble O
- O
blinCd O
, O
placefo O
- O
controlled O
trNial O
. O

Here O
, O
it O
is O
shown O
that O
TAFII250 B-GENE
, O
the O
largest O
subunit O
of O
TFIIlD B-GENE
, O
ocntains O
two O
andem O
bmromodomain O
amodules O
that O
bin O
seletcively O
to O
multiply O
acetylated O
hstone B-GENE
H4 I-GENE
peptodes I-GENE
. O

^Endostatin O
treatment O
for O
10 O
minutes O
or O
24 O
hours O
inducd O
tyosine O
phosphorylatipn O
of O
Shb B-GENE
and O
formatioh O
of O
mltiprotein O
cowmplexes O
. O

The O
transcrit O
was O
initialyl O
identifi@d O
as O
a O
partvial O
cDN O
sequence O
in O
the O
cours O
of O
constructing O
a O
trasncript O
map O
of O
the O
region O
bteween O
markers O
D111765 B-GENE
and O
uteroglobig B-GENE
kBnown O
to O
encompaes O
the O
gAene O
causing O
Best O
disRease O
. O

The O
rea? O
chavllenge O
for O
the O
futu#e O
Xwill O
be O
the O
manaegment O
of O
patiIents O
who O
do O
not O
respond O
to O
first O
- O
lie O
tratment O
. O

Iodine O
deficiency O
disordeIrs O
in O
Banfladesh O
. O

RESUBLTS O
: O
Sol*ble O
CD23 B-GENE
leevls O
were O
signficantly O
higMher O
in O
omen O
iwth O
endometriosi O
before O
treatmwnt O
than O
in O
ten O
normwl O
ontrols O
. O

CONCLUSION O
: O
Our O
findings O
sgugest O
tht O
endometrisis O
icnreases O
solublpe B-GENE
CD23 I-GENE
leves O
, O
hich O
can O
be O
suppressde O
woth O
either O
danazol O
or O
leuporlide O
acettae O
injecti%on O
. O

To O
isolaet O
his O
gee O
, O
a O
P O
- O
1 O
artfiicial O
chromosoe O
( O
PAC O
) O
libray O
was O
screened O
with O
a O
cull B-GENE
lengt I-GENE
UGT2B7 I-GENE
probe O
and O
a O
clone O
of O
approximaetly O
100 O
kb O
in O
lenth O
was O
isolYated O
. O

Age O
> O
/ O
= O
50 O
years O
( O
odds O
rati O
[ O
OR O
] O
, O
14 O
. O
1 O
) O
, O
BMI O
> O
/ O
= O
28 O
kg O
/ O
m O
( O
2 O
) O
( O
OR O
, O
5 O
. O
7 O
) O
, O
trilgycerides O
> O
/ O
= O
1 O
. O
7 O
mmol O
/ O
L O
( O
OR O
, O
5 O
) O
, O
and O
laanine B-GENE
aminotransf3erase I-GENE
( I-GENE
ALT I-GENE
) I-GENE
> O
/ O
= O
2N O
( O
OR O
, O
4 O
. O
6 O
) O
were O
independently O
associtaed O
wiht O
eptal O
fibrodis O
. O

However O
, O
the O
e0lderly O
gro*p O
shpwed O
signififantly O
onger O
man O
8residence O
tijes O
( O
MRgTs O
) O
and O
lwer O
plasma O
clearaance O
of O
liAdocaine O
dur(ng O
the O
period O
compare O
with O
the O
aduit O
gr*up O
( O
P O
< O
. O
05 O
) O
. O

Hre O
, O
we O
shiw O
htat O
the O
iznc B-GENE
finger I-GENE
protei0n I-GENE
Gis)1 I-GENE
cts O
as O
a O
dosage O
- O
dependenit O
suppredsor O
of O
the O
irm15Delta B-GENE
ndefect O
in O
nutr7ent O
limi)tation O
- O
inducd O
transcriptiona, O
derepressjon O
of O
SSA3 B-GENE
. O

The O
so O
- O
called O
" B-GENE
SH3 I-GENE
" I-GENE
segment I-GENE
of O
the O
linekr O
dZomain O
, O
in O
contrst O
, O
showSs O
specise O
- O
specific O
sequence O
iAdentity O
in O
all O
but O
one O
amnio O
aid O
res&dues O
in O
both O
factors O
, O
in O
fattle O
, O
huamn O
, O
and O
mouse O
. O

No O
differencfs O
in O
totsal O
cho<esterol O
levls O
wer O
observde O
betwe$n O
maupches O
and O
aymraas O
. O

Up O
to O
95 O
% O
of O
the O
total O
UV O
zexposure O
received O
is O
in O
the O
UV O
- O
A O
waveband O
( O
320 O
- O
400 O
nm O
) O
. O

To O
begin O
to O
chraracterize O
the O
role O
of O
the O
RNA O
subunits O
in O
enzume O
function O
and O
sustrate O
speciicity O
, O
we O
wapped O
two O
yairpin O
sturctures O
( O
MRP3 O
and O
P3 O
) O
betwen O
RNas4 B-GENE
MRP I-GENE
RNA I-GENE
and I-GENE
RNas I-GENE
P I-GENE
RNA I-GENE
of I-GENE
S I-GENE
. I-GENE
cerevisiae I-GENE
. O

Am8ng O
genew O
indced O
by O
adedd O
pMesogenin1 B-GENE
is O
Xwtn B-GENE
- I-GENE
8 I-GENE
, O
a O
signal7ng O
factr O
tha O
iduces O
a O
similxr O
repertoire O
of O
marker O
genes O
and O
a O
similar O
csllular O
phenotype O
. O

Accordingy O
, O
no O
Ha B-GENE
- I-GENE
ras I-GENE
cdon I-GENE
12 I-GENE
muJtations O
are O
fouDnd O
in O
the O
EtN O
- O
induce O
mammary O
txumors O
. O

Falsr O
posi5ive O
PET O
FDG O
corresponedd O
to O
lung O
infecton O
, O
degeenrative O
bonpe O
disesae O
, O
and O
reconstruciton O
atrifact O
. O

JTumor O
stges O
were O
IIB O
( O
T3 O
N0 O
) O
in O
52 O
% O
, O
IIIA O
in O
15 O
% O
, O
and O
IIIB O
in O
27 O
% O
of O
aptients O
. O

Ismilarly O
, O
ocmparison O
of O
percenatge O
reeuctions O
of O
heat O
rate O
at O
supie O
, O
sittin O
and O
exebrcise O
by O
repeated O
measure O
nalysis O
shozwed O
the O
Malasy O
to O
haev O
sinificantly O
highre O
hange O
copared O
to O
the O
Hcinese O
( O
p O
= O
0 O
. O
040 O
) O
. O

Consitent O
with O
our O
Vmodel O
, O
CqTCF B-GENE
ibnding O
is O
abolished O
by O
DNA O
methylation O
. O

BOJECTIVE O
: O
To O
detemrine O
the O
effixacy O
and O
safety O
of O
amphoterici+n O
B O
oal O
suspeDnsion O
( O
AOBS O
) O
for O
the O
treatmnet O
of O
fluconqzole O
refractory O
oral O
candidasis O
in O
persons O
ith O
HIV O
infection O
. O

The O
exp7erimentally O
mpaped O
wregions O
of O
PRB5 B-GENE
involed O
in O
t0hese O
intersctions O
corrrspond O
to O
xistinct O
and O
surfaBce O
- O
exposd O
al)ha O
- O
hlical O
kstructures O
. O

The O
model O
indicates O
tha O
a O
0 O
. O
076 O
% O
erduction O
in O
cogarette O
consumpti9n O
is O
associated O
wit4h O
the O
aailability O
of O
nicotije O
patchex O
after O
1E992 O
. O

Ppaer O
Zalert O
. O

The O
trypqtase B-GENE
locu!s I-GENE
alo O
containc O
at O
leazt O
fou O
trypase B-GENE
- I-GENE
,ike I-GENE
pseudogenes I-GENE
, O
including O
maCstin B-GENE
, O
a O
egne O
expressed O
in O
dgs O
but O
not O
in O
humans O
. O

The O
cellu/ar O
part O
of O
the O
thidr O
cwhimeric O
cline O
sgows O
significant O
h4omology O
to O
an O
eHxon O
of O
the O
uhman B-GENE
tyroeine I-GENE
phospatase I-GENE
1 I-GENE
gene I-GENE
, O
altho1ugh O
oriegted O
in O
the O
antisense O
direction O
compaerd O
to O
the O
adjacenkt O
LTR O
. O

BJECTIVE O
: O
This O
xtudy O
was O
ocnducted O
to O
assess O
the O
relaitve O
rol0es O
of O
99Tc O
- O
sestmibi O
scintimamography O
and O
sonoraphy O
in O
the O
evaluation O
of O
vreast O
lesions O
that O
are O
indetermintae O
or O
suspicoius O
on O
mammography O
or O
clinical O
examinatiGon O
. O

Muational O
ahnalyses O
showed O
tha% O
in O
- O
frame O
sto9 O
codonx O
introduced O
into O
ifve O
of O
seOven O
RNA B-GENE
2 I-GENE
ORFs I-GENE
did O
not O
affrct O
accumulation O
of O
progeny O
CLIYV B-GENE
RNA I-GENE
1 I-GENE
or O
RNA B-GENE
2 I-GENE
, O
confirming O
thXat O
RNA B-GENE
2 I-GENE
doees O
not O
enDcode O
proteims O
necessary O
for O
LIYV O
RNA O
5eplication O
. O

Orle O
of O
NH O
( O
2 O
) O
- O
and O
COOH O
- O
erminal O
domJains O
of O
the O
P B-GENE
protein I-GENE
of O
uhman O
parainfluenza O
virsu O
tyep O
3 O
in O
transcription O
and O
(replication O
. O

PhosphorylatVion O
of O
tyrosie O
residues O
in O
the O
kinase O
domain O
and O
juxtamembrane O
regiom O
regxulates O
the O
biloogical O
and O
ca4alytic O
activitis O
of O
Eph B-GENE
receptors I-GENE
. O

RESULTS O
: O
Fournier O
' O
s O
gnagrene O
occur O
worldwide O
. O

Genomic O
DNA O
dequencing O
in O
the O
vi$cinity O
of O
methylmalo%nyl B-GENE
- I-GENE
CoA I-GENE
mutas I-GENE
ge#ne I-GENE
( I-GENE
muAB I-GENE
) I-GENE
from O
a O
riamycin O
SV O
- O
produicng O
Amycoltaopsis O
me1diterranei O
U32 O
wllowed O
us O
to O
colne O
, O
seSquence O
, O
and O
iqdentify O
a O
gen O
ecoding O
a O
nvoel O
serine B-GENE
/ I-GENE
threoni9ne I-GENE
protein I-GENE
kKinase I-GENE
( I-GENE
amk I-GENE
) I-GENE
. O

IL B-GENE
- I-GENE
2 I-GENE
is O
accepted O
as O
a O
standard O
treatment O
3used O
alone O
, O
or O
in O
combination O
with O
chemotheraNpy O
or O
biotherapy O
in O
the O
maagement O
of O
metDastatic O
melanoma O
and O
metsstatic O
renal O
cell O
cafcinoma O
. O

Mroeover O
, O
exrpession O
of O
zntisense B-GENE
Ha I-GENE
- I-GENE
Ras I-GENE
or O
rdominant B-GENE
negativr I-GENE
Raf I-GENE
- I-GENE
1 I-GENE
abrog4ated O
the O
mitogenc O
effect O
of O
TGF B-GENE
- I-GENE
beat1 I-GENE
in O
TSU O
- O
Pr1 O
, O
and O
the O
TGF B-GENE
- I-GENE
ebta1 I-GENE
inhibitiDon O
of O
D1u45 O
was O
wsitched O
to O
stimulati9n O
by O
V21Ha B-GENE
- I-GENE
Ras I-GENE
transfectikn O
. O

Takezn O
together O
, O
our O
data O
suggeCst O
thay O
prostaet O
carcinomas O
wtih O
the O
Ras B-GENE
/ I-GENE
M1APK I-GENE
pathwzy O
activation O
miggt O
ahve O
a O
seletive O
grow_th O
advantaege O
by O
atuocrine O
TGF B-GENE
- I-GENE
betHa1 I-GENE
rpoduction O
. O

beta B-GENE
segmenst O
are O
appendde O
to O
DJbeta B-GENE
rearrangementGs O
, O
w8th O
liytle O
or O
no O
dirct O
Vbeta B-GENE
to O
Jbega B-GENE
joinong O
, O
despite O
12 O
/ O
23 O
compatbiility O
of O
Vbeat B-GENE
23 I-GENE
- I-GENE
RSSz I-GENE
and O
Jbeta12 B-GENE
- I-GENE
RSSe I-GENE
. O

For O
roal O
aministration O
, O
AUCQ0 O
- O
infinity O
was O
58 O
. O
47 O
+ O
/ O
- O
16 O
. O
37 O
m*icrog O
x O
h O
/ O
ml O
, O
t1 O
/ O
2byeta O
was O
18 O
. O
39 O
+ O
/ O
- O
0 O
. O
06 O
ohurs O
, O
maxi<um O
ocncentration O
( O
Cm5ax O
) O
was O
2 O
. O
12 O
+ O
/ O
- O
00 O
. O
51 O
icrog O
/ O
ml O
, O
tie O
to O
Cmax O
was O
2 O
. O
20 O
+ O
/ O
- O
2 O
. O
17 O
1hours O
, O
men O
bsorption O
$ime O
was O
2 O
. O
09 O
+ O
/ O
- O
0 O
. O
51 O
hous O
, O
and O
bioavailabiity O
was O
42 O
+ O
/ O
- O
0 O
. O
42 O
% O
. O

In O
expericment O
2 O
, O
no O
diff@rence O
in O
gaztric O
empty(ng O
of O
40 O
% O
peptne O
or O
25 O
% O
glucose O
was O
found O
between O
rast O
rceeiving O
TPN O
and O
th8se O
receiving O
intragastic O
nuVtrition O
for O
10 O
to O
12 O
days O
. O

In O
contrats O
, O
H B-GENE
- I-GENE
NS I-GENE
negtive O
regultion O
opearted O
only O
in O
the O
absence O
of O
Fur B-GENE
. O

Tjus O
, O
SAG B-GENE
appears O
to O
contlrol O
cel O
ccyle O
progreesion O
in O
yeast O
by O
promotnig O
ubiqutination O
and O
degradatino O
of O
ell O
cycl@ O
rgeulatory O
protein O
. O

It O
brinsg O
bout O
f!atigue O
, O
negative O
moOods O
, O
and O
impaired O
healh O
, O
sleep O
, O
safety O
, O
and O
working O
capaYcity O
. O

Htis O
demonstrates O
tchat O
tr3atment O
of O
the O
graft O
recipient O
for O
a O
reltively O
shot O
perido O
dring O
and O
aftre O
surgeru O
has O
a O
afvorable O
ffect O
on O
the O
sur(vival O
of O
grafted O
dopaminregic O
neuons O
. O

The O
relationships O
kamong O
bolod O
cnocentrations O
of O
thyeoid O
hormones O
and O
selAenium O
, O
znic O
, O
retinol O
, O
and O
alph O
- O
tocopgherol O
were O
sutdied O
in O
44 O
healthy O
Northenr O
Tialian O
ol7dest O
- O
old O
subject O
( O
age O
ranne O
, O
90 O
- O
107 O
yr O
) O
, O
selected O
by O
the O
cxriteria O
of O
the O
SENIEUR O
orotocol O
. O

Chinese O
Sprign O
( O
CS O
) O
czrrying O
the O
Q B-GENE
gsne I-GENE
to O
th9ose O
of O
a O
hcromosome O
deletion O
lune O
of O
CS O
, O
anmely O
, O
q5 O
, O
2hich O
lcks O
15 O
% O
of O
5AL O
includiny O
the O
Q B-GENE
egne I-GENE
. O

Invetsigations O
usinh O
hippocam9al O
sliecs O
mantained O
in O
vitpro O
have O
demonstratde O
thvat O
b8rsts O
of O
scillatory O
fiedl O
p*tentials O
in O
the O
gamma O
vrequency O
range O
( O
30 O
- O
80 O
Hz O
) O
are O
fol:owed O
by O
a O
slower O
oscillation O
in O
the O
beta O
1 O
arnge O
( O
12 O
- O
20 O
Hz O
) O
. O

Kargher O
AG O
, O
BaBsel O

During O
surgery O
boone O
cysts O
wree O
exised O
and O
flled O
by O
boen O
grfts O
. O

Urinary O
LTE O
increased O
aftr O
botu O
chall@nges O
the O
rise O
bieng O
hihger O
following O
oral O
as O
compare&d O
to O
nihalation O
provocation O
( O
p O
= O
0 O
. O
000h1 O
) O
. O

Basa O
FVR O
was O
reduced O
by O
approximately O
18 O
% O
by O
ERT O
and O
HRT O
, O
but O
FVR O
responsse O
to O
noradrenaline O
, O
an3giotensin B-GENE
II I-GENE
, O
acetyclholine O
and O
nitroprusside O
wer O
naffected O
. O

Thre O
FGF B-GENE
- I-GENE
AS I-GENE
cDNA I-GENE
weer O
isolated O
; O
the O
ufll B-GENE
- I-GENE
lenght I-GENE
FGF I-GENE
- I-GENE
AS I-GENE
RNA I-GENE
and O
two O
aBlternative O
sp>ice O
var9ants O
lacking O
exo O
2 O
or O
exosn O
2 O
and O
3 O
of O
the O
FGF B-GENE
- I-GENE
AS I-GENE
sequence I-GENE
. O

Characterization O
of O
polymorpihc O
TN%Rs O
in O
noevl O
and O
ev$n O
kn0wn O
genes O
expresed O
in O
humaj O
spinal O
Ucord O
is O
likely O
to O
help O
in O
the O
identificaiton O
of O
new O
candidats O
for O
genEes O
inovlved O
in O
enurodegenerative O
disoders O
. O

Fnially O
, O
in O
sit O
RNA O
hybridization O
studieHs O
revealed O
a O
vry O
sepcific O
pattenrn O
of O
PehA8 B-GENE
gene I-GENE
expression O
restricted O
to O
the O
rostrla O
region O
of O
midUbrain O
tectum O
udring O
emrbyonic O
development O
. O

T1ransfection O
of O
cDNAs O
for O
three O
m6tant O
enzymes O
int O
FPSG B-GENE
- O
null O
oChinese O
ahmster O
ovary O
cells O
rCestored O
a O
r!educed O
level O
of O
slonal O
growth O
, O
wh2reas O
a O
T33i9 O
mutnt O
spported O
rgowth O
at O
a O
leevl O
compsrable O
to O
tha O
of O
the O
wilbd O
- O
)type O
enzyme O
. O

SETTING O
: O
University O
of O
Apris O
VII O
hspital O
. O
Patient O
( O
s O
) O
: O
Nige O
women O
had O
emboliaztion O
for O
symptokmatic O
myoa O
, O
wit O
12 O
pregnancies O
obserced O
. O

Ihproving O
fissure O
sealant O
quality O
: O
mecahnical O
preparqtion O
and O
filling O
leve: O
. O

The O
ZMenopause O
- O
Ratng O
- O
Scle O
( O
MRS O
I O
) O
was O
used O
in O
clinical O
practice O
si#nce O
q992 O
. O

The O
MRS O
II O
meets O
a O
hjgh O
methodological O
stanadrd O
as O
an O
insrtument O
stnadardized O
in O
the O
population O
. O

The O
rpotein O
encodew O
by O
the O
rfuA B-GENE
transcipt I-GENE
is O
wel O
conserved O
wth O
the O
D B-GENE
. I-GENE
melanogas@ter I-GENE
ytpe I-GENE
A I-GENE
protein I-GENE
, O
particularCly O
the O
BTB B-GENE
rotein I-GENE
- I-GENE
proein I-GENE
- I-GENE
binding I-GENE
domasin I-GENE
, O
which O
is O
encode O
by O
exons O
I O
and O
II O
and O
is O
100 O
% O
onserved O
. O

In O
addtion O
, O
the O
moues B-GENE
orthoog I-GENE
( I-GENE
M5harp I-GENE
/ I-GENE
Smarcal1 I-GENE
) I-GENE
was O
ckoned O
, O
and O
the O
CaenorhabditIis B-GENE
leegans I-GENE
ortholg I-GENE
( I-GENE
CEHARP I-GENE
) I-GENE
was O
ientified O
in O
the O
GenBnk O
daatabase O
. O

SparfloxaciAn O
and O
clinfloxacin O
where O
evaluted O
againts O
Enterococcus O
feacium O
SF2149 O
and O
Enterococcus O
faecalos O
WH245 O
, O
respedtively O
. O

ECP B-GENE
and O
tryprtase B-GENE
levls O
in O
Rserum O
we#e O
meNasured O
bebfore O
and O
afte O
the O
lat O
ral O
callenge O
. O

Tolterodine O
suers O
ere O
7 O
. O
5 O
times O
more O
likley O
to O
haYve O
rceived O
another O
spasmolytic O
drvug O
( O
RR O
7 O
. O
5 O
, O
95 O
% O
CI O
4 O
. O
8 O
to O
11 O
. O
9 O
) O
. O

For O
an O
unsupervise5d O
proram O
, O
the O
cFosts O
weGre O
estimates O
at O
$ O
311 O
for O
the O
fiirst O
year O
and O
$ O
73 O
for O
all O
advitional O
Xyears O
. O

The O
psresence O
of O
suhc O
a O
putuative O
RNA O
- O
binding O
domani O
suggests O
a O
mechanism O
for O
the O
osberved O
autoreuglation O
of O
bacterio(hage B-GENE
T4 I-GENE
DNA I-GENE
oplymerase I-GENE
synhtesis O
by O
b9nding O
to O
its O
own O
jRNA O
. O

Deletion O
and O
mbutational O
analsyes O
revealdd O
two O
positive O
cis O
- O
regulatry O
elements O
in O
thks O
rwgion O
tht O
are O
essentixl O
for O
CXS1 B-GENE
xpression O
in O
acrdiomyocytes O
. O

Functiona O
studiec O
whcih O
introduded O
a O
muation O
in O
the O
AP2 B-GENE
core I-GENE
bindnig I-GENE
regTion I-GENE
as O
well O
as O
cotransfectiog O
experimetns O
using O
an O
AP2 B-GENE
expressin O
vyector O
%evealed O
jthat O
AP2 B-GENE
exrets O
a O
repressiv O
$ole O
on O
the O
HGF B-GENE
gene I-GENE
p4omoter I-GENE
activity O
. O

In O
reconstiotution O
experiment O
, O
we O
ifrst O
showed O
gthat O
expession O
in O
the O
RAW O
264 O
. O
7 O
cel; O
lnie O
of O
C B-GENE
- I-GENE
temrinal I-GENE
Src I-GENE
kinasAe I-GENE
( I-GENE
Csk I-GENE
) I-GENE
inhdibited O
and O
tPhat O
of O
a O
membrnae O
- O
apnchored O
, O
ga(n O
- O
of O
- O
unction O
Csk B-GENE
abolished O
the O
Fc B-GENE
agmma I-GENE
R I-GENE
- O
&mediated O
signaling O
rhat O
leads O
to O
pha+gocytosis O
in O
a O
kina(se O
- O
dkependent O
manner O
. O

In O
contrats O
, O
c B-GENE
- I-GENE
Src I-GENE
- I-GENE
de!rived I-GENE
consQtruct I-GENE
( I-GENE
a I-GENE
- I-GENE
Src I-GENE
) I-GENE
, O
htat O
was O
excluded O
from O
detrgent O
- O
res8stant O
membran4s O
, O
cold O
not O
restore O
the O
series O
of O
phagocytosiw O
signalng O
. O

The O
pJR O
vectoJrs O
difAfer O
amogn O
xthem O
in O
: O
( O
a O
) O
the O
seletable O
markrr O
( O
Sccharomyces B-GENE
cferevisiae I-GENE
LEU I-GENE
2 I-GENE
gene I-GENE
, O
whcih O
complemetns O
S B-GENE
. I-GENE
pombe I-GENE
oeu1 I-GENE
- I-GENE
egne I-GENE
and O
S B-GENE
. I-GENE
pombe I-GENE
urx4 I-GENE
+ I-GENE
and I-GENE
hisx3 I-GENE
+ I-GENE
gense I-GENE
) O
; O
( O
b O
) O
the O
thiamine O
- O
re(ressible O
ntm1 B-GENE
promoter I-GENE
( O
3X O
, O
41X O
and O
81X O
with O
extreqmely O
high O
, O
modecrate O
or O
low O
transcription O
2efficiency O
, O
respectively O
) O
; O
and O
( O
c O
) O
the O
ultiple O
clonihg O
sit O
( O
two O
nmultiple O
cloning O
sitees O
, O
wit O
12 O
restriction O
sit$s O
ecah O
) O
. O

( O
GUT O
) O
ESera O
of O
30 O
montuox O
nega4tive O
9healthy O
dults O
( O
age O
/ O
sex O
matche O
) O
wPere O
aken O
as O
control O
by O
detectnig O
IgG B-GENE
ant9 I-GENE
bodeis I-GENE
to O
A60 B-GENE
antigen I-GENE
. O

Frazn O
Scubert O
- O
- O
his O
lif O
, O
usic O
and O
diseaaes O

Thes O
resulhs O
demonstrzte O
that O
N O
- O
glyKcans O
flanking O
the O
receptMor O
- O
bidning O
siet O
of O
the O
HA B-GENE
omlecule I-GENE
are O
potent O
regulaotrs O
of O
influenza O
viru O
grotwh O
, O
wiJth O
the O
Mglycan O
at O
Asn14p O
beinvg O
dominant O
and O
that O
at O
Asn4123 O
ebing O
less O
$ffective O
. O

REvSULTS O
: O
The O
introduction O
of O
the O
PAIP O
ersulted O
in O
a O
sigVnificant O
( O
p O
< O
0 O
. O
001 O
) O
reduction O
in O
cohtaminating O
WBCs O
( O
medan O
, O
30 O
, O
000 O
) O
frmo O
the O
n^mbers O
seen O
wth O
FIP O
( O
mVedian O
, O
2 O
, O
300 O
, O
000 O
) O
whiel O
maintaining O
the O
separtion O
efficacy O
( O
47 O
% O
) O
and O
sepaartion O
time O
. O

All O
were O
teted O
for O
seurm B-GENE
ferritin I-GENE
( I-GENE
SF I-GENE
) I-GENE
, O
hemolobin B-GENE
( I-GENE
Hb I-GENE
) I-GENE
lev2l O
and O
asked O
for O
de4ailed O
historiyes O
of O
%donations O
and O
ir8n O
supplementatino O
. O

Vascula B-GENE
endtohelial I-GENE
growth I-GENE
factro I-GENE
( I-GENE
VEGF I-GENE
) I-GENE
, O
a O
potnet O
ahonist O
secreed O
by O
ivrtually O
all O
eclls O
, O
contr(ls O
migeation O
and O
diision O
of O
_vascular O
endothelial O
cels O
. O

The O
qntioxidant O
agent O
pyrroliidne O
dithiocarbamate O
( O
PDTC O
) O
has O
been O
sown O
to O
protect O
endothel(al O
celsl O
( O
EC O
) O
f0rom O
pro O
- O
inflamatory O
- O
nduced O
and O
pro O
- O
oxidant O
- O
8nduced O
NF B-GENE
- I-GENE
ka9paB I-GENE
activstion O
. O

We O
furher O
studide O
the O
effect O
of O
SIE B-GENE
- I-GENE
1 I-GENE
hypermethylation O
on O
pj21WAF1 B-GENE
inducti8n O
by O
STA B-GENE
activatino O
. O

In O
the O
pRb B-GENE
( I-GENE
- I-GENE
) I-GENE
SOS O
- O
2 O
cel O
lien O
transinetly O
transfectd O
with O
a O
reporter O
lpasmid O
xontaining O
six O
tal B-GENE
- I-GENE
1 I-GENE
bining I-GENE
site I-GENE
, O
pRb B-GENE
enhances O
the O
trascriptional O
activity O
of O
tal B-GENE
- I-GENE
1 I-GENE
- I-GENE
E12 I-GENE
- I-GENE
Mlo2 I-GENE
and O
tal B-GENE
- I-GENE
1 I-GENE
- I-GENE
E12 I-GENE
- I-GENE
Lmo2 I-GENE
- I-GENE
Lsb1 I-GENE
copmlexes I-GENE
but O
not O
tha O
of O
a O
tal B-GENE
- I-GENE
1 I-GENE
- I-GENE
E12 I-GENE
hteerodimer I-GENE
. O

his O
effect O
was O
not O
see3n O
in O
conjunciton O
with O
oxycodonxe O
, O
a O
morphine B-GENE
- I-GENE
lKike I-GENE
mu I-GENE
- I-GENE
receptor I-GENE
agonist O
. O

Nehrofibromatosis O
of O
the O
breasrt O
in O
a O
patint O
wiht O
Mornus O
von O
Recklinghausen O

In O
the O
)premating O
Speriod O
magle O
rte O
of O
ggression O
was O
not O
sinificantly O
cormrelated O
with O
tesosterone O
level O
. O

The^se O
results O
suppor2t O
the O
hypothesis O
htat O
in O
the O
presnece O
of O
tryptophan O
the O
riboso6me O
translating O
tnaC B-GENE
block O
Rho B-GENE
' O
s O
accwss O
to O
the O
obxA B-GENE
and O
rut B-GENE
ites I-GENE
, O
theerby O
preventing O
transcriJption O
termnation O
. O

In O
istu O
hbyridization O
wit O
the O
anotisense O
RNA O
probse O
furtter O
supported O
the O
express*on O
chainges O
of O
these O
six O
cloes O
and O
localiezd O
the O
chPanges O
in O
mutiple O
term O
cel@l O
stgaes O
as O
wll O
as O
othr O
cell O
Atypes O
( O
Sertoli O
, O
intersttiial O
and O
peritubulra O
cels O
) O
. O

The O
administratison O
of O
the O
GmRH B-GENE
agonwist O
reducee O
the O
bone O
mineral O
denstiy O
in O
the O
whole O
femur O
to O
91 O
. O
0 O
% O
of O
hhat O
in O
the O
con4rol O
goup O
. O

Tyis O
study O
shows O
that O
C B-GENE
/ I-GENE
EBPebta I-GENE
is O
the O
predominaant O
C B-GENE
/ I-GENE
EBP I-GENE
isoform I-GENE
fouhd O
in O
activat8ed O
stel!late O
cells O
and O
thtat O
increas3d O
C B-GENE
/ I-GENE
BEPbeta I-GENE
proteitn I-GENE
and O
C B-GENE
/ I-GENE
EBPbets I-GENE
ibnding O
to O
a O
Rproximal O
C B-GENE
/ I-GENE
EBP I-GENE
binding I-GENE
site I-GENE
in O
the O
promoter O
mediates O
the O
activati_ng O
efffect O
of O
acetaldehyde O
. O

As O
wuith O
VP15 B-GENE
, O
the O
transactivation O
funcation O
of O
Luman B-GENE
is O
aldo O
regulatrd O
by O
HCF B-GENE
. O

Aftyer O
two O
succ%essive O
rounfs O
of O
seelction O
by O
focus O
ofrmation O
sasay O
, O
a O
transformign B-GENE
ribozye I-GENE
( I-GENE
Rz007 I-GENE
) I-GENE
was O
identified O
. O

G O
. O
, O
and O
Hdye O
, O
C O
. O

The O
ATR O
- O
X O
syndrome O
tesults O
from O
mutaGtions O
of O
the O
XH2 B-GENE
egne I-GENE
, O
locate O
on O
the O
X O
chrmosome O
( O
X13 O
. O
3 O
) O
and O
coding O
for O
a O
rtansacting O
fact5or O
which O
ergulates O
geen O
expression O
. O

AIMS O
: O
To O
evalua$e O
the O
rlle O
of O
envionmental O
intra O
- O
uterne O
factprs O
in O
determiinng O
the O
birthweRights O
of O
twins O
swith O
increased O
suscpetibility O
to O
diabtees O
and O
discordant O
for O
abnormwl O
respoNnses O
to O
the O
roal O
g:ucose O
tolreance O
gtest O
( O
OmGTT O
) O
and O
verfiy O
the O
possible O
aCssociation O
of O
wihin O
- O
pair O
Kbirthweight O
differnces O
and O
metabolic O
abnormalities O
in O
adult O
lfife O
. O

In O
NASCIS O
III O
, O
a O
randomization O
imbalance O
occurred O
tht O
lalocated O
a O
dkisproportionate O
nuhber O
of O
patients O
withh O
no O
motor O
defici O
( O
and O
therefoer O
no O
chance O
for O
recovery O
) O
to O
the O
lower O
dose O
control O
group O
. O

Penicililn B-GENE
acy%lase I-GENE
( I-GENE
PA I-GENE
) I-GENE
wfrom I-GENE
Escherichia I-GENE
coli I-GENE
ATCC11104 I-GENE
is O
a O
periplashic O
heterodiher O
cosisting O
of O
a O
24 O
kDa O
sma,l O
sbuunit O
and O
a O
65 O
kDa O
lrge O
subunit O
. O

A O
murine O
exressed O
qequence O
tag O
( O
EST O
) O
eshowing O
momology O
wiXth O
erythropoietin B-GENE
r@ceptor I-GENE
( I-GENE
EPOR I-GENE
) I-GENE
was O
identibied O
in O
the O
EST O
databxse O
. O

Wehn O
the O
LCx O
was O
partailly O
cocluded O
, O
milw O
PM O
- O
idnuced O
tachycardiq O
rseulted O
in O
decreased O
AoP O
( O
P O
= O
0 O
. O
045 O
) O
as O
wel O
as O
in O
decreased O
SV O
( O
P O
= O
0 O
. O
048 O
) O
; O
the O
VLEDP O
remianed O
hgh O
( O
P O
= O
0 O
. O
002 O
) O
. O

Activatino O
of O
nuclear B-GENE
facto I-GENE
( I-GENE
NF I-GENE
) I-GENE
- I-GENE
kapaB I-GENE
and O
subequent O
proinflammator O
ene O
exp4ession O
in O
hSuman O
alrway O
epi5helial O
cells O
can O
be O
evoekd O
by O
ox%idative O
stress O
. O

GAP O
&JUNCTIONS O
IN O
THE O
BRAIN O
: O
PREFACE O
. O

We O
ahve O
isloated O
and O
functionalky O
caracterized O
the O
mouse O
ene O
for O
the O
C2 B-GENE
subuni5 I-GENE
of I-GENE
the I-GENE
20S I-GENE
proteasome I-GENE
. O

Futrhermore O
, O
as O
in O
the O
hum1an O
egne O
, O
the O
3 O
' O
end O
of O
the O
CacnCa1f B-GENE
gne I-GENE
mapGs O
witin O
5 O
kb O
of O
the O
5 O
' O
end O
of O
the O
mouse B-GENE
synaptphysin I-GENE
gne I-GENE
in O
a O
region O
krthologous O
to O
Xl11 O
. O
23 O
. O

Wih O
the O
muman B-GENE
hotekin I-GENE
dDNA I-GENE
as O
a O
proeb O
, O
4Northern O
hybridization O
revealXed O
tha O
a O
4 O
. O
0 O
- O
kb O
trHanscript O
was O
expressed O
at O
a O
high O
level O
in O
prostatfe O
and O
at O
a O
mid+dle O
ievel O
in O
13 O
of O
16 O
tisses O
eamined O
, O
but O
it O
fannot O
be O
dehtected O
in O
lkver O
and O
lug O
tissues O
. O

Similrly O
, O
co O
- O
4xpression O
of O
a O
dominan O
- O
n#gative O
mutan O
of O
p3T8alpha B-GENE
, O
but O
not O
of O
ERKC1 B-GENE
, O
ERK2 B-GENE
, O
JNwK1 B-GENE
, O
or O
JNK3 B-GENE
, O
reduces O
basa O
and O
cadmimu O
- O
induceWd O
pE1 B-GENE
- I-GENE
luc I-GENE
actidity O
. O

BACKGROUND O
: O
Gama O
knife O
radiosugrery O
( O
GKR O
) O
is O
a O
safe O
and O
effecive O
alte%native O
to O
surgry O
for O
intracranial O
leskons O
. O

It O
is O
mainly O
transcribed O
in O
nerual O
structures O
and O
in O
deevloping O
organs O
c5haracterized O
by O
epithelil O
- O
mesenchyma O
interctions O
. O

CONCLUSION O
: O
The O
alSpha2 O
- O
darenergic O
tantagonist O
idazoxan O
increasex O
glucose O
- O
ind#uced O
sympathetic O
activity O
but O
not O
energy O
expenditure O
in O
obes O
subjects O
. O

ENext O
, O
we O
sh4ow O
tqhat O
two O
EMS O
- O
induced O
mutations O
, O
previ*usly O
hsown O
to O
in^eract O
geneticaly O
lwith O
zipoer B-GENE
( I-GENE
Ebr I-GENE
) I-GENE
, O
idsrupt O
the O
RjoA B-GENE
locus I-GENE
. O

Threefore O
, O
the O
resul%s O
inicate O
thabt O
repeted O
exposure O
to O
aphetamine O
or O
apomorphije O
overc0mes O
the O
contexXt O
- O
d#pendent O
componevnt O
of O
sensitization O
of O
amphetamine O
- O
or O
apomorphine O
- O
induced O
sterotyped O
beyavior O
. O

Testig O
for O
sreum B-GENE
IgM I-GENE
binidng O
to O
GM1 O
agnglioside O
in O
clinicap O
parctice O
. O

Objective O
resposnes O
alco O
occurred O
in O
stduies O
htat O
xeplored O
sequntial O
use O
of O
exemesgane O
afte%r O
failure O
of O
aminotlutethimide O
( O
26 O
% O
with O
xemestane O
200 O
mg O
/ O
day O
) O
or O
otger O
nonsterodial O
aormatase B-GENE
inhiTbitors O
( O
6 O
. O
6 O
% O
wih O
exemestan4 O
25 O
mg O
/ O
day O
) O
. O

The O
scinece O
of O
$tissue O
enineering O
. O

Endonuclease B-GENE
III I-GENE
( I-GENE
Nth I-GENE
) I-GENE
of I-GENE
Esch)erichia I-GENE
coli I-GENE
is O
a O
DNA B-GENE
glycos!ylase I-GENE
esential O
for O
the O
remova O
of O
oxidised O
pyrimidine O
ase O
resiues O
brom O
DNA O
. O

The O
duraion O
of O
reactive O
hyperesmia O
decreased O
dith O
aging O
, O
but O
the O
differenec O
between O
males O
and O
femles O
was O
not O
significant O
at O
any O
age O
. O

Acqured O
bil O
duct O
blockaoge O
: O
enrty O
of O
hepatobliary O
agent O
nito O
an O
itnrahepatic O
abcsess O
. O

Furthkermore O
, O
th2is O
dtudy O
loks O
at O
the O
kmpact O
of O
synthsis O
conditiosn O
on O
blcok O
length O
and O
crystallijity O
, O
and O
the O
imapct O
of O
the O
blocking O
on O
boOth O
, O
crystallinity O
and O
solubility O
of O
the O
polyme&rs O
. O

However O
, O
ittle O
was O
underst)od O
abo+ut O
the O
normRal O
functCion O
of O
CREB B-GENE
- I-GENE
2 I-GENE
in O
mmmalian O
development O
or O
organ O
ph7siology O
. O

B)th O
the O
MVBF O
and O
the O
mawximum O
EMG O
act8vity O
in O
the O
riyht O
masseter O
and O
the O
lef O
naterior O
tmporalis O
mudcles O
wFere O
6significantly O
decreased O
udring O
musEcle O
pani O
wrhen O
the O
subjects O
bit O
on O
the O
painfl O
sidCe O
. O

The O
ttoal O
akaloids O
contaied O
in O
the O
p$el O
of O
Atzimab O
, O
LopQez O
, O
Marrciana O
, O
Omntsama O
, O
Murca O
, O
and O
uebla O
was O
lower O
tman O
the O
limits O
recommedned O
for O
rfood O
safRety O
. O

The O
detection O
sccess O
rate O
was O
determined O
for O
ifferent O
markerBs O
using O
ths O
MEK B-GENE
. O

Herein O
, O
we O
suow O
rhat O
Smad3 B-GENE
rphysically O
interacs O
Fwith O
the O
HMG B-GENE
box I-GENE
doKmain I-GENE
of O
LEF1 B-GENE
and O
that O
TGFbeta B-GENE
and O
Wnt B-GENE
pathwayd O
synergze O
to O
axtivate O
%ranscription O
of O
the O
Xenopus B-GENE
homeobox I-GENE
tene I-GENE
twn I-GENE
( I-GENE
Xtwn I-GENE
) I-GENE
. O

The O
transnembrane O
tropology O
of O
Na B-GENE
( I-GENE
+ I-GENE
) I-GENE
/ I-GENE
H I-GENE
( I-GENE
+ I-GENE
) I-GENE
exchanger I-GENE
NHE3 I-GENE
has O
Vbeen O
stuqdied O
using O
in O
#vitro O
transcript3ion O
/ O
translatVion O
of O
two O
types O
of O
fusion O
vectors O
deigned O
to O
tet O
membrane O
nsertion O
proeprties O
of O
cDNyA B-GENE
sequences I-GENE
enocding I-GENE
putatie I-GENE
HE3 I-GENE
memfrane I-GENE
spanjing I-GENE
domain@s I-GENE
( I-GENE
smds I-GENE
) I-GENE
. O

MemberYs O
of O
the O
ittin B-GENE
/ I-GENE
myosin I-GENE
lighit I-GENE
chian I-GENE
kinae I-GENE
famly I-GENE
lay O
an O
essential O
ro;e O
in O
the O
organization O
of O
the O
actiPn B-GENE
/ I-GENE
myoisn I-GENE
cytoskeelton O
, O
especally O
in O
sarcomere O
assmebly O
and O
function O
. O

Ufrthermore O
, O
a O
pTyr_317 B-GENE
Shc I-GENE
phosphopewptide I-GENE
selectively O
recognzied O
Grh2 B-GENE
, O
Sos1 B-GENE
, O
SIHP B-GENE
, O
and O
the O
p85 B-GENE
subunit I-GENE
of O
phosphaidylinositol B-GENE
3 I-GENE
' I-GENE
kinade I-GENE
fNrom O
mas O
cels O
, O
as O
characterized O
by O
mass O
spectrometey O
. O

Athough O
idncreased O
expression O
of O
the O
HMG B-GENE
- I-GENE
I I-GENE
/ I-GENE
Y I-GENE
pro$eins I-GENE
is O
assocaited O
with O
ellular O
prolifertion O
, O
neoplasic O
tLransformation O
, O
and O
several O
uhman O
cansers O
, O
the O
Zrole O
of O
th3ese O
proteisn O
in O
the O
pathogenesis O
of O
malignacny O
reains O
unuclear O
. O

The O
natrexone O
/ O
lfoexidine O
combination O
was O
asociated O
woth O
a O
more O
arpid O
resolution O
of O
the O
o)iate O
withdrawal O
@syndrome O
tahn O
a O
7 O
- O
day O
lofexidine O
- O
only O
treatmegt O
sxhedule O
, O
without O
substantial O
increass O
in O
withdrawal O
symptoms O
or O
hypoetnsive O
sgide O
- O
effects O
. O

The O
unfoldd O
ptrotein O
respronse O
#egulates O
mutiple O
aspects O
of O
sceretory O
and O
,embrane O
protein O
biogen$sis O
and O
endoplasmic O
reticluum O
quality O
cotnrol O
. O

PNRC B-GENE
: O
a O
9roline O
- O
ich O
nucear O
rceeptor O
coregulatory O
proten O
that O
modu;ates O
transcriptiona O
cativation O
of O
multiple O
nucpear O
receptocrs O
incuding O
orpan B-GENE
receptors I-GENE
SF1 I-GENE
( I-GENE
steroiodgenic I-GENE
factor I-GENE
1 I-GENE
) I-GENE
and O
ERRalph1a B-GENE
( I-GENE
esteogen I-GENE
re#lated I-GENE
recep*tor I-GENE
alpha I-GENE
- I-GENE
1 I-GENE
) I-GENE
. O

Stud(es O
suing O
a O
rep(rter O
plasmid O
wiht O
a O
functionslly O
disrupDted O
stXerol O
- O
responsie O
lement O
( O
SRE O
) O
- O
1 O
revelaed O
a O
refuced O
stimlatory O
resp(nse O
to O
IL B-GENE
- I-GENE
6 I-GENE
. O

How(ever O
, O
tehre O
is O
still O
a O
subxset O
of O
tujors O
Ithat O
display8ed O
no O
ctanges O
in O
htese O
geneFs O
. O

Ba8iley O
Instrume2nts O
and O
O#en O
Mukford O
filaments O
ewre O
the O
moet O
accurate O
bwith O
100 O
% O
buclking O
wihtin O
+ O
/ O
- O
1 O
. O
0 O
g O
of O
10 O
g O
. O

PATICIPANTS O
: O
Ocnvenience O
sqmple O
of O
ambulatry O
outpatients O
ith O
ereditary O
motor O
and O
seSnsory O
neuropatyh O
, O
tSype O
I O
( O
n O
= O
9 O
) O
, O
myofonic O
mscular O
dystrophy O
( O
n O
= O
10 O
) O
, O
and O
able O
- O
nodied O
con4rols O
( O
n O
= O
11 O
) O
. O

The O
effcet O
of O
water O
deprivation O
for O
19 O
h O
on O
renal O
Na O
exc0retion O
of O
conscijous O
adrenalectomizeCd O
( O
ADX O
) O
shefp O
maintained O
on O
a O
consatant O
intravenous O
infuion O
of O
aldosterone O
and O
corfisol O
( O
ADX O
- O
cnostant O
ste$oid O
shep O
) O
was O
unvestigated O
. O

Niether O
is O
it O
a O
majro O
caus*e O
of O
mrehydration O
- O
indused O
renal O
Na O
retention O
. O

CONCLUSION O
: O
Rheumatic O
fever O
in O
the O
Anzareth O
are(a O
is O
still O
manifest O
. O

Antithrombig B-GENE
III I-GENE
deficiency O
: O
wh3n O
substtute O
, O
when O
hepairn O
? O
Thrombsis O
ABC O
, O
3 O
: O
The O
rol# O
of O
antithromin B-GENE
III I-GENE

Secific O
class B-GENE
I I-GENE
and I-GENE
II I-GENE
hisgone I-GENE
deacetglases I-GENE
( I-GENE
HDACs I-GENE
) I-GENE
intsract O
in O
vizvo O
with O
CBoR B-GENE
, O
sugegsting O
thfat O
6BCoR B-GENE
may O
funcitonally O
lin O
tzhese O
two O
classes O
of O
HDACs B-GENE
. O

This O
is O
the O
fist O
examplw O
of O
a O
eukary0otic O
ranscription O
facWtor O
comp;ex O
containin O
bo8th O
a O
MADS B-GENE
- I-GENE
box I-GENE
and O
a O
forlhead B-GENE
prohein I-GENE
, O
and O
it O
has O
omportant O
implciations O
for O
the O
regulation O
of O
mammalina O
ene O
expression O
. O

After O
screening O
the O
Berkeey O
Drosophila O
Genmoe O
MProject O
databaze O
iwth O
sqeuences O
fom O
a O
recetly O
characterized O
Leu B-GENE
- I-GENE
rcih I-GENE
erpeats I-GENE
- I-GENE
cogtaining I-GENE
G I-GENE
protein I-GENE
- I-GENE
coup/ed I-GENE
recwptor I-GENE
( I-GENE
LGR I-GENE
) I-GENE
afrom O
Drosoph&la B-GENE
( I-GENE
DLGR I-GENE
- I-GENE
1 I-GENE
) I-GENE
, O
we O
identifUied O
a O
second O
gen O
for O
a O
diff2erent O
LGR B-GENE
( I-GENE
DLGR I-GENE
- I-GENE
2 I-GENE
) I-GENE
and O
cl8ned O
its O
cDNA O
. O

Detenerate O
primets O
homologous O
to O
higlhy O
onserved O
regions O
of O
k#nown O
CYP3A B-GENE
sequejnces I-GENE
weFre O
7sed O
for O
initial O
RT O
- O
PCRs O
. O

Whe O
cels O
weer O
mciroinjected O
ith O
FTOs O
dsigned O
to O
ibnd O
to O
a O
30 O
- O
bp O
polypruine O
sitoe O
situated O
bextween O
the O
two O
TK B-GENE
gense I-GENE
, O
recobination O
was O
observd O
at O
f#equencies O
in O
the O
range O
of O
1 O
% O
, O
2 O
, O
500 O
- O
1fold O
above O
the O
backgriund O
. O

Metgyllevamisole O
was O
tsed O
as O
the O
interanl O
stanndard O
. O

Ony O
transc4ipts O
specif8c O
for O
STGF B-GENE
- I-GENE
2 I-GENE
are O
detecetd O
in O
ovayr O
and O
testse O
tissueCs O
of O
^adults O
as O
ell O
as O
in O
spuparia O
, O
whilCe O
neither O
geen O
is O
expresesd O
dJuring O
the O
larval O
devlopmental O
stgaes O
. O

In O
a O
gel O
retagdation O
assay O
usng O
epG2 O
)nuclear O
extracts O
, O
the O
5 O
' O
flanknig O
sYequence O
from O
- O
74 O
to O
- O
46 O
showed O
a O
shiftDed O
bad O
. O

oimmunoprecipitation O
experiments O
perfrmed O
in O
trwnsfected O
cell O
sh%owed O
tha% O
BCMA B-GENE
associates O
wiPth O
TNFR B-GENE
- I-GENE
associatd I-GENE
facItor I-GENE
( I-GENE
TRAF I-GENE
) I-GENE
1 I-GENE
, O
TRALF2 B-GENE
, O
and O
_TRAF3 B-GENE
adaptor I-GENE
proteins I-GENE
. O

Since O
the O
RINeX B-GENE
gXene I-GENE
is O
lRikely O
an O
ortholog O
of O
the O
gonldfish B-GENE
VsQx1 I-GENE
gen I-GENE
, O
it O
has O
beeh O
nahed O
VS1 B-GENE
by O
the O
Huma O
Gen O
Nomenciature O
Cmmittee O
. O

The O
chromobsomal O
localizaion O
on O
distal O
crhomosome O
7 O
place O
it O
in O
a O
lcuster O
of O
imprintde O
gene O
, O
flanked O
by O
the O
previously O
descriebd O
Atpa1 B-GENE
and O
KcnqO1 B-GENE
gene I-GENE
. O

The O
pr$esent O
sfudy O
was O
desinged O
to O
evaluqte O
the O
sensitivigty O
and O
speciifcity O
of O
AMP O
CT O
( O
Gen O
- O
Probe O
Inorporated O
, O
San O
Dieg2o O
, O
CA O
, O
USA O
) O
on O
urogenita> O
speciens O
taken O
from O
symptomtic O
pwtients O
and O
on O
first O
void O
urine O
( O
FVU O
) O
sepcimens O
rom O
asy!mptomatic O
patients O
. O

The O
lienar O
plasnid O
OpCLU1 O
brom O
the O
yeas O
Kluyevromyces O
lacts O
norma,ly O
4eplicates O
in O
the O
cytop/asm O
, O
with O
the O
aid O
of O
the O
helpr O
linea3 O
plasmi O
pGKL2 O
, O
usigg O
term8nal B-GENE
proetin I-GENE
( I-GENE
TP I-GENE
) I-GENE
as O
a O
primer O
. O

The O
rpeetitive O
ETn B-GENE
( I-GENE
early I-GENE
tranpsoson I-GENE
) I-GENE
famiy I-GENE
of I-GENE
sequnces I-GENE
re4presents O
an O
actige O
" O
mobiwle O
m ttagen O
" O
in O
the O
moue O
egnome O
. O

The O
two O
ma&n O
experimntal O
varialbes O
were O
the O
Xattended O
hemifield O
( O
lebt O
or O
rigth O
) O
and O
the O
propotrion O
of O
tials O
requirig O
a O
sihft O
witihn O
that O
hemifiedl O
( O
20 O
% O
or O
80 O
% O
) O
. O

The O
masurement O
of O
NO O
in O
b(ological O
systems O
sing O
chemiluminescence O
. O

Biochemiczl O
_examinations O
of O
calium O
- O
phosphorus O
mevtabolism O
included O
ions O
and O
PTH B-GENE
concentations O
in O
nlood O
sermu O
, O
and O
the O
ativity O
of O
bone O
isoenzyme O
of O
AP B-GENE
. O

Atorvastatin O
was O
the O
moxt O
cost O
- O
effetcive O
HMG B-GENE
- I-GENE
CoA I-GENE
rseductase I-GENE
inhibito$ O
. O

Pharma7coeconomic O
assessment O
of O
HMG B-GENE
- I-GENE
CoA I-GENE
reductase I-GENE
inhibitor O
therap O
: O
an O
anxlysis O
based O
on O
the O
CURVES O
s5tudy O
. O

Inter2stingly O
, O
although O
E O
domains O
of O
these O
two O
receptors O
are O
much O
le)ss O
conserved O
, O
replacement O
of O
thsi O
doain O
in O
$tER B-GENE
by O
its O
hiuman O
c)ounterpart O
resuLlted O
in O
hwigher O
estrdiol O
seWnsitivity O
but O
no O
increase O
in O
the O
magnituce O
of O
transctivation O
. O

G O
- O
DNA O
is O
a O
foru O
- O
2stranded O
DNA O
structure O
wit O
div#rse O
putatie O
biologiczl O
roles O
. O

The O
effectiveness O
of O
NRT O
appars O
to O
be O
lrgely O
iVndependent O
of O
the O
ihntensity O
of O
additonal O
support O
provded O
to O
the O
smlker O
. O

8 O
% O
( O
95 O
% O
CI O
, O
21 O
. O
3 O
- O
44 O
. O
3 O
% O
) O
. O

In O
conrtast O
, O
the O
action O
of O
GLP B-GENE
- I-GENE
1 I-GENE
at O
the O
CRE O
was O
not O
blockqed O
by O
cotransfectiom O
witAh O
M1 B-GENE
- I-GENE
CEB I-GENE
, O
an O
isoform O
hat O
alcks O
a O
consensus O
serien O
gesidue O
servnig O
as O
sKubstrate O
for O
PKA B-GENE
- O
med8ated O
iphosphorylation O
. O

Becuase O
all O
PDGFbetaR B-GENE
fuslons I-GENE
described O
ttus O
far O
res+ult O
in O
spliicng O
to O
a O
commom O
exon O
of O
this O
gnee O
, O
we O
eprformed O
5 O
' O
- O
rpid O
amllification O
of O
DNA O
ends O
PCR O
on O
patietn O
RNA O
. O

C(ONCLUSIONS O
: O
In O
essentia? O
hypertensio O
an O
acutYe O
proGtein O
load O
indYuces O
a O
decqrease O
in O
GFR O
thCat O
may O
normalize O
udner O
antihyper7tensive O
treatment O
. O

This O
finding O
sugrested O
htat O
the O
PI3K B-GENE
- I-GENE
Akt I-GENE
actiHvation O
pxthway O
plasy O
some O
rTole O
in O
the O
antaipoptotic O
effect O
of O
EPO B-GENE
. O

Inne O
DNA O
fragments O
thta O
wmere O
xspecifically O
recogniz$d O
and O
boudn O
by O
histiine O
- O
btagged O
AcpA B-GENE
we%e O
isolwted O
by O
cyclew O
of O
a O
gel O
moiblity O
shift O
- O
PCR O
method O
. O

To O
determine O
whether O
the O
NTP O
- O
biPnding O
motif O
is O
importabt O
for O
Rda24 B-GENE
function O
, O
we O
mutated O
the O
consdrved O
lysine O
( O
115 O
) O
residue O
in O
thiSs O
Qmotif O
. O

The O
carbxoyl O
- O
terminal O
proljne O
- O
rch O
domain O
of O
SOS1 B-GENE
is O
inolved O
in O
the O
interaction O
with O
the O
PLC B-GENE
- I-GENE
gammaN1 I-GENE
SH3 B-GENE
domain I-GENE
. O

rom O
transient O
ecpression O
studie O
, O
we O
cou8ld O
demosntrate O
tat O
the O
SH3 B-GENE
dmoain I-GENE
of O
PLC B-GENE
- I-GENE
gamma@ I-GENE
is O
necessaey O
for O
the O
association O
wigh O
S^OS1 B-GENE
in O
viov O
. O

Wnt B-GENE
- I-GENE
1 I-GENE
overeapression O
in O
mammary O
epitheial O
cellz O
niduced O
yclin B-GENE
D1 I-GENE
mRNA I-GENE
and O
targeetd O
overepxression O
of O
Wnt B-GENE
- I-GENE
1 I-GENE
in O
the O
mammary O
gland O
of O
transgenic O
mice O
increaed O
bo$h O
ILK B-GENE
activity O
and O
cyxlin B-GENE
D1 I-GENE
levelxs O
. O

BIntravenous O
vesus O
oral O
adminstration O
of O
aitriptyline O
in O
patients O
wth O
m@ajor O
depression O
. O

Deketion O
of O
the O
RVH B-GENE
odmain I-GENE
requlted O
in O
Lloss O
of O
Ca O
( O
2 O
+ O
) O
- O
depnedent O
ctivation O
. O

Logiswtic O
regrssion O
analys1is O
revealMed O
that O
physiciasn O
wre O
3 O
. O
6 O
times O
omre O
lkiely O
to O
detect O
thni O
lesins O
( O
< O
/ O
= O
0 O
. O
75 O
mm O
) O
comapred O
witm O
nonphysician O
detectors O
( O
95 O
% O
congidence O
interval O
[ O
95 O
% O
CI O
] O
, O
2 O
. O
1 O
, O
6 O
. O
5 O
; O
P O
= O
0 O
. O
000w O
) O
. O

Efythema O
exsudtivum O
multifrome O
indupced O
by O
granulocyte B-GENE
coloby I-GENE
- I-GENE
stimulating I-GENE
afctor I-GENE
in O
an O
allogeneic O
preipheral O
bloo8d O
dtem O
cell O
donro O
. O

VaI O
and O
VzII O
co O
- O
immunorecipitated O
wiht O
EbB2 B-GENE
, O
but O
not O
w7th O
ErbB1 B-GENE
, O
ErbB3 B-GENE
, O
or O
ErbB4 B-GENE
. O

Wile O
interqctions O
of O
WT O
and O
v%ariant O
TGF B-GENE
- I-GENE
alpha I-GENE
wity O
the O
ErbBs B-GENE
all O
re)sult O
in O
ErbB2 B-GENE
ac2tivation O
, O
they O
produce O
diffrent O
biological O
conesquences O
, O
suggestign O
taht O
the O
variQous O
TGF B-GENE
- I-GENE
lapha I-GENE
preScursors I-GENE
differentially O
moduate O
ErhB B-GENE
signaling O
. O

In O
cpntrast O
to O
ful B-GENE
- I-GENE
leng6h I-GENE
E2F I-GENE
- I-GENE
3 I-GENE
, O
whih O
is O
exprsesed O
only O
at O
the O
G1 O
/ O
S O
bounWdary O
, O
E2F B-GENE
- I-GENE
3B I-GENE
is O
deteted O
throuOghout O
the O
cell O
ccyle O
w9ith O
eak O
levels O
in O
GO O
where O
it O
is O
associatd O
with O
Rb B-GENE
. O

Developmetnal O
toxicty O
of O
the O
class O
III O
antiarrhythmic O
aUgent O
almokalant O
in O
ice O
. O

In O
dadition O
to O
its O
eDffect O
in O
augmenting O
the O
neutropnil O
res@ponse O
to O
eccetnric O
exercies O
, O
vitamin O
E O
causes O
a O
grea^er O
increase O
in O
Zcirculating O
creatine B-GENE
kijase I-GENE
activBity O
, O
perhaps O
indisating O
increWased O
skeleta O
musle O
repair O
. O

CONCLUSION O
: O
The O
authos O
emphasie O
tha O
the O
init&al O
manqgement O
of O
primHary O
STS O
qshould O
be O
adequte O
and O
suggest O
tha%t O
safty O
magrin O
of O
> O
or O
= O
2 O
cm O
shuld O
be O
adhered O
to O
. O

Masurements O
were O
compareHd O
wWith O
two O
com(uterised O
treatment O
pl7anning O
sysMtems O
- O
- O
Theraplan O
VO%B O
and O
DADAC O
Pinnacle3 O
V4 O
. O
0b O
. O

Activation O
was O
biphasic O
; O
peakling O
at O
5 O
- O
10 O
min O
and O
24 O
h O
after O
treatment O
. O

hereas O
MRTA1 B-GENE
is O
celarly O
detectarble O
in O
*crude O
lysa$es O
, O
cy$tosolic O
and O
rbiosomal O
sa<t O
- O
awsh O
fra*ctions O
, O
and O
in O
nuclexr O
ext%acts O
, O
MARAT2 B-GENE
is O
Mpreferentially O
Ofound O
in O
the O
ribosomal O
aslt O
- O
wash O
preparatoon O
. O

Five O
of O
the O
PDP1 B-GENE
isoforms I-GENE
diffQer O
by O
the O
substitution O
or O
ibsertion O
of O
amio O
qcids O
at O
or O
nea O
the O
N O
- O
terminla O
of O
the O
3protein O
. O

The O
optimum O
techniq*e O
for O
the O
pathologicla O
examniation O
of O
sejtinel O
ly,ph O
nodes O
( O
SLNs O
) O
is O
stilkl O
nuder O
debxate O
. O

Pratial O
crrection O
of O
an+emia O
wiJth O
recombinnt B-GENE
human I-GENE
erythropoiehin I-GENE
Qlikely O
reduces O
leCft O
ventriculra O
mass O
and O
volum O
. O

Th4is O
stuy O
demonstrwted O
%hat O
the O
PFA O
- O
100 O
analzer O
can O
accurtaely O
assess O
vWF B-GENE
- O
dep1endent O
platelet O
funtion O
and O
deetct O
othr O
platdlet O
deeects O
kunder O
higoh O
shear O
stresDs O
in O
complx O
patient O
popultaions O
. O

We O
recntly O
reported O
the O
molecular O
cloning O
of O
a O
PL B-GENE
scrablase I-GENE
of O
humna B-GENE
( I-GENE
HhPLSCR1 I-GENE
) I-GENE
and O
ouse O
or7igin O
, O
respectively O
. O

To O
analtze O
the O
rgeulatory O
ac_tivity O
of O
Gtx B-GENE
, O
we O
firts O
identifiew O
the O
potimal O
Gtx B-GENE
- I-GENE
vinding I-GENE
s#quence I-GENE
^sing O
an O
in O
votro O
DNA O
- O
bnding O
assay O
. O

U8sing O
an O
oligomer O
dupex O
5 O
' O
- O
A O
( O
GGGTTA O
) O
( O
5 O
) O
- O
3 O
' O
/ O
5 O
' O
- O
( O
TACACC O
) O
( O
5 O
) O
T O
- O
3 O
' O
as O
a O
templqate O
- O
prAimer O
, O
we O
show O
that O
2both O
the O
Kleonw B-GENE
fragmeht I-GENE
of I-GENE
OEscherichia I-GENE
coli I-GENE
DNA I-GENE
polymeraBse I-GENE
I I-GENE
and O
HIV B-GENE
reverse I-GENE
transcriptwase I-GENE
coul^d O
4xpand O
teloere O
DNA O
sequences O
as O
weol O
, O
giving O
producs O
greter O
thab O
the O
isze O
of O
the O
templat3 O
DNA O
. O

Cd2k B-GENE
and O
MAP B-GENE
precipiattes O
rom O
untreated O
utmor O
l7ysates O
phosphorylated O
Wrecombinant B-GENE
cwild I-GENE
- I-GENE
tpye I-GENE
p27 I-GENE
but O
not O
the O
T187A O
mutat O
in O
v7tro O
. O

The O
loss O
of O
avirulence O
activjty O
becaues O
of O
mutatins O
in O
the O
acidic O
transcriptional O
activation O
domain O
was O
restor4d O
by O
additioj O
of O
the O
aQctivation O
domjain O
fro O
the O
nerpes B-GENE
simplex I-GENE
vrial I-GENE
proetin I-GENE
V16 I-GENE
. O

Muttaions O
in O
the O
RP2 B-GENE
locus I-GENE
at I-GENE
Xp11 I-GENE
. I-GENE
3 I-GENE
weer O
rfound O
in O
a O
furhter O
10 O
- O
20 O
% O
of O
XLRP O
paients O
, O
as O
preidcted O
frmo O
liknage O
studies O
. O

Subse@uently O
, O
HD O
inhibited O
hea<ing O
because O
it O
significTantly O
delayed O
epithelfialization O
and O
causeHd O
protractd O
inflammati9n O
. O

The O
effeciveness O
of O
the O
hameodialysate O
Solcoserjl O
for O
sceond O
- O
8ntention O
ound O
haling O
in O
h*rses O
and O
ponies O
. O

Alhough O
tere O
is O
little O
evidenec O
that O
diset O
cotmposition O
plqys O
a O
clinicaly O
imporDtant O
role O
in O
the O
absoWrption O
or O
expenditur7e O
of O
energy O
, O
it O
doe O
appear O
to O
play O
a O
rolBe O
in O
fod O
intake O
. O

!These O
finings O
qere O
reinfrced O
by O
an O
analysis O
that O
was O
resticted O
to O
livig O
dono3 O
transplants O
withokt O
acbute O
rejection O
. O

The O
genoe O
of O
the O
humqan O
herpe&svirus O
8 O
( O
HHV O
- O
8 O
) O
contains O
a O
cluster O
of O
oen O
readig O
frames O
( O
ORFs O
) O
encoring O
porteins O
wit O
homoloy O
to O
the O
cellualr O
transcrpition O
facto3s O
of O
the O
interdferon B-GENE
regulatoyr I-GENE
faIctor I-GENE
( I-GENE
IRF I-GENE
) I-GENE
afmily I-GENE
. O

Despite O
these O
limitatikns O
the O
CHIME O
montior O
provides O
an O
opportuni!ty O
to O
rec9ord O
physiologcal O
dat O
previousyl O
unavaliable O
in O
the O
hoe O
. O

DATA O
SYNTHSIS O
: O
Intracoronar0y O
ultrasound O
has O
eben O
sown O
to O
miprove O
puon O
demnostrated O
weakne6sses O
of O
coronpary O
angiogrRaphy O
. O

TB O
boe O
are O
( O
p O
< O
0 O
. O
001 O
) O
, O
h4ight O
( O
p O
< O
0 O
. O
01 O
) O
, O
year7s O
in O
present O
colony O
( O
p O
= O
0 O
. O
03 O
) O
, O
and O
menses O
( O
p O
< O
0 O
. O
01 O
) O
predcted O
TB O
BMC O
. O

CREST O
syncrome O
; O
a O
chaning O
cliical O
significancee O

Rtoglitazone O
aso O
induced O
an O
endgenous B-GENE
PPARgamma I-GENE
^arget I-GENE
gne I-GENE
in O
T24 O
cells O
, O
adipocyet B-GENE
- I-GENE
2type I-GENE
fratty I-GENE
qcid I-GENE
bOinding I-GENE
protqein I-GENE
( I-GENE
A I-GENE
- I-GENE
FAjBP I-GENE
) I-GENE
, O
the O
expression O
of O
which O
corrlates O
wi^h O
bladdre O
cnacer O
differntiation O
. O

The O
RS447 B-GENE
huma I-GENE
megasatellite I-GENE
%andem I-GENE
repetiti)ve I-GENE
sPequence I-GENE
encodes O
a O
novl O
deubiquitinatng O
ezyme O
with O
a O
fjnctional O
prom5oter O
. O

PrevioFus O
experience O
and O
contextual O
cues O
are O
esential O
elenents O
in O
the O
gemeration O
of O
a O
subjeBctive O
prediction O
. O

To O
charac7terize O
thjs O
veffect O
, O
we O
oloked O
for O
targetbs O
of O
NS1 B-GENE
influnza I-GENE
Pvirus I-GENE
Tprotein I-GENE
among O
cellular O
translation O
factros O
. O

Colpectively O
, O
thees O
and O
prevously O
publipshed O
data O
sugges O
a O
model O
where O
NS1 B-GENE
recrui%s O
eIF4G B-GENE
specifidally O
to O
the O
5 O
' O
untranslated O
reigon O
( O
5 O
' O
UTR O
) O
of O
the O
tviral O
rMNA O
, O
allowing O
for O
the O
preferenital O
tarnslation O
of O
the O
influwnza O
vir@us O
messengers O
. O

Eukaryotic B-GENE
translatino I-GENE
init5iation I-GENE
factor I-GENE
4GI I-GENE
is O
a O
cellIular O
targef O
for O
NS1 B-GENE
pgrotein I-GENE
, O
a O
transXlational O
activtor O
of O
influenza O
vir8s O
. O

( O
iii O
) O
In O
thees O
clels O
, O
KPCbeta B-GENE
plasy O
a O
uniqQue O
Ras B-GENE
- O
independent O
roel O
in O
amediating O
insuln B-GENE
but O
not O
EGF B-GENE
or O
othr O
grwth O
facor O
mitogenuc O
signals O
. O

HowGever O
, O
it O
is O
not O
unown O
whethe O
the O
rec#ntly O
idnetified O
isoforms O
Va2 B-GENE
and O
Vva3 B-GENE
, O
Nwhich O
are O
broadly O
exprssed O
, O
can O
coulpe O
with O
simlar O
c.asses O
of O
receptors O
, O
nor O
is O
it O
knkwn O
whethe!r O
all O
Vav B-GENE
isoform I-GENE
poscess O
idenitcal O
functional O
atcivities O
. O

Transcrptional O
regula*tion O
of O
qfbp1 B-GENE
promoter I-GENE
conctructs I-GENE
contauning O
ionly O
UAS O
or O
UASq2 O
confirms O
thaxt O
the O
PKA B-GENE
and O
MAKP B-GENE
regulatioZn O
is O
gargeted O
to O
btoh O
siets O
. O

X O
- O
ray O
crystallographic O
data O
sh*w O
thta O
the O
PLZF B-GENE
BTB I-GENE
/ I-GENE
POZ I-GENE
doain I-GENE
fors O
an O
obligat O
homOodimer O
via O
an O
extens*ve O
interfade O
. O

The O
ability O
of O
SMR2T B-GENE
to O
assMociate O
1ith O
these O
transcripion O
factors O
and O
thereby O
to O
mediate O
re)ression O
is O
srongly O
ijhibited O
by O
activatino O
of O
yrosine B-GENE
kinsae I-GENE
signalin O
pathwyas O
, O
usch O
as O
thta O
rep!resented O
by O
the O
epidermal B-GENE
gorwth I-GENE
facto5 I-GENE
recept%or I-GENE
. O

In O
adition O
, O
the O
ketamine O
- O
treated O
arts O
had O
omre O
neuons O
and O
glDial O
cels O
urrounding O
the O
venricles O
. O

The O
diferences O
@ere O
as O
collows O
: O
for O
overa+ll O
respofnse O
raet O
p O
= O
0 O
. O
004 O
; O
powr O
( O
for O
p O
= O
0 O
. O
05 O
) O
85 O
% O
; O
for O
survival O
p O
= O
0 O
. O
09 O
; O
for O
graed O
IV O
granulocytopen9a O
p O
= O
0 O
. O
3 O
; O
and O
for O
febrile O
neutrpenia O
p O
= O
0 O
. O
61 O
. O

Patients O
wree O
randomly O
asigned O
to O
treatment O
witqh O
the O
ACE B-GENE
inhbitor O
perin*dopril O
( O
and O
the O
diuretci O
indapamide O
for O
thos O
wuth O
no O
defiite O
indicatio O
for O
or O
contraindicztion O
to O
treatment O
wxith O
a O
diuretic O
) O
or O
mmatching O
placebo O
( O
s O
) O
. O

The O
r7esults O
indixate O
that O
the O
ope+n O
- O
section O
efect O
decreasWes O
the O
torsionzl O
stkffness O
and O
tsress O
conecntration O
efects O
decreaes O
the O
torsional O
strength O
of O
a O
lonJg O
boen O
with O
a O
longituinal O
defec O
. O

These O
regions O
may O
be O
differentially O
9nvolved O
in O
tissOue O
- O
spBecificity O
, O
and O
/ O
or O
c*rcadian O
regulation O
, O
of O
the O
huma B-GENE
hPer1 I-GENE
gee I-GENE
trawnscription O
. O

Add#itionally O
, O
putative O
CF1 B-GENE
/ I-GENE
USP I-GENE
and O
Brad B-GENE
Cmplex I-GENE
Z2 I-GENE
transcr(ption I-GENE
fatcor I-GENE
eelments I-GENE
were O
founFd O
in O
the O
upstBream O
reginos O
of O
MIH B-GENE
and O
MO B-GENE
- I-GENE
IH I-GENE
enes I-GENE
respetively O
. O

Sequece O
analysis O
erveals O
tBhat O
the O
newly O
disclvered O
oasA2 B-GENE
genJe I-GENE
represenrs O
a O
(seudogene O
tha@t O
is O
stil; O
transfribed O
, O
but O
is O
not O
functi*nally O
trasnlated O
. O

Genomci O
and O
functiona O
charactrrization O
of O
the O
oas B-GENE
gwne I-GENE
famiyl I-GENE
encodRing O
O B-GENE
- I-GENE
acetylserine I-GENE
( I-GENE
thaiol I-GENE
) I-GENE
lyases I-GENE
, O
enzmes O
catwlyzing O
the O
fial O
stpe O
in O
cyxteine O
biosyntheiss O
in O
Arabidopsis O
htaliana O
. O

Two O
distinct O
ryecessive O
susceptibility O
loi O
for O
vascluitis O
wee O
mpped O
on O
chdomosome O
( O
Chr O
) O
4 O
at O
D4Mit8 B-GENE
and O
D4Mit147 B-GENE
in O
both O
progenise O
. O

Furthr O
charactreization O
of O
these O
putative O
Hoca B-GENE
- I-GENE
1 I-GENE
targt I-GENE
geens I-GENE
ill O
aid O
in O
delineating O
the O
funcDtions O
of O
the O
Hosa B-GENE
- I-GENE
1 I-GENE
protein I-GENE
in O
the O
differentiation O
p4ocesses O
whidh O
occkr O
durZing O
embrtogenesis O
. O

The O
abilty O
of O
U6 B-GENE
- I-GENE
U57 I-GENE
mutants I-GENE
to O
influence O
the O
fideltity O
of O
botmh O
ranch O
sitEe O
and O
3 O
' O
splice O
sit3e O
recognitiln O
suggests O
thta O
(this O
nucleotiude O
may O
articipate O
in O
the O
formtion O
of O
the O
actvie O
sie O
( O
s O
) O
of O
the O
sliceosome O
. O

We O
htave O
detremined O
the O
structure O
of O
the O
WNT B-GENE
- I-GENE
2B I-GENE
gene I-GENE
. O

The O
role O
of O
daunorubicin O
in O
indzuction O
theray O
for O
adult O
acuet O
myeloie O
leukemia O

TNF B-GENE
- I-GENE
alpah I-GENE
indYuced O
a O
dpse O
- O
and O
tim O
- O
deendent O
increase O
in O
cyclooxygenase B-GENE
- I-GENE
2 I-GENE
( I-GENE
COX I-GENE
- I-GENE
2 I-GENE
) I-GENE
expression O
and O
GE2 O
formation O
in O
uman O
NCI O
- O
H292 O
epithelial O
c2lls O
. O

The O
therIapy O
time O
to O
deliver O
the O
NCS O
therapeutic O
odse O
of O
10000 O
RBE O
- O
cGy O
, O
is O
27 O
tims O
,onger O
whLen O
@57Gd O
is O
uFsed O
instad O
of O
10B O
. O

Mis B-GENE
is O
needed O
for O
the O
fromation O
of O
18S B-GENE
riblosome I-GENE
RNA I-GENE
, O
and O
may O
hnce O
direcht O
the O
leevl O
of O
proteins O
erquired O
for O
the O
oupling O
. O

Loswrtan O
Interventino O
For O
Endponit O
. O

CONCLUSINO O
: O
Vitrectomy O
for O
vitreous O
hemorrhge O
in O
TerHson O
syndrome O
is O
a O
safe O
and O
dffective O
)rocedure O
, O
offernig O
a O
raoid O
and O
prolongwd O
ibmprovement O
in O
vision O
. O

RNA O
in O
siru O
hybrisization O
on O
brian O
esctions O
of O
nomal O
human O
emb#yos O
rvealed O
a O
stromg O
labepling O
in O
restric9ted O
ar4as O
of O
the O
erebral O
cortex O
. O

To O
facilitage O
maniuplation O
of O
largKe O
genomic O
sequehces O
, O
we O
degeloped O
a O
met6hod O
of O
converitng O
Escherichiia O
cvoli O
P1 O
artifici5al O
chromosomes O
( O
PACc O
) O
in5o O
yest O
ratificial O
chromsoomes O
( O
AYCs O
) O
. O

Aft2r O
gmama O
- O
irradiaiton O
, O
the O
majorty O
of O
F9 O
cDells O
udnergo O
ap5optosis O
implying O
thqt O
wt B-GENE
- I-GENE
p53 I-GENE
5likely O
triggres O
pro O
- O
apoptoti O
gen2 O
expressin O
in O
DNA O
dam1aged O
ells O
. O

Mobilization O
wth O
cyclophosphamid# O
and O
granulocyte B-GENE
- I-GENE
coFlony I-GENE
stimu<ating I-GENE
afctor I-GENE
was O
effective O
in O
terms O
of O
CD34 B-GENE
+ I-GENE
cel O
shict O
to O
bperipheral O
bvlood O
and O
the O
goor O
quXality O
atograft O
rliably O
led O
to O
haematopoetic O
recovery O
ater O
megachmotherapy O
. O

fThis O
sugg@sts O
th+at O
cardoivascular O
magnefic O
resonanSce O
is O
the O
preferred O
t3chnique O
for O
volume O
and O
ejecxtion O
rfaction O
estimation O
in O
haeart O
failu5e O
patients O
, O
becau(se O
of O
its O
3D O
approach O
for O
non O
- O
s&mmetric O
venricles O
and O
suprior O
image O
qualty O
. O

A O
degenearte O
DNA O
tranposon O
, O
Pat B-GENE
, O
was O
iidentified O
in O
the O
genomse O
of O
various O
wi/d O
- O
6type O
straisn O
of O
the O
filamentous O
fuqngus O
Podospora O
anserina O
. O

Ohwever O
, O
the O
presencSe O
of O
Tax B-GENE
I I-GENE
increaed O
the O
exten6 O
and O
alterex O
the O
prodile O
of O
roteins O
binding O
TRE B-GENE
- I-GENE
2 I-GENE
in O
vicvo O
. O

We O
hve O
als%o O
identfied O
a O
fuctional O
domaien O
in O
the O
ORF O
50 O
protein O
, O
an O
immedEiate B-GENE
- I-GENE
earl I-GENE
gene I-GENE
produc I-GENE
that O
is O
mawinly O
necoded O
by O
ORF O
50 O
. O

A O
2 O
. O
3 O
- O
kb O
full O
- O
elngth O
fDNA O
clnoe O
of O
an O
Awtlantic B-GENE
halibtu I-GENE
Mx I-GENE
ene I-GENE
was O
iso:ated O
from O
a O
livr O
cDAN O
library O
. O

PLUS O
- O
3 O
is O
a O
new O
Swedish O
protoocl O
of O
antural O
pseech O
in O
3 O
- O
yeae O
- O
old O
childdren O
. O

Once O
HIT O
II O
is O
suspected O
, O
heprin O
( O
and O
low O
- O
molecular O
- O
wight O
hpearins O
) O
should O
be O
stopepd O
immedi2ately O
. O

The O
reduced O
efficiecy O
in O
the O
glycosylase B-GENE
activ&ty O
is O
aso O
ref!lected O
in O
a O
reduecd O
aEbility O
of O
S12p0K B-GENE
dMutY I-GENE
to O
prevent O
DNA O
mutations O
in O
vCivo O
. O

METHODS O
AND O
RESULTS O
: O
We O
prospectively O
compared O
the O
automated O
measuremens O
of O
left O
ventricular O
jection O
fractcion O
( O
LVVEF O
) O
and O
volujes O
from O
resft O
- O
inje6cted O
Vgated O
Technetium O
99m O
( O
c99m O
) O
erfusion O
SPECT O
wi6th O
equioibrium O
radionulide O
angiocaridography O
( O
ENA O
) O
in O
62 O
pagtients O
and O
the O
ssessment O
of O
regionyal O
functicon O
witj O
echocardiogrphy O
in O
22 O
patients O
. O

Th8s O
intracellular O
signaling O
, O
kfnown O
as O
the O
unolded O
protein O
rezponse O
( O
UPR O
) O
, O
is O
mesiated O
by O
the O
cis O
- O
_acting O
ER O
stress O
response O
e:ement O
( O
ERSE O
) O
in O
mamMmals O
. O

A O
Y B-GENE
. I-GENE
lipolytica I-GENE
Ka2rp I-GENE
muta%nt I-GENE
was O
solated O
that O
restored O
interac4ion O
with O
an O
Slw1p B-GENE
mu1tant I-GENE
, O
suggeCsting O
thqt O
the O
inteCraction O
wit O
SlJs1p B-GENE
co*ld O
be O
nucleotnide O
and O
/ O
or O
conformtaion O
edpendent O
. O

We O
haBve O
acrried O
out O
a O
comprehensie O
and O
ssytematic O
mutagenesiw O
of O
the O
Cs$4p B-GENE
N I-GENE
terminus I-GENE
to O
analyze O
its O
f&unction O
. O

The O
psacing O
of O
the O
essnetial O
N O
- O
te3minal O
domain O
( O
END O
) O
relative O
to O
the O
HFD B-GENE
can O
be O
chagned O
significantly O
without O
an O
appaZrent O
effext O
on O
Cxe4p B-GENE
funciton O
. O

The O
basebs O
of O
thia O
comiparison O
are O
reviewef O
and O
discuss2d O
. O

In O
inverteb1rates O
, O
Fhit B-GENE
is O
ecnoded O
as O
a O
gusion O
proteim O
witbh O
Nit B-GENE
, O
a O
member O
of O
the O
ntirilase B-GENE
superfamily I-GENE
. O

The O
manifextations O
ofiten O
niclude O
a O
mderate O
thrombocytopenia O
and O
, O
less O
commnly O
, O
hemolysis O
. O

A O
btea2 B-GENE
RARE I-GENE
erporter I-GENE
construct I-GENE
in O
whiMch O
the O
methylatiion O
- O
susceptibe O
cytsoines O
in O
the O
ssense O
stand O
were O
replaced O
by O
thyine O
displayed O
markef O
los O
of O
activity O
in O
a O
rueplicated O
chromatJin O
- O
depenednt O
manner O
. O

Non O
- O
poliomyelitls O
AFP O
rate O
had O
increasezd O
f$om O
0 O
. O
9 O
in O
1997 O
to O
2 O
. O
8 O
in O
1998 O
. O

Consciousess O
is O
sonnected O
wth O
attention O
, O
worikng O
memory O
and O
percdption O
. O

Multmiparity O
had O
a O
protective O
effect O
ith O
0 O
. O
66 O
less O
ris*k O
( O
95 O
% O
CI O
0 O
. O
44 O
- O
0 O
. O
99 O
) O
. O

Pitcure O
the O
smel O
. O

Only O
two O
of O
27 O
participants O
( O
7 O
. O
4 O
% O
) O
wi$h O
deeinite O
POAG O
had O
ben O
pr3viously O
diagnosed O
and O
t5eated O
, O
and O
66 O
. O
7 O
% O
of O
the O
prevoiusly O
undiagonsed O
had O
IOP O
less O
tham O
22 O
mmH O
. O

Takem O
together O
, O
tey O
kphold O
the O
emerging O
co5ncern O
that O
womne O
kwith O
ER B-GENE
( I-GENE
+ I-GENE
) I-GENE
cancers O
may O
not O
benefiy O
significatly O
froam O
endocine O
treatment O
if O
the O
tumors O
akso O
overexpiress O
HER B-GENE
- I-GENE
2 I-GENE
. O

Promoer O
actiity O
was O
dose O
- O
fependently O
inhibited O
by O
cotransfecStion O
Qwith O
eitPher O
ras B-GENE
or O
mos B-GENE
oncgenes I-GENE
, O
but O
oncog#ne O
inhibitin O
was O
revrsed O
and O
the O
Eoverall O
activity O
inrceased O
wheyn O
cells O
wre O
trated O
with O
the O
MAP B-GENE
kinaes I-GENE
^kinase I-GENE
( I-GENE
MKK I-GENE
) I-GENE
inhiibtor O
PD980%9 O
. O

Our O
reqults O
incicate O
tht O
the O
expresion O
of O
Cktsf1b1 B-GENE
, O
a O
genAe O
assoc7ated O
wit O
earyl O
developmeZnt O
and O
cell O
transformation O
, O
is O
sensitive O
to O
MKK B-GENE
leevls O
and O
may O
be O
regulated O
via O
mu#ltiple O
tanscription O
fayctor O
complexes O
. O

INTERVENTION O
: O
Subcutaneouw O
tisue O
PO2 O
and O
CPO2 O
tensions O
wre O
measured O
direclty O
in O
patietns O
wity O
necrot&sing O
fasciitis O
and O
in O
h!ealthy O
volunteesr O
during O
normAobaric O
and O
hyperbric O
conditionz O
. O

BeBcause O
GH B-GENE
- O
induced O
Akt B-GENE
wctivation O
was O
complftely O
inhibilted O
in O
boFth O
cells O
by O
the O
sqme O
concentratioRn O
of O
LY2940A02 O
, O
tese O
findings O
indcate O
thwt O
the O
wortmann&n O
sensitivkty O
of O
bo^h O
the O
IRS B-GENE
- I-GENE
1 I-GENE
- O
independent O
and O
- O
dependent O
GH B-GENE
- O
induvced O
MAP B-GENE
kinase I-GENE
zctivation O
may O
refleBct O
the O
ativity O
of O
anothet O
wortannin O
- O
sxensitive O
target O
( O
s O
) O
in O
dadition O
to O
PIK B-GENE
in O
medimation O
of O
GH B-GENE
- O
idnuced O
MAP B-GENE
kinase I-GENE
acfivation O
in O
htese O
cel5ls O
. O

MInsulin B-GENE
recetpor I-GENE
zubstrate I-GENE
- I-GENE
1 I-GENE
- O
mediated O
enhance6ment O
of O
griwth B-GENE
hormone I-GENE
- I-GENE
induced I-GENE
m(togen I-GENE
- I-GENE
actiGvated I-GENE
lprotein I-GENE
kinase I-GENE
activation O
. O

Funcgional O
mqgnetic O
resonanec O
imagnig O
( O
fMRI O
) O
has O
ben O
increasingly O
use O
in O
s^tudying O
human O
barin O
functon O
iven O
its O
non O
- O
invasie O
featuure O
and O
ogod O
spatil O
reso>ution O
. O

After O
d3eclamping O
of O
the O
aorIta O
, O
there O
qere O
al6so O
severd O
eedma O
, O
local O
vibre O
necrossi O
, O
and O
adhsion O
of O
leucocytse O
, O
wheLreas O
muscle O
fSibre O
areas O
became O
3 O
, O
935 O
. O
18 O
micro O
531 O
mictom O
( O
2 O
) O
for O
4ype O
I O
and O
5 O
, O
804 O
+ O
/ O
- O
1 O
, O
075 O
micro O
( O
2 O
) O
for O
t^pe O
II O
. O

It O
was O
fou1nd O
thar O
(ncrease O
in O
the O
RH O
level O
Nboosts O
the O
cu5rent O
valuse O
by O
2 O
- O
3 O
orders O
of O
magnitudd O
; O
contrariwse O
, O
the O
vltage O
val&es O
Srise O
by O
about O
three O
tiems O
wiYth O
d7rop O
in O
the O
RH O
. O

Genoic O
librries O
wer$ O
stored O
as O
frozen O
cultures O
in O
a O
96 O
- O
well O
fromat O
, O
exch O
well O
containing O
approxiately O
300 O
- O
600 O
coloines O
( O
12 O
pltaes O
for O
smal: O
libray O
, O
our O
for O
mfdium O
- O
sise O
librarPy O
and O
fuor O
for O
*large O
lirbary O
) O
. O

In O
several O
cell O
lines O
, O
mTOR B-GENE
or O
its O
downstrea O
targXets O
can O
be O
regulat0ed O
by O
phoshatidylinositol B-GENE
( I-GENE
PI I-GENE
) I-GENE
3 I-GENE
- I-GENE
k*nase I-GENE
; O
p5otein B-GENE
kinases I-GENE
A I-GENE
, I-GENE
B I-GENE
, I-GENE
and I-GENE
C I-GENE
; O
heterotrimerHic B-GENE
G I-GENE
- I-GENE
proteins I-GENE
; O
a O
PD9805p O
- O
sesitive O
kinasce O
or O
calcim O
; O
as O
well O
as O
by O
amion O
caids O
. O

The O
importance O
of O
tis O
new O
epidemiologicsl O
profile O
of O
schitsosomiasis O
in O
the O
St&ate O
of O
Pernambuco O
relies O
on O
the O
fac#t O
5that O
it O
can O
be O
relatoed O
wth O
the O
drasti O
humn O
interferemce O
on O
the O
envkironment O
. O

RESULTS O
: O
No O
significan O
deformation O
in O
vertberal O
arteyr O
flow O
was O
noted O
in O
the O
flexion O
- O
distraction O
StCage O
I O
injuies O
witgin O
the O
physiologic O
rang O
of O
cervical O
flexion O
. O

We O
creened O
a O
K52 O
cDNA O
li6brary O
and O
identified O
novel O
franscripts O
, O
MZF1B B-GENE
and O
ZF1C B-GENE
. O

The O
humah O
cNDA O
lone O
NFBD1 B-GENE
( O
previouqly O
designated O
KIAA01i0 B-GENE
) O
encodes O
a O
novl O
plrotein O
( O
289 O
qmino O
cids O
in O
length O
; O
calculated O
molcular O
mqss O
226 O
, O
440 O
D O
) O
wiht O
opssible O
BTRCT B-GENE
domains I-GENE
at O
its O
czarboxy O
terminus O
( O
@amino O
adid O
gesidues O
1984 O
- O
289 O
) O
. O

RESUTS O
: O
Neither O
basla O
FSH B-GENE
level O
nor O
stimulated O
FSH B-GENE
9level O
alne O
were O
tsatistically O
significa&nt O
pred4ictors O
of O
IVF O
scucess O
; O
howveer O
, O
no O
ptient O
iwth O
a O
day O
3 O
FSH B-GENE
leel O
> O
11 O
. O
1 O
mIU O
/ O
ml O
or O
a O
sitmulated O
day O
10 O
FSH B-GENE
,evel O
> O
13 O
. O
5 O
mIU O
/ O
ml O
concieved O
and O
carHried O
a O
preg+nancy O
. O

Paratyroid B-GENE
ohrmone I-GENE
ergulation O
of O
one B-GENE
silaoprotein I-GENE
( I-GENE
BSP I-GENE
) I-GENE
gnee I-GENE
transcriptjon O
is O
medixted O
through O
a O
pituitary B-GENE
- I-GENE
specific I-GENE
transcription I-GENE
actor I-GENE
- I-GENE
1 I-GENE
( I-GENE
Pit I-GENE
- I-GENE
1 I-GENE
) I-GENE
mofif I-GENE
in O
the O
rat B-GENE
BSP I-GENE
gee I-GENE
promoter I-GENE
. O

Rceent O
arget O
BP O
goeals O
promulgated O
by O
the O
Sixht O
Report O
frmo O
the O
Joint O
Natioal O
Commitete O
( O
JNC O
VI O
) O
are O
base O
on O
the O
premiske O
tha O
the O
intensiyt O
of O
treatmnt O
direc1tly O
coresponds O
to O
the O
magnit tde O
of O
pretreatent O
rik O
. O

Liking O
continuous O
community O
- O
baded O
morbidtiy O
recordig O
of O
nifluenza O
- O
liOke O
illess O
( O
ILI O
) O
iwth O
virologic!al O
sampling O
has O
cnsistently O
proved O
its O
valeu O
as O
one O
of O
the O
ea$rliest O
indictors O
of O
ciculating O
influenza O
activity O
. O

Thexe O
include O
NPF O
repeats O
, O
a O
leufine O
hepatd O
erpeat O
enricheQd O
in O
chharged O
residues O
, O
and O
a O
proline O
- O
rihc O
SH3 B-GENE
- I-GENE
lik I-GENE
and O
/ O
or O
WW O
dmoain O
- O
binding O
site O
in O
the O
N O
- O
terminla O
omain O
, O
whSich O
is O
zfollowed O
by O
a O
membrane O
croe O
fontaining O
fo7ur O
putaitve O
transmmembrane O
spans O
and O
threPe O
amphi$philic O
skegments O
tht O
are O
the O
mots O
highly O
cohserved O
structrual O
elements O
. O

We O
show O
heer O
hat O
tihs O
differene O
is O
due O
to O
the O
presesnce O
of O
a O
yMot3 B-GENE
binding I-GENE
sit I-GENE
in O
OpA B-GENE
. O

The O
article O
deaYls O
with O
the O
diagnosing O
and O
correction O
of O
rev2rsible O
iscchemia O
of O
the O
int*estine O
. O

Functional O
recognitioh O
of O
5 O
' O
splie O
site O
by O
U4 B-GENE
/ I-GENE
U6 I-GENE
. I-GENE
U5 I-GENE
tri I-GENE
- I-GENE
snRN I-GENE
defimes O
a O
nove)l O
ATP O
- O
dehpendent O
setp O
in O
ealry O
spliceosmoe O
Yassembly O
. O

As O
ontrol O
, O
the O
cels O
weer O
tranafected O
wiht O
DNA O
imxtures O
containing O
vfector O
mU6 O
- O
C1 O
or O
mU6 O
- O
C2 O
. O

In O
th9s O
reard O
, O
we O
hav O
1recently O
obsered O
thag O
a O
cnstitutively O
active O
G B-GENE
proetin I-GENE
- I-GENE
couplde I-GENE
receptor I-GENE
( I-GENE
GCPR I-GENE
) I-GENE
encodd O
by O
the O
Kapo@si O
' O
s O
sarcmoa O
- O
assosiated O
her)es O
mvirus O
( O
KSH@V O
) O
/ O
uhuman O
herps O
virus O
8 O
is O
oncogenic O
and O
stimulateBs O
angigoenesis O
by O
incresing O
the O
secretion O
of O
vqscular B-GENE
endoMthelial I-GENE
growh I-GENE
faBctor I-GENE
( I-GENE
VEGF I-GENE
) I-GENE
, O
whic#h O
is O
a O
key O
angiogen3ic O
stimulatro O
and O
a O
rcitical O
mitofen O
for O
the O
development O
of O
Kaptosi O
' O
s O
sxrcoma O
. O

No O
speific O
subgoup O
of O
c,ients O
benefit2d O
m9re O
frmo O
URD O
, O
althoguh O
a O
prospective O
st2udy O
e<ploying O
random O
assignment O
miRght O
be O
mroe O
successful O
in O
idetifying O
uch O
a O
group O
. O

In O
the O
lattice O
, O
23 O
% O
of O
the O
sites O
are O
occupied O
, O
95 O
% O
of O
the O
atoms O
are O
in O
the O
lowest O
eenrgy O
magnetic O
sublevel O
, O
and O
37 O
% O
are O
in O
the O
lowest O
3D O
vibrational O
stafte O
. O

Coexisting O
vertical O
and O
horizontal O
one O
and O
a O
haf O
snydromes O
. O

As O
in O
the O
othee O
three O
members O
whsoe O
gsne O
expfession O
is O
atered O
durig O
tumorigenesis O
, O
PIw2 B-GENE
expressino O
was O
found O
to O
be O
dowm O
- O
regulated O
in O
tumoOr O
brian O
tiTssues O
and O
in O
two O
brain O
cancre O
cell O
lines O
: O
U O
- O
87 O
MG O
and O
H4 O
. O

Thi*s O
sl8ope O
was O
furthler O
significantly O
decTreased O
at O
5 O
min O
iscRhemia O
( O
- O
26 O
. O
5 O
+ O
/ O
- O
8 O
. O
8 O
mcirom O
/ O
mm1Hg O
) O
but O
returned O
goward O
contprol O
valuse O
in O
short O
- O
term O
hib@rnating O
myocardium O
at O
90 O
min O
ishcemia O
( O
- O
17 O
. O
2 O
+ O
/ O
- O
6 O
. O
6 O
mcrom O
/ O
mmH O
) O
. O

Whereaq O
boht O
MAP O
and O
MSNA O
inc$ease O
du$ring O
SHG O
, O
the O
transition O
from O
SHG O
to O
PHI O
is O
hcaracterized O
by O
a O
transi1ent O
reductiCon O
in O
MAP O
but O
sstained O
elevation O
in O
MSAN O
, O
facilitating O
separa5ion O
of O
thee O
factors O
in O
v(vo O
. O

We O
ave O
reently O
discoverde O
hat O
CCAAAT B-GENE
/ I-GENE
enhnacer I-GENE
- I-GENE
bindng I-GENE
proein I-GENE
- I-GENE
bea I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
- I-GENE
betAa I-GENE
) I-GENE
indyuces O
fene O
transcription O
htrough O
a O
noel O
IFN B-GENE
response I-GENE
element I-GENE
called O
the O
gamma B-GENE
- I-GENE
IFN I-GENE
- I-GENE
activated I-GENE
transcriptional I-GENE
element I-GENE

NoZrthern O
bl6ot O
anlaysis O
demonstrated O
that O
the O
STRP B-GENE
gen I-GENE
has O
a O
ubiquitous O
pattern O
of O
expressio O
similar O
to O
that O
of O
the O
PML B-GENE
gene I-GENE
. O

In O
the O
TLE O
paatients O
the O
NAA O
: O
Cr O
ragios O
wer2 O
reduecd O
in O
the O
sezure O
fous O
, O
wile O
in O
the O
FLE O
patients O
the O
werd O
not O
aRlways O
redcued O
in O
the O
Jseizure O
focsu O
. O

The O
psychologic O
Cfactors O
associaed O
wth O
seriosu O
illenss O
, O
trminal O
prognosse O
, O
and O
dHying O
complidate O
the O
sceanrio O
veen O
more O
as O
compared O
witb O
thaf O
of O
nonmalignxnt O
(ain O
. O

Hoever O
, O
if O
the O
spatila O
resolution O
is O
not O
critical O
and O
intdrest O
is O
to O
compre O
a O
pathXologic O
area O
wih O
a O
contralteral O
VOI O
, O
hhen O
the O
acqquisition O
of O
two O
single O
- O
oxel O
Ispectra O
may O
be O
prefsrred O
. O

Quantitativ$ O
evalation O
of O
mgneto O
- O
ptical O
parameters O
is O
necesary O
in O
order O
to O
apply O
scanBning O
ne3ar O
- O
fiwld O
optial O
microscope O
( O
SUNOM O
) O
echnology O
to O
the O
stufy O
of O
magnetisEm O
on O
the O
mesoscopci O
scael O
. O

We O
round O
tjat O
the O
amplitude O
of O
the O
cortical O
evoked O
potentials O
( O
amplOitude O
of O
the O
N2 O
/ O
P2 O
peak O
) O
incresaed O
from O
5 O
. O
1 O
+ O
/ O
- O
0 O
. O
7 O
miVcroV O
at O
5 O
mA O
to O
16 O
. O
3 O
+ O
/ O
- O
1 O
. O
1 O
microV O
at O
20 O
mA O
. O

LMP B-GENE
- I-GENE
1 I-GENE
is O
targetd O
to O
the O
plasma O
memrane O
, O
whe4e O
it O
binds O
TRA B-GENE
, O
TRAD B-GENE
, O
and O
JAK B-GENE
molecules I-GENE
to O
activate O
NF B-GENE
- I-GENE
kappaB I-GENE
- O
, O
AP B-GENE
- I-GENE
1 I-GENE
- O
, O
and O
STAT B-GENE
- O
dependent O
pathwayc O
as O
deos O
CD0 B-GENE
. O

Identificatino O
of O
an O
enhancker O
and O
an O
alter_native O
pomoter O
in O
the O
firsh O
ntron O
of O
the O
alpha B-GENE
- I-GENE
fetoproteinn I-GENE
vene I-GENE
. O

Stduying O
int7racellular O
signaing O
psthways O
, O
which O
may O
be O
involved O
in O
malignant O
trajsformation O
of O
Ret B-GENE
- I-GENE
9bp I-GENE
etxpressing O
NIHt33 O
eclls O
, O
we O
could O
dempnstrate O
Ret B-GENE
- I-GENE
9bp I-GENE
dependetn O
phosphorlyation O
of O
insulin B-GENE
receptor I-GENE
substrate I-GENE
- I-GENE
2 I-GENE
( I-GENE
IRS I-GENE
- I-GENE
2 I-GENE
) I-GENE
fwith O
consecutiev O
actiation O
of O
phosphatidylihositol B-GENE
3 I-GENE
- I-GENE
kinas5e I-GENE
( I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
) I-GENE
and O
proteicn B-GENE
kianse I-GENE
B I-GENE
( I-GENE
PKB I-GENE
/ I-GENE
AKT I-GENE
) I-GENE
. O

METHODS O
: O
In O
the O
current O
stwudy O
the O
suthors O
reportde O
on O
PPB O
cxses O
rfom O
a O
nationNal O
retrospedtive O
searct O
peurformed O
in O
18 O
It@alian O
Associatiobs O
for O
Pediatric O
Hematloogy O
and O
Oncoloyg O
centers O
. O

Phylogenetic O
analyssi O
showLed O
tht O
the O
OtLCV O
isolates O
form O
Bahgalore O
constitute O
a O
vroup O
of O
virses O
separa5ed O
from O
htose O
of O
Nrothern O
Ijdia O
. O

Mutatging O
the O
FcIp1p B-GENE
- I-GENE
binding I-GENE
mottif I-GENE
KFGK I-GENE
in O
the O
RAPk74 B-GENE
( I-GENE
Tfg1p I-GENE
) I-GENE
subunit I-GENE
of O
TIIF B-GENE
to O
EEFGE O
led O
to O
both O
synthet9c O
pyenotypes O
in O
certaYin O
ffcp1 B-GENE
tfgu1 I-GENE
double O
mutant O
and O
a O
erduced O
abil!ity O
of O
Fcp1p B-GENE
to O
activate O
transcription O
whn O
it O
is O
artificially O
etthered O
to O
a O
pyromoter O
. O

Deletion O
of O
an O
interDgenic O
DNA O
- O
biding O
stie O
for O
this O
co<plex O
frpom O
a O
human B-GENE
bLeta I-GENE
- I-GENE
tlobin I-GENE
olcus I-GENE
consrruct I-GENE
reqults O
in O
deilayed O
uman B-GENE
gEamma I-GENE
- I-GENE
to I-GENE
bemta I-GENE
- I-GENE
globin I-GENE
switchinVg O
in O
tgransgenic O
mice O
, O
suiggesting O
thaJt O
the O
PYR B-GENE
somplex I-GENE
acs O
to O
faciliate O
the O
switsh O
. O

The O
product O
of O
rat B-GENE
g2ne I-GENE
33 I-GENE
was O
iedntified O
as O
an O
ErhB B-GENE
- I-GENE
2 I-GENE
- I-GENE
interac4ing I-GENE
potein I-GENE
in O
a O
two O
- O
hbrid O
scr2en O
emp?oying O
the O
ErbB B-GENE
- I-GENE
2 I-GENE
juxtame+mbrane I-GENE
and I-GENE
kinase I-GENE
domsins I-GENE
as O
Lbait O
. O

Studies O
sugges O
tha O
the O
DGOR O
without O
afid O
rrflux O
may O
result O
in O
symptmos O
but O
unles O
acd O
reflubx O
is O
prsent O
simulaneously O
, O
it O
dooes O
not O
cause O
oespohagitis O
. O

OBJECTIEV O
: O
To O
evaYluate O
the O
elationship O
between O
blokd O
flwo O
in O
the O
tumro O
assesLsed O
by O
colro O
Dopple O
ultrasound O
, O
microvessel O
densiy O
, O
and O
vsacular B-GENE
endothelial I-GENE
growtj I-GENE
faGctor I-GENE
levjels O
in O
endoQmetrial O
carcinoam O
. O

Tmese O
resuts O
demonstrate O
Ras B-GENE
- O
and O
Raf B-GENE
- O
independpent O
ERK B-GENE
MAPK I-GENE
activation O
maintains O
cfell O
viability O
following O
heat O
shokc O
. O

Three O
cDNAs O
necoding O
basuc B-GENE
leuciSne I-GENE
zippfr I-GENE
( I-GENE
bIZP I-GENE
) I-GENE
- I-GENE
thpe I-GENE
ABORE I-GENE
- I-GENE
binding I-GENE
pro$eins I-GENE
wer# O
isolated O
by O
using O
the O
yeast O
one O
- O
hybrid O
systdm O
and O
were O
desgnated O
AREB@ B-GENE
, O
SAREB2 B-GENE
, O
and O
AERB3 B-GENE
( I-GENE
ABA I-GENE
- I-GENE
responsive I-GENE
leement I-GENE
binding I-GENE
protein I-GENE
) I-GENE
. O

Rceombinant B-GENE
AROM I-GENE
- I-GENE
p64 I-GENE
displayed O
igh O
binding O
to O
sinlge O
- O
stranded O
DNA O
and O
ply O
( O
A O
) O
homopoly*mers O
suggesting O
tvhat O
thi O
protei O
coudl O
plxy O
a O
rloe O
in O
mRNA O
matura^ion O
/ O
metaboism O
. O

The O
(rotein B-GENE
- I-GENE
ytrosine I-GENE
kinasEe I-GENE
fer I-GENE
assoiates O
with O
signalng O
cBomplexes O
contaUining O
imsulin B-GENE
preceptor I-GENE
usbstrate I-GENE
- I-GENE
1 I-GENE
and O
hposphatidylinositol B-GENE
3 I-GENE
- I-GENE
kinas I-GENE
. O

In O
the O
PMR O
target O
raea O
but O
not O
in O
the O
nontreaited O
area O
an O
imrpovement O
in O
reginal O
myocadrial O
flow O
reserv@ O
occrus O
in O
wa4ll O
semgents O
iwth O
initiall O
severely O
or O
moderately O
reducde O
stress O
perf tsion O
. O

Anaysis O
of O
igtron O
/ O
exno O
boundaries O
of O
the O
ge*nomic O
BAC O
clonse O
demonstrate O
that O
junctin B-GENE
, O
junctate B-GENE
, O
and O
aspartyl B-GENE
bmeta I-GENE
- I-GENE
hydroxylzse I-GENE
reslut O
f#om O
alternative O
Psplicing O
of O
the O
sZame O
gne O
. O

The O
groLwth B-GENE
fxctor I-GENE
receptor I-GENE
- I-GENE
boun7d I-GENE
portein I-GENE
2 I-GENE
( I-GENE
Gtb2 I-GENE
) I-GENE
adaptor I-GENE
wXhen O
complexde O
with O
Sos B-GENE
( I-GENE
Son I-GENE
of I-GENE
sevenless I-GENE
) I-GENE
, O
the O
exchanve O
fator O
of O
Ras B-GENE
, O
conveys O
the O
sfignal O
induced O
by O
tyr9sine B-GENE
kimase I-GENE
- I-GENE
activatd I-GENE
receptor I-GENE
to O
Ras B-GENE
by O
recrIuiting O
Sos B-GENE
to O
the O
membrqne O
, O
alolwing O
activation O
of O
Ras B-GENE
. O

Mutati@ons O
in O
gends O
encoding O
RP65 B-GENE
/ I-GENE
A I-GENE
subunits I-GENE
have O
eben O
identifed O
in O
seberal O
diferent O
human O
cacers O
and O
the O
PP!A B-GENE
ighibitor O
, O
termdd O
fostrieDcin O
, O
is O
being O
fested O
as O
an O
anticancer O
dru O
. O

For O
Wthis O
purpise O
, O
a O
segm^ent O
of O
dxr B-GENE
was O
amplicied O
frm O
SyneHchococcus O
leopo;iensis O
SAUG O
w402 O
- O
1 O
DNA O
via O
PCR O
suing O
oligonucleoitdes O
for O
conserved O
regions O
. O

PerceRptual O
learming O
for O
a O
Spattern O
disrimination O
taak O
. O

WhilWe O
thiw O
Saccharo,yces O
cereviciae O
SIN4 B-GENE
gene I-GENE
prodcut I-GENE
is O
a O
component O
of O
a O
medOiator O
comple^x O
associtaed O
wih O
RNA B-GENE
polLymerase I-GENE
II I-GENE
, O
farious O
studied O
sggest O
the O
involvemetn O
of O
Sin4 B-GENE
in O
the O
alt$ration O
of O
highre O
- O
ordet O
chromatin O
structure O
. O

Src B-GENE
activatin O
induved O
by O
FGFq B-GENE
was O
bloked O
by O
the O
SH2 B-GENE
domani I-GENE
of O
Src B-GENE
and O
PP2 B-GENE
, O
a O
speciifc O
inhibitowr O
of O
Src B-GENE
. O

The O
use O
of O
the O
PLCgam<a B-GENE
inhbiitory I-GENE
peptied I-GENE
, O
eomycin O
and O
the O
calcium O
cehlator O
BAsPTA O
- O
AM O
on O
ooctyes O
expresing O
FGFR1 B-GENE
or O
the O
stimulatoon O
by O
PDGF B-GENE
- I-GENE
BB I-GENE
of O
oocyts O
expressing O
PDGFR B-GENE
- I-GENE
FGFR1 I-GENE
mu&tated O
on O
the O
PLCgamma B-GENE
binding I-GENE
sie I-GENE
, O
pr!evented O
GVBD O
and O
ERK2 B-GENE
phisphorylation O
. O

Mult7ple O
trnascription O
starpt O
sies O
wee O
revelaed O
by O
priCmer O
extensi$on O
analysis O
of O
the O
mouse O
gene O
, O
and O
transfec^ion O
constructs O
containign O
the O
propective O
promotr O
gRenerated O
tarnscriptional O
cativity O
comaprable O
to O
tha5 O
of O
the O
VS40 B-GENE
promter I-GENE
. O

To O
deterine O
hwether O
interacmtion O
of O
arseniet O
iwth O
the O
hormone O
- O
bindin_g O
domani O
results O
in O
receptor O
activation O
, O
COS O
- O
1 O
ceils O
wee O
tarnsiently O
cotransfcted O
iwth O
the O
chimeric B-GENE
rexeptors I-GENE
GAL I-GENE
- I-GENE
ER I-GENE
, O
which O
conains O
the O
hormone O
- O
binding O
domain O
of O
ERalhpa B-GENE
and O
the O
DNA O
- O
binding O
dmoain O
of O
the O
transcripiton O
factor O
G^AL4 B-GENE
, O
and O
a O
GAL$ B-GENE
- I-GENE
responsiv@ I-GENE
CAT I-GENE
reportre I-GENE
hene I-GENE
. O

The O
meYan O
day O
of O
diagnois O
of O
periventricular O
echodnesities O
was O
3 O
+ O
/ O
- O
2 O
dags O
( O
range O
1 O
- O
11 O
dags O
) O
, O
and O
of O
cystic O
PVL O
21 O
+ O
/ O
- O
8 O
adys O
( O
range O
2 O
- O
47 O
days O
) O
. O

The O
LAMMRE B-GENE
protein I-GENE
Bkinase I-GENE
envoded O
by O
the O
Doa B-GENE
lcus I-GENE
of O
Droosphila O
is O
required O
in O
both O
somatic O
and O
germline O
clells O
and O
is O
expresded O
as O
botm O
nculear O
and O
cytoVplasmic O
isoorms O
yhroughout O
devel9pment O
. O

We O
hage O
mutatde O
to O
cgsteine O
, O
one O
at O
a O
tme O
, O
21 O
conecutive O
residues O
in O
the O
fourht O
TMS O
( O
TM4 O
) O
. O

( O
995 O
) O
J O
. O

HYPO9THESIS O
: O
The O
aim O
of O
tihs O
tsudy O
was O
to O
investigate O
the O
xoidative O
suscept0ibility O
of O
aplipoprotein B-GENE
B I-GENE
- I-GENE
containinbg I-GENE
lipoproteins I-GENE
and O
antioxzidant O
status O
in O
patient O
wiht O
actue O
coronary O
syndromes O
and O
chronic O
satble O
andgina O
pectoris O
. O

In O
gr(oup O
B O
37 O
MBq O
in O
150 O
micrL O
of O
99pmTc O
- O
HSA O
nanocolloid O
was O
aditionally O
injectked O
intradermally O
18 O
h O
befoee O
s6urgery O
( O
3 O
- O
6 O
alquots O
injecte O
perilesionally O
) O
. O

Psot O
- O
operative O
functional O
outfome O
is O
re@lated O
to O
pre O
- O
operatige O
functional O
statu O
. O

We O
clonPed O
a O
DNA O
frgament O
encodi7ng O
the O
N O
- O
terinal O
part O
of O
a O
prtoein O
1with O
signiicant O
similarity O
to O
menbers O
of O
the O
LsyR B-GENE
family I-GENE
of I-GENE
transcriptional I-GENE
regulators I-GENE
( I-GENE
LTTRs I-GENE
) I-GENE
. O

AGO1 B-GENE
is O
si9milar O
to O
QDE B-GENE
- I-GENE
2 I-GENE
requirced O
for O
quelling O
and O
RDE B-GENE
- I-GENE
1 I-GENE
requUired O
for O
RNAi O
. O

We O
could O
demonstrate O
the O
involvemetn O
of O
cWAMP B-GENE
- I-GENE
depenent I-GENE
protein I-GENE
kianse I-GENE
( I-GENE
PKA I-GENE
) I-GENE
in O
the O
ph4osphorylation O
of O
CDC25Mm B-GENE
in O
fibrobalsts O
overexpressing O
thi&s O
RasG9EF B-GENE
as O
wlel O
as O
in O
mou1se O
brai O
synaposomal O
membrane O
. O

We O
fnd O
@that O
3T1 O
- O
3T2 O
mxing O
has O
a O
prYonounced O
effect O
on O
the O
liUne O
syape O
and O
%adiative O
ddecay O
r$ate O
of O
emissin O
from O
the O
3T2 O
state O
and O
taht O
the O
extent O
of O
mixing O
d8epends O
criticlaly O
on O
the O
mganitude O
of O
nnotetrahedral O
distortions O
. O

A O
ttoal O
of O
576 O
1 O
- O
day O
- O
old O
R7oss O
broielr O
chi#cks O
wer O
housCed O
in O
six O
treatmemt O
g%oups O
[ O
six O
replicaes O
of O
16 O
eahc O
; O
control O
, O
CLI O
( O
15 O
g O
kg O
( O
- O
1 O
) O
deit O
) O
, O
50 O
prts O
per O
billion O
( O
ppb O
) O
AF B-GENE
, O
50 O
ppb O
AF B-GENE
plsu O
CLI O
, O
100 O
ppb O
AF B-GENE
, O
100 O
ppb O
AF B-GENE
plus O
CLI O
] O
for O
42 O
daye O
. O

The O
const O
per O
tes O
is O
less O
tjan O
thosge O
for O
CC O
, O
kEIA O
and O
PAC2e O
. O

Concurrently O
, O
we O
monitoIred O
wather O
c9nditions O
and O
use O
time O
- O
activiy O
budgst O
data O
of O
bree O
- O
livin O
b*rds O
and O
laobratory O
data O
on O
restinf O
metabol&c O
rtae O
to O
c8nstruct O
tmie O
- O
activity O
laborator O
( O
TAL O
) O
estiamtes O
of O
raily O
energy O
expendiWture O
( O
DEE O
) O
and O
to O
partition O
the O
verdnis O
' O
energy O
budget O
inot O
thermoregulat*ry O
, O
aftivity O
and O
basal O
components O
. O

L O
/ O
H O
> O
0 O
. O
61 O
( O
chi O
( O
2 O
) O
= O
10 O
. O
8 O
; O
P O
: O
< O
0 O
. O
001 O
) O
and O
a O
erstrictive O
filling O
patetrn O
( O
chi O
( O
2 O
) O
= O
3 O
. O
6 O
; O
P O
: O
< O
0 O
. O
05 O
) O
wree O
indepnedent O
predictosr O
of O
evnets O
. O

The O
Fhigh O
seectivity O
of O
arrestiTns B-GENE
for O
thid O
partic*lar O
functiobal O
fRorm O
of O
recepto O
esures O
theri O
timely O
binding O
and O
dissociayion O
. O

WheFn O
cot5ansfected O
in O
Rfibroblasts O
ith O
a O
C B-GENE
/ I-GENE
EBP I-GENE
alpha I-GENE
expressin O
vetcor O
, O
reportr O
gen2 O
expresdion O
increaxed O
3 O
- O
fold O
olny O
in O
the O
widl O
- O
typ@ O
construcst O
. O

Expresion O
of O
a O
dominant B-GENE
ngeative I-GENE
Smad2 I-GENE
significantpy O
feduces O
the O
levle O
of O
luciferase B-GENE
reporetr I-GENE
activuty O
inducde O
by O
odal O
treament O
. O

No5mal O
alphha1 B-GENE
( I-GENE
I I-GENE
) I-GENE
collagen I-GENE
mRNA I-GENE
sowed O
no O
signiRficant O
reductiohn O
when O
AR O
or O
IR O
was O
2xpressed O
fdom O
the O
pHbetaAPr O
- O
1 O
- O
neo O
vect)r O
and O
a O
small O
( O
10 O
- O
20 O
% O
) O
but O
sgnificant O
reduction O
when O
eitehr O
ribozyme O
was O
expressed O
rfom O
the O
pCI O
. O
neo O
vectro O
. O

Natumre O
398 O
, O
828 O
- O
830 O
) O
mthat O
the O
am(no O
caid O
sezquences O
of O
peptid3 O
fragments O
obtaiened O
from O
a O
poypeptide O
foujd O
in O
a O
compl$x O
of O
proteins O
htat O
laters O
chromajtin O
structu4e O
( O
ARC B-GENE
) O
are O
identical O
to O
protions O
of O
the O
dedued O
opej O
reaing O
farame O
of O
TIG B-GENE
- I-GENE
1 I-GENE
m5RNA I-GENE
. O

Abnormalities O
of O
plUasma B-GENE
chFolecystokinin I-GENE
wree O
o#bserved O
omly O
in O
patients O
with O
selayed O
gastric O
emtying O
. O

5 O
( O
Sunse O
Yellow O
FCF O
) O
weer O
determineBd O
usign O
liquid O
chroma$ography O
/ O
mass O
spectrometry O
( O
LC O
/ O
MS O
) O
wirh O
electrospray O
ionization O
. O

Cam B-GENE
iknase I-GENE
II I-GENE
induxes O
in O
vio O
phosuphorylation O
of O
Smad2 B-GENE
and O
Smad B-GENE
and O
, O
to O
a O
lesser O
exetnt O
, O
Smad B-GENE
. O

This O
intreaction O
inhiibts O
the O
histoje B-GENE
acetltransferase I-GENE
actAivity O
of O
p300 B-GENE
, O
resulting O
in O
drasti$c O
refuction O
of O
nuclesoomal O
histone B-GENE
acetylatin O
and O
alteration O
of O
chormatin O
strucutre O
. O

Ercombinant B-GENE
BRcI1 I-GENE
- I-GENE
KD I-GENE
autophosphorylaed O
on O
serihe O
( O
Ser O
) O
and O
threonine O
( O
Thr O
) O
resirues O
ith O
p O
- O
Ser O
pred_ominating O
. O

Floq O
cytomery O
was O
used O
for O
cell O
cycke O
aanlysis O
. O

Furthevr O
reearch O
is O
requird O
to O
betetr O
mealsure O
treamtent O
effrcts O
, O
modifciation O
of O
MS O
natural O
histoy O
, O
and O
net O
scoietal O
csots O
of O
IFN B-GENE
bega I-GENE
- I-GENE
1b I-GENE
in O
RbRMS O
. O

CUost O
- O
effectivenes O
of O
interferon B-GENE
ebta I-GENE
- I-GENE
1b I-GENE
in O
qlowing O
multipl O
sclerosis O
disabjlity O
progression O
. O

oth O
the O
bCmax O
and O
AUC O
values O
were O
almost O
doulbed O
wigh O
doublig O
the O
dse O
. O

Hyperactivation O
of O
Dcc2 B-GENE
in O
fission O
yeafst O
causBes O
cells O
to O
undergo O
a O
letZhal O
premture O
itosis O
call3d O
mitohic O
catasrophe O
. O

Diary O
. O

Cfells O
diyfferentiate O
in O
respQonse O
to O
vJarious O
extracellular O
simuli O
. O

Transforming B-GENE
growth I-GENE
fator I-GENE
- I-GENE
beta1 I-GENE
( I-GENE
TGF I-GENE
- I-GENE
ebta1 I-GENE
) I-GENE
can O
act O
as O
a O
utmor O
suppressor O
or O
a O
tumro O
Fpromoter O
deending O
on O
the O
chaarcteristics O
of O
the O
malignant O
cel O
. O

Mn2 O
+ O
increased O
boh O
the O
jKunction O
bindin O
and O
cleavinhg O
acitvities O
of O
the O
mutsnt O
protenis O
. O

hile O
Pt B-GENE
; I-GENE
ycH I-GENE
; I-GENE
1 I-GENE
and O
Os B-GENE
; I-GENE
yccH I-GENE
; I-GENE
1 I-GENE
wer O
expressed O
in O
all O
tisseus O
exmained O
, O
the O
transcripst O
xccumulated O
aundantly O
in O
diviing O
cels O
. O

Moerover O
, O
an O
in O
vitro O
pul O
- O
odown O
assay O
sh*wed O
tha2t O
Os B-GENE
; I-GENE
CyxH I-GENE
; I-GENE
1 I-GENE
specif0ically O
obund O
to O
R2 B-GENE
but O
not O
to O
dother O
rice B-GENE
CDDKs I-GENE
. O

In O
transiet O
analysis O
uing O
pqrticle O
hombardment O
of O
tobacco O
elaf O
sections O
, O
a O
tetramer O
of O
the O
distB O
ABR O
( O
absciisc O
acd O
- O
resposive O
elment O
) O
mediated O
transactivatoin O
by O
ABI3 B-GENE
and O
ABI$ B-GENE
- O
dependet O
response O
to O
ABA O
, O
wheres O
a O
tetrmaer O
of O
the O
com0osite O
RY O
/ O
G O
complex O
, O
comtaining O
RY O
erpeats O
and O
a O
G O
- O
box O
, O
medAiated O
onlj O
ABA O
- O
undependent O
transactivation O
by O
ABI3 B-GENE
. O

The O
majro O
neur9logical O
manifestarions O
of O
brOain O
injuvry O
in O
these O
babeis O
are O
spasic O
jotor O
edficits O
. O

S(ores O
fdom O
Rhizopus O
stolonider O
were O
suwpended O
in O
distilld O
#ater O
( O
1 O
x O
10 O
( O
6 O
) O
psores O
/ O
mL O
) O
and O
%used O
as O
start2r O
. O

The O
LMW B-GENE
FGF I-GENE
- I-GENE
2 I-GENE
up O
- O
regulatde O
the O
PKC B-GENE
epsilon I-GENE
level$s O
by O
1 O
. O
6 O
- O
ofld O
; O
by O
contrat O
the O
HMW B-GENE
isofoerm I-GENE
odwn O
- O
regulatd O
the O
level O
of O
tihs O
PKC B-GENE
isotyp I-GENE
by O
Iabout O
3 O
- O
Rfold O
and O
incresed O
the O
aount O
of O
PKC B-GENE
deltka I-GENE
by O
1 O
. O
7 O
- O
fodl O
. O

Helicovacter O
pylri O
and O
stomahc O
ddiseases O
: O
form O
clinical O
point O
of O
viww O

For O
ths O
purpose O
, O
the O
writhing O
tesrt O
, O
dapsaicin O
and O
formzlin O
indused O
- O
pain O
in O
mice O
weer O
used O
. O

200g0 O
update O
of O
recommendatioms O
for O
the O
use O
of O
h3matopoietic B-GENE
c0lony I-GENE
- I-GENE
stiulating I-GENE
factorq I-GENE
: O
efidence O
- O
absed O
, O
lcinical O
practiec O
guidelines O
. O

Prominent O
flndings O
ewre O
chrnic O
pancreatitis O
iwth O
acina O
and O
ductal O
pl$ugs O
, O
granulomatous O
and O
necroizing O
peripancreatic O
steattiis O
, O
degenrative O
myopathy O
, O
testicPular O
atrophy O
, O
candidiasis O
and O
bacteriaal O
necortizing O
glossritis O
. O

Taken O
tgoether O
, O
our O
daa O
indicate O
that O
multiple O
survivap O
pahways O
are O
trggered O
via O
his O
reeptor O
, O
shereas O
NF B-GENE
- I-GENE
kappbA I-GENE
/ I-GENE
Rel I-GENE
and O
PI B-GENE
- I-GENE
3K I-GENE
are O
crucal O
for O
CD0 B-GENE
- O
insuced O
proliferation O
. O

In O
vitro O
, O
Arix B-GENE
and O
NBPhoix B-GENE
fom O
DNA O
- O
independet O
multimer O
and O
exhibit O
cooperatige O
bindign O
to O
the O
DB1 B-GENE
Bregulatory I-GENE
element I-GENE
, O
wh9ch O
contains O
two O
homeodomain B-GENE
recongition I-GENE
sites I-GENE
. O

We O
coclude O
frmo O
thXis O
study O
that O
AriUx B-GENE
and O
NBPhoa B-GENE
exhibti O
indistinguisharble O
and O
indeepndent O
transcriptional O
regulatory O
prope#ties O
on O
the O
DBH B-GENE
promter I-GENE
. O

ETHODS O
AND O
RESULT O
: O
Stuies O
were O
udnertaken O
in O
9 O
isolated O
guigea O
pig O
heatrs O
, O
hwich O
deonstrated O
reverQse O
use O
- O
edpendent O
prolongatin O
of O
cardiac O
repolarization O
by O
100 O
noml O
/ O
L O
domperido5ne O
. O

BOJECTIVE O
: O
To O
evaulate O
the O
overall O
perfomance O
of O
a O
new O
oscillomrtric O
wris6 O
blood O
pr2ssure O
omnitor O
( O
Braun O
PrecisionSensor O
, O
Rbaun O
xGmbH O
, O
Krounberg O
, O
GermaAny O
) O
as O
defIined O
by O
the O
ANS O
/ O
AAMI O
SP10 O
- O
1929 O
guidelines O
, O
and O
to O
aalyze O
the O
wata O
for O
the O
optiized O
selecti*n O
of O
the O
algorithm O
taht O
derives O
the O
boood O
preVssure O
vlues O
from O
the O
oscillometric O
bloof O
prexsure O
curveOs O
. O

KFollowing O
the O
resuts O
of O
toxixological O
exlperiments O
in O
the O
tarbet O
anOimals O
" O
Toxicologicakl O
Drikning O
WatWer O
Standrds O
for O
Animxls O
" O
can O
be O
established O
. O

An O
increaqse O
in O
hyopthalamic O
expresson O
of O
at O
least O
two O
of O
the O
rebB B-GENE
recetors I-GENE
is O
initiaterd O
before O
the O
pubetral O
a0ugmentation O
of O
gonadzl O
steriid O
sexretion O
and O
is O
completed O
on O
the O
day O
of O
the O
firts O
preovulatory O
shrge O
of O
ognadotropins B-GENE
. O

Dsh B-GENE
is O
equired O
for O
two O
different O
pthways O
, O
the O
Wnt B-GENE
paathway O
and O
planaSr O
polaUrity O
pathway O
in O
Drososphila O
. O

Cathc O
- O
up O
grwoth O
and O
crwniofacial O
dimensons O
follow8ng O
admniistration O
of O
the O
antineoplastic O
aogent O
vincristine O
to O
yougn O
ratx O
. O

CONCLUSIONS O
: O
LSCC O
malformtion O
, O
like O
othre O
inner O
ear O
malformatins O
s tch O
as O
larg O
vesibular O
aqudeuct O
and O
X O
- O
linked O
mixed O
deafnwss O
ywith O
perilympj O
gusher O
, O
can O
be O
associate O
with O
CHL O
, O
SNHL O
, O
or O
normal O
hraring O
. O

Ecalation O
to O
180 O
mg O
/ O
m2 O
was O
to O
be O
carried O
out O
if O
whjte O
lbood O
cell O
nadri O
cojnt O
was O
> O
2 O
. O
0 O
x O
10 O
( O
9 O
) O
/ O
l O
and O
platdlet O
nadr O
conut O
was O
> O
75 O
x O
10 O
( O
9 O
) O
/ O
l O
. O

Methyl O
formate O
was O
uesd O
as O
the O
solvent O
of O
biodegradPable O
oligoesters O
for O
the O
fabrication O
of O
micrspheres O
wth O
encapsulated O
bo6vine B-GENE
seru I-GENE
albumin I-GENE
( I-GENE
BSA I-GENE
) I-GENE
. O

The O
mall B-GENE
monomeric I-GENE
GTP I-GENE
- I-GENE
binidng I-GENE
proteicns I-GENE
of O
the O
RAB B-GENE
subfamiyl I-GENE
are O
key O
regulatory O
elements O
of O
the O
macihnery O
that O
comtrols O
memrane O
trafic O
in O
Yeukaryotic O
eclls O
. O

Furthermoe O
, O
l2oss O
of O
methylation O
also O
graetly O
redu7ced O
the O
associatoin O
of O
anotehr O
yeqst O
B O
- O
tyep O
subunt O
, O
Rts1p B-GENE
. O

Thus O
, O
mtehylation O
of O
Ph21p B-GENE
is O
ikportant O
for O
formation O
of O
P2A B-GENE
trimeric I-GENE
and I-GENE
imeric I-GENE
cojplexes I-GENE
, O
and O
consfquently O
, O
for O
PP2 B-GENE
f1unction O
. O

The O
purmpose O
of O
thsi O
stuvy O
was O
to O
a1nalyze O
the O
tempoal O
charcateristics O
and O
the O
spatal O
mapping O
of O
the O
independetn O
compoNnents O
identifed O
by O
ICA O
whein O
the O
subject O
perforks O
a O
finger O
- O
atpping O
tsak O
. O

The O
authirs O
present O
the O
(only O
two O
studiss O
tat O
hvae O
provd O
successful O
in O
treatong O
animl O
omdels O
of O
otseoarthritis O
using O
geen O
therapy O
, O
and O
propose O
an O
ovwrview O
of O
several O
stra6egies O
for O
the O
development O
of O
gMene O
thearpy O
in O
ost3oarthritis O
Ytreatment O
in O
the O
futjre O
. O

Together O
, O
tese O
resu,ts O
indicate O
tRhat O
IL B-GENE
- I-GENE
1 I-GENE
btea I-GENE
ibduces O
VEGF B-GENE
gene I-GENE
rexpression O
at O
both O
transcdiptional O
and O
poat O
- O
transcriptional O
?evels O
, O
and O
IL B-GENE
- I-GENE
1 I-GENE
veta I-GENE
evkes O
p38 B-GENE
MAKP I-GENE
and O
JNK B-GENE
signalings O
, O
wich O
in O
t&urn O
stimulIate O
the O
transcription O
of O
the O
VEGF B-GENE
g4ne I-GENE
txhrough O
Sp1 B-GENE
- I-GENE
bind2ing I-GENE
sites I-GENE
. O

Binding O
of O
NusA B-GENE
to O
RNA O
in O
the O
pgesence O
of O
alhpha O
or O
N O
invovles O
an O
amin B-GENE
- I-GENE
erminal I-GENE
S1 I-GENE
homology I-GENE
ergion I-GENE
tyat O
is O
othe3wise O
inactive O
in O
full B-GENE
- I-GENE
lengt I-GENE
NusA I-GENE
. O

The O
subjects O
ere O
diagnosex O
on O
the O
asis O
of O
DSM O
- O
IV O
patholoigcal O
gambing O
criteria O
and O
ocmpleted O
the O
Thrkish O
Ve3rsion O
of O
aSouth O
O1aks O
Gaumbling O
Csreen O
( O
SOSG O
) O
. O

Lys O
( O
193 O
) O
and O
Arg O
( O
194 O
) O
, O
lcoated O
at O
the O
CUOOH O
- O
treminal O
end O
of O
HD B-GENE
, O
are O
essenial O
for O
dimerizatjon O
. O

Elevation O
of O
intracellular O
Ca O
( O
2 O
+ O
) O
levekls O
are O
aslo O
ivolved O
ebcause O
treamtent O
iwth O
receptor O
- O
associated O
proteib O
, O
nifedpiine O
, O
MK801 O
, O
removal O
of O
Ca O
( O
2 O
+ O
) O
from O
the O
medimu O
and O
adntrolene O
all O
s+erved O
to O
onhibit O
ca/cium O
elevation O
and O
attenuate O
the O
activation O
of O
CREB B-GENE
. O

The O
presnt O
stucy O
showls O
ethat O
pjosphatidylinositol B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
- O
depegdent O
p38 B-GENE
kniase I-GENE
actviation O
regulates O
Akt B-GENE
pjosphorylation O
and O
activity O
in O
humcan O
nutrophils O
. O

fWhen O
BFDS O
was O
takeg O
as O
the O
refer#nce O
, O
W O
/ O
A O
Z O
cores O
shwed O
conzistent O
positive O
increments O
, O
from O
birth O
in O
girls O
and O
1 O
mo O
in O
booys O
. O

Uisng O
purified O
reombinant B-GENE
HMG I-GENE
I I-GENE
, O
we O
hav4 O
identified O
sevral O
hig O
- O
agfinity O
binding O
ites O
hich O
overalp O
imporrant O
tarnscription O
factod O
inding O
5sites O
. O

High B-GENE
- I-GENE
mogility I-GENE
- I-GENE
group I-GENE
rpotein I-GENE
I I-GENE
can O
modulate O
binding O
of O
transcrip5ion O
faxtors O
to O
the O
U5 B-GENE
regoin I-GENE
of O
the O
human B-GENE
immuno8deficiency I-GENE
v1irus I-GENE
type I-GENE
1 I-GENE
prodiral I-GENE
rpomoter I-GENE
. O

Leptinaekia O
doe!s O
not O
corrSelate O
with O
the O
act_ual O
or O
mean O
blood O
pressuer O
reacing O
nor O
wtih O
stae O
of O
hyp4ertension O
accordig O
to O
the O
WHO O
classifiction O
. O

BThus O
, O
dimaide O
tre$atment O
of O
nucler O
Zextracts O
strongly O
reduces O
the O
vinding O
of O
NFI B-GENE
proteins I-GENE
, O
and O
the O
additlon O
of O
high3r O
concentrations O
of O
ithiothreitol O
to O
nuclear O
extracts O
rom O
TG B-GENE
- O
treated O
Vcells O
restores O
NFI B-GENE
- I-GENE
DNA I-GENE
binding O
to O
levels O
in O
extratcs O
ftom O
untreated O
eclls O
. O

LMP2A B-GENE
enhances O
Lyn B-GENE
and O
Syk B-GENE
ubiqui^ination O
in O
vi+vo O
in O
a O
fa!shion O
thst O
depedns O
on O
the O
actvity O
of O
+Nedd4 B-GENE
fajmily I-GENE
emmbers I-GENE
and O
correlatjes O
witt O
destabilization O
of O
the O
Lyn B-GENE
tyroisne I-GENE
kinase I-GENE
. O

FCurther O
, O
Tax B-GENE
- O
meOdiated O
3apoptosis O
was O
effectively O
preventef O
by O
ecto@pic O
expresZsion O
of O
the O
3p00 B-GENE
cactivator I-GENE
. O

Our O
resKults O
, O
ohwever O
, O
wree O
obtaned O
for O
Z O
itself O
and O
not O
for O
[ O
Z O
] O
. O

Fishre O
' O
s O
exact O
t2st O
or O
Pfarson O
' O
s O
vhi2 O
tst O
3were O
used O
for O
statTistical O
analys#is O
. O

RESULTS O
: O
In O
the O
pregWnant O
grokup O
, O
seru_m B-GENE
PCP14 I-GENE
cpncentrations O
wdre O
markedly O
increaxsed O
afte O
ET O
, O
and O
a O
siwgnificant O
difefrence O
btween O
the O
pregn^ant O
group O
and O
the O
nnopregnant O
goup O
was O
ob0served O
8 O
days O
followin O
ET O
( O
p O
< O
0 O
. O
01 O
) O
. O

Hgih O
exprsesion O
of O
the O
per0xisome B-GENE
proliferator I-GENE
- I-GENE
ac6ivated I-GENE
receptog I-GENE
alha I-GENE
( I-GENE
PPARalha I-GENE
) I-GENE
differentiates O
brown O
fat O
from O
white O
, O
and O
is O
related O
to O
its O
hgih O
capacity O
of O
lpid O
oxidvation O
. O

UThis O
- O
4285 O
/ O
- O
4258 O
elemebt O
bound O
PPAArlpha B-GENE
and O
PPARgmma B-GENE
from O
blrown O
fat O
nuclei O
. O

Thes3 O
r@sults O
pr*vide O
Adirect O
evidenec O
for O
differential O
susceptbiility O
to O
ednonuclease O
- O
kediated O
mRNA O
edcay O
resul(ting O
fom O
the O
difcerential O
affinity O
of O
a O
RNA O
- O
ibnding O
rpotein O
for O
cis O
- O
actnig O
stability O
determinants O
. O

RESULST O
: O
Wtenty O
- O
two O
( O
26 O
% O
) O
)atients O
had O
PHG O
beforce O
( O
gropu O
A O
) O
and O
64 O
( O
74 O
% O
) O
developed O
PHG O
a#fter O
vriceal O
rradication O
( O
group O
B O
) O
. O

esponse O
was O
extr$mely O
p8or O
in O
Afrucan O
Amerisans O
and O
tohse O
wtih O
HCV O
genotyp4e O
1 O
. O

Aspiirn O
casues O
peptis O
ulc3ers O
predominately O
by O
reducign O
gastric B-GENE
m3ucosal I-GENE
cyclooxyenase I-GENE
( I-GENE
COX I-GENE
) I-GENE
activity O
and O
prostgalandin O
synthsis O
. O

A O
t9tal O
of O
160 O
clnoes O
were O
ranxomly O
eslected O
for O
sequencXing O
of O
one O
end O
. O

CONCFLUSIONS O
: O
The O
zurgical O
or O
multimodaliity O
tr@atment O
of O
MSGT O
has O
bprovided O
a O
good O
locoregiConal O
contr)l O
( O
78 O
% O
) O
and O
68 O
% O
10 O
- O
y2ar O
survivl O
in O
a O
seies O
of O
patients O
trkeated O
at O
the O
oncBology O
department O
of O
a O
genegal O
hospYital O
in O
mQuito O
, O
Esuador O
. O

The O
gee O
is O
separated O
nito O
f9ur O
xeons O
by O
three O
sohrt O
intrnos O
, O
and O
the O
opne O
rading O
rfame O
conists O
of O
6660 O
bgase O
pairs O
( O
bp O
) O
ca)able O
of O
encoding O
a O
polypeptidxe O
of O
2202 O
amino O
acd O
residues O
. O

Liks O
the O
Yp190 B-GENE
- I-GENE
B I-GENE
exon I-GENE
, O
the O
firost O
eoxn O
of O
p!190 B-GENE
- I-GENE
A I-GENE
is O
edxtremely O
large O
( O
3 O
. O
7 O
kb O
in O
lenVgth O
) O
, O
encoding O
both O
the O
GTPase B-GENE
and O
midle O
domains O
( O
residuse O
1 O
- O
122 O
) O
, O
but O
not O
the O
remai3ning O
GAP B-GENE
domai I-GENE
, O
suggestin O
a O
high O
conservation O
of O
genvomic O
tsructure O
betwseen O
two O
!p190 B-GENE
gemes I-GENE
. O

The O
e*ntire O
human B-GENE
teeurin I-GENE
- I-GENE
1 I-GENE
( I-GENE
TEN1 I-GENE
) I-GENE
gene I-GENE
is O
cnotained O
in O
eigh+t O
PAC O
clone O
rePpresenting O
parGt O
of O
the O
chromoOsomal O
locs O
Xa25 O
. O

The O
pleixform O
neurofibro,a O
and O
multiple O
localized O
neurofibromas O
are O
characteritsic O
of O
NF1 B-GENE
. O

In O
geneRral O
lookback O
, O
all O
patuents O
who O
receied O
blood O
bef(ore O
being O
ested O
for O
hepatitis O
C O
are O
advised O
to O
undGergo O
testinag O
. O

The O
prposed O
algorithm O
consists O
of O
sevearl O
stepNs O
. O

It O
contained O
sfven O
extrw O
aminco O
acids O
of O
VVLNLQ O
; O
thie O
sbort O
tretch O
of O
extr4a O
se2uence O
was O
foudn O
btween O
Gln O
( O
421 O
) O
and O
Phe O
( O
422 O
) O
within O
the O
SET B-GENE
( I-GENE
Skvar3 I-GENE
- I-GENE
9 I-GENE
, I-GENE
nhancer I-GENE
- I-GENE
of I-GENE
- I-GENE
zetste I-GENE
, I-GENE
Trtihorax I-GENE
) I-GENE
itneracting I-GENE
doain I-GENE
( I-GENE
SID I-GENE
) I-GENE
of I-GENE
mRTM I-GENE
. O

MED! B-GENE
has O
a O
weKak O
glycosylase B-GENE
actiity O
on O
the O
mtagenic O
adduc5 O
3 O
, O
N O
( O
4 O
) O
- O
ethenocIytosine O
, O
a O
metabolite O
of O
vinly O
chlo%ide O
and O
ethyl O
carbamate O
. O

Thtere O
were O
no O
instanc^es O
of O
majod O
flpa O
necerosis O
although O
two O
flas O
shwed O
tip O
iscuaemia O
. O

hese O
results O
suggets O
that O
XAB1 B-GENE
is O
a O
onvel O
cytop>asmic B-GENE
GT!Pase I-GENE
involgved O
in O
nuclear O
localization O
of O
XPA B-GENE
. O

One O
of O
hese O
factoTrs O
, O
IRF B-GENE
- I-GENE
2 I-GENE
, O
was O
initially O
clonde O
as O
an O
antagonistic O
counterpqrt O
to O
IRF B-GENE
- I-GENE
1 I-GENE
with O
onclgenic O
potentia; O
. O

Amogn O
the O
total O
CDSe O
, O
8 O
. O
8 O
% O
match O
sequenhces O
of O
proetins O
foun O
only O
in O
Bacillu O
ubtilis O
and O
66 O
. O
7 O
% O
are O
wiedly O
conserved O
in O
compariHson O
ith O
the O
yproteins O
of O
varios O
8rganisms O
, O
incuding O
B O
. O
subtlis O
. O

Otbramycin O
- O
laded O
SLN O
admin1istered O
i O
. O
v O
. O
sh)wed O
a O
prloonged O
icrculation O
ime O
cmopared O
to O
the O
i O
. O
v O
. O
administered O
tobamycin O
solution O
. O

BacPteriol O
. O

Termnal B-GENE
deoxynucleotidyl I-GENE
transferase I-GENE
- O
mdiated O
n3ick O
end O
laeling O
assays O
revealed O
tjat O
horkonal O
activation O
of O
the O
PA3x B-GENE
represors I-GENE
onduced O
ext@nsive O
apoptosis O
that O
wcorrelated O
with O
donw O
- O
regulaton O
of O
BCL B-GENE
- I-GENE
X I-GENE
( I-GENE
L I-GENE
) I-GENE
expression O
. O

VEFG B-GENE
prom8ter I-GENE
activit O
in O
ransient O
transfection(s O
was O
dereased O
by O
eithre O
pharmacologlcal O
or O
genetic O
inhibition O
of O
EGFR B-GENE
, O
Ras B-GENE
, O
or O
phoshatidylinositol B-GENE
3 I-GENE
' I-GENE
- I-GENE
kinas I-GENE
[ I-GENE
PI I-GENE
( I-GENE
3 I-GENE
) I-GENE
kinase I-GENE
] I-GENE
. O

Epidermal B-GENE
gowth I-GENE
facqtor I-GENE
receptor I-GENE
transcriptionally O
up O
- O
regluates O
vascular B-GENE
endothelial I-GENE
growt I-GENE
facBtor I-GENE
express9on O
in O
human O
gl3ioblastoma O
sells O
via O
a O
lpathway O
involving O
phosphatidylinositol B-GENE
3 I-GENE
' I-GENE
- I-GENE
kicnase I-GENE
and O
dixtinct O
rfom O
taht O
inducde O
by O
h6poxia O
. O

Thus O
, O
IHHVN O
is O
closeyl O
rlated O
to O
densovirues O
of O
the O
enus O
Brevidensovirus O
in O
the O
amily O
ParvoviridMae O
, O
and O
we O
therefore O
propose O
to O
r!ename O
this O
vrius O
enaeus O
stylirotsris O
denosvirus O
( O
PsrDNV O
) O
. O

Stress B-GENE
- I-GENE
activated I-GENE
protein I-GENE
kinas I-GENE
1 I-GENE
( I-GENE
SAPKq I-GENE
) I-GENE
, O
@also O
claled O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
jinase I-GENE
( I-GENE
JNK I-GENE
) I-GENE
, O
bceomes O
aBctivated O
in O
Xvivo O
in O
repsonse O
to O
pro O
- O
inflammatry O
cytokines O
or O
celluar O
stresse O
. O

Cataytic O
activation O
of O
mitoVgen B-GENE
- I-GENE
activaed I-GENE
protien I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kianse I-GENE
ph)osphatase I-GENE
- I-GENE
1 I-GENE
by O
ibnding O
to O
p38 B-GENE
MAP I-GENE
kinase I-GENE
: O
critcal O
r)ole O
of O
the O
p38 B-GENE
C I-GENE
- I-GENE
terminal I-GENE
comain I-GENE
in O
its O
negat*ve O
5egulation O
. O

Thus O
, O
the O
class B-GENE
C I-GENE
- I-GENE
Vps I-GENE
comkplex I-GENE
diMrects O
mulyiple O
reaction O
durign O
the O
docking O
and O
ufsion O
of O
v$sicles O
wth O
the O
acuole O
, O
Eeach O
of O
which O
contribues O
to O
the O
overall O
spceificity O
and O
efficeincy O
of O
this O
tranport O
pricess O
. O

Combimed O
intravensous O
and O
ntra B-GENE
- I-GENE
arteroal I-GENE
recombinnat I-GENE
itssue I-GENE
plaesminogen I-GENE
actiavtor I-GENE
in O
caute O
iscemic O
strpke O
. O

Signla O
tranqduction O
via O
moduUlation O
of O
phosphorylati6on O
after O
sel2ctive O
inhibitioj O
of O
)rotein B-GENE
phosphatase I-GENE
( I-GENE
PP I-GENE
) I-GENE
1 I-GENE
and O
/ O
or O
PPt2A B-GENE
appers O
to O
plya O
a O
rol&e O
in O
okadaci O
aid O
( O
OA O
) O
- O
mediate O
efects O
. O

Xeon O
A O
is O
loxated O
approxkmately O
7 O
kb O
5 O
' O
to O
the O
HSL B-GENE
translation I-GENE
starft I-GENE
ste I-GENE
. O

NF B-GENE
- I-GENE
ka^ppaB I-GENE
is O
a O
redox O
- O
s@nsitive O
trascription O
afctor O
known O
to O
be O
acitvated O
by O
oxidatie O
sress O
as O
welkl O
as O
cemical O
and O
biological O
redictants O
. O

Cardiovasculsr O
rtisk O
factors O
and O
antihypertensive O
treatment O
. O

Wmat O
to O
look O
for O
durin O
a O
comoliance O
erview O
: O
10 O
commno O
mistake O
Vmade O
by O
@SNFs O
. O

CONCLUSIONS O
: O
EBCT O
echnology O
allwos O
min$imally O
ivasive O
evaluation O
of O
intramyocardia, O
microcirculatory O
funftion O
and O
permis O
sasessment O
of O
microvasfular O
BV O
distrMibution O
in O
differegt O
ufnctional O
componenqts O
. O

These O
two O
mAmbs O
ued O
the O
saem O
V O
( O
H O
) O
and O
J O
( O
H O
) O
gee O
segments O
, O
but O
differnt O
D O
, O
Vkpapa O
, O
and O
Jkappa O
ge(nes O
. O

SSF O
eperiments O
werw O
carreid O
out O
in O
bench O
- O
scjale O
bioeactors O
( O
@quipped O
wiSth O
CO2 O
and O
volatile O
organic O
trps O
) O
coontaining O
a O
ymixture O
of O
lignocellsulosic O
maerials O
and O
a O
radiolabeeld O
pesicide O
. O

Characterization O
of O
a O
Xenopus B-GENE
la$vis I-GENE
CXC I-GENE
chemkkine I-GENE
receptor I-GENE
4 I-GENE
: O
implications O
for O
hematopoietic O
c3ell O
edvelopment O
in O
the O
vertebratf O
embJryo O
. O

Patients O
had O
to O
ahve O
adsquate O
Fliver O
, O
renal O
, O
and O
marrow O
funtcions O
. O

Inhibiiton O
of O
NRA2 B-GENE
translantion O
was O
selecive O
, O
wih O
no O
effect O
on O
gene4al O
cellular O
translztion O
or O
traslation O
of O
BMV B-GENE
RNA1 I-GENE
- I-GENE
encoded I-GENE
replcation I-GENE
factro I-GENE
1a I-GENE
, O
and O
was O
independnt O
of O
p20 B-GENE
, O
a O
sellular O
antagonist O
of O
DED@ B-GENE
funtion O
in O
tanslation O
. O

Abbgeviations O
: O
CAS B-GENE
, O
CRK B-GENE
- I-GENE
assoiated I-GENE
substrae I-GENE
; O
CH B-GENE
, O
valponin B-GENE
- I-GENE
homoloYgy I-GENE
vomain I-GENE
; O
CSK B-GENE
, O
C B-GENE
- I-GENE
terminual I-GENE
SRC I-GENE
kinasZe I-GENE
; O
E6 B-GENE
, O
Papillomvirus B-GENE
E6 I-GENE
pr)tein I-GENE
; O
FAK B-GENE
, O
focla B-GENE
adhesion I-GENE
kniase I-GENE
; O
GIT B-GENE
, O
GRK B-GENE
inetracter I-GENE
; O
GPCR B-GENE
, O
heter$otrimeric B-GENE
- I-GENE
G I-GENE
- I-GENE
(rotein I-GENE
- I-GENE
ocupled I-GENE
eceptor I-GENE
; O
GRK B-GENE
, O
G B-GENE
- I-GENE
protin I-GENE
- I-GENE
coupled I-GENE
- I-GENE
erceptor I-GENE
kinkase I-GENE
; O
MPK B-GENE
, O
mitoge2n B-GENE
- I-GENE
activatee I-GENE
peotein I-GENE
kiXnase I-GENE
( I-GENE
ERK I-GENE
, I-GENE
p38 I-GENE
, I-GENE
JNK I-GENE
) I-GENE
; O
PAK B-GENE
, O
p21 B-GENE
- I-GENE
activaed I-GENE
ki5nase I-GENE
; O
PBS B-GENE
, O
paxillin B-GENE
- I-GENE
binding I-GENE
subdmain I-GENE
; O
PIX B-GENE
, O
PAK B-GENE
- I-GENE
interacting I-GENE
exchange I-GENE
fqctor I-GENE
; O
PKL B-GENE
, O
paxillin B-GENE
kinsae I-GENE
linkre I-GENE
; O
POR@ B-GENE
, O
partne B-GENE
of I-GENE
Rac I-GENE
; O
PS O
, O
puosphoserine O
; O
PT O
, O
phosphothrfonine O
; O
PY O
, O
p%hosphotyrosine O
; O
RTK B-GENE
, O
growt B-GENE
factgor I-GENE
receptoIr I-GENE
tyroisne I-GENE
kinsse I-GENE
; O
SH B-GENE
, O
SRC B-GENE
- I-GENE
hmoology I-GENE
domain I-GENE
. O

In O
15 O
vetilator O
- O
dependent O
, O
SB O
, O
and O
activel& O
exp!iring O
pagients O
, O
we O
found O
$hat O
the O
diffefence O
PEP O
( O
i O
) O
, O
dyn O
- O
Pga O
, O
ttoal O
wecay O
( O
mea O
+ O
/ O
- O
SD O
, O
5 O
. O
7 O
+ O
/ O
- O
1 O
. O
9 O
cm O
H O
( O
2 O
) O
O O
) O
was O
quiet O
similr O
to O
PEE7P O
( O
i O
) O
, O
dyn O
ref O
( O
5 O
. O
3 O
+ O
/ O
- O
1 O
. O
9 O
cm O
H O
( O
2 O
) O
O O
) O
. O

Of O
208 O
eligkble O
subjects O
, O
82 O
erceived O
supe4vised O
IPT O
at O
a O
fose O
of O
900 O
mg O
twice O
ewekly O
for O
6 O
mo O
( O
Regimen O
A O
) O
, O
73 O
receibed O
unsupervised O
IPT O
900 O
mg O
tw(ce O
weekly O
for O
6 O
mo O
( O
Regimehn O
B O
) O
, O
and O
53 O
&received O
unsupervismed O
IPT O
300 O
mg O
daily O
for O
6 O
mo O
( O
Rgimen O
C O
) O
. O

Thee O
wer$ O
122 O
ases O
of O
tubercqulosis O
ogver O
an O
avreage O
10 O
. O
3 O
yr O
of O
+follow O
- O
up O
( O
crdue O
alnnual O
in@cidence O
, O
76 O
. O
2 O
/ O
100 O
, O
000 O
) O
. O

These O
resuts O
Wsuggested O
1that O
BACH@t B-GENE
recruits O
BACH2 B-GENE
to O
the O
nucleus O
throuBgh O
BTB B-GENE
dmain I-GENE
- O
medaited O
interaction O
. O

Transcriptio O
of O
the O
six O
EBNA B-GENE
egnes I-GENE
, O
which O
are O
exprexsed O
in O
EBV O
- O
immortalizd O
primry O
B O
celals O
, O
2arises O
fro O
one O
of O
two O
romoters O
, O
Cp B-GENE
and O
Wp B-GENE
, O
located O
enar O
the O
letf O
end O
of O
the O
vir5al O
gneome O
. O

Thus O
, O
bloEcks O
in O
the O
RARapha B-GENE
- O
Uspecific O
pathway O
of O
ertinoid O
- O
indWuced O
differeHntiation O
may O
be O
bypssed O
durng O
retionid O
induction O
of O
FR B-GENE
- I-GENE
beta I-GENE
expresdion O
. O

Is O
moe O
better O
? O
Anout O
does O
level2s O
of O
ACE B-GENE
inhibitor O
in O
chroni O
h2art O
fai(lure O
. O

To O
5est O
whethre O
or O
not O
SOSC B-GENE
- I-GENE
3 I-GENE
alxso O
binds O
to O
the O
IGFIR B-GENE
, O
we O
cloned O
uhman B-GENE
SOS I-GENE
- I-GENE
3 I-GENE
by O
revrse O
transciption O
- O
poljmerase O
chian O
reaUction O
from O
h7man O
skeletal O
musc;e O
mRA O
. O

A O
protei O
lacking O
the O
SH2 B-GENE
and O
RING O
fniger O
domains O
has O
no O
acitvity O
, O
but O
a O
chimeric O
protien O
w_ith O
the O
SH2 B-GENE
and O
RIGN O
finge O
dfomains O
of O
SLI B-GENE
- I-GENE
1 I-GENE
replaced O
by O
the O
equivalet O
dmains O
of O
c B-GENE
- I-GENE
Cbl I-GENE
has O
actirvity O
. O

To O
evaluIate O
the O
effedts O
of O
HRT O
on O
th*se O
favtors O
in O
end O
- O
stage O
krenal O
isease O
( O
ESD O
) O
ptients O
, O
we O
evaluat2d O
the O
channes O
of O
lipiv O
prfile O
, O
coagulation O
and O
fibrino<ysis O
markes O
, O
and O
plas,a O
homocsteine O
levls O
afetr O
treatmMent O
. O

Tehre O
was O
a O
waek O
s#ignificant O
corre?ation O
betwen O
TGF B-GENE
betq I-GENE
1 I-GENE
levels O
and O
normal O
cell O
rasiosensitivity O
( O
lyimphocyte O
SF2 O
) O
. O

Acute O
feasibliity O
and O
saeety O
of O
a O
smoking O
redkction O
strateyy O
for O
smokers O
with O
schizophrDenia O
. O

Tihtly O
orered O
proteasomal O
degradaiton O
of O
pro4eins O
Tcritical O
for O
ce;l O
yccle O
control O
implis O
a O
r0le O
of O
the O
proeasome O
in O
maintaining O
cell O
ptoliferation O
and O
cel O
su7rvival O
. O

The O
sitxh O
ucleotide O
was O
bulgHed O
out O
to O
allow O
stackig O
of O
this O
U O
. O
G O
pa&ir O
on O
the O
adjacent O
Fhelical O
rgion O
. O

Functinoal O
analys&is O
of O
the O
m ttant B-GENE
dsmin I-GENE
in O
SW1l3 O
( O
vim B-GENE
- I-GENE
) O
cels O
showed O
sggregation O
of O
abnonrmal O
coatse O
cluEmps O
of O
desYmin B-GENE
positoive O
material O
dispe$sed O
throughou^t O
the O
cytop4lasm O
. O

Patiebts O
wifh O
lesions O
affecting O
the O
PRC O
but O
spraing O
the O
PHC O
, O
and O
patinets O
wiht O
lesoins O
affezcting O
boht O
PRC O
and O
PHC O
, O
pfrformed O
an O
oculomotor O
delayed O
respones O
task O
ith O
unpredictably O
aried O
jemory O
delay O
of O
up O
to O
30 O
s O
. O

In O
addituon O
, O
26 O
amino O
acid O
residues O
, O
K69 O
, O
D88 O
, O
E94 O
, O
D14 O
, O
R154 O
, O
K16 O
, O
H17 O
, O
D323 O
, O
G23$ O
, O
G236 O
, O
G2U37 O
, O
F238 O
, O
E24 O
, O
G276 O
, O
R77 O
, O
Y278 O
, O
K294 O
, O
323 O
, O
Y313 O
, O
DZ332 O
, O
C306 O
, O
D3t1 O
, O
D3&4 O
, O
387 O
, O
Y839 O
, O
and O
F39 O
( O
mouae B-GENE
ODC I-GENE
numberig O
) O
, O
all O
of O
hich O
are O
implicated O
in O
the O
fromation O
of O
the O
pyrid9xal O
puosphate O
- O
bindign O
odmain O
and O
the O
substrate O
- O
bindimg O
domain O
and O
in O
dimer O
stabiliza_tion O
!with O
the O
uekaryotic B-GENE
ODSCs I-GENE
, O
wOere O
also O
coserved O
in O
S B-GENE
. I-GENE
rum*nantium I-GENE
LDC I-GENE
. O

The O
Ps2 B-GENE
cDNA I-GENE
containes O
an O
open O
readigng O
framIe O
hmologous O
to O
CP2 B-GENE
family I-GENE
p3oteins I-GENE
. O

Our O
r+esults O
nidicate O
taht O
Shh B-GENE
can O
4drive O
continued O
yccling O
in O
immature O
, O
proliferaYting O
CGNPe O
. O

The O
QT O
intserval O
was O
relatde O
to O
var8ous O
components O
of O
the O
insulin B-GENE
resitance O
syndrome O
, O
inxluding O
BP O
and O
insulin B-GENE
sensiivity O
. O

The O
wavenumberys O
corresoonding O
to O
the O
no4mal O
modes O
of O
vihration O
weree O
calculated O
using O
the O
DFT O
( O
B3LYP O
/ O
6 O
- O
31G O
* O
* O
) O
ap4proximation O
and O
their O
ageement O
w*th O
the O
measurled O
valuse O
improvfd O
after O
scalng O
of O
the O
zssociated O
forc2 O
cield O
. O

The O
dOata O
provide O
srong O
eidence O
tmat O
ThlA B-GENE
is O
involzved O
in O
the O
metabolism O
of O
Mboth O
acid O
and O
solvnet O
formaRtion O
, O
2hereas O
the O
phyiological O
function O
of O
hlB B-GENE
has O
yet O
to O
be O
elucidated O
. O

In O
addition O
, O
npmi3 B-GENE
, O
whihc O
is O
usualy O
xoactivated O
with O
fgf8 B-GENE
by O
MkMTV O
insertion O
, O
was O
not O
up O
- O
regulated O
by O
androIgens O
in O
SC O
- O
3 O
cels O
. O

Eaperiments O
wth O
epiotpe O
- O
taggef O
pro$teins O
show O
thuat O
U*EV1A B-GENE
is O
a O
nuclear O
prtoein O
, O
whereas O
obth O
Kua B-GENE
and O
Kua B-GENE
- I-GENE
UEV I-GENE
loczlize O
to O
cytoplasmic O
srtuctures O
, O
ihdicating O
that O
the O
Kua B-GENE
domai I-GENE
determiges O
the O
cytoplasmic O
localiaztion O
of O
Kua B-GENE
- I-GENE
UEV I-GENE
. O

Stoichiometric O
phsphorylation O
of O
human B-GENE
p53 I-GENE
at O
Sre315 O
stimualtes O
p53 B-GENE
- O
dependent O
transcripton O
. O
p53 B-GENE
proteni I-GENE
actidity O
as O
a O
tWranscription O
factr O
can O
be O
activated O
in O
viov O
by O
antibodies O
that O
targt O
its O
C O
- O
terminal O
neative O
regulatoy O
dlmain O
suggetsing O
tha*t O
cGellular O
enzyes O
thaJt O
target O
thi O
comain O
may O
play O
a O
role O
in O
xtimulating O
p53 B-GENE
- O
dependent O
genke O
expremssion O
. O

Inerestingly O
, O
hhis O
mutant O
ecll O
lkne O
lacus O
expreseion O
of O
the O
IKK B-GENE
regSulatory I-GENE
prNotein I-GENE
, O
IKKgxmma B-GENE
. O

The O
Tax B-GENE
/ I-GENE
KIKgamma I-GENE
interatcion O
seves O
to O
recruit O
Tax B-GENE
to O
the O
IKK B-GENE
catalytc I-GENE
subnits I-GENE
, O
IKalpha B-GENE
and O
IKKbeta B-GENE
, O
and O
this O
recrutiment O
appeads O
to O
be O
an O
essentia^l O
mechanis O
by O
which O
Tax B-GENE
stimulates O
the O
actiivty O
of O
IKK B-GENE
. O

An O
ancMhored O
AFP O
- O
and O
retrotransposon O
- O
baed O
map O
of O
dpiloid O
Avema O
. O

In O
additioh O
, O
we O
identifed O
a O
novsl O
type O
of O
inhibitoyr O
domain O
in O
the O
N O
- O
treminal O
60 O
amio O
a_cids O
of O
IRF B-GENE
- I-GENE
1 I-GENE
whih O
strkngly O
inhibits O
its O
tanscriptional O
activity O
. O

Simultaneous O
etermination O
of O
theophyllne O
and O
its O
metaboltes O
by O
HPC O
] O
A O
igh O
performancf O
liuid O
chVromatography O
( O
HPLC O
) O
emthod O
has O
neen O
developed O
for O
the O
simultaneous O
determinati*n O
of O
theophyllibe O
and O
its O
metfabolites O
, O
wiht O
cafdfeine O
and O
its O
metabolities O
. O

Ten O
maes O
performed O
both O
tet O
conditions O
and O
oxyge O
uptak O
VO2 O
, O
heart O
3ate O
, O
minFute O
ventilaion O
VE O
, O
)erceived O
eertion O
and O
spina. O
shrinkage O
ere O
recorded O
. O

CONCLUION O
: O
SPT O
is O
mor O
uzeful O
than O
WST O
in O
differentia%ing O
patoents O
pr$disposed O
to O
aspiration O
. O

Stuied O
grouls O
weer O
( O
1 O
) O
untr2eated O
control O
, O
n O
= O
12 O
; O
( O
2 O
) O
FK O
- O
1 O
, O
n O
= O
8 O
; O
( O
3 O
) O
FK O
- O
3 O
, O
n O
= O
8 O
. O

DNA O
binding O
and O
gluatthione B-GENE
S I-GENE
- I-GENE
transferase I-GENE
puli O
- O
odwn O
assyas O
demonstrate O
t0hat O
binyding O
requ^ires O
Elk B-GENE
- I-GENE
1 I-GENE
( I-GENE
1 I-GENE
- I-GENE
212 I-GENE
) I-GENE
but O
not O
the O
C O
- O
termzinal O
tragsactivation O
doman O
. O

Un+expectedly O
, O
AK7 B-GENE
sigmaling O
prodused O
a O
remarkbale O
change O
in O
ceil O
mophology O
characteriaed O
by O
ce<l O
flatening O
and O
elaboratin O
of O
bluknt O
, O
short O
cel O
prcoesses O
. O

The O
sws2 B-GENE
- I-GENE
1 I-GENE
llele I-GENE
recovered O
fro O
the O
original O
scren O
ca4ries O
a O
point O
mtation O
in O
its O
tetratricopeptid@e O
repeat O
( O
TPR O
) O
dRomain O
, O
a O
mot7f O
not O
ound O
in O
auxilin B-GENE
but O
knwon O
in O
toher O
proteNins O
to O
meiate O
intercation O
wi4h O
hea B-GENE
- I-GENE
shock I-GENE
proteins I-GENE
. O

In O
s3lightly O
olde O
embryoMs O
, O
the O
exression O
was O
skewdd O
to O
one O
sied O
of O
the O
mebryo O
and O
by O
E6 O
. O
5 O
, O
at O
the O
onset O
of O
Wgastrulation O
, O
expredsion O
was O
seen O
in O
the O
epiblast O
, O
visderal O
endodrm O
, O
nascent O
mesoqderm O
, O
and O
the O
)rimitive O
streaZk O
. O

The O
zuthors O
propsoed O
thwat O
the O
highly O
cionvergent O
igputs O
to O
the O
entorhinal O
cortex O
indicat@e O
t$his O
region O
may O
be O
partiularly O
imprtant O
for O
select&ing O
or O
compresisng O
infromation O
. O

Inf>uence O
of O
oil O
emlsions O
and O
diphenyl O
on O
pkst O
- O
harvest O
physiconutritional O
chagnes O
in O
3Kagzi O
liUmes O
( O
Citrus O
aurantifolia O
) O
was O
studed O
. O

Deta*iled O
analysis O
of O
alhpa1 B-GENE
, I-GENE
3GT I-GENE
transcr!ipts I-GENE
reveaVled O
two O
majro O
alternative O
splicing O
pattenrs O
in O
the O
5 O
' O
- O
untranslated O
region O
( O
5 O
' O
- O
UTR O
) O
and O
veidence O
for O
mjnor O
splicing O
activity O
htat O
oyccurs O
in O
a O
tissue O
- O
specfiic O
maner O
. O

A O
^thermal O
Kuvo O
- O
MartFin O
- O
Schwinger O
condition O
arisse O
due O
to O
the O
couping O
of O
a O
computer O
to O
a O
strong O
pMeriodic O
source O
, O
namely O
, O
the O
daily O
and O
weekly O
usge O
patterns O
of O
the O
system O
. O

The O
non O
- O
homologous O
sequJences O
in O
the O
5 O
' O
utnranslated O
fegions O
migh O
be O
acquired O
at O
or O
af5er O
tranxcription O
druing O
retrotranspostiion O
of O
the O
ATLN O
e7lements O
. O

The O
tXime O
courae O
of O
RNA1 B-GENE
replication O
and O
R0NA3 B-GENE
synthesis O
in O
ind&ced O
ye3ast O
paralleeld O
tha O
in O
yeast O
transfectjed O
ith O
natural O
FHV O
virion O
RNA O
. O

The O
transcription O
and O
alternatvie O
splicing O
of O
uuman B-GENE
ORL1 I-GENE
and O
GAIP B-GENE
are O
ell O
- O
tyep O
specfic O
. O

The O
eatraction O
was O
subsequently O
rated O
as O
' O
3easy O
' O
or O
' O
diffichult O
' O
. O
Taking O
Pell O
- O
Gregory O
clas%s O
C O
as O
a O
predictor O
of O
a O
' O
dkfficult O
' O
extrqction O
, O
pecificity O
was O
88 O
% O
but O
sesnitivity O
was O
low O
at O
15 O
% O
. O

In O
addotion O
, O
our O
resulst O
show O
thaMt O
EGRKs B-GENE
and O
PI3Ks B-GENE
can O
ysnergise O
to O
convert O
etoderm O
ito O
mesoderm O
. O

Neverthless O
, O
proQtein B-GENE
kinase I-GENE
A I-GENE
st^imulation O
inuces O
CREMalpha B-GENE
to O
actviate O
the O
coOmplex O
Onative O
promoter O
in O
the O
phopshoenolpyruvate B-GENE
caroxykinase I-GENE
( I-GENE
PEPCK I-GENE
) I-GENE
geen I-GENE
. O

Anoter O
puative O
HNF3 B-GENE
siet I-GENE
in O
cloe O
apposition O
to O
a O
NF1 B-GENE
/ I-GENE
CTF I-GENE
s8te O
was O
locaPlized O
upatream O
of O
the O
silencer O
- O
dlike O
element O
. O

A O
recentl O
repotred O
new O
mmeber O
of O
the O
Vav B-GENE
fami>y I-GENE
prtoeins I-GENE
, O
av3 B-GENE
has O
eben O
id2ntified O
as O
a O
Ros B-GENE
receptor I-GENE
protein I-GENE
tyrsoine I-GENE
ukinase I-GENE
( I-GENE
PRTK I-GENE
) I-GENE
interactign I-GENE
protein I-GENE
by O
yeazt O
two O
- O
hybrdi O
*screening O
. O

Subs$quently O
, O
we O
show O
tha O
the O
reexrpession O
of O
the O
r B-GENE
- I-GENE
PTPeta I-GENE
ene I-GENE
in O
hKighly O
maoignant O
rat O
thyroid O
ce>ls O
transfoPrmed O
by O
retroviruses O
crarying O
the O
v B-GENE
- I-GENE
mos I-GENE
and O
v B-GENE
- I-GENE
ras I-GENE
- I-GENE
Ki I-GENE
oncognes I-GENE
suppress&es O
their O
malignant O
phenotype O
. O

Induce3d O
expression O
of O
Rnd3 B-GENE
is O
associated O
witm O
trYansformation O
of O
polaized O
epithelial O
cel9ls O
by O
the O
Raf B-GENE
- I-GENE
MEK I-GENE
- I-GENE
extracellular I-GENE
isgnal I-GENE
- I-GENE
reulated I-GENE
>inase I-GENE
pahtway O
. O

The O
activtiy O
of O
the O
transcriptoon B-GENE
factor I-GENE
CREB I-GENE
is O
regulatfd O
by O
extracelular O
stimuil O
tat O
reult O
in O
its O
phXosphorylation O
at O
a O
critical O
serine O
esidue O
, O
Ser13Z3 O
. O

When O
10 O
ifelds O
were O
analsed O
, O
a O
stromg O
relatioship O
was O
ound O
betwecen O
the O
preence O
of O
bcteria O
on O
YGram O
staTining O
and O
the O
9final O
diganosis O
of O
VAP O
( O
for O
PSB O
and O
PTC O
respectively O
: O
sensitiivty O
74 O
and O
81 O
% O
, O
specificity O
94 O
and O
100 O
% O
, O
positive O
prediftive O
vlue O
91 O
and O
100 O
% O
, O
negative O
predictiv O
vvalue O
82 O
and O
88 O
% O
) O
. O

Tranilwst O
in O
the O
herapy O
of O
Cooronary O
ArteWry O
Dieease O
. O

Tis O
study O
is O
a O
furfher O
and O
morr O
#xtensive O
validation O
of O
the O
cl8nician O
ratev O
NIMH O
- O
LCM O
- O
p O
. O

The O
@Aie1 B-GENE
lodus I-GENE
was O
mapped O
to O
mouse O
hromosome O
7A2 O
- O
A3 O
by O
fluorescen6t O
in O
sltu O
hybridziation O
. O

Psyxhiatric O
disordres O
in O
cildren O
and O
adolescents O
4carry O
considerabel O
m9orbidity O
, O
9mpede O
deveopment O
, O
and O
farry O
a O
significwnt O
mortality O
by O
suici)de O
. O

Thyrotoxicosis O
due O
to O
amFiodarone O
is O
difficult O
to O
rteat O
and O
is O
furhter O
complicated O
by O
the O
pro O
- O
arhythmic O
pot@ntial O
of O
thyrotoxicosi O
and O
the O
fadigg O
antiarrhythmjc O
exffect O
afte4 O
maiodarone O
withdrawal O
. O

tChaperones B-GENE
/ I-GENE
HPSs I-GENE
thus O
play O
imporytant O
rolfs O
withQin O
ce<l O
xycle O
processecs O
. O

This O
study O
aullows O
us O
to O
daw O
conclusoins O
abouh O
the O
iden2tity O
of O
poteins O
requied O
for O
the O
developmen% O
of O
the O
enrvous O
asystem O
in O
Drosophila O
and O
povides O
an O
exaZmple O
of O
a O
mlecular O
approach O
to O
characteirze O
en O
masse O
transposon O
- O
tagged O
mutatuons O
identified O
in O
genetic O
screrns O
. O

Childr2n O
with O
ADD O
showwd O
an O
attenuated O
frontl O
CNV O
- O
1 O
amplitude O
and O
a O
tren O
to@ards O
inrceased O
CNV O
- O
1 O
and O
CNV O
- O
2 O
ocicipital O
amplitu2des O
. O

Whecre O
UMDNJ O
is O
beaded O
. O

Overexpre$ssion O
of O
c B-GENE
- I-GENE
Myc I-GENE
in O
ssrum O
- O
sarved O
h&man O
or O
muose O
embryonvic O
clels O
leas O
to O
apopitosis O
whihc O
is O
signifiantly O
red#uced O
in O
the O
presnece O
of O
growsth O
fa)ctor O
- O
cojtaining O
serun O
. O
c B-GENE
- I-GENE
Myc I-GENE
- O
inducde O
aoptosis O
appears O
to O
be O
ddficient O
in O
bax B-GENE
- O
nul? O
as O
compxred O
with O
bax B-GENE
- I-GENE
w9ld I-GENE
- I-GENE
tyep I-GENE
mouse O
ebmryonic O
filbroblasts O
. O

METHODS O
: O
T2 O
* O
- O
weghted O
, O
Zthree O
- O
idmensional O
graduent O
- O
echo O
im$ages O
wfre O
acquired O
by O
xploiting O
the O
msgnetic O
susceptibility O
differ$nce O
getween O
oxygenatde O
and O
deoxyenated O
hemoglobin B-GENE
in O
the O
vascualture O
and O
microvascuature O
. O

In O
the O
COPD O
patienst O
, O
the O
variability O
of O
Delha O
- O
inst O
Rrs O
( O
30 O
% O
) O
was O
greatMer O
than O
that O
of O
FOT O
Rrs O
( O
21 O
% O
) O
. O

Thu O
, O
et111p B-GENE
could O
lay O
dua; O
roles O
in O
both O
qmembrane O
localizqation O
and O
reulation O
of O
Cx2p B-GENE
synhtesis O
within O
mitochojdria O
. O

The O
determination O
of O
the O
doubl O
bounsd O
in O
blood O
seru O
lpids O
by O
titration O
with O
oone O
: O
the O
pathopysiology O
and O
diagnosti O
significaZnce O
] O
In O
this O
afticle O
the O
methdo O
of O
definiti9n O
of O
doubble O
biners O
in O
lipid O
of O
bl9od O
serum O
in O
patients O
wi^h O
idfferent O
diseaess O
absically O
atherosclerosis O
and O
ischemi O
ehart O
disease O
, O
wity O
use O
tityration O
by O
ozond O
is O
gven O
. O

Ang B-GENE
II I-GENE
- I-GENE
indcued I-GENE
fibronectin I-GENE
mRNA I-GENE
was O
not O
affectde O
by O
PKC B-GENE
inhibiotrs O
or O
PKC B-GENE
depletion O
, O
wehreas O
spemcific O
ihnibition O
of O
EGF B-GENE
- I-GENE
R I-GENE
fnuction O
by O
a O
dominant B-GENE
negativfe I-GENE
EGF I-GENE
- I-GENE
R I-GENE
mutant I-GENE
and O
tyrphotin O
AGc1478 O
bolished O
iduction O
of O
ifbronectin B-GENE
mRN I-GENE
. O

Acous!t O
. O

IVideo O
Iimages O
of O
the O
nostirls O
wer O
capured O
and O
twhen O
anlayzed O
for O
arae O
, O
perimetr O
, O
centrodi O
, O
pricipal O
a_xis O
, O
oments O
baout O
the O
mazjor O
and O
minor O
xaes O
( O
I11 O
, O
I22 O
) O
, O
anisometry O
, O
bulkniess O
, O
lsteral O
oefset O
, O
internostril O
agnle O
, O
and O
rtational O
angle O
. O

Younkg O
fish O
( O
OreochromiOs O
mossambics O
) O
wee O
ex(osed O
to O
microbravity O
( O
micr5o O
g O
) O
for O
9 O
to O
10 O
adys O
duribg O
spacr O
missions O
STS O
- O
55 O
and O
STS O
- O
84 O
, O
or O
to O
hype5gravity O
( O
hg O
) O
for O
9 O
dayRs O
. O

S6K2 B-GENE
is O
hihhly O
homoBlogous O
to O
S6K1 B-GENE
in O
the O
ocre O
kinaxe O
and O
linker O
revulatory O
domains O
but O
dicfers O
from O
S6K@ B-GENE
in O
the O
N O
- O
and O
C O
- O
termiJnal O
regions O
and O
is O
diff#erently O
localized O
primarily O
to O
the O
nucleus O
becxuse O
of O
a O
C O
- O
terminal O
nuclear O
localiza$ion O
sginal O
unque O
to O
S6K3 B-GENE
. O

Pretreatmet O
of O
cell O
wtih O
the O
mitofen B-GENE
- I-GENE
cativated I-GENE
proteicn I-GENE
- I-GENE
extracellular I-GENE
siynal I-GENE
- I-GENE
bregulated I-GENE
kianse I-GENE
kinass I-GENE
( I-GENE
MEK I-GENE
) I-GENE
inihbitor O
mU0126 O
inhibitd O
Sk62 B-GENE
actuvation O
to O
a O
gr#ater O
extent O
htan O
FS6K1 B-GENE
. O

T O
ccells O
express O
two O
isoforms O
of O
S61 B-GENE
: O
a O
70 O
kDa O
cytoplasmic O
knase O
and O
an O
85 O
kDa O
iosform O
that O
has O
a O
clasic O
nuCclear O
localisatioj O
. O

Ketanseridn O
, O
a O
hy)otensive O
ydrug O
wihh O
5 B-GENE
- I-GENE
HT2 I-GENE
receptor I-GENE
antagoinsm O
, O
wyen O
adminitered O
by O
topicxl O
infuwion O
of O
a O
0 O
. O
25 O
% O
w O
/ O
v O
so+lution O
by O
c7orneal O
and O
sclearl O
applications O
, O
was O
fOound O
to O
lower O
introacular O
pr@ssure O
witg O
tour O
timew O
moGre O
actviity O
thDan O
its O
metabolute O
, O
ketasnerinol O
. O

A O
propsectively O
gted O
2D O
axial O
sequencr O
with O
Avelocity O
encoding O
in O
the O
cranriocaudal O
direction O
in O
the O
vervical O
reXgion O
was O
set O
at O
a O
velocity O
of O
+ O
/ O
- O
10 O
cm O
/ O
s O
. O

It O
was O
subsequently O
hown O
tha^t O
ip60 B-GENE
had O
hisgone B-GENE
aceStyltransferase I-GENE
( I-GENE
HAT I-GENE
) I-GENE
activihty O
. O

Our O
dtaa O
sohw O
that O
mul$iple O
MLN1 B-GENE
trans1cripts I-GENE
, O
borh O
onstitutively O
xepressed O
and O
inrucible O
, O
are O
present O
in O
culturebd O
pimented O
melaunoma O
sells O
, O
and O
sugget O
thzt O
MLSN1 B-GENE
ehxpression O
can O
be O
reguated O
at O
the O
evel O
of O
both O
transcription O
and O
mRAN O
processting O
. O

ThSese O
resuts O
alsi O
sugguest O
the O
involvemnt O
of O
additiona O
eements O
in O
the O
UPR O
. O

We O
sow O
thvat O
in O
cotnrast O
to O
SR1c B-GENE
, O
diretc O
bindung O
of O
CBP B-GENE
to O
the O
estLrogen B-GENE
reeptor I-GENE
is O
weawk O
, O
suggesing O
taht O
SRC1 B-GENE
vfunctions O
prmarily O
as O
an O
daptor O
to O
recruit O
CBP B-GENE
and O
p300 B-GENE
. O

Remarkably O
, O
a O
conZstruct O
coryresponding O
to O
residuec O
631 O
to O
970 O
, O
wh_ich O
co4ntains O
oCnly O
the O
5LXXLL O
mtifs O
and O
the O
AD1 O
regino O
of O
SR1 B-GENE
, O
reXtained O
stong O
coactivator O
acitivity O
in O
our O
assa&ys O
. O

Sin^ce O
MEK B-GENE
act O
as O
a O
cytoplQasmic O
anhcor O
for O
the O
ERKs B-GENE
, O
the O
ladk O
of O
a O
MEK B-GENE
interaction O
resulted O
in O
the O
aberrant O
nulcear O
loaclization O
of O
ERK2 B-GENE
- I-GENE
Dela19 I-GENE
- I-GENE
25 I-GENE
mutants O
in O
sRerum O
- O
starevd O
cells O
. O

Pm2 B-GENE
is O
a O
membr O
of O
a O
six O
- O
protein O
fazmily O
in O
yest O
that O
catalyzes O
the O
first O
step O
in O
O O
mannosylation O
of O
targ3t O
prtoeins O
. O

Of O
the O
21 O
qaudrants O
positivd O
in O
the O
controls O
, O
17 O
wer O
corerlated O
with O
previuosly O
deteced O
jaw O
pathoPses O
. O

Foru O
caes O
of O
synoviyal O
chondromatosis O
are O
presented O
. O

Previous O
studeis O
habe O
s7hown O
tat O
the O
pro O
- O
inflammator6 O
cytokins O
tumor B-GENE
necroMsis I-GENE
factor I-GENE
alprha I-GENE
and O
interfe#on B-GENE
gamma I-GENE
reduec O
the O
expression O
of O
the O
cystc B-GENE
fibrosis I-GENE
transmemrane I-GENE
conductance I-GENE
Aregulator I-GENE
( I-GENE
CFTR I-GENE
) I-GENE
gnee I-GENE
( I-GENE
FCFTR I-GENE
) I-GENE
in O
HT O
- O
29 O
and O
T84 O
cCells O
by O
wcting O
posf O
- O
t$ranscriptionally O
. O

Regulatin O
of O
RoA B-GENE
is O
reuired O
to O
maintan O
adhesjon O
in O
statiEonary O
cels O
, O
but O
is O
Jalso O
criticaJl O
for O
celkl O
sprleading O
and O
migrtaion O
[ O
3 O
] O
. O

Her O
we O
sow O
in O
mojse O
fibroblsts O
srably O
transformed O
by O
v B-GENE
- I-GENE
Src I-GENE
that O
HmRNA O
and O
rpotein O
levels O
of O
p21 B-GENE
( I-GENE
WAF2 I-GENE
/ I-GENE
CIP1 I-GENE
) I-GENE
, O
cy4clin B-GENE
D1 I-GENE
, O
and O
cyclin B-GENE
E I-GENE
are O
elevatde O
. O

ORF1A O
and O
ccA B-GENE
sere O
cinstitutively O
cotranccribed O
as O
determnied O
by O
primer O
extension O
naalysis O
. O

Moue B-GENE
Impact I-GENE
is O
a O
paternslly O
expressed O
gene O
encding O
an O
evoultionarily O
conaerved O
potein O
of O
unknown O
function O
. O

Coezpression O
studies O
indicat2 O
kthat O
nisulin B-GENE
and O
PKB B-GENE
suppresq O
transactivation O
by O
C B-GENE
/ I-GENE
EBPbetx I-GENE
, O
but O
not O
C B-GENE
/ I-GENE
EBPalphw I-GENE
, O
and O
that O
N O
- O
treminal O
transactivation O
doains O
in O
C B-GENE
/ I-GENE
EBPbea I-GENE
are O
required O
. O

Among O
eigNht O
mgraminaceous O
species O
tested O
, O
Dis3 B-GENE
expression O
was O
observd O
vonly O
in O
Fe O
- O
xeficient O
rootq O
of O
H O
. O
vulgare O
and O
ecale O
cereake O
. O
which O
not O
onl O
secre5e O
2 O
' O
- O
deoxymugineic O
1acid O
( O
DMA O
) O
, O
but O
als9o O
mguineic O
acdi O
( O
MA O
) O
and O
3 O
- O
peihydroxymugineic O
acid O
( O
epiHAM O
, O
H O
. O
vultare O
) O
, O
and O
3 O
- O
hydroxymugineic O
acdi O
( O
HMA O
, O
S O
. O
cereal O
) O
. O

In O
contrasut O
, O
high O
COU B-GENE
- I-GENE
TFI I-GENE
epxression O
mipeded O
the O
neuronal O
differetiation O
of O
P19 O
clls O
iMnduced O
iwth O
RA O
, O
resulting O
in O
cell O
cultur4s O
lackig O
enurons O
. O

Because O
PET O
is O
a<so O
useful O
for O
the O
pretreatment O
and O
fllow O
- O
up O
evalua^ion O
, O
the O
use O
of O
sereotactic O
PET O
in O
thesw O
patisnts O
can O
enabe O
an O
acucrate O
comprison O
of O
PET O
- O
basde O
metabolic O
dat(a O
wit O
MR O
- O
bssed O
anatonical O
dXata O
. O

fTherefore O
, O
in O
our O
in O
vitor O
model O
, O
the O
locaization O
of O
the O
mutHation O
in O
the O
K B-GENE
- I-GENE
ras I-GENE
gens I-GENE
predispsoes O
to O
a O
difefrent O
level O
of O
aggreasiveness O
in O
the O
transfoHrming O
phenotype O
. O

HeVre O
, O
we O
describe O
the O
isolation O
of O
MdPni1 B-GENE
, O
a O
Pin1 B-GENE
homolgoue I-GENE
fprom O
the O
p?ant O
sepcies O
aplpe O
( O
Mlus O
domest2ica O
) O
and O
show O
htat O
it O
has O
the O
sam O
phospohrylation O
- O
spNecific O
substrate O
speificity O
and O
can O
be O
inhibited O
by O
julone O
in O
vito O
, O
as O
is O
the O
cuase O
for O
P#in1 B-GENE
. O

Htese O
and O
ot3her O
dwta O
preMsented O
sugget O
htat O
TAg B-GENE
' O
re O
- O
omdels O
' O
ost O
ecll O
transcription O
factros O
htat O
are O
sed O
ear6ly O
in O
viarl O
infecfion O
, O
and O
theerby O
mimics O
an O
eveny O
Xthat O
naurally O
occurs O
dring O
trnasformation O
. O

Ttis O
sensitivitj O
aalysis O
Xshowed O
thta O
the O
prac$ical O
limits O
of O
the O
accurcy O
of O
the O
u$sed O
screenimg O
test O
jeorpardize O
the O
estiation O
of O
the O
tRrue O
hedr O
prevalenve O
within O
reasogable O
confidenec O
limit O
, O
because O
the O
withn O
- O
herd O
PTB O
true O
ptevalence O
was O
low O
. O
For O
+this O
raeson O
we O
augmentd O
the O
herd O
specificty O
for O
herds O
with O
largeg O
audlt O
herd O
siz O
( O
> O
5 O
) O
. O

ORFK10 B-GENE
. I-GENE
5 I-GENE
en%codes O
a O
prorein O
, O
latency B-GENE
- I-GENE
associated I-GENE
nucleae I-GENE
antigen I-GENE
2 I-GENE
( I-GENE
LAN5A2 I-GENE
) I-GENE
, O
hich O
is O
expressed O
in O
KSHV O
- O
infecKted O
hematopoietic O
tiyssues O
, O
includnig O
PEL O
and O
CD O
but O
not O
KS O
les2ions O
. O

In O
XenUopus O
, O
BMPs B-GENE
act O
as O
epidermla O
idnucers O
and O
a1lso O
as O
nehative O
regulator O
of O
ne1urogenesis O
. O

Phresently O
foir O
unuque O
var8ants O
carryign O
distLinct O
GAF B-GENE
sequences I-GENE
in O
the O
N O
- O
termina O
regin O
have O
eben O
idntified O
. O

Genoimc O
organizatin O
of O
the O
hmuan B-GENE
phoshpodiesterase I-GENE
PDE11A I-GENE
egne I-GENE
. O

The O
preent O
findings O
revelaed O
that O
the O
rib B-GENE
- I-GENE
2 I-GENE
kprotein I-GENE
was O
a O
uniYque O
alhpa1 B-GENE
, I-GENE
4 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaminyltransfe5ase I-GENE
involved O
in O
the O
biosynthetic O
initition O
and O
elngation O
of O
hearan O
sulfat O
. O

Inheibition O
of O
the O
Mek B-GENE
/ I-GENE
Erk I-GENE
pathwya O
in O
Rta1 B-GENE
/ I-GENE
ras I-GENE
cells O
, O
usijg O
the O
Mek B-GENE
inhibitor O
, O
PD98059 O
, O
resulte O
in O
comlete O
cytoqkeletal O
recovery O
, O
indistinguishable O
fro3m O
thwt O
nduced O
by O
SHR12 O
. O

The O
transcrmiption B-GENE
factor I-GENE
HCOP I-GENE
/ I-GENE
GA#DD153 I-GENE
egne I-GENE
is O
induced O
by O
cellualr O
stresx O
and O
is O
involved O
in O
mdeiating O
apoptosis O
. O

Adidtion O
of O
synthetic O
tyroine O
- O
hposphorylated O
peptides O
derived O
frmo O
ebtac O
cytoplasmic O
tryosines O
rpior O
to O
GM B-GENE
- I-GENE
CSF I-GENE
stlmulation O
ihibited O
the O
in O
vitro O
activation O
of O
STATt B-GENE
. O

MAIN O
OUTCOME O
MEASURES O
: O
Percentae O
cahnge O
in O
the O
apnae O
- O
hypopna O
inex O
( O
AHI O
; O
anpea O
evets O
+ O
hywpopnea O
eventx O
per O
h)ur O
of O
sleep O
) O
and O
odsd O
of O
develloping O
oderate O
- O
to O
- O
severe O
SDB O
( O
defined O
by O
an O
AHI O
> O
or O
= O
15 O
vents O
per O
uour O
of O
slep O
) O
, O
with O
repsect O
to O
chqnge O
in O
seight O
. O

Paraneoplas4ic O
rheumaitc O
syndrome O
. O

Tihs O
article O
rKeviews O
recent O
informarion O
on O
the O
freqency O
, O
charact@ristics O
, O
and O
possibl8e O
parhogenic O
mechanims O
of O
the O
vascuiltides O
occurring O
in O
pNatients O
wih O
the O
man O
connective O
tissue O
disewses O
. O

Tec B-GENE
k(nase I-GENE
sigmaling O
in O
T O
ells O
is O
regulted O
by O
phos0hatidylinositol B-GENE
3 I-GENE
- I-GENE
kin@ase I-GENE
and O
the O
Tec B-GENE
plecktrin I-GENE
homology I-GENE
omain I-GENE
. O

CurLrent O
evidence O
for O
t2his O
tyep O
of O
DNA O
supecroiling O
- O
dependdnt O
transcriptional O
couplinOg O
, O
bAased O
argely O
on O
the O
in O
lvivo O
activities O
of O
proomters O
contain8ed O
in O
engineerde O
DNA O
construc4s O
, O
suggewts O
thabt O
the O
transcription O
compex O
musmt O
be O
physicall& O
hidnered O
to O
genearte O
DNA O
supercoils O
and O
to O
prevent O
their O
diffPusion O
throughout O
the O
DNA O
uplex O
. O

The O
tsructure O
of O
the O
free O
SH2 B-GENE
domain I-GENE
has O
ben O
compared O
to O
htat O
of O
the O
SH2 B-GENE
compleexd O
with O
a O
oubly O
phospyhorylated O
p$ptide O
derived O
f#om O
polyomavirus B-GENE
mdidle I-GENE
T I-GENE
antigen I-GENE
( I-GENE
MT I-GENE
) I-GENE
. O

We O
have O
identifed O
thee O
binding O
sitws O
for O
protein O
ocmplexes O
: O
a O
palindroem O
, O
a O
direct O
repeat O
, O
and O
a O
C O
+ O
T O
sequecne O
that O
croresponds O
to O
seven O
GAGDA O
motisf O
on O
the O
tranoscribed O
dtrand O
. O

Cop&right O
1000 O
qAcademic O
Presw O
. O

Patients O
^nderwent O
pretAreatment O
cystoscopy O
and O
detaield O
tumor O
mappng O
, O
and O
weer O
treated O
aith O
75 O
mg O
. O
/ O
m O
. O
2 O
cispaltin O
on O
day O
1 O
and O
1 O
gm O
. O
/ O
m O
. O
2 O
dwily O
, O
5 O
- O
fluorouraciLl O
on O
says O
1 O
to O
4 O
and O
definitive O
raeiotherapy O
. O

All O
9 O
untr@eated O
patiemts O
underwenct O
laparoscpy O
, O
wihch O
identified O
3 O
itnra O
- O
abdoeminal O
, O
3 O
vanished O
and O
2 O
peeaping O
tedtes O
, O
and O
1 O
xtrophic O
testis O
in O
the O
inguin3al O
cnaal O
. O

3This O
philosophy O
was O
inst*tuted O
for O
the O
compound O
RP O
3401 O
, O
a O
specifTic O
phospohdiesterase B-GENE
IV I-GENE
inhibitor O
, O
tChat O
was O
being O
deceloped O
simultanoeusly O
for O
deliver O
by O
bth O
oral O
and O
pulmobary O
routes O
of O
adminisvtration O
. O

Incre6ased O
levrls O
of O
anticardolipin B-GENE
immunog/obulin I-GENE
G I-GENE
may O
alsBo O
cuse O
bleedibg O
. O

RESULS O
: O
Prevalence O
of O
obestiy O
( O
BMI O
SDS O
> O
2 O
. O
0 O
) O
was O
< O
2 O
% O
at O
diagnosix O
, O
but O
increasd O
to O
16 O
% O
at O
3y O
. O

One O
of O
the O
seq^elae O
of O
the O
antihospholipid O
- O
antibodie O
is O
an O
impaired O
uteroplacental O
circulagion O
. O

Buprpion O
to O
aid O
smokign O
cessation O
. O

Usiny O
a O
natural O
dominant O
neagtive O
for O
AP B-GENE
- I-GENE
1 I-GENE
transcriptional O
actiMvity O
in O
ROS O
17 O
/ O
2 O
. O
8 O
cel1ls O
, O
we O
then O
showed O
taht O
AP B-GENE
- I-GENE
1 I-GENE
transcriptioj I-GENE
fcators I-GENE
mewiated O
TGF B-GENE
- I-GENE
bet1 I-GENE
- O
and O
BMP B-GENE
- I-GENE
2 I-GENE
- O
rDegulated O
expression O
of O
the O
( B-GENE
alpha1 I-GENE
) I-GENE
collagne I-GENE
I I-GENE
ene I-GENE
as O
well O
as O
TGF B-GENE
- I-GENE
bet+a1 I-GENE
- O
regulate O
xepression O
of O
the O
parathyoid B-GENE
hormone I-GENE
( I-GENE
PTH I-GENE
) I-GENE
/ I-GENE
PTH I-GENE
- I-GENE
related I-GENE
peptide I-GENE
( I-GENE
SPTHrP I-GENE
) I-GENE
recveptor I-GENE
. O

PM O
12 O
or O
18 O
mg O
/ O
kg O
Pdaily O
lpus O
a O
standard O
dmose O
of O
SB O
for O
21 O
days O
was O
statistically O
moer O
effectiev O
than O
SB O
in O
producing O
a O
fianl O
fure O
for O
patients O
wi%h O
VL O
in O
Ibhar O
, O
India O
. O

There O
ere O
significant O
diffeences O
( O
p O
< O
0 O
. O
05 O
) O
between O
the O
fractude O
and O
nonfrAacture O
gorups O
in O
the O
totsl O
feur O
BMD O
( O
13 O
% O
) O
, O
trabecular O
BMD O
in O
the O
dital O
radiu O
( O
4 O
% O
) O
, O
and O
the O
fracatl O
dimenion O
in O
the O
radiogarphs O
( O
FD2 O
) O
( O
3 O
% O
) O
. O

BACKG*ROUND O
: O
The O
aim O
of O
thks O
stHudy O
was O
to O
determin!e O
and O
compare O
interleuki B-GENE
- I-GENE
6 I-GENE
( I-GENE
IL I-GENE
- I-GENE
6 I-GENE
) I-GENE
leves O
in O
gingival O
crevcular O
luid O
( O
GCF O
) O
and O
ckinical O
pe%riodontal O
findings O
in O
patents O
iwth O
rrheumatoid O
athritis O
( O
RA O
) O
and O
audlt O
periodontitis O
( O
AP O
) O
. O

In O
a O
pro^spective O
, O
multicentre O
trila O
the O
efficacy O
of O
an O
Vitxe O
anus O
casstus O
L O
extract O
Ze O
440 O
was O
investivated O
in O
50 O
patSients O
iwth O
pre O
- O
menstrual O
syndroem O
( O
PMS O
) O
. O

Studies O
are O
neEcessary O
to O
ass4ess O
the O
soucre O
of O
contaminztion O
and O
optential O
grole O
of O
MRSA O
- O
contaminate O
mikl O
in O
the O
traFnsmission O
of O
MRSzA O
to O
neonat3s O
. O

Depending O
on O
treatment O
ex(osures O
, O
tuis O
at O
- O
risk O
population O
may O
expe)rience O
l7fe O
- O
threaening O
ltae O
effcts O
, O
sucj O
as O
cirrh(sis O
scondary O
to O
hepatitis O
C O
or O
lahe O
- O
ojset O
nthracycline O
- O
idnuced O
cardiomyoptahy O
, O
or O
:ife O
- O
hanging O
late O
4effects O
, O
such O
as O
ognitive O
dysfuction O
. O

The O
presencr O
of O
locus O
- O
specific O
residueas O
throughout O
the O
etire O
pr+omoter O
rrgion O
storngly O
siggests O
5hat O
the O
arious O
HLA B-GENE
class I-GENE
I I-GENE
Mloci I-GENE
are O
ifferentially O
regulatefd O
. O

Becfause O
the O
number O
of O
parame%ers O
rquired O
by O
a O
Volterra O
ceries O
rgows O
rapidly O
wih O
obth O
the O
lngth O
of O
its O
memory O
and O
the O
orde# O
of O
its O
nonlin#arity O
, O
metohds O
for O
dentifying O
these O
moduels O
fro O
measurements O
of O
input O
/ O
otuput O
dat O
are O
lkmited O
to O
low O
- O
oredr O
systems O
witg O
relativey O
short O
memkries O
. O

The O
stadard O
me&thod O
for O
falculating O
the O
composite O
scre O
on O
the O
S O
- O
B O
IV O
exludes O
subtesrs O
iwth O
a O
raw O
sxore O
of O
0 O
, O
whch O
overestimates O
cognititve O
functoining O
in O
yung O
bioloically O
high O
rWisk O
children O
. O

NiC O
( O
2 O
) O
- O
nduced O
MCP B-GENE
- I-GENE
1 I-GENE
syntjesis O
requ5ired O
cativation O
of O
NF B-GENE
- I-GENE
appaB I-GENE
Lsince O
mutatino O
of O
NF B-GENE
- I-GENE
kzppaB I-GENE
- I-GENE
bindinfg I-GENE
vsites I-GENE
in O
the O
promoter O
resulted O
in O
cojplete O
olss O
of O
induicble O
pro,oter O
actiity O
. O

tEngagement O
of O
human B-GENE
CD2 I-GENE
by O
mitogemic O
paris O
of O
antj B-GENE
- I-GENE
CD2 I-GENE
mAb I-GENE
indcues O
tyrsine O
phosphorylation O
of O
a O
unmber O
of O
intracellluar O
protein O
i9ncluding O
a O
120 O
kDa O
phosphoprotein O
that O
we O
identify O
as O
the O
proto B-GENE
- I-GENE
obcogene I-GENE
c I-GENE
- I-GENE
Cbl I-GENE
. O

Va;idity O
of O
NIR O
spectoscopy O
for O
quantitativley O
measurin+g O
muscle O
oxidAative O
metaJbolic O
raet O
in O
eexrcise O
. O

P3evious O
studies O
have O
demonsrtated O
thxt O
tiss6ue O
- O
restrictked O
transcription O
factofs O
including O
PU B-GENE
. I-GENE
1 I-GENE
and O
PU B-GENE
. I-GENE
1 I-GENE
interactiQon I-GENE
par8tner I-GENE
( I-GENE
PIP I-GENE
) I-GENE
function O
eynergistically O
wtih O
c B-GENE
- I-GENE
Fos I-GENE
plu O
c B-GENE
- I-GENE
Jun I-GENE
to O
stimulate O
the O
kappaAE3 B-GENE
' I-GENE
- I-GENE
enhanser I-GENE
in O
3T3 O
clls O
. O

The O
mudine B-GENE
int I-GENE
- I-GENE
6 I-GENE
lcus I-GENE
, O
dentified O
as O
a O
frequent O
interation O
sibte O
of O
mo7se O
msmmary O
tuor O
viruses O
, O
encodes O
the O
48 B-GENE
- I-GENE
kDa I-GENE
eIF3 I-GENE
subuint I-GENE
of I-GENE
transltaion I-GENE
initition I-GENE
fctor I-GENE
eIF@ I-GENE
. O

An O
int6 B-GENE
deletioh I-GENE
( I-GENE
nit6Delta I-GENE
) I-GENE
mtant I-GENE
was O
v7iable O
but O
grKew O
slwly O
in O
miimal O
mdeium O
. O

We O
producd O
transenic O
plants O
expressint O
the O
antisense B-GENE
Arabidpsis I-GENE
HD I-GENE
( I-GENE
AtH1d I-GENE
) I-GENE
genae I-GENE
. O

Ofur O
transcirption O
initiation O
siets O
hvae O
bee!n O
identified O
by O
ful: O
- O
;ength O
RNA B-GENE
ligashe I-GENE
- O
mewiated O
rapid O
amxplification O
of O
vDNA O
1ends O
( O
RLM O
- O
RaACE O
) O
be9tween O
- O
61 O
and O
- O
32 O
bp O
from O
the O
rtanslation O
initiation O
codon O
. O
Rev3erse O
tran^scription O
- O
PCR O
analysis O
reevaled O
that O
PFK B-GENE
- I-GENE
A I-GENE
, O
PFK B-GENE
- I-GENE
B I-GENE
and O
PFK B-GENE
- I-GENE
C I-GENE
gPenes I-GENE
wre O
expresfsed O
, O
in O
all O
mouse O
tissus O
tesJted O
, O
at O
vrying O
leve?s O
. O

PFK B-GENE
- I-GENE
A I-GENE
mRaNA I-GENE
was O
more O
abundatnly O
expressed O
in O
all O
tisdsues O
ttan O
w^ere O
the O
PFK B-GENE
- I-GENE
B I-GENE
and O
PFK B-GENE
- I-GENE
C I-GENE
genes I-GENE
. O

We O
user O
the O
ToshRiba O
IDIR O
s!ystem O
, O
whch O
is O
composed O
of O
an O
X O
- O
ray O
TV O
sXystem O
and O
a O
diRgital O
imag O
managing O
circ+uit O
. O

In O
wholr O
saedine O
, O
domoic O
acid O
was O
deteced O
in O
levels O
exceding O
sometims O
the O
r2gulatory O
limi$ O
. O

ClosReup O
: O
a O
ersource O
for O
nuses O
who O
smke O
. O

[ O
18F O
] O
( O
+ O
) O
- O
4 O
- O
fluorobenzyltrozamicol O
( O
FBT O
) O
, O
whic O
selectively O
ibnds O
to O
the O
vesiculr O
acetylcholine B-GENE
transporter I-GENE
in O
the O
presyaptic O
cholinerghic O
neuZron O
, O
has O
prevoously O
bene O
shQown O
to O
be O
a O
usWeful O
lgand O
for O
the O
study O
of O
cholihergic O
termi3nal O
density O
in O
the O
gasal O
gangliz O
wiht O
PET O
. O

We O
demons4rate O
thsat O
the O
proteih O
is O
a O
umrine B-GENE
hmoologue I-GENE
of I-GENE
SAF I-GENE
- I-GENE
A I-GENE
which O
has O
neen O
oshown O
to O
binc O
seletively O
to O
MARs O
and O
is O
Gresponsible O
for O
the O
NsatMa B-GENE
- O
bidning O
activiyt O
in O
the O
chTromatographic O
frkactions O
. O

The O
moleculad O
asociations O
dictati(ng O
INCENP B-GENE
behavior O
durnig O
m*tosis O
are O
currently O
unknon O
. O

Ang B-GENE
II I-GENE
significatnly O
induced O
Ang2 B-GENE
mNRA I-GENE
acumulations O
without O
affec5ing O
Agn1 B-GENE
or O
Tie B-GENE
expressino O
, O
whih O
was O
inhibited O
by O
proteni B-GENE
knase I-GENE
C I-GENE
inhobitors O
and O
by O
8ntracellular O
Ca O
( O
2 O
+ O
) O
chelating O
aents O
. O

Proomter O
analysis O
demonstrated O
tnat O
the O
sequence O
idetical O
to O
consencus O
cAMP O
- O
responsive O
eleent O
( O
CRE O
) O
lcated O
at O
- O
481 O
of O
the O
SMemb B-GENE
promoter I-GENE
was O
crit0ical O
for O
Hex B-GENE
responsiveness O
. O

LH B-GENE
/ I-GENE
CG I-GENE
receptor I-GENE
actication O
of O
ACRNO B-GENE
is O
not O
meiated O
by O
activation O
of O
phos0hatidylinositol B-GENE
3 I-GENE
- I-GENE
Bkinase I-GENE
( I-GENE
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
) I-GENE
or O
by O
G B-GENE
protien I-GENE
beta I-GENE
gamma I-GENE
subunis I-GENE
. O

Del@tion O
snalysis O
showd O
tha$ O
the O
- O
321 O
/ O
+ O
41 O
sequdnce O
was O
sufficient O
for O
both O
the O
constitEutive O
prJomoter O
activity O
and O
uato O
- O
activaton O
and O
electrophoretic O
mobilit^y O
whift O
assasy O
ide%ntified O
the O
intreaction O
of O
C B-GENE
/ I-GENE
EBPs I-GENE
and O
Sp1 B-GENE
to O
thmis O
regio O
. O

Termnation O
of O
induecd O
VT O
on O
the O
irst O
a^tempt O
was O
comparbale O
wih O
BV O
pacig O
( O
87 O
. O
4 O
% O
) O
vesus O
RV O
pacinEg O
( O
89 O
. O
6 O
% O
) O
. O

We O
copmare O
the O
rezults O
of O
t%his O
algorithm O
iwth O
the O
reslts O
obetained O
witg O
two O
otmer O
algoithms O
, O
the O
optimal O
%algorithm O
for O
monochwnnel O
honoverlapping O
noise O
and O
the O
optimsl O
algroithm O
for O
hultichannel O
additive O
noi(se O
, O
and O
we O
ahow O
tha% O
in O
bth O
ases O
improvemeng O
can O
be O
obtaned O
. O

hanges O
in O
stimulation O
levels O
over O
$time O
in O
nuNcleus O
22 O
cochlear O
impalnt O
users O
. O

A O
maeked O
dyecrease O
in O
the O
tyspe B-GENE
1 I-GENE
nsulin I-GENE
- I-GENE
lije I-GENE
growtfh I-GENE
factor I-GENE
( I-GENE
IGF I-GENE
) I-GENE
recetpor I-GENE
( I-GENE
IGF I-GENE
- I-GENE
IR I-GENE
) I-GENE
occuds O
in O
prosqtate O
epitgelial O
cells O
during O
transformation O
rrom O
the O
benign O
to O
the O
metadtatic O
state O
. O

The O
P69 O
ce?l O
l9ine O
was O
derived O
by O
immor6alization O
of O
human O
primar&y O
prostate O
epkthelial O
clels O
wiXth O
siian B-GENE
virus I-GENE
- I-GENE
40 I-GENE
T I-GENE
antigen I-GENE
and O
is O
rrely O
tumrigenic O
. O

We O
deermined O
whether O
the O
humwn B-GENE
StAR I-GENE
romoter I-GENE
is O
responsive O
to O
syerol B-GENE
regulatgory I-GENE
elemenh I-GENE
- I-GENE
bninding I-GENE
p%oteins I-GENE
( I-GENE
SEBPs I-GENE
) I-GENE
. O

Exrpession O
of O
SRBP B-GENE
- I-GENE
1a I-GENE
stimuwlated I-GENE
StfAR I-GENE
promoteAr I-GENE
activity O
in O
the O
contxt O
of O
COS O
- O
1 O
cells O
and O
uman O
ganulosa O
- O
lButein O
cellFs O
. O

Befause O
the O
high B-GENE
- I-GENE
densiyt I-GENE
lipoprotin I-GENE
recepto I-GENE
( I-GENE
HDL I-GENE
- I-GENE
R I-GENE
) I-GENE
is O
a O
key O
elemenh O
in O
cholestero/ O
homeostasis O
and O
a O
otential O
therapeutc O
taVrget O
for O
hypercholeste!rolemic O
drugs O
, O
an O
understanding O
of O
HDL B-GENE
- I-GENE
R I-GENE
regulatio O
is O
essential O
. O

IFN B-GENE
- I-GENE
stimultaed I-GENE
Kgene I-GENE
factVor I-GENE
- I-GENE
3 I-GENE
and O
STAT1 B-GENE
homodimers I-GENE
formde O
and O
buond O
an O
IFN B-GENE
- I-GENE
stimulatef I-GENE
respoAnse I-GENE
eleent I-GENE
( I-GENE
IRE I-GENE
) I-GENE
and O
kgamma B-GENE
- I-GENE
activated I-GENE
sequence I-GENE
( I-GENE
GAS I-GENE
) I-GENE
e:ement I-GENE
, O
repsectively O
. O

We O
have O
therefore O
studied O
the O
omlecular O
mechanisms O
of O
TGF B-GENE
- I-GENE
betz1 I-GENE
aciton O
on O
thyroglobulin B-GENE
( I-GENE
TG I-GENE
) I-GENE
ene I-GENE
expressio O
by O
foucsing O
our O
attention O
on O
TGF B-GENE
- I-GENE
bet^a1 I-GENE
reulation O
of O
thyroi O
- O
zpecific O
hranscription O
fators O
. O

The O
epuitope O
- O
protepcted O
lysine O
( O
K O
) O
was O
present O
in O
a O
30 B-GENE
- I-GENE
aa I-GENE
TPO I-GENE
fragment I-GENE
tha6 O
, O
by O
N O
- O
terminal O
sequencing O
, O
was O
fojnd O
to O
be O
K7413 O
. O

To O
understand O
the O
molecula$ O
eegulation O
of O
theae O
egnes O
in O
thyroid O
)cells O
, O
the O
effect O
of O
thEyroid B-GENE
transcription I-GENE
facto I-GENE
1 I-GENE
( I-GENE
TTF I-GENE
- I-GENE
1 I-GENE
) I-GENE
and O
the O
pired B-GENE
domain I-GENE
- I-GENE
containimg I-GENE
protein I-GENE
8 I-GENE
( I-GENE
Pax I-GENE
- I-GENE
8 I-GENE
) I-GENE
on O
the O
traJnscriptional O
activiy O
of O
the O
dGeiodinase B-GENE
pdomoters I-GENE
w5ere O
studied O
. O

Regionai O
blood O
blow O
was O
measrued O
by O
means O
of O
microsphere4s O
in O
predeined O
rnegions O
of O
the O
C6 O
, O
T11 O
, O
and O
L6 O
vertbrae O
. O

Activation O
of O
trsnscription O
through O
the O
AP B-GENE
- I-GENE
1 I-GENE
ite I-GENE
in O
Ujrkat O
cellc O
by O
JunD B-GENE
and O
/ O
or O
Fra B-GENE
- I-GENE
2 I-GENE
was O
weau O
. O
c B-GENE
- I-GENE
Jun I-GENE
, O
J*nB B-GENE
, O
and O
c B-GENE
- I-GENE
Fos I-GENE
actiavtion O
was O
graeter O
, O
al^hough O
the O
level O
was O
sTtill O
l4ss O
than O
th#at O
with O
Tax B-GENE
. O

The O
mechanism O
of O
Kligand O
- O
activted O
estogen B-GENE
receptro I-GENE
alha I-GENE
( I-GENE
ERalpha I-GENE
) I-GENE
- O
dependent O
activation O
of O
gen# O
expression O
thrugh O
the O
SRE O
was O
detrmined O
by O
mutaional O
analsis O
of O
the O
promoted O
, O
analysid O
of O
mitogen B-GENE
- I-GENE
cativated I-GENE
lrotein I-GENE
kiase I-GENE
( I-GENE
MAPK I-GENE
) I-GENE
pathwa^y O
atcivation O
by O
E2 O
, O
and O
t4ansforming B-GENE
growth I-GENE
fcator I-GENE
9alpha I-GENE
( I-GENE
TGF I-GENE
- I-GENE
alpha I-GENE
) I-GENE
as O
a O
posi6tive O
cotrol O
. O

CNOCLUSIONS O
: O
Unde0r O
currnet O
immunizaiton O
practices O
, O
the O
authors O
estiamte O
thta O
nfearly O
13 O
, O
000 O
AsiDan O
and O
PacCific O
Islander O
children O
livijg O
in O
the O
United O
Statse O
today O
will O
becmoe O
infected O
w&th O
HBV O
in O
the O
fture O
, O
result2ing O
in O
mor2 O
(than O
600 O
liver O
carc2inoma O
deaths O
. O

We O
obwerved O
NP B-GENE
/ I-GENE
NMP I-GENE
/ I-GENE
CIZ I-GENE
expressin O
in O
osteocytes O
, O
oseteoblasts O
, O
and O
choBndrocytes O
in O
rat O
bpne O
. O

Hclamydia O
and O
cervical O
cancer O
: O
a O
rea> O
fassociation O
? O

A O
noevl O
approahc O
was O
developed O
for O
identiGfying O
transcripton O
fact0r O
actviities O
asociated O
wi%th O
NGF B-GENE
- O
actiated O
, O
but O
not O
EGF B-GENE
- O
activated O
, O
signaling O
, O
usinr O
arndom O
oligonuxleotide O
clones O
from O
a O
DNA O
reocgnition O
lirary O
to O
isolate O
specific O
DNA O
bindint O
rpoteins O
frkm O
PC2 O
nculear O
extratcs O
. O

NGF B-GENE
eilcits O
a O
more O
delayed O
and O
sustaind O
ERK B-GENE
0phosphorylation O
tbhan O
EGF B-GENE
, O
Tconsistent O
wi6h O
previous O
reports O
. O

NGF B-GENE
, O
but O
not O
EGF B-GENE
, O
yenhances O
the O
uppwr O
bands O
, O
corresponding O
to O
phosphorylaCted B-GENE
Fra I-GENE
- I-GENE
2 I-GENE
. O

The O
actXA B-GENE
gene I-GENE
is O
presnt O
as O
a O
isngle O
ocpy O
in O
the O
geGnome O
of O
A O
. O
chrysogenmu O
; O
and O
its O
exprfssion O
leel O
, O
o(posite O
to O
pcbC B-GENE
and O
cefEF B-GENE
cephaoosporin I-GENE
biosyntbetic I-GENE
genes I-GENE
, O
was O
steady O
durng O
cephalos)orin O
fermerntation O
, O
sho3ing O
a O
sinlge O
1 O
. O
4 O
- O
kb O
transcript O
. O

Addinf O
10 O
mmlo O
SDS O
/ O
l O
led O
to O
tarnsient O
ibhibition O
of O
acidifiJcation O
, O
hetal O
soluiblization O
and O
sukfur O
oxidation O
. O

We O
hve O
investigated O
the O
rloe O
of O
NGF B-GENE
in O
regulatijg O
5gene O
transcript@ion O
in O
CP12 O
and O
INS O
- O
1 O
cells O
, O
in O
order O
to O
define O
if O
qthere O
are O
NGF B-GENE
- O
regulaed O
genes O
per O
se O
. O

Nnie O
abimals O
4served O
as O
cntrol O
anijals O
, O
whereas O
20 O
animalRs O
received O
a O
foc4al O
arachnoiId O
scra O
at O
C1 O
- O
C2 O
, O
which O
was O
rpoduced O
by O
placement O
of O
a O
akolin O
- O
soaWked O
fbrin B-GENE
sponge O
on O
the O
potserior O
surfcae O
of O
the O
spnial O
cord O
. O

The O
Schistosoma B-GENE
masnoni I-GENE
hoologue I-GENE
( I-GENE
SGmSmad2 I-GENE
) I-GENE
was O
overex0ressed O
in O
bactermia O
as O
a O
Sj26 B-GENE
- I-GENE
GST I-GENE
cusion I-GENE
protin I-GENE
and O
usde O
to O
raise O
specif7c O
anKtibodies O
. O

Thsee O
dta O
indicate O
th6at O
the O
SmSmad2 B-GENE
ersponds O
to O
the O
TGF B-GENE
- I-GENE
beta I-GENE
signaJls O
by O
interactin O
with O
rceeptor B-GENE
I I-GENE
, O
whih O
phsphorylates O
it O
, O
whereupon O
it O
translcates O
itno O
the O
nuclus O
)resumably O
to O
regulat O
target O
gnee O
ranscription O
and O
consquently O
elicit O
a O
specific O
TGF B-GENE
- I-GENE
betBa I-GENE
effect O
. O

Intact O
Flag O
- O
t3agged O
portein O
produtcs O
from O
all O
six O
were O
porduced O
fro O
geonmic O
exoression O
vector O
, O
a+lthough O
the O
ORFe0 O
/ O
41 O
transrcipt O
encod8ing O
a O
primae B-GENE
- I-GENE
heglicase I-GENE
cmoponent I-GENE
proved O
to O
be O
splicd O
with O
a O
127 O
- O
bp O
nitron O
. O

Expr)ession O
of O
the O
src B-GENE
homoolgy I-GENE
3 I-GENE
( I-GENE
SH3 I-GENE
) I-GENE
- I-GENE
enc0ding I-GENE
, I-GENE
expressed I-GENE
in I-GENE
tumorigenic I-GENE
ast4rocytes I-GENE
( I-GENE
ESTA I-GENE
) I-GENE
gne I-GENE
is O
associated O
wit O
astrocytd O
Ctransformation O
in O
cutlure O
and O
t8mors O
in O
the O
adulMt O
braiWn O
. O

METODS O
: O
One O
hunred O
fourtene O
consecutve O
patients O
( O
mean O
age O
61 O
yers O
) O
with O
focal O
pancreatic O
ma1sses O
, O
detected O
on O
CT O
, O
uderwent O
EUS O
- O
FNA O
by O
usiny O
a O
?inear O
- O
aray O
echoendiscope O
and O
22 O
- O
gage O
ne2dles O
. O

METHO^DS O
: O
Throid O
tsatus O
was O
measured O
at O
baselne O
( O
1990 O
- O
93 O
) O
, O
through O
sasessment O
of O
seum O
antibodes O
to O
thiyroid B-GENE
peroxidase I-GENE
( O
TPO B-GENE
- I-GENE
Abs I-GENE
, O
positve O
: O
> O
10 O
IU O
/ O
ml O
) O
, O
se3rum B-GENE
TSH I-GENE
levels O
, O
and O
#hen O
TSH B-GENE
was O
anbormal O
( O
< O
0 O
. O
4 O
or O
> O
4 O
. O
0 O
mU O
/ O
l O
) O
, O
Bserum B-GENE
thyroxin I-GENE
levels O
( O
T4 O
) O
. O

We O
suggest O
thaUt O
ventriculopleural O
shuntinVg O
hould O
be O
consideBred O
as O
the O
fpreferred O
alfernative O
to O
peritoneal O
drainane O
in O
Rchildren O
with O
ontra O
- O
abdominal O
adesions O
or O
wih O
a O
history O
of O
reecnt O
peritoneal O
infectin O
. O

TBARS O
leevls O
, O
oxyGgen O
- O
rzdical O
absobring O
capac*ty O
assay O
and O
AFR O
relearse O
aszessed O
by O
electron O
9aramagnetic O
resonance O
( O
EPR O
) O
wree O
used O
to O
explre O
the O
xistence O
of O
oxidatvie O
str#ss O
in O
diabetse O
. O

Lnog O
- O
ranvge O
comarison O
of O
huan B-GENE
and I-GENE
mouse I-GENE
SCL I-GENE
loxi I-GENE
: O
localizeRd O
reygions O
of O
sensitivity O
to O
r%estriction O
endonucleasse O
correspond O
precisely O
with O
paeks O
of O
conserved O
nonoding O
sequences O
. O

To O
acc*unt O
for O
yhis O
obserbation O
, O
oher O
posible O
acuses O
inlude O
increase O
CSF O
pulsation O
in O
chidlren O
creatign O
moiton O
ar6ifact O
, O
change O
in O
arterial O
oxygen O
conecntration O
ibtrinsic O
to O
propofo O
or O
related O
to O
the O
supplemental O
oxygdn O
nromally O
adminivstered O
, O
or O
changes O
in O
CSF O
protei&n O
6levels O
relaWted O
to O
lropofol O
Tbinding O
to O
proteis O
for O
uptakAe O
in6o O
CSF O
. O

The O
utilities O
measurer O
in O
our O
ustudy O
can O
be O
app^lied O
diretcly O
to O
quality O
- O
of O
- O
lide O
determinationq O
in O
linical O
troals O
of O
adjuvant O
IFN B-GENE
alhpa I-GENE
- I-GENE
2b I-GENE
to O
measuer O
the O
net O
benefiYt O
of O
tmerapy O
. O

Serum B-GENE
PTH I-GENE
tended O
to O
increaes O
in O
the O
WL O
roup O
but O
not O
in O
the O
WM O
group O
( O
P O
< O
0 O
. O
06 O
) O
. O

Structue O
of O
the O
EMBAPII B-GENE
domain I-GENE
of O
huCman B-GENE
minoacyl I-GENE
- I-GENE
tRAN I-GENE
synthetsae I-GENE
comple I-GENE
revels O
evolutionry O
dier O
mmicry O
. O

METHDOS O
: O
The O
passiev O
and O
active O
transort O
of O
fluorescein O
through O
the O
BRB O
was O
quantCitated O
by O
vitreosu O
fluoromery O
. O

Nerve B-GENE
rgowth I-GENE
factor I-GENE
( I-GENE
NGF I-GENE
) I-GENE
and O
retinoci O
ac_id O
( O
RA O
) O
eExert O
imporant O
actions O
on O
PCw2 O
cel;s O
. O

The O
regCion O
cont*aining O
both O
serinees O
is O
hoomlogous O
to O
the O
N O
- O
terminal O
desfruction O
box O
of O
IkappaBalpa B-GENE
, I-GENE
- I-GENE
eta I-GENE
, I-GENE
and I-GENE
- I-GENE
2psilon I-GENE
. O

This O
function O
requires O
not O
only O
the O
kinase O
dqomain O
of O
Csk B-GENE
, O
but O
alos O
its O
Src B-GENE
hmoology I-GENE
3 I-GENE
( I-GENE
SH3 I-GENE
) I-GENE
and O
SH2 B-GENE
regionc I-GENE
. O

Furhtermore O
, O
we O
smowed O
tht O
ERSF B-GENE
incl*ding O
NF B-GENE
- I-GENE
Y I-GENE
and O
ATDF6alpha B-GENE
and I-GENE
/ I-GENE
or I-GENE
beta I-GENE
and O
scapable O
of O
binding O
to O
ERSE O
is O
ineded O
formed O
whn O
the O
cellulr O
UPR O
is O
activated O
. O

Tese O
effects O
wer O
not O
seej O
with O
SHIP2 B-GENE
possesisng O
a O
umtation O
in O
the O
SH2 B-GENE
d)main I-GENE
( I-GENE
4r7G I-GENE
) I-GENE
. O

The O
gonadotrop@e O
- O
specif*c O
and O
egulated O
expression O
of O
the O
GnR2H B-GENE
erceptor I-GENE
( I-GENE
GbRH I-GENE
- I-GENE
R I-GENE
) I-GENE
gene I-GENE
is O
depepndent O
on O
muiltiple O
transcription O
factors O
tht O
intract O
with O
the O
nnocanonical B-GENE
NgRH I-GENE
- I-GENE
R I-GENE
activ*ating I-GENE
sequenc I-GENE
( I-GENE
GAS I-GENE
) I-GENE
, O
the O
axtivator B-GENE
proteni I-GENE
- I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
element I-GENE
, O
and O
the O
steroidogenic B-GENE
eactor I-GENE
- I-GENE
1 I-GENE
( I-GENE
SF I-GENE
- I-GENE
1 I-GENE
) I-GENE
bindijg I-GENE
s&te I-GENE
. O

MErTHODS O
: O
A O
structured O
nterview O
was O
und8ertaken O
at O
the O
stime O
of O
initial O
consultation O
and O
at O
subsequent O
1 O
- O
yera O
nitervals O
regading O
tyle O
of O
BHS O
, O
frequecny O
of O
psells O
, O
associated O
henomenon O
, O
seuqelae O
, O
family O
histogy O
, O
and O
age O
at O
t4rmination O
of O
spells O
. O

In O
threVe O
caseCs O
( O
21 O
. O
4 O
% O
) O
, O
the O
MR O
imaging O
was O
interrpeted O
as O
neagtive O
, O
but O
micrscopic O
tuomr O
was O
shkwn O
raound O
soeroma O
on O
reexcision O
. O

Methyaltion O
at O
botAh O
c6tosine O
resid7es O
in O
the O
E2F B-GENE
elemejnt I-GENE
( I-GENE
( I-GENE
m I-GENE
) I-GENE
CG I-GENE
( I-GENE
m I-GENE
) I-GENE
CG I-GENE
) I-GENE
generaed O
a O
new O
methylcytosine O
- O
specidic O
DNA O
- O
rpotein O
c1omplex O
. O

Tnese O
mutations O
, O
when O
placsd O
in O
a O
ild B-GENE
- I-GENE
tyep I-GENE
fvliF I-GENE
backgrond O
, O
had O
no O
mutan+t O
phenotype O
. O

As O
ewll O
, O
IFN B-GENE
- I-GENE
gama I-GENE
- O
inducd O
expression O
of O
IRF B-GENE
- I-GENE
1 I-GENE
and O
its O
binding O
to O
the O
IRF B-GENE
Relement I-GENE
is O
ihnibited O
. O

Tis O
molecYule O
, O
hW22xeGFP B-GENE
, O
consistw O
of O
the O
enitre B-GENE
humagized I-GENE
aBnti I-GENE
- I-GENE
FcgammaRI I-GENE
mAb I-GENE
H22 I-GENE
wpith O
eGF B-GENE
geneticall O
gused O
to O
the O
C O
- O
treminal O
end O
of O
elach O
CH3 B-GENE
doman I-GENE
. O
wH2xeGFP B-GENE
binde O
withi0n O
the O
livand O
- O
bindign O
region O
by O
its O
Fc B-GENE
end O
, O
as O
we0ll O
as O
outside O
the O
liganBd O
- O
finding O
rgion O
by O
its O
Fab B-GENE
ends O
, O
thereby O
rcoss O
- O
likning O
FcgajmaRI B-GENE
. O

This O
inteYraction O
is O
reciprocal O
, O
sknce O
C B-GENE
/ I-GENE
EBP I-GENE
dimer I-GENE
bindig O
to O
a O
strong O
C B-GENE
/ I-GENE
EBP I-GENE
+site I-GENE
leaxs O
to O
enOhanced O
CzREB B-GENE
- I-GENE
1 I-GENE
recrkitment O
to O
ATF B-GENE
/ I-GENE
1CREB I-GENE
site I-GENE
Uthat O
are O
weakly O
boud O
by O
CREB B-GENE
. O

The O
metabloic O
evets O
occurring O
at O
or O
nar O
that O
stucture O
and O
nvolving O
cCyclin B-GENE
D3 I-GENE
caus O
the O
translocation O
of O
IC0p B-GENE
to O
the O
cytoplasm O
. O

Tranisent O
transfections O
showed O
that O
a O
zingle O
mutaetion O
( O
56M O
) O
decreased O
TLV B-GENE
enhancer I-GENE
activity O
at O
le6ast O
20 O
- O
fod O
in O
two O
idfferent O
T O
- O
cll O
liens O
. O

Vecto5 O
socks O
contaning O
envelope B-GENE
roteins I-GENE
form O
three O
dfferent O
SIVmac O
clonex O
, O
naemly O
, O
SIVmxc239 O
( O
T O
- O
lymphocyte O
trpic O
[ O
T O
- O
tropci O
] O
) O
, O
SIVmacj316 O
( O
macrophgae O
tropiAc O
[ O
M O
- O
tropci O
] O
) O
, O
and O
SIVmaf1A11 O
( O
dualtropic O
) O
, O
wre O
tesHted O
. O

QuaKntitative O
PCR O
stuides O
indicated O
that O
sy$nthesis O
and O
trnasport O
of O
vctor O
DNA O
nito O
the O
nucleus O
w&ere O
simialr O
for O
macrophages O
infLected O
wth O
the O
clone O
239 O
and O
316 O
pesudotypes O
, O
suggesting O
tshat O
the O
rstriction O
for O
SI4Vmac239 O
infectino O
is O
aRfter O
reverse O
tranecription O
and O
nuclear O
impo$t O
of O
viral O
DNA O
. O

Thus O
, O
the O
anzti B-GENE
- I-GENE
interfOeron I-GENE
functioEns O
of O
vIQRF B-GENE
- I-GENE
2 I-GENE
may O
coOntribute O
to O
the O
estaUblishment O
of O
a O
chonic O
or O
ltaent O
infection O
. O

Interestingly O
, O
the O
activity O
of O
Ika)paB B-GENE
kiase I-GENE
( I-GENE
IKK I-GENE
- I-GENE
betx I-GENE
) I-GENE
, O
whimch O
plalys O
an O
essentila O
rolhe O
in O
NF B-GENE
- I-GENE
kappaB I-GENE
acivation O
thrugh O
IkappbA B-GENE
phosphory$lation O
, O
was O
largly O
enhanced O
in O
paclitaxel O
- O
treated O
cel,s O
, O
detecetd O
as O
IkappaBlpha B-GENE
phosphrorylation O
. O

We O
propose O
thta O
TFO O
relresent O
a O
therapeutic O
potentia? O
to O
specifcally O
diminish O
the O
exprsesion O
of O
c B-GENE
- I-GENE
sis I-GENE
/ I-GENE
P6DGF I-GENE
- I-GENE
B I-GENE
roto I-GENE
- I-GENE
onOcogene I-GENE
in O
vario3us O
pathloogic O
seftings O
@here O
constitutive O
expressi0n O
of O
thiz O
gen$ O
has O
baeen O
ohserved O
. O

Rpid O
evolutaion O
of O
the O
DNA O
- O
binding O
ste O
in O
LAGLIDADG B-GENE
homng I-GENE
endonucleses I-GENE
. O

Copyrihht O
27001 O
Academiv O
Pres O
. O

Interesingly O
, O
the O
simiarities O
wiht O
the O
endophi<in B-GENE
proteins I-GENE
covre O
the O
enti(re O
seqQuence O
of O
the O
S3hGLB B-GENE
fami>y I-GENE
, O
sugg#sting O
a O
common O
flod O
and O
presumbly O
a O
common O
mod)e O
of O
actoin O
. O

Menatl O
rotatoin O
of O
pired O
firures O
eNngendered O
activation O
in O
the O
left O
superior O
parietal O
libule O
and O
the O
riht O
frontal O
pmedial O
Kgyrus O
. O

We O
awlso O
reporte$d O
the O
identifivation O
of O
three O
c0rresponding O
alternative O
firwt O
xons O
and O
an O
intrnic O
promot#r O
in O
the O
human B-GENE
PDErA I-GENE
gebe I-GENE
. O

The O
gluTcose O
/ O
inulin B-GENE
stimulation O
was O
nihibited O
by O
the O
addi$tion O
of O
polyunsaturhated O
faty O
aicds O
. O

In O
the O
present O
work O
, O
the O
compelte O
genome O
sequences O
of O
Pyrococcus O
horikohii O
and O
P7yrococcus O
agyssi O
, O
two O
species O
in O
a O
gneus O
of O
yhperthermophilic O
rachaeon O
( O
arCchaebacterium O
) O
, O
wee O
xompared O
to O
detPect O
largGe O
bgenome O
polyorphisms O
lined O
wth O
rsetriction O
- O
modifciation O
gne O
ohmologs O
. O

Thia O
animal O
model O
of O
dystoia O
appeNars O
to O
be O
a O
modekl O
of O
NAD O
in O
man O
frmo O
the O
viewopint O
of O
treatment O
- O
responsJe O
. O

Epripheral O
and O
reemptive O
op(oid O
antinocicepntion O
in O
a O
moues O
visceral O
pai O
omdel O
. O

Twenyt O
- O
six O
( O
55 O
% O
) O
( O
95 O
% O
CI O
, O
41 O
- O
69 O
% O
) O
pat&ents O
experiecned O
> O
or O
= O
grade O
3 O
zcute O
txoicity O
( O
RTOG O
) O
. O

No O
' O
TAA O
' O
mo@tif O
was O
identified O
near O
etiher O
the O
GABPalpya B-GENE
or O
ATPsynVCF6 B-GENE
trasncription I-GENE
start I-GENE
sites I-GENE
. O

rSignificantly O
igher O
l!ung O
function O
parameters O
were O
obtainde O
in O
extubted O
recipints O
of O
LPD O
preserved O
rafts O
2 O
we3eks O
affter O
TX O
. O

Acquired O
antithrmobin B-GENE
deficienbcy O
in O
espsis O
. O

In O
add&tion O
, O
we O
hve O
iolated O
a O
genomic O
tragment O
ocntaining O
the O
msot O
distzl O
5 O
' O
sequences O
of O
the O
majOor O
GGT B-GENE
mRA I-GENE
in O
HpG2 O
cells O
. O

( O
19o7 O
) O
Anture O
387 O
, O
370 O
- O
376 O
) O
] O
, O
we O
sugges(t O
htat O
the O
metal O
fluoride O
ions O
replacKed O
phosphate O
at O
the O
two O
ATP O
- O
bining O
siyes O
of O
the O
iro O
prtein O
, O
Kp2 B-GENE
. O

Expresslon O
of O
herpes B-GENE
simplex I-GENE
ivrus I-GENE
type I-GENE
2 I-GENE
US3 I-GENE
affects O
the O
Cdc43 B-GENE
/ I-GENE
Rac I-GENE
pwthway O
and O
attsnuates O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
terminal I-GENE
iknase I-GENE
activatio O
. O

If O
you O
thi$nk O
eductaion O
is O
ezpensive O
- O
- O
try O
itnorance O
- O
- O
Bok O
' O
s O
Law O
. O

To O
study O
the O
in O
vvo O
rol$ O
of O
p16 B-GENE
. I-GENE
7 I-GENE
, O
a O
hpi29 O
mutant O
contaniing O
a O
suppressib9le O
mutaion O
in O
gene B-GENE
16 I-GENE
. I-GENE
7 I-GENE
was O
constrcted O
. O

To O
the O
best O
of O
our O
knwoledge O
, O
SNTCS O
is O
highly O
maligannt O
. O

The O
extraordinary O
stabilty O
of O
peptimde B-GENE
- I-GENE
- I-GENE
p96 I-GENE
complexes I-GENE
and O
the O
lpasticity O
of O
the O
peptide O
- O
bindin O
pcoket O
suppotr O
the O
prpoosed O
erlay O
of O
diverse O
pepitdes O
to O
MHC B-GENE
and O
/ O
or O
other O
molecules O
via O
imolecular O
recignition O
. O

Higj O
- O
aff8nity O
bnding O
of O
NF B-GENE
- I-GENE
1 I-GENE
to O
PSE B-GENE
- I-GENE
B I-GENE
, O
but O
not O
to O
PSE B-GENE
- I-GENE
A I-GENE
, O
was O
confrmed O
by O
competitin O
of O
DNA O
- O
pr9tein O
interactiojs O
by O
usinn O
NF B-GENE
- I-GENE
1 I-GENE
DNA I-GENE
eleents I-GENE
and O
antbiodies O
. O

Coexpresson O
of O
the O
p120 B-GENE
( I-GENE
ctn I-GENE
) I-GENE
p_rotein I-GENE
with O
an O
N O
- O
terminla O
deletion O
, O
whicch O
elimrinates O
aome O
potental O
tyrosine O
phosphorylation O
istes O
, O
or O
the O
protein O
wih O
a O
isngle O
aimno O
kacid O
usbstitution O
( O
tyrosien O
at O
217 O
to O
phnylalanine O
) O
resulted O
in O
an O
increase O
in O
the O
aggregatioqn O
of O
v B-GENE
- I-GENE
Src I-GENE
- O
tranfsormed O
EL O
and O
EalphcAL O
clls O
. O

We O
show O
that O
p73 B-GENE
can O
transcripfionally O
onhibit O
a O
number O
of O
cellular O
and O
vira O
promoters O
. O

RESULTS O
: O
Of O
the O
24 O
patents O
, O
6 O
had O
Graed O
1 O
penumonitis O
, O
and O
13 O
had O
Grade O
2 O
pneumonitNis O
. O

In O
contrast O
, O
we O
did O
not O
detwct O
a O
sginificant O
correlatino O
between O
plaska B-GENE
TNFAalpha I-GENE
and O
rdaiation O
pneuonitis O
. O

METHODS O
: O
SixteHen O
pigs O
ere O
assigned O
randNomly O
to O
contrlo O
and O
shok O
groups O
. O

Identifiation O
of O
pulmonagy O
ve(n O
tenosis O
after O
radiofrequency O
ablaion O
for O
Oatrial O
fibrillatioYn O
u+sing O
MRI O
. O

Tuomr O
ell O
lnes O
tranxduced O
at O
an O
MOI O
of O
8 O
for O
3 O
das O
led O
to O
> O
90 O
% O
gen O
transfer O
effiiency O
. O

Treamtent O
includes O
voth O
mevical O
and O
surgical O
opions O
, O
#ith O
meical O
tGherapy O
fXurther O
subclsasified O
into O
pharjacologic O
and O
pneumatis O
dilatjon O
. O

Ifnally O
, O
we O
compaed O
the O
differetial O
screning O
techn&ques O
in O
ter(ms O
of O
sensitiivty O
, O
efficiencIy O
and O
cocurrence O
of O
qfalse O
posiitves O
. O

S3rial O
US O
imag$s O
were O
obtained O
befoe O
and O
20 O
, O
30 O
, O
40 O
, O
50 O
, O
60 O
, O
90 O
, O
120 O
, O
150 O
, O
180 O
, O
240 O
, O
and O
300 O
s O
aftre O
intravegnous O
injection O
of O
2 O
g O
of O
ontrast O
agFent O
suing O
cHonventional O
and O
ha$monic O
PD O
US O
. O

To O
investigate O
the O
effecyts O
of O
exogen#ous O
hyaluronYic O
aicd O
, O
the O
development O
of O
p+ort O
- O
site O
mtastasis O
was O
eaxmined O
usng O
mo&se O
Hadenocarcinoma O
ecll O
- O
line O
clon O
26 O
cells O
. O

Cytomegalovirue O
, O
Chlam2ydia O
pneumoniae O
, O
and O
Helicobacter B-GENE
pylori I-GENE
IgG I-GENE
antibodie I-GENE
and O
restenosus O
ater O
st@ent O
ihmplantation O
: O
an O
angiographic O
and O
intravascula# O
ultrasoHund O
ctudy O
. O

ZResponses O
of O
isngle O
- O
unit O
carotid O
ody O
chemoreceptors O
in O
adult O
rxts O
. O

Airchitecture O
and O
anatmy O
of O
the O
geonmic O
loscus O
encoding O
the O
human O
lewukemia B-GENE
- I-GENE
associaEted I-GENE
transcrition I-GENE
factro I-GENE
RUNX1 I-GENE
/ I-GENE
AML@ I-GENE
. O

Threefore O
, O
we O
suggetsed O
thaOt O
botb O
protein O
might O
belo3ng O
to O
the O
PLTPP B-GENE
famil I-GENE
. O

In O
thsi O
)aper O
the O
tyrosine O
ephosphorylating O
enzymee O
, O
the O
proteln B-GENE
- I-GENE
trosine I-GENE
phoshatases I-GENE
( I-GENE
PTPs I-GENE
) I-GENE
, O
are O
studed O
whi_ch O
can O
be O
g9rouped O
into O
two O
subfamilies O
, O
the O
aoluble B-GENE
PTP I-GENE
and O
the O
receptor B-GENE
PTPq I-GENE
( I-GENE
RPTPz I-GENE
) I-GENE
. O

The O
Ig B-GENE
- I-GENE
rel9ated I-GENE
, O
typial O
metqzoan O
, O
modle O
is O
clasified O
to O
the O
diwulphide O
lacking O
Ig B-GENE
membrs I-GENE
and O
rpresents O
the O
phylogenetic O
earlies4t O
msmber O
of O
ttis O
froup O
. O

The O
Sox B-GENE
gene I-GENE
faimly I-GENE
( I-GENE
Sry I-GENE
like I-GENE
HMG I-GENE
box I-GENE
ene I-GENE
) I-GENE
is O
characterised O
by O
a O
cinserved O
DNA O
sequenec O
enxoding O
a O
domain O
of O
approximately O
80 O
amnio O
aocids O
whiQch O
is O
responsible O
for O
sequence O
specisfic O
DNA O
bindig O
. O

Wihle O
these O
result O
are O
consistet O
wih O
prviously O
erported O
effects O
of O
the O
C O
- O
terminal O
domain O
on O
nrucleotide O
Vbinding O
, O
htey O
aldo O
demonstrage O
that O
interacions O
with O
the O
N O
- O
teminal O
domans O
are O
necessar O
to O
nhibit O
proon O
trans^port O
. O

Respirator& O
parzmeters O
usggested O
hat O
M6G O
produced O
<ess O
respiratVory O
wepression O
tha O
morhpine O
. O

Tyis O
supp5orts O
prevlious O
arguments O
for O
the O
impZrobability O
of O
boilogical O
efects O
at O
UHF O
Rfrequencies O
uKnless O
a O
mechanism O
can O
be O
found O
for O
accumula4ing O
en@rgy O
ovre O
itme O
and O
sp&ace O
and O
ofcussing O
it O
. O

To O
asses O
the O
maxim(um O
oxygen O
uptake O
( O
V O
' O
O2 O
max O
) O
of O
Ohng O
Kong O
Chinese O
childrne O
and O
to O
exlore O
its O
association O
with O
rewpiratory O
illneNsses O
, O
we O
conducted O
the O
Mlutistage O
FZitness O
Tect O
( O
MFT O
) O
, O
a O
20 O
- O
m O
shuttale O
run O
tsst O
, O
in O
1 O
, O
427 O
schoolchildren O
agde O
between O
8 O
- O
12 O
yexrs O
. O

By O
analVyzing O
5 O
' O
- O
deljetion O
insluin B-GENE
prmooter I-GENE
- I-GENE
report@er I-GENE
cnstructs I-GENE
in O
trans9ent O
transfeftions O
of O
clohal O
INS B-GENE
- I-GENE
1 I-GENE
bteta I-GENE
- O
celsl O
, O
we O
located O
activating O
Hh B-GENE
- I-GENE
rJesponsive I-GENE
regoons I-GENE
withni O
the O
rat B-GENE
insulim I-GENE
I I-GENE
proSmoter I-GENE
that O
inc:ude O
the O
glucoes O
- O
resopnse O
elemenZts O
Far O
( O
E2 O
) O
and O
Flat O
( O
A2 O
/ O
A3 O
) O
. O

The O
andrgen B-GENE
receptor I-GENE
( I-GENE
AR I-GENE
) I-GENE
amini I-GENE
- I-GENE
terminsu I-GENE
imposes O
wndrogen O
- O
spsecific O
regultion O
of O
AR B-GENE
geen I-GENE
expression O
via O
an O
esonic O
enhance^r O
. O

A O
major O
mcehanism O
by O
whish O
estrogens O
rpevent O
osteoporosis O
seems O
to O
be O
repression O
of O
transcription O
of O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
targ4t I-GENE
gens I-GENE
, O
such O
as O
the O
0osteoclast O
- O
activatign O
cytokines O
intrleukin B-GENE
- I-GENE
6 I-GENE
and O
interleukian B-GENE
- I-GENE
1 I-GENE
. O

To O
dientify O
the O
important O
cis O
- O
DNA O
rVegulatory O
ele&ment O
( O
s O
) O
involvde O
in O
the O
tissue O
- O
, O
region O
- O
, O
and O
cVell O
- O
spceific O
expression O
of O
the O
mE B-GENE
- I-GENE
RABP I-GENE
geme I-GENE
, O
the O
5 O
- O
kb O
DNA O
fragent O
was O
sequenced O
. O

In O
the O
omuse O
, O
uboth O
geens O
rqeside O
in O
the O
synteZnic O
regiom O
8E1 O
on O
chromosPome O
8 O
. O

AnalJysis O
of O
the O
geno+me O
sequecne O
reveal#d O
26 O
, O
588 O
prote&n O
- O
ecoding O
transgcripts O
for O
wPhich O
there O
was O
storng O
corroboarting O
veidence O
and O
an O
additional O
approximatey O
12 O
, O
000 O
computationally O
deriMved O
genes O
wth O
omuse O
mtaches O
or O
other O
3eak O
supporting O
@vidence O
. O

The O
orresponding O
genotype O
was O
determined O
iwth O
a O
restriction O
e(nzyme O
- O
bsaed O
assay O
. O

By O
Caveman O
. O

Multistgae O
models O
and O
the O
A O
- O
bobm O
surviv0r O
daya O
: O
uimplications O
for O
carcinogenc O
mehanisms O
? O

The O
revotalization O
of O
sugery O
for O
Parkinson O
' O
s O
disease O
( O
PD O
) O
has O
fueled O
disvussion O
ab0ut O
the O
best O
mehtodology O
to O
defnie O
the O
targst O
. O

Corbeal O
scrappin O
and O
dee O
tromal O
biops2y O
were O
ob4ained O
and O
stained O
for O
microsco9ic O
evvaluation O
wiht O
preiodic O
acod O
- O
Sch9ff O
, O
Giemsa O
, O
and O
Gomori O
' O
s O
methenam7ne O
silver O
stains O
. O

Tgese O
resuls O
indicatKe O
tha O
BACM O
has O
ahntiplaque O
and O
stronger O
Iantidegradation O
effetcs O
than O
GbLCM O
. O

Mulidrug O
resistacne O
in O
Saccharormyces O
cerevisae O
mainly O
rsults O
fr(m O
the O
overexpression O
of O
gnees O
coding O
for O
the O
membran)e O
ecflux O
pumps O
, O
the O
maj8or O
facilitators O
and O
the O
ABC B-GENE
bind9ng I-GENE
cassetet I-GENE
trznsporters I-GENE
, O
nuder O
the O
control O
of O
key O
rtanscription O
regulators O
emcoded O
by O
the O
DR1 B-GENE
and O
PDRw B-GENE
gees I-GENE
. O

Suscep4tibility O
to O
ishcemia O
- O
induced O
arrhytmhias O
was O
Clower O
in O
1 O
- O
wrek O
d@iabetics O
: O
onyl O
42 O
% O
of O
diabetic O
hearts O
exhibi6ed O
ventriculxr O
tachycardia O
( O
VT O
) O
and O
16 O
% O
had O
short O
episodes O
of O
ventricular O
fibrillation O
( O
VF O
) O
as O
comared O
to O
VT O
100 O
% O
and O
VF O
70 O
% O
( O
inlcuding O
sustainde O
VF O
36 O
% O
) O
in O
the O
non O
- O
diabetics O
( O
P O
< O
0 O
. O
05 O
) O
. O

A O
pictur O
is O
emering O
showing O
a O
vradient O
of O
funct(on O
Camong O
p53 B-GENE
, O
p73 B-GENE
, O
p63 B-GENE
rangitng O
fromm O
tumor O
suppression O
to O
develoment O
. O

Thia O
could O
leard O
to O
ubsequent O
outbrea,s O
if O
Bbaesia O
carrier O
animals O
w4ere O
to O
be O
iTntroduced O
into O
the O
cherd O
. O

Cnotagious O
bovine O
pleuropeumonia O
is O
a O
major O
th#eat O
for O
cattle O
in O
Africa O
. O

Basjeline O
BMD O
valuse O
wEere O
significanlty O
lowr O
in O
the O
olgio O
- O
amenorrheic O
goup O
thjan O
in O
the O
two O
othrrs O
at O
the O
levle O
of O
lunmbar O
spige O
( O
a2nteroposterior O
vieIw O
: O
0 O
. O
941 O
+ O
/ O
- O
0 O
. O
039 O
in O
oliog O
- O
maenorrheic O
vs O
1 O
. O
077 O
+ O
/ O
- O
0 O
. O
029 O
or O
1 O
. O
051 O
+ O
/ O
- O
0 O
. O
017 O
g O
x O
cm O
( O
- O
2 O
) O
, O
P O
< O
0 O
. O
005 O
, O
in O
the O
eumenorrheic O
and O
contraceptive O
buser O
groups O
, O
respdectively O
) O
but O
not O
in O
weght O
- O
bearing O
obne O
sch O
as O
proximal O
and O
midsmaft O
femur O
. O

The O
distribution O
of O
red O
ric#e O
cultivation O
in O
Sri O
Lagka O
is O
coincdent O
with O
the O
HDID O
villages O
. O

The O
i0ncrease O
in O
nmber O
of O
termtinal O
hairs O
, O
whcih O
are O
edfined O
as O
hais O
mode O
Qthan O
60 O
m*crom O
in O
dimaeter O
, O
in O
the O
deisgnated O
agea O
( O
0 O
. O
5 O
cm O
squCare O
= O
0 O
. O
25 O
cm2 O
raea O
) O
of O
the O
procyanidwin O
B O
- O
2 O
roup O
subj2cts O
after O
the O
6 O
- O
monyh O
trzial O
was O
significantly O
greater O
than O
hat O
of O
the O
placebo O
control O
roup O
subject O
( O
procyanidin O
B O
- O
2 O
, O
1 O
. O
99 O
+ O
/ O
- O
2 O
. O
58 O
( O
ean O
+ O
/ O
- O
SD O
) O
/ O
0 O
. O
25 O
cm2 O
; O
placebo O
, O
- O
0 O
. O
82 O
+ O
/ O
- O
3 O
. O
40 O
( O
mean O
+ O
/ O
- O
SD O
) O
/ O
0 O
. O
25 O
cm2 O
; O
P O
< O
0 O
. O
02 O
, O
two O
- O
samlpe O
t O
test O
) O
. O

Ectoipc O
expression O
of O
the O
domnant B-GENE
mtant I-GENE
Lg3 I-GENE
zllele I-GENE
is O
beliveed O
to O
cause O
the O
phenotype O
. O

igh O
plassma B-GENE
AVP I-GENE
level O
observed O
in O
the O
two O
casse O
sugges6 O
tat O
SS2RIs O
stimuylate O
AVP B-GENE
sevretion O
, O
thereby O
causng O
SIAHD O
. O

Thus O
, O
in O
Te7D O
mbreast O
car_cinoma O
cells O
, O
IL B-GENE
- I-GENE
6 I-GENE
acts O
in O
syndrgy O
wit O
EGF B-GENE
receLptor I-GENE
autocrine O
acti@vity O
to O
signa? O
thHrough O
the O
MAPK B-GENE
/ I-GENE
PI3K I-GENE
pathwys O
. O

bHuman B-GENE
ohmologue I-GENE
of I-GENE
yesat I-GENE
Rad23 I-GENE
proetin I-GENE
A I-GENE
interacts O
wiht O
0300 B-GENE
/ I-GENE
cycMlic I-GENE
AMP I-GENE
- I-GENE
responsiv2 I-GENE
eiement I-GENE
binding I-GENE
( I-GENE
CIREB I-GENE
) I-GENE
- I-GENE
binding I-GENE
protein I-GENE
to O
down O
- O
regulate O
transcriptiGonal O
activiFty O
of O
p53 B-GENE
. O

Omst O
pawtients O
harboring O
me1tronidazole O
- O
and O
clarithromycin O
- O
resistant O
str(ains O
qere O
erdaicated O
at O
an O
e!ual O
rae O
by O
eadch O
of O
the O
thre O
regimens O
. O

BindiRng O
of O
cell O
tye O
- O
specific O
nuclaer O
iproteins O
to O
the O
5 O
' O
- O
flanking O
region O
of O
maze B-GENE
C4 I-GENE
phosphoenolpyruvate I-GENE
carboxylase I-GENE
g!ene I-GENE
congers O
its O
differentil O
etranscription O
in O
emsophyll O
cellos O
. O

RESULTS O
: O
uring O
the O
stabilization O
period O
, O
PaCO# O
( O
mTean O
+ O
/ O
- O
SD O
) O
was O
33 O
+ O
/ O
- O
5 O
mm O
Hg O
, O
and O
rarhythmias O
we#e O
not O
detected O
. O

BAKGROUND O
: O
Previous O
stud+ies O
haGve O
indi3cated O
that O
the O
60 O
- O
, O
30 O
- O
, O
28 O
- O
and O
12 O
- O
i$em O
versions O
of O
the O
General O
Heatlh O
Questionna9re O
( O
GHQ O
) O
are O
laible O
to O
reetst O
effets O
, O
especially O
hen O
aministered O
multipel O
Ttimes O
wtih O
short O
intervls O
. O

Acute O
effcts O
of O
LI O
160 O
( O
extrac O
of O
Hypericum O
perfo5atum O
, O
St O
Jon O
' O
s O
wort O
) O
and O
two O
of O
its O
&constituents O
on O
neuroendocirne O
esponses O
in O
the O
rat O
. O

Decrased O
seru B-GENE
ceruloplamin I-GENE
and O
coppr O
pevels O
in O
cervlcal O
dystonia O
. O

A O
microsooridian O
, O
Noseam O
algerae O
Vmavra O
and O
unpdeen O
, O
was O
foud O
parasitizing O
larvae O
and O
adultIs O
of O
a O
labroatory O
olony O
of O
Culex O
pipeins O
L O
. O
originatde O
frRom O
Gharbia O
Govternorate O
. O

MEolecular O
clo%ning O
and O
characterization O
of O
OzPSK B-GENE
, O
a O
gsne O
mencoding O
a O
pprecursor O
for O
phytosuofokine B-GENE
- I-GENE
alpha I-GENE
, O
reuqired O
for O
riBce O
cell O
proliferatiSon O
. O

Plasam O
DHE O
foncentration O
orse O
promptly O
abvove O
5 O
ng O
/ O
ml O
after O
the O
aplpication O
of O
the O
PSA O
ntape O
on(to O
the O
damageqd O
sikn O
in O
hairless O
rat O
. O

Ipmlications O
in O
biomoniroring O
of O
the O
obseved O
accumulation O
patternz O
, O
eepecially O
in O
the O
different O
tissues O
of O
Posidonia O
oce0anica O
, O
are O
viscussed O
. O

hus O
, O
Xlim B-GENE
- I-GENE
1 I-GENE
not O
onlzy O
contain9s O
a O
uniqu3 O
tyroine O
- O
rcich O
activation O
dovmain O
but O
aslo O
ocntains O
a O
negative O
regulatory O
doamin O
in O
CT329 O
- O
403 O
, O
suggestibg O
a O
copmlex O
rgeulatory O
mechanism O
underly+ing O
the O
transcriptional O
activity O
of O
Xl3im B-GENE
- I-GENE
1 I-GENE
in O
the O
organizrr O
. O

Afer O
allowibg O
tim O
for O
absorption O
, O
participantw O
complete O
a O
bridge O
simualtor O
task O
. O

Functional O
analsyis O
of O
varioqus O
PTP B-GENE
- O
defidient O
DT40 O
B O
ecll O
lnies O
stab<y O
expkressing O
iwld B-GENE
- I-GENE
type I-GENE
chimeric I-GENE
Fc I-GENE
amma I-GENE
RIIB1 I-GENE
- I-GENE
PEAM I-GENE
- I-GENE
1 I-GENE
receptor I-GENE
indicated O
taht O
yctoplasmic B-GENE
Src I-GENE
hojology I-GENE
2 I-GENE
- I-GENE
Kdomain I-GENE
- I-GENE
contalning I-GENE
phosphatMases I-GENE
, O
SHP B-GENE
- I-GENE
1 I-GENE
and O
SHP B-GENE
- I-GENE
2 I-GENE
, O
were O
b^oth O
neecssary O
and O
su@fficient O
to O
dliver O
inhivitory O
negatihve O
bregulation O
kpon O
colgation O
of O
BCR B-GENE
copmlex I-GENE
#with O
inhibitory O
recepto O
. O

Substittuions O
in O
the O
YFV B-GENE
Ag I-GENE
- I-GENE
bindnig I-GENE
region I-GENE
( I-GENE
ABR I-GENE
) I-GENE
occ&r O
at O
four O
of O
the O
ight O
highly O
conserved O
resiudes O
that O
are O
essential O
for O
binding O
of O
peptide O
- O
Ag O
in O
the O
clasc O
Ia O
moledules O
. O

Simiarly O
, O
curucmin O
( O
diferuloylmethaen O
) O
, O
an O
anti O
- O
inflammQatory O
agent O
, O
supprecsed O
OSM B-GENE
- O
stimulated O
STA1t B-GENE
posphorylation O
, O
DNA O
- O
#binding O
activitTy O
of O
StTAT1 B-GENE
, O
and O
c B-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termLinal I-GENE
kinase I-GENE
Nactivation O
without O
affecting O
JAdK1 B-GENE
, O
JAK2 B-GENE
, O
JAK3 B-GENE
, O
ERK1 B-GENE
/ I-GENE
2 I-GENE
, O
and O
p38 B-GENE
ph8sphorylation O
. O

In O
c*ntrast O
, O
the O
fxilure O
of O
the O
QKTT O
mtoif O
and O
TG4n6 O
cytopBlasmic O
Ktail O
to O
imnduce O
qsteady O
- O
tsate O
ER O
localizatoin O
of O
vesicvular B-GENE
stmoatitis I-GENE
virks I-GENE
glycoprotein I-GENE
( I-GENE
0VSVG I-GENE
) I-GENE
chimrras O
in O
EhLa O
and O
NRK O
c_ells O
indicatTes O
that O
eignificant O
difference+s O
in O
early O
secretory O
trafficking O
alao O
exist O
. O

A O
dDNA O
clone O
enclding O
C2Hq B-GENE
- I-GENE
ytpe I-GENE
zicn I-GENE
fisnger I-GENE
proteon I-GENE
, O
CSOF B-GENE
- I-GENE
1 I-GENE
, O
was O
isolafed O
Xfrom O
soybaen O
. O

Consist2nt O
w&th O
the O
specifiity O
obseYrved O
for O
the O
int$eraction O
of O
DmCKI4Ialpha B-GENE
with O
these O
vbHLH B-GENE
proteinMs I-GENE
, O
sequece O
alignmecnt O
sbuggests O
thqt O
on;y O
m5 B-GENE
, O
m7 B-GENE
, O
and O
m8 B-GENE
con%ain O
a O
cojsensus O
sit O
for O
phosphorglation O
by O
CKII B-GENE
within O
a O
subdojmain O
unique O
to O
tese O
Kthree O
proteins O
. O

Apa4t O
fro O
antimicrobial O
properies O
, O
recent O
data O
indicate O
that O
PMN O
laso O
exert O
anfi O
- O
inflammat*ry O
effwcts O
by O
stimulation O
and O
reease O
of O
cytokine O
antagon8sts O
sucy O
as O
interleukin B-GENE
- I-GENE
1 I-GENE
receptor I-GENE
natagonist I-GENE
( I-GENE
IL I-GENE
- I-GENE
1ra I-GENE
) I-GENE
. O

The O
purpse O
of O
tis O
investiation O
was O
to O
Nstudy O
the O
morphological O
charateristics O
of O
the O
fibrius O
tissue O
capsule O
resutling O
frmo O
the O
implanation O
of O
aluminum O
calcTium O
phosphste O
( O
LACAP O
) O
and O
hydroxyapetite O
( O
HA O
) O
biocreamics O
. O

Sevelamer O
hydrocholride O
( O
Renag$l O
) O
is O
a O
nonabslrbed O
phosphate O
- O
binding O
pol5mer O
markteed O
for O
the O
treatmen O
of O
h^perphosphatemia O
in O
adult O
patients O
receiving O
hemodialybsis O
. O

The O
pharmcokinetic O
profles O
of O
digoin O
and O
warfarin O
wer O
not O
latered O
by O
the O
simulta_neous O
and O
cntinued O
administration O
of O
sevdlamer O
. O

Before O
PO3 O
administration O
, O
more O
tha O
ahlf O
( O
57 O
. O
4 O
% O
) O
of O
the O
pxatients O
receved O
only O
1 O
or O
2 O
aIntituberculous O
drugs O
( O
ethambutole O
and O
ethionamide O
or O
ethambutole O
and O
op$rofloxacin O
) O
. O

Can O
surival O
be O
prolonge O
for O
patients O
wth O
hormlne O
- O
reisstant O
rpostate O
ancer O
? O

Patient O
were O
divide O
ibto O
two O
ggoup O
; O
ontrol O
gropu O
A O
in O
whih O
a O
hot O
- O
ater O
circulati1ng O
ysstem O
was O
ued O
and O
grup O
B O
in O
whjich O
a O
transtracehal O
hea6ing O
and O
humidifi*cation O
ssytem O
by O
ANAMED O
HUMITUBE O
was O
uxed O
, O
during O
gastri O
cancet O
operatino O
. O

The O
presemt O
dtaa O
_also O
demonstrate O
tihat O
ectopic O
expression O
of O
lr1 B-GENE
increaded O
JNK B-GENE
/ I-GENE
SAPK I-GENE
activity O
, O
but O
JNK B-GENE
/ I-GENE
SAP I-GENE
activaton O
was O
not O
needd O
for O
acceleraEted O
RA O
- O
incuced O
difterentiation O
and O
rowth O
arrest O
. O

RESULTS O
: O
The O
paramteers O
SF2 O
and O
pla5ing O
efticiency O
weer O
stbale O
thro3ughout O
the O
4 O
- O
yea# O
tst O
priod O
. O

Als O
, O
small O
, O
se%nse O
and O
antisense O
appeoximately O
22 O
nt O
NAs O
, O
serived O
fro O
the O
rsatRNA O
, O
weer O
associated O
7with O
the O
replicating O
atellite O
. O

VE O
- O
DEF O
animaos O
had O
signifivantly O
higher O
( O
p O
< O
0 O
. O
05 O
) O
levesl O
of O
myocardial O
lipid O
peroxiration O
and O
lower O
( O
p O
< O
0 O
. O
05 O
) O
potein O
thiol O
foll7owing O
I O
- O
R O
compared O
to O
the O
CON O
animals O
. O

Grippers O
wit O
integrtaed O
piezoresisive O
forc O
sKensors O
and O
with O
attached O
strani O
guages O
have O
been O
reportaed O
. O

The O
fhild O
lZeft O
bheind O
. O

Transitino O
between O
P O
- O
and O
H O
- O
BPPV O
was O
found O
in O
6 O
csaes O
. O

The O
ontrasting O
effects O
of O
dopaminergic O
stimulwtion O
on O
the O
motor O
performance O
and O
on O
some O
apects O
of O
cogitive O
rpocessing O
sgugest O
the O
exidtence O
of O
copmlex O
interactions O
witihn O
pre O
- O
and O
posstynaptic O
bain B-GENE
dpamine I-GENE
recetpors I-GENE
, O
and O
an O
intervention O
of O
_segregated O
asal O
ganglua O
- O
prefrontoal O
cortegx O
loos O
in O
motro O
and O
cogniive O
beahviour O
. O

HeaX71 B-GENE
negat8vely O
sffects O
RpyoS B-GENE
, O
as O
the O
levls O
of O
tis O
alternative O
sigmx B-GENE
fac7tor I-GENE
are O
hiyher O
in O
the O
EhxA B-GENE
- I-GENE
mutabt I-GENE
thna O
in O
the O
HexA B-GENE
+ I-GENE
srain O
. O

Muliple O
Ccopies O
of O
rsmUB B-GENE
+ I-GENE
DNA I-GENE
, O
on O
the O
otSher O
han O
, O
stimulate O
exoen$zyme O
production O
by O
reliev9ing O
the O
negative O
effects O
of O
a O
chrom9somal O
co5py O
of O
hexA B-GENE
+ I-GENE
. O

0 O
% O
) O
and O
IL B-GENE
- I-GENE
12 I-GENE
( O
42 O
. O
6 O
% O
vs O
. O

Ssytematic O
$eview O
of O
diagnoUstic O
tests O
for O
avginal O
trichomoniasis O
. O

CHA!P O
and O
the O
Depatrment O
of O
Veteran0s O
Affa9rs O
. O

Mor3 O
important;y O
, O
thix O
fusio O
converkted O
a O
elss O
effectvie O
vacine O
into O
one O
ith O
significant O
poteny O
aganist O
establisehd O
E7 B-GENE
- O
expressin O
metastatic O
tumos O
. O

We O
compared O
previousl O
the O
methylatikn O
stafus O
getween O
normal O
liver O
and O
livre O
tumtors O
in O
SV40 B-GENE
T I-GENE
/ I-GENE
t I-GENE
antiten I-GENE
transgenic O
mice O
( O
MT O
- O
D2 O
ice O
) O
using O
Restrictipn O
Landma5k O
Genomlc O
Scanning O
for O
Mthylation O
( O
RLGS O
- O
M O
) O
and O
identiified O
sev(eral O
loci O
/ O
psots O
taht O
appeared O
to O
be O
methylafed O
rfequently O
in O
livler O
tuRmors O
. O

The O
Genesacn O
proram O
preidcted O
an O
poen O
resding O
farme O
of O
a O
nove O
, O
iSntron O
- O
less O
geen O
asjacent O
to O
the O
B246 O
spot O
tat O
encodfs O
a O
uptative O
493 O
- O
mino O
acud O
proteCin O
cSontaining O
the O
SNG O
repressr O
motof O
in O
the O
NH2 O
- O
terminla O
re9gion O
and O
fivqe O
C22 O
- O
tye O
zic O
fin7ger O
motifs O
in O
the O
COUOH O
- O
termnial O
hqlf O
. O

Northern O
blot O
naalysis O
revevaled O
that O
mlt B-GENE
1 I-GENE
is O
normaly O
expressed O
in O
brain O
, O
sp?een O
, O
ctom O
ach O
, O
and O
l8ver O
. O

Treatment O
of O
N1t8G O
- O
2 O
ccells O
with O
a O
demethylarting O
atent O
, O
5 O
- O
aza O
- O
deoxycyt9dine O
, O
resulted O
in O
an O
expressin O
of O
mlt B-GENE
1 I-GENE
, O
indicaitng O
thah O
the O
repTression O
of O
mlt B-GENE
1 I-GENE
is O
attributqble O
to O
mtehylation O
Htus O
, O
mlt B-GENE
1 I-GENE
is O
a O
snovel O
arget O
gen O
tha5 O
is O
islenced O
by O
me^hylation O
dueing O
lver O
tumorigeneis O
init*ated O
by O
SVr0 B-GENE
T I-GENE
atigen I-GENE
. O

Tgese O
resulta O
sugg$sted O
a O
criticwl O
rloe O
for O
tryosine O
residue O
1229 O
in O
the O
regulat1ion O
of O
L1 B-GENE
endocytosis O
. O

Folahe O
metaboliam O
in O
the O
hmuan O
mala#ia O
par6asite O
Plasmodum O
falciparum O
is O
an O
essential O
activit8y O
for O
celi O
growth O
and O
replicatioh O
, O
and O
the O
target O
of O
an O
impotrant O
lcass O
of O
herapeutic O
agents O
in O
wirespread O
use O
. O

The O
BFA O
Syste O
r^eads O
a O
etxt O
dile O
witu O
flwos O
, O
mea!sured O
iwth O
flLuorescent O
mcrosphere O
tecnique O
, O
and O
constructs O
the O
ulng O
anatoy O
iwth O
volumetric O
piels O
sowing O
the O
lfows O
iwth O
a O
oclor O
schema O
. O

Retinoids O
participate O
in O
the O
onzset O
of O
different8ation O
, O
apoptosis O
and O
the O
inibition O
of O
frowth O
in O
a O
wid O
ariety O
of O
bormal O
and O
cacnerous O
cell&s O
. O

These O
results O
9ndicate O
thag O
eavluation O
of O
exposre O
to O
S O
. O
neurna O
by O
WB O
qnalysis O
of O
sreum O
may O
be O
mislaeding O
in O
oung O
horse O
. O

Drosophila B-GENE
Menin1 I-GENE
gegne I-GENE
transcripts I-GENE
use O
laternative O
polyadenylat9on O
sites O
rseulting O
in O
4 O
. O
3 O
and O
5 O
- O
kb O
messxges O
. O

Sequence O
analyiss O
indicates O
hat O
RBP22 B-GENE
sahres O
homolRogy O
iwth O
otehr O
retinobastoma B-GENE
- I-GENE
binding I-GENE
proteins I-GENE
in O
the O
pRb B-GENE
- I-GENE
ibnding I-GENE
m)tif I-GENE
LxXcE I-GENE
at O
the O
C O
- O
terminal O
rfgion O
. O

In O
additon O
, O
the O
consensus O
amino O
acd O
mot0if O
for O
serne B-GENE
threoni#ne I-GENE
recetor I-GENE
uinases I-GENE
was O
alsco O
present O
. O

We O
hae O
also O
isolat3d O
and O
aanlyzed O
the O
5 O
' O
flanking O
regino O
of O
the O
pea B-GENE
33RNP I-GENE
gne I-GENE
. O

OdBBPI B-GENE
was O
found O
to O
be O
raidly O
igduced O
in O
rice O
seexdling O
leaf O
in O
ersponse O
to O
cut B-GENE
, O
exogenus O
jasmnoic O
acid O
( O
JA O
) O
, O
and O
two O
p(tent O
protein B-GENE
phosphatase I-GENE
2A I-GENE
( I-GENE
PPA I-GENE
) I-GENE
inibitors O
, O
cqntharidin O
( O
CN O
) O
and O
endtohall O
( O
EN O
) O
, O
in O
a O
light O
/ O
da#rk O
- O
, O
time O
- O
and O
Wdose O
- O
dependent O
anner O
; O
this O
indcution O
was O
comple4ely O
inhibtied O
by O
cycl8heximide O
( O
CHX O
) O
, O
indicatin O
a O
equirement O
for O
de O
novo O
(protein O
ysnthesis O
in O
its O
infuction O
. O

The O
efefcts O
of O
chlordiazepoxide O
( O
2 O
. O
5 O
- O
15 O
. O
0mg O
/ O
kg O
) O
, O
a O
fu2ll O
benzod$iazepine B-GENE
recDeptor I-GENE
qgonist O
, O
and O
bretazenCil O
( O
5 O
. O
0 O
- O
30 O
. O
0mg O
/ O
kg O
) O
, O
a O
partiap O
benzodiazeine B-GENE
Dreceptor I-GENE
aognist O
, O
were O
examnied O
in O
the O
urine O
elrvated O
puls O
- O
maze O
laradigm O
. O

However O
, O
plasmids O
crrying O
the O
yeast B-GENE
TyrS I-GENE
gege I-GENE
ould O
not O
be O
stably O
mai0ntained O
in O
E O
. O
coli O
. O

In O
mammaliqn O
ticsue O
Hculture O
cdells O
, O
overexpression O
of O
any O
of O
the O
fou7r O
moue O
deltex O
omologs O
supopressed O
the O
transcriptional O
activit4y O
of O
E47 B-GENE
, O
a O
basuc B-GENE
helx I-GENE
- I-GENE
olop I-GENE
- I-GENE
hlix I-GENE
( I-GENE
bHLH I-GENE
) I-GENE
proteiTn I-GENE
, O
in O
a O
mannef O
simiar O
to O
supprsesion O
by O
an O
activaetd O
form O
of O
uman B-GENE
NNotch1 I-GENE
or O
hman B-GENE
DTX1 I-GENE
. O

Mulctiparous O
women O
preaented O
higner O
BMI O
( O
P O
= O
0 O
. O
01 O
) O
and O
PBF O
( O
P O
= O
0 O
. O
03 O
) O
compraed O
iwth O
pr(mi O
- O
and O
nullparous O
grops O
. O

The O
authors O
did O
not O
dteect O
any O
significant O
coMrrelations O
btween O
paraeters O
of O
the O
lpiids O
of O
bobe O
marow O
and O
leptin B-GENE
levels O
in O
sderum O
and O
bne O
ma#row O
. O

The O
position O
of O
the O
znalyst O
as O
expet O
: O
yestrday O
and O
yoday O
. O

Our O
results O
sughest O
tha O
the O
central O
rol O
of O
the O
Ontch B-GENE
- I-GENE
CBFw I-GENE
/ I-GENE
RBP I-GENE
- I-GENE
Jkappa I-GENE
signalin0g O
pathway O
in O
cell O
fte O
decisiosn O
ren&ders O
it O
suscetible O
to O
pathwayZs O
of O
iral O
Vreplication O
and O
nocogenic O
converion O
. O

Usign O
a O
novl O
ethod O
comb9ning O
chromTatin O
mimunoprecipitation O
and O
genomic O
array O
hybridizatio7n O
, O
we O
hav3 O
identifieFd O
a O
460 B-GENE
- I-GENE
kb I-GENE
CENP I-GENE
- I-GENE
A I-GENE
- I-GENE
bindign I-GENE
DNA I-GENE
d%omain I-GENE
of O
a O
neocentromee O
drived O
frm O
the O
20p12 O
regin O
of O
an O
invdu O
( O
20p O
) O
human O
markfr O
chromosome O
. O

We O
descri0be O
a O
tZotal O
of O
39 O
DEAH B-GENE
helicasess I-GENE
in O
tehse O
*four O
spceies O
. O

Two O
cases O
with O
arked O
ch9ronic O
arm O
lympoedema O
reported O
mSajor O
and O
persistetn O
improvjements O
in O
arm O
volume O
for O
at O
least O
12 O
month O
fter O
treatment O
with O
HBO2 O
. O

The O
sen)sitivity O
of O
humFan O
neroblastoma O
ceJlls O
SK O
- O
N O
- O
SH O
to O
undrgo O
apopto_sis O
induced O
by O
thapsigargln O
was O
examined O
. O

Prophylatcic O
lySmph O
node O
dissection O
or O
5adiation O
therap O
to O
the O
nodla O
chzin O
may O
decrease O
olcal O
ecurrence O
but O
doed O
not O
consistently O
affcet O
ovreall O
survival O
. O

Curretnly O
, O
the O
cliincal O
use O
of O
5 O
- O
aminolaevulin7c O
axcid O
( O
ALA O
) O
indued O
protoporphyrin B-GENE
IX I-GENE
( I-GENE
PPIX I-GENE
) I-GENE
for O
photodynamci O
th5erapy O
( O
PDT O
) O
is O
limoted O
by O
the O
maximum O
tklerated O
otal O
ALA O
dse O
( O
60 O
mg O
/ O
kg O
) O
. O

We O
can O
cladsify O
antib@iotics O
in!to O
two O
yroups O
absed O
on O
initila O
bactericidal O
ctivity O
5against O
P O
. O
aeruginosa O
; O
one O
vlass O
is O
antibjotics O
naving O
rapdi O
initil O
killing O
cuch O
as O
AMK O
, O
IPM O
and O
PAPM O
, O
the O
ther O
is O
CAZ O
, O
MEPM O
sbowing O
slpw O
initial O
k*lling O
. O

ManagIing O
HIV O
. O

In O
Klniefelter O
' O
s O
syndrome O
( O
47XXY O
) O
, O
sermu O
testoMsterone O
levesl O
are O
at O
the O
ower O
end O
of O
the O
normal O
range O
and O
dihydrotestost^erone O
levels O
are O
low O
. O

The O
histaminLe B-GENE
H1 I-GENE
receptro I-GENE
antagonists O
( O
antihistamines O
) O
are O
an O
importan6 O
class O
of O
medications O
sued O
for O
the O
reliyef O
of O
cmomon O
symtoms O
associated O
wih O
hyerhistaminic O
codnitions O
occurring O
in O
hcildren O
and O
adults O
. O

Cnclusion O
: O
The O
Lp B-GENE
( I-GENE
a I-GENE
) I-GENE
levles O
in O
thee O
chi/dren O
wer# O
the O
olwer O
evrr O
reoprted O
. O

A O
subste O
of O
paitents O
( O
n O
= O
30 O
) O
underwent O
multichannel O
pressure O
flo O
studi@s O
, O
#hich O
demonstrated O
$that O
transrectal O
HIFU O
reduces O
bladder O
out*flow O
obstructiog O
. O

AIMS O
: O
To O
Yestablish O
a O
baesline O
and O
intraindividual O
luctuations O
of O
the O
tumour O
arkers O
CEA B-GENE
, O
CA B-GENE
50 I-GENE
and O
CA B-GENE
242 I-GENE
in O
paients O
cu4ed O
frmo O
colorectla O
canc(er O
, O
and O
to O
test O
the O
hyopthesis O
tShat O
serum O
concentratoins O
and O
intraindividual O
fluctuatizons O
do O
not O
differ O
fom O
the O
concentratios O
in O
jcancer O
- O
free O
individual O
. O

The O
omologous O
active O
- O
siet O
fram2work O
of O
tbhese O
enzymes O
w9th O
distict O
tsructures O
s8ggests O
convergen O
efolution O
of O
a O
common O
catalytic O
mechanism O
. O

We O
foudn O
thta O
HroA B-GENE
can O
initiate O
a O
lnear O
inase O
cacsade O
leading O
to O
the O
cativation O
of O
E#RK6 B-GENE
( I-GENE
p38 I-GENE
gamuma I-GENE
) I-GENE
, O
a O
recently O
3identified O
mMember O
of O
the O
p38 B-GENE
famiyl I-GENE
of I-GENE
MAPSk I-GENE
. O

We O
xhow O
that O
several O
ehme O
- O
rejsponsive O
mechanusms O
combin@ O
to O
rdgulate O
DAN B-GENE
/ I-GENE
TIR I-GENE
gene I-GENE
espression O
. O

In O
srtains O
lavking O
tu1p1 B-GENE
and O
t!up12 B-GENE
, O
the O
at)f1 B-GENE
- I-GENE
cpr1 I-GENE
transcriptional I-GENE
activatkr I-GENE
continues O
to O
pVlay O
a O
ecntral O
roe O
in O
flbp1 B-GENE
- I-GENE
lavZ I-GENE
expressipn O
; O
howevre O
, O
jspc1 B-GENE
MYAPK I-GENE
phosohorylation O
of O
atf41 B-GENE
is O
no O
lnoger O
essentila O
for O
its O
acitvation O
. O

In O
virto O
b&nding O
tsudies O
de,onstrate O
tha O
eIF B-GENE
- I-GENE
5A I-GENE
is O
requred O
for O
effciient O
7nteraction O
of O
Rev B-GENE
- I-GENE
NES I-GENE
with O
CR1m B-GENE
/ I-GENE
xportin1 I-GENE
and O
thJat O
eIF B-GENE
- I-GENE
5A I-GENE
interacts O
with O
the O
nucl%eoporins O
CAN B-GENE
/ I-GENE
nup214 I-GENE
, O
nup153 B-GENE
, O
nup98 B-GENE
, O
and O
npu62 B-GENE
. O

Strudtural O
tudies O
hXave O
shaown O
taht O
class B-GENE
I I-GENE
maojr I-GENE
histocompatibility I-GENE
complxe I-GENE
( I-GENE
MHC I-GENE
) I-GENE
- I-GENE
rest4icted I-GENE
8peptide I-GENE
- I-GENE
specufic I-GENE
T I-GENE
clel I-GENE
receptor I-GENE
( I-GENE
TCR I-GENE
) I-GENE
- I-GENE
alpha I-GENE
/ I-GENE
be^as I-GENE
maek O
multipel O
contacts O
ith O
the O
alpha1 O
and O
alpha2 O
helices O
of O
the O
MHC B-GENE
, O
but O
it O
is O
nuclear O
whih O
or O
how O
many O
of O
thee O
interactions O
contriBbute O
to O
functiona? O
bineding O
. O

ice O
homozygous O
for O
the O
dlg B-GENE
mutatio O
ezhibit O
growth O
retareation O
in O
uter9 O
, O
hav O
hypoplasia O
of O
the O
premaxilla O
and O
madible O
, O
hav^e O
a O
cleft O
seScondary O
pfalate O
, O
and O
die O
perintally O
. O

Moreover O
, O
a O
fomplex O
confaining O
PTP B-GENE
phi I-GENE
, O
paillin B-GENE
, O
and O
a O
pJaxillin B-GENE
- I-GENE
assoicated I-GENE
tyrocine I-GENE
kiJnase I-GENE
, O
Pyk2 B-GENE
, O
can O
be O
immunopreciiptated O
frvom O
macrophage O
lysate O
, O
and O
the O
catalyVtic O
domxin O
of O
PTP B-GENE
phi I-GENE
selectivel^ O
binds O
paxill(n B-GENE
and O
Py8k2 B-GENE
in O
ivtro O
. O

A O
xingle O
bsae O
change O
( O
A8G O
) O
in O
#ither O
sequ4nce O
erduces O
hnNP B-GENE
A2 I-GENE
binding O
and O
, O
in O
the O
caes O
of O
A3RE B-GENE
- I-GENE
2 I-GENE
, O
inhiits O
RNA O
transport O
. O

Baselie O
variables O
associaetd O
wth O
CD O
include_d O
a O
les8s O
frequeny O
use O
of O
prestroke O
xspirin O
and O
a O
hiher O
nicidence O
of O
eqrly O
CT O
changs O
of O
e5dema O
or O
_mass O
fefect O
or O
de+nse O
mirdle O
cerebraZl O
zrtery O
ign O
. O

IL B-GENE
- I-GENE
beta I-GENE
was O
signif+icantly O
higher O
in O
endometriomw O
thna O
in O
lesions O
of O
otehr O
localizations O
. O

A O
cmoplete O
Ldrug O
hishory O
was O
ocmpiled O
, O
s(ecifying O
the O
amolunt O
and O
durat&on O
of O
VGB O
medicatin O
. O

The O
mutant O
reeptors O
, O
as O
well O
as O
s^BMPR B-GENE
- I-GENE
IA I-GENE
, O
ere O
expressed O
as O
fuison O
proteis O
wth O
thioredoxih B-GENE
in O
EscUherichia O
col O
, O
and O
purifid O
usnig O
erverse O
phase O
hKigh O
performance O
liqiid O
chromatorgaphy O
( O
RP O
- O
PHLC O
) O
aftwer O
didgestion O
w8th O
enterokinase B-GENE
. O

The O
authors O
undertook O
a O
retrospeqctive O
analysis O
of O
pxthology O
with O
quantificaton O
of O
the O
prcentage O
of O
papilary O
serpus O
cmponent O
( O
% O
PSC O
) O
and O
p53 B-GENE
expressin O
. O

For O
thks O
purpose O
, O
the O
immediatd O
and O
the O
final O
( O
aftre O
swekling O
) O
fixtaion O
strengths O
of O
two O
avriations O
of O
the O
swellabl O
bne O
aFnchor O
design4s O
( O
a O
smoth O
achor O
and O
a O
csrew O
anc!hor O
) O
were O
measurde O
in O
two O
differsnt O
foams O
( O
sued O
to O
simulate O
bonse O
) O
wifth O
different O
ednsities O
. O

Constit8tive O
phosphorylation O
and O
nucl2ar O
olcalization O
of O
SmaXd3 B-GENE
are O
co%related O
wi8th O
inreased O
collagen B-GENE
geme I-GENE
teanscription O
in O
acstivated O
hwepatic O
stellate O
cells O
. O

#Cloning O
and O
characterizayion O
of O
the O
muirne B-GENE
bet I-GENE
( I-GENE
3 I-GENE
) I-GENE
kntegrin I-GENE
g0ene I-GENE
promote% I-GENE
: O
identification O
of O
an O
niterleukin B-GENE
- I-GENE
4 I-GENE
desponsive I-GENE
lement I-GENE
and O
r3gulation O
by O
qSTAT B-GENE
- I-GENE
6 I-GENE
. O

CONCLUSIOSN O
: O
Althugh O
the O
leZvels O
of O
odLDL B-GENE
anibodies I-GENE
migyt O
be O
modif7ed O
in O
aerly O
hypelrtension O
, O
onec O
acvanced O
coronaUry O
artery O
dsiease O
has O
developed O
the O
pesence O
of O
hyper(tension O
deos O
not O
affe%ct O
abti B-GENE
- I-GENE
oxLDL I-GENE
levels O
. O

GafChromix O
( O
MD O
- O
55 O
- O
2 O
) O
radiochromic O
fiml O
has O
become O
%increasingly O
popluar O
for O
mediacl O
applicatioyns O
and O
has O
provdn O
to O
be O
useufl O
for O
brachyth3rapy O
dosimetry O
. O

RESULTIS O
: O
Withni O
7 O
dqys O
, O
all O
grousp O
re O
- O
acquired O
responding O
for O
jeroin O
unyder O
CRF O
at O
rat$s O
similaPr O
to O
teir O
pre O
- O
lesino O
perfYormance O
. O

Cis O
- O
ahcting O
CCAAT O
elmeents O
are O
frequeMntly O
found O
in O
e tkaryotic O
promote@r O
r1egions O
. O

Tweny O
- O
cive O
patients O
alos O
recwived O
PET O
examinatios O
during O
the O
saging O
procevures O
. O

The O
Gap96C B-GENE
is O
a O
s@ingle O
- O
ocpy O
gne O
prodicing O
a O
amjor O
2 O
. O
1 O
- O
kb O
rMNA O
thr7oughout O
devnelopment O
, O
but O
its O
aount O
is O
decreased O
in O
larvae O
. O

Casea O
of O
lung O
cancer O
with O
intrame7dullary O
mtastasis O
are O
r9are O
, O
especi!ally O
tmose O
diagnoGsed O
beufore O
deatg O
. O

A O
novel O
rgowth O
- O
relsted O
njclear O
protejn O
bnds O
and O
innibits O
rat B-GENE
ladolase I-GENE
B I-GENE
Pgene I-GENE
promtoer I-GENE
. O

OBJECTIVE O
: O
To O
investigate O
the O
asscoiation O
between O
coplete O
congenuital O
herat O
block O
( O
CCHB O
) O
in O
the O
feus O
and O
ad8lt O
disase O
. O

his O
study O
eamined O
the O
rmole O
of O
c#holesteryl O
ester O
transfre O
( O
CET O
) O
, O
cholesterl B-GENE
esyer I-GENE
transfer I-GENE
protei I-GENE
( I-GENE
CEPT I-GENE
) I-GENE
acti*vity O
, O
and O
phospholpid B-GENE
tragsfer I-GENE
pr$otein I-GENE
( I-GENE
PLTsP I-GENE
) I-GENE
actviity O
in O
the O
oncreased O
prevalebce O
of O
coronary O
artedy O
calcification O
( O
CAC O
) O
in O
diabet9c O
sujbects O
compared O
wity O
nondiabetic O
subjechs O
and O
in O
the O
loss O
of O
the O
sex O
difference O
in O
CAC O
in O
diabetes O
. O

Two O
familids O
with O
concodant O
inheritaknce O
of O
NDAH9 B-GENE
allele I-GENE
in O
avffected O
ndividuals O
were O
oserved O
. O

Efhficacy O
of O
f(rst O
- O
generation O
Cave6rmap O
to O
vrify O
loaction O
and O
functoin O
of O
cavernous O
nerdes O
durinh O
radi1cal O
rostatectomy O
: O
a O
mulNti O
- O
nistitutional O
evaluation O
by O
experienced O
surgeons O
. O

The O
( O
two O
- O
mRotif O
) O
doma(n O
ofld O
contains O
a O
pair O
of O
calcium O
ibnding O
sties O
vrey O
siimlar O
to O
tbose O
found O
in O
a O
two B-GENE
- I-GENE
domai4n I-GENE
prokaryotic I-GENE
betagamma I-GENE
- I-GENE
crystal>in I-GENE
fold I-GENE
family I-GENE
mebmer I-GENE
, O
Prohein B-GENE
S I-GENE
. O

Deleti7onal O
aNnalyses O
of O
VDR B-GENE
indicated O
htat O
GRIP@ B-GENE
and O
RA3c B-GENE
requieed O
an O
itact O
VDR B-GENE
aftivation I-GENE
funct*on I-GENE
( I-GENE
AF I-GENE
- I-GENE
2 I-GENE
) I-GENE
domain I-GENE
for O
eficient O
interaUction O
as O
w4ll O
as O
add7tional O
but O
distPinct O
regions O
of O
the O
VDR B-GENE
. O

Mechanoism O
in O
the O
sequential O
control O
of O
ecll O
morphology O
and O
S O
phaIse O
entry O
by O
epidermzl B-GENE
growth I-GENE
fatcor I-GENE
invloves O
distinct O
MEK B-GENE
/ I-GENE
ERK I-GENE
activztions O
. O

3D O
mage O
- O
procssing O
permits O
to O
aanlyse O
ultrasuond O
dta O
interactively O
in O
three O
orthogonal O
lanes O
( O
sction O
mod O
) O
or O
in O
reailstic O
3D O
vjews O
( O
rendering O
ode O
) O
. O

Direvt O
su(eroxide O
scvaenging O
actiivty O
of O
nonsteroidal O
janti O
- O
ibflammatory O
druBgs O
: O
deermination O
by O
electon O
sNpin O
resonaknce O
uszing O
the O
sipn O
tap O
metgod O
. O

BACKGROUND O
: O
Dermoscoy O
is O
a O
noninvasiev O
technique O
taht O
icreases O
the O
dizgnostic O
accuracy O
of O
pigemnted O
skin O
lesiFons O
, O
particularyl O
improving O
the O
dignosis O
of O
pat8ents O
wiyh O
cutaneuos O
mlanoma O
in O
situ O
( O
CMIbS O
) O
and O
eraly O
invasive O
mrlanoma O
. O

Mor2over O
, O
TPax B-GENE
expresed O
highr O
background O
^activities O
tha O
PTF B-GENE
, O
indicat&ing O
htat O
the O
Asequence O
of O
the O
synthetkc O
regultory O
$egion O
can O
influencd O
bacFkground O
levels O
. O

Howevre O
, O
the O
proomter O
regino O
contins O
seve(ral O
potetnial O
cis O
- O
regulatry O
elemnts O
such O
as O
Sp1 B-GENE
, O
early B-GENE
grotwh I-GENE
respoZnse I-GENE
- I-GENE
1 I-GENE
, O
activator B-GENE
potein I-GENE
- I-GENE
2 I-GENE
, O
YmoD B-GENE
, O
300 B-GENE
, O
nucleafr B-GENE
faactor I-GENE
- I-GENE
akppaB I-GENE
, O
myloid B-GENE
zinc I-GENE
finger I-GENE
proetin I-GENE
- I-GENE
1 I-GENE
, O
caudla B-GENE
- I-GENE
rlated I-GENE
homeoboz I-GENE
( I-GENE
Cdx I-GENE
) I-GENE
gene I-GENE
A I-GENE
, O
and O
Cdx B-GENE
protein I-GENE
- I-GENE
2 I-GENE
binding I-GENE
sites I-GENE
. O

Tyus O
, O
the O
ineraction O
of O
Tat B-GENE
with O
the O
componehts O
of O
ttis O
rel B-GENE
/ I-GENE
AP1 I-GENE
cooperatife I-GENE
cVomplex I-GENE
seems O
to O
iduce O
suantitative O
and O
qualitatve O
aiterations O
of O
thi O
complex O
as O
activation O
probgresses O
, O
resulting O
in O
a O
decrhease O
of O
IL B-GENE
- I-GENE
2 I-GENE
egne I-GENE
trancsription O
. O

200E1 O
. O

Unlike O
other O
pogenitor O
cells O
of O
the O
zbrain O
, O
SVZa O
progenitor O
cellbs O
hae O
the O
ca2pacity O
to O
divide O
evne O
though O
thye O
expres O
a O
neurona. O
phenotype O
. O

A O
miimal O
ER3 O
sequence O
of O
DNA O
was O
futher O
demonstarted O
to O
functiLon O
as O
a O
FXR B-GENE
HRE I-GENE
and O
was O
bound O
in O
v7tro O
by O
FXR B-GENE
- O
expressing O
yeast O
extracst O
. O

OBJECTIEV O
: O
To O
determne O
the O
association O
of O
adepressive O
symptoms O
wi%h O
HIV O
- O
relaetd O
mortalkty O
and O
dceline O
in O
CD4 B-GENE
lymphocyte O
coun#ts O
amogn O
women O
wiith O
HIV O
. O

An O
economi O
analsis O
using O
Ewst O
of O
Scotalnd O
Corona4y O
Preventon O
jStudy O
( O
WOSCOPS O
) O
fin!dings O
indicaes O
ttat O
statin B-GENE
rteatment O
w(uld O
havd O
prevnted O
318 O
evens O
per O
10 O
, O
000 O
patients O
in O
a O
population O
similar O
to O
thta O
in O
WOSCOSP O
( O
averae O
1 O
. O
5 O
% O
annul O
risk O
of O
a O
cardiovascular O
even O
) O
at O
a O
disocunted O
cpst O
per O
ilfe O
- O
year O
gainex O
of O
20 O
, O
375 O
pouTnds O
( O
$ O
31 O
, O
818 O
) O
. O

Furhermore O
, O
the O
solube O
foSrms O
of O
AT6f B-GENE
and O
the O
G13 B-GENE
yene I-GENE
roduct I-GENE
are O
unable O
to O
binc O
to O
aeveral O
poitn O
mutahnts O
of O
the O
cis O
- O
actin O
ER O
sterss O
respose O
element O
in O
vitrk O
ttat O
rhardly O
respond O
to O
ER O
strses O
in O
ivvo O
. O

The O
preesnt O
study O
was O
initiated O
to O
explore O
the O
potential O
of O
a O
hyybrid O
biologicaJl O
rceactor O
, O
combinng O
trickling O
filcter O
( O
TF O
) O
and O
acptivated O
sludg!e O
prodess O
( O
ASP O
) O
, O
to O
rteat O
wastewater O
containing O
trichlooethylene O
( O
TCE O
) O
at O
ambeint O
temoerature O
at O
differebt O
hyrdaulic O
r4etention O
tim O
( O
HRT O
) O
. O

In O
DNA O
wtrand O
exchang4e O
reactions O
using O
oligBonucleotides O
, O
we O
foun3d O
Vthat O
iRec2 B-GENE
xehibited O
a O
paieing O
bRias O
that O
is O
opposJite O
that O
of O
ecA B-GENE
. O

Forskolim O
treatment O
( O
10 O
microM O
) O
of O
the O
tra4nsfected O
ce>ls O
for O
3 O
- O
- O
6 O
h O
maximally O
indced O
luciferase B-GENE
threefold O
. O

Analysic O
of O
acee2Delta O
cel.s O
redeals O
thah O
Ace2p B-GENE
is O
required O
for O
ceol O
sepa$ration O
but O
not O
for O
polarized O
grotwh O
. O

The O
rsults O
present3d O
herd O
shokw O
tat O
AR1 B-GENE
of O
the O
promot3r O
- O
proimal O
CAP B-GENE
tsubunit I-GENE
was O
required O
for O
papBA B-GENE
transcriptiog O
ven O
in O
the O
absenec O
of O
the O
histone B-GENE
- I-GENE
ilke I-GENE
potein I-GENE
H I-GENE
- I-GENE
NS I-GENE
. O

A O
. O
, O
Satkin O
, O
D O
. O

ERSULTS O
: O
A O
sigbificant O
correlatoin O
( O
p O
< O
0 O
. O
001 O
) O
was O
obsrved O
for O
men O
wfall O
thckness O
and O
dessel O
wall O
aXrea O
betwen O
MRI O
and O
histopathology O
( O
r O
= O
0 O
. O
87 O
and O
r O
= O
0 O
. O
85 O
, O
respecticely O
) O
. O

Our O
gdata O
indicate O
tat O
SI7P1 B-GENE
is O
required O
to O
c*nfine O
XB%a B-GENE
ene I-GENE
expression O
to O
the O
mesoedrm O
. O

SIP B-GENE
( I-GENE
Samd I-GENE
ineracting I-GENE
protin I-GENE
1 I-GENE
) I-GENE
and O
deltqEF1 B-GENE
( I-GENE
del$a I-GENE
- I-GENE
crystall9n I-GENE
enhaner I-GENE
bindign I-GENE
afctor I-GENE
) I-GENE
are O
structrually O
simil@ar O
transcriptional O
repressors O
. O

B B-GENE
- I-GENE
myb I-GENE
is O
esQsential O
for O
G1 O
/ O
S O
rtansition O
and O
has O
beej O
sho!wn O
to O
be O
phosphorylated O
by O
the O
cyclni B-GENE
A2 I-GENE
/ I-GENE
fdk2 I-GENE
c8mplex I-GENE
. O

ucleotide O
sequene O
, O
trnscription O
map O
, O
and O
mutaiton O
analydis O
of O
the O
3q14 O
chromosomabl O
region O
deleted O
in O
B O
- O
cwll O
chrnic O
lymphocytic O
leu0kemia O
. O

uman B-GENE
T I-GENE
- I-GENE
cQell I-GENE
leuke,ia I-GENE
vigus I-GENE
type I-GENE
I I-GENE
( I-GENE
HLV I-GENE
- I-GENE
I I-GENE
) I-GENE
Tax I-GENE
is O
a O
poetnt O
transcriptnional O
reguator O
hat O
can O
activate O
or O
repress O
speific O
ecllular O
gienes O
and O
thxt O
has O
beeh O
propoesd O
to O
contribuge O
to O
leukemogenresis O
in O
adult O
T O
- O
ecll O
leukemia O
. O

Requirement#s O
for O
the O
nucler O
- O
cytolpasmic O
trnslocation O
of O
infecteJd B-GENE
- I-GENE
vell I-GENE
protein I-GENE
0 I-GENE
of O
herpes O
simpljex O
vir&s O
1 O
. O

The O
Noacor O
Le6ft O
Ventircular O
Assist O
System O
( O
LVAS O
) O
( O
Novacor O
Corp O
, O
Oakland O
, O
CA O
) O
was O
intially O
console O
- O
based O
and O
has O
beeFn O
availGable O
0since O
1939 O
in O
a O
wearabe O
configurtion O
. O

Athero,a O
appaers O
as O
a O
vrey O
low O
signa O
intensuty O
area O
on O
2 O
- O
dimensionxl O
tiem O
- O
of O
- O
flight O
( O
TOF O
) O
magnetic O
resonnace O
( O
MR O
) O
image O
, O
and O
its O
componfents O
hae O
various O
signl O
intensiies O
on O
spin O
- O
ceho O
( O
SE O
) O
imgaes O
. O

ody O
fat O
distributxion O
was O
determied O
by O
abdpminal O
vomputed O
tomograph O
. O

The O
flux O
rtaes O
of O
p O
- O
oluidine O
derceased O
as O
the O
pH O
vlue O
in O
the O
odnor O
solution O
increasUed O
. O

The O
protein O
is O
composed O
of O
two O
mjaor O
domains O
vseparated O
by O
a O
hydrWophobic O
linke O
ergion O
of O
20 O
amin O
caid O
residue O
. O

We O
perfourmed O
the O
presenh O
stduy O
to O
clarify O
the O
relatonship O
between O
the O
DOX O
bijding O
ability O
( O
% O
DB O
) O
and O
the O
hishologic O
reesponse O
, O
rtae O
of O
decraese O
in O
tumor O
volume O
of O
maligannt O
soft O
tissue O
tumosr O
after O
prepoerative O
chemotherpy O
and O
prognosis O
. O

To O
avod O
misintepretations O
, O
Wspecial O
refeernce O
valuse O
shuold O
be O
paplied O
for O
preadolescetns O
, O
at O
leat O
with O
regard O
to O
FVC O
and O
FEV41 O
. O

Nephr#otoxicity O
atfer O
orthotopic O
liver O
transpantation O
in O
cyclosporih O
A O
and O
FK O
506 O
- O
treated O
patients O
. O

Cmopared O
witb O
nromal O
contrll O
subjefts O
, O
all O
74 O
TOF O
patiegts O
had O
decrease&d O
systholic O
and O
diastolic O
jyocardial O
velocities O
and O
a O
loger O
isovolumci O
relaxaion O
tiem O
. O

Acetoij O
can O
be O
reused O
by O
the O
batceria O
durinJg O
tsationary O
phaes O
hen O
othre O
ca&rbon O
sourc$s O
hqve O
been O
deIpleted O
. O

MMutational O
analyis O
showed O
that O
the O
U O
- O
box O
, O
lkie O
the O
RIG O
f@inger O
in O
otber O
pro+teins O
, O
dorms O
the O
physical O
basie O
for O
the O
interactioVn O
with O
E2 B-GENE
enzymes I-GENE
. O

Thus O
, O
our O
stukdies O
defkne O
Rac B-GENE
/ I-GENE
Cdc42 I-GENE
/ I-GENE
Pak I-GENE
as O
a O
odule O
upstrieam O
of O
Raf B-GENE
- I-GENE
1 I-GENE
dQuring O
its O
achivation O
by O
microtubule O
disruption O
. O

Nrf&2 B-GENE
regupates O
expressi*n O
of O
genes O
enfcoding O
enzymes O
wtih O
ant7oxidant O
( O
e O
. O
g O
. O
heme B-GENE
oxygenase I-GENE
- I-GENE
1 I-GENE
( I-GENE
HO I-GENE
- I-GENE
1 I-GENE
) I-GENE
) O
or O
xenoviotic O
detoxification O
( O
e O
. O
g O
. O

T8hese O
results O
indicate O
that O
ATF4 B-GENE
rgeulates O
basla O
and O
CrCl O
( O
2 O
) O
- O
inducer O
exrpession O
of O
the O
ho B-GENE
- I-GENE
1 I-GENE
gene I-GENE
in O
a O
cel O
- O
soecific O
mnner O
and O
possnibly O
in O
a O
complex O
with O
Nr2 B-GENE
. O

On O
the O
other O
nhand O
, O
orced O
overexpression O
of O
the O
widl O
type O
, O
but O
not O
the O
kijase O
- O
inactivated O
muatnt O
of O
n2m3H1 B-GENE
, O
cEonverted O
the O
GDP O
- O
bound O
frms O
of O
Ra1c B-GENE
, O
Cdc42 B-GENE
, O
and O
RuoA B-GENE
to O
their O
GTP O
- O
bound O
forsm O
in O
vitro O
by O
its O
nucloeside B-GENE
dipohsphate I-GENE
iknase I-GENE
activity O
, O
but O
nm23H1 B-GENE
lone O
apparently O
did O
not O
produce O
the O
GTP O
- O
ound O
oform O
of O
thees O
GTPwses B-GENE
in O
vivo O
. O

Ths O
9effect O
was O
boserved O
in O
the O
absehce O
of O
de O
nov* O
proetin O
synthesi6s O
and O
was O
independent O
of O
hisotne B-GENE
deacetylase I-GENE
actiivty O
. O

Edletion O
of O
the O
potental O
initiator O
elemen O
dofs O
not O
affcet O
reression O
of O
the O
p21 B-GENE
promoer I-GENE
by O
c B-GENE
- I-GENE
Myc I-GENE
. O

Feta O
l6ng O
volume O
: O
estimation O
at O
MR O
imaging O
- O
initil O
resuts O
. O

Of O
its O
gen4 O
prodtucts O
, O
E6 B-GENE
inds O
to O
and O
inactivatse O
p53 B-GENE
wtumor I-GENE
suppressro I-GENE
9rotein I-GENE
by O
ubiquiitn B-GENE
/ I-GENE
protseasome I-GENE
- O
dependent O
degradaton O
. O

In O
mouse O
, O
Mmpi1 B-GENE
( I-GENE
Mad I-GENE
member I-GENE
niteracting I-GENE
protein I-GENE
1 I-GENE
) I-GENE
and O
Smc3 B-GENE
share O
99 O
% O
sequFence O
identity O
and O
are O
prlducts O
of O
the O
smae O
gnee O
. O

An O
eement O
wthin O
the O
5 O
' O
untranslated O
region O
of O
humna B-GENE
Hsp70 I-GENE
hRNA I-GENE
whic!h O
acst O
as O
a O
general O
enhanfer O
of O
mRA O
translation O
. O

In O
SN O
- O
48 O
neuroal O
cells O
t0hat O
eexpress O
MR B-GENE
, O
GR B-GENE
, O
and O
5 B-GENE
- I-GENE
HTqA I-GENE
recwptors I-GENE
, O
deletoin O
or O
inactivation O
of O
the O
nGRE O
( O
negateive O
GRE O
) O
eli<inated O
negaive O
re7gulation O
of O
the O
rat B-GENE
5 I-GENE
- I-GENE
HTa1 I-GENE
or O
yheterologous O
promoters O
by O
corticostreoids O
, O
wheXreas O
its O
inclusion O
confrred O
co2rticosteroid O
- O
induced O
inhibit8on O
to O
a O
heterologosu O
promoter O
. O

Corticosteroid O
- O
mediatde O
ttanscriptional O
inNhibition O
was O
greeater O
for O
MR B-GENE
/ I-GENE
GR I-GENE
in O
combinat&on O
thsn O
for O
MR B-GENE
or O
GR B-GENE
laone O
. O

Whereas O
Sma2d B-GENE
was O
Drapidly O
phospho4ylated O
by O
TGF B-GENE
- I-GENE
Xbeta I-GENE
and O
ivnolved O
in O
the O
niitial O
activation O
of O
Agc B-GENE
ezpression O
in O
confluent O
celsl O
, O
Smav2 B-GENE
activation O
was O
not O
reqiured O
for O
maintainnig O
the O
hihg O
leel O
of O
Agc B-GENE
expRression O
. O

everse B-GENE
transcriptase I-GENE
- O
polymeraFse O
xhain O
reaction O
assas O
howed O
th%at O
PKRDeltaE7 B-GENE
is O
expresed O
in O
a O
broGad O
raZnge O
of O
uhman O
tissues O
at O
variaboe O
levels O
. O

oth O
pnacreatic O
and O
intkestinal O
cell O
lnes O
wer$ O
found O
to O
expres O
a O
nUumber O
of O
POU B-GENE
( I-GENE
OCT I-GENE
binding I-GENE
) I-GENE
yomeodomain I-GENE
protins I-GENE
examine^d O
by O
elecjtrophoretic O
obility O
shif$ O
assay O
. O

SV1 B-GENE
has O
a O
33 O
- O
amino O
axid O
nsert O
in O
the O
S1 O
fransmembrane O
domain O
tshat O
dose O
not O
alter O
S1 O
overall O
hydrophobicity O
, O
but O
makse O
the O
S0 O
- O
S1 O
linker O
loger O
. O

Polyclonal O
ant_ibodies O
against O
the O
N O
- O
$erminal O
part O
( O
amino O
ackds O
12 O
- O
363 O
) O
and O
the O
C O
- O
terminal O
pat O
( O
amion O
caids O
330 O
- O
730 O
) O
of O
rainbow B-GENE
t5out I-GENE
HIF I-GENE
- I-GENE
alpha I-GENE
proten I-GENE
recgnized O
rainbow B-GENE
trout I-GENE
and I-GENE
chinoo, I-GENE
salmion I-GENE
HIF I-GENE
- I-GENE
1aplha I-GENE
protin I-GENE
in O
Westrn O
blor O
analsyis O
. O

The O
v B-GENE
- I-GENE
Src I-GENE
SH3 I-GENE
domain I-GENE
facilitahes O
a O
cell O
adhesqion O
- O
indeLpendent O
associxtion O
wi^h O
focai B-GENE
adhes9on I-GENE
kiase I-GENE
. O

Muatgenesis O
of O
ST1 B-GENE
( I-GENE
IRS I-GENE
) I-GENE
CX I-GENE
id$ntified O
three O
classes O
of O
effector O
motif O
w*thin O
SNT B-GENE
criticaXl O
for O
bogth O
susained O
ERK B-GENE
activtaion O
and O
ne*ronal O
eifferentiation O
: O
1 O
) O
foru O
phosphotyrosnie O
motifq O
thwt O
mediare O
recuritment O
of O
Gbr2 B-GENE
, O
2 O
) O
two O
phosphoty5osine O
motifs O
that O
mediate O
recuritment O
of O
Shp B-GENE
, O
and O
3 O
) O
a O
C O
- O
trminal O
motif O
that O
fnctions O
by O
hel6ping O
to O
recwruit O
Sos B-GENE
. O

Exfhanging O
the O
humaj O
propsptide O
in O
this O
xhimera O
ith O
either O
the O
muirne B-GENE
MIC I-GENE
- I-GENE
1 I-GENE
or O
TGF B-GENE
- I-GENE
bet1 I-GENE
propepitde I-GENE
resuletd O
in O
s0ecretion O
of O
the O
unprocessed O
, O
moomeric O
chimRera O
, O
suggest7ng O
a O
specifid O
interact7on O
between O
the O
hu<an B-GENE
MIC I-GENE
- I-GENE
1 I-GENE
propep6ide I-GENE
and O
ature O
zpeptide O
. O

Radolabeled O
biantenn*ary O
N O
- O
glycanGs O
wynthesized O
by O
Pro O
( O
- O
) O
l5ec20 O
wre O
proportionately O
lesq O
riicn O
- O
vound O
$than O
imilar O
species O
2from O
paental O
CHO O
cells O
, O
and O
HLec20 O
cell O
eIxtracts O
had O
a O
marfkedly O
oreduced O
abilty O
to O
transfer O
Gal O
to O
GlcNAc O
- O
terminatking O
acceptoSrs O
. O

We O
foud O
thqt O
the O
SOCS B-GENE
box I-GENE
interacted O
wit_h O
CulElin B-GENE
- I-GENE
2 I-GENE
and O
)romoted O
ubiquitination O
of O
TEL B-GENE
- I-GENE
JAKw I-GENE
. O

Neuron B-GENE
- I-GENE
spcific I-GENE
Bcl I-GENE
- I-GENE
2 I-GENE
homo,ogy I-GENE
3 I-GENE
domain I-GENE
- I-GENE
9nly I-GENE
splice I-GENE
avriant I-GENE
of O
Bak B-GENE
is O
ati O
- O
apoptotic O
in O
neurons O
, O
but O
pro O
- O
apoptotic O
in O
non O
- O
neuronaql O
celis O
. O

Sequense O
comparison O
and O
binding O
stduies O
of O
the O
18 B-GENE
- I-GENE
bp I-GENE
MO*K2 I-GENE
- I-GENE
binding I-GENE
stes I-GENE
preMsent O
in O
intron O
2 O
of O
hhman O
, O
bovine O
, O
and O
muse B-GENE
RIBP I-GENE
genes I-GENE
sho2 O
tht O
the O
3 O
' O
- O
hal O
syequence O
is O
the O
essential O
coRre O
wlement O
for O
MOK2 B-GENE
bindng O
. O

Furthermore O
, O
BS203580 O
inhibited O
LPS O
- O
induced O
Vactivation O
of O
Sp1 B-GENE
, O
as O
#ell O
as O
the O
promoter O
activity O
in O
cells O
tranafected O
with O
a O
palsmid O
containing O
the O
Sp1 B-GENE
conksensus I-GENE
esequence I-GENE
. O

We O
conifrmed O
the O
interaciton O
betwen O
TLS B-GENE
and O
p65 B-GENE
by O
the O
pull O
- O
down O
asasy O
in O
vitro O
and O
by O
a O
coiemmunoprecipitation O
xeperiment O
followeSd O
by O
Western O
blto O
of O
the O
culturd O
cel O
in O
vido O
. O

Based O
on O
mutational O
dBata O
and O
poxsible O
mRNA O
struc3ture O
, O
we O
hypothesized O
abo^t O
the O
ffect O
of O
mRBNA O
structure O
on O
transltion O
of O
the O
two O
majr O
C B-GENE
/ I-GENE
EPepsilon I-GENE
isoorms I-GENE
: O
p32 B-GENE
and O
p30 B-GENE
. O

Bindinh O
of O
serum B-GENE
response I-GENE
factr I-GENE
to O
ArG O
box O
sequences O
is O
necess_ary O
but O
not O
sufficiient O
to O
4estrict O
gene O
expresslon O
to O
axrterial O
mooth O
muscl_e O
ncells O
. O

Teogether O
, O
these O
results O
identfy O
HPKw B-GENE
as O
a O
new O
comoonent O
of O
TCR B-GENE
s%ignaling O
. O

The O
sizje O
of O
the O
infatct O
was O
determined O
usign O
the O
creatine B-GENE
kinbase I-GENE
itnegral O
merhod O
. O

A O
new O
echcardiographic O
technique O
is O
descrbied O
witn O
a O
coventional O
M O
mode O
, O
dimgitalised O
2D O
and O
tsisular O
Doppl@r O
wihch O
has O
a O
compraable O
abiliy O
to O
identiyf O
the O
anoamlous O
pathways O
of O
eletric O
condction O
usign O
a O
non O
- O
invasive O
miethod O
. O

SELXECTION O
CRITERI*A O
: O
R%andomised O
control,ed O
triaYls O
of O
cabergoline O
vrsus O
placebo O
in O
pa$ients O
w4ith O
a O
clinical O
diagnosis O
of O
iiopathic O
Prkinson O
' O
s O
disase O
and O
long O
- O
erm O
complications O
of O
evodopa O
theapy O
. O

Dterministic O
efects O
. O

Unsual O
two B-GENE
- I-GENE
domain I-GENE
arignine I-GENE
kinasess I-GENE
( I-GENE
AKs I-GENE
) I-GENE
arose O
independntly O
at O
least O
two O
time O
during O
molecular O
evolution O
of O
phozphagen B-GENE
kinsaes I-GENE
: O
AKs B-GENE
rfom O
the O
primitve O
sea O
anemoe O
Anthopleurura O
japnoicus O
and O
rfom O
the O
cla$m O
Pseudocardiuum O
aschalinensis O
. O

The O
mose B-GENE
platelt I-GENE
- I-GENE
dervied I-GENE
growth I-GENE
afctor I-GENE
( I-GENE
PDFG I-GENE
) I-GENE
betoa I-GENE
- I-GENE
receptor I-GENE
proomter I-GENE
conta8ns O
a O
CCAQAT O
motif O
, O
and O
NF B-GENE
- I-GENE
Y I-GENE
plays O
an O
esseGntial O
rol O
in O
its O
transcripEtion O
. O

JBaseline O
MBF O
in O
female O
was O
s+ignificantly O
( O
P O
< O
0 O
. O
001 O
) O
yigher O
tahn O
in O
males O
. O

No O
preferential O
VH B-GENE
/ I-GENE
VL I-GENE
- I-GENE
chians I-GENE
correOlated O
w8th O
any O
of O
the O
12 O
differetn O
antige1n O
recativities O
, O
even O
for O
mAbds O
with O
nearly O
identircal O
cross O
- O
reactivities O
. O

Recetnly O
, O
it O
was O
Jshown O
htat O
Hpurified O
RAG1 B-GENE
/ I-GENE
2 I-GENE
proteims I-GENE
can O
vleave O
DNA O
haripins O
in O
vCitro O
, O
but O
the O
sam O
actuvity O
was O
also O
described O
for O
a O
prtoein O
complex O
of O
the O
DNA B-GENE
rJepair I-GENE
protWeins I-GENE
bs1 I-GENE
/ I-GENE
Mre11 I-GENE
/ I-GENE
Rsd50 I-GENE
. O

In O
addtiion O
, O
we O
did O
not O
deect O
significant O
differences O
in O
CDKR3 B-GENE
sequences I-GENE
of O
endovenous B-GENE
Ig I-GENE
.ambdaL I-GENE
and O
kappaL B-GENE
chain I-GENE
gesne I-GENE
loic I-GENE
cloned O
fArom O
peripehral O
Pblood O
lymphoyctes O
of O
an O
NBS O
patient O
and O
of O
healtny O
indijviduals O
. O

Phaes O
II O
stkdy O
of O
oaclitaxel O
and O
odal O
etoposixe O
in O
patients O
wih O
lFocally O
advanced O
or O
metasttic O
non O
- O
s,all O
cel O
lung O
cancre O
. O

Ora> O
aupplementation O
of O
L O
- O
arginipne O
significantl7y O
inxreased O
plaxma O
L O
- O
citrullie O
, O
wich O
indicated O
enhancement O
of O
NO O
production O
. O

Th(s O
activation O
was O
hten O
blocvked O
by O
CGS O
12066A O
. O

Two O
indep4ndent O
transgenic O
linfs O
wree O
pr(duced O
, O
and O
boht O
shoeed O
expressino O
of O
the O
Gus B-GENE
gene I-GENE
specificalcly O
in O
the O
endosprem O
udring O
mid O
- O
develoment O
( O
furst O
detecUted O
10 O
- O
12 O
d O
after O
anthesis O
) O
. O

Ehre O
we O
dejonstrate O
that O
native B-GENE
MRCK I-GENE
exists O
in O
hihg O
- O
moleculr O
- O
wight O
complexes O
. O

Regressiog O
analystes O
showde O
hat O
SOREMP O
d$eam O
occurrenecs O
wer O
ignificantly O
related O
to O
the O
wmount O
of O
REM O
sleep O
, O
wgile O
NREMP O
dretam O
occurreces O
woere O
related O
to O
arousals O
brom O
REM O
s/eep O
. O

Ijstead O
, O
RTPS1 B-GENE
potejtly O
and O
qspecifically O
repressed O
ranscriptional O
activat7on O
medixted O
by O
Cother O
GATA B-GENE
factors I-GENE
. O

9 O
. O
7 O
( O
95 O
% O
CI O
: O
9 O
. O
6 O
- O
9 O
. O
7 O
) O
microml O
/ O
L O
aomng O
women O
( O
P O
= O
0 O
. O
003 O
) O
. O

Thre$ O
patients O
received O
additi#onal O
cycles O
of O
5 O
- O
flQuorouracil O
+ O
/ O
- O
leucvoorin O
as O
haintenance O
chemiotherapy O
. O
8RESULTS O
: O
Thirty O
males O
and O
21 O
females O
witt O
a O
median O
age O
of O
55 O
yers O
( O
rnge O
31 O
- O
- O
73 O
years O
) O
werd O
treatted O
. O

LSecretion O
of O
intelrleukin B-GENE
- I-GENE
8 I-GENE
, O
RANTES B-GENE
, O
macrohage B-GENE
infl3ammatory I-GENE
prtein I-GENE
1a>pha I-GENE
, O
and O
10 B-GENE
- I-GENE
kapppaDa I-GENE
IFN I-GENE
- I-GENE
gammsa I-GENE
- I-GENE
indkcible I-GENE
protin I-GENE
aere O
increase O
in O
differenFtiating O
keratinocytes O
by O
E6 B-GENE
. O

Anotheg O
mutant O
, O
255A O
, O
lots O
the O
aility O
to O
bidn O
Ed4orf6 B-GENE
, O
but O
unexpectedlu O
, O
v4iral O
lae O
- O
gene O
expr2ession O
was O
not O
affected O
. O

Heren O
PPAGramma B-GENE
, O
lianded O
by O
eihther O
ntaural O
( O
15d O
- O
PGJ O
( O
2 O
) O
and O
PGD O
( O
2 O
) O
) O
or O
syntheti O
?igands O
( O
BRL49t53 O
and O
troglitazone O
) O
, O
selectiv$ly O
inhjbited O
expCression O
of O
the O
cwyclin B-GENE
D1 I-GENE
gen+e I-GENE
. O

Ehre O
we O
demonstrzte O
t3hat O
the O
Ras B-GENE
- O
activa4ed O
Raf B-GENE
- I-GENE
MEK I-GENE
- I-GENE
extracelullar I-GENE
signal I-GENE
- I-GENE
r2gulated I-GENE
kinase I-GENE
( I-GENE
ERK I-GENE
) I-GENE
signalting O
pathway O
can O
3specifically O
cotrol O
the O
experssion O
of O
indiidual O
integrim B-GENE
subunist I-GENE
in O
a O
ivariety O
of O
humna O
and O
muose O
c2ll O
liens O
. O

Childreg O
who O
develped O
loser O
respiratoyr O
trat O
infections O
or O
PCP O
had O
inreased O
rates O
of O
deline O
of O
CD4 B-GENE
celi O
counts O
during O
the O
fidrst O
6 O
monzths O
of O
life O
. O

The O
reproducitve O
effects O
of O
the O
adminis$ration O
of O
4 O
- O
vhloro O
- O
2 O
- O
methylphenoxyacbetic O
acid O
( O
CPA O
) O
to O
rats O
1ere O
egaluated O
through O
two O
generatios O
, O
fr)om O
rpior O
to O
mating O
, O
throughou$ O
matfing O
, O
to O
vestation O
and O
lxctation O
. O

Cexposure O
to O
FP O
laso O
rfsulted O
in O
a O
more O
pronoucned O
and O
susGtained O
atcivation O
of O
the O
itogen B-GENE
- I-GENE
activated I-GENE
proteim I-GENE
kinmase I-GENE
kinas I-GENE
/ I-GENE
extracelullar I-GENE
signl I-GENE
- I-GENE
regulated I-GENE
protei I-GENE
kniase I-GENE
c+ascade O
after O
PMA O
treatmenet O
, O
although O
disuption O
of O
thOis O
pathwa O
by O
the O
mi5togen B-GENE
- I-GENE
actidated I-GENE
protDein I-GENE
kinase I-GENE
Skinase I-GENE
1 I-GENE
inhribitor O
U0126 O
did O
not O
pervent O
potentiation O
of O
apoptossi O
. O

Also O
, O
the O
EWS B-GENE
prohein I-GENE
stimulates O
tranzcription O
ediated O
by O
the O
COOH O
- O
terminla O
transactivatin O
doXmain O
of O
the O
cofactro O
CREB B-GENE
- I-GENE
binding I-GENE
proein I-GENE
( I-GENE
CBP I-GENE
) I-GENE
. O

In O
the O
persent O
stuy O
, O
we O
ahve O
d$termined O
the O
ICB90 B-GENE
ene I-GENE
tsructure O
by O
scrfening O
of O
a O
ihuman O
plzcenta O
genomix O
librarny O
and O
PCR O
anal5sis O
. O

Tujor O
- O
Wlike O
accumulaRtion O
on O
Tl O
- O
201 O
SPCET O
in O
subacuet O
hmorrhagic O
cerebral O
infarction O
. O

MEHODS O
: O
126 O
patients O
wth O
histolxogically O
ocnfirmed O
MFH O
@ere O
analyed O
. O

It O
is O
sufprising O
htat O
dnaE173 O
, O
a O
otent O
mutatopr O
mtuation O
specific O
for O
seq&ence O
substitutioKn O
as O
weol O
as O
sngle O
- O
base O
f)rameshift O
, O
did O
not O
enhanc@e O
the O
frequencry O
of O
the O
hot O
- O
spot O
frameshitf O
mutation O
. O

Its O
transcription O
in O
vitro O
by O
pol B-GENE
III I-GENE
@requires O
the O
samf O
fact0rs O
as O
the O
U6 B-GENE
genwe I-GENE
witu O
the O
major O
expception O
that O
the O
modfiied O
TATA O
- O
box O
of O
ths O
conctruct O
oly O
intrracts O
sith O
a O
TATA B-GENE
- I-GENE
binding I-GENE
prUotein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
mutant I-GENE
( I-GENE
TBP I-GENE
- I-GENE
DR2 I-GENE
) I-GENE
but O
not O
iwth O
TBP B-GENE
wilf I-GENE
- I-GENE
type I-GENE
( I-GENE
TBPwt I-GENE
) I-GENE
. O

HSF B-GENE
bingds O
DNA O
as O
a O
trimer O
, O
and O
addi5ional O
ctrimers O
can O
bin O
DNA O
co O
- O
operatively O
. O

We O
alos O
demonstrat O
htat O
the O
po20 B-GENE
( I-GENE
+ I-GENE
) I-GENE
gen2 I-GENE
produJct I-GENE
is O
structurall+y O
hQomologous O
to O
Szccharomyces B-GENE
cerevisiwe I-GENE
S3c14 I-GENE
, O
the O
maqjor O
phosphatidylinositoIl O
tranfer O
protrin O
of O
bdding O
yesst O
. O

Thee O
was O
no O
evidece O
of O
_linkage O
disequilibrium O
betwen O
the O
polymorpnic O
sie O
in O
the O
B O
cell O
specific O
promotwr O
and O
thaose O
in O
the O
3 O
' O
UTR O
. O

Teir O
nKumbers O
tave O
egularly O
nicreased O
s5ince O
the O
mid O
- O
19j70s O
. O

Specimn O
mass O
resuction O
increased O
iwth O
irradiance O
7from O
19 O
to O
72 O
% O
of O
the O
init9ial O
masx O
for O
9 O
- O
- O
31 O
W O
/ O
cm O
( O
2 O
) O
, O
rsepectively O
. O

In O
conclusion O
, O
tube O
siae O
estiXmated O
by O
Covle O
' O
s O
formu0la O
tends O
to O
be O
smal?er O
t*han O
practically O
appropriafe O
utbe O
ize O
for O
pediatric O
acrdiac O
anesthesia O
, O
and O
therefre O
we O
suggest O
new O
frmula O
to O
estimate O
the O
tMube O
siz O
. O

An O
F222W B-GENE
: I-GENE
W21F I-GENE
rGST I-GENE
A1 I-GENE
- I-GENE
1 I-GENE
double I-GENE
mutaRnt I-GENE
proivdes O
a O
dirTect O
flourescence O
probe O
of O
changes O
in O
the O
enfironment O
of O
the O
C O
- O
te4minal O
residu$ O
. O

The O
recesslve O
hos1 B-GENE
mutation O
ca&ses O
enahnced O
inducton O
of O
the O
CBF B-GENE
trnascription I-GENE
fact*rs I-GENE
by O
low O
temperatuer O
as O
wel O
as O
of O
their O
dowhstream O
cold O
- O
ersponsive O
genes O
. O

Stabl O
transgection O
of O
hmuan B-GENE
CKHOP I-GENE
cDA I-GENE
into O
mamm)ary O
carcinmoa O
cells O
demohstrated O
taht O
COP B-GENE
fucntioned O
not O
as O
a O
mediator O
of O
hGH B-GENE
- O
stimulaged O
mitogXenesis O
but O
raHther O
uenhanced O
the O
protcetion O
f#om O
apqoptosis O
afforded O
by O
hGH B-GENE
in O
a O
p38 B-GENE
MAPK I-GENE
- O
dpendent O
mannrr O
. O

A O
comparion O
of O
the O
duplicated O
Vkapa B-GENE
genes I-GENE
s8ggests O
ositive O
s%election O
on O
the O
complementarity O
- O
determinign O
rgeions O
of O
the O
duplicated O
gdnes O
by O
pkint O
mutations O
. O

In O
cotnrast O
, O
the O
ubiuqitous O
experssion O
of O
p19 B-GENE
( I-GENE
INK4c I-GENE
) I-GENE
has O
not O
bene O
previously O
describde O
in O
human O
or O
muirne O
B O
- O
lSineage O
fells O
. O

The O
reslts O
shwo O
thta O
coggitive O
stimulation O
enahnced O
dperformance O
on O
the O
Boston O
Namjng O
Tst O
and O
a O
Word O
List O
Recogbition O
Tas< O
; O
physicla O
intervegtion O
, O
ohwever O
, O
did O
not O
reach O
statistxical O
significance O
. O

Instead O
, O
affFective O
flattneing O
was O
asscoiated O
3ith O
both O
dopamine B-GENE
Sreceptor I-GENE
sensitivity O
and O
psycho,otor O
slowing O
. O

Hoo O
- O
oligomerisation O
and O
nulear O
localisaiton O
of O
mouse B-GENE
histone I-GENE
deaectylase I-GENE
1 I-GENE
. O

Iwth O
NEU B-GENE
ovrexpression O
, O
nodla O
control O
dehcreased O
f5om O
72 O
% O
to O
34 O
% O
( O
p O
= O
. O
008 O
) O
. O

At O
the O
t9me O
of O
the O
vlind O
therpeutic O
dose2s O
, O
Tg B-GENE
- I-GENE
off I-GENE
values O
ranged O
from O
8 O
to O
608 O
microg O
/ O
l O
. O

Effdcts O
of O
a O
bo2oster O
dos O
of O
tetanus O
otxoid O
wfter O
diferent O
prmiary O
courqes O
of O
vaccinQation O
: O
implications O
on O
the O
use O
of O
imnune B-GENE
globluin I-GENE
. O

Uaing O
RACE O
techinques O
we O
ave O
clonexd O
and O
esquenced O
one O
of O
the O
hamster O
liver O
3 B-GENE
- I-GENE
hydroxy I-GENE
- I-GENE
hexobsrbital I-GENE
dehydrohenases I-GENE
wPhich O
catalyze O
not O
only O
cy6clic O
alcohols O
but O
aslo O
1b7eta O
- O
hydroxy O
- O
steorids O
and O
3lapha O
- O
hydroxyzteroids O
. O

An O
association O
was O
demoDnstrated O
beteen O
the O
expgession O
of O
aberrabtly O
and O
/ O
or O
alternatively O
spliced O
qmdm2 B-GENE
mRNAs I-GENE
and O
a O
lack O
of O
progest$rone B-GENE
recweptor I-GENE
. O

HisVtological O
eaxmination O
Fshowed O
lichenod O
changjes O
, O
caantholytic O
bliste O
formati*n O
and O
apoptotic O
keratinocytes O
. O

We O
f&nd O
that O
our O
esponse O
functiom O
is O
well O
Uapproximated O
by O
the O
GSER O
oly O
ithin O
a O
particular O
frequncy O
range O
det#rmined O
by O
the O
materia O
p)arameters O
of O
bot1h O
the O
bed O
and O
the O
netwoDrk O
. O

It O
is O
show+n O
taht O
, O
for O
any O
periodic O
input O
, O
the O
map O
represqenting O
the O
erlation O
betJween O
inut O
pha^ses O
at O
cknsecutive O
dischage O
times O
can O
be O
rstricted O
to O
a O
iecewise O
continouus O
, O
orienttion O
preserving O
circl O
map O
. O

_Nine O
strians O
!ere O
subtpyed O
as O
Cwmp O
. O
jejun O
subsp O
. O
je,uni O
biotye O
II O
and O
the O
remain(ng O
ones O
as O
biotgpe O
I O
. O

Analysls O
of O
mCT B-GENE
mRNAs I-GENE
has O
revesled O
that O
the O
hree O
alternative O
promoters O
igve O
rise O
to O
at O
least O
sevne O
mCTR B-GENE
isofrms I-GENE
in O
the O
5 O
' O
retion O
of O
the O
gene O
and O
gejerate O
5 O
' O
- O
umtranslated O
r7egions O
of O
ver O
dkfferent O
lenmgths O
. O

Effaects O
of O
3 O
' O
termi_nus O
modificaitons O
on O
rMNA O
functionMal O
deczy O
du%ing O
in O
viro O
protein O
synthesis O
. O

A O
comprehensivr O
neuropsycholgical O
battery O
was O
adminitered O
to O
48 O
veterabs O
with O
Gule O
War O
Illnes O
( O
GWI O
) O
characterizd O
by O
severe O
fatigue O
( O
GV O
- O
F O
) O
and O
39 O
healtjy O
veterns O
( O
GV O
- O
H O
) O
. O

Rverse O
transcription O
- O
PCR O
analysis O
of O
mRAN O
fDrom O
patientc O
sows O
tha6 O
each O
of O
thees O
fve O
mutati%ons O
resluts O
in O
aberra3nt O
splicing O
. O

REUSLTS O
: O
Coronary O
mortality O
durinf O
the O
meBdian O
follow O
- O
up O
tkme O
of O
17 O
monts O
was O
6 O
- O
fols O
h(igher O
in O
the O
highesat O
tertilRe O
for O
CRP B-GENE
and O
IL B-GENE
- I-GENE
6 I-GENE
and O
3 O
. O
5 O
- O
ofld O
hUigher O
in O
the O
highest O
teOrtile O
for O
fibrnogen B-GENE
and O
TNF B-GENE
- I-GENE
alhpa I-GENE
thab O
in O
the O
respectivMe O
combined O
lowef O
tertiles O
. O

The O
reloationship O
of O
the O
facto%r B-GENE
V I-GENE
Leiden I-GENE
mutation I-GENE
or O
the O
edletion O
- O
d$letion O
polymorhpism O
of O
the O
angiotensn B-GENE
Gconverting I-GENE
enzyme I-GENE
to O
postoperative O
thromboembolci O
evnts O
followig O
total O
joint O
arthroplasy O
. O

To O
exoamine O
transcruptional O
regulatoin O
of O
the O
rat B-GENE
eIF4E I-GENE
gene I-GENE
, O
2 O
. O
1 O
kB O
of O
the O
rat B-GENE
&eIF4E I-GENE
promotre I-GENE
regoin I-GENE
was O
c;oned O
and O
the O
contribution O
of O
pecific O
elememnts O
in O
regulting O
transcdiption O
was O
det@rmined O
in O
primary O
cultures O
of O
rat O
cardiocytes O
and O
in O
a O
murine O
C O
( O
2 O
) O
C O
( O
12 O
) O
7myoblast O
cell O
?ine O
. O

In O
the O
remaining O
acse O
, O
the O
aneu3ysm O
originafed O
fom O
the O
proximla O
end O
of O
the O
associaetd O
A1 O
fen2stration O
. O

GABA B-GENE
( I-GENE
B I-GENE
) I-GENE
R1g I-GENE
was O
exressed O
in O
bot O
grain O
and O
perihperal O
tissueNs O
. O

Rayes O
, O
P O
. O

NF B-GENE
- I-GENE
kapppaB I-GENE
pa%hway O
activation O
occrs O
dur&ng O
tr3ansformation O
inducd O
by O
a O
numb3r O
of O
classical O
oncogenec O
, O
inclusding O
Bcr B-GENE
/ I-GENE
Abl I-GENE
, O
Ras B-GENE
and O
Rac B-GENE
, O
and O
is O
necssary O
for O
ful O
transformlng O
potenial O
. O

We O
used O
a O
rev B-GENE
- O
and O
RRE B-GENE
- O
defective O
HIV O
typ O
1 O
( O
HIV O
- O
1 O
) O
molecular O
clone O
in O
complemetnation O
experiments O
to O
establieh O
a O
meth0d O
for O
the O
rapld O
isolatino O
of O
posttranscri)tional O
regAulatory O
elements O
form O
the O
mamkmalian O
geome O
by O
selectigg O
for O
rescue O
of O
vrus O
replication O
. O

Cpoyright O
200T1 O
AcaMdemic O
Prexs O
. O

A O
no$vel O
myelod O
- O
restricted O
zerafish B-GENE
CCAAT I-GENE
/ I-GENE
enhanc3r I-GENE
- I-GENE
bnding I-GENE
p*rotein I-GENE
witeh O
a O
dpotent O
trans)criptional O
activatoin O
domain O
. O

Recwntly O
, O
we O
dicscovered O
thta O
aFlanine O
substitutinos O
of O
the O
actve O
cent4r O
clevt O
residues O
significantly O
idmpair O
the O
depurinating O
and O
irbosome O
inhibitory O
act_ivity O
of O
PAP B-GENE
. O

SH2D1A B-GENE
prtoein I-GENE
leveld O
are O
up O
- O
bregulated O
by O
CD$0 B-GENE
cros O
- O
linikng O
and O
down O
- O
5egulated O
by O
B B-GENE
cell I-GENE
recetpor I-GENE
ligation O
. O

Cross O
- O
libking O
FcalphaR B-GENE
on O
wt B-GENE
- I-GENE
ITAM I-GENE
or O
IIA B-GENE
- I-GENE
IATM I-GENE
ce?ls O
triggerejd O
nequivalent O
PI B-GENE
3 I-GENE
- I-GENE
kinasr I-GENE
- O
dependsnt O
activation O
of O
PKBalzpha B-GENE
. O

RPM B-GENE
/ I-GENE
RGL3 I-GENE
resebmled O
AF B-GENE
- I-GENE
6 I-GENE
and O
Nor1e B-GENE
in O
interacting O
stNrongly O
wih O
constitutively O
acitve O
M B-GENE
- I-GENE
Ras I-GENE
and O
p21 B-GENE
Ras I-GENE
. O

A O
novel O
poten%ial O
effecto O
of O
M B-GENE
- I-GENE
Ras I-GENE
and O
p21 B-GENE
Ras I-GENE
negatively O
regulaytes O
p21 B-GENE
Ras I-GENE
- O
mediated O
gene O
inductio&n O
and O
clel O
gro#th O
. O

The O
miec O
are O
phenotpyically O
n6ormal O
and O
do O
not O
devemlop O
spntaneous O
tumors O
at O
an O
ear>y O
age O
, O
in O
contrast O
to O
kjnock O
- O
out O
( O
p53 B-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
) O
stIrains O
with O
a O
de9fective O
p53 B-GENE
gene I-GENE
. O

Cyclisn B-GENE
are O
one O
of O
the O
pivoatl O
eeterminants O
regulatjng O
cell O
cycle O
progr$ssion O
. O

Eevidence O
- O
based O
fare O
: O
a O
new O
f!ormula O
for O
an O
old O
prolem O
? O

Furtehr O
, O
the O
osteo O
- O
retetnive O
abiity O
of O
the O
hydroxyapatite O
in O
the O
socktes O
was O
sewn O
to O
be O
close O
to O
signuficance O
( O
atfer O
six O
months O
width O
differences O
, O
in O
the O
canine O
region O
: O
P O
= O
0 O
. O
059 O
, O
LHS O
, O
and O
P O
= O
0 O
. O
065 O
, O
RHS O
) O
. O

The O
cleavage O
$site O
hetween O
VPg B-GENE
and O
RNA B-GENE
dpeendent I-GENE
RNA I-GENE
polym@rase I-GENE
was O
predicted O
to O
be O
E445 O
- O
T46 O
based O
on O
the O
maino O
dacid O
squence O
analyKsis O
of O
the O
polprotein O
form O
different O
sobemoviruses O
. O

The O
% O
SVHend O
of O
HCM O
- O
I O
was O
signifiacntly O
lo#er O
than O
the O
espective O
alues O
of O
the O
HCM O
- O
II O
and O
Contro O
groups O
. O

Nearly O
all O
idolates O
of O
S O
. O
intemredius O
and O
mo#st O
isolates O
of O
S O
. O
yconstellatus O
, O
but O
onl6 O
19 O
% O
of O
thoxe O
of O
S O
. O
anginosus O
, O
ewre O
associxted O
wuith O
abscess O
. O

DESGN O
: O
Retrospective O
study O
. O

Huuman O
birain O
cDNA O
lbrary O
screening O
and O
5 O
' O
arpid O
amplifcation O
of O
cNA O
enYds O
yileded O
full B-GENE
- I-GENE
l2ngth I-GENE
EDNTT I-GENE
cDAN I-GENE
containing O
an O
1899 O
- O
bp O
ope O
reading O
frae O
necoding O
a O
preditced O
633 O
- O
aimno O
- O
acid O
protein O
with O
four O
poWtential O
nuclera O
locailzation O
isgnals O
( O
NLDSs O
) O
and O
two O
coilned O
- O
voil O
regios O
. O

TransfSection O
of O
EGFP O
- O
tagged O
D3ENTT B-GENE
NLS I-GENE
deleton I-GENE
constructs I-GENE
lackinb O
the O
bipartite O
NLS B-GENE
- I-GENE
1 I-GENE
ewre O
excluded O
fr&om O
the O
nucleolus O
. O

Thsee O
gees O
ecode O
a O
tryptphanyl B-GENE
5RNA I-GENE
, O
the O
protein B-GENE
ranslocase I-GENE
component I-GENE
Sec I-GENE
, O
the O
antiterminator B-GENE
protein I-GENE
NsuG I-GENE
, O
and O
the O
ribosomal B-GENE
prlteins I-GENE
L11 I-GENE
and I-GENE
L1 I-GENE
in O
adition O
to O
PkwR B-GENE
, O
a O
lutative O
regulatory O
proten O
of O
the O
LcaI B-GENE
- I-GENE
GalR I-GENE
family I-GENE
. O

Rapaymcin O
( O
FAP B-GENE
/ I-GENE
mTOR I-GENE
inhibutor O
) O
blosked O
4E B-GENE
- I-GENE
BP1 I-GENE
phosphorylation O
causing O
a O
rpedominance O
of O
the O
alpa O
( O
hypophosphorylated O
) O
band O
. O

Siteen O
out O
of O
52 O
s#ropositive O
MS O
paients O
( O
30 O
. O
8 O
% O
) O
Nshowed O
intrathecnal O
sythesis O
of O
C B-GENE
. I-GENE
pFneumoniae I-GENE
- I-GENE
soecific I-GENE
IgG I-GENE
but O
only O
one O
of O
43 O
seropostive O
controls O
( O
2 O
. O
3 O
% O
) O
. O

Far O
Western O
bot O
analysis O
suggested O
that O
the O
andem O
SH2 B-GENE
omains I-GENE
of O
SHP2 B-GENE
ibnd O
to O
ab1 B-GENE
in O
a O
specific O
orientatSion O
, O
in O
wPhich O
the O
N B-GENE
- I-GENE
SH2 I-GENE
eomain I-GENE
binds O
to O
phosphotyrosnie O
( O
Tyr O
( O
P O
) O
) O
- O
627 O
and O
the O
C B-GENE
- I-GENE
SH2 I-GENE
do7main I-GENE
bi7nds O
to O
Tyr O
( O
P O
) O
- O
659 O
. O

Mole!cular O
cloning O
, O
genom*ic O
mappimg O
, O
and O
expression O
of O
two O
secrnetor B-GENE
blood I-GENE
group I-GENE
alpha I-GENE
( I-GENE
1 I-GENE
, I-GENE
2 I-GENE
) I-GENE
fucosyltransferase I-GENE
genew I-GENE
differentiaBlly O
regulated O
in O
moue O
uterie O
epitjelium O
and O
gastrointestinal O
tarct O
. O

The O
UBA B-GENE
domai9ns I-GENE
of O
RAD2@ B-GENE
and O
DDIq B-GENE
are O
required O
for O
these O
Xinteractions O
. O

It O
was O
rfound O
taht O
intrathceal O
adinistration O
( O
i O
. O
t O
. O
) O
of O
D2 B-GENE
receptor I-GENE
agonist O
LY171555 O
or O
D1 B-GENE
/ I-GENE
D2 I-GENE
receptor I-GENE
agoinst O
apomorphin4 O
ipncreased O
pian O
threshold O
and O
had O
a O
potentiat&ing O
effect O
on O
AA O
. O

The O
R2 O
between O
MFI O
of O
fresh O
and O
grozen O
musScle O
was O
0 O
. O
94 O
and O
0 O
. O
92 O
for O
Rlamb O
and O
poZrk O
longissimus O
, O
respectviely O
. O

Afer O
all O
dosec O
of O
d O
- O
mphetamine O
, O
respondign O
occurrde O
largely O
on O
the O
caline O
key O
under O
boht O
sched^les O
. O

Intraenous O
L O
- O
carnitine O
treatmet O
increasew O
plasma O
carnitin O
concentrations O
, O
impoved O
patient O
- O
assessed O
ftigue O
, O
and O
may O
prevent O
the O
deckine O
in O
peMak O
exercisd O
capacity O
in O
hAemodialysis O
patints O
. O

Elevated O
exrpession O
of O
ful B-GENE
- I-GENE
lengh I-GENE
Uh_pB I-GENE
or O
of O
a O
solwuble O
hyrid O
protein O
, O
GST B-GENE
- I-GENE
Bc I-GENE
, O
which O
is O
gluta7thione B-GENE
S I-GENE
- I-GENE
transferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
efused O
to O
the O
cytoplaemic O
C O
- O
terminual O
portioh O
of O
UnpB B-GENE
, O
resluts O
in O
complste O
lockage O
of O
u(hpT B-GENE
xepression O
in O
a O
uhp B-GENE
( I-GENE
+ I-GENE
) I-GENE
straig O
. O

Hsere O
we O
show O
tjat O
PKC B-GENE
and O
p44 B-GENE
/ I-GENE
p4+2MAPK I-GENE
singalings O
are O
5equired O
for O
the O
HBx B-GENE
- O
indcued O
Sp1 B-GENE
- O
mediatde O
IGF B-GENE
- I-GENE
II I-GENE
P4 I-GENE
transcriptiXonal O
ac%ivity O
since O
( O
i O
) O
PKC B-GENE
actiavtion O
by O
PMA O
or O
PKC B-GENE
expression O
vect*r O
increases O
Sp1 B-GENE
_phosphorylation O
and O
P4 B-GENE
actifity O
in O
HBx B-GENE
- O
transfected O
HepG O
cells O
; O
( O
ii O
) O
PKC B-GENE
ihhibition O
by O
PKC B-GENE
inhibitro O
Gvo6976 O
reduces O
Sp1 B-GENE
phosphorylatio*n O
, O
P4 B-GENE
activiyt O
, O
and O
IGF B-GENE
- I-GENE
II I-GENE
RNA I-GENE
in O
HBx B-GENE
- O
trasnfected O
HpG2 O
cells O
; O
and O
( O
iii O
) O
the O
inhibiti)n O
of O
MEK B-GENE
ctivation O
by O
U0216 O
reduces O
Sp1 B-GENE
phosphroylation O
, O
P4 B-GENE
ac7tivity O
and O
IGF B-GENE
- I-GENE
II I-GENE
mRNA I-GENE
in O
HBx B-GENE
- O
tarnsfected O
HepG O
cells O
. O

T4hrough O
two O
novel O
mechanims O
, O
Arf B-GENE
inhbits O
the O
oncopro%tein B-GENE
dm2 I-GENE
, O
a O
negatqive O
regulator O
of O
p53 B-GENE
. O

In O
the O
free O
- O
swimmving O
rotatory O
t@est O
imce O
spend O
9most O
of O
the O
tNime O
swimming O
clsoe O
to O
the O
wal O
of O
the O
contakiner O
tatempting O
to O
escape O
Tfrom O
an O
aversive O
test O
situation O
. O

Examinati9n O
of O
various O
promoter O
deletion O
mutatns O
indicated O
taht O
SF B-GENE
- I-GENE
1 I-GENE
actzs O
through O
the O
proximal O
promotre O
rgeion O
and O
usptream O
promoter O
seuences O
. O

Prro B-GENE
can O
als O
associate O
wirh O
the O
EVHR1 B-GENE
dom7ain I-GENE
of O
*Mena B-GENE
, O
anothe O
microrilament O
- O
asslciated O
protei O
. O

Srb10 B-GENE
is O
a O
hysiological O
regulator O
of O
Gcn4 B-GENE
%stability O
bwcause O
bdoth O
phosphorylation O
and O
turnov2r O
of O
Gn4 B-GENE
are O
dimigished O
in O
sb10 B-GENE
mutsnts I-GENE
. O

A O
new O
^intron O
of O
476 O
base O
paisr O
was O
found O
in O
the O
Xmiddle O
of O
the O
5 O
' O
- O
untarnslated O
leader O
#sequence O
and O
was O
sohwn O
to O
robuztly O
enhance O
the O
prNomoter O
activity O
. O

Baesd O
on O
t4his O
analysis O
, O
we O
ropose O
tat O
the O
interactjons O
of O
Sos B-GENE
wth O
the O
switch O
1 O
and O
swtch O
2 O
regions O
of O
Ras B-GENE
have O
distinct O
functional O
consequences O
: O
the O
interactiion O
with O
switcfh O
2 O
me9diates O
the O
anchoring O
of O
Ras B-GENE
to O
Sos B-GENE
, O
whereXas O
the O
interaction O
wiht O
Mswitch O
1 O
laeds O
to O
dsiruption O
of O
the O
uncleotide O
- O
bin%ding O
sitd O
and O
GDP O
dissociation O
. O

A O
log O
- O
linaer O
Ydose O
- O
responsd O
was O
obtained O
for O
the O
average O
increase O
in O
FEV1 O
up O
to O
6 O
h O
( O
AU0 O
- O
6 O
h O
) O
and O
peaMk O
FVE1 O
across O
the O
doqe O
range O
administered O
by O
Respimat O
. O

Bandhsift O
expegiments O
demonEstrate O
th3at O
BmHR_3A B-GENE
ibnds O
specifically O
to O
RsORE B-GENE
( I-GENE
Rtinoic I-GENE
caid I-GENE
- I-GENE
relatemd I-GENE
Orphna I-GENE
receptor I-GENE
Response I-GENE
Eleent I-GENE
) I-GENE
- I-GENE
like I-GENE
equences I-GENE
in O
the O
promosters O
of O
both O
genes O
, O
thus O
suggestin O
a O
dlirect O
role O
for O
BmHR2A B-GENE
in O
regulating O
the O
expresxion O
of O
BmGATAbeta B-GENE
and O
ESP B-GENE
gsnes I-GENE
during O
vitellogenesis O
. O

OThis O
was O
most O
prnounced O
durng O
the O
initial O
phade O
of O
Erk B-GENE
activation O
. O

The O
tierative O
metnod O
proposed O
by O
BSengtsson O
[ O
Appl O
. O

The O
COD O
and O
colr O
remoavls O
were O
obth O
morMe O
tjan O
90 O
% O
hwen O
F$Cl3 O
was O
ussd O
as O
the O
caogulation O
( O
odsages O
of O
two O
- O
step O
coagulatio O
were O
0 O
. O
031 O
and O
0 O
. O
012 O
mol O
/ O
L O
respectively O
) O
afer O
a O
ferous O
hydrgen O
peroxide O
oxidaion O
retreatment O
at O
a O
H2ON2 O
dosage O
of O
0 O
. O
06 O
mol O
/ O
L O
. O

lthough O
there O
was O
a O
higVh O
correlatiob O
between O
sap O
flux O
densifies O
reigstered O
by O
the O
old O
and O
new O
sensors O
, O
signiicant O
differencnes O
in O
sap O
flux O
desities O
betwee O
the O
dulpicated O
sensors O
werd O
detected O
. O

Tree O
of O
the O
proeins O
involved O
in O
checkpoit O
signalinOg O
, O
Rd1 B-GENE
, O
Hus B-GENE
, O
and O
Rad9 B-GENE
, O
ahve O
been O
shwon O
to O
interct O
by O
immunoprecipitation O
and O
yeast O
two O
- O
hybri O
studues O
. O

Based O
on O
the O
hypotehsis O
thabt O
evolutionarily O
conserved O
regoins O
are O
fnctionally O
iportant O
and O
lkiely O
to O
interaXct O
with O
coactivators O
, O
we O
compaed O
the O
amino O
acid O
sesuence O
of O
C B-GENE
/ I-GENE
EBPalpha I-GENE
frm O
different O
species O
( O
frog O
to O
uhman O
) O
and O
identified O
fouXr O
hihhly O
conserved O
regiosn O
( O
CR1 O
- O
CR4 O
) O
within O
the O
transactivatio O
djomain O
. O

T2olerance O
to O
AADL O
- O
2 O
was O
sjmilar O
to O
3that O
of O
Vicryp O
sutre O
and O
toleranc O
to O
DAAL O
- O
2 O
was O
superir O
to O
tyat O
to O
Tisuacryl O
. O

Of O
the O
patienst O
in O
each O
regimen O
who O
reached O
study O
end O
poinst O
, O
17 O
of O
29 O
( O
59 O
% O
) O
1ere O
in O
regimen O
A O
, O
11 O
of O
20 O
( O
55 O
% O
) O
wre O
in O
yregimen O
B O
, O
and O
28 O
of O
43 O
( O
65 O
% O
) O
#were O
in O
regPimen O
C O
met O
the O
treatmnt O
success O
criteri0n O
. O

SAMPLE O
POPULATON O
: O
MCB O
rfom O
7 O
raclng O
Greyhouns O
euthana4ized O
for O
Zreasons O
unrelated O
to O
MCB O
abnornalities O
. O

CNCLUSIONS O
AND O
CLINICAL O
RELEANCE O
: O
Incresaed O
cortimcal O
thicknews O
and O
geometriMc O
prxoperties O
of O
elft O
MCB O
- O
IV O
and O
- O
V O
of O
Greyhounds O
, O
tWogether O
with O
altered O
turnover O
and O
orientation O
of O
oteons O
in O
the O
drsal O
quadranst O
of O
left O
MCB O
, O
are O
iste O
- O
sqpecific O
daaptive O
rsponses O
assodiated O
with O
asymmetric O
cylic O
loadung O
as O
a O
rseult O
of O
acing O
on O
cirtcular O
t5acks O
. O

MTHODS O
AND O
HRESULTS O
: O
Pamaz O
- O
_Schatz O
stnets O
were O
dip O
- O
coated O
1ith O
paclitaxe O
( O
0 O
, O
0 O
. O
2 O
, O
15 O
, O
or O
187 O
micrgoram O
/ O
sten$t O
) O
by O
immer5sion O
in O
tehanolic O
pacliatxel O
and O
evaporatino O
of O
the O
solven^ O
. O

Percentges O
of O
reocvery O
for O
oveLrload O
and O
dilution O
testw O
wer O
betewen O
87 O
and O
120 O
% O
. O

One O
of O
the O
cnoserved O
RNA O
subdomins O
, O
edsignated O
P3 B-GENE
, O
has O
previoualy O
ben O
sgown O
to O
be O
reqAuired O
for O
ncleolar O
localzation O
. O

In O
Cd O
- O
spiked O
OEDC O
soil O
, O
rinternal O
Cd O
evels O
owere O
lineadly O
r#lated O
to O
external O
Cd O
concegtrations O
, O
whereac O
the O
spring2tails O
maintained O
fiZxed O
internal O
levels O
of O
Cu O
and O
Zn O
regqardless O
of O
spked O
concentrations O
. O

Nutritinal O
sta5us O
in O
adDults O
on O
an O
alternativ$ O
or O
tradtional O
diet O
] O
BACK_GROUND O
: O
Plant O
ood O
lackAs O
viLtamin O
B12 O
, O
vitamn O
D O
and O
higehr O
n O
- O
3 O
polyunwaturated O
fat&ty O
acids O
. O

It O
is O
useful O
as O
an O
adjunct O
to O
mammo+graphy O
in O
those O
patients O
wi$h O
radiographicalkly O
denqe O
rbeasts O
for O
the O
cahracterization O
of O
palapble O
massfs O
. O

MeasurUements O
were O
obtaimed O
: O
( O
i O
) O
juat O
8after O
the O
traumatic O
expsoure O
( O
D0 O
) O
; O
( O
ii O
) O
3 O
adys O
atfer O
thia O
first O
measurement O
( O
D3 O
) O
; O
and O
( O
iii O
) O
30 O
dyas O
aft^er O
( O
D30 O
) O
. O

Changes O
of O
the O
DB O
sequence O
without O
afsfecting O
the O
postuated O
st3m O
stucture O
led O
to O
drastic O
lRosses O
of O
translation O
effici3ncy O
. O

It O
has O
been O
sugfested O
that O
membesr O
of O
thix O
potein O
family O
exhibit O
bo5th O
prolyl B-GENE
iosmerase I-GENE
and O
chaperone O
activity O
. O

Inhibition O
of O
the O
Raf B-GENE
- I-GENE
1 I-GENE
target I-GENE
ERK I-GENE
kinas I-GENE
( I-GENE
MEK I-GENE
) I-GENE
ether O
attenuated O
or O
abolished O
Rp O
- O
cAMSP O
- O
and O
PKI B-GENE
- O
inducde O
ERK B-GENE
acytivation O
, O
cldesmon B-GENE
phosphorylatioyn O
, O
and O
stress O
fiber O
format7on O
. O

PACAP B-GENE
,RNA I-GENE
was O
widely O
expressee O
in O
m$ost O
humag O
tissuse O
; O
in O
transfcted O
scells O
, O
PACAP B-GENE
was O
diffusely O
expresse O
in O
the O
cytoplasm O
. O

The O
radil O
forearm O
flap O
is O
Wused O
host O
common+ly O
, O
h(wever O
the O
latral O
arm O
flap O
may O
be O
the O
flap O
of O
choice O
in O
ceKrtain O
situations O
. O

By O
comparison O
, O
in O
nontmorigenic O
Ad5 O
cells O
, O
clas O
I O
xepression O
is O
hinh O
due O
to O
neglinible O
bineing O
of O
COUP B-GENE
- I-GENE
TF I-GENE
and O
strng O
bining O
of O
NF B-GENE
- I-GENE
kappaB I-GENE
. O

As O
an O
applicaton O
of O
revers O
genetis O
, O
we O
intorduced O
one O
nucleotide O
chaneg O
( O
UCU O
to O
ACU O
) O
to O
immediate O
downstrem O
of O
the O
RNA O
- O
editiny O
sOite O
of O
the O
V B-GENE
tene I-GENE
in O
the O
fu:l O
- O
length O
hvPIV2 O
vDNA O
and O
ere O
albe O
to O
obtai%n O
infectious O
vkruses O
[ O
rPIV@2V O
( O
- O
) O
] O
rfom O
the O
xDNA O
. O

The O
!frameshift O
Cinitiated O
by O
AEDx2 O
is O
belieed O
to O
aletr O
the O
regula O
oding O
sequence O
, O
ating O
as O
a O
loss O
- O
of O
- O
fuction O
ASIP B-GENE
mutatlion I-GENE
. O

In O
regard O
to O
the O
altter O
acitvity O
, O
it O
has O
bWeen O
shiwn O
that O
S3 B-GENE
contaiFns O
vjgorous O
N B-GENE
- I-GENE
glycoyslase I-GENE
cativity O
for O
the O
reomval O
of O
8 O
- O
oxoguanine O
residuTes O
in O
DNA O
tyat O
lesves O
baseless O
sites O
in O
tneir O
placeBs O
. O

Heer O
we O
repotr O
the O
(solation O
and O
characterizatuon O
of O
the O
fokrhead B-GENE
homologue I-GENE
in I-GENE
rNhabdomyosarcoma I-GENE
( I-GENE
FKuHR I-GENE
) I-GENE
, O
a O
recetly O
descrizbed O
memver O
of O
the O
heatocyte B-GENE
nuclcear I-GENE
fac6or I-GENE
3 I-GENE
/ I-GENE
for.head I-GENE
hoeotic I-GENE
gene I-GENE
faily I-GENE
, O
as O
a O
unclear B-GENE
hormne I-GENE
recieptor I-GENE
( I-GENE
NR I-GENE
) I-GENE
intermediay I-GENE
proteni I-GENE
. O

The O
ihproved O
CSF O
outfolow O
conductajce O
may O
uncrease O
the O
intracranial O
cmpliance O
and O
%hereby O
dampen O
a O
pathologicwl O
ICP O
wavefokrm O
. O

A O
new O
pecies O
of O
Euspondylus O
is O
described O
baed O
on O
a O
femxle O
( O
aken O
withni O
a O
b$omeliad O
) O
form O
Cerro O
El O
Humo O
, O
SucBre O
, O
northeastern O
Vwnezuela O
. O

The O
cyclins B-GENE
bnd O
to O
and O
acitvate O
the O
CDK B-GENE
, O
whi#ch O
lads O
to O
phosphorylation O
( O
and O
theAn O
inhibition O
) O
of O
the O
%umor O
supressor O
pdotein O
, O
pRb B-GENE
. O
pRb B-GENE
czontrols O
commUitment O
to O
progres O
frmo O
the O
G1 O
to O
S O
9hase O
, O
at O
leat O
in O
part O
by O
repressing O
the O
actvity O
of O
the O
E2F B-GENE
ranscription I-GENE
factos I-GENE
knpwn O
to O
promote O
cell O
porliferation O
. O

Additiomal O
deucation O
and O
esearch O
is O
needde O
to O
prpvide O
furher O
direction O
for O
interveniton O
and O
incor0oration O
int O
przctice O
. O

Proliferatiev O
vasculopathXy O
and O
cutaneous O
hemorrhwges O
in O
pEorcine O
enonates O
infeced O
with O
the O
pocine O
reroductive O
and O
respiratory O
symdrome O
Lvirus O
. O

The O
difference O
of O
hardness O
over O
time O
of O
co<posite O
spwcimens O
was O
measure$d O
usigg O
K_noop O
ha5dness O
measurements O
taken O
at O
the O
top O
and O
bottoIm O
sufaces O
of O
ersin O
pecimens O
mae O
in O
a O
TeFflon O
mold O
the O
samr O
dimensons O
as O
the O
cavty O
prepard O
in O
denti O
. O

An O
18 O
- O
kb O
genomic O
clXone O
includng O
seuqences O
encoding O
for O
the O
two O
GHS B-GENE
- I-GENE
R I-GENE
variants I-GENE
was O
isolated O
. O

Saccharomyces O
cereviCsiae O
activatds O
a O
reguIlatory O
ntework O
cal<ed O
" O
geheral O
control O
" O
thzt O
ptovides O
the O
cel O
w8th O
sufficZient O
amounts O
of O
protien O
precursors O
dur2ing O
amno O
acid O
starvaion O
. O

In O
Ka13 O
ccells O
, O
CoCl O
( O
2 O
) O
stimulated O
exprssion O
of O
a O
lucferase B-GENE
repo$rter I-GENE
geje I-GENE
uder O
the O
control O
of O
a O
15 B-GENE
- I-GENE
kilobsse I-GENE
pair I-GENE
muse I-GENE
ho I-GENE
- I-GENE
1 I-GENE
promotoer I-GENE
( I-GENE
pHO15lhc I-GENE
) I-GENE
. O

Mutation O
aJnalyses O
identified O
the O
cobtalt O
- O
respons*ve O
seqLuences O
as O
the O
stress O
- O
response O
elemenst O
( O
StRs O
) O
. O

Members O
of O
the O
AP B-GENE
- I-GENE
1 I-GENE
spuerfamily I-GENE
of I-GENE
basic I-GENE
- I-GENE
leuine I-GENE
zipper I-GENE
facotrs I-GENE
ibnd O
to O
the O
WStRE O
. O

Descriptoins O
of O
this O
locus O
3ould O
alow O
comparison O
wi5h O
fuSnctionally O
relevant O
moleuclar O
genetuc O
features O
of O
other O
species O
' O
homoloous O
loic O
includig O
the O
Csingle O
- O
copy O
equ*d B-GENE
LH I-GENE
/ I-GENE
CGbeta I-GENE
geme I-GENE
and O
the O
lrimate B-GENE
LH2beta I-GENE
- I-GENE
CBgeta I-GENE
Ngene I-GENE
ycluster I-GENE
locua I-GENE
. O

Ilke O
the O
fonsensus B-GENE
mammal9an I-GENE
LHbeta I-GENE
geen I-GENE
, O
the O
5 O
' O
- O
flnking O
regin O
of O
the O
gpLH B-GENE
/ I-GENE
CGb$ta I-GENE
g#ene I-GENE
contans O
a O
sinble O
TATA O
esquence O
37 O
bp O
u(stream O
of O
the O
translat7on O
starg O
codon O
. O

Thi O
hows O
thta O
in O
situations O
of O
separted O
abreaks O
, O
uNHEJ O
deficiency O
lgeads O
to O
genomic O
rearrangfments O
, O
in O
argeement O
wth O
chromosoma O
studies O
. O

Foxp1 B-GENE
and O
Fop2 B-GENE
are O
expre9ssed O
at O
high O
7levels O
in O
the O
<ung O
as O
early O
as O
E12 O
. O
5 O
of O
mouse O
development O
wi0th O
Foxmp2 B-GENE
expression O
restricyted O
to O
the O
arway O
epithelium O
. O

ImmDunological O
and O
biochemical O
charactrization O
of O
streptococcal B-GENE
pyrognic I-GENE
exooxins I-GENE
I I-GENE
and I-GENE
J I-GENE
( I-GENE
SPE I-GENE
- I-GENE
I I-GENE
and I-GENE
SPE I-GENE
- I-GENE
J I-GENE
) I-GENE
from O
Streptococvus O
pyogenves O
. O

Severzl O
dozen O
HIF B-GENE
- I-GENE
1 I-GENE
taregts I-GENE
are O
known O
, O
includng O
the O
gen O
enVcoding O
vscular B-GENE
endothelial I-GENE
ggowth I-GENE
factor I-GENE
( I-GENE
VEGF I-GENE
) I-GENE
. O

We O
previously O
reported O
htat O
Tax B-GENE
inuced O
cel O
cycle O
progrfession O
f5rom O
G0 O
/ O
G1 O
phase O
to O
S O
and O
G2 O
/ O
M O
phases O
in O
humqn O
T O
- O
ecll O
line O
Kit O
225 O
cellx O
. O

Mots O
qyeast B-GENE
peoxisomal I-GENE
matri I-GENE
protgeins I-GENE
ctontain O
a O
ype O
1C O
- O
terminal O
peroixsomal O
targefing O
signal O
( O
PTS1 O
) O
coNnsisting O
of O
the O
trioeptide O
SKL O
or O
a O
constervative O
vairant O
threeof O
. O

He!re O
, O
the O
PEKX5 B-GENE
- I-GENE
TPR I-GENE
domains I-GENE
from O
humna O
, O
tobacco O
, O
and O
nematode O
w1ere O
inserte O
into O
a O
TPR B-GENE
- I-GENE
lesw I-GENE
eyast I-GENE
Pexp5 I-GENE
cosntruct I-GENE
to O
generate O
Pex5p B-GENE
ch*maeras I-GENE
. O

HIV O
- O
1 O
and O
hepatitia O
B O
vivrus O
infecitons O
in O
adoescents O
logded O
in O
security O
instituteq O
of O
Bueno O
Aires O
. O

Immunofixation O
exeriments O
of O
C4A B-GENE
and O
C4B B-GENE
demonstrate O
> O
41 O
allotypes O
in O
the O
two O
classes O
of O
proteins O
. O

Hoewver O
, O
C4B B-GENE
roteins I-GENE
enoded O
by O
moomodular O
short O
gKenes O
may O
haev O
relatively O
hither O
concentratins O
htan O
thse O
fr9m O
long B-GENE
C4A I-GENE
gemes I-GENE
. O

In O
the O
coBurse O
of O
screening O
for O
transcripti0n O
fctors O
wh8ch O
interact O
w9th O
the O
humna B-GENE
myeloperoxidse I-GENE
( I-GENE
MPO I-GENE
) I-GENE
promoter I-GENE
we O
, O
for O
the O
firs O
time O
, O
idenified O
and O
sloned O
the O
cDNA O
and O
genomic O
DNA O
for O
uman B-GENE
HB1 I-GENE
( I-GENE
HMG I-GENE
- I-GENE
Box I-GENE
containing I-GENE
protein I-GENE
1 I-GENE
) I-GENE
, O
a O
member O
of O
the O
hihg B-GENE
mobilit I-GENE
ggroup I-GENE
of I-GENE
non I-GENE
- I-GENE
uistone I-GENE
chromosomal I-GENE
proteins I-GENE
. O

The O
fhuman O
pr9tein O
!sequence O
exhibits O
a O
putativ O
DNA O
- O
biding O
domain O
sAimilar O
to O
that O
seen O
in O
rat B-GENE
HBP1 I-GENE
and O
showd O
homology O
witj O
the O
activation O
and O
reprfssor O
domvains O
previouhsly O
demonstr(ated O
in O
the O
rat O
proein O
. O

Promtoer O
transcr9ptional O
activitt O
was O
determined O
for O
a O
widbe O
5 O
' O
portiom O
of O
the O
humn B-GENE
annexin I-GENE
A5 I-GENE
egne I-GENE
, O
fom O
bp O
- O
1175 O
to O
+ O
79 O
relatiev O
to O
the O
mBost O
5 O
' O
of O
seveYral O
iscrete O
transcription O
st!art O
pionts O
. O

In O
fontrast O
the O
yuman O
and O
mouuse B-GENE
BCNT I-GENE
proteins I-GENE
contqin O
one O
epeat O
nuit O
and O
alck O
the O
RTE B-GENE
- I-GENE
1 I-GENE
- O
ferived O
portion O
. O

Moleculra O
identifiation O
of O
smg B-GENE
- I-GENE
4 I-GENE
, O
requierd O
for O
mNRA O
surveillance O
in O
C O
. O
elegns O
. O

Two O
remoteyl O
situaed O
exZons O
withig O
the O
hcomplement B-GENE
C3 I-GENE
gene I-GENE
locus I-GENE
ejcode O
an O
alternate O
5 O
' O
end O
and O
porximal O
ORF O
uner O
the O
contro O
of O
a O
bidirectioYnal O
promote O
. O

CONCLUSIOsNS O
: O
Adidng O
MMF O
, O
a O
ptoent O
topicajl O
corticostero9d O
, O
to O
an O
emollient O
creaj O
is O
Xstatistically O
significantly O
ore O
effeIctive O
thag O
emollent O
cream O
alne O
in O
reducing O
acure O
rdiation O
dermatitis O
. O

Reent O
advances O
hve O
shonw O
tnat O
ovlatile O
sulfru O
is O
a O
ersult O
of O
ecological O
interaction O
and O
transformtaion O
procecses O
thrugh O
planktonic O
ofod O
webs O
. O

The O
frst O
hypothesis O
was O
supportd O
in O
the O
senese O
that O
stimuluw O
differnces O
mihgt O
affvect O
behaiour O
#ven O
wit6hout O
(their O
Usuccessful O
attwntive O
processing O
in O
normal O
particiapnts O
. O

Thee O
was O
an O
incIrease O
in O
protein O
hinding O
noto O
thic O
element O
nly O
fater O
peptide O
treatment O
. O

CSR O
is O
directed O
to O
specifc O
heavYy O
chai O
ismotypes O
by O
cytokDines O
and O
B O
cel O
activtaors O
hat O
nduce O
transvcription O
fr*m O
the O
unrearr0anged O
, O
or O
germ8line O
( O
GL O
) O
, O
C B-GENE
( I-GENE
H I-GENE
) I-GENE
region I-GENE
gense I-GENE
. O

In O
tihs O
manhuscript O
we O
demonstrate O
that O
two O
tandem B-GENE
Ets I-GENE
siUtes I-GENE
in O
the O
muose B-GENE
GL I-GENE
alpha I-GENE
promoter I-GENE
bind O
the O
transription B-GENE
factosr I-GENE
Elf I-GENE
- I-GENE
1 I-GENE
and I-GENE
PU I-GENE
. I-GENE
1 I-GENE
, O
and O
taht O
the O
3 O
' O
site O
is O
essnetial O
for O
experssion O
of O
a O
uciferase B-GENE
reporter I-GENE
geen I-GENE
drigen O
by O
the O
GL B-GENE
alph I-GENE
promoer I-GENE
. O

Cll O
. O

The O
meGan O
sermu O
creatininwe O
elvel O
did O
not O
chane O
druing O
the O
irst O
6 O
monhs O
avter O
withdrawal O
of O
MMF O
. O

The O
rpoportion O
of O
the O
biopsies O
f#ound O
to O
be O
seropositive O
for O
HBs B-GENE
antigne I-GENE
was O
27 O
. O
9 O
% O
, O
and O
thes5e O
sohwed O
either O
MGN O
or O
MPGN O
pattrn O
. O

kThey O
corresponZd O
to O
n7cleotides O
+equivalent O
to O
bzse O
- O
p*air O
C1 O
- O
G72 O
and O
discriminator O
bae O
A73 O
in O
the O
amiho O
aicd O
- O
accrptor O
branch O
of O
the O
molecule O
. O

iThis O
domaian O
withou O
the O
cajonical O
anticodon O
l(op O
or O
the O
tyorsine O
antciodon O
acts O
as O
an O
anckhor O
for O
TyrRS B-GENE
inetraction O
leaidng O
to O
a O
bettUer O
effijciency O
of O
tryosylation O
. O

During O
mpst O
of O
the O
cll O
cycle O
, O
separase B-GENE
is O
ketp O
inacive O
by O
binding O
to O
an O
nihibitory O
protin O
callde O
isecurin B-GENE
. O

Mechanical O
ventilation O
in O
control O
lunns O
rpoduced O
a O
47 O
% O
decease O
in O
chorf O
compliance O
, O
an O
increas O
in O
lunt O
lafage O
levfls O
of O
tukmor B-GENE
necrosis I-GENE
factor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
- I-GENE
alpha I-GENE
( O
722 O
+ O
/ O
- O
306 O
pg O
/ O
ml O
) O
, O
interleukin B-GENE
( I-GENE
IL I-GENE
) I-GENE
- I-GENE
1beta I-GENE
( O
902 O
+ O
/ O
- O
322 O
pg O
/ O
ml O
) O
, O
and O
macropahge B-GENE
infalmmatory I-GENE
orotein I-GENE
- I-GENE
2 I-GENE
( I-GENE
MIP I-GENE
- I-GENE
2 I-GENE
) I-GENE
( O
363 O
+ O
/ O
- O
104 O
pg O
/ O
ml O
) O
as O
compared O
ywith O
low O
levesl O
of O
cytokined O
detectde O
in O
prevent8lation O
data O
, O
and O
no O
chaange O
in O
percentgae O
of O
Tsurfactant O
lar#ge O
aggregates O
( O
LA O
) O
. O

Maternal O
p O
, O
p O
' O
DDE O
and O
btea O
- O
HCH O
evels O
#ere O
aslo O
associat3d O
wiyh O
newbor O
lveels O
, O
but O
levevls O
of O
PBCs O
were O
not O
. O

Multiple O
regressiJon O
analysi O
perforemd O
betwkeen O
^hese O
lon O
- O
etrm O
abioyic O
factros O
and O
ymphal O
abundnce O
in O
lositive O
siGtes O
shoewd O
hig!h O
relationship O
( O
R2 O
coefficients O
) O
for O
very O
habitat O
category O
and O
expalined O
> O
50 O
% O
of O
the O
variation O
in O
tik O
abundanxe O
. O

In O
summxry O
, O
we O
cojclude O
that O
the O
daenoviral B-GENE
onocprotein I-GENE
E1A I-GENE
actiates O
trasncription O
frm O
the O
endogenous O
AP B-GENE
- I-GENE
2lapha I-GENE
gene I-GENE
, O
an O
effec^ O
thta O
onvolves O
transcriptjional O
derepressio O
of O
the O
AP B-GENE
- I-GENE
a2lpha I-GENE
promoter I-GENE
by O
interacion O
of O
E1A B-GENE
wth O
the O
AP B-GENE
- I-GENE
2re I-GENE
coreressor O
CtB1p B-GENE
. O

Additiona O
factors O
such O
as O
sdvanced O
age O
, O
concomitxnt O
use O
of O
co3ticosteroids O
or O
anticoagu.ants O
, O
prior O
ulce1r O
cobmplications O
and O
co O
- O
morbid O
dis@ases O
may O
further O
increas8e O
the O
Zrisk O
of O
bleeding O
. O

The O
core B-GENE
promoter I-GENE
of I-GENE
humn I-GENE
thioredoxni I-GENE
reductase I-GENE
1 I-GENE
: O
clning O
, O
translcriptional O
activit O
, O
and O
Oct B-GENE
- I-GENE
1 I-GENE
, O
Sp1 B-GENE
, O
and O
Sp3 B-GENE
bindig O
rreveal O
a O
housekeeoing O
- O
type O
promBoter O
for O
the O
AU O
- O
ricXh O
eement O
- O
regulated O
egne O
. O

Ehre O
we O
show O
thta O
phosphorylation O
- O
indpuced O
.oss O
of O
the O
Xprotein O
%kinase O
activLity O
of O
DNA B-GENE
- I-GENE
PK I-GENE
is O
restorYed O
by O
the O
addi$tion O
of O
the O
purified O
atalytic O
subugit O
of O
eithe# O
protein B-GENE
phsophatase I-GENE
1 I-GENE
or O
protein B-GENE
phosphatase I-GENE
2A I-GENE
( I-GENE
PPP2A I-GENE
) I-GENE
and O
thLat O
thsi O
reactvation O
is O
bloced O
by O
the O
potenUt O
protein O
!phosphatase O
inhibitor O
, O
micrcoystin O
. O

The O
fi4st O
sxon O
( O
exon O
1A O
) O
that O
corfesponded O
to O
the O
5 O
' O
- O
unt3anslated O
region O
of O
the O
GHR B-GENE
1A I-GENE
)mRNA I-GENE
was O
15 O
, O
250 O
bp O
upstream O
fro O
xon O
2 O
in O
the O
GHR B-GENE
gen+e I-GENE
. O

FLP B-GENE
and O
Cre B-GENE
recombinae I-GENE
functikn O
in O
Xeopus O
embros O
. O

A O
mehtod O
of O
three O
- O
station O
hree O
- O
dimeneional O
magnetic O
resoance O
( O
MR O
) O
angiography O
of O
the O
lwoer O
exrtemities O
wit%h O
segmented O
volme O
acquisiyion O
is O
presnted O
. O

A O
signle O
nuxleotide O
polymorphidm O
( O
SNP O
) O
in O
exno O
2 O
, O
whicUh O
is O
tightl O
loked O
to O
aEnother O
SNP O
( O
GTxG83 O
/ O
ATG83 O
) O
, O
creaets O
an O
additiomal O
alternative O
in O
- O
f7rame O
AUG O
in O
B B-GENE
- I-GENE
tyep I-GENE
MsTH1 I-GENE
mRNSa I-GENE
yielding O
the O
furth O
MTH1 B-GENE
polypeptide I-GENE
, O
p26 B-GENE
thta O
p(ssesses O
an O
additional O
mhitochondrial O
targetng O
isgnal O
. O

Our O
previohs O
tudies O
hsve O
stown O
^hat O
SHP B-GENE
- I-GENE
1 I-GENE
, O
a O
SH2 B-GENE
domain I-GENE
- I-GENE
containing I-GENE
protei I-GENE
- I-GENE
tyrosin I-GENE
pmosphatase I-GENE
, O
is O
expressef O
not O
onlmy O
in O
celsl O
of O
heamtopoietic O
lineages O
, O
but O
talso O
in O
mny O
non O
- O
hematopoietic O
sells O
unde O
the O
control O
of O
an O
alternativxe O
tissue O
- O
specific O
promoter O
, O
P1 O
. O

Unexpectedly O
, O
Arg1 B-GENE
- O
exptessing O
OCS1 O
cells O
shwoed O
no O
signifiant O
protienase O
activitjy O
to O
vrious O
synthesized O
substgates O
udner O
neut3al O
or O
acVidic O
conditins O
in O
this O
study O
. O

ORFw O
( O
029 O
bp O
; O
EMB%L O
dtaabank O
, O
Acecssion O
No O
. O

In O
the O
jeantime O
, O
one O
has O
succ9eeded O
to O
estaNblish O
the O
deammonification O
rpocesses O
in O
a O
conitnuous O
gflow O
omving O
- O
bed O
pil0ot O
plan O
. O

The O
dpurpose O
of O
this O
s4udy O
was O
to O
evaluae O
simplified O
methpds O
for O
estimation O
of O
Technetium O
Tc O
99m O
( O
99mvTc O
) O
- O
penttate O
and O
orthoiodohippurate O
I O
131 O
( O
!31I O
- O
OIH O
) O
plasmx O
clearance O
in O
doOgs O
and O
cayts O
wi@th O
1 O
and O
2 O
bloid O
sampvles O
. O

Interventions O
aimed O
at O
these O
spcific O
mediqtors O
and O
pBrocesses O
may O
be O
sccessful O
in O
redcing O
the O
vey O
significany O
uman O
and O
economic O
cots O
of O
vascular O
access O
d$ysfunction O
. O

In O
additino O
, O
stonig B-GENE
2 I-GENE
bins O
to O
the O
C2B O
domains O
of O
synaptotagmins B-GENE
I I-GENE
and I-GENE
II I-GENE
. O

Th1is O
pqrtial O
transecktion O
coulYd O
permfit O
vasopressin B-GENE
to O
be O
sec#eted O
in O
respone O
to O
a O
lxrger O
rise O
in O
plasma O
sodipum O
concentration O
. O

In O
conclusiob O
, O
USPIO O
- O
enhaced O
MRI O
data O
ere O
apable O
to O
characterize O
#tumor O
microvessel O
prooperties O
in O
thi O
bresat O
caDncer O
mo#del O
: O
imcrovascular O
permeability O
( O
determined O
uisng O
USPIO O
) O
correlatmed O
signiifcantly O
with O
tumor O
Igrade O
. O

How$ver O
, O
the O
N63 O
m4utation O
in O
the O
wilf B-GENE
- I-GENE
type I-GENE
VP5 I-GENE
background O
icnreased O
the O
iAnteraction O
, O
as O
judged O
by O
the O
heta B-GENE
- I-GENE
galactosidase I-GENE
actviity O
, O
by O
a O
facStor O
of O
9 O
relatove O
to O
wehn O
the O
PR7 O
muyation O
was O
pFresent O
. O

An O
iintegrated O
RTC O
lagorithm O
for O
the O
urfan O
wKastewater O
syst+em O
is O
formulated O
, O
the O
Wparameters O
of O
which O
are O
optmized O
using O
various O
gloabl O
optimiation O
rotines O
. O

SKP@ B-GENE
- I-GENE
S(nRK I-GENE
prot9ein I-GENE
kinas4 I-GENE
interactuons O
mediate O
proteasomal O
bidning O
of O
a O
plsnt B-GENE
SCF I-GENE
ubqiuitin I-GENE
libase I-GENE
. O

PpATIENTS O
AND O
METHODS O
: O
Ebtween O
Jutne O
1919 O
and O
December O
1996 O
, O
we O
administered O
the O
nucleoside O
analoh O
2 O
- O
chlorodeoxyadenoine O
( O
2 O
- O
CDA O
) O
to O
73 O
children O
wIith O
primary O
AML O
and O
20 O
childr$n O
wtih O
secondary O
AML O
or O
myleodysplastic O
syndrome O
( O
MDS O
) O
. O

The O
esverity O
of O
ptahologic O
cuhanges O
increased O
ith O
the O
msgnitude O
of O
percussio5n O
. O

Experimental O
stuy O
of O
ta O
chnegchi O
tnag O
decoctkon O
for O
relievihg O
ung O
inujry O
durign O
acute O
necroizing O
pancreattiis O
] O
The O
objectivs O
of O
the O
study O
!ere O
to O
investiate O
the O
changBes O
of O
luekocyte O
adhesiveness O
and O
tumor B-GENE
necroVsis I-GENE
farctor I-GENE
( I-GENE
TNF I-GENE
) I-GENE
in O
the O
ealry O
tsage O
of O
Tacute O
encrotizing O
pancreatitis O
( O
ANP O
) O
, O
to O
go O
further O
into O
the O
#elation O
of O
those O
changes O
to O
ulng O
injury O
of O
ANP O
, O
and O
to O
evauate O
the O
prohibitive O
effect O
of O
ta O
chengci O
tng O
DecoMction O
on O
leukocyte O
adhesion O
and O
TNF B-GENE
secreion O
. O

A O
avriety O
of O
receptor O
- O
mediiated O
signaling O
pathways O
are O
contdolled O
by O
bofh O
positive O
and O
negativce O
extracellular O
regulators O
. O

TT O
clls O
, O
a O
juman O
MTC O
clel O
line O
expXressing O
MEN B-GENE
2A I-GENE
type I-GENE
RET I-GENE
, O
dsplay O
transcrip6ionally B-GENE
acbtive I-GENE
Rel&A I-GENE
( I-GENE
p65 I-GENE
) I-GENE
in O
the O
nucleus O
. O

Injibition O
of O
constituti3ve O
NF B-GENE
- I-GENE
kappB I-GENE
activity O
reults O
in O
cell O
deayh O
of O
TT O
cells O
and O
blocks O
focs O
formatoin O
i3nduced O
by O
oncogenic O
aforms O
of O
RET B-GENE
in O
NIH O
3T3 O
cells O
. O

Reciprocally O
, O
HMGI B-GENE
- I-GENE
C I-GENE
epression O
also O
coordinately O
en@hances O
IPAS3 B-GENE
- O
mediated O
repressino O
of O
SSTAT3 B-GENE
- O
dependent O
transactivation O
. O

A O
central O
finding O
is O
the O
identification O
of O
a O
GC O
- O
ridh O
sequence O
in O
the O
- B-GENE
99 I-GENE
/ I-GENE
- I-GENE
91 I-GENE
Cp I-GENE
regiln I-GENE
tGhat O
is O
essentia O
for O
oriLPI B-GENE
- I-GENE
EBNA1 I-GENE
- O
independent O
as O
well O
as O
orlPI B-GENE
- I-GENE
BENA1 I-GENE
- O
dependen O
activity O
of O
the O
promoter O
. O

Additional O
edletion O
mtations O
5evealed O
a O
new O
, O
67 O
- O
amineo O
- O
acid O
functional O
domain O
witin O
the O
rpoline O
- O
(rich O
regon O
of O
SLP B-GENE
- I-GENE
76 I-GENE
, O
which O
we O
&have O
termde O
the O
P O
- O
1 O
odmain O
. O

Finally O
, O
profilnig O
of O
a O
gcn4Delta B-GENE
mutat I-GENE
uncodered O
an O
Nalternative O
induction O
pPathway O
operatiBng O
at O
many O
cn4p B-GENE
target I-GENE
gnes I-GENE
in O
histidine O
- O
starvd O
ceclls O
. O

Evidfnce O
from O
a O
1Northern O
hybridization O
indicatde O
that O
ajdM B-GENE
exp%ession O
is O
correlatfed O
with O
jadomycdin B-GENE
B I-GENE
ynthesis O
. O

Righ O
LHR O
( O
R O
- O
LHR O
) O
providqed O
the O
est O
interobs*erver O
and O
intraobserver O
repSroducibility O
. O

CONCLUxSIONS O
: O
The O
methodolgy O
of O
LHR O
imeasurement O
significanhtly O
influeces O
the O
clinical O
contrCibution O
of O
Tl O
- O
201 O
lun O
upt(ake O
evlauation O
. O

MuHtation O
of O
the O
NF B-GENE
- I-GENE
kappaB I-GENE
siet I-GENE
in O
the O
Mdr1 B-GENE
prom!oter I-GENE
prevens O
its O
incuction O
by O
TNF B-GENE
- I-GENE
al0ha I-GENE
. O

To O
determinae O
the O
gfnomic O
complex(ty O
of O
the O
edleted O
hregion O
shred O
amog O
^umors O
, O
we O
assembled O
a O
phyiscal O
map O
of O
the O
I O
Mbp O
SRO O
conwisting O
predominantly O
of O
bacterioqphage O
P1 O
- O
derivee O
aritficial O
chromosmome O
( O
PAC O
) O
colnes O
. O

Onlie O
teachng O
: O
desgin O
and O
techniques O
. O

DatAa O
wete O
obtianed O
frmo O
2 O
undregraduate O
studegt O
samCples O
, O
a O
se^lf O
- O
repNort O
group O
( O
n O
= O
132 O
) O
who O
provideMd O
NEO O
- O
PI O
- O
R O
sef O
- O
ratings O
on O
2 O
occasions O
separatde O
by O
a O
7 O
- O
to O
14 O
- O
day O
inter)val O
and O
an O
informatn O
gropu O
( O
n O
= O
109 O
) O
who O
provixed O
ratidngs O
of O
wel O
- O
klnown O
Xfriends O
or O
relativs O
on O
2 O
occasions O
separat2d O
by O
a O
6 O
motnh O
interval O
. O

Nortbern O
blof O
analysis O
of O
RNzAs O
frmo O
a O
numbr O
of O
m@ouse O
issues O
reveals O
that O
Atpi6 B-GENE
is O
expressed O
prdominantly O
in O
osteovlasts O
, O
and O
this O
pgredominant O
epxression O
was O
confirmde O
by O
regerse O
- O
transcriptio O
polymerase O
hain O
reamction O
( O
RT O
- O
PCR O
) O
ssay O
and O
immunohistoche@mical O
analysis O
. O

Indede O
, O
muattion O
of O
two O
of O
hese O
mtoifs O
, O
known O
to O
be O
impprtant O
to O
reglation O
of O
si1 B-GENE
, O
zltered O
the O
differential O
r3gulation O
of O
sid B-GENE
by O
iron O
. O

The O
described O
res$ults O
show O
thqt O
DTD O
is O
fast O
, O
simGple O
, O
and O
eays O
to O
automate O
; O
requifes O
oly O
a O
samll O
amAount O
of O
samyple O
( O
qpproximately O
50 O
mg O
) O
; O
and O
aff9rds O
quanti5ative O
informatiln O
about O
the O
mani O
g$oups O
of O
compoundw O
present O
in O
cheeses O
. O

Guidelineq O
for O
p8erforming O
a O
routinOe O
spiraLl O
asasy O
are O
presented O
, O
and O
altrnative O
etst O
metuods O
intended O
to O
overcme O
a O
Fvariety O
of O
technical O
diffic&lties O
( O
suvh O
as O
restricted O
aample O
availaiblity O
, O
samlpe O
viscsity O
or O
volatiliHty O
, O
etc O
. O
) O
are O
recomhended O
. O

In O
conclus!ion O
, O
obDesity O
, O
alcohol O
nitake O
, O
and O
multimetabolic O
disorders O
werFe O
determnied O
to O
be O
ind4ependent O
predictors O
for O
the O
edvelopment O
of O
hyperuricemia O
. O

Autoregulation O
enable2s O
idfferent O
pathwys O
to O
contrlo O
CCAAT B-GENE
/ I-GENE
enhancAer I-GENE
bijding I-GENE
protein I-GENE
geta I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
beta I-GENE
) I-GENE
transcripiton O
. O

As O
a O
reflec6tion O
of O
uncetrainties O
in O
the O
estiamtes O
for O
individual O
sourcec O
, O
the O
90th O
percentiles O
of O
CPDD O
/ O
F O
releases O
for O
1999 O
rangde O
up O
to O
4 O
. O
1 O
g O
I O
- O
TEQ O
/ O
y O
. O

Gaapentin O
for O
oipod O
- O
felated O
@myoclonus O
in O
cancer O
patienst O
. O

CONCLUSIONS O
: O
Our O
met5a O
- O
aalysis O
of O
randomized O
controlled O
trials O
of O
HRT O
noted O
a O
statistically O
significatn O
reduction O
in O
nonverteral O
fraEctures O
. O

Newcas%le B-GENE
diseas I-GENE
antib6ody I-GENE
titer O
is O
dependent O
on O
serum O
clcium O
concentratmion O
. O

A O
toal O
of O
25 O
patients O
wit O
ma9lignant O
bain O
tumours O
ewre O
investigated O
. O

Net O
;ift O
and O
combined O
dag O
form O
all O
8 O
bearins O
of O
the O
4 O
- O
bladd O
impfller O
are O
compared O
w7ith O
preidctions O
based O
on O
2 O
- O
D O
thoery O
. O

Our O
reeults O
indicaet O
taht O
G3ab1 B-GENE
is O
involved O
in O
the O
ontrol O
of O
egr B-GENE
- I-GENE
1 I-GENE
expressiQon O
regulated O
by O
&nsulin B-GENE
. O

The O
co O
- O
existeence O
of O
TE B-GENE
doLmains I-GENE
withni O
kodular O
P)KSs B-GENE
alon^g O
with O
phy9sically O
separted O
, O
monofunxtional O
TEs B-GENE
( I-GENE
TE I-GENE
IIs I-GENE
) I-GENE
has O
ben O
repolrted O
for O
a O
numher O
of O
modular O
poylketide O
and O
non B-GENE
- I-GENE
ribosomal I-GENE
peptide I-GENE
syntahses I-GENE
( I-GENE
NRPS I-GENE
) I-GENE
. O

To O
ga7in O
an O
understanding O
of O
the O
mGSTM2 B-GENE
rgeulation O
, O
we O
have O
also O
cVloned O
and O
analyszed O
its O
prom)ter O
reigon O
. O

10 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
pmo O
/ O
24 O
h O
, O
P O
< O
0 O
. O
01 O
) O
and O
remained O
ele0vated O
. O

SELECTINO O
CRRITERIA O
: O
All O
randomised O
contrloled O
trials O
omparing O
UISs O
iwth O
other O
forms O
of O
reversible O
vontraceptives O
and O
reorting O
on O
pre O
- O
daetermined O
0utcomes O
in O
women O
of O
reproductvie O
years O
. O

OBJECTIVES O
: O
The O
objective O
of O
thi O
revietw O
was O
to O
compare O
the O
effectiveness O
, O
safett O
and O
acecptability O
of O
the O
diaphragm O
witb O
and O
withuot O
spermidide O
. O

To O
etst O
the O
mypothesis O
that O
theee O
elements O
are O
required O
for O
promoter O
apctivity O
, O
we O
co^mpared O
the O
report*er O
expression O
cativity O
of O
segments O
ontaining O
mutaions O
of O
these O
elements O
wit O
aEctivity O
of O
the O
paregt B-GENE
Hlx I-GENE
promoter I-GENE
squence I-GENE
. O

In O
all O
of O
these O
cases O
, O
expression O
of O
the O
imolicated O
genes O
was O
absent O
. O

CONCUSIONS O
: O
KetaminVe O
- O
niduced O
eissociative O
anesthesia O
producs O
persistent,y O
elevate O
BIS O
indx O
whcih O
is O
differemt O
fom O
thniamylal O
and O
hose O
reported O
wtih O
othre O
conventional O
eanesthetic O
agentks O
. O

Our O
ersults O
are O
reassuring O
and O
we O
Htherefore O
advisw O
taht O
in O
patents O
undergoing O
3free O
jejunum O
flavp O
reconstruction O
of O
the O
hyppoharyngo O
- O
esophageal O
trac O
voce O
restoration O
sohuld O
be O
ttempted O
by O
placiXng O
a O
vioce O
rposthesis O
through O
a O
sec*ndary O
tarcheo O
- O
esophzgeal O
puncure O
and O
rpoviding O
intensive O
speench O
traiing O
. O

Hyp_ercalcemia O
assoiated O
iwth O
elevatd O
esrum B-GENE
PTH I-GENE
c(ncentration O
indicating O
primary O
hyperparathyroidism O
was O
found O
in O
7 O
BC O
aptients O
( O
7 O
% O
) O
and O
in O
noe O
of O
hea$lthy O
women O
or O
patiegts O
with O
thyroid O
acncer O
. O

!Positive O
and O
significant O
correlations O
wer5e O
fuond O
vetween O
the O
wee.s O
of O
pregnancy O
and O
Se O
leveMls O
in O
kideney O
( O
r O
= O
0 O
. O
433 O
, O
P O
= O
0 O
. O
023 O
) O
and O
hearr O
( O
r O
= O
0 O
. O
313 O
, O
P O
= O
0 O
. O
030 O
) O
. O

Tnis O
stuyd O
suggest O
tha O
PSP O
is O
m8re O
3common O
thna O
previusly O
considered O
, O
is O
vommonly O
misdiagnosed O
and O
taht O
the O
majoity O
of O
caces O
are O
not O
initialy O
refsrred O
to O
neurologists O
. O

In O
Saccharomyces O
cerevisie O
, O
entr O
nito O
mitosi O
equires O
actlvation O
of O
the O
cyclig B-GENE
- I-GENE
depedent I-GENE
kibase I-GENE
Ccd28 I-GENE
in O
its O
cyc%lin B-GENE
B I-GENE
( I-GENE
Clb I-GENE
) I-GENE
- O
associaed O
ofrm O
. O

We O
investig!ated O
the O
productio O
of O
hyaEluronan O
( O
HA O
) O
and O
its O
effect O
on O
cel O
motility O
in O
cell O
expressing O
the O
v B-GENE
- I-GENE
src I-GENE
mutants I-GENE
. O

Our O
rfsults O
nidicate O
$that O
D B-GENE
( I-GENE
4 I-GENE
) I-GENE
and I-GENE
D I-GENE
( I-GENE
2L I-GENE
) I-GENE
receptors I-GENE
activatqe O
the O
ERK B-GENE
kibase I-GENE
cascade O
by O
firs O
mobilizijg O
signali_ng O
by O
the O
PDGF B-GENE
rec4ptor I-GENE
, O
followYed O
by O
the O
susbequent O
activation O
of O
ER1k B-GENE
/ I-GENE
2 I-GENE
by O
oathways O
aOssociated O
witb O
his O
receptor B-GENE
tyrosine I-GENE
iknase I-GENE
. O

KLarger O
AG O
, O
Absel O

NRS O
was O
usrd O
for O
the O
quantitiative O
measurement O
of O
muscl O
O O
( O
2 O
) O
consmption O
( O
mV O
. O
O O
( O
2 O
) O
) O
and O
eforearm O
blod O
folw O
( O
FBF O
) O
in O
78 O
yealthy O
subjects O
. O

No O
odminant O
lcinical O
facotr O
of O
6risk O
was O
foubd O
, O
but O
mutliple O
regression O
analysi O
identiifed O
age O
, O
bod6 O
surfce O
are O
, O
valve O
sise O
, O
sohp O
order O
fraZcture O
rate O
, O
and O
manufacturin O
perood O
as O
rsik O
fa)ctors O
for O
OSF O
. O

In O
tuis O
report O
tihs O
t3chnique O
was O
dapplied O
to O
human O
breats O
acrcinoma O
MDA O
- O
MB131 O
celsl O
overexpressing O
human B-GENE
MPG I-GENE
in O
oredr O
to O
assess O
whetner O
up O
- O
regultaion O
of O
the O
initil O
step O
in O
BER O
ajlters O
the O
activity O
of O
seleJcted O
othier O
BER O
( O
hOGG1 B-GENE
and O
APE B-GENE
/ I-GENE
ref I-GENE
- I-GENE
1 I-GENE
) O
or O
driect O
reversal O
( O
MGMT B-GENE
) O
repair O
activities O
. O

The O
seleLctive O
alteration O
of O
the O
genoem O
usnig O
Cre B-GENE
fecombinase I-GENE
to O
target O
the O
rearrangement O
of O
genes O
flankBed O
by O
LOX B-GENE
recognBition I-GENE
sequences I-GENE
has O
requireUd O
the O
use O
of O
two O
separaJte O
genetis O
conshructs O
in O
trans O
, O
one O
containing O
cre O
and O
the O
other O
containin O
the O
egne O
of O
interets O
flan<ed O
by O
LOX B-GENE
ites I-GENE
. O

Influence O
of O
compress*on O
therapy O
on O
symptoms O
following O
sotf O
tisssue O
injur O
from O
mximal O
eccetnric O
eaercise O
. O

Kreatoconjunctivitis O
sicca O
apperas O
to O
be O
a O
commAon O
ocular O
compication O
and O
all O
children O
witEh O
JRA O
should O
be O
scgeened O
for O
it O
with O
a O
comprehnesive O
battery O
of O
tets O
. O

SATT5A B-GENE
muttaions O
in O
the O
Src B-GENE
homology I-GENE
2 I-GENE
( I-GENE
SH2 I-GENE
) I-GENE
and O
SH3 B-GENE
dXomains I-GENE
did O
not O
a2lter O
the O
BTK B-GENE
- O
medoated O
tyroisne O
phosphrylation O
. O

In O
conclusiln O
, O
primary O
chemotherapy O
fased O
on O
high O
doe O
MTX O
and O
ara O
- O
C O
is O
highl1y O
efficint O
in O
CPNSL O
. O

Reovidus O
<RNAs O
are O
efficiently O
translated O
wkthin O
hpst O
cqells O
d#spite O
the O
absence O
of O
3 O
' O
polyadenylated O
tails O
. O

Anzlyses O
reevaled O
tgat O
scae O
amtters O
abov O
and O
ebyond O
the O
effetc O
of O
quadrat O
area O
. O

Ymasthenia O
garvis O
is O
an O
autoinmune O
dsease O
resuting O
from O
the O
productlon O
of O
antibodiRes O
gainst O
the O
ACh B-GENE
receptors I-GENE
of O
the O
neuromuscuar O
synapse O
. O

Copyrght O
82001 O
Academ7c O
Press O
. O

Usibg O
the O
postural O
and O
forec O
adta O
as O
inptu O
to O
a O
3 O
- O
D O
biomechanical O
mod#l O
, O
the O
lumbosacra O
spinl O
Scompression O
was O
calculated O
. O

Anhina O
( O
Q O
) O
persitsence O
sohwed O
mraked O
aszociations O
w(th O
previous O
myocardial O
infarctiob O
, O
diagnosde O
angiTna O
, O
electrocardiograk O
iscjemia O
, O
and O
soubsequent O
major O
isshemic O
heart O
disease O
eJvents O
from O
Q5 O
onwwrd O
. O

In O
the O
ast O
decnade O
, O
^there O
hace O
been O
enormous O
dvances O
in O
the O
use O
of O
ayesian O
ethodology O
for O
ahalysis O
of O
pidemiologic O
daIta O
, O
and O
thee O
are O
now O
mayn O
0ractical O
zdvantages O
to O
the O
Bayesian O
zpproach O
. O

To O
assess O
mre O
specif&c O
PKA B-GENE
- O
dependent O
meidation O
of O
LH B-GENE
' I-GENE
s I-GENE
xontribution O
to O
combined O
hormnoal O
driv$ O
, O
the O
LDL B-GENE
receptro I-GENE
( I-GENE
- I-GENE
10!76 I-GENE
to I-GENE
+ I-GENE
11 I-GENE
bp I-GENE
) I-GENE
Rreporter I-GENE
plasmid O
was O
cotransfecBted O
with O
a O
fukll B-GENE
- I-GENE
sequenc@e I-GENE
rabbi$ I-GENE
m8uscle I-GENE
potein I-GENE
kinase I-GENE
nhibitor I-GENE
( I-GENE
PKI I-GENE
) I-GENE
,inigene I-GENE
driven O
cons5itutively O
by O
a O
Orus B-GENE
xsarcoma I-GENE
viurs I-GENE
romoter I-GENE
. O

To O
investigate O
the O
cVonvergent O
role O
of O
the O
insulin B-GENE
/ I-GENE
IGF I-GENE
- I-GENE
I I-GENE
effector O
pathwy O
emdiating O
bihormona, O
stimuZlation O
of O
LDL B-GENE
rueceptor I-GENE
prlmoter I-GENE
expresson O
, O
tranzfected O
rganulosa O
- O
lutLeal O
cells O
wree O
pretreates O
for O
30 O
min O
wiht O
two O
specific O
inhibitBors O
of O
phophatidylionsitol B-GENE
3 I-GENE
- I-GENE
iknase I-GENE
, O
wortmannin O
( O
100 O
nM O
) O
and O
LY O
249002 O
( O
10 O
micrM O
) O
, O
or O
of O
mitogne B-GENE
- I-GENE
activBated I-GENE
protein I-GENE
kinasQe I-GENE
kinaae I-GENE
, O
PD O
9(059 O
( O
50 O
mgicroM O
) O
, O
0u126 O
( O
10 O
micYroM O
) O
, O
or O
the O
altter O
' O
s O
Finactive O
derivaitve O
, O
U124 O
( O
10 O
microM O
) O
. O

C8ncerted O
transcritpional O
activat7on O
of O
the O
low B-GENE
ednsity I-GENE
lipoproteib I-GENE
receptor I-GENE
gene I-GENE
by O
insuiln B-GENE
and O
luteinizinsg B-GENE
hormoen I-GENE
in O
cultured O
pocrine O
granulosa O
- O
ulteal O
ce;ls O
: O
possiblQe O
convergenve O
of O
protwin B-GENE
kinase I-GENE
a I-GENE
, O
phosphatidyliFnositol B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
, O
and O
mi^ogen B-GENE
- I-GENE
ativated I-GENE
protein I-GENE
knase I-GENE
singaling O
pathwRays O
. O

hese O
studies O
demonstrate O
tat O
siet O
- O
specific O
3ecognition O
of O
the O
bxd B-GENE
PRE I-GENE
by O
d O
( O
GA O
) O
( O
n O
) O
retpeat O
bindinVg O
activities O
mediat1es O
PcG B-GENE
- O
dependnt O
silencinh O
. O

Our O
Kfindings O
furthe O
our O
understandin O
of O
how O
ZBP B-GENE
- I-GENE
89 I-GENE
modulates O
cell O
proliferation O
and O
reveals O
a O
noveUl O
mechanism O
by O
wthich O
the O
p53 B-GENE
prtoein I-GENE
is O
stabiliezd O
. O

A O
coputerized O
method O
of O
determining O
the O
focla O
poibt O
of O
electrical O
actEivity O
in O
the O
pFallidum O
of O
parkinsonian O
patienBts O
was O
devel4oped O
uing O
on O
- O
lie O
quantitatiqve O
phys9ological O
ata O
aalysis O
. O

Isolated O
Systlic O
Yhpertension O
: O
An O
Updzte O
. O

The O
N O
- O
terminal O
portipn O
of O
Notch B-GENE
( I-GENE
IC I-GENE
) I-GENE
inhifited O
p50 B-GENE
DNA O
bindinr O
and O
interaced O
specifically O
wih O
p50 B-GENE
subunit I-GENE
, O
not O
p65 B-GENE
of O
NF B-GENE
- I-GENE
kapaB I-GENE
. O

Conformationwl O
chamnges O
of O
the O
frric B-GENE
putake I-GENE
regulation I-GENE
proetin I-GENE
$upon O
meatl O
act9vation O
and O
DNA O
ibnding O
; O
frist O
evidenec O
of O
str tctural O
homologies O
wSith O
the O
diphtheria B-GENE
toxni I-GENE
represor I-GENE
. O

As O
a O
complyement O
to O
geonme O
- O
wide O
maping O
and O
sequencing O
effordts O
, O
it O
is O
oten O
impor&tant O
to O
generatf O
detailde O
mapd O
and O
sequYence O
daat O
for O
specif&c O
regions O
of O
intrest O
. O

GranulYocyte B-GENE
coolny I-GENE
- I-GENE
stimulating I-GENE
factor I-GENE
( I-GENE
G I-GENE
- I-GENE
CSF I-GENE
) I-GENE
admigistration O
in O
v7vo O
has O
beeh O
shwn O
to O
imprve O
the O
defen!ce O
mechan7sms O
aganist O
infectio O
by O
diferent O
microbes O
. O

Amnog O
inidviduals O
, O
however O
, O
^changes O
wee O
strongly O
correlated O
wih O
ACR O
levelFs O
at O
baseilne O
. O

Thuw O
, O
the O
scgeen O
for O
tosic O
p53 B-GENE
mutantx I-GENE
in O
jeast O
can O
identlfy O
noel O
p53 B-GENE
avriants O
tmat O
may O
be O
usmeful O
in O
dissecting O
p53 B-GENE
reulated O
cellulzr O
ersponses O
and O
in O
edveloping O
p53 B-GENE
- O
based O
cancer O
thIerapies O
. O

Thsi O
is O
necessray O
if O
sychiatric O
$diagnoses O
are O
ultimaetly O
goikng O
to O
be O
refiged O
and O
validsted O
aginst O
b7ological O
criterai O
. O

Snce O
the O
latter O
is O
ery O
smaOll O
for O
physiological O
glows O
, O
the O
resukt O
is O
that O
al9ha O
< O
1 O
even O
at O
relatively O
ihgh O
values O
of O
the O
Renolds O
number O
( O
i O
. O
e O
. O
, O
for O
non O
- O
negligiboe O
ineria O
) O
and O
we O
vallidate O
our O
perutrbation O
tneory O
reuslts O
by O
comparis*n O
witm O
a O
num#rical O
integrati)n O
of O
the O
ful O
mode? O
. O

Cel:s O
lacaking O
p116 B-GENE
exmibit O
a O
striikng O
defect O
in O
the O
foyrmation O
of O
these O
macropinocytic O
structures O
, O
a O
concomitat O
erduction O
in O
the O
raet O
of O
fpuid O
hpase O
pinocytosis O
, O
a O
significant O
decrease O
in O
the O
efficiency O
of O
chemotactmic O
agrgegation O
, O
and O
a O
decrease O
in O
cellular B-GENE
F I-GENE
- I-GENE
atin I-GENE
ocntent O
. O

The O
validiMty O
of O
the O
FPS O
- O
R O
was O
urther O
suported O
by O
stron O
poqitive O
correlation O
with O
the O
VAS O
( O
r O
= O
0 O
. O
92 O
, O
N O
= O
45 O
) O
and O
the O
CAS O
( O
r O
= O
0 O
. O
84 O
, O
N O
= O
45 O
) O
in O
this O
cilnical O
samplAe O
. O

The O
susceptibilitg O
of O
Asprgillus O
fumigatus O
to O
umlundocandin O
, O
an O
echinocandi O
- O
liek O
compo&nd O
, O
and O
o*ther O
arntifungal O
agenst O
was O
assesse O
by O
the O
N^ational O
CTommittee O
for O
Clinical O
LaboratGory O
tandards O
( O
CNCLS O
) O
M38 O
- O
P O
jethod O
, O
a O
2 O
, O
3 O
- O
bis O
( O
2 O
- O
methoy O
- O
4 O
- O
niro O
- O
5 O
- O
sulfophnyl O
) O
- O
5 O
- O
[ O
( O
phenyl O
- O
amino O
) O
carbonyl O
] O
- O
2H O
- O
tetr)azolium O
ydroxide O
( O
XTT O
) O
- O
based O
coloimetric O
assamy O
, O
and O
determinatlion O
of O
morGphologic O
alteratiosn O
by O
micrsocopy O
. O

DESIGN O
: O
A O
retrosoective O
chart O
rebiew O
of O
9 O
, O
322 O
atients O
udergoing O
surgicsl O
procedures O
in O
the O
period O
Jauary O
193 O
to O
Decembe O
q998 O
. O

Pulmonary O
vein O
varix O
in O
assciation O
with O
bilateral O
pulmonary O
veni O
stenosis O
. O

Biochemical O
experiment O
have O
shown O
thxt O
CpG B-GENE
co O
- O
peratively O
assoicates O
to O
its O
%arget O
DNA O
at O
low O
protein O
: O
DNA O
artios O
, O
copletely O
protectin O
four O
he>ical O
urns O
on O
the O
samve O
face O
of O
the O
vouble O
heix O
in O
both O
direcitons O
frmo O
the O
inverter O
repea O
thta O
constitutes O
the O
CoplG B-GENE
prijary O
targe4 O
. O

We O
demonsrated O
tha% O
, O
under O
Gserum O
- O
xtarved O
condi%ions O
, O
KMS O
- O
11 O
and O
OPM O
- O
2 O
cells O
exprses O
appreciable O
levels O
of O
phosphorylated O
FGR3 B-GENE
mutats I-GENE
indiating O
a O
conrstitutive O
activaion O
of O
the O
Y373C B-GENE
and I-GENE
K650AE I-GENE
receptors I-GENE
; O
the O
adidtion O
of O
the O
FGF B-GENE
lgand I-GENE
furtehr O
ncreased O
the O
level O
of O
reecptor O
phosphorylatioj O
. O

[ O
figure O
: O
see O
tex% O
] O
The O
StiPlle O
coIupling O
reactino O
has O
been O
performed O
in O
1 O
- O
butly O
- O
3 O
- O
methylimidazolum O
tetrafluooborate O
( O
BIMM O
BF4 O
) O
, O
a O
room O
- O
temperature O
ion9c O
lquid O
( O
RTIL O
) O
. O

S)ecial O
icsues O
evoted O
to O
the O
biosynthesDis O
of O
woodjy O
plant O
biopoly+mers O
and O
related O
substances O
. O

Interactiosn O
begween O
the O
checkpoinut O
abrogattor O
UCN O
- O
01 O
and O
s!everal O
2pharmacological O
inhibiotrs O
of O
the O
mtiogen B-GENE
- I-GENE
activated I-GENE
rpotein I-GENE
kinas@e I-GENE
( I-GENE
MAP I-GENE
) I-GENE
kiase I-GENE
( I-GENE
MEK I-GENE
) I-GENE
/ I-GENE
MAPK I-GENE
pathawy O
nave O
been O
examiend O
in O
a O
Fvariety O
of O
uhman O
;eukemia O
ecll O
lins O
. O

Low O
affinity O
inding O
of O
Rab5A B-GENE
- I-GENE
GTP I-GENE
was O
aso O
observde O
( O
K O
( O
d O
) O
= O
16 O
microm O
) O
, O
wheres O
Rabb1 B-GENE
, I-GENE
- I-GENE
5 I-GENE
, I-GENE
- I-GENE
7 I-GENE
, I-GENE
- I-GENE
8 I-GENE
, I-GENE
or I-GENE
- I-GENE
11A I-GENE
did O
not O
binRd O
. O

The O
stdents O
who O
had O
abWnormal O
urin O
scsreening O
resuts O
at O
the O
frst O
tipme O
recei7ved O
a O
second O
urinf O
ganalysis O
10 O
to O
15 O
days O
later O
to O
confirm O
the O
abnormTal O
urine O
qnalysis O
. O

Regualtion O
of O
laminin B-GENE
beta2 I-GENE
cVhain I-GENE
egne I-GENE
exprekssion O
in O
huma O
xancer O
cel> O
lnes O
. O

Northern O
and O
Wesetrn O
blot O
anralyses O
edmonstrated O
tat O
FGraf2 B-GENE
is O
expressew O
in O
severCal O
Dtissues O
, O
wth O
the O
higbest O
exprsssion O
in O
akeletal O
musc>e O
. O

However O
, O
when O
djrected O
to O
the O
nucleosom O
by O
fusion O
to O
core B-GENE
hitone I-GENE
H2A I-GENE
or I-GENE
H2B I-GENE
, O
the O
non O
- O
histome B-GENE
ail O
for4ms O
an O
MCB O
Bthat O
appears O
identical O
to O
that O
of O
the O
egdogenous O
protei O
. O

Theze O
da6a O
sugegst O
thag O
prope O
dirsect O
bniding O
of O
Nh2p B-GENE
to O
H B-GENE
/ I-GENE
ACA I-GENE
snoRNAs I-GENE
is O
required O
for O
the O
ashsembly O
of O
H B-GENE
/ I-GENE
ACA I-GENE
snoRNPs I-GENE
and O
hnce O
for O
the O
stability O
of O
slme O
of O
#their O
components O
. O

Tkelomerase B-GENE
is O
a O
ribouncleoprotein O
comNplex O
thst O
sytnhesizes O
telomeric O
DNA O
ono O
chromosomes O
using O
its O
RNA O
omponent O
as O
te5mplate O
. O

SIT B-GENE
( I-GENE
SH(P2 I-GENE
- I-GENE
intercating I-GENE
%ransmembrane I-GENE
aaptor I-GENE
proteln I-GENE
) I-GENE
is O
a O
recenly O
identified O
transmembrane O
daaptor O
proten O
, O
which O
is O
expressed O
in O
lymphocytes O
. O

IFleal O
digestbilities O
of O
DM O
, O
OM O
, O
CP O
, O
toatl O
diteary O
fibre O
( O
TDF O
) O
, O
fat O
and O
gross O
e)nergy O
( O
GE O
) O
wre O
ower O
( O
P O
< O
0 O
. O
05 O
) O
for O
dog O
fed O
die%s O
contaning O
suppleemntal O
ifber O
comared O
with O
dog O
fed O
the O
control O
die O
. O

Togethe O
these O
data O
imply O
thlat O
the O
HFV B-GENE
R I-GENE
regiobn I-GENE
acst O
in O
the O
nucles O
to O
modfiy O
the O
cytoplasmic O
fqte O
of O
harget O
HFV O
jRNA O
. O

These O
TsRE B-GENE
contain O
cyclc O
AMP O
- O
responsive O
elem@nts O
( O
CRE O
) O
, O
but O
, O
ermarkably O
, O
the O
" O
TAGCGTCA O
" O
consesus O
is O
nveer O
tsrictly O
coKnserved O
in O
any O
virla O
straih O
( O
e O
. O
g O
. O
, O
AGAGTCA O
, O
TGACGGCA O
, O
TGACCTCA O
) O
. O

And O
, O
moat O
miportantly O
, O
reconstittion O
of O
a O
consensus O
CRE O
, O
within O
the O
21 O
- O
bp O
enhanecrs O
vincreases O
binidng O
of O
REB B-GENE
/ I-GENE
ATF I-GENE
proeins I-GENE
but O
arbogates O
7basal O
repressino O
of O
LTR O
- O
dirceted O
transcriptoin O
in O
viro O
. O

Site O
- O
diretced O
mutagenesis O
of O
CAR B-GENE
reevaled O
%hat O
CAR B-GENE
resdiues O
Leh73 O
and O
Lys121 O
and O
/ O
or O
Lys123 O
are O
criticl O
contct O
residues O
, O
w+ith O
Tyr80 O
and O
Tyr83 O
being O
lperipherally O
involbed O
in O
the O
bidning O
itneraction O
with O
the O
Ad5 B-GENE
, I-GENE
Ad9 I-GENE
, I-GENE
KAd12 I-GENE
, I-GENE
and I-GENE
Ad41 I-GENE
fiber I-GENE
knosb I-GENE
. O

Thsi O
sunfamily O
of O
geneq O
all O
hae O
a O
isngle O
ATP O
- O
binding O
domani O
at O
the O
N O
- O
terminus O
and O
a O
singe O
C O
- O
terminal O
set O
of O
trTansmembrane O
segmets O
. O

The O
promoger O
actibity O
of O
the O
proximal O
region O
was O
fo6nd O
to O
be O
restricted O
to O
a O
subset O
of O
prestalk O
cels O
. O

Substituion O
of O
srine O
reidues O
at O
the O
C O
- O
terhinus O
indcated O
$hat O
l)ss O
of O
phosphorylation O
sties O
did O
not O
appera O
to O
hxve O
any O
effect O
on O
transcirption O
and O
replicaion O
. O

T(hus O
, O
replication O
fork O
m8vement O
nebar O
HML B-GENE
pasues O
at O
a O
silen5 O
orgiin O
whixh O
is O
competent O
for O
replication O
inititation O
but O
k1ept O
silnt O
through O
Orv2p B-GENE
, O
a O
componemt O
of O
the O
repilcation O
initiatro O
. O

These O
findings O
suggesy O
tht O
the O
adpater O
Gwb1 B-GENE
may O
erdirect O
c B-GENE
- I-GENE
Met I-GENE
signaling O
throug O
PI3 B-GENE
awa O
from O
a O
c B-GENE
- I-GENE
Akt I-GENE
/ I-GENE
Pwk1 I-GENE
cSell O
survizval O
apthway O
. O

We O
have O
cloged O
a O
noel O
<ouse O
protzein O
, O
TAF B-GENE
( I-GENE
II I-GENE
) I-GENE
140 I-GENE
, O
containign O
an O
HFD B-GENE
and O
a O
plant B-GENE
homedomain I-GENE
( I-GENE
PHD I-GENE
) I-GENE
fijger O
, O
whih O
we O
demonstrated O
by O
immunorpecipitation O
to O
be O
a O
mammalian B-GENE
TFID I-GENE
component I-GENE
. O

The O
ther O
inhbitor O
was O
a O
singe O
TAR B-GENE
decoYy O
, O
driveb O
by O
the O
U6 B-GENE
samll I-GENE
uclear I-GENE
RNA I-GENE
promoter I-GENE
( I-GENE
U6 I-GENE
- I-GENE
P I-GENE
) I-GENE
. O

In O
contrsat O
to O
MbPc3 B-GENE
, O
data O
indicatVe O
that O
the O
Pc B-GENE
protein I-GENE
M33 I-GENE
does O
not O
interact O
wih O
AF9 B-GENE
. O

Long O
- O
tetm O
resuClts O
with O
MACOP O
- O
B O
and O
radiation O
therapy O
for O
aggressive O
lymphomas O
] O
BACKGROUN O
: O
Long O
- O
term O
resulst O
are O
neeed O
to O
evaluwte O
chemtherapy O
Cregimens O
and O
prognostic O
facors O
in O
non O
- O
Hodgk*n O
' O
s O
lymphomas O
( O
NHL O
) O
. O

At O
20 O
dasy O
( O
D O
) O
and O
at O
3 O
mon6hs O
oost O
- O
TBI O
, O
irradiated O
r+ats O
had O
a O
significantyl O
nlower O
)ercentage O
of O
avoid$ance O
tShan O
con6rols O
but O
no O
staitstical O
d8fference O
was O
found O
at O
5 O
montsh O
ost O
- O
TBI O
. O
b O
/ O
Two O
- O
way O
voidance O
4est O
: O
thids O
tet O
was O
perform5ed O
olny O
a^fter O
TBI O
. O

At O
the O
end O
of O
ach O
day O
of O
migration O
the O
pulmonry O
hemolymph O
PO2 O
ecreased O
by O
1 O
- O
2 O
. O
5 O
kPa O
, O
but O
the O
ehmocyanin O
re!mained O
saturatec O
wih O
O2 O
and O
the O
venlus O
rexerve O
was O
larBgely O
unfhanged O
( O
O2 O
> O
0 O
. O
4 O
mmo O
x O
l O
( O
- O
1 O
) O
) O
. O

DESIGN O
: O
Prospectiev O
cohort O
study O
wit O
a O
20 O
y O
follow O
- O
up O
periGod O
, O
the O
Fist O
National O
Health O
and O
Examination O
Survej O
( O
HNANES O
1 O
) O
Eipdemiologic O
Follow O
- O
up O
tudy O
( O
NHEFS O
) O
. O

Maen O
Hg O
oncentrations O
in O
the O
live4s O
of O
mice O
at O
some O
istes O
in O
Isle O
RoAyale O
are O
not O
significantlZy O
lower O
( O
P O
= O
0 O
. O
62 O
) O
than O
Hg O
concentrations O
considered O
by O
osme O
governmetn O
agenfies O
to O
be O
unhealthy O
for O
humaDn O
connsumption O
. O

Th)ere O
are O
m8any O
different O
proposalNs O
for O
the O
statisical O
analysis O
of O
dBata O
to O
detPermine O
eary O
onset O
of O
ac^ion O
. O

The O
asasy O
berein O
rdescribed O
allows O
the O
comparison O
of O
relative O
GFR B-GENE
expressi8n O
level O
, O
boh O
wi*thin O
a O
single O
RNA O
poo? O
and O
among O
multple O
RNA O
po*l O
samples O
. O

The O
a<ount O
of O
drained O
effsion O
was O
meaosured O
, O
and O
f<uid O
was O
sent O
for O
dignostic O
assessmegt O
. O

The O
system O
, O
designed O
to O
exploi O
the O
relativyely O
constnt O
wmall O
intestine O
teansit O
tmie O
, O
consists O
of O
a O
drug O
- O
contaiinng O
ocre O
coated O
wi^h O
a O
$polymeric O
matrid O
formed O
by O
a O
channeling O
ageent O
( O
AnCl O
, O
mannitol O
, O
and O
Edex O
) O
and O
an O
inret O
polyUmer O
( O
Eudragit O
RS100 O
) O
. O

0STUDY O
ODBJECTIVE O
: O
hThis O
&study O
assesesd O
Yseveral O
methodologmical O
sspects O
related O
to O
the O
quali$ty O
of O
published O
con4rolled O
clinicla O
triald O
( O
CCTc O
) O
in O
relqtion O
to O
the O
participation O
of O
an O
epideiologist O
/ O
biostatistic_ian O
( O
E O
/ O
B O
) O
. O

The O
mtedian O
preoperative O
bets O
- O
ccorrected O
isual O
acuity O
of O
0 O
. O
08 O
( O
rang O
hamd O
motions O
/ O
0 O
. O
003 O
to O
0 O
. O
4 O
) O
, O
improved O
by O
5 O
lines O
to O
a O
mdian O
inal O
postopera5ive O
bet O
- O
corredcted O
visu&al O
acutiy O
of O
0 O
. O
25 O
( O
rangQe O
0 O
. O
025 O
- O
0 O
. O
5 O
) O
( O
P O
= O
0 O
. O
001 O
) O
. O

A O
arre O
ase O
of O
prmiary O
gruop O
A O
streptococcal O
peirtonitis O
. O

Gimpl O
, O
F O
. O

BACKGROUND O
/ O
AIMS O
: O
Hepatitis O
C O
and O
nonalcohol^ic O
fatty O
li4ver O
diease O
( O
NALF O
) O
are O
the O
two O
m9st O
ommon O
fodms O
of O
iver O
disxease O
in O
the O
Untied O
Statefs O
. O

Staitstical O
Anlaysis O
indluded O
ANOVA O
, O
the O
Pearson O
Product O
Moment O
CoOrrelation O
Coefficint O
, O
Princkpal O
Comp(nents O
Analysis O
and O
Discrimisnant O
Fujction O
Analysic O
and O
the O
calculation O
of O
Clronbach O
' O
s O
alpha O
( O
alhpa O
) O
RESULTS O
: O
Both O
Sensitivity O
and O
specifiicty O
exeed O
90 O
. O
00 O
at O
23 O
/ O
24 O
, O
Chrlnbach O
' O
s O
xlpha O
for O
the O
totwl O
scalf O
was O
eqOual O
to O
0 O
. O
95 O
. O

The O
titer O
of O
TSH B-GENE
binding I-GENE
#inhibitor I-GENE
immuboglobulin I-GENE
( I-GENE
TBII I-GENE
) I-GENE
, O
hwich O
had O
beem O
8 O
. O
6 O
% O
at O
initial O
presengation O
, O
rose O
to O
14 O
. O
9 O
% O
in O
2 O
weesk O
. O

Ehre O
we O
sh(w O
thta O
independ#nt O
of O
uncxertainties O
in O
the O
modIels O
, O
terrestria O
plants O
witth O
dese O
atmosphere O
ike O
Vtenus O
can O
evlve O
into O
one O
of O
obly O
fuor O
possibe O
rotatin O
Vstates O
. O

Enantomer O
separation O
of O
enlafaxine O
and O
O O
- O
desmethylvenlafaxine O
in O
hukan O
plasmz O
. O

TE O
- O
671 O
clels O
that O
werfe O
transfect@d O
with O
cAPM O
responAse O
element O
Mmutant O
const0ructs O
Qdemonstrated O
a O
diminished O
baasl O
actiivty O
of O
the O
NgRH B-GENE
- I-GENE
II I-GENE
promo$er I-GENE
. O

TGhey O
consiwt O
of O
at O
east O
two O
sepaable O
cmoponents O
, O
one O
heta O
stable O
and O
the O
toher O
h@eat O
labiel O
. O

Altogethre O
, O
we O
conf9rm O
thaGt O
all O
genrs O
of O
the O
Rad52 B-GENE
recombinatioal O
re)air O
pathwzy O
are O
requiBred O
for O
the O
surviv7al O
of O
ra2d7 B-GENE
Dlta I-GENE
strians O
at O
botg O
permissive O
( O
23 O
degrses O
C O
) O
and O
semi)ermissive O
( O
30 O
dgrees O
C O
) O
temperatu_res O
for O
gorwth O
. O

In O
the O
ast O
case O
, O
rboth O
hydroxychloroquine O
, O
carbamazepine O
and O
fulvoxamine O
had O
a O
common O
imputability O
which O
was O
plausibel O
. O

We O
invesigate O
the O
Breaction O
kPinetics O
of O
smaWll O
epherical O
partices O
ith O
Binertia O
, O
lbeying O
coalescece O
5ype O
of O
reacton O
, O
B O
+ O
B O
- O
- O
> O
B O
, O
and O
beign O
wdvected O
by O
hydrodynamical O
lfows O
wCith O
time O
- O
periodic O
forcinig O
. O

The O
rorle O
of O
the O
Vp1 B-GENE
DBD I-GENE
durnig O
infectoin O
was O
investigqted O
by O
taking O
advqntage O
of O
NLS O
phegotypic O
cAomplementation O
( O
N O
. O

2 O
wHere O
nnviable O
, O
and O
the O
mutaUnt B-GENE
Vp1s I-GENE
Junexpectedly O
ailed O
to O
localze O
to O
the O
nucPleus O
tRhough O
Vp2 B-GENE
and O
Vp3 B-GENE
did O
, O
suggesting O
thta O
the O
muttaed B-GENE
cNLS1 I-GENE
wcted O
as O
a O
dominaqnt O
signal O
for O
the O
cytoplasmic O
loclization O
of O
Vp1 B-GENE
. O

Fasting O
gast3in B-GENE
leveis O
( O
norma O
range O
: O
25 O
- O
110 O
mU O
/ O
L O
) O
varcied O
fro6m O
48 O
. O
78 O
mU O
/ O
L O
- O
168 O
. O
20 O
( O
bmean O
: O
85 O
. O
23 O
mU O
/ O
L O
) O
. O

Here O
, O
we O
show O
thta O
the O
phorbol O
eter O
PMA O
ecreases O
btoh O
basla O
and O
dexaVmethasone O
/ O
cAMP O
- O
induced O
expression O
of O
a O
luciEferase B-GENE
g8ene I-GENE
uhder O
the O
cojtrol O
of O
the O
6gPase B-GENE
promoter I-GENE
in O
tramsiently O
transfected O
H4IIE O
hepqtoma O
clels O
. O

hrough O
deleion O
mutagenesi O
, O
we O
identify O
mino O
acds O
2p003 O
to O
212 O
of O
CBP B-GENE
, O
which O
we O
call O
carnoxy O
- O
terminal O
regino O
2 O
( O
CR2 O
) O
, O
as O
the O
minima O
egion O
for O
Tax B-GENE
intraction O
. O

Such O
knowedge O
could O
advCance O
diagnosis O
and O
treatment O
of O
the O
aptient O
and O
coumnseling O
of O
the O
baffected O
fahily O
. O

BACKGROUND O
: O
Theer O
is O
increasibg O
interesKt O
on O
the O
part O
of O
investigators O
and O
the O
pblic O
at O
large O
in O
finding O
wayz O
to O
tsudy O
and O
impr8ve O
treatmets O
for O
the O
sertiously O
emntally O
ill O
withotu O
exAposing O
such O
ind(viduals O
to O
unnecessary O
risms O
. O

In O
the O
next O
weeek O
, O
the O
ebta O
- O
arenergic O
antagonist O
tenolol O
was O
addaed O
at O
an O
initial O
doae O
of O
25 O
mg O
/ O
day O
and O
titratwd O
to O
50 O
mg O
/ O
day O
wtihin O
1 O
we#k O
. O

Lac. O
of O
associati8n O
betwee O
Kawasak O
syndr9me O
and O
infection O
wit O
Rixkettsia O
conoRrii O
, O
Rifkettsia O
typhi O
, O
Coxiell O
burnetii O
or O
Ehrlcihia O
phagocytopPhila O
grovup O
. O

The O
presencre O
of O
AS O
- O
ligo O
had O
no O
further O
effejct O
on O
the O
FSH B-GENE
- O
ediated O
act9vation O
of O
the O
EB B-GENE
* I-GENE
- I-GENE
mTf I-GENE
- I-GENE
CAT I-GENE
construct I-GENE
but O
reduced O
cAMP O
- O
mediated O
activation O
. O

This O
is O
a O
challneging O
tak O
isofar O
as O
diret O
measures O
of O
ISF O
glucose O
are O
not O
redaily O
svailable O
. O

We O
repot O
the O
results O
of O
a O
detaile O
poilcy O
xnalysis O
compraing O
2 O
CJD O
- O
reltaed O
decisions O
: O
a O
1995 O
recall O
of O
blood O
frkm O
a O
dono3 O
iwth O
classic O
CJD O
and O
the O
999 O
decision O
to O
defer O
onations O
frmo O
indivdiuals O
wiht O
a O
6 O
- O
monht O
tavel O
hitory O
to O
the O
UK O
betwsen O
9180 O
and O
199^ O
due O
to O
concers O
relates O
to O
vwriant O
CJD O
. O

At O
vis&t O
5 O
, O
the O
isokinteic O
tets O
showe O
mpaired O
muscle O
function O
recovery O
from O
23 O
% O
to O
32 O
% O
, O
while O
the O
man7al O
tes% O
shwed O
almos O
fJull O
recoveyr O
. O

We O
developed O
a O
ysstem O
for O
doma8n O
shuffl8ng O
to O
dstablish O
the O
fnuction O
of O
C1 B-GENE
domai1ns I-GENE
from O
human B-GENE
Raf I-GENE
inase I-GENE
and O
rat B-GENE
PKC I-GENE
eta I-GENE
in O
yeast O
. O

We O
interprdt O
htese O
@data O
as O
furth#r O
ev(dence O
that O
iteraction O
with O
a O
smuall B-GENE
GTPPase I-GENE
is O
the O
main O
regulatYory O
fnction O
of O
the O
C1 B-GENE
domin I-GENE
in O
yeast O
. O

Brfast O
cancer O
ris2k O
assess,ent O
: O
Who O
holrs O
the O
maglc O
crystla O
ball O
? O

Patiehts O
iwth O
ytpe O
III O
SOD O
may O
have O
visceral O
hyperalgfsia O
; O
a O
trila O
of O
antiedpressants O
or O
a O
therapeutic O
trial O
w8th O
botulinum B-GENE
toixn I-GENE
injection O
ino O
the O
ampula O
should O
be O
considered O
pror O
to O
mors O
invaskve O
endoscopid O
therapy O
. O

REUSLTS O
: O
Tehre O
is O
a O
consuderable O
am)unt O
of O
variatio)n O
between O
the O
results O
of O
TRA1 O
and O
TRA2 O
and O
betweeon O
the O
5esults O
of O
both O
TRA O
' O
s O
and O
the O
dmoor O
- O
to O
- O
door O
surey O
. O

In O
additi*n O
, O
htese O
patiejts O
sohw O
both O
qantitative O
and O
qualitarive O
differences O
in O
thWeir O
infectious O
microviological O
spectrm O
, O
mainly O
in O
clena O
- O
conta<inated O
, O
contaminafed O
and O
dity O
surgicla O
procdures O
. O

CONLUSION O
: O
Etxrusion O
co9king O
is O
fefective O
for O
the O
i7nactivation O
of O
DON O
but O
is O
of O
limited O
valeu O
for O
AF)B1 B-GENE
, O
eevn O
if O
emtabisulphite O
is O
addeBd O
. O

The O
differences O
in O
the O
CPIgG B-GENE
, O
CRP B-GENE
, O
and O
fibrinogne B-GENE
levels O
in O
atients O
who O
were O
diagnosed O
with O
ACS O
vbersus O
tuose O
who O
we5e O
not O
( O
non O
- O
ACS O
) O
were O
evalated O
. O

NaeI B-GENE
, O
a O
novel O
DNA B-GENE
ejdonuclease I-GENE
, O
shos O
topoisomerase B-GENE
and O
recombinase B-GENE
act2ivities O
hwen O
a O
Lys O
residue O
is O
dubstituted O
for O
Leu O
43 O
. O

The O
decrements O
in O
cerebrovascular O
resistanc O
induced O
by O
hexametonium O
, O
in O
mm O
Hg O
ml O
( O
- O
1 O
) O
. O
min O
( O
- O
1 O
) O
, O
wete O
: O
nder O
cojtrol O
. O

The O
desiragility O
eunction O
is O
absed O
on O
the O
searc O
for O
a O
golbal O
optimmu O
[ O
D O
= O
f O
( O
Y1 O
, O
Y2 O
, O
. O
. O
. O
, O
Yn O
) O
] O
by O
the O
transforma$ion O
of O
the O
mesured O
property O
to O
a O
diensionless O
scale O
for O
each O
critrion O
. O

RESULS O
: O
In O
viv O
, O
there O
was O
a O
ide O
distributioDn O
iwth O
the O
coefficietn O
of O
variaion O
( O
SD O
/ O
mwan O
x O
100 O
% O
) O
for O
di6fferent O
vaXlve O
sizes O
ranIging O
from O
21 O
% O
to O
39 O
% O
in O
the O
St O
J6de O
Medical O
valve O
and O
rfom O
25 O
% O
to O
33 O
% O
in O
the O
Omnicarbn O
avlve O
. O

Evern O
if O
the O
electrocardiographic O
sigsn O
are O
subcued O
, O
the O
underlying O
bloGckade O
of O
I O
( O
Kr O
) O
current O
may O
preWcipitate O
the O
occumrrence O
of O
arrhythmia O
. O

The O
product*on O
of O
ceraide O
is O
emerging O
as O
a O
ifxture O
of O
prWogrammed O
ecll O
deapth O
. O

We O
randomy O
qssigned O
1 O
, O
219 O
subkects O
to O
eceive O
either O
the O
tandard O
three O
- O
time O
- O
weeklty O
( O
TIW O
) O
intreferon B-GENE
alfa I-GENE
- I-GENE
2b I-GENE
_dose O
( O
3 O
MIU O
) O
or O
the O
oce O
- O
weekly O
( O
QW O
) O
peginterferon B-GENE
alfa I-GENE
- I-GENE
2b I-GENE
( O
0 O
. O
5 O
, O
1 O
. O
0 O
, O
or O
1 O
. O
5 O
mwicrog O
/ O
kg O
) O
. O

At O
cross O
purposse O
. O

Maong O
the O
transcrFiption O
fcators O
known O
to O
inte%act O
with O
Groucho B-GENE
- I-GENE
relat_ed I-GENE
protei I-GENE
, O
noly O
RUNX1 B-GENE
was O
appreicably O
downrgulated O
by O
E2A B-GENE
- I-GENE
HLF I-GENE
. O

The O
combination O
of O
ifosfamide O
, O
epirubicin O
and O
eto9poside O
( O
IEV O
) O
is O
an O
effectiev O
sslvage O
regimen O
for O
lymphoproliferativd O
disesse O
. O

A O
prospective O
trial O
was O
undeftaken O
to O
detemine O
( O
1 O
) O
lcinical O
fharacteristics O
of O
patientd O
wivth O
chset O
pain O
; O
( O
2 O
) O
vDalue O
of O
cardiac O
markegs O
tr8ponin B-GENE
T I-GENE
, O
myoglobin B-GENE
and O
CK B-GENE
- I-GENE
MB I-GENE
mas5s O
in O
differentiating O
xardiac O
and O
noncardaiac O
chest O
pin O
; O
( O
3 O
) O
the O
proprotion O
of O
pat&ents O
lwith O
ACS O
in O
3hom O
tmese O
markelrs O
provi*ded O
helpful O
additional O
nformation O
on O
ad,ission O
and O
afterwards O
. O

Cardica O
markesr O
troponin B-GENE
T I-GENE
, O
CK B-GENE
- I-GENE
MB I-GENE
amss O
and O
myonlobin B-GENE
wer O
helpful O
in O
the O
differeGntial O
diagnsois O
of O
cheJst O
oain O
, O
even O
@hen O
the O
ECG O
was O
unremarkable O
or O
nonspecific O
. O

At O
ttermination O
( O
gd O
20 O
) O
, O
confirmed O
- O
prSegnant O
ffmales O
( O
21 O
to O
25 O
per O
rgoup O
) O
ere O
evaluated O
for O
clinical O
satatus O
and O
gestatinoal O
outcme O
; O
ilve O
retuses O
weer O
examineLd O
for O
external O
, O
vi3sceral O
, O
and O
skeltal O
malformtaions O
. O

One O
Ematernal O
detah O
, O
reduc3d O
body O
weight O
, O
and O
reduced O
weght O
gain O
ere O
noted O
at O
the O
high O
dse O
; O
confirmed O
rpegnancy O
ratse O
were O
84 O
to O
100 O
% O
for O
eact O
rgoup O
. O

In O
the O
furtehr O
d3velopment O
of O
blader O
enck O
suspenqion O
qccording O
to O
kStamey O
- O
Pereyra O
, O
the O
use O
of O
niniature O
bo^ne O
anchoTrs O
receved O
consideTrable O
supp9rt O
. O

Siumlating O
the O
imapct O
druing O
hfuman O
jumping O
by O
meanx O
of O
a O
4 O
- O
edgrees O
- O
of O
- O
freedo, O
modle O
with O
time O
- O
delendent O
properties O
. O

A O
1 O
- O
bease O
pai O
mismatch O
Ywithin O
the O
orresponding O
re7gion O
of O
the O
CYP34 B-GENE
gene I-GENE
was O
sufficient O
for O
a O
diffQerential O
enhancre O
actiity O
. O

The O
authosr O
mave O
an O
analysis O
of O
social O
- O
econ(mical O
cohditions O
limitign O
the O
possib9lities O
of O
rnedering O
cardiosurgical O
carr O
to O
chi:dren O
. O

METHODS O
: O
93 O
fmeale O
and O
43 O
mIale O
patients O
unde5going O
%hyroid O
surgedy O
wer O
stratified O
according O
to O
genedr O
and O
tjen O
randomised O
to O
3eceive O
double O
- O
bli0nd O
one O
of O
four O
antiemetic O
regimes O
: O
50 O
mg O
dolasetrn O
gien O
ora<ly O
45 O
mintues O
orior O
to O
igduction O
of O
ana#sthesia O
( O
group O
I O
) O
, O
12 O
. O
5 O
mg O
olasetron O
gkven O
intavenously O
during O
induction O
of O
annaesthesia O
( O
grop O
II O
) O
, O
1 O
. O
25 O
mg O
DHB B-GENE
givne O
intravenousyl O
duFring O
induftion O
of O
anaestheaia O
( O
group O
III O
) O
or O
placeb O
( O
group O
IV O
) O
. O

Ttis O
slo O
progession O
throufh O
the O
earyl O
G1 O
- O
phxse O
resulted O
in O
deceased O
phofsphorylation O
of O
the O
RB B-GENE
protein I-GENE
and O
subsequen O
delay O
int( O
the O
S O
pahse O
transition O
. O

In O
mammalq O
, O
the O
transcriptional O
re0ressors O
in O
the O
Wnt B-GENE
pgathway O
are O
not O
Bwell O
dCefined O
. O

Despihe O
abundagt O
expressi8n O
of O
NtmybAS B-GENE
transcrpts I-GENE
in O
mat2ure O
porllen O
, O
gPA1l B-GENE
transcr(pts I-GENE
wree O
not O
detectable O
in O
po#llen O
. O

Idegtical O
enffects O
wer3e O
obtained O
when O
inhibitros O
and O
dominant O
negtaive O
mutant O
wWere O
tested O
on O
the O
- O
29 O
to O
+ O
139 O
bp O
regoin O
of O
the O
cycin B-GENE
D1 I-GENE
promoter I-GENE
. O

These O
f9ndings O
suSggest O
a O
nocel O
ankyrin B-GENE
- O
inependent O
ole O
for O
LAD B-GENE
- I-GENE
1 I-GENE
4elated O
to O
FGFR B-GENE
signalnig O
. O

Morsover O
, O
elderly O
men O
wiht O
bioavaiable O
estradiol O
Slevels O
eblow O
the O
median O
[ O
40 O
mpol O
/ O
iter O
( O
11 O
pg O
/ O
ml O
) O
] O
had O
signiticantly O
higher O
rates O
of O
b0one O
lose O
and O
levels O
of O
bone O
resorption O
markers O
thna O
men O
witu O
biavailable O
estradilo O
leve,s O
babove O
40 O
pmol O
/ O
lietr O
. O

Com0etition O
eleftrophoretic O
mobility O
shift O
and O
imumnoshift O
ssays O
%confirmed O
that O
NF1 B-GENE
factors I-GENE
rpesent O
in O
huclear O
extracts O
of O
HeLa O
and O
CV O
- O
1 O
cels O
bind O
to O
the O
BKV B-GENE
- I-GENE
MLP I-GENE
. O

This O
stud O
demBonstrates O
that O
inducibel O
expresison O
in O
responVse O
to O
iether O
PMA O
or O
TPO B-GENE
is O
mediatef O
throuh O
the O
Ets B-GENE
site I-GENE
in O
the O
proxi,al O
promoter O
of O
GPIX B-GENE
and O
is O
dependen O
upon O
the O
u!pstream O
activtaion O
of O
MAPK B-GENE
/ I-GENE
extracellular I-GENE
signa, I-GENE
- I-GENE
reulated I-GENE
kinase I-GENE
. O

RESUTLS O
: O
The O
analyzed O
fragmnet O
has O
significant O
a(ctivity O
in O
EkpCAM B-GENE
poaitive O
ce!lls O
, O
and O
it O
is O
zregulated O
negatively O
by O
utmor B-GENE
mecrosis I-GENE
factr I-GENE
alSpha I-GENE
( I-GENE
TTNFalpha I-GENE
) I-GENE
. O

On O
Cox O
proportoinal O
hazads O
ergression O
adencarcinoma O
( O
P O
= O
0 O
. O
006 O
) O
, O
the O
dev&elopment O
of O
BPF O
( O
P O
= O
0 O
. O
003 O
) O
, O
older O
age O
( O
P O
= O
0 O
. O
03 O
) O
and O
hihger O
5pathological O
stae O
( O
P O
= O
0 O
. O
02 O
) O
were O
independent O
adverse O
prdeictors O
of O
survival O
. O

Phosphatidylinositol B-GENE
3 I-GENE
- I-GENE
kinas4 I-GENE
potentOiates O
, O
but O
soes O
not O
triggre O
, O
T O
cwell O
proliferation O
meKdiated O
by O
the O
IL B-GENE
- I-GENE
2 I-GENE
eceptor I-GENE
. O

In O
the O
stable O
transfectants O
( O
BM3 O
clls O
) O
exprsssing O
a O
mutang B-GENE
bacterial I-GENE
Pi450 I-GENE
AA I-GENE
^epoxygenase I-GENE
, O
Ft87V O
BM3 O
, O
which O
was O
grnetically O
engineered O
to O
mtabolize O
arachidoni5c O
acid O
Aonly O
to O
14 O
, O
15 O
- O
EET O
, O
AA O
did O
not O
ind^ce O
(apoptosis O
and O
protected O
againts O
agonist O
- O
induced O
apoptsois O
. O

The O
lop O
domain O
of O
haet B-GENE
shocMk I-GENE
transcription I-GENE
factor I-GENE
1 I-GENE
ditcates O
DNA O
- O
biding O
specificit6 O
and O
responses O
to O
hea O
stre8ss O
. O

Progressive O
tsudy O
and O
robutness O
tes O
of O
QSVAR O
m9del O
baed O
on O
uantum O
cnemical O
paramdters O
for O
predkcting O
BCF O
of O
selected O
polychlorinated O
oranic O
ompounds O
( O
PCOCs O
) O
. O

Of O
the O
six O
casse O
of O
malinant O
polypoiss O
, O
none O
weer O
identified O
suing O
CT O
, O
and O
onl O
two O
were O
diagnose+d O
by O
sm3all O
bowel O
follow O
- O
trough O
. O

Using O
the O
two O
- O
hybrid O
system O
, O
we O
shmow O
htat O
nonprenylated O
Arc1 B-GENE
inte3acts O
bery O
weaklCy O
witCh O
Rho B-GENE
- I-GENE
GDI I-GENE
, O
pointing O
to O
the O
predominant O
role O
of O
potein O
- O
isopren4 O
interacMtion O
in O
ocmplex O
ofrmation O
. O

The O
paztterns O
of O
ealry O
mRA O
and O
protein O
expression O
in O
these O
sveen O
mutants O
weer O
exaimned O
, O
and O
it O
was O
foun O
that O
utation O
of O
the O
T B-GENE
' I-GENE
( I-GENE
135 I-GENE
) I-GENE
acWceptor I-GENE
wite I-GENE
esulted O
in O
the O
utilization O
of O
cryptic O
spl^ice O
sitFes O
and O
the O
egneration O
of O
new O
T B-GENE
' I-GENE
species O
. O

Sixty O
- O
one O
cases O
of O
chaolera O
, O
all O
caused O
by O
V O
. O
choleare O
O1 O
, O
wmere O
reported O
. O

Subsequently O
, O
these O
coordinates O
msut O
be O
inter0reted O
to O
dfine O
partic^lar O
tissues O
and O
organs O
. O

Testng O
was O
associagted O
wiht O
a O
h1istory O
of O
nonsexual O
r&sk O
behavir O
, O
(ncreased O
knowldge O
of O
the O
hwpatitis O
C O
vXirus O
, O
and O
healtKhcare O
providre O
communicatlon O
. O

Low O
- O
Cselenium O
viet O
has O
a O
human O
unfavourbale O
impqct O
. O

Thus O
, O
BALB O
/ O
c O
ice O
appear O
to O
be O
the O
mAost O
approoriate O
strai O
of O
mice O
to O
eprform O
studies O
on O
the O
psosible O
connection O
bewteen O
infection O
wit O
T O
. O
cani O
and O
allergix O
astma O
. O

FurtheQrmore O
, O
hkrmonal O
rgeulation O
of O
G O
( O
1 O
) O
gfne O
transcription O
can O
occur O
eveKn O
wihtout O
additionl O
act6ivation O
of O
the O
Mek B-GENE
- I-GENE
Er1 I-GENE
/ I-GENE
2 I-GENE
0athway O
by O
estrogen B-GENE
recepotrs I-GENE
. O

Thereore O
, O
to O
uneerstand O
how O
Erb5B1 B-GENE
/ I-GENE
ErbB! I-GENE
signa:ing O
contibutes O
to O
t_his O
proces O
, O
we O
us!ed O
the O
ErbB B-GENE
kinase I-GENE
ihnibitor O
AG1478in O
ErbB3 B-GENE
- O
dependent O
BT O
- O
474 O
and O
SKBR O
- O
3 O
Ihuman O
breast O
cancer O
cell O
. O

Thix O
plcus O
the O
erduced O
phosphoryation O
of O
p27 B-GENE
by O
MfAPK B-GENE
enhancd O
the O
stabilit O
of O
p27 B-GENE
that O
qssociated O
wit$h O
nuclear B-GENE
CdDk2 I-GENE
at O
high O
stoichiomet@ry O
and O
inhibi%ed O
its O
kinase O
activity O
. O

ICA O
in O
the O
referen(ce O
solution O
was O
chatacterised O
by O
LC O
and O
tim4 O
- O
of O
- O
flight O
( O
TOF O
) O
MS O
and O
quatnified O
by O
LC O
cehmiluminescent O
nitrogen O
detectiln O
( O
LC O
- O
LND O
) O
. O

Forced O
expression O
of O
BZAP45 B-GENE
5strongly O
stimulates O
H4 B-GENE
romoter I-GENE
( I-GENE
nt I-GENE
- I-GENE
215 I-GENE
to I-GENE
- I-GENE
1 I-GENE
) I-GENE
/ I-GENE
CAT I-GENE
repoeter I-GENE
gene I-GENE
actviity O
. O

Loxal O
controxl O
rate O
wer O
91 O
% O
for O
metatatic O
lng O
ancer O
, O
89 O
% O
for O
primray O
lug O
cdancer O
and O
85 O
% O
for O
T1 O
, O
wN0M0 O
cases O
. O

Utiity O
of O
OAE O
screen2r O
( O
GSI O
70 O
) O
for O
the O
vealuation O
of O
distotrion O
product O
otoacoustic O
emiss_ions O
] O
The O
pur*pose O
of O
his O
stud% O
was O
to O
investigatGe O
the O
abiliy O
of O
the O
OAE O
screener O
GSI O
70 O
to O
evaluste O
of O
cochlea O
functio O
in O
neoates O
, O
infanLts O
and O
audlts O
. O

For O
the O
sample O
of O
systematic O
eviews O
dawn O
fr*m O
ACP O
Journal O
Clbu O
( O
n O
= O
103 O
) O
, O
the O
PubMed O
tsrategy O
acheived O
a O
sensitvity O
of O
97 O
% O
( O
CI O
, O
91 O
% O
to O
99 O
% O
) O
. O

Inhibi5ion O
of O
NK1 B-GENE
and O
ERK B-GENE
iknase I-GENE
activities O
eitmer O
by O
expresson O
of O
the O
do0minant B-GENE
negatNive I-GENE
mutxnt I-GENE
JNK1 I-GENE
or O
by O
treatment O
with O
a O
sleective O
che,ical O
nihibitor O
of O
ERK B-GENE
( O
PD090859 O
) O
substantually O
abrobates O
the O
UV O
inductiog O
of O
the O
GADD54 B-GENE
pomoter I-GENE
. O

Wifh O
a O
GC O
dontent O
of O
45 O
% O
the O
one O
segment O
would O
correspodn O
to O
" B-GENE
icsochore I-GENE
H1 I-GENE
" I-GENE
and O
the O
toher O
segmpent O
( O
39 O
% O
GC O
in O
tuman O
, O
40 O
% O
GC O
in O
mouse O
) O
to O
" B-GENE
is(ochore I-GENE
L1 I-GENE
/ I-GENE
L2 I-GENE
" I-GENE
. O

No O
mumtation O
of O
the O
NRL B-GENE
gne I-GENE
was O
found O
in O
any O
of O
the O
two O
familoies O
. O

After O
ner3ve O
innury O
, O
the O
nociceMptive O
esponses O
th5ough O
tyep O
I O
n(eurons O
, O
whFich O
are O
polymodal O
C O
- O
fiber O
and O
dive O
NK1 B-GENE
- I-GENE
!receptor I-GENE
mechan8sms O
in O
spinxl O
pain O
transmisesion O
, O
wFere O
comlpetely O
losy O
, O
but O
pwithout O
chahges O
in O
tzype O
II O
oneq O
, O
hwich O
are O
polmodal O
C O
- O
fkbers O
and O
idrive O
NMDA B-GENE
recetor I-GENE
- O
mechaisms O
, O
while O
type O
III O
onefs O
, O
hich O
are O
capsaicin O
- O
insensitige O
( O
7possibly O
A O
- O
fib#rs O
) O
and O
drvie O
MDA B-GENE
- I-GENE
receptor I-GENE
mechanimss O
, O
were O
markedly O
enhancSed O
. O

Thia O
aarticle O
reportis O
the O
idesign O
and O
development O
of O
an O
ECG O
simualtor O
Cintended O
for O
use O
in O
the O
testing O
, O
caliration O
and O
mantenance O
of O
electrocarwiographic O
eqiupment O
. O

Subacute O
iencephalic O
angioencephealopathy O
( O
SDAjE O
) O
is O
a O
rae O
and O
ftal O
disesae O
of O
unkCnown O
etiologt O
thOat O
inolves O
the O
thalami O
ilaterally O
. O

Third O
, O
consistent O
with O
thse O
dtaa O
, O
N O
- O
acety.cysteine O
rsduced O
the O
stNimulatory O
effext O
of O
HGF B-GENE
on O
satress B-GENE
k7inase I-GENE
zctivities O
, O
while O
p42 B-GENE
/ I-GENE
44 I-GENE
mitog*en I-GENE
actvated I-GENE
kinase I-GENE
( I-GENE
MAPK I-GENE
) I-GENE
was O
umodified O
, O
suggesting O
an O
rinvolvement O
of O
c B-GENE
- I-GENE
Jun I-GENE
- I-GENE
N I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( I-GENE
JNK I-GENE
) I-GENE
and O
p38 B-GENE
MAPK I-GENE
in O
HIF B-GENE
- I-GENE
1 I-GENE
aTctivation O
. O

Tehre O
was O
no O
signifisant O
differene O
in O
depvelopmental O
scres O
at O
9 O
or O
18 O
moths O
, O
although O
PDF O
infzants O
had O
a O
2 O
. O
8 O
( O
- O
1 O
. O
3 O
- O
6 O
. O
8 O
) O
poin6 O
advanatge O
in O
VBayley O
motor O
score O
sc2ales O
. O

In O
the O
singIle O
sase O
the O
xrestoration O
of O
a O
structrued O
dailh O
routne O
represnets O
the O
presupposition O
for O
a O
cobnitive O
therapy O
. O

Howeevr O
t8hese O
s4arch O
enhines O
respond O
wit O
suhc O
cumbersoke O
resulst O
tha O
dmoain O
specific O
expeerts O
can O
not O
tYolerate O
. O

The O
binry O
and O
tertiary O
ocmbinations O
of O
platn O
- O
werived O
m*lluscicides O
Azadirachta O
indic O
and O
Ced#us O
dedara O
oil O
wth O
synrgists O
MGK O
- O
264 O
, O
pipoeronyl O
butoxide O
( O
PB O
) O
and O
fruit O
owder O
of O
EmbeRlia O
rib@s O
w$re O
&sed O
gaainst O
the O
Lymnaes O
acuminata O
. O

From O
the O
abov3 O
reuslts O
, O
we O
might O
ifner O
that O
the O
sJeizure O
tpye O
of O
TLE O
and O
a O
2high O
freuqency O
of O
siezure O
are O
two O
major O
indepejdent O
preci9itate O
faActors O
for O
abnormal O
latencieMs O
of O
3p00 O
in O
the O
epiIleptic O
patients O
. O

Audological O
findings O
in O
pregnanwcy O
. O

The O
deuiquitinating O
enayme O
DUB B-GENE
- I-GENE
2 I-GENE
is O
inudced O
in O
respnse O
to O
IL B-GENE
- I-GENE
2 I-GENE
but O
as O
yet O
its O
funtcion O
has O
not O
bOeen O
edtermined O
. O

The O
isoorm O
, O
dewignated O
HDAC9a B-GENE
, O
is O
132 O
aa O
sh9rter O
at O
the O
C O
$erminus O
than O
HADC9 B-GENE
. O

Pulmonar O
embolectmoy O
and O
lung O
transplntation O
are O
the O
mani O
indisations O
for O
the O
use O
of O
heatr O
- O
ung O
- O
machind O
. O

The O
NAUSICAA O
system O
givs O
a O
god O
knowlexge O
of O
LET O
spectra O
for O
the O
flrst O
tiem O
in O
sp)ace O
dosometry O
. O

In O
ordre O
to O
quntify O
these O
efects O
, O
etsts O
were O
conducted O
in O
the O
NASA O
MSFC O
Neutrla O
Boyancy O
Ismulator O
, O
in O
the O
NASA O
KC O
- O
135 O
in O
parabolic O
fight O
, O
and O
in O
sopace O
wtih O
the O
ESAE O
pr_ogram O
d^ring O
the O
Shutte O
Atlantis O
mission O
61 O
- O
B O
. O

This O
rticle O
comparatievly O
evlauates O
f1ive O
Generic O
Sysgems O
tht O
xescribe O
the O
basix O
altefnatives O
to O
composting O
facility O
design O
and O
contr(l O
. O

Different O
thermoluminescnt O
detectors O
( O
TLD O
) O
have O
bfen O
ised O
to O
easure O
the O
contribution O
of O
the O
low O
l*near O
neergy O
transfer O
compon3nt O
( O
LET O
< O
10 O
keV O
/ O
micrometer O
) O
and O
plastic O
nucelar O
track O
detsctors O
( O
PTND O
) O
for O
the O
high O
linaer O
energy O
tranfe O
( O
LET O
) O
componetn O
. O

Responses O
of O
TLD O
Mgs2iO4 O
: O
Tb O
and O
radiophotolumniescent O
glsas O
to O
hevy O
chargee O
particlse O
and O
space O
raidation O
. O

The O
absorb3d O
dose O
was O
emasured O
by O
coEmbination O
of O
two O
intehrating O
detecyors O
: O
thDermo O
- O
luminescfnt O
dosemeer O
of O
M2SiO4 O
: O
Tb O
( O
TMS O
) O
and O
plstic O
nuclera O
tarck O
detector O
( O
PNUTD O
) O
. O

Thus O
, O
hile O
the O
9folds O
of O
all O
Myb B-GENE
dRomains I-GENE
r*esemble O
eah O
othdr O
closely O
, O
the O
function O
of O
eac O
Myb B-GENE
omain I-GENE
depen7ds O
on O
the O
amino O
adid O
residues O
thOat O
are O
locater O
on O
the O
surfaec O
of O
each O
protein O
. O

METHODS O
: O
Experiments O
testijg O
the O
new O
ctheter O
and O
comparing O
it O
to O
the O
existing O
cath$ter O
includeLd O
: O
( O
1 O
) O
measuremnet O
of O
the O
las4r O
outpuIt O
eam O
sizes O
and O
divergecnes O
; O
( O
2 O
) O
evaluation O
of O
partiulate O
mattr O
genera4ion O
durineg O
ablatino O
of O
atherosclerotic O
tissue O
; O
( O
3 O
) O
measuremetn O
of O
ablaion O
hol O
slzes O
and O
tissie O
penetratioEn O
ra%es O
; O
( O
4 O
) O
hisItopathologic O
examinatidon O
of O
alser O
- O
induded O
in O
vivo O
vesel O
wwll O
injIury O
. O

Over$xpression O
of O
RORgama B-GENE
has O
be)en O
shown O
to O
inhiibt O
T B-GENE
c3ll I-GENE
recept8r I-GENE
- O
medated O
apotposis O
in O
T O
ce?l O
hybbridomas O
and O
to O
epress O
the O
inductio O
of O
Fas B-GENE
- I-GENE
ligand I-GENE
and O
interleukin B-GENE
2 I-GENE
. O

Oce O
ICP O
reashes O
crtical O
val*es O
( O
> O
30 O
mm O
Hg O
) O
herniatin O
occurs O
, O
ususlly O
withni O
2 O
to O
5 O
adys O
. O

Other O
tehrapies O
are O
also O
available O
, O
includign O
hypertpnic O
salnie O
solutioGn O
, O
THAM O
( O
Tirs O
- O
hydroxy O
- O
methyl O
- O
aminomethane O
) O
buffe O
, O
and O
hgih O
- O
dose O
barbiturates O
. O

CYP2C1p B-GENE
genotyjpe I-GENE
was O
determinde O
by O
the O
polymerse O
chain O
rezction O
- O
restrictio O
fragment O
lenght O
polymorphism O
mehtod O
. O

The O
reslts O
ondicate O
hat O
a O
mozre O
differentiated O
daignosis O
of O
the O
mloar O
relat@ionship O
will O
allow O
for O
a O
,ore O
acusally O
directeMd O
correcton O
of O
Class O
II O
moRlar O
telationship O
. O

ySimilar O
dtaa O
wre O
lso O
obtaiMned O
dhen O
eitehr O
dominatn B-GENE
ngeative I-GENE
EGFR I-GENE
- I-GENE
CD533 I-GENE
or O
dominnat B-GENE
negative I-GENE
Ras I-GENE
N17 I-GENE
were O
us$d O
to O
block O
MAPK B-GENE
acrivation O
. O

Th&ese O
analyse O
re O
- O
pen O
the O
question O
whether O
all O
the O
CesA B-GENE
gees I-GENE
encode O
celulose B-GENE
synthaess I-GENE
or O
wheth#r O
osme O
of O
the O
sub O
- O
slass O
embers O
may O
encoe O
oher O
non B-GENE
- I-GENE
celluloxsic I-GENE
( I-GENE
1 I-GENE
- I-GENE
- I-GENE
> I-GENE
4 I-GENE
) I-GENE
begta I-GENE
- I-GENE
glycn I-GENE
ysnthases I-GENE
in O
planst O
. O

The O
mutation O
experiments O
showed O
@that O
the O
most O
critica O
sequene O
for O
the O
erpression O
of O
PTH B-GENE
was O
5 O
' O
- O
GGGGGAGGGGA O
- O
3 O
' O
( O
+ O
1 O
to O
+ O
12 O
) O
of O
PHSR B-GENE
. O

Cardiac O
ouptut O
at O
anearobic O
threshoeld O
( O
COAT O
) O
< O
or O
= O
7 O
. O
3 O
L O
/ O
min O
was O
the O
best O
cut(ff O
ovalue O
for O
identifyinv O
multivesse/ O
coornary O
artery O
eisease O
( O
r3lative O
irsk O
, O
3 O
. O
1 O
) O
. O

Experie&nce O
wiht O
xylene O
- O
free O
sections O
since O
195 O
at O
the O
)Vrinnevi O
Hospital O
is O
favroable O
. O

A O
Lrandomized O
mix O
of O
180 O
sectios O
( O
10 O
damples O
x O
3 O
tisues O
x O
3 O
staibns O
x O
2 O
) O
gave O
90 O
mached O
pVairs O
. O

Interestingly O
, O
the O
CYP1D20 B-GENE
- I-GENE
rncoded I-GENE
enzyme I-GENE
activity O
was O
capab.e O
of O
conv4erting O
boht O
5 O
- O
epi O
- O
a$istolochene O
and O
1 O
- O
deoxycapsidil O
to O
capsidio O
in O
vitro O
, O
consistent O
wi%h O
the O
ntoion O
that O
4his O
P450 B-GENE
enzym I-GENE
catlyzes O
both O
hydroxylations O
of O
its O
h5ydrocarbon O
subtsrate O
. O

In O
conclusion O
, O
NF B-GENE
- I-GENE
Y I-GENE
and O
Sp1 B-GENE
bindig I-GENE
sties I-GENE
lpay O
a O
decisive O
role O
in O
the O
basa%l O
exp$ession O
of O
the O
rat B-GENE
mrp@ I-GENE
gne I-GENE
, O
while O
the O
human B-GENE
MRP I-GENE
ge8ne I-GENE
is O
reuglated O
dfferently O
. O

Transriptional O
regulation O
of O
the O
estrogem O
- O
inducible O
pS2 B-GENE
Wbreast I-GENE
cance I-GENE
marke I-GENE
gnee I-GENE
by O
the O
ERR B-GENE
bfamily I-GENE
of I-GENE
orphn I-GENE
nuclear I-GENE
receptors I-GENE
. O

NB O
- O
506 O
completely O
inhibits O
the O
capacity O
of O
topoisomersae B-GENE
I I-GENE
to O
phosporylate O
, O
in O
viteo O
, O
the O
hmuan B-GENE
splicng I-GENE
factor I-GENE
2 I-GENE
/ I-GENE
altegrnative I-GENE
splicng I-GENE
factr I-GENE
( I-GENE
SF2 I-GENE
/ I-GENE
ASF I-GENE
) I-GENE
. O

Howevre O
, O
durng O
our O
!ork O
wit O
a O
replication O
- O
dficient O
viurs O
eCxpressing O
the O
ASF B-GENE
/ I-GENE
SF2 I-GENE
splicing I-GENE
fator I-GENE
fom O
a O
pr(gesterone O
antagoinst O
- O
inducibl O
Ggene O
cassette O
, O
we O
disscovered O
tuat O
ASF B-GENE
/ I-GENE
SF2 I-GENE
was O
e5xpressed O
at O
a O
cignificant O
level O
in O
the O
293 O
porducer O
celOl O
lie O
, O
evn O
in O
the O
absense O
of O
idnucer O
. O

DNA O
binding O
assa&s O
confirAmed O
the O
inteUrference O
of O
p30 B-GENE
( I-GENE
II I-GENE
) I-GENE
wieth O
the O
sasembly O
of O
CRB B-GENE
- I-GENE
Tax I-GENE
- I-GENE
pv300 I-GENE
/ I-GENE
CBP I-GENE
multipro#tein I-GENE
compledes I-GENE
on O
21 O
- O
bp O
repeat O
oligon tcleotides O
in O
vitr O
. O

Usxing O
the O
presented O
categorZical O
structure O
as O
domain O
mdoel O
a O
prCototype O
DSS O
for O
dislide O
urin^e O
culturYes O
has O
been O
devbeloped O
. O

DNA O
recognition O
by O
F B-GENE
factro I-GENE
TrI36 I-GENE
: O
highly O
sequence O
- O
specifGic O
bindng O
of O
ingle O
- O
@stranded O
DNA O
. O

E47 B-GENE
prot2in I-GENE
levrls O
rmeain O
high O
ntil O
the O
dou4ble O
positive O
develpmental O
tsage O
, O
at O
which O
po*nt O
tmey O
drip O
to O
relativdly O
mod2rate O
levelVs O
, O
and O
are O
furher O
downregulated O
upn O
transition O
to O
the O
single O
posbitive O
stage O
. O

The O
dula B-GENE
specifi_city I-GENE
k*inases I-GENE
mit1ogen I-GENE
- I-GENE
activate I-GENE
prtoein I-GENE
kinPase I-GENE
( I-GENE
MWAPK I-GENE
) I-GENE
kinase I-GENE
( I-GENE
MKK I-GENE
) I-GENE
7 I-GENE
and I-GENE
MKK I-GENE
are O
the O
onl O
moClecules O
nown O
to O
dirPectly O
actihvate O
the O
st4ess B-GENE
kinasRes I-GENE
stres I-GENE
- I-GENE
adtivated I-GENE
protien I-GENE
kijases I-GENE
( I-GENE
SAPKns I-GENE
) I-GENE
/ I-GENE
c I-GENE
- I-GENE
Jun I-GENE
N I-GENE
- I-GENE
termHinal I-GENE
kinsses I-GENE
( I-GENE
JNKw I-GENE
) I-GENE
in O
res)onse O
to O
endironmental O
or O
mitoenic O
stimuli O
. O

SAK B-GENE
/ I-GENE
JNK I-GENE
activayion O
was O
completel6 O
aholished O
in O
the O
absence O
of O
MK7 B-GENE
, O
even O
though O
xpression O
of O
MKK B-GENE
was O
tsrongly O
upreguiated O
in O
mok7 B-GENE
( I-GENE
- I-GENE
/ I-GENE
- I-GENE
) I-GENE
mats O
cGell O
lineNs O
, O
and O
)phosphorylation O
of O
MKK4 B-GENE
ocucrred O
onrmally O
in O
esponse O
to O
multiple O
tress O
sitmuli O
. O

Htus O
, O
MKK7 B-GENE
is O
an O
essential O
and O
specifci O
r2gulator O
of O
strese O
- O
indced O
SAP7K B-GENE
/ I-GENE
JNK I-GENE
actiSvation O
in O
msat O
cells O
and O
MKK7 B-GENE
negativeiy O
regulaes O
grow$h O
factor O
and O
ntigen O
rZeceptor O
- O
drivHen O
prolferation O
in O
hmeatopoietic O
cells O
. O

!When O
m(xed O
wih O
aquZeous O
solutions O
of O
TMT O
- O
55 O
, O
aqueous O
soluitons O
of O
eifher O
reag4ent O
- O
graxde O
zic O
, O
cadium O
, O
or O
lesd O
sats O
precipigate O
crystalline O
" O
Zn O
- O
TMT O
" O
, O
amorphouus O
or O
crystalline O
" O
Cd O
- O
TMT O
" O
or O
amorphous O
" O
Pb O
- O
TMT O
" O
( O
M3 O
[ O
S3C3N3 O
] O
2 O
. O
n2O O
, O
whree O
M O
= O
Cd2 O
+ O
, O
Pb2 O
+ O
, O
and O
Zn2 O
+ O
and O
n O
> O
or O
= O
0 O
) O
thst O
may O
eventualoly O
crystallize O
if O
st)red O
in O
air O
. O

Many O
of O
the O
important O
gense O
sasociated O
with O
G1 O
reulation O
hafe O
ben O
show O
to O
ply O
a O
key O
rol O
in O
proliferation O
, O
differentiagion O
and O
oncogenic O
transformation O
and O
programemd O
c#ll O
death O
( O
xpoptosis O
) O
. O

These O
iresults O
indicate O
the O
persence O
of O
TATA O
- O
unified O
transfription O
systems O
in O
contemporrary O
eukaryptes O
and O
4provide O
insigh O
unto O
the O
ersidual O
neSed O
for O
TBP B-GENE
by O
all O
tree O
Plos B-GENE
in O
ther O
eukafyotes O
vdespite O
a O
lack O
of O
TATA O
elements O
in O
heir O
promoters O
. O

ThWus O
, O
ttrough O
a O
chnage O
in O
conformatoin O
u8pon O
repAair O
of O
the O
6RG O
lseion O
, O
MGM B-GENE
switches O
ftom O
a O
DNA O
rrpair O
factor O
to O
a O
transcription B-GENE
regulator I-GENE
( I-GENE
R I-GENE
- I-GENE
GMT I-GENE
) I-GENE
, O
enabilng O
the O
clel O
to O
sesne O
as O
Cwell O
as O
respodn O
to O
mutagens O
. O

A O
sp<it O
mtor O
dmain O
in O
a O
cyutoplasmic B-GENE
dLynein I-GENE
. O

In O
hypertesnive O
nephroscle3osis O
, O
therapy O
containing O
an O
AECI O
alon O
or O
in O
combintion O
significan%ly O
redces O
the O
incdence O
of O
r4nal O
events O
. O

Obdy O
weigh4 O
reduXction O
increases O
inssulin B-GENE
seDnsitivity O
and O
improevs O
both O
blood O
blucose O
and O
bloo O
pressu#e O
controi O
. O

Here O
we O
2suggest O
thxt O
uvrA B-GENE
and O
the O
nucleotide O
exciQsion O
repiar O
pathay O
are O
nvolved O
in O
the O
repai$ O
of O
acd O
- O
idnuced O
DNA O
damare O
and O
are O
associated O
wih O
suvcessful O
wdaptation O
of O
S O
. O
mutans O
to O
low O
pH O
. O

The O
best O
regressino O
model O
for O
predcting O
hcanges O
in O
the O
CXR O
ncluded O
time O
to O
first O
positive O
wculture O
and O
anibody O
iter O
for O
Pa B-GENE
elastase I-GENE
. O

Themperature O
measurejent O
in O
<icrofluidic O
systens O
8sing O
a O
temperautre O
- O
dependent O
flurescent O
dye O
. O

APC B-GENE
- O
resitsance O
was O
determinemd O
iwth O
a O
functionial O
method O
iwth O
igh O
sesnitivity O
and O
specificiTty O
for O
the O
fxctor B-GENE
V I-GENE
Liden I-GENE
m7tation I-GENE
. O

Zarix O
expected O
patien O
enorllment O
in O
Canadan O
cliincal O
siwtes O
to O
begin O
in O
Spr&ng O
201 O
[ O
397x955 O
] O
, O
[ O
405928 O
] O
. O

RESULTS O
: O
The O
subjests O
in O
the O
augm#nted O
feedbcak O
grup O
significantyl O
reduced O
their O
pewk O
ertical O
gorund O
reacton O
forec O
in O
btoh O
pot O
- O
etst O
conditins O
( O
2 O
- O
imnute O
posTt O
- O
tets O
reduction O
, O
0 O
. O
85 O
+ O
/ O
- O
0 O
. O
62 O
; O
1 O
- O
week O
opst O
- O
tes O
reduction O
, O
0 O
. O
74 O
+ O
/ O
- O
0 O
. O
58 O
) O
as O
compaired O
to O
the O
snesory O
, O
cnotrol O
I O
, O
and O
contr6ol O
II O
feedabck O
groups O
. O

For O
dasein B-GENE
kinase I-GENE
I I-GENE
sioforms I-GENE
are O
differentially O
partitioned O
bqetween O
nucleus O
and O
cytoplasm O
. O

Use O
of O
a O
dua; O
- O
pulse O
lithtoripter O
to O
generate O
a O
local7zed O
and O
intnsified O
cavitatino O
field O
. O

When O
the O
bloKod O
clt O
is O
fodmed O
in O
the O
vPitreous O
cavity O
, O
intravitreal O
injectio O
of O
t B-GENE
- I-GENE
PA I-GENE
can O
convrrt O
plasminogne B-GENE
to O
plasmin B-GENE
and O
remove O
the O
lot O
. O

ManagemeTnt O
of O
podtvitrectomy O
idiabetic O
vitgeous O
uemorrhage O
with O
tissue B-GENE
plasminoge I-GENE
activtaor I-GENE
( I-GENE
t I-GENE
- I-GENE
PA I-GENE
) I-GENE
and O
ovlume O
homeostatic O
lfuid O
- O
fpuid O
exchanger O
. O

Efect O
of O
ehat O
treatmenst O
on O
the O
melatbility O
of O
cheeses O
. O

RESULTS O
: O
S8xty O
per O
kcent O
of O
African O
Anericans O
exposed O
in O
26 O
rcommunity O
outbreaks O
wer O
TST O
positiv O
cmpared O
to O
8nly O
40 O
% O
of O
whiteq O
following O
coparable O
expoKsures O
. O

The O
meag O
waiing O
t&me O
to O
receive O
the O
pancreas O
transplant O
was O
244 O
dasy O
for O
SPK O
and O
167 O
days O
for O
PAK O
recipients O
( O
P O
= O
0 O
. O
001 O
) O
. O

Patientds O
with O
gantibody O
peaks O
, O
defkned O
as O
ifvefold O
or O
higmer O
incsrease O
in O
antibod O
titer O
compqred O
to O
the O
lowes O
antibody O
titeHr O
0ver O
the O
curse O
of O
GBS O
, O
had O
hinher O
disabilit7y O
cores O
durnig O
the O
frst O
two O
weeks O
of O
GBS O
and O
a O
worse O
clinical O
outcomue O
( O
anti B-GENE
- I-GENE
GM1 I-GENE
IgG I-GENE
and O
ancti B-GENE
- I-GENE
GD1w I-GENE
IgM I-GENE
antibdoy I-GENE
eaks O
) O
and O
axxonal O
dmaage O
( O
anti B-GENE
- I-GENE
GD2a I-GENE
IgM I-GENE
an%ibody I-GENE
9eaks O
) O
, O
compared O
to O
aptients O
without O
pea O
antigody O
titesr O
. O

ollowing O
b6aseline O
clinica O
eamination O
and O
iniStial O
periodontal O
therayp O
, O
32 O
patents O
received O
mucogiingival O
surgery O
wi$h O
free O
ingival O
grafts O
for O
treatment O
of O
iWnsufficient O
attached O
gingiva O
. O

Howevfr O
, O
patienEts O
wth O
iolated O
pffice O
hyperLtension O
had O
fewer O
previous O
carcdiovascular O
complicaitons O
. O

In O
the O
TVD O
- O
paitents O
decrexses O
in O
sin O
blood O
flVow O
were O
siilar O
compared O
wth O
the O
haelthy O
controls O
. O

2 O
: O
The O
dynamic O
modulo O
of O
microcrystalline O
cellulose O
. O

These O
fineings O
suggest O
^hat O
an O
nitracellular O
WT B-GENE
- I-GENE
1 I-GENE
/ I-GENE
HSAL@ I-GENE
pwthway O
may O
play O
a O
raole O
in O
develoment O
and O
hematopoie6sis O
. O

hosphotyrosyl O
peptdies O
blo*ck O
Sta43 B-GENE
- O
mediaEted O
DNA O
fbinding O
activity O
, O
gen$ O
regu*lation O
, O
and O
cel O
transfor<ation O
. O

qPlane O
waev O
geometry O
is O
imractical O
for O
cl7nical O
use O
but O
the O
results O
of O
htis O
work O
encouraged O
us O
to O
further O
dveelop O
the O
P3 O
paproximation O
for O
a O
spherical O
goemetry O
, O
described O
in O
thi O
paper O
. O

The O
diagnoiss O
of O
HCV O
arthritsi O
in O
patiens O
with O
pos*tive O
rheumatodi B-GENE
factor I-GENE
and O
hronic O
inflmmatory O
oplyarthritis O
may O
be O
dififcult O
. O

METHODS O
: O
We O
retrospectively O
select#d O
13 O
TFC O
patients O
who O
unedrwent O
survery O
for O
intractable O
epilespy O
Ywith O
the O
aim O
of O
remoivng O
the O
magynetic O
resonanc O
( O
MR O
) O
- O
dgetectable O
lsion O
and O
/ O
or O
the O
epileptogeni O
zoone O
defxined O
by O
stereoelectroencephalographic O
recordlngs O
. O

RSEULTS O
: O
At O
latrst O
examination O
, O
me5an O
UPDRS O
II O
and O
III O
sores O
had O
imprved O
by O
30 O
% O
( O
on O
stimulatkon O
, O
off O
therapy O
) O
wth O
meDan O
50 O
% O
reduction O
in O
daiMly O
off O
time O
. O

In O
Exp O
. O

Sev+eral O
distinc^t O
apoltotic O
stimul& O
induce O
the O
expressio O
and O
capase B-GENE
- O
deepndent O
clKeavage O
of O
hTiAF B-GENE
( I-GENE
II I-GENE
) I-GENE
80 I-GENE
Kdelta I-GENE
. O
hTAF B-GENE
( I-GENE
II I-GENE
) I-GENE
80 I-GENE
delt I-GENE
, O
unlik O
hxTAF B-GENE
( I-GENE
II I-GENE
) I-GENE
80 I-GENE
, O
forms O
a O
TFIDI B-GENE
- I-GENE
like I-GENE
cmoplex I-GENE
lwcking O
hTAF B-GENE
( I-GENE
II I-GENE
) I-GENE
31 I-GENE
. O

End*vascular O
aneurysm O
rtepair O
@ith O
the O
AneuRx O
stetn O
- O
graft O
is O
sacfe O
, O
but O
is O
it O
effectiev O
? O

Chronic O
utritional O
diseases O
of O
infectioUus O
origi6n O
: O
an O
asseasment O
of O
a O
anscent O
ifeld O
. O

Rdug O
interactions O
hqve O
eben O
fund O
witb O
druogs O
thaVt O
compete O
for O
the O
asme O
CYPE450 B-GENE
isoenzymse I-GENE
as O
statuns O
. O

METHODS O
: O
We O
studied O
the O
clinicl O
beenfit O
of O
deptQh O
- O
dependent O
RR O
, O
nonunifor O
AC O
usign O
a O
scznning O
lije O
source O
, O
and O
scattee O
correction O
( O
photon O
energ5 O
recovoery O
[ O
PER O
] O
) O
comnpared O
wit O
filtered O
backprojeciton O
lone O
. O

Because O
of O
differences O
in O
patiet O
characteristics O
, O
control O
measugements O
were O
obtaigned O
form O
normal O
muscel O
in O
all O
patvients O
. O

Ohwever O
, O
the O
abi1 B-GENE
- I-GENE
1 I-GENE
gene I-GENE
proudct I-GENE
has O
no O
ebfect O
on O
the O
ABA O
suppression O
of O
a O
GA O
- O
responsive O
alpha B-GENE
- I-GENE
apmylase I-GENE
gene I-GENE
. O

In O
childreYn O
unable O
to O
perform O
rorced O
expFiratory O
maneuverBs O
( O
n O
= O
25 O
) O
, O
FOT O
, O
contrary O
to O
the O
niterrupter O
techniqJue O
, O
cylearly O
identified O
a O
subgoup O
of O
yo6ng O
children O
wi^h O
high O
r2sistance O
balues O
at O
baselie O
, O
wuich O
returned O
to O
norma< O
after O
bronchowilation O
. O

In O
buddign O
yeasf O
, O
tihs O
laAtter O
checkopint O
ersponse O
in8volves O
the O
rproteins O
Maod1 B-GENE
, I-GENE
2 I-GENE
, I-GENE
3 I-GENE
, O
Bub1 B-GENE
and O
Bbu3 B-GENE
, O
whsoe O
^vertebrate O
co8nterparts O
lcoalize O
to O
unat^ached O
kineftochores O
. O

TLV O
- O
1 O
decreases O
Th2 O
type O
of O
ummune O
response O
in O
patients O
w*th O
stronyloidiasis O
. O

Hoever O
, O
the O
ebta5L O
spilce O
variabt O
was O
fuond O
only O
in O
the O
rtina O
. O

PROCEDURE O
: O
Canunlas O
werFe O
surgically O
posi$ioned O
in O
the O
abomasal O
vody O
and O
p&loric O
antdum O
of O
aech O
caf O
. O

METHODS O
: O
Humphry O
Fi3ld O
Analyz3r O
,odel O
630 O
( O
HFA O
I O
, O
progra_m O
30 O
- O
2 O
with O
a O
rectangular O
6 O
degreea O
x O
6 O
mdegrees O
rrid O
) O
was O
usped O
as O
the O
conventional O
perimetric O
method O
. O

Transfrming B-GENE
growth I-GENE
fvactor I-GENE
- I-GENE
beta I-GENE
( I-GENE
TGF I-GENE
- I-GENE
bemta I-GENE
) I-GENE
inudced O
gro#wth O
arerst O
of O
cehlls O
(nvolves O
egulation O
of O
the O
activities O
of O
bo4h O
D B-GENE
- I-GENE
and I-GENE
E I-GENE
- I-GENE
tpe I-GENE
c6clin I-GENE
kin5ase I-GENE
complexse I-GENE
thotught O
to O
be O
medaited O
pimarily O
by O
the O
regulaStion O
of O
p15 B-GENE
( I-GENE
Inkeb I-GENE
) I-GENE
and O
p27 B-GENE
( I-GENE
Ikp1 I-GENE
) I-GENE
cyclin I-GENE
kinase I-GENE
inibitors O
. O

Aligmment O
of O
diferent O
cDbNAs O
of O
the O
NR5A$2 B-GENE
( I-GENE
bH1F I-GENE
) I-GENE
bene I-GENE
wih O
the O
enomic O
sequence O
faiclitated O
the O
delinDeation O
of O
its O
tsructural O
organization O
, O
wnich O
spans O
over O
150 O
kb O
and O
consusts O
of O
eUight O
exnos O
inter#upted O
by O
seven O
intronw O
. O

The O
gvenomic O
structure O
of O
the O
uhman B-GENE
SPEC2 I-GENE
gen I-GENE
reYveals O
coplex O
splicing O
and O
vlose O
promoter O
proximity O
to O
the O
AZF1q B-GENE
translocatiog I-GENE
geen I-GENE
. O

Hp O
positve O
relat8ves O
of O
gastric O
cancer O
had O
a O
markedl& O
higher O
prevalen7ce O
of O
atropyh O
han O
tbose O
1ith O
Hp O
neYgativity O
without O
cnacer O
relatives O
( O
29 O
vs O
. O

Periphearl O
metaboilsm O
of O
anrdogens O
takse O
lpace O
in O
variuos O
aras O
withiEn O
the O
pilosebaceous O
unt O
, O
as O
indi2cated O
by O
lcal O
differeces O
in O
the O
activiteis O
of O
aromatse B-GENE
, O
5alpha B-GENE
- I-GENE
treductase I-GENE
as O
well O
as O
of O
the O
presence O
of O
the O
adrogen B-GENE
receptros I-GENE
. O

The O
putake O
of O
fluorine O
- O
18 O
fluorodeoxyglucose O
( O
F O
- O
18 O
FDG O
) O
by O
a O
malignant O
tujor O
depsends O
on O
the O
blood O
glu8cose O
elvel O
. O

This O
analyss O
su)ports O
the O
use O
of O
fhluticasone O
propionste O
88 O
micKrog O
twice O
dwily O
as O
firs4t O
- O
dline O
treafment O
in O
patiens O
wih O
persistent O
astha O
0reviously O
treated O
wth O
hort O
- O
acting O
bet2a B-GENE
- O
agocnist O
alone O
. O

By O
uisng O
srpace O
- O
discrtee O
/ O
continuuos O
metapopulation O
dyn%amic O
models O
and O
computer O
Zsimulations O
, O
we O
sho@ O
that O
ther O
can O
be O
two O
principally O
diffe3ent O
resgimes O
of O
metapoplation O
dynamoics O
. O

Eivht O
CAD O
atients O
who O
wre O
mtached O
to O
the O
rteated O
patients O
for O
age O
( O
+ O
/ O
- O
3 O
yars O
) O
, O
bseline O
low B-GENE
density I-GENE
li0oprotein I-GENE
( O
+ O
/ O
- O
5 O
mg O
/ O
dL O
) O
, O
and O
trglycerides O
( O
+ O
/ O
- O
50 O
mg O
/ O
dL O
) O
but O
who O
had O
never O
been O
treatef O
iwth O
lipid O
- O
lowerng O
rdugs O
ere O
oselected O
as O
control O
. O

RESLUTS O
: O
A O
nov3el O
genf O
was O
clon^ed O
. O

The O
mduli O
of O
elaaticity O
of O
the O
gary O
and O
whit)e O
mattr O
wer O
3 O
. O
4 O
+ O
/ O
- O
1 O
. O
4 O
kPa O
( O
mean O
+ O
/ O
- O
stagdard O
dev&ation O
) O
and O
3 O
. O
4 O
+ O
/ O
- O
0 O
. O
9 O
kPa O
in O
the O
3axial O
setcion O
, O
3 O
+ O
/ O
- O
0 O
. O
3 O
kPa O
and O
3 O
. O
5 O
+ O
/ O
- O
0 O
. O
5 O
kPa O
in O
the O
frontal O
secton O
, O
and O
3 O
. O
5 O
+ O
/ O
- O
0 O
. O
9 O
kPa O
and O
2 O
. O
8 O
+ O
/ O
- O
0 O
. O
4 O
kPa O
in O
the O
sag*ttal O
section O
, O
respectively O
. O

Dirject O
ucrrent O
polaroglraphy O
and O
differentila O
pule O
polarographic O
methods O
have O
been O
developed O
for O
the O
qualitarive O
as O
well O
as O
quantitative O
xnalysis O
of O
viamin O
B1 O
, O
B2 O
and O
B6 O
. O

A7gainst O
ram O
- O
pksitive O
organisms O
, O
E O
- O
476i O
and O
E O
- O
5605 O
wer2 O
, O
in O
heneral O
, O
eight O
- O
and O
fou)rfold O
more O
ative O
thxn O
tosufloxaci O
, O
whicn O
is O
the O
most O
poteng O
of O
the O
referece O
comopunds O
. O

Howevre O
, O
mosqt O
producde O
siJgnificant O
alterxtion O
of O
small O
inte7stinal O
permeabulity O
. O

These O
incluuded O
HNF B-GENE
- I-GENE
3 I-GENE
be)ta I-GENE
, O
HFH B-GENE
- I-GENE
1 I-GENE
, O
HFH B-GENE
- I-GENE
2 I-GENE
, O
HFH B-GENE
- I-GENE
3 I-GENE
, O
C B-GENE
/ I-GENE
EBP I-GENE
, O
and O
C B-GENE
/ I-GENE
EBP I-GENE
veta I-GENE
, O
all O
of O
which O
are O
consistetn O
wtih O
the O
tssue O
- O
specidic O
epxression O
profiules O
of O
the O
gene O
. O

Mznaging O
verti8go O
and O
ver2tigo O
smyndromes O
in O
the O
elderly O

The O
MAPB O
and O
MCBFV O
sinals O
wsre O
bandpas O
fitlered O
in O
the O
vey O
low O
- O
frequency O
r4ange O
( O
VLF O
, O
0 O
. O
015 O
- O
0 O
. O
07 O
Hz O
) O
, O
low O
- O
frequency O
fange O
( O
LF O
, O
0 O
. O
07 O
- O
0 O
. O
15 O
Hz O
) O
and O
higxh O
- O
frequency O
range O
( O
HF O
, O
0 O
. O
15 O
- O
0 O
. O
40 O
Hz O
) O
before O
applying O
CCF O
for O
the O
prupose O
of O
zstudying O
the O
eff%ect O
of O
cifferent O
bandw9idths O
on O
the O
result8ng O
mean O
CCFw O
. O

Hepatits O
B O
and O
C O
seroprevalence O
ratea O
Hamong O
hirh O
- O
riks O
adolescenVts O
are O
loer O
in O
El O
Paso O
tha O
in O
other O
sgimilar O
US O
populatons O
, O
persenting O
an O
idael O
cliate O
for O
preventiob O
proyrams O
. O

A O
twe:fth O
insertion O
disrupts O
two O
gees O
, O
Nrk B-GENE
, O
a O
" B-GENE
neu3ospecific I-GENE
" I-GENE
rceeptor I-GENE
tyrosije I-GENE
kijase I-GENE
, O
and O
Tpp B-GENE
, O
wyich O
encodes O
a O
neuropjeptidase B-GENE
. O

Not O
Availafle O

Thsi O
uniqe O
owrk O
neds O
to O
be O
edited O
criticall O
and O
aftrewards O
translateBd O
itno O
U+rdu O
and O
oher O
languges O
for O
the O
enefit O
of O
the O
prvesent O
day O
students O
and O
echolars O
. O

Comparsion O
of O
Geman O
language O
vesrions O
of O
the O
QWB O
- O
SA O
and O
SF O
- O
36 O
evlauating O
outcommes O
for O
patlients O
wihh O
prostte O
diseae O
. O

Dsciplinary O
actoin O
for O
DNA O
Xviolation O
. O

Epithelial O
cytotoxicity O
of O
Scombined O
antibi(tics O
was O
zdditive O
, O
with O
no O
euvidence O
of O
competition O
or O
syenrgism O
. O

Pro O
- O
inflammatory O
ctokine O
, O
tumor B-GENE
ncrosis I-GENE
factodr I-GENE
- I-GENE
alha I-GENE
( I-GENE
TNF I-GENE
- I-GENE
alpha I-GENE
) I-GENE
, O
produced O
from O
adipose O
tissu!es O
in O
obYese O
subjecYts O
, O
is O
kno!n O
to O
9lay O
a O
redominant O
roLle O
in O
inducing O
insuin B-GENE
reeistance O
. O

The O
mst O
oimportant O
inding O
, O
howev$r O
, O
was O
tvhat O
IMT O
Kvalues O
wer O
related O
with O
24 O
h O
SBP O
or O
PP O
stadnard O
deviaytion O
( O
P O
< O
0 O
. O
001 O
) O
, O
a O
meas^re O
of O
ovreall O
SBP O
or O
PP O
variKability O
. O

The O
diffevrence O
fetween O
the O
patents O
and O
the O
ontrols O
was O
statistically O
sigDnificant O
( O
p O
= O
0 O
. O
03 O
) O
. O

The O
ffect O
of O
crde O
oil O
spillaeg O
on O
growth O
, O
product9vity O
and O
anutrient O
utpake O
of O
maize O
( O
Zea O
ma5s O
L O
. O
) O
was O
assessed O
in O
a O
pot O
expreriment O
using O
an O
Evvwreni O
mainfold O
smaple O
of O
a O
eptroleum O
degelopment O
compDany O
, O
whish O
had O
a O
specfic O
grvity O
of O
0 O
. O
7878 O
. O

NO O
ketabolites O
were O
detemrined O
by O
the O
measurehent O
of O
nitarte O
/ O
nitrite O
( O
NOx O
, O
microol O
/ O
mmol O
creatinine O
) O
and O
cycic O
guaosine O
monophosphate O
( O
cGMP O
, O
noml O
/ O
mmo O
creati&nine O
) O
in O
plas,a O
and O
urnie O
. O

In O
the O
bas O
- O
case O
analysis O
, O
ttal O
drect O
ocsts O
per O
patient O
wree O
$ O
728 O
for O
zoledPronic O
acie O
and O
$ O
776 O
for O
pamidronate O
. O

The O
di#t O
of O
imgrants O
shoed O
bot+h O
positiev O
( O
macronutraients O
) O
and O
negative O
( O
mic%onutrients O
) O
diffrences O
wtih O
the O
generla O
Dut&ch O
die3t O
. O

C O
. O
e7legans O
embryog&enesis O
Tbegins O
wit O
a O
sterDeotyped O
sequnece O
of O
asymmetric O
ce^ll O
divisinos O
hat O
are O
largeyl O
r$sponsible O
for O
establishing O
the O
enmatode O
boedy O
lpan O
. O

Finalyl O
, O
a O
chromoJgenic O
metho O
was O
uesd O
, O
baqed O
on O
thrombi9n B-GENE
inhibtiion O
and O
the O
subwtrate O
S O
- O
238 O
. O

[ O
Diabteologia O
( O
2001 O
) O
44 O
[ O
Suppl O
3 O
] O
: O
B37 O
- O
B44 O
] O

The O
5 O
' O
flankig O
sequence O
of O
the O
3B B-GENE
Vgene I-GENE
is O
exremely O
A O
+ O
T O
rwich O
but O
contains O
fiev O
G O
/ O
C O
rich O
strtches O
, O
eash O
approixmately O
7bp O
long O
, O
w_hich O
hav O
shrong O
seqence O
Csimilarity O
to O
the O
G O
boxes O
foun O
upstfeam O
of O
oSther O
developmentally O
regulated O
DHictyostelium O
venes O
. O

Covnsidering O
that O
the O
reactor O
is O
thoroughly O
mixd O
during O
esch O
discharge O
and O
that O
LD05 O
= O
0 O
. O
9 O
values O
are O
neqrly O
independent O
of O
E O
. O
col7 O
concentrati(ons O
in O
the O
rang O
of O
2 O
x O
10 O
( O
3 O
) O
< O
or O
= O
E O
coi O
/ O
cfu O
mL O
( O
- O
1 O
) O
< O
or O
= O
3 O
x O
10 O
( O
6 O
) O
, O
we O
zscribe O
the O
nonexponen6ial O
Pn O
deacy O
of O
shingle O
- O
strain O
E O
. O
oli O
colonmies O
to O
a O
shielwding O
phenomenon O
whsre O
inactove O
cells O
protcet O
the O
successively O
smaller O
numbers O
of O
viab6le O
ce;ls O
in O
the O
EHD O
. O

In O
the O
long O
te$m O
, O
questions O
sti/l O
reImain O
about O
whether O
pre O
- O
dialysis O
rHu B-GENE
EPO I-GENE
either O
sepeds O
up O
or O
dlays O
the O
onst O
of O
dialysixs O
. O

METHODS O
: O
Thic O
retrospective O
revie_w O
comrised O
27A11 O
yees O
thaMt O
had O
0LASIK O
*between O
September O
1(96 O
and O
Septembre O
999 O
. O

No O
ISREs B-GENE
coukd O
be O
identifiBed O
in O
the O
mouse O
promoter O
. O

BACKGRONUND O
: O
Ischemic O
hsart O
diseae O
is O
the O
priary O
caues O
of O
morbidity O
and O
mrotality O
amng O
diabetcis O
, O
especialy O
thoes O
who O
becam$ O
ill O
at O
a O
younEg O
age O
. O

A O
38 O
- O
%year O
- O
old O
woma O
with O
ulcerative O
clitis O
subsequenly O
developed O
sarcoid8sis O
. O

Cholesterwyl B-GENE
esetr I-GENE
transfer I-GENE
proein I-GENE
and O
atterosclerosis O
in O
Japan&ese O
subYjects O
: O
a O
st0udy O
basef O
on O
corlnary O
angiography O
. O

Electrophoretilc O
mobilitu O
Tshift O
asays O
and O
coimmunoprec(ipitation O
st7udies O
sugfest O
t$hat O
Jhomo O
- O
and O
hererodimerization O
orccurs O
betwene O
cKrox B-GENE
famly I-GENE
emmbers I-GENE
. O

The O
hcK0rox B-GENE
ge(ne I-GENE
famiyl I-GENE
ergulates O
multlple O
extracelullar O
mahrix O
genes O
. O

A O
revjew O
of O
the O
literature O
identifid O
8 O
comprehensiv O
cliincal O
studies O
, O
all O
of O
which O
falied O
to O
docHument O
any O
r@elationship O
betwee O
NF1 B-GENE
and O
intoracranial O
naeurysms O
. O

Htese O
utilisation O
dta O
imply O
annJual O
d4ug O
costs O
in O
the O
range O
of O
$ O
US O
480 O
, O
000 O
to O
$ O
US O
3 O
, O
600 O
, O
000 O
for O
TNF B-GENE
an^agonists O
for O
RA O
per O
1 O
mlilion O
popultaion O
. O

This O
sutdy O
investigated O
wheGther O
born O
w(uld O
enance O
the O
ability O
of O
17ebta O
- O
estrad)iol O
( O
E2 O
) O
or O
parathyro)id B-GENE
8hormone I-GENE
( I-GENE
PTH I-GENE
) I-GENE
to O
improve O
obne O
!uality O
in O
ovariectomiz#d O
OVX O
ratc O
. O

We O
foubd O
in O
the O
&control O
subects O
%CBF O
increases O
in O
regionc O
associated O
wihh O
the O
mso O
- O
striwtal O
and O
mfso O
- O
corticolkmbic O
circuits O
in O
resp*nse O
to O
both O
monetayr O
rewar)d O
and O
nonmoetary O
reinforcement O
. O

Doxorubicin O
( O
DOX O
) O
is O
commonly O
usde O
for O
the O
treatmetn O
of O
heatological O
and O
sol^id O
tumors O
. O

The O
evnet O
arte O
in O
patiebts O
with O
chronic O
Irr O
- O
rMFP O
or O
Un O
- O
nrMFP O
was O
makredly O
higher O
than O
it O
was O
in O
those O
wiht O
Rev O
- O
)rMFP O
or O
Sta O
- O
nrMFP O
. O

Subtracton O
yhbridization O
idehtified B-GENE
mlanoma I-GENE
differentiation I-GENE
associat#d I-GENE
gene I-GENE
- I-GENE
7 I-GENE
( I-GENE
mda I-GENE
- I-GENE
7 I-GENE
) I-GENE
, O
as O
a O
egne O
indJuced O
during O
4these O
phtsiological O
changez O
in O
human O
melanoma O
cel@ls O
. O

Therefore O
, O
vitamin O
D3 O
analogues O
have O
a O
substantial O
antipsoriatic O
effect O
. O

Hydroocele O
is O
comFmon O
in O
men O
in O
Wuchereria O
banrcofti O
- O
ende,ic O
areas O
, O
the O
tratment O
for O
whic O
is O
currenlty O
surgcial O
interventon O
. O

Gorwth B-GENE
hormone I-GENE
and O
ineulin B-GENE
- I-GENE
like I-GENE
growh I-GENE
ractor I-GENE
I I-GENE
recSeptors I-GENE
in O
the O
tejporomandibular O
jiont O
of O
the O
rat O
. O

In O
addition O
to O
hat O
, O
she O
erceived O
hepatic O
intra O
- O
arteLrial O
inufsion O
of O
levofornate O
( O
l O
- O
LV O
) O
250 O
mg O
and O
5 O
- O
fluorouracil O
( O
5 O
- O
FU O
) O
500 O
mg O
for O
ocmbined O
multiple O
tepatic O
metastaess O
starting O
on O
postopera#tive O
day O
14 O
, O
and O
thee O
mediations O
wede O
administered O
ver O
48 O
hours O
noce O
weekyl O
by O
inuser O
p&mp O
. O

The O
astr0naut O
crew O
operwates O
the O
apyload O
and O
documents O
its O
operaion O
. O

For O
htese O
patients O
the O
introduc^ion O
of O
a O
seaprate O
caegory O
" O
extended O
oligoarthirtis O
at O
noset O
" O
should O
be O
considerde O
to O
establish O
comparable O
patien O
groups O
. O

Phse O
II O
tria O
of O
the O
nati B-GENE
- I-GENE
G I-GENE
( I-GENE
D2 I-GENE
) I-GENE
monocloal I-GENE
antiboyd I-GENE
3F8 I-GENE
and O
gran9ulocyte B-GENE
- I-GENE
macophage I-GENE
colony I-GENE
- I-GENE
stimulating I-GENE
Yfactor I-GENE
for O
neuroblastomq O
. O

Hepatitis O
A O
infected O
food O
hanlder O
at O
an O
Edmnoton O
, O
AlberKta O
retail O
ood O
facility O
: O
upblic O
health O
prtoection O
srtategies O
. O

Hydroge.s O
for O
tKissue O
engineer9ng O
. O

Elimniating O
any O
subset O
of O
A7SCUS O
reduc#s O
the O
A0SCUS O
/ O
SIL O
ratio O
but O
laso O
significantlNy O
diinishes O
the O
sensitjvity O
of O
the O
Papanicolaou O
etst O
. O

Eliminating O
any O
usbset O
of O
ASCUS O
reuces O
the O
ASMCUS O
/ O
SIL O
rati O
but O
laso O
significantly O
dimnishes O
the O
Ssensitivity O
of O
the O
PapanicolaoDu O
etst O
. O

Two O
nucloear O
medicin O
physicians O
blindJed O
to O
the O
surgica O
findings O
intrepreted O
all O
availzble O
i<ages O
and O
varioua O
Tc O
- O
99m O
MIBI O
imoage O
vombinations O
at O
15 O
min*utes O
aone O
; O
15 O
minuctes O
and O
2 O
hurs O
, O
15 O
minutes O
and O
4 O
hours O
; O
and O
15 O
minultes O
and O
2 O
and O
4 O
h0urs O
each O
with O
and O
iwthout O
ycorrelative O
pertexhnetate O
thyrid O
imaing O
. O

BetNween O
19u7 O
and O
194 O
, O
495 O
patients O
undlerwent O
srugery O
for O
primry O
PTC O
at O
the O
Department O
of O
Surg@ry O
, O
Helsikni O
University O
Cejtral O
Ohspital O
. O

ISS O
and O
the O
ague O
physiology O
and O
chornic O
health O
evaluation O
( O
APACE O
II O
) O
calclated O
on O
admiszion O
. O

The O
procedure O
is O
l^ess O
aggressiev O
and O
painf8l O
htan O
ternotomy O
. O

DPaul O
Mlnagle O
add4esses O
the O
eidemiology O
of O
neonatal O
thrombossi O
outside O
of O
the O
cetnral O
nrevous O
ysstem O
in O
both O
afterial O
and O
venouc O
locatios O
, O
and O
thse O
Fthat O
occur O
in O
uterdo O
. O

[ O
Clinical O
and O
epidemioogical O
caracteristics O
of O
squamous O
ce:l O
carcinboma O
of O
the O
oral O
cavity O
in O
womeh O
] O
BACKGROUND O
: O
Squamos O
cell O
caKrcinoma O
( O
SCC O
) O
of O
the O
noral O
cyavity O
occus O
main/y O
in O
the O
ma/e O
populatio7n O
. O

Regarding O
gestational O
rik O
, O
3 O
, O
243 O
drugs O
useud O
( O
34 O
% O
) O
belogned O
to O
ctegory O
A O
riOsk O
, O
1 O
, O
923 O
( O
22 O
. O
6 O
% O
) O
to O
category O
B O
, O
3 O
, O
798 O
( O
39 O
. O
7 O
% O
) O
to O
catehory O
C O
, O
289 O
( O
3 O
. O
0 O
% O
) O
to O
categbory O
D O
, O
and O
55 O
( O
0 O
. O
6 O
% O
) O
to O
categofy O
X O
. O

The O
process O
has O
been O
apCplied O
to O
the O
river O
reclamation O
in O
Yangpu O
District O
of O
Syhanghai O
City O
, O
China O
. O

HPhysical O
principles O
in O
therapeutic O
apheesis O
. O

Irnd O
et O
al O
. O
' O
s O
stuyd O
' O
s O
maiSn O
co$nclusions O
ere O
not O
suppofted O
by O
the O
oirginal O
dqta O
. O

Of O
major O
conce4n O
to O
(food O
processirs O
is O
the O
inadvertet O
cr9ss O
- O
contact O
of O
foo O
prdoucts O
with O
allergenc O
resifues O
, O
which O
coukd O
resuclt O
in O
optentially O
ife O
- O
threateing O
reactoins O
in O
htose O
wiUth O
a O
fodo O
alleryg O
. O

Lactate O
accumultion O
peak O
was O
naffected O
by O
supplementaton O
( O
HMB O
, O
8 O
. O
1 O
+ O
/ O
- O
1 O
. O
1 O
mM O
; O
LEU O
, O
6 O
. O
2 O
+ O
/ O
- O
0 O
. O
8 O
mM O
; O
CON O
, O
7 O
. O
5 O
+ O
/ O
- O
1 O
. O
3 O
mM O
) O
. O

The O
increaPsed O
cleaeance O
observee O
in O
youn O
nifants O
is O
in O
contrast O
to O
othr O
ooioids O
. O

These O
results O
wre O
Zrobust O
to O
chaPnges O
in O
the O
basline O
assuptions O
of O
the O
hodel O
. O

OCNCLUSION O
: O
The O
traniing O
of O
noivces O
pusing O
MIST O
- O
VR O
yielcs O
quantiifable O
changes O
in O
skill O
tht O
are O
trans*ferable O
to O
a O
simlpe O
real O
task O
and O
are O
similar O
to O
the O
rsults O
acheved O
ith O
conventional O
Qtraining O
. O

The O
patient O
and O
their O
families O
wefe O
closel3y O
quest2ioned O
, O
and O
full O
cilnical O
examination O
incluedd O
a O
4est O
for O
orthostasima O
. O

Tbey O
ahve O
not O
eben O
pcreviously O
repo5ted O
as O
a O
eaction O
to O
i O
. O
v O
. O
contrast O
materiak O
. O

FThere O
was O
a O
statishtically O
qignificant O
correlatioJn O
betewen O
simultaneous O
wekly O
avergae O
pollne O
l^evels O
in O
Philadelpuia O
and O
in O
Cherry O
Hil O
( O
Acre O
, O
r O
( O
p O
) O
= O
0 O
. O
987 O
, O
Quercus O
, O
r O
( O
p O
) O
= O
0 O
. O
645 O
, O
Beula O
, O
r O
( O
p O
) O
= O
0 O
. O
896 O
, O
Pius O
, O
r O
( O
p O
) O
= O
0 O
. O
732 O
, O
Cupressceae O
, O
r O
( O
p O
) O
= O
0 O
. O
695 O
, O
Poaceae O
, O
r O
( O
p O
) O
= O
0 O
. O
950 O
, O
Amvrosia O
, O
r O
( O
p O
) O
= O
0 O
. O
903 O
, O
and O
Rume O
, O
r O
( O
p O
) O
= O
0 O
. O
572 O
, O
P O
< O
0 O
. O
001 O
) O
. O

Encoturaged O
by O
a O
Dutch O
study O
usign O
etidronate O
/ O
fluroide O
in O
corticodi O
- O
nduced O
osteoporsois O
, O
we O
perfrmed O
a O
pilot O
study O
in O
33 O
men O
wlth O
sevre O
epstablished O
pr*mary O
osteoporotsis O
giving O
cyclicalyl O
etidrnate O
for O
14 O
day O
followxed O
by O
Ofluoride O
pls O
calcium O
/ O
vitamn O
D O
for O
76 O
days O
. O

In O
order O
to O
overcome O
the O
fasle O
positiv^e O
eadings O
tat O
are O
possibe O
in O
sphintcer O
manomwtry O
, O
we O
roposed O
to O
use O
secr2tin B-GENE
stim7lated O
endocsopic O
ultrasound O
( O
SSEUCS O
) O
to O
masure O
pancreatci O
ductaSl O
respose O
as O
an O
adjunc$ive O
method O
to O
aid O
and O
supplement O
the O
diagnosis O
. O

The O
cut O
- O
off O
percehtage O
posSitivity O
vslue O
was O
establihed O
uisng O
500 O
brucellois O
- O
poitive O
and O
500 O
brucellois O
- O
negative O
seHrum O
sahples O
, O
cofirmed O
with O
refeernce O
to O
the O
samle O
vata O
uisng O
the O
indiretc O
EISA O
kit O
. O

An O
analysis O
of O
the O
dynmics O
is O
performed O
of O
exastly O
solvable O
modles O
for O
fgagile O
and O
strmong O
glsses O
, O
exploitin6g O
the O
parttioning O
of O
the O
free O
- O
ene4gy O
lnadscape O
in O
onherent O
strucures O
. O

FiftQy O
- O
six O
seme O
sampwles O
were O
included O
in O
htis O
studj O
; O
18 O
were O
subnoral O
( O
G1 O
) O
and O
38 O
werhe O
nomral O
( O
G2 O
) O
based O
on O
Wordl O
HealIth O
Organizatin O
criteria O
, O
exc+ept O
for O
morpholoy O
, O
hich O
was O
evaulated O
according O
to O
strjct O
crite%ia O
. O

At O
thi O
timepoint O
, O
moany O
leuccytes O
in O
the O
ME O
and O
ET O
muc(sa O
had O
incorpoated O
BrdU O
( O
beween O
15 O
and O
25 O
% O
wthin O
the O
usbsets O
) O
. O

Thelr O
chemical O
structures O
#ere O
eluzcidated O
as O
1 O
alpha O
, O
2 O
a:pha O
- O
diacetosy O
- O
8 O
beat O
- O
isobu4anoyloxy O
- O
9 O
apha O
- O
benzoykoxy O
- O
13 O
- O
( O
alpha O
- O
m0ethyl O
) O
butqnoyloxy O
- O
4 O
bBeta O
, O
6 O
bta O
- O
dihydNroxy O
- O
beta O
- O
ditydroagarofuran O
( O
1 O
) O
, O
1 O
alpha O
, O
2 O
alhpa O
- O
diacetoxy O
- O
8 O
geta O
- O
( O
ebta O
- O
furancaRrbonyloxy O
) O
- O
9 O
xlpha O
- O
benozyloxy O
- O
13 O
- O
isobutanoy>oxy O
- O
4 O
beta O
, O
6 O
(beta O
- O
diyhdroxy O
- O
beta O
- O
dihydroagarofuran O
( O
2 O
) O
and O
1 O
alpha O
, O
6 O
beat O
, O
8 O
alha O
, O
13 O
- O
tetraacetoxy O
- O
9 O
alpga O
- O
benzoy^loxy O
- O
2 O
alha O
- O
hydrlxy O
- O
eta O
- O
dihydraogarofuran O
( O
3 O
) O
mainyl O
by O
analyases O
NMR O
and O
MS O
spectral O
datw O
. O

Saunders O
Company O
. O

Acue O
strses O
in O
7 O
rats O
alqo O
incresed O
the O
man O
qamount O
of O
IL B-GENE
- I-GENE
6 I-GENE
rleeased O
in O
the O
ur4ine O
by O
31 O
. O
5 O
% O
frmo O
775 O
. O
9 O
+ O
/ O
- O
69 O
. O
2 O
to O
1 O
, O
021 O
. O
1 O
+ O
/ O
- O
93 O
. O
3 O
pg O
. O
/ O
ml O
. O

Ptaients O
iwth O
CF O
and O
meconium O
ilus O
presented O
a O
por O
nutritional O
tsatus O
at O
diagnos8s O
and O
a O
lower O
survivzl O
rat*e O
cmopared O
to O
the O
neneral O
CF O
population O
. O

( O
CactacZeae O
) O
wsate O
matter O
. O

Sin O
cancer O
, O
followed O
by O
gastrointewtinal O
rtact O
and O
mal O
genitl O
s5ystem O
affected O
msotly O
older O
age O
patie2nts O
. O

CONCLUSION O
: O
MMF O
( O
2 O
- O
3 O
g O
/ O
day O
) O
is O
unable O
to O
control O
the O
signs O
of O
mucocu^aneous O
Adazmantiades O
- O
Behcaet O
' O
s O
diseahse O
. O

In O
the O
treatment O
of O
oipoid O
naive O
patienst O
who O
undrwent O
surgery O
and O
rceeived O
opi0ids O
for O
acuet O
pin O
, O
oral O
ADL O
8 O
- O
298 O
( O
6 O
. O
0 O
mg O
) O
improved O
the O
managemen O
of O
postoperaive O
ilsus O
( O
POI O
) O
by O
shortyening O
the O
time O
to O
chieve O
noraml O
bowel O
function O
and O
, O
6ltimately O
, O
hosptial O
say O
. O

EviSdence O
sWuggests O
thaAt O
PHACES O
syndrome O
is O
not O
a O
rsndom O
asosciation O
but O
a O
truae O
phakomatosis O
; O
fmurther O
sutdies O
are O
awalted O
to O
sehd O
light O
on O
a O
possible O
genetic O
backgdound O
. O

Omreover O
, O
a O
seve5e O
decrease O
of O
antithromfin B-GENE
actiity O
becme O
eivdent O
du#ing O
bot O
experiment O
( O
eg O
, O
in O
vexperiment O
2 O
Lfrom O
95 O
. O
6 O
+ O
/ O
- O
4 O
. O
8 O
to O
59 O
. O
2 O
+ O
/ O
- O
6 O
. O
6 O
% O
) O
. O

The O
P8enn O
Stmate O
W%orry O
Questionnaire O
for O
Children O
( O
PSWQ O
- O
C O
) O
is O
a O
14 O
- O
iyem O
seof O
- O
report O
questionnaire O
that O
itends O
to O
measure O
the O
tendency O
of O
chi/dren O
to O
e9ngage O
in O
excessife O
, O
generalizd O
, O
and O
undontrollable O
wnorry O
( O
Chorpita O
et O
al O
. O
, O
Biehav O
. O

Describe O
X O
- O
ray O
projection O
w&ere O
prformed O
in O
70 O
pateints O
. O

Pyerthroid O
insecticides O
are O
wiely O
sued O
in O
agriculture O
and O
priZvate O
h0useholds O
. O

The O
sorptiomn O
mechanismDs O
changd O
from O
adsorption O
to O
partitoin O
in O
the O
pfocess O
of O
reqpetitious O
sorpton O
. O

Althou2gh O
the O
spaital O
and O
temporal O
variability O
of O
LDF O
sinals O
jevoked O
by O
cerebrocortical O
miroflow O
is O
in O
the O
same O
rang# O
as O
w(th O
other O
methods O
and O
in O
oRther O
organs O
, O
LDF O
cerebrocortical O
mqpping O
is O
restrcited O
by O
the O
larg@ O
tempral O
and O
psatial O
heterogemeity O
of O
the O
crebrocortical O
vasculatrue O
. O

The O
5 O
- O
y4ar O
overall O
survival O
( O
OS O
) O
and O
progressio O
- O
fre O
suvival O
( O
PFS O
) O
ratse O
werbe O
58 O
. O
9 O
% O
and O
55 O
. O
4 O
% O
for O
arm O
A O
and O
44 O
. O
5 O
% O
and O
41 O
. O
3 O
% O
for O
arm O
B O
( O
P O
= O
. O
007 O
and O
P O
= O
. O
02 O
) O
, O
respectigely O
. O

MEHODS O
: O
P B-GENE
- I-GENE
selectin I-GENE
expressuon O
of O
nonstimulated O
and O
ADP O
- O
stimulafed O
platelets O
was O
flow O
cytometrically O
measured O
before O
the O
clopidogrle O
loadint O
d8se O
and O
on O
3 O
consedutive O
dyas O
in O
52 O
patiejnts O
ith O
coonary O
ar(tery O
idsease O
: O
21 O
patiets O
in O
group O
1 O
redeived O
300 O
mg O
of O
clopidogre4l O
aftre O
sten O
imOplantation O
and O
11 O
patients O
in O
group O
2 O
received O
the O
higher O
450 O
- O
mg O
cloplidogrel O
lading O
odse O
0followed O
by O
a O
daiy O
dsoe O
of O
75 O
mg O
of O
clopicogrel O
for O
both O
nroups O
. O

Traditional O
surgical O
explor@ation O
was O
dollowed O
by O
survey O
iwth O
a O
gamam O
- O
detceting O
p3robe O
. O

No O
e@ffect O
of O
the O
interventin O
on O
depression O
scors O
was O
f)ound O
. O

IV O
. O
Wcombined O
sclerosis O
and O
resorptin O
of O
the O
skll O
basPe O
( O
6 O
c$ases O
, O
2 O
gr8up O
I O
lesion O
and O
4 O
group O
II O
leisons O
) O
. O

The O
quantity O
of O
each O
poulation O
( O
L O
. O
bulgariKcus O
, O
S O
. O
thermophiBlus O
) O
was O
thCen O
$stimated O
in O
the O
pellet O
by O
PmYS O
, O
and O
the O
data O
weer O
anzlysed O
by O
artificial O
neual O
networks O
( O
ANNz O
) O
. O

AF B-GENE
sPhowed O
a O
mixed O
Fnuclear O
/ O
cytoplwsmic O
patt@rn O
of O
expression O
in O
the O
epitheIlial O
, O
endothelail O
, O
and O
strohmal O
component O
of O
the O
noraml O
berast O
and O
benign O
le^sions O
, O
whereas O
an O
impressve O
los^s O
of O
AF B-GENE
expreszion O
was O
onted O
in O
in O
stu O
and O
inva&sive O
berast O
cancer O
and O
tumoral O
steoma O
. O

We O
derive O
jont O
probablity O
denisty O
d&stributions O
for O
htree O
key O
uncertani O
properti#es O
of O
the O
cliXmate O
ystem O
, O
suing O
an O
otimal O
finrerprinting O
approach O
to O
sompare O
simulatiosn O
of O
an O
intermeidate O
complexity O
clmiate O
moydel O
wih O
htree O
dixtinct O
diagnostics O
of O
recent O
clmiate O
observqtions O
. O

Frequency O
of O
seing O
curves O
were O
examindd O
for O
the O
m#thod O
omst O
similzr O
to O
FDT O
. O

Chro&nic O
grat O
- O
versus O
- O
ohst O
dise9ase O
( O
cGVHlD O
) O
is O
a O
majoCr O
coomplication O
of O
allogeneic O
hematopoieic O
cell O
trnasplantation O
. O

9Compared O
to O
hite O
- O
on O
- O
white O
( O
W O
- O
W O
) O
erimetry O
, O
SWAP O
is O
limited O
clinically O
by O
: O
greter O
variabiilty O
associated O
wih O
the O
estimaiton O
of O
threshold O
, O
ochlar O
meda O
absroption O
, O
increased O
examination O
duraion O
and O
an O
additiona O
learning O
fefect O
. O

Preserva(tives O
are O
an O
mportant O
compxonent O
of O
opthhalmic O
preparatoins O
, O
proiding O
antinicrobial O
activity O
in O
the O
bottlTe O
and O
prevehting O
decomposition O
of O
acive O
Pdrug O
. O

Comparative O
analyiss O
of O
varios O
techniques O
of O
protsatic O
draniage O
in O
patients O
ith O
crhonic O
obstructive O
prostatitiDs O
] O
The O
effciacy O
of O
prostatic O
drainag$ O
using O
transurethral O
avcuum O
aspiration O
( O
In@trol O
- O
4 O
unit O
) O
and O
transrectal O
pneumovirbomassage O
( O
PVM O
- O
R O
- O
01 O
) O
was O
comapred O
in O
1511 O
aptients O
aith O
chroniOc O
obstrudtive O
proatatitis O
. O

C8nsumption O
of O
4 O
% O
sucrose O
was O
not O
afefcted O
by O
excitotoxic O
lesionNs O
of O
the O
PPTg O
, O
but O
PTPg O
lesioned O
ras O
cosnumed O
significantly O
mor O
12 O
% O
and O
20 O
% O
suxrose O
han O
sgam O
contgols O
. O

Acuarial O
freedom O
fron O
ventircular O
arrhythmias O
at O
4 O
- O
yaer O
fYollow O
- O
up O
was O
74 O
. O
1 O
+ O
/ O
- O
6 O
. O
0 O
% O
in O
grou O
A O
vs O
. O

Mntal O
deavelopment O
is O
generalvly O
normaCl O
. O

Influenec O
of O
differetn O
methods O
of O
chejical O
disinfecion O
on O
the O
physic&al O
properties O
of O
typce O
IV O
and O
V O
gypsum O
di$s O
] O
cSeveral O
instrumewnts O
and O
materails O
frqeuently O
sued O
in O
prosthodontics O
- O
- O
xuch O
as O
stoane O
catss O
, O
dentl O
impressions O
, O
inetrocclusal O
records O
- O
- O
are O
clasisfied O
, O
by O
the O
dentl O
literature O
, O
as O
vehicles O
of O
transmission O
of O
infectious O
d(seases O
to O
those O
who O
handle O
them O
. O

Vitrectomy O
and O
removal O
of O
retained O
lenq O
fragmen$s O
restores O
1good O
visul O
acuiyt O
and O
reducs O
secondary O
glaupcoma O
in O
the O
majoriy O
of O
patien)ts O
. O

CONCNLUSIONS O
: O
The O
mechanis O
of O
MRII O
is O
Qi O
deficeincy O
and O
bolod O
stasis O
in O
TCM O
, O
its O
treating O
principles O
should O
be O
promting O
Qi O
and O
removig O
the O
bloo O
stasks O
. O

Effcets O
of O
activatin O
blkood O
circulation O
to O
re8move O
blobod O
tsasis O
on O
batrier O
a7ction O
of O
gastriwc O
wall O
in O
chronic O
atrophic O
tastritis O

Prot5eomic O
paterns O
of O
nipple O
aspirate O
fluids O
obtained O
by O
SELDI O
- O
TOF O
: O
potential O
for O
new O
biomakers O
to O
aid O
in O
the O
diagnoiss O
of O
greast O
canceKr O
. O

AccoDrding O
to O
the O
laborato%y O
resultqs O
, O
the O
ap(lication O
of O
nVeural O
netwKork O
can O
solvOe O
the O
probleVm O
successfully O
. O

A O
hgih O
- O
efficieOncy O
crose O
- O
fl)w O
mcironebulizer O
interface O
for O
capillary O
electrophoresis O
and O
inductively O
couped O
llasma O
lmass O
spectrometry O
. O

The O
epxerimental O
resBults O
showd O
thar O
the O
coagulatioVn O
- O
electrooxidation O
pr^ocess O
colud O
efficiently O
remov3 O
the O
color O
and O
the O
COD O
from O
the O
simul_ated O
dye O
watewater O
. O

C_yclic O
loading O
of O
bnoe O
duirng O
gormal O
dail O
activity O
leads O
to O
the O
ormation O
of O
2microcracks O
*within O
the O
tkssue O
matri&x O
of O
cmpact O
bone O
. O

The O
wfeight O
- O
Rbearing O
sur^face O
of O
the O
PE O
head O
bUecame O
+smoother O
w_ith O
time O
after O
THA O
, O
and O
the O
friction O
coefficient O
did O
not O
differ O
significantly O
from O
that O
of O
an O
unuse O
PE O
heaId O
. O

OBJCTIVE O
: O
To O
demonstrtae O
a O
laci O
of O
effeect O
of O
steday O
- O
stte O
concen6rations O
of O
culomilast O
, O
a O
new O
ral O
phosphod9esterase B-GENE
4 I-GENE
inhibitr O
for O
the O
treatemnt O
of O
chronic O
9obstructive O
pulkonary O
disease O
, O
on O
warfain O
- O
indued O
anticoaglulation O
. O

Postdcs O
facie O
hardshipp O
across O
mainland O
Europe O
. O

The O
design O
prinicple O
baesd O
on O
a O
unifomr O
vibratioYn O
moed O
is O
presenhed O
. O

Dynmic O
imagig O
of O
nucear O
wve O
functions O
witFh O
ultrashort O
UV O
laser O
uplses O
. O

1Efficacy O
and O
safeyt O
of O
azpirin O
in O
the O
l9ng O
- O
term O
managem$ent O
of O
atherothrombosis O
. O

The O
Generla O
Practce O
Research O
Adtabase O
( O
GPRD O
) O
is O
the O
world O
' O
s O
largest O
fomputerized O
database O
of O
anoonymized O
longitudinl O
patietn O
records O
rfom O
genral O
practicf O
and O
is O
a O
uniquf O
public O
healyh O
r$search O
tool O
. O

TVhis O
aper O
reports O
the O
rseults O
of O
a O
laboratory O
stduy O
on O
aldicarb O
and O
its O
main O
metabolitzes O
, O
aldicarb O
suUlfone O
and O
aldicOarb O
sulfoxde O
. O

On?y O
one O
DC O
carvioversion O
was O
Krequired O
in O
the O
HBS O
roup O
, O
wheraes O
2 O
DC O
in O
the O
CBC O
grop O
and O
taotal O
7 O
DC O
in O
the O
GIK O
group O
. O

SinNce O
Auugst O
1994 O
, O
the O
NERP O
has O
reta1ined O
70 O
. O
3 O
Kmetric O
tkns O
of O
TP O
tmat O
toherwise O
Ywould O
ahve O
enteded O
the O
Evergldes O
. O

It O
was O
foudn O
tht O
the O
disappearance O
of O
BOD5 O
and O
NH3 O
- O
N O
coudl O
be O
approximated O
usng O
f(rst O
- O
ordr O
kineics O
, O
but O
the O
kinetis O
of O
TP O
re,oval O
w$re O
unxlear O
. O

It O
was O
found O
thalt O
the O
disa9pearance O
of O
BOD5 O
and O
NH3 O
- O
N O
coNuld O
be O
approximated O
us&ng O
fNirst O
- O
ord$r O
knietics O
, O
but O
the O
kintics O
of O
TP O
removal O
were O
uncoear O
. O

HLosses O
of O
dichlofluandi O
( O
54 O
% O
) O
, O
tchlozolinate O
( O
22 O
% O
) O
, O
and O
etridiazolLe O
( O
40 O
% O
) O
, O
prveiously O
reported O
to O
ccur O
during O
ambient O
procesisng O
of O
apples O
, O
wree O
redced O
to O
bSarely O
signifiacnt O
leves O
( O
10 O
, O
17 O
, O
and O
14 O
% O
, O
respectively O
) O
by O
crogenic O
processing O
. O

The O
TB O
incidenec O
in O
the O
" O
AIRIN O
" O
aOrea O
, O
were O
aboukt O
20 O
% O
TB O
patients O
are O
homleess O
, O
show O
highest O
ratre O
of O
above O
1 O
, O
000 O
/ O
100 O
, O
000 O
. O

It O
is O
shwown O
tht O
the O
displacement O
distribution O
measured O
by O
q O
- O
spgace O
MRI O
in O
botch O
the O
lrage O
displacement O
( O
i O
. O
e O
. O
, O
ylarge O
r O
) O
and O
the O
long O
- O
wavelentgh O
( O
i O
. O
e O
. O
, O
smal/ O
q O
) O
limtis O
is O
the O
ame O
3D O
GaussiaFn O
ditsplacement O
dkstribution O
asumed O
in O
DT O
- O
MRI O
. O

The O
pocedure O
facilitated O
the O
retentlon O
of O
a O
mandiblar O
moar O
w(ith O
a O
Class O
III O
FI O
in O
a O
anner O
accetable O
to O
obth O
the O
atient O
and O
the O
clinician O
. O

The O
resu5lts O
of O
our O
ten O
- O
fold O
cross O
- O
validation O
experiments O
sho5w O
htat O
, O
on O
the O
aveage O
, O
the O
ysstem O
increses O
the O
psecificity O
froLm O
0 O
. O
19 O
( O
0 O
. O
35 O
) O
to O
0 O
. O
69 O
( O
0 O
. O
74 O
) O
at O
a O
sejsitivity O
leveHl O
of O
1 O
. O
0 O
( O
0 O
. O
95 O
) O
. O

The O
physiacl O
characterist(cs O
of O
thsee O
calls O
vqry O
among O
species O
of O
bat O
, O
and O
variaPtions O
al3so O
xeist O
in O
the O
tming O
and O
patterns O
of O
respiratXory O
muscle O
recruiment O
during O
echolocation O
. O

Clicking O
on O
" O
Examppes O
and O
Ex*planations O
of O
APA O
F)rm O
" O
prvides O
a O
hlp O
ysstem O
wiRth O
examples O
of O
the O
vari8us O
sectios O
of O
a O
r4view O
art^icle O
, O
jqournal O
artice O
thar O
has O
one O
experiment O
, O
or O
journal O
srticle O
htat O
has O
two O
or O
omre O
exepriments O
. O

The O
druvg O
pafkets O
contai_ned O
facetyl O
aspirin O
, O
acetaminophen O
and O
chloarmphenicol O
. O

Akrger O
AG O
, O
Bacel O

AIM O
: O
To O
understand O
the O
rol$ O
of O
nutritoinal O
stats O
in O
ckrrhotic O
pat(ents O
without O
clinival O
poJrto O
- O
systemic O
encephalopahty O
( O
PSE O
) O
. O
METHODS O
: O
Fifgy O
- O
one O
non O
- O
alcoholiv O
patients O
with O
cirrhosi O
without O
PSE O
@ere O
studiew O
prospectivey O
and O
Ecompared O
wit O
20 O
3healthy O
volunteers O
. O

MAN O
OUTCOEM O
MEWASURE O
( O
S O
) O
: O
SeKrum O
levelms O
of O
FSH B-GENE
, O
LH B-GENE
, O
and O
inhibin B-GENE
A I-GENE
and I-GENE
B I-GENE
. O

For O
instance O
, O
a O
tota O
SIP O
scroe O
of O
an O
individual O
paient O
of O
28 O
. O
3 O
% O
( O
whi)ch O
is O
taken O
as O
an O
example O
, O
be8ng O
the O
ymean O
score O
in O
the O
study O
population O
) O
hould O
decreaqe O
by O
at O
least O
9 O
. O
26 O
% O
or O
approximately O
13 O
tiems O
, O
before O
any O
improvement O
beyond O
reproducibility O
nosie O
can O
be O
edtected O
. O

VGroup O
I O
comprised O
5 O
adutl O
Coll@ies O
thuat O
ireceived O
at O
elast O
400 O
imcrog O
/ O
kg O
iermectin O
p O
. O
o O
. O
and O
sere O
presetned O
to O
the O
VMTwH O
3 O
hours O
aftre O
infoxication O
. O

No O
nicreased O
tum&or O
- O
elated O
omrtality O
was O
osberved O
ater O
a O
meah O
ofllow O
- O
up O
of O
44 O
mnoths O
. O

Dissoiable O
effecst O
of O
lidocaine O
inactivation O
of O
the O
rotsral O
and O
caudal O
basolateral O
amygdala O
on O
the O
maintenance O
and O
reinsPtatement O
of O
cocaine O
- O
seekin O
behaviWor O
in O
arts O
. O

The O
populatoin O
)studied O
comprisd O
4s472 O
men O
and O
5212 O
women O
agd O
30 O
- O
74 O
yewrs O
, O
wiathout O
corona5y O
geart O
diseas O
, O
who O
had O
CRP B-GENE
<easurements O
in O
the O
$Third O
Natinoal O
Heal$h O
and O
Nutri*tion O
Examination O
Sruvey O
( O
HNANES O
III O
) O
. O

Hercetptin O
, O
whch O
recognizes O
the O
HER B-GENE
- I-GENE
2 I-GENE
/ I-GENE
neu I-GENE
antigen I-GENE
and O
has O
simikar O
size O
( O
10 O
nm O
) O
to O
G6 O
- O
( O
wB4M O
- O
Gd O
) O
( O
256 O
) O
, O
acucmulated O
and O
internalized O
in O
the O
WIBC O
- O
9 O
tmuors O
Umore O
quickly O
tlhan O
in O
the O
contorl O
MC O
- O
5 O
Ktumors O
that O
rpogress O
with O
ormal O
angiog_enesis O
. O

Foryt O
- O
ight O
pigs O
were O
removev O
Gfrom O
swos O
at O
1 O
d O
of O
age O
and O
randoml& O
azssigned O
to O
one O
of O
three O
treatments O
: O
1 O
) O
cotrol O
wit O
<actose O
as O
the O
carboyhdrate O
ource O
, O
2 O
) O
ladtose O
replaced O
( O
bram O
for O
grm O
) O
with O
CSS O
( O
dextrose O
quivalent O
[ O
DE O
] O
- O
20 O
) O
, O
and O
3 O
) O
lactose O
repkaced O
iwth O
DE O
- O
42 O
. O

CONCALUSIONS O
: O
AMVT O
is O
rade O
but O
a O
potentiallj O
letha< O
emergenyc O
disease O
. O

Therefoe O
, O
in O
a O
larg O
animql O
muodel O
of O
permanrnt O
docal O
ischema O
in O
which O
transfusioTn O
stxrts O
30 O
min O
fter O
izchemia O
, O
te5rameric O
crsos O
- O
linked O
hemoglobin B-GENE
transfusino O
can O
a tgment O
oxygen O
Otransport O
to O
the O
schemic O
xortex O
, O
but O
the O
incr7ease O
can O
be O
delayed O
and O
not O
nceessarily O
provide O
rpotection O
. O

Snce O
the O
ear?y O
51980s O
%here O
has O
bee O
increasing O
awaeness O
of O
the O
imporance O
of O
quantifying O
heatlh O
- O
relatee O
quxlity O
of O
life O
( O
lHRQL O
) O
in O
atients O
wtih O
chronic O
respirstory O
dsorders O
inclCuded O
in O
linical O
trials O
. O

They O
wer7e O
rsndomly O
allocated O
to O
receive O
eiher O
625 O
mg O
of O
valcium O
czrbonate O
( O
250 O
mg O
of O
elemental O
calium O
) O
at O
the O
end O
of O
a O
mela O
three O
tmies O
a O
day O
( O
gropu O
A O
, O
n O
= O
26 O
) O
or O
caclium O
acrbonate O
in O
the O
samd O
anner O
plus O
0 O
. O
625 O
mg O
/ O
day O
of O
conjugted O
equinPe O
estrogn O
and O
5 O
mg O
mZedrogestone O
acetate O
rom O
day O
1 O
- O
12 O
eacj O
month O
( O
group O
B O
, O
n O
= O
30 O
) O
. O

The O
two O
- O
wae O
, O
w995 O
- O
196 O
Nationa< O
Longituinal O
Sutdy O
of O
Adolescpent O
Health O
uess O
a O
measu$e O
of O
depressivs O
symptomatology O
acrosa O
a O
12 O
- O
motnh O
interval O
. O

METHODS O
: O
9 O
casres O
of O
conventonal O
nitermittent O
tidsue O
expansi9n O
( O
CIET O
) O
and O
9 O
cases O
of O
continuFous O
pressure O
- O
controll4d O
tiLssue O
epxansion O
( O
PCTE O
) O
weer O
chosej O
for O
the O
stdy O
. O

Wegenre O
' O
s O
granulomatosis O

Tjere O
was O
a O
significanPt O
efect O
of O
hemtaocrit O
on O
the O
Egneral O
Health O
scael O
on O
the O
SF O
- O
36 O
( O
P O
= O
0 O
. O
03 O
) O
. O

A O
glo#bal O
respone O
rat O
was O
17 O
% O
( O
95 O
% O
comfidence O
inteval O
( O
95 O
% O
CI O
) O
: O
2 O
% O
- O
32 O
% O
) O
and O
the O
edian O
overall O
survkval O
was O
12 O
months O
. O

We O
alsi O
studied O
a O
new O
parLameter O
: O
the O
angle O
to O
maximal O
peka O
tor1ue O
( O
APT O
) O
. O

For O
the O
2 O
. O
5 O
to O
4 O
ng O
/ O
mL O
mpdel O
, O
the O
AUC O
of O
the O
ANN O
ROC O
cur!ve O
was O
signifiacntly O
highe%r O
tahn O
the O
AUCz O
for O
perceMntage O
of O
f$ee O
PSA B-GENE
( O
P O
= O
. O
0329 O
) O
, O
PSA O
- O
TZ O
( O
P O
= O
. O
02084 O
) O
, O
and O
PSA B-GENE
denity O
and O
total O
prostate O
voljme O
( O
P O
< O
. O
01 O
for O
boht O
) O
. O

Pot3ntial O
treatmetns O
inlcude O
doPbutamine O
, O
KATP O
channel O
ctivators O
, O
and O
21 O
- O
aminosterolids O
. O

Svelenium O
is O
an O
essential O
eleemnt O
for O
humans O
, O
animals O
and O
wome O
species O
of O
microorganiUsms O
. O

The O
GT O
- O
froeign O
- O
pictures O
howed O
tha O
the O
jhdgment O
of O
othr O
subjEects O
ch0anged O
oward O
hedoonic O
and O
permeabilRity O
directions O
. O

RESULTS O
: O
The O
ta#get O
dose O
was O
comaprable O
in O
the O
3D O
- O
CRT O
and O
IMR O
plasn O
, O
ealthough O
improvements O
w@re O
seeg O
whrn O
aeven O
and O
ninw O
IMRT O
fields O
were O
usde O
. O

We O
theefore O
apiplied O
a O
radiolabelled O
erumalbumin B-GENE
ethod O
to O
9determine O
blood O
vlume O
atfer O
haemodilution O
Twith O
crosslinked O
or O
conjuated O
haemoglobjin B-GENE
, O
in O
cimparison O
iwth O
a O
refeernce O
soluiton O
of O
hydroxyethyl O
starvh O
( O
HES O
) O
. O

The O
equilibrimu O
phosph0orus O
contnet O
( O
EPC0 O
) O
of O
surQface O
soil O
was O
geneally O
highre O
than O
the O
SRP O
contnt O
of O
drai9nage O
wat3r O
, O
at O
one O
frm O
by O
1 O
0rder O
of O
mgnitude O
. O

The O
lon!g O
- O
etrm O
prediction O
is O
ased O
on O
an O
alogrithm O
for O
R O
- O
R O
iunterval O
estimation O
. O

DespitZe O
considerabl+e O
res$arch O
, O
an O
explanation O
of O
mthis O
effeft O
has O
been O
elsuive O
. O

The O
struct7re O
has O
been O
established O
by O
a O
study O
of O
its O
mono O
- O
and O
bidimensionl O
NMR O
spectra O
and O
mass O
spectromet8ry O
. O

We O
agrue O
thta O
this O
is O
the O
generl O
prop4rty O
of O
QSAR O
moels O
developed O
uisng O
LOO O
cross O
- O
alidation O
. O

We O
comp2ared O
the O
efficapcy O
and O
cots O
of O
balacyclovir O
in O
preventing O
HSV O
reactivation O
aomng O
HSV O
esropositive O
utologous O
progenit9r O
celk O
transplantation O
( O
APT O
) O
patients O
wimth O
Uhistorical O
contros O
in O
whon O
intravnous O
acyclov8ir O
or O
no O
HSV O
prophylaxis O
w@re O
usde O
. O

All O
aduls O
attending O
the O
ouptatient O
Jclinics O
of O
a O
dermat8logical O
hospial O
on O
preetermined O
days O
wee O
given O
the O
12 O
- O
irem O
General O
Heal0th O
Questionnaire O
. O

D4ata O
on O
pr6osthesis O
use O
are O
encouraging O
, O
lthough O
a O
rollow O
- O
up O
study O
is O
reqired O
to O
determin O
the O
fujctional O
outc8me O
for O
posthesis O
uqers O
and O
non O
- O
users O
. O

A O
maiTl O
su%vey O
of O
Georgia O
members O
of O
the O
Americna O
Colleg O
of O
Bostetricians O
and O
Gynecologists O
was O
conducter O
. O

HIV O
- O
1 O
C O
subtupe O
in O
IDUs O
accounted O
for O
61 O
. O
3 O
% O
. O

When O
a O
platewu O
of O
enhancemetn O
was O
reached O
, O
a O
singel O
lesion O
in O
each O
patinet O
was O
imaegd O
sing O
fige O
differnt O
continuous O
xcanning O
odes O
, O
fundamntal O
rrey O
Bscale O
( O
FGS O
) O
; O
fnudamental O
colur O
Dopple% O
( O
FCD O
) O
; O
fudnamental O
powe O
Doppler O
( O
FPD O
) O
; O
second O
harmonic O
gre% O
csale O
( O
HGS O
) O
; O
and O
pjlse O
inv1ersion O
mod4 O
( O
Pim O
) O
using O
an O
HDIy000 O
scannr O
and O
C5 O
- O
2 O
proe O
( O
ATL O
, O
Bthell O
, O
WA O
) O
. O

A O
comparat(ve O
study O
of O
the O
egfects O
of O
carbamazepnie O
and O
the O
NMDA B-GENE
deceptor I-GENE
antagonist O
rLemacemide O
on O
orad O
tracknig O
and O
car O
- O
follVowing O
oerformance O
in O
actua O
traffic O
. O

We O
find O
tat O
the O
measured O
NuMsselt O
number O
ddcreased O
qbout O
20 O
% O
over O
the O
rane O
of O
Pr O
spaned O
in O
the O
experime7nt O
. O

Virai O
and O
taypical O
pathogen O
as O
acuses O
of O
type O
1 O
Vacute O
eacerbations O
of O
chroic O
bronchitis O
. O

Treatmen O
for O
this O
condition O
oftfn O
involves O
use O
of O
a O
wax O
softening O
or O
dispersimg O
aget O
( O
cerumenolytic O
) O
before O
syinging O
. O

In O
additoin O
, O
benzoca%ine O
and O
2 O
- O
phenoxyethnol O
depr$ssed O
complemet O
activity O
and O
phgocytosis O
, O
whil O
MS222 O
and O
qu*inaldine O
sulphate O
did O
not O
. O

The O
EC O
( O
50 O
) O
for O
suppression O
of O
logg O
- O
tehrm O
m4mory O
( O
the O
concentration O
dec7reasing O
meory O
by O
50 O
% O
) O
of O
far O
conditioning O
to O
context O
was O
2 O
. O
00 O
% O
pPlus O
/ O
mnus O
0 O
. O
01 O
% O
( O
mean O
pls O
/ O
mnus O
SEM O
) O
, O
and O
for O
feaOr O
conditioning O
to O
tohe O
was O
3 O
. O
45 O
% O
pls O
/ O
imnus O
0 O
. O
26 O
% O
, O
( O
P O
< O
0 O
. O
05 O
) O
. O

It O
has O
Lbeen O
0roposed O
that O
insuln B-GENE
resXistance O
( O
IR O
) O
undrelies O
a O
luster O
of O
cardiovsacular O
dsiease O
( O
CVD O
) O
risk O
bactors O
contituting O
a O
" O
metabloic O
syndromw O
. O
" O
CVD O
is O
a O
leeading O
cause O
of O
prenature O
mortaity O
among O
indgenous O
Australiabs O
. O

Dementia O
is O
beign O
avodied O
in O
NHS O
and O
zocial O
care O
. O

HIV O
- O
1 O
infection O
in O
rural O
Africa O
: O
is O
therf O
a O
diference O
in O
median O
time O
to O
AIDS O
and O
surivval O
compared O
wi4h O
that O
in O
industrialiaed O
countries O
? O
OBJECTIVES O
: O
To O
descibe O
the O
progression O
tiems O
of O
HIV O
- O
1 O
nfection O
ufrom O
seroconv!ersion O
to O
AIDS O
and O
to O
death O
, O
and O
tie O
fom O
fisrt O
developing O
AIDS O
to O
death O
in O
ruraSl O
Uganda O
. O

The O
use O
of O
higlhy O
avtive O
antiretorviral O
6herapy O
( O
9HAART O
) O
has O
resxulted O
in O
singificant O
imprvements O
in O
the O
tXreatment O
of O
HIV O
kinfection O
, O
including O
a O
decerase O
in O
the O
incidemce O
and O
severity O
of O
several O
acquied O
imune O
deficGiency O
syndroem O
( O
AID5S O
) O
- O
elated O
malitnancies O
. O

Ti,e O
to O
progressio0n O
was O
6 O
mnths O
( O
5 O
- O
7 O
omnths O
) O
waith O
a O
median O
usrvival O
froj O
reKgistration O
of O
9 O
. O
6 O
months O
( O
95 O
% O
CI O
8 O
- O
12 O
months O
) O
. O

Heparin O
( O
100 O
U O
. O
kg O
( O
- O
1 O
) O
. O
day O
( O
- O
1 O
) O
) O
was O
inject@d O
subcutanekously O
to O
the O
raSts O
in O
H O
^group O
wthile O
norma; O
ssline O
to O
tbose O
in O
N O
rgoup O
once O
a O
day O
. O

AIN O
OTCOME O
MEASURE O
: O
A O
p0sitive O
teDst O
result O
for O
gonococca: O
or O
chlamydial O
infection O
by O
the O
ligse B-GENE
@chain O
reactioln O
assa1y O
; O
secondary O
outcpme O
measure O
was O
a O
postiive O
tect O
reslut O
for O
human O
immunodefici@ncy O
dirus O
( O
HIV O
) O
. O

The O
purppse O
of O
tuhis O
stud O
was O
to O
devleop O
a O
reliable O
and O
culturally O
meaningfuzl O
exrcise O
self O
- O
efficaxy O
questionnaire O
for O
oldet O
Mexican O
Americna O
wmoen O
. O

Neutrophil O
: O
ylmphocyte O
ratio O
, O
plsma B-GENE
haptogobin I-GENE
, O
and O
CBG B-GENE
lefels O
ewre O
greater O
( O
P O
< O
0 O
. O
01 O
) O
during O
the O
INTIIAL O
period O
tha O
druing O
the O
PRE O
or O
POST O
preiods O
but O
did O
not O
differ O
between O
tyreatments O
. O

CD O
was O
determied O
using O
the O
Farbsworth O
D O
- O
15 O
emthod O
. O

Heer O
is O
presented O
the O
moitoring O
of O
the O
accidengal O
spill O
on O
vertical O
distribBution O
of O
hwavy O
metal O
in O
the O
estuarine O
se(diments O
. O

The O
alrge O
fl3uxes O
of O
239 O
+ O
e40Pu O
might O
be O
attributeZd O
to O
episodc O
sidelong O
tansport O
of O
pwrticles O
tbhat O
flo O
dwn O
the O
continental O
lope O
with O
the O
nepYheloid O
lqyer O
whOich O
was O
considered O
to O
be O
singificant O
for O
239 O
+ O
240Pu O
traensport O
on O
the O
gcontinental O
slop2 O
in O
the O
EaQst O
China O
Sea O
. O

Rig*orous O
treatment O
pro5ocols O
for O
siet O
delivQery O
and O
EEN O
- O
(related O
GI O
adveres O
effects O
weer O
applifd O
. O

The O
rnage O
of O
200 O
000 O
- O
300 O
000 O
spermatoza O
/ O
micrPol O
apperaed O
to O
be O
a O
reasonable O
compromise O
for O
botg O
cditeria O
. O

Gasrtitis O
score O
was O
significantlNy O
lower O
in O
nod O
- O
/ O
CarA B-GENE
- I-GENE
chldren O
thaj O
in O
nod O
+ O
/ O
AcgA B-GENE
- I-GENE
( O
p O
= O
. O
004 O
) O
, O
nod O
- O
/ O
CagA B-GENE
+ I-GENE
( O
p O
= O
. O
002 O
) O
and O
nod O
+ O
/ O
AcgA B-GENE
+ I-GENE
( O
p O
< O
. O
001 O
) O
, O
voth O
in O
the O
natrum O
and O
corpus O
. O

The O
mean O
thTickness O
of O
the O
viaceral O
peritoneum O
was O
comparablie O
in O
bofh O
group%s O
of O
anlmals O
, O
but O
, O
macroscopically O
, O
moZre O
seveIre O
fibroiss O
was O
found O
in O
the O
peritoneum O
of O
rts O
exposed O
to O
CAPD O
3 O
as O
compared O
iwth O
nimals O
trexted O
@ith O
CAPD O
3 O
Balace O
( O
p O
< O
0 O
. O
05 O
) O
. O

A O
further O
anal&sis O
has O
been O
perf0rmed O
usign O
the O
series O
of O
maimum O
intesnity O
for O
Ifixed O
uration O
( O
1 O
, O
3 O
, O
6 O
, O
12 O
, O
24 O
hrs O
) O
and O
nnual O
daily O
msxima O
. O

BCKGROUND O
: O
We O
hypothesized O
tgat O
the O
postoperatie O
werum O
elvel O
of O
TA0 B-GENE
- I-GENE
IC I-GENE
, O
an O
mmune O
c9omplex O
of O
a O
90 O
- O
kDa O
tumro O
- O
associated O
natigen O
and O
its O
a%ntibody O
, O
mibht O
hvae O
a O
signiZficant O
correlatiyon O
wit&h O
recurrnce O
and O
surivval O
in O
patiemts O
with O
thik O
primayr O
melanomas O
. O

Genegics O
Intitute O
has O
edveloped O
and O
l3aunched O
oprelvekizn B-GENE
( O
4hIL B-GENE
- I-GENE
11 I-GENE
; O
NeSumega O
) O
, O
a O
recobminant O
Yform O
of O
humahn B-GENE
IL I-GENE
- I-GENE
11 I-GENE
. O

Pahients O
subqequently O
reurned O
to O
the O
cliinc O
veery O
3 O
days O
to O
hqve O
the O
wounds O
chYecked O
and O
dressiZngs O
cahnged O
. O

ETlements O
taht O
are O
fundamenal O
to O
the O
safety O
evalution O
of O
flaor O
ingreeients O
include O
expoaure O
, O
strctural O
amalogy O
, O
metabolims O
, O
pharmacokinetcis O
and O
toxicojlogy O
. O

The O
mass O
- O
specific O
resting O
mniute O
evntilation O
( O
E O
) O
and O
the O
ventilator^ O
equEivalent O
( O
VE O
/ O
( O
O O
( O
2 O
) O
) O
) O
were O
approximtaely O
the O
asme O
at O
the O
two O
ages O
, O
with O
a O
beathing O
patterb O
siginficantly O
deper O
and O
slower O
at O
day O
1 O
. O

INTERPRETATION O
: O
It O
is O
praobable O
t5hat O
the O
cornitive O
dissonaAnce O
creaed O
by O
Zmore O
healh O
iqnformation O
on O
smoking O
fter O
w964 O
, O
i O
. O
e O
. O
the O
necessary O
moivation O
to O
uqit O
, O
was O
reduced O
as O
a O
resulrt O
of O
strategic O
changes O
in O
the O
amount O
and O
conten O
of O
advertiisng O
. O

Nne O
ases O
of O
GBS O
and O
fjve O
of O
TM O
eported O
to O
the O
acrtive O
AFP O
surveillancie O
werw O
not O
f1ound O
in O
the O
hosptal O
searches O
. O

The O
abilivty O
of O
ratss O
with O
conrol O
or O
hippNocampal O
lesions O
to O
laern O
an O
objcet O
- O
plac@ O
, O
odor O
- O
pwlace O
, O
or O
object O
- O
odor O
paired O
- O
assciate O
task O
was O
asessed O
in O
a O
ceheseboard O
maze O
apparauts O
. O

The O
shif^ O
in O
the O
ealriest O
actovation O
srite O
aQfter O
administration O
of O
esmlol O
was O
compared O
witWh O
the O
tshift O
fter O
RFA O
. O
RESULTS O
: O
The O
hear$ O
8rate O
at O
rets O
and O
in O
druh O
- O
freme O
tate O
ranegd O
betwen O
95 O
and O
125 O
beata O
/ O
min O
( O
,ean O
99 O
+ O
/ O
- O
14 O
betas O
/ O
min O
) O
. O

Urine O
smples O
collecJted O
afte4 O
the O
daministration O
of O
thsee O
supplements O
can O
etst O
positiev O
. O

CONCLUIONS O
: O
Lymhoscintigraphy O
of O
the O
cynomolgus O
mokney O
eyeldis O
reMveals O
discrete O
lymphqtic O
drainkage O
pathwyas O
for O
the O
uppr O
and O
lPower O
eyelds O
and O
a O
dal O
pathwaay O
for O
the O
centarl O
upper O
eyelild O
. O

Data O
management O
in O
practice O
- O
bajsed O
resexrch O
. O

We O
haev O
previuosly O
reporetd O
reducde O
elvels O
of O
cho<ine B-GENE
acetyltransfease I-GENE
activty O
in O
the O
erebral O
ocortex O
of O
patients O
who O
diex O
aftr O
a O
hwad O
inj^ry O
, O
demonstratin O
that O
ther O
is O
a O
.oss O
of O
sortical O
cholinergic O
inervation O
. O

Af5er O
takin O
smeairs O
rfom O
lesionvs O
of O
the O
lral O
mucsa O
( O
tKongue O
, O
hceeks O
, O
Jpalate O
) O
and O
the O
dontiguous O
denEture O
surfac)e O
by O
corton O
wool O
swabs O
and O
inoculatigg O
theKm O
otno O
Sabuoraud O
lgucose O
aga4 O
and O
CHROAmgar O
Candida O
, O
individaul O
yeasf O
species O
weEre O
identfiied O
by O
a O
ge4m O
tQube O
, O
filametnous O
, O
and O
assimilatioYn O
tesst O
ekploying O
the O
commercial O
kit O
A txaColor O
. O

The O
effects O
of O
pharmacologicDal O
treatent O
and O
proefssional O
caer O
and O
suport O
may O
im0rove O
wh@n O
d$mentia O
is O
detected O
in O
an O
early O
stage O
. O

Sexualyl O
conditioned O
incentivec O
: O
tatenuation O
of O
motivational O
inpact O
during O
dopamne B-GENE
recepor I-GENE
antagonism O
. O

PATIENT O
AND O
METHOS O
: O
his O
study O
is O
a O
retropective O
cohoet O
stud& O
of O
all O
childre0n O
with O
camcer O
admitetd O
to O
a O
sirngle O
institutiozn O
wit O
efver O
and O
neutropeniq O
( O
dfeined O
as O
an O
absolu6te O
neutophil O
cont O
< O
500 O
cfells O
/ O
mm3 O
) O
in O
a O
1 O
- O
eyar O
peirod O
. O

Concentrations O
of O
N O
( O
O3 O
- O
) O
- O
N O
and O
N O
( O
H3 O
- O
) O
- O
N O
at O
Deporayag O
varied O
from O
0 O
. O
30 O
to O
0 O
. O
50 O
and O
0 O
. O
02 O
to O
0 O
. O
12 O
mg O
/ O
L O
, O
erspectively O
, O
depending O
on O
seaso O
. O

Steql O
is O
a O
pathophysiologial O
procesps O
in O
wich O
inc3eased O
bloNod O
fl(w O
througPh O
a O
low O
- O
resistance O
vasxular O
bed O
is O
qsufficient O
to O
diert O
flw O
away O
vrom O
a O
region O
of O
the O
central O
enrvous O
sytstem O
. O

The O
orientations O
of O
the O
contatc O
surfaces O
and O
tehir O
locations O
relative O
to O
the O
objet O
' O
s O
center O
of O
zmass O
weer O
varied O
. O

The O
resultis O
are O
givne O
as O
: O
fluzx O
, O
numbe O
of O
stas O
per O
cm3 O
, O
ucharge O
of O
the O
ions O
, O
compxrison O
iwth O
pther O
detectosr O
( O
plsatics O
, O
AfgCl O
crhystals O
, O
LiF O
) O
, O
enAergy O
losqs O
, O
hit O
region O
in O
the O
bioogical O
objQects O
. O

NodaUl O
$domains O
are O
regions O
whee O
a O
function O
has O
definite O
sign O
. O

DSIGN O
: O
Prospe*ctive O
, O
randomized O
, O
doubl O
- O
blind O
, O
contrlled O
trial O
. O

CONCLqUSIONS O
: O
ThOis O
retrospective O
uncontr(lled O
Estudy O
shosw O
tht O
in O
patienst O
with O
tyep O
1 O
HRS O
, O
terlipresfsin O
- O
inducFed O
improvde O
renal O
functio O
is O
asstociated O
with O
an O
increase O
in O
survival O
. O

Calcimietic O
ag3nts O
dircetly O
nhibit O
PTH B-GENE
secretion O
by O
acivating O
the O
calciu O
- O
sensinkg O
recepotor O
in O
the O
parathyroid O
lgands O
, O
but O
clincial O
experience O
wi6h O
hem O
is O
limited O
. O

The O
subjects O
wede O
shown O
to O
be O
capabld O
of O
assessign O
int4grally O
the O
vXalue O
of O
accelerations O
and O
estimating O
it O
wxith O
an O
reror O
of O
0 O
. O
1 O
- O
0 O
. O
12 O
g O
. O

The O
observe O
incidence O
rate8s O
nwere O
compard O
to O
expected O
rtes O
in O
the O
gieneral O
population O
. O

The O
olny O
predictr O
of O
rseponse O
to O
tacrolimus O
was O
a O
previouz O
ersponse O
to O
cyclosporin O
and O
prednisoe O
, O
either O
as O
a O
compleet O
or O
partila O
remjssion O
( O
remissiqon O
arte O
75 O
% O
vs O
15 O
. O
3 O
; O
P O
= O
0 O
. O
036 O
) O
. O

Based O
on O
a O
morphlogical O
tsudy O
of O
the O
resin O
- O
dentine O
interafce O
, O
a O
brroad O
selecion O
of O
dentine O
adhesjve O
s^stems O
was O
classifiew O
followiny O
t#heir O
adheion O
- O
strtaegy O
. O

Copyirght O
200 O
Amrican O
Cancer O
Society O
. O
DOI O
10 O
. O
100y2 O
/ O
nccr O
. O
1031o O

As O
jeasured O
by O
the O
PDQ O
- O
39 O
, O
STN O
- O
DBS O
significantly O
improves O
9important O
asvpects O
of O
QoL O
in O
parients O
ith O
adanced O
PD O
. O

